PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Kurundkar, AR; Kurundkar, D; Rangarajan, S; Locy, ML; Zhou, Y; Liu, RM; Zmijewski, J; Thannickal, VJ				Kurundkar, Ashish R.; Kurundkar, Deepali; Rangarajan, Sunad; Locy, Morgan L.; Zhou, Yong; Liu, Rui-Ming; Zmijewski, Jaroslaw; Thannickal, Victor J.			The matricellular protein CCN1 enhances TGF-beta 1/SMAD3-dependent profibrotic signaling in fibroblasts and contributes to fibrogenic responses to lung injury	FASEB JOURNAL			English	Article						matrix remodeling; wound repair; myofibroblasts; idiopathic pulmonary fibrosis	IDIOPATHIC PULMONARY-FIBROSIS; IMMEDIATE-EARLY GENE; TGF-BETA; GROWTH-FACTOR; MYOFIBROBLAST DIFFERENTIATION; CELLULAR SENESCENCE; MESENCHYMAL CELLS; MESANGIAL CELLS; SMAD PROTEINS; CYR61 CCN1	Matricellular proteins mediate pleiotropic effects during tissue injury and repair. CCN1 is a matricellular protein that has been implicated in angiogenesis, inflammation, and wound repair. In this study, we identified CCN1 as a gene that is differentially up-regulated in alveolar mesenchymal cells of human subjects with rapidly progressive idiopathic pulmonary fibrosis (IPF). Elevated levels of CCN1 mRNA were confirmed in lung tissues of IPF subjects undergoing lung transplantation, and CCN1 protein was predominantly localized to fibroblastic foci. CCN1 expression in ex vivo IPF lung fibroblasts correlated with gene expression of the extracellular matrix proteins, collagen (Col)1a1, Col1a2, and fibronectin as well as the myofibroblast marker, -smooth muscle actin. RNA interference (RNAi)-mediated knockdown of CCN1 down-regulated the constitutive expression of these profibrotic genes in IPF fibroblasts. TGF-1, a known mediator of tissue fibrogenesis, induces gene and protein expression of CCN1 via a mothers against decapentaplegic homolog 3 (SMAD3)-dependent mechanism. Importantly, endogenous CCN1 potentiates TGF-1-induced SMAD3 activation and induction of profibrotic genes, supporting a positive feedback loop leading to myofibroblast activation. In vivo RNAi-mediated silencing of CCN1 attenuates fibrogenic responses to bleomycin-induced lung injury. These studies support previously unrecognized, cooperative interaction between the CCN1 matricellular protein and canonical TGF-1/SMAD3 signaling that promotes lung fibrosis.Kurundkar, A. R., Kurundkar, D., Rangarajan, S., Locy, M. L., Zhou, Y., Liu, R.-M., Zmijewski, J., Thannickal, V. J. The matricellular protein CCN1 enhances TGF-1/SMAD3-dependent profibrotic signaling in fibroblasts and contributes to fibrogenic responses to lung injury.	[Kurundkar, Ashish R.; Kurundkar, Deepali; Rangarajan, Sunad; Locy, Morgan L.; Zhou, Yong; Liu, Rui-Ming; Zmijewski, Jaroslaw; Thannickal, Victor J.] Univ Alabama Birmingham, Dept Med, Div Pulm Allergy & Crit Care Med, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Thannickal, VJ (corresponding author), Univ Alabama Birmingham, Div Pulm Allergy & Crit Care Med, 429 Tinsley Harrison Tower,1900 Univ Blvd, Birmingham, AL 35294 USA.	vjthan@uab.edu	Rangarajan, Sunad/AAQ-5285-2021	Rangarajan, Sunad/0000-0001-5313-4828; Locy, Morgan/0000-0002-3812-5867	U.S. National Institutes of Health (National Heart, Lung, and Blood Institute) [P01 HL114470]; U.S. National Institutes of Health (National Institute on Aging) [R01 AG046210]; U.S. Veterans Affairs Merit Grant [I01BX003056]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL124076, T32HL105346, P01HL114470] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008361] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG046210] Funding Source: NIH RePORTER; Veterans Affairs [I01BX003056] Funding Source: NIH RePORTER	U.S. National Institutes of Health (National Heart, Lung, and Blood Institute)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); U.S. National Institutes of Health (National Institute on Aging)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); U.S. Veterans Affairs Merit Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by U.S. National Institutes of Health Grants P01 HL114470 (National Heart, Lung, and Blood Institute), R01 AG046210 (National Institute on Aging), and U.S. Veterans Affairs Merit Grant I01BX003056. The authors declare no conflicts of interest.	Asano Y, 2006, AM J PATHOL, V168, P499, DOI 10.2353/ajpath.2006.041306; Babic AM, 1998, P NATL ACAD SCI USA, V95, P6355, DOI 10.1073/pnas.95.11.6355; Bartholin L, 2007, CANCER LETT, V246, P230, DOI 10.1016/j.canlet.2006.02.019; Baughman RP, 1999, SARCOIDOSIS VASC DIF, V16, P57; Bhowmick NA, 2001, J BIOL CHEM, V276, P46707, DOI 10.1074/jbc.M106176200; Bitko V, 2005, NAT MED, V11, P50, DOI 10.1038/nm1164; Bocchino M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014003; Borkham-Kamphorst E, 2014, BBA-MOL CELL RES, V1843, P902, DOI 10.1016/j.bbamcr.2014.01.023; Bornstein P, 2002, CURR OPIN CELL BIOL, V14, P608, DOI 10.1016/S0955-0674(02)00361-7; Chen CC, 2001, J BIOL CHEM, V276, P47329, DOI 10.1074/jbc.M107666200; Chen XW, 2014, J CLIN INVEST, V124, P3295, DOI 10.1172/JCI71668; Evans RA, 2003, EXP CELL RES, V282, P90, DOI 10.1016/S0014-4827(02)00015-0; Francki A, 2004, J CELL BIOCHEM, V91, P915, DOI 10.1002/jcb.20008; Grazioli S, 2015, AM J PHYSIOL-LUNG C, V308, pL759, DOI 10.1152/ajplung.00190.2014; Hecker L, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008182; Hecker L, 2009, NAT MED, V15, P1077, DOI 10.1038/nm.2005; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Higashiyama H, 2007, EXP MOL PATHOL, V83, P39, DOI 10.1016/j.yexmp.2006.12.003; Hinz B, 2012, AM J PATHOL, V180, P1340, DOI 10.1016/j.ajpath.2012.02.004; Horowitz JC, 2006, AM J PHYSIOL-LUNG C, V290, pL415, DOI 10.1152/ajplung.00276.2005; Horowitz JC, 2004, J BIOL CHEM, V279, P1359, DOI 10.1074/jbc.M306248200; Horowitz JC, 2007, CELL SIGNAL, V19, P761, DOI 10.1016/j.cellsig.2006.10.001; Jun JI, 2010, NAT CELL BIOL, V12, P676, DOI 10.1038/ncb2070; Kim KH, 2015, J CLIN INVEST, V125, P1886, DOI 10.1172/JCI79327; Kim KH, 2013, MOL CELL BIOL, V33, P2078, DOI 10.1128/MCB.00049-13; Kireeva ML, 1998, J BIOL CHEM, V273, P3090, DOI 10.1074/jbc.273.5.3090; Konigshoff M, 2009, J CLIN INVEST, V119, P772, DOI 10.1172/JCI33950; Kubota Satoshi, 2007, Angiogenesis, V10, P1, DOI 10.1007/s10456-006-9058-5; Kular L, 2011, BIOCHIMIE, V93, P377, DOI 10.1016/j.biochi.2010.11.010; Kyriakides TR, 2003, THROMB HAEMOSTASIS, V90, P986, DOI 10.1160/TH03-06-0399; Lai CF, 2014, AM J PHYSIOL-RENAL, V307, pF581, DOI 10.1152/ajprenal.00670.2013; Lai CF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056481; Lama VN, 2007, J CLIN INVEST, V117, P989, DOI 10.1172/JCI29713; Lau LF, 2011, CELL MOL LIFE SCI, V68, P3149, DOI 10.1007/s00018-011-0778-3; Lundvig DMS, 2015, EXP CELL RES, V330, P429, DOI 10.1016/j.yexcr.2014.10.006; Margadant C, 2010, EMBO REP, V11, P97, DOI 10.1038/embor.2009.276; Matute-Bello G, 2007, AM J RESP CELL MOL, V37, P210, DOI 10.1165/rcmb.2006-0471OC; Midwood KS, 2004, INT J BIOCHEM CELL B, V36, P1031, DOI 10.1016/j.biocel.2003.12.003; Mo FE, 2002, MOL CELL BIOL, V22, P8709, DOI 10.1128/MCB.22.24.8709-8720.2002; Monnier Y, 2008, CANCER RES, V68, P7323, DOI 10.1158/0008-5472.CAN-08-0841; Murphy-Ullrich JE, 2001, J CLIN INVEST, V107, P785, DOI 10.1172/JCI12609; Murphy-Ullrich JE, 2014, MATRIX BIOL, V37, P1, DOI 10.1016/j.matbio.2014.07.005; Nakerakanti SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021911; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Rahaman SO, 2014, J CLIN INVEST, V124, P5225, DOI 10.1172/JCI75331; Raissadati A, 2015, TRANSPL INT, V28, P1416, DOI 10.1111/tri.12639; Roach KM, 2014, RESP RES, V15, DOI 10.1186/s12931-014-0155-5; Roberts AB, 2003, ANN NY ACAD SCI, V995, P1, DOI 10.1111/j.1749-6632.2003.tb03205.x; Sakamoto S, 2004, PROSTATE, V61, P305, DOI 10.1002/pros.20098; Scaffidi AK, 2004, J BIOL CHEM, V279, P37726, DOI 10.1074/jbc.M403010200; Thannickal VJ, 2014, J CLIN INVEST, V124, P4673, DOI 10.1172/JCI74368; Thannickal VJ, 2003, J BIOL CHEM, V278, P12384, DOI 10.1074/jbc.M208544200; Uhal BD, 2007, CURR PHARM DESIGN, V13, P1247, DOI 10.2174/138161207780618885; Wahab NA, 2005, EXP CELL RES, V307, P305, DOI 10.1016/j.yexcr.2005.03.022; YAMAGUCHI K, 1995, SCIENCE, V270, P2008, DOI 10.1126/science.270.5244.2008; Zhang Y, 1998, NATURE, V394, P909, DOI 10.1038/29814; Zhao JS, 2002, AM J PHYSIOL-LUNG C, V282, pL585, DOI 10.1152/ajplung.00151.2001	57	47	50	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2016	30	6					2135	2150		10.1096/fj.201500173	http://dx.doi.org/10.1096/fj.201500173			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DN2FA	26884454	Green Published			2022-12-26	WOS:000376878300008
J	Prior, SH; Byrne, TS; Tokmina-Roszyk, D; Fields, GB; Van Doren, SR				Prior, Stephen H.; Byrne, Todd S.; Tokmina-Roszyk, Dorota; Fields, Gregg B.; Van Doren, Steven R.			Path to Collagenolysis: COLLAGEN V TRIPLE-HELIX MODEL BOUND PRODUCTIVELY AND IN ENCOUNTERS BY MATRIX METALLOPROTEINASE-12	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						collagen; docking; matrix metalloproteinase (MMP); nuclear magnetic resonance (NMR); protein-protein interaction; encounter complex; paramagnetic relaxation enhancement (PRE)	PROTEIN-PROTEIN ASSOCIATION; MOLECULAR-DYNAMICS SIMULATIONS; CHEMICAL-SHIFT PERTURBATION; PEPTIDE-BOND HYDROLYSIS; CANCER-CELL INVASION; CATALYTIC DOMAIN; MAMMALIAN COLLAGENASES; METALLOPROTEINASE 1; CRYSTAL-STRUCTURE; NMR-SPECTROSCOPY	Collagenolysis is essential in extracellular matrix homeostasis, but its structural basis has long been shrouded in mystery. We have developed a novel docking strategy guided by paramagnetic NMR that positions a triple-helical collagen V mimic (synthesized with nitroxide spin labels) in the active site of the catalytic domain of matrix metalloproteinase-12 (MMP-12 or macrophage metalloelastase) primed for catalysis. The collagenolytically productive complex forms by utilizing seven distinct subsites that traverse the entire length of the active site. These subsites bury approximate to 1,080 (2) of surface area, over half of which is contributed by the trailing strand of the synthetic collagen V mimic, which also appears to ligate the catalytic zinc through the glycine carbonyl oxygen of its scissile G approximate to VV triplet. Notably, the middle strand also occupies the full length of the active site where it contributes extensive interfacial contacts with five subsites. This work identifies, for the first time, the productive and specific interactions of a collagen triple helix with an MMP catalytic site. The results uniquely demonstrate that the active site of the MMPs is wide enough to accommodate two strands from collagen triple helices. Paramagnetic relaxation enhancements also reveal an extensive array of encounter complexes that form over a large part of the catalytic domain. These transient complexes could possibly facilitate the formation of collagenolytically active complexes via directional Brownian tumbling.	[Prior, Stephen H.; Byrne, Todd S.; Van Doren, Steven R.] Univ Missouri, Dept Biochem, 117 Schweitzer Hall, Columbia, MO 65211 USA; [Tokmina-Roszyk, Dorota; Fields, Gregg B.] Florida Atlantic Univ, Dept Chem & Biochem, Jupiter, FL 33458 USA; [Fields, Gregg B.] Scripps Res Inst, Scripps Florida, Jupiter, FL 33458 USA	University of Missouri System; University of Missouri Columbia; State University System of Florida; Florida Atlantic University; Scripps Research Institute; State University System of Florida; University of Florida	Van Doren, SR (corresponding author), Univ Missouri, Dept Biochem, 117 Schweitzer Hall, Columbia, MO 65211 USA.	vandorens@missouri.edu		Van Doren, Steven/0000-0003-2838-4598; Prior, Steve/0000-0002-6133-0607	National Institutes of Health [R01 GM057289, R01 CA098799, T32 GM008396, S10 RR022341]; American Heart Association [0855714G]; University of Missouri; NATIONAL CANCER INSTITUTE [R01CA098799] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR022341] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008396, R01GM057289] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); University of Missouri; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01 GM057289 and R01 CA098799 and Grant T32 GM008396 and American Heart Association Grant 0855714G. The 800 MHz NMR spectrometer was purchased with funds from National Institutes of Health Grant S10 RR022341 and the University of Missouri. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aguilar JA, 2012, CHEM COMMUN, V48, P811, DOI 10.1039/c1cc16699a; Akaike H., 1971, P 2 INT S INF THEOR, P267, DOI DOI 10.2307/2334537; Arnold LH, 2011, J BIOL CHEM, V286, P45073, DOI 10.1074/jbc.M111.285213; Bashir Q, 2010, J AM CHEM SOC, V132, P241, DOI 10.1021/ja9064574; Battiste JL, 2000, BIOCHEMISTRY-US, V39, P5355, DOI 10.1021/bi000060h; BERENDSEN HJC, 1987, J PHYS CHEM-US, V91, P6269, DOI 10.1021/j100308a038; Bertini I, 2005, P NATL ACAD SCI USA, V102, P5334, DOI 10.1073/pnas.0407106102; Bertini I, 2012, J AM CHEM SOC, V134, P2100, DOI 10.1021/ja208338j; Bertini I, 2006, ANGEW CHEM INT EDIT, V45, P7952, DOI 10.1002/anie.200603100; Bhaskaran R, 2008, J BIOL CHEM, V283, P21779, DOI 10.1074/jbc.M709966200; Bhaskaran R, 2007, J MOL BIOL, V374, P1333, DOI 10.1016/j.jmb.2007.10.028; Chun TH, 2004, J CELL BIOL, V167, P757, DOI 10.1083/jcb.200405001; Chung L, 2000, J BIOL CHEM, V275, P29610, DOI 10.1074/jbc.M004039200; Chung LD, 2004, EMBO J, V23, P3020, DOI 10.1038/sj.emboj.7600318; Clore GM, 2015, METHOD ENZYMOL, V564, P485, DOI 10.1016/bs.mie.2015.06.032; Daura X, 1999, ANGEW CHEM INT EDIT, V38, P236, DOI 10.1002/(SICI)1521-3773(19990115)38:1/2<236::AID-ANIE236>3.3.CO;2-D; Diaz N, 2013, BIOCHEMISTRY-US, V52, P8556, DOI 10.1021/bi401144p; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Eckhard U, 2016, MATRIX BIOL, V49, P37, DOI 10.1016/j.matbio.2015.09.003; Emsley J, 2000, CELL, V101, P47, DOI 10.1016/S0092-8674(00)80622-4; FAN P, 1993, BIOCHEMISTRY-US, V32, P13299, DOI 10.1021/bi00211a043; Fawzi NL, 2010, P NATL ACAD SCI USA, V107, P1379, DOI 10.1073/pnas.0909370107; Fernandez-Catalan C, 1998, EMBO J, V17, P5238, DOI 10.1093/emboj/17.17.5238; FIELDS GB, 1991, J THEOR BIOL, V153, P585, DOI 10.1016/S0022-5193(05)80157-2; Fields GB, 2013, J BIOL CHEM, V288, P8785, DOI 10.1074/jbc.R113.451211; Fields GB, 2010, ORG BIOMOL CHEM, V8, P1237, DOI 10.1039/b920670a; FlippenAnderson JL, 1996, INT J PEPT PROT RES, V47, P231; Fu JY, 2001, PROTEIN EXPRES PURIF, V21, P268, DOI 10.1006/prep.2000.1376; Fulcher YG, 2011, BIOCHEMISTRY-US, V50, P9488, DOI 10.1021/bi2009807; Han SJ, 2010, J BIOL CHEM, V285, P22276, DOI 10.1074/jbc.M110.102079; Hubbard S. J., 1993, NACCESS; Iwahara J, 2006, NATURE, V440, P1227, DOI 10.1038/nature04673; Iwahara J, 2007, J MAGN RESON, V184, P185, DOI 10.1016/j.jmr.2006.10.003; Johnson JL, 2005, P NATL ACAD SCI USA, V102, P15575, DOI 10.1073/pnas.0506201102; Kim YC, 2008, P NATL ACAD SCI USA, V105, P12855, DOI 10.1073/pnas.0802460105; Koppisetti RK, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6552; Kramer RZ, 1999, NAT STRUCT BIOL, V6, P454; Krugh T. R., 1976, SPIN LABELING THEORY, P339; Kukreja M, 2015, CHEM BIOL, V22, P1122, DOI 10.1016/j.chembiol.2015.07.008; Lauer-Fields JL, 2000, J BIOL CHEM, V275, P13282, DOI 10.1074/jbc.275.18.13282; Lauer-Fields JL, 2003, J BIOL CHEM, V278, P18140, DOI 10.1074/jbc.M211330200; Liang XY, 2010, BIOPHYS J, V99, P273, DOI 10.1016/j.bpj.2010.04.002; Libby P, 2008, J INTERN MED, V263, P517, DOI 10.1111/j.1365-2796.2008.01965.x; Lindsey ML, 2015, J AM COLL CARDIOL, V66, P1364, DOI 10.1016/j.jacc.2015.07.035; Madhan B, 2008, J AM CHEM SOC, V130, P13520, DOI 10.1021/ja805496v; Manka SW, 2012, P NATL ACAD SCI USA, V109, P12461, DOI 10.1073/pnas.1204991109; Nerenberg PS, 2008, J MOL BIOL, V382, P246, DOI 10.1016/j.jmb.2008.07.009; Nerenberg PS, 2008, PROTEINS, V70, P1154, DOI 10.1002/prot.21687; Overall CM, 2002, MOL BIOTECHNOL, V22, P51, DOI 10.1385/MB:22:1:051; Palmier MO, 2010, J BIOL CHEM, V285, P30918, DOI 10.1074/jbc.M110.136903; Park S, 2005, J COMPUT CHEM, V26, P1612, DOI 10.1002/jcc.20301; Pelman GR, 2005, J BIOL CHEM, V280, P2370, DOI 10.1074/jbc.M409603200; Prior SH, 2015, STRUCTURE, V23, P2099, DOI 10.1016/j.str.2015.08.013; Rundhaug JE, 2005, J CELL MOL MED, V9, P267, DOI 10.1111/j.1582-4934.2005.tb00355.x; Sarkar SK, 2012, CURR BIOL, V22, P1047, DOI 10.1016/j.cub.2012.04.012; Scanu S, 2013, J AM CHEM SOC, V135, P7681, DOI 10.1021/ja4015452; Schilder J, 2013, CURR OPIN STRUC BIOL, V23, P911, DOI 10.1016/j.sbi.2013.07.009; Schwieters CD, 2001, J MAGN RESON, V149, P239, DOI 10.1006/jmre.2001.2300; SHAPIRO SD, 1993, J BIOL CHEM, V268, P23824; Shoulders MD, 2009, ANNU REV BIOCHEM, V78, P929, DOI 10.1146/annurev.biochem.77.032207.120833; Stultz CM, 2002, J MOL BIOL, V319, P997, DOI 10.1016/S0022-2836(02)00421-7; Stura EA, 2013, FASEB J, V27, P4395, DOI 10.1096/fj.13-233601; Taddese S, 2010, BBA-PROTEINS PROTEOM, V1804, P731, DOI 10.1016/j.bbapap.2009.11.014; Takeda M, 2003, J BIOL CHEM, V278, P43550, DOI 10.1074/jbc.M308199200; Tang C, 2006, NATURE, V444, P383, DOI 10.1038/nature05201; Troeberg L, 2012, BBA-PROTEINS PROTEOM, V1824, P133, DOI 10.1016/j.bbapap.2011.06.020; Van Doren SR, 2015, MATRIX BIOL, V44-46, P224, DOI 10.1016/j.matbio.2015.01.005; Volkov AN, 2010, J AM CHEM SOC, V132, P11487, DOI 10.1021/ja100867c; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Williamson MP, 2013, PROG NUCL MAG RES SP, V73, P1, DOI 10.1016/j.pnmrs.2013.02.001; Wolf K, 2007, NAT CELL BIOL, V9, P893, DOI 10.1038/ncb1616; Woskowicz AM, 2013, J BIOL CHEM, V288, P35126, DOI 10.1074/jbc.M113.496067; Zhao YC, 2015, STRUCTURE, V23, P257, DOI 10.1016/j.str.2014.11.021; Zhen EY, 2008, ARTHRITIS RHEUM-US, V58, P2420, DOI 10.1002/art.23654	74	5	5	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2016	291	15					7888	7901		10.1074/jbc.M115.703124	http://dx.doi.org/10.1074/jbc.M115.703124			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DJ2SZ	26887942	Green Published, hybrid			2022-12-26	WOS:000374056700012
J	Magnano, C; Belov, P; Krawiecki, J; Hagemeier, J; Beggs, C; Zivadinov, R				Magnano, Christopher; Belov, Pavel; Krawiecki, Jacqueline; Hagemeier, Jesper; Beggs, Clive; Zivadinov, Robert			Internal Jugular Vein Cross-Sectional Area Enlargement Is Associated with Aging in Healthy Individuals	PLOS ONE			English	Article							CEREBROSPINAL VENOUS INSUFFICIENCY; ENDOTHELIAL PROGENITOR CELLS; MULTIPLE-SCLEROSIS; INTRAVASCULAR ULTRASOUND; CATHETER VENOGRAPHY; ALZHEIMERS-DISEASE; COLOR-DOPPLER; ABNORMALITIES; FLOW; HEMODYNAMICS	Background Internal jugular vein (IJV) narrowing has been implicated in central nervous system pathologies, however normal physiological age-and gender-related IJV variance in healthy individuals (HIs) has not been adequately assessed. Objectives We assessed the relationship between IJV cross-sectional area (CSA) and aging. Materials and Methods This study involved 193 HIs (63 males and 130 females) who received 2-dimensional magnetic resonance venography at 3T. The minimum CSA of the IJVs at cervical levels C2/C3, C4, C5/C6, and C7/T1 was obtained using a semi-automated contouring-thresholding technique. Subjects were grouped by decade. Pearson and partial correlation (controlled for cardiovascular risk factors, including hypertension, heart disease, smoking and body mass index) and analysis of variance analyses were used, with paired t-tests comparing side differences. Results Mean right IJV CSA ranges were: in males, 41.6 mm(2) (C2/C3) to 82.0 mm(2) (C7/T1); in females, 38.0 mm(2) (C2/C3) to 62.3 mm(2) (C7/T1), while the equivalent left side ranges were: in males, 28.0 mm(2) (C2/C3) to 52.2 mm(2) (C7/T1); in females, 27.2 mm(2) (C2/C3) to 47.8 mm(2) (C7/T1). The CSA of the right IJVs was significantly larger (p<0.001) than the left at all cervical levels. Controlling for cardiovascular risk factors, the correlation between age and IJV CSA was more robust in males than in the females for all cervical levels. Conclusions In HIs age, gender, hand side and cervical location all affect IJV CSA. These findings suggest that any definition of IJV stenosis needs to account for these factors.	[Magnano, Christopher; Belov, Pavel; Krawiecki, Jacqueline; Hagemeier, Jesper; Beggs, Clive; Zivadinov, Robert] SUNY Buffalo, Sch Med & Biomed Sci, Dept Neurol, Buffalo Neuroimaging Anal Ctr, Buffalo, NY 14260 USA; [Magnano, Christopher; Zivadinov, Robert] SUNY Buffalo, Sch Med & Biomed Sci, MRI Clin & Translat Res Ctr, Buffalo, NY 14260 USA; [Beggs, Clive] Univ Bradford, Ctr Infect Control & Biophys, Richmond Rd, Bradford BD7 1DP, W Yorkshire, England; [Beggs, Clive] Leeds Beckett Univ, Inst Sport Phys Act & Leisure, Leeds LS1 3HE, W Yorkshire, England	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University of Bradford; Leeds Beckett University	Zivadinov, R (corresponding author), SUNY Buffalo, Sch Med & Biomed Sci, Dept Neurol, Buffalo Neuroimaging Anal Ctr, Buffalo, NY 14260 USA.; Zivadinov, R (corresponding author), SUNY Buffalo, Sch Med & Biomed Sci, MRI Clin & Translat Res Ctr, Buffalo, NY 14260 USA.	rzivadinov@bnac.net	Zivadinov, Robert/Q-2054-2019; Belov, Pavel/AAN-7857-2020	Zivadinov, Robert/0000-0002-7799-1485; Belov, Pavel/0000-0002-5107-2763; Hagemeier, Jesper/0000-0002-3286-5207	Jacquemin Family Foundation	Jacquemin Family Foundation	This study was supported by the Jacquemin Family Foundation.	Beggs C, 2014, PHLEBOLOGY, V29, P191, DOI 10.1258/phleb.2012.012039; Beggs C, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-157; Beggs CB, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-142; Blinkenberg M, 2012, ACTA NEUROL SCAND, V126, P421, DOI 10.1111/j.1600-0404.2012.01671.x; Bloomfield GL, 1997, CRIT CARE MED, V25, P496, DOI 10.1097/00003246-199703000-00020; Chung CP, 2014, J ALZHEIMERS DIS, V39, P601, DOI 10.3233/JAD-131112; Chung CP, 2011, ANN NEUROL, V69, P553, DOI 10.1002/ana.22276; Chung CP, 2010, ULTRASOUND MED BIOL, V36, P1776, DOI 10.1016/j.ultrasmedbio.2010.07.006; Ciuti G, 2013, AM J NEURORADIOL, V34, P2000, DOI 10.3174/ajnr.A3557; Di Berardino F, 2015, PHLEBOLOGY, V30, P274, DOI 10.1177/0268355514526871; Doepp F, 2010, ANN NEUROL, V68, P173, DOI 10.1002/ana.22085; Feng W, 2012, NEUROL RES, V34, P802, DOI 10.1179/1743132812Y.0000000079; Filipo R, 2015, EUR ARCH OTO-RHINO-L, V272, P77, DOI 10.1007/s00405-013-2841-1; FISHER J, 1982, CIRCULATION, V65, P188, DOI 10.1161/01.CIR.65.1.188; Frezza EE, 2004, DIGEST DIS SCI, V49, P1062, DOI 10.1023/B:DDAS.0000034572.76687.2d; Frezza EE, 2007, DIGEST DIS SCI, V52, P1038, DOI 10.1007/s10620-006-9203-4; Haacke EM, 2012, J VASC INTERV RADIOL, V23, P60, DOI 10.1016/j.jvir.2011.09.027; Hutter R, 2012, MED CLIN N AM, V96, P93, DOI 10.1016/j.mcna.2012.01.008; Kappus N, 2016, J NEUROL NEUROSUR PS, V87, P181, DOI 10.1136/jnnp-2014-310051; Karmon Y, 2013, J VASC INTERV RADIOL, V24, P1487, DOI 10.1016/j.jvir.2013.06.012; Liu MJ, 2015, J VASC SURG, V61, P1511, DOI 10.1016/j.jvs.2014.02.021; Magnano C., 2014, VEINS LYMPHAT, V3, DOI [10.4081/vl.2014.4632, DOI 10.4081/VL.2014.4632]; McAuliffe W, 2013, AM J NEURORADIOL, V34, P1370, DOI 10.3174/ajnr.A3390; PATEL S, 1981, J COMPUT ASSIST TOMO, V5, P197, DOI 10.1097/00004728-198104000-00010; Rahman MS, 2013, ANAL BIOCHEM, V433, P79, DOI 10.1016/j.ab.2012.10.018; Robb AO, 2007, REPRODUCTION, V133, P1, DOI 10.1530/REP-06-0219; Scalise F, 2013, PHLEBOLOGY, V28, P409, DOI 10.1258/phleb.2012.012079; Schaller B, 2004, BRAIN RES REV, V46, P243, DOI 10.1016/j.brainresrev.2004.04.005; Sethi SK, 2015, J NEUROIMAGING, V25, P600, DOI 10.1111/jon.12183; Sieveking DP, 2010, CURR OPIN ENDOCRINOL, V17, P277, DOI 10.1097/MED.0b013e3283394e20; Traboulsee AL, 2014, LANCET, V383, P138, DOI 10.1016/S0140-6736(13)61747-X; Zamboni P, 2009, J NEUROL NEUROSUR PS, V80, P392, DOI 10.1136/jnnp.2008.157164; Zamboni P, 2012, J APPL PHYSIOL, V112, P904, DOI 10.1152/japplphysiol.00712.2011; Zamboni P, 2009, J NEUROL SCI, V282, P21, DOI 10.1016/j.jns.2008.11.027; Zivadinov R, 2011, NEUROLOGY, V77, P138, DOI 10.1212/WNL.0b013e318212a901; Zivadinov R, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-260; Zivadinov R, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-151	37	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0149532	10.1371/journal.pone.0149532	http://dx.doi.org/10.1371/journal.pone.0149532			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3DG	26895434	Green Published, Green Accepted, gold			2022-12-26	WOS:000371223400062
J	Xie, B; Zhang, PH; Liu, MG; Zeng, W; Yang, JT; Liu, HM				Xie, Bin; Zhang, Penghui; Liu, Menggang; Zeng, Wei; Yang, Juntao; Liu, Hongming			Deltex1 Polymorphisms Are Associated with Hepatitis B Vaccination Non-Response in Southwest China	PLOS ONE			English	Article							VIRUS INFECTION; GENE POLYMORPHISMS; IMMUNE-RESPONSE; NOTCH; VARIANTS; ANTIGEN; POPULATION; MECHANISMS; INTRONS; PROTEIN	Background Hepatitis B vaccination is the most important tool available for preventing hepatitis B virus (HBV) infection and reducing the prevalence of infection. However, epidemiological studies have demonstrated that morethan 5% of patients exhibit a non-or hypo-response to the HBV vaccine. Genetic variations associated with T cell immunity contribute to the immune response to HBV vaccination. The deltex 1 (DTX1) gene is involved in T cell anergy, which may also be associated with the immune response to the HBV vaccination. Methods We detected 10 single nucleotide polymorphisms (SNPs) in or around the DTX1 gene in 601 infants out of a population from Southwest China, including 299 high responders(HRs; HBsAb > 100 mIU/mL) and 302 non-responders (NRs; HBsAb < 10 mIU/mL). An additional validation study was performed, comprising 230 adult patients(135 HRs and 95 NRs) from Southwest China. Results This study found that the minor allele 'G' of rs2384077 (adjusted p = 2.63E(-04),) and the minor allele 'C' of rs10744794 (adjusted p = 3.69E(-04)) in the first intron of the DTX1 gene were remarkably associated with the immune response to HBV vaccination in both infant and adult populations. Moreover, a subsequent analysis indicated that haplotypes (A-T, G-C) of the two SNPs were significantly associated with the immune response to HBV vaccination. Conclusions Two SNPs (rs2384077 and rs10744794) in an intron of DTX1 and the linkage disequilibrium (LD) block are significantly associated with the immune response to HBV vaccination. The functional element annotation of the LD block between the two SNPs contains four transcriptional regulatory elements. The results suggest that these two SNPs may be involved in the immune response to HBV vaccination.	[Xie, Bin; Liu, Menggang; Zeng, Wei; Yang, Juntao; Liu, Hongming] Third Mil Med Univ, Daping Hosp, Dept Hepatobiliary Surg, Chongqing, Peoples R China; [Xie, Bin; Liu, Menggang; Zeng, Wei; Yang, Juntao; Liu, Hongming] Third Mil Med Univ, Inst Surg Res, Chongqing, Peoples R China; [Zhang, Penghui] Chongqing Med Univ, Childrens Hosp, Dept Clin Lab Med, Chongqing, Peoples R China	Army Medical University; Army Medical University; Chongqing Medical University	Liu, HM (corresponding author), Third Mil Med Univ, Daping Hosp, Dept Hepatobiliary Surg, Chongqing, Peoples R China.; Liu, HM (corresponding author), Third Mil Med Univ, Inst Surg Res, Chongqing, Peoples R China.	lhming56@163.com			Nature Science Foundation of China [81172739]	Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	Hongming Liu recieved funding from the Nature Science Foundation of China, grant number: 81172739 (http://www.nsfc.gov.cn).	Bayard F, 2010, VACCINE, V28, P3818, DOI 10.1016/j.vaccine.2010.03.026; Bhathena A, 2008, CURR OPIN PHARMACOL, V8, P639, DOI 10.1016/j.coph.2008.07.013; Chen R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013574; Chorev Michal, 2012, Frontiers in Genetics, V3, P55, DOI 10.3389/fgene.2012.00055; Desombere I, 1998, TISSUE ANTIGENS, V51, P593, DOI 10.1111/j.1399-0039.1998.tb03001.x; Ganem D, 2004, NEW ENGL J MED, V350, P1118, DOI 10.1056/NEJMra031087; Grzegorzewska AE, 2013, MOL BIOL REP, V40, P6899, DOI 10.1007/s11033-013-2809-7; Hori K, 2004, DEVELOPMENT, V131, P5527, DOI 10.1242/dev.01448; Hou SH, 2015, MICROBIOL IMMUNOL, V59, P209, DOI 10.1111/1348-0421.12239; Hsiao HW, 2009, IMMUNITY, V31, P72, DOI 10.1016/j.immuni.2009.04.017; Hu QD, 2003, CELL, V115, P163, DOI 10.1016/S0092-8674(03)00810-9; Hui CK, 2005, J CLIN VIROL, V34, pS44, DOI 10.1016/S1386-6532(05)80009-5; Izon DJ, 2002, IMMUNITY, V16, P231, DOI 10.1016/S1074-7613(02)00271-6; Johnson S, 2015, J IMMUNOL, V194, P1755, DOI 10.4049/jimmunol.1401771; Kimkong I, 2015, TISSUE ANTIGENS, V85, P177, DOI 10.1111/tan.12517; Krawczyk A, 2014, VACCINE, V32, P5077, DOI 10.1016/j.vaccine.2014.06.076; Li XF, 2014, MICROB PATHOGENESIS, V74, P59, DOI 10.1016/j.micpath.2014.07.010; Lobaina Y, 2015, MOL IMMUNOL, V63, P320, DOI 10.1016/j.molimm.2014.08.003; Mert G, 2014, J MICROBIOL IMMUNOL, V47, P9, DOI 10.1016/j.jmii.2013.01.004; Almeida APMM, 2014, VACCINE, V32, P2181, DOI 10.1016/j.vaccine.2014.02.053; Pan LP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035303; Ramain P, 2001, CURR BIOL, V11, P1729, DOI 10.1016/S0960-9822(01)00562-0; Rogozin IB, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-11; Romano Maurizio, 2013, Int J Cell Biol, V2013, P810572, DOI 10.1155/2013/810572; Ryckman KK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012273; Saffar H, 2014, HEPAT MON, V14, DOI 10.5812/hepatmon.22223; Tan PL, 2001, VACCINE, V19, P2434, DOI 10.1016/S0264-410X(00)00468-0; Van LH, 2001, ENV HLTH PERSPECT, V109, P757; Vermehren J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032605; Wang CB, 2004, HEPATOLOGY, V39, P978, DOI 10.1002/hep.20142; Wang HC, 2009, MOL CELL BIOL, V29, P4640, DOI 10.1128/MCB.00119-09; Yao JY, 2015, WORLD J GASTROENTERO, V21, P4232, DOI 10.3748/wjg.v21.i14.4232; Ye B, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.42; Yenerall P, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-29; Yucesoy B, 2002, VACCINE, V20, P3193, DOI 10.1016/S0264-410X(02)00267-0; Yucesoy B, 2013, VACCINE, V31, P5381, DOI 10.1016/j.vaccine.2013.09.026; Yun TJ, 2003, J IMMUNOL, V170, P5834, DOI 10.4049/jimmunol.170.12.5834; Zhang X, 2014, INT J IMMUNOGENET, V41, P298, DOI 10.1111/iji.12120; Zuckerman JN, 2000, J INFECTION, V41, P130, DOI 10.1053/jinf.2000.0720; Zweifel ME, 2005, STRUCTURE, V13, P1599, DOI 10.1016/j.str.2005.07.015	40	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0149199	10.1371/journal.pone.0149199	http://dx.doi.org/10.1371/journal.pone.0149199			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3DG	26894927	Green Published, Green Submitted, gold			2022-12-26	WOS:000371223400036
J	Jansen, PA; Grontvedt, RN; Tarpai, A; Helgesen, KO; Horsberg, TE				Jansen, Peder A.; Grontvedt, Randi N.; Tarpai, Attila; Helgesen, Kari O.; Horsberg, Tor Einar			Surveillance of the Sensitivity towards Antiparasitic Bath-Treatments in the Salmon Louse (Lepeophtheirus salmonis)	PLOS ONE			English	Article							SEA LICE; EMAMECTIN BENZOATE; REDUCED SENSITIVITY; DRUG-RESISTANCE; ATLANTIC; SALAR; AQUACULTURE; BIOASSAY; COPEPODA; FARMS	The evolution of drug resistant parasitic sea lice is of major concern to the salmon farming industry worldwide and challenges sustainable growth of this enterprise. To assess current status and development of L. salmonis sensitivity towards different pesticides used for parasite control in Norwegian salmon farming, a national surveillance programme was implemented in 2013. The programme aims to summarize data on the use of different pesticides applied to control L. salmonis and to test L. salmonis sensitivity to different pesticides in farms along the Norwegian coast. Here we analyse two years of test-data from biological assays designed to detect sensitivity-levels towards the pesticides azamethiphos and deltamethrin, both among the most common pesticides used in bath-treatments of farmed salmon in Norway in later years. The focus of the analysis is on how different variables predict the binomial outcome of the bioassay tests, being whether L. salmonis are immobilized/die or survive pesticide exposure. We found that local kernel densities of bath treatments, along with a spatial geographic index of test-farm locations, were significant predictors of the binomial outcome of the tests. Furthermore, the probability of L. salmonis being immobilized/dead after test-exposure was reduced by odds-ratios of 0.60 (95% CI: 0.42-0.86) for 2014 compared to 2013 and 0.39 (95% CI: 0.36-0.42) for low concentration compared to high concentration exposure. There were also significant but more marginal effects of parasite gender and developmental stage, and a relatively large random effect of test-farm. We conclude that the present data support an association between local intensities of bath treatments along the coast and the outcome of bioassay tests where salmon lice are exposed to azamethiphos or deltamethrin. Furthermore, there is a predictable structure of L. salmonis phenotypes along the coast in the data, characterized by high susceptibility to pesticides in the far north and far south, but low susceptibility in mid Norway. The study emphasizes the need to address local susceptibility to pesticides and the need for restrictive use of pesticides to preserve treatment efficacy.	[Jansen, Peder A.; Grontvedt, Randi N.; Tarpai, Attila] Norwegian Vet Inst, Oslo, Norway; [Helgesen, Kari O.; Horsberg, Tor Einar] Sea Lice Res Ctr, NMBU Sch Vet Sci, Oslo, Norway; [Jansen, Peder A.] Univ Bergen, Dept Biol, Sea Lice Res Ctr, Bergen, Norway	Norwegian Veterinary Institute; Norwegian University of Life Sciences; University of Bergen	Jansen, PA (corresponding author), Norwegian Vet Inst, Oslo, Norway.	Peder.jansen@vetinst.no			Norwegian Food safety Authority	Norwegian Food safety Authority	The Norwegian Food safety Authority, http://www.mattilsynet.no/, is responsible for management of fish health. Thereby, they fund the Surveillance program for salmon louse resistance to antiparasitics. The paper reports data from this activity.	Aaen SM, 2015, TRENDS PARASITOL, V31, P72, DOI 10.1016/j.pt.2014.12.006; Aldrin M, 2011, J R SOC INTERFACE, V8, P1346, DOI 10.1098/rsif.2010.0737; Aldrin M, 2010, PREV VET MED, V93, P51, DOI 10.1016/j.prevetmed.2009.09.010; [Anonymous], 2015, FORUTSIGBAR MILJOMES; Besnier F, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-937; Cleveland W. S., 1992, LOCAL REGRESSION MOD, DOI 10.1201/9780203738535; Denholm I, 2002, PEST MANAG SCI, V58, P528, DOI 10.1002/ps.482; Dohoo I., 2003, VET EPIDEMIOLOGY RES; Fallang A, 2005, DIS AQUAT ORGAN, V65, P129, DOI 10.3354/dao065129; Glover KA, 2011, MAR ECOL PROG SER, V427, P161, DOI 10.3354/meps09045; Grontvedt R. J., 2015, SURVEILLANCE PROGRAM; Helgesen KO, 2014, J FISH DIS, V37, P877, DOI 10.1111/jfd.12223; Helgesen KO, 2013, J FISH DIS, V36, P261, DOI 10.1111/jfd.12053; Jansen PA, 2012, P ROY SOC B-BIOL SCI, V279, P2330, DOI 10.1098/rspb.2012.0084; JONES MW, 1992, J FISH DIS, V15, P197, DOI 10.1111/j.1365-2761.1992.tb00654.x; Jones PG, 2012, DIS AQUAT ORGAN, V102, P53, DOI 10.3354/dao02517; Kaur K, 2015, PLOS ONE UNPUB; Kaur K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124220; Kristoffersen AB, 2013, PREV VET MED, V111, P165, DOI 10.1016/j.prevetmed.2013.03.015; Kristoffersen AB, 2014, EPIDEMICS-NETH, V9, P31, DOI 10.1016/j.epidem.2014.09.007; Kristoffersen AB, 2013, PREV VET MED, V109, P136, DOI 10.1016/j.prevetmed.2012.08.012; Leclercq E, 2014, PEST MANAG SCI, V70, P1274, DOI 10.1002/ps.3692; Lees F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001549; Ljungfeldt LER, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-108; Marin SL, 2015, PREV VET MED, V122, P33, DOI 10.1016/j.prevetmed.2015.09.017; McEwan GF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139128; R Development Coar Team, 2014, R LANG ENV STAT COMP; Read AF, 2011, P NATL ACAD SCI USA, V108, P10871, DOI 10.1073/pnas.1100299108; Roth M, 1996, AQUACULTURE, V140, P217, DOI 10.1016/0044-8486(95)01181-1; Sevatdal S, 2005, AQUACULTURE, V244, P19, DOI 10.1016/j.aquaculture.2004.11.009; Sevatdal S, 2003, AQUACULTURE, V218, P21, DOI 10.1016/S0044-8486(02)00339-3; Skiftesvik AB, 2014, MAR BIOL RES, V10, P289, DOI 10.1080/17451000.2013.810760; Tjensvoll K, 2006, DIS AQUAT ORGAN, V68, P251, DOI 10.3354/dao068251; Todd CD, 2004, CAN J FISH AQUAT SCI, V61, P1176, DOI 10.1139/F04-069; Torrissen O, 2013, J FISH DIS, V36, P171, DOI 10.1111/jfd.12061; Viljugrein H, 2009, DIS AQUAT ORGAN, V88, P35, DOI 10.3354/dao02151	36	18	18	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2016	11	2							e0149006	10.1371/journal.pone.0149006	http://dx.doi.org/10.1371/journal.pone.0149006			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3CO	26889677	Green Published, gold, Green Submitted			2022-12-26	WOS:000371221500019
J	Yasuga, H; Kawano, R; Takinoue, M; Tsuji, Y; Osaki, T; Kamiya, K; Miki, N; Takeuchi, S				Yasuga, Hiroki; Kawano, Ryuji; Takinoue, Masahiro; Tsuji, Yutaro; Osaki, Toshihisa; Kamiya, Koki; Miki, Norihisa; Takeuchi, Shoji			Logic Gate Operation by DNA Translocation through Biological Nanopores	PLOS ONE			English	Article							ALPHA-HEMOLYSIN; COMPUTATION; CHANNELS; SENSORS; SYSTEM; ROBOTS	Logical operations using biological molecules, such as DNA computing or programmable diagnosis using DNA, have recently received attention. Challenges remain with respect to the development of such systems, including label-free output detection and the rapidity of operation. Here, we propose integration of biological nanopores with DNA molecules for development of a logical operating system. We configured outputs "1" and "0" as single-stranded DNA (ssDNA) that is or is not translocated through a nanopore; unlabeled DNA was detected electrically. A negative-AND (NAND) operation was successfully conducted within approximately 10 min, which is rapid compared with previous studies using unlabeled DNA. In addition, this operation was executed in a four-droplet network. DNA molecules and associated information were transferred among droplets via biological nanopores. This system would facilitate linking of molecules and electronic interfaces. Thus, it could be applied to molecular robotics, genetic engineering, and even medical diagnosis and treatment.	[Yasuga, Hiroki; Kawano, Ryuji; Tsuji, Yutaro; Osaki, Toshihisa; Kamiya, Koki; Miki, Norihisa; Takeuchi, Shoji] Kanagawa Acad Sci & Technol, Artificial Cell Membrane Syst Grp, Kawasaki, Kanagawa, Japan; [Yasuga, Hiroki; Tsuji, Yutaro; Miki, Norihisa] Keio Univ, Dept Mech Engn, Yokohama, Kanagawa 223, Japan; [Takinoue, Masahiro] Tokyo Inst Technol, Interdisciplinary Grad Sch Sci & Engn, Yokohama, Kanagawa 227, Japan; [Osaki, Toshihisa; Takeuchi, Shoji] Univ Tokyo, Inst Ind Sci, Tokyo, Japan; [Kawano, Ryuji] Tokyo Univ Agr & Technol, Dept Biotechnol & Life Sci, Tokyo, Japan	Kanagawa Academy Science & Technology; Keio University; Tokyo Institute of Technology; University of Tokyo; Tokyo University of Agriculture & Technology	Takeuchi, S (corresponding author), Kanagawa Acad Sci & Technol, Artificial Cell Membrane Syst Grp, Kawasaki, Kanagawa, Japan.; Takeuchi, S (corresponding author), Univ Tokyo, Inst Ind Sci, Tokyo, Japan.	takeuchi@iis.u-tokyo.ac.jp	Takinoue, Masahiro/AAI-6179-2020; Takinoue, Masahiro/A-1490-2014; Kamiya, Koki/F-9889-2018; Yasuga, Hiroki/AGZ-6419-2022; OSAKI, Toshihisa/F-3815-2012; Miki, Norihisa/F-7659-2014; Takeuchi, Shoji/J-5349-2019; Kamiya, Koki/AAL-6950-2020; Kawano, Ryuji/A-3177-2011	Takinoue, Masahiro/0000-0002-3874-2670; Takinoue, Masahiro/0000-0002-3874-2670; OSAKI, Toshihisa/0000-0003-1659-2541; Kamiya, Koki/0000-0001-9143-9841; Kawano, Ryuji/0000-0001-6523-0649; Takeuchi, Shoji/0000-0001-6946-0409; Yasuga, Hiroki/0000-0003-2040-9017	Regional Innovation Strategy Support Program; Ministry of Education, Culture, Sports, Science, and Technology, Japan [25246017];  [24104002];  [26540160];  [25708024]; Grants-in-Aid for Scientific Research [15H00803, 26540160] Funding Source: KAKEN	Regional Innovation Strategy Support Program; Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); ; ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas "Molecular Robotics" (No. 24104002) to RK and MT; a Grant-in-Aid for Challenging Exploratory Research (No. 26540160) to RK; a Grant-in-Aid for Young Scientists (A) (No. 25708024) to RK; the Regional Innovation Strategy Support Program to ST; a Grant-in-Aid for Scientific Research (A) (No. 25246017) to ST of The Ministry of Education, Culture, Sports, Science, and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amir Y, 2014, NAT NANOTECHNOL, V9, P353, DOI [10.1038/NNANO.2014.58, 10.1038/nnano.2014.58]; Ayukawa S, 2011, ACCOUNTS CHEM RES, V44, P1369, DOI 10.1021/ar200128b; Bayley H, 2008, MOL BIOSYST, V4, P1191, DOI 10.1039/b808893d; Benenson Y, 2001, NATURE, V414, P430, DOI 10.1038/35106533; Benenson Y, 2004, NATURE, V429, P423, DOI 10.1038/nature02551; Branton D, 2008, NAT BIOTECHNOL, V26, P1146, DOI 10.1038/nbt.1495; Deamer D, 2010, ANNU REV BIOPHYS, V39, P79, DOI 10.1146/annurev.biophys.093008.131250; Dirks RM, 2007, SIAM REV, V49, P65, DOI 10.1137/060651100; Faulhammer D, 2000, P NATL ACAD SCI USA, V97, P1385, DOI 10.1073/pnas.97.4.1385; Gouaux E, 1998, J STRUCT BIOL, V121, P110, DOI 10.1006/jsbi.1998.3959; GOUAUX JE, 1994, P NATL ACAD SCI USA, V91, P12828, DOI 10.1073/pnas.91.26.12828; Hagiya M, 2014, ACCOUNTS CHEM RES, V47, P1681, DOI 10.1021/ar400318d; Howorka S, 2009, CHEM SOC REV, V38, P2360, DOI 10.1039/b813796j; Kawano R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102427; Kawano R, 2013, SCI REP-UK, V3, DOI 10.1038/srep01995; Kawano R, 2011, J AM CHEM SOC, V133, P8474, DOI 10.1021/ja2026085; Miyamoto T, 2013, ACS SYNTH BIOL, V2, P72, DOI 10.1021/sb3001112; Qian L, 2011, NATURE, V475, P368, DOI 10.1038/nature10262; Reiner JE, 2012, CHEM REV, V112, P6431, DOI 10.1021/cr300381m; Sauer-Budge AF, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.238101; Sekiya K, 2007, MICROBES INFECT, V9, P1341, DOI 10.1016/j.micinf.2007.06.010; Stojanovic MN, 2002, J AM CHEM SOC, V124, P3555, DOI 10.1021/ja016756v; Tsuji Y, 2013, ANAL CHEM, V85, P10913, DOI 10.1021/ac402299z; Tsuji Y, 2013, LAB CHIP, V13, P1476, DOI 10.1039/c3lc41359d; Yoshida W, 2007, CHEM COMMUN, P195, DOI 10.1039/b613201d; You MX, 2015, J AM CHEM SOC, V137, P667, DOI 10.1021/ja509263k; Zhang DY, 2011, NAT CHEM, V3, P103, DOI [10.1038/nchem.957, 10.1038/NCHEM.957]	27	26	27	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2016	11	2							e0149667	10.1371/journal.pone.0149667	http://dx.doi.org/10.1371/journal.pone.0149667			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3CO	26890568	Green Submitted, Green Published, gold			2022-12-26	WOS:000371221500070
J	Jagannadham, J; Jaiswal, HK; Agrawal, S; Rawal, K				Jagannadham, Jaisri; Jaiswal, Hitesh Kumar; Agrawal, Stuti; Rawal, Kamal			Comprehensive Map of Molecules Implicated in Obesity	PLOS ONE			English	Article							PROTEIN-PROTEIN INTERACTIONS; SIGNALING PATHWAYS; BIOLOGICAL NETWORKS; INSULIN-RESISTANCE; ANTIOBESITY DRUGS; GHRELIN; MICROARRAY; MODULARITY; ADIPOGENESIS; EXPRESSION	Obesity is a global epidemic affecting over 1.5 billion people and is one of the risk factors for several diseases such as type 2 diabetes mellitus and hypertension. We have constructed a comprehensive map of the molecules reported to be implicated in obesity. A deep curation strategy was complemented by a novel semi-automated text mining system in order to screen 1,000 full-length research articles and over 90,000 abstracts that are relevant to obesity. We obtain a scale free network of 804 nodes and 971 edges, composed of 510 proteins, 115 genes, 62 complexes, 23 RNA molecules, 83 simple molecules, 3 phenotype and 3 drugs in "bow-tie" architecture. We classify this network into 5 modules and identify new links between the recently discovered fat mass and obesity associated FTO gene with well studied examples such as insulin and leptin. We further built an automated docking pipeline to dock orlistat as well as other drugs against the 24,000 proteins in the human structural proteome to explain the therapeutics and side effects at a network level. Based upon our experiments, we propose that therapeutic effect comes through the binding of one drug with several molecules in target network, and the binding propensity is both statistically significant and different in comparison with any other part of human structural proteome.	[Jagannadham, Jaisri; Jaiswal, Hitesh Kumar; Agrawal, Stuti; Rawal, Kamal] Jaypee Inst Informat Technol, Dept Biotechnol, Noida 201307, UP, India; [Jagannadham, Jaisri] Jaipur Natl Univ, Jaipur, Rajasthan, India; [Agrawal, Stuti] Univ Chicago, Ctr Data Intens Sci, Chicago, IL 60637 USA	Jaypee Institute of Information Technology (JIIT); Jaipur National University; University of Chicago	Rawal, K (corresponding author), Jaypee Inst Informat Technol, Dept Biotechnol, Noida 201307, UP, India.	kamal.rawal@gmail.com						Allison DB, 2006, NAT REV GENET, V7, P55, DOI 10.1038/nrg1749; Aronne LJ, 2002, OBES RES, V10, p105S, DOI 10.1038/oby.2002.203; Assenov Y, 2008, BIOINFORMATICS, V24, P282, DOI 10.1093/bioinformatics/btm554; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Barrat A, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.066149; Bourguignon PY, 2006, LECT NOTES COMPUT SC, V4220, P1; Brandes U, 2007, LECT NOTES COMPUT SC, V4769, P121; Bravard A, 2011, DIABETES, V60, P258, DOI 10.2337/db10-0281; Brohee S, 2008, NUCLEIC ACIDS RES, V36, pW444, DOI 10.1093/nar/gkn336; Brown CD, 2000, OBES RES, V8, P605, DOI 10.1038/oby.2000.79; Calzone L, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.7; Chung F, 2007, P NATL ACAD SCI USA, V104, P19735, DOI 10.1073/pnas.0708838104; Cohen R, 2000, PHYS REV LETT, V85, P4626, DOI 10.1103/PhysRevLett.85.4626; de Silva E, 2005, J R SOC INTERFACE, V2, P419, DOI 10.1098/rsif.2005.0067; Dhillon IS, 2007, IEEE T PATTERN ANAL, V29, P1944, DOI 10.1109/TP'AMI.2007.1115; Ebert MH, 1997, J NEUROPSYCH CLIN N, V9, P75; Eisenberg E, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.138701; Elangbam CS, 2009, VET PATHOL, V46, P10, DOI 10.1354/vp.46-1-10; ERDOS P, 1960, B INT STATIST INST, V38, P343; Fraser HB, 2002, SCIENCE, V296, P750, DOI 10.1126/science.1068696; Fruhbeck G, 2006, BIOCHEM J, V393, P7, DOI 10.1042/BJ20051578; Funahashi Akira, 2003, Biosilico, V1, P159, DOI 10.1016/S1478-5382(03)02370-9; Gallagher EJ, 2010, CURR DIABETES REP, V10, P93, DOI 10.1007/s11892-010-0101-y; Gao ZT, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-104; Gesta S, 2007, CELL, V131, P242, DOI 10.1016/j.cell.2007.10.004; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Haw R, 2011, DATABASE, V2011, P1; Hearn T, 2005, DIABETES, V54, P1581, DOI 10.2337/diabetes.54.5.1581; Higham DJ, 2007, J COMPUT APPL MATH, V204, P25, DOI 10.1016/j.cam.2006.04.026; Hogart A, 2007, HUM MOL GENET, V16, P691, DOI 10.1093/hmg/ddm014; Hopkins AL, 2008, NAT CHEM BIOL, V4, P682, DOI 10.1038/nchembio.118; Ichimura A, 2012, NATURE, V483, P350, DOI 10.1038/nature10798; Itariu BK, 2012, AM J CLIN NUTR, V96, P1137, DOI 10.3945/ajcn.112.037432; Janjic V, 2012, MOL BIOSYST, V8, P2614, DOI 10.1039/c2mb25230a; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Jordan IK, 2003, BMC EVOL BIOL, V3, DOI 10.1186/1471-2148-3-1; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kapushesky M, 2012, NUCLEIC ACIDS RES, V40, pD1077, DOI 10.1093/nar/gkr913; Karger DR, 1996, J ACM, V43, P601, DOI 10.1145/234533.234534; Kitano H, 2004, DIABETES, V53, pS6, DOI 10.2337/diabetes.53.suppl_3.S6; Knox C, 2011, NUCLEIC ACIDS RES, V39, pD1035, DOI 10.1093/nar/gkq1126; Kohn KW, 1999, MOL BIOL CELL, V10, P2703, DOI 10.1091/mbc.10.8.2703; Le Novere N, 2009, NAT BIOTECHNOL, V27, P735, DOI 10.1038/nbt.1558; Lee H, 2011, J ETHNOPHARMACOL, V133, P788, DOI 10.1016/j.jep.2010.11.009; Lee M, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S17-S6; Li S, 2006, BIOINFORMATICS, V22, P2143, DOI 10.1093/bioinformatics/btl363; Liu HF, 2010, J MOL GRAPH MODEL, V29, P326, DOI 10.1016/j.jmgm.2010.09.004; Logsdon BA, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-53; Lusis AJ, 2010, CIRCULATION, V121, P157, DOI 10.1161/CIRCULATIONAHA.108.847699; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Meyer M, 2009, JASSS-J ARTIF SOC S, V12, pA224; Miller WC, 1997, INT J OBESITY, V21, P941, DOI 10.1038/sj.ijo.0800499; Mitka M, 2003, JAMA-J AM MED ASSOC, V289, P1761, DOI 10.1001/jama.289.14.1761; Mizuno S, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-52; Mokdad AH, 1999, JAMA-J AM MED ASSOC, V282, P1519, DOI 10.1001/jama.282.16.1519; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P176; Newman MEJ, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.036104; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Nishikawa T, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.014101; Niswender KD, 2011, NEUROPSYCHOPHARMACOL, V36, P359, DOI 10.1038/npp.2010.167; Nogueiras R, 2008, ANN NY ACAD SCI, V1126, P14, DOI 10.1196/annals.1433.054; Oda K, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100057; Oda K, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100014; Orchard S, 2012, NAT METHODS, V9, P345, DOI [10.1038/NMETH.1931, 10.1038/nmeth.1931]; Pastor-Satorras R, 2001, PHYS REV LETT, V86, P3200, DOI 10.1103/PhysRevLett.86.3200; Pontzer H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040503; Prestwich TC, 2007, CURR OPIN CELL BIOL, V19, P612, DOI 10.1016/j.ceb.2007.09.014; PRICE RA, 1989, HUM HERED, V39, P121; PRICE RA, 1990, HUM BIOL, V62, P747; Purnell JQ, 2013, CIRCULATION, V127, P180, DOI 10.1161/CIRCULATIONAHA.111.077487; Rankinen T, 2006, OBESITY, V14, P529, DOI 10.1038/oby.2006.71; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Saeed R, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-128; Scardoni G., 2011, INT J COMPLEX SYST S, V1, P164; Scerif M, 2011, MOL CELL ENDOCRINOL, V340, P15, DOI 10.1016/j.mce.2011.02.011; Schwikowski B, 2000, NAT BIOTECHNOL, V18, P1257, DOI 10.1038/82360; Smith SC, 2011, NEOPLASIA, V13, P72, DOI 10.1593/neo.101214; Spirin V, 2003, P NATL ACAD SCI USA, V100, P12123, DOI 10.1073/pnas.2032324100; Tam CS, 2011, EXPERT OPIN BIOL TH, V11, P1677, DOI 10.1517/14712598.2011.619974; Tieri P, 2011, METHODS MOL BIOL, V719, P415, DOI 10.1007/978-1-61779-027-0_19; Toh SA, 2011, METABOLIC BASIS OF OBESITY, P293, DOI 10.1007/978-1-4419-1607-5_15; Toshinai K, 2003, ENDOCRINOLOGY, V144, P1506, DOI 10.1210/en.2002-220788; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Tseng YH, 2008, NATURE, V454, P1000, DOI 10.1038/nature07221; Turnbaugh PJ, 2009, J PHYSIOL-LONDON, V587, P4153, DOI 10.1113/jphysiol.2009.174136; Ucar D, 2006, LECT NOTES ARTIF INT, V4213, P371; Uruno A, 2011, J MOL ENDOCRINOL, V46, P37, DOI 10.1677/JME-10-0088; Verma A, 2008, SAUDI MED J, V29, P1135; Viner RM, 2010, OBES REV, V11, P593, DOI 10.1111/j.1467-789X.2009.00651.x; Wang JG, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr251; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wu G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010137; Yamada N, 2011, ENDOCRINOLOGY, V152, P2634, DOI 10.1210/en.2011-0004; Yoon J, 2006, BIOINFORMATICS, V22, P3106, DOI 10.1093/bioinformatics/btl533; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684; Zhang N, 2011, AM J MED SCI, V341, P48, DOI 10.1097/MAJ.0b013e3181ec41ed	99	12	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0146759	10.1371/journal.pone.0146759	http://dx.doi.org/10.1371/journal.pone.0146759			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26886906	Green Published, Green Submitted, gold			2022-12-26	WOS:000371218400003
J	Prachantasena, S; Charununtakorn, P; Muangnoicharoen, S; Hankla, L; Techawal, N; Chaveerach, P; Tuitemwong, P; Chokesajjawatee, N; Williams, N; Humphrey, T; Luangtongkum, T				Prachantasena, Sakaoporn; Charununtakorn, Petcharatt; Muangnoicharoen, Suthida; Hankla, Luck; Techawal, Natthaporn; Chaveerach, Prapansak; Tuitemwong, Pravate; Chokesajjawatee, Nipa; Williams, Nicola; Humphrey, Tom; Luangtongkum, Taradon			Distribution and Genetic Profiles of Campylobacter in Commercial Broiler Production from Breeder to Slaughter in Thailand	PLOS ONE			English	Article							FIELD GEL-ELECTROPHORESIS; ANTIMICROBIAL RESISTANCE; JEJUNI STRAINS; POULTRY; SPP.; FLOCKS; CONTAMINATION; PREVALENCE; CHICKEN; MEAT	Poultry and poultry products are commonly considered as the major vehicle of Campylobacter infection in humans worldwide. To reduce the number of human cases, the epidemiology of Campylobacter in poultry must be better understood. Therefore, the objective of the present study was to determine the distribution and genetic relatedness of Campylobacter in the Thai chicken production industry. During June to October 2012, entire broiler production processes (i.e., breeder flock, hatchery, broiler farm and slaughterhouse) of five broiler production chains were investigated chronologically. Representative isolates of C. jejuni from each production stage were characterized by flaA SVR sequencing and multilocus sequence typing (MLST). Amongst 311 selected isolates, 29 flaA SVR alleles and 17 sequence types (STs) were identified. The common clonal complexes (CCs) found in this study were CC-45, CC-353, CC-354 and CC-574. C. jejuni isolated from breeders were distantly related to those isolated from broilers and chicken carcasses, while C. jejuni isolates from the slaughterhouse environment and meat products were similar to those isolated from broiler flocks. Genotypic identification of C. jejuni in slaughterhouses indicated that broilers were the main source of Campylobacter contamination of chicken meat during processing. To effectively reduce Campylobacter in poultry meat products, control and prevention strategies should be aimed at both farm and slaughterhouse levels.	[Prachantasena, Sakaoporn; Charununtakorn, Petcharatt; Muangnoicharoen, Suthida; Hankla, Luck; Techawal, Natthaporn; Luangtongkum, Taradon] Chulalongkorn Univ, Fac Vet Sci, Dept Vet Publ Hlth, Bangkok, Thailand; [Luangtongkum, Taradon] Chulalongkorn Univ, Fac Vet Sci, Res Unit Microbial Food Safety & Antimicrobial Re, Bangkok, Thailand; [Chaveerach, Prapansak] Khon Kaen Univ, Fac Vet Med, Dept Vet Publ Hlth, Khon Kaen, Thailand; [Tuitemwong, Pravate] King Mongkuts Univ Technol Thonburi, Fac Sci, Dept Microbiol, Bangkok, Thailand; [Chokesajjawatee, Nipa] Natl Sci & Technol Dev Agcy, Natl Ctr Genet Engn & Biotechnol, Pathum Thani, Thailand; [Williams, Nicola] Univ Liverpool, Inst Infect & Global Hlth, Liverpool L69 3BX, Merseyside, England; [Humphrey, Tom] Swansea Univ, Coll Med, Singleton Pk, Swansea, W Glam, Wales	Chulalongkorn University; Chulalongkorn University; Khon Kaen University; King Mongkuts University of Technology Thonburi; National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC); University of Liverpool; Swansea University	Luangtongkum, T (corresponding author), Chulalongkorn Univ, Fac Vet Sci, Dept Vet Publ Hlth, Bangkok, Thailand.; Luangtongkum, T (corresponding author), Chulalongkorn Univ, Fac Vet Sci, Res Unit Microbial Food Safety & Antimicrobial Re, Bangkok, Thailand.	taradon.L@chula.ac.th		Humphrey, Tom/0000-0001-7965-8988; Luangtongkum, Taradon/0000-0001-6150-3259; Williams, Nicola/0000-0003-4709-4190	National Science and Technology Development Agency (NSTDA) [P-11-00757]; H. M. the King Bhumibol Adulyadej's 72nd Anniversary Scholarship; Royal Golden Jubilee Ph.D. Program [PHD/0006/2554]; TRF [RTA5780006]; Biotechnology and Biological Sciences Research Council [BB/J019771/1] Funding Source: researchfish	National Science and Technology Development Agency (NSTDA); H. M. the King Bhumibol Adulyadej's 72nd Anniversary Scholarship; Royal Golden Jubilee Ph.D. Program(Thailand Research Fund (TRF)); TRF(Thailand Research Fund (TRF)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study was funded by the National Science and Technology Development Agency (NSTDA) grant P-11-00757. Ms. Sakaoporn Prachantasena is a recipient of H. M. the King Bhumibol Adulyadej's 72nd Anniversary Scholarship and the Royal Golden Jubilee Ph.D. Program (PHD/0006/2554). Financial support to Ms. Prachantasena from the TRF Senior Scholar to Alongkorn Amonsin (RTA5780006) is also acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agunos A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104905; Altekruse SF, 2003, J AM VET MED ASSOC, V223, P445, DOI 10.2460/javma.2003.223.445; Andreoletti O, 2011, EFSA J, V9, DOI [10.2903/j.efsa.2011.2105, 10.2903/j.efsa.2011.2490]; Arsenault J, 2007, PREV VET MED, V81, P250, DOI 10.1016/j.prevetmed.2007.04.016; Bull SA, 2006, APPL ENVIRON MICROB, V72, P645, DOI 10.1128/AEM.72.1.645-652.2006; Colles FM, 2012, MICROBIOL-SGM, V158, P2695, DOI 10.1099/mic.0.062000-0; Colles FM, 2015, ENVIRON MICROBIOL, V17, P938, DOI 10.1111/1462-2920.12415; Colles FM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022825; Dingle KE, 2001, J CLIN MICROBIOL, V39, P14, DOI 10.1128/JCM.39.1.14-23.2001; Dingle KE, 2005, J CLIN MICROBIOL, V43, P340, DOI 10.1128/JCM.43.1.340-347.2005; Gerchman I, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-90; Gibreel A, 2006, J ANTIMICROB CHEMOTH, V58, P243, DOI 10.1093/jac/dkl210; Griekspoor P, 2010, VET MICROBIOL, V140, P180, DOI 10.1016/j.vetmic.2009.07.022; Habib I, 2009, APPL ENVIRON MICROB, V75, P4264, DOI 10.1128/AEM.00168-09; Hansson I, 2007, J APPL MICROBIOL, V103, P640, DOI 10.1111/j.1365-2672.2007.03291.x; Hansson I, 2005, J APPL MICROBIOL, V99, P1149, DOI 10.1111/j.1365-2672.2005.02689.x; Hermans D, 2012, VECTOR-BORNE ZOONOT, V12, P89, DOI 10.1089/vbz.2011.0676; Hermans D, 2011, VET MICROBIOL, V152, P219, DOI 10.1016/j.vetmic.2011.03.010; Hofshagen M, 2005, J FOOD PROTECT, V68, P2220, DOI 10.4315/0362-028X-68.10.2220; Hook H, 2005, VET MICROBIOL, V106, P109, DOI 10.1016/j.vetmic.2004.12.017; Jolley KA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-595; Kaakoush NO, 2015, CLIN MICROBIOL REV, V28, P687, DOI 10.1128/CMR.00006-15; Kalupahana RS, 2013, APPL ENVIRON MICROB, V79, P393, DOI 10.1128/AEM.02269-12; Levin RE, 2007, FOOD BIOTECHNOL, V21, P271, DOI 10.1080/08905430701536565; Linton D, 1996, RES MICROBIOL, V147, P707, DOI 10.1016/S0923-2508(97)85118-2; Meinersmann RJ, 1997, J CLIN MICROBIOL, V35, P2810, DOI 10.1128/JCM.35.11.2810-2814.1997; Melero B, 2012, FOOD MICROBIOL, V32, P124, DOI 10.1016/j.fm.2012.04.020; Messens W, 2009, VET MICROBIOL, V138, P120, DOI 10.1016/j.vetmic.2009.02.012; Newell DG, 2011, APPL ENVIRON MICROB, V77, P8605, DOI 10.1128/AEM.01090-10; O'Mahony E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028490; PACHA RE, 1987, APPL ENVIRON MICROB, V53, P1574, DOI 10.1128/AEM.53.7.1574-1579.1987; Patriarchi A, 2011, FOODBORNE PATHOG DIS, V8, P99, DOI 10.1089/fpd.2010.0637; Peyrat MB, 2008, INT J FOOD MICROBIOL, V124, P188, DOI 10.1016/j.ijfoodmicro.2008.03.030; Ragimbeau C, 2008, APPL ENVIRON MICROB, V74, P7715, DOI 10.1128/AEM.00865-08; Reich F, 2008, INT J FOOD MICROBIOL, V127, P116, DOI 10.1016/j.ijfoodmicro.2008.06.018; Rosenquist H, 2009, EPIDEMIOL INFECT, V137, P1742, DOI 10.1017/S0950268809002684; Sasaki Y, 2013, ZOONOSES PUBLIC HLTH, V60, P134, DOI 10.1111/j.1863-2378.2012.01509.x; Schonberg-Norio D, 2010, EPIDEMIOL INFECT, V138, P1004, DOI 10.1017/S0950268809991099; Sheppard SK, 2007, ZOONOSES PUBLIC HLTH, V54, P36; Sheppard SK, 2009, INT J FOOD MICROBIOL, V134, P96, DOI 10.1016/j.ijfoodmicro.2009.02.010; Slader J, 2002, APPL ENVIRON MICROB, V68, P713, DOI 10.1128/AEM.68.2.713-719.2002; Sopwith W, 2008, EMERG INFECT DIS, V14, P1769, DOI 10.3201/eid1411.071678; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Wales AD, 2015, ANTIBIOTICS-BASEL, V4, P567, DOI 10.3390/antibiotics4040567; Williams NJ, 2010, APPL ENVIRON MICROB, V76, P7318, DOI 10.1128/AEM.00511-10; Young KT, 2007, NAT REV MICROBIOL, V5, P665, DOI 10.1038/nrmicro1718; Zweifel C, 2008, INT J FOOD MICROBIOL, V125, P182, DOI 10.1016/j.ijfoodmicro.2008.03.038	47	26	26	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0149585	10.1371/journal.pone.0149585	http://dx.doi.org/10.1371/journal.pone.0149585			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26886590	Green Published, gold, Green Submitted			2022-12-26	WOS:000371218400099
J	Senger, DR; Li, D; Jaminet, SC; Cao, SG				Senger, Donald R.; Li, Dan; Jaminet, Shou-Ching; Cao, Shugeng			Activation of the Nrf2 Cell Defense Pathway by Ancient Foods: Disease Prevention by Important Molecules and Microbes Lost from the Modern Western Diet	PLOS ONE			English	Article							TRADITIONAL FERMENTED FOODS; TRANSCRIPTION FACTOR NRF2; CAFFEIC ACID METABOLISM; OXIDATIVE STRESS; PHENOLIC-COMPOUNDS; LACTOBACILLUS-PLANTARUM; KNOCKOUT MICE; CHEMOPREVENTIVE AGENTS; PROTECTIVE ENZYMES; ALZHEIMERS-DISEASE	The Nrf2 (NFE2L2) cell defense pathway protects against oxidative stress and disorders including cancer and neurodegeneration. Although activated modestly by oxidative stress alone, robust activation of the Nrf2 defense mechanism requires the additional presence of co-factors that facilitate electron exchange. Various molecules exhibit this co-factor function, including sulforaphane from cruciferous vegetables. However, natural co-factors that are potent and widely available from dietary sources have not been identified previously. The objectives of this study were to investigate support of the Nrf2 cell defense pathway by the alkyl catechols: 4-methylcatechol, 4-vinylcatechol, and 4-ethylcatechol. These small electrochemicals are naturally available from numerous sources but have not received attention. Findings reported here illustrate that these compounds are indeed potent co-factors for activation of the Nrf2 pathway both in vitro and in vivo. Each strongly supports expression of Nrf2 target genes in a variety of human cell types; and, in addition, 4-ethylcatechol is orally active in mice. Furthermore, findings reported here identify important and previously unrecognized sources of these compounds, arising from biotransformation of common plant compounds by lactobacilli that express phenolic acid decarboxylase. Thus, for example, Lactobacillus plantarum, Lactobacillus brevis, and Lactobacillus collinoides, which are consumed from a diet rich in traditionally fermented foods and beverages, convert common phenolic acids found in fruits and vegetables to 4-vinylcatechol and/or 4-ethylcatechol. In addition, all of the alkyl catechols are found in wood smoke that was used widely for food preservation. Thus, the potentially numerous sources of alkyl catechols in traditional foods suggest that these co-factors were common in ancient diets. However, with radical changes in food preservation, alkyl catechols have been lost from modern foods. The absence of alkyl catechols from the modern Western diet suggests serious negative consequences for Nrf2 cell defense, resulting in reduced protection against multiple chronic diseases associated with oxidative stress.	[Senger, Donald R.; Li, Dan; Jaminet, Shou-Ching] Beth Israel Deaconess Med Ctr, Dept Pathol, 330 Brookline Ave, Boston, MA 02215 USA; [Senger, Donald R.; Li, Dan; Jaminet, Shou-Ching] Beth Israel Deaconess Med Ctr, Vasc Biol Res Ctr, Boston, MA 02215 USA; [Senger, Donald R.; Jaminet, Shou-Ching] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Cao, Shugeng] Univ Hawaii, Dept Pharmaceut Sci, Daniel K Inouye Coll Pharm, Hilo, HI 96720 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; University of Hawaii System; University Hawaii Hilo	Senger, DR (corresponding author), Beth Israel Deaconess Med Ctr, Dept Pathol, 330 Brookline Ave, Boston, MA 02215 USA.; Senger, DR (corresponding author), Beth Israel Deaconess Med Ctr, Vasc Biol Res Ctr, Boston, MA 02215 USA.; Senger, DR (corresponding author), Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA.	dsenger@bidmc.harvard.edu			National Center for Complementary and Integrative Health of the National Institutes of Health [R01AT007022]; National Center for Complementary & Integrative Health [R01AT007022] Funding Source: NIH RePORTER	National Center for Complementary and Integrative Health of the National Institutes of Health; National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Research reported in this publication was supported by the National Center for Complementary and Integrative Health of the National Institutes of Health under Award Number R01AT007022. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aerts JL, 2004, BIOTECHNIQUES, V36, P84, DOI 10.2144/04361ST04; Almenier Hazem A, 2012, Front Biosci (Elite Ed), V4, P1335; Curiel JA, 2010, FOOD CHEM, V120, P225, DOI 10.1016/j.foodchem.2009.10.012; BAKKE OM, 1969, J NUTR, V98, P209, DOI 10.1093/jn/98.2.209; Balogun E, 2003, BIOCHEM J, V371, P887, DOI 10.1042/BJ20021619; Bas A, 2004, SCAND J IMMUNOL, V59, P566, DOI 10.1111/j.0300-9475.2004.01440.x; Basu S, 2001, BIOCHEM BIOPH RES CO, V288, P275, DOI 10.1006/bbrc.2001.5747; Becks L, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-540; Bel-Rhlid R, 2013, AMB EXPRESS, V3, DOI 10.1186/2191-0855-3-28; Bensasson RV, 2008, CHEM RES TOXICOL, V21, P805, DOI 10.1021/tx7002883; Berlett BS, 1997, J BIOL CHEM, V272, P20313, DOI 10.1074/jbc.272.33.20313; Beyer TA, 2008, EMBO J, V27, P212, DOI 10.1038/sj.emboj.7601950; Borgstrom G., 2012, FISH FOOD V3 PROCE 1, P72; Bravo L, 1998, NUTR REV, V56, P317, DOI 10.1111/j.1753-4887.1998.tb01670.x; Buron N, 2012, INT J FOOD MICROBIOL, V153, P159, DOI 10.1016/j.ijfoodmicro.2011.11.002; Buron N, 2011, FOOD MICROBIOL, V28, P1243, DOI 10.1016/j.fm.2011.05.001; Buron N, 2011, FOOD CHEM, V125, P542, DOI 10.1016/j.foodchem.2010.09.046; Cabrita MJ, 2012, CIENCIA TECNOL ALIME, V32, P106, DOI 10.1590/S0101-20612012005000024; Calkins MJ, 2009, ANTIOXID REDOX SIGN, V11, P497, DOI [10.1089/ars.2008.2242, 10.1089/ARS.2008.2242]; Carmody RN, 2011, P NATL ACAD SCI USA, V108, P19199, DOI 10.1073/pnas.1112128108; Carroll RE, 2011, CANCER PREV RES, V4, P354, DOI 10.1158/1940-6207.CAPR-10-0098; Cavin JF, 1997, APPL ENVIRON MICROB, V63, P1939, DOI 10.1128/AEM.63.5.1939-1944.1997; Chatonnet P, 1995, AM J ENOL VITICULT, V46, P463; Chian S, 2014, BIOCHEM BIOPH RES CO, V447, P602, DOI 10.1016/j.bbrc.2014.04.039; Cornblatt BS, 2007, CARCINOGENESIS, V28, P1485, DOI 10.1093/carcin/bgm049; Dalleau S, 2013, CELL DEATH DIFFER, V20, P1615, DOI 10.1038/cdd.2013.138; de Ferrars RM, 2014, BRIT J PHARMACOL, V171, P3268, DOI 10.1111/bph.12676; de Ferrars RM, 2014, MOL NUTR FOOD RES, V58, P490, DOI 10.1002/mnfr.201300322; Dinkova-Kostova AT, 2006, CANCER LETT, V240, P243, DOI 10.1016/j.canlet.2005.09.012; Dinkova-Kostova AT, 2015, FREE RADICAL BIO MED, V88, P179, DOI 10.1016/j.freeradbiomed.2015.04.036; Dinkova-Kostova AT, 2002, P NATL ACAD SCI USA, V99, P11908, DOI 10.1073/pnas.172398899; Doe P., 1998, FISH DRYING SMOKING, P44; EDLIN DAN, 1995, FEMS MICROBIOL LETT, V125, P311, DOI [10.1111/j.1574-6968.1995.tb07374.x, 10.1016/0378-1097(94)00516-T]; Egner PA, 2011, CANCER PREV RES, V4, P384, DOI 10.1158/1940-6207.CAPR-10-0296; EPA, HLTH EFF BREATH WOOD; Fernandes R, 2011, AM J PHYSIOL-CELL PH, V300, pC927, DOI 10.1152/ajpcell.00140.2010; Filannino P, 2015, FOOD MICROBIOL, V46, P272, DOI 10.1016/j.fm.2014.08.018; Fonseca-Azevedo K, 2012, P NATL ACAD SCI USA, V109, P18571, DOI 10.1073/pnas.1206390109; Forbes JM, 2008, DIABETES, V57, P1446, DOI 10.2337/db08-0057; Frank O, 2007, J AGR FOOD CHEM, V55, P1945, DOI 10.1021/jf0632280; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI20042162S, 10.1172/JCI21625]; Gadaga TH, 1999, INT J FOOD MICROBIOL, V53, P1, DOI 10.1016/S0168-1605(99)00154-3; Ganzle MG, 2014, FOOD MICROBIOL, V37, P2, DOI 10.1016/j.fm.2013.04.007; Giacco F, 2010, CIRC RES, V107, P1058, DOI 10.1161/CIRCRESAHA.110.223545; Gilgun-Sherki Y, 2004, J NEUROL, V251, P261, DOI 10.1007/s00415-004-0348-9; Gills JJ, 2006, CANCER LETT, V236, P72, DOI 10.1016/j.canlet.2005.05.007; Godoy L, 2014, FOOD CONTROL, V45, P81, DOI 10.1016/j.foodcont.2014.03.041; Guglielmetti S, 2008, APPL ENVIRON MICROB, V74, P1284, DOI 10.1128/AEM.02093-07; Halliwell B, 2007, BIOCHEM J, V401, P1, DOI 10.1042/BJ20061131; Hallowell B., 2007, FREE RADICALS BIOL M; Hayes JD, 2014, TRENDS BIOCHEM SCI, V39, P199, DOI 10.1016/j.tibs.2014.02.002; Heitzer T, 2001, CIRCULATION, V104, P2673, DOI 10.1161/hc4601.099485; Hirota A, 2011, EXP DERMATOL, V20, P664, DOI 10.1111/j.1600-0625.2011.01292.x; Holland R, 2010, ANTIOXID REDOX SIGN, V13, P1749, DOI 10.1089/ars.2010.3273; Holmstrom KM, 2013, BIOL OPEN, V2, P761, DOI 10.1242/bio.20134853; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; Huys G, 2008, J FOOD PROTECT, V71, P339, DOI 10.4315/0362-028X-71.2.339; Inano H, 1999, CARCINOGENESIS, V20, P1011, DOI 10.1093/carcin/20.6.1011; Itoh K, 2003, GENES CELLS, V8, P379, DOI 10.1046/j.1365-2443.2003.00640.x; Itoh K, 2010, ANTIOXID REDOX SIGN, V13, P1665, DOI 10.1089/ars.2010.3222; Jain M, 2004, CIRCULATION, V109, P898, DOI 10.1161/01.CIR.0000112605.43318.CA; Jenner P, 2003, ANN NEUROL, V53, pS26, DOI 10.1002/ana.10483; Ji LL, 2015, FREE RADICAL BIO MED, V85, P12, DOI 10.1016/j.freeradbiomed.2015.03.035; Johnson JA, 2008, ANN NY ACAD SCI, V1147, P61, DOI 10.1196/annals.1427.036; Kabak B, 2011, CRIT REV FOOD SCI, V51, P248, DOI 10.1080/10408390903569640; Kang MI, 2004, P NATL ACAD SCI USA, V101, P2046, DOI 10.1073/pnas.0308347100; Keller UAD, 2006, MOL CELL BIOL, V26, P3773, DOI 10.1128/MCB.26.10.3773-3784.2006; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Kensler TW, 2013, TOP CURR CHEM, V329, P163, DOI 10.1007/128_2012_339; Khor TO, 2008, CANCER PREV RES, V1, P187, DOI 10.1158/1940-6207.CAPR-08-0028; Kim J, 2010, PHYSIOL GENOMICS, V40, P100, DOI 10.1152/physiolgenomics.00105.2009; Knockaert D, 2012, J SCI FOOD AGR, V92, P2291, DOI 10.1002/jsfa.5623; Kumar RS, 2013, INT J FOOD SCI NUTR, V64, P415, DOI 10.3109/09637486.2012.746288; Kwak MK, 2002, MOL CELL BIOL, V22, P2883, DOI 10.1128/MCB.22.9.2883-2892.2002; Larcher R, 2008, ANAL CHIM ACTA, V609, P235, DOI 10.1016/j.aca.2007.12.038; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Lippross S, 2014, CALCIFIED TISSUE INT, V95, P349, DOI 10.1007/s00223-014-9900-5; Liu M, 2009, KIDNEY INT, V76, P277, DOI 10.1038/ki.2009.157; Long DJ, 2000, CANCER RES, V60, P5913; Lucas PW, 2011, P NATL ACAD SCI USA, V108, P19101, DOI 10.1073/pnas.1116813108; Manach C, 2004, AM J CLIN NUTR, V79, P727, DOI 10.1093/ajcn/79.5.727; Miller CJ, 2012, BBA-MOL BASIS DIS, V1822, P1038, DOI 10.1016/j.bbadis.2012.02.007; Montazeri N, 2013, FOOD SCI NUTR, V1, P102, DOI 10.1002/fsn3.9; Motohashi H, 2004, TRENDS MOL MED, V10, P549, DOI 10.1016/j.molmed.2004.09.003; Mtshali PS, 2010, J APPL MICROBIOL, V108, P1389, DOI 10.1111/j.1365-2672.2009.04535.x; Nakamura Y, 2003, BIOCHEMISTRY-US, V42, P4300, DOI 10.1021/bi0340090; Oelofse A, 2008, S AFR J ENOL VITIC, V29, P128; Olthof MR, 2001, J NUTR, V131, P66, DOI 10.1093/jn/131.1.66; Paupe V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004253; PEPPERCO.MA, 1972, P NATL ACAD SCI USA, V69, P1413, DOI 10.1073/pnas.69.6.1413; PEPPERCORN MA, 1971, J BACTERIOL, V108, P996, DOI 10.1128/JB.108.3.996-1000.1971; Pohanka M, 2014, CURR MED CHEM, V21, P356; Prasad S, 2014, CANCER RES TREAT, V46, P2, DOI 10.4143/crt.2014.46.1.2; Pratico D, 2008, TRENDS PHARMACOL SCI, V29, P609, DOI 10.1016/j.tips.2008.09.001; PROCHASKA HJ, 1985, P NATL ACAD SCI USA, V82, P8232, DOI 10.1073/pnas.82.23.8232; Radjendirane V, 1998, J BIOL CHEM, V273, P7382, DOI 10.1074/jbc.273.13.7382; Ramos-Gomez M, 2001, P NATL ACAD SCI USA, V98, P3410, DOI 10.1073/pnas.051618798; Rangasamy T, 2005, J EXP MED, V202, P47, DOI 10.1084/jem.20050538; RAO CV, 1995, CANCER RES, V55, P259; Reuter G, 2001, Curr Issues Intest Microbiol, V2, P43; Rhee SJ, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-S1-S5; Roberts RA, 2009, TOXICOL SCI, V112, P4, DOI 10.1093/toxsci/kfp179; Rodriguez H, 2008, FOOD CHEM, V107, P1393, DOI 10.1016/j.foodchem.2007.09.067; Rodriguez H, 2009, INT J FOOD MICROBIOL, V132, P79, DOI 10.1016/j.ijfoodmicro.2009.03.025; Sanchez-Maldonado AF, 2011, J APPL MICROBIOL, V111, P1176, DOI 10.1111/j.1365-2672.2011.05141.x; Satoh T, 2009, BIOCHEM BIOPH RES CO, V379, P537, DOI 10.1016/j.bbrc.2008.12.106; Saw CL, 2011, MOL CARCINOGEN, V50, P479, DOI 10.1002/mc.20725; Scalbert A, 2005, CRIT REV FOOD SCI, V45, P287, DOI 10.1080/1040869059096; Schwanke S. K., 1995, J FOOD LIPIDS, V2, P239, DOI DOI 10.1111/J.1745-4522.1995.TB00046.X; Sharma RA, 2005, EUR J CANCER, V41, P1955, DOI 10.1016/j.ejca.2005.05.009; SHARPE ME, 1973, J GEN MICROBIOL, V77, P37, DOI 10.1099/00221287-77-1-37; Shih SC, 2005, EXP MOL PATHOL, V79, P14, DOI 10.1016/j.yexmp.2005.03.004; Shureiqi I, 2011, CANCER PREV RES, V4, P296, DOI 10.1158/1940-6207.CAPR-11-0060; Silva I, 2011, J APPL MICROBIOL, V111, P360, DOI 10.1111/j.1365-2672.2011.05052.x; Slocum SL, 2011, ARCH TOXICOL, V85, P273, DOI 10.1007/s00204-011-0675-4; Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59; Stahl B, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00376-13; Svensson L, 2010, J AGR FOOD CHEM, V58, P9214, DOI 10.1021/jf101504v; Swain Manas Ranjan, 2014, Biotechnol Res Int, V2014, P250424, DOI 10.1155/2014/250424; Takagi H, 1998, DIABETES, V47, P1480, DOI 10.2337/diabetes.47.9.1480; Tang XW, 2011, FREE RADICAL BIO MED, V50, P1599, DOI 10.1016/j.freeradbiomed.2011.03.008; Tanigawa S, 2007, FREE RADICAL BIO MED, V42, P1690, DOI 10.1016/j.freeradbiomed.2007.02.017; van Beek S, 2000, APPL ENVIRON MICROB, V66, P5322, DOI 10.1128/AEM.66.12.5322-5328.2000; Wada Y, 2011, CYTOTECHNOLOGY, V63, P25, DOI 10.1007/s10616-010-9315-8; Wakabayashi N, 2004, P NATL ACAD SCI USA, V101, P2040, DOI 10.1073/pnas.0307301101; Wakabayashi N, 2003, NAT GENET, V35, P238, DOI 10.1038/ng1248; Walker WA, 1998, J NUTR BIOCHEM, V9, P668, DOI 10.1016/S0955-2863(98)00058-8; Walter J, 2008, APPL ENVIRON MICROB, V74, P4985, DOI 10.1128/AEM.00753-08; WATTENBERG LW, 1980, CANCER RES, V40, P2820; Wells PG, 2009, TOXICOL SCI, V108, P4, DOI 10.1093/toxsci/kfn263; WHITING GC, 1959, NATURE, V184, P1427, DOI 10.1038/1841427a0; WHITING GC, 1957, NATURE, V180, P1479, DOI 10.1038/1801479a0; Wilson Carol, 2014, Nat Rev Endocrinol, V10, P3, DOI 10.1038/nrendo.2013.225; Wittkowski R RJ, 1992, ACS SYM SER, P232; Wrangham RW, 2009, CATCHING FIRE COOKIN; Wruck CJ, 2011, ANN RHEUM DIS, V70, P844, DOI 10.1136/ard.2010.132720; Wu RP, 2010, P NATL ACAD SCI USA, V107, P7479, DOI 10.1073/pnas.1002890107; Xu CJ, 2006, CANCER RES, V66, P8293, DOI 10.1158/0008-5472.CAN-06-0300; Xu YZ, 2010, FASEB J, V24, P609, DOI 10.1096/fj.09-135731; Yakobson C., CROOKED STAVE ARTISA; Yet SF, 2003, FASEB J, V17, P1759, DOI 10.1096/fj.03-0187fje; Yet SF, 1999, J CLIN INVEST, V103, pR23, DOI 10.1172/JCI6163; Yoh K, 2001, KIDNEY INT, V60, P1343, DOI 10.1046/j.1523-1755.2001.00939.x; Zhang DD, 2003, MOL CELL BIOL, V23, P8137, DOI 10.1128/MCB.23.22.8137-8151.2003; Zhang TS, 2014, ARCH BIOCHEM BIOPHYS, V557, P36, DOI 10.1016/j.abb.2014.05.023; ZHANG YS, 1992, P NATL ACAD SCI USA, V89, P2399, DOI 10.1073/pnas.89.6.2399; ZHANG YS, 1994, P NATL ACAD SCI USA, V91, P3147, DOI 10.1073/pnas.91.8.3147; Zhao ZY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019456	148	69	70	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0148042	10.1371/journal.pone.0148042	http://dx.doi.org/10.1371/journal.pone.0148042			40	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26885667	Green Published, gold			2022-12-26	WOS:000371218400015
J	Dinculescu, A; Stupay, RM; Deng, WT; Dyka, FM; Min, SH; Boye, SL; Chiodo, VA; Abrahan, CE; Zhu, P; Li, QH; Strettoi, E; Novelli, E; Nagel-Wolfrum, K; Wolfrum, U; Smith, WC; Hauswirth, WW				Dinculescu, Astra; Stupay, Rachel M.; Deng, Wen-Tao; Dyka, Frank M.; Min, Seok-Hong; Boye, Sanford L.; Chiodo, Vince A.; Abrahan, Carolina E.; Zhu, Ping; Li, Qiuhong; Strettoi, Enrica; Novelli, Elena; Nagel-Wolfrum, Kerstin; Wolfrum, Uwe; Smith, W. Clay; Hauswirth, William W.			AAV-Mediated Clarin-1 Expression in the Mouse Retina: Implications for USH3A Gene Therapy	PLOS ONE			English	Article							SYNDROME TYPE-III; USHER PROTEIN NETWORK; LEBER CONGENITAL AMAUROSIS; PHOTORECEPTOR CELLS; CAUSATIVE GENE; TRANSDUCIN TRANSLOCATION; MONOCLONAL-ANTIBODIES; INDUCED DEGENERATION; ROD PHOTORECEPTORS; MOLECULAR LINKS	Usher syndrome type III (USH3A) is an autosomal recessive disorder caused by mutations in clarin-1 (CLRN1) gene, leading to progressive retinal degeneration and sensorineural deafness. Efforts to develop therapies for preventing photoreceptor cell loss are hampered by the lack of a retinal phenotype in the existing USH3 mouse models and by conflicting reports regarding the endogenous retinal localization of clarin-1, a transmembrane protein of unknown function. In this study, we used an AAV-based approach to express CLRN1 in the mouse retina in order to determine the pattern of its subcellular localization in different cell types. We found that all major classes of retinal cells express AAV-delivered CLRN1 driven by the ubiquitous, constitutive small chicken beta-actin promoter, which has important implications for the design of future USH3 gene therapy studies. Within photoreceptor cells, AAV-expressed CLRN1 is mainly localized at the inner segment region and outer plexiform layer, similar to the endogenous expression of other usher proteins. Subretinal delivery using a full strength viral titer led to significant loss of retinal function as evidenced by ERG analysis, suggesting that there is a critical limit for CLRN1 expression in photoreceptor cells. Taken together, these results suggest that CLRN1 expression is potentially supported by a variety of retinal cells, and the right combination of AAV vector dose, promoter, and delivery method needs to be selected to develop safe therapies for USH3 disorder.	[Dinculescu, Astra; Stupay, Rachel M.; Deng, Wen-Tao; Dyka, Frank M.; Min, Seok-Hong; Boye, Sanford L.; Chiodo, Vince A.; Abrahan, Carolina E.; Zhu, Ping; Li, Qiuhong; Smith, W. Clay; Hauswirth, William W.] Univ Florida, Ophthalmol, Gainesville, FL USA; [Nagel-Wolfrum, Kerstin; Wolfrum, Uwe] Johannes Gutenberg Univ Mainz, Inst Zool, Cell & Matrix Biol, Saarstr 21, Mainz, Germany; [Strettoi, Enrica; Novelli, Elena] CNR, Inst Neurosci, I-56100 Pisa, Italy	State University System of Florida; University of Florida; Johannes Gutenberg University of Mainz; Consiglio Nazionale delle Ricerche (CNR); Istituto di Neuroscienze (IN-CNR)	Dinculescu, A (corresponding author), Univ Florida, Ophthalmol, Gainesville, FL USA.	astra@ufl.edu	Smith, W. Clay/AAQ-1589-2021; Nagel-Wolfrum, Kerstin/AAX-6477-2020; Deng, Wen-Tao/AAC-4754-2021	Deng, Wen-Tao/0000-0002-9357-0656; Novelli, Elena/0000-0002-6588-4930; hauswirth, william/0000-0002-3244-4947; Strettoi, Enrica/0000-0002-6101-599X	Usher III Initiative, Inc.,; Foundation Fighting Blindness; Research to Prevent Blindness, Inc.; Macula Vision Research Foundation; NEI grant [P30EY021721]; Deutsche Forschungsgemeinschaft (DFG) [GRK 1044]; ProRetina Stiftung; FAUN-Stiftung, Nuremberg; European Community [FP7/2009/241955, FP7/2009/242013]; BMBF [0314106]; Macula Vision Research Foundation (MVRF), USA; Foundation Fighting Blindness (FFB) [TA-NMT-0611-0538-JGU]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001427] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [T32EY007132, P30EY021721] Funding Source: NIH RePORTER	Usher III Initiative, Inc.,; Foundation Fighting Blindness(European Commission); Research to Prevent Blindness, Inc.(Research to Prevent Blindness (RPB)); Macula Vision Research Foundation; NEI grant; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); ProRetina Stiftung; FAUN-Stiftung, Nuremberg; European Community(European Commission); BMBF(Federal Ministry of Education & Research (BMBF)); Macula Vision Research Foundation (MVRF), USA; Foundation Fighting Blindness (FFB); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Support was provided by Usher III Initiative, Inc., Foundation Fighting Blindness, Research to Prevent Blindness, Inc., and Macula Vision Research Foundation; NEI grant P30EY021721; the Deutsche Forschungsgemeinschaft (DFG, GRK 1044 to UW); the ProRetina Stiftung (UW); the FAUN-Stiftung, Nuremberg (to UW and KNW); European Community FP7/2009/241955 (SYSCILIA) (to UW) and FP7/2009/242013 (TREATRUSH) (to UW); BMBF, grant 0314106 (HOPE2) (to UW), and under the frame of E-Rare-2, the ERA-Net for Research on Rare Diseases (EUR-USH) (to KNW), and Foundation Fighting Blindness (FFB; TA-NMT-0611-0538-JGU to UW and KNW). ES is the recipient of a grant from Macula Vision Research Foundation (MVRF), USA.	ADAMUS G, 1991, VISION RES, V31, P17, DOI 10.1016/0042-6989(91)90069-H; Adato A, 2002, EUR J HUM GENET, V10, P339, DOI 10.1038/sj.ejhg.5200831; Ahmed ZM, 2013, PHYSIOL GENOMICS, V45, P987, DOI 10.1152/physiolgenomics.00135.2013; Alagramam KN, 2001, HUM MOL GENET, V10, P1709, DOI 10.1093/hmg/10.16.1709; Arshavsky VY, 2012, J BIOL CHEM, V287, P1620, DOI 10.1074/jbc.R111.305243; Baker SA, 2008, J CELL BIOL, V183, P485, DOI 10.1083/jcb.200806009; Bonnet C, 2012, CURR OPIN NEUROL, V25, P42, DOI 10.1097/WCO.0b013e32834ef8b2; Boye SE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011306; Cohen M, 2007, INT J AUDIOL, V46, P82, DOI 10.1080/14992020600975279; Coleman JE, 2005, INVEST OPHTH VIS SCI, V46, P12, DOI 10.1167/iovs.04-0691; Fields RR, 2002, AM J HUM GENET, V71, P607, DOI 10.1086/342098; Geller SF, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000607; Geng RS, 2012, J NEUROSCI, V32, P9485, DOI 10.1523/JNEUROSCI.0311-12.2012; Geng RS, 2009, HUM MOL GENET, V18, P2748, DOI 10.1093/hmg/ddp210; Gopal SR, 2015, J NEUROSCI, V35, P10188, DOI 10.1523/JNEUROSCI.1096-15.2015; Gurevich VV, 2011, PROG RETIN EYE RES, V30, P405, DOI 10.1016/j.preteyeres.2011.07.002; Hanson SM, 2007, J MOL BIOL, V368, P375, DOI 10.1016/j.jmb.2007.02.053; Hemler ME, 2005, NAT REV MOL CELL BIO, V6, P801, DOI 10.1038/nrm1736; Herrera W, 2008, INVEST OPHTH VIS SCI, V49, P2651, DOI 10.1167/iovs.07-1505; Isosomppi J, 2009, MOL VIS, V15, P1806; Jacobson SG, 2006, MOL THER, V13, P1074, DOI 10.1016/j.ymthe.2006.03.005; Joensuu T, 2001, AM J HUM GENET, V69, P673, DOI 10.1086/323610; Kassai H, 2005, NEURON, V47, P529, DOI 10.1016/j.neuron.2005.07.025; Kimberling WJ, 2010, GENET MED, V12, P512, DOI 10.1097/GIM.0b013e3181e5afb8; KNOSPE V, 1988, CURR EYE RES, V7, P1137, DOI 10.3109/02713688809001885; Kong L, 2006, NEUROBIOL DIS, V21, P468, DOI 10.1016/j.nbd.2005.08.017; Kremer H, 2006, HUM MOL GENET, V15, pR262, DOI 10.1093/hmg/ddl205; KUHN H, 1984, FEBS LETT, V176, P473, DOI 10.1016/0014-5793(84)81221-1; Maerker T, 2008, HUM MOL GENET, V17, P71, DOI 10.1093/hmg/ddm285; Malm E, 2011, EUR J OPHTHALMOL, V21, P30, DOI 10.5301/EJO.2010.5433; Mercer AJ, 2011, VISUAL NEUROSCI, V28, P453, DOI 10.1017/S0952523811000356; Millan JM, 2011, J OPHTHALMOL, V2011, DOI 10.1155/2011/417217; Nagel-Wolfrum K, 2014, ADV EXP MED BIOL, V801, P741, DOI 10.1007/978-1-4614-3209-8_93; Nair KS, 2005, NEURON, V46, P555, DOI 10.1016/j.neuron.2005.03.023; Ness SL, 2003, J MED GENET, V40, P767, DOI 10.1136/jmg.40.10.767; Nevin LM, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-36; Ogun O, 2014, J CELL BIOL, V207, P375, DOI 10.1083/jcb.201404016; Overlack N, 2008, VISION RES, V48, P400, DOI 10.1016/j.visres.2007.08.021; Overlack N, 2011, BBA-MOL CELL RES, V1813, P1883, DOI 10.1016/j.bbamcr.2011.05.015; Pakarinen L, 1996, INT OPHTHALMOL, V19, P307; Pang JJ, 2008, INVEST OPHTH VIS SCI, V49, P4278, DOI 10.1167/iovs.07-1622; Pang JJ, 2006, MOL THER, V13, P565, DOI 10.1016/j.ymthe.2005.09.001; Pearring JN, 2013, PROG RETIN EYE RES, V36, P24, DOI 10.1016/j.preteyeres.2013.03.002; Peng YW, 2011, INVEST OPHTH VIS SCI, V52, P6421, DOI 10.1167/iovs.10-6557; Petrs-Silva H, 2009, MOL THER, V17, P463, DOI 10.1038/mt.2008.269; Phillips JB, 2013, GENE EXPR PATTERNS, V13, P473, DOI 10.1016/j.gep.2013.09.001; Plantinga RF, 2006, ACTA OPHTHALMOL SCAN, V84, P36, DOI 10.1111/j.1600-0420.2005.00507.x; Plantinga RF, 2005, AUDIOL NEURO-OTOL, V10, P79, DOI 10.1159/000083363; Rachel Rivka A, 2012, Cilia, V1, P22, DOI 10.1186/2046-2530-1-22; Ratnam K, 2013, JAMA OPHTHALMOL, V131, P67, DOI 10.1001/2013.jamaophthalmol.2; Reiners J, 2006, ADV EXP MED BIOL, V572, P349; Reiners J, 2005, HUM MOL GENET, V14, P3933, DOI 10.1093/hmg/ddi417; Reiners J, 2003, INVEST OPHTH VIS SCI, V44, P5006, DOI 10.1167/iovs.03-0483; Reiners J, 2006, EXP EYE RES, V83, P97, DOI 10.1016/j.exer.2005.11.010; Roepman Ronald, 2007, V43, P209, DOI 10.1007/978-1-4020-5943-8_10; Sahly I, 2012, J CELL BIOL, V199, P381, DOI 10.1083/jcb.201202012; Saihan Z, 2009, CURR OPIN NEUROL, V22, P19, DOI 10.1097/WCO.0b013e3283218807; Siegert S, 2012, NAT NEUROSCI, V15, P487, DOI 10.1038/nn.3032; SMITH RJH, 1994, AM J MED GENET, V50, P32, DOI 10.1002/ajmg.1320500107; Smith WC, 2013, PROG MOL BIOL TRANSL, V118, P243, DOI 10.1016/B978-0-12-394440-5.00010-3; Smith WC, 1996, EXP EYE RES, V62, P585; Tian G, 2009, J BIOL CHEM, V284, P18980, DOI 10.1074/jbc.M109.003160; Tian M, 2014, EXP EYE RES, V118, P145, DOI 10.1016/j.exer.2013.10.021; van Wijk E, 2006, HUM MOL GENET, V15, P751, DOI 10.1093/hmg/ddi490; van Wijk E, 2009, HUM MOL GENET, V18, P51, DOI 10.1093/hmg/ddn312; Vastinsalo H, 2011, EUR J HUM GENET, V19, P30, DOI 10.1038/ejhg.2010.140; Williams DS, 2008, VISION RES, V48, P433, DOI 10.1016/j.visres.2007.08.015; Wright RN, 2012, INVEST OPHTH VIS SCI, V53, P1519, DOI 10.1167/iovs.11-8845; Yan D, 2010, J HUM GENET, V55, P327, DOI 10.1038/jhg.2010.29; Zallocchi M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030573; Zallocchi M, 2009, HEARING RES, V255, P109, DOI 10.1016/j.heares.2009.06.006; Ziccardi L, 2012, J NEUROSCI, V32, P13010, DOI 10.1523/JNEUROSCI.1913-12.2012	73	7	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0148874	10.1371/journal.pone.0148874	http://dx.doi.org/10.1371/journal.pone.0148874			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	26881841	Green Published, Green Submitted, gold			2022-12-26	WOS:000371219000028
J	Johnson, RC; Vance-Borland, K				Johnson, R. C.; Vance-Borland, Ken			Linking Genetic Variation in Adaptive Plant Traits to Climate in Tetraploid and Octoploid Basin Wildrye [Leymus cinereus (Scribn. & Merr.) A. Love] in the Western US	PLOS ONE			English	Article							PHENOTYPIC PLASTICITY; POPULATION DIFFERENTIATION; CHAMERION-ANGUSTIFOLIUM; SEED TRANSFER; TRADE-OFFS; ADAPTATION; GENECOLOGY; ZONES; POLYPLOIDY; ROSACEAE	Few studies have assessed how ploidy type within a species affects genetic variation among populations in relation to source climates. Basin wildrye (Leymus cinereus (Scribn. & Merr.) A. Love) is a large bunchgrass common in the intermountain Western U.S. found in both octoploid and tetraploid types. In common gardens at two sites over two years differences in both ploidy type and genetic variation within ploidy were observed in phenology, morphology, and production traits on 57 octoploid and 52 tetraploid basin wildrye from the intermountain Western U.S. (P<0.01). Octoploids had larger leaves, longer culms, and greater crown circumference than tetraploids but the numerical ranges of plant traits and their source climates overlapped between ploidy types. Still, among populations octoploids often had greater genetic variation for traits and occupied more diverse climates than tetraploids. Genetic variation for both ploidy types was linked to source climates in canonical correlation analysis, with the first two variates explaining 70% of the variation. Regression of those canonical variates with seed source climate variables produced models that explained 64% and 38% of the variation, respectively, and were used to map 15 seed zones covering 673258 km(2). Utilization of these seed zones will help ensure restoration with adaptive seed sources for both ploidy types. The link between genetic traits and seed source climates suggests climate driven natural selection and adaptive evolution in basin wildrye. The more diverse climates occupied by octoploids and higher trait variation suggests a higher capacity for ecological differentiation than tetraploids in the intermountain Western U.S.	[Johnson, R. C.] ARS, Plant Germplasm Res & Testing, USDA, Pullman, WA USA; [Vance-Borland, Ken] Conservat Planning Inst, Corvallis, OR USA	United States Department of Agriculture (USDA)	Johnson, RC (corresponding author), ARS, Plant Germplasm Res & Testing, USDA, Pullman, WA USA.	rcjohnson@wsu.edu		Vance-Borland, Ken/0000-0003-2179-8106	United States Department of Agriculture-Agriculture Research Service; Bureau of Land Management; Great Basin Native Plant Project	United States Department of Agriculture-Agriculture Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service); Bureau of Land Management; Great Basin Native Plant Project	This work was funded by United States Department of Agriculture-Agriculture Research Service, Bureau of Land Management, and Great Basin Native Plant Project.	AKAIKE H, 1969, ANN I STAT MATH, V21, P243, DOI 10.1007/BF02532251; Anamthawat-Jonsson K, 2014, J SYST EVOL, V52, P716, DOI 10.1111/jse.12106; Anderson JT, 2015, AM NAT, V186, pS60, DOI 10.1086/682404; [Anonymous], 1986, MULTIVARIATE STAT ME; Bischoff A, 2010, OIKOS, V119, P445, DOI 10.1111/j.1600-0706.2009.17776.x; Bretagnolle F, 2001, INT J PLANT SCI, V162, P309, DOI 10.1086/319572; Buggs RJA, 2007, EVOLUTION, V61, P125, DOI 10.1111/j.1558-5646.2007.00010.x; CAMPBELL RK, 1986, SILVAE GENET, V35, P85; Cash SD, 1998, CROP SCI, V38, P278, DOI 10.2135/cropsci1998.0011183X003800010052x; Cochran W.G., 1967, STAT METHODS; Culumber CM, 2013, CROP SCI, V53, P996, DOI 10.2135/cropsci2012.06.0396; Davies GM, 2012, ECOL APPL, V22, P1562, DOI 10.1890/10-2089.1; Draper N.R., 1981, APPL REGRESSION ANAL, Vsecond, DOI DOI 10.1002/9781118625590; Endler J. A., 1986, NATURAL SELECTION WI; Erickson V. J., 2008, Native Plants Journal, V9, P255, DOI 10.2979/NPJ.2008.9.3.255; Espeland, 2013, NATIVE PLANTS J, V14, P231, DOI [10.3368/npj.14.3.231, DOI 10.3368/NPJ.14.3.231]; Fan X, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-247; Galloway LF, 2000, EVOLUTION, V54, P1173, DOI 10.1111/j.0014-3820.2000.tb00552.x; GATES DM, 1968, ANN REV PLANT PHYSIO, V19, P211, DOI 10.1146/annurev.pp.19.060168.001235; HANCOCK J F JR, 1979, American Journal of Botany, V66, P366; HANCOCK JF, 1981, AM J BOT, V68, P1, DOI 10.2307/2442984; Hancock N, 2013, RESTOR ECOL, V21, P569, DOI 10.1111/j.1526-100X.2012.00931.x; Hao GY, 2013, NEW PHYTOL, V197, P970, DOI 10.1111/nph.12051; Hereford J, 2009, AM NAT, V173, P579, DOI 10.1086/597611; Horning ME, 2010, RESTOR ECOL, V18, P235, DOI 10.1111/j.1526-100X.2008.00441.x; Hufford KM, 2003, TRENDS ECOL EVOL, V18, P147, DOI 10.1016/S0169-5347(03)00002-8; Husband BC, 2004, NEW PHYTOL, V161, P703, DOI 10.1046/j.1469-8137.2004.00998.x; Johnson RC, 2013, BOTANY, V91, P686, DOI 10.1139/cjb-2013-0046; Johnson RC, 2012, RANGELAND ECOL MANAG, V65, P523, DOI 10.2111/REM-D-11-00165.1; Johnson RC, 2015, EVOL APPL, V8, P172, DOI 10.1111/eva.12240; Jones TA, 2005, USDA FOREST SERVICE, P49; Kawecki TJ, 2004, ECOL LETT, V7, P1225, DOI 10.1111/j.1461-0248.2004.00684.x; Leimu R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004010; Lenormand T, 2002, TRENDS ECOL EVOL, V17, P183, DOI 10.1016/S0169-5347(02)02497-7; Levitt J., 1972, Responses of plants to environmental stresses.; Li WL, 1996, AM J BOT, V83, P15, DOI 10.2307/2445949; Littell R. C., 2006, SAS SYSTEMS MIXED MO, V2nd; MACDONALD SE, 1989, AM J BOT, V76, P1627, DOI 10.2307/2444400; Manzaneda AJ, 2015, EVOLUTION, V69, P2689, DOI 10.1111/evo.12776; Maricle BR, 2007, ENVIRON EXP BOT, V60, P458, DOI 10.1016/j.envexpbot.2007.01.001; Martin SL, 2013, EVOLUTION, V67, P1780, DOI 10.1111/evo.12065; Nicotra AB, 2010, TRENDS PLANT SCI, V15, P684, DOI 10.1016/j.tplants.2010.09.008; Ogle D, 2012, PLANT GUIDE COMMON S; OMERNIK JM, 1987, ANN ASSOC AM GEOGR, V77, P118, DOI 10.1111/j.1467-8306.1987.tb00149.x; Petit C, 1997, J ECOL, V85, P657, DOI 10.2307/2960536; Ramsey J, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0352; Ramsey J, 2011, P NATL ACAD SCI USA, V108, P7096, DOI 10.1073/pnas.1016631108; Rice KJ, 2003, FRONT ECOL ENVIRON, V1, P469, DOI 10.1890/1540-9295(2003)001[0469:MMRITF]2.0.CO;2; SCHEINER SM, 1984, EVOLUTION, V38, P845, DOI 10.1111/j.1558-5646.1984.tb00356.x; St Clair JB, 2005, ANN BOT, V96, P1199, DOI [10.1093/aob/mci278, DOI 10.1093/AOB/MCI278, DOI 10.1093/A0B/MCI278]; St Clair JB, 2013, EVOL APPL, V6, P933, DOI 10.1111/eva.12077; Wang TL, 2012, J APPL METEOROL CLIM, V51, P16, DOI 10.1175/JAMC-D-11-043.1; Wang TL, 2010, ECOL APPL, V20, P153, DOI 10.1890/08-2257.1; Westerling AL, 2006, SCIENCE, V313, P940, DOI 10.1126/science.1128834	54	8	8	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0148982	10.1371/journal.pone.0148982	http://dx.doi.org/10.1371/journal.pone.0148982			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	26881894	gold, Green Submitted, Green Published			2022-12-26	WOS:000371219000039
J	Fan, XQ; Zhang, X; Shen, J; Zhao, HB; Yu, XT; Chen, YA; Zhuang, ZN; Deng, XL; Feng, H; Wang, YF; Peng, L				Fan, Xiaoqiang; Zhang, Xiu; Shen, Jie; Zhao, Haibin; Yu, Xuetao; Chen, Yong'an; Zhuang, Zhuonan; Deng, Xiaolong; Feng, Hua; Wang, Yunfei; Peng, Long			Decreased TUSC3 Promotes Pancreatic Cancer Proliferation, Invasion and Metastasis	PLOS ONE			English	Article							NF-KAPPA-B; OVARIAN-CANCER; ADJUVANT CHEMOTHERAPY; PLUS GEMCITABINE; SURVIVAL; TRIAL; ADENOCARCINOMA; RESECTION; IMPACT; CARCINOGENESIS	Pancreatic cancer is an aggressive disease with dismal prognosis. It is of paramount importance to understand the underlying etiological mechanisms and identify novel, consistent, and easy-to-apply prognostic factors for precision therapy. TUSC3 (tumor suppressor candidate 3) was identified as a potential tumor suppressor gene and previous study showed TUSC3 is decreased in pancreatic cancer at mRNA level, but its putative tumor suppressor function remains to be verified. In this study, TUSC3 expression was found to be suppressed both at mRNA and protein levels in cell line models as well as in clinical samples; decreased TUSC3 expression was associated with higher pathological TNM staging and poorer outcome. In three pairs of cell lines with different NF-kappa B activity, TUSC3 expression was found to be reversely correlated with NF-kappa B activity. TUSC3-silenced pancreatic cancer cell line exhibited enhanced potential of proliferation, migration and invasion. In an orthotopic implanted mice model, TUSC3 silenced cells exhibited more aggressive phenotype with more liver metastasis. In conclusion, the current study shows that decreased immunological TUSC3 staining is a factor prognostic of poor survival in pancreatic cancer patients and decreased TUSC3 promotes pancreatic cancer cell proliferation, invasion and metastasis. The reverse correlation between NF-kappa B activity and TUSC3 expression may suggest a novel regulation pattern for this molecule.	[Fan, Xiaoqiang; Zhang, Xiu; Shen, Jie; Yu, Xuetao; Chen, Yong'an; Deng, Xiaolong; Feng, Hua; Wang, Yunfei; Peng, Long] Jimin Hosp, Dept Oncol, Shanghai, Peoples R China; [Zhao, Haibin] Taihu Hosp, Dept Pathol, Wuxi, Jiangsu, Peoples R China; [Zhuang, Zhuonan] Shandong Univ, Affiliated Qilu Hosp, Dept Gen Surg, Jinan 250100, Shandong, Peoples R China	Shandong University	Shen, J (corresponding author), Jimin Hosp, Dept Oncol, Shanghai, Peoples R China.	Jieshendoc@163.com			Shanghai Municipal 415 Commission of Health and Family Planning [201440345]; Shanghai Municipal Commission of Health and Family Planning [201440345]	Shanghai Municipal 415 Commission of Health and Family Planning; Shanghai Municipal Commission of Health and Family Planning	This study was supported by Shanghai Municipal 415 Commission of Health and Family Planning (Grant No. 201440345 to Xiaoqiang Fan) [http://www.wsjsw.gov.cn/wsj/]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank for Dr Paul J. Chiao from MD Anderson Cancer Center, Texas University, USA for providing cell lines as gifts and advice. This study was supported by Shanghai Municipal Commission of Health and Family Planning (Grant No. 201440345).	Ali S, 2010, J CELL BIOCHEM, V110, P171, DOI 10.1002/jcb.22523; Arbieva ZH, 2000, GENOME RES, V10, P244, DOI 10.1101/gr.10.2.244; Bashyam MD, 2005, NEOPLASIA, V7, P556, DOI 10.1593/neo.04586; Birnbaum DJ, 2011, GENE CHROMOSOME CANC, V50, P456, DOI 10.1002/gcc.20870; Chang Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101452; Chen H, 2010, EJSO-EUR J SURG ONC, V36, P657, DOI 10.1016/j.ejso.2010.05.014; Combs SE, 2014, ANN SURG ONCOL, V21, P2801, DOI 10.1245/s10434-014-3607-8; Conroy T, 2011, NEW ENGL J MED, V364, P1817, DOI 10.1056/NEJMoa1011923; Cooke SL, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-288; Dobrovolskaia MA, 2005, CURR CANCER DRUG TAR, V5, P325, DOI 10.2174/1568009054629645; Fujioka S, 2003, ONCOGENE, V22, P1365, DOI 10.1038/sj.onc.1206323; Fujioka S, 2003, CLIN CANCER RES, V9, P346; Garcea G, 2011, WORLD J SURG, V35, P868, DOI 10.1007/s00268-011-0984-z; Harder J, 2012, BRIT J CANCER, V106, P1033, DOI 10.1038/bjc.2012.18; Horak P, 2014, SCI REP-UK, V4, DOI 10.1038/srep03739; Ishibashi H, 2003, J CLIN ENDOCR METAB, V88, P2309, DOI 10.1210/jc.2002-021353; Jamieson NB, 2005, BRIT J CANCER, V92, P21, DOI 10.1038/sj.bjc.6602305; Kelleher DJ, 2006, GLYCOBIOLOGY, V16, p47R, DOI 10.1093/glycob/cwj066; Kratochvilova K, 2015, INT J CANCER, V137, P1330, DOI 10.1002/ijc.29502; Mohorko E, 2011, J INHERIT METAB DIS, V34, P869, DOI 10.1007/s10545-011-9337-1; Moore MJ, 2007, J CLIN ONCOL, V25, P1960, DOI 10.1200/JCO.2006.07.9525; Oettle H, 2007, JAMA-J AM MED ASSOC, V297, P267, DOI 10.1001/jama.297.3.267; Oettle H, 2013, JAMA-J AM MED ASSOC, V310, P1473, DOI 10.1001/jama.2013.279201; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Pils D, 2005, CANCER-AM CANCER SOC, V104, P2417, DOI 10.1002/cncr.21538; Pils D, 2013, CANCER-AM CANCER SOC, V119, P946, DOI 10.1002/cncr.27850; Raimondi S, 2009, NAT REV GASTRO HEPAT, V6, P699, DOI 10.1038/nrgastro.2009.177; Raut CP, 2007, ANN SURG, V246, P52, DOI 10.1097/01.sla.0000259391.84304.2b; Sclabas Guido M, 2003, Int J Gastrointest Cancer, V33, P15, DOI 10.1385/IJGC:33:1:15; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Szkandera J, 2014, BRIT J CANCER, V110, P183, DOI 10.1038/bjc.2013.701; Vanhara P, 2013, INT J ONCOL, V42, P1383, DOI 10.3892/ijo.2013.1824; Von Hoff DD, 2013, NEW ENGL J MED, V369, P1691, DOI 10.1056/NEJMoa1304369; Xu XL, 2004, WORLD J GASTROENTERO, V10, P3441; Zhou H, 2009, P NATL ACAD SCI USA, V106, P15750, DOI 10.1073/pnas.0908332106	35	22	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149028	10.1371/journal.pone.0149028	http://dx.doi.org/10.1371/journal.pone.0149028			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26871953	Green Published, gold, Green Submitted			2022-12-26	WOS:000370054100090
J	Hennerici, T; Pollmann, R; Schmidt, T; Seipelt, M; Tackenberg, B; Mobs, C; Ghoreschi, K; Hertl, M; Eming, R				Hennerici, Tina; Pollmann, Robert; Schmidt, Thomas; Seipelt, Maria; Tackenberg, Bjoern; Moebs, Christian; Ghoreschi, Kamran; Hertl, Michael; Eming, Ruediger			Increased Frequency of T Follicular Helper Cells and Elevated Interleukin-27 Plasma Levels in Patients with Pemphigus	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; SYSTEMIC-LUPUS-ERYTHEMATOSUS; MYASTHENIA-GRAVIS; B-CELLS; DESMOGLEIN 3; SJOGRENS-SYNDROME; IMMUNE-RESPONSE; PATHOGENIC IGG; P-28 SUBUNIT; VULGARIS	Pemphigus is an autoimmune disease in which IgG auto-antibodies (auto-ab) against the desmosomal cadherins desmoglein (Dsg) 3 and Dsg1 cause loss of epidermal keratinocyte adhesion. Aim of this study was to investigate cytokines derived from antigen-presenting cells (APC) and their relation to CD4+ T cell subpopulations and to the auto-ab response in pemphigus. In this regard, patients with pemphigus were compared to patients with myasthenia gravis (MG), an unrelated auto-ab-mediated autoimmune disease, and healthy controls. In pemphigus and MG, the plasma concentrations of the APC-derived immunomodulatory cytokine IL-27 were highly increased. Strikingly, IL-27 strongly correlated with Dsg-specific IgG auto-ab titers. T helper (Th) 17 cells were augmented in both pemphigus and MG patients while T follicular helper (Tfh) cells, which are essential in providing B cell help, were increased only in pemphigus along with increasing plasma concentrations of IL-21, a cytokine produced by Th17 and Tfh cells. Moreover, we could detect Dsg3-specific autoreactive T cells producing IL-21 upon ex vivo stimulation with Dsg3. These findings suggest that IL-27 and IL-21-producing T cells, are involved in the pathogenesis of pemphigus. The further characterization of IL-21-producing T cells and of the role of IL-27 will lead to a more defined understanding of the auto-ab response in pemphigus.	[Hennerici, Tina; Pollmann, Robert; Schmidt, Thomas; Moebs, Christian; Hertl, Michael; Eming, Ruediger] Univ Marburg, Dept Dermatol & Allergol, Marburg, Germany; [Seipelt, Maria; Tackenberg, Bjoern] Univ Marburg, Dept Neurol, Marburg, Germany; [Ghoreschi, Kamran] Univ Tubingen, Dept Dermatol, Tubingen, Germany	Philipps University Marburg; Philipps University Marburg; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Eming, R (corresponding author), Univ Marburg, Dept Dermatol & Allergol, Marburg, Germany.	eming@med.uni-marburg.de		Pollmann, Robert/0000-0002-4596-516X; Mobs, Christian/0000-0002-5197-7669; Ghoreschi, Kamran/0000-0002-5526-7517	German Research Foundation (Deutsche Forschungsgemeinschaft) [HE 1602/7-3]; University Hospital Giessen and Marburg GmbH, Marburg, Germany (UKGM)	German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); University Hospital Giessen and Marburg GmbH, Marburg, Germany (UKGM)	This work was supported by Grant HE 1602/7-3 (to M.H. and R.E.) from the German Research Foundation (Deutsche Forschungsgemeinschaft). MH received a grant from the University Hospital Giessen and Marburg GmbH, Marburg, Germany (UKGM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amber KT, 2013, EXP DERMATOL, V22, P699, DOI 10.1111/exd.12229; Asothai R, 2015, IMMUNOBIOLOGY, V220, P1129, DOI 10.1016/j.imbio.2015.06.008; Batten M, 2010, J EXP MED, V207, P2895, DOI 10.1084/jem.20100064; Berrih-Aknin S, 2014, J AUTOIMMUN, V52, P90, DOI 10.1016/j.jaut.2013.12.011; Bovenschen HJ, 2011, J INVEST DERMATOL, V131, P1853, DOI 10.1038/jid.2011.139; Cao YX, 2008, J IMMUNOL, V180, P922, DOI 10.4049/jimmunol.180.2.922; Coquet JM, 2007, J IMMUNOL, V178, P2827, DOI 10.4049/jimmunol.178.5.2827; Crotty S, 2014, IMMUNITY, V41, P529, DOI 10.1016/j.immuni.2014.10.004; Dolff S, 2011, ARTHRITIS RES THER, V13, pR157, DOI DOI 10.1186/AR3474; Eming R, 2008, J INVEST DERMATOL, V128, P2850, DOI 10.1038/jid.2008.172; Eming R, 2014, J IMMUNOL, V193, P4391, DOI 10.4049/jimmunol.1401081; Franchimont D, 2004, ANN NY ACAD SCI, V1024, P124, DOI 10.1196/annals.1321.009; Frew JW, 2011, DERMATOL CLIN, V29, P599, DOI 10.1016/j.det.2011.07.001; Ganguly D, 2013, NAT REV IMMUNOL, V13, P566, DOI 10.1038/nri3477; Gertel-Lapter S, 2013, AUTOIMMUN REV, V12, P894, DOI 10.1016/j.autrev.2013.03.009; Giordano CN, 2012, AUTOIMMUNITY, V45, P427, DOI 10.3109/08916934.2012.697593; Goldberg R, 2004, J IMMUNOL, V173, P6465, DOI 10.4049/jimmunol.173.10.6465; Goldberg R, 2004, J IMMUNOL, V173, P1171, DOI 10.4049/jimmunol.173.2.1171; Gringhuis SI, 2014, FUCOSE BASED PAMPS P, P5; Hall RP, 2015, BRIT J DERMATOL, V172, P760, DOI 10.1111/bjd.13350; Hertl M, 2006, J CLIN INVEST, V116, P1159, DOI 10.1172/JCI28547; Hertl M, 1998, J INVEST DERMATOL, V110, P62, DOI 10.1046/j.1523-1747.1998.00086.x; Honda K, 2005, INFLAMM BOWEL DIS, V11, P1044, DOI 10.1097/01.MIB.0000191611.05466.1f; Jin L, 2014, INT J CLIN EXP PATHO, V7, P1988; Kneisel A, 2011, J DTSCH DERMATOL GES, V9, P844, DOI 10.1111/j.1610-0387.2011.07793.x; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Larousserie F, 2004, J PATHOL, V202, P164, DOI 10.1002/path.1508; Li JF, 2005, J NEUROL SCI, V232, P3, DOI 10.1016/j.jns.2004.12.013; Li QT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079746; Li Y, 2014, NEUROL SCI, V35, P29, DOI 10.1007/s10072-013-1460-3; Linterman MA, 2010, J EXP MED, V207, P353, DOI 10.1084/jem.20091738; Liu R, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar4100; Liu Y, 2014, INT IMMUNOPHARMACOL, V22, P98, DOI 10.1016/j.intimp.2014.06.024; Luo CM, 2013, J NEUROIMMUNOL, V256, P55, DOI 10.1016/j.jneuroim.2012.12.001; Mobs C, 2010, J IMMUNOL, V184, P2194, DOI 10.4049/jimmunol.0901379; Morita R, 2011, IMMUNITY, V34, P108, DOI 10.1016/j.immuni.2010.12.012; Muller R, 2008, EXP DERMATOL, V17, P35, DOI 10.1111/j.1600-0625.2007.00615.x; Murrell DE, 2008, J AM ACAD DERMATOL, V58, P1043, DOI 10.1016/j.jaad.2008.01.012; Nishifuji K, 2000, J INVEST DERMATOL, V114, P88, DOI 10.1046/j.1523-1747.2000.00840.x; Pflanz S, 2002, IMMUNITY, V16, P779, DOI 10.1016/S1074-7613(02)00324-2; Saito R, 2005, J NEUROIMMUNOL, V170, P172, DOI 10.1016/j.jneuroim.2005.09.001; Shen H, 2011, ARTHRITIS RHEUM-US, V63, P860, DOI 10.1002/art.30180; Shibata S, 2013, J INVEST DERMATOL, V133, P479, DOI 10.1038/jid.2012.313; Shibata S, 2010, J INVEST DERMATOL, V130, P1034, DOI 10.1038/jid.2009.349; Simpson N, 2010, ARTHRITIS RHEUM-US, V62, P234, DOI 10.1002/art.25032; Spolski R, 2014, NAT REV DRUG DISCOV, V13, P381, DOI 10.1038/nrd4296; Stanley JR, 2008, J INVEST DERMATOL, V128, pE16, DOI [10.1038/skinbio.2008.2, DOI 10.1038/SKINBIO.2008.2]; Sugiyama H, 2007, DERMATOLOGY, V214, P210, DOI 10.1159/000099585; Tackenberg B, 2007, EUR J IMMUNOL, V37, P849, DOI 10.1002/eji.200636449; Takahashi H, 2008, J IMMUNOL, V181, P1526, DOI 10.4049/jimmunol.181.2.1526; Takahashi H, 2009, J IMMUNOL, V182, P1740, DOI 10.4049/jimmunol.182.3.1740; Tangye SG, 2013, NAT REV IMMUNOL, V13, P412, DOI 10.1038/nri3447; Veldman C, 2004, J IMMUNOL, V172, P6468, DOI 10.4049/jimmunol.172.10.6468; Wang J, 2013, CLIN EXP IMMUNOL, V174, P212, DOI 10.1111/cei.12162; Wei L, 2007, J BIOL CHEM, V282, P34605, DOI 10.1074/jbc.M705100200; Xia L, 2012, SCAND J RHEUMATOL, V41, P73, DOI 10.3109/03009742.2011.620574; Xu RC, 2013, EUR J DERMATOL, V23, P795, DOI 10.1684/ejd.2013.2177; Yilmaz V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123546	58	38	38	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0148919	10.1371/journal.pone.0148919	http://dx.doi.org/10.1371/journal.pone.0148919			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26872212	Green Published, Green Submitted, gold			2022-12-26	WOS:000370054100074
J	Huang, SQ; Cao, XJ; Tian, XC; Wang, WM				Huang, Songqian; Cao, Xiaojuan; Tian, Xianchang; Wang, Weimin			High-Throughput Sequencing Identifies MicroRNAs from Posterior Intestine of Loach (Misgurnus anguillicaudatus) and Their Response to Intestinal Air-Breathing Inhibition	PLOS ONE			English	Article							HUMAN ENDOTHELIAL-CELLS; CANCER-CELLS; VASCULAR INTEGRITY; GENE-EXPRESSION; MIR-200 FAMILY; C-ELEGANS; RT-PCR; ANGIOGENESIS; GROWTH; ZEBRAFISH	MicroRNAs (miRNAs) exert important roles in animal growth, immunity, and development, and regulate gene expression at the post-transcriptional level. Knowledges about the diversities of miRNAs and their roles in accessory air-breathing organs (ABOs) of fish remain unknown. In this work, we used high-throughput sequencing to identify known and novel miRNAs from the posterior intestine, an important ABO, in loach (Misgurnus anguillicaudatus) under normal and intestinal air-breathing inhibited conditions. A total of 204 known and 84 novel miRNAs were identified, while 47 miRNAs were differentially expressed between the two small RNA libraries (i.e. between the normal and intestinal air-breathing inhibited group). Potential miRNA target genes were predicted by combining our transcriptome data of the posterior intestine of the loach under the same conditions, and then annotated using COG, GO, KEGG, Swissprot and Nr databases. The regulatory networks of miRNAs and their target genes were analyzed. The abundances of nine known miRNAs were validated by qRT-PCR. The relative expression profiles of six known miRNAs and their eight corresponding target genes, and two novel potential miRNAs were also detected. Histological characteristics of the posterior intestines in both normal and air-breathing inhibited group were further analyzed. This study contributes to our understanding on the functions and molecular regulatory mechanisms of miRNAs in accessory air-breathing organs of fish.	[Huang, Songqian; Cao, Xiaojuan; Tian, Xianchang; Wang, Weimin] Huazhong Agr Univ, Minist Agr, Minist Educ,Key Lab Freshwater Anim Breeding, Coll Fisheries,Key Lab Agr Anim Genet Breeding &, Wuhan 437000, Hubei, Peoples R China; [Cao, Xiaojuan; Wang, Weimin] Freshwater Aquaculture Collaborat Innovat Ctr Hub, Wuhan, Hubei, Peoples R China	Huazhong Agricultural University; Ministry of Agriculture & Rural Affairs	Cao, XJ; Wang, WM (corresponding author), Huazhong Agr Univ, Minist Agr, Minist Educ,Key Lab Freshwater Anim Breeding, Coll Fisheries,Key Lab Agr Anim Genet Breeding &, Wuhan 437000, Hubei, Peoples R China.; Cao, XJ; Wang, WM (corresponding author), Freshwater Aquaculture Collaborat Innovat Ctr Hub, Wuhan, Hubei, Peoples R China.	caoxiaojuan@mail.hzau.edu.cn; wangwm@mail.hzau.edu.cn	黄, 松钱/ABB-8634-2021		National Natural Science Foundation of China [31201719]; Fundamental Research Funds for the Central Universities of China [2662015PY033]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities)	This study was financially supported by National Natural Science Foundation of China (Project Number: 31201719) and the Fundamental Research Funds for the Central Universities of China (Project Number: 2662015PY033).	Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Cao XJ, 2009, ANAT HISTOL EMBRYOL, V38, P254, DOI 10.1111/j.1439-0264.2009.00932.x; Chan LS, 2009, EUR J PHARM SCI, V38, P370, DOI 10.1016/j.ejps.2009.08.008; Chan SY, 2010, CELL CYCLE, V9, P1072, DOI 10.4161/cc.9.6.11006; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen Y, 2008, BLOOD, V111, P1217, DOI 10.1182/blood-2007-07-104133; Cheng WW, 2011, INT J MOL MED, V27, P393, DOI 10.3892/ijmm.2011.598; Cheung TH, 2012, NATURE, V482, P524, DOI 10.1038/nature10834; Choi YC, 2011, MOL CELLS, V32, P77, DOI 10.1007/s10059-011-1042-2; Davis-Dusenbery BN, 2011, J BIOL CHEM, V286, P28097, DOI 10.1074/jbc.M111.236950; Doebele C, 2010, BLOOD, V115, P4944, DOI 10.1182/blood-2010-01-264812; Fasanaro P, 2008, J BIOL CHEM, V283, P15878, DOI 10.1074/jbc.M800731200; Fish JE, 2008, DEV CELL, V15, P272, DOI 10.1016/j.devcel.2008.07.008; Fu YS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022957; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Grundmann S, 2011, CIRCULATION, V123, P999, DOI 10.1161/CIRCULATIONAHA.110.000323; Harris TA, 2008, P NATL ACAD SCI USA, V105, P1516, DOI 10.1073/pnas.0707493105; Hassel D, 2012, CIRC RES, V111, P1421, DOI 10.1161/CIRCRESAHA.112.279711; Jalali S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046808; Ji RR, 2007, CIRC RES, V100, P1579, DOI 10.1161/CIRCRESAHA.106.141986; Kikkawa N, 2010, BRIT J CANCER, V103, P877, DOI 10.1038/sj.bjc.6605811; Kim HK, 2006, J CELL BIOL, V174, P677, DOI 10.1083/jcb.200603008; Kloosterman WP, 2006, NUCLEIC ACIDS RES, V34, P2558, DOI 10.1093/nar/gkl278; Kuhnert F, 2008, DEVELOPMENT, V135, P3989, DOI 10.1242/dev.029736; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Li SC, 2010, GENOMICS, V96, P1, DOI 10.1016/j.ygeno.2010.03.009; Ma YH, 2010, CANCER LETT, V298, P150, DOI 10.1016/j.canlet.2010.06.012; MCMAHON BR, 1987, J EXP BIOL, V133, P371; Menghini R, 2009, CIRCULATION, V120, P1524, DOI 10.1161/CIRCULATIONAHA.109.864629; Nelson JS, 2006, FISHES WORLD, DOI DOI 10.1002/9781119174844; Nikolic Iva, 2010, J Angiogenes Res, V2, P9, DOI 10.1186/2040-2384-2-9; O'Connell RM, 2009, P NATL ACAD SCI USA, V106, P7113, DOI 10.1073/pnas.0902636106; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pulkkinen K, 2008, FEBS LETT, V582, P2397, DOI 10.1016/j.febslet.2008.05.048; Randall D. J., 1981, EVOLUTION AIR BREATH; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Romualdi C, 2003, PHYSIOL GENOMICS, V12, P159, DOI 10.1152/physiolgenomics.00096.2002; Saito Y, 2009, BIOCHEM BIOPH RES CO, V379, P726, DOI 10.1016/j.bbrc.2008.12.098; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Stahlhut C, 2012, DEVELOPMENT, V139, P4356, DOI 10.1242/dev.083774; Suarez Y, 2007, CIRC RES, V100, P1164, DOI 10.1161/01.RES.0000265065.26744.17; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; Urbich C, 2008, CARDIOVASC RES, V79, P581, DOI 10.1093/cvr/cvn156; Wang SS, 2008, DEV CELL, V15, P261, DOI 10.1016/j.devcel.2008.07.002; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Wu HJ, 2014, ANTI-CANCER DRUG, V25, P799, DOI 10.1097/CAD.0000000000000107; Xu ZQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054174; Yi SK, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-754; Yue JQ, 2013, LAB INVEST, V93, P748, DOI 10.1038/labinvest.2013.63; Zhou QB, 2012, MIRNAS HUMAN DIS, P25; Zhou QB, 2011, P NATL ACAD SCI USA, V108, P8287, DOI 10.1073/pnas.1105254108; Zhu N, 2011, ATHEROSCLEROSIS, V215, P286, DOI 10.1016/j.atherosclerosis.2010.12.024	55	16	17	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149123	10.1371/journal.pone.0149123	http://dx.doi.org/10.1371/journal.pone.0149123			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26872032	Green Published, Green Submitted, gold			2022-12-26	WOS:000370054100109
J	Marcelin, JR; Berg, ML; Tan, EM; Amer, H; Cummins, NW; Rizza, SA				Marcelin, Jasmine R.; Berg, Melody L.; Tan, Eugene M.; Amer, Hatem; Cummins, Nathan W.; Rizza, Stacey A.			Is Abnormal Urine Protein/Osmolality Ratio Associated with Abnormal Renal Function in Patients Receiving Tenofovir Disoproxil Fumarate?	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; GLOMERULAR-FILTRATION-RATE; HIV-INFECTED PATIENTS; HIV-1-INFECTED PATIENTS; ANTIRETROVIRAL THERAPY; TUBULAR DYSFUNCTION; DOUBLE-BLIND; EMTRICITABINE; ALAFENAMIDE; PROTEINURIA	Background Risk factors for and optimal surveillance of renal dysfunction in patients on tenofovir disoproxil fumarate (TDF) remain unclear. We investigated whether a urine protein-osmolality (P/O) ratio would be associated with renal dysfunction in HIV-infected persons on TDF. Methods This retrospective, single-center study investigated the relationship between parameters of renal function (estimated glomerular filtration rate (eGFR) and P/O-ratio) and risk factors for development of kidney dysfunction. Subjects were HIV-infected adults receiving TDF with at least one urinalysis and serum creatinine performed between 2010 and 2013. Regression analyses were used to analyze risk factors associated with abnormal P/O-ratio and abnormal eGFR during TDF therapy. Results Patients were predominately male (81%); (65%) were Caucasian. Mean age was 45.1 (+/- 11.8) years; median [IQR] TDF duration was 3.3 years. [1.5-7.6]. Median CD4(+) T cell count and HIV viral load were 451 cells/mu L [267.5-721.5] and 62 copies/mL [0-40,150], respectively. Abnormal P/O-ratio was not associated with low eGFR. 68% of subjects had an abnormal P/O-ratio and 9% had low eGFR. Duration of TDF use, age, diabetes and hypertension were associated with renal dysfunction in this study. After adjustment for age, subjects on TDF > 5 years had almost a four-fold increased likelihood of having an abnormal P/O-ratio than subjects on TDF for < 1yr (OR 3.9; 95% CI 1.2-14.0; p = 0.024). Conclusion Abnormal P/O-ratio is common in HIV-infected patients on TDF but was not significantly associated with low eGFR, suggesting that abnormal P/O-ratio may be a very early biomarker of decreased renal function in HIV infected patients.	[Marcelin, Jasmine R.; Berg, Melody L.; Cummins, Nathan W.; Rizza, Stacey A.] Mayo Clin, Div Infect Dis, Dept Med, Rochester, MN USA; [Tan, Eugene M.] Mayo Clin, Dept Internal Med, Rochester, MN USA; [Amer, Hatem] Mayo Clin, Div Nephrol & Hypertens, Dept Med, Rochester, MN USA; [Berg, Melody L.] Indiana Univ, Hlth Methodist Hosp, Dept Pharm, Indianapolis, IN 46204 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Indiana University System; Indiana University-Purdue University Indianapolis	Marcelin, JR; Rizza, SA (corresponding author), Mayo Clin, Div Infect Dis, Dept Med, Rochester, MN USA.	marcelin.jasmine@mayo.edu; rizza.stacey@mayo.edu	Amer, Hatem/AAN-2676-2020	Amer, Hatem/0000-0002-9570-0506; Marcelin, Jasmine/0000-0003-0504-753X; Tan, Eugene/0000-0003-4141-7155	National Center for Advancing Translational Sciences (NCATS) [UL1 TR000135]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000135] Funding Source: NIH RePORTER	National Center for Advancing Translational Sciences (NCATS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This publication was supported by Grant Number UL1 TR000135 from the National Center for Advancing Translational Sciences (NCATS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH.	Abraham P, 2013, J BIOMED SCI, V20, DOI 10.1186/1423-0127-20-61; Baxi SM, 2015, AIDS; Canale D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103055; Cooper RD, 2010, CLIN INFECT DIS, V51, P496, DOI 10.1086/655681; Fernandez-Fernandez B, 2011, AIDS RES TREAT, V2011, DOI 10.1155/2011/354908; Fernando SK, 2008, AM J MED SCI, V335, P89, DOI 10.1097/MAJ.0b013e31812e6b34; Gara N, 2012, ALIMENT PHARM THER, V35, P1317, DOI 10.1111/j.1365-2036.2012.05093.x; Gervasoni C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080242; Guaraldi G, 2009, J ANTIMICROB CHEMOTH, V63, P374, DOI 10.1093/jac/dkn499; Gunthard HF, 2014, JAMA-J AM MED ASSOC, V312, P410, DOI 10.1001/jama.2014.8722; Izzedine H, 2005, NEPHROL DIAL TRANSPL, V20, P743, DOI 10.1093/ndt/gfh658; Kearney BP, 2004, CLIN PHARMACOKINET, V43, P595, DOI 10.2165/00003088-200443090-00003; Kiertiburanakul Sasisopin, 2011, J Int Assoc Physicians AIDS Care (Chic), V10, P297, DOI 10.1177/1545109711406735; Kinai E, 2009, AIDS RES HUM RETROV, V25, P387, DOI 10.1089/aid.2008.0202; Kohler JJ, 2011, LAB INVEST, V91, P852, DOI 10.1038/labinvest.2011.48; Labarga P, 2009, AIDS, V23, P689, DOI 10.1097/QAD.0b013e3283262a64; Lamb EJ, 2013, CLIN CHEM, V59, P462, DOI 10.1373/clinchem.2012.184259; Levey AS, 2007, CLIN CHEM, V53, P766, DOI 10.1373/clinchem.2006.077180; Levin A, 2013, KIDNEY INT SUPPL, V3, P5, DOI 10.1038/kisup.2012.77; Lucas GM, 2014, CLIN PRACTICE GUIDEL; Mills A., 2015, LANCET INFECT DIS; Mills A, 2015, JAIDS-J ACQ IMM DEF, V69, P439, DOI 10.1097/QAI.0000000000000618; Mugwanya KK, 2015, JAMA INTERN MED, V175, P246, DOI 10.1001/jamainternmed.2014.6786; Nishijima T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029977; Nishijima T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022661; O'Donnell EP, 2011, J ANTIMICROB CHEMOTH, V66, P1120, DOI 10.1093/jac/dkr039; Overton ET, 2009, HIV MED, V10, P343, DOI 10.1111/j.1468-1293.2009.00693.x; Panel on Antiretroviral Guidelines for Adults and Adolescents, GUID US ANT AG HIV 1; Peyriere H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142491; Rollot F, 2003, CLIN INFECT DIS, V37, pE174, DOI 10.1086/379829; Ryom L, 2013, J INFECT DIS, V207, P1359, DOI 10.1093/infdis/jit043; Sax Paul E, 2014, J Acquir Immune Defic Syndr, V67, P52, DOI 10.1097/QAI.0000000000000225; Sax PE, 2015, LANCET, V385, P2606, DOI 10.1016/S0140-6736(15)60616-X; Sise ME, 2015, AIDS, V29, P941, DOI 10.1097/QAD.0000000000000628; Tordato F, 2011, HIV MED, V12, P4, DOI 10.1111/j.1468-1293.2010.00855.x; Tourret J, 2013, J AM SOC NEPHROL, V24, P1519, DOI 10.1681/ASN.2012080857; Wever K, 2010, JAIDS-J ACQ IMM DEF, V55, P78, DOI 10.1097/QAI.0b013e3181d05579; WHO, 2010, ANT THER HIV INF AD; WILSON DM, 1993, AM J CLIN PATHOL, V100, P419, DOI 10.1093/ajcp/100.4.419; Young B, 2009, AIDS PATIENT CARE ST, V23, P589, DOI 10.1089/apc.2008.0232; Zimmermann AE, 2006, CLIN INFECT DIS, V42, P283, DOI 10.1086/499048	41	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149562	10.1371/journal.pone.0149562	http://dx.doi.org/10.1371/journal.pone.0149562			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26872144	Green Published, Green Submitted, gold			2022-12-26	WOS:000370054100164
J	Perez-Fontan, M; Lopes, DM; Enriquez, AG; Lopez-Calvino, B; Lopez-Muniz, A; Falcon, TG; Rodriguez-Carmona, A				Perez-Fontan, Miguel; Lopes, Daniela Machado; Garcia Enriquez, Alba; Lopez-Calvino, Beatriz; Lopez-Muniz, Andres; Garcia Falcon, Teresa; Rodriguez-Carmona, Ana			Inhibition of Gastric Acid Secretion by H2 Receptor Antagonists Associates a Definite Risk of Enteric Peritonitis and Infectious Mortality in Patients Treated with Peritoneal Dialysis	PLOS ONE			English	Article							PROTON PUMP INHIBITORS; SUPPRESSION; DISEASE; ORIGIN	Background Evidences linking treatment with inhibitors of gastric acid secretion (IGAS) and an increased risk of serious infections are inconclusive, both in the population at large and in the particular case of patients with chronic kidney disease. We have undertaken an investigation to disclose associations between treatment with IGAS and infectious outcomes, in patients undergoing chronic Peritoneal Dialysis (PD). Method Observational, historic cohort, single center design. Six hundred and ninety-one patients incident on PD were scrutinized for an association among treatment with IGAS (H2 antagonists H2A or proton pump inhibitors PPI) (main study variable), on one side, and the risks of enteric peritoneal infection (main outcome), overall peritoneal infection, and general and infectious mortality (secondary outcomes). We applied a three-step multivariate approach, based on classic Cox models (baseline variables), time-dependent analyses and, when appropriate, competing risk analyses. Main results The clinical characteristics of patients treated with H2A, PPI or none of these were significantly different. Multivariate analyses disclosed a consistently increased risk of enteric peritonitis in patients treated with IGAS (RR 1.65, 95% CI 1.08-2.55, p = 0.018, Cox). Stratified analysis indicated that patients treated with H2A, rather than those on PPI, supported the burden of this risk. Similar findings applied for the risk of infectious mortality. On the contrary, we were not able to detect any association among the study variables, on one side, and the general risks of peritonitis or mortality, on the other. Conclusions Treatment with IGAS associates increased incidences of enteric peritonitis and infectious mortality, among patients on chronic PD. The association is clear in the case of H2A but less consistent in the case of PPI. Our results support the convenience of preferring PPI to H2A, for gastric acid inhibition in PD patients.	[Perez-Fontan, Miguel; Garcia Enriquez, Alba; Lopez-Muniz, Andres; Garcia Falcon, Teresa; Rodriguez-Carmona, Ana] Univ Hosp A Coruna, Div Nephrol, La Coruna, Spain; [Lopes, Daniela Machado] Hosp de Gaia, Div Nephrol, Vilanova De Gaia, Portugal; [Lopez-Calvino, Beatriz] Univ Hosp A Coruna, Div Epidemiol 2, La Coruna, Spain	Complejo Hospitalario Universitario A Coruna; Complejo Hospitalario Universitario A Coruna	Perez-Fontan, M (corresponding author), Univ Hosp A Coruna, Div Nephrol, La Coruna, Spain.	Miguel.Perez.Fontan@sergas.es	Perez-Fontán, Miguel/ABG-4064-2020	Perez-Fontán, Miguel/0000-0001-7027-2296; Lopez-Calvino, Beatriz/0000-0002-2869-1929				Abraham NS, 2012, CURR OPIN GASTROEN, V28, P615, DOI 10.1097/MOG.0b013e328358d5b9; Bavishi C, 2011, ALIMENT PHARM THER, V34, P1269, DOI 10.1111/j.1365-2036.2011.04874.x; Caravaca F, 1998, PERITON DIALYSIS INT, V18, P41; del Peso G, 2001, PERITON DIALYSIS INT, V21, P360; Eom CS, 2011, CAN MED ASSOC J, V183, P310, DOI 10.1503/cmaj.092129; Fisher LD, 1999, ANNU REV PUBL HEALTH, V20, P145, DOI 10.1146/annurev.publhealth.20.1.145; Kalman RS, 2015, SEMIN DIALYSIS, V28, P68, DOI 10.1111/sdi.12301; Kanno T, 2009, BIOCHEM BIOPH RES CO, V381, P666, DOI 10.1016/j.bbrc.2009.02.109; Kwon JE, 2014, WORLD J GASTROENTERO, V20, P8187, DOI 10.3748/wjg.v20.i25.8187; Leonard J, 2007, AM J GASTROENTEROL, V102, P2047, DOI 10.1111/j.1572-0241.2007.01275.x; Manlucu J, 2005, NEPHROL DIAL TRANSPL, V20, P2376, DOI 10.1093/ndt/gfi025; MURPHY SA, 1991, STOCH PROC APPL, V39, P153, DOI 10.1016/0304-4149(91)90039-F; Nessim SJ, 2008, PERITON DIALYSIS INT, V28, P246; Sabatino A, 2015, NEPHROL DIAL TRANSPL, V30, P924, DOI 10.1093/ndt/gfu287; Shirazian S, 2010, NAT REV NEPHROL, V6, P480, DOI 10.1038/nrneph.2010.84; Siple JF, 2012, ANN PHARMACOTHER, V46, P1413, DOI 10.1345/aph.1R174; Stiefel U, 2006, ANTIMICROB AGENTS CH, V50, P3905, DOI 10.1128/AAC.00522-06; Theisen J, 2000, J GASTROINTEST SURG, V4, P50, DOI 10.1016/S1091-255X(00)80032-3; Tleyjeh IM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056498; Trikudanathan G, 2011, INT J CLIN PRACT, V65, P674, DOI 10.1111/j.1742-1241.2011.02650.x; Vakil N, 2009, AM J GASTROENTEROL, V104, pS17, DOI 10.1038/ajg.2009.47; Wallace JL, 2011, GOODMAN GILMANS PHAR; Zedtwitz-Liebenstein K, 2002, CRIT CARE MED, V30, P1118, DOI 10.1097/00003246-200205000-00026	23	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0148806	10.1371/journal.pone.0148806	http://dx.doi.org/10.1371/journal.pone.0148806			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26872254	Green Published, Green Submitted, gold			2022-12-26	WOS:000370054100057
J	Welc, SS; Morse, DA; Mattingly, AJ; Laitano, O; King, MA; Clanton, TL				Welc, Steven S.; Morse, Deborah A.; Mattingly, Alex J.; Laitano, Orlando; King, Michelle A.; Clanton, Thomas L.			The Impact of Hyperthermia on Receptor-Mediated Interleukin-6 Regulation in Mouse Skeletal Muscle	PLOS ONE			English	Article							NF-KAPPA-B; LPS-BINDING-PROTEIN; INCREASES INTERLEUKIN-6; LIPOPOLYSACCHARIDE LPS; ADRENERGIC-RECEPTORS; CYTOKINE EXPRESSION; C2C12 MYOBLASTS; TOLL-LIKE; STRESS; IL-6	In inflammatory cells, hyperthermia inhibits lipopolysaccharide (LPS)-induced interleukin-6 (IL-6) gene expression and protein secretion. Since hyperthermia alone stimulates IL-6 in skeletal muscle, we hypothesized that it would amplify responses to other receptor-mediated stimuli. IL-6 regulation was tested in C2C12 myotubes and in soleus during treatment with epinephrine (EPI) or LPS. In EPI-treated myotubes (100 ng/ml), 1 h exposure at 40.5 degrees C-42 degrees C transiently increased IL-6 mRNA compared to EPI treatment alone at 37 degrees C. In LPS-treated myotubes (1 mu g/ml), exposure to 41 degrees C-42 degrees C also increased IL-6 mRNA. In isolated mouse soleus, similar amplifications of IL-6 gene expression were observed in 41 degrees C, during both low (1 ng/ml) and high dose (100 ng/ml) EPI, but only in high dose LPS (1 mu g/ml). In myotubes, heat increased IL-6 secretion during EPI exposure but had no effect or inhibited secretion with LPS. In soleus there were no effects of heat on IL-6 secretion during either EPI or LPS treatment. Mechanisms for the effects of heat on IL-6 mRNA were explored using a luciferase-reporter in C2C12 myotubes. Overexpression of heat shock factor-1 (HSF-1) had no impact on IL-6 promoter activity during EPI stimulation, but elevated IL-6 promoter activity during LPS stimulation. In contrast, when the activator protein-1 (AP-1) element was mutated, responses to both LPS and EPI were suppressed in heat. Using siRNA against activating transcription factor-3 (ATF-3), a heat-stress-induced inhibitor of IL-6, no ATF-3-dependent effects were observed. The results demonstrate that, unlike inflammatory cells, hyperthermia in muscle fibers amplifies IL-6 gene expression to EPI and LPS. The effect appears to reflect differential engagement of HSF-1 and AP-1 sensitive elements on the IL-6 gene, with no evidence for involvement of ATF-3. The functional significance of increased IL-6 mRNA expression during heat may serve to overcome the well-known suppression of protein synthetic pathways occurring during heat shock.	[Welc, Steven S.; Morse, Deborah A.; Mattingly, Alex J.; Laitano, Orlando; King, Michelle A.; Clanton, Thomas L.] Univ Florida, Coll Hlth & Human Performance, Dept Appl Physiol & Kinesiol, Gainesville, FL USA; [Laitano, Orlando] Fed Univ Vale do Sao Francisco, Phys Educ Sch, Petrolina, Brazil	State University System of Florida; University of Florida	Clanton, TL (corresponding author), Univ Florida, Coll Hlth & Human Performance, Dept Appl Physiol & Kinesiol, Gainesville, FL USA.	tclanton@hhp.ufl.edu	Laitano, Orlando/C-3965-2013; Laitano, Orlando/AAM-8085-2021; Clanton, Thomas/AAS-9422-2020	Laitano, Orlando/0000-0003-2768-1427; Laitano, Orlando/0000-0003-2768-1427; Clanton, Thomas/0000-0003-0600-7150; Welc, Steven/0000-0002-2353-0325	American Heart Association [11GRNT7990119]; University of Florida BK; Betty Stevens Endowment; Brazilian Council for the Development of Science and Technology (CNPq) [249094/2013-4]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001427] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); University of Florida BK; Betty Stevens Endowment; Brazilian Council for the Development of Science and Technology (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	The work was supported by American Heart Association #11GRNT7990119 (TLC), University of Florida BK, and Betty Stevens Endowment (TLC). OL was supported by a post-doctoral fellowship from the Brazilian Council for the Development of Science and Technology (CNPq-#249094/2013-4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baccam M, 2003, J IMMUNOL, V170, P3099, DOI 10.4049/jimmunol.170.6.3099; Blix IJS, 1999, J PERIODONTAL RES, V34, P34, DOI 10.1111/j.1600-0765.1999.tb02219.x; BOSENBERG AT, 1988, J APPL PHYSIOL, V65, P106, DOI 10.1152/jappl.1988.65.1.106; BROOKS GA, 1971, AM J PHYSIOL, V221, P427, DOI 10.1152/ajplegacy.1971.221.2.427; Chen HQ, 2006, FEBS LETT, V580, P3145, DOI 10.1016/j.febslet.2006.04.066; Chen Q, 2006, NAT IMMUNOL, V7, P1299, DOI 10.1038/ni1406; Dever TE, 2002, CELL, V108, P545, DOI 10.1016/S0092-8674(02)00642-6; Dodge IL, 2003, J IMMUNOL, V170, P4457, DOI 10.4049/jimmunol.170.9.4457; FEBBRAIO MA, 1994, J APPL PHYSIOL, V77, P2827, DOI 10.1152/jappl.1994.77.6.2827; Fernandez-Verdejo R, 2014, INT J SPORTS MED, V35, P273, DOI 10.1055/s-0033-1353147; Fisher DT, 2010, IMMUNOL RES, V46, P177, DOI 10.1007/s12026-009-8122-9; FLEGEL WA, 1989, INFECT IMMUN, V57, P2237, DOI 10.1128/IAI.57.7.2237-2245.1989; Frost RA, 2006, AM J PHYSIOL-REG I, V290, pR773, DOI 10.1152/ajpregu.00490.2005; Frost RA, 2004, AM J PHYSIOL-ENDOC M, V286, pE809, DOI 10.1152/ajpendo.00560.2003; Frost RA, 2003, AM J PHYSIOL-REG I, V285, pR1153, DOI 10.1152/ajpregu.00164.2003; Frost RA, 2002, AM J PHYSIOL-REG I, V283, pR698, DOI 10.1152/ajpregu.00039.2002; FURCHGOTT RF, 1953, J PHARMACOL EXP THER, V108, P129; Gelinas JN, 2007, J BIOL CHEM, V282, P27527, DOI 10.1074/jbc.M701077200; Gentile LF, 2013, SHOCK, V39, P113, DOI 10.1097/SHK.0b013e318277109c; Greiwe JS, 1999, J APPL PHYSIOL, V86, P531, DOI 10.1152/jappl.1999.86.2.531; Hagiwara S, 2007, INFLAMM RES, V56, P297, DOI 10.1007/s00011-007-6161-z; HAHN PY, 1995, SHOCK, V4, P269, DOI 10.1097/00024382-199510000-00007; Inouye S, 2007, J BIOL CHEM, V282, P33210, DOI 10.1074/jbc.M704471200; Ip YT, 1998, CURR OPIN CELL BIOL, V10, P205, DOI 10.1016/S0955-0674(98)80143-9; Jones SA, 2005, J IMMUNOL, V175, P3463, DOI 10.4049/jimmunol.175.6.3463; Koj A, 1996, BBA-MOL BASIS DIS, V1317, P84, DOI 10.1016/S0925-4439(96)00048-8; Koyama S, 2000, AM J PHYSIOL-LUNG C, V278, pL658, DOI 10.1152/ajplung.2000.278.4.L658; KREGEL KC, 1991, J APPL PHYSIOL, V71, P192, DOI 10.1152/jappl.1991.71.1.192; Kropfl JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106120; Milne KJ, 2002, J APPL PHYSIOL, V93, P561, DOI 10.1152/japplphysiol.00528.2001; Opal SM, 1999, J INFECT DIS, V180, P1584, DOI 10.1086/315093; Ostberg JR, 2000, J LEUKOCYTE BIOL, V68, P815; PANNIERS R, 1994, BIOCHIMIE, V76, P737, DOI 10.1016/0300-9084(94)90078-7; Parikh AA, 1998, J SURG RES, V77, P40, DOI 10.1006/jsre.1998.5332; Patel H, 2012, CARDIOL RES PRACT, V2012, DOI 10.1155/2012/121237; RHEE JG, 1984, INT J RADIAT ONCOL, V10, P393, DOI 10.1016/0360-3016(84)90060-9; Rhind SG, 2004, INT J HYPERTHER, V20, P503, DOI 10.1080/02656730410001670651; RYAN TP, 1993, J BIOCHEM TOXICOL, V8, P33, DOI 10.1002/jbt.2570080106; Santos NC, 2003, CHEMBIOCHEM, V4, P96, DOI 10.1002/cbic.200390020; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Sigala I, 2011, AM J PHYSIOL-REG I, V300, pR1152, DOI 10.1152/ajpregu.00376.2010; Steensberg A, 2001, J PHYSIOL-LONDON, V537, P633, DOI 10.1111/j.1469-7793.2001.00633.x; Steensberg A, 2000, J PHYSIOL-LONDON, V529, P237, DOI 10.1111/j.1469-7793.2000.00237.x; Takii R, 2010, J IMMUNOL, V184, P1041, DOI 10.4049/jimmunol.0902579; van Wijck K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022366; VANALPHEN GWHM, 1963, INT J NEUROPHARMACOL, V2, P259, DOI 10.1016/0028-3908(63)90001-7; Wagstaff MJD, 1998, EUR J NEUROSCI, V10, P3343, DOI 10.1046/j.1460-9568.1998.00339.x; Wang Q, 2000, CLIN SCI, V99, P489, DOI 10.1042/CS20000059; Warren GL, 2011, MUSCLE NERVE, V44, P85, DOI 10.1002/mus.22001; WEBB P, 1992, EUR J APPL PHYSIOL O, V64, P471, DOI 10.1007/BF00625070; Welc SS, 2013, J APPL PHYSIOL, V115, P1126, DOI 10.1152/japplphysiol.00636.2013; Welc SS, 2013, AM J PHYSIOL-CELL PH, V305, pC406, DOI 10.1152/ajpcell.00084.2013; Welc SS, 2013, EXP PHYSIOL, V98, P359, DOI 10.1113/expphysiol.2012.068189; Welc SS, 2012, AM J PHYSIOL-CELL PH, V303, pC455, DOI 10.1152/ajpcell.00028.2012; Yamaki T, 2012, AM J PHYSIOL-CELL PH, V303, pC135, DOI 10.1152/ajpcell.00111.2012; Yu B, 1996, J BIOL CHEM, V271, P4100; Zakharova E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009900; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780; ZUO JR, 1994, MOL CELL BIOL, V14, P7557, DOI 10.1128/MCB.14.11.7557; ZUO JR, 1995, MOL CELL BIOL, V15, P4319	60	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0148927	10.1371/journal.pone.0148927	http://dx.doi.org/10.1371/journal.pone.0148927			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26872389	gold, Green Published, Green Submitted			2022-12-26	WOS:000370054100076
J	Wright, HJ; Arulmoli, J; Motazedi, M; Nelson, LJ; Heinemann, FS; Flanagan, LA; Razorenova, OV				Wright, H. J.; Arulmoli, J.; Motazedi, M.; Nelson, L. J.; Heinemann, F. S.; Flanagan, L. A.; Razorenova, O. V.			CDCP1 cleavage is necessary for homodimerization-induced migration of triple-negative breast cancer	ONCOGENE			English	Article							DOMAIN-CONTAINING PROTEIN-1; CUB-DOMAIN; CELL CARCINOMA; TYROSINE PHOSPHORYLATION; TARGET GENE; PKC-DELTA; SURVIVAL; SRC; ADHESION; IDENTIFICATION	Triple-negative breast cancer (TNBC) is a highly aggressive and metastatic form of breast cancer that lacks the estrogen, progesterone and HER2 receptors and is resistant to targeted and hormone therapies. TNBCs express high levels of the transmembrane glycoprotein, complement C1r/C1s, Uegf, Bmp1 (CUB)-domain containing protein 1 (CDCP1), which has been correlated with the aggressiveness and poor prognosis of multiple carcinomas. Full-length CDCP1 (flCDCP1) can be proteolytically cleaved, resulting in a cleaved membrane-bound isoform (cCDCP1). CDCP1 is phosphorylated by Src family kinases in its full-length and cleaved states, which is important for its pro-metastatic signaling. We observed that cCDCP1, compared with flCDCP1, induced a dramatic increase in phosphorylation of the migration-associated proteins: PKCd, ERK1/2 and p38 mitogen-activated protein kinase in HEK 293T. In addition, only cCDCP1 induced migration of HEK 293T cells and rescued migration of the TNBC cell lines expressing short hairpin RNA against CDCP1. Importantly, we found that only cCDCP1 is capable of dimerization, which can be blocked by expression of the extracellular portion of cCDCP1 (ECC), indicating that dimerization occurs through CDCP1's ectodomain. We found that ECC inhibited phosphorylation of PKCd and migration of TNBC cells in two-dimensional culture. Furthermore, ECC decreased cell invasiveness, inhibited proliferation and stimulated apoptosis of TNBC cells in three-dimensional culture, indicating that the cCDCP1 dimer is an important contributor to TNBC aggressiveness. These studies have important implications for the development of a therapeutic to block CDCP1 activity and TNBC metastasis.	[Wright, H. J.; Motazedi, M.; Nelson, L. J.; Razorenova, O. V.] Univ Calif Irvine, Dept Mol Biol & Biochem, 845 Hlth Sci Rd,Gross Hall,Room 3010, Irvine, CA 92697 USA; [Arulmoli, J.; Flanagan, L. A.] Univ Calif Irvine, Dept Biomed Engn, Irvine, CA USA; [Heinemann, F. S.] Hoag Mem Hosp, Dept Pathol, 301 Newport Blvd, Newport Beach, CA 92663 USA; [Flanagan, L. A.] Univ Calif Irvine, Dept Neurol, Irvine, CA 92717 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Razorenova, OV (corresponding author), Univ Calif Irvine, Dept Mol Biol & Biochem, 845 Hlth Sci Rd,Gross Hall,Room 3010, Irvine, CA 92697 USA.	olgar@uci.edu		Motazedi, Maryam/0000-0002-9856-4933	NIH [F31CA196226]; NATIONAL CANCER INSTITUTE [T32CA121940, F31CA196226] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001414, TL1TR001415] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by NIH Award F31CA196226 to HJW. We thank Drs Alice Police and Erin Lin for providing primary TNBC tissue, Dr Peter Kaiser for MDA-MB-231 and MDA-MB-468 cell lines, Dr Dan Mercola for MDA-MB-453 cell line, Dr Xing Dai for MCF10A cell line, Dr Albert Koong for split-luciferase vectors, Dr Inder Verma for pVSVG and Delta R8.2 lentivirus packaging plasmids, Dr Jae-Won Soh for pHACE-PKC delta construct, Dr Sanford Shattil for pRC-CMV-Src construct, Dr Peter Chumakov for pLM-CMV lentiviral vector, Miranda Paley from Dr Jennifer Prescher lab and Linan Liu from Dr Weian Zhao's lab for help with IVIS Lumina Imager, and Dr David Fruman and Dr Hung Fan for critical reading of the manuscript.	Adams MN, 2015, ONCOGENE, V34, P1375, DOI 10.1038/onc.2014.88; Alajati A, 2015, CELL REP, V11, P564, DOI 10.1016/j.celrep.2015.03.044; Arora R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098370; Benes CH, 2012, ONCOGENE, V31, P653, DOI 10.1038/onc.2011.262; Benes CH, 2005, CELL, V121, P271, DOI 10.1016/j.cell.2005.02.019; Bhatt AS, 2005, ONCOGENE, V24, P5333, DOI 10.1038/sj.onc.1208582; BORK P, 1993, J MOL BIOL, V231, P539, DOI 10.1006/jmbi.1993.1305; Brown TA, 2004, J BIOL CHEM, V279, P14772, DOI 10.1074/jbc.M309678200; Casar B, 2014, ONCOGENE, V33, P255, DOI 10.1038/onc.2012.547; Casar B, 2012, ONCOGENE, V31, P3924, DOI 10.1038/onc.2011.555; Chaudary Naz, 2006, Breast Dis, V26, P55; Choi CYH, 2008, MOL IMAGING, V7, P139, DOI 10.2310/7290.2008.00017; Cvetkovic D, 2014, JOVE-J VIS EXP, DOI 10.3791/51341; Emerling BM, 2013, P NATL ACAD SCI USA, V110, P3483, DOI 10.1073/pnas.1222435110; Gandji LY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123472; Guiro K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118724; He Y, 2016, ONCOGENE, V35, P468, DOI 10.1038/onc.2015.101; He Y, 2010, J BIOL CHEM, V285, P26162, DOI 10.1074/jbc.M109.096453; Hooper JD, 2003, ONCOGENE, V22, P1783, DOI 10.1038/sj.onc.1206220; Huang C, 2004, J CELL SCI, V117, P4619, DOI 10.1242/jcs.01481; Kim KH, 2010, J LIPID RES, V51, P3425, DOI 10.1194/jlr.M007989; Kim S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119473; Kollmorgen G, 2013, MOL ONCOL, V7, P1142, DOI 10.1016/j.molonc.2013.08.009; Kollmorgen G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053050; Law ME, 2013, ONCOGENE, V32, P1316, DOI 10.1038/onc.2012.138; Lee HX, 2009, GENE DEV, V23, P2551, DOI 10.1101/gad.1839309; Leroy C, 2015, ONCOGENE, V34, P5593, DOI 10.1038/onc.2015.19; Lin CY, 2014, CANCER RES, V74, P5229, DOI 10.1158/0008-5472.CAN-13-2995; Liu H, 2011, P NATL ACAD SCI USA, V108, P1379, DOI 10.1073/pnas.1017228108; Maller O, 2013, J CELL SCI, V126, P4108, DOI 10.1242/jcs.121590; Mamat S, 2010, ONCOL REP, V23, P1221, DOI 10.3892/or_00000753; Metzger O, 2012, J CLIN ONCOL, V30, P1879, DOI 10.1200/JCO.2011.38.2010; Miroshnikova YA, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/2/026013; Miyazawa Y, 2013, MOL CANCER RES, V11, P628, DOI 10.1158/1541-7786.MCR-12-0544; Miyazawa Y, 2010, CANCER RES, V70, P5136, DOI 10.1158/0008-5472.CAN-10-0220; Ng D, 2009, PLOS BIOL, V7, P278, DOI 10.1371/journal.pbio.1000041; Nieva C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046456; Qiu B, 2015, CANCER DISCOV, V5, P652, DOI 10.1158/2159-8290.CD-14-1507; Razorenova OV, 2014, MOL CELL BIOL, V34, P739, DOI 10.1128/MCB.00644-12; Razorenova OV, 2011, P NATL ACAD SCI USA, V108, P1931, DOI 10.1073/pnas.1011777108; Razorenova OV, 2005, GENE, V350, P89, DOI 10.1016/j.gene.2005.02.006; Romero A, 1996, FEBS LETT, V382, P15, DOI 10.1016/0014-5793(96)00133-0; Sandercock AM, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0415-0; Seidel J, 2011, BIOCHEM BIOPH RES CO, V414, P226, DOI 10.1016/j.bbrc.2011.09.062; Siva AC, 2008, CANCER RES, V68, P3759, DOI 10.1158/0008-5472.CAN-07-1657; Sowter HM, 2003, CANCER RES, V63, P6130; Spassov DS, 2011, MOL CELL BIOL, V31, P766, DOI 10.1128/MCB.00841-10; Tu YF, 2011, BBA-BIOENERGETICS, V1807, P1125, DOI 10.1016/j.bbabio.2011.04.015; Uekita T, 2008, AM J PATHOL, V172, P1729, DOI 10.2353/ajpath.2008.070981; Uekita T, 2007, MOL CELL BIOL, V27, P7649, DOI 10.1128/MCB.01246-07; Uekita T, 2014, MOL CANCER RES, V12, P1449, DOI 10.1158/1541-7786.MCR-13-0587; Uekita T, 2013, CANCER SCI, V104, P865, DOI 10.1111/cas.12154; Wortmann A, 2011, J BIOL CHEM, V286, P42303, DOI 10.1074/jbc.M111.227462; Zhau HYE, 2011, CLIN CANCER RES, V17, P2159, DOI 10.1158/1078-0432.CCR-10-2523	54	26	27	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 8	2016	35	36					4762	4772		10.1038/onc.2016.7	http://dx.doi.org/10.1038/onc.2016.7			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DW0IS	26876198	Green Accepted, Green Submitted			2022-12-26	WOS:000383324700009
J	Fang, Z; He, QW; Li, Q; Chen, XL; Baral, S; Jin, HJ; Zhu, YY; Li, M; Xia, YP; Mao, L; Hu, B				Fang, Zhi; He, Quan-Wei; Li, Qian; Chen, Xiao-Lu; Baral, Suraj; Jin, Hui-Juan; Zhu, Yi-Yi; Li, Man; Xia, Yuan-Peng; Mao, Ling; Hu, Bo			MicroRNA-150 regulates blood-brain barrier permeability via Tie-2 after permanent middle cerebral artery occlusion in rats	FASEB JOURNAL			English	Article						apoptosis; BMEC; claudin-5; ischemic stroke	ENDOTHELIAL-CELLS; EXPRESSION; VEGF; ANGIOPOIETIN-1; DISRUPTION; ISCHEMIA; ANGIOGENESIS; VASCULOGENESIS; CONTRIBUTES; RECEPTOR	The mechanism of blood-brain barrier (BBB) disruption, involved in poststroke edema and hemorrhagic transformation, is important but elusive. We investigated microRNA-150 (miR-150)-mediated mechanism in the disruption of BBB after stroke in rats. We found that up-regulation of miR-150 increased permeability of BBB as detected by MRI after permanent middle cerebral artery occlusion in vivo as well as increased permeability of brain microvascular endothelial cells after oxygen-glucose deprivation in vitro. The expression of claudin-5, a key tight junction protein, was decreased in the ischemic boundary zone after up-regulation of miR-150. We found in brain microvascular endothelial cells that overexpression of miR-150 decreased not only cell survival rate but also the expression levels of claudin-5 after oxygen-glucose deprivation. With dual-luciferase assay, we confirmed that miR-150 could directly regulate the angiopoietin receptor Tie-2. Moreover, silencing Tie-2 with lentivirus-delivered small interfering RNA reversed the effect of miR-150 on endothelial permeability, cell survival, and claudin-5 expression. Furthermore, poststroke treatment with antagomir-150, a specific miR-150 antagonist, contributed to BBB protection, infarct volume reduction, and amelioration of neurologic deficits. Collectively, our findings suggested that miR-150 could regulate claudin-5 expression and endothelial cell survival by targeting Tie-2, thus affecting the permeability of BBB after permanent middle cerebral artery occlusion in rats, and that miR-150 might be a potential alternative target for the treatment of stroke.Fang, Z., He, Q.-W., Li, Q., Chen, X.-L., Baral, S., Jin, H.-J., Zhu, Y.-Y., Li, M., Xia, Y.-P., Mao, L., Hu, B. MicroRNA-150 regulates blood-brain barrier permeability via Tie-2 after permanent middle cerebral artery occlusion in rats.	[Fang, Zhi; He, Quan-Wei; Li, Qian; Chen, Xiao-Lu; Baral, Suraj; Jin, Hui-Juan; Zhu, Yi-Yi; Li, Man; Xia, Yuan-Peng; Mao, Ling; Hu, Bo] Huazhong Univ Sci & Technol, Dept Neurol, Union Hosp, Tongji Med Coll, Wuhan 430022, Peoples R China	Huazhong University of Science & Technology	Hu, B (corresponding author), Huazhong Univ Sci & Technol, Dept Neurol, Union Hosp, Tongji Med Coll, Wuhan 430022, Peoples R China.	hubo@mail.hust.edu.cn	xia, yuanpeng/S-7988-2019; Fang, Zhi/AGE-7582-2022	He, Quan-Wei/0000-0002-8318-6976; Fang, Zhi/0000-0002-9495-4467	National Natural Science Foundation of China [81070938, 81371311, 81400969]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded in part by Grants 81070938, 81371311, and 81400969 from the National Natural Science Foundation of China.	Alvarez-Sabin J, 2013, LANCET NEUROL, V12, P689, DOI 10.1016/S1474-4422(13)70055-3; Augustin HG, 2009, NAT REV MOL CELL BIO, V10, P165, DOI 10.1038/nrm2639; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Desilles JP, 2013, NEUROLOGY, V80, P844, DOI 10.1212/WNL.0b013e31828406de; Ding G, 2014, NEUROSCIENCE, V271, P1, DOI 10.1016/j.neuroscience.2014.04.025; DUMONT DJ, 1994, GENE DEV, V8, P1897, DOI 10.1101/gad.8.16.1897; Fraisl P, 2009, DEV CELL, V16, P167, DOI 10.1016/j.devcel.2009.01.003; Gamble JR, 2000, CIRC RES, V87, P603, DOI 10.1161/01.RES.87.7.603; Gavard J, 2008, DEV CELL, V14, P25, DOI 10.1016/j.devcel.2007.10.019; Gavard J, 2006, NAT CELL BIOL, V8, P1223, DOI 10.1038/ncb1486; He QW, 2013, MOL NEUROBIOL, V47, P976, DOI 10.1007/s12035-013-8396-8; Hoareau-Aveilla C, 2015, J CLIN INVEST, V125, P3505, DOI 10.1172/JCI78488; Hori S, 2004, J NEUROCHEM, V89, P503, DOI 10.1111/j.1471-4159.2004.02343.x; Jeyaseelan K, 2008, STROKE, V39, P959, DOI 10.1161/STROKEAHA.107.500736; Kim BJ, 2015, J CLIN INVEST, V125, P2473, DOI 10.1172/JCI74159; Latour LL, 2004, ANN NEUROL, V56, P468, DOI 10.1002/ana.20199; Liu CH, 2015, P NATL ACAD SCI USA, V112, P12163, DOI 10.1073/pnas.1508426112; Liu DZ, 2010, J CEREBR BLOOD F MET, V30, P92, DOI 10.1038/jcbfm.2009.186; Liu YC, 2013, PROTEIN CELL, V4, P932, DOI 10.1007/s13238-013-3092-z; Lopez-Ramirez MA, 2014, FASEB J, V28, P2551, DOI 10.1096/fj.13-248880; Luo ZL, 2013, STEM CELLS, V31, P1749, DOI 10.1002/stem.1448; Ma YL, 2012, GUT, V61, P1447, DOI 10.1136/gutjnl-2011-301122; Mao L, 2014, CNS NEUROSCI THER, V20, P460, DOI 10.1111/cns.12238; Moss A, 2013, CYTOKINE GROWTH F R, V24, P579, DOI 10.1016/j.cytogfr.2013.05.009; Mraz M, 2014, BLOOD, V124, P84, DOI 10.1182/blood-2013-09-527234; Pillai DR, 2009, J CEREBR BLOOD F MET, V29, P1846, DOI 10.1038/jcbfm.2009.106; Rom S, 2015, J CEREBR BLOOD F MET, V35, P1957, DOI 10.1038/jcbfm.2015.154; Saddouk F. Z., FASEB J IN PRESS; Song L, 2007, BLOOD, V109, P1515, DOI 10.1182/blood-2006-07-034009; Suri C, 1996, CELL, V87, P1171, DOI 10.1016/S0092-8674(00)81813-9; Tano N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023114; Ullal AJ, 2010, APOPTOSIS, V15, P586, DOI 10.1007/s10495-010-0470-3; Valable S, 2005, J CEREBR BLOOD F MET, V25, P1491, DOI 10.1038/sj.jcbfm.9600148; Valable S, 2003, FASEB J, V17, P443, DOI 10.1096/fj.02-0372fje; Wang MD, 2016, MOL NEUROBIOL, V53, P1310, DOI 10.1007/s12035-015-9099-0; Xia YP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068891; Yan BA, 2015, CIRC RES, V116, P1143, DOI 10.1161/CIRCRESAHA.116.305510; Yu ZY, 2013, MOL MED REP, V8, P287, DOI 10.3892/mmr.2013.1493; Zhang ZG, 2002, J CEREBR BLOOD F MET, V22, P379, DOI 10.1097/00004647-200204000-00002	40	58	63	0	23	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2016	30	6					2097	2107		10.1096/fj.201500126	http://dx.doi.org/10.1096/fj.201500126			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DN2FA	26887441				2022-12-26	WOS:000376878300004
J	Tian, YF; Gawlak, G; O'Donnell, JJ; Birukova, AA; Birukov, KG				Tian, Yufeng; Gawlak, Grzegorz; O'Donnell, James J., III; Birukova, Anna A.; Birukov, Konstantin G.			Activation of Vascular Endothelial Growth Factor ( VEGF) Receptor 2 Mediates Endothelial Permeability Caused by Cyclic Stretch	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED LUNG INJURY; BARRIER-PROTECTIVE RESPONSE; OXIDIZED PHOSPHOLIPIDS; SHEAR-STRESS; CELL JUNCTIONS; MECHANOSENSORY COMPLEX; TIGHT JUNCTIONS; BETA-CATENIN; CADHERIN; RHO	High tidal volume mechanical ventilation and the resultant excessive mechanical forces experienced by lung vascular endothelium are known to lead to increased vascular endothelial leak, but the underlying molecular mechanisms remain incompletely understood. One reported mechanotransduction pathway of increased endothelial cell (EC) permeability caused by high magnitude cyclic stretch (18% CS) involves CS-induced activation of the focal adhesion associated signalosome, which triggers Rho GTPase signaling. This study identified an alternative pathway of CS-induced EC permeability. We show here that high magnitude cyclic stretch (18% CS) rapidly activates VEGF receptor 2 (VEGFR2) signaling by dissociating VEGFR2 from VE-cadherin at the cell junctions. This results in VEGFR2 activation, Src-dependent VE-cadherin tyrosine phosphorylation, and internalization leading to increased endothelial permeability. This process is also accompanied by CS-induced phosphorylation and internalization of PECAM1. Importantly, CS-induced endothelial barrier disruption was attenuated by VEGFR2 inhibition. 18% CS-induced EC permeability was linked to dissociation of cell junction scaffold afadin from the adherens junctions. Forced expression of recombinant afadin in pulmonary endothelium attenuated CS-induced VEGFR2 and VE-cadherin phosphorylation, preserved adherens junction integrity and VEGFR2.VE-cadherin complex, and suppressed CS-induced EC permeability. This study shows for the first time a mechanism whereby VEGFR2 activation mediates EC permeability induced by pathologically relevant cyclic stretch. In this mechanism, CS induces dissociation of the VE-cadherin.VEGFR2 complex localized at the adherens juctions, causing activation of VEGFR2, VEGFR2-mediated Src-dependent phosphorylation of VE-cadherin, disassembly of adherens junctions, and EC barrier failure.	Univ Chicago, Lung Injury Ctr, Chicago, IL 60637 USA; Univ Chicago, Dept Med, Sect Pulm & Crit Care Med, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Birukov, KG (corresponding author), Univ Chicago, Dept Med, Sect Pulm & Crit Med, Lung Injury Ctr, 5841 S Maryland Ave,Off N-611, Chicago, IL 60637 USA.	kbirukov@medicine.bsd.uchicago.edu	Birukov, Konstantin/FJB-5755-2022		NHLBI, National Institutes of Health [HL87823, HL076259, HL107920, GM114171]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R56HL107920, R01HL076259, R01HL107920, R01HL087823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM114171] Funding Source: NIH RePORTER	NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NHLBI, National Institutes of Health Grants HL87823, HL076259, HL107920, and GM114171. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abdulnour REE, 2006, AM J PHYSIOL-LUNG C, V291, pL345, DOI 10.1152/ajplung.00453.2005; Amado-Azevedo J, 2014, CELL TISSUE RES, V355, P557, DOI 10.1007/s00441-014-1828-6; Bazzoni G, 2004, PHYSIOL REV, V84, P869, DOI 10.1152/physrev.00035.2003; Beckers CML, 2010, THROMB HAEMOSTASIS, V103, P40, DOI 10.1160/TH09-06-0403; Birukov KG, 2004, CIRC RES, V95, P892, DOI 10.1161/01.RES.0000147310.18962.06; Birukov KG, 2003, AM J PHYSIOL-LUNG C, V285, pL785, DOI 10.1152/ajplung.00336.2002; Birukov KG, 2002, AM J RESP CELL MOL, V26, P453, DOI 10.1165/ajrcmb.26.4.4725; Birukova AA, 2006, AM J PATHOL, V168, P1749, DOI 10.2353/ajpath.2006.050431; Birukova AA, 2004, FASEB J, V18, P1879, DOI 10.1096/fj.04-2328com; Birukova AA, 2004, J CELL PHYSIOL, V201, P55, DOI 10.1002/jcp.20055; Birukova AA, 2008, AM J PHYSIOL-LUNG C, V295, pL612, DOI 10.1152/ajplung.90236.2008; Birukova AA, 2007, AM J PHYSIOL-LUNG C, V293, pL199, DOI 10.1152/ajplung.00020.2007; Birukova AA, 2007, J CELL PHYSIOL, V211, P608, DOI 10.1002/jcp.20966; Birukova AA, 2013, MOL BIOL CELL, V24, P2678, DOI 10.1091/mbc.E13-02-0098; Birukova AA, 2012, J CELL PHYSIOL, V227, P3405, DOI 10.1002/jcp.24041; Birukova AA, 2012, AM J PHYSIOL-LUNG C, V302, pL965, DOI 10.1152/ajplung.00292.2011; Birukova AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030957; Birukova AA, 2012, J CELL PHYSIOL, V227, P1883, DOI 10.1002/jcp.22916; Birukova AA, 2011, EXP CELL RES, V317, P859, DOI 10.1016/j.yexcr.2010.11.011; Birukova AA, 2010, AM J PHYSIOL-LUNG C, V298, pL837, DOI 10.1152/ajplung.00263.2009; Birukova AA, 2010, TRANSL RES, V155, P44, DOI 10.1016/j.trsl.2009.09.002; Birukova AA, 2009, J APPL PHYSIOL, V107, P1900, DOI 10.1152/japplphysiol.00462.2009; Birukova AA, 2008, EXP CELL RES, V314, P3466, DOI 10.1016/j.yexcr.2008.09.003; Cavanaugh KJ, 2002, AM J PHYSIOL-CELL PH, V283, pC1801, DOI 10.1152/ajpcell.00341.2002; Chiu YJ, 2008, J CELL BIOL, V182, P753, DOI 10.1083/jcb.200801062; Cohen TS, 2008, EUR RESPIR J, V32, P854, DOI 10.1183/09031936.00141007; Conway Daniel, 2012, F1000 Biol Rep, V4, P1, DOI 10.3410/B4-1; Coon BG, 2015, J CELL BIOL, V208, P975, DOI 10.1083/jcb.201408103; Corada M, 2001, BLOOD, V97, P1679, DOI 10.1182/blood.V97.6.1679; Cullere X, 2005, BLOOD, V105, P1950, DOI 10.1182/blood-2004-05-1987; Dejana E, 2004, NAT REV MOL CELL BIO, V5, P261, DOI 10.1038/nrm1357; Dejana E, 2008, J CELL SCI, V121, P2115, DOI 10.1242/jcs.017897; DiPaolo BC, 2012, AM J PHYSIOL-LUNG C, V302, pL992, DOI 10.1152/ajplung.00175.2011; Dubrovskyi O, 2013, LAB INVEST, V93, P254, DOI 10.1038/labinvest.2012.159; Eggers CT, 2009, J BIOL CHEM, V284, P32869, DOI 10.1074/jbc.M109.022582; Frank JA, 2003, CRIT CARE, V7, P233, DOI 10.1186/cc1829; Fujiwara K, 2006, J INTERN MED, V259, P373, DOI 10.1111/j.1365-2796.2006.01623.x; Gavard Julie, 2014, Cell Adh Migr, V8, P158; Gawlak G, 2014, FASEB J, V28, P3249, DOI 10.1096/fj.13-245142; Harris ES, 2010, CURR OPIN CELL BIOL, V22, P651, DOI 10.1016/j.ceb.2010.07.006; Iwaki M, 2009, BIOCHEM BIOPH RES CO, V389, P531, DOI 10.1016/j.bbrc.2009.09.020; Kooistra MRH, 2005, FEBS LETT, V579, P4966, DOI 10.1016/j.febslet.2005.07.080; Lambeng N, 2005, CIRC RES, V96, P384, DOI 10.1161/01.RES.0000156652.99586.9f; Lampugnani MG, 2006, J CELL BIOL, V174, P593, DOI 10.1083/jcb.200602080; Lampugnani MG, 2003, J CELL BIOL, V161, P793, DOI 10.1083/jcb.200209019; Matsuzaki I, 2005, AM J PHYSIOL-HEART C, V288, pH336, DOI 10.1152/ajpheart.00025.2004; Nawroth R, 2002, EMBO J, V21, P4885, DOI 10.1093/emboj/cdf497; Newman PJ, 2003, ARTERIOSCL THROM VAS, V23, P953, DOI 10.1161/01.ATV.0000071347.69358.D9; Ooshio T, 2010, J BIOL CHEM, V285, P5003, DOI 10.1074/jbc.M109.043760; Orsenigo F, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2199; Peng FF, 2010, CELL SIGNAL, V22, P34, DOI 10.1016/j.cellsig.2009.09.003; Prasain N, 2009, MICROVASC RES, V77, P53, DOI 10.1016/j.mvr.2008.09.012; Privratsky JR, 2014, CELL TISSUE RES, V355, P607, DOI 10.1007/s00441-013-1779-3; Sarelius IH, 2015, TISSUE BARRIERS, V3, DOI 10.4161/21688370.2014.985954; Schlegel N, 2014, CELL TISSUE RES, V355, P587, DOI 10.1007/s00441-013-1755-y; Shay-Salit A, 2002, P NATL ACAD SCI USA, V99, P9462, DOI 10.1073/pnas.142224299; Shikata Y, 2005, EXP CELL RES, V304, P40, DOI 10.1016/j.yexcr.2004.11.001; Singh AJ, 2005, MOL BIOL CELL, V16, P2106, DOI 10.1091/mbc.E04-08-0749; Slutsky AS, 1998, AM J RESP CRIT CARE, V157, P1721, DOI 10.1164/ajrccm.157.6.9709092; Sun HR, 2006, MICROCIRCULATION, V13, P237, DOI 10.1080/10739680600556944; Takai Y, 2003, J CELL SCI, V116, P17, DOI 10.1242/jcs.00167; Takai Y, 2008, ANNU REV CELL DEV BI, V24, P309, DOI 10.1146/annurev.cellbio.24.110707.175339; Tawa H, 2010, CIRC RES, V106, P1731, DOI 10.1161/CIRCRESAHA.110.216747; Tschumperlin DJ, 2000, AM J RESP CRIT CARE, V162, P357, DOI 10.1164/ajrccm.162.2.9807003; Tschumperlin DJ, 1999, J APPL PHYSIOL, V86, P2026, DOI 10.1152/jappl.1999.86.6.2026; Tsukita S, 2009, ANN NY ACAD SCI, V1165, P44, DOI 10.1111/j.1749-6632.2009.04056.x; Tzima E, 2002, EMBO J, V21, P6791, DOI 10.1093/emboj/cdf688; Tzima E, 2005, NATURE, V437, P426, DOI 10.1038/nature03952; Uhlig S, 2002, AM J PHYSIOL-LUNG C, V282, pL892, DOI 10.1152/ajplung.00124.2001; Vandenbroucke E, 2008, ANN NY ACAD SCI, V1123, P134, DOI 10.1196/annals.1420.016; Weber C, 2007, NAT REV IMMUNOL, V7, P467, DOI 10.1038/nri2096; Zimman A, 2007, ARTERIOSCL THROM VAS, V27, P332, DOI 10.1161/01.ATV.0000252842.57585.df	72	42	42	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2016	291	19					10032	10045		10.1074/jbc.M115.690487	http://dx.doi.org/10.1074/jbc.M115.690487			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DL4KB	26884340	Green Published, hybrid			2022-12-26	WOS:000375602800016
J	Ghavami, A; van der Giessen, E; Onck, PR				Ghavami, Ali; van der Giessen, Erik; Onck, Patrick R.			Energetics of Transport through the Nuclear Pore Complex	PLOS ONE			English	Article							FG-REPEAT DOMAINS; FREE-ENERGY; FACILITATED TRANSPORT; PERMEABILITY BARRIER; STRUCTURAL BASIS; NUCLEOPORINS; TRANSLOCATION; ARCHITECTURE; DYNAMICS; MODEL	Molecular transport across the nuclear envelope in eukaryotic cells is solely controlled by the nuclear pore complex (NPC). The NPC provides two types of nucleocytoplasmic transport: passive diffusion of small molecules and active chaperon-mediated translocation of large molecules. It has been shown that the interaction between intrinsically disordered proteins that line the central channel of the NPC and the transporting cargoes is the determining factor, but the exact mechanism of transport is yet unknown. Here, we use coarse-grained molecular dynamics simulations to quantify the energy barrier that has to be overcome for molecules to pass through the NPC. We focus on two aspects of transport. First, the passive transport of model cargo molecules with different sizes is studied and the size selectivity feature of the NPC is investigated. Our results show that the transport probability of cargoes is significantly reduced when they are larger than similar to 5 nm in diameter. Secondly, we show that incorporating hydrophobic binding spots on the surface of the cargo effectively decreases the energy barrier of the pore. Finally, a simple transport model is proposed which characterizes the energy barrier of the NPC as a function of diameter and hydrophobicity of the transporting particles.	[Ghavami, Ali; van der Giessen, Erik; Onck, Patrick R.] Univ Groningen, Zernike Inst Adv Mat, Groningen, Netherlands	University of Groningen	Onck, PR (corresponding author), Univ Groningen, Zernike Inst Adv Mat, Groningen, Netherlands.	p.r.onck@rug.nl	Institute, Zernike/W-7033-2019	Ghavami, Ali/0000-0002-8523-1515; Van der Giessen, Erik/0000-0002-8369-2254; Onck, Patrick/0000-0001-5632-9727	Zernike Institute for Advanced Materials at the University of Groningen	Zernike Institute for Advanced Materials at the University of Groningen	This research was funded by the Zernike Institute for Advanced Materials at the University of Groningen. The authors thank SURFsara (www.surfsara.nl) for the support in using the Lisa Compute Cluster. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alber F, 2007, NATURE, V450, P695, DOI 10.1038/nature06405; Alber F, 2007, NATURE, V450, P683, DOI 10.1038/nature06404; Ando D, 2014, BIOPHYS J, V106, P1997, DOI 10.1016/j.bpj.2014.03.021; Bayliss R, 2000, CELL, V102, P99, DOI 10.1016/S0092-8674(00)00014-3; Bayliss R, 1999, J MOL BIOL, V293, P579, DOI 10.1006/jmbi.1999.3166; Denning DP, 2003, P NATL ACAD SCI USA, V100, P2450, DOI 10.1073/pnas.0437902100; Egorov SA, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4757017; Ermilov V, 2010, MACROMOLECULES, V43, P3511, DOI 10.1021/ma9027273; Feldherr CM, 1997, J CELL SCI, V110, P3065; Fiserova J, 2010, J CELL SCI, V123, P2773, DOI 10.1242/jcs.070730; Frey S, 2006, SCIENCE, V314, P815, DOI 10.1126/science.1132516; Fribourg S, 2001, MOL CELL, V8, P645, DOI 10.1016/S1097-2765(01)00348-3; Ghavami A, 2014, BIOPHYS J, V107, P1393, DOI [10.1016/j.bpj.2014.07.060, 10.1016/j.bpj.20014.07.060]; Ghavami A, 2013, J CHEM THEORY COMPUT, V9, P432, DOI 10.1021/ct300684j; Goryaynov A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088792; Halperin A, 2011, MACROMOLECULES, V44, P3622, DOI 10.1021/ma200068d; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Isgro TA, 2005, STRUCTURE, V13, P1869, DOI 10.1016/j.str.2005.09.007; Isgro TA, 2007, STRUCTURE, V15, P977, DOI 10.1016/j.str.2007.06.011; Isgro TA, 2007, J MOL BIOL, V366, P330, DOI 10.1016/j.jmb.2006.11.048; Izaguirre JA, 2001, J CHEM PHYS, V114, P2090, DOI 10.1063/1.1332996; Keminer O, 1999, BIOPHYS J, V77, P217, DOI 10.1016/S0006-3495(99)76883-9; Krishnan VV, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000145; Lim RYH, 2007, SCIENCE, V318, P640, DOI 10.1126/science.1145980; Ma J, 2012, P NATL ACAD SCI USA, V109, P7326, DOI 10.1073/pnas.1201724109; Ma J, 2010, P NATL ACAD SCI USA, V107, P7305, DOI 10.1073/pnas.0908269107; Merlitz H, 2012, MACROMOLECULES, V45, P8494, DOI 10.1021/ma301781b; Miao L, 2010, BIOPHYS J, V98, P1658, DOI 10.1016/j.bpj.2009.12.4305; Miao LL, 2009, STRUCTURE, V17, P449, DOI 10.1016/j.str.2008.12.021; Milchev A, 2008, POLYMER, V49, P3611, DOI 10.1016/j.polymer.2008.04.032; Mincer JS, 2011, P NATL ACAD SCI USA, V108, pE351, DOI 10.1073/pnas.1104521108; Mohr D, 2009, EMBO J, V28, P2541, DOI 10.1038/emboj.2009.200; Morrison J, 2003, J MOL BIOL, V333, P587, DOI 10.1016/j.jmb.2003.08.050; Moussavi-Baygi R, 2011, BIOPHYS J, V100, P1410, DOI 10.1016/j.bpj.2011.01.061; Moussavi-Baygi R, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002049; Naim B, 2007, J BIOL CHEM, V282, P3881, DOI 10.1074/jbc.M608329200; Naim B, 2009, EMBO J, V28, P2697, DOI 10.1038/emboj.2009.225; Osmanovic D, 2013, BIOPHYS J, V105, P2781, DOI 10.1016/j.bpj.2013.11.013; PAINE PL, 1975, NATURE, V254, P109, DOI 10.1038/254109a0; PETERS R, 1984, EMBO J, V3, P1831, DOI 10.1002/j.1460-2075.1984.tb02055.x; Peters R, 2005, TRAFFIC, V6, P421, DOI 10.1111/j.1600-0854.2005.00287.x; Peters R, 2009, BIOESSAYS, V31, P466, DOI 10.1002/bies.200800159; Rangl M, 2013, ANGEW CHEM, V125, P10546, DOI DOI 10.1002/ANGE.201305359; Ribbeck K, 2002, EMBO J, V21, P2664, DOI 10.1093/emboj/21.11.2664; Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635; Rout MP, 2003, TRENDS CELL BIOL, V13, P622, DOI 10.1016/j.tcb.2003.10.007; Strawn LA, 2004, NAT CELL BIOL, V6, P197, DOI 10.1038/ncb1097; Tagliazucchi M, 2013, P NATL ACAD SCI USA, V110, P3363, DOI 10.1073/pnas.1212909110; Terry LJ, 2007, SCIENCE, V318, P1412, DOI 10.1126/science.1142204; TORRIE GM, 1977, J COMPUT PHYS, V23, P187, DOI 10.1016/0021-9991(77)90121-8; Walde S, 2010, TRENDS CELL BIOL, V20, P461, DOI 10.1016/j.tcb.2010.05.001; Yamada J, 2010, MOL CELL PROTEOMICS, V9, P2205, DOI 10.1074/mcp.M000035-MCP201; Yang Q, 1998, MOL CELL, V1, P223, DOI 10.1016/S1097-2765(00)80023-4	53	35	35	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0148876	10.1371/journal.pone.0148876	http://dx.doi.org/10.1371/journal.pone.0148876			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3DG	26894898	Green Published, Green Submitted, gold			2022-12-26	WOS:000371223400025
J	Valdes-Donoso, P; Jarvis, LS; Wright, D; Alvarez, J; Perez, AM				Valdes-Donoso, Pablo; Jarvis, Lovell S.; Wright, Dave; Alvarez, Julio; Perez, Andres M.			Measuring Progress on the Control of Porcine Reproductive and Respiratory Syndrome (PRRS) at a Regional Level: The Minnesota N212 Regional Control Project (Rcp) as a Working Example	PLOS ONE			English	Article							EPIDEMIC-DIARRHEA-VIRUS; CLASSICAL SWINE-FEVER; RISK-FACTORS; 2ND-ORDER ANALYSIS; ECONOMIC-IMPACT; TRANSMISSION; INFECTION; HERDS; TRANSPORT; VEHICLES	Due to the highly transmissible nature of porcine reproductive and respiratory syndrome (PRRS), implementation of regional programs to control the disease may be critical. Because PRRS is not reported in the US, numerous voluntary regional control projects (RCPs) have been established. However, the effect of RCPs on PRRS control has not been assessed yet. This study aims to quantify the extent to which RCPs contribute to PRRS control by proposing a methodological framework to evaluate the progress of RCPs. Information collected between July 2012 and June 2015 from the Minnesota Voluntary Regional PRRS Elimination Project (RCP-N212) was used. Demography of premises (e.g. composition of farms with sows = SS and without sows = NSS) was assessed by a repeated analysis of variance. By using general linear mixed-effects models, active participation of farms enrolled in the RCP-N212, defined as the decision to share (or not to share) PRRS status, was evaluated and used as a predictor, along with other variables, to assess the PRRS trend over time. Additionally, spatial and temporal patterns of farmers' participation and the disease dynamics were investigated. The number of farms enrolled in RCP-N212 and its geographical coverage increased, but the proportion of SS and NSS did not vary significantly over time. A significant increasing (p<0.001) trend in farmers' decision to share PRRS status was observed, but with NSS producers less willing to report and a large variability between counties. The incidence of PRRS significantly (p<0.001) decreased, showing a negative correlation between degree of participation and occurrence of PRRS (p<0.001) and a positive correlation with farm density at the county level (p = 0.02). Despite a noted decrease in PRRS, significant spatio-temporal patterns of incidence of the disease over 3-weeks and 3-kms during the entire study period were identified. This study established a systematic approach to quantify the effect of RCPs on PRRS control. Despite an increase in number of farms enrolled in the RCP-N212, active participation is not ensured. By evaluating the effect of participation on the occurrence of PRRS, the value of sharing information among producers may be demonstrated, in turn justifying the existence of RCPs.	[Valdes-Donoso, Pablo; Wright, Dave; Alvarez, Julio; Perez, Andres M.] Univ Minnesota, Coll Vet Med, Dept Vet Populat Med, St Paul, MN 55108 USA; [Valdes-Donoso, Pablo; Jarvis, Lovell S.] Univ Calif Davis, Dept Agr & Resource Econ, Davis, CA 95616 USA	University of Minnesota System; University of Minnesota Twin Cities; University of California System; University of California Davis	Valdes-Donoso, P (corresponding author), Univ Minnesota, Coll Vet Med, Dept Vet Populat Med, St Paul, MN 55108 USA.; Valdes-Donoso, P (corresponding author), Univ Calif Davis, Dept Agr & Resource Econ, Davis, CA 95616 USA.	pablovd@umn.edu	donoso, pablo valdes/U-3208-2017; Alvarez, Julio/H-8292-2013; Perez, Andres/HGD-8377-2022	Alvarez, Julio/0000-0002-8999-9417; 	government of Chile through the Becas Chile program; University of Minnesota MnDrive program; Boehringer Ingelheim Vet Medica Inc.; Becas-Chile program of the National Commission for Scientific and Technological Research (CONICYT); Boehringer Ingelheim(R)	government of Chile through the Becas Chile program; University of Minnesota MnDrive program; Boehringer Ingelheim Vet Medica Inc.(Boehringer Ingelheim); Becas-Chile program of the National Commission for Scientific and Technological Research (CONICYT); Boehringer Ingelheim(R)(Boehringer Ingelheim)	This study was supported in part by grants provided by the government of Chile through the Becas Chile program, the University of Minnesota MnDrive program, and Boehringer Ingelheim Vet Medica Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The Becas-Chile program of the National Commission for Scientific and Technological Research (CONICYT) has supported Pablo Valdes-Donoso to develop his Master and PhD in the US. Additional support for his Master and PhD project has been partially provided by the University of Minnesota MnDrive program and Boehringer Ingelheim(R). Also, we thank swine producers from the RCP-N212, who shared data, as well as the Swine Disease Eradication Center (SDEC) of University of Minnesota that provided the server in which data were stored and protected. No other conflicts of interest exist.	Albina E, 1997, VET MICROBIOL, V55, P309, DOI 10.1016/S0378-1135(96)01322-3; Alvarez J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120532; Bates D, 2011, LINEAR MIXED MODEL I; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Becker RA, 2014, MAPS DRAW GEOGRAPHIC; Connor J, 2014, 2014 N AM PRRS S; Corzo CA, 2010, VIRUS RES, V154, P185, DOI 10.1016/j.virusres.2010.08.016; Dee S, 2003, CAN J VET RES, V67, P12; Dee SA, 2004, CAN J VET RES, V68, P128; DIGGLE PJ, 1991, BIOMETRICS, V47, P1155, DOI 10.2307/2532668; Diggle PJ, 2005, SPATIO TEMPORAL POIN, P78; Edwards S, 2000, VET MICROBIOL, V73, P103, DOI 10.1016/S0378-1135(00)00138-3; EPA, 2012, PORK GLOSS 2012; Gabriel E, 2014, INVENTORSSTPP SPACE; Gabriel E, 2013, J STAT SOFTW, V53, P1; Gabriel E, 2009, STAT NEERL, V63, P43, DOI 10.1111/j.1467-9574.2008.00407.x; GOYAL SM, 1993, J VET DIAGN INVEST, V5, P656, DOI 10.1177/104063879300500435; Hennessy DA, 1996, AM J AGR ECON, V78, P1034, DOI 10.2307/1243859; Holtkamp DJ, 2013, J SWINE HEALTH PROD, V21, P72; Holtkamp DJ, 2011, J SWINE HEALTH PROD, V19, P44; Hurt C, 1994, CHOICES, V9; Kulldorff M, SATSCANTM V9 4 SOFTW; Kulldorff M, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-58; Kwong GPS, 2013, PREV VET MED, V110, P405, DOI 10.1016/j.prevetmed.2013.01.004; Lowe J, 2014, EMERG INFECT DIS, V20, P872, DOI 10.3201/eid2005.131628; Moennig V, 2000, VET MICROBIOL, V73, P93, DOI 10.1016/S0378-1135(00)00137-1; Morrison R, 2011, AD LEM SWIN C 2011; Mortensen S, 2002, PREV VET MED, V53, P83, DOI 10.1016/S0167-5877(01)00260-4; Neumann EJ, 2005, JAVMA-J AM VET MED A, V227, P385, DOI 10.2460/javma.2005.227.385; OIE, 2015, LIST DIS INF INF FOR; Otake S, 2002, J SWINE HEALTH PROD, V10, P59; Perez AM, 2015, JAVMA-J AM VET MED A, V246, P1304, DOI 10.2460/javma.246.12.1304; Pitkin A, 2009, CAN J VET RES, V73, P298; R C inventor, 2014, R LANG ENV STAT COMP; Rasmusen E, 2006, GAMES INFORM INTRO G; Schroeder J, 2014, ARC PROGRAMS CONTROL; Service NAS, CENS AGR 2012, P1; Service NAS, 2014, LIV SLAUGHT 2013 SUM; Stevenson GW, 2013, J VET DIAGN INVEST, V25, P649, DOI 10.1177/1040638713501675; Taft A. C., 2000, Veterinary Research (Paris), V31, P157, DOI 10.1051/vetres:2000052; Tousignant SJ, CANADIAN J IN PRESS; USCB, 2010, QUICKFACTS; Velasova M, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-184; Wright D, 2012, PRRS VIRUS OVERVIEW; Wright D., 2015, DECADE PROGR VOLUNTA	45	12	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0149498	10.1371/journal.pone.0149498	http://dx.doi.org/10.1371/journal.pone.0149498			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3DG	26895148	Green Published, Green Submitted, gold			2022-12-26	WOS:000371223400059
J	Andrews, AM; Rizzo, V				Andrews, Allison M.; Rizzo, Victor			Microparticle-Induced Activation of the Vascular Endothelium Requires Caveolin-1/Caveolae	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; NF-KAPPA-B; MONOCYTE-DERIVED MICROPARTICLES; ANGIOTENSIN-II; POLY(ADP-RIBOSE) POLYMERASE; CIRCULATING MICROPARTICLES; NUCLEAR TRANSLOCATION; CELL MICROPARTICLES; LUNG INFLAMMATION; PLASMA-MEMBRANE	Microparticles (MPs) are small membrane fragments shed from normal as well as activated, apoptotic or injured cells. Emerging evidence implicates MPs as a causal and/or contributing factor in altering normal vascular cell phenotype through initiation of proinflammatory signal transduction events and paracrine delivery of proteins, mRNA and miRNA. However, little is known regarding the mechanism by which MPs influence these events. Caveolae are important membrane microdomains that function as centers of signal transduction and endocytosis. Here, we tested the concept that the MP-induced pro-inflammatory phenotype shift in endothelial cells (ECs) depends on caveolae. Consistent with previous reports, MP challenge activated ECs as evidenced by upregulation of intracellular adhesion molecule-1 (ICAM-1) expression. ICAM-1 upregulation was mediated by activation of NF-kappa B, Poly [ ADP-ribose] polymerase 1 (PARP-1) and the epidermal growth factor receptor (EGFR). This response was absent in ECs lacking caveolin-1/caveolae. To test whether caveolae-mediated endocytosis, a dynamin-2 dependent process, is a feature of the proinflammatory response, EC's were pretreated with the dynamin-2 inhibitor dynasore. Similar to observations in cells lacking caveolin-1, inhibition of endocytosis significantly attenuated MPs effects including, EGFR phosphorylation, activation of NF-kappa B and upregulation of ICAM-1 expression. Thus, our results indicate that caveolae play a role in mediating the pro-inflammatory signaling pathways which lead to EC activation in response to MPs.	[Andrews, Allison M.; Rizzo, Victor] Temple Univ, Lewis Katz Sch Med, Independence Blue Cross Cardiovasc Res Ctr, Philadelphia, PA 19140 USA; [Rizzo, Victor] Temple Univ, Lewis Katz Sch Med, Dept Anat & Cell Biol, Philadelphia, PA 19140 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Rizzo, V (corresponding author), Temple Univ, Lewis Katz Sch Med, 3500 North Broad St, Philadelphia, PA 19140 USA.	rizzov@temple.edu			NIH [HL086551]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086551] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding for this work was provided by NIH HL086551.	Abulrob A, 2010, J BIOL CHEM, V285, P3145, DOI 10.1074/jbc.M109.073338; Agelaki S, 2009, CANCER BIOL THER, V8, P1470, DOI 10.4161/cbt.8.15.8939; Aird WC, 2007, CIRC RES, V100, P158, DOI 10.1161/01.RES.0000255691.76142.4a; Bardelli C, 2012, BRIT J PHARMACOL, V165, P716, DOI 10.1111/j.1476-5381.2011.01593.x; Boulanger CM, 2006, HYPERTENSION, V48, P180, DOI 10.1161/01.HYP.0000231507.00962.b5; Boulares AH, 2003, AM J RESP CELL MOL, V28, P322, DOI 10.1165/rcmb.2001-0015OC; Burger D, 2011, ARTERIOSCL THROM VAS, V31, P1898, DOI 10.1161/ATVBAHA.110.222703; Burkle A, 2005, FEBS J, V272, P4576, DOI 10.1111/j.1742-4658.2005.04864.x; Chen XW, 2010, MOL CELL BIOL, V30, P3048, DOI 10.1128/MCB.00892-09; Chironi GN, 2009, CELL TISSUE RES, V335, P143, DOI 10.1007/s00441-008-0710-9; del Pozo MA, 2005, NAT CELL BIOL, V7, P901, DOI 10.1038/ncb1293; Dey-Hazra E, 2010, VASC HEALTH RISK MAN, V6, P1125, DOI 10.2147/VHRM.S13236; Distler JHW, 2005, P NATL ACAD SCI USA, V102, P2892, DOI 10.1073/pnas.0409781102; Engel D, 2011, FASEB J, V25, P3838, DOI 10.1096/fj.11-183350; Ferreira AC, 2004, CIRCULATION, V110, P3599, DOI 10.1161/01.CIR.0000148820.55611.6B; Fleming I, 1996, MOL CELL BIOCHEM, V157, P137; Henriksen L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058148; HINSHAW JE, 1995, NATURE, V374, P190, DOI 10.1038/374190a0; Hussein MNA, 2008, THROMB RES, V121, P865, DOI 10.1016/j.thromres.2007.08.005; Jansen F, 2013, CARDIOVASC RES, V98, P94, DOI 10.1093/cvr/cvt013; Jansen F, 2012, ARTERIOSCL THROM VAS, V32, P1925, DOI 10.1161/ATVBAHA.112.253229; Jimenez JJ, 2003, THROMB RES, V109, P175, DOI 10.1016/S0049-3848(03)00064-1; Kauppinen TM, 2013, BBA-MOL CELL RES, V1833, P1985, DOI 10.1016/j.bbamcr.2013.04.005; Liu ML, 2012, ARTERIOSCL THROM VAS, V32, P2113, DOI 10.1161/ATVBAHA.112.255471; Makki N, 2013, INT J MOL SCI, V14, P20597, DOI 10.3390/ijms141020597; Marino M, 2008, STEROIDS, V73, P853, DOI 10.1016/j.steroids.2007.12.003; Martin S, 2004, CIRCULATION, V109, P1653, DOI 10.1161/01.CIR.0000124065.31211.6E; Massey Kerri A, 2009, Proc Am Thorac Soc, V6, P419, DOI 10.1513/pats.200903-011AW; Mastronardi ML, 2011, CRIT CARE MED, V39, P1739, DOI 10.1097/CCM.0b013e3182190b4b; Masuelli L, 2012, J CELL PHYSIOL, V227, P3344, DOI 10.1002/jcp.24034; Mause SF, 2010, CIRC RES, V107, P1047, DOI 10.1161/CIRCRESAHA.110.226456; Minshall RD, 2003, AM J PHYSIOL-LUNG C, V285, pL1179, DOI 10.1152/ajplung.00242.2003; Mirza MK, 2010, AM J PATHOL, V176, P2344, DOI 10.2353/ajpath.2010.091088; Moreno-Caceres J, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.294; Mostefai HA, 2008, J IMMUNOL, V180, P5028, DOI 10.4049/jimmunol.180.7.5028; Neri T, 2011, EUR RESPIR J, V37, P1494, DOI 10.1183/09031936.00023310; Oh P, 1998, J CELL BIOL, V141, P101, DOI 10.1083/jcb.141.1.101; Oh P, 2012, J BIOL CHEM, V287, P17353, DOI 10.1074/jbc.M111.338897; Oumouna-Benachour K, 2007, CIRCULATION, V115, P2442, DOI 10.1161/CIRCULATIONAHA.106.668756; Park SS, 2005, HISTOPATHOLOGY, V47, P625, DOI 10.1111/j.1365-2559.2005.02303.x; Parton RG, 2007, NAT REV MOL CELL BIO, V8, P185, DOI 10.1038/nrm2122; Parton RG, 2013, NAT REV MOL CELL BIO, V14, P98, DOI 10.1038/nrm3512; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Rom S, 2015, J CEREBR BLOOD F MET, V35, P28, DOI 10.1038/jcbfm.2014.167; Sabatier F, 2002, BLOOD, V99, P3962, DOI 10.1182/blood.V99.11.3962; Schock SC, 2014, BIOCHEM BIOPH RES CO, V450, P912, DOI 10.1016/j.bbrc.2014.06.096; Sigismund S, 2005, P NATL ACAD SCI USA, V102, P2760, DOI 10.1073/pnas.0409817102; Sigismund S, 2008, DEV CELL, V15, P209, DOI 10.1016/j.devcel.2008.06.012; Sinha B, 2011, CELL, V144, P402, DOI 10.1016/j.cell.2010.12.031; Sprague AH, 2009, BIOCHEM PHARMACOL, V78, P539, DOI 10.1016/j.bcp.2009.04.029; Takaguri A, 2011, J MOL CELL CARDIOL, V50, P545, DOI 10.1016/j.yjmcc.2010.12.009; Takayanagi T, 2014, CLIN SCI, V126, P785, DOI 10.1042/CS20130660; Terrisse AD, 2010, J THROMB HAEMOST, V8, P2810, DOI 10.1111/j.1538-7836.2010.04088.x; Tesse A, 2005, ARTERIOSCL THROM VAS, V25, P2522, DOI 10.1161/01.ATV.0000189298.62240.5d; TEWARI M, 1995, CELL, V81, P801, DOI 10.1016/0092-8674(95)90541-3; Tiruppathi C, 2008, J BIOL CHEM, V283, P4210, DOI 10.1074/jbc.M703153200; van Ierssel SH, 2010, THROMB RES, V125, P332, DOI 10.1016/j.thromres.2009.12.019; Wang JG, 2011, BLOOD, V118, P2366, DOI 10.1182/blood-2011-01-330878; Werner N, 2006, ARTERIOSCL THROM VAS, V26, P112, DOI 10.1161/01.ATV.0000191634.13057.15; Xu L, 2014, ONCOL REP, V32, P318, DOI 10.3892/or.2014.3183; Xu XB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028216; Yoshida J, 2010, LIFE SCI, V86, P124, DOI 10.1016/j.lfs.2009.11.014; Zerfaoui M, 2008, CELL SIGNAL, V20, P186, DOI 10.1016/j.cellsig.2007.10.007; Zhang BF, 2007, CELL SIGNAL, V19, P1690, DOI 10.1016/j.cellsig.2007.03.005; Zhang Y, 2010, ANTIOXID REDOX SIGN, V13, P959, DOI 10.1089/ars.2009.2908	65	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2016	11	2							e0149272	10.1371/journal.pone.0149272	http://dx.doi.org/10.1371/journal.pone.0149272			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3CO	26891050	Green Published, Green Submitted, gold			2022-12-26	WOS:000371221500030
J	Liu, HB; Qin, YY; Kong, ZZ; Shao, QX; Su, ZL; Wang, SJ; Chen, JG				Liu, Haibing; Qin, Yanyan; Kong, Zhenzhen; Shao, Qixiang; Su, Zhaoliang; Wang, Shengjun; Chen, Jianguo			siRNA Targeting the 2A(pro) Genomic Region Prevents Enterovirus 71 Replication In Vitro	PLOS ONE			English	Article							SMALL INTERFERING RNA; MOUTH-DISEASE; EPIDEMIOLOGY; INHIBITION; EXPRESSION; INFECTION; INDUCTION; CHILDREN; FOOT; HAND	Enterovirus 71 (EV71) is the most important etiological agent of hand, foot, and mouth disease (HFMD) in young children, which is associated with severe neurological complications and has caused significant mortalities in recent HFMD outbreaks in Asia. However, there is no effective antiviral therapy against EV71. In this study, RNA interference (RNAi) was used as an antiviral strategy to inhibit EV71 replication. Three small interfering RNAs (siRNAs) targeting the 2A(pro) region of the EV71 genome were designed and synthesized. All the siRNAs were transfected individually into rhabdomyosarcoma (RD) cells, which were then infected with strain EV71-2006-52-9. The cytopathic effects (CPEs) in the infected RD cells, cell viability, viral titer, and viral RNA and protein expression were examined to evaluate the specific viral inhibition by the siRNAs. The results of cytopathogenicity and MTT tests indicated that the RD cells transfected with the three siRNAs showed slight CPEs and significantly high viability. The 50% tissue culture infective dose (TCID50) values demonstrated that the viral titer of the groups treated with three siRNAs were lower than those of the control groups. qRT-PCR and western blotting revealed that the levels of viral RNA and protein in the RD cells treated with the three siRNAs were lower than those in the controls. When RD cells transfected with siRNAs were also infected with strain EV71-2008-43-16, the expression of the VP1 protein was significantly inhibited. The levels of interferon alpha (IFN-alpha) and IFN-beta did not differ significantly in any group. These results suggest that siRNAs targeting the 2A(pro) region of the EV71 genome exerted antiviral effects in vitro.	[Liu, Haibing; Wang, Shengjun; Chen, Jianguo] Jiangsu Univ, Affiliated Peoples Hosp, Dept Clin Lab, Zhenjiang, Peoples R China; [Qin, Yanyan; Kong, Zhenzhen; Shao, Qixiang; Su, Zhaoliang] Jiangsu Univ, Inst Lab Med, Dept Immunol, Zhenjiang, Peoples R China	Jiangsu University; Jiangsu University	Chen, JG (corresponding author), Jiangsu Univ, Affiliated Peoples Hosp, Dept Clin Lab, Zhenjiang, Peoples R China.	cjg02@126.com	, 雷克思/ABG-3956-2020	, 雷克思/0000-0003-4102-8934; Shao, Qixiang/0000-0002-8332-1605				Ang LW, 2009, ANN ACAD MED SINGAP, V38, P106; Cai QX, 2013, J VIROL, V87, P7348, DOI 10.1128/JVI.03541-12; Chan YF, 2010, INFECT GENET EVOL, V10, P404, DOI 10.1016/j.meegid.2009.05.010; Deng J-X, 2012, J BIOMEDICAL SCI, V19, P1; Feng XB, 2015, SCI REP-UK, V5, DOI 10.1038/srep11700; Guo PX, 2010, ADV DRUG DELIVER REV, V62, P650, DOI 10.1016/j.addr.2010.03.008; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Hornung V, 2005, NAT MED, V11, P263, DOI 10.1038/nm1191; Juliano R, 2008, NUCLEIC ACIDS RES, V36, P4158, DOI 10.1093/nar/gkn342; Kuo RL, 2002, J GEN VIROL, V83, P1367, DOI 10.1099/0022-1317-83-6-1367; Lu WW, 2004, BIOCHEM BIOPH RES CO, V325, P494, DOI 10.1016/j.bbrc.2004.10.062; Luan Y, 2012, VIRUS RES, V163, P183, DOI 10.1016/j.virusres.2011.09.016; Ramachandran PV, 2013, APPL BIOCHEM BIOTECH, V169, P1774, DOI 10.1007/s12010-013-0098-1; Reynolds A, 2006, RNA, V12, P988, DOI 10.1261/rna.2340906; Sharp PA, 2001, GENE DEV, V15, P485, DOI 10.1101/gad.880001; Shih SR, 2011, J VIROL, V85, P9658, DOI 10.1128/JVI.05063-11; Sim ACN, 2005, VIROLOGY, V341, P72, DOI 10.1016/j.virol.2005.06.047; Tu YF, 2015, INT J INFECT DIS, V34, P105, DOI 10.1016/j.ijid.2015.03.017; Vlachakis D, 2013, EVOL BIOINFORM, V9, P203, DOI 10.4137/EBO.S11412; Wang SM, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/876241; Wang Y, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0308-2; Wen WH, 2007, HEPATOLOGY, V46, P84, DOI 10.1002/hep.21663; Wu ZQ, 2009, J VIROL METHODS, V159, P233, DOI 10.1016/j.jviromet.2009.04.002; Yip Cyril C Y, 2013, Emerg Health Threats J, V6, P19780, DOI 10.3402/ehtj.v6i0.19780; Zhang Y, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-94	25	8	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0149470	10.1371/journal.pone.0149470	http://dx.doi.org/10.1371/journal.pone.0149470			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26886455	Green Published, gold, Green Submitted			2022-12-26	WOS:000371218400087
J	Lobbens, ES; Fodera, V; Nyberg, NT; Andersen, K; Jager, AK; Jorgensen, L; van de Weert, M				Lobbens, Eva S.; Fodera, Vito; Nyberg, Nils T.; Andersen, Kirsten; Jager, Anna K.; Jorgensen, Lene; van de Weert, Marco			The Inhibitory Effect of Natural Products on Protein Fibrillation May Be Caused by Degradation Products - A Study Using Aloin and Insulin	PLOS ONE			English	Article							THIOFLAVIN-T; AMYLOID FIBRILS; ALPHA-SYNUCLEIN; IN-VITRO; DISEASE; BINDING; TEMPERATURE; MECHANISM; RICH	Protein fibrillation is the pathological hallmark of several neurodegenerative diseases and also complicates the manufacturing and use of protein drugs. As a case study, the inhibitory activity of the natural compound aloin against insulin fibrillation was investigated. Based on Thioflavin T assays, high-performance liquid chromatography and transmission electron microscopy it was found that a degradation product of aloin, formed over weeks of storage, was able to significantly inhibit insulin fibrillation. The activity of the stored aloin was significantly reduced in the presence of small amounts of sodium azide or ascorbic acid, suggesting the active compound to be an oxidation product. A high-performance liquid chromatography method and a liquid chromatography-mass spectrometry method were developed to investigate the degradation products in the aged aloin solution. We found that the major compounds in the solution were aloin A and aloin B. In addition, 10-hydroxy aloin and elgonica dimers were detected in smaller amounts. The identified compounds were isolated and tested for activity by means of Thioflavin T assays, but no activity was observed. Thus, the actual fibrillation inhibitor is an as yet unidentified and potentially metastable degradation product of aloin. These results suggest that degradation products, and in particular oxidation products, are to be considered thoroughly when natural products are investigated for activity against protein fibrillation.	[Lobbens, Eva S.; Fodera, Vito; Andersen, Kirsten; Jorgensen, Lene; van de Weert, Marco] Univ Copenhagen, Fac Hlth & Med Sci, Dept Pharm, Copenhagen, Denmark; [Nyberg, Nils T.; Jager, Anna K.] Univ Copenhagen, Fac Hlth & Med Sci, Dept Drug Design & Pharmacol, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen	van de Weert, M (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Dept Pharm, Copenhagen, Denmark.	marco.vandeweert@sund.ku.dk	Lobbens, Eva/Q-4433-2016; Jorgensen, L/C-4290-2008; Foderà, Vito/AAZ-9925-2020; Foderà, Vito/F-9029-2010; van de Weert, Marco/AGR-7726-2022	Lobbens, Eva/0000-0001-8319-6798; Jorgensen, L/0000-0002-9110-6470; Foderà, Vito/0000-0003-2855-0568; Foderà, Vito/0000-0003-2855-0568; 	Alfred Benzon Fonden; DRA; FluoStar platereader, The Danish National Technology Foundation; Danish Research Council for Technology and Production Sciences; Danish Advanced Technology Foundation; FP7 Marie-404 Curie Actions Intra European Fellowship (IEF) for Career Development [299385]; Danish Research Council for Independent Research Nature and Universe [10-08564]	Alfred Benzon Fonden; DRA; FluoStar platereader, The Danish National Technology Foundation; Danish Research Council for Technology and Production Sciences; Danish Advanced Technology Foundation; FP7 Marie-404 Curie Actions Intra European Fellowship (IEF) for Career Development; Danish Research Council for Independent Research Nature and Universe	The authors received no specific funding for this work. However, the following funding is acknowledged: Alfred Benzon Fonden and DRA for co-funding the FluoStar platereader, The Danish National Technology Foundation for funding the HPLC, The Danish Research Council for Technology and Production Sciences for funding the centrifuge and The Danish Advanced Technology Foundation for funding the water bath. VF acknowledges support from the FP7 Marie-404 Curie Actions Intra European Fellowship (IEF) for Career Development 2012-2014, project nr. 299385 "FibCat" (University of Copenhagen). NMR equipment used in this work was purchased via grant #10-08564 from the Danish Research Council for Independent Research Nature and Universe.; The authors would like to thank Minna Gronning for helping setting up the ThT assay, Thomas Sylvest Christiansen, Henrik Thyge Corfitsen and Javohirhon Turaev for coming up with initial ideas for the project, Hamzeh Diab for performing the ThT assay investigating the activity of D-(+)-Glucose. Karina Juul Vissing for performing the studies on the shelf life of ThT. The Core Facility for Integrated Microscopy, Faculty of Health and Medical Sciences, University of Copenhagen for the TEM experiments. Alfred Benzon Fonden and DRA for co-funding the FluoStar platereader, The Danish National Technology Foundation for funding the HPLC, The Danish Research Council for Technology and Production Sciences for funding the centrifuge and The Danish Advanced Technology Foundation for funding the water bath. VF acknowledges support from the FP7 Marie-Curie Actions Intra European Fellowship (IEF) for Career Development 2012-2014, project nr. 299385 "FibCat" (University of Copenhagen). NMR equipment used in this work was purchased via grant #10-08564 from the Danish Research Council for Independent Research Nature and Universe.	Amini R, 2013, INT J BIOL MACROMOL, V60, P334, DOI 10.1016/j.ijbiomac.2013.06.013; Calcul L, 2012, FUTURE MED CHEM, V4, P1751, DOI [10.4155/FMC.12.124, 10.4155/fmc.12.124]; Dewick Pau M., 2009, MEDICINAL NATURAL PR; Ding WJ, 2014, INT J FOOD SCI TECH, V49, P1773, DOI [10.1111/ijfs.12500, 10.1111/ijfs.125]; Dobson CM, 1999, TRENDS BIOCHEM SCI, V24, P329, DOI 10.1016/S0968-0004(99)01445-0; Esmaeili A., 2014, PHARM BIOL, P1; Fodera V, 2008, J PHYS CHEM B, V112, P3853, DOI 10.1021/jp710131u; Fodera V, 2012, J PHYS CHEM LETT, V3, P2803, DOI 10.1021/jz301375d; Gibson TJ, 2006, PROTEIN SCI, V15, P1133, DOI 10.1110/ps.051879606; Groenning M, 2009, CURR PROTEIN PEPT SC, V10, P509, DOI 10.2174/138920309789352038; Groenning M, 2007, J STRUCT BIOL, V159, P483, DOI 10.1016/j.jsb.2007.06.004; Groenning M, 2007, J STRUCT BIOL, V158, P358, DOI 10.1016/j.jsb.2006.12.010; Hong DP, 2006, BIOCHEMISTRY-US, V45, P9342, DOI 10.1021/bi0604936; Hudson SA, 2009, FEBS J, V276, P5960, DOI 10.1111/j.1742-4658.2009.07307.x; Ivanova MI, 2009, P NATL ACAD SCI USA, V106, P18990, DOI 10.1073/pnas.0910080106; Krebs MRH, 2005, J STRUCT BIOL, V149, P30, DOI 10.1016/j.jsb.2004.08.002; Li J, 2004, CHEM BIOL, V11, P1513, DOI 10.1016/j.chembiol.2004.08.025; Li XZ, 2013, FITOTERAPIA, V84, P273, DOI 10.1016/j.fitote.2012.12.009; Liu KN, 2012, BBA-GEN SUBJECTS, V1820, P1774, DOI 10.1016/j.bbagen.2012.07.012; MANITTO P, 1990, J CHEM SOC PERK T 1, P1297, DOI 10.1039/p19900001297; Nielsen L, BIOCHEMISTRY, V40, P6036; Palhano FL, 2013, J AM CHEM SOC, V135, P7503, DOI 10.1021/ja3115696; Rasmussen T, 2010, PHARM RES-DORDR, V27, P1337, DOI 10.1007/s11095-010-0116-8; Shikama Y, 2010, INTERNAL MED, V49, P397, DOI 10.2169/internalmedicine.49.2633; Smith MI, 2012, COLLOID SURFACE B, V89, P216, DOI 10.1016/j.colsurfb.2011.09.018; Stefani M, 2013, INT J MOL SCI, V14, P12411, DOI 10.3390/ijms140612411; VASSAR PS, 1959, ARCH PATHOL, V68, P487; Wamer WG, 2003, FREE RADICAL BIO MED, V34, P233, DOI 10.1016/S0891-5849(02)01242-X; Zhu JJ, 2010, J CHROMATOGR A, V1217, P5384, DOI 10.1016/j.chroma.2010.05.039; Zhu M, 2004, J BIOL CHEM, V279, P26846, DOI 10.1074/jbc.M403129200	30	6	6	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0149148	10.1371/journal.pone.0149148	http://dx.doi.org/10.1371/journal.pone.0149148			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	26882071	Green Published, Green Submitted, gold			2022-12-26	WOS:000371219000051
J	Maimela, E; Alberts, M; Modjadji, SEP; Choma, SSR; Dikotope, SA; Ntuli, TS; Van Geertruyden, JP				Maimela, Eric; Alberts, Marianne; Modjadji, Sewela E. P.; Choma, Solomon S. R.; Dikotope, Sekgothe A.; Ntuli, Thembelihle S.; Van Geertruyden, Jeane-Pierre			The Prevalence and Determinants of Chronic Non-Communicable Disease Risk Factors amongst Adults in the Dikgale Health Demographic and Surveillance System (HDSS) Site, Limpopo Province of South Africa	PLOS ONE			English	Article							PHYSICAL INACTIVITY; TOBACCO USE; POPULATION; HYPERTENSION; VARIABILITY; CONSUMPTION; OVERWEIGHT; PATTERNS; PRIORITY; SMOKING	Background The aim of the study was to determine the prevalence and determinants of chronic non-communicable disease (NCD) risk factors in a rural community in the Limpopo Province of South Africa. Methods This survey was conducted using the WHO "STEPwise approach to the surveillance of non-communicable diseases" (STEPS) methodology. Participants were residents of the Dikgale HDSS site and standardised international protocols were used to measure behavioural risk factors (smoking, alcohol consumption, fruit and vegetable intake and, physical activity) and physical characteristics (weight, height, waist and hip circumferences and blood pressure-BP). Fasting blood glucose, triglyceride, cholesterol and HDL-C were determined in 732 participants. Data were analysed using STATA 12 for Windows. Results The prevalence of current smokers amongst the participants was 13.7%, of which 81.3% were daily smokers. Alcohol was consumed by 16.3% of the participants. The majority of participants (88.6%) had low daily intake of fruit and vegetables and low physical activity (66.5%). The prevalence of hypertension amongst the participants was 38.2%. Overweight, obesity and high waist circumference were prevalent in females. The cardio-metabolic risk profile was not significantly different between men and women. People who were older than 40 years, overweight or obese and those who consumed alcohol were more likely to be hypertensive. Smoking was associated significantly with older age, males, never married and divorced people. Alcohol consumption was associated with older age, males, low educational status and low income. Conclusion High levels of risk factors for NCDs among adults in the Dikgale HDSS suggest an urgent need for health interventions to control these risk factors at the population level in order to reduce the prevalence of NCDs.	[Maimela, Eric; Alberts, Marianne; Modjadji, Sewela E. P.; Choma, Solomon S. R.; Dikotope, Sekgothe A.; Ntuli, Thembelihle S.] Univ Limpopo, Dept Med Sci Publ Hlth & Hlth Promot, Turfloop Campus, Polokwane, South Africa; [Maimela, Eric; Van Geertruyden, Jeane-Pierre] Univ Antwerp, Int Hlth Unit, B-2020 Antwerp, Belgium	University of Limpopo; University of Antwerp	Maimela, E (corresponding author), Univ Limpopo, Dept Med Sci Publ Hlth & Hlth Promot, Turfloop Campus, Polokwane, South Africa.; Maimela, E (corresponding author), Univ Antwerp, Int Hlth Unit, B-2020 Antwerp, Belgium.	ericmaimela@webmail.co.za	Van geertruyden, Jean-Pierre/K-6425-2014; Modjadji, Perpetua/GRS-2210-2022; Van geertruyden, Jean-Pierre/S-3254-2019	Van geertruyden, Jean-Pierre/0000-0001-5006-6364; Modjadji, Perpetua/0000-0002-8339-9875; Van geertruyden, Jean-Pierre/0000-0001-5006-6364; Maimela, Eric/0000-0003-2843-4663; Choma, Solomon/0000-0003-1338-6523	University of Limpopo; International Health Unit; Antwerp University in Belgium; Vlaamse Interuniversitaire Raad (VLIR); Medical Science Department, University of Limpopo, in South Africa; International Health Unit, Antwerp University in Belgium; VLIR-UOS programme in Belgium	University of Limpopo; International Health Unit; Antwerp University in Belgium; Vlaamse Interuniversitaire Raad (VLIR); Medical Science Department, University of Limpopo, in South Africa; International Health Unit, Antwerp University in Belgium; VLIR-UOS programme in Belgium	The financial support for the conduct of the research and preparation of the article was provided by University of Limpopo, the International Health Unit, Antwerp University in Belgium, and the Vlaamse Interuniversitaire Raad (VLIR) (http://www.vliruos.be). VLIR contributed in the study design, data collection and analysis, and decision to publish the manuscript. The sponsors contributed in the payment to attend courses on Epidemiology, Biostatistics and Qualitative data analysis including writing of the article. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank the Medical Science Department, University of Limpopo, in South Africa and the International Health Unit, Antwerp University in Belgium for their human and financial support during the execution of the study, not forgetting the immeasurable financial support received from the VLIR-UOS programme in Belgium.	Afridi I, 2003, J HYPERTENS, V21, P1983, DOI 10.1097/01.hjh.0000084751-37215.d2; Al-Nsour M, 2012, PREV CHRONIC DIS, V9, DOI 10.5888/pcd9.110077; Alberts M, 1999, S AFR MED J, V89, P851; Alberts M, 2005, EUROPEAN J CARDIOVAS; Alikhani S, 2009, PUBLIC HEALTH, V123, P358, DOI 10.1016/j.puhe.2009.02.011; AlNuaim AR, 1996, INT J CARDIOL, V54, P41, DOI 10.1016/0167-5273(96)02555-7; Anand K, 2007, NATL MED J INDIA, V20, P3; [Anonymous], 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d3823; Ashraf A, 2009, GLOBAL HEALTH ACTION, V2, P19, DOI 10.3402/gha.v2i0.1997; Beaglehole R, 2011, LANCET, V377, P1438, DOI 10.1016/S0140-6736(11)60393-0; Bhasin SK, 2013, INDIAN MED GAZET AUG; Bradshaw D, 2001, DETERMINANTS HLTH TH; Bradshaw D, NONCOMMUNICABLE DIS; Cook I, 2012, THESIS U CAPE TOWN S; Cook I, 2012, J PHYS ACT HEALTH, V9, P300, DOI 10.1123/jpah.9.2.300; Cowie CC, 2006, DIABETES CARE, V29, P1263, DOI 10.2337/dc06-0062; Dalton M, 2003, J INTERN MED, V254, P555, DOI 10.1111/j.1365-2796.2003.01229.x; Geneau R, 2010, LANCET, V376, P1689, DOI 10.1016/S0140-6736(10)61414-6; Goedecke JH, CHRONIC DISEASES OF; Guthold R, 2008, AM J PREV MED, V34, P486, DOI 10.1016/j.amepre.2008.02.013; Hall JN, 2009, AM J PREV MED, V36, P402, DOI 10.1016/j.amepre.2009.01.029; Hamrah MS, 2013, ASIAN PAC J CANCER P, V14, P1919, DOI 10.7314/APJCP.2013.14.3.1919; Hansen BH, 2012, MED SCI SPORT EXER, V44, P266, DOI 10.1249/MSS.0b013e31822cb354; Hoy D, 2013, PREV CHRONIC DIS, V10, DOI 10.5888/pcd10.120067; Hunter DJ, 2013, NEW ENGL J MED, V369, P14; Kakde S, 2012, PUBLIC HEALTH, V126, P635, DOI 10.1016/j.puhe.2012.05.002; Kanjala C, 2010, GLOBAL HEALTH ACTION, V3, P59, DOI 10.3402/gha.v3i0.5236; Kanungsukkasem U, 2009, GLOBAL HEALTH ACTION, V2, P35, DOI 10.3402/gha.v2i0.1988; Kaur P, 2011, J POSTGRAD MED, V57, P9, DOI 10.4103/0022-3859.74284; Lazzeri G, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-123; Lumley T., 2004, J STAT SOFTW, V9, P1, DOI [10.18637/jss.v009.i08, DOI 10.18637/JSS.V009.I08]; Manuc D, 2006, J PREVENTIVE MED, V14, P3; Mehan BM, 2006, INT J DIABDEVCTRIES, V26, P4; Minh HV, 2005, PREV CHRONIC DIS; Motala AA, 2011, DIABETES CARE, V34, P1032, DOI 10.2337/dc10-1921; Msyamboza KP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020316; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; Ng N, 2006, B WHO, V84; Ng N, 2009, GLOBAL HEALTH ACTION, V2, P44, DOI 10.3402/gha.v2i0.1985; Ng N, 2009, GLOBAL HEALTH ACTION, V2, P7, DOI 10.3402/gha.v2i0.1984; Peltzer K, 2012, GLOBAL HEALTH ACTION, V5, DOI [10.3402/gha.v5i0.18545, 10.3402/gha.v5i0.18668]; Pham LH, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-291; Pickering Thomas G, 2005, J Clin Hypertens (Greenwich), V7, P102, DOI 10.1111/j.1524-6175.2005.04377.x; Puoane TR, 2012, S AFRICAN HLTH REV; Reddy P, 1996, S AFR MED J, V86, P1389; Singh RB, 2000, J HUM HYPERTENS, V14, P749, DOI 10.1038/sj.jhh.1001057; Sugathan TN, 2008, INDIAN J MED RES, V127, P555; Thankappan KR, 2010, INDIAN J MED RES, V131, P53; Thorogood M, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-326; Traissac P, 1999, REV EPIDEMIOL SANTE, V47, P593; Bich TH, 2009, GLOBAL HEALTH ACTION, V2, P28, DOI 10.3402/gha.v2i0.2017; Venkitachalam L, 2012, CIRCULATION, V125, P1858, DOI 10.1161/CIRCULATIONAHA.111.064378; WHO, 2011, STEPS MAN STEPS INST; World Health Organization, 2007, REG OFF S E AS REG F; World Health Organization, 2007, NAUR NCD RISK FACT S; World Health Organization, GLOB STAT REP NONC D; Zhou JC, 2012, HEALTH PLACE, V18, P1300, DOI 10.1016/j.healthplace.2012.09.001	57	61	61	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0147926	10.1371/journal.pone.0147926	http://dx.doi.org/10.1371/journal.pone.0147926			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF3BP	26882033	gold, Green Published, Green Submitted			2022-12-26	WOS:000371219000010
J	Ma, ZC; Han, Q; Wang, XL; Ai, ZS; Zheng, YJ				Ma, Zhicong; Han, Qi; Wang, Xiaolei; Ai, Zisheng; Zheng, Yongjun			Galectin-3 Inhibition Is Associated with Neuropathic Pain Attenuation after Peripheral Nerve Injury	PLOS ONE			English	Article							MICROGLIAL ACTIVATION; IL-1-BETA PRODUCTION; MULTIPLE-SCLEROSIS; SIGNALING PATHWAY; INNATE IMMUNITY; AUTOPHAGY; CONTRIBUTES; MECHANISMS; EXPRESSION; SENSOR	Neuropathic pain remains a prevalent and persistent clinical problem because it is often poorly responsive to the currently used analgesics. It is very urgent to develop novel drugs to alleviate neuropathic pain. Galectin-3 (gal3) is a multifunctional protein belonging to the carbohydrate-ligand lectin family, which is expressed by different cells. Emerging studies showed that gal3 elicits a pro-inflammatory response by recruiting and activating lymphocytes, macrophages and microglia. In the study we investigated whether gal3 inhibition could suppress neuroinflammation and alleviate neuropathic pain following peripheral nerve injury. We found that L5 spinal nerve ligation (SNL) increases the expression of gal3 in dorsal root ganglions at the mRNA and protein level. Intrathecal administration of modified citrus pectin (MCP), a gal3 inhibitor, reduces gal3 expression in dorsal root ganglions. MCP treatment also inhibits SNL-induced gal3 expression in primary ratmicroglia. SNL results in an increased activation of autophagy that contributes to microglial activation and subsequent inflammatory response. Intrathecal administration of MCP significantly suppresses SNL-induced autophagy activation. MCP also inhibits lipopolysaccharide (LPS)-induced autophagy in cultured microglia in vitro. MCP further decreases LPS-induced expression of proinflammatory mediators including IL-1 beta, TNF-alpha and IL-6 by regulating autophagy. Intrathecal administration of MCP results in adecreased mechanical and cold hypersensitivity following SNL. These results demonstrated that gal3 inhibition is associated with the suppression of SNL-induced inflammatory process andneurophathic pain attenuation.	[Ma, Zhicong] Shanxi Med Univ, Hosp 2, Dept Anesthesiol, Taiyuan 030001, Peoples R China; [Ma, Zhicong] Cent S Univ, Xiangya Hosp, Dept Anesthesiol, Changsha 410008, Hunan, Peoples R China; [Han, Qi; Wang, Xiaolei; Zheng, Yongjun] Fudan Univ, Huadong Hosp, Dept Pain Management, 221 West Yanan Rd, Shanghai 200040, Peoples R China; [Han, Qi; Wang, Xiaolei; Zheng, Yongjun] Fudan Univ, Huadong Hosp, Shanghai Key Lab Clin Geriatr Med, 221 West Yanan Rd, Shanghai 200040, Peoples R China; [Ai, Zisheng] Tongji Univ, Coll Med, Dept Prevent Med, Shanghai 200092, Peoples R China	Shanxi Medical University; Central South University; Fudan University; Fudan University; Tongji University	Zheng, YJ (corresponding author), Fudan Univ, Huadong Hosp, Dept Pain Management, 221 West Yanan Rd, Shanghai 200040, Peoples R China.; Zheng, YJ (corresponding author), Fudan Univ, Huadong Hosp, Shanghai Key Lab Clin Geriatr Med, 221 West Yanan Rd, Shanghai 200040, Peoples R China.	zhengyongjun1971@126.com	wang, xiao/HGB-7081-2022	wang, xiao/0000-0002-4088-3341; Ai, Zi-Sheng/0000-0001-8417-4160	Shanghai Key Laboratory of Clinical Geriatric Medicine [13dz2260700]	Shanghai Key Laboratory of Clinical Geriatric Medicine	This work was supported by the Shanghai Key Laboratory of Clinical Geriatric Medicine (13dz2260700). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arad U, 2015, CYTOKINE, V73, P30, DOI 10.1016/j.cyto.2015.01.016; Boza-Serrano A, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0156-0; Burguillos MA, 2015, CELL REP, V10, P1626, DOI 10.1016/j.celrep.2015.02.012; Calvier L, 2015, JACC-HEART FAIL, V3, P59, DOI 10.1016/j.jchf.2014.08.002; Calvo M, 2011, GLIA, V59, P554, DOI 10.1002/glia.21124; Carson MJ, 2002, GLIA, V40, P218, DOI 10.1002/glia.10145; Choy YJ, 2015, J CHEM NEUROANAT, V66-67, P10, DOI 10.1016/j.jchemneu.2015.03.003; Deretic V, 2013, NAT REV IMMUNOL, V13, P722, DOI 10.1038/nri3532; Dominguez E, 2008, J NEUROCHEM, V107, P50, DOI 10.1111/j.1471-4159.2008.05566.x; Dominguez E, 2010, J NEUROSCI, V30, P5754, DOI 10.1523/JNEUROSCI.5007-09.2010; Ge YH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097436; Guo ML, 2015, AUTOPHAGY, V11, P995, DOI 10.1080/15548627.2015.1052205; Hughes RAC, 2002, BRIT MED J, V324, P466, DOI 10.1136/bmj.324.7335.466; Jeon SB, 2010, J IMMUNOL, V185, P7037, DOI 10.4049/jimmunol.1000154; Jia WZ, 2013, AM J PATHOL, V182, P1821, DOI 10.1016/j.ajpath.2013.01.017; Kapinas K, 2010, J BIOL CHEM, V285, P25221, DOI 10.1074/jbc.M110.116137; Kim CF, 2011, J PAIN, V12, P370, DOI 10.1016/j.jpain.2010.08.003; KIM SH, 1992, PAIN, V50, P355, DOI 10.1016/0304-3959(92)90041-9; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Kolatsi-Joannou M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018683; Lalancette-Hebert M, 2012, J NEUROSCI, V32, P10383, DOI 10.1523/JNEUROSCI.1498-12.2012; Leal MF, 2015, CLIN EXP MED, V15, P415, DOI 10.1007/s10238-014-0299-0; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Liang PZ, 2015, NEUROSCI BULL, V31, P435, DOI 10.1007/s12264-015-1545-5; Meng N, 2010, J CELL PHYSIOL, V225, P174, DOI 10.1002/jcp.22210; Milligan ED, 2009, NAT REV NEUROSCI, V10, P23, DOI 10.1038/nrn2533; Moalem G, 2006, BRAIN RES REV, V51, P240, DOI 10.1016/j.brainresrev.2005.11.004; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Satoh K, 2011, BRAIN RES, V1382, P266, DOI 10.1016/j.brainres.2011.01.049; Seetharaman J, 1998, J BIOL CHEM, V273, P13047, DOI 10.1074/jbc.273.21.13047; Shi CS, 2012, NAT IMMUNOL, V13, P255, DOI 10.1038/ni.2215; Shi GD, 2013, GLIA, V61, P504, DOI 10.1002/glia.22451; Uceyler N, 2007, BRAIN BEHAV IMMUN, V21, P553, DOI 10.1016/j.bbi.2006.10.003; Uceyler N, 2007, PAIN, V132, P195, DOI 10.1016/j.pain.2007.07.031; Xu Y, 2008, AUTOPHAGY, V4, P110, DOI 10.4161/auto.5225; Xu Y, 2007, IMMUNITY, V27, P135, DOI 10.1016/j.immuni.2007.05.022; Yang Z, 2015, NEUROPATH APPL NEURO, V41, pe95, DOI 10.1111/nan.12177; Zhou XL, 2014, MOL PAIN, V10, DOI 10.1186/1744-8069-10-51	38	31	32	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0148792	10.1371/journal.pone.0148792	http://dx.doi.org/10.1371/journal.pone.0148792			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26872020	gold, Green Published, Green Submitted			2022-12-26	WOS:000370054100055
J	Patnaik, BB; Wang, TH; Kang, SW; Hwang, HJ; Park, SY; Park, EB; Chung, JM; Song, DK; Kim, C; Kim, S; Lee, JS; Han, YS; Park, HS; Lee, YS				Patnaik, Bharat Bhusan; Wang, Tae Hun; Kang, Se Won; Hwang, Hee-Ju; Park, So Young; Park, Eun Bi; Chung, Jong Min; Song, Dae Kwon; Kim, Changmu; Kim, Soonok; Lee, Jun Sang; Han, Yeon Soo; Park, Hong Seog; Lee, Yong Seok			Sequencing, De Novo Assembly, and Annotation of the Transcriptome of the Endangered Freshwater Pearl Bivalve, Cristaria plicata, Provides Novel Insights into Functional Genes and Marker Discovery	PLOS ONE			English	Article							TANDEM-REPEAT GALECTIN; MOLECULAR-CLONING; RUDITAPES-PHILIPPINARUM; MANTLE TRANSCRIPTOME; EXPRESSION ANALYSIS; PROTOZOAN PARASITE; INNATE IMMUNITY; THERMAL-STRESS; PACIFIC OYSTER; MANILA CLAM	Background The freshwater mussel Cristaria plicata (Bivalvia: Eulamellibranchia: Unionidae), is an economically important species in molluscan aquaculture due to its use in pearl farming. The species have been listed as endangered in South Korea due to the loss of natural habitats caused by anthropogenic activities. The decreasing population and a lack of genomic information on the species is concerning for environmentalists and conservationists. In this study, we conducted a de novo transcriptome sequencing and annotation analysis of C. plicata using Illumina HiSeq 2500 next-generation sequencing (NGS) technology, the Trinity assembler, and bioinformatics databases to prepare a sustainable resource for the identification of candidate genes involved in immunity, defense, and reproduction. Results The C. plicata transcriptome analysis included a total of 286,152,584 raw reads and 281,322,837 clean reads. The de novo assembly identified a total of 453,931 contigs and 374,794 non-redundant unigenes with average lengths of 731.2 and 737.1 bp, respectively. Furthermore, 100% coverage of C. plicata mitochondrial genes within two unigenes supported the quality of the assembler. In total, 84,274 unigenes showed homology to entries in at least one database, and 23,246 unigenes were allocated to one or more Gene Ontology (GO) terms. The most prominent GO biological process, cellular component, and molecular function categories (level 2) were cellular process, membrane, and binding, respectively. A total of 4,776 unigenes were mapped to 123 biological pathways in the KEGG database. Based on the GO terms and KEGG annotation, the unigenes were suggested to be involved in immunity, stress responses, sex-determination, and reproduction. A total of 17,251 cDNA simple sequence repeats (cSSRs) were identified from 61,141 unigenes (size of > 1 kb) with the most abundant being dinucleotide repeats. Conclusions This dataset represents the first transcriptome analysis of the endangered mollusc, C. plicata. The transcriptome provides a comprehensive sequence resource for the conservation of genetic information in this species and enrichment of the genetic database. The development of molecular markers will assist in the genetic improvement of C. plicata.	[Patnaik, Bharat Bhusan; Wang, Tae Hun; Kang, Se Won; Hwang, Hee-Ju; Park, So Young; Park, Eun Bi; Chung, Jong Min; Song, Dae Kwon; Lee, Yong Seok] Soonchunhyang Univ, Coll Nat Sci, Dept Life Sci & Biotechnol, 22 Soonchunhyangro, Asan 336745, Chungchungnam D, South Korea; [Kim, Changmu; Kim, Soonok] Natl Inst Biol Resources, Inchon 404170, South Korea; [Lee, Jun Sang] Kangwon Natl Univ, Inst Environm Res, 1 Kangwondaehak Gil, Chuncheon Si 200701, Gangwon Do, South Korea; [Han, Yeon Soo] Chonnam Natl Univ, Coll Agr & Life Sci, 300 Yongbong Dong, Gwangju 500757, South Korea; [Park, Hong Seog] GnC BIO Co LTD, Res Inst, 621-6 Banseok Dong, Daejeon 305150, South Korea; [Patnaik, Bharat Bhusan] TACT, Trident Sch Biotech Sci, Bhubaneswar 751024, Odisha, India	Soonchunhyang University; National Institute of Biological Resources; Kangwon National University; Chonnam National University	Lee, YS (corresponding author), Soonchunhyang Univ, Coll Nat Sci, Dept Life Sci & Biotechnol, 22 Soonchunhyangro, Asan 336745, Chungchungnam D, South Korea.	yslee@sch.ac.kr	LEE, YONGSEOK/AAF-3965-2020; Patnaik, Bharat Bhusan/H-2973-2019	Patnaik, Bharat Bhusan/0000-0003-1383-6758; Lee, Yongseok/0000-0002-8687-589X	grant entitled "The Genetic and Genomic Evaluation of Indigenous Biological Resources" - National Institute of Biological Resources [NIBR201503202]; grant entitled "The Genetic and Genomic Evaluation of Indigenous Biological Resources" - National Institute of Biological Resources, Incheon, Korea [NIBR201503202]	grant entitled "The Genetic and Genomic Evaluation of Indigenous Biological Resources" - National Institute of Biological Resources; grant entitled "The Genetic and Genomic Evaluation of Indigenous Biological Resources" - National Institute of Biological Resources, Incheon, Korea	This work was supported by the grant entitled "The Genetic and Genomic Evaluation of Indigenous Biological Resources" funded by the National Institute of Biological Resources (NIBR201503202).; This work was supported by the grant entitled "The Genetic and Genomic Evaluation of Indigenous Biological Resources (NIBR201503202)" funded by the National Institute of Biological Resources, Incheon, Korea.	Abdul-Muneer PM, 2014, GENET RES INT, V2014, DOI 10.1155/2014/691759; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arancibia SA, 2007, BIOL RES, V40, P97, DOI 10.4067/S0716-97602007000200001; Diaz GA, 2010, ISJ-INVERT SURVIV J, V7, P157; Artigaud S, 2014, MAR GENOM, V15, P3, DOI 10.1016/j.margen.2014.03.006; Bai Z, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0022886, DOI 10.1371/J0URNAL.P0NE.0022886]; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Birol I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130720; Blankenberg D, 2010, BIOINFORMATICS, V26, P1783, DOI 10.1093/bioinformatics/btq281; Bogan AE, 2015, IUCN RED LIST THREAT; Bouhouche N, 2000, TRENDS MICROBIOL, V8, P77, DOI 10.1016/S0966-842X(99)01679-0; Boutet I, 2008, GENE, V407, P130, DOI 10.1016/j.gene.2007.10.005; Castellanos-Martinez S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107873; Chatterjee B.P., 2013, MARINE PROTEINS PEPT, V1st ed., P41, DOI [10.1002/9781118375082.ch3, DOI 10.1002/9781118375082.CH3]; Chavez-Villalba J, 2011, J SHELLFISH RES, V30, P231, DOI 10.2983/035.030.0206; Che RB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087940; Chen HH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079516; Cheng CF, 2012, SCI WORLD J, DOI 10.1100/2012/906737; Clark MS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-362; Collins AJ, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00091; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Deng YW, 2014, BIOSCI BIOTECH BIOCH, V78, P1685, DOI 10.1080/09168451.2014.936351; Dong Y, 2014, INT J MOL SCI, V15, P19472, DOI 10.3390/ijms151119472; Dong Zhi-Guo, 2004, Acta Hydrobiologica Sinica, V28, P440; Estari M., 2011, Biology and Medicine, V3, P191; Evans TG, 2012, PHILOS T R SOC B, V367, P1733, DOI 10.1098/rstb.2012.0019; Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243; Feldmeyer B, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-317; Franchini Paolo, 2011, BMC Research Notes, V4, DOI 10.1186/1756-0500-4-59; Galloway TS, 2001, ECOTOXICOLOGY, V10, P5, DOI 10.1023/A:1008939520263; Gerdol Marco, 2014, BMC Research Notes, V7, P722, DOI 10.1186/1756-0500-7-722; Gorbushin AM, 2015, DEV COMP IMMUNOL, V48, P210, DOI 10.1016/j.dci.2014.10.007; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guo XM, 2015, FISH SHELLFISH IMMUN, V46, P107, DOI 10.1016/j.fsi.2015.05.018; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; He J, FRESHWATER BIVALVES; Hook SE, 2014, AQUAT TOXICOL, V146, P247, DOI 10.1016/j.aquatox.2013.11.001; Hoshino AA, GENET DIVERS MICROOR, V6, P149; Hou R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021560; Hu XJ, 2014, FISH SHELLFISH IMMUN, V40, P446, DOI 10.1016/j.fsi.2014.07.005; Huang ZX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051279; Jia ZY, 2008, MOL ECOL RESOUR, V8, P1520, DOI 10.1111/j.1755-0998.2008.02310.x; Joshi NA, SICKLE SLIDING WINDO; Jung H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027938; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kang Se Won, 2015, Korean Journal of Malacology, V31, P243, DOI 10.9710/kjm.2015.31.3.243; Kashimada K, 2010, DEVELOPMENT, V137, P3921, DOI 10.1242/dev.048983; Kim JY, 2008, DEV COMP IMMUNOL, V32, P1131, DOI 10.1016/j.dci.2008.03.002; Kondo T, SPECIAL PUBLICATION, V3, pv; Kong PF, 2011, FISH SHELLFISH IMMUN, V30, P836, DOI 10.1016/j.fsi.2011.01.005; Kopp A, 2012, TRENDS GENET, V28, P175, DOI 10.1016/j.tig.2012.02.002; Kuchel RP, 2010, J INVERTEBR PATHOL, V104, P97, DOI 10.1016/j.jip.2010.02.001; Lee JH, 2012, MITOCHONDR DNA, V23, P39, DOI 10.3109/19401736.2011.643882; Lefebvre V, 2007, INT J BIOCHEM CELL B, V39, P2195, DOI 10.1016/j.biocel.2007.05.019; Leung PTY, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-804; Li YC, 2002, MOL ECOL, V11, P2453, DOI 10.1046/j.1365-294X.2002.01643.x; Llera-Herrera R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073176; Lopez-Uribe MM, 2013, APIDOLOGIE, V44, P163, DOI 10.1007/s13592-012-0168-3; Ma JJ, 2010, FISH SHELLFISH IMMUN, V29, P501, DOI 10.1016/j.fsi.2010.05.006; Ma KY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039727; Martin J, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-663; Matsumoto T, 2003, ZOOL SCI, V20, P37, DOI 10.2108/zsj.20.37; Matsumoto T, 2013, ZOOL SCI, V30, P826, DOI 10.2108/zsj.30.826; Mehr S, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1565-6; Meng XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064485; Micallef G, 2012, MAR BIOTECHNOL, V14, P559, DOI 10.1007/s10126-012-9447-2; Milan M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-234; Naimi A, 2009, COMP BIOCHEM PHYS B, V154, P134, DOI 10.1016/j.cbpb.2009.05.011; Ning X, 2015, FISH SHELLFISH IMMUN; Niu D, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0067456, DOI 10.1371/J0URNAL.P0NE.0067456]; Noh JY, 2014, GENE, V534, P204, DOI 10.1016/j.gene.2013.10.058; Osada M, 2004, COMP BIOCHEM PHYS B, V139, P123, DOI 10.1016/j.cbpc.2004.07.002; Oshima Y, 2008, GEN COMP ENDOCR, V159, P170, DOI 10.1016/j.ygcen.2008.08.013; Pairett AN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069852; Pauletto M, 2014, FISH SHELLFISH IMMUN, V37, P154, DOI 10.1016/j.fsi.2014.01.017; Penarrubia L, 2015, CONSERV GENET RESOUR, V7, P393, DOI 10.1007/s12686-014-0378-2; Peng K, 2012, AQUACULTURE, V334, P45, DOI 10.1016/j.aquaculture.2011.12.039; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Philipp EER, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033091; Prentis PJ, 2014, MAR GENOM, V18, P113, DOI 10.1016/j.margen.2014.08.004; Qiao L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075211; Ren Q, 2011, FISH SHELLFISH IMMUN, V31, P1232, DOI 10.1016/j.fsi.2011.07.020; Rhee SY, 2008, NAT REV GENET, V9, P509, DOI 10.1038/nrg2363; Roberts S, 2009, MAR BIOTECHNOL, V11, P24, DOI 10.1007/s10126-008-9117-6; Robertson G, 2010, NAT METHODS, V7, P909, DOI 10.1038/nmeth.1517; Romero A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017003; Sanz N, 2013, BIOL INVASIONS, V15, P2333, DOI 10.1007/s10530-013-0456-5; Schmitt P, 2010, J BIOL CHEM, V285, P29208, DOI 10.1074/jbc.M110.143388; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Senatore A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118321; Shi MJ, 2013, MAR BIOTECHNOL, V15, P706, DOI 10.1007/s10126-013-9517-0; Smith SA, 2011, NATURE, V480, P364, DOI 10.1038/nature10526; Tanaka SS, 2014, CELL MOL LIFE SCI, V71, P4781, DOI 10.1007/s00018-014-1703-3; Tanguy Marion, 2013, Results Immunol, V3, P40, DOI 10.1016/j.rinim.2013.04.001; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Teaniniuraitemoana V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122819; Teaniniuraitemoana V, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-491; The Gene Ontology Consortium, 2008, NUCL ACIDS RES, V36; Tindwa H, 2013, INT J MOL SCI, V14, P22462, DOI 10.3390/ijms141122462; Tong Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134280; Toubiana M, 2014, DEV COMP IMMUNOL, V45, P300, DOI 10.1016/j.dci.2014.03.021; Uliano-Silva M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102973; Vasta GR, 2012, ANN NY ACAD SCI, V1253, pE14, DOI 10.1111/j.1749-6632.2012.06698.x; Venier P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-69; Venier P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-72; Vidotto M, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-407; Vogel H, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-308; Wang H, 2016, MITOCHONDRIAL DNA A, V27, P1478, DOI 10.3109/19401736.2014.953100; Wang L, 2011, ISJ-INVERT SURVIV J, V8, P241; Wang W, 2014, MAR BIOTECHNOL, V16, P547, DOI 10.1007/s10126-014-9573-0; Wang ZY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-726; Wei GY, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0786-0; Whitten MMA, 2004, J IMMUNOL, V172, P2177, DOI 10.4049/jimmunol.172.4.2177; Woo S, 2013, ZOOL STUD, V52, DOI 10.1186/1810-522X-52-15; Wu D, 2013, FISH SHELLFISH IMMUN, V34, P1033, DOI 10.1016/j.fsi.2012.12.009; Xie YL, 2014, BIOINFORMATICS, V30, P1660, DOI 10.1093/bioinformatics/btu077; Yan YB, 2011, AM J BOT, V98, pE1, DOI 10.3732/ajb.1000387; Yang XL, 2011, FISH SHELLFISH IMMUN, V31, P389, DOI 10.1016/j.fsi.2011.06.003; Yu FF, 2011, J SHELLFISH RES, V30, P247, DOI 10.2983/035.030.0208; Yue HM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127332; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zeng DG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057515; Zhang DC, 2011, GENET MOL RES, V10, P1963, DOI 10.4238/vol10-3gmr1149; Zhang GF, 2012, NATURE, V490, P49, DOI 10.1038/nature11413; Zhang LL, 2014, MAR BIOTECHNOL, V16, P17, DOI 10.1007/s10126-013-9526-z; Zhang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056732; Zhang ZH, 2012, GENE, V497, P172, DOI 10.1016/j.gene.2012.01.058	127	41	42	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0148622	10.1371/journal.pone.0148622	http://dx.doi.org/10.1371/journal.pone.0148622			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26872384	Green Published, gold, Green Submitted			2022-12-26	WOS:000370054100040
J	Tse, G; Tse, V; Yeo, JM; Sun, B				Tse, Gary; Tse, Vivian; Yeo, Jie Ming; Sun, Bing			Atrial Anti-Arrhythmic Effects of Heptanol in Langendorff-Perfused Mouse Hearts	PLOS ONE			English	Article							GAP-JUNCTION PROTEIN; VENTRICULAR-TACHYCARDIA; INCREASED VULNERABILITY; CONDUCTION SYSTEM; IONIC MECHANISMS; SODIUM CURRENT; WILD-TYPE; REPOLARIZATION; ARRHYTHMIAS; MICE	Acute effects of heptanol (0.1 to 2 mM) on atrial electrophysiology were explored in Langendorff- perfused mouse hearts. Left atrial bipolar electrogram or monophasic action potential recordings were obtained during right atrial stimulation. Regular pacing at 8 Hz elicited atrial activity in 11 out of 11 hearts without inducing atrial arrhythmias. Programmed electrical stimulation using a S1S2 protocol provoked atrial tachy-arrhythmias in 9 of 17 hearts. In the initially arrhythmic group, 2 mM heptanol exerted anti-arrhythmic effects (Fisher's exact test, P < 0.05) and increased atrial effective refractory period (ERP) from 26.0 +/- 1.9 to 57.1 +/- 2.5 ms (ANOVA, P < 0.001) despite increasing activation latency from 18.7 +/- 1.1 to 28.9 +/- 2.1 ms (P < 0.001) and leaving action potential duration at 90% repolarization (APD(90)) unaltered (25.6 +/- 1.2 vs. 27.2 +/- 1.2 ms; P > 0.05), which led to increases in ERP/latency ratio from 1.4 +/- 0.1 to 2.1 +/- 0.2 and ERP/APD(90) ratio from 1.0 +/- 0.1 to 2.1 +/- 0.2 (P < 0.001). In contrast, in the initially non-arrhythmic group, heptanol did not alter arrhythmogenicity, increased AERP from 47.3 +/- 5.3 to 54.5 +/- 3.1 ms (P < 0.05) and activation latency from 23.7 +/- 2.2 to 31.3 +/- 2.5 ms and did not alter APD(90) (24.1 +/- 1.2 vs. 25.0 +/- 2.3 ms; P > 0.05), leaving both AERP/latency ratio (2.1 +/- 0.3 vs. 1.9 +/- 0.2; P > 0.05) and ERP/APD(90) ratio (2.0 +/- 0.2 vs. 2.1 +/- 0.1; P > 0.05) unaltered. Lower heptanol concentrations (0.1, 0.5 and 1 mM) did not alter arrhythmogenicity or the above parameters. The present findings contrast with known ventricular pro-arrhythmic effects of heptanol associated with decreased ERP/ latency ratio, despite increased ERP/APD ratio observed in both the atria and ventricles.	[Tse, Gary] Univ Hong Kong, Li Ka Shing Fac Med, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China; [Tse, Vivian] McGill Univ, Dept Physiol, Montreal, PQ, Canada; [Yeo, Jie Ming] Univ London Imperial Coll Sci Technol & Med, Fac Med, London, England; [Sun, Bing] Tongji Univ, Affiliated Tongji Hosp, Dept Cardiol, Shanghai 200092, Peoples R China	University of Hong Kong; McGill University; Imperial College London; Tongji University	Sun, B (corresponding author), Tongji Univ, Affiliated Tongji Hosp, Dept Cardiol, Shanghai 200092, Peoples R China.	woowoocncn@163.com	Tse, Gary/P-1171-2015	Tse, Gary/0000-0001-5510-1253; Yeo, Jie Ming/0000-0001-9541-8941	Wellcome Trust Vacation Scholarship; Trinity Hall, Cambridge; Biotechnology and Biological Sciences Research Council (BBSRC) Doctoral CASE Studentship at the Department of Biochemistry, University of Cambridge; British Heart Foundation; Medical Research Council; Xention Discovery	Wellcome Trust Vacation Scholarship(Wellcome Trust); Trinity Hall, Cambridge; Biotechnology and Biological Sciences Research Council (BBSRC) Doctoral CASE Studentship at the Department of Biochemistry, University of Cambridge(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Xention Discovery	Support was provided by: Wellcome Trust Vacation Scholarship; Trinity Hall, Cambridge; a Biotechnology and Biological Sciences Research Council (BBSRC) Doctoral CASE Studentship at the Department of Biochemistry, University of Cambridge, in conjunction with Xention Discovery; British Heart Foundation; Medical Research Council.	Abriel H, 2010, J MOL CELL CARDIOL, V48, P2, DOI 10.1016/j.yjmcc.2009.08.025; Alcolea S, 2004, CIRC RES, V94, P100, DOI 10.1161/01.RES.0000108261.67979.2A; Antzelevitch C, 2005, HEART RHYTHM, V2, P804, DOI 10.1016/j.hrthm.2005.05.013; Antzelevitch C, 1999, CURR OPIN CARDIOL, V14, P274, DOI 10.1097/00001573-199905000-00013; Antzelevitch Charles, 2011, Card Electrophysiol Clin, V3, P23, DOI 10.1016/j.ccep.2010.10.012; Arora Rishi, 2003, Indian Pacing Electrophysiol J, V3, P187; Aschar-Sobbi R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7018; Balasubramaniam R, 2003, J PHYSIOL-LONDON, V552, P535, DOI 10.1113/jphysiol.2003.048249; BASTIAANSE EML, 1993, J MEMBRANE BIOL, V136, P135, DOI 10.1007/BF02505758; Berul CI, 2003, PHYSIOL GENOMICS, V13, P207, DOI 10.1152/physiolgenomics.00183.2002; BEYER EC, 1987, J CELL BIOL, V105, P2621, DOI 10.1083/jcb.105.6.2621; BOERSMA L, 1994, CIRCULATION, V90, P1012, DOI 10.1161/01.CIR.90.2.1012; Boyett MR, 2009, EXP PHYSIOL, V94, P1035, DOI 10.1113/expphysiol.2009.046920; BRUGADA P, 1985, PACE, V8, P889, DOI 10.1111/j.1540-8159.1985.tb05908.x; Chen BP, 2005, CLIN EXP PHARMACOL P, V32, P655, DOI 10.1111/j.0305-1870.2005.04246.x; Dautova Y, 2010, EXP PHYSIOL, V95, P994, DOI 10.1113/expphysiol.2010.053868; Dautova Y, 2009, PFLUG ARCH EUR J PHY, V458, P443, DOI 10.1007/s00424-008-0633-z; DAVIS LM, 1994, J AM COLL CARDIOL, V24, P1124, DOI 10.1016/0735-1097(94)90879-6; Fabritz L, 2003, BASIC RES CARDIOL, V98, P25, DOI 10.1007/s00395-003-0386-y; Fahmi AI, 2001, J PHYSIOL-LONDON, V537, P693; GELLENS ME, 1992, P NATL ACAD SCI USA, V89, P554, DOI 10.1073/pnas.89.2.554; GROS D, 1994, CIRC RES, V74, P839, DOI 10.1161/01.RES.74.5.839; Gussak I, 2000, J ELECTROCARDIOL, V33, P159, DOI 10.1016/S0022-0736(00)80072-2; Head CE, 2005, J CARDIOVASC ELECTR, V16, P1329, DOI 10.1111/j.1540-8167.2005.00200.x; Jansen JA, 2010, J MOL CELL CARDIOL, V48, P76, DOI 10.1016/j.yjmcc.2009.08.018; Keevil VL, 2000, PFLUG ARCH EUR J PHY, V440, P275, DOI 10.1007/s004240051049; Killeen MJ, 2008, ACTA PHYSIOL, V192, P455, DOI 10.1111/j.1748-1716.2007.01822.x; Knollmann BC, 2001, J CARDIOVASC ELECTR, V12, P1286, DOI 10.1046/j.1540-8167.2001.01286.x; KOLLER BS, 1995, CIRCULATION, V91, P2378, DOI 10.1161/01.CIR.91.9.2378; Li GH, 2002, CARDIOVASC PATHOL, V11, P158, DOI 10.1016/S1054-8807(02)00102-3; Li GR, 2002, J MOL CELL CARDIOL, V34, P1185, DOI 10.1006/jmcc.2002.2053; Lin XM, 2010, J MOL CELL CARDIOL, V48, P238, DOI 10.1016/j.yjmcc.2009.05.014; NELSON WL, 1991, CIRC RES, V68, P977, DOI 10.1161/01.RES.68.4.977; Ohara T, 2002, AM J PHYSIOL-HEART C, V283, pH1116, DOI 10.1152/ajpheart.00927.2001; Remme CA, 2009, BASIC RES CARDIOL, V104, P511, DOI 10.1007/s00395-009-0012-8; ROZANSKI GJ, 1984, CIRC RES, V55, P486, DOI 10.1161/01.RES.55.4.486; Sabir IN, 2007, PFLUG ARCH EUR J PHY, V454, P209, DOI 10.1007/s00424-007-0217-3; Sabir IN, 2008, PROG BIOPHYS MOL BIO, V98, P208, DOI 10.1016/j.pbiomolbio.2008.10.011; Schroeter A, 2010, J MOL CELL CARDIOL, V49, P16, DOI 10.1016/j.yjmcc.2010.04.004; Sepp R, 1996, HEART, V76, P412, DOI 10.1136/hrt.76.5.412; Shaw RM, 1997, CIRC RES, V81, P727; Sheikh SM, 2001, J PHYSIOL-LONDON, V535, P579, DOI 10.1111/j.1469-7793.2001.t01-1-00579.x; SMEETS JLRM, 1986, CIRC RES, V58, P96, DOI 10.1161/01.RES.58.1.96; SPACH MS, 1994, J CARDIOVASC ELECTR, V5, P182, DOI 10.1111/j.1540-8167.1994.tb01157.x; Sun DQ, 2001, P NATL ACAD SCI USA, V98, P9983, DOI 10.1073/pnas.171317998; Temple IP, 2013, HEART RHYTHM, V10, P297, DOI 10.1016/j.hrthm.2012.10.020; THOMAS GP, 1995, J PHARMACOL EXP THER, V274, P1379; Tse G, 2016, J ARRYTHM, V32, P75, DOI 10.1016/j.joa.2015.11.003; Tse G, 2015, IJC HEART VASC, V9, P75, DOI 10.1016/j.ijcha.2015.10.003; Tse G, 2016, BIOMED REP, V4, P313, DOI 10.3892/br.2016.577; Tse G, 2012, J PHYSIOL SCI, V62, P79, DOI 10.1007/s12576-011-0187-2; Verheule S, 2004, CIRC RES, V94, P1458, DOI 10.1161/01.RES.0000129579.59664.9d; WIENER N, 1946, Arch Inst Cardiol Mex, V16, P205	53	33	34	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0148858	10.1371/journal.pone.0148858	http://dx.doi.org/10.1371/journal.pone.0148858			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26872148	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000370054100065
J	Al-Tobasei, R; Paneru, B; Salem, M				Al-Tobasei, Rafet; Paneru, Bam; Salem, Mohamed			Genome-Wide Discovery of Long Non-Coding RNAs in Rainbow Trout	PLOS ONE			English	Article							INTEGRATIVE ANNOTATION; GENE-REGULATION; EXPRESSION; EVOLUTION; DATABASE; TRANSCRIPTION; REVEALS; POPULATIONS; REPRESSION; INSIGHTS	The ENCODE project revealed that similar to 70% of the human genome is transcribed. While only 1-2% of the RNAs encode for proteins, the rest are non-coding RNAs. Long non-coding RNAs (lncRNAs) form a diverse class of non-coding RNAs that are longer than 200nt. Emerging evidence indicates that lncRNAs play critical roles in various cellular processes including regulation of gene expression. LncRNAs show low levels of gene expression and sequence conservation, which make their computational identification in genomes difficult. In this study, more than two billion Illumina sequence reads were mapped to the genome reference using the TopHat and Cufflinks software. Transcripts shorter than 200nt, with more than 83-100 amino acids ORF, or with significant homologies to the NCBI nr-protein database were removed. In addition, a computational pipeline was used to filter the remaining transcripts based on a protein-coding-score test. Depending on the filtering stringency conditions, between 31,195 and 54,503 lncRNAs were identified, with only 421 matching known lncRNAs in other species. A digital gene expression atlas revealed 2,935 tissue-specific and 3,269 ubiquitously-expressed lncRNAs. This study annotates the lncRNA rainbow trout genome and provides a valuable resource for functional genomics research in salmonids.	[Al-Tobasei, Rafet; Salem, Mohamed] Middle Tennessee State Univ, Computat Sci Program, Murfreesboro, TN 37132 USA; [Paneru, Bam; Salem, Mohamed] Middle Tennessee State Univ, Dept Biol, Murfreesboro, TN 37132 USA; [Paneru, Bam; Salem, Mohamed] Middle Tennessee State Univ, Mol Biosci Program, Murfreesboro, TN 37132 USA	Middle Tennessee State University; Middle Tennessee State University; Middle Tennessee State University	Salem, M (corresponding author), Middle Tennessee State Univ, Computat Sci Program, Murfreesboro, TN 37132 USA.; Salem, M (corresponding author), Middle Tennessee State Univ, Dept Biol, Murfreesboro, TN 37132 USA.; Salem, M (corresponding author), Middle Tennessee State Univ, Mol Biosci Program, Murfreesboro, TN 37132 USA.	Mohamed.salem@mtsu.edu	Salem, Mohamed/AGB-2739-2022	Salem, Mohamed/0000-0003-2142-6716; Paneru, Bam/0000-0001-6589-8446; Al-Tobasei, Rafet/0000-0002-0578-0734	United States Department of Agriculture, National Institute of Food and Agriculture [2014-67015-21602]	United States Department of Agriculture, National Institute of Food and Agriculture(United States Department of Agriculture (USDA))	This study was supported by a competitive grant No. 2014-67015-21602 from the United States Department of Agriculture, National Institute of Food and Agriculture (MS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bass BL, 2002, ANNU REV BIOCHEM, V71, P817, DOI 10.1146/annurev.biochem.71.110601.135501; Beaulieu YB, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003078; Berthelot C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4657; Bu DC, 2012, NUCLEIC ACIDS RES, V40, pD210, DOI 10.1093/nar/gkr1175; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Carrieri C, 2012, NATURE, V491, P454, DOI 10.1038/nature11508; Chan PP, 2009, NUCLEIC ACIDS RES, V37, pD93, DOI 10.1093/nar/gkn787; Clark MB, 2013, ESSAYS BIOCHEM, V54, P1, DOI [10.1042/bse0540001, 10.1042/BSE0540001]; Davidson WS, 2012, MOL ECOL, V21, P219, DOI 10.1111/j.1365-294X.2011.05387.x; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Dougan SK, 2011, MOL CELL BIOL, V31, P1145, DOI 10.1128/MCB.00967-10; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Fox SE, 2014, MAR GENOM, V15, P13, DOI 10.1016/j.margen.2013.12.001; Giaquinto PC, 2008, BIOL RES, V41, P33, DOI [10.4067/S0716-97602008000100005, /S0716-97602008000100005]; Gibb EA, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-38; Ginger MR, 2006, P NATL ACAD SCI USA, V103, P5781, DOI 10.1073/pnas.0600745103; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Guttman M, 2012, NATURE, V482, P339, DOI 10.1038/nature10887; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Howe EA, 2011, BIOINFORMATICS, V27, P3209, DOI 10.1093/bioinformatics/btr490; Huarte M, 2010, CELL, V142, P409, DOI 10.1016/j.cell.2010.06.040; Hung T, 2011, NAT GENET, V43, P621, DOI 10.1038/ng.848; Jeon Y, 2011, CELL, V146, P119, DOI 10.1016/j.cell.2011.06.026; Kambara H, 2014, NUCLEIC ACIDS RES, V42, P10668, DOI 10.1093/nar/gku713; Kaushik K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083616; Kino T, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000568; Kong L, 2007, NUCLEIC ACIDS RES, V35, pW345, DOI 10.1093/nar/gkm391; Kotake Y, 2011, ONCOGENE, V30, P1956, DOI 10.1038/onc.2010.568; Kretz M, 2013, NATURE, V493, P231, DOI 10.1038/nature11661; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li L, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r40; Louro R, 2009, GENOMICS, V93, P291, DOI 10.1016/j.ygeno.2008.11.009; Luo M, 2013, CANCER LETT, V333, P213, DOI 10.1016/j.canlet.2013.01.033; Martianov I, 2007, NATURE, V445, P666, DOI 10.1038/nature05519; MCLAREN BA, 1947, FED PROC, V6, P413; Mercer TR, 2008, P NATL ACAD SCI USA, V105, P716, DOI 10.1073/pnas.0706729105; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Narum SR, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1246-5; Orom UA, 2010, CELL, V143, P46, DOI 10.1016/j.cell.2010.09.001; Pandey RR, 2008, MOL CELL, V32, P232, DOI 10.1016/j.molcel.2008.08.022; Papanastasiou AD, 2007, MOL IMMUNOL, V44, P1300, DOI 10.1016/j.molimm.2006.05.014; Patel M, 2006, AQUAT TOXICOL, V80, P362, DOI 10.1016/j.aquatox.2006.09.012; Pauli A, 2012, GENOME RES, V22, P577, DOI 10.1101/gr.133009.111; Petrov AI, 2015, NUCLEIC ACIDS RES, V43, pD123, DOI 10.1093/nar/gku991; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Prasanth KV, 2005, CELL, V123, P249, DOI 10.1016/j.cell.2005.08.033; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Quek XC, 2015, NUCLEIC ACIDS RES, V43, pD168, DOI 10.1093/nar/gku988; Ravasi T, 2006, GENOME RES, V16, P11, DOI 10.1101/gr.4200206; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Salem M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121778; Salem M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-564; Schmitz KM, 2010, GENE DEV, V24, P2264, DOI 10.1101/gad.590910; Speare DJ, 1998, CONTEMP TOP LAB ANIM, V37, P55; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Tripathi V, 2012, MOL BIOL CELL, V23, P3694, DOI 10.1091/mbc.E12-03-0206; Tripathi V, 2010, MOL CELL, V39, P925, DOI 10.1016/j.molcel.2010.08.011; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; Ulitsky I, 2013, CELL, V154, P26, DOI 10.1016/j.cell.2013.06.020; Van Peer G, 2014, DATABASE-OXFORD, DOI 10.1093/database/bau080; Villegas VE, 2015, INT J MOL SCI, V16, P3251, DOI 10.3390/ijms16023251; Welsh PG, 2008, ECOTOX ENVIRON SAFE, V69, P199, DOI 10.1016/j.ecoenv.2007.04.003; Wen YD, 2000, P NATL ACAD SCI USA, V97, P7202, DOI 10.1073/pnas.97.13.7202; Williams DE, 2012, COMP BIOCHEM PHYS C, V155, P121, DOI 10.1016/j.cbpc.2011.05.013; Wuyts J, 2002, NUCLEIC ACIDS RES, V30, P183, DOI 10.1093/nar/30.1.183; Xie CY, 2014, NUCLEIC ACIDS RES, V42, pD98, DOI 10.1093/nar/gkt1222; Yang Z, 2011, ANN SURG ONCOL, V18, P1243, DOI 10.1245/s10434-011-1581-y; Yap KL, 2010, MOL CELL, V38, P662, DOI 10.1016/j.molcel.2010.03.021; Yin QF, 2012, MOL CELL, V48, P219, DOI 10.1016/j.molcel.2012.07.033; Yoon JH, 2013, J MOL BIOL, V425, P3723, DOI 10.1016/j.jmb.2012.11.024; Zhang KS, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-845; Zhu QH, 2012, GENES-BASEL, V3, P176, DOI 10.3390/genes3010176; Zong XY, 2011, RNA BIOL, V8, P968, DOI 10.4161/rna.8.6.17606	76	62	63	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0148940	10.1371/journal.pone.0148940	http://dx.doi.org/10.1371/journal.pone.0148940			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3DG	26895175	Green Published, gold			2022-12-26	WOS:000371223400027
J	Ayuob, N; ElBeshbeishy, R				Ayuob, Nasra; ElBeshbeishy, Rana			Impact of an Energy Drink on the Structure of Stomach and Pancreas of Albino Rat: Can Omega-3 Provide a Protection?	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; BETA-CELL FUNCTION; INSULIN-RESISTANCE; CAFFEINE; GLUCOSE; FISH	Background and Objectives A controversy developed between the benefits of energy drinks (EDs) versus the possible health threats since its revolution. Lack of information was a call to assess the effect of chronic consumption of Power Horse (PH) as one of the EDs, on the structure of pancreas and fundic mucosa of stomach in rats, and possible protective role of Omega-3. Materials and Methods Thirty two adult male albino rats were divided equally into 4 groups; control received group which only received a standard diet, Omega-3 group, PH group which given PH and PH plus Omega-3 group received both PH plus Omega-3 for 4 weeks. Biochemical assessment of blood glucose, serum insulin, gastrin, tumor necrosis factor alpha (TNF-alpha) and inducible nitric oxide synthetase (iNOS) was performed. The antioxidant activity and histopathological examination of both pancreatic tissue and fundic mucosa of stomach were assessed. Results Administration of PH significantly increased serum insulin and glucose levels while it significantly reduced serum gastrin level compared to control. PH also caused oxidants/antioxidants imbalance in both pancreas and fundic mucosa. The latter revealed degenerative changes and increased apoptosis which was evident by increased caspase-3 immunoexpression. Pancreas exhibited signs of beta-cells overstimulation. Fundic mucosa showed reduced number of parietal cells, gastrin hormone expression compared to control group. Omega-3 administration could alleviate, to some extent, these changes. It significantly decreased TNF-alpha, iNOS and reduced glutathione (GSH) as well as significantly increasing superoxide dismutase (SOD) and glutathione peroxidase (GPx) activities compared to the group which received PH alone. Conclusion Power Horse intake significantly injures islet cells, pancreatic acini as well as the glandular cells of the fundic mucosa. Omega-3 decreases these detrimental effects mostly through its antioxidant and anti-inflammatory action.	[Ayuob, Nasra; ElBeshbeishy, Rana] King Abdulaziz Univ, Fac Med, Dept Anat, Jeddah 21413, Saudi Arabia; [Ayuob, Nasra] Mansoura Univ, Fac Med, Dept Histol, Mansoura, Egypt; [ElBeshbeishy, Rana] Ain Shams Univ, Fac Med, Dept Anat, Cairo, Egypt	King Abdulaziz University; Egyptian Knowledge Bank (EKB); Mansoura University; Egyptian Knowledge Bank (EKB); Ain Shams University	Ayuob, N (corresponding author), King Abdulaziz Univ, Fac Med, Dept Anat, Jeddah 21413, Saudi Arabia.; Ayuob, N (corresponding author), Mansoura Univ, Fac Med, Dept Histol, Mansoura, Egypt.	nasraayuob@gmail.com	Ayuob, Nasra/D-2504-2012	Ayuob, Nasra/0000-0002-3369-2897	Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah [140-006-D1434]; DSR	Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah; DSR	This work was funded by the Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah, under grant No. (140-006-D1434). The authors, therefore, acknowledge with thanks DSR technical and financial support.	Abd El-Haleem MR, 2013, EGYPTIAN J HISTOLOGY, V36, P60; Afifi N.M., 2012, EGYPT J HISTOL, V35, P458, DOI [10.1097/01.ehx.0000418062.59636.5b, DOI 10.1097/01.EHX.0000418062.59636.5B]; Akande I. S., 2011, Annual Review & Research in Biology, V1, P45; Amer MG., 2013, EGYPT J HISTOL, V36, P13, DOI [10.1097/01.EHX.0000425554.35720.27, DOI 10.1097/01.EHX.0000425554.35720.27]; Angerer P, 2000, CURR OPIN LIPIDOL, V11, P57, DOI 10.1097/00041433-200002000-00009; [Anonymous], 2001, 13 WEEK OR GAV UNPUB; Attila S, 2011, NUTRITION, V27, P316, DOI 10.1016/j.nut.2010.02.008; Bancroft JD, 2002, J NEUROPATH EXP NEUR, V5th; Belluzzi A, 2002, P NUTR SOC, V61, P391, DOI 10.1079/PNS2002171; Boekema PJ, 1999, SCAND J GASTROENTERO, V34, P35, DOI 10.1080/003655299750025525; Bouckenooghe T, 2006, CURR OPIN CLIN NUTR, V9, P728, DOI 10.1097/01.mco.0000247469.26414.55; Bronstein AC, 2008, CLIN TOXICOL, V46, P927, DOI 10.1080/15563650802559632; Calder PC, 2009, BIOCHIMIE, V91, P791, DOI 10.1016/j.biochi.2009.01.008; Chang AM, 2006, J CLIN ENDOCR METAB, V91, P3303, DOI 10.1210/jc.2006-0913; Chepkova AN, 2002, EUR J NEUROSCI, V16, P1523, DOI 10.1046/j.1460-9568.2002.02223.x; Clauson KA, 2008, J AM PHARM ASSOC, V48, pE55, DOI 10.1331/JAPhA.2008.07055; CRISAN M, 2013, ANN OF RSCB, V18, P118; Delarue J, 2004, REPROD NUTR DEV, V44, P289, DOI 10.1051/rnd:2004033; Dias TR, 2015, TOXICOLOGY, V328, P12, DOI 10.1016/j.tox.2014.12.003; Dworzanski Wojciech, 2009, Pol Merkur Lekarski, V27, P357; Ebuehi O A T, 2011, Nig Q J Hosp Med, V21, P29; Fetterman JW, 2009, AM J HEALTH-SYST PH, V66, P1169, DOI 10.2146/ajhp080411; Fredholm BB, 1999, PHARMACOL REV, V51, P83; Hamada E, 1997, BBA-MOL CELL RES, V1356, P198, DOI 10.1016/S0167-4889(96)00177-2; Heneman K, ANR PUBLICATION, V8265; HOLLANDER D, 1991, J CLIN GASTROENTEROL, V13, pS72, DOI 10.1097/00004836-199112001-00012; Kangwan N, 2014, CURR OPIN PHARMACOL, V19, P17, DOI 10.1016/j.coph.2014.06.003; Khayyat L., 2012, The Journal of American Science, V8, P688; Khayyat LI, 2014, J ENVIRON BIOL, V35, P883; Knip M, 2005, DIABETES, V54, pS125, DOI 10.2337/diabetes.54.suppl_2.S125; KOITER TR, 1995, PHYSIOL BEHAV, V57, P717, DOI 10.1016/0031-9384(94)00290-8; Kolnes AJ, 2010, ACTA PHYSIOL, V200, P65, DOI 10.1111/j.1748-1716.2010.02103.x; LINN T, 1989, DIABETES, V38, P1402, DOI 10.2337/diabetes.38.11.1402; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Milon H., 1988, COFFEE, V3, P81; Miyazaki R., 2010, AGING MED, V35, P26, DOI [10.3793/jaam.7.26, DOI 10.3793/JAAM.7.26]; Mubarak R., 2012, The Journal of American Science, V8, P366; Nawrot P, 2003, FOOD ADDIT CONTAM A, V20, P1, DOI 10.1080/0265203021000007840; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Paget GE., 1964, EVALUATION DRUG ACT, P161; Ramos-Vara JA, 2008, J VET DIAGN INVEST, V20, P393, DOI 10.1177/104063870802000401; Sadowska J, 2012, ACTA SCI POLON-TECHN, V11, P311; SAYED SS, 2013, EGYPTIAN J HISTOLOGY, V36, P253, DOI DOI 10.1097/01.EHX.0000426051.01947.cb; Schubert ML, 2009, CURR OPIN GASTROEN, V25, P529, DOI 10.1097/MOG.0b013e328331b62a; Soliman NBE., 2010, EGYPT J HISTOL, V33, P620; Spite M, 2013, P NUTR SOC, V72, P441, DOI 10.1017/S0029665113003030; Starling S., 2008, ENERGY DRINKS SAFETY; Suresh Y, 2003, NUTRITION, V19, P213, DOI 10.1016/S0899-9007(02)00855-9; Thomson B, 2010, RISK PROFILE CAFFEIN; Wall R, 2010, NUTR REV, V68, P280, DOI 10.1111/j.1753-4887.2010.00287.x; Ward OP, 2005, PROCESS BIOCHEM, V40, P3627, DOI 10.1016/j.procbio.2005.02.020; Yu JH, 2009, ANN NY ACAD SCI, V1171, P359, DOI 10.1111/j.1749-6632.2009.04703.x; Zhou SS, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-746	53	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0149191	10.1371/journal.pone.0149191	http://dx.doi.org/10.1371/journal.pone.0149191			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3DG	26894845	Green Published, Green Submitted, gold			2022-12-26	WOS:000371223400035
J	Delwig, A; Larsen, DD; Yasumura, D; Yang, CF; Shah, NM; Copenhagen, DR				Delwig, Anton; Larsen, DeLaine D.; Yasumura, Douglas; Yang, Cindy F.; Shah, Nirao M.; Copenhagen, David R.			Retinofugal Projections from Melanopsin-Expressing Retinal Ganglion Cells Revealed by Intraocular Injections of Cre-Dependent Virus	PLOS ONE			English	Article							NEURONS; LIGHT	To understand visual functions mediated by intrinsically photosensitive melanopsin-expressing retinal ganglion cells (mRGCs), it is important to elucidate axonal projections from these cells into the brain. Initial studies reported that melanopsin is expressed only in retinal ganglion cells within the eye. However, recent studies in Opn4-Cre mice revealed Cre-mediated marker expression in multiple brain areas. These discoveries complicate the use of melanopsin-driven genetic labeling techniques to identify retinofugal projections specifically from mRGCs. To restrict labeling to mRGCs, we developed a recombinant adenoassociated virus (AAV) carrying a Cre-dependent reporter (human placental alkaline phosphatase) that was injected into the vitreous of Opn4-Cre mouse eyes. The labeling observed in the brain of these mice was necessarily restricted specifically to retinofugal projections from mRGCs in the injected eye. We found that mRGCs innervate multiple nuclei in the basal forebrain, hypothalamus, amygdala, thalamus and midbrain. Midline structures tended to be bilaterally innervated, whereas the lateral structures received mostly contralateral innervation. As validation of our approach, we found projection patterns largely corresponded with previously published results; however, we have also identified a few novel targets. Our discovery of projections to the central amygdala suggests a possible direct neural pathway for aversive responses to light in neonates. In addition, projections to the accessory optic system suggest that mRGCs play a direct role in visual tracking, responses that were previously attributed to other classes of retinal ganglion cells. Moreover, projections to the zona incerta raise the possibility that mRGCs could regulate visceral and sensory functions. However, additional studies are needed to investigate the actual photosensitivity of mRGCs that project to the different brain areas. Also, there is a concern of "overlabeling" with very sensitive reporters that uncover low levels of expression. Light-evoked signaling from these cells must be shown to be of sufficient sensitivity to elicit physiologically relevant responses.	[Delwig, Anton; Larsen, DeLaine D.; Yasumura, Douglas; Copenhagen, David R.] Univ Calif San Francisco, Dept Ophthalmol, San Francisco, CA USA; [Yang, Cindy F.; Shah, Nirao M.] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; [Copenhagen, David R.] Univ Calif San Francisco, Dept Physiol, Box 0444, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Copenhagen, DR (corresponding author), Univ Calif San Francisco, Dept Ophthalmol, San Francisco, CA USA.; Copenhagen, DR (corresponding author), Univ Calif San Francisco, Dept Physiol, Box 0444, San Francisco, CA USA.	cope@phy.ucsf.edu		Larsen, DeLaine/0000-0002-9689-8454; Yang, Cindy/0000-0001-6144-4658	National Institute of Neurological Disease and Stroke [R01NS049488]; NIH National Institute of Neurological Disease and Stroke [R01NS083872]; NIH National Eye Institute [R01EY02317, R01EY01869, T32EY007120]; NIH [P30EY002162]; National Eye Institute, NIH; Benign Essential Blepharospasm Research Foundation; That Man May See, UCSF; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [R01EY002317, R01EY023179, R01EY001869, T32EY007120, P30EY002162] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS049488, R01NS083872] Funding Source: NIH RePORTER	National Institute of Neurological Disease and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH National Institute of Neurological Disease and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Eye Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Benign Essential Blepharospasm Research Foundation; That Man May See, UCSF; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by R01NS049488 (NMS) National Institute of Neurological Disease and Stroke, NIH R01NS083872 (NMS) National Institute of Neurological Disease and Stroke, NIH R01EY02317 (DRC) National Eye Institute, NIH R01EY01869 (DRC) National Eye Institute, NIH T32EY007120 (AD) National Eye Institute, NIH P30EY002162 (Matthew LaVail, PI), Core Grant, National Eye Institute, NIH, Benign Essential Blepharospasm Research Foundation (DRC), www.blepharospasm.org/, That Man May See, UCSF (DRC), thatmanmaysee.org/, and Research to Prevent Blindness (DRC and Dept. of Ophthalmology, UCSF), www.rpbusa.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown TM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000558; Delwig A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043787; Dhande OS, 2013, J NEUROSCI, V33, P17797, DOI 10.1523/JNEUROSCI.2778-13.2013; Do MTH, 2010, PHYSIOL REV, V90, P1547, DOI 10.1152/physrev.00013.2010; Ecker JL, 2010, NEURON, V67, P49, DOI 10.1016/j.neuron.2010.05.023; Franklin K.B.J., 2013, PAXINOS FRANKLINS MO; Giolli RA, 2006, PROG BRAIN RES, V151, P407, DOI 10.1016/S0079-6123(05)51013-6; Gooley JJ, 2003, J NEUROSCI, V23, P7093, DOI 10.1523/JNEUROSCI.23-18-07093.2003; Hannibal J, 2004, CELL TISSUE RES, V316, P99, DOI 10.1007/s00441-004-0858-x; Hattar S, 2006, J COMP NEUROL, V497, P326, DOI 10.1002/cne.20970; Hellstrom M, 2009, GENE THER, V16, P521, DOI 10.1038/gt.2008.178; Lasky RE, 2009, PEDIATRICS, V123, P540, DOI 10.1542/peds.2007-3418; Ma TP, 1996, NEUROREPORT, V7, P2713, DOI 10.1097/00001756-199611040-00061; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Masri R, 2009, J NEUROPHYSIOL, V102, P181, DOI 10.1152/jn.00152.2009; Mitrofanis J, 2005, NEUROSCIENCE, V130, P1, DOI 10.1016/j.neuroscience.2004.08.017; Noseda R, 2011, J NEUROSCI, V13, P239, DOI [10.1038/nn.2475, DOI 10.1038/NN.2475]; Noseda R, 2010, NAT NEUROSCI, V13, P239, DOI 10.1038/nn.2475; Schmidt TM, 2014, NEURON, V82, P781, DOI 10.1016/j.neuron.2014.03.022; Shah NM, 2004, NEURON, V43, P313, DOI 10.1016/j.neuron.2004.07.008; Shogan M G, 1993, Neonatal Netw, V12, P7; WONGRILEY MTT, 1984, J COMP NEUROL, V222, P18, DOI 10.1002/cne.902220103; Xue T, 2011, NATURE, V479, P67, DOI 10.1038/nature10567; Yang CF, 2013, CELL, V153, P896, DOI 10.1016/j.cell.2013.04.017	24	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0149501	10.1371/journal.pone.0149501	http://dx.doi.org/10.1371/journal.pone.0149501			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3DG	26895233	gold, Green Published			2022-12-26	WOS:000371223400060
J	Engel, AC; Herbst, F; Kerres, A; Galle, JN; Hegemann, JH				Engel, Astrid C.; Herbst, Frauke; Kerres, Anne; Galle, Jan N.; Hegemann, Johannes H.			The Type III Secretion System-Related CPn0809 from Chlamydia pneumoniae	PLOS ONE			English	Article							PROTEIN; MEMBRANE; IDENTIFICATION; TRANSLOCATORS; LOCALIZATION; PREDICTION; INFECTION; REGION; CELLS; MODEL	Chlamydia pneumoniae is an intracellular Gram-negative bacterium that possesses a type III secretion system (T3SS), which enables the pathogen to deliver, in a single step, effector proteins for modulation of host-cell functions into the human host cell cytosol to establish a unique intracellular niche for replication. The translocon proteins located at the top of the T3SS needle filament are essential for its function, as they form pores in the host-cell membrane. Interestingly, unlike other Gram-negative bacteria, C. pneumoniae has two putative translocon operons, named LcrH_1 and LcrH_2. However, little is known about chlamydial translocon proteins. In this study, we analyzed CPn0809, one of the putative hydrophobic translocators encoded by the LcrH_1 operon, and identified an 'SseC-like family' domain characteristic of T3S translocators. Using bright-field and confocal microscopy, we found that CPn0809 is associated with EBs during early and very late phases of a C. pneumoniae infection. Furthermore, CPn0809 forms oligomers, and interacts with the T3SS chaperone LcrH_1, via its N-terminal segment. Moreover, expression of full-length CPn0809 in the heterologous host Escherichia coli causes a grave cytotoxic effect that leads to cell death. Taken together, our data indicate that CPn0809 likely represents one of the translocon proteins of the C. pneumoniae T3SS, and possibly plays a role in the translocation of effector proteins in the early stages of infection.	[Engel, Astrid C.; Herbst, Frauke; Kerres, Anne; Galle, Jan N.; Hegemann, Johannes H.] Univ Dusseldorf, Lehrstuhl Funkt Genomforsch Mikroorganismen, Dusseldorf, Germany	Heinrich Heine University Dusseldorf	Hegemann, JH (corresponding author), Univ Dusseldorf, Lehrstuhl Funkt Genomforsch Mikroorganismen, Dusseldorf, Germany.	Johannes.Hegemann@hhu.de		Galle, Jan Niklas/0000-0002-4433-0779	ERA-NET PathoGenoMics [0313935D, 0315442B]	ERA-NET PathoGenoMics	This work was supported by grants ERA-NET PathoGenoMics (ECIBUG; grant Nr. 0313935D; Pathomics, 362 grant Nr. 0315442B) to JHH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbdelRahman YM, 2005, FEMS MICROBIOL REV, V29, P949, DOI 10.1016/j.femsre.2005.03.002; Aistleitner K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055010; Allmond LR, 2003, INFECT IMMUN, V71, P2230, DOI 10.1128/IAI.71.4.2230-2233.2003; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Beeckman DSA, 2010, CURR ISSUES MOL BIOL, V12, P17; Betts-Hampikian HJ, 2010, FRONT MICROBIOL, V1, DOI 10.3389/fmicb.2010.00114; Birket SE, 2007, BIOCHEMISTRY-US, V46, P8128, DOI 10.1021/bi700099c; Blasi F, 2009, CLIN MICROBIOL INFEC, V15, P29, DOI 10.1111/j.1469-0691.2008.02130.x; Bulir DC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099315; Burillo A, 2010, INFECT DIS CLIN N AM, V24, P61, DOI 10.1016/j.idc.2009.10.002; Burkinshaw BJ, 2014, BBA-MOL CELL RES, V1843, P1649, DOI 10.1016/j.bbamcr.2014.01.035; Chaturvedi AK, 2010, CANCER EPIDEM BIOMAR, V19, P1498, DOI 10.1158/1055-9965.EPI-09-1261; Cornelis GR, 2006, NAT REV MICROBIOL, V4, P811, DOI 10.1038/nrmicro1526; Dasanayake D, 2011, MOL MICROBIOL, V81, P734, DOI 10.1111/j.1365-2958.2011.07727.x; Delorenzi M, 2002, BIOINFORMATICS, V18, P617, DOI 10.1093/bioinformatics/18.4.617; Dersch P, 1999, EMBO J, V18, P1199, DOI 10.1093/emboj/18.5.1199; Entian KD, 1999, MOL GEN GENET, V262, P683, DOI 10.1007/PL00013817; Fechtner T, 2013, J BACTERIOL, V195, P5323, DOI 10.1128/JB.00780-13; Fields KA, 2005, J BACTERIOL, V187, P6466, DOI 10.1128/JB.187.18.6466-6478.2005; Hammerschlag MR, 2000, EUR RESPIR J, V16, P1001, DOI 10.1183/09031936.00.16510010; Harlow E, 1999, USING ANTIBODIES POR; Herrmann M, 2006, RES MICROBIOL, V157, P513, DOI 10.1016/j.resmic.2005.12.005; Hume PJ, 2003, MOL MICROBIOL, V49, P425, DOI 10.1046/j.1365-2958.2003.03559.x; Hybiske K, 2007, P NATL ACAD SCI USA, V104, P11430, DOI 10.1073/pnas.0703218104; Jantos CA, 1997, J CLIN MICROBIOL, V35, P620, DOI 10.1128/JCM.35.3.620-623.1997; Kall L, 2007, NUCLEIC ACIDS RES, V35, pW429, DOI 10.1093/nar/gkm256; KOEHLER JE, 1992, MOL MICROBIOL, V6, P1087; Lugert R, 2004, MED MICROBIOL IMMUN, V193, P163, DOI 10.1007/s00430-003-0206-x; LUNDEMOSE AG, 1990, INFECT IMMUN, V58, P2478, DOI 10.1128/IAI.58.8.2478-2486.1990; Luo JH, 2007, MICROB PATHOGENESIS, V42, P111, DOI 10.1016/j.micpath.2006.11.006; Maurer AP, 2007, PLOS PATHOG, V3, P752, DOI 10.1371/journal.ppat.0030083; Markkula E, 2013, MICROB PATHOGENESIS, V54, P46, DOI 10.1016/j.micpath.2012.09.004; Mattei PJ, 2011, FEBS J, V278, P414, DOI 10.1111/j.1742-4658.2010.07974.x; MENARD R, 1994, CELL, V79, P515, DOI 10.1016/0092-8674(94)90260-7; Molleken K, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003325; Molleken K, 2010, MOL MICROBIOL, V78, P1004, DOI 10.1111/j.1365-2958.2010.07386.x; Moller S, 2001, BIOINFORMATICS, V17, P646, DOI 10.1093/bioinformatics/17.7.646; Mueller CA, 2008, MOL MICROBIOL, V68, P1085, DOI 10.1111/j.1365-2958.2008.06237.x; Nans A, 2014, CELL MICROBIOL; Neyt C, 1999, MOL MICROBIOL, V31, P143, DOI 10.1046/j.1365-2958.1999.01154.x; Ouellette SP, 2005, J BACTERIOL, V187, P7853, DOI 10.1128/JB.187.22.7853-7856.2005; Peters J, 2007, TRENDS MICROBIOL, V15, P241, DOI 10.1016/j.tim.2007.04.005; ROBLIN PM, 1992, J CLIN MICROBIOL, V30, P1968, DOI 10.1128/JCM.30.8.1968-1971.1992; Romano FB, 2011, BIOCHEMISTRY-US, V50, P7117, DOI 10.1021/bi200905x; Sambrook J, 1989, MOL CLONING LAB MANU, V2nd; Scidmore MA, 2011, MICROBES INFECT, V13, P527, DOI 10.1016/j.micinf.2011.02.001; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Subtil A, 2000, MICROBES INFECT, V2, P367, DOI 10.1016/S1286-4579(00)00335-X; Wilkat M, 2014, HISTOCHEM CELL BIOL, V142, P171, DOI 10.1007/s00418-014-1189-y; Wolf K, 2000, INFECT IMMUN, V68, P2379, DOI 10.1128/IAI.68.4.2379-2385.2000; Wuppermann FN, 2001, J INFECT DIS, V184, P181, DOI 10.1086/322009; Wuppermann FN, 2008, J BACTERIOL, V190, P3757, DOI 10.1128/JB.01638-07	53	3	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0148509	10.1371/journal.pone.0148509	http://dx.doi.org/10.1371/journal.pone.0148509			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3DG	26895250	Green Published, gold			2022-12-26	WOS:000371223400017
J	Buemo, CP; Gambini, A; Moro, LN; Hiriart, MI; Fernandez-Martin, R; Collas, P; Salamone, DF				Paola Buemo, Carla; Gambini, Andres; Natalia Moro, Lucia; Ines Hiriart, Maria; Fernandez-Martin, Rafael; Collas, Philippe; Felipe Salamone, Daniel			Embryo Aggregation in Pig Improves Cloning Efficiency and Embryo Quality	PLOS ONE			English	Article							IN-VITRO DEVELOPMENT; NUCLEAR TRANSFER EMBRYOS; GENE-EXPRESSION; CLONED EMBRYOS; EPIGENETIC REGULATION; CELL NUMBER; STAGE; APOPTOSIS; TROPHECTODERM; BODIES	In this study, we analyzed the effects of the cloned embryo aggregation on in vitro embryo development and embryo quality by measuring blastocyst diameter and cell number, DNA fragmentation levels and the expression of genes associated with pluripotency, apoptosis, trophoblast and DNA methylation in the porcine. Zona-free reconstructed cloned embryos were cultured in the well of the well system, placing one (1x non aggregated group) or three (3x group) embryos per microwell. Our results showed that aggregation of three embryos increased blastocyst formation rate and blastocyst diameter of cloned pig embryos. DNA fragmentation levels in 3x aggregated cloned blastocysts were significantly decreased compared to 1x blastocysts. Levels of Oct4, Klf4, Igf2, Bax and Dnmt 1 transcripts were significantly higher in aggregated embryos, whereas Nanog levels were not affected. Transcripts of Cdx2 and Bcl-xl were essentially non-detectable. Our study suggests that embryo aggregation in the porcine may be beneficial for cloned embryo development and embryo quality, through a reduction in apoptotic levels and an improvement in cell reprogramming.	[Paola Buemo, Carla; Gambini, Andres; Natalia Moro, Lucia; Ines Hiriart, Maria; Fernandez-Martin, Rafael; Felipe Salamone, Daniel] Univ Buenos Aires, Fac Agr, Lab Anim Biotechnol, Buenos Aires, DF, Argentina; [Paola Buemo, Carla; Gambini, Andres; Natalia Moro, Lucia; Ines Hiriart, Maria; Fernandez-Martin, Rafael; Felipe Salamone, Daniel] Natl Inst Sci & Technol Res, Buenos Aires, DF, Argentina; [Collas, Philippe] Univ Oslo, Inst Basic Med Sci, Fac Med, Dept Mol Med, Oslo, Norway; [Collas, Philippe] Norwegian Ctr Stem Cell Res, Oslo, Norway	University of Buenos Aires; University of Oslo	Salamone, DF (corresponding author), Univ Buenos Aires, Fac Agr, Lab Anim Biotechnol, Buenos Aires, DF, Argentina.; Salamone, DF (corresponding author), Natl Inst Sci & Technol Res, Buenos Aires, DF, Argentina.	salamone@agro.uba.ar	Salamone, Daniel F/G-1096-2019; Gambini, Andres/H-9119-2019	Salamone, Daniel F/0000-0003-0858-0313; Gambini, Andres/0000-0002-3652-2068; Fernandez-Martin, Rafael/0000-0002-4838-407X				Akagi S, 2011, J REPROD DEVELOP, V57, P500, DOI 10.1262/jrd.10-140A; Aston KI, 2010, CELL REPROGRAM, V12, P23, DOI 10.1089/cell.2009.0042; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Balbach ST, 2010, DEV BIOL, V343, P71, DOI 10.1016/j.ydbio.2010.04.012; Bang JI, 2015, THERIOGENOLOGY, V84, P509, DOI 10.1016/j.theriogenology.2015.04.008; Bestor TH, 2000, HUM MOL GENET, V9, P2395, DOI 10.1093/hmg/9.16.2395; Betts DH, 2001, THERIOGENOLOGY, V55, P171, DOI 10.1016/S0093-691X(00)00453-2; Beyhan Z, 2007, MOL REPROD DEV, V74, P18, DOI 10.1002/mrd.20618; Boiani M, 2003, EMBO J, V22, P5304, DOI 10.1093/emboj/cdg507; Bordignon V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064613; Brison DR, 1997, BIOL REPROD, V56, P1088, DOI 10.1095/biolreprod56.5.1088; Burgstaller JP, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-141; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Eckardt S, 2004, ANIM REPROD SCI, V82-3, P97, DOI 10.1016/j.anireprosci.2004.04.017; Fabian D, 2005, THERIOGENOLOGY, V64, P221, DOI 10.1016/j.theriogenology.2004.11.022; Gambini A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110998; Gambini A, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.098855; Gao Y, 2011, EPIGENETICS-US, V6, P1149, DOI 10.4161/epi.6.9.16954; Golding MC, 2011, MOL REPROD DEV, V78, P306, DOI 10.1002/mrd.21306; Haimovich G, 2013, CELL, V153, P1000, DOI 10.1016/j.cell.2013.05.012; Hao YH, 2003, BIOL REPROD, V69, P501, DOI 10.1095/biolreprod.103.016170; Hardy K, 1997, MOL HUM REPROD, V3, P919, DOI 10.1093/molehr/3.10.919; Hardy K, 2002, J ENDOCRINOL, V172, P221, DOI 10.1677/joe.0.1720221; Huan YJ, 2013, J REPROD DEVELOP, V59, P442, DOI 10.1262/jrd.2013-026; Hyun S, 2003, BIOL REPROD, V69, P1060, DOI 10.1095/biolreprod.102.014886; Jeong YI, 2013, ASIAN AUSTRAL J ANIM, V26, P1680, DOI 10.5713/ajas.2013.13029; Jones PL, 1999, SEMIN CANCER BIOL, V9, P339, DOI 10.1006/scbi.1999.0134; Ju SQ, 2010, J ASSIST REPROD GEN, V27, P49, DOI 10.1007/s10815-009-9378-7; Kamjoo M, 2002, MOL REPROD DEV, V61, P67, DOI 10.1002/mrd.1132; Kurosaka S, 2007, CLONING STEM CELLS, V9, P630, DOI 10.1089/clo.2007.0015; Lee SG, 2007, MOL REPROD DEV, V74, P1436, DOI 10.1002/mrd.20728; LEONHARDT H, 1992, CELL, V71, P865, DOI 10.1016/0092-8674(92)90561-P; Meyer S, 2004, CRIT REV BIOCHEM MOL, V39, P197, DOI 10.1080/10409230490513991; Misica-Turner PA, 2007, BIOL REPROD, V76, P268, DOI 10.1095/biolreprod.106.050922; Moro LN, 2015, REPRODUCTION, V150, P1, DOI 10.1530/REP-15-0048; Nagashima H, 2003, THERIOGENOLOGY, V59, P95, DOI 10.1016/S0093-691X(02)01261-X; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Park SK, 2014, J VET SCI, V15, P73, DOI 10.4142/jvs.2014.15.1.73; Parker R, 2004, NAT STRUCT MOL BIOL, V11, P121, DOI 10.1038/nsmb724; Parker R, 2007, MOL CELL, V25, P635, DOI 10.1016/j.molcel.2007.02.011; Pauley KM, 2006, EMBO REP, V7, P904, DOI 10.1038/sj.embor.7400783; Polejaeva IA, 2000, NATURE, V407, P86, DOI 10.1038/35024082; Prather RS, 2007, ADV EXP MED BIOL, V591, P1; Ribeiro ED, 2009, CLONING STEM CELLS, V11, P377, DOI 10.1089/clo.2009.0022; Siriboon C, 2014, REPROD FERT DEVELOP, V26, P395, DOI 10.1071/RD12243; Strumpf D, 2005, DEVELOPMENT, V132, P2093, DOI 10.1242/dev.01801; Tamada H, 2004, CYTOGENET GENOME RES, V105, P285, DOI 10.1159/000078200; Tang PC, 2000, ZYGOTE, V8, P235, DOI 10.1017/S0967199400001039; Terashita Y, 2011, REPROD DOMEST ANIM, V46, P189, DOI 10.1111/j.1439-0531.2010.01614.x; Vajta G, 2005, REPROD FERT DEVELOP, V17, P97, DOI 10.1071/RD04116; Vajta G, 2000, MOL REPROD DEV, V55, P256, DOI 10.1002/(SICI)1098-2795(200003)55:3&lt;256::AID-MRD3&gt;3.0.CO;2-7; Yoon SW, 2009, REPROD FERT DEVELOP, V21, P210, DOI 10.1071/RDv21n1Ab225; Zhao JG, 2010, CELL TISSUE RES, V341, P13, DOI 10.1007/s00441-010-1000-x; Zhou WL, 2008, MOL REPROD DEV, V75, P1281, DOI 10.1002/mrd.20875	54	22	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0146390	10.1371/journal.pone.0146390	http://dx.doi.org/10.1371/journal.pone.0146390			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3DG	26894831	Green Published, gold, Green Submitted			2022-12-26	WOS:000371223400002
J	Gao, HH; Zhai, YF; Wang, WB; Chen, H; Zhou, XH; Zhuang, QY; Yu, Y; Li, RM				Gao, Huanhuan; Zhai, Yifan; Wang, Wenbo; Chen, Hao; Zhou, Xianhong; Zhuang, Qianying; Yu, Yi; Li, Rumei			Transcriptome Analysis and Discovery of Genes Relevant to Development in Bradysia odoriphaga at Three Developmental Stages	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; DIPTERA; EXPRESSION; INSECT; GENOME; FLY; SILKWORM; PLATFORM; BEETLE; LARVAE	Bradysia odoriphaga (Diptera: Sciaridae) is the most important pest of Chinese chive (Allium tuberosum) in Asia; however, the molecular genetics are poorly understood. To explore the molecular biological mechanism of development, Illumina sequencing and de novo assembly were performed in the third-instar, fourth-instar, and pupal B. odoriphaga. The study resulted in 16.2 Gb of clean data and 47,578 unigenes (>= 125bp) contained in 7,632,430contigs, 46.21% of which were annotated from non-redundant protein (NR), Gene Ontology (GO), Clusters of Orthologous Groups (COG), Eukaryotic Orthologous Groups (KOG), and Kyoto Encyclopedia of Genes and Genomes (KEGG) databases. It was found that 19.67% of unigenes matched the homologous species mainly, including Aedes aegypti, Culex quinquefasciatus, Ceratitis capitata, and Anopheles gambiae. According to differentially expressed gene (DEG) analysis, 143, 490, and 309 DEGs were annotated as involved in the developmental process in the GO database respectively, in the comparisons of third-instar and fourth-instar larvae, third-instar larvae and pupae, and fourth-instar larvae and pupae. Twenty-five genes were closely related to these processes, including developmental process, reproduction process, and reproductive organs development and programmed cell death (PCD). The information of unigenes assembled in B. odoriphaga through transcriptome and DEG analyses could provide a detailed genetic basis and regulated information for elaborating the developmental mechanism from the larval, pre-pupal to pupal stages of B. odoriphaga.	[Gao, Huanhuan; Zhai, Yifan; Chen, Hao; Zhou, Xianhong; Zhuang, Qianying; Yu, Yi; Li, Rumei] Shandong Acad Agr Sci, Inst Plant Protect, Jinan, Peoples R China; [Wang, Wenbo] Shandong Acad Agr Sci, Inst Qual Stand & Testing Technol Agri Prod, Jinan, Peoples R China	Shandong Academy of Agricultural Sciences; Shandong Academy of Agricultural Sciences	Yu, Y (corresponding author), Shandong Acad Agr Sci, Inst Plant Protect, Jinan, Peoples R China.	robertyuyi@163.com			Special Fund for Agro-scientific Research in the Public Interest from the Ministry of Agriculture of China [201303027]	Special Fund for Agro-scientific Research in the Public Interest from the Ministry of Agriculture of China	Funding for this study was provided by grants from the Special Fund for Agro-scientific Research in the Public Interest from the Ministry of Agriculture of China (201303027). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to Biomarker Technologies Co. Ltd for transcriptome analysis related experiments. This work was financially supported through a grant from the Special Fund for Agro-scientific Research in the Public Interest from the Ministry of Agriculture of China (201303027).	Anholt RRH, 2003, NAT GENET, V35, P180, DOI 10.1038/ng1240; Ansorge WJ, 2009, NEW BIOTECHNOL, V25, P195, DOI 10.1016/j.nbt.2008.12.009; Arensburger P, 2010, SCIENCE, V330, P86, DOI 10.1126/science.1191864; Arrese EL, 2010, ANNU REV ENTOMOL, V55, P207, DOI 10.1146/annurev-ento-112408-085356; Chen HL, 2015, COMP BIOCHEM PHYS D, V16, P20, DOI 10.1016/j.cbd.2015.07.001; Choi JH, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-703; Daines B, 2011, GENOME RES, V21, P315, DOI 10.1101/gr.107854.110; Fender JE, 2012, APPL ENVIRON MICROB, V78, P6225, DOI 10.1128/AEM.01778-12; Feng H.Q., 1987, J AGRI UNIVK SHANDON, V18, P71; Gibbons JG, 2009, MOL BIOL EVOL, V26, P2731, DOI 10.1093/molbev/msp188; Hahn DA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-234; He Hua-Liang, 2012, Acta Entomologica Sinica, V55, P1; Huang JH, 2005, GENOMICS, V86, P233, DOI 10.1016/j.ygeno.2005.04.011; Ianella P, 2008, GENET MOL RES, V7, P476, DOI 10.4238/vol7-2gmr412; Imahori Y, 2004, POSTHARVEST BIOL TEC, V31, P295, DOI 10.1016/j.postharvbio.2003.09.004; JOANISSE DR, 1994, CAN J ZOOL, V72, P1079, DOI 10.1139/z94-145; Keeling CI, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-3-r27; Kovtunovych G, 1999, PLANT SOIL, V215, P1, DOI 10.1023/A:1004790122353; Lemke S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-278; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li Hong, 2007, Chinese Bulletin of Entomology, V44, P834; Li YP, 2000, INSECT SCI, V7, P135; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; [卢巧英 LU Qiaoying], 2006, [西北农业学报, Acat Agriculturae Boreali-Occidentalis Sinica], V15, P75; Manji GA, 2001, J BIOL CHEM, V276, P16704, DOI 10.1074/jbc.M010179200; Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007; Margam VM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021388; Mei Zeng-Xia, 2003, Entomological Knowledge, V40, P396; Misawa T, 2013, J GEN PLANT PATHOL, V79, P280, DOI 10.1007/s10327-013-0455-5; Mizrachi E, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-681; Morozova O, 2008, GENOMICS, V92, P255, DOI 10.1016/j.ygeno.2008.07.001; Munoz-Torres MC, 2011, NUCLEIC ACIDS RES, V39, pD658, DOI 10.1093/nar/gkq1145; Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878; Nirmala X, 2013, GENE, V517, P212, DOI 10.1016/j.gene.2012.12.012; Papanicolaou A, 2008, NUCLEIC ACIDS RES, V36, pD582, DOI 10.1093/nar/gkm853; Parchman TL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-180; Pascual L, 2012, INSECT BIOCHEM MOLEC, V42, P557, DOI 10.1016/j.ibmb.2012.04.003; Schulze SK, 2012, BMC GENOMICS, V13, P1, DOI 10.1186/1471-2164-13-524; Schuster SC, 2008, NAT METHODS, V5, P16, DOI [10.1038/nmeth1156, 10.1038/NMETH1156]; Shi K., 2013, TAXONOMY 8 GENERA PH; Simon CR, 2004, GENESIS, V40, P22, DOI 10.1002/gene.20059; Sze SH, 2012, INSECT MOL BIOL, V21, P205, DOI 10.1111/j.1365-2583.2011.01127.x; Wang ET, 2012, CELL, V150, P710, DOI 10.1016/j.cell.2012.06.041; Xia QY, 2008, INSECT BIOCHEM MOLEC, V38, P1036, DOI [10.1016/j.ibmb.2009.01.004, 10.1016/j.ibmb.2008.11.004]; Yang J. K., 1985, ACTA AGRU PERKINENSI, V11, P153; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang P, 2014, PESTIC BIOCHEM PHYS, V111, P31, DOI 10.1016/j.pestbp.2014.04.003; Zhen JQ., 2004, HDB CONT VEGETABLE P; Zou CS, 2014, J INSECT SCI, V14, DOI 10.1093/jisesa/ieu122	49	13	13	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2016	11	2							e0146812	10.1371/journal.pone.0146812	http://dx.doi.org/10.1371/journal.pone.0146812			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3CO	26891450	Green Submitted, gold, Green Published			2022-12-26	WOS:000371221500003
J	Novakova, L; Kovacovicova, K; Dang-Nguyen, TQ; Sodek, M; Skultety, M; Anger, M				Novakova, Lucia; Kovacovicova, Kristina; Thanh Quang Dang-Nguyen; Sodek, Martin; Skultety, Michel; Anger, Martin			A Balance between Nuclear and Cytoplasmic Volumes Controls Spindle Length	PLOS ONE			English	Article							MITOTIC SPINDLE; SIZE; CELLS; TPX2; ATTACHMENTS; VERTEBRATE; MECHANISMS; TRANSITION; OOCYTES; NUMBER	Proper assembly of the spindle apparatus is crucially important for faithful chromosome segregation during anaphase. Thanks to the effort over the last decades, we have very detailed information about many events leading to spindle assembly and chromosome segregation, however we still do not understand certain aspects, including, for example, spindle length control. When tight regulation of spindle size is lost, chromosome segregation errors emerge. Currently, there are several hypotheses trying to explain the molecular mechanism of spindle length control. The number of kinetochores, activity of molecular rulers, intracellular gradients, cell size, limiting spindle components, and the balance of the spindle forces seem to contribute to spindle size regulation, however some of these mechanisms are likely specific to a particular cell type. In search for a general regulatory mechanism, in our study we focused on the role of cell size and nuclear to cytoplasmic ratio in this process. To this end, we used relatively large cells isolated from 2-cell mouse embryos. Our results showed that the spindle size upper limit is not reached in these cells and suggest that accurate control of spindle length requires balanced ratio between nuclear and cytoplasmic volumes.	[Novakova, Lucia; Kovacovicova, Kristina; Thanh Quang Dang-Nguyen; Sodek, Martin; Skultety, Michel; Anger, Martin] Vet Res Inst, Cent European Inst Technol, Hudcova 70, Brno 62100, Czech Republic; [Novakova, Lucia; Kovacovicova, Kristina; Sodek, Martin; Anger, Martin] Inst Anim Physiol & Genet AS CR, Rumburska 89, Libechov 27721, Czech Republic; [Thanh Quang Dang-Nguyen] Natl Inst Agrobiol Sci, 2-1-2 Kannondai, Tsukuba, Ibaraki 3058062, Japan	Czech Veterinary Research Institute; Czech Academy of Sciences; Institute of Animal Physiology & Genetics of the Czech Academy of Sciences; National Institute of Agrobiological Sciences - Japan	Anger, M (corresponding author), Vet Res Inst, Cent European Inst Technol, Hudcova 70, Brno 62100, Czech Republic.; Anger, M (corresponding author), Inst Anim Physiol & Genet AS CR, Rumburska 89, Libechov 27721, Czech Republic.	anger@vri.cz	Anger, Martin/R-9917-2019; Anger, Martin/A-3152-2015; Kovacovicova, Kristina/C-4964-2019	Anger, Martin/0000-0003-0128-1054; Anger, Martin/0000-0003-0128-1054; Dang Nguyen, Thanh Quang/0000-0001-8176-4827	Czech science foundation [P502/12/2201]; Ministry of Education, Youth and Sports (MEYS) [ED1.1.00/02.0068, LH 13072]	Czech science foundation(Grant Agency of the Czech Republic); Ministry of Education, Youth and Sports (MEYS)(Ministry of Education, Youth & Sports - Czech Republic)	This work was supported by Czech science foundation project P502/12/2201 and by Ministry of Education, Youth and Sports (MEYS) projects ED1.1.00/02.0068 - Central European Institute of Technology (CEITEC) and LH 13072 - Kontakt II.	Bastiaens P, 2006, TRENDS CELL BIOL, V16, P125, DOI 10.1016/j.tcb.2006.01.005; Bird AW, 2008, J CELL BIOL, V182, P289, DOI 10.1083/jcb.200802005; Chan YHM, 2012, SCIENCE, V337, P1186, DOI 10.1126/science.1223539; Choi SH, 2012, CURR BIOL, V22, P225, DOI 10.1016/j.cub.2011.12.022; Ciemerych MA, 1999, ZYGOTE, V7, P293, DOI 10.1017/S0967199499000696; Courtois A, 2012, J CELL BIOL, V198, P357, DOI 10.1083/jcb.201202135; Dumont J, 2007, J CELL BIOL, V176, P295, DOI 10.1083/jcb.200605199; Dumont S, 2009, CURR BIOL, V19, pR749, DOI 10.1016/j.cub.2009.07.028; Edens LJ, 2013, TRENDS CELL BIOL, V23, P151, DOI 10.1016/j.tcb.2012.11.004; Fragouli E, 2013, HUM GENET, V132, P1001, DOI 10.1007/s00439-013-1309-0; Fu JY, 2015, J CELL BIOL, V210, P373, DOI 10.1083/jcb.201412109; Goehring NW, 2012, CURR BIOL, V22, pR330, DOI 10.1016/j.cub.2012.03.046; Good MC, 2013, SCIENCE, V342, P856, DOI 10.1126/science.1243147; Goshima G, 2010, ANNU REV CELL DEV BI, V26, P21, DOI 10.1146/annurev-cellbio-100109-104006; Greenan G, 2010, CURR BIOL, V20, P353, DOI 10.1016/j.cub.2009.12.050; Hazel J, 2013, SCIENCE, V342, P853, DOI 10.1126/science.1243110; Helmke KJ, 2014, J CELL BIOL, V206, P385, DOI 10.1083/jcb.201401014; Howe K, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.112151; Jevtic P, 2015, CURR BIOL, V25, P45, DOI 10.1016/j.cub.2014.10.051; Jevtic P, 2014, CURR OPIN CELL BIOL, V28, P16, DOI 10.1016/j.ceb.2014.01.003; Kalab P, 2008, J CELL SCI, V121, P1577, DOI 10.1242/jcs.005959; Kirkham M, 2003, CELL, V112, P575, DOI 10.1016/S0092-8674(03)00117-X; Nannas NJ, 2014, MOL BIOL CELL, V25, P4034, DOI 10.1091/mbc.E14-01-0016; NICKLAS RB, 1985, J CELL BIOL, V100, P1, DOI 10.1083/jcb.100.1.1; Walczak CE, 2010, NAT REV MOL CELL BIO, V11, P91, DOI 10.1038/nrm2832; Wuhr M, 2008, CURR BIOL, V18, P1256, DOI 10.1016/j.cub.2008.07.092; Wuhr M, 2015, CURR BIOL, V25, P2663, DOI 10.1016/j.cub.2015.08.047; Yamagata K, 2013, CELL CYCLE, V12, P157, DOI 10.4161/cc.23052	28	15	15	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0149535	10.1371/journal.pone.0149535	http://dx.doi.org/10.1371/journal.pone.0149535			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26886125	gold, Green Published, Green Submitted			2022-12-26	WOS:000371218400095
J	Stindt, S; Cebula, P; Albrecht, U; Keitel, V; Esch, JSA; Knoefel, WT; Bartenschlager, R; Haussinger, D; Bode, JG				Stindt, Sabine; Cebula, Patricia; Albrecht, Ute; Keitel, Verena; Esch, Jan Schulte Am; Knoefel, Wolfram T.; Bartenschlager, Ralf; Haeussinger, Dieter; Bode, Johannes G.			Hepatitis C Virus Activates a Neuregulin-Driven Circuit to Modify Surface Expression of Growth Factor Receptors of the ErbB Family	PLOS ONE			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; NONSTRUCTURAL 3/4A PROTEASE; SIGNAL-TRANSDUCTION; CELL-LINES; ENTRY; TRANSCRIPTION; REPLICATION; MITHRAMYCIN; STABILITY; CLEAVAGE	Recently, the epidermal growth factor (EGF) receptor (EGFR), a member of the ErbB receptor family, and its down-stream signalling have been identified as co-factors for HCV entry and replication. Since EGFR also functions as a heterodimer with other ErbB receptor family members, the subject of the present study was to investigate a possible viral interference with these cellular components. By using genotype 1b replicon cells as well as an infection-based system we found that while transcript and protein levels of EGFR and ErbB2 were up-regulated or unaffected, respectively, HCV induced a substantial reduction of ErbB3 and ErbB4 expression. Down-regulation of ErbB3 expression by HCV involves specificity protein (Sp) 1-mediated induction of Neuregulin (NRG) 1 expression as well as activation of Akt. Consistently, at transcript level disruption of ErbB3 expression by HCV can be prevented by knockdown of NRG1 or Sp1 expression, whereas reconstitution of ErbB3 protein levels requires inhibition of HCV-induced NRG1 expression and of Akt activity. Interestingly, the NRG1-mediated suppression of ErbB3 expression by HCV results in an enhanced expression of EGFR and ErbB2 on the cell surface, which can be mimicked by siRNA-mediated knockdown of ErbB3 expression. These data delineate a novel mechanism enabling HCV to sway the composition of the ErbB family members on the surface of its host cell by an NRG1-driven circuit and unravels a yet unknown cross-regulation between ErbB3 and the two other family members ErbB2 and EGFR. The shift of the receptor surface expression of the ErbB family towards enhanced expression of ErbB2 and EGFR triggered by HCV was found to promote viral RNA replication and infectivity. This suggests that HCV rearranges expression of ErbB family members to adapt the cellular environment to its requirements.	[Stindt, Sabine; Cebula, Patricia; Albrecht, Ute; Keitel, Verena; Haeussinger, Dieter; Bode, Johannes G.] Univ Dusseldorf, Univ Hosp, Fac Med, Dept Gastroenterol Hepatol & Infect Dis, Moorenstr 5, D-40225 Dusseldorf, Germany; [Esch, Jan Schulte Am; Knoefel, Wolfram T.] Univ Dusseldorf, Univ Hosp, Fac Med, Dept Gen Visceral & Pediat Surg, Moorenstr 5, D-40225 Dusseldorf, Germany; [Bartenschlager, Ralf] Heidelberg Univ, Dept Infect Dis, Mol Virol, Heidelberg, Germany; [Bartenschlager, Ralf] German Canc Res Ctr, Div Virus Associated Carcinogenesis, Heidelberg, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ)	Bode, JG (corresponding author), Univ Dusseldorf, Univ Hosp, Fac Med, Dept Gastroenterol Hepatol & Infect Dis, Moorenstr 5, D-40225 Dusseldorf, Germany.	johannes.bode@med.uni-duesseldorf.de	Esch, Jan Schulte am/AAL-9904-2021; Keitel, Verena/AAH-9016-2021; Keitel, Verena/AAF-3471-2019; Bartenschlager, Ralf/L-2582-2015	Esch, Jan Schulte am/0000-0002-2101-5012; Keitel, Verena/0000-0003-1383-7662; Bartenschlager, Ralf/0000-0001-5601-9307	Deutsche Forschungsgemeinschaft [SFB 974]; Virtual Liver Network by the German Federal Ministry of Education and Research (Forderkennzeichen) [0315713]; medical faculty, Heinrich-Heine-University of Dusseldorf; graduate school molecule of infections - Jurgen Manchot foundation;  [FOR 729];  [FOR 1202]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Virtual Liver Network by the German Federal Ministry of Education and Research (Forderkennzeichen); medical faculty, Heinrich-Heine-University of Dusseldorf; graduate school molecule of infections - Jurgen Manchot foundation; ; 	This work was supported by grants from the Deutsche Forschungsgemeinschaft in particular through the collaborative research centre SFB 974 (JGB, DH) and the research units FOR 729 (SSt, JGB, DH) and FOR 1202 (RB). Further funding came from projects of the Virtual Liver Network (UA, JGB) funded by the German Federal Ministry of Education and Research (Forderkennzeichen 0315713) and from intramural research funds of the medical faculty, Heinrich-Heine-University of Dusseldorf (SSt and JGB) as well as from the graduate school molecule of infections funded by the Jurgen Manchot (JGB) foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awasthi S, 2014, J CELL PHYSIOL, V229, P1831, DOI 10.1002/jcp.24637; Bauhofer O, 2012, GASTROENTEROLOGY, V143, P429, DOI 10.1053/j.gastro.2012.04.018; Bertelsen V, 2014, MEMBRANES, V4, P424, DOI 10.3390/membranes4030424; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Bode JG, 2008, BIOL CHEM, V389, P1283, DOI 10.1515/BC.2008.147; Bode JG, 2009, BIOL CHEM, V390, P1013, DOI 10.1515/BC.2009.118; Brenndorfer ED, 2014, J IMMUNOL, V192, P1671, DOI 10.4049/jimmunol.1301077; Brenndorfer ED, 2009, HEPATOLOGY, V49, P1810, DOI 10.1002/hep.22857; Cao ZW, 2007, MOL CELL BIOL, V27, P2180, DOI 10.1128/MCB.01245-06; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Diao JY, 2012, J VIROL, V86, P10935, DOI 10.1128/JVI.00750-12; Ehlting C, 2015, CELL SIGNAL, V27, P555, DOI 10.1016/j.cellsig.2014.12.016; Eierhoff T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001099; Falls DL, 2003, EXP CELL RES, V284, P14, DOI 10.1016/S0014-4827(02)00102-7; Frensing T, 2008, BBA-GENE REGUL MECH, V1779, P139, DOI 10.1016/j.bbagrm.2007.11.007; Horiuchi K, 2005, DEV BIOL, V283, P459, DOI 10.1016/j.ydbio.2005.05.004; Kaul A, 2007, J VIROL, V81, P13168, DOI 10.1128/JVI.01362-07; Kim S, 2013, J VIROL, V87, P4214, DOI 10.1128/JVI.00954-12; Liu Z, 2012, J BIOL CHEM, V287, P41922, DOI 10.1074/jbc.M112.414789; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; Lupberger J, 2011, NAT MED, V17, P589, DOI 10.1038/nm.2341; Mattila E, 2005, NAT CELL BIOL, V7, P78, DOI 10.1038/ncb1209; Molleken K, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003325; NAKABAYASHI H, 1982, CANCER RES, V42, P3858; Osada N, 2013, J PHARMACOL SCI, V122, P251, DOI 10.1254/jphs.13R02CP; Pei RJ, 2011, J GEN VIROL, V92, P2237, DOI 10.1099/vir.0.032581-0; Pietschmann T, 2002, J VIROL, V76, P4008, DOI 10.1128/JVI.76.8.4008-4021.2002; Pietschmann T, 2006, P NATL ACAD SCI USA, V103, P7408, DOI 10.1073/pnas.0504877103; Presser LD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056367; Rahbin N, 2013, BIOCHEM BIOPH RES CO, V433, P31, DOI 10.1016/j.bbrc.2013.02.075; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Suske G, 1999, GENE, V238, P291, DOI 10.1016/S0378-1119(99)00357-1; Tiganis T, 1998, MOL CELL BIOL, V18, P1622, DOI 10.1128/MCB.18.3.1622; VANDYKE MW, 1983, BIOCHEMISTRY-US, V22, P2373, DOI 10.1021/bi00279a011; Waris G, 2005, J VIROL, V79, P9725, DOI 10.1128/JVI.79.15.9725-9734.2005; Zhang HT, 2007, J CLIN INVEST, V117, P2051, DOI 10.1172/JCI32278; Zona L, 2013, CELL HOST MICROBE, V13, P302, DOI 10.1016/j.chom.2013.02.006	37	10	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0148711	10.1371/journal.pone.0148711	http://dx.doi.org/10.1371/journal.pone.0148711			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26886748	gold, Green Submitted, Green Published			2022-12-26	WOS:000371218400045
J	Sugden, K; Moffitt, TE; Pinto, L; Poulton, R; Williams, BS; Caspi, A				Sugden, Karen; Moffitt, Terrie E.; Pinto, Lauriane; Poulton, Richie; Williams, Benjamin S.; Caspi, Avshalom			Is Toxoplasma Gondii Infection Related to Brain and Behavior Impairments in Humans? Evidence from a Population-Representative Birth Cohort	PLOS ONE			English	Article							SCHIZOPHRENIA; HEALTH; RISK; SEROPREVALENCE; SEROPOSITIVITY; ASSOCIATION; PERSONALITY; DEPRESSION; DISORDERS; DOPAMINE	Background Toxoplasma gondii (T. gondii) is a protozoan parasite present in around a third of the human population. Infected individuals are commonly asymptomatic, though recent reports have suggested that infection might influence aspects of the host's behavior. In particular, Toxoplasma infection has been linked to schizophrenia, suicide attempt, differences in aspects of personality and poorer neurocognitive performance. However, these studies are often conducted in clinical samples or convenience samples. Methods/Results In a population-representative birth-cohort of individuals tested for presence of antibodies to T. gondii (N = 837) we investigated the association between infection and four facets of human behavior: neuropsychiatric disorder (schizophrenia and major depression), poor impulse control (suicidal behavior and criminality), personality, and neurocognitive performance. Suicide attempt was marginally more frequent among individuals with T. gondii seropositivity (p = .06). Seropositive individuals also performed worse on one out of 14 measures of neuropsychological function. Conclusion On the whole, there was little evidence that T. gondii was related to increased risk of psychiatric disorder, poor impulse control, personality aberrations or neurocognitive impairment.	[Sugden, Karen; Moffitt, Terrie E.; Williams, Benjamin S.; Caspi, Avshalom] Duke Univ, Dept Psychol & Neurosci, Durham, NC USA; [Sugden, Karen; Moffitt, Terrie E.; Pinto, Lauriane; Williams, Benjamin S.; Caspi, Avshalom] Duke Univ, Duke Ctr Genom & Computat Biol, Durham, NC USA; [Moffitt, Terrie E.; Caspi, Avshalom] Duke Univ, Sch Med, Dept Psychiat & Behav Sci, Durham, NC USA; [Moffitt, Terrie E.; Caspi, Avshalom] Kings Coll London, Social Genet & Dev Psychiat Ctr, Inst Psychiat, London WC2R 2LS, England; [Poulton, Richie] Univ Otago, Dept Psychol, Dunedin, New Zealand	Duke University; Duke University; Duke University; University of London; King's College London; University of Otago	Sugden, K (corresponding author), Duke Univ, Dept Psychol & Neurosci, Durham, NC USA.; Sugden, K (corresponding author), Duke Univ, Duke Ctr Genom & Computat Biol, Durham, NC USA.	karen.sugden@duke.edu	caspi, avshalom/AAJ-5874-2020; Sugden, Karen/O-6046-2019; Moffitt, Terrie E/D-5295-2011	caspi, avshalom/0000-0003-0082-4600; Sugden, Karen/0000-0002-4076-5927; Moffitt, Terrie E/0000-0002-8589-6760; Pinto, Lauriane/0000-0003-4160-1710	New Zealand Health Research Council; US National Institute on Aging (NIA) [AG032282, AG048895]; UK Medical Research Council [MR/K00381X]; Jacobs Foundation; NATIONAL INSTITUTE ON AGING [R01AG048895, P30AG034424, R01AG032282] Funding Source: NIH RePORTER; Medical Research Council [MR/K00381X/1] Funding Source: researchfish; MRC [MR/K00381X/1] Funding Source: UKRI	New Zealand Health Research Council(Health Research Council of New Zealand); US National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Jacobs Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The Dunedin Multidisciplinary Health and Development Research Unit is supported by the New Zealand Health Research Council (http://www.hrc.govt.nz/; RP). This research received support from US National Institute on Aging (NIA: https://www.nia.nih.gov/) grants AG032282, AG048895 (AC and TEM), and UK Medical Research Council (http://www.mrc.ac.uk/) grant MR/K00381X (AC and TEM). Additional support was provided by the Jacobs Foundation (http://jacobsfoundation.org/) Jacobs Prize 2010 (AC and TEM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarado-Esquivel C, 2014, EUR J MICROBIOL IMMU, V4, P76, DOI 10.1556/EuJMI.4.2014.1.7; [Anonymous], 1944, ARM IND BATT MAN DIR; Arling TA, 2009, J NERV MENT DIS, V197, P905, DOI 10.1097/NMD.0b013e3181c29a23; Beste C, 2014, NEUROBIOL AGING, V35, P1037, DOI 10.1016/j.neurobiolaging.2013.11.012; Bondy B, 2011, WORLD J BIOL PSYCHIA, V12, P81, DOI 10.3109/15622975.2010.546428; Borsini A, 2015, TRENDS NEUROSCI, V38, P145, DOI 10.1016/j.tins.2014.12.006; Carruthers VB, 2007, SCHIZOPHRENIA BULL, V33, P745, DOI 10.1093/schbul/sbm008; Cook TB, 2015, J PSYCHIATR RES, V60, P87, DOI 10.1016/j.jpsychires.2014.09.019; Flegr J, 2003, BIOL PSYCHOL, V63, P253, DOI 10.1016/S0301-0511(03)00075-9; Flegr J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090203; Flegr J, 2013, J EXP BIOL, V216, P127, DOI 10.1242/jeb.073635; Furtado JM, 2011, J GLOB INFECT DIS, V3, P281, DOI 10.4103/0974-777X.83536; Gale SD, 2014, FOLIA PARASIT, V61, P285, DOI 10.14411/fp.2014.038; Goldman-Mellor SJ, 2014, JAMA PSYCHIAT, V71, P119, DOI 10.1001/jamapsychiatry.2013.2803; Hanauer DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070585; Havlicek J, 2001, PARASITOLOGY, V122, P515, DOI 10.1017/S0031182001007624; Ingram WM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075246; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Israel S, 2014, J PERS SOC PSYCHOL, V106, P484, DOI 10.1037/a0035687; John O.P., 1999, HDB PERSONALITY THEO, VVolume 2, P102; Jones JL, 2001, AM J EPIDEMIOL, V154, P357, DOI 10.1093/aje/154.4.357; Kannan G, 2010, FOLIA PARASIT, V57, P151, DOI 10.14411/fp.2010.019; Kar N, 2004, BMC PSYCHIATRY, V4, DOI 10.1186/1471-244X-4-1; Khandaker GM, 2015, LANCET PSYCHIAT, V2, P258, DOI 10.1016/S2215-0366(14)00122-9; Kocazeybek B, 2009, FORENSIC SCI INT, V187, P103, DOI 10.1016/j.forsciint.2009.03.007; Lester D, 2012, PSYCHOL REP, V111, P196, DOI 10.2466/12.15.16.PR0.111.4.196-197; Lester D, 2010, PSYCHOL REP, V107, P424, DOI 10.2466/12.13.PR0.107.5.424; Lezak M.D., 1995, NEUROPSYCHOLOGICAL A; Ling VJ, 2011, J NERV MENT DIS, V199, P440, DOI 10.1097/NMD.0b013e318221416e; Mcauliffe K, 2012, ATLANTIC; McLeod R, 2009, MEM I OSWALDO CRUZ, V104, P320, DOI 10.1590/S0074-02762009000200029; Meier MH, 2014, AM J PSYCHIAT, V171, P91, DOI 10.1176/appi.ajp.2013.12111438; Meier MH, 2012, P NATL ACAD SCI USA, V109, pE2657, DOI 10.1073/pnas.1206820109; Najjar S, 2015, SCHIZOPHR RES, V161, P102, DOI 10.1016/j.schres.2014.04.041; Parlog A, 2015, PARASITE IMMUNOL, V37, P159, DOI 10.1111/pim.12157; Pearce BD, 2012, BIOL PSYCHIAT, V72, P290, DOI 10.1016/j.biopsych.2012.01.003; Poulton R, 2006, NZ MED J, V119, P1235; Poulton R, 2015, SOC PSYCH PSYCH EPID, V50, P679, DOI 10.1007/s00127-015-1048-8; Prandovszky E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023866; Priplatova L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112771; SAHAKIAN BJ, 1992, J ROY SOC MED, V85, P399; Torrey EF, 2012, SCHIZOPHRENIA BULL, V38, P642, DOI 10.1093/schbul/sbs043; Torrey EF, 2003, EMERG INFECT DIS, V9, P1375, DOI 10.3201/eid0911.030143; Wechsler D., 1997, WECHSLER MEMORY SCAL, Vthird; Wechsler D., 2012, WAIS 4 KASIKIRJA; Xiao J, 2014, NEUROSCIENCE, V268, P128, DOI 10.1016/j.neuroscience.2014.03.015; Yagmur F, 2010, FORENSIC SCI INT, V199, P15, DOI 10.1016/j.forsciint.2010.02.020; Yereli K, 2006, FORENSIC SCI INT, V163, P34, DOI 10.1016/j.forsciint.2005.11.002; Zhu XL, 2014, NAT NEUROSCI, V17, P773, DOI 10.1038/nn.3713	49	83	83	2	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0148435	10.1371/journal.pone.0148435	http://dx.doi.org/10.1371/journal.pone.0148435			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF3BJ	26886853	Green Submitted, Green Published, gold			2022-12-26	WOS:000371218400035
J	Majekova, M; Paal, T; Plowman, NS; Bryndova, M; Kasari, L; Norberg, A; Weiss, M; Bishop, TR; Luke, SH; Sam, K; Le Bagousse-Pinguet, Y; Leps, J; Gotzenberger, L; de Bello, F				Majekova, Maria; Paal, Taavi; Plowman, Nichola S.; Bryndova, Michala; Kasari, Liis; Norberg, Anna; Weiss, Matthias; Bishop, Tom R.; Luke, Sarah H.; Sam, Katerina; Le Bagousse-Pinguet, Yoann; Leps, Jan; Goetzenberger, Lars; de Bello, Francesco			Evaluating Functional Diversity: Missing Trait Data and the Importance of Species Abundance Structure and Data Transformation	PLOS ONE			English	Article							PLANT-COMMUNITIES; DISTRIBUTIONS; ASSEMBLAGES; COMPETITION; ECOSYSTEMS; ECOLOGY; FOREST; SCALE; ANT	Functional diversity (FD) is an important component of biodiversity that quantifies the difference in functional traits between organisms. However, FD studies are often limited by the availability of trait data and FD indices are sensitive to data gaps. The distribution of species abundance and trait data, and its transformation, may further affect the accuracy of indices when data is incomplete. Using an existing approach, we simulated the effects of missing trait data by gradually removing data from a plant, an ant and a bird community dataset (12, 59, and 8 plots containing 62, 297 and 238 species respectively). We ranked plots by FD values calculated from full datasets and then from our increasingly incomplete datasets and compared the ranking between the original and virtually reduced datasets to assess the accuracy of FD indices when used on datasets with increasingly missing data. Finally, we tested the accuracy of FD indices with and without data transformation, and the effect of missing trait data per plot or per the whole pool of species. FD indices became less accurate as the amount of missing data increased, with the loss of accuracy depending on the index. But, where transformation improved the normality of the trait data, FD values from incomplete datasets were more accurate than before transformation. The distribution of data and its transformation are therefore as important as data completeness and can even mitigate the effect of missing data. Since the effect of missing trait values pool-wise or plot-wise depends on the data distribution, the method should be decided case by case. Data distribution and data transformation should be given more careful consideration when designing, analysing and interpreting FD studies, especially where trait data are missing. To this end, we provide the R package "traitor" to facilitate assessments of missing trait data.	[Majekova, Maria] Comenius Univ, Dept Soil Sci, Fac Nat Sci, Bratislava, Slovakia; [Majekova, Maria; Le Bagousse-Pinguet, Yoann; Leps, Jan; de Bello, Francesco] Univ South Bohemia, Fac Sci, Dept Bot, Ceske Budejovice, Czech Republic; [Paal, Taavi; Kasari, Liis] Univ Tartu, Inst Ecol & Earth Sci, Ulikooli 18, EE-50090 Tartu, Estonia; [Plowman, Nichola S.; Weiss, Matthias; Sam, Katerina; Leps, Jan] Biol Ctr CAS, Inst Entomol, Ceske Budejovice, Czech Republic; [Plowman, Nichola S.; Sam, Katerina] Univ South Bohemia, Fac Sci, Dept Zool, Ceske Budejovice, Czech Republic; [Bryndova, Michala] Biol Ctr CAS, Inst Soil Biol, Ceske Budejovice, Czech Republic; [Bryndova, Michala] Univ South Bohemia, Fac Sci, Dept Ecosyst Biol, Ceske Budejovice, Czech Republic; [Norberg, Anna] Univ Helsinki, Dept Biosci, Helsinki, Finland; [Bishop, Tom R.] Univ Liverpool, Dept Earth Ocean & Ecol Sci, Liverpool L69 3BX, Merseyside, England; [Bishop, Tom R.] Univ Pretoria, Dept Zool & Entomol, Ctr Invas Biol, ZA-0002 Pretoria, South Africa; [Luke, Sarah H.] Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England; [Luke, Sarah H.] Univ Cambridge, Dept Zool, Cambridge, England; [Le Bagousse-Pinguet, Yoann] Univ Rey Juan Carlos, Area Biodiversidad & Conservac, Dept Ciencias, Escuela Super Ciencias Expt & Tecnol, C Tulipan S-N, Mostoles, Spain; [Goetzenberger, Lars; de Bello, Francesco] Biol Ctr CAS, Inst Bot, Trebon, Czech Republic	Comenius University Bratislava; University of South Bohemia Ceske Budejovice; University of Tartu; Tartu University Institute of Ecology & Earth Sciences; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice; University of Helsinki; University of Liverpool; University of Pretoria; University of East Anglia; University of Cambridge; Universidad Rey Juan Carlos; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; Institute of Botany of the Czech Academy of Sciences	Plowman, NS (corresponding author), Biol Ctr CAS, Inst Entomol, Ceske Budejovice, Czech Republic.; Plowman, NS (corresponding author), Univ South Bohemia, Fac Sci, Dept Zool, Ceske Budejovice, Czech Republic.	nichola.plowman@gmail.com	Leps, Jan/B-6913-2013; Le Bagousse-Pinguet, Yoann/I-2413-2016; de Bello, Francesco/AFQ-8650-2022; Sam, Katerina/I-2209-2014; Plowman, Nichola S/H-5616-2019; de Bello, Francesco/H-1582-2014; de Bello, Francesco/HCI-1196-2022; Götzenberger, Lars/H-1587-2014; Bishop, Tom Rhys/G-3213-2014; Weiss, Matthias/R-6659-2018; Tůmová, Michala/GWR-0053-2022	Leps, Jan/0000-0002-4822-7429; Le Bagousse-Pinguet, Yoann/0000-0002-5615-5541; Sam, Katerina/0000-0002-3436-0579; de Bello, Francesco/0000-0001-9202-8198; de Bello, Francesco/0000-0001-9202-8198; Götzenberger, Lars/0000-0003-3040-2900; Bishop, Tom Rhys/0000-0001-7061-556X; Tůmová, Michala/0000-0002-5417-3340; Luke, Sarah H./0000-0002-8335-5960; Weiss, Matthias/0000-0001-9095-0779; Norberg, Anna/0000-0002-3520-1043	VEGA [2/0016/15]; European Social Fund's Doctoral Studies and Internationalisation Programme DoRa (T6); Estonian Research Council [IUT 20-31]; Grant Agency of University of South Bohemia [156/2013/P]; Czech Science Foundation [14-36098G]; SAFE Project from the Sime Darby Foundation; UK Natural Environment Research Council (NERC); GACR [14-32024P, P505/12/1296]; project Postdoc USB through EU Education for Competitiveness Operational Programme [CZ.1.07/2.3.00/30.0006]; European Social Fund; Czech State Budget; Marie Sklodowska-Curie Actions Individual Fellowship (MSCA-IF) within the European Program Horizon (DRYFUN Project) [656035]; European Union's Seventh Framework Programme for research, technological development and demonstration [GA-2010-267243];  [APVV-0866-12]; Natural Environment Research Council [1230944, 1122589] Funding Source: researchfish	VEGA(Vedecka grantova agentura MSVVaS SR a SAV (VEGA)European Commission); European Social Fund's Doctoral Studies and Internationalisation Programme DoRa (T6); Estonian Research Council(Estonian Research Council); Grant Agency of University of South Bohemia; Czech Science Foundation(Grant Agency of the Czech Republic); SAFE Project from the Sime Darby Foundation; UK Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); GACR(Grant Agency of the Czech Republic); project Postdoc USB through EU Education for Competitiveness Operational Programme; European Social Fund(European Social Fund (ESF)); Czech State Budget; Marie Sklodowska-Curie Actions Individual Fellowship (MSCA-IF) within the European Program Horizon (DRYFUN Project); European Union's Seventh Framework Programme for research, technological development and demonstration; ; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	MM was supported by VEGA 2/0016/15 and the project No. APVV-0866-12, TP was supported by European Social Fund's Doctoral Studies and Internationalisation Programme DoRa (T6) and Estonian Research Council (grant no IUT 20-31), NSP was supported by the Grant Agency of University of South Bohemia (156/2013/P) and the Czech Science Foundation (14-36098G), SHL was supported by the SAFE Project (including funding from the Sime Darby Foundation) and the UK Natural Environment Research Council (NERC), and KS was supported by GACR No. 14-32024P. YLBP was supported by the project Postdoc USB (reg. no. CZ.1.07/2.3.00/30.0006) realized through EU Education for Competitiveness Operational Programme. This project is funded by European Social Fund and Czech State Budget. YLBP is also supported by a Marie Sklodowska-Curie Actions Individual Fellowship (MSCA-IF) within the European Program Horizon 2020(DRYFUN Project 656035). LG received funding from the European Union's Seventh Framework Programme for research, technological development and demonstration under grant agreement no. GA-2010-267243 - PLANT FELLOWS; FdB and JL were supported by GACR P505/12/1296.	Anderson BJ, 2012, METHODS ECOL EVOL, V3, P783, DOI 10.1111/j.2041-210X.2012.00229.x; Botta-Dukat Z, 2005, J VEG SCI, V16, P533, DOI 10.1111/j.1654-1103.2005.tb02393.x; Carmona CP, 2015, FUNCT ECOL, V29, P579, DOI 10.1111/1365-2435.12366; Chiarucci A, 1999, J VEG SCI, V10, P35, DOI 10.2307/3237158; Cornelissen JHC, 2003, AUST J BOT, V51, P335, DOI 10.1071/BT02124; de Bello F, 2013, J VEG SCI, V24, P807, DOI 10.1111/jvs.12008; Ewers RM, 2011, PHILOS T R SOC B, V366, P3292, DOI 10.1098/rstb.2011.0049; Garnier E, 2004, ECOLOGY, V85, P2630, DOI 10.1890/03-0799; Gibb H, 2015, OECOLOGIA, V177, P519, DOI 10.1007/s00442-014-3101-9; Grime JP, 1998, J ECOL, V86, P902, DOI 10.1046/j.1365-2745.1998.00306.x; Laliberte E., 2014, FD MEASURING FUNCTIO; Laughlin DC, 2014, J ECOL, V102, P186, DOI 10.1111/1365-2745.12187; Leps J, 1999, J VEG SCI, V10, P219, DOI 10.2307/3237143; Leps J, 2006, PRESLIA, V78, P481; Leps J, 2014, J APPL ECOL, V51, P978, DOI 10.1111/1365-2664.12255; Limpert E, 2001, BIOSCIENCE, V51, P341, DOI 10.1641/0006-3568(2001)051[0341:LNDATS]2.0.CO;2; Luke SH, 2014, BIODIVERS CONSERV, V23, P2817, DOI 10.1007/s10531-014-0750-2; MACARTHUR R, 1960, AM NAT, V94, P25, DOI 10.1086/282106; Mason NWH, 2013, J VEG SCI, V24, P777, DOI 10.1111/jvs.12097; McGill BJ, 2006, TRENDS ECOL EVOL, V21, P178, DOI 10.1016/j.tree.2006.02.002; Pakeman RJ, 2007, APPL VEG SCI, V10, P91, DOI 10.1111/j.1654-109X.2007.tb00507.x; Pakeman RJ, 2014, METHODS ECOL EVOL, V5, P9, DOI 10.1111/2041-210X.12136; Penone C, 2014, METHODS ECOL EVOL, V5, P961, DOI 10.1111/2041-210X.12232; Pinheiro J., 2014, R PACKAGE VERSION, V3, P1; Pinheiro J, 2001, MIXED EFFECTS MODELS; Sam Katerina, 2014, BULLETIN OF THE BRITISH ORNITHOLOGISTS CLUB, V134, P116; Sandel B, 2015, J VEG SCI, V26, P828, DOI 10.1111/jvs.12292; Sasaki T, 2014, J APPL ECOL, V51, P299, DOI 10.1111/1365-2664.12192; Schleuter D, 2010, ECOL MONOGR, V80, P469, DOI 10.1890/08-2225.1; Swenson NG, 2011, P ROY SOC B-BIOL SCI, V278, P877, DOI 10.1098/rspb.2010.1369; Taugourdeau S, 2014, ECOL EVOL, V4, P944, DOI 10.1002/ece3.989; Tilman D, 1997, SCIENCE, V277, P1300, DOI 10.1126/science.277.5330.1300; Tvardikova K., 2013, TROPHIC RELATIONSHIP; Violle C, 2007, OIKOS, V116, P882, DOI 10.1111/j.2007.0030-1299.15559.x; Westoby M, 1998, PLANT SOIL, V199, P213, DOI 10.1023/A:1004327224729; WHITTAKER RH, 1965, SCIENCE, V147, P250, DOI 10.1126/science.147.3655.250	36	64	64	0	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0149270	10.1371/journal.pone.0149270	http://dx.doi.org/10.1371/journal.pone.0149270			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	26881747	Green Submitted, Green Published, gold			2022-12-26	WOS:000371219000066
J	Nieboer, D; van der Ploeg, T; Steyerberg, EW				Nieboer, Daan; van der Ploeg, Tjeerd; Steyerberg, Ewout W.			Assessing Discriminative Performance at External Validation of Clinical Prediction Models	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; ADMISSION CHARACTERISTICS; IMPACT; REGRESSION; FRAMEWORK	Introduction External validation studies are essential to study the generalizability of prediction models. Recently a permutation test, focusing on discrimination as quantified by the c-statistic, was proposed to judge whether a prediction model is transportable to a new setting. We aimed to evaluate this test and compare it to previously proposed procedures to judge any changes in c-statistic from development to external validation setting. Methods We compared the use of the permutation test to the use of benchmark values of the c-statistic following from a previously proposed framework to judge transportability of a prediction model. In a simulation study we developed a prediction model with logistic regression on a development set and validated them in the validation set. We concentrated on two scenarios: 1) the case-mix was more heterogeneous and predictor effects were weaker in the validation set compared to the development set, and 2) the case-mix was less heterogeneous in the validation set and predictor effects were identical in the validation and development set. Furthermore we illustrated the methods in a case study using 15 datasets of patients suffering from traumatic brain injury. Results The permutation test indicated that the validation and development set were homogenous in scenario 1 (in almost all simulated samples) and heterogeneous in scenario 2 (in 17%-39% of simulated samples). Previously proposed benchmark values of the c-statistic and the standard deviation of the linear predictors correctly pointed at the more heterogeneous case-mix in scenario 1 and the less heterogeneous case-mix in scenario 2. Conclusion The recently proposed permutation test may provide misleading results when externally validating prediction models in the presence of case-mix differences between the development and validation population. To correctly interpret the c-statistic found at external validation it is crucial to disentangle case-mix differences from incorrect regression coefficients.	[Nieboer, Daan; Steyerberg, Ewout W.] Erasmus MC Univ Med Ctr, Dept Publ Hlth, Rotterdam, Netherlands; [van der Ploeg, Tjeerd] Inholland Univ, Med Ctr Alkmaar, Dept Sci, Alkmaar, Netherlands	Erasmus University Rotterdam; Erasmus MC; Medical Center Of Alkmaar	Nieboer, D (corresponding author), Erasmus MC Univ Med Ctr, Dept Publ Hlth, Rotterdam, Netherlands.	d.nieboer@erasmusmc.nl		van der Ploeg, Tjeerd/0000-0003-0429-6753	Netherlands Organization for Scientific Research (ZonMw) [ZonMw 9120.8004 (TOP)]	Netherlands Organization for Scientific Research (ZonMw)(Netherlands Organization for Scientific Research (NWO)Netherlands Organization for Health Research and Development)	This work was funded by The Netherlands Organization for Scientific Research (ZonMw 9120.8004 (TOP)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin PC, 2014, STAT MED, V33, P517, DOI 10.1002/sim.5941; Austin PC, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-82; Bleeker SE, 2003, J CLIN EPIDEMIOL, V56, P826, DOI 10.1016/S0895-4356(03)00207-5; COX DR, 1958, BIOMETRIKA, V45, P562, DOI 10.1093/biomet/45.3-4.562; Debray TPA, 2015, J CLIN EPIDEMIOL, V68, P280, DOI 10.1016/j.jclinepi.2014.06.018; HARRELL FE, 1982, JAMA-J AM MED ASSOC, V247, P2543, DOI 10.1001/jama.247.18.2543; Hukkelhoven CWPM, 2005, J NEUROTRAUM, V22, P1025, DOI 10.1089/neu.2005.22.1025; Justice AC, 1999, ANN INTERN MED, V130, P515, DOI 10.7326/0003-4819-130-6-199903160-00016; Maas AIR, 2013, LANCET NEUROL, V12, P1200, DOI 10.1016/S1474-4422(13)70234-5; Moons KGM, 2012, HEART, V98, P691, DOI 10.1136/heartjnl-2011-301247; R Core Team, 2018, R LANG ENV STAT COMP; Roozenbeek B, 2012, CRIT CARE MED, V40, P1609, DOI 10.1097/CCM.0b013e31824519ce; Siontis GCM, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3318; Steyerberg EW, CLIN PREDICTION MODE; Steyerberg EW, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001381; Steyerberg EW, 2010, EPIDEMIOLOGY, V21, P128, DOI 10.1097/EDE.0b013e3181c30fb2; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Vergouwe Y, 2010, AM J EPIDEMIOL, V172, P971, DOI 10.1093/aje/kwq223; Wang LY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116957; Wessler BS, 2015, CIRC-CARDIOVASC QUAL, V8, P368, DOI 10.1161/CIRCOUTCOMES.115.001693	20	23	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0148820	10.1371/journal.pone.0148820	http://dx.doi.org/10.1371/journal.pone.0148820			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	26881753	Green Published, gold, Green Submitted			2022-12-26	WOS:000371219000026
J	Ying, SZ; Cao, H; Hu, H; Wang, X; Tang, YH; Huang, CX				Ying, Shaozhen; Cao, Hong; Hu, He; Wang, Xin; Tang, Yanhong; Huang, Congxin			Alk7 Depleted Mice Exhibit Prolonged Cardiac Repolarization and Are Predisposed to Ventricular Arrhythmia	PLOS ONE			English	Article							MYOCARDIAL ISCHEMIA/REPERFUSION INJURY; LONG QT SYNDROME; K+ CHANNEL; ADIPOSE-TISSUE; X-RECEPTOR; I-TO; APOPTOSIS; PROTECTS; CELLS; PATHOGENESIS	We aimed to investigate the role of activin receptor-like kinase (ALK7) in regulating cardiac electrophysiology. Here, we showed that Alk7(-/-) mice exhibited prolonged QT intervals in telemetry ECG recordings. Furthermore, Langendorff-perfused Alk7(-/-) hearts had significantly longer action potential duration (APD) and greater incidence of ventricular arrhythmia (AV) induced by burst pacing. Using whole-cell patch clamp, we found that the densities of repolarizing K+ currents I-to and I-K1 were profoundly reduced in Alk7(-/-) ventricular cardiomyocytes. Mechanistically, the expression of Kv4.2 (a major subunit of I-to carrying channel) and KCHIP2 (a key accessory subunit of I-to carrying channel), was markedly decreased in Alk7(-/-) hearts. These findings suggest that endogenous expression of ALK7 is necessary to maintain repolarizing K+ currents in ventricular cardiomyocytes, and finally prevent action potential prolongation and ventricular arrhythmia.	[Ying, Shaozhen; Cao, Hong; Hu, He; Wang, Xin; Tang, Yanhong; Huang, Congxin] Wuhan Univ, Renmin Hosp, Dept Cardiol, 238 Jiefang Rd, Wuhan 430060, Hubei Province, Peoples R China	Wuhan University	Huang, CX (corresponding author), Wuhan Univ, Renmin Hosp, Dept Cardiol, 238 Jiefang Rd, Wuhan 430060, Hubei Province, Peoples R China.	CongxinHuang@hotmail.com			National Science Technology Support Plan [2011BAI11B12]; National Natural Science Foundation of China [81370282]	National Science Technology Support Plan; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study is supported by funding from The National Science Technology Support Plan (Grant No. 2011BAI11B12) and the National Natural Science Foundation of China (Grant No. 81370282). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study is supported by funding from The National Science Technology Support Plan (Grant No. 2011BAI11B12) and the National Natural Science Foundation of China (Grant No. 81370282).	Andersson O, 2008, P NATL ACAD SCI USA, V105, P7252, DOI 10.1073/pnas.0800272105; Bertolino P, 2008, P NATL ACAD SCI USA, V105, P7246, DOI 10.1073/pnas.0801285105; Bingen BO, 2015, SCI REP-UK, V5, DOI 10.1038/srep15187; Brunet S, 2004, J PHYSIOL-LONDON, V559, P103, DOI 10.1113/jphysiol.2004.063347; Camm AJ, 2000, EUR HEART J, V21, P1232, DOI 10.1053/euhj.2000.2222; Carlsson LMS, 2009, BIOCHEM BIOPH RES CO, V382, P309, DOI 10.1016/j.bbrc.2009.03.014; Chang H, 2002, ENDOCR REV, V23, P787, DOI 10.1210/er.2002-0003; Cheng JH, 2004, ACTA PHARMACOL SIN, V25, P137; Clancy CE, 2005, PHYSIOL REV, V85, P33, DOI 10.1152/physrev.00005.2004; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; He Q, 2014, CIRC-HEART FAIL, V7, P1032, DOI 10.1161/CIRCHEARTFAILURE.114.001260; Hibino H, 2010, PHYSIOL REV, V90, P291, DOI 10.1152/physrev.00021.2009; Huang H, 2015, CARDIOVASC RES, V108, P50, DOI 10.1093/cvr/cvv206; Isbrandt D, 2002, J MOL MED-JMM, V80, P524, DOI 10.1007/s00109-002-0364-0; Jia Y, 2003, CARDIOVASC RES, V60, P278, DOI 10.1016/S0008-6363(03)00528-5; Kaese S, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00345; Kogame M, 2006, J MED INVESTIG, V53, P238, DOI 10.2152/jmi.53.238; KOUMI S, 1995, CIRCULATION, V92, P164, DOI 10.1161/01.CIR.92.2.164; Kwon JJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep11450; Li G-R., 2010, OPEN CIRC VASC J, V3, P95, DOI [10.2174/1877382601003010095, DOI 10.2174/1877382601003010095]; Li HL, 2010, P NATL ACAD SCI USA, V107, P13818, DOI 10.1073/pnas.1008397107; Lu Y, 2003, J PHYSIOL-LONDON, V551, P253, DOI 10.1113/jphysiol.2003.046045; Menegola M, 2006, J NEUROSCI, V26, P12137, DOI 10.1523/JNEUROSCI.2783-06.2006; Mukherjee D, 2015, J PINEAL RES, V58, P275, DOI 10.1111/jpi.12213; Nadeem L, 2011, AM J PATHOL, V178, P1177, DOI 10.1016/j.ajpath.2010.11.066; Nagaya T, 2010, EUR J EPIDEMIOL, V25, P195, DOI 10.1007/s10654-009-9423-y; Patel SP, 2005, J PHYSIOL-LONDON, V569, P7, DOI 10.1113/jphysiol.2005.086223; Patel SP, 2004, J PHYSIOL-LONDON, V557, P19, DOI 10.1113/jphysiol.2003.058172; Plaster NM, 2001, CELL, V105, P511, DOI 10.1016/S0092-8674(01)00342-7; Pu J, 2014, J AM COLL CARDIOL, V63, P2220, DOI 10.1016/j.jacc.2014.02.576; Pu J, 2013, EUR HEART J, V34, P1834, DOI 10.1093/eurheartj/ehs011; Qin M, 2012, J MOL CELL CARDIOL, V53, P880, DOI 10.1016/j.yjmcc.2012.10.003; Rossow CF, 2009, J MOL CELL CARDIOL, V46, P249, DOI 10.1016/j.yjmcc.2008.10.016; Shan PR, 2008, BIOCHEM BIOPH RES CO, V375, P628, DOI 10.1016/j.bbrc.2008.08.074; Tracy CC, 2003, AM J PHYSIOL-HEART C, V284, pH168, DOI 10.1152/ajpheart.00661.2002; Tsuchida K, 2004, MOL CELL ENDOCRINOL, V220, P59, DOI 10.1016/j.mce.2004.03.009; van Noord C, 2010, EUR J ENDOCRINOL, V162, P241, DOI 10.1530/EJE-09-0878; Wang Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep07681; Wickenden AD, 1998, CARDIOVASC RES, V37, P312, DOI 10.1016/S0008-6363(97)00256-3; Yao JJ, 2012, J BIOL CHEM, V287, P41534, DOI 10.1074/jbc.M112.390260; Yao TB, 2015, ANTIOXID REDOX SIGN, V22, P633, DOI 10.1089/ars.2014.5887; Yeung HM, 2015, J PINEAL RES, V58, P12, DOI 10.1111/jpi.12190; Yu LM, 2014, J PINEAL RES, V57, P228, DOI 10.1111/jpi.12161; Zhang N, 2006, DIABETOLOGIA, V49, P506, DOI 10.1007/s00125-005-0095-1; Zhang WC, 2013, ARQ BRAS CARDIOL, V101, P134, DOI [10.5935/abc.20130148, 10.5935/abc.20130129]	45	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0149205	10.1371/journal.pone.0149205	http://dx.doi.org/10.1371/journal.pone.0149205			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	26882027	Green Published, Green Submitted, gold			2022-12-26	WOS:000371219000059
J	Zurcher, K; Ballif, M; Zwahlen, M; Rieder, HL; Egger, M; Fenner, L				Zuercher, Kathrin; Ballif, Marie; Zwahlen, Marcel; Rieder, Hans L.; Egger, Matthias; Fenner, Lukas			Tuberculosis Mortality and Living Conditions in Bern, Switzerland, 1856-1950	PLOS ONE			English	Article							BRIEF EPIDEMIOLOGIC HISTORY; ENGLAND; AMERICA; DISEASE; ARCANA; EUROPE; WALES	Background Tuberculosis (TB) is a poverty-related disease that is associated with poor living conditions. We studied TB mortality and living conditions in Bern between 1856 and 1950. Methods We analysed cause-specific mortality based on mortality registers certified by autopsies, and public health reports 1856 to 1950 from the city council of Bern. Results TB mortality was higher in the Black Quarter (550 per 100,000) and in the city centre (327 per 100,000), compared to the outskirts (209 per 100,000 in 1911-1915). TB mortality correlated positively with the number of persons per room (r = 0.69, p = 0.026), the percentage of rooms without sunlight (r = 0.72, p = 0.020), and negatively with the number of windows per apartment (r = -0.79, p = 0.007). TB mortality decreased 10-fold from 330 per 100,000 in 1856 to 33 per 100,000 in 1950, as housing conditions improved, indoor crowding decreased, and open-air schools, sanatoria, systematic tuberculin skin testing of school children and chest radiography screening were introduced. Conclusions Improved living conditions and public health measures may have contributed to the massive decline of the TB epidemic in the city of Bern even before effective antibiotic treatment became finally available in the 1950s.	[Zuercher, Kathrin; Ballif, Marie; Zwahlen, Marcel; Egger, Matthias; Fenner, Lukas] Univ Bern, Inst Social & Prevent Med, Bern, Switzerland; [Ballif, Marie; Fenner, Lukas] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Ballif, Marie; Fenner, Lukas] Univ Basel, Basel, Switzerland; [Rieder, Hans L.] Univ Zurich, Epidemiol Biostat & Prevent Inst, Zurich, Switzerland	University of Bern; University of Basel; Swiss Tropical & Public Health Institute; University of Basel; University of Zurich	Fenner, L (corresponding author), Univ Bern, Inst Social & Prevent Med, Bern, Switzerland.; Fenner, L (corresponding author), Swiss Trop & Publ Hlth Inst, Basel, Switzerland.; Fenner, L (corresponding author), Univ Basel, Basel, Switzerland.	lukas.fenner@ispm.unibe.ch	Zwahlen, Marcel/AFF-8559-2022	Zwahlen, Marcel/0000-0002-6772-6346; Zurcher, Kathrin/0000-0002-7915-3194; Egger, Matthias/0000-0001-7462-5132; Fenner, Lukas/0000-0003-3309-4835				[Anonymous], 1908, Proc R Soc Med, V1, P1; [Anonymous], 1870, BERICHT SANITATS COM; [Anonymous], 2008, HIST STAT SCHWEIZ ON; [Anonymous], 1882, BERLINER KLIN WOCHEN, V19, P221; [Anonymous], 1927, TODESFALLE TODESURSA; Baumann H, 1937, TUBERKULOSEFURSORGE; BHATTI N, 1995, BRIT MED J, V310, P967, DOI 10.1136/bmj.310.6985.967; BLOWER SM, 1995, NAT MED, V1, P815, DOI 10.1038/nm0895-815; D'Arcy Hart P, 1939, TUBERCLE, V21, P30; Daniel TM, 2006, RESP MED, V100, P1862, DOI 10.1016/j.rmed.2006.08.006; DANIELS M, 1949, BMJ-BRIT MED J, V2, P1135, DOI 10.1136/bmj.2.4637.1135; Davies RPO, 1999, INT J TUBERC LUNG D, V3, P1051; Drolet GJ, 1952, NEW YORK TUBERCULOSI, V1952, P1; Drolet GJ, 1924, TUBERCLE, V5, P232; Egger M, 2014, PHILOSOPHIE AACH KANT: NEUE WEGE ZUM VERSTANDNIS VON KANTS TRANSZENDENTAL- UND MORALPHILOSOPHIE, P1; Freudiger H, 1930, STAT AMT STADT BERN; GRIGG ERN, 1958, AM REV TUBERC PULM, V78, P151; GRIGG ERN, 1958, AM REV TUBERC PULM, V78, P426; Holloway KL, 2014, J BIOSOC SCI, V46, P600, DOI 10.1017/S0021932013000527; Landolt C., 1899, WOHNUNGS ENQUETE STA; Marie-Davy F., 1911, REV HYG POLICE SANIT, V33, P714; Mosse M., 1913, EINFLUSS SOZIALEN LA, P551; Murphy S, 2002, INT J EPIDEMIOL, V31, P742, DOI 10.1093/ije/31.4.742; Nepfer M., 1996, WOHNUNGSFRAGE STADT; Oei W, 2012, COMPUT MATH METHOD M, V2012, DOI 10.1155/2012/124861; Pernet P., 2014, PRIERE NE PAS CRACHE; QGIS Development Team, 2015, QGIS GEOGR INF SYST; Redeker F, 1958, HBD TUBERCULOSE, P407; Regli J., 1995, BERNISCHE HOHENKLINI; Rieder HL, 1998, SOZ PRAVENTIV MED, V43, P162, DOI 10.1007/BF01359724; SPENCE DPS, 1993, BRIT MED J, V307, P759, DOI 10.1136/bmj.307.6907.759; Stead WW, 2001, INT J TUBERC LUNG D, V5, P807; Walser E, 1976, BERNER Z GESCH HEIMA, V38, P99; WHO, 2013, WORLD MALARIA REPORT 2013, P1; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; WILSON LG, 1990, J HIST MED ALL SCI, V45, P366, DOI 10.1093/jhmas/45.3.366	36	11	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0149195	10.1371/journal.pone.0149195	http://dx.doi.org/10.1371/journal.pone.0149195			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	26881850	Green Published, Green Accepted, gold			2022-12-26	WOS:000371219000057
J	Cao, JW; Huang, WL				Cao, Jingwen; Huang, Wenlong			Compensatory Increase of Transglutaminase 2 Is Responsible for Resistance to mTOR Inhibitor Treatment (Publication with Expression of Concern. See vol. 15, 2020)	PLOS ONE			English	Article; Publication with Expression of Concern							FACTOR-KAPPA-B; TISSUE TRANSGLUTAMINASE; CANCER-CELLS; MAMMALIAN TARGET; UP-REGULATION; ACTIVATION; COMPLEX; DRUG; APOPTOSIS; SURVIVAL	The mechanistic target of rapamycin complex 1 (mTORC1) plays a crucial role in controlling cell growth and homeostasis. Deregulation of mTOR signaling is frequently observed in some cancers, making it an attractive drug target for cancer therapy. Although mTORC1 inhibitor rapalog-based therapy has shown positive results in various pre-clinical animal cancer studies, tumors rebound upon treatment discontinuation. Moreover, several recent clinical trials showed that the mTORC1 inhibitors rapamycin and rapalog only reduce the capacity for cell proliferation without promoting cell death, consistent with the concept that rapamycin is cytostatic and reduces disease progression but is not cytotoxic. It is imperative that rapamycin-regulated events and additional targets for more effective drug combinations be identified. Here, we report that rapamycin treatment promotes a compensatory increase in transglutaminase 2 (TGM2) levels in mTORC1-driven tumors. TGM2 inhibition potently sensitizes mTORC1-hyperactive cancer cells to rapamycin treatment, and a rapamycininduced autophagy blockade inhibits the compensatory TGM2 upregulation. More importantly, tumor regression was observed in MCF-7-xenograft tumor-bearing mice treated with both mTORC1 and TGM2 inhibitors compared with those treated with either a single inhibitor or the vehicle control. These results demonstrate a critical role for the compensatory increase in transglutaminase 2 levels in promoting mTORC1 inhibitor resistance and suggest that rational combination therapy may potentially suppress cancer therapy resistance.	[Cao, Jingwen; Huang, Wenlong] China Pharmaceut Univ, Nanjing, Jiangsu, Peoples R China; [Cao, Jingwen] Chinese Acad Med Sci, Beijing 100730, Peoples R China	China Pharmaceutical University; Chinese Academy of Medical Sciences - Peking Union Medical College	Huang, WL (corresponding author), China Pharmaceut Univ, Nanjing, Jiangsu, Peoples R China.	wenlonghuangcpu@gmail.com			National Soft Science Research Program of China [2013GXS4B083]	National Soft Science Research Program of China	The National Soft Science Research Program of China (Grant No. 2013GXS4B083). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai LB, 2012, J BIOL CHEM, V287, P18330, DOI 10.1074/jbc.M112.339317; Akimov SS, 2000, J CELL BIOL, V148, P825, DOI 10.1083/jcb.148.4.825; Baldo P, 2008, CURR CANCER DRUG TAR, V8, P647, DOI 10.2174/156800908786733513; Bissler JJ, 2008, NEW ENGL J MED, V358, P140, DOI 10.1056/NEJMoa063564; Bjornsti MA, 2004, NAT REV CANCER, V4, P335, DOI 10.1038/nrc1362; Boehm JE, 2002, J BIOL CHEM, V277, P20127, DOI 10.1074/jbc.C200147200; Boroughs LK, 2014, J BIOL CHEM, V289, P10115, DOI 10.1074/jbc.M113.464693; Britschgi A, 2012, CANCER CELL, V22, P796, DOI 10.1016/j.ccr.2012.10.023; Budillon A, 2013, AMINO ACIDS, V44, P63, DOI 10.1007/s00726-011-1167-9; Cao LY, 2008, CARCINOGENESIS, V29, P1893, DOI 10.1093/carcin/bgn158; Carew JS, 2011, TARGET ONCOL, V6, P17, DOI 10.1007/s11523-011-0167-8; Choi K, 2005, CHEM BIOL, V12, P469, DOI 10.1016/j.chembiol.2005.02.007; Delhase M, 2012, P NATL ACAD SCI USA, V109, pE177, DOI 10.1073/pnas.1119296109; Dibble CC, 2012, MOL CELL, V47, P535, DOI 10.1016/j.molcel.2012.06.009; Duvel K, 2010, MOL CELL, V39, P171, DOI 10.1016/j.molcel.2010.06.022; Frese-Schaper M, 2010, FEBS LETT, V584, P2867, DOI 10.1016/j.febslet.2010.04.072; Ghosh S, 2006, CANCER CELL, V10, P215, DOI 10.1016/j.ccr.2006.08.007; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; He WX, 2015, EXP THER MED, V10, P1413, DOI 10.3892/etm.2015.2679; Herman JF, 2006, ONCOGENE, V25, P3049, DOI 10.1038/sj.onc.1209324; Hoang B, 2012, J BIOL CHEM, V287, P21796, DOI 10.1074/jbc.M111.304626; Huang L, 2015, AM J CANCER RES, V5, P2756; Iwanami A, 2013, P NATL ACAD SCI USA, V110, P4339, DOI 10.1073/pnas.1217602110; Jang GY, 2010, ONCOGENE, V29, P356, DOI 10.1038/onc.2009.342; Katt WP, 2015, MOL PHARMACEUT, V12, P46, DOI 10.1021/mp500405h; Khanna M, 2011, MOL CANCER THER, V10, P626, DOI 10.1158/1535-7163.MCT-10-0912; Kim DS, 2006, CANCER RES, V66, P10936, DOI 10.1158/0008-5472.CAN-06-1521; Kumar A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013390; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Li J, 2014, CELL METAB, V19, P373, DOI 10.1016/j.cmet.2014.01.001; Lim HJ, 2015, J CANCER RES CLIN, V141, P671, DOI 10.1007/s00432-014-1803-3; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Mangala LS, 2007, ONCOGENE, V26, P2459, DOI 10.1038/sj.onc.1210035; Mann AP, 2006, CANCER RES, V66, P8788, DOI 10.1158/0008-5472.CAN-06-1457; Marsh DJ, 2008, NAT CLIN PRACT ONCOL, V5, P357, DOI 10.1038/ncponc1112; Martz CA, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.aaa1877; Mehta K, 2010, BIOCHEM PHARMACOL, V80, P1921, DOI 10.1016/j.bcp.2010.06.029; Menon S, 2008, Oncogene, V27 Suppl 2, pS43, DOI 10.1038/onc.2009.352; Menon S, 2014, CELL, V156, P771, DOI 10.1016/j.cell.2013.11.049; Mikaelian I, 2013, CANCER RES, V73, P6621, DOI 10.1158/0008-5472.CAN-13-0560; Ng S, 2011, AUTOPHAGY, V7, P1173, DOI 10.4161/auto.7.10.16681; Park D, 2010, AMINO ACIDS, V39, P619, DOI 10.1007/s00726-010-0500-z; Sabatini DM, 2006, NAT REV CANCER, V6, P729, DOI 10.1038/nrc1974; Sato N, 2010, GENE CHROMOSOME CANC, V49, P353, DOI 10.1002/gcc.20747; Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3; Verma A, 2007, CURR CANCER DRUG TAR, V7, P559, DOI 10.2174/156800907781662275; Wang Y, 2012, BIOCHEM BIOPH RES CO, V417, P251, DOI 10.1016/j.bbrc.2011.11.094; Yamaguchi H, 2006, MOL CELL BIOL, V26, P569, DOI 10.1128/MCB.26.2.569-579.2006; Zha XJ, 2015, CANCER LETT, V359, P97, DOI 10.1016/j.canlet.2015.01.001	50	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149388	10.1371/journal.pone.0149388	http://dx.doi.org/10.1371/journal.pone.0149388			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26872016	gold, Green Published, Green Submitted			2022-12-26	WOS:000370054100154
J	Jovic, D; Vukovic, D; Marinkovic, J				Jovic, Dragana; Vukovic, Dejana; Marinkovic, Jelena			Prevalence and Patterns of Multi-Morbidity in Serbian Adults: A Cross-Sectional Study	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; HEALTH SURVEY; MULTIMORBIDITY; IMPACT; RISK; OSTEOARTHRITIS; DEPRESSION; ASTHMA; INDEX	Introduction Like many developing countries, Serbia is facing a growing burden of chronic diseases. Within such public health issue, multi-morbidity requires a special attention. Aims This study investigated the prevalence of multi-morbidity in the Serbia population and assessed the co-occurrence of chronic diseases by age and gender. Methods We analyzed data from the 2013 National Health Survey, which included 13,103 individuals >= 20 years old. Multi-morbidity patterns were identified by exploratory factor analysis of data on self-reported chronic diseases, as well as data on measured body weight and height. The analysis was stratified by age and gender. Results Multi-morbidity was present in nearly one-third of respondents (26.9%) and existed in all age groups, with the highest prevalence among individuals aged 65 years and older (47.2% of men and 65.0% of women). Six patterns of multi-morbidity were identified: non-communicable, cardio-metabolic, respiratory, cardiovascular, aggregate, and mechanical/mental/metabolic. The non-communicable pattern was observed in both genders but only in the 20-44 years age group, while the aggregate pattern occurred only in middle-aged men. Cardio-metabolic and respiratory patterns were present in all age groups. Cardiovascular and mechanical/mental/metabolic patterns showed similar presentation in both men and women. Conclusions Multi-morbidity is a common occurrence among adults in Serbia, especially in the elderly. While several patterns may be explained by underlying pathophysiologies, some require further investigation and follow-up. Recognizing the complexity of multi-morbidity in Serbia is of great importance from both clinical and preventive perspectives given that it affects one-third of the population and may require adjustment of the healthcare system to address the needs of affected individuals.	[Jovic, Dragana] Inst Publ Hlth Serbia, Ctr Hyg & Human Ecol, Belgrade, Serbia; [Vukovic, Dejana] Univ Belgrade, Fac Med, Inst Social Med, Belgrade, Serbia; [Marinkovic, Jelena] Univ Belgrade, Fac Med, Inst Med Stat & Informat, Belgrade, Serbia	University of Belgrade; University of Belgrade	Jovic, D (corresponding author), Inst Publ Hlth Serbia, Ctr Hyg & Human Ecol, Belgrade, Serbia.	drdraganajovic@gmail.com		Vukovic, Dejana/0000-0002-3323-3711; Marinkovic, Jelena/0000-0001-8852-384X				Agborsangaya CB, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-201; [Anonymous], 2012, EUROPEAN HLTH INTERV; [Anonymous], 2011, TG EHIS 2012 M; Arthritis foundation, 2014, OST KIDN; Bay-Jensen AC, 2012, MENOPAUSE, V20; Booth HP, 2014, FAM PRACT, V31, P38, DOI 10.1093/fampra/cmt061; Breedveld FC, 2004, RHEUMATOLOGY, V43, pI4, DOI 10.1093/rheumatology/keh102; Diederichs C, 2011, J GERONTOL A-BIOL, V66, P301, DOI 10.1093/gerona/glq208; European Health Interview Survey Task Force II, 2009, EUR HLTH INT SURV WA; Eurostat, 2008, SURV SAMPL REF GUID; Felson DT, 2000, ANN INTERN MED, V133, P635, DOI 10.7326/0003-4819-133-8-200010170-00016; Ferketich AK, 2000, ARCH INTERN MED, V160, P1261, DOI 10.1001/archinte.160.9.1261; Foguet-Boreu Q, 2014, BMC FAM PRACT, V15, DOI 10.1186/1471-2296-15-55; Fortin M, 2005, ANN FAM MED, V3, P223, DOI 10.1370/afm.272; Fortin M, 2012, ANN FAM MED, V10, P142, DOI 10.1370/afm.1337; Fortin M, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-111; Garin N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084794; Hare DL, 2014, EUR HEART J, V35, P1365, DOI 10.1093/eurheartj/eht462; Hartmann J, 2011, HLTH INT, P11; Holden L, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-15; Huang HL, 2014, BMC PULM MED, V14, DOI 10.1186/1471-2466-14-80; Huertas Alice, 2011, Ther Adv Respir Dis, V5, P217, DOI 10.1177/1753465811400490; Institute of Public Health of Serbia "Dr Milan Jovanovic Batut", 2014, HLTH STAT YB REP SER; Jankovic J, 2011, SCAND J PUBLIC HEALT, V39, P230, DOI 10.1177/1403494811401477; Jankovic S, 2007, EUR J PUBLIC HEALTH, V17, P80, DOI 10.1093/eurpub/ckl072; Khatib O, 2004, East Mediterr Health J, V10, P778; Laniado-Laborin R, 2009, INT J ENV RES PUB HE, V6, P209, DOI 10.3390/ijerph6010209; Liu DW, 2013, CHINESE MED J-PEKING, V126, P4093, DOI 10.3760/cma.j.issn.0366-6999.20131431; Abad-Diez JM, 2014, BMC GERIATR, V14, DOI 10.1186/1471-2318-14-75; Mayoclinic.org, 1998, DIS COND; Mehta LS, 2011, HEART FAIL CLIN, V7, P39, DOI 10.1016/j.hfc.2010.08.005; Mercer SW, 2009, FAM PRACT, V26, P79, DOI 10.1093/fampra/cmp020; Ministry of Health of the Republic of Serbia. National Health Survey Serbia, 2006, NAT HLTH SURV SERB 2; Nagorni-Obradovic LM, 2014, NPJ PRIM CARE RESP M, V24, DOI 10.1038/npjpcrm.2014.8; Nichols GA, 2011, DIABETOLOGIA, V54, P523, DOI 10.1007/s00125-010-1965-8; Organization WH, 2009, GLOB HLTH RISKS MORT; Osborne J., 2005, PRACTICAL ASSESSMENT, V10, P1, DOI [10.7275/jyj1-4868, DOI 10.7275/JYJ1-4868, 10.4135/9781412995627.d8, DOI 10.4135/9781412995627.D8]; Palange P, 1998, THORAX, V53, P989, DOI 10.1136/thx.53.11.989; Poblador-Plou B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100375; Prados-Torres A, 2014, J CLIN EPIDEMIOL, V67, P254, DOI 10.1016/j.jclinepi.2013.09.021; Prados-Torres A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032190; Schafer I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015941; Srbija Republika, 2014, REZ ISTR ZDRAVLJ STA; van den Akker M, 2001, J CLIN EPIDEMIOL, V54, P675, DOI 10.1016/S0895-4356(00)00358-9; van den Akker M, 1996, EUR J GEN PRACT, V2, P65, DOI [DOI 10.3109/13814789609162146, 10.3109/13814789609162146]; Vukovic D, 2008, CROAT MED J, V49, P832, DOI 10.3325/cmj.2008.49.832; Wang HHX, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0188-0; Ward BW, 2014, PREV CHRONIC DIS, V11, DOI 10.5888/pcd11.130389; WHO Regional Office for Europe, 2010, EV ORG PROV PRIM CAR; Wilson Ian, 2006, Int J Chron Obstruct Pulmon Dis, V1, P61, DOI 10.2147/copd.2006.1.1.61	50	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0148646	10.1371/journal.pone.0148646	http://dx.doi.org/10.1371/journal.pone.0148646			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26871936	Green Published, Green Submitted, gold			2022-12-26	WOS:000370054100045
J	Kol, A; Walker, NJ; Nordstrom, M; Borjesson, DL				Kol, A.; Walker, N. J.; Nordstrom, M.; Borjesson, D. L.			Th17 Pathway As a Target for Multipotent Stromal Cell Therapy in Dogs: Implications for Translational Research	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; INFLAMMATORY-BOWEL-DISEASE; T-CELLS; HEALTHY DOGS; IN-VITRO; DIFFERENTIATION; EXPRESSION; CYTOKINE; BLOOD; TISSUES	Detrimental Th17 driven inflammatory and autoimmune disease such as Crohn's disease, graft versus host disease and multiple sclerosis remain a significant cause of morbidity and mortality worldwide. Multipotent stromal/stem cell (MSC) inhibit Th17 polarization and activation in vitro and in rodent models. As such, MSC based therapeutic approaches are being investigated as novel therapeutic approaches to treat Th17 driven diseases in humans. The significance of naturally occurring diseases in dogs is increasingly recognized as a realistic platform to conduct pre-clinical testing of novel therapeutics. Full characterization of Th17 cells in dogs has not been completed. We have developed and validated a flow-cytometric method to detect Th17 cells in canine blood. We further demonstrate that Th17 and other IL17 producing cells are present in tissues of dogs with naturally occurring chronic inflammatory diseases. Finally, we have determined the kinetics of a canine specific Th17 polarization in vitro and demonstrate that canine MSC inhibit Th17 polarization in vitro, in a PGE2 independent mechanism. Our findings provide fundamental research tools and suggest that naturally occurring diseases in dogs, such as inflammatory bowel disease, may be harnessed to translate novel MSC based therapeutic strategies that target the Th17 pathway.	[Kol, A.; Walker, N. J.; Nordstrom, M.; Borjesson, D. L.] Univ Calif Davis, Sch Vet Med, Dept Pathol Microbiol & Immunol, Davis, CA 95616 USA	University of California System; University of California Davis	Borjesson, DL (corresponding author), Univ Calif Davis, Sch Vet Med, Dept Pathol Microbiol & Immunol, Davis, CA 95616 USA.	dlborjesson@ucdavis.edu		Kol, Amir/0000-0003-2324-6962	Center of Companion Animal Health, UC Davis School of Veterinary Medicine [2015-06-F]; California Institute for Regenerative Medicine's Stem Cell Training Program; ARCS foundation	Center of Companion Animal Health, UC Davis School of Veterinary Medicine; California Institute for Regenerative Medicine's Stem Cell Training Program; ARCS foundation	This work was supported by the Center of Companion Animal Health, UC Davis School of Veterinary Medicine (Grant # 2015-06-F) and a generous gift from Mr. Dick and Carolyn Randall. AK was supported by the California Institute for Regenerative Medicine's Stem Cell Training Program and a scholarship from the ARCS foundation.	Artis D, 2015, NATURE, V517, P293, DOI 10.1038/nature14189; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; Baumgart DC, 2007, LANCET, V369, P1627, DOI 10.1016/S0140-6736(07)60750-8; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Chao K, 2014, J GASTROEN HEPATOL, V29, P1808, DOI 10.1111/jgh.12592; Chatterjee D, 2014, BLOOD, V123, P594, DOI 10.1182/blood-2013-09-524827; Chizzolini C, 2008, BLOOD, V112, P3696, DOI 10.1182/blood-2008-05-155408; Clark KC, 2015, STEM CELL REV; Collins FS, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002747; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Cua DJ, 2010, NAT REV IMMUNOL, V10, P479, DOI 10.1038/nri2800; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Eysteinsdottir JH, 2013, SCAND J IMMUNOL, V78, P529, DOI 10.1111/sji.12114; Fellman CL, 2011, VET IMMUNOL IMMUNOP, V140, P175, DOI 10.1016/j.vetimm.2010.11.005; Firth FA, 2015, ARCH DERMATOL RES, V307, P333, DOI 10.1007/s00403-015-1540-8; Fossiez F, 1996, J EXP MED, V183, P2593, DOI 10.1084/jem.183.6.2593; Ghannam S, 2010, J IMMUNOL, V185, P302, DOI 10.4049/jimmunol.0902007; Gullick NJ, 2013, CLIN EXP IMMUNOL, V174, P292, DOI 10.1111/cei.12167; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Honkanen J, 2010, J IMMUNOL, V185, P1959, DOI 10.4049/jimmunol.1000788; Igarashi H, 2015, VET IMMUNOL IMMUNOP, V164, P160, DOI 10.1016/j.vetimm.2015.02.005; Jain P, 2012, HAEMATOL-HEMATOL J, V97, P599, DOI 10.3324/haematol.2011.047316; Kebir H, 2007, NAT MED, V13, P1173, DOI 10.1038/nm1651; Kenealy SJ, 2003, J NEUROIMMUNOL, V143, P7, DOI [10.1016/j.jneuroim.2003.08.005, 10.1016/j.jneuroim.2003.08.009]; Knights D, 2013, GUT, V62, P1505, DOI 10.1136/gutjnl-2012-303954; Kol A, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa9116; Kol A, 2014, STEM CELLS DEV, V23, P1831, DOI 10.1089/scd.2014.0128; Kondo T, 2009, J IMMUNOL, V182, P1794, DOI 10.4049/jimmunol.0801347; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Lin S, 2014, P NATL ACAD SCI USA, V111, P17224, DOI 10.1073/pnas.1413624111; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Liu XX, 2015, IMMUNOL RES, V61, P219, DOI 10.1007/s12026-014-8612-2; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lubberts E, 2015, NAT REV RHEUMATOL, V11, P415, DOI 10.1038/nrrheum.2015.53; Luz-Crawford P, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt216; Marinoni B, 2014, AUTOIMMUN HIGHLIGHTS, V5, P9, DOI 10.1007/s13317-013-0057-4; McGeachy MJ, 2013, J LEUKOCYTE BIOL, V94, P921, DOI 10.1189/jlb.0313113; Nagasawa M, 2015, SCIENCE, V348, P333, DOI 10.1126/science.1261022; Obermajer N, 2014, J IMMUNOL, V193, P4988, DOI 10.4049/jimmunol.1401776; Ohta H, 2013, VET IMMUNOL IMMUNOP, V155, P259, DOI 10.1016/j.vetimm.2013.07.006; Olsson M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001332; Park ES, 2013, VET PATHOL, V50, P1127, DOI 10.1177/0300985813488957; Paulissen SMJ, 2013, J IMMUNOL, V191, P1364, DOI 10.4049/jimmunol.1300274; Pelletier M, 2010, BLOOD, V115, P335, DOI 10.1182/blood-2009-04-216085; Pianta S, 2014, STEM CELL REV; Raychaudhuri SK, 2015, CLIN RHEUMATOL; Rei M, 2015, CANCER RES, V75, P798, DOI 10.1158/0008-5472.CAN-14-3228; Schmitz S, 2014, SCAND J IMMUNOL, V80, P85, DOI 10.1111/sji.12186; Schmitz S, 2012, VET IMMUNOL IMMUNOP, V146, P87, DOI 10.1016/j.vetimm.2012.01.013; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; Singer NG, 2011, ANNU REV PATHOL-MECH, V6, P457, DOI 10.1146/annurev-pathol-011110-130230; Suchodolski JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039333; Tzartos JS, 2008, AM J PATHOL, V172, P146, DOI 10.2353/ajpath.2008.070690; Valli JL, 2010, VET IMMUNOL IMMUNOP, V134, P218, DOI 10.1016/j.vetimm.2009.09.023; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Wang GD, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2814; Wilbe M, 2010, NAT GENET, V42, P250, DOI 10.1038/ng.525; Xu H, 2012, MUCOSAL IMMUNOL, V5, P658, DOI 10.1038/mi.2012.39; Yamamoto K, 2015, NAT REV RHEUMATOL, V11, P375, DOI 10.1038/nrrheum.2015.7; Yen HR, 2009, J IMMUNOL, V183, P7161, DOI 10.4049/jimmunol.0900368; YOO ZB, 1995, J IMMUNOL, V155, P5483; Zerhouni EA, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000341	63	16	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0148568	10.1371/journal.pone.0148568	http://dx.doi.org/10.1371/journal.pone.0148568			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26872054	Green Published, gold			2022-12-26	WOS:000370054100037
J	Qin, JY; Wang, ZZ; Hoogeveen-Westerveld, M; Shen, GB; Gong, WM; Nellist, M; Xu, WQ				Qin, Jiayue; Wang, Zhizhi; Hoogeveen-Westerveld, Marianne; Shen, Guobo; Gong, Weimin; Nellist, Mark; Xu, Wenqing			Structural Basis of the Interaction between Tuberous Sclerosis Complex 1 (TSC1) and Tre2-Bub2-Cdc16 Domain Family Member 7 (TBC1D7)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						crystal structure; isothermal titration calorimetry (ITC); mTOR complex (mTORC); protein complex; tuberous sclerosis complex (TSC); TBC1D7; TSC1	INTELLECTUAL DISABILITY; PROTEIN COMPLEX; GENE-PRODUCTS; DIRECT TARGET; RHEB; HAMARTIN; MTOR; ACTIVATION; IDENTIFICATION; PREDICTION	Mutations in TSC1 or TSC2 cause tuberous sclerosis complex (TSC), an autosomal dominant disorder characterized by the occurrence of benign tumors in various vital organs and tissues. TSC1 and TSC2, the TSC1 and TSC2 gene products, form the TSC protein complex that senses specific cellular growth conditions to control mTORC1 signaling. TBC1D7 is the third subunit of the TSC complex, and helps to stabilize the TSC1-TSC2 complex through its direct interaction with TSC1. Homozygous inactivation of TBC1D7 causes intellectual disability and megaencephaly. Here we report the crystal structure of a TSC1-TBC1D7 complex and biochemical characterization of the TSC1-TBC1D7 interaction. TBC1D7 interacts with the C-terminal region of the predicted coiled-coil domain of TSC1. The TSC1-TBC1D7 interface is largely hydrophobic, involving the 4 helix of TBC1D7. Each TBC1D7 molecule interacts simultaneously with two parallel TSC1 helices from two TSC1 molecules, suggesting that TBC1D7 may stabilize the TSC complex by tethering the C-terminal ends of two TSC1 coiled-coils.	[Qin, Jiayue; Gong, Weimin; Xu, Wenqing] Chinese Acad Sci, Inst Biophys, Beijing 100101, Peoples R China; [Qin, Jiayue; Wang, Zhizhi; Shen, Guobo; Xu, Wenqing] Univ Washington, Dept Biol Struct, Seattle, WA 98195 USA; [Qin, Jiayue] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Hoogeveen-Westerveld, Marianne; Nellist, Mark] Erasmus MC, Dept Clin Genet, NL-3015 CN Rotterdam, Netherlands; [Gong, Weimin] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; University of Washington; University of Washington Seattle; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Erasmus University Rotterdam; Erasmus MC; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Gong, WM (corresponding author), Chinese Acad Sci, Inst Biophys, Beijing 100101, Peoples R China.; Xu, WQ (corresponding author), Univ Washington, Dept Biol Struct, Seattle, WA 98195 USA.; Nellist, M (corresponding author), Erasmus MC, Dept Clin Genet, NL-3015 CN Rotterdam, Netherlands.	wgong@ibp.ac.cn; m.nellist@erasmusmc.nl; wxu@uw.edu	Qin, Jiayue/X-5590-2019; Qin, Jiayue/CAA-1134-2022; Wang, Zhizhi/K-3271-2016	Qin, Jiayue/0000-0003-4721-0016; Qin, Jiayue/0000-0003-4721-0016; Wang, Zhizhi/0000-0003-4948-925X; Xu, Wenqing/0000-0002-2884-3101	Office of Science, Office of Basic Energy Sciences of the United States Department of Energy [DE-AC02-05CH11231]	Office of Science, Office of Basic Energy Sciences of the United States Department of Energy(United States Department of Energy (DOE))	We are grateful to the staff at ALS beamlines BL 8.2.1 and 8.2.2 for assistance with synchrotron data collection. The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy under Contract DE-AC02-05CH11231.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alfaiz AA, 2014, HUM MUTAT, V35, P447, DOI 10.1002/humu.22529; Anttila V, 2013, NAT GENET, V45, P912, DOI 10.1038/ng.2676; Apostolovic B, 2010, CHEM SOC REV, V39, P3541, DOI 10.1039/b914339b; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Capo-Chichi JM, 2013, J MED GENET, V50, P740, DOI 10.1136/jmedgenet-2013-101680; Castro AF, 2003, J BIOL CHEM, V278, P32493, DOI 10.1074/jbc.C300226200; Chong-Kopera H, 2006, J BIOL CHEM, V281, P8313, DOI 10.1074/jbc.C500451200; Crino PB, 2006, NEW ENGL J MED, V355, P1345, DOI 10.1056/NEJMra055323; Curatolo Paolo, 2002, Eur J Paediatr Neurol, V6, P15, DOI 10.1053/ejpn.2001.0538; de Vries PJ, 2007, TRENDS MOL MED, V13, P319, DOI 10.1016/j.molmed.2007.06.003; DELANO WL, 1994, PROTEINS, V20, P105, DOI 10.1002/prot.340200202; Dibble CC, 2012, MOL CELL, V47, P535, DOI 10.1016/j.molcel.2012.06.009; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Frasa MAM, 2012, NAT REV MOL CELL BIO, V13, P67, DOI 10.1038/nrm3267; Garami A, 2003, MOL CELL, V11, P1457, DOI 10.1016/S1097-2765(03)00220-X; Gillingham AK, 2003, BBA-MOL CELL RES, V1641, P71, DOI 10.1016/S0167-4889(03)00088-0; Han JM, 2011, FEBS LETT, V585, P973, DOI 10.1016/j.febslet.2011.02.001; Hoogeveen-Westerveld M, 2012, BMC BIOCHEM, V13, DOI 10.1186/1471-2091-13-18; Hoogeveen-Westerveld M, 2010, BBA-MOL BASIS DIS, V1802, P774, DOI 10.1016/j.bbadis.2010.06.004; Hu J, 2008, GENE DEV, V22, P866, DOI 10.1101/gad.1624008; Inoki K, 2005, NAT GENET, V37, P19, DOI 10.1038/ng1494; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Ishida T, 2008, BIOINFORMATICS, V24, P1344, DOI 10.1093/bioinformatics/btn195; Khwaja OS, 2011, CURR OPIN PEDIATR, V23, P633, DOI 10.1097/MOP.0b013e32834c9251; Kwiatkowski DJ, 2005, HUM MOL GENET, V14, pR251, DOI 10.1093/hmg/ddi260; Lima AJS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093940; Menon S, 2014, CELL, V156, P771, DOI 10.1016/j.cell.2013.11.049; Mozaffari M, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-88; Nakashima A, 2007, BIOCHEM BIOPH RES CO, V361, P218, DOI 10.1016/j.bbrc.2007.07.011; Nellist M, 2005, EUR J HUM GENET, V13, P59, DOI 10.1038/sj.ejhg.5201276; Neuman NA, 2011, EMBO MOL MED, V3, P189, DOI 10.1002/emmm.201100131; Otwinowski Z., 1997, PROCESSING XRAY DIFF; Pan XJ, 2006, NATURE, V442, P303, DOI 10.1038/nature04847; Rosner M, 2008, MUTAT RES-REV MUTAT, V658, P234, DOI 10.1016/j.mrrev.2008.01.001; Sahin M, 2012, CURR OPIN NEUROBIOL, V22, P895, DOI 10.1016/j.conb.2012.04.008; Sato N, 2010, GENE CHROMOSOME CANC, V49, P353, DOI 10.1002/gcc.20747; Sun W, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3135; Tee AR, 2003, CURR BIOL, V13, P1259, DOI 10.1016/S0960-9822(03)00506-2; Tee AR, 2005, SEMIN CELL DEV BIOL, V16, P29, DOI 10.1016/j.semcdb.2004.11.005; Thien A, 2015, DEV CELL, V32, P617, DOI 10.1016/j.devcel.2015.01.026; Tomasoni R, 2011, BIOCHEM SOC T, V39, P466, DOI 10.1042/BST0390466; van Slegtenhorst M, 1998, HUM MOL GENET, V7, P1053, DOI 10.1093/hmg/7.6.1053; Woolfson DN, 2012, CURR OPIN STRUC BIOL, V22, P432, DOI 10.1016/j.sbi.2012.03.002; Yoshimura S, 2007, J CELL BIOL, V178, P363, DOI 10.1083/jcb.200703047; Zhang Y, 2003, NAT CELL BIOL, V5, P578, DOI 10.1038/ncb999	46	21	22	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2016	291	16					8591	8601		10.1074/jbc.M115.701870	http://dx.doi.org/10.1074/jbc.M115.701870			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK2VT	26893383	Green Published, hybrid			2022-12-26	WOS:000374773200023
J	Ong, TH; Romanova, EV; Roberts-Galbraith, RH; Yang, N; Zimmerman, TA; Collins, JJ; Lee, JE; Kelleher, NL; Newmark, PA; Sweedler, JV				Ong, Ta-Hsuan; Romanova, Elena V.; Roberts-Galbraith, Rachel H.; Yang, Ning; Zimmerman, Tyler A.; Collins, James J., III; Lee, Ji Eun; Kelleher, Neil L.; Newmark, Phillip A.; Sweedler, Jonathan V.			Mass Spectrometry Imaging and Identification of Peptides Associated with Cephalic Ganglia Regeneration in Schmidtea mediterranea	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						imaging; mass spectrometry (MS); neurogenesis; neuropeptide; regeneration	PLURIPOTENT STEM-CELLS; HEAD-REGENERATION; PLANARIAN BRAIN; ANIMAL REGENERATION; MOLECULAR ANALYSIS; NEUROPEPTIDES; PEPTIDOMICS; EXPRESSION; DISCOVERY; SYSTEM	Tissue regeneration is a complex process that involves a mosaic of molecules that vary spatially and temporally. Insights into the chemical signaling underlying this process can be achieved with a multiplex and untargeted chemical imaging method such as mass spectrometry imaging (MSI), which can enable de novo studies of nervous system regeneration. A combination of MSI and multivariate statistics was used to differentiate peptide dynamics in the freshwater planarian flatworm Schmidtea mediterranea at different time points during cephalic ganglia regeneration. A protocol was developed to make S. mediterranea tissues amenable for MSI. MS ion images of planarian tissue sections allow changes in peptides and unknown compounds to be followed as a function of cephalic ganglia regeneration. In conjunction with fluorescence imaging, our results suggest that even though the cephalic ganglia structure is visible after 6 days of regeneration, the original chemical composition of these regenerated structures is regained only after 12 days. Differences were observed in many peptides, such as those derived from secreted peptide 4 and EYE53-1. Peptidomic analysis further identified multiple peptides from various known prohormones, histone proteins, and DNA- and RNA-binding proteins as being associated with the regeneration process. Mass spectrometry data also facilitated the identification of a new prohormone, which we have named secreted peptide prohormone 20 (SPP-20), and is up-regulated during regeneration in planarians.	[Ong, Ta-Hsuan; Romanova, Elena V.; Yang, Ning; Zimmerman, Tyler A.; Lee, Ji Eun; Sweedler, Jonathan V.] Univ Illinois, Dept Chem, Urbana, IL 61801 USA; [Ong, Ta-Hsuan; Romanova, Elena V.; Yang, Ning; Zimmerman, Tyler A.; Lee, Ji Eun; Sweedler, Jonathan V.] Univ Illinois, Beckman Inst, Urbana, IL 61801 USA; [Roberts-Galbraith, Rachel H.; Collins, James J., III; Newmark, Phillip A.] Univ Illinois, Dept Cell & Dev Biol, Howard Hughes Med Inst, Urbana, IL 61801 USA; [Kelleher, Neil L.] Northwestern Univ, Prote Ctr Excellence, Dept Chem, Evanston, IL 60611 USA; [Kelleher, Neil L.] Northwestern Univ, Prote Ctr Excellence, Dept Mol Biosci, Evanston, IL 60611 USA; [Zimmerman, Tyler A.] NIST, Mass Spectrometry Data Ctr Grp, Gaithersburg, MD 20899 USA; [Collins, James J., III] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Lee, Ji Eun] Korea Inst Sci & Technol, Biomed Res Inst, Ctr Theragnosis, Seoul 136791, South Korea	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Howard Hughes Medical Institute; University of Illinois System; University of Illinois Urbana-Champaign; Northwestern University; Northwestern University; National Institute of Standards & Technology (NIST) - USA; University of Texas System; University of Texas Southwestern Medical Center Dallas; Korea Institute of Science & Technology (KIST)	Sweedler, JV (corresponding author), Univ Illinois, Dept Chem, Urbana, IL 61801 USA.	jsweedle@illinois.edu	Sweedler, Jonathan V/A-9405-2009	Sweedler, Jonathan V/0000-0003-3107-9922; Newmark, Phillip/0000-0003-0793-022X; Romanova, Elena/0000-0002-2040-3312; Zimmerman, Tyler/0000-0002-5408-9771	National Institutes of Health NINDS [RO1 NS031609]; NICHD [R01 HD043403]; National Institute on Drug Abuse [P30 DA018310]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD043403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS031609] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA018310] Funding Source: NIH RePORTER	National Institutes of Health NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The work was supported by the National Institutes of Health NINDS Grant RO1 NS031609, NICHD Grant R01 HD043403, and National Institute on Drug Abuse Grant P30 DA018310. The content is solely the responsibility of the authors and does not necessarily represent the official views of the funding agencies. The authors have no conflicts of interest to declare.	Agata K, 2008, PHILOS T R SOC B, V363, P2071, DOI 10.1098/rstb.2008.2260; BAGUNA J, 1989, International Journal of Developmental Biology, V33, P261; Boser A, 2013, CELL REP, V5, P1142, DOI 10.1016/j.celrep.2013.10.035; Brandl H, 2016, NUCLEIC ACIDS RES, V44, pD764, DOI 10.1093/nar/gkv1148; Brockes JR, 2008, ANNU REV CELL DEV BI, V24, P525, DOI 10.1146/annurev.cellbio.24.110707.175336; Bruand J, 2011, J PROTEOME RES, V10, P1915, DOI 10.1021/pr101159e; Brubacher JL, 2014, NAT PROTOC, V9, P661, DOI 10.1038/nprot.2014.041; Buchberger A, 2015, ANNU REV ANAL CHEM, V8, P485, DOI 10.1146/annurev-anchem-071114-040210; Casadonte R, 2011, NAT PROTOC, V6, P1695, DOI 10.1038/nprot.2011.388; Cebria F, 2002, NATURE, V419, P620, DOI 10.1038/nature01042; Chen XG, 2015, DEV GENES EVOL, V225, P79, DOI 10.1007/s00427-015-0494-3; Collins JJ, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000509; Deininger SO, 2010, METHODS MOL BIOL, V656, P385, DOI 10.1007/978-1-60761-746-4_22; Eisenhoffer GT, 2008, CELL STEM CELL, V3, P327, DOI 10.1016/j.stem.2008.07.002; Elliott SA, 2013, WIRES DEV BIOL, V2, P301, DOI 10.1002/wdev.82; Fernandez-Taboada E, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-133; Fraguas S, 2012, INT J DEV BIOL, V56, P143, DOI 10.1387/ijdb.113428sf; Fricker LD, 2007, ENDOCRINOLOGY, V148, P4185, DOI 10.1210/en.2007-0123; Gessel MM, 2014, J PROTEOMICS, V107, P71, DOI 10.1016/j.jprot.2014.03.021; Goldstein AL, 2012, EXPERT OPIN BIOL TH, V12, P37, DOI 10.1517/14712598.2012.634793; HALL JD, 1990, J NEUROBIOL, V21, P858, DOI 10.1002/neu.480210604; Hori I, 1997, J SUBMICR CYTOL PATH, V29, P91; Iglesias M, 2011, DEV BIOL, V358, P68, DOI 10.1016/j.ydbio.2011.07.013; Inoue T, 2004, ZOOL SCI, V21, P275, DOI 10.2108/zsj.21.275; King RS, 2013, BMC DEV BIOL, V13, DOI 10.1186/1471-213X-13-8; King RS, 2012, J CELL BIOL, V196, P553, DOI 10.1083/jcb.201105099; Kreshchenko ND, 2014, BIOCHEM MOSC SUPPL S, V8, P89, DOI 10.1134/S1990747813050097; Kreshchenko N D, 2009, Ontogenez, V40, P3; Kreshchenko ND, 2008, ACTA BIOL HUNG, V59, P199, DOI 10.1556/ABiol.59.2008.Suppl.29; Kumar A, 2012, TRENDS NEUROSCI, V35, P691, DOI 10.1016/j.tins.2012.08.003; Labbe RM, 2012, STEM CELLS, V30, P1734, DOI 10.1002/stem.1144; Lanni EJ, 2012, J PROTEOMICS, V75, P5036, DOI 10.1016/j.jprot.2012.03.017; Lapan SW, 2012, CELL REP, V2, P294, DOI 10.1016/j.celrep.2012.06.018; Maezawa T, 2014, MECH DEVELOP, V132, P69, DOI 10.1016/j.mod.2013.12.003; Masyuko RN, 2014, ANALYST, V139, P5700, DOI 10.1039/c4an00435c; McVeigh P, 2005, PARASITOLOGY, V131, pS41, DOI 10.1017/S0031182005008851; Meriaux C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018359; Mineta K, 2003, P NATL ACAD SCI USA, V100, P7666, DOI 10.1073/pnas.1332513100; Newmark PA, 2000, DEV BIOL, V220, P142, DOI 10.1006/dbio.2000.9645; Newmark PA, 2002, NAT REV GENET, V3, P210, DOI 10.1038/nrg759; Nishimura K, 2011, J NEUROCHEM, V119, P1217, DOI 10.1111/j.1471-4159.2011.07518.x; Okamoto K, 2005, ZOOL SCI, V22, P535, DOI 10.2108/zsj.22.535; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Rangiah K, 2013, RAPID COMMUN MASS SP, V27, P2439, DOI 10.1002/rcm.6706; Rink JC, 2009, SCIENCE, V326, P1406, DOI 10.1126/science.1178712; Robb SMC, 2014, CURR TOP DEV BIOL, V108, P71, DOI 10.1016/B978-0-12-391498-9.00004-8; Roberts-Galbraith RH, 2015, CURR OPIN GENET DEV, V32, P37, DOI 10.1016/j.gde.2015.01.009; Roberts-Galbraith RH, 2013, P NATL ACAD SCI USA, V110, P1363, DOI 10.1073/pnas.1214053110; Romanova EV, 2015, J NEUROCHEM, V135, P1038, DOI 10.1111/jnc.13265; Romanova EV, 2015, TRENDS PHARMACOL SCI, V36, P579, DOI 10.1016/j.tips.2015.05.009; Romanova EV, 2013, CURR OPIN CHEM BIOL, V17, P801, DOI 10.1016/j.cbpa.2013.05.030; Romanova EV, 2012, J NEUROCHEM, V123, P276, DOI 10.1111/j.1471-4159.2012.07912.x; Rouhana L, 2014, DEVELOPMENT, V141, P2592, DOI 10.1242/dev.101618; Rowinska-Zyrek M, 2015, COORDIN CHEM REV, V284, P298, DOI 10.1016/j.ccr.2014.03.026; Rubakhin SS, 2010, METHODS MOL BIOL, V656, P21, DOI 10.1007/978-1-60761-746-4_2; Sandmann T, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r76; Seeley EH, 2011, TRENDS BIOTECHNOL, V29, P136, DOI 10.1016/j.tibtech.2010.12.002; Sheman I. M., 2010, ONTOGENEZ, V41, P114; Sikes JM, 2013, NATURE, V500, P77, DOI 10.1038/nature12403; Solana J, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-3-r19; Southey BR, 2014, ANAL CHEM, V86, P443, DOI 10.1021/ac4023378; Spengler B, 2015, ANAL CHEM, V87, P64, DOI 10.1021/ac504543v; Strand FL, 1999, NEUROPEPTIDES REGULA; Umesono Y, 2009, DEV GROWTH DIFFER, V51, P185, DOI 10.1111/j.1440-169X.2009.01099.x; van Wolfswinkel JC, 2014, CELL STEM CELL, V15, P326, DOI 10.1016/j.stem.2014.06.007; Vasquez-Doorman C, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004452; Wagner DE, 2012, CELL STEM CELL, V10, P299, DOI 10.1016/j.stem.2012.01.016; Wenemoser D, 2010, DEV BIOL, V344, P979, DOI 10.1016/j.ydbio.2010.06.017; Yang JH, 2011, ANAL CHEM, V83, P5728, DOI 10.1021/ac200998a; Yang Yong, 2007, J Biomol Tech, V18, P226; Zamdborg L, 2007, NUCLEIC ACIDS RES, V35, pW701, DOI 10.1093/nar/gkm371	71	19	19	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2016	291	15					8109	8120		10.1074/jbc.M115.709196	http://dx.doi.org/10.1074/jbc.M115.709196			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DJ2SZ	26884331	Green Published, hybrid			2022-12-26	WOS:000374056700028
J	Rizzetto, L; Ifrim, DC; Moretti, S; Tocci, N; Cheng, SC; Quintin, J; Renga, G; Oikonomou, V; De Filippo, C; Weil, T; Blok, BA; Lenucci, MS; Santos, MAS; Romani, L; Netea, MG; Cavalieri, D				Rizzetto, Lisa; Ifrim, Daniela C.; Moretti, Silvia; Tocci, Noemi; Cheng, Shih-Chin; Quintin, Jessica; Renga, Giorgia; Oikonomou, Vasilis; De Filippo, Carlotta; Weil, Tobias; Blok, Bastiaan A.; Lenucci, Marcello S.; Santos, Manuel A. S.; Romani, Luigina; Netea, Mihai G.; Cavalieri, Duccio			Fungal Chitin Induces Trained Immunity in Human Monocytes during Cross-talk of the Host with Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell wall; cellular immune response; fungi; host-pathogen interaction; phagocytosis	CANDIDA-ALBICANS; DENDRITIC CELLS; IN-VIVO; IL-17 PRODUCTION; HUMAN SKIN; DEFENSE; MEMORY; METABOLISM; STRAINS; YEAST	The immune system is essential to maintain the mutualistic homeostatic interaction between the host and its micro- and mycobiota. Living as a commensal, Saccharomyces cerevisiae could potentially shape the immune response in a significant way. We observed that S. cerevisiae cells induce trained immunity in monocytes in a strain-dependent manner through enhanced TNF and IL-6 production upon secondary stimulation with TLR ligands, as well as bacterial and fungal commensals. Differential chitin content accounts for the differences in training properties observed among strains, driving induction of trained immunity by increasing cytokine production and direct antimicrobial activity both in vitro and in vivo. These chitin-induced protective properties are intimately associated with its internalization, identifying a critical role of phagosome acidification to facilitate microbial digestion. This study reveals how commensal and passenger microorganisms could be important in promoting health and preventing mucosal diseases by modulating host defense toward pathogens and thus influencing the host microbiota-immune system interactions.	[Rizzetto, Lisa; Tocci, Noemi; De Filippo, Carlotta; Weil, Tobias; Cavalieri, Duccio] Fdn Edmund Mach, Res & Innovat Ctr, I-38010 San Michele All Adige, TN, Italy; [Ifrim, Daniela C.; Cheng, Shih-Chin; Quintin, Jessica; Blok, Bastiaan A.; Netea, Mihai G.] Radboud Univ Nijmegen, Med Ctr, Div Expt Internal Med, Dept Internal Med, NL-6525 GA Nijmegen, Netherlands; [Moretti, Silvia; Oikonomou, Vasilis; Romani, Luigina] Univ Perugia, Polo Unico StAndrea Fratte, Dept Expt Med, I-06123 Perugia, PG, Italy; [De Filippo, Carlotta; Cavalieri, Duccio] CNR, Inst Biometeorol, I-50145 Florence, Italy; [Lenucci, Marcello S.] Univ Salento, Dipartimento Sci & Tecnol Biol Ambientali, I-73100 Lecce, LE, Italy; [Santos, Manuel A. S.] Univ Aveiro, Dept Biol, P-3810193 Aveiro, Portugal; [Santos, Manuel A. S.] Univ Aveiro, CESAM Ctr Estudos Ambiente & Mar, P-3810193 Aveiro, Portugal; [Cavalieri, Duccio] Univ Florence, Dept Biol, Via Madonna Piano 6, I-50019 Sesto Fiorentino, FI, Italy; [Quintin, Jessica] Inst Pasteur, Dept Mycol, Immunol Fungal Infect Grp, F-75724 Paris 15, France	Fondazione Edmund Mach; Radboud University Nijmegen; University of Perugia; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biometeorologia (IBIMET-CNR); University of Salento; Universidade de Aveiro; Universidade de Aveiro; University of Florence; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Cavalieri, D (corresponding author), Univ Florence, Dept Biol, Via Madonna Piano 6, I-50019 Sesto Fiorentino, FI, Italy.	duccio.cavalieri@unifi.it	Netea, Mihai/N-5155-2014; De Filippo, Carlotta/AAB-5805-2019; Romani, Luigina/O-9987-2018; CHENG, SHIH-CHIN/M-3773-2019; Rizzetto, Lisa/C-7304-2016; De Filippo, Carlotta/AAE-4683-2021; Cheng, Shih-Chin/H-4567-2015; CAVALIERI, DUCCIO/T-3097-2017	De Filippo, Carlotta/0000-0002-2222-6524; CHENG, SHIH-CHIN/0000-0003-1251-8774; Rizzetto, Lisa/0000-0002-2170-9276; Cheng, Shih-Chin/0000-0003-1251-8774; CAVALIERI, DUCCIO/0000-0001-6426-5719; Romani, Luigina/0000-0002-1356-525X; MORETTI, Silvia/0000-0002-8177-7254; Renga, Giorgia/0000-0002-9762-6493; Oikonomou, Vasileios/0000-0002-7553-0159; Santos, Manuel/0000-0002-0437-1146	European Union [HEALTH-2010-242220, HEALTH-2010-260338]; Vici grant from the Netherlands Organization for Scientific Research; ERC [310372]; MetafoodbookLabs grant from Provincia Autonoma di Trento and UNIFARM	European Union(European Commission); Vici grant from the Netherlands Organization for Scientific Research; ERC(European Research Council (ERC)European Commission); MetafoodbookLabs grant from Provincia Autonoma di Trento and UNIFARM	This work was supported from the European Union's Seventh Framework Programme (FP7/2007-2013) under Grant Agreement HEALTH-2010-242220 ("SYBARIS"; to D. C), by a Vici grant from the Netherlands Organization for Scientific Research (to J. Q., S.-C. C., and M. G. N.), by ERC Consolidator Grant 310372 (to M. G. N.), by European Union's Seventh Framework Programme (FP7/2007-2013) under Grant Agreement HEALTH-2010-260338 ("ALLFUN"; to D. C. I. and M. G. N.), and by the MetafoodbookLabs grant from Provincia Autonoma di Trento and UNIFARM (to D. C., L. R., N. T., and T. W.). The authors declare that they have no conflicts of interest with the contents of this article.	Alvarez FJ, 2014, MOLECULES, V19, P4433, DOI 10.3390/molecules19044433; Angebault C, 2013, J INFECT DIS, V208, P1705, DOI 10.1093/infdis/jit389; Bonifazi P, 2009, MUCOSAL IMMUNOL, V2, P362, DOI 10.1038/mi.2009.17; Brachmann CB, 1998, YEAST, V14, P115; Cheng SC, 2014, SCIENCE, V345, P1579, DOI 10.1126/science.1250684; Cheng SC, 2010, J IMMUNOL, V185, P2450, DOI 10.4049/jimmunol.1000756; Chien MW, 2015, J BIOL CHEM, V290, P29329, DOI 10.1074/jbc.M115.674671; Conrath U, 2011, TRENDS PLANT SCI, V16, P524, DOI 10.1016/j.tplants.2011.06.004; Da Silva CA, 2009, J IMMUNOL, V182, P3573, DOI 10.4049/jimmunol.0802113; Dallies N, 1998, YEAST, V14, P1297, DOI 10.1002/(SICI)1097-0061(1998100)14:14<1297::AID-YEA310>3.0.CO;2-L; Durrant WE, 2004, ANNU REV PHYTOPATHOL, V42, P185, DOI 10.1146/annurev.phyto.42.040803.140421; Eloe-Fadrosh EA, 2015, MBIO, V6, DOI 10.1128/mBio.00231-15; Ferreira C, 2006, FEMS YEAST RES, V6, P1027, DOI 10.1111/j.1567-1364.2006.00110.x; Findley K, 2013, NATURE, V498, P367, DOI 10.1038/nature12171; Foligne B, 2007, WORLD J GASTROENTERO, V13, P236, DOI 10.3748/wjg.v13.i2.236; Foligne B, 2010, APPL ENVIRON MICROB, V76, P8259, DOI 10.1128/AEM.01976-10; Foligne B, 2010, WORLD J GASTROENTERO, V16, P2134, DOI 10.3748/wjg.v16.i17.2134; Hirschfeld M, 2000, J IMMUNOL, V165, P618, DOI 10.4049/jimmunol.165.2.618; Ifrim DC, 2013, J IMMUNOL, V190, P4129, DOI 10.4049/jimmunol.1202611; Iliev ID, 2012, SCIENCE, V336, P1314, DOI 10.1126/science.1221789; Ip WKE, 2010, J IMMUNOL, V184, P7071, DOI 10.4049/jimmunol.1000110; KANE SM, 1974, J BACTERIOL, V118, P8, DOI 10.1128/JB.118.1.8-14.1974; Kekkonen RA, 2008, WORLD J GASTROENTERO, V14, P2029, DOI 10.3748/wjg.14.2029; Kelly B, 2015, CELL RES, V25, P771, DOI 10.1038/cr.2015.68; Klis FM, 2001, MED MYCOL, V39, P1, DOI 10.1080/744118876; Kurtz J, 2005, TRENDS IMMUNOL, V26, P186, DOI 10.1016/j.it.2005.02.001; Landry CR, 2006, MOL ECOL, V15, P575, DOI 10.1111/j.1365-294X.2006.02778.x; Lowman DW, 2011, CARBOHYD RES, V346, P2752, DOI 10.1016/j.carres.2011.09.029; Marakalala MJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003315; Mora-Montes HM, 2011, INFECT IMMUN, V79, P1961, DOI 10.1128/IAI.01282-10; Mukherjee PK, 2015, NAT REV GASTRO HEPAT, V12, P77, DOI 10.1038/nrgastro.2014.188; Muller A, 1996, J IMMUNOL, V156, P3418; Netea MG, 2011, CELL HOST MICROBE, V9, P355, DOI 10.1016/j.chom.2011.04.006; O'Neill LAJ, 2016, J EXP MED, V213, P15, DOI 10.1084/jem.20151570; Oh J, 2013, GENOME RES, V23, P2103, DOI 10.1101/gr.159467.113; Poulain D, 2009, DIGEST DIS, V27, P104, DOI 10.1159/000268129; Quintin J, 2014, CURR OPIN IMMUNOL, V29, P1, DOI 10.1016/j.coi.2014.02.006; Quintin J, 2012, CELL HOST MICROBE, V12, P223, DOI 10.1016/j.chom.2012.06.006; Rizzetto L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056651; Rizzetto L, 2010, J IMMUNOL, V184, P4258, DOI 10.4049/jimmunol.0902972; Romani L, 2015, SEMIN IMMUNOPATHOL, V37, P163, DOI 10.1007/s00281-014-0464-2; Romani L, 2014, EUR J IMMUNOL, V44, P3192, DOI 10.1002/eji.201344406; Saeed S, 2014, SCIENCE, V345, P1578, DOI 10.1126/science.1251086; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Tan Z, 2015, J IMMUNOL, V194, P6082, DOI 10.4049/jimmunol.1402469; Wagener J, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004050; Xu JP, 1999, J CLIN MICROBIOL, V37, P3835, DOI 10.1128/JCM.37.12.3835-3843.1999; Yoshida K, 2015, NAT IMMUNOL, V16, P1034, DOI 10.1038/ni.3257	48	56	57	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2016	291	15					7961	7972		10.1074/jbc.M115.699645	http://dx.doi.org/10.1074/jbc.M115.699645			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DJ2SZ	26887946	Green Published, hybrid			2022-12-26	WOS:000374056700018
J	Chen, YM; Lai, CH; Chang, HC; Chao, TY; Tseng, CC; Fang, WF; Wang, CC; Chung, YH; Wang, YH; Su, MC; Liu, SF; Huang, KT; Chen, HC; Chang, YC; Lin, MC				Chen, Yu-Mu; Lai, Chien-Hao; Chang, Huang-Chih; Chao, Tung-Ying; Tseng, Chia-Cheng; Fang, Wen-Feng; Wang, Chin-Chou; Chung, Yu-Hsiu; Wang, Yi-Hsi; Su, Mao-Chang; Liu, Shih-Feng; Huang, Kuo-Tung; Chen, Hung-Chen; Chang, Ya-Chun; Lin, Meng-Chih			Antacid Use and De Novo Brain Metastases in Patients with Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer Who Were Treated Using First-Line First-Generation Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors	PLOS ONE			English	Article							NERVOUS-SYSTEM METASTASES; PHASE-III; ERLOTINIB; GEFITINIB; MUTATIONS; CHEMOTHERAPY; THERAPY; TAIWAN; TUMORS; NSCLC	Background Antacid treatments decrease the serum concentrations of first-generation epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors (TKIs), although it is unknown whether antacids affect clinical outcomes. As cerebrospinal fluid concentrations of TKIs are much lower than serum concentrations, we hypothesized that this drug-drug interaction might affect the prognosis of patients with de novo brain metastases. Materials and Methods This retrospective study evaluated 269 patients with EGFR-mutant non-small cell lung cancer (NSCLC) who had been diagnosed between December 2010 and December 2013, and had been treated using first-line first-generation EGFR-TKIs. Among these patients, we identified patients who concurrently used H2 receptor antagonists (H2RAs) and proton pump inhibitors (PPIs) as antacids. Patients who exhibited >30% overlap between the use of TKIs and antacids were considered antacid users. Results Fifty-seven patients (57/269, 21.2%) were antacid users, and antacid use did not significantly affect progression-free survival (PFS; no antacids: 11.2 months, H2RAs: 9.4 months, PPIs: 6.7 months; p = 0.234). However, antacid use significantly reduced overall survival (OS; no antacids: 25.0 months, H2RAs: 15.5 months, PPIs: 11.3 months; p = 0.002). Antacid use did not affect PFS for various metastasis sites, although antacid users with de novo brain metastases exhibited significantly shorter OS, compared to non-users (11.8 vs. 16.3 months, respectively; p = 0.041). Antacid use did not significantly affect OS in patients with bone, liver, or pleural metastases. Conclusion Antacid use reduced OS among patients with EGFR-mutant NSCLC who were treated using first-line first-generation EGFR-TKIs, and especially among patients with de novo brain metastases.	[Chen, Yu-Mu; Lai, Chien-Hao; Chang, Huang-Chih; Chao, Tung-Ying; Tseng, Chia-Cheng; Fang, Wen-Feng; Wang, Chin-Chou; Chung, Yu-Hsiu; Wang, Yi-Hsi; Su, Mao-Chang; Liu, Shih-Feng; Huang, Kuo-Tung; Chen, Hung-Chen; Chang, Ya-Chun; Lin, Meng-Chih] Chang Gung Univ, Chang Gung Mem Hosp, Div Pulm & Crit Care Med, Dept Internal Med,Kaohsiung Med Ctr,Coll Med, Kaohsiung, Taiwan; [Fang, Wen-Feng] Chang Gung Inst Technol, Dept Resp Care, Chiayi, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University of Science & Technology	Lin, MC (corresponding author), Chang Gung Univ, Chang Gung Mem Hosp, Div Pulm & Crit Care Med, Dept Internal Med,Kaohsiung Med Ctr,Coll Med, Kaohsiung, Taiwan.	mengchih@adm.cgmh.org.tw	Fang, Wen-Feng/AAT-6296-2021	Fang, Wen-Feng/0000-0003-0350-9059; chen, hong cheng/0000-0001-9713-3835; Liu, Shih-Feng/0000-0003-1394-5401				Budha NR, 2012, CLIN PHARMACOL THER, V92, P203, DOI 10.1038/clpt.2012.73; Chen G, 2013, ANN ONCOL, V24, P1615, DOI 10.1093/annonc/mdt012; Chen YM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136252; Chu MP, 2015, CLIN LUNG CANCER, V16, P33, DOI 10.1016/j.cllc.2014.07.005; Deng YM, 2014, MOL CLIN ONCOL, V2, P116, DOI 10.3892/mco.2013.190; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Fukudo M, 2013, CLIN PHARMACOKINET, V52, P593, DOI 10.1007/s40262-013-0058-5; Gurpide A, 2005, CLIN LUNG CANCER, V7, P138, DOI 10.3816/CLC.2005.n.030; Henley SJ, 2014, MMWR-MORBID MORTAL W, V63, P1; Heon S, 2010, CLIN CANCER RES, V16, P5873, DOI 10.1158/1078-0432.CCR-10-1588; Hilton JF, 2013, LUNG CANCER, V82, P136, DOI 10.1016/j.lungcan.2013.06.008; Horiike A, 2007, CHEST, V131, P1628, DOI 10.1378/chest.06-1673; Kogure Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135393; Kosaka T, 2004, CANCER RES, V64, P8919, DOI 10.1158/0008-5472.CAN-04-2818; Lie CH, 2011, CLIN LUNG CANCER, V12, P116, DOI 10.1016/j.cllc.2011.03.006; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Thongprasert S, 2011, J THORAC ONCOL, V6, P1872, DOI 10.1097/JTO.0b013e31822adaf7; Togashi Y, 2012, CANCER CHEMOTH PHARM, V70, P399, DOI 10.1007/s00280-012-1929-4; Togashi Y, 2010, J THORAC ONCOL, V5, P950, DOI 10.1097/JTO.0b013e3181e2138b; Tokumo M, 2005, CLIN CANCER RES, V11, P1167; Wang BY, 2013, J THORAC ONCOL, V8, P1128, DOI 10.1097/JTO.0b013e31829ceba4; Yang JCH, 2015, LANCET ONCOL, V16, P141, DOI 10.1016/S1470-2045(14)71173-8	22	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0149722	10.1371/journal.pone.0149722	http://dx.doi.org/10.1371/journal.pone.0149722			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3DG	26894507	Green Published, gold, Green Submitted			2022-12-26	WOS:000371223400077
J	Franca, VF; Barbosa, AR; D'Orsi, E				Franca, Vivian Francielle; Barbosa, Aline Rodrigues; D'Orsi, Eleonora			Cognition and Indicators of Dietary Habits in Older Adults from Southern Brazil	PLOS ONE			English	Article							MENTAL-STATE-EXAMINATION; ALZHEIMERS-DISEASE; MEDITERRANEAN DIET; PHYSICAL-ACTIVITY; FISH CONSUMPTION; POPULATION; IMPAIRMENT; AGE; ASSOCIATIONS; DECLINE	Objective To assess the association between unhealthy dietary habits and cognition in older adults from Southern Brazil. Methods This cross-sectional study analyzed data from the second wave of a population-and house-hold-based epidemiological survey (2013-2014) conducted in the city of Florianopolis. A total of 1,197 older adults (778 women) over 60 years old participated in the study. Cognition, the dependent variable, was measured by the Mini-Mental State Examination (MMSE). The independent variables were the following indicators of unhealthy dietary habits: low intake of fruits and vegetables (<= 4 servings/day); fish (< 1 serving/week); and habitual fatty meat intake (yes/no). Adjustments were made for age, education level, income, smoking status, alcohol intake, leisure-time physical activity, depression symptoms, chronic diseases, and body mass index. Simple and multiple linear regression analyses were performed, considering sampling weights and stratification by gender. Results The mean MMSE scores for men and women were 25.15 +/- 5.56 and 24.26 +/- 5.68, respectively (p = 0.009). After adjustments, in women low fruit and vegetable intake (<= 4 servings/day) was independently associated with the lowest MMSE scores. No associations were found in men. Additionally, women's mean MMSE scores increased as their daily frequency of fruit and vegetable intake increased (p = 0.001). Conclusion Women with low fruit and vegetable intake according to the World Health Organization (WHO) have lower cognition scores. Regular intake of fruits, vegetables, and fish in exchange of fatty meats may be a viable public policy strategy to preserve cognition in aging.	[Franca, Vivian Francielle] Univ Fed Santa Catarina, Programa Pos Grad Nutr, Florianopolis, SC, Brazil; [Barbosa, Aline Rodrigues] Univ Fed Santa Catarina, Programa Pos Grad Nutr, Ctr Desportos, Dept Nutr, Florianopolis, SC, Brazil; [D'Orsi, Eleonora] Univ Fed Santa Catarina, Programa Pos Grad Saude Colet, Dept Saude Publ, Florianopolis, SC, Brazil	Universidade Federal de Santa Catarina (UFSC); Universidade Federal de Santa Catarina (UFSC); Universidade Federal de Santa Catarina (UFSC)	Franca, VF (corresponding author), Univ Fed Santa Catarina, Programa Pos Grad Nutr, Florianopolis, SC, Brazil.	vivianfranca@unipar.br	d'Orsi, Eleonora/D-1905-2015		Brazilian National Council for Scientific and Technological Development (CNPq) [569834/2008-2]	Brazilian National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This paper is based on the EPIFLORIPA2009 - Florianopolis Ageing Health Survey. Funding institution: Brazilian National Council for Scientific and Technological Development (CNPq), grant number 569834/2008-2. URL: http://www.cnpq.br/. Author who received the funding: ED. This research was developed in the Graduate Program in Public Health, Federal University of Santa Catarina, Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida OP, 1999, ARQ NEURO-PSIQUIAT, V57, P421, DOI 10.1590/S0004-282X1999000300013; Almeida OP, 1998, ARQ NEURO-PSIQUIAT, V56, P605, DOI 10.1590/S0004-282X1998000400014; Andrade FCD, 2014, ARCH GERONTOL GERIAT, V58, P219, DOI 10.1016/j.archger.2013.10.007; Babor TF., 2001, AUDIT ALCOHOL USE DI; Bernstein M, 2012, J ACAD NUTR DIET, V112, P1255, DOI 10.1016/j.jand.2012.06.015; BERTOLUCCI PHF, 1994, ARQ NEURO-PSIQUIAT, V52, P1, DOI 10.1590/S0004-282X1994000100001; Brasil. Ministerio da Saude, 2012, VIG FAT RISC PROT DO; Brasil. Ministerio da Saude, 2012, ATENCAO A SAUDE DO I; Brasil. Ministerio da Saude, 2004, VIG AL NUTR SISV OR; Brasil. Ministerio da Saude, 2010, AL SAUD PESS ID MAN; Brasil. Ministerio da Saude. Secretaria de Vigilancia em Saude. Departamento de Vigilancia de Doencas e Agravos nao Transmissiveis e Promocao da Saude, 2013, VIG FAT RISC PROT DO; Campolina AG, 2013, CAD SAUDE PUBLICA, V29, P1217, DOI [10.1590/S0102-311X2013000600018, 10.1590/S0102-311X2013001000018]; Cardoso BR, 2013, CLIN INTERV AGING, V8, P531, DOI 10.2147/CIA.S27983; Chan R, 2013, J NUTR HEALTH AGING, V17, P757, DOI 10.1007/s12603-013-0348-5; Chang SL, 2015, PREV MED, V77, P68, DOI 10.1016/j.ypmed.2015.05.001; Chen X, 2012, J NUTR HEALTH AGING, V16, P549, DOI 10.1007/s12603-012-0023-2; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Davis SW, 2009, NEUROIMAGE, V46, P530, DOI 10.1016/j.neuroimage.2009.01.068; Eshkoor SA, 2015, CLIN INTERV AGING, V10, P687, DOI 10.2147/CIA.S73922; Feart C, 2013, P NUTR SOC, V72, P140, DOI 10.1017/S0029665112002959; FRISANCHO AR, 1984, AM J CLIN NUTR, V40, P808, DOI 10.1093/ajcn/40.4.808; Gao Ming-yue, 2015, Beijing Da Xue Xue Bao Yi Xue Ban, V47, P443; Han C, 2008, ARCH GERONTOL GERIAT, V47, P302, DOI 10.1016/j.archger.2007.08.012; Instituto Brasileiro de Geografia e Estatistica (IBGE), 2011, PESQ ORC FAM POF 200; Kesse-Guyot E, 2011, J NUTR HEALTH AGING, V15, P115, DOI 10.1007/s12603-011-0023-7; Kiefer I., 2005, J MENS HLTH GENDER, V2, P194, DOI 10.1016/j.jmhg.2005.04.010; Li RN, 2014, FRONT NEUROENDOCRIN, V35, P385, DOI 10.1016/j.yfrne.2014.01.002; Loef M, 2012, J NUTR HEALTH AGING, V16, P626, DOI 10.1007/s12603-012-0097-x; Lourenco RA, 2006, REV SAUDE PUBL, V40, P712, DOI 10.1590/S0034-89102006000500023; Monteiro CA, 2008, REV SAUDE PUBL, V42, P582, DOI 10.1590/S0034-89102008000400002; Morris MC, 2006, NEUROLOGY, V67, P1370, DOI 10.1212/01.wnl.0000240224.38978.d8; Morris MC, 2005, ARCH NEUROL-CHICAGO, V62, P1849, DOI 10.1001/archneur.62.12.noc50161; Nitrini R., 1999, ARQ NEURO-PSIQUIAT, V57, P7; Parrott MD, 2013, J NUTR, V143, P1767, DOI 10.3945/jn.113.181115; Pastor-Valero M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104139; Programa das Nacoes Unidas para o desenvolvimento (PNUD), 2013, ATL DES HUM BRAS; Raji CA, 2014, AM J PREV MED, V47, P444, DOI 10.1016/j.amepre.2014.05.037; Scazufca M, 2009, EUR ARCH PSY CLIN N, V259, P8, DOI 10.1007/s00406-008-0827-6; Soares LM, 2012, ARCH GERONTOL GERIAT, V54, pE187, DOI 10.1016/j.archger.2011.11.014; Titova OE, 2013, EXP GERONTOL, V48, P1443, DOI 10.1016/j.exger.2013.10.002; Titova OE, 2013, AGE, V35, P1495, DOI 10.1007/s11357-012-9453-3; Torres SJ, 2012, NUTRIENTS, V4, P1542, DOI 10.3390/nu4111542; Tur JA, 2012, BRIT J NUTR, V107, pS23, DOI 10.1017/S0007114512001456; Valle EA, 2009, CAD SAUDE PUBLICA, V25, P918, DOI 10.1590/S0102-311X2009000400023; Veras Renato, 2009, Rev. Saúde Pública, V43, P548, DOI 10.1590/S0034-89102009005000025; Warnberg J, 2009, ANN NY ACAD SCI, V1153, P164, DOI 10.1111/j.1749-6632.2008.03985.x; Wang Y, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0116359, 10.1371/journal.pone.0124566]; Wang ZQ, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-595; WHO, 2003, DIET NUTR PREVENTION, V916; WHO, 2005, ENV AT POL SAUD; Holz Adriana Winter, 2013, Rev. bras. epidemiol., V16, P880, DOI 10.1590/S1415-790X2013000400008; Ye XW, 2013, BRIT J NUTR, V109, P503, DOI 10.1017/S0007114512001183; Zattar LC, 2013, CAD SAUDE PUBLICA, V29, P507, DOI 10.1590/S0102-311X2013000300009	53	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0147820	10.1371/journal.pone.0147820	http://dx.doi.org/10.1371/journal.pone.0147820			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF3DG	26894259	Green Published, gold			2022-12-26	WOS:000371223400009
J	Jain, S; Aresu, L; Comazzi, S; Shi, JG; Worrall, E; Clayton, J; Humphries, W; Hemmington, S; Davis, P; Murray, E; Limeneh, AA; Ball, K; Ruckova, E; Muller, P; Vojtesek, B; Fahraeus, R; Argyle, D; Hupp, TR				Jain, Saurabh; Aresu, Luca; Comazzi, Stefano; Shi, Jianguo; Worrall, Erin; Clayton, John; Humphries, William; Hemmington, Sandra; Davis, Paul; Murray, Euan; Limeneh, Asmare A.; Ball, Kathryn; Ruckova, Eva; Muller, Petr; Vojtesek, Borek; Fahraeus, Robin; Argyle, David; Hupp, Ted R.			The Development of a Recombinant scFv Monoclonal Antibody Targeting Canine CD20 for Use in Comparative Medicine	PLOS ONE			English	Article							NON-HODGKINS-LYMPHOMA; ONE WORLD; AUTOIMMUNE-DISEASES; ONE HEALTH; PHAGE-DISPLAY; MOUSE MODELS; B-CELLS; CANCER; RITUXIMAB; THERAPY	Monoclonal antibodies are leading agents for therapeutic treatment of human diseases, but are limited in use by the paucity of clinically relevant models for validation. Sporadic canine tumours mimic the features of some human equivalents. Developing canine immunotherapeutics can be an approach for modeling human disease responses. Rituximab is a pioneering agent used to treat human hematological malignancies. Biologic mimics that target canine CD20 are just being developed by the biotechnology industry. Towards a comparative canine-human model system, we have developed a novel anti-CD20 monoclonal antibody (NCD1.2) that binds both human and canine CD20. NCD1.2 has a sub-nanomolar K-d as defined by an octet red binding assay. Using FACS, NCD1.2 binds to clinically derived canine cells including B-cells in peripheral blood and in different histotypes of B-cell lymphoma. Immunohistochemical staining of canine tissues indicates that the NCD1.2 binds to membrane localized cells in Diffuse Large B-cell lymphoma, Marginal Zone Lymphoma, and other canine B-cell lymphomas. We cloned the heavy and light chains of NCD1.2 from hybridomas to determine whether active scaffolds can be acquired as future biologics tools. The V-H and V-L genes from the hybridomas were cloned using degenerate primers and packaged as single chains (scFv) into a phage-display library. Surprisingly, we identified two scFv (scFv-3 and scFv-7) isolated from the hybridoma with bioactivity towards CD20. The two scFv had identical VH genes but different V-L genes and identical CDR3s, indicating that at least two light chain mRNAs are encoded by NCD1.2 hybridoma cells. Both scFv-3 and scFv-7 were cloned into mammalian vectors for secretion in CHO cells and the antibodies were bioactive towards recombinant CD20 protein or peptide. The scFv-3 and scFv-7 were cloned into an ADEPT-CPG2 bioconjugate vector where bioactivity was retained when expressed in bacterial systems. These data identify a recombinant anti-CD20 scFv that might form a useful tool for evaluation in bioconjugate-directed anti-CD20 immunotherapies in comparative medicine.	[Jain, Saurabh; Shi, Jianguo; Worrall, Erin; Murray, Euan; Ball, Kathryn; Argyle, David; Hupp, Ted R.] Univ Edinburgh, Inst Genet & Mol Med, Edinburgh EH4 2XR, Midlothian, Scotland; [Jain, Saurabh; Shi, Jianguo; Worrall, Erin; Murray, Euan; Ball, Kathryn; Argyle, David; Hupp, Ted R.] Sch Vet Med, Edinburgh EH4 2XR, Midlothian, Scotland; [Aresu, Luca] Univ Padua, Dept Comparat Biomed & Food Sci, Dipartimento Biomed Comparata & Alimentaz BCA, I-35020 Legnaro, PD, Italy; [Comazzi, Stefano] Univ Milan, Dipartimento Sci Vet & Sanita Pubbl, Via Celoria 10, I-20133 Milan, Italy; [Clayton, John; Humphries, William; Hemmington, Sandra; Davis, Paul] Mologic Ltd, Bedford Technol Pk, Bedford MK44 2YP, England; [Limeneh, Asmare A.] Bahit Dar Univ, Coll Med & Hlth Sci, Dept Med Biochem & Mol Biol, Bahir Dar, Ethiopia; [Ruckova, Eva; Muller, Petr; Vojtesek, Borek] Masaryk Mem Canc Inst, Reg Ctr Appl Mol Oncol, Brno 65653, Czech Republic; [Murray, Euan; Fahraeus, Robin] Univ Paris 07, Hop St Louis, Inst Genet Mol, INSERM U940, 27 Rue Juliette Dodu, Paris, France	University of Edinburgh; University of Padua; University of Milan; Masaryk Memorial Cancer Institute; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Hupp, TR (corresponding author), Univ Edinburgh, Inst Genet & Mol Med, Edinburgh EH4 2XR, Midlothian, Scotland.; Hupp, TR (corresponding author), Sch Vet Med, Edinburgh EH4 2XR, Midlothian, Scotland.	Ted.Hupp@ed.ac.uk	Muller, Petr/AAK-5014-2021; Muller, Petr/F-7762-2015; fahraeus, robin/K-8726-2014; Aresu, Luca/J-9788-2018	Muller, Petr/0000-0002-8404-4494; Muller, Petr/0000-0002-8404-4494; Humphries, William/0000-0002-6869-6601; , robin/0000-0003-0402-8492; Hupp, Ted/0000-0003-0391-0352; Aresu, Luca/0000-0002-7893-1740	BBSRC [BB/J00751X/1]; INSERM (Inserm Plan Cancer) [A12112HS]; Petplan; project Ministry of Education Youth and Sports (MEYS) [NPS-I - LO1413]; Czech Science Foundation (GACR) [P206/12/G151]; Regional Center for Applied Molecular Oncology (RECAMO) [ED2.1.00/03.0101]; Biotechnology and Biological Sciences Research Council [BB/J00751X/1] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); INSERM (Inserm Plan Cancer); Petplan; project Ministry of Education Youth and Sports (MEYS); Czech Science Foundation (GACR)(Grant Agency of the Czech Republic); Regional Center for Applied Molecular Oncology (RECAMO); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the BBSRC (BB/J00751X/1), INSERM (Inserm Plan Cancer A12112HS; EM), partially supported by Petplan, and was partially supported by the project Ministry of Education Youth and Sports (MEYS) - NPS-I - LO1413. BV and PM were supported with Czech Science Foundation (GACR) P206/12/G151. BV, ER, and PM were supported by ED2.1.00/03.0101 - Regional Center for Applied Molecular Oncology (RECAMO) (2011-2014, MSM / ED). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagshawe KD, 2009, CURR DRUG TARGETS, V10, P152, DOI 10.2174/138945009787354520; Bhatia J, 2000, INT J CANCER, V85, P571; BLAKEY DC, 1995, BRIT J CANCER, V72, P1083, DOI 10.1038/bjc.1995.469; Calistri P, 2013, TRANSBOUND EMERG DIS, V60, P4, DOI 10.1111/tbed.12145; Castillo-Trivino T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066308; Chambers SA, 2005, LUPUS, V14, P210, DOI 10.1191/0961203305lu2138oa; Comazzi S, 2011, VET J, V188, P149, DOI 10.1016/j.tvjl.2010.03.011; Das Thakur M, 2014, J PATHOL, V232, P103, DOI 10.1002/path.4285; Doerner A, 2014, FEBS LETT, V588, P278, DOI 10.1016/j.febslet.2013.11.025; Du JM, 2007, J BIOL CHEM, V282, P15073, DOI 10.1074/jbc.M701654200; Eisenhardt SU, 2007, NAT PROTOC, V2, P3063, DOI 10.1038/nprot.2007.455; Ernst JA, 2005, BIOCHEMISTRY-US, V44, P15150, DOI 10.1021/bi0511078; Ferraresso S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092707; Griffin MM, 2013, EXPERT OPIN BIOL TH, V13, P803, DOI 10.1517/14712598.2013.786698; Grillo-Lopez Antonio J, 2002, Expert Rev Anticancer Ther, V2, P485, DOI 10.1586/14737140.2.5.485; Henry Carolyn J, 2013, Mo Med, V110, P216; Ito D, 2014, VET IMMUNOLOGY IMMUN; Ito D, 2014, LEUKEMIA LYMPHOMA; Jubala CM, 2005, VET PATHOL, V42, P468, DOI 10.1354/vp.42-4-468; Khanna C, 2006, NAT BIOTECHNOL, V24, P1065, DOI 10.1038/nbt0906-1065b; Klopfleisch R, 2011, VET J, V190, P236, DOI 10.1016/j.tvjl.2011.04.010; Kola I, 2004, NAT REV DRUG DISCOV, V3, P711, DOI 10.1038/nrd1470; LANE DP, 1981, J IMMUNOL METHODS, V47, P303, DOI 10.1016/0022-1759(81)90286-6; Lee S, 2010, J ALLERGY CLIN IMMUN, V125, P814, DOI 10.1016/j.jaci.2010.02.025; Luengo-Fernandez R, 2013, LANCET ONCOL, V14, P1165, DOI 10.1016/S1470-2045(13)70442-X; Malaney P, 2014, CANCER LETT, V344, P1, DOI 10.1016/j.canlet.2013.10.010; Maloney DG, 1997, BLOOD, V90, P2188; Milenic DE, 2002, CURR PHARM DESIGN, V8, P1749, DOI 10.2174/1381612023393963; Mittra J, 2012, NEW BIOTECHNOL, V29, P709, DOI 10.1016/j.nbt.2012.03.003; Mudaliar MAV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072591; Nathan Sheila, 2002, J Biochem Mol Biol Biophys, V6, P45, DOI 10.1080/10258140290010232; Nixon AE, 2014, MABS-AUSTIN, V6, P73, DOI 10.4161/mabs.27240; Osburn B, 2009, REV SCI TECH OIE, V28, P481, DOI 10.20506/rst.28.2.1884; Parker HG, 2010, ANNU REV GENET, V44, P309, DOI 10.1146/annurev-genet-102808-115200; Peldschus K, 2014, METHODS MOL BIOL, V1070, P213, DOI 10.1007/978-1-4614-8244-4_16; Perosa F, 2005, AUTOIMMUN REV, V4, P526, DOI 10.1016/j.autrev.2005.04.004; Perosa F, 2009, J IMMUNOL, V182, P416, DOI 10.4049/jimmunol.182.1.416; Pinho SS, 2012, TRANSL RES, V159, P165, DOI 10.1016/j.trsl.2011.11.005; Poggi A, 2013, VET COMP ONCOLOGY; Porrello A, 2006, J EXP CLIN CANC RES, V25, P97; Pouget JP, 2011, NAT REV CLIN ONCOL, V8, P720, DOI 10.1038/nrclinonc.2011.160; Powers Glenn A, 2012, Methods Mol Biol, V907, P699, DOI 10.1007/978-1-61779-974-7_39; Ranieri G, 2013, CRIT REV ONCOL HEMAT, V88, P187, DOI 10.1016/j.critrevonc.2013.03.005; Ricart AD, 2007, NAT CLIN PRACT ONCOL, V4, P245, DOI 10.1038/ncponc0774; Scott AM, 2012, NAT REV CANCER, V12, P278, DOI 10.1038/nrc3236; Shearin AL, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000310; Siller E, 2010, J MOL BIOL, V396, P1310, DOI 10.1016/j.jmb.2009.12.042; Sinha A, 2013, NAT REV NEPHROL, V9, P154, DOI 10.1038/nrneph.2012.289; Sinha G, 2014, NAT BIOTECHNOL, V32, P12, DOI 10.1038/nbt.2793; Siolas D, 2013, CANCER RES, V73, P5315, DOI 10.1158/0008-5472.CAN-13-1069; Tobinai K, 2003, CANCER CHEMOTH PHARM, V52, pS90, DOI 10.1007/s00280-003-0595-y; Torgerson PR, 2013, VET PARASITOL, V195, P223, DOI 10.1016/j.vetpar.2013.04.004; van Helden PD, 2013, EMBO REP, V14, P497, DOI 10.1038/embor.2013.61; Vital EM, 2013, EXPERT OPIN BIOL TH, V13, P1049, DOI 10.1517/14712598.2013.787064; Vo AA, 2014, TRANSPLANTATION; Weiner LM, 2010, NAT REV IMMUNOL, V10, P317, DOI 10.1038/nri2744; Wiseman GA, 2002, BLOOD, V99, P4336, DOI 10.1182/blood.V99.12.4336; Yang J, 2013, BIOTECHNOL APPL BIOC, V60, P289, DOI 10.1002/bab.1080	58	25	25	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0148366	10.1371/journal.pone.0148366	http://dx.doi.org/10.1371/journal.pone.0148366			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3DG	26894679	Green Submitted, Green Published, gold			2022-12-26	WOS:000371223400012
J	Aron-Wisnewsky, J; Verger, EO; Bounaix, C; Dao, MC; Oppert, JM; Bouillot, JL; Chevallier, JM; Clement, K				Aron-Wisnewsky, Judith; Verger, Eric O.; Bounaix, Carine; Dao, Maria Carlota; Oppert, Jean-Michel; Bouillot, Jean-Luc; Chevallier, Jean-Marc; Clement, Karine			Nutritional and Protein Deficiencies in the Short Term following Both Gastric Bypass and Gastric Banding	PLOS ONE			English	Article							VERTICAL BANDED GASTROPLASTY; LIFE-STYLE INTERVENTION; MORBIDLY OBESE-PATIENTS; BARIATRIC SURGERY; BODY-COMPOSITION; WEIGHT-LOSS; NATIONAL NUTRITION; DIETARY-INTAKE; MANAGEMENT; VITAMIN	Background The number of morbidly obese patients undergoing bariatric surgery (BS) has increased dramatically in recent years. Therefore, monitoring food intake and its consequences in terms of nutritional status is necessary to prevent nutritional deficiencies. The aim of this study was to analyze the effect of food restriction on nutritional parameters in the short-term (<= 3 months) period after BS in morbid obesity. Method In a prospective study, we followed 22 obese women who underwent Roux-en-Y gastric bypass (GBP) or adjustable gastric banding (AGB) at baseline (T0) and 1 (T1) and 3 (T3) months after surgery. We evaluated food intake, nutrient adequacy and serum concentrations of vitamins and minerals known to be at risk for deficiency following BS. Results Before surgery, we observed suboptimal food intakes, leading to a risk of micronutrient deficiencies. Serum analysis confirmed nutritional deficiencies for iron and thiamine for 27 and 23% of the patients, respectively. The drastic energy and food reduction seen in the short term led to very low probabilities of adequacy for nutrients equivalent across both surgeries. Serum analysis demonstrated a continuous decrease in prealbumin during the follow-up, indicating mild protein depletion in 21 and 57% of GBP patients and 50 and 63% of AGB patients, respectively, at T1 and T3. Regarding vitamins and minerals, systematic supplementation after GBP prevented most nutritional deficiencies. By contrast, AGB patients, for whom there is no systematic supplementation, developed such deficiencies. Conclusions Our results suggest that cautious monitoring of protein intake after BS is mandatory. Furthermore, AGB patients might also benefit from systematic multivitamin and mineral supplementation at least in the short term.	[Aron-Wisnewsky, Judith; Verger, Eric O.; Dao, Maria Carlota; Oppert, Jean-Michel; Clement, Karine] Hop La Pitie Salpetriere, AP HP, ICAN, Inst Cardiometab & Nutr,Dept Nutr, F-75013 Paris, France; [Aron-Wisnewsky, Judith; Bounaix, Carine; Clement, Karine] UPMC Univ Paris 06, Univ Sorbonne, UMR S 1166 I, ICAN,Nutri Team, F-75005 Paris, France; [Aron-Wisnewsky, Judith; Verger, Eric O.; Bounaix, Carine; Dao, Maria Carlota; Clement, Karine] INSERM, UMR S U1166, Nutri Team, F-75013 Paris, France; [Bouillot, Jean-Luc] Ambroise Pare Hosp, AP HP, Visceral Surg Dept, F-92100 Boulogne, France; [Chevallier, Jean-Marc] Hop Europeen Georges Pompidou, AP HP, Visceral Surg Dept, F-75015 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite	Aron-Wisnewsky, J; Clement, K (corresponding author), Hop La Pitie Salpetriere, AP HP, ICAN, Inst Cardiometab & Nutr,Dept Nutr, F-75013 Paris, France.; Aron-Wisnewsky, J; Clement, K (corresponding author), UPMC Univ Paris 06, Univ Sorbonne, UMR S 1166 I, ICAN,Nutri Team, F-75005 Paris, France.; Aron-Wisnewsky, J; Clement, K (corresponding author), INSERM, UMR S U1166, Nutri Team, F-75013 Paris, France.	judith.aron-wisnewsky@psl.aphp.fr; karine.clement@psl.aphp.fr	Clément, karine/R-1120-2017; Oppert, Jean-Michel/F-2810-2017; ARON-WISNEWSKY, judith/AAH-7608-2020; Verger, Eric/J-9163-2016	Verger, Eric/0000-0002-8689-8290	European Union [HEALTH-F4-2012-305312]; "Programme Hospitalier de Recherche Clinique" from Health ministry [PHRC Microbaria AOM10285/ P100111]; Institut Appert; Nestle research	European Union(European Commission); "Programme Hospitalier de Recherche Clinique" from Health ministry; Institut Appert(Centre National de la Recherche Scientifique (CNRS)); Nestle research(Nestle SA)	This project has received funding from the European Union's Seventh Framework Programme for research, technological development and demonstration under grant agreement HEALTH-F4-2012-305312 (Metacardis). It is also supported by the "Programme Hospitalier de Recherche Clinique" from Health ministry (PHRC Microbaria AOM10285/ P100111). JAW received a grant from Institut Appert and from Nestle research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This project has received funding from the European Union's Seventh Framework Programme for research, technological development and demonstration under grant agreement HEALTH-F4-2012-305312 (Metacardis). It is also supported by the "Programme Hospitalier de Recherche Clinique" from Health ministry (PHRC Microbaria AOM10285/ P100111). JAW received a grant from Institut Appert and from Nestle research.	Aasheim ET, 2008, AM J CLIN NUTR, V87, P362, DOI 10.1093/ajcn/87.2.362; Aasheim ET, 2009, AM J CLIN NUTR, V90, P15, DOI 10.3945/ajcn.2009.27583; Aasheim ET, 2008, ANN SURG, V248, P714, DOI 10.1097/SLA.0b013e3181884308; Aasheim ET, 2012, SURG OBES RELAT DIS, V8, P169, DOI 10.1016/j.soard.2011.01.038; Andreu A, 2010, OBES SURG, V20, P1509, DOI 10.1007/s11695-010-0268-y; Angrisani L, 2015, OBES SURG, V25, P1822, DOI 10.1007/s11695-015-1657-z; Aron-Wisnewsky J, 2012, J HEPATOL, V56, P225, DOI 10.1016/j.jhep.2011.04.022; Bavaresco M, 2010, OBES SURG, V20, P716, DOI 10.1007/s11695-008-9721-6; Bernert CP, 2007, DIABETES METAB, V33, P13, DOI 10.1016/j.diabet.2006.11.004; Black JA, 2013, OBES REV, V14, P634, DOI 10.1111/obr.12037; Bozbora A, 2000, OBES SURG, V10, P274, DOI 10.1381/096089200321643610; Buchwald H, 2004, JAMA-J AM MED ASSOC, V292, P1724, DOI 10.1001/jama.292.14.1724; Carrodeguas L, 2005, SURG OBES RELAT DIS, V1, P522, DOI DOI 10.1016/j.soard.2005.08.003; Castetbon K, 2009, BRIT J NUTR, V102, P733, DOI 10.1017/S0007114509274745; Chapman AE, 2004, SURGERY, V135, P326, DOI 10.1016/S0039-6060(03)00392-1; Ciangura C, 2010, OBESITY, V18, P760, DOI 10.1038/oby.2009.348; Coupaye M, 2014, OBES SURG, V24, P276, DOI 10.1007/s11695-013-1089-6; Coupaye M, 2009, OBES SURG, V19, P56, DOI 10.1007/s11695-008-9571-2; Cui YF, 2011, J GASTROINTEST SURG, V15, P1879, DOI 10.1007/s11605-011-1585-8; Rocha VCA, 2012, NUTR HOSP, V27, P1134, DOI 10.3305/nh.2012.27.4.5812; Dalmas E, 2011, AM J CLIN NUTR, V94, P450, DOI 10.3945/ajcn.111.013771; Davis CJ, 2012, JPEN-PARENTER ENTER, V36, P197, DOI 10.1177/0148607111413896; Dias Maria Carolina G., 2006, Clinics, V61, P93, DOI 10.1590/S1807-59322006000200002; Dixon JB, 2011, NAT REV GASTRO HEPAT, V8, P429, DOI 10.1038/nrgastro.2011.112; Dyson PA, 2010, DIABETES OBES METAB, V12, P941, DOI 10.1111/j.1463-1326.2010.01256.x; Ells LJ, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011740; Ernst B, 2009, OBES SURG, V19, P274, DOI 10.1007/s11695-008-9769-3; Estaquio C, 2009, J AM DIET ASSOC, V109, P1031, DOI 10.1016/j.jada.2009.03.012; Favretti F, 2002, AM J SURG, V184, p38S, DOI 10.1016/S0002-9610(02)01178-9; Foster-Schubert KE, 2011, CURR OPIN ENDOCRINOL, V18, P129, DOI 10.1097/MED.0b013e32834449b9; Freeman RA, 2014, OBES RES CLIN PRACT, V8, pE183, DOI 10.1016/j.orcp.2013.02.002; Fried M, 2013, OBESITY FACTS, V6, P449, DOI [10.1159/000355480, 10.1007/s11695-013-1079-8]; Gesquiere I, 2014, OBES SURG, V24, P1896, DOI 10.1007/s11695-014-1325-8; Godlewski AE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022324; Heber D, 2010, J CLIN ENDOCR METAB, V95, P4823, DOI 10.1210/jc.2009-2128; Hercberg S, 2008, INT J PUBLIC HEALTH, V53, P68, DOI 10.1007/s00038-008-7016-2; Johnson LK, 2013, BRIT J NUTR, V110, P127, DOI 10.1017/S0007114512004631; KENLER HA, 1990, AM J CLIN NUTR, V52, P87, DOI 10.1093/ajcn/52.1.87; Le Moullec N, CAH NUTR DIETETIQUE, V31, P158; Ledoux S, 2006, OBES SURG, V16, P1041, DOI 10.1381/096089206778026415; Lefebvre P, 2014, SURG OBES RELAT DIS, V10, P540, DOI 10.1016/j.soard.2013.10.003; Lissner L, 1998, EUR J CLIN NUTR, V52, P316, DOI 10.1038/sj.ejcn.1600567; Livingstone MBE, 2003, J NUTR, V133, p895S, DOI 10.1093/jn/133.3.895S; Lo Menzo E, 2014, BARIATR SURG PRACT P, V9, P9, DOI 10.1089/bari.2014.9969; Mechanick JI, 2009, OBESITY, V17, pS1, DOI 10.1038/oby.2009.28; Moize V, 2003, OBES SURG, V13, P23, DOI 10.1381/096089203321136548; Moize V, 2013, CLIN NUTR, V32, P550, DOI 10.1016/j.clnu.2012.11.007; Nielsen BM, 2009, J NUTR, V139, P2337, DOI 10.3945/jn.109.112599; O'Brien PE, 2010, JAMA-J AM MED ASSOC, V303, P519, DOI 10.1001/jama.2010.81; Olbers T, 2006, ANN SURG, V244, P715, DOI 10.1097/01.sla.0000218085.25902.f8; Peterson LA, 2015, MALNUTRITION BARIATR; Quesada KR, 2014, J AM COLL NUTR, V33, P155, DOI 10.1080/07315724.2013.874893; Raftopoulos I, 2011, SURG OBES RELAT DIS, V7, P733, DOI 10.1016/j.soard.2011.07.008; Sanchez A, 2015, OBES SURG; Schweiger C, 2010, OBES SURG, V20, P193, DOI 10.1007/s11695-009-0008-3; Shah M, 2006, J CLIN ENDOCR METAB, V91, P4223, DOI 10.1210/jc.2006-0557; TALLAKSEN CME, 1991, J CHROMATOGR-BIOMED, V564, P127, DOI 10.1016/0378-4347(91)80075-N; Touvier M, 2011, BRIT J NUTR, V105, P1055, DOI 10.1017/S0007114510004617; TROSTLER N, 1995, OBES SURG, V5, P39, DOI 10.1381/096089295765558141; Verger EO, 2015, OBES SURG; Verger EO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042155; Veugelers PJ, 2015, NUTRIENTS, V7, P10189, DOI 10.3390/nu7125527; Vuillemin A, 2000, MED SCI SPORT EXER, V32, P1119, DOI 10.1097/00005768-200006000-00013; Wing RR, 2005, AM J CLIN NUTR, V82, p222S, DOI 10.1093/ajcn/82.1.222S; Zitsman JL, 2015, SURG OBES RELAT DIS, V11, P101, DOI 10.1016/j.soard.2014.06.001	65	56	56	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2016	11	2							e0149588	10.1371/journal.pone.0149588	http://dx.doi.org/10.1371/journal.pone.0149588			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3CO	26891123	Green Published, Green Submitted, gold			2022-12-26	WOS:000371221500061
J	Borne, Y; Smith, JG; Nilsson, PM; Melander, O; Hedblad, B; Engstrom, G				Borne, Yan; Smith, J. Gustav; Nilsson, Peter M.; Melander, Olle; Hedblad, Bo; Engstroem, Gunnar			Total and Differential Leukocyte Counts in Relation to Incidence of Diabetes Mellitus: A Prospective Population-Based Cohort Study	PLOS ONE			English	Article							INTIMA-MEDIA THICKNESS; NECROSIS-FACTOR-ALPHA; BLOOD-CELL COUNT; GENETIC-VARIANTS; MALMO DIET; INSULIN SENSITIVITY; ADAPTER PROTEIN; INTERLEUKIN-6; RISK; ATHEROSCLEROSIS	Objective High concentrations of leukocytes in blood have been associated with diabetes mellitus. This prospective study aimed to explore whether total and differential leukocyte counts are associated with incidence of diabetes. A missense variant R262W in the SH2B3 (SH2B adaptor protein 3) gene, coding for a protein that negatively regulates hematopoietic cell proliferation, was also studied in relation to incidence of diabetes. Methods and Results Leukocyte count and its subtypes (neutrophils, lymphocytes and mixed cells) were analyzed in 26,667 men and women, 45-73 years old, from the population-based Malmo Diet and Cancer study. Information about the R262W polymorphism (rs3184504) in SH2B3 was genotyped in 24,489 subjects. Incidence of diabetes was studied during a mean follow-up of 14 years. Cox proportional hazards regression was used to examine incidence of diabetes by total and differential leukocyte counts. Mendelian randomization analysis using R262W as an instrumental variable was performed with two-stage least squares regression. A total of 2,946 subjects developed diabetes during the follow-up period. After taking several possible confounders into account, concentrations of total leukocyte count, neutrophils and lymphocytes were all significantly associated with incidence of diabetes. The adjusted hazard ratios (95% confidence interval; quartile 4 vs quartile 1) were 1.37 (1.22-1.53) for total leukocytes, 1.33 (1.19-1.49) for neutrophils and 1.29 (1.15-1.44) for lymphocytes. The R262W polymorphism was strongly associated with leukocytes (0.11x10(9) cells/l per T allele, p = 1.14 x10(-12)), lymphocytes (p = 4.3 x10(-16)), neutrophils (p = 8.0 x10(-6)) and mixed cells (p = 3.0 x10(-6)). However, there was no significant association between R262W and fasting glucose, HbA1c or incidence of diabetes. Conclusions Concentrations of total leukocytes, neutrophils and lymphocytes are associated with incidence of diabetes. However, the lack of association with the R262W polymorphism suggests that the associations may not be causal, although limitations in statistical power and balancing pleiotropic effects cannot be excluded.	[Borne, Yan; Nilsson, Peter M.; Melander, Olle; Hedblad, Bo; Engstroem, Gunnar] Lund Univ, Dept Clin Sci, Malmo, Sweden; [Smith, J. Gustav] Lund Univ, Dept Cardiol, Clin Sci, Lund, Sweden; [Smith, J. Gustav] Skane Univ Hosp, Lund, Sweden; [Smith, J. Gustav] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Smith, J. Gustav] Harvard Univ, Sch Med, Boston, MA USA; [Smith, J. Gustav] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA; [Smith, J. Gustav] Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA USA; [Nilsson, Peter M.; Melander, Olle] Skane Univ Hosp, Dept Internal Med, Malmo, Sweden	Lund University; Lund University; Lund University; Skane University Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Lund University; Skane University Hospital	Borne, Y (corresponding author), Lund Univ, Dept Clin Sci, Malmo, Sweden.	Yan.Borne@med.lu.se	b, y/AAG-3349-2019	Melander, Olle/0000-0002-2581-484X	Swedish Research Council [2011-3891, 2014-2265]; Swedish Heart and Lung Foundation [20100244, 20130249]; Lundstrom Foundation; Skane University Hospital; Novo Nordisk Fonden [NNF13OC0005339] Funding Source: researchfish	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Lundstrom Foundation; Skane University Hospital; Novo Nordisk Fonden(Novo Nordisk Foundation)	The study was supported by grants from the Swedish Research Council (Dnr 2011-3891; 2014-2265), the Swedish Heart and Lung Foundation (Grant Nos. 20100244; 20130249), the Lundstrom Foundation and by funds from the Skane University Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The Swedish National Diabetes Register (NDR), the Malmo HbA<INF>1c</INF> register (MHR), the Diabetes 2000 registers and the National Board of Health and Welfare are acknowledged for valuable assistance in retrieval of diabetes end-points. The study was supported by grants from the Swedish Heart and Lung foundation and the Swedish Research council.	Alcina A, 2010, GENES IMMUN, V11, P439, DOI 10.1038/gene.2010.30; Barzilay JI, 2001, DIABETES, V50, P2384, DOI 10.2337/diabetes.50.10.2384; Baum C., IVREG2 STATA MODULE; BERGLUND G, 1993, J INTERN MED, V233, P45, DOI 10.1111/j.1365-2796.1993.tb00647.x; Crosslin DR, 2012, HUM GENET, V131, P639, DOI 10.1007/s00439-011-1103-9; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Ebrahim S, 2008, HUM GENET, V123, P15, DOI 10.1007/s00439-007-0448-6; Enhorning S, 2010, CIRCULATION, V121, P2102, DOI 10.1161/CIRCULATIONAHA.109.909663; Fernandez-Real JM, 2000, DIABETES, V49, P517, DOI 10.2337/diabetes.49.3.517; Fitau J, 2006, J BIOL CHEM, V281, P20148, DOI 10.1074/jbc.M510997200; Ford ES, 2002, AM J EPIDEMIOL, V155, P57, DOI 10.1093/aje/155.1.57; Gkrania-Klotsas E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013405; Gudbjartsson DF, 2009, NAT GENET, V41, P342, DOI 10.1038/ng.323; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Hedblad B, 2000, DIABETIC MED, V17, P299, DOI 10.1046/j.1464-5491.2000.00280.x; Levy D, 2009, NAT GENET, V41, P677, DOI 10.1038/ng.384; Li C, 2009, EUR J CLIN NUTR, V63, P1448, DOI 10.1038/ejcn.2009.69; Li YJ, 2000, J IMMUNOL, V164, P5199, DOI 10.4049/jimmunol.164.10.5199; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; Maahs DM, 2010, ENDOCRIN METAB CLIN, V39, P481, DOI 10.1016/j.ecl.2010.05.011; Manjer J, 2001, EUR J CANCER PREV, V10, P489, DOI 10.1097/00008469-200112000-00003; Melander O, 2012, JAMA-J AM MED ASSOC, V308, P1469, DOI 10.1001/jama.2012.12998; Muller-Steinhardt M, 2007, CLIN EXP IMMUNOL, V147, P339, DOI 10.1111/j.1365-2249.2006.03273.x; Nalls MA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002113; Nilsson J, 1998, ARTERIOSCL THROM VAS, V18, P1199, DOI 10.1161/01.ATV.18.8.1199; Orru V, 2013, CELL, V155, P242, DOI 10.1016/j.cell.2013.08.041; Perez-Garcia A, 2013, BLOOD, V122, P2425, DOI 10.1182/blood-2013-05-500850; Pradhan AD, 2001, JAMA-J AM MED ASSOC, V286, P327, DOI 10.1001/jama.286.3.327; Reddy MVPL, 2011, GENES IMMUN, V12, P208, DOI 10.1038/gene.2010.70; Rosvall M, 2015, ATHEROSCLEROSIS, V239, P615, DOI 10.1016/j.atherosclerosis.2015.01.030; Rosvall M, 2000, AM J EPIDEMIOL, V152, P334, DOI 10.1093/aje/152.4.334; Schmidt MI, 1999, LANCET, V353, P1649, DOI 10.1016/S0140-6736(99)01046-6; Senn JJ, 2002, DIABETES, V51, P3391, DOI 10.2337/diabetes.51.12.3391; Smedman C, 2009, J IMMUNOL METHODS, V346, P1, DOI 10.1016/j.jim.2009.04.001; Soranzo N, 2009, NAT GENET, V41, P1182, DOI 10.1038/ng.467; Takaki S, 2002, J EXP MED, V195, P151, DOI 10.1084/jem.20011170; Vozarova B, 2002, DIABETES, V51, P455, DOI 10.2337/diabetes.51.2.455; Wilson PWF, 2007, ARCH INTERN MED, V167, P1068, DOI 10.1001/archinte.167.10.1068; Zheng JS, 2013, J NUTR, V143, P354, DOI 10.3945/jn.112.168401; Zia E, 2012, J INTERN MED, V272, P298, DOI 10.1111/j.1365-2796.2012.02526.x; Zia E, 2007, STROKE, V38, P2681, DOI 10.1161/STROKEAHA.106.479725	41	7	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2016	11	2							e0148963	10.1371/journal.pone.0148963	http://dx.doi.org/10.1371/journal.pone.0148963			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3CO	26891449	Green Published, gold			2022-12-26	WOS:000371221500018
J	Devakumar, D; Hallal, PC; Horta, BL; Barros, FC; Wells, JCK				Devakumar, D.; Hallal, P. C.; Horta, B. L.; Barros, F. C.; Wells, J. C. K.			Association between Birth Interval and Cardiovascular Outcomes at 30 Years of Age: A Prospective Cohort Study from Brazil	PLOS ONE			English	Article							DEVELOPING-COUNTRIES; NUTRITIONAL-STATUS; BODY-COMPOSITION; CHILD HEALTH; PREGNANCY; INFANT; FETAL; DISEASE; GROWTH; UNDERNUTRITION	Background Birth interval is an important and potentially modifiable factor that is associated with child health. Whether an association exists with longer-term outcomes in adults is less well known. Methods Using the 1982 Pelotas (Brazil) Birth Cohort Study, the association of birth interval with markers of cardiovascular health at 30 years of age was examined. Multivariable linear regression was used with birth interval as a continuous variable and categorical variable, and effect modification by gender was explored. Results Birth interval and cardiovascular data were present for 2,239 individuals. With birth interval as a continuous variable, no association was found but stratification by gender tended to show stronger associations for girls. When compared to birth intervals of <18 months, as binary variable, longer intervals were associated with increases in height (1.6 cm; 95% CI: 0.5, 2.8) and lean mass (1.7 kg; 95% CI: 0.2, 3.2). No difference was seen with other cardiovascular outcomes. Conclusions An association was generally not found between birth interval and cardiovascular outcomes at 30 years of age, though some evidence existed for differences between males and females and for an association with height and lean mass for birth intervals of 18 months and longer.	[Devakumar, D.] UCL, Inst Global Hlth, London, England; [Hallal, P. C.; Horta, B. L.; Barros, F. C.] Univ Fed Pelotas, Postgrad Programme Epidemiol, Pelotas, Brazil; [Wells, J. C. K.] UCL, Inst Child Hlth, London, England	University of London; University College London; Universidade Federal de Pelotas; University of London; University College London	Devakumar, D (corresponding author), UCL, Inst Global Hlth, London, England.	d.devakumar@ucl.ac.uk	Wells, Jonathan/A-4604-2009; Horta, Bernardo/A-7604-2008	Wells, Jonathan/0000-0003-0411-8025; Horta, Bernardo/0000-0001-9843-412X; Barros, Fernando/0000-0001-5973-1746	Wellcome Trust; International Development Research Center (Canada); Brazilian National Research Council (CNPq); Rio Grande do Sul State Research Support Foundation (FAPERGS); Brazilian Ministry of Health; International Development Research Center; World Health Organization; Overseas Development Administration; European Union; National Support Program for Centers of Excellence (PRONEX); CNPq; FAPERGS; National Institute for Health Research; Wellcome Trust through a New Investigator Award; National Institute for Health Research [ACF-2007-18-008, CL-2015-18-004] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); International Development Research Center (Canada)(CGIAR); Brazilian National Research Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Rio Grande do Sul State Research Support Foundation (FAPERGS); Brazilian Ministry of Health; International Development Research Center; World Health Organization(World Health Organization); Overseas Development Administration; European Union(European Commission); National Support Program for Centers of Excellence (PRONEX); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERGS(Fundacao de Amparo a Ciencia e Tecnologia do Estado do Rio Grande do Sul (FAPERGS)); National Institute for Health Research(National Institute for Health Research (NIHR)); Wellcome Trust through a New Investigator Award(Wellcome Trust); National Institute for Health Research(National Institute for Health Research (NIHR))	The authors received no specific funding for this work. The cohort study was funded by the Wellcome Trust; the International Development Research Center (Canada); the Brazilian National Research Council (CNPq); Rio Grande do Sul State Research Support Foundation (FAPERGS); and the Brazilian Ministry of Health. The study is based on data from the study "Pelotas Birth Cohort, 1982" done by the Postgraduate Program in Epidemiology at Universidade Federal de Pelotas, with the collaboration of the Brazilian Public Health Association (ABRASCO). From 2004 to 2013, the Wellcome Trust supported the 1982 birth cohort study. The International Development Research Center, World Health Organization, Overseas Development Administration, European Union, National Support Program for Centers of Excellence (PRONEX), CNPq, FAPERGS, and the Brazilian Ministry of Health supported previous phases of the study. PCH is funded by the Wellcome Trust through a New Investigator Award. DD receives salary support from the National Institute for Health Research.	BARKER DJP, 1995, BRIT MED J, V311, P171, DOI 10.1136/bmj.311.6998.171; BARKER DJP, 1993, LANCET, V341, P938, DOI 10.1016/0140-6736(93)91224-A; Barros FC, 2008, REV SAUDE PUBL, V42, P7, DOI 10.1590/S0034-89102008000900003; Conde-Agudelo A, 2005, INT J GYNECOL OBSTET, V89, pS34, DOI 10.1016/j.ijgo.2004.08.003; Conde-Agudelo A, 2012, STUD FAMILY PLANN, V43, P93, DOI 10.1111/j.1728-4465.2012.00308.x; Dewey KG, 2007, MATERN CHILD NUTR, V3, P151, DOI 10.1111/j.1740-8709.2007.00092.x; Gernand AD, 2012, J NUTR, V142, P2010, DOI 10.3945/jn.112.163634; Gribble JN, 2009, MATERN CHILD NUTR, V5, P49, DOI 10.1111/j.1740-8709.2008.00158.x; HALES CN, 1991, BMJ-BRIT MED J, V303, P1019, DOI 10.1136/bmj.303.6809.1019; Horta BL, 2015, INT J EPIDEMIOL, V44, P441, DOI 10.1093/ije/dyv017; HUTTLY SRA, 1992, PEDIATRICS, V89, P1049; Jansen WH, 2005, INT J GYNECOL OBSTET, V89, pS50, DOI 10.1016/j.ijgo.2004.11.013; Kirkwood BR, 2003, ESSENTIAL MED STAT; Kozuki N, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-S3-S6; Kozuki N, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-S3-S5; Mason JB, 2014, GLOBAL HEALTH ACTION, V7, DOI 10.3402/gha.v7.23623; Mathews F, 2004, AM J CLIN NUTR, V79, P103; Mathews F, 1999, BRIT MED J, V319, P339, DOI 10.1136/bmj.319.7206.339; Norton M, 2005, INT J GYNECOL OBSTET, V89, pS1, DOI 10.1016/j.ijgo.2004.12.012; O' Connor C, 2014, PRENATAL DIAG, V34, P605, DOI 10.1002/pd.4336; Painter RC, 2006, AM J CLIN NUTR, V84, P322; Razzaque A, 2005, INT J GYNECOL OBSTET, V89, pS41, DOI 10.1016/j.ijgo.2005.01.003; RichEdwards JW, 1997, BRIT MED J, V315, P396, DOI 10.1136/bmj.315.7105.396; Rutstein SO, 2005, INT J GYNECOL OBSTET, V89, pS7, DOI 10.1016/j.ijgo.2004.11.012; Siervo M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013907; Thame M, 2004, EUR J CLIN NUTR, V58, P894, DOI 10.1038/sj.ejcn.1601909; Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4; Wells JCK, 2011, AM J EPIDEMIOL, V174, P1028, DOI 10.1093/aje/kwr232; Wells JCK, 2010, AM J HUM BIOL, V22, P1, DOI 10.1002/ajhb.20994; Wendt A, 2012, PAEDIATR PERINAT EP, V26, P239, DOI 10.1111/j.1365-3016.2012.01285.x; Wilcox AJ, 2001, INT J EPIDEMIOL, V30, P1233, DOI 10.1093/ije/30.6.1233; World Health Organization, 2006, REP WHO TECHN CONS B	32	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2016	11	2							e0149054	10.1371/journal.pone.0149054	http://dx.doi.org/10.1371/journal.pone.0149054			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3CO	26890250	gold, Green Published, Green Submitted			2022-12-26	WOS:000371221500023
J	Mittra, ES; Koglin, N; Mosci, C; Kumar, M; Hoehne, A; Keu, KV; Iagaru, AH; Mueller, A; Berndt, M; Bullich, S; Friebe, M; Schmitt-Willich, H; Gekeler, V; Fels, LM; Bacher-Stier, C; Moon, DH; Chin, FT; Stephens, AW; Dinkelborg, LM; Gambhir, SS				Mittra, Erik S.; Koglin, Norman; Mosci, Camila; Kumar, Meena; Hoehne, Aileen; Keu, Khun Visith; Iagaru, Andrei H.; Mueller, Andre; Berndt, Mathias; Bullich, Santiago; Friebe, Matthias; Schmitt-Willich, Heribert; Gekeler, Volker; Fels, Lueder M.; Bacher-Stier, Claudia; Moon, Dae Hyuk; Chin, Frederick T.; Stephens, Andrew W.; Dinkelborg, Ludger M.; Gambhir, Sanjiv S.			Pilot Preclinical and Clinical Evaluation of (4S)-4-(3-[F-18]Fluoropropyl)-L-Glutamate (18F-FSPG) for PET/CT Imaging of Intracranial Malignancies	PLOS ONE			English	Article							X(C)(-) TRANSPORTER ACTIVITY; CYSTINE/GLUTAMATE ANTIPORTER; GLUTAMATE TRANSPORTERS; TUMOR; ACID; DIAGNOSIS; GLIOMAS; PATHWAY	Purpose (S)-4-(3-[F-18] Fluoropropyl)-L-glutamic acid (18F-FSPG) is a novel radiopharmaceutical for Positron Emission Tomography (PET) imaging. It is a glutamate analogue that can be used to measure x(C)(-) transporter activity. This study was performed to assess the feasibility of 18F-FSPG for imaging orthotopic brain tumors in small animals and the translation of this approach in human subjects with intracranial malignancies. Experimental Design For the small animal study, GS9L glioblastoma cells were implanted into brains of Fischer rats and studied with 18F-FSPG, the 18F-labeled glucose derivative 18F-FDG and with the 18F-labeled amino acid derivative 18F-FET. For the human study, five subjects with either primary or metastatic brain cancer were recruited (mean age 50.4 years). After injection of 300 MBq of 18F-FSPG, 3 whole-body PET/Computed Tomography (CT) scans were obtained and safety parameters were measured. The three subjects with brain metastases also had an 18F-FDG PET/CT scan. Quantitative and qualitative comparison of the scans was performed to assess kinetics, biodistribution, and relative efficacy of the tracers. Results In the small animals, the orthotopic brain tumors were visualized well with 18F-FSPG. The high tumor uptake of 18F-FSPG in the GS9L model and the absence of background signal led to good tumor visualization with high contrast (tumor/brain ratio: 32.7). 18F-FDG and 18F-FET showed T/B ratios of 1.7 and 2.8, respectively. In the human pilot study, 18F-FSPG was well tolerated and there was similar distribution in all patients. All malignant lesions were positive with 18F-FSPG except for one low-grade primary brain tumor. In the 18F-FSPG-PET-positive tumors a similar T/B ratio was observed as in the animal model. Conclusions 18F-FSPG is a novel PET radiopharmaceutical that demonstrates good uptake in both small animal and human studies of intracranial malignancies. Future studies on larger numbers of subjects and a wider array of brain tumors are planned.	[Mittra, Erik S.; Mosci, Camila; Kumar, Meena; Hoehne, Aileen; Keu, Khun Visith; Iagaru, Andrei H.; Chin, Frederick T.; Gambhir, Sanjiv S.] Stanford Hosp & Clin, Dept Radiol, Mol Imaging Program, Stanford, CA USA; [Koglin, Norman; Mueller, Andre; Berndt, Mathias; Friebe, Matthias; Schmitt-Willich, Heribert; Gekeler, Volker; Fels, Lueder M.; Bacher-Stier, Claudia; Stephens, Andrew W.; Dinkelborg, Ludger M.] Bayer Pharma AG, Berlin, Germany; [Koglin, Norman; Mueller, Andre; Berndt, Mathias; Bullich, Santiago; Friebe, Matthias; Schmitt-Willich, Heribert; Stephens, Andrew W.; Dinkelborg, Ludger M.] Piramal Imaging GmbH, Berlin, Germany; [Moon, Dae Hyuk] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Nucl Med, Seoul, South Korea; [Gambhir, Sanjiv S.] Stanford Univ, Dept Mat Sci & Engn, Dept Bioengn, Bio X Program, Stanford, CA 94305 USA	Stanford University; Bayer AG; Bayer Healthcare Pharmaceuticals; University of Ulsan; Asan Medical Center; Stanford University	Gambhir, SS (corresponding author), Stanford Hosp & Clin, Dept Radiol, Mol Imaging Program, Stanford, CA USA.; Gambhir, SS (corresponding author), Stanford Univ, Dept Mat Sci & Engn, Dept Bioengn, Bio X Program, Stanford, CA 94305 USA.	sgambhir@stanford.edu	Moon, Dae Hyuk/ACK-5262-2022	Koglin, Norman/0000-0001-7583-8201; Mueller, Andre/0000-0001-7271-9303	Bayer Healthcare; Ben and Catherine Ivy Foundation; NCI In Vivo Cellular & Molecular Imaging Center [ICMIC P50]; Bayer HealthCare, Inc. / Piramal Imaging	Bayer Healthcare(Bayer AGBayer Healthcare Pharmaceuticals); Ben and Catherine Ivy Foundation; NCI In Vivo Cellular & Molecular Imaging Center; Bayer HealthCare, Inc. / Piramal Imaging	The study was sponsored by Bayer Healthcare. Bayer Healthcare provided support in the form of salaries for authors [NK, AM, MB, HSW, VG, MF, LMD, AWS, LMF, and CBS], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Funding was also provided by the Ben and Catherine Ivy Foundation (SSG), and the NCI In Vivo Cellular & Molecular Imaging Center (ICMIC P50) (SSG).; The clinical work was supported by funding from Bayer HealthCare, Inc. / Piramal Imaging as part of a sponsored clinical research trial. We would like to thank the research study participants and families, our referring physicians, our clinical research coordinators, the Radiochemistry Facility and staff, in particular Dr. Bin Shen, Amit Hetstron, and So-Hee Kim, all our PET/CT technologists, and the research staff at Bayer HealthCare / Piramal Imaging Berlin for their assistance in this project. We would also like to thank the Ben and Catherine Ivy Foundation (SSG), and the NCI In Vivo Cellular & Molecular Imaging Center (ICMIC P50) (SSG) for funding support.	Alexiou GA, 2009, J NEURO-ONCOL, V95, P1, DOI 10.1007/s11060-009-9897-1; Baek S, 2013, J NUCL MED, V54, P117, DOI 10.2967/jnumed.112.108704; Baek S, 2012, CLIN CANCER RES, V18, P5427, DOI 10.1158/1078-0432.CCR-12-0214; Bridges RJ, 2012, BRIT J PHARMACOL, V165, P20, DOI 10.1111/j.1476-5381.2011.01480.x; Cha S, 2009, NEUROTHERAPEUTICS, V6, P465, DOI 10.1016/j.nurt.2009.05.002; Fahlbusch Rudolf, 2007, Clin Neurosurg, V54, P100; Ferguson SD, 2011, DM-DIS MON, V57, P558, DOI 10.1016/j.disamonth.2011.08.020; Gao HL, 2013, CANCER IMAGING, V13, P466, DOI 10.1102/1470-7330.2013.0039; Heiss P, 1999, J NUCL MED, V40, P1367; Heiss WD, 2014, J NUCL MED, V55, P1219, DOI 10.2967/jnumed.114.142661; Heiss WD, 2011, J NUCL MED, V52, P1585, DOI 10.2967/jnumed.110.084210; Howlader N NA, 2008, SEER CANCER STATISTI; Iagaru A, 2009, HELL J NUCL MED, V12, P26; Iagaru AH, 2008, NUCL MED COMMUN, V29, P1046, DOI 10.1097/MNM.0b013e32831089cb; Ishimoto T, 2011, CANCER CELL, V19, P387, DOI 10.1016/j.ccr.2011.01.038; Koglin N, 2011, CLIN CANCER RES, V17, P6000, DOI 10.1158/1078-0432.CCR-11-0687; la Fougere C, 2011, NEURO-ONCOLOGY, V13, P806, DOI 10.1093/neuonc/nor054; Lapa C, 2014, J NUCL MED, V55, P1611, DOI 10.2967/jnumed.114.140608; Lewerenz J, 2006, J NEUROCHEM, V98, P916, DOI 10.1111/j.1471-4159.2006.03921.x; Lyons SA, 2007, CANCER RES, V67, P9463, DOI 10.1158/0008-5472.CAN-07-2034; Marshall D, 2012, HAND CLINIC, V104, P309, DOI 10.1016/B978-0-444-52138-5.00020-7; Nedergaard MK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100009; Parney IF, 2012, HAND CLINIC, V104, P187, DOI 10.1016/B978-0-444-52138-5.00015-3; Penas-Prado M, 2012, HAND CLINIC, V105, P485, DOI 10.1016/B978-0-444-53502-3.00004-5; Prabhu A, 2014, CANCER RES, V74, P787, DOI 10.1158/0008-5472.CAN-13-1423; Robert SM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa8103; Robert SM, 2014, CELL MOL LIFE SCI, V71, P1839, DOI 10.1007/s00018-013-1521-z; Smolarz K, 2013, J NUCL MED, V54, P861, DOI 10.2967/jnumed.112.112581; Takeuchi S, 2013, NEUROSURGERY, V72, P33, DOI 10.1227/NEU.0b013e318276b2de; Venneti S, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa1009; Watkins S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5196; Webster JM, 2014, J NUCL MED, V55, P657, DOI 10.2967/jnumed.113.126664	32	36	37	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2016	11	2							e0148628	10.1371/journal.pone.0148628	http://dx.doi.org/10.1371/journal.pone.0148628			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3CO	26890637	Green Published, gold, Green Submitted			2022-12-26	WOS:000371221500011
J	Sunnadeniya, R; Bean, A; Brown, M; Akhavan, N; Hatlestad, G; Gonzalez, A; Symonds, VV; Lloyd, A				Sunnadeniya, Rasika; Bean, Alexander; Brown, Matthew; Akhavan, Neda; Hatlestad, Gregory; Gonzalez, Antonio; Symonds, V. Vaughan; Lloyd, Alan			Tyrosine Hydroxylation in Betalain Pigment Biosynthesis Is Performed by Cytochrome P450 Enzymes in Beets (Beta vulgaris)	PLOS ONE			English	Article							POLYPHENOL OXIDASE; LOCUS ENCODES; PURIFICATION; EXPRESSION; IDENTIFICATION; DIOXYGENASE; EVOLUTION; VECTORS; PROTEIN; CLONING	Yellow and red-violet betalain plant pigments are restricted to several families in the order Caryophyllales, where betacyanins play analogous biological roles to anthocyanins. The initial step in betalain biosynthesis is the hydroxylation of tyrosine to form L-DOPA. Using gene expression experiments in beets, yeast, and Arabidopsis, along with HPLC/MS analysis, the present study shows that two novel cytochrome P450 (CYP450) enzymes, CYP76AD6 and CYP76AD5, and the previously described CYP76AD1 can perform this initial step. Co-expressing these CYP450s with DOPA 4,5-dioxygenase in yeast, and overexpression of these CYP450s in yellow beets show that CYP76AD1 efficiently uses L-DOPA leading to red betacyanins while CYP76AD6 and CYP76AD5 lack this activity. Furthermore, CYP76AD1 can complement yellow beetroots to red while CYP76AD6 and CYP76AD5 cannot. Therefore CYP76AD1 uniquely performs the beet R locus function and beets appear to be genetically redundant for tyrosine hydroxylation. These new functional data and ancestral character state reconstructions indicate that tyrosine hydroxylation alone was the most likely ancestral function of the CYP76AD alpha and beta groups and the ability to convert L-DOPA to cyclo-DOPA evolved later in the alpha group.	[Sunnadeniya, Rasika; Bean, Alexander; Brown, Matthew; Akhavan, Neda; Hatlestad, Gregory; Gonzalez, Antonio; Lloyd, Alan] Univ Texas Austin, Dept Mol Biosci, Austin, TX 78712 USA; [Symonds, V. Vaughan] Massey Univ, Inst Fundamental Sci, Palmerston North, New Zealand	University of Texas System; University of Texas Austin; Massey University	Lloyd, A (corresponding author), Univ Texas Austin, Dept Mol Biosci, Austin, TX 78712 USA.	amlloyd@utexas.edu		Symonds, Vaughan/0000-0003-2533-6830	US National Science Foundation [MCB-1122179]; Direct For Biological Sciences [1556348] Funding Source: National Science Foundation	US National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Funded by US National Science Foundation MCB-1122179. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by funds from the US National Science Foundation.	BILYK A, 1981, J FOOD SCI, V46, P298, DOI 10.1111/j.1365-2621.1981.tb14588.x; Brockington SF, 2015, NEW PHYTOL, V207, P1170, DOI 10.1111/nph.13441; Brockington SF, 2011, NEW PHYTOL, V190, P854, DOI 10.1111/j.1469-8137.2011.03687.x; Christinet L, 2004, PLANT PHYSIOL, V134, P265, DOI 10.1104/pp.103.031914; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; DeLoache WC, 2015, NAT CHEM BIOL, V11, P465, DOI 10.1038/nchembio.1816; Dohm JC, 2014, NATURE, V505, P546, DOI 10.1038/nature12817; Gandia-Herrero F, 2005, NATURE, V437, P334, DOI 10.1038/437334a; Gandia-Herrero F, 2004, J AGR FOOD CHEM, V52, P609, DOI 10.1021/jf034381m; Gandia-Herrero F, 2013, J AGR FOOD CHEM, V61, P4294, DOI 10.1021/jf400337g; Gandia-Herrero F, 2012, PLANTA, V236, P91, DOI 10.1007/s00425-012-1593-2; Gao ZJ, 2009, FOOD CHEM, V117, P342, DOI 10.1016/j.foodchem.2009.04.013; Harris NN, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-34; Hatlestad GJ, 2015, NAT GENET, V47, P92, DOI 10.1038/ng.3163; Hatlestad GJ, 2012, NAT GENET, V44, P816, DOI 10.1038/ng.2297; JOY RW, 1995, PLANT PHYSIOL, V107, P1083, DOI 10.1104/pp.107.4.1083; Kapadia GJ, 2003, PHARMACOL RES, V47, P141, DOI 10.1016/S1043-6618(02)00285-2; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Keller W, 1936, J AGRIC RES, V52, P0027; Khan MI, 2012, LWT-FOOD SCI TECHNOL, V47, P315, DOI 10.1016/j.lwt.2012.01.025; KONCZ C, 1986, MOL GEN GENET, V204, P383, DOI 10.1007/BF00331014; Mayer AM, 2006, PHYTOCHEMISTRY, V67, P2318, DOI 10.1016/j.phytochem.2006.08.006; Nakatsuka T, 2013, SCI REP-UK, V3, DOI 10.1038/srep01970; Polturak G, 2016, NEW PHYTOL, V210, P269, DOI 10.1111/nph.13796; QUANDT HJ, 1993, MOL PLANT MICROBE IN, V6, P699, DOI 10.1094/MPMI-6-699; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Sasaki N, 2009, PLANT CELL PHYSIOL, V50, P1012, DOI 10.1093/pcp/pcp053; Schliemann W, 1999, PLANT PHYSIOL, V119, P1217, DOI 10.1104/pp.119.4.1217; Steiner U, 1999, PLANTA, V208, P114, DOI 10.1007/s004250050541; Stintzing FC, 2004, TRENDS FOOD SCI TECH, V15, P19, DOI 10.1016/j.tifs.2003.07.004; Strack D, 2001, ANGEW CHEM INT EDIT, V40, P3791, DOI 10.1002/1521-3773(20011015)40:20<3791::AID-ANIE3791>3.0.CO;2-T; Sullivan ML, 2015, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00783; Urban P, 1997, J BIOL CHEM, V272, P19176, DOI 10.1074/jbc.272.31.19176; Van Mullem V, 2003, YEAST, V20, P739, DOI 10.1002/yea.999; Xu B, 2013, MOL BIOL EVOL, V30, P2723, DOI 10.1093/molbev/mst179; Yamamoto K, 2001, PLANT CELL PHYSIOL, V42, P969, DOI 10.1093/pcp/pce125; Zhao M, 2008, DEVELOPMENT, V135, P1991, DOI 10.1242/dev.016873	38	61	69	3	87	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2016	11	2							e0149417	10.1371/journal.pone.0149417	http://dx.doi.org/10.1371/journal.pone.0149417			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3CO	26890886	gold, Green Published, Green Submitted			2022-12-26	WOS:000371221500043
J	Olson, ZH; Beasley, JC; Rhodes, OE				Olson, Zachary H.; Beasley, James C.; Rhodes, Olin E., Jr.			Carcass Type Affects Local Scavenger Guilds More than Habitat Connectivity	PLOS ONE			English	Article							PATCH OCCUPANCY; CARRION; SELECTION; SANITARY; VULTURES; DECOMPOSITION; VERTEBRATES; COMPETITION; PARAMETERS; PATHOGENS	Scavengers and decomposers provide an important ecosystem service by removing carrion from the environment. Scavenging and decomposition are known to be temperature-dependent, but less is known about other factors that might affect carrion removal. We conducted an experiment in which we manipulated combinations of patch connectivity and carcass type, and measured responses by local scavenger guilds along with aspects of carcass depletion. We conducted twelve, 1-month trials in which five raccoon (Procyon lotor), Virginia opossum (Didelphis virginiana), and domestic rabbit (Oryctolagus spp.) carcasses (180 trials total) were monitored using remote cameras in 21 forest patches in north-central Indiana, USA. Of 143 trials with complete data, we identified fifteen species of vertebrate scavengers divided evenly among mammalian (N = 8) and avian species (N = 7). Fourteen carcasses (9.8%) were completely consumed by invertebrates, vertebrates exhibited scavenging behavior at 125 carcasses (87.4%), and four carcasses (2.8%) remained unexploited. Among vertebrates, mammals scavenged 106 carcasses, birds scavenged 88 carcasses, and mammals and birds scavenged 69 carcasses. Contrary to our expectations, carcass type affected the assemblage of local scavenger guilds more than patch connectivity. However, neither carcass type nor connectivity explained variation in temporal measures of carcass removal. Interestingly, increasing richness of local vertebrate scavenger guilds contributed moderately to rates of carrion removal (approximate to 6% per species increase in richness). We conclude that scavenger-specific differences in carrion utilization exist among carcass types and that reliable delivery of carrion removal as an ecosystem service may depend on robust vertebrate and invertebrate communities acting synergistically.	[Olson, Zachary H.] Univ New England, Dept Psychol, 11 Hills Beach Rd, Biddeford, ME USA; [Beasley, James C.; Rhodes, Olin E., Jr.] Univ Georgia, Savannah River Ecol Lab, Aiken, SC USA; [Beasley, James C.] Univ Georgia, DB Warnell Sch Forestry & Nat Resources, Athens, GA 30602 USA; [Rhodes, Olin E., Jr.] Univ Georgia, Odum Sch Ecol, Athens, GA 30602 USA	University of New England - Maine; United States Department of Energy (DOE); Savannah River Ecology Laboratory; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Olson, ZH (corresponding author), Univ New England, Dept Psychol, 11 Hills Beach Rd, Biddeford, ME USA.	zolson@une.edu			Indiana Academy of Science; Purdue University, Department of Forestry & Natural Resouces; Department of Forestry and Natural Resources at Purdue University	Indiana Academy of Science; Purdue University, Department of Forestry & Natural Resouces; Department of Forestry and Natural Resources at Purdue University	This study was funded in part by a research grant from the Indiana Academy of Science (Fall 2008) to ZHO and OER. < http://www.indianaacademyofscience.org/Research-Grants.aspx >. Purdue University, Department of Forestry & Natural Resouces also provided support for this work. < https://ag.purdue.edu/fnr/Pages/default.aspx >. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the landowners of the Upper Wabash River Basin for allowing us access to their land. This study was supported by the Department of Forestry and Natural Resources at Purdue University.	Allen ML, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102257; Anderson MJ, 2011, ECOL LETT, V14, P19, DOI 10.1111/j.1461-0248.2010.01552.x; Arnold TW, 2010, J WILDLIFE MANAGE, V74, P1175, DOI 10.2193/2009-367; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Beasley JC, 2010, CAN J ZOOL, V88, P161, DOI 10.1139/Z09-137; Beasley JC, 2007, J WILDLIFE MANAGE, V71, P1125, DOI 10.2193/2006-228; Beasley JC, 2012, OIKOS, V121, P1021, DOI 10.1111/j.1600-0706.2012.20353.x; Beatty WS, 2014, CAN J ZOOL, V92, P41, DOI 10.1139/cjz-2013-0225; Blazquez M, 2009, ACTA OECOL, V35, P645, DOI 10.1016/j.actao.2009.06.002; Bormann F. H., 1979, PATTERN PROCESS FORE, DOI [10.1007/978-1-4612-6232-9, DOI 10.1007/978-1-4612-6232-9]; Bump JK, 2009, ECOLOGY, V90, P3159, DOI 10.1890/09-0292.1; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Byrd JH, 2001, FORENSIC SCI INT, V120, P79, DOI 10.1016/S0379-0738(01)00431-5; Carter DO, 2007, NATURWISSENSCHAFTEN, V94, P12, DOI 10.1007/s00114-006-0159-1; Castner J.L., 2010, FORENSIC ENTOMOLOGY, V2nd, P493; Castrale JS, 1998, ATLAS BREEDING BIRDS; DeVault TL, 2004, CAN J ZOOL, V82, P502, DOI 10.1139/Z04-022; DeVault TL, 2003, OIKOS, V102, P225, DOI 10.1034/j.1600-0706.2003.12378.x; DeVault TL, 2011, BASIC APPL ECOL, V12, P268, DOI 10.1016/j.baae.2011.02.008; Donazar JA, 2009, SCIENCE, V326, P664, DOI 10.1126/science.326_664a; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Fauth JE, 1996, AM NAT, V147, P282, DOI 10.1086/285850; Fenwick SG, 2004, J WILDLIFE DIS, V40, P566, DOI 10.7589/0090-3558-40.3.566; Gibbs JP, 2001, ECOL APPL, V11, P79, DOI 10.1890/1051-0761(2001)011[0079:HFAACC]2.0.CO;2; Green GI, 1997, J WILDLIFE MANAGE, V61, P1040, DOI 10.2307/3802101; Green RE, 2004, J APPL ECOL, V41, P793, DOI 10.1111/j.0021-8901.2004.00954.x; Hanski I, 1998, NATURE, V396, P41, DOI 10.1038/23876; Hart BL, 2011, PHILOS T R SOC B, V366, P3406, DOI 10.1098/rstb.2011.0092; HART BL, 1990, NEUROSCI BIOBEHAV R, V14, P273, DOI 10.1016/S0149-7634(05)80038-7; Henning J, 2005, EPIDEMIOL INFECT, V133, P719, DOI 10.1017/S0950268805003766; JANZEN DH, 1977, AM NAT, V111, P691, DOI 10.1086/283200; Killengreen ST, 2012, DIVERS DISTRIB, V18, P563, DOI 10.1111/j.1472-4642.2011.00861.x; Kjorlien YP, 2009, FORENSIC SCI INT, V188, P103, DOI 10.1016/j.forsciint.2009.03.022; Krofel M, 2012, BEHAV ECOL SOCIOBIOL, V66, P1297, DOI 10.1007/s00265-012-1384-6; KRUUK H, 1967, ARDEA, V55, P171; Kuznetsova A, 2013, IMERTEST TESTS RANDO, P0; Maichak EJ, 2009, J WILDLIFE DIS, V45, P398, DOI 10.7589/0090-3558-45.2.398; Margalida A, 2014, ECOL APPL, V24, P436, DOI 10.1890/13-0414.1; Margalida A, 2012, SCI REP-UK, V2, DOI 10.1038/srep00753; Margalida A, 2010, J APPL ECOL, V47, P931, DOI 10.1111/j.1365-2664.2010.01835.x; Matuszewski S, 2010, FORENSIC SCI INT, V194, P85, DOI 10.1016/j.forsciint.2009.10.016; McGarigal K., 2002, FRAGSTATS SPATIAL PA, DOI DOI 10.1016/S0022-3913(12)00047-9; Moleon M, 2015, OIKOS, V124, P1391, DOI 10.1111/oik.02222; Moore JE, 2005, J WILDLIFE MANAGE, V69, P933, DOI 10.2193/0022-541X(2005)069[0933:MPOBFR]2.0.CO;2; Moreno-Opo R, 2015, ECOSPHERE, V6, DOI 10.1890/ES15-00009.1; Moreno-Opo R, 2015, BIOL CONSERV, V181, P27, DOI 10.1016/j.biocon.2014.10.022; Mumford RE., 2010, MAMMALS OF INDIANA; NICHOLSON AJ, 1954, AUST J ZOOL, V2, P9, DOI 10.1071/ZO9540009; Ogada DL, 2012, CONSERV BIOL, V26, P453, DOI 10.1111/j.1523-1739.2012.01827.x; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Olson ZH, 2012, OIKOS, V121, P77, DOI 10.1111/j.1600-0706.2011.19771.x; Parmenter RR, 2009, ECOL MONOGR, V79, P637, DOI 10.1890/08-0972.1; Pereira LM, 2014, MAMMAL REV, V44, P44, DOI 10.1111/mam.12005; R Core Team, 2021, R LANGUAGE ENV STAT; Rouquet P, 2005, EMERG INFECT DIS, V11, P283, DOI 10.3201/eid1102.040533; Sebastian-Gonzalez E, 2013, IBIS, V155, P881, DOI 10.1111/ibi.12079; Selva N, 2005, CAN J ZOOL, V83, P1590, DOI 10.1139/Z05-158; Shivik JA, 2006, BIOSCIENCE, V56, P819, DOI 10.1641/0006-3568(2006)56[819:AVBADS]2.0.CO;2; Simmons T, 2010, J FORENSIC SCI, V55, P8, DOI 10.1111/j.1556-4029.2009.01206.x; Sugiura S, 2013, BIOL CONSERV, V159, P206, DOI 10.1016/j.biocon.2012.11.003; Swihart RK, 2003, J BIOGEOGR, V30, P1259, DOI 10.1046/j.1365-2699.2003.00925.x; Tomberlin JK, 2011, ANNU REV ENTOMOL, V56, P401, DOI 10.1146/annurev-ento-051710-103143; Turnbull PCB, 2008, ONDERSTEPOORT J VET, V75, P95; Warton DI, 2012, METHODS ECOL EVOL, V3, P89, DOI 10.1111/j.2041-210X.2011.00127.x; WERNER EE, 1984, ANNU REV ECOL SYST, V15, P393, DOI 10.1146/annurev.es.15.110184.002141; Wikenros C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077373; Wilson EE, 2011, TRENDS ECOL EVOL, V26, P129, DOI 10.1016/j.tree.2010.12.011	67	44	47	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0147798	10.1371/journal.pone.0147798	http://dx.doi.org/10.1371/journal.pone.0147798			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26886299	Green Published, Green Submitted, gold			2022-12-26	WOS:000371218400009
J	Sainju, UM				Sainju, Upendra M.			Can Novel Management Practice Improve Soil and Environmental Quality and Sustain Crop Yield Simultaneously?	PLOS ONE			English	Article							LONG-TERM TILLAGE; NITROUS-OXIDE; CARBON-DIOXIDE; GREENHOUSE GASES; NO-TILL; IRRIGATION; INTENSITY; EMISSIONS; SYSTEMS; AGRICULTURE	Little is known about management practices that can simultaneously improve soil and environmental quality and sustain crop yields. The effects of novel and traditional management practices that included a combination of tillage, crop rotation, and N fertilization on soil C and N, global warming potential (GWP), greenhouse gas intensity (GHGI), and malt barley (Hordeum vulgarie L.) yield and quality were examined under non-irrigated and irrigated cropping systems from 2008 to 2011 in eastern Montana and western North Dakota, USA. In loamy soil under non-irrigated condition in eastern Montana, novel and traditional management practices were no-till malt barley-pea (Pisum sativum L.) with 80 kg N ha(-1) and conventional till malt barley-fallow with 80 kg N ha(-1), respectively. In sandy loam soil under irrigated and non-irrigated conditions in western North Dakota, novel and traditional management practices included no-till malt barley-pea with 67 (non-irrigated) to 134 kg N ha(-1) (irrigated) and conventional till malt barley with 67 (non-irrigated) to 134 kg N ha(-1) (irrigated), respectively. Compared with the traditional management practice, soil organic C (SOC) and total N (STN) at 0-120 cm were 5% greater with the novel management practice under non-irrigated condition in eastern Montana and under irrigated condition in western North Dakota, but were not different under non-irrigated condition in western North Dakota. In both places under irrigated and non-irrigated conditions, total applied N rate, residual soil NO3-N content at 0-120 cm, global warming potential (GWP), and greenhouse gas intensity (GHGI) were 15 to 70% lower with the novel than the traditional management practice. Malt barley yield and quality were not different between the two practices in both places. Novel management practices, such as no-till malt barley-pea with reduced N rate, can simultaneously enhance soil and environmental quality, reduce N input, and sustain crop yield compared with traditional practices in the northern Great Plains, USA.	[Sainju, Upendra M.] ARS, USDA, Northern Plains Agr Res Lab, Sidney, MT 59270 USA	United States Department of Agriculture (USDA)	Sainju, UM (corresponding author), ARS, USDA, Northern Plains Agr Res Lab, Sidney, MT 59270 USA.	upendra.sainju@ars.usda.gov	ONE, PLOS/H-3321-2019	ONE, PLOS/0000-0001-6943-733X	USDA-ARS-GRACEnet project; USDA-ARS, Sidney, MT; ARS [ARS-0425353] Funding Source: Federal RePORTER	USDA-ARS-GRACEnet project; USDA-ARS, Sidney, MT; ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	Funded in part by USDA-ARS-GRACEnet project. Other funding was contributed by USDA-ARS, Sidney, MT. No proposal was submitted and therefore no grant number.	AASE JK, 1995, AGRON J, V87, P652, DOI 10.2134/agronj1995.00021962008700040008x; Al-Kaisi MM, 2008, J ENVIRON QUAL, V37, P325, DOI 10.2134/jeq2007.0240; American Malting Barley Association, 2005, MALT BARL BREED GUID; Amos B, 2005, SOIL SCI SOC AM J, V69, P387, DOI 10.2136/sssaj2005.0387; Barsotti JL, 2013, SOIL SCI SOC AM J, V77, P1012, DOI 10.2136/sssaj2012.0386; Bergstrom L, 2004, J ENVIRON QUAL, V33, P1786, DOI 10.2134/jeq2004.1786; BRONSON KF, 1994, BIOL FERT SOILS, V17, P263, DOI 10.1007/BF00383979; DEIBERT EJ, 1986, J SOIL WATER CONSERV, V41, P53; Denef K, 2008, GEODERMA, V145, P121, DOI 10.1016/j.geoderma.2008.03.002; Drury CF, 2006, SOIL SCI SOC AM J, V70, P570, DOI 10.2136/sssaj2005.0042; Dusenbury MP, 2008, J ENVIRON QUAL, V37, P542, DOI 10.2134/jeq2006.0395; ECK HV, 1992, AGRON J, V84, P660, DOI 10.2134/agronj1992.00021962008400040025x; Farahani HJ, 1998, ADV AGRON, V64, P197, DOI 10.1016/S0065-2113(08)60505-2; Follett RF, 2001, SOIL TILL RES, V61, P77, DOI 10.1016/S0167-1987(01)00180-5; Follett RF, 2013, SOIL SCI SOC AM J, V77, P951, DOI 10.2136/sssaj2012.0413; Gregory PJ, 2002, AGR ECOSYST ENVIRON, V88, P279, DOI 10.1016/S0167-8809(01)00263-8; Hallberg G. R., 1989, Nitrogen management and ground water protection., P35; Halvorson AD, 2002, SOIL SCI SOC AM J, V66, P906, DOI 10.2136/sssaj2002.0906; HUTCHINSON GL, 1981, SOIL SCI SOC AM J, V45, P311, DOI 10.2136/sssaj1981.03615995004500020017x; Kuo S, 1997, SOIL SCI SOC AM J, V61, P1392, DOI 10.2136/sssaj1997.03615995006100050016x; Lal R, 2004, ENVIRON INT, V30, P981, DOI 10.1016/j.envint.2004.03.005; Lal R., 1995, Subsoil management techniques., P1; Lemke RL, 1999, CAN J SOIL SCI, V79, P15, DOI 10.4141/S98-013; Lenssen AW, 2007, SOIL TILL RES, V94, P362, DOI 10.1016/j.still.2006.08.012; Liebig MA, 2010, SOIL SCI SOC AM J, V74, P358, DOI 10.2136/sssaj2008.0368; Littell RC, 1991, SAS SYSTEM FOR LINEA; Miller PR, 2002, AGRON J, V94, P261, DOI 10.2134/agronj2002.0261; Mosier AR, 2005, NUTR CYCL AGROECOSYS, V72, P67, DOI 10.1007/s10705-004-7356-0; Mosier AR, 2006, J ENVIRON QUAL, V35, P1584, DOI 10.2134/jeq2005.0232; Paustian K., 1995, ADV SOIL SCI, P69; Peterson GA, 1998, SOIL TILL RES, V47, P207, DOI 10.1016/S0167-1987(98)00107-X; Robertson G. Philip, 2004, Environment Development and Sustainability, V6, P51, DOI 10.1023/B:ENVI.0000003629.32997.9e; Robertson GP, 2009, ANNU REV ENV RESOUR, V34, P97, DOI 10.1146/annurev.environ.032108.105046; Robertson GP, 2000, SCIENCE, V289, P1922, DOI 10.1126/science.289.5486.1922; SAINJU UM, 2010, J ENVIRON QUAL, V37, P98, DOI DOI 10.2134/JEQ2006.0392; Sainju UM, 2012, SOIL TILL RES, V118, P123, DOI 10.1016/j.still.2011.10.020; Sainju UM, 2011, SOIL SCI SOC AM J, V75, P669, DOI 10.2136/sssaj2010.0221; Sainju UM, 2009, AGRON J, V101, P243, DOI 10.2134/agronj2008.0080x; Schipper LA, 2013, SOIL SCI SOC AM J, V77, P246, DOI 10.2136/sssaj2012.0126; Stevens WB, 2010, AGRON J, V102, P1745, DOI 10.2134/agronj2010.0122; Vigil MF, 1997, CROP SCI, V37, P844, DOI 10.2135/cropsci1997.0011183X003700030025x; WOOD CW, 1990, AGRON J, V82, P1115, DOI 10.2134/agronj1990.00021962008200060018x	42	3	3	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0149005	10.1371/journal.pone.0149005	http://dx.doi.org/10.1371/journal.pone.0149005			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26886932	gold, Green Submitted, Green Published			2022-12-26	WOS:000371218400058
J	Bullard, RL; Williams, J; Karim, S				Bullard, Rebekah L.; Williams, Jaclyn; Karim, Shahid			Temporal Gene Expression Analysis and RNA Silencing of Single and Multiple Members of Gene Family in the Lone Star Tick Amblyomma americanum	PLOS ONE			English	Article							SERINE-PROTEASE INHIBITOR; SALIVARY-GLAND; IXODES-SCAPULARIS; MOLECULAR CHARACTERIZATION; METALLOPROTEASES; CLONING; ACARI; IDENTIFICATION; VECTOR; PROTEINS	Saliva is an integral factor in the feeding success of veterinary and medically important ticks. Therefore, the characterization of the proteins present in tick saliva is an important area of tick research. Here, we confirmed previously generated sialotranscriptome data using quantitative real-time PCR. The information obtained in this in-depth study of gene expression was used to measure the effects of metalloprotease gene silencing on tick feeding. We analyzed the temporal expression of seven housekeeping genes and 44 differentially expressed salivary molecules selected from a previously published Amblyomma americanum sialotranscriptome. Separate reference genes were selected for the salivary glands and midgut from among the seven housekeeping genes, to normalize the transcriptional expression of differentially expressed genes. The salivary gland reference gene, ubiquitin, was used to normalize the expression of 44 salivary genes. Unsurprisingly, each gene family was expressed throughout the blood meal, but the expression of specific genes differed at each time point. To further clarify the complex nature of the many proteins found in the saliva, we disrupted the translation of several members of the metalloprotease family. Intriguingly, the nucleotide sequence similarity of the reprolysin metalloprotease gene family is so homologous that a single synthesized dsRNA sequence knocked down multiple members of the family. The use of multigene knockdown yielded a more significant picture of the role of metalloproteases in tick feeding success, and changes were observed in the female engorgement weight and larval hatching success. Interestingly, the depletion of metalloprotease transcripts also reduced the total number of bacteria present in the salivary glands. These data provide insight into the expression and functions of tick salivary proteins expressed while feeding on its host.	[Bullard, Rebekah L.; Williams, Jaclyn; Karim, Shahid] Univ So Mississippi, Dept Biol Sci, Hattiesburg, MS 39406 USA	University of Southern Mississippi	Karim, S (corresponding author), Univ So Mississippi, Dept Biol Sci, Hattiesburg, MS 39406 USA.	Shahid.karim@usm.edu		Karim, Shahid/0000-0001-5596-3304	National Institute of Allergy and Infectious Diseases [AI099919]; National Science Foundation [EPS 0903787, EPS 1006883]; United States Department of State [PGA-P21049]; National Institutes of General Medical Sciences award [P20RR016476]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016476] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103476] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Science Foundation(National Science Foundation (NSF)); United States Department of State; National Institutes of General Medical Sciences award; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institute of Allergy and Infectious Diseases award #AI099919, the National Science Foundation (EPS 0903787 and EPS 1006883 to MS-EPSCoR), United States Department of State award#PGA-P21049 (Pakistan-United States Science and Technology Cooperation Program) to SK and the National Institutes of General Medical Sciences award #P20RR016476 to the MS-INBRE core facility. The funders had no role in study design, data collection, analysis, decision to publish, or manuscript preparation.	Alarcon-Chaidez FJ, 2007, INSECT BIOCHEM MOLEC, V37, P48, DOI 10.1016/j.ibmb.2006.10.002; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Anderson JF, 2008, INFECT DIS CLIN N AM, V22, P195, DOI 10.1016/j.idc.2007.12.006; Barnard AC, 2012, VET PARASITOL, V186, P403, DOI 10.1016/j.vetpar.2011.11.026; Barrett A. J., 2004, HDB PROTEOLYTIC ENZY, V1; Beaufays J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003987; Beaufays J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003941; Bergman DK, 2000, J PARASITOL, V86, P516, DOI 10.1645/0022-3395(2000)086[0516:IAMCOA]2.0.CO;2; Bishop R, 2002, INT J PARASITOL, V32, P833, DOI 10.1016/S0020-7519(02)00027-9; Browning R, 2013, INSECT MOL BIOL, V22, P245, DOI 10.1111/imb.12017; Browning R, 2012, J MED ENTOMOL, V49, P1339, DOI 10.1603/ME12123; Budachetri K, 2015, INSECT MOL BIOL, V24, P570, DOI 10.1111/imb.12184; Ceraul SM, 2008, INFECT IMMUN, V76, P5429, DOI 10.1128/IAI.00866-08; Ceraul SM, 2011, INFECT IMMUN, V79, P321, DOI 10.1128/IAI.00362-10; Childs JE, 2003, ANNU REV ENTOMOL, V48, P307, DOI 10.1146/annurev.ento.48.091801.112728; Chmelar J, 2012, J PROTEOMICS, V75, P3842, DOI 10.1016/j.jprot.2012.04.026; Commins SP, 2011, J ALLERGY CLIN IMMUN, V127, P1286, DOI 10.1016/j.jaci.2011.02.019; Cortinas R, 2014, J MED ENTOMOL, V51, P352, DOI 10.1603/ME13122; Decrem Y, 2008, INT J PARASITOL, V38, P549, DOI 10.1016/j.ijpara.2007.09.003; Decrem Y, 2008, FEBS J, V275, P1485, DOI 10.1111/j.1742-4658.2008.06308.x; Diaz-Martin V, 2013, J PROTEOMICS, V80, P216, DOI 10.1016/j.jprot.2013.01.015; Duell JR, 2013, J MED ENTOMOL, V50, P1330, DOI 10.1603/ME13117; Fitak RR, 2014, TICKS TICK-BORNE DIS, V5, P797, DOI 10.1016/j.ttbdis.2014.06.005; Flower DR, 1996, BIOCHEM J, V318, P1; Francischetti IMB, 2002, BLOOD, V99, P3602, DOI 10.1182/blood-2001-12-0237; Francischetti IMB, 2003, BIOCHEM BIOPH RES CO, V305, P869, DOI 10.1016/S0006-291X(03)00857-X; Francischetti IMB, 2009, FRONT BIOSCI-LANDMRK, V14, P2051, DOI 10.2741/3363; Frauenschuh A, 2007, J BIOL CHEM, V282, P27250, DOI 10.1074/jbc.M704706200; Gargano AFG, 2014, J CHROMATOGR A, V1351, P70, DOI 10.1016/j.chroma.2014.05.031; Gebbia JA, 2001, INFECT IMMUN, V69, P456, DOI 10.1128/IAI.69.1.456-462.2001; Goddard J, 2009, VET PARASITOL, V160, P1, DOI 10.1016/j.vetpar.2008.10.089; Gong HY, 2007, J INSECT PHYSIOL, V53, P1079, DOI 10.1016/j.jinsphys.2007.06.008; Grubhoffer L, 2004, PARASITOLOGY, V129, pS113, DOI 10.1017/S0031182004004858; Harnnoi T, 2007, COMP BIOCHEM PHYS B, V147, P93, DOI 10.1016/j.cbpb.2006.12.008; Havlikova S, 2009, INT J PARASITOL, V39, P1485, DOI 10.1016/j.ijpara.2009.05.005; Karim S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131292; Karim S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028525; Kato N, 2005, J BIOCHEM, V138, P225, DOI 10.1093/jb/mvi123; Keirans JE, 1998, J PARASITOL, V84, P629, DOI 10.2307/3284739; Koci J, 2013, J MED ENTOMOL, V50, P79, DOI 10.1603/ME12034; Lalzar I, 2014, ENVIRON MICROBIOL, V16, P3657, DOI 10.1111/1462-2920.12455; Li WF, 2006, PEPTIDES, V27, P2350, DOI 10.1016/j.peptides.2006.03.016; Liu XY, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002993; Mangeon A, 2010, PLANT SIGNAL BEHAV, V5, P99, DOI 10.4161/psb.5.2.10336; Mans BJ, 2008, INSECT BIOCHEM MOLEC, V38, P841, DOI 10.1016/j.ibmb.2008.06.007; Matsushita M, 2010, J INNATE IMMUN, V2, P24, DOI 10.1159/000228160; Narasimhan S, 2014, CELL HOST MICROBE, V15, P58, DOI 10.1016/j.chom.2013.12.001; Nijhof AM, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-112; Paddock CD, 2007, CURR TOP MICROBIOL, V315, P289; Paesen GC, 1999, MOL CELL, V3, P661, DOI 10.1016/S1097-2765(00)80359-7; PATRICK CD, 1975, J MED ENTOMOL, V12, P389, DOI 10.1093/jmedent/12.3.389; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Platts-Mills TAE, 2015, IMMUNOL ALLERGY CLIN, V35, P247, DOI 10.1016/j.iac.2015.01.009; Rachinsky A, 2007, INSECT BIOCHEM MOLEC, V37, P1291, DOI 10.1016/j.ibmb.2007.08.001; Ramos OHP, 2003, PROTEIN EXPRES PURIF, V28, P34, DOI 10.1016/S1046-5928(02)00644-7; Ribeiro JMC, 1998, EXP PARASITOL, V89, P213, DOI 10.1006/expr.1998.4296; Rice GI, 2004, BIOCHEM J, V383, P45, DOI 10.1042/BJ20040634; Sachetto-Martins G, 2000, BBA-GENE STRUCT EXPR, V1492, P1, DOI 10.1016/S0167-4781(00)00064-6; Sangamnatdej S, 2002, INSECT MOL BIOL, V11, P79, DOI 10.1046/j.0962-1075.2001.00311.x; Sasaki SD, 2008, EXP PARASITOL, V118, P214, DOI 10.1016/j.exppara.2007.08.003; Savage HM, 2013, AM J TROP MED HYG, V89, P445, DOI 10.4269/ajtmh.13-0209; Sayler KA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115769; Schwarz A, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-4; Silver N, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-33; Sitnik JL, 2014, GENETICS, V196, P781, DOI 10.1534/genetics.113.160945; Springer YP, 2014, J MED ENTOMOL, V51, P342, DOI 10.1603/ME13115; Steen NA, 2006, TOXICON, V47, P1, DOI 10.1016/j.toxicon.2005.09.010; Tonk M, 2014, GENE, V540, P146, DOI 10.1016/j.gene.2014.03.002; Turner AJ, 2001, BIOESSAYS, V23, P261, DOI 10.1002/1521-1878(200103)23:3<261::AID-BIES1036>3.0.CO;2-K; Valdes JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062562; Valenzuela JG, 2002, J EXP BIOL, V205, P2843; Viljakainen L, 2005, INSECT MOL BIOL, V14, P335, DOI 10.1111/j.1365-2583.2005.00564.x; Wikel SK, 1999, INT J PARASITOL, V29, P851, DOI 10.1016/S0020-7519(99)00042-9; Yi HY, 2014, APPL MICROBIOL BIOT, V98, P5807, DOI 10.1007/s00253-014-5792-6	74	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0147966	10.1371/journal.pone.0147966	http://dx.doi.org/10.1371/journal.pone.0147966			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26872360	Green Published, Green Submitted, gold			2022-12-26	WOS:000370054100013
J	Papalia, I; Magaudda, L; Righi, M; Ronchi, G; Viano, N; Geuna, S; Colonna, MR				Papalia, Igor; Magaudda, Ludovico; Righi, Maria; Ronchi, Giulia; Viano, Nicoletta; Geuna, Stefano; Colonna, Michele Rosario			Epineurial Window Is More Efficient in Attracting Axons than Simple Coaptation in a Sutureless (Cyanoacrylate-Bound) Model of End-to-Side Nerve Repair in the Rat Upper Limb: Functional and Morphometric Evidences and Review of the Literature	PLOS ONE			English	Article							CILIARY NEUROTROPHIC FACTOR; LONG-TERM EVALUATION; PERIPHERAL-NERVE; QUANTITATIVE ASSESSMENT; FIBRIN GLUE; MUSCLE REINNERVATION; PERINEURIAL WINDOW; REGENERATING AXONS; UPPER-EXTREMITY; SCHWANN-CELLS	End-to-side nerve coaptation brings regenerating axons from the donor to the recipient nerve. Several techniques have been used to perform coaptation: microsurgical sutures with and without opening a window into the epi(peri)neurial connective tissue; among these, window techniques have been proven more effective in inducing axonal regeneration. The authors developed a sutureless model of end-to-side coaptation in the rat upper limb. In 19 adult Wistar rats, the median and the ulnar nerves of the left arm were approached from the axillary region, the median nerve transected and the proximal stump sutured to the pectoral muscle to prevent regeneration. Animals were then randomly divided in two experimental groups (7 animals each, 5 animals acting as control): Group 1: the distal stump of the transected median nerve was fixed to the ulnar nerve by applying cyanoacrylate solution; Group 2: a small epineurial window was opened into the epineurium of the ulnar nerve, caring to avoid damage to the nerve fibres; the distal stump of the transected median nerve was then fixed to the ulnar nerve by applying cyanoacrylate solution. The grasping test for functional evaluation was repeated every 10-11 weeks starting from week-15, up to the sacrifice (week 36). At week 36, the animals were sacrificed and the regenerated nerves harvested and processed for morphological investigations (high-resolution light microscopy as well as stereological and morphometrical analysis). This study shows that a) cyanoacrylate in end-to-side coaptation produces scarless axon regeneration without toxic effects; b) axonal regeneration and myelination occur even without opening an epineurial window, but c) the window is related to a larger number of regenerating fibres, especially myelinated and mature, and better functional outcomes.	[Papalia, Igor; Magaudda, Ludovico; Righi, Maria] Univ Messina, Dept Biomed Sci & Morphol & Funct Images, Messina, Italy; [Ronchi, Giulia; Viano, Nicoletta; Geuna, Stefano] Univ Turin, Dept Clin & Biol Sci, Turin, Italy; [Ronchi, Giulia; Geuna, Stefano] Univ Turin, Cavalieri Ottolenghi Fdn NICO, Neurosci Inst, Turin, Italy; [Colonna, Michele Rosario] Univ Messina, Dept Expt & Clin Surg & Med Specialties, Messina, Italy	University of Messina; University of Turin; University of Turin; University of Messina	Geuna, S (corresponding author), Univ Turin, Dept Clin & Biol Sci, Turin, Italy.; Geuna, S (corresponding author), Univ Turin, Cavalieri Ottolenghi Fdn NICO, Neurosci Inst, Turin, Italy.	stefano.geuna@unito.it	Ronchi, Giulia/J-4785-2018; Colonna, Michele/ABI-6680-2020	Ronchi, Giulia/0000-0002-4795-7024; Colonna, Michele/0000-0001-5586-4066; Geuna, Stefano/0000-0002-6962-831X				Akeda K, 2006, PLAST RECONSTR SURG, V117, P1194, DOI 10.1097/01.prs.0000201460.54187.d7; Al-Qattan MM, 1998, BRIT J PLAST SURG, V51, P238, DOI 10.1054/bjps.1997.0188; Al-Qattan MM, 2002, J HAND SURG-AM, V27A, P739, DOI 10.1053/jhsu.2002.34313; Al-Qattan MM, 2001, J RECONSTR MICROSURG, V17, P99, DOI 10.1055/s-2001-12698; Amr SM, 2005, MICROSURG, V25, P126, DOI 10.1002/micr.20036; Bajrovic F, 2002, NEUROSCIENCE, V111, P587, DOI 10.1016/S0306-4522(01)00588-7; Battiston B, 1999, J HAND SURG-AM, V24A, P1185; Beck-Broichsitter BE, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/724197; Bertelli JA, 2003, J RECONSTR MICROSURG, V19, P313; Bertelli JA, 1996, J RECONSTR MICROSURG, V12, P559, DOI 10.1055/s-2007-1006630; BERTELLI JA, 1995, J NEUROSCI METH, V58, P151, DOI 10.1016/0165-0270(94)00169-H; Bontioti E, 2005, J PERIPHER NERV SYST, V10, P58, DOI 10.1111/j.1085-9489.2005.10109.x; Bontioti E, 2009, INT REV NEUROBIOL, V87, P251, DOI 10.1016/S0074-7742(09)87012-8; Bontioti EN, 2003, J PERIPHER NERV SYST, V8, P159, DOI 10.1046/j.1529-8027.2003.03023.x; BRUSHART TME, 1988, J NEUROSCI, V8, P1026; BRUSHART TME, 1993, J NEUROSCI, V13, P2730, DOI 10.1523/JNEUROSCI.13-06-02730.1993; Cederna PS, 2001, PLAST RECONSTR SURG, V107, P789, DOI 10.1097/00006534-200103000-00021; Cederna PS, 2000, PLAST RECONSTR SURG, V105, P2003, DOI 10.1097/00006534-200005000-00014; Chen YG, 1998, J HAND SURG-AM, V23A, P1025, DOI 10.1016/S0363-5023(98)80010-5; Choi BH, 2004, INT J ORAL MAX SURG, V33, P777, DOI 10.1016/j.ijom.2004.03.006; Choi EH, 2005, MICROSURG, V25, P495, DOI 10.1002/micr.20154; Chung K, 2001, BRAIN RES, V895, P204, DOI 10.1016/S0006-8993(01)02092-3; Colonna M, 2016, PLAST AESTH IN PRESS; Dvali LT, 2008, HAND CLIN, V24, P455, DOI 10.1016/j.hcl.2008.04.006; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Fox IK, 2012, MICROSURG, V32, P552, DOI 10.1002/micr.22036; Frey M, 2003, EUR J PLAST SURG, V26, P89; Frey M, 2003, EUR J PLAST SURG, V26, P85, DOI [10.1007/s00238-003-0475-z., DOI 10.1007/s00238-003-0475-z]; Gencer ZK, 2014, J CRANIOFAC SURG, V25, P652, DOI 10.1097/SCS.0000000000000605; Geuna S, 2000, ANN ANAT, V182, P23, DOI 10.1016/S0940-9602(00)80117-X; Geuna S, 2006, BRAIN RES REV, V52, P381, DOI 10.1016/j.brainresrev.2006.05.002; Giovanoli P, 2000, PLAST RECONSTR SURG, V106, P383, DOI 10.1097/00006534-200008000-00021; GORDON T, 1993, BRAIN RES BULL, V30, P477, DOI 10.1016/0361-9230(93)90281-F; GURNEY ME, 1992, J NEUROSCI, V12, P3241, DOI 10.1523/JNEUROSCI.12-08-03241.1992; Hayashi A, 2004, PLAST RECONSTR SURG, V114, P129, DOI 10.1097/01.PRS.0000129075.96217.92; Hilliard MA, 2009, J NEUROCHEM, V108, P23, DOI 10.1111/j.1471-4159.2008.05754.x; Kanje M, 2000, NEUROREPORT, V11, P2455, DOI 10.1097/00001756-200008030-00023; Kayikcioglu A, 2000, ANN PLAS SURG, V45, P641; Kelly EJ, 2007, J PLAST RECONSTR AES, V60, P1, DOI 10.1016/j.bjps.2005.12.059; Kim JK, 2011, J PLAST RECONSTR AES, V64, P255, DOI 10.1016/j.bjps.2010.04.033; Kolter M, 2015, J CONTROL RELEASE, V197, P165, DOI 10.1016/j.jconrel.2014.11.005; Kostakoglu N, 1999, BRIT J PLAST SURG, V52, P404, DOI 10.1054/bjps.1999.3123; Kovacic U, 2007, EXP NEUROL, V203, P358, DOI 10.1016/j.expneurol.2006.08.018; Landegren T, 2006, SCAND J PLAST RECONS, V40, P65, DOI 10.1080/02844310500513030; Landegren T, 2010, INT J ORAL MAX SURG, V39, P705, DOI 10.1016/j.ijom.2010.03.008; Landegren T, 2007, SCAND J PLAST RECONS, V41, P217, DOI 10.1080/02844310701552001; Larsen JO, 1998, J NEUROSCI METH, V85, P107, DOI 10.1016/S0165-0270(98)00129-0; Liang XD, 2014, NEURAL REGEN RES, V9, P594, DOI 10.4103/1673-5374.130099; Liu K, 1999, J ORTHOP RES, V17, P293, DOI 10.1002/jor.1100170220; LUNDBORG G, 1994, J HAND SURG-BRIT EUR, V19B, P277, DOI 10.1016/0266-7681(94)90069-8; Lutz BS, 2000, BRIT J PLAST SURG, V53, P149, DOI 10.1054/bjps.1999.3252; MACKINNON SE, 1991, MUSCLE NERVE, V14, P1116, DOI 10.1002/mus.880141113; Matsumoto M, 1999, J RECONSTR MICROSURG, V15, P281, DOI 10.1055/s-2007-1000102; McCallister WV, 2001, J HAND SURG-AM, V26A, P478, DOI 10.1053/jhsu.2001.24148; McCallister WV, 1999, J RECONSTR MICROSURG, V15, P597, DOI 10.1055/s-2007-1000144; Mennen U, 2004, J HAND SURG-BRIT EUR, V29B, P514, DOI 10.1016/j.jhsh.2004.03.009; Mennen U, 1999, S AFR MED J, V89, P1188; Mennen U, 1998, HAND SURG, V3, P1; Mennen Ulrich, 2003, Hand Surg, V8, P25, DOI 10.1142/S0218810403001340; Millesi H, 2008, HAND CLIN, V24, P461, DOI 10.1016/j.hcl.2008.04.007; Myckatyn TM, 2004, J RECONSTR MICROSURG, V20, P533, DOI 10.1055/s-2004-836125; Noah EM, 1997, J RECONSTR MICROSURG, V13, P99, DOI 10.1055/s-2007-1000224; Silva DNE, 2012, ACTA CIR BRAS, V27, P325, DOI 10.1590/S0102-86502012000400008; Silva DNE, 2010, ACTA CIR BRAS, V25, P158, DOI 10.1590/S0102-86502010000200007; Okajima S, 2000, J RECONSTR MICROSURG, V16, P313, DOI 10.1055/s-2000-7339; Ornelas L, 2006, J RECONSTR MICROSURG, V22, P123, DOI 10.1055/s-2006-932507; PALAZZI S, 1995, J RECONSTR MICROSURG, V11, P135, DOI 10.1055/s-2007-1006521; Pannucci C, 2007, RESTOR NEUROL NEUROS, V25, P45; Papalia I, 2007, MICROSURG, V27, P56, DOI 10.1002/micr.20303; Papalia I, 2003, J NEUROSCI METH, V127, P43, DOI 10.1016/S0165-0270(03)00098-0; Papalia I, 2007, J NEUROSURG, V107, P378, DOI 10.3171/JNS-07/08/0378; Piskin A, 2009, MICROSURG, V29, P144, DOI 10.1002/micr.20599; Rovak JM, 2000, MICROSURG, V20, P6, DOI 10.1002/(SICI)1098-2752(2000)20:1<6::AID-MICR2>3.0.CO;2-5; Samal F, 2006, ANN ANAT, V188, P337, DOI 10.1016/j.aanat.2006.01.017; Sananpanich K, 2002, J HAND SURG-AM, V27A, P133, DOI 10.1053/jhsu.2002.30370; Sananpanich K, 2007, J NEUROTRAUM, V24, P864, DOI 10.1089/neu.2006.0226; Schmitz C, 2005, NEUROSCIENCE, V130, P813, DOI 10.1016/j.neuroscience.2004.08.050; Sherif MM, 2010, J HAND SURG-AM, V35A, P446, DOI 10.1016/j.jhsa.2009.10.033; SPENCER PS, 1975, BRAIN RES, V96, P323, DOI 10.1016/0006-8993(75)90742-8; Tam SL, 2003, J NEUROBIOL, V57, P221, DOI 10.1002/neu.10276; Tanigawa N, 2005, J NEUROTRAUM, V22, P605, DOI 10.1089/neu.2005.22.605; Tarasidis G, 1998, OTOLARYNG HEAD NECK, V119, P337, DOI 10.1016/S0194-5998(98)70074-9; Tarasidis G, 1997, ANN OTO RHINOL LARYN, V106, P506, DOI 10.1177/000348949710600612; Terzis JK, 2009, PLAST RECONSTR SURG, V124, P1142, DOI 10.1097/PRS.0b013e3181b2b8bc; Tham SKY, 1998, J HAND SURG-AM, V23A, P844, DOI 10.1016/S0363-5023(98)80161-5; Tos P, 2011, ACTA NEUROCHIR SUPPL, V108, P241, DOI 10.1007/978-3-211-99370-5_37; Tung TH, 2003, J NEUROSURG, V98, P313, DOI 10.3171/jns.2003.98.2.0313; Tung THH, 2001, J HAND SURG-AM, V26A, P1065, DOI 10.1053/jhsu.2001.28427; VITERBO F, 1994, PLAST RECONSTR SURG, V94, P1038, DOI 10.1097/00006534-199412000-00019; Viterbo F, 1992, Rev Paul Med, V110, P267; Viterbo Fausto, 2009, Plast Reconstr Surg, V124, pe351, DOI 10.1097/PRS.0b013e3181bf8471; Walker JC, 2004, J NEUROTRAUM, V21, P217, DOI 10.1089/089771504322778677; Wieken K, 2003, J RECONSTR MICROSURG, V19, P17, DOI 10.1055/s-2003-37186; Witzel C, 2005, J COMP NEUROL, V485, P183, DOI 10.1002/cne.20436; Wood MD, 2015, EXP NEUROL, V265, P171, DOI 10.1016/j.expneurol.2015.02.001; Yamauchi Toru, 2000, Medical Electron Microscopy, V33, P151, DOI 10.1007/s007950000015; Yan JG, 2002, J HAND SURG-AM, V27A, P484, DOI 10.1053/jhsu.2002.32953; Yan YH, 2011, MICROSURG, V31, P122, DOI 10.1002/micr.20840; Yuksel F, 2004, MICROSURG, V24, P363, DOI 10.1002/micr.20058; Zhang F, 2002, MICROSURG, V22, P122, DOI 10.1002/micr.21736; Zhang Z, 2001, Am J Orthop (Belle Mead NJ), V30, P400; Zhang ZJ, 2006, MICROSURG, V26, P262, DOI 10.1002/micr.20237; Zhang ZJ, 2000, J RECONSTR MICROSURG, V16, P303, DOI 10.1055/s-2000-7338; Zhao JZ, 1997, J RECONSTR MICROSURG, V13, P31, DOI 10.1055/s-2008-1063938; Zhu QT, 2008, MUSCLE NERVE, V38, P1506, DOI 10.1002/mus.21116	105	15	15	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0148443	10.1371/journal.pone.0148443	http://dx.doi.org/10.1371/journal.pone.0148443			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26872263	Green Published, gold			2022-12-26	WOS:000370054100030
J	Singh, A; Kamal, R; Mudiam, MKR; Gupta, MK; Satyanarayana, GNV; Bihari, V; Shukla, N; Khan, AH; Kesavachandran, CN				Singh, Amarnath; Kamal, Ritul; Mudiam, Mohana Krishna Reddy; Gupta, Manoj Kumar; Satyanarayana, Gubbala Naga Venkata; Bihari, Vipin; Shukla, Nishi; Khan, Altaf Hussain; Kesavachandran, Chandrasekharan Nair			Heat and PAHs Emissions in Indoor Kitchen Air and Its Impact on Kidney Dysfunctions among Kitchen Workers in Lucknow, North India	PLOS ONE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; MUTAGENIC ALDEHYDES; PARTICULATE MATTER; CANCER-MORTALITY; COOKING FUMES; RENAL-DISEASE; EXPOSURE; ALBUMINURIA; ULTRAFINE; WORKING	Indoor air quality and heat exposure have become an important occupational health and safety concern in several workplaces including kitchens of hotels. This study investigated the heat, particulate matter (PM), total volatile organic compounds (TVOCs) and polycyclic aromatic hydrocarbons (PAHs) emissions in indoor air of commercial kitchen and its association with kidney dysfunctions among kitchen workers. A cross sectional study was conducted on 94 kitchen workers employed at commercial kitchen in Lucknow city, North India. A questionnaire-based survey was conducted to collect the personal and occupational history of the kitchen workers. The urine analysis for specific gravity and microalbuminuria was conducted among the study subjects. Indoor air temperature, humidity, wet/dry bulb temperature and humidex heat stress was monitored during cooking activities at the kitchen. Particulate matter (PM) for 1 and 2.5 microns were monitored in kitchen during working hours using Hazdust. PAHS in indoor air was analysed using UHPLC. Urinary hydroxy-PAHs in kitchen workers were measured using GC/MS-MS. Higher indoor air temperature, relative humidity, PM1 and PM2.5 (p<0.001) was observed in the kitchen due to cooking process. Indoor air PAHs identified are Napthalene, fluorine, acenaphthene, phenanthrene, pyrene, chrysene and indeno [1,2,3-cd) pyrene. Concentrations of all PAHs identified in kitchen were above the permissible OSHA norms for indoor air. Specific gravity of urine was significantly higher among the kitchen workers (p<0.001) as compared to the control group. Also, the prevalence of microalbuminuria was higher (p<0.001) among kitchen workers. Urinary PAH metabolites detected among kitchen workers were 1-NAP, 9-HF, 3-HF, 9-PHN and 1-OHP. Continuous heat exposure in kitchens due to cooking can alter kidney functions viz., high specific gravity of urine in kitchen workers. Exposure to PM, VOCs and PAHs in indoor air and presence of urinary PAHs metabolites may lead to inflammation, which can cause microalbuminuria in kitchen workers, as observed in the present study.	[Singh, Amarnath; Kamal, Ritul; Bihari, Vipin; Kesavachandran, Chandrasekharan Nair] CSIR Indian Inst Toxicol Res, Div Epidemiol, PB 80,MG Marg, Lucknow 226001, Uttar Pradesh, India; [Shukla, Nishi; Khan, Altaf Hussain] CSIR Indian Inst Toxicol Res, Environm Monitoring Div, PB 80,MG Marg, Lucknow 226001, Uttar Pradesh, India; [Mudiam, Mohana Krishna Reddy; Gupta, Manoj Kumar; Satyanarayana, Gubbala Naga Venkata] CSIR Indian Inst Toxicol Res, Div Analyt Chem, PB 80,MG Marg, Lucknow 226001, Uttar Pradesh, India; [Singh, Amarnath] Babu Banarasi Univ, Dept Biochem, BBD City, Faizabad Rd, Lucknow 226028, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Toxicology Research (IITR); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Toxicology Research (IITR); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Toxicology Research (IITR); Babu Banarasi Das University	Kesavachandran, CN (corresponding author), CSIR Indian Inst Toxicol Res, Div Epidemiol, PB 80,MG Marg, Lucknow 226001, Uttar Pradesh, India.	ckesavachandran@gmail.com	Mudiam, Mohana Krishna Reddy/O-6824-2014	Mudiam, Mohana Krishna Reddy/0000-0002-0771-8053; Kamal, Ritul/0000-0001-9741-1698	Council of Scientific and Industrial Research, New Delhi-Network program, Government of India [INDEPTH-BSC-0111]	Council of Scientific and Industrial Research, New Delhi-Network program, Government of India	This study was funded by the Council of Scientific and Industrial Research, New Delhi-Network program (Code: INDEPTH-BSC-0111), Government of India.	Afshari A, 2005, INDOOR AIR, V15, P141, DOI 10.1111/j.1600-0668.2005.00332.x; Al-Tawheed AR, 2003, ANN SAUDI MED, V23, P283, DOI 10.5144/0256-4947.2003.283; Alshaarawy O, 2013, ENVIRON RES, V126, P98, DOI 10.1016/j.envres.2013.07.006; Armstrong LE, 1998, INT J SPORT NUTR, V8, P345, DOI 10.1123/ijsn.8.4.345; Barr DB, 2005, ENVIRON HEALTH PERSP, V113, P192, DOI 10.1289/ehp.7337; Beldean-Galea MS, 2014, ACTA CHIM SLOV, V61, P202; Biswas Rajib, 2011, Indian J Occup Environ Med, V15, P120, DOI 10.4103/0019-5278.93202; Brake DJ, 2003, OCCUP ENVIRON MED, V60, P90, DOI 10.1136/oem.60.2.90; BUCKLEY TJ, 1992, BRIT J IND MED, V49, P113; Buonanno G, 2011, AEROSOL SCI TECH, V45, P1069, DOI 10.1080/02786826.2011.580797; BURGAZ S, 1992, INT ARCH OCC ENV HEA, V63, P397, DOI 10.1007/BF00386935; Canadian Centre for Occupational Health and Safety, 2015, HUM RAT WORK; Center for Disease Control and Prevention, 2012, FREQ ASK QUEST EXTR; CORTEZ OD, 2009, GLOB HLTH ACTION, V2, P2069, DOI DOI 10.3402/GHA.V2I0.2069; Crowe J, 2014, OCCUP ENV MED S1, V71, pA51, DOI [DOI 10.1136/OEMED-2014-102362.157, DOI 10.1136/0EMED-2014-102362.157]; Festa A, 2000, KIDNEY INT, V58, P1703, DOI 10.1046/j.1523-1755.2000.00331.x; Gallagner KP, 1964, MONOGRAPHS NATL CANC, V53, P89; Glassock RJ, 2010, CURR HYPERTENS REP, V12, P364, DOI 10.1007/s11906-010-0133-3; GRIMMER G, 1991, INT J ENVIRON AN CH, V43, P177, DOI 10.1080/03067319108026974; Gupta MK, 2015, J ANAL TOXICOL, V39, P365, DOI 10.1093/jat/bkv023; Hallan SI, 2009, J AM SOC NEPHROL, V20, P1069, DOI 10.1681/ASN.2008070730; Hansen AL, 2008, INT J EPIDEMIOL, V37, P1359, DOI 10.1093/ije/dyn165; Haruyama Y, 2010, IND HEALTH, V48, P135, DOI 10.2486/indhealth.48.135; HERIKSTAD BV, 1993, CARCINOGENESIS, V14, P307, DOI 10.1093/carcin/14.2.307; Hoy WE, 2001, KIDNEY INT, V60, P249, DOI 10.1046/j.1523-1755.2001.00793.x; Jakubowski Marek, 2005, International Journal of Occupational Medicine and Environmental Health, V18, P5; Johnson DW, 2012, MED J AUSTRALIA, V197, P224, DOI 10.5694/mja11.11468; JONGENEELEN FJ, 1992, INT ARCH OCC ENV HEA, V63, P511, DOI 10.1007/BF00386338; Kamijo YI, 2006, IND HEALTH, V44, P345, DOI 10.2486/indhealth.44.345; KING H, 1973, J CHRON DIS, V26, P623, DOI 10.1016/0021-9681(73)90053-2; Lamers RJAN, 2005, OSTEOARTHR CARTILAGE, V13, P762, DOI 10.1016/j.joca.2005.04.005; Levin A, 2008, CLIN J AM SOC NEPHRO, V3, P862, DOI 10.2215/CJN.04841107; McLaughlin M., 2013, 9 11 RESPONDERS SUFF; Moret S, 2000, J CHROMATOGR A, V882, P245, DOI 10.1016/S0021-9673(00)00079-0; Mumford JL, 1995, CARCINOGENESIS, V16, P3031, DOI 10.1093/carcin/16.12.3031; NY ET, 1993, AM IND HYG ASSOC J, V54, P277, DOI 10.1202/0002-8894(1993)054<0277:TRBPAH>2.0.CO;2; Occupational Health and Safety, ACC IND AIR QUAL LEV; Occupational Safety and Health Administration, OSHA FACT SHEET PROT; Occupational Safety and Health Administration, OSHA TECHN MAN OSHA; Raju DSSK., 2014, ASIAN J PHARM CLIN R, V7, P53; Robinson AL, 2006, ENVIRON SCI TECHNOL, V40, P7820, DOI 10.1021/es060781p; SANTELLA RM, 1993, CANCER EPIDEM BIOMAR, V2, P59; SCHOENBERG JB, 1984, J NATL CANCER I, V72, P973; Sjaastad AK, 2010, OCCUP ENVIRON MED, V67, P228, DOI 10.1136/oem.2009.046144; Sjaastad AK, 2009, ANN OCCUP HYG, V53, P723, DOI 10.1093/annhyg/mep059; Sjaastad AK, 2008, ANN OCCUP HYG, V52, P739, DOI 10.1093/annhyg/men060; Srivastava A, 2000, ANN OCCUP HYG, V44, P449, DOI 10.1016/S0003-4878(00)00003-X; Svendsen K, 2002, ANN OCCUP HYG, V46, P395, DOI 10.1093/annhyg/mef045; To WM, 2000, INDOOR BUILT ENVIRON, V9, P228, DOI 10.1177/1420326X0000900312; Vaidya C, 2010, CLEV CLIN J MED, V77, P715, DOI 10.3949/ccjm.77a.08051; VAINIOTALO S, 1993, AM IND HYG ASSOC J, V54, P376, DOI 10.1202/0002-8894(1993)054<0376:CFAAHP>2.0.CO;2; Venkatachalam MA, 2010, AM J PHYSIOL-RENAL, V298, pF1078, DOI 10.1152/ajprenal.00017.2010; Wallace LA, 2004, ENVIRON SCI TECHNOL, V38, P2304, DOI 10.1021/es0306260; Wallace L, 2008, ENVIRON SCI TECHNOL, V42, P8641, DOI 10.1021/es801402v; World Healh Organisation, 1991, PRINC METH ASS NEPHR; World Health Organization, 1996, GUIDELINES; Zhu LZ, 2003, CHEMOSPHERE, V50, P611, DOI 10.1016/S0045-6535(02)00668-9	57	38	42	7	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0148641	10.1371/journal.pone.0148641	http://dx.doi.org/10.1371/journal.pone.0148641			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26871707	Green Published, Green Submitted, gold			2022-12-26	WOS:000370054100044
J	Tu, YH; Wang, YL; Ding, LN; Zhang, J; Wu, WC				Tu, Yunhai; Wang, Yilong; Ding, Luna; Zhang, Jiao; Wu, Wencan			Development of a Novel Thyroid Function Fluctuated Animal Model for Thyroid-Associated Ophthalmopathy	PLOS ONE			English	Article							GRAVES-OPHTHALMOPATHY; THYROTROPIN RECEPTOR; CURRENT INSIGHTS; DISEASE; ORBITOPATHY; HYPERTHYROIDISM; EXPRESSION; AUTOANTIBODIES; PATHOGENESIS; ANTIBODIES	Background The establishment of a suitable and stable animal model is critical for research on thyroid-associated ophthalmopathy (TAO). In clinical practice, we found that patients treated with I-131 often exhibit TAO; therefore, we aimed to establish a novel thyroid function fluctuated animal model of TAO by simulating the clinical treatment process. Methods We treated SD rats with I-131 to damage the thyroid and then used sodium levothyroxine (L-T4) to supplement the thyroid hormone (TH) levels every seven days, leading to a fluctuating level of thyroid hormones that simulated the status of clinical TAO patients. Rats administered normal saline were considered as a control. The weight, intraocular pressure, and serum T3, T4, TSH and TRAb levels of the rats were measured, and the pathological changes were analyzed by H& E staining and transmission electron microscopy (TEM). Results The experimental rats (TAO group) exhibited significantly reduced weight and elevated intraocular pressure compared with the control rats. Meanwhile, the serum levels of T3 and T4 were up-regulated in the TAO group, but the TSH level decreased during the 10-week study. Moreover, increased numbers of blood vessels and inflammatory cell infiltrations were observed in the orbital tissues of the TAOrats, while no abnormal changes occurred in the control rats. The orbital myofibrils in the TAO rats appeared fractured and dissolved, with twisted structures. Mitochondrial swelling and vacuoles within the endoplasmic reticulum, swelling nerve fibers, shedding nerve myelin, and macrophages were found in the TAO group. Conclusion Rats treated with I-131 and sodium levothyroxine exhibited characteristics similar to those of TAO patients in the clinic, providing an effective and simple method for the establishment of a stable animal model for research on the pathogenesis and treatment of TAO.	[Tu, Yunhai; Ding, Luna; Zhang, Jiao; Wu, Wencan] Wenzhou Med Univ, Hosp Eye, Wenzhou 325000, Peoples R China; [Wang, Yilong] Wenzhou Med Univ, Dept Lab Anim Ctr, Wenzhou 325000, Peoples R China	Wenzhou Medical University; Wenzhou Medical University	Wu, WC (corresponding author), Wenzhou Med Univ, Hosp Eye, Wenzhou 325000, Peoples R China.	wuwencan118@163.com			Zhejiang Provincial Natural Science Foundation of China [LQ12H12004, LY12H12006]; Eye Hospital of Wenzhou Medical University [YNCX201315]	Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Eye Hospital of Wenzhou Medical University	This study was financially supported by the Zhejiang Provincial Natural Science Foundation of China under Grant Nos. LQ12H12004 and LY12H12006, and The Eye Hospital of Wenzhou Medical University (YNCX201315).	Arnold K, 1996, ORBIT, V15, P159, DOI 10.3109/01676839609150233; BAHN RS, 1993, NEW ENGL J MED, V329, P1468; Banga JP, 2015, HORM METAB RES, V47, P797, DOI 10.1055/s-0035-1555956; Bartalena L, 2000, ENDOCR REV, V21, P168, DOI 10.1210/er.21.2.168; Bartalena L, 1998, NEW ENGL J MED, V338, P73, DOI 10.1056/NEJM199801083380201; BARTLEY GB, 1995, AM J OPHTHALMOL, V119, P792, DOI 10.1016/S0002-9394(14)72787-4; Clement SC, 2015, CANC TREAT REV, V10; Cockerham KP, 1997, OPHTHALMOLOGY, V104, P914, DOI 10.1016/S0161-6420(97)30207-3; Costagliola S, 1998, J IMMUNOL, V160, P1458; Czarnywojtek Agata, 2013, Neuro Endocrinol Lett, V34, P241; Eckstein AK, 2009, HORM METAB RES, V41, P456, DOI 10.1055/s-0029-1220935; Eckstein AK, 2004, BRIT J OPHTHALMOL, V88, P803, DOI 10.1136/bjo.2003.035915; Eckstein AK, 2006, J CLIN ENDOCR METAB, V91, P3464, DOI 10.1210/jc.2005-2813; Gerding MN, 2000, CLIN ENDOCRINOL, V52, P267, DOI 10.1046/j.1365-2265.2000.00959.x; HEUFELDER AE, 1992, EUR J CLIN INVEST, V22, P529, DOI 10.1111/j.1365-2362.1992.tb01501.x; HEUFELDER AE, 1993, EUR J CLIN INVEST, V23, P10, DOI 10.1111/j.1365-2362.1993.tb00712.x; Jang SY, 2013, EYE, V27, P964, DOI 10.1038/eye.2013.120; Kim SE, 2012, GRAEF ARCH CLIN EXP, V250, P1521, DOI 10.1007/s00417-012-2092-7; Klee GG, 1997, ENDOCRIN METAB CLIN, V26, P763, DOI 10.1016/S0889-8529(05)70281-4; Konuk EBY, 2006, EUR J ENDOCRINOL, V155, P681, DOI 10.1530/eje.1.02280; KROLL AJ, 1966, ARCH OPHTHALMOL-CHIC, V76, P244, DOI 10.1001/archopht.1966.03850010246017; Maheshwari R, 2012, INDIAN J OPHTHALMOL, V60, P87, DOI 10.4103/0301-4738.94048; Molnar I, 1997, AUTOIMMUNITY, V25, P91, DOI 10.3109/08916939708996275; Moshkelgosha S, 2015, CURR PHARM DESIGN, V21, P2414, DOI 10.2174/1381612821666150316121945; Noh JY, 2000, THYROID, V10, P809, DOI 10.1089/thy.2000.10.809; Salvi M, 2015, HORM METAB RES, V47, P779, DOI 10.1055/s-0035-1554721; Sen E, 2012, J GLAUCOMA, V21, P586, DOI 10.1097/IJG.0b013e31822e8c4f; SMITH BR, 1988, ENDOCR REV, V9, P106, DOI 10.1210/edrv-9-1-106; SURKS MI, 1990, JAMA-J AM MED ASSOC, V263, P1529, DOI 10.1001/jama.263.11.1529; TALLSTEDT L, 1992, NEW ENGL J MED, V326, P1733, DOI 10.1056/NEJM199206253262603; Traisk F, 2009, J CLIN ENDOCR METAB, V94, P3700, DOI 10.1210/jc.2009-0747; TSALOUMAS MD, 1994, EYE, V8, P638, DOI 10.1038/eye.1994.159; Vondrichova T, 2007, THYROID, V17, P511, DOI 10.1089/thy.2007.0028; Weetman AP, 1997, MOL CELL ENDOCRINOL, V126, P113, DOI 10.1016/S0303-7207(96)03986-X; Wiesweg B, 2013, HORM METAB RES, V45, P549, DOI 10.1055/s-0033-1343451	35	2	4	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0148595	10.1371/journal.pone.0148595	http://dx.doi.org/10.1371/journal.pone.0148595			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26872324	Green Published, gold, Green Submitted			2022-12-26	WOS:000370054100039
J	Akagi, S; Kono, N; Ariyama, H; Shindou, H; Shimizu, T; Arai, H				Akagi, Sosuke; Kono, Nozomu; Ariyama, Hiroyuki; Shindou, Hideo; Shimizu, Takao; Arai, Hiroyuki			Lysophosphatidylcholine acyltransferase 1 protects against cytotoxicity induced by polyunsaturated fatty acids	FASEB JOURNAL			English	Article						phospholipid metabolism; fatty acid metabolism; membrane phospholipid homeostasis	IMAGING MASS-SPECTROMETRY; LYSOPHOSPHOLIPID ACYLTRANSFERASE; EICOSAPENTAENOIC ACID; LIPID-COMPOSITION; MBOAT FAMILY; ACYL-COA; MEMBRANE; CELLS; CHAIN; PHOSPHATIDYLCHOLINE	The degree of fatty acid unsaturation in membrane phospholipids affects many membrane-associated functions and can be influenced by dietary consumption of fatty acids such as saturated fatty acids and polyunsaturated fatty acids (PUFAs). Cells must adapt to changes in composition of membrane fatty acids by regulating lipid-metabolizing enzymes. In this study, we investigated how cells respond to loading with excess PUFAs, such as arachidonic acid, eicosapentaenoic acid, and docosahexaenoic acid. A lipidomics analysis revealed that dipalmitoylphosphatidylcholine (DPPC) was increased after the production of PUFA-containing phospholipids in cells loaded with PUFAs. An RNA interference screen of lipid-metabolizing enzymes revealed that lysophosphatidylcholine acyltransferase 1 (LPCAT1) was involved in the DPPC production. Moreover, LPCAT1 knockdown markedly enhanced the cytotoxicity induced by excess PUFAs. PUFA-induced cytotoxicity was dependent on caspase and unfolded protein response (UPR) sensor proteins inositol requiring 1 alpha and protein kinase R-like endoplasmic reticulum kinase, suggesting that excess PUFAs trigger UPR-mediated apoptosis. In murine retina, in which PUFAs are highly enriched, DPPC was produced along with increase of PUFA-containing phospholipids. In LPCAT1 knockout mice, DPPC level was reduced and UPR was activated in the retina. Our results provide insight into understanding of the retinal degeneration seen in rd11 mice that lack LPCAT1.-Akagi, S., Kono, N., Ariyama, H., Shindou, H., Shimizu, T., Arai, H. Lysophosphatidylcholine acyltransferase 1 protects against cytotoxicity induced by polyunsaturated fatty acids. www.fasebj.org	[Akagi, Sosuke; Kono, Nozomu; Ariyama, Hiroyuki; Arai, Hiroyuki] Univ Tokyo, Grad Sch Pharmaceut Sci, Dept Hlth Chem, Tokyo 1130033, Japan; [Shindou, Hideo; Shimizu, Takao] Natl Ctr Global Hlth & Med, Res Inst, Dept Lipid Signaling, Tokyo, Japan; [Shindou, Hideo; Arai, Hiroyuki] Japan Agcy Med Res & Dev, Core Res Evolutionary Sci & Technol AMED CREST, Tokyo, Japan; [Shimizu, Takao] Univ Tokyo, Grad Sch Med, Dept Lipid, Tokyo 1130033, Japan	University of Tokyo; National Center for Global Health & Medicine - Japan; University of Tokyo	Kono, N; Arai, H (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Dept Hlth Chem, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	nozomu@mol.f.u-tokyo.ac.jp; harai@mol.f.u-tokyo.ac.jp	Shimizu, Takao/AAV-7052-2021; KONO, nozomu/AAM-3178-2020		Japan Society for the Promotion of Science (KAKENHI) [23227004, 25460060, 24229003]; Japan Agency for Medical Research and Development-Core Research for Evolutionary Science and Technology (AMED-CREST); Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries, and Food Industry	Japan Society for the Promotion of Science (KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Agency for Medical Research and Development-Core Research for Evolutionary Science and Technology (AMED-CREST)(Japan Agency for Medical Research and Development (AMED)); Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries, and Food Industry	The authors gratefully acknowledge the technical assistance from K. Mukai, H. Fukuda, M. Kamio, T. Akimura, and Y. Takada. This work was supported by Japan Society for the Promotion of Science (KAKENHI) Grants 23227004 (to H. A.), 25460060 (to N.K.), and 24229003 (to T.S.); by the Japan Agency for Medical Research and Development-Core Research for Evolutionary Science and Technology (AMED-CREST) (to H. A. and H.S.); and by the Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries, and Food Industry (to H.A.).	Anasagasti A, 2012, VISION RES, V75, P117, DOI 10.1016/j.visres.2012.09.012; Anderson DMG, 2014, J AM SOC MASS SPECTR, V25, P1394, DOI 10.1007/s13361-014-0883-2; Ariyama H, 2010, J BIOL CHEM, V285, P22027, DOI 10.1074/jbc.M110.126870; Ban N, 2007, J BIOL CHEM, V282, P9628, DOI 10.1074/jbc.M611767200; Berdeaux O, 2010, J CHROMATOGR A, V1217, P7738, DOI 10.1016/j.chroma.2010.10.039; Bigay J, 2012, DEV CELL, V23, P886, DOI 10.1016/j.devcel.2012.10.009; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Borradaile NM, 2006, J LIPID RES, V47, P2726, DOI 10.1194/jlr.M600299-JLR200; Bridges JP, 2010, J CLIN INVEST, V120, P1736, DOI 10.1172/JCI38061; Browman DT, 2006, J CELL SCI, V119, P3149, DOI 10.1242/jcs.03060; CARAVAGGIO LL, 1963, EXP EYE RES, V2, P12, DOI 10.1016/S0014-4835(63)80018-4; Chen P, 2014, INVEST OPHTH VIS SCI, V55, P8031, DOI 10.1167/iovs.14-14098; Chen XN, 2006, P NATL ACAD SCI USA, V103, P11724, DOI 10.1073/pnas.0604946103; Corsetto PA, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-73; Dobrzyn A, 2005, J BIOL CHEM, V280, P23356, DOI 10.1074/jbc.M502436200; Estadella D, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/137579; FALCONER JS, 1994, BRIT J CANCER, V69, P826, DOI 10.1038/bjc.1994.161; Fan YY, 2012, J LIPID RES, V53, P1287, DOI 10.1194/jlr.M024216; Flowers MT, 2008, CURR OPIN LIPIDOL, V19, P248, DOI 10.1097/MOL.0b013e3282f9b54d; Friedman JS, 2010, P NATL ACAD SCI USA, V107, P15523, DOI 10.1073/pnas.1002897107; Garofalo T, 2005, CELL DEATH DIFFER, V12, P1378, DOI 10.1038/sj.cdd.4401672; Giusto NM, 2000, PROG LIPID RES, V39, P315, DOI 10.1016/S0163-7827(00)00009-6; Gorbatyuk M, 2013, MOL VIS, V19, P1985; Harayama T, 2014, CELL METAB, V20, P295, DOI 10.1016/j.cmet.2014.05.019; Harayama T, 2009, J LIPID RES, V50, P1824, DOI 10.1194/jlr.M800500-JLR200; Hayasaka T, 2008, RAPID COMMUN MASS SP, V22, P3415, DOI 10.1002/rcm.3751; Hayashi T, 2010, MOL PHARMACOL, V77, P517, DOI 10.1124/mol.109.062539; Haynes CA, 2008, J LIPID RES, V49, P1113, DOI 10.1194/jlr.D800001-JLR200; Helms JB, 2004, TRAFFIC, V5, P247, DOI 10.1111/j.1600-0854.2004.0181.x; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Hishikawa D, 2008, P NATL ACAD SCI USA, V105, P2830, DOI 10.1073/pnas.0712245105; Holzer RG, 2011, CELL, V147, P173, DOI 10.1016/j.cell.2011.08.034; Imae R, 2010, MOL BIOL CELL, V21, P3114, DOI 10.1091/mbc.E10-03-0195; KENNEDY EP, 1956, J BIOL CHEM, V222, P193; Koeberle A, 2012, FASEB J, V26, P169, DOI 10.1096/fj.11-184879; Lands WEM, 2000, BBA-MOL CELL BIOL L, V1483, P1, DOI 10.1016/S1388-1981(99)00177-8; LANDSCHULZ KT, 1994, BIOCHEM BIOPH RES CO, V200, P763, DOI 10.1006/bbrc.1994.1516; Lee HC, 2008, MOL BIOL CELL, V19, P1174, DOI 10.1091/mbc.E07-09-0893; Lee S, 2012, GENES CELLS, V17, P728, DOI 10.1111/j.1365-2443.2012.01622.x; MACDONALD JIS, 1991, BIOCHIM BIOPHYS ACTA, V1084, P105, DOI 10.1016/0005-2760(91)90209-Z; Matsuda S, 2008, GENES CELLS, V13, P879, DOI 10.1111/j.1365-2443.2008.01212.x; Matsuzaka T, 2007, NAT MED, V13, P1193, DOI 10.1038/nm1662; Merendino N, 2005, NUTR CANCER, V52, P225, DOI 10.1207/s15327914nc5202_12; Mitchell DC, 2001, J BIOL CHEM, V276, P42801, DOI 10.1074/jbc.M105772200; Moon YA, 2014, J LIPID RES, V55, P2597, DOI 10.1194/jlr.M054353; Nakanishi H, 2006, J BIOL CHEM, V281, P20140, DOI 10.1074/jbc.M600225200; Niu SL, 2004, J BIOL CHEM, V279, P31098, DOI 10.1074/jbc.M404376200; Pantazi D, 2013, LIPIDS, V48, P827, DOI 10.1007/s11745-013-3800-8; Peter A, 2009, DIABETES, V58, P1757, DOI 10.2337/db09-0188; Pinot M, 2014, SCIENCE, V345, P693, DOI 10.1126/science.1255288; Rawicz W, 2000, BIOPHYS J, V79, P328, DOI 10.1016/S0006-3495(00)76295-3; Rong X, 2013, CELL METAB, V18, P685, DOI 10.1016/j.cmet.2013.10.002; Sato SB, 2011, PROSTAG LEUKOTR ESS, V84, P31, DOI 10.1016/j.plefa.2010.09.006; Sessler AM, 1996, J BIOL CHEM, V271, P29854, DOI 10.1074/jbc.271.47.29854; Shimomura I, 1998, J BIOL CHEM, V273, P35299, DOI 10.1074/jbc.273.52.35299; Shindou H, 2007, J BIOL CHEM, V282, P6532, DOI 10.1074/jbc.M609641200; Shindou H, 2009, J BIOL CHEM, V284, P1, DOI 10.1074/jbc.R800046200; SPECTOR AA, 1985, J LIPID RES, V26, P1015; Stahlman MT, 2007, J HISTOCHEM CYTOCHEM, V55, P71, DOI 10.1369/jhc.6A6962.2006; Stoffel W, 2008, EMBO J, V27, P2281, DOI 10.1038/emboj.2008.156; Stulnig TM, 1998, J CELL BIOL, V143, P637, DOI 10.1083/jcb.143.3.637; Stulnig TM, 2001, J BIOL CHEM, V276, P37335, DOI 10.1074/jbc.M106193200; Swaroop A, 2010, NAT REV NEUROSCI, V11, P563, DOI 10.1038/nrn2880; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; Tanito M, 2009, J LIPID RES, V50, P807, DOI 10.1194/jlr.M800170-JLR200; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; Vasquez V, 2014, CELL REP, V6, P70, DOI 10.1016/j.celrep.2013.12.012; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wilson R, 2001, J CHROMATOGR A, V905, P251, DOI 10.1016/S0021-9673(00)01006-2; YAMAOKA S, 1988, J NUTR, V118, P290, DOI 10.1093/jn/118.3.290; Zech T, 2009, EMBO J, V28, P466, DOI 10.1038/emboj.2009.6; Zhao Y, 2008, J BIOL CHEM, V283, P8258, DOI 10.1074/jbc.M710422200; Zou CB, 2011, J BIOL CHEM, V286, P2719, DOI 10.1074/jbc.M110.192377	73	16	17	0	23	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2016	30	5					2027	2039		10.1096/fj.201500149	http://dx.doi.org/10.1096/fj.201500149			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DK4HW	26887439				2022-12-26	WOS:000374879400029
J	Tsukagoshi, Y; Suzuki, H; Seki, H; Muranaka, T; Ohyama, K; Fujimoto, Y				Tsukagoshi, Yuki; Suzuki, Hideyuki; Seki, Hikaru; Muranaka, Toshiya; Ohyama, Kiyoshi; Fujimoto, Yoshinori			Ajuga 24-Sterol Reductase Catalyzes the Direct Reductive Conversion of 24-Methylenecholesterol to Campesterol	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						biosynthesis; enzyme mechanism; plant biochemistry; reductase; sterol	REPTANS VAR ATROPURPUREA; HAIRY ROOTS; HIGHER-PLANTS; SITOSTEROL BIOSYNTHESIS; AMSONIA-ELLIPTICA; CULTURED-CELLS; DOUBLE-BOND; CHOLESTEROL; STEROLS; MECHANISM	Dimunito/Dwarf1 (DWF1) is an oxidoreductase enzyme that is responsible for the conversion of C-28- and C-29-(24(28))-olefinic sterols to 24-methyl- and 24-ethylcholesterols. Generally, the reaction proceeds in two steps via the (24(25)) intermediate. In this study, we characterized the ArDWF1 gene from an expression sequence tag library of Ajuga reptans var. atropurpurea hairy roots. The gene was functionally expressed in the yeast T21 strain. The in vivo and in vitro study of the transformed yeast indicated that ArDWF1 catalyzes the conversion of 24-methylenecholesterol to campesterol. A labeling study followed by GC-MS analysis suggested that the reaction proceeded with retention of the C-25 hydrogen. The 25-H retention was established by the incubation of the enzyme with (23,23,25-H-2(3),28-C-13)-24-methylenecholesterol, followed by C-13 NMR analysis of the resulting campesterol. Thus, it has been concluded that ArDWF1 directly reduces 24-methylenecholesterol to produce campesterol without passing through a (24(25)) intermediate. This is the first characterization of such a unique DWF1 enzyme. For comparison purposes, Oryza sativa DWF1 (OsDWF1) was similarly expressed in yeast. An in vivo assay of OsDWF1 supported the generally accepted two-step mechanism because the C-25 hydrogen of 24-methylenecholesterol was eliminated during its conversion to 24-methylcholesterol. As expected, the 24-methylcholesterol produced by OsDWF1 was a mixture of campesterol and dihydrobrassicasterol. Furthermore, the 24-methylcholesterol contained in the Ajuga hairy roots was determined to be solely campesterol through its analysis using chiral GC-MS. Therefore, ArDWF1 has another unique property in that only campesterol is formed by the direct reduction catalyzed by the enzyme.	[Tsukagoshi, Yuki; Ohyama, Kiyoshi; Fujimoto, Yoshinori] Tokyo Inst Technol, Dept Chem & Mat Sci, Meguro Ku, Tokyo 1528551, Japan; [Suzuki, Hideyuki] Kazusa DNA Res Inst, 2-6-7 Kazusa Kamatari, Kisarazu, Chiba 2920818, Japan; [Seki, Hikaru; Muranaka, Toshiya] Osaka Univ, Grad Sch Engn, Dept Biotechnol, 2-1 Yamadaoka, Suita, Osaka 5650871, Japan	Tokyo Institute of Technology; Kazusa DNA Research Institute; Osaka University	Fujimoto, Y (corresponding author), Tokyo Inst Technol, Dept Chem & Mat Sci, Meguro Ku, Tokyo 1528551, Japan.	fujimoto.y.aa@gmail.com	Muranaka, Toshiya/D-4351-2016; Suzuki, Hideyuki/J-7571-2016; Seki, Hikaru/C-9730-2017	Muranaka, Toshiya/0000-0003-1058-2473; 	Ministry of Education, Culture, Sports, Science, and Technology [26450138]; Grants-in-Aid for Scientific Research [26350967] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grant-in-Aid for Scientific Research (C) 26450138 (to K. O.) from the Ministry of Education, Culture, Sports, Science, and Technology. The authors declare that they have no conflicts of interest with the contents of this article.	CAMPS F, 1983, AN QUIM C-ORG BIOQ, V79, P228; Du LQ, 2005, NATURE, V437, P741, DOI 10.1038/nature03973; FONTENEAU P, 1977, PLANT SCI LETT, V10, P147, DOI 10.1016/0304-4211(77)90122-5; Fujimoto Y, 1998, BIOORG MED CHEM LETT, V8, P205, DOI 10.1016/S0960-894X(97)10220-7; FUJIMOTO Y, 1990, J CHEM SOC PERK T 1, P2041, DOI 10.1039/p19900002041; FUJIMOTO Y, 1984, CHEM PHARM BULL, V32, P4372; Fujimoto Y, 2000, LIPIDS, V35, P279, DOI 10.1007/s11745-000-0524-z; Fujimoto Y, 1997, CHEM COMMUN, P681, DOI 10.1039/a700492c; Fujimoto Y, 2015, PHYTOCHEMISTRY, V111, P59, DOI 10.1016/j.phytochem.2014.12.019; GROVE MD, 1979, NATURE, V281, P216, DOI 10.1038/281216a0; Hyodo R, 2000, PHYTOCHEMISTRY, V53, P733, DOI 10.1016/S0031-9422(00)00018-2; Klahre U, 1998, PLANT CELL, V10, P1677, DOI 10.1105/tpc.10.10.1677; LAI MH, 1994, GENE, V140, P41; LENTON JR, 1975, PHYTOCHEMISTRY, V14, P1523, DOI 10.1016/0031-9422(75)85344-1; MALHOTRA HC, 1971, J BIOL CHEM, V246, P4934; MARUYAMA S, 1982, TETRAHEDRON LETT, V23, P1701, DOI 10.1016/S0040-4039(00)87194-4; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; MULHEIRN LJ, 1973, TETRAHEDRON LETT, P3175; NAGAKARI M, 1994, PHYTOCHEMISTRY, V36, P907, DOI 10.1016/S0031-9422(00)90461-8; Nes WD, 2003, J BIOL CHEM, V278, P34505, DOI 10.1074/jbc.M303359200; NES WD, 1991, J BIOL CHEM, V266, P15202; NES WR, 1977, BIOCH STEROIDS OTHER, P325; Niwa R, 2004, J BIOL CHEM, V279, P35942, DOI 10.1074/jbc.M404514200; Okuzumi K, 2003, TETRAHEDRON LETT, V44, P323, DOI 10.1016/S0040-4039(02)02565-0; Okuzumi T, 1999, TETRAHEDRON LETT, V40, P8863, DOI 10.1016/S0040-4039(99)01862-6; Patterson G. W., 1991, PHYSL BIOCH STEROLS, P83; Sawai S, 2014, PLANT CELL, V26, P3763, DOI 10.1105/tpc.114.130096; Schaller H, 2004, PLANT PHYSIOL BIOCH, V42, P465, DOI 10.1016/j.plaphy.2004.05.012; SEO S, 1992, J CHEM SOC PERK T 1, P569, DOI 10.1039/p19920000569; Takahashi K, 2003, TETRAHEDRON LETT, V44, P341, DOI 10.1016/S0040-4039(02)02567-4; TAKAHASHI T, 1995, GENE DEV, V9, P97, DOI 10.1101/gad.9.1.97; Tsukagoshi Y., 2016, FUNCTIONAL CHARACTER; UOMORI A, 1992, PHYTOCHEMISTRY, V31, P1569, DOI 10.1016/0031-9422(92)83108-B; Waterham HR, 2001, AM J HUM GENET, V69, P685, DOI 10.1086/323473; Yagi T, 1996, PHYTOCHEMISTRY, V41, P1057, DOI 10.1016/0031-9422(95)00766-0; Yamada J, 1997, TETRAHEDRON, V53, P877, DOI 10.1016/S0040-4020(96)01008-3	36	12	14	3	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2016	291	15					8189	8198		10.1074/jbc.M115.703470	http://dx.doi.org/10.1074/jbc.M115.703470			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DJ2SZ	26872973	Green Published, hybrid			2022-12-26	WOS:000374056700035
J	Azuma, J; Wong, RJ; Morisawa, T; Hsu, M; Maegdefessel, L; Zhao, H; Kalish, F; Kayama, Y; Wallenstein, MB; Deng, AC; Spin, JM; Stevenson, DK; Dalman, RL; Tsao, PS				Azuma, Junya; Wong, Ronald J.; Morisawa, Takeshi; Hsu, Mark; Maegdefessel, Lars; Zhao, Hui; Kalish, Flora; Kayama, Yosuke; Wallenstein, Matthew B.; Deng, Alicia C.; Spin, Joshua M.; Stevenson, David K.; Dalman, Ronald L.; Tsao, Philip S.			Heme Oxygenase-1 Expression Affects Murine Abdominal Aortic Aneurysm Progression	PLOS ONE			English	Article							GENE-EXPRESSION; CARBON-MONOXIDE; SIMVASTATIN SUPPRESSES; STATINS; ANTIOXIDANT; BILIRUBIN; MECHANISM; MICE; POLYMORPHISM; INHIBITOR	Heme oxygenase-1 (HO-1), the rate-limiting enzyme in heme degradation, is a cytoprotective enzyme upregulated in the vasculature by increased flow and inflammatory stimuli. Human genetic data suggest that a diminished HO-1 expression may predispose one to abdominal aortic aneurysm (AAA) development. In addition, heme is known to strongly induce HO-1 expression. Utilizing the porcine pancreatic elastase (PPE) model of AAA induction in HO-1 heterozygous (HO-1(+/-), HO-1 Het) mice, we found that a deficiency in HO-1 leads to augmented AAA development. Peritoneal macrophages from HO-1(+/-) mice showed increased gene expression of pro-inflammatory cytokines, including MCP-1, TNF-alpha, IL-1-beta, and IL-6, but decreased expression of anti-inflammatory cytokines IL-10 and TGF-beta. Furthermore, treatment with heme returned AAA progression in HO-1 Het mice to a wild-type profile. Using a secondmurine AAA model (Ang II-ApoE(-/-)), we showed that low doses of the HMG-CoA reductase inhibitor rosuvastatin can induce HO-1 expression in aortic tissue and suppress AAA progression in the absence of lipid lowering. Our results support those studies that suggest that pleiotropic statin effects might be beneficial in AAA, possibly through the upregulation of HO-1. Specific targeted therapies designed to induce HO-1 could become an adjunctive therapeutic strategy for the prevention of AAA disease.	[Azuma, Junya; Hsu, Mark; Maegdefessel, Lars; Kayama, Yosuke; Deng, Alicia C.; Spin, Joshua M.; Tsao, Philip S.] Stanford Univ, Sch Med, Div Cardiovasc Med, Stanford, CA 94305 USA; [Wong, Ronald J.; Morisawa, Takeshi; Zhao, Hui; Kalish, Flora; Wallenstein, Matthew B.; Stevenson, David K.] Stanford Univ, Dept Pediat, Sch Med, Div Neonatal & Dev Med, Stanford, CA 94305 USA; [Dalman, Ronald L.] Stanford Univ, Sch Med, Div Vasc Surg, Stanford, CA 94305 USA; [Kayama, Yosuke; Deng, Alicia C.; Spin, Joshua M.; Tsao, Philip S.] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA	Stanford University; Stanford University; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Wong, RJ (corresponding author), Stanford Univ, Dept Pediat, Sch Med, Div Neonatal & Dev Med, Stanford, CA 94305 USA.	rjwong@stanford.edu	Maegdefessel, Lars/AAW-8243-2020; Maegdefessel, Lars/C-2955-2015	Spin, Joshua/0000-0002-4256-9161; Maegdefessel, Lars/0000-0001-5228-2634	National Institutes of Health [1R01HL122939]; Department of Veterans Affairs [101BX002641]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL122939] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by research grants from the National Institutes of Health (1R01HL122939 [PST]) and the Department of Veterans Affairs (101BX002641 [PST]).	Ailawadi G, 2003, J VASC SURG, V38, P584, DOI 10.1016/S0741-5214(03)00324-0; ANIDJAR S, 1992, J VASC SURG, V16, P139, DOI 10.1016/0741-5214(92)90101-D; Bigatel DA, 1999, J VASC SURG, V29, P130, DOI 10.1016/S0741-5214(99)70354-X; Carsten CG, 2001, J VASC SURG, V33, P1255, DOI 10.1067/mva.2001.112706; Chen YH, 2002, HUM GENET, V111, P1, DOI 10.1007/s00439-002-0769-4; Dalman RL, 2006, ANN NY ACAD SCI, V1085, P92, DOI 10.1196/annals.1383.008; Datta PK, 1999, KIDNEY INT, V55, P1734, DOI 10.1046/j.1523-1755.1999.00429.x; Daugherty A, 2004, ARTERIOSCL THROM VAS, V24, P429, DOI 10.1161/01.ATV.0000118013.72016.ea; Duckers HJ, 2001, NAT MED, V7, P693, DOI 10.1038/89068; Dulak J, 2005, ENDOTHELIUM-J ENDOTH, V12, P233, DOI 10.1080/10623320500476559; Durante W, 1997, CIRC RES, V80, P557, DOI 10.1161/01.RES.80.4.557; Eto M, 2002, CIRCULATION, V105, P1756, DOI 10.1161/01.CIR.0000015465.73933.3B; Evans J, 2007, EUR J VASC ENDOVASC, V34, P302, DOI 10.1016/j.ejvs.2007.04.011; Ferguson CD, 2010, AM HEART J, V159, DOI 10.1016/j.ahj.2009.11.016; Foresti R, 2001, AM J PHYSIOL-HEART C, V281, pH1976, DOI 10.1152/ajpheart.2001.281.5.H1976; Grosser N, 2004, FREE RADICAL BIO MED, V37, P2064, DOI 10.1016/j.freeradbiomed.2004.09.009; Grosser N, 2004, BIOCHEM BIOPH RES CO, V325, P871, DOI 10.1016/j.bbrc.2004.10.123; Hance KA, 2002, J VASC SURG, V35, P254, DOI 10.1067/mva.2002.120382; He CX, 2011, PEDIATR RES, V70, P467, DOI 10.1203/PDR.0b013e31822e1675; Hoekstra KA, 2004, BIOCHEM CELL BIOL, V82, P351, DOI 10.1139/O04-006; Hsu M, 2006, BIOCHEM BIOPH RES CO, V343, P738, DOI 10.1016/j.bbrc.2006.03.036; Johanning JM, 2001, J VASC SURG, V33, P579, DOI 10.1067/mva.2001.111805; Kalyanasundaram A, 2006, J VASC SURG, V43, P117, DOI 10.1016/j.jvs.2005.08.007; Koh KK, 2000, CARDIOVASC RES, V47, P648, DOI 10.1016/S0008-6363(00)00146-2; Laufs U, 1998, J BIOL CHEM, V273, P24266, DOI 10.1074/jbc.273.37.24266; Lawrence DM, 2004, J VASC SURG, V40, P334, DOI 10.1016/j.jvs.2004.05.020; Lee TS, 2004, CIRCULATION, V110, P1296, DOI 10.1161/01.CIR.0000140694.67251.9C; Maegdefessel L, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003441; Maron DJ, 2000, CIRCULATION, V101, P207, DOI 10.1161/01.CIR.101.2.207; Muchova L, 2007, CAN J PHYSIOL PHARM, V85, P800, DOI 10.1139/Y07-077; Nagashima H, 2002, J VASC SURG, V36, P158, DOI 10.1067/mva.2002.123680; Nakahashi TK, 2002, ARTERIOSCL THROM VAS, V22, P2017, DOI 10.1161/01.ATV.0000042082.38014.EA; Nydegger UE, 2002, TRANSPL IMMUNOL, V9, P215, DOI 10.1016/S0966-3274(02)00049-7; Otterbein LE, 2003, TRENDS IMMUNOL, V24, P449, DOI 10.1016/S1471-4906(03)00181-9; Schillinger M, 2002, THROMB RES, V106, P131, DOI 10.1016/S0049-3848(02)00100-7; Schouten O, 2006, EUR J VASC ENDOVASC, V32, P21, DOI 10.1016/j.ejvs.2005.12.024; Schulz S, 2015, PEDIATR RES, V77, P640, DOI 10.1038/pr.2015.22; Son JW, 2003, INT J CARDIOL, V88, P77, DOI 10.1016/S0167-5273(02)00368-6; Steinmetz EF, 2005, ANN SURG, V241, P92, DOI 10.1097/01.sla.0000150258.36236.e0; STOCKER R, 1987, SCIENCE, V235, P1043, DOI 10.1126/science.3029864; STOCKER R, 1989, FREE RADICAL RES COM, V6, P57, DOI 10.3109/10715768909073428; Suttner DM, 1999, FASEB J, V13, P1800, DOI 10.1096/fasebj.13.13.1800; Takagi H, 2010, J VASC SURG, V52, P1675, DOI 10.1016/j.jvs.2010.04.082; Takemoto M, 2001, ARTERIOSCL THROM VAS, V21, P1712, DOI 10.1161/hq1101.098486; Tedesco MM, 2009, ARTERIOSCL THROM VAS, V29, P1452, DOI 10.1161/ATVBAHA.109.187757; Thompson RW, 2006, ANN NY ACAD SCI, V1085, P59, DOI 10.1196/annals.1383.029; Vitek L., 2006, CURR ENZYM INHIB, V2, P261, DOI DOI 10.2174/157340806777934775; VREMAN HJ, 1988, ANAL BIOCHEM, V168, P31, DOI 10.1016/0003-2697(88)90006-1; Wagner CT, 1997, J CLIN INVEST, V100, P589, DOI 10.1172/JCI119569; Wierzbicki AS, 2003, PHARMACOL THERAPEUT, V99, P95, DOI 10.1016/S0163-7258(03)00055-X; Wilson WRW, 2005, EUR J VASC ENDOVASC, V30, P259, DOI 10.1016/j.ejvs.2005.02.044; Yajima N, 2002, J VASC SURG, V36, P379, DOI 10.1067/mva.2002.124366; Yet SF, 2003, FASEB J, V17, P1759, DOI 10.1096/fj.03-0187fje	53	22	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0149288	10.1371/journal.pone.0149288	http://dx.doi.org/10.1371/journal.pone.0149288			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3DG	26894432	Green Submitted, gold, Green Published			2022-12-26	WOS:000371223400043
J	Bodnar, AL; Schroder, MN; Scott, MP				Bodnar, Anastasia L.; Schroder, Megan N.; Scott, M. Paul			Recurrent Selection for Transgene Activity Levels in Maize Results in Proxy Selection for a Native Gene with the Same Promoter	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; ZEIN; MARKER	High activity levels of a transgene can be very useful, making a transgene easier to evaluate for safety and efficacy. High activity levels can also increase the economic benefit of the production of high value proteins in transgenic plants. The goal of this research is to determine if recurrent selection for activity of a transgene will result in higher activity, and if selection for activity of a transgene controlled by a native promoter will also increase protein levels of the native gene with the same promoter. To accomplish this goal we used transgenic maize containing a construct encoding green fluorescent protein controlled by the promoter for the maize endosperm-specific 27kDa gamma zein seed storage protein. We carried out recurrent selection for fluorescence intensity in two breeding populations. After three generations of selection, both selected populations were significantly more fluorescent and had significantly higher levels of 27kDa gamma zein than the unselected control populations. These higher levels of the 27kDa gamma zein occurred independently of the presence of the transgene. The results show that recurrent selection can be used to increase activity of a transgene and that selection for a transgene controlled by a native promoter can increase protein levels of the native gene with the same promoter via proxy selection. Moreover, the increase in native gene protein level is maintained in the absence of the transgene, demonstrating that proxy selection can be used to produce non-transgenic plants with desired changes in gene expression.	[Bodnar, Anastasia L.; Schroder, Megan N.] Iowa State Univ, Interdept Genet Program, Ames, IA USA; [Scott, M. Paul] ARS, USDA, Corn Insects & Crop Genet Res Unit, Ames, IA USA; [Bodnar, Anastasia L.] Anim & Plant Hlth Inspect Serv, USDA, Plant Protect & Quarantine, Riverdale, MD USA; [Schroder, Megan N.] DuPont Pioneer, Johnston, IA USA	Iowa State University; United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); DuPont; Pioneer Hi-Bred International, Inc.	Scott, MP (corresponding author), ARS, USDA, Corn Insects & Crop Genet Res Unit, Ames, IA USA.	paul.scott@ars.usda.gov		Bodnar, Anastasia/0000-0002-3320-825X	United States Department of Agriculture Agricultural Research Service [3625-21000-055D]; United States Department of Agriculture Cooperative State Ressearch, Education and Extension Service; ARS [ARS-0425213] Funding Source: Federal RePORTER	United States Department of Agriculture Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service); United States Department of Agriculture Cooperative State Ressearch, Education and Extension Service; ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This work was funded by the United States Department of Agriculture Agricultural Research Service (http://www.ars.usda.gov/main/main.htm) CRIS project number 3625-21000-055D, MPS and the United States Department of Agriculture Cooperative State Ressearch, Education and Extension Service (no URL available) special appropriation Biotechnology Test Production, IA: Recovery and Purification of Recombinant Proteins from Plants for Therapeutics and Industrial Enzymes, ALB, MNS.	BIANCHI MW, 1988, PLANT MOL BIOL, V11, P203, DOI 10.1007/BF00015672; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; Chiu WL, 1996, CURR BIOL, V6, P325, DOI 10.1016/S0960-9822(02)00483-9; Cho MJ, 2000, PLANT CELL REP, V19, P1084, DOI 10.1007/s002990000238; Coleman CE, 1996, PLANT CELL, V8, P2335, DOI 10.1105/tpc.8.12.2335; de Leon N, 2002, CROP SCI, V42, P325, DOI 10.2135/cropsci2002.0325; Dudley J. W., 2004, Plant Breeding Reviews, V24, P79; Flint-Garcia SA, 2009, THEOR APPL GENET, V119, P1129, DOI 10.1007/s00122-009-1115-1; Hallauer A. R., 2004, Plant Breeding Reviews, V24, P153; HALLAUER.AR, 1967, CROP SCI, V7, P192, DOI 10.2135/cropsci1967.0011183X000700030007x; Hood EE, 2003, PLANT BIOTECHNOL J, V1, P129, DOI 10.1046/j.1467-7652.2003.00014.x; HORNER ES, 1990, CROP SCI, V30, P964, DOI 10.2135/cropsci1990.0011183X003000040057x; Kawakatsu T, 2010, PLANT BIOTECHNOLOGY, V8, P1; LOPES MA, 1991, CROP SCI, V31, P1655, DOI 10.2135/cropsci1991.0011183X003100060055x; PAULIS JW, 1977, J AGR FOOD CHEM, V25, P265, DOI 10.1021/jf60210a022; SAS INSTITUTE INC, 2008, JMP VERS 8; Scott MP, 2008, CROP SCI, V48, P1705, DOI 10.2135/cropsci2008.01.0010; Shepherd CT, 2008, CEREAL CHEM, V85, P188, DOI 10.1094/CCHEM-85-2-0188; THOMPSON GA, 1989, BIOESSAYS, V10, P108, DOI 10.1002/bies.950100404; Tracy WF, 2007, MAYDICA, V52, P71; Wang ZD, 1998, GENE, V223, P321, DOI 10.1016/S0378-1119(98)00244-3; WILSON CM, 1991, PLANT PHYSIOL, V95, P777, DOI 10.1104/pp.95.3.777	22	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0148587	10.1371/journal.pone.0148587	http://dx.doi.org/10.1371/journal.pone.0148587			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3DG	26895451	gold, Green Published, Green Submitted			2022-12-26	WOS:000371223400019
J	He, SS; Liu, FH; Xu, L; Yin, P; Li, DY; Mei, C; Jiang, LS; Ma, YF; Xu, JQ				He, Shasha; Liu, Fenghua; Xu, Lei; Yin, Peng; Li, Deyin; Mei, Chen; Jiang, Linshu; Ma, Yunfei; Xu, Jianqin			Protective Effects of Ferulic Acid against Heat Stress-Induced Intestinal Epithelial Barrier Dysfunction In Vitro and In Vivo	PLOS ONE			English	Article							TIGHT JUNCTIONS; E-CADHERIN; PROTEIN EXPRESSION; INDUCED INJURY; OCCLUDIN; PERMEABILITY; PATHOGENESIS; HOMEOSTASIS; MECHANISMS; CLAUDIN-1	Heat stress is important in the pathogenesis of intestinal epithelial barrier dysfunction. Ferulic acid (FA), a phenolic acid widely found in fruits and vegetables, can scavenge free radicals and activate cell stress responses. This study is aimed at investigating protective effects of FA on heat stress-induced dysfunction of the intestinal epithelial barrier in vitro and in vivo. Intestinal epithelial (IEC-6) cells were pretreated with FA for 4 h and then exposed to heat stress. Heat stress caused decreased transepithelial electrical resistance (TER) and increased permeability to 4-kDa fluorescein isothiocyanate (FITC)-dextran (FD4). Both effects were inhibited by FA in a dose-dependent manner. FA significantly attenuated the decrease in occludin, ZO-1 and E-cadherin expression observed with heat stress. The distortion and redistribution of occludin, ZO-1 and E-cadherin proteins were also effectively prevented by FA pretreatment. Moreover, heat stress diminished electron-dense material detected in tight junctions (TJs), an effect also alleviated by FA in a dose-dependent manner. In an in vivo heat stress model, FA (50 mg/kg) was administered to male Sprague- Dawley rats for 7 consecutive days prior to exposure to heat stress. FA pretreatment significantly attenuated the effects of heat stress on the small intestine, including the increased FD4 permeability, disrupted tight junctions and microvilli structure, and reduced occludin, ZO-1 and E-cadherin expression. Taken together, our results demonstrate that FA pretreatment is potentially protective against heat stress-induced intestinal epithelial barrier dysfunction.	[He, Shasha; Yin, Peng; Ma, Yunfei; Xu, Jianqin] CAU, Coll Vet Med, CAU BUA TCVM Teaching & Researching Team, Beijing, Peoples R China; [Liu, Fenghua; Xu, Lei; Li, Deyin; Mei, Chen; Jiang, Linshu] BUA, Coll Anim Sci & Technol, Beijing Key Lab Dairy Cow Nutr, Beijing, Peoples R China	Beijing University of Agriculture; China Agricultural University	Ma, YF; Xu, JQ (corresponding author), CAU, Coll Vet Med, CAU BUA TCVM Teaching & Researching Team, Beijing, Peoples R China.; Jiang, LS (corresponding author), BUA, Coll Anim Sci & Technol, Beijing Key Lab Dairy Cow Nutr, Beijing, Peoples R China.	kjxnb@vip.sina.com; yunfeima@cau.edu.cn; xujianqincau@126.com		Jiang, Linshu/0000-0002-9076-5749	National Twelve-Five Technological Supported Plan of China [2013BAD10B04]; Ministry of Agriculture, Public Service Sectors Agriculture Research Projects [201403051-07]; Importation and Development of High-Caliber Talents Project of Beijing Municipal Institutions [CITTCD20130324]	National Twelve-Five Technological Supported Plan of China; Ministry of Agriculture, Public Service Sectors Agriculture Research Projects; Importation and Development of High-Caliber Talents Project of Beijing Municipal Institutions	This work was supported by grants from National Twelve-Five Technological Supported Plan of China (No. 2013BAD10B04), Ministry of Agriculture, Public Service Sectors Agriculture Research Projects (No. 201403051-07), Importation and Development of High-Caliber Talents Project of Beijing Municipal Institutions (CIT&TCD20130324).	Aijaz S, 2006, INT REV CYTOL, V248, P261, DOI 10.1016/S0074-7696(06)48005-0; Al-Sadi R, 2011, AM J PHYSIOL-GASTR L, V300, pG1054, DOI 10.1152/ajpgi.00055.2011; Costantini TW, 2009, LIFE SCI, V84, P18, DOI 10.1016/j.lfs.2008.10.007; Dorfel MJ, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/807356; Dokladny K, 2008, AM J PATHOL, V172, P659, DOI 10.2353/ajpath.2008.070522; Fasano A, 2005, NAT CLIN PRACT GASTR, V2, P416, DOI 10.1038/ncpgasthep0259; Fink Mitchell P, 2003, Curr Opin Crit Care, V9, P143, DOI 10.1097/00075198-200304000-00011; FURUSE M, 1993, J CELL BIOL, V123, P1777, DOI 10.1083/jcb.123.6.1777; Furuse M, 1998, J CELL BIOL, V141, P1539, DOI 10.1083/jcb.141.7.1539; He SS, 2015, MOL BIOSYST, V11, P826, DOI 10.1039/c4mb00495g; Kim HJ, 2013, PHYTOTHER RES, V27, P362, DOI 10.1002/ptr.4717; Krack A, 2005, EUR HEART J, V26, P2368, DOI 10.1093/eurheartj/ehi389; Lambert G. Patrick, 2008, V53, P61, DOI 10.1159/000151550; Laukoetter MG, 2008, WORLD J GASTROENTERO, V14, P401, DOI 10.3748/wjg.14.401; Mancuso C, 2014, FOOD CHEM TOXICOL, V65, P185, DOI 10.1016/j.fct.2013.12.024; McCall IC, 2009, TOXICOL APPL PHARM, V241, P61, DOI 10.1016/j.taap.2009.08.002; Nita-Lazar M, 2010, EXP CELL RES, V316, P1871, DOI 10.1016/j.yexcr.2010.02.008; Pearce SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070215; Perez-Moreno M, 2003, CELL, V112, P535, DOI 10.1016/S0092-8674(03)00108-9; Quiros M, 2014, SEMIN CELL DEV BIOL, V36, P194, DOI 10.1016/j.semcdb.2014.09.003; Rodgers LS, 2013, J CELL SCI, V126, P1565, DOI 10.1242/jcs.113399; Sander GR, 2005, FEBS LETT, V579, P4851, DOI 10.1016/j.febslet.2005.07.066; Schneider MR, 2015, BIOESSAYS, V37, P294, DOI 10.1002/bies.201400141; Schneider MR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014325; Schnoor M, 2015, DIGEST DIS SCI, V60, P816, DOI 10.1007/s10620-015-3622-z; Severson EA, 2010, BIOCHEM BIOPH RES CO, V397, P592, DOI 10.1016/j.bbrc.2010.05.164; Shanthakumar J, 2012, EUR J PHARMACOL, V691, P268, DOI 10.1016/j.ejphar.2012.06.027; Shen L, 2011, ANNU REV PHYSIOL, V73, P283, DOI 10.1146/annurev-physiol-012110-142150; Srinivasan M, 2007, J CLIN BIOCHEM NUTR, V40, P92, DOI 10.3164/jcbn.40.92; Suzuki T, 2013, CELL MOL LIFE SCI, V70, P631, DOI 10.1007/s00018-012-1070-x; Tsukita S, 2001, NAT REV MOL CELL BIO, V2, P285, DOI 10.1038/35067088; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; Varasteh S, 2015, J FUNCT FOODS, V16, P265, DOI 10.1016/j.jff.2015.04.045; Wang H, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/787393; WHEELOCK MJ, 1992, J CELL BIOL, V117, P415, DOI 10.1083/jcb.117.2.415; Xiao GZ, 2015, SHOCK, V44, P348, DOI 10.1097/SHK.0000000000000417; Xiao GZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073571; Xu QL, 2015, CELL BIOL INT, V39, P411, DOI 10.1002/cbin.10408; Yang PC, 2007, J GASTROEN HEPATOL, V22, P1823, DOI 10.1111/j.1440-1746.2006.04710.x; Yu J, 2013, STRESS, V16, P99, DOI 10.3109/10253890.2012.680526; Zhao ZH, 2008, FOOD CHEM, V109, P691, DOI 10.1016/j.foodchem.2008.02.039	41	31	36	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0145236	10.1371/journal.pone.0145236	http://dx.doi.org/10.1371/journal.pone.0145236			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3DG	26894689	Green Published, gold, Green Submitted			2022-12-26	WOS:000371223400001
J	Mizokami, SS; Hohmann, MSN; Staurengo-Ferrari, L; Carvalho, TT; Zarpelon, AC; Possebon, MI; de Souza, AR; Veneziani, RCS; Arakawa, NS; Casagrande, R; Verri, WA				Mizokami, Sandra S.; Hohmann, Miriam S. N.; Staurengo-Ferrari, Larissa; Carvalho, Thacyana T.; Zarpelon, Ana C.; Possebon, Maria I.; de Souza, Anderson R.; Veneziani, Rodrigo C. S.; Arakawa, Nilton S.; Casagrande, Rubia; Verri, Waldiceu A., Jr.			Pimaradienoic Acid Inhibits Carrageenan-Induced Inflammatory Leukocyte Recruitment and Edema in Mice: Inhibition of Oxidative Stress, Nitric Oxide and Cytokine Production	PLOS ONE			English	Article							VIGUIERA-ARENARIA ASTERACEAE; CHANNEL SIGNALING PATHWAY; PIMARANE-TYPE DITERPENES; ACUTE CORONARY SYNDROMES; KAPPA-B ACTIVATION; ANTIMICROBIAL ACTIVITY; NEUTROPHIL MIGRATION; KAURENOIC ACID; PERITONEAL-MACROPHAGES; RHEUMATOID-ARTHRITIS	Pimaradienoic acid (PA; ent-pimara-8(14), 15-dien-19-oic acid) is a pimarane diterpene found in plants such as Vigueira arenaria Baker (Asteraceae) in the Brazilian savannas. Although there is evidence on the analgesic and in vitro inhibition of inflammatory signaling pathways, and paw edema by PA, its anti-inflammatory effect deserves further investigation. Thus, the objective of present study was to investigate the anti-inflammatory effect of PA in carrageenan-induced peritoneal and paw inflammation in mice. Firstly, we assessed the effect of PA in carrageenan-induced leukocyte recruitment in the peritoneal cavity and paw edema and myeloperoxidase activity. Next, we investigated the mechanisms involved in the anti-inflammatory effect of PA. The effect of PA on carrageenan-induced oxidative stress in the paw skin and peritoneal cavity was assessed. We also tested the effect of PA on nitric oxide, superoxide anion, and inflammatory cytokine production in the peritoneal cavity. PA inhibited carrageenan-induced recruitment of total leukocytes and neutrophils to the peritoneal cavity in a dose-dependent manner. PA also inhibited carrageenan-induced paw edema and myeloperoxidase activity in the paw skin. The anti-inflammatory mechanism of PA depended on maintaining paw skin antioxidant activity as observed by the levels of reduced glutathione, ability to scavenge the ABTS cation and reduce iron as well as by the inhibition of superoxide anion and nitric oxide production in the peritoneal cavity. Furthermore, PA inhibited carrageenan-induced peritoneal production of inflammatory cytokines TNF-alpha and IL-1 beta. PA presents prominent anti-inflammatory effect in carrageenan-induced inflammation by reducing oxidative stress, nitric oxide, and cytokine production. Therefore, it seems to be a promising anti-inflammatory molecule that merits further investigation.	[Mizokami, Sandra S.; Hohmann, Miriam S. N.; Staurengo-Ferrari, Larissa; Carvalho, Thacyana T.; Zarpelon, Ana C.; Verri, Waldiceu A., Jr.] Univ Estadual Londrina, Ctr Ciencias Biol, Dept Ciencias Patol, Londrina, Parana, Brazil; [Possebon, Maria I.; Arakawa, Nilton S.; Casagrande, Rubia] Univ Estadual Londrina, Ctr Ciencias Saude, Dept Ciencias Farmaceut, Londrina, Parana, Brazil; [de Souza, Anderson R.; Veneziani, Rodrigo C. S.] Univ Franca, Nucleo Pesquisa Ciencias Exatas & Tecnol, Sao Paulo, Brazil	Universidade Estadual de Londrina; Universidade Estadual de Londrina; Universidad de Franca	Verri, WA (corresponding author), Univ Estadual Londrina, Ctr Ciencias Biol, Dept Ciencias Patol, Londrina, Parana, Brazil.; Casagrande, R (corresponding author), Univ Estadual Londrina, Ctr Ciencias Saude, Dept Ciencias Farmaceut, Londrina, Parana, Brazil.	rubiacasa@uel.br; waverri@uel.br	Veneziani, Rodrigo Cassio Sola/C-2360-2012; de Carvalho, Thacyana Teixeira/AAJ-7187-2020; Casagrande, Rubia/I-1377-2013; Casagrande, Rubia/U-6019-2019; WA, Verri/I-1330-2013; Arakawa, Nilton/I-6240-2012	Veneziani, Rodrigo Cassio Sola/0000-0001-7057-9706; de Carvalho, Thacyana Teixeira/0000-0002-8580-6200; Casagrande, Rubia/0000-0002-2296-1668; WA, Verri/0000-0003-2756-9283; Arakawa, Nilton/0000-0002-0325-1660; Hohmann, Miriam Sayuri Nagashima/0000-0003-2667-3919	Coordenadoria de Aperfeicoamento de Pessoal de Nivel Superior (CAPES, Brazil); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brazil); Ministerio da Ciencia, Tecnologia e Inovacao (MCTI)/Secretaria da Ciencia, Tecnologia e Ensino Superior (SETI)/Fundacao Araucaria; Parana State Government (Brazil); CAPES/Fundacao Araucaria; CNPq; Ministerio da Ciencia, Tecnologia e Inovacao (MCTI); Secretaria da Ciencia, Tecnologia e Ensino Superior (SETI)/Fundacao Araucaria; Governo do Estado do Parana (Brazil)	Coordenadoria de Aperfeicoamento de Pessoal de Nivel Superior (CAPES, Brazil)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Ministerio da Ciencia, Tecnologia e Inovacao (MCTI)/Secretaria da Ciencia, Tecnologia e Ensino Superior (SETI)/Fundacao Araucaria; Parana State Government (Brazil); CAPES/Fundacao Araucaria; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Ministerio da Ciencia, Tecnologia e Inovacao (MCTI); Secretaria da Ciencia, Tecnologia e Ensino Superior (SETI)/Fundacao Araucaria; Governo do Estado do Parana (Brazil)	This work was supported by Brazilian grants from Coordenadoria de Aperfeicoamento de Pessoal de Nivel Superior (CAPES, Brazil-SSM MSNH TTC ACZ ARS RC WAV), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brazil-LSF RCSV RC WAV), Ministerio da Ciencia, Tecnologia e Inovacao (MCTI)/Secretaria da Ciencia, Tecnologia e Ensino Superior (SETI)/Fundacao Araucaria, and Parana State Government (Brazil-MSNH ACZ RC WAV). ACZ received a post-doc fellowship from CAPES/Fundacao Araucaria. LSF received a post-doc fellowship of CNPq. The specific roles of these authors are articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by grants from Coordenadoria de Aperfeicoamento de Pessoal de Nivel Superior (CAPES, Brazil), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brazil), Ministerio da Ciencia, Tecnologia e Inovacao (MCTI), Secretaria da Ciencia, Tecnologia e Ensino Superior (SETI)/Fundacao Araucaria and Governo do Estado do Parana (Brazil). The authors thank F. B. Costa for providing the plant material. ACZ received a post-doc fellowship from CAPES/Fundacao Araucaria. LSF received a post-doc fellowship of CNPq.	Ambrosio SR, 2008, Z NATURFORSCH C, V63, P326; Ambrosio SR, 2006, LIFE SCI, V79, P925, DOI 10.1016/j.lfs.2006.05.015; Ambrosio SR, 2004, BIOCHEM SYST ECOL, V32, P221, DOI 10.1016/S0305-1978(03)00139-X; Ambrosio SR, 2002, FITOTERAPIA, V73, P484, DOI 10.1016/S0367-326X(02)00170-3; Ashley NT, 2012, ANNU REV ECOL EVOL S, V43, P385, DOI 10.1146/annurev-ecolsys-040212-092530; Biswas SK, 2001, NITRIC OXIDE-BIOL CH, V5, P566, DOI 10.1006/niox.2001.0370; BRADLEY PP, 1982, J INVEST DERMATOL, V78, P206, DOI 10.1111/1523-1747.ep12506462; Campanini MZ, 2013, J PHOTOCH PHOTOBIO B, V127, P153, DOI 10.1016/j.jphotobiol.2013.08.007; Carvalho TC, 2011, MOLECULES, V16, P543, DOI 10.3390/molecules160100543; Casagrande R, 2006, J PHOTOCH PHOTOBIO B, V84, P21, DOI 10.1016/j.jphotobiol.2006.01.006; Dal Secco D, 2003, NITRIC OXIDE-BIOL CH, V9, P153, DOI 10.1016/j.niox.2003.11.001; de Miguel LS, 2002, J AM COLL CARDIOL, V39, P818, DOI 10.1016/S0735-1097(01)01828-9; DRAPIER JC, 1988, J IMMUNOL, V140, P2829; Joosten LAB, 2006, P NATL ACAD SCI USA, V103, P3298, DOI 10.1073/pnas.0511233103; Kang HS, 1996, CELL IMMUNOL, V170, P212, DOI 10.1006/cimm.1996.0154; Kang OH, 2008, EUR J PHARMACOL, V601, P179, DOI 10.1016/j.ejphar.2008.10.012; Kato FH, 2012, MUTAT RES-GEN TOX EN, V749, P87, DOI 10.1016/j.mrgentox.2012.09.001; Klebanoff SJ, 2005, J LEUKOCYTE BIOL, V77, P598, DOI 10.1189/jlb.1204697; Komala I, 2010, J NAT MED-TOKYO, V64, P417, DOI 10.1007/s11418-010-0423-8; Li JM, 2005, MOL CELL BIOL, V25, P2320, DOI 10.1128/MCB.25.6.2320-2330.2005; Lim H, 2009, ARCH PHARM RES, V32, P1237, DOI 10.1007/s12272-009-1909-3; Lu JM, 2010, J CELL MOL MED, V14, P840, DOI 10.1111/j.1582-4934.2009.00897.x; Maioli NA, 2015, BRAZ J MED BIOL RES, V48, P321, DOI [10.1590/1414-431X20144187, 10.1590/1414-431x20144187]; Martin KR, 2015, SWISS MED WKLY, V145, DOI 10.4414/smw.2015.14056; Martinez RM, 2012, REV BRAS FARMACOGN, V22, P587, DOI 10.1590/S0102-695X2012005000006; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Michlewska S, 2009, FASEB J, V23, P844, DOI 10.1096/fj.08-121228; Mittal M, 2014, ANTIOXID REDOX SIGN, V20, P1126, DOI 10.1089/ars.2012.5149; Mizokami SS, 2012, J NAT PROD, V75, P896, DOI 10.1021/np200989t; Navarro SA, 2013, PHARMACOL BIOCHEM BE, V105, P183, DOI 10.1016/j.pbb.2013.02.018; OKUYAMA E, 1991, CHEM PHARM BULL, V39, P405, DOI 10.1248/cpb.39.405; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; Peterson K, 2010, DRUG CLASS REVIEW NO; Porto TS, 2009, MOLECULES, V14, P191, DOI 10.3390/molecules14010191; Porto TS, 2009, FITOTERAPIA, V80, P432, DOI 10.1016/j.fitote.2009.06.003; Possebon MI, 2014, J NAT PROD, V77, P2488, DOI 10.1021/np500563b; Prado WA, 2002, EUR J PHARMACOL, V441, P57, DOI 10.1016/S0014-2999(02)01413-9; Pulli B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067976; Rubio J, 2005, Z NATURFORSCH C, V60, P711; Saito S, 1996, J LEUKOCYTE BIOL, V59, P908, DOI 10.1002/jlb.59.6.908; Schacke H, 2002, PHARMACOL THERAPEUT, V96, P23, DOI 10.1016/S0163-7258(02)00297-8; Schilling E. E., 2000, Edinburgh Journal of Botany, V57, P323, DOI 10.1017/S0960428600000330; Sugiyama S, 2001, AM J PATHOL, V158, P879, DOI 10.1016/S0002-9440(10)64036-9; SUZUKI K, 1983, ANAL BIOCHEM, V132, P345, DOI 10.1016/0003-2697(83)90019-2; Tirapelli CR, 2005, J PHARM PHARMACOL, V57, P997, DOI 10.1211/0022357056578; Tirapelli CR, 2004, EUR J PHARMACOL, V492, P233, DOI 10.1016/j.ejphar.2004.04.003; Tirapelli CR, 2004, PHARMACOLOGY, V70, P31, DOI 10.1159/000074240; Valerio DAR, 2007, EUR J PHARMACOL, V562, P155, DOI 10.1016/j.ejphar.2007.01.029; Verri WA, 2007, EUR J IMMUNOL, V37, P3373, DOI 10.1002/eji.200737488; Verri WA, 2006, PHARMACOL THERAPEUT, V112, P116, DOI 10.1016/j.pharmthera.2006.04.001; Verri WA, 2010, ANN RHEUM DIS, V69, P1697, DOI 10.1136/ard.2009.122655; Wu CH, 2002, MOL CELL ENDOCRINOL, V194, P9, DOI 10.1016/S0303-7207(02)00212-5; Zarpelon AC, 2013, BRIT J PHARMACOL, V169, P90, DOI 10.1111/bph.12110	53	29	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0149656	10.1371/journal.pone.0149656	http://dx.doi.org/10.1371/journal.pone.0149656			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3DG	26895409	Green Published, gold			2022-12-26	WOS:000371223400073
J	Trebicky, V; Fialova, J; Kleisner, K; Havlicek, J				Trebicky, Vit; Fialova, Jitka; Kleisner, Karel; Havlicek, Jan			Focal Length Affects Depicted Shape and Perception of Facial Images	PLOS ONE			English	Article							TO-HEIGHT RATIO; PERCEIVED DOMINANCE; ATTRACTIVENESS; WIDTH; FACE; INCREASES; PICTURES; PREDICTS; COLOR; FRUIT	Static photographs are currently the most often employed stimuli in research on social perception. The method of photograph acquisition might affect the depicted subject's facial appearance and thus also the impression of such stimuli. An important factor influencing the resulting photograph is focal length, as different focal lengths produce various levels of image distortion. Here we tested whether different focal lengths (50, 85, 105 mm) affect depicted shape and perception of female and male faces. We collected three portrait photographs of 45 (22 females, 23 males) participants under standardized conditions and camera setting varying only in the focal length. Subsequently, the three photographs from each individual were shown on screen in a randomized order using a 3-alternative forced-choice paradigm. The images were judged for attractiveness, dominance, and femininity/masculinity by 369 raters (193 females, 176 males). Facial width-to-height ratio (fWHR) was measured from each photograph and overall facial shape was analysed employing geometric morphometric methods (GMM). Our results showed that photographs taken with 50 mm focal length were rated as significantly less feminine/masculine, attractive, and dominant compared to the images taken with longer focal lengths. Further, shorter focal lengths produced faces with smaller fWHR. Subsequent GMM revealed focal length significantly affected overall facial shape of the photographed subjects. Thus methodology of photograph acquisition, focal length in this case, can significantly affect results of studies using photographic stimuli perhaps due to different levels of perspective distortion that influence shapes and proportions of morphological traits.	[Trebicky, Vit; Fialova, Jitka; Kleisner, Karel; Havlicek, Jan] Charles Univ Prague, Fac Sci, Prague, Czech Republic; [Trebicky, Vit; Fialova, Jitka; Havlicek, Jan] Natl Inst Mental Hlth, Klecany, Czech Republic	Charles University Prague; National Institute of Mental Health - Czech Republic	Trebicky, V (corresponding author), Charles Univ Prague, Fac Sci, Prague, Czech Republic.; Trebicky, V (corresponding author), Natl Inst Mental Hlth, Klecany, Czech Republic.	vit.trebicky@natur.cuni.cz	Trebicky, Vit/P-3115-2016; Havlíček, Jan/F-8985-2011; Fialová, Jitka/E-3125-2018; Kleisner, Karel/M-2718-2017	Trebicky, Vit/0000-0003-1440-1772; Havlíček, Jan/0000-0003-2374-7337; Fialová, Jitka/0000-0003-2419-7461; Kleisner, Karel/0000-0002-3277-8365	Charles University Grant Agency [GAUK 918214]; Czech Science Foundation [GACR P407/15-05048S]; project "National Institute of Mental Health (NIMH-CZ)" [ED2.1.00/03.0078]; project "National Institute of Mental Health (NIMH-CZ)" (European Regional Development Fund)	Charles University Grant Agency; Czech Science Foundation(Grant Agency of the Czech Republic); project "National Institute of Mental Health (NIMH-CZ)"; project "National Institute of Mental Health (NIMH-CZ)" (European Regional Development Fund)	JF was supported by Charles University Grant Agency GAUK 918214 (http://www.cuni.cz/ukeng-33.html), VT and KK by Czech Science Foundation GACR P407/15-05048S (http://gacr.cz/en/) and VT, JF, and JH by the project "National Institute of Mental Health (NIMH-CZ)", grant number ED2.1.00/03.0078 (and the European Regional Development Fund, http://ec.europa.eu/regional_policy/en/funding/erdf/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, 1 IMPRESSIONS; Banks MS, 2014, ECOL PSYCHOL, V26, P30, DOI 10.1080/10407413.2014.877284; Bohrnstedt GW, 1970, ATTITUDE MEASUREMENT, P81; Borenstein M, 2009, CONVERTING EFFECT SI; Bryan R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045301; Burke D, 2010, EVOL PSYCHOL-US, V8, P573, DOI 10.1177/147470491000800404; Burriss RP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130093; Calder A., 2011, OXFORD HDB FACE PERC; Carre JM, 2008, P ROY SOC B-BIOL SCI, V275, P2651, DOI 10.1098/rspb.2008.0873; Cooper EA, 2012, J VISION, V12, DOI 10.1167/12.5.8; Deutschmann R, 2011, MULTIPLE FLASH PHOTO; Fritz CO, 2012, J EXP PSYCHOL GEN, V141, P2, DOI 10.1037/a0024338; Geniole SN, 2015, EVOL HUM BEHAV, V36, P279, DOI 10.1016/j.evolhumbehav.2014.12.005; Haselhuhn MP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122637; HAYDUK LA, 1983, PSYCHOL BULL, V94, P293, DOI 10.1037/0033-2909.94.2.293; Hehman E, 2013, J EXP SOC PSYCHOL, V49, P747, DOI 10.1016/j.jesp.2013.02.015; Hong GW, 2001, COLOR RES APPL, V26, P76, DOI 10.1002/1520-6378(200102)26:1<76::AID-COL8>3.0.CO;2-3; Jenkins F.A., 2001, FUNDAMENTALS OPTICS, Vfourth; Kelby S, 2010, DIGITAL PHOTOGRAPHY, V3; Kingslake R, 1992, OPTICS PHOTOGRAPHY; Kleisner K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0081237; Kleisner K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053285; Kleisner K, 2010, PERS INDIV DIFFER, V49, P59, DOI 10.1016/j.paid.2010.03.011; Lefevre CE, 2015, Q J EXP PSYCHOL, V68, P284, DOI 10.1080/17470218.2014.944194; Little AC, 2014, WIRES COGN SCI, V5, P621, DOI 10.1002/wcs.1316; Loehr J, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0049; Mileva VR, 2014, PERS INDIV DIFFER, V69, P115, DOI 10.1016/j.paid.2014.05.019; Oksanen AJ, 2015, PACKAGE VEGAN, P280; Park JH, 2007, PERS INDIV DIFFER, V43, P1960, DOI 10.1016/j.paid.2007.05.020; Peron Ana Paula Lazzari Marques, 2012, Dental Press J. Orthod., V17, P124; Perona P., 2010, J VIS, V7, P992; Pezdirc K, 2015, NUTRIENTS, V7, P5800, DOI 10.3390/nu7075251; Postma E, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2013.0966; RCore Team, 2020, R LANG ENV STAT COMP; Roberts SC, 2004, P ROY SOC B-BIOL SCI, V271, pS270, DOI 10.1098/rsbl.2004.0174; Rohlf F, 2004, TPSSUPER VERSION 1 1; Rohlf FJ., 2008, TPSRELW VERSION 146; Rubesova A., 2011, SOCIAL PSYCHOL DYNAM, P113; Schneider TM, 2012, PERCEPTION, V41, P121, DOI 10.1068/p7140; Stephen ID, 2009, INT J PRIMATOL, V30, P845, DOI 10.1007/s10764-009-9380-z; Stirrat M, 2010, PSYCHOL SCI, V21, P349, DOI 10.1177/0956797610362647; Sulikowski D, 2015, ETHOLOGY, V121, P1002, DOI 10.1111/eth.12412; Todorov A, 2015, ANNU REV PSYCHOL, V66, P519, DOI 10.1146/annurev-psych-113011-143831; Trebicky V, 2015, AGGRESSIVE BEHAV, V41, P331, DOI 10.1002/ab.21559; Trebicky V, 2013, PSYCHOL SCI, V24, P1664, DOI 10.1177/0956797613477117; Valentine KA, 2014, PSYCHOL SCI, V25, P806, DOI 10.1177/0956797613511823; Verhoff MA, 2008, FORENSIC SCI INT, V178, P153, DOI 10.1016/j.forsciint.2008.03.011; Whitehead RD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032988; Windhager S, 2011, AM J HUM BIOL, V23, P805, DOI 10.1002/ajhb.21219	49	33	33	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0149313	10.1371/journal.pone.0149313	http://dx.doi.org/10.1371/journal.pone.0149313			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF3DG	26894832	gold, Green Published, Green Submitted			2022-12-26	WOS:000371223400046
J	Dominguez-Vicent, A; Birkeldh, U; Carl-Gustaf, L; Nilson, M; Brautaset, R				Dominguez-Vicent, Alberto; Birkeldh, Ulrika; Carl-Gustaf, Laurell; Nilson, Maria; Brautaset, Rune			Objective Assessment of Nuclear and Cortical Cataracts through Scheimpflug Images: Agreement with the LOCS III Scale	PLOS ONE			English	Article							CLASSIFICATION-SYSTEM-III; HUMAN LENS; LIGHT; AGE; PARAMETERS; SEGMENT; INDEX	Purpose To assess nuclear and cortical opacities through the objective analysis of Scheimpflug images, and to check the correlation with the Lens Opacity Classification System III (LOCS III). Methods Nuclear and cortical opacities were graded according to the LOCS III rules after pupil dilation. The maximum and average pixel intensity values along an elliptical mask within the lens nucleus were taken to analyse nuclear cataracts. A new metric based on the percentage of opaque pixels within a region of interest was used to analyse cortical cataracts. The percentage of opaque pixels was also calculated for half, third and quarter areas from the region of interest's periphery. Results The maximum and average intensity values along the nucleus were directly proportional to the LOCS III grade: The larger the LOCS III value, the larger maximum and average intensity ones. These metrics showed a positive and significant correlation with the LOCS grade: The larger the LOCS grade, the higher was percentage of opaque pixels along the cortex within the same mask's size. This metric showed a significant correlation to the LOCS grade. Conclusion The metrics used to assess nuclear opacities showed good correlation with the LOCS III. The percentage of opaque pixels showed to be a useful metric to measure objectively the severity of the cortical opacity. These metrics could be implemented in an algorithm to detect and grade lens opacities automatically and objectively.	[Dominguez-Vicent, Alberto] Univ Valencia, Dept Opt & Optometry & Vis Sci, Optometry Res Grp, Burjassot, Comunidad Valen, Spain; [Birkeldh, Ulrika; Carl-Gustaf, Laurell; Nilson, Maria; Brautaset, Rune] Karolinska Inst, Dept Clin Neurosci, Unit Optometry, Stockholm, Sweden; [Birkeldh, Ulrika; Carl-Gustaf, Laurell] St Erik Eye Hosp, Stockholm, Sweden	University of Valencia; Karolinska Institutet	Dominguez-Vicent, A (corresponding author), Univ Valencia, Dept Opt & Optometry & Vis Sci, Optometry Res Grp, Burjassot, Comunidad Valen, Spain.	alberto.vicent@uv.es	Brautaset, Rune/GQZ-1681-2022; Dominguez-Vicent, Alberto/GPT-0905-2022	Nilsson, Maria/0000-0001-8416-4819	"Atraccio de talent" research scholarship (Universidad de Valencia) [UV-INV-PREDOC13-110412]	"Atraccio de talent" research scholarship (Universidad de Valencia)	This research was founded by an "Atraccio de talent" research scholarship (Universidad de Valencia) awarded to Alberto Dominguez-Vicent (UV-INV-PREDOC13-110412), and the funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CHYLACK LT, 1993, ARCH OPHTHALMOL-CHIC, V111, P831, DOI 10.1001/archopht.1993.01090060119035; DATILES MB, 1995, BRIT J OPHTHALMOL, V79, P527, DOI 10.1136/bjo.79.6.527; Eckerskorn U, 1987, Dev Ophthalmol, V15, P82; Fan S H, 2003, AUTOMATIC SYSTEM CLA, P592; Foo KPY, 1996, OPHTHALMIC RES, V28, P32, DOI 10.1159/000267954; FUJISAWA K, 1995, OPHTHALMIC RES, V27, P89, DOI 10.1159/000267604; Grewal DS, 2009, OPHTHALMOLOGY, V116, P1436, DOI 10.1016/j.ophtha.2009.03.002; Gupta M, 2013, J CATARACT REFR SURG, V39, P1818, DOI 10.1016/j.jcrs.2013.05.052; KARBASSI M, 1993, OPTOMETRY VISION SCI, V70, P923, DOI 10.1097/00006324-199311000-00009; Kirwan JF, 2003, OPHTHALMIC EPIDEMIOL, V10, P259, DOI 10.1076/opep.10.4.259.15908; Lee DA, 1999, CLIN GUIDE COMPREHEN; Li HQ, 2010, IEEE T BIO-MED ENG, V57, P1690, DOI 10.1109/TBME.2010.2041454; MAGNO BV, 1994, CURR EYE RES, V13, P825, DOI 10.3109/02713689409025138; Michael R, 2011, PHILOS T R SOC B, V366, P1278, DOI 10.1098/rstb.2010.0300; Pan AP, 2015, AM J OPHTHALMOL, V159, P241, DOI 10.1016/j.ajo.2014.10.025; Pei X, 2008, BRIT J OPHTHALMOL, V92, P1471, DOI 10.1136/bjo.2007.136978; Qian W, 2000, EYE, V14, P56, DOI 10.1038/eye.2000.12; Sasaki H, 1999, OPHTHALMIC RES, V31, P93, DOI 10.1159/000055519; Savini G, 2013, J REFRACT SURG, V29, P121, DOI 10.3928/1081597X-20130117-07; Shetty R, 2014, INVEST OPHTH VIS SCI, V55, P5263, DOI 10.1167/iovs.14-15055; Tan AC, 2008, J CATARACT REFR SURG, V34, P1948, DOI 10.1016/j.jcrs.2008.06.037; Tkachov SI, 2006, GRAEF ARCH CLIN EXP, V244, P596, DOI 10.1007/s00417-005-0091-7; Ullrich K, 2012, J CATARACT REFR SURG, V38, P2100, DOI 10.1016/j.jcrs.2012.07.033; Wegener A, 2009, CLIN EXP OPHTHALMOL, V37, P144, DOI 10.1111/j.1442-9071.2009.02018.x	24	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2016	11	2							e0149249	10.1371/journal.pone.0149249	http://dx.doi.org/10.1371/journal.pone.0149249			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3CO	26890694	Green Published, gold, Green Submitted			2022-12-26	WOS:000371221500027
J	Zhang, DL; Dubey, J; Koushika, SP; Rongo, C				Zhang, Donglei; Dubey, Jyoti; Koushika, Sandhya P.; Rongo, Christopher			RAB-6.1 and RAB-6.2 Promote Retrograde Transport in C-elegans	PLOS ONE			English	Article							GLR-1 GLUTAMATE RECEPTORS; J-DOMAIN PROTEIN; ENDOPLASMIC-RETICULUM; MOLECULAR-CLONING; RAB GENES; RETROMER; ENDOSOMES; ASSOCIATION; SECRETION; FAMILY	Retrograde transport is a critical mechanism for recycling certain membrane cargo. Following endocytosis from the plasma membrane, retrograde cargo is moved from early endosomes to Golgi followed by transport (recycling) back to the plasma membrane. The complete molecular and cellular mechanisms of retrograde transport remain unclear. The small GTPase RAB-6.2 mediates the retrograde recycling of the AMPA-type glutamate receptor (AMPAR) subunit GLR-1 in C. elegans neurons. Here we show that RAB-6.2 and a close paralog, RAB-6.1, together regulate retrograde transport in both neurons and non-neuronal tissue. Mutants for rab-6.1 or rab-6.2 fail to recycle GLR-1 receptors, resulting in GLR-1 turnover and behavioral defects indicative of diminished GLR-1 function. Loss of both rab-6.1 and rab-6.2 results in an additive effect on GLR-1 retrograde recycling, indicating that these two C. elegans Rab6 isoforms have overlapping functions. MIG-14 (Wntless) protein, which undergoes retrograde recycling, undergoes a similar degradation in intestinal epithelia in both rab-6.1 and rab-6.2 mutants, suggesting a broader role for these proteins in retrograde transport. Surprisingly, MIG-14 is localized to separate, spatially segregated endosomal compartments in rab-6.1 mutants compared to rab-6.2 mutants. Our results indicate that RAB-6.1 and RAB-6.2 have partially redundant functions in overall retrograde transport, but also have their own unique cellular-and subcellular functions.	[Zhang, Donglei; Rongo, Christopher] Rutgers State Univ, Waksman Inst, Dept Genet, Piscataway, NJ USA; [Dubey, Jyoti; Koushika, Sandhya P.] Tata Inst Fundamental Res, Dept Biol Sci, Homi Bhabha Rd, Bombay 400005, Maharashtra, India; [Dubey, Jyoti] Inst Stem Cell Biol & Regenerat Med InStem, Bangalore, Karnataka, India; [Dubey, Jyoti] Manipal Univ, Manipal, Karnataka, India; [Zhang, Donglei] Univ Chicago, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA	Rutgers State University New Brunswick; Tata Institute of Fundamental Research (TIFR); Department of Biotechnology (DBT) India; Institute for Stem Cell Biology & Regenerative Medicine - inStem; Manipal Academy of Higher Education (MAHE); University of Chicago	Rongo, C (corresponding author), Rutgers State Univ, Waksman Inst, Dept Genet, Piscataway, NJ USA.	rongo@waksman.rutgers.edu		Zhang, Donglei/0000-0002-2720-1414; Koushika, Sandhya/0000-0002-1742-7356	National Institutes of Health [R01 NS42023, R01 GM101972]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101972] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042023] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by (CR) National Institutes of Health R01 NS42023, https://www.nihms.nih.gov/db/sub.cgi?; (CR) National Institutes of Health R01 GM101972, https://www.nihms.nih.gov/db/sub.cgi?. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the C. elegans Genetics Center, Barth Grant, Villu Maricq, Joshua Kaplan, and Shohei Mitani for reagents and strains. In addition, we thank Barth Grant and Eunchan Park for suggestions and feedback on the experimental approach and the manuscript. This work was supported by National Institutes of Health (NIH) R01 NS42023 and R01 GM101972.	Armstrong J, 1996, J CELL SCI, V109, P1265; Babst M, 2002, DEV CELL, V3, P283, DOI 10.1016/S1534-5807(02)00219-8; BALDINI G, 1995, P NATL ACAD SCI USA, V92, P4284, DOI 10.1073/pnas.92.10.4284; Belenkaya TY, 2008, DEV CELL, V14, P120, DOI 10.1016/j.devcel.2007.12.003; Bonifacino JS, 2008, CURR OPIN CELL BIOL, V20, P427, DOI 10.1016/j.ceb.2008.03.009; Bonifacino JS, 2006, NAT REV MOL CELL BIO, V7, P568, DOI 10.1038/nrm1985; Burbea M, 2002, NEURON, V35, P107, DOI 10.1016/S0896-6273(02)00749-3; Chang HCH, 2005, J CELL SCI, V118, P1945, DOI 10.1242/jcs.02320; Chen D, 1996, GENE, V174, P129, DOI 10.1016/0378-1119(96)00509-4; Chen D, 1997, BIOCHEM MOL MED, V60, P27, DOI 10.1006/bmme.1996.2559; Chun DK, 2008, MOL BIOL CELL, V19, P2682, DOI 10.1091/mbc.E07-11-1120; DARCHEN F, 1990, P NATL ACAD SCI USA, V87, P5692, DOI 10.1073/pnas.87.15.5692; Del Nery E, 2006, TRAFFIC, V7, P394, DOI 10.1111/j.1600-0854.2006.00395.x; Echard A, 2000, MOL BIOL CELL, V11, P3819, DOI 10.1091/mbc.11.11.3819; Franch-Marro X, 2008, NAT CELL BIOL, V10, P170, DOI 10.1038/ncb1678; Fukuda M, 2008, CELL MOL LIFE SCI, V65, P2801, DOI 10.1007/s00018-008-8351-4; Glodowski DR, 2007, MOL BIOL CELL, V18, P4387, DOI 10.1091/mbc.E07-05-0486; Glodowski DR, 2005, MOL BIOL CELL, V16, P1417, DOI 10.1091/mbc.E04-10-0885; Grigoriev I, 2007, DEV CELL, V13, P305, DOI 10.1016/j.devcel.2007.06.010; HART AC, 1995, NATURE, V378, P82, DOI 10.1038/378082a0; Henley JM, 2011, TRENDS NEUROSCI; Hoerndli FJ, 2015, NEURON, V86, P457, DOI 10.1016/j.neuron.2015.03.011; Hoerndli FJ, 2013, NEURON, V80, P1421, DOI 10.1016/j.neuron.2013.10.050; Iezzi M, 1999, MOL ENDOCRINOL, V13, P202, DOI 10.1210/me.13.2.202; Januschke J, 2007, DEVELOPMENT, V134, P3419, DOI 10.1242/dev.008078; Johannes L, 2008, CELL, V135, P1175, DOI 10.1016/j.cell.2008.12.009; Lundquist Erik A, 2006, WormBook, P1; Mallard F, 2002, J CELL BIOL, V156, P653, DOI 10.1083/jcb.200110081; MARICQ AV, 1995, NATURE, V378, P78, DOI 10.1038/378078a0; Martinez O, 1997, P NATL ACAD SCI USA, V94, P1828, DOI 10.1073/pnas.94.5.1828; Mellem JE, 2002, NEURON, V36, P933, DOI 10.1016/S0896-6273(02)01088-7; Monteiro MI, 2012, MOL BIOL CELL, V23, P3647, DOI 10.1091/mbc.E12-04-0334; Nonet ML, 1998, J NEUROSCI, V18, P70; NUOFFER C, 1994, J CELL BIOL, V125, P225, DOI 10.1083/jcb.125.2.225; Opdam FJM, 2000, J CELL SCI, V113, P2725; Pan CL, 2008, DEV CELL, V14, P132, DOI 10.1016/j.devcel.2007.12.001; Park EC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004284; Port F, 2008, NAT CELL BIOL, V10, P178, DOI 10.1038/ncb1687; Rojas R, 2007, MOL CELL BIOL, V27, P1112, DOI 10.1128/MCB.00156-06; Rolls MM, 2002, MOL BIOL CELL, V13, P1778, DOI 10.1091/mbc.01-10-0514; Rongo C, 1998, CELL, V94, P751, DOI 10.1016/S0092-8674(00)81734-1; Sato Ken, 2014, WormBook, P1, DOI 10.1895/wormbook.1.77.2; Shafaq-Zadah M, 2016, NAT CELL BIOL, V18, P54, DOI 10.1038/ncb3287; Shepherd JD, 2007, ANNU REV CELL DEV BI, V23, P613, DOI 10.1146/annurev.cellbio.23.090506.123516; Shi AB, 2009, EMBO J, V28, P3290, DOI 10.1038/emboj.2009.272; Shim J, 2004, MOL BIOL CELL, V15, P4818, DOI 10.1091/mbc.E04-02-0108; STENMARK H, 1994, EMBO J, V13, P1287, DOI 10.1002/j.1460-2075.1994.tb06381.x; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; TISDALE EJ, 1992, J CELL BIOL, V119, P749, DOI 10.1083/jcb.119.4.749; Valente C, 2010, NAT CELL BIOL, V12, P635, DOI 10.1038/ncb0710-635; VONMOLLARD GF, 1990, P NATL ACAD SCI USA, V87, P1988, DOI 10.1073/pnas.87.5.1988; Wandinger-Ness A, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a022616; Yang PT, 2008, DEV CELL, V14, P140, DOI 10.1016/j.devcel.2007.12.004; Yeo SCL, 2003, J CELL SCI, V116, P3957, DOI 10.1242/jcs.00751; Young J, 2010, J MOL BIOL, V397, P69, DOI 10.1016/j.jmb.2010.01.009; Zhang D, 2012, J CELL BIOL, V196, P85, DOI 10.1083/jcb.201104141; Zhang YH, 2001, MOL BIOL CELL, V12, P2011, DOI 10.1091/mbc.12.7.2011; Zheng Y, 1999, NEURON, V24, P347, DOI 10.1016/S0896-6273(00)80849-1	59	4	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2016	11	2							e0149314	10.1371/journal.pone.0149314	http://dx.doi.org/10.1371/journal.pone.0149314			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3CO	26891225	Green Published, Green Submitted, gold			2022-12-26	WOS:000371221500032
J	Changrob, S; Wang, B; Han, JH; Lee, SK; Nyunt, MH; Lim, CS; Tsuboi, T; Chootong, P; Han, ET				Changrob, Siriruk; Wang, Bo; Han, Jin-Hee; Lee, Seong-Kyun; Nyunt, Myat Htut; Lim, Chae Seung; Tsuboi, Takafumi; Chootong, Patchanee; Han, Eun-Taek			Naturally-Acquired Immune Response against Plasmodium vivax Rhoptry-Associated Membrane Antigen	PLOS ONE			English	Article							MEROZOITE SURFACE PROTEIN-1; C-TERMINAL REGION; FALCIPARUM-MALARIA; VACCINE CANDIDATE; ANTIBODY-RESPONSES; IGG SUBCLASSES; INDIVIDUALS; INFECTION; IDENTIFICATION; IMMUNIZATION	Rhoptry-associated membrane antigen (RAMA) is an abundant glycophosphatidylinositol (GPI)-anchored protein that is embedded within the lipid bilayer and is implicated in parasite invasion. Antibody responses against rhoptry proteins are produced by individuals living in a malaria-endemic area, suggesting the immunogenicity of Plasmodium vivax RAMA (PvRAMA) for induction of immune responses during P. vivax infection. To determine whether PvRAMA contributes to the acquisition of immunity to malaria and could be a rational candidate for a vaccine, the presence of memory T cells and the stability of the antibody response against PvRAMA were evaluated in P. vivax-exposed individuals. The immunogenicity of PvRAMA for the induction of T cell responses was evaluated by in vitro stimulation of peripheral blood mononuclear cells (PBMCs). High levels of interferon (IFN)-gamma and interleukin (IL)-10 cytokines were detected in the culture supernatant of PBMCs, and the CD4(+) T cells predominantly produced IL-10 cytokine. The levels of total anti-PvRAMA immunoglobulin G (IgG) antibody were significantly elevated, and these antibodies persisted over the 12 months of the study. Interestingly, IgG1, IgG2 and IgG3 were the major antibody subtypes in the response to PvRAMA. The frequency of IgG3 in specific to PvRAMA antigen maintained over 12 months. These data could explain the immunogenicity of PvRAMA antigen in induction of both cell-mediated and antibody-mediated immunity in natural P. vivax infection, in which IFN-gamma helps antibody class switching toward the IgG1, IgG2 and IgG3 isotypes and IL-10 supports PvRAMA-specific antibody production.	[Changrob, Siriruk; Chootong, Patchanee] Mahidol Univ, Fac Med Technol, Dept Clin Microbiol & Appl Technol, Bangkok 10700, Thailand; [Wang, Bo; Han, Jin-Hee; Lee, Seong-Kyun; Nyunt, Myat Htut] Kangwon Natl Univ, Dept Med Environm Biol & Trop Med, Sch Med, Chunchon, Gangwon Do, South Korea; [Wang, Bo; Han, Eun-Taek] Anhui Med Univ, Affiliated Hosp 1, Dept Clin Lab, Hefei, Anhui, Peoples R China; [Nyunt, Myat Htut] Dept Med Res, Yangon, Myanmar; [Lim, Chae Seung] Korea Univ, Guro Hosp, Coll Med, Dept Lab Med, Seoul, South Korea; [Tsuboi, Takafumi] Ehime Univ, Div Malaria Res, Proteosci Ctr, Matsuyama, Ehime, Japan	Mahidol University; Kangwon National University; Anhui Medical University; Korea University; Korea University Medicine (KU Medicine); Ehime University	Chootong, P (corresponding author), Mahidol Univ, Fac Med Technol, Dept Clin Microbiol & Appl Technol, Bangkok 10700, Thailand.; Han, ET (corresponding author), Anhui Med Univ, Affiliated Hosp 1, Dept Clin Lab, Hefei, Anhui, Peoples R China.	pchooton@gmail.com; ethan@kangwon.ac.kr	Nyunt, Myat Htut/R-2424-2017; Tsuboi, Takafumi/AAK-6145-2021; Changrob, Siriruk/AAZ-6282-2021	Nyunt, Myat Htut/0000-0002-2026-8026; Changrob, Siriruk/0000-0002-1826-4333; Tsuboi, Takafumi/0000-0002-7415-1325; Han, Jin-Hee/0000-0003-0836-6675	National Research Foundation of Korea (NRF) - Korea government (MSIP) [NRF-2014R1A2A1A11052079]; Korea Health Technology R&D Project, the Ministry of Health & Welfare, Republic of Korea [A121180]	National Research Foundation of Korea (NRF) - Korea government (MSIP); Korea Health Technology R&D Project, the Ministry of Health & Welfare, Republic of Korea	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) (No. NRF-2014R1A2A1A11052079) and a grant from the Korea Health Technology R&D Project, the Ministry of Health & Welfare, Republic of Korea (A121180). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam MT, 2008, PARASITE IMMUNOL, V30, P379, DOI 10.1111/j.1365-3024.2008.01033.x; Arevalo-Herrera M, 2010, HUM VACCINES, V6, P124, DOI 10.4161/hv.6.1.9931; Artavanis-Tsakonas K, 2003, CLIN EXP IMMUNOL, V133, P145, DOI 10.1046/j.1365-2249.2003.02174.x; Aucan C, 2000, INFECT IMMUN, V68, P1252, DOI 10.1128/IAI.68.3.1252-1258.2000; Bruhns P, 2009, BLOOD, V113, P3716, DOI 10.1182/blood-2008-09-179754; Changrob S, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0681-8; Chen JH, 2010, J PROTEOME RES, V9, P6479, DOI 10.1021/pr100705g; CLYDE DF, 1990, B WORLD HEALTH ORGAN, V68, P9; CLYDE DF, 1975, AM J TROP MED HYG, V24, P397, DOI 10.4269/ajtmh.1975.24.397; Counihan NA, 2013, TRENDS PARASITOL, V29, P228, DOI 10.1016/j.pt.2013.03.003; Fonjungo PN, 1998, INFECT IMMUN, V66, P1037, DOI 10.1128/IAI.66.3.1037-1044.1998; Gething PW, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001814; Holdsworth SR, 1999, KIDNEY INT, V55, P1198, DOI 10.1046/j.1523-1755.1999.00369.x; Ismail HA, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-425; Kraaij MD, 2014, CYTOKINE, V67, P7, DOI 10.1016/j.cyto.2014.02.001; Langhorne J, 2008, NAT IMMUNOL, V9, P725, DOI 10.1038/ni.f.205; Lu F, 2014, J PROTEOMICS, V102, P66, DOI 10.1016/j.jprot.2014.02.029; Bouillet LEM, 2011, INFECT IMMUN, V79, P3642, DOI 10.1128/IAI.05048-11; MCGREGOR IA, 1964, AM J TROP MED HYG, V13, P237, DOI 10.4269/ajtmh.1964.13.237; Mehrizi AA, 2009, ACTA TROP, V112, P1, DOI 10.1016/j.actatropica.2009.05.016; Menard R, 2013, NAT REV MICROBIOL, V11, P701, DOI 10.1038/nrmicro3111; Mongui A, 2007, BIOCHEM BIOPH RES CO, V358, P861, DOI 10.1016/j.bbrc.2007.05.015; Pandey JP, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-229; Patarroyo MA, 2005, BIOCHEM BIOPH RES CO, V337, P853, DOI 10.1016/j.bbrc.2005.09.120; Perez-Leal O, 2006, BIOCHEM BIOPH RES CO, V341, P1053, DOI 10.1016/j.bbrc.2006.01.061; Pitabut Nada, 2007, Southeast Asian Journal of Tropical Medicine and Public Health, V38, P1; Riccio EKP, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-326; Richards JS, 2009, IMMUNOL CELL BIOL, V87, P377, DOI 10.1038/icb.2009.27; RIDLEY RG, 1990, PARASITOLOGY, V101, P187, DOI 10.1017/S0031182000063228; Rojas-Caraballo J, 2009, VACCINE, V27, P2870, DOI 10.1016/j.vaccine.2009.02.083; SABCHAREON A, 1991, AM J TROP MED HYG, V45, P297, DOI 10.4269/ajtmh.1991.45.297; Sauerwein RW, 2011, NAT REV IMMUNOL, V11, P57, DOI 10.1038/nri2902; Targett GAT, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-362; Teirlinck AC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002389; Tongren JE, 2006, INFECT IMMUN, V74, P257, DOI 10.1128/IAI.74.1.257-264.2006; Topolska AE, 2004, INFECT IMMUN, V72, P3325, DOI 10.1128/IAI.72.6.3325-3330.2004; Tran TM, 2005, AM J TROP MED HYG, V73, P244, DOI 10.4269/ajtmh.2005.73.244; Tsuboi T, 2008, INFECT IMMUN, V76, P1702, DOI 10.1128/IAI.01539-07; Wang B, 2015, INFECT IMMUN, V83, P3083, DOI 10.1128/IAI.03067-14; Wang B, 2013, PARASITOL RES, V112, P585, DOI 10.1007/s00436-012-3170-9; Wipasa J, 2002, IMMUNOL CELL BIOL, V80, P401, DOI 10.1046/j.1440-1711.2002.01107.x; Wipasa J, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001281; Wipasa J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000770; Woodberry T, 2008, J INFECT DIS, V198, P134, DOI 10.1086/588711; Zakeri S, 2011, AM J TROP MED HYG, V84, P944, DOI 10.4269/ajtmh.2011.11-0001; Zeeshan M, 2013, J INFECT DIS, V207, P175, DOI 10.1093/infdis/jis650	46	8	8	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0148723	10.1371/journal.pone.0148723	http://dx.doi.org/10.1371/journal.pone.0148723			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26886867	gold, Green Published, Green Submitted			2022-12-26	WOS:000371218400046
J	Guida, L; Walker, TI; Reina, RD				Guida, Leonardo; Walker, Terence I.; Reina, Richard D.			Temperature Insensitivity and Behavioural Reduction of the Physiological Stress Response to Longline Capture by the Gummy Shark, Mustelus antarcticus	PLOS ONE			English	Article							GILL-NET CAPTURE; POSTRELEASE SURVIVORSHIP; ELASMOBRANCH; SURVIVAL; CAUGHT; INDICATORS; MORTALITY; TRANSPORT	Many factors influence the physiological stress response to fisheries capture in elasmobranchs. However, the influence of sea surface temperatures (SST) and behaviour are unknown and crucial considering global fishing pressures. We investigated the effect of SST and behaviour on the physiological stress response to capture of the gummy shark, Mustelus antarcticus, and compared our results to a laboratory study using similar conditions to test whether stress responses of in situ capture are consistent with those from laboratory simulations. Capture time for 23 M. antarcticus ranged 32-241 min as measured by hook timers or time depth recorders (TDR) in SSTs ranging 12-20 degrees C. TDR data from 13 M. antarcticus were analysed to quantify capture behaviour as the percentage of time spent moving during capture. Several physiological variables measured from blood samples obtained immediately upon the animals' landing indicated that although warmer SSTs increased metabolic rate, the stress response to capture was not exacerbated by capture duration. During capture movement occurred for an average of 10% of the time and since M. antarcticus can respire whilst stationary, restricted movement probably mitigated potential influences of increased SSTs and capture duration on the stress response. Previous laboratory findings were also shown to be indicative of in situ conditions and we thus advise that studies control for water temperature given the influence it has on variables (e.g. lactate) used to measure capture stress in elasmobranchs. We highlight the importance of seasonal water temperatures and capture behaviour when assessing the resilience to fisheries capture and the implementation of appropriate fisheries management strategies.	[Guida, Leonardo; Walker, Terence I.; Reina, Richard D.] Monash Univ, Sch Biol Sci, Clayton, Vic 3800, Australia	Monash University	Guida, L (corresponding author), Monash Univ, Sch Biol Sci, Clayton, Vic 3800, Australia.	leoguida85@gmail.com	Reina, Richard/AAC-7017-2019; Walker, Terence I/AAD-8458-2019	Walker, Terence I/0000-0001-6552-9042	Australian Research Council Linkage [LP110200572]	Australian Research Council Linkage(Australian Research Council)	This work was supported by Australian Research Council Linkage grant LP110200572 to RDR and TIW which included the Department of Economic Development, Jobs, Transport and Resources Victoria; Australian Fisheries Management Authority; Melbourne Aquarium and Monash University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brooks EJ, 2012, COMP BIOCHEM PHYS A, V162, P94, DOI 10.1016/j.cbpa.2011.04.012; Camhi M. D., 2008, SHARKS OPEN OCEAN BI, P166; Cicia AM, 2012, COMP BIOCH PHYSL A; Dapp DR, 2016, FISH FISH, V17, P507, DOI 10.1111/faf.12124; Davis MW, 2002, CAN J FISH AQUAT SCI, V59, P1834, DOI 10.1139/F02-139; Ditmer MA, 2015, ECOSPHERE, V6, DOI 10.1890/ES14-00199.1; Dulvy NK, 2014, ELIFE, V3, DOI 10.7554/eLife.00590; Ellison AM, 1996, ECOL APPL, V6, P1036, DOI 10.2307/2269588; Frick LH, 2012, COMP BIOCHEM PHYS A, V162, P88, DOI 10.1016/j.cbpa.2011.02.023; Frick LH, 2010, J EXP MAR BIOL ECOL, V385, P29, DOI 10.1016/j.jembe.2010.01.013; Frick LH, 2009, N AM J FISH MANAGE, V29, P127, DOI 10.1577/M08-031.1; Gallagher AJ, 2014, GLOB ECOL CONSERV, V1, P50, DOI 10.1016/j.gecco.2014.06.003; Gallagher AJ, 2014, MAR ECOL PROG SER, V496, P207, DOI 10.3354/meps10490; Gallagher AJ, 2010, J AQUAT ANIM HEALTH, V22, P229, DOI 10.1577/H10-012.1; Gilman E, 2008, MAR POLICY, V32, P1, DOI 10.1016/j.marpol.2007.05.001; Grace MA, 2010, SOUTHEAST NAT, V9, P191, DOI 10.1656/058.009.0201; Harter TS, 2015, CONSERV PHYSL, V3, DOI [10.1093/conphys/cov002, DOI 10.1093/CONPHYS/C0V002]; Hight BV, 2007, MAR FRESHWATER RES, V58, P145, DOI 10.1071/MF05260; Hoffmayer ER, 2012, COMP BIOCHEM PHYS A, V162, P81, DOI 10.1016/j.cbpa.2011.05.002; HOPKINS TE, 1994, COPEIA, P529, DOI 10.2307/1447005; Hyatt MW, 2012, COMP BIOCHEM PHYS A, V162, P113, DOI 10.1016/j.cbpa.2011.05.004; Jones S, 2014, J APPL ANIM WELF SCI, V17, P18, DOI 10.1080/10888705.2014.856241; Kneebone J, 2013, FISH RES, V147, P103, DOI 10.1016/j.fishres.2013.04.009; Mandelman JW, 2007, ICES J MAR SCI, V64, P122, DOI 10.1093/icesjms/fsl003; Mandelman JW, 2009, J COMP PHYSIOL B, V179, P267, DOI 10.1007/s00360-008-0306-4; Manire C, 2001, T AM FISH SOC, V130, P1038, DOI 10.1577/1548-8659(2001)130&lt;1038:SCAWGN&gt;2.0.CO;2; Morgan Alexia, 2007, Gulf and Caribbean Research, V19, P123; Morgan A, 2010, FISH RES, V101, P32, DOI 10.1016/j.fishres.2009.09.004; Moyes CD, 2006, T AM FISH SOC, V135, P1389, DOI 10.1577/T05-224.1; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Renshaw GMC, 2012, COMP BIOCHEM PHYS A, V162, P101, DOI 10.1016/j.cbpa.2011.08.001; Santurtun E, 2015, J ANIM SCI, V93, P1250, DOI 10.2527/jas.2014-8037; Skomal G, 2010, CRC MAR BIOL SER, P459; Skomal GB, 2012, COMP BIOCHEM PHYS A, V162, P146, DOI 10.1016/j.cbpa.2011.10.002; Van Rijn JA, 2010, FISH SHELLFISH IMMUN, V29, P534, DOI 10.1016/j.fsi.2010.04.016; Walker TI, 1998, MAR FRESHWATER RES, V49, P553, DOI 10.1071/MF98017; Water Melbourne, 2011, W PORT ENV SCI REV	37	19	19	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0148829	10.1371/journal.pone.0148829	http://dx.doi.org/10.1371/journal.pone.0148829			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26886126	gold, Green Published, Green Submitted			2022-12-26	WOS:000371218400051
J	Hall, KW; Eisthen, HL; Williams, BL				Hall, Kevin W.; Eisthen, Heather L.; Williams, Barry L.			Proteinaceous Pheromone Homologs Identified from the Cloacal Gland Transcriptome of a Male Axolotl, Ambystoma mexicanum	PLOS ONE			English	Article							NEWT CYNOPS-PYRRHOGASTER; VENOM ALPHA-NEUROTOXINS; RNA-SEQ DATA; TERRESTRIAL SALAMANDER; COURTSHIP PHEROMONE; FEMALE RECEPTIVITY; ABDOMINAL GLAND; GENES; SIGNALS; GENOME	Pheromones play an important role in modifying vertebrate behavior, especially during courtship and mating. Courtship behavior in urodele amphibians often includes female exposure to secretions from the cloacal gland, as well as other scent glands. The first vertebrate proteinaceous pheromone discovered, the decapeptide sodefrin, is a female attracting pheromone secreted by the cloacal gland of male Cynops pyrrhogaster. Other proteinaceous pheromones in salamanders have been shown to elicit responses from females towards conspecific males. The presence and levels of expression of proteinaceous pheromones have not been identified in the family Ambystomatidae, which includes several important research models. The objective of this research was therefore to identify putative proteinaceous pheromones from male axolotls, Ambystoma mexicanum, as well as their relative expression levels. The results indicate that axolotls possess two different forms of sodefrin precursor-like factor (alpha and beta), as well as a putative ortholog of plethodontid modulating factor. The beta form of sodefrin precursor-like factor was amongst the most highly expressed transcripts within the cloacal gland. The ortholog of plethodontid modulating factor was expressed at a level equivalent to the beta sodefrin precursor-like factor. The results are from a single male axolotl; therefore, we are unable to assess how representative our results may be. Nevertheless, the presence of these highly expressed proteinaceous pheromones suggests that male axolotls use multiple chemical cues to attract female conspecifics. Behavioral assays would indicate whether the putative protein pheromones elicit courtship activity from female axolotls.	[Williams, Barry L.] Michigan State Univ, Dept Integrat Biol, E Lansing, MI 48824 USA; Michigan State Univ, BEACON Ctr Study Evolut Act, E Lansing, MI 48824 USA	Michigan State University; Michigan State University	Williams, BL (corresponding author), Michigan State Univ, Dept Integrat Biol, E Lansing, MI 48824 USA.	BarryW@msu.edu			U. S. National Science Foundation [IOS-1354089, DBI-0951484]; Michigan State University; Division Of Integrative Organismal Systems [1354089] Funding Source: National Science Foundation	U. S. National Science Foundation(National Science Foundation (NSF)); Michigan State University; Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the U. S. National Science Foundation (Grant Number: IOS-1354089) (HLE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank the Ambystoma Genetic Stock Center (supported by the U. S. National Science Foundation, DBI-0951484) for supplying the axolotl used in this experiment. We thank Cory B. Kohn for his assistance with understanding how to code scripts to more efficiently process and analyze data and Dr. Matthew Scholz for his assistance in understanding of the various modules utilized in the assembly and analysis of the transcriptome discussed in this thesis. This work was supported by the U. S. National Science Foundation (IOS-1354089) as well as by Michigan State University through computational resources provided by the Institute for Cyber-Enabled Research.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amaldi F, 1995, BIOCHEM CELL BIOL, V73, P969, DOI 10.1139/o95-104; Armstrong J, 1989, RAISING AXOLOTL CAPT; Arnold S.J., 1977, P141; Bolger AM, 2014, BIOINFORMATICS; Brown C.T., 2012, ARXIV12034802; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Crusoe M, 2014, KHMER SOFTWARE PACKA; Di Lullo GA, 2002, J BIOL CHEM, V277, P4223, DOI 10.1074/jbc.M110709200; Dulac C, 2003, NAT REV NEUROSCI, V4, P551, DOI 10.1038/nrn1140; Eisthen HL, 2005, CHEM SIGNAL, V10, P216, DOI 10.1007/0-387-25160-X_26; Gadow H, 1903, NATURE, V67, P330, DOI 10.1038/067330b0; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Hellsten U, 2010, SCIENCE, V328, P633, DOI 10.1126/science.1183670; Houck LD, 2008, CHEM SENSES, V33, P623, DOI 10.1093/chemse/bjn027; Houck LD, 2008, CHEM SIGNAL, V11, P213, DOI 10.1007/978-0-387-73945-8_20; Huggins P, 2012, COMP BIOCHEM PHYS C, V155, P128, DOI 10.1016/j.cbpc.2011.03.006; Iwata T, 2004, PEPTIDES, V25, P1537, DOI 10.1016/j.peptides.2003.10.027; JAEGER RG, 1981, AM NAT, V117, P962, DOI 10.1086/283780; Janssenswillen S, 2015, MOL BIOL EVOL, V32, P472, DOI 10.1093/molbev/msu316; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; KIEFFER B, 1994, BIOCHEMISTRY-US, V33, P4471, DOI 10.1021/bi00181a006; Kikuyama S, 2002, COMP BIOCHEM PHYS B, V132, P69, DOI 10.1016/S1096-4959(01)00534-6; KIKUYAMA S, 1995, SCIENCE, V267, P1643, DOI 10.1126/science.7886452; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li B, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0553-5; Li FG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123730; Lo CC, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/s12859-014-0366-2; MASON RT, 1989, SCIENCE, V245, P290, DOI 10.1126/science.2749261; MATHIS A, 1990, BEHAVIOUR, V112, P162, DOI 10.1163/156853990X00176; Meredith M, 1998, ANN NY ACAD SCI, V855, P349, DOI 10.1111/j.1749-6632.1998.tb10593.x; Nakada T, 2007, PEPTIDES, V28, P774, DOI 10.1016/j.peptides.2006.12.006; Osikowski A, 2008, ZOOL SCI, V25, P587, DOI 10.2108/zsj.25.587; Palmer CA, 2007, FEBS J, V274, P2300, DOI 10.1111/j.1742-4658.2007.05766.x; Palmer CA, 2007, EVOLUTION, V61, P202, DOI 10.1111/j.1558-5646.2007.00017.x; Park D, 2004, J COMP PHYSIOL A, V190, P415, DOI 10.1007/s00359-004-0510-y; PLOUG M, 1994, FEBS LETT, V349, P163, DOI 10.1016/0014-5793(94)00674-1; Rajchard J, 2005, VET MED-CZECH, V50, P385, DOI 10.17221/5637-VETMED; Ramskold D, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000598; Rawls JF, 2006, CELL, V127, P423, DOI 10.1016/j.cell.2006.08.043; Rollmann SM, 1999, SCIENCE, V285, P1907, DOI 10.1126/science.285.5435.1907; SALTHE SN, 1967, COPEIA, P100; SMITH HM, 1969, BIOSCIENCE, V19, P593, DOI 10.2307/1294932; Smith JJ, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-181; Stacey N, 2003, CAN J PHYSIOL PHARM, V81, P329, DOI [10.1139/y03-024, 10.1139/Y03-024]; Stebbins R. C., 2021, NATURAL HIST AMPHIBI; Stewart R, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002936; Tsetlin V, 1999, EUR J BIOCHEM, V264, P281, DOI 10.1046/j.1432-1327.1999.00623.x; Van Bocxlaer I, 2014, PEERJ PREPRINTS, P2; Wheat CW, 2011, METHODS MOL BIOL, V772, P129, DOI 10.1007/978-1-61779-228-1_7; Yamamoto K, 2000, FEBS LETT, V472, P267, DOI 10.1016/S0014-5793(00)01455-1; Zhang P, 2008, MOL PHYLOGENET EVOL, V49, P586, DOI 10.1016/j.ympev.2008.08.020; Zhang SY, 2013, ZOOL SCI, V30, P658, DOI 10.2108/zsj.30.658	54	6	6	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0146851	10.1371/journal.pone.0146851	http://dx.doi.org/10.1371/journal.pone.0146851			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26885665	Green Published, gold, Green Submitted			2022-12-26	WOS:000371218400004
J	Kimura, K; Huang, RCC				Kimura, Kotohiko; Huang, Ru Chih C.			Tetra-O-Methyl Nordihydroguaiaretic Acid Broadly Suppresses Cancer Metabolism and Synergistically Induces Strong Anticancer Activity in Combination with Etoposide, Rapamycin and UCN-01	PLOS ONE			English	Article							MITOCHONDRIAL ELECTRON-TRANSPORT; INHIBITOR TERAMEPROCOL; OXIDATIVE STRESS; CELL-DEATH; PHASE-I; AUTOPHAGY; APOPTOSIS; TARGETS; BNIP3; CLEAVAGE	The ability of Tetra-O-methyl nordihydroguaiaretic acid (M4N) to induce rapid cell death in combination with Etoposide, Rapamycin, or UCN-01 was examined in LNCaP cells, both in cell culture and animal experiments. Mice treated with M4N drug combinations with either Etoposide or Rapamycin showed no evidence of tumor and had a 100% survival rate 100 days after tumor implantation. By comparison all other vehicles or single drug treated mice failed to survive longer than 30 days after implantation. This synergistic improvement of anticancer effect was also confirmed in more than 20 cancer cell lines. In LNCaP cells, M4N was found to reduce cellular ATP content, and suppress NDUFS1 expression while inducing hyperpolarization of mitochondrial membrane potential. M4N-treated cells lacked autophagy with reduced expression of BNIP3 and ATG5. To understand the mechanisms of this anticancer activity of M4N, the effect of this drug on three cancer cell lines (LNCaP, AsPC-1, and L428 cells) was further examined via transcriptome and metabolomics analyses. Metabolomic results showed that there were reductions of 26 metabolites essential for energy generation and/or production of cellular components in common with these three cell lines following 8 hours of M4N treatment. Deep RNA sequencing analysis demonstrated that there were sixteen genes whose expressions were found to be modulated following 6 hours of M4N treatment similarly in these three cell lines. Six out of these 16 genes were functionally related to the 26 metabolites described above. One of these up-regulated genes encodes for CHAC1, a key enzyme affecting the stress pathways through its degradation of glutathione. In fact M4N was found to suppress glutathione content and induce reactive oxygen species production. The data overall indicate that M4N has profound specific negative impacts on a wide range of cancer metabolisms supporting the use of M4N combination for cancer treatments.	[Kimura, Kotohiko; Huang, Ru Chih C.] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA	Johns Hopkins University	Huang, RCC (corresponding author), Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA.	rhuang@jhu.edu			National Institutes of Health [R01DE12165]; Biocuremedical, LLC; Dorothy Yen Trust [P690-C25-2407]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE012165] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biocuremedical, LLC; Dorothy Yen Trust; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This study was supported by grants from the National Institutes of Health (R01DE12165), Biocuremedical, LLC, and the Dorothy Yen Trust (P690-C25-2407) to RCH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinaga S, 2000, ANTI-CANCER DRUG DES, V15, P43; Al-Lazikani B, 2012, NAT BIOTECHNOL, V30, P679, DOI 10.1038/nbt.2284; Amaravadi RK, 2007, J CLIN INVEST, V117, P326, DOI 10.1172/JCI28833; Arlt A, 2013, CANCER LETT, V332, P346, DOI 10.1016/j.canlet.2010.10.015; Balasubramanian MN, 2013, AM J PHYSIOL-ENDOC M, V304, pE789, DOI 10.1152/ajpendo.00015.2013; Beale EG, 2007, CELL BIOCHEM BIOPHYS, V48, P89, DOI 10.1007/s12013-007-0025-6; Beishline K, 2015, FEBS J, V282, P224, DOI 10.1111/febs.13148; Bellot G, 2009, MOL CELL BIOL, V29, P2570, DOI 10.1128/MCB.00166-09; Ben-Sahra I, 2013, CELL DEATH DIFFER, V20, P611, DOI 10.1038/cdd.2012.157; Bonnefont Jean-Paul, 2004, Molecular Aspects of Medicine, V25, P495, DOI 10.1016/j.mam.2004.06.004; Boohaker RJ, 2011, AM J PHYSIOL-CELL PH, V300, pC1466, DOI 10.1152/ajpcell.00325.2010; Boucher D, 2012, P NATL ACAD SCI USA, V109, P5669, DOI 10.1073/pnas.1200934109; Cain DW, 2013, J IMMUNOL, V191, P4665, DOI 10.4049/jimmunol.1300581; Chang CC, 2004, P NATL ACAD SCI USA, V101, P13239, DOI 10.1073/pnas.0405407101; Chen Y, 2009, CELL DEATH DIFFER, V16, P1040, DOI 10.1038/cdd.2009.49; Cheong H, 2012, NAT BIOTECHNOL, V30, P671, DOI 10.1038/nbt.2285; Chinnadurai G, 2008, ONCOGENE, V27, pS114, DOI 10.1038/onc.2009.49; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Chua BT, 2000, J BIOL CHEM, V275, P5131, DOI 10.1074/jbc.275.7.5131; Dent P, 2011, MOL INTERV, V11, P133, DOI 10.1124/mi.11.2.11; Di Lisa F, 2009, J MOL CELL CARDIOL, V46, P775, DOI 10.1016/j.yjmcc.2009.03.006; Flaveny CA, 2015, CANCER CELL, V28, P42, DOI 10.1016/j.ccell.2015.05.007; Fruehauf JP, 2008, EXPERT REV ANTICANC, V8, P1751, DOI 10.1586/14737140.8.11.1751; Gafni J, 2009, J BIOL CHEM, V284, P25441, DOI 10.1074/jbc.M109.038174; Gergely P, 2002, J IMMUNOL, V169, P1092, DOI 10.4049/jimmunol.169.2.1092; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Glick D, 2012, MOL CELL BIOL, V32, P2570, DOI 10.1128/MCB.00167-12; Grossman SA, 2012, NEURO-ONCOLOGY, V14, P511, DOI 10.1093/neuonc/nor230; Gustafsson AB, 2011, PEDIATR CARDIOL, V32, P267, DOI 10.1007/s00246-010-9876-5; Hardie DG, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-36; Heller JD, 2001, CANCER RES, V61, P5499; Huang RC, 2011, US Patent, Patent No. [0014192 A1, 0014192]; Huang RC, 2013, PCT/US13/24595, Patent No. 1324595; Huang SL, 2003, CANCER BIOL THER, V2, P222, DOI 10.4161/cbt.2.3.360; Hwu JR, 1998, J MED CHEM, V41, P2994, DOI 10.1021/jm970819w; Iuso A, 2006, J BIOL CHEM, V281, P10374, DOI 10.1074/jbc.M513387200; Joo NE, 2012, CANCER MED-US, V1, P295, DOI 10.1002/cam4.35; Kim MY, 2005, GENE DEV, V19, P1951, DOI 10.1101/gad.1331805; Kumar A, 2012, EMBO REP, V13, P1095, DOI 10.1038/embor.2012.156; Lambert JD, 2001, J CHROMATOGR B, V754, P85, DOI 10.1016/S0378-4347(00)00592-2; Lee J, 2012, BIOCHEM J, V441, P523, DOI 10.1042/BJ20111451; Li TK, 2001, ANNU REV PHARMACOL, V41, P53, DOI 10.1146/annurev.pharmtox.41.1.53; Lopez RA, 2007, ANTI-CANCER DRUG, V18, P933; Lu JM, 2010, MED SCI MONITOR, V16, pRA93; Ly JD, 2003, APOPTOSIS, V8, P115, DOI 10.1023/A:1022945107762; Manda G., 2009, CURR CHEM BIOL, V3, P22, DOI [10.2174/187231309787158271, DOI 10.2174/187231309787158271, DOI 10.2174/22127968109030]; Morales JC, 2014, CRIT REV EUKAR GENE, V24, P15, DOI 10.1615/CritRevEukaryotGeneExpr.2013006875; Mungrue IN, 2009, J IMMUNOL, V182, P466, DOI 10.4049/jimmunol.182.1.466; Oakhill JS, 2011, SCIENCE, V332, P1433, DOI 10.1126/science.1200094; PARDINI RS, 1970, BIOCHEM PHARMACOL, V19, P2695, DOI 10.1016/0006-2952(70)90095-X; PARDINI RS, 1973, BIOCHEM PHARMACOL, V22, P1921, DOI 10.1016/0006-2952(73)90052-X; Park R, 2005, CLIN CANCER RES, V11, P4601, DOI 10.1158/1078-0432.CCR-04-2188; Pavlides S, 2010, CELL CYCLE, V9, P3485, DOI 10.4161/cc.9.17.12721; Porporato PE, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00049; Rubinsztein DC, 2009, AUTOPHAGY, V5, P585, DOI 10.4161/auto.5.5.8823; Rutter J, 2010, MITOCHONDRION, V10, P393, DOI 10.1016/j.mito.2010.03.001; Ruzza P, 2009, ANTI-CANCER AGENT ME, V9, P763, DOI 10.2174/187152009789056895; Salani R, 2006, INT J GYNECOLOGIC S3, V16, P682; Schlaepfer IR, 2014, MOL CANCER THER, V13, P2361, DOI 10.1158/1535-7163.MCT-14-0183; Schulze A, 2012, NATURE, V491, P364, DOI 10.1038/nature11706; Spans L, 2012, PROSTATE, V72, P1317, DOI 10.1002/pros.22480; Thompson MR, 2009, J MOL MED, V87, P1053, DOI 10.1007/s00109-009-0520-x; Tibes R, 2015, INVEST NEW DRUG, V33, P389, DOI 10.1007/s10637-014-0198-y; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vander Heiden MG, 2011, NAT REV DRUG DISCOV, V10, P671, DOI 10.1038/nrd3504; Vanella A, 2000, CELL BIOL TOXICOL, V16, P99, DOI 10.1023/A:1007638025856; Wang LW, 2003, CLIN CANCER RES, V9, P6371; Wang XO, 1999, PROSTATE, V39, P182, DOI 10.1002/(SICI)1097-0045(19990515)39:3<182::AID-PROS6>3.0.CO;2-B; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; White E, 2009, CLIN CANCER RES, V15, P5308, DOI 10.1158/1078-0432.CCR-07-5023; Wlodkowic D, 2011, METHOD CELL BIOL, V103, P55, DOI 10.1016/B978-0-12-385493-3.00004-8; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515; Yousefi S, 2006, NAT CELL BIOL, V8, P1124, DOI 10.1038/ncb1482; Zaugg K, 2011, GENE DEV, V25, P1041, DOI 10.1101/gad.1987211; Zhang J, 2009, CELL DEATH DIFFER, V16, P939, DOI 10.1038/cdd.2009.16	76	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0148685	10.1371/journal.pone.0148685	http://dx.doi.org/10.1371/journal.pone.0148685			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26886430	gold, Green Published, Green Submitted			2022-12-26	WOS:000371218400043
J	Long, LC; Fox, MP; Sauls, C; Evans, D; Sanne, I; Rosen, SB				Long, Lawrence C.; Fox, Matthew P.; Sauls, Celeste; Evans, Denise; Sanne, Ian; Rosen, Sydney B.			The High Cost of HIV-Positive Inpatient Care at an Urban Hospital in Johannesburg, South Africa	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; ADULTS; INFECTION; MORBIDITY; HIV/AIDS; DISEASE; IMPACT; SOWETO	Background While most HIV care is provided on an outpatient basis, hospitals continue to treat serious HIV-related admissions, which is relatively resource-intensive and expensive. This study reports the primary reasons for HIV-related admission at a regional, urban hospital in Johannesburg, South Africa and estimates the associated lengths of stay and costs. Methods and Findings A retrospective cohort study of adult, medical admissions was conducted. Each admission was assigned a reason for admission and an outcome. The length of stay was calculated for all patients (N = 1,041) and for HIV-positive patients (n = 469), actual utilization and associated costs were also estimated. Just under half were known to be HIV-positive admissions. Deaths and transfers were proportionately higher amongst HIV-positive admissions compared to HIV-negative and unknown. The three most common reasons for admission were tuberculosis and other mycobacterial infections (18%, n = 187), cardiovascular disorders (12%, n = 127) and bacterial infections (12%, n = 121). The study sample utilized a total of 7,733 bed days of those, 55% (4,259/7,733) were for HIV-positive patients. The average cost per admission amongst confirmed HIV-positive patients, which was an average of 9.3 days in length, was $1,783 (United States Dollars). Conclusions Even in the era of large-scale antiretroviral treatment, inpatient facilities in South Africa shoulder a significant HIV burden. The majority of this burden is related to patients not on ART (298/469, 64%), and accounts for more than half of all inpatient resources. Reducing the costs of inpatient care is thus another important benefit of expanding access to ART, promoting earlier ART initiation, and achieving rates of ART retention and adherence.	[Long, Lawrence C.; Fox, Matthew P.; Sauls, Celeste; Evans, Denise; Sanne, Ian; Rosen, Sydney B.] Univ Witwatersrand, Fac Hlth Sci, Sch Clin Med, Dept Internal Med, Johannesburg, South Africa; [Long, Lawrence C.; Fox, Matthew P.; Evans, Denise; Sanne, Ian] Univ Witwatersrand, Fac Hlth Sci, Sch Publ Hlth, Johannesburg, South Africa; [Long, Lawrence C.; Fox, Matthew P.; Sauls, Celeste; Evans, Denise; Sanne, Ian; Rosen, Sydney B.] Wits Hlth Consortium, Hlth Econ & Epidemiol Res Off, Johannesburg, South Africa; [Fox, Matthew P.; Sanne, Ian] Boston Univ, Ctr Global Hlth & Dev, Boston, MA 02215 USA; [Fox, Matthew P.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA	University of Witwatersrand; University of Witwatersrand; University of Witwatersrand; Boston University; Harvard University; Harvard T.H. Chan School of Public Health	Long, LC (corresponding author), Univ Witwatersrand, Fac Hlth Sci, Sch Clin Med, Dept Internal Med, Johannesburg, South Africa.; Long, LC (corresponding author), Univ Witwatersrand, Fac Hlth Sci, Sch Publ Hlth, Johannesburg, South Africa.; Long, LC (corresponding author), Wits Hlth Consortium, Hlth Econ & Epidemiol Res Off, Johannesburg, South Africa.	llong@heroza.org	Fox, Matthew/K-2004-2019; Sanne, Ian/ABH-2231-2020	Rosen, Sydney/0000-0002-6560-2964; Long, Lawrence/0000-0003-4986-4988	United States Agency for International Development (USAID) [674-A-00-09-00018-00, 674-A-12-00029]; USAID [674-A-12-00029]	United States Agency for International Development (USAID)(United States Agency for International Development (USAID)); USAID(United States Agency for International Development (USAID))	LCL, MPF, CS, DE, and SBR were funded for this work by United States Agency for International Development (USAID) through the following agreements: 674-A-00-09-00018-00 & 674-A-12-00029. IS was funded for this work by USAID through the following agreement: 674-A-12-00029. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The author's views expressed in this publication do not necessarily reflect the views of the United States Agency for International Development or the United States Government.	Badri M, 2006, PLOS MED, V3, P48, DOI 10.1371/journal.pmed.0030004; Cleary SM, 2008, AIDS, V22, pS35, DOI 10.1097/01.aids.0000327621.24232.71; Cleary Susan M, 2006, Cost Eff Resour Alloc, V4, P20, DOI 10.1186/1478-7547-4-20; Colvin M, 2001, INT J STD AIDS, V12, P386, DOI 10.1258/0956462011923336; Corbett EL, 2002, CLIN INFECT DIS, V34, P1251, DOI 10.1086/339540; de Cherif TKS, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-205; Department of Public Service and Administration, 2013, SCAL TRANS KEYS EMPL; Floyd K, 1999, JAMA-J AM MED ASSOC, V282, P1087, DOI 10.1001/jama.282.11.1087; Gilks CF, 1998, J ACQ IMMUN DEF SYND, V18, P234, DOI 10.1097/00042560-199807010-00006; GOVENDER V, 2000, COSTS PERCEIVED QUAL; Harling G, 2007, JAIDS-J ACQ IMM DEF, V45, P348; HASSIG SE, 1990, AIDS, V4, P883, DOI 10.1097/00002030-199009000-00009; Kevany S, 2009, SAMJ S AFR MED J, V99, P320; Leisegang R, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000189; Long L, 2010, AIDS, V24, P915, DOI 10.1097/QAD.0b013e3283360976; Martinson N, 2009, JAIDS-J ACQ IMM DEF, V50, P327, DOI 10.1097/QAI.0b013e3181958546; Massyn N, 2013, DISTRICT HLTH BAROME; Meyer-Rath G, NATL ART COST MODEL; Meyer-Rath G, 2013, JAIDS-J ACQ IMM DEF, V62, P322, DOI 10.1097/QAI.0b013e31827e8785; Meyer-Rath G, 2013, AIDS, V27, P243, DOI 10.1097/QAD.0b013e32835a5b92; Meyer-Rath G, 2012, JAIDS-J ACQ IMM DEF, V61, pE25, DOI 10.1097/QAI.0b013e31826cc575; Pfuntner A., 2013, MOST FREQUENT CONDIT; Rosen S, 2008, TROP MED INT HEALTH, V13, P1005, DOI 10.1111/j.1365-3156.2008.02114.x; Shisana O, 2014, S AFRICAN NATL HIV P; TEMBO G, 1994, AIDS, V8, P1169, DOI 10.1097/00002030-199408000-00021; Thomas LS, 2007, JAIDS-J ACQ IMM DEF, V46, P410, DOI 10.1097/QAI.0b013e318156ec90; UNAIDS, 2014, GAP REP; Walensky RP, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000382; Wilkinson D, 1999, INT J STD AIDS, V10, P735, DOI 10.1258/0956462991913439; Winter J, 2015, ADMITTED PATIENT CAR	30	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0148546	10.1371/journal.pone.0148546	http://dx.doi.org/10.1371/journal.pone.0148546			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26885977	Green Published, Green Submitted, gold			2022-12-26	WOS:000371218400039
J	Szabo-Rogers, H; Yakob, W; Liu, KJ				Szabo-Rogers, Heather; Yakob, Wardati; Liu, Karen J.			Frontal Bone Insufficiency in Gsk3 beta Mutant Mice	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3; EPITHELIAL-MESENCHYMAL TRANSITION; CUBITUS INTERRUPTUS; BETA-CATENIN; CANCER CELLS; NEURAL-TUBE; SKULL VAULT; DIFFERENTIATION; TWIST; MORPHOGENESIS	The development of the mammalian skull is a complex process that requires multiple tissue interactions and a balance of growth and differentiation. Disrupting this balance can lead to changes in the shape and size of skull bones, which can have serious clinical implications. For example, insufficient ossification of the bony elements leads to enlarged anterior fontanelles and reduced mechanical protection of the brain. In this report, we find that loss of Gsk3 beta leads to a fully penetrant reduction of frontal bone size and subsequent enlarged frontal fontanelle. In the absence of Gsk3 beta the frontal bone primordium undergoes increased cell death and reduced proliferation with a concomitant increase in Fgfr2-IIIc and Twist1 expression. This leads to a smaller condensation and premature differentiation. This phenotype appears to be Wnt-independent and is not rescued by decreasing the genetic dose of beta-catenin/Ctnnb1. Taken together, our work defines a novel role for Gsk3 beta in skull development.	[Szabo-Rogers, Heather; Yakob, Wardati; Liu, Karen J.] Kings Coll London, Craniofacial Dev & Stem Cell Biol, Floor 27,Tower Wing,Guys Campus, London SE1 9RT, England; [Szabo-Rogers, Heather] Univ Pittsburgh, Dept Dev Biol, Dept Oral Biol, Ctr Craniofacial Regenerat, Pittsburgh, PA 15261 USA; [Yakob, Wardati] Minist Hlth, Dept Dent Serv, Negara, Brunei	University of London; King's College London; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Liu, KJ (corresponding author), Kings Coll London, Craniofacial Dev & Stem Cell Biol, Floor 27,Tower Wing,Guys Campus, London SE1 9RT, England.	karen.liu@kcl.ac.uk	Liu, Karen/F-2870-2010	Liu, Karen/0000-0002-2483-2165; Szabo-Rogers, Heather/0000-0002-7921-8031	Wellcome Trust [081880/Z/06/Z]; Biotechnology and Biological Sciences Research Council [BB/I021922/1, BB/E013872/1]; BBSRC [BB/I021922/1, BB/E013872/1]; MRC [MR/L017237/1]; Medical Research Council [MR/L017237/1] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Funding for this project was provided to KJL by the Wellcome Trust (081880/Z/06/Z, http://www.wellcome.ac.uk/) and the Biotechnology and Biological Sciences Research Council (BB/I021922/1 and BB/E013872/1, http://www.bbsrc.ac.uk/). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Jacqui Tabler for critical reading of the manuscript. We would also like to thank members of the Liu lab and the Department of Craniofacial Development and Stem Cell Biology for helpful discussions, with particular thanks to Triona Bolger and Jacqui Tabler for their enthusiasm. Funding for this project was provided by the Wellcome Trust (081880/Z/06/Z), the BBSRC (BB/I021922/1 and BB/E013872/1) and the MRC (MR/L017237/1).	Alliman S, 2010, CLIN GENET, V78, P162, DOI 10.1111/j.1399-0004.2010.01373.x; Ashique AM, 2002, INT J DEV BIOL, V46, P243; Barrell WB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050422; Behr B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070240; Bialek P, 2004, DEV CELL, V6, P423, DOI 10.1016/S1534-5807(04)00058-9; Bildsoe H, 2009, DEV BIOL, V331, P176, DOI 10.1016/j.ydbio.2009.04.034; CHEN ZF, 1995, GENE DEV, V9, P686, DOI 10.1101/gad.9.6.686; Connerney J, 2008, DEV BIOL, V318, P323, DOI 10.1016/j.ydbio.2008.03.037; Connerney J, 2006, DEV DYNAM, V235, P1345, DOI 10.1002/dvdy.20717; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; Doble BW, 2007, DEV CELL, V12, P957, DOI 10.1016/j.devcel.2007.04.001; FUCHTBAUER EM, 1995, DEV DYNAM, V204, P316; Gillespie JR, 2013, ENDOCRINOLOGY, V154, P3702, DOI 10.1210/en.2013-1155; Glass DA, 2005, DEV CELL, V8, P751, DOI 10.1016/j.devcel.2005.02.017; Goodnough LH, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004152; Hill TP, 2005, DEV CELL, V8, P727, DOI 10.1016/j.devcel.2005.02.013; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Huelsken J, 2001, CELL, V105, P533, DOI 10.1016/S0092-8674(01)00336-1; Ishii M, 2003, DEVELOPMENT, V130, P6131, DOI 10.1242/dev.00793; Jia JH, 2002, NATURE, V416, P548, DOI 10.1038/nature733; Jiang XB, 2002, DEV BIOL, V241, P106, DOI 10.1006/dbio.2001.0487; Johnson D, 2011, EUR J HUM GENET, V19, P369, DOI 10.1038/ejhg.2010.235; Kerkela R, 2008, J CLIN INVEST, V118, P3609, DOI 10.1172/JCI36245; Kim WY, 2009, NAT NEUROSCI, V12, P1390, DOI 10.1038/nn.2408; Kress W, 2006, EUR J HUM GENET, V14, P39, DOI 10.1038/sj.ejhg.5201507; Kugimiya F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000837; Lander R, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2543; Lewandoski M, 1997, NAT GENET, V17, P223, DOI 10.1038/ng1097-223; Liberman Z, 2005, J BIOL CHEM, V280, P4422, DOI 10.1074/jbc.M410610200; Liu B, 2007, DEV BIOL, V301, P298, DOI 10.1016/j.ydbio.2006.10.018; Liu KJ, 2007, NATURE, V446, P79, DOI 10.1038/nature05557; MacAulay K, 2007, CELL METAB, V6, P329, DOI 10.1016/j.cmet.2007.08.013; Murray SA, 2006, CELL CYCLE, V5, P2566, DOI 10.4161/cc.5.22.3502; Murray SA, 2006, P NATL ACAD SCI USA, V103, P10300, DOI 10.1073/pnas.0602234103; Price MA, 2002, CELL, V108, P823, DOI 10.1016/S0092-8674(02)00664-5; Reimao R, 2003, PEDIATR NEUROL, V29, P341, DOI 10.1016/S0887-8994(03)00279-0; Richtsmeier JT, 2013, ACTA NEUROPATHOL, V125, P469, DOI 10.1007/s00401-013-1104-y; Saito H, 2012, DIS MODEL MECH, V5, P948, DOI 10.1242/dmm.009274; Soo K, 2002, DEV BIOL, V247, P251, DOI 10.1006/dbio.2002.0699; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Stankunas K, 2003, MOL CELL, V12, P1615, DOI 10.1016/S1097-2765(03)00491-X; SUN JK, 1995, RADIOLOGY, V197, P497, DOI 10.1148/radiology.197.2.7480701; Surjit M, 2007, CELL CYCLE, V6, P580, DOI 10.4161/cc.6.5.3899; Szabo-Rogers HL, 2008, DEV BIOL, V318, P289, DOI 10.1016/j.ydbio.2008.03.027; Tabler JM, 2013, DEV CELL, V25, P623, DOI 10.1016/j.devcel.2013.05.021; Thomas BL, 1998, EUR J ORAL SCI, V106, P48, DOI 10.1111/j.1600-0722.1998.tb02153.x; Ting MC, 2009, DEVELOPMENT, V136, P855, DOI 10.1242/dev.028605; Wang Q, 2008, CELL DEATH DIFFER, V15, P908, DOI 10.1038/cdd.2008.2; Winslow MM, 2006, DEV CELL, V10, P771, DOI 10.1016/j.devcel.2006.04.006; WOODGETT JR, 1990, EMBO J, V9, P2431, DOI 10.1002/j.1460-2075.1990.tb07419.x; Wuyts W, 2000, HUM MOL GENET, V9, P1251, DOI 10.1093/hmg/9.8.1251; Yaguchi Y, 2009, DEV DYNAM, V238, P2058, DOI 10.1002/dvdy.22013; Yook JI, 2005, J BIOL CHEM, V280, P11740, DOI 10.1074/jbc.M413878200; Yook JI, 2006, NAT CELL BIOL, V8, P1398, DOI 10.1038/ncb1508; Yoshida Toshiyuki, 2005, Kokubyo Gakkai Zasshi, V72, P19; Yoshida T, 2008, MECH DEVELOP, V125, P797, DOI 10.1016/j.mod.2008.06.007; Yu HMI, 2005, DEVELOPMENT, V132, P1995, DOI 10.1242/dev.01786; Zhou BHP, 2004, NAT CELL BIOL, V6, P931, DOI 10.1038/ncb1173; Zhou XP, 2001, AM J HUM GENET, V69, P704, DOI 10.1086/323703	60	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0149604	10.1371/journal.pone.0149604	http://dx.doi.org/10.1371/journal.pone.0149604			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26886780	Green Published, gold, Green Submitted			2022-12-26	WOS:000371218400100
J	Virlogeux, V; Yang, J; Fang, VJ; Feng, LZ; Tsang, TK; Jiang, H; Wu, P; Zheng, JD; Lau, EHY; Qin, Y; Peng, ZB; Peiris, JSM; Yu, HJ; Cowling, BJ				Virlogeux, Victor; Yang, Juan; Fang, Vicky J.; Feng, Luzhao; Tsang, Tim K.; Jiang, Hui; Wu, Peng; Zheng, Jiandong; Lau, Eric H. Y.; Qin, Ying; Peng, Zhibin; Peiris, J. S. Malik; Yu, Hongjie; Cowling, Benjamin J.			Association between the Severity of Influenza A(H7N9) Virus Infections and Length of the Incubation Period	PLOS ONE			English	Article							ACUTE RESPIRATORY SYNDROME; A H7N9; CORONAVIRUS	Background In early 2013, a novel avian-origin influenza A(H7N9) virus emerged in China, and has caused sporadic human infections. The incubation period is the delay from infection until onset of symptoms, and varies from person to person. Few previous studies have examined whether the duration of the incubation period correlates with subsequent disease severity. Methods and Findings We analyzed data of period of exposure on 395 human cases of laboratory-confirmed influenza A(H7N9) virus infection in China in a Bayesian framework using a Weibull distribution. We found a longer incubation period for the 173 fatal cases with a mean of 3.7 days (95% credibility interval, CrI: 3.4-4.1), compared to a mean of 3.3 days (95% CrI: 2.9-3.6) for the 222 non-fatal cases, and the difference in means was marginally significant at 0.47 days (95% CrI: -0.04, 0.99). There was a statistically significant correlation between a longer incubation period and an increased risk of death after adjustment for age, sex, geographical location and underlying medical conditions (adjusted odds ratio 1.70 per day increase in incubation period; 95% credibility interval 1.47-1.97). Conclusions We found a significant association between a longer incubation period and a greater risk of death among human H7N9 cases. The underlying biological mechanisms leading to this association deserve further exploration.	[Virlogeux, Victor] Ecole Normale Super Lyon, Dept Biol, 15 Parvis Rene Descartes, F-69007 Lyon, France; [Virlogeux, Victor; Fang, Vicky J.; Tsang, Tim K.; Wu, Peng; Lau, Eric H. Y.; Peiris, J. S. Malik; Cowling, Benjamin J.] Univ Hong Kong, Sch Publ Hlth, Li Ka Shing Fac Med, WHO Collaborating Ctr Infect Dis Epidemiol & Cont, 21 Sassoon Rd, Hong Kong, Hong Kong, Peoples R China; [Yang, Juan; Feng, Luzhao; Jiang, Hui; Zheng, Jiandong; Qin, Ying; Peng, Zhibin; Yu, Hongjie] Chinese Ctr Dis Control & Prevent, Div Infect Dis, Key Lab Surveillance & Early Warning Infect Dis, 155 Changbai Rd, Beijing 102206, Peoples R China	Ecole Normale Superieure de Lyon (ENS de LYON); University of Hong Kong; World Health Organization; Chinese Center for Disease Control & Prevention	Yu, HJ (corresponding author), Chinese Ctr Dis Control & Prevent, Div Infect Dis, Key Lab Surveillance & Early Warning Infect Dis, 155 Changbai Rd, Beijing 102206, Peoples R China.	yuhj@chinacdc.cn	Cowling, Benjamin John/C-4263-2009; Yu, Hongjie/GZK-5351-2022; Lau, Eric/AAJ-6588-2021; Peiris, Joseph Sriyal Malik/C-4380-2009	Cowling, Benjamin John/0000-0002-6297-7154; Lau, Eric/0000-0002-6688-9637; Tsang, Tim Kam Lun/0000-0001-5037-6776; Wu, Peng/0000-0003-1157-9401; Peiris, Joseph Sriyal Malik/0000-0001-8217-5995; Yang, Juan/0000-0001-5028-2227	Ministry of Science and Technology of China [2014BAI13B05]; US National Institutes of Health [U19 AI51915]; Program for Changjiang Scholars, Ministry of Education of the People's Republic of China; Harvard Center for Communicable Disease Dynamics from the National Institute of General Medical Sciences [U54 GM088558]; Health and Medical Research Fund of the Health, Welfare and Food Bureau of the Hong Kong SAR Government; Research Grants Council of the Hong Kong Special Administrative Region, China [T11-705/14N];  [81525023]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI051915] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM088558] Funding Source: NIH RePORTER	Ministry of Science and Technology of China(Ministry of Science and Technology, China); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Program for Changjiang Scholars, Ministry of Education of the People's Republic of China; Harvard Center for Communicable Disease Dynamics from the National Institute of General Medical Sciences; Health and Medical Research Fund of the Health, Welfare and Food Bureau of the Hong Kong SAR Government; Research Grants Council of the Hong Kong Special Administrative Region, China(Hong Kong Research Grants Council); ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was funded by grants from the Ministry of Science and Technology of China (2014BAI13B05)(http://www.most.gov.cn/eng/) (HJY), the US National Institutes of Health (Comprehensive International Program for Research on AIDS grant U19 AI51915) (http://nih.gov/)(HJY), Distinguished Young Scholars (81525023)(http://www.nsfc.gov.cn/publish/portal1/) (HJY), Program for Changjiang Scholars, Ministry of Education of the People's Republic of China (http://en.moe.gov.cn/)(HJY), the Harvard Center for Communicable Disease Dynamics from the National Institute of General Medical Sciences (grant no. U54 GM088558)(http://www.nigms.nih.gov/Pages/default.aspx)(BJC), a commissioned grant from the Health and Medical Research Fund of the Health, Welfare and Food Bureau of the Hong Kong SAR Government (http://rfs1.fhb.gov.hk/), and the Research Grants Council of the Hong Kong Special Administrative Region (http://www.ugc.edu.hk/eng/rgc/index.htm), China (Project No. T11-705/14N) (BJC). The funding bodies had no role in study design, data collection and analysis, preparation of the manuscript, or the decision to publish.	Chen Y, 2013, LANCET, V381, P1916, DOI 10.1016/S0140-6736(13)60903-4; Cowling BJ, 2007, EPIDEMIOLOGY, V18, P253, DOI 10.1097/01.ede.0000254660.07942.fb; Cowling BJ, 2013, LANCET, V382, P129, DOI 10.1016/S0140-6736(13)61171-X; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; de Wilde AH, 2013, J GEN VIROL, V94, P1749, DOI 10.1099/vir.0.052910-0; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Ho MS, 2005, EMERG INFECT DIS, V11, P1730, DOI 10.3201/eid1111.040659; Hui DS, 2014, CURR OPIN PULM MED, V20, P233, DOI 10.1097/MCP.0000000000000046; Josset L, 2013, MBIO, V4, DOI 10.1128/mBio.00165-13; Kindler E, 2013, MBIO, V4, DOI 10.1128/mBio.00611-12; Kopecky-Bromberg SA, 2007, J VIROL, V81, P548, DOI 10.1128/JVI.01782-06; Lessler J, 2009, LANCET INFECT DIS, V9, P291, DOI 10.1016/S1473-3099(09)70069-6; Meliopoulos VA, 2014, J VIROL, V88, P12982, DOI 10.1128/JVI.01571-14; MOSER MR, 1979, AM J EPIDEMIOL, V110, P1; Peiris M, 2006, NOVART FDN SYMP, V279, P60; Peiris M, 2006, NOVART FDN SYMP, V279, P216; Peiris Malik, 2006, Novartis Found Symp, V279, P56; van den Brand JMA, 2015, J PATHOL, V235, P175, DOI 10.1002/path.4458; Virlogeux V, 2016, EMERG INFECT DIS, V22, P526, DOI 10.3201/eid2203.151437; Virlogeux V, 2015, AM J EPIDEMIOL, V182, P723, DOI 10.1093/aje/kwv115; Virlogeux V, 2015, EPIDEMIOLOGY, V26, P666, DOI 10.1097/EDE.0000000000000339; Zielecki F, 2013, J VIROL, V87, P5300, DOI 10.1128/JVI.03496-12	22	11	11	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0148506	10.1371/journal.pone.0148506	http://dx.doi.org/10.1371/journal.pone.0148506			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26885816	Green Published, gold			2022-12-26	WOS:000371218400038
J	Hu, XG; Liu, H; Jin, YQ; Sun, YQ; Li, Y; Zhao, W; El-Kassaby, YA; Wang, XR; Mao, JF				Hu, Xian-Ge; Liu, Hui; Jin, YuQing; Sun, Yan-Qiang; Li, Yue; Zhao, Wei; El-Kassaby, Yousry A.; Wang, Xiao-Ru; Mao, Jian-Feng			De Novo Transcriptome Assembly and Characterization for the Widespread and Stress-Tolerant Conifer Platycladus orientalis	PLOS ONE			English	Article							PICEA-GLAUCA GENOME; TERPENE SYNTHASES; RNA-SEQ; INTERIOR SPRUCE; SSR MARKERS; GENE FAMILY; TOOL; EVOLUTION; SELECTION; KEGG	Platycladus orientalis, of the family Cupressaceae, is a widespread conifer throughout China and is extensively used for ecological reforestation, horticulture, and in medicine. Transcriptome assemblies are required for this ecologically important conifer for understanding genes underpinning adaptation and complex traits for breeding programs. To enrich the species' genomic resources, a de novo transcriptome sequencing was performed using Illumina paired-end sequencing. In total, 104,073,506 high quality sequence reads (approximately 10.3 Gbp) were obtained, which were assembled into 228,948 transcripts and 148,867 unigenes that were longer than 200 nt. Quality assessment using CEGMA showed that the transcriptomes obtained were mostly complete for highly conserved core eukaryotic genes. Based on similarity searches with known proteins, 62,938 (42.28% of all unigenes), 42,158 (28.32%), and 23,179 (15.57%) had homologs in the Nr, GO, and KOG databases, 25,625 (17.21%) unigenes were mapped to 322 pathways by BLASTX comparison against the KEGG database and 1,941 unigenes involved in environmental signaling and stress response were identified. We also identified 43 putative terpene synthase (TPS) functional genes loci and compared them with TPSs from other species. Additionally, 5,296 simple sequence repeats (SSRs) were identified in 4,715 unigenes, which were assigned to 142 motif types. This is the first report of a complete transcriptome analysis of P. orientalis. These resources provide a foundation for further studies of adaptation mechanisms and molecular-based breeding programs.	[Hu, Xian-Ge; Liu, Hui; Jin, YuQing; Sun, Yan-Qiang; Li, Yue; Zhao, Wei; Wang, Xiao-Ru; Mao, Jian-Feng] Beijing Forestry Univ, Natl Engn Lab Tree Breeding, Key Lab Genet & Breeding Forest Trees & Ornamenta, Minist Educ,Coll Biol Sci & Technol, Beijing, Peoples R China; [Zhao, Wei; Wang, Xiao-Ru] Umea Univ, Dept Ecol & Environm Sci, Umea, Sweden; [El-Kassaby, Yousry A.] Univ British Columbia, Fac Forestry, Dept Forest & Conservat Sci, Vancouver, BC V6T 1W5, Canada	Beijing Forestry University; Umea University; University of British Columbia	Mao, JF (corresponding author), Beijing Forestry Univ, Natl Engn Lab Tree Breeding, Key Lab Genet & Breeding Forest Trees & Ornamenta, Minist Educ,Coll Biol Sci & Technol, Beijing, Peoples R China.	jianfeng.mao@bjfu.edu.cn	El-Kassaby, Yousry A/K-9856-2016; Mao, Jian-Feng/V-9251-2019; LIU, HUI/AAN-5354-2021; Wang, Xiao-Ru/AAC-4444-2020; Wang, Xiao-Ru/H-6811-2012	El-Kassaby, Yousry A/0000-0002-4887-8977; Mao, Jian-Feng/0000-0001-9735-8516; Wang, Xiao-Ru/0000-0002-6150-7046; Wang, Xiao-Ru/0000-0002-6150-7046; Liu, Hui/0000-0003-1980-5952	Fundamental Research Funds for the Central Universities [YX2013-41]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	Funding provided by Fundamental Research Funds for the Central Universities (NO. YX2013-41). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews S., 2010, FASTQC QUALITY CONTR; Aubourg S, 2002, MOL GENET GENOMICS, V267, P730, DOI 10.1007/s00438-002-0709-y; Birol I, 2013, BIOINFORMATICS, V29, P1492, DOI 10.1093/bioinformatics/btt178; Bohlmann J, 1998, P NATL ACAD SCI USA, V95, P4126, DOI 10.1073/pnas.95.8.4126; Chen F, 2011, PLANT J, V66, P212, DOI 10.1111/j.1365-313X.2011.04520.x; Chen X. W., 2010, Journal of Sustainable Forestry, V29, P1, DOI 10.1080/10549810903463346; Cheng J-Q, 1992, CHINESE WOODY PLANTS; CHU JM, 2012, J METEOROLOGY ENV, V28, P15; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Dong T. M., 1990, PLATYCLADUS ORIENTAL; Dudareva N, 2003, PLANT CELL, V15, P1227, DOI 10.1105/tpc.011015; El-Dien OG, GENES GENOM IN PRESS; El-Dien OG, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1597-y; El-Kassaby YA, 2012, NEW FOREST, V43, P631, DOI 10.1007/s11056-012-9338-4; El-Kassaby YA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025737; El-Kassaby YA, 2009, GENET RES, V91, P111, DOI 10.1017/S001667230900007X; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Irmisch S, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0270-y; Jiang P, 2009, J SHIHEZI U NATURAL, V27, P30; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Kulheim C, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1598-x; Kuwahara K, 2014, PLANT GENET RESOUR-C, V12, P185, DOI 10.1017/S1479262113000464; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li Xin-ping, 2011, Forest Research, V24, P91; Luikart G, 2003, NAT REV GENET, V4, P981, DOI 10.1038/nrg1226; Luo W-X, 1988, SHAANXI FOREST SCI T, V16, P1; Martin DM, 2004, PLANT PHYSIOL, V135, P1908, DOI 10.1104/pp.104.042028; Meglecz E, 2014, MOL ECOL RESOUR, V14, P1302, DOI 10.1111/1755-0998.12271; Neale DB, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r59; Noormohammadi Z, 2014, SCI HORTIC-AMSTERDAM, V178, P175, DOI 10.1016/j.scienta.2014.08.002; Nystedt B, 2013, NATURE, V497, P579, DOI 10.1038/nature12211; [潘宪伟 Pan Xianwei], 2012, [中草药, Chinese Traditional and Herbal Drugs], V43, P1641; Parra G, 2007, BIOINFORMATICS, V23, P1061, DOI 10.1093/bioinformatics/btm071; Parra G, 2009, NUCLEIC ACIDS RES, V37, P289, DOI 10.1093/nar/gkn916; Proost S, 2009, PLANT CELL, V21, P3718, DOI 10.1105/tpc.109.071506; Qiao F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106900; Rambaut A, 2009, FIGTREE V1 3 1; Ratcliffe B, 2015, HEREDITY, V115, P547, DOI 10.1038/hdy.2015.57; Shi X-B, 1987, FOREST SCI TECHNOLOG, V7, P15; Silva RA, 2014, AUSTRALAS PLANT PATH, V43, P89, DOI 10.1007/s13313-013-0249-4; Temnykh S, 2001, GENOME RES, V11, P1441, DOI 10.1101/gr.184001; Van Bel M, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-12-r134; W-Y Shi, 1986, J BEIJING FORESTRY U, V8, P74; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Warren RL, 2015, PLANT J, V83, P189, DOI 10.1111/tpj.12886; Wilhelm BT, 2008, NATURE, V453, P1239, DOI 10.1038/nature07002; Wu TD, 2005, BIOINFORMATICS, V21, P1859, DOI 10.1093/bioinformatics/bti310; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; [张俊飞 Zhang Junfei], 2013, [时珍国医国药, Lishizhen Medicine and Materia Medica Research], V24, P2231; Zhang YJ, 2014, G3-GENES GENOM GENET, V4, P851, DOI 10.1534/g3.113.009779	54	38	38	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0148985	10.1371/journal.pone.0148985	http://dx.doi.org/10.1371/journal.pone.0148985			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	26881995	Green Published, Green Submitted, gold			2022-12-26	WOS:000371219000040
J	Kaur, K; Jansen, PA; Aspehaug, VT; Horsberg, TE				Kaur, Kiranpreet; Jansen, Peder Andreas; Aspehaug, Vidar Teis; Horsberg, Tor Einar			Phe362Tyr in AChE: A Major Factor Responsible for Azamethiphos Resistance in Lepeophtheirus salmonis in Norway	PLOS ONE			English	Article							INSECTICIDE RESISTANCE; SEA LICE; MUTATIONS; BIOASSAY	Organophosphates (OP) are one of the major treatments used against the salmon louse (Lepeophtherius salmonis) in Norwegian salmonid aquaculture. The use of OP since the late 1970s has resulted in widespread resistant parasites. Recently, we reported a single mutation (Phe362Tyr) in acetylcholinesterase (AChE) as the major mechanism behind resistance in salmon louse towards OP. The present study was carried out to validate this mechanism at the field level. A total of 6658 salmon louse samples were enrolled from 56 different fish farms across the Norwegian coast, from Vest Agder in the south to Finnmark in the north. All the samples were genotyped using a TaqMan probe assay for the Phe362Tyr mutation. A strong association was observed between areas with frequent use of the OP (azamethiphos) and the Phe362Tyr mutation. This was confirmed at 15 sites where results from independently conducted bioassays and genotyping of parasites correlated well. Furthermore, genotyping of surviving and moribund parasites from six bioassay experiments demonstrated a highly significant negative correlation between the frequency of resistance alleles and the probability of dying when exposed to azamethiphos in a bioassay. Based on these observations, we could strongly conclude that the Phe362Tyr mutation is a major factor responsible for OP resistance in salmon louse on Norwegian fish farms.	[Kaur, Kiranpreet; Horsberg, Tor Einar] NMBU Sch Vet Sci, Sea Lice Res Ctr, POB 8146 Dept, NO-0033 Oslo, Norway; [Jansen, Peder Andreas] Norwegian Vet Inst, Pb 750, N-0106 Oslo, Norway; [Aspehaug, Vidar Teis] PatoGen Anal AS, Postboks 1527, N-6025 Alesund, Norway	Norwegian University of Life Sciences; Norwegian Veterinary Institute	Kaur, K (corresponding author), NMBU Sch Vet Sci, Sea Lice Res Ctr, POB 8146 Dept, NO-0033 Oslo, Norway.	kiran.kaur@nmbu.no	Kaur, Kiran/R-3535-2018	Kaur, Kiran/0000-0002-7285-5513	Norwegian Research Council through the centre for Innovation Sea Lice Research Centre [NFR 203513/O30]	Norwegian Research Council through the centre for Innovation Sea Lice Research Centre	The study was financially supported by the Norwegian Research Council through the centre for Innovation Sea Lice Research Centre, grant number NFR 203513/O30. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This funding organisation did not play any role in the study design, data collection and analysis, decision to publish or preparation of the manuscript and provided only financial support in the form of salaries to Kiranpreet Kaur and Tor Einar Horsberg. The specific roles of all the authors are articulated in the 'author contributions' section. One of the authors of the study is from a commercial company called PatoGen Analyse AS, who contributed in sample collection, running of TaqMan Probe assay and compilation of data for analysis. Moreover, this author did not play any role in the study design, statistical data analysis or the decision to publish.	Aaen SM, 2015, TRENDS PARASITOL, V31, P72, DOI 10.1016/j.pt.2014.12.006; Bass C, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-51; Cleveland W. S., 1992, LOCAL REGRESSION MOD, DOI 10.1201/9780203738535; Denholm I, 2002, PEST MANAG SCI, V58, P528, DOI 10.1002/ps.482; Dohoo I., 2003, VET EPIDEMIOLOGY RES; Grave K, 2004, DIS AQUAT ORGAN, V60, P123, DOI 10.3354/dao060123; GRAVE K, 1991, ACTA VET SCAND, V32, P1; Grontvedt RN, 2015, ANN REPORT 2014 NORW; Helgesen KO, 2014, J FISH DIS, V37, P877, DOI 10.1111/jfd.12223; Helgesen KO, 2013, J FISH DIS, V36, P261, DOI 10.1111/jfd.12053; Hotelier T, 2010, J PESTIC SCI, V35, P315, DOI 10.1584/jpestics.R10-10; Jansen PA, 2015, PLOS ONE UNPUB; Kaur K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125362; Kaur K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124220; Kristoffersen AB, 2013, PREV VET MED, V109, P136, DOI 10.1016/j.prevetmed.2012.08.012; Naerings og fiskeridepartementet, FORSKR BEKJ LAKS AKV; R Core Team, 2020, R LANG ENV STAT COMP; Shi MA, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-5; Weill M, 2003, NATURE, V423, P136, DOI 10.1038/423136b	19	21	21	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0149264	10.1371/journal.pone.0149264	http://dx.doi.org/10.1371/journal.pone.0149264			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	26882536	gold, Green Published, Green Submitted, Green Accepted			2022-12-26	WOS:000371219000064
J	Li, F; Shen, KX; Long, XL; Wen, JS; Xie, XJ; Zeng, XY; Liang, YY; Wei, YS; Lin, ZF; Huang, WR; Zhong, RD				Li, Feng; Shen, Kaixuan; Long, Xiaolin; Wen, Jiasheng; Xie, Xiaojie; Zeng, Xiangyun; Liang, Yanyan; Wei, Yansha; Lin, Zefeng; Huang, Wenrou; Zhong, Ruida			Preparation and Characterization of Biochars from Eichornia crassipes for Cadmium Removal in Aqueous Solutions	PLOS ONE			English	Article							POTENTIAL USE; IMPACT; MECHANISMS; IMMOBILIZATION; ADSORPTION; PERTINENT; CU(II); CD(II); WATER	The study investigated the preparation and characterization of biochars from water hyacinth at 300 degrees C to 700 degrees C for cadmium (Cd) removal from aqueous solutions. The adsorption process was dominated by oxygen-containing functional groups with irregular surfaces via esterification reactions. Furthermore, the mineral components in the biochars also contributed to Cd absorption through precipitation. Parameters such as the effects of solution pH, contact time, and initial concentration were studied. The optimum pH value was observed at 5.0, in which nearly 90% of Cd was removed. The maximum Cd adsorption capacities based on the Langmuir isotherm were calculated at 49.837, 36.899, and 25.826 mg g(-1). The adsorption processes of the biochars followed the pseudo-second-order kinetics, with the equilibrium achieved around 5 h. The biochar from E. crassipes is a promising adsorbent for the treatment of wastewater, which can in turn convert one environmental problem to a new cleaning Technology.	[Li, Feng; Shen, Kaixuan; Long, Xiaolin; Wen, Jiasheng; Xie, Xiaojie; Zeng, Xiangyun; Liang, Yanyan; Wei, Yansha; Lin, Zefeng; Huang, Wenrou; Zhong, Ruida] S China Univ Technol, Sch Civil Engn, Guangzhou 510640, Guangdong, Peoples R China; [Li, Feng] S China Univ Technol, State Key Lab Subtrop Bldg Sci, Guangzhou 510640, Guangdong, Peoples R China	South China University of Technology; South China University of Technology	Li, F (corresponding author), S China Univ Technol, Sch Civil Engn, Guangzhou 510640, Guangdong, Peoples R China.; Li, F (corresponding author), S China Univ Technol, State Key Lab Subtrop Bldg Sci, Guangzhou 510640, Guangdong, Peoples R China.	hjlifeng@scut.edu.cn			China Geological Survey [1212010914020]; National Natural Science Foundation of China [41001341]; Fundamental Research Funds for the Central Universities [2014ZZ0012]; National Natural Science Foundation of China (NSFC); Fundamental Research Funds for the Central Universities (FRFC); Ministry of Education; South China University of Technology; Guangdong Province [2012B091100143, 2013B090500022]; China Ministry of education [2012B091100143, 2013B090500022]; Science and Technology Planning Project of Dongguan City [2014108101042]; Baibuti Project of SCUT [DA20315001]; Student Research Project of SCUT [105612015S586]	China Geological Survey(China Geological Survey); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities (FRFC); Ministry of Education; South China University of Technology; Guangdong Province; China Ministry of education(Ministry of Education, China); Science and Technology Planning Project of Dongguan City; Baibuti Project of SCUT; Student Research Project of SCUT	This study was founded by the projects of China Geological Survey (Grant No. 1212010914020), National Natural Science Foundation of China (Grant No. 41001341), and the Fundamental Research Funds for the Central Universities (Grant No. 2014ZZ0012). National Natural Science Foundation of China (NSFC) is the most important funding agency of creative basic research. The URL of NSFC's web site is (http://www.nsfc.gov.cn/Portal0/default152.htm). The Fundamental Research Funds for the Central Universities (FRFC) has established by state educational ministry of china, and the main goal is to support the basic research. Research funds of FRFC are allocated by central universities (That is, the universities directly under the Ministry of Education, including South China University of Technology). The URL of web sites related to FRFC: The department of science & technology, Ministry of Education of the People's Republic of China (http://www.dost.moe.edu.cn/dostmoe) (http://www.dost.moe.edu.cn/dostmoe/tzgg/zxtz/20120416112009). The department of science & technology, South China University of Technology (http://www2.scut.edu.cn/science) (http://www2.scut.edu.cn/s/41/t/18/51/71/info86385.htm). The projects of China Geological Survey (http://www.cgs.gov.cn/gzdt/gzdongtai/19910.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r This study was funded by the projects of National Natural Science Foundation of China (Grant No.41001341), the Fundamental Research Funds for the Central Universities (Grant No. 2014ZZ0012), the joint funding research project by Guangdong Province and China Ministry of education (Grant No. 2012B091100143, 2013B090500022), Science and Technology Planning Project of Dongguan City (2014108101042), Baibuti Project of SCUT (DA20315001), and Student Research Project of SCUT (105612015S586)	Atkinson CJ, 2010, PLANT SOIL, V337, P1, DOI 10.1007/s11104-010-0464-5; Beesley L, 2011, ENVIRON POLLUT, V159, P474, DOI 10.1016/j.envpol.2010.10.016; Cantrell KB, 2012, BIORESOURCE TECHNOL, V107, P419, DOI 10.1016/j.biortech.2011.11.084; Cao XD, 2010, BIORESOURCE TECHNOL, V101, P5222, DOI 10.1016/j.biortech.2010.02.052; Chen T, 2015, CHEMOSPHERE, V134, P286, DOI 10.1016/j.chemosphere.2015.04.052; Dong XL, 2011, J HAZARD MATER, V190, P909, DOI 10.1016/j.jhazmat.2011.04.008; Gai XP, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0113888, 10.1371/journal.pone.0097730]; Gilbert UA, 2011, BIOMASS BIOENERG, V35, P2517, DOI 10.1016/j.biombioe.2011.02.024; Gurwick NP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075932; Ho YS, 2006, BIOCHEM ENG J, V30, P117, DOI 10.1016/j.bej.2006.02.012; Lehmann J, 2009, EARTHSCAN, DOI [10.4324/9780203762264, DOI 10.4324/9780203762264]; Liu ZG, 2009, J HAZARD MATER, V167, P933, DOI 10.1016/j.jhazmat.2009.01.085; Masto RE, 2013, CATENA, V111, P64, DOI 10.1016/j.catena.2013.06.025; Meng J, 2014, ENVIRON SCI POLLUT R, V21, P7035, DOI 10.1007/s11356-014-2627-z; Mohan D, 2014, BIORESOURCE TECHNOL, V160, P191, DOI 10.1016/j.biortech.2014.01.120; Mohan D, 2014, CHEM ENG J, V236, P513, DOI 10.1016/j.cej.2013.09.057; Patel S, 2012, REV ENVIRON SCI BIO, V11, P249, DOI 10.1007/s11157-012-9289-4; Roh H, 2015, J IND ENG CHEM, V26, P226, DOI 10.1016/j.jiec.2014.11.034; Ruiz Tellez T., 2008, Aquatic Invasions, V3, P42, DOI 10.3391/ai.2008.3.1.8; Su Q, 2010, J COLLOID INTERF SCI, V349, P607, DOI 10.1016/j.jcis.2010.05.052; Sun K, 2013, ENVIRON SCI TECHNOL, V47, P11473, DOI 10.1021/es4026744; Tan XF, 2015, ENVIRON SCI POLLUT R, V22, P12597, DOI 10.1007/s11356-015-4523-6; Tsai WT, 2012, CHEMOSPHERE, V89, P198, DOI 10.1016/j.chemosphere.2012.05.085; Uchimiya M, 2010, J AGR FOOD CHEM, V58, P5538, DOI 10.1021/jf9044217; Wang HY, 2015, BIORESOURCE TECHNOL, V197, P356, DOI 10.1016/j.biortech.2015.08.132; Xu XY, 2013, ENVIRON SCI POLLUT R, V20, P358, DOI 10.1007/s11356-012-0873-5	26	46	49	1	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0148132	10.1371/journal.pone.0148132	http://dx.doi.org/10.1371/journal.pone.0148132			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	26882239	Green Published, Green Submitted, gold			2022-12-26	WOS:000371219000012
J	Prazuck, T; Karon, S; Gubavu, C; Andre, J; Legall, JM; Bouvet, E; Kreplak, G; Teglas, JP; Pialoux, G				Prazuck, Thierry; Karon, Stephen; Gubavu, Camelia; Andre, Jerome; Legall, Jean Marie; Bouvet, Elisabeth; Kreplak, Georges; Teglas, Jean Paul; Pialoux, Gilles			A Finger-Stick Whole-Blood HIV Self-Test as an HIV Screening Tool Adapted to the General Public	PLOS ONE			English	Article							COLLECTION; INFECTION; POLICY; RISK	Background In 2013, the French Health Authority approved the use of HIV self-tests in pharmacies for the general public. This screening tool will allow an increase in the number of screenings and a reduction in the delay between infection and diagnosis, thus reducing the risk of further infections. We previously compared 5 HIV-self test candidates (4 oral fluid and one whole blood) and demonstrated that the whole blood HIV test exhibited the optimal level of performance (sensitivity/specificity). We studied the practicability of an easy-to-use finger-stick whole blood HIV self-test "autotest VIH (R)", when used in the general public. Methods and Materials This multicenter cross-sectional study involved 411 participants from the Parisian region (AIDES and HF association) between April and July 2014 and was divided into 2 separate studies: one evaluating the capability of participants to obtain an interpretable result using only the information notice, and a second evaluating the interpretation of test results, using a provided chart. Results A total of 411 consenting participants, 264 in the first study and 147 in the second, were included. All participants were over 18 years of age. In the first study, 99.2% of the 264 participants correctly administered the auto-test, and 21.2% needed, upon their request, telephone assistance. Ninety-two percent of participants responded that the test was easy/very easy to perform, and 93.5% did not find any difficulty obtaining a sufficient good quantity of blood. In the second study, 98.1% of the 147 participants correctly interpreted the results. The reading/interpretation errors concerned the negative (2.1%) or the indeterminate (3.3%) auto-tests. Conclusions The success rate of handling and interpretation of this self-test is very satisfactory, demonstrating its potential for use by the general public and its utility to increase the number of opportunities to detect HIV patients.	[Prazuck, Thierry; Karon, Stephen; Gubavu, Camelia] Ctr Hosp Reg, Dept Infect Dis, Orleans, France; [Andre, Jerome] HF Prevent, Trappes, France; [Legall, Jean Marie] Aides, Paris, France; [Bouvet, Elisabeth] Hop Univ Bichat Claude Bernard, Dept Infect Dis, Paris, France; [Kreplak, Georges] CBCV, Paris, France; [Teglas, Jean Paul] Hop Kremlin Bicetre, INSERM, INED, U822, Le Kremlin Bicetre, France; [Pialoux, Gilles] Hop Tenon, Dept Infect Dis, F-75970 Paris, France	Centre Hospitalier Annecy Genevois; Centre Hospitalier Regional d'Orleans; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite	Prazuck, T (corresponding author), Ctr Hosp Reg, Dept Infect Dis, Orleans, France.	thierry.prazuck@chr-orleans.fr			CHR Orleans	CHR Orleans	The study was sponsored by the public hospital (CHR Orleans) without a grant from pharmaceutical companies. No grant was received from the HIV test manufacturer.	[Anonymous], CMAJ, V162, P1545; [Anonymous], INF REG HOM ACC HIV; [Anonymous], CMAJ, V162, P1547; Cazein F, 2014, B EPIDEMIOLOGIQUE HE, V9-10, P154; Colfax GN, 2002, AIDS CARE, V14, P675, DOI 10.1080/0954012021000005533a; Conseil national du sida, 2012, AV AUT DEP INF VIH; Delpierre C, 2006, AIDS PATIENT CARE ST, V20, P838, DOI 10.1089/apc.2006.20.838; Figueroa C, 2015, AIDS BEHAV; Frith L, 2007, LANCET, V369, P243, DOI 10.1016/S0140-6736(07)60113-5; Jaspard M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101148; Katz D, 2012, C RETR OPP INF CROI; Krause J, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-735; Mayer K., 2014, AIDS 2014; Ochako R, 2014, INSIGHTS POTENTIAL U; Pai NP, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001414; Pai NP, 2012, LANCET INFECT DIS, V12, P373, DOI 10.1016/S1473-3099(11)70368-1; Peck RB, 2014, AIDS BEHAV, V18, pS422, DOI 10.1007/s10461-014-0818-8; Richter ML, 2012, S AFR J HIV MED, P186, DOI 10.7196/SAJHIVMED.858; Spielberg F, 2004, LANCET INFECT DIS, V4, P640, DOI 10.1016/S1473-3099(04)01150-8; Spielberg F, 2001, SEX TRANSM DIS, V28, P51, DOI 10.1097/00007435-200101000-00012	20	25	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0146755	10.1371/journal.pone.0146755	http://dx.doi.org/10.1371/journal.pone.0146755			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	26882229	Green Submitted, Green Published, gold			2022-12-26	WOS:000371219000002
J	Stelmach, P; Wedemeyer, C; Fuest, L; Kurscheid, G; Gehrke, T; Klenke, S; Jager, M; Kauther, MD; Bachmann, HS				Stelmach, Patrick; Wedemeyer, Christian; Fuest, Lena; Kurscheid, Gina; Gehrke, Thorsten; Klenke, Stefanie; Jaeger, Marcus; Kauther, Max D.; Bachmann, Hagen S.			The BCL2-938C > A Promoter Polymorphism Is Associated with Risk for and Time to Aseptic Loosening of Total Hip Arthroplasty	PLOS ONE			English	Article							GENETIC SUSCEPTIBILITY; CC GENOTYPE; BCL2; -938C-GREATER-THAN-A; APOPTOSIS; REPLACEMENT; MEMBRANE; PATHWAYS; SURVIVAL; OUTCOMES	Aseptic loosening is a major cause of revision surgery of total hip arthroplasty (THA). Only few host factors affecting aseptic loosening have been identified until now, although they are urgently needed to identify and possibly treat those patients at higher risk for aseptic loosening. To determine whether the functional single nucleotide polymorphism (SNP) c.-938C>A (rs2279115), located in the promoter region of the BCL2 gene has an impact on aseptic loosening of THA we genotyped and analyzed 234 patients suffering from aseptic loosening and 231 patients after primary THA. The polymorphism is associated with risk for aseptic loosening with the CC genotype at highest risk for aseptic loosening, Odds Ratio CC vs. AA 1.93, 95%CI 1.15-3.25, p = 0.013. In contrast, low risk AA genotype carriers that still developed aseptic loosening showed a significantly shorter time to aseptic loosening than patients carrying the C allele (p = 0.004). These results indicate that the BCL2 -938C>A polymorphism influences the occurrence and course of aseptic loosening and suggests this polymorphism as an interesting candidate for prospective studies and analyses in THA registers.	[Stelmach, Patrick; Fuest, Lena; Kurscheid, Gina; Klenke, Stefanie; Bachmann, Hagen S.] Univ Hosp Essen, Inst Pharmacogenet, Essen, Germany; [Wedemeyer, Christian; Fuest, Lena; Kurscheid, Gina; Jaeger, Marcus; Kauther, Max D.] Univ Hosp Essen, Dept Orthopaed & Trauma Surg, Essen, Germany; [Gehrke, Thorsten] Helios ENDO Klin, Dept Joint Surg, Hamburg, Germany; [Klenke, Stefanie] Univ Hosp Essen, Dept Anaesthesiol & Intens Care, Essen, Germany	University of Duisburg Essen; University of Duisburg Essen; University of Duisburg Essen	Bachmann, HS (corresponding author), Univ Hosp Essen, Inst Pharmacogenet, Essen, Germany.	hagen.bachmann@uk-essen.de		Jager, Marcus/0000-0001-9516-1058	German Research Foundation (DFG), Bonn, Germany [WE 3634/1-2]	German Research Foundation (DFG), Bonn, Germany(German Research Foundation (DFG))	The study was supported by the German Research Foundation (DFG), Bonn, Germany (WE 3634/1-2) www.dfg.de. The funder has no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelani MA, 2014, CLIN ORTHOP RELAT R, V472, P1518, DOI 10.1007/s11999-013-3377-9; Bachmann HS, 2007, CLIN CANCER RES, V13, P5790, DOI 10.1158/1078-0432.CCR-06-2673; Bachmann HS, 2011, INT J CANCER, V129, P2390, DOI 10.1002/ijc.25904; Bachmann HS, 2003, PHARMACOGENETICS, V13, P759, DOI 10.1097/00008571-200312000-00006; Cherian J. J., 2015, CLIN ORTHOP RELAT RE; Del Buono A, 2012, BRIT MED BULL, V101, P39, DOI 10.1093/bmb/ldr011; Dorjgochoo T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060915; El Hindy N, 2011, J NEUROSURG, V114, P1631, DOI 10.3171/2010.12.JNS10478; Gallo J, 2014, ACTA BIOMATER, V10, P2354, DOI 10.1016/j.actbio.2014.02.003; Gorenoi Vitali, 2009, GMS Health Technol Assess, V5, pDoc13, DOI 10.3205/hta000075; Greenfield EM, 2014, CLIN ORTHOP RELAT R, V472, P3709, DOI 10.1007/s11999-014-3786-4; Huk OL, 2001, J MATER SCI-MATER M, V12, P653, DOI 10.1023/A:1011254029864; Javid J, 2015, CLIN TRANSL ONCOL, V17, P289, DOI 10.1007/s12094-014-1226-2; Karrholm J, 2010, ACTA ORTHOP, V81, P3, DOI 10.3109/17453671003635918; Kunkele A, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-452; Landgraeber S, 2006, BIOMATERIALS, V27, P3010, DOI 10.1016/j.biomaterials.2006.01.006; Landgraeber S, 2008, BIOMATERIALS, V29, P3444, DOI 10.1016/j.biomaterials.2008.04.044; Lehnerdt GF, 2009, ANN ONCOL, V20, P1094, DOI 10.1093/annonc/mdn763; Lucht U, 2000, ACTA ORTHOP SCAND, V71, P433, DOI 10.1080/000164700317381081; Maclnnes SJ, 2014, ORS 2014 ANN M; Mahomed NN, 2003, J BONE JOINT SURG AM, V85A, P27, DOI 10.2106/00004623-200301000-00005; Makela KT, 2008, J BONE JOINT SURG AM, V90A, P2160, DOI 10.2106/JBJS.G.00870; Makela KT, 2014, ACTA ORTHOP, V85, P107, DOI 10.3109/17453674.2014.893498; Nich C, 2013, J BIOMED MATER RES A, V101, P3033, DOI 10.1002/jbm.a.34599; Pan FY, 2014, J ORTHOP SURG RES, V9, DOI 10.1186/s13018-014-0108-1; Park BL, 2004, J HUM GENET, V49, P449, DOI 10.1007/s10038-004-0173-0; Park YH, 2009, CLIN CANCER RES, V15, P2107, DOI 10.1158/1078-0432.CCR-08-1588; Rodriguez S, 2009, AM J EPIDEMIOL, V169, P505, DOI 10.1093/aje/kwn359; Sadoghi P, 2013, J ARTHROPLASTY, V28, P1329, DOI 10.1016/j.arth.2013.01.012; Sundfeldt M, 2006, ACTA ORTHOP, V77, P177, DOI 10.1080/17453670610045902; Teng SS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125294; Volkmann N, 2014, CELL DEATH DIFFER, V21, P206, DOI 10.1038/cdd.2013.153; Wedemeyer C, 2009, EUR J MED RES, V14, P250, DOI 10.1186/2047-783X-14-6-250; YAN YZ, 2014, BIOL RES, V47, DOI DOI 10.1186/S13000-014-0177-9; Yang F, 2011, BIOMATERIALS, V32, P9159, DOI 10.1016/j.biomaterials.2011.08.039; Zhang C, 2014, J AFFECT DISORDERS, V155, P288, DOI 10.1016/j.jad.2013.11.010; Zhang N, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-48	37	7	7	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0149528	10.1371/journal.pone.0149528	http://dx.doi.org/10.1371/journal.pone.0149528			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	26881923	Green Submitted, Green Published, gold			2022-12-26	WOS:000371219000079
J	de Bruijn, HS; Brooks, S; van der Ploeg-van den Heuvel, A; ten Hagen, TLM; de Haas, ERM; Robinson, DJ				de Bruijn, Henriette S.; Brooks, Sander; van der Ploeg-van den Heuvel, Angelique; ten Hagen, Timo L. M.; de Haas, Ellen R. M.; Robinson, Dominic J.			Light Fractionation Significantly Increases the Efficacy of Photodynamic Therapy Using BF-200 ALA in Normal Mouse Skin	PLOS ONE			English	Article							TOPICAL 5-AMINOLEVULINIC ACID; BASAL-CELL CARCINOMA; 2-FOLD ILLUMINATION SCHEMES; PROTOPORPHYRIN-IX; AMINOLEVULINIC-ACID; METHYL AMINOLEVULINATE; FOLLOW-UP; LIPOSOMES; DERIVATIVES; GUIDELINES	Background Light fractionation significantly increases the efficacy of 5-aminolevulinic acid (ALA) based photodynamic therapy (PDT) using the nano-emulsion based gel formulation BF-200. PDT using BF-200 ALA has recently been clinically approved and is under investigation in several phase III trials for the treatment of actinic keratosis. This study is the first to compare BF-200 ALA with ALA in preclinical models. Results In hairless mouse skin there is no difference in the temporal and spatial distribution of protoporphyrin IX determined by superficial imaging and fluorescence microscopy in frozen sections. In the skin-fold chamber model, BF-200 ALA leads to more PpIX fluorescence at depth in the skin compared to ALA suggesting an enhanced penetration of BF-200 ALA. Light fractionated PDT after BF-200 ALA application results in significantly more visual skin damage following PDT compared to a single illumination. Both ALA formulations show the same visual skin damage, rate of photobleaching and change in vascular volume immediately after PDT. Fluorescence immunohistochemical imaging shows loss of VE-cadherin in the vasculature at day 1 post PDT which is greater after BF-200 ALA compared to ALA and more profound after light fractionation compared to a single illumination. Discussion The present study illustrates the clinical potential of light fractionated PDT using BF-200 ALA for enhancing PDT efficacy in (pre-) malignant skin conditions such as basal cell carcinoma and vulval intraepithelial neoplasia and its application in other lesion such as cervical intraepithelial neoplasia and oral squamous cell carcinoma where current approaches have limited efficacy.	[de Bruijn, Henriette S.; van der Ploeg-van den Heuvel, Angelique; Robinson, Dominic J.] Erasmus MC, Dept Otolaryngol & Head & Neck Surg, Ctr Opt Diagnost & Therapy, Rotterdam, Netherlands; [Brooks, Sander; de Haas, Ellen R. M.] Erasmus MC, Dept Dermatol, Rotterdam, Netherlands; [ten Hagen, Timo L. M.] Erasmus MC, Dept Surg Oncol, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	de Bruijn, HS (corresponding author), Erasmus MC, Dept Otolaryngol & Head & Neck Surg, Ctr Opt Diagnost & Therapy, Rotterdam, Netherlands.	h.debruijn@erasmusmc.nl			Biofrontera Pharmaceuticals AG	Biofrontera Pharmaceuticals AG	This study was supported by Biofrontera Pharmaceuticals AG (http://biofrontera.com/en/) to DJR in a grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand S, 2011, CANCER RES, V71, P6040, DOI 10.1158/0008-5472.CAN-11-0805; Blake E, 2013, PHOTODIAGN PHOTODYN, V10, P575, DOI 10.1016/j.pdpdt.2013.06.006; Braathen LR, 2007, J AM ACAD DERMATOL, V56, P125, DOI 10.1016/j.jaad.2006.06.006; Choi MC, 2015, LASER SURG MED, V47, P566, DOI 10.1002/lsm.22384; de Bruijn HS, 2006, J PHOTOCH PHOTOBIO B, V85, P184, DOI 10.1016/j.jphotobiol.2006.07.004; de Bruijn HS, 2007, PHOTOCH PHOTOBIO SCI, V6, P1325, DOI 10.1039/b708340h; de Bruijn HS, 2006, PHOTODERMATOL PHOTO, V22, P238, DOI 10.1111/j.1600-0781.2006.00240.x; de Bruijn HS, 2013, PHOTOCH PHOTOBIO SCI, V12, P241, DOI 10.1039/c2pp25287b; de Bruijn HS, 2008, J PHOTOCH PHOTOBIO B, V92, P91, DOI 10.1016/j.jphotobiol.2008.05.005; de Bruijn HS, 1999, CANCER RES, V59, P901; de Haas ERM, 2006, J INVEST DERMATOL, V126, P2679, DOI 10.1038/sj.jid.5700460; de Vijlder HC, 2012, ACTA DERM-VENEREOL, V92, P641, DOI 10.2340/00015555-1448; Dirschka T, 2013, BRIT J DERMATOL, V168, P825, DOI 10.1111/bjd.12158; Dreher F, 1997, J CONTROL RELEASE, V45, P131, DOI 10.1016/S0168-3659(96)01559-3; Foldvari M, 2010, MOL PHARMACEUT, V7, P751, DOI 10.1021/mp900283x; Fotinos N, 2006, PHOTOCHEM PHOTOBIOL, V82, P994, DOI 10.1562/2006-02-03-IR-794; Gerritsen MJP, 2009, DERMATOLOGY, V218, P193, DOI 10.1159/000183753; Helgesen ALO, 2015, BRIT J DERMATOL, V173, P1156, DOI 10.1111/bjd.14033; Hillemanns P, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2014.10.1107; Jerjes W, 2011, LASER SURG MED, V43, P192, DOI 10.1002/lsm.21036; Juzeniene A, 2002, PHOTOCHEM PHOTOBIOL, V76, P329, DOI 10.1562/0031-8655(2002)076<0329:TAOAAA>2.0.CO;2; Kawczyk-Krupka A, 2012, PHOTODIAGN PHOTODYN, V9, P148, DOI 10.1016/j.pdpdt.2011.12.007; Kriska T, 2005, ARCH BIOCHEM BIOPHYS, V433, P435, DOI 10.1016/j.abb.2004.09.025; Lesar A, 2007, PHOTODIAGN PHOTODYN, V4, P224, DOI 10.1016/j.pdpdt.2007.09.002; Maisch T, 2007, PHOTOCH PHOTOBIO SCI, V6, P545, DOI 10.1039/b614770d; Maisch T, 2010, EXP DERMATOL, V19, pE302, DOI 10.1111/j.1600-0625.2009.01001.x; Middelburg TA, 2013, PHOTODIAGN PHOTODYN, V10, P703, DOI 10.1016/j.pdpdt.2013.09.002; Middelburg TA, 2014, PHOTOCHEM PHOTOBIOL, V90, P896, DOI 10.1111/php.12271; Moan J, 2003, INT J CANCER, V103, P132, DOI 10.1002/ijc.10802; MOAN J, 1990, J PHOTOCH PHOTOBIO B, V6, P343, DOI 10.1016/1011-1344(90)85104-5; Morton C, 2015, EUR J DERMATOL; Morton CA, 2008, BRIT J DERMATOL, V159, P1245, DOI 10.1111/j.1365-2133.2008.08882.x; Neittaanmaki-Perttu N, 2014, BRIT J DERMATOL, V171, P1172, DOI 10.1111/bjd.13326; Oh EK, 2011, EUR J PHARM SCI, V44, P149, DOI 10.1016/j.ejps.2011.07.003; RATCLIFFE SL, 1995, BRIT J CANCER, V71, P300, DOI 10.1038/bjc.1995.60; Robinson DJ, 2000, PHOTOCHEM PHOTOBIOL, V72, P794, DOI 10.1562/0031-8655(2000)072<0794:TAAPTO>2.0.CO;2; Robinson DJ, 1999, PHOTOCHEM PHOTOBIOL, V69, P61, DOI 10.1111/j.1751-1097.1999.tb05307.x; Robinson DJ, 2003, PHOTOCHEM PHOTOBIOL, V77, P319, DOI 10.1562/0031-8655(2003)077<0319:DATOTF>2.0.CO;2; Robinson DJ, 1998, PHOTOCHEM PHOTOBIOL, V67, P140, DOI 10.1562/0031-8655(1998)067<0140:FPOAIP>2.3.CO;2; Seynhaeve ALB, 2007, CANCER RES, V67, P9455, DOI 10.1158/0008-5472.CAN-07-1599; Star WM, 2006, ACTA DERM-VENEREOL, V86, P412, DOI 10.2340/00015555-0129; van der Veen N, 1999, PHOTOCHEM PHOTOBIOL, V70, P921, DOI 10.1562/0031-8655(1999)070<0921:PEAVIH>2.3.CO;2; ZELLMER S, 1995, BBA-BIOMEMBRANES, V1237, P176, DOI 10.1016/0005-2736(95)00100-H	43	20	20	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0148850	10.1371/journal.pone.0148850	http://dx.doi.org/10.1371/journal.pone.0148850			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26872051	Green Submitted, Green Published, gold			2022-12-26	WOS:000370054100064
J	Reitan, T; Nielsen, A				Reitan, Trond; Nielsen, Anders			Do Not Divide Count Data with Count Data; A Story from Pollination Ecology with Implications Beyond	PLOS ONE			English	Article							SPECIES RICHNESS; PLANTS; DIVERSITY; DECLINES; MODELS; TRENDS	Studies in ecology are often describing observed variations in a certain ecological phenomenon by use of environmental explanatory variables. A common problem is that the numerical nature of the ecological phenomenon does not always fit the assumptions underlying traditional statistical tests. A text book example comes from pollination ecology where flower visits are normally reported as frequencies; number of visits per flower per unit time. Using visitation frequencies in statistical analyses comes with two major caveats: the lack of knowledge on its error distribution and that it does not include all information found in the data; 10 flower visits in 20 flowers is treated the same as recording 100 visits in 200 flowers. We simulated datasets with various "flower visitation distributions" over various numbers of flowers observed (exposure) and with different types of effects inducing variation in the data. The different datasets were then analyzed first with the traditional approach using number of visits per flower and then by using count data models. The analysis of count data gave a much better chance of detecting effects than the traditionally used frequency approach. We conclude that if the data structure, statistical analyses and interpretations of results are mixed up, valuable information can be lost.	[Reitan, Trond; Nielsen, Anders] Univ Oslo, Dept Biosci, CEES, POB 1066 Blindern, NO-0316 Oslo, Norway	University of Oslo	Reitan, T (corresponding author), Univ Oslo, Dept Biosci, CEES, POB 1066 Blindern, NO-0316 Oslo, Norway.	trond.reitan@ibv.uio.no	Reitan, Trond/P-4554-2019		Norwegian Research Council [230279/E50]; Research Council of Norway [230279/E50-PolliClim]	Norwegian Research Council(Research Council of NorwayEuropean Commission); Research Council of Norway(Research Council of Norway)	This work was supported by the Norwegian Research Council, 230279/E50. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The Research Council of Norway (project 230279/E50-PolliClim) financially supported this study. We thank Dr. Lars Qviller for useful comments on an earlier draft of the manuscript.	ANDERSON RM, 1978, J ANIM ECOL, V47, P219, DOI 10.2307/3933; Bates D, 2014, J STAT SOFTWAR UNPUB; Biesmeijer JC, 2006, SCIENCE, V313, P351, DOI 10.1126/science.1127863; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Chamorro S, 2012, ANN BOT; Chao A, 2003, ENVIRON ECOL STAT, V10, P429, DOI 10.1023/A:1026096204727; Dauber J, 2010, J ECOL, V98, P188, DOI 10.1111/j.1365-2745.2009.01590.x; Denison DGT, 2002, BAYESIAN METHODS NON, P18; Dunstan PK, 2013, J AGR BIOL ENVIR ST, V18, P357, DOI 10.1007/s13253-013-0146-x; Fournier DA, 2012, OPTIM METHOD SOFTW, V27, P233, DOI 10.1080/10556788.2011.597854; Frimpong E. A., 2009, International Journal of Tropical Insect Science, V29, P62, DOI 10.1017/S1742758409990117; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Handeland K, 2013, VET PARASITOL, V195, P142, DOI 10.1016/j.vetpar.2013.02.012; Herrera CM, 2005, AM J BOT, V92, P13, DOI 10.3732/ajb.92.1.13; Kearns CA, 1998, ANNU REV ECOL SYST, V29, P83, DOI 10.1146/annurev.ecolsys.29.1.83; Lazaro A, 2010, OIKOS, V119, P825, DOI 10.1111/j.1600-0706.2009.18017.x; Lewis F, 2011, METHODS ECOL EVOL, V2, P155, DOI 10.1111/j.2041-210X.2010.00063.x; Mao CX, 2005, ECOLOGY, V86, P1143, DOI 10.1890/04-1078; McCulloch C. E., 2008, GEN LINEAR MIXED MOD; Nielsen A, 2012, BASIC APPL ECOL, V13, P489, DOI 10.1016/j.baae.2012.08.008; Nielsen A, 2011, ECOL RES, V26, P969, DOI 10.1007/s11284-011-0852-1; O'Hara RB, 2010, METHODS ECOL EVOL, V1, P118, DOI 10.1111/j.2041-210X.2010.00021.x; Popic TJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066665; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Qviller L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071299; Reitan T, 2009, STOCH ENV RES RISK A, V23, P627, DOI 10.1007/s00477-008-0248-0; Rhodes JR, 2011, ECOGRAPHY, V34, P1040, DOI 10.1111/j.1600-0587.2011.06370.x; Rodven R, 2009, J ANIM ECOL, V78, P600, DOI 10.1111/j.1365-2656.2008.01515.x; Skaug H. J., 2014, GEN LINEAR MIXED MOD; Totland O, 2006, AM J BOT, V93, P868, DOI 10.3732/ajb.93.6.868; Tylianakis JM, 2010, BIOL CONSERV, V143, P2270, DOI 10.1016/j.biocon.2009.12.004; Warton DI, 2011, ECOLOGY, V92, P3, DOI 10.1890/10-0340.1; Westphal C, 2008, ECOL MONOGR, V78, P653, DOI 10.1890/07-1292.1	33	28	28	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149129	10.1371/journal.pone.0149129	http://dx.doi.org/10.1371/journal.pone.0149129			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26872136	Green Published, gold, Green Submitted			2022-12-26	WOS:000370054100110
J	Sanchez-Fernandez, G; Cabezudo, S; Caballero, A; Garcia-Hoz, C; Tall, GG; Klett, J; Michnick, SW; Mayor, F; Ribas, C				Sanchez-Fernandez, Guzman; Cabezudo, Sofia; Caballero, Alvaro; Garcia-Hoz, Carlota; Tall, Gregory G.; Klett, Javier; Michnick, Stephen W.; Mayor, Federico, Jr.; Ribas, Catalina			Protein Kinase C zeta Interacts with a Novel Binding Region of G alpha q to Act as a Functional Effector	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COUPLED RECEPTOR KINASE; STRUCTURAL BASIS; ACTIVATION; DOMAIN; PATHWAY; COMPLEX; PKC; REGULATOR	Heterotrimeric G proteins play an essential role in the initiation of G protein-coupled receptor (GPCR) signaling through specific interactions with a variety of cellular effectors. We have recently reported that GPCR activation promotes a direct interaction between G alpha q and protein kinase C zeta (PKC zeta), leading to the stimulation of the ERK5 pathway independent of the canonical effector PLC beta. We report herein that the activation-dependent G alpha q/PKC zeta complex involves the basic PB1-type II domain of PKC zeta and a novel interaction module in G alpha q different from the classical effector-binding site. Point mutations in this G alpha q region completely abrogate ERK5 phosphorylation, indicating that G alpha q/PKC zeta association is required for the activation of the pathway. Indeed, PKC zeta was demonstrated to directly bind ERK5 thus acting as a scaffold between G alpha q and ERK5 upon GPCR activation. The inhibition of these protein complexes by G protein-coupled receptor kinase 2, a known G alpha q modulator, led to a complete abrogation of ERK5 stimulation. Finally, we reveal that G alpha q/PKC zeta complexes link G alpha q to apoptotic cell death pathways. Our data suggest that the interaction between this novel region in G alpha q and the effector PKC zeta is a key event in G alpha q signaling.	[Sanchez-Fernandez, Guzman; Cabezudo, Sofia; Caballero, Alvaro; Garcia-Hoz, Carlota; Klett, Javier; Mayor, Federico, Jr.; Ribas, Catalina] Univ Autonoma Madrid, Dept Mol Biol, CSIC UAM, E-28049 Madrid, Spain; [Sanchez-Fernandez, Guzman; Cabezudo, Sofia; Caballero, Alvaro; Garcia-Hoz, Carlota; Klett, Javier; Mayor, Federico, Jr.; Ribas, Catalina] Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, CSIC UAM, E-28049 Madrid, Spain; [Sanchez-Fernandez, Guzman; Cabezudo, Sofia; Caballero, Alvaro; Garcia-Hoz, Carlota; Mayor, Federico, Jr.; Ribas, Catalina] Inst Invest Sanitaria La Princesa, Madrid 29006, Spain; [Sanchez-Fernandez, Guzman] Max Planck Inst Heart & Lung Res, Dept Pharmacol, D-61231 Bad Nauheim, Germany; [Tall, Gregory G.] Univ Rochester, Med Ctr, Dept Pharmacol, Rochester, NY 14642 USA; [Tall, Gregory G.] Univ Rochester, Med Ctr, Dept Physiol, Rochester, NY 14642 USA; [Michnick, Stephen W.] Univ Montreal, Dept Biochim, CP 6128,Succursale Ctr Ville, Montreal, PQ H3C 3J7, Canada	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Max Planck Society; University of Rochester; University of Rochester; Universite de Montreal	Mayor, F; Ribas, C (corresponding author), Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, E-28049 Madrid, Spain.	fmayor@cbm.csic.es; cribas@cbm.csic.es	Cabezudo, Sofia/AAA-6434-2020; Mayor, Federico/N-7644-2016; Klett, Javier/L-4595-2014	Klett, Javier/0000-0001-8495-6568; Garcia-Hoz, Carlota/0000-0001-8268-4159; Cabezudo, Sofia/0000-0001-5675-458X	Ministerio de Educacion y Ciencia [SAF2011-23800, SAF2014-55511-R]; Fundacion Ramon Areces; Cardiovascular Diseases Network of Ministerio Sanidad y Consumo-Instituto Carlos III [RD12/0042/0012]; Comunidad de Madrid [S-2011/BMD-2332]; Instituto de Salud Carlos III [PI11/00126, PI14/00201]; NIGMS, National Institutes of Health [R01-GM088242]; Canadian Institutes of Health Research (CIHR) [MOP-GMX-231013]; EMBO; Fondo Europeo de Desarrollo Regional (FEDER, European Union); Spanish Ministry of Education; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088242] Funding Source: NIH RePORTER	Ministerio de Educacion y Ciencia(Spanish Government); Fundacion Ramon Areces; Cardiovascular Diseases Network of Ministerio Sanidad y Consumo-Instituto Carlos III; Comunidad de Madrid(Comunidad de Madrid); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); EMBO(European Molecular Biology Organization (EMBO)); Fondo Europeo de Desarrollo Regional (FEDER, European Union); Spanish Ministry of Education(Spanish Government); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from Ministerio de Educacion y Ciencia (SAF2011-23800, SAF2014-55511-R), Fundacion Ramon Areces, The Cardiovascular Diseases Network of Ministerio Sanidad y Consumo-Instituto Carlos III (RD12/0042/0012), Comunidad de Madrid (S-2011/BMD-2332), and Instituto de Salud Carlos III (PI11/00126, PI14/00201) (to F. M. and C. R.). This work was also supported in part by the NIGMS, National Institutes of Health Grant R01-GM088242 (to G. T.), the Canadian Institutes of Health Research (CIHR) (MOP-GMX-231013) (to S. M.), an EMBO Short Fellowship (to G. S. F.), and Fondo Europeo de Desarrollo Regional (FEDER, European Union). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.r Recipients of FPU fellowships from the Spanish Ministry of Education.	Adams JW, 2000, CIRC RES, V87, P1180, DOI 10.1161/01.RES.87.12.1180; Carman CV, 1999, J BIOL CHEM, V274, P34483, DOI 10.1074/jbc.274.48.34483; Chan P, 2011, J BIOL CHEM, V286, P2625, DOI 10.1074/jbc.M110.178897; Diaz-Meco MT, 2012, IMMUNOL REV, V246, P154, DOI 10.1111/j.1600-065X.2012.01093.x; Diaz-Meco MT, 2001, MOL CELL BIOL, V21, P1218, DOI 10.1128/MCB.21.4.1218-1227.2001; Fan GF, 2003, J BIOL CHEM, V278, P52432, DOI 10.1074/jbc.M310982200; Garcia-Hoz C, 2012, J BIOL CHEM, V287, P7792, DOI 10.1074/jbc.M111.282210; Garcia-Hoz C, 2010, J BIOL CHEM, V285, P13480, DOI 10.1074/jbc.M109.098699; Graybill C, 2012, J BIOL CHEM, V287, P21003, DOI 10.1074/jbc.M112.360495; Hirano Y, 2005, J BIOL CHEM, V280, P9653, DOI 10.1074/jbc.M409823200; Hirano Y, 2004, J BIOL CHEM, V279, P31883, DOI 10.1074/jbc.M403092200; Ke N, 2011, METHODS MOL BIOL, V740, P33, DOI 10.1007/978-1-61779-108-6_6; Kim JY, 2013, P NATL ACAD SCI USA, V110, P6418, DOI 10.1073/pnas.1221799110; Limame R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046536; Lutz S, 2005, J BIOL CHEM, V280, P11134, DOI 10.1074/jbc.M411322200; Lutz S, 2007, SCIENCE, V318, P1923, DOI 10.1126/science.1147554; Medina R, 1996, J BIOL CHEM, V271, P24720, DOI 10.1074/jbc.271.40.24720; Moscat J, 2006, MOL CELL, V23, P631, DOI 10.1016/j.molcel.2006.08.002; Nazarenko I, 2010, MOL CANCER RES, V8, P919, DOI 10.1158/1541-7786.MCR-09-0358; Nigro P, 2010, BLOOD, V116, P1971, DOI 10.1182/blood-2010-02-269134; Nithianandarajah-Jones GN, 2012, CELL SIGNAL, V24, P2187, DOI 10.1016/j.cellsig.2012.07.007; Oldham WM, 2006, Q REV BIOPHYS, V39, P117, DOI 10.1017/S0033583506004306; Peavy RD, 2005, MOL PHARMACOL, V67, P2102, DOI 10.1124/mol.104.007799; Penela P, 2010, BRIT J PHARMACOL, V160, P821, DOI 10.1111/j.1476-5381.2010.00727.x; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Remy Ingrid, 2004, Methods Mol Biol, V261, P411; Rhee SG, 2001, ANNU REV BIOCHEM, V70, P281, DOI 10.1146/annurev.biochem.70.1.281; Ribas C, 2007, BBA-BIOMEMBRANES, V1768, P913, DOI 10.1016/j.bbamem.2006.09.019; Sanchez-Fernandez G, 2014, CELL SIGNAL, V26, P833, DOI 10.1016/j.cellsig.2014.01.010; Sanchez-Fernandez G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084174; Shankaranarayanan A, 2010, CELL SIGNAL, V22, P1114, DOI 10.1016/j.cellsig.2010.03.006; Shankaranarayanan A, 2008, J BIOL CHEM, V283, P34923, DOI 10.1074/jbc.M805860200; Sohn SJ, 2008, EMBO J, V27, P1896, DOI 10.1038/emboj.2008.114; Sprang SR, 2007, ADV PROTEIN CHEM, V74, P1, DOI 10.1016/S0065-3233(07)74001-9; Sterne-Marr R, 2003, J BIOL CHEM, V278, P6050, DOI 10.1074/jbc.M208787200; Sturla LM, 2005, CANCER RES, V65, P5683, DOI 10.1158/0008-5472.CAN-04-2283; Sumimoto Hideki, 2007, Sci STKE, V2007, pre6, DOI 10.1126/stke.4012007re6; Tall GG, 2003, J BIOL CHEM, V278, P8356, DOI 10.1074/jbc.M211862200; Tesmer VM, 2005, SCIENCE, V310, P1686, DOI 10.1126/science.1118890; Turjanski AG, 2007, ONCOGENE, V26, P3240, DOI 10.1038/sj.onc.1210415; Waldo GL, 2010, SCIENCE, V330, P974, DOI 10.1126/science.1193438; Zhang XM, 2012, NAT CELL BIOL, V14, P850, DOI 10.1038/ncb2529	42	9	9	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2016	291	18					9513	9525		10.1074/jbc.M115.684308	http://dx.doi.org/10.1074/jbc.M115.684308			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DL4JY	26887939	Green Published, hybrid			2022-12-26	WOS:000375602300012
J	Wang, SM; Lu, Y; Yin, MX; Wang, C; Wu, W; Li, JH; Wu, WQ; Ge, L; Hu, LX; Zhao, Y; Zhang, L				Wang, Shimin; Lu, Yi; Yin, Meng-Xin; Wang, Chao; Wu, Wei; Li, Jinhui; Wu, Wenqing; Ge, Ling; Hu, Lianxin; Zhao, Yun; Zhang, Lei			Importin 1 Mediates Yorkie Nuclear Import via an N-terminal Non-canonical Nuclear Localization Signal	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Hippo pathway; nuclear translocation; nuclear transport; oncogene; yes-associated protein (YAP); Importin; NLS; yorkie	ORGAN SIZE CONTROL; TUMOR-SUPPRESSOR PATHWAY; CELL-PROLIFERATION; PROMOTES APOPTOSIS; CRYSTALLOGRAPHIC ANALYSIS; KARYOPHERIN ALPHA; STRUCTURAL BASIS; TEAD/TEF FAMILY; BANTAM MICRORNA; PROTEIN IMPORT	The Hippo signaling pathway controls organ size by orchestrating cell proliferation and apoptosis. When the Hippo pathway was inactivated, the transcriptional co-activator Yorkie translocates into the nucleus and forms a complex with transcription factor Scalloped to promote the expression of Hippo pathway target genes. Therefore, the nuclear translocation of Yorkie is a critical step in Hippo signaling. Here, we provide evidence that the N-terminal 1-55 amino acids of Yorkie, especially Arg-15, were essential for its nuclear localization. By mass spectrometry and biochemical analyses, we found that Importin 1 can directly interact with the Yorkie N terminus and drive Yorkie into the nucleus. Further experiments show that the upstream component Hippo can inhibit Importin 1-mediated Yorkie nuclear import. Taken together, we identified a potential nuclear localization signal at the N-terminal end of Yorkie as well as a critical role for Importin 1 in Yorkie nuclear import.	[Wang, Shimin; Lu, Yi; Yin, Meng-Xin; Wang, Chao; Wu, Wei; Li, Jinhui; Wu, Wenqing; Ge, Ling; Hu, Lianxin; Zhao, Yun; Zhang, Lei] Chinese Acad Sci, Shanghai Inst Biol Sci, State Key Lab Cell Biol,Inst Biochem & Cell Biol, CAS Ctr Excellence Mol Cell Sci,Innovat Ctr Cell, Shanghai 200031, Peoples R China; [Zhao, Yun; Zhang, Lei] ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai 201210, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; ShanghaiTech University	Zhang, L (corresponding author), Chinese Acad Sci, State Key Lab Cell Biol, Inst Biochem & Cell Biol, Shanghai Inst Biol Sci, 320 Yue Yang Rd, Shanghai 200031, Peoples R China.	rayzhang@sibcb.ac.cn		Hu, Lianxin/0000-0001-5600-5634; Wang, Chao/0000-0001-6191-5261	National Basic Research Program of China (973 Program) [2012CB945001]; "Strategic Priority Research Program" of the Chinese Academy of Sciences [XDA01010406]; National Natural Science Foundation of China [31171394, 31371462]; State Key Program of National Natural Science of China [31530043]; "Cross and Cooperation in Science and Technology Innovation Team" project of the Chinese Academy of Sciences; CAS/SAFEA International Partnership Program for Creative Research Teams	National Basic Research Program of China (973 Program)(National Basic Research Program of China); "Strategic Priority Research Program" of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Program of National Natural Science of China(National Natural Science Foundation of China (NSFC)); "Cross and Cooperation in Science and Technology Innovation Team" project of the Chinese Academy of Sciences; CAS/SAFEA International Partnership Program for Creative Research Teams(Chinese Academy of Sciences)	This work was supported by grants from the National Basic Research Program of China (973 Program 2012CB945001), the "Strategic Priority Research Program" of the Chinese Academy of Sciences (XDA01010406), the National Natural Science Foundation of China (31171394, 31371462), supported by the State Key Program of National Natural Science of China (31530043), the "Cross and Cooperation in Science and Technology Innovation Team" project of the Chinese Academy of Sciences, and the CAS/SAFEA International Partnership Program for Creative Research Teams. The authors declare that they have no conflicts of interest with the contents of this article.	Conti E, 1998, CELL, V94, P193, DOI 10.1016/S0092-8674(00)81419-1; Conti E, 2000, STRUCTURE, V8, P329, DOI 10.1016/S0969-2126(00)00107-6; DINGWALL C, 1991, TRENDS BIOCHEM SCI, V16, P478, DOI 10.1016/0968-0004(91)90184-W; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Fontes MRM, 2003, BIOCHEM J, V375, P339, DOI 10.1042/BJ20030510; Fontes MRM, 2003, J BIOL CHEM, V278, P27981, DOI 10.1074/jbc.M303275200; Goldfarb DS, 2004, TRENDS CELL BIOL, V14, P505, DOI 10.1016/j.tcb.2004.07.016; Gorjanacz M, 2002, DEV BIOL, V251, P271, DOI 10.1006/dbio.2002.0827; Gorlich D, 1996, EMBO J, V15, P5584, DOI 10.1002/j.1460-2075.1996.tb00943.x; Goulev Y, 2008, CURR BIOL, V18, P435, DOI 10.1016/j.cub.2008.02.034; Harvey KF, 2003, CELL, V114, P457, DOI 10.1016/S0092-8674(03)00557-9; Hodel MR, 2001, J BIOL CHEM, V276, P1317, DOI 10.1074/jbc.M008522200; Huang HL, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001620; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; Jakel S, 1998, EMBO J, V17, P4491, DOI 10.1093/emboj/17.15.4491; JUSTICE RW, 1995, GENE DEV, V9, P534, DOI 10.1101/gad.9.5.534; Kosugi S, 2009, J BIOL CHEM, V284, P478, DOI 10.1074/jbc.M807017200; KUSSEL P, 1995, J CELL BIOL, V129, P1491, DOI 10.1083/jcb.129.6.1491; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Macara IG, 2001, MICROBIOL MOL BIOL R, V65, P570, DOI 10.1128/MMBR.65.4.570-594.2001; Makkerh JPS, 1996, CURR BIOL, V6, P1025, DOI 10.1016/S0960-9822(02)00648-6; Marfori M, 2012, TRAFFIC, V13, P532, DOI 10.1111/j.1600-0854.2012.01329.x; Mason DA, 2002, GENETICS, V161, P157; Mathe E, 2000, DEV BIOL, V223, P307, DOI 10.1006/dbio.2000.9743; Nolo R, 2006, CURR BIOL, V16, P1895, DOI 10.1016/j.cub.2006.08.057; Oh H, 2009, ONCOGENE, V28, P1916, DOI 10.1038/onc.2009.43; Oh H, 2008, DEVELOPMENT, V135, P1081, DOI 10.1242/dev.015255; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Pantalacci S, 2003, NAT CELL BIOL, V5, P921, DOI 10.1038/ncb1051; Peng HW, 2009, GENE DEV, V23, P2307, DOI 10.1101/gad.1820009; Poon IKH, 2005, TRAFFIC, V6, P173, DOI 10.1111/j.1600-0854.2005.00268.x; Ren FF, 2010, DEV BIOL, V337, P303, DOI 10.1016/j.ydbio.2009.10.046; ROBBINS J, 1991, CELL, V64, P615, DOI 10.1016/0092-8674(91)90245-T; Sorokin AV, 2007, BIOCHEMISTRY-MOSCOW+, V72, P1439, DOI 10.1134/S0006297907130032; Stewart M, 2007, NAT REV MOL CELL BIO, V8, P195, DOI 10.1038/nrm2114; Thompson BJ, 2006, CELL, V126, P767, DOI 10.1016/j.cell.2006.07.013; TOROK I, 1995, J CELL BIOL, V129, P1473, DOI 10.1083/jcb.129.6.1473; Tran EJ, 2006, CELL, V125, P1041, DOI 10.1016/j.cell.2006.05.027; Udan RS, 2003, NAT CELL BIOL, V5, P914, DOI 10.1038/ncb1050; Wagstaff KM, 2009, TRAFFIC, V10, P1188, DOI 10.1111/j.1600-0854.2009.00937.x; Wu S, 2003, CELL, V114, P445, DOI 10.1016/S0092-8674(03)00549-X; Wu S, 2008, DEV CELL, V14, P388, DOI 10.1016/j.devcel.2008.01.007; XU TA, 1995, DEVELOPMENT, V121, P1053; Yin MX, 2015, ACTA BIOCH BIOPH SIN, V47, P39, DOI 10.1093/abbs/gmu111; Yin MX, 2011, J GENET GENOMICS, V38, P471, DOI 10.1016/j.jgg.2011.09.009; Zhang L, 2008, DEV CELL, V14, P377, DOI 10.1016/j.devcel.2008.01.006; Zhao B, 2011, NAT CELL BIOL, V13, P877, DOI 10.1038/ncb2303; Zhao B, 2010, GENE DEV, V24, P862, DOI 10.1101/gad.1909210	48	27	27	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2016	291	15					7926	7937		10.1074/jbc.M115.700823	http://dx.doi.org/10.1074/jbc.M115.700823			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DJ2SZ	26887950	Green Published, hybrid			2022-12-26	WOS:000374056700015
J	Golinelli-Cohen, MP; Lescop, E; Mons, C; Goncalves, S; Clemancey, M; Santolini, J; Guittet, E; Blondin, G; Latour, JM; Bouton, C				Golinelli-Cohen, Marie-Pierre; Lescop, Ewen; Mons, Cecile; Goncalves, Sergio; Clemancey, Martin; Santolini, Jerome; Guittet, Eric; Blondin, Genevieve; Latour, Jean-Marc; Bouton, Cecile			Redox Control of the Human Iron-Sulfur Repair Protein MitoNEET Activity via Its Iron-Sulfur Cluster	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL-MEMBRANE PROTEIN; RESONANCE RAMAN-SPECTROSCOPY; DRUG TARGET MITONEET; FE-S CLUSTER; 2FE-2S CLUSTER; ELECTRON-TRANSFER; STAPHYLOCOCCUS-AUREUS; REGULATORY PROTEIN-1; 2-COMPONENT SYSTEM; ESCHERICHIA-COLI	Human mitoNEET (mNT) is the first identified Fe-S protein of the mammalian outer mitochondrial membrane. Recently, mNT has been implicated in cytosolic Fe-S repair of a key regulator of cellular iron homeostasis. Here, we aimed to decipher the mechanism by which mNT triggers its Fe-S repair capacity. By using tightly controlled reactions combined with complementary spectroscopic approaches, we have determined the differential roles played by both the redox state of the mNT cluster and dioxygen in cluster transfer and protein stability. We unambiguously demonstrated that only the oxidized state of them NT cluster triggers cluster transfer to a generic acceptor protein and that dioxygen is neither required for the cluster transfer reaction nor does it affect the transfer rate. In the absence of apo-acceptors, a large fraction of the oxidized holo-mNT form is converted back to reduced holo-mNT under low oxygen tension. Reduced holo-mNT, which holds a [2Fe-2S](+) with a global protein fold similar to that of the oxidized form is, by contrast, resistant in losing its cluster or in transferring it. Our findings thus demonstrate that mNT uses an iron-based redox switch mechanism to regulate the transfer of its cluster. The oxidized state is the "active state," which reacts promptly to initiate Fe-Stransfer independently of dioxygen, whereas the reduced state is a "dormant form." Finally, we propose that the redox-sensing function of mNT is a key component of the cellular adaptive response to help stress-sensitive Fe-S proteins recover from oxidative injury.	[Golinelli-Cohen, Marie-Pierre; Lescop, Ewen; Mons, Cecile; Goncalves, Sergio; Guittet, Eric; Bouton, Cecile] Univ Paris Saclay, Univ Paris 11, CNRS UPR 2301, ICSN, F-91190 Gif Sur Yvette, France; [Clemancey, Martin; Blondin, Genevieve; Latour, Jean-Marc] Univ Grenoble Alpes, LCBM, F-38054 Grenoble, France; [Clemancey, Martin; Blondin, Genevieve; Latour, Jean-Marc] CEA, DSV, IRTSV, LCBM,Equipe Physicochim Met Biol PMB, F-38054 Grenoble, France; [Clemancey, Martin; Blondin, Genevieve; Latour, Jean-Marc] CNRS, UMR 5249, LCBM, F-38054 Grenoble, France; [Santolini, Jerome] Univ Paris Saclay, Univ Paris 11, CNRS, CEA,Inst Integrat Biol Cell I2BC, F-91190 Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Golinelli-Cohen, MP; Bouton, C (corresponding author), CNRS, UPR 2301, Inst Chim Subst Nat, 1 Ave Terrasse, F-91190 Gif Sur Yvette, France.	marie-pierre.golinelli@cnrs.fr; cecile.bouton@cnrs.fr	Golinelli, Marie-Pierre/K-4287-2013; Lescop, Ewen/AAA-8700-2019	Golinelli, Marie-Pierre/0000-0002-6738-8631; Guittet, Eric/0000-0002-8368-6719; Santolini, Jerome/0000-0001-8919-112X; Lescop, Ewen/0000-0002-2623-9365	Fondation pour la Recherche Medicale [ING20101220983]; Agence Nationale de la Recherche [ANR-13BSV8-0017-01]; French Infrastructure for Integrated Structural Biology (FRISBI) [ANR-10-INSB-05-01]; French Ministry of National Education, Research, and Technology	Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Agence Nationale de la Recherche(French National Research Agency (ANR)); French Infrastructure for Integrated Structural Biology (FRISBI); French Ministry of National Education, Research, and Technology	This work was supported by the Fondation pour la Recherche Medicale (ING20101220983; to S. G.), the Agence Nationale de la Recherche (ANR-13BSV8-0017-01), and the French Infrastructure for Integrated Structural Biology (FRISBI) (ANR-10-INSB-05-01). The authors declare that they have no conflicts of interest with the contents of this article.r Recipient of a doctoral grant from the French Ministry of National Education, Research, and Technology.	Bak DW, 2013, BIOCHEMISTRY-US, V52, P4687, DOI 10.1021/bi400540m; Bak DW, 2009, BIOCHEMISTRY-US, V48, P10193, DOI 10.1021/bi9016445; Boal AK, 2007, J INORG BIOCHEM, V101, P1913, DOI 10.1016/j.jinorgbio.2007.05.001; Bonomi F, 2005, J BIOL CHEM, V280, P29513, DOI 10.1074/jbc.M504344200; Boron WF, 2004, ADV PHYSIOL EDUC, V28, P160, DOI 10.1152/advan.00045.2004; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Camilloni C, 2012, BIOCHEMISTRY-US, V51, P2224, DOI 10.1021/bi3001825; Carboni M, 2012, INORG CHEM, V51, P10447, DOI 10.1021/ic301725z; Chahal HK, 2012, J INORG BIOCHEM, V116, P126, DOI 10.1016/j.jinorgbio.2012.06.008; Ciriolo MR, 1997, J BIOL CHEM, V272, P2700, DOI 10.1074/jbc.272.5.2700; CLELAND WW, 1964, BIOCHEMISTRY-US, V3, P480, DOI 10.1021/bi00892a002; Colca JR, 2004, AM J PHYSIOL-ENDOC M, V286, pE252, DOI 10.1152/ajpendo.00424.2003; Couturier J, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00259; Dixon SJ, 2012, CELL, V149, P1060, DOI 10.1016/j.cell.2012.03.042; Ferecatu I, 2014, J BIOL CHEM, V289, P28070, DOI 10.1074/jbc.M114.548438; Finkel T, 2012, J BIOL CHEM, V287, P4434, DOI 10.1074/jbc.R111.271999; Fleischhacker AS, 2012, BIOCHEMISTRY-US, V51, P4453, DOI 10.1021/bi3003204; FU WG, 1992, J BIOL CHEM, V267, P15502; Galy B, 2010, CELL METAB, V12, P194, DOI 10.1016/j.cmet.2010.06.007; Gaudu P, 1996, P NATL ACAD SCI USA, V93, P10094, DOI 10.1073/pnas.93.19.10094; Giel JL, 2013, MOL MICROBIOL, V87, P478, DOI 10.1111/mmi.12052; Giorgio M, 2005, CELL, V122, P221, DOI 10.1016/j.cell.2005.05.011; Gupta V, 2009, J AM CHEM SOC, V131, P6149, DOI 10.1021/ja807551e; Hall JW, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00682; Hou XW, 2007, J BIOL CHEM, V282, P33242, DOI 10.1074/jbc.C700172200; Hsueh KL, 2010, J AM CHEM SOC, V132, P7908, DOI 10.1021/ja1026387; Kalogeris T, 2012, INT REV CEL MOL BIO, V298, P229, DOI 10.1016/B978-0-12-394309-5.00006-7; Kobayashi K, 2011, BIOCHEMISTRY-US, V50, P9468, DOI 10.1021/bi201526y; Kusminski CM, 2012, NAT MED, V18, P1539, DOI 10.1038/nm.2899; Landry AP, 2015, FREE RADICAL BIO MED, V81, P119, DOI 10.1016/j.freeradbiomed.2015.01.017; Landry AP, 2014, J BIOL CHEM, V289, P4307, DOI 10.1074/jbc.M113.542050; Lescop E, 2007, J MAGN RESON, V187, P163, DOI 10.1016/j.jmr.2007.04.002; Lin JZ, 2007, P NATL ACAD SCI USA, V104, P14640, DOI 10.1073/pnas.0702426104; Marchi Saverio, 2012, J Signal Transduct, V2012, P329635, DOI 10.1155/2012/329635; Meyer J, 2002, BIOCHEMISTRY-US, V41, P3096, DOI 10.1021/bi015981m; MOULIS JM, 1982, BIOCHEMISTRY-US, V21, P4762, DOI 10.1021/bi00262a037; MUNCK E, 1972, BIOCHEMISTRY-US, V11, P855; Nechushtai R, 2012, PLANT CELL, V24, P2139, DOI 10.1105/tpc.112.097634; Paddock ML, 2007, P NATL ACAD SCI USA, V104, P14342, DOI 10.1073/pnas.0707189104; PETERING D, 1971, J BIOL CHEM, V246, P643; Porcelli AM, 2005, BIOCHEM BIOPH RES CO, V326, P799, DOI 10.1016/j.bbrc.2004.11.105; Ren B, 2009, J BIOL CHEM, V284, P4829, DOI 10.1074/jbc.M807943200; Saouma CT, 2014, INORG CHEM, V53, P3153, DOI 10.1021/ic403131p; Schanda P, 2005, J BIOMOL NMR, V33, P199, DOI 10.1007/s10858-005-4425-x; Sohn YS, 2013, P NATL ACAD SCI USA, V110, P14676, DOI 10.1073/pnas.1313198110; Stys A, 2011, J BIOL CHEM, V286, P22846, DOI 10.1074/jbc.M111.231902; Sun F, 2012, J AM CHEM SOC, V134, P305, DOI 10.1021/ja2071835; TA DT, 1992, J BIOL CHEM, V267, P11120; Tirrell TF, 2009, BIOCHEMISTRY-US, V48, P4747, DOI 10.1021/bi900028r; West AP, 2011, NAT REV IMMUNOL, V11, P389, DOI 10.1038/nri2975; Wiley SE, 2007, J BIOL CHEM, V282, P23745, DOI 10.1074/jbc.C700107200; Wiley SE, 2007, P NATL ACAD SCI USA, V104, P5318, DOI 10.1073/pnas.0701078104; Wolfe MD, 2002, BIOCHEMISTRY-US, V41, P9611, DOI 10.1021/bi025912n; Wu Y, 2009, J BACTERIOL, V191, P1248, DOI 10.1128/JB.01086-08; Xiao YM, 2008, BIOCHEMISTRY-US, V47, P6612, DOI 10.1021/bi701433m; Zhang B, 2012, P NATL ACAD SCI USA, V109, P15734, DOI 10.1073/pnas.1208787109; Zhou T, 2010, BIOCHEMISTRY-US, V49, P9604, DOI 10.1021/bi101168c; Zuris JA, 2011, P NATL ACAD SCI USA, V108, P13047, DOI 10.1073/pnas.1109986108	58	45	47	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2016	291	14					7583	7593		10.1074/jbc.M115.711218	http://dx.doi.org/10.1074/jbc.M115.711218			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DW2BJ	26887944	Green Published, hybrid			2022-12-26	WOS:000383447600031
J	Giles, DA; Moreno-Fernandez, ME; Stankiewicz, TE; Cappelletti, M; Huppert, SS; Iwakura, Y; Dong, C; Shanmukhappa, SK; Divanovic, S				Giles, Daniel A.; Moreno-Fernandez, Maria E.; Stankiewicz, Traci E.; Cappelletti, Monica; Huppert, Stacey S.; Iwakura, Yoichiro; Dong, Chen; Shanmukhappa, Shiva K.; Divanovic, Senad			Regulation of Inflammation by IL-17A and IL-17F Modulates Non-Alcoholic Fatty Liver Disease Pathogenesis	PLOS ONE			English	Article							CHOLINE-DEFICIENT DIET; HEPATIC STEATOSIS; IL-17-PRODUCING CELLS; KUPFFER CELLS; FIBROSIS; STEATOHEPATITIS; PROGRESSION; NASH; ADIPOGENESIS; RECRUITMENT	Non-alcoholic fatty liver disease (NAFLD) has become the most common chronic liver disease worldwide. While it is well-accepted that inflammation is central to NAFLD pathogenesis, the immune pathway(s) orchestrating disease progression are poorly defined. Notably, IL-17RA signaling, via IL-17A, plays an important role in obesity-driven NAFLD pathogenesis. However, the role of the IL-17F, another IL-17RA ligand, in NAFLD pathogenesis has not been examined. Further, the cell types expressing IL-17RA and producing IL-17RA ligands in the pathogenesis of NAFLD have not been defined. Here, IL-17RA(-/-), IL-17A(-/-), IL-17F(-/-) and wild-type (WT) mice were fed either standard chow diet or methionine and choline deficient diet (MCDD)-a diet known to induce steatosis and hepatic inflammation through beta-oxidation dysfunction-and hepatic inflammation and NAFLD progression were subsequently quantified. MCDD feeding augmented hepatic IL-17RA expression and significantly increased hepatic infiltration of macrophages and IL-17A and IL-17F producing CD4(+) and CD8(+) T cells in WT mice. In contrast, IL-17RA(-/-), IL-17A(-/-), and IL-17F(-/-) mice, despite increased steatosis, exhibited significant protection from hepatocellular damage compared to WT controls. Protection from hepatocellular damage correlated with decreased levels of hepatic T-cell and macrophage infiltration and decreased expression of inflammatory mediators associated with NAFLD. In sum, our results indicate that the IL-17 axis also plays a role in a MCDD-induced model of NAFLD pathogenesis. Further, we show for the first time that IL-17F, and not only IL-17A, plays an important role in NAFLD driven inflammation.	[Giles, Daniel A.; Moreno-Fernandez, Maria E.; Stankiewicz, Traci E.; Cappelletti, Monica; Divanovic, Senad] Cincinnati Childrens Hosp Res Fdn, Div Immunobiol, Cincinnati, OH USA; [Giles, Daniel A.; Moreno-Fernandez, Maria E.; Stankiewicz, Traci E.; Cappelletti, Monica; Huppert, Stacey S.; Shanmukhappa, Shiva K.; Divanovic, Senad] Univ Cincinnati, Coll Med, Cincinnati, OH USA; [Huppert, Stacey S.] Cincinnati Childrens Hosp Res Fdn, Div Gastroenterol Hepatol & Nutr, Cincinnati, OH USA; [Iwakura, Yoichiro] Tokyo Univ Sci, Res Inst Biomed Sci, Noda, Chiba 278, Japan; [Dong, Chen] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA; [Shanmukhappa, Shiva K.] Cincinnati Childrens Hosp Res Fdn, Div Pathol & Lab Med, Cincinnati, OH USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; Tokyo University of Science; University of Texas System; UTMD Anderson Cancer Center; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation	Divanovic, S (corresponding author), Cincinnati Childrens Hosp Res Fdn, Div Immunobiol, Cincinnati, OH USA.; Divanovic, S (corresponding author), Univ Cincinnati, Coll Med, Cincinnati, OH USA.	senad.divanovic@cchmc.org	dong, chen/B-3181-2009; Huppert, Stacey S/A-4103-2010; Iwakura, Yoichiro/E-5457-2011	dong, chen/0000-0002-0084-9130; Huppert, Stacey S/0000-0003-3977-8728; Iwakura, Yoichiro/0000-0002-9934-5775	NIH [R01DK099222, R01DK099222-S1]; PHS [P30 DK078392]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK099222, P30DK078392] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by NIH R01DK099222 and R01DK099222-S1 (to S.D.) and by PHS Grant P30 DK078392 Pathology of the Digestive Disease Research Core Center at CCHMC. There was no additional external funding received for this study.	Ahmed M, 2013, CYTOKINE, V61, P898, DOI 10.1016/j.cyto.2012.12.007; Alam S, 2014, INDIAN J GASTROENTER, V33, P452, DOI 10.1007/s12664-014-0488-5; Anstee QM, 2006, INT J EXP PATHOL, V87, P1, DOI 10.1111/j.0959-9673.2006.00465.x; Baeck C, 2012, GUT, V61, P416, DOI 10.1136/gutjnl-2011-300304; Balanescu P, 2012, Rom J Intern Med, V50, P13; Chae MK, 2012, EXP DIABETES RES, DOI 10.1155/2012/762565; Chang SH, 2007, CELL RES, V17, P435, DOI 10.1038/cr.2007.35; Ciric B, 2009, J IMMUNOL, V182, P5296, DOI 10.4049/jimmunol.0900036; Cua DJ, 2010, NAT REV IMMUNOL, V10, P479, DOI 10.1038/nri2800; Divanovic S, 2005, NAT IMMUNOL, V6, P571, DOI 10.1038/ni1198; Divanovic S, 2012, J INFECT DIS, V205, P152, DOI 10.1093/infdis/jir621; Divanovic S, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001316; Du WJ, 2013, DIAGN PATHOL, V8, DOI 10.1186/1746-1596-8-40; Fabrega E, 2009, LIVER TRANSPLANT, V15, P629, DOI 10.1002/lt.21724; Gaffen SL, 2014, NAT REV IMMUNOL, V14, P585, DOI 10.1038/nri3707; Gaffen SL, 2009, NAT REV IMMUNOL, V9, P556, DOI 10.1038/nri2586; Giles DA, 2015, CURR DRUG TARGETS; Harley ITW, 2014, HEPATOLOGY, V59, P1830, DOI 10.1002/hep.26746; Huang TT, 2006, HUM MOL GENET, V15, P1187, DOI 10.1093/hmg/ddl034; Itagaki H, 2013, INT J CLIN EXP PATHO, V6, P2683; Jie ZL, 2014, J IMMUNOL, V192, P3289, DOI 10.4049/jimmunol.1303281; Jin W, 2013, EMERG MICROBES INFEC, V2, DOI 10.1038/emi.2013.58; Karlmark KR, 2009, HEPATOLOGY, V50, P261, DOI 10.1002/hep.22950; Kohli R, 2010, HEPATOLOGY, V52, P934, DOI 10.1002/hep.23797; Lan RYZ, 2009, J AUTOIMMUN, V32, P43, DOI 10.1016/j.jaut.2008.11.001; Lemmers A, 2009, HEPATOLOGY, V49, P646, DOI 10.1002/hep.22680; Li ZZ, 2009, J BIOL CHEM, V284, P5637, DOI 10.1074/jbc.M807616200; Liu Y, 2014, INT IMMUNOPHARMACOL, V23, P489, DOI 10.1016/j.intimp.2014.09.024; Lu L, 2013, J IMMUNOTHER, V36, P451, DOI 10.1097/CJI.0b013e3182a802cf; Martinez F.O., 2014, F1000PRIME REP, V6, DOI DOI 10.12703/P6-13; Meng FL, 2012, GASTROENTEROLOGY, V143, P765, DOI 10.1053/j.gastro.2012.05.049; Park HS, 2011, MOL CELLS, V32, P571, DOI 10.1007/s10059-011-0184-6; Peverill W, 2014, INT J MOL SCI, V15, P8591, DOI 10.3390/ijms15058591; Provenzano A, 2014, LIVER INT, V34, P918, DOI 10.1111/liv.12500; Rinella ME, 2008, J LIPID RES, V49, P1068, DOI 10.1194/jlr.M800042-JLR200; Rinella ME, 2011, HEPATOLOGY, V54, P1118, DOI 10.1002/hep.24634; Sundrud MS, 2013, SEMIN IMMUNOL, V25, P263, DOI 10.1016/j.smim.2013.10.021; Tiniakos DG, 2010, ANNU REV PATHOL-MECH, V5, P145, DOI 10.1146/annurev-pathol-121808-102132; Trujillo G, 2008, AM J PATHOL, V172, P1209, DOI 10.2353/ajpath.2008.070832; Vizzutti F, 2010, LAB INVEST, V90, P104, DOI 10.1038/labinvest.2009.112; Wang AJ, 2015, J IMMUNOL, V195, P4771, DOI 10.4049/jimmunol.1500337; Xu RF, 2013, ACTA BIOCH BIOPH SIN, V45, P726, DOI 10.1093/abbs/gmt065; Yamaguchi K, 2010, LAB INVEST, V90, P1169, DOI 10.1038/labinvest.2010.75; Yan S, 2012, IMMUNOL CELL BIOL, V90, P421, DOI 10.1038/icb.2011.59; Zhang JP, 2009, J HEPATOL, V50, P980, DOI 10.1016/j.jhep.2008.12.033; Zhang X, 2014, J HEPATOL, V61, P1365, DOI 10.1016/j.jhep.2014.07.006; Zigmond E, 2014, J IMMUNOL, V193, P344, DOI 10.4049/jimmunol.1400574; Zuniga LA, 2010, J IMMUNOL, V185, P6947, DOI 10.4049/jimmunol.1001269	48	67	70	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0149783	10.1371/journal.pone.0149783	http://dx.doi.org/10.1371/journal.pone.0149783			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3DG	26895034	gold, Green Published, Green Submitted			2022-12-26	WOS:000371223400081
J	Hehre, EJ; Meeuwig, JJ				Hehre, E. James; Meeuwig, Jessica J.			A Global Analysis of the Relationship between Farmed Seaweed Production and Herbivorous Fish Catch	PLOS ONE			English	Article							CORAL-REEFS; FISHERIES; PHILIPPINES; SIGANIDAE; RECOVERY; IMPACTS; FUTURE; DEGRADATION; BIOMASS; SHIFTS	Globally, farmed seaweed production is expanding rapidly in shallow marine habitats. While seaweed farming provides vital income to millions of artisanal farmers, it can negatively impact shallow coral reef and seagrass habitats. However, seaweed farming may also potentially provide food subsidies for herbivorous reef fish such as the Siganidae, a valuable target family, resulting in increased catch. Comparisons of reef fish landings across the central Philippines revealed that the catch of siganids was positively correlated to farmed seaweed production whilst negatively correlated to total reef fish catch over the same period of time. We tested the generality of this pattern by analysing seaweed production, siganid catch, and reef fish catch for six major seaweed-producing countries in the tropics. We hypothesized that increased seaweed production would correspond with increased catch of siganids but not other reef fish species. Analysis of the global data showed a positive correlation between farmed seaweeds and siganids in Southeast Asia (Indonesia, Malaysia, and the Philippines) but not Africa (Tanzania and Zanzibar), or the Western Pacific (Fiji). In Southeast Asia, siganid catch increased disproportionately faster with seaweed production than did reef fish catch. Low continuity, sporadic production and smaller volumes of seaweed farming may explain the differences.	[Hehre, E. James] Univ British Columbia, Sea Us Project, Inst Oceans & Fisheries, Vancouver, BC V5Z 1M9, Canada; [Meeuwig, Jessica J.] Univ Western Australia, Sch Anim Biol, Crawley, WA, Australia; [Meeuwig, Jessica J.] Univ Western Australia, Ctr Marine Futures, Crawley, WA, Australia	University of British Columbia; University of Western Australia; University of Western Australia	Hehre, EJ (corresponding author), Univ British Columbia, Sea Us Project, Inst Oceans & Fisheries, Vancouver, BC V5Z 1M9, Canada.	jhehre@gmail.com		Meeuwig, Jessica/0000-0003-1169-8785	Jerry and Jan Barto Foundation; Craig and Gigi Barto Foundation; Endeavour Fellowship; UBC Four Year Fellowship	Jerry and Jan Barto Foundation; Craig and Gigi Barto Foundation; Endeavour Fellowship; UBC Four Year Fellowship	This study was funded in part by The Jerry and Jan Barto Foundation, Craig and Gigi Barto Foundation, The Endeavour Fellowship, and the UBC Four Year Fellowship. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen DC, 2012, ECOLOGY, V93, P2165, DOI 10.1890/11-1541.1; Allen KR, 1971, RELATION PRODUCTION; Allison EH, 2001, MAR POLICY, V25, P377, DOI 10.1016/S0308-597X(01)00023-9; Anticamara JA, 2011, FISH RES, V107, P131, DOI 10.1016/j.fishres.2010.10.016; Armada N, 2009, COAST MANAGE, V37, P308, DOI 10.1080/08920750902851609; Badjeck MC, 2010, MAR POLICY, V34, P375, DOI 10.1016/j.marpol.2009.08.007; Beddington J.R., 1983, 242 FAO; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Bergman KC, 2001, MAR POLLUT BULL, V42, P1379, DOI 10.1016/S0025-326X(01)00168-0; BLANKENHORN SU, 2007, THESIS; Borsa P, 2007, MOL PHYLOGENET EVOL, V44, P427, DOI 10.1016/j.ympev.2007.01.015; Brandl SJ, 2014, CORAL REEFS, V33, P421, DOI 10.1007/s00338-013-1110-5; Brandl SJ, 2013, CORAL REEFS, V32, P835, DOI 10.1007/s00338-013-1042-0; Bryceson I, 2002, WEST INDIAN OCEAN J, V1, P1; Burke Lauretta, 2011, REEFS AT RISK; Chopin T, 2001, J PHYCOL, V37, P975, DOI 10.1046/j.1529-8817.2001.01137.x; Christensen V, 1995, NAGA ICLARM Q, P34; Christie P., 2006, COASTAL ENV FISHERIE, P1; de la Torre-Castro M, 2010, MAR POLICY, V34, P77, DOI 10.1016/j.marpol.2009.04.012; Eklof JS, 2006, MAR ECOL PROG SER, V325, P73, DOI 10.3354/meps325073; FAO (Food and Agriculture Organization of the United Nations) Fisheries and Aquaculture Department, 2012, THE STATE OF THE WOR; Fox RJ, 2008, CORAL REEFS, V27, P605, DOI 10.1007/s00338-008-0359-6; Fox RJ, 2009, MAR ECOL PROG SER, V385, P261, DOI 10.3354/meps08059; Frocklin S, 2011, WORLD AQUACULTURE, V356, P30; Graham NAJ, 2006, P NATL ACAD SCI USA, V103, P8425, DOI 10.1073/pnas.0600693103; Graham NAJ, 2015, NATURE, V518, P94, DOI 10.1038/nature14140; Graham NAJ, 2014, CURR BIOL, V24, pR359, DOI 10.1016/j.cub.2014.03.069; Green S, 2004, FLUID VORTICES, P1; Harper S, 2011, FISHERIES CATCH RE 2, P19; Hehre EJ, 2015, PLOS ONE, P1; Hill NAO, 2012, CONSERV BIOL, V26, P324, DOI 10.1111/j.1523-1739.2011.01796.x; Hoey AS, 2013, CORAL REEFS, V32, P973, DOI 10.1007/s00338-013-1043-z; Hoey AS, 2011, ECOL LETT, V14, P267, DOI 10.1111/j.1461-0248.2010.01581.x; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Jennings S, 1996, AMBIO, V25, P44; Juanich GL, 1988, MANUAL SEAWEED FARMI; Kite-Powell H, 2005, INTEGRATED SEAWEED S, P12; Knowlton N, 2001, P NATL ACAD SCI USA, V98, P5419, DOI 10.1073/pnas.091092998; Lal A., 2010, SPC WOMEN FISHERIES, V21, P11; LAM TJ, 1974, AQUACULTURE, V3, P325, DOI 10.1016/0044-8486(74)90001-5; MacNeil MA, 2015, NATURE, V520, P341, DOI 10.1038/nature14358; Mantyka CS, 2007, CORAL REEFS, V26, P435, DOI 10.1007/s00338-007-0214-1; Marcus JE, 2007, MAR POLLUT BULL, V54, P1483, DOI 10.1016/j.marpolbul.2007.04.011; Maunder MN, 2006, ICES J MAR SCI, V63, P1373, DOI 10.1016/j.icesjms.2006.05.008; McClanahan TR, 2007, ECOL APPL, V17, P1055, DOI 10.1890/06-1450; McCook LJ, 1997, MAR BIOL, V129, P713, DOI 10.1007/s002270050214; McManus JW, 1997, CORAL REEFS, V16, pS121, DOI 10.1007/s003380050248; Msuya F.E., 2007, COMP EC ANAL 2 SEAWE, P27; Munro J, 1996, CHAPMAN HALL FISH FI, DOI [10.1007/978-94-015-8779-2_1, DOI 10.1007/978-94-015-8779-2_1]; Myers RA, 2003, NATURE, V423, P280, DOI 10.1038/nature01610; NORBERG RA, 1977, J ANIM ECOL, V46, P511, DOI 10.2307/3827; OGDEN J C, 1978, Environmental Biology of Fishes, V3, P49, DOI 10.1007/BF00006308; ORTH RJ, 1984, ESTUARIES, V7, P339, DOI 10.2307/1351618; Pauly D., 1994, TRADITIONAL MARINE R, V3, P7; Pettersson-Lofquist P., 1995, SOCIAL EC CHANGE ZAN; Polunin NVC, 1996, TROPHODYNAMICS REEF; Rasher DB, 2013, ECOLOGY, V94, P1347, DOI 10.1890/12-0389.1; Robinson J, 2007, INVESTIGATION IMPORT; Rogers A, 2014, CURR BIOL, V24, P1000, DOI 10.1016/j.cub.2014.03.026; Samoilys M. A., 2013, WIOMSA BOOK SERIES, V13, P33; Sievanen L, 2005, OCEAN COAST MANAGE, V48, P297, DOI 10.1016/j.ocecoaman.2005.04.015; SOLIMAN VS, 2008, KUROSHIO SCI, V2, P67; Spalding M. D., 2001, WORLD ATLAS CORAL RE; Swartz W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015143; Vincent I. V., 2011, Western Indian Ocean Journal of Marine Science, V10, P83; Williamson DH, 2014, ECOL EVOL, V4, P337, DOI 10.1002/ece3.934; Wilson SK, 2010, ECOL APPL, V20, P442, DOI 10.1890/08-2205.1; Woodland DJ, 1990, INDOPACIIFIC FISH; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294; Worm B, 2012, TRENDS ECOL EVOL, V27, P594, DOI 10.1016/j.tree.2012.07.005; Zar JH., 2010, BIOSTAT ANAL, V5th	73	23	25	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0148250	10.1371/journal.pone.0148250	http://dx.doi.org/10.1371/journal.pone.0148250			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3DG	26894553	Green Published, Green Submitted, gold			2022-12-26	WOS:000371223400011
J	Shashkova, T; Popenko, A; Tyakht, A; Peskov, K; Kosinsky, Y; Bogolubsky, L; Raigorodskii, A; Ischenko, D; Alexeev, D; Govorun, V				Shashkova, Tatiana; Popenko, Anna; Tyakht, Alexander; Peskov, Kirill; Kosinsky, Yuri; Bogolubsky, Lev; Raigorodskii, Andrei; Ischenko, Dmitry; Alexeev, Dmitry; Govorun, Vadim			Agent Based Modeling of Human Gut Microbiome Interactions and Perturbations	PLOS ONE			English	Article							CHAIN FATTY-ACIDS; ANTIBIOTIC PERTURBATION; GASTROINTESTINAL-TRACT; INTESTINAL MICROBIOTA; BACTERIAL BIOFILMS; METABOLISM; DYNAMICS; COLON; SUSCEPTIBILITY; INFLAMMATION	Background Intestinal microbiota plays an important role in the human health. It is involved in the digestion and protects the host against external pathogens. Examination of the intestinal microbiome interactions is required for understanding of the community influence on host health. Studies of the microbiome can provide insight on methods of improving health, including specific clinical procedures for individual microbial community composition modification and microbiota correction by colonizing with new bacterial species or dietary changes. Methodology/Principal Findings In this work we report an agent-based model of interactions between two bacterial species and between species and the gut. The model is based on reactions describing bacterial fermentation of polysaccharides to acetate and propionate and fermentation of acetate to butyrate. Antibiotic treatment was chosen as disturbance factor and used to investigate stability of the system. System recovery after antibiotic treatment was analyzed as dependence on quantity of feedback interactions inside the community, therapy duration and amount of antibiotics. Bacterial species are known to mutate and acquire resistance to the antibiotics. The ability to mutate was considered to be a stochastic process, under this suggestion ratio of sensitive to resistant bacteria was calculated during antibiotic therapy and recovery. Conclusion/Significance The model confirms a hypothesis of feedbacks mechanisms necessity for providing functionality and stability of the system after disturbance. High fraction of bacterial community was shown to mutate during antibiotic treatment, though sensitive strains could become dominating after recovery. The recovery of sensitive strains is explained by fitness cost of the resistance. The model demonstrates not only quantitative dynamics of bacterial species, but also gives an ability to observe the emergent spatial structure and its alteration, depending on various feedback mechanisms. Visual version of the model shows that spatial structure is a key factor, which helps bacteria to survive and to adapt to changed environmental conditions.	[Shashkova, Tatiana; Popenko, Anna; Tyakht, Alexander; Ischenko, Dmitry; Alexeev, Dmitry; Govorun, Vadim] Res Inst Phys Chem Med, Malaya Pirogovskaya 1a, Moscow 119435, Russia; [Shashkova, Tatiana; Alexeev, Dmitry] Moscow Inst Phys & Technol, Inst Skiy Pereulok 9, Dolgoprudnyi 141700, Russia; [Peskov, Kirill; Kosinsky, Yuri] M&S Decis LLC, Narishkinskaya Alleya 5, Moscow 125167, Russia; [Bogolubsky, Lev; Raigorodskii, Andrei] Yandex LLC, 16 Leo Tolstoy St, Moscow 119021, Russia	Lopukhin Federal Research & Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency; Moscow Institute of Physics & Technology	Alexeev, D (corresponding author), Res Inst Phys Chem Med, Malaya Pirogovskaya 1a, Moscow 119435, Russia.; Alexeev, D (corresponding author), Moscow Inst Phys & Technol, Inst Skiy Pereulok 9, Dolgoprudnyi 141700, Russia.	alexeev@niifhm.ru	Govorun, Vadim M/A-9043-2018; Tyakht, Alexander/O-1327-2015; Shashkova, Tatiana/AAO-3579-2020; Alexeev, Dmitry/A-6167-2013; Raigorodskii, Andrei M/L-5095-2017	Shashkova, Tatiana/0000-0002-8754-8727; Alexeev, Dmitry/0000-0003-0783-1176; Raigorodskii, Andrei/0000-0001-8614-9612; Bogolubsky, Lev/0000-0001-6178-7239; Tyakht, Alexander/0000-0002-7358-2537; Peskov, Kirill/0000-0003-0678-5729	Russian ministry of education and science [14.604.21.0119]; Rusiina scientific foundation [15-14-00066]; Russian Science Foundation [15-14-00066] Funding Source: Russian Science Foundation	Russian ministry of education and science(Ministry of Education and Science, Russian Federation); Rusiina scientific foundation; Russian Science Foundation(Russian Science Foundation (RSF))	Russian ministry of education and science-grant number 14.604.21.0119-supported the data collection and Rusiina scientific foundation-grant 15-14-00066-supported the model development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcock J, 2014, BIOESSAYS, V36, P940, DOI 10.1002/bies.201400071; An G., 2013, WILEY INTERDISCIP RE, V1, P156; An G, 2008, THEOR BIOL MED MODEL, V5, DOI 10.1186/1742-4682-5-11; Ananthasubramaniam B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104761; Andersson DI, 2010, NAT REV MICROBIOL, V8, P260, DOI 10.1038/nrmicro2319; Antonopoulos DA, 2009, INFECT IMMUN, V77, P2367, DOI 10.1128/IAI.01520-08; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; BERGMAN EN, 1990, PHYSIOL REV, V70, P567, DOI 10.1152/physrev.1990.70.2.567; Bucci V, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002497; Bucci V, 2011, AM NAT, V178, pE162, DOI 10.1086/662668; Carey HV, 2013, AM J PHYSIOL-REG I, V304, pR33, DOI 10.1152/ajpregu.00387.2012; Cerf-Bensussan N, 2010, NAT REV IMMUNOL, V10, P735, DOI 10.1038/nri2850; Cinquin O, 2002, J THEOR BIOL, V216, P229, DOI 10.1006/jtbi.2002.2544; Claesson MJ, 2012, NATURE, V488, P178, DOI 10.1038/nature11319; Cockrell C, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003507; Costello EK, 2012, SCIENCE, V336, P1255, DOI 10.1126/science.1224203; Davey ME, 2000, MICROBIOL MOL BIOL R, V64, P847, DOI 10.1128/MMBR.64.4.847-867.2000; den Besten G, 2013, J LIPID RES, V54, P2325, DOI 10.1194/jlr.R036012; Dethlefsen L, 2011, P NATL ACAD SCI USA, V108, P4554, DOI 10.1073/pnas.1000087107; Dicksved J, 2008, ISME J, V2, P716, DOI 10.1038/ismej.2008.37; Dodd D, 2010, J BIOL CHEM, V285, P30261, DOI 10.1074/jbc.M110.141788; Faust K, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002606; Faust K, 2012, NAT REV MICROBIOL, V10, P538, DOI 10.1038/nrmicro2832; Fernandes J, 2014, NUTR DIABETES, V4, DOI 10.1038/nutd.2014.23; Flint HJ, 2012, GUT MICROBES, V3, P289, DOI 10.4161/gmic.19897; Frey E, 2010, PHYSICA A, V389, P4265, DOI 10.1016/j.physa.2010.02.047; Gore J, 2009, NATURE, V459, P253, DOI 10.1038/nature07921; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; HARIG JM, 1991, AM J PHYSIOL, V260, pG776, DOI 10.1152/ajpgi.1991.260.5.G776; Heinken A, 2015, WIRES SYST BIOL MED, V7, P195, DOI 10.1002/wsbm.1301; Heinken A, 2015, APPL ENVIRON MICROB, V81, P4049, DOI 10.1128/AEM.00101-15; Hu YF, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3151; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Inglis R. F., 2013, BIOL LETT, V9, P8; Johnson S, 2014, P NATL ACAD SCI USA, V111, P17923, DOI 10.1073/pnas.1409077111; Kau AL, 2011, NATURE, V474, P327, DOI 10.1038/nature10213; Koren O, 2012, CELL, V150, P470, DOI 10.1016/j.cell.2012.07.008; Levy R, 2013, P NATL ACAD SCI USA, V110, P12804, DOI 10.1073/pnas.1300926110; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Li XX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026542; Li YH, 2012, SENSORS-BASEL, V12, P2519, DOI 10.3390/s120302519; Lidicker WZ, 1979, CLARIFICATION INTERA, V29, P475; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; Lupton JR, 2004, J NUTR, V134, P479, DOI 10.1093/jn/134.2.479; Mahowald MA, 2009, P NATL ACAD SCI USA, V106, P5859, DOI 10.1073/pnas.0901529106; Mariat D, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-123; Marino S, 2014, P NATL ACAD SCI USA, V111, P439, DOI 10.1073/pnas.1311322111; MAY RM, 1975, SIAM J APPL MATH, V29, P243, DOI 10.1137/0129022; Moreira CG, 2010, INFECT IMMUN, V78, P914, DOI 10.1128/IAI.01038-09; Morohashi M, 2002, J THEOR BIOL, V216, P19, DOI 10.1006/jtbi.2002.2537; Nadell CD, 2009, FEMS MICROBIOL REV, V33, P206, DOI 10.1111/j.1574-6976.2008.00150.x; Panda S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095476; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Rendulic S, 2004, SCIENCE, V303, P689, DOI 10.1126/science.1093027; Rhee Sang H, 2013, PRINCIPLES AND CLINI, P6; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Russell SL, 2012, EMBO REP, V13, P440, DOI 10.1038/embor.2012.32; Sahoo S, 2015, FEBS J, V282, P297, DOI 10.1111/febs.13128; Scheuring I, 2012, ECOL LETT, V15, P1300, DOI 10.1111/j.1461-0248.2012.01853.x; Schluter J, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001424; Schwiertz A, 2010, OBESITY, V18, P190, DOI 10.1038/oby.2009.167; Sekirov I, 2008, INFECT IMMUN, V76, P4726, DOI 10.1128/IAI.00319-08; Seth EC, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00350; Shulzhenko N, 2011, NAT MED, V17, P1585, DOI 10.1038/nm.2505; Sommer MOA, 2011, CURR OPIN MICROBIOL, V14, P556, DOI 10.1016/j.mib.2011.07.005; Stein RR, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003388; Theriot CM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4114; Tosh PK, 2012, CLIN INFECT DIS, V54, P707, DOI 10.1093/cid/cir899; Tyakht AV, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3469; VONENGELHARDT W, 1994, J PHYSIOL-LONDON, V477, P365, DOI 10.1113/jphysiol.1994.sp020198; Vos M, 2009, ISME J, V3, P199, DOI 10.1038/ismej.2008.93; Wagener S, 2004, J PEDIATR SURG, V39, P166, DOI 10.1016/j.jpedsurg.2003.10.002; Winter SE, 2010, NATURE, V467, P426, DOI 10.1038/nature09415; Wintermute EH, 2010, GENE DEV, V24, P2603, DOI 10.1101/gad.1985210; Zoetendal EG, 2002, APPL ENVIRON MICROB, V68, P3401, DOI 10.1128/AEM.68.7.3401-3407.2002	75	35	37	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0148386	10.1371/journal.pone.0148386	http://dx.doi.org/10.1371/journal.pone.0148386			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3DG	26894828	gold, Green Published			2022-12-26	WOS:000371223400013
J	Kolawole, KA; Folayan, MO; Agbaje, HO; Oyedele, TA; Oziegbe, EO; Onyejaka, NK; Chukwumah, NM; Oshomoji, OV				Kolawole, Kikelomo Adebanke; Folayan, Morenike Oluwatoyin; Agbaje, Hakeem Olatunde; Oyedele, Titus Ayodeji; Oziegbe, Elizabeth Obhioneh; Onyejaka, Nneka Kate; Chukwumah, Nneka Maureen; Oshomoji, Olusegun Victor			Digit Sucking Habit and Association with Dental Caries and Oral Hygiene Status of Children Aged 6 Months to 12 Years Resident in Semi-Urban Nigeria	PLOS ONE			English	Article							THUMB-SUCKING; HEALTH; EXPERIENCE; DENTITION; GENDER	Objectives Non-nutritive sucking (NNS) is a common behavior in childhood. The association between digit sucking, dental caries and oral health has been studied with inconclusive results. The objectives of this study were to determine the prevalence of, and the association between digit sucking, caries and oral hygiene status of children age six months to 12 years, resident in Ile-Ife, Osun State, Nigeria. Methods A cross-sectional study was conducted in Ife Central Local Government Area of Osun State. Data were collected through a household survey using a multi-stage sampling procedure from children between six months and 12 years. Details of each child's socio-demographic characteristics, digit sucking habits, caries status and oral health status were collected. The association between digit sucking, caries status and oral hygiene status was determined using Chi square and Logistic regression. Results The mean age of the 992 study participants was 5.8 +/- (3.2) years. The prevalence of digit sucking, caries and poor oral hygiene were 7.2%, 10.5% and 2.4% respectively. The mean dmft score was 0.22 +/- (0.80), mean DMFT score was 0.04 +/- (0.30) while mean Oral Hygiene Index score was 1.27 +/- (0.73). Digit sucking increased the odds of having caries (OR: 1.28; CI: 0.58-2.81) but decreased the odds of having poor oral hygiene (OR: 0.58; CI: 0.341.01) insignificantly. Conclusions Digit sucking was not a significant predictor of caries and oral hygiene status, although the odds of having caries increased while the odds of having poor oral hygiene decreased with digit sucking.	[Kolawole, Kikelomo Adebanke; Folayan, Morenike Oluwatoyin; Oziegbe, Elizabeth Obhioneh] Obafemi Awolowo Univ, Fac Dent, Dept Child Dent Hlth, Ife, Osun State, Nigeria; [Agbaje, Hakeem Olatunde; Oyedele, Titus Ayodeji; Onyejaka, Nneka Kate; Chukwumah, Nneka Maureen; Oshomoji, Olusegun Victor] Obafemi Awolowo Univ, Teaching Hosp Complex, Dept Child Dent Hlth, Ife, Osun State, Nigeria	Obafemi Awolowo University; Obafemi Awolowo University	Kolawole, KA (corresponding author), Obafemi Awolowo Univ, Fac Dent, Dept Child Dent Hlth, Ife, Osun State, Nigeria.	kikelomokolawole@gmail.com	Kate, Onyejaka Nneka/W-3283-2019; Folayan, Morenike/A-8632-2018	Folayan, Morenike/0000-0002-9008-7730; Agbaje, Hakeem/0000-0002-8257-5283				Adair Steven M, 2003, Pediatr Dent, V25, P449; Akpata ES, 2009, AFR HEALTH SCI, V9, P227; Al-Jobair A, 2004, Int J Paediatr Dent, V14, P347, DOI 10.1111/j.1365-263X.2004.00567.x; [Anonymous], 2003, RES METHODOLOGY STAT; [Anonymous], 1934, WEBST NEW INT DICT; Boing Antonio Fernando, 2014, Rev. bras. epidemiol., V17, P102, DOI 10.1590/1809-4503201400060009; Cinar Dede Nursan, 2004, Contemp Nurse, V17, P109; Du MQ, 2007, QUINTESSENCE INT, V38, P143; Dye BA, 2015, SERVICES USDOHAH; Ferri M, 2010, INT J BIOMED IMAGING, V2010, DOI [10.1155/2010/621357, 10.1155/2010/649643]; Folayan M O, 2004, Eur J Paediatr Dent, V5, P19; Folayan M O, 2003, Int J Paediatr Dent, V13, P20, DOI 10.1046/j.1365-263X.2003.00411.x; Folayan M, 2007, AM J PHYS ANTHROPOL, V134, P443, DOI 10.1002/ajpa.20635; Folayan Morenike, 2008, J Clin Pediatr Dent, V32, P171; Folayan MO, 2014, BMC ORAL HEALTH, V14, DOI 10.1186/1472-6831-14-156; FRIMAN PC, 1993, PEDIATRICS, V91, P784; Gopinath Vellore Kannan, 2015, Eur J Dent, V9, P36, DOI 10.4103/1305-7456.149636; GREENE JC, 1964, J AM DENT ASSOC, V68, P7, DOI 10.14219/jada.archive.1964.0034; Ha DH, 2014, AUST J RURAL HEALTH, V22, P316, DOI 10.1111/ajr.12107; Jyoti S, 2014, DENTISTRY, V4, P1; Khanal S, 2014, Nepal Med Coll J, V16, P84; Kharbanda O P, 2003, J Indian Soc Pedod Prev Dent, V21, P120; Kolawole KA, 2011, INT J DENT HYG, V9, P143, DOI 10.1111/j.1601-5037.2010.00466.x; Misbah M.M., 2005, J BAGHDAD COLL DENT, V17, P109; Natto Z S, 2014, Niger Postgrad Med J, V21, P241; Nicklisch N, 2015, ANN ANAT; Olusanya O., 1985, W AFR J MED, V4, P205; Oredugba F., 2012, ORAL HLTH CARE PEDIA, P69, DOI [10.5772/21727, DOI 10.5772/21727]; Oziegbe EO, 2013, EUR ARCH PAEDIATR DE, V14, P227, DOI 10.1007/s40368-013-0052-5; Peres KG, 2007, REV SAUDE PUBL, V41, P343, DOI 10.1590/S0034-89102007000300004; Petersen PE, 2004, INT DENT J, V54, P329; Proffit W, 2007, ORTODONCJA WSPOLCZES, V4th; Quashie-Williams R, 2010, Niger Postgrad Med J, V17, P113; Rowe N H, 1976, Pediatrics, V57, P457; Salah Afraa, 2007, Int J Orofacial Myology, V33, P37; Sgan-Cohen HD, 2014, COMMUNITY DENT HLTH, V31, P163, DOI 10.1922/CDH_3362Cohen04; Singh G, 2017, TXB ORTHODONTICS; Sowole A, 2007, Eur Arch Paediatr Dent, V8, P206; TurgeonOBrien H, 1996, J DENT CHILD, V63, P321; Vallejos-Sanchez AA, 2006, J DENT, V34, P709, DOI 10.1016/j.jdent.2006.01.003; Warren JJ, 2002, AM J ORTHOD DENTOFAC, V121, P347, DOI 10.1067/mod.2002.121445; WATSON TS, 1993, J AM ACAD CHILD PSY, V32, P830, DOI 10.1097/00004583-199307000-00019; WHO, 1997, WHO ORAL HLTH SURV B; Yonezu Takuro, 2008, Bull Tokyo Dent Coll, V49, P59, DOI 10.2209/tdcpublication.49.59; Zeng XJ, 2014, BMC ORAL HEALTH, V14, DOI 10.1186/1472-6831-14-138	45	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2016	11	2							e0148322	10.1371/journal.pone.0148322	http://dx.doi.org/10.1371/journal.pone.0148322			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3CO	26890262	Green Published, Green Submitted, gold			2022-12-26	WOS:000371221500008
J	Liu, XY; Winterton, SL				Liu, Xingyue; Winterton, Shaun L.			A New Fishfly Species (Megaloptera: Corydalidae: Neohermes Banks) Discovered from North America by a Systematic Revision, with Phylogenetic and Biogeographic Implications	PLOS ONE			English	Article							UNITED-STATES; GENUS; VICARIANCE; DISPERSAL; SIALIDAE	The taxonomy of Megaloptera from the Nearctic region is fairly well known and their faunal diversity has been largely surveyed, even in relatively remote regions. However, the evolutionary history of Nearctic Megaloptera is still poorly known with phylogenetic and biogeographic studies lacking. In this paper, we report a new fishfly species of the endemic North American genus Neohermes Banks, 1908, increasing the total number known of species to six. This new species (Neohermes inexpectatus sp. nov.) is currently known to occur only in California (USA) and is apparently confined to the Northern Coastal Range. The new species resembles the three Neohermes species from eastern North America based on the relatively small body size and the presence of female gonostyli 9. However, our phylogenetic analysis using adult morphological data recovered the new species as the sister species to the remaining Neohermes, which includes two species from western North America and three from eastern North America. According to the present interspecific phylogeny of Neohermes, with reconstructed ancestral areas, the initial divergence within the genus was found to take place in western North America, with a subsequent eastward dispersal. This likely lead to the modern distribution of Neohermes in eastern North America with the closure of the Mid-Continental Seaway, which separated western and eastern North America in the Mid-Late Cretaceous (100-80 MYA) and finally disappeared at the end of the Cretaceous (70 MYA). The uplift of the Cordilleran System probably accounted for the divergence between the eastern and two western Neohermes species.	[Liu, Xingyue] China Agr Univ, Dept Entomol, Beijing 100193, Peoples R China; [Winterton, Shaun L.] Calif Dept Food & Agr, Calif State Collect Arthropods, Sacramento, CA 95814 USA	China Agricultural University; California Department of Food & Agriculture	Liu, XY (corresponding author), China Agr Univ, Dept Entomol, Beijing 100193, Peoples R China.	xingyue_liu@yahoo.com	Liu, Xingyue/A-3019-2013	Liu, Xingyue/0000-0002-9168-0659	National Natural Science Foundation of China [31322501, 41271063]; Foundation for the Author of National Excellent Doctoral Dissertation of PR China [201178]; United States National Science Foundation [DEB-1144119]; Division Of Environmental Biology [1144119] Funding Source: National Science Foundation	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation for the Author of National Excellent Doctoral Dissertation of PR China(Foundation for the Author of National Excellent Doctoral Dissertation of China); United States National Science Foundation(National Science Foundation (NSF)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was supported by the National Natural Science Foundation of China (Nos. 31322501 and 41271063), the Foundation for the Author of National Excellent Doctoral Dissertation of PR China (No. 201178) and the United States National Science Foundation (DEB-1144119).	Aspock H, 1980, NEUROPTEREN EUROPAS, V1; Avise John C., 1996, P431; Banks N., 1903, Proceedings of the Entomological Society of Washington, Vv, P237; Banks Nathan, 1908, Proceedings of the Entomological Society of Washington DC, V10; Bowles David E., 1992, Insecta Mundi, V6, P145; Contreras-Ramos A., 1998, MARYLAND T SAY MONOG; Contreras-Ramos A., 2007, ANN MUSEO CIVICO STO, V8, P67; Contreras-Ramos A, 2008, ANN ENTOMOL SOC AM, V101, P808, DOI 10.1603/0013-8746(2008)101[808:NOSNAS]2.0.CO;2; Contreras-Ramos A, 2011, ZOOTAXA, P1; Dedering U., 2010, WIKIMEDIA COMMONS FR; Evans E.D., 1972, THESIS OREGON STATE; EVANS ED, 1984, PAN-PAC ENTOMOL, V60, P1; FLINT O S JR, 1973, Revista Chilena de Entomologia, V7, P31; FLINT OLIVER S., 1965, PSYCHE J ENTOMOL [CAMBRIDGE MASSACHUSETTS], V72, P255; GLORIOSO MJ, 1981, SYST ENTOMOL, V6, P253, DOI 10.1111/j.1365-3113.1981.tb00440.x; GOLOBOFF PA, 1993, CLADISTICS, V9, P83, DOI 10.1111/j.1096-0031.1993.tb00209.x; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Johnson KP, 2011, J BIOGEOGR, V38, P1069, DOI 10.1111/j.1365-2699.2011.02501.x; Liu X.Y., 2010, FAUNA SINICA INSECTA, V51; Liu XY, 2016, SYST ENTOMOL, V41, P256, DOI 10.1111/syen.12154; Liu XY, 2015, ARTHROPOD SYST PHYLO, V73, P41; Liu XY, 2015, CLADISTICS, V31, P18, DOI 10.1111/cla.12071; Liu XY, 2011, ZOOTAXA, P1; Liu XY, 2014, ZOOTAXA, V3796, P320, DOI 10.11646/zootaxa.3796.2.5; Liu XY, 2013, SYST ENTOMOL, V38, P543, DOI 10.1111/syen.12009; Liu XY, 2012, SYST ENTOMOL, V37, P657, DOI 10.1111/j.1365-3113.2012.00635.x; Liu XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040345; Liu XY, 2009, ZOOTAXA, P22, DOI 10.11646/zootaxa.2146.1.2; Misof B, 2014, SCIENCE, V346, P763, DOI 10.1126/science.1257570; New Timothy R., 1993, Handbuch der Zoologie (Berlin), V4, P1; Nixon K.C., 2002, WINCLADA VER 1 00 08; Oswald J.D., 2015, NEUROPTERIDA SPECIES; Pauly GB, 2007, MOL ECOL, V16, P415, DOI 10.1111/j.1365-294X.2006.03149.x; PENNY ND, 1993, ENTOMOL NEWS, V104, P17; Ronquist F, 1997, SYST BIOL, V46, P195, DOI 10.2307/2413643; Ross H. H., 1937, ILLINOIS NATURAL HIS, V21, P57; Sanmartin I, 2001, BIOL J LINN SOC, V73, P345, DOI 10.1006/bijl.2001.0542; TARTER DC, 1979, ENTOMOL NEWS, V90, P29; THEISCHINGER G, 1983, AQUAT INSECT, V5, P77, DOI 10.1080/01650428309361130; VSHIVKOVA T S, 1985, Entomologicheskoe Obozrenie, V64, P146; WHITING MF, 1991, GREAT BASIN NAT, V51, P411; Yu Y., 2011, RASP RECONSTRUCT ANC	42	1	1	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0148319	10.1371/journal.pone.0148319	http://dx.doi.org/10.1371/journal.pone.0148319			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26886194	Green Published, gold, Green Submitted			2022-12-26	WOS:000371218400030
J	Barnes, JC; Boutwell, BB; Miller, JM; DeShay, RA; Beaver, KM; White, N				Barnes, J. C.; Boutwell, Brian B.; Miller, J. Mitchell; DeShay, Rashaan A.; Beaver, Kevin M.; White, Norman			Exposure to Pre- and Perinatal Risk Factors Partially Explains Mean Differences in Self-Regulation between Races	PLOS ONE			English	Article							LOW-BIRTH-WEIGHT; DISPARITIES; CARE; HEALTH; OUTCOMES; SMOKING; DELINQUENCY; GOTTFREDSON; BEHAVIORS; PREGNANCY	Objectives To examine whether differential exposure to pre- and perinatal risk factors explained differences in levels of self-regulation between children of different races (White, Black, Hispanic, Asian, and Other). Methods Multiple regression models based on data from the Early Childhood Longitudinal Study, Birth Cohort (n approximate to 9,850) were used to analyze the impact of pre- and perinatal risk factors on the development of self-regulation at age 2 years. Results Racial differences in levels of self-regulation were observed. Racial differences were also observed for 9 of the 12 pre-/perinatal risk factors. Multiple regression analyses revealed that a portion of the racial differences in self-regulation was explained by differential exposure to several of the pre-/perinatal risk factors. Specifically, maternal age at childbirth, gestational timing, and the family's socioeconomic status were significantly related to the child's level of self-regulation. These factors accounted for a statistically significant portion of the racial differences observed in self-regulation. Conclusions The findings indicate racial differences in self-regulation may be, at least partially, explained by racial differences in exposure to pre- and perinatal risk factors.	[Barnes, J. C.] Univ Cincinnati, Sch Criminal Justice, Cincinnati, OH USA; [Boutwell, Brian B.; White, Norman] St Louis Univ, Coll Publ Hlth & Social Justice, Sch Social Work, Criminol & Criminal Justice, St Louis, MO 63103 USA; [Boutwell, Brian B.] St Louis Univ, Coll Publ Hlth & Social Justice, Dept Epidemiol Secondary Appointment, St Louis, MO 63103 USA; [Miller, J. Mitchell] Univ N Florida, Dept Criminol & Criminal Justice, Jacksonville, FL USA; [DeShay, Rashaan A.] Calif State Univ Stanislaus, Dept Criminal Justice, Turlock, CA 95382 USA; [Beaver, Kevin M.] Florida State Univ, Coll Criminol & Criminal Justice, Tallahassee, FL 32306 USA	University System of Ohio; University of Cincinnati; Saint Louis University; Saint Louis University; State University System of Florida; University of North Florida; California State University System; California State University Stanislaus; State University System of Florida; Florida State University	Barnes, JC (corresponding author), Univ Cincinnati, Sch Criminal Justice, Cincinnati, OH USA.	jc.barnes@uc.edu	Beaver, Kevin M./B-4631-2013	DeShay, Rashaan/0000-0003-2360-9858; Barnes, J.C./0000-0001-6932-5397				AHADI SA, 1993, EUR J PERSONALITY, V7, P359, DOI 10.1002/per.2410070506; Alexander GR, 2005, OBSTET GYN CLIN N AM, V32, P1, DOI 10.1016/j.ogc.2004.10.005; Alexander GR, 2002, MENT RETARD DEV D R, V8, P215, DOI 10.1002/mrdd.10047; Alexander GR, 2002, AM J PUBLIC HEALTH, V92, P1970, DOI 10.2105/AJPH.92.12.1970; Alexander GR, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.06.006; Allison PD, 2002, MISSING DATA; Baler RD, 2008, J PSYCHIATR NEUROSCI, V33, P187; Barkley R. A., 1997, ADHD NATURE SELF CON; Barnes JC, 2013, DEV PSYCHOL, V49, P2272, DOI 10.1037/a0032061; Beaver KM, 2014, MERRILL PALMER QUART, V60, P142, DOI 10.13110/merrpalmquar1982.60.2.0142; Beaver KM, 2013, PERS INDIV DIFFER, V55, P29, DOI 10.1016/j.paid.2013.01.020; Beaver KM, 2005, INT J OFFENDER THER, V49, P450, DOI 10.1177/0306624X05274687; Bengiamin MI, 2010, MATERN CHILD HLTH J, V14, P618, DOI 10.1007/s10995-009-0485-y; Berger A, 2007, PROG NEUROBIOL, V82, P256, DOI 10.1016/j.pneurobio.2007.06.004; Bethel J., 2005, ECLS B METHODOLOGY R, V2; Boutwell BB, 2010, J RES CRIME DELINQ, V47, P174, DOI 10.1177/0022427809357715; Bronson MB, 2000, SELF-REGULATION IN EARLY CHILDHOOD, P1; Burke W, 2007, JAMA-J AM MED ASSOC, V298, P1682, DOI 10.1001/jama.298.14.1682; Caspi A, 2001, PSYCHOL INQ, V12, P49, DOI 10.1207/S15327965PLI1202_01; D'Onofrio BM, 2008, DEV PSYCHOPATHOL, V20, P139, DOI 10.1017/S0954579408000072; D'Onofrio BM, 2009, J CHILD PSYCHOL PSYC, V50, P1018, DOI 10.1111/j.1469-7610.2009.02068.x; DeGangi GA., 1995, INFANT TODDLER SYMPT; Executive Office of the President Office of Management and Budget, 2000, STAND OCC CLASS MAN; FISCELLA K, 1995, OBSTET GYNECOL, V85, P468, DOI 10.1016/0029-7844(94)00408-6; Gibson CL, 2010, J RES CRIME DELINQ, V47, P31, DOI 10.1177/0022427809348903; Gottfredson M.R., 1990, GEN THEORY CRIME; Graham JW, 2009, ANNU REV PSYCHOL, V60, P549, DOI 10.1146/annurev.psych.58.110405.085530; Hay C, 2006, CRIMINOLOGY, V44, P739, DOI 10.1111/j.1745-9125.2006.00062.x; Heaman M.I., 2008, BMC PREGNANCY CHILDB, V8; Herrnstein Richard J., 1994, THE BELL CURVE INTEL; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Leblanc N, 2008, J ABNORM CHILD PSYCH, V36, P977, DOI 10.1007/s10802-008-9227-7; LYNAM D, 1993, J ABNORM PSYCHOL, V102, P187, DOI 10.1037/0021-843X.102.2.187; Lynch JL, 2011, SOCIOL INQ, V81, P499, DOI 10.1111/j.1475-682X.2011.00390.x; MARKUS HR, 1991, PSYCHOL REV, V98, P224, DOI 10.1037/0033-295X.98.2.224; Martin JW, 2010, NATIVE AMERICANS, CHRISTIANITY, AND THE RESHAPING OF THE AMERICAN RELIGIOUS LANDSCAPE, P1; Martin Joyce A, 2002, Natl Vital Stat Rep, V51, P1; McLafferty Sara, 2004, J Med Syst, V28, P321, DOI 10.1023/B:JOMS.0000032848.76032.28; Mega JL, 2014, JAMA-J AM MED ASSOC, V312, P1969, DOI 10.1001/jama.2014.15224; Meldrum RC, 2008, J CRIM JUST, V36, P244, DOI 10.1016/j.jcrimjus.2008.04.005; Mick E, 2002, J DEV BEHAV PEDIATR, V23, P16, DOI 10.1097/00004703-200202000-00004; Miller HV, 2011, AM J HEALTH BEHAV, V35, P15; Moffitt TE, 2011, P NATL ACAD SCI USA, V108, P2693, DOI 10.1073/pnas.1010076108; Morris RG, 2011, CRIM JUSTICE BEHAV, V38, P584, DOI 10.1177/0093854811402453; Muraven M, 2000, PSYCHOL BULL, V126, P247, DOI 10.1037/0033-2909.126.2.247; Nord C., 2004, EARLY CHILDHOOD LONG; Olds D, 1998, JAMA-J AM MED ASSOC, V280, P1238, DOI 10.1001/jama.280.14.1238; Paul IM, 2008, MATERN CHILD HLTH J, V12, P452, DOI 10.1007/s10995-007-0280-6; Poehlmann J, 2011, DEV PSYCHOPATHOL, V23, P177, DOI 10.1017/S0954579410000726; Pogarsky G, 2003, CRIMINOLOGY, V41, P1249, DOI 10.1111/j.1745-9125.2003.tb01019.x; Pratt TC, 2000, CRIMINOLOGY, V38, P931, DOI 10.1111/j.1745-9125.2000.tb00911.x; Pratt TC, 2006, INT J OFFENDER THER, V50, P672, DOI 10.1177/0306624X06286623; Raine A., 2013, ANATOMY VIOLENCE BIO; Rushton JP, 2005, PSYCHOL PUBLIC POL L, V11, P235, DOI 10.1037/1076-8971.11.2.235; Schilling CM, 2011, J CRIM JUST, V39, P3, DOI 10.1016/j.jcrimjus.2010.11.001; Shi LY, 2004, HEALTH SERV RES, V39, P1881, DOI 10.1111/j.1475-6773.2004.00323.x; Unnever J.D., 2011, THEORY AFRICAN AM OF; van Ierland Y, 2009, EARLY HUM DEV, V85, P617, DOI 10.1016/j.earlhumdev.2009.09.009; Wilson J.Q., 1985, CRIME HUMAN NATURE; Wright JP, 2005, CRIMINOLOGY, V43, P1169, DOI 10.1111/j.1745-9125.2005.00036.x	60	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0141954	10.1371/journal.pone.0141954	http://dx.doi.org/10.1371/journal.pone.0141954			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF3BP	26882110	Green Published, gold, Green Submitted			2022-12-26	WOS:000371219000001
J	Liu, B; Yang, L; Yang, YZ; Lu, YH				Liu, Bing; Yang, Long; Yang, Yizhong; Lu, Yanhui			Influence of Landscape Diversity and Composition on the Parasitism of Cotton Bollworm Eggs in Maize	PLOS ONE			English	Article							CONSERVATION BIOLOGICAL-CONTROL; NATURAL ENEMIES; AGRICULTURAL LANDSCAPES; BIOCONTROL SERVICES; CEREAL APHIDS; CROP PEST; HETEROGENEITY; CONFIGURATION; BIODIVERSITY; HABITAT	We deployed >50,000 Helicoverpa armigera eggs in maize fields to assess the rate of parasitism by Trichogramma chilonis across 33 sites during a three-year span (2012-2014) in northern China. Subsequently, we used a partial least squares (PLS) regression approach to assess the relationship of landscape diversity with composition and parasitism potential. The parasitism rate of H. armigera eggs by T. chilonis ranged from 0-25.8%, with a mean value of 5.6%. Landscape diversity greatly enhanced parasitism at all four different spatial scales (0.5, 1.0, 1.5 and 2.0 km radius). Both the proportion of arable area and the total planting area of two major crops (cotton and maize) had a negative correlation to the parasitism rate at each scale, whereas parasitism was positively correlated to the proportion of host crops of H. armigera other than cotton and maize at the 0.5 to 2.0 km radius scales as well as to that of non-crop habitat at the 0.5 and 1.0 km radius scales. The study indicated that maintaining landscape diversity provided an important biocontrol service by limiting H. armigera through the egg parasitoid T. chilonis, whereas rapid agricultural intensification would greatly reduce the presence and parasitism of T. chilonis in China.	[Liu, Bing; Yang, Yizhong] Yangzhou Univ, Coll Hort & Plant Protect, Yangzhou 225009, Jiangsu, Peoples R China; [Liu, Bing; Yang, Long; Lu, Yanhui] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China	Yangzhou University; Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS	Yang, YZ (corresponding author), Yangzhou Univ, Coll Hort & Plant Protect, Yangzhou 225009, Jiangsu, Peoples R China.; Lu, YH (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China.	yzyang@yzu.edu.cn; yhlu@ippcaas.cn		Liu, Bing/0000-0001-7303-4496; Lu, Yanhui/0000-0002-6552-0248	National Natural Science Funds [31222046, 31321004]; Jiangsu Province graduate student research and creative projects [CXZZ13_0907]	National Natural Science Funds(National Natural Science Foundation of China (NSFC)); Jiangsu Province graduate student research and creative projects	This research was supported by the National Natural Science Funds (No. 31222046, 31321004), and the Jiangsu Province graduate student research and creative projects (No. CXZZ13_0907).	Alignier A, 2014, BIOL CONTROL, V77, P76, DOI 10.1016/j.biocontrol.2014.06.006; Benton TG, 2003, TRENDS ECOL EVOL, V18, P182, DOI 10.1016/S0169-5347(03)00011-9; Bianchi FJJA, 2006, P ROY SOC B-BIOL SCI, V273, P1715, DOI 10.1098/rspb.2006.3530; Bianchi FJJA, 2005, AGR ECOSYST ENVIRON, V107, P145, DOI 10.1016/j.agee.2004.11.007; Briggs CJ, 2004, THEOR POPUL BIOL, V65, P299, DOI 10.1016/j.tpb.2003.11.001; Cardinale BJ, 2006, NATURE, V443, P989, DOI 10.1038/nature05202; Chaplin-Kramer R, 2011, ECOL LETT, V14, P922, DOI 10.1111/j.1461-0248.2011.01642.x; ESRI, 2010, ARCGIS 10 ARCMAP VER; Gardiner MM, 2010, BIOL CONTROL, V55, P11, DOI 10.1016/j.biocontrol.2010.06.008; Gardiner MM, 2009, DIVERS DISTRIB, V15, P554, DOI 10.1111/j.1472-4642.2009.00563.x; Gardiner MM, 2009, ECOL APPL, V19, P143, DOI 10.1890/07-1265.1; Grez AA, 2014, BIOL CONTROL, V76, P1, DOI 10.1016/j.biocontrol.2014.04.005; Guo YY, 1998, RESEARCH OF COTTON B; Jonsson M, 2012, J APPL ECOL, V49, P706, DOI 10.1111/j.1365-2664.2012.02130.x; Landis DA, 2000, ANNU REV ENTOMOL, V45, P175, DOI 10.1146/annurev.ento.45.1.175; Landis DA, 2008, P NATL ACAD SCI USA, V105, P20552, DOI 10.1073/pnas.0804951106; Liang GeMei, 1999, Plant Protection, V25, P15; Liu B, 2016, BIOL CONTROL, V93, P15, DOI 10.1016/j.biocontrol.2015.11.004; McGarigal K, 2012, FRAGSTATS V4 SPAT PA; Naranjo SE, 2015, ANNU REV ENTOMOL, V60, P621, DOI 10.1146/annurev-ento-010814-021005; Ostman O, 2001, BASIC APPL ECOL, V2, P365, DOI 10.1078/1439-1791-00072; Plecas M, 2014, AGR ECOSYST ENVIRON, V183, P1, DOI 10.1016/j.agee.2013.10.016; Power AG, 2010, PHILOS T R SOC B, V365, P2959, DOI 10.1098/rstb.2010.0143; Ramsden MW, 2015, AGR ECOSYST ENVIRON, V199, P94, DOI 10.1016/j.agee.2014.08.024; Rand TA, 2006, ECOL LETT, V9, P603, DOI 10.1111/j.1461-0248.2006.00911.x; Roschewitz I, 2005, AGR ECOSYST ENVIRON, V108, P218, DOI 10.1016/j.agee.2005.02.005; Roubos CR, 2014, BIOL CONTROL, V75, P28, DOI 10.1016/j.biocontrol.2014.01.006; SAS Institute, 2011, SAS STAT 9 3 US GUID; Sivakoff FS, 2012, BIOL CONTROL, V63, P296, DOI 10.1016/j.biocontrol.2012.09.008; Steckel J, 2014, BIOL CONSERV, V172, P56, DOI 10.1016/j.biocon.2014.02.015; Tenenhaus M, 2005, FOOD QUAL PREFER, V16, P315, DOI 10.1016/j.foodqual.2004.05.013; Thies C, 2003, OIKOS, V101, P18, DOI 10.1034/j.1600-0706.2003.12567.x; Thies C, 1999, SCIENCE, V285, P893, DOI 10.1126/science.285.5429.893; Thies C, 2011, ECOL APPL, V21, P2187, DOI 10.1890/10-0929.1; Tscharntke T, 2007, BIOL CONTROL, V43, P294, DOI 10.1016/j.biocontrol.2007.08.006; Tscharntke T, 2012, BIOL REV, V87, P661, DOI 10.1111/j.1469-185X.2011.00216.x; Vasseur C, 2013, AGR ECOSYST ENVIRON, V166, P3, DOI 10.1016/j.agee.2012.08.013; Wold S, 2001, CHEMOMETR INTELL LAB, V58, P109, DOI 10.1016/S0169-7439(01)00155-1; Wold S., 1995, QSAR CHEMOMETRIC MET, V2, P195; Woltz JM, 2014, AGR FOREST ENTOMOL, V16, P341, DOI 10.1111/afe.12064; Wu KM, 2008, SCIENCE, V321, P1676, DOI 10.1126/science.1160550; Wyckhuys KAG, 2013, BIOL CONTROL, V65, P152, DOI 10.1016/j.biocontrol.2012.11.010; Zhang Y. J., 1981, Natural Enemies of Insects, V3, P14; Zhao ZH, 2014, J ECON ENTOMOL, V107, P630, DOI 10.1603/EC13054; Zhou K, 2014, AGR ECOSYST ENVIRON, V183, P176, DOI 10.1016/j.agee.2013.11.008	45	12	14	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0149476	10.1371/journal.pone.0149476	http://dx.doi.org/10.1371/journal.pone.0149476			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	26881784	Green Published, Green Submitted, gold			2022-12-26	WOS:000371219000077
J	Borghese, MFA; Ortiz, MC; Balonga, S; Szokalo, RM; Majowicz, MP				Albertoni Borghese, Maria F.; Ortiz, Maria C.; Balonga, Sabrina; Moreira Szokalo, Rocio; Majowicz, Monica P.			The Role of Endothelin System in Renal Structure and Function during the Postnatal Development of the Rat Kidney	PLOS ONE			English	Article							BLOOD-PRESSURE; SEX-DIFFERENCES; NEPHRON NUMBER; SIGNALING PATHWAYS; GLOMERULAR VOLUME; MICE DEFICIENT; RECEPTORS; PROLIFERATION; EXPRESSION; REDUCTION	Renal development in rodents, unlike in humans, continues during early postnatal period. We aimed to evaluate whether the pharmacological inhibition of Endothelin system during this period affects renal development, both at structural and functional level in male and female rats. Newborn rats were treated orally from postnatal day 1 to 20 with vehicle or bosentan (Actelion, 20 mg/kg/day), a dual endothelin receptor antagonist (ERA). The animals were divided in 4 groups: control males, control females, ERA males and ERA females. At day 21, we evaluated renal function, determined the glomerular number by a maceration method and by morphometric analysis and evaluated possible structural renal alterations by three methods: < alpha >-Smooth muscle actin (alpha-SMA) immunohistochemistry, Masson's trichrome and Sirius red staining. The pharmacological inhibition of Endothelin system with a dual ERA during the early postnatal period of the rat did not leads to renal damage in the kidneys of male and female rats. However, ERA administration decreased the number of glomeruli, the juxtamedullary filtration surface area and the glomerular filtration rate and increased the proteinuria. These effects could predispose to hypertension or renal diseases in the adulthood. On the other hand, these effects were more pronounced in male rats, suggesting that there are sex differences that could be greater later in life. These results provide evidence that Endothelin has an important role in rat renal postnatal development. However these results do not imply that the same could happen in humans, since human renal development is complete at birth.	[Albertoni Borghese, Maria F.; Ortiz, Maria C.; Balonga, Sabrina; Moreira Szokalo, Rocio; Majowicz, Monica P.] Univ Buenos Aires, Fac Farm & Bioquim, Dept Ciencias Biol, Catedra Biol Celular & Mol, RA-1113 Buenos Aires, DF, Argentina	University of Buenos Aires	Majowicz, MP (corresponding author), Univ Buenos Aires, Fac Farm & Bioquim, Dept Ciencias Biol, Catedra Biol Celular & Mol, RA-1113 Buenos Aires, DF, Argentina.	mmajow@ffyb.uba.ar			University of Buenos Aires [UBACYT 20020090200685, UBACYT 20020130200184BA]	University of Buenos Aires(University of Buenos Aires)	This work was supported by grants from the University of Buenos Aires (http://www.uba.ar/secyt/), grants UBACYT 20020090200685 and UBACYT 20020130200184BA (to MM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadie L, 1996, PEDIATR NEPHROL, V10, P185; Adur J, 2003, BIOCHEM BIOPH RES CO, V305, P700, DOI 10.1016/S0006-291X(03)00769-1; Barton M, 2012, CLIN KIDNEY J, V5, P17, DOI 10.1093/ckj/sfs001; Boesen EI, 2015, CURR OPIN PHARMACOL, V21, P25, DOI 10.1016/j.coph.2014.12.007; Bouallegue A, 2007, CURR VASC PHARMACOL, V5, P45, DOI 10.2174/157016107779317161; Chen QW, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-52; Clouthier DE, 2000, DEV BIOL, V217, P10, DOI 10.1006/dbio.1999.9527; Cowley AW, 2013, HYPERTENSION, V62, P85, DOI 10.1161/HYPERTENSIONAHA.113.01194; DAMADIAN RV, 1965, J LAB CLIN MED, V65, P26; De Miguel C, 2016, CURR OPIN NEPHROL HY, V25, P35, DOI 10.1097/MNH.0000000000000185; Foschi M, 1997, EMBO J, V16, P6439, DOI 10.1093/emboj/16.21.6439; Garg P, 2011, ADV CHRONIC KIDNEY D, V18, P233, DOI 10.1053/j.ackd.2011.06.001; Guron G, 1999, J AM SOC NEPHROL, V10, P1550; Ho J, 2014, FRONT PEDIATR, V2, DOI 10.3389/fped.2014.00128; HOSODA K, 1994, CELL, V79, P1267, DOI 10.1016/0092-8674(94)90017-5; Hoy WE, 2008, CURR OPIN NEPHROL HY, V17, P258, DOI 10.1097/MNH.0b013e3282f9b1a5; Hua H, 2003, AM J PHYSIOL-RENAL, V284, pF303, DOI 10.1152/ajprenal.00127.2002; Jin CH, 2013, AM J PHYSIOL-RENAL, V305, pF1099, DOI 10.1152/ajprenal.00400.2013; Kim SI, 2014, J AM SOC NEPHROL, V25, P1966, DOI 10.1681/ASN.2013030252; Kittikulsuth W, 2013, BRIT J PHARMACOL, V168, P318, DOI 10.1111/j.1476-5381.2012.01922.x; Kittikulsuth W, 2013, CLIN EXP PHARMACOL P, V40, P362, DOI 10.1111/1440-1681.12084; Kohan DE, 2011, PHYSIOL REV, V91, P1, DOI 10.1152/physrev.00060.2009; Kuo Hung-Tien, 2006, KAOHSIUNG JOURNAL OF MEDICAL SCIENCES, V22, P371, DOI 10.1016/S1607-551X(09)70325-0; KURIHARA Y, 1994, NATURE, V368, P703, DOI 10.1038/368703a0; KURIHARA Y, 1995, J CLIN INVEST, V96, P293, DOI 10.1172/JCI118033; Lee JJ, 2007, KAOHSIUNG J MED SCI, V23, P170, DOI 10.1016/S1607-551X(09)70393-6; Little MH, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008300; Tomat AL, 2008, AM J PHYSIOL-REG I, V295, pR543, DOI 10.1152/ajpregu.00050.2008; Tomat AL, 2013, NUTRITION, V29, P568, DOI 10.1016/j.nut.2012.09.008; Loria A, 2007, AM J PHYSIOL-REG I, V293, pR695, DOI 10.1152/ajpregu.00191.2007; Loria A, 2007, AM J PHYSIOL-RENAL, V293, pF506, DOI 10.1152/ajprenal.00066.2007; Maguire JJ, 2014, BRIT J PHARMACOL, V171, P5555, DOI 10.1111/bph.12874; MALKUSCH W, 1995, EXP LUNG RES, V21, P67, DOI 10.3109/01902149509031745; Marquez MG, 2002, ANAT EMBRYOL, V205, P431, DOI 10.1007/s00429-002-0262-9; Moritz KM, 2009, AM J PHYSIOL-RENAL, V296, pF1, DOI 10.1152/ajprenal.00049.2008; Murawski IJ, 2010, ORGANOGENESIS, V6, P189, DOI 10.4161/org.6.3.12125; Nigam S., 1996, KIDNEY, P72; POLDERMAN KH, 1993, ANN INTERN MED, V118, P429, DOI 10.7326/0003-4819-118-6-199303150-00006; Puddu M, 2009, AM J NEPHROL, V30, P162, DOI 10.1159/000211324; RUBANYI GM, 1994, PHARMACOL REV, V46, P325; Saez F, 2007, HYPERTENSION, V49, P1429, DOI 10.1161/HYPERTENSIONAHA.107.087957; Samuel T, 2005, J AM SOC NEPHROL, V16, P3102, DOI 10.1681/ASN.2005010123; Sorokin A, 2002, CLIN SCI, V103, p132S, DOI 10.1042/CS103S132S; SOUSTER LP, 1980, J ANAT, V130, P595; Suganami T, 2003, HYPERTENSION, V42, P1183, DOI 10.1161/01.HYP.0000101689.64849.97; Tostes RC, 2008, CLIN SCI, V114, P85, DOI 10.1042/CS20070169; Uchide T, 2002, CLIN SCI, V103, p167S, DOI 10.1042/CS103S167S; Vignon-Zellweger N, 2012, LIFE SCI, V91, P490, DOI 10.1016/j.lfs.2012.03.026; Welch AK, 2013, BRIT J PHARMACOL, V168, P327, DOI 10.1111/j.1476-5381.2012.01826.x; Yanagisawa H, 1998, DEVELOPMENT, V125, P825; Yoo KH, 2009, J KOREAN MED SCI, V24, P138, DOI 10.3346/jkms.2009.24.1.138	51	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0148866	10.1371/journal.pone.0148866	http://dx.doi.org/10.1371/journal.pone.0148866			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26872270	gold, Green Published, Green Submitted			2022-12-26	WOS:000370054100066
J	Matsumoto, Y; Sakakihara, S; Grushnikov, A; Kikuchi, K; Noji, H; Yamaguchi, A; Iino, R; Yagi, Y; Nishino, K				Matsumoto, Yoshimi; Sakakihara, Shouichi; Grushnikov, Andrey; Kikuchi, Kazuma; Noji, Hiroyuki; Yamaguchi, Akihito; Iino, Ryota; Yagi, Yasushi; Nishino, Kunihiko			A Microfluidic Channel Method for Rapid Drug-Susceptibility Testing of Pseudomonas aeruginosa	PLOS ONE			English	Article							GRAM-NEGATIVE BACTERIA; AUTOMATED MICROSCOPY; EFFLUX PUMPS; STAPHYLOCOCCUS-AUREUS; CARBAPENEM RESISTANCE; MEXAB-OPRM; FLUOROQUINOLONE RESISTANCE; MULTIDRUG-RESISTANCE; CLINICAL STRAINS; CULTURE DEVICE	The recent global increase in the prevalence of antibiotic-resistant bacteria and lack of development of new therapeutic agents emphasize the importance of selecting appropriate antimicrobials for the treatment of infections. However, to date, the development of completely accelerated drug susceptibility testing methods has not been achieved despite the availability of a rapid identification method. We proposed an innovative rapid method for drug susceptibility testing for Pseudomonas aeruginosa that provides results within 3 h. The drug susceptibility testing microfluidic (DSTM) device was prepared using soft lithography. It consisted of five sets of four microfluidic channels sharing one inlet slot, and the four channels are gathered in a small area, permitting simultaneous microscopic observation. Antimicrobials were pre-introduced into each channel and dried before use. Bacterial suspensions in cation-adjusted Mueller-Hinton broth were introduced from the inlet slot and incubated for 3 h. Susceptibilities were microscopically evaluated on the basis of differences in cell numbers and shapes between drug-treated and control cells, using dedicated software. The results of 101 clinically isolated strains of P. aeruginosa obtained using the DSTM method strongly correlated with results obtained using the ordinary microbroth dilution method. Ciprofloxacin, meropenem, ceftazidime, and piperacillin caused elongation in susceptible cells, while meropenem also induced spheroplast and bulge formation. Morphological observation could alternatively be used to determine the susceptibility of P. aeruginosa to these drugs, although amikacin had little effect on cell shape. The rapid determination of bacterial drug susceptibility using the DSTM method could also be applicable to other pathogenic species, and it could easily be introduced into clinical laboratories without the need for expensive instrumentation.	[Matsumoto, Yoshimi; Sakakihara, Shouichi; Grushnikov, Andrey; Kikuchi, Kazuma; Yamaguchi, Akihito; Yagi, Yasushi; Nishino, Kunihiko] Osaka Univ, Inst Sci & Ind Res, Osaka, Japan; [Noji, Hiroyuki] Univ Tokyo, Grad Sch Engn, Dept Appl Chem, Tokyo, Japan; [Iino, Ryota] Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, 5-1 Higashiyama, Okazaki, Aichi 4448787, Japan; [Iino, Ryota] Natl Inst Nat Sci, Inst Mol Sci, 38 Nishigonaka, Okazaki, Aichi 4448585, Japan; [Iino, Ryota] Grad Univ Adv Studies SOKENDAI, Miura Dist, Kanagawa, Japan	Osaka University; University of Tokyo; National Institutes of Natural Sciences (NINS) - Japan; Okazaki Institute for Integrative Bioscience (OIIB); National Institutes of Natural Sciences (NINS) - Japan; Institute for Molecular Science (IMS); Graduate University for Advanced Studies - Japan	Matsumoto, Y (corresponding author), Osaka Univ, Inst Sci & Ind Res, Osaka, Japan.	yoshimi@sanken.osaka-u.ac.jp	Iino, Ryota/B-7746-2011	Iino, Ryota/0000-0003-0110-5704	Japanese Society for the Promotion of Science; Center of Innovation Program from Japan Science and Technology Agency; Adaptable and Seamless Technology Transfer Program through target-driven RD (JST) [AS242Z01738P, AS2531229P]; (NEXT Program) from the Cabinet Office, Government of Japan [LS080]; Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation from the Japan Society for the Promotion of Science [07-03]; Ministry of Education, Culture, Sports, Science and Technology of Japan; Grants-in-Aid for Scientific Research [26000011, 26713004, 26102507] Funding Source: KAKEN	Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Center of Innovation Program from Japan Science and Technology Agency; Adaptable and Seamless Technology Transfer Program through target-driven RD (JST); (NEXT Program) from the Cabinet Office, Government of Japan; Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation from the Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by Grants-in-Aid from the Japanese Society for the Promotion of Science, the Center of Innovation Program from Japan Science and Technology Agency, the Grant AS242Z01738P (YM) and AS2531229P (YM) from Adaptable and Seamless Technology Transfer Program through target-driven R&D (JST), the Grant LS080 (KN) (NEXT Program) from the Cabinet Office, Government of Japan, and the Grant Project ID 07-03 (AY) Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation from the Japan Society for the Promotion of Science, and the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akasaka T, 2001, ANTIMICROB AGENTS CH, V45, P2263, DOI 10.1128/AAC.45.8.2263-2268.2001; Alva A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082809; Angeletti S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120502; Aoki N, 2009, J ANTIMICROB CHEMOTH, V63, P534, DOI 10.1093/jac/dkn530; Ballestero S, 1996, J ANTIMICROB CHEMOTH, V38, P39, DOI 10.1093/jac/38.1.39; Banerjee R, 2015, CLIN INFECT DIS, V61, P1071, DOI 10.1093/cid/civ447; Barnini S, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0459-8; Burnham CAD, 2014, J CLIN MICROBIOL, V52, P982, DOI 10.1128/JCM.03255-13; Calderaro A, 2014, CLIN MICROBIOL INFEC, V20, pO468, DOI 10.1111/1469-0691.12490; Chen CH, 2010, ANAL CHEM, V82, P1012, DOI 10.1021/ac9022764; Choi J, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009650; Choi J, 2013, LAB CHIP, V13, P280, DOI 10.1039/c2lc41055a; den Hertog AL, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-380; Douglas IS, 2015, AM J RESP CRIT CARE, V191, P566, DOI 10.1164/rccm.201408-1468OC; El Amin N, 2005, APMIS, V113, P187, DOI 10.1111/j.1600-0463.2005.apm1130306.x; Fredborg M, 2013, J CLIN MICROBIOL, V51, P2047, DOI 10.1128/JCM.00440-13; Giske CG, 2008, MICROB DRUG RESIST, V14, P23, DOI 10.1089/mdr.2008.0778; Hakki M, 2007, BONE MARROW TRANSPL, V39, P687, DOI 10.1038/sj.bmt.1705653; Henrichfreise B, 2007, ANTIMICROB AGENTS CH, V51, P4062, DOI 10.1128/AAC.00148-07; Hou ZN, 2014, LAB CHIP, V14, P3409, DOI 10.1039/c4lc00451e; HUANG HJ, 1993, J BACTERIOL, V175, P7793, DOI 10.1128/JB.175.24.7793-7800.1993; Huang ZK, 2015, J ANTIMICROB CHEMOTH, V70, P456, DOI 10.1093/jac/dku384; Iino R, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00300; Iino R, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00040; Institute CaLS, 2006, M7A7 I CALS CLSI; Kalashnikov M, 2012, LAB CHIP, V12, P4523, DOI 10.1039/c2lc40531h; Kimura S, 2005, DIAGN MICR INFEC DIS, V53, P241, DOI 10.1016/j.diagmicrobio.2005.05.017; Kinnunen P, 2012, SMALL, V8, P2477, DOI 10.1002/smll.201200110; Kirikae T, 2008, J ANTIMICROB CHEMOTH, V61, P612, DOI 10.1093/jac/dkm537; Koh TH, 2008, INT J ANTIMICROB AG, V32, P446, DOI 10.1016/j.ijantimicag.2008.05.017; Kohler T, 1999, ANTIMICROB AGENTS CH, V43, P424, DOI 10.1128/AAC.43.2.424; Lay JO, 2000, METH MOL B, V146, P461, DOI 10.1385/1-59259-045-4:461; Lister PD, 2009, CLIN MICROBIOL REV, V22, P582, DOI 10.1128/CMR.00040-09; Livermore DM, 2002, CLIN INFECT DIS, V34, P634, DOI 10.1086/338782; Llanes C, 2004, ANTIMICROB AGENTS CH, V48, P1797, DOI 10.1128/AAC.48.5.1797-1802.2004; Lu Y, 2013, ANAL CHEM, V85, P3971, DOI 10.1021/ac4004248; Makristathis A, 2014, CLIN MICROBIOL INFEC, V20, pO760, DOI 10.1111/1469-0691.12561; Maniati M, 2007, J ANTIMICROB CHEMOTH, V60, P132, DOI 10.1093/jac/dkm126; Masuda N, 2000, ANTIMICROB AGENTS CH, V44, P3322, DOI 10.1128/AAC.44.12.3322-3327.2000; Matsumoto Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018547; Mesaros N, 2007, CLIN MICROBIOL INFEC, V13, P560, DOI 10.1111/j.1469-0691.2007.01681.x; Metzger S, 2014, DIAGN MICR INFEC DIS, V79, P160, DOI 10.1016/j.diagmicrobio.2013.11.029; Michael JS, 2010, INT J TUBERC LUNG D, V14, P482; Mohan R, 2013, BIOSENS BIOELECTRON, V49, P118, DOI 10.1016/j.bios.2013.04.046; Moore DAJ, 2006, NEW ENGL J MED, V355, P1539, DOI 10.1056/NEJMoa055524; Morita Y, 2001, J GEN APPL MICROBIOL, V47, P27, DOI 10.2323/jgam.47.27; Nakajima A, 2002, MICROBIOL IMMUNOL, V46, P391, DOI 10.1111/j.1348-0421.2002.tb02711.x; NIKAIDO H, 1994, SCIENCE, V264, P382, DOI 10.1126/science.8153625; Nordmann P, 2002, CLIN MICROBIOL INFEC, V8, P321, DOI 10.1046/j.1469-0691.2002.00401.x; Pages JM, 2008, NAT REV MICROBIOL, V6, P893, DOI 10.1038/nrmicro1994; Peitz I, 2010, LAB CHIP, V10, P2944, DOI 10.1039/c004691d; Poole K, 2005, ANTIMICROB AGENTS CH, V49, P479, DOI 10.1128/AAC.49.2.479-487.2005; Price CS, 2014, J MICROBIOL METH, V98, P50, DOI 10.1016/j.mimet.2013.12.021; Quale J, 2006, ANTIMICROB AGENTS CH, V50, P1633, DOI 10.1128/AAC.50.5.1633-1641.2006; Ryan BM, 2001, EXPERT OPIN INV DRUG, V10, P1409, DOI 10.1517/13543784.10.8.1409; Satoh Ritsuko, 2008, Journal of Infection and Chemotherapy, V14, P325, DOI 10.1007/s10156-008-0620-5; Schweizer Herbert P, 2003, Genet Mol Res, V2, P48; Sekiguchi JI, 2005, ANTIMICROB AGENTS CH, V49, P3734, DOI 10.1128/AAC.49.9.3734-3742.2005; Sekiguchi Jun-ichiro, 2007, Journal of Infection and Chemotherapy, V13, P418, DOI 10.1007/s10156-007-0560-5; Sekiguchi JI, 2007, J CLIN MICROBIOL, V45, P979, DOI 10.1128/JCM.01772-06; Senda K, 1996, ANTIMICROB AGENTS CH, V40, P349, DOI 10.1128/AAC.40.2.349; Shiferaw G, 2007, J CLIN MICROBIOL, V45, P1093, DOI 10.1128/JCM.01949-06; Strateva T, 2009, J MED MICROBIOL, V58, P1133, DOI 10.1099/jmm.0.009142-0; Takagi R, 2013, ANALYST, V138, P1000, DOI 10.1039/c2an36323b; Wagner VE, 2008, CLIN REV ALLERG IMMU, V35, P124, DOI 10.1007/s12016-008-8079-9; Whitesides GM, 2001, ANNU REV BIOMED ENG, V3, P335, DOI 10.1146/annurev.bioeng.3.1.335	66	39	41	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0148797	10.1371/journal.pone.0148797	http://dx.doi.org/10.1371/journal.pone.0148797			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26872134	gold, Green Published, Green Submitted			2022-12-26	WOS:000370054100056
J	Hemmann, JL; Saurel, O; Ochsner, AM; Stodden, BK; Kiefer, P; Milon, A; Vorholt, JA				Hemmann, Jethro L.; Saurel, Olivier; Ochsner, Andrea M.; Stodden, Barbara K.; Kiefer, Patrick; Milon, Alain; Vorholt, Julia A.			The One-carbon Carrier Methylofuran from Methylobacterium extorquens AM1 Contains a Large Number of alpha- and gamma-Linked Glutamic Acid Residues	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIOXIDE REDUCTION FACTOR; METHYLOTROPHIC BACTERIA; METHANOBACTERIUM-THERMOAUTOTROPHICUM; METHANOCALDOCOCCUS-JANNASCHII; NONMETHYLOTROPHIC CONDITIONS; METHANOFURAN BIOSYNTHESIS; TETRAHYDROMETHANOPTERIN; IDENTIFICATION; COENZYMES; ENZYMES	Methylobacterium extorquens AM1 uses dedicated cofactors for one-carbon unit conversion. Based on the sequence identities of enzymes and activity determinations, a methanofuran analog was proposed to be involved in formaldehyde oxidation in Alphaproteobacteria. Here, we report the structure of the cofactor, which we termed methylofuran. Using an in vitro enzyme assay and LC-MS, methylofuran was identified in cell extracts and further purified. From the exact mass and MS-MS fragmentation pattern, the structure of the cofactor was determined to consist of a polyglutamic acid side chain linked to a core structure similar to the one present in archaeal methanofuran variants. NMR analyses showed that the core structure contains a furan ring. However, instead of the tyramine moiety that is present in methanofuran cofactors, a tyrosine residue is present in methylofuran, which was further confirmed by MS through the incorporation of a C-13-labeled precursor. Methylofuran was present as a mixture of different species with varying numbers of glutamic acid residues in the side chain ranging from 12 to 24. Notably, the glutamic acid residues were not solely gamma-linked, as is the case for all known methanofurans, but were identified by NMR as a mixture of alpha- and gamma-linked amino acids. Considering the unusual peptide chain, the elucidation of the structure presented here sets the basis for further research on this cofactor, which is probably the largest cofactor known so far.	[Hemmann, Jethro L.; Ochsner, Andrea M.; Kiefer, Patrick; Vorholt, Julia A.] ETH, Inst Microbiol, Vladimir Prelog Weg 4, CH-8093 Zurich, Switzerland; [Saurel, Olivier; Milon, Alain] CNRS, Inst Pharmacol & Struct Biol, F-31077 Toulouse, France; [Saurel, Olivier; Milon, Alain] Univ Toulouse 3, F-31077 Toulouse, France; [Stodden, Barbara K.] INRA CNRS 441 2594, Lab Interact Plantes Microorganismes, Castanet Tolosan, France	Swiss Federal Institutes of Technology Domain; ETH Zurich; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS)	Vorholt, JA (corresponding author), ETH, Inst Microbiol, Vladimir Prelog Weg 4, CH-8093 Zurich, Switzerland.	jvorholt@ethz.ch	Hemmann, Jethro L/GPP-3825-2022; Olivier, Saurel/AAQ-7007-2020; Vorholt, Julia/K-3514-2016	Hemmann, Jethro L/0000-0003-4687-5577; Vorholt, Julia/0000-0002-6011-4910; Saurel, Olivier/0000-0003-1439-4103; Ochsner, Andrea/0000-0002-5170-5022	Ibisa; Region Midi-Pyrenees; European structural funds	Ibisa; Region Midi-Pyrenees(Region OccitanieRegion Provence-Alpes-Cote d'Azur); European structural funds	We thank Philipp Christen, ETH Zurich, for support in running fed-batch cultures. The IPBS (Institute of Pharmacology and Structural Biology) NMR equipment belonged to the Genotoul-PICT platform and received specific funding by Ibisa, the Region Midi-Pyrenees and European structural funds.	Allen KD, 2014, BIOCHEMISTRY-US, V53, P6199, DOI 10.1021/bi500973h; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anthony C, 1982, BIOCH METHYLOTROPHS, P95; BAX A, 1985, J MAGN RESON, V65, P355, DOI 10.1016/0022-2364(85)90018-6; BOBIK TA, 1987, ARCH BIOCHEM BIOPHYS, V254, P430, DOI 10.1016/0003-9861(87)90121-4; Bosch G, 2008, PROTEOMICS, V8, P3494, DOI 10.1002/pmic.200800152; Chistoserdova L, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-2-208; Chistoserdova L, 2004, MOL BIOL EVOL, V21, P1234, DOI 10.1093/molbev/msh113; Chistoserdova L, 2004, J BACTERIOL, V186, P22, DOI 10.1128/JB.186.1.22-28.2004; Chistoserdova L, 1998, SCIENCE, V281, P99, DOI 10.1126/science.281.5373.99; DEROME AE, 1990, J MAGN RESON, V88, P177, DOI 10.1016/0022-2364(90)90123-Q; DIMARCO AA, 1990, ANNU REV BIOCHEM, V59, P355, DOI 10.1146/annurev.biochem.59.1.355; ESCALANTESEMERENA JC, 1984, J BIOL CHEM, V259, P9447; Hagemeier CH, 2000, EUR J BIOCHEM, V267, P3762, DOI 10.1046/j.1432-1327.2000.01413.x; HOUCK DR, 1991, J AM CHEM SOC, V113, P3162, DOI 10.1021/ja00008a053; KASAI T, 1973, AGR BIOL CHEM TOKYO, V37, P685, DOI 10.1080/00021369.1973.10860731; KELTJENS JT, 1983, EUR J BIOCHEM, V130, P537, DOI 10.1111/j.1432-1033.1983.tb07183.x; Kezmarsky ND, 2005, BBA-GEN SUBJECTS, V1722, P175, DOI 10.1016/j.bbagen.2004.12.003; Kiefer P, 2013, BIOINFORMATICS, V29, P963, DOI 10.1093/bioinformatics/btt080; LARGE PJ, 1961, BIOCHEM J, V81, P470, DOI 10.1042/bj0810470; Laukel M, 2004, PROTEOMICS, V4, P1247, DOI 10.1002/pmic.200300713; LEIGH JA, 1984, J AM CHEM SOC, V106, P3636, DOI 10.1021/ja00324a037; LEIGH JA, 1983, J BIOL CHEM, V258, P7536; Marx CJ, 2003, J BACTERIOL, V185, P7169, DOI 10.1128/JB.185.24.7169-7175.2003; Miller D, 2014, BIOCHEMISTRY-US, V53, P4635, DOI 10.1021/bi500615p; Pomper BK, 2002, FEBS LETT, V523, P133, DOI 10.1016/S0014-5793(02)02962-9; Pomper BK, 1999, EUR J BIOCHEM, V261, P475, DOI 10.1046/j.1432-1327.1999.00291.x; Pomper BK, 2001, EUR J BIOCHEM, V268, P4769, DOI 10.1046/j.1432-1327.2001.02401.x; Shima S, 2001, METHOD ENZYMOL, V331, P317; TAYLOR CD, 1974, J BIOL CHEM, V249, P4879; Vorholt JA, 2002, ARCH MICROBIOL, V178, P239, DOI 10.1007/s00203-002-0450-2; Vorholt JA, 1999, J BACTERIOL, V181, P5750, DOI 10.1128/JB.181.18.5750-5757.1999; Vorholt JA, 2000, J BACTERIOL, V182, P6645, DOI 10.1128/JB.182.23.6645-6650.2000; Wang Y, 2015, J BACTERIOL, V197, P2850, DOI 10.1128/JB.00401-15; Wang Y, 2014, BIOCHEMISTRY-US, V53, P6220, DOI 10.1021/bi500879h; WHITE RH, 1988, J BACTERIOL, V170, P4594, DOI 10.1128/jb.170.10.4594-4597.1988	36	6	8	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2016	291	17					9042	9051		10.1074/jbc.M116.714741	http://dx.doi.org/10.1074/jbc.M116.714741			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK3WV	26895963	Green Published, hybrid			2022-12-26	WOS:000374849000018
J	Hamon, Y; Legowska, M; Herve, V; Dallet-Choisy, S; Marchand-Adam, S; Vanderlynden, L; Demonte, M; Williams, R; Scott, CJ; Si-Tahar, M; Heuze-Vourc'h, N; Lalmanach, G; Jenne, DE; Lesner, A; Gauthier, F; Korkmaz, B				Hamon, Yveline; Legowska, Monika; Herve, Virginie; Dallet-Choisy, Sandrine; Marchand-Adam, Sylvain; Vanderlynden, Lise; Demonte, Michele; Williams, Rich; Scott, Christopher J.; Si-Tahar, Mustapha; Heuze-Vourc'h, Nathalie; Lalmanach, Gilles; Jenne, Dieter E.; Lesner, Adam; Gauthier, Francis; Korkmaz, Brice			Neutrophilic Cathepsin C Is Maturated by a Multistep Proteolytic Process and Secreted by Activated Cells during Inflammatory Lung Diseases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIPEPTIDYL-PEPTIDASE-I; PAPILLON-LEFEVRE-SYNDROME; SERINE PROTEASES; INHIBITION; EXPRESSION; REQUIRES; GRANULES; PROTEINASE-3; GENE; VIVO	The cysteine protease cathepsin C (CatC) activates granule-associated proinflammatory serine proteases in hematopoietic precursor cells. Its early inhibition in the bone marrow is regarded as a new therapeutic strategy for treating proteolysis-driven chronic inflammatory diseases, but its complete inhibition is elusive in vivo. Controlling the activity of CatC may be achieved by directly inhibiting its activity with a specific inhibitor or/and by preventing its maturation. We have investigated immunochemically and kinetically the occurrence of CatC and its proform in human hematopoietic precursor cells and in differentiated mature immune cells in lung secretions. The maturation of proCatC obeys a multistep mechanism that can be entirely managed by CatS in neutrophilic precursor cells. CatS inhibition by a cell-permeable inhibitor abrogated the release of the heavy and light chains from proCatC and blocked similar to 80% of CatC activity. Under these conditions the activity of neutrophil serine proteases, however, was not abolished in precursor cell cultures. In patients with neutrophilic lung inflammation, mature CatC is found in large amounts in sputa. It is secreted by activated neutrophils as confirmed through lipopolysaccharide administration in a nonhuman primate model. CatS inhibitors currently in clinical trials are expected to decrease the activity of neutrophilic CatC without affecting those of elastase-like serine proteases.	[Hamon, Yveline; Herve, Virginie; Dallet-Choisy, Sandrine; Marchand-Adam, Sylvain; Vanderlynden, Lise; Demonte, Michele; Si-Tahar, Mustapha; Heuze-Vourc'h, Nathalie; Lalmanach, Gilles; Gauthier, Francis; Korkmaz, Brice] INSERM, U1100, Ctr Etud Pathol Resp, F-37032 Tours, France; [Hamon, Yveline; Herve, Virginie; Dallet-Choisy, Sandrine; Marchand-Adam, Sylvain; Vanderlynden, Lise; Demonte, Michele; Si-Tahar, Mustapha; Heuze-Vourc'h, Nathalie; Lalmanach, Gilles; Gauthier, Francis; Korkmaz, Brice] Univ Tours, F-37032 Tours, France; [Legowska, Monika; Lesner, Adam] Univ Gdansk, Fac Chem, Wita Stwosza 63, PL-80308 Gdansk, Poland; [Williams, Rich; Scott, Christopher J.] Queens Univ Belfast, Lisburn Rd, Belfast BT9 7BL, Antrim, North Ireland; [Hamon, Yveline; Jenne, Dieter E.] German Ctr Lung Res DZL, Inst Lung Biol & Dis, Comprehens Pneumol Ctr, D-81377 Munich, Germany; [Hamon, Yveline; Jenne, Dieter E.] Max Planck Inst Neurobiol, D-82152 Planegg Martinsried, Germany	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Tours; Fahrenheit Universities; University of Gdansk; Queens University Belfast; Max Planck Society	Korkmaz, B (corresponding author), Univ Tours, INSERM U1100, Ctr Etud Pathol Resp, Fac Med, F-37032 Tours, France.	brice.korkmaz@inserm.fr	Jenne, Dieter Erich/AAP-1414-2020; SI-TAHAR, Mustapha/L-4149-2014; HEUZE-VOURC'H, Nathalie/P-8081-2016; Lesner, Adam/M-2732-2019; Si-Tahar, Mustapha/W-8034-2019	SI-TAHAR, Mustapha/0000-0002-5792-7742; Si-Tahar, Mustapha/0000-0002-5792-7742; marchand-adam, sylvain/0000-0002-9522-3738; Williams, Rich/0000-0002-7710-2975; Dallet-Choisy, Sandrine/0000-0002-6530-4107; Heuze-Vourc'h, Nathalie/0000-0003-4929-5068; KORKMAZ, BRICE/0000-0002-5159-8706; Lesner, Adam/0000-0001-8335-3431; Lalmanach, Gilles/0000-0001-8562-4821	Association Vaincre la Mucoviscidose (VLM) [RF20130500913]; INSERM (ITMO Immunology, Hematology, Pneumology); Region Centre-Val de Loire (Project BPCOlyse); "National Science Centre" in Poland [UMO-2012/07/N/ST5/00128]; European Union's Horizon research and innovation program [668036]; Alexandre von Humboldt Foundation	Association Vaincre la Mucoviscidose (VLM); INSERM (ITMO Immunology, Hematology, Pneumology); Region Centre-Val de Loire (Project BPCOlyse)(Region Centre-Val de Loire); "National Science Centre" in Poland; European Union's Horizon research and innovation program; Alexandre von Humboldt Foundation	This work was supported by the "Association Vaincre la Mucoviscidose (VLM)" (RF20130500913), INSERM (ITMO Immunology, Hematology, Pneumology), "Region Centre-Val de Loire (Project BPCOlyse)," and the "National Science Centre" in Poland (UMO-2012/07/N/ST5/00128). In addition, this project has received funding from the European Union's Horizon 2020 research and innovation program under grant agreement 668036 (RELENT). The authors declare that they have no conflicts of interest in the research.; Recipient of a short term institutional research training grant from the Alexandre von Humboldt Foundation.	Adkison AM, 2002, J CLIN INVEST, V109, P363, DOI 10.1172/JCI13462; Andoniou CE, 2011, IMMUNOL CELL BIOL, V89, P540, DOI 10.1038/icb.2010.115; Attucci S, 2002, BIOCHEM J, V366, P965, DOI 10.1042/BJ20020321; BROWN GR, 1993, J IMMUNOL, V150, P4733; Cigic B, 1999, EUR J BIOCHEM, V264, P944, DOI 10.1046/j.1432-1327.1999.00697.x; Clair JMS, 2004, J CLIN INVEST, V113, P628, DOI 10.1172/JCI200419062; Clair JMS, 2006, BIOL CHEM, V387, P1143, DOI 10.1515/BC.2006.141; D'Angelo ME, 2010, J BIOL CHEM, V285, P20514, DOI 10.1074/jbc.M109.094573; Dahl SW, 2001, BIOCHEMISTRY-US, V40, P1671, DOI 10.1021/bi001693z; DOLENC I, 1995, J BIOL CHEM, V270, P21626, DOI 10.1074/jbc.270.37.21626; Dubois AV, 2013, AM J RESP CRIT CARE, V188, P703, DOI 10.1164/rccm.201305-0912OC; Faurschou M, 2003, MICROBES INFECT, V5, P1317, DOI 10.1016/j.micinf.2003.09.008; Firatli E, 1996, J PERIODONTOL, V67, P617, DOI 10.1902/jop.1996.67.6.617; Gauthier JY, 2007, BIOORG MED CHEM LETT, V17, P4929, DOI 10.1016/j.bmcl.2007.06.023; Guarino C, 2014, J BIOL CHEM, V289, P31777, DOI 10.1074/jbc.M114.591339; Guay D, 2009, BIOORG MED CHEM LETT, V19, P5392, DOI 10.1016/j.bmcl.2009.07.114; HANEKE E, 1979, HUM GENET, V51, P1, DOI 10.1007/BF00278288; Hart TC, 1999, J MED GENET, V36, P881; Koike M, 2013, EUR J NEUROSCI, V37, P816, DOI 10.1111/ejn.12096; Kono H, 2012, J IMMUNOL, V189, P3734, DOI 10.4049/jimmunol.1200136; Korkmaz B, 2008, NAT PROTOC, V3, P991, DOI 10.1038/nprot.2008.63; Korkmaz B, 2013, SEMIN IMMUNOPATHOL, V35, P411, DOI 10.1007/s00281-013-0362-z; Korkmaz B, 2011, FEBS J, V278, P2635, DOI 10.1111/j.1742-4658.2011.08189.x; Laine DI, 2010, EXPERT OPIN THER PAT, V20, P497, DOI 10.1517/13543771003657172; Liu RK, 2000, J CLIN PERIODONTOL, V27, P69, DOI 10.1034/j.1600-051x.2000.027001069.x; Lominadze G, 2005, MOL CELL PROTEOMICS, V4, P1503, DOI 10.1074/mcp.M500143-MCP200; MACH L, 1994, J BIOL CHEM, V269, P13030; Maubach G, 1997, EUR J BIOCHEM, V250, P745, DOI 10.1111/j.1432-1033.1997.00745.x; MCGUIRE MJ, 1993, J BIOL CHEM, V268, P2458; Methot N, 2008, MOL PHARMACOL, V73, P1857, DOI 10.1124/mol.108.045682; Methot N, 2007, J BIOL CHEM, V282, P20836, DOI 10.1074/jbc.M702615200; Papillon MM, 1924, B SOC FRANCAISE DERM, V31, P82; Perera NC, 2013, J IMMUNOL, V191, P2700, DOI 10.4049/jimmunol.1301293; Pham CTN, 2004, J IMMUNOL, V173, P7277, DOI 10.4049/jimmunol.173.12.7277; Pham CTN, 1997, J BIOL CHEM, V272, P10695, DOI 10.1074/jbc.272.16.10695; Pham CTN, 1999, P NATL ACAD SCI USA, V96, P8627, DOI 10.1073/pnas.96.15.8627; Rao NV, 1997, J BIOL CHEM, V272, P10260; Redecke L, 2013, SCIENCE, V339, P227, DOI 10.1126/science.1229663; Ruffell B, 2013, GENE DEV, V27, P2086, DOI 10.1101/gad.224899.113; Sorensen OE, 2014, J CLIN INVEST, V124, P4539, DOI 10.1172/JCI76009; Sutherland RE, 2014, BIOCHEM BIOPH RES CO, V450, P818, DOI 10.1016/j.bbrc.2014.06.062; Toomes C, 1999, NAT GENET, V23, P421, DOI 10.1038/70525; Tran TV, 2002, ARCH BIOCHEM BIOPHYS, V403, P160, DOI 10.1016/S0003-9861(02)00217-5; Turk D, 2001, EMBO J, V20, P6570, DOI 10.1093/emboj/20.23.6570; Turk V, 2012, BBA-PROTEINS PROTEOM, V1824, P68, DOI 10.1016/j.bbapap.2011.10.002; Wilkinson RDA, 2015, BIOL CHEM, V396, P867, DOI 10.1515/hsz-2015-0114; Wolters PJ, 1998, J BIOL CHEM, V273, P15514, DOI 10.1074/jbc.273.25.15514; Wolters PJ, 2000, AM J RESP CELL MOL, V22, P183, DOI 10.1165/ajrcmb.22.2.3767; Wolters PJ, 2001, J BIOL CHEM, V276, P18551, DOI 10.1074/jbc.M100223200	49	35	35	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2016	291	16					8486	8499		10.1074/jbc.M115.707109	http://dx.doi.org/10.1074/jbc.M115.707109			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK2VT	26884336	Green Published, hybrid			2022-12-26	WOS:000374773200015
J	Jin, YP; Bai, YY; Li, Q; Bhugul, PA; Huang, XC; Liu, LW; Pan, LL; Ni, HZ; Chen, BC; Sun, HW; Zhang, QY; Hehir, M; Zhou, MT				Jin, Yuepeng; Bai, Yongyu; Li, Qiang; Bhugul, Pravin Avinash; Huang, Xince; Liu, Lewei; Pan, Liangliang; Ni, Haizhen; Chen, Bicheng; Sun, Hongwei; Zhang, Qiyu; Hehir, Michael; Zhou, Mengtao			Reduced Pancreatic Exocrine Function and Organellar Disarray in a Canine Model of Acute Pancreatitis	PLOS ONE			English	Article							MITOCHONDRIAL INJURY; IMPAIRED AUTOPHAGY; ACINAR-CELL; RATS; PATHOGENESIS; SECRETION; DYSFUNCTION; ACTIVATION	The aim of the present study was to investigate the pancreatic exocrine function in a canine model and to analyze the changes in organelles of pancreatic acinar cells during the early stage of acute pancreatitis (AP). AP was induced by retrograde injection of 5% sodium taurocholate (0.5 ml/kg) into the main pancreatic duct of dogs. The induction of AP resulted in serum hyperamylasemia and a marked reduction of amylase activity in the pancreatic fluid (PF). The pancreatic exocrine function was markedly decreased in subjects with AP compared with the control group. After the induction of AP, histological examination showed acinar cell edema, cytoplasmic vacuolization, fibroblasts infiltration, and inflammatory cell infiltration in the interstitium. Electron micrographs after the induction of AP revealed that most of the rough endoplasmic reticulum (RER) were dilated and that some of the ribosomes were no longer located on the RER. The mitochondria were swollen, with shortened and broken cristae. The present study demonstrated, in a canine model, a reduced volume of PF secretion with decreased enzyme secretion during the early stage of AP. Injury of mitochondria and dilatation and degranulation of RER may be responsible for the reduced exocrine function in AP. Furthermore, the present model and results may be useful for researching novel therapeutic measures in AP.	[Jin, Yuepeng; Ni, Haizhen; Sun, Hongwei; Zhang, Qiyu; Zhou, Mengtao] Wenzhou Med Univ, Affiliated Hosp 1, Dept Surg, Wenzhou, Zhejiang, Peoples R China; [Bai, Yongyu; Li, Qiang; Bhugul, Pravin Avinash; Huang, Xince; Pan, Liangliang] Wenzhou Med Univ, Wenzhou, Zhejiang, Peoples R China; [Liu, Lewei] Wenzhou Med Univ, YueQing Peoples Hosp, YueQing Affiliated Hosp, Yueqing, Zhejiang, Peoples R China; [Chen, Bicheng] Wenzhou Med Univ, Affiliated Hosp 1, Dept Surg, Zhejiang Prov Top Key Discipline Surg,Wenzhou Key, Wenzhou, Zhejiang, Peoples R China; [Hehir, Michael] Ningbo Univ, Sch Med, Ningbo 315211, Zhejiang, Peoples R China	Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University; Ningbo University	Zhou, MT (corresponding author), Wenzhou Med Univ, Affiliated Hosp 1, Dept Surg, Wenzhou, Zhejiang, Peoples R China.	zmt0417@hotmail.com			Zhejiang Provincial Natural Science Foundation of China [LY12H03007]; China National Natural Science Foundation [81370563]; Ministry of Health of China [WKJ2012-2-033]; Science Technology Department of Zhejiang province [2012C23108]	Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); China National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Ministry of Health of China; Science Technology Department of Zhejiang province	This work was funded by the Zhejiang Provincial Natural Science Foundation of China (No. LY12H03007), China National Natural Science Foundation (No. 81370563), Ministry of Health of China (No. WKJ2012-2-033), and Public Welfare Technology application research project supported by Science Technology Department of Zhejiang province (No. 2012C23108).	Babic T, 2013, AM J PHYSIOL-GASTR L, V304, pG437, DOI 10.1152/ajpgi.00402.2012; bdulla A, 2011, J LEUKOCYTE BIOL, V90, P975, DOI [10.1189/jlb.0411195, DOI 10.1189/JLB.0411195]; Biczo G, 2011, ANTIOXID REDOX SIGN, V15, P2669, DOI 10.1089/ars.2011.4065; Bumbasirevic V, 2009, PANCREAS, V38, P122, DOI 10.1097/MPA.0b013e31818a392f; Cao YN, 2013, PANCREAS, V42, P301, DOI 10.1097/MPA.0b013e31825b9f2c; Czako L, 1997, PANCREAS, V15, P83, DOI 10.1097/00006676-199707000-00012; Czako L, 1997, DIGEST DIS SCI, V42, P265, DOI 10.1023/A:1018893230319; Dawra R, 2011, GASTROENTEROLOGY, V141, P2210, DOI 10.1053/j.gastro.2011.08.033; Gerasimenko OV, 2012, PFLUG ARCH EUR J PHY, V464, P89, DOI 10.1007/s00424-012-1117-8; Gukovsky I, 2012, J GASTROEN HEPATOL, V27, P27, DOI 10.1111/j.1440-1746.2011.07004.x; Gukovsky I, 2011, ANTIOXID REDOX SIGN, V15, P2699, DOI 10.1089/ars.2011.4068; Hegyi P, 2011, GUT, V60, P544, DOI 10.1136/gut.2010.218461; Leung PS, 2006, INT J BIOCHEM CELL B, V38, P1024, DOI 10.1016/j.biocel.2005.12.001; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Maleth J, 2013, ACTA PHYSIOL, V207, P226, DOI 10.1111/apha.12037; Mooren FC, 2003, J BIOL CHEM, V278, P9361, DOI 10.1074/jbc.M207454200; MURAYAMA KM, 1990, SURGERY, V107, P302; NIEDERAU C, 1990, GASTROENTEROLOGY, V99, P1120, DOI 10.1016/0016-5085(90)90633-C; Noble MD, 2005, CURR OPIN GASTROEN, V21, P531, DOI 10.1097/01.mog.0000174220.85085.95; Ogasawara T, 1999, INT J PANCREATOL, V26, P59, DOI 10.1007/BF02781732; Pandol SJ, 2007, GASTROENTEROLOGY, V132, P1127, DOI 10.1053/j.gastro.2007.01.055; Sailai Y, 2010, J INVEST MED, V58, P38, DOI 10.2310/JIM.0b013e3181b91bd6; Samuel I, 2006, J GASTROINTEST SURG, V10, P1376, DOI 10.1016/j.gassur.2006.09.003; Sata N, 1996, J GASTROENTEROL, V31, P94, DOI 10.1007/BF01211193; Sun ZZ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0055124, 10.1371/journal.pone.0055249, 10.1371/journal.pone.0074672]; Xu P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081767	26	3	4	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0148458	10.1371/journal.pone.0148458	http://dx.doi.org/10.1371/journal.pone.0148458			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3DG	26895040	Green Submitted, Green Published, gold			2022-12-26	WOS:000371223400015
J	Lawlor, C; O'Connor, G; O'Leary, S; Gallagher, PJ; Cryan, SA; Keane, J; O'Sullivan, MP				Lawlor, Ciaran; O'Connor, Gemma; O'Leary, Seonadh; Gallagher, Paul J.; Cryan, Sally-Ann; Keane, Joseph; O'Sullivan, Mary P.			Treatment of Mycobacterium tuberculosis-Infected Macrophages with Poly(Lactic-Co-Glycolic Acid) Microparticles Drives NF kappa B and Autophagy Dependent Bacillary Killing	PLOS ONE			English	Article							DENDRITIC CELLS; INHALABLE MICROPARTICLES; ALVEOLAR MACROPHAGES; IN-VITRO; PLGA-MICROSPHERES; DEFENSE-MECHANISM; PHAGOCYTOSIS; APOPTOSIS; IMMUNOTHERAPY; INHIBITION	The emergence of multiple-drug-resistant tuberculosis (MDR-TB) has pushed our available repertoire of anti-TB therapies to the limit of effectiveness. This has increased the urgency to develop novel treatment modalities, and inhalable microparticle (MP) formulations are a promising option to target the site of infection. We have engineered poly(lactic-co-glycolic acid) (PLGA) MPs which can carry a payload of anti-TB agents, and are successfully taken up by human alveolar macrophages. Even without a drug cargo, MPs can be potent immunogens; yet little is known about how they influence macrophage function in the setting of Mycobacterium tuberculosis (Mtb) infection. To address this issue we infected THP-1 macrophages with Mtb H37Ra or H37Rv and treated with MPs. In controlled experiments we saw a reproducible reduction in bacillary viability when THP-1 macrophages were treated with drug-free MPs. NF kappa B activity was increased in MP-treated macrophages, although cytokine secretion was unaltered. Confocal microscopy of immortalized murine bone marrow-derived macrophages expressing GFP-tagged LC3 demonstrated induction of autophagy. Inhibition of caspases did not influence the MP-induced restriction of bacillary growth, however, blockade of NF kappa B or autophagy with pharmacological inhibitors reversed this MP effect on macrophage function. These data support harnessing inhaled PLGA MP-drug delivery systems as an immunotherapeutic in addition to serving as a vehicle for targeted drug delivery. Such "added value" could be exploited in the generation of inhaled vaccines as well as inhaled MDR-TB therapeutics when used as an adjunct to existing treatments.	[Lawlor, Ciaran; O'Connor, Gemma; Gallagher, Paul J.; Cryan, Sally-Ann] Royal Coll Surgeons Ireland, Sch Pharm, Dublin 2, Ireland; [Cryan, Sally-Ann] Trinity Coll Dublin, Trinity Ctr Bioengn, Dublin 2, Ireland; [Lawlor, Ciaran; O'Connor, Gemma; O'Leary, Seonadh; Keane, Joseph; O'Sullivan, Mary P.] Trinity Coll Dublin, Inst Mol Med, Dept Clin Med, Dublin 2, Ireland; [Lawlor, Ciaran; O'Connor, Gemma; O'Leary, Seonadh; Keane, Joseph; O'Sullivan, Mary P.] St James Hosp, Dublin 8, Ireland; [Lawlor, Ciaran] Moderna Therapeut, Cambridge, MA USA	Royal College of Surgeons - Ireland; Trinity College Dublin; Trinity College Dublin; Trinity College Dublin	O'Sullivan, MP (corresponding author), Trinity Coll Dublin, Inst Mol Med, Dept Clin Med, Dublin 2, Ireland.	mary.osullivan@tcd.ie	Keane, Joseph/AAX-6658-2021; O'Sullivan, Mary P/C-9413-2012	Keane, Joseph/0000-0001-5313-385X; O'Sullivan, Mary P/0000-0002-6104-8943; O'Leary, Seonadh/0000-0002-7903-2325; Cryan, Sally-Ann/0000-0002-3941-496X	Irish Health Research Board [RP/2006/152, HRB HRAPOR/2012/43, HRB CSA/2012/16]; Royal City of Dublin Hospital Trust; Science Foundation Ireland [08/RFP/BMT1689]	Irish Health Research Board; Royal City of Dublin Hospital Trust; Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	This work was supported by the Irish Health Research Board (http://www.hrb.ie/home/) under grant RP/2006/152 and HRB HRAPOR/2012/43 (SAC), HRB CSA/2012/16 and the Royal City of Dublin Hospital Trust, (JK) and Science Foundation Ireland (http://www.sfi.ie/) 08/RFP/BMT1689 (MOS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arcila ML, CELLULAR IMMUNOLOGY, V249, P80; Bonilla DL, 2013, IMMUNITY, V39, P537, DOI 10.1016/j.immuni.2013.08.026; Briken V, 2008, FUTURE MICROBIOL, V3, P415, DOI 10.2217/17460913.3.4.415; Deretic V, 2006, CELL MICROBIOL, V8, P719, DOI 10.1111/j.1462-5822.2006.00705.x; Edwards DA, 2002, ANNU REV BIOMED ENG, V4, P93, DOI 10.1146/annurev.bioeng.4.100101.132311; Evora C, 1998, J CONTROL RELEASE, V51, P143, DOI 10.1016/S0168-3659(97)00149-1; Getts DR, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007563; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Harris J, 2011, J BIOL CHEM, V286, P9587, DOI 10.1074/jbc.M110.202911; Hartman ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027972; Hirota K, 2010, J CONTROL RELEASE, V142, P339, DOI 10.1016/j.jconrel.2009.11.020; Keane J, 1997, INFECT IMMUN, V65, P298, DOI 10.1128/IAI.65.1.298-304.1997; Keane J, 2000, J IMMUNOL, V164, P2016, DOI 10.4049/jimmunol.164.4.2016; Lawlor C, 2012, J MATER SCI-MATER M, V23, P89, DOI 10.1007/s10856-011-4511-4; Lawlor C, 2011, TUBERCULOSIS, V91, P93, DOI 10.1016/j.tube.2010.12.001; Lawlor C, 2011, MOL PHARMACEUT, V8, P1100, DOI 10.1021/mp1004178; Lewis JS, 2012, BIOMATERIALS, V33, P7221, DOI 10.1016/j.biomaterials.2012.06.049; Lu DM, 2007, PHARM RES-DORDR, V24, P1834, DOI 10.1007/s11095-007-9302-8; Malyala P, 2008, J PHARM SCI-US, V97, P1155, DOI 10.1002/jps.21065; Marques AP, 2004, J BIOMED MATER RES A, V71A, P419, DOI 10.1002/jbm.a.30155; Mueller M, 2012, J CONTROL RELEASE, V162, P159, DOI 10.1016/j.jconrel.2012.06.015; Muttil P, 2007, EUR J PHARM SCI, V32, P140, DOI 10.1016/j.ejps.2007.06.006; Muttil P, 2009, PHARM RES-DORDR, V26, P2401, DOI 10.1007/s11095-009-9957-4; Nicolete R, 2011, INT IMMUNOPHARMACOL, V11, P1557, DOI 10.1016/j.intimp.2011.05.014; O'Hara P, 2000, PHARMACEUT RES, V17, P955, DOI 10.1023/A:1007527204887; O'Leary S, 2011, AM J RESP CELL MOL, V45, P172, DOI 10.1165/rcmb.2010-0319OC; O'Sullivan MP, 2007, INFECT IMMUN, V75, P1984, DOI 10.1128/IAI.01107-06; Pham NLL, 2010, P NATL ACAD SCI USA, V107, P12198, DOI 10.1073/pnas.1004661107; Ramakrishnan L, 2012, NAT REV IMMUNOL, V12, P352, DOI 10.1038/nri3211; Roberts RA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062115; Ryan RCM, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-237; Salminen Antero, 2012, Int J Cell Biol, V2012, P849541, DOI 10.1155/2012/849541; Sanjuan MA, 2007, NATURE, V450, P1253, DOI 10.1038/nature06421; Schlosser E, 2008, VACCINE, V26, P1626, DOI 10.1016/j.vaccine.2008.01.030; Sharma R, 2007, J ANTIMICROB CHEMOTH, V59, P499, DOI 10.1093/jac/dkl533; Sharma R, 2011, TUBERCULOSIS, V91, P107, DOI 10.1016/j.tube.2010.11.003; Sharp FA, 2009, P NATL ACAD SCI USA, V106, P870, DOI 10.1073/pnas.0804897106; Shui WQ, 2008, P NATL ACAD SCI USA, V105, P16952, DOI 10.1073/pnas.0809218105; Stern ST, 2012, PART FIBRE TOXICOL, V9, DOI 10.1186/1743-8977-9-20; Thi EP, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002551; van der Vaart M, 2014, CELL HOST MICROBE, V15, P753, DOI 10.1016/j.chom.2014.05.005; Waeckerle-Men Y, 2004, J IMMUNOL METHODS, V287, P109, DOI 10.1016/j.jim.2004.01.010; Wang CC, 2009, AAPS J, V11, P139, DOI 10.1208/s12248-009-9089-0; Yadav AB, 2010, TUBERCULOSIS, V90, P188, DOI 10.1016/j.tube.2010.03.001; Yadav AB, 2009, INDIAN J EXP BIOL, V47, P469	45	40	41	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0149167	10.1371/journal.pone.0149167	http://dx.doi.org/10.1371/journal.pone.0149167			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3DG	26894562	Green Published, gold, Green Submitted			2022-12-26	WOS:000371223400033
J	Yang, HJ; Zhang, JY; Wei, C; Yang, LY; Zuo, QF; Zhuang, Y; Feng, YJ; Srinivas, S; Zeng, H; Zou, QM				Yang, Hui-Jie; Zhang, Jin-Yong; Wei, Chao; Yang, Liu-Yang; Zuo, Qian-Fei; Zhuang, Yuan; Feng, You-Jun; Srinivas, Swaminath; Zeng, Hao; Zou, Quan-Ming			Immunisation With Immunodominant Linear B Cell Epitopes Vaccine of Manganese Transport Protein C Confers Protection against Staphylococcus aureus Infection	PLOS ONE			English	Article							COMMUNITY-ASSOCIATED MRSA; UNITED-STATES; COLONIZATION; ANTIBODIES; RESISTANCE; VIRULENCE; EFFICACY	Vaccination strategies for Staphylococcus aureus, particularly methicillin-resistant S. aureus (MRSA) infections have attracted much research attention. Recent efforts have been made to select manganese transport protein C, or manganese binding surface lipoprotein C (MntC), which is a metal ion associated with pathogen nutrition uptake, as potential candidates for an S. aureus vaccine. Although protective humoral immune responses to MntC are well-characterised, much less is known about detailed MntC-specific B cell epitope mapping and particularly epitope vaccines, which are less-time consuming and more convenient. In this study, we generated a recombinant protein rMntC which induced strong antibody response when used for immunisation with CFA/IFA adjuvant. On the basis of the results, linear B cell epitopes within MntC were finely mapped using a series of overlapping synthetic peptides. Further studies indicate that MntC113-136, MntC209-232, and MntC263-286 might be the original linear B-cell immune dominant epitope of MntC, furthermore, three-dimensional (3-d) crystal structure results indicate that the three immunodominant epitopes were displayed on the surface of the MntC antigen. On the basis of immunodominant MntC113-136, MntC209-232, and MntC263-286 peptides, the epitope vaccine for S. aureus induces a high antibody level which is biased to TH2 and provides effective immune protection and strong opsonophagocytic killing activity in vitro against MRSA infection. In summary, the study provides strong proof of the optimisation of MRSA B cell epitope vaccine designs and their use, which was based on the MntC antigen in the development of an MRSA vaccine.	[Yang, Hui-Jie; Zhang, Jin-Yong; Wei, Chao; Yang, Liu-Yang; Zuo, Qian-Fei; Zhuang, Yuan; Zeng, Hao; Zou, Quan-Ming] Third Mil Med Univ, Dept Microbiol & Biochem Pharm, Coll Pharm, Natl Engn Res Ctr Immunol Prod, Chongqing 400038, Peoples R China; [Feng, You-Jun] Zhejiang Univ, Sch Basic Med Sci, Hangzhou 310058, Zhejiang, Peoples R China; [Srinivas, Swaminath] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA	Army Medical University; Zhejiang University; University of Illinois System; University of Illinois Urbana-Champaign	Zeng, H; Zou, QM (corresponding author), Third Mil Med Univ, Dept Microbiol & Biochem Pharm, Coll Pharm, Natl Engn Res Ctr Immunol Prod, Chongqing 400038, Peoples R China.	zeng1109@163.com; qmzou2007@163.com	liu, yang/HHY-8583-2022; yang, liu/GVU-8760-2022; Srinivas, Swaminath/AAK-7213-2021	Zhang, Jinyong/0000-0001-9622-5834; Srinivas, Swaminath/0000-0002-7210-5122	National Key Technology R & D Programme of China [2012EP001003/2014BAI15B00]; Chinese National Natural Science Foundation [31370932, 31400792]; "Young 1000 Talents" Award	National Key Technology R & D Programme of China(National Key Technology R&D Program); Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); "Young 1000 Talents" Award	This work was supported by The National Key Technology R & D Programme of China (2012EP001003/2014BAI15B00), Chinese National Natural Science Foundation Project (Nos 31370932 and 31400792). YF is a recipient of the "Young 1000 Talents" Award. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja S, 2015, STRUCTURE, V23, P713, DOI 10.1016/j.str.2015.01.020; Anderson AS, 2012, J INFECT DIS, V205, P1688, DOI 10.1093/infdis/jis272; Barg N, 1998, J ANTIMICROB CHEMOTH, V42, P257, DOI 10.1093/jac/42.2.257; Barroso L, 2014, VACCINE, V32, P1218, DOI 10.1016/j.vaccine.2013.06.056; Bassetti M, 2009, INT J ANTIMICROB AG, V34, pS15, DOI 10.1016/S0924-8579(09)70544-8; Blot S, 1998, NEW ENGL J MED, V339, P2025; Burton RL, 2012, CLIN VACCINE IMMUNOL, V19, P835, DOI 10.1128/CVI.00086-12; Chambers HF, 2005, NEW ENGL J MED, V352, P1485, DOI 10.1056/NEJMe058023; Chen L, 2013, GASTROENTEROLOGY, V144, P591, DOI 10.1053/j.gastro.2012.12.002; Coady A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138350; Cosseron-Zerbib M, 1998, J HOSP INFECT, V40, P225, DOI 10.1016/S0195-6701(98)90140-2; Daum RS, 1998, PEDIATR INFECT DIS J, V17, P745, DOI 10.1097/00006454-199808000-00015; Diep BA, 2014, J INFECT DIS, V209, P1533, DOI 10.1093/infdis/jit662; Gill SR, 2005, J BACTERIOL, V187, P2426, DOI 10.1128/JB.187.7.2426-2438.2005; Gong R, 2010, CLIN VACCINE IMMUNOL, V17, P1746, DOI 10.1128/CVI.00162-10; Gorwitz RJ, 2008, J INFECT DIS, V197, P1226, DOI 10.1086/533494; Gribenko A, 2013, J MOL BIOL, V425, P3429, DOI 10.1016/j.jmb.2013.06.033; Gupta SK, 2010, VACCINE, V28, P7092, DOI 10.1016/j.vaccine.2010.08.005; Harenska K, 1998, Przegl Epidemiol, V52, P199; Hu DL, 2003, J INFECT DIS, V188, P743, DOI 10.1086/377308; Ibarra JA, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-126; Jin X, 2009, VACCINE, V27, P7080, DOI 10.1016/j.vaccine.2009.09.060; Karauzum H, 2012, J BIOL CHEM, V287, P25203, DOI 10.1074/jbc.M112.364075; Klein E, 2007, EMERG INFECT DIS, V13, P1840, DOI 10.3201/eid1312.070629; Lin MS, 2011, IMMUNOL RES, V50, P213, DOI 10.1007/s12026-011-8215-0; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Manhold C, 1998, INTENS CARE MED, V24, P1327, DOI 10.1007/s001340050770; McKenna M, 2012, NATURE, V482, P23, DOI 10.1038/482023a; McNamara LA, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-18; Mohammadi M, 1997, GASTROENTEROLOGY, V113, P1848, DOI 10.1016/S0016-5085(97)70004-0; Oliveira D., 1998, Clin Microbiol Infect, V4, P373, DOI 10.1111/j.1469-0691.1998.tb00081.x; Olmos A, 1998, J CLIN MICROBIOL, V36, P1128, DOI 10.1128/JCM.36.4.1128-1134.1998; Paul S, 2010, EXPERT REV VACCINES, V9, P1027, DOI 10.1586/ERV.10.77; PLOS ONE Staff, 2015, PLoS One, V10, pe0121192, DOI 10.1371/journal.pone.0121192; Rozemeijer W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116945; Uruse M, 2014, J BIOCHEM, V155, P265, DOI 10.1093/jb/mvu005; Varshney AK, 2011, J BIOL CHEM, V286, P9737, DOI 10.1074/jbc.M110.212407; Vaudaux P, 1998, DRUG RESIST UPDATE, V1, P352, DOI 10.1016/S1368-7646(98)80011-3; Wang J, 1998, J HOSP INFECT, V39, P221, DOI 10.1016/S0195-6701(98)90261-4; Yi L, 2016, VIRUS RES, V213, P1, DOI 10.1016/j.virusres.2015.10.022; Yzerman EPF, 1998, J ANTIMICROB CHEMOTH, V42, P233, DOI 10.1093/jac/42.2.233; Zhao Z, 2015, SCI REP-UK, V5, DOI 10.1038/srep12371	42	19	21	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0149638	10.1371/journal.pone.0149638	http://dx.doi.org/10.1371/journal.pone.0149638			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3DG	26895191	gold, Green Published, Green Submitted			2022-12-26	WOS:000371223400071
J	Husain, I; Sharma, A; Kumar, S; Malik, F				Husain, Islam; Sharma, Anjana; Kumar, Suresh; Malik, Fayaz			Purification and Characterization of Glutaminase Free Asparaginase from Enterobacter cloacae: In-Vitro Evaluation of Cytotoxic Potential against Human Myeloid Leukemia HL-60 Cells	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; EXTRACELLULAR L-ASPARAGINASE; ESCHERICHIA-COLI; CANCER; ELECTROPHORESIS; APOPTOSIS; CLEAVAGE; SERUM; YEAST; VIVO	Asparaginase is an important antileukemic agent extensively used worldwide but the intrinsic glutaminase activity of this enzymatic drug is responsible for serious life threatening side effects. Hence, glutaminase free asparaginase is much needed for upgradation of therapeutic index of asparaginase therapy. In the present study, glutaminase free asparaginase produced from Enterobacter cloacae was purified to apparent homogeneity. The purified enzyme was found to be homodimer of approximately 106 kDa with monomeric size of approximately 52 kDa and p/ 4.5. Purified enzyme showed optimum activity between pH 7-8 and temperature 35-40 degrees C, which is close to the internal environment of human body. Monovalent cations such as Na+ and K+ enhanced asparaginase activity whereas divalent and trivalent cations, Ca2+, Mg2+, Zn2+, Mn2+, and Fe3+ inhibited the enzyme activity. Kinetic parameters K-m, V-max and K-cat of purified enzyme were found to be 1.58x10(-3) M, 2.22 IU mu g(-1) and 5.3 x 10(4) S-1, respectively. Purified enzyme showed prolonged in vitro serum (T-1/2 = similar to 39 h) and trypsin (T-1/2 = similar to 32min) half life, which is therapeutically remarkable feature. The cytotoxic activity of enzyme was examined against a panel of human cancer cell lines, HL-60, MOLT-4, MDA-MB-231 and T47D, and highest cytotoxicity observed against HL-60 cells (IC50 similar to 3.1 IU ml(-1)), which was comparable to commercial asparaginase. Cell and nuclear morphological studies of HL-60 cells showed that on treatment with purified asparaginase symptoms of apoptosis were increased in dose dependent manner. Cell cycle progression analysis indicates that enzyme induces apoptosis by cell cycle arrest in G0/G1 phase. Mitochondrial membrane potential loss showed that enzyme also triggers the mitochondrial pathway of apoptosis. Furthermore, the enzyme was found to be nontoxic for human noncancerous cells FR-2 and non-hemolytic for human erythrocytes.	[Husain, Islam; Sharma, Anjana] Rani Durgavati Univ, Dept PG Studies & Res Biol Sci, Bacteriol Lab, Jabalpur, Madhya Pradesh, India; [Kumar, Suresh; Malik, Fayaz] Indian Inst Integrat Med, Canc Pharmacol Div, Jammu, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Integrative Medicine (IIIM)	Sharma, A (corresponding author), Rani Durgavati Univ, Dept PG Studies & Res Biol Sci, Bacteriol Lab, Jabalpur, Madhya Pradesh, India.	anjoo1999@gmail.com	Husain, Islam/S-4237-2019	Husain, Islam/0000-0002-6150-5788; Malik, Fayaz/0000-0001-5475-6610	Madhya Pradesh Biotechnology Council (MPBC), Bhopal, India [56]	Madhya Pradesh Biotechnology Council (MPBC), Bhopal, India	Madhya Pradesh Biotechnology Council (MPBC), Bhopal, India, provided funds for this research work by issuing letter no. 56, dated 26-01-2012 (http://www.mpbiotech.nic.in). However, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], INT J PHARM BIO SC B; [Anonymous], 2015, INT J CURR MICROBIOL; ASSELIN BL, 1989, CANCER RES, V49, P4363; Avramis VI, 2002, BLOOD, V99, P1986, DOI 10.1182/blood.V99.6.1986; Bansal S, 2010, BIOCHEMISTRY-MOSCOW+, V75, P375, DOI 10.1134/S0006297910030144; BROOME JD, 1965, J NATL CANCER I, V35, P967; BROOME JD, 1961, NATURE, V191, P1114, DOI 10.1038/1911114a0; Bulmus V, 2003, J CONTROL RELEASE, V93, P105, DOI 10.1016/j.jconrel.2003.06.001; Chan WK, 2014, BLOOD, V123, P3596, DOI 10.1182/blood-2013-10-535112; Denicourt C, 2004, SCIENCE, V305, P1411, DOI 10.1126/science.1102974; Dey SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058055; El-Bessoumy AA, 2004, J BIOCHEM MOL BIOL, V37, P387, DOI 10.5483/BMBRep.2004.37.4.387; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; GONG SS, 1990, NUCLEIC ACIDS RES, V18, P3509, DOI 10.1093/nar/18.12.3509; GORG A, 1988, ELECTROPHORESIS, V9, P531, DOI 10.1002/elps.1150090913; HASKELL CM, 1969, CANCER RES, V29, P974; Huang SH, 2013, INT J BIOL MACROMOL, V62, P124, DOI 10.1016/j.ijbiomac.2013.08.048; IMADA A, 1973, J GEN MICROBIOL, V76, P85, DOI 10.1099/00221287-76-1-85; Kavitha CV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069103; Kumar NSM, 2013, WORLD J MICROB BIOT, V29, P577, DOI 10.1007/s11274-012-1213-0; Kumar S, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.399; Kumar S, 2011, BIORESOURCE TECHNOL, V102, P2077, DOI 10.1016/j.biortech.2010.07.114; Kurtzberg J, 2003, CANC MED, VIV, P699; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lambu MR, 2013, J MED CHEM, V56, P6122, DOI 10.1021/jm400515c; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lubkowski J, 1996, EUR J BIOCHEM, V241, P201, DOI 10.1111/j.1432-1033.1996.0201t.x; Mahajan RV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099037; Malik F, 2007, APOPTOSIS, V12, P2115, DOI 10.1007/s10495-007-0129-x; MANNA S, 1995, CURR MICROBIOL, V30, P291, DOI 10.1007/BF00295504; MESAS JM, 1990, J GEN MICROBIOL, V136, P515, DOI 10.1099/00221287-136-3-515; Mukherjee J, 1999, FOLIA MICROBIOL, V44, P15, DOI 10.1007/BF02816214; Muller HJ, 1998, CRIT REV ONCOL HEMAT, V28, P97, DOI 10.1016/S1040-8428(98)00015-8; Narta UK, 2007, CRIT REV ONCOL HEMAT, V61, P208, DOI 10.1016/j.critrevonc.2006.07.009; OHNUMA T, 1967, BIOCHEM J, V103, P238, DOI 10.1042/bj1030238; Onishi Y, 2011, ANN MICROBIOL, V61, P517, DOI 10.1007/s13213-010-0167-4; Pal HC, 2010, TOXICOL IN VITRO, V24, P1599, DOI 10.1016/j.tiv.2010.06.007; PETERSON RE, 1969, APPL MICROBIOL, V18, P64, DOI 10.1128/AEM.18.1.64-67.1969; Piatkowska-Jakubas Beata, 2008, Pol Arch Med Wewn, V118, P664; Pieters R, 2011, CANCER-AM CANCER SOC, V117, P238, DOI 10.1002/cncr.25489; Prakasham RS, 2010, APPL BIOCHEM BIOTECH, V160, P72, DOI 10.1007/s12010-009-8679-8; Prista A. A., 2001, MOL CELL BIOCHEM, V216, P93; Pui CH, 2008, LANCET, V371, P1030, DOI 10.1016/S0140-6736(08)60457-2; Ramya LN, 2012, APPL BIOCHEM BIOTECH, V167, P2144, DOI 10.1007/s12010-012-9755-z; Ribble D, 2005, BMC BIOTECHNOL, V5, DOI 10.1186/1472-6750-5-12; Shahabuddin MS, 2011, INVEST NEW DRUG, V29, P523, DOI 10.1007/s10637-009-9379-5; Shimizu T, 1998, EUR J PEDIATR, V157, P561, DOI 10.1007/s004310050878; Singh Y, 2013, APPL BIOCHEM BIOTECH, V171, P1759, DOI 10.1007/s12010-013-0455-0; STORY MD, 1993, CANCER CHEMOTH PHARM, V32, P129, DOI 10.1007/BF00685615; Tabandeh MR, 2009, J BIOTECHNOL, V141, P189, DOI 10.1016/j.jbiotec.2009.03.020; TRIANTAFILLOU DJ, 1988, MOL CELL BIOCHEM, V81, P43; Trung LQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055183; Tsuchiya E, 2010, BIOSCI BIOTECH BIOCH, V74, P411, DOI 10.1271/bbb.90633; Wei YJ, 2008, J CHROMATOGR SCI, V46, P556, DOI 10.1093/chromsci/46.6.556; Wikman LEK, 2005, ACTA CRYSTALLOGR F, V61, P407, DOI 10.1107/S1744309105008249; WILLIS RC, 1974, J BACTERIOL, V118, P231, DOI 10.1128/JB.118.1.231-241.1974; WRISTON JC, 1985, METHOD ENZYMOL, V113, P608; Zhang YQ, 2005, J BIOTECHNOL, V120, P315, DOI 10.1016/j.jbiotec.2005.06.027	58	52	54	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2016	11	2							e0148877	10.1371/journal.pone.0148877	http://dx.doi.org/10.1371/journal.pone.0148877			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3CO	26891220	Green Published, Green Submitted, gold			2022-12-26	WOS:000371221500016
J	Brennan, GI; Abbott, Y; Burns, A; Leonard, F; McManus, BA; O'Connell, B; Coleman, DC; Shore, AC				Brennan, Grainne I.; Abbott, Yvonne; Burns, Aisling; Leonard, Finola; McManus, Brenda A.; O'Connell, Brian; Coleman, David C.; Shore, Anna C.			The Emergence and Spread of Multiple Livestock-Associated Clonal Complex 398 Methicillin-Resistant and Methicillin-Susceptible Staphylococcus aureus Strains among Animals and Humans in the Republic of Ireland, 2010-2014	PLOS ONE			English	Article							GENE; MRSA; DNA; ST398; PIGS; PCR	Clonal complex (CC) 398 methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-susceptible S. aureus (MSSA) are associated with carriage and infection among animals and humans but only a single case of CC398 MRSA has been reported in the Republic of Ireland (ROI). The present study investigated the molecular epidemiology of CC398 MRSA (n = 22) and MSSA (n = 10) from animals and humans in the ROI from 2010-2014. Isolates underwent antimicrobial susceptibility testing, spa typing, DNA microarray profiling and PCR for CC398-associated resistance genes. All MRSA underwent SCCmec IV or V subtyping. Four distinct CC398-MRSA incidents were identified from (i) a man in a nursing home (spa type t011-SCCmec IVa, immune evasion complex (IEC) negative), (ii) a horse and veterinarian who had recently travelled to Belgium (t011-IVa, IEC positive), (iii) pigs (n = 9) and farm workers (n = 9) on two farms, one which had been restocked with German gilts and the other which was a finisher farm (t034-VT, IEC negative, 3/9 pigs; t011-VT, IEC negative, 6/9 pigs & 9/9 farm workers), and (iv) a child who had worked on a pig farm in the UK (t034-VT, IEC negative). Isolates also carried different combinations of multiple resistance genes including erm(A), erm(B), tet(K), tet(M) & tet(L), fexA, spc, dfrG, dfrK aacAaphD and aadD further highlighting the presence of multiple CC398-MRSA strains. CC398 MSSA were recovered from pigs (n = 8) and humans (n = 2). CC398 MSSA transmission was identified among pigs but zoonotic transmission was not detected with animal and human isolates exhibiting clade-specific traits. This study highlights the importation and zoonotic spread of CC398 MRSA in the ROI and the spread of CC398 MSSA among pigs. Increased surveillance is warranted to prevent further CC398 MRSA importation and spread in a country that was considered CC398 MRSA free.	[Brennan, Grainne I.; McManus, Brenda A.; O'Connell, Brian] St James Hosp, Natl MRSA Reference Lab, Jamess St, Dublin 8, Ireland; [Brennan, Grainne I.; Coleman, David C.; Shore, Anna C.] Univ Dublin Trinity Coll, Dublin Dent Univ Hosp, Div Oral Biosci, Microbiol Res Unit, Dublin 2, Ireland; [Abbott, Yvonne; Burns, Aisling; Leonard, Finola] Natl Univ Ireland Univ Coll Dublin, Sch Vet Med, Pathobiol, Dublin 4, Ireland; [O'Connell, Brian; Shore, Anna C.] Univ Dublin, Trinity Coll, St Jamess Hosp, Dept Clin Microbiol, Jamess St, Dublin 8, Ireland	Trinity College Dublin; Trinity College Dublin; University College Dublin; Trinity College Dublin	Shore, AC (corresponding author), Univ Dublin Trinity Coll, Dublin Dent Univ Hosp, Div Oral Biosci, Microbiol Res Unit, Dublin 2, Ireland.; Shore, AC (corresponding author), Univ Dublin, Trinity Coll, St Jamess Hosp, Dept Clin Microbiol, Jamess St, Dublin 8, Ireland.	anna.shore@dental.tcd.ie	Coleman, David C./C-2008-2009; McManus, Brenda/H-8600-2019	Coleman, David C./0000-0003-1797-2888; McManus, Brenda/0000-0003-3969-054X	Microbiology Research Unit, Dublin Dental University Hospital; Food Institute Research Measure from The Department of Agriculture, Food and the Marine [08 RDD 680]	Microbiology Research Unit, Dublin Dental University Hospital; Food Institute Research Measure from The Department of Agriculture, Food and the Marine	This work was supported by the Microbiology Research Unit, Dublin Dental University Hospital and, in part, by the Food Institute Research Measure grant 08 RDD 680 from The Department of Agriculture, Food and the Marine (FL). The grant body had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argudin MA, 2011, APPL ENVIRON MICROB, V77, P3052, DOI 10.1128/AEM.02260-10; Brennan GI, 2012, EPI INSIGHT, V13; CARROLL D, 1995, MOL MICROBIOL, V16, P877, DOI 10.1111/j.1365-2958.1995.tb02315.x; Chroboczek T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068462; Clinical and Laboratory Standards Institute, 2013, M100S23 CLSI; COLEMAN DC, 1989, J GEN MICROBIOL, V135, P1679; Cuny C, 2015, VET MICROBIOL, V177, P219, DOI 10.1016/j.vetmic.2015.02.031; Cuny C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083165; Dahms C, 2014, ACTA VET SCAND, V56, DOI 10.1186/s13028-014-0053-3; EUCAST, 2014, BREAKP TABL INT MICS; EUCAST (European Committee on Antimicrobial Susceptibility Testing), 2015, ANT SUSC TEST EUCAST; Fessler A, 2010, J ANTIMICROB CHEMOTH, V65, P619, DOI 10.1093/jac/dkq021; GOV. UK, 2013, LIV ASS MRSA FOUND F; Hadjirin NF, 2015, EUROSURVEILLANCE, V20, DOI 10.2807/1560-7917.ES2015.20.24.21156; Hall S, 2015, VET REC, V176, DOI 10.1136/vr.h627; Hartley H, 2014, VET REC, V175, DOI 10.1136/vr.g4620; Higuchi W, 2008, BIOCHEM BIOPH RES CO, V377, P752, DOI 10.1016/j.bbrc.2008.10.009; Horgan M, 2011, VET J, V190, P255, DOI 10.1016/j.tvjl.2010.10.025; Kadlec K, 2012, CLIN MICROBIOL INFEC, V18, P745, DOI 10.1111/j.1469-0691.2012.03842.x; Kadlec K, 2009, ANTIMICROB AGENTS CH, V53, P776, DOI 10.1128/AAC.01128-08; Kock R, 2014, BERL MUNCH TIERARZTL, V127, P384, DOI 10.2376/0005-9366-127-384; Krupa P, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/141475; Loeffler A, 2009, J HOSP INFECT, V72, P269, DOI 10.1016/j.jhin.2009.04.002; Malachowa N, 2010, CELL MOL LIFE SCI, V67, P3057, DOI 10.1007/s00018-010-0389-4; McManus BA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138079; Mellmann A, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-98; Milheirico C, 2007, J ANTIMICROB CHEMOTH, V60, P42, DOI 10.1093/jac/dkm112; Monecke S, 2008, CLIN MICROBIOL INFEC, V14, P534, DOI 10.1111/j.1469-0691.2008.01986.x; Monecke S, 2008, FEMS IMMUNOL MED MIC, V53, P237, DOI 10.1111/j.1574-695X.2008.00426.x; Ng LK, 2001, MOL CELL PROBE, V15, P209, DOI 10.1006/mcpr.2001.0363; Pantosti A, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00127; Price LB, 2012, MBIO, V3, DOI 10.1128/mBio.00305-11; Rossney AS, 2007, J CLIN MICROBIOL, V45, P2554, DOI 10.1128/JCM.00245-07; ROSSNEY AS, 1990, J CLIN PATHOL, V43, P246, DOI 10.1136/jcp.43.3.246; Shopsin B, 1999, J CLIN MICROBIOL, V37, P3556, DOI 10.1128/JCM.37.11.3556-3563.1999; Stegger M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079645; Uhlemann AC, 2013, CLIN INFECT DIS, V57, P700, DOI 10.1093/cid/cit375; Valentin-Domelier AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028369; Van den Eede A, 2009, VET MICROBIOL, V133, P138, DOI 10.1016/j.vetmic.2008.06.021; Vandendriessche S, 2014, J ANTIMICROB CHEMOTH, V69, P355, DOI 10.1093/jac/dkt366; Voss A, 2005, EMERG INFECT DIS, V11, P1965, DOI 10.3201/eid1112.050428	41	18	19	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0149396	10.1371/journal.pone.0149396	http://dx.doi.org/10.1371/journal.pone.0149396			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26886749	Green Published, gold, Green Submitted			2022-12-26	WOS:000371218400078
J	Cui, FR; Wang, JJ; Opal, SM; Tripathi, A				Cui, Francis R.; Wang, Jingjing; Opal, Steven M.; Tripathi, Anubhav			Isolating Influenza RNA from Clinical Samples Using Microfluidic Oil-Water Interfaces	PLOS ONE			English	Article							EXTRACTION METHODS; DNA EXTRACTION; PURIFICATION; VIRUS; SYSTEMS	The effective and robust separation of biomolecules of interest from patient samples is an essential step in diagnostic applications. We present a platform for the fast extraction of nucleic acids from clinical specimens utilizing paramagnetic PMPs, an oil-water interface, a small permanent magnet and a microfluidic channel to separate and purify captured nucleic acids from lysate in less than one minute, circumventing the need for multiple washing steps and greatly simplifying and expediting the purification procedure. Our device was able to isolate influenza RNA from clinical nasopharyngeal swab samples with high efficiency when compared to the Ambion (R) MagMAX (TM) Viral RNA Isolation Kit, sufficiently separating nucleic acid analytes from PCR-inhibiting contaminants within the lysate while also critically maintaining high integrity of the viral genome. We find that this design has great potential for rapid, efficient and sensitive nucleic acid separation from patient sample.	[Cui, Francis R.; Wang, Jingjing; Tripathi, Anubhav] Brown Univ, Sch Engn, Ctr Biomed Engn, Providence, RI 02912 USA; [Opal, Steven M.] Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA; [Opal, Steven M.] Brown Univ, Mem Hosp Rhode Isl, Pawtucket, RI 02860 USA	Brown University; Brown University; Brown University	Tripathi, A (corresponding author), Brown Univ, Sch Engn, Ctr Biomed Engn, Providence, RI 02912 USA.	anubhav_tripathi@brown.edu	WANG, JINGYI/GSJ-1241-2022; wang, jing/GRS-7509-2022		Brown University; National Aeronautics Space Administration -Rhode Island grant	Brown University; National Aeronautics Space Administration -Rhode Island grant	The work was supported by Brown University seed funds. No number assigned to it. F.R.C. was partially supported through National Aeronautics Space Administration -Rhode Island grant. No number was assigned to it. F.R.C was also supported by Graduate Student Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bendall SC, 2012, NAT BIOTECHNOL, V30, P639, DOI 10.1038/nbt.2283; Berry SM, 2014, J MOL DIAGN, V16, P297, DOI 10.1016/j.jmoldx.2014.01.004; Berry SM, 2011, BIOMED MICRODEVICES, V13, P1033, DOI 10.1007/s10544-011-9573-z; Berry SM, 2011, LAB CHIP, V11, P1747, DOI 10.1039/c1lc00004g; Bordelon H, 2011, ACS APPL MATER INTER, V3, P2161, DOI 10.1021/am2004009; Breadmore MC, 2003, ANAL CHEM, V75, P1880, DOI 10.1021/ac0204855; Cady NC, 2003, BIOSENS BIOELECTRON, V19, P59, DOI 10.1016/S0956-5663(03)00123-4; Cui F, 2014, ANNU REV BIOMED ENG, DOI [10.1146/annurev-bioeng-071114-040538, DOI 10.1146/ANNUREV-BI0ENG-071114-040538]; den Dulk RC, 2013, LAB CHIP, V13, P106, DOI 10.1039/c2lc40929a; Deng MY, 2005, J VET DIAGN INVEST, V17, P574, DOI 10.1177/104063870501700609; Holland CA, 2005, CURR OPIN MICROBIOL, V8, P504, DOI 10.1016/j.mib.2005.08.001; Kim J, 2009, INTEGR BIOL-UK, V1, P574, DOI 10.1039/b905844c; MCGEOCH D, 1976, P NATL ACAD SCI USA, V73, P3045, DOI 10.1073/pnas.73.9.3045; Monleau M, 2009, J CLIN MICROBIOL, V47, P1107, DOI 10.1128/JCM.02255-08; Rahman MM, 2012, DRUG DISCOV TODAY, V17, P1199, DOI 10.1016/j.drudis.2012.07.001; Ribaudo Randall, 2001, Curr Protoc Immunol, VChapter 10, DOI 10.1002/0471142735.im1011s04; Stals A, 2012, FOOD ENVIRON VIROL, V4, P153, DOI 10.1007/s12560-012-9092-y; Strotman LN, 2012, ANALYST, V137, P4023, DOI 10.1039/c2an35506j; Sur K, 2010, J MOL DIAGN, V12, P620, DOI 10.2353/jmoldx.2010.090190; Tan SC, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/574398; van Reenen A, 2014, LAB CHIP, V14, P1966, DOI 10.1039/c3lc51454d; Wen J, 2006, ANAL CHEM, V78, P1673, DOI 10.1021/ac051796t; World Health Organization, 2009, CDC PROT REALT RTPCR	23	12	12	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0149522	10.1371/journal.pone.0149522	http://dx.doi.org/10.1371/journal.pone.0149522			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26886007	Green Submitted, Green Published, gold			2022-12-26	WOS:000371218400094
J	Costa-Cabral, S; Brough, R; Konde, A; Aarts, M; Campbell, J; Marinari, E; Riffell, J; Bardelli, A; Torrance, C; Lord, CJ; Ashworth, A				Costa-Cabral, Sara; Brough, Rachel; Konde, Asha; Aarts, Marieke; Campbell, James; Marinari, Eliana; Riffell, Jenna; Bardelli, Alberto; Torrance, Christopher; Lord, Christopher J.; Ashworth, Alan			CDK1 Is a Synthetic Lethal Target for KRAS Mutant Tumours	PLOS ONE			English	Article							CYCLIN-DEPENDENT KINASES; SMALL-MOLECULE INHIBITOR; K-RAS ONCOGENES; COLORECTAL-CANCER; LUNG-CARCINOMA; BREAST-CANCER; CELL-CYCLE; THERAPY; REVEALS; PATIENT	Activating KRAS mutations are found in approximately 20% of human cancers but no RAS-directed therapies are currently available. Here we describe a novel, robust, KRAS synthetic lethal interaction with the cyclin dependent kinase, CDK1. This was discovered using parallel siRNA screens in KRAS mutant and wild type colorectal isogenic tumour cells and subsequently validated in a genetically diverse panel of 26 colorectal and pancreatic tumour cell models. This established that the KRAS/CDK1 synthetic lethality applies in tumour cells with either amino acid position 12 ( p.G12V, pG12D, p.G12S) or amino acid position 13 (p.G13D) KRAS mutations and can also be replicated in vivo in a xenograft model using a small molecule CDK1 inhibitor. Mechanistically, CDK1 inhibition caused a reduction in the S-phase fraction of KRAS mutant cells, an effect also characterised by modulation of Rb, a master control of the G1/S checkpoint. Taken together, these observations suggest that the KRAS/CDK1 interaction is a robust synthetic lethal effect worthy of further investigation.	[Costa-Cabral, Sara; Brough, Rachel; Konde, Asha; Aarts, Marieke; Campbell, James; Marinari, Eliana; Riffell, Jenna; Lord, Christopher J.; Ashworth, Alan] Inst Canc Res, CRUK Gene Funct Lab, London SW3 6JB, England; [Costa-Cabral, Sara; Brough, Rachel; Konde, Asha; Aarts, Marieke; Campbell, James; Marinari, Eliana; Riffell, Jenna; Lord, Christopher J.; Ashworth, Alan] Inst Canc Res, Breakthrough Breast Canc Res Ctr, London SW3 6JB, England; [Bardelli, Alberto] IFOM FIRC Inst Mol Oncol, Via Adamello 16, I-20139 Milan, Italy; [Torrance, Christopher] Horizon Discovery, 7100 Cambridge Res Pk, Cambridge CB25 9TL, England; [Torrance, Christopher] PhoreMost, 23 Cambridge Sci Pk,Milton Rd, Cambridge CB4 0EY, England; [Ashworth, Alan] Univ Calif San Francisco, UCSF Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94158 USA	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; IFOM - FIRC Institute of Molecular Oncology; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center	Lord, CJ (corresponding author), Inst Canc Res, CRUK Gene Funct Lab, London SW3 6JB, England.; Lord, CJ (corresponding author), Inst Canc Res, Breakthrough Breast Canc Res Ctr, London SW3 6JB, England.	Chris.Lord@icr.ac.uk	Lord, Christopher J/B-3295-2012; Lord, Christopher/AAX-7130-2021	Lord, Christopher J/0000-0002-3226-0515; Campbell, James/0000-0001-6756-8766	Cancer Research UK [C347/A8363]; Fundacao para a Ciencia e a Tecnologia [SFRH/BD/65004/2009]; Cancer Research UK [14276] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Cancer Research UK(Cancer Research UK)	This worked was funded by Cancer Research UK, C347/A8363, CJL AA, and Fundacao para a Ciencia e a Tecnologia, SFRH/BD/65004/2009, SCC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Horizon Discovery did not provide financial support in either the form of authors' salaries and/or research materials; they provided the KRAS isogenic cell lines.	Aleem E, 2005, NAT CELL BIOL, V7, P831, DOI 10.1038/ncb1284; Allegra CJ, 2009, J CLIN ONCOL, V27, P2091, DOI 10.1200/JCO.2009.21.9170; Ashworth A, 2011, CELL, V145, P30, DOI 10.1016/j.cell.2011.03.020; Barbie DA, 2009, NATURE, V462, P108, DOI 10.1038/nature08460; Biankin AV, 2012, NATURE, V491, P399, DOI 10.1038/nature11547; BOS JL, 1989, CANCER RES, V49, P4682; Brough R, 2011, CANCER DISCOV, V1, P260, DOI 10.1158/2159-8290.CD-11-0107; Byth KF, 2009, MOL CANCER THER, V8, P1856, DOI 10.1158/1535-7163.MCT-08-0836; Cheng CK, 2012, P NATL ACAD SCI USA, V109, P12722, DOI 10.1073/pnas.1202492109; Corcoran RB, 2013, CANCER CELL, V23, P121, DOI 10.1016/j.ccr.2012.11.007; Di Nicolantonio F, 2008, P NATL ACAD SCI USA, V105, P20864, DOI 10.1073/pnas.0808757105; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Engelman JA, 2008, NAT MED, V14, P1351, DOI 10.1038/nm.1890; Enserink JM, 2010, CELL DIV, V5, DOI 10.1186/1747-1028-5-11; Fry DW, 2004, MOL CANCER THER, V3, P1427; Goga A, 2007, NAT MED, V13, P820, DOI 10.1038/nm1606; Horiuchi D, 2012, J EXP MED, V209, P679, DOI 10.1084/jem.20111512; Hu X, 2011, CELL PROLIFERAT, V44, P205, DOI 10.1111/j.1365-2184.2011.00753.x; Jancik S, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/150960; Jimeno A, 2009, J CLIN ONCOL, V27, P1130, DOI 10.1200/JCO.2008.19.8168; Johnson N, 2011, NAT MED, V17, P875, DOI 10.1038/nm.2377; Karnoub AE, 2008, NAT REV MOL CELL BIO, V9, P517, DOI 10.1038/nrm2438; Knudsen ES, 1996, J BIOL CHEM, V271, P8313, DOI 10.1074/jbc.271.14.8313; Kumar MS, 2012, CELL, V149, P642, DOI 10.1016/j.cell.2012.02.059; Lievre A, 2006, CANCER RES, V66, P3992, DOI 10.1158/0008-5472.CAN-06-0191; Lord CJ, 2009, J CLIN PATHOL, V62, P195, DOI 10.1136/jcp.2008.058735; Malumbres M, 2004, CELL, V118, P493, DOI 10.1016/j.cell.2004.08.002; Malumbres M, 2005, TRENDS BIOCHEM SCI, V30, P630, DOI 10.1016/j.tibs.2005.09.005; Malumbres M, 2007, CURR OPIN GENET DEV, V17, P60, DOI 10.1016/j.gde.2006.12.008; NAKANO H, 1984, P NATL ACAD SCI-BIOL, V81, P71, DOI 10.1073/pnas.81.1.71; Ostrem JM, 2013, NATURE, V503, P548, DOI 10.1038/nature12796; Parry D, 2010, MOL CANCER THER, V9, P2344, DOI 10.1158/1535-7163.MCT-10-0324; Puyol M, 2010, CANCER CELL, V18, P63, DOI 10.1016/j.ccr.2010.05.025; Pylayeva-Gupta Y, 2011, NAT REV CANCER, V11, P761, DOI 10.1038/nrc3106; Salic A, 2008, P NATL ACAD SCI USA, V105, P2415, DOI 10.1073/pnas.0712168105; Santamaria D, 2007, NATURE, V448, P811, DOI 10.1038/nature06046; SANTOS E, 1984, SCIENCE, V223, P661, DOI 10.1126/science.6695174; Scholl C, 2009, CELL, V137, P821, DOI 10.1016/j.cell.2009.03.017; Schubbert S, 2007, NAT REV CANCER, V7, P295, DOI 10.1038/nrc2109; Singh A, 2012, CELL, V148, P639, DOI 10.1016/j.cell.2011.12.033; Singh A, 2009, CANCER CELL, V15, P489, DOI 10.1016/j.ccr.2009.03.022; Squires MS, 2009, MOL CANCER THER, V8, P324, DOI 10.1158/1535-7163.MCT-08-0890; Steckel M, 2012, CELL RES, V22, P1227, DOI 10.1038/cr.2012.82; Timofeev O, 2010, J BIOL CHEM, V285, P16978, DOI 10.1074/jbc.M109.096552; Vassilev LT, 2006, P NATL ACAD SCI USA, V103, P10660, DOI 10.1073/pnas.0600447103; Wang Y, 2010, ONCOGENE, V29, P4658, DOI 10.1038/onc.2010.218; WHITEHEAD RH, 1985, JNCI-J NATL CANCER I, V74, P759	47	48	54	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0149099	10.1371/journal.pone.0149099	http://dx.doi.org/10.1371/journal.pone.0149099			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	26881434	Green Submitted, Green Published, gold			2022-12-26	WOS:000371219000045
J	Li, GL; Zhao, H; Wang, HF; Guo, XL; Guo, XQ; Sun, QH; Xu, BH				Li, Guilin; Zhao, Hang; Wang, Hongfang; Guo, Xulei; Guo, Xingqi; Sun, Qinghua; Xu, Baohua			Characterization of a Decapentapletic Gene (AccDpp) from Apis cerana cerana and Its Possible Involvement in Development and Response to Oxidative Stress	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; GLUTATHIONE-S-TRANSFERASE; ASIAN HONEY-BEE; MOLECULAR CHARACTERIZATION; EXPRESSION; MECHANISMS; ROS; ACTIVATION; GENERATION; PATTERN	To tolerate many acute and chronic oxidative stress-producing agents that exist in the environment, organisms have evolved many classes of signal transduction pathways, including the transforming growth factor beta (TGF beta) signal pathway. Decapentapletic gene (Dpp) belongs to the TGF beta superfamily, and studies on Dpp have mainly focused on its role in the regulation of development. No study has investigated the response of Dpp to oxidative pressure in any organism, including Apis cerana cerana (A. cerana cerana). In this study, we identified a Dpp gene from A. cerana cerana named AccDpp. The 5' flanking region of AccDpp had many transcription factor binding sites that relevant to development and stress response. AccDpp was expressed at all stages of A. cerana cerana, with its highest expression in 15-day worker bees. The mRNA level of AccDpp was higher in the poison gland and midgut than other tissues. Furthermore, the transcription of AccDpp could be repressed by 4 degrees C and UV, but induced by other treatments, according to our qRT-PCR analysis. It is worth noting that the expression level of AccDpp protein was increased after a certain time when A. cerana cerana was subjected to all simulative oxidative stresses, a finding that was not completely consistent with the result from qRT-PCR. It is interesting that recombinant AccDpp restrained the growth of Escherichia coli, a function that might account for the role of the antimicrobial peptides of AccDpp. In conclusion, these results provide evidence that AccDpp might be implicated in the regulation of development and the response of oxidative pressure. The findings may lay a theoretical foundation for further genetic studies of Dpp.	[Li, Guilin; Zhao, Hang; Guo, Xulei; Guo, Xingqi; Sun, Qinghua] Shandong Agr Univ, Coll Life Sci, State Key Lab Crop Biol, Tai An 271018, Shandong, Peoples R China; [Wang, Hongfang; Xu, Baohua] Shandong Agr Univ, Coll Anim Sci & Technol, Tai An 271018, Shandong, Peoples R China	Shandong Agricultural University; Shandong Agricultural University	Sun, QH (corresponding author), Shandong Agr Univ, Coll Life Sci, State Key Lab Crop Biol, Tai An 271018, Shandong, Peoples R China.; Xu, BH (corresponding author), Shandong Agr Univ, Coll Anim Sci & Technol, Tai An 271018, Shandong, Peoples R China.	qhsun@sdau.edu.cn; bhxu@sdau.edu.cn			Chian Agriculture Research System [CARS-45]; National Natural Science Foundation of China [31172275]; Shandong Province Fine Varieties Breeding Projects	Chian Agriculture Research System; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong Province Fine Varieties Breeding Projects	This work was financially supported by the earmarked fund for the Chian Agriculture Research System (No. CARS-45), the National Natural Science Foundation of China (No.31172275) and Shandong Province Fine Varieties Breeding Projects (2014-2016).	Abrashev RI, 2008, CAN J MICROBIOL, V54, P977, DOI 10.1139/W08-091; Affolter M, 2001, EMBO J, V20, P3298, DOI 10.1093/emboj/20.13.3298; Agarwal A, 2008, ANTIOXID REDOX SIGN, V10, P1375, DOI 10.1089/ars.2007.1964; Alaux C., 2010, BIOL LETT, DOI 101098/rsbl 2009.0986.; Ashwal-Fluss R, 2014, MOL CELL, V56, P55, DOI 10.1016/j.molcel.2014.08.019; ASSOIAN RK, 1983, J BIOL CHEM, V258, P7155; Banerjee B D, 2001, Rev Environ Health, V16, P1; Black D, 2004, J HEPATOL, V40, P942, DOI 10.1016/j.jhep.2004.02.031; BLACKMAN RK, 1991, DEVELOPMENT, V111, P657; Boileau TWM, 2003, J BIOCHEM MOL TOXIC, V17, P108, DOI 10.1002/jbt.10067; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Brown SE, 2009, INSECT BIOCHEM MOLEC, V39, P792, DOI 10.1016/j.ibmb.2009.09.004; Chen JC, 2012, J AM SOC NEPHROL, V23, P215, DOI 10.1681/ASN.2011070645; Chen X, 2015, NEPHROLOGY, V20, P20; Chen Y., 2014, MEDIATORS INFLAMM, P2014; Cheng S. L., 2001, APICULTURAL SCI CHIN; Chiu C, 2001, INT J MOL MED, V8, P251; Enayati AA, 2005, INSECT MOL BIOL, V14, P3, DOI 10.1111/j.1365-2583.2004.00529.x; Ericsson A, 2006, J IMMUNOL, V176, P3642, DOI 10.4049/jimmunol.176.6.3642; FERGUSON EL, 1992, CELL, V71, P451, DOI 10.1016/0092-8674(92)90514-D; Filipic M, 2006, HUM EXP TOXICOL, V25, P67, DOI 10.1191/0960327106ht590oa; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; FU YH, 1987, MOL CELL BIOL, V7, P1691, DOI 10.1128/MCB.7.5.1691; GOGOS JA, 1992, SCIENCE, V257, P1951, DOI 10.1126/science.1290524; Hanafusa H, 1999, J BIOL CHEM, V274, P27161, DOI 10.1074/jbc.274.38.27161; Hubackova S, 2012, AGING-US, V4, P932, DOI 10.18632/aging.100520; Imjongjirak C, 2005, J BIOCHEM MOL BIOL, V38, P49; IRISH VF, 1987, GENE DEV, V1, P868, DOI 10.1101/gad.1.8.868; Jiang Q, 2006, INT J MOL MED, V18, P381; Kerr JT, 2015, SCIENCE, V349, P177, DOI 10.1126/science.aaa7031; Lal MA, 2002, KIDNEY INT, V61, P2006, DOI 10.1046/j.1523-1755.2002.00367.x; Lecuit T, 1996, NATURE, V381, P387, DOI 10.1038/381387a0; Lee SH, 2001, SCIENCE, V292, P2083, DOI 10.1126/science.1059501; Lee YW, 2001, NEUROCHEM RES, V26, P1187, DOI 10.1023/A:1013955020515; Li JH, 2005, ARCH INSECT BIOCHEM, V60, P1, DOI 10.1002/arch.20075; Li YZ, 2012, ARCH INSECT BIOCHEM, V79, P121, DOI 10.1002/arch.21011; Lourenco AP, 2008, APIDOLOGIE, V39, P372, DOI 10.1051/apido:2008015; Marionnet C, 2003, J INVEST DERMATOL, V121, P1447, DOI 10.1111/j.1523-1747.2003.12629.x; Massague J, 2000, NAT REV MOL CELL BIO, V1, P169, DOI 10.1038/35043051; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Mates JM, 2010, FREE RADICAL BIO MED, V49, P1328, DOI 10.1016/j.freeradbiomed.2010.07.028; Memczak S, 2013, NATURE, V495, P333, DOI 10.1038/nature11928; Meng F., 2014, J CHEM, V2014, P1, DOI DOI 10.1371/J0URNAL.P0NE.0093100; Michaeloudes C, 2011, AM J PHYSIOL-LUNG C, V300, pL295, DOI 10.1152/ajplung.00134.2010; MICHELETTE ERD, 1993, APIDOLOGIE, V24, P431, DOI 10.1051/apido:19930410; Mitobe J, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-110; Moustakas A, 2002, IMMUNOL LETT, V82, P85, DOI 10.1016/S0165-2478(02)00023-8; Nebreda AR, 2000, TRENDS BIOCHEM SCI, V25, P257, DOI 10.1016/S0968-0004(00)01595-4; Nellen D, 1996, CELL, V85, P357, DOI 10.1016/S0092-8674(00)81114-9; Ninov N, 2010, CURR BIOL, V20, P513, DOI 10.1016/j.cub.2010.01.063; Niwa N, 2000, DEVELOPMENT, V127, P4373; Owsiak A, 2015, J MICROB BIOTEC FOOD, V4, P48, DOI 10.15414/jmbfs.2015.4.special1.48-51; PADGETT RW, 1993, P NATL ACAD SCI USA, V90, P2905, DOI 10.1073/pnas.90.7.2905; Park D, 2015, BMC GENOMICS, V16, DOI 10.1186/1471-2164-16-1; PENG YS, 1987, J INVERTEBR PATHOL, V49, P54, DOI 10.1016/0022-2011(87)90125-X; Ray PD, 2012, CELL SIGNAL, V24, P981, DOI 10.1016/j.cellsig.2012.01.008; ROBERTS AB, 1981, P NATL ACAD SCI-BIOL, V78, P5339, DOI 10.1073/pnas.78.9.5339; Samarakoon R, 2013, CELL SIGNAL, V25, P264, DOI 10.1016/j.cellsig.2012.10.003; Sanchez A, 1996, J BIOL CHEM, V271, P7416, DOI 10.1074/jbc.271.13.7416; Santoro MG, 2000, BIOCHEM PHARMACOL, V59, P55, DOI 10.1016/S0006-2952(99)00299-3; Scharlaken B, 2008, DEV COMP IMMUNOL, V32, P883, DOI 10.1016/j.dci.2008.01.010; Sharma K, 2005, AM J PHYSIOL-RENAL, V288, pF1069, DOI 10.1152/ajprenal.00345.2004; Shi JH, 2008, BIOMATERIALS, V29, P2820, DOI 10.1016/j.biomaterials.2008.03.020; Shin DM, 2008, FASEB J, V22, P2498, DOI 10.1096/fj.07-095455; Soltaninejad K, 2009, MED SCI MONITOR, V15, pRA75; Spokony RF, 2007, DEV GENES EVOL, V217, P499, DOI 10.1007/s00427-007-0159-y; Srisuparbh D, 2003, J BIOCHEM MOL BIOL, V36, P572; STJOHNSTON RD, 1990, GENE DEV, V4, P1114, DOI 10.1101/gad.4.7.1114; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Umasuthan N, 2012, COMP BIOCHEM PHYS C, V155, P539, DOI 10.1016/j.cbpc.2012.01.001; WHARTON KA, 1993, DEVELOPMENT, V117, P807; Wiggers GA, 2008, AM J PHYSIOL-HEART C, V295, pH1033, DOI 10.1152/ajpheart.00430.2008; Wongsiri, 2009, ASIAN HONEY BEES BIO; Yin KF, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-998; Yuksel S, 2008, ACTA BIOL HUNG, V59, P57, DOI 10.1556/ABiol.59.2008.1.5; Zhang YY, 2013, CELL STRESS CHAPERON, V18, P503, DOI 10.1007/s12192-013-0406-2; Zhao HT, 2014, J GENET, V93, P53, DOI 10.1007/s12041-014-0332-9	77	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0149117	10.1371/journal.pone.0149117	http://dx.doi.org/10.1371/journal.pone.0149117			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	26881804	gold, Green Submitted, Green Published			2022-12-26	WOS:000371219000048
J	Peternel, L; Noda, T; Petric, T; Ude, A; Morimoto, J; Babic, J				Peternel, Luka; Noda, Tomoyuki; Petric, Tadej; Ude, Ales; Morimoto, Jun; Babic, Jan			Adaptive Control of Exoskeleton Robots for Periodic Assistive Behaviours Based on EMG Feedback Minimisation	PLOS ONE			English	Article							MOVEMENT; DESIGN; TORQUE; NORMALIZATION; ADAPTATION; MODEL	In this paper we propose an exoskeleton control method for adaptive learning of assistive joint torque profiles in periodic tasks. We use human muscle activity as feedback to adapt the assistive joint torque behaviour in a way that the muscle activity is minimised. The user can then relax while the exoskeleton takes over the task execution. If the task is altered and the existing assistive behaviour becomes inadequate, the exoskeleton gradually adapts to the new task execution so that the increased muscle activity caused by the new desired task can be reduced. The advantage of the proposed method is that it does not require biomechanical or dynamical models. Our proposed learning system uses Dynamical Movement Primitives (DMPs) as a trajectory generator and parameters of DMPs are modulated using Locally Weighted Regression. Then, the learning system is combined with adaptive oscillators that determine the phase and frequency of motion according to measured Electromyography (EMG) signals. We tested the method with real robot experiments where subjects wearing an elbow exoskeleton had to move an object of an unknown mass according to a predefined reference motion. We further evaluated the proposed approach on a wholearm exoskeleton to show that it is able to adaptively derive assistive torques even for multiple-joint motion.	[Peternel, Luka; Petric, Tadej; Ude, Ales; Babic, Jan] Jozef Stefan Inst, Dept Automat Biocybernet & Robot, Ljubljana, Slovenia; [Peternel, Luka; Noda, Tomoyuki; Morimoto, Jun] ATR Computat Neurosci Labs, Dept Brain Robot Interface, Kyoto, Japan	Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute	Peternel, L (corresponding author), Jozef Stefan Inst, Dept Automat Biocybernet & Robot, Ljubljana, Slovenia.; Peternel, L (corresponding author), ATR Computat Neurosci Labs, Dept Brain Robot Interface, Kyoto, Japan.	luka.peternel@ijs.si	Ude, Aleš/ABB-7839-2020; Peternel, Luka/AAX-9766-2021; Petric, Tadej/AAS-2471-2021	Ude, Aleš/0000-0003-3677-3972; Peternel, Luka/0000-0002-8696-3689; Petric, Tadej/0000-0002-3407-4206; Babic, Jan/0000-0002-1870-8264; Noda, Tomoyuki/0000-0002-1055-5080	Japanese Ministry of Education, Culture, Sports, Science and Technology SRPBS; European Commission FP-7 through the CoDyCo project [600716]; European Commission Horizon through the SPEXOR project [687662]; Japanese Ministry of Internal Affairs and Communications under contract entitled " Novel and innovative R&D making use of brain structures"; Cabinet Office Government of Japan ImPACT; New Energy andIndustrial Technology Development Organization; Slovene Human Resources Development and Scholarship Fund [146, 163]; Japanese Ministry of Internal Affairs and Communications SCOPE; Japanese Ministry of Education, Culture, Sports, Science and Technology KAKENHI [23120004]; Japan Science and Technology Agency SICP; Japan Society for the Promotion of Science and Slovenian Ministry of Education, Science and Sport: Japan-Slovenia research Cooperative Program; Japan Society for the Promotion of Science KAKENHI [24700203]	Japanese Ministry of Education, Culture, Sports, Science and Technology SRPBS; European Commission FP-7 through the CoDyCo project; European Commission Horizon through the SPEXOR project; Japanese Ministry of Internal Affairs and Communications under contract entitled " Novel and innovative R&D making use of brain structures"; Cabinet Office Government of Japan ImPACT; New Energy andIndustrial Technology Development Organization(New Energy and Industrial Technology Development Organization (NEDO)); Slovene Human Resources Development and Scholarship Fund; Japanese Ministry of Internal Affairs and Communications SCOPE; Japanese Ministry of Education, Culture, Sports, Science and Technology KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Science and Technology Agency SICP; Japan Society for the Promotion of Science and Slovenian Ministry of Education, Science and Sport: Japan-Slovenia research Cooperative Program; Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Japanese Ministry of Education, Culture, Sports, Science and Technology SRPBS; by European Commission FP-7 through the CoDyCo project (#600716); by European Commission Horizon 2020 through the SPEXOR project (#687662)"; by Japanese Ministry of Internal Affairs and Communications under contract entitled " Novel and innovative R&D making use of brain structures"; by Cabinet Office Government of Japan ImPACT; and by a project commissioned by New Energy andIndustrial Technology Development Organization. LP was supported by Slovene Human Resources Development and Scholarship Fund (146. and 163. JR)<SUP>2</SUP>. JM was supported by Japanese Ministry of Internal Affairs and Communications SCOPE; by Japanese Ministry of Education, Culture, Sports, Science and Technology KAKENHI (#23120004); by Japan Science and Technology Agency SICP; and by Japan Society for the Promotion of Science and Slovenian Ministry of Education, Science and Sport: Japan-Slovenia research Cooperative Program. TN was supported by Japan Society for the Promotion of Science KAKENHI (#24700203). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre-Ollinger G, 2013, IEEE INT C INT ROBOT, P1182, DOI 10.1109/IROS.2013.6696500; Babic J, 2011, ADAPT BEHAV, V19, P250, DOI 10.1177/1059712311411112; Beyl P, 2014, IEEE-ASME T MECH, V19, P1046, DOI 10.1109/TMECH.2013.2268942; Cavallaro EE, 2006, IEEE T BIO-MED ENG, V53, P2387, DOI 10.1109/TBME.2006.880883; Chou CP, 1996, IEEE T ROBOTIC AUTOM, V12, P90, DOI 10.1109/70.481753; De Luca CJ, 2010, J BIOMECH, V43, P1573, DOI 10.1016/j.jbiomech.2010.01.027; De Luca CJ, 1997, J APPL BIOMECH, V13, P135, DOI 10.1123/jab.13.2.135; Dollar AM, 2008, IEEE T ROBOT, V24, P144, DOI 10.1109/TRO.2008.915453; Earp JE, 2013, J ELECTROMYOGR KINES, V23, P238, DOI 10.1016/j.jelekin.2012.08.015; Ferris DP, 2006, GAIT POSTURE, V23, P425, DOI 10.1016/j.gaitpost.2005.05.004; Fleischer C, 2008, IEEE T ROBOT, V24, P872, DOI 10.1109/TRO.2008.926860; Gams A, 2013, IEEE T BIO-MED ENG, V60, P1636, DOI 10.1109/TBME.2013.2240682; Gams A, 2009, AUTON ROBOT, V27, P3, DOI 10.1007/s10514-009-9118-y; Hermens H.J.M.R.F.B., 1999, SENIAM EUROPEAN RECO; Hesse S, 2010, J NEUROENG REHABIL, V7, DOI 10.1186/1743-0003-7-30; Hildebrandt A, 2005, P AMER CONTR CONF, P680, DOI 10.1109/ACC.2005.1470036; Ijspeert AJ, 2002, 2002 IEEE/RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS, VOLS 1-3, PROCEEDINGS, P958, DOI 10.1109/IRDS.2002.1041514; Ijspeert AJ, 2013, NEURAL COMPUT, V25, P328, DOI 10.1162/NECO_a_00393; Kandel E., 2000, PRINCIPLES NEURAL SC; Kawamoto H., 2002, 2002 IEEE International Conference on Systems, Man and Cybernetics. Conference Proceedings (Cat. No.02CH37349), DOI 10.1109/ICSMC.2002.1173328; Kazerooni H, 2006, INT J ROBOT RES, V25, P561, DOI 10.1177/0278364906065505; Kiguchi K, 2001, IEEE T SYST MAN CY B, V31, P353, DOI 10.1109/3477.931520; Kong KC, 2006, IEEE-ASME T MECH, V11, P428, DOI 10.1109/TMECH.2006.878550; Lenzi T, 2012, IEEE T BIO-MED ENG, V59, P2180, DOI 10.1109/TBME.2012.2198821; Noda T, 2014, IEEE INT C INT ROBOT, P3573, DOI 10.1109/IROS.2014.6943062; Noda T, 2012, IEEE-RAS INT C HUMAN, P21, DOI 10.1109/HUMANOIDS.2012.6651494; Noda T, 2013, IEEE INT CONF ROBOT, P2657, DOI 10.1109/ICRA.2013.6630942; Peternel L, 2015, PROCEEDINGS OF THE 17TH INTERNATIONAL CONFERENCE ON ADVANCED ROBOTICS (ICAR), P34, DOI 10.1109/ICAR.2015.7251430; Peternel L, 2015, IEEE INT CONF ROBOT, P1497, DOI 10.1109/ICRA.2015.7139387; Peternel L, 2014, AUTON ROBOT, V36, P123, DOI 10.1007/s10514-013-9361-0; Petric T, 2014, IEEE INT CONF ROBOT, P4770, DOI 10.1109/ICRA.2014.6907557; Petric T, 2011, INT J ROBOT RES, V30, P1775, DOI 10.1177/0278364911421511; Pratt JE, 2004, IEEE INT CONF ROBOT, P2430, DOI 10.1109/ROBOT.2004.1307425; Riener R, 2005, IEEE T NEUR SYS REH, V13, P380, DOI 10.1109/TNSRE.2005.848628; Righetti L, 2006, PHYSICA D, V216, P269, DOI 10.1016/j.physd.2006.02.009; Ronsse R, 2011, MED BIOL ENG COMPUT, V49, P1173, DOI 10.1007/s11517-011-0816-1; Ronsse R, 2011, IEEE T BIO-MED ENG, V58, P1001, DOI 10.1109/TBME.2010.2089629; Rosen J, 2001, IEEE T SYST MAN CY A, V31, P210, DOI 10.1109/3468.925661; Sardellitti I, 2007, 2007 IEEE/RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS, VOLS 1-9, P1828; Schaal S, 1998, NEURAL COMPUT, V10, P2047, DOI 10.1162/089976698300016963; Song R, 2005, MED BIOL ENG COMPUT, V43, P473, DOI 10.1007/BF02344728; Sugar TG, 2007, IEEE T NEUR SYS REH, V15, P336, DOI 10.1109/TNSRE.2007.903903; Todorov E, 2002, NAT NEUROSCI, V5, P1226, DOI 10.1038/nn963; Tsagarakis NG, 2003, AUTON ROBOT, V15, P21, DOI 10.1023/A:1024484615192; Ugurlu B, 2014, HUMAN MACHINE SYSTEM, VPP, P1; Ugurlu B, 2015, IEEE INT C INT ROBOT, P1633, DOI 10.1109/IROS.2015.7353586; UNO Y, 1989, BIOL CYBERN, V61, P89, DOI 10.1007/BF00204593; Veneman JF, 2007, IEEE T NEUR SYS REH, V15, P379, DOI 10.1109/TNSRE.2007.903919; Wang DH, 2014, IEEE-ASME T MECH, V19, P1268, DOI 10.1109/TMECH.2013.2278207; Yang DP, 2009, J BIONIC ENG, V6, P255, DOI 10.1016/S1672-6529(08)60119-5; Yang DP, 2012, INT J HUM ROBOT, V9, DOI 10.1142/S0219843612500077; YANG JF, 1984, ARCH PHYS MED REHAB, V65, P517; Zoss AB, 2006, IEEE-ASME T MECH, V11, P128, DOI 10.1109/TMECH.2006.871087	53	90	95	6	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0148942	10.1371/journal.pone.0148942	http://dx.doi.org/10.1371/journal.pone.0148942			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	26881743	gold, Green Published, Green Submitted			2022-12-26	WOS:000371219000036
J	Fischer, KD; Hall, SC; Agrawal, DK				Fischer, Kimberly D.; Hall, Sannette C.; Agrawal, Devendra K.			Vitamin D Supplementation Reduces Induction of Epithelial-Mesenchymal Transition in Allergen Sensitized and Challenged Mice	PLOS ONE			English	Article							AIRWAY INFLAMMATION; D DEFICIENCY; MOUSE MODEL; N-CADHERIN; TGF-BETA; ASTHMA; MYOFIBROBLAST	Asthma is a chronic disease of the lung associated with airway hyperresponsiveness (AHR), airway obstruction and airway remodeling. Airway remodeling involves differentiation of airway epithelial cells into myofibroblasts via epithelial-mesenchymal transition (EMT) to intensify the degree of subepithelial fibrosis. EMT involves loss in E-cadherin with an increase in mesenchymal markers, including vimentin and N-cadherin. There is growing evidence that vitamin D has immunomodulatory and anti-inflammatory properties. However, the underlying molecular mechanisms of these effects are still unclear. In this study, we examined the contribution of vitamin D on the AHR, airway inflammation and expression of EMT markers in the airways of mice sensitized and challenged with a combination of clinically relevant allergens, house dust mite, ragweed, and Alternaria (HRA). Female Balb/c mice were fed with vitamin D-sufficient (2000 IU/kg) or vitamin D-supplemented (10,000 IU/kg) diet followed by sensitization with HRA. The density of inflammatory cells in the bronchoalveolar lavage fluid (BALF), lung histology, and expression of EMT markers by immunofluorescence were examined. Vitamin D-supplementation decreased AHR, airway inflammation in the BALF and the features of airway remodeling compared to vitamin D-sufficiency in HRA-sensitized and -challenged mice. This was accompanied with increased expression of E-cadherin and decreased vimentin and N-cadherin expression in the airways. These results indicate that vitamin D may be a beneficial adjunct in the treatment regime in allergic asthma.	[Fischer, Kimberly D.; Agrawal, Devendra K.] Creighton Univ, Sch Med, Dept Med Microbiol & Immunol, Omaha, NE USA; [Hall, Sannette C.; Agrawal, Devendra K.] Creighton Univ, Sch Med, Dept Biomed Sci, Omaha, NE 68178 USA; [Agrawal, Devendra K.] Creighton Univ, Sch Med, Dept Clin & Translat Sci, Omaha, NE USA	Creighton University; Creighton University; Creighton University	Agrawal, DK (corresponding author), Creighton Univ, Sch Med, Dept Med Microbiol & Immunol, Omaha, NE USA.; Agrawal, DK (corresponding author), Creighton Univ, Sch Med, Dept Biomed Sci, Omaha, NE 68178 USA.; Agrawal, DK (corresponding author), Creighton Univ, Sch Med, Dept Clin & Translat Sci, Omaha, NE USA.	DKAGR@creighton.edu	Agrawal, Devendra/GLR-3925-2022	Agrawal, Devendra/0000-0001-5445-0013	National Institutes of Health, USA [R01HL086680, R01AI075315]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL116042, R01HL086680] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI075315] Funding Source: NIH RePORTER	National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by research grant R01HL086680 and R01AI075315 from the National Institutes of Health, USA to DK Agrawal. The content of this article is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Agrawal T, 2013, CLIN EXP ALLERGY, V43, P672, DOI 10.1111/cea.12102; Agrawal T, 2012, J CLIN IMMUNOL, V32, P1093, DOI 10.1007/s10875-012-9696-x; Arshi S, 2014, ANN ALLERG ASTHMA IM, V113, P404, DOI 10.1016/j.anai.2014.07.005; Bener A, 2012, INT ARCH ALLERGY IMM, V157, P168, DOI 10.1159/000323941; Berair R, 2014, ASTHMA THERAPY ITS E; Bergeron C, 2010, CAN RESPIR J, V17, pE85, DOI 10.1155/2010/318029; Bergeron Celine, 2009, Proc Am Thorac Soc, V6, P301, DOI 10.1513/pats.200808-089RM; Berraies A, 2014, J ASTHMA ALLERGY, V7, P23, DOI 10.2147/JAA.S46944; Castro M, 2014, JAMA-J AM MED ASSOC, V311, P2083, DOI 10.1001/jama.2014.5052; Cupisti A, 2015, INT J NEPHROL RENOV, V8, P151, DOI 10.2147/IJNRD.S90968; De Wever O, 2004, J CELL SCI, V117, P4691, DOI 10.1242/jcs.01322; Doerner AM, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-100; Fan M, 2006, INT IMMUNOPHARMACOL, V6, P36, DOI 10.1016/j.intimp.2005.07.008; Fischer KD, 2014, RESP RES, V15, DOI 10.1186/s12931-014-0146-6; Foong RE, 2014, PHYSIOL REP, V2, DOI 10.1002/phy2.276; Freishtat RJ, 2010, J PEDIATR-US, V156, P948, DOI 10.1016/j.jpeds.2009.12.033; Ge XN, 2010, J IMMUNOL, V185, P1205, DOI 10.4049/jimmunol.1000039; Gorman S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067823; Gorman S, 2012, PEDIAT ALLERG IMM-UK, V23, P83, DOI 10.1111/j.1399-3038.2011.01146.x; Hackett TL, 2013, AM J RESP CELL MOL, V49, P662, DOI 10.1165/rcmb.2013-0124OC; Hansdottir S, 2010, J IMMUNOL, V184, P965, DOI 10.4049/jimmunol.0902840; Hatami G, 2014, IRAN J PEDIATR, V24, P710; Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385; Jensen EC, 2013, ANAT REC, V296, P378, DOI 10.1002/ar.22641; Johnson JR, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-118; Johnson JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016175; Kelly MM, 2010, J ALLERGY CLIN IMMUN, V125, P349, DOI 10.1016/j.jaci.2009.09.011; Kim MH, 2014, J ENDOCRINOL, V220, P117, DOI 10.1530/JOE-13-0381; Lambrecht BN, 2012, NAT MED, V18, P684, DOI 10.1038/nm.2737; Lemanske Robert F. Jr., 2003, Journal of Allergy and Clinical Immunology, V111, pS502; Locke NR, 2007, AM J RESP CELL MOL, V36, P625, DOI 10.1165/rcmb.2006-0083OC; Majak P, 2011, J ALLERGY CLIN IMMUN, V127, P1294, DOI 10.1016/j.jaci.2010.12.016; Micallef L, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-S1-S5; Muehleisen B, 2013, J ALLERGY CLIN IMMUN, V131, P324, DOI 10.1016/j.jaci.2012.12.1562; Nanzer AM, 2014, J ALLERGY CLIN IMMUN, V133, P1755, DOI 10.1016/j.jaci.2014.03.015; Nials AT, 2008, DIS MODEL MECH, V1, P213, DOI 10.1242/dmm.000323; Ramirez AM, 2010, J STEROID BIOCHEM, V118, P142, DOI 10.1016/j.jsbmb.2009.11.004; Rosen CJ, 2012, J CLIN ENDOCR METAB, V97, P1146, DOI 10.1210/jc.2011-2218; Shao ZF, 2009, J ALLERGY CLIN IMMUN, V123, P917, DOI 10.1016/j.jaci.2009.01.052; Sorkness RL, 2007, AM J PHYSIOL-LUNG C, V292, pL85, DOI 10.1152/ajplung.00234.2006; Sun Z, 2014, MICROCIRCULATION, V21, P208, DOI 10.1111/micc.12123; Taher YA, 2008, J IMMUNOL, V180, P5211, DOI 10.4049/jimmunol.180.8.5211; Yawn J, 2015, J STEROID BIOCHEM, V148, P326, DOI 10.1016/j.jsbmb.2015.01.017; Yin K, 2014, J INFLAMM RES, V7, P69, DOI 10.2147/JIR.S63898; Zhang M, 2009, LUNG, V187, P187, DOI 10.1007/s00408-009-9139-5	45	28	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149180	10.1371/journal.pone.0149180	http://dx.doi.org/10.1371/journal.pone.0149180			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26872336	gold, Green Published, Green Submitted			2022-12-26	WOS:000370054100120
J	Hu, JZ; Ni, SF; Cao, Y; Zhang, T; Wu, TD; Yin, XZ; Lang, Y; Lu, HB				Hu, Jianzhong; Ni, Shuangfei; Cao, Yong; Zhang, Tao; Wu, Tianding; Yin, Xianzhen; Lang, Ye; Lu, Hongbin			The Angiogenic Effect of microRNA-21 Targeting TIMP3 through the Regulation of MMP2 and MMP9	PLOS ONE			English	Article							SPINAL-CORD-INJURY; TISSUE INHIBITOR; MATRIX METALLOPROTEINASES; IN-VITRO; CONTUSION INJURY; DOWN-REGULATION; TUMOR-GROWTH; MIR-21; APOPTOSIS; EXPRESSION	microRNAs are a novel set of small, non-protein-coding nucleotide RNAs that negatively regulate the expression of target mRNAs. miRNA-21 is a microRNA that is highly enriched in endothelial cells. miRNA-21 has been shown to be a potential pro-angiogenic factor in some biological systems. Our previous study showed that the expression of miRNA-21 was up-regulated after spinal cord injury. However, the effect of miRNA-21 on angiogenesis in the spinal cord was unclear. In this study, to understand the role of miRNA-21 on injured endothelial cells exclusively, an oxygen and glucose deprivation model of endothelial cells was constructed, and the up-regulation of miRNA-21 was discovered in this model. An increased level of miRNA-21 by mimics promoted the survival, migration and tube formation of endothelial cells, which simultaneously inhibited tissue inhibitor of metalloproteinase-3 (TIMP3) expression and promoted matrix metalloproteinase-2 (MMP2) and matrix metalloproteinase-9 (MMP9) expression and secretion. A decreased level of miRNA-21 by antagomir exerted an opposite effect. As is well known, survival, migration and tube formation of endothelial cells are necessary prerequisites for angiogenesis after injury. TIMP3 was validated as a direct target of miRNA-21 by dual-luciferase reporter assay. Silencing with small interfering RNA against TIMP3 promoted tube formation and increased MMP2 and MMP9 expression at the protein level. In vivo, we found that decreased levels of miRNA-21 inhibited angiogenesis after spinal cord injury in rats using synchrotron radiation micro-computed tomography. In summary, these findings suggest that miRNA-21 has a protective effect on angiogenesis by reducing cell death and promoting cell survival, migration and tube formation via partially targeting the TIMP3 by potentially regulating MMP2 and MMP9. TIMP3 is a functional target gene. Identifying the role of miRNA-21 in the protection of angiogenesis might offer a novel therapeutic target for secondary spinal cord injury, in which angiogenesis is indispensable.	[Hu, Jianzhong; Ni, Shuangfei; Cao, Yong; Zhang, Tao; Wu, Tianding; Lang, Ye] Cent S Univ, Xiangya Hosp, Dept Spine Surg, Changsha 410008, Hunan, Peoples R China; [Yin, Xianzhen] Chinese Acad Sci, Shanghai Inst Mat Med, Ctr Drug Delivery Syst, Shanghai 201203, Peoples R China; [Lu, Hongbin] Cent S Univ, Xiangya Hosp, Res Ctr Sports Med, Dept Sports Med, Changsha 410008, Hunan, Peoples R China	Central South University; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Central South University	Lu, HB (corresponding author), Cent S Univ, Xiangya Hosp, Res Ctr Sports Med, Dept Sports Med, Changsha 410008, Hunan, Peoples R China.	hongbinlu@hotmail.com		Yin, Xianzhen/0000-0002-7870-1718	National Natural Science Foundation of China [81371956, 81171698]; Specialized Research Fund for the Doctoral Program of Higher Education [20130162110078]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by the National Natural Science Foundation of China (No. 81371956 and No. 81171698) and Specialized Research Fund for the Doctoral Program of Higher Education (No. 20130162110078). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, J Spinal Cord Med, V36, P715, DOI 10.1179/1079026813Z.000000000230; Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856; Benton RL, 2009, ASN NEURO, V1, DOI 10.1042/AN20090008; Bhalala OG, 2012, J NEUROSCI, V32, P17935, DOI 10.1523/JNEUROSCI.3860-12.2012; Bond M, 2000, J BIOL CHEM, V275, P41358, DOI 10.1074/jbc.M007929200; Brown RC, 2005, BIOCHEM BIOPH RES CO, V327, P1114, DOI 10.1016/j.bbrc.2004.12.123; Cao Y, 2015, SCI REP-UK, V5, DOI [10.1038/srep12643, 10.1038/srep18326]; Casella GTB, 2006, EXP NEUROL, V202, P8, DOI 10.1016/j.expneurol.2006.05.028; Casella GTB, 2002, EXP NEUROL, V173, P63, DOI 10.1006/exnr.2001.7827; Chang L, 2015, MOL MED REP, V12, P1197, DOI 10.3892/mmr.2015.3477; Clark IA, 2008, INT J BIOCHEM CELL B, V40, P1362, DOI 10.1016/j.biocel.2007.12.006; Das AM, 2014, ANGIOGENESIS, V17, P163, DOI 10.1007/s10456-013-9385-2; Deryugina EI, 2015, MATRIX BIOL, V44-46, P94, DOI 10.1016/j.matbio.2015.04.004; Di Giovanni S, 2003, ANN NEUROL, V53, P454, DOI 10.1002/ana.10472; Dray C, 2009, P NATL ACAD SCI USA, V106, P9459, DOI 10.1073/pnas.0900222106; Dumont RJ, 2001, CLIN NEUROPHARMACOL, V24, P254, DOI 10.1097/00002826-200109000-00002; Handsley MM, 2005, INT J CANCER, V115, P849, DOI 10.1002/ijc.20945; Hu JZ, 2013, J NEUROTRAUM, V30, P1349, DOI 10.1089/neu.2012.2748; Hu JZ, 2014, MED PHYS, V41, DOI 10.1118/1.4894704; Ji RR, 2007, CIRC RES, V100, P1579, DOI 10.1161/CIRCRESAHA.106.141986; Jiang FS, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/501581; Kang KH, 2008, CARDIOVASC RES, V79, P150, DOI 10.1093/cvr/cvn072; Lambert V, 2003, FASEB J, V17, P2290, DOI 10.1096/fj.03-0113fje; Lan FM, 2015, J NEUROCHEM, V134, P811, DOI 10.1111/jnc.13174; Li ZB, 2015, EUR REV MED PHARMACO, V19, P3208; Liu NK, 2009, EXP NEUROL, V219, P424, DOI 10.1016/j.expneurol.2009.06.015; Ma XD, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8151; Ma XT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082604; Naglich JG, 2001, CANCER RES, V61, P8480; Nieto-Diaz M, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00053; Ning B, 2014, INT J BIOL SCI, V10, P997, DOI 10.7150/ijbs.9058; Ouyang YB, 2014, NEUROSCI LETT, V565, P53, DOI 10.1016/j.neulet.2013.11.015; Qi JH, 2003, NAT MED, V9, P407, DOI 10.1038/nm846; Qi JH, 2015, APOPTOSIS, V20, P523, DOI 10.1007/s10495-014-1076-y; Rundhaug JE, 2005, J CELL MOL MED, V9, P267, DOI 10.1111/j.1582-4934.2005.tb00355.x; Schrimpf C, 2012, J AM SOC NEPHROL, V23, P868, DOI 10.1681/ASN.2011080851; Senger DR, 2011, CSH PERSPECT BIOL, V3, DOI DOI 10.1101/cshperspect.a005090; Surey S, 2014, NEUROSCIENCE, V275, P62, DOI 10.1016/j.neuroscience.2014.06.003; Voellenkle C, 2012, RNA, V18, P472, DOI 10.1261/rna.027615.111; Wang CB, 2014, COGN NEUROSCI-UK, V5, P3, DOI 10.1080/17588928.2013.797388; Wang LJ, 2015, ONCOTARGET, V6, P5932, DOI 10.18632/oncotarget.3465; Wang N, 2013, DIGEST DIS SCI, V58, P1863, DOI 10.1007/s10620-013-2612-2; Wang SS, 2009, CURR OPIN GENET DEV, V19, P205, DOI 10.1016/j.gde.2009.04.002; Yang XL, 2013, NUCLEIC ACIDS RES, V41, P9688, DOI 10.1093/nar/gkt680; Yang Y, 2015, BRAIN RES, V1623, P30, DOI 10.1016/j.brainres.2015.04.024; Yoon YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068600; Yu YM, 2011, EUR J NEUROSCI, V33, P1587, DOI 10.1111/j.1460-9568.2011.07643.x; Zen K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001826; Zhang AM, 2011, UROLOGY, V78, DOI 10.1016/j.urology.2011.03.030; Zhang L, 2013, BIOMED ENG ONLINE, V12, DOI 10.1186/1475-925X-12-30; Zhang MQ, 2014, BRIT J RADIOL, V87, DOI 10.1259/bjr.20130670; Zhang W, 2014, ONCOL REP, V32, P1913, DOI 10.3892/or.2014.3418; Zhang WF, 2013, CELL BIOL INT, V37, P47, DOI 10.1002/cbin.10011; Zhao Y, 2013, TOXICOL LETT, V223, P35, DOI 10.1016/j.toxlet.2013.08.020	54	43	46	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149537	10.1371/journal.pone.0149537	http://dx.doi.org/10.1371/journal.pone.0149537			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26872030	Green Published, gold, Green Submitted			2022-12-26	WOS:000370054100163
J	Yun, BH; Chon, SJ; Choi, YS; Cho, S; Lee, BS; Seo, SK				Yun, Bo Hyon; Chon, Seung Joo; Choi, Young Sik; Cho, SiHyun; Lee, Byung Seok; Seo, Seok Kyo			Pathophysiology of Endometriosis: Role of High Mobility Group Box-1 and Toll-Like Receptor 4 Developing Inflammation in Endometrium	PLOS ONE			English	Article							NF-KAPPA-B; HMGB1; PATHOGENESIS; EXPRESSION; CYTOKINE; PROTEIN; DISEASE; TLR4	Oxidative stress has been proposed as a potential factor associated with the establishment and progression of endometriosis. Although a few studies have shown possible mechanisms which may play roles in development, progression of endometriosis, few are known in regards of initiation of the disease, especially in the relationship with endometrium. The aim of our study was to investigate whether normal endometrium may be changed by Damage-associated molecular patterns (DAMPs), which may contribute developing pathologic endometrium to induce endometriosis. Endometrial tissues were obtained from 10 patients with fibroids undergoing hysterectomy at a university hospital. High mobility group box-1 (HMGB-1), which is a representative DAMP, has been chosen that may induce alteration in endometrium. In preceding immunohistochemistry experiments using paraffin-block sections from endometriosis (N = 33) and control (N = 27) group, retrospectively, HMGB-1 expression was shown in both epithelial and stromal cell. HMGB-1 expression was significantly increased in secretory phase of endometriosis group, comparing to the controls. To examine the alteration of endometrial stromal cell (HESC) by oxidative stress in terms of HMGB-1, cell proliferation and expression of its receptor, TLR4 was measured according to recombinant HMGB-1 use. Cell proliferation was assessed by CCK-8 assay; real-time PCR and western blotting were used to quantify Toll like receptor 4 (TLR4) mRNA and protein expression respectively. A TLR4 antagonist (LPS-RS) and an inhibitor of the NF-kappa B pathway (TPCA-1, an IKK-2 inhibitor) were used to confirm the relationships between HMGB-1, TLR4, and the NF-kappa B pathway. Passive release of HMGB-1 was significantly proportional to the increase in cell death (P < 0.05). HESCs showed significant proliferation following treatment with rHMGB-1 (P < 0.05), and increased TLR4 expression was observed following rHMGB-1 treatment (P < 0.05) in a concentration-dependent manner. Treatment with a TLR4 antagonist and an NF-kappa B inhibitor resulted in suppression of rHMGB-1-induced HESC proliferation (P < 0.05). Levels of IL-6 were significantly decreased following treatment with an NF-kappa B inhibitor (P < 0.05). Our results support the development of altered, pathological endometrium resulted from oxidative stress in normal endometrium. These findings may provide important insights into the changes in endometrium linking the development and progression of endometriosis.	[Yun, Bo Hyon; Chon, Seung Joo; Choi, Young Sik; Lee, Byung Seok; Seo, Seok Kyo] Yonsei Univ, Coll Med, Severance Hosp, Dept Obstet & Gynecol, Seoul, South Korea; [Yun, Bo Hyon; Choi, Young Sik; Cho, SiHyun; Lee, Byung Seok; Seo, Seok Kyo] Yonsei Univ, Coll Med, Inst Womens Life Med Sci, Seoul, South Korea; [Chon, Seung Joo] Gachon Univ Med & Sci, Grad Sch Med, Gil Hosp, Dept Obstet & Gynecol, Inchon, South Korea; [Cho, SiHyun] Yonsei Univ, Coll Med, Dept Obstet & Gynecol, Gangnam Severance Hosp, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Gachon University; Yonsei University; Yonsei University Health System	Seo, SK (corresponding author), Yonsei Univ, Coll Med, Severance Hosp, Dept Obstet & Gynecol, Seoul, South Korea.; Seo, SK (corresponding author), Yonsei Univ, Coll Med, Inst Womens Life Med Sci, Seoul, South Korea.	tudeolseo@yuhs.ac		Yun, Bo Hyon/0000-0001-5703-797X; Cho, SiHyun/0000-0003-2718-6645; Choi, Young Sik/0000-0002-1157-4822; Seo, Seok Kyo/0000-0003-3404-0484; LEE, Byung Seok/0000-0001-6001-2079	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science, and Technology [NRF-2012R1A1A1013167]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science, and Technology	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science, and Technology (NRF-2012R1A1A1013167). The Design of study and the experiments were modified and supported by NRF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson GD, 2010, J ENDOMETR PELVIC PA, V2, P3, DOI 10.1177/228402651000200102; Allhorn S, 2008, REPROD BIOL ENDOCRIN, V6, DOI 10.1186/1477-7827-6-40; Andersson U, 2010, BBA-GENE REGUL MECH, V1799, P141, DOI 10.1016/j.bbagrm.2009.11.003; Barkauskaite V, 2007, LUPUS, V16, P794, DOI 10.1177/0961203307081895; Bhutada S, 2014, HUM REPROD, V29, P763, DOI 10.1093/humrep/det461; Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164; BIANCHI ME, 1989, SCIENCE, V243, P1056, DOI 10.1126/science.2922595; Bulun SE, 2009, NEW ENGL J MED, V360, P268, DOI 10.1056/NEJMra0804690; Chapron C, 2006, HUM REPROD, V21, P1839, DOI 10.1093/humrep/del079; Dhupar R, 2011, SHOCK, V35, P293, DOI 10.1097/SHK.0b013e3181f6aab0; Gonzalez-Ramos R, 2012, FERTIL STERIL, V98, P520, DOI 10.1016/j.fertnstert.2012.06.021; Guo SW, 2007, GYNECOL OBSTET INVES, V63, P71, DOI 10.1159/000096047; Huang WC, 2010, CYTOKINE, V51, P119, DOI 10.1016/j.cyto.2010.02.021; Kang R, 2014, ONCOGENE, V33, P567, DOI 10.1038/onc.2012.631; Kobayashi H, 2014, MOL MED REP, V9, P9, DOI 10.3892/mmr.2013.1755; Lebovic DI, 2001, FERTIL STERIL, V75, P1, DOI 10.1016/S0015-0282(00)01630-7; Lee SA, 2014, YONSEI MED J, V55, P1165, DOI 10.3349/ymj.2014.55.5.1165; Lucidi RS, 2005, FERTIL STERIL, V84, P16, DOI 10.1016/j.fertnstert.2004.10.058; Maiorov EG, 2013, SEMIN CANCER BIOL, V23, P243, DOI 10.1016/j.semcancer.2013.05.003; Murphy AA, 1998, SEMIN REPROD ENDOCR, V16, P263, DOI 10.1055/s-2007-1016286; Ngo C, 2009, AM J PATHOL, V175, P225, DOI 10.2353/ajpath.2009.080804; Noyes R W, 1975, Am J Obstet Gynecol, V122, P262; Reis FM, 2013, HUM REPROD UPDATE, V19, P406, DOI 10.1093/humupd/dmt010; Sahu D, 2008, FEBS LETT, V582, P3973, DOI 10.1016/j.febslet.2008.09.061; Seo SK, 2010, HUM REPROD, V25, P1251, DOI 10.1093/humrep/deq027; Treutiger CJ, 2003, J INTERN MED, V254, P375, DOI 10.1046/j.1365-2796.2003.01204.x; van Beijnum JR, 2013, ONCOGENE, V32, P363, DOI 10.1038/onc.2012.49; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; Weng H, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-311	29	27	30	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0148165	10.1371/journal.pone.0148165	http://dx.doi.org/10.1371/journal.pone.0148165			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26872033	Green Published, gold, Green Submitted			2022-12-26	WOS:000370054100019
J	Chan, JY; LaPara, K; Yee, D				Chan, J. Y.; LaPara, K.; Yee, D.			Disruption of insulin receptor function inhibits proliferation in endocrine-resistant breast cancer cells	ONCOGENE			English	Article							GROWTH-FACTOR-I; ADVANCED SOLID TUMORS; DOWN-REGULATION; MONOCLONAL-ANTIBODIES; CLINICAL-IMPLICATIONS; PHASE-I; EXPRESSION; TAMOXIFEN; ESTROGEN; THERAPY	The insulin-like growth factor (IGF) system is a well-studied growth regulatory pathway implicated in breast cancer biology. Clinical trials testing monoclonal antibodies directed against the type I IGF receptor (IGF1R) in combination with estrogen receptor-a (ER) targeting have been completed, but failed to show benefits in patients with endocrine-resistant tumors compared to ER targeting alone. We have previously shown that the closely related insulin receptor (InsR) is expressed in tamoxifen-resistant (TamR) breast cancer cells. Here we examined if inhibition of InsR affected TamR breast cancer cells. InsR function was inhibited by three different mechanisms: InsR short hairpin RNA, a small InsR-blocking peptide, S961 and an InsR monoclonal antibody (mAb). Suppression of InsR function by these methods in TamR cells successfully blocked insulin-mediated signaling, monolayer proliferation, cell cycle progression and anchorage-independent growth. This strategy was not effective in parental cells likely because of the presence of IGFR/InsR hybrid receptors. Downregulation of IGF1R in conjunction with InsR inhibition was more effective in blocking IGF- and insulin-mediated signaling and growth in parental cells compared with single-receptor targeting alone. Our findings show TamR cells were stimulated by InsR and were not sensitive to IGF1R inhibition, whereas in tamoxifen-sensitive parental cancer cells, the presence of both receptors, especially hybrid receptors, allowed cross-reactivity of ligand-mediated activation and growth. To suppress the IGF system, targeting of both IGF1R and InsR is optimal in endocrine-sensitive and -resistant breast cancer.	[Chan, J. Y.; Yee, D.] Univ Minnesota, Dept Pharmacol, 3-249 Millard Hall, Minneapolis, MN 55455 USA; [LaPara, K.; Yee, D.] Univ Minnesota, Mason Canc Ctr, MMC 806,420 Delaware St SE, Minneapolis, MN 55414 USA; [Yee, D.] Univ Minnesota, Dept Med, Box 736 UMHC, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Yee, D (corresponding author), Univ Minnesota, Mason Canc Ctr, MMC 806,420 Delaware St SE, Minneapolis, MN 55414 USA.	yeexx006@umn.edu		Yee, Douglas/0000-0002-3387-4009	NIH/NCI [2P30-CA077598, P50CA116201]; Komen for the Cure [SAC110039]; NATIONAL CANCER INSTITUTE [P50CA116201, P30CA077598] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Komen for the Cure(Susan G. Komen Breast Cancer Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We acknowledge the assistance of the University Flow Cytometry Resource at the University of Minnesota; Novo Nordisk for supplying S961 peptides. Funding was provided by NIH/NCI 2P30-CA077598 (JYC, KL and DY), NIH/NCI P50CA116201 (DY), and Komen for the Cure SAC110039 (DY).	Arnedos M, 2014, ANN ONCOL, V25, P605, DOI 10.1093/annonc/mdt575; Arpino G, 2009, ONCOLOGY-BASEL, V77, P23, DOI 10.1159/000258493; Baselga J, 2012, NEW ENGL J MED, V366, P520, DOI 10.1056/NEJMoa1109653; Becker MA, 2011, MOL ENDOCRINOL, V25, P516, DOI 10.1210/me.2010-0373; Belfiore A, 2011, ENDOCR-RELAT CANCER, V18, pR125, DOI 10.1530/ERC-11-0074; Belfiore A, 2009, ENDOCR REV, V30, P586, DOI 10.1210/er.2008-0047; Chen HX, 2013, CHIN J CANCER, V32, P242, DOI 10.5732/cjc.012.10263; Dowling RJO, 2012, J MOL ENDOCRINOL, V48, pR31, DOI 10.1530/JME-12-0007; Drury SC, 2011, ENDOCR-RELAT CANCER, V18, P565, DOI 10.1530/ERC-10-0046; Fagan DH, 2012, CANCER RES, V72, P3372, DOI 10.1158/0008-5472.CAN-12-0684; Fagan D, 2008, J MAMMARY GLAND BIOL, V13, P423, DOI 10.1007/s10911-008-9098-0; Frasca F, 1999, MOL CELL BIOL, V19, P3278, DOI 10.1128/mcb.19.5.3278; Fulzele K, 2007, J BIOL CHEM, V282, P25649, DOI 10.1074/jbc.M700651200; Garber K, 2014, SCIENCE, V345, P865, DOI 10.1126/science.345.6199.865; Giovannucci E, 2010, CA-CANCER J CLIN, V60, P207, DOI 10.3322/caac.20078; Giuliano M, 2011, BREAST, V20, pS42, DOI 10.1016/S0960-9776(11)70293-4; Harrington SC, 2012, GROWTH HORM IGF RES, V22, P108, DOI 10.1016/j.ghir.2012.04.001; JAQUES G, 1989, EXP CELL RES, V184, P396, DOI 10.1016/0014-4827(89)90339-X; Jiang LY, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-131; Jones HE, 2006, BRIT J CANCER, V95, P172, DOI 10.1038/sj.bjc.6603237; Jones RL, 2015, CLIN CANCER RES, V21, P693, DOI 10.1158/1078-0432.CCR-14-0265; Josefson D, 2000, BRIT MED J, V320, P1496; Kalli KR, 2002, ENDOCRINOLOGY, V143, P3259, DOI 10.1210/en.2001-211408; Knudsen L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051972; Lee AV, 1997, J ENDOCRINOL, V152, P39, DOI 10.1677/joe.0.1520039; Macaskill EJ, 2006, ONCOLOGIST, V11, P1081, DOI 10.1634/theoncologist.11-10-1081; MILAZZO G, 1992, CANCER RES, V52, P3924; MOLLER DE, 1989, MOL ENDOCRINOL, V3, P1263, DOI 10.1210/mend-3-8-1263; Nadji M, 2005, AM J CLIN PATHOL, V123, P21, DOI 10.1309/4WV79N2GHJ3X1841; OBRIEN RM, 1987, EMBO J, V6, P4003, DOI 10.1002/j.1460-2075.1987.tb02743.x; PAPA V, 1990, J CLIN INVEST, V86, P1503, DOI 10.1172/JCI114868; Paridaens RJ, 2008, J CLIN ONCOL, V26, P4883, DOI 10.1200/JCO.2007.14.4659; Puzanov I, 2015, CLIN CANCER RES, V21, P701, DOI 10.1158/1078-0432.CCR-14-0303; Ramos RR, 2007, P NATL ACAD SCI USA, V104, P10470, DOI 10.1073/pnas.0701114104; Ring A, 2004, ENDOCR-RELAT CANCER, V11, P643, DOI 10.1677/erc.1.00776; Rose DP, 2007, ENDOCR REV, V28, P763, DOI 10.1210/er.2006-0019; Rostoker R, 2015, ENDOCR-RELAT CANCER, V22, P145, DOI 10.1530/ERC-14-0490; Shah SP, 2009, NATURE, V461, P809, DOI 10.1038/nature08489; SOOS MA, 1986, BIOCHEM J, V235, P199, DOI 10.1042/bj2350199; Thompson MD, 2015, CANCER PREV RES, V8, P231, DOI 10.1158/1940-6207.CAPR-14-0181-T; Ulanet DB, 2010, P NATL ACAD SCI USA, V107, P10791, DOI 10.1073/pnas.0914076107; ULLRICH A, 1986, EMBO J, V5, P2503, DOI 10.1002/j.1460-2075.1986.tb04528.x; Weinstein D, 2014, ENDOCR CONNECT, V3, P24, DOI 10.1530/EC-13-0086; Yee D, 2012, JNCI-J NATL CANCER I, V104, P975, DOI 10.1093/jnci/djs258; Zhang H, 2010, ONCOGENE, V29, P2517, DOI 10.1038/onc.2010.17; Zhang H, 2007, CANCER RES, V67, P391, DOI 10.1158/0008-5472.CAN-06-1712; Zhang H, 2009, BREAST CANCER RES TR, V114, P277, DOI 10.1007/s10549-008-0014-5	47	25	26	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG	2016	35	32					4235	4243		10.1038/onc.2015.488	http://dx.doi.org/10.1038/onc.2015.488			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DU3YY	26876199	Green Accepted			2022-12-26	WOS:000382149800008
J	Berezhnov, AV; Soutar, MPM; Fedotova, EI; Frolova, MS; Plun-Favreau, H; Zinchenko, VP; Abramov, AY				Berezhnov, Alexey V.; Soutar, Marc P. M.; Fedotova, Evgeniya I.; Frolova, Maria S.; Plun-Favreau, Helene; Zinchenko, Valery P.; Abramov, Andrey Y.			Intracellular pH Modulates Autophagy and Mitophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						autophagy; lysosome; mitochondria; mitophagy; neurodegeneration; intracellular pH	MITOCHONDRIA; PARKIN; LYSOSOME; RELEASE; CELLS	The specific autophagic elimination of mitochondria (mitophagy) plays the role of quality control for this organelle. Deregulation of mitophagy leads to an increased number of damaged mitochondria and triggers cell death. The deterioration of mitophagy has been hypothesized to underlie the pathogenesis of several neurodegenerative diseases, most notably Parkinson disease. Although some of the biochemical and molecular mechanisms of mitochondrial quality control are described in detail, physiological or pathological triggers of mitophagy are still not fully characterized. Here we show that the induction of mitophagy by the mitochondrial uncoupler FCCP is independent of the effect of mitochondrial membrane potential but dependent on acidification of the cytosol by FCCP. The ionophore nigericin also reduces cytosolic pH and induces PINK1/PARKIN-dependent and -independent mitophagy. The increase of intracellular pH with monensin suppresses the effects of FCCP and nigericin on mitochondrial degradation. Thus, a change in intracellular pH is a regulator of mitochondrial quality control.	[Berezhnov, Alexey V.; Fedotova, Evgeniya I.; Frolova, Maria S.; Zinchenko, Valery P.] Russian Acad Sci, Inst Cell Biophys, Dept Intracellular Signaling, Pushchino 142290, Moscow Region, Russia; [Soutar, Marc P. M.; Plun-Favreau, Helene; Abramov, Andrey Y.] UCL, Inst Neurol, Dept Mol Neurosci, Queen Sq, London WC1N 3BG, England	Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Cell Biophysics RAS; University of London; University College London	Abramov, AY (corresponding author), UCL, Inst Neurol, Dept Mol Neurosci, Queen Sq, London WC1N 3BG, England.	a.abramov@ucl.ac.uk	Abramov, Andrey Y/H-9053-2012; Abramov, Andrey/AAC-6712-2019; Fedotova, Evgeniya/R-8947-2016; Soutar, Marc P M/G-3637-2011; Plun-Favreau, Helene/Q-4111-2016; Berezhnov, Alexey/C-7479-2015	Abramov, Andrey Y/0000-0002-7646-7235; Abramov, Andrey/0000-0002-7646-7235; Soutar, Marc P M/0000-0003-0008-9423; Plun-Favreau, Helene/0000-0002-1401-9656; Fedotova, Evgeniya/0000-0001-6619-4563; Berezhnov, Alexey/0000-0003-0271-6179	Russian Foundation for Basic Research [14-04-31870]; Leverhulme Trust [RPG-2012-447]; MRC [G0700183] Funding Source: UKRI; Medical Research Council [G0700183] Funding Source: researchfish	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Leverhulme Trust(Leverhulme Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Russian Foundation for Basic Research (Grant No. 14-04-31870) and The Leverhulme Trust (RPG-2012-447). The authors declare that they have no conflicts of interest with the contents of this article.	Allen GFG, 2013, EMBO REP, V14, P1127, DOI 10.1038/embor.2013.168; Appelqvist H, 2013, J MOL CELL BIOL, V5, P214, DOI 10.1093/jmcb/mjt022; Ardley HC, 2003, MOL BIOL CELL, V14, P4541, DOI 10.1091/mbc.E03-02-0078; Ashrafi G, 2013, CELL DEATH DIFFER, V20, P31, DOI 10.1038/cdd.2012.81; BERG TO, 1994, BIOCHEM J, V300, P229, DOI 10.1042/bj3000229; Bevensee MO, 2008, BRAIN RES, V1193, P143, DOI 10.1016/j.brainres.2007.12.002; Burchell VS, 2013, NAT NEUROSCI, V16, P1257, DOI 10.1038/nn.3489; Chu CT, 2011, PARKINSONS DIS-US, V2011, DOI 10.4061/2011/789431; Cookson MR, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009415; Deas E, 2011, BBA-MOL CELL RES, V1813, P623, DOI 10.1016/j.bbamcr.2010.08.007; Dechant R, 2010, EMBO J, V29, P2515, DOI 10.1038/emboj.2010.138; Frank M, 2012, BBA-MOL CELL RES, V1823, P2297, DOI 10.1016/j.bbamcr.2012.08.007; Gegg ME, 2010, HUM MOL GENET, V19, P4861, DOI 10.1093/hmg/ddq419; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Green DR, 2011, SCIENCE, V333, P1109, DOI 10.1126/science.1201940; GRINDE B, 1983, EXP CELL RES, V149, P27, DOI 10.1016/0014-4827(83)90377-4; HARTLEY Z, 1993, J NEUROSCI, V13, P4690; Kockskamper J, 2005, J PHYSIOL-LONDON, V564, P697, DOI 10.1113/jphysiol.2004.078782; Kubli DA, 2012, CIRC RES, V111, P1208, DOI 10.1161/CIRCRESAHA.112.265819; Lazarou M, 2015, NATURE, V524, P309, DOI 10.1038/nature14893; Lemasters JJ, 2014, REDOX BIOL, V2, P749, DOI 10.1016/j.redox.2014.06.004; Marino ML, 2012, J BIOL CHEM, V287, P30664, DOI 10.1074/jbc.M112.339127; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Owens LM, 1996, CIRCULATION, V94, P10, DOI 10.1161/01.CIR.94.1.10; Plun-Favreau H, 2007, NAT CELL BIOL, V9, P1243, DOI 10.1038/ncb1644; Scarpulla RC, 2011, BBA-MOL CELL RES, V1813, P1269, DOI 10.1016/j.bbamcr.2010.09.019; Strappazzon F, 2015, CELL DEATH DIFFER, V22, P419, DOI 10.1038/cdd.2014.139; Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952; Togashi K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081313; Yao Z, 2011, J CELL SCI, V124, P4194, DOI 10.1242/jcs.088260; ZIEGELSTEIN RC, 1994, CARDIOVASC RES, V28, P1433, DOI 10.1093/cvr/28.9.1433	31	64	64	3	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2016	291	16					8701	8708		10.1074/jbc.M115.691774	http://dx.doi.org/10.1074/jbc.M115.691774			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK2VT	26893374	hybrid, Green Published, Green Submitted			2022-12-26	WOS:000374773200032
J	Ding, XQ; Thapa, A; Ma, HW; Xu, JH; Elliott, MH; Rodgers, KK; Smith, ML; Wang, JS; Pittler, SJ; Kefalov, VJ				Ding, Xi-Qin; Thapa, Arjun; Ma, Hongwei; Xu, Jianhua; Elliott, Michael H.; Rodgers, Karla K.; Smith, Marci L.; Wang, Jin-Shan; Pittler, Steven J.; Kefalov, Vladimir J.			The B3 Subunit of the Cone Cyclic Nucleotide-gated Channel Regulates the Light Responses of Cones and Contributes to the Channel Structural Flexibility	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ion channel; photoreceptor; phototransduction; retina; vision; achromatopsia; cng channel; cone	ENDOPLASMIC-RETICULUM STRESS; CNG CHANNEL; ION CHANNELS; PHOTORECEPTOR DEGENERATION; RETINAL DEGENERATION; BETA-SUBUNIT; FLICKER ERG; MOUSE MODEL; ROD; MUTATIONS	Cone photoreceptor cyclic nucleotide-gated (CNG) channels play a pivotal role in cone phototransduction, which is a process essential for daylight vision, color vision, and visual acuity. Mutations in the cone channel subunits CNGA3 and CNGB3 are associated with human cone diseases, including achromatopsia, cone dystrophies, and early onset macular degeneration. Mutations in CNGB3 alone account for 50% of reported cases of achromatopsia. This work investigated the role of CNGB3 in cone light response and cone channel structural stability. As cones comprise only 2-3% of the total photoreceptor population in the wild-type mouse retina, we used Cngb3(-/-)/Nrl(-/-) mice with CNGB3 deficiency on a cone-dominant background in our study. We found that, in the absence of CNGB3, CNGA3 was able to travel to the outer segments, co-localize with cone opsin, and form tetrameric complexes. Electroretinogram analyses revealed reduced cone light response amplitude/sensitivity and slower response recovery in Cngb3(-/-)/Nrl(-/-) mice compared with Nrl(-/-) mice. Absence of CNGB3 expression altered the adaptation capacity of cones and severely compromised function in bright light. Biochemical analysis demonstrated that CNGA3 channels lacking CNGB3 were more resilient to proteolysis than CNGA3/CNGB3 channels, suggesting a hindered structural flexibility. Thus, CNGB3 regulates cone light response kinetics and the channel structural flexibility. This work advances our understanding of the biochemical and functional role of CNGB3 in cone photoreceptors.	[Ding, Xi-Qin; Thapa, Arjun; Ma, Hongwei; Xu, Jianhua] Univ Oklahoma, Dept Cell Biol, Hlth Sci Ctr, 940 Stanton L Young Blvd,BMSB 553, Oklahoma City, OK 73104 USA; [Elliott, Michael H.] Univ Oklahoma, Dept Ophthalmol, Hlth Sci Ctr, Oklahoma City, OK 73104 USA; [Rodgers, Karla K.] Univ Oklahoma, Dept Biochem, Hlth Sci Ctr, Oklahoma City, OK 73104 USA; [Elliott, Michael H.] Dean McGee Eye Inst, Oklahoma City, OK USA; [Smith, Marci L.; Pittler, Steven J.] Univ Alabama Birmingham, Dept Vis Sci, Birmingham, AL 35924 USA; [Wang, Jin-Shan] Washington Univ, Dept Ophthalmol & Visual Sci, Sch Med, St Louis, MO 63110 USA; [Thapa, Arjun] Univ New Mexico, Dept Chem & Nucl Engn, Ctr Biomed Engn, Albuquerque, NM 87131 USA; [Xu, Jianhua] Fudan Univ, Inst Biomed Sci, Inst Reprod & Dev, 2140 Xietu Rd, Shanghai 200032, Peoples R China	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Alabama System; University of Alabama Birmingham; Washington University (WUSTL); University of New Mexico; Fudan University	Ding, XQ (corresponding author), Univ Oklahoma, Dept Cell Biol, Hlth Sci Ctr, 940 Stanton L Young Blvd,BMSB 553, Oklahoma City, OK 73104 USA.	xi-qin-ding@ouhsc.edu	; Pittler, Steven/J-7091-2013	Rodgers, Karla/0000-0002-7338-0281; Kefalov, Vladimir/0000-0002-1659-008X; Pittler, Steven/0000-0002-8464-9303	National Center for Research Resources [P20RR017703]; National Eye Institute [P30EY021725, T32EY023202, EY019490, EY019494, AI-094141, EY018143, EY003039, EY019312, EY021126, EY002687]; Research to Prevent Blindness; Oklahoma Center for the Advancement of Science and Technology; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017703] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R24EY021126, P30EY021725, R01EY019490, P30EY002687, R01EY019312, R01EY019494, R01EY018143, P30EY003039, T32EY023202] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI094141] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Oklahoma Center for the Advancement of Science and Technology; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the National Center for Research Resources (P20RR017703), the National Eye Institute (P30EY021725, T32EY023202, EY019490 (X. Q. D.), EY019494 (M. H. E.), AI-094141 (K. K. R.), EY018143 (S. J. P.), EY003039 (S. J. P.), EY019312 (V. J. K.), EY021126 (V. J. K.), and EY002687 to the Department of Ophthalmology and Visual Sciences at Washington University), the Research to Prevent Blindness, and the Oklahoma Center for the Advancement of Science and Technology. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Biel Martin, 2009, V191, P111, DOI 10.1007/978-3-540-68964-5_7; Biel M, 2009, J BIOL CHEM, V284, P9017, DOI 10.1074/jbc.R800075200; Bradley J, 2005, CURR OPIN NEUROBIOL, V15, P343, DOI 10.1016/j.conb.2005.05.014; Chakraborty D, 2009, HUM MOL GENET, V18, P797, DOI 10.1093/hmg/ddn406; COOK NJ, 1989, J BIOL CHEM, V264, P6996; Daiger SP, 2013, CLIN GENET, V84, P132, DOI 10.1111/cge.12203; Daniele LL, 2005, INVEST OPHTH VIS SCI, V46, P2156, DOI 10.1167/iovs.04-1427; Ding XQ, 2008, BIOCHEMISTRY-US, V47, P3677, DOI 10.1021/bi7019645; Ding XQ, 2009, HUM MOL GENET, V18, P4770, DOI 10.1093/hmg/ddp440; Ding XQ, 2004, HUM MOL GENET, V13, P2075, DOI 10.1093/hmg/ddh211; Ding XQ, 2002, MOL PHARMACOL, V61, P1041, DOI 10.1124/mol.61.5.1041; Faillace MP, 2004, J BIOL CHEM, V279, P22643, DOI 10.1074/jbc.M400035200; Farjo R, 2006, J CELL BIOL, V173, P59, DOI 10.1083/jcb.200509036; Gerstner A, 2000, J NEUROSCI, V20, P1324; Goldberg AFX, 2001, J BIOL CHEM, V276, P42700, DOI 10.1074/jbc.M107511200; Huttl S, 2005, J NEUROSCI, V25, P130, DOI 10.1523/JNEUROSCI.3764-04.2005; Johnson S, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.011437; Kaupp UB, 2002, PHYSIOL REV, V82, P769, DOI 10.1152/physrev.00008.2002; KAUPP UB, 1989, NATURE, V342, P762, DOI 10.1038/342762a0; Kohl S, 2005, EUR J HUM GENET, V13, P302, DOI 10.1038/sj.ejhg.5201269; Kohl S, 1998, NAT GENET, V19, P257, DOI 10.1038/935; Kohl S, 2000, HUM MOL GENET, V9, P2107, DOI 10.1093/hmg/9.14.2107; Kolandaivelu S, 2011, J BIOL CHEM, V286, P33252, DOI 10.1074/jbc.M111.259101; Kolesnikov AV, 2012, JOVE-J VIS EXP, DOI 10.3791/3424; Kondo M, 2001, INVEST OPHTH VIS SCI, V42, P305; Korenbrot JI, 2013, J NEUROSCI, V33, P17763, DOI 10.1523/JNEUROSCI.2659-13.2013; Kunchithapautham K, 2009, INVEST OPHTH VIS SCI, V50, P4858, DOI 10.1167/iovs.08-3008; Liu DT, 1996, NEURON, V16, P983, DOI 10.1016/S0896-6273(00)80121-X; Ma HW, 2015, J BIOL CHEM, V290, P20880, DOI 10.1074/jbc.M115.641159; Ma HW, 2013, HUM MOL GENET, V22, P3906, DOI 10.1093/hmg/ddt245; Matveev AV, 2008, J NEUROCHEM, V106, P2042, DOI 10.1111/j.1471-4159.2008.05548.x; Matveev AV, 2010, BIOCHEMISTRY-US, V49, P1628, DOI 10.1021/bi901960u; Mears AJ, 2001, NAT GENET, V29, P447, DOI 10.1038/ng774; Michalakis S, 2006, J BIOL CHEM, V281, P35156, DOI 10.1074/jbc.M606409200; Nakamoto RK, 1998, J BIOL CHEM, V273, P7338, DOI 10.1074/jbc.273.13.7338; Nishiguchi KM, 2005, HUM MUTAT, V25, P248, DOI 10.1002/humu.20142; Okada A, 2004, INVEST OPHTH VIS SCI, V45, P2324, DOI 10.1167/iovs.03-1094; Parker R, 2011, J NEUROSCI, V31, P4714, DOI 10.1523/JNEUROSCI.3722-10.2011; PEACHEY NS, 1993, NEUROSCI LETT, V162, P9, DOI 10.1016/0304-3940(93)90547-X; Peng CH, 2003, J BIOL CHEM, V278, P24617, DOI 10.1074/jbc.M301699200; PICONES A, 1995, BIOPHYS J, V69, P120, DOI 10.1016/S0006-3495(95)79881-2; Qian H, 2008, EXP EYE RES, V87, P71, DOI 10.1016/j.exer.2008.04.011; Raz-Prag D, 2006, INVEST OPHTH VIS SCI, V47, P3603, DOI 10.1167/iovs.05-1527; Rebrik TI, 2012, J NEUROSCI, V32, P3142, DOI 10.1523/JNEUROSCI.5518-11.2012; Rebrik TI, 1998, J GEN PHYSIOL, V112, P537, DOI 10.1085/jgp.112.5.537; Roger JE, 2012, J NEUROSCI, V32, P528, DOI 10.1523/JNEUROSCI.3591-11.2012; Schon C, 2013, MOL GENET GENOMICS, V288, P459, DOI 10.1007/s00438-013-0766-4; Seddon JM, 2006, ANIM GENET, V37, P407, DOI 10.1111/j.1365-2052.2006.01484.x; Shuart NG, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1466; Sidjanin DJ, 2002, HUM MOL GENET, V11, P1823, DOI 10.1093/hmg/11.16.1823; Siligardi G, 1998, ENANTIOMER, V3, P77; Thapa A, 2012, J BIOL CHEM, V287, P18018, DOI 10.1074/jbc.M112.342220; Trudeau MC, 2004, J GEN PHYSIOL, V124, P211, DOI 10.1085/jgp.200409101; Trudeau MC, 2002, P NATL ACAD SCI USA, V99, P8424, DOI 10.1073/pnas.122015999; Vinberg F, 2014, VISION RES, V101, P108, DOI 10.1016/j.visres.2014.06.003; Wang JS, 2014, J NEUROSCI, V34, P11212, DOI 10.1523/JNEUROSCI.1245-14.2014; Wang JS, 2009, NAT NEUROSCI, V12, P295, DOI 10.1038/nn.2258; Weitz D, 2002, NEURON, V36, P881, DOI 10.1016/S0896-6273(02)01098-X; Weitz D, 1998, EMBO J, V17, P2273, DOI 10.1093/emboj/17.8.2273; Wissinger B, 2001, AM J HUM GENET, V69, P722, DOI 10.1086/323613; Xu JH, 2013, J NEUROSCI, V33, P14939, DOI 10.1523/JNEUROSCI.0909-13.2013; Xu JH, 2011, INVEST OPHTH VIS SCI, V52, P3557, DOI 10.1167/iovs.10-6358; Yeh CY, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-27; Zagotta WN, 1996, ANNU REV NEUROSCI, V19, P235, DOI 10.1146/annurev.ne.19.030196.001315; Zhang Y, 2009, J CELL SCI, V122, P1192, DOI 10.1242/jcs.042531; Zhu XM, 2003, J NEUROSCI, V23, P6152, DOI 10.1523/JNEUROSCI.23-14-06152.2003	66	2	2	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2016	291	16					8721	8734		10.1074/jbc.M115.696138	http://dx.doi.org/10.1074/jbc.M115.696138			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK2VT	26893377	Green Published, hybrid			2022-12-26	WOS:000374773200034
J	Pech-Puch, D; Cruz-Lopez, H; Canche-Ek, C; Campos-Espinosa, G; Garcia, E; Mascaro, M; Rosas, C; Chavez-Velasco, D; Rodriguez-Morales, S				Pech-Puch, Dawrin; Cruz-Lopez, Honorio; Canche-Ek, Cindy; Campos-Espinosa, Gabriela; Garcia, Elpidio; Mascaro, Maite; Rosas, Carlos; Chavez-Velasco, Daniel; Rodriguez-Morales, Sergio			Chemical Tools of Octopus maya during Crab Predation Are Also Active on Conspecifics	PLOS ONE			English	Article							POSTERIOR SALIVARY-GLANDS; ELEDONE-CIRRHOSA MOLLUSCA; CEPHALOPODA; VULGARIS; CYANEA; PREY; PHARMACOLOGY; INJECTION; SEROTONIN; PROTEINS	Octopus maya is a major socio-economic resource from the Yucatan Peninsula in Mexico. In this study we report for the first time the chemical composition of the saliva of O. maya and its effect on natural prey, i.e. the blue crab (Callinectes sapidus), the crown conch snail (Melongena corona bispinosa), as well as conspecifics. Salivary posterior glands were collected from octopus caught by local fishers and extracted with water; this extract paralyzed and predigested crabs when it was injected into the third pereiopod. The water extract was fractionated by membrane ultrafiltration with a molecular weight cut-off of 3kDa leading to a metabolic phase (>3kDa) and a neurotoxic fraction (<3kDa). The neurotoxic fraction injected in the crabs caused paralysis and postural changes. Crabs recovered to their initial condition within two hours, which suggests that the effects of the neurotoxic fraction were reversible. The neurotoxic fraction was also active on O. maya conspecifics, partly paralyzing and sedating them; this suggests that octopus saliva might be used among conspecifics for defense and for reduction of competition. Bioguided separation of the neurotoxic fraction by chromatography led to a paralysis fraction and a relaxing fraction. The paralyzing activity of the saliva was exerted by amino acids, while the relaxing activity was due to the presence of serotonin. Prey-handling studies revealed that O. maya punctures the eye or arthrodial membrane when predating blue crabs and uses the radula to bore through crown conch shells; these differing strategies may help O. maya to reduce the time needed to handle its prey.	[Pech-Puch, Dawrin; Cruz-Lopez, Honorio; Canche-Ek, Cindy; Campos-Espinosa, Gabriela; Rodriguez-Morales, Sergio] Univ Nacl Autonoma Mexico, Fac Quim, Unidad Quim Sisal, Sisal, Yucatan, Mexico; [Garcia, Elpidio] Univ Nacl Autonoma Mexico, Fac Quim, Dept Bioquim, Mexico City 04510, DF, Mexico; [Mascaro, Maite; Rosas, Carlos] Univ Nacl Autonoma Mexico, Fac Ciencias, Unidad Multidisciplinaria Docencia & Invest, Sisal, Yucatan, Mexico; [Chavez-Velasco, Daniel] Inst Tecnol Tijuana, Ctr Grad & Invest Quim, Tijuana, Baja Calif Nort, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Rodriguez-Morales, S (corresponding author), Univ Nacl Autonoma Mexico, Fac Quim, Unidad Quim Sisal, Sisal, Yucatan, Mexico.	sergiorodriguez@unam.mx	MIQUELAJAUREGUI, MAITE MASCARO/AAD-5843-2021; Cruz-Lopez, Honorio/B-1687-2017; Rodriguez, Sergio/ABA-8038-2021; Garcia, Elpidio/L-5258-2019; Rosas, Carlos/A-7052-2009; Pech-Puch, Dawrin/GVR-8458-2022; Cruz-López, Honorio/AAA-3197-2019	MIQUELAJAUREGUI, MAITE MASCARO/0000-0003-3614-4383; Cruz-Lopez, Honorio/0000-0001-9736-0288; Cruz-López, Honorio/0000-0001-9736-0288; PECH-PUCH, DAWRIN/0000-0002-1680-4340; Rosas, Carlos/0000-0002-1301-7368	Direccion General de Asuntos del Personal Academico (DGAPA)-UNAM (PAPIIT) [TA200314]; Consejo Nacional de Ciencia y Tecnologia (CONACyT); Yucatan government (FOMIX-YUCATAN) [107350]	Direccion General de Asuntos del Personal Academico (DGAPA)-UNAM (PAPIIT); Consejo Nacional de Ciencia y Tecnologia (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Yucatan government (FOMIX-YUCATAN)	This work was supported by grants from the Direccion General de Asuntos del Personal Academico (DGAPA)-UNAM (PAPIIT TA200314), from Consejo Nacional de Ciencia y Tecnologia (CONACyT) and the Yucatan government (FOMIX-YUCATAN 107350).	Agnisola C, 1996, PHYSIOL BEHAV, V59, P729, DOI 10.1016/0031-9384(95)02153-1; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Anderson RC, 2008, MAR ECOL PROG SER, V371, P199, DOI 10.3354/meps07649; Anderson RC, 2008, VELIGER, V50, P326; ANDREWS PLR, 1981, PROC R SOC SER B-BIO, V213, P93, DOI 10.1098/rspb.1981.0056; ARNOLD JM, 1969, AM ZOOL, V9, P991; BARLOW JJ, 1974, J COMP PHYSIOL, V89, P105, DOI 10.1007/BF00694786; Boyle P, 2005, CEPHALOPODS: ECOLOGY AND FISHERIES, P222; BOYLE PR, 1981, J ZOOL, V193, P1; Brodie E, 2009, CURR BIOL, pR927; Caldwell RL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134152; CARIELLO L, 1977, COMP BIOCHEM PHYS C, V57, P169, DOI 10.1016/0306-4492(77)90066-1; Clarke K, 2006, PRIMER V6 USER MANUA, P190; Cooke I. R., 2015, EVOLUTION VENOMOUS A; Fiorito G, 2014, INVERTEBR NEUROSCI, V14, P13, DOI 10.1007/s10158-013-0165-x; FLACHSENBERGER W, 1985, TOXICON, V23, P997, DOI 10.1016/0041-0101(85)90393-9; Forsythe JW, 1997, J EXP MAR BIOL ECOL, V209, P15, DOI 10.1016/S0022-0981(96)00057-3; Fry BG, 2009, J MOL EVOL, V68, P311, DOI 10.1007/s00239-009-9223-8; George-Zamora A, 2011, AQUACULTURE, V314, P215, DOI 10.1016/j.aquaculture.2011.02.022; GERSCHENFELD HM, 1973, PHYSIOL REV, V53, P1, DOI 10.1152/physrev.1973.53.1.1; GHIRETTI F, 1960, ANN NY ACAD SCI, V90, P726, DOI 10.1111/j.1749-6632.1960.tb26417.x; Gleadall IG, 2013, J EXP MAR BIOL ECOL, V447, P23, DOI 10.1016/j.jembe.2013.02.008; Grisley MS, 1996, J EXP MAR BIOL ECOL, V202, P225, DOI 10.1016/0022-0981(96)00035-4; Hanlon RT, 2008, MAR FRESHW BEHAV PHY, V41, P19, DOI 10.1080/10236240701661123; Hanlon RT, 1999, BIOL J LINN SOC, V66, P1; HARTWICK EB, 1978, MAR BEHAV PHYSIOL, V5, P193, DOI 10.1080/10236247809378535; HOWDEN MEH, 1974, TOXICON, V12, P317, DOI 10.1016/0041-0101(74)90076-2; Huffard CL, 2015, MOLLUSCAN RES, V35, P12, DOI 10.1080/13235818.2014.909558; Ibanez CM, 2010, REV FISH BIOL FISHER, V20, P123, DOI 10.1007/s11160-009-9129-y; JUORIO AV, 1973, COMP BIOCHEM PHYSIOL, V44, P1059, DOI 10.1016/0300-9629(73)90243-0; Kanda A, 2003, PEPTIDES, V24, P35, DOI 10.1016/S0196-9781(02)00274-7; Key LN, 2002, TOXICON, V40, P677, DOI 10.1016/S0041-0101(01)00254-9; Krnjevic K, 2010, J PHYSIOL-LONDON, V588, P33, DOI 10.1113/jphysiol.2009.176990; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Legendre P, 2012, DEV ENV MODELLING, V24, P109; Leite TS, 2009, MAR BIOL, V156, P2355, DOI 10.1007/s00227-009-1264-4; LIVINGSTONE MS, 1980, SCIENCE, V208, P76, DOI 10.1126/science.208.4439.76; Mather J. A., 1994, Vie et Milieu, V44, P267; MATHER JA, 1991, B MAR SCI, V49, P256; Mather JA, 2014, CEPHALOPOD CULTURE, P17, DOI [DOI 10.1007/978-94-017-8648-5, 10.1007/978-94-017-8648-5]; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:FMMTCD]2.0.CO;2; NIXON M, 1980, J ZOOL, V191, P75; NIXON M, 1979, J ZOOL, V187, P291; NIXON M, 1984, J ZOOL, V202, P441, DOI 10.1111/j.1469-7998.1984.tb05094.x; Rosas C., 2014, CEPHALOPOD CULTURE, DOI [10.1007/978-94-017-8648-5_20, DOI 10.1007/978-94-017-8648-5_20]; Rothschild BJ, 1992, 92003036 CBL; Sanchez-Rodriguez J, 2006, ARCH TOXICOL, V80, P436, DOI 10.1007/s00204-006-0059-3; Spitzer N, 2008, J EXP BIOL, V211, P92, DOI 10.1242/jeb.012450; Steer MA, 2003, J EXP MAR BIOL ECOL, V290, P165, DOI 10.1016/S0022-0981(03)00076-5; Sykes AV, 2014, CEPHALOPOD CULTURE, P59, DOI DOI 10.1007/978-94-017-8648-5_4; Undheim EAB, 2010, TOXICON, V56, P897, DOI 10.1016/j.toxicon.2010.06.013; Uriarte I, 2011, J WORLD AQUACULT SOC, V42, P735, DOI 10.1111/j.1749-7345.2011.00524.x; WODINSKY J, 1973, MAR BIOL, V20, P154, DOI 10.1007/BF00351454; WODINSKY J, 1969, AM ZOOL, V9, P997; WOOD DE, 1995, J COMP PHYSIOL A, V177, P321	55	12	12	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0148922	10.1371/journal.pone.0148922	http://dx.doi.org/10.1371/journal.pone.0148922			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3DG	26895025	gold, Green Published, Green Submitted			2022-12-26	WOS:000371223400026
J	Devoe, NC; Corbett, IJ; Barker, L; Chang, R; Gudis, P; Mullen, N; Perez, K; Raposo, H; Scholz, J; May, M				Devoe, Neil C.; Corbett, Ian J.; Barker, Linsey; Chang, Robert; Gudis, Polyxeni; Mullen, Nathan; Perez, Kailey; Raposo, Hugo; Scholz, John; May, Meghan			Differential Evolutionary Selection and Natural Evolvability Observed in ALT Proteins of Human Filarial Parasites	PLOS ONE			English	Article							LYMPHATIC FILARIASIS; BRUGIA-MALAYI; WUCHERERIA-BANCROFTI; LARVAL; ANTIGEN; GENES; INFORMATION; POPULATION; PROTECTION; INFECTION	The abundant larval transcript (ALT-2) protein is present in all members of the Filarioidea, and has been reported as a potential candidate antigen for a subunit vaccine against lymphatic filariasis. To assess the potential for vaccine escape or heterologous protection, we examined the evolutionary selection acting on ALT-2. The ratios of nonsynonymous (K(a)) to synonymous (K(s)) mutation frequencies (omega) were calculated for the alt-2 genes of the lymphatic filariasis agents Brugia malayi and Wuchereria bancrofti and the agents of river blindness and African eyeworm disease Onchocerca volvulus and Loa loa. Two distinct Bayesian models of sequence evolution showed that ALT-2 ofW. bancrofti and L. loa were under significant (P< 0.05; P < 0.001) diversifying selection, while ALT-2 of B. malayi and O. volvulus were under neutral to stabilizing selection. Diversifying selection as measured by omega values was notably strongest on the region of ALT-2 encoding the signal peptide of L. loa and was elevated in the variable acidic domain of L. loa and W. bancrofti. Phylogenetic analysis indicated that the ALT-2 consensus sequences formed three clades: the first consisting of B. malayi, the second consisting ofW. bancrofti, and the third containing both O. volvulus and L. loa. ALT-2 selection was therefore not predictable by phylogeny or pathology, as the two species parasitizing the eye were selected differently, as were the two species parasitizing the lymphatic system. The most immunogenic regions of L. loa andW. bancrofti ALT-2 sequence as modeled by antigenicity prediction analysis did not correspond with elevated levels of diversifying selection, and were not selected differently than predicted antigenic epitopes in B. malayi and O. volvulus. Measurements of ALT-2 evolvability made by chi(2) analysis between alleles that were stable (O. volvulus and B. malayi) and those that were under diversifying selection (W. bancrofti and L. loa) indicated significant (P<0.01) deviations from a normal distribution for both W. bancrofti and L. loa. The relationship between evolvability and selection in L. loa followed a second order polynomial distribution (R-2 = 0.89), indicating that the two factors relate to one another in accordance with an additional unknown factor. Taken together, these findings indicate discrete evolutionary drivers acting on ALT-2 of the four organisms examined, and the described variation has implications for design of novel vaccines and diagnostic reagents. Additionally, this represents the first mathematical description of evolvability in a naturally occurring setting.	[Devoe, Neil C.; Corbett, Ian J.; Barker, Linsey; Chang, Robert; Gudis, Polyxeni; Mullen, Nathan; Perez, Kailey; Raposo, Hugo; Scholz, John; May, Meghan] Univ New England, Coll Osteopath Med, Biddeford, ME 04005 USA	University of New England - Maine	May, M (corresponding author), Univ New England, Coll Osteopath Med, Biddeford, ME 04005 USA.	mmay3@une.edu						Allen JE, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000217; Aparnaa R, 2014, PARASITE IMMUNOL, V36, P475, DOI 10.1111/pim.12120; APPEL RD, 1994, TRENDS BIOCHEM SCI, V19, P258, DOI 10.1016/0968-0004(94)90153-8; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Dakshinamoorthy G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112982; Das L. K., 2003, Filaria Journal, V2; Doron-Faigenboim A, 2005, BIOINFORMATICS, V21, P2101, DOI 10.1093/bioinformatics/bti259; ECK RV, 1966, SCIENCE, V152, P363, DOI 10.1126/science.152.3720.363; FELSENSTEIN J, 1992, GENET RES, V60, P209, DOI 10.1017/S0016672300030962; Fernandez-Fuentes N, 2007, NUCLEIC ACIDS RES, V35, pW363, DOI 10.1093/nar/gkm341; Fong MY, 2008, TROP BIOMED, V25, P87; Frank GR, 1996, MOL BIOCHEM PARASIT, V75, P231, DOI 10.1016/0166-6851(95)02534-0; Ghedin E, 2007, SCIENCE, V317, P1756, DOI 10.1126/science.1145406; Gomez-Escobar N, 2002, MOL BIOCHEM PARASIT, V125, P59, DOI 10.1016/S0166-6851(02)00219-0; Gopal Vijaya, 2010, Syst Synth Biol, V4, P293, DOI 10.1007/s11693-011-9074-7; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Graves CJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003766; Gregory WF, 2000, INFECT IMMUN, V68, P4174, DOI 10.1128/IAI.68.7.4174-4179.2000; Gregory WF, 1997, MOL BIOCHEM PARASIT, V87, P85, DOI 10.1016/S0166-6851(97)00050-9; Hodges MH, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-120; Hussain MA, 2014, INFECT DIS POVERTY, V3, DOI 10.1186/2049-9957-3-31; Joseph GT, 1998, MOL BIOCHEM PARASIT, V96, P177, DOI 10.1016/S0166-6851(98)00094-2; Joseph SK, 2013, VACCINE, V31, P3320, DOI 10.1016/j.vaccine.2013.05.077; KAR SK, 1993, ACTA TROP, V55, P21, DOI 10.1016/0001-706X(93)90045-D; Lu YJ, 2013, ASIAN PAC J TROP MED, V6, P709, DOI 10.1016/S1995-7645(13)60123-6; Madhumathi J, 2010, PARASITE IMMUNOL, V32, P760, DOI 10.1111/j.1365-3024.2010.01239.x; Mahalakshmi N, 2013, PARASITOL RES, V112, P3203, DOI 10.1007/s00436-013-3496-y; May M, 2011, J BACTERIOL, V193, P2116, DOI 10.1128/JB.00022-11; Mugal CF, 2014, MOL BIOL EVOL, V31, P212, DOI 10.1093/molbev/mst192; Nei M, 1998, P NATL ACAD SCI USA, V95, P12390, DOI 10.1073/pnas.95.21.12390; Nielsen H, 1997, Int J Neural Syst, V8, P581, DOI 10.1142/S0129065797000537; OTTESEN EA, 1992, PARASITOLOGY, V104, pS71, DOI 10.1017/S0031182000075259; Pieper U, 2014, NUCLEIC ACIDS RES, V42, pD336, DOI 10.1093/nar/gkt1144; PINDER M, 1988, J IMMUNOL, V141, P2480; Ramachandran S, 2004, MICROBIOL IMMUNOL, V48, P945, DOI 10.1111/j.1348-0421.2004.tb03624.x; Ramanathan A, 2015, LYMPHAT RES BIOL, V13, P120, DOI 10.1089/lrb.2014.0034; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schwab AE, 2005, AM J TROP MED HYG, V73, P234, DOI 10.4269/ajtmh.2005.73.234; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Sharmila S, 2011, EXP PARASITOL, V129, P247, DOI 10.1016/j.exppara.2011.08.005; Sniegowski PD, 2006, CURR BIOL, V16, pR831, DOI 10.1016/j.cub.2006.08.080; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Stern A, 2007, NUCLEIC ACIDS RES, V35, pW506, DOI 10.1093/nar/gkm382; Swanson WJ, 2003, CURR OPIN GENET DEV, V13, P617, DOI 10.1016/j.gde.2003.10.007; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thirugnanam S, 2007, EXP PARASITOL, V116, P483, DOI 10.1016/j.exppara.2007.02.017; WHO, 2013, WKLY EPIDEMIOL REC, V88, P389; Yang ZH, 2000, TRENDS ECOL EVOL, V15, P496, DOI 10.1016/S0169-5347(00)01994-7; Zarowiecki M, 2015, PARASITOLOGY, V142, pS85, DOI 10.1017/S0031182014001449	51	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2016	11	2							e0148611	10.1371/journal.pone.0148611	http://dx.doi.org/10.1371/journal.pone.0148611			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3CO	26890364	Green Published, gold			2022-12-26	WOS:000371221500009
J	Greninger, AL; Chatterjee, SS; Chan, LC; Hamilton, SM; Chambers, HF; Chiu, CY				Greninger, Alexander L.; Chatterjee, Som S.; Chan, Liana C.; Hamilton, Stephanie M.; Chambers, Henry F.; Chiu, Charles Y.			Whole-Genome Sequencing of Methicillin-Resistant Staphylococcus aureus Resistant to Fifth-Generation Cephalosporins Reveals Potential Non-mecA Mechanisms of Resistance	PLOS ONE			English	Article							PENICILLIN-BINDING PROTEINS; BETA-LACTAM RESISTANCE; CEFTAROLINE FOSAMIL; INTEGRATED ANALYSIS; COMPLICATED SKIN; SUSCEPTIBILITY; MUTATIONS; EPIDEMIOLOGY; MULTICENTER; VANCOMYCIN	Fifth-generation cephalosporins, ceftobiprole and ceftaroline, are promising drugs for treatment of bacterial infections from methicillin-resistant Staphylococcus aureus (MRSA). These antibiotics are able to bind native PBP2a, the penicillin-binding protein encoded by the mecA resistance determinant that mediates broad class resistance to nearly all other beta-lactam antibiotics, at clinically achievable concentrations. Mechanisms of resistance to ceftaroline based on mecA mutations have been previously described. Here we compare the genomes of 11 total parent-daughter strains of Staphylococcus aureus for which specific selection by serial passaging with ceftaroline or ceftobiprole was used to identify novel non-mecA mechanisms of resistance. All 5 ceftaroline-resistant strains, derived from 5 different parental strains, contained mutations directly upstream of the pbp4 gene (coding for the PBP4 protein), including four with the same thymidine insertion located 377 nucleotides upstream of the promoter site. In 4 of 5 independent ceftaroline-driven selections, we also isolated mutations to the same residue (Asn138) in PBP4. In addition, mutations in additional candidate genes such as ClpX endopeptidase, PP2C protein phosphatase and transcription terminator Rho, previously undescribed in the context of resistance to ceftaroline or ceftobiprole, were detected in multiple selections. These genomic findings suggest that non-mecA mechanisms, while yet to be encountered in the clinical setting, may also be important in mediating resistance to 5th-generation cephalosporins.	[Greninger, Alexander L.; Chiu, Charles Y.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; [Greninger, Alexander L.; Chiu, Charles Y.] UCSF Abbott Viral Diagnost & Discovery Ctr, San Francisco, CA USA; [Chatterjee, Som S.; Chan, Liana C.; Hamilton, Stephanie M.; Chambers, Henry F.] San Francisco Gen Hosp, Div Infect Dis, Dept Med, San Francisco, CA 94110 USA	University of California System; University of California San Francisco; San Francisco General Hospital Medical Center	Chiu, CY (corresponding author), Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA.; Chiu, CY (corresponding author), UCSF Abbott Viral Diagnost & Discovery Ctr, San Francisco, CA USA.	charles.chiu@ucsf.edu		Greninger, Alexander/0000-0002-7443-0527	NIH (National Institutes of Health) [R01-AI100291]; NIH [R01-AI100291, R01-HL105704]; Abbott Pathogen Discovery Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105704] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI100291] Funding Source: NIH RePORTER	NIH (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Abbott Pathogen Discovery Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded in part by NIH (National Institutes of Health) grant R01-AI100291 (to HFC), NIH grant R01-HL105704 (to CYC), and an Abbott Pathogen Discovery Award (to CYC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was funded in part by NIH grant R01-AI100291 (to HFC), NIH grant R01-HL105704 (to CYC), and an Abbott Pathogen Discovery Award (to CYC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alm RA, 2014, J ANTIMICROB CHEMOTH, V69, P2065, DOI 10.1093/jac/dku114; Baek KT, 2014, ANTIMICROB AGENTS CH, V58, P4593, DOI 10.1128/AAC.02802-14; Baneriee R, 2008, ANTIMICROB AGENTS CH, V52, P2089, DOI 10.1128/AAC.01403-07; Banerjee R, 2010, ANTIMICROB AGENTS CH, V54, P4900, DOI 10.1128/AAC.00594-10; Beresford E, 2014, EXPERT REV CLIN PHAR, V7, P123, DOI 10.1586/17512433.2014.884457; Biedenbach DJ, 2016, ANTIMICROB AGENTS CH, V60, P343, DOI 10.1128/AAC.01867-15; Boucher HW, 2008, CLIN INFECT DIS, V46, pS344, DOI 10.1086/533590; Chambers HF, 2001, EMERG INFECT DIS, V7, P178, DOI 10.3201/eid0702.010204; Chan LC, 2015, ANTIMICROB AGENTS CH, V59, P2960, DOI 10.1128/AAC.05004-14; Corey GR, 2010, CLIN INFECT DIS, V51, P641, DOI 10.1086/655827; Dantes R, 2013, JAMA INTERN MED, V173, P1970, DOI 10.1001/jamainternmed.2013.10423; Das AK, 1996, EMBO J, V15, P6798, DOI 10.1002/j.1460-2075.1996.tb01071.x; File TM, 2010, CLIN INFECT DIS, V51, P1395, DOI 10.1086/657313; Henze UU, 1996, ANTIMICROB AGENTS CH, V40, P2121, DOI 10.1128/AAC.40.9.2121; Jones RN, 2010, J ANTIMICROB CHEMOTH, V65, piv17, DOI 10.1093/jac/dkq252; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kosowska-Shick K, 2010, ANTIMICROB AGENTS CH, V54, P1670, DOI 10.1128/AAC.00019-10; Kristich CJ, 2011, MBIO, V2, DOI 10.1128/mBio.00199-11; Kumar KM, 2014, 3 BIOTECH, V4, P241, DOI 10.1007/s13205-013-0147-z; Lee YH, 2014, J BACTERIOL, V196, P3700, DOI 10.1128/JB.02022-14; Leski TA, 2005, J BACTERIOL, V187, P1815, DOI 10.1128/JB.187.5.1815-1824.2005; Long SW, 2014, ANTIMICROB AGENTS CH, V58, P6668, DOI 10.1128/AAC.03622-14; Macheboeuf P, 2006, FEMS MICROBIOL REV, V30, P673, DOI 10.1111/j.1574-6976.2006.00024.x; Martin M., 2011, EMBNET J, V17, P10, DOI 10.14806/ej.17.1.200; Memmi G, 2008, ANTIMICROB AGENTS CH, V52, P3955, DOI 10.1128/AAC.00049-08; Mendes RE, 2012, J CLIN MICROBIOL, V50, P3694, DOI 10.1128/JCM.02024-12; Moisan H, 2010, J ANTIMICROB CHEMOTH, V65, P713, DOI 10.1093/jac/dkp503; Navratna V, 2010, J BACTERIOL, V192, P134, DOI 10.1128/JB.00822-09; Zapun A, 2008, FEMS MICROBIOL REV, V32, P361, DOI 10.1111/j.1574-6976.2007.00095.x	29	40	41	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2016	11	2							e0149541	10.1371/journal.pone.0149541	http://dx.doi.org/10.1371/journal.pone.0149541			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3CO	26890675	Green Published, gold, Green Submitted			2022-12-26	WOS:000371221500056
J	Lerman, K; Yan, XR; Wu, XZ				Lerman, Kristina; Yan, Xiaoran; Wu, Xin-Zeng			The "Majority Illusion" in Social Networks	PLOS ONE			English	Article							DYNAMICS; BEHAVIOR; SPREAD; GRAPHS; MODEL	Individual's decisions, from what product to buy to whether to engage in risky behavior, often depend on the choices, behaviors, or states of other people. People, however, rarely have global knowledge of the states of others, but must estimate them from the local observations of their social contacts. Network structure can significantly distort individual's local observations. Under some conditions, a state that is globally rare in a network may be dramatically over-represented in the local neighborhoods of many individuals. This effect, which we call the "majority illusion," leads individuals to systematically overestimate the prevalence of that state, which may accelerate the spread of social contagions. We develop a statistical model that quantifies this effect and validate it with measurements in synthetic and real-world networks. We show that the illusion is exacerbated in networks with a heterogeneous degree distribution and disassortative structure.	[Lerman, Kristina; Yan, Xiaoran; Wu, Xin-Zeng] USC Informat Sci Inst, Marina Del Rey, CA USA; [Wu, Xin-Zeng] Univ So Calif, Dept Phys & Astron, Los Angeles, CA USA; [Yan, Xiaoran] Indiana Univ, Network Sci Inst, Bloomington, IN USA	University of Southern California; University of Southern California; Indiana University System; Indiana University Bloomington	Lerman, K (corresponding author), USC Informat Sci Inst, Marina Del Rey, CA USA.	lerman@isi.edu	Lerman, Kristina/P-5138-2019; Lerman, Kristina/F-4198-2010	Lerman, Kristina/0000-0002-5071-0575	Air Force Office of Scientific Research [FA9550-10-1-0569]; National Science Foundation [CIF-1217605]; Defense Advanced Research Projects Agency [W911NF-12-1-0034]; AFOSR [FA9550-10-1-0569]; NSF [CIF-1217605]; DARPA [W911NF-12-1-0034]	Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); National Science Foundation(National Science Foundation (NSF)); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); AFOSR(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); NSF(National Science Foundation (NSF)); DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA))	This work was supported in part by Air Force Office of Scientific Research (contract FA9550-10-1-0569), by the National Science Foundation (grant CIF-1217605) and by Defense Advanced Research Projects Agency (contract W911NF-12-1-0034). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Authors are grateful to Nathan Hodas and Farshad Kooti for their inputs into this work. This work was supported in part by AFOSR (contract FA9550-10-1-0569), by NSF (grant CIF-1217605) and by DARPA (contract W911NF-12-1-0034).	Achlioptas D., 2005, P 37 ACM S THEOR COM; Adamic L. A., 2005, 3 INT WORKSH LINK DI, P36, DOI DOI 10.1145/1134271.1134277; BAER JS, 1991, J STUD ALCOHOL, V52, P580, DOI 10.15288/jsa.1991.52.580; Bearak JM, 2014, SOC FORCES, V93, P091, DOI [10.1093/sf/sou091, DOI 10.1093/SF/S0U091]; BENDER EA, 1978, J COMB THEORY A, V24, P296, DOI 10.1016/0097-3165(78)90059-6; Berkowitz A. D., 2005, CHANGING CULTURE COL, P193; Bettencourt LMA, 2006, PHYSICA A, V364, P513, DOI 10.1016/j.physa.2005.08.083; Centola D, 2005, AM J SOCIOL, V110, P1009, DOI 10.1086/427321; Centola D, 2007, PHYSICA A, V374, P449, DOI 10.1016/j.physa.2006.06.018; Centola D, 2015, P NATL ACAD SCI USA, V112, P1989, DOI 10.1073/pnas.1418838112; Centola D, 2010, SCIENCE, V329, P1194, DOI 10.1126/science.1185231; Christakis NA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012948; Cohen R, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.247901; Eom YH, 2014, SCI REP-UK, V4, DOI 10.1038/srep04603; Feld S. L., 1977, RES HIGH EDUC, V6, P215, DOI [DOI 10.1007/BF00991287, 10.1007/BF00991287]; FELD SL, 1991, AM J SOCIOL, V96, P1464, DOI 10.1086/229693; Galam S., 2013, GLOBAL ECON REV, V18, P2, DOI [DOI 10.1016/S2340-1540(13)70002-1, 10.1016/S2340-1540(13)70002-1]; Garcia-Herranz M, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0092413, 10.1371/journal.pone.0086067]; GRANOVETTER M, 1978, AM J SOCIOL, V83, P1420, DOI 10.1086/226707; Gupta S, 2015, 2015 IEEE C COMP VIS; Hodas NO., 2013, P 7 INT AAAI C WEBL, V13, P8; Hogg T, 2012, EPJ DATA SCI, V1, DOI 10.1140/epjds5; Jo HH, 2014, PHYS REV E, V90, DOI 10.1103/PhysRevE.90.022809; Joshi-Tope G, 2005, NUCLEIC ACIDS RES, V33, pD428, DOI 10.1093/nar/gki072; Kempe D., 2003, P 9 ACM SIGKDD INT C, V11, P105, DOI DOI 10.1145/956750.956769; Kitts JA, 2003, SOC PSYCHOL QUART, V66, P222, DOI 10.2307/1519823; Kooti F, 2014, P 8 INT AAAI C WEBL, P266; LATANE B, 1969, AM SCI, V57, P244; Leskovec J, 2007, ACM T WEB, V1, DOI 10.1145/1232722.1232727; Lloyd-Smith JO, 2005, NATURE, V438, P355, DOI 10.1038/nature04153; MARKS G, 1987, PSYCHOL BULL, V102, P72, DOI 10.1037/0033-2909.102.1.72; McPherson M, 2001, ANNU REV SOCIOL, V27, P415, DOI 10.1146/annurev.soc.27.1.415; MILLER DT, 1994, PERS SOC PSYCHOL B, V20, P541, DOI 10.1177/0146167294205011; MOLLOY M, 1995, RANDOM STRUCT ALGOR, V6, P161, DOI 10.1002/rsa.3240060204; Newman MEJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.208701; PRENTICE DA, 1993, J PERS SOC PSYCHOL, V64, P243, DOI 10.1037/0022-3514.64.2.243; Rogers E.M., 2003, DIFFUSION INNOVATION, V5th ed; Salganik MJ, 2011, SOC NETWORKS, V33, P70, DOI 10.1016/j.socnet.2010.10.006; Salganik MJ, 2006, SCIENCE, V311, P854, DOI 10.1126/science.1121066; SCHELLING TC, 1973, J CONFLICT RESOLUT, V17, P381, DOI 10.1177/002200277301700302; Smith LM, 2013, ASE IEEE INT C SOC C; TVERSKY A, 1973, COGNITIVE PSYCHOL, V5, P207, DOI 10.1016/0010-0285(73)90033-9; Valente TW, 1995, QUANTITATIVE METHODS; Watts DJ, 2002, P NATL ACAD SCI USA, V99, P5766, DOI 10.1073/pnas.082090499; Young HP, 2011, P NATL ACAD SCI USA, V108, P21285, DOI 10.1073/pnas.1100973108	47	84	84	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0147617	10.1371/journal.pone.0147617	http://dx.doi.org/10.1371/journal.pone.0147617			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF3BJ	26886112	Green Published, Green Submitted, gold			2022-12-26	WOS:000371218400007
J	Winther, M; Knudsen, S; Dahlgaard, J; Jensen, T; Hansen, A; Jensen, PB; Tramm, T; Alsner, J; Nordsmark, M				Winther, Mette; Knudsen, Steen; Dahlgaard, Jesper; Jensen, Thomas; Hansen, Anker; Jensen, Peter Buhl; Tramm, Trine; Alsner, Jan; Nordsmark, Marianne			Clinical Impact of a Novel MicroRNA Chemo-Sensitivity Predictor in Gastrooesophageal Cancer	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; ESOPHAGEAL; CHEMOTHERAPY; RESISTANCE; THERAPY	Background miRNAs might be potentially useful biomarkers for prediction of response to chemotherapeutic agents, radiotherapy and survival. The aim of this retrospective study was to validate miRNA response predictors in a cohort of patients with gastrooesophageal cancer in order to predict overall survival (OS) and disease-specific survival (DSS). Material and Methods The study population encompassed 53 patients treated with curative intend for loco-regional gastrooesophageal cancer. miRNA expression was quantified from pre-therapeutic and diagnostic, formalin-fixed, paraffin embedded tumour specimens using Affymetrix GeneChip miRNA 1.0 Array. Based on growth inhibition of the NCI60 panel in the presence of cisplatin, epirubicine and capecitabine, a miRNA based response predictor was developed. The Cox proportional hazards model was applied to assess the correlations of the response predictor with OS and DSS. Results A univariate analysis demonstrated a statistical significant improvement of OS for patients who had undergone surgical resection with prediction scores above the median prediction score (HR: 0.41 (95% CI: 0.17-0.96). Adjusting for surgery and stage, this predictor was identified to be independently associated with both OS (HR: 0.37 (95% CI: 0.16-0.87)) and DSS (HR: 0.32 (0.12-0.87)). Conclusion The miRNA profile predictive for sensitivity to cisplatin, epirubicine and capecitabine was shown to be independently associated with OS and DSS in patients with gastrooesophageal cancer.	[Winther, Mette; Alsner, Jan] Aarhus Univ Hosp, Dept Expt Clin Oncol, DK-8000 Aarhus, Denmark; [Knudsen, Steen; Jensen, Thomas; Hansen, Anker; Jensen, Peter Buhl] Med Prognosis Inst, Horsholm, Denmark; [Dahlgaard, Jesper] VIA Univ Coll, Ctr Hlth Promot & Rehabil, Fac Hlth Sci, Aarhus, Denmark; [Tramm, Trine] Aarhus Univ Hosp, Dept Pathol, DK-8000 Aarhus, Denmark; [Nordsmark, Marianne] Aarhus Univ Hosp, Dept Oncol, DK-8000 Aarhus, Denmark	Aarhus University; Aarhus University; Aarhus University; Aarhus University	Winther, M (corresponding author), Aarhus Univ Hosp, Dept Expt Clin Oncol, DK-8000 Aarhus, Denmark.	mette@oncology.dk		Alsner, Jan/0000-0002-5395-3193; Dahlgaard, Jesper/0000-0002-1798-6799; Tramm, Trine/0000-0003-3894-4552	Danish Cancer Society; CIRRO - The Lundbeck Foundation Center for Interventional Research in Radiation Oncology; Danish Council for Strategic Research; Karen A. Tolstrups Fond; A. P. Moeller Foundation for the Advancement of Medical Science; Dansk Kraeftforsknings Fond	Danish Cancer Society(Danish Cancer Society); CIRRO - The Lundbeck Foundation Center for Interventional Research in Radiation Oncology; Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF)); Karen A. Tolstrups Fond; A. P. Moeller Foundation for the Advancement of Medical Science; Dansk Kraeftforsknings Fond	The study was financially supported by The Danish Cancer Society, CIRRO - The Lundbeck Foundation Center for Interventional Research in Radiation Oncology and The Danish Council for Strategic Research, Karen A. Tolstrups Fond, The A. P. Moeller Foundation for the Advancement of Medical Science and Dansk Kraeftforsknings Fond.	Broxterman HJ, 2009, DRUG RESIST UPDATE, V12, P114, DOI 10.1016/j.drup.2009.07.001; Chan E, 2011, TRENDS MOL MED, V17, P235, DOI 10.1016/j.molmed.2011.01.008; Chang L, 2014, PATHOL ONCOL RES, V20, P93, DOI 10.1007/s12253-013-9664-7; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Hamano R, 2011, CLIN CANCER RES, V17, P3029, DOI 10.1158/1078-0432.CCR-10-2532; Hartgrink HH, 2009, LANCET, V374, P477, DOI 10.1016/S0140-6736(09)60617-6; Imanaka Y, 2011, J HUM GENET, V56, P270, DOI 10.1038/jhg.2011.1; Kent OA, 2006, ONCOGENE, V25, P6188, DOI 10.1038/sj.onc.1209913; Knudsen S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115538; Kong YW, 2012, LANCET ONCOL, V13, pE249, DOI 10.1016/S1470-2045(12)70073-6; Pennathur A, 2013, LANCET, V381, P400, DOI 10.1016/S0140-6736(12)60643-6; Sarkar FH, 2010, DRUG RESIST UPDATE, V13, P57, DOI 10.1016/j.drup.2010.02.001; Skinner HD, 2014, CANCER-AM CANCER SOC, V120, P3635, DOI 10.1002/cncr.28911; Sugimura K, 2012, CLIN CANCER RES, V18, P5144, DOI 10.1158/1078-0432.CCR-12-0701; Tanaka K, 2013, ANN SURG ONCOL, V20, pS607, DOI 10.1245/s10434-013-3093-4; Tang HL, 2013, CLIN CANCER RES, V19, P5602, DOI 10.1158/1078-0432.CCR-13-1326	16	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0148070	10.1371/journal.pone.0148070	http://dx.doi.org/10.1371/journal.pone.0148070			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26885979	Green Published, Green Submitted, gold			2022-12-26	WOS:000371218400017
J	Zindel, S; Ehret, V; Ehret, M; Hentschel, M; Witt, S; Kramer, A; Fiebig, D; Juttner, N; Frols, S; Pfeifer, F; Fuchsbauer, HL				Zindel, Stephan; Ehret, Vera; Ehret, Marina; Hentschel, Madeleine; Witt, Samantha; Kraemer, Andreas; Fiebig, David; Juettner, Norbert; Froels, Sabrina; Pfeifer, Felicitas; Fuchsbauer, Hans-Lothar			Involvement of a Novel Class C Beta-Lactamase in the Transglutaminase Mediated Cross-Linking Cascade of Streptomyces mobaraensis DSM 40847	PLOS ONE			English	Article							PENICILLIN-BINDING PROTEINS; STREPTOVERTICILLIUM-MOBARAENSE; CYSTEINE PROTEASES; KINETIC-PARAMETERS; SUBSTRATE; PURIFICATION; INHIBITOR; METALLOPROTEASE; COELICOLOR	Streptomyces mobaraensis DSM 40847 secretes transglutaminase that cross-links proteins via gamma-glutamyl-epsilon-lysine isopeptide bonds. Characterized substrates are inhibitory proteins acting against various serine, cysteine and metalloproteases. In the present study, the bacterial secretome was examined to uncover additional transglutaminase substrates. Fractional ethanol precipitation of the exported proteins at various times of culture growth, electrophoresis of the precipitated proteins, and sequencing of a 39 kDa protein by mass spectrometry revealed the novel beta-lactamase Sml-1. As indicated by biotinylated probes, Sml-1, produced in E. coli, exhibits glutamine and lysine residues accessible for transglutaminase. The chromogenic cephalosporin analogue, nitrocefin, was hydrolyzed by Sml-1 with low velocity. The obtained K-m and k(cat) values of the recombinant enzyme were 94.3 +/- 1.8 mu M and 0.39 +/- 0.03 s(-1), respectively. Penicillin G and ampicillin proved to be weak inhibitors of nitrocefin hydrolysis (K-i of 0.1 mM and 0.18 mM). Negligible influence of metals on beta-lactamase activity ruled out that Sml-1 is a Zn2+-dependent class B beta-lactamase. Rather, sequence motifs such as SITK, YSN, and HDG forming the active core in a hypothetical structure may be typical for class C beta-lactamases. Based on the results, we assume that the novel transglutaminase substrate ensures undisturbed growth of aerial hyphae in Streptomyces mobaraensis by trapping and inactivating hostile beta-lactam antibiotics.	[Zindel, Stephan; Ehret, Vera; Ehret, Marina; Hentschel, Madeleine; Witt, Samantha; Kraemer, Andreas; Fiebig, David; Juettner, Norbert; Fuchsbauer, Hans-Lothar] Univ Appl Sci Darmstadt, Dept Chem Engn & Biotechnol, Darmstadt, Germany; [Froels, Sabrina; Pfeifer, Felicitas] Tech Univ Darmstadt, Dept Biol, Darmstadt, Germany	Hochschule Darmstadt; Technical University of Darmstadt	Fuchsbauer, HL (corresponding author), Univ Appl Sci Darmstadt, Dept Chem Engn & Biotechnol, Darmstadt, Germany.	hans-lothar.fuchsbauer@h-da.de		Kramer, Andreas/0000-0003-3294-2660; Fuchsbauer, Hans-Lothar/0000-0003-4954-5741; Pfeifer, Felicitas/0000-0003-1631-1543				ANDO H, 1989, AGR BIOL CHEM TOKYO, V53, P2613, DOI 10.1080/00021369.1989.10869735; Chater KF, 2011, STREPTOMYCES: MOLECULAR BIOLOGY AND BIOTECHNOLOGY, P43; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Claessen D, 2004, MOL MICROBIOL, V53, P433, DOI 10.1111/j.1365-2958.2004.04143.x; Claessen D, 2003, GENE DEV, V17, P1714, DOI 10.1101/gad.264303; DEMEESTER F, 1987, BIOCHEM J, V244, P427, DOI 10.1042/bj2440427; FELICI A, 1993, BIOCHEM J, V291, P151, DOI 10.1042/bj2910151; Folk J E, 1977, Adv Protein Chem, V31, P1, DOI 10.1016/S0065-3233(08)60217-X; GALLENI M, 1988, BIOCHEM J, V255, P123, DOI 10.1042/bj2550123; GERBER U, 1994, BIOCHEM J, V299, P825, DOI 10.1042/bj2990825; GHUYSEN JM, 1991, ANNU REV MICROBIOL, V45, P37, DOI 10.1146/annurev.mi.45.100191.000345; Goffin C, 1998, MICROBIOL MOL BIOL R, V62, P1079, DOI 10.1128/MMBR.62.4.1079-1093.1998; Jacoby GA, 2009, CLIN MICROBIOL REV, V22, P161, DOI 10.1128/CMR.00036-08; Kashiwagi T, 2002, J BIOL CHEM, V277, P44252, DOI 10.1074/jbc.M203933200; Kodani S, 2004, P NATL ACAD SCI USA, V101, P11448, DOI 10.1073/pnas.0404220101; Lenzini M V, 1985, J Enzyme Inhib, V1, P25, DOI 10.3109/14756368509031279; Mehta K, 2005, PROGR EXPT TUMOR RES, P38; OCALLAGHAN CH, 1972, ANTIMICROB AGENTS CH, V1, P283, DOI 10.1128/AAC.1.4.283; Ogawara H, 2015, J ANTIBIOT, V68, P223, DOI 10.1038/ja.2014.148; Pasternack R, 1998, EUR J BIOCHEM, V257, P570, DOI 10.1046/j.1432-1327.1998.2570570.x; Pratt RF, 2008, CELL MOL LIFE SCI, V65, P2138, DOI 10.1007/s00018-008-7591-7; Ruzin A, 2002, J BACTERIOL, V184, P2141, DOI 10.1128/JB.184.8.2141-2147.2002; Sarafeddinov A, 2011, J MICROBIOL BIOTECHN, V21, P617, DOI 10.4014/jmb.1012.12004; Sarafeddinov A, 2009, BIOSCI BIOTECH BIOCH, V73, P993, DOI 10.1271/bbb.80769; Sauvage E, 2008, FEMS MICROBIOL REV, V32, P234, DOI 10.1111/j.1574-6976.2008.00105.x; Schmidt S, 2008, FEBS LETT, V582, P3132, DOI 10.1016/j.febslet.2008.07.049; Wilkinson AS, 2003, BIOCHEMISTRY-US, V42, P1950, DOI 10.1021/bi0266941; Zindel S, 2013, ANTIMICROB AGENTS CH, V57, P3388, DOI 10.1128/AAC.00129-13; Zotzel J, 2003, EUR J BIOCHEM, V270, P4149, DOI 10.1046/j.1432-1033.2003.03809.x; Zotzel J, 2003, EUR J BIOCHEM, V270, P3214, DOI 10.1046/j.1432-1033.2003.03703.x	30	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0149145	10.1371/journal.pone.0149145	http://dx.doi.org/10.1371/journal.pone.0149145			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26886195	Green Submitted, gold, Green Published			2022-12-26	WOS:000371218400063
J	Cope, RC; Ross, JV; Wittmann, TA; Prowse, TAA; Cassey, P				Cope, Robert C.; Ross, Joshua V.; Wittmann, Talia A.; Prowse, Thomas A. A.; Cassey, Phillip			Integrative Analysis of the Physical Transport Network into Australia	PLOS ONE			English	Article							BIOLOGICAL INVASIONS; INSECT INVASIONS; EXOTIC BARK; TRADE; RISK; GLOBALIZATION; ESTABLISHMENT; COLEOPTERA; DISPERSAL; FRAMEWORK	Effective biosecurity is necessary to protect nations and their citizens from a variety of threats, including emerging infectious diseases, agricultural or environmental pests and pathogens, and illegal wildlife trade. The physical pathways by which these threats are transported internationally, predominantly shipping and air traffic, have undergone significant growth and changes in spatial distributions in recent decades. An understanding of the specific pathways and donor-traffic hotspots created by this integrated physical transport network is vital for the development of effective biosecurity strategies into the future. In this study, we analysed the physical transport network into Australia over the period 1999-2012. Seaborne and air traffic were weighted to calculate a "weighted cumulative impact" score for each source region worldwide, each year. High risk source regions, and those source regions that underwent substantial changes in risk over the study period, were determined. An overall risk ranking was calculated by integrating across all possible weighting combinations. The source regions having greatest overall physical connectedness with Australia were Singapore, which is a global transport hub, and the North Island of New Zealand, a close regional trading partner with Australia. Both those regions with large amounts of traffic across multiple vectors (e.g., Hong Kong), and those with high levels of traffic of only one type (e.g., Bali, Indonesia with respect to passenger flights), were represented among high risk source regions. These data provide a baseline model for the transport of individuals and commodities against which the effectiveness of biosecurity controls may be assessed, and are a valuable tool in the development of future biosecurity policy.	[Cope, Robert C.; Ross, Joshua V.] Univ Adelaide, Sch Math Sci, Adelaide, SA 5005, Australia; [Wittmann, Talia A.; Prowse, Thomas A. A.; Cassey, Phillip] Univ Adelaide, Benham Labs, Sch Biol Sci, Adelaide, SA 5005, Australia	University of Adelaide; University of Adelaide	Cope, RC (corresponding author), Univ Adelaide, Sch Math Sci, Adelaide, SA 5005, Australia.	robert.cope@adelaide.edu.au		Ross, Joshua/0000-0002-9918-8167; Cope, Robert/0000-0002-2048-858X; Prowse, Thomas/0000-0002-4093-767X; Cassey, Phillip/0000-0002-2626-0172	Australian Research Council Discovery Grant [DP140102319, FT0991420, FT130100254]	Australian Research Council Discovery Grant(Australian Research Council)	This study was supported by an Australian Research Council Discovery Grant (DP140102319) to PC and JVR, and Future Fellowships to PC (FT0991420) and JVR (FT130100254). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alacs E, 2008, AUST J FORENSIC SCI, V40, P147, DOI 10.1080/00450610802491382; [Anonymous], 2014, R LANG ENV STAT COMP; Banks NC, 2015, ECOL LETT, V18, P188, DOI 10.1111/ele.12397; Beale R., 2008, ONE BIOSECURITY WORK; Berdal Mats R., 2002, TRANSNATIONAL ORG CR; Blackburn TM, 2011, TRENDS ECOL EVOL, V26, P333, DOI 10.1016/j.tree.2011.03.023; Blackburn TM, 2015, J ORNITHOL, P1; Brockerhoff EG, 2006, CAN J FOREST RES, V36, P263, DOI 10.1139/x06-013; Brockerhoff EG, 2006, CAN J FOREST RES, V36, P289, DOI [10.1139/x05-250, 10.1139/X05-250]; Bureau of Infrastructure Transport and Regional Economics, 2014, INT AIRL ACT TIME SE; Coker RJ, 2011, LANCET, V377, P599, DOI 10.1016/S0140-6736(10)62004-1; Cope RC, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.150039; Department of Agriculture Fisheries and Forestry Biosecurity, 2012, REP REV IMP IN PRESS; Garcia-Diaz P, 2015, GLOBAL CHANGE BIOL, V21, P1078, DOI 10.1111/gcb.12790; Haack RA, 2006, CAN J FOREST RES, V36, P269, DOI 10.1139/x05-249; Henderson W, 2011, WILDLIFE RES, V38, P501, DOI 10.1071/WR11089; Heymann David, 2003, J HUMAN DEV, V4, P191, DOI DOI 10.1080/1464988032000087541; Hulme PE, 2008, J APPL ECOL, V45, P403, DOI 10.1111/j.1365-2664.2007.01442.x; Hulme PE, 2015, J APPL ECOL, V52, P1418, DOI 10.1111/1365-2664.12470; Hulme PE, 2009, J APPL ECOL, V46, P10, DOI 10.1111/j.1365-2664.2008.01600.x; International Maritime Organization, 2012, INT SHIPP FACTS FIG; Kaluza P, 2010, J R SOC INTERFACE, V7, P1093, DOI 10.1098/rsif.2009.0495; Kenis M, 2007, B ENTOMOL RES, V97, P489, DOI 10.1017/S0007485307005184; Lakoff Andrew, 2008, BIOSECURITY INTERVEN; Liebhold Andrew M., 2006, American Entomologist, V52, P48; Maritime & Port Authority of Singapore, 2014, ANN REPORT; Meyerson LA, 2003, FRONT ECOL ENVIRON, V1, P307, DOI 10.2307/3868091; Meyerson LA, 2002, BIOSCIENCE, V52, P593, DOI 10.1641/0006-3568(2002)052[0593:BMTACA]2.0.CO;2; Meyerson LA, 2007, FRONT ECOL ENVIRON, V5, P199, DOI 10.1890/1540-9295(2007)5[199:IASIAE]2.0.CO;2; Puth LM, 2005, ECOL LETT, V8, P715, DOI 10.1111/j.1461-0248.2005.00774.x; Pysek P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024890; Richardson DM, 2013, DIVERS DISTRIB, V19, P1461, DOI 10.1111/ddi.12150; RStudio and Inc, 2014, SHIN WEB APPL FRAM R; Ruiz GM, 1997, AM ZOOL, V37, P621; Seebens H, 2013, ECOL LETT, V16, P782, DOI 10.1111/ele.12111; Simberloff D, 2013, TRENDS ECOL EVOL, V28, P58, DOI 10.1016/j.tree.2012.07.013; Tatem AJ, 2006, ADV PARASIT, V62, P293, DOI 10.1016/S0065-308X(05)62009-X; Tatem AJ, 2006, P NATL ACAD SCI USA, V103, P6242, DOI 10.1073/pnas.0508391103; Tatem AJ, 2009, ECOGRAPHY, V32, P94, DOI 10.1111/j.1600-0587.2008.05588.x; United Nations, 2013, REV MAR TRANSP; Upham P, 2003, J AIR TRANSP MANAG, V9, P145, DOI 10.1016/S0969-6997(02)00078-9; WILSON D, 2002, SURVEILLANCE SOC, V5, P124, DOI DOI 10.24908/SS.V5I2.3431	42	10	10	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0148831	10.1371/journal.pone.0148831	http://dx.doi.org/10.1371/journal.pone.0148831			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	26881782	Green Published, gold, Green Submitted			2022-12-26	WOS:000371219000027
J	Maidenbaum, S; Buchs, G; Abboud, S; Lavi-Rotbain, O; Amedi, A				Maidenbaum, Shachar; Buchs, Galit; Abboud, Sami; Lavi-Rotbain, Ori; Amedi, Amir			Perception of Graphical Virtual Environments by Blind Users via Sensory Substitution	PLOS ONE			English	Article							DEVICE; COLOR; PEOPLE; AREA	Graphical virtual environments are currently far from accessible to blind users as their content is mostly visual. This is especially unfortunate as these environments hold great potential for this population for purposes such as safe orientation, education, and entertainment. Previous tools have increased accessibility but there is still a long way to go. Visual-toaudio Sensory-Substitution-Devices (SSDs) can increase accessibility generically by sonifying on-screen content regardless of the specific environment and offer increased accessibility without the use of expensive dedicated peripherals like electrode/vibrator arrays. Using SSDs virtually utilizes similar skills as when using them in the real world, enabling both training on the device and training on environments virtually before real-world visits. This could enable more complex, standardized and autonomous SSD training and new insights into multisensory interaction and the visually-deprived brain. However, whether congenitally blind users, who have never experienced virtual environments, will be able to use this information for successful perception and interaction within them is currently unclear. We tested this using the EyeMusic SSD, which conveys whole-scene visual information, to perform virtual tasks otherwise impossible without vision. Congenitally blind users had to navigate virtual environments and find doors, differentiate between them based on their features (Experiment1:task1) and surroundings (Experiment1:task2) and walk through them; these tasks were accomplished with a 95% and 97% success rate, respectively. We further explored the reactions of congenitally blind users during their first interaction with a more complex virtual environment than in the previous tasks-walking down a virtual street, recognizing different features of houses and trees, navigating to cross-walks, etc. Users reacted enthusiastically and reported feeling immersed within the environment. They highlighted the potential usefulness of such environments for understanding what visual scenes are supposed to look like and their potential for complex training and suggested many future environments they wished to experience.	[Maidenbaum, Shachar; Buchs, Galit; Abboud, Sami; Lavi-Rotbain, Ori; Amedi, Amir] Hebrew Univ Jerusalem, Edmond & Lily Safra Ctr Brain Res, Jerusalem, Israel; [Maidenbaum, Shachar; Abboud, Sami; Amedi, Amir] Hebrew Univ Jerusalem, Inst Med Res Israel Canada, Dept Med Neurobiol, Fac Med, Jerusalem, Israel; [Buchs, Galit; Amedi, Amir] Hebrew Univ Jerusalem, Dept Cognit Sci, Fac Humanities, Jerusalem, Israel; [Amedi, Amir] Univ Paris 06, Sorbonne Univ, Inst Vis Paris, Paris, France	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem; UDICE-French Research Universities; Sorbonne Universite	Amedi, A (corresponding author), Hebrew Univ Jerusalem, Edmond & Lily Safra Ctr Brain Res, Jerusalem, Israel.; Amedi, A (corresponding author), Hebrew Univ Jerusalem, Inst Med Res Israel Canada, Dept Med Neurobiol, Fac Med, Jerusalem, Israel.; Amedi, A (corresponding author), Hebrew Univ Jerusalem, Dept Cognit Sci, Fac Humanities, Jerusalem, Israel.; Amedi, A (corresponding author), Univ Paris 06, Sorbonne Univ, Inst Vis Paris, Paris, France.	amir.amedi@ekmd.huji.ac.il	Maidenbaum, Shachar/K-4277-2019	Maidenbaum, Shachar/0000-0002-2078-3896; Amedi, Amir/0000-0001-5042-2533	European Research Council [310809]; Charitable Gatsby Foundation; James S. McDonnell Foundation Scholar Award [220020284]; Israel Science Foundation [ISF 1684/08]; The Edmond and Lily Safra Center for Brain Sciences (ELSC) Vision center	European Research Council(European Research Council (ERC)European Commission); Charitable Gatsby Foundation; James S. McDonnell Foundation Scholar Award; Israel Science Foundation(Israel Science Foundation); The Edmond and Lily Safra Center for Brain Sciences (ELSC) Vision center	This work was supported by a European Research Council grant (grant number 310809); The Charitable Gatsby Foundation; The James S. McDonnell Foundation Scholar Award (grant number 220020284); The Israel Science Foundation (grant number ISF 1684/08); The Edmond and Lily Safra Center for Brain Sciences (ELSC) Vision center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r The Authors wish to thank Michal Rabinovits for her help in running the experiment. This work was supported by a European Research Council grant (grant number 310809); The Charitable Gatsby Foundation; The James S. McDonnell Foundation Scholar Award (grant number 220020284); The Israel Science Foundation (grant number ISF 1684/08); The Edmond and Lily Safra Center for Brain Sciences (ELSC) Vision center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abboud S., 2014, ISSUES, V12, P14; Abboud S, 2015, NATURE COMUNICATIONS; Alsberg BK, 2012, IS SENSING SPATIALLY; Bach-y-Rita P, 1972, BRAIN MECH SENSORY S, DOI 10.1068/p010491; Chebat DR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126307; Chebat DR, 2011, NEUROREPORT, V22, P342, DOI 10.1097/WNR.0b013e3283462def; Connors E., 2014, FRONTIERS HUMAN NEUR, V8; Deroy O, 2012, FRONTIERS PSYCHOL, V3; Elli GV, 2014, MULTISENS RES, V27, P271, DOI 10.1163/22134808-00002460; Feintuch U, 2006, 2006 INTERNATIONAL WORKSHOP ON VIRTUAL REHABILITATION, P78, DOI 10.1109/IWVR.2006.1707531; Giudice NA, 2010, ACM T APPL PERCEPT, V7, DOI 10.1145/1658349.1658352; Gomez JD, 2014, J ASSIST TECHNOL, V8, P77, DOI 10.1108/JAT-08-2013-0025; Haigh A, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00330; Hamilton-Fletcher G, 2013, MULTISENS RES, V26, P503, DOI 10.1163/22134808-00002434; Hanneton S, 2010, APPL BIONICS BIOMECH, V7, P269, DOI 10.1080/11762322.2010.512734; Hertz U, 2014, CEREB CORTEX; Kaspar K, 2014, CONSCIOUS COGN, V28, P47, DOI 10.1016/j.concog.2014.06.006; Kupers R, 2010, P NATL ACAD SCI USA, V107, P12716, DOI 10.1073/pnas.1006199107; Lahav O, 2012, ICDVRAT 2012; Lahav O., 2011, IEEE VIRTUAL REHABIL, P1; Lazar J, 2007, INT J HUM-COMPUT INT, V22, P247, DOI 10.1080/10447310709336964; Lenay C., 2003, TOUCHING KNOWING COG, P275, DOI [10.1075/aicr.53.22len, DOI 10.1075/AICR.53.22LEN]; Levy-Tzedek S, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00358; Levy-Tzedek S, 2012, SCI REP-UK, V2, DOI 10.1038/srep00949; Loomis JM, 2012, SENSORY SUBSTITUTION; Maidenbaum S., 2012, P 9 INT C DIS VIRT R, P471; Maidenbaum S, 2014, VISION DEPRIVED VIRT, P1231; Maidenbaum S, 2014, VISION OTHER SENSES; Maidenbaum S, 2014, RESTOR NEUROL NEUROS, V32, P813, DOI 10.3233/RNN-130351; Maidenbaum S, 2014, NEUROSCI BIOBEHAV R, V41, P3, DOI 10.1016/j.neubiorev.2013.11.007; Maidenbaum S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072555; Manduchi R, 2011, AER J RES PRACTICE V; MEIJER PBL, 1992, IEEE T BIO-MED ENG, V39, P112, DOI 10.1109/10.121642; Merabet LB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044958; Palani H., 2014, P 16 INT ACM SIGACCE, P293; Poppinga B., 2011, MOBILEHCI 2011, P545, DOI [10.1145/2037373.2037458, DOI 10.1145/2037373.2037458]; Proulx MJ, 2014, NEUROSCI BIOBEHAV R, V41, P16, DOI 10.1016/j.neubiorev.2012.11.017; Reardon S, 2011, SCIENCE, V333, P1816, DOI 10.1126/science.333.6051.1816; Reynolds Z., 2009, P AP CAP OCT, P131; Reynolds Z., 2012, PHILOS STUDY, V2, P432, DOI [10.17265/2159-5313, DOI 10.17265/2159-5313]; Smith K, 2012, UNIVERSAL ACCESS INF, V11, P387, DOI 10.1007/s10209-011-0254-8; Stiles NRB, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00842; Striem-Amit E, 2014, CURR BIOL, V24, P687, DOI 10.1016/j.cub.2014.02.010; Striem-Amit E, 2012, NEURON, V76, P640, DOI 10.1016/j.neuron.2012.08.026; Su J, 2010, INT CONF COMPUT AUTO, P177, DOI 10.1109/ICCAE.2010.5452046; Ward J, 2010, CONSCIOUS COGN, V19, P492, DOI 10.1016/j.concog.2009.10.006; Westin T, 2011, LECT NOTES COMPUT SC, V6766, P400, DOI 10.1007/978-3-642-21663-3_43; White G. R., 2008, P 3 INT C DIG INT ME, P134, DOI DOI 10.1145/1413634.1413663; WHO WhO, 2014, VIS IMP BLINDN KEY F; Wright TD, 2015, EXP BRAIN RES, V233, P851, DOI 10.1007/s00221-014-4160-1; Yip AW, 2002, PERCEPTION, V31, P995, DOI 10.1068/p3376	51	20	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0147501	10.1371/journal.pone.0147501	http://dx.doi.org/10.1371/journal.pone.0147501			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	26882473	Green Published, gold, Green Submitted			2022-12-26	WOS:000371219000004
J	Zheng, FH; Jang, WC; Fung, FKC; Lo, ACY; Wong, IYH				Zheng, Feihui; Jang, Wai-Chi; Fung, Frederic K. C.; Lo, Amy C. Y.; Wong, Ian Y. H.			Up-Regulation of ENO1 by HIF-1 alpha in Retinal Pigment Epithelial Cells after Hypoxic Challenge Is Not Involved in the Regulation of VEGF Secretion	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; INDUCIBLE FACTOR-1; ALPHA-ENOLASE; CHOROIDAL NEOVASCULARIZATION; LACTATE-DEHYDROGENASE; PROTEIN EXPRESSION; OXIDATIVE STRESS; GENE; MECHANISMS; IDENTIFICATION	Purpose Alpha-enolase (ENO1), a major glycolytic enzyme, is reported to be over-expressed in various cancer tissues. It has been demonstrated to be regulated by the Hypoxia-inducible factor 1-alpha (HIF-1 alpha), a crucial transcriptional factor implicated in tumor progression and cancer angiogenesis. Choroidal neovascularization (CNV), which is a leading cause of severe vision loss caused by newly formed blood vessels in the choroid, is also engendered by hypoxic stress. In this report, we investigated the expression of ENO1 and the effects of its down-regulation upon cobalt (II) chloride-induced hypoxia in retinal pigment epithelial cells, identified as the primary source of ocular angiogenic factors. Methods HIF-1 alpha-diminished retinal pigment epithelial cells were generated by small interfering RNA (siRNA) technology in ARPE-19 cells, a human retinal pigment epithelial cell line. Both normal and HIF-1 alpha-diminished ARPE-19 cells were then subjected to hypoxic challenge using cobalt (II) chloride (CoCl2) or anaerobic chamber. The relation between ENO1 expression and vascular endothelial growth factor (VEGF) secretion by retinal pigment epithelial cells were examined. Protein levels of HIF-1 alpha and ENO1 were analyzed using Western Blot, while VEGF secretion was essayed by enzyme-linked immunosorbent assay (ELISA). Cytotoxicity after hypoxia was detected by Lactate Dehydrogenase (LDH) Assay. Results Upon 24 hr of CoCl2-induced hypoxia, the expression levels of ENO1 and VEGF were increased along with HIF-1 alpha in ARPE-19 cells, both of which can in turn be down-regulated by HIF-1 alpha siRNA application. However, knockdown of ENO1 alone or together with HIF-1 alpha did not help suppress VEGF secretion in hypoxic ARPE-19 cells. Conclusion ENO1 was demonstrated to be up-regulated by HIF-1 alpha in retinal pigment epithelial cells in response to hypoxia, without influencing VEGF secretion.	[Zheng, Feihui; Jang, Wai-Chi; Fung, Frederic K. C.; Lo, Amy C. Y.; Wong, Ian Y. H.] Univ Hong Kong, Li Ka Shing Fac Med, Dept Ophthalmol, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong	Lo, ACY; Wong, IYH (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Dept Ophthalmol, Hong Kong, Hong Kong, Peoples R China.	amylo@hku.hk; wongyhi@hku.hk	CHENG, FREYA/GOH-0443-2022; Lo, Amy C. Y./C-1195-2009	CHENG, FREYA/0000-0001-9179-3461; Lo, Amy C. Y./0000-0003-4239-6851				AARONSON RM, 1995, J BIOL CHEM, V270, P27752, DOI 10.1074/jbc.270.46.27752; Adamus G, 1996, CLIN IMMUNOL IMMUNOP, V78, P120, DOI 10.1006/clin.1996.0021; Arjamaa O, 2006, EXP EYE RES, V83, P473, DOI 10.1016/j.exer.2006.01.016; Armstrong RA, 2014, OPHTHAL PHYSL OPT, V34, P502, DOI 10.1111/opo.12131; Baby SM, 2003, HISTOCHEM CELL BIOL, V120, P343, DOI 10.1007/s00418-003-0588-2; CHUNG EH, 1995, INVEST OPHTH VIS SCI, V36, P1336; DAMORE PA, 1994, INVEST OPHTH VIS SCI, V35, P3974; Dong A, 2009, J CELL PHYSIOL, V219, P544, DOI 10.1002/jcp.21698; Finnegan S, 2008, PROTEOME SCI, V6, DOI 10.1186/1477-5956-6-34; Forooghian F, 2007, BRIT J OPHTHALMOL, V91, DOI 10.1136/bjo.2007.123125; Gao J, 2013, ONCOL REP, V29, P1322, DOI 10.3892/or.2013.2269; GIALLONGO A, 1990, EUR J BIOCHEM, V190, P567, DOI 10.1111/j.1432-1033.1990.tb15611.x; Jang W-c, 2009, THESIS U HONG KONG H; Jester JV, 2005, INVEST OPHTH VIS SCI, V46, P2369, DOI 10.1167/iovs.04-1225; Jiang BH, 1997, CANCER RES, V57, P5328; Jiang BH, 1996, J BIOL CHEM, V271, P17771, DOI 10.1074/jbc.271.30.17771; Joachim SC, 2007, GRAEF ARCH CLIN EXP, V245, P619, DOI 10.1007/s00417-006-0429-9; Kapphahn RJ, 2006, EXP EYE RES, V83, P165, DOI 10.1016/j.exer.2005.11.017; KOH JY, 1987, J NEUROSCI METH, V20, P83, DOI 10.1016/0165-0270(87)90041-0; KRAFT HJ, 1994, EXP EYE RES, V58, P389, DOI 10.1006/exer.1994.1031; Lassen N, 2008, SEMIN CELL DEV BIOL, V19, P100, DOI 10.1016/j.semcdb.2007.10.004; Li H, 1996, J BIOL CHEM, V271, P21262, DOI 10.1074/jbc.271.35.21262; Lin MK, 2012, INVEST OPHTH VIS SCI, V53, P6197, DOI 10.1167/iovs.11-8936; Nielsen K, 2006, EXP EYE RES, V82, P201, DOI 10.1016/j.exer.2005.06.009; Pernemalm M, 2013, J PROTEOME RES, V12, P3934, DOI 10.1021/pr4002096; Piatigorsky Joram, 2003, Journal of Structural and Functional Genomics, V3, P131; Sang NL, 2002, MOL CELL BIOL, V22, P2984, DOI 10.1128/MCB.22.9.2984-2992.2002; Semenza GL, 1996, J BIOL CHEM, V271, P32529, DOI 10.1074/jbc.271.51.32529; Semenza GL, 2002, BIOCHEM PHARMACOL, V64, P993, DOI 10.1016/S0006-2952(02)01168-1; Sharma NK, 2013, J PROTEOMICS, V79, P277, DOI 10.1016/j.jprot.2012.12.020; Song Y, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-65; Spilsbury K, 2000, AM J PATHOL, V157, P135, DOI 10.1016/S0002-9440(10)64525-7; Srivastava OP, 2006, MOL VIS, V12, P1615; Trojanowicz B, 2009, J MOL ENDOCRINOL, V42, P249, DOI 10.1677/JME-08-0118; Wang-Su ST, 2003, INVEST OPHTH VIS SCI, V44, P4829, DOI 10.1167/iovs.03-0556; Weleber RG, 2005, AM J OPHTHALMOL, V139, P780, DOI 10.1016/j.ajo.2004.12.104; Wenger RH, 1997, KIDNEY INT, V51, P560, DOI 10.1038/ki.1997.79; Yeo EJ, 2003, J NATL CANCER I, V95, P516, DOI 10.1093/jnci/95.7.516	38	13	14	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0147961	10.1371/journal.pone.0147961	http://dx.doi.org/10.1371/journal.pone.0147961			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	26882120	Green Published, Green Submitted, gold			2022-12-26	WOS:000371219000011
J	Banhos, A; Hrbek, T; Sanaiotti, TM; Farias, IP				Banhos, Aureo; Hrbek, Tomas; Sanaiotti, Tania M.; Farias, Izeni Pires			Reduction of Genetic Diversity of the Harpy Eagle in Brazilian Tropical Forests	PLOS ONE			English	Article							ATLANTIC FOREST; MICROSATELLITE MARKERS; POPULATION-GENETICS; MUSEUM SPECIMENS; ESPIRITO-SANTO; MATO-GROSSO; CONSERVATION; AMAZON; PATTERNS; RECORDS	Habitat loss and fragmentation intensify the effects of genetic drift and endogamy, reducing genetic variability of populations with serious consequences for wildlife conservation. The Harpy Eagle (Harpia harpyja) is a forest dwelling species that is considered near threatened and suffers from habitat loss in the forests of the Neotropical region. In this study, 72 historical and current samples were assessed using eight autosomal microsatellite markers to investigate the distribution of genetic diversity of the Harpy Eagle of the Amazonian and Atlantic forests in Brazil. The results showed that the genetic diversity of Harpy Eagle decreased in the regions where deforestation is intense in the southern Amazon and Atlantic Forest.	[Banhos, Aureo] Univ Fed Espirito Santo, Ctr Ciencias Exatas Nat & Saude, Dept Biol, Alegre, ES, Brazil; [Hrbek, Tomas; Farias, Izeni Pires] Univ Fed Amazonas, Inst Ciencias Biol, Dept Genet, Lab Evolucao & Genet Anim, Manaus, Amazonas, Brazil; [Sanaiotti, Tania M.] Inst Nacl de Pesquisas da Amazonia, Coordenacao Biodiversidade, Manaus, Amazonas, Brazil; [Banhos, Aureo; Sanaiotti, Tania M.] Inst Nacl de Pesquisas da Amazonia, Programa Conservacao Gaviao Real, Manaus, Amazonas, Brazil	Universidade Federal do Espirito Santo; Universidade Federal de Amazonas; Institute Nacional de Pesquisas da Amazonia; Institute Nacional de Pesquisas da Amazonia	Banhos, A (corresponding author), Univ Fed Espirito Santo, Ctr Ciencias Exatas Nat & Saude, Dept Biol, Alegre, ES, Brazil.; Banhos, A (corresponding author), Inst Nacl de Pesquisas da Amazonia, Programa Conservacao Gaviao Real, Manaus, Amazonas, Brazil.	aureo.santos@ufes.br	Hrbek, Tomas/J-6988-2012; Farias, Izeni Pires/J-3069-2014	Hrbek, Tomas/0000-0003-3239-7068; Farias, Izeni Pires/0000-0002-1416-4351	National Counsel of Technological and Scientific Development (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao de Amparo a Pesquisa do Estado do Amazonas (FAPEAM); Fundacao de Amparo a Pesquisa do Espirito Santo (FAPES); Fundacao Grupo Boticario de Protecao a Natureza (FBPN); Scott Neotropical Fund	National Counsel of Technological and Scientific Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado do Amazonas (FAPEAM)(Fundacao de Amparo a Pesquisa do Estado do Amazonas (FAPEAM)); Fundacao de Amparo a Pesquisa do Espirito Santo (FAPES); Fundacao Grupo Boticario de Protecao a Natureza (FBPN); Scott Neotropical Fund	This work was supported by the National Counsel of Technological and Scientific Development (CNPq) - http://www.cnpq.br/; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) - http://www.capes.gov.br/; Fundacao de Amparo a Pesquisa do Estado do Amazonas (FAPEAM) - http://www.fapeam.am.gov.br/; Fundacao de Amparo a Pesquisa do Espirito Santo (FAPES) - http://www.fapes.es.gov.br/; Fundacao Grupo Boticario de Protecao a Natureza (FBPN) - http://www.fundacaogrupoboticario.org.br/; and the Scott Neotropical Fund - http://www.clevelandmetroparks.com/Zoo/Grants/Scott-Neotropical-Fund-1.aspx.	Ab'Saber A.N, 1977, GEOMORFOLOGIA, V52, P1, DOI DOI 10.3897/ZOOKEYS.150.2109; Aguiar-Silva FH, 2013, P 1 WORLDW RAPT C 20, P51; Aguiar-Silva FH, 2012, REV BRAS ORNITOL, V20, P148; Allendorf F., 2007, CONSERVATION GENETIC; Athrey G, 2011, CONSERV GENET, V12, P1345, DOI 10.1007/s10592-011-0235-8; Avise J, 2004, MOL MARKERS NATURAL; Banhos A, 2008, GENET MOL BIOL, V31, P146, DOI 10.1590/S1415-47572008000100025; Batalha H, 2013, J ORNITHOL, V154, P41, DOI 10.1007/s10336-012-0866-7; Bierregaard Richard O. Jr., 1995, Bird Conservation International, V5, P325; Bird JP, 2012, DIVERS DISTRIB, V18, P273, DOI 10.1111/j.1472-4642.2011.00843.x; Bourke BP, 2010, CONSERV GENET, V11, P1837, DOI 10.1007/s10592-010-0076-x; Busch JD, 2005, MOL ECOL NOTES, V5, P39, DOI 10.1111/j.1471-8286.2004.00823.x; Collar N.J., 1989, World Birdwatch, V11, P5; Coser R, 2014, CONSERV GENET RESOUR, V6, P999, DOI 10.1007/s12686-014-0268-7; Costa LP, 2003, J BIOGEOGR, V30, P71, DOI 10.1046/j.1365-2699.2003.00792.x; Costa MH, 2010, INT J CLIMATOL, V30, P1970, DOI 10.1002/joc.2048; DeLuca JJ, 2012, TROP CONSERV SCI, V5, P301, DOI 10.1177/194008291200500306; DiBattista JD, 2008, CONSERV GENET, V9, P141, DOI 10.1007/s10592-007-9317-z; DINERSTEIN E, 1990, CONSERV BIOL, V4, P417, DOI 10.1111/j.1523-1739.1990.tb00316.x; Eizirik E, 2001, MOL ECOL, V10, P65, DOI 10.1046/j.1365-294X.2001.01144.x; Evans SR, 2008, CONSERV BIOL, V22, P1016, DOI 10.1111/j.1523-1739.2008.00972.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Food and Agriculture Organization of the United Nations, 2015, PREPRINT; Frankham R, 2005, BIOL CONSERV, V126, P131, DOI 10.1016/j.biocon.2005.05.002; Frankham R., 2010, INTRO CONSERVATION G, DOI DOI 10.1017/CBO9780511809002; Freitas MA, 2014, ATUAL ORNITOL, V178, P12; Fundacao SOS Mata Atlantica Instituto Nacional de Pesquisas Espaciais, 2015, PREPRINT; Galetti Mauro, 1997, Bulletin of the British Ornithologists' Club, V117, P27; Garner A, 2005, CONSERV BIOL, V19, P1215, DOI 10.1111/j.1523-1739.2005.00105.x; Hailer F, 2005, MOL ECOL NOTES, V5, P938, DOI 10.1111/j.1471-8286.2005.01122.x; Hailer F, 2006, BIOL LETTERS, V2, P316, DOI 10.1098/rsbl.2006.0453; Harvey MG, 2015, MOL PHYLOGENET EVOL, V83, P305, DOI 10.1016/j.ympev.2014.10.023; Aguiar-Silva FH, 2014, J RAPTOR RES, V48, P24, DOI 10.3356/JRR-13-00017.1; Horvath MB, 2005, J AVIAN BIOL, V36, P84, DOI 10.1111/j.0908-8857.2005.03370.x; Instituto Nacional de Pesquisas Espaciais, 2014, PROJ PROD MON FLOR A; International Birdlife, 2015, SPEC FACTSH HARP HAR; Johnson JA, 2009, MOL ECOL, V18, P54, DOI [10.1111/j.1365-294X.2009.04240.x, 10.1111/j.1365-294X.2008.04012.x]; Johnson PCD, 2005, MOL ECOL NOTES, V5, P208, DOI 10.1111/j.1471-8286.2005.00878.x; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Kuniy AA, 2015, BRAZ J BIOL, V75, P1035, DOI 10.1590/1519-6984.24714; Laurance WF, 2001, SCIENCE, V291, P438, DOI 10.1126/science.291.5503.438; Leonard JA, 2008, MOL ECOL, V17, P4186, DOI 10.1111/j.1365-294X.2008.03891.x; Lerner HRL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007336; LINK C. A., 2005, MEGADIVERSIDADE, V1, P147, DOI DOI 10.1590/S0100-69912009000400001; Lopes Leonardo Esteves, 2009, Pap. Avulsos Zool. (São Paulo), V49, P9, DOI 10.1590/S0031-10492009000200001; Martinez-Cruz B, 2007, MOL ECOL, V16, P477, DOI 10.1111/j.1365-294X.2007.03147.x; Martinez-Cruz B, 2004, MOL ECOL, V13, P2243, DOI 10.1111/j.1365-294X.2004.02220.x; Martins Pereira Alexandre de Matos, 2006, Revista Brasileira de Ornitologia, V14, P157; Meirmans PG, 2011, MOL ECOL RESOUR, V11, P5, DOI 10.1111/j.1755-0998.2010.02927.x; Mira S, 2005, MOL ECOL NOTES, V5, P493, DOI 10.1111/j.1471-8286.2005.00967.x; Muniz-Lopez Ruth, 2008, Cotinga, V29, P42; Myers Norman, 2000, Nature (London), V403, P853, DOI 10.1038/35002501; NEI M, 1978, GENETICS, V89, P583; Nesje M, 2000, MOL ECOL, V9, P1438, DOI 10.1046/j.1365-294x.2000.00999-4.x; Oliveira AL, 2006, REV BRAS ORNITOL, V14, P433; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Pivatto M.A.C., 2006, ATUALIDADES ORNITOLO, V129, P1; Pritchard JK, 2000, GENETICS, V155, P945; Pritcharda JK, 2010, PREPRINT; Reed DH, 2003, CONSERV BIOL, V17, P230, DOI 10.1046/j.1523-1739.2003.01236.x; Ribeiro MC, 2009, BIOL CONSERV, V142, P1141, DOI 10.1016/j.biocon.2009.02.021; Rocha G.F., 2011, REV BRASILEIRA CARTO, V63, P341; ROY MS, 1994, EXPERIENTIA, V50, P551, DOI 10.1007/BF01921724; Sanaiotti TM, 2015, BRAZ J BIOL, V75, pS190, DOI [10.1590/1519-6984.00614BM, 10.1590/1519-6984.00614bm]; Sanchez-Lalinde C, 2011, REV BRAS ORNITOL, V19, P436; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Silva DA, 2013, REV BRAS ORNITOL, V21, P295; Silveira Luís Fábio, 2002, Pap. Avulsos Zool., V42, P265; Soares BS, 2006, NATURE, V440, P520, DOI 10.1038/nature04389; Sobral-Souza T, 2015, EVOL ECOL, V29, P643, DOI 10.1007/s10682-015-9780-9; Spielman D, 2004, P NATL ACAD SCI USA, V101, P15261, DOI 10.1073/pnas.0403809101; Srbek-Araujo AC, 2006, REV BRAS ZOOL, V23, P1264, DOI 10.1590/S0101-81752006000400040; SWART MKJ, 1994, J HERED, V85, P261, DOI 10.1093/oxfordjournals.jhered.a111453; Taberlet P, 1999, TRENDS ECOL EVOL, V14, P323, DOI 10.1016/S0169-5347(99)01637-7; Trinca Cristiano Trape, 2008, Cotinga, V30, P12; Ubaid FK, 2011, REV BRAS ORNITOL, V19, P88; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vargas JD, 2006, ORNITOL NEOTROP, V17, P39; Wandeler P, 2007, TRENDS ECOL EVOL, V22, P634, DOI 10.1016/j.tree.2007.08.017; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x	80	10	10	2	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0148902	10.1371/journal.pone.0148902	http://dx.doi.org/10.1371/journal.pone.0148902			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26871719	gold, Green Published, Green Submitted			2022-12-26	WOS:000370054100071
J	Barcelo, MA; Coll-Negre, M; Coll-de-Tuero, G; Saez, M				Barcelo, Maria A.; Coll-Negre, Montserrat; Coll-de-Tuero, Gabriel; Saez, Marc			Effects of the Financial Crisis on Psychotropic Drug Consumption in a Cohort from a Semi-Urban Region in Catalonia, Spain	PLOS ONE			English	Article							ECONOMIC RECESSION; MENTAL-DISORDERS; HEALTH; POPULATION; PRESCRIPTION; SUICIDE; UNEMPLOYMENT; DEPRESSION; AUSTERITY; ENGLAND	Purpose Evidence of whether the recent economic crisis has or has not had an effect on psychotropic drug consumption is very scarce. Our objective was to determine if there had in fact been an increase in psychotropic drug use as a result of the financial crisis. Methods In our study a retrospective cohort (between January 1, 2005, and December 31, 2012) was made up of individuals from the general population in a region in the northeast of Catalonia, Spain. We specified a generalized linear mixed model along with combined 'selection on observables' as (propensity scoring) matching and 'selection on unobservables' as (random coefficient) the panel data model methods, and performed inferences using a Bayesian framework. Results In the period following the economic crisis (post 2009), there was an increase in the consumption of psychotropic drugs which was significantly higher among those who had already been consuming psychotropic drugs prior to 2009 and those most likely to be unemployed. The increase was of greater significance when consumption was measured by the number of drugs being taken, rather than by the defined daily dose (DDD), with the greatest increase occurring in 2011; the very year in which Spain was most affected by the crisis. Conclusions Once the financial crisis had ended, there was an increase in the severity, rather than the intensity, of mental health disorders in individuals who had already had disorders before the crisis. This increase occurred in those most likely to be unemployed, and the severity was accentuated in the toughest year of the economic crisis.	[Barcelo, Maria A.; Saez, Marc] Univ Girona, Res Grp Stat Econometr & Hlth GRECS, Girona, Spain; [Barcelo, Maria A.; Coll-de-Tuero, Gabriel; Saez, Marc] CIBER Epidemiol & Publ Hlth CIBERESP, Madrid, Spain; [Coll-Negre, Montserrat] Cambian Churchill Hosp, Mental Hlth Serv, London, England; [Coll-de-Tuero, Gabriel] Univ Inst Res Primary Care Jordi Gol IdIAP Gol, Res Support Unit, Girona, Spain; [Coll-de-Tuero, Gabriel] Univ Girona, Dept Med Sci, Girona, Spain	Universitat de Girona; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Universitat de Girona	Saez, M (corresponding author), Univ Girona, Res Grp Stat Econometr & Hlth GRECS, Girona, Spain.; Saez, M (corresponding author), CIBER Epidemiol & Publ Hlth CIBERESP, Madrid, Spain.	marc.saez@udg.edu	Coll-de-Tuero, Gabriel/H-3475-2016; Barceló, Maria A/AAT-6212-2020	Coll-de-Tuero, Gabriel/0000-0001-7578-9569; Barceló, Maria A/0000-0001-9720-690X	'Crisis and Health', CIBER of Epidemiology and Public Health (CIBERESP), Spain [2014SGR551]; 'Compositional and Spatial Analysis' (COSDA), AGAUR, 'Generalitat de Catalunya' [2014SGR551]; Call of Singular Actions, University of Girona, Spain	'Crisis and Health', CIBER of Epidemiology and Public Health (CIBERESP), Spain; 'Compositional and Spatial Analysis' (COSDA), AGAUR, 'Generalitat de Catalunya'; Call of Singular Actions, University of Girona, Spain	This was developed within the scope of two projects: 'Crisis and Health', CIBER of Epidemiology and Public Health (CIBERESP), Spain, together with the 'Compositional and Spatial Analysis' (COSDA), AGAUR, 'Generalitat de Catalunya', 2014SGR551. It was partly supported by the 2012 Call of Singular Actions, University of Girona, Spain (http://www.udg.edu). The work did not obtain additional funding for its development.	Alameda-Palacios J, 2014, GAC SANIT, V28, P309, DOI 10.1016/j.gaceta.2013.12.005; Cordoba-Dona JA, 2014, INT J EQUITY HEALTH, V13, DOI 10.1186/1475-9276-13-55; Astell-Burt T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056674; Baumann A., 2010, MENTAL HLTH WELL BEI; Bernal JAL, 2013, EUR J PUBLIC HEALTH, V23, P732, DOI 10.1093/eurpub/ckt083; Bradford WD, 2014, HEALTH ECON, V23, P1301, DOI 10.1002/hec.2983; Chang SS, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5239; Chen J, 2014, J BEHAV HLT IN PRESS; Corcoran P, 2015, INT J EPIDEMIOL, V44, P969, DOI 10.1093/ije/dyv058; Craig P, 2012, J EPIDEMIOL COMMUN H, V66, P1182, DOI 10.1136/jech-2011-200375; Gili Margalida, 2014, Gac Sanit, V28 Suppl 1, P104, DOI 10.1016/j.gaceta.2014.02.005; Gili M, 2013, EUR J PUBLIC HEALTH, V23, P103, DOI 10.1093/eurpub/cks035; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Hafslund B, 2012, CANCER NURS, V35, pE26, DOI 10.1097/NCC.0b013e3182341ddb; Heckman JJ, 1997, REV ECON STUD, V64, P605, DOI 10.2307/2971733; HM Treasury, GLOSS TREAS TERMS; Ilyas S, 2012, BRIT J PSYCHIAT, V200, P393, DOI 10.1192/bjp.bp.111.104257; Jones A.M., 2009, 0909 HEDG U YORK; Karanikolos M, 2013, LANCET, V381, P1323, DOI 10.1016/S0140-6736(13)60102-6; McInerney M, 2013, J HEALTH ECON, V32, P1090, DOI 10.1016/j.jhealeco.2013.09.002; Mckenzie SK, 2014, J EPIDEMIOL COMMUN H, V68, P253, DOI 10.1136/jech-2013-203013; Morris S, 2005, SOC SCI MED, V60, P1251, DOI 10.1016/j.socscimed.2004.07.016; Nandi A, 2013, J EPIDEMIOL COMMUN H, V67, P1038, DOI 10.1136/jech-2012-202260; Ng CG, 2013, PSYCHO-ONCOLOGY, V22, P762, DOI 10.1002/pon.3056; Nuffield Trust, 2014, FOC ANT PRESCR; Olesen J, 2003, EUR J NEUROL, V10, P471, DOI 10.1046/j.1468-1331.2003.00682.x; Perez-Garcia F, 2015, PUBLIC SERVICES REGI; Pinheiro J, 2001, MIXED EFFECTS MODELS; Ponsa J. A., 2003, FULLS EC SISTEMA SAN, V37, P8; Punekar RS, 2012, PSYCHO-ONCOLOGY, V21, P1237, DOI 10.1002/pon.2039; R Core Team, 2021, R LANGUAGE ENV STAT; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Rue H, 2009, J R STAT SOC B, V71, P319, DOI 10.1111/j.1467-9868.2008.00700.x; Ruhm CJ, 2000, Q J ECON, V115, P617, DOI 10.1162/003355300554872; Ruhm CJ, 2003, J HEALTH ECON, V22, P637, DOI 10.1016/S0167-6296(03)00041-9; Sáez M., 2003, Gac Sanit, V17, P412; Sargent-Cox K, 2011, SOC SCI MED, V73, P1105, DOI 10.1016/j.socscimed.2011.06.063; Saurina C, 2015, INT J EQUIT IN PRESS; Saurina C, 2015, INT J EQUITY HEALTH, V14, DOI 10.1186/s12939-015-0192-9; Verdu ES, 2014, ATEN PRIM, V46, P416, DOI 10.1016/j.aprim.2013.11.006; Minana JS, 2012, ATEN PRIM, V44, P335, DOI 10.1016/j.aprim.2011.06.009; The R-INLA project, RAND WALK MOD ORD 1; Tresserras-Gaju Ricard, 2011, Med Clin (Barc), V137 Suppl 2, P16, DOI 10.1016/S0025-7753(11)70023-9; Urbanos-Garrido RM, 2015, EUR J HEALTH ECON, V16, P175, DOI 10.1007/s10198-014-0563-y; Uutela A, 2010, CURR OPIN PSYCHIATR, V23, P127, DOI 10.1097/YCO.0b013e328336657d; Sanchez MPV, 2013, REV ESP SALUD PUBLIC, V87, P247, DOI [10.4321/S1135-57272013000300004, 10.4321/s1135-57272013000300004]; Wang JL, 2010, CAN J PSYCHIAT, V55, P598, DOI 10.1177/070674371005500908; WHO Collaborating Center for Drug Statistics and Methodology, 2014, ATC DDD IND 2015; Wise J, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3607; Zivin K, 2011, PSYCHOL MED, V41, P1343, DOI 10.1017/S003329171000173X	51	16	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0148594	10.1371/journal.pone.0148594	http://dx.doi.org/10.1371/journal.pone.0148594			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DD6SI	26872210	gold, Green Published, Green Submitted			2022-12-26	WOS:000370054100038
J	Cameron, SJS; Lewis, KE; Huws, SA; Lin, WC; Hegarty, MJ; Lewis, PD; Mur, LAJ; Pachebat, JA				Cameron, Simon J. S.; Lewis, Keir E.; Huws, Sharon A.; Lin, Wanchang; Hegarty, Matthew J.; Lewis, Paul D.; Mur, Luis A. J.; Pachebat, Justin A.			Metagenomic Sequencing of the Chronic Obstructive Pulmonary Disease Upper Bronchial Tract Microbiome Reveals Functional Changes Associated with Disease Severity	PLOS ONE			English	Article							BACTERIAL-INFECTIONS; ACUTE EXACERBATION; CYSTIC-FIBROSIS; SIALIC ACIDS; COPD; PROGRESSION; PREVALENCE; BIOMARKERS; PROTEIN	Chronic Obstructive Pulmonary Disease (COPD) is a major source of mortality and morbidity worldwide. The microbiome associated with this disease may be an important component of the disease, though studies to date have been based on sequencing of the 16S rRNA gene, and have revealed unequivocal results. Here, we employed metagenomic sequencing of the upper bronchial tract (UBT) microbiome to allow for greater elucidation of its taxonomic composition, and revealing functional changes associated with the disease. The bacterial metagenomes within sputum samples from eight COPD patients and ten 'healthy' smokers (Controls) were sequenced, and suggested significant changes in the abundance of bacterial species, particularly within the Streptococcus genus. The functional capacity of the COPD UBT microbiome indicated an increased capacity for bacterial growth, which could be an important feature in bacterial-associated acute exacerbations. Regression analyses correlated COPD severity (FEV1% of predicted) with differences in the abundance of Streptococcus pneumoniae and functional classifications related to a reduced capacity for bacterial sialic acid metabolism. This study suggests that the COPD UBT microbiome could be used in patient risk stratification and in identifying novel monitoring and treatment methods, but study of a longitudinal cohort will be required to unequivocally relate these features of the microbiome with COPD severity.	[Cameron, Simon J. S.; Huws, Sharon A.; Lin, Wanchang; Hegarty, Matthew J.; Mur, Luis A. J.; Pachebat, Justin A.] Inst Biol Environm & Rural Sci, Edward Llywd Bldg,Penglais Campus, Aberystwyth SY23 3FG, Ceredigion, Wales; [Lewis, Keir E.] Hywel Dda Univ, Hlth Board, Prince Phillip Hosp, Dept Resp Med, Llanelli SA14 8QF, England; [Lewis, Keir E.; Lewis, Paul D.] Swansea Univ, Coll Med, Swansea SA2 8PP, W Glam, Wales	Aberystwyth University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Institute of Biological, Environmental, Rural & Sciences (IBERS); Swansea University	Mur, LAJ (corresponding author), Inst Biol Environm & Rural Sci, Edward Llywd Bldg,Penglais Campus, Aberystwyth SY23 3FG, Ceredigion, Wales.	lum@aber.ac.uk	Mur, Luis a. j./U-1052-2017	Mur, Luis a. j./0000-0002-0961-9817; Lewis, Keir/0000-0002-8248-6774; Pachebat, Justin/0000-0003-3369-3205; Lewis, Keir/0000-0001-9756-4723; Hegarty, Matthew/0000-0001-6547-3800; Huws, Sharon/0000-0002-9284-2453; Cameron, Simon/0000-0001-9570-135X	Aberystwyth University; National Institute for Social Care and Health Research; The British Council [172629373] Funding Source: researchfish	Aberystwyth University; National Institute for Social Care and Health Research; The British Council	This work was supported by Aberystwyth University through a studentship grant awarded to S.J.S.C. and partially supported through grants from National Institute for Social Care and Health Research, Wales to K.E.L. and P.D.L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; SJSC is grateful for studentship from Aberystwyth University. We wish to thank Dr Paul Griffiths, Consultant histopathologist, for sputum cytological assessment and Dr Chris Creevey and Dr Martin Swain for helpful discussion. This work was supported by Aberystwyth University through a studentship grant awarded to S.J.S.C. and partially supported through grants from National Institute for Social Care and Health Research, Wales to K.E.L. and P.D.L. In addition, we would like to thank the reviewers of this manuscript for their constructive comments, the addressing of which, we believe, have made for a better manuscript.	Bittar F, 2010, CLIN MICROBIOL INFEC, V16, P809, DOI 10.1111/j.1469-0691.2010.03236.x; Borges TJ, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00095; Cabrera-Rubio R, 2012, J CLIN MICROBIOL, V50, P3562, DOI 10.1128/JCM.00767-12; Cao HA, 2011, IMMUNOLOGY, V132, P18, DOI 10.1111/j.1365-2567.2010.03368.x; Carlin AF, 2007, J BACTERIOL, V189, P1231, DOI 10.1128/JB.01155-06; Chang YC, 2014, GLYCOBIOLOGY, V24, P818, DOI 10.1093/glycob/cwu067; Chiba S, 2006, MOL MICROBIOL, V60, P448, DOI 10.1111/j.1365-2958.2006.05104.x; Cho I, 2012, NAT REV GENET, V13, P260, DOI 10.1038/nrg3182; Ciofu O, 2013, CURR OPIN PULM MED, V19, P251, DOI 10.1097/MCP.0b013e32835f1afc; Dongarra J, 1979, LINPACK USERS GUIDES; Erb-Downward JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016384; Field D, 2006, NAT BIOTECHNOL, V24, P801, DOI 10.1038/nbt0706-801; Friendly M, 2012, CORRGRAMS; Garcha DS, 2012, THORAX, V67, P1075, DOI 10.1136/thoraxjnl-2012-201924; Groenewegen KH, 2003, RESP MED, V97, P770, DOI 10.1016/S0954-6111(03)00026-X; Han MK, 2014, LANCET RESP MED, V2, P548, DOI 10.1016/S2213-2600(14)70069-4; Han MK, 2012, THORAX, V67, P456, DOI 10.1136/thoraxjnl-2011-201183; Hauser PM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090934; Hirschmann JV, 2000, CHEST, V118, P193, DOI 10.1378/chest.118.1.193; Huang YJ, 2010, OMICS, V14, P9, DOI 10.1089/omi.2009.0100; Husgafvel-Pursiainen K, 2004, MUTAT RES-REV MUTAT, V567, P427, DOI 10.1016/j.mrrev.2004.06.004; Kherad O, 2010, CHEST, V138, P896, DOI 10.1378/chest.09-2225; Lim YW, 2013, J CYST FIBROS, V12, P154, DOI 10.1016/j.jcf.2012.07.009; Lopez AD, 2006, EUR RESPIR J, V27, P397, DOI 10.1183/09031936.06.00025805; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Monso E, 2003, EPIDEMIOL INFECT, V131, P799, DOI 10.1017/S0950268803008872; Morris A, 2013, AM J RESP CRIT CARE, V187, P1067, DOI 10.1164/rccm.201210-1913OC; Nseir S, 2006, CRIT CARE MED, V34, P2959, DOI 10.1097/01.CCM.0000245666.28867.C6; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Parr DG, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-136; Patel IS, 2002, THORAX, V57, P759, DOI 10.1136/thorax.57.9.759; Perez-Losada M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131819; Pragman AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047305; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Renom F, 2010, RESP MED, V104, P840, DOI 10.1016/j.rmed.2009.12.010; Severi E, 2007, MICROBIOL-SGM, V153, P2817, DOI 10.1099/mic.0.2007/009480-0; Shaughnessy J, 2009, INFECT IMMUN, V77, P2094, DOI 10.1128/IAI.01561-08; Shaw JG, 2014, J THORAC DIS, V6, P1532, DOI 10.3978/j.issn.2072-1439.2014.11.33; Sze MA, 2012, AM J RESP CRIT CARE, V185, P1073, DOI 10.1164/rccm.201111-2075OC; Turnbaugh PJ, 2009, J PHYSIOL-LONDON, V587, P4153, DOI 10.1113/jphysiol.2009.174136; Varki A, 2007, NATURE, V446, P1023, DOI 10.1038/nature05816; Varki A, 2012, ANN NY ACAD SCI, V1253, P16, DOI 10.1111/j.1749-6632.2012.06517.x; Vimr E, 2002, TRENDS MICROBIOL, V10, P254, DOI 10.1016/S0966-842X(02)02361-2; Willner D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007370; Xia JG, 2012, NUCLEIC ACIDS RES, V40, pW127, DOI 10.1093/nar/gks374; Zawadzki MA, 2005, United State of America: US Patent, Patent No. [6837248 B2, 6837248]	46	34	34	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149095	10.1371/journal.pone.0149095	http://dx.doi.org/10.1371/journal.pone.0149095			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26872143	Green Published, gold, Green Submitted			2022-12-26	WOS:000370054100101
J	Fung, C; Murek, M; Klinger-Gratz, PP; Fiechter, M; Z'Graggen, WJ; Gautschi, OP; El-Koussy, M; Gralla, J; Schaller, K; Zbinden, M; Arnold, M; Fischer, U; Mattle, HP; Raabe, A; Beck, J				Fung, Christian; Murek, Michael; Klinger-Gratz, Pascal P.; Fiechter, Michael; Z'Graggen, Werner J.; Gautschi, Oliver P.; El-Koussy, Marwan; Gralla, Jan; Schaller, Karl; Zbinden, Martin; Arnold, Marcel; Fischer, Urs; Mattle, Heinrich P.; Raabe, Andreas; Beck, Juergen			Effect of Decompressive Craniectomy on Perihematomal Edema in Patients with Intracerebral Hemorrhage	PLOS ONE			English	Article							ASSOCIATION/AMERICAN-STROKE-ASSOCIATION; MIDDLE CEREBRAL-ARTERY; BRAIN-INJURY; PERIHEMORRHAGIC EDEMA; MALIGNANT INFARCTION; THROMBIN; VOLUME; BLOOD; MECHANISMS; MANAGEMENT	Background Perihematomal edema contributes to secondary brain injury in the course of intracerebral hemorrhage. The effect of decompressive surgery on perihematomal edema after intracerebral hemorrhage is unknown. This study analyzed the course of PHE in patients who were or were not treated with decompressive craniectomy. Methods More than 100 computed tomography images from our published cohort of 25 patients were evaluated retrospectively at two university hospitals in Switzerland. Computed tomography scans covered the time from admission until day 100. Eleven patients were treated by decompressive craniectomy and 14 were treated conservatively. Absolute edema and hematoma volumes were assessed using 3-dimensional volumetric measurements. Relative edema volumes were calculated based on maximal hematoma volume. Results Absolute perihematomal edema increased from 42.9 ml to 125.6 ml (192.8%) after 21 days in the decompressive craniectomy group, versus 50.4 ml to 67.2 ml (33.3%) in the control group (Delta at day 21 = 58.4 ml, p = 0.031). Peak edema developed on days 25 and 35 in patients with decompressive craniectomy and controls respectively, and it took about 60 days for the edema to decline to baseline in both groups. Eight patients (73%) in the decompressive craniectomy group and 6 patients (43%) in the control group had a good outcome (modified Rankin Scale score 0 to 4) at 6 months (P = 0.23). Conclusions Decompressive craniectomy is associated with a significant increase in perihematomal edema compared to patients who have been treated conservatively. Perihematomal edema itself lasts about 60 days if it is not treated, but decompressive craniectomy ameliorates the mass effect exerted by the intracerebral hemorrhage plus the perihematomal edema, as reflected by the reduced midline shift.	[Fung, Christian; Murek, Michael; Fiechter, Michael; Z'Graggen, Werner J.; Raabe, Andreas; Beck, Juergen] Univ Hosp Bern, Dept Neurosurg, CH-3010 Bern, Switzerland; [Klinger-Gratz, Pascal P.; El-Koussy, Marwan; Gralla, Jan; Zbinden, Martin] Univ Hosp Bern, Inst Diagnost & Intervent Neuroradiol, CH-3010 Bern, Switzerland; [Fung, Christian; Gautschi, Oliver P.; Schaller, Karl] Univ Hosp Geneva, Dept Neurosurg, Geneva, Switzerland; [Arnold, Marcel; Fischer, Urs; Mattle, Heinrich P.] Univ Hosp Bern, Dept Neurol, CH-3010 Bern, Switzerland	University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern; University of Geneva; University of Bern; University Hospital of Bern	Beck, J (corresponding author), Univ Hosp Bern, Dept Neurosurg, CH-3010 Bern, Switzerland.	Juergen.beck@insel.ch		Beck, Jurgen/0000-0002-7687-6098; Z'Graggen, Werner/0000-0002-5684-4419; Fischer, Urs/0000-0003-0521-4051				Appelboom G, 2013, J NEUROL NEUROSUR PS, V84, P488, DOI 10.1136/jnnp-2012-303160; Babu R, 2012, NEUROSURG FOCUS, V32, DOI 10.3171/2012.1.FOCUS11366; Bates D, LME4 LINEAR MIXED EF; Broderick J, 2007, STROKE, V38, P2001, DOI 10.1161/STROKEAHA.107.183689; BRODERICK JP, 1994, STROKE, V25, P1342, DOI 10.1161/01.STR.25.7.1342; BRODERICK JP, 1993, STROKE, V24, P987, DOI 10.1161/01.STR.24.7.987; Brott T, 1997, STROKE, V28, P1, DOI 10.1161/01.STR.28.1.1; Butcher KS, 2004, STROKE, V35, P1879, DOI 10.1161/01.STR.0000131807.54742.1a; Castillo J, 2002, NEUROLOGY, V58, P624, DOI 10.1212/WNL.58.4.624; COOPER PR, 1979, NEUROSURGERY, V4, P296, DOI 10.1227/00006123-197904000-00004; Dowlatshahi D, 2011, NEUROLOGY, V76, P1238, DOI 10.1212/WNL.0b013e3182143317; Ferro JM, 2011, STROKE, V42, P2825, DOI 10.1161/STROKEAHA.111.615393; Fung C, 2012, STROKE, V43, P3207, DOI 10.1161/STROKEAHA.112.666537; Gebel JM, 2002, STROKE, V33, P2636, DOI 10.1161/01.STR.0000035283.34109.EA; GIROUD M, 1991, J NEUROL NEUROSUR PS, V54, P595, DOI 10.1136/jnnp.54.7.595; Guresir E, 2011, J NEUROSURG, V114, P954, DOI 10.3171/2009.12.JNS091065; Hanley DF, 2009, STROKE, V40, P1533, DOI 10.1161/STROKEAHA.108.535419; Hemphill JC, 2015, STROKE, V46, P2032, DOI 10.1161/STR.0000000000000069; Hua Y, 2006, NEUROSURGERY, V58, P542, DOI 10.1227/01.NEU.0000197333.55473.AD; Kollmar R, 2010, STROKE, V41, P1684, DOI 10.1161/STROKEAHA.110.587758; Lee KR, 1997, J NEUROSURG, V86, P272, DOI 10.3171/jns.1997.86.2.0272; McCourt R, 2015, STROKE, V46, P954, DOI 10.1161/STROKEAHA.114.007544; Nagel A, 2009, NEUROCRIT CARE, V11, P384, DOI 10.1007/s12028-009-9269-x; Nakamura Takehiro, 2003, Neurosurg Focus, V15, pECP4; Park J, 2015, J NEUROSURG, V122, P383, DOI 10.3171/2014.9.JNS131784; REULEN HJ, 1977, J NEUROSURG, V46, P24, DOI 10.3171/jns.1977.46.1.0024; Schellinger PD, 2003, STROKE, V34, P1674, DOI 10.1161/01.STR.0000076010.10696.55; Staykov D, 2013, NEUROCRIT CARE, V18, P178, DOI 10.1007/s12028-012-9762-5; Staykov D, 2011, STROKE, V42, P2625, DOI 10.1161/STROKEAHA.111.618611; Team R.C., 2003, R LANG ENV STAT COMP; Tuhrim S, 1999, CRIT CARE MED, V27, P617, DOI 10.1097/00003246-199903000-00045; Vahedi K, 2007, LANCET NEUROL, V6, P215, DOI 10.1016/S1474-4422(07)70036-4; Wagner I, 2011, STROKE, V42, P1540, DOI 10.1161/STROKEAHA.110.609479; Wagner KR, 1996, STROKE, V27, P490, DOI 10.1161/01.STR.27.3.490; Wagner S, 2001, J NEUROSURG, V94, P693, DOI 10.3171/jns.2001.94.5.0693; Weiner GM, 2010, NEUROSURGERY, V66, P1111, DOI 10.1227/01.NEU.0000369607.71913.3E; Wirtz C R, 1997, Neurosurg Focus, V2, pE3; Wu G, 2006, ACTA NEUROCHIR SUPPL, V96, P78; Wu JM, 2003, STROKE, V34, P2964, DOI 10.1161/01.STR.0000103140.52838.45; Xi GH, 2006, LANCET NEUROL, V5, P53, DOI 10.1016/S1474-4422(05)70283-0; Xi GH, 1998, J NEUROSURG, V89, P991, DOI 10.3171/jns.1998.89.6.0991; Xi GH, 2003, J NEUROCHEM, V84, P3, DOI 10.1046/j.1471-4159.2003.01268.x; Yang J, 2015, STROKE, V46, P1009, DOI 10.1161/STROKEAHA.114.007154	43	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149169	10.1371/journal.pone.0149169	http://dx.doi.org/10.1371/journal.pone.0149169			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26872068	Green Published, Green Submitted, gold			2022-12-26	WOS:000370054100118
J	Miskovich, TA; Pedersen, WS; Belleau, EL; Shollenbarger, S; Lisdahl, KM; Larson, CL				Miskovich, Tara A.; Pedersen, Walker S.; Belleau, Emily L.; Shollenbarger, Skyler; Lisdahl, Krista M.; Larson, Christine L.			Cortical Gyrification Patterns Associated with Trait Anxiety	PLOS ONE			English	Article							SURFACE-BASED ANALYSIS; FUNCTIONAL CONNECTIVITY; INDIVIDUAL-DIFFERENCES; ORBITOFRONTAL CORTEX; PERSONALITY-TRAITS; PANIC DISORDER; NETWORK; ADOLESCENTS; ABNORMALITIES; VARIABILITY	Dispositional anxiety is a stable personality trait that is a key risk factor for internalizing disorders, and understanding the neural correlates of trait anxiety may help us better understand the development of these disorders. Abnormal cortical folding is thought to reflect differences in cortical connectivity occurring during brain development. Therefore, assessing gyrification may advance understanding of cortical development and organization associated with trait anxiety. Previous literature has revealed structural abnormalities in trait anxiety and related disorders, but no study to our knowledge has examined gyrification in trait anxiety. We utilized a relatively novel measure, the local gyrification index (LGI), to explore differences in gyrification as a function of trait anxiety. We obtained structural MRI scans using a 3T magnetic resonance scanner on 113 young adults. Results indicated a negative correlation between trait anxiety and LGI in the left superior parietal cortex, specifically the precuneus, reflecting less cortical complexity among those high on trait anxiety. Our findings suggest that aberrations in cortical gyrification in a key region of the default mode network is a correlate of trait anxiety and may reflect disrupted local parietal connectivity.	[Miskovich, Tara A.; Pedersen, Walker S.; Belleau, Emily L.; Shollenbarger, Skyler; Lisdahl, Krista M.; Larson, Christine L.] Univ Wisconsin, Dept Psychol, Milwaukee, WI 53201 USA	University of Wisconsin System; University of Wisconsin Milwaukee	Larson, CL (corresponding author), Univ Wisconsin, Dept Psychol, Milwaukee, WI 53201 USA.	larsoncl@uwm.edu	Lisdahl, Krista/P-8470-2019	Lisdahl, Krista/0000-0001-9515-1335	National Institutes of Health [MH086809]; NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH086809] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA030354] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the National Institutes of Health (MH086809). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleman-Gomez Y, 2013, J NEUROSCI, V33, P15004, DOI 10.1523/JNEUROSCI.1459-13.2013; ARMSTRONG E, 1995, CEREB CORTEX, V5, P56, DOI 10.1093/cercor/5.1.56; Barnes LLB, 2002, EDUC PSYCHOL MEAS, V62, P603, DOI 10.1177/0013164402062004005; Bartley AJ, 1997, BRAIN, V120, P257, DOI 10.1093/brain/120.2.257; Berman MG, 2011, SOC COGN AFFECT NEUR, V6, P548, DOI 10.1093/scan/nsq080; Blackford JU, 2012, CHILD ADOL PSYCH CL, V21, P501, DOI 10.1016/j.chc.2012.05.002; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; CHI JG, 1977, ANN NEUROL, V1, P86, DOI 10.1002/ana.410010109; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Dauvermann MR, 2012, CURR PHARM DESIGN, V18, P434; Donzuso G, 2014, BRAIN BEHAV, V4, P504, DOI 10.1002/brb3.232; First MB, 2002, STRUCTURED CLIN INTE; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fuentes P, 2012, COGN AFFECT BEHAV NE, V12, P491, DOI 10.3758/s13415-012-0099-5; Gardini S, 2009, BRAIN RES BULL, V79, P265, DOI 10.1016/j.brainresbull.2009.03.005; Hahn A, 2011, NEUROIMAGE, V56, P881, DOI 10.1016/j.neuroimage.2011.02.064; Hardan AY, 2004, PSYCHIAT RES-NEUROIM, V131, P263, DOI 10.1016/j.pscychresns.2004.06.001; Hogstrom LJ, 2013, CEREB CORTEX, V23, P2521, DOI 10.1093/cercor/bhs231; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Klein D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084914; Kotov R, 2010, PSYCHOL BULL, V136, P768, DOI 10.1037/a0020327; Kuhn S, 2011, J AFFECT DISORDERS, V134, P315, DOI 10.1016/j.jad.2011.06.003; Lahey BB, 2009, AM PSYCHOL, V64, P241, DOI 10.1037/a0015309; Laughlin SB, 2003, SCIENCE, V301, P1870, DOI 10.1126/science.1089662; Lohmann G, 1999, CEREB CORTEX, V9, P754, DOI 10.1093/cercor/9.7.754; Milad MR, 2007, ANN NY ACAD SCI, V1121, P546, DOI 10.1196/annals.1401.006; Nixon NL, 2014, BRIT J PSYCHIAT, V204, P283, DOI 10.1192/bjp.bp.113.129965; Palaniyappan L, 2011, BIOL PSYCHIAT, V69, P974, DOI 10.1016/j.biopsych.2010.12.012; Pannekoek JN, 2013, J AFFECT DISORDERS, V145, P29, DOI 10.1016/j.jad.2012.07.006; Paulesu E, 2010, PSYCHOL MED, V40, P117, DOI 10.1017/S0033291709005649; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Ralchle ME, 2007, NEUROIMAGE, V37, P1083, DOI 10.1016/j.neuroimage.2007.02.041; Rauch SL, 2005, NEUROREPORT, V16, P1909, DOI 10.1097/01.wnr.0000186599.66243.50; Raznahan A, 2011, J NEUROSCI, V31, P7174, DOI 10.1523/JNEUROSCI.0054-11.2011; Roy AK, 2009, NEUROIMAGE, V45, P614, DOI 10.1016/j.neuroimage.2008.11.030; Schaer M, 2008, IEEE T MED IMAGING, V27, P161, DOI 10.1109/TMI.2007.903576; Schaer M, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00750; Schaer M, 2012, JOVE-J VIS EXP, DOI 10.3791/3417; Servaas MN, 2014, HUM BRAIN MAPP, V35, P4303, DOI 10.1002/hbm.22476; Spielberger C. D., 1983, MIND GARDEN; Strawn JR, 2015, J ANXIETY DISORD, V32, P81, DOI 10.1016/j.janxdis.2015.03.004; Strawn JR, 2013, NEUROPSYCHOBIOLOGY, V67, P224, DOI 10.1159/000347090; Strawn JR, 2012, DEPRESS ANXIETY, V29, P939, DOI 10.1002/da.21961; Sylvester CM, 2012, TRENDS NEUROSCI, V35, P527, DOI 10.1016/j.tins.2012.04.012; Tallinen T, 2014, P NATL ACAD SCI USA, V111, P12667, DOI 10.1073/pnas.1406015111; VanEssen DC, 1997, NATURE, V385, P313, DOI 10.1038/385313a0; Wallace GL, 2013, BRAIN, V136, P1956, DOI 10.1093/brain/awt106; White T, 2003, BIOL PSYCHIAT, V54, P418, DOI 10.1016/S0006-3223(03)00065-9; White T, 2002, CEREB CORTEX, V12, P486, DOI 10.1093/cercor/12.5.486; White T, 2010, BRAIN COGNITION, V72, P36, DOI 10.1016/j.bandc.2009.10.009; Wright CI, 2006, CEREB CORTEX, V16, P1809, DOI 10.1093/cercor/bhj118; Yoon S, 2013, J PSYCHIATR RES, V47, P1446, DOI 10.1016/j.jpsychires.2013.06.015; Zhang S, 2012, NEUROIMAGE, V59, P3548, DOI 10.1016/j.neuroimage.2011.11.023; Zhang YC, 2009, NEUROREPORT, V20, P378, DOI 10.1097/WNR.0b013e3283249b34; ZILLES K, 1988, ANAT EMBRYOL, V179, P173, DOI 10.1007/BF00304699	56	12	12	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149434	10.1371/journal.pone.0149434	http://dx.doi.org/10.1371/journal.pone.0149434			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26872350	Green Published, gold, Green Submitted			2022-12-26	WOS:000370054100157
J	Daude, N; Lee, I; Kim, TK; Janus, C; Glaves, JP; Gapeshina, H; Yang, J; Sykes, BD; Carlson, GA; Hood, LE; Westaway, D				Daude, Nathalie; Lee, Inyoul; Kim, Taek-Kyun; Janus, Christopher; Glaves, John Paul; Gapeshina, Hristina; Yang, Jing; Sykes, Brian D.; Carlson, George A.; Hood, Leroy E.; Westaway, David			A Common Phenotype Polymorphism in Mammalian Brains Defined by Concomitant Production of Prolactin and Growth Hormone	PLOS ONE			English	Article							RAT-BRAIN; IMMUNOREACTIVE PROLACTIN; MESSENGER-RNA; CELLULAR-LOCALIZATION; GENE-EXPRESSION; TRANSGENIC MICE; RECEPTOR; STRESS; MOUSE; HYPOTHALAMUS	Pituitary Prolactin (PRL) and Growth Hormone (GH) are separately controlled and sub-serve different purposes. Surprisingly, we demonstrate that extra-pituitary expression in the adult mammalian central nervous system(CNS) is coordinated at mRNA and protein levels. However this was not a uniform effect within populations, such that wide inter-individual variation was superimposed on coordinate PRL/GH expression. Up to 44% of individuals in healthy cohorts of mice and rats showed protein levels above the norm and coordinated expression of PRL and GH transcripts above baseline occurred in the amygdala, frontal lobe and hippocampus of 10% of human subjects. High levels of PRL and GH present in post mortem tissue were often presaged by altered responses in fear conditioning and stress induced hyperthermia behavioral tests. Our data define a common phenotype polymorphism in healthy mammalian brains, and, given the pleiotropic effects known for circulating PRL and GH, further consequences of coordinated CNS over-expression may await discovery.	[Daude, Nathalie; Gapeshina, Hristina; Yang, Jing; Westaway, David] Univ Alberta, Ctr Prions & Prot Folding Dis, Edmonton, AB, Canada; [Lee, Inyoul; Kim, Taek-Kyun; Hood, Leroy E.] Inst Syst Biol, 401 Terry Ave North, Seattle, WA 98109 USA; [Janus, Christopher] Univ Florida, Coll Med, Ctr Translat Res Neurodegenerat Dis, Gainesville, FL 32611 USA; [Glaves, John Paul; Sykes, Brian D.] Univ Alberta, Dept Biochem, Edmonton, AB, Canada; [Carlson, George A.; Westaway, David] Mclaughlin Res Inst, 1520 23rd St South, Great Falls, MT 59405 USA	University of Alberta; Institute for Systems Biology (ISB); State University System of Florida; University of Florida; University of Alberta; McLaughlin Research Institute for Biomedical Sciences, Inc.	Westaway, D (corresponding author), Univ Alberta, Ctr Prions & Prot Folding Dis, Edmonton, AB, Canada.; Westaway, D (corresponding author), Mclaughlin Res Inst, 1520 23rd St South, Great Falls, MT 59405 USA.	david.westaway@ualberta.ca			Canada Foundation for Innovation; Canada Research Chair award; USA Department of Defense Research Contracts [W911NF-10-2-0001, W911SR-07-C0101]; USPHS, NIH, NINDS program [NS41997]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS041997] Funding Source: NIH RePORTER	Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Canada Research Chair award(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); USA Department of Defense Research Contracts(United States Department of Defense); USPHS, NIH, NINDS program; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Work in the CPPFD was supported by the Canada Foundation for Innovation and a Canada Research Chair award to DW. The authors thank Quentin Pittman and Sui Hwang for useful discussions. Work at Institute for Systems Biology was supported by USA Department of Defense Research Contracts, W911NF-10-2-0001 and W911SR-07-C0101). Work at the McLaughlin Research Institute was supported by USPHS, NIH, NINDS program project grant number NS41997.	Addison ML, 2012, ENDOCRINOLOGY, V153, P1898, DOI 10.1210/en.2011-1982; Balcombe JP, 2004, CONTEMP TOP LAB ANIM, V43, P42; Bartke A, 2011, TRENDS ENDOCRIN MET, V22, P437, DOI 10.1016/j.tem.2011.07.004; BenJonathan N, 1996, ENDOCR REV, V17, P639, DOI 10.1210/er.17.6.639; BERWAER M, 1994, MOL ENDOCRINOL, V8, P635, DOI 10.1210/me.8.5.635; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; BLANCHARD RJ, 1969, J COMP PHYSIOL PSYCH, V67, P370, DOI 10.1037/h0026779; Bole-Feysot C, 1998, ENDOCR REV, V19, P225, DOI 10.1210/edrv.19.3.0334; BRIDGES RS, 1985, SCIENCE, V227, P782, DOI 10.1126/science.3969568; Brown RSE, 2010, J COMP NEUROL, V518, P92, DOI 10.1002/cne.22208; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Buvat J, 2003, INT J IMPOT RES, V15, P373, DOI 10.1038/sj.ijir.3901043; CARLSON GA, 1994, P NATL ACAD SCI USA, V91, P5690, DOI 10.1073/pnas.91.12.5690; Daude N, 2012, P NATL ACAD SCI USA, V109, P9035, DOI 10.1073/pnas.1202130109; de Jonge HJM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000898; DECHIARA TM, 1991, CELL, V64, P849, DOI 10.1016/0092-8674(91)90513-X; DEVITO WJ, 1988, NEUROENDOCRINOLOGY, V47, P284, DOI 10.1159/000124926; Donahue CP, 2006, P NATL ACAD SCI USA, V103, P6031, DOI 10.1073/pnas.0507776103; DRAGO F, 1982, PHYSIOL BEHAV, V28, P1, DOI 10.1016/0031-9384(82)90092-0; Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002; EMANUELE NV, 1992, MOL ENDOCRINOL, V6, P35, DOI 10.1210/me.6.1.35; Freemark M, 1996, ENDOCRINOLOGY, V137, P934, DOI 10.1210/en.137.3.934; Fujikawa T, 2000, BRAIN RES, V874, P186, DOI 10.1016/S0006-8993(00)02576-2; Gehlenborg N, 2009, DATABASE-OXFORD, DOI 10.1093/database/bap011; GELLERSEN B, 1994, MOL ENDOCRINOL, V8, P356, DOI 10.1210/me.8.3.356; Goffin V, 1996, ENDOCR REV, V17, P385, DOI 10.1210/er.17.4.385; Grattan DR, 2008, J NEUROENDOCRINOL, V20, P752, DOI 10.1111/j.1365-2826.2008.01736.x; Hanna A, 2012, ALZHEIMERS RES THER, V4, DOI 10.1186/alzrt124; HARLAN RE, 1989, NEUROENDOCRINOLOGY, V49, P7, DOI 10.1159/000125085; Harvey S, 2003, J MOL NEUROSCI, V20, P1, DOI 10.1385/JMN:20:1:1; Harvey S, 2012, ENDOCRINE, V41, P19, DOI 10.1007/s12020-011-9557-z; Harvey S, 2014, GEN COMP ENDOCR, V205, P55, DOI 10.1016/j.ygcen.2014.03.041; Hoffman AR, 2000, GROWTH HORM IGF RES, V10, pS18, DOI 10.1016/S1096-6374(00)90008-X; HOJVAT S, 1982, DEV BRAIN RES, V4, P427, DOI 10.1016/0165-3806(82)90186-9; Hsu SD, 2008, NUCLEIC ACIDS RES, V36, pD165, DOI 10.1093/nar/gkm1012; Hurst JL, 2010, NAT METHODS, V7, P825, DOI [10.1038/nmeth.1500, 10.1038/NMETH.1500]; Hwang D, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.10; Janus C, 2004, LEARN MEMORY, V11, P337, DOI 10.1101/lm.70104; Janus C, 2014, BEHAV BRAIN RES, V259, P253, DOI 10.1016/j.bbr.2013.11.010; JONES BK, 1995, MOL CELL BIOL, V15, P7010; Kim JS, 2008, J NEUROSCI, V28, P6030, DOI 10.1523/JNEUROSCI.0891-08.2008; Kinney BA, 2001, PHYSIOL BEHAV, V72, P653, DOI 10.1016/S0031-9384(01)00423-1; Laron Zvi, 2011, Pediatr Endocrinol Rev, V9, P546; Larsen CM, 2010, ENDOCRINOLOGY, V151, P3805, DOI 10.1210/en.2009-1385; Leimar O, 2005, AM NAT, V165, P669, DOI 10.1086/429566; Levites Y, 2006, J NEUROSCI, V26, P11923, DOI 10.1523/JNEUROSCI.2795-06.2006; MILLER WL, 1981, PEDIATR RES, V15, P1550, DOI 10.1203/00006450-198112000-00093; Moderscheim TAE, 2007, NEUROSCIENCE, V145, P963, DOI 10.1016/j.neuroscience.2006.12.053; NIALL HD, 1971, P NATL ACAD SCI USA, V68, P866, DOI 10.1073/pnas.68.4.866; Nyberg F, 1996, HORM RES, V45, P18, DOI 10.1159/000184753; ONO M, 1990, P NATL ACAD SCI USA, V87, P4330, DOI 10.1073/pnas.87.11.4330; Ormandy CJ, 1997, GENE DEV, V11, P167, DOI 10.1101/gad.11.2.167; Passini MA, 2003, J VIROL, V77, P7034, DOI 10.1128/JVI.77.12.7034-7040.2003; Pathipati P, 2011, NEUROSCIENCE, V190, P409, DOI 10.1016/j.neuroscience.2011.05.029; PAUTPAGANO L, 1993, NEUROENDOCRINOLOGY, V58, P682, DOI 10.1159/000126609; Poos K, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003210; Rivera JC, 2008, EXP EYE RES, V86, P314, DOI 10.1016/j.exer.2007.11.003; SCHACHTER BS, 1984, ENDOCRINOLOGY, V114, P1947, DOI 10.1210/endo-114-5-1947; Shingo T, 2003, SCIENCE, V299, P117, DOI 10.1126/science.1076647; SINHA YN, 1992, TRENDS ENDOCRIN MET, V3, P100, DOI 10.1016/1043-2760(92)90021-R; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; THOMPSON SA, 1982, CELL TISSUE RES, V225, P79, DOI 10.1007/BF00216220; Torner L, 2001, J NEUROSCI, V21, P3207, DOI 10.1523/JNEUROSCI.21-09-03207.2001; Torner L, 2002, STRESS, V5, P249, DOI 10.1080/1025389021000048638; TOUBEAU G, 1979, J ENDOCRINOL, V83, P261, DOI 10.1677/joe.0.0830261; VanderHeyden JAM, 1997, PHYSIOL BEHAV, V62, P463, DOI 10.1016/S0031-9384(97)00157-1; Voikar V, 2004, GENES BRAIN BEHAV, V3, P27, DOI 10.1046/j.1601-183X.2003.0044.x; Walker JR, 2004, GENOME RES, V14, P742, DOI 10.1101/gr.2161804; Wang XW, 2008, BIOINFORMATICS, V24, P325, DOI 10.1093/bioinformatics/btm595; Wang XW, 2008, RNA, V14, P1012, DOI 10.1261/rna.965408; West-Eberhard MJ, 2005, P NATL ACAD SCI USA, V102, P6543, DOI 10.1073/pnas.0501844102; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Yip SH, 2012, J NEUROENDOCRINOL, V24, P1484, DOI 10.1111/j.1365-2826.2012.02357.x; Yoshizato H, 1998, ENDOCRINOLOGY, V139, P2545, DOI 10.1210/en.139.5.2545; Yue M, 2011, NEUROBIOL AGING, V32, P590, DOI 10.1016/j.neurobiolaging.2009.04.006; Zhang ZC, 2010, J BIOL CHEM, V285, P34718, DOI 10.1074/jbc.M110.126441	76	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0149410	10.1371/journal.pone.0149410	http://dx.doi.org/10.1371/journal.pone.0149410			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3DG	26894278	Green Submitted, gold, Green Published			2022-12-26	WOS:000371223400053
J	Jee, D; Kang, S; Yuan, CZ; Cho, E; Arroyo, JG				Jee, Donghyun; Kang, Seungbum; Yuan, Changzheng; Cho, Eunyoung; Arroyo, Jorge G.		Epidemiologic Survey Comm Korean	Serum 25-Hydroxyvitamin D Levels and Dry Eye Syndrome: Differential Effects of Vitamin D on Ocular Diseases	PLOS ONE			English	Article							NUTRITION EXAMINATION SURVEY; KOREA NATIONAL-HEALTH; ASSOCIATION	Purpose To investigate associations between serum 25-hydroxyvitamin D levels and dry eye syndrome (DES), and to evaluate the differential effect of vitamin D on ocular diseases including age-related macular disease (AMD), diabetic retinopathy (DR), cataract, and DES. Methods A total of 16,396 participants aged >19 years were randomly selected from the Korean National Health and Nutrition Examination Survey. All participants participated in standardized interviews, blood 25-hydroxyvitamin D level evaluations, and comprehensive ophthalmic examinations. DES was defined by a history of clinical diagnosis of dry eyes by a physician. The association between vitamin D and DES was compared to the associations between vitamin D and AMD, DR, cataract, and DES from our previous studies. Results The odds of DES non-significantly decreased as the quintiles of serum 25-hydroxyvitamin D levels increased (quintile 5 versus 1, OR = 0.85, 95% CI: 0.55-1.30, P for trend = 0.076) after adjusting for potential confounders including age, sex, hypertension, diabetes, smoking status, and sunlight exposure times. The relative odds of DES (OR = 0.70, 95% CI: 0.30-1.64) and cataract (OR = 0.76, 95% CI: 0.59-0.99) were relatively high, while those of DR (OR = 0.37, 95% CI: 0.18-0.76) and late AMD (OR = 0.32, 95% CI: 0.12-0.81) were lower in men. Conclusions The present study does not support an association between serum 25-hydroxyvitamin D levels and DES. The preventive effect of serum 25-hydroxyvitamin D may be more effective for DR and late AMD than it is for cataract and DES.	[Jee, Donghyun] Catholic Univ Korea, Coll Med, Dept Ophthalmol & Visual Sci, Suwon, South Korea; [Jee, Donghyun] Harvard Univ, TH Chan Sch Publ Hlth, Dept Epidemiol & Biostat, Boston, MA 02115 USA; [Kang, Seungbum] Catholic Univ Korea, Daejeon St Marys Hosp, Coll Med, Dept Ophthalmol & Visual Sci, Daejeon, South Korea; [Yuan, Changzheng] Harvard Univ, TH Chan Sch Publ Hlth, Dept Nutr & Epidemiol, Boston, MA 02115 USA; [Cho, Eunyoung] Brigham & Womens Hosp, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA; [Cho, Eunyoung] Harvard Univ, Sch Med, Boston, MA USA; [Cho, Eunyoung] Brown Univ, Dept Dermatol, Warren Alpert Med Sch, Providence, RI 02912 USA; [Arroyo, Jorge G.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Ophthalmol, Boston, MA 02215 USA	Catholic University of Korea; Harvard University; Harvard T.H. Chan School of Public Health; Catholic University of Korea; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Brown University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Kang, S (corresponding author), Catholic Univ Korea, Daejeon St Marys Hosp, Coll Med, Dept Ophthalmol & Visual Sci, Daejeon, South Korea.	john7030@catholic.ac.kr	Cho, Eunyoung/AAV-4469-2020	Cho, Eunyoung/0000-0001-6594-2582; Arroyo, Jorge/0000-0001-9812-296X	St. Vincent's hospital, research institute of medical science [SVHR-2013-12]	St. Vincent's hospital, research institute of medical science	The authors wish to acknowledge the financial support of the St. Vincent's hospital, research institute of medical science (SVHR-2013-12). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JM, 2014, AM J OPHTHALMOL, V158, P1205, DOI 10.1016/j.ajo.2014.08.021; Alvarez JA, 2014, CLIN ENDOCRINOL, V81, P458, DOI 10.1111/cen.12449; Chailurkit LO, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-853; Choi HS, 2008, J CLIN ENDOCR METAB, V96, P643, DOI DOI 10.1210/JC.2010-2133; Choi JL, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/456569; Chun YH, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-84; Dang Sen-Tao, 2004, Di Yi Jun Yi Da Xue Xue Bao, V24, P892; Galor A, 2014, CORNEA, V33, P437, DOI 10.1097/ICO.0000000000000089; Grant W B, 2003, J Cosmet Dermatol, V2, P86, DOI 10.1111/j.1473-2130.2004.00041.x; Hagenau T, 2009, OSTEOPOROSIS INT, V20, P133, DOI 10.1007/s00198-008-0626-y; Jee D, 2015, J CATARACT REFR SURG, V41, P1705, DOI 10.1016/j.jcrs.2014.12.052; Jee D, 2015, J CATARACT REFR SURG, V41, P756, DOI 10.1016/j.jcrs.2014.11.034; Jee DY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115199; Jee D, 2014, INVEST OPHTH VIS SCI, V55, P5081, DOI 10.1167/iovs.14-14483; Kim EC, 2014, INVEST OPHTH VIS SCI, V55, P4823, DOI 10.1167/iovs.14-14763; Kim Yangho, 2013, J Prev Med Public Health, V46, P96, DOI 10.3961/jpmph.2013.46.2.96; Kurtul BE, 2015, EYE, V29, P1081, DOI 10.1038/eye.2015.96; Lee YA, 2014, PUBLIC HEALTH NUTR, V17, P764, DOI 10.1017/S1368980013000438; Lu L, 2009, DIABETES CARE, V32, P1278, DOI 10.2337/dc09-0209; Mangge H, 2013, CURRENT VASCULAR PHA; Millen AE, 2011, ARCH OPHTHALMOL-CHIC, V129, P481, DOI 10.1001/archophthalmol.2011.48; Muller MJ, 2015, CLIN CHEM, V61, P1033, DOI 10.1373/clinchem.2015.241430; Nimitphong H, 2013, DERM-ENDOCRINOL, V5, DOI 10.4161/derm.24054; Park HA, 2013, KOREAN J FAM MED, V34, P79, DOI 10.4082/kjfm.2013.34.2.79; Patrick PA, 2012, ARCH OPHTHALMOL-CHIC, V130, P756, DOI 10.1001/archophthalmol.2011.2749; Payne JF, 2012, ENDOCR PRACT, V18, P185, DOI 10.4158/EP11147.OR; Sempos CT, 2012, SCAND J CLIN LAB INV, V72, P32, DOI 10.3109/00365513.2012.681935; Smith M, 2010, BIOSCI HORIZ, V3, P124; Suzuki T, 2000, INVEST OPHTH VIS SCI, V41, P154; Uberti F, 2014, J CLIN ENDOCR METAB, V99, P1367, DOI 10.1210/jc.2013-2103; Uchino Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045805; Wakamatsu TH, 2008, ARQ BRAS OFTALMOL, V71, P72, DOI 10.1590/S0004-27492008000700015; Waterhouse JC, 2009, ANN NY ACAD SCI, V1173, P757, DOI 10.1111/j.1749-6632.2009.04637.x; Wei Y, 2014, EYE CONTACT LENS, V40, P248, DOI 10.1097/ICL.0000000000000042; Yildirim P, 2016, INT J RHEUM DIS, V19, P49, DOI 10.1111/1756-185X.12727; Yin ZH, 2011, INVEST OPHTH VIS SCI, V52, P7359, DOI 10.1167/iovs.11-7605	36	20	20	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0149294	10.1371/journal.pone.0149294	http://dx.doi.org/10.1371/journal.pone.0149294			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3DG	26894581	Green Published, gold, Green Submitted			2022-12-26	WOS:000371223400044
J	Yamada, K; Yokomaku, K; Haruki, R; Taguchi, K; Nagao, S; Maruyama, T; Otagiri, M; Komatsu, T				Yamada, Kana; Yokomaku, Kyoko; Haruki, Risa; Taguchi, Kazuaki; Nagao, Saori; Maruyama, Toru; Otagiri, Masaki; Komatsu, Teruyuki			Influence of Molecular Structure on O-2-Binding Properties and Blood Circulation of Hemoglobin Albumin Clusters	PLOS ONE			English	Article							HUMAN SERUM-ALBUMIN; PROTEIN; BOVINE; GLYCOL	A hemoglobin wrapped covalently by three human serum albumins, a Hb-HSA(3) cluster, is an artificial O-2-carrier with the potential to function as a red blood cell substitute. This paper describes the synthesis and O-2-binding properties of new hemoglobin. albumin clusters (i) bearing four HSA units at the periphery (Hb-HSA(4), large-size variant) and (ii) containing an intramolecularly crosslinked Hb in the center (XLHb-HSA(3), high O-2-affinity variant). Dynamic light scattering measurements revealed that the Hb-HSA(4) diameter is greater than that of either Hb-HSA(3) or XLHb-HSA(3). The XLHb-HSA(3) showed moderately high O-2-affinity compared to the others because of the chemical linkage between the Cys-93(beta) residues in Hb. Furthermore, the blood circulation behavior of I-125-labeled clusters was investigated by assay of blood retention and tissue distribution after intravenous administration into anesthetized rats. The XLHb-HSA(3) was metabolized faster than Hb-HSA(3) and Hb-HSA(4). Results suggest that the molecular structure of the protein cluster is a factor that can influence in vivo circulation behavior.	[Yamada, Kana; Yokomaku, Kyoko; Haruki, Risa; Komatsu, Teruyuki] Chuo Univ, Dept Appl Chem, Fac Sci & Engn, Bunkyo Ku, 1-13-27 Kasuga, Tokyo 1128551, Japan; [Taguchi, Kazuaki; Otagiri, Masaki] Sojo Univ, Fac Pharmaceut Sci, Nishi Ku, 4-22-1 Ikeda, Kumamoto 8600082, Japan; [Nagao, Saori; Maruyama, Toru] Kumamoto Univ, Grad Sch Pharmaceut Sci, Dept Biopharmaceut, Chuo Ku, 5-1 Oe Honmachi, Kumamoto 8620973, Japan	Chuo University; Sojo University; Kumamoto University	Komatsu, T (corresponding author), Chuo Univ, Dept Appl Chem, Fac Sci & Engn, Bunkyo Ku, 1-13-27 Kasuga, Tokyo 1128551, Japan.	komatsu@kc.chuo-u.ac.jp			MEXT Japan [2107, 21108013]; Chuo University; Institute of Science and Engineering, Chuo University	MEXT Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Chuo University; Institute of Science and Engineering, Chuo University	This work was supported by a Grant-in-Aid for Scientific Research on Innovative Area ("Coordination Programming" Area 2107, No. 21108013) from MEXT Japan, Chuo University Grant for Special Research, and Joint Research Grant from the Institute of Science and Engineering, Chuo University.	Antonini E., 1971, N HOLLAND RES MONOGR, V21, P13; Buehler PW, 2005, ANAL CHEM, V77, P3466, DOI 10.1021/ac050064y; Bureau of Social Welfare and Public Health, RES BLOOD TRANSF SIT; Daijima Y, 2014, CHEM COMMUN, V50, P14716, DOI 10.1039/c4cc06076h; Doherty DH, 1998, NAT BIOTECHNOL, V16, P672, DOI 10.1038/nbt0798-672; Ghuman J, 2005, J MOL BIOL, V353, P38, DOI 10.1016/j.jmb.2005.07.075; Gould SA, 1996, WORLD J SURG, V20, P1200; GRASSETTI DR, 1967, ARCH BIOCHEM BIOPHYS, V119, P41, DOI 10.1016/0003-9861(67)90426-2; GUYTON AC, 1964, CIRC RES, V15, P60; Haruki R, 2015, SCI REP-UK, V5, DOI 10.1038/srep12778; Hosaka H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110541; Hu DX, 2008, BIOCHEMISTRY-US, V47, P12551, DOI 10.1021/bi801452b; Hu T, 2007, BIOCHEM J, V402, P143, DOI 10.1042/BJ20061434; Intaglietta M, 2004, PROG APPL MICROCIR, V25, P8; Jahr JS, 2008, EXPERT OPIN BIOL TH, V8, P1425, DOI 10.1517/14712598.8.9.1425 ; Jahr JS, 2011, CHEMISTRY AND BIOCHEMISTRY OF OXYGEN THERAPEUTICS: FROM TRANSFUSION TO ARTIFICIAL BLOOD, P301; Kimura T, 2015, J MATER CHEM B, V3, P6157, DOI 10.1039/c5tb00540j; Kluger R, 2003, J AM CHEM SOC, V125, P6070, DOI 10.1021/ja034376z; Kluger R., 2013, HEMOGLOBIN BASED OXY, P159, DOI DOI 10.1007/978-3-642-40717-8_10; Kluger R, 2010, CURR OPIN CHEM BIOL, V14, P538, DOI 10.1016/j.cbpa.2010.03.021; Komatsu T, 2004, BBA-GEN SUBJECTS, V1675, P21, DOI 10.1016/j.bbagen.2004.08.010; Li DX, 2009, BIOCONJUGATE CHEM, V20, P2062, DOI 10.1021/bc900170e; Manjula BN, 2003, BIOCONJUGATE CHEM, V14, P464, DOI 10.1021/bc0200733; Manjula BN, 2000, J BIOL CHEM, V275, P5527, DOI 10.1074/jbc.275.8.5527; Ministry of Health Labor and Welfare Japan., 2014, P BLOOD DON PROM COM; Mueser TC, 2000, BIOCHEMISTRY-US, V39, P15353, DOI 10.1021/bi0012944; Natanson C, 2008, JAMA-J AM MED ASSOC, V299, P2304, DOI 10.1001/jama.299.19.jrv80007; Pearce L.B., 2006, BLOOD SUBSTITUTES, P437; Rennen HJJM, 2001, NUCL MED BIOL, V28, P401, DOI 10.1016/S0969-8051(01)00208-6; Rohlfs RJ, 1998, J BIOL CHEM, V273, P12128, DOI 10.1074/jbc.273.20.12128; SCHULTZ SC, 1993, J LAB CLIN MED, V122, P301; Tomita D, 2013, BIOMACROMOLECULES, V14, P1816, DOI 10.1021/bm400204y; Vandegriff KD, 2003, TRANSFUSION, V43, P509, DOI 10.1046/j.1537-2995.2003.00341.x; Winslow RM, 2003, J INTERN MED, V253, P508, DOI 10.1046/j.1365-2796.2003.01150.x; Zhang N, 2010, BIOTECHNOL PROGR, V26, P1481, DOI 10.1002/btpr.467; Zhang YL, 2008, BIOCONJUGATE CHEM, V19, P2221, DOI 10.1021/bc8003205	36	4	4	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0149526	10.1371/journal.pone.0149526	http://dx.doi.org/10.1371/journal.pone.0149526			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3DG	26895315	Green Published, Green Submitted, gold			2022-12-26	WOS:000371223400061
J	Yu, Y; Wang, K; Deng, JH; Sun, M; Jia, J; Wang, XM				Yu, Yan; Wang, Ke; Deng, Jiahui; Sun, Min; Jia, Jun; Wang, Xiaomin			Electroacupuncture Produces the Sustained Motor Improvement in 6-Hydroxydopamine-Lesioned Mice	PLOS ONE			English	Article							MEDIAL FOREBRAIN-BUNDLE; PARKINSONS-DISEASE; MOUSE MODEL; ACUPUNCTURE; STIMULATION; NEURONS; RATS; THERAPY; LESIONS; TIME	Clinical and research evidence has shown that electroacupuncture (EA) promotes recovery of motor function in patients with Parkinson's disease (PD). However, the "efficacy span" of EA treatment, especially the long-term effect of EA that is thought to last after the cessation of EA treatment, has not been investigated. The present study thus investigated and compared the effect of EA during and after chronic EA application on motor activity and dopamine lesions in a 6-hydroxydopamine (6-OHDA)-lesioned mouse model of PD. Chronic EA treatment (30 min a day, 6 days a week for 2 or 4 weeks) significantly attenuated motor deficiency and reduced dopamine neuron degeneration. Remarkably, EA showed a long-lasting effect after the cessation of EA stimulation. At 2 and 4 weeks after the termination of EA, EA continued to improve motor function in 6-OHDA-lesioned mice. Consistent with sustained behavioral effects, EA induced an enduring increase in the dopamine turnover ratio in the striatum 2 weeks after the cessation of EA treatment. Here we demonstrated that the therapeutic effect of EA outlasted the duration of EA application. During a relatively long period of time after the completion of EA treatment, EA is able to continue to improve motor function and enhance dopamine availability in 6-OHDA-lesioned PD mice.	[Jia, Jun; Wang, Xiaomin] Capital Med Univ, Beijing Inst Brain Disorders, Beijing Key Lab Parkinsons Dis, Dept Neurobiol,Key Lab Neurodegenerat Disorders,M, Beijing 100069, Peoples R China; [Jia, Jun; Wang, Xiaomin] Capital Med Univ, Beijing Inst Brain Disorders, Beijing Key Lab Parkinsons Dis, Dept Physiol,Key Lab Neurodegenerat Disorders,Min, Beijing 100069, Peoples R China	Capital Medical University; Capital Medical University	Jia, J; Wang, XM (corresponding author), Capital Med Univ, Beijing Inst Brain Disorders, Beijing Key Lab Parkinsons Dis, Dept Neurobiol,Key Lab Neurodegenerat Disorders,M, Beijing 100069, Peoples R China.; Jia, J; Wang, XM (corresponding author), Capital Med Univ, Beijing Inst Brain Disorders, Beijing Key Lab Parkinsons Dis, Dept Physiol,Key Lab Neurodegenerat Disorders,Min, Beijing 100069, Peoples R China.	jiajun@ccmu.edu.cn; xmwang@ccmu.edu.cn			National Basic Research Program of China [2011CB504100]; National Natural Science Foundation of China [81072858, 81473770, 31401024]; Beijing Natural Science Foundation [7152021]; Importation and Development of High-Caliber Talents Project of Beijing Municipal Institutions [CITTCD201304185]; Project of Construction of Innovative Teams and Teacher Career Development for Universities and Colleges under the Beijing Municipality [IDHT20140514]; Seed Grant of International Alliance of Translational Neuroscience [PXM2014_014226_000015]; Postdoctoral Science Foundation of China [2014M561007]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Importation and Development of High-Caliber Talents Project of Beijing Municipal Institutions; Project of Construction of Innovative Teams and Teacher Career Development for Universities and Colleges under the Beijing Municipality; Seed Grant of International Alliance of Translational Neuroscience; Postdoctoral Science Foundation of China(China Postdoctoral Science Foundation)	This study was supported by the National Basic Research Program of China (2011CB504100; http://www.973.gov.cn), the National Natural Science Foundation of China (81072858, 81473770, 31401024; http://www.nsfc.gov.cn), Beijing Natural Science Foundation (7152021; http://www.bjkw.gov.cn), the Importation and Development of High-Caliber Talents Project of Beijing Municipal Institutions (CIT&TCD201304185; www.bjedu.gov.cn), the Project of Construction of Innovative Teams and Teacher Career Development for Universities and Colleges under the Beijing Municipality (IDHT20140514; http://www.bjedu.gov.cn), the Seed Grant of International Alliance of Translational Neuroscience (PXM2014_014226_000015; http://www.bibd.org.cn), and Postdoctoral Science Foundation of China (2014M561007; http://jj.chinapostdoctor.org.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTAR CA, 1992, P NATL ACAD SCI USA, V89, P11347, DOI 10.1073/pnas.89.23.11347; Alvarez-Fischer D, 2008, EXP NEUROL, V210, P182, DOI 10.1016/j.expneurol.2007.10.012; Asakawa T, 2012, INTRACTABLE RARE DIS, V1, P144, DOI 10.5582/irdr.2012.v1.4.144; Boix J, 2015, BEHAV BRAIN RES, V284, P196, DOI 10.1016/j.bbr.2015.01.053; Cho SY, 2012, PARKINSONISM RELAT D, V18, P948, DOI 10.1016/j.parkreldis.2012.04.030; Cohen AD, 2011, BRAIN RES, V1370, P80, DOI 10.1016/j.brainres.2010.11.006; Cristian A, 2005, MOVEMENT DISORD, V20, P1185, DOI 10.1002/mds.20503; Deng JH, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0302-z; Dewey RB, 2004, NEUROLOGY, V62, pS3, DOI 10.1212/WNL.62.6_suppl_4.S3; Grealish S, 2010, EUR J NEUROSCI, V31, P2266, DOI 10.1111/j.1460-9568.2010.07265.x; Huang C, 2000, NEUROSCI LETT, V294, P159, DOI 10.1016/S0304-3940(00)01572-X; Iancu R, 2005, BEHAV BRAIN RES, V162, P1, DOI 10.1016/j.bbr.2005.02.023; Jia J, 2010, BEHAV NEUROSCI, V124, P305, DOI 10.1037/a0018931; Jia J, 2009, BEHAV BRAIN RES, V205, P214, DOI 10.1016/j.bbr.2009.06.024; Kawagishi K, 2014, NEUROSCIENCE, V272, P29, DOI 10.1016/j.neuroscience.2014.04.050; Kim HJ, 2013, PARKINSONISM RELAT D, V19, P831, DOI 10.1016/j.parkreldis.2013.03.018; Kim HJ, 2014, J NEUROL SCI, V341, P1, DOI 10.1016/j.jns.2014.04.016; Kim SH, 2011, PLOS ONE, V6; Liang XB, 2002, MOL BRAIN RES, V108, P51, DOI 10.1016/S0169-328X(02)00513-2; Meissner W, 2002, NEUROSCI LETT, V328, P105, DOI 10.1016/S0304-3940(02)00463-9; Rabinstein AA, 2003, NEUROLOGIST, V9, P137, DOI 10.1097/00127893-200305000-00002; SAINTCYR JA, 1993, NEUROLOGY, V43, P47; Shiotsuki H, 2010, J NEUROSCI METH, V189, P180, DOI 10.1016/j.jneumeth.2010.03.026; Sun ZL, 2012, NEUROSCI LETT, V520, P32, DOI 10.1016/j.neulet.2012.05.021; Wang H. W., 2013, WORLD CHINESE MED, V8, P5, DOI DOI 10.1371/J0UNIAL.P0NE.0063225; Wang HM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019790; Wang X, 2008, NEUROCHEM RES, V33, P1956, DOI 10.1007/s11064-008-9691-z; Yuan H, 2005, J NEUROSCI METH, V144, P35, DOI 10.1016/j.jneumeth.2004.10.004; Zeng BY, 2013, INT REV NEUROBIOL, V111, P141, DOI 10.1016/B978-0-12-411545-3.00007-9	29	13	13	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0149111	10.1371/journal.pone.0149111	http://dx.doi.org/10.1371/journal.pone.0149111			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3DG	26894437	Green Published, Green Submitted, gold			2022-12-26	WOS:000371223400032
J	Chi, MH; Craven, KD				Chi, Myoung-Hwan; Craven, Kelly D.			RacA-Mediated ROS Signaling Is Required for Polarized Cell Differentiation in Conidiogenesis of Aspergillus fumigatus	PLOS ONE			English	Article							CANDIDA-ALBICANS; NADPH OXIDASES; NIDULANS; GROWTH; FUNGUS; ABAA; DOWNSTREAM; EMERGENCE; HOMOLOG; KINASE	Conidiophore development of fungi belonging to the genus Aspergillus involves dynamic changes in cellular polarity and morphogenesis. Synchronized differentiation of phialides from the subtending conidiophore vesicle is a good example of the transition from isotropic to multi-directional polarized growth. Here we report a small GTPase, RacA, which is essential for reactive oxygen species (ROS) production in the vesicle as well as differentiation of phialides in Aspergillus fumigatus. We found that wild type A. fumigatus accumulates ROS in these conidiophore vesicles and that null mutants of racA did not, resulting in the termination of conidiophore development in this early vesicle stage. Further, we found that stress conditions resulting in atypical ROS accumulation coincide with partial recovery of phialide emergence but not subsequent apical dominance of the phialides in the racA null mutant, suggesting alternative means of ROS generation for the former process that are lacking in the latter. Elongation of phialides was also suppressed by inhibition of NADPH-oxidase activity. Our findings provide not only insights into role of ROS in fungal cell polarity and morphogenesis but also an improved model for the developmental regulatory pathway of conidiogenesis in A. fumigatus.	[Chi, Myoung-Hwan; Craven, Kelly D.] Samuel Roberts Noble Fdn Inc, Div Plant Biol, 2510 Sam Noble Pkwy, Oklahoma City, OK USA	Noble Research Institute	Craven, KD (corresponding author), Samuel Roberts Noble Fdn Inc, Div Plant Biol, 2510 Sam Noble Pkwy, Oklahoma City, OK USA.	kdcraven@noble.org		Craven, Kelly/0000-0002-1597-9413	Samuel Roberts Noble Foundation	Samuel Roberts Noble Foundation	This research is funded internally by the Samuel Roberts Noble Foundation. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research is funded internally by the Samuel Roberts Noble Foundation.	ADAMS TH, 1988, CELL, V54, P353, DOI 10.1016/0092-8674(88)90198-5; Adams TH, 1998, MICROBIOL MOL BIOL R, V62, P35, DOI 10.1128/MMBR.62.1.35-54.1998; ANDRIANOPOULOS A, 1994, MOL CELL BIOL, V14, P2503, DOI 10.1128/MCB.14.4.2503; Bassilana M, 2006, EUKARYOT CELL, V5, P321, DOI 10.1128/EC.5.2.321-329.2006; Chen JS, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000202; Chi MH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074805; Egan MJ, 2007, P NATL ACAD SCI USA, V104, P11772, DOI 10.1073/pnas.0700574104; HANSBERG W, 1993, FREE RADICAL BIO MED, V14, P287, DOI 10.1016/0891-5849(93)90025-P; Hernandez-Rodriguez Y, 2012, EUKARYOT CELL, V11, P311, DOI 10.1128/EC.05164-11; HOWARD RJ, 1991, P NATL ACAD SCI USA, V88, P11281, DOI 10.1073/pnas.88.24.11281; Hurtado CAR, 2000, J BACTERIOL, V182, P2376, DOI 10.1128/JB.182.9.2376-2386.2000; Juvvadi PR, 2011, BIOCHEM BIOPH RES CO, V405, P238, DOI 10.1016/j.bbrc.2011.01.017; Kafer E, 1977, Adv Genet, V19, P33, DOI 10.1016/S0065-2660(08)60245-X; Lara-Ortiz T, 2003, MOL MICROBIOL, V50, P1241, DOI 10.1046/j.1365-2958.2003.03800.x; Li HY, 2011, EUKARYOT CELL, V10, P174, DOI 10.1128/EC.00288-10; Lindsey R, 2010, EUKARYOT CELL, V9, P155, DOI 10.1128/EC.00269-09; Mah JH, 2006, EUKARYOT CELL, V5, P1585, DOI 10.1128/EC.00192-06; Morre DJ, 2002, ANTIOXID REDOX SIGN, V4, P207, DOI 10.1089/152308602753625960; Munkres KD., 1990, FUNG GENET NEWSLETT, V37, P24, DOI DOI 10.4148/1941-4765.1477; Nesher I, 2011, EUKARYOT CELL, V10, P1122, DOI 10.1128/EC.00321-10; Ni M, 2010, CELLULAR AND MOLECULAR BIOLOGY OF FILAMENTOUS FUNGI, P559; Nierman WC, 2005, NATURE, V438, P1151, DOI 10.1038/nature04332; Rolke Y, 2008, MOL MICROBIOL, V68, P405, DOI 10.1111/j.1365-2958.2008.06159.x; Ryder LS, 2013, P NATL ACAD SCI USA, V110, P3179, DOI 10.1073/pnas.1217470110; Semighini CP, 2008, GENETICS, V179, P1919, DOI 10.1534/genetics.108.089318; SEWALL TC, 1990, PLANT CELL, V2, P731, DOI 10.1105/tpc.2.8.731; Shimizu K, 2001, GENETICS, V157, P591; Sudbery P, 2004, TRENDS MICROBIOL, V12, P317, DOI 10.1016/j.tim.2004.05.008; Tanaka A, 2008, MOL MICROBIOL, V68, P1165, DOI 10.1111/j.1365-2958.2008.06217.x; Tao L, 2011, MICROBIOL-SGM, V157, P313, DOI 10.1099/mic.0.044271-0; Vallim MA, 2005, EUKARYOT CELL, V4, P1066, DOI 10.1128/EC.4.6.1066-1078.2005; Yu JH, 2006, EUKARYOT CELL, V5, P1577, DOI 10.1128/EC.00193-06	32	13	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2016	11	2							e0149548	10.1371/journal.pone.0149548	http://dx.doi.org/10.1371/journal.pone.0149548			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3CO	26890813	gold, Green Submitted, Green Published			2022-12-26	WOS:000371221500057
J	Marschner, JA; Schafer, H; Holderied, A; Anders, HJ				Marschner, Julian A.; Schaefer, Hannah; Holderied, Alexander; Anders, Hans-Joachim			Optimizing Mouse Surgery with Online Rectal Temperature Monitoring and Preoperative Heat Supply. Effects on Post-Ischemic Acute Kidney Injury	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; BODY-TEMPERATURE; RENAL-FAILURE; HYPOTHERMIA; ANESTHESIA; RECOVERY; MODEL; PROTECTION; INFUSION; RATS	Body temperature affects outcomes of tissue injury. We hypothesized that online body core temperature recording and selective interventions help to standardize peri-interventional temperature control and the reliability of outcomes in experimental renal ischemia reperfusion injury (IRI). We recorded core temperature in up to seven mice in parallel using a Thermes USB recorder and ret-3-iso rectal probes with three different protocols. Setup A: Heating pad during ischemia time; Setup B: Heating pad from incision to wound closure; Setup C: A ventilated heating chamber before surgery and during ischemia time with surgeries performed on a heating pad. Temperature profile recording displayed significant declines upon installing anesthesia. The profile of the baseline experimental setup A revealed that <1% of the temperature readings were within the target range of 36.5 to 38.5 degrees C. Setup B and C increased the target range readings to 34.6 +/- 28.0% and 99.3 +/- 1.5%, respectively. Setup C significantly increased S3 tubular necrosis, neutrophil influx, and mRNA expression of kidney injury markers. In addition, using setup C different ischemia times generated a linear correlation with acute tubular necrosis parameters at a low variability, which further correlated with the degree of kidney atrophy 5 weeks after surgery. Changing temperature control setup A to C was equivalent to 10 minutes more ischemia time. We conclude that body temperature drops quickly in mice upon initiating anesthesia. Immediate heat supply, e.g. in a ventilated heating chamber, and online core temperature monitoring can help to standardize and optimize experimental outcomes.	[Marschner, Julian A.; Schaefer, Hannah; Holderied, Alexander; Anders, Hans-Joachim] Klinikum Univ Munchen, Med Klin & Poliklin 4, Munich, Germany	University of Munich	Anders, HJ (corresponding author), Klinikum Univ Munchen, Med Klin & Poliklin 4, Munich, Germany.	hjanders@med.uni-muenchen.de	Marschner, Julian A./AAC-4421-2020; Anders, Hans-Joachim/ABD-6247-2021	Marschner, Julian Aurelio/0000-0002-5564-7085; Anders, Hans-Joachim/0000-0003-2434-2956	Deutsche Forschungsgemeinschaft [AN372/11-2, AN372/23-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (http://www.dfg.de/): AN372/11-2 and AN372/23-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Deutsche Forschungsgemeinschaft (AN372/11-2 and AN372/23-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CALNE RY, 1963, BMJ-BRIT MED J, P651; Caro AC, 2013, J AM ASSOC LAB ANIM, V52, P577; Delbridge MS, 2007, TRANSPL P, V39, P2983, DOI 10.1016/j.transproceed.2007.04.028; Devey L, 2008, LAB ANIM-UK, V42, P12, DOI 10.1258/la.2007.06009e; Flecknell Pa ScienceDirect (Online service), 1996, LAB ANIMAL ANAESTHES; Haq M, 1998, J AM SOC NEPHROL, V9, P614; Harkness JE, 1995, BIOL MED RABBITS ROD; HEIER T, 1991, ANESTHESIOLOGY, V74, P815, DOI 10.1097/00000542-199105000-00003; Hoyt RE, 2007, MOUSE BIOMEDICAL RES, P23, DOI DOI 10.1016/B978-012369454-6/50056-X; JUST B, 1992, ANESTHESIOLOGY, V76, P60, DOI 10.1097/00000542-199201000-00009; Kim HJ, 2014, J IMMUNOL METHODS, V407, P146, DOI 10.1016/j.jim.2014.03.014; Lech M, 2014, J AM SOC NEPHROL, V25, P292, DOI 10.1681/ASN.2013020152; Lech M, 2013, KIDNEY INT, V83, P647, DOI 10.1038/ki.2012.463; MITCHELL RM, 1957, TRANSPLAN B, V4, P15; Moler FW, 2015, NEW ENGL J MED, V372, P1898, DOI 10.1056/NEJMoa1411480; Niemann CU, 2015, NEW ENGL J MED, V373, P405, DOI 10.1056/NEJMoa1501969; OSIAS MB, 1977, ARCH SURG-CHICAGO, V112, P729; Ponticelli CE, 2015, KIDNEY INT, V87, P272, DOI 10.1038/ki.2014.359; R Core Team, 2013, R LANG ENV STAT COMP; Roehl AB, 2011, LAB ANIM-UK, V45, P45, DOI 10.1258/la.2010.010076; Sanchez-Alavez M, 2011, AGE, V33, P89, DOI 10.1007/s11357-010-9164-6; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Taylor DK, 2007, J AM ASSOC LAB ANIM, V46, P37; VALERI CR, 1987, ANN SURG, V205, P175, DOI 10.1097/00000658-198702000-00012; Vielhauer V, 2001, J AM SOC NEPHROL, V12, P1173, DOI 10.1681/ASN.V1261173; Wei QQ, 2012, AM J PHYSIOL-RENAL, V303, pF1487, DOI 10.1152/ajprenal.00352.2012; Yamada K, 2004, J IMMUNOL, V172, P3869, DOI 10.4049/jimmunol.172.6.3869; ZAGER RA, 1989, CIRC RES, V65, P1263, DOI 10.1161/01.RES.65.5.1263	28	28	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2016	11	2							e0149489	10.1371/journal.pone.0149489	http://dx.doi.org/10.1371/journal.pone.0149489			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3CO	26890071	Green Published, Green Submitted, gold			2022-12-26	WOS:000371221500052
J	Williams, PB; Mangelsdorf, HH; Kontra, C; Nusbaum, HC; Hoeckner, B				Williams, Patrick B.; Mangelsdorf, Heather H.; Kontra, Carly; Nusbaum, Howard C.; Hoeckner, Berthold			The Relationship between Mental and Somatic Practices and Wisdom	PLOS ONE			English	Article							LOVING-KINDNESS; MOTOR-SKILLS; KNOWLEDGE; CHILDREN; ANXIETY; HANDS; MIND	In this study we sought to explore how experience with specific mental and somatic practices is associated with wisdom, using self-report measures of experience and wisdom. We administered standard surveys to measure wisdom and experience among four groups of practitioners of mental and somatic practices, namely, meditators, practitioners of the Alexander Technique, practitioners of the Feldenkrais Method, and classical ballet dancers. We additionally administered surveys of trait anxiety and empathy to all participants to explore possible mediating relationships of experience and wisdom by characteristics thought to be components of wisdom. Wisdom was higher on average among meditation practitioners, and lowest among ballet dancers, and this difference held when controlling for differences in age between practices, supporting the view that meditation is linked to wisdom and that ballet is not. However, we found that increased experience with meditation and ballet were both positively associated with wisdom, and that lowered trait anxiety mediated this positive association among meditation practitioners, and, non-significantly, among ballet dancers. These results suggest that not all practices that are purported to affect mental processing are related to wisdom to the same degree and different kinds of experience appear to relate to wisdom in different ways, suggesting different mechanisms that might underlie the development of wisdom with experience.	[Williams, Patrick B.; Mangelsdorf, Heather H.; Kontra, Carly; Nusbaum, Howard C.] Univ Chicago, Dept Psychol, 5848 S Univ Ave, Chicago, IL 60637 USA; [Hoeckner, Berthold] Univ Chicago, Dept Mus, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Williams, PB (corresponding author), Univ Chicago, Dept Psychol, 5848 S Univ Ave, Chicago, IL 60637 USA.	pbwilliams@uchicago.edu		Mangelsdorf, Heather/0000-0003-3621-3326	Templeton Grant from the John Templeton Foundation [37775]	Templeton Grant from the John Templeton Foundation	This study was supported by Templeton Grant ID#: 37775 from the John Templeton Foundation (www.templeton.org). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts Hugo J E M, 2011, Mindfulness (N Y), V2, P73; Ardelt M, 2004, HUM DEV, V47, P257, DOI 10.1159/000079154; Ardelt M, 2003, RES AGING, V25, P275, DOI 10.1177/0164027503025003004; Ardelt M, 1998, J AGING STUD, V12, P291, DOI 10.1016/S0890-4065(98)90005-6; Ardelt M, 2010, J ADULT DEV, V17, P193, DOI 10.1007/s10804-009-9088-5; Bailey A., 2008, J UNCONVENTIONAL PAR, V1, P9; Baltes PB, 2000, AM PSYCHOL, V55, P122, DOI 10.1037/0003-066X.55.1.122; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Barrell G, 2013, MED PROBLEMS PERFORM, V18, P59; Barsalou LW, 1999, BEHAV BRAIN SCI, V22, P577, DOI 10.1017/S0140525X99532147; Benedikovicova J, 2008, STUD PSYCHOL, V50, P179; Bergen-Cico D, 2014, MINDFULNESS, V5, P505, DOI 10.1007/s12671-013-0205-y; Bergsma A, 2012, J HAPPINESS STUD, V13, P481, DOI 10.1007/s10902-011-9275-5; Bizarro, 2015, PSYCHOL NEUROSCI, V8, P350, DOI [DOI 10.1037/PNE0000015, https://doi.org/10.1037/pne0000015]; Blasing B, 2009, PSYCHOL SPORT EXERC, V10, P350, DOI 10.1016/j.psychsport.2008.10.001; Bodhidharma, 1987, ZEN TEACHING BODHIDH; Bohmig-Krumhaar SA, 2002, Z ENTWICKL PADAGOGIS, V34, P30, DOI 10.1026//0049-8637.34.1.30; Broaders SC, 2007, J EXP PSYCHOL GEN, V136, P539, DOI 10.1037/0096-3445.136.4.539; Calvo-Merino B, 2005, CEREB CORTEX, V15, P1243, DOI 10.1093/cercor/bhi007; Carney DR, 2010, PSYCHOL SCI, V21, P1363, DOI 10.1177/0956797610383437; Casasanto D, 2009, J EXP PSYCHOL GEN, V138, P351, DOI 10.1037/a0015854; Colzato LS, 2012, PSYCHON B REV, V19, P541, DOI 10.3758/s13423-012-0241-y; Duckworth AL, 2007, J PERS SOC PSYCHOL, V92, P1087, DOI 10.1037/0022-3514.92.6.1087; Ferrari M., 2013, SCI STUDY PERSONAL W; Ferrari M, 2011, RES HUM DEV, V8, P128, DOI 10.1080/15427609.2011.568869; Glck J., 2013, SCI STUDY PERSONAL W, P75, DOI [DOI 10.1007/978-94-007-7987-7_4, 10.1007/978-94-007-7987-7_4]; Goldin-Meadow S, 2009, PSYCHOL SCI, V20, P267, DOI 10.1111/j.1467-9280.2009.02297.x; Hauk O, 2004, NEURON, V41, P301, DOI 10.1016/S0896-6273(03)00838-9; Hofmann SG, 2010, J CONSULT CLIN PSYCH, V78, P169, DOI 10.1037/a0018555; Hopper C., 1999, J BODYWORK MOVEMENT, V3, P238, DOI DOI 10.1016/S1360-8592(99)80010-2; Hutcherson CA, 2008, EMOTION, V8, P720, DOI 10.1037/a0013237; James Michelle, 1998, Aust J Physiother, V44, P49; Jeste DV, 2010, JAMA-J AM MED ASSOC, V304, P1602, DOI 10.1001/jama.2010.1458; Jola C, 2011, EXP BRAIN RES, V213, P257, DOI 10.1007/s00221-011-2743-7; Jolliffe D, 2006, J ADOLESCENCE, V29, P589, DOI 10.1016/j.adolescence.2005.08.010; Jones FP, 1997, FREEDOM CHANGE DEV S; Kiken LG, 2014, J RES PERS, V53, P22, DOI 10.1016/j.jrp.2014.08.002; Kiken LG, 2011, SOC PSYCHOL PERS SCI, V2, P425, DOI 10.1177/1948550610396585; Kitchener K., 1990, WISDOM ITS NATURE OR, P212, DOI [DOI 10.1017/CBO9781139173704.011, https://doi.org/10.1017/CBO9781139173704.011]; Kleiner S, 2009, SYMB INTERACT, V32, P236, DOI 10.1525/si.2009.32.3.236; Kontra C, 2015, PSYCHOL SCI, V26, P737, DOI 10.1177/0956797615569355; Kross E, 2012, J EXP PSYCHOL GEN, V141, P43, DOI 10.1037/a0024158; Lake B, 1985, Aust Fam Physician, V14, P1175; LESTE A, 1990, AM J DANCE THER, V12, P19, DOI 10.1007/BF00844312; Leung MK, 2013, SOC COGN AFFECT NEUR, V8, P34, DOI 10.1093/scan/nss076; Novack MA, 2014, PSYCHOL SCI, V25, P903, DOI 10.1177/0956797613518351; Ping R., UNPACKING G IN PRESS; Ping RM, 2008, DEV PSYCHOL, V44, P1277, DOI 10.1037/0012-1649.44.5.1277; Reniers RLEP, 2011, J PERS ASSESS, V93, P84, DOI 10.1080/00223891.2010.528484; RISKIND J H, 1982, Motivation and Emotion, V6, P273, DOI 10.1007/BF00992249; Shapiro SL, 2007, TRAIN EDUC PROF PSYC, V1, P105, DOI 10.1037/1931-3918.1.2.105; Sobel M.E., 1982, SOCIOL METHODOL, V13, P290, DOI [10.2307/270723, DOI 10.2307/270723]; Soloway E, 1996, INT FELDENKRAIS FEDE, V3, P22; Spielberger C. D., 1973, MANUAL STATE TRAIT I; Spielberger C. D., 1989, STATE TRAIT ANXIETY; Stallibrass C, 2002, CLIN REHABIL, V16, P695, DOI 10.1191/0269215502cr544oa; Staudinger U. M., 2013, SCI STUDY PERSONAL W, DOI [10.1007/978-90-481-9231-1_1, DOI 10.1007/978-94-007-7987-7_1]; Staudinger UM, 1996, J PERS SOC PSYCHOL, V71, P746, DOI 10.1037/0022-3514.71.4.746; STAUDINGER UM, 2006, SOCIAL STRUCTURES AG, P33; STEPPER S, 1993, J PERS SOC PSYCHOL, V64, P211, DOI 10.1037/0022-3514.64.2.211; Tiberius V., 2008, REFLECTIVE LIFE LIVI; Wilson M, 2002, PSYCHON B REV, V9, P625, DOI 10.3758/BF03196322	62	10	11	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2016	11	2							e0149369	10.1371/journal.pone.0149369	http://dx.doi.org/10.1371/journal.pone.0149369			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF3CO	26890493	Green Published, Green Submitted, gold			2022-12-26	WOS:000371221500040
J	Yamada, H; Mori, S; Miyakawa, T; Morikawa, R; Katagiri, F; Hozumi, K; Kikkawa, Y; Nomizu, M; Takasu, M				Yamada, Hironao; Mori, Sakiko; Miyakawa, Takeshi; Morikawa, Ryota; Katagiri, Fumihiko; Hozumi, Kentaro; Kikkawa, Yamato; Nomizu, Motoyoshi; Takasu, Masako			Structural Study of Cell Attachment Peptide Derived from Laminin by Molecular Dynamics Simulation	PLOS ONE			English	Article							HOMOLOGOUS LOOP REGIONS; FREE-ENERGY LANDSCAPE; BINDING-SITES; BETA-HAIRPIN; BIOLOGICAL-ACTIVITIES; ALPHA-DYSTROGLYCAN; CRYSTAL-STRUCTURE; G-DOMAIN; CHAIN; IDENTIFICATION	Peptides with cell attachment activity are beneficial component of biomaterials for tissue engineering. Conformational structure is one of the important factors for the biological activities. The EF1 peptide (DYATLQLQEGRLHFMFDLG) derived from laminin promotes cell spreading and cell attachment activity mediated by alpha 2 beta 1 integrin. Although the sequence of the EF2 peptide (DFATVQLRNGFPYFSYDLG) is homologous sequence to that of EF1, EF2 does not promote cell attachment activity. To determine whether there are structural differences between EF1 and EF2, we performed replica exchange molecular dynamics (REMD) simulations and conventional molecular dynamics (MD) simulations. We found that EF1 and EF2 had beta-sheet structure as a secondary structure around the global minimum. However, EF2 had variety of structures around the global minimum compared with EF1 and has easily escaped from the bottom of free energy. The structural fluctuation of the EF1 is smaller than that of the EF2. The structural variation of EF2 is related to these differences in the structural fluctuation and the number of the hydrogen bonds (H-bonds). From the analysis of H-bonds in the beta-sheet, the number of H-bonds in EF1 is larger than that in EF2 in the time scale of the conventional MD simulation, suggesting that the formation of H-bonds is related to the differences in the structural fluctuation between EF1 and EF2. From the analysis of other non-covalent interactions in the amino acid sequences of EF1 and EF2, EF1 has three pairs of residues with hydrophobic interaction, and EF2 has two pairs. These results indicate that several non-covalent interactions are important for structural stabilization. Consequently, the structure of EF1 is stabilized by H-bonds and pairs of hydrophobic amino acids in the terminals. Hence, we propose that non-covalent interactions around N-terminal and C-terminal of the peptides are crucial for maintaining the beta-sheet structure of the peptides.	[Yamada, Hironao; Mori, Sakiko; Miyakawa, Takeshi; Morikawa, Ryota; Takasu, Masako] Tokyo Univ Pharm & Life Sci, Sch Life Sci, 1432-1 Horinouchi, Tokyo 1920392, Japan; [Katagiri, Fumihiko; Hozumi, Kentaro; Kikkawa, Yamato; Nomizu, Motoyoshi] Tokyo Univ Pharm & Life Sci, Sch Pharm, 1432-1 Horinouchi, Tokyo 1920392, Japan	Tokyo University of Pharmacy & Life Sciences; Tokyo University of Pharmacy & Life Sciences	Yamada, H (corresponding author), Tokyo Univ Pharm & Life Sci, Sch Life Sci, 1432-1 Horinouchi, Tokyo 1920392, Japan.	s077112@toyaku.ac.jp	Kikkawa, Yamato/D-1503-2010	Hozumi, Kentaro/0000-0002-6671-4386	JSPS KAKENHI [24540442]; Grants-in-Aid for Scientific Research [26430123] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Number 24540442.	Alberts B, 2007, MOL BIOL CELL, P1167; Altis A, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2945165; Aumailley M, 2005, MATRIX BIOL, V24, P326, DOI 10.1016/j.matbio.2005.05.006; BURGESON RE, 1994, MATRIX BIOL, V14, P209, DOI 10.1016/0945-053X(94)90184-8; Chodera JD, 2007, J CHEM THEORY COMPUT, V3, P26, DOI 10.1021/ct0502864; Collier JH, 2011, BIOMATERIALS, V32, P4198, DOI 10.1016/j.biomaterials.2011.02.030; Colognato H, 2000, DEV DYNAM, V218, P213, DOI 10.1002/(SICI)1097-0177(200006)218:2<213::AID-DVDY1>3.0.CO;2-R; Csontos J, 2008, BIOPOLYMERS, V89, P1002, DOI 10.1002/bip.21049; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Durbeej M, 2010, CELL TISSUE RES, V339, P259, DOI 10.1007/s00441-009-0838-2; EISENHABER F, 1995, J COMPUT CHEM, V16, P273, DOI 10.1002/jcc.540160303; Garcia AE, 2001, PROTEINS, V42, P345, DOI 10.1002/1097-0134(20010215)42:3<345::AID-PROT50>3.0.CO;2-H; Hallmann R, 2005, PHYSIOL REV, V85, P979, DOI 10.1152/physrev.00014.2004; Harrison D, 2007, J BIOL CHEM, V282, P11573, DOI 10.1074/jbc.M610657200; Hatfield MPD, 2010, J PHYS CHEM B, V114, P3028, DOI 10.1021/jp910465e; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hohenester E, 1999, MOL CELL, V4, P783, DOI 10.1016/S1097-2765(00)80388-3; Holmes TC, 2002, TRENDS BIOTECHNOL, V20, P16, DOI 10.1016/S0167-7799(01)01840-6; Hozumi K, 2012, BIOMATERIALS, V33, P4241, DOI 10.1016/j.biomaterials.2012.02.055; Iivanainen A, 1999, J BIOL CHEM, V274, P14107, DOI 10.1074/jbc.274.20.14107; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Katagiri F, 2014, BIOCHEMISTRY-US, V53, P3699, DOI 10.1021/bi5003822; Kato K, 2002, BIOCHEMISTRY-US, V41, P10747, DOI 10.1021/bi020180k; Li SH, 2003, DEV CELL, V4, P613, DOI 10.1016/S1534-5807(03)00128-X; Libby RT, 2000, J NEUROSCI, V20, P6517, DOI 10.1523/JNEUROSCI.20-17-06517.2000; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Makino M, 2002, EXP CELL RES, V277, P95, DOI 10.1006/excr.2002.5540; Miner JH, 2004, ANNU REV CELL DEV BI, V20, P255, DOI 10.1146/annurev.cellbio.20.010403.094555; Miner JH, 1997, J CELL BIOL, V137, P685, DOI 10.1083/jcb.137.3.685; Nielsen PK, 2000, J BIOL CHEM, V275, P14517, DOI 10.1074/jbc.275.19.14517; Nomizu M, 1997, J BIOL CHEM, V272, P32198, DOI 10.1074/jbc.272.51.32198; Nomizu M, 1998, J BIOL CHEM, V273, P32491, DOI 10.1074/jbc.273.49.32491; NOMIZU M, 1995, J BIOL CHEM, V270, P20583, DOI 10.1074/jbc.270.35.20583; Nomizu M, 2000, ARCH BIOCHEM BIOPHYS, V378, P311, DOI 10.1006/abbi.2000.1828; Okabe T, 2001, CHEM PHYS LETT, V335, P435, DOI 10.1016/S0009-2614(01)00055-0; Okazaki I, 2002, J BIOL CHEM, V277, P37070, DOI 10.1074/jbc.M201672200; Pande VS, 1999, P NATL ACAD SCI USA, V96, P9062, DOI 10.1073/pnas.96.16.9062; Powell SK, 1997, INT J BIOCHEM CELL B, V29, P401, DOI 10.1016/S1357-2725(96)00110-0; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Ramadhani D, 2012, ACTA HISTOCHEM CYTOC, V45, P309, DOI 10.1267/ahc.12028; Sasaki T, 2004, J CELL BIOL, V164, P959, DOI 10.1083/jcb.200401058; Singh G, 2007, NIC SERIES, V36, P275; Suzuki N, 2003, J BIOL CHEM, V278, P45697, DOI 10.1074/jbc.M304667200; Tisi D, 2000, EMBO J, V19, P1432, DOI 10.1093/emboj/19.7.1432; Umezawa K, 2009, BIOPOLYMERS, V92, P124, DOI 10.1002/bip.21148; Utani A, 2001, J BIOL CHEM, V276, P28779, DOI 10.1074/jbc.M101420200; Yamada H, 2013, PEPTIDE SCI, V2012, P339; Yamada H, 2014, JPS C P, V1; Yamada H, 2012, PEPTIDE SCI, V2011, P201; YAMADA KM, 1991, J BIOL CHEM, V266, P12809; Yamada Yoshihiko, 1992, Current Opinion in Cell Biology, V4, P819, DOI 10.1016/0955-0674(92)90105-L; Yamaguchi H, 2000, J BIOL CHEM, V275, P29458, DOI 10.1074/jbc.M003103200; Zhang W, 2005, J CHEM PHYS, V123, DOI 10.1063/1.2056540; Zhou RH, 2004, J MOL GRAPH MODEL, V22, P451, DOI 10.1016/j.jmgm.2003.12.011; Zhou RH, 2001, P NATL ACAD SCI USA, V98, P14931, DOI 10.1073/pnas.201543998; ZIMMERMANN K, 1991, J COMPUT CHEM, V12, P310, DOI 10.1002/jcc.540120305	57	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2016	11	2							e0149474	10.1371/journal.pone.0149474	http://dx.doi.org/10.1371/journal.pone.0149474			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3CO	26889829	Green Submitted, Green Published, gold			2022-12-26	WOS:000371221500050
J	Ding, T; Case, KA; Omolo, MA; Reiland, HA; Metz, ZP; Diao, XY; Baumler, DJ				Ding, Tong; Case, Kyle A.; Omolo, Morrine A.; Reiland, Holly A.; Metz, Zachary P.; Diao, Xinyu; Baumler, David J.			Predicting Essential Metabolic Genome Content of Niche-Specific Enterobacterial Human Pathogens during Simulation of Host Environments	PLOS ONE			English	Article							ESCHERICHIA-COLI; RECONSTRUCTIONS	Microorganisms have evolved to occupy certain environmental niches, and the metabolic genes essential for growth in these locations are retained in the genomes. Many microorganisms inhabit niches located in the human body, sometimes causing disease, and may retain genes essential for growth in locations such as the bloodstream and urinary tract, or growth during intracellular invasion of the hosts' macrophage cells. Strains of Escherichia coli (E. coli) and Salmonella spp. are thought to have evolved over 100 million years from a common ancestor, and now cause disease in specific niches within humans. Here we have used a genome scale metabolic model representing the pangenome of E. coli which contains all metabolic reactions encoded by genes from 16 E. coli genomes, and have simulated environmental conditions found in the human bloodstream, urinary tract, and macrophage to determine essential metabolic genes needed for growth in each location. We compared the predicted essential genes for three E. coli strains and one Salmonella strain that cause disease in each host environment, and determined that essential gene retention could be accurately predicted using this approach. This project demonstrated that simulating human body environments such as the bloodstream can successfully lead to accurate computational predictions of essential/important genes.	[Ding, Tong; Case, Kyle A.; Omolo, Morrine A.; Reiland, Holly A.; Metz, Zachary P.; Diao, Xinyu; Baumler, David J.] Univ Minnesota Twin Cities, Dept Food Sci & Nutr, St Paul, MN USA; [Baumler, David J.] Univ Minnesota Twin Cities, Microbial & Plant Genom Inst, St Paul, MN USA; [Baumler, David J.] Univ Minnesota Twin Cities, Inst Biotechnol, St Paul, MN USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Baumler, DJ (corresponding author), Univ Minnesota Twin Cities, Dept Food Sci & Nutr, St Paul, MN USA.; Baumler, DJ (corresponding author), Univ Minnesota Twin Cities, Microbial & Plant Genom Inst, St Paul, MN USA.; Baumler, DJ (corresponding author), Univ Minnesota Twin Cities, Inst Biotechnol, St Paul, MN USA.	dbaumler@umn.edu			Department of Food Science and Nutrition at the University of Minnesota-Twin Cities; College of Food, Agricultural and Natural Resource Sciences at the University of Minnesota-Twin Cities; Global Food Ventures Graduate Student Fellowship from the University of Minnesota-Twin Cities; Schlumberger Faculty for the Future Graduate Student Fellowship	Department of Food Science and Nutrition at the University of Minnesota-Twin Cities; College of Food, Agricultural and Natural Resource Sciences at the University of Minnesota-Twin Cities; Global Food Ventures Graduate Student Fellowship from the University of Minnesota-Twin Cities; Schlumberger Faculty for the Future Graduate Student Fellowship(Schlumberger)	We would also like to thank Dr(s). William R. Harcombe, Guy Plunkett III, Bob Mau, and Eric Cabot for insightful discussions regarding gene essentiality within the genomes of members of the family Enterobacteriaceae. This work was partially funded by the Department of Food Science and Nutrition and the College of Food, Agricultural and Natural Resource Sciences at the University of Minnesota-Twin Cities (DJB), and partially by the Global Food Ventures Graduate Student Fellowship from the University of Minnesota-Twin Cities (ZPM), and the Schlumberger Faculty for the Future Graduate Student Fellowship (MAO).	Baumler DJ, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-46; Baumler DJ, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-182; Feist AM, 2008, NAT BIOTECHNOL, V26, P659, DOI 10.1038/nbt1401; Feist AM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100155; Feist AM, 2010, CURR OPIN MICROBIOL, V13, P344, DOI 10.1016/j.mib.2010.03.003; Glasner JD, 2006, NUCLEIC ACIDS RES, V34, pD41, DOI 10.1093/nar/gkj164; KEITEL HG, 1955, BLOOD, V10, P370, DOI 10.1182/blood.V10.4.370.370; Monk JM, 2013, P NATL ACAD SCI USA, V110, P20338, DOI 10.1073/pnas.1307797110; Orth JD, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.65; Orth JD, 2010, NAT BIOTECHNOL, V28, P245, DOI 10.1038/nbt.1614; Pal C, 2006, NATURE, V440, P667, DOI 10.1038/nature04568; Putnam D.F., 1971, COMPOSITION CONCENTR; Raghunathan A, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-38; Reed JL, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r54; Reiland HA, 2014, ADV MICROBIOLOGY, V4, P7; Russo TA, 2003, MICROBES INFECT, V5, P449, DOI 10.1016/S1286-4579(03)00049-2	16	11	11	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0149423	10.1371/journal.pone.0149423	http://dx.doi.org/10.1371/journal.pone.0149423			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26885654	Green Published, gold, Green Submitted			2022-12-26	WOS:000371218400081
J	Even, Y; Escande, ML; Fayet, C; Geneviere, AM				Even, Yasmine; Escande, Marie-Line; Fayet, Claire; Geneviere, Anne-Marie			CDK13, a Kinase Involved in Pre-mRNA Splicing, Is a Component of the Perinucleolar Compartment	PLOS ONE			English	Article							TRACT-BINDING PROTEIN; POLYMERASE-III TRANSCRIPTS; CYCLIN-DEPENDENT KINASES; INTRANUCLEAR DISTRIBUTION; MYOTONIC-DYSTROPHY; K/CDK12 COMPLEX; HNRNP-I; CANCER; PTB; DNA	The perinucleolar compartment (PNC) is a subnuclear stucture forming predominantly in cancer cells; its prevalence positively correlates with metastatic capacity. Although several RNA-binding proteins have been characterized in PNC, the molecular function of this compartment remains unclear. Here we demonstrate that the cyclin-dependent kinase 13 (CDK13) is a newly identified constituent of PNC. CDK13 is a kinase involved in the regulation of gene expression and whose overexpression was found to alter pre-mRNA processing. In this study we show that CDK13 is enriched in PNC and co-localizes all along the cell cycle with the PNC component PTB. In contrast, neither the cyclins K and L, known to associate with CDK13, nor the potential kinase substrates accumulate in PNC. We further show that CDK13 overexpression increases PNC prevalence suggesting that CDK13 may be determinant for PNC formation. This result linked to the finding that CDK13 gene is amplified in different types of cancer indicate that this kinase can contribute to cancer development in human.	[Even, Yasmine; Escande, Marie-Line; Fayet, Claire; Geneviere, Anne-Marie] Univ Paris 06, Sorbonne Univ, CNRS, BIOM,Observ Oceanol, F-66650 Banyuls Sur Mer, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite	Geneviere, AM (corresponding author), Univ Paris 06, Sorbonne Univ, CNRS, BIOM,Observ Oceanol, F-66650 Banyuls Sur Mer, France.	anne-marie.geneviere@obs-banyuls.fr			Cancer Research foundation, "Association pour la Recherche sur le Cancer" [ARC 5290]; Cancer Research foundation, "Ligue contre le cancer" Languedoc-Roussillon (LR); Fondation pour la Recherche Medicale; "Ligue contre le cancer" LR; Soroptimist	Cancer Research foundation, "Association pour la Recherche sur le Cancer"; Cancer Research foundation, "Ligue contre le cancer" Languedoc-Roussillon (LR); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); "Ligue contre le cancer" LR; Soroptimist	This work was funded by grants from Cancer Research foundations, "Association pour la Recherche sur le Cancer" (ARC 5290), and "Ligue contre le cancer" Languedoc-Roussillon (LR). Y. Even received short-term fellowships from the "Fondation pour la Recherche Medicale", "Ligue contre le cancer" LR and Soroptimist. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansari D, 2015, J CANCER RES CLIN, V141, P369, DOI 10.1007/s00432-014-1817-x; Ball LJ, 2005, ANGEW CHEM INT EDIT, V44, P2852, DOI 10.1002/anie.200400618; Bartkowiak B, 2010, GENE DEV, V24, P2303, DOI 10.1101/gad.1968210; Berro R, 2008, J VIROL, V82, P7155, DOI 10.1128/JVI.02543-07; BIGGIOGERA M, 1990, DEVELOPMENT, V110, P1263; Blazek D, 2012, CELL CYCLE, V11, P1049, DOI 10.4161/cc.11.6.19678; Blazek D, 2011, GENE DEV, V25, P2158, DOI 10.1101/gad.16962311; Bubulya PA, 2004, J CELL BIOL, V167, P51, DOI 10.1083/jcb.200404120; Cao LH, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-10; Chen HR, 2014, EXP NEUROL, V261, P10, DOI 10.1016/j.expneurol.2014.06.024; Chen HH, 2007, BIOCHEM BIOPH RES CO, V354, P735, DOI 10.1016/j.bbrc.2007.01.049; Chen TP, 1999, MOL BIOL CELL, V10, P3015, DOI 10.1091/mbc.10.9.3015; Colwill K, 1996, EMBO J, V15, P265, DOI 10.1002/j.1460-2075.1996.tb00357.x; Dai Q, 2012, J BIOL CHEM, V287, P25344, DOI 10.1074/jbc.M111.321760; Duncan PI, 1998, EXP CELL RES, V241, P300, DOI 10.1006/excr.1998.4083; Even Y, 2006, J CELL BIOCHEM, V99, P890, DOI 10.1002/jcb.20986; Fernandez-Guerra A, 2006, DEV BIOL, V300, P238, DOI 10.1016/j.ydbio.2006.09.012; Galbraith MD, 2010, TRANSCR-AUSTIN, V1, P4, DOI 10.4161/trns.1.1.12373; GHETTI A, 1992, NUCLEIC ACIDS RES, V20, P3671, DOI 10.1093/nar/20.14.3671; Gromak N, 2003, EMBO J, V22, P6356, DOI 10.1093/emboj/cdg609; Guen VJ, 2013, P NATL ACAD SCI USA, V110, P19525, DOI 10.1073/pnas.1306814110; Harfmann AM, 1999, MOL BIOL CELL, V10, P3909, DOI 10.1091/mbc.10.11.3909; Hernandez-Verdun D, 2002, J CELL SCI, V115, P2265; Hu DL, 2003, J BIOL CHEM, V278, P8623, DOI 10.1074/jbc.M210057200; Huang S, 1997, J CELL BIOL, V137, P965, DOI 10.1083/jcb.137.5.965; Huang S, 2000, J STRUCT BIOL, V129, P233, DOI 10.1006/jsbi.2000.4247; Kamath RV, 2005, CANCER RES, V65, P246; Kim HE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043223; Kohoutek J, 2012, CELL DIV, V7, DOI 10.1186/1747-1028-7-12; Li PL, 2013, CHIN RES PERSP SOC, V1, P1; Liang K, 2015, MOL CELL BIOL, V35, P928, DOI 10.1128/MCB.01426-14; LIN CH, 1995, RNA, V1, P234; Loyer P, 2008, J BIOL CHEM, V283, P7721, DOI 10.1074/jbc.M708188200; Malumbres M, 2014, GENOME BIOL, V15, DOI 10.1186/gb4184; Mao YTS, 2011, TRENDS GENET, V27, P295, DOI 10.1016/j.tig.2011.05.006; Marques F, 2000, BIOCHEM BIOPH RES CO, V279, P832, DOI 10.1006/bbrc.2000.4042; MATERA AG, 1995, J CELL BIOL, V129, P1181, DOI 10.1083/jcb.129.5.1181; Norton JT, 2008, CANCER-AM CANCER SOC, V113, P861, DOI 10.1002/cncr.23632; Norton JT, 2009, J BIOL CHEM, V284, P4090, DOI 10.1074/jbc.M807255200; OCHS RL, 1985, BIOL CELL, V54, P123, DOI 10.1111/j.1768-322X.1985.tb00387.x; PATTON JG, 1991, GENE DEV, V5, P1237, DOI 10.1101/gad.5.7.1237; Philips AV, 1998, SCIENCE, V280, P737, DOI 10.1126/science.280.5364.737; Pollock C, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000679; RASKA I, 1989, BIOL CELL, V65, P79, DOI 10.1016/0248-4900(89)90013-0; Rodgers JT, 2010, CELL METAB, V11, P23, DOI 10.1016/j.cmet.2009.11.006; Savkur RS, 2001, NAT GENET, V29, P40, DOI 10.1038/ng704; Shepard PJ, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-242; Shin C, 2004, NAT REV MOL CELL BIO, V5, P727, DOI 10.1038/nrm1467; Sleeman JE, 1999, CURR OPIN CELL BIOL, V11, P372, DOI 10.1016/S0955-0674(99)80052-0; Soret J, 2003, Prog Mol Subcell Biol, V31, P89; Valcarcel J, 1997, CURR BIOL, V7, pR705, DOI 10.1016/S0960-9822(06)00361-7; Venables JP, 2004, CANCER RES, V64, P7647, DOI 10.1158/0008-5472.CAN-04-1910; Wang C, 2003, MOL BIOL CELL, V14, P2425, DOI 10.1091/mbc.E02-12-0818	54	13	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0149184	10.1371/journal.pone.0149184	http://dx.doi.org/10.1371/journal.pone.0149184			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26886422	gold, Green Published			2022-12-26	WOS:000371218400065
J	Liu, ZY; Brown, A; Fisher, D; Wu, YM; Warren, J; Cui, XX				Liu, Zhenyi; Brown, Andrew; Fisher, Dan; Wu, Yumei; Warren, Joe; Cui, Xiaoxia			Tissue Specific Expression of Cre in Rat Tyrosine Hydroxylase and Dopamine Active Transporter-Positive Neurons	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; MESSENGER-RNA EXPRESSION; GENE KNOCKOUT RATS; HOMOLOGOUS RECOMBINATION; PROGRAMMABLE NUCLEASES; BRAIN; MICROINJECTION; ESTABLISHMENT; CRISPR/CAS9; BLASTOCYSTS	The rat is a preferred model system over the mouse for neurological studies, and cell type-specific Cre expression in the rat enables precise ablation of gene function in neurons of interest, which is especially valuable for neurodegenerative disease modeling and optogenetics. Yet, few such Cre rats are available. Here we report the characterization of two Cre rats, tyrosine hydroxylase (TH)-Cre and dopamine active transporter (DAT or Slc6a3)-Cre, by using a combination of immunohistochemistry (IHC) and mRNA fluorescence in situ hybridization (FISH) as well as a fluorescent reporter for Cre activity. We detected Cre expression in expected neurons in both Cre lines. Interestingly, we also found that in Th-Cre rats, but not DAT-Cre rats, Cre is expressed in female germ cells, allowing germline excision of the floxed allele and hence the generation of whole-body knockout rats. In summary, our data demonstrate that targeted integration of Cre cassette lead to faithful recapitulation of expression pattern of the endogenous promoter, and mRNA FISH, in addition to IHC, is an effective method for the analysis of the spatiotemporal gene expression patterns in the rat brain, alleviating the dependence on high quality antibodies that are often not available against rat proteins. The Th-Cre and the DAT-Cre rat lines express Cre in selective subsets of dopaminergic neurons and should be particularly useful for researches on Parkinson's disease.	[Liu, Zhenyi; Brown, Andrew; Fisher, Dan; Wu, Yumei; Warren, Joe; Cui, Xiaoxia] SAGE Labs, St Louis, MO USA		Cui, XX (corresponding author), SAGE Labs, St Louis, MO USA.	xiaoxia.cui@horizondiscovery.com						Beck IM, 2015, TRANSGENIC RES, V24, P179, DOI 10.1007/s11248-014-9856-2; Branda CS, 2004, DEV CELL, V6, P7, DOI 10.1016/S1534-5807(03)00399-X; Brown AJ, 2013, NAT METHODS, V10, P638, DOI 10.1038/nmeth.2516; Buehr M, 2008, CELL, V135, P1287, DOI 10.1016/j.cell.2008.12.007; CERRUTI C, 1993, MOL BRAIN RES, V18, P181, DOI 10.1016/0169-328X(93)90187-T; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cui XX, 2011, NAT BIOTECHNOL, V29, P64, DOI 10.1038/nbt.1731; DOETSCHMAN T, 1987, NATURE, V330, P576, DOI 10.1038/330576a0; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; FUJITA M, 1993, MOL BRAIN RES, V19, P222, DOI 10.1016/0169-328X(93)90031-J; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; GALL CM, 1987, J COMP NEUROL, V266, P307, DOI 10.1002/cne.902660302; Geurts AM, 2009, SCIENCE, V325, P433, DOI 10.1126/science.1172447; GU H, 1994, SCIENCE, V265, P103, DOI 10.1126/science.8016642; Iannaccone PM, 2009, DIS MODEL MECH, V2, P206, DOI 10.1242/dmm.002733; Kim H, 2014, NAT REV GENET, V15, P321, DOI 10.1038/nrg3686; Li P, 2008, CELL, V135, P1299, DOI 10.1016/j.cell.2008.12.006; Liu ZY, 2015, DEVELOPMENT, V142, P1193, DOI 10.1242/dev.119529; Liu ZY, 2013, DEV CELL, V25, P585, DOI 10.1016/j.devcel.2013.05.022; Liu ZY, 2011, J CLIN INVEST, V121, P800, DOI 10.1172/JCI43114; Ma YW, 2014, FEBS J, V281, P3779, DOI 10.1111/febs.12935; Ma YW, 2014, CELL RES, V24, P122, DOI 10.1038/cr.2013.157; Madisen L, 2012, NAT NEUROSCI, V15, P793, DOI 10.1038/nn.3078; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Nagatsu T, 1995, ESSAYS BIOCHEM, V30, P15; Nunes I, 2003, P NATL ACAD SCI USA, V100, P4245, DOI 10.1073/pnas.0230529100; Sato Y, 2004, BIOCHEM BIOPH RES CO, V319, P1197, DOI 10.1016/j.bbrc.2004.04.204; Satoh A, 2010, J NEUROSCI, V30, P10220, DOI 10.1523/JNEUROSCI.1385-10.2010; Schonig K, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-77; Taniguchi H, 2011, NEURON, V71, P995, DOI 10.1016/j.neuron.2011.07.026; Tesson L, 2011, NAT BIOTECHNOL, V29, P695, DOI 10.1038/nbt.1940; THOMAS KR, 1987, CELL, V51, P503, DOI 10.1016/0092-8674(87)90646-5; Tong C, 2011, NAT PROTOC, V6, P827, DOI 10.1038/nprot.2011.338; Tong C, 2010, NATURE, V467, P211, DOI 10.1038/nature09368; Tsien JZ, 1996, CELL, V87, P1317, DOI 10.1016/S0092-8674(00)81826-7; Vooijs M, 2007, DEVELOPMENT, V134, P535, DOI 10.1242/dev.02733; Weber T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028283; Winkeler CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042005; Witten IB, 2011, NEURON, V72, P721, DOI 10.1016/j.neuron.2011.10.028; Zhang J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082818	41	15	15	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0149379	10.1371/journal.pone.0149379	http://dx.doi.org/10.1371/journal.pone.0149379			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26886559	Green Submitted, gold, Green Published			2022-12-26	WOS:000371218400077
J	Tallman, M				Tallman, Melissa			Shape Ontogeny of the Distal Femur in the Hominidae with Implications for the Evolution of Bipedality	PLOS ONE			English	Article							T-BOX GENES; LOWLAND GORILLAS; KNUCKLE-WALKING; GREAT APES; HOX GENES; HINDLIMB; TBX5; PITX1; HETEROCHRONY; MORPHOLOGY	Heterochrony has been invoked to explain differences in the morphology of modern humans as compared to other great apes. The distal femur is one area where heterochrony has been hypothesized to explain morphological differentiation among Plio-Pleistocene hominins. This hypothesis is evaluated here using geometric morphometric data to describe the ontogenetic shape trajectories of extant hominine distal femora and place Plio-Pleistocene hominins within that context. Results of multivariate statistical analyses showed that in both Homo and Gorilla, the shape of the distal femur changes significantly over the course of development, whereas that of Pan changes very little. Development of the distal femur of Homo is characterized by an elongation of the condyles, and a greater degree of enlargement of the medial condyle relative to the lateral condyle, whereas Gorilla are characterized by a greater degree of enlargement of the lateral condyle, relative to the medial. Early Homo and Australopithecus africanus fossils fell on the modern human ontogenetic shape trajectory and were most similar to either adult or adolescent modern humans while specimens of Australopithecus afarensis were more similar to Gorilla/Pan. These results indicate that shape differences among the distal femora of Plio-Pleistocene hominins and humans cannot be accounted for by heterochrony alone; heterochrony could explain a transition from the distal femoral shape of early Homo/A. africanus to modern Homo, but not a transition from A. afarensis to Homo. That change could be the result of genetic or epigenetic factors.	[Tallman, Melissa] Grand Valley State Univ, Dept Biomed Sci, Allendale, MI 49401 USA	Grand Valley State University	Tallman, M (corresponding author), Grand Valley State Univ, Dept Biomed Sci, Allendale, MI 49401 USA.	tallmame@gvsu.edu	Tallman, Melissa/H-3189-2019	Tallman, Melissa/0000-0003-3747-5600	Wenner-Gren Grant [7515]; National Science Foundation Doctoral Dissertation Improvement Grant [0550901]	Wenner-Gren Grant; National Science Foundation Doctoral Dissertation Improvement Grant(National Science Foundation (NSF))	This work was supported by Wenner-Gren Grant 7515 and the National Science Foundation Doctoral Dissertation Improvement Grant 0550901. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DC, 2004, ITAL J ZOOL, V71, P5, DOI 10.1080/11250000409356545; Agarwal P, 2003, DEVELOPMENT, V130, P623, DOI 10.1242/dev.00191; Ahn DG, 2002, NATURE, V417, P754, DOI 10.1038/nature00814; ALBERCH P, 1979, PALEOBIOLOGY, V5, P296, DOI 10.1017/S0094837300006588; Bastir M, 2007, P ROY SOC B-BIOL SCI, V274, P1125, DOI 10.1098/rspb.2006.0448; Berge C, 1996, NATO ADV SCI INST SE, V284, P441; Bookstein F.L., 1991, MORPHOMETRIC TOOLS L; BROMAGE TG, 1987, J HUM EVOL, V16, P257, DOI 10.1016/0047-2484(87)90002-9; Capellini TD, 2012, AM J PHYS ANTHROPOL, V147, P111; Chapman DL, 1996, DEV DYNAM, V206, P379, DOI 10.1002/(SICI)1097-0177(199608)206:4<379::AID-AJA4>3.0.CO;2-F; Dainton M, 1999, J HUM EVOL, V36, P171, DOI 10.1006/jhev.1998.0265; DeLaurier A, 2006, DEV BIOL, V299, P22, DOI 10.1016/j.ydbio.2006.06.055; Doran D, 1996, APE SOC, P213; Doran DM, 1997, J HUM EVOL, V32, P323, DOI 10.1006/jhev.1996.0095; Erlacher L, 1998, J BONE MINER RES, V13, P383, DOI 10.1359/jbmr.1998.13.3.383; FromentalRamain C, 1996, DEVELOPMENT, V122, P2997; GibsonBrown JJ, 1996, MECH DEVELOP, V56, P93, DOI 10.1016/0925-4773(96)00514-X; Godfrey LR, 1996, AM J PHYS ANTHROPOL, V99, P17, DOI 10.1002/ajpa.1330990102; Gordon AR, 2010, HUMAN ORIGINS DATABA; Gould S. J., 1977, ONTOGENY PHYLOGENY; Hasson P, 2010, DEV CELL, V18, P148, DOI 10.1016/j.devcel.2009.11.013; HEIPLE KG, 1971, AM J PHYS ANTHROPOL, V35, P75, DOI 10.1002/ajpa.1330350109; Hotten GC, 1996, GROWTH FACTORS, V13, P65, DOI 10.3109/08977199609034567; INOUYE SE, 1994, J HUM EVOL, V26, P459, DOI 10.1006/jhev.1994.1028; Johanson DC, 1978, NEW SPECIES GENUS AU, V28; KETTELKAMP DB, 1973, ARCH SURG-CHICAGO, V107, P406; Kim K, 2002, PALEOBIOLOGY, V28, P364, DOI 10.1666/0094-8373(2002)028<0364:MAOOAA>2.0.CO;2; Kivell TL, 2009, P NATL ACAD SCI USA, V106, P14241, DOI 10.1073/pnas.0901280106; Klingenberg CP, 2011, MOL ECOL RESOUR, V11, P353, DOI 10.1111/j.1755-0998.2010.02924.x; Kmita M, 2005, NATURE, V435, P1113, DOI 10.1038/nature03648; Lague MR, 2002, J HUM EVOL, V42, P609, DOI 10.1006/jhev.2002.0545; LEAKEY REF, 1973, NATURE, V242, P447, DOI 10.1038/242447a0; Logan M, 1999, SCIENCE, V283, P1736, DOI 10.1126/science.283.5408.1736; Lovejoy CO, 2007, GAIT POSTURE, V25, P325, DOI 10.1016/j.gaitpost.2006.05.001; Lovejoy CO, 1999, P NATL ACAD SCI USA, V96, P13247, DOI 10.1073/pnas.96.23.13247; LOVEJOY CO, 1988, SCI AM, V259, P118, DOI 10.1038/scientificamerican1188-118; Marcil A, 2003, DEVELOPMENT, V130, P45, DOI 10.1242/dev.00192; McDougall I, 2008, J GEOL SOC LONDON, V165, P549, DOI 10.1144/0016-76492006-170; MCNAMARA KJ, 1986, J PALEONTOL, V60, P4, DOI 10.1017/S0022336000021454; McNulty K. P., 2003, THESIS CITY U NEW YO; Merino R, 1999, DEV BIOL, V206, P33, DOI 10.1006/dbio.1998.9129; Minguillon C, 2005, DEV CELL, V8, P75, DOI 10.1016/j.devcel.2004.11.013; Mitteroecker P, 2005, EVOL DEV, V7, P244, DOI 10.1111/j.1525-142X.2005.05027.x; Mitteroecker P, 2004, J HUM EVOL, V46, P679, DOI 10.1016/j.jhevol.2004.03.006; Naiche LA, 2003, DEVELOPMENT, V130, P2681, DOI 10.1242/dev.00504; Preuschoft H, 1996, FOLIA PRIMATOL, V66, P82, DOI 10.1159/000157187; Rallis C, 2003, DEVELOPMENT, V130, P2741, DOI 10.1242/dev.00473; REMIS M, 1995, AM J PHYS ANTHROPOL, V97, P413, DOI 10.1002/ajpa.1330970408; Remis MJ, 1998, PRIMATE LOCOMOTION, P95; Robinson J.T., 1972, EARLY HOMINID POSTUR; Rohlf FJ, 1999, J CLASSIF, V16, P197, DOI 10.1007/s003579900054; Ross SR, 2006, APPL ANIM BEHAV SCI, V96, P143, DOI 10.1016/j.applanim.2005.06.005; RUFF C, 1988, J HUM EVOL, V17, P687, DOI 10.1016/0047-2484(88)90025-5; Ruvinsky I, 2000, DEV GENES EVOL, V210, P82, DOI 10.1007/s004270050014; Senut B., 1985, P193; SHEA BT, 1985, AM J PRIMATOL, V8, P183, DOI 10.1002/ajp.1350080208; Shubin N, 1997, NATURE, V388, P639, DOI 10.1038/41710; SMITH BH, 1991, AM J PHYS ANTHROPOL, V86, P157, DOI 10.1002/ajpa.1330860206; STERN JT, 1983, AM J PHYS ANTHROPOL, V60, P279, DOI 10.1002/ajpa.1330600302; Storm EE, 1999, DEV BIOL, V209, P11, DOI 10.1006/dbio.1999.9241; Susman RL, 2001, J HUM EVOL, V41, P607, DOI 10.1006/jhev.2001.0510; Szeto DP, 1999, GENE DEV, V13, P484, DOI 10.1101/gad.13.4.484; TABIN C, 1993, NATURE, V361, P692, DOI 10.1038/361692a0; Tallman M, 2010, THESIS CITY U NEW YO; Tallman M, 2013, ANAT REC, V296, P290, DOI 10.1002/ar.22624; Tardieu C, 1998, AM J PHYS ANTHROPOL, V107, P163; Tardieu C, 1999, AM J PHYS ANTHROPOL, V110, P365, DOI 10.1002/(SICI)1096-8644(199911)110:3<365::AID-AJPA8>3.0.CO;2-T; Tardieu C, 1997, CR ACAD SCI II A, V325, P899, DOI 10.1016/S1251-8050(99)80191-8; Torchia, 1998, DEV HUMAN CLIN ORIEN; Turley K, 2014, AM J PHYS ANTHROPOL, V154, P447, DOI 10.1002/ajpa.22528; Vrba ES, 1996, J ANTHROPOL RES, V52, P1; Walker Alan, 1993, P63; Zakany J, 2004, SCIENCE, V304, P1669, DOI 10.1126/science.1096049; Zelditch ML, 2000, EVOLUTION, V54, P1363; [No title captured]	75	9	9	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0148371	10.1371/journal.pone.0148371	http://dx.doi.org/10.1371/journal.pone.0148371			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26886416	Green Published, gold			2022-12-26	WOS:000371218400032
J	Xu, WF; Li, HZ; Ji, ZG; Yan, WG; Zhang, YS; Zhang, XB; Li, Q				Xu, Weifeng; Li, Hanzhong; Ji, Zhigang; Yan, Weigang; Zhang, Yushi; Zhang, Xuebin; Li, Qian			Retroperitoneal Laparoscopic Management of Paraganglioma: A Single Institute Experience	PLOS ONE			English	Article							OPEN ADRENALECTOMY; PHEOCHROMOCYTOMA; RESECTION; OUTCOMES	Objectives To explore the feasibility and safety of retroperitoneal laparoscopic resection of paraganglioma (RLPG) in a large study population. Methods In a six-year period, 49 patients with primary retroperitoneal paragangliomas (PG) underwent retroperitoneal laparoscopic surgery in a single center. Medical records were reviewed, and collected the following data, which were clinical characteristics, perioperative data (operative time, estimated blood loss, intraoperative hemodynamic changes, intraoperative and postoperative complications, and open conversions), and follow-up data (recurrence or distant metastases). Results All PGs were removed with negative tumor margin confirmed by postoperative histopathology. The operative time of RLPG was 101.59 +/- 31.12 minutes, and the estimated blood loss was 169.78 +/- 176.70ml. Intraoperative hypertensive and hypotensive episodes occurred in 25 cases and 27 cases, respectively. Two open conversions occurred. Two intraoperative complications occurred but were successfully managed endoscopically. Postoperative complications were minor and unremarkable. No local recurrence or distant metastasis were observed during the follow-up period. Conclusions Our experience indicates the feasibility and safety of resection of PGs in a relatively large study population.	[Xu, Weifeng; Li, Hanzhong; Ji, Zhigang; Yan, Weigang; Zhang, Yushi; Zhang, Xuebin] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Urol, Beijing 100730, Peoples R China; [Li, Qian] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Radiol, Boston, MA USA	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital	Li, HZ (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Urol, Beijing 100730, Peoples R China.	windslipper@163.com	Li, Qian/J-5883-2019	Li, Qian/0000-0001-8827-939X; Yan, Weigang/0000-0002-8995-1456				Bhandarkar D, 2012, SURG LAPARO ENDO PER, V22, pE148, DOI 10.1097/SLE.0b013e318248be1c; Chai YJ, 2014, INT J ENDOCRINOL, V2014, DOI 10.1155/2014/918346; Conzo G, 2013, INT J SURG, V11, P152, DOI 10.1016/j.ijsu.2012.12.007; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Disick Grant I S, 2007, Curr Urol Rep, V8, P83, DOI 10.1007/s11934-007-0025-5; Goers TA, 2013, SURG ENDOSC, V27, P428, DOI 10.1007/s00464-012-2451-9; Hattori S, 2014, J ENDOUROL, V28, P686, DOI 10.1089/end.2013.0706; Hisano M, 2012, CLINICS, V67, P161, DOI 10.6061/clinics/2012(Sup01)27; Lang B, 2008, J UROLOGY, V179, P57, DOI 10.1016/j.juro.2007.08.147; Li HZ, 2011, UROLOGY, V77, P131, DOI 10.1016/j.urology.2010.03.094; Li QY, 2010, J ENDOUROL, V24, P1441, DOI 10.1089/end.2010.0065; Nozaki T, 2013, J ENDOUROL, V27, P862, DOI 10.1089/end.2012.0745; ORiordain DS, 1996, WORLD J SURG, V20, P916, DOI 10.1007/s002689900139; Solorzano CC, 2007, ANN SURG ONCOL, V14, P3004, DOI 10.1245/s10434-007-9489-2; Thapar PM, 2006, J LAPAROENDOSC ADV S, V16, P620, DOI 10.1089/lap.2006.16.620; Tiberio GAM, 2008, SURG ENDOSC, V22, P1435, DOI 10.1007/s00464-008-9904-1; Tiyadath BN, 2007, ASIAN J SURG, V30, P244, DOI 10.1016/S1015-9584(08)60033-0; Tobias-Machado Marcos, 2006, Arch Esp Urol, V59, P49; Walz MK, 2006, WORLD J SURG, V30, P899, DOI 10.1007/s00268-005-0373-6; Walz MK, 2002, WORLD J SURG, V26, P1005, DOI 10.1007/s00268-002-6632-x; Wang JJ, 2014, J ENDOUROL, V28, P1345, DOI 10.1089/end.2014.0345; Yankovic F, 2014, J PEDIATR UROL, V10, DOI 10.1016/j.jpurol.2013.10.024; Zacharias M, 2006, EUR UROL, V49, P448, DOI 10.1016/j.eururo.2006.01.014	23	20	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0149433	10.1371/journal.pone.0149433	http://dx.doi.org/10.1371/journal.pone.0149433			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26885838	Green Submitted, Green Published, gold			2022-12-26	WOS:000371218400082
J	Dua, R; Comella, K; Butler, R; Castellanos, G; Brazille, B; Claude, A; Agarwal, A; Liao, J; Ramaswamy, S				Dua, Rupak; Comella, Kristin; Butler, Ryan; Castellanos, Glenda; Brazille, Bryn; Claude, Andrew; Agarwal, Arvind; Liao, Jun; Ramaswamy, Sharan			Integration of Stem Cell to Chondrocyte-Derived Cartilage Matrix in Healthy and Osteoarthritic States in the Presence of Hydroxyapatite Nanoparticles	PLOS ONE			English	Article							ARTICULAR-CARTILAGE; KNEE ARTHROSCOPIES; OSTEOCHONDRAL DEFECTS; ENGINEERED CARTILAGE; REPAIR; BONE; TRANSPLANTATION; REGENERATION; PHENOTYPE; FIXATION	We investigated the effectiveness of integrating tissue engineered cartilage derived from human bone marrow derived stem cells (HBMSCs) to healthy as well as osteoarthritic cartilage mimics using hydroxyapatite (HA) nanoparticles immersed within a hydrogel substrate. Healthy and diseased engineered cartilage from human chondrocytes (cultured in agar gels) were integrated with human bone marrow stem cell (HBMSC)-derived cartilaginous engineered matrix with and without HA, and evaluated after 28 days of growth. HBMSCs were seeded within photopolymerizable poly (ethylene glycol) diacrylate (PEGDA) hydrogels. In addition, we also conducted a preliminary in vivo evaluation of cartilage repair in rabbit knee chondral defects treated with subchondral bone microfracture and cell-free PEGDA with and without HA. Under in vitro conditions, the interfacial shear strength between tissue engineered cartilage derived from HBMSCs and osteoarthritic chondrocytes was significantly higher (p < 0.05) when HA nanoparticles were incorporated within the HBMSC culture system. Histological evidence confirmed a distinct spatial transition zone, rich in calcium phosphate deposits. Assessment of explanted rabbit knees by histology demonstrated that cellularity within the repair tissues that had filled the defects were of significantly higher number (p < 0.05) when HA was used. HA nanoparticles play an important role in treating chondral defects when osteoarthritis is a co-morbidity. We speculate that the calcified layer formation at the interface in the osteoarthritic environment in the presence of HA is likely to have attributed to higher interfacial strength found in vitro. From an in vivo standpoint, the presence of HA promoted cellularity in the tissues that subsequently filled the chondral defects. This higher presence of cells can be considered important in the context of accelerating long-term cartilage remodeling. We conclude that HA nanoparticles play an important role in engineered to native cartilage integration and cellular processes.	[Dua, Rupak; Comella, Kristin; Castellanos, Glenda; Ramaswamy, Sharan] Florida Int Univ, Dept Biomed Engn, TEMIM Lab, Tissue Engn Mech Imaging & Mat Lab, Miami, FL 33174 USA; [Butler, Ryan; Claude, Andrew] Mississippi State Univ, Coll Vet Med, Starkville, MS 39762 USA; [Brazille, Bryn; Liao, Jun] Mississippi State Univ, Dept Agr & Biol Engn, Tissue Bioengn Lab, Starkville, MS 39762 USA; [Agarwal, Arvind] Florida Int Univ, Dept Mech & Mat Engn, AMERI, Miami, FL 33174 USA	State University System of Florida; Florida International University; Mississippi State University; Mississippi State University; State University System of Florida; Florida International University	Ramaswamy, S (corresponding author), Florida Int Univ, Dept Biomed Engn, TEMIM Lab, Tissue Engn Mech Imaging & Mat Lab, Miami, FL 33174 USA.	sramaswa@fiu.edu	Dua, Rupak/AAJ-4313-2021; Sharan, Ramaswamy/H-4469-2019; Liao, Jun/AAW-3591-2021	Liao, Jun/0000-0003-1049-5783; Dua, Rupak/0000-0001-6897-7617; Ramaswamy, Sharan/0000-0003-4108-7141	College of Engineering and Computing at Florida International University (FIU); university graduate school at FIU	College of Engineering and Computing at Florida International University (FIU); university graduate school at FIU	Financial support for this study was provided by the College of Engineering and Computing at Florida International University (FIU). Additionally, a Dissertation Year Fellowship to support Rupak Dua, provided by the university graduate school at FIU is gratefully acknowledged.; Financial support for this study was provided by the College of Engineering and Computing at Florida International University (FIU). Additionally, a Dissertation Year Fellowship to support Rupak Dua, provided by the university graduate school at FIU is gratefully acknowledged. The authors sincerely acknowledge the equipment and services provided by the Advanced Materials Engineering Research Institute (AMERI) at FIU, related to the FEG-SEM with EDS capabilities. Finally, the authors wish to thank Dr. Nicolas Tsoukias for permitting access and use of facilities in his laboratory.	Aroen A, 2004, AM J SPORT MED, V32, P211, DOI 10.1177/0363546503259345; Benders KEM, 2013, TRENDS BIOTECHNOL, V31, P169, DOI 10.1016/j.tibtech.2012.12.004; Betz MW, 2008, J BIOMED MATER RES A, V86A, P662, DOI 10.1002/jbm.a.31640; Bruns TB, 2000, AM FAM PHYSICIAN, V61, P1383; Buckwalter JA, 1998, AAOS INSTR COURS LEC, V47, P487; Curl WW, 1997, ARTHROSCOPY, V13, P456, DOI 10.1016/S0749-8063(97)90124-9; Djouad F, 2009, TISSUE ENG PT A, V15, P2825, DOI [10.1089/ten.tea.2008.0663, 10.1089/ten.TEA.2008.0663]; Dua R, 2012, CYTOTECHNOLOGY, P1; Dua R, 2013, J BIOMEDICAL MAT R B; Fleming Braden C, 2005, Curr Opin Orthop, V16, P354, DOI 10.1097/01.bco.0000176423.07865.d2; Furman BD, 2006, J ORTHOP TRAUMA, V20, P719, DOI 10.1097/01.bot.0000211160.05864.14; Gebhard PM, 2003, J ORTHOPAED RES, V21, P96, DOI 10.1016/S0736-0266(02)00094-3; Gilbert J E, 1998, Am J Knee Surg, V11, P42; Goldring MB, 2012, THER ADV MUSCULOSKEL, V4, P269, DOI 10.1177/1759720X12448454; HERRMANN JB, 1970, ARCH SURG-CHICAGO, V100, P486; Hjelle K, 2002, ARTHROSCOPY, V18, P730, DOI 10.1053/jars.2002.32839; Hoemann CD, 2007, OSTEOARTHR CARTILAGE, V15, P78, DOI 10.1016/j.joca.2006.06.015; Huang CYC, 2004, ANAT REC PART A, V278A, P428, DOI 10.1002/ar.a.20010; Hunziker EB, 1998, J BONE JOINT SURG BR, V80B, P144, DOI 10.1302/0301-620X.80B1.7531; Khanarian NT, 2012, TISSUE ENG PT A, V18, P533, DOI [10.1089/ten.tea.2011.0279, 10.1089/ten.TEA.2011.0279]; Khashan Moursi, 2010, Harefuah, V149, P542; Kim YS, 2012, AM J SPORT MED, V40, P1824, DOI 10.1177/0363546512449292; Kuo CK, 2006, CURR OPIN RHEUMATOL, V18, P64, DOI 10.1097/01.bor.0000198005.88568.df; Lopa S, 2014, TISSUE ENG A; Martinez-Sanchez A, 2012, J BIOL CHEM, V287, P916, DOI 10.1074/jbc.M111.302430; Messner K, 1996, ACTA ORTHOP SCAND, V67, P523, DOI 10.3109/17453679608996682; Munirah S, 2010, TISSUE CELL, V42, P282, DOI 10.1016/j.tice.2010.07.002; MYERS TW, 1991, BIOCHEMISTRY-US, V30, P7661, DOI 10.1021/bi00245a001; Nettles DL, 2008, TISSUE ENG PT A, V14, P1133, DOI [10.1089/ten.tea.2007.0245, 10.1089/tea.2007.0245]; Panseri S, 2012, KNEE SURG SPORT TR A, V20, P1182, DOI 10.1007/s00167-011-1655-1; Perkins GL, 2005, DIFFERENTIATION, V73, P199, DOI 10.1111/j.1432-0436.2005.00024.x; Ramaswamy S, 2008, TISSUE ENG PART C-ME, V14, P243, DOI 10.1089/ten.tec.2007.0423; Ramaswamy S, 2008, J BIOMED MATER RES B, V86B, P375, DOI 10.1002/jbm.b.31030; ROBERTSON DB, 1986, AM J SPORT MED, V14, P398, DOI 10.1177/036354658601400512; Shelbourne KD, 2003, J BONE JOINT SURG AM, V85A, P8, DOI 10.2106/00004623-200300002-00002; Smyth NA, 2013, J BONE JOINT SURG AM, V95A, P2185, DOI 10.2106/JBJS.L.01497; Stengel D, 2009, AM J SPORT MED, V37, P1692, DOI 10.1177/0363546509333008; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vijayan S, 2010, INDIAN J ORTHOP, V44, P238, DOI 10.4103/0019-5413.65136; Wang DA, 2007, NAT MATER, V6, P385, DOI 10.1038/nmat1890; Zantop T, 2004, KNEE SURG SPORT TR A, V12, P520, DOI 10.1007/s00167-004-0509-5	41	14	14	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149121	10.1371/journal.pone.0149121	http://dx.doi.org/10.1371/journal.pone.0149121			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26871903	gold, Green Submitted, Green Published			2022-12-26	WOS:000370054100108
J	Li, Q; Mao, M; Qiu, YL; Liu, GF; Sheng, TT; Yu, XF; Wang, S; Zhu, DL				Li, Qian; Mao, Min; Qiu, Yanli; Liu, Gaofeng; Sheng, Tingting; Yu, Xiufeng; Wang, Shuang; Zhu, Daling			Key Role of ROS in the Process of 15-Lipoxygenase/15-Hydroxyeicosatetraenoiccid-Induced Pulmonary Vascular Remodeling in Hypoxia Pulmonary Hypertension	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; NITRIC-OXIDE SYNTHASE; GROWTH-FACTOR; 15-HYDROXYEICOSATETRAENOIC ACID; OXIDATIVE STRESS; INDUCED PROLIFERATION; ENDOTHELIAL-CELLS; NAD(P)H OXIDASE; NADPH OXIDASES; ARTERY	We previously reported that 15-lipoxygenase (15-LO) and its metabolite 15-hydroxyeicosatetraenoic acid (15-HETE) were up-regulated in pulmonary arterial cells from both pulmonary artery hypertension patients and hypoxic rats and that these factors mediated the progression of pulmonary hypertension (PH) by affecting the proliferation and apoptosis of pulmonary arterial (PA) cells. However, the underlying mechanisms of the remodeling induced by 15-HETE have remained unclear. As reactive oxygen species (ROS) and 15-LO are both induced by hypoxia, it is possible that ROS are involved in the events of hypoxiainduced 15-LO expression that lead to PH. We employed immunohistochemistry, tube formation assays, bromodeoxyuridine (BrdU) incorporation assays, and cell cycle analyses to explore the role of ROS in the process of 15-HETE-mediated hypoxic pulmonary hypertension (HPH). We found that exogenous 15-HETE facilitated the generation of ROS and that this effect was mainly localized to mitochondria. In particular, the mitochondrial electron transport chain and nicotinamide-adenine dinucleotide phosphate oxidase 4 (Nox4) were responsible for the significant 15-HETE-stimulated increase in ROS production. Moreover, ROS induced by 15-HETE stimulated endothelial cell (EC) migration and promoted pulmonary artery smooth muscle cell (PASMC) proliferation under hypoxia via the p38 MAPK pathway. These results indicated that 15-HETE-regulated ROS mediated hypoxia-induced pulmonary vascular remodeling (PVR) via the p38 MAPK pathway.	[Li, Qian; Qiu, Yanli; Wang, Shuang] Harbin Med Univ, Dept Pharmaceut Anal, Coll Pharm, Harbin, Heilongjiang Pr, Peoples R China; [Li, Qian] Purdue Univ, Biol Sci, W Lafayette, IN 47907 USA; [Mao, Min; Sheng, Tingting; Yu, Xiufeng; Zhu, Daling] Harbin Med Univ Daqing, Dept Pathophysiol, Daqing, Heilongjiang Pr, Peoples R China; [Mao, Min; Zhu, Daling] Harbin Med Univ, Biopharmaceut Key Lab Harbin, Harbin, Heilongjiang Pr, Peoples R China; [Liu, Gaofeng] Harbin Med Univ, Affiliated Hosp 2, Dept Pharm, Harbin, Heilongjiang Pr, Peoples R China	Harbin Medical University; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Harbin Medical University; Harbin Medical University; Harbin Medical University	Zhu, DL (corresponding author), Harbin Med Univ Daqing, Dept Pathophysiol, Daqing, Heilongjiang Pr, Peoples R China.; Zhu, DL (corresponding author), Harbin Med Univ, Biopharmaceut Key Lab Harbin, Harbin, Heilongjiang Pr, Peoples R China.	liqian@ems.hrbmu.edu.cn			National Natural Science Foundation of China [31100835]; National Foundation for Post-doctoral Scholars [2013M531066]; Heilongjiang Province Foundation for Post-doctoral Scholars [LBH-Z11059]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Foundation for Post-doctoral Scholars; Heilongjiang Province Foundation for Post-doctoral Scholars	The authors are grateful for financial support from the National Natural Science Foundation of China (grant number 31100835); the National Foundation for Post-doctoral Scholars (2013M531066); the Heilongjiang Province Foundation for Post-doctoral Scholars (LBH-Z11059).	Ahmad M, 2010, AM J PHYSIOL-HEART C, V298, pH1879, DOI 10.1152/ajpheart.01228.2009; Archer SL, 2008, AM J PHYSIOL-HEART C, V294, pH570, DOI 10.1152/ajpheart.01324.2007; Barman SA, 2014, ARTERIOSCLER THROMB; Basuroy S, 2011, AM J PHYSIOL-CELL PH, V300, pC256, DOI 10.1152/ajpcell.00272.2010; Brahimi-Horn MC, 2007, J MOL MED-JMM, V85, P1301, DOI 10.1007/s00109-007-0281-3; DeMarco VG, 2010, WORLD J CARDIOL, V2, P316, DOI 10.4330/wjc.v2.i10.316; Fan YF, 2013, CARDIOVASC RES, V99, P395, DOI 10.1093/cvr/cvt109; Fernandes DJ, 2004, BRIT J PHARMACOL, V142, P1182, DOI 10.1038/sj.bjp.0705809; Fike CD, 2013, PULM CIRC, V3, P551, DOI 10.1086/674307; Fu SF, 2014, EXP THER MED, V8, P1453, DOI 10.3892/etm.2014.1971; Gao WY, 2014, MOLECULES, V19, P8503, DOI 10.3390/molecules19068503; Geiszt M, 2000, P NATL ACAD SCI USA, V97, P8010, DOI 10.1073/pnas.130135897; Graham KA, 2010, CANCER BIOL THER, V10, DOI 10.4161/cbt.10.3.12207; Guzik TJ, 2006, DRUG DISCOV TODAY, V11, P524, DOI 10.1016/j.drudis.2006.04.003; HISLOP A, 1976, BRIT J EXP PATHOL, V57, P542; Humbert M, 2004, NEW ENGL J MED, V351, P1425, DOI 10.1056/NEJMra040291; Ismail S, 2009, AM J PHYSIOL-LUNG C, V296, pL489, DOI 10.1152/ajplung.90488.2008; Jiang J, 2011, J RECEPT SIG TRANSD, V31, P45, DOI 10.3109/10799893.2010.512013; Lan AP, 2013, NEUROCHEM RES, V38, P1454, DOI 10.1007/s11064-013-1044-x; Landmesser U, 2003, J CLIN INVEST, V111, P1201, DOI 10.1172/JCI200314172; Lee SH, 2010, AM J PHYSIOL-CELL PH, V298, pC847, DOI 10.1152/ajpcell.00418.2009; Li Q, 2014, MOLECULES, V19, P19036, DOI 10.3390/molecules191119036; Liu Y, 2012, INT J BIOCHEM CELL B, V44, P1184, DOI 10.1016/j.biocel.2012.04.009; Lu CL, 2006, CAN J PHYSIOL PHARM, V84, P1061, DOI 10.1139/Y06-057; Ma C, 2014, BRIT J PHARMACOL, V171, P3352, DOI 10.1111/bph.12594; Ma C, 2011, HYPERTENSION, V58, P679, DOI 10.1161/HYPERTENSIONAHA.111.171561; Ma J, 2013, INT J BIOCHEM CELL B, V45, P1031, DOI 10.1016/j.biocel.2013.02.018; Ma J, 2010, J CELL PHYSIOL, V222, P82, DOI 10.1002/jcp.21923; Mandegar M, 2004, MICROVASC RES, V68, P75, DOI 10.1016/j.mvr.2004.06.001; Montezano AC, 2011, CLIN SCI, V120, P131, DOI 10.1042/CS20100384; Morrell NW, 2009, J AM COLL CARDIOL, V54, pS20, DOI 10.1016/j.jacc.2009.04.018; Nie XW, 2013, INT J BIOCHEM CELL B, V45, P964, DOI 10.1016/j.biocel.2013.01.017; Nie XW, 2012, PROSTAG OTH LIPID M, V97, P50, DOI 10.1016/j.prostaglandins.2011.11.003; Nozik-Grayck E, 2007, ADV EXP MED BIOL, V618, P101; Ogura S, 2013, AM J PHYSIOL-HEART C, V305, pH155, DOI 10.1152/ajpheart.00169.2012; Park J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023211; Park S, 2010, J MOL MED, V88, P807, DOI 10.1007/s00109-010-0622-5; Pokreisz P, 2006, HYPERTENSION, V47, P762, DOI 10.1161/01.HYP.0000208299.62535.58; Ray PD, 2012, CELL SIGNAL, V24, P981, DOI 10.1016/j.cellsig.2012.01.008; Recchia AG, 2011, J BIOL CHEM, V286, P10773, DOI 10.1074/jbc.M110.172247; Schramm A, 2012, VASC PHARMACOL, V56, P216, DOI 10.1016/j.vph.2012.02.012; Schumacker Paul T, 2011, Proc Am Thorac Soc, V8, P477, DOI 10.1513/pats.201103-032MW; Shen TT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083132; Sturrock A, 2006, AM J PHYSIOL-LUNG C, V290, pL661, DOI 10.1152/ajplung.00269.2005; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296; Touyz RM, 2012, CIRC RES, V110, P1159, DOI 10.1161/CIRCRESAHA.112.269068; Wang S, 2010, PROSTAG OTH LIPID M, V91, P51, DOI 10.1016/j.prostaglandins.2009.12.007; Ward JPT, 2006, J APPL PHYSIOL, V101, P993, DOI 10.1152/japplphysiol.00480.2006; Waypa GB, 2002, CIRC RES, V91, P719, DOI 10.1161/01.RES.0000036751.04896.F1; Waypa GB, 2008, EXP PHYSIOL, V93, P133, DOI 10.1113/expphysiol.2007.041236; Wei LP, 2014, CELL SIGNAL, V26, P1476, DOI 10.1016/j.cellsig.2014.03.008; Weir EK, 2006, J APPL PHYSIOL, V101, P995, DOI 10.1152/japplphysiol.00480a.2006; Welsh DJ, 2006, PULM PHARMACOL THER, V19, P128, DOI 10.1016/j.pupt.2005.04.008; Wolin MS, 2009, AM J PHYSIOL-HEART C, V296, pH539, DOI 10.1152/ajpheart.01167.2008; Xiao GF, 2014, EUR J PHARMACOL, V727, P29, DOI 10.1016/j.ejphar.2014.01.051; Yang XD, 2002, AM J RESP CELL MOL, V27, P688, DOI 10.1165/rcmb.2002-0067OC; Yuan DD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096510; Zhu D, 2014, J CELL MOL MED; Zinkevich NS, 2011, AM J PHYSIOL-HEART C, V301, pH647, DOI 10.1152/ajpheart.01271.2010	59	22	24	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149164	10.1371/journal.pone.0149164	http://dx.doi.org/10.1371/journal.pone.0149164			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26871724	Green Submitted, Green Published, gold			2022-12-26	WOS:000370054100116
J	Neumann, B; Wu, HJ; Hackmann, A; Krebber, H				Neumann, Bettina; Wu, Haijia; Hackmann, Alexandra; Krebber, Heike			Nuclear Export of Pre-Ribosomal Subunits Requires Dbp5, but Not as an RNA-Helicase as for mRNA Export	PLOS ONE			English	Article							BOX PROTEIN DBP5; SACCHAROMYCES-CEREVISIAE; PORE COMPLEX; YEAST; TRANSLATION; NUP159; GLE1; TRANSCRIPTION; NUCLEOPORIN; NMD3P	The DEAD-box RNA-helicase Dbp5/Rat8 is known for its function in nuclear mRNA export, where it displaces the export receptor Mex67 from the mRNA at the cytoplasmic side of the nuclear pore complex (NPC). Here we show that Dbp5 is also required for the nuclear export of both pre-ribosomal subunits. Yeast temperature-sensitive dbp5 mutants accumulate both ribosomal particles in their nuclei. Furthermore, Dbp5 genetically and physically interacts with known ribosomal transport factors such as Nmd3. Similar to mRNA export we show that also for ribosomal transport Dbp5 is required at the cytoplasmic side of the NPC. However, unlike its role in mRNA export, Dbp5 does not seem to undergo its ATPase cycle for this function, as ATPase-deficient dbp5 mutants that selectively inhibit mRNA export do not affect ribosomal transport. Furthermore, mutants of GLE1, the ATPase stimulating factor of Dbp5, show no major ribosomal export defects. Consequently, while Dbp5 uses its ATPase cycle to displace the export receptor Mex67 from the translocated mRNAs, Mex67 remains bound to ribosomal subunits upon transit to the cytoplasm, where it is detectable on translating ribosomes. Therefore, we propose a model, in which Dbp5 supports ribosomal transport by capturing ribosomal subunits upon their cytoplasmic appearance at the NPC, possibly by binding export factors such as Mex67. Thus, our findings reveal that although different ribonucleoparticles, mRNAs and pre-ribosomal subunits, use shared export factors, they utilize different transport mechanisms.	[Neumann, Bettina; Wu, Haijia; Hackmann, Alexandra; Krebber, Heike] Univ Gottingen, GZMB, Inst Mikrobiol & Genet, Abt Mol Genet, Gottingen, Germany; [Wu, Haijia] Carl von Ossietzky Univ Oldenburg, Biochem Grp, Dept Neurosci, Oldenburg, Germany	University of Gottingen; Carl von Ossietzky Universitat Oldenburg	Krebber, H (corresponding author), Univ Gottingen, GZMB, Inst Mikrobiol & Genet, Abt Mol Genet, Gottingen, Germany.	heike.krebber@biologie.uni-goettingen.de			Deutsche Forschungsgemeinschaft [SFB860]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft SFB860 to HK. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcazar-Roman AR, 2006, NAT CELL BIOL, V8, P711, DOI 10.1038/ncb1427; Baierlein C, 2013, MOL CELL BIOL, V33, P4811, DOI 10.1128/MCB.00873-13; Bassler J, 2001, MOL CELL, V8, P517, DOI 10.1016/S1097-2765(01)00342-2; Bolger Timothy A, 2008, Cell, V134, P624, DOI 10.1016/j.cell.2008.06.027; Del Priore V, 1997, J CELL SCI, V110, P2987; DelPriore V, 1996, MOL BIOL CELL, V7, P1601, DOI 10.1091/mbc.7.10.1601; Estruch F, 2003, MOL BIOL CELL, V14, P1664, DOI 10.1091/mbc.E02-09-0602; Estruch F, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-80; Faza MB, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002915; Gadal O, 2001, MOL CELL BIOL, V21, P3405, DOI 10.1128/MCB.21.10.3405-3415.2001; Garre E, 2012, MOL BIOL CELL, V23, P137, DOI 10.1091/mbc.E11-05-0419; Gerhardy S, 2014, CHROMOSOMA, V123, P327, DOI 10.1007/s00412-014-0463-z; Gleizes PE, 2001, J CELL BIOL, V155, P923, DOI 10.1083/jcb.200108142; GORSCH LC, 1995, J CELL BIOL, V129, P939, DOI 10.1083/jcb.129.4.939; Gross T, 2007, SCIENCE, V315, P646, DOI 10.1126/science.1134641; Hackmann A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4123; Hackmann A, 2011, EMBO REP, V12, P1024, DOI 10.1038/embor.2011.155; Hedges J, 2005, EMBO J, V24, P567, DOI 10.1038/sj.emboj.7600547; Ho JHN, 2000, J CELL BIOL, V151, P1057, DOI 10.1083/jcb.151.5.1057; Hodge CA, 1999, EMBO J, V18, P5778, DOI 10.1093/emboj/18.20.5778; Hodge CA, 2011, GENE DEV, V25, P1052, DOI 10.1101/gad.2041611; KADOWAKI T, 1994, MOL BIOL CELL, V5, P1253, DOI 10.1091/mbc.5.11.1253; Kappel L, 2012, J CELL BIOL, V199, P771, DOI 10.1083/jcb.201205021; Kelly SM, 2009, TRAFFIC, V10, P1199, DOI 10.1111/j.1600-0854.2009.00944.x; Lei EP, 2001, GENE DEV, V15, P1771, DOI 10.1101/gad.892401; Linder P, 2011, NAT REV MOL CELL BIO, V12, P505, DOI 10.1038/nrm3154; Lund MK, 2005, MOL CELL, V20, P645, DOI 10.1016/j.molcel.2005.10.005; Milkereit P, 2003, J BIOL CHEM, V278, P4072, DOI 10.1074/jbc.M208898200; Moy TI, 2002, J CELL SCI, V115, P2985; Moy TI, 1999, GENE DEV, V13, P2118, DOI 10.1101/gad.13.16.2118; Murphy R, 1996, NATURE, V383, P357, DOI 10.1038/383357a0; Noble KN, 2011, GENE DEV, V25, P1065, DOI 10.1101/gad.2040611; Panse VG, 2010, TRENDS BIOCHEM SCI, V35, P260, DOI 10.1016/j.tibs.2010.01.001; Pertschy B, 2007, MOL CELL BIOL, V27, P6581, DOI 10.1128/MCB.00668-07; Scarcelli JJ, 2008, GENETICS, V179, P1945, DOI 10.1534/genetics.108.091256; Schmitt C, 1999, EMBO J, V18, P4332, DOI 10.1093/emboj/18.15.4332; Snay-Hodge CA, 1998, EMBO J, V17, P2663, DOI 10.1093/emboj/17.9.2663; Stage-Zimmermann T, 2000, MOL BIOL CELL, V11, P3777, DOI 10.1091/mbc.11.11.3777; Thomas F, 2003, J CELL SCI, V116, P2409, DOI 10.1242/jcs.00464; Tieg B, 2013, BBA-GENE REGUL MECH, V1829, P791, DOI 10.1016/j.bbagrm.2012.10.010; Tran EJ, 2007, MOL CELL, V28, P850, DOI 10.1016/j.molcel.2007.09.019; Trotta CR, 2003, EMBO J, V22, P2841, DOI 10.1093/emboj/cdg249; Tseng SSL, 1998, EMBO J, V17, P2651, DOI 10.1093/emboj/17.9.2651; Weirich CS, 2006, NAT CELL BIOL, V8, P668, DOI 10.1038/ncb1424; Weirich CS, 2004, MOL CELL, V16, P749, DOI 10.1016/j.molcel.2004.10.032; Wente SR, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000562; Windgassen M, 2004, MOL CELL BIOL, V24, P10479, DOI 10.1128/MCB.24.23.10479-10491.2004; Wu HJ, 2014, CELL REP, V8, P1630, DOI 10.1016/j.celrep.2014.08.021; Yao W, 2007, MOL CELL, V26, P51, DOI 10.1016/j.molcel.2007.02.018; Zemp I, 2009, J CELL BIOL, V185, P1167, DOI 10.1083/jcb.200904048	50	17	17	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149571	10.1371/journal.pone.0149571	http://dx.doi.org/10.1371/journal.pone.0149571			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26872259	Green Published, Green Submitted, gold			2022-12-26	WOS:000370054100165
J	Huang, B; Song, JH; Cheng, Y; Abraham, JM; Ibrahim, S; Sun, Z; Ke, X; Meltzer, SJ				Huang, B.; Song, J. H.; Cheng, Y.; Abraham, J. M.; Ibrahim, S.; Sun, Z.; Ke, X.; Meltzer, S. J.			Long non-coding antisense RNA KRT7-AS is activated in gastric cancers and supports cancer cell progression by increasing KRT7 expression	ONCOGENE			English	Article							NATURAL ANTISENSE; ESOPHAGEAL ADENOCARCINOMA; COLORECTAL-CANCER; GENE-EXPRESSION; MESSENGER-RNA; TRANSCRIPT; H19; OVEREXPRESSION; PROLIFERATION; EVOLUTION	Alterations in long non-coding RNAs (lncRNAs) are associated with human carcinogenesis. One group of lncRNAs, which are antisense in orientation to coding mRNAs (ASs), have been recently described in cancers but are poorly understood. We sought to identify ASs involved in human gastric cancer (GC) and to elucidate their mechanisms of action in carcinogenesis. We performed massively parallel RNA sequencing in GCs and matched normal tissues, as well as in GC-derived and normal gastric epithelial cell lines. One AS, designated Homo sapiens keratin 7 (KRT7-AS), was selected due to its marked upregulation and concordant expression with its cognate sense counterpart, KRT7, in GC tissues and cell lines. KRT7-AS formed an RNA-RNA hybrid with KRT7 and controlled KRT7 expression at both the mRNA and the post-transcriptional levels. Moreover, forced overexpression of the KRT7-overlapping region (OL) of KRT7-AS (but not its non-KRT7-OL portions) increased keratin 7 protein levels in cells. Finally, forced overexpression of full-length KRT7-AS or OL KRT7-AS (but not its non-KRT7-OL regions) promoted GC cell proliferation and migration. We conclude that lncRNA KRT7-AS promotes GC, at least in part, by increasing KRT7 expression.	[Huang, B.] Tongji Univ, Sch Med, Tongji Hosp, Dept Gastroenterol, Shanghai, Peoples R China; [Huang, B.; Song, J. H.; Cheng, Y.; Abraham, J. M.; Ibrahim, S.; Sun, Z.; Ke, X.; Meltzer, S. J.] Johns Hopkins Univ, Sch Med, Dept Med, Div Gastroenterol, 1503 E Jefferson St,Room 112, Baltimore, MD 21287 USA; [Huang, B.; Song, J. H.; Cheng, Y.; Abraham, J. M.; Ibrahim, S.; Sun, Z.; Ke, X.; Meltzer, S. J.] Johns Hopkins Univ, Sch Med, Dept Oncol, Div Gastroenterol, 1503 E Jefferson St,Room 112, Baltimore, MD 21287 USA; [Huang, B.; Song, J. H.; Cheng, Y.; Abraham, J. M.; Ibrahim, S.; Sun, Z.; Ke, X.; Meltzer, S. J.] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, 1503 E Jefferson St,Room 112, Baltimore, MD 21287 USA	Tongji University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine	Meltzer, SJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Div Gastroenterol, 1503 E Jefferson St,Room 112, Baltimore, MD 21287 USA.; Meltzer, SJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Oncol, Div Gastroenterol, 1503 E Jefferson St,Room 112, Baltimore, MD 21287 USA.; Meltzer, SJ (corresponding author), Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, 1503 E Jefferson St,Room 112, Baltimore, MD 21287 USA.	smeltzer@jhmi.edu			NIH [CA190040, CA85069, DK087454, CA133012, CA173390]; China Scholarship Council (CSC); Joint Johns Hopkins University-Tongji University of China student scholarship; NATIONAL CANCER INSTITUTE [R01CA190040, R01CA146799, U01CA085069, R21CA173390, R01CA133012] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK087454] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); China Scholarship Council (CSC)(China Scholarship Council); Joint Johns Hopkins University-Tongji University of China student scholarship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	SJM, the Harry and Betty Myerberg/Thomas R Hendrix Professor of Gastroenterology, is also an American Cancer Society Clinical Research Professor and was supported by NIH grants CA190040, CA85069, DK087454, CA133012, CA173390, and Sidney Kimmel Comprehensive Cancer Center Core facilities. BH was supported by an Exchange Scholarship from the China Scholarship Council (CSC). BH is a recipient of a Joint Johns Hopkins University-Tongji University of China student scholarship. BH was supported by an Exchange Scholarship from the China Scholarship Council (CSC).	Alam T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109443; Balbin OA, 2015, GENOME RES, V25, P1068, DOI 10.1101/gr.180596.114; Byun HM, 2007, CANCER RES, V67, P10753, DOI 10.1158/0008-5472.CAN-07-0329; Carrieri C, 2012, NATURE, V491, P454, DOI 10.1038/nature11508; Cayre A, 2003, BREAST CANCER RES, V5, pR223, DOI 10.1186/bcr652; Cunnington MS, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000899; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Faghihi MA, 2008, NAT MED, V14, P723, DOI 10.1038/nm1784; Faghihi MA, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-r56; Faghihi MA, 2009, NAT REV MOL CELL BIO, V10, P637, DOI 10.1038/nrm2738; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Harbaum L, 2011, HISTOPATHOLOGY, V59, P225, DOI 10.1111/j.1365-2559.2011.03694.x; Houghton J, 2005, GASTROENTEROLOGY, V128, P1567, DOI 10.1053/j.gastro.2005.03.037; Iacobucci I, 2011, LEUKEMIA RES, V35, P1052, DOI 10.1016/j.leukres.2011.02.020; Kanduc D, 2002, J VIROL, V76, P7040, DOI 10.1128/JVI.76.14.7040-7048.2002; Karantza V, 2011, ONCOGENE, V30, P127, DOI 10.1038/onc.2010.456; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; Kimura T, 2013, CELL MOL LIFE SCI, V70, P1451, DOI 10.1007/s00018-012-1216-x; Lambaudie E, 2014, ANTICANCER RES, V34, P177; Liang WC, 2015, ONCOTARGET, V6, P22513, DOI 10.18632/oncotarget.4154; Medrzycki M, 2014, CANCER RES, V74, P6463, DOI 10.1158/0008-5472.CAN-13-2922; Michael DR, 2011, J BIOL CHEM, V286, P19523, DOI 10.1074/jbc.M111.233916; Munroe SH, 2006, CELL MOL LIFE SCI, V63, P2102, DOI 10.1007/s00018-006-6070-2; Nishizawa M, 2015, FRONT BIOSCI-LANDMRK, V20, P1, DOI 10.2741/4297; Oue N, 2012, ANN SURG ONCOL, V19, P1902, DOI 10.1245/s10434-011-2175-4; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Pujal J, 2009, FASEB J, V23, P1366, DOI 10.1096/fj.08-115576; Salameh A, 2015, P NATL ACAD SCI USA, V112, P8403, DOI 10.1073/pnas.1507882112; Sandilands A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064404; Saxonov S, 2006, P NATL ACAD SCI USA, V103, P1412, DOI 10.1073/pnas.0510310103; Schmid M, 2015, CELL REP, V12, P128, DOI 10.1016/j.celrep.2015.06.008; Span PN, 2011, ENDOCR-RELAT CANCER, V18, P323, DOI 10.1530/ERC-10-0184; Su WY, 2012, CELL RES, V22, P1374, DOI 10.1038/cr.2012.57; Tan JY, 2015, GENOME RES, V25, P655, DOI 10.1101/gr.181974.114; Thrash-Bingham CA, 1999, JNCI-J NATL CANCER I, V91, P143, DOI 10.1093/jnci/91.2.143; Villegas VE, 2015, INT J MOL SCI, V16, P3251, DOI 10.3390/ijms16023251; Wahlestedt C, 2006, DRUG DISCOV TODAY, V11, P503, DOI 10.1016/j.drudis.2006.04.013; Wight M, 2013, ESSAYS BIOCHEM, V54, P91, DOI [10.1042/BSE0540091, 10.1042/bse0540091]; Wu WJ, 2013, GASTROENTEROLOGY, V144, P956, DOI 10.1053/j.gastro.2013.01.019; Xi QL, 2014, INT J BIOCHEM CELL B, V55, P242, DOI 10.1016/j.biocel.2014.09.012; Yamaguchi N, 2001, LANCET ONCOL, V2, P88, DOI 10.1016/S1470-2045(00)00225-4; Yang F, 2012, FEBS J, V279, P3159, DOI 10.1111/j.1742-4658.2012.08694.x; Yang X, 2014, GUT, V63, P881, DOI 10.1136/gutjnl-2013-305266; Yap KL, 2010, MOL CELL, V38, P662, DOI 10.1016/j.molcel.2010.03.021; Zhou XY, 2015, SCI REP-UK, V5, DOI 10.1038/srep11516	45	104	107	2	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 15	2016	35	37					4927	4936		10.1038/onc.2016.25	http://dx.doi.org/10.1038/onc.2016.25			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DW0LA	26876208	Green Accepted			2022-12-26	WOS:000383330700010
J	Xie, X; Lozano, G; Siddik, ZH				Xie, X.; Lozano, G.; Siddik, Z. H.			Heterozygous p53(V172F) mutation in cisplatin-resistant human tumor cells promotes MDM4 recruitment and decreases stability and transactivity of p53	ONCOGENE			English	Article							WILD-TYPE P53; DNA-DAMAGE; DEGRADATION; ACTIVATION; PHOSPHORYLATION; PROTEIN; CANCER; SENSITIVITY; APOPTOSIS; IMPACT	Cisplatin is an important antitumor agent, but its clinical utility is often limited by multifactorial mechanism of resistance. Loss of tumor suppressor p53 function is a major mechanism that is affected by either mutation in the DNA-binding domain or dysregulation by overexpression of p53 inhibitors MDM2 and MDM4, which destabilize p53 by increasing its proteosomal degradation. In the present study, cisplatin-resistant 2780CP/Cl-16 ovarian tumor cells expressed a heterozygous, temperature-sensitive p53(V172F) mutation, which reduced p53 half-life by two-to threefold compared with homozygous wild-type (wt) p53 in parental A2780 cells. Although reduced p53 stability in 2780CP/Cl-16 cells was associated with moderate cellular overexpression of MDM2 or MDM4 (o1.5-fold), their binding to p53 was substantially enhanced (five-to eightfold). The analogous cisplatin-resistant 2780CP/Cl-24 cells, which express loss of p53 heterozygosity, retained the p53V172F mutation and high p53-MDM4 binding, but demonstrated lower p53-bound MDM2 that was associated with reduced p53 ubiquitination and enhanced p53 stability. The inference that p53 was unstable as a heteromeric p53wt/p53(V172F) complex was confirmed in 2780CP/Cl-24 cells transfected with wt p53 or multimer-inhibiting p53(L344P) mutant, and further supported by normalization of p53 stability in both resistant cell lines grown at the permissive temperature of 32.5 degrees C. Surprisingly, in 2780CP/Cl-16 and 2780CP/Cl-24 models, cisplatin-induced transactivity of p53 was attenuated at 37 degrees C, and this correlated with cisplatin resistance. However, downregulation of MDM2 or MDM4 by small interfering RNA in either resistant cell line induced p53 and restored p21 transactivation at 37 degrees C, as did cisplatin-induced DNA damage at 32.5 degrees C that coincided with reduced p53-MDM4 binding and cisplatin resistance. These results demonstrate that cisplatin-mediated p53(V172F) mutation regulates p53 stability at the normothermic temperature, but it is the increased recruitment of MDM4 by the homomeric or heteromeric mutant p53(V172F) complex that inhibits p53-dependent transactivation. This represents a novel cellular mechanism of p53 inhibition, and, thereby, induction of cisplatin resistance.	[Xie, X.; Siddik, Z. H.] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, 1515 Holcombe Blvd,Unit 1950, Houston, TX 77030 USA; [Lozano, G.] Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Siddik, ZH (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, 1515 Holcombe Blvd,Unit 1950, Houston, TX 77030 USA.	zsiddik@mdanderson.org			US Public Health Service - National Cancer Institute [CA160687, CA16672]; Megan McBride Franz Endowed Research Fund; NATIONAL CANCER INSTITUTE [P30CA016672, R01CA160687] Funding Source: NIH RePORTER	US Public Health Service - National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)United States Public Health Service); Megan McBride Franz Endowed Research Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The research support from the US Public Health Service Grants CA160687 to ZHS and Support Grant CA16672 to MD Anderson Cancer Center, awarded by the National Cancer Institute, and in part from the Megan McBride Franz Endowed Research Fund, is gratefully acknowledged. We thank Dr Shiaw-Yih Lin (MD Anderson Cancer Center) for the His-Ubiquitin plasmid, and also Dr Guangan He and Michelle Martinez for helpful discussions.	Brachova P, 2013, INT J MOL SCI, V14, P19257, DOI 10.3390/ijms140919257; Chen LH, 2005, EMBO J, V24, P3411, DOI 10.1038/sj.emboj.7600812; Cocker HA, 2001, BRIT J CANCER, V85, P1746, DOI 10.1054/bjoc.2001.2145; Davison TS, 1998, ONCOGENE, V17, P651, DOI 10.1038/sj.onc.1202062; Gaglia G, 2013, P NATL ACAD SCI USA, V110, P15497, DOI 10.1073/pnas.1311126110; Gu JJ, 2002, J BIOL CHEM, V277, P19251, DOI 10.1074/jbc.C200150200; He G, 2013, BRIT J CANCER, V109, P2378, DOI 10.1038/bjc.2013.613; He GG, 2011, GYNECOL ONCOL, V122, P402, DOI 10.1016/j.ygyno.2011.04.034; Kawai H, 2003, J BIOL CHEM, V278, P45946, DOI 10.1074/jbc.M308295200; Komlodi-Pasztor E, 2009, ONCOGENE, V28, P3111, DOI 10.1038/onc.2009.166; KONDO S, 1995, ONCOGENE, V10, P2001; Kuang J, 2001, CLIN CANCER RES, V7, P3629; Lam S, 2010, ONCOGENE, V29, P2415, DOI 10.1038/onc.2009.522; Lenos K, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/876173; Lu XH, 2001, CLIN CANCER RES, V7, P2114; Mancini F, 2004, J BIOL CHEM, V279, P8169, DOI 10.1074/jbc.M311793200; Martinez-Rivera M, 2012, BIOCHEM PHARMACOL, V83, P1049, DOI 10.1016/j.bcp.2011.12.026; Mujoo K, 2003, J CANCER RES CLIN, V129, P709, DOI 10.1007/s00432-003-0480-4; Okamoto K, 2005, MOL CELL BIOL, V25, P9608, DOI 10.1128/MCB.25.21.9608-9620.2005; Pei DS, 2012, ONCOTARGET, V3, P228; Perry ME, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000968; Sdek P, 2005, MOL CELL, V20, P699, DOI 10.1016/j.molcel.2005.10.017; Siddik ZH, 2006, CANC DRUG DISC DEV, P283, DOI 10.1007/978-1-59745-035-5_16; Siddik ZH, 1998, CANCER RES, V58, P698; Terzian T, 2008, GENE DEV, V22, P1337, DOI 10.1101/gad.1662908; Toledo F, 2007, INT J BIOCHEM CELL B, V39, P1476, DOI 10.1016/j.biocel.2007.03.022; Tsvetkov P, 2010, CELL DEATH DIFFER, V17, P103, DOI 10.1038/cdd.2009.67; Wang XJ, 2012, FEBS LETT, V586, P1390, DOI 10.1016/j.febslet.2012.02.049; Wang YV, 2007, P NATL ACAD SCI USA, V104, P12365, DOI 10.1073/pnas.0701497104; Yang WL, 2009, SCIENCE, V325, P1134, DOI 10.1126/science.1175065; Yazlovitskaya EM, 2001, BIOCHEM BIOPH RES CO, V283, P732, DOI 10.1006/bbrc.2001.4849	31	12	12	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 8	2016	35	36					4798	4806		10.1038/onc.2016.12	http://dx.doi.org/10.1038/onc.2016.12			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DW0IS	26876197	Green Accepted			2022-12-26	WOS:000383324700012
J	Ratner, D; Orning, MPA; Starheim, KK; Marty-Roix, R; Proulx, MK; Goguen, JD; Lien, E				Ratner, Dmitry; Orning, M. Pontus A.; Starheim, Kristian K.; Marty-Roix, Robyn; Proulx, Megan K.; Goguen, Jon D.; Lien, Egil			Manipulation of Interleukin-1 beta and Interleukin-18 Production by Yersinia pestis Effectors YopJ and YopM and Redundant Impact on Virulence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; III SECRETION SYSTEM; INFLAMMASOME ACTIVATION; CELL-DEATH; EPITHELIAL-CELLS; BUBONIC PLAGUE; IMMUNE CELLS; CASPASE-1; INFECTION; EXPRESSION	Innate immunity plays a central role in resolving infections by pathogens. Host survival during plague, caused by the Gram-negative bacterium Yersinia pestis, is favored by a robust early innate immune response initiated by IL-1 beta and IL-18. These cytokines are produced by a two-step mechanism involving NF-kappa B-mediated pro-cytokine production and inflammasome-driven maturation into bioactive inflammatory mediators. Because of the anti-microbial effects induced by IL-1 beta/IL-18, it may be desirable for pathogens to manipulate their production. Y. pestis type III secretion system effectors YopJ and YopM can interfere with different parts of this process. Both effectors have been reported to influence inflammasome caspase-1 activity; YopJ promotes caspase-8-dependent cell death and caspase-1 cleavage, whereas YopM inhibits caspase-1 activity via an incompletely understood mechanism. However, neither effector appears essential for full virulence in vivo. Here we report that the sum of influences by YopJ and YopM on IL-1 beta/IL-18 release is suppressive. In the absence of YopM, YopJ minimally affects caspase-1 cleavage but suppresses IL-1 beta, IL-18, and other cytokines and chemokines. Importantly, we find that Y. pestis containing combined deletions of YopJ and YopM induces elevated levels of IL-1 beta/IL-18 in vitro and in vivo and is significantly attenuated in a mouse model of bubonic plague. The reduced virulence of the YopJ-YopM mutant is dependent on the presence of IL-1 beta, IL-18, and caspase-1. Thus, we conclude that Y. pestis YopJ and YopM can both exert a tight control of host IL-1 beta/IL-18 production to benefit the bacteria, resulting in a redundant impact on virulence.	[Ratner, Dmitry; Orning, M. Pontus A.; Starheim, Kristian K.; Marty-Roix, Robyn; Lien, Egil] Univ Massachusetts, Sch Med, Dept Med, Div Infect Dis & Immunol,Program Innate Immun, Worcester, MA 01605 USA; [Orning, M. Pontus A.; Starheim, Kristian K.; Lien, Egil] Norwegian Univ Sci & Technol, Dept Canc Res & Mol Med, Ctr Mol Inflammat Res, N-7491 Trondheim, Norway; [Proulx, Megan K.; Goguen, Jon D.] Univ Massachusetts, Dept Microbiol & Physiol Syst, Worcester, MA 01655 USA	University of Massachusetts System; University of Massachusetts Worcester; Norwegian University of Science & Technology (NTNU); University of Massachusetts System; University of Massachusetts Worcester	Lien, E (corresponding author), Univ Massachusetts, Sch Med, Dept Med, Div Infect Dis & Immunol,Program Innate Immun, Worcester, MA 01605 USA.; Lien, E (corresponding author), Norwegian Univ Sci & Technol, Dept Canc Res & Mol Med, Ctr Mol Inflammat Res, N-7491 Trondheim, Norway.	egil.lien@umassmed.edu		Proulx, Megan/0000-0002-9524-8302	National Institutes of Health [AI07538, AI095213]; Norwegian Cancer Society; Research Council of Norway Center of Excellence Funding Scheme Project [223255/F50]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007538, T32AI095213] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Norwegian Cancer Society(Norwegian Cancer Society); Research Council of Norway Center of Excellence Funding Scheme Project; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work was supported by National Institutes of Health Grants AI07538 (to E. L.) and AI095213 (to D. R.), the Norwegian Cancer Society, and Research Council of Norway Center of Excellence Funding Scheme Project 223255/F50. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alli M, 2008, INT J MED MICROBIOL, V298, P183, DOI 10.1016/j.ijmm.2007.04.007; Autenrieth SE, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001212; Bossaller L, 2012, J IMMUNOL, V189, P5508, DOI 10.4049/jimmunol.1202121; Brodsky IE, 2010, CELL HOST MICROBE, V7, P376, DOI 10.1016/j.chom.2010.04.009; Brodsky IE, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000067; Broz P, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003144; Broz P, 2012, NATURE, V490, P288, DOI 10.1038/nature11419; Caulfield AJ, 2014, CELL HOST MICROBE, V15, P424, DOI 10.1016/j.chom.2014.03.005; Chung LK, 2014, MBIO, V5, DOI 10.1128/mBio.01402-14; Edwards RA, 1998, GENE, V207, P149, DOI 10.1016/S0378-1119(97)00619-7; Gurung P, 2015, AM J PATHOL, V185, P17, DOI 10.1016/j.ajpath.2014.08.025; Hentschke M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013165; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Kayagaki N, 2015, NATURE, V526, P666, DOI 10.1038/nature15541; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Kerschen EJ, 2004, INFECT IMMUN, V72, P4589, DOI 10.1128/IAI.72.8.4589-4602.2004; LaRock CN, 2012, CELL HOST MICROBE, V12, P799, DOI 10.1016/j.chom.2012.10.020; Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452; Lemaitre N, 2006, INFECT IMMUN, V74, P5126, DOI 10.1128/IAI.00219-06; Lenz JD, 2011, J BACTERIOL, V193, P5936, DOI 10.1128/JB.05877-11; LEUNG KY, 1990, INFECT IMMUN, V58, P3262, DOI 10.1128/IAI.58.10.3262-3271.1990; Lilo S, 2008, INFECT IMMUN, V76, P3911, DOI 10.1128/IAI.01695-07; Lindner I, 2007, EUR J IMMUNOL, V37, P2450, DOI 10.1002/eji.200635947; Maelfait J, 2008, J EXP MED, V205, P1967, DOI 10.1084/jem.20071632; Marketon MM, 2005, SCIENCE, V309, P1739, DOI 10.1126/science.1114580; McCoy MW, 2010, INFECT IMMUN, V78, P2584, DOI 10.1128/IAI.00141-10; McPhee JB, 2010, INFECT IMMUN, V78, P3529, DOI 10.1128/IAI.00269-10; Meinzer U, 2012, CELL HOST MICROBE, V11, P337, DOI 10.1016/j.chom.2012.02.009; Mittal R, 2006, P NATL ACAD SCI USA, V103, P18574, DOI 10.1073/pnas.0608995103; Mombaerts P, 1995, Int Rev Immunol, V13, P43, DOI 10.3109/08830189509061737; Montminy SW, 2006, NAT IMMUNOL, V7, P1066, DOI 10.1038/ni1386; Mukherjee S, 2008, METHOD ENZYMOL, V438, P343, DOI 10.1016/S0076-6879(07)38024-5; Mukherjee S, 2006, SCIENCE, V312, P1211, DOI 10.1126/science.1126867; Palace SG, 2014, MBIO, V5, DOI 10.1128/mBio.01385-14; Paquette N, 2012, P NATL ACAD SCI USA, V109, P12710, DOI 10.1073/pnas.1008203109; Perry RD, 1997, CLIN MICROBIOL REV, V10, P35, DOI 10.1128/CMR.10.1.35; Philip NH, 2014, P NATL ACAD SCI USA, V111, P7385, DOI 10.1073/pnas.1403252111; Philipovskiy AV, 2007, INFECT IMMUN, V75, P878, DOI 10.1128/IAI.01529-06; Rosadini CV, 2015, CELL HOST MICROBE, V18, P682, DOI 10.1016/j.chom.2015.11.006; Schmid-Burgk JL, 2016, J BIOL CHEM, V291, P103, DOI 10.1074/jbc.C115.700492; Schotte P, 2004, J BIOL CHEM, V279, P25134, DOI 10.1074/jbc.M401245200; Shi HX, 2016, NAT IMMUNOL, V17, P250, DOI 10.1038/ni.3333; Shi JJ, 2015, NATURE, V526, P660, DOI 10.1038/nature15514; SODEINDE OA, 1992, SCIENCE, V258, P1004, DOI 10.1126/science.1439793; Szaba FM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004142; Szaba FM, 2009, INFECT IMMUN, V77, P4295, DOI 10.1128/IAI.00273-09; Thinwa J, 2014, J IMMUNOL, V193, P1373, DOI 10.4049/jimmunol.1400145; Uittenbogaard AM, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00155; Viboud GI, 2005, ANNU REV MICROBIOL, V59, P69, DOI 10.1146/annurev.micro.59.030804.121320; Vladimer GI, 2013, CURR OPIN MICROBIOL, V16, P23, DOI 10.1016/j.mib.2012.11.008; Vladimer GI, 2012, IMMUNITY, V37, P96, DOI 10.1016/j.immuni.2012.07.006; Weng D, 2014, P NATL ACAD SCI USA, V111, P7391, DOI 10.1073/pnas.1403477111; Ye Z, 2011, INFECT IMMUN, V79, P674, DOI 10.1128/IAI.00808-10; Ye Z, 2009, INFECT IMMUN, V77, P3791, DOI 10.1128/IAI.00284-09; Zauberman A, 2006, INFECT IMMUN, V74, P3239, DOI 10.1128/IAI.00097-06; Zauberman A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005938; Zheng Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036019; Zhou HL, 2005, J EXP MED, V202, P1327, DOI 10.1084/jem.20051194; Zhou LM, 2004, RESP PHYSIOL NEUROBI, V140, P89, DOI 10.1016/j.resp.2003.12.003; Zwack EE, 2015, MBIO, V6, DOI 10.1128/mBio.02095-14	60	22	23	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2016	291	19					9894	9905		10.1074/jbc.M115.697698	http://dx.doi.org/10.1074/jbc.M115.697698			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DL4KB	26884330	Green Published, hybrid			2022-12-26	WOS:000375602800004
J	Prabhu, AV; Luu, W; Sharpe, LJ; Brown, AJ				Prabhu, Anika V.; Luu, Winnie; Sharpe, Laura J.; Brown, Andrew J.			Cholesterol-mediated Degradation of 7-Dehydrocholesterol Reductase Switches the Balance from Cholesterol to Vitamin D Synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cholesterol; cholesterol regulation; enzyme degradation; genetic disease; vitamin D; 7-dehydrocholesterol; DHCR7	LEMLI-OPITZ-SYNDROME; HMG-COA REDUCTASE; GENOME-WIDE ASSOCIATION; STEROL-SENSING DOMAIN; 3-HYDROXY-3-METHYLGLUTARYL-COA REDUCTASE; SYNDROME SLOS; MENDELIAN RANDOMIZATION; SQUALENE MONOOXYGENASE; UBIQUITIN LIGASE; PROTEIN	Cholesterol is detrimental to human health in excess but is also essential for normal embryogenesis. Hence, enzymes involved in its synthesis possess many layers of regulation to achieve balanced cholesterol levels. 7-Dehydrocholesterol reductase (DHCR7) is the terminal enzyme of cholesterol synthesis in the Kandutsch-Russell pathway, converting 7-dehydrocholesterol (7DHC) to cholesterol. In the absence of functional DHCR7, accumulation of 7DHC and a lack of cholesterol production leads to the devastating developmental disorder, Smith-Lemli-Opitz syndrome. This study identifies that statin treatment can ameliorate the low DHCR7 expression seen with common Smith-Lemli-Opitz syndrome mutations. Furthermore, we show that wild-type DHCR7 is also relatively labile. In an example of end-product inhibition, cholesterol accelerates the proteasomal degradation of DHCR7, resulting in decreased protein levels and activity. The loss of enzymatic activity results in the accumulation of the substrate 7DHC, which leads to an increased production of vitamin D. Thus, these findings highlight DHCR7 as an important regulatory switch between cholesterol and vitamin D synthesis.	[Prabhu, Anika V.; Luu, Winnie; Sharpe, Laura J.; Brown, Andrew J.] Univ New S Wales, Sch Biotechnol & Biomol Sci, Biol Sci Bldg D26, Sydney, NSW 2052, Australia	University of New South Wales Sydney	Brown, AJ (corresponding author), Univ New S Wales, Sch Biotechnol & Biomol Sci, Biol Sci Bldg D26, Sydney, NSW 2052, Australia.	aj.brown@unsw.edu.au		Prabhu, Anika/0000-0002-3809-1716; Sharpe, Laura/0000-0002-9896-294X	University of New South Wales Goldstar Award; National Health and Medical Research Council [1060515]	University of New South Wales Goldstar Award; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by The University of New South Wales Goldstar Award and National Health and Medical Research Council Grant 1060515. The authors declare that they have no conflicts of interest with the contents of this article.	Afzal S, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6330; Afzal S, 2014, LANCET DIABETES ENDO, V2, P298, DOI 10.1016/S2213-8587(13)70200-6; Ahn J, 2010, HUM MOL GENET, V19, P2739, DOI 10.1093/hmg/ddq155; Bae SH, 1999, J BIOL CHEM, V274, P14624, DOI 10.1074/jbc.274.21.14624; BLOCH K, 1965, SCIENCE, V150, P19, DOI 10.1126/science.150.3692.19; Brown AJ, 2002, MOL CELL, V10, P237, DOI 10.1016/S1097-2765(02)00591-9; Correa-Cerro LS, 2006, HUM MOL GENET, V15, P839, DOI 10.1093/hmg/ddl003; Cross JL, 2015, CLIN GENET, V87, P570, DOI 10.1111/cge.12425; DeLuca HF, 2008, NUTR REV, V66, pS73, DOI 10.1111/j.1753-4887.2008.00105.x; Du XM, 2006, MOL BIOL CELL, V17, P2735, DOI 10.1091/mbc.E05-11-1094; Elias ER, 1997, AM J MED GENET, V68, P305, DOI 10.1002/(SICI)1096-8628(19970131)68:3<305::AID-AJMG11>3.0.CO;2-X; Faulkner RA, 2013, J LIPID RES, V54, P1011, DOI 10.1194/jlr.M033639; FEINGOLD KR, 1983, METABOLISM, V32, P75, DOI 10.1016/0026-0495(83)90160-9; Fitzky BU, 1998, P NATL ACAD SCI USA, V95, P8181, DOI 10.1073/pnas.95.14.8181; Gill S, 2011, CELL METAB, V13, P260, DOI 10.1016/j.cmet.2011.01.015; Haas D, 2007, J INHERIT METAB DIS, V30, P375, DOI 10.1007/s10545-007-0537-7; Hampton RY, 2002, CURR OPIN CELL BIOL, V14, P476, DOI 10.1016/S0955-0674(02)00358-7; Holmer L, 1998, GENOMICS, V54, P469, DOI 10.1006/geno.1998.5615; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Hossein-nezhad A, 2013, MAYO CLIN PROC, V88, P720, DOI 10.1016/j.mayocp.2013.05.011; KANDUTSCH AA, 1960, J BIOL CHEM, V235, P2256; Kielar D, 2001, CLIN CHEM, V47, P2089; Kuan V, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-144; Kuwabara PE, 2002, TRENDS GENET, V18, P193, DOI 10.1016/S0168-9525(02)02640-9; Lange Y, 2008, J BIOL CHEM, V283, P1445, DOI 10.1074/jbc.M706967200; Lanthaler B, 2014, GENE, V550, P136, DOI 10.1016/j.gene.2014.08.016; Lehmann B, 1997, J INVEST DERMATOL, V108, P78, DOI 10.1111/1523-1747.ep12285640; Li XC, 2015, NATURE, V517, P104, DOI 10.1038/nature13797; Luu W, 2015, J LIPID RES, V56, P888, DOI 10.1194/jlr.M056986; Luu W, 2014, J LIPID RES, V55, P410, DOI 10.1194/jlr.M043257; Mbonye UR, 2008, J BIOL CHEM, V283, P8611, DOI 10.1074/jbc.M710137200; McDonald JG, 2012, J LIPID RES, V53, P1399, DOI 10.1194/jlr.D022285; Meyer HE, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h321; Mitsche MA, 2015, ELIFE, V4, DOI 10.7554/eLife.07999; Oregon Health and Science University, 2012, SMITH LEML OP SYNDR; Pasta S, 2015, MOL GENET METAB REP, V4, P92, DOI 10.1016/j.ymgmr.2015.07.006; Porter F. D., 2014, INVESTIGATION SIMVAS; Prabhu AV, 2014, BBA-MOL CELL BIOL L, V1841, P1431, DOI 10.1016/j.bbalip.2014.07.006; Prasad C, 2002, AM J MED GENET, V108, P64, DOI 10.1002/ajmg.10211; Rodwell V W, 1976, Adv Lipid Res, V14, P1; Sever N, 2003, MOL CELL, V11, P25, DOI 10.1016/S1097-2765(02)00822-5; Sharpe LJ, 2013, J BIOL CHEM, V288, P18707, DOI 10.1074/jbc.R113.479808; Shinkyo R, 2011, J BIOL CHEM, V286, P33021, DOI 10.1074/jbc.M111.282434; Sikora DM, 2004, J PEDIATR-US, V144, P783, DOI 10.1016/j.jpeds.2004.02.036; SMITH DW, 1964, J PEDIATR-US, V64, P210, DOI 10.1016/S0022-3476(64)80264-X; Song BL, 2005, CELL METAB, V1, P179, DOI 10.1016/j.cmet.2005.01.001; Song BL, 2004, J BIOL CHEM, V279, P28798, DOI 10.1074/jbc.M402442200; Tierney E, 2010, AM J MED GENET A, V152A, P91, DOI 10.1002/ajmg.a.33148; TINT GS, 1994, NEW ENGL J MED, V330, P107, DOI 10.1056/NEJM199401133300205; Wang TJ, 2010, LANCET, V376, P180, DOI 10.1016/S0140-6736(10)60588-0; Waterham HR, 2012, AM J MED GENET C, V160C, P263, DOI 10.1002/ajmg.c.31346; Waterham HR, 2000, BBA-MOL CELL BIOL L, V1529, P340, DOI 10.1016/S1388-1981(00)00159-1; Witsch-Baumgartner M, 2008, J MED GENET, V45, P200, DOI 10.1136/jmg.2007.053520; Xu LB, 2009, J AM CHEM SOC, V131, P13037, DOI 10.1021/ja9029076; YANG JX, 1994, GENE DEV, V8, P1910, DOI 10.1101/gad.8.16.1910; Zelcer N, 2014, MOL CELL BIOL, V34, P1262, DOI 10.1128/MCB.01140-13; Zerenturk EJ, 2012, BBA-MOL CELL BIOL L, V1821, P1269, DOI 10.1016/j.bbalip.2011.11.009; Zou L, 2015, J STEROID BIOCHEM, V148, P64, DOI 10.1016/j.jsbmb.2014.12.001	58	67	68	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2016	291	16					8363	8373		10.1074/jbc.M115.699546	http://dx.doi.org/10.1074/jbc.M115.699546			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK2VT	26887953	hybrid, Green Published			2022-12-26	WOS:000374773200005
J	Qayyum, MZ; Dey, D; Sen, R				Qayyum, M. Zuhaib; Dey, Debashish; Sen, Ranjan			Transcription Elongation Factor NusA Is a General Antagonist of Rho-dependent Termination in Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Escherichia coli (E; coli); gene regulation; microarray; RNA polymerase; transcription termination; NusA; Rho; nut site; rut site	RNA-EXIT CHANNEL; DEFECTIVE-MUTANTS; NASCENT RNA; PROTEIN PSU; IN-VITRO; POLYMERASE; ANTITERMINATION; COMPLEX; MECHANISM; TRANSLATION	NusA is an essential protein that binds to RNA polymerase and also to the nascent RNA and influences transcription by inducing pausing and facilitating the process of transcription termination/antitermination. Its participation in Rho-dependent transcription termination has been perceived, but the molecular nature of this involvement is not known. We hypothesized that, because both Rho and NusA are RNA-binding proteins and have the potential to target the same RNA, the latter is likely to influence the global pattern of the Rho-dependent termination. Analyses of the nascent RNA binding properties and consequent effects on the Rho-dependent termination functions of specific NusA-RNA binding domain mutants revealed an existence of Rho-NusA direct competition for the overlapping nut (NusA-binding site) and rut (Rho-binding site) sites on the RNA. This leads to delayed entry of Rho at the rut site that inhibits the latter's RNA release process. High density tiling microarray profiles of these NusA mutants revealed that a significant number of genes, together with transcripts from intergenic regions, are up-regulated. Interestingly, the majority of these genes were also up-regulated when the Rho function was compromised. These results provide strong evidence for the existence of NusA-binding sites in different operons that are also the targets of Rho-dependent terminations. Our data strongly argue in favor of a direct competition between NusA and Rho for the access of specific sites on the nascent transcripts in different parts of the genome. We propose that this competition enables NusA to function as a global antagonist of the Rho function, which is unlike its role as a facilitator of hairpin-dependent termination.	[Qayyum, M. Zuhaib; Dey, Debashish; Sen, Ranjan] Ctr DNA Fingerprinting & Diagnost, Transcript Lab, Tuljaguda Complex,4-1-714 Mozamjahi Rd, Hyderabad 500001, Andhra Pradesh, India; [Qayyum, M. Zuhaib] Manipal Univ, Grad Studies, Manipal 576104, Karnataka, India	Department of Biotechnology (DBT) India; Centre for DNA Fingerprinting & Diagnostics (CDFD); Manipal Academy of Higher Education (MAHE)	Sen, R (corresponding author), Ctr DNA Fingerprinting & Diagnost, Transcript Lab, Tuljaguda Complex,4-1-714 Mozamjahi Rd, Hyderabad 500001, Andhra Pradesh, India.	rsen@cdfd.org.in	Qayyum, Mohammad Zuhaib/AAD-8672-2022	Qayyum, Mohammad Zuhaib/0000-0003-2442-4812	Department of Biotechnology, Government of India [BT/PR13297/BRB/10/746/2009]; Center for DNA Fingerprinting and Diagnostics	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Center for DNA Fingerprinting and Diagnostics	This work was supported by Department of Biotechnology, Government of India, Grant BT/PR13297/BRB/10/746/2009 and the intramural grant of the Center for DNA Fingerprinting and Diagnostics. The authors declare that they have no conflicts of interest with the contents of this article.	ALBRECHTSEN B, 1990, J MOL BIOL, V213, P123, DOI 10.1016/S0022-2836(05)80125-1; Artsimovitch I, 2000, P NATL ACAD SCI USA, V97, P7090, DOI 10.1073/pnas.97.13.7090; Banerjee S, 2006, J MICROBIOL, V44, P11; BARIK S, 1985, J MOL BIOL, V182, P495, DOI 10.1016/0022-2836(85)90236-0; Burmann BM, 2010, SCIENCE, V328, P501, DOI 10.1126/science.1184953; Burns CM, 1998, J MOL BIOL, V278, P307, DOI 10.1006/jmbi.1998.1691; Cardinale CJ, 2008, SCIENCE, V320, P935, DOI 10.1126/science.1152763; Chalissery J, 2007, J MOL BIOL, V371, P855, DOI 10.1016/j.jmb.2007.06.013; Chalissery J, 2011, J MOL BIOL, V405, P49, DOI 10.1016/j.jmb.2010.10.044; Cheeran A, 2005, J MOL BIOL, V352, P28, DOI 10.1016/j.jmb.2005.06.052; Dutta D, 2008, J BIOL CHEM, V283, P20243, DOI 10.1074/jbc.M801926200; Figueroa-Bossi N, 2009, GENE DEV, V23, P2004, DOI 10.1101/gad.541609; Gusarov I, 2001, CELL, V107, P437, DOI 10.1016/S0092-8674(01)00582-7; Gutierrrez P, 2007, J BIOL CHEM, V282, P23348, DOI 10.1074/jbc.M702010200; Ha KS, 2010, J MOL BIOL, V401, P708, DOI 10.1016/j.jmb.2010.06.036; Harinarayanan R, 2003, J MOL BIOL, V332, P31, DOI 10.1016/S0022-2836(03)00753-8; Hollands K, 2012, P NATL ACAD SCI USA, V109, P5376, DOI 10.1073/pnas.1112211109; JIN DJ, 1992, P NATL ACAD SCI USA, V89, P1453, DOI 10.1073/pnas.89.4.1453; Kalyani BS, 2011, J MOL BIOL, V413, P548, DOI 10.1016/j.jmb.2011.08.053; Kolb KE, 2014, J BIOL CHEM, V289, P1151, DOI 10.1074/jbc.M113.521393; LI J, 1993, GENE DEV, V7, P161, DOI 10.1101/gad.7.1.161; Menouni R, 2013, P NATL ACAD SCI USA, V110, P14414, DOI 10.1073/pnas.1303400110; Mishra S, 2013, J BIOL CHEM, V288, P28089, DOI 10.1074/jbc.M113.472209; Mooney RA, 2009, MOL CELL, V33, P97, DOI 10.1016/j.molcel.2008.12.021; Muteeb G, 2012, NUCLEIC ACIDS RES, V40, P11213, DOI 10.1093/nar/gks872; Muteeb G, 2010, METHODS MOL BIOL, V634, P411, DOI 10.1007/978-1-60761-652-8_29; Pani B, 2006, J BIOL CHEM, V281, P26491, DOI 10.1074/jbc.M603982200; Paul BJ, 2004, ANNU REV GENET, V38, P749, DOI 10.1146/annurev.genet.38.072902.091347; Peters JM, 2012, GENE DEV, V26, P2621, DOI 10.1101/gad.196741.112; Peters JM, 2011, J MOL BIOL, V412, P793, DOI 10.1016/j.jmb.2011.03.036; Pichoff S, 1998, MOL MICROBIOL, V29, P859, DOI 10.1046/j.1365-2958.1998.00981.x; Prasch S, 2009, NUCLEIC ACIDS RES, V37, P4736, DOI 10.1093/nar/gkp452; Rabhi M, 2011, EMBO J, V30, P2805, DOI 10.1038/emboj.2011.192; Ranjan A, 2013, NUCLEIC ACIDS RES, V41, P6839, DOI 10.1093/nar/gkt336; Richardson JP, 2002, BBA-GENE STRUCT EXPR, V1577, P251, DOI 10.1016/S0167-4781(02)00456-6; Saxena S, 2011, J BACTERIOL, V193, P3842, DOI 10.1128/JB.00221-11; SCHMIDT MC, 1987, J MOL BIOL, V195, P809, DOI 10.1016/0022-2836(87)90486-4; Schweimer K, 2011, STRUCTURE, V19, P945, DOI 10.1016/j.str.2011.03.024; Sen Ranjan, 2008, EcoSal Plus, V3, DOI 10.1128/ecosalplus.4.5.3.1; Sevostyanova A, 2015, P NATL ACAD SCI USA, V112, pE6835, DOI 10.1073/pnas.1515383112; Shashni R, 2014, NUCLEIC ACIDS RES, V42, P9677, DOI 10.1093/nar/gku690; Shashni R, 2012, MICROBIOL-SGM, V158, P1468, DOI 10.1099/mic.0.056804-0; Skordalakes E, 2003, CELL, V114, P135, DOI 10.1016/S0092-8674(03)00512-9; Skordalakes E, 2006, CELL, V127, P553, DOI 10.1016/j.cell.2006.08.051; Squires CL, 2000, ANNU REV MICROBIOL, V54, P775, DOI 10.1146/annurev.micro.54.1.775; SQUIRES CL, 1993, P NATL ACAD SCI USA, V90, P970, DOI 10.1073/pnas.90.3.970; SULLIVAN SL, 1992, CELL, V68, P989, DOI 10.1016/0092-8674(92)90041-A; Toulokhonov I, 2001, SCIENCE, V292, P730, DOI 10.1126/science.1057738; Worbs M, 2001, MOL CELL, V7, P1177, DOI 10.1016/S1097-2765(01)00262-3; ZHENG CH, 1994, P NATL ACAD SCI USA, V91, P7543, DOI 10.1073/pnas.91.16.7543	50	22	22	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2016	291	15					8090	8108		10.1074/jbc.M115.701268	http://dx.doi.org/10.1074/jbc.M115.701268			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DJ2SZ	26872975	Green Published, hybrid			2022-12-26	WOS:000374056700027
J	Zhao, RB; Najmi, M; Fiser, A; Goldman, ID				Zhao, Rongbao; Najmi, Mitra; Fiser, Andras; Goldman, I. David			Identification of an Extracellular Gate for the Proton-coupled Folate Transporter (PCFT-SLC46A1) by Cysteine Cross-linking	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cysteine-mediated cross-linking; folate; homology modeling; membrane transport; transporter	TRANSMEMBRANE CONDUCTANCE REGULATOR; HELA-CELLS LACKING; ACCESSIBILITY METHOD; FUNCTIONAL ROLES; MOLECULAR-BASIS; PHARMACOLOGICAL-ACTIVITY; CRYSTAL-STRUCTURE; LINING RESIDUES; AMINO-ACID; MALABSORPTION	The proton-coupled folate transporter (PCFT, SLC46A1) is required for intestinal folate absorption and folate homeostasis in humans. A homology model of PCFT, based upon the Escherichia coli glycerol 3-phosphate transporter structure, predicted that PCFT transmembrane domains (TMDs) 1, 2, 7, and 11 form an extracellular gate in the inward-open conformation. To assess this model, five residues (Gln(45)-TMD1, Asn(90)-TMD2, Leu(290)-TMD7, Ser(407)-TMD11 and Asn(411)-TMD11) in the predicted gate were substituted with Cys to generate single and nine double mutants. Transport function of the mutants was assayed in transient transfectants by measurement of [H-3]substrate influx as was accessibility of the Cys residues to biotinylation. Pairs of Cys residues were assessed for spontaneous formation of a disulfide bond, induction of a disulfide bond by oxidization with dichloro(1,10-phenanthroline)copper (II) (CuPh), or the formation of a Cd2+ complex. The data were consistent with the formation of a spontaneous disulfide bond between the N90C/S407C pair and a CuPh- and Cd2+-induced disulfide bond and complex, respectively, for the Q45C/L290C and L290C/N411C pairs. The decrease in activity induced by cross-linkage of the Cys residue pairs was due to a decrease in the influx V-max consistent with restriction in the mobility of the transporter. The presence of folate substrate decreased the CuPh-induced inhibition of transport. Hence, the data support the glycerol 3-phosphate transporter-based homology model of PCFT and the presence of an extracellular gate formed by TMDs 1, 2, 7, and 11.	[Zhao, Rongbao; Najmi, Mitra; Goldman, I. David] Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA; [Zhao, Rongbao; Goldman, I. David] Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA; [Fiser, Andras] Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA; [Fiser, Andras] Albert Einstein Coll Med, Dept Syst & Computat Biol, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Goldman, ID (corresponding author), 1300 Morris Pk Ave, Bronx, NY 10461 USA.	i.david.goldman@einstein.yu.edu			National Cancer Institute, National Institutes of Health [CA082621]; NATIONAL CANCER INSTITUTE [P30CA013330, R01CA082621] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Cancer Institute, National Institutes of Health Grant CA082621. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Benitah JP, 1996, P NATL ACAD SCI USA, V93, P7392, DOI 10.1073/pnas.93.14.7392; Cheung M, 1996, BIOPHYS J, V70, P2688, DOI 10.1016/S0006-3495(96)79838-7; Deng D, 2015, NATURE, V526, P391, DOI 10.1038/nature14655; Diop-Bove N, 2014, GENEREVIEWS; Diop-Bove NK, 2009, MOL CANCER THER, V8, P2424, DOI 10.1158/1535-7163.MCT-08-0938; Duddempudi PK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078301; Fernandez-Fuentes N, 2007, NUCLEIC ACIDS RES, V35, pW363, DOI 10.1093/nar/gkm341; Fernandez-Fuentes N, 2007, BIOINFORMATICS, V23, P2558, DOI 10.1093/bioinformatics/btm377; Hildebrand A, 2009, PROTEINS, V77, P128, DOI 10.1002/prot.22499; Hilwi M, 2014, J BIOL CHEM, V289, P34258, DOI 10.1074/jbc.M114.593061; Karlin A, 1998, METHOD ENZYMOL, V293, P123; Lasry I, 2008, BLOOD, V112, P2055, DOI 10.1182/blood-2008-04-150276; Lasry I, 2009, BIOCHEM BIOPH RES CO, V386, P426, DOI 10.1016/j.bbrc.2009.06.007; Liu XH, 2006, J BIOL CHEM, V281, P8275, DOI 10.1074/jbc.M512458200; Liu XH, 2008, BIOMETALS, V21, P277, DOI 10.1007/s10534-007-9117-4; Loo TW, 2014, J BIOL CHEM, V289, P24749, DOI 10.1074/jbc.M114.583021; Mahadeo K, 2010, AM J PHYSIOL-CELL PH, V299, pC1153, DOI 10.1152/ajpcell.00113.2010; Mueckler M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031412; Parker JL, 2014, NATURE, V507, P68, DOI 10.1038/nature13116; Pedersen BP, 2013, NATURE, V496, P533, DOI 10.1038/nature12042; Penmatsa A, 2013, NATURE, V503, P85, DOI 10.1038/nature12533; Qiu A, 2007, AM J PHYSIOL-CELL PH, V293, pC1669, DOI 10.1152/ajpcell.00202.2007; Qiu AD, 2006, CELL, V127, P917, DOI 10.1016/j.cell.2006.09.041; Rai BK, 2006, PROTEINS, V63, P644, DOI 10.1002/prot.20835; Rai BK, 2006, BIOINFORMATICS, V22, P2691, DOI 10.1093/bioinformatics/btl449; Shabaneh M, 2014, J BIOL CHEM, V289, P11175, DOI 10.1074/jbc.M114.550277; Shin DS, 2013, AM J PHYSIOL-CELL PH, V304, pC1159, DOI 10.1152/ajpcell.00353.2012; Shin DS, 2012, AM J PHYSIOL-CELL PH, V303, pC834, DOI 10.1152/ajpcell.00171.2012; Shin DS, 2012, AM J PHYSIOL-CELL PH, V302, pC1405, DOI 10.1152/ajpcell.00435.2011; Shin DS, 2010, BLOOD, V116, P5162, DOI 10.1182/blood-2010-06-291237; SIPPL MJ, 1993, PROTEINS, V17, P355, DOI 10.1002/prot.340170404; Sun J, 2014, NATURE, V507, P73, DOI 10.1038/nature13074; Tusnady GE, 1998, J MOL BIOL, V283, P489, DOI 10.1006/jmbi.1998.2107; Umapathy NS, 2007, INVEST OPHTH VIS SCI, V48, P5299, DOI 10.1167/iovs.07-0288; Unal ES, 2009, AM J PHYSIOL-CELL PH, V297, pC66, DOI 10.1152/ajpcell.00096.2009; Unal ES, 2009, J BIOL CHEM, V284, P17846, DOI 10.1074/jbc.M109.008060; Unal ES, 2008, BBA-BIOMEMBRANES, V1778, P1407, DOI 10.1016/j.bbamem.2008.03.009; Valdes R, 2014, J BIOL CHEM, V289, P8799, DOI 10.1074/jbc.M113.546960; Valdes R, 2012, J BIOL CHEM, V287, P44036, DOI 10.1074/jbc.M112.414433; Visentin M, 2015, AM J PHYSIOL-CELL PH, V308, pC631, DOI 10.1152/ajpcell.00238.2014; Visentin M, 2014, ANNU REV PHYSIOL, V76, P251, DOI 10.1146/annurev-physiol-020911-153251; Wilson MR, 2014, J BIOL CHEM, V289, P25287, DOI 10.1074/jbc.M114.578252; Yang Y, 2014, ANTIOXID REDOX SIGN, V20, P937, DOI 10.1089/ars.2013.5483; Zhao RB, 2004, CLIN CANCER RES, V10, P8735, DOI 10.1158/1078-0432.CCR-04-0932; Zhao RB, 2004, CANCER RES, V64, P3313, DOI 10.1158/0008-5472.CAN-03-3953; Zhao RB, 2004, CLIN CANCER RES, V10, P718, DOI 10.1158/1078-0432.CCR-1066-03; Zhao RB, 2008, MOL PHARMACOL, V74, P854, DOI 10.1124/mol.108.045443; Zhao R, 2007, BLOOD, V110, P1147, DOI 10.1182/blood-2007-02-077099; Zhao RB, 2012, AM J PHYSIOL-CELL PH, V303, pC673, DOI 10.1152/ajpcell.00123.2012; Zhao RB, 2011, BBA-BIOMEMBRANES, V1808, P1140, DOI 10.1016/j.bbamem.2011.01.008; Zhao RB, 2010, BIOCHEMISTRY-US, V49, P2925, DOI 10.1021/bi9021439	51	13	13	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2016	291	15					8162	8172		10.1074/jbc.M115.693929	http://dx.doi.org/10.1074/jbc.M115.693929			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DJ2SZ	26884338	Green Published, hybrid			2022-12-26	WOS:000374056700033
J	Sassa, T; Hirayama, T; Kihara, A				Sassa, Takayuki; Hirayama, Taisuke; Kihara, Akio			Enzyme Activities of the Ceramide Synthases CERS2-6 Are Regulated by Phosphorylation in the C-terminal Region	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE CK2; SPHINGOSINE 1-PHOSPHATE; CASEIN KINASE; PERMEABILITY BARRIER; SPHINGOLIPIDS; METABOLISM; SUSCEPTIBILITY; DEHYDROGENASE; EXPRESSION; INHIBITOR	Ceramide and complex sphingolipids regulate important cellular functions including cell growth, apoptosis, and signaling. Dysregulation of sphingolipid metabolism leads to pathological consequences such as sphingolipidoses and insulin resistance. Ceramides in mammals vary greatly in their acyl-chain composition: six different ceramide synthase isozymes (CERS1-6) that exhibit distinct substrate specificity and tissue distribution account for this diversity. In the present study, we demonstrated that CERS2-6 were phosphorylated at the cytoplasmic C-terminal regions. Most of the phosphorylated residues conformed to a consensus motif for phosphorylation by casein kinase 2 (CK2), and treatment of cells with the CK2-specific inhibitor CX-4945 lowered the phosphorylation levels of CERS2, -4, -5, and -6. Phosphorylation of CERS2 was especially important for its catalytic activity, acting mainly by increasing its V-max value. Phosphorylation modestly increased the catalytic activities of CERS4 and -5 and mildly increased those of CERS3 and -6. Dephosphorylation of endogenous ceramide synthases in the mouse brain led to severely reduced activity toward the Cers2 substrates C22:0/C24:0-CoAs and modestly reduced activity toward the Cers5/6 substrate C16:0-CoA. These results suggest that the phosphorylation of ceramide synthases may be a key regulatory point in the control of the distribution and levels of sphingolipids of various acyl-chain lengths.	[Sassa, Takayuki; Hirayama, Taisuke; Kihara, Akio] Hokkaido Univ, Fac Pharmaceut Sci, Biochem Lab, Kita Ku, Sapporo, Hokkaido 0600812, Japan	Hokkaido University	Kihara, A (corresponding author), Hokkaido Univ, Fac Pharmaceut Sci, Biochem Lab, Kita Ku, Sapporo, Hokkaido 0600812, Japan.	kihara@pharm.hokudai.ac.jp	SASSA, Takayuki/B-2519-2012; KIHARA, AKIO/A-3802-2012	SASSA, Takayuki/0000-0003-3145-9829; KIHARA, AKIO/0000-0001-5889-0788	Advanced Research and Development Programs for Medical Innovation (AMED-CREST) from the Japan Agency for Medical Research and Development (AMED); Japan Society for the Promotion of Science [26251010, 24590073]; Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program from the Ministry of Education, Culture, Sports, Science and Technology, Japan; Grants-in-Aid for Scientific Research [26251010, 16K08220] Funding Source: KAKEN	Advanced Research and Development Programs for Medical Innovation (AMED-CREST) from the Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program from the Ministry of Education, Culture, Sports, Science and Technology, Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the Advanced Research and Development Programs for Medical Innovation (AMED-CREST) (to A. K.) from the Japan Agency for Medical Research and Development (AMED), by Grants-in-Aid for Scientific Research (A) 26251010 (to A. K.) and (C) 24590073 (to T. S.) from the Japan Society for the Promotion of Science, and funding from Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program (to A. K.) from the Ministry of Education, Culture, Sports, Science and Technology, Japan. The authors declare that they have no conflicts of interest with the content of this article.	Atilla-Gokcumen GE, 2014, CELL, V156, P428, DOI 10.1016/j.cell.2013.12.015; Becker I, 2008, HISTOCHEM CELL BIOL, V129, P233, DOI 10.1007/s00418-007-0344-0; Breiden B, 2014, BBA-MOL CELL BIOL L, V1841, P441, DOI 10.1016/j.bbalip.2013.08.010; Chon HJ, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00070; Eckl KM, 2013, J INVEST DERMATOL, V133, P2202, DOI 10.1038/jid.2013.153; Ferguson AD, 2011, FEBS LETT, V585, P104, DOI 10.1016/j.febslet.2010.11.019; Fresques T, 2015, J BIOL CHEM, V290, P1395, DOI 10.1074/jbc.M114.621086; Gangoiti P, 2010, PROG LIPID RES, V49, P316, DOI 10.1016/j.plipres.2010.02.004; Ginkel C, 2012, J BIOL CHEM, V287, P41888, DOI 10.1074/jbc.M112.413500; Harrer H, 2013, MOL NUTR FOOD RES, V57, P516, DOI 10.1002/mnfr.201200465; Ikeda M, 2008, FEBS LETT, V582, P2435, DOI 10.1016/j.febslet.2008.06.007; Jennemann R, 2012, HUM MOL GENET, V21, P586, DOI 10.1093/hmg/ddr494; Kihara A, 2007, PROG LIPID RES, V46, P126, DOI 10.1016/j.plipres.2007.03.001; Kihara A, 2014, BBA-MOL CELL BIOL L, V1841, P766, DOI 10.1016/j.bbalip.2013.08.014; Kihara A, 2012, J BIOCHEM, V152, P387, DOI 10.1093/jb/mvs105; Kitamura T, 2015, BIOCHEM J, V465, P79, DOI 10.1042/BJ20140624; Laviad EL, 2012, J BIOL CHEM, V287, P21025, DOI 10.1074/jbc.M112.363580; Mendelson K, 2014, DEVELOPMENT, V141, P5, DOI 10.1242/dev.094805; Mesicek J, 2010, CELL SIGNAL, V22, P1300, DOI 10.1016/j.cellsig.2010.04.006; Mizutani Y, 2005, BIOCHEM J, V390, P263, DOI 10.1042/BJ20050291; Mizutani Y, 2006, BIOCHEM J, V398, P531, DOI 10.1042/BJ20060379; Mizutani Y, 2009, BIOCHIMIE, V91, P784, DOI 10.1016/j.biochi.2009.04.001; Muir A, 2014, ELIFE, V3, DOI 10.7554/eLife.03779; Mullen TD, 2012, BIOCHEM J, V441, P789, DOI 10.1042/BJ20111626; Nakahara K, 2012, MOL CELL, V46, P461, DOI 10.1016/j.molcel.2012.04.033; Ohno Y, 2015, P NATL ACAD SCI USA, V112, P7707, DOI 10.1073/pnas.1503491112; Ohno Y, 2010, P NATL ACAD SCI USA, V107, P18439, DOI 10.1073/pnas.1005572107; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Park JW, 2014, BBA-MOL CELL BIOL L, V1841, P671, DOI 10.1016/j.bbalip.2013.08.019; Rabionet M, 2015, HUM MOL GENET, V24, P4792, DOI 10.1093/hmg/ddv204; Raichur S, 2014, CELL METAB, V20, P687, DOI 10.1016/j.cmet.2014.09.015; Ruzzene M, 2010, BBA-PROTEINS PROTEOM, V1804, P499, DOI 10.1016/j.bbapap.2009.07.018; Sassa T, 2014, BIOMOL THER, V22, P83, DOI 10.4062/biomolther.2014.017; Sassa T, 2013, MOL CELL BIOL, V33, P2787, DOI 10.1128/MCB.00192-13; Sassa T, 2012, BBA-MOL CELL BIOL L, V1821, P1031, DOI 10.1016/j.bbalip.2012.04.008; Schulze H, 2014, BBA-MOL CELL BIOL L, V1841, P799, DOI 10.1016/j.bbalip.2013.10.015; Siddiqui-Jain A, 2010, CANCER RES, V70, P10288, DOI 10.1158/0008-5472.CAN-10-1893; Sridevi P, 2009, BBA-MOL CELL RES, V1793, P1218, DOI 10.1016/j.bbamcr.2009.04.006; Sugimoto M, 2015, BBA-MOL CELL BIOL L, V1851, P1554, DOI 10.1016/j.bbalip.2015.09.004; Truman JP, 2014, BBA-MOL CELL BIOL L, V1841, P1174, DOI 10.1016/j.bbalip.2013.12.013; Turpin S. M., 2014, OBESITY INDUCED CERS; Vanni N, 2014, ANN NEUROL, V76, P206, DOI 10.1002/ana.24170; Venerando A, 2014, BIOCHEM J, V460, P141, DOI 10.1042/BJ20140178; Winter E, 2002, TRENDS BIOCHEM SCI, V27, P381, DOI 10.1016/S0968-0004(02)02154-0; Zhao LH, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002063	45	38	39	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2016	291	14					7477	7487		10.1074/jbc.M115.695858	http://dx.doi.org/10.1074/jbc.M115.695858			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DW2BJ	26887952	Green Published, hybrid			2022-12-26	WOS:000383447600023
J	Cai, XN; Wang, C; Chen, SD; Lu, J				Cai, Xiaonan; Wang, Chen; Chen, Shengdi; Lu, Jian			Model Development for Risk Assessment of Driving on Freeway under Rainy Weather Conditions	PLOS ONE			English	Article							YOUNG NOVICE DRIVERS; ACCIDENTS	Rainy weather conditions could result in significantly negative impacts on driving on freeways. However, due to lack of enough historical data and monitoring facilities, many regions are not able to establish reliable risk assessment models to identify such impacts. Given the situation, this paper provides an alternative solution where the procedure of risk assessment is developed based on drivers' subjective questionnaire and its performance is validated by using actual crash data. First, an ordered logit model was developed, based on questionnaire data collected from Freeway G15 in China, to estimate the relationship between drivers' perceived risk and factors, including vehicle type, rain intensity, traffic volume, and location. Then, weighted driving risk for different conditions was obtained by the model, and further divided into four levels of early warning (specified by colors) using a rank order cluster analysis. After that, a risk matrix was established to determine which warning color should be disseminated to drivers, given a specific condition. Finally, to validate the proposed procedure, actual crash data from Freeway G15 were compared with the safety prediction based on the risk matrix. The results show that the risk matrix obtained in the study is able to predict driving risk consistent with actual safety implications, under rainy weather conditions.	[Cai, Xiaonan; Lu, Jian] Shanghai Jiao Tong Univ, Sch Naval Architecture Ocean & Civil Engn, Transportat Res Ctr, Shanghai 200030, Peoples R China; [Wang, Chen; Lu, Jian] Tongji Univ, Sch Transportat Engn, Shanghai 200092, Peoples R China; [Chen, Shengdi] Shanghai Maritime Univ, Coll Transport & Commun, Shanghai, Peoples R China	Shanghai Jiao Tong University; Tongji University; Shanghai Maritime University	Wang, C (corresponding author), Tongji Univ, Sch Transportat Engn, Shanghai 200092, Peoples R China.	wkobec@hotmail.com			Shanghai Pujiang Program [15PJC093]; Fundamental Research Funds for the Central Universities [1600219254]	Shanghai Pujiang Program(Shanghai Pujiang Program); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This research project was partly sponsored by "Shanghai Pujiang Program" (15PJC093) and "the Fundamental Research Funds for the Central Universities" (1600219254). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrey J, 1993, WEATHER HAZARDS DRIV; Andrey J, 2013, WEATHER INFORM ROAD, V6, P14; Berdica K., 2002, TRANSPORT POL, V9, P117, DOI [10.1016/S0967-070X(02)00011-2, DOI 10.1016/S0967-070X(02)00011-2]; China Meteorological Administration, 2010, GRAD WEATH COND FREE; Clarke DD, 2006, ACCIDENT ANAL PREV, V38, P871, DOI 10.1016/j.aap.2006.02.013; Deery HA, 1999, J SAFETY RES, V30, P225, DOI 10.1016/S0022-4375(99)00018-3; Department of Transportation of P. R. China, 2004, TECHN STAND HIGHW EN; Doherty ST., 1993, CLIMATOLOGICAL B, V27, P154; Eisenberg D, 2004, ACCIDENT ANAL PREV, V36, P637, DOI 10.1016/S0001-4575(03)00085-X; ElDessouki WM, 2004, US DEP TRANSPORTATIO; Gregersen NP, 1996, ACCIDENT ANAL PREV, V28, P229, DOI 10.1016/0001-4575(95)00063-1; Henry JJ, 1998, NCHRP SYNTHESIS HIGH, V291; Kamrin MA, 2003, REPORTING RISK JOURN; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Morris RS Mounce JM Button JW Walton NE, 1977, TRANSPORT RES REC, P19; OECD (Organization for Economic Co-operation and Development) Research Group, 1976, ADV WEATH RED VIS RO; Office of Operations, 2014, ROAD WEATHER MANAGEM, V10, P16; Palutikof J. P., 1991, JOURNAL OF HIGHWAY M, P163; Ramsey D. J, 2006, IMPACT DRIVER INATTE; ROSE JG, 1977, TRANSPORT ENG-J ASCE, V103, P491; SHERRETZ LA, 1978, J APPL METEOROL, V17, P711, DOI 10.1175/1520-0450(1978)017<0711:AAOTRB>2.0.CO;2; Traffic Management Administration of the Ministry of Public Security, 2012, ANN REP ROAD ACC PEO; Underwood G, 2007, ERGONOMICS, V50, P1235, DOI 10.1080/00140130701318707	23	3	3	4	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0149442	10.1371/journal.pone.0149442	http://dx.doi.org/10.1371/journal.pone.0149442			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3DG	26894434	Green Published, gold, Green Submitted			2022-12-26	WOS:000371223400054
J	Desingu, PA; Ray, PK; Patel, BHM; Singh, R; Singh, RK; Saikumar, G				Desingu, P. A.; Ray, Pradeep K.; Patel, B. H. M.; Singh, R.; Singh, R. K.; Saikumar, G.			Pathogenic and Genotypic Characterization of a Japanese Encephalitis Virus Isolate Associated with Reproductive Failure in an Indian Pig Herd	PLOS ONE			English	Article							CHINA; FLAVIVIRUSES; PERSPECTIVE; INFECTION; PIGLETS	Background India is endemic to Japanese encephalitis virus (JEV) and recurrent outbreaks occur mainly in rice growing areas. Pigs are considered to be the amplifying host for JEV and infection in gestating pigs results in reproductive failure. Most studies conducted on JEV infection in Indian pigs have been serological surveys and very little is known about JEV genotypes circulating in pigs. So the potential risk posed by pigs in JEV transmission and the genetic relationship between viruses circulating in pigs, mosquitoes and humans is poorly understood. Methodology/Principal Findings This study was conducted in pigs with a history of reproductive failure characterized by stillborn piglets with neuropathological lesions. Japanese encephalitis (JE) suspected brain specimens inoculated intracerebrally into mice and Vero cells resulted in successful isolation of JEV/SW/IVRI/395A/2014. Clinicopathological observations in infected mice, demonstration of JEV antigen in brain, and analysis of the envelope protein identified the swine isolate as being neurovirulent. Phylogenetic analysis based on prM and E gene sequences showed that it belonged to genotype III. This swine isolate was closely related to JEV associated with the 2005 outbreak in India and JaoArS982 from Japan. Phylogenetic analysis of JEV strains collected between 1956 and 2014 in India categorized the GIII viruses into different clades blurring their spatial distribution, which has been discernible in the previous century. Conclusions/Significance Isolation of JEV from stillborn piglets and its close genetic relationship with viruses detected at least three decades ago in humans and mosquitoes in Japan suggests that the virus may have been circulating among Indian pigs for several decades. The close similarity between the present swine isolate and those detected in humans affected in the 2005 outbreak in Uttar Pradesh, India, suggests the need for more intensive surveillance of pigs and implementation of suitable strategies to control JE in India.	[Desingu, P. A.; Ray, Pradeep K.; Saikumar, G.] Indian Vet Res Inst, Div Pathol, Swine Dis Lab, Izatnagar 243122, Uttar Pradesh, India; [Patel, B. H. M.] Indian Vet Res Inst, Div Livestock Prod & Management, Izatnagar 243122, Uttar Pradesh, India; [Singh, R.] Indian Vet Res Inst, Div Pathol, Izatnagar 243122, Uttar Pradesh, India; [Singh, R. K.] Indian Vet Res Inst, Izatnagar 243122, Uttar Pradesh, India	Indian Council of Agricultural Research (ICAR); ICAR - Indian Veterinary Research Institute; Indian Council of Agricultural Research (ICAR); ICAR - Indian Veterinary Research Institute; Indian Council of Agricultural Research (ICAR); ICAR - Indian Veterinary Research Institute; Indian Council of Agricultural Research (ICAR); ICAR - Indian Veterinary Research Institute	Saikumar, G (corresponding author), Indian Vet Res Inst, Div Pathol, Swine Dis Lab, Izatnagar 243122, Uttar Pradesh, India.	saikumarivri@gmail.com	RCER, ICAR/ABD-1024-2020; Desingu, P./AGM-5446-2022; Ray, Pradeep Kumar/AAZ-2613-2020; Desingu, Perumal/AGH-9777-2022	RCER, ICAR/0000-0002-6025-3363; Desingu, P./0000-0003-4395-4472; Ray, Pradeep Kumar/0000-0002-6145-6920; 	ICAR-IVRI, Izatnagar, India	ICAR-IVRI, Izatnagar, India	The authors are thankful to ICAR-IVRI, Izatnagar, India, for financial support to conduct this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arroyo J, 2001, J VIROL, V75, P934, DOI 10.1128/JVI.75.2.934-942.2001; Ayers M, 2006, J VIROL METHODS, V135, P235, DOI 10.1016/j.jviromet.2006.03.009; BURNS KF, 1950, P SOC EXP BIOL MED, V75, P621, DOI 10.3181/00379727-75-18285; Campbell GL, 2011, B WORLD HEALTH ORGAN, V89, P766, DOI 10.2471/BLT.10.085233; Cao QS, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-472; Dhillon G P S, 2008, J Indian Med Assoc, V106, P660; Fulmali PV, 2011, EMERG INFECT DIS, V17, P319, DOI 10.3201/eid1702.100815; GEEVARGHESE G, 1987, INDIAN J MED RES, V86, P273; Ghosh D, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000437; Gresham A, 2003, IN PRACTICE, V25, P466; Han N, 2014, J VIROL, V88, P11469, DOI 10.1128/JVI.02050-14; HOSOYA H., 1950, Jikken Igaku Zasshi = Japanese Journal of Experimental Medicine, V20, P587; Huxtable C.R, 1992, PATHOLOGY DOMESTIC A, VI, P412; Joo HS, 1999, DIS SWINE, P173; KALIMUDDIN MD, 1982, INT J ZOONOSES, V9, P39; Kumari Roop, 2012, WHO South East Asia J Public Health, V1, P374, DOI 10.4103/2224-3151.207040; Liu WJ, 2013, VIRUS RES, V178, P547, DOI 10.1016/j.virusres.2013.09.002; Mackenzie JS, 2004, NAT MED, V10, pS98, DOI 10.1038/nm1144; MORIMOTO T, 1972, NATL I ANIM HEALTH Q, V12, P127; Namachivayam V, 1982, P NAT C JAP ENC, P30; OIE, 2010, OIE TERR MAN 2010; Parida M, 2006, EMERG INFECT DIS, V12, P1427, DOI 10.3201/eid1209.060200; Ratho R. K., 1999, Journal of Communicable Diseases, V31, P113; SALMON H, 1984, REPROD NUTR DEV, V24, P197, DOI 10.1051/rnd:19840219; Sarkar A, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-271; Solomon T, 2006, NEW ENGL J MED, V355, P869, DOI 10.1056/NEJMp058263; Tiwari S, 2012, BRAZ J INFECT DIS, V16, P564, DOI 10.1016/j.bjid.2012.10.004; Wang HY, 2007, J GEN VIROL, V88, P885, DOI 10.1099/vir.0.82185-0; Yamada M, 2004, VET PATHOL, V41, P62, DOI 10.1354/vp.41-1-62	29	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0147611	10.1371/journal.pone.0147611	http://dx.doi.org/10.1371/journal.pone.0147611			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3DG	26895440	Green Published, gold, Green Submitted			2022-12-26	WOS:000371223400008
J	Hu, K; Ma, RR; Cheng, JM; Ye, X; Sun, Q; Yuan, HL; Liang, N; Fang, WH; Li, HR; Yang, XL				Hu, Kun; Ma, Rong-Rong; Cheng, Jun-Ming; Ye, Xin; Sun, Qi; Yuan, Hai-Lan; Liang, Nan; Fang, Wen-Hong; Li, Hao-Ran; Yang, Xian-Le			Analysis of Saprolegnia parasitica Transcriptome following Treatment with Copper Sulfate	PLOS ONE			English	Article							PATHOGEN; EFFICACY; SPHTP1; TOPHAT	Background Massive infection caused by oomycete fungus Saprolegnia parasitica is detrimental to freshwater fish. Recently, we showed that copper sulfate demonstrated good efficacy for controlling S. parasitica infection in grass carp. In this study, we investigated the mechanism of inhibition of S. parasitica growth by copper sulfate by analyzing the transcriptome of copper sulfate-treated S. parasitica. To examine the mechanism of copper sulfate inhibiting S. parasitica, we utilized RNA-seq technology to compare differential gene expression in S. parasitica treated with or without copper sulfate. Results The total mapped rates of the reads with the reference genome were 90.50% in the control group and 73.50% in the experimental group. In the control group, annotated splice junctions, partial novel splice junctions and complete novel splice junctions were about 83%, 3% and 14%, respectively. In the treatment group, the corresponding values were about 75%, 6% and 19%. Following copper sulfate treatment, a total 310 genes were markedly upregulated and 556 genes were markedly downregulated in S. parasitica. Material metabolism related GO terms including cofactor binding (33 genes), 1,3-beta-D-glucan synthase complex (4 genes), carboxylic acid metabolic process (40 genes) were the most significantly enriched. KEGG pathway analysis also determined that the metabolism-related biological pathways were significantly enriched, including the metabolic pathways (98 genes), biosynthesis of secondary metabolites pathways (42 genes), fatty acid metabolism (13 genes), phenylalanine metabolism (7 genes), starch and sucrose metabolism pathway (12 genes). The qRT-PCR results were largely consistent with the RNA-Seq results. Conclusion Our results indicate that copper sulfate inhibits S. parasitica growth by affecting multiple biological functions, including protein synthesis, energy biogenesis, and metabolism.	[Hu, Kun; Ma, Rong-Rong; Cheng, Jun-Ming; Ye, Xin; Sun, Qi; Yuan, Hai-Lan; Liang, Nan; Li, Hao-Ran; Yang, Xian-Le] Shanghai Ocean Univ, Natl Pathogen Collect Ctr Aquat Anim, 999 Hucheng Huan Rd, Shanghai 201306, Peoples R China; [Ma, Rong-Rong; Fang, Wen-Hong] Chinese Acad Fishery Sci, East China Sea Fisheries Res Inst, Shanghai 201306, Peoples R China	Shanghai Ocean University; Chinese Academy of Fishery Sciences; East China Sea Fisheries Research Institute, CAFS	Yang, XL (corresponding author), Shanghai Ocean Univ, Natl Pathogen Collect Ctr Aquat Anim, 999 Hucheng Huan Rd, Shanghai 201306, Peoples R China.	xlyang@shou.edu.cn	Li, Hao/GPS-9834-2022; Yang, Xian/GVU-9087-2022		863 Program [2011AA10A216]; Special Fund for Agro-scientific Research in the Public Interest [201203085]; National Natural Resources Platform; Shanghai University Knowledge Service Platform	863 Program(National High Technology Research and Development Program of China); Special Fund for Agro-scientific Research in the Public Interest; National Natural Resources Platform; Shanghai University Knowledge Service Platform	This study was supported by the 863 Program (Grant 2011AA10A216), the Special Fund for Agro-scientific Research in the Public Interest (Grant 201203085), the National Natural Resources Platform and the Shanghai University Knowledge Service Platform. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; Jiang RHY, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003272; Li CZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047442; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Meinelt T, 2007, AQUAT TOXICOL, V83, P93, DOI 10.1016/j.aquatox.2007.03.013; MEYER FP, 1991, J ANIM SCI, V69, P4201, DOI 10.2527/1991.69104201x; Nakagawa K, 2012, J ANTIBIOT, V65, P599, DOI 10.1038/ja.2012.86; Peng YL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090636; Price DP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022573; Rach JJ, 2005, N AM J AQUACULT, V67, P148, DOI 10.1577/A04-062.1; Srivastava S, 2004, AQUAT TOXICOL, V66, P319, DOI 10.1016/j.aquatox.2003.09.008; Stammati A, 2005, TOXICOL IN VITRO, V19, P853, DOI 10.1016/j.tiv.2005.06.021; Sun Q, 2014, J WORLD AQUACULT SOC, V45, P220, DOI 10.1111/jwas.12113; Torto-Alalibo T, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-46; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Van West Pieter, 2006, Mycologist, V20, P99, DOI 10.1016/j.mycol.2006.06.004; van West P, 2010, FEMS MICROBIOL LETT, V310, P127, DOI 10.1111/j.1574-6968.2010.02055.x; Warrilow AGS, 2014, APPL ENVIRON MICROB, V80, P6154, DOI 10.1128/AEM.01195-14; Wawra S, 2012, P NATL ACAD SCI USA, V109, P2096, DOI 10.1073/pnas.1113775109; Yan HZ, 2006, FUNGAL GENET BIOL, V43, P430, DOI 10.1016/j.fgb.2006.01.010	21	12	12	3	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0147445	10.1371/journal.pone.0147445	http://dx.doi.org/10.1371/journal.pone.0147445			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3DG	26895329	gold, Green Published			2022-12-26	WOS:000371223400007
J	Zaini, WH; Giuliani, F; Beaulieu, C; Kalra, S; Hanstock, C				Zaini, Wan Hazlin; Giuliani, Fabrizio; Beaulieu, Christian; Kalra, Sanjay; Hanstock, Christopher			Fatigue in Multiple Sclerosis: Assessing Pontine Involvement Using Proton MR Spectroscopic Imaging	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; WHITE-MATTER; LOCUS-COERULEUS; BASAL GANGLIA; EARLY-STAGE; METABOLISM; SYSTEM; CORTEX; GRAY; MS	Background/Objective The underlying mechanism of fatigue in multiple sclerosis (MS) remains poorly understood. Our study investigates the involvement of the ascending reticular activating system (ARAS), originating in the pontine brainstem, in MS patients with symptoms of fatigue. Methods Female relapsing-remitting MS patients (n = 17) and controls (n = 15) underwent a magnetic resonance spectroscopic imaging protocol at 1.5T. Fatigue was assessed in every subject using the Fatigue Severity Scale (FSS). Using an FSS cut-off of 36, patients were categorized into a low (n = 9, 22 +/- 10) or high (n = 10, 52 +/- 6) fatigue group. The brain metabolites N-acetylaspartate (NAA) and total creatine (tCr) were measured from sixteen 5x5x10 mm(3) spectroscopic imaging voxels in the rostral pons. Results MS patients with high fatigue had lower NAA/tCr concentration in the tegmental pons compared to control subjects. By using NAA and Cr values in the cerebellum for comparison, these NAA/tCr changes in the pons were driven by higher tCr concentration, and that these changes were focused in the WM regions. Discussion/Conclusion Since there were no changes in NAA concentration, the increase in tCr may be suggestive of gliosis, or an imbalanced equilibrium of the creatine and phosphocreatine ratio in the pons of relapsing-remitting MS patients with fatigue.	[Zaini, Wan Hazlin; Beaulieu, Christian; Hanstock, Christopher] Univ Alberta, Dept Biomed Engn, Edmonton, AB, Canada; [Giuliani, Fabrizio; Kalra, Sanjay] Univ Alberta, Dept Med, Div Neurol, Edmonton, AB, Canada	University of Alberta; University of Alberta	Hanstock, C (corresponding author), Univ Alberta, Dept Biomed Engn, Edmonton, AB, Canada.	Chris.hanstock@ualberta.ca	Beaulieu, Christian/E-9796-2011	Beaulieu, Christian/0000-0002-2342-3298; Kalra, Sanjay/0000-0003-4762-8746	University of Alberta Hospital Foundation; Multiple Sclerosis Society of Canada - EndMS Program; MS Society of Canada-EndMS Program	University of Alberta Hospital Foundation(University of Alberta); Multiple Sclerosis Society of Canada - EndMS Program; MS Society of Canada-EndMS Program	This work was supported by the University of Alberta Hospital Foundation, http://www.universityhospitalfoundation.ab.ca, and Multiple Sclerosis Society of Canada - EndMS Program, https://beta.mssociety.ca.; We acknowledge the financial support of the University of Alberta Hospital Foundation, and the MS Society of Canada-EndMS Program. We would also like to thank Dr Gregg Blevins for assistance with patient recruitment.	Aston-Jones G, 1999, BIOL PSYCHIAT, V46, P1309, DOI 10.1016/S0006-3223(99)00140-7; Beck CA, 2005, MULT SCLER J, V11, P516, DOI 10.1191/1352458505ms1192oa; BLOMSTRAND E, 1989, ACTA PHYSIOL SCAND, V136, P473, DOI 10.1111/j.1748-1716.1989.tb08689.x; BOTTOMLEY PA, 1984, SELECTIVE VOLUME MET; Chaudhuri A, 2004, LANCET, V363, P978, DOI 10.1016/S0140-6736(04)15794-2; Duong MVA, 2007, J NEUROL, V254, P914, DOI 10.1007/s00415-006-0474-7; Filippi M, 2010, J MAGN RESON IMAGING, V31, P770, DOI 10.1002/jmri.22102; Gadea M, 2004, BRAIN, V127, P89, DOI 10.1093/brain/awh002; Garcia-Rill E, 2015, SLEEP SCI, V8, P82, DOI 10.1016/j.slsci.2015.04.003; Hattingen E, 2011, NMR BIOMED, V24, P536, DOI 10.1002/nbm.1621; HUSTED CA, 1994, ANN NEUROL, V36, P157, DOI 10.1002/ana.410360207; Induruwa I, 2012, J NEUROL SCI, V323, P9, DOI 10.1016/j.jns.2012.08.007; Ke Y, 2002, MAGNET RESON MED, V47, P232, DOI 10.1002/mrm.10063; Kirov II, 2013, NEUROLOGY, V80, P39, DOI 10.1212/WNL.0b013e31827b1a8c; KORF J, 1973, NEUROPHARMACOLOGY, V12, P933, DOI 10.1016/0028-3908(73)90024-5; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; Loder C, 2002, MED HYPOTHESES, V59, P594, DOI 10.1016/S0306-9877(02)00261-X; Moll NM, 2011, ANN NEUROL, V70, P764, DOI 10.1002/ana.22521; Narayana PA, 2005, J NEUROIMAGING, V15, p46S, DOI 10.1177/1051228405284200; NEWCOMBE J, 1980, J NEUROCHEM, V34, P700, DOI 10.1111/j.1471-4159.1980.tb11200.x; NEWCOMBE J, 1986, J NEUROCHEM, V47, P1713, DOI 10.1111/j.1471-4159.1986.tb13079.x; Ordidge R, 1983, METHODS APPARATUS OB; Pardini M, 2010, BEHAV NEUROSCI, V124, P329, DOI 10.1037/a0019585; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Poulsen MB, 2015, STROKE, V46, P3470, DOI 10.1161/STROKEAHA.115.010860; Provencher SW, 2001, NMR BIOMED, V14, P260, DOI 10.1002/nbm.698; Rocca MA, 2007, HUM BRAIN MAPP, V28, P373, DOI 10.1002/hbm.20279; Roelcke U, 1997, NEUROLOGY, V48, P1566, DOI 10.1212/WNL.48.6.1566; Sajja BR, 2009, NEUROIMAG CLIN N AM, V19, P45, DOI 10.1016/j.nic.2008.08.002; Sepulcre J, 2009, MULT SCLER J, V15, P337, DOI 10.1177/1352458508098373; Staub F, 2001, CEREBROVASC DIS, V12, P75, DOI 10.1159/000047685; Steen C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010811; Tedeschi G, 2007, J NEUROL SCI, V263, P15, DOI 10.1016/j.jns.2007.07.004; Tellez N, 2008, NEURORADIOLOGY, V50, P17, DOI 10.1007/s00234-007-0304-3; Weber-Fahr W, 2002, NEUROIMAGE, V16, P49, DOI 10.1006/nimg.2002.1057; WINTERFELD M, 1977, J NEUROL, V215, P261, DOI 10.1007/BF00312497	36	12	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0149622	10.1371/journal.pone.0149622	http://dx.doi.org/10.1371/journal.pone.0149622			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3DG	26895076	gold, Green Published, Green Submitted			2022-12-26	WOS:000371223400070
J	Yu, CJ; Du, JC; Chiou, HC; Yang, SH; Liao, KW; Yang, WN; Chung, MY; Chien, LC; Hwang, BT; Chen, ML				Yu, Ching-Jung; Du, Jung-Chieh; Chiou, Hsien-Chih; Yang, Shang-Han; Liao, Kai-Wei; Yang, Winnie; Chung, Ming-Yi; Chien, Ling-Chu; Hwang, Betau; Chen, Mei-Lien			Attention Deficit/Hyperactivity Disorder and Urinary Nonylphenol Levels: A Case-Control Study in Taiwanese Children	PLOS ONE			English	Article							DEFICIT HYPERACTIVITY DISORDER; BLOOD LEAD LEVELS; VERSION-IV SCALE; BISPHENOL-A; PSYCHOMETRIC PROPERTIES; ENDOCRINE DISRUPTORS; CHINESE CHILDREN; BIRTH-WEIGHT; ALCOHOL-USE; EXPOSURE	Objective Nonylphenol (NP) belongs to the family of endocrine disruptors, and it is widely used in industrial applications and is ubiquitous in daily foods. Animal studies have suggested that NP exposure might promote motor hyperactivity, likely by causing deficits in dopaminergic neurons. However, research assessing NP exposure and epidemiology studies on human populations are limited. The aim of this study was to explore the association between child NP exposure and ADHD while considering particular covariants, such as lead levels and dopamine-related gene variations. Methods A case-control study was conducted on patients with clinically diagnosed ADHD; the Swanson, Nolan and Pelham, Fourth Revision (SNAP-IV) questionnaire was used to identify normal controls aged 4-15 years. Participants were examined for urinary NP concentrations, blood lead levels, and select single-nucleotide polymorphisms of two dopamine-related genes (D4 dopamine receptor, DRD4, and dopamine transporter, DAT1). Socio-demographic variables, maternal lifestyle factors during pregnancy and family medical history were obtained using a questionnaire. Results A total of 97 children with doctor-diagnosed ADHD and 110 normal controls were enrolled. The blood lead levels in both groups were similar (1.57 +/- 0.73 vs. 1.73 +/- 0.77 mu g/dL, p = 0.15). No significant difference in urinary NP concentration was found between the children with ADHD and the control subjects (4.52 +/- 3.22 mu g/g cr. vs. 4.64 +/- 2.95 mu g/g cr., p = 0.43). ADHD was significantly more prevalent among males in this study (male to female ratio:5:1 for the ADHD group and 1.3:1 for the control group, p<0.01). The analysis was repeated after excluding the females, but this had no effect on the association between NP and ADHD. The regression model, including or excluding females, indicated no increased odds of having ADHD in the context of NP exposure after adjusting for covariants. Conclusion This study indicated that NP exposure might not promote ADHD in children, even though children in Taiwan had relatively high levels of NP compared to those reported previously and those in developed nations.	[Yu, Ching-Jung; Yang, Shang-Han; Liao, Kai-Wei; Chen, Mei-Lien] Natl Yang Ming Univ, Inst Environm & Occupat Hlth Sci, Sch Med, Taipei 112, Taiwan; [Du, Jung-Chieh; Hwang, Betau] Taipei City Hosp, Zhongxiao branch, Dept Pediat, Taipei, Taiwan; [Chiou, Hsien-Chih] Taipei City Hosp, Songde Branch, Dept Child & Adolescent Psychiat, Taipei, Taiwan; [Yang, Winnie] Taipei City Hosp, Yangming Branch, Dept Pediat, Taipei, Taiwan; [Chung, Ming-Yi] Natl Yang Ming Univ, Dept Life Sci, Taipei 112, Taiwan; [Chung, Ming-Yi] Natl Yang Ming Univ, Inst Genome Sci, Taipei 112, Taiwan; [Chien, Ling-Chu] Taipei Med Univ, Sch Publ Hlth, Taipei, Taiwan	National Yang Ming Chiao Tung University; Taipei City Hospital; Taipei City Hospital; Taipei City Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Medical University	Chen, ML (corresponding author), Natl Yang Ming Univ, Inst Environm & Occupat Hlth Sci, Sch Med, Taipei 112, Taiwan.	mlchen@ym.edu.tw	Liao, Kai-Wei/AAW-5992-2020	Liao, Kai-Wei/0000-0003-3842-416X; Chien, Ling-Chu/0000-0001-5539-8974; Chung, Ming-yi/0000-0003-2198-6860	Department of Health, Taipei City Government; Aiming for the Top University Plan from the Ministry of Education of the Republic of China, Taiwan; National Science Council of Taiwan [NSC 96-2314-B-010-020-MY3]; National Core Facility Program for Biotechnology of Taiwan [MOST 103-2319-B-010-001]	Department of Health, Taipei City Government; Aiming for the Top University Plan from the Ministry of Education of the Republic of China, Taiwan; National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); National Core Facility Program for Biotechnology of Taiwan	This study was financially supported by Department of Health, Taipei City Government, and Aiming for the Top University Plan from the Ministry of Education of the Republic of China, Taiwan. The work was also supported by the National Science Council of Taiwan, grant number NSC 96-2314-B-010-020-MY3, and by MOST 103-2319-B-010-001 from the National Core Facility Program for Biotechnology of Taiwan. The funding sources had no involvement in study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the article for publication.; We would like to thank the Department of Health, Taipei City Government, and Aiming for the Top University Plan from the Ministry of Education of the Republic of China, Taiwan, for financially supporting this research. The work was also supported by the National Science Council of Taiwan. The authors also acknowledge the High-throughput Genome Analysis Core Facility of National Core Facility Program for Biotechnology, Taiwan, for SNP genotyping. This manuscript has been edited by American Journal Experts.	Aguiar A, 2010, ENVIRON HEALTH PERSP, V118, P1646, DOI 10.1289/ehp.1002326; Aronson M, 1997, DEV MED CHILD NEUROL, V39, P583; Asimakopoulos AG, 2012, TOXICOL LETT, V210, P141, DOI 10.1016/j.toxlet.2011.07.032; Association A. P., 2000, DIAGN STAT MAN TEXT; Biederman J, 2005, BIOL PSYCHIAT, V57, P1215, DOI 10.1016/j.biopsych.2004.10.020; Biederman J, 2002, AM J PSYCHIAT, V159, P36, DOI 10.1176/appi.ajp.159.1.36; Biederman J, 2014, AM J PSYCHIAT; Bouchard MF, 2010, PEDIATRICS, V125, pE1270, DOI 10.1542/peds.2009-3058; Brooke L, 2005, AMBIENT AQUATIC LIFE; Brookes K, 2006, MOL PSYCHIATR, V11, P934, DOI 10.1038/sj.mp.4001869; Bussing R, 2008, ASSESSMENT, V15, P317, DOI 10.1177/1073191107313888; Calafat AM, 2005, ENVIRON HEALTH PERSP, V113, P391, DOI 10.1289/ehp.7534; CDC, CDCS CHILDH LEAD POI; Chang CH, 2013, CHEMOSPHERE, V93, P1145, DOI 10.1016/j.chemosphere.2013.06.048; Chen HW, 2013, SCI TOTAL ENVIRON, V449, P20, DOI 10.1016/j.scitotenv.2013.01.038; Chen ML, 2008, CHEMOSPHERE, V73, pS239, DOI 10.1016/j.chemosphere.2007.04.091; Chen ML, 2009, CHEMOSPHERE, V76, P927, DOI 10.1016/j.chemosphere.2009.04.054; Chen ML, 2005, INT J ENVIRON AN CH, V85, P335, DOI 10.1080/03067310412331315575; Cheng CY, 2002, J CHROMATOGR A, V968, P143, DOI 10.1016/S0021-9673(02)00959-7; Cheuk DKL, 2006, NEUROPEDIATRICS, V37, P234, DOI 10.1055/s-2006-924577; Chiodo LM, 2004, NEUROTOXICOL TERATOL, V26, P359, DOI 10.1016/j.ntt.2004.01.010; CORYSLECHTA DA, 1995, ANNU REV PHARMACOL, V35, P391, DOI 10.1146/annurev.pharmtox.35.1.391; Das Banerjee T, 2007, ACTA PAEDIATR, V96, P1269, DOI 10.1111/j.1651-2227.2007.00430.x; de Cock M, 2012, ACTA PAEDIATR, V101, P811, DOI 10.1111/j.1651-2227.2012.02693.x; DiMaio S, 2003, J PSYCHIATR NEUROSCI, V28, P27; Ding WH, 2000, J CHROMATOGR A, V866, P79, DOI 10.1016/S0021-9673(99)01059-6; Emond V, 2009, ENCEPHALE, V35, P107, DOI 10.1016/j.encep.2008.01.005; Eubig PA, 2010, ENVIRON HEALTH PERSP, V118, P1654, DOI 10.1289/ehp.0901852; Faraone SV, 2005, BIOL PSYCHIAT, V57, P1313, DOI 10.1016/j.biopsych.2004.11.024; Frumkin H. e, 2005, ENV HLTH GLOBAL LOCA, V11; Gau SSF, 2008, INT J METH PSYCH RES, V17, P35, DOI 10.1002/mpr.237; Gau SSF, 2009, J PEDIATR PSYCHOL, V34, P850, DOI 10.1093/jpepsy/jsn133; Guenther K, 2002, ENVIRON SCI TECHNOL, V36, P1676, DOI 10.1021/es010199v; Hechtman L, 1996, CAN J PSYCHIAT, V41, P350, DOI 10.1177/070674379604100605; HEINEGAR.D, 1973, CLIN CHIM ACTA, V43, P305, DOI 10.1016/0009-8981(73)90466-X; Huang HL, 2003, PSYCHIAT CLIN NEUROS, V57, P275, DOI 10.1046/j.1440-1819.2003.01117.x; Huang PC, 2012, ENVIRON INT, V40, P88, DOI 10.1016/j.envint.2011.10.011; Huang YF, 2014, ENVIRON RES, V134, P143, DOI 10.1016/j.envres.2014.07.004; Inoue K, 2001, FOOD ADDIT CONTAM, V18, P157, DOI 10.1080/02652030010018930; John DM, 1998, J BACTERIOL, V180, P4332, DOI 10.1128/JB.180.17.4332-4338.1998; Kajta M, 2013, PHARMACOL REP, V65, P1632, DOI 10.1016/S1734-1140(13)71524-X; Kim BN, 2009, BIOL PSYCHIAT, V66, P958, DOI 10.1016/j.biopsych.2009.07.034; Knopik VS, 2006, PSYCHOL MED, V36, P1461, DOI 10.1017/S0033291706007884; Kuppers E, 2001, HORM BEHAV, V40, P196, DOI 10.1006/hbeh.2001.1671; Laws SC, 2000, TOXICOL SCI, V54, P154, DOI 10.1093/toxsci/54.1.154; Li X, 2013, ENVIRON INT, V52, P81, DOI 10.1016/j.envint.2011.03.026; Linnet KM, 2006, ARCH DIS CHILD, V91, P655, DOI 10.1136/adc.2005.088872; Linnet KM, 2003, AM J PSYCHIAT, V160, P1028, DOI 10.1176/appi.ajp.160.6.1028; Lopez-Espinosa MJ, 2009, CHEMOSPHERE, V76, P847, DOI 10.1016/j.chemosphere.2009.03.063; Loyo-Rosales JE, 2004, J AGR FOOD CHEM, V52, P2016, DOI 10.1021/jf0345696; Lu J, 2008, CHEMOSPHERE, V71, P345, DOI 10.1016/j.chemosphere.2007.08.068; Lu YY, 2007, ENVIRON INT, V33, P903, DOI 10.1016/j.envint.2007.04.008; MALDONADO G, 1993, AM J EPIDEMIOL, V138, P923, DOI 10.1093/oxfordjournals.aje.a116813; Mao Z, 2008, NEUROSCI LETT, V439, P147, DOI 10.1016/j.neulet.2008.05.006; Markey CM, 2002, J STEROID BIOCHEM, V83, P235, DOI 10.1016/S0960-0760(02)00272-8; Masuo Y, 2004, REGUL PEPTIDES, V123, P225, DOI 10.1016/j.regpep.2004.05.010; Masuo Yoshinori, 2004, Neural Plasticity, V11, P59, DOI 10.1155/NP.2004.59; Mick E, 2002, J AM ACAD CHILD PSY, V41, P378, DOI 10.1097/00004583-200204000-00009; Millichap J.G., 2009, ATTENTION DEFICIT HY; Millichap JG, 2008, PEDIATRICS, V121, pE358, DOI 10.1542/peds.2007-1332; Muller S, 1998, ENVIRON TOXICOL PHAR, V5, P257, DOI 10.1016/S1382-6689(98)00009-X; Mundry R, 1998, ANIM BEHAV, V56, P256, DOI 10.1006/anbe.1998.0756; NEEDLEMAN HL, 1993, NEUROTOXICOLOGY, V14, P161; Nielsen E, TOXICOLOGICAL EVALUA; Pan YP, 2009, CHEMOSPHERE, V76, P381, DOI 10.1016/j.chemosphere.2009.03.034; Pirard C, 2012, ENVIRON INT, V48, P78, DOI 10.1016/j.envint.2012.07.003; Rothman K., 1998, MODERN EPIDEMIOLOGY; Sauver JLS, 2004, MAYO CLIN P; Schneider JS, 2003, NEUROTOXICOL TERATOL, V25, P555, DOI 10.1016/S0892-0362(03)00018-7; Shen Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079838; Shue MF, 2010, ENVIRON MONIT ASSESS, V168, P91, DOI 10.1007/s10661-009-1093-4; Soares A, 2008, ENVIRON INT, V34, P1033, DOI 10.1016/j.envint.2008.01.004; Swanson JM, 2001, J AM ACAD CHILD PSY, V40, P168, DOI 10.1097/00004583-200102000-00011; Swanson JM., 1995, SNAP 4 SCALE; Tan BLL, 2003, TOXICOL LETT, V143, P261, DOI 10.1016/S0378-4274(03)00172-3; Thapar A, 2013, J CHILD PSYCHOL PSYC, V54, P3, DOI 10.1111/j.1469-7610.2012.02611.x; Tsai MS, 2013, SCI TOTAL ENVIRON, V458, P367, DOI [10.1016/j.scitotenv.2013.04,039, 10.1016/j.scitotenv.2013.04.039]; Wang CL, 2002, ENVIRON RES, V89, P12, DOI 10.1006/enrs.2002.4342; Wang HL, 2008, ENVIRON HEALTH PERSP, V116, P1401, DOI 10.1289/ehp.11400; WHITE R, 1994, ENDOCRINOLOGY, V135, P175, DOI 10.1210/en.135.1.175; Willcutt E, 2012, NEUROTHERAPEUTICS, V9, P490, DOI 10.1007/s13311-012-0135-8	81	14	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2016	11	2							e0149558	10.1371/journal.pone.0149558	http://dx.doi.org/10.1371/journal.pone.0149558			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3CO	26890918	Green Published, Green Submitted, gold			2022-12-26	WOS:000371221500059
J	Almoosawi, S; Jones, AR; Parkinson, KN; Pearce, MS; Collins, H; Adamson, AJ				Almoosawi, Suzana; Jones, Angela R.; Parkinson, Kathryn N.; Pearce, Mark S.; Collins, Heather; Adamson, Ashley J.			Parental Perception of Weight Status: Influence on Children's Diet in the Gateshead Millennium Study	PLOS ONE			English	Article							OVERWEIGHT; ASSOCIATION; ADOLESCENTS; PATTERNS; OBESITY; ADULTHOOD; CHILDHOOD; THINNESS; HEALTH; RISK	Objective Recognising overweight and obesity is critical to prompting action, and consequently preventing and treating obesity. The present study examined the association between parental perceptions of child weight status and child's diet. Methods Participants were members of the Gateshead Millennium Study. Parental perception of their child's weight status was assessed using a questionnaire and compared against International Obesity Task Force cut-offs for childhood overweight and obesity when the children were aged 6-8 years old. Diet was assessed at age 6-8years old using the FAST (Food Assessment in Schools Tool) food diary method. The association between parental perception and dietary patterns as defined by Principal Components Analysis, was assessed using multivariate regression after adjustment for child's gender, child's weight status, maternal body mass index (BMI), maternal education and deprivation status. Results Of the 361 parents who provided complete data on confounders and on their perception of their child's weight status, 63 (17%) parents perceived their child as being of 'normal' weight or 'overweight' when they were actually 'overweight' or 'obese', respectively. After adjustment for confounders, parents who misperceived their child's weight had children with a lower 'healthy' dietary pattern score compared to children whose parents correctly perceived their weight (beta = -0.88; 95% CI: -1.7, -0.1; P-value = 0.028). This association was found despite higher consumption of reduced sugar carbonated drinks amongst children whose parents incorrectly perceived their weight status compared to children whose parents perceived their weight correctly (52.4% vs. 33.6%; P-value = 0.005). Conclusions In conclusion, children whose parents did not correctly perceive their weight status scored lower on the 'healthy' dietary pattern. Further research is required to define parents' diets based on their perception status and to examine if a child's or parent's diet mediates the association between parental perception and child weight.	[Almoosawi, Suzana; Jones, Angela R.; Parkinson, Kathryn N.; Adamson, Ashley J.] Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Almoosawi, Suzana; Jones, Angela R.; Parkinson, Kathryn N.; Adamson, Ashley J.] Newcastle Univ, Human Nutr Res Ctr, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Pearce, Mark S.] Royal Victoria Infirm, Inst Hlth & Soc, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Pearce, Mark S.] Royal Victoria Infirm, Sir James Spence Inst Child Hlth, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Collins, Heather] Newcastle Univ, Fac Med Sci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK; Newcastle University - UK; Newcastle University - UK; Newcastle University - UK	Almoosawi, S (corresponding author), Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.; Almoosawi, S (corresponding author), Newcastle Univ, Human Nutr Res Ctr, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	suzana.almoosawi@ncl.ac.uk		Adamson, Ashley/0000-0003-3735-2846; Pearce, Mark/0000-0002-0583-3779; Jones, Angela/0000-0001-8293-0858; almoosawi, suzana/0000-0003-2803-6120	National Prevention Research Initiative (British Heart Foundation); National Prevention Research Initiative (Cancer Research UK); National Prevention Research Initiative (Department of Health); National Prevention Research Initiative (Diabetes UK); National Prevention Research Initiative (Economic and Social Research Council); National Prevention Research Initiative (Food Standards Agency); National Prevention Research Initiative (Medical Research Council); National Prevention Research Initiative (Research and Development Office for the Northern Ireland Health and Social Services); National Prevention Research Initiative (Chief Scientist Office, Scottish Government Health Directorates); National Prevention Research Initiative (Welsh Assembly Government); National Prevention Research Initiative (World Cancer Research Fund); Henry Smith Charity; Sport Aiding Research in Kids (SPARKS); Gateshead NHS Trust RD; Northern and Yorkshire NHS RD; Northumberland, Tyne and Wear NHS Trust [CZH/4/484]; National Institute for Health Research (NIHR); NIHR [NIHR-RP-R2-12-001]; External Reference Group; Gateshead Education Authority; Medical Research Council [MR/K02325X/1B, G0501306, MR/K02325X/1] Funding Source: researchfish; National Institute for Health Research [NIHR-RP-02-12-001] Funding Source: researchfish; MRC [G0501306] Funding Source: UKRI	National Prevention Research Initiative (British Heart Foundation); National Prevention Research Initiative (Cancer Research UK); National Prevention Research Initiative (Department of Health); National Prevention Research Initiative (Diabetes UK)(Diabetes UK); National Prevention Research Initiative (Economic and Social Research Council); National Prevention Research Initiative (Food Standards Agency); National Prevention Research Initiative (Medical Research Council); National Prevention Research Initiative (Research and Development Office for the Northern Ireland Health and Social Services); National Prevention Research Initiative (Chief Scientist Office, Scottish Government Health Directorates); National Prevention Research Initiative (Welsh Assembly Government); National Prevention Research Initiative (World Cancer Research Fund); Henry Smith Charity; Sport Aiding Research in Kids (SPARKS); Gateshead NHS Trust RD; Northern and Yorkshire NHS RD; Northumberland, Tyne and Wear NHS Trust; National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); NIHR(National Institute for Health Research (NIHR)); External Reference Group; Gateshead Education Authority; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The Gateshead Millennium Study is supported by a grant from the National Prevention Research Initiative (incorporating funding from British Heart Foundation; Cancer Research UK; Department of Health; Diabetes UK; Economic and Social Research Council; Food Standards Agency; Medical Research Council; Research and Development Office for the Northern Ireland Health and Social Services; Chief Scientist Office, Scottish Government Health Directorates; Welsh Assembly Government and World Cancer Research Fund). The cohort was first established with funding from the Henry Smith Charity and Sport Aiding Research in Kids (SPARKS) and followed up with grants from Gateshead NHS Trust R&D, Northern and Yorkshire NHS R&D, and Northumberland, Tyne and Wear NHS Trust (CZH/4/484). AJA is funded by the National Institute for Health Research (NIHR) Professorship and SA is a postdoctoral fellow under the NIHR Professorship Grant (NIHR-RP-R2-12-001).; The survey was ran and field data collected by the Gateshead Millennium Study core team.We acknowledge the support of an External Reference Group in conducting the study. We appreciate the support of Gateshead Education Authority and local schools. We warmly thank the research team for their effort. Thanks are especially due to the Gateshead Millennium Study families and children for their participation in the study.	Adamson AJ, 2003, P NUTR SOC, V62, p35A; Adamson AJ, 2003, FAST FOOD ASSESSMENT, p84A; Baughcum AE, 2000, PEDIATRICS, V106, P1380, DOI 10.1542/peds.106.6.1380; Cole TJ, 2012, PEDIATR OBES, V7, P284, DOI 10.1111/j.2047-6310.2012.00064.x; Cole TJ, 2007, BMJ-BRIT MED J, V335, P194, DOI 10.1136/bmj.39238.399444.55; Craig LCA, 2010, BRIT J NUTR, V103, P319, DOI 10.1017/S0007114509991942; de Hoog MLA, 2012, INT J OBESITY, V36, P53, DOI 10.1038/ijo.2011.199; Doolen J, 2009, J AM ACAD NURSE PRAC, V21, P160, DOI 10.1111/j.1745-7599.2008.00382.x; Eckstein KC, 2006, PEDIATRICS, V117, P681, DOI 10.1542/peds.2005-0910; Faith MS, 2012, CIRCULATION, V125, P1186, DOI 10.1161/CIR.0b013e31824607ee; Freedman DS, 2001, PEDIATRICS, V108, P712, DOI 10.1542/peds.108.3.712; Genovesi S, 2005, ACTA PAEDIATR, V94, P747, DOI 10.1080/08035250510028894; GREGORY J, 2000, NATL DIET NUTR SURVE, V1; Gregory JR, 1995, NATL DIET NUTR SURVE; Huang JS, 2007, PEDIATRICS, V120, pE112, DOI 10.1542/peds.2006-2143; Jeffery AN, 2004, EARLYBIRD, V21; Jones AR, 2011, INT J OBESITY, V35, P953, DOI 10.1038/ijo.2011.106; Krebs J., 2002, MCCANCE WIDDOWSONS C; Lim HJ, 2013, OBESITY, V21, P2596, DOI 10.1002/oby.20361; Mikkila V, 2005, BRIT J NUTR, V93, P923, DOI 10.1079/BJN20051418; Neumark-Sztainer D, 2008, PEDIATRICS, V121, pE1495, DOI 10.1542/peds.2007-2642; Parkinson KN, 2011, INT J OBESITY, V35, P510, DOI 10.1038/ijo.2010.260; Parkinson KN, 2011, INT J EPIDEMIOL, V40, P308, DOI 10.1093/ije/dyq015; PARKINSON KN, 2007, INT J SOC RES METHOD, V10, P335; Rhee KE, 2005, PEDIATRICS, V116, pE94, DOI 10.1542/peds.2004-2479; Rietmeijer-Mentink M, 2013, MATERN CHILD NUTR, V9, P3, DOI 10.1111/j.1740-8709.2012.00462.x; Skala M, 2007, INT J RADIAT ONCOL, V68, P690, DOI 10.1016/j.ijrobp.2006.12.064; Tompkins CL, 2015, J CHILD FAM STUD, V24, P1384, DOI 10.1007/s10826-014-9945-0; WHO, 2000, OB PREV MAN GLOB EP; WHO, 2014, CHILDH OV OB	30	31	31	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0144931	10.1371/journal.pone.0144931	http://dx.doi.org/10.1371/journal.pone.0144931			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26886851	gold, Green Published, Green Submitted			2022-12-26	WOS:000371218400002
J	Andersen, TR; Schmidt, JF; Pedersen, MT; Krustrup, P; Bangsbo, J				Andersen, Thomas Rostgaard; Schmidt, Jakob Friis; Pedersen, Mogens Theisen; Krustrup, Peter; Bangsbo, Jens			The Effects of 52 Weeks of Soccer or Resistance Training on Body Composition and Muscle Function in+65-Year-Old Healthy Males - A Randomized Controlled Trial	PLOS ONE			English	Article							HUMAN SKELETAL-MUSCLE; CARDIOVASCULAR HEALTH; PHYSICAL-ACTIVITY; EXERCISE; FOOTBALL; PROTEIN; STRENGTH; PERFORMANCE; PREVENTION; PROFILE	The effects of 52 weeks of soccer or resistance training were investigated in untrained elderly men. The subjects aged 68.1 +/- 2.1 yrs were randomised into a soccer (SG; n = 9), a resistance (RG; n = 9) and a control group (CG; n = 8). The subjects in SG and RG, respectively, trained 1.7 +/- 0.3 and 1.8 +/- 0.3 times weekly on average during the intervention period. Muscle function and body composition were determined before and after 16 and 52 weeks of the intervention period. In SG, BMI was reduced by 1.5% and 3.0% (p<0.05) after 16 and 52 weeks, respectively, unchanged in RG and 2% higher (p<0.05) in CG after 52 weeks of the intervention period. In SG, the response to a glucose tolerance test was 16% lower (p<0.05) after 16 wks, but not after 52 wks, compared to before the intervention period, and unchanged in RG and CG. In SG, superoxide dismutase-2 expression was 59% higher (p<0.05) after 52 wks compared to before the intervention period, and unchanged in RG and CG. In RG, upper body lean mass was 3 and 2% higher (p<0.05) after 16 and 52 wks, respectively, compared to before the intervention period, and unchanged in SG and CG. In RG, Akt-2 expression increased by 28% (p<0.01) and follistatin expression decreased by 38% (p<0.05) during the 52-wk intervention period, and was unchanged in SG and CG. Thus, long-term soccer training reduces BMI and improves anti-oxidative capacity, while long-term resistance training impacts muscle protein enzyme expression and increases lean body mass in elderly men.	[Andersen, Thomas Rostgaard; Schmidt, Jakob Friis; Pedersen, Mogens Theisen; Krustrup, Peter; Bangsbo, Jens] Univ Copenhagen, Dept Nutr Exercise & Sports, Copenhagen Ctr Team Sport & Hlth, Copenhagen, Denmark; [Schmidt, Jakob Friis] Gentofte Univ Hosp, Dept Cardiol, Gentofte, Denmark; [Krustrup, Peter] Univ Exeter, Coll Life & Environm Sci, Sport & Hlth Sci, Exeter, Devon, England	University of Copenhagen; University of Copenhagen; Herlev & Gentofte Hospital; University of Exeter	Bangsbo, J (corresponding author), Univ Copenhagen, Dept Nutr Exercise & Sports, Copenhagen Ctr Team Sport & Hlth, Copenhagen, Denmark.	jbangsbo@nexs.ku.dk	Krustrup, Peter/D-2659-2019; Bangsbo, Jens/A-7192-2015; Pedersen, Mogens Theisen/C-6991-2015	Krustrup, Peter/0000-0002-1461-9838; Andersen, Thomas Rostgaard/0000-0002-0315-0202; Bangsbo, Jens/0000-0003-1305-9274; Pedersen, Mogens Theisen/0000-0002-3178-6320	FIFA - Medical Assessment and Research Centre (FMARC) (F-MARC Project) [31964]; Danish Ministry of Culture (Kulturministeriets Udvalg for Idraetsforskning) [TKIF 2010-027]; Nordea-fonden [02-2011-4360]; FIFA-Medical Assessment and Research Centre (F-MARC) [31964]	FIFA - Medical Assessment and Research Centre (FMARC) (F-MARC Project); Danish Ministry of Culture (Kulturministeriets Udvalg for Idraetsforskning); Nordea-fonden; FIFA-Medical Assessment and Research Centre (F-MARC)	The study was supported by the FIFA - Medical Assessment and Research Centre (FMARC) (F-MARC Project 31964; http://www.f-marc.com/), The Danish Ministry of Culture (Kulturministeriets Udvalg for Idraetsforskning) (TKIF 2010-027; http://kum.dk/), and Nordea-fonden (Grant code: 02-2011-4360; http://nordeafonden.dk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to sincerely thank the participants in the study for their efforts. Also, the technical and practical assistance of Peter Bergmann Pill, Morten Bredsgaard Randers Thomsen, Jens Jung Nielsen, Eva Wulff Helge, Martin Thomassen, Therese Hornstrup, Marie Von Hagman and Joshua Horton is greatly appreciated. The study was supported by the FIFA-Medical Assessment and Research Centre (F-MARC) (F-MARC Project 31964) The Danish Ministry of Culture (Kulturministeriets Udvalg for Idraetsforskning) (TKIF 2010-027) and Nordea-fonden (Grant code: 02-2011-4360). The authors have declared that no competing interests exist.	American College of Sports Medicine, 2009, Med Sci Sports Exerc, V41, P1510, DOI 10.1249/MSS.0b013e3181a0c95c; Andersen LG, 2010, SCAND J PUBLIC HEALT, V38, P707, DOI 10.1177/1403494810380099; Andersen TR, 2014, SCAND J MED SCI SPOR, V24, P76, DOI 10.1111/sms.12245; Andersen TR, 2014, SCAND J MED SCI SPOR, V24, P43, DOI 10.1111/sms.12259; Bangsbo J, 2014, SCAND J MED SCI SPOR, V24, P147, DOI 10.1111/sms.12271; Bangsbo J, 2015, BRIT J SPORT MED, V49, P568, DOI 10.1136/bjsports-2015-094781; BERGSTROM J, 1962, SCAND J CLIN LAB INV, V14, P1; BLAIR SN, 1995, JAMA-J AM MED ASSOC, V273, P1093, DOI 10.1001/jama.273.14.1093; Bloemberg D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035273; Daugaard JR, 2001, ACTA PHYSIOL SCAND, V171, P267, DOI 10.1046/j.1365-201x.2001.00829.x; DELA F, 1994, DIABETES, V43, P862, DOI 10.2337/diabetes.43.7.862; Durstine J Larry, 2002, J Cardiopulm Rehabil, V22, P385, DOI 10.1097/00008483-200211000-00002; Duscha BD, 2012, INT J SPORTS MED, V33, P218, DOI 10.1055/s-0031-1291323; Egan B, 2013, CELL METAB, V17, P162, DOI 10.1016/j.cmet.2012.12.012; Esmarck B, 2001, J PHYSIOL-LONDON, V535, P301, DOI 10.1111/j.1469-7793.2001.00301.x; FRONTERA WR, 1990, J APPL PHYSIOL, V68, P329, DOI 10.1152/jappl.1990.68.1.329; Fry CS, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-11; Gliemann L, 2013, J PHYSIOL-LONDON, V591, P5047, DOI 10.1113/jphysiol.2013.258061; Hamburg NM, 2007, ARTERIOSCL THROM VAS, V27, P2650, DOI 10.1161/ATVBAHA.107.153288; Harris JA, 1918, P NATL ACAD SCI USA, V4, P370, DOI 10.1073/pnas.4.12.370; Helge EW, 2014, SCAND J MED SCI SPOR; Houmard JA, 1998, J APPL PHYSIOL, V85, P1337, DOI 10.1152/jappl.1998.85.4.1337; Krustrup P, 2009, BRIT J SPORT MED, V43, P825, DOI 10.1136/bjsm.2008.053124; LOWRY OH, 1972, FLEXIBLE SYSTEM ENZY, P237; McHugh ML, 2011, BIOCHEM MEDICA, V21, P203; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; McQueen MJ, 2008, LANCET, V372, P224, DOI 10.1016/S0140-6736(08)61076-4; Mero AA, 2013, EUR J APPL PHYSIOL, V113, P641, DOI 10.1007/s00421-012-2466-x; Nelson ME, 2007, MED SCI SPORT EXER, V39, P1435, DOI [10.1249/mss.0b013e3180616aa2, 10.1161/CIRCULATIONAHA.107.185650]; Nielsen G, 2014, SCAND J MED SCI SPOR, V24, P66, DOI 10.1111/sms.12275; Nielsen JL, 2012, J PHYSIOL-LONDON, V590, P4351, DOI 10.1113/jphysiol.2012.237008; Nordsborg N, 2008, J PHYSIOL-LONDON, V586, P1447, DOI 10.1113/jphysiol.2007.143073; Nyberg M, 2014, FREE RADIC BIOL MED; Oja P, 2015, BR J SPORTS MED; Phillips SM, 1997, AM J PHYSIOL-ENDOC M, V273, pE99, DOI 10.1152/ajpendo.1997.273.1.E99; Randers MB, 2010, SCAND J MED SCI SPOR, V20, P14, DOI 10.1111/j.1600-0838.2010.01069.x; Schmidt JF, 2013, SCAND J MED SCI SPOR; Schmidt JF, 2014, SCAND J MED SCI SPOR; Thomassen M, 2010, J APPL PHYSL; Tipton KD, 2013, NESTLE NUTR WORKS SE, V76, P73, DOI 10.1159/000350259; Weinert BT, 2003, J APPL PHYSIOL, V95, P1706, DOI 10.1152/japplphysiol.00288.2003	41	23	25	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0148236	10.1371/journal.pone.0148236	http://dx.doi.org/10.1371/journal.pone.0148236			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26886262	gold, Green Published, Green Submitted			2022-12-26	WOS:000371218400020
J	Herzog, Q; Rabus, M; Ribeiro, BW; Laforsch, C				Herzog, Quirin; Rabus, Max; Ribeiro, Bernard Wolfschoon; Laforsch, Christian			Inducible Defenses with a "Twist": Daphnia barbata Abandons Bilateral Symmetry in Response to an Ancient Predator	PLOS ONE			English	Article							MORPHOLOGY; INDUCTION; GENOME	Predation is one of the most important drivers of natural selection. In consequence a huge variety of anti-predator defenses have evolved in prey species. Under unpredictable and temporally variable predation pressure, the evolution of phenotypically plastic defensive traits is favored. These "inducible defenses", range from changes in behavior, life history, physiology to morphology and can be found in almost all taxa from bacteria to vertebrates. An important group of model organisms in ecological, evolutionary and environmental research, water fleas of the genus Daphnia (Crustacea: Cladocera), are well known for their ability to respond to predators with an enormous variety of inducible morphological defenses. Here we report on the "twist", a body torsion, as a so far unrecognized inducible morphological defense in Daphnia, expressed by Daphnia barbata exposed to the predatory tadpole shrimp Triops cancriformis. This defense is realized by a twisted carapace with the helmet and the tail spine deviating from the body axis into opposing directions, resulting in a complete abolishment of bilateral symmetry. The twisted morphotype should considerably interfere with the feeding apparatus of the predator, contributing to the effectiveness of the array of defensive traits in D. barbata. As such this study does not only describe a completely novel inducible defense in the genus Daphnia but also presents the first report of a free living Bilateria to flexibly respond to predation risk by abandoning bilateral symmetry.	[Herzog, Quirin] Univ Munich, Dept Biol 2, Planegg Martinsried, Germany; [Rabus, Max; Ribeiro, Bernard Wolfschoon; Laforsch, Christian] Univ Bayreuth, Dept Anim Ecol 1, Bayreuth, Germany; [Laforsch, Christian] Univ Bayreuth, BayCEER, Bayreuth, Germany	University of Munich; University of Bayreuth; University of Bayreuth	Laforsch, C (corresponding author), Univ Bayreuth, Dept Anim Ecol 1, Bayreuth, Germany.; Laforsch, C (corresponding author), Univ Bayreuth, BayCEER, Bayreuth, Germany.	christian.laforsch@uni-bayreuth.de			Universitat Bayern e.V.; German Research Foundation (DFG); University of Bayreuth	Universitat Bayern e.V.; German Research Foundation (DFG)(German Research Foundation (DFG)); University of Bayreuth	QH received a research scholarship from the Universitat Bayern e.V. (http://www.unibayern.de/). This publication was funded by the German Research Foundation (DFG) and the University of Bayreuth in the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRONMARK C, 1992, SCIENCE, V258, P1348, DOI 10.1126/science.258.5086.1348; Colbourne JK, 2011, SCIENCE, V331, P555, DOI 10.1126/science.1197761; DODSON SI, 1974, LIMNOL OCEANOGR, V19, P721, DOI 10.4319/lo.1974.19.5.0721; Ebert D, 2011, SCIENCE, V331, P539, DOI 10.1126/science.1202092; FRYER G, 1988, PHILOS T ROY SOC B, V321, P27, DOI 10.1098/rstb.1988.0091; GILBERT JJ, 1966, SCIENCE, V151, P1234, DOI 10.1126/science.151.3715.1234; Gilbert JJ, 2011, FRESHWATER BIOL, V56, P926, DOI 10.1111/j.1365-2427.2010.02538.x; Harvell CD, 1999, THE ECOLOGY AND EVOL; Herzog Q, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-113; Lampert W., 1987, Memorie dell'Istituto Italiano di Idrobiologia Dott Marco de Marchi, V45, P143; Lampert W, 2011, DAPHNIA DEV MODEL OR, P45; Lively CM, 2000, ECOLOGY, V81, P1240, DOI 10.1890/0012-9658(2000)081[1240:PIDVFI]2.0.CO;2; Martindale MQ, 1998, AM ZOOL, V38, P672; Miner BG, 2005, TRENDS ECOL EVOL, V20, P685, DOI 10.1016/j.tree.2005.08.002; Palmer AR, 1996, P NATL ACAD SCI USA, V93, P14279, DOI 10.1073/pnas.93.25.14279; Petrusek A, 2009, P NATL ACAD SCI USA, V106, P2248, DOI 10.1073/pnas.0808075106; Rabus M, 2011, FUNCT ECOL, V25, P1137, DOI 10.1111/j.1365-2435.2011.01840.x; TOLLRIAN R, 1994, ARCH HYDROBIOL, V130, P69; TOLLRIAN R, 1999, ECOLOGY EVOLUTION IN; Verschoor AM, 2004, ECOL LETT, V7, P1143, DOI 10.1111/j.1461-0248.2004.00675.x	20	25	25	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0148556	10.1371/journal.pone.0148556	http://dx.doi.org/10.1371/journal.pone.0148556			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26886196	gold, Green Published, Green Submitted			2022-12-26	WOS:000371218400041
J	Rodriguez-Poncelas, A; Mundet-Tuduri, X; Miravet-Jimenez, S; Casellas, A; Barrot-De la Puente, JF; Franch-Nadal, J; Coll-de Tuero, G				Rodriguez-Poncelas, Antonio; Mundet-Tuduri, Xavier; Miravet-Jimenez, Sonia; Casellas, Aina; Barrot-De la Puente, Joan F.; Franch-Nadal, Josep; Coll-de Tuero, Gabriel			Chronic Kidney Disease and Diabetic Retinopathy in Patients with Type 2 Diabetes	PLOS ONE			English	Article							RISK-FACTORS; RENAL-INSUFFICIENCY; PRIMARY-CARE; MICROALBUMINURIA; ASSOCIATION; PREVALENCE; ALBUMINURIA	Purpose To explore the relationship between chronic kidney disease (CKD) and diabetic retinopathy (DR) in a representative population of type 2 diabetes mellitus (DM2) patients in Catalonia (Spain). Methods This was a population-based, cross-sectional study. A total of 28,344 patients diagnosed with DM2 who had recorded ophthalmologic and renal functional examinations were evaluated. Data were obtained from a primary healthcare electronic database of medical records. CKD was defined as an estimated glomerular filtration ratio (eGFR) of <60 ml/min/1.73m(2) and/or urine albumin to creatinine ratio (UACR) >= 30 mg/g. DR was categorized as non-vision threatening diabetic retinopathy and vision threatening diabetic retinopathy. Results CKD was associated with a higher rate of DR [OR], 95% confidence interval [CI], 1.5 (1.4-1.7). When we analyzed the association between different levels of UACR and DR prevalence observed that DR prevalence rose with the increase of UACR levels, and this association was significant from UACR values >= 10 mg/g, and increased considerably with UACR values >= 300mg/g (Odds ratio [OR], 95% confidence interval [CI], 2.0 (1.6-2.5). This association was lower in patients with eGFR levels 44 to 30 mL/min/1.73m(2) [OR], 95% confidence interval [CI], 1.3 (1.1-1.6). Conclusions These results show that CKD, high UACR and/or low eGFR, appear to be associated with DR in this DM2 population.	[Rodriguez-Poncelas, Antonio; Coll-de Tuero, Gabriel] Inst Catala Salut, Gerencia Terr Girona, Primary Hlth Care Ctr Angles, Girona, Spain; [Rodriguez-Poncelas, Antonio; Casellas, Aina; Barrot-De la Puente, Joan F.; Coll-de Tuero, Gabriel] Inst Univ Invest Atencio Primaria Jordi Gol IDIAP, Unitat Suport Recerca Girona, Barcelona, Spain; [Rodriguez-Poncelas, Antonio; Mundet-Tuduri, Xavier; Miravet-Jimenez, Sonia; Franch-Nadal, Josep] Inst Univ Invest Atencio Primaria Jordi Gol IDIAP, Unitat Suport Recerca Barcelona Ciutat, Barcelona, Spain; [Mundet-Tuduri, Xavier] Univ Autonoma Barcelona, Bellaterra, Spain; [Miravet-Jimenez, Sonia] Inst Catala Salut, Gerencia Terr Metropolitana Sud, Primary Hlth Care Ctr Martorell, Barcelona, Spain; [Barrot-De la Puente, Joan F.] Inst Catala Salut, Gerencia Terr Girona, Primary Hlth Care Ctr Jordi Nadal Salt, Barcelona, Spain; [Franch-Nadal, Josep] Inst Catala Salut, Gerencia Ambit Atencio Primaria Barcelona Ciutat, Primary Hlth Care Ctr Raval Sud, Barcelona, Spain; [Franch-Nadal, Josep] Inst Salud Carlos III, CIBER Diabet & Associated Metab Dis CIBERDEM, Madrid, Spain	Autonomous University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; Instituto de Salud Carlos III	Mundet-Tuduri, X (corresponding author), Inst Univ Invest Atencio Primaria Jordi Gol IDIAP, Unitat Suport Recerca Barcelona Ciutat, Barcelona, Spain.; Mundet-Tuduri, X (corresponding author), Univ Autonoma Barcelona, Bellaterra, Spain.	xavier.mundet@uab.cat	Coll-de-Tuero, Gabriel/H-3475-2016; Franch-Nadal, Josep/AAC-1945-2019; Rodriguez Poncelas, Antonio/F-9397-2016; Casellas, Aina/Q-1247-2016	Coll-de-Tuero, Gabriel/0000-0001-7578-9569; Franch-Nadal, Josep/0000-0002-5175-1555; Rodriguez Poncelas, Antonio/0000-0003-2100-9701; Casellas, Aina/0000-0003-4939-8411; Barrot de la Puente, Joan/0000-0002-7482-7647	IDIAP J. Gol (SIDIAP from Fundacio J Gol i Gurina); Education and Research in Family Practice Chair (UAB-Novartis); IDIAP J. Gol	IDIAP J. Gol (SIDIAP from Fundacio J Gol i Gurina); Education and Research in Family Practice Chair (UAB-Novartis); IDIAP J. Gol	This study was supported by a grant from the IDIAP J. Gol (SIDIAP-2013 from Fundacio J Gol i Gurina, www.idiapjordigol.com) and the Education and Research in Family Practice Chair (UAB-Novartis). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by a grant from the IDIAP J. Gol and the Education and Research in Family Practice Chair (UAB-Novartis). We acknowledge Monica Gratacos and Amanda Prowse for providing support in the manuscript preparation and editing. CIBER of Diabetes and Associated Metabolic Diseases (CIBERDEM) is an initiative from Instituto de Salud Carlos III.	Adler AI, 2000, BMJ-BRIT MED J, V321, P412, DOI 10.1136/bmj.321.7258.412; Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; Bolibar B, 2012, MED CLIN-BARCELONA, V138, P617, DOI 10.1016/j.medcli.2012.01.020; Chen YH, 2012, DIABETES CARE, V35, P803, DOI 10.2337/dc11-1955; Diabet Control Complications DCCT Res Grp, 1995, KIDNEY INT, V47, P1703; Estacio RO, 1998, AM J KIDNEY DIS, V31, P947, DOI 10.1053/ajkd.1998.v31.pm9631838; Kramer HJ, 2003, JAMA-J AM MED ASSOC, V289, P3273, DOI 10.1001/jama.289.24.3273; KROLEWSKI AS, 1986, DIABETES CARE, V9, P443, DOI 10.2337/diacare.9.5.443; Lee WJ, 2014, EYE, V28, P1119, DOI 10.1038/eye.2014.130; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Lopez-Bastida J, 2007, DIABETIC MED, V24, P403, DOI 10.1111/j.1464-5491.2007.02074.x; Lu B, 2008, J DIABETES COMPLICAT, V22, P96, DOI 10.1016/j.jdiacomp.2007.08.001; Man REK, 2015, INVEST OPHTH VIS SCI, V56, P4810, DOI 10.1167/iovs.15-16987; Manaviat Masoud R, 2004, BMC Ophthalmol, V4, P9, DOI 10.1186/1471-2415-4-9; MATHIESEN ER, 1995, DIABETIC MED, V12, P482, DOI 10.1111/j.1464-5491.1995.tb00528.x; Nwanyanwu KH, 2013, DIABETES CARE, V36, P1562, DOI 10.2337/dc12-0790; PARVING HH, 1988, BMJ-BRIT MED J, V296, P156, DOI 10.1136/bmj.296.6616.156; Pedro RA, 2010, OPHTHAL EPIDEMIOL, V17, P251, DOI 10.3109/09286586.2010.498661; Penno G, 2012, DIABETES CARE, V35, P2317, DOI 10.2337/dc12-0628; Pugliese G, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/1475-2840-13-59; Ra H, 2012, DIABETOL METAB SYNDR, V4, DOI 10.1186/1758-5996-4-29; Sabanayagam C, 2014, J DIABETES, V6, P556, DOI 10.1111/1753-0407.12148; Satchell SC, 2008, DIABETOLOGIA, V51, P714, DOI 10.1007/s00125-008-0961-8; Stratton IM, 2001, DIABETOLOGIA, V44, P156, DOI 10.1007/s001250051594; Tone A, 2005, DIABETES RES CLIN PR, V69, P237, DOI 10.1016/j.diabres.2005.02.009; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; Vinagre I, 2012, DIABETES CARE, V35, P774, DOI 10.2337/dc11-1679; Wilkinson CP, 2003, OPHTHALMOLOGY, V110, P1677, DOI 10.1016/S0161-6420(03)00475-5; Wolf G, 2007, CLIN NEPHROL, V68, P81; Wong TY, 2008, OPHTHALMOLOGY, V115, P1869, DOI 10.1016/j.ophtha.2008.05.014; Wu JY, 2015, J OPHTHALMOL, V2015, DOI 10.1155/2015/326209	31	51	52	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0149448	10.1371/journal.pone.0149448	http://dx.doi.org/10.1371/journal.pone.0149448			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26886129	Green Submitted, Green Published, gold			2022-12-26	WOS:000371218400084
J	Ujiie, Y; Ishitani, Y				Ujiie, Yurika; Ishitani, Yoshiyuki			Evolution of a Planktonic Foraminifer during Environmental Changes in the Tropical Oceans	PLOS ONE			English	Article							BAYESIAN PHYLOGENETIC INFERENCE; MAXIMUM-LIKELIHOOD; EARLY PLIOCENE; PACIFIC-OCEAN; MARINE BIODIVERSITY; MOLECULAR EVIDENCE; CRYPTIC DIVERSITY; DNA-SEQUENCES; SPECIATION; PATTERNS	Ecological adaptation to environmental changes is a strong driver of evolution, enabling speciation of pelagic plankton in the open ocean without the presence of effective physical barriers to gene flow. The tropical ocean environment, which plays an important role in shaping marine biodiversity, has drastically and frequently changed since the Pliocene. Nevertheless, the evolutionary history of tropical pelagic plankton has been poorly understood, as phylogeographic investigations are still in the developing state and paleontological approaches are insufficient to obtain a sequential record from the deep-sea sediments. The planktonic foraminifer Pulleniatina obliquiloculata is widely distributed in the tropical area throughout the world's oceans, and its phylogeography is well established. It is thus one of the best candidates to examine how past environmental changes may have shifted the spatial distribution and affected the diversification of tropical pelagic plankton. Such an examination requires the divergence history of the planktonic foraminifers, yet the gene marker (partial small subunit (SSU) rDNA) previously used for phylogeographic studies was not powerful enough to achieve a high accuracy in estimating the divergence times. The present study focuses on improving the precision of divergence time estimates for the splits between sibling species (genetic types) of planktonic foraminifers by increasing the number of genes as well as the number of nucleotide bases used for molecular clock estimates. We have amplified the entire coding regions of two ribosomal RNA genes (SSU rDNA and large subunit (LSU) rDNA) of three genetic types of P. obliquiloculata and two closely related species for the first time and applied them to the Bayesian relaxed clock method. The comparison of the credible intervals of the four datasets consisting either of sequences of the partial SSU rDNA, the complete SSU rDNA, LSU rDNA, or a combination of both genes (SSU +LSU) clearly demonstrated that the two-gene dataset improved the accuracy of divergence time estimates. The P. obliquiloculata lineage diverged twice, first at the end of the Pliocene (3.1 Ma) and again in the middle Pleistocene (1.4 Ma). Both timings coincided with the environmental changes, which indirectly involved geographic separation of populations. The habitat of P. obliquiloculata was expanded toward the higher latitudinal zones during the stable warm periods and subsequently placed on the steep environmental gradients following the global cooling. Different environmental conditions in the stable warm tropics and unstable higher latitudes may have triggered ecological divergence among the populations, leading to adaptive differentiation and eventually speciation. A comprehensive analysis of divergence time estimates combined with phylogeography enabled us to reveal the evolutionary history of the pelagic plankton and to find the potential paleoenvironmental events, which could have changed their biogeography and ecology.	[Ujiie, Yurika] Shinshu Univ, Dept Biol, Matsumoto, Nagano 390, Japan; [Ishitani, Yoshiyuki] Univ Tokyo, Atmosphere & Ocean Res Inst, Kashiwa, Chiba, Japan	Shinshu University; University of Tokyo	Ujiie, Y (corresponding author), Shinshu Univ, Dept Biol, Matsumoto, Nagano 390, Japan.	yurikaw@shinshu-u.ac.jp		Ujiie, Yurika/0000-0001-7627-7979; Ishitani, Yoshiyuki/0000-0001-8941-6990	Japan Society for the Promotion of Science [23710012, 26400501]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by the Japan Society for the Promotion of Science, no. 23710012 and 26400501. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aurahs R, 2011, MAR MICROPALEONTOL, V79, P1, DOI 10.1016/j.marmicro.2010.12.001; Aurahs R, 2009, MOL ECOL, V18, P1692, DOI 10.1111/j.1365-294X.2009.04136.x; Aze T, 2011, BIOL REV, V86, P900, DOI 10.1111/j.1469-185X.2011.00178.x; Barton AD, 2010, SCIENCE, V327, P1509, DOI 10.1126/science.1184961; Be A.W.H., 1977, P1; BERGGREN WA, 1995, GEOL SOC AM BULL, V107, P1272, DOI 10.1130/0016-7606(1995)107<1272:LNCNPI>2.3.CO;2; Brierley CM, 2009, SCIENCE, V323, P1714, DOI 10.1126/science.1167625; Caron DA, 2009, ISME J, V3, P4, DOI 10.1038/ismej.2008.101; Casteleyn G, 2010, P NATL ACAD SCI USA, V107, P12952, DOI 10.1073/pnas.1001380107; Darling KF, 2004, P NATL ACAD SCI USA, V101, P7657, DOI 10.1073/pnas.0402401101; de Vargas C, 1998, MOL PHYLOGENET EVOL, V9, P463, DOI 10.1006/mpev.1998.0491; de Vargas C, 1999, P NATL ACAD SCI USA, V96, P2864, DOI 10.1073/pnas.96.6.2864; Douzery EJP, 2004, P NATL ACAD SCI USA, V101, P15386, DOI 10.1073/pnas.0403984101; Drummond A., 2008, TRACER; Duda TF, 2005, MOL PHYLOGENET EVOL, V34, P257, DOI 10.1016/j.ympev.2004.09.012; Fedorov AV, 2013, NATURE, V496, P43, DOI 10.1038/nature12003; Flakowski J, 2006, J MOL EVOL, V63, P30, DOI 10.1007/s00239-005-0061-z; Ford HL, 2015, GEOPHYS RES LETT, V42, P4878, DOI 10.1002/2015GL064215; Funk WC, 2016, J EVOLUTION BIOL, V29, P241, DOI 10.1111/jeb.12760; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Groussin M, 2011, MOL PHYLOGENET EVOL, V61, P157, DOI 10.1016/j.ympev.2011.06.008; GU X, 1995, MOL BIOL EVOL, V12, P546; Herbert GS, 2005, VELIGER, V47, P294; Ishitani Y, 2014, MOL PHYLOGENET EVOL, V78, P215, DOI 10.1016/j.ympev.2014.05.021; Ishitani Y, 2011, MAR MICROPALEONTOL, V81, P32, DOI 10.1016/j.marmicro.2011.06.007; Jobb G, 2008, TREEFINDER VERSION O; Kennett J.P., 1983, NEOGENE PLANKTONIC F; Kumar S, 2002, P NATL ACAD SCI USA, V99, P803, DOI 10.1073/pnas.022629899; LaRiviere JP, 2012, NATURE, V486, P97, DOI 10.1038/nature11200; Leigh EG, 2014, BIOL REV, V89, P148, DOI 10.1111/brv.12048; Locarnini RA, 2005, NOAA ATLAS NESDIS, V61, P182; Locarnini RA, 2005, WORLD OCEAN DATABASE, V1, P182; Lunt DJ, 2008, NATURE, V454, P1102, DOI 10.1038/nature07223; Meyer CP, 2003, BIOL J LINN SOC, V79, P401, DOI 10.1046/j.1095-8312.2003.00197.x; Molnar P, 2015, PALEOCEANOGRAPHY, V30, P196, DOI 10.1002/2014PA002752; Morard R, 2015, MOL ECOL RESOUR, V15, P1472, DOI 10.1111/1755-0998.12410; Nosil P, 2012, OX ECOL EV, P1, DOI 10.1093/acprof:osobl/9780199587100.001.0001; Nylander J. A. A., 2004, MRMODELTEST V2; O'Brien CL, 2014, NAT GEOSCI, V7, P607, DOI 10.1038/NGEO2194; PAWLOWSKI J, 1994, MOL BIOL EVOL, V11, P929; Pawlowski J, 2010, J EUKARYOT MICROBIOL, V57, P197, DOI 10.1111/j.1550-7408.2009.00468.x; Peijnenburg KTCA, 2013, ECOL EVOL, V3, P2765, DOI 10.1002/ece3.644; Postaire B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095040; Rannala B, 2007, SYST BIOL, V56, P453, DOI 10.1080/10635150701420643; Ravelo AC, 2004, NATURE, V429, P263, DOI 10.1038/nature02567; Renema W, 2008, SCIENCE, V321, P654, DOI 10.1126/science.1155674; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rutherford S, 1999, NATURE, V400, P749, DOI 10.1038/23449; Schlitzer R., 2016, OCEAN DATA VIEW; Schweizer M, 2008, MAR MICROPALEONTOL, V66, P233, DOI 10.1016/j.marmicro.2007.10.003; Seears HA, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-54; Tittensor DP, 2010, NATURE, V466, P1098, DOI 10.1038/nature09329; Tornabene L, 2015, MOL PHYLOGENET EVOL, V82, P200, DOI 10.1016/j.ympev.2014.09.012; Ujiie Y, 2003, MAR MICROPALEONTOL, V49, P335, DOI 10.1016/S0377-8398(03)00062-8; Ujiie Y, 2012, ECOL EVOL, V2, P1725, DOI 10.1002/ece3.286; Ujiie Y, 2009, J FORAMIN RES, V39, P145, DOI 10.2113/gsjfr.39.3.145; Wara MW, 2005, SCIENCE, V309, P758, DOI 10.1126/science.1112596; Weiner AKM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092148; YANG ZB, 1994, J MOL EVOL, V39, P105; Yang ZH, 1997, MOL BIOL EVOL, V14, P717, DOI 10.1093/oxfordjournals.molbev.a025811; YANG ZH, 1994, J MOL EVOL, V39, P306, DOI 10.1007/BF00160154; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhang YG, 2014, SCIENCE, V344, P84, DOI 10.1126/science.1246172	63	9	10	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0148847	10.1371/journal.pone.0148847	http://dx.doi.org/10.1371/journal.pone.0148847			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26886349	Green Published, Green Submitted, gold			2022-12-26	WOS:000371218400053
J	Chen, JH; He, JC; Chen, YY; Xu, JJ; Wu, HR; Wang, FF; Lu, F; Jiang, J				Chen, Junhong; He, Ji C.; Chen, Yunyun; Xu, Jingjing; Wu, Haoran; Wang, Feifu; Lu, Fan; Jiang, Jun			Interocular Difference of Peripheral Refraction in Anisomyopic Eyes of Schoolchildren	PLOS ONE			English	Article							AXIAL LENGTH; INTRAOCULAR-PRESSURE; MYOPIC ANISOMETROPIA; OPTICAL-COMPONENTS; CHILDREN; ORTHOKERATOLOGY; CYCLOPLEGIA; PROGRESSION; PREVALENCE; ERROR	Purpose Refraction in the peripheral visual field is believed to play an important role in the development of myopia. The purpose of this study was to investigate the differences in peripheral refraction among anisomyopia, isomyopia, and isoemmetropia for schoolchildren. Methods Thirty-eight anisomyopic children were recruited and divided into two groups: (1) both eyes were myopic (anisomyopic group, AM group) and (2) one eye was myopic and the contralateral eye was emmetropic (emmetropic anisomyopic group, EAM group). As controls, 45 isomyopic and isoemmetropic children were also recruited with age and central spherical equivalent (SE) matched to those of the AM and EAM groups. The controls were divided into three groups: (1) intermediate myopia group (SE matched to the more myopic eye of AM group), (2) low myopia group (SE matched to the less myopic eye of AM group and the more myopic eye of EAM group), and (3) emmetropia group (SE matched to the less myopic eye of EAM group). Peripheral refraction at 7 points across the central +/- 30 degrees on the horizontal visual field with a 10 degrees interval was measured with an autorefractor. Axial length (AL), corneal curvature (CC), and anterior chamber depth (ACD) were also determined by using the Zeiss IOL-Master. Results The relative peripheral spherical equivalent [RPR(M)] and relative peripheral spherical value [RPR(S)] of the more myopic eye was shifted more hyperopically than the contralateral eye in both the AM and the EAM groups (both p<0.0001). The RPR(M, S) of the less myopic eyes in the AM and EAM groups showed a relatively flat trend across the visual field and were not significantly different from the emmetropia group. The RPR(M, S) of less myopic eyes in the AM group were shifted less hyperopically than in the isomyopic low myopia group and the more myopic eye of the EAM group [RPR(M), p = 0.007; RPR(S), p = 0.001], although the central SEs of the three groups were not significantly different from each other. However, RPR(M, S) of the more myopic eyes were not different from the corresponding isomyopic groups. There was also no significant difference in the relative peripheral astigmatism [RPR(J0, J45)] between the more and the less myopic eyes in either the AM or the EAM group. Conclusion Refraction of anisomyopia differs between the two eyes not only at the central visual field but also at the off-axis periphery. The relative peripheral refraction of the more myopic eye of anisomyopia was shifted hyperopically, as occurs in isomyopia with similar central subjective SE values. Less myopic eyes were much less hyperopically shifted in relative peripheral refraction than the corresponding isomyopic eyes, but are comparable to emmetropic eyes. This emmetropia-like relative peripheral refraction in less myopic eyes might be a factor responsible for slowing down the progression of myopia.	[Chen, Junhong; He, Ji C.; Chen, Yunyun; Xu, Jingjing; Wu, Haoran; Wang, Feifu; Lu, Fan; Jiang, Jun] Wenzhou Med Coll, Sch Optometry & Ophthalmol, Wenzhou, Zhejiang, Peoples R China; [He, Ji C.] New England Coll Optometry, Boston, MA USA	Wenzhou Medical University	Lu, F; Jiang, J (corresponding author), Wenzhou Med Coll, Sch Optometry & Ophthalmol, Wenzhou, Zhejiang, Peoples R China.	lufan62@mail.eye.ac.cn; jjhsj@hotmail.com		Wu, Haoran/0000-0002-2248-3547	National Natural Science Foundation of China; Natural Science Foundation of Zhejiang Province; National Key Basic Research Program [81170869, LY14H120007, 2011CB504600]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); National Key Basic Research Program(National Basic Research Program of China)	The study was supported by National Natural Science Foundation of China, Natural Science Foundation of Zhejiang Province, National Key Basic Research Program, Grants 81170869, LY14H120007, and 2011CB504600. The funders had participate in the design of this study.	Adenuga OO, 2014, MIDDLE EAST AFR J OP, V21, P275, DOI 10.4103/0974-9233.134695; Atchison DA, 2006, VISION RES, V46, P1450, DOI 10.1016/j.visres.2005.10.023; Atchison DA, 2005, INVEST OPHTH VIS SCI, V46, P2698, DOI 10.1167/iovs.04-1506; Awadein A, 2011, J AAPOS, V15, P545, DOI 10.1016/j.jaapos.2011.07.008; BONOMI L, 1982, INT OPHTHALMOL, V5, P145, DOI 10.1007/BF00149143; Borchert M, 2010, OPHTHALMOLOGY, V117, P148, DOI 10.1016/j.ophtha.2009.06.008; Chen X, 2010, VISION RES, V50, P31, DOI 10.1016/j.visres.2009.10.004; Cheung SW, 2009, CLIN EXP OPTOM, V92, P476, DOI 10.1111/j.1444-0938.2009.00419.x; Cheung SW, 2004, OPTOMETRY VISION SCI, V81, P653, DOI 10.1097/01.opx.0000144742.57847.b1; Deng L, 2012, INVEST OPHTH VIS SCI, V53, P3782, DOI 10.1167/iovs.11-8727; Downie LE, 2013, EYE CONTACT LENS, V39, P303, DOI 10.1097/ICL.0b013e318298ee76; Ehsaei A, 2011, OPHTHAL PHYSL OPT, V31, P413, DOI 10.1111/j.1475-1313.2011.00838.x; Feng L, 2012, OPTOMETRY VISION SCI, V89, P507, DOI 10.1097/OPX.0b013e318249d73a; Hashemi H, 2011, OPHTHAL EPIDEMIOL, V18, P122, DOI 10.3109/09286586.2011.574333; HOOGERHEIDE J, 1971, OPHTHALMOLOGICA, V163, P209, DOI 10.1159/000306646; Huang JH, 2012, OPTOMETRY VISION SCI, V89, P1691, DOI 10.1097/OPX.0b013e3182772f4f; Jiang ZP, 2013, EYE CONTACT LENS, V39, P277, DOI 10.1097/ICL.0b013e318296790b; Kang PL, 2011, OPTOMETRY VISION SCI, V88, P476, DOI 10.1097/OPX.0b013e31820f16fb; Kim Su-Young, 2013, Korean J Ophthalmol, V27, P44, DOI 10.3341/kjo.2013.27.1.44; Kuo NW, 2011, J CHIN MED ASSOC, V74, P310, DOI 10.1016/j.jcma.2011.05.007; Kwan WCK, 2009, CLIN EXP OPTOM, V92, P304, DOI 10.1111/j.1444-0938.2009.00378.x; Lam AKC, 2003, OPHTHAL PHYSL OPT, V23, P315, DOI 10.1046/j.1475-1313.2003.00122.x; Lam CSY, 2014, BRIT J OPHTHALMOL, V98, P40, DOI 10.1136/bjophthalmol-2013-303914; Lee SMY, 2000, OPTOMETRY VISION SCI, V77, P675, DOI 10.1097/00006324-200012000-00015; Lee TT, 2013, OPHTHAL PHYSL OPT, V33, P283, DOI 10.1111/opo.12057; Liang YB, 2009, OPHTHALMOLOGY, V116, P2119, DOI 10.1016/j.ophtha.2009.04.040; Mayer DL, 2001, ARCH OPHTHALMOL-CHIC, V119, P1625; MILLERMEEKS MJ, 1990, AM J OPHTHALMOL, V109, P199, DOI 10.1016/S0002-9394(14)75987-2; MILLODOT M, 1981, AM J OPTOM PHYS OPT, V58, P691; Mutti DO, 2007, INVEST OPHTH VIS SCI, V48, P2510, DOI 10.1167/iovs.06-0562; Okamoto F, 2001, OPHTHALMOLOGICA, V215, P435, DOI 10.1159/000050904; Queiros A, 2010, OPTOMETRY VISION SCI, V87, P323, DOI 10.1097/OPX.0b013e3181d951f7; Sankaridurg P, 2011, INVEST OPHTH VIS SCI, V52, P9362, DOI 10.1167/iovs.11-7260; Saunders KJ, 2002, BRIT J OPHTHALMOL, V86, P1035, DOI 10.1136/bjo.86.9.1035; Smith EL, 2007, INVEST OPHTH VIS SCI, V48, P3914, DOI 10.1167/iovs.06-1264; Smith EL, 2009, VISION RES, V49, P2386, DOI 10.1016/j.visres.2009.07.011; Sng CCA, 2011, INVEST OPHTH VIS SCI, V52, P7880, DOI 10.1167/iovs.11-7290; Sng CCA, 2011, INVEST OPHTH VIS SCI, V52, P1181, DOI 10.1167/iovs.10-5601; SORSBY A, 1962, VISION RES, V2, P43, DOI 10.1016/0042-6989(62)90062-7; Thibos LN, 1997, OPTOMETRY VISION SCI, V74, P367, DOI 10.1097/00006324-199706000-00019; Tian Y T J, 2006, INVEST OPHTHALMOL VI, V47; Vincent SJ, 2014, CLIN EXP OPTOM, V97, P291, DOI 10.1111/cxo.12171; Vincent SJ, 2011, OPTOMETRY VISION SCI, V88, P1454, DOI 10.1097/OPX.0b013e318233ee5f; VONNOORDEN GK, 1987, INVEST OPHTH VIS SCI, V28, P750; Walline JJ, 2013, OPTOMETRY VISION SCI, V90, P1207, DOI 10.1097/OPX.0000000000000036; Wallman J, 2004, NEURON, V43, P447, DOI 10.1016/j.neuron.2004.08.008; Weiss AH, 2003, BRIT J OPHTHALMOL, V87, P1025, DOI 10.1136/bjo.87.8.1025; Yekta A, 2010, STRABISMUS, V18, P104, DOI 10.3109/09273972.2010.502957; Yuksel N, 2014, J AAPOS, V18, P248, DOI 10.1016/j.jaapos.2014.01.013; Zhu MJ, 2014, BMC OPHTHALMOL, V14, DOI 10.1186/1471-2415-14-141	50	3	4	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0149110	10.1371/journal.pone.0149110	http://dx.doi.org/10.1371/journal.pone.0149110			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	26881745	Green Submitted, Green Published, gold			2022-12-26	WOS:000371219000046
J	Dalli, J; Sanger, JM; Rodriguez, AR; Chiang, N; Spur, BW; Serhan, CN				Dalli, Jesmond; Sanger, Julia M.; Rodriguez, Ana R.; Chiang, Nan; Spur, Bernd W.; Serhan, Charles N.			Identification and Actions of a Novel Third Maresin Conjugate in Tissue Regeneration: MCTR3	PLOS ONE			English	Article							LIPID MEDIATORS; RESOLUTION; RESOLVIN; INFLAMMATION; INFECTION; PATHWAYS; DISEASE	Maresin conjugates in tissue regeneration (MCTR) are a new family of evolutionarily conserved chemical signals that orchestrate host responses to promote tissue regeneration and resolution of infections. Herein, we identified the novel MCTR3 and established rank order potencies and matched the stereochemistries of MCTR1, MCTR2 and MCTR3 using material prepared by total organic synthesis and mediators isolated from both mouse and human systems. MCTR3 was produced from endogenous substrate by E. coli activated human macrophages and identified in sepsis patients. Each of the three synthetic MCTR dose-dependently (1-100nM) accelerated tissue regeneration in planaria by 0.6-0.9 days. When administered at the onset or peak of inflammation, each of the MCTR promoted resolution of E. coli infections in mice. They increased bacterial phagocytosis by exudate leukocytes (similar to 15-50%), limited neutrophil infiltration (similar to 20-50%), promoted efferocytosis (similar to 30%) and reduced eicosanoids. MCTR1 and MCTR2 upregulated human neutrophil and macrophage phagocytic responses where MCTR3 also proved to possess potent actions. These results establish the complete stereochemistry and rank order potencies for MCTR1, MCTR2 and MCTR3 that provide novel resolution moduli in regulating host responses to clear infections and promote tissue regeneration.	[Dalli, Jesmond; Sanger, Julia M.; Chiang, Nan; Serhan, Charles N.] Brigham & Womens Hosp, Harvard Inst Med, Ctr Expt Therapeut & Reperfus Injury, 75 Francis St, Boston, MA 02115 USA; [Dalli, Jesmond; Sanger, Julia M.; Chiang, Nan; Serhan, Charles N.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Rodriguez, Ana R.; Spur, Bernd W.] Rowan Univ SOM, Dept Cell Biol, Stratford, NJ USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Rowan University; Rowan University School of Osteopathic Medicine	Serhan, CN (corresponding author), Brigham & Womens Hosp, Harvard Inst Med, Ctr Expt Therapeut & Reperfus Injury, 75 Francis St, Boston, MA 02115 USA.; Serhan, CN (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.	cnserhan@zeus.bwh.harvard.edu	Chiang, Nan/ABA-4924-2021	Chiang, Nan/0000-0003-1963-1585; Rodriguez Rosich, Ana/0000-0002-4802-2845; Spur, Bernd/0000-0002-7581-4741; Dalli, Jesmond/0000-0001-6328-3640	National Institutes of Health Institute of General Medical Sciences [P01GM095467]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM095467] Funding Source: NIH RePORTER	National Institutes of Health Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health Institute of General Medical Sciences [Grant P01GM095467] to CNS.	Chiang N, 2012, NATURE, V484, P524, DOI 10.1038/nature11042; Dalli J, 2015, FASEB J, V29, P2120, DOI 10.1096/fj.14-268441; Dalli J, 2014, P NATL ACAD SCI USA, V111, pE4753, DOI 10.1073/pnas.1415006111; Dalli J, 2013, FASEB J, V27, P2573, DOI 10.1096/fj.13-227728; El Kebir D, 2012, P NATL ACAD SCI USA, V109, P14983, DOI 10.1073/pnas.1206641109; Haeggstrom JZ, 2011, CHEM REV, V111, P5866, DOI 10.1021/cr200246d; Haeggstrom JZ, 2004, J BIOL CHEM, V279, P50639, DOI 10.1074/jbc.R400027200; Marcon R, 2013, J IMMUNOL, V191, P4288, DOI 10.4049/jimmunol.1202743; Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502; NES WD, 1994, ISOPENTENOIDS OTHER; Rius B, 2014, FASEB J, V28, P836, DOI 10.1096/fj.13-235614; Rodriguez AR, 2015, TETRAHEDRON LETT, V56, P3936, DOI 10.1016/j.tetlet.2015.04.131; SAMUELSSON B, 1983, BIOSCIENCE REP, V3, P791, DOI 10.1007/BF01133779; Samuelsson B, 2012, J BIOL CHEM, V287, P10070, DOI 10.1074/jbc.X112.351437; Sanchez-Alvarado A, 2006, CELL, V124, P241, DOI 10.1016/j.cell.2006.01.012; Serhan CN, 2014, NATURE, V510, P92, DOI 10.1038/nature13479; Serhan CN, 2013, CURR OPIN PHARMACOL, V13, P632, DOI 10.1016/j.coph.2013.05.012; Tabas I, 2013, SCIENCE, V339, P166, DOI 10.1126/science.1230720; Terrando N, 2013, FASEB J, V27, P3564, DOI 10.1096/fj.13-230276; Vong L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039244	20	45	45	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0149319	10.1371/journal.pone.0149319	http://dx.doi.org/10.1371/journal.pone.0149319			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	26881986	Green Submitted, Green Published, gold			2022-12-26	WOS:000371219000070
J	Centeno, M; Tierney, TM; Perani, S; Shamshiri, EA; StPier, K; Wilkinson, C; Konn, D; Banks, T; Vulliemoz, S; Lemieux, L; Pressler, RM; Clark, CA; Cross, JH; Carmichael, DW				Centeno, Maria; Tierney, Tim M.; Perani, Suejen; Shamshiri, Elhum A.; StPier, Kelly; Wilkinson, Charlotte; Konn, Daniel; Banks, Tina; Vulliemoz, Serge; Lemieux, Louis; Pressler, Ronit M.; Clark, Christopher A.; Cross, J. Helen; Carmichael, David W.			Optimising EEG-fMRI for Localisation of Focal Epilepsy in Children	PLOS ONE			English	Article							INTERICTAL EPILEPTIFORM DISCHARGES; RESPONSES; SURGERY; STATE; CONNECTIVITY; PATTERNS; ARTIFACT; TIME	Background Early surgical intervention in children with drug resistant epilepsy has benefits but requires using tolerable and minimally invasive tests. EEG-fMRI studies have demonstrated good sensitivity for the localization of epileptic focus but a poor yield although the reasons for this have not been systematically addressed. While adults EEG-fMRI studies are performed in the "resting state"; children are commonly sedated however, this has associated risks and potential confounds. In this study, we assessed the impact of the following factors on the tolerability and results of EEG-fMRI in children: viewing a movie inside the scanner; movement; occurrence of interictal epileptiform discharges (IED); scan duration and design efficiency. This work's motivation is to optimize EEG-fMRI parameters to make this test widely available to paediatric population Methods Forty-six children with focal epilepsy and 20 controls (6-18) underwent EEG-fMRI. For two 10 minutes sessions subjects were told to lie still with eyes closed, as it is classically performed in adult studies ("rest sessions"), for another two sessions, subjects watched a child friendly stimulation i.e. movie ("movie sessions"). IED were mapped with EEG-fMRI for each session and across sessions. The resulting maps were classified as concordant/discordant with the presumed epileptogenic focus for each subject. Findings Movement increased with scan duration, but the movie reduced movement by similar to 40% when played within the first 20 minutes. There was no effect of movie on the occurrence of IED, nor in the concordance of the test. Ability of EEG-fMRI to map the epileptogenic region was similar for the 20 and 40 minute scan durations. Design efficiency was predictive of concordance. Conclusions A child friendly natural stimulus improves the tolerability of EEG-fMRI and reduces in-scanner movement without having an effect on IED occurrence and quality of EEG-fMRI maps. This allowed us to scan children as young as 6 and obtain localising information without sedation. Our data suggest that similar to 20 minutes is the optimal length of scanning for EEG-fMRI studies in children with frequent IED. The efficiency of the fMRI design derived from spontaneous IED generation is an important factor for producing concordant results.	[Centeno, Maria; Tierney, Tim M.; Perani, Suejen; Shamshiri, Elhum A.; Banks, Tina; Clark, Christopher A.; Cross, J. Helen; Carmichael, David W.] UCL, Inst Child Hlth, Dev Imaging & Biophys Sect, London, England; [Centeno, Maria; StPier, Kelly; Wilkinson, Charlotte; Pressler, Ronit M.; Cross, J. Helen] Great Ormond St Hosp Sick Children, Epilepsy Unit, Great Ormond St, London WC1N 3JH, England; [Perani, Suejen] Kings Coll London, Inst Psychiat Psychol & Neurosci, Div Neurosci, London, England; [Konn, Daniel] Southampton Univ Hosp, Dept Neurophysiol, Southampton, Hants, England; [Vulliemoz, Serge] Univ Hosp Geneva, Neurol, EEG & Epilepsy Unit, Geneva, Switzerland; [Vulliemoz, Serge] Fac Med Geneva, Geneva, Switzerland; [Lemieux, Louis] UCL, Inst Neurol, Dept Clin & Expt Epilepsy, London, England	University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; King's College London; University of Southampton; University of Geneva; University of Geneva; University of London; University College London	Centeno, M (corresponding author), UCL, Inst Child Hlth, Dev Imaging & Biophys Sect, London, England.; Centeno, M (corresponding author), Great Ormond St Hosp Sick Children, Epilepsy Unit, Great Ormond St, London WC1N 3JH, England.	m.centeno@ucl.ac.uk	Cross, J. Helen/ACK-3032-2022; Carmichael, David/A-5391-2009	Cross, J. Helen/0000-0001-7345-4829; Carmichael, David/0000-0001-9972-0718; Pressler, Ronit/0000-0002-2905-6839; Lemieux, Louis/0000-0003-3036-7412; Centeno, Maria/0000-0003-4801-4535	Action Medical Research grant [SP4646]; Engineering and Physical Sciences Research Council [EP/M001393/1]; James Lewis Foundation (via Great Ormond Street Hospital Children's Charity) the Child Health Research Appeal Trust; University College London Overseas Research Scholarship; NIHR Biomedical Research founding; Swiss National Science Foundation [SNF 141165]; National Institute of Health Research Great Ormond Street Hospital Biomedical Research Centre; EPSRC [EP/M001393/1] Funding Source: UKRI; Action Medical Research [1830] Funding Source: researchfish	Action Medical Research grant; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); James Lewis Foundation (via Great Ormond Street Hospital Children's Charity) the Child Health Research Appeal Trust; University College London Overseas Research Scholarship; NIHR Biomedical Research founding; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Institute of Health Research Great Ormond Street Hospital Biomedical Research Centre; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Action Medical Research	This project was funded by Action Medical Research grant number SP4646. D. C. is supported by the Engineering and Physical Sciences Research Council grant EP/M001393/1. E. S. and T. T. are supported by the James Lewis Foundation (via Great Ormond Street Hospital Children's Charity) the Child Health Research Appeal Trust. E. S. is funded by University College London Overseas Research Scholarship. T. T. is founded by University College London IMPACT. S. P. is supported by NIHR Biomedical Research founding. S. V. is supported by Swiss National Science Foundation grant SNF 141165. The authors acknowledge the support of the National Institute of Health Research Great Ormond Street Hospital Biomedical Research Centre in performing this work.	Allen PJ, 1998, NEUROIMAGE, V8, P229, DOI 10.1006/nimg.1998.0361; Allen PJ, 2000, NEUROIMAGE, V12, P230, DOI 10.1006/nimg.2000.0599; An DM, 2013, EPILEPSIA, V54, P2184, DOI 10.1111/epi.12434; [Anonymous], 2014, R LANG ENV STAT COMP; Ansari SF, 2010, CHILD NERV SYST, V26, P945, DOI 10.1007/s00381-009-1056-7; Barnea-Goraly N, 2014, PEDIATR RADIOL, V44, P181, DOI 10.1007/s00247-013-2798-7; Binnie CD, 2003, LANCET NEUROL, V2, P725, DOI 10.1016/S1474-4422(03)00584-2; Centeno M, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00093; Chaudhary UJ, 2012, BRAIN, V135, P3645, DOI 10.1093/brain/aws302; Dale AM, 1999, HUM BRAIN MAPP, V8, P109, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<109::AID-HBM7>3.0.CO;2-W; de Bie HMA, 2012, HUM BRAIN MAPP, V33, P1189, DOI 10.1002/hbm.21280; Duncan JS, 2010, NAT REV NEUROL, V6, P537, DOI 10.1038/nrneurol.2010.131; Gotman J, 2005, P NATL ACAD SCI USA, V102, P15236, DOI 10.1073/pnas.0504935102; Gotman J, 2011, EPILEPSIA, V52, P38, DOI 10.1111/j.1528-1167.2011.03151.x; Hamandi K, 2006, NEUROIMAGE, V31, P1700, DOI 10.1016/j.neuroimage.2006.02.016; Jacobs J, 2007, EPILEPSIA, V48, P2068, DOI 10.1111/j.1528-1167.2007.01192.x; Laufs H, 2007, HUM BRAIN MAPP, V28, P1023, DOI 10.1002/hbm.20323; Lemieux L, 2008, HUM BRAIN MAPP, V29, P329, DOI 10.1002/hbm.20389; Magnuson ME, 2014, NMR BIOMED, V27, P291, DOI 10.1002/nbm.3062; Marcar VL, 2004, PEDIATR RES, V56, P104, DOI 10.1203/01.PDR.0000130479.43442.5C; Moeller F, 2013, EPILEPSIA, V54, P971, DOI 10.1111/epi.12197; Moeller F, 2010, EPILEPSIA, V51, P2000, DOI 10.1111/j.1528-1167.2010.02698.x; Murta T, 2012, NEUROIMAGE, V62, P1634, DOI 10.1016/j.neuroimage.2012.05.053; Ngugi AK, 2011, NEUROLOGY, V77, P1005, DOI 10.1212/WNL.0b013e31822cfc90; Pittau F, 2012, NEUROLOGY, V78, P1479, DOI 10.1212/WNL.0b013e3182553bf7; Rosenkranz K, 2010, MAGN RESON MATER PHY, V23, P309, DOI 10.1007/s10334-009-0196-9; Salek-Haddadi A, 2006, BRAIN RES, V1088, P148, DOI 10.1016/j.brainres.2006.02.098; Skirrow C, 2011, NEUROLOGY, V76, P1330, DOI 10.1212/WNL.0b013e31821527f0; Stamatakis EA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014224; Tellez-Zenteno JF, 2005, BRAIN, V128, P1188, DOI 10.1093/brain/awh449; Thoresen M, 1997, ELECTROEN CLIN NEURO, V102, P152, DOI 10.1016/S0921-884X(96)96509-1; Thornton R, 2010, J NEUROL NEUROSUR PS, V81, P922, DOI 10.1136/jnnp.2009.196253; Tierney TM, 2016, NEUROIMAGE, V124, P1009, DOI 10.1016/j.neuroimage.2015.09.034; van Houdt P, 2013, CLIN NEUROPHYSIOL, V124, P2070, DOI 10.1016/j.clinph.2013.06.007; van Houdt PJ, 2013, NEUROIMAGE, V75, P238, DOI 10.1016/j.neuroimage.2013.02.033; Vanderwal T, 2014, NOVEL VIDEO PARADIGM; Vaudano AE, 2012, NEUROLOGY, V79, P249, DOI 10.1212/WNL.0b013e31825fdf3a; White T, 2014, BRAIN CONNECT, V4, P417, DOI 10.1089/brain.2013.0195; Wirrell EC, 2010, J CLIN NEUROPHYSIOL, V27, P239, DOI 10.1097/WNP.0b013e3181ea4288; Zijlmans M, 2007, BRAIN, V130, P2343, DOI 10.1093/brain/awm141	40	18	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149048	10.1371/journal.pone.0149048	http://dx.doi.org/10.1371/journal.pone.0149048			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26872220	gold, Green Published, Green Submitted			2022-12-26	WOS:000370054100092
J	Handy, C; Yanaga, S; Reiss, A; Zona, N; Robinson, E; Saxton, KB				Handy, Christine; Yanaga, Stephanie; Reiss, Avery; Zona, Nicole; Robinson, Emily; Saxton, Katherine B.			Stress during Adolescence Alters Palatable Food Consumption in a Context-Dependent Manner	PLOS ONE			English	Article							DEPRESSION-LIKE BEHAVIORS; EARLY-LIFE STRESS; PRENATAL STRESS; FEEDING-BEHAVIOR; RESTRAINT STRESS; FEMALE RATS; ENVIRONMENTAL-INFLUENCES; INDUCED OBESITY; COMFORT FOODS; BODY-WEIGHT	Food consumption and preferences may be shaped by exposure to stressful environments during sensitive periods in development, and even small changes in consumption can have important effects on long term health. Adolescence is increasingly recognized as a sensitive period, in which adverse experiences can alter development, but the specific programming effects that may occur during adolescence remain incompletely understood. The current study seeks to explore the effects of stress during late adolescence on consumption of a palatable, high-fat, high-sugar food in adulthood-under basal conditions, as well following acute stress. Male Long-Evans rats were exposed to a regimen of variable stress for seven days in late adolescence (PND 45-51). During the stress regimen, stressed animals gained significantly less weight than control animals, but weight in adulthood was unaffected by adolescent stress. Palatable food consumption differed between experimental groups, and the direction of effect depended on context; stressed rats ate significantly more palatable food than controls upon first exposure, but ate less following an acute stressor. Leptin levels and exploratory behaviors did not differ between stressed and non-stressed groups, suggesting that other factors regulate preference for a palatable food. Altered food consumption following adolescent stress suggests that rats remain sensitive to stress during late adolescence, and that adult feeding behavior may be affected by previous adverse experiences. Such programming effects highlight adolescence as a period of plasticity, with the potential to shape long term food consumption patterns and preferences.	[Handy, Christine; Yanaga, Stephanie; Reiss, Avery; Zona, Nicole; Robinson, Emily; Saxton, Katherine B.] Santa Clara Univ, Dept Biol, Santa Clara, CA 95053 USA	Santa Clara University	Saxton, KB (corresponding author), Santa Clara Univ, Dept Biol, Santa Clara, CA 95053 USA.	ksaxton@scu.edu			Santa Clara University; Faculty Student Research Assistant Program award; Denardo Science Scholar Award	Santa Clara University; Faculty Student Research Assistant Program award; Denardo Science Scholar Award	Funds were provided by Santa Clara University, including a Faculty Student Research Assistant Program award to AR and NZ and a Denardo Science Scholar Award to ER. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam TC, 2007, PHYSIOL BEHAV, V91, P449, DOI 10.1016/j.physbeh.2007.04.011; Adriani W, 2004, BEHAV PHARMACOL, V15, P341, DOI 10.1097/00008877-200409000-00005; Andersen SL, 2008, TRENDS NEUROSCI, V31, P183, DOI 10.1016/j.tins.2008.01.004; Barha CK, 2011, HIPPOCAMPUS, V21, P1216, DOI 10.1002/hipo.20829; Barker DJP, 1997, NUTRITION, V13, P807, DOI 10.1016/S0899-9007(97)00193-7; Bateson P, 2004, NATURE, V430, P419, DOI 10.1038/nature02725; Beery AK, 2011, NEUROSCI BIOBEHAV R, V35, P1552, DOI 10.1016/j.neubiorev.2011.03.012; Bingham B, 2011, NEUROPSYCHOPHARMACOL, V36, P896, DOI 10.1038/npp.2010.229; Bjorntorp P, 2001, Obes Rev, V2, P73, DOI 10.1046/j.1467-789x.2001.00027.x; Bourin M, 2003, EUR J PHARMACOL, V463, P55, DOI 10.1016/S0014-2999(03)01274-3; Brunton PJ, 2013, J ENDOCRINOL, V217, P161, DOI 10.1530/JOE-12-0540; Calvez J, 2011, PHYSIOL BEHAV, V104, P675, DOI 10.1016/j.physbeh.2011.07.012; Cartwright M, 2003, HEALTH PSYCHOL, V22, P362, DOI 10.1037/0278-6133.22.4.362; Casey BJ, 2008, ANN NY ACAD SCI, V1124, P111, DOI 10.1196/annals.1440.010; Chaby LE, 2015, ANIM BEHAV, V105, P37, DOI 10.1016/j.anbehav.2015.03.028; Clinton S, 2008, PSYCHONEUROENDOCRINO, V33, P162, DOI 10.1016/j.psyneuen.2007.10.012; Dallman MF, 2010, TRENDS ENDOCRIN MET, V21, P159, DOI 10.1016/j.tem.2009.10.004; DIETZ WH, 1994, AM J CLIN NUTR, V59, P955, DOI 10.1093/ajcn/59.5.955; Duckworth AL, 2013, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00608; Ellis BJ, 2011, DEV PSYCHOPATHOL, V23, P7, DOI 10.1017/S0954579410000611; Ely DR, 1997, PHYSIOL BEHAV, V61, P395, DOI 10.1016/S0031-9384(96)00450-7; Epel E.S., 2012, FOOD ADDICTION, P266, DOI [10.1093/med:psych/9780199738168.003.0040, DOI 10.1093/MED:PSYCH/9780199738168.003.0040]; Galvan A, 2012, DEV PSYCHOBIOL, V54, P433, DOI 10.1002/dev.20602; Gibson EL, 2006, PHYSIOL BEHAV, V89, P53, DOI 10.1016/j.physbeh.2006.01.024; Gluckman PD, 2005, P ROY SOC B-BIOL SCI, V272, P671, DOI 10.1098/rspb.2004.3001; Gugusheff JR, 2015, FASEB J, V29, P365, DOI 10.1096/fj.14-255976; Harris RBS, 1998, AM J PHYSIOL-REG I, V275, pR1928, DOI 10.1152/ajpregu.1998.275.6.R1928; Harris RBS, 2002, AM J PHYSIOL-REG I, V282, pR77, DOI 10.1152/ajpregu.2002.282.1.R77; Harris RBS, 2006, HORM BEHAV, V49, P615, DOI 10.1016/j.yhbeh.2005.12.001; Hill JO, 2009, AM J CLIN NUTR, V89, P477, DOI 10.3945/ajcn.2008.26566; Jenkins SK, 2005, COMPR CHILD ADOLES N, V28, P175, DOI 10.1080/01460860500227580; Johnson SB, 2012, J ADOLESCENT HEALTH, V51, pS34, DOI 10.1016/j.jadohealth.2012.04.021; Laviola G, 2003, NEUROSCI BIOBEHAV R, V27, P19, DOI 10.1016/S0149-7634(03)00006-X; Lesage J, 2004, J ENDOCRINOL, V181, P291, DOI 10.1677/joe.0.1810291; Lupien SJ, 2009, NAT REV NEUROSCI, V10, P434, DOI 10.1038/nrn2639; Machado TD, 2013, STRESS, V16, P549, DOI 10.3109/10253890.2013.816841; Maniam J, 2012, NEUROPHARMACOLOGY, V63, P97, DOI 10.1016/j.neuropharm.2012.04.017; Martin SS, 2008, J AM COLL CARDIOL, V52, P1201, DOI 10.1016/j.jacc.2008.05.060; McCormick CM, 2008, BEHAV BRAIN RES, V187, P228, DOI 10.1016/j.bbr.2007.09.005; McCormick CM, 2010, PROG NEURO-PSYCHOPH, V34, P756, DOI 10.1016/j.pnpbp.2009.09.019; McCormick CM, 2010, BRAIN COGNITION, V72, P73, DOI 10.1016/j.bandc.2009.06.003; Miller SM, 2011, PHARMACOL BIOCHEM BE, V100, P130, DOI 10.1016/j.pbb.2011.08.002; Oliver G, 2000, PSYCHOSOM MED, V62, P853, DOI 10.1097/00006842-200011000-00016; Parker KJ, 2007, PSYCHONEUROENDOCRINO, V32, P785, DOI 10.1016/j.psyneuen.2007.05.008; Pervanidou P, 2012, METABOLISM, V61, P611, DOI 10.1016/j.metabol.2011.10.005; Pijiman FTA, 2003, BEHAV BRAIN RES, V139, P131, DOI 10.1016/S0166-4328(02)00124-9; Pohl J, 2007, BEHAV NEUROSCI, V121, P462, DOI 10.1037/0735-7044.121.3.462; Romeo RD, 2010, DEV PSYCHOBIOL, V52, P244, DOI 10.1002/dev.20437; Sanchez MM, 2001, DEV PSYCHOPATHOL, V13, P419, DOI 10.1017/S0954579401003029; Sandoval DA, 2003, J DIABETES COMPLICAT, V17, P108, DOI 10.1016/S1056-8727(02)00167-8; Saul ML, 2012, BEHAV BRAIN RES, V229, P226, DOI 10.1016/j.bbr.2012.01.022; Schmidt MV, 2006, J NEUROENDOCRINOL, V18, P865, DOI 10.1111/j.1365-2826.2006.01482.x; STEINBERG H, 1960, NATURE, V185, P615, DOI 10.1038/185615a0; Story M, 2002, J AM DIET ASSOC, V102, pS40, DOI 10.1016/S0002-8223(02)90421-9; Tamashiro KLK, 2009, DIABETES, V58, P1116, DOI 10.2337/db08-1129; Taylor PD, 2007, EXP PHYSIOL, V92, P287, DOI 10.1113/expphysiol.2005.032854; Toledo-Rodriguez M, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00017; Tomiyama AJ, 2012, PHYSIOL BEHAV, V107, P34, DOI 10.1016/j.physbeh.2012.04.021; Wilkin MM, 2012, BEHAV NEUROSCI, V126, P344, DOI 10.1037/a0027258	59	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0148261	10.1371/journal.pone.0148261	http://dx.doi.org/10.1371/journal.pone.0148261			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DD6SI	26872268	Green Submitted, Green Published, gold			2022-12-26	WOS:000370054100021
J	Hung, MH; Chen, YL; Chu, PY; Shih, CT; Yu, HC; Tai, WT; Shiau, CW; Chen, KF				Hung, M-H; Chen, Y-L; Chu, P-Y; Shih, C-T; Yu, H-C; Tai, W-T; Shiau, C-W; Chen, K-F			Upregulation of the oncoprotein SET determines poor clinical outcomes in hepatocellular carcinoma and shows therapeutic potential	ONCOGENE			English	Article							PROTEIN PHOSPHATASE 2A; ACUTE MYELOID-LEUKEMIA; ANTICANCER THERAPY; TUMOR-SUPPRESSOR; CELL-SURVIVAL; OKADAIC ACID; PP2A; INHIBITION; SORAFENIB; CANCER	The SET protein is a potent inhibitor of protein phosphatase 2A (PP2A). Here, we report the oncogenic role of SET in hepatocarcinogenesis, clinical aggressiveness and anti-hepatocellular carcinoma (HCC) therapeutics. By analyzing samples obtained from 147 HCC patients, we found that SET overexpression was detected specifically in 30.6% HCC tumor samples, and was significantly associated with worse clinical features and high p-Akt expression in HCC tumors. Co-expression of SET and Akt predicted shorter post-operative recurrence-free survival in this cohort (P = 0.045). Furthermore, SET was significantly associated with cell growth and hepatosphere formation. To elucidate the anti-HCC potential of targeting SET, we generated a novel SET antagonist, EMQA (N-4-(3-ethynylphenyl)-6,7-dimethoxy-N-2-(4-phenoxyphenyl) quinazoline-2,4-diamine). EMQA enhanced PP2A activity via disrupting SET-PP2Ac (catalytic domain of PP2A) binding in HCC cells, which restored PP2A-mediated p-Akt downregulation and promoted HCC cell death. In HCC cells or recombinant proteins expressing the N- and C-truncated forms of SET, only the C-terminal SET was required for EMQA targeting. Furthermore, combining sorafenib and EMQA showed good synergism in inhibiting HCC survival. Our findings suggested the oncogenic role of SET and the adverse prognostic value of SET overexpression in HCC. This alteration defines a subgroup of HCC patients who could benefit from SET antagonists, such as EMQA.	[Hung, M-H] Taipei Vet Gen Hosp, Dept Oncol, Div Med Oncol, Taipei, Taiwan; [Hung, M-H] Taipei Vet Gen Hosp, Dept Med, Div Hematol & Oncol, Taipei, Taiwan; [Hung, M-H] Natl Yang Ming Univ, Sch Life Sci, Program Mol Med, Taipei, Taiwan; [Hung, M-H] Natl Yang Ming Univ, Sch Med, Taipei, Taiwan; [Chen, Y-L] Kaohsiung Med Univ, Sch Med, Kaohsiung, Taiwan; [Chen, Y-L] Changhua Christian Hosp, Dept Surg, Changhua, Taiwan; [Chu, P-Y] Show Chwan Mem Hosp, Dept Pathol, Changhua, Taiwan; [Chu, P-Y] Fu Jen Catholic Univ, Coll Med, Sch Med, New Taipei, Taiwan; [Shih, C-T; Yu, H-C; Tai, W-T; Chen, K-F] Natl Taiwan Univ Hosp, Dept Med Res, 7 Chung Shan S Rd, Taipei 100, Taiwan; [Tai, W-T; Chen, K-F] Natl Taiwan Univ Hosp, Natl Ctr Excellence Clin Trial & Res, Taipei, Taiwan; [Shiau, C-W] Natl Yang Ming Univ, Inst Biopharmaceut Sci, 155,Sec 2,Li Nong St, Taipei, Taiwan	Taipei Veterans General Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Kaohsiung Medical University; Changhua Christian Hospital; Show Chwan Memorial Hospital; Fu Jen Catholic University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Yang Ming Chiao Tung University	Chen, KF (corresponding author), Natl Taiwan Univ Hosp, Dept Med Res, 7 Chung Shan S Rd, Taipei 100, Taiwan.; Shiau, CW (corresponding author), Natl Yang Ming Univ, Inst Biopharmaceut Sci, 155,Sec 2,Li Nong St, Taipei, Taiwan.	cwshiau@ym.edu.tw; kfchen1970@ntu.edu.tw		Chu, Pei-Yi/0000-0001-7336-2465	Ministry of Science and Technology [MOST-104-3113-B-076-001]; Taipei Veterans General Hospital [104DHA0100480, V105B-015]; Taiwan Clinical Oncology Research Foundation; Taipei Veterans General Hospital-National Yang-Ming University Excellent Physician Scientists Cultivation Program	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Taipei Veterans General Hospital(Taipei Veterans General Hospital); Taiwan Clinical Oncology Research Foundation; Taipei Veterans General Hospital-National Yang-Ming University Excellent Physician Scientists Cultivation Program	This study is supported by grant MOST-104-3113-B-076-001 from the Ministry of Science and Technology and grant 104DHA0100480 and V105B-015 from Taipei Veterans General Hospital, and partial support from Taiwan Clinical Oncology Research Foundation, Taipei Veterans General Hospital-National Yang-Ming University Excellent Physician Scientists Cultivation Program.	Agarwal A, 2014, CLIN CANCER RES, V20, P2092, DOI 10.1158/1078-0432.CCR-13-2575; Al-Murrani SWK, 1999, BIOCHEM J, V341, P293, DOI 10.1042/0264-6021:3410293; Arnaud L, 2011, FEBS LETT, V585, P2653, DOI 10.1016/j.febslet.2011.07.020; Arroyo JD, 2005, ONCOGENE, V24, P7746, DOI 10.1038/sj.onc.1209038; Bononi A, 2011, ENZYME RES, V2011, DOI [10.4061/2011/329098, DOI 10.4061/2011/329098]; Bruix J, 2014, J CLIN ONCOL, V32, DOI 10.1200/jco.2014.32.15_suppl.4006; Carlson SG, 1998, J AM SOC NEPHROL, V9, P1873; Carnero A, 2008, CURR CANCER DRUG TAR, V8, P187, DOI 10.2174/156800908784293659; Chen KF, 2010, ONCOGENE, V29, P6257, DOI 10.1038/onc.2010.357; Chen KF, 2012, BIOORGAN MED CHEM, V20, P6144, DOI 10.1016/j.bmc.2012.08.039; Chen KF, 2011, J PHARMACOL EXP THER, V337, P155, DOI 10.1124/jpet.110.175786; Chen W, 2004, CANCER CELL, V5, P127, DOI 10.1016/S1535-6108(04)00026-1; Chen WB, 2013, GASTROENT RES PRACT, V2013, DOI 10.1155/2013/675429; Cheng AL, 2009, LANCET ONCOL, V10, P25, DOI 10.1016/S1470-2045(08)70285-7; Christensen DJ, 2011, J IMMUNOL, V186, P2535, DOI 10.4049/jimmunol.1002847; Cristobal I, 2015, CLIN CANCER RES, V21, P347, DOI 10.1158/1078-0432.CCR-14-0724; Cristobal I, 2012, HAEMATOL-HEMATOL J, V97, P543, DOI 10.3324/haematol.2011.050542; EISENMANN DM, 1994, GENETICS, V137, P647; El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683; Fukukawa C, 2000, CANCER LETT, V161, P89, DOI 10.1016/S0304-3835(00)00598-X; HAYSTEAD TAJ, 1989, NATURE, V337, P78, DOI 10.1038/337078a0; Issa NP, 2015, NEUROLOGY, V84, P99, DOI 10.1212/WNL.0000000000001109; Janghorban M, 2014, P NATL ACAD SCI USA, V111, P9157, DOI 10.1073/pnas.1317630111; Junttila MR, 2008, FASEB J, V22, P954, DOI 10.1096/fj.06-7859rev; Junttila MR, 2007, CELL, V130, P51, DOI 10.1016/j.cell.2007.04.044; Kubota D, 2014, J PROTEOME RES, V13, P2250, DOI 10.1021/pr400929h; Leopoldino AM, 2012, MOL CELL BIOCHEM, V363, P65, DOI 10.1007/s11010-011-1158-x; LI L, 1994, P NATL ACAD SCI USA, V91, P5012, DOI 10.1073/pnas.91.11.5012; LI M, 1995, BIOCHEMISTRY-US, V34, P1988, DOI 10.1021/bi00006a020; Li M, 1996, J BIOL CHEM, V271, P11059, DOI 10.1074/jbc.271.19.11059; Liu GP, 2012, NEUROBIOL AGING, V33, P254, DOI 10.1016/j.neurobiolaging.2010.01.016; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Mumby M, 2007, CELL, V130, P21, DOI 10.1016/j.cell.2007.06.034; Muto S, 2007, P NATL ACAD SCI USA, V104, P4285, DOI 10.1073/pnas.0603762104; Neviani P, 2005, CANCER CELL, V8, P355, DOI 10.1016/j.ccr.2005.10.015; Neviani P, 2013, J CLIN INVEST, V123, P4144, DOI 10.1172/JCI68951; Patching SG, 2014, BBA-BIOMEMBRANES, V1838, P43, DOI 10.1016/j.bbamem.2013.04.028; Pelletier D, 2012, NEW ENGL J MED, V366, P339, DOI 10.1056/NEJMct1101691; Perrotti D, 2013, LANCET ONCOL, V14, pE229, DOI 10.1016/S1470-2045(12)70558-2; Pippa R, 2014, LEUKEMIA, V28, P1915, DOI 10.1038/leu.2014.141; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; SUGANUMA M, 1988, P NATL ACAD SCI USA, V85, P1768, DOI 10.1073/pnas.85.6.1768; Switzer CH, 2011, ONCOGENE, V30, P2504, DOI 10.1038/onc.2010.622; Tai WT, 2014, HEPATOLOGY, V59, P190, DOI 10.1002/hep.26640; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Torti D, 2011, EMBO MOL MED, V3, P623, DOI 10.1002/emmm.201100176; VONLINDERN M, 1992, MOL CELL BIOL, V12, P3346, DOI 10.1128/MCB.12.8.3346; Yu HC, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.325; Yu HC, 2013, BIOCHEM PHARMACOL, V85, P356, DOI 10.1016/j.bcp.2012.11.009; Zhai B, 2014, MOL CANCER THER, V13, P1589, DOI 10.1158/1535-7163.MCT-13-1043	50	27	28	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 15	2016	35	37					4891	4902		10.1038/onc.2016.21	http://dx.doi.org/10.1038/onc.2016.21			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DW0LA	26876205				2022-12-26	WOS:000383330700007
J	Adongo, PB; Tabong, PTN; Asampong, E; Ansong, J; Robalo, M; Adanu, RM				Adongo, Philip Baba; Tabong, Philip Teg-Nefaah; Asampong, Emmanuel; Ansong, Joana; Robalo, Magda; Adanu, Richard M.			Beyond Knowledge and Awareness: Addressing Misconceptions in Ghana's Preparation towards an Outbreak of Ebola Virus Disease	PLOS ONE			English	Article							STIGMA	Background Ebola Virus Disease (EVD) is not new to the world. However, the West African EVD epidemic which started in 2014 evolved into the largest, most severe and most complex outbreak in the history of the disease. The three most-affected countries faced enormous challenges in stopping the transmission and providing care for all patients. Although Ghana had not recorded any confirmed Ebola case, social factors have been reported to hinder efforts to control the outbreak in the three most affected countries. This qualitative study was designed to explore community knowledge and attitudes about Ebola and its transmission. Methods This study was carried out in five of the ten regions in Ghana. Twenty-five focus group discussions (N = 235) and 40 in-depth interviews were conducted across the five regions with community members, stakeholders and opinion leaders. The interviews were recorded digitally and transcribed verbatim. Framework analysis was adopted in the analysis of the data using Nvivo 10. Results The results showed a high level of awareness and knowledge about Ebola. The study further showed that knowledge on how to identify suspected cases of Ebola was also high among respondents. However, there was a firm belief that Ebola was a spiritual condition and could also be transmitted through air, mosquito bites and houseflies. These misconceptions resulted in perceptions of stigma and discrimination towards people who may get Ebola or work with Ebola patients. Conclusion We conclude that although knowledge and awareness about Ebola is high among Ghanaians who participated in the study, there are still misconceptions about the disease. The study recommends that health education on Ebola disease should move beyond creating awareness to targeting the identified misconceptions to improve future containment efforts.	[Adongo, Philip Baba; Tabong, Philip Teg-Nefaah; Asampong, Emmanuel] Univ Ghana, Sch Publ Hlth, Dept Social & Behav Sci, Legon, Accra, Ghana; [Ansong, Joana; Robalo, Magda] WHO, Country Off Ghana, Accra, Ghana; [Adanu, Richard M.] Univ Ghana, Dept Populat Family & Reprod Hlth, Sch Publ Hlth, Legon, Accra, Ghana	University of Ghana; World Health Organization; University of Ghana	Tabong, PTN (corresponding author), Univ Ghana, Sch Publ Hlth, Dept Social & Behav Sci, Legon, Accra, Ghana.	philgh2001@yahoo.com	Tabong, Philip Teg-Nefaah/AAG-5478-2020	Tabong, Philip/0000-0001-9445-1643; Adongo, Philip Baba/0000-0002-0614-4756	World Health Organization country office for Ghana	World Health Organization country office for Ghana	The study was funded by the World Health Organization country office for Ghana. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors will like to express their unconditional gratitude to the World Health Organization Country Office for Ghana for providing funding for this study. We also acknowledge the contribution of various stakeholders who attended the dissemination seminar organized by WHO country Office for Ghana in collaboration with the School of Public Health, University of Ghana and Ghana Health Service. Participants in this dissemination seminar had demonstrated high interest in using the findings of this study to inform health education on ebola in Ghana. We are also grateful to the participants and the research assistants who collected the data.	Aboud FE, 2010, SOC SCI MED, V71, P1897, DOI 10.1016/j.socscimed.2010.09.002; Abubakar A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071998; Agyepong I A, 2014, Ghana Med J, V48, P168, DOI 10.4314/gmj.v48i3.9; Aidoo H., 2014, GUARDIAN; Allen R, 1997, AUST NZ J PSYCHIAT, V31, P375, DOI 10.3109/00048679709073847; Alqahtani AS, 2015, EUROSURVEILLANCE, P1; Andrews M., 2013, DOING NARRATIVE RES; Aylward B, 2014, NEW ENGL J MED, V371, P1481, DOI 10.1056/NEJMoa1411100; Bello IS, 2014, MALARIA J, V13, pP9, DOI [10.1186/1475-2875-13-S1-P9, DOI 10.1186/1475-2875-13-S1-P9]; Bem DJ, 1972, ADV EXPT SOCIAL PSYC, V6, P1, DOI DOI 10.1016/S0065-2601(08)60024-6; CDC, 2014, WHAT YOU NEED KNOW E; Christie A, 2015, MMWR-MORBID MORTAL W, V64, P479; CPP, 2014, STUD EB VIR DIS EVD; CRS/UNICEF/Focus 1000, 2014, STUD PUBL KNOWL ATT; Feldmann H, 2011, LANCET, V377, P849, DOI 10.1016/S0140-6736(10)60667-8; Fishbein M, 2000, AIDS CARE, V12, P273, DOI 10.1080/09540120050042918; Ghana Statistical Service (GSS), 2012, 2010 POP HOUS CENS F; Gidado S, 2015, PLOS CURR OUTBREAKS; Hewlett BS, 2003, EMERG INFECT DIS, V9, P1242; Kucharski AJ, 2014, LANCET, V384, P1260, DOI 10.1016/S0140-6736(14)61706-2; Letamo G, 2003, J HEALTH POPUL NUTR, V21, P347; Letamo G, 2007, AJAR-AFR J AIDS RES, V6, P193, DOI 10.2989/16085900709490414; Lieber E, 2006, AIDS BEHAV, V10, P463, DOI 10.1007/s10461-005-9047-5; Link BG, 2006, LANCET, V367, P528, DOI 10.1016/S0140-6736(06)68184-1; Link BG, 2001, ANNU REV SOCIOL, V27, P363, DOI 10.1146/annurev.soc.27.1.363; Mate SE, 2015, NEW ENGL J MED, V373, P2448, DOI 10.1056/NEJMoa1509773; PAHO/WHO, 2014, EBOL VIR DIS EVD IMP; Piot P, 2001, AIDS Policy Law, V16, P5; Qian H, 2009, AIDS CARE, V27, P417, DOI [10.1055/s-0029-1237430.Imprinting, DOI 10.1055/S-0029-1237430.IMPRINTING]; Ritchie J, 2002, ANAL QUALITATIVE DAT, P187; Rogstad KE, 2015, CURR OPIN INFECT DIS, V28, P83, DOI 10.1097/QCO.0000000000000135; Smith Joanna, 2011, Nurse Res, V18, P52; Stroebe W., 2000, SOCIAL PSYCHOL HLTH, V2nd ed; Tabong PTN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054429; Wahl O. F., 1997, MEDIA MADNESS PUBLIC; WAHL OF, 1992, J COMMUNITY PSYCHOL, V20, P343, DOI 10.1002/1520-6629(199210)20:4<343::AID-JCOP2290200408>3.0.CO;2-2; Wahl Otto E., 2002, PSYCHIAT REHABILITAT, V6, P9, DOI [DOI 10.1080/10973430208408417, 10.1080/10973430208408417]; Walsh MG, 2015, PEERJ, V3, DOI 10.7717/peerj.735; Weingartl HM, 2012, SCI REP-UK, V2, DOI 10.1038/srep00811; Wertz FJ, 2005, J COUNS PSYCHOL, V52, P167, DOI 10.1037/0022-0167.52.2.167; WHO, 2014, EB RESP ROAD MAP SIT; WHO, 2014, EB SIT LIB NONC INT; WHO, 2014, FREQ ASK QUEST EB VI; World Health Organization, 2014, EB VIR DIS PREP STRE; Yoder P, 1997, MED ANTHROPOL Q, V11, P1997; Zierler SE Al, 2000, VIOLENCE VICTIMIZATI, V90	47	21	21	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2016	11	2							e0149627	10.1371/journal.pone.0149627	http://dx.doi.org/10.1371/journal.pone.0149627			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF3CO	26889683	gold, Green Submitted, Green Published			2022-12-26	WOS:000371221500064
J	Khor, SC; Razak, AM; Ngah, WZW; Yusof, YAM; Karim, NA; Makpol, S				Khor, Shy Cian; Razak, Azraul Mumtazah; Ngah, Wan Zurinah Wan; Yusof, Yasmin Anum Mohd; Karim, Norwahidah Abdul; Makpol, Suzana			The Tocotrienol-Rich Fraction Is Superior to Tocopherol in Promoting Myogenic Differentiation in the Prevention of Replicative Senescence of Myoblasts	PLOS ONE			English	Article							REGULATORY FACTORS MYOD; SKELETAL-MUSCLE; ALPHA-TOCOPHEROL; SELF-RENEWAL; STEM-CELLS; OXIDATIVE DAMAGE; SATELLITE CELLS; VITAMIN-E; REGENERATION; YOUNG	Aging results in a loss of muscle mass and strength. Myoblasts play an important role in maintaining muscle mass through regenerative processes, which are impaired during aging. Vitamin E potentially ameliorates age-related phenotypes. Hence, this study aimed to determine the effects of the tocotrienol-rich fraction (TRF) and alpha-tocopherol (ATF) in protecting myoblasts from replicative senescence and promoting myogenic differentiation. Primary human myoblasts were cultured into young and senescent stages and were then treated with TRF or ATF for 24 h, followed by an analysis of cell proliferation, senescence biomarkers, cellular morphology and differentiation. Our data showed that replicative senescence impaired the normal regenerative processes of myoblasts, resulting in changes in cellular morphology, cell proliferation, senescence-associated beta-galactosidase (SA-beta-gal) expression, myogenic differentiation and myogenic regulatory factors (MRFs) expression. Treatment with both TRF and ATF was beneficial to senescent myoblasts in reclaiming the morphology of young cells, improved cell viability and decreased SA-beta-gal expression. However, only TRF treatment increased BrdU incorporation in senescent myoblasts, as well as promoted myogenic differentiation through the modulation of MRFs at the mRNA and protein levels. MYOD1 and MYOG gene expression and myogenin protein expression were modulated in the early phases of myogenic differentiation. In conclusion, the tocotrienol-rich fraction is superior to alpha-tocopherol in ameliorating replicative senescence-related aberration and promoting differentiation via modulation of MRFs expression, indicating vitamin E potential in modulating replicative senescence of myoblasts.	[Khor, Shy Cian; Razak, Azraul Mumtazah; Ngah, Wan Zurinah Wan; Yusof, Yasmin Anum Mohd; Karim, Norwahidah Abdul; Makpol, Suzana] Univ Kebangsaan Malaysia, Med Ctr, Dept Biochem, Fac Med, Level 17,Preclin Bldg, Kuala Lumpur 56000, Malaysia	Universiti Kebangsaan Malaysia	Makpol, S (corresponding author), Univ Kebangsaan Malaysia, Med Ctr, Dept Biochem, Fac Med, Level 17,Preclin Bldg, Kuala Lumpur 56000, Malaysia.	suzanamakpol@ppukm.ukm.edu.my	MAKPOL, SUZANA/AAN-4709-2021; Khor, Shy Cian/ABA-4364-2021	Khor, Shy Cian/0000-0002-2493-1761	Universiti Kebangsaan Malaysia [AP-2012-012, UKM-FF-2013-259]	Universiti Kebangsaan Malaysia	This study was funded by the Universiti Kebangsaan Malaysia grants AP-2012-012 and UKM-FF-2013-259. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsharidah M, 2013, AGING CELL, V12, P333, DOI 10.1111/acel.12051; Alway SE, 2001, EXP PHYSIOL, V86, P509, DOI 10.1113/eph8602235; Arthur PG, 2008, CURR OPIN CLIN NUTR, V11, P408, DOI 10.1097/MCO.0b013e328302f3fe; Barberi L, 2013, BIOGERONTOLOGY, V14, P273, DOI 10.1007/s10522-013-9429-4; Bernet JD, 2014, NAT MED, V20, P265, DOI 10.1038/nm.3465; Bigot A, 2008, BIOL CELL, V100, P189, DOI 10.1042/BC20070085; Cao Y, 2010, DEV CELL, V18, P662, DOI 10.1016/j.devcel.2010.02.014; Carlson ME, 2009, EMBO MOL MED, V1, P381, DOI 10.1002/emmm.200900045; Carosio S, 2011, AGEING RES REV, V10, P35, DOI 10.1016/j.arr.2009.08.001; Cesari M, 2004, AM J CLIN NUTR, V79, P289; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Chin SF, 2008, NUTRITION, V24, P1, DOI 10.1016/j.nut.2007.08.006; Cho KA, 2004, J BIOL CHEM, V279, P42270, DOI 10.1074/jbc.M402352200; Collins CA, 2005, CELL, V122, P289, DOI 10.1016/j.cell.2005.05.010; Collins CA, 2007, STEM CELLS, V25, P885, DOI 10.1634/stemcells.2006-0372; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Decary S, 2000, NEUROMUSCULAR DISORD, V10, P113, DOI 10.1016/S0960-8966(99)00093-0; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Fano G, 2001, J MUSCLE RES CELL M, V22, P345, DOI 10.1023/A:1013122805060; Fielding RA, 2011, J AM MED DIR ASSOC, V12, P249, DOI 10.1016/j.jamda.2011.01.003; HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9; Howard AC, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1594; Khor SC, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/914853; Kitzmann M, 1998, J CELL BIOL, V142, P1447, DOI 10.1083/jcb.142.6.1447; Kuang SH, 2007, CELL, V129, P999, DOI 10.1016/j.cell.2007.03.044; Lee EJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092447; Lee SP, 2009, EUR J APPL PHYSIOL, V107, P587, DOI 10.1007/s00421-009-1159-6; Lim JJ, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/978101; Londhe P, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-14; Lorenzon P, 2004, EXP GERONTOL, V39, P1545, DOI 10.1016/j.exger.2004.07.008; Makpol S, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/506171; Malatesta M, 2011, EUR J HISTOCHEM, P55; Mazlan M, 2006, J NEUROL SCI, V243, P5, DOI 10.1016/j.jns.2005.10.006; Mouly V, 2005, ACTA PHYSIOL SCAND, V184, P3, DOI 10.1111/j.1365-201X.2005.01417.x; Nehlin JO, 2011, BIOGERONTOLOGY, V12, P349, DOI 10.1007/s10522-011-9336-5; Owens J, 2013, IN VITRO CELL DEV-AN, V49, P695, DOI 10.1007/s11626-013-9655-8; Rafique R, 2004, FREE RADICAL RES, V38, P157, DOI 10.1080/10715760310001643311; Renault V, 2002, AGING CELL, V1, P132, DOI 10.1046/j.1474-9728.2002.00017.x; Saito Y, 2004, ANN NY ACAD SCI, V1031, P368, DOI 10.1196/annals.1331.047; Sen CK, 2006, LIFE SCI, V78, P2088, DOI 10.1016/j.lfs.2005.12.001; SERBINOVA E, 1991, FREE RADICAL BIO MED, V10, P263, DOI 10.1016/0891-5849(91)90033-Y; SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771; Sousa-Victor P, 2014, NATURE, V506, P316, DOI 10.1038/nature13013; SUZUKI Y, 1993, BIOCHEMISTRY-US, V32, P10692, DOI 10.1021/bi00091a020; Vasilaki A, 2006, MECH AGEING DEV, V127, P830, DOI 10.1016/j.mad.2006.08.004; Yablonka-Reuveni Z, 1999, DEV BIOL, V210, P440, DOI 10.1006/dbio.1999.9284; Yin H, 2013, PHYSIOL REV, V93, P23, DOI 10.1152/physrev.00043.2011	47	26	26	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0149265	10.1371/journal.pone.0149265	http://dx.doi.org/10.1371/journal.pone.0149265			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26885980	Green Submitted, Green Published, gold			2022-12-26	WOS:000371218400072
J	Kowalczyk, M; Siermontowski, P; Mucha, D; Ambrozy, T; Orlowski, M; Zinkiewicz, K; Kurpiewski, W; Pasnik, K; Kowalczyk, I; Pedrycz, A				Kowalczyk, Marek; Siermontowski, Piotr; Mucha, Dariusz; Ambrozy, Tadeusz; Orlowski, Marcin; Zinkiewicz, Krzysztof; Kurpiewski, Waldemar; Pasnik, Krzysztof; Kowalczyk, Iwona; Pedrycz, Agnieszka			Chromoendoscopy with a Standard-Resolution Colonoscope for Evaluation of Rectal Aberrant Crypt Foci	PLOS ONE			English	Article							COLORECTAL-CANCER; COLON; QUANTIFICATION; IDENTIFICATION; DYSPLASIA	Colorectal cancer (CRC) is the second most common cause of death worldwide. According to the theory by Vogelstein, colorectal carcinogenesis involves a series of successive changes in the normal colonic mucosa, starting with excessive proliferation and focal disorders of intestinal crypts, followed by adenoma and its subsequent malignant transformation. The first identifiable changes in CRC carcinogenesis are aberrant crypt foci (ACF). ACF are invisible during routine colonoscopy yet are well identifiable in chromoendoscopy using methylene blue or indigo carmine. High-resolution colonoscopes are used for assessment of ACF. The aim of the present study was to evaluate the usefulness of standard-resolution colonoscopy for identification of rectal ACF. The following parameters were evaluated: duration of chromoendoscopy of a given rectal segment, type of ACF, sensitivity and specificity of endoscopy combined with histopathological evaluation. The mean duration of colonoscopy and chromoendoscopy was 26.8 min. In the study population, typical ACF were found in 73 patients (p = 0.489), hyperplastic ACF in 49 (p = 0.328), and dysplastic ACF in 16 patients (p = 0.107). Mixed ACF were observed in 11 individuals (p = 0.073). The sensitivity of the method was found to be 0.96 whereas its specificity 0.99. Identification of rectal ACF using standard-resolution colonoscopy combined with rectal mucosa staining with 0.25% methylene blue is characterised by high sensitivity and specificity.	[Kowalczyk, Marek; Kurpiewski, Waldemar] Univ Hosp, Dept Oncol & Gen Surg, Olsztyn, Poland; [Siermontowski, Piotr] Mil Inst Med Gdynia, Dept Maritime, Gdynia, Poland; [Mucha, Dariusz; Ambrozy, Tadeusz] Mil Inst Med Gdynia, Hyperbar Med Dept, Gdynia, Poland; [Orlowski, Marcin] Acad Phys Educ Cracow, Dept Phys Educ & Sport, Krakow, Poland; [Zinkiewicz, Krzysztof] Ctr Diag & Treatment Gastrointestinal Dis, Gdansk, Poland; [Pasnik, Krzysztof] Med Univ Lublin, Dept Gen Gastroenterol & Gastrointestinal Oncol S, Univ Hosp 1, Lublin, Poland; [Kowalczyk, Iwona] Mil Hosp, Mil Inst Med, Dept Gen Oncol Metab & Thorac Surg, Warsaw, Poland; [Pedrycz, Agnieszka] Univ Hosp, Unit Lab Diagnost, Olsztyn, Poland; Med Univ Lublin, Dept Histol & Embryol, Unit Expt Cytol, Lublin, Poland	Medical University of Lublin; Military Institute of Aviation Medicine; Medical University of Lublin	Mucha, D (corresponding author), Mil Inst Med Gdynia, Hyperbar Med Dept, Gdynia, Poland.	nauka.autograf@gmail.com	Ambroży, Tadeusz/AAZ-4796-2021; Pedrycz, Agnieszka/AAE-2024-2019; Siermontowski, Piotr/V-7339-2018	Ambroży, Tadeusz/0000-0001-7361-9478; Siermontowski, Piotr/0000-0003-2557-3561; Kurpiewski, Waldemar/0000-0002-7363-4026; Zinkiewicz, Krzysztof/0000-0002-7048-3621; Kowalczyk, Marek/0000-0003-4202-023X				Adler DG, 2002, GASTROINTEST ENDOSC, V56, P657, DOI 10.1067/mge.2002.128540; Adler DG, 2005, COMMENTARY GASTROENT, V2, P391; BIRD RP, 1987, CANCER LETT, V37, P147, DOI 10.1016/0304-3835(87)90157-1; DiGregori C, 1997, HISTOPATHOLOGY, V30, P328, DOI 10.1046/j.1365-2559.1997.d01-626.x; Fenoglio-Preiser CM, 1999, TOXICOL PATHOL, V27, P632, DOI 10.1177/019262339902700604; Greenspan EJ, 2007, CARCINOGENESIS, V28, P769, DOI 10.1093/carcin/bgl209; Gupta AK, 2009, GASTROINTEST ENDOSC, V70, P322, DOI 10.1016/j.gie.2008.12.060; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hurlstone DP, 2005, AM J GASTROENTEROL, V100, P1283, DOI 10.1111/j.1572-0241.2005.40891.x; Kowalczyk M, 2013, POLISH HYPERBARIC RE, V3, P97; Marion JF, 2008, AM J GASTROENTEROL, V103, P2342, DOI 10.1111/j.1572-0241.2008.01934.x; Nascimbeni R, 1999, AM J SURG PATHOL, V23, P1256, DOI 10.1097/00000478-199910000-00011; Nucci MR, HUMAN PATHOLOGY, V28, P1396; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; PRETLOW TP, 1991, CANCER RES, V51, P1564; Rasheed S, 2008, GASTROINTEST ENDOSC, V67, P1103, DOI 10.1016/j.gie.2007.10.038; RONCUCCI L, 1991, HUM PATHOL, V22, P287, DOI 10.1016/0046-8177(91)90163-J; Rudolph RE, 2005, CANCER EPIDEM BIOMAR, V14, P605, DOI 10.1158/1055-9965.EPI-04-0058; Samowitz WS, 2007, MOL CANCER RES, V5, P165, DOI 10.1158/1541-7786.MCR-06-0398; Shpitz B, 1998, HUM PATHOL, V29, P469, DOI 10.1016/S0046-8177(98)90062-4; Shpitz B, 2003, GUT, V52, P1598, DOI 10.1136/gut.52.11.1598; Siu IM, 1997, AM J PATHOL, V150, P1805; Stevens RG, 2007, CANCER LETT, V248, P262, DOI 10.1016/j.canlet.2006.08.003; Takayama T, 1998, NEW ENGL J MED, V339, P1277, DOI 10.1056/NEJM199810293391803; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901	25	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0148286	10.1371/journal.pone.0148286	http://dx.doi.org/10.1371/journal.pone.0148286			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26886097	Green Published, Green Submitted, gold			2022-12-26	WOS:000371218400029
J	Lopes, FAC; Catao, ECP; Santana, RH; Cabral, AD; Paranhos, R; Rangel, TP; de Rezende, CE; Edwards, RA; Thompson, CC; Thompson, FL; Kruger, RH				Cardoso Lopes, Fabyano Alvares; Pires Catao, Elisa Caldeira; Santana, Renata Henrique; Cabral, Anderson de Souza; Paranhos, Rodolfo; Rangel, Thiago Pessanha; de Rezende, Carlos Eduardo; Edwards, Robert A.; Thompson, Cristiane C.; Thompson, Fabiano L.; Kruger, Ricardo Henrique			Microbial Community Profile and Water Quality in a Protected Area of the Caatinga Biome	PLOS ONE			English	Article							FRESH-WATER; NONPARAMETRIC-ESTIMATION; NORTHEASTERN BRAZIL; EMAMECTIN BENZOATE; SEQUENCING DATA; FLOW-CYTOMETRY; SOIL; BACTERIAL; PESTICIDES; POPULATION	The Caatinga is a semi-arid biome in northeast Brazil. The Paraguacu River is located in the Caatinga biome, and part of its course is protected by the National Park of Chapada Diamantina (PNCD). In this study we evaluated the effect of PNCD protection on the water quality and microbial community diversity of this river by analyzing water samples obtained from points located inside and outside the PNCD in both wet and dry seasons. Results of water quality analysis showed higher levels of silicate, ammonia, particulate organic carbon, and nitrite in samples from the unprotected area compared with those from protected areas. Pyrosequencing of the 16S rRNA genes revealed that Burkholderiales was abundant in samples from all three sites during both seasons and was represented primarily by the genus Polynucleobacter and members of the Comamonadaceae family (e.g., genus Limnohabitans). During the dry season, the unprotected area showed a higher abundance of Flavobacterium sp. and Arthrobacter sp., which are frequently associated with the presence and/or degradation of arsenic and pesticide compounds. In addition, genes that appear to be related to agricultural impacts on the environment, as well as those involved in arsenic and cadmium resistance, copper homeostasis, and propanediol utilization, were detected in the unprotected areas by metagenomic sequencing. Although PNCD protection improves water quality, agricultural activities around the park may affect water quality within the park and may account for the presence of bacteria capable of pesticide degradation and assimilation, evidencing possible anthropogenic impacts on the Caatinga.	[Cardoso Lopes, Fabyano Alvares; Pires Catao, Elisa Caldeira; Kruger, Ricardo Henrique] Univ Brasilia, Dept Cellular Biol, Brasilia, DF, Brazil; [Santana, Renata Henrique] Univ Catolica Brasilia, Genom Sci & Biotechnol, Brasilia, DF, Brazil; [Cabral, Anderson de Souza; Paranhos, Rodolfo; Thompson, Cristiane C.; Thompson, Fabiano L.] Univ Fed Rio de Janeiro, Inst Biol, Rio De Janeiro, Brazil; [Rangel, Thiago Pessanha; de Rezende, Carlos Eduardo] Univ Estadual N Fluminen, Lab Environm Sci, Campos dos Goytacazes, Brazil; [Edwards, Robert A.] San Diego State Univ, Computat Sci Res Ctr, San Diego, CA 92182 USA; [Edwards, Robert A.] San Diego State Univ, Dept Comp Sci, San Diego, CA 92182 USA	Universidade de Brasilia; Universidade Catolica de Brasilia; Universidade Federal do Rio de Janeiro; California State University System; San Diego State University; California State University System; San Diego State University	Kruger, RH (corresponding author), Univ Brasilia, Dept Cellular Biol, Brasilia, DF, Brazil.; Thompson, FL (corresponding author), Univ Fed Rio de Janeiro, Inst Biol, Rio De Janeiro, Brazil.	fabianothompson1@gmail.com; kruger@unb.br	Thompson, Cristiane C/I-5783-2016; Lopes, Fabyano Alvares Cardoso/E-1969-2015; Edwards, Robert/Q-1691-2019; Lopes, Fabyano A.C./F-7558-2018; de Rezende, Carlos E/I-1893-2015; Kruger, Ricardo/Y-9595-2019	Edwards, Robert/0000-0001-8383-8949; Lopes, Fabyano A.C./0000-0002-4565-9103; de Rezende, Carlos/0000-0003-2804-8930; Catao, Elisa C.P./0000-0003-4620-1097; Thompson, Fabiano/0000-0002-7562-1683; Kruger, Ricardo/0000-0002-8443-9402	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq; Instituto Chico Mendes de Conservacao da Biodiversidade - ICMBio [551994/2011-8]; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); National Park of Chapada Diamantina; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) fellowship; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Instituto Chico Mendes de Conservacao da Biodiversidade (ICMBio); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); CAPES fellowship; Direct For Biological Sciences [1330800] Funding Source: National Science Foundation	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Instituto Chico Mendes de Conservacao da Biodiversidade - ICMBio; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); National Park of Chapada Diamantina; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) fellowship(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Instituto Chico Mendes de Conservacao da Biodiversidade (ICMBio); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CAPES fellowship(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq - and Instituto Chico Mendes de Conservacao da Biodiversidade - ICMBio - (grant number 551994/2011-8; www.cnpq.br; www.icmbio.gov.br). The authors are grateful for the support offered by Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) and National Park of Chapada Diamantina. F.A.C.L. is supported by a Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by grants from the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Instituto Chico Mendes de Conservacao da Biodiversidade (ICMBio), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). We are grateful for the support offered by Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) and National Park of Chapada Diamantina. F.A.C.L. is supported by a CAPES fellowship.	Andrade L, 2003, J MICROBIOL METH, V55, P841, DOI 10.1016/j.mimet.2003.08.002; Armougom F., 2009, J COMPUT SCI SYST BI, V2, P74, DOI DOI 10.4172/JCSB.1000019; Boyd RA, 2000, SCI TOTAL ENVIRON, V248, P241, DOI 10.1016/S0048-9697(99)00546-X; Bruce T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036687; Brussaard CPD, 2000, J VIROL METHODS, V85, P175, DOI 10.1016/S0166-0934(99)00167-6; Cao LD, 2013, J ANAL METHODS CHEM, V2013, DOI 10.1155/2013/121783; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Carpenter SR, 2005, P NATL ACAD SCI USA, V102, P10002, DOI 10.1073/pnas.0503959102; Castro WD, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00812-14; CHAO A, 1984, SCAND J STAT, V11, P265; Chao A, 2003, ENVIRON ECOL STAT, V10, P429, DOI 10.1023/A:1026096204727; Compant S, 2008, FEMS MICROBIOL REV, V32, P607, DOI 10.1111/j.1574-6976.2008.00113.x; Cox MP, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-485; DEALBUQUERQUE SG, 1995, PESQUI AGROPECU BRAS, V30, P885; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; EPA S, 1995, MICR ASS AC DIG SIL; Fang H, 2014, SCI TOTAL ENVIRON, V470, P983, DOI 10.1016/j.scitotenv.2013.10.076; Fanigliulo A, 2008, Commun Agric Appl Biol Sci, V73, P651; Fiedler S, 2008, BIOGEOSCIENCES, V5, P1615, DOI 10.5194/bg-5-1615-2008; Gasol JM, 2000, SCI MAR, V64, P197, DOI 10.3989/scimar.2000.64n2197; Ghai R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023785; Giongo V., 2011, Dynamic Soil, Dynamic Plant, V5, P12; Giulietti AM, 2006, GREATER KNOWLEDGE BR, P11; Gomez-Alvarez V, 2009, ISME J, V3, P1314, DOI 10.1038/ismej.2009.72; GOOD IJ, 1953, BIOMETRIKA, V40, P237, DOI 10.2307/2333344; Gorlach-Lira K, 2007, BRAZ J MICROBIOL, V38, P135, DOI 10.1590/S1517-83822007000100028; Grasshoff K, 1999, METHODS SEAWATER ANA; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Hahn MW, 2010, INT J SYST EVOL MICR, V60, P166, DOI 10.1099/ijs.0.010595-0; Hahn MW, 2009, INT J SYST EVOL MICR, V59, P2002, DOI 10.1099/ijs.0.005801-0; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hemme CL, 2010, ISME J, V4, P660, DOI 10.1038/ismej.2009.154; Hillebrand H, 2007, P NATL ACAD SCI USA, V104, P10904, DOI 10.1073/pnas.0701918104; Hundt K, 1998, CHEMOSPHERE, V36, P2321, DOI 10.1016/S0045-6535(97)10201-6; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Hussen A, 2007, J CHROMATOGR A, V1152, P247, DOI 10.1016/j.chroma.2007.02.076; Jezbera J, 2012, FEMS MICROBIOL ECOL, V81, P467, DOI 10.1111/j.1574-6941.2012.01372.x; Kavamura VN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073606; Kiaune L, 2011, REV ENVIRON CONTAM T, V213, P1, DOI 10.1007/978-1-4419-9860-6_1; Kuo JN, 2010, ENVIRON TOXICOL CHEM, V29, P1816, DOI 10.1002/etc.209; Liu JW, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00064; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Marcon AE, 2010, CHEMOSPHERE, V81, P773, DOI 10.1016/j.chemosphere.2010.07.006; Marie D, 1996, APPL ENVIRON MICROB, V62, P1649, DOI 10.1128/AEM.62.5.1649-1655.1996; Marie D, 2005, PHYTOPLANKTON CELL C; MARQUES JSJ, 2011, GEST COSTEIRA INTEG, V11, P379, DOI DOI 10.5894/RGCI183; Mattes TE, 2008, APPL ENVIRON MICROB, V74, P6405, DOI 10.1128/AEM.00197-08; Menezes RSC, 2012, BRAZ J BIOL, V72, P643, DOI 10.1590/S1519-69842012000400004; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; MMA-Ministerio do Meio Ambiente, 2010, PLAN AC PREV CONTR D; Monteiro JM, 2009, J MICROBIOL, V47, P363, DOI 10.1007/s12275-009-0048-3; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Pacchioni RG, 2014, MICROBIOLOGYOPEN, V3, P299, DOI 10.1002/mbo3.169; Padro DE, 2003, ECOLOGIA CONSERVACAO; Paerl H, 2008, ADV EXP MED BIOL, V619, P217, DOI 10.1007/978-0-387-75865-7_10; Parks DH, 2010, BIOINFORMATICS, V26, P715, DOI 10.1093/bioinformatics/btq041; Paul D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118735; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; R Core Team, 2013, R LANG ENV STAT COMP; Reeder J, 2010, NAT METHODS, V7, P668, DOI 10.1038/nmeth0910-668b; Rezende CE, 2010, ESTUAR COAST SHELF S, V87, P479, DOI 10.1016/j.ecss.2010.02.008; Ribeiro CAO, 2006, PARTICIPACAO SOCIAL; Riedel SL, 2014, APPL MICROBIOL BIOT, V98, P1469, DOI 10.1007/s00253-013-5430-8; Ryan MP, 2007, J APPL MICROBIOL, V103, P754, DOI 10.1111/j.1365-2672.2007.03361.x; Sagarkar S, 2016, APPL MICROBIOL BIOT, V100, P903, DOI 10.1007/s00253-015-6975-5; Sant'Anna CL, 2011, NEUROTOX RES, V19, P389, DOI 10.1007/s12640-010-9177-z; Santana RH, 2015, MICROB ECOL, V70, P545, DOI 10.1007/s00248-015-0581-z; Shegunova P, 2007, ENVIRON POLLUT, V146, P257, DOI 10.1016/j.envpol.2006.03.057; Simek K, 2010, APPL ENVIRON MICROB, V76, P631, DOI 10.1128/AEM.02203-09; Starliper CE, 2011, J ADV RES, V2, P97, DOI 10.1016/j.jare.2010.04.001; Tseng CH, 2013, ISME J, V7, P2374, DOI 10.1038/ismej.2013.118; van-Elsas JD, 2006, MODERN SOIL MICROBIO, P83; Vazquez-Baeza Y, 2013, GIGASCIENCE, V2, DOI 10.1186/2047-217X-2-16; Wang QF, 2013, INT BIODETER BIODEGR, V77, P63, DOI 10.1016/j.ibiod.2012.11.003; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wang QY, 2009, SOIL BIOL BIOCHEM, V41, P1504, DOI 10.1016/j.soilbio.2009.04.010; Wilke A, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-141; Willis KJ, 2003, AQUACULTURE, V221, P289, DOI 10.1016/S0044-8486(03)00066-8; Yan Q, 2015, SCI REP-UK, V5, DOI 10.1038/srep08605; Zarcinas BA, 2004, ENVIRON GEOCHEM HLTH, V26, P343, DOI 10.1007/s10653-005-4669-0; Zhang JY, 2007, J ENVIRON SCI, V19, P338, DOI 10.1016/S1001-0742(07)60055-2; Zhao FJ, 2009, NEW PHYTOL, V181, P777, DOI 10.1111/j.1469-8137.2008.02716.x; Zorb C, 2014, J PLANT PHYSIOL, V171, P656, DOI 10.1016/j.jplph.2013.08.008	84	8	9	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0148296	10.1371/journal.pone.0148296	http://dx.doi.org/10.1371/journal.pone.0148296			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	26881432	Green Published, gold, Green Submitted			2022-12-26	WOS:000371219000015
J	Wu, CC; Chen, BS				Wu, Chia-Chou; Chen, Bor-Sen			A Systems Biology Approach to the Coordination of Defensive and Offensive Molecular Mechanisms in the Innate and Adaptive Host-Pathogen Interaction Networks	PLOS ONE			English	Article							CANDIDA-ALBICANS; STAPHYLOCOCCUS-AUREUS; GLUCOSE SENSOR; ZEBRAFISH; IMMUNITY; INFECTION; IDENTIFICATION; NEUTROPHILS; RESISTANCE; MEMORY	Infected zebrafish coordinates defensive and offensive molecular mechanisms in response to Candida albicans infections, and invasive C. albicans coordinates corresponding molecular mechanisms to interact with the host. However, knowledge of the ensuing infection-activated signaling networks in both host and pathogen and their interspecific crosstalk during the innate and adaptive phases of the infection processes remains incomplete. In the present study, dynamic network modeling, protein interaction databases, and dual transcriptome data from zebrafish and C. albicans during infection were used to infer infectionactivated host-pathogen dynamic interaction networks. The consideration of host-pathogen dynamic interaction systems as innate and adaptive loops and subsequent comparisons of inferred innate and adaptive networks indicated previously unrecognized crosstalk between known pathways and suggested roles of immunological memory in the coordination of host defensive and offensive molecular mechanisms to achieve specific and powerful defense against pathogens. Moreover, pathogens enhance intraspecific crosstalk and abrogate host apoptosis to accommodate enhanced host defense mechanisms during the adaptive phase. Accordingly, links between physiological phenomena and changes in the coordination of defensive and offensive molecular mechanisms highlight the importance of host-pathogen molecular interaction networks, and consequent inferences of the host-pathogen relationship could be translated into biomedical applications.	[Wu, Chia-Chou; Chen, Bor-Sen] Natl Tsing Hua Univ, Automat Control Signal Proc & Syst Biol Lab, Hsinchu 30013, Taiwan	National Tsing Hua University	Chen, BS (corresponding author), Natl Tsing Hua Univ, Automat Control Signal Proc & Syst Biol Lab, Hsinchu 30013, Taiwan.	bschen@ee.nthu.edu.tw	Wu, Chia-Chou/L-1058-2013; Chen, Bor-Sen/D-9114-2017	Wu, Chia-Chou/0000-0002-4009-6858; 	Ministry of Science and Technology [MOST-103-2745-E-007-001-ASP]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	The authors are grateful for the support provided by the Ministry of Science and Technology through grant no. MOST-103-2745-E-007-001-ASP.	Ashida H, 2011, J CELL BIOL, V195, P931, DOI 10.1083/jcb.201108081; Basson NJ, 2000, J MED MICROBIOL, V49, P969, DOI 10.1099/0022-1317-49-11-969; Besedovsky L, 2012, PFLUG ARCH EUR J PHY, V463, P121, DOI 10.1007/s00424-011-1044-0; Bevan MJ, 2011, NAT IMMUNOL, V12, P463, DOI 10.1038/ni.2041; Brown HM, 2012, CELL MICROBIOL, V14, P1554, DOI 10.1111/j.1462-5822.2012.01820.x; Brown JN, 2010, J VIROL, V84, P12058, DOI 10.1128/JVI.01129-10; Brown V, 2006, EUKARYOT CELL, V5, P1726, DOI 10.1128/EC.00186-06; Buckley CD, 2013, NAT REV IMMUNOL, V13, P59, DOI 10.1038/nri3362; Chao CC, 2010, INFECT IMMUN, V78, P2512, DOI 10.1128/IAI.01293-09; Chasman D, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145120; Chatr-aryamontri A, 2015, NUCLEIC ACIDS RES, V43, pD470, DOI 10.1093/nar/gku1204; Chen YY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072483; Ciarleglio CM, 2011, NEUROSCIENCE, V197, P8, DOI 10.1016/j.neuroscience.2011.09.036; Croft D, 2014, NUCLEIC ACIDS RES, V42, pD472, DOI 10.1093/nar/gkt1102; Duhring S, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00625; Ferro VA, 2004, VACCINE, V22, P1024, DOI 10.1016/j.vaccine.2003.08.043; Frantz S, 2005, CIRC RES, V96, P15, DOI 10.1161/01.RES.0000153188.68898.ac; Gao Y, 2008, BIOCHEMISTRY-US, V47, P11367, DOI 10.1021/bi801122t; Gow NAR, 2012, NAT REV MICROBIOL, V10, P112, DOI 10.1038/nrmicro2711; Hamza TH, 2010, NAT GENET, V42, P781, DOI 10.1038/ng.642; Hasnain SE, 2003, J BIOSCIENCES, V28, P349, DOI 10.1007/BF02970153; Hawn TR, 2015, IMMUNOL REV, V264, P344, DOI 10.1111/imr.12255; Inglis DO, 2012, NUCLEIC ACIDS RES, V40, pD667, DOI 10.1093/nar/gkr945; Johansson R, 1993, PRENTICE HALL INFORM; Johnson EE, 2012, MICROBES INFECT, V14, P207, DOI 10.1016/j.micinf.2011.10.001; Kaba HEJ, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-16; Kannarkat GT, 2013, J PARKINSON DIS, V3, P493, DOI 10.3233/JPD-130250; Kumar H, 2011, INT REV IMMUNOL, V30, P16, DOI 10.3109/08830185.2010.529976; Kuo ZY, 2013, J INNATE IMMUN, V5, P137, DOI 10.1159/000347104; Lan CY, 2004, MOL MICROBIOL, V53, P1451, DOI 10.1111/j.1365-2958.2004.04214.x; Leach MD, 2011, MOL BIOL CELL, V22, P687, DOI 10.1091/mbc.E10-07-0632; Lin C, 2014, BMC SYST BIOL, V8, DOI 10.1186/s12918-014-0116-0; Louveau A, 2015, NATURE, V523, P337, DOI 10.1038/nature14432; Maidan MM, 2005, BIOCHEM SOC T, V33, P291, DOI 10.1042/BST0330291; Mantovani A, 2011, NAT REV IMMUNOL, V11, P519, DOI 10.1038/nri3024; Meijer AH, 2011, CURR DRUG TARGETS, V12, P1000; Mi HY, 2013, NUCLEIC ACIDS RES, V41, pD377, DOI 10.1093/nar/gks1118; Molnar E, 2012, J BIOL CHEM, V287, P42664, DOI 10.1074/jbc.M112.386045; Netea MG, 2015, NAT IMMUNOL, V16, P675, DOI 10.1038/ni.3178; Nitzan M, 2015, NUCLEIC ACIDS RES, V43, P1357, DOI 10.1093/nar/gkv001; Ostlund G, 2010, NUCLEIC ACIDS RES, V38, pD196, DOI 10.1093/nar/gkp931; Rodaki A, 2009, MOL BIOL CELL, V20, P4845, DOI 10.1091/mbc.E09-01-0002; Rolf J, 2013, EUR J IMMUNOL, V43, P889, DOI 10.1002/eji.201243008; Romani L, 2011, NAT REV IMMUNOL, V11, P275, DOI 10.1038/nri2939; Sabina J, 2009, EUKARYOT CELL, V8, P1314, DOI 10.1128/EC.00138-09; Scheiermann C, 2012, IMMUNITY, V37, P290, DOI 10.1016/j.immuni.2012.05.021; Spaan AN, 2013, ANNU REV MICROBIOL, V67, P629, DOI 10.1146/annurev-micro-092412-155746; Sun X, 2002, P NATL ACAD SCI USA, V99, P4686, DOI 10.1073/pnas.062585499; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Tong SYC, 2012, SEMIN IMMUNOPATHOL, V34, P185, DOI 10.1007/s00281-011-0300-x; Trede NS, 2004, IMMUNITY, V20, P367, DOI 10.1016/S1074-7613(04)00084-6; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; Wang YC, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-79; Westermann AJ, 2012, NAT REV MICROBIOL, V10, P618, DOI 10.1038/nrmicro2852; Wu CC, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0097902, 10.1371/journal.pone.0105362]; Yang DR, 2015, WORLD J GASTROENTERO, V21, P3786, DOI 10.3748/wjg.v21.i13.3786	56	7	7	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0149303	10.1371/journal.pone.0149303	http://dx.doi.org/10.1371/journal.pone.0149303			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	26881892	Green Published, Green Submitted, gold			2022-12-26	WOS:000371219000069
J	Warren, BH; Baudin, R; Franck, A; Hugel, S; Strasberg, D				Warren, Ben H.; Baudin, Remy; Franck, Antoine; Hugel, Sylvain; Strasberg, Dominique			Predicting Where a Radiation Will Occur: Acoustic and Molecular Surveys Reveal Overlooked Diversity in Indian Ocean Island Crickets (Mogoplistinae: Ornebius)	PLOS ONE			English	Article							ADAPTIVE RADIATION; MODEL; ORTHOPTERA; SPECIATION; EVOLUTION; DIVERGENCE; GRYLLOIDEA; PHYLOGENY; IMPACT; SCALE	Recent theory suggests that the geographic location of island radiations (local accumulation of species diversity due to cladogenesis) can be predicted based on island area and isolation. Crickets are a suitable group for testing these predictions, as they show both the ability to reach some of the most isolated islands in the world, and to speciate at small spatial scales. Despite substantial song variation between closely related species in many island cricket lineages worldwide, to date this characteristic has not received attention in the western Indian Ocean islands; existing species descriptions are based on morphology alone. Here we use a combination of acoustics and DNA sequencing to survey these islands for Ornebius crickets. We uncover a small but previously unknown radiation in the Mascarenes, constituting a three-fold increase in the Ornebius species diversity of this archipelago (from two to six species). A further new species is detected in the Comoros. Although double archipelago colonisation is the best explanation for species diversity in the Seychelles, in situ cladogenesis is the best explanation for the six species in the Mascarenes and two species of the Comoros. Whether the radiation of Mascarene Ornebius results from intra-or purely inter-island speciation cannot be determined on the basis of the phylogenetic data alone. However, the existence of genetic, song and ecological divergence at the intra-island scale is suggestive of an intra-island speciation scenario in which ecological and mating traits diverge hand-in-hand. Our results suggest that the geographic location of Ornebius radiations is partially but not fully explained by island area and isolation. A notable anomaly is Madagascar, where our surveys are consistent with existing accounts in finding no Ornebius species present. Possible explanations are discussed, invoking ecological differences between species and differences in environmental history between islands.	[Warren, Ben H.; Baudin, Remy; Strasberg, Dominique] Univ La Reunion, UMR PVBMT, 7 Chemin IRAT, Ligne Paradis 97410, Reunion, France; [Warren, Ben H.] Univ Zurich, Inst Systemat Bot, Zollikerstr 107, CH-8008 Zurich, Switzerland; [Franck, Antoine] Cirad, UMR PVBMT, 7 Chemin IRAT, Ligne Paradis 97410, Reunion, France; [Hugel, Sylvain] Univ Strasbourg, UPR CNRS 3212, 5 Rue Blaise Pascal, F-67084 Strasbourg 3, France	University of La Reunion; University of Zurich; CIRAD; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Warren, BH (corresponding author), Univ La Reunion, UMR PVBMT, 7 Chemin IRAT, Ligne Paradis 97410, Reunion, France.; Warren, BH (corresponding author), Univ Zurich, Inst Systemat Bot, Zollikerstr 107, CH-8008 Zurich, Switzerland.	ben.warren@systbot.uzh.ch		Strasberg, Dominique/0000-0003-3012-252X; Hugel, Sylvain/0000-0003-2464-3601	French National Research Agency's biodiversity programme [ANR-2006-BDIV002]; European Union [263958, 267243]; Societe Entomologique de France, Cirad Reunion; Fondation pour la Recherche sur la Biodiversite	French National Research Agency's biodiversity programme(French National Research Agency (ANR)); European Union(European Commission); Societe Entomologique de France, Cirad Reunion; Fondation pour la Recherche sur la Biodiversite	This work was supported by the French National Research Agency's biodiversity programme (ANR-2006-BDIV002) and the European Union Seventh Framework Programme (263958 and 267243). Additional fieldwork was supported by the Societe Entomologique de France, Cirad Reunion, the Fondation pour la Recherche sur la Biodiversite and self-funding by SH. Apart from the latter, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], NATURAL HIST MADAGAS; Bolivar I., 1912, Transactions of the Linnean Society London, V15; Bolivar J., 1895, Annales de la Societe Entomologique de France, P369; Boughman JW, 2002, TRENDS ECOL EVOL, V17, P571, DOI 10.1016/S0169-5347(02)02595-8; Chopard L., 1957, Memoires de l'Institut Scientifique de MadagascarTananarive (E), V8, P31; Chopard L, 1958, MEMOIRES I SCI MAD E, VX, P4; Colgan DJ, 1998, AUST J ZOOL, V46, P419, DOI 10.1071/ZO98048; DESCAMPS M, 1969, ANN SOC ENTOMOL FR, V5, P537; Doebeli M, 2000, AM NAT, V156, pS77, DOI 10.1086/303417; Duncan R. A., 2009, ENCY ISLANDS, V2, P620; Eades DC, 2012, ORTHOPTERA SPECIES F; Eisenhauer A., 1999, Linnean Society Occasional Publication, V2, P21; Erixon P, 2003, SYST BIOL, V52, P665, DOI 10.1080/10635150390235485; Farris JS, 1995, CLADISTICS, V10, P315, DOI [DOI 10.1111/J.1096-0031.1994.TB00181.X, DOI 10.1111/J.1096-0031.1996.TB00196.X]; Flook PK, 1997, MOL PHYLOGENET EVOL, V8, P89, DOI 10.1006/mpev.1997.0412; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Gavrilets S, 2009, SCIENCE, V732, P1; Gavrilets S, 2009, SCIENCE, V323, P732, DOI 10.1126/science.1157966; Gillespie RG, 2010, THEORY OF ISLAND BIOGEOGRAPHY REVISITED, P358; Goodman S.M., 2014, EXTINCT MADAGASCAR P; Grace JL, 2012, CURR ZOOL, V58, P416, DOI 10.1093/czoolo/58.3.416; Grace JL, 2011, EVOLUTION, V65, P2184, DOI 10.1111/j.1558-5646.2011.01278.x; Guerin-Meneville MFE, 1844, ICONOGRAPHIE REGNE A; Heaney LR, 2000, GLOBAL ECOL BIOGEOGR, V9, P59, DOI 10.1046/j.1365-2699.2000.00163.x; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Huelsenbeck JP, 2001, SCIENCE, V294, P2310, DOI 10.1126/science.1065889; Hugel S, 2009, NEW LANDREVINAE MASC, V45; Hugel S, 2015, J INSECT CONSERV, V19, P87, DOI 10.1007/s10841-014-9746-1; Hugel S, 2012, J INSECT CONSERV, V16, P473, DOI 10.1007/s10841-012-9476-1; Ingrisch S, 2006, REV SUISSE ZOOL, V113, P133, DOI 10.5962/bhl.part.80345; Jaiswara R, 2012, ZOOL J LINN SOC-LOND, V164, P285, DOI 10.1111/j.1096-3642.2011.00769.x; Kisel Y, 2010, AM NAT, V175, P316, DOI 10.1086/650369; Lomolino M.V., 2010, BIOGEOGRAPHY, Vfourth; Losos JB, 2000, NATURE, V408, P847, DOI 10.1038/35048558; MAC ARTHUR ROBERT H., 1967; Mendelson TC, 2005, NATURE, V433, P375, DOI 10.1038/433375a; Montaggioni L., 1988, REUNION ILE MAURICE; Moore J, 2011, J VOLCANOL GEOTH RES, V207, P47, DOI 10.1016/j.jvolgeores.2011.07.005; Nattier R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048047; Nylander JAA., 2004, BIOINFORMATICS; Oneal E, 2010, J BIOGEOGR, V37, P530, DOI 10.1111/j.1365-2699.2009.02231.x; Otte D., 1983, MONOGRAPHS OF THE ACADEMY OF NATURAL SCIENCES OF PHILADELPHIA, V22, P1; Otte D., 1994, CRICKETS HAWAII ORIG; Parnaudeau Raphael, 2013, Bulletin de la Societe Entomologique de France, V118, P111; PEAKE JF, 1971, PHILOS T ROY SOC B, V260, P581, DOI 10.1098/rstb.1971.0027; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Price T, 2008, SPECIATION BIRDS; Rabosky DL, 2010, P NATL ACAD SCI USA, V107, P22178, DOI 10.1073/pnas.1007606107; Ragge D.R, 1998, SONGS GRASSHOPPERS C; Rosindell J, 2011, ECOL LETT, V14, P552, DOI 10.1111/j.1461-0248.2011.01617.x; Rundle HD, 2005, ECOL LETT, V8, P336, DOI 10.1111/j.1461-0248.2004.00715.x; Schoener TW, 2010, THEORY OF ISLAND BIOGEOGRAPHY REVISITED, P52; Shaw KL, 2000, EVOLUTION, V54, P1303, DOI 10.1111/j.0014-3820.2000.tb00563.x; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; VIETTE P, 1991, FAUNE MADAGASCAR S, V2, P1; Warren BH, 2006, MOL ECOL, V15, P3769, DOI 10.1111/j.1365-294X.2006.03058.x; Warren BH, 2015, ECOL LETT, V18, P200, DOI 10.1111/ele.12398; Warren BH, 2012, EVOLUTION, V66, P1490, DOI 10.1111/j.1558-5646.2011.01550.x; Warren BH, 2010, CLADISTICS, V26, P526, DOI 10.1111/j.1096-0031.2009.00300.x; Warren BH, 2013, BIRDS AFRICA, V8, P35; XIONG B, 1991, GENOME, V34, P306, DOI 10.1139/g91-050	61	7	7	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0148971	10.1371/journal.pone.0148971	http://dx.doi.org/10.1371/journal.pone.0148971			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26871932	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000370054100081
J	Liu, ZJ; Sneve, M; Haroldson, TA; Smith, JP; Drewes, LR				Liu, Zejian; Sneve, Mary; Haroldson, Thomas A.; Smith, Jeffrey P.; Drewes, Lester R.			Regulation of Monocarboxylic Acid Transporter 1 Trafficking by the Canonical Wnt/-Catenin Pathway in Rat Brain Endothelial Cells Requires Cross-talk with Notch Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						endocytosis; gene regulation; Notch pathway; ubiquitylation (ubiquitination); Wnt pathway; monocarboxylic acid transporter; RBE4; SLC16A1; blood-brain barrier; cross-talk	COLORECTAL-CANCER; COLON-CANCER; TARGET; EXPRESSION; GLUCOSE; PROTEIN; MOTIF; ACTIVATION; MECHANISMS; BARRIER	The transport of monocarboxylate fuels such as lactate, pyruvate, and ketone bodies across brain endothelial cells is mediated by monocarboxylic acid transporter 1 (MCT1). Although the canonical Wnt/-catenin pathway is required for rodent blood-brain barrier development and for the expression of associated nutrient transporters, the role of this pathway in the regulation of brain endothelial MCT1 is unknown. Here we report expression of nine members of the frizzled receptor family by the RBE4 rat brain endothelial cell line. Furthermore, activation of the canonical Wnt/-catenin pathway in RBE4 cells via nuclear -catenin signaling with LiCl does not alter brain endothelial Mct1 mRNA but increases the amount of MCT1 transporter protein. Plasma membrane biotinylation studies and confocal microscopic examination of mCherry-tagged MCT1 indicate that increased transporter results from reduced MCT1 trafficking from the plasma membrane via the endosomal/lysosomal pathway and is facilitated by decreased MCT1 ubiquitination following LiCl treatment. Inhibition of the Notch pathway by the -secretase inhibitor N-[N-(3,5-difluorophenacetyl)-l-alanyl]-S-phenylglycine t-butyl ester negated the up-regulation of MCT1 by LiCl, demonstrating a cross-talk between the canonical Wnt/-catenin and Notch pathways. Our results are important because they show, for the first time, the regulation of MCT1 in cerebrovascular endothelial cells by the multifunctional canonical Wnt/-catenin and Notch signaling pathways.	[Liu, Zejian; Sneve, Mary; Haroldson, Thomas A.; Drewes, Lester R.] Univ Minnesota, Med Sch Duluth, Dept Biomed Sci, Duluth, MN 55812 USA; [Smith, Jeffrey P.] Colorado State Univ, Dept Biol, Pueblo, CO 81001 USA	University of Minnesota System; University of Minnesota Duluth; Colorado State University	Liu, ZJ (corresponding author), Yale Univ, Sch Med, Endocrinol Sect, Dept Internal Med, 300 Cedar St, New Haven, CT 06519 USA.; Drewes, LR (corresponding author), Univ Minnesota, Dept Biomed Sci, 1035 Univ Dr, Duluth, MN 55812 USA.	zejian.liu@yale.edu; ldrewes@d.umn.edu	Drewes, Lester R/X-9794-2018	Drewes, Lester R/0000-0002-7440-0387	American Heart Association [0855638G]; NINDS/National Institute of Health [1R15NS062404-01A2]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R15NS062404] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); NINDS/National Institute of Health; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by American Heart Association Grant 0855638G (to L. R. D.) and NINDS/National Institute of Health Grant 1R15NS062404-01A2 (to J. P. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams J, 2004, NAT REV CANCER, V4, P349, DOI 10.1038/nrc1361; Alwan HAJ, 2003, J BIOL CHEM, V278, P35781, DOI 10.1074/jbc.M301326200; Andrews MT, 2009, AM J PHYSIOL-REG I, V296, pR383, DOI 10.1152/ajpregu.90795.2008; Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; Ayyanan A, 2006, P NATL ACAD SCI USA, V103, P3799, DOI 10.1073/pnas.0600065103; Barker Nick, 2008, V468, P5, DOI 10.1007/978-1-59745-249-6_1; Becker HM, 2010, AM J PHYSIOL-RENAL, V299, pF141, DOI 10.1152/ajprenal.00488.2009; Bialer M, 2007, NEUROTHERAPEUTICS, V4, P130, DOI 10.1016/j.nurt.2006.11.007; Birsoy K, 2013, NAT GENET, V45, P104, DOI 10.1038/ng.2471; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Camps J, 2013, CANCER RES, V73, P2003, DOI 10.1158/0008-5472.CAN-12-3159; Chalamalasetty RB, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1381; Chenal J, 2007, J NEUROCHEM, V102, P389, DOI 10.1111/j.1471-4159.2007.04495.x; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Coon AL, 2006, AM J NEURORADIOL, V27, P1053; Corada M, 2010, DEV CELL, V18, P938, DOI 10.1016/j.devcel.2010.05.006; CORVERA S, 1994, J CELL BIOL, V126, P979, DOI 10.1083/jcb.126.4.979; Cuff M, 2005, GASTROENTEROLOGY, V128, P676, DOI 10.1053/j.gastro.2004.12.003; Daneman R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013741; De Giorgis V, 2013, SEIZURE-EUR J EPILEP, V22, P803, DOI 10.1016/j.seizure.2013.07.003; DEVIVO DC, 1991, NEW ENGL J MED, V325, P703, DOI 10.1056/NEJM199109053251006; Doherty JR, 2013, J CLIN INVEST, V123, P3685, DOI 10.1172/JCI69741; Dong YF, 2010, DEVELOPMENT, V137, P1461, DOI 10.1242/dev.042911; Duarte A, 2004, GENE DEV, V18, P2474, DOI 10.1101/gad.1239004; Freeman J, 2006, EPILEPSY RES, V68, P145, DOI 10.1016/j.eplepsyres.2005.10.003; Frykholm P, 2005, J NEUROSURG, V102, P1076, DOI 10.3171/jns.2005.102.6.1076; Gale NW, 2004, P NATL ACAD SCI USA, V101, P15949, DOI 10.1073/pnas.0407290101; Gerhart DZ, 1997, AM J PHYSIOL-ENDOC M, V273, pE207, DOI 10.1152/ajpendo.1997.273.1.E207; Guruharsha KG, 2012, NAT REV GENET, V13, P654, DOI 10.1038/nrg3272; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Hovanes K, 2001, NAT GENET, V28, P53, DOI 10.1038/88264; Inoki K, 2006, CELL, V126, P955, DOI 10.1016/j.cell.2006.06.055; Jope RS, 2003, TRENDS PHARMACOL SCI, V24, P441, DOI 10.1016/S0165-6147(03)00206-2; Kim HA, 2012, J CLIN INVEST, V122, P3248, DOI 10.1172/JCI61216; Kimelman D, 2006, ONCOGENE, V25, P7482, DOI 10.1038/sj.onc.1210055; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Krebs LT, 2000, GENE DEV, V14, P1343; Kwon C, 2011, NAT CELL BIOL, V13, P1244, DOI 10.1038/ncb2313; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; Lee YJ, 2012, NATURE, V487, P443, DOI 10.1038/nature11314; Li CY, 2011, J CANCER RES CLIN, V137, P771, DOI 10.1007/s00432-010-0934-4; Liebner S, 2008, J CELL BIOL, V183, P409, DOI 10.1083/jcb.200806024; Lim JC, 2008, J NEUROCHEM, V106, P1855, DOI 10.1111/j.1471-4159.2008.05537.x; Lu C, 2007, TRAFFIC, V8, P1246, DOI 10.1111/j.1600-0854.2007.00602.x; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Maier MM, 2000, BIOCHEM BIOPH RES CO, V275, P652, DOI 10.1006/bbrc.2000.3354; Marks MS, 1996, J CELL BIOL, V135, P341, DOI 10.1083/jcb.135.2.341; Matson Christian T, 2003, Methods Mol Med, V89, P479; McCullagh KJA, 1996, AM J PHYSIOL-ENDOC M, V271, pE143, DOI 10.1152/ajpendo.1996.271.1.E143; Mellman I, 1996, ANNU REV CELL DEV BI, V12, P575, DOI 10.1146/annurev.cellbio.12.1.575; Miller JR, 1999, J CELL BIOL, V146, P427, DOI 10.1083/jcb.146.2.427; Murray CM, 2005, NAT CHEM BIOL, V1, P371, DOI 10.1038/nchembio744; NEHLIG A, 1993, PROG NEUROBIOL, V40, P163, DOI 10.1016/0301-0082(93)90022-K; Panhuysen M, 2004, MOL CELL NEUROSCI, V26, P101, DOI 10.1016/j.mcn.2004.01.011; Park CH, 2005, BIOCHEM BIOPH RES CO, V328, P227, DOI 10.1016/j.bbrc.2004.12.151; Peignon G, 2011, GUT, V60, P166, DOI 10.1136/gut.2009.204719; Phng LK, 2009, DEV CELL, V16, P196, DOI 10.1016/j.devcel.2009.01.015; Piper RC, 2011, TRENDS CELL BIOL, V21, P647, DOI 10.1016/j.tcb.2011.08.007; Polakis P, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008052; Reis M, 2012, J EXP MED, V209, P1611, DOI 10.1084/jem.20111580; Rodilla V, 2009, P NATL ACAD SCI USA, V106, P6315, DOI 10.1073/pnas.0813221106; Roux F, 2005, CELL MOL NEUROBIOL, V25, P41, DOI 10.1007/s10571-004-1376-9; ROUX F, 1994, J CELL PHYSIOL, V159, P101, DOI 10.1002/jcp.1041590114; Saeki Y, 2008, NATURE, V453, P460, DOI 10.1038/453460a; Shewan AM, 2000, BIOCHEM J, V350, P99, DOI 10.1042/0264-6021:3500099; Shtutman M, 1999, P NATL ACAD SCI USA, V96, P5522, DOI 10.1073/pnas.96.10.5522; Smith JK, 2012, PSYCHOL AESTHET CREA, V6, P1, DOI 10.1037/a0027241; Smith JP, 2006, J BIOL CHEM, V281, P2053, DOI 10.1074/jbc.M511577200; Stenman JM, 2008, SCIENCE, V322, P1247, DOI 10.1126/science.1164594; Storch S, 2004, J BIOL CHEM, V279, P53625, DOI 10.1074/jbc.M410930200; Suzuki A, 2011, CELL, V144, P810, DOI 10.1016/j.cell.2011.02.018; Tsai A, 2006, NAT PROTOC, V1, P2820, DOI 10.1038/nprot.2006.371; Uhernik AL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085957; Vannucci SJ, 2003, AM J PHYSIOL-ENDOC M, V285, pE1127, DOI 10.1152/ajpendo.00187.2003; Xia S, 2008, P NATL ACAD SCI USA, V105, P5609, DOI 10.1073/pnas.0801456105	75	18	18	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2016	291	15					8059	8069		10.1074/jbc.M115.710277	http://dx.doi.org/10.1074/jbc.M115.710277			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DJ2SZ	26872974	hybrid, Green Published			2022-12-26	WOS:000374056700025
J	Chen, PW; Jian, XY; Heissler, SM; Le, K; Luo, RH; Jenkins, LM; Nagy, A; Moss, J; Sellers, JR; Randazzo, PA				Chen, Pei-Wen; Jian, Xiaoying; Heissler, Sarah M.; Le, Kang; Luo, Ruibai; Jenkins, Lisa M.; Nagy, Attila; Moss, Joel; Sellers, James R.; Randazzo, Paul A.			The Arf GTPase-activating Protein, ASAP1, Binds Nonmuscle Myosin 2A to Control Remodeling of the Actomyosin Network	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CIRCULAR DORSAL RUFFLES; ACTIN CYTOSKELETON; CELL-MIGRATION; ANIONIC PHOSPHOLIPIDS; FOCAL ADHESIONS; PHOSPHORYLATION; DOMAIN; ASSOCIATION; EXPRESSION; PODOSOMES	ASAP1 regulates F-actin-based structures and functions, including focal adhesions (FAs) and circular dorsal ruffles (CDRs), cell spreading and migration. ASAP1 function requires its N-terminal BAR domain. We discovered that nonmuscle myosin 2A (NM2A) directly bound the BAR-PH tandem of ASAP1 in vitro. ASAP1 and NM2A co-immunoprecipitated and colocalized in cells. Knockdown of ASAP1 reduced colocalization of NM2A and F-actin in cells. Knockdown of ASAP1 or NM2A recapitulated each other's effects on FAs, cell migration, cell spreading, and CDRs. The NM2A-interacting BAR domain contributed to ASAP1 control of cell spreading and CDRs. Exogenous expression of NM2A rescued the effect of ASAP1 knockdown on CDRs but ASAP1 did not rescue NM2A knockdown defect in CDRs. Our results support the hypothesis that ASAP1 is a positive regulator of NM2A. Given other binding partners of ASAP1, ASAP1 may directly link signaling and the mechanical machinery of cell migration.	[Chen, Pei-Wen; Jian, Xiaoying; Luo, Ruibai; Randazzo, Paul A.] NCI, Lab Cellular & Mol Biol, Bethesda, MD 20892 USA; [Jenkins, Lisa M.] NCI, Cell Biol Lab, Bethesda, MD 20892 USA; [Heissler, Sarah M.; Nagy, Attila; Sellers, James R.] NHLBI, Lab Mol Physiol, NIH, Bldg 10, Bethesda, MD 20892 USA; [Le, Kang; Moss, Joel] NHLBI, Cardiovasc & Pulm Branch, NIH, Bldg 10, Bethesda, MD 20892 USA; [Chen, Pei-Wen] Grinnell Coll, Dept Biol, Grinnell, IA 50112 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Randazzo, PA (corresponding author), NCI, Lab Cellular & Mol Biol, Bethesda, MD 20892 USA.	randazzp@mail.nih.gov	Jenkins, Lisa/AAI-2490-2021		NCI, National Institutes of Health [BC 007365]; NHLBI, National Institutes of Health; NATIONAL CANCER INSTITUTE [ZICBC011430, Z01BC007365] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL000627, ZIAHL001786, ZIAHL000659] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the intramural program of the NCI, National Institutes of Health (to P. W. C., X. J., R. L., and P. R., Project BC 007365) and NHLBI, National Institutes of Health (to K. L., J. M., A. N., S. H., and J. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Bharti S, 2007, MOL CELL BIOL, V27, P8271, DOI 10.1128/MCB.01781-06; Buccione R, 2004, NAT REV MOL CELL BIO, V5, P647, DOI 10.1038/nrm1436; Cai YF, 2010, J CELL SCI, V123, P413, DOI 10.1242/jcs.058297; Campellone KG, 2010, NAT REV MOL CELL BIO, V11, P237, DOI 10.1038/nrm2867; Chen PW, 2013, J BIOL CHEM, V288, P5849, DOI 10.1074/jbc.M112.415778; Chen PW, 2010, CELL ADHES MIGR, V4, P527, DOI 10.4161/cam.4.4.12399; Chen P, 2012, INORG CHEM COMMUN, V17, P17, DOI 10.1016/j.inoche.2011.12.005; Choi CK, 2008, NAT CELL BIOL, V10, P1039, DOI 10.1038/ncb1763; DANIEL JL, 1992, METHOD ENZYMOL, V215, P78; Doyle AD, 2012, J CELL SCI, V125, P2244, DOI 10.1242/jcs.098806; Gorelik R, 2014, NAT PROTOC, V9, P1931, DOI 10.1038/nprot.2014.131; Gu ZZ, 2011, J CELL BIOL, V193, P61, DOI 10.1083/jcb.201007003; Hoon JL, 2012, MOL CELL BIOL, V32, P4246, DOI 10.1128/MCB.00551-12; Inoue H, 2007, TRAFFIC, V8, P1465, DOI 10.1111/j.1600-0854.2007.00624.x; Itoh T, 2013, J BIOCHEM, V153, P21, DOI 10.1093/jb/mvs138; Jian XY, 2015, STRUCTURE, V23, P1977, DOI 10.1016/j.str.2015.08.008; Jian XY, 2009, J BIOL CHEM, V284, P1652, DOI 10.1074/jbc.M804218200; Kahn RA, 2008, J CELL BIOL, V182, P1039, DOI 10.1083/jcb.200806041; Kam JL, 2000, J BIOL CHEM, V275, P9653, DOI 10.1074/jbc.275.13.9653; LI DQ, 1994, P NATL ACAD SCI USA, V91, P853, DOI 10.1073/pnas.91.3.853; Liu YH, 2005, J BIOL CHEM, V280, P8884, DOI 10.1074/jbc.M412200200; Liu YH, 2002, MOL BIOL CELL, V13, P2147, DOI 10.1091/mbc.E02-01-0018; Myers KR, 2008, TRENDS CELL BIOL, V18, P184, DOI 10.1016/j.tcb.2008.02.002; Nishiya N, 2005, NAT CELL BIOL, V7, P343, DOI 10.1038/ncb1234; Oda A, 2003, J BIOL CHEM, V278, P6456, DOI 10.1074/jbc.M210817200; Onodera Y, 2005, EMBO J, V24, P963, DOI 10.1038/sj.emboj.7600588; Orth JD, 2006, CANCER RES, V66, P11094, DOI 10.1158/0008-5472.CAN-06-3397; Pasapera AM, 2010, J CELL BIOL, V188, P877, DOI 10.1083/jcb.200906012; Randazzo PA, 2000, P NATL ACAD SCI USA, V97, P4011, DOI 10.1073/pnas.070552297; Randazzo PA, 2007, BIOL CELL, V99, P583, DOI 10.1042/BC20070034; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Vicente-Manzanares M, 2009, NAT REV MOL CELL BIO, V10, P778, DOI 10.1038/nrm2786	32	18	19	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2016	291	14					7517	7526		10.1074/jbc.M115.701292	http://dx.doi.org/10.1074/jbc.M115.701292			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DW2BJ	26893376	Green Published, hybrid			2022-12-26	WOS:000383447600026
J	Laura, RP; Dong, D; Reynolds, WF; Maki, RA				Laura, Richard P.; Dong, David; Reynolds, Wanda F.; Maki, Richard A.			T47D Cells Expressing Myeloperoxidase Are Able to Process, Traffic and Store the Mature Protein in Lysosomes: Studies in T47D Cells Reveal a Role for Cys(319) in MPO Biosynthesis that Precedes Its Known Role in Inter-Molecular Disulfide Bond Formation	PLOS ONE			English	Article							MANNOSE 6-PHOSPHATE RECEPTOR; HUMAN EOSINOPHIL PEROXIDASE; RAY CRYSTAL-STRUCTURE; HYDROGEN-PEROXIDE; ANGSTROM RESOLUTION; CARBOXYPEPTIDASE E; PRECURSOR; FORMS; PROPEPTIDE; GRANULES	Among the human heme-peroxidase family, myeloperoxidase (MPO) has a unique disulfide-linked oligomeric structure resulting from multi-step processing of the pro-protein monomer (proMPO) after it exits the endoplasmic reticulum (ER). Related family members undergo some, but not all, of the processing steps involved with formation of mature MPO. Lactoperoxidase has its pro-domain proteolytically removed and is a monomer in its mature form. Eosinophil peroxidase undergoes proteolytic removal of its pro-domain followed by proteolytic separation into heavy and light chains and is a heterodimer. However, only MPO undergoes both these proteolytic modifications and then is further oligomerized into a heterotetramer by a single inter-molecular disulfide bond. The details of how and where the post-ER processing steps of MPO occur are incompletely understood. We report here that T47D breast cancer cells stably transfected with an MPO expression plasmid are able to efficiently replicate all of the processing steps that lead to formation of the mature MPO heterotetramer. MPO also traffics to the lysosome granules of T47D cells where it accumulates, allowing in-depth immunofluorescent microscopy studies of MPO trafficking and storage for the first time. Using this novel cell model we show that formation of MPO's single inter-molecular disulfide bond can occur normally in the absence of the proteolytic events that lead to separation of the MPO heavy and light chains. We further demonstrate that Cys(319), which forms MPO's unique inter-molecular disulfide bond, is important for events that precede this step. Mutation of this residue alters the glycosylation and catalytic activity of MPO and blocks its entry into the endocytic pathway where proteolytic processing and disulfide bonding occur. Finally, using the endocytic trafficking of lysosomal hydrolases as a guide, we investigate the role of candidate receptors in the endocytic trafficking of MPO.	[Laura, Richard P.; Maki, Richard A.] Torrey Pines Pharmaceut, Del Mar, CA USA; [Dong, David; Reynolds, Wanda F.; Maki, Richard A.] Sanford Burnham Prebys Med Discovery Inst, La Jolla, CA USA	Sanford Burnham Prebys Medical Discovery Institute	Maki, RA (corresponding author), Torrey Pines Pharmaceut, Del Mar, CA USA.; Maki, RA (corresponding author), Sanford Burnham Prebys Med Discovery Inst, La Jolla, CA USA.	rmaki@sbpdiscovery.org		Dong, David/0000-0003-0192-307X	NIH [RO1 HL088428, RO1-AG017879, RO1-NS074303, RO1-AG040623, R43 HL095251, R43 AG040935]; Sanford-Burnham-Prebys Medical Discovery Institute; Torrey Pines Pharmaceuticals; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088428, R43HL095251] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS074303] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG017879, R43AG040935] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sanford-Burnham-Prebys Medical Discovery Institute; Torrey Pines Pharmaceuticals; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported in part by the NIH (RO1 HL088428, RO1-AG017879, and RO1-NS074303, RO1-AG040623 to WFR and R43 HL095251 and R43 AG040935 to RAM). Additional funds to support this study have been generously provided by Sanford-Burnham-Prebys Medical Discovery Institute. The funder (Torrey Pines Pharmaceuticals) provided support in the form of salaries for authors RPL and RAM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	AKIN DT, 1986, J BIOL CHEM, V261, P8370; Andersson E, 1998, J BIOL CHEM, V273, P4747, DOI 10.1074/jbc.273.8.4747; Arnaoutova I, 2003, BIOCHEMISTRY-US, V42, P10445, DOI 10.1021/bi034277y; BAINTON DF, 1988, EXP HEMATOL, V16, P150; Borregaard N, 2007, TRENDS IMMUNOL, V28, P340, DOI 10.1016/j.it.2007.06.002; Braulke T, 2009, BBA-MOL CELL RES, V1793, P605, DOI 10.1016/j.bbamcr.2008.10.016; Bulow E, 2002, J LEUKOCYTE BIOL, V71, P279; CULLY J, 1989, EXP CELL RES, V180, P440, DOI 10.1016/0014-4827(89)90070-0; Dahms NM, 2002, BBA-GEN SUBJECTS, V1572, P317, DOI 10.1016/S0304-4165(02)00317-3; Dell'Angelica EC, 2000, FASEB J, V14, P1265, DOI 10.1096/fj.14.10.1265; Dhanvantari S, 2000, J BIOL CHEM, V275, P29887, DOI 10.1074/jbc.M005364200; Fiedler TJ, 2000, J BIOL CHEM, V275, P11964, DOI 10.1074/jbc.275.16.11964; Fomenko DE, 2003, ANTIOXID REDOX SIGN, V5, P397, DOI 10.1089/152308603768295131; Franck T, 2015, FREE RADICAL RES, V49, P790, DOI 10.3109/10715762.2015.1027197; Furtmuller PG, 2006, ARCH BIOCHEM BIOPHYS, V445, P199, DOI 10.1016/j.abb.2005.09.017; Goedken M, 2007, J BIOL CHEM, V282, P27994, DOI 10.1074/jbc.M701984200; Hansson M, 2006, ARCH BIOCHEM BIOPHYS, V445, P214, DOI 10.1016/j.abb.2005.08.009; HASILIK A, 1984, EMBO J, V3, P2671, DOI 10.1002/j.1460-2075.1984.tb02192.x; Herskowitz JH, 2012, MOL BIOL CELL, V23, P2645, DOI 10.1091/mbc.E12-01-0014; Hope HR, 2000, PROTEIN EXPRES PURIF, V18, P269, DOI 10.1006/prep.1999.1197; HUR SJ, 1989, J BIOL CHEM, V264, P8542; Jacob KD, 2013, MECH AGEING DEV, V134, P139, DOI 10.1016/j.mad.2013.02.008; Jadot M, 1999, J BIOL CHEM, V274, P21104, DOI 10.1074/jbc.274.30.21104; Kallquist L, 2008, BLOOD, V112, P3444, DOI 10.1182/blood-2007-10-116285; Kao J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006146; Makrypidi G, 2012, MOL CELL BIOL, V32, P774, DOI 10.1128/MCB.06195-11; McCormick S, 2012, ARCH BIOCHEM BIOPHYS, V527, P31, DOI 10.1016/j.abb.2012.07.013; McGirr R, 2013, J ENDOCRINOL, V217, P229, DOI 10.1530/JOE-12-0468; MESSNER DJ, 1993, ARCH BIOCHEM BIOPHYS, V306, P391, DOI 10.1006/abbi.1993.1528; Miller EW, 2010, P NATL ACAD SCI USA, V107, P15681, DOI 10.1073/pnas.1005776107; Mullerr-Loennies S, 2010, AM J PATHOL, V177, P240, DOI 10.2353/ajpath.2010.090954; Nauseef WM, 1996, J BIOL CHEM, V271, P9546, DOI 10.1074/jbc.271.16.9546; NAUSEEF WM, 1992, BLOOD, V80, P2622; Nielsen MS, 2007, MOL CELL BIOL, V27, P6842, DOI 10.1128/MCB.00815-07; OLSEN RL, 1986, BIOCHEM J, V237, P559, DOI 10.1042/bj2370559; Oxvig C, 1999, J BIOL CHEM, V274, P16953, DOI 10.1074/jbc.274.24.16953; Pallesen LT, 2012, MOL NEUROBIOL, V45, P379, DOI 10.1007/s12035-012-8236-2; Paumann-Page M, 2013, ARCH BIOCHEM BIOPHYS, V539, P51, DOI 10.1016/j.abb.2013.09.004; PEMBER SO, 1983, ARCH BIOCHEM BIOPHYS, V221, P391, DOI 10.1016/0003-9861(83)90158-3; Probst OC, 2006, J CELL SCI, V119, P4935, DOI 10.1242/jcs.03283; Puissant E, 2014, TRAFFIC, V15, P500, DOI 10.1111/tra.12162; Purvis AR, 2007, P NATL ACAD SCI USA, V104, P15647, DOI 10.1073/pnas.0705175104; Purvis AR, 2004, J BIOL CHEM, V279, P49982, DOI 10.1074/jbc.M408727200; Qian MQ, 2008, MOL CELL PROTEOMICS, V7, P58, DOI 10.1074/mcp.M700217-MCP200; Ravnsborg T, 2010, BBA-PROTEINS PROTEOM, V1804, P2046, DOI 10.1016/j.bbapap.2010.07.001; Reinhold WC, 2012, CANCER RES, V72, P3499, DOI 10.1158/0008-5472.CAN-12-1370; Shankavaram UT, 2007, MOL CANCER THER, V6, P820, DOI 10.1158/1535-7163.MCT-06-0650; Shishehbor Mehdi H, 2004, Curr Atheroscler Rep, V6, P243, DOI 10.1007/s11883-004-0038-1; Singh AK, 2009, BIOPHYS J, V96, P646, DOI 10.1016/j.bpj.2008.09.019; SLEAT DE, 1995, CANCER RES, V55, P3424; STROMBERG K, 1986, EUR J CELL BIOL, V39, P424; Sun PL, 2008, P NATL ACAD SCI USA, V105, P16590, DOI 10.1073/pnas.0807472105; Takeuchi N, 2003, J BIOL CHEM, V278, P45318, DOI 10.1074/jbc.M307620200; Thomsen AR, 2000, ARCH BIOCHEM BIOPHYS, V379, P147, DOI 10.1006/abbi.2000.1866; VALENZANO KJ, 1995, J BIOL CHEM, V270, P16441, DOI 10.1074/jbc.270.27.16441; Van Antwerpen P, 2010, J BIOL CHEM, V285, P16351, DOI 10.1074/jbc.M109.089748; Veal EA, 2007, MOL CELL, V26, P1, DOI 10.1016/j.molcel.2007.03.016; ZENG J, 1992, J MOL BIOL, V226, P185, DOI 10.1016/0022-2836(92)90133-5	58	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2016	11	2							e0149391	10.1371/journal.pone.0149391	http://dx.doi.org/10.1371/journal.pone.0149391			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3CO	26890638	Green Published, Green Submitted, gold			2022-12-26	WOS:000371221500041
J	Shimizu, H; Arimura, Y; Onodera, K; Takahashi, H; Okahara, S; Kodaira, J; Oohashi, H; Isshiki, H; Kawakami, K; Yamashita, K; Shinomura, Y; Hosokawa, M				Shimizu, Haruo; Arimura, Yoshiaki; Onodera, Kei; Takahashi, Hiroaki; Okahara, Satoshi; Kodaira, Junichi; Oohashi, Hirokazu; Isshiki, Hiroyuki; Kawakami, Kentaro; Yamashita, Kentaro; Shinomura, Yasuhisa; Hosokawa, Masao			Malignant Potential of Gastrointestinal Cancers Assessed by Structural Equation Modeling	PLOS ONE			English	Article								Background Parameters reported in pathologic reviews have been failing to assess exactly the malignant potential of gastrointestinal cancers. We hypothesized that malignant potential could be defined by common latent variables (hypothesis I), but there are substantial differences in the associations between malignant potential and pathologic parameters according to the origin of gastrointestinal cancers (hypothesis II). We shed light on these issues by structural equation modeling. Materials and Methods We conducted a cross-sectional survey of 217 esophageal, 192 gastric, and 175 colorectal cancer patients who consecutively underwent curative surgery for their pathologic stage I cancers at Keiyukai Sapporo Hospital. Latent variables identified by factor analysis and seven conventional pathologic parameters were introduced in the structural equation modeling analysis. Results Because latent variables were disparate except for their number, 'three' in the examined gastrointestinal cancers, the first hypothesis was rejected. Because configural invariance across gastrointestinal cancers was not approved, the second hypothesis was verified. We could trace the three significant paths on the causal graph from latent variables to lymph node metastasis, which were mediated through depth, lymphatic invasion, and matrilysin expression in esophageal cancer, whereas only one significant path could be traced in both gastric and colorectal cancer. Two of the three latent variables were exogenous in esophageal cancer, whereas one factor was exogenous in the other gastrointestinal cancers. Cancer stemness promoted viability in esophageal cancer, but it was suppressed in others. Conclusion These results reflect the malignant potential of esophageal cancer is higher than that of the other gastrointestinal cancers. Such information might contribute to refining clinical treatments for gastrointestinal cancers.	[Shimizu, Haruo; Arimura, Yoshiaki; Onodera, Kei; Isshiki, Hiroyuki; Kawakami, Kentaro; Yamashita, Kentaro; Shinomura, Yasuhisa] Sapporo Med Univ, Dept Gastroenterol Rheumatol & Clin Immunol, Sapporo, Hokkaido, Japan; [Takahashi, Hiroaki; Okahara, Satoshi; Kodaira, Junichi; Oohashi, Hirokazu] Keiyukai Daini Hosp, Dept Gastroenterol, Sapporo, Hokkaido, Japan; [Hosokawa, Masao] Keiyukai Hosp, Dept Surg, Sapporo, Hokkaido, Japan; [Shinomura, Yasuhisa] Ikeda Municipal Hosp, Dept Gastroenterol, Osaka, Japan	Sapporo Medical University	Arimura, Y (corresponding author), Sapporo Med Univ, Dept Gastroenterol Rheumatol & Clin Immunol, Sapporo, Hokkaido, Japan.	arimura@sapmed.ac.jp			Grants-in-Aid for Scientific Research [25460954] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Ajani J, 2015, GASTRIC CANC; Al B, 2015, RECTAL CANC; Al B, 2015, COLON CANC; Ancona E, 2008, ANN SURG ONCOL, V15, P3278, DOI 10.1245/s10434-008-0065-1; Bentler PM, 2008, EQS 6 1 WINDOWS USER, P1; Bollen K. A., 1993, TESTING STRUCTURAL E; Bollen KA, 2011, P NATL ACAD SCI USA, V108, P15639, DOI 10.1073/pnas.1010661108; Bryan A, 2007, AIDS BEHAV, V11, P365, DOI 10.1007/s10461-006-9150-2; BUSE A, 1982, AM STAT, V36, P153, DOI 10.2307/2683166; Bou JC, 2010, ORGAN RES METHODS, V13, P738, DOI 10.1177/1094428109340433; Dean J., 2009, JALT TESTING EVALUAT, V13, P20; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P101, DOI 10.1007/s10120-011-0041-5; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P113, DOI 10.1007/s10120-011-0042-4; Japanese Society for Cancer of the Colon and Rectum, 2009, JAP CLASS COL CARC; Joreskog K. G., 1970, ETS RES B SER, V1970, P1, DOI DOI 10.1002/J.2333-8504.1970.TB00783.X; Kurokawa S, 2005, GUT, V54, P1751, DOI 10.1136/gut.2005.071035; Liefers GJ, 1998, NEW ENGL J MED, V339, P223, DOI 10.1056/NEJM199807233390403; Pennathur A, 2009, ANN THORAC SURG, V87, P1048, DOI 10.1016/j.athoracsur.2008.12.060; Preacher KJ, 2006, POWER SAMPLE SIZE US; Sobin L, 2009, TNM CLASSIFICATION M; Takubo K, 2009, ESOPHAGUS-TOKYO, V6, P1, DOI 10.1007/s10388-009-0169-0; Ueno H, 2004, GASTROENTEROLOGY, V127, P385, DOI 10.1053/j.gastro.2004.04.022; Wu, 2007, ED MEASUREMENT ISSUE, V26, P33, DOI DOI 10.1111/J.1745-3992.2007.00099.X	25	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2016	11	2							e0149327	10.1371/journal.pone.0149327	http://dx.doi.org/10.1371/journal.pone.0149327			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3CO	26889682	Green Submitted, Green Published, gold			2022-12-26	WOS:000371221500034
J	Caselli, E; D'Accolti, M; Vandini, A; Lanzoni, L; Camerada, MT; Coccagna, M; Branchini, A; Antonioli, P; Balboni, PG; Di Luca, D; Mazzacane, S				Caselli, Elisabetta; D'Accolti, Maria; Vandini, Alberta; Lanzoni, Luca; Camerada, Maria Teresa; Coccagna, Maddalena; Branchini, Alessio; Antonioli, Paola; Balboni, Pier Giorgio; Di Luca, Dario; Mazzacane, Sante			Impact of a Probiotic-Based Cleaning Intervention on the Microbiota Ecosystem of the Hospital Surfaces: Focus on the Resistome Remodulation	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; ENVIRONMENTAL CONTAMINATION; CLOSTRIDIUM-DIFFICILE; INFECTION PREVENTION; WASTE-WATER; TRANSMISSION; DISINFECTION; PATHOGENS; PCR; ENTEROCOCCI	Background Contamination of hospital surfaces by clinically-relevant pathogens represents a major concern in healthcare facilities, due to its impact on transmission of healthcare-associated infections (HAIs) and to the growing drug resistance of HAI-associated pathogens. Routinely used chemical disinfectants show limitations in controlling pathogen contamination, due to their inefficacy in preventing recontamination and selection of resistant strains. Recently we observed that an innovative approach, based on a cleanser added with spores of non-pathogenic probiotic Bacilli, was effective in stably counteracting the growth of several pathogens contaminating hospital surfaces. Methods Here, we wanted to study the impact of the Bacillus-based cleanser on the drug-resistance features of the healthcare pathogens population. In parallel, the ability of cleanser-derived Bacilli to infect hospitalized patients was also investigated. Results Collected data showed that Bacilli spores can germinate on dry inanimate surfaces, generating the bacterial vegetative forms which counteract the growth of pathogens and effectively substitute for them on treated surfaces. Strikingly, this procedure did not select resistant species, but conversely induced an evident decrease of antibiotic resistance genes in the contaminating microbial population. Also importantly, all the six HAI-positive patients hosted in the treated areas resulted negative for probiotic Bacilli, thus adding evidences to their safety-to-use. Conclusions These results indicate that this probiotic-based procedure is active not only in controlling surface microbial contamination but also in lowering drug-resistant species, suggesting that it may have relevant clinical and therapeutical implications for the management of HAIs.	[Caselli, Elisabetta; D'Accolti, Maria; Di Luca, Dario] Univ Ferrara, Dept Med Sci, Sect Microbiol & Med Genet, I-44100 Ferrara, Italy; [Caselli, Elisabetta; D'Accolti, Maria; Vandini, Alberta; Lanzoni, Luca; Camerada, Maria Teresa; Coccagna, Maddalena; Balboni, Pier Giorgio; Di Luca, Dario; Mazzacane, Sante] Univ Ferrara, CIAS Interdept Res Ctr Pollut Control High Steril, I-44100 Ferrara, Italy; [Branchini, Alessio] Univ Ferrara, Dept Life Sci & Biotechnol, Sect Biochem & Mol Biol, I-44100 Ferrara, Italy; [Antonioli, Paola] S Anna Univ Hosp, Dept Infect Prevent Control & Risk Management, Ferrara, Italy; [Vandini, Alberta; Camerada, Maria Teresa] Univ Ferrara, Dept Architecture, Architecture & Urban Planning Cycle 30, I-44100 Ferrara, Italy	University of Ferrara; University of Ferrara; University of Ferrara; University of Ferrara; Arcispedale Sant'Anna; University of Ferrara	Caselli, E (corresponding author), Univ Ferrara, Dept Med Sci, Sect Microbiol & Med Genet, I-44100 Ferrara, Italy.; Caselli, E (corresponding author), Univ Ferrara, CIAS Interdept Res Ctr Pollut Control High Steril, I-44100 Ferrara, Italy.	elisabetta.caselli@unife.it	Elisabetta, Caselli/H-1513-2012; Branchini, Alessio/H-8636-2019; antonioli, paola/M-8975-2016	Elisabetta, Caselli/0000-0001-6048-9141; Branchini, Alessio/0000-0002-6113-2694; antonioli, paola/0000-0002-1257-3434; Coccagna, Maddalena/0000-0003-0447-1363; D'Accolti, Maria/0000-0003-1937-5534	COPMA scrl (Ferrara, Italy)	COPMA scrl (Ferrara, Italy)	This study was financially supported by COPMA scrl (Ferrara, Italy). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allegranzi B, 2011, LANCET, V377, P228, DOI 10.1016/S0140-6736(10)61458-4; [Anonymous], 2013, POINT PREVALENCE SUR; BAUER AW, 1966, AM J CLIN PATHOL, V45, P493; Boyce JM, 2007, J HOSP INFECT, V65, P50, DOI 10.1016/S0195-6701(07)60015-2; Boyce JM, 2011, INFECT CONT HOSP EP, V32, P1187, DOI 10.1086/662626; Bueche M, 2013, APPL ENVIRON MICROB, V79, P5302, DOI 10.1128/AEM.01376-13; Caini S, 2013, EURO SURVEILL, V18; Carling PC, 2008, INFECT CONT HOSP EP, V29, P1, DOI 10.1086/524329; Carling PC, 2010, AM J INFECT CONTROL, V38, pS41, DOI 10.1016/j.ajic.2010.03.004; Caselli E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002951; *CLIN LAB STAND I, 2011, M100S21 CLSI; Cookson B, 2013, J HOSP INFECT, V85, P45, DOI 10.1016/j.jhin.2013.04.019; Dancer SJ, 2011, EUR J CLIN MICROBIOL, V30, P1473, DOI 10.1007/s10096-011-1250-x; Davies A, 2011, J HOSP INFECT, V77, P199, DOI 10.1016/j.jhin.2010.08.012; Gentili V, 2012, EUR J CLIN MICROBIOL, V31, P1523, DOI 10.1007/s10096-011-1473-x; Goodman ER, 2008, INFECT CONT HOSP EP, V29, P593, DOI 10.1086/588566; Hota B, 2004, CLIN INFECT DIS, V39, P1182, DOI 10.1086/424667; Huslage K, 2013, INFECT CONT HOSP EP, V34, P211, DOI 10.1086/669092; Kramer A, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-130; Kummerer K, 2001, CHEMOSPHERE, V45, P957, DOI 10.1016/S0045-6535(01)00144-8; La Fauci V, 2015, MICROBIAL BIOCH TECH, V7, P5, DOI DOI 10.4172/1948-5948.1000198; Otter JA, 2013, J HOSP INFECT, V83, P1, DOI 10.1016/j.jhin.2012.10.002; Rutala WA, 2013, AM J INFECT CONTROL, V41, pS36, DOI 10.1016/j.ajic.2012.11.006; Rutala WA, 2011, INFECT CONT HOSP EP, V32, P743, DOI 10.1086/661226; Vandini A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108598; Wattiau P, 2001, APPL MICROBIOL BIOT, V56, P816, DOI 10.1007/s002530100691; Weber DJ, 2013, AM J INFECT CONTROL, V41, pS31, DOI 10.1016/j.ajic.2012.12.005; Weber DJ, 2013, AM J INFECT CONTROL, V41, pS105, DOI 10.1016/j.ajic.2012.12.009; Weber DJ, 2010, AM J INFECT CONTROL, V38, pS25, DOI 10.1016/j.ajic.2010.04.196; Weber DJ, 1997, INFECT CONT HOSP EP, V18, P306; Wu XY, 2006, J MICROBIOL METH, V64, P107, DOI 10.1016/j.mimet.2005.04.021	32	51	54	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0148857	10.1371/journal.pone.0148857	http://dx.doi.org/10.1371/journal.pone.0148857			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26886448	Green Published, gold, Green Submitted			2022-12-26	WOS:000371218400054
J	Chen, Q; Zhao, YA; Pan, SL; Wang, Y				Chen, Qun; Zhao, Yunan; Pan, Shuangli; Wang, Yan			Survey of the Influence of the Width of Urban Branch Roads on the Meeting of Two-Way Vehicle Flows	PLOS ONE			English	Article							CELLULAR-AUTOMATON MODEL; MIXED TRAFFIC CONDITIONS; CAR-FOLLOWING MODEL; LANE WIDTH; COMMUNICATION; CAPACITY; MEMORY; INDIA	Branch roads, which are densely distributed in cities, allow for the flow of local traffic and provide connections between the city and outlying areas. Branch roads are typically narrow, and two-way traffic flows on branch roads are thus affected when vehicles traveling in opposite directions meet. This study investigates the changes in the velocities of vehicles when they meet on two-way branch roads. Various widths of branch roads were selected, and their influence on traffic flows was investigated via a video survey. The results show that, depending on the average vehicle velocity, branch roads require different widths to prevent a large decrease in velocity when vehicles meet. When the velocity on a branch road is not high (e.g., the average velocity without meeting is approximately 6 m/s), appropriately increasing the road width will notably increase the meeting velocity. However, when the velocity is high (e.g., the average velocity without meeting is greater than 10 m/s), there is a large decrease in velocity when meeting even if the road surface is wide (6.5 m). This study provides a basis for selecting the width of urban branch roads and the simulation of bidirectional traffic on such roads.	[Chen, Qun; Zhao, Yunan; Pan, Shuangli] Cent S Univ, Sch Traff & Transportat Engn, Changsha, Hunan, Peoples R China; [Wang, Yan] Cent S Univ, Sch Publ Adm, Changsha, Hunan, Peoples R China	Central South University; Central South University	Chen, Q (corresponding author), Cent S Univ, Sch Traff & Transportat Engn, Changsha, Hunan, Peoples R China.	chenqun631@csu.edu.cn	Chen, Qun/HGD-0868-2022		National Social Science Fund of China [13CGL001]; Research Fund for Young Scholars of Central South University [2014JSJJ015]	National Social Science Fund of China; Research Fund for Young Scholars of Central South University	This work was supported by the National Social Science Fund of China under Grant [number 13CGL001, QC receives funding] and the Research Fund for Young Scholars of Central South University under Grant [number 2014JSJJ015, QC receives funding]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the National Social Science Fund of China under Grant Number 13CGL001 and the Research Fund for Young Scholars of Central South University under Grant Number 2014JSJJ015.	AASHTO, 2011, POLICY GEOMETRIC DES; [Anonymous], 1995, 502201995 GB; Arasan VT, 2010, J TRANSP ENG, V136, P1110, DOI 10.1061/(ASCE)TE.1943-5436.0000176; Chandra S, 2003, J TRANSP ENG-ASCE, V129, P155, DOI 10.1061/(ASCE)0733-947X(2003)129:2(155); Chen Q, 2015, PHYSICA A, V432, P43, DOI 10.1016/j.physa.2015.03.004; Code for Design of Urban Road Engineering, 2012, 372012 CJJ; DAGANZO CF, 1994, TRANSPORT RES B-METH, V28, P269, DOI 10.1016/0191-2615(94)90002-7; Fitzpatrick K, 2008, TRANSPORT RES REC, P18, DOI 10.3141/2065-03; Fouladvand ME, 1999, PHYS REV E, V60, P6465, DOI 10.1103/PhysRevE.60.6465; Gibreel GM, 1999, J TRANSP ENG, V125, P305, DOI 10.1061/(ASCE)0733-947X(1999)125:4(305); Gross F, 2009, TRANSPORT RES REC, P42, DOI 10.3141/2103-06; Heimbach C. L., 1983, TRANSPORT RES REC, V923, P69; Helbing D, 1996, PHYS REV E, V53, P2366, DOI 10.1103/PhysRevE.53.2366; Highway Research Board, 1975, 87 HIGH RES BOARD NA; Hoogendoorn SP, 1998, TRANSPORT RES REC, P18, DOI 10.3141/1646-03; Institute of Transportation Engineers, 1992, GUID URB MAJ STREET; Isebrands H, 2015, ITE J, V85, P36; Jia B, 2005, PHYSICA A, V348, P544, DOI 10.1016/j.physa.2004.09.034; Jiang R, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.017101; Krishnamurthy K, 2014, J ADV TRANSPORT, V48, P1, DOI 10.1002/atr.196; Lee HW, 1997, J PHYS A-MATH GEN, V30, P8497, DOI 10.1088/0305-4470/30/24/014; Li PY, 2002, TRANSPORT RES C-EMER, V10, P275, DOI 10.1016/S0968-090X(02)00004-9; Lighthill M. J., 1955, PROC R SOC LON SER A, VA299, P317, DOI DOI 10.1098/RSPA.1955.0089; Mailaender T., 1999, HIGHWAY DESIGN TRAFF; Minocha VK, 2004, J TRANSP ENG, V130, P402, DOI 10.1061/(ASCE)0733-947X(2004)130:3(402); Payne HJ., 1979, TRANSP RES REC, V722, P68; Popkov V, 2000, J PHYS A-MATH GEN, V33, P3989, DOI 10.1088/0305-4470/33/22/303; Rosey F, 2009, TRANSPORT RES REC, P112, DOI 10.3141/2138-15; Simon PM, 1998, PHYS REV E, V57, P2441, DOI 10.1103/PhysRevE.57.2441; Tang TQ, 2014, MEASUREMENT, V58, P286, DOI 10.1016/j.measurement.2014.08.051; Tang TQ, 2014, NONLINEAR DYNAM, V76, P2017, DOI 10.1007/s11071-014-1265-9; Transportation Research Board, 2000, HIGHW CAP MAN 2000; Wang G, 1990, URBAN ROAD PLANNING; YAGAR S, 1983, TRANSPORT RES A-POL, V17, P315, DOI 10.1016/0191-2607(83)90094-8; Yu SW, 2015, PHYSICA A, V428, P206, DOI 10.1016/j.physa.2015.01.064; Yu SW, 2015, MEASUREMENT, V64, P34, DOI 10.1016/j.measurement.2014.12.036	36	0	0	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0149188	10.1371/journal.pone.0149188	http://dx.doi.org/10.1371/journal.pone.0149188			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	26881427	Green Submitted, Green Published, gold			2022-12-26	WOS:000371219000055
J	Diekman, EF; Visser, G; Schmitz, JPJ; Nievelstein, RAJ; de Sain-van der Velden, M; Wardrop, M; Van der Pol, WL; Houten, SM; van Riel, NAW; Takken, T; Jeneson, JAL				Diekman, E. F.; Visser, G.; Schmitz, J. P. J.; Nievelstein, R. A. J.; de Sain-van der Velden, M.; Wardrop, M.; Van der Pol, W. L.; Houten, S. M.; van Riel, N. A. W.; Takken, T.; Jeneson, J. A. L.			Altered Energetics of Exercise Explain Risk of Rhabdomyolysis in Very Long-Chain Acyl-CoA Dehydrogenase Deficiency	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; DUCHENNE MUSCULAR-DYSTROPHY; MAXIMAL FAT OXIDATION; ACID BETA-OXIDATION; SKELETAL-MUSCLE; MITOCHONDRIAL MYOPATHIES; IN-VIVO; RESISTANCE; FATIGUE; KINASE	Rhabdomyolysis is common in very long-chain acyl-CoA dehydrogenase deficiency (VLCADD) and other metabolic myopathies, but its pathogenic basis is poorly understood. Here, we show that prolonged bicycling exercise against a standardized moderate workload in VLCADD patients is associated with threefold bigger changes in phosphocreatine (PCr) and inorganic phosphate (Pi) concentrations in quadriceps muscle and twofold lower changes in plasma acetyl-carnitine levels than in healthy subjects. This result is consistent with the hypothesis that muscle ATP homeostasis during exercise is compromised in VLCADD. However, the measured rates of PCr and Pi recovery post-exercise showed that the mitochondrial capacity for ATP synthesis in VLCADD muscle was normal. Mathematical modeling of oxidative ATP metabolism in muscle composed of three different fiber types indicated that the observed altered energy balance during submaximal exercise in VLCADD patients may be explained by a slow-to-fast shift in quadriceps fiber-type composition corresponding to 30% of the slow-twitch fiber-type pool in healthy quadriceps muscle. This study demonstrates for the first time that quadriceps energy balance during exercise in VLCADD patients is altered but not because of failing mitochondrial function. Our findings provide new clues to understanding the risk of rhabdomyolysis following exercise in human VLCADD.	[Diekman, E. F.; Visser, G.; de Sain-van der Velden, M.] Wilhelmina Childrens Hosp, Univ Med Ctr Utrecht, Dept Metab Dis, Utrecht, Netherlands; [Diekman, E. F.; Visser, G.; Houten, S. M.] Univ Amsterdam, Acad Med Ctr, Dept Clin Chem, Lab Genet Metab Dis,Emma Childrens Hosp, NL-1105 AZ Amsterdam, Netherlands; [Diekman, E. F.; Visser, G.; Houten, S. M.] Univ Amsterdam, Acad Med Ctr, Dept Pediat, Lab Genet Metab Dis,Emma Childrens Hosp, NL-1105 AZ Amsterdam, Netherlands; [Schmitz, J. P. J.] Eindhoven Univ Technol, Dept Biomed Technol, Computat Biol Grp, POB 513, NL-5600 MB Eindhoven, Netherlands; [Schmitz, J. P. J.; van Riel, N. A. W.] Vrije Univ Amsterdam, Dept Life & Earth Sci, Syst Bioinformat, Amsterdam, Netherlands; [Nievelstein, R. A. J.] Univ Med Ctr Utrecht, Dept Radiol, Utrecht, Netherlands; [Wardrop, M.; Takken, T.; Jeneson, J. A. L.] Wilhelmina Childrens Hosp, Univ Med Ctr Utrecht, Child Dev & Exercise Ctr, Utrecht, Netherlands; [Van der Pol, W. L.] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Neurol & Neurosurg, Spieren Spieren Childrens Ctr, Utrecht, Netherlands; [Jeneson, J. A. L.] Univ Groningen, Univ Med Ctr Groningen, Dept Pediat, Lab Liver Digest & Metab Dis, NL-9713 AV Groningen, Netherlands; [Jeneson, J. A. L.] Univ Groningen, Univ Med Ctr Groningen, Div Neurosci, Neuroimaging Ctr, NL-9713 AV Groningen, Netherlands	Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Eindhoven University of Technology; Vrije Universiteit Amsterdam; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; Utrecht University; Utrecht University Medical Center; University of Groningen; University of Groningen	Jeneson, JAL (corresponding author), Wilhelmina Childrens Hosp, Univ Med Ctr Utrecht, Child Dev & Exercise Ctr, Utrecht, Netherlands.; Jeneson, JAL (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Pediat, Lab Liver Digest & Metab Dis, NL-9713 AV Groningen, Netherlands.; Jeneson, JAL (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Div Neurosci, Neuroimaging Ctr, NL-9713 AV Groningen, Netherlands.	j.a.l.jeneson@umcg.nl	Takken, Tim/A-9912-2010; Houten, Sander/Y-3599-2019; van Riel, Natal/J-5319-2013	Houten, Sander/0000-0002-6167-9147; van Riel, Natal/0000-0001-9375-4730	Roorda Foundation; NIH [HL-072011]; ZonMW [20032006]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL072011] Funding Source: NIH RePORTER	Roorda Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ZonMW(Netherlands Organization for Health Research and Development); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by ZonMW (dossiernr. 20032006) (to GV), Roorda Foundation (to TT), and NIH HL-072011 (to JALJ).	Achten J, 2002, MED SCI SPORT EXER, V34, P92, DOI 10.1097/00005768-200201000-00015; Allen DG, 2008, PHYSIOL REV, V88, P287, DOI 10.1152/physrev.00015.2007; ARNOLD DL, 1985, ANN NEUROL, V18, P189, DOI 10.1002/ana.410180205; Arnold GL, 2009, MOL GENET METAB, V96, P85, DOI 10.1016/j.ymgme.2008.09.008; Atkinson DF, 1978, J FOOD BIOCHEM, V2, P209, DOI [10.1111/j.1745-4514.1978.tb00613.x, DOI 10.1111/J.1745-4514.1978.TB00613.X]; BARBIROLI B, 1993, J NEUROL SCI, V119, P65, DOI 10.1016/0022-510X(93)90192-2; Baruteau J, 2013, J INHERIT METAB DIS, V36, P795, DOI 10.1007/s10545-012-9542-6; Bergmeyer HU, 1986, METHODS ENZYMATIC AN; Bonnefont JP, 1999, MOL GENET METAB, V68, P424, DOI 10.1006/mgme.1999.2938; Bottinelli R, 2000, PROG BIOPHYS MOL BIO, V73, P195, DOI 10.1016/S0079-6107(00)00006-7; BRUMBACK RA, 1980, J NEUROL SCI, V48, P383, DOI 10.1016/0022-510X(80)90110-0; Chuang CK, 2009, J CHROMATOGR A, V1216, P8947, DOI 10.1016/j.chroma.2009.10.074; DAWSON MJ, 1978, NATURE, V274, P861, DOI 10.1038/274861a0; de Sain-van der Velden MGM, 2013, MOL GENET METAB, V110, P116, DOI 10.1016/j.ymgme.2013.04.008; den Boer MEJ, 2003, J PEDIATR-US, V142, P684, DOI 10.1067/mpd.2003.231; den Boer MEJ, 2002, PEDIATRICS, V109, P99, DOI 10.1542/peds.109.1.99; DENNETT X, 1988, AUST PAEDIATR J, V24, P15; Diekman EF, 2014, J INHERIT METAB DIS, V37, P405, DOI 10.1007/s10545-013-9666-3; DUNN JF, 1991, BIOCHIM BIOPHYS ACTA, V1096, P115, DOI 10.1016/0925-4439(91)90048-E; Feneson JAL, 2010, MAGN RESON MED, V63, P257, DOI 10.1002/mrm.22179; FROM AHL, 1986, FEBS LETT, V206, P257, DOI 10.1016/0014-5793(86)80992-9; Houten SM, 2010, J INHERIT METAB DIS, V33, P469, DOI 10.1007/s10545-010-9061-2; Huerta-Alardin AL, 2005, CRIT CARE, V9, P158, DOI 10.1186/cc2978; HULTMAN E, 1995, P NUTR SOC, V54, P107, DOI 10.1079/PNS19950041; Jeneson JAL, 2007, ACTA PHYSIOL, V190, P151, DOI 10.1111/j.1748-1716.2007.01680.x; Jeneson JAL, 1997, MOL CELL BIOCHEM, V174, P17, DOI 10.1023/A:1006891420109; Jeneson JAL, 2000, AM J PHYSIOL-CELL PH, V279, pC813, DOI 10.1152/ajpcell.2000.279.3.C813; Jeneson JAL, 2011, AM J PHYSIOL-REG I, V300, pR1316, DOI 10.1152/ajpregu.00204.2010; Kahle M, 2015, MOL METAB, V4, P39, DOI 10.1016/j.molmet.2014.11.004; KIHIRA S, 1985, J NEUROL SCI, V70, P139, DOI 10.1016/0022-510X(85)90083-8; KIM DK, 1991, AM J PHYSIOL, V260, pH1767, DOI 10.1152/ajpheart.1991.260.6.H1767; Kushmerick MJ, 1985, AM J PHYSL; Laforet P, 2009, NEUROMUSCULAR DISORD, V19, P324, DOI 10.1016/j.nmd.2009.02.007; Lindner M, 2010, J INHERIT METAB DIS, V33, P521, DOI 10.1007/s10545-010-9076-8; McBride A, 2009, CELL METAB, V9, P23, DOI 10.1016/j.cmet.2008.11.008; MEYER RA, 1988, AM J PHYSIOL, V254, pC548, DOI 10.1152/ajpcell.1988.254.4.C548; Milone M, 2013, MOL GENET METAB, V110, P35, DOI 10.1016/j.ymgme.2013.07.007; Morris AAM, 1998, CURR OPIN NEUROL, V11, P485, DOI 10.1097/00019052-199810000-00011; Orngreen MC, 2014, NEUROLOGY, V82, P607, DOI 10.1212/WNL.0000000000000118; PERONNET F, 1991, CAN J SPORT SCI, V16, P23; PIPER MH, 1984, BASIC RES CARDIOL, V79, P186, DOI 10.1007/BF01908305; Roberts LD, 2014, CELL METAB, V19, P96, DOI 10.1016/j.cmet.2013.12.003; Rowell LB, HDB PHYSL EXERCISE R; Rubio-Gozalbo M. E., 2004, Molecular Aspects of Medicine, V25, P521, DOI 10.1016/j.mam.2004.06.007; Scholte HR, 1999, NEUROMUSCULAR DISORD, V9, P313, DOI 10.1016/S0960-8966(99)00032-2; Staron RS, 2000, J HISTOCHEM CYTOCHEM, V48, P623, DOI 10.1177/002215540004800506; STRAUSS AW, 1995, P NATL ACAD SCI USA, V92, P10496, DOI 10.1073/pnas.92.23.10496; ter Veld F, 2006, PFLUG ARCH EUR J PHY, V452, P342, DOI 10.1007/s00424-005-0041-6; Tosetti M, 2011, MUSCLE NERVE, V44, P816, DOI 10.1002/mus.22181; Tucci S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045429; van Brussel M, 2015, ACAD RADIOL, V22, P1443, DOI 10.1016/j.acra.2015.06.013; van Oorschot JWM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076628; Veech RL, 2001, IUBMB LIFE, V51, P241; VENTURA FV, 1995, BBA-MOL BASIS DIS, V1272, P14, DOI 10.1016/0925-4439(95)00064-B; Vianey-Saban C, 1998, CLIN CHIM ACTA, V269, P43, DOI 10.1016/S0009-8981(97)00185-X; Violante S, 2010, BBA-MOL BASIS DIS, V1802, P728, DOI 10.1016/j.bbadis.2010.06.002; Vissing CR, 2013, NEUROLOGY, V80, P1908, DOI 10.1212/WNL.0b013e3182929fb2; Visweswaran P, 1999, CRIT CARE CLIN, V15, P415, DOI 10.1016/S0749-0704(05)70061-0; WATANABE H, 1989, BIOCHIM BIOPHYS ACTA, V980, P315, DOI 10.1016/0005-2736(89)90318-0; WEBSTER C, 1988, CELL, V52, P503, DOI 10.1016/0092-8674(88)90463-1; Weibel ER, 1996, J EXP BIOL, V199, P1699; WESTERHOFF HV, 1995, BIOPHYS CHEM, V54, P137, DOI 10.1016/0301-4622(94)00129-8; Wu F, 2007, AM J PHYSIOL-CELL PH, V292, pC115, DOI 10.1152/ajpcell.00237.2006; York B, 2012, CELL METAB, V15, P752, DOI 10.1016/j.cmet.2012.03.020; Zakrzewski J, 2011, PEDIATR EXERC SCI, V23, P122, DOI 10.1123/pes.23.1.122	65	29	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0147818	10.1371/journal.pone.0147818	http://dx.doi.org/10.1371/journal.pone.0147818			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	26881790	Green Published, Green Submitted, gold			2022-12-26	WOS:000371219000007
J	Tuettenberg, A; Hahn, SA; Mazur, J; Gerhold-Ay, A; Scholma, J; Marg, I; Ulges, A; Satoh, K; Bopp, T; Joore, J; Jonuleit, H				Tuettenberg, Andrea; Hahn, Susanne A.; Mazur, Johanna; Gerhold-Ay, Aslihan; Scholma, Jetse; Marg, Iris; Ulges, Alexander; Satoh, Kazuki; Bopp, Tobias; Joore, Jos; Jonuleit, Helmut			Kinome Profiling of Regulatory T Cells: A Closer Look into a Complex Intracellular Network	PLOS ONE			English	Article							SUPPRESSIVE FUNCTION; PERIPHERAL-BLOOD; HELPER-CELLS; CANCER-CELLS; KINASE; ACTIVATION; RECEPTOR; PHOSPHORYLATION; PROLIFERATION; EXPRESSIONS	Regulatory T cells (Treg) are essential for T cell homeostasis and maintenance of peripheral tolerance. They prevent activation of auto-reactive T effector cells (Teff) in the context of autoimmunity and allergy. Otherwise, Treg also inhibit effective immune responses against tumors. Besides a number of Treg-associated molecules such as Foxp3, CTLA-4 or GARP, known to play critical roles in Treg differentiation, activation and function, the involvement of additional regulatory elements is suggested. Herein, kinase activities seem to play an important role in Treg fine tuning. Nevertheless, our knowledge regarding the complex intracellular signaling pathways controlling phenotype and function of Treg is still limited and based on single kinase cascades so far. To gain a more comprehensive insight into the pathways determining Treg function we performed kinome profiling using a phosphorylation- based kinome array in human Treg at different activation stages compared to Teff. Here we have determined intriguing quantitative differences in both populations. Resting and activated Treg showed an altered pattern of CD28-dependent kinases as well as of those involved in cell cycle progression. Additionally, significant up-regulation of distinct kinases such as EGFR or CK2 in activated Treg but not in Teff not only resemble data we obtained in previous studies in the murine system but also suggest that those specific molecular activation patterns can be used for definition of the activation and functional state of human Treg. Taken together, detailed investigation of kinome profiles opens the possibility to identify novel molecular mechanisms for a better understanding of Treg biology but also for development of effective immunotherapies against unwanted T cell responses in allergy, autoimmunity and cancer.	[Tuettenberg, Andrea; Hahn, Susanne A.; Marg, Iris; Satoh, Kazuki; Jonuleit, Helmut] Johannes Gutenberg Univ Mainz, Dept Dermatol, Univ Med Ctr Mainz, D-55122 Mainz, Germany; [Mazur, Johanna; Gerhold-Ay, Aslihan] Johannes Gutenberg Univ Mainz, IMBEI, Univ Med Ctr Mainz, D-55122 Mainz, Germany; [Ulges, Alexander; Bopp, Tobias] Johannes Gutenberg Univ Mainz, Inst Immunol, Univ Med Ctr Mainz, Obere Zahlbacher Str 67, Mainz, Germany; [Scholma, Jetse] Univ Twente, Dept Dev Bioengn, POB 217, NL-7500 AE Enschede, Netherlands; [Joore, Jos] Pepscope BV, Utrecht, Netherlands	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; University of Twente	Tuettenberg, A (corresponding author), Johannes Gutenberg Univ Mainz, Dept Dermatol, Univ Med Ctr Mainz, D-55122 Mainz, Germany.	andrea.tuettenberg@unimedizin-mainz.de	Bopp, Tobias/A-4328-2018; Jonuleit, Helmut/D-8059-2011	Bopp, Tobias/0000-0002-3232-8065; Jonuleit, Helmut/0000-0002-5672-9365; Joore, Jos/0000-0002-2744-4862	Deutsche Forschungsgemeinschaft [SFB 1066]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Work was funded by the Deutsche Forschungsgemeinschaft, SFB 1066 to AT, TB and HJ. JJ and JS are employees of Pepscope BV. Both authors collected and analyzed data and were involved in the preparation of the manuscript. The company provided support in the form of salaries for authors JJ and JS, but did not have any additional role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Adler HS, 2008, CELL CYCLE, V7, P169, DOI 10.4161/cc.7.2.5312; Andersen P, 2008, INT J CANCER, V122, P342, DOI 10.1002/ijc.23109; Bianchini R, 2011, EUR J IMMUNOL, V41, P2269, DOI 10.1002/eji.201040943; Claperon A, 2012, ONCOGENE, V31, P1376, DOI 10.1038/onc.2011.334; Correll A, 2010, EXP DERMATOL, V19, pE213, DOI 10.1111/j.1600-0625.2009.01055.x; de Borst MH, 2007, AM J PHYSIOL-RENAL, V293, pF428, DOI 10.1152/ajprenal.00367.2006; Diks SH, 2004, J BIOL CHEM, V279, P49206, DOI 10.1074/jbc.M405028200; Dong ZC, 2013, SCI CHINA LIFE SCI, V56, P960, DOI 10.1007/s11427-013-4557-2; Fanayan S, 2013, J PROTEOME RES, V12, P1732, DOI 10.1021/pr3010869; Gemini-Piperni S, 2014, BIOTECHNOL BIOENG, V111, P1900, DOI 10.1002/bit.25246; Guereschi MG, 2013, EUR J IMMUNOL, V43, P1001, DOI 10.1002/eji.201243005; He HQ, 2014, IMMUNOLOGY, V141, P362, DOI 10.1111/imm.12198; Huynh A, 2015, NAT IMMUNOL, V16, P188, DOI 10.1038/ni.3077; Jaffer ZM, 2002, INT J BIOCHEM CELL B, V34, P713, DOI 10.1016/S1357-2725(01)00158-3; Jonuleit H, 2002, J EXP MED, V196, P255, DOI 10.1084/jem.20020394; Jonuleit H, 2005, METH MOLEC MED, V109, P285; Jonuleit H, 2001, J EXP MED, V193, P1285, DOI 10.1084/jem.193.11.1285; King HA, 2014, BRIEF FUNCT GENOMICS; Knight JDR, 2013, J PROTEOMICS, V81, P43, DOI 10.1016/j.jprot.2012.10.015; Koenig A, 2014, J BIOL CHEM, V289, P1183, DOI 10.1074/jbc.M113.506428; Konig S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040896; Kubach J, 2007, BLOOD, V110, P1550, DOI 10.1182/blood-2007-01-069229; Lowenberg M, 2006, ENDOCRINOLOGY, V147, P3555, DOI 10.1210/en.2005-1602; Parikh K, 2010, CANCER RES, V70, P2575, DOI 10.1158/0008-5472.CAN-09-3989; Pietruczuk M, 2012, J BIOL REG HOMEOS AG, V26, P627; Roncarolo MG, 2008, EUR J IMMUNOL, V38, P925, DOI 10.1002/eji.200838168; Roorda BD, 2009, CANCER BIOL THER, V8, P1239, DOI 10.4161/cbt.8.13.8688; Sanman LE, 2014, ANNU REV BIOCHEM, V83, P249, DOI 10.1146/annurev-biochem-060713-035352; Shevach EM, 2009, IMMUNITY, V30, P636, DOI 10.1016/j.immuni.2009.04.010; Stassen M, 2004, J IMMUNOL, V173, P267, DOI 10.4049/jimmunol.173.1.267; Stassen M, 2004, EUR J IMMUNOL, V34, P1303, DOI 10.1002/eji.200324656; Svensson H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030695; Taher TE, 2010, ARTHRITIS RHEUM-US, V62, P2412, DOI 10.1002/art.27505; Ulges A, 2015, NAT IMMUNOL, V16, P267, DOI 10.1038/ni.3083; van der Sligte NE, 2014, PROTEOMICS; Wang L., 2015, J CLIN INVEST; Yao WF, 2012, AMINO ACIDS, V43, P2027, DOI 10.1007/s00726-012-1277-z; Yuan CH, 2015, ONCOTARGET, V6, P32138, DOI 10.18632/oncotarget.5171; Zaiss DMW, 2013, IMMUNITY, V38, P275, DOI 10.1016/j.immuni.2012.09.023	39	4	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0149193	10.1371/journal.pone.0149193	http://dx.doi.org/10.1371/journal.pone.0149193			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	26881744	Green Published, gold, Green Submitted			2022-12-26	WOS:000371219000056
J	Choi, HI; Ma, SK; Bae, EH; Lee, J; Kim, SW				Choi, Hoon-In; Ma, Seong Kwon; Bae, Eun Hui; Lee, JongUn; Kim, Soo Wan			Peroxiredoxin 5 Protects TGF-beta Induced Fibrosis by Inhibiting Stat3 Activation in Rat Kidney Interstitial Fibroblast Cells	PLOS ONE			English	Article							RENAL TUBULOINTERSTITIAL FIBROSIS; TUBULAR EPITHELIAL-CELLS; OBSTRUCTIVE NEPHROPATHY; MESENCHYMAL TRANSITION; SIGNALING PATHWAY; MESANGIAL CELLS; ANTIOXIDANT; PREVENTS; GROWTH; CONTRIBUTES	Renal fibrosis is a common final pathway of end-stage kidney disease which is induced by aberrant accumulation of myofibroblasts. This process is triggered by reactive oxygen species (ROS) and proinflammatory cytokines generated by various source of injured kidney cells. Peroxiredoxin 5 (Prdx5) is a thiol-dependent peroxidase that reduces oxidative stress by catalyzing intramolecular disulfide bonds. Along with its antioxidant effects, expression level of Prdx5 also was involved in inflammatory regulation by immune stimuli. However, the physiological effects and the underlying mechanisms of Prdx5 in renal fibrosis have not been fully characterized. Sprague-Dawley rats were subjected to unilateral ureteral obstruction (UUO) for 1 or 7 days. For the in vitro model, NRK49F cells, a rat kidney interstitial fibroblast cell lines, were treated with transforming growth factor beta (TGF-beta) for 0, 1, 3, or 5 days. To access the involvement of its peroxidase activity in TGF-beta induced renal fibrosis, wild type Prdx5 (WT) and double mutant Prdx5 (DM), converted two active site cysteines at Cys 48 and Cys 152 residue to serine, were transiently expressed in NRK49F cells. The protein expression of Prdx5 was reduced in UUO kidneys. Upregulation of fibrotic markers, such as fibronectin and alpha-smooth muscle actin (a-SMA), declined at 5 days in time point of higher Prdx5 expression in TGF-beta treated NRK49F cells. The overexpression of wild type Prdx5 by transient transfection in NRK49F cells attenuated the TGF-beta induced upregulation of fibronectin and a-SMA. On the other hand, the transient transfection of double mutant Prdx5 did not prevent the activation of fibrotic markers. Overexpression of Prdx5 also suppressed the TGF-beta induced upregulation of Stat3 phosphorylation, while phosphorylation of Smad 2/3 was unchanged. In conclusion, Prdx5 protects TGF-beta induced fibrosis in NRK49F cells by modulating Stat3 activation in a peroxidase activity dependent manner.	[Choi, Hoon-In; Ma, Seong Kwon; Bae, Eun Hui; Kim, Soo Wan] Chonnam Natl Univ, Sch Med, Dept Internal Med, Gwangju, South Korea; [Lee, JongUn] Chonnam Natl Univ, Sch Med, Dept Physiol, Gwangju, South Korea	Chonnam National University; Chonnam National University	Kim, SW (corresponding author), Chonnam Natl Univ, Sch Med, Dept Internal Med, Gwangju, South Korea.	skimw@chonnam.ac.kr			Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [2014R1A1A3053193]; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and future Planning [2013R1A2A2A01067611]; Pioneer Research Center Program through the National Research Foundation of Korea - Ministry of Science, ICT & Future Planning [2014M3C1A3053036]; Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI); Ministry of Health & Welfare, Republic of Korea [HI14C2084]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning(National Research Foundation of Korea); Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and future Planning(National Research Foundation of Korea); Pioneer Research Center Program through the National Research Foundation of Korea - Ministry of Science, ICT & Future Planning; Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI)(Korea Health Industry Development Institute (KHIDI)); Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (2014R1A1A3053193), by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and future Planning (2013R1A2A2A01067611), by the Pioneer Research Center Program through the National Research Foundation of Korea funded by the Ministry of Science, ICT & Future Planning (2014M3C1A3053036), and by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number : HI14C2084). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas K, 2009, FREE RADICAL BIO MED, V47, P794, DOI 10.1016/j.freeradbiomed.2009.06.018; Avila PC, 2008, LUNG, V186, P103, DOI 10.1007/s00408-007-9066-2; Banes AK, 2004, AM J PHYSIOL-RENAL, V286, pF653, DOI 10.1152/ajprenal.00163.2003; Barnes JL, 2011, KIDNEY INT, V79, P944, DOI 10.1038/ki.2010.516; Choi HI, 2013, FREE RADICAL BIO MED, V65, P270, DOI 10.1016/j.freeradbiomed.2013.06.038; Chuang PY, 2010, KIDNEY INT, V78, P231, DOI 10.1038/ki.2010.158; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Eddy AA, 2000, PEDIATR NEPHROL, V15, P290, DOI 10.1007/s004670000461; Ellison MA, 2012, EUR J IMMUNOL, V42, P1609, DOI 10.1002/eji.201142157; Farris AB, 2012, CURR OPIN NEPHROL HY, V21, P289, DOI 10.1097/MNH.0b013e3283521cfa; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Fujii J, 2002, REDOX REP, V7, P123, DOI 10.1179/135100002125000352; Jiang F, 2011, PHARMACOL REV, V63, P218, DOI 10.1124/pr.110.002980; Kim J, 2009, AM J PHYSIOL-RENAL, V297, pF461, DOI 10.1152/ajprenal.90735.2008; Klahr S, 2002, AM J PHYSIOL-RENAL, V283, pF861, DOI 10.1152/ajprenal.00362.2001; Knoops B, 2011, ANTIOXID REDOX SIGN, V15, P817, DOI 10.1089/ars.2010.3584; Kopp JB, 1996, LAB INVEST, V74, P991; Krutilina Raisa I, 2006, J Inflamm (Lond), V3, P13, DOI 10.1186/1476-9255-3-13; Kuma A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103240; Kuratsune M, 2007, NEPHROLOGY, V12, P565, DOI 10.1111/j.1440-1797.2007.00881.x; Lee I, 2013, J PHARMACOL EXP THER, V345, P284, DOI 10.1124/jpet.112.201079; Lijnen PJ, 2012, J HYPERTENS, V30, P1986, DOI 10.1097/HJH.0b013e32835726c1; Liu YH, 2006, KIDNEY INT, V69, P213, DOI 10.1038/sj.ki.5000054; Liu YH, 2011, NAT REV NEPHROL, V7, P684, DOI 10.1038/nrneph.2011.149; Lu TC, 2009, KIDNEY INT, V76, P63, DOI 10.1038/ki.2009.98; Ma YN, 2014, FREE RADICAL BIO MED, V76, P251, DOI 10.1016/j.freeradbiomed.2014.08.015; Manevich Y, 2004, P NATL ACAD SCI USA, V101, P3780, DOI 10.1073/pnas.0400181101; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Matsui F, 2012, J SURG RES, V178, P339, DOI 10.1016/j.jss.2012.06.050; Mehra A, 2002, BIOCHEM CELL BIOL, V80, P605, DOI 10.1139/O02-161; Mei WJ, 2015, NEPHROLOGY, V20, P832, DOI 10.1111/nep.12515; Mu YB, 2012, CELL TISSUE RES, V347, P11, DOI 10.1007/s00441-011-1201-y; Nie J, 2012, CHINESE MED J-PEKING, V125, P2598, DOI 10.3760/cma.j.issn.0366-6999.2012.14.035; Oberley TD, 2001, FREE RADICAL BIO MED, V30, P412, DOI 10.1016/S0891-5849(00)00486-X; Pang MY, 2010, KIDNEY INT, V78, P257, DOI 10.1038/ki.2010.154; Qi WE, 2006, INT J BIOCHEM CELL B, V38, P1, DOI 10.1016/j.biocel.2005.09.005; Rhyu DY, 2005, J AM SOC NEPHROL, V16, P667, DOI 10.1681/ASN.2004050425; Runyan CE, 2005, J BIOL CHEM, V280, P8300, DOI 10.1074/jbc.M407939200; Sachse A, 2007, J AM SOC NEPHROL, V18, P2439, DOI 10.1681/ASN.2007020149; Strutz F, 2001, KIDNEY INT, V59, P579, DOI 10.1046/j.1523-1755.2001.059002579.x; Sun HN, 2010, J NEUROCHEM, V114, P39, DOI 10.1111/j.1471-4159.2010.06691.x; Wang MX, 2002, FEBS LETT, V531, P359, DOI 10.1016/S0014-5793(02)03511-1; Wang XD, 2002, DIABETES, V51, P3505, DOI 10.2337/diabetes.51.12.3505; Yuan YG, 2012, FREE RADICAL BIO MED, V53, P30, DOI 10.1016/j.freeradbiomed.2012.03.015; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328	46	27	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149266	10.1371/journal.pone.0149266	http://dx.doi.org/10.1371/journal.pone.0149266			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26872211	Green Published, gold, Green Submitted			2022-12-26	WOS:000370054100137
J	Wagner, JM; Zollner, H; Wallner, C; Ismer, B; Schira, J; Abraham, S; Harati, K; Lehnhardt, M; Behr, B				Wagner, Johannes Maximilian; Zoellner, Hannah; Wallner, Christoph; Ismer, Britta; Schira, Jessica; Abraham, Stephanie; Harati, Kamran; Lehnhardt, Marcus; Behr, Bjoern			Surgical Debridement Is Superior to Sole Antibiotic Therapy in a Novel Murine Posttraumatic Osteomyelitis Model	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; ACUTE HEMATOGENOUS OSTEOMYELITIS; IN-VIVO; ANIMAL-MODEL; REDUCE INFECTION; BONE INFECTION; MOUSE MODEL; REAL-TIME; RATS; EFFICACY	Introduction Bone infections after trauma, i.e. posttraumatic osteomyelitis, pose one of the biggest problems of orthopedic surgery. Even after sufficient clinical therapy including vast debridement of infected bone and antibiotic treatment, regeneration of postinfectious bone seems to be restricted. One explanation includes the large sized defects resulting from sufficient debridement. Furthermore, it remains unclear if inflammatory processes after bone infection do affect bone regeneration. For continuing studies in this field, an animal model is needed where bone regeneration after sufficient treatment can be studied in detail. Methods For this purpose we created a stable infection in murine tibiae by Staphylococcus aureus inoculation. Thereafter, osteomyelitic bones were debrided thoroughly and animals were subsequently treated with antibiotics. Controls included debrided, non-infected, as well as infected animals exclusively treated with antibiotics. To verify sufficient treatment of infected bone, different assessments detecting S. aureus were utilized: agar plates, histology and RT-qPCR. Results All three detection methods revealed massive reduction or eradication of S. aureus within debrided bones 1 and 2 weeks postoperatively, whereas sole antibiotic therapy could not provide sufficient treatment of osteomyelitic bones. Debrided, previously infected bones showed significantly decreased bone formation, compared to debrided, non-infected controls. Discussion Thus, the animal model presented herein provides a reliable and fascinating tool to study posttraumatic osteomyelitis for clinical therapies.	[Wagner, Johannes Maximilian; Zoellner, Hannah; Wallner, Christoph; Ismer, Britta; Schira, Jessica; Abraham, Stephanie; Harati, Kamran; Lehnhardt, Marcus; Behr, Bjoern] Ruhr Univ Bochum, Dept Plast Surg, BG Bergmannsheil Bochum, Univ Str 150, Bochum, Germany	Ruhr University Bochum	Behr, B (corresponding author), Ruhr Univ Bochum, Dept Plast Surg, BG Bergmannsheil Bochum, Univ Str 150, Bochum, Germany.	bjorn.behr@rub.de	Behr, Björn/AAS-1877-2021; Harati, Kamran/AHD-3426-2022	Schira-Heinen, Jessica/0000-0002-2184-9746	Mercator Research Center Ruhr [An-2013-0053]	Mercator Research Center Ruhr	This work was supported by a grant of the Mercator Research Center Ruhr (An-2013-0053). The URL of the funder is: http://www.mercurresearch.de. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behr B, 2010, P NATL ACAD SCI USA, V107, P11853, DOI 10.1073/pnas.1003317107; Bertolini D, 1968, NATURE, V319, P516; Bilgili F, 2015, CLIN ORTHOP RELAT R, V473, P3190, DOI 10.1007/s11999-015-4331-9; Brin YS, 2008, J CONTROL RELEASE, V131, P121, DOI 10.1016/j.jconrel.2008.07.022; Brown Kate V, 2010, J Surg Orthop Adv, V19, P18; Buxton TB, 2005, COMPARATIVE MED, V55, P123; Chadha HS, 1999, J ORTHOPAED RES, V17, P376, DOI 10.1002/jor.1100170312; Chai HW, 2011, J MATER SCI-MATER M, V22, P2525, DOI 10.1007/s10856-011-4427-z; Chang YH, 2006, CLIN ORTHOP RELAT R, P242, DOI 10.1097/01.blo.0000229324.75911.c7; Cierny G, 2003, CLIN ORTHOP RELAT R, P7, DOI 10.1097/01.blo.0000088564.81746.62; Claro T, 2013, MICROBIOL-SGM, V159, P147, DOI 10.1099/mic.0.063016-0; Costerton JW, 2006, CLIN ORTHOP RELAT R, V437, P7; Cremonesi P, 2014, FOOD MICROBIOL, V43, P35, DOI 10.1016/j.fm.2014.04.007; Darouiche RO, 2007, J BONE JOINT SURG AM, V89A, P792, DOI 10.2106/JBJS.F.00414; Ding H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085472; Eerenberg J P, 1994, J Invest Surg, V7, P453, DOI 10.3109/08941939409016511; Folsch C, 2015, INT ORTHOP, V39, P981, DOI 10.1007/s00264-014-2582-9; Funao H, 2012, INFECT IMMUN, V80, P733, DOI 10.1128/IAI.06166-11; Gatin L, 2014, ANTIMICROB AGENTS CH, V58, P6496, DOI 10.1128/AAC.03600-14; Gaudin A, 2011, LETT APPL MICROBIOL, V52, P253, DOI 10.1111/j.1472-765X.2010.02992.x; Guelcher SA, 2011, J ORTHOP TRAUMA, V25, P477, DOI 10.1097/BOT.0b013e31821f624c; GUSTILO RB, 1990, J BONE JOINT SURG AM, V72A, P299, DOI 10.2106/00004623-199072020-00023; Helbig L, 2014, INT ORTHOP, V38, P891, DOI 10.1007/s00264-013-2149-1; Inzana JA, 2015, BONE, V72, P128, DOI 10.1016/j.bone.2014.11.019; Isefuku S, 2003, J ORTHOP TRAUMA, V17, P212, DOI 10.1097/00005131-200303000-00010; Jones D, 2011, J CLIN INVEST, V121, P2534, DOI 10.1172/JCI46262; Karmakar S, 2010, RHEUM DIS CLIN N AM, V36, P385, DOI 10.1016/j.rdc.2010.03.003; Leung Andraay H C, 2015, Open Orthop J, V9, P372, DOI 10.2174/1874325001509010372; Lew DP, 2004, LANCET, V364, P369, DOI 10.1016/S0140-6736(04)16727-5; Li GY, 2013, J ORTHOP RES, V31, P949, DOI 10.1002/jor.22299; Lindsey BA, 2010, J ORTHOP RES, V28, P38, DOI 10.1002/jor.20960; Lucke M, 2003, J BIOMED MATER RES B, V67B, P593, DOI 10.1002/jbm.b.10051; Nanes MS, 2003, GENE, V321, P1, DOI 10.1016/S0378-1119(03)00841-2; Odekerken JC, 2014, BIOMED RES INT, V2014, DOI [10.1155/2014/424652, DOI 10.1155/2014/424652]; Ozturan KE, 2010, J ORTHOP RES, V28, P1368, DOI 10.1002/jor.21159; Patel Mitul, 2009, Semin Plast Surg, V23, P148, DOI 10.1055/s-0029-1214167; Penn-Barwell JG, 2012, J BONE JOINT SURG BR, V94B, P107, DOI 10.1302/0301-620X.94B1.27026; PINZUR MS, 1992, ORTHOPEDICS, V15, P1033; Pribaz JR, 2012, J ORTHOP RES, V30, P335, DOI 10.1002/jor.21519; Reizner W, 2014, EUR CELLS MATER, V27, P196, DOI 10.22203/eCM.v027a15; RISSING JP, 1985, INFECT IMMUN, V47, P581, DOI 10.1128/IAI.47.3.581-586.1985; Ritter V, 2009, J AOAC INT, V92, P1432; Sheehan E, 2004, J ORTHOP RES, V22, P39, DOI 10.1016/S0736-0266(03)00152-9; Shiels SM, 2015, BMC MUSCULOSKEL DIS, V16, DOI 10.1186/s12891-015-0699-7; SPAGNOLO N, 1993, INFECT IMMUN, V61, P5225, DOI 10.1128/IAI.61.12.5225-5230.1993; SPEERS DJ, 1985, INFECT IMMUN, V49, P443, DOI 10.1128/IAI.49.2.443-446.1985; Subasi M, 2001, ARCH ORTHOP TRAUM SU, V121, P170, DOI 10.1007/s004020000209; Wallner C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118823; Walsh NC, 2009, J BONE MINER RES, V24, P1572, DOI [10.1359/jbmr.090320, 10.1359/JBMR.090320]; Walter G, 2012, DTSCH ARZTEBL INT, V109, P257, DOI [10.3238/arztebl.012.0257, 10.3238/arztebl.2012.0257]; Wei S, 2005, J CLIN INVEST, V115, P282, DOI 10.1172/JCI200523394; Widaa A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040586; Zhu C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086874	53	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149389	10.1371/journal.pone.0149389	http://dx.doi.org/10.1371/journal.pone.0149389			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26872128	Green Published, Green Submitted, gold			2022-12-26	WOS:000370054100155
J	Hossain, ST; Malhotra, A; Deutscher, MP				Hossain, Sk Tofajjen; Malhotra, Arun; Deutscher, Murray P.			How RNase R Degrades Structured RNA: ROLE OF THE HELICASE ACTIVITY AND THE S1 DOMAIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATP; conformational change; Escherichia coli (E; coli); RNA degradation; RNA helicase; P-loop domain; duplex RNA; ribonuclase	ESCHERICHIA-COLI; POLYNUCLEOTIDE PHOSPHORYLASE; NUCLEASE DOMAIN; RIBONUCLEASE R; RIBOSOMAL-RNA; BINDING; DEGRADOSOME; FLUORESCENCE; DEGRADATION; STABILITY	RNase R, a ubiquitous 3 exoribonuclease, plays an important role in many aspects of RNA metabolism. In contrast to other exoribonucleases, RNase R can efficiently degrade highly structured RNAs, but the mechanism by which this is accomplished has remained elusive. It is known that RNase R contains an unusual, intrinsic RNA helicase activity that facilitates degradation of duplex RNA, but how it stimulates the nuclease activity has also been unclear. Here, we have made use of specifically designed substrates to compare the nuclease and helicase activities of RNase R. We have also identified and mutated several residues in the S1 RNA-binding domain that are important for interacting with duplex RNA and have measured intrinsic tryptophan fluorescence to analyze the conformational changes that occur upon binding of structured RNA. Using these approaches, we have determined the relation of the RNA helicase, ATP binding, and nuclease activities of RNase R. This information has been combined with a structural analysis of RNase R, based on its homology to RNase II, whose structure has been determined, to develop a detailed model that explains how RNase R digests structured RNA and how this differs from its action on single-stranded RNA.	[Hossain, Sk Tofajjen; Malhotra, Arun; Deutscher, Murray P.] Univ Miami, Dept Biochem & Mol Biol, Miller Sch Med, POB 016129, Miami, FL 33101 USA	University of Miami	Deutscher, MP (corresponding author), Univ Miami, Dept Biochem & Mol Biol, Miller Sch Med, POB 016129, Miami, FL 33101 USA.	m.deutscher@med.miami.edu	Malhotra, Arun/Z-5140-2019	Malhotra, Arun/0000-0001-6656-7841; Hossain, Sk Tofajjen/0000-0002-1448-1015	National Institutes of Health [GM 16317]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM016317, R01GM016317] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM 16317 (to M.P.D.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Awano N, 2007, J BACTERIOL, V189, P5808, DOI 10.1128/JB.00655-07; Awano N, 2010, J BACTERIOL, V192, P1344, DOI 10.1128/JB.01368-09; BEECHEM JM, 1985, ANNU REV BIOCHEM, V54, P43, DOI 10.1146/annurev.biochem.54.1.43; Bhattacharya M, 2011, J FLUORESC, V21, P1083, DOI 10.1007/s10895-010-0781-3; Carpousis AJ, 2002, BIOCHEM SOC T, V30, P150, DOI 10.1042/bst0300150; Cheng ZF, 2005, MOL CELL, V17, P313, DOI 10.1016/j.molcel.2004.11.048; Cheng ZF, 2003, P NATL ACAD SCI USA, V100, P6388, DOI 10.1073/pnas.1231041100; Frazao C, 2006, NATURE, V443, P110, DOI 10.1038/nature05080; Hossain ST, 2015, J BIOL CHEM, V290, P15697, DOI 10.1074/jbc.M115.650176; Khemici V, 2004, MOL MICROBIOL, V51, P777, DOI 10.1046/j.1365-2958.2003.03862.x; Liang WX, 2012, J BIOL CHEM, V287, P33472, DOI 10.1074/jbc.M112.375287; Liang WX, 2011, MOL CELL, V44, P160, DOI 10.1016/j.molcel.2011.06.037; Liang WX, 2010, J BIOL CHEM, V285, P29054, DOI 10.1074/jbc.C110.168641; Lin PH, 2005, P NATL ACAD SCI USA, V102, P16590, DOI 10.1073/pnas.0500994102; Liou GG, 2002, J BIOL CHEM, V277, P41157, DOI 10.1074/jbc.M206618200; Lustig B, 1997, NUCLEIC ACIDS RES, V25, P2562, DOI 10.1093/nar/25.13.2562; Matos RG, 2009, BIOCHEM J, V423, P291, DOI 10.1042/BJ20090839; Royer CA, 2006, CHEM REV, V106, P1769, DOI 10.1021/cr0404390; Sulthana S, 2013, J BIOL CHEM, V288, P12574, DOI 10.1074/jbc.C113.459172; Tanaka N, 2005, BIOCHEMISTRY-US, V44, P9795, DOI 10.1021/bi050407m; Vincent HA, 2006, J BIOL CHEM, V281, P29769, DOI 10.1074/jbc.M606744200; Vincent HA, 2009, J MOL BIOL, V387, P570, DOI 10.1016/j.jmb.2009.01.068; Vincent HA, 2009, J BIOL CHEM, V284, P486, DOI 10.1074/jbc.M806468200; WONG I, 1993, P NATL ACAD SCI USA, V90, P5428, DOI 10.1073/pnas.90.12.5428; Zuo YH, 2006, MOL CELL, V24, P149, DOI 10.1016/j.molcel.2006.09.004	26	33	34	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2016	291	15					7877	7887		10.1074/jbc.M116.717991	http://dx.doi.org/10.1074/jbc.M116.717991			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DJ2SZ	26872969	hybrid, Green Published			2022-12-26	WOS:000374056700011
J	Beeg, M; Stravalaci, M; Romeo, M; Carra, AD; Cagnotto, A; Rossi, A; Diomede, L; Salmona, M; Gobbi, M				Beeg, Marten; Stravalaci, Matteo; Romeo, Margherita; Carra, Arianna Dorotea; Cagnotto, Alfredo; Rossi, Alessandro; Diomede, Luisa; Salmona, Mario; Gobbi, Marco			Clusterin Binds to A(1-42) Oligomers with High Affinity and Interferes with Peptide Aggregation by Inhibiting Primary and Secondary Nucleation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alzheimer disease; amyloid (A); Caenorhabditis elegans; chaperone; kinetics; surface plasmon resonance (SPR); clusterin; kinetics of fibril formation	AMYLOID-BETA-PEPTIDE; ABERRANT PROTEIN OLIGOMERS; A-BETA; ALZHEIMERS-DISEASE; EXTRACELLULAR CHAPERONES; CAENORHABDITIS-ELEGANS; MOLECULAR-MECHANISMS; IN-VITRO; TOXICITY; A-BETA(1-42)	The aggregation of amyloid protein (A) is a fundamental pathogenic mechanism leading to the neuronal damage present in Alzheimer disease, and soluble A oligomers are thought to be a major toxic culprit. Thus, better knowledge and specific targeting of the pathways that lead to these noxious species may result in valuable therapeutic strategies. We characterized some effects of the molecular chaperone clusterin, providing new and more detailed evidence of its potential neuroprotective effects. Using a classical thioflavin T assay, we observed a dose-dependent inhibition of the aggregation process. The global analysis of time courses under different conditions demonstrated that clusterin has no effect on the elongation rate but mainly interferes with the nucleation processes (both primary and secondary), reducing the number of nuclei available for further fibril growth. Then, using a recently developed immunoassay based on surface plasmon resonance, we obtained direct evidence of a high-affinity (K-D = 1 nm) interaction of clusterin with biologically relevant A(1-42) oligomers, selectively captured on the sensor chip. Moreover, with the same technology, we observed that substoichiometric concentrations of clusterin prevent oligomer interaction with the antibody 4G8, suggesting that the chaperone shields hydrophobic residues exposed on the oligomeric assemblies. Finally, we found that preincubation with clusterin antagonizes the toxic effects of A(1-42) oligomers, as evaluated in a recently developed in vivo model in Caenorhabditis elegans. These data substantiate the interaction of clusterin with biologically active regions exposed on nuclei/oligomers of A(1-42), providing a molecular basis for the neuroprotective effects of the chaperone.	[Beeg, Marten; Stravalaci, Matteo; Romeo, Margherita; Carra, Arianna Dorotea; Cagnotto, Alfredo; Rossi, Alessandro; Diomede, Luisa; Salmona, Mario; Gobbi, Marco] IRCCS, Ist Ric Farmacol Mario Negri, Dept Mol Biochem & Pharmacol, Via La Masa 19, I-20156 Milan, Italy	Istituto di Ricerche Farmacologiche Mario Negri IRCCS	Gobbi, M (corresponding author), IRCCS, Ist Ric Farmacol Mario Negri, Dept Mol Biochem & Pharmacol, Via La Masa 19, I-20156 Milan, Italy.	marco.gobbi@marionegri.it	Cagnotto, Alfredo/AAB-3083-2020; Stravalaci, Matteo/AAB-8963-2019; Diomede, Luisa/P-3417-2014; salmona, mario/AAA-7116-2020; Beeg, Marten/AAA-9269-2020; salmona, mario/ABI-4066-2020; Gobbi, Marco/J-2638-2016	Cagnotto, Alfredo/0000-0002-1390-8240; Stravalaci, Matteo/0000-0002-5636-4204; Diomede, Luisa/0000-0002-2258-0531; salmona, mario/0000-0002-9098-9873; Beeg, Marten/0000-0001-7201-6704; Gobbi, Marco/0000-0003-1014-6225; Romeo, Margherita/0000-0002-3020-8545	National Institutes of Health Office Research Infrastructure Programs [P40 OD010440]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	National Institutes of Health Office Research Infrastructure Programs; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Flamma Spa (Bergamo, Italy) for providing Fmoc amino acids for peptide synthesis. Purified immunoglobulin light chain H7 was provided by Prof. G. Merlini and Dr. P. Rognoni (IRCCS Policlinico San Matteo, Pavia, Italy). C. elegans and OP50 E. coli were provided by the Caenorhabditis Genetics Center, funded by the National Institutes of Health Office Research Infrastructure Programs (P40 OD010440).	Bailey RW, 2001, BIOCHEMISTRY-US, V40, P11828, DOI 10.1021/bi010135x; Balducci C, 2010, P NATL ACAD SCI USA, V107, P2295, DOI 10.1073/pnas.0911829107; Beeg M, 2013, CURR OPIN PHARMACOL, V13, P797, DOI 10.1016/j.coph.2013.05.010; Beeg M, 2011, ANAL BIOCHEM, V411, P297, DOI 10.1016/j.ab.2010.12.032; Bemporad F, 2012, CHEM BIOL, V19, P315, DOI 10.1016/j.chembiol.2012.02.003; Boggs LN, 1996, J NEUROCHEM, V67, P1324; Bravman T, 2006, ANAL BIOCHEM, V358, P281, DOI 10.1016/j.ab.2006.08.005; Buell AK, 2012, ANGEW CHEM INT EDIT, V51, P5247, DOI 10.1002/anie.201108040; Campioni S, 2010, NAT CHEM BIOL, V6, P140, DOI [10.1038/NCHEMBIO.283, 10.1038/nchembio.283]; Cascella R, 2013, BBA-MOL BASIS DIS, V1832, P1217, DOI 10.1016/j.bbadis.2013.04.012; Cohen SIA, 2015, NAT STRUCT MOL BIOL, V22, P207, DOI 10.1038/nsmb.2971; Cohen SIA, 2013, P NATL ACAD SCI USA, V110, P9758, DOI 10.1073/pnas.1218402110; Cohen SIA, 2012, J MOL BIOL, V421, P160, DOI 10.1016/j.jmb.2012.02.031; DeMattos RB, 2004, NEURON, V41, P193, DOI 10.1016/S0896-6273(03)00850-X; Desikan RS, 2014, JAMA NEUROL, V71, P180, DOI 10.1001/jamaneurol.2013.4560; Diomede L, 2014, BLOOD, V123, P3543, DOI 10.1182/blood-2013-10-525634; Ferrone F, 1999, METHOD ENZYMOL, V309, P256; Ferrone FA, 2006, METHOD ENZYMOL, V412, P285, DOI 10.1016/S0076-6879(06)12017-0; Ferrone FA, 2015, J MOL BIOL, V427, P287, DOI 10.1016/j.jmb.2014.10.028; Finder VH, 2010, J MOL BIOL, V396, P9, DOI 10.1016/j.jmb.2009.12.016; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Hatters DM, 2002, EUR J BIOCHEM, V269, P2789, DOI 10.1046/j.1432-1033.2002.02957.x; Humphreys DT, 1999, J BIOL CHEM, V274, P6875, DOI 10.1074/jbc.274.11.6875; Jiang Q, 2008, NEURON, V58, P681, DOI 10.1016/j.neuron.2008.04.010; Kayed R, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-18; Kuipers BJH, 2007, J AGR FOOD CHEM, V55, P5445, DOI 10.1021/jf070337l; Ladiwala ARA, 2012, J BIOL CHEM, V287, P24765, DOI 10.1074/jbc.M111.329763; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; Ly S, 2013, J BIOL CHEM, V288, P11628, DOI 10.1074/jbc.M112.411900; Mannini B, 2012, P NATL ACAD SCI USA, V109, P12479, DOI 10.1073/pnas.1117799109; Mansson C, 2014, J BIOL CHEM, V289, P31066, DOI 10.1074/jbc.M114.595124; Matsubara E, 1996, BIOCHEM J, V316, P671, DOI 10.1042/bj3160671; McHattie S, 1999, BIOCHEM BIOPH RES CO, V259, P336, DOI 10.1006/bbrc.1999.0781; Meisl G, 2016, NAT PROTOC, V11, P252, DOI 10.1038/nprot.2016.010; Minati L, 2009, AM J ALZHEIMERS DIS, V24, P95, DOI 10.1177/1533317508328602; Murphy RM, 2002, ANNU REV BIOMED ENG, V4, P155, DOI 10.1146/annurev.bioeng.4.092801.094202; Narayan P, 2012, NAT STRUCT MOL BIOL, V19, P79, DOI 10.1038/nsmb.2191; ODA T, 1995, EXP NEUROL, V136, P22, DOI 10.1006/exnr.1995.1080; Petrlova J, 2011, PROTEINS, V79, P402, DOI 10.1002/prot.22891; Sohma Y, 2006, CHEMBIOCHEM, V7, P1549, DOI 10.1002/cbic.200600112; Stravalaci M, 2012, J BIOL CHEM, V287, P27796, DOI 10.1074/jbc.M111.334979; Stravalaci M, 2011, BIOSENS BIOELECTRON, V26, P2772, DOI 10.1016/j.bios.2010.10.038; Taniguchi A, 2009, CHEMBIOCHEM, V10, P710, DOI 10.1002/cbic.200800765; Tjernberg LO, 1999, J BIOL CHEM, V274, P12619, DOI 10.1074/jbc.274.18.12619; Wyatt AR, 2013, ANNU REV BIOCHEM, V82, P295, DOI 10.1146/annurev-biochem-072711-163904; Wyatt AR, 2012, J MOL BIOL, V421, P499, DOI 10.1016/j.jmb.2012.01.004; Wyatt AR, 2009, J BIOL CHEM, V284, P21920, DOI 10.1074/jbc.M109.033688; Yerbury JJ, 2007, FASEB J, V21, P2312, DOI 10.1096/fj.06-7986com	49	74	76	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2016	291	13					6958	6966		10.1074/jbc.M115.689539	http://dx.doi.org/10.1074/jbc.M115.689539			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DI2BC	26884339	Green Published, hybrid			2022-12-26	WOS:000373299700032
J	de Jong, DM; Seaver, EC				de Jong, Danielle M.; Seaver, Elaine C.			A Stable Thoracic Hox Code and Epimorphosis Characterize Posterior Regeneration in Capitella teleta	PLOS ONE			English	Article							ENCHYTRAEUS-JAPONENSIS OLIGOCHAETA; ANNELID PLATYNEREIS-DUMERILII; NERVOUS-SYSTEM; POLYCHAETE CHAETOPTERUS; ANTERIOR REGENERATION; EXPRESSION PATTERNS; CAUDAL REGENERATION; LIMB REGENERATION; STEM-CELLS; GENES	Regeneration, the ability to replace lost tissues and body parts following traumatic injury, occurs widely throughout the animal tree of life. Regeneration occurs either by remodeling of pre-existing tissues, through addition of new cells by cell division, or a combination of both. We describe a staging system for posterior regeneration in the annelid, Capitella teleta, and use the C. teleta Hox gene code as markers of regional identity for regenerating tissue along the anterior-posterior axis. Following amputation of different posterior regions of the animal, a blastema forms and by two days, proliferating cells are detected by EdU incorporation, demonstrating that epimorphosis occurs during posterior regeneration of C. teleta. Neurites rapidly extend into the blastema, and gradually become organized into discrete nerves before new ganglia appear approximately seven days after amputation. In situ hybridization shows that seven of the ten Hox genes examined are expressed in the blastema, suggesting roles in patterning the newly forming tissue, although neither spatial nor temporal colinearity was detected. We hypothesized that following amputation, Hox gene expression in pre-existing segments would be re-organized to scale, and the remaining fragment would express the complete suite of Hox genes. Surprisingly, most Hox genes display stable expression patterns in the ganglia of pre-existing tissue following amputation at multiple axial positions, indicating general stability of segmental identity. However, the three Hox genes, CapI-lox4, CapI-lox2 and CapI-Post2, each shift its anterior expression boundary by one segment, and each shift includes a subset of cells in the ganglia. This expression shift depends upon the axial position of the amputation. In C. teleta, thoracic segments exhibit stable positional identity with limited morphallaxis, in contrast with the extensive body remodeling that occurs during regeneration of some other annelids, planarians and acoel flatworms.	[de Jong, Danielle M.; Seaver, Elaine C.] Univ Florida, Whitney Lab Marine Biosci, St Augustine, FL USA	State University System of Florida; University of Florida	Seaver, EC (corresponding author), Univ Florida, Whitney Lab Marine Biosci, St Augustine, FL USA.	seaver@whitney.ufl.edu			National Science Foundation [IOS09-23754]; Hawaii Community Foundation [12ADVC-51348]; Division Of Integrative Organismal Systems [1457102] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Hawaii Community Foundation; Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by National Science Foundation IOS09-23754 to ECS (http://www.nsf.gov/); Hawaii Community Foundation 12ADVC-51348 to ECS (https://www.hawaiicommunityfoundation.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade SCS, 2015, MOL BIOL EVOL, V32, P2860, DOI 10.1093/molbev/msv157; Bayascas JR, 1997, DEVELOPMENT, V124, P141; BEAUCHEMIN M, 1994, INT J DEV BIOL, V38, P641; Bely AE, 2006, INTEGR COMP BIOL, V46, P508, DOI 10.1093/icb/icj051; Bely AE, 2014, INT J DEV BIOL, V58, P623, DOI 10.1387/ijdb.140142ab; Bely AE, 2014, INTEGR COMP BIOL, V54, P688, DOI 10.1093/icb/icu109; Bely AE, 2010, TRENDS ECOL EVOL, V25, P161, DOI 10.1016/j.tree.2009.08.005; Ben Khadra Y, 2014, BIOCHEM GENET, V52, P166, DOI 10.1007/s10528-013-9637-2; BERRILL NJ, 1978, J EMBRYOL EXP MORPH, V47, P85; BERRILL NJ, 1952, BIOL REV, V27, P401, DOI 10.1111/j.1469-185X.1952.tb01512.x; BILELLO AA, 1974, ROUX ARCH DEV BIOL, V174, P234, DOI 10.1007/BF00573227; BOILLYMARER Y, 1971, CR ACAD SCI D NAT, V272, P261; Bosch TCG, 2007, DEV BIOL, V303, P421, DOI 10.1016/j.ydbio.2006.12.012; Boyle MJ, 2008, EVOL DEV, V10, P89, DOI 10.1111/j.1525-142X.2007.00216.x; Carlson MRJ, 2001, DEV BIOL, V229, P396, DOI 10.1006/dbio.2000.0104; Christen B, 2003, DEV DYNAM, V226, P349, DOI 10.1002/dvdy.10231; CORNEC JP, 1987, CAN J ZOOL, V65, P403, DOI 10.1139/z87-061; de Rosa R, 2005, EVOL DEV, V7, P574; DREWES CD, 1990, DEV BIOL, V138, P94, DOI 10.1016/0012-1606(90)90179-M; ECKELBARGER KJ, 1987, MAR BIOL, V95, P415, DOI 10.1007/BF00409572; Economides KD, 2003, DEV BIOL, V256, P317, DOI 10.1016/S0012-1606(02)00137-9; Faulkner GH, 1932, J MORPHOL, V53, P23, DOI 10.1002/jmor.1050530103; Fischer A, 2004, BIOESSAYS, V26, P314, DOI 10.1002/bies.10409; Frobius AC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004004; Gardiner DM, 1996, INT J DEV BIOL, V40, P797; GARDINER DM, 1995, DEVELOPMENT, V121, P1731; Gazave E, 2013, DEV BIOL, V382, P246, DOI 10.1016/j.ydbio.2013.07.013; Gersch RP, 2005, J ORTHOP RES, V23, P882, DOI 10.1016/j.orthres.2005.02.005; Giani VC, 2011, EVODEVO, V2, DOI 10.1186/2041-9139-2-10; GOLDING DW, 1967, J EMBRYOL EXP MORPH, V18, P67; GRASSLE JP, 1976, SCIENCE, V192, P567, DOI 10.1126/science.1257794; Hausen H, 2005, HYDROBIOLOGIA, V535, P37, DOI 10.1007/s10750-004-1836-8; HERLANT-MEEWIS HENRIETTE, 1964, ADVANCE MORPHOGENESIS, V4, P155; Hill SD, 2009, ANNELIDS IN MODERN BIOLOGY, P87; Hughes CL, 2004, EVOL DEV, V6, P393, DOI 10.1111/j.1525-142X.2004.04048.x; Hyman LH, 1940, AM NAT, V74, P513, DOI 10.1086/280919; Irvine SQ, 2000, DEV BIOL, V217, P333, DOI 10.1006/dbio.1999.9541; Khan PA, 1999, DEV GENES EVOL, V209, P323, DOI 10.1007/s004270050260; Kumar A, 2012, TRENDS NEUROSCI, V35, P691, DOI 10.1016/j.tins.2012.08.003; Lee JY, 2015, INT J BIOL SCI, V11, P701, DOI 10.7150/ijbs.11431; Licciano M, 2012, INVERTEBR BIOL, V131, P40, DOI 10.1111/j.1744-7410.2012.00257.x; Lybrand ZR, 2012, DEV NEUROBIOL, V72, P1256, DOI 10.1002/dneu.20993; Maloof JN, 1998, DEVELOPMENT, V125, P181; Martinez VG, 2008, J EXP ZOOL PART B, V310B, P520, DOI 10.1002/jez.b.21224; Martinez VG, 2005, MECH DEVELOP, V122, P721, DOI 10.1016/j.mod.2004.12.003; Meyer NP, 2015, FRONT ZOOL, V12, DOI 10.1186/s12983-015-0108-y; Morgan T. H., 1901, REGENERATION, P1; Morgan TH, 1902, ARCH ENTWICKLUNG ORG, V14, P562, DOI 10.1007/BF02188504; Muller MCM, 2004, DEV GROWTH DIFFER, V46, P471; Muller MCM, 2003, ZOOMORPHOLOGY, V122, P95, DOI 10.1007/s00435-003-0073-4; Myohara M, 2004, DEV DYNAM, V231, P349, DOI 10.1002/dvdy.20115; Myohara M, 1999, DEV GROWTH DIFFER, V41, P549; Nogi T, 2001, DEV GROWTH DIFFER, V43, P177; Novikova EL, 2013, EVODEVO, V4, DOI 10.1186/2041-9139-4-14; Ohgo S, 2010, DEV BIOL, V338, P148, DOI 10.1016/j.ydbio.2009.11.026; Pfeifer K, 2012, DEV GENES EVOL, V222, P165, DOI 10.1007/s00427-012-0402-z; Prokop A, 1998, MECH DEVELOP, V74, P99, DOI 10.1016/S0925-4773(98)00068-9; Randolph H., 1891, Zoologischer Anzeiger, Vxiv, P154; Randolph H., 1892, Journal of Morphology, Vvii, P317; Reddien PW, 2004, ANNU REV CELL DEV BI, V20, P725, DOI 10.1146/annurev.cellbio.20.010403.095114; Seaver EC, 2006, DEV BIOL, V289, P179, DOI 10.1016/j.ydbio.2005.10.025; SIMON HG, 1993, DEVELOPMENT, V117, P1397; SINGER MARCUS, 1952, QUART REV BIOL, V27, P169, DOI 10.1086/398873; Srivastava M, 2014, CURR BIOL, V24, P1107, DOI 10.1016/j.cub.2014.03.042; Stephan-Dubois F., 1954, Bull Biol, V88, P181; Sugio M, 2008, GENE EXPR PATTERNS, V8, P227, DOI 10.1016/j.gep.2007.12.008; Tadokoro R, 2006, CURR BIOL, V16, P1012, DOI 10.1016/j.cub.2006.04.036; Takeo M, 2008, DEV DYNAM, V237, P1284, DOI 10.1002/dvdy.21518; Tanaka EM, 2011, DEV CELL, V21, P172, DOI 10.1016/j.devcel.2011.06.016; Telford MJ, 1998, DEV GENES EVOL, V208, P591, DOI 10.1007/s004270050219; Thummel R, 2007, DEV GENES EVOL, V217, P413, DOI 10.1007/s00427-007-0154-3; Tornini VA, 2014, DEV CELL, V29, P139, DOI 10.1016/j.devcel.2014.04.007; Torok MA, 1998, DEV BIOL, V200, P225, DOI 10.1006/dbio.1998.8956; Varhalmi E, 2008, J MOL NEUROSCI, V36, P166, DOI 10.1007/s12031-008-9125-z; Weidhase M, 2014, J MORPHOL, V275, P1418, DOI 10.1002/jmor.20316; Yoshida-Noro C, 2000, DEV GENES EVOL, V210, P311, DOI 10.1007/s004270050318; Zattara EE, 2013, J EXP ZOOL PART B, V320, P471, DOI 10.1002/jez.b.22523; Zattara EE, 2011, EVOL DEV, V13, P80, DOI 10.1111/j.1525-142X.2010.00458.x	78	24	28	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0149724	10.1371/journal.pone.0149724	http://dx.doi.org/10.1371/journal.pone.0149724			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3DG	26894631	Green Published, gold, Green Submitted			2022-12-26	WOS:000371223400078
J	Lu, WY; Wang, WM; Wang, SJ; Feng, YH; Liu, KY				Lu, Wenyi; Wang, Weimin; Wang, Shujuan; Feng, Yonghuai; Liu, Kaiyan			Rosiglitazone Promotes Bone Marrow Adipogenesis to Impair Myelopoiesis under Stress	PLOS ONE			English	Article							ACTIVATED-RECEPTOR-GAMMA; HEMATOPOIETIC STEM-CELLS; PPAR-GAMMA; IN-VITRO; PIOGLITAZONE; DIFFERENTIATION; RECOVERY; ADIPOCYTES; INHIBITION; HEMATOCRIT	Objective The therapeutic use of thiazolidinediones (TZDs) causes unwanted hematological side effects, although the underlying mechanisms of these effects are poorly understood. This study tests the hypothesis that rosiglitazone impairs the maintenance and differentiation of hematopoietic stem/progenitor cells, which ultimately leads to hematological abnormalities. Methods Mice were fed a rosiglitazone-supplemented diet or a normal diet for 6 weeks. To induce hematopoietic stress, all mice were injected once with 250 mg/kg 5-fluorouracil (5-Fu) intraperitoneally. Next, hematopoietic recovery, hematopoietic stem/progenitor cells (HSPCs) subsets, and myeloid differentiation after 5-Fu treatment were evaluated. The adipogenesis induced by rosiglitazone was assessed by histopathology and oil red O staining. The effect of adipocytes on HSPCs was studied with an in vitro co-culture system. Results Rosiglitazone significantly enhanced bone marrow adipogenesis and delayed hematopoietic recovery after 5-Fu treatment. Moreover, rosiglitazone inhibited proliferation of a granulocyte/monocyte progenitor (GMP) cell population and granulocyte/macrophage colony-stimulating factor (GM-CSF) colonies, although the proliferation andmobilization of Lin-c-kit+Sca-1+ cells (LSK) was maintained following hematopoietic stress. These effects could be partially reversed by the selective PPAR. antagonist BADGE. Finally, we demonstrated in a co-culture system that differentiated adipocytes actively suppressed the myeloid differentiation of HSPCs. Conclusion Taken together, our results demonstrate that rosiglitazone inhibits myeloid differentiation of HSPCs after stress partially by inducing bone marrow adipogenesis. Targeting the bone marrow microenvironment might be one mechanism by which rosiglitazone impairs stress-induced hematopoiesis.	[Lu, Wenyi; Wang, Weimin; Wang, Shujuan; Feng, Yonghuai; Liu, Kaiyan] Peking Univ, Peoples Hosp, Dept Hematol, Beijing 100871, Peoples R China; [Lu, Wenyi; Wang, Weimin; Wang, Shujuan; Feng, Yonghuai; Liu, Kaiyan] Peking Univ, Inst Hematol, Beijing 100871, Peoples R China; [Lu, Wenyi; Wang, Weimin; Wang, Shujuan; Feng, Yonghuai; Liu, Kaiyan] Beijing Key Lab Hematopoiet Stem Cell Transplanta, Beijing, Peoples R China; [Lu, Wenyi; Liu, Kaiyan] Peking Univ, Collaborat Innovat Ctr Hematol, Beijing 100871, Peoples R China	Peking University; Peking University; Peking University	Liu, KY (corresponding author), Peking Univ, Peoples Hosp, Dept Hematol, Beijing 100871, Peoples R China.; Liu, KY (corresponding author), Peking Univ, Inst Hematol, Beijing 100871, Peoples R China.; Liu, KY (corresponding author), Beijing Key Lab Hematopoiet Stem Cell Transplanta, Beijing, Peoples R China.; Liu, KY (corresponding author), Peking Univ, Collaborat Innovat Ctr Hematol, Beijing 100871, Peoples R China.	liukaiyan@medmail.com.cn			National Natural Science Foundation of China [81270572]; National Basic Research 973 Program [2013CB733701]; Major Special Project of National Science and Technology "Creation of Major New Drugs" [2012ZX09303019]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research 973 Program(National Basic Research Program of China); Major Special Project of National Science and Technology "Creation of Major New Drugs"	The authors were supported by fundings from National Natural Science Foundation of China (grant number 81270572) and National Basic Research 973 Program (grant number 2013CB733701). The authors were also supported by funding from Major Special Project of National Science and Technology "Creation of Major New Drugs" (2012ZX09303019). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi P, 2015, CELL J, V17, P15; Ahmadian M, 2013, NAT MED, V19, P557, DOI 10.1038/nm.3159; Akbiyik F, 2004, BLOOD, V104, P1361, DOI 10.1182/blood-2004-03-0926; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Avagyan S, 2011, BLOOD, V118, P6078, DOI 10.1182/blood-2011-07-365080; Beck GR, 2013, TRANSL RES, V161, P145, DOI 10.1016/j.trsl.2012.08.006; Belaid-Choucair Z, 2008, STEM CELLS, V26, P1556, DOI 10.1634/stemcells.2008-0068; Berria R, 2006, CLIN PHARMACOL THER, V80, P105, DOI 10.1016/j.clpt.2006.03.014; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Campeau PM, 2012, J LIPID RES, V53, P1968, DOI 10.1194/jlr.P025437; Challen GA, 2009, CYTOM PART A, V75A, P14, DOI 10.1002/cyto.a.20674; Clevidence Derek E, 2009, WMJ, V108, P462; Djazayeri K, 2005, EUR J PHARMACOL, V522, P122, DOI 10.1016/j.ejphar.2005.08.053; Frascoli M, 2012, JOVE-J VIS EXP, DOI 10.3791/3736; Geresi K, 2012, EUR J PHARMACOL, V696, P172, DOI 10.1016/j.ejphar.2012.09.018; HARRISON DE, 1991, BLOOD, V78, P1237; Karakurt F, 2010, EXP CLIN ENDOCR DIAB, V118, P96, DOI 10.1055/s-0029-1234065; Konopleva M, 2002, CURR OPIN HEMATOL, V9, P294, DOI 10.1097/00062752-200207000-00006; Lazarenko OP, 2007, ENDOCRINOLOGY, V148, P2669, DOI 10.1210/en.2006-1587; Lin KD, 2014, DIABETIC MED, V31, P1341, DOI 10.1111/dme.12481; Miyamoto T, 2013, WORLD J ORTHOP, V4, P198, DOI 10.5312/wjo.v4.i4.198; Nagasawa E, 2005, EXP HEMATOL, V33, P857, DOI 10.1016/j.exphem.2005.05.003; Nagasawa T, 2010, Patent, Patent No. [WO2011030847-A1, 2011030847]; Naveiras O, 2009, NATURE, V460, P259, DOI 10.1038/nature08099; Patel JJ, 2014, CELL BIOCHEM FUNCT, V32, P368, DOI 10.1002/cbf.3025; Prost S, 2008, J CLIN INVEST, V118, P1765, DOI 10.1172/JCI33037; Rodriguez S, 2009, BLOOD, V114, P4064, DOI 10.1182/blood-2009-04-214916; Rotolin S, 2006, J CELL PHYSIOL, V209, P967, DOI 10.1002/jcp.20804; Sadie-Van Gijsen H, 2013, BONE, V56, P255, DOI 10.1016/j.bone.2013.06.016; Saiki M, 2006, INT J ONCOL, V29, P437; Schlezinger JJ, 2002, J IMMUNOL, V169, P6831, DOI 10.4049/jimmunol.169.12.6831; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sottile V, 2004, CALCIFIED TISSUE INT, V75, P329, DOI 10.1007/s00223-004-0224-8; Spindler TJ, 2014, STEM CELLS DEV, V23, P434, DOI 10.1089/scd.2013.0227; Tang WHW, 2003, J AM COLL CARDIOL, V41, P1394, DOI 10.1016/S0735-1097(03)00159-1; Wang WM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120629; Wu ZD, 1999, MOL CELL, V3, P151, DOI 10.1016/S1097-2765(00)80306-8; Zang CB, 2004, LEUKEMIA RES, V28, P387, DOI 10.1016/j.leukres.2003.07.005; Zhang DE, 1997, P NATL ACAD SCI USA, V94, P569, DOI 10.1073/pnas.94.2.569; Zhao M, 2012, BLOOD, V120, P1831, DOI 10.1182/blood-2011-11-393991; Zhu RJ, 2013, INT J HEMATOL, V97, P58, DOI 10.1007/s12185-012-1233-4	41	14	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0149543	10.1371/journal.pone.0149543	http://dx.doi.org/10.1371/journal.pone.0149543			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3DG	26895498	Green Submitted, Green Published, gold			2022-12-26	WOS:000371223400063
J	Sasaki, A; Sato, N; Suzuki, N; Kano, M; Tanaka, Y; Kanazawa, M; Aoki, M; Fukudo, S				Sasaki, Ayaka; Sato, Naoko; Suzuki, Naoki; Kano, Michiko; Tanaka, Yukari; Kanazawa, Motoyori; Aoki, Masashi; Fukudo, Shin			Associations between Single-Nucleotide Polymorphisms in Corticotropin-Releasing Hormone-Related Genes and Irritable Bowel Syndrome	PLOS ONE			English	Article							FUNCTIONAL GASTROINTESTINAL DISORDERS; ANTIDEPRESSANT TREATMENT RESPONSE; FACTOR BINDING-PROTEIN; POSTTRAUMATIC-STRESS; ADULT DEPRESSION; MAJOR DEPRESSION; CRHR1 GENE; PITUITARY; HAPLOTYPE; EXPRESSION	Irritable bowel syndrome (IBS) is a common functional disorder with distinct features of stress-related pathophysiology. A key mediator of the stress response is corticotropin-releasing hormone (CRH). Although some candidate genes have been identified in stress-related disorders, few studies have examined CRH-related gene polymorphisms. Therefore, we tested our hypothesis that single-nucleotide polymorphisms (SNPs) in CRH-related genes influence the features of IBS. Methods: In total, 253 individuals (123 men and 130 women) participated in this study. They comprised 111 IBS individuals and 142 healthy controls. The SNP genotypes in CRH (rs28364015 and rs6472258) and CRH-binding protein (CRH-BP) (rs10474485) were determined by direct sequencing and real-time polymerase chain reaction. The emotional states of the subjects were evaluated using the State-Trait Anxiety Inventory, Perceived Stress Scale, and the Self-rating Depression Scale. Results: Direct sequencing of the rs28364015 SNP of CRH revealed no genetic variation among the study subjects. There was no difference in the genotype distributions and allele frequencies of rs6472258 and rs10474485 between IBS individuals and controls. However, IBS subjects with diarrhea symptoms without the rs10474485 A allele showed a significantly higher emotional state score than carriers. Conclusions: These results suggest that the CRH and CRH-BP genes have no direct effect on IBS status. However, the CRH-BP SNP rs10474485 has some effect on IBS-related emotional abnormalities and resistance to psychosocial stress.	[Sasaki, Ayaka; Sato, Naoko; Kano, Michiko; Tanaka, Yukari; Kanazawa, Motoyori; Fukudo, Shin] Tohoku Univ, Grad Sch Med, Dept Behav Med, Sendai, Miyagi 980, Japan; [Suzuki, Naoki; Aoki, Masashi] Tohoku Univ, Dept Neurol, Grad Sch Med, Sendai, Miyagi 980, Japan; [Kano, Michiko] Tohoku Univ, Frontier Res Inst Interdisciplinary Sci, Sendai, Miyagi 980, Japan	Tohoku University; Tohoku University; Tohoku University	Fukudo, S (corresponding author), Tohoku Univ, Grad Sch Med, Dept Behav Med, Sendai, Miyagi 980, Japan.	sfukudo@med.tohoku.ac.jp	Fukudo, Shin/J-4813-2014; Suzuki, Naoki/J-6331-2019	Suzuki, Naoki/0000-0001-8880-8554	Ministry of Education, Science, and Culture of Japan [15H04799, 15H15267]; Ministry of Health, Welfare, and Labor of Japan [26-4]	Ministry of Education, Science, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Welfare, and Labor of Japan(Ministry of Health, Labour and Welfare, Japan)	This research was supported by Grant-in-Aid for Scientific Research from the Ministry of Education, Science, and Culture of Japan No. 15H04799, 15H15267 (http://www.mext.go.jp/english/) and Grant-in-Aid for Scientific Research from the Ministry of Health, Welfare, and Labor of Japan (26-4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleksandra S, 2011, J AFFECT DISORDERS, V134, P138, DOI [10.1016/j.jad.2011.06.020, DOI 10.1016/J.JAD.2011.06.020]; Barr CS, 2009, P NATL ACAD SCI USA, V106, P14593, DOI 10.1073/pnas.0902863106; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BEHAN DP, 1995, FRONT NEUROENDOCRIN, V16, P362, DOI 10.1006/frne.1995.1013; Bevilacqua L, 2011, NATURE, V470, DOI 10.1038/nature09808; Binder EB, 2010, ARCH GEN PSYCHIAT, V67, P369, DOI 10.1001/archgenpsychiatry.2010.18; Bogdan R, 2010, GENES BRAIN BEHAV, V9, P658, DOI 10.1111/j.1601-183X.2010.00600.x; Bradley RG, 2008, ARCH GEN PSYCHIAT, V65, P190, DOI 10.1001/archgenpsychiatry.2007.26; Claes S, 2003, BIOL PSYCHIAT, V54, P867, DOI 10.1016/S0006-3223(03)00425-6; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; Coste SC, 2000, NAT GENET, V24, P403, DOI 10.1038/74255; Davydow DS, 2014, J CRIT CARE, V29, P101, DOI 10.1016/j.jcrc.2013.08.016; de Kloet CS, 2007, PROG BRAIN RES, V167, P287, DOI 10.1016/S0079-6123(07)67025-3; De Luca V, 2010, J PSYCHOPHARMACOL, V24, P677, DOI 10.1177/0269881108097817; Dekker MJHJ, 2012, J CLIN ENDOCR METAB, V97, pE233, DOI 10.1210/jc.2011-0601; Enoch MA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003620; Fujisawa TX, 2011, NEUROENDOCRINOL LETT, V32, P836; Fukuda K, 1973, Seishin Shinkeigaku Zasshi, V75, P673; Fukudo S, 2009, NEUROIMAGE, V47, P946, DOI 10.1016/j.neuroimage.2009.04.083; Fukudo S, 2007, J GASTROENTEROL, V42, P48, DOI 10.1007/s00535-006-1942-7; Grover M, 2008, CURR OPIN PHARMACOL, V8, P715, DOI 10.1016/j.coph.2008.07.012; Henry BA, 2005, J NEUROENDOCRINOL, V17, P135, DOI 10.1111/j.1365-2826.2005.01274.x; Iwahasi S, 2002, JPN J PSYCHOSOM MED, V42, P459; Jahn O, 2005, MINI-REV MED CHEM, V5, P953, DOI 10.2174/138955705774329500; Kanazawa M, 2004, DIGEST DIS SCI, V49, P1046, DOI 10.1023/B:DDAS.0000034570.52305.10; Kapeller J, 2009, GASTROENTEROLOGY, V136, pA155; Keck ME, 2008, AM J MED GENET B, V147B, P1196, DOI 10.1002/ajmg.b.30750; Korte SM, 2005, NEUROSCI BIOBEHAV R, V29, P3, DOI 10.1016/j.neubiorev.2004.08.009; Levran O, 2014, ANN HUM GENET, V78, P290, DOI 10.1111/ahg.12064; Levy RL, 2006, GASTROENTEROLOGY, V130, P1447, DOI 10.1053/j.gastro.2005.11.057; Li YY, 2007, DIGEST DIS SCI, V52, P2942, DOI 10.1007/s10620-006-9679-y; Licinio J, 2004, MOL PSYCHIATR, V9, P1075, DOI 10.1038/sj.mp.4001587; Liu ZC, 2006, NEUROSCI LETT, V404, P358, DOI 10.1016/j.neulet.2006.06.016; Longstreth GF, 2006, GASTROENTEROLOGY, V130, P1480, DOI 10.1053/j.gastro.2005.11.061; Lovell RM, 2012, CLIN GASTROENTEROL H, V10, P712, DOI 10.1016/j.cgh.2012.02.029; McEwen Bruce S, 2006, Dialogues Clin Neurosci, V8, P367; NAKAZATO K, 1989, PERCEPT MOTOR SKILL, V69, P611, DOI 10.2466/pms.1989.69.2.611; NIESLER B, 2009, EUR J GASTROENTEROL; OWENS MJ, 1991, PHARMACOL REV, V43, P425; Polanczyk G, 2009, ARCH GEN PSYCHIAT, V66, P978, DOI 10.1001/archgenpsychiatry.2009.114; POTTER E, 1994, P NATL ACAD SCI USA, V91, P8777, DOI 10.1073/pnas.91.19.8777; Ray LA, 2011, ALCOHOL CLIN EXP RES, V35, P166, DOI 10.1111/j.1530-0277.2010.01333.x; Riedl A, 2008, J PSYCHOSOM RES, V64, P573, DOI 10.1016/j.jpsychores.2008.02.021; Sagami Y, 2004, GUT, V53, P958, DOI 10.1136/gut.2003.018911; Sanchez-Martin JR, 2011, PSYCHONEUROENDOCRINO, V36, P750, DOI 10.1016/j.psyneuen.2010.10.011; Sapolsky RM, 2001, COPING ENV NEURAL EN, P517; Sato N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042450; Seasholtz AF, 2002, J ENDOCRINOL, V175, P89, DOI 10.1677/joe.0.1750089; Sikander A, 2009, J CLIN GASTROENTEROL, V43, P957, DOI 10.1097/MCG.0b013e3181b37e8c; Southwick SM, 2005, ANNU REV CLIN PSYCHO, V1, P255, DOI 10.1146/annurev.clinpsy.1.102803.143948; Speert DB, 2002, ENDOCRINOLOGY, V143, P4730, DOI 10.1210/en.2002-220556; Speilberger, 1970, STAI MANUAL, P23; Talley NJ, 2008, NEUROGASTROENT MOTIL, V20, P121, DOI 10.1111/j.1365-2982.2008.01097.x; Tsartsali L, 2012, NEUROIMMUNOMODULAT, V19, P88, DOI 10.1159/000329592; VALE W, 1981, SCIENCE, V213, P1394, DOI 10.1126/science.6267699; van de Stolpe A, 2004, MOL ENDOCRINOL, V18, P2908, DOI 10.1210/me.2003-0446; Van Den Eede F, 2007, PSYCHIAT RES, V153, P17, DOI 10.1016/j.psychres.2006.12.018; van der Veek PPJ, 2005, EUR J GASTROEN HEPAT, V17, pA26; Villani A, 2009, GASTROENTEROLOGY, V296, pG211; Wasserman D, 2008, GENES BRAIN BEHAV, V7, P14, DOI 10.1111/j.1601-183X.2007.00310.x; WHITEHEAD WE, 1994, HEALTH PSYCHOL, V13, P99, DOI 10.1037/0278-6133.13.2.99; ZUNG WWK, 1965, ARCH GEN PSYCHIAT, V12, P63, DOI 10.1001/archpsyc.1965.01720310065008	62	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0149322	10.1371/journal.pone.0149322	http://dx.doi.org/10.1371/journal.pone.0149322			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	26882083	Green Submitted, gold, Green Published			2022-12-26	WOS:000371219000071
J	Wolmetz, M; Elhilali, M				Wolmetz, Michael; Elhilali, Mounya			Attentional and Contextual Priors in Sound Perception	PLOS ONE			English	Article							HUMAN AUDITORY-CORTEX; INATTENTIONAL BLINDNESS; ORIENTATION PERCEPTION; SELECTIVE ATTENTION; SPATIAL ATTENTION; DYNAMIC EVENTS; FREQUENCY; NOISE; REPRESENTATION; EXPECTATIONS	Behavioral and neural studies of selective attention have consistently demonstrated that explicit attentional cues to particular perceptual features profoundly alter perception and performance. The statistics of the sensory environment can also provide cues about what perceptual features to expect, but the extent to which these more implicit contextual cues impact perception and performance, as well as their relationship to explicit attentional cues, is not well understood. In this study, the explicit cues, or attentional prior probabilities, and the implicit cues, or contextual prior probabilities, associated with different acoustic frequencies in a detection task were simultaneously manipulated. Both attentional and contextual priors had similarly large but independent impacts on sound detectability, with evidence that listeners tracked and used contextual priors for a variety of sound classes (pure tones, harmonic complexes, and vowels). Further analyses showed that listeners updated their contextual priors rapidly and optimally, given the changing acoustic frequency statistics inherent in the paradigm. A Bayesian Observer model accounted for both attentional and contextual adaptations found with listeners. These results bolster the interpretation of perception as Bayesian inference, and suggest that some effects attributed to selective attention may be a special case of contextual prior integration along a feature axis.	[Wolmetz, Michael] Johns Hopkins Univ, Appl Neurosci Sect, Appl Phys Lab, 11100 Johns Hopkins Rd, Laurel, MD 20723 USA; [Elhilali, Mounya] Johns Hopkins Univ, Dept Elect & Comp Engn, 3400 N Charles St,Barton Hall,Rm 105, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; Johns Hopkins University	Elhilali, M (corresponding author), Johns Hopkins Univ, Dept Elect & Comp Engn, 3400 N Charles St,Barton Hall,Rm 105, Baltimore, MD 21218 USA.	mounya@jhu.edu	Elhilali, Mounya/A-3396-2010	Elhilali, Mounya/0000-0003-2597-738X	National Science Foundation [IIS-0846112]; National Institutes of Health [1R01AG036424, T32 DC 23-27]; Office of Naval Research [N00014-12-1-0740, N000141010278]; NATIONAL INSTITUTE ON AGING [R01AG036424] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R13DC002327] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Naval Research(Office of Naval Research); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This research was supported by National Science Foundation grant IIS-0846112, National Institutes of Health grants 1R01AG036424 and T32 DC 23-27, and Office of Naval Research grants N00014-12-1-0740 and N000141010278. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by National Science Foundation grant IIS-0846112, National Institutes of Health grants 1R01AG036424 and T32 DC 23-27, and Office of Naval Research grants N00014-12-1-0740 and N000141010278. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors thank research assistants Katherine Simeon and Nicha Apichitsopa for their valuable suggestions and contributions to data collection.	Ahveninen J, 2006, P NATL ACAD SCI USA, V103, P14608, DOI 10.1073/pnas.0510480103; Ahveninen J, 2011, P NATL ACAD SCI USA, V108, P4182, DOI 10.1073/pnas.1016134108; Andersen SK, 2009, J VISION, V9, DOI 10.1167/9.6.2; Baluchi F, 2011, TRENDS NEUROSCI, V34, P210, DOI 10.1016/j.tins.2011.02.003; Bendor D, 2005, NATURE, V436, P1161, DOI 10.1038/nature03867; Bizley JK, 2009, J NEUROSCI, V29, P2064, DOI 10.1523/JNEUROSCI.4755-08.2009; BOTTE MC, 1995, J ACOUST SOC AM, V98, P2475, DOI 10.1121/1.414464; Chalk M, 2010, J VISION, V10, DOI 10.1167/10.8.2; Ciaramitaro VM, 2001, VISION RES, V41, P57, DOI 10.1016/S0042-6989(00)00203-0; Conway CM, 2005, J EXP PSYCHOL LEARN, V31, P24, DOI 10.1037/0278-7393.31.1.24; Cousineau D, 2005, TUTOR QUANT METHODS, V1, P42, DOI 10.20982/tqmp.01.1.p042; DAI HP, 1991, J ACOUST SOC AM, V89, P2837, DOI 10.1121/1.400721; Dalton P, 2012, COGNITION, V124, P367, DOI 10.1016/j.cognition.2012.05.012; Doherty JR, 2005, J NEUROSCI, V25, P8259, DOI 10.1523/JNEUROSCI.1821-05.2005; Feldman NH, 2009, PSYCHOL REV, V116, P752, DOI 10.1037/a0017196; Girshick AR, 2011, NAT NEUROSCI, V14, P926, DOI 10.1038/nn.2831; GLASBERG BR, 1990, HEARING RES, V47, P103, DOI 10.1016/0378-5955(90)90170-T; Green DM, 1966, SIGNAL DETECTION THE; GREENBERG GZ, 1968, J ACOUST SOC AM, V44, P1513, DOI 10.1121/1.1911290; Griffiths TL, 2006, PSYCHOL SCI, V17, P767, DOI 10.1111/j.1467-9280.2006.01780.x; Guo K, 2004, VISION RES, V44, P2349, DOI 10.1016/j.visres.2004.04.014; Hansen NC, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01052; Jazayeri M, 2006, NAT NEUROSCI, V9, P690, DOI 10.1038/nn1691; Kauramaki J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000909; Kersten D, 2004, ANNU REV PSYCHOL, V55, P271, DOI 10.1146/annurev.psych.55.090902.142005; Kingdom F, 2009, PALAMEDES MATLAB ROU; Knill DC, 2008, PERCEPTION AS BAYESI; Kover H, 2010, CORTICAL PLASTICITY, V5; Luck SJ, 1997, J NEUROPHYSIOL, V77, P24, DOI 10.1152/jn.1997.77.1.24; Ma WJ, 2011, NAT NEUROSCI, V14, P783, DOI 10.1038/nn.2814; MONDOR TA, 1994, PERCEPT PSYCHOPHYS, V56, P268, DOI 10.3758/BF03209761; Norris D, 2006, PSYCHOL REV, V113, P327, DOI 10.1037/0033-295X.113.2.327; Nostl A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048569; O'Craven KM, 1999, NATURE, V401, P584, DOI 10.1038/44134; Obleser J, 2004, J COGNITIVE NEUROSCI, V16, P31, DOI 10.1162/089892904322755539; Okamoto H, 2007, J NEUROSCI, V27, P10383, DOI 10.1523/JNEUROSCI.2963-07.2007; Peterson P, 2009, INTRO DECISION THEOR; Poor V., 1994, INTRO SIGNAL DETECTI; Raviv O, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002731; RECANZONE GH, 1993, J NEUROSCI, V13, P87; SCHARF B, 1987, PERCEPT PSYCHOPHYS, V42, P215, DOI 10.3758/BF03203073; Scharf B., 1970, CRITICAL BANDS, V1, P157; SCHLAUCH RS, 1991, J ACOUST SOC AM, V90, P1332, DOI 10.1121/1.401925; Signoret C, 2011, FACILITATED AUDITORY, V2; Simons DJ, 1999, PERCEPTION, V28, P1059, DOI 10.1068/p2952; Simons DJ, 2000, TRENDS COGN SCI, V4, P147, DOI 10.1016/S1364-6613(00)01455-8; Stocker AA, 2006, NAT NEUROSCI, V9, P578, DOI 10.1038/nn1669; Summerfield C, 2009, TRENDS COGN SCI, V13, P403, DOI 10.1016/j.tics.2009.06.003; Tan MN, 2008, HEARING RES, V241, P18, DOI 10.1016/j.heares.2008.04.003; TANNER WP, 1958, J ACOUST SOC AM, V30, P919, DOI 10.1121/1.1909406; Turk-Browne NB, 2005, J EXP PSYCHOL GEN, V134, P552, DOI 10.1037/0096-3445.134.4.552; Walker KMM, 2011, J NEUROSCI, V31, P14565, DOI 10.1523/JNEUROSCI.2074-11.2011; WARREN RM, 1970, SCIENCE, V167, P392, DOI 10.1126/science.167.3917.392; Watanabe T, 2001, NATURE, V413, P844, DOI 10.1038/35101601; Whiteley L, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00100; Wright BA, 2005, J ACOUST SOC AM, V117, P1299, DOI 10.1121/1.1855771; Yaron A, 2012, NEURON, V76, P603, DOI 10.1016/j.neuron.2012.08.025	57	2	2	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0149635	10.1371/journal.pone.0149635	http://dx.doi.org/10.1371/journal.pone.0149635			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF3BP	26882228	Green Submitted, Green Published, gold			2022-12-26	WOS:000371219000082
J	Ahlstrom, C; Barkema, HW; Stevenson, K; Zadoks, RN; Biek, R; Kao, R; Trewby, H; Haupstein, D; Kelton, DF; Fecteau, G; Labrecque, O; Keefe, GP; McKenna, SLB; Tahlan, K; De Buck, J				Ahlstrom, Christina; Barkema, Herman W.; Stevenson, Karen; Zadoks, Ruth N.; Biek, Roman; Kao, Rowland; Trewby, Hannah; Haupstein, Deb; Kelton, David F.; Fecteau, Gilles; Labrecque, Olivia; Keefe, Greg P.; McKenna, Shawn L. B.; Tahlan, Kapil; De Buck, Jeroen			Genome-Wide Diversity and Phylogeography of Mycobacterium avium subsp paratuberculosis in Canadian Dairy Cattle	PLOS ONE			English	Article							CYTOKINE RESPONSES; NETWORK ANALYSIS; VARIABLE-NUMBER; SEQUENCE; MACROPHAGES; STRAINS; TUBERCULOSIS; ANNOTATION; DISEASE; HERDS	Mycobacterium avium subsp. paratuberculosis (MAP) is the causative bacterium of Johne's disease (JD) in ruminants. The control of JD in the dairy industry is challenging, but can be improved with a better understanding of the diversity and distribution of MAP subtypes. Previously established molecular typing techniques used to differentiate MAP have not been sufficiently discriminatory and/or reliable to accurately assess the population structure. In this study, the genetic diversity of 182 MAP isolates representing all Canadian provinces was compared to the known global diversity, using single nucleotide polymorphisms identified through whole genome sequencing. MAP isolates from Canada represented a subset of the known global diversity, as there were global isolates intermingled with Canadian isolates, as well as multiple global subtypes that were not found in Canada. One Type III and six "Bison type" isolates were found in Canada as well as one Type II subtype that represented 86% of all Canadian isolates. Rarefaction estimated larger subtype richness in Quebec than in other Canadian provinces using a strict definition of MAP subtypes and lower subtype richness in the Atlantic region using a relaxed definition. Significant phylogeographic clustering was observed at the inter-provincial but not at the intra-provincial level, although most major clades were found in all provinces. The large number of shared subtypes among provinces suggests that cattle movement is a major driver of MAP transmission at the herd level, which is further supported by the lack of spatial clustering on an intra-provincial scale.	[Ahlstrom, Christina; Barkema, Herman W.; De Buck, Jeroen] Univ Calgary, Calgary, AB, Canada; [Stevenson, Karen; Zadoks, Ruth N.] Moredun Res Inst, Penicuik, Midlothian, Scotland; [Zadoks, Ruth N.; Biek, Roman; Kao, Rowland; Trewby, Hannah] Univ Glasgow, Glasgow, Lanark, Scotland; [Haupstein, Deb] SaskMilk, Regina, SK, Canada; [Kelton, David F.] Univ Guelph, Guelph, ON N1G 2W1, Canada; [Fecteau, Gilles] Univ Montreal, Montreal, PQ, Canada; [Labrecque, Olivia] Lab Epidemiosurveillance Anim Quebec, St Hyacinthe, PQ, Canada; [Keefe, Greg P.; McKenna, Shawn L. B.] Univ Prince Edward Isl, Charlottetown, PE C1A 4P3, Canada; [Tahlan, Kapil] Mem Univ Newfoundland, St John, NF, Canada; [Tahlan, Kapil] Labrador, St John, NF, Canada	University of Calgary; Moredun Research Institute; University of Glasgow; University of Guelph; Universite de Montreal; University of Prince Edward Island; Memorial University Newfoundland	De Buck, J (corresponding author), Univ Calgary, Calgary, AB, Canada.	jdebuck@ucalgary.ca	Biek, Roman/AAT-8109-2020; Barkema, Herman/B-9583-2008; De Buck, Jeroen/H-5509-2018	Biek, Roman/0000-0003-3471-5357; Barkema, Herman/0000-0002-9678-8378; De Buck, Jeroen/0000-0002-4824-9580; McKenna, Shawn/0000-0002-9699-1464; Kao, Rowland/0000-0003-0919-6401; Stevenson, Karen/0000-0003-0270-9550; Zadoks, Ruth/0000-0002-1164-8000	Alberta Livestock and Meat Agency; Dairy Farmers of Canada; SaskMilk; BBSRC [BB/M01262X/1, BB/L010569/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/M01262X/1, 1096836, BB/L010569/1] Funding Source: researchfish; Alberta Innovates [201401123] Funding Source: researchfish	Alberta Livestock and Meat Agency; Dairy Farmers of Canada; SaskMilk; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Alberta Innovates	This research was supported by the Alberta Livestock and Meat Agency and Dairy Farmers of Canada. SaskMilk provided support in the form of salaries for author DH, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of all authors are articulated in the 'author contributions' section.	Ahlstrom C, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1387-6; Ahlstrom C, 2014, APPL ENVIRON MICROB, V80, P534, DOI 10.1128/AEM.03212-13; Alexander DC, 2009, J BACTERIOL, V191, P1018, DOI 10.1128/JB.01340-08; Amonsin A, 2004, J CLIN MICROBIOL, V42, P1694, DOI 10.1128/JCM.42.4.1694-1702.2004; [Anonymous], 2015, ATLANTIC JOHNES DIS; [Anonymous], 2013, ANIMAL IND MARKET IN; [Anonymous], 2015, ANIMAL IND MARKET IN; Barkema HW, 2011, ZOONOTIC PATHOGENS IN THE FOOD CHAIN, P197, DOI 10.1079/9781845936815.0197; Barkema HW, 2010, PARATUBERCULOSIS: ORGANISM, DISEASE, CONTROL, P10, DOI 10.1079/9781845936136.0010; Behr MA, 2010, INFLAMM BOWEL DIS, V16, P896, DOI 10.1002/ibd.21171; Biek R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003008; Borrmann E, 2011, VET MICROBIOL, V152, P101, DOI 10.1016/j.vetmic.2011.04.002; Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975; COLLINS DM, 1990, J CLIN MICROBIOL, V28, P1591, DOI 10.1128/JCM.28.7.1591-1596.1990; Collins DM, 2010, STRAIN CHARACTERIZAT; Coscolla Mireilla, 2010, Drug Discov Today Dis Mech, V7, pe43, DOI 10.1016/j.ddmec.2010.09.004; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Dube C, 2008, TRANSBOUND EMERG DIS, V55, P382, DOI 10.1111/j.1865-1682.2008.01053.x; Gardy JL, 2011, NEW ENGL J MED, V364, P730, DOI 10.1056/NEJMoa1003176; Gollnick NS, 2007, VET IMMUNOL IMMUNOP, V120, P93, DOI 10.1016/j.vetimm.2007.07.017; Green DM, 2008, P R SOC B, V275, P1001, DOI 10.1098/rspb.2007.1601; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Janagama HK, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-10; Keim P, 2004, INFECT GENET EVOL, V4, P205, DOI 10.1016/j.meegid.2004.02.005; Lavers CJ, 2013, CAN VET J, V54, P1053; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr931, 10.1093/nar/gkr201]; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li LL, 2005, P NATL ACAD SCI USA, V102, P12344, DOI 10.1073/pnas.0505662102; McKenna SLB, 2006, CAN VET J, V47, P1089; Motiwala AS, 2006, INFECT IMMUN, V74, P6046, DOI 10.1128/IAI.00326-06; Nouvellet P, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0061588, 10.1371/currents.outbreaks.097a904d3f3619db2fe78d24bc776098]; Parker J, 2008, INFECT GENET EVOL, V8, P239, DOI 10.1016/j.meegid.2007.08.001; R Core Team, R LANG ENV STAT COMP; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Sohal JS, 2014, J CLIN MICROBIOL, V52, P2764, DOI 10.1128/JCM.00386-14; Strimmer K, 1997, P NATL ACAD SCI USA, V94, P6815, DOI 10.1073/pnas.94.13.6815; Thibault VC, 2007, J CLIN MICROBIOL, V45, P2404, DOI 10.1128/JCM.00476-07; VARY PH, 1990, J CLIN MICROBIOL, V28, P933, DOI 10.1128/JCM.28.5.933-937.1990; Whittington RJ, 2001, MOL CELL PROBE, V15, P139, DOI 10.1006/mcpr.2001.0346; Wolf R, 2014, J DAIRY SCI, V97, P6250, DOI 10.3168/jds.2014-8101; Wynne JW, 2010, J BACTERIOL, V192, P6319, DOI 10.1128/JB.00972-10	43	20	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149017	10.1371/journal.pone.0149017	http://dx.doi.org/10.1371/journal.pone.0149017			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26871723	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000370054100089
J	Allison, JR; Lechner, M; Hoeppner, MP; Poole, AM				Allison, Jane R.; Lechner, Marcus; Hoeppner, Marc P.; Poole, Anthony M.			Positive Selection or Free to Vary? Assessing the Functional Significance of Sequence Change Using Molecular Dynamics	PLOS ONE			English	Article							BRANCH-SITE; RNA; EVOLUTION; VIRUS; GENES; RECOGNITION; SIMULATIONS; SUPPRESSION; PREDICTION; ORIGINS	Evolutionary arms races between pathogens and their hosts may be manifested as selection for rapid evolutionary change of key genes, and are sometimes detectable through sequence-level analyses. In the case of protein-coding genes, such analyses frequently predict that specific codons are under positive selection. However, detecting positive selection can be non-trivial, and false positive predictions are a common concern in such analyses. It is therefore helpful to place such predictions within a structural and functional context. Here, we focus on the p19 protein from tombusviruses. P19 is a homodimer that sequesters siRNAs, thereby preventing the host RNAi machinery from shutting down viral infection. Sequence analysis of the p19 gene is complicated by the fact that it is constrained at the sequence level by overprinting of a viral movement protein gene. Using homology modeling, in silico mutation and molecular dynamics simulations, we assess how non-synonymous changes to two residues involved in forming the dimer interface-one invariant, and one predicted to be under positive selection-impact molecular function. Interestingly, we find that both observed variation and potential variation (where a non-synonymous change to p19 would be synonymous for the overprinted movement protein) does not significantly impact protein structure or RNA binding. Consequently, while several methods identify residues at the dimer interface as being under positive selection, MD results suggest they are functionally indistinguishable from a site that is free to vary. Our analyses serve as a caveat to using sequence-level analyses in isolation to detect and assess positive selection, and emphasize the importance of also accounting for how non-synonymous changes impact structure and function.	[Allison, Jane R.] Massey Univ Albany, Ctr Theoret Chem & Phys, Auckland, New Zealand; [Allison, Jane R.] Massey Univ Albany, Inst Nat & Math Sci, Auckland, New Zealand; [Allison, Jane R.; Poole, Anthony M.] Univ Canterbury, Biomol Interact Ctr, Christchurch 1, New Zealand; [Allison, Jane R.] Massey Univ Albany, Maurice Wilkins Ctr Mol Biodiscovery, Auckland, New Zealand; [Lechner, Marcus] Univ Marburg, Dept Pharmaceut Chem, Marburg, Germany; [Hoeppner, Marc P.] Univ Kiel, Inst Clin Mol Biol, Kiel, Germany; [Poole, Anthony M.] Univ Canterbury, Sch Biol Sci, Christchurch 1, New Zealand	Massey University; Massey University; University of Canterbury; Massey University; University of Auckland; Philipps University Marburg; University of Kiel; University of Canterbury	Allison, JR (corresponding author), Massey Univ Albany, Ctr Theoret Chem & Phys, Auckland, New Zealand.; Allison, JR (corresponding author), Massey Univ Albany, Inst Nat & Math Sci, Auckland, New Zealand.; Allison, JR; Poole, AM (corresponding author), Univ Canterbury, Biomol Interact Ctr, Christchurch 1, New Zealand.; Allison, JR (corresponding author), Massey Univ Albany, Maurice Wilkins Ctr Mol Biodiscovery, Auckland, New Zealand.; Poole, AM (corresponding author), Univ Canterbury, Sch Biol Sci, Christchurch 1, New Zealand.	j.allison@massey.ac.nz; anthony.poole@canterbury.ac.nz	Allison, Jane R/E-9582-2010	Allison, Jane R/0000-0002-5699-1726; Poole, Anthony/0000-0001-9940-2824	Royal Society of New Zealand Marsden Fund Fast Start award [13-MAU-039]; Royal Society of New Zealand Rutherford Discovery Fellowship [RDF-11-UOC-013]; Biomolecular Interaction Centre, University of Canterbury; Massey University Research Fund Early Career Grant; Swedish Research Council; Marsden Fund Fast Start award [13-MAU-039]; Rutherford Discovery Fellowships programme of the Royal Society of New Zealand; Biomolecular Interaction Centre at the University of Canterbury	Royal Society of New Zealand Marsden Fund Fast Start award; Royal Society of New Zealand Rutherford Discovery Fellowship(Royal Society of New Zealand); Biomolecular Interaction Centre, University of Canterbury; Massey University Research Fund Early Career Grant; Swedish Research Council(Swedish Research CouncilEuropean Commission); Marsden Fund Fast Start award(Royal Society of New ZealandMarsden Fund (NZ)); Rutherford Discovery Fellowships programme of the Royal Society of New Zealand; Biomolecular Interaction Centre at the University of Canterbury	The authors received funding from the following sources: Royal Society of New Zealand Marsden Fund Fast Start award (13-MAU-039) to JRA; Royal Society of New Zealand Rutherford Discovery Fellowship (RDF-11-UOC-013) to AMP; Biomolecular Interaction Centre, University of Canterbury (to AMP, JRA); Massey University Research Fund Early Career Grant (to JRA); and Swedish Research Council (to AMP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to acknowledge the high performance computing facility at the University of Canterbury (UC HPC) for provision of supercomputing facilities, and financial support from the Biomolecular Interaction Centre at the University of Canterbury (JRA, AMP). JRA acknowledges support from a Massey University Research Fund Early Career Grant and a Marsden Fund Fast Start award (13-MAU-039). AMP acknowledges current support via the Rutherford Discovery Fellowships programme of the Royal Society of New Zealand, and past support from the Swedish Research Council.	Belshaw R, 2007, GENOME RES, V17, P1496, DOI 10.1101/gr.6305707; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Chamary JV, 2006, NAT REV GENET, V7, P98, DOI 10.1038/nrg1770; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Ding KY, 2005, MOL BIOL EVOL, V22, P148, DOI 10.1093/molbev/msh266; Dunoyer P, 2010, SCIENCE, V328, P912, DOI 10.1126/science.1185880; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Feller SE, 2000, J PHYS CHEM B, V104, P7510, DOI 10.1021/jp0007843; Firth AE, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-75; Galiana-Arnoux D, 2006, NAT IMMUNOL, V7, P590, DOI 10.1038/ni1335; Guindon S, 2009, METHODS MOL BIOL, V537, P113, DOI 10.1007/978-1-59745-251-9_6; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Hughes AL, 2001, J VIROL, V75, P7966, DOI 10.1128/JVI.75.17.7966-7972.2001; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Incarbone M, 2013, TRENDS PLANT SCI, V18, P382, DOI 10.1016/j.tplants.2013.04.001; Izaguirre JA, 2001, J CHEM PHYS, V114, P2090, DOI 10.1063/1.1332996; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; KEESE P, 1993, CURR OPIN GENET DEV, V3, P873, DOI 10.1016/0959-437X(93)90007-C; KEESE PK, 1992, P NATL ACAD SCI USA, V89, P9489, DOI 10.1073/pnas.89.20.9489; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Klauda JB, 2005, J PHYS CHEM B, V109, P5300, DOI 10.1021/jp0468096; Li F, 2006, ANNU REV MICROBIOL, V60, P503, DOI 10.1146/annurev.micro.60.080805.142205; Lu R, 2005, NATURE, V436, P1040, DOI 10.1038/nature03870; Merai Z, 2005, J VIROL, V79, P7217, DOI 10.1128/JVI.79.11.7217-7226.2005; Nozawa M, 2009, P NATL ACAD SCI USA, V106, P6700, DOI 10.1073/pnas.0901855106; Obbard DJ, 2006, CURR BIOL, V16, P580, DOI 10.1016/j.cub.2006.01.065; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pond SK, 2005, MOL BIOL EVOL, V22, P2375, DOI 10.1093/molbev/msi232; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rubinstein ND, 2011, MOL BIOL EVOL, V28, P3297, DOI 10.1093/molbev/msr162; Ruiz-Ferrer V, 2007, BIOESSAYS, V29, P319, DOI 10.1002/bies.20556; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sabath N, 2012, MOL BIOL EVOL, V29, P3767, DOI 10.1093/molbev/mss179; Scholthof HB, 2006, NAT REV MICROBIOL, V4, P405, DOI 10.1038/nrmicro1395; Schott G, 2012, EMBO J, V31, P2553, DOI 10.1038/emboj.2012.92; Shabalina SA, 2008, TRENDS ECOL EVOL, V23, P578, DOI 10.1016/j.tree.2008.06.005; Suzuki Y, 2004, MOL BIOL EVOL, V21, P914, DOI 10.1093/molbev/msh098; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Vargason JM, 2003, CELL, V115, P799, DOI 10.1016/S0092-8674(03)00984-X; Wang XH, 2006, SCIENCE, V312, P452, DOI 10.1126/science.1125694; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Ye KQ, 2003, NATURE, V426, P874, DOI 10.1038/nature02213; Zambon RA, 2006, CELL MICROBIOL, V8, P880, DOI 10.1111/j.1462-5822.2006.00688.x	45	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0147619	10.1371/journal.pone.0147619	http://dx.doi.org/10.1371/journal.pone.0147619			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26871901	Green Published, gold, Green Submitted			2022-12-26	WOS:000370054100009
J	Lopez-Cortes, LF; Castano, MA; Lopez-Ruz, MA; Rios-Villegas, MJ; Hernandez-Quero, J; Merino, D; Jimenez-Aguilar, P; Marquez-Solero, M; Terron-Pernia, A; Tellez-Perez, F; Viciana, P; Orihuela-Canadas, F; Palacios-Baena, Z; Vinuesa-Garcia, D; Fajardo-Pico, JM; Romero-Palacios, A; Ojeda-Burgos, G; Pasquau-Liano, J				Lopez-Cortes, Luis F.; Castano, Manuel A.; Lopez-Ruz, Miguel A.; Rios-Villegas, Maria J.; Hernandez-Quero, Jose; Merino, Dolores; Jimenez-Aguilar, Patricia; Marquez-Solero, Manuel; Terron-Pernia, Alberto; Tellez-Perez, Francisco; Viciana, Pompeyo; Orihuela-Canadas, Francisco; Palacios-Baena, Zaira; Vinuesa-Garcia, David; Fajardo-Pico, Jose M.; Romero-Palacios, Alberto; Ojeda-Burgos, Guillermo; Pasquau-Liano, Juan			Effectiveness of Ritonavir-Boosted Protease Inhibitor Monotherapy in Clinical Practice Even with Previous Virological Failures to Protease Inhibitor-Based Regimens	PLOS ONE			English	Article							LOPINAVIR/RITONAVIR MONOTHERAPY; MAINTENANCE THERAPY; DARUNAVIR/RITONAVIR MONOTHERAPY; VIRAL SUPPRESSION; INDUCTION THERAPY; HIV-1 INFECTION; EFFICACY; TRIAL; RNA	Background and Objective Significant controversy still exists about ritonavir-boosted protease inhibitor monotherapy (mtPI/rtv) as a simplification strategy that is used up to now to treat patients that have not experienced previous virological failure (VF) while on protease inhibitor (PI) -based regimens. We have evaluated the effectiveness of two mtPI/rtv regimens in an actual clinical practice setting, including patients that had experienced previous VF with PI-based regimens. Methods This retrospective study analyzed 1060 HIV-infected patients with undetectable viremia that were switched to lopinavir/ritonavir or darunavir/ritonavir monotherapy. In cases in which the patient had previously experienced VF while on a PI-based regimen, the lack of major HIV protease resistance mutations to lopinavir or darunavir, respectively, was mandatory. The primary endpoint of this study was the percentage of participants with virological suppression after 96 weeks according to intention-to-treat analysis (non-complete/missing = failure). Results A total of 1060 patients were analyzed, including 205 with previous VF while on PI-based regimens, 90 of whom were on complex therapies due to extensive resistance. The rates of treatment effectiveness (intention-to-treat analysis) and virological efficacy (on-treatment analysis) at week 96 were 79.3% (CI95, 76.8-81.8) and 91.5% (CI95, 89.6-93.4), respectively. No relationships were found between VF and earlier VF while on PI-based regimens, the presence of major or minor protease resistance mutations, the previous time on viral suppression, CD4(+) T-cell nadir, and HCV-coinfection. Genotypic resistance tests were available in 49 out of the 74 patients with VFs and only four patients presented new major protease resistance mutations. Conclusion Switching to mtPI/rtv achieves sustained virological control in most patients, even in those with previous VF on PI-based regimens as long as no major resistance mutations are present for the administered drug.	[Lopez-Cortes, Luis F.; Viciana, Pompeyo] Univ Seville, CSIC, Hosp Univ Virgen del Rocio, Inst Biomed Sevilla, Seville, Spain; [Castano, Manuel A.; Orihuela-Canadas, Francisco] Hosp Univ Carlos Haya, Malaga, Spain; [Lopez-Ruz, Miguel A.; Pasquau-Liano, Juan] Hosp Univ Virgen de las Nieves, Granada, Spain; [Rios-Villegas, Maria J.; Palacios-Baena, Zaira] Hosp Univ Virgen Macarena, Seville, Spain; [Hernandez-Quero, Jose] Hosp Univ San Cecilio, Granada, Spain; [Merino, Dolores; Fajardo-Pico, Jose M.] Complejo Hosp Juan Ramon Jimenez, Huelva, Spain; [Jimenez-Aguilar, Patricia; Romero-Palacios, Alberto] Hosp Univ Puerto Real, Cadiz, Spain; [Marquez-Solero, Manuel; Ojeda-Burgos, Guillermo] Hosp Univ Virgen de la Victoria, Malaga, Spain; [Terron-Pernia, Alberto] Hosp Jerez de la Frontera, Cadiz, Spain; [Tellez-Perez, Francisco] Hosp La Linea, Cadiz, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital; Hospital Carlos Haya; Hospital Universitario Virgen de las Nieves; Hospital Universitario Virgen Macarena; Hospital Universitario San Cecilio; Universidad de Cadiz; Hospital Universitario Puerto Real; Hospital Virgen de la Victoria; Universidad de Malaga; Hospital de Jerez	Lopez-Cortes, LF (corresponding author), Univ Seville, CSIC, Hosp Univ Virgen del Rocio, Inst Biomed Sevilla, Seville, Spain.	lflopez@us.es	Lopez.Cortes, Luis Fernando/W-8323-2019; IBIS, VIH/O-8856-2015	Lopez.Cortes, Luis Fernando/0000-0002-3804-3458; Romero Palacios, Alberto/0000-0003-1345-4901; Tellez, Francisco/0000-0002-9997-6761; Ojeda Burgos, Guillermo/0000-0003-0544-4690; Palacios-Baena, Zaira R./0000-0002-1713-6807	Abbvie laboratories (Spain); Bristol-Myers Squibb; Glaxo Smithkline; Gilead Sciences; Janssen Espana; Merck Sharp Dohme Espana; Roche Pharma SA; ViiV Healthcare; Abbott laboratories (Spain); Janssen; Abbvie laboratories; Merck Sharp Dohme; Roche Pharma	Abbvie laboratories (Spain)(AbbVie); Bristol-Myers Squibb(Bristol-Myers Squibb); Glaxo Smithkline(GlaxoSmithKline); Gilead Sciences(Gilead Sciences); Janssen Espana; Merck Sharp Dohme Espana(Merck & Company); Roche Pharma SA; ViiV Healthcare; Abbott laboratories (Spain); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Abbvie laboratories(AbbVie); Merck Sharp Dohme(Merck & Company); Roche Pharma	FL and PV have received unrestricted grants for research and personal fees for speaking at symposia on behalf of Abbvie laboratories (Spain), Bristol-Myers Squibb, Glaxo Smithkline, Gilead Sciences, Janssen Espana, Merck Sharp & Dohme Espana, Roche Pharma SA, and ViiV Healthcare. MAL and MM have received unrestricted research grants and personal fees for speaking at symposia on behalf of Abbott laboratories (Spain), Janssen Espana, Merck Sharp & Dohme Espana, and ViiV Healthcare. JP has received unrestricted grants for research and speaker honoraria from Bristol-Myers Squibb, Janssen, Abbvie laboratories, Merck Sharp & Dohme, ViiV Healthcare, Gilead Sciences and Roche Pharma. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials. All other authors have no competing interests to declare.	*AIDS CLIN TRIALS, 1996, TABL GRAD SEV AD ADV; Arribas JR, 2013, AIDS RES THER, V10, DOI 10.1186/1742-6405-10-3; Arribas JR, 2009, JAIDS-J ACQ IMM DEF, V51, P147, DOI 10.1097/QAI.0b013e3181a56de5; Arribas JR, 2005, JAIDS-J ACQ IMM DEF, V40, P280, DOI 10.1097/01.qai.0000180077.59159.f4; BenMarzouk-Hidalgo OJ, 2014, CLIN MICROBIOL INFEC, V20, P1297, DOI 10.1111/1469-0691.12521; Brogan AJ, 2010, HIV CLIN TRIALS, V11, P133, DOI 10.1310/hct1103-133; Clumeck N, 2011, J ANTIMICROB CHEMOTH, V66, P1878, DOI 10.1093/jac/dkr199; Department for Health and Human Services, 2015, GUID US ANT AG HIV 1; Estebanez M, 2014, JAIDS-J ACQ IMM DEF, V67, P419, DOI 10.1097/QAI.0000000000000337; European AIDS Clinical Society, 2015, EUR GUID TREATM HIV; European AIDS Clinical Society (EACS), 2009, EUROPEAN AIDS CLIN S; Gunthard HF, 2014, JAMA-J AM MED ASSOC, V312, P410, DOI 10.1001/jama.2014.8722; Havlir DV, 1998, NEW ENGL J MED, V339, P1261, DOI 10.1056/NEJM199810293391801; Hoen B, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.19034; Johnson Victoria A, 2010, Top HIV Med, V18, P156; Lambert-Niclot S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041390; Lambert-Niclot S, 2011, J INFECT DIS, V204, P1211, DOI 10.1093/infdis/jir518; Lambert-Niclot S, 2010, ANTIMICROB AGENTS CH, V54, P4910, DOI 10.1128/AAC.00725-10; Mathis S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022003; Meynard JL, 2010, J ANTIMICROB CHEMOTH, V65, P2436, DOI 10.1093/jac/dkq327; Panel de expertos de GeSIDA y Plan Nacional sobre el Sida, 2015, DOC CONS GES PLAN NA; Panel Expertos Gesida & Plan Nacl, 2009, ENFERM INFEC MICR CL, V27, P222, DOI 10.1016/j.eimc.2008.11.002; Pasquau J, 2012, APPL HEALTH ECON HEA, V10, P139, DOI 10.2165/11598380-000000000-00000; Perez-Valero I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069493; Pialoux G, 1998, NEW ENGL J MED, V339, P1269, DOI 10.1056/NEJM199810293391802; Pulido F, 2008, J ANTIMICROB CHEMOTH, V61, P1359, DOI 10.1093/jac/dkn103; Pulido F, 2009, ANTIVIR THER, V14, P195; Reijers MHE, 1998, LANCET, V352, P185, DOI 10.1016/S0140-6736(98)06193-5; Ruelle J, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-100; Torres-Cornejo A, 2014, AIDS, V28, P201, DOI 10.1097/QAD.0000000000000060; Valantin MA, 2012, J ANTIMICROB CHEMOTH, V67, P691, DOI 10.1093/jac/dkr504; Verhofstede C, 2010, J CLIN VIROL, V47, P335, DOI 10.1016/j.jcv.2010.01.008; Vinuesa D, 2014, AIDS, V28, P1835, DOI 10.1097/QAD.0000000000000312; Williams I, 2014, HIV MED, V15, P1, DOI 10.1111/hiv.12119; Yeh RF, 2007, 11 EUR AIDS CLIN SOC	35	15	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0148924	10.1371/journal.pone.0148924	http://dx.doi.org/10.1371/journal.pone.0148924			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26872331	gold, Green Published			2022-12-26	WOS:000370054100075
J	Zheng, D; Gui, B; Gray, KP; Tinay, I; Rafiei, S; Huang, Q; Sweeney, CJ; Kibel, AS; Jia, L				Zheng, D.; Gui, B.; Gray, K. P.; Tinay, I.; Rafiei, S.; Huang, Q.; Sweeney, C. J.; Kibel, A. S.; Jia, L.			Secretory leukocyte protease inhibitor is a survival and proliferation factor for castration-resistant prostate cancer	ONCOGENE			English	Article							RECEPTOR-MEDIATED TRANSCRIPTION; SERINE PROTEINASE-INHIBITORS; GRANULIN-EPITHELIN PRECURSOR; GROWTH-FACTOR; EXPRESSION; PROGRESSION; GENES; MODEL; OVEREXPRESSION; INFLAMMATION	Androgen receptor (AR)-mediated gene expression continues to have a critical role in promoting castration-resistant prostate cancer (CRPC) survival and growth even after androgen deprivation therapy. AR cistrome analyses in CRPC cells have identified a large number of AR target genes involved in proliferative and cell cycle-related functions, and hold promise for development of novel therapeutic approaches for CRPC. However, there is little understanding of how these genes function in vivo and what the clinical implications are. We previously reported that secretory leukocyte peptidase inhibitor (SLPI) is regulated by the AR in a ligand-independent manner in CRPC cells and required for CRPC cell proliferation under androgen-deprived conditions. SLPI is a secreted serine protease inhibitor, which is overexpressed in a number of cancers, including lung, breast and ovarian cancer, and involved in tumor progression. However, the oncogenic potential of SLPI in prostate cancer remains unknown. Here we provide the first evidence that SLPI is upregulated in a subset of CRPC cell lines and CRPC patient tumors. In addition, serum SLPI levels are significantly elevated in metastatic CRPC patients compared with hormone naive patients, raising the possibility that this could serve as a biomarker. We demonstrated that SLPI expression has functional significance, as it promotes CRPC cell survival and growth after androgen withdrawal in vivo and in vitro. Last, we demonstrated that the oncogenic effect of SLPI may be due to protection of growth factor progranulin from enzymatic cleavage or suppression of CRPC cell apoptosis independent of anti-protease activity of SLPI. These findings implicate SLPI as a potential biomarker of resistance to AR inhibition and therapeutic target for CRPC treatment.	[Zheng, D.; Huang, Q.] Washington Univ, Sch Med, Dept Med, Ctr Pharmacogen, St Louis, MO 63110 USA; [Gui, B.; Tinay, I.; Rafiei, S.; Kibel, A. S.; Jia, L.] Brigham & Womens Hosp, Dept Surg, Div Urol, 45 Francis St,ASB 2-3, Boston, MA 02115 USA; [Gui, B.; Tinay, I.; Rafiei, S.; Sweeney, C. J.; Kibel, A. S.; Jia, L.] Harvard Med Sch, 45 Francis St,ASB 2-3, Boston, MA 02115 USA; [Gray, K. P.] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Gray, K. P.] Harvard Sch Publ Hlth, Boston, MA USA; [Sweeney, C. J.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA	Washington University (WUSTL); Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Dana-Farber Cancer Institute	Jia, L (corresponding author), Brigham & Womens Hosp, Dept Surg, Div Urol, 45 Francis St,ASB 2-3, Boston, MA 02115 USA.; Jia, L (corresponding author), Harvard Med Sch, 45 Francis St,ASB 2-3, Boston, MA 02115 USA.	ljia@bwh.harvard.edu	Zheng, Dali/J-2973-2019	Zheng, Dali/0000-0003-2345-4040	Anthony DiNovi Fund; 'Turkiye Kanserle Savas Vakfi' Scholarship Program	Anthony DiNovi Fund; 'Turkiye Kanserle Savas Vakfi' Scholarship Program	This work was supported by Anthony DiNovi Fund. Ilker Tinay was partially supported by the 'Turkiye Kanserle Savas Vakfi' Scholarship Program.	American Cancer Society, 2015, CANC FACTS FIG 2015; Ameshima S, 2000, CANCER-AM CANCER SOC, V89, P1448, DOI 10.1002/1097-0142(20001001)89:7<1448::AID-CNCR6>3.0.CO;2-Q; Bernard B, 2015, CURR UROL REP, V16, DOI 10.1007/s11934-015-0488-8; Bouchard D, 2006, LANCET ONCOL, V7, P167, DOI 10.1016/S1470-2045(06)70579-4; Chandran UR, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-64; Cheng WL, 2008, INT J CANCER, V123, P1787, DOI 10.1002/ijc.23746; Chopra DP, 2004, CANCER LETT, V203, P145, DOI 10.1016/j.canlet.2003.09.016; Davis JS, 2011, MOL ENDOCRINOL, V25, P611, DOI 10.1210/me.2010-0312; De Bono JS, 2011, NEW ENGL J MED, V364, P1995, DOI 10.1056/NEJMoa1014618; Decker KF, 2012, NUCLEIC ACIDS RES, V40, P10765, DOI 10.1093/nar/gks888; Devoogdt N, 2003, P NATL ACAD SCI USA, V100, P5778, DOI 10.1073/pnas.1037154100; Devoogdt N, 2009, CANCER SCI, V100, P434, DOI 10.1111/j.1349-7006.2009.01076.x; Flavin R, 2014, CLIN CANCER RES, V20, P4904, DOI 10.1158/1078-0432.CCR-13-1341; Gipson TS, 1999, J IMMUNOL, V162, P3653; GRONDAHLHANSEN J, 1993, CANCER RES, V53, P2513; He ZH, 2003, J MOL MED-JMM, V81, P600, DOI 10.1007/s00109-003-0474-3; He ZH, 2003, NAT MED, V9, P225, DOI 10.1038/nm816; HIGASHIYAMA M, 1995, CANCER-AM CANCER SOC, V76, P1368, DOI 10.1002/1097-0142(19951015)76:8<1368::AID-CNCR2820760812>3.0.CO;2-N; Ho JC, 2008, HEPATOLOGY, V47, P1524, DOI 10.1002/hep.22191; Hoskins E, 2011, GYNECOL ONCOL, V122, P656, DOI 10.1016/j.ygyno.2011.04.052; Hough CD, 2000, CANCER RES, V60, P6281; Hu FH, 2010, NEURON, V68, P654, DOI 10.1016/j.neuron.2010.09.034; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jia L, 2006, MOL CELL BIOL, V26, P7331, DOI 10.1128/MCB.00581-06; Johnsen M, 1998, CURR OPIN CELL BIOL, V10, P667, DOI 10.1016/S0955-0674(98)80044-6; Karantanos T, 2013, ONCOGENE, V32, P5501, DOI 10.1038/onc.2013.206; Kataoka H, 2002, PATHOL INT, V52, P89, DOI 10.1046/j.1440-1827.2002.01320.x; Kluger HM, 2005, CANCER RES, V65, P5578, DOI 10.1158/0008-5472.CAN-05-0108; Kluger HM, 2004, LAB INVEST, V84, P320, DOI 10.1038/labinvest.3700044; Lee ECY, 2003, CELL DEATH DIFFER, V10, P761, DOI 10.1038/sj.cdd.4401228; Lentsch AB, 1999, GASTROENTEROLOGY, V117, P953, DOI 10.1016/S0016-5085(99)70355-0; Liotta LA, 2001, NATURE, V411, P375, DOI 10.1038/35077241; Lovat F, 2009, CARCINOGENESIS, V30, P861, DOI 10.1093/carcin/bgp050; Lowe AW, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000323; MCELVANEY NG, 1992, J CLIN INVEST, V90, P1296, DOI 10.1172/JCI115994; Monami G, 2009, AM J PATHOL, V174, P1037, DOI 10.2353/ajpath.2009.080735; Nukiwa T, 2008, CANCER SCI, V99, P849, DOI 10.1111/j.1349-7006.2008.00772.x; Pan CX, 2004, CLIN CANCER RES, V10, P1333, DOI 10.1158/1078-0432.CCR-1123-03; Rasool N, 2010, CLIN CANCER RES, V16, P600, DOI 10.1158/1078-0432.CCR-09-1979; Ryan CJ, 2013, NEW ENGL J MED, V368, P138, DOI 10.1056/NEJMoa1209096; Scher HI, 2012, NEW ENGL J MED, V367, P1187, DOI 10.1056/NEJMoa1207506; Shen MM, 2010, GENE DEV, V24, P1967, DOI 10.1101/gad.1965810; Simpkins FA, 2008, CARCINOGENESIS, V29, P466, DOI 10.1093/carcin/bgm212; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Song XY, 1999, J EXP MED, V190, P535, DOI 10.1084/jem.190.4.535; Taggart CC, 2005, J EXP MED, V202, P1659, DOI 10.1084/jem.20050768; Tangkeangsirisin W, 2004, CANCER RES, V64, P1737, DOI 10.1158/0008-5472.CAN-03-2364; Tanner MM, 2000, CLIN CANCER RES, V6, P1833; THALMANN GN, 1994, CANCER RES, V54, P2577; Thompson M, 2008, PROSTATE, V68, P1248, DOI 10.1002/pros.20792; Tomlins SA, 2008, CANCER CELL, V13, P519, DOI 10.1016/j.ccr.2008.04.016; Treda CJ, 2014, CARCINOGENESIS, V35, P896, DOI 10.1093/carcin/bgt382; Tsukishiro S, 2005, GYNECOL ONCOL, V96, P516, DOI 10.1016/j.ygyno.2004.10.036; Varambally S, 2005, CANCER CELL, V8, P393, DOI 10.1016/j.ccr.2005.10.001; Wagenblast E, 2015, NATURE, V520, P358, DOI 10.1038/nature14403; Wang DP, 2009, CANCER RES, V69, P9448, DOI 10.1158/0008-5472.CAN-09-1903; Zelvyte I, 2004, ANTICANCER RES, V24, P241; Zheng DL, 2013, MOL CANCER RES, V11, P482, DOI 10.1158/1541-7786.MCR-12-0520; Zhu J, 2002, CELL, V111, P867, DOI 10.1016/S0092-8674(02)01141-8	59	22	23	1	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 8	2016	35	36					4807	4815		10.1038/onc.2016.13	http://dx.doi.org/10.1038/onc.2016.13			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DW0IS	26876202				2022-12-26	WOS:000383324700013
J	Donovan, KA; Zhu, SL; Liuni, P; Peng, F; Kessans, SA; Wilson, DJ; Dobson, RCJ				Donovan, Katherine A.; Zhu, Shaolong; Liuni, Peter; Peng, Fen; Kessans, Sarah A.; Wilson, Derek J.; Dobson, Renwick C. J.			Conformational Dynamics and Allostery in Pyruvate Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELECTROSPRAY MASS-SPECTROMETRY; SITE-DIRECTED MUTAGENESIS; ESCHERICHIA-COLI; ENERGY LANDSCAPE; BINDING-SITE; CATALYSIS; PROTEINS; FRUCTOSE-1,6-BISPHOSPHATE; RECOGNITION; TRANSITIONS	Pyruvate kinase catalyzes the final step in glycolysis and is allosterically regulated to control flux through the pathway. Two models are proposed to explain how Escherichia coli pyruvate kinase type 1 is allosterically regulated: the "domain rotation model" suggests that both the domains within the monomer and the monomers within the tetramer reorient with respect to one another; the "rigid body reorientation model" proposes only a reorientation of the monomers within the tetramer causing rigidification of the active site. To test these hypotheses and elucidate the conformational and dynamic changes that drive allostery, we performed time-resolved electrospray ionization mass spectrometry coupled to hydrogen-deuterium exchange studies followed by mutagenic analysis to test the activation mechanism. Global exchange experiments, supported by thermostability studies, demonstrate that fructose 1,6-bisphosphate binding to the allosteric domain causes a shift toward a globally more dynamic ensemble of conformations. Mapping deuterium exchange to peptides within the enzyme highlight site-specific regions with altered conformational dynamics, many of which increase in conformational flexibility. Based upon these and mutagenic studies, we propose an allosteric mechanism whereby the binding of fructose 1,6-bisphosphate destabilizes an alpha-helix that bridges the allosteric and active site domains within the monomeric unit. This destabilizes the beta-strands within the (beta/alpha)(8)-barrel domain and the linked active site loops that are responsible for substrate binding. Our data are consistent with the domain rotation model but inconsistent with the rigid body reorientation model given the increased flexibility at the interdomain interface, and we can for the first time explain how fructose 1,6-bisphosphate affects the active site.	[Donovan, Katherine A.; Kessans, Sarah A.; Dobson, Renwick C. J.] Univ Canterbury, Biomol Interact Ctr, Private Bag 4800, Christchurch 8041, New Zealand; [Donovan, Katherine A.; Kessans, Sarah A.; Dobson, Renwick C. J.] Univ Canterbury, Sch Biol Sci, Private Bag 4800, Christchurch 8041, New Zealand; [Zhu, Shaolong; Liuni, Peter; Wilson, Derek J.] York Univ, Dept Chem, Toronto, ON M3J 1P3, Canada; [Peng, Fen] Univ Houston, Biol & Biochem, Houston, TX 77204 USA; [Wilson, Derek J.] York Univ, Dept Chem, Ctr Res Mass Spectrometry, 4700 Keele St, Toronto, ON M3J 1P3, Canada; [Dobson, Renwick C. J.] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Dept Biochem & Mol Biol, 30 Flemington Rd, Parkville, Vic 3010, Australia	University of Canterbury; University of Canterbury; York University - Canada; University of Houston System; University of Houston; York University - Canada; University of Melbourne	Wilson, DJ (corresponding author), York Univ, Dept Chem, Toronto, ON M3J 1P3, Canada.; Wilson, DJ (corresponding author), York Univ, Dept Chem, Ctr Res Mass Spectrometry, 4700 Keele St, Toronto, ON M3J 1P3, Canada.; Dobson, RCJ (corresponding author), Univ Canterbury, Sch Biol Sci, Biomol Interact Ctr, Private Bag 4800, Christchurch 1, New Zealand.	dkwilson@yorku.ca; renwick.dobson@canterbury.ac.nz	Dobson, Renwick/AAZ-7020-2021; Donovan, Katherine Aleisha/R-7539-2018	Dobson, Renwick/0000-0002-5506-4939; Donovan, Katherine Aleisha/0000-0002-8539-5106	Maurice Wilkins Centre; Journal of Cell Science travel fellowship; Natural Sciences and Engineering Research Council of Canada; Ministry of Business, Innovation and Employment [UOCX1208]; New Zealand Royal Society Marsden Fund [UOC1013]; United States Army Research Laboratory; United States Army Research Office [W911NF-11-1-0481]	Maurice Wilkins Centre; Journal of Cell Science travel fellowship; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Ministry of Business, Innovation and Employment(New Zealand Ministry of Business, Innovation and Employment (MBIE)); New Zealand Royal Society Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ)); United States Army Research Laboratory; United States Army Research Office	Supported by Maurice Wilkins Centre flexible research funding and a Journal of Cell Science travel fellowship.; Supported by a Natural Sciences and Engineering Research Council of Canada discovery grant.; Supported in part by Ministry of Business, Innovation and Employment Contract UOCX1208, New Zealand Royal Society Marsden Fund Contract UOC1013, and United States Army Research Laboratory and United States Army Research Office Contract/Grant W911NF-11-1-0481.	Allen SC, 1996, ACTA CRYSTALLOGR D, V52, P499, DOI 10.1107/S0907444995016040; Boehr DD, 2006, SCIENCE, V313, P1638, DOI 10.1126/science.1130258; Boehr DD, 2009, NAT CHEM BIOL, V5, P789, DOI 10.1038/nchembio.232; BOITEUX A, 1983, BIOCHEM J, V211, P631, DOI 10.1042/bj2110631; Changeux JP, 2013, NAT REV MOL CELL BIO, V14, P819, DOI 10.1038/nrm3695; del Sol A, 2009, STRUCTURE, V17, P1042, DOI 10.1016/j.str.2009.06.008; Donovan KA, 2016, ACTA CRYSTALLOGR D, V72, P512, DOI 10.1107/S205979831600142X; Eisenmesser EZ, 2005, NATURE, V438, P117, DOI 10.1038/nature04105; Fenton AW, 2008, TRENDS BIOCHEM SCI, V33, P420, DOI 10.1016/j.tibs.2008.05.009; Fenton AW, 2010, BIOCHEMISTRY-US, V49, P7202, DOI 10.1021/bi100147w; Fenton AW, 2002, ARCH BIOCHEM BIOPHYS, V397, P28, DOI 10.1006/abbi.2001.2634; FOTHERGILLGILMORE LA, 1993, PROG BIOPHYS MOL BIO, V59, P105, DOI 10.1016/0079-6107(93)90001-Z; FRAUENFELDER H, 1991, SCIENCE, V254, P1598, DOI 10.1126/science.1749933; Goodey NM, 2008, NAT CHEM BIOL, V4, P474, DOI 10.1038/nchembio.98; Hill A.V., 1910, J PHYSL, V40, pi, DOI DOI 10.1113/JPHYSIOL.1910.SP191040SUPPLTOC; Ishwar A, 2015, BIOCHEMISTRY-US, V54, P1516, DOI 10.1021/bi501426w; Jeoung NH, 2014, REV ENDOCR METAB DIS, V15, P99, DOI 10.1007/s11154-013-9284-2; Jurica MS, 1998, STRUCTURE, V6, P195, DOI 10.1016/S0969-2126(98)00021-5; Kerns SJ, 2015, NAT STRUCT MOL BIOL, V22, P124, DOI 10.1038/nsmb.2941; Kumar S, 2011, J PHYS CHEM B, V115, P6784, DOI 10.1021/jp201862a; LEVINE M, 1978, NATURE, V271, P626, DOI 10.1038/271626a0; Liuni P, 2012, ANGEW CHEM INT EDIT, V51, P9666, DOI 10.1002/anie.201204903; Lovell SC, 1998, J MOL BIOL, V276, P839, DOI 10.1006/jmbi.1997.1569; Ma BY, 2011, STRUCTURE, V19, P907, DOI 10.1016/j.str.2011.06.002; MALCOVATI M, 1982, METHOD ENZYMOL, V90, P170; Mattevi A, 1996, CURR OPIN STRUC BIOL, V6, P824, DOI 10.1016/S0959-440X(96)80013-3; Mattevi A, 1996, FEBS LETT, V389, P15, DOI 10.1016/0014-5793(96)00462-0; MATTEVI A, 1995, STRUCTURE, V3, P729, DOI 10.1016/S0969-2126(01)00207-6; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; MONOD J, 1963, J MOL BIOL, V6, P306, DOI 10.1016/S0022-2836(63)80091-1; Morgan HP, 2014, ROY SOC OPEN SCI, V1, DOI 10.1098/rsos.140120; Morgan HP, 2011, J BIOL CHEM, V286, P31232, DOI 10.1074/jbc.M110.212613; Morgan HP, 2010, J BIOL CHEM, V285, P12892, DOI 10.1074/jbc.M109.079905; Motlagh HN, 2014, NATURE, V508, P331, DOI 10.1038/nature13001; MUIRHEAD H, 1986, EMBO J, V5, P475, DOI 10.1002/j.1460-2075.1986.tb04236.x; Munoz ME, 2003, COMP BIOCHEM PHYS B, V135, P197, DOI 10.1016/S1096-4959(03)00081-2; Nussinov R, 2015, CURR OPIN STRUC BIOL, V30, P17, DOI 10.1016/j.sbi.2014.11.005; PONCE E, 1995, J BACTERIOL, V177, P5719, DOI 10.1128/jb.177.19.5719-5722.1995; Resetca D, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.595454; Rob T, 2012, ANAL CHEM, V84, P3771, DOI 10.1021/ac300365u; Rob T, 2009, J AM SOC MASS SPECTR, V20, P124, DOI 10.1016/j.jasms.2008.09.005; Smock RG, 2009, SCIENCE, V324, P198, DOI 10.1126/science.1169377; Strohalm M, 2010, ANAL CHEM, V82, P4648, DOI 10.1021/ac100818g; Suzuki H, 2014, STRUCTURE, V22, P47, DOI 10.1016/j.str.2013.09.023; Tsai CJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003394; URFER R, 1992, PROTEIN SCI, V1, P31; Valentin G, 2000, J BIOL CHEM, V275, P18145, DOI 10.1074/jbc.M001870200; WALKER D, 1992, J MOL BIOL, V228, P265, DOI 10.1016/0022-2836(92)90505-E; WAYGOOD EB, 1975, CAN J BIOCHEM CELL B, V53, P444, DOI 10.1139/o75-061; Wilson DJ, 2003, ANAL CHEM, V75, P6408, DOI 10.1021/ac0346757; Yuan Y, 2015, CHEM REV, V115, P1702, DOI 10.1021/cr500495x; Zhong WH, 2014, BIOCHEM J, V458, P301, DOI 10.1042/BJ20130790; Zhu T, 2010, BIOCHIMIE, V92, P116, DOI 10.1016/j.biochi.2009.09.016	53	24	25	2	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2016	291	17					9244	9256		10.1074/jbc.M115.676270	http://dx.doi.org/10.1074/jbc.M115.676270			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK3WV	26879751	Green Published, hybrid			2022-12-26	WOS:000374849000034
J	Laas, E; Mallon, P; Duhoux, FP; Hamidouche, A; Rouzier, R; Reyal, F				Laas, Enora; Mallon, Peter; Duhoux, Francois P.; Hamidouche, Amina; Rouzier, Roman; Reyal, Fabien			Low Concordance between Gene Expression Signatures in ER Positive HER2 Negative Breast Carcinoma Could Impair Their Clinical Application	PLOS ONE			English	Article							NOTTINGHAM-PROGNOSTIC-INDEX; ESTROGEN-RECEPTOR; RECURRENCE SCORE; IMMUNE-RESPONSE; CANCER PATIENTS; PREDICTION; SURVIVAL; RISK; CHEMOTHERAPY; METASTASIS	Background Numerous prognostic gene expression signatures have been recently described. Among the signatures there is variation in the constituent genes that are utilized. We aim to evaluate prognostic concordance among eight gene expression signatures, on a large dataset of ER positive HER2 negative breast cancers. Methods We analysed the performance of eight gene expression signatures on six different datasets of ER+ HER2- breast cancers. Survival analyses were performed using the Kaplan-Meier estimate of survival function. We assessed discrimination and concordance between the 8 signatures on survival and recurrence rates The Nottingham Prognostic Index (NPI) was used to to stratify the risk of recurrence/death. Results The discrimination ability of the whole signatures, showed fair discrimination performances, with AUC ranging from 0.64 (95% CI 0.55-0.73 for the 76-genes signatures, to 0.72 (95% CI 0.64-0.8) for the Molecular Prognosis Index T17. Low concordance was found in predicting events in the intermediate and high-risk group, as defined by the NPI. Low risk group was the only subgroup with a good signatures concordance. Conclusion Genomic signatures may be a good option to predict prognosis as most of them perform well at the population level. They exhibit, however, a high degree of discordance in the	[Laas, Enora; Mallon, Peter; Hamidouche, Amina; Rouzier, Roman; Reyal, Fabien] Inst Curie, Dept Surg, Paris, France; [Laas, Enora; Reyal, Fabien] Hop Tenon, Dept Gynaecol Surg, F-75970 Paris, France; [Duhoux, Francois P.; Reyal, Fabien] Inst Curie, Dept Med Oncol, Paris, France; [Duhoux, Francois P.; Reyal, Fabien] Catholic Univ Louvain, Clin Univ St Luc, Ctr Canc, B-1200 Brussels, Belgium; [Reyal, Fabien] Inst Curie, Translat Res Dept, Residual Tumor & Response Treatment, RT2Lab, Paris, France; [Reyal, Fabien] Inst Curie, UMR932, Immun & Canc, Paris, France; [Mallon, Peter] Craigavon Area Hosp, Breast Unit, Portadown BT63 5QQ, North Ireland	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Universite Paris Cite	Reyal, F (corresponding author), Inst Curie, Dept Surg, Paris, France.; Reyal, F (corresponding author), Hop Tenon, Dept Gynaecol Surg, F-75970 Paris, France.; Reyal, F (corresponding author), Inst Curie, Dept Med Oncol, Paris, France.; Reyal, F (corresponding author), Catholic Univ Louvain, Clin Univ St Luc, Ctr Canc, B-1200 Brussels, Belgium.; Reyal, F (corresponding author), Inst Curie, Translat Res Dept, Residual Tumor & Response Treatment, RT2Lab, Paris, France.; Reyal, F (corresponding author), Inst Curie, UMR932, Immun & Canc, Paris, France.	fabien.reyal@curie.fr	; Rouzier, Roman/G-2953-2018	Duhoux, Francois/0000-0002-5429-7888; Rouzier, Roman/0000-0002-8167-6808				Albain KS, 2010, LANCET ONCOL, V11, P55, DOI 10.1016/S1470-2045(09)70314-6; BALSLEV I, 1994, BREAST CANCER RES TR, V32, P281, DOI 10.1007/BF00666005; Barry WT, 2010, J CLIN ONCOL, V28, P2198, DOI 10.1200/JCO.2009.26.7245; Barton S, 2012, BRIT J CANCER, V106, P1760, DOI 10.1038/bjc.2012.166; Blamey RW, 2007, EUR J CANCER, V43, P1548, DOI 10.1016/j.ejca.2007.01.016; BROWN J, 1993, BREAST CANCER RES TR, V25, P283; Carter SL, 2006, NAT GENET, V38, P1043, DOI 10.1038/ng1861; Chang HY, 2005, P NATL ACAD SCI USA, V102, P3738, DOI 10.1073/pnas.0409462102; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; Cuzick J, 2011, J CLIN ONCOL, V29, P4273, DOI 10.1200/JCO.2010.31.2835; Desmedt C, 2007, CLIN CANCER RES, V13, P3207, DOI 10.1158/1078-0432.CCR-06-2765; Dowsett M, 2011, JNCI-J NATL CANCER I, V103, P1656, DOI 10.1093/jnci/djr393; Ein-Dor L, 2005, BIOINFORMATICS, V21, P171, DOI 10.1093/bioinformatics/bth469; Engelhardt EG, 2014, J CLIN ONCOL, V32, P238, DOI 10.1200/JCO.2013.50.3417; Fan C, 2006, NEW ENGL J MED, V355, P560, DOI 10.1056/NEJMoa052933; Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304; Gong Y, 2007, LANCET ONCOL, V8, P203, DOI 10.1016/S1470-2045(07)70042-6; Haibe-Kains B, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-394; Haury A-C, 2010, ARXIV PREPR ARXIV100; HAYBITTLE JL, 1982, BRIT J CANCER, V45, P361, DOI 10.1038/bjc.1982.62; Hornberger J, 2012, JNCI-J NATL CANCER I, V104, P1068, DOI 10.1093/jnci/djs261; Kim SY, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-147; Liu R, 2007, NEW ENGL J MED, V356, P217, DOI 10.1056/NEJMoa063994; Loi S, 2007, J CLIN ONCOL, V25, P1239, DOI 10.1200/JCO.2006.07.1522; Michiels S, 2005, LANCET, V365, P488, DOI 10.1016/S0140-6736(05)17866-0; Millar EKA, 2011, BRIT J CANCER, V105, P272, DOI 10.1038/bjc.2011.228; Miller LD, 2005, P NATL ACAD SCI USA, V102, P13550, DOI 10.1073/pnas.0506230102; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Paik S, 2006, J CLIN ONCOL, V24, P3726, DOI 10.1200/JCO.2005.04.7985; Pawitan Y, 2005, BREAST CANCER RES, V7, pR953, DOI 10.1186/bcr1325; Reyal F, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2192; Sotiriou C, 2006, JNCI-J NATL CANCER I, V98, P262, DOI 10.1093/jnci/djj052; Tang G, 2011, J CLIN ONCOL, V29, P4365, DOI 10.1200/JCO.2011.35.3714; Teschendorff AE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r157; Teschendorff AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r101; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van Vliet MH, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-375; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Wirapati P, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2124; Zhao X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017845	42	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0148957	10.1371/journal.pone.0148957	http://dx.doi.org/10.1371/journal.pone.0148957			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3DG	26895349	gold, Green Submitted, Green Published			2022-12-26	WOS:000371223400029
J	Nanni, L; Paci, M; dos Santos, FLC; Skottman, H; Juuti-Uusitalo, K; Hyttinen, J				Nanni, Loris; Paci, Michelangelo; dos Santos, Florentino Luciano Caetano; Skottman, Heli; Juuti-Uusitalo, Kati; Hyttinen, Jari			Texture Descriptors Ensembles Enable Image-Based Classification of Maturation of Human Stem Cell-Derived Retinal Pigmented Epithelium	PLOS ONE			English	Article							SUBCELLULAR STRUCTURES; FEATURE-EXTRACTION; DIFFERENTIATION; PATTERNS; COOCCURRENCE; FREQUENCY	Aims A fast, non-invasive and observer-independent method to analyze the homogeneity and maturity of human pluripotent stem cell (hPSC) derived retinal pigment epithelial (RPE) cells is warranted to assess the suitability of hPSC-RPE cells for implantation or in vitro use. The aim of this work was to develop and validate methods to create ensembles of state-of-the-art texture descriptors and to provide a robust classification tool to separate three different maturation stages of RPE cells by using phase contrast microscopy images. The same methods were also validated on a wide variety of biological image classification problems, such as histological or virus image classification. Methods For image classification we used different texture descriptors, descriptor ensembles and preprocessing techniques. Also, three new methods were tested. The first approach was an ensemble of preprocessing methods, to create an additional set of images. The second was the region-based approach, where saliency detection and wavelet decomposition divide each image in two different regions, from which features were extracted through different descriptors. The third method was an ensemble of Binarized Statistical Image Features, based on different sizes and thresholds. A Support Vector Machine (SVM) was trained for each descriptor histogram and the set of SVMs combined by sum rule. The accuracy of the computer vision tool was verified in classifying the hPSC-RPE cell maturation level. Dataset and Results The RPE dataset contains 1862 subwindows from 195 phase contrast images. The final descriptor ensemble outperformed the most recent stand-alone texture descriptors, obtaining, for the RPE dataset, an area under ROC curve (AUC) of 86.49% with the 10-fold cross validation and 91.98% with the leave-one-image-out protocol. The generality of the three proposed approaches was ascertained with 10 more biological image datasets, obtaining an average AUC greater than 97%. Conclusions Here we showed that the developed ensembles of texture descriptors are able to classify the RPE cell maturation stage. Moreover, we proved that preprocessing and region-based decomposition improves many descriptors' accuracy in biological dataset classification. Finally, we built the first public dataset of stem cell-derived RPE cells, which is publicly available to the scientific community for classification studies. The proposed tool is available at https://www.dei.unipd.it/node/2357 and the RPE dataset at http://www.biomeditech.fi/data/RPE_dataset/. Both are available at https://figshare.com/s/d6fb591f1beb4f8efa6f.	[Nanni, Loris] Univ Padua, Dept Informat Engn, Padua, Italy; [Paci, Michelangelo; dos Santos, Florentino Luciano Caetano; Hyttinen, Jari] Tampere Univ Technol, Dept Elect & Commun Engn, BioMediTech, FIN-33101 Tampere, Finland; [Skottman, Heli; Juuti-Uusitalo, Kati] Univ Tampere, BioMediTech, FIN-33101 Tampere, Finland	University of Padua; Tampere University; Tampere University	Nanni, L (corresponding author), Univ Padua, Dept Informat Engn, Padua, Italy.; Paci, M (corresponding author), Tampere Univ Technol, Dept Elect & Commun Engn, BioMediTech, FIN-33101 Tampere, Finland.	loris.nanni@unipd.it; michelangelo.paci@tut.fi	Hyttinen, Jari A/G-4280-2014; Caetano dos Santos, Florentino Luciano/D-3502-2015	Hyttinen, Jari A/0000-0003-1850-3055; Caetano dos Santos, Florentino Luciano/0000-0001-8151-3585; Juuti-Uusitalo, Kati/0000-0003-2275-5562; Skottman, Heli/0000-0002-4127-8792	Finnish Funding Agency for Technology and Innovation; Academy of Finland [252225, 218050, 137801]	Finnish Funding Agency for Technology and Innovation(Finnish Funding Agency for Technology & Innovation (TEKES)); Academy of Finland(Academy of Finland)	This work was financially supported by the Finnish Funding Agency for Technology and Innovation (www.tekes.fi, Human Spare Parts project, MP and FLCS) and the Academy of Finland (www.aka.fi, grant numbers 252225 JH, 218050 HS and 137801 KJU). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdesselam Abdelhamid, 2013, Lecture Notes on Software Engineering, V1, P360, DOI 10.7763/LNSE.2013.V1.77; Baddeley RJ, 2006, VISION RES, V46, P2824, DOI 10.1016/j.visres.2006.02.024; Bianconi F, 2013, EXPERT SYST APPL, V40, P1636, DOI 10.1016/j.eswa.2012.09.007; Boland MV, 1998, CYTOMETRY, V33, P366; Boland MV, 2001, BIOINFORMATICS, V17, P1213, DOI 10.1093/bioinformatics/17.12.1213; Braz G, 2009, COMPUT BIOL MED, V39, P1063, DOI 10.1016/j.compbiomed.2009.08.009; Burke JM, 1996, EXP EYE RES, V62, P63, DOI 10.1006/exer.1996.0008; Chen J, 2010, IEEE T PATTERN ANAL, V32, P1705, DOI 10.1109/TPAMI.2009.155; Croze RH, 2014, STEM CELL TRANSL MED, V3, P1066, DOI 10.5966/sctm.2014-0079; Cruz-Roa A, 2011, ARTIF INTELL MED, V52, P91, DOI 10.1016/j.artmed.2011.04.010; Dalal N, 2005, PROC CVPR IEEE, P886, DOI 10.1109/cvpr.2005.177; DAUGMAN JG, 1985, J OPT SOC AM A, V2, P1160, DOI 10.1364/JOSAA.2.001160; dos Santos FLC, 2015, BIOSYST ENG, V138, P11, DOI 10.1016/j.biosystemseng.2015.01.005; Fathi A, 2012, PATTERN RECOGN LETT, V33, P1093, DOI 10.1016/j.patrec.2012.01.017; Fink JL, 2006, NUCLEIC ACIDS RES, V34, pD213, DOI 10.1093/nar/gkj069; Fu JJC, 2014, COMPUT MED IMAG GRAP, V38, P267, DOI 10.1016/j.compmedimag.2013.12.009; Guo YM, 2011, PROCEEDINGS OF THE BRITISH MACHINE VISION CONFERENCE 2011, DOI 10.5244/C.25.119; Guo ZH, 2010, IEEE T IMAGE PROCESS, V19, P1657, DOI 10.1109/TIP.2010.2044957; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Heath M, 1998, COMP IMAG VIS, V13, P457; Hou XD, 2012, IEEE T PATTERN ANAL, V34, P194, DOI 10.1109/TPAMI.2011.146; Hu S, 2014, BIO-MED MATER ENG, V24, P129, DOI 10.3233/BME-130793; Jantzen J., 2005, P NISIS, P1; Jiang Y, 2013, INVEST OPHTH VIS SCI, V54, P7274, DOI 10.1167/iovs.13-12450; Juuti-Uusitalo K, 2013, INVEST OPHTH VIS SCI, V54, P3510, DOI 10.1167/iovs.13-11800; Juuti-Uusitalo K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030089; Kamao H, 2014, INVEST OPHTH VIS SCI, V55, P8309, DOI 10.1167/iovs.14-14694; Kannala J, 2012, INT C PATT RECOG, P1363; Kylberg G, 2011, LECT NOTES COMPUT SC, V7042, P573, DOI 10.1007/978-3-642-25085-9_68; Loukas C, 2013, COMPUT MATH METHOD M, V2013, DOI 10.1155/2013/829461; MALLAT SG, 1989, IEEE T PATTERN ANAL, V11, P674, DOI 10.1109/34.192463; Manthalkar R, 2003, PATTERN RECOGN LETT, V24, P2061, DOI 10.1016/S0167-8655(03)00043-6; Nanni L., 2014, LOCAL BINARY PATTERN, P177; Nanni L, 2015, APPL COMPUT INFORM; Nanni L, 2011, EXPERT SYST APPL, V38, P6209, DOI 10.1016/j.eswa.2010.11.048; Nanni L, 2010, ARTIF INTELL MED, V49, P117, DOI 10.1016/j.artmed.2010.02.006; Nanni L, 2010, J THEOR BIOL, V264, P1024, DOI 10.1016/j.jtbi.2010.03.020; Vu NS, 2014, IMAGE VISION COMPUT, V32, P424, DOI 10.1016/j.imavis.2014.04.006; Nosaka R, 2014, PATTERN RECOGN, V47, P2428, DOI 10.1016/j.patcog.2013.09.018; Nosaka R, 2011, LECT NOTES COMPUT SC, V7088, P82, DOI 10.1007/978-3-642-25346-1_8; Ojala T, 2002, IEEE T PATTERN ANAL, V24, P971, DOI 10.1109/TPAMI.2002.1017623; Ojansivu V, 2008, LECT NOTES COMPUT SC, V5099, P236, DOI 10.1007/978-3-540-69905-7_27; Paci M, 2013, CURR BIOINFORM, V8, P208, DOI 10.2174/1574893611308020009; PUDIL P, 1994, PATTERN RECOGN LETT, V15, P1119, DOI 10.1016/0167-8655(94)90127-9; Rowland TJ, 2013, J TISSUE ENG REGEN M, V7, P642, DOI 10.1002/term.1458; Schwartz SD, 2012, LANCET, V379, P713, DOI 10.1016/S0140-6736(12)60028-2; Singh R, 2013, INVEST OPHTH VIS SCI, V54, P6767, DOI 10.1167/iovs.13-11943; Skottman H, 2010, IN VITRO CELL DEV-AN, V46, P206, DOI 10.1007/s11626-010-9286-2; Sorkio A, 2014, TISSUE ENG PT A, V20, P622, DOI 10.1089/ten.TEA.2013.0049; Strandmark P, 2012, INT C PATT RECOG, P33; Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004; Strzelecki M, 2006, COMPUT MED IMAG GRAP, V30, P95, DOI 10.1016/j.compmedimag.2005.11.004; Tan XY, 2010, IEEE T IMAGE PROCESS, V19, P1635, DOI 10.1109/TIP.2010.2042645; Toivonen S, 2013, STEM CELL TRANSL MED, V2, P83, DOI 10.5966/sctm.2012-0047; Vaajasaari H, 2011, MOL VIS, V17, P558; Vecsei A, 2011, COMPUT BIOL MED, V41, P313, DOI 10.1016/j.compbiomed.2011.03.009; Vu NS, 2013, IEEE T INF FOREN SEC, V8, P295, DOI 10.1109/TIFS.2012.2224866; Vugler A, 2008, EXP NEUROL, V214, P347, DOI 10.1016/j.expneurol.2008.09.007; Ylioinas Juha, 2013, Computer Vision - ACCV 2012. 11th Asian Conference on Computer Vision. Revised Selected Papers, P375, DOI 10.1007/978-3-642-37431-9_29; Zhao GY, 2012, IEEE T IMAGE PROCESS, V21, P1465, DOI 10.1109/TIP.2011.2175739	61	13	13	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0149399	10.1371/journal.pone.0149399	http://dx.doi.org/10.1371/journal.pone.0149399			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3DG	26895509	Green Published, gold, Green Submitted			2022-12-26	WOS:000371223400052
J	Zhao, YZ; Jin, RR; Yang, W; Xiang, Q; Yu, WZ; Lin, Q; Tian, FR; Mao, KL; Lv, CZ; Wang, YXJ; Lu, CT				Zhao, Ying-Zheng; Jin, Rong-Rong; Yang, Wei; Xiang, Qi; Yu, Wen-Ze; Lin, Qian; Tian, Fu-Rong; Mao, Kai-Li; Lv, Chuan-Zhu; Wang, Yi-Xiang J.; Lu, Cui-Tao			Using Gelatin Nanoparticle Mediated Intranasal Delivery of Neuropeptide Substance P to Enhance Neuro-Recovery in Hemiparkinsonian Rats	PLOS ONE			English	Article							IN-VITRO; ALPHA-SYNUCLEIN; CELL-DEATH; MODEL; BRAIN; EXPRESSION; SYSTEM; 6-HYDROXYDOPAMINE; OPTIMIZATION; ACTIVATION	Purpose Intranasal administration of phospholipid-based gelatin nanoparticles (GNP) was prepared to investigate the neuro-recovery effects of neuropeptide Substance P (SP) on hemiparkin-sonian rats. Methods The SP-loaded gelatin nanoparticles (SP-GNP) were prepared by a water-in-water emulsion method and possessed high stability, encapsulating efficiency and loading capacity. PC-12 cells were used to examine the growth enhancement of SP-GNP in vitro by MTT assays and flow cytometry (FCM). The therapeutic effects of SP-GNP on 6-hydroxydopamine (6-OHDA) induced hemiparkinsonian rats were assessed by quantifying rotational behavior and the levels of tyrosine hydroxylase (TH), phosphorylated c-Jun protein (p-cJun) and Caspase-3 (Cas-3) expressed in substantia nigra (SN) region of hemiparkinsonian rats. Results PC-12 cells under SP-GNP treatment showed better cell viability and lower degree of apoptosis than those under SP solution treatment. Hemiparkinsonian rats under intranasal SPGNP administration demonstrated better behavioral improvement, higher level of TH in SN along with much lower extent of p-c-Jun and Cas-3 than those under intranasal SP solution administration and intravenous SP-GNP administration. Conclusions With the advantages of GNP and nose-to-brain pathway, SP can be effectively delivered into the damaged SN region and exhibit its neuro-recovery function through the inhibition on JNK pathway and dopaminergic neuron apoptosis.	[Zhao, Ying-Zheng; Yang, Wei; Yu, Wen-Ze; Lin, Qian; Tian, Fu-Rong; Mao, Kai-Li; Lu, Cui-Tao] Wenzhou Med Univ, Coll Pharmaceut Sci, Wenzhou 325035, Zhejiang, Peoples R China; [Zhao, Ying-Zheng; Lu, Cui-Tao] Wenzhou Med Univ, Affiliated Hosp 2, Wenzhou 325000, Zhejiang, Peoples R China; [Zhao, Ying-Zheng; Lv, Chuan-Zhu] Hainan Med Coll, Haikou 570102, Hainan, Peoples R China; [Jin, Rong-Rong] Taizhou Tradit Chinese Med Hosp, Taizhou 318000, Zhejiang, Peoples R China; [Xiang, Qi] Jinan Univ, Biopharmaceut R&D Ctr, Guangzhou 510000, Guangdong, Peoples R China; [Wang, Yi-Xiang J.] Chinese Univ Hong Kong, Prince Wales Hosp, Fac Med, Dept Imaging & Intervent Radiol, Shatin, Hong Kong, Peoples R China	Wenzhou Medical University; Wenzhou Medical University; Hainan Medical University; Jinan University; Chinese University of Hong Kong; Prince of Wales Hospital	Lu, CT (corresponding author), Wenzhou Med Univ, Coll Pharmaceut Sci, Wenzhou 325035, Zhejiang, Peoples R China.; Lu, CT (corresponding author), Wenzhou Med Univ, Affiliated Hosp 2, Wenzhou 325000, Zhejiang, Peoples R China.; Wang, YXJ (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Fac Med, Dept Imaging & Intervent Radiol, Shatin, Hong Kong, Peoples R China.	yixiang_wang@cuhk.edu.hk; lctuua@sina.com	Wang, Yi Xiang/I-5952-2016; Tian, Furong/AAA-6037-2020	Wang, Yi Xiang/0000-0001-5697-0717; Tian, Furong/0000-0002-4953-1131	National Natural Science Foundation of China [81360195, 81301982, 81571392, 81272160, 81302726, 81460299]; Zhejiang Provincial Foundation for Health Department [2015ZDA023, 2016139678]; Key support of high level talent innovation and technology project of Wenzhou; Major Scientific Project of Guangdong Province [2012A080201010]; Science and Technology Plan Project of Guangzhou [201508020001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Foundation for Health Department; Key support of high level talent innovation and technology project of Wenzhou; Major Scientific Project of Guangdong Province; Science and Technology Plan Project of Guangzhou	This research was supported by National Natural Science Foundation of China (Grant No. 81360195, 81301982, 81571392, 81272160, 81302726 and 81460299); Zhejiang Provincial Foundation for Health Department (Grant No. 2015ZDA023 and 2016139678), Key support of high level talent innovation and technology project of Wenzhou (Ying-Zheng Zhao, 2015); Major Scientific Project of Guangdong Province (Grant No. 2012A080201010); Science and Technology Plan Project of Guangzhou, (201508020001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad N, 2013, PROTOPLASMA, V250, P1327, DOI 10.1007/s00709-013-0516-9; Barbiero JK, 2014, PROG NEURO-PSYCHOPH, V53, P35, DOI 10.1016/j.pnpbp.2014.02.009; BARKER R, 1991, NEUROPEPTIDES, V20, P73, DOI 10.1016/0143-4179(91)90054-M; Betarbet R, 2004, EXP NEUROL, V189, P393, DOI 10.1016/j.expneurol.2004.05.041; Chambers JW, 2013, J BIOL CHEM, V288, P1079, DOI 10.1074/jbc.M112.421354; Costantino HR, 2007, INT J PHARMACEUT, V337, P1, DOI 10.1016/j.ijpharm.2007.03.025; Covenas R, 2014, HISTOL HISTOPATHOL, V29, P881, DOI 10.14670/HH-29.881; Das S, 2011, AAPS PHARMSCITECH, V12, P62, DOI 10.1208/s12249-010-9563-0; Decressac M, 2011, BRAIN, V134, P2302, DOI 10.1093/brain/awr149; Elzoghby AO, 2013, J CONTROL RELEASE, V172, P1075, DOI 10.1016/j.jconrel.2013.09.019; Fiebich BL, 2000, J IMMUNOL, V165, P5606, DOI 10.4049/jimmunol.165.10.5606; Fujita H, 2006, BRAIN RES, V1113, P10, DOI 10.1016/j.brainres.2006.06.079; Gagliardi M, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2014.04.020; Giuliani P, 2012, PANMINERVA MED S4, V54, P43; Illum L, 2000, EUR J PHARM SCI, V11, P1, DOI 10.1016/S0928-0987(00)00087-7; Jiang MH, 2013, NEUROREPORT, V24, P846, DOI 10.1097/WNR.0b013e3283650e3d; Kabanov AV, 2007, PROG POLYM SCI, V32, P1054, DOI 10.1016/j.progpolymsci.2007.05.014; Kemeny S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038837; Krasnova IN, 2000, NEUROSCIENCE, V95, P113; Lee E, 2014, J NEUROSCI RES, V92, P130, DOI 10.1002/jnr.23307; Lee JH, 2012, QUANT IMAGING MED SU, V2, P266, DOI 10.3978/j.issn.2223-4292.2012.12.04; Lee SJ, 2013, J CONTROL RELEASE, V172, P358, DOI 10.1016/j.jconrel.2013.09.002; Li XF, 2011, BRAIN RES, V1382, P9, DOI 10.1016/j.brainres.2011.01.015; Lochhead JJ, 2012, ADV DRUG DELIVER REV, V64, P614, DOI 10.1016/j.addr.2011.11.002; McLean JR, 2014, NEUROSCI LETT, V576, P73, DOI 10.1016/j.neulet.2014.05.044; Mistry A, 2009, INT J PHARMACEUT, V379, P146, DOI 10.1016/j.ijpharm.2009.06.019; Oh M, 2012, J NUCL MED, V53, P399, DOI 10.2967/jnumed.111.095224; Pan J, 2005, NEUROSCIENCE, V131, P147, DOI 10.1016/j.neuroscience.2004.09.031; Pan J, 2007, MOL PHARMACOL, V72, P1607, DOI 10.1124/mol.107.038463; Pardeshi CV, 2013, J MATER SCI-MATER M, V24, P2101, DOI 10.1007/s10856-013-4965-7; Patel S, 2011, J DRUG TARGET, V19, P468, DOI 10.3109/1061186X.2010.523787; Shukla AK, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2014.04.008; Sivera M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103675; TAQUET H, 1988, NEUROPEPTIDES, V12, P105, DOI 10.1016/0143-4179(88)90039-X; Thorne RG, 2001, CLIN PHARMACOKINET, V40, P907, DOI 10.2165/00003088-200140120-00003; Thornton E, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0042630, 10.1371/journal.pone.0034138]; Thornton E, 2010, NEUROSCI LETT, V481, P64, DOI 10.1016/j.neulet.2010.06.057; Upadhyay RK, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/869269; Vandelli MA, 2001, INT J PHARM, V215, P175, DOI 10.1016/S0378-5173(00)00681-5; Varshosaz J, 2010, J LIPOSOME RES, V20, P286, DOI 10.3109/08982100903443065; Varshosaz J, 2010, PHARM DEV TECHNOL, V15, P89, DOI 10.3109/10837450903013568; Vyas Tushar K., 2005, Current Drug Delivery, V2, P165, DOI 10.2174/1567201053586047; Wang YXJ, 2013, CURR PHARM DESIGN, V19, P6575; Wu AG, 2013, INT J MOL SCI, V14, P22618, DOI 10.3390/ijms141122618; Zaki NM, 2007, EUR J PHARM SCI, V32, P296, DOI 10.1016/j.ejps.2007.08.006; Zhang X, 2008, NEUROPHARMACOLOGY, V54, P1143, DOI 10.1016/j.neuropharm.2008.03.005	46	25	30	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0148848	10.1371/journal.pone.0148848	http://dx.doi.org/10.1371/journal.pone.0148848			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3DG	26894626	gold, Green Published, Green Submitted			2022-12-26	WOS:000371223400023
J	Liu, W; Wang, DM; Liu, JJ; Li, DW; Yin, DX				Liu, Wei; Wang, Dongmei; Liu, Jianjun; Li, Dengwu; Yin, Dongxue			Quality Evaluation of Potentilla fruticosa L. by High Performance Liquid Chromatography Fingerprinting Associated with Chemometric Methods	PLOS ONE			English	Article							TRADITIONAL CHINESE MEDICINE; ANTIOXIDANT ACTIVITY; COMPONENT ANALYSIS; EXTRACTION; SINENSIS; PARTS	The present study was performed to assess the quality of Potentilla fruticosa L. sampled from distinct regions of China using high performance liquid chromatography (HPLC) fingerprinting coupled with a suite of chemometric methods. For this quantitative analysis, the main active phytochemical compositions and the antioxidant activity in P. fruticosa were also investigated. Considering the high percentages and antioxidant activities of phytochemicals, P. fruticosa samples from Kangding, Sichuan were selected as the most valuable raw materials. Similarity analysis (SA) of HPLC fingerprints, hierarchical cluster analysis (HCA), principle component analysis (PCA), and discriminant analysis (DA) were further employed to provide accurate classification and quality estimates of P. fruticosa. Two principal components (PCs) were collected by PCA. PC1 separated samples from Kangding, Sichuan, capturing 57.64% of the variance, whereas PC2 contributed to further separation, capturing 18.97% of the variance. Two kinds of discriminant functions with a 100% discrimination ratio were constructed. The results strongly supported the conclusion that the eight samples from different regions were clustered into three major groups, corresponding with their morphological classification, for which HPLC analysis confirmed the considerable variation in phytochemical compositions and that P. fruticosa samples from Kangding, Sichuan were of high quality. The results of SA, HCA, PCA, and DA were in agreement and performed well for the quality assessment of P. fruticosa. Consequently, HPLC fingerprinting coupled with chemometric techniques provides a highly flexible and reliable method for the quality evaluation of traditional Chinese medicines.	[Liu, Wei; Wang, Dongmei; Li, Dengwu] Northwest A&F Univ, Coll Forestry, Yangling, Peoples R China; [Liu, Wei] Henan Univ Sci & Technol, Coll Agr, Luoyang, Peoples R China; [Liu, Jianjun] Northwest A&F Univ, Coll Landscape Architecture & Arts, Yangling, Peoples R China; [Yin, Dongxue] Henan Univ Sci & Technol, Coll Agr Engn, Luoyang, Peoples R China	Northwest A&F University - China; Henan University of Science & Technology; Northwest A&F University - China; Henan University of Science & Technology	Li, DW (corresponding author), Northwest A&F Univ, Coll Forestry, Yangling, Peoples R China.; Yin, DX (corresponding author), Henan Univ Sci & Technol, Coll Agr Engn, Luoyang, Peoples R China.	dengwuli@163.com; milk2egg@163.com			Forestry Research Foundation for the Public Service Industry of China [200904004]	Forestry Research Foundation for the Public Service Industry of China	This work was supported by the program from the Forestry Research Foundation for the Public Service Industry of China (Grant numbers: 200904004; http://english.forestry.gov.cn/web/index.do). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Salces RM, 2005, FOOD CHEM, V91, P91, DOI 10.1016/j.foodchem.2004.05.049; Aryayeva M. M., 1999, Rastitel'nye Resursy, V35, P91; Bai DY, 2007, CHINESE AGR SCI B, V23, P371; Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292; Bergeron C, 1998, PHYTOCHEMISTRY, V49, P233, DOI 10.1016/S0031-9422(97)00878-9; BLOIS MS, 1958, NATURE, V181, P1199, DOI 10.1038/1811199a0; BRAND-WILLIAMS W, 1995, FOOD SCI TECHNOL-LEB, V28, P25; BRATCHELL N, 1989, CHEMOMETR INTELL LAB, V6, P105, DOI 10.1016/0169-7439(87)80054-0; Chen C, 2009, CHINESE J ANAL LAB, V28, P54; Davidson CG, 1995, ACTA HORTIC, P157, DOI 10.17660/ActaHortic.1995.413.24; Faria AF, 2011, FOOD CHEM, V126, P1571, DOI 10.1016/j.foodchem.2010.12.007; FEDOSEEVA GM, 1979, KHIM PRIR SOEDIN+, P575; Feng Y, 2001, TALANTA, V53, P1155, DOI 10.1016/S0039-9140(00)00594-4; Feng Y, 2006, ARTIF INTELL MED, V38, P219, DOI 10.1016/j.artmed.2006.07.005; Flora of China Editorial Committee, 2003, FLORA CHINA, V9; Fuglevand G, 1996, PLANT CELL, V8, P2347, DOI 10.1105/tpc.8.12.2347; GANENKO TV, 1988, KHIM PRIR SOEDIN+, P451; Gouveia S, 2012, PHYTOCHEM ANALYSIS, V23, P72, DOI 10.1002/pca.1326; Harwood M, 2007, FOOD CHEM TOXICOL, V45, P2179, DOI 10.1016/j.fct.2007.05.015; Heim KE, 2002, J NUTR BIOCHEM, V13, P572, DOI 10.1016/S0955-2863(02)00208-5; Helrich KC., 1965, OFFICIAL METHODS OF, V2; Jia Z, 1999, FOOD CHEM, V64, P555, DOI 10.1016/S0308-8146(98)00102-2; Kalil SJ, 2000, PROCESS BIOCHEM, V35, P539, DOI 10.1016/S0032-9592(99)00101-6; Li BY, 2004, ANAL CHIM ACTA, V514, P69, DOI 10.1016/j.aca.2004.03.041; Li FM, 2006, CHIN J CHROMATOGR, V24, P537, DOI 10.1016/S1872-2059(06)60022-9; Li H. C., 2007, J W CHINA FORESTRY S, V36, P71; Li W, 2007, J PHARMACEUT BIOMED, V45, P38, DOI 10.1016/j.jpba.2007.05.027; Miliauskas G, 2007, MEAT SCI, V77, P703, DOI 10.1016/j.meatsci.2007.05.026; Miliauskas G, 2004, J SCI FOOD AGR, V84, P1997, DOI 10.1002/jsfa.1914; Ni YN, 2009, ANAL CHIM ACTA, V647, P149, DOI 10.1016/j.aca.2009.06.021; Nkiliza J, 1997, Fr Patent Appl, Patent No. [FR2749303A1, 2749303]; Nuntanakorn P, 2007, PHYTOCHEM ANALYSIS, V18, P219, DOI 10.1002/pca.975; Nyambaka H, 2004, TALANTA, V64, P23, DOI 10.1016/j.talanta.2004.02.037; Ong ES, 2002, J SEP SCI, V25, P825, DOI 10.1002/1615-9314(20020901)25:13&lt;825::AID-JSSC825&gt;3.0.CO;2-; Peng L, 2011, FOOD CHEM, V125, P1064, DOI 10.1016/j.foodchem.2010.09.079; Pierce KM, 2006, TALANTA, V70, P797, DOI 10.1016/j.talanta.2006.01.038; Qian K, 2011, FOOD CHEM, V127, P722, DOI 10.1016/j.foodchem.2010.12.132; Robards K, 1999, FOOD CHEM, V66, P401, DOI 10.1016/S0308-8146(99)00093-X; Sagdic O, 2011, FOOD CHEM, V126, P1749, DOI 10.1016/j.foodchem.2010.12.075; Shi XM, 2008, WORLD J MICROB BIOT, V24, P2443, DOI 10.1007/s11274-008-9766-7; Singleton VL., 1965, AM J ENOL VITICULT, V16, P144, DOI DOI 10.12691/IJEBB-2-1-5; Tomczyk M, 2010, MOLECULES, V15, P4639, DOI 10.3390/molecules15074639; Tomczyk M, 2009, J ETHNOPHARMACOL, V122, P184, DOI 10.1016/j.jep.2008.12.022; Wan JB, 2006, J PHARMACEUT BIOMED, V41, P1596, DOI 10.1016/j.jpba.2006.01.058; Wang DM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096329; Wang S, 2007, TALANTA, V72, P434, DOI 10.1016/j.talanta.2006.11.006; Wannes WA, 2010, FOOD CHEM TOXICOL, V48, P1362, DOI 10.1016/j.fct.2010.03.002; WHO, 2000, GEN GUID METH RES EV; Xu SJ, 2009, J CHROMATOGR A, V1216, P2163, DOI 10.1016/j.chroma.2008.04.064; Yang DF, 2007, CHROMATOGRAPHIA, V66, P509, DOI 10.1365/s10337-007-0359-7; Yang J, 2007, J SEP SCI, V30, P1276, DOI 10.1002/jssc.200600389; Yang LC, 2013, J AGR FOOD CHEM, V61, P1772, DOI 10.1021/jf3042825; Yanhuaia Liu, 2004, World Patent Information, V26, P91, DOI 10.1016/S0172-2190(03)00110-8; YU RQ, 1992, CHEMOMETR INTELL LAB, V14, P23, DOI 10.1016/0169-7439(92)80090-Q; Yuan R, 2000, PHARMACOL THERAPEUT, V86, P191, DOI 10.1016/S0163-7258(00)00039-5; Zhang P, 2005, CHEM PHARM BULL, V53, P1582, DOI 10.1248/cpb.53.1582; Zhang YG, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0109159, 10.1371/journal.pone.0105725, 10.1371/journal.pone.0093458, 10.1371/journal.pone.0088491]; Zou YP, 2004, J AGR FOOD CHEM, V52, P5032, DOI 10.1021/jf049571r	58	14	14	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2016	11	2							e0149197	10.1371/journal.pone.0149197	http://dx.doi.org/10.1371/journal.pone.0149197			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3CO	26890416	Green Submitted, Green Published, gold			2022-12-26	WOS:000371221500025
J	Yamamoto, S; Matsushita, Y; Nakagawa, T; Honda, T; Hayashi, T; Noda, M; Mizoue, T				Yamamoto, Shuichiro; Matsushita, Yumi; Nakagawa, Toru; Honda, Toru; Hayashi, Takeshi; Noda, Mitsuhiko; Mizoue, Tetsuya			Visceral Fat Accumulation, Insulin Resistance, and Elevated Depressive Symptoms in Middle-Aged Japanese Men	PLOS ONE			English	Article							ADIPOSE-TISSUE; COMORBID DEPRESSION; WAIST CIRCUMFERENCE; MAJOR DEPRESSION; ABDOMINAL FAT; RISK-FACTOR; OBESITY; INFLAMMATION; ASSOCIATION; ADULTS	Objective To investigate visceral fat accumulation and markers of insulin resistance in relation to elevated depressive symptoms (EDS). Methods Participants were 4,333 male employees (mean age, 49.3 years) who underwent abdominal computed tomography scanning, measured fasting insulin, and did not self-report diabetes and mental disorders under treatment and history of cancer, myocardial infarction, and stroke. Multivariable logistic regression was used to assess the association of EDS with abdominal fat deposition and markers of insulin resistance. Results Visceral fat area (VFA) and fasting insulin were significantly, positively associated with EDS. Multivariable-adjusted odds ratios (95% confidence interval) of high VFA for the lowest through highest quartile of depression score were 1 (reference), 1.18 (0.97-1.42), 1.25 (1.02-1.54), 1.23 (1.01-1.51), respectively, and corresponding figures for high fasting insulin were 1 (reference), 0.98 (0.80-1.19), 1.12 (0.91-1.38), and 1.29 (1.06-1.57), respectively. Subcutaneous fat area was not associated with EDS. Conclusions Results suggest that EDS is related to visceral, but not subcutaneous, fat accumulation and insulin resistance in middle-aged Japanese men.	[Yamamoto, Shuichiro; Nakagawa, Toru; Honda, Toru; Hayashi, Takeshi] Hitachi Ltd, Hitachi Hlth Care Ctr, Occupat Hlth Sect, Hitachi, Ibaraki, Japan; [Matsushita, Yumi] Natl Ctr Global Hlth & Med, Ctr Clin Sci, Dept Clin Res, Shinjuku Ku, Tokyo, Japan; [Noda, Mitsuhiko] Saitama Med Univ, Dept Endocrinol & Diabet, Saitama, Japan; [Mizoue, Tetsuya] Natl Ctr Global Hlth & Med, Ctr Clin Sci, Dept Epidemiol & Prevent, Shinjuku Ku, Tokyo, Japan	Hitachi Limited; National Center for Global Health & Medicine - Japan; Saitama Medical University; National Center for Global Health & Medicine - Japan	Yamamoto, S (corresponding author), Hitachi Ltd, Hitachi Hlth Care Ctr, Occupat Hlth Sect, Hitachi, Ibaraki, Japan.	shuichiro.yamamoto.sr@hitachi.com	Noda, Mitsuhiko/W-3905-2019	Noda, Mitsuhiko/0000-0003-0413-4631	Ministry of Health, Labor and Welfare of Japan; Industrial Health Foundation; Japan Society for the Promotion of Science [KAKENHI 25293146]; Hitachi, Ltd.	Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Industrial Health Foundation; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Hitachi, Ltd.	This work was supported by Ministry of Health, Labor and Welfare of Japan: YM (http://www.mhlw.go.jp/english/); Industrial Health Foundation: TM (http://www.ihf.or.jp/); and Japan Society for the Promotion of Science: TM, KAKENHI 25293146 (http://www.jsps.go.jp/english/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Hitachi, Ltd. provided support in the form of salaries for authors SY, TN, TH, and TH, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ajilore O, 2007, NEUROPSYCHOPHARMACOL, V32, P1224, DOI 10.1038/sj.npp.1301248; Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069; Cohen S, 2012, P NATL ACAD SCI USA, V109, P5995, DOI 10.1073/pnas.1118355109; de Groot M, 2001, PSYCHOSOM MED, V63, P619, DOI 10.1097/00006842-200107000-00015; DiMatteo MR, 2000, ARCH INTERN MED, V160, P2101, DOI 10.1001/archinte.160.14.2101; Dowlati Y, 2010, BIOL PSYCHIAT, V67, P446, DOI 10.1016/j.biopsych.2009.09.033; Engstrom G, 2003, DIABETES, V52, P2097, DOI 10.2337/diabetes.52.8.2097; Everson-Rose SA, 2009, PSYCHOSOM MED, V71, P410, DOI 10.1097/PSY.0b013e3181a20c9c; Golden SH, 2008, JAMA-J AM MED ASSOC, V299, P2751, DOI 10.1001/jama.299.23.2751; Herva A, 2006, INT J OBESITY, V30, P520, DOI 10.1038/sj.ijo.0803174; Hsieh CJ, 2014, DIABETOL METAB SYNDR, V6, DOI 10.1186/1758-5996-6-49; Huber JD, 2008, CURR PHARM DESIGN, V14, P1594, DOI 10.2174/138161208784705441; Kadowaki T, 2006, INT J OBESITY, V30, P1163, DOI 10.1038/sj.ijo.0803248; Kahl KG, 2005, PSYCHOSOM MED, V67, P407, DOI 10.1097/01.psy.0000160458.95955.f4; Kan C, 2013, DIABETES CARE, V36, P480, DOI 10.2337/dc12-1442; Katon WJ, 2005, DIABETES CARE, V28, P2668, DOI 10.2337/diacare.28.11.2668; Kivimaki M, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3765; Lawlor DA, 2005, BRIT MED J, V330, P705, DOI 10.1136/bmj.38377.616921.F7; Lovell GP, 2015, NURS HEALTH SCI, V17, P134, DOI 10.1111/nhs.12147; Luppino FS, 2010, ARCH GEN PSYCHIAT, V67, P220, DOI 10.1001/archgenpsychiatry.2010.2; Lustman PJ, 2000, DIABETES CARE, V23, P934, DOI 10.2337/diacare.23.7.934; Masand Prakash S, 2002, Ann Clin Psychiatry, V14, P175, DOI 10.3109/10401230209147454; Matsushita Y, 2010, DIABETES CARE, V33, P2117, DOI 10.2337/dc10-0120; Miller GE, 2002, AM J CARDIOL, V90, P1279, DOI 10.1016/S0002-9149(02)02863-1; Murabito JM, 2013, OBESITY, V21, P1713, DOI 10.1002/oby.20130; Pearson S, 2010, DIABETES CARE, V33, P1128, DOI 10.2337/dc09-1940; PEDERSEN SB, 1994, J CLIN ENDOCR METAB, V78, P1354, DOI 10.1210/jc.78.6.1354; Preis SR, 2010, OBESITY, V18, P2191, DOI 10.1038/oby.2010.59; Pyykkonen AJ, 2011, DIABETES CARE, V34, P2545, DOI 10.2337/dc11-0107; REBUFFESCRIVE M, 1990, J CLIN ENDOCR METAB, V71, P1215, DOI 10.1210/jcem-71-5-1215; Remigio-Baker RA, 2014, PSYCHONEUROENDOCRINO, V47, P78, DOI 10.1016/j.psyneuen.2014.05.004; Rivenes AC, 2009, J PSYCHOSOM RES, V66, P269, DOI 10.1016/j.jpsychores.2008.07.012; Roos C, 2007, METABOLISM, V56, P825, DOI 10.1016/j.metabol.2007.01.013; Seino Y, 2010, J DIABETES INVEST, V1, P1, DOI 10.1111/j.2040-1124.2010.00005.x; Shoelson SE, 2007, GASTROENTEROLOGY, V132, P2169, DOI 10.1053/j.gastro.2007.03.059; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Talbot F, 2000, DIABETES CARE, V23, P1556, DOI 10.2337/diacare.23.10.1556; Thakore JH, 1997, BIOL PSYCHIAT, V41, P1140, DOI 10.1016/S0006-3223(97)85394-2; Vogelzangs N, 2010, J CLIN PSYCHIAT, V71, P391, DOI 10.4088/JCP.08m04743blu; Walker B R, 2001, Growth Horm IGF Res, V11 Suppl A, pS91, DOI 10.1016/S1096-6374(01)80015-0; Yakura N., 2009, ASIA PAC J DIS MANAG, V3, P21, DOI [10.7223/apjdm.3.21, DOI 10.7223/APJDM.3.21]; Yamamoto S, 2014, NUTR DIABETES, V4, DOI 10.1038/nutd.2014.27; Yokoyama K, 2015, PSYCHIAT RES, V226, P494, DOI 10.1016/j.psychres.2015.01.026; Zhao GX, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-130	44	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2016	11	2							e0149436	10.1371/journal.pone.0149436	http://dx.doi.org/10.1371/journal.pone.0149436			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3CO	26891344	Green Submitted, Green Published, gold			2022-12-26	WOS:000371221500047
J	Carmenta, R; Blackburn, GA; Davies, G; de Sassi, C; Lima, A; Parry, L; Tych, W; Barlow, J				Carmenta, Rachel; Blackburn, George Alan; Davies, Gemma; de Sassi, Claudio; Lima, Andre; Parry, Luke; Tych, Wlodek; Barlow, Jos			Does the Establishment of Sustainable Use Reserves Affect Fire Management in the Humid Tropics?	PLOS ONE			English	Article							PROTECTED AREAS; LAND-USE; CLIMATE-CHANGE; DEFORESTATION; AMAZON; FORESTS; CONSERVATION; VARIABILITY; PREVENTION; CARBON	Tropical forests are experiencing a growing fire problem driven by climatic change, agricultural expansion and forest degradation. Protected areas are an important feature of forest protection strategies, and sustainable use reserves (SURs) may be reducing fire prevalence since they promote sustainable livelihoods and resource management. However, the use of fire in swidden agriculture, and other forms of land management, may be undermining the effectiveness of SURs in meeting their conservation and sustainable development goals. We analyse MODIS derived hot pixels, TRMM rainfall data, Terra-Class land cover data, socio-ecological data from the Brazilian agro-census and the spatial extent of rivers and roads to evaluate whether the designation of SURs reduces fire occurrence in the Brazilian Amazon. Specifically, we ask (1) a. Is SUR location (i.e., de facto) or (1) b. designation (i.e. de jure) the driving factor affecting performance in terms of the spatial density of fires?, and (2), Does SUR creation affect fire management (i.e., the timing of fires in relation to previous rainfall)? We demonstrate that pre-protection baselines are crucial for understanding reserve performance. We show that reserve creation had no discernible impact on fire density, and that fires were less prevalent in SURs due to their characteristics of sparser human settlement and remoteness, rather than their status de jure. In addition, the timing of fires in relation to rainfall, indicative of local fire management and adherence to environmental law, did not improve following SUR creation. These results challenge the notion that SURs promote environmentally sensitive fire-management, and suggest that SURs in Amazonia will require special attention if they are to curtail future accidental wildfires, particularly as plans to expand the road infrastructure throughout the region are realised. Greater investment to support improved fire management by farmers living in reserves, in addition to other fire users, will be necessary to help ameliorate these threats.	[Carmenta, Rachel] Ctr Int Forestry Res, Forests & Governance, Bogor, West Java, Indonesia; [Carmenta, Rachel; Blackburn, George Alan; Davies, Gemma; Parry, Luke; Tych, Wlodek; Barlow, Jos] Univ Lancaster, Lancaster Environm Ctr, Lancaster, England; [de Sassi, Claudio] Forests & Livelihoods, Ctr Int Forestry Res, Bogor, West Java, Indonesia; [Lima, Andre] Natl Inst Space Res, Sao Jose Dos Campos, SP, Brazil	CGIAR; Center for International Forestry Research (CIFOR); Lancaster University; CGIAR; Center for International Forestry Research (CIFOR); Instituto Nacional de Pesquisas Espaciais (INPE)	Carmenta, R (corresponding author), Ctr Int Forestry Res, Forests & Governance, Bogor, West Java, Indonesia.; Carmenta, R (corresponding author), Univ Lancaster, Lancaster Environm Ctr, Lancaster, England.	rachelcarmenta@gmail.com	Tych, Wlodek/K-6510-2012; Barlow, Jos/HGE-9486-2022; Barlow, Jos/E-7861-2014; Parry, Luke/ABD-4194-2021	Tych, Wlodek/0000-0003-1655-844X; Parry, Luke/0000-0003-0330-9516; Davies, Gemma/0000-0002-7420-2479; Carmenta, Rachel/0000-0001-8607-4147; De Sassi, Claudio/0000-0002-8811-7347	Natural Environment Research Council and Economic and Social Research Council (NERC-ESRC) [ES/F012500/1]; Darwin Initiative [17-023]; Instituto Nacional de Ciencia e Tecnologia - Biodiversidade e Uso da Terra na Amazonia [CNPq 574008/2008-0]; Norwegian Agency for Development Cooperation; Australian Agency for International Development; Natural Environment Research Council [ceh010010] Funding Source: researchfish	Natural Environment Research Council and Economic and Social Research Council (NERC-ESRC); Darwin Initiative; Instituto Nacional de Ciencia e Tecnologia - Biodiversidade e Uso da Terra na Amazonia; Norwegian Agency for Development Cooperation; Australian Agency for International Development; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This research was funded by the Natural Environment Research Council and Economic and Social Research Council (NERC-ESRC grant ES/F012500/1 : RC), the Darwin Initiative (17-023: JB, LP, RC) (http://www.darwininitiative.org.uk/), the Instituto Nacional de Ciencia e Tecnologia - Biodiversidade e Uso da Terra na Amazonia (CNPq 574008/2008-0: JB, LP, RC) (http://inct.cnpq.br/web/inct-biodiversidade-e-uso-da-terra-na-amazonia), the Norwegian Agency for Development Cooperation (http://www.norad.no/en/front-page: RC), and the Australian Agency for International Development (www.ausaid.gov.au: RC).	Adeney JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005014; Aldersley A, 2011, SCI TOTAL ENVIRON, V409, P3472, DOI 10.1016/j.scitotenv.2011.05.032; Alencar A, 2011, ECOL APPL, V21, P2397, DOI 10.1890/10-1168.1; Amaral S, 2012, POPUL ENVIRON, V34, P142, DOI 10.1007/s11111-012-0168-2; [Anonymous], 2010, THE CAPTAIN TOOLBOX; Aragao LEOC, 2008, PHILOS T R SOC B, V363, P1779, DOI 10.1098/rstb.2007.0026; Aragao LEOC, 2007, GEOPHYS RES LETT, V34, DOI [10.1029/2006GL028946., 10.1029/2006GL028946]; Armenteras D, 2009, BIOL CONSERV, V142, P1411, DOI 10.1016/j.biocon.2009.02.002; Austin PC, 2007, STAT MED, V26, P734, DOI 10.1002/sim.2580; Austin PC, 2009, STAT MED, V28, P3083, DOI 10.1002/sim.3697; Barber CP, 2012, BIOL CONSERV, V149, P6, DOI 10.1016/j.biocon.2011.08.024; Barlow J, 2006, BIOL CONSERV, V128, P182, DOI 10.1016/j.biocon.2005.09.028; Barlow J, 2012, BIOL CONSERV, V154, P1, DOI 10.1016/j.biocon.2012.03.034; Berenguer E, 2014, GLOBAL CHANGE BIOL, V20, P3713, DOI 10.1111/gcb.12627; Biswas S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124346; Bowman MS, 2008, ECOL ECON, V67, P117, DOI 10.1016/j.ecolecon.2007.12.003; Brando PM, 2014, P NATL ACAD SCI USA, V111, P6347, DOI 10.1073/pnas.1305499111; Bruner AG, 2001, SCIENCE, V291, P125, DOI 10.1126/science.291.5501.125; Bueno MCD, 2011, EUR FOR GEOSTATISTIC; Cardoso Catarina, 2002, EXTRACTIVE RESERVES; Carmenta R, 2013, EARTH OBSERVATIONS E; Carmenta R, 2013, HUM ECOL, V41, P603, DOI 10.1007/s10745-013-9600-1; Carmenta R, 2011, ECOL SOC, V16; Carr DL, 2009, POPUL ENVIRON, V30, P222, DOI 10.1007/s11111-009-0090-4; Chen Y, 2011, SCIENCE, V334, P787, DOI 10.1126/science.1209472; Cochrane MA, 1999, SCIENCE, V284, P1832, DOI 10.1126/science.284.5421.1832; Cox PM, 2004, THEOR APPL CLIMATOL, V78, P137, DOI 10.1007/s00704-004-0049-4; de Mendonca MJC, 2004, ECOL ECON, V49, P89, DOI 10.1016/j.ecolecon.2003.11.011; de Vasconcelos SS, 2013, REMOTE SENS ENVIRON, V136, P199, DOI 10.1016/j.rse.2013.05.005; DeFries R, 2005, ECOL APPL, V15, P19, DOI 10.1890/03-5258; Ehringhaus C, 2005, POSTVICTORY DILEMMAS; Fearnside PM, 2007, ENVIRON MANAGE, V39, P601, DOI 10.1007/s00267-006-0149-2; Fearnside PM, 2012, NOVOS CAD NAEA, V15, P25; Ferraro PJ, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/2/025011; Ferreira J, 2014, SCIENCE, V346, P706, DOI 10.1126/science.1260194; FIRMS, 2012, FIR INF RES MAN SYST; Foundation TI, 2014, INGA FDN RESTORING L; Giglio L, 2003, REMOTE SENS ENVIRON, V87, P273, DOI 10.1016/S0034-4257(03)00184-6; Herrera D, 2013, IMPACTS BRAZILIAN AM; Houghton RA, 2000, NATURE, V403, P301, DOI 10.1038/35002062; Imbens GW, 2009, J ECON LIT, V47, P5, DOI 10.1257/jel.47.1.5; Jolly WM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8537; Joppa L, 2010, ANN NY ACAD SCI, V1185, P135, DOI 10.1111/j.1749-6632.2009.05162.x; Joppa LN, 2008, P NATL ACAD SCI USA, V105, P6673, DOI 10.1073/pnas.0802471105; McDaniel J, 2005, SOC NATUR RESOUR, V18, P921, DOI 10.1080/08941920500248921; Monzon-Alvarado C, 2014, LAND USE POLICY, V39, P12, DOI 10.1016/j.landusepol.2014.03.003; Morton DC, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0163; Nelson A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022722; Nepstad D, 2006, CONSERV BIOL, V20, P65, DOI 10.1111/j.1523-1739.2006.00351.x; Nepstad DC, 2008, PHILOS T R SOC B, V363, P1737, DOI 10.1098/rstb.2007.0036; Nolte C, 2013, CONSERV BIOL, V27, P155, DOI 10.1111/j.1523-1739.2012.01930.x; Ostrom, 2015, GOVERNING COMMONS EV, DOI DOI 10.1017/CBO9780511807763; Parry L, 2010, CONSERV LETT, V3, P251, DOI 10.1111/j.1755-263X.2010.00106.x; Peres CA, 2003, CONSERV BIOL, V17, P521, DOI 10.1046/j.1523-1739.2003.01413.x; Peres CA, 2011, CONSERV BIOL, V25, P1124, DOI 10.1111/j.1523-1739.2011.01770.x; Peskett L, 2011, ENVIRON SCI POLICY, V14, P216, DOI 10.1016/j.envsci.2010.10.004; Pinheiro J, R PACKAGE VERSION; Rayn D, 2011, BIODIVERS CONSERV, V20, P1625, DOI 10.1007/s10531-011-0051-y; Rodriguez N, 2013, REG ENVIRON CHANGE, V13, P423, DOI 10.1007/s10113-012-0356-8; Roman-Cuesta RM, 2006, CONSERV BIOL, V20, P1074, DOI 10.1111/j.1523-1739.2006.00478.x; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Schroeder W, 2008, REMOTE SENS ENVIRON, V112, P2711, DOI 10.1016/j.rse.2008.01.005; Schwartz NB, 2015, CLIMATE LANDOWNER RE, P144; Schwartzman S, 2000, CONSERV BIOL, V14, P1351, DOI 10.1046/j.1523-1739.2000.99329.x; Shaw E.M., 2010, HYDROLOGY PRACTICE, V4th; Silva MM, 2006, REV BRASILEIRA AGROE, V1; Silvestrini RA, 2011, ECOL APPL, V21, P1573, DOI 10.1890/10-0827.1; Soares B, 2010, P NATL ACAD SCI USA, V107, P10821, DOI 10.1073/pnas.0913048107; Stolle F, 2004, INT J REMOTE SENS, V25, P471, DOI 10.1080/01431160310001618022; UHL C, 1985, BIOTROPICA, V17, P265, DOI 10.2307/2388588; Vadjunec JM, 2009, ECOL SOC, V14; Verissimo A, 2011, AREAS PROTEGIDAS AMA; Wong D., 2009, SAGE HDB SPATIAL ANA, P105, DOI DOI 10.4135/9780857020130.N7	74	11	11	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0149292	10.1371/journal.pone.0149292	http://dx.doi.org/10.1371/journal.pone.0149292			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26886207	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000371218400074
J	Routson, CC; Overpeck, JT; Woodhouse, CA; Kenney, WF				Routson, Cody C.; Overpeck, Jonathan T.; Woodhouse, Connie A.; Kenney, William F.			Three Millennia of Southwestern North American Dustiness and Future Implications	PLOS ONE			English	Article							WESTERN UNITED-STATES; DUST DEPOSITION; DESERT DUST; COLORADO; CLIMATE; LAKE; RECORD; ECOSYSTEMS; MOUNTAINS; IMPACTS	Two sediment records of dust deposition from Fish Lake, in southern Colorado, offer a new perspective on southwest United States (Southwest) aridity and dustiness over the last similar to 3000 years. Micro scanning X-ray fluorescence and grain size analysis provide separate measures of wind-deposited dust in the lake sediment. Together these new records confirm anomalous dustiness in the 19th and 20th centuries, associated with recent land disturbance, drought, and livestock grazing. Before significant anthropogenic influences, changes in drought frequency and aridity also generated atmospheric dust loading. Medieval times were associated with high levels of dustiness, coincident with widespread aridity. These records indicate the Southwest is naturally prone to dustiness. As global and regional temperatures rise and the Southwest shifts toward a more arid landscape, the Southwest will likely become dustier, driving negative impacts on snowpack and water availability, as well as human health.	[Routson, Cody C.] No Arizona Univ, Sch Earth Sci & Environm Sustainabil, 625 S Knoles Dr,POB 4099, Flagstaff, AZ 86011 USA; [Overpeck, Jonathan T.] Univ Arizona, Inst Environm, 1064 E Lowell St, Tucson, AZ 85721 USA; [Overpeck, Jonathan T.; Woodhouse, Connie A.] Univ Arizona, Dept Geosci, 1040 E 4th St,Room 208, Tucson, AZ 85721 USA; [Overpeck, Jonathan T.] Univ Arizona, Dept Atmospher Sci, 1118 E 4th St, Tucson, AZ 85721 USA; [Woodhouse, Connie A.] Univ Arizona, Sch Geog & Dev, 1064 E Lowell St, Tucson, AZ 85721 USA; [Woodhouse, Connie A.] Univ Arizona, Tree Ring Res Lab, 1215 E Lowell St, Tucson, AZ 85721 USA; [Kenney, William F.] Univ Florida, Land Use & Environm Change Inst, 241 Williamson Hall, Gainesville, FL 32611 USA	Northern Arizona University; University of Arizona; University of Arizona; University of Arizona; University of Arizona; University of Arizona; State University System of Florida; University of Florida	Routson, CC (corresponding author), No Arizona Univ, Sch Earth Sci & Environm Sustainabil, 625 S Knoles Dr,POB 4099, Flagstaff, AZ 86011 USA.	cody.routson@nau.edu			NOAA The Climate Program Office [NA11OAR4310162]; National Science Foundation; Science Foundation Arizona; NOAA; Colorado Scientific Society; University of Arizona Department of Geoscience; National Oceanic and Atmospheric Administration (NOAA)	NOAA The Climate Program Office; National Science Foundation(National Science Foundation (NSF)); Science Foundation Arizona; NOAA(National Oceanic Atmospheric Admin (NOAA) - USA); Colorado Scientific Society; University of Arizona Department of Geoscience; National Oceanic and Atmospheric Administration (NOAA)(National Oceanic Atmospheric Admin (NOAA) - USA)	The NOAA The Climate Program Office funded the analyses for this research, grant number NA11OAR4310162. National Science Foundation and Science Foundation Arizona graduate research fellowships respectively provided support for CCR while conducting this research. The NOAA funded Climate Assessment for the Southwest, the Colorado Scientific Society, and the University of Arizona Department of Geoscience contributed research funds to this research for conducting fieldwork.; We thank K. Routson, R. Yetman, and C. Stielstra for extensive help in the field. We thank N. Mckay, J. Betancourt, A. Cohen, E. Brown, D. Meko, J. Conroy, S. Hayes, J. Addison, and M. Sliwinski for comments and insights. The National Oceanic and Atmospheric Administration (NOAA), the National Science Foundation, the Science Foundation Arizona, the NOAA funded Climate Assessment for the Southwest, the Colorado Scientific Society, and the University of Arizona Department of Geoscience contributed funding and support for this research.	ABRUZZI WS, 1995, HUM ECOL, V23, P75, DOI 10.1007/BF01190099; Anchukaitis KJ, 2013, CLIM DYNAM, V41, P1291, DOI 10.1007/s00382-012-1483-0; Christen JA, 2010, BAYESIAN ANAL, V5, P263, DOI 10.1214/10-BA60; APPLEBY PG, 1983, HYDROBIOLOGIA, V103, P29, DOI 10.1007/BF00028424; Appleby PG, 1987, PALEOLIMNOLOGY, P21; Ault TR, 2014, J CLIMATE, V27, P7529, DOI 10.1175/JCLI-D-12-00282.1; Bales RC, 2006, WATER RESOUR RES, V42, DOI 10.1029/2005WR004387; Ballantyne AP, 2011, BIOGEOSCIENCES, V8, P2689, DOI 10.5194/bg-8-2689-2011; Belnap J, 1997, LAND DEGRAD DEV, V8, P355, DOI 10.1002/(SICI)1099-145X(199712)8:4<355::AID-LDR266>3.0.CO;2-H; Belnap J, 2014, AEOLIAN RES, V14, P15, DOI 10.1016/j.aeolia.2014.03.007; Binford, 1990, J PALEOLIMNOL, V3, P253, DOI DOI 10.1007/BF00219461; Blaauw M, 2011, BAYESIAN ANAL, V6, P457, DOI 10.1214/ba/1339616472; Brahney J, 2015, LIMNOL OCEANOGR, V60, P678, DOI 10.1002/lno.10050; Brahney J, 2014, BIOGEOCHEMISTRY, V120, P259, DOI 10.1007/s10533-014-9994-x; Brahney J, 2013, AEOLIAN RES, V10, P77, DOI 10.1016/j.aeolia.2013.04.003; Bryant AC, 2013, GEOPHYS RES LETT, V40, P3945, DOI 10.1002/grl.50773; Carling GT, 2012, SCI TOTAL ENVIRON, V432, P65, DOI 10.1016/j.scitotenv.2012.05.077; Chen FH, 2013, J GEOPHYS RES-ATMOS, V118, P2149, DOI 10.1002/jgrd.50140; Chu GQ, 2009, QUATERN INT, V194, P108, DOI 10.1016/j.quaint.2008.08.005; Clow DW, 1997, WATER RESOUR RES, V33, P1335, DOI 10.1029/97WR00856; Collins DQ, 2013, CLIMATE CHANGE 2013; Conroy JL, 2008, QUATERNARY SCI REV, V27, P1166, DOI 10.1016/j.quascirev.2008.02.015; Conroy JL, 2013, GLOBAL PLANET CHANGE, V107, P132, DOI 10.1016/j.gloplacha.2013.04.009; Cook BI, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400082; Cook BI, 2013, J CLIMATE, V26, P4414, DOI 10.1175/JCLI-D-12-00022.1; Cook BI, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL033486; Cook ER, 2004, SCIENCE, V306, P1015, DOI 10.1126/science.1102586; COOK ER, 1995, HOLOCENE, V5, P229, DOI 10.1177/095968369500500211; Cook ER, 2008, IGBP PAGESWORLD DATA, V46, P2008; Deems JS, 2013, HYDROL EARTH SYST SC, V17, P4401, DOI 10.5194/hess-17-4401-2013; Derbyshire E, 2007, AMBIO, V36, P73, DOI 10.1579/0044-7447(2007)36[73:NMDAHH]2.0.CO;2; Forman SL, 2006, QUATERNARY RES, V66, P97, DOI 10.1016/j.yqres.2005.12.003; Ghio AJ, 2014, INHAL TOXICOL, V26, P299, DOI 10.3109/08958378.2014.888109; Goudie AS, 2014, ENVIRON INT, V63, P101, DOI 10.1016/j.envint.2013.10.011; Halfen AF, 2013, AEOLIAN RES, V10, P135, DOI 10.1016/j.aeolia.2013.03.001; He Y, 2015, SCI REP; Huang XT, 2011, QUATERNARY SCI REV, V30, P3661, DOI 10.1016/j.quascirev.2011.09.011; Landry CC, 2014, WATER RESOUR RES, V50, P1773, DOI 10.1002/2013WR013711; Lawrence CR, 2013, GEOCHIM COSMOCHIM AC, V107, P27, DOI 10.1016/j.gca.2012.12.023; Lawrence CR, 2010, J GEOPHYS RES-BIOGEO, V115, DOI 10.1029/2009JG001077; Lawrence CR, 2009, CHEM GEOL, V267, P46, DOI 10.1016/j.chemgeo.2009.02.005; Lipman PW, 1974, MISCILLANEOUS INVEST; Mahowald NM, 2010, ATMOS CHEM PHYS, V10, P10875, DOI 10.5194/acp-10-10875-2010; Miao XD, 2007, GEOLOGY, V35, P119, DOI 10.1130/G23133A.1; Mulitza S, 2010, NATURE, V466, P226, DOI 10.1038/nature09213; Munson SM, 2011, P NATL ACAD SCI USA, V108, P3854, DOI 10.1073/pnas.1014947108; Neff JC, 2008, NAT GEOSCI, V1, P189, DOI 10.1038/ngeo133; Neff JC, 2013, J GEOPHYS RES-ATMOS, V118, P11201, DOI 10.1002/jgrd.50855; Painter TH, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030284; Painter TH, 2012, WATER RESOUR RES, V48, DOI 10.1029/2012WR011985; Painter TH, 2010, P NATL ACAD SCI USA, V107, P17125, DOI 10.1073/pnas.0913139107; Prospero JM, 2003, SCIENCE, V302, P1024, DOI 10.1126/science.1089915; Qiang MR, 2014, GEOPHYS RES LETT, V41, P589, DOI 10.1002/2013GL058806; REHEIS MC, 1995, GEOL SOC AM BULL, V107, P1003, DOI 10.1130/0016-7606(1995)107&lt;1003:QSADDI&gt;2.3.CO;2; Reimer P. J., 2009, INTCAL09 MARINE09 RA; Reynolds RL, 2014, AEOLIAN RES, V15, P73, DOI 10.1016/j.aeolia.2013.08.001; Reynolds RL, 2010, J PALEOLIMNOL, V44, P161, DOI 10.1007/s10933-009-9394-8; Routson CC, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL050015; Sayre N, 1999, J SOUTHWEST, V41, P239; Schelske C.L., 1994, J PALEOLIMNOL, V10, P115, DOI [10.1007/BF00682508, DOI 10.1007/BF00682508]; Skiles SM, 2012, WATER RESOUR RES, V48, DOI 10.1029/2012WR011986; Stahle DW., 2000, EOS, V81, P121, DOI [10.1029/00EO00076, DOI 10.1029/00EO00076]; Woodhouse CA, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022413; Woodhouse CA, 1998, B AM METEOROL SOC, V79, P2693, DOI 10.1175/1520-0477(1998)079<2693:YODVIT>2.0.CO;2	64	17	17	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0149573	10.1371/journal.pone.0149573	http://dx.doi.org/10.1371/journal.pone.0149573			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26886350	Green Published, gold, Green Submitted			2022-12-26	WOS:000371218400097
J	Silva, G; Ribeiro, MJ; Costa, GN; Violante, I; Ramos, F; Saraiva, J; Castelo-Branco, M				Silva, Gilberto; Ribeiro, Maria J.; Costa, Gabriel N.; Violante, Ines; Ramos, Fabiana; Saraiva, Jorge; Castelo-Branco, Miguel			Peripheral Attentional Targets under Covert Attention Lead to Paradoxically Enhanced Alpha Desynchronization in Neurofibromatosis Type 1	PLOS ONE			English	Article							GAMMA-BAND ACTIVITY; VISUAL-SPATIAL ATTENTION; EEG ALPHA; OSCILLATORY ACTIVITY; NEURONAL DYNAMICS; FREQUENCY; CORTEX; INHIBITION; MECHANISMS; RESPONSES	The limited capacity of the human brain to process the full extent of visual information reaching the visual cortex requires the recruitment of mechanisms of information selection through attention. Neurofibromatosis type-1 (NF1) is a neurodevelopmental disease often exhibiting attentional deficits and learning disabilities, and is considered to model similar impairments common in other neurodevelopmental disorders such as autism. In a previous study, we found that patients with NF1 are more prone to miss targets under overt attention conditions. This finding was interpreted as a result of increased occipito-parietal alpha oscillations. In the present study, we used electroencephalography (EEG) to study alpha power modulations and the performance of patients with NF1 in a covert attention task. Covert attention was required in order to perceive changes (target offset) of a peripherally presented stimulus. Interestingly, alpha oscillations were found to undergo greater desynchronization under this task in the NF1 group compared with control subjects. A similar pattern of desynchronization was found for beta frequencies while no changes in gamma oscillations could be identified. These results are consistent with the notion that different attentional states and task demands generate different patterns of abnormal modulation of alpha oscillatory processes in NF1. Under covert attention conditions and while target offset was reported with relatively high accuracy (over 90% correct responses), excessive desynchronization was found. These findings suggest an abnormal modulation of oscillatory activity and attentional processes in NF1. Given the known role of alpha in modulating attention, we suggest that alpha patterns can show both abnormal increases and decreases that are task and performance dependent, in a way that enhanced alpha desynchronization may reflect a compensatory mechanism to keep performance at normal levels. These results suggest that dysregulation of alpha oscillations may occur in NF1 both in terms of excessive or diminished activation patterns.	[Silva, Gilberto; Costa, Gabriel N.; Castelo-Branco, Miguel] ICNAS Brain Imaging Network Portugal, Coimbra, Portugal; [Ribeiro, Maria J.; Costa, Gabriel N.; Castelo-Branco, Miguel] Univ Coimbra, Fac Med, IBILI Inst Biomed Imaging Life Sci, Coimbra, Portugal; [Ramos, Fabiana; Saraiva, Jorge] Pediat Hosp Coimbra, Dept Med Genet, Coimbra, Portugal; [Violante, Ines] Univ London Imperial Coll Sci Technol & Med, Computat Cognit & Clin Neuroimaging Lab, Div Brain Sci, London, England	Universidade de Coimbra; Universidade de Coimbra; Universidade de Coimbra; Centro Hospitalar e Universitario de Coimbra (CHUC); Imperial College London	Castelo-Branco, M (corresponding author), ICNAS Brain Imaging Network Portugal, Coimbra, Portugal.; Castelo-Branco, M (corresponding author), Univ Coimbra, Fac Med, IBILI Inst Biomed Imaging Life Sci, Coimbra, Portugal.	mcbranco@fmed.uc.pt	Castelo-Branco, Miguel/F-3866-2019; Ribeiro, Maria J/J-4618-2013	Castelo-Branco, Miguel/0000-0003-4364-6373; Ribeiro, Maria J/0000-0001-6422-3279; Saraiva, Jorge Manuel/0000-0002-7232-3509; Ribeiro Silva, Gilberto Miguel/0000-0002-2093-288X; Costa, Gabriel/0000-0001-9630-1155; Violante, Ines/0000-0002-4787-2901; Ramos, Fabiana/0000-0001-7780-9762	From molecules to man: novel diagnostic imaging tools in neurological and psychiatric disorders [CENTRO-07-ST24-FEDER-00205]; Taking imaging into the therapeutic domain: Self-regulation of brain systems for mental disorders [FP7-HEALTH-2013-INNOVATION-1 - 602186 - BRAINTRAIN-]; CNC. IBILI, Compete [POCI-01-0145-FEDER-007440, UID/NEU/04539/2013]; A direct test of the binding by synchrony hypothesis in humans: the neural correlates of coherent object perception, Bial Foundation [Bial 133/2012]; Fundacao para a Ciencia e Tecnologia [PTDC/SAU-ORG/118380/201]	From molecules to man: novel diagnostic imaging tools in neurological and psychiatric disorders; Taking imaging into the therapeutic domain: Self-regulation of brain systems for mental disorders; CNC. IBILI, Compete; A direct test of the binding by synchrony hypothesis in humans: the neural correlates of coherent object perception, Bial Foundation(Bial Foundation); Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission)	MCB received funding from the following grants: CENTRO-07-ST24-FEDER-00205 From molecules to man: novel diagnostic imaging tools in neurological and psychiatric disorders 1176470,59 Euros 2013-2015; FP7-HEALTH-2013-INNOVATION-1 - 602186 - BRAINTRAIN- Taking imaging into the therapeutic domain: Self-regulation of brain systems for mental disorders; POCI-01-0145-FEDER-007440, CNC. IBILI, Compete, UID/NEU/04539/2013; Bial 133/2012 A direct test of the binding by synchrony hypothesis in humans: the neural correlates of coherent object perception, Bial Foundation, 2013; Fundacao para a Ciencia e Tecnologia, PTDC/SAU-ORG/118380/201. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Capotosto P, 2009, J NEUROSCI, V29, P5863, DOI 10.1523/JNEUROSCI.0539-09.2009; Castelhano J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066363; Cooper NR, 2003, INT J PSYCHOPHYSIOL, V47, P65, DOI 10.1016/S0167-8760(02)00107-1; Dockree PM, 2007, EUR J NEUROSCI, V25, P900, DOI 10.1111/j.1460-9568.2007.05324.x; Engel AK, 2010, CURR OPIN NEUROBIOL, V20, P156, DOI 10.1016/j.conb.2010.02.015; Ergenoglu T, 2004, COGNITIVE BRAIN RES, V20, P376, DOI 10.1016/j.cogbrainres.2004.03.009; Foxe JJ, 1998, NEUROREPORT, V9, P3929, DOI 10.1097/00001756-199812010-00030; Foxe JJ, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00154; Fu KMG, 2001, COGNITIVE BRAIN RES, V12, P145, DOI 10.1016/S0926-6410(01)00034-9; Handel BF, 2011, J COGNITIVE NEUROSCI, V23, P2494, DOI 10.1162/jocn.2010.21557; Hanslmayr S, 2011, BRAIN RES REV, V67, P331, DOI 10.1016/j.brainresrev.2011.04.002; Herrmann CS, 2010, NEUROSCI BIOBEHAV R, V34, P981, DOI 10.1016/j.neubiorev.2009.09.001; Hoogenboom N, 2006, NEUROIMAGE, V29, P764, DOI 10.1016/j.neuroimage.2005.08.043; Hopfinger JB, 2006, NEUROIMAGE, V31, P774, DOI 10.1016/j.neuroimage.2005.12.049; Horschig JM, 2014, BRAIN TOPOGR; Kayl AE, 2000, BEHAV PHENOTYPE NEUR, V124, P117; Klimesch W, 1999, BRAIN RES REV, V29, P169, DOI 10.1016/S0165-0173(98)00056-3; Klimesch W, 2007, BRAIN RES REV, V53, P63, DOI 10.1016/j.brainresrev.2006.06.003; Klimesch W, 2012, TRENDS COGN SCI, V16, P606, DOI 10.1016/j.tics.2012.10.007; Levine Terry M, 2006, Semin Pediatr Neurol, V13, P8, DOI 10.1016/j.spen.2006.01.006; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; Mazaheri A, 2009, HUM BRAIN MAPP, V30, P1791, DOI 10.1002/hbm.20763; Medendorp WP, 2007, CEREB CORTEX, V17, P2364, DOI 10.1093/cercor/bhl145; Muthukumaraswamy SD, 2013, NEUROIMAGE, V69, P223, DOI 10.1016/j.neuroimage.2012.12.038; Muthukumaraswamy SD, 2010, NEUROIMAGE, V49, P3349, DOI 10.1016/j.neuroimage.2009.11.045; Muthukumaraswamy SD, 2009, P NATL ACAD SCI USA, V106, P8356, DOI 10.1073/pnas.0900728106; O'Connell RG, 2009, J NEUROSCI, V29, P8604, DOI 10.1523/JNEUROSCI.5967-08.2009; Okazaki YO, 2015, REAL TIME MEG NEUROF; Oostenveld R, 2001, CLIN NEUROPHYSIOL, V112, P713, DOI 10.1016/S1388-2457(00)00527-7; Orekhova EV, 2007, BIOL PSYCHIAT, V62, P1022, DOI 10.1016/j.biopsych.2006.12.029; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Ribeiro MJ, 2014, J NEURODEV DISORD, V6, DOI 10.1186/1866-1955-6-4; Rihs TA, 2007, EUR J NEUROSCI, V25, P603, DOI 10.1111/j.1460-9568.2007.05278.x; Sauseng P, 2005, EUR J NEUROSCI, V22, P2917, DOI 10.1111/j.1460-9568.2005.04482.x; Scheeringa R, 2011, NEURON, V69, P572, DOI 10.1016/j.neuron.2010.11.044; Schreckenberger M, 2004, NEUROIMAGE, V22, P637, DOI 10.1016/j.neuroimage.2004.01.047; Stumpf D, 1988, ARCH NEUROL; Sun LM, 2012, J NEUROSCI, V32, P9563, DOI 10.1523/JNEUROSCI.1073-12.2012; Thut G, 2006, J NEUROSCI, V26, P9494, DOI 10.1523/JNEUROSCI.0875-06.2006; Toscani M, 2010, EXP BRAIN RES, V207, P213, DOI 10.1007/s00221-010-2444-7; Uhlhaas PJ, 2012, NEURON, V75, P963, DOI 10.1016/j.neuron.2012.09.004; van Driel J, 2012, J NEUROSCI, V32, P16795, DOI 10.1523/JNEUROSCI.0802-12.2012; van Pelt S, 2013, NEUROIMAGE, V78, P439, DOI 10.1016/j.neuroimage.2013.04.040; Vijayan S, 2013, J NEUROSCI, V33, P11070, DOI 10.1523/JNEUROSCI.5670-12.2013; Violante IR, 2013, BRAIN, V136, P918, DOI 10.1093/brain/aws368; Violante IR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038785; Wechsler D., 2003, ESCALA INTELIGENCIA; Williams VC, 2009, PEDIATRICS, V123, P124, DOI 10.1542/peds.2007-3204; Worden MS, 2000, J NEUROSCI, V20; Yamagishi N, 2003, NEUROIMAGE, V20, P98, DOI 10.1016/S1053-8119(03)00341-0	50	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0148600	10.1371/journal.pone.0148600	http://dx.doi.org/10.1371/journal.pone.0148600			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	26881921	Green Published, Green Submitted, gold			2022-12-26	WOS:000371219000019
J	Adibi, M; Yoshida, S; Weijers, D; Fleck, C				Adibi, Milad; Yoshida, Saiko; Weijers, Dolf; Fleck, Christian			Centering the Organizing Center in the Arabidopsis thaliana Shoot Apical Meristem by a Combination of Cytokinin Signaling and Self-Organization	PLOS ONE			English	Article							STEM-CELL HOMEOSTASIS; RESPONSE REGULATORS; VASCULAR DEVELOPMENT; ESCHERICHIA-COLI; DIFFUSION; EXPRESSION; GENES; MODEL; FATE; DIFFERENTIATION	Plants have the ability to continously generate new organs by maintaining populations of stem cells throught their lives. The shoot apical meristem (SAM) provides a stable environment for the maintenance of stem cells. All cells inside the SAM divide, yet boundaries and patterns are maintained. Experimental evidence indicates that patterning is independent of cell lineage, thus a dynamic self-regulatory mechanism is required. A pivotal role in the organization of the SAM is played by the WUSCHEL gene (WUS). An important question in this regard is that how WUS expression is positioned in the SAM via a cell-lineage independent signaling mechanism. In this study we demonstrate via mathematical modeling that a combination of an inhibitor of the Cytokinin (CK) receptor, Arabidopsis histidine kinase 4 (AHK4) and two morphogens originating from the top cell layer, can plausibly account for the cell lineage-independent centering of WUS expression within SAM. Furthermore, our laser ablation and microsurgical experiments support the hypothesis that patterning in SAM occurs at the level of CK reception and signaling. The model suggests that the interplay between CK signaling, WUS/CLV feedback loop and boundary signals can account for positioning of the WUS expression, and provides directions for further experimental investigation.	[Adibi, Milad; Fleck, Christian] Wageningen Univ, Lab Syst & Synthet Biol, NL-6700 AP Wageningen, Netherlands; [Yoshida, Saiko; Weijers, Dolf] Wageningen Univ, Biochem Lab, NL-6700 AP Wageningen, Netherlands; [Adibi, Milad] Max Planck Inst Plant Breeding Res, Cologne, Germany; [Yoshida, Saiko] IST Austria, Campus 1, Klosterneuburg, Austria	Wageningen University & Research; Wageningen University & Research; Max Planck Society; Institute of Science & Technology - Austria	Adibi, M; Fleck, C (corresponding author), Wageningen Univ, Lab Syst & Synthet Biol, NL-6700 AP Wageningen, Netherlands.; Adibi, M (corresponding author), Max Planck Inst Plant Breeding Res, Cologne, Germany.	adibi@mpipz.mpg.de; christian.fleck@wur.nl	Yoshida, Saiko/AAE-5693-2019; Weijers, Dolf/ABI-1332-2020; Weijers, Dolf/A-2076-2010	Yoshida, Saiko/0000-0001-6111-9353; Weijers, Dolf/0000-0003-4378-141X; Weijers, Dolf/0000-0003-4378-141X; Fleck, Christian/0000-0002-6371-4495				Banasiak A, 2011, PLANTA, V233, P49, DOI 10.1007/s00425-010-1280-0; Barton MK, 2010, DEV BIOL, V341, P95, DOI 10.1016/j.ydbio.2009.11.029; Bauby H, 2007, PLANT CELL PHYSIOL, V48, P97, DOI 10.1093/pcp/pcl045; Besnard F, 2014, PLANT SIGNAL BEHAV, V9, DOI 10.4161/psb.28788; Besnard F, 2014, NATURE, V505, P417, DOI 10.1038/nature12791; Brand U, 2002, PLANT PHYSIOL, V129, P565, DOI 10.1104/pp.001867; Carlsbecker A, 2010, NATURE, V465, P316, DOI 10.1038/nature08977; Chickarmane VS, 2012, P NATL ACAD SCI USA, V109, P4002, DOI 10.1073/pnas.1200636109; Daum G, 2014, P NATL ACAD SCI USA, V111, P14619, DOI 10.1073/pnas.1406446111; De Rybel B, 2014, SCIENCE, V345, DOI 10.1126/science.1255215; Dello Ioio R, 2007, CURR BIOL, V17, P678, DOI 10.1016/j.cub.2007.02.047; Dodsworth S, 2009, DEV BIOL, V336, P1, DOI 10.1016/j.ydbio.2009.09.031; Fujita H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018243; Goda H, 2008, PLANT J, V55, P526, DOI [10.1111/j.1365-313X.2008.03510.x, 10.1111/j.0960-7412.2008.03510.x]; Gordon SP, 2009, P NATL ACAD SCI USA, V106, P16529, DOI 10.1073/pnas.0908122106; Graf P, 2010, PLANT CELL, V22, P716, DOI 10.1105/tpc.109.068296; Grandjean O, 2004, PLANT CELL, V16, P74, DOI 10.1105/tpc.017962; Hohm T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009189; Hwang I, 2001, NATURE, V413, P383, DOI 10.1038/35096500; Hwang I, 2012, ANNU REV PLANT BIOL, V63, P353, DOI 10.1146/annurev-arplant-042811-105503; Jacqmard A, 2002, PLANTA, V214, P970, DOI 10.1007/s00425-002-0742-4; Jensen KH, 2012, J THEOR BIOL, V304, P286, DOI 10.1016/j.jtbi.2012.03.012; Jonsson H, 2005, BIOINFORMATICS, V21, pI232, DOI 10.1093/bioinformatics/bti1036; Jonsson H, 2003, SIGNALLING MULTICELL, P156; Kalwarczyk T, 2012, BIOINFORMATICS, V28, P2971, DOI 10.1093/bioinformatics/bts537; Kieber Joseph J, 2014, Arabidopsis Book, V12, pe0168, DOI 10.1199/tab.0168; Kierzkowski D, 2012, SCIENCE, V335, P1096, DOI 10.1126/science.1213100; Kim CY, 2007, J PLANT BIOL, V50, P274, DOI 10.1007/BF03030655; Knauer S, 2013, DEV CELL, V24, P125, DOI 10.1016/j.devcel.2012.12.009; Kramer EM, 2007, J EXP BOT, V58, P3005, DOI 10.1093/jxb/erm155; Kudo T, 2010, J INTEGR PLANT BIOL, V52, P53, DOI 10.1111/j.1744-7909.2010.00898.x; Kurakawa T, 2007, NATURE, V445, P652, DOI 10.1038/nature05504; Kyozuka J, 2007, CURR OPIN PLANT BIOL, V10, P442, DOI 10.1016/j.pbi.2007.08.010; Laufs P, 1998, PLANT CELL, V10, P1375, DOI 10.1105/tpc.10.8.1375; Lee CH, 2013, WIRES DEV BIOL, V2, P671, DOI 10.1002/wdev.110; Leibfried A, 2005, NATURE, V438, P1172, DOI 10.1038/nature04270; Lenhard M, 2003, DEVELOPMENT, V130, P3163, DOI 10.1242/dev.00525; Mahonen AP, 2006, SCIENCE, V311, P94, DOI 10.1126/science.1118875; Maini PK, 2006, SCIENCE, V314, P1397, DOI 10.1126/science.1136396; Mason MG, 2005, PLANT CELL, V17, P3007, DOI 10.1105/tpc.105.035451; McConnell JR, 2001, NATURE, V411, P709, DOI 10.1038/35079635; Meinhardt H, 2000, BIOESSAYS, V22, P753, DOI 10.1002/1521-1878(200008)22:8<753::AID-BIES9>3.3.CO;2-Q; Muller B, 2008, NATURE, V453, P1094, DOI 10.1038/nature06943; Murray J. D., 2002, MATH BIOL, V2; Nakamasu A, 2009, P NATL ACAD SCI USA, V106, P8429, DOI 10.1073/pnas.0808622106; Nenninger A, 2010, J BACTERIOL, V192, P4535, DOI 10.1128/JB.00284-10; Reinhardt D, 2003, DEVELOPMENT, V130, P4073, DOI 10.1242/dev.00596; Schoof H, 2000, CELL, V100, P635, DOI 10.1016/S0092-8674(00)80700-X; Sick S, 2006, SCIENCE, V314, P1447, DOI 10.1126/science.1130088; STEWART RN, 1970, AM J BOT, V57, P816, DOI 10.2307/2441339; To JPC, 2008, TRENDS PLANT SCI, V13, P85, DOI 10.1016/j.tplants.2007.11.005; To JPC, 2007, PLANT CELL, V19, P3901, DOI 10.1105/tpc.107.052662; To JPC, 2004, PLANT CELL, V16, P658, DOI 10.1105/tpc.018978; To JPC, 2007, PROQUEST; Tucker MR, 2007, TRENDS CELL BIOL, V17, P403, DOI 10.1016/j.tcb.2007.06.002; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; Williams L, 2005, DEVELOPMENT, V132, P3657, DOI 10.1242/dev.01942; Winter D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000718; Yadav RK, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.8; Yadav RK, 2011, GENE DEV, V25, P2025, DOI 10.1101/gad.17258511; Yadav RK, 2009, P NATL ACAD SCI USA, V106, P4941, DOI 10.1073/pnas.0900843106; Yanai O, 2005, CURR BIOL, V15, P1566, DOI 10.1016/j.cub.2005.07.060; Zhao Z, 2010, NATURE, V465, P1089, DOI 10.1038/nature09126; Zhou GK, 2007, PLANT CELL PHYSIOL, V48, P391, DOI 10.1093/pcp/pcm008	64	21	21	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0147830	10.1371/journal.pone.0147830	http://dx.doi.org/10.1371/journal.pone.0147830			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26872130	gold, Green Published			2022-12-26	WOS:000370054100011
J	Chang, YT; Huang, CW; Chen, NC; Lin, KJ; Huang, SH; Chang, YH; Hsu, SW; Chang, WN; Lui, CC; Hsu, CW; Chang, CC				Chang, Ya-Ting; Huang, Chi-Wei; Chen, Nai-Ching; Lin, Kun-Ju; Huang, Shu-Hua; Chang, Yen-Hsiang; Hsu, Shih-Wei; Chang, Wen-Neng; Lui, Chun-Chung; Hsu, Che-Wei; Chang, Chiung-Chih			Prefrontal Lobe Brain Reserve Capacity with Resistance to Higher Global Amyloid Load and White Matter Hyperintensity Burden in Mild Stage Alzheimer's Disease	PLOS ONE			English	Article							COGNITIVE IMPAIRMENT; HIPPOCAMPAL ATROPHY; NORMAL INDIVIDUALS; MEMORY DECLINE; AMNESTIC MCI; FDG PET; MRI; DEMENTIA; LESIONS; ASSOCIATION	Background Amyloid deposition and white matter lesions (WMLs) in Alzheimer's disease (AD) are both considered clinically significant while a larger brain volume is thought to provide greater brain reserve (BR) against these pathological effects. This study identified the topography showing BR in patients with mild AD and explored the clinical balances among BR, amyloid, and WMLs burden. Methods Thirty patients with AD were enrolled, and AV-45 positron emission tomography was conducted to measure the regional standardized uptake value ratio (SUVr) in 8 cortical volumes-of-interests (VOIs). The quantitative WMLs burden was measured from magnetic resonance imaging while the normalized VOIs volumes represented BR in this study. The cognitive test represented major clinical correlates. Results Significant correlations between the prefrontal volume and global (r = 0.470, p = 0.024), but not regional (r = 0.264, p = 0.223) AV-45 SUVr were found. AD patients having larger regional volume in the superior- (r = 0.572, p = 0.004), superior medial- (r = 0.443, p = 0.034), and middle-prefrontal (r = 0.448, p = 0.032) regions had higher global AV-45 SUVr. For global WML loads, the prefrontal (r = -0.458, p = 0.019) and hippocampal volume (r = -0.469, p = 0.016) showed significant correlations while the prefrontal (r = -0.417, p = 0.043) or hippocampal volume (r = -0.422, p = 0.04) also predicted better composite memory scores. There were no interactions between amyloid SUVr and WML loads on the prefrontal volume. Conclusions BR of the prefrontal region might modulate the adverse global pathological burden caused by amyloid deposition. While prefrontal volume positively associated with hippocampal volume, WMLs had an adverse impact on the hippocampal volume that predicts memory performance in mild stage AD.	[Chang, Ya-Ting; Huang, Chi-Wei; Chen, Nai-Ching; Chang, Wen-Neng; Hsu, Che-Wei; Chang, Chiung-Chih] Chang Gung Univ, Kaohsiung Chang Gung Mem Hosp, Cognit & Aging Ctr, Dept Neurol,Coll Med, Kaohsiung, Taiwan; [Huang, Shu-Hua; Chang, Yen-Hsiang] Chang Gung Univ, Coll Med, Kaohsiung Chang Gung Mem Hosp, Nucl Med, Kaohsiung, Taiwan; [Hsu, Shih-Wei; Lui, Chun-Chung] Chang Gung Univ, Coll Med, Kaohsiung Chang Gung Mem Hosp, Radiol, Kaohsiung, Taiwan; [Lin, Kun-Ju] Chang Gung Mem Hosp, Dept Nucl Med, Taoyuan, Taiwan; [Lin, Kun-Ju] Chang Gung Mem Hosp, Ctr Adv Mol Imaging & Translat, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital	Chang, CC (corresponding author), Chang Gung Univ, Kaohsiung Chang Gung Mem Hosp, Cognit & Aging Ctr, Dept Neurol,Coll Med, Kaohsiung, Taiwan.	neur099@adm.cgmh.org.tw	Lin, Kun-Ju/H-3120-2015	Lin, Kun-Ju/0000-0003-1933-4564	Chang Gung Memorial Hospital [8B1001, 8C0571, 8D0771]; National Research Program for Biopharmaceuticals [103-2325-B-182A-009]	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital); National Research Program for Biopharmaceuticals	This work was supported by grants from Chang Gung Memorial Hospital (8B1001, 8C0571 and 8D0771) and National Research Program for Biopharmaceuticals (103-2325-B-182A-009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes J, 2010, NEUROIMAGE, V53, P1244, DOI 10.1016/j.neuroimage.2010.06.025; Bartley AJ, 1997, BRAIN, V120, P257, DOI 10.1093/brain/120.2.257; Bourgeat P, 2010, NEUROLOGY, V74, P121, DOI 10.1212/WNL.0b013e3181c918b5; Cagnin A, 2001, BRAIN, V124, P2014, DOI 10.1093/brain/124.10.2014; Chetelat G, 2013, NEUROIMAGE-CLIN, V2, P356, DOI 10.1016/j.nicl.2013.02.006; Chetelat G, 2010, BRAIN, V133, P3349, DOI 10.1093/brain/awq187; Chu L. W., 2000, Annals Academy of Medicine Singapore, V29, P474; Clark CM, 2011, JAMA-J AM MED ASSOC, V305, P275, DOI 10.1001/jama.2010.2008; de Leeuw FE, 2004, NEUROLOGY, V62, P310, DOI 10.1212/01.WNL.0000103289.03648.AD; Defrancesco M, 2013, J ALZHEIMERS DIS, V34, P665, DOI 10.3233/JAD-122095; Dewey J, 2010, NEUROIMAGE, V51, P1334, DOI 10.1016/j.neuroimage.2010.03.033; Du AT, 2005, NEUROBIOL AGING, V26, P553, DOI 10.1016/j.neurobiolaging.2004.05.002; Dubois B, 2014, LANCET NEUROL, V13, P614, DOI 10.1016/S1474-4422(14)70090-0; Dubois B, 2010, LANCET NEUROL, V9, P1118, DOI 10.1016/S1474-4422(10)70223-4; Edison P, 2008, NEUROBIOL DIS, V32, P412, DOI 10.1016/j.nbd.2008.08.001; Erten-Lyons D, 2009, NEUROLOGY, V72, P354, DOI 10.1212/01.wnl.0000341273.18141.64; Godin O, 2009, CEREBROVASC DIS, V28, P177, DOI 10.1159/000226117; GOLOMB J, 1993, ARCH NEUROL-CHICAGO, V50, P967, DOI 10.1001/archneur.1993.00540090066012; Greenberg DL, 2008, NEUROBIOL AGING, V29, P290, DOI 10.1016/j.neurobiolaging.2006.09.016; Guedj E, 2009, EUR J NUCL MED MOL I, V36, P1101, DOI 10.1007/s00259-009-1060-x; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Huang CW, 2013, EUR J NEUROL, V20, P1191, DOI 10.1111/ene.12159; Huang CW, 2010, CURR ALZHEIMER RES, V7, P527; Huang KL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058974; Huijbers W, 2015, BRAIN, V138, P1023, DOI 10.1093/brain/awv007; Jack CR, 2009, BRAIN, V132, P1355, DOI 10.1093/brain/awp062; Jansen WJ, 2015, JAMA-J AM MED ASSOC, V313, P1924, DOI 10.1001/jama.2015.4668; Karow DS, 2010, RADIOLOGY, V256, P932, DOI 10.1148/radiol.10091402; Kimura N, 2013, DEMENT GER COGN D EX, V3, P96, DOI 10.1159/000350317; Meyer-Luehmann M, 2008, NATURE, V451, P720, DOI 10.1038/nature06616; Mielke MM, 2012, ALZHEIMERS DEMENT, V8, P105, DOI 10.1016/j.jalz.2011.05.2416; Mori E, 1997, AM J PSYCHIAT, V154, P18, DOI 10.1176/ajp.154.1.18; Mormino EC, 2014, NEUROPSYCHOL REV, V24, P300, DOI 10.1007/s11065-014-9267-4; Mortimer JA, 1997, GERIATRICS, V52, pS50; Nemmi F, 2014, EUR J NUCL MED MOL I, V41, P1408, DOI 10.1007/s00259-014-2728-4; Nithianantharajah J, 2009, PROG NEUROBIOL, V89, P369, DOI 10.1016/j.pneurobio.2009.10.001; Nobili F, 2008, EUR J NUCL MED MOL I, V35, P2191, DOI 10.1007/s00259-008-0869-z; Okello A, 2009, NEUROLOGY, V72, P56, DOI 10.1212/01.wnl.0000338622.27876.0d; Pantoni L, 1997, STROKE, V28, P652, DOI 10.1161/01.STR.28.3.652; Perneczky R, 2006, J NEUROL NEUROSUR PS, V77, P1060, DOI 10.1136/jnnp.2006.094714; ROSEN WG, 1980, ANN NEUROL, V7, P486, DOI 10.1002/ana.410070516; Schmidt P, 2012, NEUROIMAGE, V59, P3774, DOI 10.1016/j.neuroimage.2011.11.032; Schofield PW, 1997, NEUROLOGY, V49, P30, DOI 10.1212/WNL.49.1.30; Springer MV, 2005, NEUROPSYCHOLOGY, V19, P181, DOI 10.1037/0894-4105.19.2.181; Stern Y, 1999, NEUROLOGY, V53, P1942, DOI 10.1212/WNL.53.9.1942; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van der Flier WM, 2004, NEUROLOGY, V62, P1862, DOI 10.1212/01.WNL.0000125337.65553.8A; Voevodskaya O, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00264; Wahlund LO, 2001, STROKE, V32, P1318, DOI 10.1161/01.STR.32.6.1318; Weiner Michael W, 2012, Alzheimers Dement, V8, pS1, DOI [10.1016/j.jalz.2013.05.1769, 10.1016/j.jalz.2011.09.172]; YLIKOSKI R, 1993, ARCH NEUROL-CHICAGO, V50, P818, DOI 10.1001/archneur.1993.00540080029009	51	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149056	10.1371/journal.pone.0149056	http://dx.doi.org/10.1371/journal.pone.0149056			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26872386	Green Published, gold, Green Submitted			2022-12-26	WOS:000370054100094
J	Groves, IJ; Knight, ELA; Ang, QY; Scarpini, CG; Coleman, N				Groves, I. J.; Knight, E. L. A.; Ang, Q. Y.; Scarpini, C. G.; Coleman, N.			HPV16 oncogene expression levels during early cervical carcinogenesis are determined by the balance of epigenetic chromatin modifications at the integrated virus genome	ONCOGENE			English	Article							HUMAN-PAPILLOMAVIRUS TYPE-16; TRANSCRIPTION FACTOR-BINDING; GENE-EXPRESSION; IN-VITRO; HISTONE MODIFICATIONS; REGULATORY ELEMENTS; CELL-LINE; P-TEFB; KERATINOCYTES; METHYLATION	In cervical squamous cell carcinomas, high-risk human papillomavirus (HRHPV) DNA is usually integrated into host chromosomes. Multiple integration events are thought to be present within the cells of a polyclonal premalignant lesion and the features that underpin clonal selection of one particular integrant remain poorly understood. We previously used the W12 model system to generate a panel of cervical keratinocyte clones, derived from cells of a low-grade premalignant lesion naturally infected with the major HRHPV type, HPV16. The cells were isolated regardless of their selective advantage and differed only by the site of HPV16 integration into the host genome. We used this resource to test the hypothesis that levels of HPV16 E6/E7 oncogene expression in premalignant cells are regulated epigenetically. We performed a comprehensive analysis of the epigenetic landscape of the integrated HPV16 DNA in selected clones, in which levels of virus oncogene expression per DNA template varied similar to 6.6-fold. Across the cells examined, higher levels of virus expression per template were associated with more open chromatin at the HPV16 long control region, together with greater loading of chromatin remodelling enzymes and lower nucleosome occupancy. There were higher levels of histone post-translational modification hallmarks of transcriptionally active chromatin and lower levels of repressive hallmarks. There was greater abundance of the active/elongating form of the RNA polymerase-II enzyme (RNAPII-Ser2P), together with CDK9, the component of positive transcription elongation factor b complex responsible for Ser2 phosphorylation. The changes observed were functionally significant, as cells with higher HPV16 expression per template showed greater sensitivity to depletion and/or inhibition of histone acetyltransferases and CDK9 and less sensitivity to histone deacetylase inhibition. We conclude that virus gene expression per template following HPV16 integration is determined through multiple layers of epigenetic regulation, which are likely to contribute to selection of individual cells during cervical carcinogenesis.	[Groves, I. J.; Knight, E. L. A.; Ang, Q. Y.; Scarpini, C. G.; Coleman, N.] Univ Cambridge, Dept Pathol, Tennis Court Rd, Cambridge CB2 1QP, England	University of Cambridge	Coleman, N (corresponding author), Univ Cambridge, Dept Pathol, Tennis Court Rd, Cambridge CB2 1QP, England.	nc109@cam.ac.uk	Groves, Ian John/HGU-5954-2022	Groves, Ian John/0000-0001-8882-6701; Scarpini, Cinzia G./0000-0003-4730-5197; Ang, Qi Yan/0000-0002-9788-1283	Cancer Research UK [A13080]; Medical Research Council; Pathological Society of Great Britain and Ireland; Agency for Science, Technology and Research, Singapore; Cancer Research UK [13080] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Pathological Society of Great Britain and Ireland; Agency for Science, Technology and Research, Singapore(Agency for Science Technology & Research (A*STAR)); Cancer Research UK(Cancer Research UK)	This work was supported by Cancer Research UK (Programme Grant A13080); the Medical Research Council; The Pathological Society of Great Britain and Ireland (ELAK); and the Agency for Science, Technology and Research, Singapore (QYA). Funding for open access charge: Cancer Research UK and the Medical Research Council.	Arce JD, 2012, HUM MOL GENET, V21, P1693, DOI 10.1093/hmg/ddr604; Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; BEDELL MA, 1991, J VIROL, V65, P2254, DOI 10.1128/JVI.65.5.2254-2260.1991; Bernard HU, 2013, VIROLOGY, V445, P197, DOI 10.1016/j.virol.2013.04.035; Bogdanovic O, 2012, GENOME RES, V22, P2043, DOI 10.1101/gr.134833.111; Carson A, 2006, J VIROL, V80, P4356, DOI 10.1128/JVI.80.9.4356-4362.2006; Chao SH, 2000, J BIOL CHEM, V275, P28345, DOI 10.1074/jbc.C000446200; COLEMAN N, 1994, HUM PATHOL, V25, P73, DOI 10.1016/0046-8177(94)90174-0; COLEMAN N, 1993, AM J PATHOL, V143, P355; Dall KL, 2008, CANCER RES, V68, P8249, DOI 10.1158/0008-5472.CAN-08-1741; Dou YL, 2006, NAT STRUCT MOL BIOL, V13, P713, DOI 10.1038/nsmb1128; Euskirchen GM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002008; Forman D, 2012, VACCINE, V30, pF12, DOI 10.1016/j.vaccine.2012.07.055; FRIEDL F, 1970, P SOC EXP BIOL MED, V135, P543; Gray E, 2010, CANCER RES, V70, P4081, DOI 10.1158/0008-5472.CAN-09-3335; Groves IJ, 2015, J PATHOL, V235, P527, DOI 10.1002/path.4496; Groves IJ, 2009, J GEN VIROL, V90, P2364, DOI 10.1099/vir.0.012526-0; Hanning JE, 2013, BRIT J CANCER, V108, P450, DOI 10.1038/bjc.2012.564; Hanning JE, 2013, J PATHOL, V231, P354, DOI 10.1002/path.4244; Hanning JE, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-159; Hazzalin CA, 2005, PLOS BIOL, V3, P2111, DOI 10.1371/journal.pbio.0030393; He HP, 2012, CELL CYCLE, V11, P617, DOI 10.4161/cc.11.3.19115; Herdman MT, 2006, CARCINOGENESIS, V27, P2341, DOI 10.1093/carcin/bgl172; Hyland PL, 2011, J VIROL, V85, P10999, DOI 10.1128/JVI.00160-11; JEON S, 1995, J VIROL, V69, P2989, DOI 10.1128/JVI.69.5.2989-2997.1995; Jeong KW, 2011, NAT STRUCT MOL BIOL, V18, P1358, DOI 10.1038/nsmb.2153; Jha S, 2010, MOL CELL, V38, P700, DOI 10.1016/j.molcel.2010.05.020; Johannsen E, 2013, VIROLOGY, V445, P205, DOI 10.1016/j.virol.2013.07.016; Johansson C, 2015, VIROLOGY, V482, P244, DOI 10.1016/j.virol.2015.02.053; Kelly TK, 2012, GENOME RES, V22, P2497, DOI 10.1101/gr.143008.112; Kim CH, 2015, BIOSCI BIOTECH BIOCH, V79, P532, DOI 10.1080/09168451.2014.993914; Kruppel U, 2008, VIROLOGY, V377, P151, DOI 10.1016/j.virol.2008.04.006; Li GL, 2012, CELL, V148, P84, DOI 10.1016/j.cell.2011.12.014; McLaughlin-Drubin ME, 2011, P NATL ACAD SCI USA, V108, P2130, DOI 10.1073/pnas.1009933108; Palermo RD, 2008, BIOCHEM SOC T, V36, P625, DOI 10.1042/BST0360625; Pena LD, 2001, J VIROL, V75, P10005, DOI 10.1128/JVI.75.20.10005-10013.2001; Pett M, 2007, J PATHOL, V212, P356, DOI 10.1002/path.2192; Pett MR, 2004, CANCER RES, V64, P1359, DOI 10.1158/0008-5472.CAN-03-3214; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Scarpini CG, 2014, J PATHOL, V233, P281, DOI 10.1002/path.4358; Simon JM, 2012, NAT PROTOC, V7, P256, DOI 10.1038/nprot.2011.444; Smith JA, 2014, VIROLOGY, V468, P311, DOI 10.1016/j.virol.2014.08.022; STANLEY MA, 1989, INT J CANCER, V43, P672, DOI 10.1002/ijc.2910430422; STOLER MH, 1992, HUM PATHOL, V23, P117, DOI 10.1016/0046-8177(92)90232-R; Stunkel W, 1999, J VIROL, V73, P1918; Sun YL, 2009, NAT CELL BIOL, V11, P1376, DOI 10.1038/ncb1982; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang S, 2008, TRENDS PHARMACOL SCI, V29, P302, DOI 10.1016/j.tips.2008.03.003; Wang WM, 2011, J BIOL CHEM, V286, P40974, DOI 10.1074/jbc.M111.290874; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; Wentzensen N, 2004, CANCER RES, V64, P3878, DOI 10.1158/0008-5472.CAN-04-0009; Wentzensen N, 2012, JNCI-J NATL CANCER I, V104, P1738, DOI 10.1093/jnci/djs425; Wooldridge TR, 2008, VIROLOGY, V374, P371, DOI 10.1016/j.virol.2007.12.011; Xu M, 2013, VIROLOGY, V446, P17, DOI 10.1016/j.virol.2013.07.014; Yew CW, 2011, CANCER RES, V71, P6696, DOI 10.1158/0008-5472.CAN-11-1271; Zhu YR, 1997, GENE DEV, V11, P2622, DOI 10.1101/gad.11.20.2622	56	16	17	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 8	2016	35	36					4773	4786		10.1038/onc.2016.8	http://dx.doi.org/10.1038/onc.2016.8			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DW0IS	26876196	Green Published, hybrid			2022-12-26	WOS:000383324700010
J	Goetzl, EJ; Goetzl, L; Karliner, JS; Tang, N; Pulliam, L				Goetzl, Edward J.; Goetzl, Laura; Karliner, Joel S.; Tang, Norina; Pulliam, Lynn			Human plasma platelet-derived exosomes: effects of aspirin	FASEB JOURNAL			English	Article						chemokines; glycoproteins; HMGB1; intercellular communication; atherosclerosis	BLOOD EXOSOMES; MICROPARTICLES; PROTEINS; HMGB1; ATHEROSCLEROSIS; MICROVESICLES; RELEASE; DISEASE; ROLES	Platelet-derived exosomes mediate platelet atherogenic interactions with endothelial cells and monocytes. A new method for isolation of plasma platelet derived exosomes is described and used to examine effects of aging and aspirin on exosome cargo proteins. Exosome secretion by purified platelets in vitro did not increase after exposure to thrombin or collagen, as assessed by exosome counts and quantification of the CD81 exosome marker. Thrombin and collagen increased exosome content of a-granule chemokines CXCL4 and CXCL7 and cytoplasmic high-mobility group box 1 (HMGB1) protein, but not membrane platelet glycoprotein VI (GPVI), with dependence on extracellular calcium. Aspirin consumption significantly blocked thrombin-and collagen-induced increases in exosome cargo levels of chemokines and HMGB1, without altering total exosome secretion or GPVI cargo. Plasma platelet-derived exosomes, enriched by absorption with mouse antihuman CD42b [platelet glycoprotein Ib (GPIb)] mAb, had sizes and cargo protein contents similar to those of exosomes from purified platelets. The plasma platelet-derived exosome number is lower and its chemokine and HMGB1 levels higher after age 65 yr. Aspirin consumption significantly suppressed cargo protein levels of plasma platelet-derived exosomes without altering total levels of exosomes. Cargo proteins of human plasma platelet-derived exosomes may biomark platelet abnormalities and in vivo effects of drugs.-Goetzl, E. J., Goetzl, L., Karliner, J. S., Tang, N., Pulliam, L. Human plasma platelet-derived exosomes: effects of aspirin. www.fasebj.org	[Goetzl, Edward J.; Karliner, Joel S.; Pulliam, Lynn] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Pulliam, Lynn] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; [Goetzl, Edward J.] Jewish Home San Francisco, San Francisco, CA USA; [Goetzl, Laura] Temple Univ, Dept Obstet Gynecol & Reprod Sci, Philadelphia, PA 19122 USA; [Karliner, Joel S.; Tang, Norina; Pulliam, Lynn] Vet Affairs Med Ctr, San Francisco, CA 94121 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Goetzl, EJ (corresponding author), JHSF, Geriatr Res Ctr, 302 Silver Ave, San Francisco, CA 94112 USA.	edward.goetzl@ucsf.edu		Goetzl, Laura/0000-0003-4130-2809	U.S. National Institutes of Health, National Heart, Lung, and Blood Institute [HL129853]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL129853] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors are grateful to Judith H. Goetzl (Geriatric Research Center, Jewish Home of San Francisco) for expert preparation of the graphic illustrations. These studies were supported, in part, by Grant HL129853 (to L.P.) from the U.S. National Institutes of Health, National Heart, Lung, and Blood Institute. E.J.G. has filed a provisional patent application involving the methodology for isolation and analyses of platelet exosomes from plasma, and has also developed the methodology, obtained blood, performed exosome isolations and ELISAs, analyzed data, and drafted the manuscript; L.G. participated in study design and edited the manuscript; J.S.K. participated in study design and edited the manuscript; N.T. performed exosome counts; and L.P. analyzed data and edited the manuscript.	Aatonen MT, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.24692; Burnouf T, 2014, BLOOD REV, V28, P155, DOI 10.1016/j.blre.2014.04.002; Fiandaca MS, 2015, ALZHEIMERS DEMENT, V11, P600, DOI 10.1016/j.jalz.2014.06.008; Fiuza C, 2003, BLOOD, V101, P2652, DOI 10.1182/blood-2002-05-1300; Goetzl EJ, 2015, ANN CLIN TRANSL NEUR, V2, P769, DOI 10.1002/acn3.211; Goetzl EJ, 2015, NEUROLOGY, V85, P40, DOI 10.1212/WNL.0000000000001702; Heijnen HFG, 1999, BLOOD, V94, P3791, DOI 10.1182/blood.V94.11.3791.423a22_3791_3799; Huber HJ, 2015, CURR OPIN LIPIDOL, V26, P412, DOI 10.1097/MOL.0000000000000214; KAPLAN KL, 1979, BLOOD, V53, P604; Kaplan ZS, 2011, HEMATOL-AM SOC HEMAT, P51, DOI 10.1182/asheducation-2011.1.51; Kapogiannis D, 2015, FASEB J, V29, P589, DOI 10.1096/fj.14-262048; Lawson C, 2016, J ENDOCRINOL, V228, pR57, DOI 10.1530/JOE-15-0201; Lievens D, 2011, THROMB HAEMOSTASIS, V106, P827, DOI 10.1160/TH11-08-0592; Lukasik M, 2013, PLATELETS, V24, P63, DOI 10.3109/09537104.2011.654292; Mause SF, 2005, ARTERIOSCL THROM VAS, V25, P1512, DOI 10.1161/01.ATV.0000170133.43608.37; Rautou PE, 2011, CIRC RES, V109, P593, DOI 10.1161/CIRCRESAHA.110.233163; Vogel S, 2015, J CLIN INVEST, V125, P4638, DOI 10.1172/JCI81660; von Hundelshausen P, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00294; Yang XY, 2015, DIAGN PATHOL, V10, DOI 10.1186/s13000-015-0348-3	19	67	70	3	30	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2016	30	5					2058	2063		10.1096/fj.201500150R	http://dx.doi.org/10.1096/fj.201500150R			6	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DK4HW	26873936	Green Published			2022-12-26	WOS:000374879400031
J	Wilson, C; Saunter, CD; Girkin, JM; McCarron, JG				Wilson, Calum; Saunter, Christopher D.; Girkin, John M.; McCarron, John G.			Clusters of specialized detector cells provide sensitive and high fidelity receptor signaling in the intact endothelium	FASEB JOURNAL			English	Article						endothelial calcium signalling; microendoscopy; gradient index; calcium imaging; endothelial heterogeneity	SMOOTH-MUSCLE; IN-VIVO; DEPENDENT HYPERPOLARIZATION; ELECTRICAL-CONDUCTION; INTRACELLULAR CALCIUM; CAROTID-ARTERY; CA2+ WAVES; CHANNELS; TUBES; ACTIVATION	Agonist-mediated signaling by the endothelium controls virtually all vascular functions. Because of the large diversity of agonists, each with varying concentrations, background noise often obscures individual cellular signals. How the endothelium distinguishes low-level fluctuations from noise and decodes and integrates physiologically relevant information remains unclear. Here, we recorded changes in intracellular Ca2+ concentrations in response to acetylcholine in areas encompassing hundreds of endothelial cells from inside intact pressurized arteries. Individual cells responded to acetylcholine with a concentration-dependent increase in Ca2+ signals spanning a single order of magnitude. Interestingly, however, intercellular response variation extended over 3 orders of magnitude of agonist concentration, thus crucially enhancing the collective bandwidth of endothelial responses to agonists. We also show the accuracy of this collective mode of detection is facilitated by spatially restricted clusters of comparably sensitive cells arising from heterogeneous receptor expression. Simultaneous stimulation of clusters triggered Ca2+ signals that were transmitted to neighboring cells in a manner that scaled with agonist concentration. Thus, the endothelium detects agonists by acting as a distributed sensing system. Specialized clusters of detector cells, analogous to relay nodes in modern communication networks, integrate population wide inputs, and enable robust noise filtering for efficient high-fidelity signaling.-Wilson, C., Saunter, C. D., Girkin, J. M., McCarron, J. G. Clusters of specialized detector cells provide sensitive and high fidelity receptor signaling in the intact endothelium. www.fasebj.org	[Wilson, Calum; McCarron, John G.] Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, SIPBS Bldg,161 Cathedral St, Glasgow G4 0RE, Lanark, Scotland; [Saunter, Christopher D.; Girkin, John M.] Univ Durham, Dept Phys, Biophys Sci Inst, Ctr Adv Instrumentat, Durham, England	University of Strathclyde; Durham University	McCarron, JG (corresponding author), Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, SIPBS Bldg,161 Cathedral St, Glasgow G4 0RE, Lanark, Scotland.	john.mccarron@strath.ac.uk	Wilson, Calum/AAI-1541-2019; Wilson, Calum/AAC-9114-2020	Wilson, Calum/0000-0003-2500-0632; Girkin, John/0000-0003-2568-3576	Wellcome Trust [092292/Z/10/Z]; British Heart Foundation [PG/11/70/29086]; British Heart Foundation [Research Excellence Award (Edinburgh-Durham University, Edinburgh, United Kingdom)	Wellcome Trust(Wellcome TrustEuropean Commission); British Heart Foundation(British Heart Foundation); British Heart Foundation [Research Excellence Award (Edinburgh-Durham University, Edinburgh, United Kingdom)	The authors thank M. E. Sandison, C. Kennedy, and S. Chalmers (University of Strathclyde) for useful discussion and comments on the manuscript. This work was funded by the Wellcome Trust (092292/Z/10/Z) and British Heart Foundation [PG/11/70/29086 and Research Excellence Award (Edinburgh-Durham University, Edinburgh, United Kingdom)], whose support is gratefully acknowledged.	Behringer EJ, 2012, CIRC RES, V110, P1311, DOI 10.1161/CIRCRESAHA.111.262592; Behringer EJ, 2012, BRIT J PHARMACOL, V166, P774, DOI 10.1111/j.1476-5381.2011.01814.x; Billaud M, 2014, PHARMACOL REV, V66, P513, DOI 10.1124/pr.112.007351; Blottiere HM, 1996, BRIT J PHARMACOL, V117, P775, DOI 10.1111/j.1476-5381.1996.tb15259.x; Boettcher M, 2011, HYPERTENSION, V57, P802, DOI 10.1161/HYPERTENSIONAHA.110.165894; Bradley KN, 2003, J CELL SCI, V116, P4291, DOI 10.1242/jcs.00713; Bruzzone R, 2005, J NEUROCHEM, V92, P1033, DOI 10.1111/j.1471-4159.2004.02947.x; BUUS NH, 1994, BRIT J PHARMACOL, V112, P579, DOI 10.1111/j.1476-5381.1994.tb13114.x; CARTER TD, 1994, PFLUG ARCH EUR J PHY, V428, P476, DOI 10.1007/BF00374568; Chalmers S, 2012, J AM CHEM SOC, V134, P758, DOI 10.1021/ja2077922; Chataigneau T, 1998, BRIT J PHARMACOL, V123, P968, DOI 10.1038/sj.bjp.0701690; Chataigneau T, 1998, BRIT J PHARMACOL, V123, P574, DOI 10.1038/sj.bjp.0701629; Daniel R, 2013, NATURE, V497, P619, DOI 10.1038/nature12148; Dora KA, 1997, P NATL ACAD SCI USA, V94, P6529, DOI 10.1073/pnas.94.12.6529; Edelstein A., 2010, CURR PROTOC MOL BIOL, V14, P20, DOI [10.1002/0471142727.mb1420s92, DOI 10.1002/0471142727.MB1420S92]; Emerson GG, 2000, CIRC RES, V86, P94, DOI 10.1161/01.RES.86.1.94; FALLOON BJ, 1995, AM J PHYSIOL-HEART C, V268, pH670, DOI 10.1152/ajpheart.1995.268.2.H670; FARACI FM, 1994, STROKE, V25, P178, DOI 10.1161/01.STR.25.1.178; Flusberg BA, 2008, NAT METHODS, V5, P935, DOI 10.1038/nmeth.1256; Ghosh KK, 2011, NAT METHODS, V8, P871, DOI [10.1038/NMETH.1694, 10.1038/nmeth.1694]; Grol MW, 2013, J CELL SCI, V126, P3615, DOI 10.1242/jcs.122705; Huang TY, 2000, FASEB J, V14, P797, DOI 10.1096/fasebj.14.5.797; Iglesias RM, 2012, NEUROCHEM RES, V37, P1355, DOI 10.1007/s11064-012-0720-6; Jung K, 2013, CIRC RES, V112, P891, DOI 10.1161/CIRCRESAHA.111.300484; Kim P, 2010, NAT METHODS, V7, P303, DOI [10.1038/NMETH.1440, 10.1038/nmeth.1440]; Lamping KG, 2001, ARTERIOSCL THROM VAS, V21, P523, DOI 10.1161/01.ATV.21.4.523; Ledoux J, 2008, P NATL ACAD SCI USA, V105, P9627, DOI 10.1073/pnas.0801963105; Lee S, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2060; Lennie P, 2003, CURR BIOL, V13, pR216, DOI 10.1016/S0960-9822(03)00153-2; LITTLE TL, 1995, CIRC RES, V76, P498, DOI 10.1161/01.RES.76.3.498; Marie I, 2002, J VASC RES, V39, P260, DOI 10.1159/000063691; McCarron JG, 2010, J CELL PHYSIOL, V224, P334, DOI 10.1002/jcp.22103; McCarron JG, 2009, J GEN PHYSIOL, V133, P439, DOI 10.1085/jgp.200810189; McGeown JG, 1996, J PHYSIOL-LONDON, V497, P321, DOI 10.1113/jphysiol.1996.sp021771; McSherry IN, 2005, CELL CALCIUM, V38, P23, DOI 10.1016/j.ceca.2005.03.007; Mudau M, 2012, CARDIOVASC J AFR, V23, DOI 10.5830/CVJA-2011-068; Ohashi M, 2005, AM J PHYSIOL-HEART C, V289, pH2244, DOI 10.1152/ajpheart.00254.2005; OHTA T, 1994, BRIT J PHARMACOL, V112, P972, DOI 10.1111/j.1476-5381.1994.tb13176.x; Plane F, 1998, BRIT J PHARMACOL, V123, P1351, DOI 10.1038/sj.bjp.0701746; Regan ER, 2012, CIRC RES, V111, P110, DOI 10.1161/CIRCRESAHA.111.261701; Sarpeshkar R, 1998, NEURAL COMPUT, V10, P1601, DOI 10.1162/089976698300017052; Saunter CD, 2012, BIOMED OPT EXPRESS, V3, P1274, DOI 10.1364/BOE.3.001274; Socha MJ, 2012, MICROCIRCULATION, V19, P757, DOI 10.1111/micc.12000; Sonkusare SK, 2012, SCIENCE, V336, P597, DOI 10.1126/science.1216283; Tallini YN, 2007, CIRC RES, V101, P1300, DOI 10.1161/CIRCRESAHA.107.149484; Taylor MS, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00447; Thurley K, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005237; Tran CHT, 2012, AM J PHYSIOL-CELL PH, V302, pC1226, DOI 10.1152/ajpcell.00418.2011; Tseng QZ, 2011, LAB CHIP, V11, P2231, DOI 10.1039/c0lc00641f; Wilson C, 2015, J PHYSIOL-LONDON, V593, P5231, DOI 10.1113/JP271157; Ying XY, 1996, CIRC RES, V79, P898, DOI 10.1161/01.RES.79.4.898	51	26	26	1	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2016	30	5					2000	2013		10.1096/fj.201500090	http://dx.doi.org/10.1096/fj.201500090			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DK4HW	26873937	hybrid, Green Accepted, Green Published			2022-12-26	WOS:000374879400027
J	Milovanovic, D; Platen, M; Junius, M; Diederichsen, U; Schaap, IAT; Honigmann, A; Jahn, R; van den Bogaart, G				Milovanovic, Dragomir; Platen, Mitja; Junius, Meike; Diederichsen, Ulf; Schaap, Iwan A. T.; Honigmann, Alf; Jahn, Reinhard; van den Bogaart, Geert			Calcium Promotes the Formation of Syntaxin 1 Mesoscale Domains through Phosphatidylinositol 4,5-Bisphosphate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						calcium; membrane structure; plasma membrane; protein-lipid interaction; SNARE proteins; PI(4; 5)P-2; clustering; membrane domains; syntaxin 1	PLASMA-MEMBRANE; NEUROTRANSMITTER RELEASE; SECRETORY GRANULES; SYNAPTIC VESICLE; FORCE MICROSCOPY; T-SNARE; CLUSTERS; EXOCYTOSIS; MICRODOMAINS; SITES	Phosphatidylinositol 4,5-bisphosphate (PI(4,5)P-2) is a minor component of total plasma membrane lipids, but it has a substantial role in the regulation of many cellular functions, including exo- and endocytosis. Recently, it was shown that PI(4,5)P-2 and syntaxin 1, a SNARE protein that catalyzes regulated exocytosis, form domains in the plasma membrane that constitute recognition sites for vesicle docking. Also, calcium was shown to promote syntaxin 1 clustering in the plasma membrane, but the molecular mechanism was unknown. Here, using a combination of superresolution stimulated emission depletion microscopy, FRET, and atomic force microscopy, we show that Ca2+ acts as a charge bridge that specifically and reversibly connects multiple syntaxin 1/PI(4,5)P-2 complexes into larger mesoscale domains. This transient reorganization of the plasma membrane by physiological Ca2+ concentrations is likely to be important for Ca2+-regulated secretion.	[Milovanovic, Dragomir; Jahn, Reinhard; van den Bogaart, Geert] Max Planck Inst Biophys Chem, Dept Neurobiol, Fassberg 11, D-37077 Gottingen, Germany; [Milovanovic, Dragomir] Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Neurosci,Program Cellular Neurosci Neurodege, 333 Cedar St, New Haven, CT 06511 USA; [Platen, Mitja; Schaap, Iwan A. T.] Univ Gottingen, Fac Phys, Inst Phys 3, D-37077 Gottingen, Germany; [Junius, Meike; Diederichsen, Ulf] Univ Gottingen, Inst Organ & Biomol Chem, D-37077 Gottingen, Germany; [Schaap, Iwan A. T.] Heriot Watt Univ, Sch Engn & Phys Sci, Edinburgh EH14 4AS, Midlothian, Scotland; [Honigmann, Alf] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; [van den Bogaart, Geert] Radboud Univ Nijmegen, Med Ctr, Dept Tumor Immunol, Geert Grootepl 10, NL-6525 GA Nijmegen, Netherlands	Max Planck Society; Howard Hughes Medical Institute; Yale University; University of Gottingen; University of Gottingen; Heriot Watt University; Max Planck Society; Radboud University Nijmegen	Jahn, R (corresponding author), Max Planck Inst Biophys Chem, Dept Neurobiol, Fassberg 11, D-37077 Gottingen, Germany.; van den Bogaart, G (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Tumor Immunol, Geert Grootepl 10, NL-6525 GA Nijmegen, Netherlands.	rjahn@gwdg.de; geert.vandenbogaart@radboudumc.ru.nl	van den Bogaart, Geert/A-1089-2014; Schaap, Iwan A. T./L-3177-2013; van den Bogaart, Geert/GLV-3283-2022; Honigmann, Alf/C-4832-2017	van den Bogaart, Geert/0000-0003-2180-6735; Schaap, Iwan A. T./0000-0001-6665-5104; van den Bogaart, Geert/0000-0003-2180-6735; Honigmann, Alf/0000-0003-0475-3790; Jahn, Reinhard/0000-0003-1542-3498; Diederichsen, Ulf/0000-0002-2654-9160; Milovanovic, Dragomir/0000-0002-6625-1879	Deutsche Forschungsgemeinschaft [SFB803]; National Institutes of Health [P01 GM072694]; Hypatia fellowship from the Radboud University Medical Center; European Research Council [FP7 336479]; Human Frontier Science Program, Netherlands Organization for Scientific Research [ALW VIDI 864.14.001]; Netherlands Organization for Scientific Research Gravitation Program [ICI-024.002.009]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM072694] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hypatia fellowship from the Radboud University Medical Center; European Research Council(European Research Council (ERC)European Commission); Human Frontier Science Program, Netherlands Organization for Scientific Research; Netherlands Organization for Scientific Research Gravitation Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Deutsche Forschungsgemeinschaft Grant SFB803 and National Institutes of Health Grant P01 GM072694 (to R. J.), a Hypatia fellowship from the Radboud University Medical Center, European Research Council Starting Grant FP7 336479, a career development award from the Human Frontier Science Program, Netherlands Organization for Scientific Research Grant ALW VIDI 864.14.001, and Netherlands Organization for Scientific Research Gravitation Program 2013 Grant ICI-024.002.009 (to G. v. d. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aoyagi K, 2005, J BIOL CHEM, V280, P17346, DOI 10.1074/jbc.M413307200; Bar-On D, 2012, J BIOL CHEM, V287, P27158, DOI 10.1074/jbc.M112.353250; Barg S, 2010, P NATL ACAD SCI USA, V107, P20804, DOI 10.1073/pnas.1014823107; BEIS I, 1975, BIOCHEM J, V152, P23, DOI 10.1042/bj1520023; Carvalho K, 2008, BIOPHYS J, V95, P4348, DOI 10.1529/biophysj.107.126912; Chapman ER, 2008, ANNU REV BIOCHEM, V77, P615, DOI 10.1146/annurev.biochem.77.062005.101135; Davies JN, 2011, BIOCHEM BIOPH RES CO, V411, P562, DOI 10.1016/j.bbrc.2011.06.185; Ellenbroek WG, 2011, BIOPHYS J, V101, P2178, DOI 10.1016/j.bpj.2011.09.039; Gandasi NR, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4914; Gottfert F, 2013, BIOPHYS J, V105, pL1, DOI 10.1016/j.bpj.2013.05.029; HESS P, 1982, J PHYSIOL-LONDON, V333, P173, DOI 10.1113/jphysiol.1982.sp014447; HEUMANN R, 1983, EXP CELL RES, V145, P179, DOI 10.1016/S0014-4827(83)80019-6; Honigmann A, 2013, NAT STRUCT MOL BIOL, V20, P679, DOI 10.1038/nsmb.2570; Jahn R, 2012, NATURE, V490, P201, DOI 10.1038/nature11320; Lang T, 2001, EMBO J, V20, P2202, DOI 10.1093/emboj/20.9.2202; Levental I, 2009, BIOCHEMISTRY-US, V48, P8241, DOI 10.1021/bi9007879; Lopez I, 2007, CELL CALCIUM, V41, P547, DOI 10.1016/j.ceca.2006.10.004; Milovanovic D, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00089; Milovanovic D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6984; Murray DH, 2011, BIOCHEMISTRY-US, V50, P9014, DOI 10.1021/bi201307u; Ortega-Esteban A, 2012, ULTRAMICROSCOPY, V114, P56, DOI 10.1016/j.ultramic.2012.01.007; Park Y, 2012, NAT STRUCT MOL BIOL, V19, P991, DOI 10.1038/nsmb.2375; Rickman C, 2010, J BIOL CHEM, V285, P13535, DOI 10.1074/jbc.M109.091058; Rizzoli SO, 2014, EMBO J, V33, P788, DOI 10.1002/embj.201386357; Saarikangas J, 2010, PHYSIOL REV, V90, P259, DOI 10.1152/physrev.00036.2009; Sarmento MJ, 2014, BBA-BIOMEMBRANES, V1838, P822, DOI 10.1016/j.bbamem.2013.11.020; Schaap IAT, 2004, EUR BIOPHYS J BIOPHY, V33, P462, DOI 10.1007/s00249-003-0386-8; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schneggenburger R, 2005, CURR OPIN NEUROBIOL, V15, P266, DOI 10.1016/j.conb.2005.05.006; Sieber JJ, 2006, BIOPHYS J, V90, P2843, DOI 10.1529/biophysj.105.079574; Sieber JJ, 2007, SCIENCE, V317, P1072, DOI 10.1126/science.1141727; Sudhof T. C., 2011, CSH PERSPECT BIOL, V3, P3, DOI DOI 10.1101/CSHPERSPECT.A005637; Sudhof TC, 2013, NEURON, V80, P675, DOI 10.1016/j.neuron.2013.10.022; Khuong TM, 2013, NEURON, V77, P1097, DOI 10.1016/j.neuron.2013.01.025; Torregrosa-Hetland CJ, 2011, J CELL SCI, V124, P727, DOI 10.1242/jcs.078600; van den Bogaart G, 2013, CURR TOP MEMBR, V72, P193, DOI 10.1016/B978-0-12-417027-8.00006-4; van den Bogaart G, 2011, NATURE, V479, P552, DOI 10.1038/nature10545; Wang YH, 2012, J AM CHEM SOC, V134, P3387, DOI 10.1021/ja208640t; Weiss N, 2012, J BIOL CHEM, V287, P2810, DOI 10.1074/jbc.M111.290882; Williams D, 2009, MOL BIOL CELL, V20, P4910, DOI 10.1091/mbc.E09-04-0284; Zhang Li, 2012, Subcell Biochem, V59, P177, DOI 10.1007/978-94-007-3015-1_6; Zilly FE, 2011, EMBO J, V30, P1209, DOI 10.1038/emboj.2011.53	42	22	22	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2016	291	15					7868	7876		10.1074/jbc.M116.716225	http://dx.doi.org/10.1074/jbc.M116.716225			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DJ2SZ	26884341	Green Published, hybrid			2022-12-26	WOS:000374056700010
J	Chiou, SC; Chang, EC				Chiou, Shiau-Chuen; Chang, Erik Chihhung			Bimanual Coordination Learning with Different Augmented Feedback Modalities and Information Types	PLOS ONE			English	Article							MOTOR; KNOWLEDGE; MOVEMENT; STIMULATION; ACQUISITION; FREQUENCY; SUPPORT; RHYTHMS; MOTION	Previous studies have shown that bimanual coordination learning is more resistant to the removal of augmented feedback when acquired with auditory than with visual channel. However, it is unclear whether this differential "guidance effect" between feedback modalities is due to enhanced sensorimotor integration via the non-dominant auditory channel or strengthened linkage to kinesthetic information under rhythmic input. The current study aimed to examine how modalities (visual vs. auditory) and information types (continuous visuospatial vs. discrete rhythmic) of concurrent augmented feedback influence bimanual coordination learning. Participants either learned a 90 degrees-out-of-phase pattern for three consecutive days with Lissajous feedback indicating the integrated position of both arms, or with visual or auditory rhythmic feedback reflecting the relative timing of the movement. The results showed diverse performance change after practice when the feedback was removed between Lissajous and the other two rhythmic groups, indicating that the guidance effect may be modulated by the type of information provided during practice. Moreover, significant performance improvement in the dual-task condition where the irregular rhythm counting task was applied as a secondary task also suggested that lower involvement of conscious control may result in better performance in bimanual coordination.	[Chiou, Shiau-Chuen; Chang, Erik Chihhung] Natl Cent Univ, Inst Cognit Neurosci, Taoyuan, Taiwan	National Central University	Chang, EC (corresponding author), Natl Cent Univ, Inst Cognit Neurosci, Taoyuan, Taiwan.	auda@ncu.edu.tw	Chiou, Shiau-Chuen/R-8633-2019	Chiou, Shiau-Chuen/0000-0002-0496-8153	Ministry of Science and Technology, Taiwan [MOST-104-2420-H-008-004-MY2]; IRICE program [MOST-103-2911-I-009-101]; cross-disciplinary grant [MOST-103-2627-E009-001]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); IRICE program; cross-disciplinary grant	The study was supported by grants from the Ministry of Science and Technology, Taiwan, to ECC (MOST-104-2420-H-008-004-MY2), and in part by the IRICE program (MOST-103-2911-I-009-101), as well as a Tcross-disciplinary grant (MOST-103-2627-E009-001). The URL of MOST is http://www.most.gov.tw/mp.aspx?mp=7. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias P, 2008, EXP BRAIN RES, V186, P589, DOI 10.1007/s00221-007-1263-y; Arrighi R, 2006, J VISION, V6, P260, DOI 10.1167/6.3.6; Bengtsson SL, 2009, CORTEX, V45, P62, DOI 10.1016/j.cortex.2008.07.002; Buchanan JJ, 2012, EXP BRAIN RES, V219, P305, DOI 10.1007/s00221-012-3092-x; Chen YQ, 2002, HUM MOVEMENT SCI, V21, P515, DOI 10.1016/S0167-9457(02)00138-0; FREIDES D, 1974, PSYCHOL BULL, V81, P284, DOI 10.1037/h0036331; Guadagnoli MA, 2004, J MOTOR BEHAV, V36, P212, DOI 10.3200/JMBR.36.2.212-224; Holcombe AO, 2009, TRENDS COGN SCI, V13, P216, DOI 10.1016/j.tics.2009.02.005; Hove MJ, 2013, NEUROIMAGE, V67, P313, DOI 10.1016/j.neuroimage.2012.11.032; IRWIN RJ, 1981, AUDIOLOGY, V20, P234; KEELE SW, 1968, PSYCHOL BULL, V70, P387, DOI 10.1037/h0026739; KELSO JAS, 1986, PHYS LETT A, V118, P279, DOI 10.1016/0375-9601(86)90359-2; Kovacs AJ, 2011, ACTA PSYCHOL, V136, P311, DOI 10.1016/j.actpsy.2010.12.004; Kovacs AJ, 2010, J EXP PSYCHOL HUMAN, V36, P936, DOI 10.1037/a0019259; Kovacs AJ, 2010, EXP BRAIN RES, V202, P519, DOI 10.1007/s00221-009-2154-1; Kovacs AJ, 2010, EXP BRAIN RES, V201, P249, DOI 10.1007/s00221-009-2031-y; Kovacs AJ, 2009, NEUROSCI LETT, V455, P162, DOI 10.1016/j.neulet.2009.02.046; Kovacs AJ, 2009, EXP BRAIN RES, V193, P129, DOI 10.1007/s00221-008-1676-2; LEE TD, 1995, J MOTOR BEHAV, V27, P263, DOI 10.1080/00222895.1995.9941716; Lissajous MJ., 1857, ANN CHIMIE PHYS, P51; Maslovat D, 2009, J MOTOR BEHAV, V41, P45, DOI 10.1080/00222895.2009.10125923; Peirce JW, 2007, J NEUROSCI METH, V162, P8, DOI 10.1016/j.jneumeth.2006.11.017; Peirce JW, 2009, FRONT NEUROINFORM, V2, DOI 10.3389/neuro.11.010.2008; POSNER MI, 1976, PSYCHOL REV, V83, P157, DOI 10.1037/0033-295X.83.2.157; PROTEAU L, 1992, Q J EXP PSYCHOL-A, V44, P557, DOI 10.1080/14640749208401298; PROTEAU L, 1987, HUM MOVEMENT SCI, V6, P181, DOI 10.1016/0167-9457(87)90011-X; Ronsse R, 2011, CEREB CORTEX, V21, P1283, DOI 10.1093/cercor/bhq209; SCHMIDT RA, 1990, HUM MOVEMENT SCI, V9, P325, DOI 10.1016/0167-9457(90)90007-Z; SCHMIDT RA, 1975, PSYCHOL REV, V82, P225, DOI 10.1037/h0076770; SCHMIDT RA, 1989, J EXP PSYCHOL LEARN, V15, P352, DOI 10.1037/0278-7393.15.2.352; Schmidt RA, 1976, J HUMAN MOVEMENT STU, V2, P239; Strumillo P., 2011, ADVANCES IN SOUND LO; Swinnen SP, 1998, COGN NEUROPSYCHOL, V15, P439, DOI 10.1080/026432998381104; Swinnen SP, 1997, J EXP PSYCHOL HUMAN, V23, P1087; Swinnen SP, 1997, HUM MOVEMENT SCI, V16, P749, DOI 10.1016/S0167-9457(97)00020-1; Thaut MH, 1999, IEEE ENG MED BIOL, V18, P101, DOI 10.1109/51.752991; Thaut MH, 2010, MUSIC PERCEPT, V27, P263, DOI 10.1525/MP.2010.27.4.263; WELCH RB, 1980, PSYCHOL BULL, V88, P638, DOI 10.1037/0033-2909.88.3.638; WINSTEIN CJ, 1990, J EXP PSYCHOL LEARN, V16, P677, DOI 10.1037/0278-7393.16.4.677; Winter D., 2009, BIOMECHANICS MOTOR C, V4th; Wulf G, 2001, RES Q EXERCISE SPORT, V72, P335, DOI 10.1080/02701367.2001.10608970; Wulf G, 2001, Q J EXP PSYCHOL-A, V54, P1143, DOI 10.1080/02724980143000118; Wulf G, 2013, INT REV SPORT EXER P, V6, P77, DOI 10.1080/1750984X.2012.723728	43	5	5	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0149221	10.1371/journal.pone.0149221	http://dx.doi.org/10.1371/journal.pone.0149221			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF3DG	26895286	Green Submitted, Green Published, gold			2022-12-26	WOS:000371223400039
J	Klaczko, J; Sherratt, E; Setz, EZF				Klaczko, Julia; Sherratt, Emma; Setz, Eleonore Z. F.			Are Diet Preferences Associated to Skulls Shape Diversification in Xenodontine Snakes?	PLOS ONE			English	Article							MORPHOLOGICAL CONVERGENCE; FEEDING SYSTEM; EVOLUTION; INTEGRATION; BEHAVIOR; HISTORY; ORIGIN; FORM	Snakes are a highly successful group of vertebrates, within great diversity in habitat, diet, and morphology. The unique adaptations for the snake skull for ingesting large prey in more primitive macrostomatan snakes have been well documented. However, subsequent diversification in snake cranial shape in relation to dietary specializations has rarely been studied (e.g. piscivory in natricine snakes). Here we examine a large clade of snakes with a broad spectrum of diet preferences to test if diet preferences are correlated to shape variation in snake skulls. Specifically, we studied the Xenodontinae snakes, a speciose clade of South American snakes, which show a broad range of diets including invertebrates, amphibians, snakes, lizards, and small mammals. We characterized the skull morphology of 19 species of xenodontine snakes using geometric morphometric techniques, and used phylogenetic comparative methods to test the association between diet and skull morphology. Using phylogenetic partial least squares analysis (PPLS) we show that skull morphology is highly associated with diet preferences in xenodontine snakes.	[Klaczko, Julia; Setz, Eleonore Z. F.] Univ Estadual Campinas, Inst Biol, Dept Biol Anim, UNICAMP, Campinas, SP, Brazil; [Sherratt, Emma] Univ New England, Sch Environm & Rural Sci, Armidale, NSW, Australia	Universidade de Sao Paulo; Universidade Estadual de Campinas; University of New England	Klaczko, J (corresponding author), Univ Estadual Campinas, Inst Biol, Dept Biol Anim, UNICAMP, Campinas, SP, Brazil.	jklaczko@gmail.com	Sherratt, Emma/A-9931-2011; Klaczko, Julia/N-1406-2013; Klaczko, Julia/N-4115-2019; Setz, Eleonore Z F/C-1050-2012	Sherratt, Emma/0000-0003-2164-7877; Klaczko, Julia/0000-0002-9215-380X; Klaczko, Julia/0000-0002-9215-380X; Setz, Eleonore Z F/0000-0001-7638-7086	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2011/17070-6]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	JK was funded from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (grant number: 2011/17070-6) as a post-doctoral fellow; http://www.fapesp.br/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DC, 2014, GEOMORPH SOFTWARE GE; Adams DC, 2014, SYST BIOL, V63, P685, DOI 10.1093/sysbio/syu030; Adams DC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094335; Adams DC, 2013, METHODS ECOL EVOL, V4, P393, DOI 10.1111/2041-210X.12035; Alencar LRV, 2013, S AM J HERPETOL, V8, P60, DOI 10.2994/SAJH-D-13-00005.1; Bizerra A, 2005, AMPHIBIA-REPTILIA, V26, P33, DOI 10.1163/1568538053693350; Bookstein F.L., 1991, MORPHOMETRIC TOOLS L; Brecko Jonathan, 2011, Mertensiella, V18, P20; Britt EJ, 2009, J HERPETOL, V43, P252, DOI 10.1670/08-109R1.1; CADLE JE, 1984, HERPETOLOGICA, V40, P8; Colston TJ, 2010, BIOL J LINN SOC, V101, P476, DOI 10.1111/j.1095-8312.2010.01502.x; Cundall David, 2000, P293, DOI 10.1016/B978-012632590-4/50010-1; De Oliveira FS, 2008, ECOLOGIA ALIMENTAR R; Franca Frederico G.R., 2006, South American Journal of Herpetology, V1, P25, DOI 10.2994/1808-9798(2006)1[25:TCSOSI]2.0.CO;2; GANS C, 1961, AM ZOOL, V1, P217; GREENE HW, 1983, AM ZOOL, V23, P431; Hampton PM, 2011, J MORPHOL, V272, P1435, DOI 10.1002/jmor.10995; HENDERSON RW, 1987, HERPETOLOGICA, V43, P241; Herrel A, 2008, J EVOLUTION BIOL, V21, P1438, DOI 10.1111/j.1420-9101.2008.01552.x; Hsiang AY, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0358-5; Jackson K, 2004, AMPHIBIA-REPTILIA, V25, P247, DOI 10.1163/1568538041975134; Klingenberg CP, 2013, HYSTRIX, V24, P43, DOI 10.4404/hystrix-24.1-6367; Klingenberg CP, 2011, MOL ECOL RESOUR, V11, P353, DOI 10.1111/j.1755-0998.2010.02924.x; Klingenberg CP, 2008, ANNU REV ECOL EVOL S, V39, P115, DOI 10.1146/annurev.ecolsys.37.091305.110054; Knox Andrew, 2010, Phyllomedusa, V9, P121; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Larson Allan, 1996, P187; Larson PM, 2004, ZOOMORPHOLOGY, V123, P95, DOI 10.1007/s00435-003-0092-1; Losos JB, 2011, EVOLUTION, V65, P1827, DOI 10.1111/j.1558-5646.2011.01289.x; Marques Otavio Augusto Vuolo, 2009, Biota Neotrop., V9, P139, DOI 10.1590/S1676-06032009000200014; Marques Otavio Augusto Vuolo, 1994, Revista Brasileira de Biologia, V54, P253; Martins Marcio, 1999, Herpetological Natural History, V6, P78; Mitteroecker P, 2009, EVOL BIOL, V36, P235, DOI 10.1007/s11692-009-9055-x; Monteiro LR, 2011, BMC EVOLUTIONARY BIO, V280; Oliveira L, 2013, HERP REV, V34, P251; Oliveira R.B., 2001, CUAD HERPETOL, V14, P117; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Pyron RA, 2011, MOL PHYLOGENET EVOL, V58, P329, DOI 10.1016/j.ympev.2010.11.006; R Development Core Team, 2014, R LANG ENV STAT COMP; Rambaut A., 2014, TRACER V1 6; Revell LJ, 2007, EVOLUTION, V61, P2898, DOI 10.1111/j.1558-5646.2007.00225.x; Rohlf F. James, 1993, Monografias del Museo Nacional de Ciencias Naturales, V1993, P131; Rohlf FJ, 2000, SYST BIOL, V49, P740, DOI 10.1080/106351500750049806; ROHLF FJ, 1990, SYST ZOOL, V39, P40, DOI 10.2307/2992207; Rohlf FJ, 2008, VERSION 2 12 TPSRELW; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Santana SE, 2012, EVOLUTION, V66, P2587, DOI 10.1111/j.1558-5646.2012.01615.x; SAVITZKY AH, 1983, AM ZOOL, V23, P397; SCARTOZZONI R. R., 2009, PROGRAMA POS GRADUAC; SCHLUTER D, 1984, AM NAT, V123, P175, DOI 10.1086/284196; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Serb JM, 2011, ZOOL J LINN SOC-LOND, V163, P571, DOI 10.1111/j.1096-3642.2011.00707.x; Stayton CT, 2005, J MORPHOL, V263, P47, DOI 10.1002/jmor.10288; STRUSSMANN C, 1993, STUD NEOTROP FAUNA E, V28, P157, DOI 10.1080/01650529309360900; Travaglia-Cardoso Silvia R., 2014, Herpetological Bulletin, P28; Vidal N, 2010, CR BIOL, V333, P48, DOI 10.1016/j.crvi.2009.11.003; Vincent SE, 2006, J EVOLUTION BIOL, V19, P1545, DOI 10.1111/j.1420-9101.2006.01126.x; Vincent SE, 2009, J EVOLUTION BIOL, V22, P1203, DOI 10.1111/j.1420-9101.2009.01739.x	58	31	31	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0148375	10.1371/journal.pone.0148375	http://dx.doi.org/10.1371/journal.pone.0148375			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26886549	Green Published, gold			2022-12-26	WOS:000371218400033
J	Sugimoto, M; Ichio, A; Kondo, M				Sugimoto, Masahiko; Ichio, Atsushi; Kondo, Mineo			Importance of Central Retinal Sensitivity for Prediction of Visual Acuity after Intravitreal Bevacizumb in Eyes with Macular Edema Associated with Branch Retinal Vein Occlusion	PLOS ONE			English	Article							CENTRAL SEROUS CHORIORETINOPATHY; SCANNING LASER OPHTHALMOSCOPE; OPTICAL COHERENCE TOMOGRAPHY; ENDOTHELIAL GROWTH-FACTOR; TEST-RETEST VARIABILITY; MICROPERIMETRY; DEGENERATION; SECONDARY; TRIAMCINOLONE; IMPAIRMENT	Objective To determine whether the baseline retinal sensitivity can predict the best-corrected visual acuity (BCVA) at 1 month after intravitreal bevacizumab (IVB) in eyes with macular edema (ME) associated with a branch retinal vein occlusion (BRVO). Subjects and Methods We evaluated 16 eyes of 16 patients who had ME associated with a BRVO. The mean +/- standard deviation age was 69.1 +/- 8.9 years, and all had a single IVB injection. The BCVA, central macular thickness (CMT), integrity of the ellipsoid zone (EZ) of the photoreceptors, and retinal sensitivity were determined before (baseline) and at 1 day, 1 week, and 1 month following the IVB. The average threshold retinal sensitivity (AT) within the central 10 degrees was determined by Macular Integrity Assessment. The correlations between the BCVA at 1 month and the CMT, integrity of the EZ, and AT at each visit were determined. Results One month after IVB, the BCVA improved significantly from 0.56 +/- 0.27 logMAR units to 0.32 +/- 0.28 logMAR units, and the CMT from 611.4 +/- 209.3 mu m to 258.7 +/- 64.0 mu m (P < 0.05). The AT improved significantly from 17.9 +/- 5.3 dB to 21.2 +/- 5.0 dB (P < 0.05). At 1 day after the treatment, both the integrity of the EZ (r = 0.59) and the retinal sensitivity (r = 0.76) were moderately correlated with the BCVA at 1 month. Conclusion These results indicate that both the integrity of the EZ and the AT at 1 day after the IVB can predict the BCVA after treatment for ME associated with BRVO. There is a possibility that these parameters will predict the effectiveness of IVB for each case.	[Sugimoto, Masahiko; Ichio, Atsushi; Kondo, Mineo] Mie Univ, Grad Sch Med, Dept Ophthalmol, Tsu, Mie 514, Japan	Mie University	Sugimoto, M (corresponding author), Mie Univ, Grad Sch Med, Dept Ophthalmol, Tsu, Mie 514, Japan.	sugimochi@clin.medic.mie-u.ac.jp			Ministry of Education, Culture, Science and Technology, Japan [18591913]	Ministry of Education, Culture, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Grant support: Ministry of Education, Culture, Science and Technology (No. 18591913), Japan.	Agardh E, 2006, DIABETOLOGIA, V49, P200, DOI 10.1007/s00125-005-0072-8; Aizawa S, 2009, EYE, V23, P304, DOI 10.1038/sj.eye.6703076; Bengtsson B, 2005, DIABETOLOGIA, V48, P2494, DOI 10.1007/s00125-005-0001-x; Brown DM, 2011, OPHTHALMOLOGY, V118, P1594, DOI 10.1016/j.ophtha.2011.02.022; Campochiaro PA, 2010, OPHTHALMOLOGY, V117, P1102, DOI 10.1016/j.ophtha.2010.02.021; Campochiaro PA, 2010, OPHTHALMOLOGY, V117, P2387, DOI 10.1016/j.ophtha.2010.03.060; Chen FK, 2009, INVEST OPHTH VIS SCI, V50, P3464, DOI 10.1167/iovs.08-2926; Chen WC, 2012, RETINA-J RET VIT DIS, V32, P1733, DOI 10.1097/IAE.0b013e318242b81a; Fujiwara Atsushi, 2014, Nippon Ganka Gakkai Zasshi, V118, P15; Haller JA, 2010, OPHTHALMOLOGY, V117, P1134, DOI 10.1016/j.ophtha.2010.03.032; HEIJL A, 1989, ARCH OPHTHALMOL-CHIC, V107, P81, DOI 10.1001/archopht.1989.01070010083032; Hoh AE, 2008, OPHTHALMOLOGE, V105, P1121, DOI 10.1007/s00347-008-1759-2; Johnson MW, 2009, AM J OPHTHALMOL, V147, P11, DOI 10.1016/j.ajo.2008.07.024; Jonas JB, 2005, EYE, V19, P65, DOI 10.1038/sj.eye.6701395; Jonas JB, 2010, ACTA OPHTHALMOL, V88, pe24, DOI 10.1111/j.1755-3768.2009.01510.x; Kiss CG, 2008, BRIT J OPHTHALMOL, V92, P84, DOI 10.1136/bjo.2007.124016; Kriechbaum K, 2009, OPHTHALMOLOGY, V116, P2415, DOI 10.1016/j.ophtha.2009.05.001; Krohne TU, 2008, AM J OPHTHALMOL, V146, P508, DOI 10.1016/j.ajo.2008.05.036; Midena E, 1997, INVEST OPHTH VIS SCI, V38, P469; Mitamura Y, 2013, J OPHTHALMOL, V2013, DOI 10.1155/2013/518170; Noma H, 2005, AM J OPHTHALMOL, V140, P256, DOI 10.1016/j.ajo.2005.03.003; Ozdemir H, 2008, EYE, V22, P204, DOI 10.1038/sj.eye.6702563; Park SP, 2010, RETINA-J RET VIT DIS, V30, P281, DOI 10.1097/IAE.0b013e3181b9f153; Prager F, 2009, BRIT J OPHTHALMOL, V93, P452, DOI 10.1136/bjo.2008.141085; Richter-Mueksch S, 2007, AM J OPHTHALMOL, V144, P23, DOI 10.1016/j.ajo.2007.03.045; Rohrschneider K, 2000, AM J OPHTHALMOL, V129, P27, DOI 10.1016/S0002-9394(99)00270-6; Roisman L, 2014, RETINA-J RET VIT DIS, V34, P713, DOI 10.1097/IAE.0b013e3182a323fe; Scott IU, 2009, OPHTHALMOLOGY, V116, P504, DOI 10.1016/j.ophtha.2008.10.017; Shimura M, 2008, ACTA OPHTHALMOL, V86, P377, DOI 10.1111/j.1600-0420.2007.01074.x; SJAARDA RN, 1993, OPHTHALMOLOGY, V100, P1513; Suh MH, 2009, AM J OPHTHALMOL, V147, P473, DOI 10.1016/j.ajo.2008.09.020; Vujosevic S, 2011, OPHTHALMOLOGICA, V225, P155, DOI 10.1159/000320340; Wu ZC, 2013, INVEST OPHTH VIS SCI, V54, P7378, DOI 10.1167/iovs.13-12617; Yamaike N, 2008, OPHTHALMOLOGY, V115, P355, DOI 10.1016/j.ophtha.2007.04.052; Yamaike N, 2009, RETINA-J RET VIT DIS, V29, P757, DOI 10.1097/IAE.0b013e31819d4fbf	35	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0149246	10.1371/journal.pone.0149246	http://dx.doi.org/10.1371/journal.pone.0149246			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26885822	Green Submitted, Green Published, gold			2022-12-26	WOS:000371218400071
J	Lee, YM; Kim, MK; Ahn, DH; Kim, HW; Park, H; Shin, SC				Lee, Yung Mi; Kim, Mi-Kyeong; Ahn, Do Hwan; Kim, Han-Woo; Park, Hyun; Shin, Seung Chul			Comparative Analysis of Lacinutrix Genomes and Their Association with Bacterial Habitat	PLOS ONE			English	Article							SP-NOV.; EMENDED DESCRIPTION; ESCHERICHIA-COLI; MARINE SEDIMENT; BIOSYNTHESIS; DATABASE; OXYGEN	The genus Lacinutrix, which belongs to the family Flavobacteriaceae, consists of seven bacterial species that were mainly isolated from marine life and sediments. As most bacteria in the family Flavobacteriaceae favor aerobic conditions, the seven bacterial species in the genus Lacinutrix also showed aerobic growth. We selected four monophyletic bacterial species living in a polar environment. Two of these species were isolated from sediment and two types were isolated from algae. In a comparative analysis, we investigated how these different environments were related to genomic features of these four species in the genus Lacinutrix. We found that the gene sets for glycolysis, the Krebs cycle, and oxidative phosphorylation were conserved in these four type strains. However, the presence of nitrous oxide reductase for denitrification and the absence of essential components related to thiamin biosynthesis for aerobic respiration were only found in isolates from sediment. Elevated bacterial metabolism on the surface of marine sediments might limit the oxygen penetration into sediment, and such an environment might affect the genomes of bacteria isolated from these habitats.	[Lee, Yung Mi; Kim, Mi-Kyeong; Ahn, Do Hwan; Kim, Han-Woo; Park, Hyun; Shin, Seung Chul] Korea Polar Res Inst, 26 Songdomirae Ro, Inchon 406840, South Korea; [Ahn, Do Hwan; Park, Hyun] Univ Sci & Technol, Daejeon 305333, South Korea	Korea Institute of Ocean Science & Technology (KIOST); Korea Polar Research Institute (KOPRI); University of Science & Technology (UST)	Shin, SC (corresponding author), Korea Polar Res Inst, 26 Songdomirae Ro, Inchon 406840, South Korea.	ssc@kopri.re.kr			Functional Genomics on Polar Organisms grant from the Korea Polar Research Institute (KOPRI) [PE15080, PE15070]	Functional Genomics on Polar Organisms grant from the Korea Polar Research Institute (KOPRI)(Korea Polar Research Institute of Marine Research Placement (KOPRI))	This work was supported by a Functional Genomics on Polar Organisms grant (PE15070 and PE15080) funded from the Korea Polar Research Institute (KOPRI).	Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bae W, 1997, J BACTERIOL, V179, P7081, DOI 10.1128/jb.179.22.7081-7088.1997; Begley TP, 1999, ARCH MICROBIOL, V171, P293, DOI 10.1007/s002030050713; Bowman JP, 2005, INT J SYST EVOL MICR, V55, P1471, DOI 10.1099/ijs.0.63527-0; Cole JR, 2007, NUCLEIC ACIDS RES, V35, pD169, DOI 10.1093/nar/gkl889; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; D'Amico S, 2006, EMBO REP, V7, P385, DOI 10.1038/sj.embor.7400662; D'Hondt S, 2015, NAT GEOSCI, V8, P299, DOI 10.1038/NGEO2387; Delcher AL, 2002, NUCLEIC ACIDS RES, V30, P2478, DOI 10.1093/nar/30.11.2478; Du QL, 2011, INT J BIOL SCI, V7, P41, DOI 10.7150/ijbs.7.41; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Ferrer M, 2003, NAT BIOTECHNOL, V21, P1266, DOI 10.1038/nbt1103-1266; Kim OS, 2012, INT J SYST EVOL MICR, V62, P716, DOI 10.1099/ijs.0.038075-0; Koike I., 1988, NITROGEN CYCLING COA, P251; Kraft B, 2011, J BIOTECHNOL, V155, P104, DOI 10.1016/j.jbiotec.2010.12.025; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lasa A, 2015, SYST APPL MICROBIOL, V38, P115, DOI 10.1016/j.syapm.2014.10.012; Lee YM, 2015, MAR GENOMICS; Lee YM, 2014, ANTON LEEUW INT J G, V106, P527, DOI 10.1007/s10482-014-0221-5; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Monteverde DR, 2015, FRONT MICROBIOL, P6; Myers EW, 2000, SCIENCE, V287, P2196, DOI 10.1126/science.287.5461.2196; Nedashkovskaya OI, 2008, INT J SYST EVOL MICR, V58, P2694, DOI 10.1099/ijs.0.65799-0; Park S, 2015, INT J SYST EVOL MICR; Pauleta SR, 2013, COORDIN CHEM REV, V257, P332, DOI 10.1016/j.ccr.2012.05.026; REVSBECH NP, 1980, SCIENCE, V207, P1355, DOI 10.1126/science.207.4437.1355; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Srinivas TNR, 2013, INT J SYST EVOL MICR, V63, P729, DOI 10.1099/ijs.0.040907-0; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Wrighton KC, 2012, SCIENCE, V337, P1661, DOI 10.1126/science.1224041; Zhou MY, 2009, MICROB ECOL, V58, P582, DOI 10.1007/s00248-009-9506-z	31	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0148889	10.1371/journal.pone.0148889	http://dx.doi.org/10.1371/journal.pone.0148889			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	26882010	Green Submitted, Green Published, gold			2022-12-26	WOS:000371219000030
J	Mu, YJ; Bi, H; Ekure, E; Ding, G; Wei, N; Hua, N; Qian, XH; Li, XR				Mu, Yajun; Bi, Hua; Ekure, Edgar; Ding, Gang; Wei, Nan; Hua, Ning; Qian, Xuehan; Li, Xiaorong			Performance of Spot Photoscreener in Detecting Amblyopia Risk Factors in Chinese Pre-school and School Age Children Attending an Eye Clinic	PLOS ONE			English	Article							VISION SCREENER; VALIDATION	Purpose To evaluate the effectiveness of Spot photoscreener in detecting amblyopia risk factors meeting 2013 the American Association of Pediatric Ophthalmology and Strabismus (AAPOS) criteria in Chinese preschool and school-age children. Methods One hundred and fifty-five children (310 eyes), aged between 4 to 7 years (5.74 +/- 1.2 years) underwent complete ophthalmologic examination, photoscreening, and cycloplegic retinoscopy refraction. The agreement of the results obtained with the photoscreening and retinoscopy was evaluated by linear regression and Bland-Altman plots. The sensitivity and specificity of detecting amblyopia risk factors were calculated based on the AAPOS 2013 guidelines. The overall effectiveness of detecting amblyopia risk factors was analyzed with Receiver Operating Characteristic (ROC) curves. Result The mean refractive errors measured with the Spot were: spherical equivalent (SE) = 0.70 +/- 1.99 D, J0 = 0.87 +/- 1.01 D, J45 = 0.09 +/- 0.60 D. The mean results from retinoscopy were: SE = 1.19 +/- 2.22 D, J0 = 0.77 +/- 1.00 D, J45 = -0.02 +/- 0.45 D. There was a strong linear agreement between results obtained from those two methods (R-2 = 0.88, P<0.01). Bland-Altman plot indicated a moderate agreement of cylinder values between the two methods. Based on the criteria specified by the AAPOS 2013 guidelines, the sensitivity and specificity (in respective order) for detecting hyperopia were 98.31% and 97.14%; for detecting myopia were 78.50% and 88.64%; for detecting astigmatism were 90.91% and 80.37%; for detecting anisometropia were 93.10% and 85.25%; and for detection of strabismus was 77.55% and 88.18%. Conclusion The refractive values measured from Spot photoscreener showed a moderate agreement with the results from cycloplegic retinoscopy refraction, however there was an overall myopic shift of -0.49D. The performance in detecting individual amblyopia risk factors was satisfactory, but could be further improved by optimizing criteria based on ROC curves.	[Mu, Yajun; Ding, Gang; Wei, Nan; Hua, Ning; Qian, Xuehan] Tianjin Med Univ, Dept Strabismus & Pediat Ophthalmol, Hosp Eye, Tianjin, Peoples R China; [Bi, Hua; Ekure, Edgar] Nova SE Univ, Coll Optometry, Ft Lauderdale, FL 33314 USA; [Li, Xiaorong] Tianjin Med Univ, Dept Retina & Vitreous, Hosp Eye, Tianjin, Peoples R China	Tianjin Medical University; Nova Southeastern University; Tianjin Medical University	Qian, XH (corresponding author), Tianjin Med Univ, Dept Strabismus & Pediat Ophthalmol, Hosp Eye, Tianjin, Peoples R China.; Li, XR (corresponding author), Tianjin Med Univ, Dept Retina & Vitreous, Hosp Eye, Tianjin, Peoples R China.	qianjohn@163.com; xiaorli@163.com	bi, huaqiang/GYJ-5005-2022					Amer Acad Pediat, 2008, PEDIATRICS, V122, P1401, DOI 10.1542/peds.2008-2624; American Academy of Ophthalmology Pediatric Ophthalmology/Strabismus_Panel, 2012, PREF PRACT PATT GUID; Barton M, 2011, PEDIATRICS, V127, P340, DOI 10.1542/peds.2010-3177; Carlton J, 2008, HEALTH TECHNOL ASSES, V12, P1; Chen X, 2015, BRIT J OPHTHALMOLOGY; Cotter S, 2003, AM J OPHTHALMOL, V136, P630, DOI 10.1016/S0002-9394(03)00458-6; Dahlmann-Noor AH, 2008, J AAPOS, V12, P104, DOI 10.1016/j.jaapos.2007.10.006; Donahue SP, 2013, J AAPOS, V17, P4, DOI 10.1016/j.jaapos.2012.09.012; Donahue SP, 2011, PEDIATRICS, V127, P569, DOI 10.1542/peds.2011-0020; Garry GA, 2014, J AAPOS, V18, P476, DOI 10.1016/j.jaapos.2014.07.156; Institut fur Qualitat und Wirtschaftlichkeit im Gesundheitswesen, 2008, FRUH SEHST BEI KIND, V6; Kirk S, 2014, J PEDIAT OPHTH STRAB, V51, P289, DOI 10.3928/01913913-20140701-01; Lagreze WA, 2010, DTSCH ARZTEBL INT, V107, P495, DOI 10.3238/arztebl.2010.0495; Matta NS, 2010, J AAPOS, V14, P147, DOI 10.1016/j.jaapos.2010.01.006; Moghaddam AAS, 2012, BRIT J OPHTHALMOL, V96, P83, DOI 10.1136/bjo.2010.190405; Peterseim MMW, 2014, J AAPOS, V18, P539, DOI 10.1016/j.jaapos.2014.07.176; Schimitzek T, 2005, GRAEF ARCH CLIN EXP, V243, P637, DOI 10.1007/s00417-004-1056-y; Silbert DI, 2014, J AAPOS, V18, P169, DOI 10.1016/j.jaapos.2013.11.019; Simons K, 2005, SURV OPHTHALMOL, V50, P123, DOI 10.1016/j.survophthal.2004.12.005; Yan XR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126052	20	27	28	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0149561	10.1371/journal.pone.0149561	http://dx.doi.org/10.1371/journal.pone.0149561			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	26882106	Green Published, gold, Green Submitted			2022-12-26	WOS:000371219000081
J	Song, HM; Cheng, YJ; Bi, G; Zhu, YH; Jun, W; Ma, WL; Wu, HM				Song, Haoming; Cheng, Youjun; Bi, Gang; Zhu, Yihui; Jun, Wei; Ma, Wenlin; Wu, Huimin			Release of Matrix Metalloproteinases-2 and 9 by S-Nitrosylated Caveolin-1 Contributes to Degradation of Extracellular Matrix in tPA-Treated Hypoxic Endothelial Cells	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; TISSUE-PLASMINOGEN-ACTIVATOR; RECEPTOR-RELATED PROTEIN; CEREBRAL-ISCHEMIA; NITRIC-OXIDE; PROSTATE-CANCER; SECRETED CAVEOLIN-1; NEUROVASCULAR UNIT; STROKE; EXPRESSION	Intracranial hemorrhage remains the most feared complication in tissue plasminogen activator (tPA) thrombolysis for ischemic stroke. However, the underlying molecular mechanisms are still poorly elucidated. In this study, we reported an important role of caveolin-1 (Cav-1) s-nitrosylation in matrix metalloproteinase (MMP)-2 and 9 secretion from tPA-treated ischemic endothelial cells. Brain vascular endothelial cells (bEND3) were exposed to oxygen-glucose deprivation (OGD) for 2 h before adding recombinant human tPA for 6 h. This treatment induced a significant increase of MMP2 and 9 in the media of bEND3 cells and a simultaneous degradation of fibronectin and laminin beta-1, the two main components of extracellular matrix (ECM). Inhibition of MMP2 and 9 with SB-3CT completely blocked the degradation of fibronectin and laminin beta-1. ODG+tPA treatment led to Cav-1 shedding from bEND3 cells into the media. Notably, OGD triggered nitric oxide (NO) production and S-nitrosylation of Cav-1 (SNCav-1). Meanwhile tPA induced activation of ERK signal pathway and stimulates the secretion of SNCav-1. Pretreatment of bEND3 cells with C-PTIO (a NO scavenger) or U0126 (a specific ERK inhibitor) significantly reduced OGD-induced S-nitrosylation of Cav-1 in cells and blocked the secretion of Cav-1 and MMP2 and 9 into the media as well as the degradation of fibronectin and laminin beta-1 in OGD and tPA-treated cells. These data indicate that OGD-triggered Cav-1 S-nitrosylation interacts with tPA-induced ERK activation to augment MMP2 and 9 secretion and subsequent ECM degradation, which may account for the exacerbation of ischemic blood brain barrier damage following tPA thrombolysis for ischemic stroke.	[Song, Haoming; Ma, Wenlin] Tongji Univ, Sch Med, Tongji Hosp, Dept Cardiol, Shanghai 200065, Peoples R China; [Cheng, Youjun] Guangzhou Med Univ, Affiliated Hosp, Guangzhou Brain Hosp, Dept Neurol, Guangzhou 510370, Guangdong, Peoples R China; [Bi, Gang; Zhu, Yihui; Jun, Wei; Ma, Wenlin; Wu, Huimin] Tongji Univ, Sch Med, Tongji Hosp, Translat Ctr Stem Cell Res,Stem Cell Res Ctr, Shanghai 200065, Peoples R China; [Bi, Gang] Tongji Univ, Sch Med, Tongji Hosp, Dept Orthoped, Shanghai 200065, Peoples R China; [Jun, Wei; Wu, Huimin] Tongji Univ, Sch Med, Tongji Hosp, Dept Gen Surg, Shanghai 200065, Peoples R China	Tongji University; Guangzhou Medical University; Tongji University; Tongji University; Tongji University	Song, HM; Ma, WL (corresponding author), Tongji Univ, Sch Med, Tongji Hosp, Dept Cardiol, Shanghai 200065, Peoples R China.; Ma, WL; Wu, HM (corresponding author), Tongji Univ, Sch Med, Tongji Hosp, Translat Ctr Stem Cell Res,Stem Cell Res Ctr, Shanghai 200065, Peoples R China.; Wu, HM (corresponding author), Tongji Univ, Sch Med, Tongji Hosp, Dept Gen Surg, Shanghai 200065, Peoples R China.	songhao-ming@163.com; mawenlin@medmail.com.cn; 13621720055@139.com						Abu Fanne R, 2010, NEUROPHARMACOLOGY, V58, P972, DOI 10.1016/j.neuropharm.2009.12.017; Adya R, 2008, CARDIOVASC RES, V78, P356, DOI 10.1093/cvr/cvm111; Alam M, 2011, NEUROSCI LETT, V495, P135, DOI 10.1016/j.neulet.2011.03.056; Alberts MJ, 1998, NEUROLOGY, V51, pS53, DOI 10.1212/WNL.51.3_Suppl_3.S53; Chaudhry K, 2010, NEUROSCI LETT, V474, P109, DOI 10.1016/j.neulet.2010.03.020; Chi OZ, 1997, ANESTH ANALG, V84, P370, DOI 10.1097/00000539-199702000-00024; Correa F, 2011, J EXP MED, V208, P1229, DOI 10.1084/jem.20101880; Davis GE, 2005, CIRC RES, V97, P1093, DOI 10.1161/01.RES.0000191547.64391.e3; del Zoppo GJ, 1998, J NEUROL NEUROSUR PS, V65, P1, DOI 10.1136/jnnp.65.1.1; Figueroa BE, 1998, STROKE, V29, P1202, DOI 10.1161/01.STR.29.6.1202; Gu Y, 2012, J NEUROCHEM, V120, P147, DOI 10.1111/j.1471-4159.2011.07542.x; HAMANN GF, 1995, STROKE, V26, P2120, DOI 10.1161/01.STR.26.11.2120; Han F, 2010, J SURG RES, V159, P443, DOI 10.1016/j.jss.2009.03.079; Ignatenko N, 2008, NEOPLASIA, V10, P140, DOI 10.1593/neo.07817; Inoue T, 2010, INVEST OPHTH VIS SCI, V51, P6461, DOI 10.1167/iovs.10-5318; Intengan HD, 2001, HYPERTENSION, V38, P581, DOI 10.1161/hy09t1.096249; Jin XC, 2012, NEUROBIOL DIS, V48, P309, DOI 10.1016/j.nbd.2012.07.007; Jin Y, 2009, FASEB J, V23, P341, DOI 10.1096/fj.08-108423; Lansberg MG, 2007, STROKE, V38, P2275, DOI 10.1161/STROKEAHA.106.480475; Leigh R, 2014, STROKE, V45, P2030, DOI 10.1161/STROKEAHA.114.005249; Liu J, 2012, J NEUROSCI, V32, P3044, DOI 10.1523/JNEUROSCI.6409-11.2012; Liu WL, 2007, J NEUROSCI RES, V85, P829, DOI 10.1002/jnr.21179; Maddahi A, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-56; Mantuano E, 2013, J BIOL CHEM, V288, P34009, DOI 10.1074/jbc.M113.509133; Meloche S, 2007, ONCOGENE, V26, P3227, DOI 10.1038/sj.onc.1210414; Montagnani M, 2001, J BIOL CHEM, V276, P30392, DOI 10.1074/jbc.M103702200; Mukhopadhyay S, 2008, AM J PHYSIOL-HEART C, V295, pH1943, DOI 10.1152/ajpheart.00642.2008; NATHAN C, 1992, FASEB J, V6, P3051, DOI 10.1096/fasebj.6.12.1381691; Navarro-Gonzalvez JA, 1998, CLIN CHEM, V44, P679; Parcq J, 2012, CELL DEATH DIFFER, V19, P1983, DOI 10.1038/cdd.2012.86; Polavarapu R, 2007, BLOOD, V109, P3270, DOI 10.1182/blood-2006-08-043125; Puddu A, 2008, BIOCHEM BIOPH RES CO, V375, P235, DOI 10.1016/j.bbrc.2008.08.003; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Schubert W, 2002, J BIOL CHEM, V277, P40091, DOI 10.1074/jbc.M205948200; Stamatovic SM, 2009, J BIOL CHEM, V284, P19053, DOI 10.1074/jbc.M109.000521; Suzuki Y, 2009, BLOOD, V114, P3352, DOI 10.1182/blood-2009-02-203919; Swendeman S, 2008, CIRC RES, V103, P916, DOI 10.1161/CIRCRESAHA.108.184416; Tahir SA, 2001, CANCER RES, V61, P3882; Tahir SA, 2008, CANCER RES, V68, P731, DOI 10.1158/0008-5472.CAN-07-2668; Taraboletti G, 2002, AM J PATHOL, V160, P673, DOI 10.1016/S0002-9440(10)64887-0; Taraboletti G, 2006, NEOPLASIA, V8, P96, DOI 10.1593/neo.05583; Tissue plasminogen activator for acute ischemic stroke, 1995, NEW ENGL J MED, V333, P1581, DOI [DOI 10.1056/NEJM199512143332401, 10.1056/NEJM199512143332401]; Wang XY, 2004, STROKE, V35, P2726, DOI 10.1161/01.STR.0000143219.16695.af; Wang XY, 2003, NAT MED, V9, P1313, DOI 10.1038/nm926; Won SJ, 2011, ANN NEUROL, V70, P583, DOI 10.1002/ana.22538; Wu DQ, 2002, J BIOL CHEM, V277, P40449, DOI 10.1074/jbc.M206270200; Xu PL, 2010, MOL CELL, V37, P551, DOI 10.1016/j.molcel.2010.01.034; Yamashita T, 2009, J CEREBR BLOOD F MET, V29, P715, DOI 10.1038/jcbfm.2008.164; Yang Y, 2011, STROKE, V42, P3323, DOI 10.1161/STROKEAHA.110.608257; Yepes M, 2003, J CLIN INVEST, V112, P1533, DOI 10.1172/JCI200319212; Zhao BQ, 2004, BLOOD, V103, P2610, DOI 10.1182/blood-2003-03-0835	51	20	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0149269	10.1371/journal.pone.0149269	http://dx.doi.org/10.1371/journal.pone.0149269			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	26881424	gold, Green Published, Green Submitted			2022-12-26	WOS:000371219000065
J	Vanselow, KA; Samimi, C; Breckle, SW				Vanselow, Kim Andre; Samimi, Cyrus; Breckle, Siegmar-W.			Preserving a Comprehensive Vegetation Knowledge Base - An Evaluation of Four Historical Soviet Vegetation Maps of the Western Pamirs (Tajikistan)	PLOS ONE			English	Article							REGIONAL-SCALE ANALYSIS; CENTRAL-ASIA; CLIMATE; PLANTS; GIS	We edited, redrew, and evaluated four unpublished historical vegetation maps of the Western Pamirs (Tajikistan) by the Soviet geobotanist Okmir E. Agakhanjanz. These maps cover an area of 5,188 km(2) and date from 1958 to 1960. The purpose of this article is to make the historic vegetation data available to the scientific community and thus preserve a hitherto non available and up to now neglected or forgotten data source with great potential for studies on vegetation and ecosystem response to global change. The original hand-drawn maps were scanned, georeferenced, and digitized and the corresponding land cover class was assigned to each polygon. The partly differing legends were harmonized and plant names updated. Furthermore, a digital elevation model and generalized additive models were used to calculate response curves of the land cover classes and to explore vegetation-topography relationships quantitatively. In total, 2,216 polygons belonging to 13 major land cover classes were included that are characterized by 252 different plant species. As such, the presented maps provide excellent comparison data for studies on vegetation and ecosystem change in an area that is deemed to be an important water tower in Central Asia.	[Vanselow, Kim Andre] Univ Erlangen Nurnberg, Dept Geog, D-91054 Erlangen, Germany; [Samimi, Cyrus] Univ Bayreuth, Dept Geog, Bayreuth, Germany; [Breckle, Siegmar-W.] Univ Bielefeld, Dept Ecol, D-33615 Bielefeld, Germany; [Samimi, Cyrus] Univ Bayreuth, BayCEER, Bayreuth, Germany	University of Erlangen Nuremberg; University of Bayreuth; University of Bielefeld; University of Bayreuth	Vanselow, KA (corresponding author), Univ Erlangen Nurnberg, Dept Geog, D-91054 Erlangen, Germany.	kim.vanselow@fau.de	Samimi, Cyrus/H-8085-2012	Samimi, Cyrus/0000-0001-7001-7893	Schmauser Foundation [DFG VA 749/1-1, DFG VA 749/4-1]; German Academic Exchange Service (DAAD); GTZ-CCD project; DFG (Deutsche Forschungsgemeinschaft); DAAD (German Academic Exchange Service); GTZ-CCD-Project Bonn; Volkswagen Foundation [AZ I81 976, AZ 85 862]; Deutsche Forschungsgemeinschaft; Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU)	Schmauser Foundation; German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); GTZ-CCD project; DFG (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); DAAD (German Academic Exchange Service)(Deutscher Akademischer Austausch Dienst (DAAD)); GTZ-CCD-Project Bonn; Volkswagen Foundation(Volkswagen); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU)	KAV received funding for travelling to the study area from Schmauser Foundation, https://www.zuv.fau.de/universitaet/stifter-foerderer/stiftungen/Schmauser-Stiftung/. SWB received funding for travelling to the study area from German Academic Exchange Service (DAAD), daad.de and the GTZ-CCD project, https://www.giz.de/fachexpertise/html/2560.html. Kim Andre Vanselow would like to thank DFG (Deutsche Forschungsgemeinschaft, www.dfg.de) and Schmauser Foundation (http://www.zuv.fau.de/universitaet/stifter-foerderer/stiftungen/Schmauser-Stiftung/) for financial support of the field campaigns in 2011 (DFG VA 749/1-1), 2014 (Schmauser), and 2015 (DFG VA 749/4-1). Siegmar-W. Breckle would like to thank DAAD (German Academic Exchange Service, www.daad.de) and GTZ-CCD-Project Bonn (www.giz.de) for financial help with the 2002 Expedition, as well as many local inhabitants and the Ministry of Environment in Dushanbe for many logistic helps. Cyrus Samimi received two research grants from Volkswagen Foundation (www.volkswagenstiftung.de, AZ I81 976, AZ 85 862) which made it possible to undertake numerous field campaigns in the Pamirs. We acknowledge support by Deutsche Forschungsgemeinschaft and Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU) within the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGACHANJANC OE, 1985, PETERMANN GEOGR MITT, V129, P17; Agachanjanz O, 1980, PAMIR AUFZEICHNUNGEN; Agachanjanz OE, 2002, WIND HEISST AFGHANE; AGAKHANJANZ O, 1995, ECOL STUD-ANAL SYNTH, V113, P63; Akhmadov KM, 2006, LAND USE CHANGE AND MOUNTAIN BIODIVERSITY, P239; Beg G. A., 2009, Experiences with and prospects for regional exchange and cooperation in mountain areas, Kathmandu, Nepal, Nov 30 - Dec 2, 2007., P184; Bohner J, 2006, BOREAS, V35, P279, DOI 10.1080/03009480500456073; Breckle SW, 2006, LAND USE CHANGE AND MOUNTAIN BIODIVERSITY, P225, DOI 10.1201/9781420002874.ch16; Breckle SW, 2013, VASCULAR PLANTS AFGH; Breu T., 2003, TAJIK PAMIRS CHALLEN; Chevallier P, 2014, HYDROLOG SCI J, V59, P1491, DOI 10.1080/02626667.2013.838004; Czerepanov SK., 1995, VASCULAR PLANTS RUSS; Frei E, 2010, BOT HELV, V120, P117, DOI 10.1007/s00035-010-0076-y; Giuliani A, 2011, MT RES DEV, V31, P16, DOI 10.1659/MRD-JOURNAL-D-10-00109.1; Gottfried M, 2012, NAT CLIM CHANGE, V2, P111, DOI [10.1038/nclimate1329, 10.1038/NCLIMATE1329]; GRABHERR G, 1994, NATURE, V369, P448, DOI 10.1038/369448a0; Grabherr G., 2010, CHALLENGES MOUNTAIN, P48; Gruber FE, 2013, NAT HAZARD EARTH SYS, V13, P2779, DOI 10.5194/nhess-13-2779-2013; Hastie TJ., 1990, GEN ADDITIVE MODELS, Vvol. 43, DOI DOI 10.1201/9780203753781; Herbers Hiltrud, 2006, LANDREFORM EXISTENZS; Kassam KA, 2009, HUM ECOL, V37, P677, DOI 10.1007/s10745-009-9284-8; Kayumov A, 2010, GLACIERS WATER RESOU; Khromova TE, 2006, REMOTE SENS ENVIRON, V102, P24, DOI 10.1016/j.rse.2006.01.019; Leyer I., 2007, MULTIVARIATE STAT OK; Loffler J, 2011, ERDKUNDE, V65, P189, DOI 10.3112/erdkunde.2011.02.06; Mamatumarov R, 2011, PLANTES MED PAMIR OR; McCullagh P, 1989, GEN LINEAR MODELS; Mergili M, 2011, NAT HAZARD EARTH SYS, V11, P1447, DOI 10.5194/nhess-11-1447-2011; Miehe G., 2001, ERDKUNDE, V55, P94, DOI [10.3112/erdkunde.2001.01.06, DOI 10.3112/ERDKUNDE.2001.01.06]; Mislimshoeva B, 2013, FOREST POLICY ECON, V37, P75, DOI 10.1016/j.forpol.2012.12.001; Narama C, 2001, GEOGR REP TOKYO METR, V36, P37; Oberhansli H, 2011, GLOBAL PLANET CHANGE, V76, P95, DOI 10.1016/j.gloplacha.2010.12.008; Ohara N, 2014, J HYDROL ENG, V19, DOI 10.1061/(ASCE)HE.1943-5584.0000988; Pachauri Rajendra, 2007, AR4 CLIMATE CHANGE 2; Qonunov Y, 2010, PASTORALISM RANGELAN, P82; Salick J, 2009, GLOBAL ENVIRON CHANG, V19, P147, DOI 10.1016/j.gloenvcha.2009.01.008; Schiemann R, 2008, INT J CLIMATOL, V28, P295, DOI 10.1002/joc.1532; Stone P., 1992, STATE WORLDS MOUNTAI; USGS NGA NASA, 2013, SHUTTL RAD TOP MISS; Walter H, 1994, OKOLOGIE DER ERDE; Walther GR, 2005, J VEG SCI, V16, P541, DOI 10.1111/j.1654-1103.2005.tb02394.x; Wood S, 2014, MIXED GAM COMPUTATIO; YEE TW, 1991, J VEG SCI, V2, P587, DOI 10.2307/3236170	43	13	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0148930	10.1371/journal.pone.0148930	http://dx.doi.org/10.1371/journal.pone.0148930			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	26881428	Green Published, Green Submitted, gold			2022-12-26	WOS:000371219000035
J	Aizawa, N; Kunikata, H; Nitta, F; Shiga, Y; Omodaka, K; Tsuda, S; Nakazawa, T				Aizawa, Naoko; Kunikata, Hiroshi; Nitta, Fumihiko; Shiga, Yukihiro; Omodaka, Kazuko; Tsuda, Satoru; Nakazawa, Toru			Age- and Sex-Dependency of Laser Speckle Flowgraphy Measurements of Optic Nerve Vessel Microcirculation	PLOS ONE			English	Article							OCULAR BLOOD-FLOW; PULSE-WAVE ANALYSIS; HEAD CIRCULATION; 2-DIMENSIONAL MEASUREMENT; VISUAL IMPAIRMENT; NORMAL EYES; POPULATION; VELOCITY; RABBITS; INDEX	Purpose To investigate the relationship between various characteristics of a normal population and laser speckle flowgraphy (LSFG) measurements of mean blur rate (MBR) in the optic nerve head (ONH). Methods A total of 189 eyes of 189 normal subjects (93 male, 96 female, mean age 45 +/- 14 years old, age range: 20-72) without any history of hypertension, hyperlipidemia or diabetes were enrolled. ONH microcirculation was measured with LSFG and overall MBR (MA), vessel-area MBR (MV), and tissue-area MBR (MT) were derived from these measurements. The statistical association of these measurements with characteristics such as sex, age, intraocular pressure (IOP) and systolic blood pressure (SBP) was then determined. Results There was a trend towards decreased IOP and MV and increased SBP with age (P = 0.002, P = 0.035, and P = 0.006, respectively). Furthermore, IOP, MV and SBP were correlated with age (r = -0.23, P = 0.011; r = -0.24, P < 0.001; and r = 0.30, P < 0.001, respectively). Separate multiple regression analyses of independent contributing factors revealed that sex and IOP contributed to MA (P < 0.001 and P = 0.002, respectively), sex, IOP, and age contributed to MV (P < 0.001, P = 0.003, and P = 0.024, respectively), while only IOP contributed to MT (P = 0.003). Conclusion In a normal population, MBR was affected by IOP in both the large vessel and capillary areas of the ONH, but not by SBP. MV was also affected by age and sex, while MT was stable independent of age or sex.	[Aizawa, Naoko; Kunikata, Hiroshi; Nitta, Fumihiko; Shiga, Yukihiro; Omodaka, Kazuko; Tsuda, Satoru; Nakazawa, Toru] Tohoku Univ, Grad Sch Med, Dept Ophthalmol, Sendai, Miyagi 980, Japan; [Kunikata, Hiroshi; Nakazawa, Toru] Tohoku Univ, Grad Sch Med, Dept Retinal Dis Control, Sendai, Miyagi 980, Japan; [Nakazawa, Toru] Tohoku Univ, Grad Sch Med, Dept Adv Ophthalm Med, Sendai, Miyagi 980, Japan	Tohoku University; Tohoku University; Tohoku University	Kunikata, H (corresponding author), Tohoku Univ, Grad Sch Med, Dept Ophthalmol, Sendai, Miyagi 980, Japan.; Kunikata, H (corresponding author), Tohoku Univ, Grad Sch Med, Dept Retinal Dis Control, Sendai, Miyagi 980, Japan.	kunikata@oph.med.tohoku.ac.jp			JST grant from JSPS KAKENHI [26293372, 26462629, 26670751]	JST grant from JSPS KAKENHI	Support was provided by a JST grant from JSPS KAKENHI Grants-in-Aid for Scientific Research (B) (TN 26293372), Scientific Research (C) (HK 26462629), and Exploratory Research (TN 26670751). The funder had no role in design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.	Aizawa N, 2014, INVEST OPHTH VIS SCI, V55, P7991, DOI 10.1167/iovs.14-15373; Aizawa N, 2014, BMC OPHTHALMOL, V14, DOI 10.1186/1471-2415-14-113; Aizawa N, 2011, CLIN OPHTHALMOL, V5, P1171, DOI 10.2147/OPTH.S22093; Boehm AG, 2005, INVEST OPHTH VIS SCI, V46, P1291, DOI 10.1167/iovs.04-0987; Chiba N, 2011, CLIN OPHTHALMOL, V5, P1549, DOI 10.2147/OPTH.S22097; Deegan BM, 2011, STROKE, V42, P1988, DOI 10.1161/STROKEAHA.110.605618; Demirkaya N, 2013, INVEST OPHTH VIS SCI, V54, P4934, DOI 10.1167/iovs.13-11913; FLORA GC, 1968, CIRCULATION, V38, P859, DOI 10.1161/01.CIR.38.5.859; Groh MJM, 1996, OPHTHALMOLOGY, V103, P529; Isono H, 2003, ARCH OPHTHALMOL-CHIC, V121, P225; Iwase A, 2006, OPHTHALMOLOGY, V113, P1354, DOI 10.1016/j.ophtha.2006.04.022; Joakimsen O, 1999, ARTERIOSCL THROM VAS, V19, P3007, DOI 10.1161/01.ATV.19.12.3007; Konishi N, 2002, OPT REV, V9, P163, DOI 10.1007/s10043-002-0163-4; Maekubo T, 2013, JPN J OPHTHALMOL, V57, P385, DOI 10.1007/s10384-013-0246-8; Nagahara M, 2011, INVEST OPHTH VIS SCI, V52, P87, DOI 10.1167/iovs.09-4422; Nomura H, 1999, OPHTHALMOLOGY, V106, P2016, DOI 10.1016/S0161-6420(99)90417-7; Quigley HA, 1996, NUMBER, V80, P389; Resnikoff S, 2004, B WORLD HEALTH ORGAN, V82, P844; Rhodes LA, 2014, INVEST OPHTH VIS SCI, V55, P8123, DOI 10.1167/iovs.14-15251; Shiba T, 2012, J ATHEROSCLER THROMB, V19, P999, DOI 10.5551/jat.13631; Shiba T, 2012, GRAEF ARCH CLIN EXP, V250, P1275, DOI 10.1007/s00417-012-1952-5; Shiga Y, 2014, INVEST OPHTH VIS SCI, V55, P3899, DOI 10.1167/iovs.14-14116; Shiga Y, 2013, CURR EYE RES, V38, P691, DOI 10.3109/02713683.2012.758292; Sugiyama T, 1996, JPN J OPHTHALMOL, V40, P339; Sugiyama T, 2014, PHOTONICS, V1, P220, DOI 10.3390/photonics1030220; Sugiyama T, 2010, ACTA OPHTHALMOL, V88, P723, DOI 10.1111/j.1755-3768.2009.01586.x; Sugiyama T, 2009, ACTA OPHTHALMOL, V87, P797, DOI 10.1111/j.1755-3768.2008.01460.x; Sugiyama T, 2009, ARCH OPHTHALMOL-CHIC, V127, P454, DOI 10.1001/archophthalmol.2008.606; Swank R L, 1983, Neurol Res, V5, P37; Takahashi H, 2013, EXP EYE RES, V108, P10, DOI 10.1016/j.exer.2012.12.003; TAMAKI Y, 1994, INVEST OPHTH VIS SCI, V35, P3825; TAMAKI Y, 1995, EXP EYE RES, V60, P373, DOI 10.1016/S0014-4835(05)80094-6; Tamura Akiko, 2013, Nippon Ganka Gakkai Zasshi, V117, P110; Toker E, 2003, ACTA OPHTHALMOL SCAN, V81, P617, DOI 10.1111/j.1395-3907.2003.00160.x; Tsuda S, 2014, CURR EYE RES, V39, P1207, DOI 10.3109/02713683.2014.905608; Tsuda S, 2013, J GLAUCOMA, V22, P398, DOI 10.1097/IJG.0b013e318237c8b3; Wang L, 2012, INVEST OPHTH VIS SCI, V53, P8303, DOI 10.1167/iovs.12-10911; Watanabe G, 2008, JPN J OPHTHALMOL, V52, P175, DOI 10.1007/s10384-007-0521-7; Wright J. D., 2011, National Health Statistics Report; Xu L, 2006, OPHTHALMOLOGY, V113, P1134, DOI 10.1016/j.ophtha.2006.01.035; Yanagida K, 2015, INVEST OPHTH VIS SCI, V56, P4880, DOI 10.1167/iovs.15-16567; Yokoyama Y, 2011, CLIN OPHTHALMOL, V5, P1721, DOI 10.2147/OPTH.S23204	42	25	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0148812	10.1371/journal.pone.0148812	http://dx.doi.org/10.1371/journal.pone.0148812			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26872348	Green Published, gold, Green Submitted			2022-12-26	WOS:000370054100058
J	Schurgers, E; Moorlag, M; Hemker, C; Lindhout, T; Kelchtermans, H; de Laat, B				Schurgers, Evelien; Moorlag, Martijn; Hemker, Coenraad; Lindhout, Theo; Kelchtermans, Hilde; de Laat, Bas			Thrombin Generation in Zebrafish Blood	PLOS ONE			English	Article							COAGULATION PATHWAY; IDENTIFICATION; HEMOSTASIS; KNOCKDOWN	To better understand hypercoagulability as an underlying cause for thrombosis, the leading cause of death in the Western world, new assays to study ex vivo coagulation are essential. The zebrafish is generally accepted as a good model for human hemostasis and thrombosis, as the hemostatic system proved to be similar to that in man. Their small size however, has been a hurdle for more widespread use in hemostasis related research. In this study we developed a method that enables the measurement of thrombin generation in a single drop of non-anticoagulated zebrafish blood. Pre-treatment of the fish with inhibitors of FXa and thrombin, resulted in a dose dependent diminishing of thrombin generation, demonstrating the validity of the assay. In order to establish the relationship between whole blood thrombin generation and fibrin formation, we visualized the resulting fibrin network by scanning electron microscopy. Taken together, in this study we developed a fast and reliable method to measure thrombin generation in whole blood collected from a single zebrafish. Given the similarities between coagulation pathways of zebrafish and mammals, zebrafish may be an ideal animal model to determine the effect of novel therapeutics on thrombin generation. Additionally, because of the ease with which gene functions can be silenced, zebrafish may serve as a model organism for mechanistical research in thrombosis and hemostasis.	[Schurgers, Evelien; Moorlag, Martijn; Hemker, Coenraad; Lindhout, Theo; Kelchtermans, Hilde; de Laat, Bas] Maastricht Univ, Med Ctr, Cardiovasc Res Inst Maastricht, NL-6200 MD Maastricht, Netherlands; [Schurgers, Evelien; Moorlag, Martijn; Hemker, Coenraad; Lindhout, Theo; Kelchtermans, Hilde; de Laat, Bas] Synapse BV, Maastricht, Netherlands	Maastricht University	Kelchtermans, H (corresponding author), Maastricht Univ, Med Ctr, Cardiovasc Res Inst Maastricht, NL-6200 MD Maastricht, Netherlands.; Kelchtermans, H (corresponding author), Synapse BV, Maastricht, Netherlands.	h.kelchtermans@thrombin.com		Hemker, Coen/0000-0003-1669-2358; Kelchtermans, Hilde/0000-0002-2724-3438; Schurgers, Evelien/0000-0001-8397-3112	Synapse BV	Synapse BV	Synapse BV provided support in the form of salaries for authors ES, MM, CH, TL, HK and BdL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Al Dieri R, 2012, BLOOD REV, V26, P197, DOI 10.1016/j.blre.2012.06.001; Carradice D, 2008, BLOOD, V111, P3331, DOI 10.1182/blood-2007-10-052761; Day K, 2004, BLOOD CELL MOL DIS, V32, P191, DOI 10.1016/j.bcmd.2003.09.004; Driever W, 1996, DEVELOPMENT, V123, P37; Gregory M, 2002, BLOOD CELL MOL DIS, V29, P286, DOI 10.1006/bcmd.2002.0568; Hemker HC, 2006, THROMB HAEMOSTASIS, V96, P553, DOI 10.1160/TH06-07-0408; Hemker HC, 2005, J THROMB HAEMOST, V3, P2399, DOI 10.1111/j.1538-7836.2005.01565.x; Hemker HC, 2003, PATHOPHYSIOL HAEMO T, V33, P4, DOI 10.1159/000071636; Jagadeeswaran P, 1999, BLOOD CELL MOL DIS, V25, P239, DOI 10.1006/bcmd.1999.0249; Jagadeeswaran P, 2000, BRIT J HAEMATOL, V110, P946, DOI 10.1046/j.1365-2141.2000.02284.x; Jagadeeswaran P, 1997, BLOOD CELL MOL DIS, V23, P410, DOI 10.1006/bcmd.1997.0158; Jagadeeswaran P, 1999, BRIT J HAEMATOL, V107, P731, DOI 10.1046/j.1365-2141.1999.01763.x; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Ninivaggi M, 2012, CLIN CHEM, V58, P1252, DOI 10.1373/clinchem.2012.184077; Ryan EA, 1999, BIOPHYS J, V77, P2813, DOI 10.1016/S0006-3495(99)77113-4; SHAH GA, 1985, THROMB RES, V40, P181, DOI 10.1016/0049-3848(85)90328-7; Sheehan J, 2001, P NATL ACAD SCI USA, V98, P8768, DOI 10.1073/pnas.131109398; Wolberg AS, 2008, TRANSFUS APHER SCI, V38, P15, DOI 10.1016/j.transci.2007.12.005	18	6	7	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149135	10.1371/journal.pone.0149135	http://dx.doi.org/10.1371/journal.pone.0149135			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26872266	Green Published, Green Submitted, gold			2022-12-26	WOS:000370054100111
J	Zhou, J; Luo, J; Wu, K; Yun, EJ; Kapur, P; Pong, RC; Du, Y; Wang, B; Authement, C; Hernandez, E; Yang, J; Xiao, G; Cha, TL; Wu, HC; Wu, D; Margulis, V; Lotan, Y; Brugarolas, J; He, D; Hsieh, JT				Zhou, J.; Luo, J.; Wu, K.; Yun, E-j; Kapur, P.; Pong, R-C; Du, Y.; Wang, B.; Authement, C.; Hernandez, E.; Yang, J.; Xiao, G.; Cha, T-L; Wu, H-C; Wu, D.; Margulis, V.; Lotan, Y.; Brugarolas, J.; He, D.; Hsieh, J-T			Loss of DAB2IP in RCC cells enhances their growth and resistance to mTOR-targeted therapies	ONCOGENE			English	Article							ABERRANT PROMOTER METHYLATION; PROTEIN HDAB2IP GENE; PROSTATE-CANCER; BREAST-CANCER; TUMOR-SUPPRESSOR; HEPATOCELLULAR-CARCINOMA; RENAL-CARCINOMA; DOWN-REGULATION; ACTIVATION; EXPRESSION	Targeted therapies using small-molecule inhibitors (SMIs) are commonly used in metastatic renal cell cancer (mRCC) patients; patients often develop drug resistance and eventually succumb to disease. Currently, understanding of mechanisms leading to SMIs resistance and any identifiable predictive marker(s) are still lacking. We discovered that DAB2IP, a novel Ras-GTPase-activating protein, was frequently epigenetically silenced in RCC, and DAB2IP loss was correlated with the overall survival of RCC patients. Loss of DAB2IP in RCC cells enhances their sensitivities to growth factor stimulation and resistances to SMI (such as mammalian target of rapamycin (mTOR) inhibitors). Mechanistically, loss of DAB2IP results in the activation of extracellular signal-regulated kinase/RSK1 and phosphoinositide-3 kinase/mTOR pathway, which synergizes the induction of hypoxia-inducible factor (HIF)-2 alpha expression. Consequently, elevated HIF-2 alpha suppresses p21/WAF1 expression that is associated with resistance to mTOR inhibitors. Thus combinatorial targeting both pathways resulted in a synergistic tumor inhibition. DAB2IP appears to be a new prognostic/predictive marker for mRCC patients, and its function provides a new insight into the molecular mechanisms of drug resistance to mTOR inhibitors, which also can be used to develop new strategies to overcome drug-resistant mRCC.	[Zhou, J.; Wu, K.; Du, Y.; Wang, B.; Wu, D.; He, D.] Xi An Jiao Tong Univ, Sch Med, Affiliated Hosp 1, Dept Urol, 277 Yanta West Rd, Xian 710061, Peoples R China; [Zhou, J.; Yun, E-j; Pong, R-C; Authement, C.; Hernandez, E.; Margulis, V.; Lotan, Y.; Hsieh, J-T] Univ Texas Southwestern Med Ctr Dallas, Dept Urol, J8-134,5323 Harry Hines, Dallas, TX 75390 USA; [Luo, J.] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Urol, Guangzhou, Guangdong, Peoples R China; [Kapur, P.] Univ Texas Southwestern Med Ctr Dallas, Dept Pathol, Dallas, TX USA; [Yang, J.; Xiao, G.] Univ Texas Southwestern Med Ctr Dallas, Dept Clin Sci, Dallas, TX 75390 USA; [Cha, T-L] Triserv Gen Hosp, Div Urol, Dept Surg, Natl Def Med Ctr, Taipei, Taiwan; [Wu, H-C] China Med Univ Hosp, Dept Urol, Taichung, Taiwan; [Brugarolas, J.] Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Dallas, TX USA	Xi'an Jiaotong University; University of Texas System; University of Texas Southwestern Medical Center Dallas; Sun Yat Sen University; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; National Defense Medical Center; Tri-Service General Hospital; China Medical University Taiwan; China Medical University Hospital - Taiwan; University of Texas System; University of Texas Southwestern Medical Center Dallas	He, D (corresponding author), Xi An Jiao Tong Univ, Sch Med, Affiliated Hosp 1, Dept Urol, 277 Yanta West Rd, Xian 710061, Peoples R China.; Hsieh, JT (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Urol, J8-134,5323 Harry Hines, Dallas, TX 75390 USA.	hedl@mail.xjtu.edu.cn; jt.hsieh@utsouthwestern.edu			National Natural Science Foundation of China [NSFC 81202014]; Fundamental Research Funds for the Central Universities in China; Endowment for Research in Urologic Oncology	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities in China; Endowment for Research in Urologic Oncology	We thank John Santoyo for editorial assistance. This work was supported in part by Jean H and John T Walter, Jr, Endowment for Research in Urologic Oncology (to J-TH), the National Natural Science Foundation of China (NSFC 81202014 to KW) and the Fundamental Research Funds for the Central Universities in China (to KW).	Abukhdeir AM, 2008, P NATL ACAD SCI USA, V105, P288, DOI 10.1073/pnas.0710887105; [Anonymous], 2013, NATURE, V499, P43, DOI [10.1038/nature12222, DOI 10.1038/NATURE12222, DOI 10.1038/nature12222]; Atkins MB, 2004, J CLIN ONCOL, V22, P909, DOI 10.1200/JCO.2004.08.185; Calvisi DF, 2011, J HEPATOL, V54, P311, DOI 10.1016/j.jhep.2010.06.036; Camp RL, 2004, CLIN CANCER RES, V10, P7252, DOI 10.1158/1078-0432.CCR-04-0713; Cariou S, 2000, P NATL ACAD SCI USA, V97, P9042, DOI 10.1073/pnas.160016897; Carracedo A, 2008, J CLIN INVEST, V118, P3065, DOI [10.1172/jCI34739, 10.1172/JCI34739]; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chen H, 2005, J BIOL CHEM, V280, P22437, DOI 10.1074/jbc.M501379200; Chen H, 2003, J BIOL CHEM, V278, P3121, DOI 10.1074/jbc.M208230200; Chen H, 2002, GENOMICS, V79, P573, DOI 10.1006/geno.2002.6739; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Cohen HT, 2005, NEW ENGL J MED, V353, P2477, DOI 10.1056/NEJMra043172; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Dalgliesh GL, 2010, NATURE, V463, P360, DOI 10.1038/nature08672; Das F, 2010, FEBS LETT, V584, P4268, DOI 10.1016/j.febslet.2010.09.010; Di Lorenzo G, 2009, EUR UROL, V56, P959, DOI 10.1016/j.eururo.2009.09.002; Dote H, 2004, CLIN CANCER RES, V10, P2082, DOI 10.1158/1078-0432.CCR-03-0236; Duggan D, 2007, JNCI-J NATL CANCER I, V99, P1836, DOI 10.1093/jnci/djm250; Escudier B, 2007, LANCET, V370, P2103, DOI 10.1016/S0140-6736(07)61904-7; Gordan JD, 2007, CANCER CELL, V11, P335, DOI 10.1016/j.ccr.2007.02.006; Huang D, 2010, CANCER RES, V70, P1063, DOI 10.1158/0008-5472.CAN-09-3965; Julien LA, 2010, MOL CELL BIOL, V30, P908, DOI 10.1128/MCB.00601-09; Kroeger N, 2014, EUR UROL, V65, P1086, DOI 10.1016/j.eururo.2013.07.031; Kucejova B, 2011, MOL CANCER RES, V9, P1255, DOI 10.1158/1541-7786.MCR-11-0302; Laptenko O, 2011, P NATL ACAD SCI USA, V108, P10385, DOI 10.1073/pnas.1105680108; Martinelli E, 2013, INT J CANCER, V133, P2089, DOI 10.1002/ijc.28236; Min J, 2010, NAT MED, V16, P286, DOI 10.1038/nm.2100; Motzer RJ, 2007, NEW ENGL J MED, V356, P115, DOI 10.1056/NEJMoa065044; Niculescu AB, 1998, MOL CELL BIOL, V18, P629, DOI 10.1128/MCB.18.1.629; Omeir RL, 2011, COMPARATIVE MED, V61, P243; Onda H, 1999, J CLIN INVEST, V104, P687, DOI 10.1172/JCI7319; Pena-LlopiS S, 2012, NAT GENET, V44, P751, DOI 10.1038/ng.2323; Qiu GH, 2007, J HEPATOL, V46, P655, DOI 10.1016/j.jhep.2006.11.012; Rini BI, 2009, LANCET ONCOL, V10, P992, DOI 10.1016/S1470-2045(09)70240-2; Roux PP, 2007, J BIOL CHEM, V282, P14056, DOI 10.1074/jbc.M700906200; RYAN MJ, 1994, KIDNEY INT, V45, P48, DOI 10.1038/ki.1994.6; Sato Y, 2013, NAT GENET, V45, P860, DOI 10.1038/ng.2699; Serra V, 2011, ONCOGENE, V30, P2547, DOI 10.1038/onc.2010.626; Serra V, 2013, J CLIN INVEST, V123, P2551, DOI 10.1172/JCI66343; Shahbazian D, 2006, EMBO J, V25, P2781, DOI 10.1038/sj.emboj.7601166; Shinojima T, 2007, CARCINOGENESIS, V28, P529, DOI 10.1093/carcin/bgl143; Smits M, 2012, CLIN CANCER RES, V18, P4048, DOI 10.1158/1078-0432.CCR-12-0399; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Wang Z, 2002, J BIOL CHEM, V277, P12622, DOI 10.1074/jbc.M110568200; Wu KJ, 2013, CLIN CANCER RES, V19, P4740, DOI 10.1158/1078-0432.CCR-13-0954; Xie DX, 2009, P NATL ACAD SCI USA, V106, P19878, DOI 10.1073/pnas.0908458106; Yano M, 2005, INT J CANCER, V113, P59, DOI 10.1002/ijc.20531; Zhang HF, 2004, J BIOL CHEM, V279, P44955, DOI 10.1074/jbc.M407617200; Zhang XJ, 2012, J GASTROEN HEPATOL, V27, P1117, DOI 10.1111/j.1440-1746.2011.07049.x	50	24	24	1	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 1	2016	35	35					4663	4674		10.1038/onc.2016.4	http://dx.doi.org/10.1038/onc.2016.4			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DU6PE	26876207				2022-12-26	WOS:000382336300012
J	Aerbajinai, W; Liu, LH; Zhu, JQ; Kumkhaek, C; Chin, K; Rodgers, GP				Aerbajinai, Wulin; Liu, Lunhua; Zhu, Jianqiong; Kumkhaek, Chutima; Chin, Kyung; Rodgers, Griffin P.			Glia Maturation Factor- Regulates Monocyte Migration through Modulation of 1-Integrin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adhesion; Arp2; 3 complex; cell migration; endocytosis; integrin; ubiquitylation (ubiquitination); glia maturation factor-gamma (GMFG)	STIMULATED GLUT4 TRANSLOCATION; CELL-MIGRATION; MEMBRANE-FUSION; FACTOR-GAMMA; NEUTROPHIL CHEMOTAXIS; LYSOSOMAL DEGRADATION; SYNIP PHOSPHORYLATION; ACTIN POLYMERIZATION; INTEGRIN TRAFFICKING; RECYCLING PATHWAYS	Monocyte migration requires the dynamic redistribution of integrins through a regulated endo-exocytosis cycle, but the complex molecular mechanisms underlying this process have not been fully elucidated. Glia maturation factor- (GMFG), a novel regulator of the Arp2/3 complex, has been shown to regulate directional migration of neutrophils and T-lymphocytes. In this study, we explored the important role of GMFG in monocyte chemotaxis, adhesion, and 1-integrin turnover. We found that knockdown of GMFG in monocytes resulted in impaired chemotactic migration toward formyl-Met-Leu-Phe (fMLP) and stromal cell-derived factor 1 (SDF-1) as well as decreased 51-integrin-mediated chemoattractant-stimulated adhesion. These GMFG knockdown impaired effects could be reversed by cotransfection of GFP-tagged full-length GMFG. GMFG knockdown cells reduced the cell surface and total protein levels of 51-integrin and increased its degradation. Importantly, we demonstrate that GMFG mediates the ubiquitination of 1-integrin through knockdown or overexpression of GMFG. Moreover, GMFG knockdown retarded the efficient recycling of 1-integrin back to the plasma membrane following normal endocytosis of 51-integrin, suggesting that the involvement of GMFG in maintaining 51-integrin stability may occur in part by preventing ubiquitin-mediated degradation and promoting 1-integrin recycling. Furthermore, we observed that GMFG interacted with syntaxin 4 (STX4) and syntaxin-binding protein 4 (STXBP4); however, only knockdown of STXBP4, but not STX4, reduced monocyte migration and decreased 1-integrin cell surface expression. Knockdown of STXBP4 also substantially inhibited 1-integrin recycling in human monocytes. These results indicate that the effects of GMFG on monocyte migration and adhesion probably occur through preventing ubiquitin-mediated proteasome degradation of 51-integrin and facilitating effective 1-integrin recycling back to the plasma membrane.	[Aerbajinai, Wulin; Zhu, Jianqiong; Kumkhaek, Chutima; Chin, Kyung; Rodgers, Griffin P.] NHLBI, Mol & Clin Hematol Branch, NIH, Bethesda, MD 20892 USA; [Liu, Lunhua] NCI, Lab Cellular & Mol Biol, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Rodgers, GP (corresponding author), NIH, Mol & Clin Hematol Branch, Bldg 10,Rm 9N-113A, Bethesda, MD 20892 USA.	gr5n@nih.gov			NIDDK, National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006005] Funding Source: NIH RePORTER	NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Intramural Research Program of NIDDK, National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aerbajinai W, 2011, J LEUKOCYTE BIOL, V90, P529, DOI 10.1189/jlb.0710424; Arjonen A, 2012, TRAFFIC, V13, P610, DOI 10.1111/j.1600-0854.2012.01327.x; Bennett MK, 1999, NAT CELL BIOL, V1, pE58, DOI 10.1038/11027; Boczkowska M, 2013, J BIOL CHEM, V288, P25683, DOI 10.1074/jbc.C113.493338; Bottcher RT, 2012, NAT CELL BIOL, V14, P584, DOI 10.1038/ncb2501; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Caswell PT, 2009, NAT REV MOL CELL BIO, V10, P843, DOI 10.1038/nrm2799; Caswell PT, 2006, TRAFFIC, V7, P14, DOI 10.1111/j.1600-0854.2005.00362.x; Cera MR, 2009, J CELL SCI, V122, P268, DOI 10.1242/jcs.037127; Chang FS, 2003, CURR BIOL, V13, P455, DOI 10.1016/S0960-9822(03)00131-3; Chen YA, 2001, NAT REV MOL CELL BIO, V2, P98, DOI 10.1038/35052017; CHULUYAN HE, 1995, J LEUKOCYTE BIOL, V58, P71, DOI 10.1002/jlb.58.1.71; Day P, 2011, INT J ONCOL, V39, P863, DOI 10.3892/ijo.2011.1101; De Franceschi N, 2015, J CELL SCI, V128, P839, DOI 10.1242/jcs.161653; Derivery E, 2009, DEV CELL, V17, P712, DOI 10.1016/j.devcel.2009.09.010; Firat-Karalar EN, 2011, CURR OPIN CELL BIOL, V23, P4, DOI 10.1016/j.ceb.2010.10.007; Gandhi M, 2010, CURR BIOL, V20, P861, DOI 10.1016/j.cub.2010.03.026; Grant BD, 2009, NAT REV MOL CELL BIO, V10, P597, DOI 10.1038/nrm2755; Hao YH, 2013, CELL, V152, P1051, DOI 10.1016/j.cell.2013.01.051; Harrison MS, 2014, P NATL ACAD SCI USA, V111, P267, DOI 10.1073/pnas.1316482111; Herter J, 2013, J IMMUNOL, V190, P4451, DOI 10.4049/jimmunol.1203179; Hsu VW, 2010, CURR OPIN CELL BIOL, V22, P528, DOI 10.1016/j.ceb.2010.05.008; Ikeda K, 2006, CIRC RES, V99, P424, DOI 10.1161/01.RES.0000237662.23539.0b; Jahn R, 2003, CELL, V112, P519, DOI 10.1016/S0092-8674(03)00112-0; Jones MC, 2006, CURR OPIN CELL BIOL, V18, P549, DOI 10.1016/j.ceb.2006.08.003; Kawaguchi T, 2010, BIOCHEM BIOPH RES CO, V391, P1336, DOI 10.1016/j.bbrc.2009.12.045; Kharitidi D, 2015, CELL REP, V13, P599, DOI 10.1016/j.celrep.2015.09.024; LAWSON MA, 1995, NATURE, V377, P75, DOI 10.1038/377075a0; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Lippert DND, 2012, BMC IMMUNOL, V13, DOI 10.1186/1471-2172-13-21; Liu LH, 2010, DEV CELL, V19, P845, DOI 10.1016/j.devcel.2010.11.004; Lobert VH, 2010, DEV CELL, V19, P148, DOI 10.1016/j.devcel.2010.06.010; LUSCINSKAS FW, 1994, J CELL BIOL, V125, P1417, DOI 10.1083/jcb.125.6.1417; Margadant C, 2011, CURR OPIN CELL BIOL, V23, P607, DOI 10.1016/j.ceb.2011.08.005; McNew JA, 2000, NATURE, V407, P153, DOI 10.1038/35025000; MEERSCHAERT J, 1995, J IMMUNOL, V154, P4099; Mellman I, 2000, J CELL BIOL, V149, P529, DOI 10.1083/jcb.149.3.529; Min J, 1999, MOL CELL, V3, P751, DOI 10.1016/S1097-2765(01)80007-1; Morel E, 2009, DEV CELL, V16, P445, DOI 10.1016/j.devcel.2009.01.007; Okada S, 2007, BIOCHEM BIOPH RES CO, V356, P102, DOI 10.1016/j.bbrc.2007.02.095; Pellinen T, 2006, J CELL SCI, V119, P3723, DOI 10.1242/jcs.03216; Platta HW, 2011, CURR OPIN CELL BIOL, V23, P393, DOI 10.1016/j.ceb.2011.03.008; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Rankin CR, 2013, J BIOL CHEM, V288, P15229, DOI 10.1074/jbc.M112.440909; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Riggs KA, 2012, J CELL SCI, V125, P3827, DOI 10.1242/jcs.102566; ROTHMAN JE, 1994, NATURE, V372, P55, DOI 10.1038/372055a0; Shattil SJ, 2010, NAT REV MOL CELL BIO, V11, P288, DOI 10.1038/nrm2871; Shi Ying, 2006, Genomics Proteomics & Bioinformatics, V4, P145, DOI 10.1016/S1672-0229(06)60027-2; Stanley P, 2012, BIOL OPEN, V1, P1161, DOI 10.1242/bio.20122824; Steeber DA, 2000, IMMUNOL RES, V22, P299, DOI 10.1385/IR:22:2-3:299; Steinberg F, 2012, J CELL BIOL, V197, P219, DOI 10.1083/jcb.201111121; Tanabe Kenji, 2011, Commun Integr Biol, V4, P742; Thapa N, 2012, DEV CELL, V22, P116, DOI 10.1016/j.devcel.2011.10.030; Tiwari A, 2011, J BIOL CHEM, V286, P36749, DOI 10.1074/jbc.M111.260828; Veale KJ, 2011, EXP CELL RES, V317, P1817, DOI 10.1016/j.yexcr.2011.04.016; Veale Kelly J, 2011, Commun Integr Biol, V4, P44, DOI 10.4161/cib.4.1.13569; Wong CHY, 2010, CARDIOVASC RES, V86, P183, DOI 10.1093/cvr/cvq040; Yamada E, 2005, J CELL BIOL, V168, P921, DOI 10.1083/jcb.200408182; Yamada E, 2014, ENDOCR J, V61, P523, DOI 10.1507/endocrj.EJ14-0099; Ydenberg CA, 2013, CURR BIOL, V23, P1037, DOI 10.1016/j.cub.2013.04.058; Yu HJ, 2013, J BIOL CHEM, V288, P18885, DOI 10.1074/jbc.M113.465450	62	18	18	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2016	291	16					8549	8564		10.1074/jbc.M115.674200	http://dx.doi.org/10.1074/jbc.M115.674200			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK2VT	26895964	Green Published, hybrid			2022-12-26	WOS:000374773200020
J	Gupt, A; Kaur, P; Kamraj, P; Murthy, BN				Gupt, Anadi; Kaur, Prabhdeep; Kamraj, P.; Murthy, B. N.			Out of Pocket Expenditure for Hospitalization among Below Poverty Line Households in District Solan, Himachal Pradesh, India, 2013	PLOS ONE			English	Article							HEALTH-INSURANCE; PROTECTION	Introduction Health insurance schemes, like Rashtriya Swasthya Bima Yojana (RSBY), should provide financial protection against catastrophic health costs by reducing out of pocket expenditure (OOPE) for hospitalizations. We estimated and compared the proportion and extent of OOPE among below poverty line (BPL) families beneficiaries and not beneficiaries by RSBY during hospitalizations in district Solan, H.P., India, 2013. Methods We conducted a cross sectional survey among hospitalized BPL families in the beneficiaries and non-beneficiaries groups. We compared proportion incurring OOPE and its extent during hospitalization, pre/post-hospitalization periods in different domains. Results Overall, proportion of non-beneficiaries who incurred OOPE was higher than the beneficiaries but it was not statistically significant (87.2% vs. 80.9%). The median overall OOPE was $39 (Rs 2567) in the non-beneficiaries group as compared to $11 (Rs 713) in the beneficiaries group (p<0.01). Median expenditure on in house and out house drugs and consumables was $23 (Rs 1500) in the non beneficiaries group as compared to nil in the beneficiaries group (p<0.01). Non-beneficiary status was significantly associated [OR: 2.4 (1.3-4.3)] with OOPE above median independently and also after adjusting for various covariates. Conclusion RSBY has decreased the extent of OOPE among the beneficiaries; however OOPE was incurred mainly due to purchase of drugs from outside the health facility. The treatment seeking behaviour in beneficiaries group has improved among comparatively older group with chronic conditions. RSBY has enabled beneficiaries to get more facilities such as drugs, consumables and diagnostics from the health facility.	[Gupt, Anadi; Kaur, Prabhdeep; Kamraj, P.; Murthy, B. N.] Govt Himachal Pradesh, Natl Hlth Mission, Block 6,SDA Complex, Shimla 171009, Himachal Prades, India		Gupt, A (corresponding author), Govt Himachal Pradesh, Natl Hlth Mission, Block 6,SDA Complex, Shimla 171009, Himachal Prades, India.	dranadigupt@yahoo.com	Kaur, Prabhdeep/AFO-2518-2022	Kaur, Prabhdeep/0000-0002-2605-3739	National Institute of Epidemiology	National Institute of Epidemiology	National Institute of Epidemiology partially funded this study. The rest of the funds were contributed by Dr. Anadi Gupt-first author.	Acharya A., 2012, IMPACT NATL HLTH INS; Berman P., 2010, Economic and Political Weekly, V45, P65; Bhojani U, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-990; Commission P, 2013, PRESS NOT POV EST 20 PRESS NOT POV EST 20; Devadasan N, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-43; Ekman Bjorn, 2007, Health Res Policy Syst, V5, P6, DOI 10.1186/1478-4505-5-6; Fan VY, 2012, INT J HEALTH CARE FI, V12, P189, DOI 10.1007/s10754-012-9110-5; Galarraga O, 2010, EUR J HEALTH ECON, V11, P437, DOI 10.1007/s10198-009-0180-3; Garg CC, 2009, HEALTH POLICY PLANN, V24, P116, DOI 10.1093/heapol/czn046; Ministry of Health and Family Welfare GoI, 2009, NAT HLTH ACC IND 200; Nguyen HTH, 2011, INT J EQUITY HEALTH, V10, DOI 10.1186/1475-9276-10-4; Ramani K V, 2006, J Health Organ Manag, V20, P560, DOI 10.1108/14777260610702307; Rao M, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004471; Rashtriya Swasthya Bima Yojana Gol, ENR BEN 2014; Selvaraj Sakthivel, 2012, ECON POLIT WEEKLY, V47, P61; Sood N, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5114; World Health Organization (WHO), 2014, MAK FAIR CHOIC PATH	17	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0149824	10.1371/journal.pone.0149824	http://dx.doi.org/10.1371/journal.pone.0149824			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3DG	26895419	Green Published, gold, Green Submitted			2022-12-26	WOS:000371223400084
J	Meseda, CA; Atukorale, V; Kuhn, J; Schmeisser, F; Weir, JP				Meseda, Clement A.; Atukorale, Vajini; Kuhn, Jordan; Schmeisser, Falko; Weir, Jerry P.			Percutaneous Vaccination as an Effective Method of Delivery of MVA and MVA-Vectored Vaccines	PLOS ONE			English	Article							PHASE-I TRIAL; VIRUS-ANKARA; SMALLPOX VACCINE; INFLUENZA-VIRUS; MICRONEEDLE ARRAYS; SKIN VACCINATION; ANTIGEN DELIVERY; IMMUNE-RESPONSES; CLINICAL-TRIAL; HEALTHY-ADULTS	The robustness of immune responses to an antigen could be dictated by the route of vaccine inoculation. Traditional smallpox vaccines, essentially vaccinia virus strains, that were used in the eradication of smallpox were administered by percutaneous inoculation (skin scarification). The modified vaccinia virus Ankara is licensed as a smallpox vaccine in Europe and Canada and currently undergoing clinical development in the United States. MVA is also being investigated as a vector for the delivery of heterologous genes for prophylactic or therapeutic immunization. Since MVA is replication-deficient, MVA and MVA-vectored vaccines are often inoculated through the intramuscular, intradermal or subcutaneous routes. Vaccine inoculation via the intramuscular, intradermal or subcutaneous routes requires the use of injection needles, and an estimated 10 to 20% of the population of the United States has needle phobia. Following an observation in our laboratory that a replication-deficient recombinant vaccinia virus derived from the New York City Board of Health strain elicited protective immune responses in a mouse model upon inoculation by tail scarification, we investigated whether MVA and MVA recombinants can elicit protective responses following percutaneous administration in mouse models. Our data suggest that MVA administered by percutaneous inoculation, elicited vaccinia-specific antibody responses, and protected mice from lethal vaccinia virus challenge, at levels comparable to or better than subcutaneous or intramuscular inoculation. High titers of specific neutralizing antibodies were elicited in mice inoculated with a recombinant MVA expressing the herpes simplex type 2 glycoprotein D after scarification. Similarly, a recombinant MVA expressing the hemagglutinin of attenuated influenza virus rgA/Viet Nam/1203/2004 (H5N1) elicited protective immune responses when administered at low doses by scarification. Taken together, our data suggest that MVA and MVA-vectored vaccines inoculated by scarification can elicit protective immune responses that are comparable to subcutaneous vaccination, and may allow for antigen sparing when vaccine supply is limited.	[Meseda, Clement A.; Atukorale, Vajini; Kuhn, Jordan; Schmeisser, Falko; Weir, Jerry P.] US FDA, Div Viral Prod, Ctr Biol Evaluat & Res, 10903 New Hampshire Ave, Silver Spring, MD 20993 USA	US Food & Drug Administration (FDA)	Meseda, CA (corresponding author), US FDA, Div Viral Prod, Ctr Biol Evaluat & Res, 10903 New Hampshire Ave, Silver Spring, MD 20993 USA.	Clement.Meseda@fda.hhs.gov	Meseda, Clement/I-6336-2019		Center for Biologics Evaluation and Research, US Food and Drug Administration; CBER/FDA	Center for Biologics Evaluation and Research, US Food and Drug Administration; CBER/FDA	The work described in this manuscript was supported by intramural research fund provided by the Center for Biologics Evaluation and Research, US Food and Drug Administration.; The authors wish to thank Drs. Bernard Moss and Linda Wyatt, NIAID/NIH, for the MVA and VV-WR viruses. We also thank Dr. Maryna Eichelberger and Dr. Alonzo Garcia, CBER/FDA, for reviewing this manuscript. This work was supported by intramural research funds from CBER/FDA.	Al-Zahrani S, 2012, EXPERT OPIN DRUG DEL, V9, P541, DOI 10.1517/17425247.2012.676038; Amato RJ, 2012, FUTURE ONCOL, V8, P231, DOI [10.2217/FON.12.7, 10.2217/fon.12.7]; Antrobus RD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048322; Becker PD, 2015, VACCINE, V33, P4691, DOI 10.1016/j.vaccine.2015.04.046; Belshe RB, 2007, VACCINE, V25, P6755, DOI 10.1016/j.vaccine.2007.06.066; Blanchard TJ, 1998, J GEN VIROL, V79, P1159, DOI 10.1099/0022-1317-79-5-1159; Boukhebza H, 2012, HUM VACC IMMUNOTHER, V8, P1746, DOI 10.4161/hv.21689; Bruner DI, 2014, J EMERG MED, V46, pE85, DOI 10.1016/j.jemermed.2013.06.001; Busquets N, 2014, ANTIVIR RES, V108, P165, DOI 10.1016/j.antiviral.2014.05.020; Carey JB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022442; Carroll MW, 1997, VIROLOGY, V238, P198, DOI 10.1006/viro.1997.8845; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P248; Chakrabarti S, 1997, BIOTECHNIQUES, V23, P1094, DOI 10.2144/97236st07; de Barra E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115161; de Vries RD, 2015, EMERG INFECT DIS, V21, P1086, DOI 10.3201/eid2106.150021; Di Bisceglie AM, 2014, GASTROENTEROLOGY, V147, P119, DOI 10.1053/j.gastro.2014.03.007; Drexler I, 2004, CURR OPIN BIOTECH, V15, P506, DOI 10.1016/j.copbio.2004.09.001; Drexler I, 1998, J GEN VIROL, V79, P347, DOI 10.1099/0022-1317-79-2-347; Earl PL, 2004, NATURE, V428, P182, DOI 10.1038/nature02331; Earl PL, 2001, CURR PROTOCOLS PROTE, DOI [10.1002/0471140864.ps0512s13, DOI 10.1002/0471140864.PS0512S13]; Eckart RE, 2004, J AM COLL CARDIOL, V44, P201, DOI 10.1016/j.jacc.2004.05.004; Edens C, 2015, VACCINE, V33, P4683, DOI 10.1016/j.vaccine.2015.01.089; Edens C, 2013, VACCINE, V31, P3403, DOI 10.1016/j.vaccine.2012.09.062; Florek KR, 2014, J VIROL, V88, P13418, DOI 10.1128/JVI.01219-14; Frey SE, 2015, VACCINE, V33, P5225, DOI 10.1016/j.vaccine.2015.06.075; Garcia F, 2011, VACCINE, V29, P8309, DOI 10.1016/j.vaccine.2011.08.098; Garcia-Arriaza J, 2014, J VIROL, V88, P3527, DOI 10.1128/JVI.03418-13; Gill HS, 2007, J CONTROL RELEASE, V117, P227, DOI 10.1016/j.jconrel.2006.10.017; Giudice EL, 2006, ADV DRUG DELIVER REV, V58, P68, DOI 10.1016/j.addr.2005.12.003; Gomez CE, 2013, J VIROL, V87, P7282, DOI 10.1128/JVI.03246-12; Green CA, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008748; Greenberg RN, 2008, EXPERT OPIN INV DRUG, V17, P555, DOI [10.1517/13543784.17.4.555, 10.1517/13543784.17.4.555 ]; Halsell JS, 2003, JAMA-J AM MED ASSOC, V289, P3283, DOI 10.1001/jama.289.24.3283; Hawkridge A, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a2052; Hessel A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016247; Hodgson SH, 2015, J INFECT DIS, V211, P1076, DOI 10.1093/infdis/jiu579; Hui EP, 2013, CANCER RES, V73, P1676, DOI 10.1158/0008-5472.CAN-12-2448; Jiang XD, 2012, NATURE, V483, P227, DOI 10.1038/nature10851; Kamlangdee A, 2014, J VIROL, V88, P13300, DOI 10.1128/JVI.01532-14; Kennedy RB, 2009, VACCINE, V27, pD73, DOI 10.1016/j.vaccine.2009.07.103; Kenney RT, 2004, NEW ENGL J MED, V351, P2295, DOI 10.1056/NEJMoa043540; Koutsonanos DG, 2015, VACCINE, V33, P4675, DOI 10.1016/j.vaccine.2015.01.086; Koutsonanos DG, 2012, SCI REP-UK, V2, DOI 10.1038/srep00357; Kreijtz JHCM, 2009, VACCINE, V27, P6296, DOI 10.1016/j.vaccine.2009.03.020; Kreijtz JHCM, 2007, J INFECT DIS, V195, P1598, DOI 10.1086/517614; Kreijtz JHCM, 2014, LANCET INFECT DIS, V14, P1196, DOI [10.1016/s1473-3099(14)70963-6, 10.1016/S1473-3099(14)70963-6]; Kreijtz JHCM, 2010, J GEN VIROL, V91, P2745, DOI 10.1099/vir.0.024885-0; Liu LZ, 2010, NAT MED, V16, P224, DOI 10.1038/nm.2078; Longley RJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep11820; MAYR A, 1978, ZBL BAKT MIK HYG B, V167, P375; Mehendale S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055831; Melamed S, 2013, VACCINE, V31, P4569, DOI 10.1016/j.vaccine.2013.07.057; Meseda CA, 2005, VIROLOGY, V339, P164, DOI 10.1016/j.virol.2005.06.002; Meseda CA, 2002, J INFECT DIS, V186, P1065, DOI 10.1086/344234; Meseda CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067984; Meyer J, 2013, VACCINE, V31, P1026, DOI 10.1016/j.vaccine.2012.12.042; Monath TP, 2004, INT J INFECT DIS, V8, pS31, DOI 10.1016/j.ijid.2004.09.002; Ndiaye BP, 2015, LANCET RESP MED, V3, P190, DOI 10.1016/S2213-2600(15)00037-5; Njuguna IN, 2014, VACCINE, V32, P5801, DOI 10.1016/j.vaccine.2014.08.034; Overton ET, 2015, OPEN FORUM INFECT DI, V2, DOI 10.1093/ofid/ofv040; Pearson FE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067888; Peters BS, 2007, VACCINE, V25, P2120, DOI 10.1016/j.vaccine.2006.11.016; Poon LLM, 2009, J IMMUNOL, V182, P3063, DOI 10.4049/jimmunol.0803467; Porter DW, 2011, VACCINE, V29, P7514, DOI 10.1016/j.vaccine.2011.03.083; Prausnitz MR, 2009, CURR TOP MICROBIOL, V333, P369, DOI 10.1007/978-3-540-92165-3_18; Quan FS, 2010, J CONTROL RELEASE, V147, P326, DOI 10.1016/j.jconrel.2010.07.125; Rice AD, 2014, J VIROL, V88, P7753, DOI 10.1128/JVI.00185-14; Rimmelzwaan GF, 2009, EXPERT REV VACCINES, V8, P447, DOI 10.1586/ERV.09.4; Rivers TM, 1935, J EXP MED, V62, P549, DOI 10.1084/jem.62.4.549; Rosales R, 2014, WORLD J CLIN ONCOL, V5, P1002, DOI 10.5306/wjco.v5.i5.1002; Rowe T, 1999, J CLIN MICROBIOL, V37, P937, DOI 10.1128/JCM.37.4.937-943.1999; Satti I, 2014, LANCET INFECT DIS, V14, P939, DOI 10.1016/S1473-3099(14)70845-X; Schmeisser F, 2012, VACCINE, V30, P3413, DOI 10.1016/j.vaccine.2012.03.033; STICKL HA, 1974, PREV MED, V3, P97, DOI 10.1016/0091-7435(74)90066-8; Stittelaar KJ, 2005, J VIROL, V79, P7845, DOI 10.1128/JVI.79.12.7845-7851.2005; Swadling L, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009185; Tameris MD, 2013, LANCET, V381, P1021, DOI 10.1016/S0140-6736(13)60177-4; Tapia MD, 2016, LANCET INFECT DIS, V16, P31, DOI 10.1016/S1473-3099(15)00362-X; Taylor GS, 2014, CLIN CANCER RES, V20, P5009, DOI 10.1158/1078-0432.CCR-14-1122-T; Verheust C, 2012, VACCINE, V30, P2623, DOI 10.1016/j.vaccine.2012.02.016; Vien NC, 2008, T ROY SOC TROP MED H, V102, P294, DOI 10.1016/j.trstmh.2007.11.010; Vollmar J, 2006, VACCINE, V24, P2065, DOI 10.1016/j.vaccine.2005.11.022; Volz A, 2015, J VIROL, V89, P8651, DOI 10.1128/JVI.00614-15; Vrdoljak A, 2012, J CONTROL RELEASE, V159, P34, DOI 10.1016/j.jconrel.2011.12.026; Walsh SR, 2013, J INFECT DIS, V207, P1888, DOI 10.1093/infdis/jit105; Weniger BG, 2013, VACCINE, V31, P3389, DOI 10.1016/j.vaccine.2013.05.048; Wilck MB, 2010, J INFECT DIS, V201, P1361, DOI 10.1086/651561; Wyatt LS, 2004, P NATL ACAD SCI USA, V101, P4590, DOI 10.1073/pnas.0401165101; Zitzmann-Roth EM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122653	89	6	7	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0149364	10.1371/journal.pone.0149364	http://dx.doi.org/10.1371/journal.pone.0149364			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3DG	26895072	Green Submitted, Green Published, gold			2022-12-26	WOS:000371223400048
J	de Araujo, RF; Garcia, VB; Leitao, RFD; Brito, GAD; Miguel, ED; Guedes, PMM; de Araujo, AA				de Araujo Junior, Raimundo Fernandes; Garcia, Vinicius Barreto; de Carvalho Leitao, Renata Ferreira; de Castro Brito, Gerly Anne; Miguel, Emilio de Castro; Matta Guedes, Paulo Marcos; de Araujo, Aurigena Antunes			Carvedilol Improves Inflammatory Response, Oxidative Stress and Fibrosis in the Alcohol-Induced Liver Injury in Rats by Regulating Kuppfer Cells and Hepatic Stellate Cells	PLOS ONE			English	Article							LIPID-PEROXIDATION; CHRONIC ETHANOL; DISEASE; EXPRESSION; CYTOKINES; SOCS; MICE; CYCLOOXYGENASE-2; MECHANISMS; SUPPRESSOR	Aim To evaluate the anti-inflammatory, anti-oxidant and antifibrotic effects of carvedilol (CARV) in rats with ethanol-induced liver injury. Methods Liver injury was induced by gavage administration of alcohol (7 g/kg) for 28 consecutive days. Eighty Wistar rats were pretreated with oral CARV at 1, 3, or 5 mg/kg or with saline 1 h before exposure to alcohol. Liver homogenates were assayed for interleukin (IL)-1 beta, IL-10, and tumor necrosis factor (TNF)-alpha level as well as for myeloperoxidase (MPO) activity and malonyldialdehyde (MDA) and glutathione (GSH) levels. Serum aspartate aminotransferase (AST) activity and liver triglyceride (TG) levels were also assayed. Immunohistochemical analyses of cyclooxygenase 2 (COX-2), receptor activator of nuclear factor kappa-B/ligand (RANK/RANKL), suppressor of cytokine signalling (SOCS1), the Kupffer cell marker IBA-1 (ionized calcium-binding adaptor molecule 1), intercellular adhesion molecule 1 (ICAM-1), superoxide dismutase (SOD-1), and glutathione peroxidase (GPx-1) expression were performed. Confocal microscopy analysis of IL-1 beta and NF-kappa B expression and real-time quantitative PCR analysis for TNF alpha, PCI, PCIII, and NF-kappa B were performed. Results CARV treatment (5 mg/kg) during the alcohol exposure protocol was associated with reduced steatosis, hepatic cord degeneration, fibrosis and necrosis, as well as reduced levels of AST (p < 0.01), ALT (p < 0.01), TG (p < 0.001), MPO (p < 0.001), MDA (p < 0.05), and proinflammatory cytokines (IL-1 beta and TNF-alpha, both p < 0.05), and increased levels of the anti-inflammatory cytokine IL-10 (p < 0.001) and GSH (p < 0.05), compared to the alcohol-only group. Treatment with CARV 5 mg/ kg also reduced expression levels of COX-2, RANK, RANKL, IBA-1, and ICAM-1 (all p < 0.05), while increasing expression of SOCS1, SOD-1, and GPx-1 (all p < 0.05) and decreasing expression of IL-1 beta and NF-kappa B (both, p < 0.05). Real-time quantitative PCR analysis showed that mRNA production of TNF-alpha, procollagen type I (PCI), procollagen type III (PCIII), and NF-kappa B were decreased in the alcohol-CARV 5 mg/kg group relative to the alcohol-only group. Conclusions CARV can reduce the stress oxidative, inflammatory response and fibrosis in ethanol-induced liver injury in a rat model by downregulating signalling of Kuppfer cells and hepatic stellate cells (HSCs) through suppression of inflammatory cytokines.	[de Araujo Junior, Raimundo Fernandes; Garcia, Vinicius Barreto] Univ Fed Rio Grande do Norte, Postgrad Program Hlth Sci, Natal, RN, Brazil; [de Araujo Junior, Raimundo Fernandes] Univ Fed Rio Grande do Norte, Dept Morphol, Postgrad Program Funct & Struct Biol, Natal, RN, Brazil; [de Carvalho Leitao, Renata Ferreira; de Castro Brito, Gerly Anne] Univ Fed Ceara, Dept Morphol, Postgrad Program Morphol, Fortaleza, Ceara, Brazil; [Miguel, Emilio de Castro] Univ Fed Ceara, Analyt Ctr, Dept Phys, Fortaleza, Ceara, Brazil; [Matta Guedes, Paulo Marcos] Univ Fed Rio Grande do Norte, Dept Microbiol & Parasitol, Natal, RN, Brazil; [de Araujo, Aurigena Antunes] Univ Fed Rio Grande do Norte, Dept Biophys & Pharmacol, Postgrad Program Publ Hlth, Natal, RN, Brazil; [de Araujo, Aurigena Antunes] Univ Fed Rio Grande do Norte, Postgrad Program Pharmaceut Sci, Natal, RN, Brazil	Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte; Universidade Federal do Ceara; Universidade Federal do Ceara; Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte	de Araujo, RF (corresponding author), Univ Fed Rio Grande do Norte, Postgrad Program Hlth Sci, Natal, RN, Brazil.; de Araujo, RF (corresponding author), Univ Fed Rio Grande do Norte, Dept Morphol, Postgrad Program Funct & Struct Biol, Natal, RN, Brazil.	araujojr@cb.ufrn.br	Leitao, Renata/ABG-7682-2020; Brito, Gerly/AHB-3965-2022; Araújo Júnior, Raimundo Fernandes/D-2354-2014; Leitão, Renata FC/GQI-3555-2022; de Araujo, Aurigena/ABI-8455-2020; Leitao, Renata/ABF-9158-2020; de Castro Brito, Gerly Anne/C-8597-2013; Guedes, Paulo/Y-2546-2018; de Castro Miguel, Emílio/B-5855-2018	Brito, Gerly/0000-0002-8214-4379; Araújo Júnior, Raimundo Fernandes/0000-0003-2349-2354; Leitão, Renata FC/0000-0003-0202-771X; de Castro Brito, Gerly Anne/0000-0002-8214-4379; de Castro Miguel, Emílio/0000-0003-4130-672X; Matta Guedes, Paulo Marcos/0000-0002-4564-6791; Araujo, Aurigena/0000-0001-9264-4695	CNPq (Conselho Nacional de Pesquisa) [47.6996/2013]	CNPq (Conselho Nacional de Pesquisa)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by CNPq (Conselho Nacional de Pesquisa)/Universal n. 47.6996/2013. RFAJ wishes to thank the study core in microscopy and image processing (NEMPI, UFC).	Albanesi C, 2007, J IMMUNOL, V179, P984, DOI 10.4049/jimmunol.179.2.984; Albano E, 2008, MOL ASPECTS MED, V29, P9, DOI 10.1016/j.mam.2007.09.004; Arab HH, 2013, TOXICOL APPL PHARM, V268, P241, DOI 10.1016/j.taap.2013.01.019; Arozal W, 2010, TOXICOLOGY, V274, P18, DOI 10.1016/j.tox.2010.05.003; Bautista AP, 2002, FRONT BIOSCI-LANDMRK, V7, pA117; Costa C.M., 2006, J BRAS PATOL MED LAB, V5, P345, DOI DOI 10.1590/S1676-24442006000; de Araujo RF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114923; Dey A, 2006, HEPATOLOGY, V43, pS63, DOI 10.1002/hep.20957; DINCHUK JE, 1995, NATURE, V378, P406, DOI 10.1038/378406a0; ESTERBAUER H, 1990, METHOD ENZYMOL, V186, P407; Frazier Thomas H, 2011, Therap Adv Gastroenterol, V4, P63, DOI 10.1177/1756283X10378925; Fujimoto M, 2003, TRENDS IMMUNOL, V24, P659, DOI 10.1016/j.it.2003.10.008; Gao B, 2012, J GASTROEN HEPATOL, V27, P89, DOI 10.1111/j.1440-1746.2011.07003.x; Hakucho A, 2014, HEPATOL RES, V44, P560, DOI 10.1111/hepr.12143; Hall P D, 1994, Alcohol Alcohol Suppl, V2, P303; Hamdy N, 2012, TOXICOL APPL PHARM, V261, P292, DOI 10.1016/j.taap.2012.04.012; Iimuro Y, 2000, HEPATOLOGY, V31, P391, DOI 10.1002/hep.510310219; ISHAK K, 1995, J HEPATOL, V22, P696, DOI 10.1016/0168-8278(95)80226-6; KENDALL C, 1983, J IMMUNOL METHODS, V56, P329, DOI 10.1016/S0022-1759(83)80022-2; Kono H, 2001, AM J PHYSIOL-GASTR L, V280, pG1289, DOI 10.1152/ajpgi.2001.280.6.G1289; Krebs DL, 2000, J CELL SCI, V113, P2813; Krebs DL, 2001, STEM CELLS, V19, P378, DOI 10.1634/stemcells.19-5-378; Li YC, 2010, EUR J PHARMACOL, V640, P112, DOI 10.1016/j.ejphar.2010.04.037; Lieber Charles S, 2005, Clin Liver Dis, V9, P1, DOI 10.1016/j.cld.2004.10.005; Liu JY, 2012, ALCOHOL CLIN EXP RES, V36, P1587, DOI 10.1111/j.1530-0277.2012.01773.x; Maine GN, 2007, EMBO J, V26, P436, DOI 10.1038/sj.emboj.7601489; Mandal P, 2010, WORLD J GASTROENTERO, V16, P1330, DOI 10.3748/wjg.v16.i11.1330; Mathurin P, 2003, HEPATOLOGY, V38, P1363, DOI 10.1016/j.hep.2003.09.038; McClain CJ, 1999, SEMIN LIVER DIS, V19, P205, DOI 10.1055/s-2007-1007110; Mendez-Sanchez Nahum, 2005, Ann Hepatol, V4, P32; Nanji AA, 1997, GASTROENTEROLOGY, V112, P943, DOI 10.1053/gast.1997.v112.pm9041257; Nanji AA MC, 1989, ALCOHOL CLIN EXP RES, V13, P5; NIEMELA O, 1994, LAB INVEST, V70, P537; Nieto N, 2000, J BIOL CHEM, V275, P20136, DOI 10.1074/jbc.M001422200; Petrasek J, 2010, GASTROENTEROL RES PR, V2010; Rajesh MG LM, 2004, NDIAN J PHARM, V36; Ronsein GE, 2005, REDOX REP, V10, P131, DOI 10.1179/135100005X38879; Rouach H, 1997, HEPATOLOGY, V25, P351; SAFIEHGARABEDIAN B, 1995, BRIT J PHARMACOL, V115, P1265, DOI 10.1111/j.1476-5381.1995.tb15035.x; Sakurai T, 2008, CANCER CELL, V14, P156, DOI 10.1016/j.ccr.2008.06.016; SCHEUER PJ, 1982, BRIT MED BULL, V38, P63, DOI 10.1093/oxfordjournals.bmb.a071735; Souza MHLP, 2003, BRAZ J MED BIOL RES, V36, P1383, DOI 10.1590/S0100-879X2003001000015; Tilg H, 2000, NEW ENGL J MED, V343, P1467, DOI 10.1056/NEJM200011163432007; Torisu T, 2008, HEPATOLOGY, V47, P1644, DOI 10.1002/hep.22214; Wu J, 2000, J GASTROENTEROL, V35, P665, DOI 10.1007/s005350070045; Zhao Feng, 2007, Zhongguo Wei Zhong Bing Ji Jiu Yi Xue, V19, P606; Zhao XJ, 2008, J IMMUNOL, V181, P3049, DOI 10.4049/jimmunol.181.5.3049	47	48	48	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2016	11	2							e0148868	10.1371/journal.pone.0148868	http://dx.doi.org/10.1371/journal.pone.0148868			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3CO	26891124	Green Published, Green Submitted, gold			2022-12-26	WOS:000371221500015
J	Gao, Y; He, XL; Wu, B; Long, QL; Shao, TW; Wang, Z; Wei, JH; Li, Y; Ding, WL				Gao, Yuan; He, Xiaoli; Wu, Bin; Long, Qiliang; Shao, Tianwei; Wang, Zi; Wei, Jianhe; Li, Yong; Ding, Wanlong			Time-Course Transcriptome Analysis Reveals Resistance Genes of Panax ginseng Induced by Cylindrocarpon destructans Infection Using RNA-Seq	PLOS ONE			English	Article							ROOT-ROT; SECONDARY METABOLISM; BIOSYNTHETIC GENES; EXPRESSION; JASMONATE; MICRORNAS; PATHOGEN; DEFENSE; PCR	Panax ginseng C. A. Meyer is a highly valued medicinal plant. Cylindrocarpon destructans is a destructive pathogen that causes root rot and significantly reduces the quality and yield of P. ginseng. However, an efficient method to control root rot remains unavailable because of insufficient understanding of the molecular mechanism underlying C. destructans-P. ginseng interaction. In this study, C. destructans-induced transcriptomes at different time points were investigated using RNA sequencing (RNA-Seq). De novo assembly produced 73,335 unigenes for the P. ginseng transcriptome after C. destructans infection, in which 3,839 unigenes were up-regulated. Notably, the abundance of the up-regulated unigenes sharply increased at 0.5 d postinoculation to provide effector-triggered immunity. In total, 24 of 26 randomly selected unigenes can be validated using quantitative reverse transcription (qRT)-PCR. Gene ontology enrichment analysis of these unigenes showed that "defense response to fungus", "defense response" and "response to stress" were enriched. In addition, differentially expressed transcription factors involved in the hormone signaling pathways after C. destructans infection were identified. Finally, differentially expressed unigenes involved in reactive oxygen species and ginsenoside biosynthetic pathway during C. destructans infection were indentified. To our knowledge, this study is the first to report on the dynamic transcriptome triggered by C. destructans. These results improve our understanding of disease resistance in P. ginseng and provide a useful resource for quick detection of induced markers in P. ginseng before the comprehensive outbreak of this disease caused by C. destructans.	[Li, Yong; Ding, Wanlong] Chinese Acad Med Sci, Inst Med Plant Dev, Beijing 100730, Peoples R China; [Li, Yong; Ding, Wanlong] Peking Union Med Coll, Beijing 100021, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Plant Development - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Li, Y; Ding, WL (corresponding author), Chinese Acad Med Sci, Inst Med Plant Dev, Beijing 100730, Peoples R China.; Li, Y; Ding, WL (corresponding author), Peking Union Med Coll, Beijing 100021, Peoples R China.	liyong@implad.ac.cn; wlding@implad.ac.cn			National Science Foundation of China [81072992, 81373911]; Fundamental Research Funds for the Central Scientific Research Institutes for Public Welfare [yz-12-17]; PUMC Youth Fund [3332013113]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Scientific Research Institutes for Public Welfare; PUMC Youth Fund	This work was supported by the National Science Foundation of China (81072992 and 81373911), the Fundamental Research Funds for the Central Scientific Research Institutes for Public Welfare (yz-12-17), and the PUMC Youth Fund (3332013113). The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Aparicio-Fabre R, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-26; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Bassanezi RB, 2002, J PHYTOPATHOL, V150, P37, DOI 10.1046/j.1439-0434.2002.00714.x; Devoto A, 2005, PLANT MOL BIOL, V58, P497, DOI 10.1007/s11103-005-7306-5; Ernst J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-191; Fang XL, 2011, AUSTRALAS PLANT PATH, V40, P109, DOI 10.1007/s13313-010-0019-5; Fang XL, 2011, SCI HORTIC-AMSTERDAM, V131, P39, DOI 10.1016/j.scienta.2011.09.025; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Jang Chang Soon, 2010, Mycobiology, V38, P33, DOI 10.4489/MYCO.2010.38.1.033; KONING AJ, 1992, PLANT PHYSIOL, V100, P801, DOI 10.1104/pp.100.2.801; Kurth F, 2014, MOL PLANT MICROBE IN, V27, P891, DOI 10.1094/MPMI-10-13-0296-R; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li CF, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-245; Liu JJ, 2006, PHYSIOL MOL PLANT P, V68, P3, DOI 10.1016/j.pmpp.2006.06.004; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo HM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-S5-S5; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Mathiyalagan R, 2013, J GINSENG RES, V37, P227, DOI 10.5142/jgr.2013.37.227; Mouekouba LDO, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102690; O'Hara M, 1998, ARCH FAM MED, V7, P523, DOI 10.1001/archfami.7.6.523; Pauwels L, 2008, PLANT SIGNAL BEHAV, V3, P846, DOI 10.4161/psb.3.10.5993; Rahman M, 2005, PHYTOPATHOLOGY, V95, P1381, DOI 10.1094/PHYTO-95-1381; Rahman M, 2006, PHYTOPATHOLOGY, V96, P1179, DOI 10.1094/PHYTO-96-1179; REGO C, 2001, PHYTOPATHOL MEDITERR, V40, P343, DOI DOI 10.14601/PHYTOPATHOL_MEDITERR-1641; Rego C, 2006, PHYTOPATHOL MEDITERR, V45, pS93; Sathiyaraj G, 2010, MOL BIOL REP, V37, P3445, DOI 10.1007/s11033-009-9936-1; Shapiro LR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077393; Song JY, 2014, MYCOBIOLOGY, V42, P174, DOI 10.5941/MYCO.2014.42.2.174; Sun C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-262; Taffouo VD, 2014, MYCORRHIZA, V24, P361, DOI 10.1007/s00572-013-0544-5; Vanholme B, 2007, TRENDS PLANT SCI, V12, P239, DOI 10.1016/j.tplants.2007.04.004; Vogler BK, 1999, EUR J CLIN PHARMACOL, V55, P567, DOI 10.1007/s002280050674; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612	34	16	18	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2016	11	2							e0149408	10.1371/journal.pone.0149408	http://dx.doi.org/10.1371/journal.pone.0149408			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3CO	26890788	Green Published, gold, Green Submitted			2022-12-26	WOS:000371221500042
J	Lewis, MC; MacArthur, B; Tare, RS; Oreffo, ROC; Please, CP				Lewis, Miranda C.; MacArthur, Ben D.; Tare, Rahul S.; Oreffo, Richard O. C.; Please, Colin P.			Extracellular Matrix Deposition in Engineered Micromass Cartilage Pellet Cultures: Measurements and Modelling	PLOS ONE			English	Article							LOW-OXYGEN TENSION; PROTEOGLYCAN SYNTHESIS; DYNAMIC COMPOSITION; CHONDROCYTES; CELLS; GROWTH	This article explores possible mechanisms governing extracellular matrix deposition in engineered cartilaginous cell pellets. A theoretical investigation is carried out alongside an experimental study measuring proteoglycan and collagen volume fractions within murine chondrogenic (ATDC-5) cell pellets. The simple mathematical model, which adopts a nutrient-dependent proteoglycan production rate, successfully reproduces the periphery-dominated proteoglycan deposition, characteristic of the growth pattern observed experimentally within pellets after 21 days of culture. The results suggest that this inhomogeneous proteoglycan production is due to nutrient deficiencies at the pellet centre. Our model analysis further indicates that a spatially uniform distribution of proteoglycan matrix could be maintained by initiating the culture process with a smaller-sized pellet. Finally, possible extensions are put forward with an aim to improve the model predictions for the early behaviour, where different mechanisms appear to dominate the matrix production within the pellets.	[Lewis, Miranda C.; MacArthur, Ben D.] Univ Southampton, Math Sci, Southampton SO17 1BJ, Hants, England; [MacArthur, Ben D.; Tare, Rahul S.; Oreffo, Richard O. C.] Univ Southampton, Fac Med, Ctr Human Dev Stem Cells & Regenerat, Southampton SO16 6YD, Hants, England; [Please, Colin P.] Univ Oxford, Math Inst, Oxford OX2 6GG, England	University of Southampton; University of Southampton; University of Oxford	Please, CP (corresponding author), Univ Oxford, Math Inst, Oxford OX2 6GG, England.	colin.please@maths.ox.ac.uk	; Oreffo, Richard/A-4615-2011	Please, Colin/0000-0001-8917-8574; Oreffo, Richard/0000-0001-5995-6726; Tare, Rahul/0000-0001-8274-8837; MacArthur, Ben/0000-0002-5396-9750	Biotechnology and Biological Sciences Research Council (UK) [BBSRC BB/D0016681/1]; BBSRC [BB/D001668/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D001668/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (UK)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by the Biotechnology and Biological Sciences Research Council (UK), grant number BBSRC BB/D0016681/1.	BUSCHMANN MD, 1992, J ORTHOPAED RES, V10, P745, DOI 10.1002/jor.1100100602; CLARK CC, 1991, J ORTHOPAED RES, V9, P477, DOI 10.1002/jor.1100090403; HANDLEY CJ, 1977, BIOCHIM BIOPHYS ACTA, V500, P132; Korff T, 1998, J CELL BIOL, V143, P1341, DOI 10.1083/jcb.143.5.1341; Malda J, 2004, OSTEOARTHR CARTILAGE, V12, P306, DOI 10.1016/j.joca.2003.12.001; Malda J, 2004, BIOTECHNOL BIOENG, V86, P9, DOI 10.1002/bit.20038; Mauck RL, 2003, OSTEOARTHR CARTILAGE, V11, P879, DOI 10.1016/j.joca.2003.08.006; Obradovic B, 2000, AICHE J, V46, P1860, DOI 10.1002/aic.690460914; Pisu M, 2004, CHEM ENG SCI, V59, P5035, DOI 10.1016/j.ces.2004.07.101; Pisu M, 2006, TISSUE ENG, V12, P2311, DOI 10.1089/ten.2006.12.2311; Razaq S, 2003, EUR SPINE J, V12, P341, DOI 10.1007/s00586-003-0582-3; Riesle J, 1998, J CELL BIOCHEM, V71, P313, DOI 10.1002/(SICI)1097-4644(19981201)71:3<313::AID-JCB1>3.0.CO;2-C; Saha A. K., 2005, Australasian Physical & Engineering Sciences in Medicine, V28, P97, DOI 10.1007/BF03178699; Saha AK, 2003, IEEE T NANOBIOSCI, V2, P89, DOI 10.1109/TNB.2003.813921; Saha AK, 2003, IEEE T NANOBIOSCI, V2, P158, DOI 10.1109/TNB.2003.816226; Saini S, 2004, TISSUE ENG, V10, P825, DOI 10.1089/1076327041348545; Sekiya I, 2002, P NATL ACAD SCI USA, V99, P4397, DOI 10.1073/pnas.052716199; Sengers BG, 2005, J BIOMECH ENG-T ASME, V127, P758, DOI 10.1115/1.1993664; Tare RS, 2005, BIOCHEM BIOPH RES CO, V333, P609, DOI 10.1016/j.bbrc.2005.05.117; van der Kraan PM, 2002, OSTEOARTHR CARTILAGE, V10, P631, DOI 10.1053/joca.2002.0806; Vunjak-Novakovic G, 1998, BIOTECHNOL PROGR, V14, P193, DOI 10.1021/bp970120j; Wilson CG, 2002, ARCH BIOCHEM BIOPHYS, V408, P246, DOI 10.1016/S0003-9861(02)00562-3; Yoo JU, 1998, J BONE JOINT SURG AM, V80A, P1745, DOI 10.2106/00004623-199812000-00004	23	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2016	11	2							e0147302	10.1371/journal.pone.0147302	http://dx.doi.org/10.1371/journal.pone.0147302			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3CO	26889833	Green Published, Green Accepted, gold			2022-12-26	WOS:000371221500005
J	Hayat, T; Shafique, M; Tanveer, A; Alsaedi, A				Hayat, Tasawar; Shafique, Maryam; Tanveer, Anum; Alsaedi, Ahmed			Radiative Peristaltic Flow of Jeffrey Nanofluid with Slip Conditions and Joule Heating	PLOS ONE			English	Article							MASS-TRANSFER; TRANSPORT; DUFOUR; FLUID; SORET; MHD	Mixed convection peristaltic flow of Jeffrey nanofluid in a channel with compliant walls is addressed here. The present investigation includes the viscous dissipation, thermal radiation and Joule heating. Whole analysis is performed for velocity, thermal and concentration slip conditions. Related problems through long wavelength and low Reynolds number are examined for stream function, temperature and concentration. Impacts of thermal radiation, Hartman number, Brownian motion parameter, thermophoresis, Joule heating and slip parameters are explored in detail. Clearly temperature is a decreasing function of Hartman number and radiation parameter.	[Hayat, Tasawar; Shafique, Maryam; Tanveer, Anum] Quaid I Azam Univ, Dept Math, Islamabad 44000, Pakistan; [Hayat, Tasawar; Alsaedi, Ahmed] King Abdulaziz Univ, Dept Math, NAAM Res Grp, Fac Sci, Jeddah 21589, Saudi Arabia	Quaid I Azam University; King Abdulaziz University	Tanveer, A (corresponding author), Quaid I Azam Univ, Dept Math, Islamabad 44000, Pakistan.	anum@math.qau.edu.pk	Alsaedi, Ahmed/A-2094-2013; Hayat, Tasawar/Y-2524-2019	Alsaedi, Ahmed/0000-0003-3452-8922; 				Abbasi FM, 2015, INT J MOD PHYS B, V29, DOI 10.1142/S0217979215501519; Abbasi FM, 2015, B POL ACAD SCI-TECH, V63, P501, DOI 10.1515/bpasts-2015-0058; Abbasi FM, 2015, PHYSICA E, V67, P47, DOI 10.1016/j.physe.2014.11.002; Ali N., 2015, COMPUT METHOD BIOMEC, V59, P1; Ebaid A, 2013, COMPUT MATH METHOD M, V2013, DOI 10.1155/2013/825376; Ellahi R, 2015, J MAGN MAGN MATER, V393, P284, DOI 10.1016/j.jmmm.2015.05.071; Ellahi R, 2014, INT J HEAT MASS TRAN, V71, P706, DOI 10.1016/j.ijheatmasstransfer.2013.12.038; Gad NS, 2014, APPL MATH COMPUT, V235, P546, DOI 10.1016/j.amc.2014.02.081; Hayat T, 2015, J MAGN MAGN MATER, V395, P48, DOI 10.1016/j.jmmm.2015.07.027; Hayat T, 2014, J MOL LIQ, V194, P93, DOI 10.1016/j.molliq.2014.01.021; Hayat T, 2014, COMPUT FLUIDS, V89, P242, DOI 10.1016/j.compfluid.2013.10.038; HAYAT T, 2014, EUR PHYS J PLUS, V129, DOI DOI 10.1140/EPJP/; Hayat T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113851; Hayat T, 2014, Z NATURFORSCH A, V69, P43, DOI 10.5560/ZNA.2013-0074; Hina S, 2014, INT J BIOMATH, V7, DOI 10.1142/S1793524514500156; Latham TW., 1996, FLUID MOTION PERISTA; Mekheimer KS, 2013, APPL BIONICS BIOMECH, V10, P19, DOI [10.3233/ABB-2012-0071, 10.1155/2013/902097]; Mustafa M, 2014, J TAIWAN INST CHEM E, V45, P308, DOI 10.1016/j.jtice.2013.07.010; Nadeem S, 2010, J TAIWAN INST CHEM E, V41, P286, DOI 10.1016/j.jtice.2009.11.004; SHAPIRO AH, 1969, J FLUID MECH, V37, P799, DOI 10.1017/S0022112069000899; Sheikholeslami M, 2014, J MAGN MAGN MATER, V369, P69, DOI 10.1016/j.jmmm.2014.06.017; Srinivas S, 2011, MATH COMPUT MODEL, V54, P1213, DOI 10.1016/j.mcm.2011.03.032; Srinivas S, 2011, COMMUN NONLINEAR SCI, V16, P1845, DOI 10.1016/j.cnsns.2010.08.004; Tripathi D, 2014, INT J HEAT MASS TRAN, V70, P61, DOI 10.1016/j.ijheatmasstransfer.2013.10.044; Vajravelu K, 2013, APPL MATH COMPUT, V225, P656, DOI 10.1016/j.amc.2013.10.014	25	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0148002	10.1371/journal.pone.0148002	http://dx.doi.org/10.1371/journal.pone.0148002			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26886919	gold, Green Published			2022-12-26	WOS:000371218400014
J	Liu, YH; Huang, XW; Yi, XW; He, Y; Mylonakis, E; Xi, LY				Liu, Yinghui; Huang, Xiaowen; Yi, Xiuwen; He, Ya; Mylonakis, Eleftherios; Xi, Liyan			Detection of Talaromyces marneffei from Fresh Tissue of an Inhalational Murine Pulmonary Model Using Nested PCR	PLOS ONE			English	Article							PENICILLIUM-MARNEFFEI; IDENTIFICATION; AMPLIFICATION; ASPERGILLUS; INFECTION; SAMPLES	Penicilliosis marneffei, often consecutive to the aspiration of Talaromyces marneffei (Penicillium marneffei), continues to be one of the significant causes of morbidity and mortality in immunocompromised patients in endemic regions such as Southeast Asia. Improving the accuracy of diagnosing this disease would aid in reducing the mortality of associated infections. In this study, we developed a stable and reproducible murine pulmonary model that mimics human penicilliosis marneffei using a nebulizer to deliver Talaromyces marneffei (SUMS0152) conidia to the lungs of BALB/c nude mice housed in exposure chamber. Using this model, we further revealed that nested PCR was sensitive and specific for detecting Talaromyces marneffei in bronchoalveolar lavage fluid and fresh tissues. This inhalation model may provide a more representative analysis tool for studying the development of penicilliosis marneffei, in addition to revealing that nested PCR has a predictive value in reflecting pulmonary infection.	[Liu, Yinghui; Yi, Xiuwen; He, Ya; Xi, Liyan] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Dermatol, Guangzhou 510275, Guangdong, Peoples R China; [Huang, Xiaowen] PLA, Guangzhou Mil Command, Gen Hosp, Dept Dermatol, Guangzhou, Guangdong, Peoples R China; [Mylonakis, Eleftherios] Brown Univ, Rhode Isl Hosp, Waren Alpert Med Sch, Div Infect Dis, Providence, RI 02903 USA	Sun Yat Sen University; Southern Theater Command General Hospital; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital	Xi, LY (corresponding author), Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Dermatol, Guangzhou 510275, Guangdong, Peoples R China.	xiliyan@mail.sysu.edu.cn		Xi, Liyan/0000-0003-1504-0147	establishment of early diagnosis of modern technology platform of AIDS, tuberculosis and other chronic diseases with invasive fungal infections-the stablishment of early diagnosis of technology platform of Penicilliosis marneffei (sub-programed) [2013ZX10004612]	establishment of early diagnosis of modern technology platform of AIDS, tuberculosis and other chronic diseases with invasive fungal infections-the stablishment of early diagnosis of technology platform of Penicilliosis marneffei (sub-programed)	The study was supported by the funding of the establishment of early diagnosis of modern technology platform of AIDS, tuberculosis and other chronic diseases with invasive fungal infections-the stablishment of early diagnosis of technology platform of Penicilliosis marneffei (sub-programed) (2013ZX10004612). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buskirk AD, 2014, J IMMUNOTOXICOL, V11, P180, DOI 10.3109/1547691X.2013.819054; Chen RQ, 2014, MICROBES INFECT, V16, P401, DOI 10.1016/j.micinf.2014.02.005; DISALVO AF, 1973, AM J CLIN PATHOL, V60, P259; Houbraken J, 2014, ADV APPL MICROBIOL, V86, P199, DOI 10.1016/B978-0-12-800262-9.00004-4; Hu YX, 2013, MYCOPATHOLOGIA, V175, P57, DOI 10.1007/s11046-012-9577-0; Huang XW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108764; Kudeken N, 1997, CLIN EXP IMMUNOL, V107, P468, DOI 10.1046/j.1365-2249.1997.d01-945.x; Kudeken N, 1996, J MED VET MYCOL, V34, P371; Lu S, 2013, MYCOPATHOLOGIA, V176, P11, DOI 10.1007/s11046-013-9650-3; Luo DQ, 2011, MYCOPATHOLOGIA, V171, P191, DOI 10.1007/s11046-010-9363-9; Pongpom M, 2009, MED MYCOL, V47, P549, DOI 10.1080/13693780802484875; Sheppard DC, 2004, ANTIMICROB AGENTS CH, V48, P1908, DOI 10.1128/AAC.48.5.1908-1911.2004; Stevens WW, 2007, J IMMUNOL METHODS, V327, P63, DOI 10.1016/j.jim.2007.07.011; Sun JF, 2014, MED MYCOL, V52, P167, DOI 10.1093/mmy/myt006; Sun JF, 2011, MYCOSES, V54, pE751, DOI 10.1111/j.1439-0507.2011.02017.x; Sun JF, 2010, FEMS IMMUNOL MED MIC, V58, P381, DOI [10.1111/j.1574-695X.2010.00647.x, 10.1111/j.1574-695X.2009.00647.x]; Zeng HX, 2009, MYCOPATHOLOGIA, V168, P31, DOI 10.1007/s11046-009-9195-7; Zhang JM, 2011, J MICROBIOL METH, V85, P33, DOI 10.1016/j.mimet.2011.01.022	18	7	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0149634	10.1371/journal.pone.0149634	http://dx.doi.org/10.1371/journal.pone.0149634			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26886887	Green Published, gold, Green Submitted			2022-12-26	WOS:000371218400101
J	Sole-Padulles, C; Castro-Fornieles, J; de la Serna, E; Romero, S; Calvo, A; Sanchez-Gistau, V; Padros-Fornieles, M; Baeza, I; Bargallo, N; Frangou, S; Sugranyes, G				Sole-Padulles, Cristina; Castro-Fornieles, Josefina; de la Serna, Elena; Romero, Soledad; Calvo, Anna; Sanchez-Gistau, Vanessa; Padros-Fornieles, Marta; Baeza, Inmaculada; Bargallo, Nria; Frangou, Sophia; Sugranyes, Gisela			Altered Cortico-Striatal Connectivity in Offspring of Schizophrenia Patients Relative to Offspring of Bipolar Patients and Controls	PLOS ONE			English	Article							DEFAULT-MODE NETWORK; FUNCTIONAL CONNECTIVITY; WORKING-MEMORY; BRAIN-FUNCTION; FAMILIAL RISK; YOUNG-PEOPLE; OULU BRAIN; DISORDER; PSYCHOSIS; METAANALYSIS	Schizophrenia (SZ) and bipolar disorder (BD) share clinical features, genetic risk factors and neuroimaging abnormalities. There is evidence of disrupted connectivity in resting state networks in patients with SZ and BD and their unaffected relatives. Resting state networks are known to undergo reorganization during youth coinciding with the period of increased incidence for both disorders. We therefore focused on characterizing resting state network connectivity in youth at familial risk for SZ or BD to identify alterations arising during this period. We measured resting -state functional connectivity in a sample of 106 youth, aged 7-19 years, comprising offspring of patients with SZ (N = 27), offspring of patients with BD (N = 39) and offspring of community control parents (N = 40). We used Independent Component Analysis to assess functional connectivity within the default mode, executive control, salience and basal ganglia networks and define their relationship to grey matter volume, clinical and cognitive measures. There was no difference in connectivity within any of the networks examined between offspring of patients with BD and offspring of community controls. In contrast, offspring of patients with SZ showed reduced connectivity within the left basal ganglia network compared to control offspring, and they showed a positive correlation between connectivity in this network and grey matter volume in the left caudate. Our findings suggest that dysconnectivity in the basal ganglia network is a robust correlate of familial risk for SZ and can be detected during childhood and adolescence.	[Sole-Padulles, Cristina; Castro-Fornieles, Josefina; Romero, Soledad; Calvo, Anna; Sanchez-Gistau, Vanessa; Baeza, Inmaculada; Sugranyes, Gisela] August Pi & Sunyer Biomed Res Inst IDIBAPS, Barcelona, Spain; [Castro-Fornieles, Josefina; Romero, Soledad; Sanchez-Gistau, Vanessa; Padros-Fornieles, Marta; Baeza, Inmaculada; Sugranyes, Gisela] Hosp Clin Barcelona, Dept Child & Adolescent Psychiat & Psychol, Inst Neurosci, SGR489, Barcelona, Spain; [Castro-Fornieles, Josefina] Univ Barcelona, Dept Psychiat & Clin Psychobiol, Barcelona, Spain; [Castro-Fornieles, Josefina; de la Serna, Elena; Romero, Soledad; Sanchez-Gistau, Vanessa; Baeza, Inmaculada; Bargallo, Nria] Biomed Res Networking Ctr Consortium CIBERSAM, Barcelona, Spain; [Calvo, Anna; Bargallo, Nria] Hosp Clin Barcelona, Magnet Resonance Imaging Core Facil, Barcelona, Spain; [Calvo, Anna] GIB UB, Bioengn Biomat & Nanomed CIBER BBN, Barcelona, Spain; [Bargallo, Nria] Hosp Clin Barcelona, CDI, Barcelona, Spain; [Frangou, Sophia] Icahn Sch Med Mt Sinai, Dept Psychiat, New York, NY 10029 USA	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; University of Barcelona; Hospital Clinic de Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN; University of Barcelona; Hospital Clinic de Barcelona; Icahn School of Medicine at Mount Sinai	Sugranyes, G (corresponding author), August Pi & Sunyer Biomed Res Inst IDIBAPS, Barcelona, Spain.; Sugranyes, G (corresponding author), Hosp Clin Barcelona, Dept Child & Adolescent Psychiat & Psychol, Inst Neurosci, SGR489, Barcelona, Spain.	gernest@clinic.cat	Baeza, Inmaculada/GQI-3365-2022; Solé-Padullés, Cristina/K-6984-2017; De la Serna, Elena/AAJ-7940-2021; Bargallo, Nuria/G-6854-2016	Solé-Padullés, Cristina/0000-0002-6653-1053; De la Serna, Elena/0000-0002-7869-9881; Sugranyes, Gisela/0000-0002-2545-7862; Frangou, Sophia/0000-0002-3210-6470; Bargallo, Nuria/0000-0001-6284-5402; Romero, Soledad/0000-0001-9934-5196; sanchez-gistau, vanessa/0000-0002-8635-7144	Fundacion Alicia Koplowitz Research Project; IDIBAPS start-up grant, Spanish Ministry of Economy and Competitiveness / Instituto de Salud Carlos III [FIS PI 07/0066, PI 11/00683]; European Regional Development Fund; La Marato de TV3 Foundation [091630]; Catalonia Government [2009SGR1119]	Fundacion Alicia Koplowitz Research Project; IDIBAPS start-up grant, Spanish Ministry of Economy and Competitiveness / Instituto de Salud Carlos III; European Regional Development Fund(European Commission); La Marato de TV3 Foundation; Catalonia Government	Funding for this study was provided by the Fundacion Alicia Koplowitz Research Project grant, IDIBAPS start-up grant, Spanish Ministry of Economy and Competitiveness / Instituto de Salud Carlos III (FIS PI 07/0066, PI 11/00683) / European Regional Development Fund, La Marato de TV3 Foundation (091630), Catalonia Government (2009SGR1119).	American Psychiatric Association (APA), 1994, DIAGNOSTIC AND STATI; Argyelan M, 2014, SCHIZOPHRENIA BULL, V40, P100, DOI [10.1093/schbul/sbu150, 10.1093/schbul/sbt092]; Baker JT, 2014, JAMA PSYCHIAT, V71, P109, DOI 10.1001/jamapsychiatry.2013.3469; Biswal BB, 1997, NMR BIOMED, V10, P165, DOI 10.1002/(SICI)1099-1492(199706/08)10:4/5<165::AID-NBM454>3.0.CO;2-7; Bora E, 2015, SCHIZOPHRENIA BULL, V41, P1095, DOI 10.1093/schbul/sbu198; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Burgund ED, 2002, NEUROIMAGE, V17, P184, DOI 10.1006/nimg.2002.1174; Busner Joan, 2007, Psychiatry (Edgmont), V4, P28; Chai XQJ, 2011, NEUROPSYCHOPHARMACOL, V36, P2009, DOI 10.1038/npp.2011.88; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Delvecchio G, 2013, PSYCHOL MED, V43, P553, DOI 10.1017/S0033291712001432; Diwadkar VA, 2011, NEUROIMAGE, V58, P234, DOI 10.1016/j.neuroimage.2011.06.033; Diwadkar VA, 2011, PROG NEURO-PSYCHOPH, V35, P1349, DOI 10.1016/j.pnpbp.2011.04.009; Ellison-Wright I, 2010, SCHIZOPHR RES, V117, P1, DOI 10.1016/j.schres.2009.12.022; Erhardt EB, 2011, HUM BRAIN MAPP, V32, P2075, DOI 10.1002/hbm.21170; Farr OM, 2014, INT J NEUROPSYCHOPH, V17, P1177, DOI 10.1017/S1461145714000674; First MB, 2002, STRUCTURED CLIN INTE; Fornito A, 2013, JAMA PSYCHIAT, V70, P1143, DOI 10.1001/jamapsychiatry.2013.1976; Fornito Alex, 2012, Front Psychiatry, V3, P72, DOI 10.3389/fpsyt.2012.00072; Frangou S, 2014, SCHIZOPHRENIA BULL, V40, P523, DOI 10.1093/schbul/sbu017; Fusar-Poli P, 2011, Mol Psychiatry, V16, P67, DOI 10.1038/mp.2009.108; Geller B, 2001, J AM ACAD CHILD PSY, V40, P450, DOI 10.1097/00004583-200104000-00014; Hamilton M., 1967, BRIT J SOC CLIN PSYC, V6, P278, DOI [10.1111/j.2044-8260.1967.tb00530.x, DOI 10.1111/J.2044-8260.1967.TB00530.X]; Heinze K, 2015, BIOL PSYCHIAT, V77, P989, DOI 10.1016/j.biopsych.2014.10.023; Hollingshead August B., 1958, SOCIAL CLASS MENTAL; Huttunen J, 2008, BIOL PSYCHIAT, V63, P114, DOI 10.1016/j.biopsych.2007.04.017; Insel TR, 2010, NATURE, V468, P187, DOI 10.1038/nature09552; Jang JH, 2011, SCHIZOPHR RES, V127, P58, DOI 10.1016/j.schres.2010.12.022; Jones P B, 2013, Br J Psychiatry Suppl, V54, ps5, DOI 10.1192/bjp.bp.112.119164; Jukuri T, 2015, SCHIZOPHR RES, V161, P177, DOI 10.1016/j.schres.2014.11.003; Jukuri T, 2013, SCHIZOPHR RES, V143, P239, DOI 10.1016/j.schres.2012.11.020; Keshavan MS, 2011, SCHIZOPHR RES, V133, P250, DOI 10.1016/j.schres.2011.09.005; Khadka S, 2013, BIOL PSYCHIAT, V74, P458, DOI 10.1016/j.biopsych.2013.04.024; Laird AR, 2011, J COGNITIVE NEUROSCI, V23, P4022, DOI 10.1162/jocn_a_00077; Lichtenstein P, 2009, LANCET, V373, P234, DOI 10.1016/S0140-6736(09)60072-6; Lois G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107829; Lui S, 2015, PSYCHOL MED, V45, P97, DOI 10.1017/S003329171400110X; Magioncalda P, 2015, HUM BRAIN MAPP, V36, P666, DOI 10.1002/hbm.22655; Maziade M, 2011, SCHIZOPHRENIA BULL, V37, P1218, DOI 10.1093/schbul/sbq026; Meda SA, 2012, BIOL PSYCHIAT, V71, P881, DOI 10.1016/j.biopsych.2012.01.025; Menon V, 2011, TRENDS COGN SCI, V15, P483, DOI 10.1016/j.tics.2011.08.003; Miller TJ, 2003, SCHIZOPHRENIA BULL, V29, P703, DOI 10.1093/oxfordjournals.schbul.a007040; Nakao T, 2011, AM J PSYCHIAT, V168, P1154, DOI 10.1176/appi.ajp.2011.11020281; Ordaz SJ, 2013, J NEUROSCI, V33, P18109, DOI 10.1523/JNEUROSCI.1741-13.2013; Orliac F, 2013, SCHIZOPHR RES, V148, P74, DOI 10.1016/j.schres.2013.05.007; Porter JN, 2015, DEV COGN NEUROS-NETH, V11, P83, DOI 10.1016/j.dcn.2014.08.011; Power JD, 2010, NEURON, V67, P735, DOI 10.1016/j.neuron.2010.08.017; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Rasic D, 2014, SCHIZOPHRENIA BULL, V40, P28, DOI 10.1093/schbul/sbt114; Sanchez-Gistau V, 2015, SCHIZOPHR RES, V168, P197, DOI 10.1016/j.schres.2015.08.034; Sato JR, 2014, J PSYCHIATR RES, V58, P89, DOI 10.1016/j.jpsychires.2014.07.004; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Shirer WR, 2012, CEREB CORTEX, V22, P158, DOI 10.1093/cercor/bhr099; Singh MK, 2014, BIPOLAR DISORD, V16, P678, DOI 10.1111/bdi.12221; Strakowski SM, 2012, BIPOLAR DISORD, V14, P313, DOI 10.1111/j.1399-5618.2012.01022.x; Supekar K, 2010, NEUROIMAGE, V52, P290, DOI 10.1016/j.neuroimage.2010.04.009; Taki Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022734; Tandon N, 2013, SCHIZOPHR RES, V148, P59, DOI 10.1016/j.schres.2013.05.024; Tang JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071061; Tu PC, 2013, SCHIZOPHR RES, V147, P339, DOI 10.1016/j.schres.2013.04.011; van Buuren M, 2012, SCHIZOPHR RES, V142, P237, DOI 10.1016/j.schres.2012.09.017; Wechsler D, 1999, WECHLSER ADULT INTEL; Wechsler D, 1994, WECHSLER INTELLIGENC; Wu MJ, 2013, J PSYCHIATR NEUROSCI, V38, P232, DOI 10.1503/jpn.120073; YOUNG RC, 1978, BRIT J PSYCHIAT, V133, P429, DOI 10.1192/bjp.133.5.429	65	19	20	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0148045	10.1371/journal.pone.0148045	http://dx.doi.org/10.1371/journal.pone.0148045			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26885824	Green Submitted, gold, Green Published			2022-12-26	WOS:000371218400016
J	Tiwari, V; Patel, MK; Chaturvedi, AK; Mishra, A; Jha, B				Tiwari, Vivekanand; Patel, Manish Kumar; Chaturvedi, Amit Kumar; Mishra, Avinash; Jha, Bhavanath			Functional Characterization of the Tau Class Glutathione-S-Transferases Gene (SbGSTU) Promoter of Salicornia brachiata under Salinity and Osmotic Stress	PLOS ONE			English	Article							EXTREME HALOPHYTE; SALT STRESS; HETEROLOGOUS EXPRESSION; ECTOPIC EXPRESSION; TRANSGENIC TOBACCO; CONFERS SALT; TOLERANCE; ARABIDOPSIS; DROUGHT; OVEREXPRESSION	Reactive oxygen or nitrogen species are generated in the plant cell during the extreme stress condition, which produces toxic compounds after reacting with the organic molecules. The glutathione-S-transferase (GST) enzymes play a significant role to detoxify these toxins and help in excretion or sequestration of them. In the present study, we have cloned 1023 bp long promoter region of tau class GST from an extreme halophyte Salicornia brachiata and functionally characterized using the transgenic approach in tobacco. Computational analysis revealed the presence of abiotic stress responsive cis-elements like ABRE, MYB, MYC, GATA, GT1 etc., phytohormones, pathogen and wound responsive motifs. Three 5'-deletion constructs of 730 (GP2), 509 (GP3) and 348 bp (GP4) were made from 1023 (GP1) promoter fragment and used for tobacco transformation. The single event transgenic plants showed notable GUS reporter protein expression in the leaf tissues of control as well as treated plants. The expression level of the GUS gradually decreases from GP1 to GP4 in leaf tissues, whereas the highest level of expression was detected with the GP2 construct in root and stem under control condition. The GUS expression was found higher in leaves and stems of salinity or osmotic stress treated transgenic plants than that of the control plants, but, lower in roots. An efficient expression level of GUS in transgenic plants suggests that this promoter can be used for both constitutive as well as stress inducible expression of gene(s). And this property, make it as a potential candidate to be used as an alternative promoter for crop genetic engineering.	[Tiwari, Vivekanand; Patel, Manish Kumar; Chaturvedi, Amit Kumar; Mishra, Avinash; Jha, Bhavanath] Cent Salt & Marine Chem Res Inst, CSIR, Div Marine Biotechnol & Ecol, GB Marg, Bhavnagar 364002, Gujarat, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Salt & Marine Chemical Research Institute (CSMCRI)	Mishra, A; Jha, B (corresponding author), Cent Salt & Marine Chem Res Inst, CSIR, Div Marine Biotechnol & Ecol, GB Marg, Bhavnagar 364002, Gujarat, India.	avinash@csmcri.org; bjha@csmcri.org	TIWARI, VIVEKANAND/AAD-9738-2020; Mishra, Avinash/AAG-2961-2019; Chaturvedi, Amit k/J-5187-2012; Mishra, Avinash/C-3210-2009; Patel, Manish Kumar/I-6335-2017	TIWARI, VIVEKANAND/0000-0002-0464-6031; Mishra, Avinash/0000-0003-0342-010X; Mishra, Avinash/0000-0003-0342-010X; Patel, Manish Kumar/0000-0001-5250-1008; Chaturvedi, Amit Kumar/0000-0003-0867-6542	Council of Scientific and Industrial Research (CSIR), Government of India, New Delhi [BSC0107-PlaGen]	Council of Scientific and Industrial Research (CSIR), Government of India, New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	This study was supported by the Council of Scientific and Industrial Research (CSIR; www.csir.res.in), Government of India, New Delhi [BSC0107-PlaGen]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard P, 2008, PLANT CELL, V20, P2117, DOI 10.1105/tpc.108.058941; Benekos K, 2010, J BIOTECHNOL, V150, P195, DOI 10.1016/j.jbiotec.2010.07.011; Bianchi MW, 2002, PHYSIOL PLANTARUM, V116, P96, DOI 10.1034/j.1399-3054.2002.1160112.x; Chaturvedi AK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111379; Chaturvedi AK, 2012, GENE, V499, P280, DOI 10.1016/j.gene.2012.03.001; Dixon David P, 2010, Arabidopsis Book, V8, pe0131, DOI 10.1199/tab.0131; Flowers TJ, 2008, NEW PHYTOL, V179, P945, DOI 10.1111/j.1469-8137.2008.02531.x; Foyer CH, 2009, ANTIOXID REDOX SIGN, V11, P861, DOI 10.1089/ars.2008.2177; Frova C, 2006, BIOMOL ENG, V23, P149, DOI 10.1016/j.bioeng.2006.05.020; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; Higo K, 1998, NUCLEIC ACIDS RES, V26, P358, DOI 10.1093/nar/26.1.358; HORSCH RB, 1985, SCIENCE, V227, P1229, DOI 10.1126/science.227.4691.1229; Huda KMK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057803; JEFFERSON RA, 1987, EMBO J, V6, P3901; Jha B., 2016, GENETICALLY MODIFIED, P305, DOI [10.1016/B978-0-12-802259-7.00027-0, DOI 10.1016/B978-0-12-802259-7.00027-0]; Jha B, 2012, J AGR FOOD CHEM, V60, P4320, DOI 10.1021/jf203632v; Jha B, 2011, MOL BIOL REP, V38, P4823, DOI 10.1007/s11033-010-0625-x; Jha B, 2009, GENES GENET SYST, V84, P111, DOI 10.1266/ggs.84.111; Jiang HW, 2010, PLANT PHYSIOL, V154, P1646, DOI 10.1104/pp.110.159152; JOSHI MC, 2013, PLOS GENET, V9, DOI DOI 10.1371/JOURNAL.PONE.0071136; Joshi M, 2012, IND CROP PROD, V35, P313, DOI 10.1016/j.indcrop.2011.06.024; Kanneganti V, 2008, PLANT MOL BIOL, V66, P445, DOI 10.1007/s11103-007-9284-2; Kitamura S, 2004, PLANT J, V37, P104, DOI 10.1046/j.1365-313X.2003.01943.x; Lescot M, 2002, NUCLEIC ACIDS RES, V30, P325, DOI 10.1093/nar/30.1.325; Lo Cicero L, 2015, PHYTOCHEMISTRY, V116, P69, DOI 10.1016/j.phytochem.2015.03.004; Loyall L, 2000, PLANT CELL, V12, P1939, DOI 10.1105/tpc.12.10.1939; Marrs KA, 1996, ANNU REV PLANT PHYS, V47, P127, DOI 10.1146/annurev.arplant.47.1.127; Miller G, 2010, PLANT CELL ENVIRON, V33, P453, DOI 10.1111/j.1365-3040.2009.02041.x; Mishra A, 2015, J FUNCT FOODS, V13, P21, DOI 10.1016/j.jff.2014.12.027; Mishra A, 2013, CARBOHYD POLYM, V92, P1942, DOI 10.1016/j.carbpol.2012.11.055; Moons A, 2005, VITAM HORM, V72, P155, DOI 10.1016/S0083-6729(05)72005-7; Moons A, 2003, FEBS LETT, V553, P427, DOI 10.1016/S0014-5793(03)01077-9; Pandey S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144469; Pandey S, 2013, APPL BIOCHEM BIOTECH, V171, P1, DOI 10.1007/s12010-013-0349-1; Patel MK, 2015, PLANT CELL TISS ORG, V122, P477, DOI 10.1007/s11240-015-0785-4; Peng L, 2014, ACTA PHYSIOL PLANT, V36, P2905, DOI 10.1007/s11738-014-1660-3; Potters G, 2010, PLANT PHYSIOL BIOCH, V48, P292, DOI 10.1016/j.plaphy.2009.12.007; Sharma R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092900; Singh N, 2014, GENE, V547, P119, DOI 10.1016/j.gene.2014.06.037; Singh N, 2014, MAR BIOTECHNOL, V16, P321, DOI 10.1007/s10126-013-9548-6; Taji T, 2004, PLANT PHYSIOL, V135, P1697, DOI 10.1104/pp.104.039909; Taji T, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-261; TIWARI V, 2015, PLOS ONE, V10, DOI DOI 10.1371/JOURNAL.PONE.0131567; Tiwari V, 2014, PLANT CELL PHYSIOL, V55, P201, DOI 10.1093/pcp/pct172; Udawat P, 2014, GENE, V536, P163, DOI 10.1016/j.gene.2013.11.020; Umezawa T, 2006, CURR OPIN BIOTECH, V17, P113, DOI 10.1016/j.copbio.2006.02.002; Yoshida T, 2014, CURR OPIN PLANT BIOL, V21, P133, DOI 10.1016/j.pbi.2014.07.009; Youm JW, 2008, PLANTA, V228, P701, DOI 10.1007/s00425-008-0782-5	48	51	56	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0148494	10.1371/journal.pone.0148494	http://dx.doi.org/10.1371/journal.pone.0148494			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26885663	Green Published, gold, Green Submitted			2022-12-26	WOS:000371218400037
J	Eldar-Yedidia, Y; Bar-Meir, M; Hillel, M; Abitbol, G; Broide, E; Falk, R; Assous, M; Schlesinger, Y				Eldar-Yedidia, Yifat; Bar-Meir, Maskit; Hillel, Miriam; Abitbol, Guila; Broide, Eti; Falk, Roni; Assous, Marc; Schlesinger, Yechiel			Low Interferon Relative-Response to Cytomegalovirus Is Associated with Low Likelihood of Intrauterine Transmission of the Virus	PLOS ONE			English	Article							PRIMARY INFECTION; EXHAUSTION; FETUS; WOMEN; RISK	Background Congenital Cytomegalovirus (CMV) is a very common intrauterine infection which can cause severe mental and hearing impairments. Notably, only 40% of primarily infected women transmit CMV to the fetus. CMV-specific T-cell response has a role in CMV disease but individual immune heterogeneity precludes reliable correlation between measurable T-cells response and intrauterine transmission. Study Aim To establish a correlation between maternal T-cells response and fetal CMV transmission using an individual normalized immune response. Methods We analyzed IFN-gamma secretion upon whole blood stimulation from primary CMV-infected pregnant women, with either CMV-peptides or PHA-mitogen. Results We established a new normalization method of individual IFN-gamma response to CMV by defining the ratio between specific-CMV response and non-specific mitogen response (defined as IFN-gamma relative response, RR), aiming to overcome high person-to-person immune variability. We found a unique subpopulation of women with low IFN-gamma RR strongly correlated with absence of transmission. IFN-gamma RR lower than 1.8% (threshold determined by ROC analysis) reduces the pre-test probability of transmission from 40% to 8%, revealing an unexpected link between low IFN-gamma RR and non-transmission. Conclusion In pregnant women with primary CMV infection, low IFN-gamma RR is associated with low risk of transmission.	[Eldar-Yedidia, Yifat; Hillel, Miriam; Abitbol, Guila; Schlesinger, Yechiel] Hebrew Univ Jerusalem, Sch Med, Shaare Zedek Med Ctr, Res Lab Infect Dis, IL-91010 Jerusalem, Israel; [Bar-Meir, Maskit; Schlesinger, Yechiel] Shaare Zedek Med Ctr, Dept Pediat, Jerusalem, Israel; [Broide, Eti; Falk, Roni; Assous, Marc] Shaare Zedek Med Ctr, Microbiol Immunol Labs, Jerusalem, Israel	Hebrew University of Jerusalem; Shaare Zedek Medical Center; Hebrew University of Jerusalem; Shaare Zedek Medical Center; Hebrew University of Jerusalem; Shaare Zedek Medical Center	Schlesinger, Y (corresponding author), Hebrew Univ Jerusalem, Sch Med, Shaare Zedek Med Ctr, Res Lab Infect Dis, IL-91010 Jerusalem, Israel.; Schlesinger, Y (corresponding author), Shaare Zedek Med Ctr, Dept Pediat, Jerusalem, Israel.	yechiel@szmc.org.il	ASSOUS, Marc Victor/CAH-0946-2022					Antoine P, 2012, J IMMUNOL, V189, P2665, DOI 10.4049/jimmunol.1101165; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Blank C, 2007, CANCER IMMUNOL IMMUN, V56, P739, DOI 10.1007/s00262-006-0272-1; Boppana SB, 2001, NEW ENGL J MED, V344, P1366, DOI 10.1056/NEJM200105033441804; Cannon MJ, 2009, J CLIN VIROL, V46, pS6, DOI 10.1016/j.jcv.2009.09.002; Cannon MJ, 2005, CLIN INFECT DIS, V40, P1701, DOI 10.1086/430172; Cheeran MCJ, 2009, CLIN MICROBIOL REV, V22, P99, DOI 10.1128/CMR.00023-08; de Vries JJC, 2011, REV MED VIROL, V21, P54, DOI 10.1002/rmv.679; Dollard SC, 2007, REV MED VIROL, V17, P355, DOI 10.1002/rmv.544; Enders G, 2011, J CLIN VIROL, V52, P244, DOI 10.1016/j.jcv.2011.07.005; FERNANDO S, 1993, J MED VIROL, V41, P108, DOI 10.1002/jmv.1890410205; FOWLER KB, 1992, NEW ENGL J MED, V326, P663, DOI 10.1056/NEJM199203053261003; Kenneson A, 2007, REV MED VIROL, V17, P253, DOI 10.1002/rmv.535; Lilleri D, 2008, J INFECT DIS, V198, P536, DOI 10.1086/590118; Lilleri D, 2007, J INFECT DIS, V195, P1062, DOI 10.1086/512245; Marshall EE, 2009, J INTERF CYTOK RES, V29, P609, DOI 10.1089/jir.2009.0064; Oliver SE, 2009, J CLIN VIROL, V46, pS22, DOI 10.1016/j.jcv.2009.08.012; Pereira L, 2013, CLIN INFECT DIS, V57, pS174, DOI 10.1093/cid/cit583; Revello MG, 1998, J INFECT DIS, V177, P1170, DOI 10.1086/515277; Revello MG, 2006, J INFECT DIS, V193, P269, DOI 10.1086/498872; Revello MG, 2002, CLIN MICROBIOL REV, V15, P680, DOI 10.1128/CMR.15.4.680-715.2002; RINALDO CR, 1977, J INFECT DIS, V136, P667, DOI 10.1093/infdis/136.5.667; Schleiss MR, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/501801; STAGNO S, 1986, JAMA-J AM MED ASSOC, V256, P1904, DOI 10.1001/jama.256.14.1904; STERN H, 1986, BRIT MED J, V292, P718, DOI 10.1136/bmj.292.6522.718; Wang CB, 2011, CLIN INFECT DIS, V52, pE11, DOI 10.1093/cid/ciq085; Yamamoto AY, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.11.018	27	10	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0147883	10.1371/journal.pone.0147883	http://dx.doi.org/10.1371/journal.pone.0147883			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	26881863	gold, Green Published, Green Submitted			2022-12-26	WOS:000371219000008
J	Paduano, F; Marrelli, M; White, LJ; Shakesheff, KM; Tatullo, M				Paduano, Francesco; Marrelli, Massimo; White, Lisa J.; Shakesheff, Kevin M.; Tatullo, Marco			Odontogenic Differentiation of Human Dental Pulp Stem Cells on Hydrogel Scaffolds Derived from Decellularized Bone Extracellular Matrix and Collagen Type I	PLOS ONE			English	Article							FIBROBLAST GROWTH FACTOR-2; EXFOLIATED DECIDUOUS TEETH; FACTOR-RELEASING HYDROGELS; SKELETAL TISSUE-REPAIR; FEMUR DEFECT MODEL; IMPERFECTA TYPE-II; 3-DIMENSIONAL SCAFFOLD; GENOMIC ORGANIZATION; VIVO; PHOSPHOPROTEIN	Objectives The aim of this study was to evaluate the level of odontogenic differentiation of dental pulp stem cells (DPSCs) on hydrogel scaffolds derived from bone extracellular matrix (bECM) in comparison to those seeded on collagen I (Col-I), one of the main components of dental pulp ECM. Methods DPSCs isolated from human third molars were characterized for surface marker expression and odontogenic potential prior to seeding into bECM or Col-I hydrogel scaffolds. The cells were then seeded onto bECM and Col-I hydrogel scaffolds and cultured under basal conditions or with odontogenic and growth factor (GF) supplements. DPSCs cultivated on tissue culture polystyrene (TCPS) with and without supplements were used as controls. Gene expression of dentin sialophosphoprotein (DSPP), dentin matrix protein 1 (DMP-1) and matrix extracellular phosphoglycoprotein (MEPE) was evaluated by quantitative reverse transcription-polymerase chain reaction (qRT-PCR) and mineral deposition was observed by Von Kossa staining. Results When DPSCs were cultured on bECM hydrogels, the mRNA expression levels of DSPP, DMP-1 and MEPE genes were significantly upregulated with respect to those cultured on Col-I scaffolds or TCPS in the absence of extra odontogenic inducers. In addition, more mineral deposition was observed on bECM hydrogel scaffolds as demonstrated by Von Kossa staining. Moreover, DSPP, DMP-1 and MEPE mRNA expressions of DPSCs cultured on bECM hydrogels were further upregulated by the addition of GFs or osteo/odontogenic medium compared to Col-I treated cells in the same culture conditions. Significance These results demonstrate the potential of the bECM hydrogel scaffolds to stimulate odontogenic differentiation of DPSCs.	[Paduano, Francesco; Tatullo, Marco] Tecnol Res Inst, Biomed Sect, Crotone, Italy; [Marrelli, Massimo] Calabrodental, Unit Maxillofacial Surg, Crotone, Italy; [White, Lisa J.; Shakesheff, Kevin M.] Univ Nottingham, Sch Pharm, Nottingham NG7 2RD, England	University of Nottingham	Tatullo, M (corresponding author), Tecnol Res Inst, Biomed Sect, Crotone, Italy.	marco.tatullo@tecnologicasrl.com	Tatullo, Marco/AAI-4864-2020; White, Lisa/AAM-9012-2021; Tatullo, Marco/GRQ-7439-2022; Paduano, Francesco/A-2548-2015; Shakesheff, Kevin M/O-6371-2018; Shakesheff, Kevin/AAR-6603-2021	Tatullo, Marco/0000-0001-7340-0708; Paduano, Francesco/0000-0003-0916-8101; Shakesheff, Kevin M/0000-0003-3236-2439; White, Lisa/0000-0003-0571-999X	Engineering and Physical Sciences Research Council [EP/N006615/1] Funding Source: researchfish; EPSRC [EP/N006615/1] Funding Source: UKRI	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		Albuquerque MTP, 2014, J DENT RES, V93, P1222, DOI 10.1177/0022034514549809; Almushayt A, 2006, GENE THER, V13, P611, DOI 10.1038/sj.gt.3302687; APLIN HM, 1995, GENOMICS, V30, P347, DOI 10.1006/geno.1995.9867; Bonnamain V, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00357; Cordeiro MM, 2008, J ENDODONT, V34, P962, DOI 10.1016/j.joen.2008.04.009; Feng JQ, 1998, J BIOL CHEM, V273, P9457, DOI 10.1074/jbc.273.16.9457; Galler KM, 2012, TISSUE ENG PT A, V18, P176, DOI [10.1089/ten.tea.2011.0222, 10.1089/ten.TEA.2011.0222]; Galler KM, 2011, REGEN MED, V6, P191, DOI 10.2217/RME.11.3; Gothard D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145080; Gronthos S, 2006, CALCIFIED TISSUE INT, V79, P310, DOI 10.1007/s00223-006-0040-4; Gronthos S, 2002, J DENT RES, V81, P531, DOI 10.1177/154405910208100806; Gronthos S, 2000, P NATL ACAD SCI USA, V97, P13625, DOI 10.1073/pnas.240309797; Gupte MJ, 2012, J DENT RES, V91, P227, DOI 10.1177/0022034511417441; He HX, 2008, CELL BIOL INT, V32, P827, DOI 10.1016/j.cellbi.2008.03.013; Hirst KL, 1997, GENOMICS, V42, P38, DOI 10.1006/geno.1997.4700; Huang GTJ, 2010, TISSUE ENG PT A, V16, P605, DOI [10.1089/ten.tea.2009.0518, 10.1089/ten.TEA.2009.0518]; Ishimatsu H, 2009, J ENDODONT, V35, P858, DOI 10.1016/j.joen.2009.03.049; Kim YS, 2010, J ENDODONT, V36, P1824, DOI 10.1016/j.joen.2010.08.020; Liu H, 2004, J DENT RES, V83, P496, DOI 10.1177/154405910408300612; Lu YB, 2007, DEV BIOL, V303, P191, DOI 10.1016/j.ydbio.2006.11.001; Marrelli M, 2015, J DENT RES, V94, P843, DOI 10.1177/0022034515570316; Marrelli M, 2013, INT J BIOL SCI, V9, P1070, DOI 10.7150/ijbs.6662; Miura M, 2003, P NATL ACAD SCI USA, V100, P5807, DOI 10.1073/pnas.0937635100; Nagy MM, 2014, J ENDODONT, V40, P192, DOI 10.1016/j.joen.2013.10.027; Prescott RS, 2008, J ENDODONT, V34, P421, DOI 10.1016/j.joen.2008.02.005; Qu TJ, 2014, TISSUE ENG PT A, V20, P2422, DOI [10.1089/ten.tea.2013.0741, 10.1089/ten.TEA.2013.0741]; Qu TJ, 2013, J MATER CHEM B, V1, P4764, DOI 10.1039/c3tb21002b; Ravindran S, 2014, TISSUE ENG PT A, V20, P92, DOI [10.1089/ten.tea.2013.0192, 10.1089/ten.TEA.2013.0192]; Rosa V, 2013, J DENT RES, V92, P970, DOI 10.1177/0022034513505772; Salmon B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056749; Sawkins MJ, 2013, ACTA BIOMATER, V9, P7865, DOI 10.1016/j.actbio.2013.04.029; Smith EL, 2014, ACTA BIOMATER, V10, P4186, DOI 10.1016/j.actbio.2014.06.011; Smith EL, 2014, ACTA BIOMATER, V10, P4197, DOI 10.1016/j.actbio.2014.05.025; Sonoyama W, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000079; Suzuki S, 2009, MATRIX BIOL, V28, P221, DOI 10.1016/j.matbio.2009.03.006; Tatullo M, 2015, J BIOL REG HOMEOS AG, V29, P713; Tatullo M, 2016, INT J IMMUNOPATH PH, V29, P3, DOI 10.1177/0394632015617951; Tatullo M, 2015, INT J MED SCI, V12, P72, DOI 10.7150/ijms.10706; Tatullo M, 2015, J TISSUE ENG REGEN M, V9, P1205, DOI 10.1002/term.1899; Thesleff I, 1999, BONE, V25, P123, DOI 10.1016/S8756-3282(99)00119-2; Wang J, 2011, BIOMATERIALS, V32, P7822, DOI 10.1016/j.biomaterials.2011.04.034; Wei X, 2007, J ENDODONT, V33, P703, DOI 10.1016/j.joen.2007.02.009; Yan M, 2011, STEM CELL REV REP, V7, P161, DOI 10.1007/s12015-010-9155-0; Yang XC, 2020, J BIOMED MATER RES A, V108, P2519, DOI 10.1002/jbm.a.34064; Yang XC, 2010, J BIOMED MATER RES A, V93A, P247, DOI 10.1002/jbm.a.32535; Yu JH, 2006, TISSUE ENG, V12, P3097, DOI 10.1089/ten.2006.12.3097; Zhang HM, 2012, TISSUE ENG PT A, V18, P677, DOI [10.1089/ten.tea.2011.0269, 10.1089/ten.TEA.2011.0269]; Zhang W, 2005, TISSUE ENG, V11, P357, DOI 10.1089/ten.2005.11.357; Zhang WB, 2006, BIOMATERIALS, V27, P5658, DOI 10.1016/j.biomaterials.2006.07.013	49	101	105	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0148225	10.1371/journal.pone.0148225	http://dx.doi.org/10.1371/journal.pone.0148225			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	26882351	Green Submitted, Green Published, gold			2022-12-26	WOS:000371219000013
J	Rizzo, G; Veronese, M; Expert, P; Turkheimer, FE; Bertoldo, A				Rizzo, Gaia; Veronese, Mattia; Expert, Paul; Turkheimer, Federico E.; Bertoldo, Alessandra			MENGA: A New Comprehensive Tool for the Integration of Neuroimaging Data and the Allen Human Brain Transcriptome Atlas	PLOS ONE			English	Article							WATER-CONTENT; MYELIN; QUANTIFICATION; PET	Introduction Brain-wide mRNA mappings offer a great potential for neuroscience research as they can provide information about system proteomics. In a previous work we have correlated mRNA maps with the binding patterns of radioligands targeting specific molecular systems and imaged with positron emission tomography (PET) in unrelated control groups. This approach is potentially applicable to any imaging modality as long as an efficient procedure of imaging-genomic matching is provided. In the original work we considered mRNA brain maps of the whole human genome derived from the Allen human brain database (ABA) and we performed the analysis with a specific region-based segmentation with a resolution that was limited by the PET data parcellation. There we identified the need for a platform for imaging-genomic integration that should be usable with any imaging modalities and fully exploit the high resolution mapping of ABA dataset. Aim In this work we present MENGA (Multimodal Environment for Neuroimaging and Genomic Analysis), a software platform that allows the investigation of the correlation patterns between neuroimaging data of any sort (both functional and structural) with mRNA gene expression profiles derived from the ABA database at high resolution. Results We applied MENGA to six different imaging datasets from three modalities (PET, single photon emission tomography and magnetic resonance imaging) targeting the dopamine and serotonin receptor systems and the myelin molecular structure. We further investigated imaging-genomic correlations in the case of mismatch between selected proteins and imaging targets.	[Rizzo, Gaia; Bertoldo, Alessandra] Univ Padua, Dept Informat Engn, Padua, Italy; [Veronese, Mattia; Expert, Paul; Turkheimer, Federico E.] Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Neuroimaging, London WC2R 2LS, England	University of Padua; University of London; King's College London	Rizzo, G (corresponding author), Univ Padua, Dept Informat Engn, Padua, Italy.	gaia.rizzo@dei.unipd.it	Expert, Paul/AAX-6356-2020; Veronese, Mattia/A-6012-2013; Veronese, Mattia/S-3114-2019; Turkheimer, Federico E/B-9485-2012	Expert, Paul/0000-0002-5016-4623; Veronese, Mattia/0000-0003-3562-0683; Turkheimer, Federico E/0000-0002-3766-3815	Programme Grant "Quantitative methodologies for Positron Emission Tomography" (UK Medical Research Council) [G1100809/1]; Padova University grant "Neuroimaging Genetics: Models and Methods to Integrate Brain Phenotype and Genotype"; NITRC; NITRC-IR; NITRC-CE; National Institute of Biomedical Imaging and Bioengineering; National Institutes of Health; Department of Health and Human Services [GS-00F-0034P, HHSN268200100090U, 1 R43 NS074540-01]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R43NS074540] Funding Source: NIH RePORTER; Medical Research Council [G1100809] Funding Source: researchfish; MRC [G1100809] Funding Source: UKRI	Programme Grant "Quantitative methodologies for Positron Emission Tomography" (UK Medical Research Council); Padova University grant "Neuroimaging Genetics: Models and Methods to Integrate Brain Phenotype and Genotype"; NITRC; NITRC-IR; NITRC-CE; National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Health and Human Services; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by the Programme Grant "Quantitative methodologies for Positron Emission Tomography" (UK Medical Research Council No. G1100809/1) and by the Padova University grant "Neuroimaging Genetics: Models and Methods to Integrate Brain Phenotype and Genotype" (2013). NITRC, NITRC-IR, and NITRC-CE have been funded in whole or in part with Federal funds from the National Institute of Biomedical Imaging and Bioengineering, the National Institutes of Health, and the Department of Health and Human Services, under GSA Contract No. GS-00F-0034P, Order Number HHSN268200100090U and SBIR No. 1 R43 NS074540-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank the Allen Institute for the data sharing and for the support during the development of the software. NITRC, NITRC-IR, and NITRC-CE have been funded in whole or in part with Federal funds from the National Institute of Biomedical Imaging and Bioengineering, the National Institutes of Health, and the Department of Health and Human Services, under GSA Contract No. GS-00F-0034P, Order Number HHSN268200100090U and SBIR No. 1 R43 NS074540-01.	Altman D.G., 1991, PRACTICAL STATISTIC; Burns CM, 1997, NATURE, V387, P303, DOI 10.1038/387303a0; Cheng MHY, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00134; French L, 2015, FRONTIERS NEUROSCIEN; Garcia-Gomez FJ, 2013, REV ESP MED NUCL IMA, V32, P350, DOI 10.1016/j.remn.2013.02.009; Grabner G, 2006, LECT NOTES COMPUT SC, V4191, P58; Grecchi E, 2014, PHYS MED BIOL, V59, P2517, DOI 10.1088/0031-9155/59/10/2517; Guo YF, 2008, ACTA BIOCH BIOPH SIN, V40, P426, DOI 10.1111/j.1745-7270.2008.00418.x; Hawrylycz MJ, 2012, NATURE, V489, P391, DOI 10.1038/nature11405; Maier T, 2009, FEBS LETT, V583, P3966, DOI 10.1016/j.febslet.2009.10.036; Neeb H, 2008, NEUROIMAGE, V42, P1094, DOI 10.1016/j.neuroimage.2008.03.060; Neeb H, 2012, NEUROIMAGE-CLIN, V1, P121, DOI 10.1016/j.nicl.2012.09.013; Rizzo G, 2014, 20 ANN M ORG HUM BRA; Rizzo G, 2014, J CEREBR BLOOD F MET, V34, P827, DOI 10.1038/jcbfm.2014.21; Tonkova V, 2012, Z MED PHYS, V22, P133, DOI 10.1016/j.zemedi.2011.09.005; Vaughan RA, 2013, TRENDS PHARMACOL SCI, V34, P489, DOI 10.1016/j.tips.2013.07.005; Veronese M, 2015, J CEREBR BLOOD F MET, V35, P1771, DOI 10.1038/jcbfm.2015.120; Zanotti-Fregonara P, 2015, J NUCL MED, V56; Zanotti-Fregonara P, 2014, NUCL MED COMMUN, V35, P1254, DOI 10.1097/MNM.0000000000000196	19	34	34	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0148744	10.1371/journal.pone.0148744	http://dx.doi.org/10.1371/journal.pone.0148744			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	26882227	Green Published, gold			2022-12-26	WOS:000371219000022
J	An, HY; Lim, C; Guillemin, GJ; Vollmer-Conna, U; Rawlinson, W; Bryant, K; Tedla, N				An, Hongyan; Lim, Chai; Guillemin, Gilles J.; Vollmer-Conna, Ute; Rawlinson, William; Bryant, Katherine; Tedla, Nicodemus			Serum Leukocyte Immunoglobulin-Like Receptor A3 (LILRA3) Is Increased in Patients with Multiple Sclerosis and Is a Strong Independent Indicator of Disease Severity; 6.7kbp LILRA3 Gene Deletion Is Not Associated with Diseases Susceptibility	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; BALANCING SELECTION; 6.7-KBP DELETION; ILT6 GENE; VITAMIN-D; IMMUNE; INTERLEUKIN-10; PROTEIN; CELLS; IL-10	Leukocyte immunoglobulin-like receptor A3 (LILRA3) is a soluble immune regulatory molecule primarily expressed by monocytes and macrophages. A homozygous 6.7kbp LILRA3 gene deletion that removes the first seven of its eight exons is predicted to lead to lack of LILRA3 protein, although this has not been experimentally confirmed. Moreover, there are conflicting results with regards to the link between the LILRA3 homozygous genetic deletion and susceptibility to multiple sclerosis (MS) in different European populations. The aim of this study was to investigate whether LILRA3 gene deletion is associated with MS susceptibility in a North American cohort of European ancestry and assess if serum LILRA3 protein level is a marker of clinical subtype and/or disease severity in MS. A total of 456 patients with MS and 99 unrelated healthy controls were genotyped for the 6.7kbp LILRA3 gene deletion and levels of LILRA3 protein in sera determined by in-house sandwich ELISA. We showed that LILRA3 gene deletion was not associated with MS susceptibility and did not affect the age of disease onset, clinical subtype or disease severity. However, we discovered for the first time that homozygous LILRA3 gene deletion results in lack of production of LILRA3 protein. Importantly, LILRA3 protein level was significantly increased in sera of patients with MS when compared with control subjects, particularly in more severe type primary progressive MS. Multiple regression analysis showed that LILRA3 level in serum was one of the strongest independent markers of disease severity in MS, which potentially can be used as a diagnostic marker.	[An, Hongyan; Bryant, Katherine; Tedla, Nicodemus] Univ New S Wales, Sch Med Sci, Dept Pathol, Inflammat & Infect Res Ctr, Sydney, NSW 2052, Australia; [Lim, Chai; Guillemin, Gilles J.] Macquarie Univ, ASAM, MND & Neurodegenerat Dis Res Ctr, Sydney, NSW 2109, Australia; [Vollmer-Conna, Ute] Univ New S Wales, Sch Psychiat, Sydney, NSW 2050, Australia; [Rawlinson, William] Prince Wales Hosp, Dept Virol, South Eastern Sydney & Illawarra Hlth Serv, Sydney, NSW 2032, Australia; [Bryant, Katherine] Univ New S Wales, South Western Sydney Clin Sch, Sydney, NSW 2170, Australia	University of New South Wales Sydney; Macquarie University; University of New South Wales Sydney; University of New South Wales Sydney	Tedla, N (corresponding author), Univ New S Wales, Sch Med Sci, Dept Pathol, Inflammat & Infect Res Ctr, Sydney, NSW 2052, Australia.	n.tedla@unsw.edu.au	Guillemin, Gilles J/C-3878-2015; Bryant, Katherine/E-8574-2010; Lim, Edwin/R-5001-2019	Guillemin, Gilles J/0000-0001-8105-4470; Bryant, Katherine/0000-0002-8686-623X; Lim, Edwin/0000-0003-3526-8405	National Health and Medical Research Council [568771]; University of New South Wales Gold Star Award	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); University of New South Wales Gold Star Award	This research was supported by National Health and Medical Research Council, project grant # 568771 (https://www.nhmrc.gov.au/) and University of New South Wales Gold Star Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An HY, 2010, J RHEUMATOL, V37, P1596, DOI 10.3899/jrheum.091119; Anderson KJ, 2009, IMMUNOLOGY, V127, P8, DOI 10.1111/j.1365-2567.2009.03097.x; Ascherio A, 2014, JAMA NEUROL, V71, P306, DOI 10.1001/jamaneurol.2013.5993; Barcellos LF, 1997, JAMA-J AM MED ASSOC, V278, P1256, DOI 10.1001/jama.278.15.1256; Beecham AH, 2013, NAT GENET, V45, P1353, DOI 10.1038/ng.2770; Bonetti A, 2009, J NEUROIMMUNOL, V208, P119, DOI 10.1016/j.jneuroim.2009.01.003; Borges L, 2000, CYTOKINE GROWTH F R, V11, P209, DOI 10.1016/S1359-6101(00)00007-1; Brown D, 2004, TISSUE ANTIGENS, V64, P215, DOI 10.1111/j.0001-2815.2004.00290.x; Bush WS, 2010, AM J HUM GENET, V86, P621, DOI 10.1016/j.ajhg.2010.02.027; Byrnes AA, 2002, ANN NEUROL, V51, P165, DOI 10.1002/ana.10084; Compston A, 2006, MCALPINES MULTIPLE S, V4th; Du Y, 2014, ARTHRITIS RHEUMATOL, V66, P822, DOI 10.1002/art.38308; Gandhi R, 2010, J NEUROIMMUNOL, V221, P7, DOI 10.1016/j.jneuroim.2009.10.015; Gourraud PA, 2012, IMMUNOL REV, V248, P87, DOI 10.1111/j.1600-065X.2012.01134.x; Heine G, 2008, EUR J IMMUNOL, V38, P2210, DOI 10.1002/eji.200838216; Hirayasu K, 2006, HUM GENET, V119, P436, DOI 10.1007/s00439-006-0152-y; Hirayasu K, 2008, AM J HUM GENET, V82, P1075, DOI 10.1016/j.ajhg.2008.03.012; Hirayasu K, 2015, J HUM GENET, V60, P703, DOI 10.1038/jhg.2015.64; Jung M, 2004, EUR J IMMUNOL, V34, P481, DOI 10.1002/eji.200324323; Kane BA, 2014, J INNATE IMMUN, V6, P727, DOI 10.1159/000363449; KHOURY SJ, 1992, J EXP MED, V176, P1355, DOI 10.1084/jem.176.5.1355; Koch S, 2005, GENES IMMUN, V6, P445, DOI 10.1038/sj.gene.6364187; Kvarnstrom M, 2013, J NEUROL SCI, V325, P79, DOI 10.1016/j.jns.2012.12.001; Lee THY, 2013, J BIOL CHEM, V288, P32873, DOI 10.1074/jbc.M113.478578; Lublin FD, 1996, NEUROLOGY, V46, P907, DOI 10.1212/WNL.46.4.907; McCauley JL, 2010, HUM MOL GENET, V19, P953, DOI 10.1093/hmg/ddp542; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Norman PJ, 2004, IMMUNOGENETICS, V56, P225, DOI 10.1007/s00251-004-0674-1; Norman PJ, 2003, IMMUNOGENETICS, V55, P165, DOI 10.1007/s00251-003-0561-1; Nylander A, 2012, J CLIN INVEST, V122, P1180, DOI 10.1172/JCI58649; Ordonez D, 2009, GENES IMMUN, V10, P579, DOI 10.1038/gene.2009.34; Ortiz MA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134414; Patsopoulos NA, 2011, ANN NEUROL, V70, P897, DOI 10.1002/ana.22609; PORRINI AM, 1995, J NEUROIMMUNOL, V61, P27, DOI 10.1016/0165-5728(95)00070-I; Prat A, 2005, CURR OPIN NEUROL, V18, P225, DOI 10.1097/01.wco.0000169737.99040.31; Salmaggi A, 1996, J NEUROL, V243, P13; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Schleithoff SS, 2006, AM J CLIN NUTR, V83, P754, DOI 10.1093/ajcn/83.4.754; Talwar S, 2006, GENE EXPRESSION PROF, P203; Tilg H, 1994, INTERLEUKIN 6 IL 6 A, P113; Torkar M, 2000, EUR J IMMUNOL, V30, P3655, DOI 10.1002/1521-4141(200012)30:12<3655::AID-IMMU3655>3.0.CO;2-Y; Trapp BD, 2008, ANNU REV NEUROSCI, V31, P247, DOI 10.1146/annurev.neuro.30.051606.094313; van Boxel-Dezaire AHH, 1999, ANN NEUROL, V45, P695, DOI 10.1002/1531-8249(199906)45:6<695::AID-ANA3>3.0.CO;2-R; Waubant E, 2001, J NEUROIMMUNOL, V112, P139, DOI 10.1016/S0165-5728(00)00355-6; Wende H, 1999, MAMM GENOME, V10, P154, DOI 10.1007/s003359900961; Wisniewski A, 2013, HUM IMMUNOL, V74, P353, DOI 10.1016/j.humimm.2012.12.006	46	14	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149200	10.1371/journal.pone.0149200	http://dx.doi.org/10.1371/journal.pone.0149200			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26871720	Green Published, gold, Green Submitted			2022-12-26	WOS:000370054100125
J	Bhide, GP; Fernandes, NRJ; Colley, KJ				Bhide, Gaurang P.; Fernandes, Ninoshka R. J.; Colley, Karen J.			Sequence Requirements for Neuropilin-2 Recognition by ST8SiaIV and Polysialylation of Its O-Glycans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-ADHESION MOLECULE; HUMAN DENDRITIC CELLS; POLYSIALIC ACID; SWISS-MODEL; III REPEAT; STRUCTURAL BASIS; NERVOUS-SYSTEM; SYNCAM 1; IN-VIVO; POLYSIALYLTRANSFERASE	Polysialic acid is an oncofetal glycopolymer, added to the glycans of a small group of substrates, that controls cell adhesion and signaling. One of these substrates, neuropilin-2, is a VEGF and semaphorin co-receptor that is polysialylated on its O-glycans in mature dendritic cells and macrophages by the polysialyltransferase ST8SiaIV. To understand the biochemical basis of neuropilin-2 polysialylation, we created a series of domain swap chimeras with sequences from neuropilin-1, a protein for which polysialylation had not been previously reported. To our surprise, we found that membrane-associated neuropilin-1 is polysialylated at similar to 50% of the level of neuropilin-2 but not polysialylated when it lacks its cytoplasmic tail and transmembrane region and is secreted from the cell. This was not the case for neuropilin-2, which is polysialylated when either membrane-associated or soluble. Evaluation of the soluble chimeric proteins demonstrated that the meprin A5 antigen-mu tyrosine phosphatase (MAM) domain and the O-glycan-containing linker region of neuropilin-2 are necessary and sufficient for its polysialylation and serve as better recognition and acceptor sites in the polysialylation process than those regions of neuropilin-1. In addition, specific acidic residues on the surface of the MAM domain are critical for neuropilin-2 polysialylation. Based on these data and pull-down experiments, we propose a model where ST8SiaIV recognizes and docks on an acidic surface of the neuropilin-2 MAM domain to polysialylate O-glycans on the adjacent linker region. These results together with those related to neural cell adhesion molecule polysialylation establish a paradigm for the process of protein-specific polysialylation.	[Bhide, Gaurang P.; Fernandes, Ninoshka R. J.; Colley, Karen J.] Univ Illinois, Dept Biochem & Mol Genet, 900 S Ashland Ave,M-C 669, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Colley, KJ (corresponding author), Univ Illinois, Dept Biochem & Mol Genet, 900 S Ashland Ave,M-C 669, Chicago, IL 60607 USA.	karenc@uic.edu	FERNANDES, NINOSHKA/AAC-1341-2022	FERNANDES, NINOSHKA/0000-0003-1386-0635; Bhide, Gaurang/0000-0002-6120-3747; Colley, Karen/0000-0002-3801-071X	National Institutes of Health [RO1 GM101949]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101949] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant RO1 GM101949 (to K. J. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Angata K, 2000, J BIOL CHEM, V275, P18594, DOI 10.1074/jbc.M910204199; Appleton BA, 2007, EMBO J, V26, P4902, DOI 10.1038/sj.emboj.7601906; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Arolas JL, 2012, P NATL ACAD SCI USA, V109, P16131, DOI 10.1073/pnas.1211076109; Bae D, 2008, J BIOL CHEM, V283, P28074, DOI 10.1074/jbc.M804203200; Ballmer-Hofer K, 2011, BLOOD, V118, P816, DOI 10.1182/blood-2011-01-328773; Bax M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006987; Berger P, 2011, SWISS MED WKLY, V141, DOI 10.4414/smw.2011.13318; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Close BE, 2003, J BIOL CHEM, V278, P30796, DOI 10.1074/jbc.M305390200; Close BE, 2000, J BIOL CHEM, V275, P4484, DOI 10.1074/jbc.275.6.4484; Close BE, 1998, J BIOL CHEM, V273, P34586, DOI 10.1074/jbc.273.51.34586; Colley KJ, 2014, CRIT REV BIOCHEM MOL, V49, P498, DOI 10.3109/10409238.2014.976606; Curreli S, 2007, J BIOL CHEM, V282, P30346, DOI 10.1074/jbc.M702965200; DUNCAN JR, 1988, J CELL BIOL, V106, P617, DOI 10.1083/jcb.106.3.617; Falconer RA, 2012, CURR CANCER DRUG TAR, V12, P925; FINNE J, 1982, J BIOL CHEM, V257, P1966; Foley DA, 2010, J BIOL CHEM, V285, P35056, DOI 10.1074/jbc.M110.170209; Friedl P, 2005, NAT REV IMMUNOL, V5, P532, DOI 10.1038/nri1647; Galuska SP, 2010, P NATL ACAD SCI USA, V107, P10250, DOI 10.1073/pnas.0912103107; Grandclement Camille, 2011, Cancers (Basel), V3, P1899, DOI 10.3390/cancers3021899; Guex N, 2009, ELECTROPHORESIS, V30, pS162, DOI 10.1002/elps.200900140; JAMES WM, 1987, BIOCHEM BIOPH RES CO, V148, P817, DOI 10.1016/0006-291X(87)90949-1; Johnson CP, 2005, J BIOL CHEM, V280, P137, DOI 10.1074/jbc.M410216200; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kiermaier E, 2016, SCIENCE, V351, P186, DOI 10.1126/science.aad0512; MALEY F, 1989, ANAL BIOCHEM, V180, P195, DOI 10.1016/0003-2697(89)90115-2; Mendiratta SS, 2006, J BIOL CHEM, V281, P36052, DOI 10.1074/jbc.M608073200; Mendiratta SS, 2005, J BIOL CHEM, V280, P32340, DOI 10.1074/jbc.M506217200; Nakamura F, 1998, NEURON, V21, P1093, DOI 10.1016/S0896-6273(00)80626-1; Neufeld G, 2002, TRENDS CARDIOVAS MED, V12, P13, DOI 10.1016/S1050-1738(01)00140-2; Okon IS, 2014, J CLIN INVEST, V124, P4590, DOI 10.1172/JCI75371; Pellet-Many C, 2008, BIOCHEM J, V411, P211, DOI 10.1042/BJ20071639; Prud'homme GJ, 2012, ONCOTARGET, V3, P921, DOI 10.18632/oncotarget.626; Rey-Gallardo A, 2011, GLYCOBIOLOGY, V21, P655, DOI 10.1093/glycob/cwq216; Rollenhagen M, 2013, J BIOL CHEM, V288, P22880, DOI 10.1074/jbc.M113.463927; Rutishauser U, 2008, NAT REV NEUROSCI, V9, P26, DOI 10.1038/nrn2285; Sato C, 2013, J BIOCHEM, V154, P115, DOI 10.1093/jb/mvt057; Sawma P, 2014, J MOL BIOL, V426, P4099, DOI 10.1016/j.jmb.2014.10.007; Schnaar RL, 2014, PHYSIOL REV, V94, P461, DOI 10.1152/physrev.00033.2013; Shintani Y, 2006, EMBO J, V25, P3045, DOI 10.1038/sj.emboj.7601188; Stamatos NM, 2014, GLYCOBIOLOGY, V24, P864, DOI 10.1093/glycob/cwu050; Tanaka F, 2000, CANCER RES, V60, P3072; Thompson MG, 2013, J BIOL CHEM, V288, P7282, DOI 10.1074/jbc.M112.438374; Thompson MG, 2011, J BIOL CHEM, V286, P4525, DOI 10.1074/jbc.M110.200386; Vander Kooi CW, 2007, P NATL ACAD SCI USA, V104, P6152, DOI 10.1073/pnas.0700043104; Werneburg S, 2015, GLIA, V63, P1240, DOI 10.1002/glia.22815; Yabe U, 2003, J BIOL CHEM, V278, P13875, DOI 10.1074/jbc.M300458200	48	15	15	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2016	291	18					9444	9457		10.1074/jbc.M116.714329	http://dx.doi.org/10.1074/jbc.M116.714329			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DL4JY	26884342	Green Published, hybrid			2022-12-26	WOS:000375602300006
J	Guo, RN; Zheng, HZ; Ou, CQ; Huang, LQ; Zhou, Y; Zhang, X; Liang, CK; Lin, JY; Zhong, HJ; Song, T; Luo, HM				Guo, Ru-ning; Zheng, Hui-zhen; Ou, Chun-quan; Huang, Li-qun; Zhou, Yong; Zhang, Xin; Liang, Can-kun; Lin, Jin-yan; Zhong, Hao-jie; Song, Tie; Luo, Hui-ming			Impact of Influenza on Outpatient Visits, Hospitalizations, and Deaths by Using a Time Series Poisson Generalized Additive Model	PLOS ONE			English	Article							RESPIRATORY SYNCYTIAL VIRUS; SEASONAL INFLUENZA; ECONOMIC BURDEN; MORTALITY; ILLNESS	Background The disease burden associated with influenza in developing tropical and subtropical countries is poorly understood owing to the lack of a comprehensive disease surveillance system and information-exchange mechanisms. The impact of influenza on outpatient visits, hospital admissions, and deaths has not been fully demonstrated to date in south China. Methods A time series Poisson generalized additive model was used to quantitatively assess influenza-like illness (ILI) and influenza disease burden by using influenza surveillance data in Zhuhai City from 2007 to 2009, combined with the outpatient, inpatient, and respiratory disease mortality data of the same period. Results The influenza activity in Zhuhai City demonstrated a typical subtropical seasonal pattern; however, each influenza virus subtype showed a specific transmission variation. The weekly ILI case number and virus isolation rate had a very close positive correlation (r = 0.774, P < 0.0001). The impact of ILI and influenza on weekly outpatient visits was statistically significant (P < 0.05). We determined that 10.7% of outpatient visits were associated with ILI and 1.88% were associated with influenza. ILI also had a significant influence on the hospitalization rates (P < 0.05), but mainly in populations < 25 years of age. No statistically significant effect of influenza on hospital admissions was found (P > 0.05). The impact of ILI on chronic obstructive pulmonary disease (COPD) was most significant (P < 0.05), with 33.1% of COPD-related deaths being attributable to ILI. The impact of influenza on the mortality rate requires further evaluation. Conclusions ILI is a feasible indicator of influenza activity. Both ILI and influenza have a large impact on outpatient visits. Although ILI affects the number of hospital admissions and deaths, we found no consistent influence of influenza, which requires further assessment.	[Guo, Ru-ning] Ctr Dis Control & Prevent Guangdong Prov, Publ Hlth Emergency Management Off, Guangzhou, Guangdong, Peoples R China; [Zheng, Hui-zhen] Ctr Dis Control & Prevent Guangdong Prov, Inst Immunizat Programs, Guangzhou, Guangdong, Peoples R China; [Ou, Chun-quan] Southern Med Univ, Sch Publ Hlth, Dept Biostat, Guangzhou, Guangdong, Peoples R China; [Huang, Li-qun; Zhou, Yong; Liang, Can-kun] Zhuhai Municipal Ctr Dis Control & Prevent, Zhuhai, Peoples R China; [Zhang, Xin] Ctr Dis Control & Prevent Guangdong Prov, Inst Pathogen Microorganisms, Guangzhou, Guangdong, Peoples R China; [Lin, Jin-yan; Song, Tie] Ctr Dis Control & Prevent Guangdong Prov, Guangzhou, Guangdong, Peoples R China; [Zhong, Hao-jie] Ctr Dis Control & Prevent Guangdong Prov, Inst Infect Dis Prevent & Control, Guangzhou, Guangdong, Peoples R China; [Luo, Hui-ming] Ctr Dis Control & Prevent, Beijing, Peoples R China	Southern Medical University - China; Chinese Center for Disease Control & Prevention	Zheng, HZ (corresponding author), Ctr Dis Control & Prevent Guangdong Prov, Inst Immunizat Programs, Guangzhou, Guangdong, Peoples R China.	zhz@cdcp.org.cn		Ou, Chun-Quan/0000-0001-6866-7213	World Health Organization [WP/2008/CHN/02/CSR/PE 15.01]; Medical Research Foundation of Guangdong Province, China [A2007079]	World Health Organization(World Health Organization); Medical Research Foundation of Guangdong Province, China	The work was supported by grants from the World Health Organization (WP/2008/CHN/02/CSR/PE 15.01), and Medical Research Foundation of Guangdong Province, China (project number: A2007079). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai-ping D, 2008, S CHINA J PREVENTIVE, V34, P14; Bhuiyan MU, 2014, INFLUENZA OTHER RESP, V8, P406, DOI 10.1111/irv.12254; Burton C, 2014, PEDIATR INFECT DIS J, V33, P710, DOI 10.1097/INF.0000000000000272; Chaves SS, 2014, PEDIATR INFECT DIS J, V33, P912, DOI 10.1097/INF.0000000000000321; Chiu SS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092914; Chow A, 2006, EMERG INFECT DIS, V12, P114, DOI 10.3201/eid1201.050826; Chowell G, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-214; Cromer D, 2014, J INFECTION, V68, P363, DOI 10.1016/j.jinf.2013.11.013; Dushoff J, 2006, AM J EPIDEMIOL, V163, P181, DOI 10.1093/aje/kwj024; Emukule GO, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105543; Falsey AR, 2005, NEW ENGL J MED, V352, P1749, DOI 10.1056/NEJMoa043951; Guo RN, 2011, PUBLIC HEALTH, V125, P389, DOI 10.1016/j.puhe.2011.03.004; Guo RN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041403; Ortiz JR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113903; Ortiz JR, 2014, CRIT CARE MED, V42, P2325, DOI 10.1097/CCM.0000000000000545; Ping H, 2004, CHINESE J DIS CONTRO, V8, P144; Shortridge K F, 1992, Semin Respir Infect, V7, P11; Silva ML, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-56; Thompson WW, 2009, AM J PUBLIC HEALTH, V99, pS225, DOI 10.2105/AJPH.2008.151944; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Viboud C, 2006, PLOS MED, V3, P468, DOI 10.1371/journal.pmed.0030089; Wang DM, 2004, CHINESE J EPIDEMIOLO, V01; WHO, PRACT GUID DES COND; WISELKA M, 1994, BRIT MED J, V308, P1341, DOI 10.1136/bmj.308.6940.1341; Wong C M, 2012, Hong Kong Med J, V18 Suppl 2, P8; Wong CM, 2004, CLIN INFECT DIS, V39, P1611, DOI 10.1086/425315; Wu AP, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000882; Yang L, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-342; Yang L, 2011, VACCINE, V29, P8909, DOI 10.1016/j.vaccine.2011.09.071; Yu H, 2012, INFLUENZA OTHER RESP, V8, P53, DOI DOI 10.1111/IRV.12205	31	13	16	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0149468	10.1371/journal.pone.0149468	http://dx.doi.org/10.1371/journal.pone.0149468			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3DG	26894876	Green Published, gold, Green Submitted			2022-12-26	WOS:000371223400057
J	Metfies, K; von Appen, WJ; Kilias, E; Nicolaus, A; Nothig, EM				Metfies, Katja; von Appen, Wilken-Jon; Kilias, Estelle; Nicolaus, Anja; Noethig, Eva-Maria			Biogeography and Photosynthetic Biomass of Arctic Marine Pico-Eukaroytes during Summer of the Record Sea Ice Minimum 2012	PLOS ONE			English	Article							EAST GREENLAND CURRENT; PHYTOPLANKTON BLOOMS; FRAM STRAIT; DIVERSITY; SEQUENCES; OCEAN; WATER; ABUNDANCE; GROWTH; NORTH	Information on recent photosynthetic biomass distribution and biogeography of Arctic marine pico-eukaryotes (0.2-3 mu m) is needed to better understand consequences of environmental change for Arctic marine ecosystems. We analysed pico-eukaryote biomass and community composition in Fram Strait and large parts of the Central Arctic Ocean (Nansen Basin, Amundsen Basin) using chlorophyll a (Chl a) measurements, automated ribosomal intergenic spacer analysis (ARISA) and 454-pyrosequencing. Samples were collected during summer 2012, the year with the most recent record sea ice minimum. Chl a concentrations were highest in eastern Fram Strait and pico-plankton accounted for 6090% of Chl a biomass during the observation period. ARISA-patterns and 454-pyrosequencing revealed that pico-eukaryote distribution is closely related to water mass distribution in the euphotic zone of the Arctic Ocean. Phaeocystaceae, Micromonas sp., Dinophyceae and Syndiniales constitute a high proportion of sequence reads, while sequence abundance of autotrophic Phaeocystaceae and mixotrophic Micromonas sp. was inversely correlated. Highest sequence abundances of Phaeocystaceae were observed in the warm Atlantic Waters in Fram Strait, while Micromonas sp. dominated the abundant biosphere in the arctic halocline. Our results are of particular interest considering existing hypotheses that environmental conditions in Nansen Basin might become more similar to the current conditions in Fram Strait. We propose that in response, biodiversity and biomass of pico-eukaryotes in Nansen Basin could resemble those currently observed in Fram Strait in the future. This would significantly alter biogeochemical cycles in a large part of the Central Arctic Ocean.	[Metfies, Katja; Kilias, Estelle; Nicolaus, Anja; Noethig, Eva-Maria] Helmholtz Ctr Polar & Marine Res, Alfred Wegener Inst, Div Biosci, Dept Polar Biol Oceanog, Bremerhaven, Germany; [von Appen, Wilken-Jon] Helmholtz Ctr Polar & Marine Res, Alfred Wegener Inst, Div Climate Sci, Phys Oceanog Polar Seas, Bremerhaven, Germany	Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research	Metfies, K (corresponding author), Helmholtz Ctr Polar & Marine Res, Alfred Wegener Inst, Div Biosci, Dept Polar Biol Oceanog, Bremerhaven, Germany.	Katja.Metfies@awi.de	Nöthig, Eva-Maria/AAS-7253-2021	Nicolaus, Anja/0000-0002-2026-3540; Nothig, Eva-Maria/0000-0002-7527-7827; von Appen, Wilken-Jon/0000-0002-7200-0099	Initiative and Networking Fund of the Helmholtz Association; funds of the German Federal Ministry of Education and Research (Co-operative project RACE) [0F0651 D]	Initiative and Networking Fund of the Helmholtz Association; funds of the German Federal Ministry of Education and Research (Co-operative project RACE)	This study was accomplished within the Young Investigator Group PLANKTOSENS (VH-NG500), funded by the Initiative and Networking Fund of the Helmholtz Association. Wilken-Jon von Appen was supported by funds of the German Federal Ministry of Education and Research (Co-operative project RACE, 0F0651 D). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksenov Y, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006637; [Anonymous], 1979, LE RECOMMENDATIONS M, V5; Behnke A, 2011, ENVIRON MICROBIOL, V13, P340, DOI 10.1111/j.1462-2920.2010.02332.x; Beszczynska-Moller A, 2012, ICES J MAR SCI, V69, P852, DOI 10.1093/icesjms/fss056; Booth BC, 1997, DEEP-SEA RES PT II, V44, P1607, DOI 10.1016/S0967-0645(97)00057-X; Cai P, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC005595; Cherkasheva A, 2014, J MARINE SYST, V132, P196, DOI 10.1016/j.jmarsys.2013.11.008; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Comeau AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027492; Damm E, 2010, BIOGEOSCIENCES, V7, P1099, DOI 10.5194/bg-7-1099-2010; de Steur L, 2014, DEEP-SEA RES PT I, V92, P26, DOI 10.1016/j.dsr.2014.05.018; de Steur L, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL041278; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; ELWOOD HJ, 1985, MOL BIOL EVOL, V2, P399; Evans CAOR, 1980, OCEAN PULSE TECHNICA, V3; Falk-Petersen S, 1998, POLAR BIOL, V20, P41, DOI 10.1007/s003000050274; Gaebler-Schwarz S, 2010, J PHYCOL, V46, P1006, DOI 10.1111/j.1529-8817.2010.00875.x; Gosselin M, 1997, DEEP-SEA RES PT II, V44, P1623, DOI 10.1016/S0967-0645(97)00054-4; Guillou L, 2008, ENVIRON MICROBIOL, V10, P3349, DOI 10.1111/j.1462-2920.2008.01731.x; Hamilton AK, 2008, LIMNOL OCEANOGR, V53, P922, DOI 10.4319/lo.2008.53.3.0922; Hartmann DL, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P159; Jaccard P., 1912, NEW PHYTOL, V11, P37, DOI [10.1111/j.1469-8137.1912.tb05611.x, DOI 10.1111/J.1469-8137.1912.TB05611.X, DOI 10.1371/journal.pbio.1001889]; Jeong Hae Jin, 2010, Ocean Science Journal, V45, P65, DOI 10.1007/s12601-010-0007-2; Jones EP, 1998, GEOPHYS RES LETT, V25, P765, DOI 10.1029/98GL00464; Kilias ES, 2015, LIMNOL OCEANOGR-METH, V13, P74, DOI 10.1002/lom3.10008; Kilias E, 2014, POLAR BIOL, V37, P1271, DOI 10.1007/s00300-014-1519-5; Kilias E, 2013, J PHYCOL, V49, P996, DOI 10.1111/jpy.12109; Kilias ES, 2014, J EUKARYOT MICROBIOL, V61, P569, DOI 10.1111/jeu.12134; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; Kwok R, 2011, PHYS TODAY, V64, P36, DOI 10.1063/1.3580491; Lasternas S, 2010, POLAR BIOL, V33, P1709, DOI 10.1007/s00300-010-0877-x; Lovejoy C, 2007, J PHYCOL, V43, P78, DOI 10.1111/j.1529-8817.2006.00310.x; Lovejoy C, 2011, J PLANKTON RES, V33, P431, DOI 10.1093/plankt/fbq124; Matsen FA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-538; McKie-Krisberg ZM, 2014, ISME J, V8, P1953, DOI 10.1038/ismej.2014.16; MEDLIN L, 1988, GENE, V71, P491, DOI 10.1016/0378-1119(88)90066-2; Miranda LN, 2012, HARMFUL ALGAE, V16, P35, DOI 10.1016/j.hal.2012.01.002; Moon-van der Staay SY, 2001, NATURE, V409, P607, DOI 10.1038/35054541; Moran XAG, 2010, GLOBAL CHANGE BIOL, V16, P1137, DOI 10.1111/j.1365-2486.2009.01960.x; NICKRENT DL, 1991, NUCLEIC ACIDS RES, V19, P227, DOI 10.1093/nar/19.2.227; Nicolaus M, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL053738; Parkinson CL, 2013, GEOPHYS RES LETT, V40, DOI 10.1002/grl.50349; Peperzak L, 2012, J PHYCOL, V48, P514, DOI 10.1111/j.1529-8817.2012.01136.x; Perovich DK, 2011, OCEANOGRAPHY, V24, P162, DOI 10.5670/oceanog.2011.68; Rabe B, 2014, GEOPHYS RES LETT, V41, P961, DOI 10.1002/2013GL058121; Ramette A, 2009, APPL ENVIRON MICROB, V75, P2495, DOI 10.1128/AEM.02409-08; Rat'kova TN, 2002, J MARINE SYST, V38, P47, DOI 10.1016/S0924-7963(02)00169-0; Richardson K, 2005, DEEP-SEA RES PT I, V52, P979, DOI 10.1016/j.dsr.2004.12.005; Rudels B, 2005, J MARINE SYST, V55, P1, DOI 10.1016/j.jmarsys.2004.06.008; Sherr EB, 2003, DEEP-SEA RES PT I, V50, P557, DOI 10.1016/S0967-0637(03)00031-1; Slapeta J, 2006, MOL BIOL EVOL, V23, P23, DOI 10.1093/molbev/msj001; Sun S, 2006, OCEAN MODEL, V15, P177, DOI 10.1016/j.ocemod.2006.05.002; Vaulot D, 2008, FEMS MICROBIOL REV, V32, P795, DOI 10.1111/j.1574-6976.2008.00121.x; Wassmann P, 2005, HARMFUL ALGAE, V4, P823, DOI 10.1016/j.hal.2004.12.009; White TJ., 1990, PCR PROTOCOLS GUIDE, P315	57	53	59	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0148512	10.1371/journal.pone.0148512	http://dx.doi.org/10.1371/journal.pone.0148512			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3DG	26895333	Green Published, Green Submitted, gold			2022-12-26	WOS:000371223400018
J	Oguz, AK; Yilmaz, ST; Oygur, CS; Candar, T; Sayin, I; Kilicoglu, SS; Ergun, I; Ates, A; Ozdag, H; Akar, N				Oguz, Ali Kemal; Yilmaz, Seda Tasir; Oygur, Cagdas Sahap; Candar, Tuba; Sayin, Irmak; Kilicoglu, Sibel Serin; Ergun, Ihsan; Ates, Askin; Ozdag, Hilal; Akar, Nejat			Behcet's: A Disease or a Syndrome? Answer from an Expression Profiling Study	PLOS ONE			English	Article							INHIBITORY RECEPTOR; GENE-EXPRESSION; MICROARRAY DATA; GENOME; SUSCEPTIBILITY; INFLAMMATION; IDENTIFICATION; ASSOCIATION; WEBGESTALT	Behcet's disease (BD) is a chronic, relapsing, multisystemic inflammatory disorder with unanswered questions regarding its etiology/pathogenesis and classification. Distinct manifestation based subsets, pronounced geographical variations in expression, and discrepant immunological abnormalities raised the question whether Behcet's is "a disease or a syndrome". To answer the preceding question we aimed to display and compare the molecular mechanisms underlying distinct subsets of BD. For this purpose, the expression data of the gene expression profiling and association study on BD by Xavier et al (2013) was retrieved from GEO database and reanalysed by gene expression data analysis/visualization and bioinformatics enrichment tools. There were 15 BD patients (B) and 14 controls (C). Three subsets of BD patients were generated: MB (isolated mucocutaneous manifestations, n = 7), OB (ocular involvement, n = 4), and VB (large vein thrombosis, n = 4). Class comparison analyses yielded the following numbers of differentially expressed genes (DEGs); B vs C: 4, MB vs C: 5, OB vs C: 151, VB vs C: 274, MB vs OB: 215, MB vs VB: 760, OB vs VB: 984. Venn diagram analysis showed that there were no common DEGs in the intersection "MB vs C" boolean AND "OB vs C" boolean AND "VB vs C". Cluster analyses successfully clustered distinct expressions of BD. During gene ontology term enrichment analyses, categories with relevance to IL-8 production (MB vs C) and immune response to microorganisms (OB vs C) were differentially enriched. Distinct subsets of BD display distinct expression profiles and different disease associated pathways. Based on these clear discrepancies, the designation as "Behcet's syndrome" (BS) should be encouraged and future research should take into consideration the immunogenetic heterogeneity of BS subsets. Four gene groups, namely, negative regulators of inflammation (CD69, CLEC12A, CLEC12B, TNFAIP3), neutrophil granule proteins (LTF, OLFM4, AZU1, MMP8, DEFA4, CAMP), antigen processing and presentation proteins (CTSS, ERAP1), and regulators of immune response (LGALS2, BCL10, ITCH, CEACAM8, CD36, IL8, CCL4, EREG, NFKBIZ, CCR2, CD180, KLRC4, NFAT5) appear to be instrumental in BS immunopathogenesis.	[Oguz, Ali Kemal; Sayin, Irmak] Ufuk Univ, Sch Med, Dept Internal Med, Ankara, Turkey; [Oguz, Ali Kemal; Yilmaz, Seda Tasir; Ozdag, Hilal] Ankara Univ, Inst Biotechnol, TR-06100 Ankara, Turkey; [Oygur, Cagdas Sahap] Baskent Univ, Sch Med, Dept Internal Med, TR-06490 Ankara, Turkey; [Candar, Tuba] Ufuk Univ, Sch Med, Dept Biochem, Ankara, Turkey; [Kilicoglu, Sibel Serin] Ufuk Univ, Sch Med, Dept Histol & Embryol, Ankara, Turkey; [Ergun, Ihsan] Ufuk Univ, Sch Med, Dept Internal Med, Div Nephrol, Ankara, Turkey; [Ates, Askin] Ankara Univ, Sch Med, Dept Internal Med, Div Rheumatol, TR-06100 Ankara, Turkey; [Akar, Nejat] TOBB Univ Econ & Technol Hosp, Dept Pediat, Ankara, Turkey	Ufuk University; Ankara University; Baskent University; Ufuk University; Ufuk University; Ufuk University; Ankara University; TOBB Ekonomi ve Teknoloji University	Oguz, AK (corresponding author), Ufuk Univ, Sch Med, Dept Internal Med, Ankara, Turkey.; Oguz, AK (corresponding author), Ankara Univ, Inst Biotechnol, TR-06100 Ankara, Turkey.	drakoguz@gmail.com	Ates, Askin/AAG-7996-2020; Oguz, Ali Kemal/AAD-4232-2022; Akar, Nejat/H-2949-2019; Oguz, Ali Kemal/ABB-7188-2021; Taşır Yılmaz, Seda/G-6235-2019; Özdag, Hilal/C-9929-2009	Ates, Askin/0000-0003-1966-3333; Oguz, Ali Kemal/0000-0002-3939-2924; Taşır Yılmaz, Seda/0000-0001-8879-0016; Özdag, Hilal/0000-0001-7940-2499; Kilicoglu, Sibel Serin/0000-0002-7658-5186				Akkurt ZM, 2015, J CLIN LAB ANAL, V29, P317, DOI 10.1002/jcla.21772; Behcet H, 1937, DERMATOL WOCHENSCHR, V105, P1152; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; BRB-ArrayTools, INT PACK VIS STAT AN; Cho S, 2014, J EUR ACAD DERMATOL, V28, P51, DOI 10.1111/jdv.12054; Cookson W, 2009, NAT REV GENET, V10, P184, DOI 10.1038/nrg2537; Couzin J, 2006, SCIENCE, V313, P1559; de Chambrun MP, 2012, AUTOIMMUN REV, V11, P687, DOI 10.1016/j.autrev.2011.11.026; Direskeneli H, 2001, ANN RHEUM DIS, V60, P996, DOI 10.1136/ard.60.11.996; Direskeneli H, 2010, BEHCET'S SYNDROME, P243, DOI 10.1007/978-1-4419-5641-5_14; Ehrlich GE, 1998, ANN INTERN MED, V128, P494, DOI 10.7326/0003-4819-128-6-199803150-00011; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Franke L, 2009, METHODS MOL BIOL, V573, P311, DOI 10.1007/978-1-60761-247-6_17; Galeone Massimiliano, 2012, Patholog Res Int, V2012, P595380, DOI 10.1155/2012/595380; Gur-Toy G, 2005, INT J DERMATOL, V44, P657, DOI 10.1111/j.1365-4632.2004.02184.x; Hatemi G, 2011, BEST PRACT RES CL RH, V25, P389, DOI 10.1016/j.berh.2011.05.002; Hoffmann SC, 2007, J BIOL CHEM, V282, P22370, DOI 10.1074/jbc.M704250200; International Study Group for Beh~et's Disease, 1990, LANCET, V335, P1078, DOI DOI 10.1016/0140-; International Team for the Revision of the International Criteria for Behcet's Disease (ITR-ICBD), 2006, CLIN EXP RHEUMATOL, V24, pS14; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kaneko F, 2003, ARTHRITIS RES THER, V5, pS5, DOI 10.1186/ar988; Kaneko F, 2003, ADV EXP MED BIOL, V528, P181; Kaneko F, 2008, EUR J DERMATOL, V18, P489, DOI 10.1684/ejd.2008.0484; Kapsimali VD, 2010, CLIN RHEUMATOL, V29, P1211, DOI 10.1007/s10067-010-1491-6; Karasneh J, 2005, ARTHRITIS RHEUM-US, V52, P1836, DOI 10.1002/art.21060; Kiraz S, 2002, THROMB RES, V105, P125, DOI 10.1016/S0049-3848(02)00006-3; Kirino Y, 2013, NAT GENET, V45, P202, DOI 10.1038/ng.2520; Lamana A, 2006, EUR J IMMUNOL, V36, P2632, DOI 10.1002/eji.200636355; Lehner T, 1979, BEHCETS SYNDROME, P1; Lehner T, 1979, BEHCETS SYNDROME CLI, P14; Lewis KA, 2007, SCAND J RHEUMATOL, V36, P1, DOI 10.1080/03009740600991927; Maalouf D, 2015, CURR OPIN HEMATOL, V22, P23, DOI 10.1097/MOH.0000000000000100; Marshall ASJ, 2004, J BIOL CHEM, V279, P14792, DOI 10.1074/jbc.M313127200; Mat MC, 2014, CLIN DERMATOL, V32, P435, DOI 10.1016/j.clindermatol.2013.11.012; Meguro A, 2010, ANN RHEUM DIS, V69, P747, DOI 10.1136/ard.2009.108571; Mukaida N, 1995, Cancer Treat Res, V80, P261; Neumann K, 2014, IMMUNITY, V40, P389, DOI 10.1016/j.immuni.2013.12.015; Oguz AK, 2015, MED HYPOTHESES, V85, P186, DOI 10.1016/j.mehy.2015.04.032; Oliveros J.C., 2007, INTERACTIVE TOOL COM; Sakane T, 1999, NEW ENGL J MED, V341, P1284, DOI 10.1056/NEJM199910213411707; Wang J, 2013, NUCLEIC ACIDS RES, V41, pW77, DOI 10.1093/nar/gkt439; Xavier JM, 2013, J MOL MED, V91, P1013, DOI 10.1007/s00109-013-1022-4; Yazici H, 1996, BRIT J RHEUMATOL, V35, P139; Yazici H, 2007, NAT CLIN PRACT RHEUM, V3, P148, DOI 10.1038/ncprheum0436; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475; Zhou Q, 2015, NAT GENET, DOI [10.1038/ng,3459, DOI 10.1038/NG,3459]; Zierhut M, 2003, CELL MOL LIFE SCI, V60, P1903, DOI 10.1007/s00018-003-2333-3	47	10	10	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2016	11	2							e0149052	10.1371/journal.pone.0149052	http://dx.doi.org/10.1371/journal.pone.0149052			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3CO	26890122	gold, Green Published, Green Submitted			2022-12-26	WOS:000371221500022
J	Xu, JP; Vilanova, G; Gomez, H				Xu, Jiangping; Vilanova, Guillermo; Gomez, Hector			A Mathematical Model Coupling Tumor Growth and Angiogenesis	PLOS ONE			English	Article							ISOGEOMETRIC ANALYSIS; NONLINEAR SIMULATION; TIP CELLS; INVASION; DYNAMICS; BLOOD; METHODOLOGY; INHIBITION; CULTURES; BLOCKADE	We present a mathematical model for vascular tumor growth. We use phase fields to model cellular growth and reaction-diffusion equations for the dynamics of angiogenic factors and nutrients. The model naturally predicts the shift from avascular to vascular growth at realistic scales. Our computations indicate that the negative regulation of the Delta-like ligand 4 signaling pathway slows down tumor growth by producing a larger density of non-functional capillaries. Our results show good quantitative agreement with experiments.	[Xu, Jiangping; Vilanova, Guillermo; Gomez, Hector] Univ A Coruna, Appl Math, La Coruna, Spain	Universidade da Coruna	Vilanova, G (corresponding author), Univ A Coruna, Appl Math, La Coruna, Spain.	gvilanovac@udc.es	Vilanova, Guillermo/L-4937-2016; Vilanova, Guillermo/H-8427-2019; Gomez, Hector/U-8002-2019	Vilanova, Guillermo/0000-0002-9650-0602; Vilanova, Guillermo/0000-0002-9650-0602; Gomez, Hector/0000-0002-2553-9091	European Research Council through the FP7 Ideas Starting Grant program [307201]	European Research Council through the FP7 Ideas Starting Grant program	This work was supported by the European Research Council through the FP7 Ideas Starting Grant program (Grant #307201; http://erc.europa.eu/starting-grants). JX, GV, and HG gratefully acknowledge this support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarcon T, 2003, J THEOR BIOL, V225, P257, DOI 10.1016/S0022-5193(03)00244-3; Augustin HG, 2009, NAT REV MOL CELL BIO, V10, P165, DOI 10.1038/nrm2639; Beenken A, 2009, NAT REV DRUG DISCOV, V8, P235, DOI 10.1038/nrd2792; Bentley K, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000549; Blanco R, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a006569; Boondirek A., 2010, INT MATH FORUM, V5, P3023; Bouis D, 2006, PHARMACOL RES, V53, P89, DOI 10.1016/j.phrs.2005.10.006; Bueno J, 2015, COMPUT MECH, V55, P1105, DOI 10.1007/s00466-014-1098-x; Byrne H, 2003, MATH MED BIOL, V20, P341; Byrne HM, 1997, EUR J APPL MATH, V8, P639, DOI 10.1017/S0956792597003264; Byrne HM, 2003, APPL MATH LETT, V16, P567, DOI 10.1016/S0893-9659(03)00038-7; Byrne HM, 1999, J MATH BIOL, V39, P59, DOI 10.1007/s002850050163; CAHN JW, 1958, J CHEM PHYS, V28, P258, DOI 10.1063/1.1744102; Cai Y, 2011, J THEOR BIOL, V279, P90, DOI 10.1016/j.jtbi.2011.02.017; Casquero H, 2015, COMPUT METHOD APPL M, V284, P943, DOI 10.1016/j.cma.2014.10.055; CHAPLAIN MAJ, 1993, MATH BIOSCI, V115, P233, DOI 10.1016/0025-5564(93)90072-I; Chen LQ, 2002, ANNU REV MATER RES, V32, P113, DOI 10.1146/annurev.matsci.32.112001.132041; CHUNG J, 1993, J APPL MECH-T ASME, V60, P371, DOI 10.1115/1.2900803; Cristini V, 2009, J MATH BIOL, V58, P723, DOI 10.1007/s00285-008-0215-x; De Smet F, 2009, ARTERIOSCL THROM VAS, V29, P639, DOI 10.1161/ATVBAHA.109.185165; Duda DG, 2011, CLIN CANCER RES, V17, P2074, DOI 10.1158/1078-0432.CCR-10-2636; Emmerich H., 2003, LECT NOTES PHYS, V73; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Frieboes HB, 2007, NEUROIMAGE, V37, pS59, DOI 10.1016/j.neuroimage.2007.03.008; Frieboes HB, 2010, J THEOR BIOL, V264, P1254, DOI 10.1016/j.jtbi.2010.02.036; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Gerlee P, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.051911; Gevertz JL, 2006, J THEOR BIOL, V243, P517, DOI 10.1016/j.jtbi.2006.07.002; Gomez H, 2014, J COMPUT PHYS, V262, P153, DOI 10.1016/j.jcp.2013.12.044; Gomez H, 2013, J COMPUT PHYS, V238, P217, DOI 10.1016/j.jcp.2012.12.018; Gomez H, 2012, COMPUT METHOD APPL M, V249, P52, DOI 10.1016/j.cma.2012.03.002; Gomez H, 2011, J COMPUT PHYS, V230, P5310, DOI 10.1016/j.jcp.2011.03.033; Gomez H, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.046702; Gomez H, 2010, COMPUT METHOD APPL M, V199, P1828, DOI 10.1016/j.cma.2010.02.010; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Hawkins-Daarud A, 2013, J MATH BIOL, V67, P1457, DOI 10.1007/s00285-012-0595-9; Hellstrom M, 2007, NATURE, V445, P776, DOI 10.1038/nature05571; Herbert SP, 2012, CURR BIOL, V22, P1789, DOI 10.1016/j.cub.2012.07.037; Herbert SP, 2011, NAT REV MOL CELL BIO, V12, P551, DOI 10.1038/nrm3176; Hicklin DJ, 2005, J CLIN ONCOL, V23, P1011, DOI 10.1200/JCO.2005.06.081; Hinow P, 2009, MATH BIOSCI ENG, V6, P521, DOI 10.3934/mbe.2009.6.521; Hogea CS, 2006, J MATH BIOL, V53, P86, DOI 10.1007/s00285-006-0378-2; Holash J, 1999, SCIENCE, V284, P1994, DOI 10.1126/science.284.5422.1994; HYSTAD ME, 1994, INT J CANCER, V57, P532, DOI 10.1002/ijc.2910570416; Iruela-Arispe ML, 1999, CIRCULATION, V100, P1423, DOI 10.1161/01.CIR.100.13.1423; Kobayashi R, 2010, AIP CONF PROC, V1270, P282, DOI 10.1063/1.3476232; Kuhnert F, 2011, VASC CELL, V3, DOI 10.1186/2045-824X-3-20; Lima EABF, 2014, MATH MOD METH APPL S, V24, DOI 10.1142/S0218202514500304; Lima EABF, 2015, NUMER METH PART D E, V31, P552, DOI 10.1002/num.21934; Liu J, 2013, J COMPUT PHYS, V248, P47, DOI 10.1016/j.jcp.2013.04.005; Logsdon EA, 2014, J CELL MOL MED, V18, P1491, DOI 10.1111/jcmm.12164; Macklin P, 2009, J MATH BIOL, V58, P765, DOI 10.1007/s00285-008-0216-9; Miles KM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112371; Moreira J, 2002, ADV COMPLEX SYST, V5, P247, DOI [10.1142/s0219525902000572, DOI 10.1142/S0219525902000572]; Nico B, 2008, HISTOL HISTOPATHOL, V23, P601, DOI 10.14670/HH-23.601; Noguera-Troise I, 2006, NATURE, V444, P1032, DOI 10.1038/nature05355; Oden JT, 2013, MATH MOD METH APPL S, V23, P1309, DOI 10.1142/S0218202513500103; Oden JT, 2010, MATH MOD METH APPL S, V20, P477, DOI 10.1142/S0218202510004313; Orme ME, 1996, MATH COMPUT MODEL, V23, P43, DOI 10.1016/0895-7177(96)00053-2; Pennacchietti S, 2003, CANCER CELL, V3, P347, DOI 10.1016/S1535-6108(03)00085-0; Perez-Garcia VM, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.021921; Perfahl H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014790; Pismen LM, 2006, PATTERNS AND INTERFA; Potente M, 2011, CELL, V146, P873, DOI 10.1016/j.cell.2011.08.039; Preziosi L, 2009, J MATH BIOL, V58, P625, DOI 10.1007/s00285-008-0218-7; Ridgway J, 2006, NATURE, V444, P1083, DOI 10.1038/nature05313; Sciume G, 2014, COMPUT MECH, V53, P465, DOI 10.1007/s00466-013-0956-2; Sciume G, 2013, ARCH COMPUT METHOD E, V20, P327, DOI 10.1007/s11831-013-9090-8; Sciume G, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/1/015005; Shan SQ, 2001, CLIN CANCER RES, V7, P2590; Sherratt JA, 2001, J MATH BIOL, V43, P291, DOI 10.1007/s002850100088; Shirinifard A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007190; SUTHERLAND RM, 1988, SCIENCE, V240, P177, DOI 10.1126/science.2451290; Thompson KE, 1999, B MATH BIOL, V61, P601, DOI 10.1006/bulm.1999.0089; Thurston G, 2008, BRIT J CANCER, V99, P1204, DOI 10.1038/sj.bjc.6604484; Thurston G, 2007, NAT REV CANCER, V7, P327, DOI 10.1038/nrc2130; Travasso RDM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019989; Vilanova G, 2015, GROWTH REGRESSION RE; Vilanova G, 2014, COMPUT MECH, V53, P449, DOI 10.1007/s00466-013-0958-0; Vilanova G, 2013, INT J NUMER METH BIO, V29, P1015, DOI 10.1002/cnm.2552; Ward JP, 1997, IMA J MATH APPL MED, V14, P39; Ward JP, 1999, IMA J MATH APPL MED, V16, P171; Wartenberg M, 2001, FASEB J, V15, P995, DOI 10.1096/fj.00-0350com; Welter M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070395; Wise SM, 2008, J THEOR BIOL, V253, P524, DOI 10.1016/j.jtbi.2008.03.027; Wu M, 2013, J THEOR BIOL, V320, P131, DOI 10.1016/j.jtbi.2012.11.031; Zheng X, 2005, B MATH BIOL, V67, P211, DOI 10.1016/j.bulm.2004.08.001	88	59	62	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2016	11	2							e0149422	10.1371/journal.pone.0149422	http://dx.doi.org/10.1371/journal.pone.0149422			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3CO	26891163	Green Published, gold, Green Submitted			2022-12-26	WOS:000371221500045
J	Kuo, YT; Chen, CY; Liu, GC; Wang, YM				Kuo, Yu-Ting; Chen, Chiao-Yun; Liu, Gin-Chung; Wang, Yun-Ming			Development of Bifunctional Gadolinium-Labeled Superparamagnetic Nanoparticles (Gd-MnMEIO) for In Vivo MR Imaging of the Liver in an Animal Model	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; ALPHA-FETOPROTEIN; CONTRAST AGENTS; ENHANCED MRI; CANCER; EPIDEMIOLOGY; METASTASES; INFECTION; DISEASE; LESIONS	Liver tumors are common and imaging methods, particularly magnetic resonance imaging (MRI), play an important role in their non-invasive diagnosis. Previous studies have shown that detection of liver tumors can be improved by injection of two different MR contrast agents. Here, we developed a new contrast agent, Gd-manganese-doped magnetism-engineered iron oxide (Gd-MnMEIO), with enhancement effects on both T1-and T2-weighted MR images of the liver. A 3.0T clinical MR scanner equipped with transmit/receiver coil for mouse was used to obtain both T1-weighted spoiled gradient-echo and T2-weighted fast spin-echo axial images of the liver before and after intravenous contrast agent injection into Balb/c mice with and without tumors. After pre-contrast scanning, six mice per group were intravenously injected with 0.1 mmol/kg Gd-MnMEIO, or the control agents, i.e., Gd-DTPA or SPIO. The scanning time points for T1-weighted images were 0.5, 5, 10, 15, 20, 25, and 30 min after contrast administration. The post-enhanced T2-weighted images were then acquired immediately after T1-weighted acquisition. We found that T1-weighted images were positively enhanced by both Gd-DTPA and Gd-MnMEIO and negatively enhanced by SPIO. The enhancement by both Gd-DTPA and Gd-MnMEIO peaked at 0.5 min and gradually declined thereafter. Gd-MnMEIO (like Gd-DTPA) enhanced T1-weighted images and (like SPIO) T2-weighted images. Marked vascular enhancement was clearly visible on dynamic T1-weighted images with Gd-MnMEIO. In addition, the T2 signal was significantly decreased at 30 min after administration of Gd-MnMEIO. Whereas the effects of Gd-MnMEIO and SPIO on T2-weighted images were similar (p = 0.5824), those of Gd-MnMEIO and Gd-DTPA differed, with Gd-MnMEIO having a significant T2 contrast effect (p = 0.0086). Our study confirms the feasibility of synthesizing an MR contrast agent with both T1 and T2 shortening effects and using such an agent in vivo. This agent enables tumor detection and characterization in single liver MRI sections.	[Kuo, Yu-Ting] Chi Mei Hosp, Dept Med Imaging, Tainan, Taiwan; [Kuo, Yu-Ting] Kaohsiung Med Univ Hosp, Dept Organ Transplantat Ctr, Kaohsiung, Taiwan; [Chen, Chiao-Yun; Liu, Gin-Chung] Kaohsiung Med Univ Hosp, Dept Med Imaging, Kaohsiung, Taiwan; [Kuo, Yu-Ting; Chen, Chiao-Yun; Liu, Gin-Chung] Kaohsiung Med Univ, Fac Med, Coll Med, Dept Radiol, Kaohsiung, Taiwan; [Wang, Yun-Ming] Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu, Taiwan; [Wang, Yun-Ming] Kaohsiung Med Univ, Dept Biomed Sci & Environm Biol, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; National Yang Ming Chiao Tung University; Kaohsiung Medical University	Wang, YM (corresponding author), Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu, Taiwan.; Wang, YM (corresponding author), Kaohsiung Med Univ, Dept Biomed Sci & Environm Biol, Kaohsiung, Taiwan.	ymwang@mail.nctu.edu.tw			Ministry of Science and Technology, Taiwan [101-2314-B-037-046-MY2]; Ministry of Health and Welfare of the Republic of China (Taiwan) [MOHW 104-TDU-B-212-124-003]; "Aim for the Top University Plan" of the National Chiao Tung University and Ministry of Education	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Ministry of Health and Welfare of the Republic of China (Taiwan); "Aim for the Top University Plan" of the National Chiao Tung University and Ministry of Education	This work was supported by 101-2314-B-037-046-MY2, Ministry of Science and Technology, Taiwan, http://www.most.gov.tw/mp.aspx?mp=7; by MOHW 104-TDU-B-212-124-003, Ministry of Health and Welfare of the Republic of China (Taiwan), http://www.mohw.gov.tw/EN/Ministry/Index.aspx; and by "Aim for the Top University Plan" of the National Chiao Tung University and Ministry of Education, http://www.edu.tw/, http://nctunews.nctu.edu.tw/index.php/en. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae KH, 2010, BIOCONJUGATE CHEM, V21, P505, DOI 10.1021/bc900424u; Brown RS, 2003, LIVER TRANSPLANT, V9, pS10, DOI 10.1053/jlts.2003.50244; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Cheng K, 2014, ACS NANO, V8, P9884, DOI 10.1021/nn500188y; Choi HS, 2007, NAT BIOTECHNOL, V25, P1165, DOI 10.1038/nbt1340; Chou CT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107869; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Harisinghani MG, 2003, NEW ENGL J MED, V348, P2491, DOI 10.1056/NEJMoa022749; Honary S, 2013, TROP J PHARM RES, V12, P265, DOI 10.4314/tjpr.v12i2.20; Kazmierczak PM, 2015, INVEST RADIOL, V50, P153, DOI 10.1097/RLI.0000000000000118; Kim SH, 2005, AM J ROENTGENOL, V184, P1069, DOI 10.2214/ajr.184.4.01841069; Kudo M, 2014, ONCOLOGY-BASEL, V87, P7, DOI 10.1159/000368141; Lee Y. J., 2015, RADIOLOGY, DOI [DOI 10.1148/RADIOL.14140690, 10.1148/radiol.14140690]; Lok AS, 2010, GASTROENTEROLOGY, V138, P493, DOI 10.1053/j.gastro.2009.10.031; Lutz AM, 2005, RADIOLOGY, V234, P765, DOI 10.1148/radiol.2343031172; Manfredi S, 2006, ANN SURG, V244, P254, DOI 10.1097/01.sla.0000217629.94941.cf; Nakamura S, 2013, ACTA MED OKAYAMA, V67, P239; Neuwelt A, 2015, AM J ROENTGENOL, V204, pW302, DOI 10.2214/AJR.14.12733; Park YS, 2014, INVEST RADIOL, V49, P183, DOI 10.1097/RLI.0000000000000011; Rohrer M, 2005, INVEST RADIOL, V40, P715, DOI 10.1097/01.rli.0000184756.66360.d3; Subleski JJ, 2015, J HEPATOL, V63, P1181, DOI 10.1016/j.jhep.2015.06.021; Szpak A, 2014, J NANOPART RES, V16, DOI 10.1007/s11051-014-2678-6; Wang FS, 2014, HEPATOLOGY, V60, P2099, DOI 10.1002/hep.27406; Williams R, 2006, HEPATOLOGY, V44, P521, DOI 10.1002/hep.21347; Yoo HJ, 2008, INVEST RADIOL, V43, P538, DOI 10.1097/RLI.0b013e3181768d96; Yoo SH, 2013, ANN SURG ONCOL, V20, P2893, DOI 10.1245/s10434-013-3001-y; Yu MH, 2014, RADIOLOGY, V271, P748, DOI 10.1148/radiol.14131996; Yu MH, 2013, J MAGN RESON IMAGING, V38, P1020, DOI 10.1002/jmri.24088; Yu NC, 2011, CLIN GASTROENTEROL H, V9, P161, DOI 10.1016/j.cgh.2010.09.017; Zhang BH, 1999, J MED SCREEN, V6, P108, DOI 10.1136/jms.6.2.108	30	6	7	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0148695	10.1371/journal.pone.0148695	http://dx.doi.org/10.1371/journal.pone.0148695			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26886558	Green Submitted, Green Published, gold			2022-12-26	WOS:000371218400044
J	Taulemesse, F; Le Gouis, J; Gouache, D; Gibon, Y; Allard, V				Taulemesse, Francois; Le Gouis, Jacques; Gouache, David; Gibon, Yves; Allard, Vincent			Bread Wheat (Triticum aestivum L.) Grain Protein Concentration Is Related to Early Post-Flowering Nitrate Uptake under Putative Control of Plant Satiety Level	PLOS ONE			English	Article							WINTER-WHEAT; NITROGEN-UPTAKE; TRANSPORTER GENE; NEGATIVE RELATIONSHIP; GLUTAMINE-SYNTHETASE; EXPRESSION PATTERNS; GENOMIC ANALYSIS; PRIMARY RESPONSE; GROWTH-STAGES; CEREAL GRAIN	The strong negative correlation between grain protein concentration (GPC) and grain yield (GY) in bread wheat complicates the simultaneous improvement of these traits. However, earlier studies have concluded that the deviation from this relationship (grain protein deviation or GPD) has strong genetic basis. Genotypes with positive GPD have an increased ability to uptake nitrogen (N) during the post-flowering period independently of the amount of N taken up before flowering, suggesting that genetic variability for N satiety could enable the breakage of the negative relationship. This study is based on two genotypes markedly contrasted for GPD grown under semi-hydroponic conditions differentiated for nitrate availability both before and after flowering. This allows exploration of the genetic determinants of post-flowering N uptake (PANU) by combining whole plant sampling and targeted gene expression approaches. The results highlights the correlation (r(2) = 0.81) with GPC of PANU occurring early during grain development (flowering-flowering + 250 degree-days) independently of GY. Early PANU was in turn correlated (r(2) = 0.80) to the stem-biomass increment after flowering through its effect on N sink activity. Differences in early PANU between genotypes, despite comparable N statuses at flowering, suggest that genetic differences in N satiety could be involved in the establishment of the GPC. Through its strong negative correlation with genes implied in N assimilation, root nitrate concentration appears to be a good marker for evaluating instantaneous plant N demand, and may provide valuable information on the genotypic N satiety level. This trait may help breeders to identify genotypes having high GPC independently of their GY.	[Taulemesse, Francois; Le Gouis, Jacques; Allard, Vincent] INRA, UMR Genet Divers & Ecophysiol Cereales 1095, 5 Chemin Beaulieu, F-63100 Clermont Ferrand, France; [Taulemesse, Francois; Le Gouis, Jacques; Allard, Vincent] Univ Blaise Pascal, UMR Genet Divers & Ecophysiol Cereales 1095, F-63178 Aubiere, France; [Taulemesse, Francois; Gouache, David] Arvalis Inst Vegetal, Stn Expt Boigneville, F-91720 Boigneville, France; [Gibon, Yves] INRA, UMR Biol Fruit & Pathol 1332, 71 Ave Edouard Bourlaux, F-33882 Villenave Dornon, France	INRAE; Centre National de la Recherche Scientifique (CNRS); Universite Clermont Auvergne (UCA); INRAE	Allard, V (corresponding author), INRA, UMR Genet Divers & Ecophysiol Cereales 1095, 5 Chemin Beaulieu, F-63100 Clermont Ferrand, France.; Allard, V (corresponding author), Univ Blaise Pascal, UMR Genet Divers & Ecophysiol Cereales 1095, F-63178 Aubiere, France.	vincent.allard@clermont.inra.fr	Gouache, David/AAX-2128-2020; Allard, Vincent/B-8806-2009	Allard, Vincent/0000-0003-1949-9158; Gibon, Yves/0000-0001-8161-1089	French "Fonds de Soutien a l'Obtention Vegetale" (FSOV) [2010F]; ANRT (Association Nationale de la Recherche et de la Technologie) [CIFRE 878/2011]	French "Fonds de Soutien a l'Obtention Vegetale" (FSOV); ANRT (Association Nationale de la Recherche et de la Technologie)(French National Research Agency (ANR))	This work was supported by the French "Fonds de Soutien a l'Obtention Vegetale" (FSOV) 2010F project (2011-2013). The authors are also grateful to the ANRT (Association Nationale de la Recherche et de la Technologie) which supports the PhD thesis (CIFRE 878/2011) during which the analyses were conducted.	[Anonymous], 2004, AZ QUANT PCR; Barbottin A, 2005, CROP SCI, V45, P1141, DOI 10.2135/cropsci2003.0361; Barneix AJ, 2007, J PLANT PHYSIOL, V164, P581, DOI 10.1016/j.jplph.2006.03.009; Bertheloot J, 2012, EUR J AGRON, V42, P11, DOI 10.1016/j.eja.2012.03.005; Bogard M, 2010, J EXP BOT, V61, P4303, DOI 10.1093/jxb/erq238; Boisson M, 2005, THEOR APPL GENET, V110, P932, DOI 10.1007/s00122-004-1913-4; Branlard G, 2001, EUPHYTICA, V119, P59, DOI 10.1023/A:1017586220359; Buchner P, 2014, J EXP BOT, V65, P5697, DOI 10.1093/jxb/eru231; CALDERINI DF, 1995, ANN BOT-LONDON, V76, P315, DOI 10.1006/anbo.1995.1101; Calderini DF, 1998, FIELD CROP RES, V57, P335, DOI 10.1016/S0378-4290(98)00080-X; Cao Y, 2008, PEDOSPHERE, V18, P664, DOI 10.1016/S1002-0160(08)60061-2; Carillo P, 2005, FUNCT PLANT BIOL, V32, P209, DOI 10.1071/FP04184; CASTLE SL, 1987, AUST J PLANT PHYSIOL, V14, P503, DOI 10.1071/PP9870503; COX MC, 1985, CROP SCI, V25, P435, DOI 10.2135/cropsci1985.0011183X002500030003x; COX MC, 1986, CROP SCI, V26, P737, DOI 10.2135/cropsci1986.0011183X002600040022x; Cross JM, 2006, PLANT PHYSIOL, V142, P1574, DOI 10.1104/pp.106.086629; Feil B., 1997, AGRONOMY, V1, P103; Forde BG, 2000, BBA-BIOMEMBRANES, V1465, P219, DOI 10.1016/S0005-2736(00)00140-1; Foulkes MJ, 2009, FIELD CROP RES, V114, P329, DOI 10.1016/j.fcr.2009.09.005; Gaju O, 2011, FIELD CROP RES, V123, P139, DOI 10.1016/j.fcr.2011.05.010; Garnett T, 2013, NEW PHYTOL, V198, P82, DOI 10.1111/nph.12166; Glass ADM, 2009, BOTANY, V87, P659, DOI 10.1139/B09-014; Gooding MJ, 2007, FIELD CROP RES, V100, P143, DOI 10.1016/j.fcr.2006.06.002; GOODING MJ, 1992, FERT RES, V32, P209, DOI 10.1007/BF01048783; GOWRI G, 1992, PLANT MOL BIOL, V18, P55, DOI 10.1007/BF00018456; Groos C, 2003, THEOR APPL GENET, V106, P1032, DOI 10.1007/s00122-002-1111-1; IMSANDE J, 1994, PLANT PHYSIOL, V105, P3, DOI 10.1104/pp.105.1.3; JUSTES E, 1994, ANN BOT-LONDON, V74, P397, DOI 10.1006/anbo.1994.1133; Kichey T, 2007, FIELD CROP RES, V102, P22, DOI 10.1016/j.fcr.2007.01.002; KING BJ, 1993, PLANT PHYSIOL, V102, P1279, DOI 10.1104/pp.102.4.1279; Koekemoer FP, 1999, CEREAL RES COMMUN, V27, P107; Le Bail M, 2005, EUR J AGRON, V23, P379, DOI 10.1016/j.eja.2005.02.003; Le Gouis J, 2000, EUR J AGRON, V12, P163, DOI 10.1016/S1161-0301(00)00045-9; Lemaire G., 1997, DIAGNOSIS NITROGEN S, P3, DOI [DOI 10.1007/978-3-642-60684-7, 10.1007/978-3-642-60684-7, DOI 10.1007/978-3-642-60684-7_1]; Leran S, 2014, TRENDS PLANT SCI, V19, P5, DOI 10.1016/j.tplants.2013.08.008; Lin CM, 2000, PLANT PHYSIOL, V122, P379, DOI 10.1104/pp.122.2.379; Liu JS, 2015, CROP PASTURE SCI, V66, P671, DOI 10.1071/CP14264; Maathuis FJM, 2009, CURR OPIN PLANT BIOL, V12, P250, DOI 10.1016/j.pbi.2009.04.003; Martre P, 2003, PLANT PHYSIOL, V133, P1959, DOI 10.1104/pp.103.030585; Martre P, 2006, EUR J AGRON, V25, P138, DOI 10.1016/j.eja.2006.04.007; Masclaux-Daubresse C, 2010, ANN BOT-LONDON, V105, P1141, DOI 10.1093/aob/mcq028; MATTSSON M, 1992, J EXP BOT, V43, P25, DOI 10.1093/jxb/43.1.25; Melino VJ, 2015, FUNCT PLANT BIOL, V42, P942, DOI 10.1071/FP15041; Miller AJ, 2007, J EXP BOT, V58, P2297, DOI 10.1093/jxb/erm066; Monaghan JM, 2001, EUPHYTICA, V122, P309, DOI 10.1023/A:1012961703208; Nazoa P, 2003, PLANT MOL BIOL, V52, P689, DOI 10.1023/A:1024899808018; Olesen JE, 2002, EUR J AGRON, V16, P279, DOI 10.1016/S1161-0301(01)00134-4; OSCARSON P, 1995, PLANT SOIL, V175, P179, DOI 10.1007/BF00011353; Oscarson P, 1996, ANN BOT-LONDON, V78, P479, DOI 10.1006/anbo.1996.0145; Oscarson P, 2000, J EXP BOT, V51, P1921, DOI 10.1093/jexbot/51.352.1921; OSCARSON P, 1995, CROP SCI, V35, P1056, DOI 10.2135/cropsci1995.0011183X003500040023x; Oury FX, 2007, EUPHYTICA, V157, P45, DOI 10.1007/s10681-007-9395-5; Oury FX, 2003, J GENET BREED, P57; PALTA JA, 1995, AUST J AGR RES, V46, P519, DOI 10.1071/AR9950519; Pang JY, 2015, FUNCT PLANT BIOL, V42, P1179, DOI 10.1071/FP15215; Paolacci AR, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-11; R Core Team, 2012, R LANG ENV STAT COMP; REDINBAUGH MG, 1993, PLANT PHYSIOL, V101, P1249, DOI 10.1104/pp.101.4.1249; Rothstein SJ, 2007, PLANT CELL, V19, P2695, DOI 10.1105/tpc.107.053074; Sadras VO, 2010, FIELD CROP RES, V118, P297, DOI 10.1016/j.fcr.2010.06.010; Shewry PR, 2007, J CEREAL SCI, V46, P239, DOI 10.1016/j.jcs.2007.06.006; SIDDIQI MY, 1990, PLANT PHYSIOL, V93, P1426, DOI 10.1104/pp.93.4.1426; SIMMONDS NW, 1995, J SCI FOOD AGR, V67, P309, DOI 10.1002/jsfa.2740670306; Stitt M, 1999, CURR OPIN PLANT BIOL, V2, P178, DOI 10.1016/S1369-5266(99)80033-8; Taulemesse F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120291; TOTTMAN DR, 1979, ANN APPL BIOL, V93, P221, DOI 10.1111/j.1744-7348.1979.tb06534.x; Triboi E, 2006, EUR J AGRON, V25, P108, DOI 10.1016/j.eja.2006.04.004; Tsay YF, 2007, FEBS LETT, V581, P2290, DOI 10.1016/j.febslet.2007.04.047; VANSANFORD DA, 1987, CROP SCI, V27, P295, DOI 10.2135/cropsci1987.0011183X002700020035x; Vidmar JJ, 2000, PLANT PHYSIOL, V123, P307, DOI 10.1104/pp.123.1.307; WALDREN RP, 1979, AGRON J, V71, P391, DOI 10.2134/agronj1979.00021962007100030004x; Wang P, 2011, AGR SCI CHINA, V10, P695, DOI 10.1016/S1671-2927(11)60052-7; Wang RC, 2000, PLANT CELL, V12, P1491, DOI 10.1105/tpc.12.8.1491; Wang RC, 2004, PLANT PHYSIOL, V136, P2512, DOI 10.1104/pp.104.044610; Yin LP, 2007, PLANT SCI, V172, P621, DOI 10.1016/j.plantsci.2006.11.014	75	28	28	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0149668	10.1371/journal.pone.0149668	http://dx.doi.org/10.1371/journal.pone.0149668			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26886933	Green Published, gold			2022-12-26	WOS:000371218400102
J	Teklemariam, A; Hodson-Tole, EF; Reeves, ND; Costen, NP; Cooper, G				Teklemariam, A.; Hodson-Tole, E. F.; Reeves, N. D.; Costen, N. P.; Cooper, G.			A Finite Element Model Approach to Determine the Influence of Electrode Design and Muscle Architecture on Myoelectric Signal Properties	PLOS ONE			English	Article							SURFACE EMG MODEL; MOTOR UNIT; GASTROCNEMIUS-MEDIALIS; RECRUITMENT PATTERNS; POTENTIALS; SIMULATION	Introduction Surface electromyography (sEMG) is the measurement of the electrical activity of the skeletal muscle tissue detected at the skin's surface. Typically, a bipolar electrode configuration is used. Most muscles have pennate and/or curved fibres, meaning it is not always feasible to align the bipolar electrodes along the fibres direction. Hence, there is a need to explore how different electrode designs can affect sEMG measurements. Method A three layer finite element (skin, fat, muscle) muscle model was used to explore different electrode designs. The implemented model used as source signal an experimentally recorded intramuscular EMG taken from the biceps brachii muscle of one healthy male. A wavelet based intensity analysis of the simulated sEMG signal was performed to analyze the power of the signal in the time and frequency domain. Results The model showed muscle tissue causing a bandwidth reduction (to 20-92-Hz). The inter-electrode distance (IED) and the electrode orientation relative to the fibres affected the total power but not the frequency filtering response. The effect of significant misalignment between the electrodes and the fibres (60 degrees-90 degrees) could be reduced by increasing the IED (25-30 mm), which attenuates signal cancellation. When modelling pennated fibres, the muscle tissue started to act as a low pass filter. The effect of different IED seems to be enhanced in the pennated model, while the filtering response is changed considerably only when the electrodes are close to the signal termination within the model. For pennation angle greater than 20 degrees, more than 50% of the source signal was attenuated, which can be compensated by increasing the IED to 25 mm. Conclusion Differences in tissue filtering properties, shown in our model, indicates that different electrode designs should be considered for muscle with different geometric properties (i.e. pennated muscles).	[Teklemariam, A.] Manchester Metropolitan Univ, Sch Engn, Manchester M15 6BH, Lancs, England; [Hodson-Tole, E. F.; Reeves, N. D.] Manchester Metropolitan Univ, Sch Healthcare Sci, Manchester M15 6BH, Lancs, England; [Costen, N. P.] Manchester Metropolitan Univ, Sch Comp Math & Digital Technol, Manchester M15 6BH, Lancs, England; [Cooper, G.] Univ Manchester, Sch Mech Aerosp & Civil Engn, Manchester, Lancs, England	Manchester Metropolitan University; University of Manchester; Manchester Metropolitan University; Manchester Metropolitan University; University of Manchester	Teklemariam, A (corresponding author), Manchester Metropolitan Univ, Sch Engn, Manchester M15 6BH, Lancs, England.	aron.teklemariam@stu.mmu.ac.uk	Hodson-Tole, Emma F./H-1113-2011; Cooper, Glen/M-5232-2017	Hodson-Tole, Emma F./0000-0003-1200-1724; Cooper, Glen/0000-0002-9568-8973; Teklemariam, Aron/0000-0002-5746-5736; Reeves, Neil/0000-0001-9213-4580; Costen, Nicholas/0000-0001-9454-8840	faculty of Science and Engineering, Manchester Metropolitan Univerity, Manchester, UK	faculty of Science and Engineering, Manchester Metropolitan Univerity, Manchester, UK	This project was funded by the faculty of Science and Engineering, Manchester Metropolitan Univerity, Manchester, UK.	ANDREASSEN S, 1978, IEEE T BIO-MED ENG, V25, P501, DOI 10.1109/TBME.1978.326283; Andreuccetti D., 1997, CALCULATION DIELECTR; Basmajian JV, 1985, MUSCLES ALIVE THEIR, pxii; Blok JH, 2002, ANN BIOMED ENG, V30, P566, DOI 10.1114/1.1475345; Botter A, 1985, J APPL PHYSIOL, V115, P1203; De Luca CJ, 2012, J BIOMECH, V45, P555, DOI 10.1016/j.jbiomech.2011.11.010; DELABARRERA EJ, 1994, ELECTROEN CLIN NEURO, V93, P91, DOI 10.1016/0168-5597(94)90071-X; FUGLEVAND AJ, 1992, BIOL CYBERN, V67, P143, DOI 10.1007/BF00201021; GIELEN FLH, 1984, MED BIOL ENG COMPUT, V22, P569, DOI 10.1007/BF02443872; GOOTZEN THJM, 1989, J APPL PHYS, V66, P4504, DOI 10.1063/1.343949; Hodson-Tole EF, 2007, J EXP BIOL, V210, P2333, DOI 10.1242/jeb.004457; Hodson-Tole EF, 2013, J ELECTROMYOGR KINES, V23, P43, DOI 10.1016/j.jelekin.2012.08.003; Lieber RL, 2011, PHILOS T R SOC B, V366, P1466, DOI 10.1098/rstb.2010.0316; Lieber RL, 2000, MUSCLE NERVE, V23, P1647, DOI 10.1002/1097-4598(200011)23:11<1647::AID-MUS1>3.0.CO;2-M; Lindstrom L, 1970, Electromyography, V10, P341; Lowery MM, 2004, IEEE T BIO-MED ENG, V51, P2138, DOI 10.1109/TBME.2004.836494; Lowery MM, 2003, IEEE T BIO-MED ENG, V50, P789, DOI 10.1109/TBME.2003.812152; Lowery MM, 2002, IEEE T BIO-MED ENG, V49, P446, DOI 10.1109/10.995683; Ltd Comsol, COMS MULT 5 0 AC DC, P32; Merletti R, 1999, IEEE T BIO-MED ENG, V46, P821, DOI 10.1109/10.771191; Merletti R, 1999, IEEE T BIO-MED ENG, V46, P810, DOI 10.1109/10.771190; Merletti R, 2009, PHILOS T R SOC A, V367, P357, DOI 10.1098/rsta.2008.0235; Mesin L, 2006, IEEE T BIO-MED ENG, V53, P593, DOI 10.1109/TBME.2006.870256; Mesin L, 2004, IEEE T BIO-MED ENG, V51, P1521, DOI 10.1109/TBME.2004.827551; Mesin L, 2011, J BIOMECH, V44, P1096, DOI 10.1016/j.jbiomech.2011.01.031; Nigg BM, 2007, BIOMECHANICS MUSCULO, Vxiii; PLONSEY R, 1967, B MATH BIOPHYS, V29, P657, DOI 10.1007/BF02476917; Sherrington C, 1929, P R SOC LOND B-CONTA, V105, P332, DOI 10.1098/rspb.1929.0047; Teklemariam A, 2014, COMM SYST NETW DIG S; Trontelj JV, 2005, ELECTROMYOGRAPHY PHY, P27; Vieira TMM, 2011, J PHYSIOL-LONDON, V589, P431, DOI 10.1113/jphysiol.2010.201806; Vieira TMM, 2015, REV ANDAL MED DEPORT, V08, P17; von Tscharner V, 2000, J ELECTROMYOGR KINES, V10, P433, DOI 10.1016/S1050-6411(00)00030-4; von Tscharner V, 2013, J ELECTROMYOGR KINES, V23, P1044, DOI 10.1016/j.jelekin.2013.07.011; Wakeling JM, 2012, ANN BIOMED ENG, V40, P1708, DOI 10.1007/s10439-012-0531-6; Wakeling JM, 2009, J ELECTROMYOGR KINES, V19, P199, DOI 10.1016/j.jelekin.2007.09.006; Wakeling JM, 2002, J EXP BIOL, V205, P359; Wakeling JM, 2001, EUR J APPL PHYSIOL, V86, P40, DOI 10.1007/s004210100508; Wheeler KA, 2010, IEEE ENG MED BIO, P4258, DOI 10.1109/IEMBS.2010.5627175	39	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0148275	10.1371/journal.pone.0148275	http://dx.doi.org/10.1371/journal.pone.0148275			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26886908	gold, Green Submitted, Green Published			2022-12-26	WOS:000371218400025
J	Iturbe-Espinoza, P; Gil-Moreno, S; Lin, WY; Calatayud, S; Palacios, O; Capdevila, M; Atrian, S				Iturbe-Espinoza, Paul; Gil-Moreno, Selene; Lin, Weiyu; Calatayud, Sara; Palacios, Oscar; Capdevila, Merce; Atrian, Silvia			The Fungus Tremella mesenterica Encodes the Longest Metallothionein Currently Known: Gene, Protein and Metal Binding Characterization	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; COPPER-METALLOTHIONEIN; CU; FEATURES; INSIGHT; YEAST; ZN; AMPLIFICATION; CADMIUM(II); EVOLUTION	Fungal Cu-thioneins, and among them, the paradigmatic Neurospora crassa metallothionein (MT) (26 residues), were once considered as the shortest MTs -the ubiquitous, versatile metal-binding proteins-among all organisms, and thus representatives of their primeval forms. Nowadays, fungal MTs of diverse lengths and sequence features are known, following the huge heterogeneity of the Kingdom of Fungi. At the opposite end of N. crassa MT, the recently reported Cryptococcus neoformans CnMT1 and CnMT2 (122 and 186 aa) constitute the longest reported fungal MTs, having been identified as virulence factors of this pathogen. CnMTs are high-capacity Cu-thioneins that appear to be built by tandem amplification of a basic unit, a 7-Cys segment homologous to N. crassa MT. Here, we report the in silico, in vivo and in vitro study of a still longer fungal MT, belonging to Tremella mesenterica (TmMT), a saprophytic ascomycete. The TmMT gene has 10 exons, and it yields a 779-bp mature transcript that encodes a 257 residue-long protein. This MT is also built by repeated fragments, but of variable number of Cys: six units of the 7-Cys building blocks-CXCX(3)CSCPPGXCXCAXCP-, two fragments of six Cys, plus three Cys at the N-terminus. TmMT metal binding abilities have been analyzed through the spectrophotometric and spectrometric characterization of its recombinant Zn-, Cd- and Cu-complexes. Results allow it to be unambiguous classified as a Cu-thionein, also of extraordinary coordinating capacity. According to this feature, when the TmMT cDNA is expressed in MT-devoid yeast cells, it is capable of restoring a high Cu tolerance level. Since it is not obvious that T. mesenterica shares the same physiological needs for a high capacity Cu-binding protein with C. neoformans, the existence of this peculiar MT might be better explained on the basis of a possible role in Cu-handling for the Cu-enzymes responsible in lignin degradation pathways.	[Iturbe-Espinoza, Paul; Lin, Weiyu; Calatayud, Sara; Atrian, Silvia] Univ Barcelona, Fac Biol, Dept Genet, Barcelona, Spain; [Gil-Moreno, Selene; Palacios, Oscar; Capdevila, Merce] Univ Autonoma Barcelona, Fac Ciencies, Dept Quim, E-08193 Barcelona, Spain	University of Barcelona; Autonomous University of Barcelona	Atrian, S (corresponding author), Univ Barcelona, Fac Biol, Dept Genet, Barcelona, Spain.	satrian@ub.edu	Palacios, Òscar/AAJ-3492-2021; Capdevila, Mercè/F-5374-2015; Palacios, Oscar/C-8974-2009; Capdevila, Mercè/ABG-4588-2020	Palacios, Òscar/0000-0002-2987-7303; Capdevila, Mercè/0000-0002-2246-0994; Palacios, Oscar/0000-0002-2987-7303; Capdevila, Mercè/0000-0002-2246-0994; Iturbe-Espinoza, Paul Adrian/0000-0002-1313-5532; Calatayud, Sara/0000-0001-8360-6179	Spanish Ministerio de Economia y Competitividad (MINECO) - European Union through the FEDER program [BIO2012-39682-C02-01, BIO2012-39682-C02-02]	Spanish Ministerio de Economia y Competitividad (MINECO) - European Union through the FEDER program	This work was supported by the Spanish Ministerio de Economia y Competitividad (MINECO), grants BIO2012-39682-C02-01 (to SA) and -02 (to MC), which are co-financed by the European Union through the FEDER program. Authors are members of the 2014SGR-423 Grup de Recerca de la Generalitat de Catalunya.	Adamo GM, 2012, MICROBIOL-SGM, V158, P2325, DOI 10.1099/mic.0.058024-0; Artells E, 2013, METALLOMICS, V5, P1397, DOI 10.1039/c3mt00123g; Binz PA, 1999, METALLOTHIONEIN IV, P7; Blindauer CA, 2014, RSC METALLOBIO SER, V2, P606; Bofill R, 1999, J INORG BIOCHEM, V73, P57, DOI 10.1016/S0162-0134(98)10091-0; Bofill R, 2009, METALLOMICS, V1, P229, DOI 10.1039/b904953c; BONGERS J, 1988, ANAL CHEM, V60, P2683, DOI 10.1021/ac00175a008; Capdevila M, 2005, ANGEW CHEM INT EDIT, V44, P4618, DOI 10.1002/anie.200501183; Capdevila M, 2012, COORDIN CHEM REV, V256, P46, DOI 10.1016/j.ccr.2011.07.006; Capdevila M, 1997, CELL MOL LIFE SCI, V53, P681, DOI 10.1007/s000180050088; Capdevila M, 2011, J BIOL INORG CHEM, V16, P977, DOI 10.1007/s00775-011-0798-3; Cols N, 1997, J INORG BIOCHEM, V68, P157, DOI 10.1016/S0162-0134(97)00085-8; CULOTTA VC, 1994, J BIOL CHEM, V269, P25295; Dallinger R, 2005, AM J PHYSIOL-REG I, V289, pR1185, DOI 10.1152/ajpregu.00052.2005; Diaz S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000291; Ding C, 2013, CELL HOST MICROBE, V13, P265, DOI 10.1016/j.chom.2013.02.002; Domenech J, 2008, BBA-PROTEINS PROTEOM, V1784, P693, DOI 10.1016/j.bbapap.2008.01.008; Espart A, 2015, MOL MICROBIOL, V98, P977, DOI 10.1111/mmi.13171; Espart Anna, 2015, Int J Biol Sci, V11, P456, DOI 10.7150/ijbs.11060; Fabris D, 1996, J AM CHEM SOC, V118, P12242, DOI 10.1021/ja962863r; Findley K, 2009, EUKARYOT CELL, V8, P353, DOI 10.1128/EC.00373-08; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Grigoriev IV, 2012, NUCLEIC ACIDS RES, V40, pD26, DOI 10.1093/nar/gkr947; Guirola M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043299; LERCH K, 1980, NATURE, V284, P368, DOI 10.1038/284368a0; Maiti BK, 2007, EUR J INORG CHEM, P5548, DOI 10.1002/ejic.200700784; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; MUNGER K, 1985, BIOCHEMISTRY-US, V24, P6751; NEMER M, 1985, P NATL ACAD SCI USA, V82, P4992, DOI 10.1073/pnas.82.15.4992; Pagani A, 2007, MOL MICROBIOL, V63, P256, DOI 10.1111/j.1365-2958.2006.05510.x; Palacios O, 2014, METALLOMICS, V6, P279, DOI 10.1039/c3mt00266g; Palacios O, 2011, J BIOL INORG CHEM, V16, P991, DOI 10.1007/s00775-011-0827-2; Palacios O, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-4; Perez-Rafael S, 2012, METALLOMICS, V4, P342, DOI 10.1039/c2mt00182a; PRINZ R, 1975, H-S Z PHYSIOL CHEM, V356, P767, DOI 10.1515/bchm2.1975.356.s1.767; Pushie MJ, 2012, BBA-BIOENERGETICS, V1817, P938, DOI 10.1016/j.bbabio.2011.10.004; Sherman F, 1994, METHODS YEAST GENETI, P151; Shuja RN, 2009, MOL BIOL REP, V36, P549, DOI 10.1007/s11033-008-9213-8; Sigel A., 2009, METAL IONS LIFE SCI, V5; Valls M, 2001, J BIOL CHEM, V276, P32835, DOI 10.1074/jbc.M102151200; Vasak M, 2000, CURR OPIN CHEM BIOL, V4, P177, DOI 10.1016/S1367-5931(00)00082-X; Wickerman L, 2012, DEPT AGRIC TECH BULL, V1029, P1; Winge D, 1994, BIOINORGANIC CHEM CO, P110; WINGE DR, 1985, J BIOL CHEM, V260, P4464	44	18	18	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0148651	10.1371/journal.pone.0148651	http://dx.doi.org/10.1371/journal.pone.0148651			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	26882011	Green Published, gold, Green Submitted			2022-12-26	WOS:000371219000020
J	Luo, T; Chen, H; Kassab, GS				Luo, Tong; Chen, Huan; Kassab, Ghassan S.			3D Reconstruction of Coronary Artery Vascular Smooth Muscle Cells	PLOS ONE			English	Article							IMAGE SEGMENTATION; LAMELLAR UNIT	Aims The 3D geometry of individual vascular smooth muscle cells (VSMCs), which are essential for understanding the mechanical function of blood vessels, are currently not available. This paper introduces a new 3D segmentation algorithm to determine VSMC morphology and orientation. Methods and Results A total of 112 VSMCs from six porcine coronary arteries were used in the analysis. A 3D semi-automatic segmentation method was developed to reconstruct individual VSMCs from cell clumps as well as to extract the 3D geometry of VSMCs. A new edge blocking model was introduced to recognize cell boundary while an edge growing was developed for optimal interpolation and edge verification. The proposed methods were designed based on Region of Interest (ROI) selected by user and interactive responses of limited key edges. Enhanced cell boundary features were used to construct the cell's initial boundary for further edge growing. A unified framework of morphological parameters (dimensions and orientations) was proposed for the 3D volume data. Virtual phantom was designed to validate the tilt angle measurements, while other parameters extracted from 3D segmentations were compared with manual measurements to assess the accuracy of the algorithm. The length, width and thickness of VSMCs were 62.9 +/- 14.9 mu m, 4.6 +/- 0.6 mu m and 6.2 +/- 1.8 mu m (mean +/- SD). In longitudinal-circumferential plane of blood vessel, VSMCs align off the circumferential direction with two mean angles of -19.4 +/- 9.3 degrees and 10.9 +/- 4.7 degrees, while an out-of-plane angle (i.e., radial tilt angle) was found to be 8 +/- 7.6 degrees with median as 5.7 degrees. Conclusions A 3D segmentation algorithm was developed to reconstruct individual VSMCs of blood vessel walls based on optical image stacks. The results were validated by a virtual phantom and manual measurement. The obtained 3D geometries can be utilized in mathematical models and leads a better understanding of vascular mechanical properties and function.	[Luo, Tong; Chen, Huan; Kassab, Ghassan S.] IUPUI, Biomed Engn, Indianapolis, IN USA; [Kassab, Ghassan S.] IUPUI, Surg, Indianapolis, IN USA; [Kassab, Ghassan S.] IUPUI, Cellular & Integrat Physiol, Indianapolis, IN USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis	Kassab, GS (corresponding author), IUPUI, Biomed Engn, Indianapolis, IN USA.; Kassab, GS (corresponding author), IUPUI, Surg, Indianapolis, IN USA.; Kassab, GS (corresponding author), IUPUI, Cellular & Integrat Physiol, Indianapolis, IN USA.	gkassab@iupui.edu			National Institute of Health-National Heart, Lung, and Blood Institute [1 R01 HL117990]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL117990] Funding Source: NIH RePORTER	National Institute of Health-National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institute of Health-National Heart, Lung, and Blood Institute Grant 1 R01 HL117990.	Bai XZ, 2009, PATTERN RECOGN, V42, P2434, DOI 10.1016/j.patcog.2009.04.003; Baskurt OK, 2004, CLIN HEMORHEOL MICRO, V30, P169; Bund SJ, 2003, J VASC RES, V40, P547, DOI 10.1159/000075678; Chen H, 2013, BIOMATERIALS, V34, P7575, DOI 10.1016/j.biomaterials.2013.06.035; Cheng J, 2013, 2013 35 ANN INT C IE; CLARK JM, 1985, ARTERIOSCLEROSIS, V5, P19, DOI 10.1161/01.ATV.5.1.19; Coelho LP, 2009, BIOM IM NAN MACR 200; Cui C, 2009, COMPUTATIONAL FRAMEW; Dryden IL, 2006, J APPL STAT, V33, P609, DOI 10.1080/02664760600679825; Elder JH, 2003, IEEE T PATTERN ANAL, V25, P661, DOI 10.1109/TPAMI.2003.1201818; Fernandez G, 1995, NEW PLANT CELL IMAGE; Fok YL, 1996, IEEE T MED IMAGING, V15, P353, DOI 10.1109/42.500144; FUJIWARA T, 1992, CELL TISSUE RES, V270, P165, DOI 10.1007/BF00381891; Funnell W Robert J, 2006, J Nanobiotechnology, V4, P10, DOI 10.1186/1477-3155-4-10; Geisler WS, 2001, VISION RES, V41, P711, DOI 10.1016/S0042-6989(00)00277-7; Ghita O, 2002, J ELECTRON IMAGING, V11, P479, DOI 10.1117/1.1501574; Goncalves W. N., 2012, ARXIV12013109; HANSEN TR, 1980, BLOOD VESSELS, V17, P302; Histace A, 2013, ANN BRIT MACHINE VIS, V2013, P1; Hollander Y, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4003324; Hukkanen J, 2011, P EUR SIGN PROC C BA; Irvine JD, 1999, J PHARM SCI, V88, P28, DOI 10.1021/js9803205; JAIN AK, 1980, IEEE T PATTERN ANAL, V2, P232, DOI 10.1109/TPAMI.1980.4767010; JI LA, 1989, PATTERN RECOGN, V22, P519, DOI 10.1016/0031-3203(89)90021-6; Jung C, 2010, IEEE T BIO-MED ENG, V57, P2825, DOI 10.1109/TBME.2010.2060486; KANIZSA G, 1979, ORG VISION ESSAYS GE; Khan MA, 2011, MOTION TWEENING SKEL, P179; Kim YJ, 2007, CYTOM PART A, V71A, P8, DOI 10.1002/cyto.a.20334; Klemencic A, 1996, PATT REC 1996 P 13 I; Kumar S, 2006, PATTERN RECOGN, V39, P1088, DOI 10.1016/j.patcog.2005.11.014; McDonald DM, 2003, NAT MED, V9, P713, DOI 10.1038/nm0603-713; Meijering E, 2012, IEEE SIGNAL PROC MAG, V29, P140, DOI 10.1109/MSP.2012.2204190; Mishra A, 2009, COMP VIS 2009 IEEE 1; Nattkemper TW, 2004, STUD HEALTH TECHNOL, V107, P847; O'Connell MK, 2008, MATRIX BIOL, V27, P171, DOI 10.1016/j.matbio.2007.10.008; PAL NR, 1993, PATTERN RECOGN, V26, P1277, DOI 10.1016/0031-3203(93)90135-J; Peyre G, 2011, COMPUT SCI ENG, V13, P94, DOI 10.1109/MCSE.2011.71; Rohde GK, 2013, 2013 35 ANN INT C IE; Saber E, 1997, IMAGE VISION COMPUT, V15, P769, DOI 10.1016/S0262-8856(97)00019-X; Schmitt O, 2009, COMPUT VIS IMAGE UND, V113, P188, DOI 10.1016/j.cviu.2008.08.011; Slomka N, 2010, J BIOMECH, V43, P1806, DOI 10.1016/j.jbiomech.2010.02.011; Smochina C, 2011, TECHNICAL REPORT; Smochina C, 2011, P 27 SPRING C COMP G; Stahl JS, 2007, IEEE T IMAGE PROCESS, V16, P2590, DOI 10.1109/TIP.2007.904463; Taber L.A., 1995, APPL MECH REV, V48, P487, DOI [10.1115/1.3005109, DOI 10.1115/1.3005109]; TODD ME, 1983, CIRC RES, V53, P319, DOI 10.1161/01.RES.53.3.319; Vito RP, 2003, ANNU REV BIOMED ENG, V5, P413, DOI 10.1146/annurev.bioeng.5.011303.120719; Wang H, 2006, COMP VIS PATT REC WO; Wang S, 2003, IEEE T PATTERN ANAL, V25, P675, DOI 10.1109/TPAMI.2003.1201819; WOLINSKY H, 1967, CIRC RES, V20, P99, DOI 10.1161/01.RES.20.1.99; Wood ST, 2013, MED IMAGE ANAL, V17, P337, DOI 10.1016/j.media.2012.12.002	51	5	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0147272	10.1371/journal.pone.0147272	http://dx.doi.org/10.1371/journal.pone.0147272			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	26882342	gold, Green Published, Green Submitted			2022-12-26	WOS:000371219000003
J	Hsu, AL; Chou, KH; Chao, YP; Fan, HY; Wu, CWW; Chen, JH				Hsu, Ai-Ling; Chou, Kun-Hsien; Chao, Yi-Ping; Fan, Hsin-Ya; Wu, Changwei W.; Chen, Jyh-Horng			Physiological Contribution in Spontaneous Oscillations: An Approximate Quality-Assurance Index for Resting-State fMRI Signals	PLOS ONE			English	Article							TO-NOISE RATIO; FUNCTIONAL CONNECTIVITY; RESPONSE FUNCTION; MOTION; BRAIN; NETWORK; MRI; RECONSTRUCTION; FLUCTUATIONS; ACTIVATION	Resting-state fMRI (rs-fMRI) is receiving substantial attention for its sensitivity to functional abnormality in the brain networks of people with psychiatric and neurological disorders. However, because of the variety of rs-fMRI processing methods, the necessity of rs-fMRI quality assurance is increasing. Conventionally, the temporal signal-to-noise ratio (tSNR) is generally adopted for quality examination, but the tSNR does not guarantee reliable functional connectivity (FC) outcomes. Theoretically, intrinsic FC is supposed to reflect the spontaneous synchronization of neuronal basis, rather than that from thermal noise or non-neuronal physiological noise. Therefore, we proposed a new quality-assurance index for rs-fMRI to estimate the physiological contributions in spontaneous oscillations (PICSO). The PICSO index was designed as a voxel-wise measure for facilitating practical applications to all existing rs-fMRI data sets on the basis of two assumptions: Gaussian distributions in temporal fluctuations and ultra-slow changes of neural-based physiological fluctuations. To thoroughly validate the sensitivity of the proposed PICSO index to FC, we calibrated the preprocessing steps according to phantom data and verified the relationship between the PICSO and factors that are considered to affect FC in healthy participants (n = 12). Our results demonstrated that FC showed a significantly positive correlation with the PICSO. Moreover, for generating robust FC outcomes, directly acquiring data at a relatively large voxel size was more effective than performing smoothness on high-resolution data sets. In conclusion, compared with tSNR, the PICSO index is more sensitive to the resulting FC, providing a practical quality-assurance indicator for all existing rs-fMRI data sets.	[Hsu, Ai-Ling; Chen, Jyh-Horng] Natl Taiwan Univ, Inst Biomed Elect & Bioinformat, Taipei 10764, Taiwan; [Chou, Kun-Hsien] Natl Yang Ming Univ, Brain Res Ctr, Taipei 112, Taiwan; [Chao, Yi-Ping] Chang Gung Univ, Grad Inst Med Mechatron, Taoyuan, Taiwan; [Fan, Hsin-Ya] Natl Yang Ming Univ, Inst Neurosci, Taipei 112, Taiwan; [Wu, Changwei W.] Natl Cent Univ, Dept Biomed Sci & Engn, Taoyuan, Taiwan; [Wu, Changwei W.] Taipei Med Univ, Shuang Ho Hosp, Brain & Consciousness Res Ctr, New Taipei, Taiwan	National Taiwan University; National Yang Ming Chiao Tung University; Chang Gung University; National Yang Ming Chiao Tung University; National Central University; Taipei Medical University; Shuang Ho Hospital	Chen, JH (corresponding author), Natl Taiwan Univ, Inst Biomed Elect & Bioinformat, Taipei 10764, Taiwan.; Wu, CWW (corresponding author), Natl Cent Univ, Dept Biomed Sci & Engn, Taoyuan, Taiwan.; Wu, CWW (corresponding author), Taipei Med Univ, Shuang Ho Hosp, Brain & Consciousness Res Ctr, New Taipei, Taiwan.	restingfmri@gmail.com; jyhhchen2@gmail.com	Chao, Yi-Ping/GOP-0833-2022	Chao, Yi-Ping/0000-0002-1681-5410; Hsu, Ai-Ling/0000-0002-6801-4658; Wu, Changwei W./0000-0001-8968-9366	Ministry of Science and Technology [MOST 104-2321-B-002-040, MOST 103-2320-B-008-001, MOST 104-2221-E-008-123]; Veterans General Hospitals University System of Taiwan [VGHUST103-G1-4-3]; Chang Gung Memorial Hospital [BMRPC78]; Chang Gung University Research Project [UERPD2D0081]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Veterans General Hospitals University System of Taiwan; Chang Gung Memorial Hospital(Chang Gung Memorial Hospital); Chang Gung University Research Project	This study was supported in part by Ministry of Science and Technology (MOST 104-2321-B-002-040, MOST 103-2320-B-008-001, and MOST 104-2221-E-008-123), Veterans General Hospitals University System of Taiwan Joint Research Program (VGHUST103-G1-4-3), the Chang Gung Memorial Hospital (BMRPC78) and Chang Gung University Research Project (UERPD2D0081).	Bianciardi M, 2009, MAGN RESON IMAGING, V27, P1019, DOI 10.1016/j.mri.2009.02.004; Birn RM, 2008, NEUROIMAGE, V40, P644, DOI 10.1016/j.neuroimage.2007.11.059; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Bodurka J, 2007, NEUROIMAGE, V34, P542, DOI 10.1016/j.neuroimage.2006.09.039; Boveroux P, 2010, ANESTHESIOLOGY, V113, P1038, DOI 10.1097/ALN.0b013e3181f697f5; Chang C, 2009, NEUROIMAGE, V44, P857, DOI 10.1016/j.neuroimage.2008.09.029; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Dietrich O, 2007, J MAGN RESON IMAGING, V26, P375, DOI 10.1002/jmri.20969; Glover GH, 2000, MAGNET RESON MED, V44, P162, DOI 10.1002/1522-2594(200007)44:1<162::AID-MRM23>3.0.CO;2-E; Gonzalez-Castillo J, 2011, NEUROIMAGE, V54, P2764, DOI 10.1016/j.neuroimage.2010.11.020; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Guldenmund P, 2013, BRAIN CONNECT, V3, P273, DOI 10.1089/brain.2012.0117; Horovitz SG, 2009, P NATL ACAD SCI USA, V106, P11376, DOI 10.1073/pnas.0901435106; Huettel SA, 2009, FUNCTIONAL MAGNETIC; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Kellman P, 2005, MAGNET RESON MED, V54, P1439, DOI 10.1002/mrm.20713; Kruger G, 2001, MAGNET RESON MED, V45, P595, DOI 10.1002/mrm.1081; Leopold DA, 2003, CEREB CORTEX, V13, P422, DOI 10.1093/cercor/13.4.422; Logothetis NK, 2007, NAT NEUROSCI, V10, P1230, DOI 10.1038/nn1007-1230; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Molloy EK, 2014, NEUROIMAGE, V86, P221, DOI 10.1016/j.neuroimage.2013.09.001; Murphy K, 2007, NEUROIMAGE, V34, P565, DOI 10.1016/j.neuroimage.2006.09.032; Power JD, 2015, NEUROIMAGE, V105, P536, DOI 10.1016/j.neuroimage.2014.10.044; Power JD, 2014, NEUROIMAGE, V84, P320, DOI 10.1016/j.neuroimage.2013.08.048; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Reeder SB, 2005, MAGNET RESON MED, V54, P748, DOI 10.1002/mrm.20636; Scheinost D, 2014, NEUROIMAGE, V95, P13, DOI 10.1016/j.neuroimage.2014.03.035; Smith SM, 2013, NEUROIMAGE, V80, P144, DOI 10.1016/j.neuroimage.2013.05.039; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Triantafyllou C, 2005, NEUROIMAGE, V26, P243, DOI 10.1016/j.neuroimage.2005.01.007; Triantafyllou C, 2006, NEUROIMAGE, V32, P551, DOI 10.1016/j.neuroimage.2006.04.182; Triantafyllou C, 2011, NEUROIMAGE, V55, P597, DOI 10.1016/j.neuroimage.2010.11.084; Weisskoff RM, 1996, MAGN RESON MED, V36, P643, DOI 10.1002/mrm.1910360422; Wink AM, 2006, INT J BIOMED IMAGING, V2006, DOI 10.1155/IJBI/2006/12014; Wu CWW, 2011, BRAIN CONNECT, V1, P401, DOI 10.1089/brain.2011.0018; Zhang DY, 2010, NAT REV NEUROL, V6, P15, DOI 10.1038/nrneurol.2009.198	36	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0148393	10.1371/journal.pone.0148393	http://dx.doi.org/10.1371/journal.pone.0148393			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26871897	Green Published, gold, Green Submitted			2022-12-26	WOS:000370054100027
J	Mdaki, KS; Larsen, TD; Weaver, LJ; Baack, ML				Mdaki, Kennedy S.; Larsen, Tricia D.; Weaver, Lucinda J.; Baack, Michelle L.			Age Related Bioenergetics Profiles in Isolated Rat Cardiomyocytes Using Extracellular Flux Analyses	PLOS ONE			English	Article							FATTY-ACID; MITOCHONDRIA; FETAL; RESPIRATION; GLYCOLYSIS; METABOLISM; HEALTH	Mitochondrial dysfunction is increasingly recognized and studied as a mediator of heart disease. Extracellular flux analysis (XF) has emerged as a powerful tool to investigate cellular bioenergetics in the context of cardiac health and disease, however its use and interpretation requires improved understanding of the normal metabolic differences in cardiomyocytes (CM) at various stages of maturation. This study standardized XF analyses methods (mitochondrial stress test, glycolytic stress test and palmitate oxidation test) and established age related differences in bioenergetics profiles of healthy CMs at newborn (NB1), weaning (3WK), adult (10WK) and aged (12-18MO) time points. Findings show that immature CMs demonstrate a more robust and sustained glycolytic capacity and a relative inability to oxidize fatty acids when compared to older CMs. The study also highlights the need to recognize the contribution of CO2 from the Krebs cycle as well as lactate from anaerobic glycolysis to the proton production rate before interpreting glycolytic capacity in CMs. Overall, this study demonstrates that caution should be taken to assure that translatable developmental time points are used to investigate mitochondrial dysfunction as a cause of cardiac disease. Specifically, XF analysis of newborn CMs should be reserved to study fetal/neonatal disease and older CMs (>= 10 weeks) should be used to investigate adult disease pathogenesis. Knowledge gained will aid in improved investigation of developmentally programmed heart disease and stress the importance of discerning maturational differences in bioenergetics when developing mitochondrial targeted preventative and therapeutic strategies for cardiac disease.	[Mdaki, Kennedy S.; Larsen, Tricia D.; Baack, Michelle L.] Sanford Res, Childrens Hlth Res Ctr, Sioux Falls, SD USA; [Weaver, Lucinda J.; Baack, Michelle L.] Univ S Dakota, Sanford Sch Med, Sioux Falls, SD USA; [Baack, Michelle L.] Sanford Childrens Hosp, Childrens Hlth Specialty Clin, Sioux Falls, SD USA	Sanford Health; University of South Dakota; Sanford Health	Baack, ML (corresponding author), Sanford Res, Childrens Hlth Res Ctr, Sioux Falls, SD USA.; Baack, ML (corresponding author), Univ S Dakota, Sanford Sch Med, Sioux Falls, SD USA.; Baack, ML (corresponding author), Sanford Childrens Hosp, Childrens Hlth Specialty Clin, Sioux Falls, SD USA.	michelle.baack@sanfordhealth.org	Baack, Michelle/T-4645-2019; Mdaki, Kennedy/A-7676-2018	Baack, Michelle/0000-0001-5966-669X; Mdaki, Kennedy/0000-0003-4642-2471	start up funds for The Baack Lab from Sanford Research; National Institutes of Health (NIH) The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) [K08HD078504]; University of South Dakota-Sanford School of Medicine Faculty Grant; Sanford Health - South Dakota State University; NIH National Institute of General Medical Sciences (NIGMS) [P20GM103548]	start up funds for The Baack Lab from Sanford Research; National Institutes of Health (NIH) The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); University of South Dakota-Sanford School of Medicine Faculty Grant; Sanford Health - South Dakota State University; NIH National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The study was financially supported by start up funds for The Baack Lab from Sanford Research and grants obatined by MLB from the following: National Institutes of Health (NIH-http://www.nih.gov/) The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) K08HD078504, a University of South Dakota-Sanford School of Medicine Faculty Grant (http://www.usd.edu/medicine) and a Sanford Health - South Dakota State University (https://www.sdstate.edu/) Collaborative Research Grant. Additionally, Seahorse plates, stains and assistance were provided by the Sanford Research Cancer COBRE via support from the NIH National Institute of General Medical Sciences (NIGMS http://www.nigms.nih.gov/Research/Mechanisms/Pages/ProgramProjectGrants.aspx) P20GM103548.	Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; Chacko BK, 2014, CLIN SCI, V127, P367, DOI 10.1042/CS20140101; Costantino S, 2016, J PHYSIOL-LONDON, V594, P2061, DOI 10.1113/JP270538; Divakaruni AS, 2013, P NATL ACAD SCI USA, V110, P5422, DOI 10.1073/pnas.1303360110; DOW JW, 1981, CARDIOVASC RES, V15, P483, DOI 10.1093/cvr/15.9.483; FISHER DJ, 1980, AM J PHYSIOL, V238, pH399, DOI 10.1152/ajpheart.1980.238.3.H399; Go AS, 2014, CIRCULATION, V129, P399, DOI 10.1161/01.cir.0000442015.53336.12; Green K, 2004, DIABETES, V53, pS110, DOI 10.2337/diabetes.53.2007.S110; Hill BG, 2009, BIOCHEM J, V424, P99, DOI 10.1042/BJ20090934; Inc. SB, SEAH BIOSC XF CELL M; Kenwood BM, 2014, MOL METAB, V3, P114, DOI 10.1016/j.molmet.2013.11.005; Kodde IF, 2007, COMP BIOCHEM PHYS A, V146, P26, DOI 10.1016/j.cbpa.2006.09.014; Liao XD, 2004, CELL RES, V14, P16, DOI 10.1038/sj.cr.7290198; Lopaschuk GD, 2010, J CARDIOVASC PHARM, V56, P130, DOI 10.1097/FJC.0b013e3181e74a14; Lopaschuk GD, 2010, PHYSIOL REV, V90, P207, DOI 10.1152/physrev.00015.2009; LOPASCHUK GD, 1991, AM J PHYSIOL, V261, pH1698, DOI 10.1152/ajpheart.1991.261.6.H1698; Marin-Garcia J, 2008, HEART FAIL REV, V13, P137, DOI 10.1007/s10741-007-9079-1; Martin DS, 2010, CRIT CARE, V14, DOI 10.1186/cc9078; McQuaker SJ, 2013, CHEMBIOCHEM, V14, P993, DOI 10.1002/cbic.201300115; Mookerjee SA, 2015, BBA-BIOENERGETICS, V1847, P171, DOI 10.1016/j.bbabio.2014.10.005; Murphy MP, 2000, ADV DRUG DELIVER REV, V41, P235, DOI 10.1016/S0169-409X(99)00069-1; Nisr RB, 2014, BBA-BIOENERGETICS, V1837, P270, DOI 10.1016/j.bbabio.2013.10.012; OHTSUKA T, 1995, J APPL PHYSIOL, V79, P1286, DOI 10.1152/jappl.1995.79.4.1286; Orr DL, 2015, NAT CHEM BIOL, V11, P834, DOI [10.1038/nchembio.1910, 10.1038/NCHEMBIO.1910]; Readnower RD, 2012, PHYSIOL GENOMICS, V44, P1208, DOI 10.1152/physiolgenomics.00129.2012; Sansbury BE, 2011, CHEM-BIOL INTERACT, V191, P288, DOI 10.1016/j.cbi.2010.12.002; Stanley WC, 2005, PHYSIOL REV, V85, P1093, DOI 10.1152/physrev.00006.2004; Tigchelaar W, 2015, AM J PHYSIOL-CELL PH, V308, pC155, DOI 10.1152/ajpcell.00227.2014; Vega RB, 2015, CIRC RES, V116, P1820, DOI 10.1161/CIRCRESAHA.116.305420; Walsh S, 2010, CARDIOVASC RES, V86, P365, DOI 10.1093/cvr/cvq005; WERNER JC, 1983, AM J PHYSIOL, V245, pE19, DOI 10.1152/ajpendo.1983.245.1.E19; Yu H, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056514, 10.1371/journal.pone.0080815]	32	23	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149002	10.1371/journal.pone.0149002	http://dx.doi.org/10.1371/journal.pone.0149002			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26872351	Green Submitted, Green Published, gold			2022-12-26	WOS:000370054100085
J	Ahronian, LG; Zhu, LJ; Chen, YW; Chu, HC; Klimstra, DS; Lewis, BC				Ahronian, L. G.; Zhu, L. J.; Chen, Y-W; Chu, H-C; Klimstra, D. S.; Lewis, B. C.			A novel KLF6-Rho GTPase axis regulates hepatocellular carcinoma cell migration and dissemination	ONCOGENE			English	Article							PROSTATE-CANCER PROGRESSION; NUCLEOTIDE EXCHANGE FACTOR; TUMOR-SUPPRESSOR GENE; RECURRENT MUTATIONS; DOWN-REGULATION; MOUSE MODEL; METASTASIS; EXPRESSION; RECEPTOR; P53	The presence of invasion into the extra-hepatic portion of the portal vein or the development of distant metastases renders hepatocellular carcinoma (HCC) patients ineligible for the only potential curative options for this malignancy-tumor resection or organ transplantation. Gene expression profiling of murine HCC cell lines identified KLF6 as a potential regulator of HCC cell migration. KLF6 knockdown increases cell migration, consistent with the correlation between decreased KLF6 mRNA levels and the presence of vascular invasion in human HCC. Concordantly, single-copy deletion of Klf6 in a HCC mouse model results in increased tumor formation, increased metastasis to the lungs and decreased survival, indicating that KLF6 suppresses both HCC development and metastasis. By combining gene expression profiling and chromatin immunoprecipitation coupled to deep sequencing, we identified novel transcriptional targets of KLF6 in HCC cells including VAV3, a known activator of the RAC1 small GTPase. Indeed, RAC1 activity is increased in KLF6-knockdown cells in a VAV3-dependent manner, and knockdown of either RAC1 or VAV3 impairs HCC cell migration. Together, our data demonstrate a novel function for KLF6 in constraining HCC dissemination through the regulation of a VAV3-RAC1 signaling axis.	[Ahronian, L. G.; Zhu, L. J.; Lewis, B. C.] Univ Massachusetts, Dept Mol Cell & Canc Biol, Sch Med, 364 Plantat St,LRB 521, Worcester, MA 01605 USA; [Zhu, L. J.; Lewis, B. C.] Univ Massachusetts, Program Mol Med, Sch Med, Worcester, MA 01605 USA; [Zhu, L. J.] Univ Massachusetts, Program Bioinformat & Integrat Biol, Sch Med, Worcester, MA 01605 USA; [Chen, Y-W; Chu, H-C] Natl Hlth Res Inst, Natl Inst Canc Res, Maioli, Taiwan; [Klimstra, D. S.] Mem Sloan Kettering Canc Ctr, Dept Pathol, 1275 York Ave, New York, NY 10021 USA; [Lewis, B. C.] Univ Massachusetts, Canc Ctr, Sch Med, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; National Health Research Institutes - Taiwan; Memorial Sloan Kettering Cancer Center; University of Massachusetts System; University of Massachusetts Worcester	Lewis, BC (corresponding author), Univ Massachusetts, Dept Mol Cell & Canc Biol, Sch Med, 364 Plantat St,LRB 521, Worcester, MA 01605 USA.	Brian.Lewis@umassmed.edu		Zhu, Lihua/0000-0001-7416-0590	NIH grant [R01 CA121171]; NATIONAL CANCER INSTITUTE [R01CA121171, P30CA008748] Funding Source: NIH RePORTER	NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Genentech for sharing Klf6<SUP>flox</SUP> mice; Scott Friedman for providing the Klf6<SUP>flox</SUP> mice and sharing data before publication. We thank JiuFeng Cai and Victor Adelanwa for technical assistance; Dr Kerry Burnstein for providing the VAV3 expression constructs; Karl Simin, Leslie Shaw, Scot Wolfe and members of the Lewis lab for helpful discussions and critical review of the manuscript. The assistance of the Memorial Sloan-Kettering Cancer Center Genomics Core and the University of Massachusetts Medical School Genomics and Deep Sequencing core facilities is gratefully acknowledged. This study was supported by NIH grant R01 CA121171 to BCL. The funders played no role in the design, execution or interpretation of the study.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Budhu A, 2006, CANCER CELL, V10, P99, DOI 10.1016/j.ccr.2006.06.016; Buendia MA, 2000, SEMIN CANCER BIOL, V10, P185; Chen LL, 2010, J CLIN INVEST, V120, P1178, DOI 10.1172/JCI40665; Chen YW, 2007, CANCER RES, V67, P7589, DOI 10.1158/0008-5472.CAN-07-0381; Chen YW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069389; Chen YW, 2009, NEOPLASIA, V11, P835, DOI 10.1593/neo.09476; Das A, 2006, J BIOL CHEM, V281, P39105, DOI 10.1074/jbc.M607720200; Difeo A, 2006, ONCOGENE, V25, P6026, DOI 10.1038/sj.onc.1209611; Ding J, 2010, NAT CELL BIOL, V12, P390, DOI 10.1038/ncb2039; Ferlay J, 2013, EUR J CANCER, V49, P1374, DOI 10.1016/j.ejca.2012.12.027; Fujimoto A, 2012, NAT GENET, V44, P760, DOI 10.1038/ng.2291; Gehrau RC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008929; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Hatami R, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004688; Hayat MJ, 2007, ONCOLOGIST, V12, P20, DOI 10.1634/theoncologist.12-1-20; Hirsch DS, 2001, J BIOL CHEM, V276, P875, DOI 10.1074/jbc.M007039200; Iizuka N, 2004, ANTICANCER RES, V24, P4085; Ito G, 2004, CANCER RES, V64, P3838, DOI 10.1158/0008-5472.CAN-04-0185; IZUMI R, 1992, J SURG ONCOL, V49, P151, DOI 10.1002/jso.2930490305; Joberty G, 1999, MOL CELL BIOL, V19, P6585; Jonkers J, 2001, NAT GENET, V29, P418, DOI 10.1038/ng747; Kan ZY, 2013, GENOME RES, V23, P1422, DOI 10.1101/gr.154492.113; Kaposi-Novak P, 2006, J CLIN INVEST, V116, P1582, DOI 10.1172/JCI27236; Katyal S, 2000, RADIOLOGY, V216, P698, DOI 10.1148/radiology.216.3.r00se24698; Kremer-Tal S, 2004, HEPATOLOGY, V40, P1047, DOI 10.1002/hep.20460; Kremer-Tal S, 2007, J HEPATOL, V46, P645, DOI 10.1016/j.jhep.2006.10.012; Lee JS, 2004, GASTROENTEROLOGY, V127, pS51, DOI 10.1053/j.gastro.2004.09.015; Leow CC, 2009, J BIOL CHEM, V284, P21057, DOI 10.1074/jbc.M109.001776; Lewis BC, 2005, MOL CELL BIOL, V25, P1228, DOI 10.1128/MCB.25.4.1228-1237.2005; Lewis BC, 1997, MOL CELL BIOL, V17, P4967, DOI 10.1128/MCB.17.9.4967; Lin KT, 2012, CANCER RES, V72, P3000, DOI 10.1158/0008-5472.CAN-11-2502; Lu X, 2010, CLIN CANCER RES, V16, P5928, DOI 10.1158/1078-0432.CCR-10-1360; Lyons LS, 2006, MOL ENDOCRINOL, V20, P1061, DOI 10.1210/me.2005-0346; Narla G, 2005, CANCER RES, V65, P1213, DOI 10.1158/0008-5472.CAN-04-4249; Narla G, 2001, SCIENCE, V294, P2563, DOI 10.1126/science.1066326; Narla G, 2008, J CLIN INVEST, V118, P2711, DOI 10.1172/JCI34780; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; Roessler S, 2010, CANCER RES, V70, P10202, DOI 10.1158/0008-5472.CAN-10-2607; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Tan BB, 2014, TUMOR BIOL, V35, P1481, DOI 10.1007/s13277-013-1204-2; Tarocchi M, 2011, HEPATOLOGY, V54, P522, DOI 10.1002/hep.24413; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Vetter D, 2012, HEPATOLOGY, V56, P1361, DOI 10.1002/hep.25810; Villanueva A, 2011, J HEPATOL, V55, P724, DOI 10.1016/j.jhep.2011.03.018; Wurmbach E, 2007, HEPATOLOGY, V45, P938, DOI 10.1002/hep.21622; Xue W, 2008, GENE DEV, V22, P1439, DOI 10.1101/gad.1672608; Zeng LY, 2000, MOL CELL BIOL, V20, P9212, DOI 10.1128/MCB.20.24.9212-9224.2000; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zheng Q, 2008, NUCLEIC ACIDS RES, V36, pW358, DOI 10.1093/nar/gkn276; Zhou X, 2008, INT J ONCOL, V32, P1285; Zhu LJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-237	52	21	21	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 1	2016	35	35					4653	4662		10.1038/onc.2016.2	http://dx.doi.org/10.1038/onc.2016.2			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DU6PE	26876204	Green Accepted			2022-12-26	WOS:000382336300011
J	Bourguignon, V; Flamion, B				Bourguignon, Virginie; Flamion, Bruno			Respective roles of hyaluronidases 1 and 2 in endogenous hyaluronan turnover	FASEB JOURNAL			English	Article						glycosaminoglycan; extracellular matrix; sinusoidal endothelial cells; lymph nodes	JAAGSIEKTE SHEEP RETROVIRUS; CHONDROITIN SULFATE; PROCESSED FORMS; RAT-LIVER; RECEPTOR; ENDOCYTOSIS; EXPRESSION; CELLS; ACID; CLEARANCE	We studied the physiologic roles of the hyaluronidase (HYAL) 1 and HYAL2 in hyaluronan (HA) turnover. HA was localized and quantified using HA binding proteins in various tissues of Hyal1(-/-) and Hyal2(-/-) mice (knockout mice) as well as control mice. HA MW was determined using gel filtration chromatography. HA endocytosis in liver nonparenchymal cells (NPCs) was quantified in vivo. Both Hyal1 and Hyal2 knockout mice showed HA accumulation in peripheral tissues without changes in HA MW distribution. HYAL2 deficiency induced buildup of very high MW (>3.10(6) Da) HA in lymph and serum with severe lymph node distortion. The lack of HYAL2 also impaired high MW HA endocytosis by liver NPCs. HYAL1 deficiency led to a moderate increase in serum HA concentration without changes in HA MW distribution and to HA overload of liver NPCs. Wild-type C57BL/6 mice served as controls. In HA injection experiments, saline-injected mice served as additional controls. We conclude that: 1) HYAL1 and HYAL2 are both needed for tissue HA catabolism; 2) HYAL2 is required for high MW HA clearance in lymph nodes and plasma and for HA endocytosis by liver NPCs; and 3) the main role of HYAL1 is HA degradation within liver NPCs.Bourguignon, V., Flamion, B. Respective roles of hyaluronidases 1 and 2 in endogenous hyaluronan turnover.	[Bourguignon, Virginie; Flamion, Bruno] Univ Namur, Mol Physiol Res Unit, Namur Res Inst Life Sci, Namur, Belgium	University of Namur	Flamion, B (corresponding author), Univ Namur URPhyM, Rue Bruxelles 61, B-5000 Namur, Belgium.	bruno.flamion@unamur.be						Andre B, 2011, BIOCHEM BIOPH RES CO, V411, P175, DOI 10.1016/j.bbrc.2011.06.125; [Anonymous], CIBA FDN S; Boonen M, 2014, BIOCHEM BIOPH RES CO, V446, P1155, DOI 10.1016/j.bbrc.2014.03.070; Campo GM, 2012, ARCH BIOCHEM BIOPHYS, V518, P42, DOI 10.1016/j.abb.2011.12.005; Colombaro V, 2015, KIDNEY INT, V88, P61, DOI 10.1038/ki.2015.53; Colombaro V, 2015, ACTA HISTOCHEM, V117, P83, DOI 10.1016/j.acthis.2014.11.007; Csoka AB, 2001, MATRIX BIOL, V20, P499, DOI 10.1016/S0945-053X(01)00172-X; de la Motte C, 2009, AM J PATHOL, V174, P2254, DOI 10.2353/ajpath.2009.080831; FRASER JRE, 1988, BIOCHEM J, V256, P153, DOI 10.1042/bj2560153; FRASER JRE, 1989, CIBA F SYMP, V143, P41; FRASER JRE, 1981, BIOCHEM J, V200, P415, DOI 10.1042/bj2000415; FRASER JRE, 1985, CELL TISSUE RES, V242, P505; Frost GI, 1997, BIOCHEM BIOPH RES CO, V236, P10, DOI 10.1006/bbrc.1997.6773; Gasingirwa MC, 2010, BIOCHEM J, V430, P305, DOI 10.1042/BJ20100711; Gopalakrishnan S, 2011, JOVE-J VIS EXP, DOI 10.3791/3138; Gushulak L, 2012, J BIOL CHEM, V287, P16689, DOI 10.1074/jbc.M112.350447; Jackson DG, 2009, IMMUNOL REV, V230, P216, DOI 10.1111/j.1600-065X.2009.00803.x; Jadin L, 2012, MATRIX BIOL, V31, P81, DOI 10.1016/j.matbio.2011.11.002; Jadin L, 2008, FASEB J, V22, P4316, DOI 10.1096/fj.08-111997; KNUDSON W, 1993, P NATL ACAD SCI USA, V90, P4003, DOI 10.1073/pnas.90.9.4003; LAURENT TC, 1986, BIOCHEM J, V234, P653, DOI 10.1042/bj2340653; LAURENT TC, 1986, CIBA F SYMP, V124, P9; LAURENT UBG, 1991, EXP PHYSIOL, V76, P695, DOI 10.1113/expphysiol.1991.sp003536; Lepperdinger G, 1998, J BIOL CHEM, V273, P22466, DOI 10.1074/jbc.273.35.22466; Machholz E, 2012, JOVE-J VIS EXP, DOI 10.3791/2771; Martin DC, 2008, HUM MOL GENET, V17, P1904, DOI 10.1093/hmg/ddn088; MCGARY CT, 1989, BIOCHEM J, V257, P875, DOI 10.1042/bj2570875; Noble PW, 2002, MATRIX BIOL, V21, P25, DOI 10.1016/S0945-053X(01)00184-6; Onclinx C, 2015, HAEMATOLOGICA, V100, P1023, DOI 10.3324/haematol.2015.123828; Pandey MS, 2013, J BIOL CHEM, V288, P14068, DOI 10.1074/jbc.M112.442889; Puissant E, 2014, TRAFFIC, V15, P500, DOI 10.1111/tra.12162; Rai SK, 2001, P NATL ACAD SCI USA, V98, P4443, DOI 10.1073/pnas.071572898; Stern R, 2006, EUR J CELL BIOL, V85, P699, DOI 10.1016/j.ejcb.2006.05.009; Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391; Triggs-Raine B, 1999, P NATL ACAD SCI USA, V96, P6296, DOI 10.1073/pnas.96.11.6296; Vigdorovich V, 2005, J VIROL, V79, P79, DOI 10.1128/JVI.79.1.79-86.2005; Weigel JA, 2003, J BIOL CHEM, V278, P9808, DOI 10.1074/jbc.M211462200	37	37	38	1	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2016	30	6					2108	2114		10.1096/fj.201500178R	http://dx.doi.org/10.1096/fj.201500178R			7	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DN2FA	26887442				2022-12-26	WOS:000376878300005
J	Tayou, J; Wang, Q; Jang, GF; Pronin, AN; Orlandi, C; Martemyanov, KA; Crabb, JW; Slepak, VZ				Tayou, Junior; Wang, Qiang; Jang, Geeng-Fu; Pronin, Alexey N.; Orlandi, Cesare; Martemyanov, Kirill A.; Crabb, John W.; Slepak, Vladlen Z.			Regulator of G Protein Signaling 7 (RGS7) Can Exist in a Homo-oligomeric Form That Is Regulated by G alpha(o) and R7-binding Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUSCARINIC M3 RECEPTOR; BETA-SUBUNIT G-BETA-5; GTPASE ACCELERATING PROTEIN; HETEROTRIMERIC G-PROTEINS; COUPLED RECEPTOR; DEP DOMAIN; TRANSFECTED CELLS; MEMBRANE ANCHOR; MICE LACKING; IN-VIVO	RGS (regulator of G protein signaling) proteins of the R7 subfamily (RGS6, -7, -9, and -11) are highly expressed in neurons where they regulate many physiological processes. R7 RGS proteins contain several distinct domains and form obligatory dimers with the atypical G beta subunit, G beta(5). They also interact with other proteins such as R7-binding protein, R9-anchoring protein, and the orphan receptors GPR158 and GPR179. These interactions facilitate plasma membrane targeting and stability of R7 proteins and modulate their activity. Here, we investigated RGS7 complexes using in situ chemical cross-linking. We found that in mouse brain and transfected cells cross-linking causes formation of distinct RGS7 complexes. One of the products had the apparent molecular mass of similar to 150 kDa on SDS-PAGE and did not contain G beta(5). Mass spectrometry analysis showed no other proteins to be present within the 150-kDa complex in the amount close to stoichiometric with RGS7. This finding suggested that RGS7 could form a homo-oligomer. Indeed, co-immunoprecipitation of differentially tagged RGS7 constructs, with or without chemical cross-linking, demonstrated RGS7 self-association. RGS7-RGS7 interaction required the DEP domain but not the RGS and DHEX domains or the G beta(5) subunit. Using transfected cells and knock-out mice, we demonstrated that R7-binding protein had a strong inhibitory effect on homo-oligomerization of RGS7. In contrast, our data indicated that GPR158 could bind to the RGS7 homo-oligomer without causing its dissociation. Co-expression of constitutively active G alpha(o) prevented the RGS7-RGS7 interaction. These results reveal the existence of RGS protein homo-oligomers and show regulation of their assembly by R7 RGS-binding partners.	[Tayou, Junior; Wang, Qiang; Pronin, Alexey N.; Slepak, Vladlen Z.] Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33136 USA; [Jang, Geeng-Fu; Crabb, John W.] Cleveland Clin, Cole Eye Inst, Cleveland, OH 44195 USA; [Orlandi, Cesare; Martemyanov, Kirill A.] Scripps Res Inst, Dept Neurosci, Jupiter, FL 33458 USA	University of Miami; Cleveland Clinic Foundation; Scripps Research Institute	Slepak, VZ (corresponding author), Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33136 USA.	VSlepak@med.miami.edu	Orlandi, Cesare/AAK-3180-2020	Orlandi, Cesare/0000-0002-4992-9350	National Institutes of Health [R01DK105427, EY018147, EY14239, DA026405, MH105482];  [P30-EY014801]; NATIONAL EYE INSTITUTE [P30EY014801, R01EY014239, R21EY018147] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK105427] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH105482] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K02DA026405, R01DA036596] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health Grants R01DK105427 (to V. Z. S.), EY018147 (to J. W. C.), EY14239 (to J. W. C.), DA026405 (to K. A. M.), MH105482 (to K. A. M.), and Center Grant P30-EY014801 (to Bascom Palmer Eye Institute). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ali MH, 2005, BIOORGAN MED CHEM, V13, P5013, DOI 10.1016/j.bmc.2005.05.037; Anderson GR, 2007, J NEUROSCI, V27, P14117, DOI 10.1523/JNEUROSCI.3884-07.2007; Anderson GR, 2009, CELL BIOCHEM BIOPHYS, V54, P33, DOI 10.1007/s12013-009-9052-9; Berman DM, 1998, J BIOL CHEM, V273, P1269, DOI 10.1074/jbc.273.3.1269; Bernstein LS, 2004, J BIOL CHEM, V279, P21248, DOI 10.1074/jbc.M312407200; Bollinger KE, 2011, INVEST OPHTH VIS SCI, V52, P8287, DOI 10.1167/iovs.11-8218; Bouvier M, 2001, NAT REV NEUROSCI, V2, P274, DOI 10.1038/35067575; Cabrera JL, 1998, BIOCHEM BIOPH RES CO, V249, P898, DOI 10.1006/bbrc.1998.9218; Chabre M, 2005, BIOCHEMISTRY-US, V44, P9395, DOI 10.1021/bi050720o; Cheever ML, 2008, NAT STRUCT MOL BIOL, V15, P155, DOI 10.1038/nsmb.1377; Chen CK, 2000, NATURE, V403, P557, DOI 10.1038/35000601; Chen CK, 2003, P NATL ACAD SCI USA, V100, P6604, DOI 10.1073/pnas.0631825100; Chen Qiuyan, 2014, Handb Exp Pharmacol, V219, P205, DOI 10.1007/978-3-642-41199-1_11; Chidiac P, 2003, RECEPTOR CHANNEL, V9, P135, DOI 10.3109/10606820308244; Clapham DE, 1997, ANNU REV PHARMACOL, V37, P167, DOI 10.1146/annurev.pharmtox.37.1.167; Cowan CW, 1998, P NATL ACAD SCI USA, V95, P5351, DOI 10.1073/pnas.95.9.5351; DOHLMAN HG, 1995, MOL CELL BIOL, V15, P3635; Drenan RM, 2005, J CELL BIOL, V169, P623, DOI 10.1083/jcb.200502007; Drenan RM, 2006, J BIOL CHEM, V281, P28222, DOI 10.1074/jbc.M604428200; Ferre S, 2014, PHARMACOL REV, V66, P413, DOI 10.1124/pr.113.008052; Gold SJ, 1997, J NEUROSCI, V17, P8024; Goodsell DS, 2000, ANNU REV BIOPH BIOM, V29, P105, DOI 10.1146/annurev.biophys.29.1.105; Grabowska D, 2008, NEUROSCIENCE, V151, P969, DOI 10.1016/j.neuroscience.2007.11.045; HELDIN CH, 1995, CELL, V80, P213, DOI 10.1016/0092-8674(95)90404-2; Heximer SP, 2003, J CLIN INVEST, V111, P1259, DOI 10.1172/JCI200318099C; Hooks SB, 2003, J BIOL CHEM, V278, P10087, DOI 10.1074/jbc.M211382200; Hu G, 2003, J BIOL CHEM, V278, P14550, DOI 10.1074/jbc.M212046200; Huang XY, 2006, MOL CELL BIOL, V26, P6870, DOI 10.1128/MCB.00314-06; Hunt RA, 2003, BIOCHEM BIOPH RES CO, V303, P594, DOI 10.1016/S0006-291X(03)00400-5; Jayaraman M, 2009, TRENDS PHARMACOL SCI, V30, P17, DOI 10.1016/j.tips.2008.10.002; Kach J, 2012, AM J PHYSIOL-HEART C, V303, pH19, DOI 10.1152/ajpheart.00764.2011; Karpinsky-Semper D, 2015, BIOCHEMISTRY-US, V54, P1077, DOI 10.1021/bi500980d; Karpinsky-Semper D, 2014, MOL PHARMACOL, V85, P758, DOI 10.1124/mol.114.091843; Klockenbusch C, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/927585; Koelle MR, 1996, CELL, V84, P115, DOI 10.1016/S0092-8674(00)80998-8; Krispel CM, 2003, J NEUROSCI, V23, P6965, DOI 10.1523/JNEUROSCI.23-18-06965.2003; Lan KL, 2000, J BIOL CHEM, V275, P33497, DOI 10.1074/jbc.M005785200; Levay K, 1999, P NATL ACAD SCI USA, V96, P2503, DOI 10.1073/pnas.96.5.2503; Liapis E, 2012, J NEUROCHEM, V122, P568, DOI 10.1111/j.1471-4159.2012.07811.x; Martemyanov KA, 2005, J BIOL CHEM, V280, P5133, DOI 10.1074/jbc.C400596200; Martemyanov KA, 2003, J NEUROSCI, V23, P10175; Masuho I, 2013, J BIOL CHEM, V288, P25129, DOI 10.1074/jbc.M113.462283; Masuho I, 2011, J BIOL CHEM, V286, P21806, DOI 10.1074/jbc.M111.241513; Narayanan V, 2007, BIOCHEMISTRY-US, V46, P6859, DOI 10.1021/bi700524w; NEER EJ, 1995, CELL, V80, P249, DOI 10.1016/0092-8674(95)90407-7; Neubig RR, 2015, PROG MOL BIOL TRANSL, V133, P13, DOI 10.1016/bs.pmbts.2015.04.010; Nini L, 2012, ENDOCRINE, V42, P214, DOI 10.1007/s12020-012-9611-5; Orlandi C, 2015, J BIOL CHEM, V290, P13622, DOI 10.1074/jbc.M115.645374; Orlandi C, 2012, J CELL BIOL, V197, P711, DOI 10.1083/jcb.201202123; Park PSH, 2004, BIOCHEMISTRY-US, V43, P15643, DOI 10.1021/bi047907k; Posner BA, 1999, J BIOL CHEM, V274, P31087, DOI 10.1074/jbc.274.43.31087; Posokhova E, 2010, CIRC RES, V107, P1350, DOI 10.1161/CIRCRESAHA.110.224212; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; Saitoh O, 2003, BIOCHEM BIOPH RES CO, V309, P836, DOI 10.1016/j.bbrc.2003.08.083; Sandiford SL, 2010, BIOCHEMISTRY-US, V49, P4998, DOI 10.1021/bi100080p; Sandiford SL, 2009, BIOCHEMISTRY-US, V48, P2282, DOI 10.1021/bi801989c; Shu FJ, 2010, CELL SIGNAL, V22, P366, DOI 10.1016/j.cellsig.2009.10.005; Slepak VZ, 2009, PROG MOL BIOL TRANSL, V86, P157, DOI 10.1016/S1877-1173(09)86006-7; Snow BE, 1998, P NATL ACAD SCI USA, V95, P13307, DOI 10.1073/pnas.95.22.13307; Stewart A, 2015, PROG MOL BIOL TRANSL, V133, P123, DOI 10.1016/bs.pmbts.2015.03.001; Takida S, 2005, MOL PHARMACOL, V67, P132, DOI 10.1124/mol.104.003418; Wang Q, 2011, FASEB J, V25, P3949, DOI 10.1096/fj.11-190157; Whorton MR, 2008, J BIOL CHEM, V283, P4387, DOI 10.1074/jbc.M703346200; Whorton MR, 2007, P NATL ACAD SCI USA, V104, P7682, DOI 10.1073/pnas.0611448104; Witherow DS, 2000, J BIOL CHEM, V275, P24872, DOI 10.1074/jbc.M001535200; Witherow DS, 2003, J BIOL CHEM, V278, P21307, DOI 10.1074/jbc.M212884200; Yang JQ, 2010, CIRC RES, V107, P1345, DOI 10.1161/CIRCRESAHA.110.224220; Yang Z, 2007, CELL PHYSIOL BIOCHEM, V20, P303, DOI 10.1159/000107516; Yuan XL, 2010, MOL CELL PROTEOMICS, V9, P1031, DOI 10.1074/mcp.M900523-MCP200; Zhang JH, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-03-j0004.2000; Zheng B, 1999, TRENDS BIOCHEM SCI, V24, P411, DOI 10.1016/S0968-0004(99)01474-7	71	4	5	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2016	291	17					9133	9147		10.1074/jbc.M115.694075	http://dx.doi.org/10.1074/jbc.M115.694075			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK3WV	26895961	Green Published, hybrid			2022-12-26	WOS:000374849000025
J	Leyme, A; Marivin, A; Garcia-Marcos, M				Leyme, Anthony; Marivin, Arthur; Garcia-Marcos, Mikel			GIV/Girdin (G alpha-interacting, Vesicle-associated Protein/Girdin) Creates a Positive Feedback Loop That Potentiates Outside-in Integrin Signaling in Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Akt PKB; cell migration; heterotrimeric G protein; integrin; metastasis; FAK; GIV; Girdin; PI3K	FOCAL ADHESION KINASE; GROWTH-FACTOR RECEPTOR; G-BETA-GAMMA; G-PROTEINS; PHOSPHOINOSITIDE 3-KINASE; TYROSINE PHOSPHORYLATION; CLINICAL-SIGNIFICANCE; COUPLED RECEPTORS; ACTIVATION; GIV	Activation of the tyrosine kinase focal adhesion kinase (FAK) upon cell stimulation by the extracellular matrix initiates integrin outside-in signaling. FAK is directly recruited to active integrins, which enhances its kinase activity and triggers downstream signaling like activation of PI3K. We recently described that G-interacting, vesicle-associated protein (GIV), a protein up-regulated in metastatic cancers, is also required for outside-in integrin signaling. More specifically, we found that GIV is a non-receptor guanine nucleotide exchange factor that activates trimeric G proteins in response to integrin stimulation to enhance PI3K signaling and tumor cell migration. In contrast, previous reports have established that GIV is involved in phosphotyrosine (Tyr(P))-based signaling in response to growth factor stimulation; i.e. GIV phosphorylation at Tyr-1764 and Tyr-1798 recruits and activates PI3K. Here we show that phosphorylation of GIV at Tyr-1764/Tyr-1798 is also required to enhance PI3K-Akt signaling and tumor cell migration in response to integrin stimulation, indicating that GIV functions in Tyr(P)-dependent integrin signaling. Unexpectedly, we found that activation of FAK, an upstream component of the integrin Tyr(P) signaling cascade, was diminished in GIV-depleted cells, suggesting that GIV is required to establish a positive feedback loop that enhances integrin-FAK signaling. Mechanistically, we demonstrate that this feedback activation of FAK depends on both guanine nucleotide exchange factor and Tyr(P) GIV signaling as well as on their convergence point, PI3K. Taken together, our results provide novel mechanistic insights into how GIV promotes proinvasive cancer cell behavior by working as a signal-amplifying platform at the crossroads of trimeric G protein and Tyr(P) signaling.	[Leyme, Anthony; Marivin, Arthur; Garcia-Marcos, Mikel] Boston Univ, Sch Med, Dept Biochem, 72 E Concord St,Silvio Conte Bldg K, Boston, MA 02118 USA	Boston University	Garcia-Marcos, M (corresponding author), Boston Univ, Sch Med, Dept Biochem, 72 E Concord St,Silvio Conte Bldg K, Boston, MA 02118 USA.	mgm1@bu.edu			National Institutes of Health [GM108733, GM112631]; American Cancer Society [RSG-13-362-01-TBE, IRG-72-001-36]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM112631, R01GM108733] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM108733 and GM112631 and American Cancer Society Grants RSG-13-362-01-TBE and IRG-72-001-36. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aznar N, 2015, ELIFE, V4, DOI 10.7554/eLife.07091; Bonacci TM, 2006, SCIENCE, V312, P443, DOI 10.1126/science.1120378; CHEN HC, 1994, J BIOL CHEM, V269, P31229; Cismowski MJ, 2000, J BIOL CHEM, V275, P23421, DOI 10.1074/jbc.C000322200; Cismowski MJ, 1999, NAT BIOTECHNOL, V17, P878, DOI 10.1038/12867; Dbouk HA, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003264; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; Dunkel Y, 2012, J BIOL CHEM, V287, P41667, DOI 10.1074/jbc.M112.390781; Enomoto A, 2005, DEV CELL, V9, P389, DOI 10.1016/j.devcel.2005.08.001; Garcia-Marcos M, 2015, J BIOL CHEM, V290, P6697, DOI 10.1074/jbc.R114.613414; Garcia-Marcos M, 2012, P NATL ACAD SCI USA, V109, P1961, DOI 10.1073/pnas.1120538109; Garcia-Marcos M, 2011, J BIOL CHEM, V286, P28138, DOI 10.1074/jbc.M110.204099; Garcia-Marcos M, 2011, FASEB J, V25, P590, DOI 10.1096/fj.10-167304; Garcia-Marcos M, 2010, J BIOL CHEM, V285, P12765, DOI 10.1074/jbc.M109.045161; Garcia-Marcos M, 2009, P NATL ACAD SCI USA, V106, P3178, DOI 10.1073/pnas.0900294106; Ghosh P, 2008, J CELL BIOL, V182, P381, DOI 10.1083/jcb.200712066; Ghosh P, 2015, AGING-US, V7, P469, DOI 10.18632/aging.100781; Ghosh P, 2010, MOL BIOL CELL, V21, P2338, DOI 10.1091/mbc.E10-01-0028; Gong HX, 2010, SCIENCE, V327, P340, DOI 10.1126/science.1174779; Higuchi M, 2013, J CELL SCI, V126, P745, DOI 10.1242/jcs.112722; Hornbeck PV, 2015, NUCLEIC ACIDS RES, V43, pD512, DOI 10.1093/nar/gku1267; Huttenlocher A, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005074; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Kim C, 2011, ANNU REV CELL DEV BI, V27, P321, DOI 10.1146/annurev-cellbio-100109-104104; Kurosu H, 1997, J BIOL CHEM, V272, P24252, DOI 10.1074/jbc.272.39.24252; Le-Niculescu H, 2005, J BIOL CHEM, V280, P22012, DOI 10.1074/jbc.M501833200; Legate KR, 2009, GENE DEV, V23, P397, DOI 10.1101/gad.1758709; Lehmann DM, 2008, MOL PHARMACOL, V73, P410, DOI 10.1124/mol.107.041780; Leyme A, 2015, J CELL BIOL, V210, P1165, DOI 10.1083/jcb.201506041; Lin CS, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002049; Ling Y, 2011, CANCER INVEST, V29, P405, DOI 10.3109/07357907.2011.568568; Liu CG, 2012, MED ONCOL, V29, P1554, DOI 10.1007/s12032-011-0087-6; Lopez-Sanchez I, 2015, MOL BIOL CELL, V26, P4313, DOI 10.1091/mbc.E15-07-0496; Lopez-Sanchez I, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5451; Luque A, 1996, J BIOL CHEM, V271, P11067, DOI 10.1074/jbc.271.19.11067; Miranti CK, 2002, NAT CELL BIOL, V4, pE83, DOI 10.1038/ncb0402-e83; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Miyamoto S, 1996, J CELL BIOL, V135, P1633, DOI 10.1083/jcb.135.6.1633; Murga C, 2000, J BIOL CHEM, V275, P12069, DOI 10.1074/jbc.275.16.12069; Omori K, 2015, BIOCHEM BIOPH RES CO, V458, P934, DOI 10.1016/j.bbrc.2015.02.065; PLOPPER GE, 1995, MOL BIOL CELL, V6, P1349, DOI 10.1091/mbc.6.10.1349; Rajala RVS, 2002, J BIOL CHEM, V277, P43319, DOI 10.1074/jbc.M206355200; Sato M, 2006, ANNU REV PHARMACOL, V46, P151, DOI 10.1146/annurev.pharmtox.46.120604.141115; Shen B, 2015, MOL BIOL CELL, V26, P3658, DOI 10.1091/mbc.E15-05-0274; Shen B, 2013, NATURE, V503, P131, DOI 10.1038/nature12613; Shibata T, 2013, ONCOL REP, V29, P2127, DOI 10.3892/or.2013.2406; Song JY, 2014, ONCOL LETT, V7, P337, DOI 10.3892/ol.2013.1745; Sulzmaier FJ, 2014, NAT REV CANCER, V14, P598, DOI 10.1038/nrc3792; Sundberg C, 1996, J CELL BIOL, V132, P741, DOI 10.1083/jcb.132.4.741; Tall GG, 2003, J BIOL CHEM, V278, P8356, DOI 10.1074/jbc.M211862200; Vadas O, 2013, P NATL ACAD SCI USA, V110, P18862, DOI 10.1073/pnas.1304801110; Wang CH, 2014, MOL CLIN ONCOL, V2, P425, DOI 10.3892/mco.2014.265; Wang SY, 2011, AM J PHYSIOL-CELL PH, V300, pC657, DOI 10.1152/ajpcell.00377.2010; Xia H, 2004, J BIOL CHEM, V279, P33024, DOI 10.1074/jbc.M313265200; Zhao LW, 2013, SCI WORLD J, DOI 10.1155/2013/986073	55	17	18	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2016	291	15					8269	8282		10.1074/jbc.M115.691550	http://dx.doi.org/10.1074/jbc.M115.691550			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DJ2SZ	26887938	Green Published, hybrid			2022-12-26	WOS:000374056700042
J	Serra-Peinado, C; Sicart, A; Llopis, J; Egea, G				Serra-Peinado, Carla; Sicart, Adria; Llopis, Juan; Egea, Gustavo			Actin Filaments Are Involved in the Coupling of V-0-V-1 Domains of Vacuolar H+-ATPase at the Golgi Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTON-TRANSLOCATING ATPASE; YEAST VACUOLAR; V-ATPASE; SECRETORY PATHWAY; BINDING SITE; ORGANELLE ACIDIFICATION; EPITHELIAL-CELLS; MAMMALIAN-CELLS; ANION CHANNEL; PH REGULATION	We previously reported that actin-depolymerizing agents promote the alkalization of the Golgi stack and the trans-Golgi network. The main determinant of acidic pH at the Golgi is the vacuolar-type H+-translocating ATPase (V-ATPase), whose V-1 domain subunits B and C bind actin. We have generated a GFP-tagged subunit B2 construct (GFP-B2) that is incorporated into the V-1 domain, which in turn is coupled to the V-0 sector. GFP-B2 subunit is enriched at distal Golgi compartments in HeLa cells. Subcellular fractionation, immunoprecipitation, and inversal FRAP experiments show that the actin depolymerization promotes the dissociation of V-1-V-0 domains, which entails subunit B2 translocation from Golgi membranes to the cytosol. Moreover, molecular interaction between subunits B2 and C1 and actin were detected. In addition, Golgi membrane lipid order disruption by D-ceramide-C6 causes Golgi pH alkalization. We conclude that actin regulates the Golgi pH homeostasis maintaining the coupling of V-1-V-0 domains of V-ATPase through the binding of microfilaments to subunits B and C and preserving the integrity of detergent-resistant membrane organization. These results establish the Golgi-associated V-ATPase activity as the molecular link between actin and the Golgi pH.	[Serra-Peinado, Carla; Sicart, Adria; Egea, Gustavo] Univ Barcelona, Fac Med, Dept Biol Cellular Immunol & Neurociencies, C Casanova 143, E-08036 Barcelona, Spain; [Egea, Gustavo] Inst Invest Biomed August Pi & Sunyer, E-08036 Barcelona, Spain; [Egea, Gustavo] Inst Nanociencia & Nanotecnol IN2UB, E-08036 Barcelona, Spain; [Llopis, Juan] Univ Castilla La Mancha, Fac Med Albacete, E-0200 Albacete, Spain; [Llopis, Juan] Univ Castilla La Mancha, Ctr Reg Invest Biomed, E-0200 Albacete, Spain; [Sicart, Adria] VIB, Ctr Biol Dis, Campus Gasthuisberg, B-3000 Leuven, Belgium; [Sicart, Adria] Katholieke Univ Leuven, Dept Human Genet, Campus Gasthuisberg, B-3000 Leuven, Belgium	University of Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Universidad de Castilla-La Mancha; Universidad de Castilla-La Mancha; Flanders Institute for Biotechnology (VIB); KU Leuven; KU Leuven	Egea, G (corresponding author), Univ Barcelona, Fac Med, Dept Biol Cellular Immunol & Neurociencies, C Casanova 143, E-08036 Barcelona, Spain.	gegea@ub.edu	Llopis, Juan/I-2622-2012; Egea, Gustavo/I-2394-2014	Llopis, Juan/0000-0002-9460-0642; Egea, Gustavo/0000-0001-5242-150X; Serra-Peinado, Carla/0000-0003-1413-3990	Ministerio de Economia y Competitividad del Gobierno de Espana [BFU2009-07186, 2012-33932]; Spanish Ministerio de Economia y Competitividad	Ministerio de Economia y Competitividad del Gobierno de Espana(Spanish Government); Spanish Ministerio de Economia y Competitividad(Spanish Government)	This work was supported in part by Grants BFU2009-07186 and 2012-33932 from Ministerio de Economia y Competitividad del Gobierno de Espana (to G. E.). The authors declare that they have no conflicts of interest with the contents of this article.r Recipient of a predoctoral fellowship from the Spanish Ministerio de Economia y Competitividad.	BALCH WE, 1984, CELL, V39, P405, DOI 10.1016/0092-8674(84)90019-9; Breton S, 2007, AM J PHYSIOL-RENAL, V292, pF1, DOI 10.1152/ajprenal.00340.2006; Casey JR, 2010, NAT REV MOL CELL BIO, V11, P50, DOI 10.1038/nrm2820; CHANSON A, 1985, PLANT PHYSIOL, V78, P232, DOI 10.1104/pp.78.2.232; Chen SH, 2004, J BIOL CHEM, V279, P7988, DOI 10.1074/jbc.M305351200; Chichili GR, 2009, CELL MOL LIFE SCI, V66, P2319, DOI 10.1007/s00018-009-0022-6; Demaurex N, 2002, NEWS PHYSIOL SCI, V17, P1; Drory O, 2006, PHYSIOLOGY, V21, P317, DOI 10.1152/physiol.00017.2006; Duran JM, 2012, EMBO J, V31, P4535, DOI 10.1038/emboj.2012.317; Egea G, 2006, CURR OPIN CELL BIOL, V18, P168, DOI 10.1016/j.ceb.2006.02.007; Egea G, 2013, HISTOCHEM CELL BIOL, V140, P347, DOI 10.1007/s00418-013-1115-8; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Gkantiragas I, 2001, MOL BIOL CELL, V12, P1819, DOI 10.1091/mbc.12.6.1819; GLICKMAN J, 1983, J CELL BIOL, V97, P1303, DOI 10.1083/jcb.97.4.1303; Gutierrez-Martinez E, 2013, J CELL SCI, V126, P2641, DOI 10.1242/jcs.117705; Holliday LS, 2005, J BIOENERG BIOMEMBR, V37, P419, DOI 10.1007/s10863-005-9483-y; Holliday LS, 2000, J BIOL CHEM, V275, P32331, DOI 10.1074/jbc.M004795200; Huang CJ, 2011, J BIOL CHEM, V286, P10058, DOI 10.1074/jbc.M110.197889; HURLEY D, 1989, PLANT PHYSIOL, V89, P391, DOI 10.1104/pp.89.2.391; Inoue T, 2005, J BIOENERG BIOMEMBR, V37, P393, DOI 10.1007/s10863-005-9478-8; Jefferies KC, 2008, ARCH BIOCHEM BIOPHYS, V476, P33, DOI 10.1016/j.abb.2008.03.025; Kane PA, 2006, MICROBIOL MOL BIOL R, V70, P177, DOI 10.1128/MMBR.70.1.177-191.2006; Kane PM, 2012, CURR PROTEIN PEPT SC, V13, P117; KANE PM, 1995, J BIOL CHEM, V270, P17025; Kornak U, 2008, NAT GENET, V40, P32, DOI 10.1038/ng.2007.45; Lafourcade C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002758; Lazaro-Dieguez F, 2007, FEBS LETT, V581, P3875, DOI 10.1016/j.febslet.2007.07.015; Lazaro-Dieguez F, 2006, CELL MOTIL CYTOSKEL, V63, P778, DOI 10.1002/cm.20161; Lee BS, 1999, J BIOL CHEM, V274, P29164, DOI 10.1074/jbc.274.41.29164; Lu M, 2004, J BIOL CHEM, V279, P8732, DOI 10.1074/jbc.M303871200; MacLeod KJ, 1998, J BIOL CHEM, V273, P150, DOI 10.1074/jbc.273.1.150; Maeda Y, 2008, NAT CELL BIOL, V10, P1135, DOI 10.1038/ncb1773; Maeda Y, 2010, METHOD ENZYMOL, V480, P495, DOI 10.1016/S0076-6879(10)80022-9; Marshansky V, 2008, CURR OPIN CELL BIOL, V20, P415, DOI 10.1016/j.ceb.2008.03.015; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Miserey-Lenkei S, 2010, NAT CELL BIOL, V12, P645, DOI 10.1038/ncb2067; MORIYAMA Y, 1989, J BIOL CHEM, V264, P18445; Nakamura N, 2005, J BIOL CHEM, V280, P1561, DOI 10.1074/jbc.M410041200; Nakamura S, 2004, AM J PHYSIOL-CELL PH, V287, pC97, DOI 10.1152/ajpcell.00469.2003; Ono M, 2003, GLYCOCONJUGATE J, V20, P71, DOI 10.1023/B:GLYC.0000018019.22070.7d; PALOKANGAS H, 1994, J BIOL CHEM, V269, P17577; Paroutis P, 2004, PHYSIOLOGY, V19, P207, DOI 10.1152/physiol.00005.2004; Parra KJ, 1998, MOL CELL BIOL, V18, P7064, DOI 10.1128/MCB.18.12.7064; Perez-Sayans M, 2012, BRAZ J BIOL, V72, P189, DOI 10.1590/S1519-69842012000100023; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Rivinoja A, 2012, ANN MED, V44, P542, DOI 10.3109/07853890.2011.579150; Rubenstein EM, 2010, EMBO J, V29, P2473, DOI 10.1038/emboj.2010.161; Sautin YY, 2005, MOL CELL BIOL, V25, P575, DOI 10.1128/MCB.25.2.575-589.2005; Sobota JA, 2009, J CELL SCI, V122, P3542, DOI 10.1242/jcs.034298; Thompson RJ, 2002, BIOPHYS J, V83, P278, DOI 10.1016/S0006-3495(02)75168-0; Valderrama F, 2001, TRAFFIC, V2, P717, DOI 10.1034/j.1600-0854.2001.21006.x; Valderrama F, 2000, P NATL ACAD SCI USA, V97, P1560, DOI 10.1073/pnas.97.4.1560; van Galen J, 2014, J CELL BIOL, V206, P609, DOI 10.1083/jcb.201405009; Vasilyeva E, 2000, J BIOL CHEM, V275, P255, DOI 10.1074/jbc.275.1.255; Vitavska O, 2005, J BIOL CHEM, V280, P1070, DOI 10.1074/jbc.M406797200; Vitavska O, 2003, J BIOL CHEM, V278, P18499, DOI 10.1074/jbc.M212844200; von Blume J, 2011, DEV CELL, V20, P652, DOI 10.1016/j.devcel.2011.03.014; Weisz OA, 2003, TRAFFIC, V4, P57, DOI 10.1034/j.1600-0854.2003.40201.x; Wu MM, 2001, J BIOL CHEM, V276, P33027, DOI 10.1074/jbc.M103917200; Xifro X, 2008, J NEUROCHEM, V105, P1596, DOI 10.1111/j.1471-4159.2008.05252.x; Xu T, 2001, J BIOL CHEM, V276, P24855, DOI 10.1074/jbc.M100637200; YILLA M, 1993, J BIOL CHEM, V268, P19092; YOUNG GPH, 1988, P NATL ACAD SCI USA, V85, P9590, DOI 10.1073/pnas.85.24.9590; ZHANG F, 1983, BIOCHEM BIOPH RES CO, V114, P620, DOI 10.1016/0006-291X(83)90825-2; Zhao YY, 2008, CANCER SCI, V99, P1304, DOI 10.1111/j.1349-7006.2008.00839.x; Zuo J, 2008, J EXP BIOL, V211, P1102, DOI 10.1242/jeb.013672	66	7	7	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2016	291	14					7286	7299		10.1074/jbc.M115.675272	http://dx.doi.org/10.1074/jbc.M115.675272			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DW2BJ	26872971	Green Published, hybrid			2022-12-26	WOS:000383447600007
J	Prabhu, PAJ; Geurden, I; Fontagne-Dicharry, S; Veron, V; Larroquet, L; Mariojouls, C; Schrama, JW; Kaushik, SJ				Prabhu, P. Antony Jesu; Geurden, Inge; Fontagne-Dicharry, Stephanie; Veron, Vincent; Larroquet, Laurence; Mariojouls, Catherine; Schrama, Johan W.; Kaushik, Sadasivam J.			Responses in Micro-Mineral Metabolism in Rainbow Trout to Change in Dietary Ingredient Composition and Inclusion of a Micro-Mineral Premix	PLOS ONE			English	Article							SALMON SALMO-SALAR; FISH-MEAL; ONCORHYNCHUS-MYKISS; IRON HOMEOSTASIS; WHOLE-BODY; SEA BREAM; EXPRESSION; MANGANESE; HEPCIDIN; COPPER	Responses in micro-mineral metabolism to changes in dietary ingredient composition and inclusion of a micro-mineral premix (Fe, Cu, Mn, Zn and Se) were studied in rainbow trout. In a 2 x 2 factorial design, triplicate groups of rainbow trout (initial weight: 20g) were fed over 12 weeks at 17 degrees C a fishmeal-based diet (M) or a plant-ingredient based diet (V), with or without inclusion of a mineral premix. Trout fed the V vs. M diet had lower feed intake, growth, hepato-somatic index, apparent availability coefficient (AAC) of Fe, Cu, Mn and Zn and also lower whole body Se and Zn concentration, whereas whole body Fe and Cu and plasma Fe concentrations were higher. Feeding the V diet increased intestinal ferric reductase activity; at transcriptional level, hepatic hepcidin expression was down-regulated and ferroportin 1 was up-regulated. Transcription of intestinal Cu-transporting ATPases and hepatic copper transporter1 were higher in V0 compared to other groups. Among the hepatic metaloenzyme activities assayed, only Se-dependent glutathione peroxidase was affected, being lower in V fed fish. Premix inclusion reduced the AAC of Fe, Cu and Zn; increased the whole body concentration of all micro-minerals; up-regulated hepatic hepcidin and downregulated intestinal ferroportin 1 transcription; and reduced the transcription of Cu-transporting ATPases in the intestine. Overall, the regulation of micro-mineral metabolism in rainbow trout, especially Fe and Cu, was affected both by a change in ingredient composition and micro-mineral premix inclusion.	[Prabhu, P. Antony Jesu; Geurden, Inge; Fontagne-Dicharry, Stephanie; Veron, Vincent; Larroquet, Laurence; Kaushik, Sadasivam J.] INRA, UR1067, Nutr Metab & Aquaculture NuMeA, Aquapole INRA, F-64310 St Pee Sur Nivelle, France; [Prabhu, P. Antony Jesu; Mariojouls, Catherine] AgroParisTech, Paris Inst Technol Life Food & Environm Sci, 16 Rue Claude Bernard, F-75231 Paris 5, France; [Prabhu, P. Antony Jesu; Schrama, Johan W.] Wageningen Univ, Aquaculture & Fisheries Grp, WIAS, POB 338, NL-6700 AH Wageningen, Netherlands; [Prabhu, P. Antony Jesu] Tamil Nadu Fisheries Univ, Coll Fisheries, Dept Aquaculture, Ponneri 601204, Tamil Nadu, India; [Prabhu, P. Antony Jesu] Tamil Nadu Fisheries Univ, Res Inst, Ponneri 601204, Tamil Nadu, India	INRAE; Universite de Pau et des Pays de l'Adour; AgroParisTech; Wageningen University & Research	Geurden, I (corresponding author), INRA, UR1067, Nutr Metab & Aquaculture NuMeA, Aquapole INRA, F-64310 St Pee Sur Nivelle, France.	inge.geurden@st-pee.inra.fr	Fontagné-Dicharry, Stéphanie/A-5485-2013; Prabhu, Antony Jesu/H-7571-2019	Fontagné-Dicharry, Stéphanie/0000-0002-4366-4590; Prabhu, Antony Jesu/0000-0002-2839-0704; Schrama, Johan/0000-0001-7156-8806	INRA, under the INRA-WUR aquaculture platform; EU [288925, 262336]	INRA, under the INRA-WUR aquaculture platform; EU(European Commission)	This work was part of a PhD thesis funded by INRA, under the INRA-WUR aquaculture platform. This work received funds from the EU seventh Framework Programmes ARRAINA (Advanced Research Initiatives for Nutrition & Aquaculture, FP7/2007-2013; grant agreement no 288925) and AQUAEXCEL (Aquaculture Infrastructures for Excellence in European Fish Research, FP7/2007-2012; grant agreement no 262336). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez CA, 2013, DEV COMP IMMUNOL, V41, P77, DOI 10.1016/j.dci.2013.04.002; Andrews NC, 2000, NAT REV GENET, V1, P208, DOI 10.1038/35042073; Bakke AM, 2011, FISH PHYSIOL, V30, P57, DOI 10.1016/S1546-5098(10)03002-5; Boyle D, 2009, COMP BIOCHEM PHYS A, V153A, pS78, DOI 10.1016/j.cbpa.2009.04.050; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buddington Randal K., 2000, P379, DOI 10.1016/B978-012529650-2/50029-9; Bury N, 2003, COMP BIOCHEM PHYS C, V135, P97, DOI 10.1016/S1532-0456(03)00021-8; Bury NR, 2003, J EXP BIOL, V206, P11, DOI 10.1242/jeb.00068; Bury NR, 2001, J EXP BIOL, V204, P3779; Carriquiriborde P, 2004, J EXP BIOL, V207, P75, DOI 10.1242/jeb.00712; Cooper CA, 2006, COMP BIOCHEM PHYS A, V143, P292, DOI 10.1016/j.cbpa.2005.11.024; Donovan A, 2005, CELL METAB, V1, P191, DOI 10.1016/j.cmet.2005.01.003; Dorschner MO, 1999, DNA CELL BIOL, V18, P573, DOI 10.1089/104454999315123; Douglas SE, 2003, DEV COMP IMMUNOL, V27, P589, DOI 10.1016/S0145-305X(03)00036-3; Fontagne S, 2008, BRIT J NUTR, V100, P102, DOI 10.1017/S0007114507876215; Fraenkel PG, 2005, J CLIN INVEST, V115, P1532, DOI 10.1172/JCI23780; Francis G, 2001, AQUACULTURE, V199, P197, DOI 10.1016/S0044-8486(01)00526-9; Ganz T, 2012, BBA-MOL CELL RES, V1823, P1434, DOI 10.1016/j.bbamcr.2012.01.014; Hambidge M, 2003, J NUTR, V133, p948S, DOI 10.1093/jn/133.3.948S; Hunt JR, 2003, AM J CLIN NUTR, V78, p633S, DOI 10.1093/ajcn/78.3.633S; Julshamn K., 1978, Fiskeridirektoratets Skrifter Serie Ernaering, V1, P117; Kaushik S, 2002, NUTR FEEDING FISH CR, P169; KNOX D, 1981, BRIT J NUTR, V46, P495, DOI 10.1079/BJN19810058; Kortner TM, 2013, BRIT J NUTR, V109, P593, DOI 10.1017/S0007114512002024; Kucukbay Z, 2006, AQUACULTURE, V257, P465, DOI 10.1016/j.aquaculture.2006.03.005; Kwong RWM, 2013, FISH PHYSIOL BIOCHEM, V39, P363, DOI 10.1007/s10695-012-9705-2; Kwong RWM, 2009, COMP BIOCHEM PHYS C, V150, P442, DOI 10.1016/j.cbpc.2009.06.011; Lall Santosh P., 2002, P259; Lin YH, 2008, AQUACULTURE, V284, P207, DOI 10.1016/j.aquaculture.2008.07.049; Lorentzen M, 1999, AQUACULT NUTR, V5, P163; Lutsenko S, 2010, CURR OPIN CHEM BIOL, V14, P211, DOI 10.1016/j.cbpa.2010.01.003; MAAGE A, 1993, AQUACULTURE, V117, P179, DOI 10.1016/0044-8486(93)90134-K; Mackenzie NC, 2004, GENE, V328, P113, DOI 10.1016/j.gene.2003.11.019; Mazoch J, 2004, EUR J BIOCHEM, V271, P553, DOI 10.1046/j.1432-1033.2003.03957.x; Minghetti M, 2008, COMP BIOCHEM PHYS C, V147, P450, DOI 10.1016/j.cbpc.2008.01.014; Minghetti M, 2010, AQUAT TOXICOL, V97, P23, DOI 10.1016/j.aquatox.2009.11.017; Nadella SR, 2011, J COMP PHYSIOL B, V181, P27, DOI 10.1007/s00360-010-0510-x; NRC, 1993, NUT REQ FISH; NRC (National Research Council), 2011, NUTR REQ FISH SHRIMP; OGINO C, 1975, B JPN SOC SCI FISH, V41, P429; Pacitti D, 2013, AQUAT TOXICOL, V130, P97, DOI 10.1016/j.aquatox.2012.12.020; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pigeon C, 2001, J BIOL CHEM, V276, P7811, DOI 10.1074/jbc.M008923200; Prabhu PAJ, 2015, FISH PHYSIOL BIOCHEM, V41, P243, DOI 10.1007/s10695-014-0020-y; Prabhu PAJ, 2014, AQUACULTURE, V430, P34, DOI 10.1016/j.aquaculture.2014.03.038; Rodrigues PNS, 2006, DEV COMP IMMUNOL, V30, P1156, DOI 10.1016/j.dci.2006.02.005; Santos EM, 2010, ENVIRON SCI TECHNOL, V44, P820, DOI 10.1021/es902558k; SATOH S, 1991, NIPPON SUISAN GAKK, V57, P99; Standal H, 1999, AQUACULT NUTR, V5, P193; Tacon AGJ, 2008, AQUACULTURE, V285, P146, DOI 10.1016/j.aquaculture.2008.08.015; Tan XY, 2012, AQUACULTURE, V326, P68, DOI 10.1016/j.aquaculture.2011.11.013; Watanabe T, 1997, AQUACULTURE, V151, P185, DOI 10.1016/S0044-8486(96)01503-7; Wyman S, 2008, FEBS LETT, V582, P1901, DOI 10.1016/j.febslet.2008.05.010; Yeh KY, 2004, AM J PHYSIOL-GASTR L, V286, pG385, DOI 10.1152/ajpgi.00246.2003; Zhang ZQ, 2012, J ANIM VET ADV, V11, P2347, DOI 10.3923/javaa.2012.2347.2351	55	15	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0149378	10.1371/journal.pone.0149378	http://dx.doi.org/10.1371/journal.pone.0149378			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3DG	26895186	Green Published, Green Submitted, gold			2022-12-26	WOS:000371223400049
J	Brant, CO; Huertas, M; Li, K; Li, WM				Brant, Cory O.; Huertas, Mar; Li, Ke; Li, Weiming			Mixtures of Two Bile Alcohol Sulfates Function as a Proximity Pheromone in Sea Lamprey	PLOS ONE			English	Article							PETROMYZON-MARINUS; OLFACTORY SENSITIVITY; LEPIDOPTERA; IDENTIFICATION; SPECIFICITY; MOTHS; DSC	Unique mixtures of pheromone components are commonly identified in insects, and have been shown to increase attractiveness towards conspecifics when reconstructed at the natural ratio released by the signaler. In previous field studies of pheromones that attract female sea lamprey (Petromyzon marinus, L.), putative components of the male-released mating pheromone included the newly described bile alcohol 3,12-diketo-4,6-petromyzonene-24-sulfate (DkPES) and the well characterized 3-keto petromyzonol sulfate (3kPZS). Here, we show chemical evidence that unequivocally confirms the elucidated structure of DkPES, electrophysiological evidence that each component is independently detected by the olfactory epithelium, and behavioral evidence that mature female sea lamprey prefer artificial nests activated with a mixture that reconstructs the male-released component ratio of 30:1 (3kPZS:DkPES, molar:molar). In addition, we characterize search behavior (sinuosity of swim paths) of females approaching ratio treatment sources. These results suggest unique pheromone ratios may underlie reproductive isolating mechanisms in vertebrates, as well as provide utility in pheromone-integrated control of invasive sea lamprey in the Great Lakes.	[Brant, Cory O.; Huertas, Mar; Li, Ke; Li, Weiming] Michigan State Univ, Dept Fisheries & Wildlife, Room 13 Nat Resources Bldg,480 Wilson Rd, E Lansing, MI 48824 USA	Michigan State University	Li, WM (corresponding author), Michigan State Univ, Dept Fisheries & Wildlife, Room 13 Nat Resources Bldg,480 Wilson Rd, E Lansing, MI 48824 USA.	liweim@msu.edu	Huertas, Mar/K-9357-2019; Huertas, Mar/B-2898-2008; Li, Ke/I-3804-2013	Huertas, Mar/0000-0002-8042-086X; Huertas, Mar/0000-0002-8042-086X; Li, Ke/0000-0003-4869-5393	Great Lakes Fishery Commission, Ann Arbor, MI, USA	Great Lakes Fishery Commission, Ann Arbor, MI, USA	This work was funded by the Great Lakes Fishery Commission, Ann Arbor, MI, USA.	Applegate VC, 1950, NATURAL HIST SEA LAM; Bjerselius R, 2000, CAN J FISH AQUAT SCI, V57, P557, DOI 10.1139/cjfas-57-3-557; Buchinger TJ, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1966; CARDE RT, 1977, J CHEM ECOL, V3, P71, DOI 10.1007/BF00988135; Coracini MDA, 2001, J ECON ENTOMOL, V94, P911, DOI 10.1603/0022-0493-94.4.911; DeBose JL, 2008, J CHEM ECOL, V34, P867, DOI 10.1007/s10886-008-9493-4; GIRON D, 1995, J THERM ANAL, V44, P217, DOI 10.1007/BF02547150; HARA TJ, 1992, FISH CHEMORECEPTION, P150; Huertas M, 2007, J FISH BIOL, V70, P1907, DOI 10.1111/j.1095-8649.2007.01467.x; Johnson NS, 2015, FISH FISH SER, V37, P265, DOI 10.1007/978-94-017-9306-3_6; Johnson NS, 2012, BEHAV ECOL SOCIOBIOL, V66, P1557, DOI 10.1007/s00265-012-1409-1; Johnson NS, 2009, P NATL ACAD SCI USA, V106, P1021, DOI 10.1073/pnas.0808530106; Kang JS, 1997, J NEUROPHYSIOL, V77, P1; KARLSON P, 1959, ANNU REV ENTOMOL, V4, P39, DOI 10.1146/annurev.en.04.010159.000351; Keller-Costa T, 2014, J EXP BIOL, V217, P4203, DOI 10.1242/jeb.111518; Li K, 2015, ORG LETT, V17, P286, DOI 10.1021/ol5033893; Li K, 2012, STEROIDS, V77, P806, DOI 10.1016/j.steroids.2012.03.006; Li KR, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0068157, 10.1371/journal.pone.0084171, 10.1371/journal.pone.0058057, 10.1371/journal.pone.0067018, 10.1371/journal.pone.0063139]; LI WM, 1995, J GEN PHYSIOL, V105, P569, DOI 10.1085/jgp.105.5.569; Li WM, 2002, SCIENCE, V296, P138, DOI 10.1126/science.1067797; LINN CE, 1989, CHEM SENSES, V14, P421, DOI 10.1093/chemse/14.3.421; Lipschitz DL, 1999, J NEUROPHYSIOL, V82, P3160, DOI 10.1152/jn.1999.82.6.3160; MANION PJ, 1980, CAN J FISH AQUAT SCI, V37, P1635, DOI 10.1139/f80-211; Reyes-Garcia L, 2014, CIENC INVESTIG AGRAR, V41, P187, DOI 10.4067/S0718-16202014000200005; Siefkes MJ, 2005, ANIM BEHAV, V70, P1037, DOI 10.1016/j.anbehav.2005.01.024; Siefkes MJ, 2003, BIOL REPROD, V69, P125, DOI 10.1095/biolreprod.102.014472; Sorensen PW, 2005, NAT CHEM BIOL, V1, P324, DOI 10.1038/nchembio739; Steiger S, 2011, P ROY SOC B-BIOL SCI, V278, P970, DOI 10.1098/rspb.2010.2285; TEETER J, 1980, CAN J FISH AQUAT SCI, V37, P2123, DOI 10.1139/f80-254; VANDOOREN AA, 1984, INT J PHARM, V20, P217, DOI 10.1016/0378-5173(84)90170-4; Wagner CM, 2009, ANIM BEHAV, V78, P593, DOI 10.1016/j.anbehav.2009.04.027; Wyatt TD, 2010, J COMP PHYSIOL A, V196, P685, DOI 10.1007/s00359-010-0564-y	32	13	13	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0149508	10.1371/journal.pone.0149508	http://dx.doi.org/10.1371/journal.pone.0149508			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26885832	Green Submitted, Green Published, gold			2022-12-26	WOS:000371218400093
J	Giupponi, APD; de Miranda, GS				de Leao Giupponi, Alessandro Ponce; de Miranda, Gustavo Silva			Eight New Species of Charinus Simon, 1892 (Arachnida: Amblypygi: Charinidae) Endemic for the Brazilian Amazon, with Notes on Their Conservational Status	PLOS ONE			English	Article							HYDROELECTRIC DEVELOPMENT; WHIP SPIDERS; SARAX SIMON; XINGU RIVER; GENUS SARAX; BELO-MONTE; DEFORESTATION; IMPACTS; CHELICERATA; HIGHWAY	Eight new species of Charinus Simon, 1892 are described for the Brazilian Amazon, from the states of Para (C. bichuetteae sp. n., C. bonaldoi sp. n., C. carajas sp. n., C. ferreus sp. n., C. guto sp. n. and C. orientalis sp. n.) and Amazonas (Charinus brescoviti sp. n. and C. ricardoi sp. n.). All new species can be differentiated from the other species of the genus by the number of pseudo-articles in basitibia IV, the presence/absence of median eyes, and the shape of the female gonopod. Brazil now becomes the country with the largest diversity of Amblypygi in the world, with 25 known species. Half of the new species described here have a high degree of endangerment: C. bichuetteae sp. n. is threatened by the flood caused by the hydroelectric dam of Belo Monte, and C. carajas sp. n., C. ferreus sp. n. and C. orientalis sp. n. are endangered by the iron mining in Carajas municipality and surroundings. The Charinus species here described are endemic to the Amazon Region, so in order to assure their preservation, it is strongly recommended a special care with their habitats (type localities) which are facing increasing rates of destruction and deforestation.	[de Leao Giupponi, Alessandro Ponce; de Miranda, Gustavo Silva] Univ Fed Rio de Janeiro, Museu Nacl, Lab Aracnol, Programa Posgrad Zool,Dept Invertebrados, Rio De Janeiro, RJ, Brazil; [de Leao Giupponi, Alessandro Ponce] Fiocruz MS, IOC, CAVAISC, Lab Referencia Nacl Vetores Riquetsioses,LIRN, BR-21045900 Rio De Janeiro, RJ, Brazil; [de Miranda, Gustavo Silva] Univ Copenhagen, Zool Museum, Nat Hist Museum Denmark, Ctr Macroecol Evolut & Climate, DK-2100 Copenhagen, Denmark	Universidade Federal do Rio de Janeiro; Fundacao Oswaldo Cruz; University of Copenhagen	Giupponi, APD (corresponding author), Univ Fed Rio de Janeiro, Museu Nacl, Lab Aracnol, Programa Posgrad Zool,Dept Invertebrados, Rio De Janeiro, RJ, Brazil.; Giupponi, APD (corresponding author), Fiocruz MS, IOC, CAVAISC, Lab Referencia Nacl Vetores Riquetsioses,LIRN, BR-21045900 Rio De Janeiro, RJ, Brazil.	agiupponi@gmail.com	Giupponi, Alessandro PL/M-5692-2013; de Miranda, Gustavo Silva/C-1252-2013	de Miranda, Gustavo Silva/0000-0002-2895-9331	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [8922-13-6]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study was financially supported by a grant from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) (www.capes.gov.br/) to GSM (process number 8922-13-6 CAPES/Science Without Borders). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonelli A, 2011, TAXON, V60, P403, DOI 10.1002/tax.602010; Armas L. F., 2010, B SOC ENTOMOLOGICA A, V47, P55; Armas L.F., 2012, REV IBERICA ARACNOLO, V21, P27; Baptista R.L.C., 2003, Revista Iberica de Aracnologia, V7, P79; Baptista Renner Luiz Cerqueira, 2002, Revista Iberica de Aracnologia, V6, P105; Barni PE, 2015, ENVIRON MANAGE, V55, P259, DOI 10.1007/s00267-014-0408-6; Bates J.M., 2001, DIVERSIDADE BIOL CUL, P119; Benchimol M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129818; Bingham Alexa, 2010, POLIS J, V4, P1; Chirivi Joya Daniel, 2012, Boletin de la SEA, V50, P395; Crisp MD, 2009, NATURE, P458; Cunha DD, 2012, BRAZ J BOT, V35, P159, DOI 10.1590/S1806-99592012000200005; De Marques AAB, 2015, ORYX, V49, P25, DOI 10.1017/S0030605314000726; De Miranda GS, 2011, ZOOTAXA, P61; Drumond MA, 2002, SEM BIOD CAAT; Dunn RA, 1949, MEM NATL MUS VICTORI, V16; Dunn RA, 1949, MEM NATL MUS VICTORI, V16; Engenharia L., 2009, APROVEITAMENTO HIDRE, P117; Environmental Systems Research Institute [ESRI], 2014, ARCGIS DESKT HELP 10; Fage L., 1939, Bulletin de la Societe Entomologique de France, V44, P153; Fearnside PM, 2006, ENVIRON MANAGE, V38, P705, DOI 10.1007/s00267-005-0295-y; Fearnside PM, 2014, ENVIRON SCI POLICY, V38, P164, DOI 10.1016/j.envsci.2013.11.004; Fearnside PM, 2005, AMAZONIA REVELADA DE, P397; Ferreira J, 2014, SCIENCE, V346, P706, DOI 10.1126/science.1260194; Filho AOS, 2005, ALERTAS AS CONSEQUEN; FRAILEY C D, 1988, Acta Amazonica, V18, P119; Giupponi A.P.L., 2002, B MUSEU NACL, V477, P1; Giupponi APL, 2013, ZOOTAXA, V3647, P329, DOI 10.11646/zootaxa.3647.2.5; Giupponi APL, 2012, AN ACAD BRAS CIENC, V84, P165, DOI 10.1590/S0001-37652012000100017; Harvey MS, 2003, CATALOGUE SMALLER AR, P398; Jocque M, 2012, ZOOTAXA, P53, DOI 10.11646/zootaxa.3158.1.4; Koch L., 1867, VERH ZOOL BOT GES WI, V17, P173; Kraepelin, 1895, VERHANDLUNGEN NATURW, V13, P3; Machado ABM, 2008, LIVRO VERMELHO FAUNA; Mello-Leitao C., 1931, ARCH MUS NAC, V33; Mello-Leitao C., 1931, ARCH MUS NAC, V33; Miranda-Ribeiro A., 1935, B MUSEU NACL, V11, P1; Vasconcelos ACO, 2013, ZOOTAXA, V 3737, P488, DOI 10.11646/zootaxa.3737.4.9; Pearman PB, 2007, TRENDS ECOL EVOL, P23; Pinto-da-Rocha R, 2002, J NAT HIST, V36, P107, DOI 10.1080/00222930110110152; Pinto-da-Rocha R, 2012, ZOOLOGIA-CURITIBA, V29, P474, DOI 10.1590/S1984-46702012000500012; Quintero Arias D., 1986, P203; QUINTERO D, 1981, J ARACHNOL, V9, P117; Quintero DJ, 1983, STUD FAUNA CURACAO, V65, P1; Rahmadi C, 2010, ZOOTAXA, P1; Rahmadi C, 2010, J ARACHNOL, V38, P475, DOI 10.1636/Ha09-95.1; Rancy A., 2000, PALEOECOLOGIA AMAZON; Reveillion F, 2015, ZOOTAXA, V4032, P190, DOI 10.11646/zootaxa.4032.2.3; Rohe F, 2009, INT J PRIMATOL, V30, P533, DOI 10.1007/s10764-009-9358-x; Rossetti DD, 2005, QUATERNARY RES, V63, P78, DOI 10.1016/j.yqres.2004.10.001; Rossetti DF, 2004, QUATERNARY RES, P61; Ruegg W, 1949, B SOC GEOLOGICA PERU, V3, P1; Seiter M, 2015, ZOOTAXA, V4012, P542, DOI 10.11646/zootaxa.4012.3.8; SILVA J., 2014, INT J GEOSCIENCES, V5, P1426, DOI [10.4236/ijg.2014.512116, DOI 10.4236/IJG.2014.512116]; Skirycz A, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00653; Swann ALS, 2015, AGR FOREST METEOROL, V214, P12, DOI 10.1016/j.agrformet.2015.07.006; Switkes G., 2008, AGUAS TURVAS ALERTAS; Teruel Rolando, 2011, Boletin de la SEA, V49, P15; Tourinho Ana Lucia, 2007, Zootaxa, V1540, P55; Vasconcelos ACO, 2014, J ARACHNOL, V42, P155, DOI 10.1636/H14-01.1; Vaz Sergio Maia, 2000, Revista Brasileira de Zoologia, V17, P183; Viquez Carlos, 2012, Revista Iberica de Aracnologia, V21, P56; VRBA ES, 1992, J MAMMAL, V73, P1, DOI 10.2307/1381862; WEBB SD, 1995, SCIENCE, V269, P361, DOI 10.1126/science.269.5222.361; WEYGOLDT P, 1972, Z MORPHOL TIERE, V71, P23; WEYGOLDT P, 1972, Senckenbergiana Biologica, V53, P281; Weygoldt P., 2000, WHIP SPIDERS CHELICE; Weygoldt P., 2005, SENCKENBERG BIOL, V85, P1; Weygoldt Peter, 2006, Verhandlungen des Naturwissenschaftlichen Vereins in Hamburg, P5; Wiens JJ, 2005, ANNU REV ECOL EVOL S, V36, P519, DOI 10.1146/annurev.ecolsys.36.102803.095431; Willig MR., 1983, B CARNEGIE MUSEUM NA, V23, P1	71	22	24	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0148277	10.1371/journal.pone.0148277	http://dx.doi.org/10.1371/journal.pone.0148277			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26885641	Green Published, gold, Green Submitted			2022-12-26	WOS:000371218400026
J	Lo, WC; Li, W; Jones, EF; Newitt, DC; Kornak, J; Wilmes, LJ; Esserman, LJ; Hylton, NM				Lo, Wei-Ching; Li, Wen; Jones, Ella F.; Newitt, David C.; Kornak, John; Wilmes, Lisa J.; Esserman, Laura J.; Hylton, Nola M.			Effect of Imaging Parameter Thresholds on MRI Prediction of Neoadjuvant Chemotherapy Response in Breast Cancer Subtypes	PLOS ONE			English	Article							RECURRENCE-FREE SURVIVAL; TRIAL-CALGB 150007/150012; PREOPERATIVE CHEMOTHERAPY; PROGNOSTIC VALUE; TUMOR VOLUME; ACRIN 6657; BIOMARKER	The purpose of this study is to evaluate the predictive performance of magnetic resonance imaging (MRI) markers in breast cancer patients by subtype. Sixty-four patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy were enrolled in this study. Each patient received a dynamic contrast-enhanced (DCE-MRI) at baseline, after 1 cycle of chemotherapy and before surgery. Functional tumor volume (FTV), the imaging marker measured by DCE-MRI, was computed at various thresholds of percent enhancement (PEt) and signal-enhancement ratio (SERE). Final FTV before surgery and percent changes of FTVs at the early and final treatment time points were used to predict patients' recurrence free survival. The full cohort and each subtype defined by the status of hormone receptor and human epidermal growth factor receptor 2 (HR+/HER2-, HER2+, triple negative) were analyzed. Predictions were evaluated using the Cox proportional hazard model when PEt changed from 30% to 200% in steps of 10% and SERE changed from 0 to 2 in steps of 0.2. Predictions with high hazard ratios and low p -values were considered as strong. Different profiles of FTV as predictors for recurrence -free survival were observed in each breast cancer subtype and strong associations with survival were observed at different PEE/SERE combinations that resulted in different FTVs. Findings from this retrospective study suggest that the predictive performance of imaging markers based on FTV may be improved with enhancement thresholds being optimized separately for clinically-relevant subtypes defined by HR and HER2 receptor expression.	[Lo, Wei-Ching; Li, Wen; Jones, Ella F.; Newitt, David C.; Wilmes, Lisa J.; Hylton, Nola M.] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA; [Kornak, John] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Esserman, Laura J.] Univ Calif San Francisco, Dept Surg & Radiol, San Francisco, CA 94143 USA; [Lo, Wei-Ching] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Case Western Reserve University	Jones, EF (corresponding author), Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA.	ella.jones@ucsf.edu	Jones, Ella F./W-2725-2019; Hylton, Nola/AAF-7861-2019; Jones, Ella/AAZ-6292-2020	Jones, Ella/0000-0001-8700-2129	National Institute of Health/National Cancer Institute [IUO1CA151235, RO1CA132870]; Susan G Komen [SAC110017]; NATIONAL CANCER INSTITUTE [R01CA132870, U01CA151235] Funding Source: NIH RePORTER	National Institute of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Susan G Komen(Susan G. Komen Breast Cancer Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funded by National Institute of Health/National Cancer Institute: IUO1CA151235; RO1CA132870 Susan G Komen: SAC110017 www.komensf.org/. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez RH, 2010, J CLIN ONCOL, V28, P3366, DOI 10.1200/JCO.2009.25.4011; [Anonymous], 2014, R LANG ENV STAT COMP; Esserman LJ, 2012, J CLIN ONCOL, V30, P3242, DOI 10.1200/JCO.2011.39.2779; Fisher B, 1998, J CLIN ONCOL, V16, P2672, DOI 10.1200/JCO.1998.16.8.2672; Han M, 2012, AM J ROENTGENOL, V199, P921, DOI 10.2214/AJR.11.7895; Heldahl MG, 2010, ACTA RADIOL, V51, P604, DOI 10.3109/02841851003782059; Hylton N, 2006, J CLIN ONCOL, V24, P3293, DOI 10.1200/JCO.2006.06.8080; Hylton NM, 2012, RADIOLOGY, V263, P663, DOI 10.1148/radiol.12110748; Jafri NF, 2014, J MAGN RESON IMAGING, V40, P476, DOI 10.1002/jmri.24351; Jones EF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061969; Kleinbaum DG, 2012, STAT BIOL HEALTH, P1, DOI 10.1007/978-1-4419-6646-9; Loo CE, 2011, J CLIN ONCOL, V29, P660, DOI 10.1200/JCO.2010.31.1258; Miller JC, 2005, JNCI-J NATL CANCER I, V97, P172, DOI 10.1093/jnci/dji023; Mukhtar RA, 2013, ANN SURG ONCOL, V20, P3823, DOI 10.1245/s10434-013-3038-y; Padhani AR, 2005, ABDOM IMAGING, V30, P324, DOI 10.1007/s00261-004-0265-5; Partridge SC, 2005, AM J ROENTGENOL, V184, P1774, DOI 10.2214/ajr.184.6.01841774; Partridge SC, 2002, AM J ROENTGENOL, V179, P1193, DOI 10.2214/ajr.179.5.1791193; Partridge SC, 1999, ST HEAL T, V62, P259; Perez EA, 2011, ONCOLOGIST, V16, P20, DOI 10.1634/theoncologist.2011-S1-20; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Pickles MD, 2009, EUR J RADIOL, V71, P498, DOI 10.1016/j.ejrad.2008.05.007; Polyak K, 2011, J CLIN INVEST, V121, P3786, DOI 10.1172/JCI60534; Rehman S, 2005, ONCOLOGIST, V10, P92, DOI 10.1634/theoncologist.10-2-92; Rouzier R, 2005, CLIN CANCER RES, V11, P5678, DOI 10.1158/1078-0432.CCR-04-2421; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Weigelt B, 2005, NAT REV CANCER, V5, P591, DOI 10.1038/nrc1670; Wolmark N, 2001, J Natl Cancer Inst Monogr, P96	28	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0142047	10.1371/journal.pone.0142047	http://dx.doi.org/10.1371/journal.pone.0142047			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26886725	Green Published, gold			2022-12-26	WOS:000371218400001
J	Nosak, C; Silva, PN; Sollazzo, P; Moon, KM; Odisho, T; Foster, LJ; Rocheleau, JV; Volchuk, A				Nosak, Courtney; Silva, Pamuditha N.; Sollazzo, Pietro; Moon, Kyung-Mee; Odisho, Tanya; Foster, Leonard J.; Rocheleau, Jonathan V.; Volchuk, Allen			Jagn1 Is Induced in Response to ER Stress and Regulates Proinsulin Biosynthesis	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; CELL-LINES; INFLAMMATION; DEFICIENCY; GOLGI	The Jagn1 protein was indentified in a SILAC proteomic screen of proteins that are increased in insulinoma cells expressing a folding-deficient proinsulin. Jagn1 mRNA was detected in primary rodent islets and in insulinoma cell lines and the levels were increased in response to ER stress. The function of Jagn1 was assessed in insulinoma cells by both knock-down and overexpression approaches. Knock-down of Jagn1 caused an increase in glucose-stimulated insulin secretion resulting from an increase in proinsulin biosynthesis. In contrast, overexpression of Jagn1 in insulinoma cells resulted in reduced cellular proinsulin and insulin levels. Our results identify a novel role for Jagn1 in regulating proinsulin biosynthesis in pancreatic beta-cells. Under ER stress conditions Jagn1 is induced which might contribute to reducing proinsulin biosynthesis, in part by helping to relieve the protein folding load in the ER in an effort to restore ER homeostasis.	[Nosak, Courtney; Odisho, Tanya; Rocheleau, Jonathan V.] Univ Toronto, Dept Physiol, Toronto, ON, Canada; [Silva, Pamuditha N.; Rocheleau, Jonathan V.] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada; [Sollazzo, Pietro] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Moon, Kyung-Mee; Foster, Leonard J.] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V5Z 1M9, Canada; [Moon, Kyung-Mee; Foster, Leonard J.] Univ British Columbia, Ctr High Throughput Biol, Vancouver, BC V5Z 1M9, Canada; [Volchuk, Allen] St Michaels Hosp, Li Ka Shing Knowledge Inst, Keenan Res Ctr, 30 Bond St, Toronto, ON M5B 1W8, Canada	University of Toronto; University of Toronto; University of Toronto; University of British Columbia; University of British Columbia; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto	Volchuk, A (corresponding author), St Michaels Hosp, Li Ka Shing Knowledge Inst, Keenan Res Ctr, 30 Bond St, Toronto, ON M5B 1W8, Canada.	allen.volchuk@utoronto.ca		Rocheleau, Jonathan/0000-0002-1760-2564	Canadian Institutes for Health Research (CIHR) [MOP-114992, MOP-77688]; Natural Science and Engineering Research Council of Canada (NSERC) [RGPIN371705]; Banting and Best Diabetes Centre (BBDC); BBDC-UHN Graduate Student award; NSERC	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Science and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Banting and Best Diabetes Centre (BBDC); BBDC-UHN Graduate Student award; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	The study was funded by operating grants from the Canadian Institutes for Health Research (CIHR) to AV (MOP-114992) and LJF (MOP-77688) (http://www.cihr-irsc.gc.ca/e/193.html) and the Natural Science and Engineering Research Council of Canada (NSERC) to JVR (RGPIN371705). CN was funded by a Banting and Best Diabetes Centre (BBDC) Graduate Student award. PNS was funded by a BBDC-UHN Graduate Student award and an NSERC Postgraduate scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASFARI M, 1992, ENDOCRINOLOGY, V130, P167, DOI 10.1210/en.130.1.167; Auweter SD, 2011, J BIOL CHEM, V286, P24023, DOI 10.1074/jbc.M111.224600; Basu A, 2014, ARTERIOSCL THROM VAS, V34, P533, DOI 10.1161/ATVBAHA.113.302573; Boztug K, 2014, NAT GENET, V46, P1021, DOI 10.1038/ng.3069; Brandizzi F, 2013, NAT REV MOL CELL BIO, V14, P382, DOI 10.1038/nrm3588; Eizirik DL, 2013, DIABETOLOGIA, V56, P234, DOI 10.1007/s00125-012-2762-3; Eizirik DL, 2008, ENDOCR REV, V29, P42, DOI 10.1210/er.2007-0015; Hartley T, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-59; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Lee MCS, 2004, ANNU REV CELL DEV BI, V20, P87, DOI 10.1146/annurev.cellbio.20.010403.105307; Lee S, 2007, J CELL BIOL, V176, P941, DOI 10.1083/jcb.200701048; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Ong SE, 2003, METHODS, V29, P124, DOI 10.1016/S1046-2023(02)00303-1; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Teodoro-Morrison T, 2013, DIABETOLOGIA, V56, P1057, DOI 10.1007/s00125-013-2855-7; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang J, 1999, J CLIN INVEST, V103, P27, DOI 10.1172/JCI4431; Wirnsberger G, 2014, NAT GENET, V46, P1028, DOI 10.1038/ng.3070; Zhang LL, 2010, FEBS LETT, V584, P2298, DOI 10.1016/j.febslet.2010.03.041; Zhang LL, 2009, J BIOL CHEM, V284, P5289, DOI 10.1074/jbc.M805477200	20	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0149177	10.1371/journal.pone.0149177	http://dx.doi.org/10.1371/journal.pone.0149177			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	26882284	Green Published, gold, Green Submitted			2022-12-26	WOS:000371219000053
J	Schaming, TD				Schaming, Taza D.			Clark's Nutcracker Breeding Season Space Use and Foraging Behavior	PLOS ONE			English	Article							HOME-RANGE; WHITEBARK-PINE; NUCIFRAGA-COLUMBIANA; DENSITY-ESTIMATION; HABITAT USE; CONSERVATION; SELECTION; DISPERSAL; EMIGRATION; RESOURCES	Considering the entire life history of a species is fundamental to developing effective conservation strategies. Decreasing populations of five-needle white pines may be leading to the decline of Clark's nutcrackers (Nucifraga columbiana). These birds are important seed dispersers for at least ten conifer species in the western U.S., including whitebark pine (Pinus albicaulis), an obligate mutualist of Clark's nutcrackers. For effective conservation of both Clark's nutcrackers and whitebark pine, it is essential to ensure stability of Clark's nutcracker populations. My objectives were to examine Clark's nutcracker breeding season home range size, territoriality, habitat selection, and foraging behavior in the southern Greater Yellowstone Ecosystem, a region where whitebark pine is declining. I radio-tracked Clark's nutcrackers in 2011, a population-wide nonbreeding year following a low whitebark pine cone crop, and 2012, a breeding year following a high cone crop. Results suggest Douglas-fir (Pseudotsuga menziesii) communities are important habitat for Clark's nutcrackers because they selected it for home ranges. In contrast, they did not select whitebark pine habitat. However, Clark's nutcrackers did adjust their use of whitebark pine habitat between years, suggesting that, in some springs, whitebark pine habitat may be used more than previously expected. Newly extracted Douglas-fir seeds were an important food source both years. On the other hand, cached seeds made up a relatively lower proportion of the diet in 2011, suggesting cached seeds are not a reliable spring food source. Land managers focus on restoring whitebark pine habitat with the assumption that Clark's nutcrackers will be available to continue seed dispersal. In the Greater Yellowstone Ecosystem, Clark's nutcracker populations may be more likely to be retained year-round when whitebark pine restoration efforts are located adjacent to Douglas-fir habitat. By extrapolation, whitebark pine restoration efforts in other regions may consider prioritizing restoration of whitebark pine stands near alternative seed sources.	[Schaming, Taza D.] Cornell Univ, Dept Nat Resources, Cornell Lab Ornithol, Fernow Hall, Ithaca, NY 14853 USA	Cornell University	Schaming, TD (corresponding author), Cornell Univ, Dept Nat Resources, Cornell Lab Ornithol, Fernow Hall, Ithaca, NY 14853 USA.	tds55@cornell.edu			Athena Fund of the Cornell Lab of Ornithology; Meg and Bert Raynes Wildlife Fund Research Grant; Cornell Lab of Ornithology; NASA Harriett G. Jenkins Pre-doctoral Fellowship [NNX10AU20A]; Cornell Lab of Ornithology Kramer Graduate Fellowship; Cornell Lab of Ornithology Halberstadt Graduate Fellowship; Cornell University Research Travel Grant; Cornell University Sigma Xi; Cornell Lab of Ornithology Samuel and Linda Kramer Award; Andrew W. Mellon Student Research Grant; American Ornithologists' Union; Mazamas Graduate Student Research Grant; Conservation and Research Foundation Research Grant; Western Bird Banding Association Research Grant; Wyoming Wildlife - The Foundation; Wyoming Community Foundation [20120167]; American Philosophical Society Lewis and Clark Fund; Garden Club of America Frances M. Peacock Scholarship; Charles Redd Center for Western Studies Summer Award for Upper Division and Graduate Students; Wilson Ornithological Society Paul A. Stewart Research Award; Explorers Club Exploration Fund; Fischer Equipment Grant; Havahart Equipment Grant	Athena Fund of the Cornell Lab of Ornithology; Meg and Bert Raynes Wildlife Fund Research Grant; Cornell Lab of Ornithology; NASA Harriett G. Jenkins Pre-doctoral Fellowship; Cornell Lab of Ornithology Kramer Graduate Fellowship; Cornell Lab of Ornithology Halberstadt Graduate Fellowship; Cornell University Research Travel Grant; Cornell University Sigma Xi; Cornell Lab of Ornithology Samuel and Linda Kramer Award; Andrew W. Mellon Student Research Grant; American Ornithologists' Union; Mazamas Graduate Student Research Grant; Conservation and Research Foundation Research Grant; Western Bird Banding Association Research Grant; Wyoming Wildlife - The Foundation; Wyoming Community Foundation; American Philosophical Society Lewis and Clark Fund; Garden Club of America Frances M. Peacock Scholarship; Charles Redd Center for Western Studies Summer Award for Upper Division and Graduate Students; Wilson Ornithological Society Paul A. Stewart Research Award; Explorers Club Exploration Fund; Fischer Equipment Grant; Havahart Equipment Grant	This study was generously funded by the Athena Fund of the Cornell Lab of Ornithology (www.birds.cornell.edu), Meg and Bert Raynes Wildlife Fund Research Grant (www.rayneswildlifefund.org)*, Cornell Lab of Ornithology (www.birds.cornell.edu), NASA Harriett G. Jenkins Pre-doctoral Fellowship (#NNX10AU20A, www.nasa.gov), Cornell Lab of Ornithology Kramer Graduate Fellowship (www.birds.cornell.edu), Cornell Lab of Ornithology Halberstadt Graduate Fellowship (www.birds.cornell.edu), Cornell University Research Travel Grant (www.cornell.edu), Cornell University Sigma Xi Grants-in-Aid of Research (www.sigmaxi.org), Cornell Lab of Ornithology Samuel and Linda Kramer Award (www.cornell.edu), Andrew W. Mellon Student Research Grant (www.mellon.org), American Ornithologists' Union (www.aou.org), Mazamas Graduate Student Research Grant (www.mazamas.org), Conservation and Research Foundation Research Grant (http://conservationresearch.wordpress.com), Western Bird Banding Association Research Grant (www.westernbirdbanding.org), Wyoming Wildlife - The Foundation, Wyoming Community Foundation, Research Grant (# 20120167; www.wyomingwildlifefoundation.org)*, American Philosophical Society Lewis and Clark Fund (http://www.amphilsoc.org), The Garden Club of America Frances M. Peacock Scholarship (www.gcamerica.org), Charles Redd Center for Western Studies Summer Award for Upper Division and Graduate Students, (https://reddcenter.byu.edu), Wilson Ornithological Society Paul A. Stewart Research Award (www.wilsonsociety.org), Explorers Club Exploration Fund (www.explorers.org), Fischer Equipment Grant (www.fischersports.com), and Havahart Equipment Grant (www.havahart.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript, with the exception of Cornell University and Cornell Lab of Ornithology students, professors, researchers and statisticians who provided feedback throughout the study design process, answered analyses questions and encouraged the decision to publish. TDS received all funding, with the exception of the two grants starred above (*). TDS wrote the two grants, and used the funding for her research only; however, per Cornell University policy, Janis Dickinson, TDS's advisor was the P.I.	Aldridge CL, 2007, ECOL APPL, V17, P508, DOI 10.1890/05-1871; Baldwin RF, 2006, J HERPETOL, V40, P442, DOI 10.1670/0022-1511(2006)40[442:CPFASW]2.0.CO;2; Barg JJ, 2005, J ANIM ECOL, V74, P139, DOI 10.1111/j.1365-2656.2004.00906.x; Barringer LE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037663; Boal CW, 2003, CONDOR, V105, P811, DOI 10.1650/7138; Bradbury W. C., 1917, Condor Hollywood, V19, DOI 10.2307/1362616; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Caro T., 1998, BEHAV ECOLOGY CONSER; Davis J., 1957, Condor, V59, P297, DOI 10.2307/1364965; Dohms KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079621; Dooley EM, 2012, THESIS SYRACUSE U SY; Duong T, 2003, J NONPARAMETR STAT, V15, P17, DOI 10.1080/10485250306039; Ellison AM, 2005, FRONT ECOL ENVIRON, V3, P479, DOI 10.1890/1540-9295(2005)003[0479:LOFSCF]2.0.CO;2; Faccio SD, 2003, J HERPETOL, V37, P479, DOI 10.1670/155-02A; FARNES PE, 1990, USDA INTERM, V270, P302; Fogg AM, 2014, AVIAN CONSERV ECOL, V9, DOI 10.5751/ACE-00671-090203; GIUNTOLI M, 1978, AUK, V95, P595; Greater Yellowstone Coordinating Committee Whitebark Pine Subcommi.ttee, 2011, WHIT PIN STRAT GREAT; HARRIS S, 1990, MAMMAL REV, V20, P97, DOI 10.1111/j.1365-2907.1990.tb00106.x; HUTCHINS HE, 1982, OECOLOGIA, V55, P192, DOI 10.1007/BF00384487; JOHNSON DH, 1980, ECOLOGY, V61, P65, DOI 10.2307/1937156; Jones MC, 1996, J AM STAT ASSOC, V91, P401, DOI 10.2307/2291420; Keane RE, 2012, RANGE WIDE RESTORATI, P108; Kernohan Brian J., 2001, P125, DOI 10.1016/B978-012497781-5/50006-2; Kie JG, 1996, WILDLIFE SOC B, V24, P342; LAIR H, 1987, ECOLOGY, V68, P1092, DOI 10.2307/1938381; Lanner R. M., 1996, MADE EACH OTHER SYMB; Law BS, 1998, BIODIVERS CONSERV, V7, P323, DOI 10.1023/A:1008877611726; Lorenz T., 2009, FINAL REPORT CLARKS; Lorenz TJ, 2011, AUK, V128, P237, DOI 10.1525/auk.2011.10101; Lorenz TJ, 2009, CONDOR, V111, P326, DOI 10.1525/cond.2009.080070; Macfarlane WW, 2013, ECOL APPL, V23, P421, DOI 10.1890/11-1982.1; Macfarlane WW, USING LANDSCAPE ASSE; Manly B., 1993, RESOURCE SELECTION A; Marzluff JM, 2004, ECOLOGY, V85, P1411, DOI 10.1890/03-0114; McKinney ST, 2009, ECOL APPL, V19, P597, DOI 10.1890/08-0151.1; MEWALDT L. RICHARD, 1956, CONDOR, V58, P3, DOI 10.2307/1365043; Millspaugh JJ, 2006, J WILDLIFE MANAGE, V70, P384, DOI 10.2193/0022-541X(2006)70[384:AORSUU]2.0.CO;2; Nielsen SE, 2006, BIOL CONSERV, V130, P217, DOI 10.1016/j.biocon.2005.12.016; ODUM E. P., 1955, AUK, V72, P128; Otis DL, 1999, J WILDLIFE MANAGE, V63, P1039, DOI 10.2307/3802819; Rota CT, 2014, FOREST ECOL MANAG, V313, P161, DOI 10.1016/j.foreco.2013.10.048; Runge CA, 2015, CONSERV BIOL, V29, P865, DOI 10.1111/cobi.12440; Savage RE, 1931, FISH INVESTIG LONG 2, V12; Schaming TD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123917; Seaman DE, 1999, J WILDLIFE MANAGE, V63, P739, DOI 10.2307/3802664; Sherry TW, 1996, ECOLOGY, V77, P36, DOI 10.2307/2265652; TOMBACK D F, 1977, Living Bird, V16, P123; Tomback DF, 2010, FOREST PATHOL, V40, P186, DOI 10.1111/j.1439-0329.2010.00655.x; Tomback D.F., 2001, WHITEBARK PINE COMMU; Tomback D. F., 1998, BIRDS N AM ONLINE; TOMBACK DF, 1982, J ANIM ECOL, V51, P451, DOI 10.2307/3976; TOMBACK DF, 1977, THESIS U CALIFORNIA; VANDERWALL SB, 1977, ECOL MONOGR, V47, P89, DOI 10.2307/1942225; VANDERWALL SB, 1981, CONDOR, V83, P162; VANDERWALL SB, 1983, CAN FIELD NAT, V97, P208; VANDERWALL SB, 1988, CONDOR, V90, P621, DOI 10.2307/1368351; White G.C., 1990, ANAL WILDLIFE RADIO; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423	59	7	9	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0149116	10.1371/journal.pone.0149116	http://dx.doi.org/10.1371/journal.pone.0149116			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	26881774	Green Published, Green Submitted, gold			2022-12-26	WOS:000371219000047
J	Duan, RH; Shi, YT; Yu, L; Zhang, GH; Li, J; Lin, YT; Guo, JF; Wang, JL; Shen, L; Jiang, H; Wang, GH; Tang, BS				Duan, Ranhui; Shi, Yuting; Yu, Li; Zhang, Gehan; Li, Jia; Lin, Yunting; Guo, Jifeng; Wang, Junling; Shen, Lu; Jiang, Hong; Wang, Guanghui; Tang, Beisha			UBA5 Mutations Cause a New Form of Autosomal Recessive Cerebellar Ataxia	PLOS ONE			English	Article							UBIQUITIN-ACTIVATING ENZYME; UFM1	Autosomal recessive cerebellar ataxia (ARCA) comprises a large and heterogeneous group of neurodegenerative disorders. For many affected patients, the genetic cause remains undetermined. Through whole-exome sequencing, we identified compound heterozygous mutations in ubiquitin-like modifier activating enzyme 5 gene (UBA5) in two Chinese siblings presenting with ARCA. Moreover, copy number variations in UBA5 or ubiquitin-fold modifier 1 gene (UFM1) were documented with the phenotypes of global developmental delays and gait disturbances in the ClinVar database. UBA5 encodes UBA5, the ubiquitin-activating enzyme of UFM1. However, a crucial role for UBA5 in human neurological disease remains to be reported. Our molecular study of UBA5-R246X revealed a dramatically decreased half-life and loss of UFM1 activation due to the absence of the catalytic cysteine Cys250. UBA5-K310E maintained its interaction with UFM1, although with less stability, which may affect the ability of this UBA5 mutant to activate UFM1. Drosophila modeling revealed that UBA5 knockdown induced locomotive defects and a shortened lifespan accompanied by aberrant neuromuscular junctions (NMJs). Strikingly, we found that UFM1 and E2 cofactor knockdown induced markedly similar phenotypes. Wild-type UBA5, but not mutant UBA5, significantly restored neural lesions caused by the absence of UBA5. The finding of a UBA5 mutation in cerebellar ataxia suggests that impairment of the UFM1 pathway may contribute to the neurological phenotypes of ARCA.	[Shi, Yuting; Guo, Jifeng; Wang, Junling; Shen, Lu; Jiang, Hong; Tang, Beisha] Cent S Univ, Xiangya Hosp, Dept Neurol, Changsha, Hunan, Peoples R China; [Duan, Ranhui; Yu, Li; Zhang, Gehan; Li, Jia; Lin, Yunting; Guo, Jifeng; Wang, Junling; Shen, Lu; Jiang, Hong; Tang, Beisha] Cent S Univ, Sch Life Sci, State Key Lab Med Genet, Changsha, Hunan, Peoples R China; [Wang, Guanghui] Soochow Univ, Coll Pharmaceut Sci, Dept Pharmacol, Suzhou, Jiangsu, Peoples R China; [Guo, Jifeng; Wang, Junling; Shen, Lu; Jiang, Hong; Tang, Beisha] Cent S Univ, Key Lab Hunan Prov Neurodegenerat Disorders, Changsha, Hunan, Peoples R China	Central South University; Central South University; Soochow University - China; Central South University	Tang, BS (corresponding author), Cent S Univ, Xiangya Hosp, Dept Neurol, Changsha, Hunan, Peoples R China.; Duan, RH; Tang, BS (corresponding author), Cent S Univ, Sch Life Sci, State Key Lab Med Genet, Changsha, Hunan, Peoples R China.; Tang, BS (corresponding author), Cent S Univ, Key Lab Hunan Prov Neurodegenerat Disorders, Changsha, Hunan, Peoples R China.	duanranhui@sklmg.edu.cn; bstang7398@163.com	Wang, Guanghui/U-3979-2017	Wang, Guanghui/0000-0001-8551-6468	State Key Program of the National Natural Science Foundation of China [81130021]; National Natural Science Foundation of China [81571253, 81172513, 81071028]	State Key Program of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The State Key Program of the National Natural Science Foundation of China (grant number: 81130021), National Natural Science Foundation of China (grant number: 81571253, 81172513, 81071028).	Anheim M, 2012, NEW ENGL J MED, V366, P636, DOI 10.1056/NEJMra1006610; Azfer A, 2006, AM J PHYSIOL-HEART C, V291, pH1411, DOI 10.1152/ajpheart.01378.2005; Bacik JP, 2010, J BIOL CHEM, V285, P20273, DOI 10.1074/jbc.M110.102921; Collins CA, 2007, CURR OPIN NEUROBIOL, V17, P35, DOI 10.1016/j.conb.2007.01.001; Daniel J, 2014, CELLS-BASEL, V3, P627, DOI 10.3390/cells3020627; De Michele G, 2004, J NEUROL, V251, P913, DOI 10.1007/s00415-004-0484-2; Depondt C, 2014, NEUROLOGY, V82, P1749, DOI 10.1212/WNL.0000000000000416; Ha BH, 2011, J BIOL CHEM, V286, P10248, DOI 10.1074/jbc.M110.172171; Hersheson J, 2012, HUM MUTAT, V33, P1324, DOI 10.1002/humu.22132; Hertel P, 2013, J BIOL CHEM, V288, P10661, DOI 10.1074/jbc.M113.458000; Komatsu M, 2004, EMBO J, V23, P1977, DOI 10.1038/sj.emboj.7600205; Lemaire K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018517; Ronnebaum Sarah M, 2014, Hum Genome Var, V1, P14018, DOI 10.1038/hgv.2014.18; Sailer A, 2012, CURR NEUROL NEUROSCI, V12, P227, DOI 10.1007/s11910-012-0267-6; Shi Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081884; Shiwaku H, 2010, EMBO J, V29, P2446, DOI 10.1038/emboj.2010.116; Tatsumi K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1182; Tatsumi K, 2010, J BIOL CHEM, V285, P5417, DOI 10.1074/jbc.M109.036814; Vermeer S, 2011, J MED GENET, V48, P651, DOI 10.1136/jmedgenet-2011-100210; Willemsen MH, 2013, J MED GENET, V50, P507, DOI 10.1136/jmedgenet-2012-101490; Xing GL, 2014, J BIOL CHEM, V289, P31867, DOI 10.1074/jbc.M114.574897; Zhang M, 2015, CELL DEATH DIFFER, V51; Zheng M, 2008, J CELL BIOCHEM, V104, P2324, DOI 10.1002/jcb.21791	23	40	47	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149039	10.1371/journal.pone.0149039	http://dx.doi.org/10.1371/journal.pone.0149039			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26872069	Green Published, gold, Green Submitted			2022-12-26	WOS:000370054100091
J	Guarnieri, G; Bevilacqua, S; De Leo, F; Farella, G; Maffia, A; Terlizzi, A; Fraschetti, S				Guarnieri, Giuseppe; Bevilacqua, Stanislao; De Leo, Francesco; Farella, Giulio; Maffia, Anna; Terlizzi, Antonio; Fraschetti, Simonetta			The Challenge of Planning Conservation Strategies in Threatened Seascapes: Understanding the Role of Fine Scale Assessments of Community Response to Cumulative Human Pressures	PLOS ONE			English	Article							HUMAN DISTURBANCE; MARINE HABITATS; MULTIVARIATE; SEA; ASSEMBLAGES; PATTERNS; UNIVARIATE; IMPACT; AREAS	Assessing the distribution and intensity of human threats to biodiversity is a prerequisite for effective spatial planning, harmonizing conservation purposes with sustainable development. In the Mediterranean Sea, the management of Marine Protected Areas (MPAs) is rarely based on explicit consideration of the distribution of multiple stressors, with direct assessment of their effects on ecosystems. This gap limits the effectiveness of protection and is conducive to conflicts among stakeholders. Here, a fine scale assessment of the potential effects of different combinations of stressors (both land- and marine-based) on vulnerable rocky habitats (i.e. lower midlittoral and shallow infralittoral) along 40 km of coast in the western Mediterranean (Ionian Sea) has been carried out. The study area is a paradigmatic example of socio-ecological interactions, where several human uses and conservation measures collide. Significant differences in the structure of assemblages according to different combinations of threats were observed, indicating distinct responses of marine habitats to different sets of human pressures. A more complex three-dimensional structure, higher taxon richness and beta-diversity characterized assemblages subject to low versus high levels of human pressure, consistently across habitats. In addition, the main drivers of change were: closeness to the harbour, water quality, and the relative extension of beaches. Our findings suggest that, although efforts to assess cumulative impacts at large scale may help in individuating priority areas for conservation purposes, the fact that such evaluations are often based on expert opinions and not on actual studies limits their ability to represent real environmental conditions at local scale. Systematic evaluations of local scale effects of anthropogenic drivers of change on biological communities should complement broad scale management strategies to achieve effective sustainability of human exploitation of marine resources.	[Guarnieri, Giuseppe; Bevilacqua, Stanislao; De Leo, Francesco; Farella, Giulio; Maffia, Anna; Terlizzi, Antonio; Fraschetti, Simonetta] Univ Salento, Dept Biol & Environm Sci & Technol, CoNISMa, I-73100 Lecce, Italy	CoNISMa; University of Salento	Guarnieri, G (corresponding author), Univ Salento, Dept Biol & Environm Sci & Technol, CoNISMa, I-73100 Lecce, Italy.	giuseppe.guarnieri@unisalento.it	Bevilacqua, Stanislao/I-1393-2019; Terlizzi, Antonio/B-6131-2015; Fraschetti, Simonetta/R-8716-2019	Bevilacqua, Stanislao/0000-0002-6417-7134; Terlizzi, Antonio/0000-0001-5968-4548; Fraschetti, Simonetta/0000-0002-1780-1651; Farella, Giulio/0000-0001-5710-911X; DE LEO, FRANCESCO/0000-0001-9709-6114; Guarnieri, Giuseppe/0000-0002-7334-9030	European Community [287844]; Italian Ministry of the Research PRIN TETRIS	European Community(European Commission); Italian Ministry of the Research PRIN TETRIS	The research leading to these results received funding from the European Community's 7th Framework Programme (FP7/2007-2013) under Grant Agreement No. 287844 for the project 'Towards COast to COast NETworks of marine protected areas (from the shore to the high and deep sea), coupled with sea-based wind energy potential' (COCONET, http://www.coconet-fp7.eu/). The support from the Italian Ministry of the Research PRIN TETRIS is also acknowledged.	Airoldi L, 2003, OCEANOGR MAR BIOL, V41, P161; Airoldi L, 2007, OCEANOGR MAR BIOL, V45, P345; Andersen JH, 2015, ESTUAR COAST SHELF S, V161, P88, DOI 10.1016/j.ecss.2015.05.002; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Anderson MJ, 2006, ECOL LETT, V9, P683, DOI 10.1111/j.1461-0248.2006.00926.x; Anderson MJ, 2003, ECOLOGY, V84, P511, DOI 10.1890/0012-9658(2003)084[0511:CAOPCA]2.0.CO;2; Anderson MJ, 2001, CAN J FISH AQUAT SCI, V58, P626, DOI 10.1139/cjfas-58-3-626; [Anonymous], 2008, OFF J EUR COMMUNITIE, V164, P19, DOI DOI 10.1016/J.BIOCON.2008.10.006; Ban NC, 2009, CONSERV LETT, V2, P206, DOI 10.1111/j.1755-263X.2009.00071.x; Ban SS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135465; Batista MI, 2014, OCEAN COAST MANAGE, V102, P248, DOI 10.1016/j.ocecoaman.2014.09.020; Benedetti-Cecchi L, 2001, MAR ECOL PROG SER, V214, P137, DOI 10.3354/meps214137; Bevilacqua S, 2006, J ANIM ECOL, V75, P908, DOI 10.1111/j.1365-2656.2006.01108.x; Bulleri F, 2010, J APPL ECOL, V47, P26, DOI 10.1111/j.1365-2664.2009.01751.x; Cheng BS, 2015, GLOBAL CHANGE BIOL, V21, P2488, DOI 10.1111/gcb.12895; Chryssovergis F, 1995, OCEANOL ACTA, V18, P649; CLARKE KR, 1993, MAR ECOL PROG SER, V92, P205, DOI 10.3354/meps092205; Claudet J, 2010, BIOL CONSERV, V143, P2195, DOI 10.1016/j.biocon.2010.06.004; Coll M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011842; Costello MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012110; Douvere F, 2008, MAR POLICY, V32, P762, DOI 10.1016/j.marpol.2008.03.021; Fernandez-Macho J, 2015, MAR POLICY, V60, P49, DOI 10.1016/j.marpol.2015.05.010; Ferretti M, 2011, STATE ITALIAN MARINE, P185; Fraschetti S, 2001, MAR ECOL PROG SER, V212, P1, DOI 10.3354/meps212001; Fraschetti S, 2009, MAR ECOL PROG SER, V375, P13, DOI 10.3354/meps07781; Gray JS, 1997, BIODIVERS CONSERV, V6, P153, DOI 10.1023/A:1018335901847; Guidetti P, 2003, MAR BIOL, V143, P1135, DOI 10.1007/s00227-003-1163-z; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Halpern BS, 2007, CONSERV BIOL, V21, P1301, DOI 10.1111/j.1523-1739.2007.00752.x; Knight AT, 2008, CONSERV BIOL, V22, P610, DOI 10.1111/j.1523-1739.2008.00914.x; Lubchenco J, 2003, ECOL APPL, V13, pS3; Mazor T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104489; McLeod K.L., 2005, SCI CONSENSUS STATEM; Micheli F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079889; Parravicini V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075767; Perkol-Finkel S, 2007, J EXP MAR BIOL ECOL, V340, P25, DOI 10.1016/j.jembe.2006.08.008; Perkol-Finkel S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010791; Philippart CJM, 2012, ESTUAR COAST SHELF S, V108, P52, DOI 10.1016/j.ecss.2012.05.014; Pinto H, 2015, MAR POLICY, V57, P167, DOI 10.1016/j.marpol.2015.03.029; Piola RF, 2008, DIVERS DISTRIB, V14, P329, DOI 10.1111/j.1472-4642.2007.00430.x; Roberts JJ, 2010, ENVIRON MODELL SOFTW, V25, P1197, DOI 10.1016/j.envsoft.2010.03.029; Smith SDA, 1996, MAR POLLUT BULL, V33, P309, DOI 10.1016/S0025-326X(96)00124-5; Tamburello L, 2012, MAR ECOL PROG SER, V457, P29, DOI 10.3354/meps09703; Terlizzi A, 2005, MAR ECOL PROG SER, V289, P27, DOI 10.3354/meps289027; Terlizzi A, 2007, MAR ECOL PROG SER, V332, P25, DOI 10.3354/meps332025; Thibaut T, 2005, MAR POLLUT BULL, V50, P1472, DOI 10.1016/j.marpolbul.2005.06.014; Turner SJ, 1997, MAR ENVIRON RES, V43, P181, DOI 10.1016/0141-1136(96)00086-4; Wernberg T, 2012, GLOBAL CHANGE BIOL, V18, P1491, DOI 10.1111/j.1365-2486.2012.02656.x	48	19	19	3	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149253	10.1371/journal.pone.0149253	http://dx.doi.org/10.1371/journal.pone.0149253			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26871942	Green Published, gold, Green Submitted			2022-12-26	WOS:000370054100135
J	Varga-Szemes, A; Kiss, P; Rab, A; Suranyi, P; Lenkey, Z; Simor, T; Bryant, RG; Elgavish, GA				Varga-Szemes, Akos; Kiss, Pal; Rab, Andras; Suranyi, Pal; Lenkey, Zsofia; Simor, Tamas; Bryant, Robert G.; Elgavish, Gabriel A.			In Vitro Longitudinal Relaxivity Profile of Gd (ABE-DTTA), an Investigational Magnetic Resonance Imaging Contrast Agent	PLOS ONE			English	Article							HIGH-FIELD MRI; SOLVENT PROTONS; CARDIAC MRI; 7 TESLA; RELAXATION; DEPENDENCE; GADOLINIUM; STRENGTH; INFARCT; LESIONS	Purpose MRI contrast agents (CA) whose contrast enhancement remains relatively high even at the higher end of the magnetic field strength range would be desirable. The purpose of this work was to demonstrate such a desired magnetic field dependency of the longitudinal relaxivity for an experimental MRI CA, Gd(ABE-DTTA). Materials and Methods The relaxivity of 0.5mM and 1mM Gd(ABE-DTTA) was measured by Nuclear Magnetic Relaxation Dispersion (NMRD) in the range of 0.0002 to 1T. Two MRI and five NMR instruments were used to cover the range between 1.5 to 20T. Parallel measurement of a GdDTPA sample was performed throughout as reference. All measurements were carried out at 37 degrees C and pH 7.4. Results The relaxivity values of 0.5mM and 1mM Gd(ABE-DTTA) measured at 1.5, 3, and 7T, within the presently clinically relevant magnetic field range, were 15.3, 11.8, 12.4 s(-1)mM(-1) and 18.1, 16.7, and 13.5 s(-1)mM(-1), respectively. The control 4 mM Gd-DTPA relaxivities at the same magnetic fields were 3.6, 3.3, and 3.0 s(-1)mM(-1), respectively. Conclusions The longitudinal relaxivity of Gd(ABE-DTTA) measured within the presently clinically relevant field range is three to five times higher than that of most commercially available agents. Thus, Gd(ABE-DTTA) could be a practical choice at any field strength currently used in clinical imaging including those at the higher end.	[Varga-Szemes, Akos; Kiss, Pal; Rab, Andras; Suranyi, Pal; Lenkey, Zsofia; Simor, Tamas; Elgavish, Gabriel A.] Univ Alabama Birmingham, Dept Biochem & Mol Genet, Birmingham, AL USA; [Varga-Szemes, Akos; Kiss, Pal; Rab, Andras; Suranyi, Pal; Lenkey, Zsofia; Simor, Tamas; Elgavish, Gabriel A.] Elgavish Paramagnet Inc, Birmingham, AL USA; [Lenkey, Zsofia; Simor, Tamas] Univ Pecs, Sch Med, Inst Heart, Pecs, Hungary; [Bryant, Robert G.] Univ Virginia, Dept Chem, Charlottesville, VA USA	University of Alabama System; University of Alabama Birmingham; University of Pecs; University of Virginia	Elgavish, GA (corresponding author), Univ Alabama Birmingham, Dept Biochem & Mol Genet, Birmingham, AL USA.; Elgavish, GA (corresponding author), Elgavish Paramagnet Inc, Birmingham, AL USA.	gabi@uab.edu	Rab, András/AAR-7804-2021; Rab, Andras/AAI-9402-2021; Varga-Szemes, Akos/AAI-9849-2020	Rab, András/0000-0003-2154-0017; Varga-Szemes, Akos/0000-0002-2781-7462	National Institutes of Health (NIH) [5R42 HL084844]; NATIONAL CANCER INSTITUTE [P30CA013148] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R42HL084844] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by National Institutes of Health (NIH) Grant 5R42 HL084844 (A.V.S.) to Elgavish Paramagnetics Inc. Drs. Kiss, Lenkey, Rab, Suranyi, and Varga-Szemes were employees, Dr. Simor is consultant, and Dr. Elgavish is officer of Elgavish Paramagnetics Inc. Elgavish Paramagnetics Inc. provided direct support in the form of salaries for the authors (except RGB), but did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Absinta M, 2013, ANN NEUROL, V74, P669, DOI 10.1002/ana.23959; Adzamli K, 1999, INVEST RADIOL, V34, P410, DOI 10.1097/00004424-199906000-00004; Aime S, 2009, J MAGN RESON IMAGING, V30, P1259, DOI 10.1002/jmri.21969; Caravan P, 2009, CONTRAST MEDIA MOL I, V4, P89, DOI 10.1002/cmmi.267; Conijn MMA, 2012, NEUROIMAGE, V59, P950, DOI 10.1016/j.neuroimage.2011.08.059; Craven I, 2011, CLIN RADIOL, V66, P278, DOI 10.1016/j.crad.2010.10.010; Dagia C., 2009, CLIN PEDIAT IMAGING, V68, P309, DOI DOI 10.1016/J.EJRAD.2008.05.019; Diakova G, 2011, J MAGN RESON, V208, P195, DOI 10.1016/j.jmr.2010.11.001; Dougherty L, 2001, MAGNET RESON MED, V45, P176, DOI 10.1002/1522-2594(200101)45:1<176::AID-MRM1025>3.0.CO;2-E; Jacques V, 2010, INVEST RADIOL, V45, P613, DOI 10.1097/RLI.0b013e3181ee6a49; Kaldoudi E, 1993, CONCEPT MAGNETIC RES, V5, P217, DOI [DOI 10.1002/CMR.1820050303, 10.1002/cmr.1820050303]; Kellar KE, 1997, MAGNET RESON MED, V37, P730, DOI 10.1002/mrm.1910370515; Kirschner R, 2010, J CARDIOVASC MAGN R, V12, DOI 10.1186/1532-429X-12-22; Kiss P, 2009, PROSTATE, V69, P449, DOI 10.1002/pros.20880; KOENIG SH, 1986, INVEST RADIOL, V21, P697, DOI 10.1097/00004424-198609000-00004; KOENIG SH, 1984, MAGN RESON MED, V1, P478, DOI 10.1002/mrm.1910010407; KOENIG SH, 1984, MAGNET RESON MED, V1, P496, DOI 10.1002/mrm.1910010408; Kwon DH, 2012, ANN NEUROL, V71, P267, DOI 10.1002/ana.22592; Nael Kambiz, 2007, Magn Reson Imaging Clin N Am, V15, P291, DOI 10.1016/j.mric.2007.08.002; Nakada T, 2007, BRAIN DEV-JPN, V29, P325, DOI 10.1016/j.braindev.2006.10.005; Noebauer-Huhmann IM, 2010, INVEST RADIOL, V45, P554, DOI 10.1097/RLI.0b013e3181ebd4e3; Pakin SK, 2006, ACAD RADIOL, V13, P1135, DOI 10.1016/j.acra.2006.06.007; Regatte RR, 2007, J MAGN RESON IMAGING, V25, P262, DOI 10.1002/jmri.20814; Rinck PA, 1999, EUR RADIOL, V9, P998, DOI 10.1007/s003300050781; Rohrer M, 2005, INVEST RADIOL, V40, P715, DOI 10.1097/01.rli.0000184756.66360.d3; Ruzsics B, 2006, PHARMACOLOGY, V77, P188, DOI 10.1159/000094864; Saab-Ismail NH, 1999, J MED CHEM, V42, P2852, DOI 10.1021/jm980454v; Simor T, 2005, J MAGN RESON IMAGING, V21, P536, DOI 10.1002/jmri.20326; Suranyi P, 2006, MAGN RESON MED, V56, P535, DOI 10.1002/mrm.20979; van Rooden Sanneke, 2014, Alzheimers Dement, V10, pe19, DOI 10.1016/j.jalz.2013.02.002; van Veluw SJ, 2013, J CEREBR BLOOD F MET, V33, P322, DOI 10.1038/jcbfm.2012.196; Vaughan T, 2006, MAGN RESON MED, V56, P1274, DOI 10.1002/mrm.21073; von Knobelsdorff-Brenkenhoff F, 2013, J CARDIOVASC MAGN R, V15, DOI 10.1186/1532-429X-15-23; Webb A., 2002, ANN REP NMR SPECTR, V45, P1, DOI DOI 10.1016/S0066-4103(02)45009-0	34	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149260	10.1371/journal.pone.0149260	http://dx.doi.org/10.1371/journal.pone.0149260			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26872055	gold, Green Published, Green Submitted			2022-12-26	WOS:000370054100136
J	Song, X; Ding, YP; Liu, G; Yang, X; Zhao, RF; Zhang, YL; Zhao, X; Anderson, GJ; Nie, GJ				Song, Xiao; Ding, Yanping; Liu, Gang; Yang, Xiao; Zhao, Ruifang; Zhang, Yinlong; Zhao, Xiao; Anderson, Gregory J.; Nie, Guangjun			Cancer Cell-derived Exosomes Induce Mitogen-activated Protein Kinase-dependent Monocyte Survival by Transport of Functional Receptor Tyrosine Kinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-ASSOCIATED MACROPHAGES; PERIPHERAL-BLOOD MONOCYTES; SIGNALING PATHWAYS; LYSOSOMAL-ENZYMES; DEATH APOPTOSIS; NECROSIS-FACTOR; IN-VITRO; GROWTH; LIPOPOLYSACCHARIDE; MICROENVIRONMENT	Tumor-associated macrophages (TAM) play pivotal roles in cancer initiation and progression. Monocytes, the precursors of TAMs, normally undergo spontaneous apoptosis within 2 days, but can subsist in the inflammatory tumor microenvironment for continuous survival and generation of sufficient TAMs. The mechanisms underlying tumor-driving monocyte survival remain obscure. Here we report that cancer cell-derived exosomes were crucial mediators for monocyte survival in the inflammatory niche. Analysis of the survival-promoting molecules in monocytes revealed that cancer cell-derived exosomes activated Ras and extracellular signal-regulated kinases in the mitogen-activated protein kinase (MAPK) pathway, resulting in the prevention of caspase cleavage. Phosphorylated receptor tyrosine kinases (RTKs), such as phosphorylated epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor 2 (HER-2), were abundantly expressed in cancer cell-derived exosomes. Knock-out of EGFR or/and HER-2, or alternatively, inhibitors against their phosphorylation significantly disturbed the exosome-mediated activation of the MAPK pathway, inhibition of caspase cleavage, and increase in survival rate in monocytes. Moreover, the deprived survival-stimulating activity of exosomes due to null expression of EGFR and HER-2 could be restored by activation of another RTK, insulin receptor. Overall, our study uncovered a mechanism of tumor-associated monocyte survival and demonstrated that cancer cell-derived exosomes can stimulate the MAPK pathway in monocytes through transport of functional RTKs, leading to inactivation of apoptosis-related caspases. This work provides insights into the long sought question on monocyte survival prior to formation of plentiful TAMs in the tumor microenvironment.	[Song, Xiao; Ding, Yanping; Liu, Gang; Yang, Xiao; Zhao, Ruifang; Zhang, Yinlong; Zhao, Xiao; Nie, Guangjun] Natl Ctr Nanosci & Technol, CAS Key Lab Biomed Effects Nanomat & Nanosafety, 11th Beiyitiao, Beijing 100190, Peoples R China; [Song, Xiao; Ding, Yanping; Liu, Gang; Yang, Xiao; Zhao, Ruifang; Zhang, Yinlong; Zhao, Xiao; Nie, Guangjun] Natl Ctr Nanosci & Technol, CAS Ctr Excellence Nanosci, 11th Beiyitiao, Beijing 100190, Peoples R China; [Yang, Xiao; Zhang, Yinlong] Jilin Univ, Coll Pharmaceut Sci, Changchun 130021, Peoples R China; [Zhao, Xiao] Tianjin Med Univ, Key Lab Canc Prevent & Therapy, Dept Pancreat Carcinoma, Canc Inst & Hosp,Natl Clin Res Ctr Canc, Tianjin 300060, Peoples R China; [Anderson, Gregory J.] Royal Brisbane Hosp, QIMR Berghofer Med Res Inst, Iron Metab Lab, Locked Bag 2000, Brisbane, Qld 4029, Australia	Chinese Academy of Sciences; National Center for Nanoscience & Technology - China; Chinese Academy of Sciences; National Center for Nanoscience & Technology - China; Jilin University; Tianjin Medical University; QIMR Berghofer Medical Research Institute; Royal Brisbane & Women's Hospital	Nie, GJ (corresponding author), Natl Ctr Nanosci & Technol, 11th Beiyitiao, Beijing 100190, Peoples R China.	niegj@nanoctr.cn	Nie, Guangjun/A-9954-2011; Anderson, Gregory/G-4148-2013	Anderson, Gregory/0000-0002-8814-5866; nie, guangjun/0000-0001-5040-9793	MoST 973 Grant [2012CB934004]; National Natural Science Foundation of China [31325010, 31300822]; Key Research Program of the Chinese Academy of Sciences [KGZD-EW-T06]; Senior Visiting Professorship of Chinese Academy of Sciences	MoST 973 Grant(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); Senior Visiting Professorship of Chinese Academy of Sciences	This work was supported in part by MoST 973 Grant 2012CB934004 (to G. N.), National Natural Science Foundation of China Grants 31325010 (to G. N.) and 31300822 (to Y. D.), and Key Research Program of the Chinese Academy of Sciences Grant KGZD-EW-T06 (to G. N.). The authors declare that they have no conflicts of interest with the contents of this article.; Senior Research Fellow of the National Health and Medical Research Council of Australia and a recipient of Senior Visiting Professorship of Chinese Academy of Sciences.	Akers JC, 2013, J NEURO-ONCOL, V113, P1, DOI 10.1007/s11060-013-1084-8; Anido J, 2003, CLIN CANCER RES, V9, P1274; BECKER S, 1987, J IMMUNOL, V139, P3703; Burysek L, 2002, J BIOL CHEM, V277, P33509, DOI 10.1074/jbc.M201941200; Dondi E, 2001, J BIOL CHEM, V276, P47004, DOI 10.1074/jbc.M104316200; Emmanouilidou E, 2010, J NEUROSCI, V30, P6838, DOI 10.1523/JNEUROSCI.5699-09.2010; Endres NF, 2013, CELL, V152, P543, DOI 10.1016/j.cell.2012.12.032; Fahy RJ, 1999, J IMMUNOL, V163, P1755; Goodsell D S, 1999, Oncologist, V4, P263; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Goyal A, 2002, AM J RESP CELL MOL, V26, P224, DOI 10.1165/ajrcmb.26.2.4640; Haile S, 2003, RNA, V9, P1491, DOI 10.1261/rna.5940703; Hazlehurst LA, 2003, ONCOGENE, V22, P7396, DOI 10.1038/sj.onc.1206943; Heidenreich S, 1997, J IMMUNOL, V159, P3178; Henson PM, 2006, TRENDS IMMUNOL, V27, P244, DOI 10.1016/j.it.2006.03.005; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Johnston SRD, 2006, DRUG TODAY, V42, P441, DOI 10.1358/dot.2006.42.7.985637; Kang I, 2014, J BIOL CHEM, V289, P15393, DOI 10.1074/jbc.M113.544338; Kelley TW, 1999, J BIOL CHEM, V274, P26393, DOI 10.1074/jbc.274.37.26393; King HW, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-421; Kostelansky MS, 2007, CELL, V129, P485, DOI 10.1016/j.cell.2007.03.016; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; MANGAN DF, 1992, J IMMUNOL, V148, P1812; MANGAN DF, 1991, J IMMUNOL, V146, P1541; Mantovani A, 2005, IMMUNITY, V23, P344, DOI 10.1016/j.immuni.2005.10.001; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Mantovani A, 2006, CANCER METAST REV, V25, P315, DOI 10.1007/s10555-006-9001-7; MUSSON RA, 1980, J RETICULOENDOTH SOC, V28, P249; MUSSON RA, 1983, AM J PATHOL, V111, P331; Nagy P, 2010, P NATL ACAD SCI USA, V107, P16524, DOI 10.1073/pnas.1002642107; Najib S, 2002, CELL IMMUNOL, V220, P143, DOI 10.1016/S0008-8749(03)00027-3; Ohshima K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013247; Ostrowski M, 2010, NAT CELL BIOL, V12, P19, DOI 10.1038/ncb2000; Pegtel DM, 2010, P NATL ACAD SCI USA, V107, P6328, DOI 10.1073/pnas.0914843107; PINK JJ, 1995, CANCER RES, V55, P2583; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Scherle PA, 1998, J IMMUNOL, V161, P5681; Simons M, 2009, CURR OPIN CELL BIOL, V21, P575, DOI 10.1016/j.ceb.2009.03.007; Solinas G, 2009, J LEUKOCYTE BIOL, V86, P1065, DOI 10.1189/jlb.0609385; Spector NL, 2005, J CLIN ONCOL, V23, P2502, DOI 10.1200/JCO.2005.12.157; SPIVAKKROIZMAN T, 1992, J BIOL CHEM, V267, P8056; Staubach S, 2009, PROTEOMICS, V9, P2820, DOI 10.1002/pmic.200800793; Tran SEF, 2001, J BIOL CHEM, V276, P16484, DOI 10.1074/jbc.M010384200; TSAKALOS ND, 1984, CELL IMMUNOL, V83, P229, DOI 10.1016/0008-8749(84)90302-2; Twaddle GM, 1999, J SURG ONCOL, V70, P83, DOI 10.1002/(SICI)1096-9098(199902)70:2<83::AID-JSO4>3.0.CO;2-L; WARREN MK, 1986, J IMMUNOL, V137, P2281; Weiss G, 1997, J IMMUNOL, V158, P420; Whiteside TL, 2002, VACCINE, V20, pA46, DOI 10.1016/S0264-410X(02)00387-0; Wollert T, 2009, NATURE, V458, P172, DOI 10.1038/nature07836	49	67	70	1	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2016	291	16					8453	8464		10.1074/jbc.M116.716316	http://dx.doi.org/10.1074/jbc.M116.716316			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK2VT	26895960	hybrid, Green Published			2022-12-26	WOS:000374773200012
J	Kalamajski, S; Bihan, D; Bonna, A; Rubin, K; Farndale, RW				Kalamajski, Sebastian; Bihan, Dominique; Bonna, Arkadiusz; Rubin, Kristofer; Farndale, Richard W.			Fibromodulin Interacts with Collagen Cross-linking Sites and Activates Lysyl Oxidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						collagen; extracellular matrix; fibromodulin; lysyl oxidase; small leucine-rich proteoglycan (SLRP); cross-linking	RICH REPEAT PROTEOGLYCAN; I COLLAGEN; PROTEOLYTIC ACTIVATION; SYNTHETIC PEPTIDES; CRYSTAL-STRUCTURE; DEFICIENT MICE; AMINE OXIDASE; HIGH-AFFINITY; NULL MICE; BINDING	The hallmark of fibrotic disorders is a highly cross-linked and dense collagen matrix, a property driven by the oxidative action of lysyl oxidase. Other fibrosis-associated proteins also contribute to the final collagen matrix properties, one of which is fibromodulin. Its interactions with collagen affect collagen cross-linking, packing, and fibril diameter. We investigated the possibility that a specific relationship exists between fibromodulin and lysyl oxidase, potentially imparting a specific collagen matrix phenotype. We mapped the fibromodulin-collagen interaction sites using the collagen II and III Toolkit peptide libraries. Fibromodulin interacted with the peptides containing the known collagen cross-linking sites and the MMP-1 cleavage site in collagens I and II. Interestingly, the interaction sites are closely aligned within the quarter-staggered collagen fibril, suggesting a multivalent interaction between fibromodulin and several collagen helices. Furthermore, we detected an interaction between fibromodulin and lysyl oxidase (a major collagen cross-linking enzyme) and mapped the interaction site to 12 N-terminal amino acids on fibromodulin. This interaction also increases the activity of lysyl oxidase. Together, the data suggest a fibromodulin-modulated collagen cross-linking mechanism where fibromodulin binds to a specific part of the collagen domain and also forms a complex with lysyl oxidase, targeting the enzyme toward specific cross-linking sites.	[Kalamajski, Sebastian; Rubin, Kristofer] Lund Univ, Dept Lab Med Sci, Medicon Village 406-3, S-22363 Lund, Sweden; [Bihan, Dominique; Bonna, Arkadiusz; Farndale, Richard W.] Univ Cambridge, Dept Biochem, Downing Site, Cambridge CB2 1QW, England	Lund University; University of Cambridge	Kalamajski, S (corresponding author), Lund Univ, Dept Lab Med Sci, Medicon Village 406-3, S-22363 Lund, Sweden.; Farndale, RW (corresponding author), Univ Cambridge, Dept Biochem, Downing Site, Cambridge CB2 1QW, England.	sebastian.kalamajski@med.lu.se; rwf10@cam.ac.uk	Rubin, Kristofer/AAC-1810-2020; Bonna, Arkadiusz/T-3927-2019	Rubin, Kristofer/0000-0003-2789-6276; Bonna, Arkadiusz/0000-0002-3957-7849; Kalamajski, Sebastian/0000-0002-6600-9302	Swedish Cancer Foundation; Swedish Research Council; Alfred Osterlund Foundation; Crafoord Foundation; Magnus Bergvall Foundation; Ake Wiberg Foundation; Wellcome Trust [094470/Z/10/Z]; British Heart Foundation [RG/15/4/31268]; MRC [G0400701] Funding Source: UKRI; British Heart Foundation [RG/09/003/27122] Funding Source: researchfish; Medical Research Council [G0400701] Funding Source: researchfish	Swedish Cancer Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Alfred Osterlund Foundation; Crafoord Foundation; Magnus Bergvall Foundation; Ake Wiberg Foundation; Wellcome Trust(Wellcome TrustEuropean Commission); British Heart Foundation(British Heart Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Supported by grants from the Swedish Cancer Foundation, the Swedish Research Council, the Alfred Osterlund Foundation, the Crafoord Foundation, the Magnus Bergvall Foundation, and the Ake Wiberg Foundation.; Supported by grants from the Wellcome Trust (094470/Z/10/Z) and British Heart Foundation (RG/15/4/31268).	Atsawasuwan P, 2008, J BIOL CHEM, V283, P34229, DOI 10.1074/jbc.M803142200; Barry-Hamilton V, 2010, NAT MED, V16, P1009, DOI 10.1038/nm.2208; Chen S, 2014, MATRIX BIOL, V35, P103, DOI 10.1016/j.matbio.2014.01.004; Chen SJ, 2013, FEBS J, V280, P2120, DOI 10.1111/febs.12136; Cox TR, 2015, NATURE, V522, P106, DOI 10.1038/nature14492; Cox TR, 2013, AM J PHYSIOL-GASTR L, V305, pG659, DOI 10.1152/ajpgi.00425.2012; CRONLUND AL, 1985, CONNECT TISSUE RES, V14, P109, DOI 10.3109/03008208509015017; Eloranta ML, 2010, ANN RHEUM DIS, V69, P1396, DOI 10.1136/ard.2009.121400; Erat MC, 2009, P NATL ACAD SCI USA, V106, P4195, DOI 10.1073/pnas.0812516106; EYRE DR, 1984, ANNU REV BIOCHEM, V53, P717, DOI 10.1146/annurev.bi.53.070184.003441; Fogelgren B, 2005, J BIOL CHEM, V280, P24690, DOI 10.1074/jbc.M412979200; FUKAE M, 1980, J BIOL CHEM, V255, P6511; Geng YQ, 2006, MATRIX BIOL, V25, P484, DOI 10.1016/j.matbio.2006.08.259; Grau-Bove X, 2015, SCI REP-UK, V5, DOI 10.1038/srep10568; HEDBOM E, 1993, J BIOL CHEM, V268, P27307; Herchenhan A, 2015, J BIOL CHEM, V290, P16440, DOI 10.1074/jbc.M115.641670; Howes JM, 2014, J BIOL CHEM, V289, P24091, DOI 10.1074/jbc.M114.583443; Jepsen KJ, 2002, J BIOL CHEM, V277, P35532, DOI 10.1074/jbc.M205398200; Kalamajski S, 2007, J BIOL CHEM, V282, P26740, DOI 10.1074/jbc.M704026200; Kalamajski S, 2014, J BIOL CHEM, V289, P18873, DOI 10.1074/jbc.M114.572941; Kim YM, 2011, MOL BIOL REP, V38, P145, DOI 10.1007/s11033-010-0088-0; KLEINMAN HK, 1978, J BIOL CHEM, V253, P5642; Konitsiotis AD, 2008, J BIOL CHEM, V283, P6861, DOI 10.1074/jbc.M709290200; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Lucero HA, 2008, J BIOL CHEM, V283, P24103, DOI 10.1074/jbc.M709897200; Maki JM, 2002, CIRCULATION, V106, P2503, DOI 10.1161/01.CIR.0000038109.84500.1E; Manka SW, 2012, P NATL ACAD SCI USA, V109, P12461, DOI 10.1073/pnas.1204991109; Maruhashi T, 2010, J BIOL CHEM, V285, P13294, DOI 10.1074/jbc.M109.088864; Mormone E, 2012, GASTROENTEROLOGY, V142, P612, DOI 10.1053/j.gastro.2011.11.029; Nagan N., 1994, P269; OLDBERG A, 1989, EMBO J, V8, P2601, DOI 10.1002/j.1460-2075.1989.tb08399.x; Oldberg A, 2007, P NATL ACAD SCI USA, V104, P13966, DOI 10.1073/pnas.0702014104; PINNELL SR, 1968, P NATL ACAD SCI USA, V61, P708, DOI 10.1073/pnas.61.2.708; Prockop DJ, 1998, J BIOL CHEM, V273, P15598, DOI 10.1074/jbc.273.25.15598; Raynal N, 2006, J BIOL CHEM, V281, P3821, DOI 10.1074/jbc.M509818200; Reyhani V, 2014, BIOCHEM J, V462, P113, DOI 10.1042/BJ20140201; Rydell-Tomaen K, 2014, SCI REP-UK, V4, DOI 10.1038/srep06383; Scott PG, 2006, J BIOL CHEM, V281, P13324, DOI 10.1074/jbc.M513470200; Scott PG, 2004, P NATL ACAD SCI USA, V101, P15633, DOI 10.1073/pnas.0402976101; Shami A, 2013, ARTERIOSCL THROM VAS, V33, P354, DOI 10.1161/ATVBAHA.112.300723; SIEGEL RC, 1976, J BIOL CHEM, V251, P5779; SIEGEL RC, 1974, P NATL ACAD SCI USA, V71, P4826, DOI 10.1073/pnas.71.12.4826; SIEGEL RC, 1970, BIOCHEMISTRY-US, V9, P4486, DOI 10.1021/bi00825a004; SIEGEL RC, 1976, J BIOL CHEM, V251, P5786; SIEGEL RC, 1970, J BIOL CHEM, V245, P1653; Steplewski A, 2007, J STRUCT BIOL, V157, P297, DOI 10.1016/j.jsb.2006.10.009; Svensson L, 1999, J BIOL CHEM, V274, P9636, DOI 10.1074/jbc.274.14.9636; Viola M, 2007, CONNECT TISSUE RES, V48, P141, DOI 10.1080/03008200701276133	48	57	57	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2016	291	15					7951	7960		10.1074/jbc.M115.693408	http://dx.doi.org/10.1074/jbc.M115.693408			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DJ2SZ	26893379	Green Published, hybrid			2022-12-26	WOS:000374056700017
J	Gedir, JV; Cain, JW; Krausman, PR; Allen, JD; Duff, GC; Morgart, JR				Gedir, Jay V.; Cain, James W., III; Krausman, Paul R.; Allen, Jamison D.; Duff, Glenn C.; Morgart, John R.			Potential Foraging Decisions by a Desert Ungulate to Balance Water and Nutrient Intake in a Water-Stressed Environment	PLOS ONE			English	Article							BIGHORN SHEEP; MOUNTAIN SHEEP; ACTIVITY PATTERNS; FECAL ANALYSIS; ORYX-LEUCORYX; OXALIC-ACID; DIETS; WILDLIFE; RAINFALL; DEER	Arid climates have unpredictable precipitation patterns, and wildlife managers often provide supplemental water to help desert ungulates endure the hottest, driest periods. When surface water is unavailable, the only source of water for ungulates comes from the forage they consume, and they must make resourceful foraging decisions to meet their requirements. We compared two desert bighorn sheep (Ovis canadensis nelsoni) populations in Arizona, USA: a treatment population with supplemental water removed during treatment, and a control population. We examined whether sheep altered their seasonal diets without supplemental water. We calculated water and nutrient intake and metabolic water production from dry matter intake and forage moisture and nitrogen content, to determine whether sheep could meet their seasonal daily water and nutrient requirements solely from forage. Diets of sheep were higher in protein (all seasons) and moisture (autumn and winter) during treatment compared to pretreatment. During treatment, sheep diet composition was similar between the treatment and control populations, which suggests, under the climatic conditions of this study, water removal did not influence sheep diets. We estimated that under drought conditions, without any surface water available (although small ephemeral potholes would contain water after rains), female and male sheep would be unable to meet their daily water requirements in all seasons, except winter, when reproductive females had a nitrogen deficit. We determined that sheep could achieve water and nutrient balances in all seasons by shifting their total diet proportions by 8-55% fromlower to higher moisture and nitrogen forage species. We elucidate how seasonal forage quality and foraging decisions by desert ungulates allow them to cope with their xeric and uncertain environment, and suggest that, with the forage conditions observed in our study area during this study period, providing supplemental water during water-stressed periods may not be necessary for desert bighorn sheep.	[Gedir, Jay V.] New Mexico State Univ, Dept Fish Wildlife & Conservat Ecol, Las Cruces, NM 88003 USA; [Cain, James W., III] New Mexico State Univ, US Geol Survey, New Mexico Cooperat Fish & Wildlife Res Unit, Dept Fish Wildlife & Conservat Ecol, Las Cruces, NM 88003 USA; [Krausman, Paul R.] Univ Arizona, Sch Nat Resources & Environm, Tucson, AZ USA; [Allen, Jamison D.; Duff, Glenn C.] Univ Arizona, Dept Anim Sci, Tucson, AZ 85721 USA; [Morgart, John R.] US Fish & Wildlife Serv, Cabeza Prieta Natl Wildlife Refuge, Ajo, AZ USA; [Allen, Jamison D.] NW Missouri State Univ, Sch Agr Sci, Maryville, MO 64468 USA; [Duff, Glenn C.] New Mexico State Univ, Dept Anim & Range Sci, Las Cruces, NM 88003 USA	New Mexico State University; New Mexico State University; United States Department of the Interior; United States Geological Survey; University of Arizona; University of Arizona; United States Department of the Interior; US Fish & Wildlife Service; New Mexico State University	Cain, JW (corresponding author), New Mexico State Univ, US Geol Survey, New Mexico Cooperat Fish & Wildlife Res Unit, Dept Fish Wildlife & Conservat Ecol, Las Cruces, NM 88003 USA.	jwcain@nmsu.edu		Cain, James/0000-0003-4743-516X	U. S. Geological Survey National Climate Change and Wildlife Science Center; U.S. Fish and Wildlife Service; Foundation for North American Wild Sheep; Arizona Desert Bighorn Sheep Society; Boone and Crockett Club; National Fish and Wildlife Foundation Budweiser Conservation Scholarship Program; Desert Bighorn Council; College of Agriculture and Life Sciences, University of Arizona; School of Natural Resources, University of Arizona; New Mexico State University Agricultural Experiment Station	U. S. Geological Survey National Climate Change and Wildlife Science Center; U.S. Fish and Wildlife Service(US Fish & Wildlife Service); Foundation for North American Wild Sheep; Arizona Desert Bighorn Sheep Society; Boone and Crockett Club; National Fish and Wildlife Foundation Budweiser Conservation Scholarship Program; Desert Bighorn Council; College of Agriculture and Life Sciences, University of Arizona; School of Natural Resources, University of Arizona; New Mexico State University Agricultural Experiment Station	This work was financially supported by U. S. Geological Survey National Climate Change and Wildlife Science Center; U.S. Fish and Wildlife Service; Foundation for North American Wild Sheep; Arizona Desert Bighorn Sheep Society; Boone and Crockett Club; National Fish and Wildlife Foundation Budweiser Conservation Scholarship Program; Desert Bighorn Council; College of Agriculture and Life Sciences, University of Arizona; School of Natural Resources, University of Arizona; and New Mexico State University Agricultural Experiment Station.	ALDERMAN JA, 1989, J WILDLIFE MANAGE, V53, P264, DOI 10.2307/3801345; Andrew N. G., 1999, CALIFORNIA WILDLIFE, V12, P1; [Anonymous], 1993, 8 C APPL CLIMATOLOGY, DOI DOI 10.1175/JCLI-D-11-00375.1; Attum O, 2014, J ARID ENVIRON, V102, P113, DOI 10.1016/j.jaridenv.2013.11.009; Augustine DJ, 2010, AFR J ECOL, V48, P1009, DOI 10.1111/j.1365-2028.2010.01207.x; AYENI J S O, 1975, East African Wildlife Journal, V13, P305; BAHARAV D, 1985, J ARID ENVIRON, V9, P167, DOI 10.1016/S0140-1963(18)31498-8; Belenguer A, 2013, ANIMAL, V7, P940, DOI 10.1017/S1751731112002455; BIGALKE R C, 1972, Zoologica Africana, V7, P333; Bleich VC, 1997, WILDLIFE MONOGR, P1; Brewer CE, 2007, SOUTHWEST NAT, V52, P97, DOI 10.1894/0038-4909(2007)52[97:DOBSIT]2.0.CO;2; Bristow KD, 1996, HABITAT USE MOVEMENT, P25; Broyles B, 1995, WILDLIFE SOC B, V23, P663; Cain III JW, 2008, WILDL MONOGR, V171; Cain JW, 2006, WILDLIFE SOC B, V34, P570, DOI 10.2193/0091-7648(2006)34[570:MOTAWB]2.0.CO;2; CANFIELD R. H., 1941, JOUR FOREST, V39, P388; Clutton-Brock T.H., 1991, EVOLUTION PARENTAL C; Corp N, 1998, J ZOOL, V246, P369; CUNNINGHAM SC, 1982, THESIS ARIZONA STATE; DEGEN AA, 1977, J AGR SCI, V88, P699, DOI 10.1017/S0021859600037400; DEGEN AA, 1986, J ANIM ECOL, V55, P421, DOI 10.2307/4728; DeYoung RW, 2000, RESTOR ECOL, V8, P57, DOI 10.1046/j.1526-100x.2000.80066.x; Duncan AJ, 1997, ANIM SCI, V65, P451, DOI 10.1017/S135772980000864X; Epaphras A. M., 2008, Wetlands Ecology and Management, V16, P183, DOI 10.1007/s11273-007-9065-3; Epps CW, 2004, CONSERV BIOL, V18, P102, DOI 10.1111/j.1523-1739.2004.00023.x; Etchberger RC, 1997, WILDLIFE SOC B, V25, P604; EVERITT JH, 1981, J RANGE MANAGE, V34, P506, DOI 10.2307/3898109; Martinez-Aguilar JF, 2009, J AGR FOOD CHEM, V57, P1933, DOI 10.1021/jf802141d; FITZGERALD AE, 1979, J WILDLIFE MANAGE, V43, P468, DOI 10.2307/3800357; Fox L. M., 1997, THESIS; Fracker SB, 1944, ECOLOGY, V25, P283, DOI 10.2307/1931277; Frausman P. R., 1990, Desert Plants, V10, P32; Fulbright TE, 2001, J ARID ENVIRON, V48, P49, DOI 10.1006/jare.2000.0738; GILL RB, 1983, J WILDLIFE MANAGE, V47, P902, DOI 10.2307/3808149; Guttman NB, 1999, J AM WATER RESOUR AS, V35, P311, DOI 10.1111/j.1752-1688.1999.tb03592.x; Hansen C. G., 1990, DESERT BIGHORN ITS L, P64; Harkleroad D, 2014, SOUTHWEST NAT, V59, P272, DOI 10.1894/N01-SGM-31.1; HEBERT DM, 1973, THESIS U BRIT COLUMB; Hochman V, 2006, OIKOS, V112, P547, DOI 10.1111/j.0030-1299.2006.14214.x; HOFMEYR MD, 1987, J ARID ENVIRON, V13, P137; HOLECHEK JL, 1982, J RANGE MANAGE, V35, P309, DOI 10.2307/3898308; HOLECHEK JL, 1981, J RANGE MANAGE, V34, P337, DOI 10.2307/3897865; Hoppe P.P., 1977, Veterinary Medical Review, V1977, P77; Houpt TR, 1970, DUKES PHYSL DOMESTIC, P743; IBM Corp, 2013, IBM SPSS STAT WINDOW; Ismail K, 2011, J ARID ENVIRON, V75, P125, DOI 10.1016/j.jaridenv.2010.09.017; Ivlev V.S., 1961, EXPT ECOLOGY FEEDING; JACOBS J, 1974, OECOLOGIA, V14, P413, DOI 10.1007/BF00384581; JAMES LF, 1972, CLIN TOXICOL, V5, P231, DOI 10.3109/15563657208991002; KALIKAWA MC, 1990, AFR J ECOL, V28, P253, DOI 10.1111/j.1365-2028.1990.tb01159.x; Karsch RC, 2014, THESIS NEW MEXICO ST; KNIGHT MH, 1988, J ARID ENVIRON, V15, P269, DOI 10.1016/S0140-1963(18)31064-4; Krausman PR, 2006, WILDLIFE SOC B, V34, P563, DOI 10.2193/0091-7648(2006)34[563:DWFWSP]2.0.CO;2; KRAUSMAN PR, 1985, WILDLIFE SOC B, V13, P71; Krausman PR, 1997, J RANGE MANAGE, V50, P513, DOI 10.2307/4003707; Krausman PR, 1999, MOUNTAIN SHEEP OF NORTH AMERICA, P139; Krausman PR, 1989, WILDL MONOGR, V102; LECHOWICZ MJ, 1982, OECOLOGIA, V52, P22, DOI 10.1007/BF00349007; LESLIE DM, 1979, WILDLIFE MONOGR, P6; LEWIS JG, 1977, J AGR SCI-CAMBRIDGE, V89, P551, DOI 10.1017/S0021859600061323; Louw GN, 1982, LONGMAN ECOLOGY DESE; MANSER MB, 1995, OECOLOGIA, V102, P404, DOI 10.1007/BF00341352; Marshal JP, 2009, CAN J ZOOL, V87, P103, DOI 10.1139/Z08-142; Marshal JP, 2005, RANGELAND ECOL MANAG, V58, P360, DOI 10.2111/1551-5028(2005)058[0360:RTAFDA]2.0.CO;2; MAZAIKA R, 1992, SOUTHWEST NAT, V37, P372, DOI 10.2307/3671788; Mckinney T, 2007, SOUTHWEST NAT, V52, P520, DOI 10.1894/0038-4909(2007)52[520:DOAALO]2.0.CO;2; MCQUIVEY RP, 1978, NEVADA DEP FISH GAME, V6, P1; Mendoza J, 1976, DESERT BIGHORN COUNC, V20, P25; MILLER GD, 1989, J WILDLIFE MANAGE, V53, P597, DOI 10.2307/3809182; Mills M.G.L., 1984, Koedoe, V27, P129; Monson G, 1958, DESERT BIGHORN COUNC, V2, P64; Monson G, 1964, DESERT BIGHORN COUNC, V8, P11; Monson G., 1990, DESERT BIGHORN ITS L; NAGY KA, 1994, J MAMMAL, V75, P860, DOI 10.2307/1382468; Oehler MW, 2005, CALIF FISH GAME, V91, P149; Olech LA., 1979, DESERT BIGHORN COUNC, V23, P33; Ostrowski S, 2002, J MAMMAL, V83, P665, DOI 10.1644/1545-1542(2002)083<0665:WIAFCO>2.0.CO;2; Owen-Smith N, 2005, J ANIM ECOL, V74, P774, DOI 10.1111/j.1365-2656.2005.00974.x; OWENSMITH N, 1994, ECOLOGY, V75, P1050, DOI 10.2307/1939429; Rautenstrauch K. R., 1988, Desert Plants, V8, P172; Robbins C. T., 1993, WILDLIFE FEEDING NUT; Rosenstock SS, 1999, J RANGE MANAGE, V52, P302, DOI 10.2307/4003538; Russo JP, 1956, AZ GAME FISH DEP B, V1; Sappington JM, 2007, J WILDLIFE MANAGE, V71, P1419, DOI 10.2193/2005-723; Seegmiller R. F., 1990, Desert Plants, V10, P87; SHACKLETON D M, 1985, Mammalian Species, P1, DOI 10.2307/3504034; Sikes RS, 2011, J MAMMAL, V92, P235, DOI 10.1644/10-MAMM-F-355.1; SPARKS DR, 1968, J RANGE MANAGE, V21, P264, DOI 10.2307/3895829; STEWARTOATEN A, 1986, ECOLOGY, V67, P929, DOI 10.2307/1939815; STEWARTOATEN A, 1992, ECOLOGY, V73, P1396, DOI 10.2307/1940685; Tarango LA, 2002, J RANGE MANAGE, V55, P530, DOI 10.2307/4003995; Taylor C. R., 1968, Symposia of the Zoological Society of London, VNo. 21, P195; TAYLOR CR, 1969, SCI AM, V220, P89, DOI 10.1038/scientificamerican0169-88; Tear TH, 1997, J WILDLIFE MANAGE, V61, P1142, DOI 10.2307/3802112; TEAR TH, 1992, THESIS U IDAHO; Turner J.C., 1973, THESIS U CALIFORNIA; Turner JC, 2004, WILDLIFE SOC B, V32, P427, DOI 10.2193/0091-7648(2004)32[427:DOCHFT]2.0.CO;2; Turner JC, 1990, DESERT BIGHORN ITS L, P100; Valdez R, 1999, MOUNTAIN SHEEP OF NORTH AMERICA, P3; Van Soest P.J., 1994, NUTR ECOLOGY RUMINAN; WARRICK GD, 1989, SOUTHWEST NAT, V34, P483, DOI 10.2307/3671506; Watts TJ, 1979, THESIS NEW MEXICO ST; Weaver RA, 1971, DESERT BIGHORN SHEEP; Western Regional Climate Data Center, 2005, AR CLIM SUMM; WESTON RH, 1988, AUST J AGR RES, V39, P679, DOI 10.1071/AR9880679; Wishart W., 1978, P161; Witham JH, 1983, THESIS COLORADO STAT; Zar J. H., 1996, BIOSTATISTICAL ANAL; [No title captured]; [No title captured]	110	17	18	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0148795	10.1371/journal.pone.0148795	http://dx.doi.org/10.1371/journal.pone.0148795			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3DG	26894504	Green Published, Green Submitted, gold			2022-12-26	WOS:000371223400022
J	Duan, XG; Cheng, S; Ai, YX; Wu, J				Duan, Xuguo; Cheng, Sheng; Ai, Yixin; Wu, Jing			Enhancing the Thermostability of Serratia plymuthica Sucrose Isomerase Using B-Factor-Directed Mutagenesis	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATION; ISOMALTULOSE SYNTHASE; STABILITY; MECHANISM; CLONING; DESIGN; ENZYME; GENE; CONVERSION; PROTEINS	The sucrose isomerase of Serratia plymuthica AS9 (AS9 PalI) was expressed in Escherichia coli BL21(DE3) and characterized. The half-life of AS9 PalI was 20 min at 45 degrees C, indicating that it was unstable. In order to improve its thermostability, six amino acid residues with higher B-factors were selected as targets for site-directed mutagenesis, and six mutants (E175N, K576D, K174D, G176D, S575D and N577K) were designed using the RosettaDesign server. The E175N and K576D mutants exhibited improved thermostability in preliminary experiments, so the double mutant E175N/K576D was constructed. These three mutants (E175N, K576D, E175N/K576D) were characterized in detail. The results indicate that the three mutants exhibit a slightly increased optimal temperature (35 degrees C), compared with that of the wild-type enzyme (30 degrees C). The mutants also share an identical pH optimum of 6.0, which is similar to that of the wild-type enzyme. The half-lives of the E175N, K576D and E175N/K576D mutants were 2.30, 1.78 and 7.65 times greater than that of the wildtype enzyme at 45 degrees C, respectively. Kinetic studies showed that the Km values for the E175N, K576D and E175N/K576D mutants decreased by 6.6%, 2.0% and 11.0%, respectively, and their k(cat)/K-m values increased by 38.2%, 4.2% and 19.4%, respectively, compared with those of the wild-type enzyme. After optimizing the conditions for isomaltulose production at 45 degrees C, we found that the E175N, K576D and E175N/K576D mutants displayed slightly improved isomaltulose yields, compared with the wild-type enzyme. Therefore, the mutants produced in this study would be more suitable for industrial biosynthesis of isomaltulose.	[Duan, Xuguo; Cheng, Sheng; Wu, Jing] Jiangnan Univ, State Key Lab Food Sci & Technol, Wuxi, Jiangsu, Peoples R China; [Duan, Xuguo; Cheng, Sheng; Wu, Jing] Jiangnan Univ, Sch Biotechnol, Wuxi, Jiangsu, Peoples R China; [Duan, Xuguo; Cheng, Sheng; Wu, Jing] Jiangnan Univ, Minist Educ, Key Lab Ind Biotechnol, Wuxi, Jiangsu, Peoples R China; [Ai, Yixin] South Univ Sci & Technol China, Dept Biol, Shenzhen, Guangdong, Peoples R China	Jiangnan University; Jiangnan University; Jiangnan University; Southern University of Science & Technology	Wu, J (corresponding author), Jiangnan Univ, State Key Lab Food Sci & Technol, Wuxi, Jiangsu, Peoples R China.; Wu, J (corresponding author), Jiangnan Univ, Sch Biotechnol, Wuxi, Jiangsu, Peoples R China.; Wu, J (corresponding author), Jiangnan Univ, Minist Educ, Key Lab Ind Biotechnol, Wuxi, Jiangsu, Peoples R China.	jingwu@jiangnan.edu.cn	Wu, Jing/GZK-5063-2022	Duan, Xuguo/0000-0002-2136-0449	National Science Fund for Distinguished Young Scholars [31425020]; National Natural Science Foundation of China [31271813, 31401636]; project of outstanding scientific and technological innovation group of Jiangsu Province; Natural Science Foundation of Jiangsu Province [BK20140142]; 111 Project [111-2-06]; China Postdoctoral Science Foundation Funded Project [2015M580390]; Production and Research Prospective Joint Research Project of Jiangsu Province [BY2015019-18]	National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); project of outstanding scientific and technological innovation group of Jiangsu Province; Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); 111 Project(Ministry of Education, China - 111 Project); China Postdoctoral Science Foundation Funded Project(China Postdoctoral Science Foundation); Production and Research Prospective Joint Research Project of Jiangsu Province	This work was funded by grants from the National Science Fund for Distinguished Young Scholars (http://www.nsfc.gov.cn/publish/portal1/ #31425020), the National Natural Science Foundation of China (http://www.nsfc.gov.cn/publish/portal1/ #31271813 and #31401636), the project of outstanding scientific and technological innovation group of Jiangsu Province (http://www.jskjjh.gov.cn/13kjskj2/), the Natural Science Foundation of Jiangsu Province (http://www.jskjjh.gov.cn/13kjskj2/ #BK20140142), the 111 Project (http://www.dost.moe. edu.cn No. 111-2-06), the China Postdoctoral Science Foundation Funded Project (2015M580390), and the Production and Research Prospective Joint Research Project of Jiangsu Province (BY2015019-18). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cha J, 2009, J APPL MICROBIOL, V107, P1119, DOI 10.1111/j.1365-2672.2009.04295.x; CHEETHAM PSJ, 1984, BIOCHEM J, V220, P213, DOI 10.1042/bj2200213; Dantas G, 2003, J MOL BIOL, V332, P449, DOI 10.1016/S0022-2836(03)00888-X; Duan XG, 2013, APPL ENVIRON MICROB, V79, P4072, DOI 10.1128/AEM.00457-13; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Fu Y, 2010, PROTEIN PEPTIDE LETT, V17, P1403, DOI 10.2174/0929866511009011403; Hamada S, 2002, PURE APPL CHEM, V74, P1293, DOI 10.1351/pac200274071293; Huang JH, 1998, J IND MICROBIOL BIOT, V21, P22, DOI 10.1038/sj.jim.2900552; Hyun Sook Kim, 2010, Enzyme and Microbial Technology, V47, P1; Kim SJ, 2010, BIOTECHNOL PROGR, V26, P1038, DOI 10.1002/btpr.408; Korkegian A, 2005, SCIENCE, V308, P857, DOI 10.1126/science.1107387; Kuhlman B, 2003, SCIENCE, V302, P1364, DOI 10.1126/science.1089427; Li S, 2011, APPL BIOCHEM BIOTECH, V163, P52, DOI 10.1007/s12010-010-9015-z; Liu Y, 2006, NUCLEIC ACIDS RES, V34, pW235, DOI 10.1093/nar/gkl163; LOW NH, 1988, J FOOD SCI, V53, P558, DOI 10.1111/j.1365-2621.1988.tb07755.x; MINAMI T, 1990, ORAL MICROBIOL IMMUN, V5, P189, DOI 10.1111/j.1399-302X.1990.tb00644.x; NAGAIMIYATA Y, 1993, BIOSCI BIOTECH BIOCH, V57, P2049, DOI 10.1271/bbb.57.2049; Nauli S, 2001, NAT STRUCT BIOL, V8, P602, DOI 10.1038/89638; Park HJ, 2014, J BIOTECHNOL, V192, P66, DOI 10.1016/j.jbiotec.2014.09.014; Parthasarathy S, 2000, PROTEIN ENG, V13, P9, DOI 10.1093/protein/13.1.9; Ravaud S, 2006, ACTA CRYSTALLOGR F, V62, P74, DOI 10.1107/S1744309105041758; Ravaud S, 2005, ACTA CRYSTALLOGR F, V61, P100, DOI 10.1107/S1744309104030623; Reetz MT, 2006, ANGEW CHEM INT EDIT, V45, P7745, DOI 10.1002/anie.200602795; Rhimi M, 2008, BIOLOGIA, V63, P1020, DOI 10.2478/s11756-008-0166-0; Sevastsyanovich YR, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-69; Sevier E., 2007, ENZYME MICROB TECHNO, V40, P1221; Sockolosky JT, 2013, PROTEIN EXPRES PURIF, V87, P129, DOI 10.1016/j.pep.2012.11.002; SUZUKI Y, 1976, BIOCHIM BIOPHYS ACTA, V445, P386, DOI 10.1016/0005-2744(76)90092-9; Veronese T, 1999, ENZYME MICROB TECH, V24, P263, DOI 10.1016/S0141-0229(98)00115-X; Vieille C, 1996, TRENDS BIOTECHNOL, V14, P183, DOI 10.1016/0167-7799(96)10026-3; Watzlawick H, 2009, APPL ENVIRON MICROB, V75, P7026, DOI 10.1128/AEM.01781-09; Wu LT, 2015, FOOD CHEM, V187, P182, DOI 10.1016/j.foodchem.2015.04.072; Wu LQ, 2005, APPL ENVIRON MICROB, V71, P1581, DOI 10.1128/AEM.71.3.1581-1590.2005; Xie Y, 2014, J BIOL CHEM, V289, P7994, DOI 10.1074/jbc.M113.536045; Xu Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074788; Zhang DH, 2003, J BIOL CHEM, V278, P35428, DOI 10.1074/jbc.M302616200; Zhang DH, 2003, FEBS LETT, V534, P151, DOI 10.1016/S0014-5793(02)03835-8; Zhang DH, 2002, APPL ENVIRON MICROB, V68, P2676, DOI 10.1128/AEM.68.6.2676-2682.2002; Zhang JH, 2012, ENZYME MICROB TECH, V50, P325, DOI 10.1016/j.enzmictec.2012.03.002	39	21	23	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0149208	10.1371/journal.pone.0149208	http://dx.doi.org/10.1371/journal.pone.0149208			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26886729	Green Published, Green Submitted, gold			2022-12-26	WOS:000371218400067
J	Jattani, RP; Tritapoe, JM; Pomerantz, JL				Jattani, Rakhi P.; Tritapoe, Julia M.; Pomerantz, Joel L.			Intramolecular Interactions and Regulation of Cofactor Binding by the Four Repressive Elements in the Caspase Recruitment Domain-containing Protein 11 (CARD11) Inhibitory Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						gene regulation; lymphoma; NF-kappa B (NF-KB); oncogene; scaffold protein; signal transduction; T-cell receptor; autoinhibitory domain; CARD11; diffuse large B cell lymphoma	NF-KAPPA-B; CELL LYMPHOMA; COMBINED IMMUNODEFICIENCY; KINASE-BETA; ACTIVATION; CARMA1; MUTATIONS; PHOSPHORYLATION; BCL10; PROLIFERATION	The CARD11 signaling scaffold transmits signaling between antigen receptors on B and T lymphocytes and the transcription factor NF-kappa B during the adaptive immune response. CARD11 activity is controlled by an inhibitory domain (ID), which participates in intramolecular interactions and prevents cofactor binding prior to receptor triggering. Oncogenic CARD11 mutations associated with the activated B cell-like subtype of diffuse large B cell lymphoma somehow perturb ID-mediated autoinhibition to confer CARD11 with the dysregulated spontaneous signaling to NF-kappa B that is required for the proliferation and survival of the lymphoma. Here, we investigate how the four repressive elements (REs) we have discovered in the CARD11 ID function to inhibit CARD11 activity with cooperativity and redundancy. We find that each RE contributes to the maintenance of the closed inactive state of CARD11 that predominates in the absence of receptor engagement. Each RE also contributes to the prevention of Bcl10 binding in the basal unstimulated state. RE1, RE2, and RE3 participate in intramolecular interactions with other CARD11 domains and share domain targets for binding. Remarkably, diffuse large B cell lymphoma-associated gain-of-function mutations in the caspase recruitment domain, LATCH, or coiled coil can perturb intramolecular interactions mediated by multiple REs, suggesting how single amino acid oncogenic CARD11 mutations can perturb or bypass the action of redundant inhibitory REs to achieve the level of hyperactive CARD11 signaling required to support lymphoma growth.	[Jattani, Rakhi P.; Tritapoe, Julia M.; Pomerantz, Joel L.] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Dept Biol Chem, Miller Res Bldg,Rm 607,733 N Broadway, Baltimore, MD 21205 USA	Johns Hopkins University	Pomerantz, JL (corresponding author), Johns Hopkins Univ, Sch Med, Inst Cell Engn, Dept Biol Chem, Miller Res Bldg,Rm 607,733 N Broadway, Baltimore, MD 21205 USA.	joel.pomerantz@jhmi.edu		Pomerantz, Joel L./0000-0002-5030-1018	National Institutes of Health [RO1CA177600]; Johns Hopkins University Institute for Cell Engineering; NATIONAL CANCER INSTITUTE [R01CA177600] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007445] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Johns Hopkins University Institute for Cell Engineering; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant RO1CA177600 and funds from The Johns Hopkins University Institute for Cell Engineering. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bu R, 2012, LEUKEMIA LYMPHOMA, V53, P1971, DOI 10.3109/10428194.2012.668286; Chan WP, 2013, MOL CELL BIOL, V33, P429, DOI 10.1128/MCB.00850-12; Compagno M, 2009, NATURE, V459, P717, DOI 10.1038/nature07968; Davis RE, 2001, J EXP MED, V194, P1861, DOI 10.1084/jem.194.12.1861; Dong GH, 2011, CLIN CANCER RES, V17, P1440, DOI 10.1158/1078-0432.CCR-10-1859; Egawa T, 2003, CURR BIOL, V13, P1252, DOI 10.1016/S0960-9822(03)00491-3; Gaide O, 2002, NAT IMMUNOL, V3, P836, DOI 10.1038/ni830; Greil J, 2013, J ALLERGY CLIN IMMUN, V131, P1376, DOI 10.1016/j.jaci.2013.02.012; Hara H, 2003, IMMUNITY, V18, P763, DOI 10.1016/S1074-7613(03)00148-1; Hara H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6555; Jattani RP, 2016, J BIOL CHEM, V291, P8324, DOI 10.1074/jbc.M115.683714; Jun JE, 2003, IMMUNITY, V18, P751, DOI 10.1016/S1074-7613(03)00141-9; Lamason RL, 2010, MOL CELL, V40, P798, DOI 10.1016/j.molcel.2010.11.007; Lamason RL, 2010, BIOCHEMISTRY-US, V49, P8240, DOI 10.1021/bi101052d; Lenz G, 2008, SCIENCE, V319, P1676, DOI 10.1126/science.1153629; Lim KH, 2012, IMMUNOL REV, V246, P359, DOI 10.1111/j.1600-065X.2012.01105.x; Lohr JG, 2012, P NATL ACAD SCI USA, V109, P3879, DOI 10.1073/pnas.1121343109; Matsumoto R, 2005, IMMUNITY, V23, P575, DOI 10.1016/j.immuni.2005.10.007; McCully RR, 2008, MOL CELL BIOL, V28, P5668, DOI 10.1128/MCB.00418-08; Newton K, 2003, CURR BIOL, V13, P1247, DOI 10.1016/S0960-9822(03)00458-5; Ngo VN, 2006, NATURE, V441, P106, DOI 10.1038/nature04687; Pomerantz JL, 2002, EMBO J, V21, P5184, DOI 10.1093/emboj/cdf505; Rui LX, 2011, NAT IMMUNOL, V12, P933, DOI 10.1038/ni.2094; Schulze-Luehrmann J, 2006, IMMUNITY, V25, P701, DOI 10.1016/j.immuni.2006.10.010; Shinohara H, 2007, J EXP MED, V204, P3285, DOI 10.1084/jem.20070379; Sommer K, 2005, IMMUNITY, V23, P561, DOI 10.1016/j.immuni.2005.09.014; Stepensky P, 2013, J ALLERGY CLIN IMMUN, V131, P477, DOI 10.1016/j.jaci.2012.11.050; Thome M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003004; Wang DH, 2002, NAT IMMUNOL, V3, P830, DOI 10.1038/ni824; Wegener E, 2006, MOL CELL, V23, P13, DOI 10.1016/j.molcel.2006.05.027; Wu CJ, 2008, P NATL ACAD SCI USA, V105, P3023, DOI 10.1073/pnas.0712313105	31	27	28	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2016	291	16					8338	8348		10.1074/jbc.M116.717322	http://dx.doi.org/10.1074/jbc.M116.717322			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK2VT	26884334	Green Published, hybrid			2022-12-26	WOS:000374773200003
J	Jurado-Arjona, J; Llorens-Martin, M; Avila, J; Hernandez, F				Jurado-Arjona, Jeronimo; Llorens-Martin, Maria; Avila, Jesus; Hernandez, Felix			GSK3 Overexpression in Dentate Gyrus Neural Precursor Cells Expands the Progenitor Pool and Enhances Memory Skills	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						astrocyte; glial cell; glycogen synthase kinase 3 (GSK-3); neural stem cell (NSC); transgenic mice	FIBRILLARY ACIDIC PROTEIN; EMBRYONIC STEM-CELLS; NEURONAL DIFFERENTIATION; ADULT NEUROGENESIS; HIPPOCAMPAL NEUROGENESIS; SYNTHASE KINASE-3-BETA; MAMMALIAN HIPPOCAMPUS; GRANULE CELLS; WNT PROTEINS; RAT-BRAIN	In restricted areas of the adult brain, like the subgranular zone of the dentate gyrus (DG), there is continuous production of new neurons. This process, named adult neurogenesis, is involved in important cognitive functions such as memory and learning. It requires the presence of newborn neurons that arise from neuronal stem cells, which divide and differentiate through successive stages in adulthood. In this work, we demonstrate that overexpression of glycogen synthase kinase (GSK) 3 in neural precursor cells (NPCs) using the glial fibrillary acidic protein promoter during DG development produces an increase in the neurogenic process, increasing NPCs numbers. Moreover, the transgenic mice show higher DG volume and increased number of mature granule neurons. In an attempt to compensate for these alterations, glial fibrillary acidic protein/GSK3-overexpressing mice show increased levels of Dkk1 and sFRP3, two inhibitors of the Wnt-frizzled complex. We have also found behavioral differences between wild type and transgenic mice, indicating a higher rating in memory tasks for GSK3-overexpressing mice compared with wild type mice. These data indicate that GSK3 is a crucial kinase in NPC physiology and suggest that this molecule plays a key role in the correct development of DG and adult neurogenesis in this region.	[Jurado-Arjona, Jeronimo; Llorens-Martin, Maria; Avila, Jesus; Hernandez, Felix] Univ Autonoma Madrid, CSIC, Ctr Biol Mol Severo Ochoa, E-28049 Madrid, Spain; [Jurado-Arjona, Jeronimo; Llorens-Martin, Maria; Avila, Jesus; Hernandez, Felix] Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid 28031, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); CIBERNED	Hernandez, F (corresponding author), Univ Autonoma Madrid, CSIC, Ctr Biol Mol Severo Ochoa, E-28049 Madrid, Spain.	fhernandez@cbm.csic.es	Llorens-Martin, Maria/R-4613-2017; Hernandez, Felix/L-2114-2015; Avila, Jesus/I-2610-2015	Llorens-Martin, Maria/0000-0001-9129-5198; Hernandez, Felix/0000-0001-8753-8249; Avila, Jesus/0000-0002-6288-0571	Ministerio de Educacion y Ciencia [SAF2011-24841, BUF2013-40664-P]; Comunidad de Madrid [S2010/BMD-2331]; Fundacion Ramon Areces	Ministerio de Educacion y Ciencia(Spanish Government); Comunidad de Madrid(Comunidad de Madrid); Fundacion Ramon Areces	This work was supported in part by Ministerio de Educacion y Ciencia Grants SAF2011-24841 and BUF2013-40664-P, Comunidad de Madrid Grant S2010/BMD-2331, and funds from the Fundacion Ramon Areces. The authors declare that they have no conflicts of interest with the contents of this article.	Aimone JB, 2014, PHYSIOL REV, V94, P991, DOI 10.1152/physrev.00004.2014; ALTMAN J, 1990, J COMP NEUROL, V301, P365, DOI 10.1002/cne.903010304; ALTMAN J, 1965, NATURE, V207, P953, DOI 10.1038/207953a0; ALTMAN J, 1990, J COMP NEUROL, V301, P325, DOI 10.1002/cne.903010302; ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; BAYER SA, 1974, J COMP NEUROL, V158, P55, DOI 10.1002/cne.901580105; BAYER SA, 1982, SCIENCE, V216, P890, DOI 10.1126/science.7079742; BESNARD F, 1991, J BIOL CHEM, V266, P18877; Beurel E, 2015, PHARMACOL THERAPEUT, V148, P114, DOI 10.1016/j.pharmthera.2014.11.016; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Eom TY, 2009, BIOL PSYCHIAT, V66, P494, DOI 10.1016/j.biopsych.2009.04.015; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Fuentealba LC, 2008, P NATL ACAD SCI USA, V105, P7732, DOI 10.1073/pnas.0803027105; Fuster-Matanzo A, 2013, HUM MOL GENET, V22, P1300, DOI 10.1093/hmg/dds533; Hirabayashi Y, 2004, DEVELOPMENT, V131, P2791, DOI 10.1242/dev.01165; Holowacz T, 2013, BIOL OPEN, V2, P812, DOI 10.1242/bio.20131941; Hur EM, 2010, NAT REV NEUROSCI, V11, P539, DOI 10.1038/nrn2870; Jang MH, 2013, CELL STEM CELL, V12, P215, DOI 10.1016/j.stem.2012.11.021; Kempermann G, 1998, J NEUROSCI, V18, P3206; Kim JS, 2011, J VET SCI, V12, P1, DOI 10.4142/jvs.2011.12.1.1; Kim WY, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00044; Kim WY, 2009, NAT NEUROSCI, V12, P1390, DOI 10.1038/nn.2408; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Kuwahara A, 2010, DEVELOPMENT, V137, P1035, DOI 10.1242/dev.046417; Lee SMK, 2000, DEVELOPMENT, V127, P457; Lin WS, 2004, J NEUROSCI, V24, P10074, DOI 10.1523/JNEUROSCI.2604-04.2004; Llorens-Martin M, 2006, HIPPOCAMPUS, V16, P480, DOI 10.1002/hipo.20175; Llorens-Martin M, 2013, MOL PSYCHIATR, V18, P395, DOI 10.1038/mp.2013.27; Llorens-Martin M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012188; Lucas JJ, 2001, EMBO J, V20, P27, DOI 10.1093/emboj/20.1.27; Mao YW, 2009, CELL, V136, P1017, DOI 10.1016/j.cell.2008.12.044; Miki T, 2011, STEM CELL REV REP, V7, P836, DOI 10.1007/s12015-011-9275-1; MUCKE L, 1991, NEW BIOL, V3, P465; Munji RN, 2011, J NEUROSCI, V31, P1676, DOI 10.1523/JNEUROSCI.5404-10.2011; Muroyama Y, 2004, BIOCHEM BIOPH RES CO, V313, P915, DOI 10.1016/j.bbrc.2003.12.023; Okamoto M, 2011, FASEB J, V25, P3570, DOI 10.1096/fj.11-184697; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Seib DRM, 2013, CELL STEM CELL, V12, P204, DOI 10.1016/j.stem.2012.11.010; Seki T, 1995, NEUROREPORT, V6, P2479, DOI 10.1097/00001756-199512150-00010; Seri B, 2001, J NEUROSCI, V21, P7153, DOI 10.1523/JNEUROSCI.21-18-07153.2001; Sirerol-Piquer M, 2011, HIPPOCAMPUS, V21, P910, DOI 10.1002/hipo.20805; Takahashi M, 2000, BRAIN RES, V857, P193, DOI 10.1016/S0006-8993(99)02424-5; Ten Berge D, 2011, NAT CELL BIOL, V13, P1070, DOI 10.1038/ncb2314; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Weber T, 2011, GLIA, V59, P615, DOI 10.1002/glia.21129; Yamashita YM, 2003, SCIENCE, V301, P1547, DOI 10.1126/science.1087795; Yu Y, 2009, J NEUROCHEM, V108, P1480, DOI 10.1111/j.1471-4159.2009.05882.x	50	17	18	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2016	291	15					8199	8213		10.1074/jbc.M115.674531	http://dx.doi.org/10.1074/jbc.M115.674531			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DJ2SZ	26887949	Green Published, hybrid			2022-12-26	WOS:000374056700036
J	Berger, GE; Smesny, S; Schafer, MR; Milleit, B; Langbein, K; Hipler, UC; Milleit, C; Klier, CM; Schlogelhofer, M; Holub, M; Holzer, I; Berk, M; McGorry, PD; Sauer, H; Amminger, GP				Berger, Gregor E.; Smesny, Stefan; Schaefer, Miriam R.; Milleit, Berko; Langbein, Kerstin; Hipler, Uta-Christina; Milleit, Christine; Klier, Claudia M.; Schloegelhofer, Monika; Holub, Magdalena; Holzer, Ingrid; Berk, Michael; McGorry, Patrick D.; Sauer, Heinrich; Amminger, G. Paul			Niacin Skin Sensitivity Is Increased in Adolescents at Ultra-High Risk for Psychosis	PLOS ONE			English	Article							FATTY-ACID; PHOSPHOLIPASE-A2 ACTIVITY; MEMBRANE ABNORMALITIES; ERYTHROCYTE-MEMBRANES; NICOTINIC-ACID; FLUSH TEST; SCHIZOPHRENIA; OMEGA-3-FATTY-ACIDS; 1ST-EPISODE; METAANALYSIS	Background Most studies provide evidence that the skin flush response to nicotinic acid (niacin) stimulation is impaired in schizophrenia. However, only little is known about niacin sensitivity in the ultra-high risk (UHR) phase of psychotic disorders. Methods We compared visual ratings of niacin sensitivity between adolescents at UHR for psychosis according to the one year transition outcome (UHR-T n = 11; UHR-NT n = 55) with healthy controls (HC n = 25) and first episode schizophrenia patients (FEP n = 25) treated with atypical antipsychotics. Results Contrary to our hypothesis niacin sensitivity of the entire UHR group was not attenuated, but significantly increased compared to the HC group, whereas no difference could be found between the UHR-T and UHR-NT groups. As expected, niacin sensitivity of FEP was attenuated compared to HC group. In UHR individuals niacin sensitivity was inversely correlated with omega-6 and -9 fatty acids (FA), but positively correlated with phospholipase A(2) (inPLA(2)) activity, a marker of membrane lipid repair/remodelling. Conclusions Increased niacin sensitivity in UHR states likely indicates an impaired balance of eicosanoids and omega-6/-9 FA at a membrane level. Our findings suggest that the emergence of psychosis is associated with an increased mobilisation of eicosanoids prior to the transition to psychosis possibly reflecting a "pro-inflammatory state", whereas thereafter eicosanoid mobilisation seems to be attenuated. Potential treatment implications for the UHR state should be further investigated.	[Berger, Gregor E.] Univ Zurich, Univ Hosp Child & Adolescent Psychiat, Neumunsterallee 9, CH-8032 Zurich, Switzerland; [Smesny, Stefan; Milleit, Berko; Langbein, Kerstin; Milleit, Christine; Sauer, Heinrich] Jena Univ Hosp, Dept Psychiat, Philosophenweg 3, D-07743 Jena, Germany; [Schaefer, Miriam R.; McGorry, Patrick D.; Amminger, G. Paul] Univ Melbourne, Orygen Youth Hlth Res Ctr, Locked Bag 10,35 Poplar Rd, Melbourne, Vic 3052, Australia; [Schaefer, Miriam R.; Klier, Claudia M.; Schloegelhofer, Monika; Amminger, G. Paul] Med Univ Vienna, Dept Child & Adolescent Psychiat, Wahringergurtel 18-20, A-1090 Vienna, Austria; [Hipler, Uta-Christina] Univ Hosp Jena, Dept Dermatol, Erfurter Str 35, D-07743 Jena, Germany; [Holub, Magdalena; Holzer, Ingrid] Univ Vienna, Dept Nutr Sci, Althanstr 14, A-1090 Vienna, Austria; [Berk, Michael] Deakin Univ Melbourne, Sch Med, Barwon Hlth, Geelong, Vic, Australia; [Berk, Michael] Florey Inst Neurosci & Mental Hlth, Parkville, Vic, Australia	University Children's Hospital Zurich; University of Zurich; Friedrich Schiller University of Jena; Orygen, The National Centre of Excellence in Youth Mental Health; University of Melbourne; Medical University of Vienna; Friedrich Schiller University of Jena; University of Vienna; Deakin University; Florey Institute of Neuroscience & Mental Health	Smesny, S (corresponding author), Jena Univ Hosp, Dept Psychiat, Philosophenweg 3, D-07743 Jena, Germany.	stefan.smesny@med.uni-jena.de	McGorry, Patrick/O-4115-2019; Berk, Michael/M-3585-2019; Berger, Gregor E/AAE-1786-2021; Amminger, G. Paul/ABE-1579-2020; Berk, Michael/M-7891-2013	Berk, Michael/0000-0002-5554-6946; Amminger, G. Paul/0000-0001-8969-4595; Berk, Michael/0000-0002-5554-6946; Berger, Gregor/0000-0003-2030-141X; McGorry, Patrick/0000-0002-3789-6168; Klier, Claudia/0000-0003-0696-8904	Stanley Medical Research Institute [03T-315]; National Health and Medical Research Council, Australia [566529]	Stanley Medical Research Institute; National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia)	The study was supported by Stanley Medical Research Institute, grant 03T-315. Dr. G. Paul Amminger was supported by grant 566529 from the National Health and Medical Research Council, Australia. The sponsor of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report.	Allen P, 2012, SCHIZOPHRENIA BULL, V38, P1268, DOI 10.1093/schbul/sbr194; Amminger GP, 2012, MOL PSYCHIATR, V17, P1150, DOI 10.1038/mp.2011.167; Amminger GP, 2010, ARCH GEN PSYCHIAT, V67, P146, DOI 10.1001/archgenpsychiatry.2009.192; Assies J, 2014, ACTA PSYCHIAT SCAND, V130, P163, DOI 10.1111/acps.12265; Bazan NG, 2005, MOL NEUROBIOL, V32, P89, DOI 10.1385/MN:32:1:089; Berger GE, 2008, NEUROPSYCHOPHARMACOL, V33, P2467, DOI 10.1038/sj.npp.1301628; Berger Gregor E, 2003, Psychopharmacol Bull, V37, P79; Berger GE, 2012, CURR PHARM DESIGN, V18, P570; Bodatsch M, 2011, BIOL PSYCHIAT, V69, P959, DOI 10.1016/j.biopsych.2010.09.057; Borgwardt S, 2013, SCHIZOPHRENIA BULL, V39, P1105, DOI 10.1093/schbul/sbs095; Buretic-Tomljanovic A, 2008, PSYCHIAT DANUB, V20, P372; Byun MS, 2009, PSYCHIAT INVEST, V6, P264, DOI 10.4306/pi.2009.6.4.264; Chang SS, 2009, SCHIZOPHRENIA BULL, V35, P213, DOI 10.1093/schbul/sbm153; Do KQ, 2009, CURR OPIN NEUROBIOL, V19, P220, DOI 10.1016/j.conb.2009.05.001; Do KQ, 2000, EUR J NEUROSCI, V12, P3721, DOI 10.1046/j.1460-9568.2000.00229.x; DWORKIN RH, 1994, SCHIZOPHRENIA BULL, V20, P235, DOI 10.1093/schbul/20.2.235; Eisenacher S, 2015, PSYCHOL MED, V45, P3329, DOI 10.1017/S0033291715001373; Emsley R, 2003, CNS DRUGS, V17, P1081, DOI 10.2165/00023210-200317150-00003; Farooqui AA, 1998, CELL MOL NEUROBIOL, V18, P599, DOI 10.1023/A:1020261600498; Farooqui AA, 2004, PROSTAG LEUKOTR ESS, V71, P161, DOI 10.1016/j.plefa.2004.03.004; FAROOQUI AA, 1994, J NEUROSCI RES, V38, P6, DOI 10.1002/jnr.490380103; FAROOQUI AA, 1987, NEUROCHEM PATHOL, V7, P99, DOI 10.1007/BF02834212; Fenton WS, 2000, BIOL PSYCHIAT, V47, P8, DOI 10.1016/S0006-3223(99)00092-X; Fusar-Poli P, 2014, SCHIZOPHRENIA BULL, V40, P120, DOI 10.1093/schbul/sbs136; GATTAZ WF, 1987, BIOL PSYCHIAT, V22, P421, DOI 10.1016/0006-3223(87)90164-8; Hermesh H, 2000, AM J PSYCHIAT, V157, P1327, DOI 10.1176/appi.ajp.157.8.1327; HOFFER A, 1964, ACTA PSYCHIAT SCAND, V40, P171, DOI 10.1111/j.1600-0447.1964.tb05744.x; HOFFER A, 1969, J AMER MED ASSOC, V207, P1355, DOI 10.1001/jama.1969.03150200121025; HORROBIN DF, 1980, J ORTHOMOL MED, V9, P33; HORROBIN DF, 1977, LANCET, V1, P936; HORROBIN DF, 1994, SCHIZOPHR RES, V13, P195, DOI 10.1016/0920-9964(94)90043-4; Horrobin DF, 1999, SEARCH FOR THE CAUSES OF SCHIZOPHRENIA, VOL IV, P261; Hudson CJ, 1997, BIOL PSYCHIAT, V41, P507, DOI 10.1016/S0006-3223(96)00112-6; Kerr M, 2008, PROSTAG LEUKOTR ESS, V79, P15, DOI 10.1016/j.plefa.2008.06.001; KLEIJNEN J, 1991, BIOL PSYCHIAT, V29, P931, DOI 10.1016/0006-3223(91)90060-Y; Klosterkotter J, 1996, EUR ARCH PSY CLIN N, V246, P147, DOI 10.1007/BF02189116; Law MH, 2006, MOL PSYCHIATR, V11, P547, DOI 10.1038/sj.mp.4001819; McGorry PD, 2014, LANCET PSYCHIAT, V1, P559, DOI 10.1016/S2215-0366(14)00082-0; Messamore E, 2003, SCHIZOPHR RES, V62, P251, DOI 10.1016/S0920-9964(02)00311-0; Miller T J, 2000, Conn Med, V64, P339; Mocking RJT, 2015, PSYCHONEUROENDOCRINO, V59, P1, DOI 10.1016/j.psyneuen.2015.04.027; Morrison AP, 2015, PSYCHOL MED, V45, P2675, DOI 10.1017/S0033291715000689; Muller N, 2012, PSYCHIAT RES, V198, P341, DOI 10.1016/j.psychres.2011.12.049; MURRELL TW, 1959, ARCH DERMATOL, V79, P545, DOI 10.1001/archderm.1959.01560170043008; Nadalin S, 2010, PSYCHIAT DANUB, V22, P14; Nieminen LRG, 2006, PROSTAG LEUKOTR ESS, V75, P309, DOI 10.1016/j.plefa.2006.07.012; Oken RJ, 1999, SCHIZOPHRENIA BULL, V25, P625, DOI 10.1093/oxfordjournals.schbul.a033407; Olabi B, 2011, BIOL PSYCHIAT, V70, P88, DOI 10.1016/j.biopsych.2011.01.032; PIOMELLI D, 1994, CRIT REV NEUROBIOL, V8, P65; Potvin S, 2008, BIOL PSYCHIAT, V63, P801, DOI 10.1016/j.biopsych.2007.09.024; Puri BK, 2002, PROG NEURO-PSYCHOPH, V26, P49, DOI 10.1016/S0278-5846(01)00220-2; Puri BK, 2001, INT J CLIN PRACT, V55, P368; Ross BM, 2007, LIPIDS HEALTH DIS, V6, DOI 10.1186/1476-511X-6-21; Ross BM, 2009, PROSTAG LEUKOTR ESS, V81, P309, DOI 10.1016/j.plefa.2009.10.004; Schultze-Lutter F, 2012, CURR PHARM DESIGN, V18, P351, DOI 10.2174/138161212799316064; Seidman LJ, 2010, ARCH GEN PSYCHIAT, V67, P578, DOI 10.1001/archgenpsychiatry.2010.66; Smesny S, 2005, PROSTAG LEUKOTR ESS, V72, P393, DOI 10.1016/j.plefa.2005.02.007; Smesny S, 2004, J PSYCHIAT RES, V38, P537, DOI 10.1016/j.jpsychires.2004.01.007; Smesny S, 2014, MOL PSYCHIATR, V19, P317, DOI 10.1038/mp.2013.7; Smesny S, 2003, J PSYCHIAT RES, V37, P237, DOI 10.1016/S0022-3956(03)00006-2; Smesny S, 2007, PROSTAG LEUKOTR ESS, V77, P79, DOI 10.1016/j.plefa.2007.08.006; Smesny S, 2007, NEUROPSYCHOPHARMACOL, V32, P2067, DOI 10.1038/sj.npp.1301343; Smesny S, 2010, J AFFECT DISORDERS, V124, P335, DOI 10.1016/j.jad.2009.12.017; Tassoni D, 2008, ASIA PAC J CLIN NUTR, V17, P220; Tavares H, 2003, SCHIZOPHR RES, V61, P1, DOI 10.1016/S0920-9964(02)00281-5; van der Kemp WJM, 2012, SCHIZOPHR RES, V141, P153, DOI 10.1016/j.schres.2012.08.014; Ward PE, 1998, SCHIZOPHR RES, V29, P269, DOI 10.1016/S0920-9964(97)00100-X; WILLIAMS JH, 1989, NATURE, V341, P739, DOI 10.1038/341739a0; Wood SJ, 2008, SCHIZOPHRENIA BULL, V34, P322, DOI 10.1093/schbul/sbm149; Wood SJ, 2010, PSYCHIAT RES-NEUROIM, V182, P180, DOI 10.1016/j.pscychresns.2009.12.003; Yao JK, 2006, DIS MARKERS, V22, P83, DOI 10.1155/2006/248387; Yao JK, 2011, ANTIOXID REDOX SIGN, V15, P2011, DOI 10.1089/ars.2010.3603; Yao Jeffrey K, 2002, ScientificWorldJournal, V2, P1922; Yao JK, 2004, PROSTAG LEUKOTR ESS, V71, P171, DOI 10.1016/j.plefa.2004.03.011; Yung AR, 2012, CURR PHARM DESIGN, V18, P346; Yung AR, 2012, AUST NZ J PSYCHIAT, V46, P7, DOI 10.1177/0004867411432205; Yung AR, 2003, SCHIZOPHR RES, V60, P21, DOI 10.1016/S0920-9964(02)00167-6	77	20	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0148429	10.1371/journal.pone.0148429	http://dx.doi.org/10.1371/journal.pone.0148429			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3DG	26894921	Green Published, Green Accepted, gold			2022-12-26	WOS:000371223400014
J	Chamnan, P; Simmons, RK; Sharp, SJ; Khaw, KT; Wareham, NJ; Griffin, SJ				Chamnan, Parinya; Simmons, Rebecca K.; Sharp, Stephen J.; Khaw, Kay-Tee; Wareham, Nicholas J.; Griffin, Simon J.			Repeat Cardiovascular Risk Assessment after Four Years: Is There Improvement in Risk Prediction?	PLOS ONE			English	Article							PRIMARY PREVENTION; PRIMARY-CARE; DISEASE; 10-YEAR; ADULTS; SCORE	Background Framingham risk equations are widely used to predict cardiovascular disease based on health information from a single time point. Little is known regarding use of information from repeat risk assessments and temporal change in estimated cardiovascular risk for prediction of future cardiovascular events. This study was aimed to compare the discrimination and risk reclassification of approaches using estimated cardiovascular risk at single and repeat risk assessments Methods Using data on 12,197 individuals enrolled in EPIC-Norfolk cohort, with 12 years of follow-up, we examined rates of cardiovascular events by levels of estimated absolute risk (Framingham risk score) at the first and second health examination four years later. We calculated the area under the receiver operating characteristic curve (aROC) and risk reclassification, comparing approaches using information from single and repeat risk assessments (i.e., estimated risk at different time points). Results The mean Framingham risk score increased from 15.5% to 17.5% over a mean of 3.7 years from the first to second health examination. Individuals with high estimated risk (>= 20%) at both health examinations had considerably higher rates of cardiovascular events than those who remained in the lowest risk category (< 10%) in both health examinations (34.0 [95% CI 31.7-36.6] and 2.7 [2.2-3.3] per 1,000 person-years respectively). Using information from the most up-to-date risk assessment resulted in a small non-significant change in risk classification over the previous risk assessment (net reclassification improvement of -4.8%, p > 0.05). Using information from both risk assessments slightly improved discrimination compared to information from a single risk assessment (aROC 0.76 and 0.75 respectively, p < 0.001). Conclusions Using information from repeat risk assessments over a period of four years modestly improved prediction, compared to using data from a single risk assessment. However, this approach did not improve risk classification.	[Chamnan, Parinya; Simmons, Rebecca K.; Sharp, Stephen J.; Wareham, Nicholas J.; Griffin, Simon J.] Univ Cambridge, Inst Metab Sci, MRC Epidemiol Unit, Cambridge, England; [Chamnan, Parinya] Sanpasitthiprasong Hosp, Dept Social Med, Cardiometab Res Grp, Ubon Ratchathani, Thailand; [Khaw, Kay-Tee] Univ Cambridge, Addenbrookes Hosp, Sch Clin Med, Clin Gerontol Unit, Cambridge CB2 2QQ, England	University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Chamnan, P (corresponding author), Univ Cambridge, Inst Metab Sci, MRC Epidemiol Unit, Cambridge, England.; Chamnan, P (corresponding author), Sanpasitthiprasong Hosp, Dept Social Med, Cardiometab Res Grp, Ubon Ratchathani, Thailand.	parinya.chamnan@cardiomet-res.org		Chamnan, Parinya/0000-0002-5202-4149; Simmons, Rebecca/0000-0002-7726-8529	National Institute for Health Research (NIHR) Programme Grant [RP-PG-0606-1259]; MRC [MC_UU_12015/1, MC_UU_12015/4]; Medical Research Council [MC_U106179474, G0401527, MR/N003284/1, MC_UU_12015/4, MC_UU_12015/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10114, NF-SI-0512-10135] Funding Source: researchfish; MRC [MR/N003284/1, MC_U106179474] Funding Source: UKRI	National Institute for Health Research (NIHR) Programme Grant; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Dr. Griffin receives support from the National Institute for Health Research (NIHR) Programme Grant funding scheme (RP-PG-0606-1259). This work was also supported by MRC grants (MC_UU_12015/1 and MC_UU_12015/4). The views expressed in this publication are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boekholdt MS, 2004, AM J MED, V117, P390, DOI 10.1016/j.amjmed.2004.04.010; Brindle P, 2006, HEART, V92, P1752, DOI 10.1136/hrt.2006.087932; Chamnan P, 2009, DIABETOLOGIA, V52, P2001, DOI 10.1007/s00125-009-1454-0; Chamnan P, 2011, DIABETES CARE, V34, P950, DOI 10.2337/dc09-2326; CUPPLES LA, 1988, STAT MED, V7, P205, DOI 10.1002/sim.4780070122; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; D'Agostino RB, 2001, JAMA-J AM MED ASSOC, V286, P180, DOI 10.1001/jama.286.2.180; Day N, 1999, BRIT J CANCER, V80, P95; *DEP HLTH, 2008, PUTTING PREVENTION F, P68431; Department of Health, 2008, EC MOD VASC CHECKS; Gaziano JM, 2012, JAMA-J AM MED ASSOC, V308, P816, DOI 10.1001/2012.jama.10456; Graham I, 2007, EUR HEART J, V28, P2375, DOI 10.1093/eurheartj/ehm316; Greenland P, 2010, CIRCULATION, V122, pE584, DOI 10.1161/CIR.0b013e3182051b4c; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Hingorani AD, 2009, JAMA-J AM MED ASSOC, V302, P2144, DOI 10.1001/jama.2009.1698; Hippisley-Cox J, 2011, BMJ-BRIT MED J, V341, pc6624; Jackson R, 2011, BMJ-BRIT MED J, V341, pc7379; Karp I, 2004, AM J EPIDEMIOL, V160, P707, DOI 10.1093/aje/kwh258; Lloyd-Jones DM, 2004, AM J CARDIOL, V94, P20, DOI 10.1016/j.amjcard.2004.03.023; Lloyd-Jones DM, 2010, CIRCULATION, V121, P1768, DOI 10.1161/CIRCULATIONAHA.109.849166; Lloyd-Jones DM, 2006, CURR OPIN LIPIDOL, V17, P619, DOI 10.1097/MOL.0b013e3280108740; Marma AK, 2010, CIRC-CARDIOVASC QUAL, V3, P8, DOI 10.1161/CIRCOUTCOMES.109.869727; National Institute for Health and Clinical Excellence, 2008, CARD RISK ASS MOD BL; Persell SD, 2010, ARCH INTERN MED, V170, P470, DOI 10.1001/archinternmed.2009.525; Wood D, 2005, HEART, V91, P1, DOI 10.1136/hrt.2005.079988	25	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0147417	10.1371/journal.pone.0147417	http://dx.doi.org/10.1371/journal.pone.0147417			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3DG	26895071	Green Published, Green Submitted, gold			2022-12-26	WOS:000371223400004
J	Ndejjo, R; Mukama, T; Musabyimana, A; Musoke, D				Ndejjo, Rawlance; Mukama, Trasias; Musabyimana, Angele; Musoke, David			Uptake of Cervical Cancer Screening and Associated Factors among Women in Rural Uganda: A Cross Sectional Study	PLOS ONE			English	Article							PAP-SMEAR; KNOWLEDGE; ATTITUDES; RISK	Background In developing countries, inadequate access to effective screening for cervical cancer often contributes to the high morbidity and mortality caused by the disease. The largest burden of this falls mostly on underserved populations in rural areas, where health care access is characterized by transport challenges, ill equipped health facilities, and lack of information access. This study assessed uptake of cervical cancer screening and associated factors among women in rural Uganda. Methods This descriptive cross sectional study was carried out in Bugiri and Mayuge districts in eastern Uganda and utilised quantitative data collection methods. Data were collected using a semi-structured questionnaire on cervical cancer screening among females aged between 25 and 49 years who had spent six or more months in the area. Data were entered in Epi-data 3.02 and analysed in STATA 12.0 statistical software. Univariate, bivariate and multivariate analyses were performed. Results Of the 900 women, only 43 (4.8%) had ever been screened for cervical cancer. Among respondents who were screened, 21 (48.8%) did so because they had been requested by a health worker, 17 (39.5%) had certain signs and symptoms they associated with cervical cancer while 16 (37.2%) did it voluntarily to know their status. Barriers to cervical cancer screening were negative individual perceptions 553 (64.5%) and health facility related challenges 142 (16.6%). Other respondents said they were not aware of the screening service 416 (48.5%). The independent predictors of cervical cancer screening were: being recommended by a health worker [AOR = 87.85, p<0.001], knowing where screening services were offered [AOR = 6.24, p = 0.004], and knowing someone who had ever been screened [AOR = 9.48, p = 0.001]. Conclusion The prevalence of cervical cancer screening is very low in rural Uganda. Interventions to increase uptake of cervical cancer screening should be implemented so as to improve access to the service in rural areas.	[Ndejjo, Rawlance; Mukama, Trasias; Musoke, David] Makerere Univ, Coll Hlth Sci, Sch Publ Hlth, Dept Dis Control & Environm Hlth, Kampala, Uganda; [Musabyimana, Angele] Univ Rwanda, Coll Med & Hlth Sci, Sch Publ Hlth, Dept Community Hlth, Kigali, Rwanda	Makerere University; University of Rwanda	Ndejjo, R (corresponding author), Makerere Univ, Coll Hlth Sci, Sch Publ Hlth, Dept Dis Control & Environm Hlth, Kampala, Uganda.	rndejjo@musph.ac.ug	Mukama, Trasias/U-7179-2019; Musabyimana, Angèle/GLR-9496-2022	Mukama, Trasias/0000-0002-6520-5272; Musabyimana, Angèle/0000-0001-9708-3137; Musoke, David/0000-0003-3262-3918; Ndejjo, Rawlance/0000-0001-9263-557X	Training Health Researchers into Vocational Excellence in East Africa (THRiVE) - Wellcome Trust [087540]	Training Health Researchers into Vocational Excellence in East Africa (THRiVE) - Wellcome Trust	This work was supported by Training Health Researchers into Vocational Excellence in East Africa (THRiVE), grant number 087540 funded by the Wellcome Trust. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the supporting offices. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullahi A, 2009, PUBLIC HEALTH, V123, P680, DOI 10.1016/j.puhe.2009.09.011; [Anonymous], 1986, B WORLD HEALTH ORGAN, V64, P607; Ayinde O A, 2003, J Obstet Gynaecol, V23, P59, DOI 10.1080/0144361021000043272; Bessler Patricia, 2007, Cancer Control, V14, P396; Bingham A, 2003, SALUD PUBLICA MEXICO, V45, pS408; Bruni L, 2019, ICO IARC INFORM CTR; Cristina Herdman JS, 2000, PLANNING APPROPRIATE; Cunningham MS, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-005828; Gakidou E, 2008, PLOS MED, V5, P863, DOI 10.1371/journal.pmed.0050132; Gamarra CJ, 2009, PUBLIC HEALTH NURS, V26, P269, DOI 10.1111/j.1525-1446.2009.00779.x; Gharoro EP, 2006, INT J GYNECOL CANCER, V16, P1063, DOI 10.1111/j.1525-1438.2006.00579.x; Gichangi P, 2003, INT J GYNECOL CANCER, V13, P827, DOI 10.1111/j.1525-1438.2003.13612.x; Hatcher J, 2011, J HEALTH CARE POOR U, V22, P176, DOI 10.1353/hpu.2011.0021; Hogg M. A., 2010, HDB SOCIAL PSYCHOL; Holowaty P, 1999, JNCI-J NATL CANCER I, V91, P252, DOI 10.1093/jnci/91.3.252; Holroyd E, 2004, J ADV NURS, V46, P42, DOI 10.1111/j.1365-2648.2003.02964.x; Kish L, 1965, SURVEY SAMPLING; Lyimo FS, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-22; Ministry of Health, 2010, STRAT PLAN CERV CANC; Mukama T, 2015, WOMENS KNOWLEDGE ATT; Mupepi SC, 2011, J WOMENS HEALTH, V20, P943, DOI 10.1089/jwh.2010.2062; Mutyaba Twaha, 2006, BMC Med Educ, V6, P13, DOI 10.1186/1472-6920-6-13; Mutyaba Twaha, 2007, Reprod Health, V4, P4, DOI 10.1186/1742-4755-4-4; Ncube B, 2015, N AM J MED SCI, V7, P104, DOI 10.4103/1947-2714.153922; Ndikom C. M., 2011, INT J NURSING MIDWIF, V3, P158; Sankaranarayanan R, 2007, LANCET, V370, P398, DOI 10.1016/S0140-6736(07)61195-7; Sudenga SL, 2013, INT J GYNECOL CANCER, V23, P895, DOI 10.1097/IGC.0b013e31828e425c; Twinomujuni C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128498; UBOS, 2014, NATL POPULATION HOUS; Waller J, 2004, BRIT J PSYCHOL, V95, P219, DOI 10.1348/000712604773952430; Wellensiek N, 2002, INT J GYNECOL CANCER, V12, P376, DOI 10.1046/j.1525-1438.2002.01114.x; Were E, 2011, AFR HEALTH SCI, V11, P58; WHO, 2006, COMPR CERV CANC CONT; World Health Organization, 2003, HUM PAP VIR INF CERV; World Health Organization (WHO), 2010, HUM PAP REL CANC	35	70	70	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0149696	10.1371/journal.pone.0149696	http://dx.doi.org/10.1371/journal.pone.0149696			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF3DG	26894270	Green Submitted, gold, Green Published			2022-12-26	WOS:000371223400075
J	Kim, J; Oh, B; Lim, JE; Kim, MK				Kim, Jihye; Oh, Bermseok; Lim, Ji Eun; Kim, Mi Kyung			No Interaction with Alcohol Consumption, but Independent Effect of C12orf51 (HECTD4) on Type 2 Diabetes Mellitus in Korean Adults Aged 40-69 Years: The KoGES_Ansan and Ansung Study	PLOS ONE			English	Article							ALDEHYDE DEHYDROGENASE GENOTYPES; GENOME-WIDE ASSOCIATION; DRINKING BEHAVIOR; INSULIN-RESISTANCE; SYNTAXIN 8; ALDH2; RISK; METAANALYSIS; JAPANESE; CHINESE	Previously, genetic polymorphisms of C12orf51 (HECTD4) (rs2074356 and/or rs11066280) have been shown to be related to alcohol consumption and type 2 diabetes (T2D). This study aimed to prospectively examine whether C12orf51 had an interaction with or independent effect on alcohol consumption and the risk of T2D. The present study included 3,244 men and 3,629 women aged 40 to 69 years who participated in the Korean Genome and Epidemiology Study (KoGES)_Ansan and Ansung Study. Cox proportional hazards models were used to estimate HRs and 95% CIs for T2D. rs2074356 and rs11066280 were associated with the risk of T2D after adjusting for alcohol consumption (rs2074356 for AA: HR = 0.39 and 95% CI = 0.17-0.87 in men, and HR = 0.36 and 95% CI = 0.13-0.96 in women; rs11066280 for AA: HR = 0.44 and 95% CI = 0.23-0.86 in men, and HR = 0.39 and 95% CI = 0.16-0.94 in women). We identified that the association of each variant (rs2074356 and rs11065756) in C12orf51 was nearly unchanged after adjusted for alcohol consumption. Therefore, the association of 2 SNPs in C12orf51 with diabetes may not be mediated by alcohol use. There was no interaction effect between alcohol consumption and the SNPs with T2D. However, even in never-drinkers, minor allele homozygote strongly influenced T2D risk reduction (rs2074356 for AA: HR = 0.35, 95% CI = 0.14-0.90, and p-trend = 0.0035 in men and HR = 0.34, 95% CI = 0.13-0.93, and p-trend = 0.2348 in women; rs11066280 for AA: HR = 0.36, 95% CI = 0.16-0.82, and p-trend = 0.0014 in men and HR = 0.39, 95% CI = 0.16-0.95, and p-trend = 0.3790 in women), while alcohol consumption did not influence the risk of T2D within each genotype. rs2074356 and rs11066280 in or near C12orf51, which is related to alcohol drinking behavior, may longitudinally decrease the risk of T2D, but not through regulation of alcohol consumption.	[Kim, Jihye; Kim, Mi Kyung] Hanyang Univ, Coll Med, Dept Prevent Med, Seoul 133791, South Korea; [Kim, Jihye; Kim, Mi Kyung] Hanyang Univ, Inst Hlth & Soc, Seoul 133791, South Korea; [Oh, Bermseok; Lim, Ji Eun] Kyung Hee Univ, Sch Med, Dept Biochem & Mol Biol, Seoul, South Korea	Hanyang University; Hanyang University; Kyung Hee University	Kim, MK (corresponding author), Hanyang Univ, Coll Med, Dept Prevent Med, Seoul 133791, South Korea.; Kim, MK (corresponding author), Hanyang Univ, Inst Hlth & Soc, Seoul 133791, South Korea.	kmkkim@hanyang.ac.kr			Research of Korea Centers for Disease Control and Prevention [HD14B0005]; Korea Centers for Disease Control & Prevention, Republic of Korea	Research of Korea Centers for Disease Control and Prevention; Korea Centers for Disease Control & Prevention, Republic of Korea	This research was supported by a fund (HD14B0005) by Research of Korea Centers for Disease Control and Prevention and MKK received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was provided with biospecimens and data from the Korean Genome Analysis Projects (4845-301), the Korean Genome and Epidemiology (4845-302) and Korea Biobank Project (4851-307, KBP-2014-000) that were supported by the Korea Centers for Disease Control & Prevention, Republic of Korea.	Aguiree F., 2013, IDF DIABETES ATLAS; Ahn Y, 2007, EUR J CLIN NUTR, V61, P1435, DOI 10.1038/sj.ejcn.1602657; Andre P, 2006, DIABETOLOGIA, V49, P2599, DOI 10.1007/s00125-006-0418-x; [Anonymous], 2013, 2013 STAT RESULTS CA; Baik I, 2008, ARCH INTERN MED, V168, P167, DOI 10.1001/archinternmed.2007.8; Baik I, 2011, AM J CLIN NUTR, V93, P809, DOI 10.3945/ajcn.110.001776; Baliunas DO, 2009, DIABETES CARE, V32, P2123, DOI 10.2337/dc09-0227; Bray GA., 2014, HDB OBESITY EPIDEMIO; Bu S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139039; Carlsson S, 2005, DIABETOLOGIA, V48, P1051, DOI 10.1007/s00125-005-1768-5; Chen CH, 2014, PHYSIOL REV, V94, P1, DOI 10.1152/physrev.00017.2013; Chen T, 2010, DIABETES RES CLIN PR, V90, P352, DOI 10.1016/j.diabres.2010.09.017; Cho YS, 2009, NAT GENET, V41, P527, DOI 10.1038/ng.357; Doran N, 2007, J STUD ALCOHOL DRUGS, V68, P789, DOI 10.15288/jsad.2007.68.789; Faerch K, 2010, DIABETOLOGIA, V53, P858, DOI 10.1007/s00125-010-1673-4; Firlej M., 2008, DIABETOLOGIA DOSWIAD, V8, P143; Freemantle N, 2008, INT J CLIN PRACT, V62, P1391, DOI 10.1111/j.1742-1241.2008.01805.x; GIOVANNUCCI E, 1991, AM J EPIDEMIOL, V133, P810; Go MJ, 2014, DIABETES METAB J, V38, P375, DOI 10.4093/dmj.2014.38.5.375; Go MJ, 2013, J HUM GENET, V58, P362, DOI 10.1038/jhg.2013.14; Higuchi S, 1996, ALCOHOL CLIN EXP RES, V20, P493, DOI 10.1111/j.1530-0277.1996.tb01080.x; HIGUCHI S, 1994, LANCET, V343, P741, DOI 10.1016/S0140-6736(94)91629-2; Hilawe EH, 2013, B WORLD HEALTH ORGAN, V91, P671, DOI 10.2471/BLT.12.113415; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hotamisligil GS, 1996, SCIENCE, V271, P665, DOI 10.1126/science.271.5249.665; Joosten MM, 2008, DIABETOLOGIA, V51, P1375, DOI 10.1007/s00125-008-1031-y; Kiage J. N., 2014, Current Nutrition Reports, V3, P213; Kim KS, 1972, J KOREAN DIABETES AS, V1, P17; Kim TH, 2012, J KOREAN MED SCI, V27, P876, DOI 10.3346/jkms.2012.27.8.876; Kim YJ, 2011, NAT GENET, V43, P990, DOI 10.1038/ng.939; Koppes LLJ, 2005, DIABETES CARE, V28, P719, DOI 10.2337/diacare.28.3.719; Lancha A, 2015, ARCH MED RES, V46, P47, DOI 10.1016/j.arcmed.2014.12.003; Luczak SE, 2006, PSYCHOL BULL, V132, P607, DOI 10.1037/0033-2909.132.4.607; Ministry of Health and Welfare KCfDCaP, 2013, KOR HLTH STAT 2013 K; MURAMATSU T, 1995, HUM GENET, V96, P151, DOI 10.1007/BF00207371; Okamoto K, 2001, ALCOHOL CLIN EXP RES, V25, p19S, DOI 10.1097/00000374-200106001-00006; Park K, 2009, DIABETES CARE, V32, P1302, DOI 10.2337/dc09-0259; Shin S, 2010, INT J GERIATR PSYCH, V25, P441, DOI 10.1002/gps.2358; The Korean Nutrition Society, 2000, RECOMMENDED DIETARY, V7th; Willett W., 2013, NUTR EPIDEMIOLOGY, V3rd, DOI DOI 10.1093/ACPROF:OSO/9780199754038.001.0001; World Health Organization, 2006, DEF DIAGN DIAB MELL; Yang XL, 2013, AM J CLIN NUTR, V97, P545, DOI 10.3945/ajcn.112.046482; Yin G, 2010, EPIDEMIOLOGY RES INT; Zhang LS, 2009, CELL MOL NEUROBIOL, V29, P115, DOI 10.1007/s10571-008-9303-0	44	8	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2016	11	2							e0149321	10.1371/journal.pone.0149321	http://dx.doi.org/10.1371/journal.pone.0149321			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3CO	26891264	Green Published, Green Submitted, gold			2022-12-26	WOS:000371221500033
J	Buckley, RC; Morrison, C; Castley, JG				Buckley, Ralf C.; Morrison, Clare; Castley, J. Guy			Net Effects of Ecotourism on Threatened Species Survival	PLOS ONE			English	Article							PENGUINS SPHENISCUS-DEMERSUS; ZEALAND SEA LIONS; GLOBAL BIODIVERSITY; FOOD AVAILABILITY; CONSERVATION; MANAGEMENT; TOURISM; ISLAND; BOULDERS; SIZE	Many threatened species rely on ecotourism for conservation funding, but simultaneously suffer direct ecological impacts from ecotourism. For a range of IUCN-Redlisted terrestrial and marine bird and mammal species worldwide, we use population viability analyses to calculate the net effects of ecotourism on expected time to extinction, in the presence of other anthropogenic threats such as poaching, primary industries and habitat loss. Species for which these calculations are currently possible, for one or more subpopulations, include: orangutan, hoolock gibbon, golden lion tamarin, cheetah, African wild dog, New Zealand sealion, great green macaw, Egyptian vulture, and African penguin. For some but not all of these species, tourism can extend expected survival time, i.e., benefits outweigh impacts. Precise outcomes depend strongly on population parameters and starting sizes, predation, and ecotourism scale and mechanisms. Tourism does not currently overcome other major conservation threats associated with natural resource extractive industries. Similar calculations for other threatened species are currently limited by lack of basic population data.	[Buckley, Ralf C.; Morrison, Clare; Castley, J. Guy] Griffith Univ, Sch Environm, Gold Coast, Australia	Griffith University	Buckley, RC (corresponding author), Griffith Univ, Sch Environm, Gold Coast, Australia.	r.buckley@griffith.edu.au	Castley, James Guy/A-7056-2010	Castley, James Guy/0000-0002-8418-5828				[Anonymous], 2010, CONSERVATION TOURISM; Bach LA, 2010, J NAT CONSERV, V18, P237, DOI 10.1016/j.jnc.2009.09.001; Balmford Andrew, 2012, WILD HOPE FRONT LINE; Barnosky AD, 2012, NATURE, V486, P52, DOI 10.1038/nature11018; Barnosky AD, 2011, NATURE, V471, P51, DOI 10.1038/nature09678; Birdlife International, 2012, SPEC FACTSH NEOPHR P; Brook BW, 2008, TRENDS ECOL EVOL, V23, P453, DOI 10.1016/j.tree.2008.03.011; Buckley R, 2014, SCIENCE, V344, P358, DOI 10.1126/science.344.6182.358-b; Buckley R, 2011, ANNU REV ENV RESOUR, V36, P397, DOI 10.1146/annurev-environ-041210-132637; Buckley RC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044134; Buckley RC, 2012, NATURE, V489, P33, DOI 10.1038/489033b; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Cassini MH, 2004, J ETHOL, V22, P127, DOI 10.1007/s10164-003-0112-0; Chassot O., 2012, PARKS, V18, P61; Chilvers BL, 2012, POLAR BIOL, V35, P1607, DOI 10.1007/s00300-011-1143-6; Chilvers B. Louise, 2008, Endangered Species Research, V5, P193, DOI 10.3354/esr00086; Coetzee BWT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105824; Coulson T, 2001, TRENDS ECOL EVOL, V16, P219, DOI 10.1016/S0169-5347(01)02137-1; Crawford RJM, 2006, BIOL CONSERV, V132, P119, DOI 10.1016/j.biocon.2006.03.019; Crawford Robert J. M., 1999, Marine Ornithology, V27, P139; Curtin S, 2009, CURR ISSUES TOUR, V12, P59, DOI 10.1080/13683500802295663; Di Minin E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071788; Dobson A, 2008, TRENDS ECOL EVOL, V23, P177, DOI 10.1016/j.tree.2007.08.019; Ferraro PJ, 2014, P NATL ACAD SCI USA, V111, P4332, DOI 10.1073/pnas.1307712111; Garcia-Ripolles C, 2011, J ORNITHOL, V152, P879, DOI 10.1007/s10336-011-0671-8; GERRODETTE T, 1990, CONSERV BIOL, V4, P423, DOI 10.1111/j.1523-1739.1990.tb00317.x; Great Plains Foundation, 2014, ZER RHIN; Gusset M, 2009, BIOL CONSERV, V142, P2774, DOI 10.1016/j.biocon.2009.07.007; Hilborn R, 2006, SCIENCE, V314, P1266, DOI 10.1126/science.1132780; Hoffmann M, 2010, SCIENCE, V330, P1503, DOI 10.1126/science.1194442; Holst B, 2006, LION TAMARIN POPULAT; Karanth KU, 2011, SCIENCE, V332, P791, DOI 10.1126/science.332.6031.791-a; Karanth KK, 2010, BIOL CONSERV, V143, P2865, DOI 10.1016/j.biocon.2010.05.002; Kiss A, 2004, TRENDS ECOL EVOL, V19, P232, DOI 10.1016/j.tree.2004.03.010; Le Saout S, 2013, SCIENCE, V342, P803, DOI 10.1126/science.1239268; Lewa Wildlife Conservancy, 2014, UNESCO WORLD HER SIT; Lewis SEF, 2012, AFR J MAR SCI, V34, P497, DOI 10.2989/1814232X.2012.716008; Lindsey P., 2009, CHEETAH ACINONYX JUB; Mace GM, 2014, SCIENCE, V345, P1558, DOI 10.1126/science.1254704; Macfie EJ, 2010, BEST PRACTICE GUIDEL; McCarthy DP, 2012, SCIENCE, V338, P946, DOI 10.1126/science.1229803; Monge G, 2009, TALLER CONSERVACION; Morrison C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043757; NACSO, 2013, COMM CONS NAM 2012 A; Pereira HM, 2010, SCIENCE, V330, P1496, DOI 10.1126/science.1196624; Perrings C, 2011, SCIENCE, V331, P1139, DOI 10.1126/science.1202400; Petersen SL, 2006, IBIS, V148, P14, DOI 10.1111/j.1474-919X.2006.00459.x; Pimm SL, 2014, SCIENCE, V344, P987, DOI 10.1126/science.1246752; Pollak JP, 2013, VORTEX STOCHASTIC SI; RANDALL RM, 1987, J FIELD ORNITHOL, V58, P445; Ripple WJ, 2014, SCIENCE, V343, P151, DOI 10.1126/science.1241484; Saterberg T, 2013, NATURE, V499, P468, DOI 10.1038/nature12277; Schwitzer C, 2014, SCIENCE, V343, P842, DOI 10.1126/science.1245783; Singleton I., 2004, ORANGUTAN POPULATION; Smith RK, 2010, CONSERV BIOL, V24, P820, DOI 10.1111/j.1523-1739.2009.01421.x; Steven R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062598; Traill LW, 2007, BIOL CONSERV, V139, P159, DOI 10.1016/j.biocon.2007.06.011; Waldron A, 2013, P NATL ACAD SCI USA, V110, P12144, DOI 10.1073/pnas.1221370110; Walker S, 2005, CONSERVATION W HOOLO; WHITTINGTON PA, 2000, AFRICAN PENGUIN POPU; World Tourism Organization (UNWTO) United Nations Environmental Programme (UNEP), 2002, WORLD EC SUMM FIN RE	61	54	56	4	194	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0147988	10.1371/journal.pone.0147988	http://dx.doi.org/10.1371/journal.pone.0147988			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26886876	Green Published, gold, Green Submitted			2022-12-26	WOS:000371218400013
J	Chapman, JR; Helin, AS; Wille, M; Atterby, C; Jarhult, JD; Fridlund, JS; Waldenstrom, J				Chapman, Joanne R.; Helin, Anu S.; Wille, Michelle; Atterby, Clara; Jarhult, Josef D.; Fridlund, Jimmy S.; Waldenstrom, Jonas			A Panel of Stably Expressed Reference Genes for Real-Time qPCR Gene Expression Studies of Mallards (Anas platyrhynchos)	PLOS ONE			English	Article							AVIAN INFLUENZA-VIRUS; INNATE IMMUNE-RESPONSES; TRANSCRIPTION-PCR DATA; SERUM-ALBUMIN; QUANTITATIVE PCR; INTERNAL CONTROL; PEKIN DUCKS; RT-QPCR; INFECTION; QUANTIFICATION	Determining which reference genes have the highest stability, and are therefore appropriate for normalising data, is a crucial step in the design of real-time quantitative PCR (qPCR) gene expression studies. This is particularly warranted in non-model and ecologically important species for which appropriate reference genes are lacking, such as the mallard-a key reservoir of many diseases with relevance for human and livestock health. Previous studies assessing gene expression changes as a consequence of infection in mallards have nearly universally used beta-actin and/or GAPDH as reference genes without confirming their suitability as normalisers. The use of reference genes at random, without regard for stability of expression across treatment groups, can result in erroneous interpretation of data. Here, eleven putative reference genes for use in gene expression studies of the mallard were evaluated, across six different tissues, using a low pathogenic avian influenza A virus infection model. Tissue type influenced the selection of reference genes, whereby different genes were stable in blood, spleen, lung, gastrointestinal tract and colon. beta-actin and GAPDH generally displayed low stability and are therefore inappropriate reference genes in many cases. The use of different algorithms (GeNorm and NormFinder) affected stability rankings, but for both algorithms it was possible to find a combination of two stable reference genes with which to normalise qPCR data in mallards. These results highlight the importance of validating the choice of normalising reference genes before conducting gene expression studies in ducks. The fact that nearly all previous studies of the influence of pathogen infection on mallard gene expression have used a single, non-validated reference gene is problematic. The toolkit of putative reference genes provided here offers a solid foundation for future studies of gene expression in mallards and other waterfowl.	[Chapman, Joanne R.; Helin, Anu S.; Wille, Michelle; Fridlund, Jimmy S.; Waldenstrom, Jonas] Linnaeus Univ, Ctr Ecol & Evolut Microbial Model Syst, Kalmar, Sweden; [Wille, Michelle; Atterby, Clara; Jarhult, Josef D.] Uppsala Univ, Dept Med Biochem & Microbiol, Zoonosis Sci Ctr, Uppsala, Sweden; [Jarhult, Josef D.] Uppsala Univ, Dept Med Sci, Infect Dis Sect, Uppsala, Sweden	Linnaeus University; Uppsala University; Uppsala University	Chapman, JR; Waldenstrom, J (corresponding author), Linnaeus Univ, Ctr Ecol & Evolut Microbial Model Syst, Kalmar, Sweden.	joanne.chapman@lnu.se; jonas.waldenstrom@lnu.se	Jarhult, Josef D./ABE-8149-2020; Wille, Michelle/F-4819-2013; Chapman, Joanne/B-9783-2011; Waldenström, Jonas/E-4460-2013	Jarhult, Josef D./0000-0002-7075-1059; Wille, Michelle/0000-0002-5629-0196; Chapman, Joanne/0000-0003-2849-1094; Waldenström, Jonas/0000-0002-1152-4235	Linnaeus University (EEMiS); Swedish Research Council VR [2011-3568]; Swedish Research Council FORMAS [211-2013-1320]	Linnaeus University (EEMiS); Swedish Research Council VR(Swedish Research Council); Swedish Research Council FORMAS(Swedish Research CouncilSwedish Research Council Formas)	Funding was provided by Linnaeus University (EEMiS), the Swedish Research Councils VR (2011-3568; vr.se) and FORMAS (211-2013-1320, formas.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams SC, 2009, MOL IMMUNOL, V46, P1744, DOI 10.1016/j.molimm.2009.01.025; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Bailey LO, 2004, J BIOMED MATER RES A, V69A, P305, DOI 10.1002/jbm.a.20134; Barber MRW, 2010, P NATL ACAD SCI USA, V107, P5913, DOI 10.1073/pnas.1001755107; Burch AD, 2005, J VIROL, V79, P10740, DOI 10.1128/JVI.79.16.10740-10749.2005; Bustin SA, 2005, J MOL ENDOCRINOL, V34, P597, DOI 10.1677/jme.1.01755; Bustin Stephen A, 2014, Biomol Detect Quantif, V2, P35; Bustin SA, 2010, METHODS, V50, P217, DOI 10.1016/j.ymeth.2009.12.006; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cagle C, 2012, AVIAN DIS, V56, P479, DOI 10.1637/10030-120511-Reg.1; Chapman JR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141853; Cheng YQ, 2015, J VET SCI, V16, P37, DOI [10.4142/jvs.2015.16.1.37, 10.4142/jvs.2015.16.1.31]; Cherry P, 2008, DOMESTIC DUCK PRODUCTION: SCIENCE AND PRACTICE, P1, DOI 10.1079/9780851990545.0000; Cornelissen JBWJ, 2013, AVIAN PATHOL, V42, P347, DOI 10.1080/03079457.2013.807325; Cornelissen JBWJ, 2012, AVIAN PATHOL, V41, P519, DOI 10.1080/03079457.2012.732691; Cramp S., 1980, HDB BIRDS EUROPE MID, V1st; Cui Z, 2014, ARCH VIROL, V159, P339, DOI 10.1007/s00705-013-1820-6; Dheda K, 2005, ANAL BIOCHEM, V344, P141, DOI 10.1016/j.ab.2005.05.022; Fleming-Canepa X, 2011, MOL IMMUNOL, V48, P1950, DOI 10.1016/j.molimm.2011.05.025; Fredericksen F, 2015, GENE, V569, P95, DOI 10.1016/j.gene.2015.05.050; Geller R, 2012, BBA-MOL CELL RES, V1823, P698, DOI 10.1016/j.bbamcr.2011.11.007; Giles S, 2003, INFECT IMMUN, V71, P6648, DOI 10.1128/IAI.71.11.6648-6652.2003; Ginzinger DG, 2002, EXP HEMATOL, V30, P503, DOI 10.1016/S0301-472X(02)00806-8; Gu CQ, 2012, POULTRY SCI, V91, P583, DOI 10.3382/ps.2011-01743; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Hellemans J, 2014, METHODS MOL BIOL, V1160, P19, DOI 10.1007/978-1-4939-0733-5_3; Hildyard John C W, 2014, PLoS Curr, V6, DOI 10.1371/currents.md.faafdde4bea8df4aa7d06cd5553119a6; Hong YH, 2006, VET IMMUNOL IMMUNOP, V114, P259, DOI 10.1016/j.vetimm.2006.08.006; Hu J, 2013, J VIROL, V87, P11063, DOI 10.1128/JVI.00760-13; Huang YH, 2013, NAT GENET, V45, P776, DOI 10.1038/ng.2657; Jarhult JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024742; Jiang HJ, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-447; Kambris Z, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001143; Klein D, 2002, TRENDS MOL MED, V8, P257, DOI 10.1016/S1471-4914(02)02355-9; Kuchipudi SV, 2014, VET RES, V45, DOI 10.1186/s13567-014-0118-3; Kuchipudi SV, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-230; Kuiken T, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0990; Kulikova IV, 2005, AUK, V122, P949, DOI 10.1642/0004-8038(2005)122[0949:POTMAP]2.0.CO;2; Latham GJ, 2010, METHODS MOL BIOL, V667, P19, DOI 10.1007/978-1-60761-811-9_2; Li N, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00425; Li R, 2013, MEM I OSWALDO CRUZ, V108, P865, DOI 10.1590/0074-0276130659; Liang QL, 2011, MOL IMMUNOL, V48, P924, DOI 10.1016/j.molimm.2010.12.011; Manger ID, 2000, CURR OPIN IMMUNOL, V12, P215, DOI 10.1016/S0952-7915(99)00077-1; Maughan MN, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-94; Okamoto T, 2006, EMBO J, V25, P5015, DOI 10.1038/sj.emboj.7601367; Overbergh L, 2003, J Biomol Tech, V14, P33; Pantin-Jackwood MJ, 2012, VIRUS RES, V167, P196, DOI 10.1016/j.virusres.2012.04.015; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; Sarmento L, 2010, AVIAN DIS, V54, P532, DOI 10.1637/8917-050409-Reg.1; Selvey S, 2001, MOL CELL PROBE, V15, P307, DOI 10.1006/mcpr.2001.0376; Sheng XD, 2014, POULTRY SCI, V93, P527, DOI 10.3382/ps.2013-03510; Solanas M, 2001, ANAL BIOCHEM, V288, P99, DOI 10.1006/abio.2000.4889; Song CP, 2014, ARCH VIROL, V159, P905, DOI 10.1007/s00705-013-1900-7; Soubies SM, 2010, J VIROL, V84, P6733, DOI 10.1128/JVI.02427-09; Stordeur P, 2003, J IMMUNOL METHODS, V276, P69, DOI 10.1016/S0022-1759(03)00074-7; Tadiso TM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-141; Tang CK, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0060038, 10.1371/journal.pone.0075307, 10.1371/journal.pone.0061093]; Tolf C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061201; Vanderven HA, 2012, MOL IMMUNOL, V51, P316, DOI 10.1016/j.molimm.2012.03.034; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Volmer C, 2011, J GEN VIROL, V92, P534, DOI 10.1099/vir.0.026443-0; Wang SH, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00588; Wolf JM, 2012, CELL MICROBIOL, V14, P762, DOI 10.1111/j.1462-5822.2012.01757.x; Xu Huaisheng, 2015, BMC Res Notes, V8, P58, DOI 10.1186/s13104-015-0973-7; Xu Q, 2015, MOL BIOL REP, V42, P431, DOI 10.1007/s11033-014-3784-3; Xu Q, 2014, MOL BIOL REP, V41, P6233, DOI 10.1007/s11033-014-3503-0; Xu Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088023; Xu Q, 2014, GENE, V533, P280, DOI 10.1016/j.gene.2013.09.047; Yang Falong, 2013, BMC Res Notes, V6, P402, DOI 10.1186/1756-0500-6-402; Yue Hua, 2010, Virologica Sinica, V25, P425, DOI 10.1007/s12250-010-3114-4; Zhang XZ, 2005, BMC MOL BIOL, V6, DOI 10.1186/1471-2199-6-4; Zhong ZF, 2015, GENE, V570, P100, DOI 10.1016/j.gene.2015.06.003; Zhou ZT, 2013, AVIAN PATHOL, V42, P129, DOI 10.1080/03079457.2013.770127	75	19	19	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0149454	10.1371/journal.pone.0149454	http://dx.doi.org/10.1371/journal.pone.0149454			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26886224	Green Published, Green Submitted, gold			2022-12-26	WOS:000371218400085
J	Olivier, CB; Meyer, M; Bauer, H; Schnabel, K; Weik, P; Zhou, Q; Bode, C; Moser, M; Diehl, P				Olivier, Christoph B.; Meyer, Melanie; Bauer, Hans; Schnabel, Katharina; Weik, Patrick; Zhou, Qian; Bode, Christoph; Moser, Martin; Diehl, Philipp			The Ratio of ADP- to TRAP-Induced Platelet Aggregation Quantifies P2Y(12)-Dependent Platelet Inhibition Independently of the Platelet Count	PLOS ONE			English	Article							PERCUTANEOUS CORONARY INTERVENTION; THROMBIN RECEPTOR; CLOPIDOGREL; REACTIVITY; THERAPY; IMPLANTATION; DEFINITION; PRASUGREL; CONSENSUS	Objective This study aimed to assess the association of clinical factors with P2Y(12)-dependent platelet inhibition as monitored by the ratio of ADP-to TRAP-induced platelet aggregation and conventional ADP-induced aggregation, respectively. Background Controversial findings to identify and overcome high platelet reactivity (HPR) after coronary stent-implantation and to improve clinical outcome by tailored anti-platelet therapy exist. Monitoring anti-platelet therapy ex vivo underlies several confounding parameters causing that ex vivo platelet aggregation might not reflect in vivo platelet inhibition. Methods In a single centre observational study, multiple electrode aggregometry was performed in whole blood of patients after recent coronary stent-implantation. Relative ADP-induced aggregation (r-ADP-agg) was defined as the ratio of ADP-to TRAP-induced aggregation reflecting the individual degree of P2Y(12)-mediated platelet reactivity. Results Platelet aggregation was assessed in 359 patients. Means (+/- SD) of TRAP-, ADP-induced aggregation and r-ADP-agg were 794 +/- 239 AU* min, 297 +/- 153 AU* min and 37 +/- 14%, respectively. While ADP-and TRAP-induced platelet aggregation correlated significantly with platelet count (ADP: r = 0.302; p< 0.001; TRAP: r = 0.509 p< 0.001), r-ADP-agg values did not (r = -0.003; p = 0.960). These findings were unaltered in multivariate analyses adjusting for a range of factors potentially influencing platelet aggregation. The presence of an acute coronary syndrome and body weight were found to correlate with both ADP-induced platelet aggregation and r-ADP-agg. Conclusion The ratio of ADP-to TRAP-induced platelet aggregation quantifies P2Y(12)-dependent platelet inhibition independently of the platelet count in contrast to conventional ADP-induced aggregation. Furthermore, r-ADP-agg was associated with the presence of an acute coronary syndrome and body weight as well as ADP-induced aggregation. Thus, the r-ADP-agg is a more valid reflecting platelet aggregation and potentially prognosis after coronary stent-implantation in P2Y(12)-mediated HPR than conventional ADP-induced platelet aggregation.	[Olivier, Christoph B.; Meyer, Melanie; Schnabel, Katharina; Weik, Patrick; Zhou, Qian; Bode, Christoph; Moser, Martin; Diehl, Philipp] Univ Freiburg, Ctr Heart, Cardiol & Angiol 1, Hugstetter Str 55, D-79106 Freiburg, Germany; [Bauer, Hans] Munich Univ Hosp, Inst & Outpatient Clin Occupat Social & Environm, Munich, Germany	University of Freiburg; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Munich	Olivier, CB (corresponding author), Univ Freiburg, Ctr Heart, Cardiol & Angiol 1, Hugstetter Str 55, D-79106 Freiburg, Germany.	Christoph.Olivier@universitaets-herzzentrum.de	Olivier, Christoph/AAK-2882-2021		German Research Foundation [OL371/1-1]; German Research Foundation (DFG); Albert Ludwigs University Freiburg	German Research Foundation(German Research Foundation (DFG)); German Research Foundation (DFG)(German Research Foundation (DFG)); Albert Ludwigs University Freiburg	This work was supported by the German Research Foundation OL371/1-1. The article processing charge was funded by the German Research Foundation (DFG) and the Albert Ludwigs University Freiburg in the funding program Open Access Publishing.	Bonello L, 2010, J AM COLL CARDIOL, V56, P919, DOI 10.1016/j.jacc.2010.04.047; Chung AWY, 2002, BRIT J PHARMACOL, V135, P1123, DOI 10.1038/sj.bjp.0704559; Collet JP, 2012, NEW ENGL J MED, V367, P2100, DOI 10.1056/NEJMoa1209979; Eslam RB, 2013, INT J CARDIOL, V168, P403, DOI 10.1016/j.ijcard.2012.09.103; Furman MI, 1998, P NATL ACAD SCI USA, V95, P3082, DOI 10.1073/pnas.95.6.3082; Gremmel T, 2011, THROMB RES, V128, P352, DOI 10.1016/j.thromres.2011.05.008; Gremmel T, 2010, PLATELETS, V21, P515, DOI 10.3109/09537104.2010.493587; Gurbel PA, 2012, JAMA-J AM MED ASSOC, V308, P1785, DOI 10.1001/jama.2012.17312; Hazarbasanov D, 2012, J THROMB THROMBOLYS, V34, P85, DOI 10.1007/s11239-012-0684-z; Ignjatovic V, 2016, J CARDIOVASC PHARM T, V21, P44, DOI 10.1177/1074248415581175; Iyu D, 2011, THROMB HAEMOSTASIS, V105, P96, DOI 10.1160/TH10-07-0482; Kosoglou T, 2012, EUR J CLIN PHARMACOL, V68, P249, DOI 10.1007/s00228-011-1120-6; Olivier C, 2013, CARDIOL THER, V2, P57, DOI 10.1007/s40119-013-0013-4; Olivier CB, 2016, THROMB RES, V138, P63, DOI 10.1016/j.thromres.2015.10.038; Olivier CB, 2014, CLIN RES CARDIOL, V103, P968, DOI 10.1007/s00392-014-0737-8; Olivier CB, 2014, THROMB HAEMOSTASIS, V111, P266, DOI 10.1160/TH13-06-0508; Price MJ, 2011, JAMA-J AM MED ASSOC, V305, P1097, DOI 10.1001/jama.2011.290; Siller-Matula JM, 2013, JACC-CARDIOVASC INTE, V6, P1111, DOI 10.1016/j.jcin.2013.06.011; Siller-Matula JM, 2013, INT J CARDIOL, V167, P2018, DOI 10.1016/j.ijcard.2012.05.040; Sofi F, 2010, THROMB HAEMOSTASIS, V103, P841, DOI 10.1160/TH09-06-0418; Tantry US, 2013, J AM COLL CARDIOL, V62, P2261, DOI 10.1016/j.jacc.2013.07.101; Trenk D, 2012, J AM COLL CARDIOL, V59, P2159, DOI 10.1016/j.jacc.2012.02.026; Varenhorst C, 2009, AM HEART J, V157, DOI 10.1016/j.ahj.2008.11.021; Voisin S, 2011, THROMB HAEMOSTASIS, V106, P227, DOI 10.1160/TH11-01-0046	24	6	6	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0149053	10.1371/journal.pone.0149053	http://dx.doi.org/10.1371/journal.pone.0149053			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26885820	Green Published, gold, Green Submitted			2022-12-26	WOS:000371218400060
J	Rendon, J; Hoyos, MC; di Filippo, D; Cortes-Mancera, F; Mantilla, C; Velasquez, MM; Sepulveda, ME; Restrepo, JC; Jaramillo, S; Arbelaez, MP; Correa, G; Navas, MC				Rendon, Julio; Cristina Hoyos, Maria; di Filippo, Diana; Cortes-Mancera, Fabian; Mantilla, Carolina; Mercedes Velasquez, Maria; Elsy Sepulveda, Maria; Carlos Restrepo, Juan; Jaramillo, Sergio; Patricia Arbelaez, Maria; Correa, Gonzalo; Navas, Maria-Cristina			Hepatitis E Virus Genotype 3 in Colombia: Survey in Patients with Clinical Diagnosis of Viral Hepatitis	PLOS ONE			English	Article							PIG LIVERS; ANTI-HEV; INFECTION; SWINE; PREVALENCE; STRAINS; IDENTIFICATION; COINFECTION; CIRCULATION; VARIANTS	Background Hepatitis E virus is a major cause of outbreaks as well as sporadic hepatitis cases worldwide. The epidemiology of this enterically transmitted infection differs between developing and developed countries. The aims of this study were to describe HEV infection in Colombian patients and to characterize the genotype. Methods A prospective study was carried out on 40 patients aged over 15 with a clinical diagnosis of viral hepatitis, recruited from five primary health units in the city of Medellin, Colombia. Fecal samples obtained from the 40 consecutives cases were analyzed for HEV RNA using nested reverse transcription PCR for both ORF1 and ORF2-3. The amplicons were sequenced for phylogenetic analyses. Results Nine (22.5%) cases of HEV infection were identified in the study population. Three HEV strains obtained from patients were classified as genotype 3. No significant association was found between cases of Hepatitis E and the variables water drinking source, garbage collection system and contact with pigs. Conclusions This is the first prospective study of hepatitis E in Colombian patients. The circulation of the genotype 3 in this population is predictable considering the reports of the region and the identification of this genotype from pigs in the state of Antioquia, of which Medellin is the capital. Further studies are necessary to establish whether zoonotic transmission of HEV is important in Colombia.	[Rendon, Julio; Cristina Hoyos, Maria; di Filippo, Diana; Cortes-Mancera, Fabian; Mantilla, Carolina; Mercedes Velasquez, Maria; Elsy Sepulveda, Maria; Carlos Restrepo, Juan; Correa, Gonzalo; Navas, Maria-Cristina] Univ Antioquia, Grp Gastrohepatol, Fac Med, Medellin, Colombia; [Cortes-Mancera, Fabian] Inst Tecnol Metropolitano, Fac Ciencias Exactas & Aplicadas, GI2B, Medellin, Colombia; [Elsy Sepulveda, Maria; Carlos Restrepo, Juan; Jaramillo, Sergio] Hosp Pablo Tobon Uribe, Medellin, Colombia; [Patricia Arbelaez, Maria] Univ Antioquia, Fac Nacl Salud Publ, Grp Epidemiol, Medellin, Colombia	Universidad de Antioquia; Universidad de Antioquia	Navas, MC (corresponding author), Univ Antioquia, Grp Gastrohepatol, Fac Med, Medellin, Colombia.	maria.navas@udea.edu.co	Navas, Maria Cristina/AAE-2528-2022; Mancera, Fabian Mauricio Cortes/R-6438-2018	Mancera, Fabian Mauricio Cortes/0000-0002-1475-3746; Arbelaez Montoya, Maria Patricia/0000-0003-2435-4658; Mantilla Rojas, Carolina/0000-0002-3320-2122; Rendon, Julio Cesar/0000-0002-4054-3582; Restrepo-Gutierrez, Juan Carlos/0000-0002-1793-5756	Departmento Nacional de Ciencia, Innovacion y Tecnologia, Colciencias [1115 408 20570]; Universidad de Anitioquia, Proyecto Sostenibilidad	Departmento Nacional de Ciencia, Innovacion y Tecnologia, Colciencias(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); Universidad de Anitioquia, Proyecto Sostenibilidad	Support was provided by the Departmento Nacional de Ciencia, Innovacion y Tecnologia, Colciencias (Grant 1115 408 20570) and the Universidad de Anitioquia, Proyecto Sostenibilidad. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Aggarwal R, 2000, LANCET, V356, P1081, DOI 10.1016/S0140-6736(00)02737-9; Aggarwal R, 2011, HEPATOLOGY, V54, P2218, DOI 10.1002/hep.24674; Alvarado-Esquivel C, 2014, HEPAT MON, V14, DOI 10.5812/hepatmon.16876; Cantu-Martinez MA, 2013, SALUD PUBLICA MEXICO, V55, P193, DOI 10.1590/S0036-36342013000200011; Betancur Carlos Alberto, 2013, Acta Med Colomb, V38, P68; Bouquet J, 2011, EMERG INFECT DIS, V17, P2018, DOI 10.3201/eid1711.110616; Gutierrez-Vergara CC, 2015, IATREIA, V28, P248, DOI 10.17533/udea.iatreia.v28n3a03; Chandra NS, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-213; Cooper K, 2005, J CLIN MICROBIOL, V43, P1684, DOI 10.1128/JCM.43.4.1684-1688.2005; Lana MVD, 2014, TROP ANIM HEALTH PRO, V46, P399, DOI 10.1007/s11250-013-0503-3; Dell'Amico MC, 2011, EMERG INFECT DIS, V17, P1488, DOI 10.3201/eid1708.100769; Direccion Seccional de Salud de Antioquia (Gobernacion de Antioquia), 2006, DIRECCION SECCIONAL; Echevarria JM, 2013, J MED VIROL, V85, P1037, DOI 10.1002/jmv.23526; Fogeda M, 2009, J MED VIROL, V81, P1743, DOI 10.1002/jmv.21564; Forero J. E, 2014, Rev. Med. Vet. Zoot., V61, P221, DOI 10.15446/rfmvz.v61n3.46868; Garcia CG, 2012, J MED VIROL, V84, P1025, DOI 10.1002/jmv.23277; Gutierrez-Vergara C, 2015, GENET MOL RES, V14, P2890, DOI 10.4238/2015.March.31.20; Haagsma EB, 2008, LIVER TRANSPLANT, V14, P547, DOI 10.1002/lt.21480; Hakze-van der Honing RW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022673; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Ibarra H, 2007, REV MED CHILE, V135, P997; Inoue J, 2006, J VIROL METHODS, V137, P325, DOI 10.1016/j.jviromet.2006.07.004; Inoue J, 2009, J GASTROENTEROL, V44, P329, DOI 10.1007/s00535-009-0012-3; Joon A, 2015, INDIAN J MED MICROBI, V33, pS102, DOI 10.4103/0255-0857.150908; Kamar N, 2014, CLIN MICROBIOL REV, V27, P116, DOI 10.1128/CMR.00057-13; Kamar N, 2012, LANCET, V379, P2477, DOI 10.1016/S0140-6736(11)61849-7; Kase JA, 2008, INT J ENVIRON HEAL R, V18, P165, DOI 10.1080/09603120701498311; Kmush B, 2013, SEMIN LIVER DIS, V33, P15, DOI 10.1055/s-0033-1338111; Krain LJ, 2014, CLIN MICROBIOL REV, V27, P139, DOI 10.1128/CMR.00062-13; dos Santos DRL, 2011, VET MICROBIOL, V149, P236, DOI 10.1016/j.vetmic.2010.10.024; dos Santos DRL, 2010, J CLIN VIROL, V47, P276, DOI 10.1016/j.jcv.2009.12.021; dos Santos DRL, 2009, VET J, V182, P474, DOI 10.1016/j.tvjl.2008.08.001; Martinez-Vargas D, 2015, 6 S COL VIR BIOM, P41; Meng X.J., 2012, VIRUS TAXONOMY CLASS; Meng XJ, 2011, VIRUS RES, V161, P23, DOI 10.1016/j.virusres.2011.01.016; Mirazo S, 2014, EMERG INFECT DIS, V20, P171, DOI 10.3201/eid2001.131471; Mirazo S, 2013, VIRUS RES, V173, P364, DOI 10.1016/j.virusres.2013.01.005; Mirazo S, 2011, ARCH VIROL, V156, P1451, DOI 10.1007/s00705-011-0991-2; Munne MS, 2006, J MED VIROL, V78, P1579, DOI 10.1002/jmv.20741; Munne MS, 2014, ANN HEPATOL, V13, P496, DOI 10.1016/S1665-2681(19)31248-7; Munne Maria Silvina, 2006, Acta Gastroenterol Latinoam, V36, P125; National Department of Statistics, FICH TECN CENS ACT P; Pelaez D, 2014, BIOMEDICA, V34, P354, DOI [10.7705/biomedica.v34i3.2236, 10.1590/S0120-41572014000300006]; Pischke S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085330; Purdy MA, 2012, EMERG INFECT DIS, V18, P339, DOI 10.3201/eid1802.111453; Rasheeda CA, 2008, EUR J GASTROEN HEPAT, V20, P362, DOI 10.1097/MEG.0b013e3282f246d6; Rein DB, 2012, HEPATOLOGY, V55, P988, DOI 10.1002/hep.25505; Lay LDLAR, 2008, J MED VIROL, V80, P798, DOI 10.1002/jmv.21147; Schlauder GG, 1998, J GEN VIROL, V79, P447, DOI 10.1099/0022-1317-79-3-447; Munne MS, 2011, J CLIN VIROL, V52, P138, DOI 10.1016/j.jcv.2011.06.015; de Souza AJS, 2012, COMP IMMUNOL MICROB, V35, P477, DOI 10.1016/j.cimid.2012.04.004; TAM AW, 1991, VIROLOGY, V185, P120, DOI 10.1016/0042-6822(91)90760-9; Tesse S, 2012, J CLIN VIROL, V54, P197, DOI 10.1016/j.jcv.2012.02.007; VELAZQUEZ O, 1990, JAMA-J AM MED ASSOC, V263, P3281, DOI 10.1001/jama.263.24.3281; World Health Organization, 2014, HEP E; Zaki ME, 2008, J MICROBIOL IMMUNOL, V41, P254; Zhai LJ, 2006, VIRUS RES, V120, P57, DOI 10.1016/j.virusres.2006.01.013	57	10	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0148417	10.1371/journal.pone.0148417	http://dx.doi.org/10.1371/journal.pone.0148417			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26886728	Green Submitted, Green Published, gold			2022-12-26	WOS:000371218400034
J	Yang, YL; Liu, WR; Ding, RF; Xiong, LL; Dou, RK; Zhang, YM; Guo, ZY				Yang, Yalan; Liu, Wenrong; Ding, Ruofan; Xiong, Lili; Dou, Rongkun; Zhang, Yiming; Guo, Zhiyun			Comprehensive Expression Profiling and Functional Network Analysis of p53-Regulated MicroRNAs in HepG2 Cells Treated with Doxorubicin	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA CELLS; FACTOR-BINDING-SITES; GENOMIC ANALYSIS; DNA-DAMAGE; P53; CANCER; PROLIFERATION; APOPTOSIS; GROWTH; TRANSCRIPTS	Acting as a sequence-specific transcription factor, p53 tumor suppressor involves in a variety of biological processes after being activated by cellular stresses such as DNA damage. In recent years, microRNAs (miRNAs) have been confirmed to be regulated by p53 in several cancer types. However, it is still unclear how miRNAs orchestrate their regulation and function in p53 network after p53 activation in hepatocellular carcinoma (HCC). In this study, we used small RNA sequencing and systematic bioinformatic analysis to characterize the regulatory networks of differentially expressed miRNAs after the p53 activation in HepG2. Here, 33 miRNAs significantly regulated by p53 (12 up-regulated and 21 down-regulated) were detected between the doxorubicin-treated and untreated HepG2 cells in two biological replicates for small RNA sequencing and 8 miRNAs have been reported previously to be associated with HCC. Gene ontology (GO) and KEGG pathway enrichment analysis showed that 87.9% (29 out of 33) and 90.9% (30 out of 33) p53-regulated miRNAs were involved in p53-related biological processes and pathways with significantly low p-value, respectively. Remarkably, 18 out of 33 p53-regulated miRNAs were identified to contain p53 binding sites around their transcription start sites (TSSs). Finally, comprehensive p53-miRNA regulatory networks were constructed and analyzed. These observations provide a new insight into p53-miRNA co-regulatory network in the context of HCC.	[Yang, Yalan; Liu, Wenrong; Ding, Ruofan; Xiong, Lili; Dou, Rongkun; Zhang, Yiming; Guo, Zhiyun] Southwest Jiaotong Univ, Sch Life Sci & Bioengn, Chengdu, Sichuan, Peoples R China	Southwest Jiaotong University	Guo, ZY (corresponding author), Southwest Jiaotong Univ, Sch Life Sci & Bioengn, Chengdu, Sichuan, Peoples R China.	zhiyunguo@gmail.com	Guo, Zhiyun/H-3394-2017	Guo, Zhiyun/0000-0003-2680-785X; Yiming, Zhang/0000-0002-5099-3894				Alexiou P, 2010, NUCLEIC ACIDS RES, V38, pD137, DOI 10.1093/nar/gkp888; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Botcheva K, 2011, CELL CYCLE, V10, P4237, DOI 10.4161/cc.10.24.18383; Collins AS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069090; Connolly E, 2008, AM J PATHOL, V173, P856, DOI 10.2353/ajpath.2008.080096; Corney DC, 2007, CANCER RES, V67, P8433, DOI 10.1158/0008-5472.CAN-07-1585; Dang YW, 2014, ASIAN PAC J CANCER P, V15, P4969, DOI 10.7314/APJCP.2014.15.12.4969; Fabregat I, 2009, WORLD J GASTROENTERO, V15, P513, DOI 10.3748/wjg.15.513; Fang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073004; Gokhale A, 2010, J CANCER RES THER, V6, P521, DOI 10.4103/0973-1482.77072; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Horn HF, 2007, ONCOGENE, V26, P1306, DOI 10.1038/sj.onc.1210263; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jung HM, 2015, J CELL BIOCHEM, V116, P836, DOI 10.1002/jcb.25039; Kim T, 2011, J EXP MED, V208, P875, DOI 10.1084/jem.20110235; Kong GY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019518; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Li S, 2015, CHINESE MED J-PEKING, V128, P941, DOI 10.4103/0366-6999.154302; Liu WH, 2009, GASTROENTEROLOGY, V136, P683, DOI 10.1053/j.gastro.2008.10.029; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Motola-Kuba Daniel, 2006, Ann Hepatol, V5, P16; Piriyapongsa J, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-61; Powrozek T, 2015, TRANSL RES, V166, P315, DOI 10.1016/j.trsl.2015.05.009; Ren ZJ, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.327; Ruffalo M, 2011, BIOINFORMATICS, V27, P2790, DOI 10.1093/bioinformatics/btr477; Saini HK, 2007, P NATL ACAD SCI USA, V104, P17719, DOI 10.1073/pnas.0703890104; Scheibner KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050895; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Tormo E, 2015, J CELL BIOCHEM, V116, P2061, DOI 10.1002/jcb.25162; Ugalde AP, 2011, EMBO J, V30, P2219, DOI 10.1038/emboj.2011.124; Wang J, 2013, NUCLEIC ACIDS RES, V41, pW77, DOI 10.1093/nar/gkt439; Wei CL, 2006, CELL, V124, P207, DOI 10.1016/j.cell.2005.10.043; Wu XJ, 2013, ASIAN PAC J CANCER P, V14, P885, DOI 10.7314/APJCP.2013.14.2.885; Xi YG, 2006, CLIN CANCER RES, V12, P2014, DOI 10.1158/1078-0432.CCR-05-1853; Yan B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073656; Yan HL, 2009, EMBO J, V28, P2719, DOI 10.1038/emboj.2009.214; Yang MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037205; Younger ST, 2015, NUCLEIC ACIDS RES, V43, P4447, DOI 10.1093/nar/gkv284; Zeron-Medina J, 2013, CELL, V155, P410, DOI 10.1016/j.cell.2013.09.017; Zhang BH, 2009, GENE, V443, P100, DOI 10.1016/j.gene.2009.04.027; Zhang Qi, 2011, Zhonghua Zhong Liu Za Zhi, V33, P885	45	14	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0149227	10.1371/journal.pone.0149227	http://dx.doi.org/10.1371/journal.pone.0149227			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26886852	gold, Green Published, Green Submitted			2022-12-26	WOS:000371218400068
J	Smilowitz, NR; Maduro, GA; Lobach, IV; Chen, Y; Reynolds, HR				Smilowitz, Nathaniel R.; Maduro, Gil A., Jr.; Lobach, Iryna V.; Chen, Yu; Reynolds, Harmony R.			Adverse Trends in Ischemic Heart Disease Mortality among Young New Yorkers, Particularly Young Black Women	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; SEX-DIFFERENCES; UNITED-STATES; CERTIFICATE DIAGNOSIS; EMERGENCY-DEPARTMENT; ATHEROSCLEROSIS RISK; SYMPTOM PRESENTATION; RACIAL-DIFFERENCES	Background Ischemic heart disease (IHD) mortality has been on the decline in the United States for decades. However, declines in IHD mortality have been slower in certain groups, including young women and black individuals. Hypothesis Trends in IHD vary by age, sex, and race in New York City (NYC). Young female minorities are a vulnerable group that may warrant renewed efforts to reduce IHD. Methods IHD mortality trends were assessed in NYC 1980-2008. NYC Vital Statistics data were obtained for analysis. Age-specific IHD mortality rates and confidence bounds were estimated. Trends in IHD mortality were compared by age and race/ethnicity using linear regression of log-transformed mortality rates. Rates and trends in IHD mortality rates were compared between subgroups defined by age, sex and race/ethnicity. Results The decline in IHD mortality rates slowed in 1999 among individuals aged 35-54 years but not >= 55. IHD mortality rates were higher among young men than women age 35-54, but annual declines in IHD mortality were slower for women. Black women age 35-54 had higher IHD mortality rates and slower declines in IHD mortality than women of other race/ethnicity groups. IHD mortality trends were similar in black and white men age 35-54. Conclusions The decline in IHD mortality rates has slowed in recent years among younger, but not older, individuals in NYC. There was an association between sex and race/ethnicity on IHD mortality rates and trends. Young black women may benefit from targeted medical and public health interventions to reduce IHD mortality.	[Smilowitz, Nathaniel R.; Reynolds, Harmony R.] NYU, Sch Med, Cardiovasc Clin Res Ctr, New York, NY USA; [Maduro, Gil A., Jr.] New York City Dept Hlth & Mental Hlth, New York, NY USA; [Lobach, Iryna V.] NYU, Sch Med, Dept Biostat, New York, NY USA; [Chen, Yu] NYU, Sch Med, Dept Populat Hlth, New York, NY USA	New York University; New York City Department of Health & Mental Hygiene; New York University; New York University	Reynolds, HR (corresponding author), NYU, Sch Med, Cardiovasc Clin Res Ctr, New York, NY USA.	Harmony.Reynolds@NYUMC.org	Reynolds, Harmony/AAU-3154-2021	Reynolds, Harmony/0000-0003-0284-0655; Chen, Yu/0000-0002-1519-4894	American Heart Association; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000260] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was funded by the American Heart Association Founders Affiliate via a Clinical Research Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson R N, 2001, Natl Vital Stat Rep, V49, P1; [Anonymous], 2013, NEW NEW YORK IMM REP; [Anonymous], 2011, TOT POP MUT EXCL RAC; Brancati FL, 2000, JAMA-J AM MED ASSOC, V283, P2253, DOI 10.1001/jama.283.17.2253; Canto JG, 2012, JAMA-J AM MED ASSOC, V307, P813, DOI 10.1001/jama.2012.199; Carnethon MR, 2006, ARCH INTERN MED, V166, P1196, DOI 10.1001/archinte.166.11.1196; Coady SA, 2001, J CLIN EPIDEMIOL, V54, P40, DOI 10.1016/S0895-4356(00)00272-9; Cowie CC, 2006, DIABETES CARE, V29, P1263, DOI 10.2337/dc06-0062; Eastwood JA, 2013, J WOMENS HEALTH, V22, P724, DOI 10.1089/jwh.2012.4031; Feinstein M, 2012, CIRCULATION, V126, P50, DOI 10.1161/CIRCULATIONAHA.111.057232; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Flink LE, 2013, CLIN CARDIOL, V36, P133, DOI 10.1002/clc.22092; Ford ES, 2007, J AM COLL CARDIOL, V50, P2128, DOI 10.1016/j.jacc.2007.05.056; Ford ES, 2011, ANNU REV PUBL HEALTH, V32, P5, DOI 10.1146/annurev-publhealth-031210-101211; Gerhard GT, 1998, AM J CARDIOL, V82, P1040, DOI 10.1016/S0002-9149(98)00554-2; Gillum RF, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-410; Gomez SL, 2006, CANCER CAUSE CONTROL, V17, P771, DOI 10.1007/s10552-006-0013-y; Gupta A, 2014, J AM COLL CARDIOL, V64, P337, DOI 10.1016/j.jacc.2014.04.054; Hajjar I, 2003, JAMA-J AM MED ASSOC, V290, P199, DOI 10.1001/jama.290.2.199; Iribarren C, 1998, AM J CARDIOL, V82, P50, DOI 10.1016/S0002-9149(98)00240-9; Jolly S, 2010, AM J MED, V123, P811, DOI 10.1016/j.amjmed.2010.04.020; Kaul P, 2007, CAN MED ASSOC J, V177, P1193, DOI 10.1503/cmaj.060711; Kershaw KN, 2015, CIRCULATION, V131, P141, DOI 10.1161/CIRCULATIONAHA.114.011345; Khan NA, 2013, JAMA INTERN MED, V173, P1863, DOI 10.1001/jamainternmed.2013.10149; Kim HJ, 2000, STAT MED, V19, P335, DOI 10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z; Lehto Hanna-Riikka, 2007, BMC Cardiovasc Disord, V7, P35, DOI 10.1186/1471-2261-7-35; Lopez L, 2010, ACAD EMERG MED, V17, P801, DOI 10.1111/j.1553-2712.2010.00823.x; Pope JH, 2000, NEW ENGL J MED, V342, P1163, DOI 10.1056/NEJM200004203421603; Redmond N, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000447; Rosamond WD, 2012, CIRCULATION, V125, P1848, DOI 10.1161/CIRCULATIONAHA.111.047480; Rubia M, 2002, AM J PREV MED, V22, P30, DOI 10.1016/S0749-3797(01)00400-7; Safford MM, 2012, JAMA-J AM MED ASSOC, V308, P1768, DOI 10.1001/jama.2012.14306; Smilowitz NR, 2011, AM HEART J, V161, P681, DOI 10.1016/j.ahj.2010.12.022; Tavora F, 2008, CARDIOVASC PATHOL, V17, P178, DOI 10.1016/j.carpath.2007.07.010; Thomas KL, 2010, AM HEART J, V160, P744, DOI 10.1016/j.ahj.2010.06.014; Tracy S, 2004, CANCER RES, V64, P7241, DOI 10.1158/0008-5472.CAN-04-1905; Vaccarino V, 2005, NEW ENGL J MED, V353, P671, DOI 10.1056/NEJMsa032214; Vaccarino V, 1999, NEW ENGL J MED, V341, P217, DOI 10.1056/NEJM199907223410401; Vaccarino V, 2001, ANN INTERN MED, V134, P173, DOI 10.7326/0003-4819-134-3-200102060-00007; Van Wye Gretchen, 2008, Prev Chronic Dis, V5, pA48; Wei GS, 2011, DIABETES CARE, V34, P873, DOI 10.2337/dc10-1786; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; Wyatt SB, 2003, AM J MED SCI, V325, P315, DOI 10.1097/00000441-200306000-00003; Xu J, 2010, DEATHS FINAL DATA 20	44	13	13	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0149015	10.1371/journal.pone.0149015	http://dx.doi.org/10.1371/journal.pone.0149015			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	26882207	Green Published, Green Submitted, gold			2022-12-26	WOS:000371219000042
J	Lund, LD; Ingmer, H; Frokiaer, H				Lund, Lisbeth Drozd; Ingmer, Hanne; Frokiaer, Hanne			D-Alanylation of Teichoic Acids and Loss of Poly-N-Acetyl Glucosamine in Staphylococcus aureus during Exponential Growth Phase Enhance IL-12 Production in Murine Dendritic Cells	PLOS ONE			English	Article							GRAM-POSITIVE BACTERIA; LIPOTEICHOIC ACID; LACTOBACILLUS-ACIDOPHILUS; CAPSULAR POLYSACCHARIDE; GENE-EXPRESSION; RECEPTOR 2; PEPTIDOGLYCAN; RECOGNITION; INFECTION; MECHANISM	Staphylococcus aureus is a major human pathogen that has evolved very efficient immune evading strategies leading to persistent colonization. During different stages of growth, S. aureus express various surface molecules, which may affect the immune stimulating properties, but very little is known about their role in immune stimulation and evasion. Depending on the growth phase, S. aureus may affect antigen presenting cells differently. Here, the impact of growth phases and the surface molecules lipoteichoic acid, peptidoglycan and poly-N-acetyl glucosamine on the induction of IL-12 imperative for an efficient clearance of S. aureus was studied in dendritic cells (DCs). Exponential phase (EP) S. aureus was superior to stationary phase (SP) bacteria in induction of IL-12, which required actin-mediated endocytosis and endosomal acidification. Moreover, addition of staphylococcal cell wall derived peptidoglycan to EP S. aureus stimulated cells increased bacterial uptake but abrogated IL-12 induction, while addition of lipoteichoic acid increased IL-12 production but had no effect on the bacterial uptake. Depletion of the capability to produce poly-N-acetyl glucosamine increased the IL-12 inducing activity of EP bacteria. Furthermore, the mutant dltA unable to produce D-alanylated teichoic acids failed to induce IL-12 but like peptidoglycan and the toll-like receptor (TLR) ligands LPS and Pam3CSK4 the mutant stimulated increased macropinocytosis. In conclusion, the IL-12 response by DCs against S. aureus is highly growth phase dependent, relies on cell wall D-alanylation, endocytosis and subsequent endosomal degradation, and is abrogated by receptor induced macropinocytosis.	[Lund, Lisbeth Drozd; Ingmer, Hanne; Frokiaer, Hanne] Univ Copenhagen, Dept Vet Dis Biol, Frederiksberg, Denmark	University of Copenhagen	Frokiaer, H (corresponding author), Univ Copenhagen, Dept Vet Dis Biol, Frederiksberg, Denmark.	hafr@sund.ku.dk	FrÃkiÃr, Hanne/P-7409-2018	Ingmer, Hanne/0000-0002-8350-5631; Hojgaard, Lisbeth Drozd/0000-0002-1052-3337; Frokiaer, Hanne/0000-0003-1472-9698	Danish Council for Independent Research \ Natural Sciences [0602-01522B]	Danish Council for Independent Research \ Natural Sciences(Det Frie Forskningsrad (DFF))	The study was sponsored by The Danish Council for Independent Research vertical bar Natural Sciences grant number 0602-01522B: "Phagocytosis and macropinocytosis in antigen presenting cells-importance for immune response development."	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Barton GM, 2009, NAT REV IMMUNOL, V9, P535, DOI 10.1038/nri2587; Bertsche U, 2011, ANTIMICROB AGENTS CH, V55, P3922, DOI 10.1128/AAC.01226-10; Bogdan C, 2004, IMMUNOL REV, V202, P33, DOI 10.1111/j.0105-2896.2004.00207.x; Christensen HR, 2002, J IMMUNOL, V168, P171, DOI 10.4049/jimmunol.168.1.171; Cunnion KM, 2001, INFECT IMMUN, V69, P6796, DOI 10.1128/IAI.69.11.6796-6803.2001; den Dunnen J, 2012, BLOOD, V120, P112, DOI 10.1182/blood-2011-12-399931; Dziarski R, 2005, INFECT IMMUN, V73, P5212, DOI 10.1128/IAI.73.8.5212-5216.2005; Farooqui AA, 2006, PHARMACOL REV, V58, P591, DOI 10.1124/pr.58.3.7; Foster TJ, 2005, NAT REV MICROBIOL, V3, P948, DOI 10.1038/nrmicro1289; George EA, 2007, CHEMBIOCHEM, V8, P847, DOI 10.1002/cbic.200700023; Gotz F, 2002, MOL MICROBIOL, V43, P1367, DOI 10.1046/j.1365-2958.2002.02827.x; Gratz N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001345; Haaber J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041075; Hashimoto M, 2006, INT IMMUNOL, V18, P355, DOI 10.1093/intimm/dxh374; Hashimoto M, 2006, J IMMUNOL, V177, P3162, DOI 10.4049/jimmunol.177.5.3162; Hultgren OH, 2001, ARTHRITIS RES, V3, P41, DOI 10.1186/ar138; IORDANESCU S, 1976, J GEN MICROBIOL, V96, P277, DOI 10.1099/00221287-96-2-277; Ip WKE, 2010, J IMMUNOL, V184, P7071, DOI 10.4049/jimmunol.1000110; Kagan JC, 2006, CELL, V125, P943, DOI 10.1016/j.cell.2006.03.047; Kapsenberg ML, 2003, NAT REV IMMUNOL, V3, P984, DOI 10.1038/nri1246; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kropec A, 2005, INFECT IMMUN, V73, P6868, DOI 10.1128/IAI.73.10.6868-6876.2005; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Matsuo M, 2011, MICROBIOL-SGM, V157, P1786, DOI 10.1099/mic.0.044727-0; Morath S, 2001, J EXP MED, V193, P393, DOI 10.1084/jem.193.3.393; Navarre WW, 1999, MICROBIOL MOL BIOL R, V63, P174, DOI 10.1128/MMBR.63.1.174-229.1999; Nilsen NJ, 2008, J LEUKOCYTE BIOL, V84, P280, DOI 10.1189/jlb.0907656; NOVICK R, 1967, VIROLOGY, V33, P155, DOI 10.1016/0042-6822(67)90105-5; NOVICK RP, 1993, EMBO J, V12, P3967, DOI 10.1002/j.1460-2075.1993.tb06074.x; Peschel A, 1999, J BIOL CHEM, V274, P8405, DOI 10.1074/jbc.274.13.8405; Pohlmann-Dietze P, 2000, INFECT IMMUN, V68, P4865, DOI 10.1128/IAI.68.9.4865-4871.2000; Reichmann NT, 2013, MICROBIOL-SGM, V159, P1868, DOI 10.1099/mic.0.069898-0; Roses RE, 2008, J IMMUNOL, V181, P5120, DOI 10.4049/jimmunol.181.7.5120; Schaffler H, 2014, INFECT IMMUN, V82, P4681, DOI 10.1128/IAI.02043-14; Schindler D, 2012, AM J PATHOL, V181, P1327, DOI 10.1016/j.ajpath.2012.06.039; Schwandner R, 1999, J BIOL CHEM, V274, P17406, DOI 10.1074/jbc.274.25.17406; Smits HH, 2004, EUR J IMMUNOL, V34, P1371, DOI 10.1002/eji.200324815; Stuart LM, 2005, J CELL BIOL, V170, P477, DOI 10.1083/jcb.200501113; Takeuchi O, 2000, J IMMUNOL, V165, P5392, DOI 10.4049/jimmunol.165.10.5392; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Thakker M, 1998, INFECT IMMUN, V66, P5183, DOI 10.1128/IAI.66.11.5183-5189.1998; Toledo-Arana A, 2005, J BACTERIOL, V187, P5318, DOI 10.1128/JB.187.15.5318-5329.2005; Travassos LH, 2004, EMBO REP, V5, P1000, DOI 10.1038/sj.embor.7400248; Valle J, 2003, MOL MICROBIOL, V48, P1075, DOI 10.1046/j.1365-2958.2003.03493.x; Wang JH, 2012, SCI REP-UK, V2, DOI 10.1038/srep00606; Weber SM, 2000, J IMMUNOL, V165, P1534, DOI 10.4049/jimmunol.165.3.1534; Weiss G, 2012, J IMMUNOL, V189, P2860, DOI 10.4049/jimmunol.1103491; Weiss G, 2010, IMMUNOLOGY, V131, P268, DOI 10.1111/j.1365-2567.2010.03301.x; Weiss G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011065; West MA, 2004, SCIENCE, V305, P1153, DOI 10.1126/science.1099153; Zeuthen LH, 2008, IMMUNOLOGY, V124, P489, DOI 10.1111/j.1365-2567.2007.02800.x; Zhao YX, 1998, IMMUNOLOGY, V93, P80	56	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149092	10.1371/journal.pone.0149092	http://dx.doi.org/10.1371/journal.pone.0149092			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26872029	Green Published, Green Submitted, gold			2022-12-26	WOS:000370054100100
J	Midde, NM; Rahman, MA; Rathi, C; Li, JH; Meibohm, B; Li, WH; Kumar, S				Midde, Narasimha M.; Rahman, Mohammad A.; Rathi, Chetan; Li, Junhao; Meibohm, Bernd; Li, Weihua; Kumar, Santosh			Effect of Ethanol on the Metabolic Characteristics of HIV-1 Integrase Inhibitor Elvitegravir and Elvitegravir/Cobicistat with CYP3A: An Analysis Using a Newly Developed LC-MS/MS Method	PLOS ONE			English	Article							TANDEM MASS-SPECTROMETRY; LIQUID-CHROMATOGRAPHY; PROTEASE INHIBITORS; SIMULTANEOUS QUANTIFICATION; CYTOCHROME-P450 ISOFORMS; DIFFERENTIAL INHIBITION; ANTIRETROVIRAL THERAPY; HUMAN-IMMUNODEFICIENCY; DRUG-INTERACTIONS; ALCOHOL-USE	Elvitegravir (EVG), an integrase inhibitor for the treatment HIV infection, is increasingly becoming the part of first-line antiretroviral therapy (ART) regimen. EVG is mainly metabolized through cytochrome P450 (CYP) 3A4. Previously, we have shown that ethanol alters ART-CYP3A4 interactions with protease inhibitors thereby altering their metabolisms. However, as EVG is a fairly new class of drug, its kinetic characteristics and the effect of ethanol on EVG-CYPP3A4 interaction is poorly understood. In this study, we characterized EVG and cobicistat (COBI)-boosted EVG metabolism in human microsomes followed by ethanol-EVG, ethanol-COBI-EVG interaction with CYP3A. First, we developed and validated a simple, sensitive, and robust liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for the quantification of EVG in the human liver microsomes. The lower limit of quantification for the drug was at 0.003 mu M (1.34ng/ml). Extraction yield, matrix effects, drug stability, and calibration curves for the proposed method were validated according to the FDA guidelines. Time dependent kinetics data showed that 20mM ethanol decreases the apparent half-life of EVG degradation by similar to 50% compared to EVG alone. Our substrate kinetic results revealed that ethanol mildly decreases the catalytic efficiency for EVG metabolism. Inhibition studies demonstrated that EVG inhibits CYP3A4, and 20 mM ethanol causes a decrease in the IC50 of EVG. However, in the presence of COBI we were unable to determine these parameters effectively because COBI, being a strong inhibitor of CYP3A4, blocked the EVG/ethanol-CYP3A4 interactions. Docking studies predicted a shift of EVG or COBI binding to the active site of CYP3A4 in the presence of ethanol. Taken together, these results suggest that ethanol interacts with microsomal CYP3A and alters EVG-CYP3A4 interaction thereby altering EVG metabolism and inhibition of CYP3A4 by EVG. This finding has clinical significance because alcohol use is highly prevalent in HIV population, and there are no separate guidelines for these patients while they are on ART medication.	[Midde, Narasimha M.; Rahman, Mohammad A.; Rathi, Chetan; Meibohm, Bernd; Kumar, Santosh] Univ Tennessee, Ctr Hlth Sci, Coll Pharm, Pharmaceut Sci, Memphis, TN 38163 USA; [Li, Junhao; Li, Weihua] E China Univ Sci & Technol, Sch Pharm, Shanghai Key Lab New Drug Design, Shanghai 200237, Peoples R China	University of Tennessee System; University of Tennessee Health Science Center; East China University of Science & Technology	Kumar, S (corresponding author), Univ Tennessee, Ctr Hlth Sci, Coll Pharm, Pharmaceut Sci, Memphis, TN 38163 USA.; Li, WH (corresponding author), E China Univ Sci & Technol, Sch Pharm, Shanghai Key Lab New Drug Design, Shanghai 200237, Peoples R China.	whli@ecust.edu.cn; ksantosh@uthsc.edu	LI, Weihua/G-7190-2011	Meibohm, Bernd/0000-0003-3923-3648	Bernd Meibohm [S10OD016226]; National Natural Science Foundation of China [81373328]; National Institute of Health (NIAAA/NIH) [AA-022063]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA022063] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD016226] Funding Source: NIH RePORTER	Bernd Meibohm; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institute of Health (NIAAA/NIH); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported by grants from the National Institute of Health to Santosh Kumar (NIAAA/NIH AA-022063) and Bernd Meibohm (S10OD016226), and the National Natural Science Foundation of China to Weihua Li (Grant 81373328). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by grant from the National Institute of Health to Santosh Kumar (NIAAA/NIH AA-022063) and the National Natural Science Foundation of China to Weihua Li (Grant 81373328).	Abbas W, 2015, VIRUSES-BASEL, V7, P1578, DOI 10.3390/v7041578; Annesley TM, 2003, CLIN CHEM, V49, P1041, DOI 10.1373/49.7.1041; Aouri M, 2013, J MASS SPECTROM, V48, P616, DOI 10.1002/jms.3200; Aquaro S, 1997, J LEUKOCYTE BIOL, V62, P138, DOI 10.1002/jlb.62.1.138; Aquaro Stefano, 2005, Methods Mol Biol, V304, P445; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; D'Avolio A, 2007, J CHROMATOGR B, V859, P234, DOI 10.1016/j.jchromb.2007.10.003; Davydov DR, 2008, EXPERT OPIN DRUG MET, V4, P1523, DOI 10.1517/17425250802500028 ; Eagling VA, 1997, BRIT J CLIN PHARMACO, V44, P190, DOI 10.1046/j.1365-2125.1997.00644.x; Earla R, 2014, DRUG METAB DISPOS, V42, P2097, DOI 10.1124/dmd.114.059378; Earla R, 2014, DRUG METAB DISPOS, V42, P282, DOI 10.1124/dmd.113.055186; Granfors MT, 2006, BASIC CLIN PHARMACOL, V98, P79, DOI 10.1111/j.1742-7843.2006.pto_249.x; Gu HD, 2014, ANAL CHEM, V86, P8959, DOI 10.1021/ac5018265; Hendershot CS, 2009, JAIDS-J ACQ IMM DEF, V52, P180, DOI 10.1097/QAI.0b013e3181b18b6e; Hidalgo M, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00217; Hughes NC, 2007, AAPS J, V9, pE353, DOI 10.1208/aapsj0903042; Jin M, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.78; Jin MY, 2011, ALCOHOL CLIN EXP RES, V35, P132, DOI 10.1111/j.1530-0277.2010.01330.x; Kumar A, 2014, CURR HIV RES, V12, P233, DOI 10.2174/1570162X1204140813095942; Kumar S. R. S., 2012, International Journal of Advanced Life Sciences (IJALS), V1, P1; Kumar S, 2015, EXPERT OPIN DRUG MET, V11, P343, DOI 10.1517/17425255.2015.996546; Kumar S, 2012, EXPERT OPIN DRUG MET, V8, P1363, DOI 10.1517/17425255.2012.714366; Kumar S, 2011, ALCOHOL CLIN EXP RES, V35, P2121, DOI 10.1111/j.1530-0277.2011.01575.x; Kumar S, 2010, BIOCHEM BIOPH RES CO, V402, P163, DOI 10.1016/j.bbrc.2010.10.014; Blanco JL, 2015, EXPERT OPIN PHARMACO, V16, P1313, DOI 10.1517/14656566.2015.1044436; Matuszewski BK, 2003, ANAL CHEM, V75, P3019, DOI 10.1021/ac020361s; Molina PE, 2014, CURR HIV RES, V12, P265, DOI 10.2174/1570162X12666140721121849; Mudra DR, 2011, CURR DRUG METAB, V12, P750; Neuman MG, 2006, SUBST USE MISUSE, V41, P1395, DOI 10.1080/10826080600846235; Pommier Y, 2005, NAT REV DRUG DISCOV, V4, P236, DOI 10.1038/nrd1660; Ramanathan S, 2011, CLIN PHARMACOKINET, V50, P229, DOI 10.2165/11584570-000000000-00000; Ramanathan S, 2010, JAIDS-J ACQ IMM DEF, V53, P209, DOI 10.1097/QAI.0b013e3181ba4536; Rokitta D, 2013, TOXICOL MECH METHOD, V23, P576, DOI 10.3109/15376516.2013.806622; Scott EE, 2005, TRENDS BIOCHEM SCI, V30, P5, DOI 10.1016/j.tibs.2004.11.004; Shah V P, 2000, Pharm Res, V17, P1551, DOI 10.1023/A:1007669411738; Shelley JC, 2007, J COMPUT AID MOL DES, V21, P681, DOI 10.1007/s10822-007-9133-z; Silverstein PS, 2014, ALCOHOL CLIN EXP RES, V38, P604, DOI 10.1111/acer.12282; Souverain S, 2004, J CHROMATOGR A, V1058, P61, DOI 10.1016/j.chroma.2004.08.118; Stribild, ELV COB EMTR TEN CLI; Vallano PT, 2005, J PHARMACEUT BIOMED, V36, P1073, DOI 10.1016/j.jpba.2004.09.010; von Moltke LL, 2001, J CLIN PHARMACOL, V41, P85, DOI 10.1177/00912700122009728; Walubo A, 2007, EXPERT OPIN DRUG MET, V3, P583, DOI 10.1517/17425225.3.4.583; Xu LH, 2010, ACS MED CHEM LETT, V1, P209, DOI 10.1021/ml1000257	43	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149225	10.1371/journal.pone.0149225	http://dx.doi.org/10.1371/journal.pone.0149225			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26872388	Green Published, gold			2022-12-26	WOS:000370054100130
J	Taylor, CM; Jost, R; Erskine, W; Nelson, MN				Taylor, Candy M.; Jost, Ricarda; Erskine, William; Nelson, Matthew N.			Identifying Stable Reference Genes for qRT-PCR Normalisation in Gene Expression Studies of Narrow-Leafed Lupin (Lupinus angustifolius L.)	PLOS ONE			English	Article							GENOME-WIDE IDENTIFICATION; POLYMERASE-CHAIN-REACTION; HOUSEKEEPING GENES; BETA-ACTIN; RT-PCR; QUANTITATIVE PCR; INTERNAL CONTROL; QUANTIFICATION; TRANSCRIPT; SELECTION	Quantitative Reverse Transcription PCR (qRT-PCR) is currently one of the most popular, high-throughput and sensitive technologies available for quantifying gene expression. Its accurate application depends heavily upon normalisation of gene-of-interest data with reference genes that are uniformly expressed under experimental conditions. The aim of this study was to provide the first validation of reference genes for Lupinus angustifolius (narrow-leafed lupin, a significant grain legume crop) using a selection of seven genes previously trialed as reference genes for the model legume, Medicago truncatula. In a preliminary evaluation, the seven candidate reference genes were assessed on the basis of primer specificity for their respective targeted region, PCR amplification efficiency, and ability to discriminate between cDNA and gDNA. Following this assessment, expression of the three most promising candidates [Ubiquitin C (UBC), Helicase (HEL), and Polypyrimidine tract-binding protein (PTB)] was evaluated using the NormFinder and RefFinder statistical algorithms in two narrow-leafed lupin lines, both with and without vernalisation treatment, and across seven organ types (cotyledons, stem, leaves, shoot apical meristem, flowers, pods and roots) encompassing three developmental stages. UBC was consistently identified as the most stable candidate and has sufficiently uniform expression that it may be used as a sole reference gene under the experimental conditions tested here. However, as organ type and developmental stage were associated with greater variability in relative expression, it is recommended using UBC and HEL as a pair to achieve optimal normalisation. These results highlight the importance of rigorously assessing candidate reference genes for each species across a diverse range of organs and developmental stages. With emerging technologies, such as RNAseq, and the completion of valuable transcriptome data sets, it is possible that other potentially more suitable reference genes will be identified for this species in future.	[Taylor, Candy M.; Jost, Ricarda; Nelson, Matthew N.] Univ Western Australia, Sch Plant Biol, Crawley, WA, Australia; [Jost, Ricarda] La Trobe Univ, ARC Ctr Excellence Plant Energy Biol, Dept Anim Plant & Soil Sci, Sch Life Sci, Bundoora, Vic, Australia; [Erskine, William] Univ Western Australia, Sch Plant Biol, Ctr Plant Genet Breeding, Crawley, WA, Australia; [Erskine, William; Nelson, Matthew N.] Univ Western Australia, UWA Inst Agr, Crawley, WA, Australia; [Nelson, Matthew N.] Royal Bot Gardens Kew, Nat Capital & Plant Hlth, Wakehurst Pl, Ardingly, W Sussex, England	University of Western Australia; La Trobe University; University of Western Australia; University of Western Australia; Royal Botanic Gardens, Kew	Taylor, CM (corresponding author), Univ Western Australia, Sch Plant Biol, Crawley, WA, Australia.	candy.taylor@research.uwa.edu.au	Jost, Ricarda/B-1254-2011; Nelson, Matthew/A-1421-2008	Jost, Ricarda/0000-0002-3819-6358; Nelson, Matthew/0000-0001-6766-4117; Taylor, Candy/0000-0003-2314-5520; Erskine, William/0000-0002-2074-4299	Grains Research and Development Corporation [UHS10659]	Grains Research and Development Corporation(Grains R&D Corp)	The Grains Research and Development Corporation contributed to the funding of this research via award of an Undergraduate Honours Scholarship (award number: UHS10659) to CMT. The URL for the Grains Research and Development Corporation is http://www.grdc.com.au/. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Artico S, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-49; Bemeur C, 2004, NEUROSCI LETT, V357, P211, DOI 10.1016/j.neulet.2003.12.081; Berger JD, 2012, THEOR APPL GENET, V124, P637, DOI 10.1007/s00122-011-1736-z; Berger JD, 2013, CROP PASTURE SCI, V64, P361, DOI 10.1071/CP13092; Brady SM, 2006, PLANT CELL, V18, P2101, DOI 10.1105/tpc.105.037572; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; Chao WS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042839; Condori Jose, 2011, BMC Res Notes, V4, P392, DOI 10.1186/1756-0500-4-392; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; De Spiegelaere W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122515; Dracup M., 1996, LUPIN DEV GUIDE; FAOSTAT, 2014, FAOSTAT PROD DAT; Foley RC, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0485-6; Garg R, 2010, BIOCHEM BIOPH RES CO, V396, P283, DOI 10.1016/j.bbrc.2010.04.079; Gerard GF, 1997, MOL BIOTECHNOL, V8, P61, DOI 10.1007/BF02762340; Ginzinger DG, 2002, EXP HEMATOL, V30, P503, DOI 10.1016/S0301-472X(02)00806-8; Glare EM, 2002, THORAX, V57, P765, DOI 10.1136/thorax.57.9.765; Haller F, 2004, ANAL BIOCHEM, V335, P1, DOI 10.1016/j.ab.2004.08.024; Kakar K, 2008, PLANT METHODS, V4, DOI 10.1186/1746-4811-4-18; Kamphuis LG, 2015, PLANT BIOTECHNOL J, V13, P14, DOI 10.1111/pbi.12229; Kim DH, 2009, ANNU REV CELL DEV BI, V25, P277, DOI 10.1146/annurev.cellbio.042308.113411; Kroc M, 2014, THEOR APPL GENET, V127, P1237, DOI 10.1007/s00122-014-2294-y; Lambers H, 2013, AM J BOT, V100, P263, DOI 10.3732/ajb.1200474; Lin F, 2014, PLANT MOL BIOL, V86, P543, DOI 10.1007/s11103-014-0246-1; LUDWIG SR, 1987, P NATL ACAD SCI USA, V84, P5833, DOI 10.1073/pnas.84.16.5833; Lurin C, 2004, PLANT CELL, V16, P2089, DOI 10.1105/tpc.104.022236; McCulloch RS, 2012, J ANIM SCI BIOTECHNO, V3, DOI 10.1186/2049-1891-3-36; Nelson M. N., 2010, CAB Reviews: Perspectives in Agriculture, Veterinary Science, Nutrition and Natural Resources, V5, P1, DOI 10.1079/PAVSNNR20105017; Nelson MN, 2006, THEOR APPL GENET, V113, P225, DOI 10.1007/s00122-006-0288-0; Nuruzzaman M, 2005, PLANT SOIL, V271, P175, DOI 10.1007/s11104-004-2386-6; O'Rourke JA, 2013, PLANT PHYSIOL, V161, P705, DOI 10.1104/pp.112.209254; OPPENHEIMER DG, 1988, GENE, V63, P87, DOI 10.1016/0378-1119(88)90548-3; Paim Rafaela M., 2012, BMC Research Notes, V5, DOI 10.1186/1756-0500-5-128; Paolacci AR, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-11; Parra-Gonzalez LB, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-425; Perez R, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-79; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Ponchel F, 2003, BMC BIOTECHNOL, V3, DOI 10.1186/1472-6750-3-18; Przysiecka L, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00268; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Selvey S, 2001, MOL CELL PROBE, V15, P307, DOI 10.1006/mcpr.2001.0376; Silver N, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-33; Tenea Gabriela N, 2011, BMC Res Notes, V4, P373, DOI 10.1186/1756-0500-4-373; Thellin O, 1999, J BIOTECHNOL, V75, P291, DOI 10.1016/S0168-1656(99)00163-7; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wan HJ, 2010, ANAL BIOCHEM, V399, P257, DOI 10.1016/j.ab.2009.12.008; Warzybok A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072887; Wiame I, 2000, BIOTECHNIQUES, V29, P252, DOI 10.2144/00292bm11; Xie FL, 2012, PLANT MOL BIOL, V80, P75, DOI 10.1007/s11103-012-9885-2; Yang HL, 2014, GENE, V538, P113, DOI 10.1016/j.gene.2013.12.057; Yuan XY, 2014, APPL BIOCHEM BIOTECH, V173, P1431, DOI 10.1007/s12010-014-0951-x	53	24	27	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0148300	10.1371/journal.pone.0148300	http://dx.doi.org/10.1371/journal.pone.0148300			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26872362	Green Published, Green Submitted, gold			2022-12-26	WOS:000370054100022
J	Van Holle, V; Van Cauwenberg, J; Gheysen, F; Van Dyck, D; Deforche, B; Van de Weghe, N; De Bourdeaudhuij, I				Van Holle, Veerle; Van Cauwenberg, Jelle; Gheysen, Freja; Van Dyck, Delfien; Deforche, Benedicte; Van de Weghe, Nico; De Bourdeaudhuij, Ilse			The Association between Belgian Older Adults' Physical Functioning and Physical Activity: What Is the Moderating Role of the Physical Environment?	PLOS ONE			English	Article							NEIGHBORHOOD WALKABILITY; BUILT ENVIRONMENT; COMPUTER-SCIENCE; WALKING; PEOPLE; PERFORMANCE; ATTRIBUTES; DECLINES; VALIDITY; MOBILITY	Background Better physical functioning in the elderly may be associated with higher physical activity levels. Since older adults spend a substantial part of the day in their residential neighborhood, the neighborhood physical environment may moderate associations between functioning and older adults' physical activity. The present study investigated the moderating role of the objective and perceived physical environment on associations between Belgian older adults' physical functioning and transport walking, recreational walking, and moderate-to-vigorous physical activity. Methods Data from 438 older adults were included. Objective physical functioning was assessed using the Short Physical Performance Battery. Potential moderators included objective neighborhood walkability and perceptions of land use mix diversity, access to recreational facilities, access to services, street connectivity, physical barriers for walking, aesthetics, crime-related safety, traffic speeding-related safety, and walking infrastructure. Transport and recreational walking were self-reported, moderate-to-vigorous physical activity was assessed through accelerometers. Multi-level regression analyses were conducted using MLwiN to examine two-way interactions between functioning and the environment on both walking outcomes. Based on a previous study where environment x neighborhood income associations were found for Belgian older adults' moderate-to-vigorous physical activity, three-way functioning x environment x income interactions were examined for moderate-to-vigorous physical activity. Results Objectively-measured walkability moderated the association between functioning and transport walking; this positive association was only present in high-walkable neighborhoods. Moreover, a three-way interaction was observed for moderate-to-vigorous physical activity. Only in high-income, high-walkable neighborhoods, there was a positive association between functioning and moderate-to-vigorous physical activity. No functioning x walkability interactions were observed for recreational walking, and none of the perceived environmental variables moderated the positive association between physical functioning and the physical activity outcomes. Conclusions For older adults with better physical functioning, living in a high-walkable neighborhood could be beneficial to engage in more transport walking. Living in high-income, high-walkable neighborhoods and having better functioning might also be beneficial for more engagement in moderate-to-vigorous physical activity. This might suggest a protective role of neighborhood walkability for preventing declining physical functioning and consequently decreasing physical activity levels in older adults. However, given the cross-sectional design of the present study, this suggestion needs to be confirmed through longitudinal assessment investigating over-time changes in the observed associations.	[Van Holle, Veerle; Gheysen, Freja; Van Dyck, Delfien; De Bourdeaudhuij, Ilse] Univ Ghent, Dept Movement & Sport Sci, B-9000 Ghent, Belgium; [Van Cauwenberg, Jelle; Deforche, Benedicte] Univ Ghent, Dept Publ Hlth, B-9000 Ghent, Belgium; [Van Cauwenberg, Jelle; Deforche, Benedicte] Vrije Univ Brussel, Dept Human Biometry & Biomech, Brussels, Belgium; [Van de Weghe, Nico] Univ Ghent, Dept Geog, B-9000 Ghent, Belgium; [Van Holle, Veerle; Van Cauwenberg, Jelle; Van Dyck, Delfien] Res Fdn Flanders FWO, Brussels, Belgium	Ghent University; Ghent University; Vrije Universiteit Brussel; Ghent University	Van Dyck, D (corresponding author), Univ Ghent, Dept Movement & Sport Sci, B-9000 Ghent, Belgium.; Van Dyck, D (corresponding author), Res Fdn Flanders FWO, Brussels, Belgium.	delfien.vandyck@ugent.be	Van de Weghe, Nico/N-4214-2019; Van de Weghe, Nico/B-7680-2011; Van Dyck, Delfien/AAO-8981-2020; De+Bourdeaudhuij, Ilse/AAC-5528-2019	Van de Weghe, Nico/0000-0002-5327-4000; Van de Weghe, Nico/0000-0002-5327-4000; De+Bourdeaudhuij, Ilse/0000-0001-9969-7597; Van Cauwenberg, Jelle/0000-0003-1292-6241; Van Dyck, Delfien/0000-0003-1783-9075	Fund for Scientific Research Flanders (FWO) [11O3115N, 11N0313N, WO12/PDO/158]	Fund for Scientific Research Flanders (FWO)(FWO)	VVH, JVC and DVD were supported by a grant from the Fund for Scientific Research Flanders (FWO; www.fwo.be). Grant numbers: VVH: 11O3115N, JVC: 11N0313N, DVD: WO12/PDO/158.	Adams MA, 2014, INT J HEALTH GEOGR, V13, DOI 10.1186/1476-072X-13-43; Berke EM, 2007, AM J PUBLIC HEALTH, V97, P486, DOI 10.2105/AJPH.2006.085837; Bruce DG, 2002, J AM GERIATR SOC, V50, P84, DOI 10.1046/j.1532-5415.2002.50012.x; Cain K.L., 2011, ACCELEROMETER DATA C; Van Cauwenberg J, 2011, HEALTH PLACE, V17, P458, DOI 10.1016/j.healthplace.2010.11.010; Cerin E, 2013, PREV MED, V56, P86, DOI 10.1016/j.ypmed.2012.10.024; Cerin E, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-84; Choi L, 2012, MED SCI SPORT EXER, V44, P2009, DOI 10.1249/MSS.0b013e318258cb36; Copeland JL, 2009, J AGING PHYS ACTIV, V17, P17, DOI 10.1123/japa.17.1.17; Giehl MWC, 2012, REV SAUDE PUBL, V46, P516, DOI 10.1590/S0034-89102012000300014; da Costa EM, 2012, ARCH PUBLIC HEALTH, V70, DOI 10.1186/0778-7367-70-1; Daly M, 2015, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.01044; Denkinger MD, 2015, AM J GERIAT PSYCHIAT, V23, P72, DOI 10.1016/j.jagp.2014.03.002; Devereux K, 2005, AUST J PHYSIOTHER, V51, P102, DOI 10.1016/S0004-9514(05)70038-6; Ferreira FR, 2010, J URBAN HEALTH, V87, P54, DOI 10.1007/s11524-009-9406-z; Forsyth A, 2009, TRANSPORT RES D-TR E, V14, P42, DOI 10.1016/j.trd.2008.10.003; Frank LD, 2010, BRIT J SPORT MED, V44, P924, DOI 10.1136/bjsm.2009.058701; Frank L, 2010, J PHYS ACT HEALTH, V7, pS82, DOI 10.1123/jpah.7.s1.s82; Freedson PS, 1998, MED SCI SPORT EXER, V30, P777, DOI 10.1097/00005768-199805000-00021; Frontera WR, 2000, AM J PHYSIOL-CELL PH, V279, pC611, DOI 10.1152/ajpcell.2000.279.3.C611; GURALNIK JM, 1994, J GERONTOL, V49, pM85, DOI 10.1093/geronj/49.2.M85; Hall KS, 2010, HEALTH EDUC RES, V25, P478, DOI 10.1093/her/cyq019; King AC, 2011, SOC SCI MED, V73, P1525, DOI 10.1016/j.socscimed.2011.08.032; Kirkendall DT, 1998, AM J SPORT MED, V26, P598, DOI 10.1177/03635465980260042401; Kremers SPJ, 2006, INT J BEHAV NUTR PHY, V3, DOI 10.1186/1479-5868-3-9; Lim K, 2005, PREV MED, V40, P33, DOI 10.1016/j.ypmed.2004.04.046; Manini TM, 2009, BRIT J SPORT MED, V43, P28, DOI 10.1136/bjsm.2008.053736; Matthews C.E., 2002, PHYS ACTIVITY ASSESS, P107; MCLEROY KR, 1988, HEALTH EDUC QUART, V15, P351, DOI 10.1177/109019818801500401; MELANSON EL, 1995, MED SCI SPORT EXER, V27, P934; Milanovic Z, 2013, CLIN INTERV AGING, V8, DOI 10.2147/CIA.S44112; Morie M, 2010, J AM GERIATR SOC, V58, P1727, DOI 10.1111/j.1532-5415.2010.03012.x; Murtagh EM, 2010, CURR OPIN CARDIOL, V25, P490, DOI 10.1097/HCO.0b013e32833ce972; National Institute of Statistics-Belgium, 2014, FOD EC KMO MIDD EN; NEWMAN PWG, 1991, TRANSPORT REV, V11, P249, DOI 10.1080/01441649108716787; Peace S., 2007, AGEING SOC, P209; Prince F, 1997, GAIT POSTURE, V5, P128, DOI 10.1016/S0966-6362(97)01118-1; Pruitt LA, 2008, J AGING PHYS ACTIV, V16, P416, DOI 10.1123/japa.16.4.416; Rasinaho M, 2007, J AGING PHYS ACTIV, V15, P90, DOI 10.1123/japa.15.1.90; Rimmer James H, 2005, Phys Med Rehabil Clin N Am, V16, P41, DOI 10.1016/j.pmr.2004.06.013; Rockwood K, 2004, J GERONTOL A-BIOL, V59, P1310, DOI 10.1093/gerona/59.12.1310; Sahlqvist S, 2012, PREV MED, V55, P206, DOI 10.1016/j.ypmed.2012.06.028; Sallis JE, 2006, ANNU REV PUBL HEALTH, V27, P297, DOI 10.1146/annurev.publhealth.27.021405.102100; Satariano WA, 2010, AM J PREV MED, V38, P419, DOI 10.1016/j.amepre.2009.12.031; Shigematsu R, 2009, MED SCI SPORT EXER, V41, P314, DOI 10.1249/MSS.0b013e318185496c; Shimura H, 2014, J PHYS ACT HEALTH, V11, P1078, DOI 10.1123/jpah.2012-0244; Shimura H, 2012, J PHYS ACT HEALTH, V9, P1004, DOI 10.1123/jpah.9.7.1004; SIEGEL PZ, 1995, AM J PUBLIC HEALTH, V85, P706, DOI 10.2105/AJPH.85.5.706; Stathi A, 2012, J AGING PHYS ACTIV, V20, P148, DOI 10.1123/japa.20.2.148; Thompson CW, 2014, BRIT J SPORT MED, V48, DOI 10.1136/bjsports-2012-091718; Twisk JWR., 2006, APPL MULTILEVEL ANAL, DOI [10.1017/CBO9780511610806, DOI 10.1017/CBO9780511610806]; United Nations, 2013, WORLD POP AG AG 2013, P114, DOI ST/ESA/SER.A/348; Van Cauwenberg J, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-142; Van Dyck D, 2015, J SPORT MED PHYS FIT, V55, P776; Van Dyck D, 2010, PREV MED, V50, pS74, DOI 10.1016/j.ypmed.2009.07.027; Van Holle V, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1785-3; Van Holle V, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/s12966-014-0110-3; Wahl HW, 2004, ANNU REV GERONTOL GE, V23, P1; Wang L, 2002, J AM GERIATR SOC, V50, P1525, DOI 10.1046/j.1532-5415.2002.50408.x; Yorston LC, 2012, J AM GERIATR SOC, V60, P719, DOI 10.1111/j.1532-5415.2012.03906.x	60	34	34	3	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0148398	10.1371/journal.pone.0148398	http://dx.doi.org/10.1371/journal.pone.0148398			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DD6SI	26872017	Green Published, Green Submitted, gold			2022-12-26	WOS:000370054100028
J	Wang, YC; Gu, WR; Xie, TL; Li, LJ; Sun, Y; Zhang, H; Li, J; Wei, S				Wang, Yongchao; Gu, Wanrong; Xie, Tenglong; Li, Lijie; Sun, Yang; Zhang, He; Li, Jing; Wei, Shi			Mixed Compound of DCPTA and CCC Increases Maize Yield by Improving Plant Morphology and Up-Regulating Photosynthetic Capacity and Antioxidants	PLOS ONE			English	Article							ACID-INDUCED CHANGES; COTTON PLANT; OXIDATIVE STRESS; IRRIGATED MAIZE; WHEAT SEEDLINGS; NITRIC-OXIDE; GROWTH; TOLERANCE; METABOLISM; ENZYMES	DCPTA (2-diethylaminoethyl-3, 4-dichlorophenylether) and CCC (2-chloroethyltrimethylammonium chloride) have a great effect on maize growth, but applying DCPTA individually can promote the increase of plant height, resulting in the rise of lodging percent. Plant height and lodging percent decrease in CCC-treated plants, but the accumulation of biomass reduce, resulting in yield decrease. Based on the former experiments, the performance of a mixture which contained 40 mg DCPTA and 20 mg CCC as active ingredients per liter of solution, called PCH was tested with applying 40mg/L DCPTA and 20mg/L CCC individually. Grain yield, yield components, internode characters, leaf area per plant, plant height and lodging percent as well as chlorophyll content, chlorophyll fluorescence, enzymatic antioxidants, membranous peroxide and organic osmolyte were analyzed in two years (2011 and 2012), using maize hybrid, Zhengdan 958 (ZD 958) at density of 6.75 plants m-2. CCC, DCPTA and PCH were sprayed on the whole plant leaves at 7 expanded leaves stage and water was used as control. Compared to control, PCH significantly increased grain yield (by 9.53% and 6.68%) from 2011 to 2012. CCC significantly decreased kernel number per ear (by 6.78% and 5.69%) and thousand kernel weight (TKW) (by 8.57% and 6.55%) from 2011 to 2012. Kernel number per ear and TKW increased in DCPTA-treated and PCH-treated plants, but showed no significant difference between them. In CCCtreated and PCH-treated plants, internode length and plant height decreased, internode diameter increased, resulting in the significant decline of lodging percent. With DCPTA application, internode diameter increased, but internode length and plant height increased at the same time, resulting in the augment of lodging percent. Bending strength and puncture strength were increased by applying different plant growth regulators (PGRs). In PCHtreated plants, bending strength and puncture strength were greater than other treatments. Compared to control, the bending strength of 3rd internode was increased by 14.47% in PCH-treated plants in 2011, increased by 18.40% in 2012, and the difference was significant. Puncture strength of 1st, 3rd and 5th internode was increased by 37.25%, 29.17% and 26.09% in 2011 and 34.04%, 25% and 23.68% in 2012, compared to control. Leaf area and dry weight per plant reduced significantly in CCC-treated plants, increased in DCPTA-treated and PCH-treated plants from 2011 to 2012. Chlorophyll content and chlorophyll fluorescence improved with CCC and DCPTA application. Due to the additive effect of DCPTA and CCC, PCH showed the significant effect on chlorophyll content and chlorophyll fluorescence. Compared to control, total enzyme activity (SOD, POD, CAT, APX and GR) and soluble protein content increased, malonaldehyde (MDA) and hydrogen peroxide (H2O2) content reduced in PCH-treated plants. The transportation of soluble sugar from leaf to kernel improved significantly at the late silking stage. The research provided the way for the further use of DCPTA and CCC into the production practice.	[Wang, Yongchao; Gu, Wanrong; Xie, Tenglong; Li, Lijie; Sun, Yang; Zhang, He; Li, Jing; Wei, Shi] Northeast Agr Univ, Coll Agr, Harbin 150030, Heilongjiang, Peoples R China; [Gu, Wanrong; Li, Jing; Wei, Shi] Minist Agr Crop Cultivat Sci Northeast Area, Observat Expt Stn, Harbin 150030, Heilongjiang, Peoples R China	Northeast Agricultural University - China	Wei, S (corresponding author), Northeast Agr Univ, Coll Agr, Harbin 150030, Heilongjiang, Peoples R China.; Wei, S (corresponding author), Minist Agr Crop Cultivat Sci Northeast Area, Observat Expt Stn, Harbin 150030, Heilongjiang, Peoples R China.	weishi5608@163.com	Li, Li/AEM-3636-2022; li, li/HII-4157-2022		National Natural Science Foundation of Youth Science Foundation [31201164]; China Postdoctoral Science Foundation [2012M510913]; Heilongjiang Postdoctoral Fund [LBH-Z12036]	National Natural Science Foundation of Youth Science Foundation; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Heilongjiang Postdoctoral Fund	This study was supported by National Natural Science Foundation of Youth Science Foundation (31201164); China Postdoctoral Science Foundation (2012M510913); Heilongjiang Postdoctoral Fund (LBH-Z12036).	Akram NA, 2012, SCI HORTIC-AMSTERDAM, V142, P143, DOI 10.1016/j.scienta.2012.05.007; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Aphalo PJ, 1997, NEW FOREST, V14, P167, DOI 10.1023/A:1006568813442; Ashraf M, 2009, BIOTECHNOL ADV, V27, P84, DOI 10.1016/j.biotechadv.2008.09.003; Avice JC, 2014, J EXP BOT, V65, P3813, DOI 10.1093/jxb/eru177; Cassman KG, 2003, ANNU REV ENV RESOUR, V28, P315, DOI 10.1146/annurev.energy.28.040202.122858; CHANCE B, 1955, METHOD ENZYMOL, V2, P764, DOI 10.1016/S0076-6879(55)02300-8; Ci DW, 2009, CHEMOSPHERE, V77, P1620, DOI 10.1016/j.chemosphere.2009.08.062; Ci XK, 2012, EUPHYTICA, V185, P395, DOI 10.1007/s10681-011-0560-5; DemmigAdams B, 1996, PHYSIOL PLANTARUM, V98, P253, DOI 10.1034/j.1399-3054.1996.980206.x; Dey A, 2013, ACTA PHYSIOL PLANT, V35, P1775, DOI 10.1007/s11738-013-1214-0; Dong ShuTing, 1997, Acta Agronomica Sinica, V23, P318; Downes BP, 1998, PLANT MOL BIOL, V37, P437, DOI 10.1023/A:1005920732211; ESECHIE HA, 1992, J AGR SCI, V119, P165, DOI 10.1017/S0021859600014076; Eum HL, 2009, FOOD SCI TECHNOL INT, V15, P223, DOI 10.1177/1082013208339706; Fischer AM, 2012, CRIT REV PLANT SCI, V31, P124, DOI 10.1080/07352689.2011.616065; FOYER CH, 1976, PLANTA, V133, P21, DOI 10.1007/BF00386001; Foyer CH, 2012, PLANT CELL ENVIRON, V35, P199, DOI 10.1111/j.1365-3040.2011.02453.x; GAUSMAN HW, 1985, BIO-TECHNOL, V3, P255, DOI 10.1038/nbt0385-255; GIANNOPOLITIS CN, 1977, PLANT PHYSIOL, V59, P315, DOI 10.1104/pp.59.2.309; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; Grassini P, 2011, FIELD CROP RES, V120, P142, DOI 10.1016/j.fcr.2010.09.012; [顾万荣 GU Wanrong], 2008, [华北农学报, Acta Agriculturae Boreali-Sinica], V23, P85; Hajiboland R, 2010, PLANT SOIL, V331, P313, DOI 10.1007/s11104-009-0255-z; Hernandez JA, 2000, PLANT CELL ENVIRON, V23, P853, DOI 10.1046/j.1365-3040.2000.00602.x; Hu HX, 2013, THEOR APPL GENET, V126, P2257, DOI 10.1007/s00122-013-2132-7; Jiao ZL, 2012, POTATO RES, V55, P293, DOI 10.1007/s11540-012-9223-8; Jung S, 2004, PLANT PHYSIOL BIOCH, V42, P225, DOI 10.1016/j.plaphy.2004.01.001; KEITHLY JH, 1990, PLANT GROWTH REGUL, V9, P127, DOI 10.1007/BF00027440; KHOSRAVI GR, 1991, PLANT GROWTH REGUL, V10, P27, DOI 10.1007/BF00035128; Kumar PP, 2013, PLANT CELL REP, V32, P943, DOI 10.1007/s00299-013-1460-z; Kumari GJ, 2006, BIOL PLANTARUM, V50, P219, DOI 10.1007/s10535-006-0010-8; Lacan D, 1998, PLANTA, V204, P377, DOI 10.1007/s004250050269; Li CZ, 2004, PLANT SCI, V166, P303, DOI 10.1016/j.plantsci.2003.09.019; Li HS, 1998, PRINCIPLE TECHNOLOGY, P56; Manjunatha G, 2010, BIOTECHNOL ADV, V28, P489, DOI 10.1016/j.biotechadv.2010.03.001; Mason TG, 1928, ANN BOT-LONDON, V42, P571, DOI 10.1093/oxfordjournals.aob.a090131; Mason TG, 1928, ANN BOT-LONDON, V42, P189, DOI 10.1093/oxfordjournals.aob.a090110; Maxwell K, 2000, J EXP BOT, V51, P659, DOI 10.1093/jexbot/51.345.659; Miret JA, 2015, ANN NY ACAD SCI, V1340, P29, DOI 10.1111/nyas.12639; NAKANO Y, 1981, PLANT CELL PHYSIOL, V22, P867; NBSC, 2014, CHIN STAT YB; NORBERG OS, 1988, AGRON J, V80, P768, DOI 10.2134/agronj1988.00021962008000050015x; PATEL R, 1992, J EXP BOT, V43, P257, DOI 10.1093/jxb/43.2.257; Perveen S, 2010, PAK J BOT, V42, P3073; Porra RJ, 2002, PHOTOSYNTH RES, V73, P149, DOI 10.1023/A:1020470224740; Qiu ZB, 2013, ECOTOX ENVIRON SAFE, V88, P135, DOI 10.1016/j.ecoenv.2012.11.001; RADEMACHER W, 1992, CURR PLANT SCI BIOT, V13, P571; Rademacher W, 2000, ANNU REV PLANT PHYS, V51, P501, DOI 10.1146/annurev.arplant.51.1.501; Richter A, 2010, PLANT CELL PHYSIOL, V51, P670, DOI 10.1093/pcp/pcq047; RUSSELL WA, 1985, MAYDICA, V30, P85; Shan CJ, 2010, PLANT SCI, V178, P130, DOI 10.1016/j.plantsci.2009.11.002; Sharaf AE, 2010, J AM SCI, V6, P559; Sharkey TD, 2010, J INTEGR PLANT BIOL, V52, P712, DOI 10.1111/j.1744-7909.2010.00975.x; Sharma N, 1998, PLANT GROWTH REGUL, V26, P97, DOI 10.1023/A:1006087729077; Shekoofa A., 2008, Journal of Agronomy, V7, P41; Tang JH, 2007, EUPHYTICA, V155, P117, DOI 10.1007/s10681-006-9312-3; Teng F, 2013, PLANT J, V73, P405, DOI 10.1111/tpj.12038; Varga B, 2012, ACTA PHYSIOL PLANT, V34, P849, DOI 10.1007/s11738-011-0882-x; Wang HQ, 2009, J PLANT GROWTH REGUL, V28, P21, DOI 10.1007/s00344-008-9069-0; Wang SH, 2004, BOT BULL ACAD SINICA, V45, P203; Wang YS, 2004, ACTA BOT SIN, V46, P819; WEI L M, 1991, ARID ZONE RES, V8, P38; Wu QS, 2006, J PLANT PHYSIOL, V163, P1101, DOI 10.1016/j.jplph.2005.09.001; Xie ZX, 2008, J PLANT PHYSIOL, V165, P375, DOI 10.1016/j.jplph.2007.06.001; Yamori W, 2010, PLANT PHYSIOL, V152, P388, DOI 10.1104/pp.109.145862; Zhang MC, 2008, PLANT GROWTH REGUL, V56, P257, DOI 10.1007/s10725-008-9305-4; Zhang Q, 2014, FIELD CROP RES, V164, P82, DOI 10.1016/j.fcr.2014.06.006; Zhang ZL, 2001, EXPT GUIDE PLANT PHY, P28; Zhou Tian, 2004, Pratacultural Science, V21, P31	70	30	31	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149404	10.1371/journal.pone.0149404	http://dx.doi.org/10.1371/journal.pone.0149404			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26872260	Green Published, gold, Green Submitted			2022-12-26	WOS:000370054100156
J	Bernaudo, S; Salem, M; Qi, X; Zhou, W; Zhang, C; Yang, W; Rosman, D; Deng, Z; Ye, G; Yang, BB; Vanderhyden, B; Wu, Z; Peng, C				Bernaudo, S.; Salem, M.; Qi, X.; Zhou, W.; Zhang, C.; Yang, W.; Rosman, D.; Deng, Z.; Ye, G.; Yang, B. B.; Vanderhyden, B.; Wu, Z.; Peng, C.			Cyclin G2 inhibits epithelial-to-mesenchymal transition by disrupting Wnt/beta-catenin signaling	ONCOGENE			English	Article							OVARIAN-CANCER; EXPRESSION; TRANSCRIPTION; CARCINOMA; MECHANISM; INVASION; CELLS; TRANSFORMATION; ACTIVATION; PATHWAY	Epithelial ovarian cancer (EOC) has the highest mortality rate among gynecological malignancies owing to poor screening methods, non-specific symptoms and limited knowledge of the cellular targets that contribute to the disease. Cyclin G2 is an unconventional cyclin that acts to oppose cell cycle progression. Dysregulation of the cyclin G2 gene (CCNG2) in a variety of human cancers has been reported; however, the role of cyclin G2 in tumorigenesis remains unclear. In this study, we investigated the function of cyclin G2 in EOC. In vitro and in vivo studies using several EOC-derived tumor cell lines revealed that cyclin G2 inhibited cell proliferation, migration, invasion and spheroid formation, as well as tumor formation and invasion. By interrogating cDNA microarray data sets, we found that CCGN2 mRNA is reduced in several large cohorts of human ovarian carcinoma when compared with normal ovarian surface epithelium or borderline tumors of the ovary. Mechanistically, cyclin G2 was found to suppress epithelial-to-mesenchymal transition (EMT), as demonstrated by the differential regulation of various EMT genes, such as Snail, Slug, vimentin and E-cadherin. Moreover, cyclin G2 potently suppressed the Wnt/beta-catenin signaling pathway by downregulating key Wnt components, namely LRP6, DVL2 and beta-catenin, which could be linked to inhibition of EMT. Taken together, our novel findings demonstrate that cyclin G2 has potent tumor-suppressive effects in EOCs by inhibiting EMT through attenuating Wnt/beta-catenin signaling.	[Bernaudo, S.; Salem, M.; Qi, X.; Zhou, W.; Zhang, C.; Yang, W.; Rosman, D.; Ye, G.; Wu, Z.; Peng, C.] York Univ, Dept Biol, 4700 Keele St, Toronto, ON M3J 1P3, Canada; [Deng, Z.; Yang, B. B.] Sunnybrook Hlth Sci Ctr, Sunnybrook Res Inst, Toronto, ON, Canada; [Vanderhyden, B.] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON, Canada; [Wu, Z.] Hong Kong Univ Sci & Technol, Div Life Sci, Hong Kong, Hong Kong, Peoples R China; [Deng, Z.] Jiangsu Univ, Peoples Hosp, Zhenjiang, Jiangsu, Peoples R China	York University - Canada; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Ottawa; Hong Kong University of Science & Technology; Jiangsu University	Peng, C (corresponding author), York Univ, Dept Biol, 4700 Keele St, Toronto, ON M3J 1P3, Canada.	cpeng@yorku.ca			Canadian Institutes of Health Research (CIHR) [MOP-89931]; Natural Science and Engineering Foundation (NSERC) [203081-2009, 227937-2012]; NSERC; OGS; York University; Ovarian Cancer Canada	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Science and Engineering Foundation (NSERC); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); OGS(Ontario Graduate Scholarship); York University; Ovarian Cancer Canada	This study was supported by grants from Canadian Institutes of Health Research (CIHR) to CP (MOP-89931) and from Natural Science and Engineering Foundation (NSERC) to CP (203081-2009) and to BY (227937-2012). SB was a recipient of graduate scholarships from NSERC, OGS and York University. We thank Dr Mien-Chie Hung for SKOV3.ip1 cells and the tumor bank at Ottawa Hospital Research Institute for providing the ovarian cancer samples. The Ottawa Ovarian Cancer Tissue Bank is supported in part by Ovarian Cancer Canada.	Adorno M, 2009, CELL, V137, P87, DOI 10.1016/j.cell.2009.01.039; Aguilar V, 2010, ENDOCRINOLOGY, V151, P5247, DOI 10.1210/en.2010-0461; Anglesio MS, 2008, MOL CANCER RES, V6, P1678, DOI 10.1158/1541-7786.MCR-08-0193; Arend RC, 2013, GYNECOL ONCOL, V131, P772, DOI 10.1016/j.ygyno.2013.09.034; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Bennin DA, 2002, J BIOL CHEM, V277, P27449, DOI 10.1074/jbc.M111693200; Bonome T, 2008, CANCER RES, V68, P5478, DOI 10.1158/0008-5472.CAN-07-6595; Burleson KM, 2004, CLIN EXP METASTAS, V21, P685, DOI 10.1007/s10585-004-5768-5; Chiu WT, 2015, ONCOTARGET, V6, P2349, DOI 10.18632/oncotarget.2957; Choi MG, 2009, J SURG RES, V157, P168, DOI 10.1016/j.jss.2008.06.020; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Conacci-Sorrell M, 2003, J CELL BIOL, V163, P847, DOI 10.1083/jcb.200308162; Davidowitz RA, 2014, J CLIN INVEST, V124, P2611, DOI 10.1172/JCI69815; Ford CE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054362; Fu G, 2011, ONCOGENE, V30, P3953, DOI 10.1038/onc.2011.127; Gajate C, 2002, J BIOL CHEM, V277, P41580, DOI 10.1074/jbc.M204644200; Gao C, 2010, NAT CELL BIOL, V12, P781, DOI 10.1038/ncb2082; Gonzalez DM, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005189; Haynes J, 2011, MOL BIOL CELL, V22, P4750, DOI 10.1091/mbc.E11-02-0119; Hendrix ND, 2006, CANCER RES, V66, P1354, DOI 10.1158/0008-5472.CAN-05-3694; Horne MC, 1997, J BIOL CHEM, V272, P12650, DOI 10.1074/jbc.272.19.12650; Horne MC, 1996, J BIOL CHEM, V271, P6050, DOI 10.1074/jbc.271.11.6050; Ito Y, 2003, ANTICANCER RES, V23, P2335; Jia Jin-Song, 2005, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V13, P254; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kasukabe T, 2005, BREAST CANCER RES, V7, pR1097, DOI 10.1186/bcr1344; Kim Y, 2004, CANCER RES, V64, P8980, DOI 10.1158/0008-5472.CAN-04-1926; Kolligs FT, 1999, MOL CELL BIOL, V19, P5696; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Lau MT, 2011, ONCOGENE, V30, P2753, DOI 10.1038/onc.2011.6; Lili LN, 2013, J OVARIAN RES, V6, DOI 10.1186/1757-2215-6-49; Liu J, 2004, WORLD J GASTROENTERO, V10, P1357; Martinez-Gac L, 2004, MOL CELL BIOL, V24, P2181, DOI 10.1128/MCB.24.5.2181-2189.2004; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; Mourgues L, 2015, LEUKEMIA, V29, P1993, DOI 10.1038/leu.2015.112; Nadeem L, 2011, AM J PATHOL, V178, P1177, DOI 10.1016/j.ajpath.2010.11.066; Pease JC, 2012, BIOL OPEN, V1, P622, DOI 10.1242/bio.2012653; Ponnusamy MP, 2010, ONCOGENE, V29, P5741, DOI 10.1038/onc.2010.309; Shell S, 2007, P NATL ACAD SCI USA, V104, P11400, DOI 10.1073/pnas.0704372104; Siragam V, 2012, ONCOTARGET, V3, P1370, DOI 10.18632/oncotarget.717; Sodek KL, 2009, INT J CANCER, V124, P2060, DOI 10.1002/ijc.24188; Stamos JL, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a007898; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; ten Berge D, 2008, CELL STEM CELL, V3, P508, DOI 10.1016/j.stem.2008.09.013; Tothill RW, 2008, CLIN CANCER RES, V14, P5198, DOI 10.1158/1078-0432.CCR-08-0196; Xu GX, 2008, MOL BIOL CELL, V19, P4968, DOI 10.1091/mbc.E08-03-0259; Ye G, 2012, ADV OVARIAN CANC MAN, P6; Yook JI, 2006, NAT CELL BIOL, V8, P1398, DOI 10.1038/ncb1508; Yoshihara K, 2009, CANCER SCI, V100, P1421, DOI 10.1111/j.1349-7006.2009.01204.x; Yuan H, 2013, CANCER RES, V73, P1581, DOI 10.1158/0008-5472.CAN-12-2377; Zhu LY, 2015, CANCER LETT, V363, P71, DOI 10.1016/j.canlet.2015.04.002	51	49	54	1	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 8	2016	35	36					4816	4827		10.1038/onc.2016.15	http://dx.doi.org/10.1038/onc.2016.15			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DW0IS	26876206	hybrid, Green Published			2022-12-26	WOS:000383324700014
J	Ghosh, S; Shinogle, HE; Galeva, NA; Dobrowsky, RT; Blagg, BSJ				Ghosh, Suman; Shinogle, Heather E.; Galeva, Nadezhda A.; Dobrowsky, Rick T.; Blagg, Brian S. J.			Endoplasmic Reticulum-resident Heat Shock Protein 90 (HSP90) Isoform Glucose-regulated Protein 94 (GRP94) Regulates Cell Polarity and Cancer Cell Migration by Affecting Intracellular Transport	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						actin; cell polarity; heat shock protein 90 (HSP90); intracellular trafficking; survivin; aha1; grp94; integrin	ACTIN CYTOSKELETON; CHAPERONE ACTIVITY; RHO-GTPASES; EXPRESSION; INTEGRIN; STRESS; METASTASIS; SECRETION; MEMBRANE; SURVIVIN	Heat shock protein 90 (HSP90) is a molecular chaperone that is up-regulated in cancer and is required for the folding of numerous signaling proteins. Consequently, HSP90 represents an ideal target for the development of new anti-cancer agents. The human HSP90 isoform, glucose-regulated protein 94 (GRP94), resides in the endoplasmic reticulum and regulates secretory pathways, integrins, and Toll-like receptors, which contribute to regulating immunity and metastasis. However, the cellular function of GRP94 remains underinvestigated. We report that GRP94 knockdown cells are defective in intracellular transport and, consequently, negatively impact the trafficking of F-actin toward the cellular cortex, integrin alpha 2 and integrin alpha L toward the cell membrane and filopodia, and secretory vesicles containing the HSP90 alpha-AHA1-survivin complex toward the leading edge. As a result, GRP94 knockdown cells form a multipolar spindle instead of bipolar morphology and consequently manifest a defect in cell migration and adhesion.	[Ghosh, Suman; Blagg, Brian S. J.] Univ Kansas, Dept Med Chem, 1251 Wescoe Hall Dr,4070 Malott Hall, Lawrence, KS 66045 USA; [Shinogle, Heather E.] Univ Kansas, Microscopy & Analyt Imaging Lab, 1251 Wescoe Hall Dr,4070 Malott Hall, Lawrence, KS 66045 USA; [Galeva, Nadezhda A.] Univ Kansas, Mass Spectrometry Lab, 1251 Wescoe Hall Dr,4070 Malott Hall, Lawrence, KS 66045 USA; [Dobrowsky, Rick T.] Univ Kansas, Dept Pharmacol & Toxicol, 1251 Wescoe Hall Dr,4070 Malott Hall, Lawrence, KS 66045 USA	University of Kansas; University of Kansas; University of Kansas; University of Kansas	Blagg, BSJ (corresponding author), Univ Kansas, Dept Med Chem, 1251 Wescoe Hall Dr,4070 Malott Hall, Lawrence, KS 66045 USA.	bblagg@ku.edu	blagg, brian s j/X-7770-2018; Ghosh, Suman/F-3453-2013	blagg, brian s j/0000-0002-6200-3480; 	National Institutes of Health [CA109265, DK095911]; NATIONAL CANCER INSTITUTE [U01CA109265] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY024232] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK095911] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS075311] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grants CA109265 (to B. S. J. B.) and DK095911 (to R. T. D.). The authors declare that they have no conflicts of interest with the contents of this article.	Altieri DC, 2015, SEMIN CELL DEV BIOL, V39, P91, DOI 10.1016/j.semcdb.2014.12.007; Barnes JA, 1997, ANAT EMBRYOL, V196, P335, DOI 10.1007/s004290050102; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; BORKOVICH KA, 1989, MOL CELL BIOL, V9, P3919, DOI 10.1128/MCB.9.9.3919; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Cartwright S, 2014, SEMIN CELL DEV BIOL, V29, P169, DOI 10.1016/j.semcdb.2013.12.010; Caswell PT, 2009, NAT REV MOL CELL BIO, V10, P843, DOI 10.1038/nrm2799; Chan KT, 2007, METHOD ENZYMOL, V426, P47, DOI 10.1016/S0076-6879(07)26003-3; Chen YA, 2001, NAT REV MOL CELL BIO, V2, P98, DOI 10.1038/35052017; Chung CY, 2000, P NATL ACAD SCI USA, V97, P5225, DOI 10.1073/pnas.97.10.5225; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; CULINE S, 1992, CANCER RES, V52, P3083; Dawe HR, 2009, J CELL SCI, V122, P2716, DOI 10.1242/jcs.043794; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Fehrenbacher N, 2008, CANCER RES, V68, P6623, DOI 10.1158/0008-5472.CAN-08-0463; Friederichs JM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002365; Ghosh S, 2015, ACS CHEM BIOL, V10, P577, DOI 10.1021/cb5008713; Ghosh S, 2012, MOL BIOL CELL, V23, P2546, DOI 10.1091/mbc.E11-07-0600; Guo FK, 2006, J BIOL CHEM, V281, P18652, DOI 10.1074/jbc.M603508200; Guo WJ, 2004, NAT REV MOL CELL BIO, V5, P816, DOI 10.1038/nrm1490; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Haque F, 2010, J BIOL CHEM, V285, P3487, DOI 10.1074/jbc.M109.071910; Hasan N, 2010, EXP CELL RES, V316, P12, DOI 10.1016/j.yexcr.2009.10.007; Honda R, 2003, MOL BIOL CELL, V14, P3325, DOI 10.1091/mbc.E02-11-0769; Jaspersen SL, 2012, NUCLEUS-PHILA, V3, P226, DOI 10.4161/nucl.20148; Khan S, 2015, HISTOL HISTOPATHOL, V30, P43, DOI 10.14670/HH-30.43; Khan S, 2011, APOPTOSIS, V16, P1, DOI 10.1007/s10495-010-0534-4; KIM KS, 1990, DIFFERENTIATION, V42, P153, DOI 10.1111/j.1432-0436.1990.tb00756.x; King SJ, 2014, CYTOSKELETON, V71, P423, DOI 10.1002/cm.21182; Liu B, 2008, BLOOD, V112, P1223, DOI 10.1182/blood-2008-03-143107; Luo ML, 2015, CELL REP, V11, P111, DOI 10.1016/j.celrep.2015.03.002; Machesky LM, 2008, FEBS LETT, V582, P2102, DOI 10.1016/j.febslet.2008.03.039; Mattila PK, 2008, NAT REV MOL CELL BIO, V9, P446, DOI 10.1038/nrm2406; MCCORMICK PJ, 1984, DEV BIOL, V105, P530, DOI 10.1016/0012-1606(84)90311-7; Mehrotra S, 2010, CANCER CELL, V17, P53, DOI 10.1016/j.ccr.2009.11.021; Meng JH, 2015, BBA-REV CANCER, V1856, P1, DOI 10.1016/j.bbcan.2015.04.002; Nyga A, 2011, J CELL COMMUN SIGNAL, V5, P239, DOI 10.1007/s12079-011-0132-4; Okado-Matsumoto A, 2001, J BIOL CHEM, V276, P38388, DOI 10.1074/jbc.M105395200; Ostrovsky O, 2009, P NATL ACAD SCI USA, V106, P11600, DOI 10.1073/pnas.0902626106; Ostrovsky O, 2009, MOL BIOL CELL, V20, P1855, DOI 10.1091/mbc.E08-04-0346; Peterson LB, 2012, MOL PHARMACEUT, V9, P1841, DOI 10.1021/mp300138n; Proux-Gillardeaux V, 2005, P NATL ACAD SCI USA, V102, P6362, DOI 10.1073/pnas.0409613102; Rachidi S, 2015, HEPATOLOGY, V61, P1766, DOI 10.1002/hep.27400; Randow F, 2001, NAT CELL BIOL, V3, P891, DOI 10.1038/ncb1001-891; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Rodriguez OC, 2003, NAT CELL BIOL, V5, P599, DOI 10.1038/ncb0703-599; Samadi AK, 2011, CANCER LETT, V312, P158, DOI 10.1016/j.canlet.2011.07.031; Sanz-Pamplona R, 2011, AM J PATHOL, V179, P564, DOI 10.1016/j.ajpath.2011.04.037; Shah SP, 2012, NATURE, V486, P395, DOI 10.1038/nature10933; Shelton SN, 2009, MOL PHARMACOL, V76, P1314, DOI 10.1124/mol.109.058545; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Small JV, 2002, TRENDS CELL BIOL, V12, P112, DOI 10.1016/S0962-8924(01)02237-1; Sokac AM, 2003, NAT CELL BIOL, V5, P727, DOI 10.1038/ncb1025; Solier S, 2012, P NATL ACAD SCI USA, V109, P12866, DOI 10.1073/pnas.1203617109; Sreedhar AS, 2004, FEBS LETT, V562, P11; Steen H, 2004, NAT REV MOL CELL BIO, V5, P699, DOI 10.1038/nrm1468; Subramani D, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-312; Sung BH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8164; Tamm I, 1998, CANCER RES, V58, P5315; Trepel J, 2010, NAT REV CANCER, V10, P537, DOI 10.1038/nrc2887; Wanderling S, 2007, MOL BIOL CELL, V18, P3764, DOI 10.1091/mbc.E07-03-0275; Woods AJ, 2004, EMBO J, V23, P2531, DOI 10.1038/sj.emboj.7600267; Yamashiro S, 1998, MOL BIOL CELL, V9, P993, DOI 10.1091/mbc.9.5.993; Zhang L, 2012, J PROTEOME RES, V11, P2581, DOI 10.1021/pr300056m; Zhang L, 2010, J PROTEOME RES, V9, P458, DOI 10.1021/pr900818g; Zheng HC, 2008, HUM PATHOL, V39, P1042, DOI 10.1016/j.humpath.2007.11.009	67	25	25	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2016	291	16					8309	8323		10.1074/jbc.M115.688374	http://dx.doi.org/10.1074/jbc.M115.688374			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK2VT	26872972	Green Published, hybrid			2022-12-26	WOS:000374773200001
J	Hung, MH; Liu, CJ; Teng, CJ; Hu, YW; Yeh, CM; Chen, SC; Chien, SH; Hung, YP; Shen, CC; Chen, TJ; Tzeng, CH; Liu, CY				Hung, Man-Hsin; Liu, Chia-Jen; Teng, Chung-Jen; Hu, Yu-Wen; Yeh, Chiu-Mei; Chen, San-Chi; Chien, Sheng-Hsuan; Hung, Yi-Ping; Shen, Cheng-Che; Chen, Tzeng-Ji; Tzeng, Cheng-Hwai; Liu, Chun-Yu			Risk of Second Non-Breast Primary Cancer in Male and Female Breast Cancer Patients: A Population-Based Cohort Study	PLOS ONE			English	Article							GLOBAL BURDEN; YOUNG AGE; MALIGNANCIES; WOMEN; EPIDEMIOLOGY; DIAGNOSIS; SURVIVAL; TRENDS	Female breast cancer patients have an increased risk of developing subsequent malignant diseases, but this issue is rarely discussed in regards to male breast cancer patients. Thus, we conducted a national survey that included 100,915 female and 578 male breast cancer patients to investigate the risk of second primary malignancy (SPM). During a follow-up period that included 529,782 person-years, 3,153 cases of SPM developed. Compared with the general population, the standardized incidence ratio (SIR) of SPM in breast cancer patients was 1.51 [95% confidence interval (CI): 1.46-1.56]. The observed risk was significantly higher in male patients (SIR 2.17, 95% CI 1.70-2.73) and in patients whose age at breast cancer diagnosis was 40 years or younger (SIR 3.39, 95% CI 2.80-4.07), comparing to age-matched general population. Compared with the overall female population, the SIRs of female breast cancer patients with uterine (SIR: 2.66, 95% CI: 2.37-2.98), thyroid (SIR: 2.30, 95% CI: 2.02-2.62), and bone and soft tissue (SIR: 2.16, 95% CI: 1.56-2.91) cancers were significantly increased. Male breast cancer patients also displayed significantly higher SIRs for thyroid (SIR: 13.2, 95% CI: 1.60-47.69), skin (SIR: 8.24, 95% CI: 3.02-17.94) and head and neck (SIR: 4.41, 95% CI: 2.35-7.54) cancers. Among breast cancer patients, risk factors significantly associated with SPM included male gender, older age, chemotherapy treatment and comorbidity with liver cirrhosis. From our analysis, we concluded that the risk of SPM was significantly higher for both male and female breast cancer patients compared with the general population, suggesting that more intensive surveillance may be needed, especially in high-risk patients.	[Hung, Man-Hsin; Hu, Yu-Wen; Hung, Yi-Ping; Liu, Chun-Yu] Taipei Vet Gen Hosp, Dept Oncol, Taipei, Taiwan; [Liu, Chia-Jen; Chen, San-Chi; Chien, Sheng-Hsuan; Tzeng, Cheng-Hwai] Taipei Vet Gen Hosp, Div Hematol & Oncol, Dept Med, Taipei, Taiwan; [Yeh, Chiu-Mei; Chen, Tzeng-Ji] Taipei Vet Gen Hosp, Dept Family Med, Taipei, Taiwan; [Hung, Man-Hsin; Teng, Chung-Jen; Hu, Yu-Wen; Chen, San-Chi; Chien, Sheng-Hsuan; Hung, Yi-Ping; Tzeng, Cheng-Hwai; Liu, Chun-Yu] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan; [Hung, Man-Hsin] Natl Yang Ming Univ, Sch Life Sci, Program Mol Med, Taipei 112, Taiwan; [Hung, Man-Hsin] Acad Sinica, Taipei 115, Taiwan; [Liu, Chia-Jen] Natl Yang Ming Univ, Inst Publ Hlth, Taipei 112, Taiwan; [Liu, Chun-Yu] Natl Yang Ming Univ, Inst Biopharmaceut Sci, Taipei 112, Taiwan; [Teng, Chung-Jen] Far Eastern Mem Hosp, Dept Med, Div Hematol & Oncol, Taipei, Taiwan; [Shen, Cheng-Che] Taichung Vet Gen Hosp, Chiayi Branch, Dept Psychiat, Chiayi, Taiwan; [Shen, Cheng-Che] Natl Chung Cheng Univ, Dept Informat Management, Chiayi 621, Taiwan	Taipei Veterans General Hospital; Taipei Veterans General Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Academia Sinica - Taiwan; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Far Eastern Memorial Hospital; Taichung Veterans General Hospital; National Chung Cheng University	Liu, CY (corresponding author), Taipei Vet Gen Hosp, Dept Oncol, Taipei, Taiwan.; Liu, CY (corresponding author), Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan.; Liu, CY (corresponding author), Natl Yang Ming Univ, Inst Biopharmaceut Sci, Taipei 112, Taiwan.	cyliu3@vghtpe.gov.tw	Chien, Sheng-Hsuan/HDM-2486-2022; Chen, TJ/AAH-8430-2021	Hu, Yu-Wen/0000-0002-7983-415X	Taiwan Clinical Oncology Research Foundation; Ministry of Science and Technology (Formerly National Science Council), Taiwan [103-2325-B-075-002, 104-2628-B-075-001-MY3]; Center of Excellence for Cancer Research at Taipei Veterans General [MOHW103-TD-B-111-02, MOHW104-TDU-B-211-124-001, MOHW105-TDU-B-211-134003]; Ministry of Health and Welfare, Executive Yuan, Taiwan; Taipei Veterans General Hospital-National Yang-Ming University Excellent Physician Scientists Cultivation Program from Taipei Veterans General Hospital [103-V-B-025, V103C-141, V103B-022, V103E10-001, V104C-151, V105C-067, V104A-001]	Taiwan Clinical Oncology Research Foundation; Ministry of Science and Technology (Formerly National Science Council), Taiwan; Center of Excellence for Cancer Research at Taipei Veterans General; Ministry of Health and Welfare, Executive Yuan, Taiwan; Taipei Veterans General Hospital-National Yang-Ming University Excellent Physician Scientists Cultivation Program from Taipei Veterans General Hospital	This study is supported partially by Taiwan Clinical Oncology Research Foundation and grants 103-2325-B-075-002, 104-2628-B-075-001-MY3 from the Ministry of Science and Technology (Formerly National Science Council), Taiwan; MOHW103-TD-B-111-02, MOHW104-TDU-B-211-124-001, and MOHW105-TDU-B-211-134003 from the Center of Excellence for Cancer Research at Taipei Veterans General, the Ministry of Health and Welfare, Executive Yuan, Taiwan; Taipei Veterans General Hospital-National Yang-Ming University Excellent Physician Scientists Cultivation Program, No. 103-V-B-025, V103C-141, V103B-022, V103E10-001, V104C-151, V105C-067 and V104A-001 from Taipei Veterans General Hospital. The study is based in part on data from the National Health Insurance Research Database provided by the Bureau of National Health Insurance, Department of Health and managed by National Health Research Institutes. The interpretation and conclusions contained herein do not represent those of Bureau of National Health Insurance, Department of Health or National Health Research Institutes.	Chen SC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116384; Coughlin SS, 2009, CANCER EPIDEMIOL, V33, P315, DOI 10.1016/j.canep.2009.10.003; Curtis R, 2006, NEW MALIGNANCIES CAN; Edwards B. K., 2013, CANCER; El Saghir NS, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-194; Fredholm H, 2009, PLOS ONE, V4, pA38, DOI 10.1371/journal.pone.0007695; Giordano SH, 2005, ONCOLOGIST, V10, P471, DOI 10.1634/theoncologist.10-7-471; Hashibe M, 2007, J NATL CANCER I, V99, P777, DOI 10.1093/jnci/djk179; Kalaitzakis E, 2011, CLIN GASTROENTEROL H, V9, P168, DOI 10.1016/j.cgh.2010.10.014; Kroger N, 2003, BONE MARROW TRANSPL, V32, P1153, DOI 10.1038/sj.bmt.1704291; Lee KD, 2008, CANCER EPIDEM BIOMAR, V17, P2647, DOI 10.1158/1055-9965.EPI-08-0109; Malone KE, 2010, J CLIN ONCOL, V28, P2404, DOI 10.1200/JCO.2009.24.2495; Mannino DM, 2007, LANCET, V370, P765, DOI 10.1016/S0140-6736(07)61380-4; Mellemkjaer L, 2006, INT J CANCER, V118, P2285, DOI 10.1002/ijc.21651; Mellemkjaer L, 2011, CANCER EPIDEM BIOMAR, V20, P1784, DOI 10.1158/1055-9965.EPI-11-0009; Nelson H. D., 2013, US PREVENTIVE SERVIC; Obedian E, 2000, J CLIN ONCOL, V18, P2406, DOI 10.1200/JCO.2000.18.12.2406; Parkin DM, 2006, BREAST J, V12, pS70, DOI 10.1111/j.1075-122X.2006.00205.x; Schaapveld M, 2008, J CLIN ONCOL, V26, P1239, DOI 10.1200/JCO.2007.11.9081; Shaitelman SF, 2011, INT J RADIAT ONCOL, V81, P1244, DOI 10.1016/j.ijrobp.2010.07.2005; Shen YC, 2005, CANCER EPIDEM BIOMAR, V14, P1986, DOI 10.1158/1055-9965.EPI-04-0932; Tutluer S, 2012, MED ONCOL, V29, P1365, DOI 10.1007/s12032-011-9896-x; Wang YP, 2012, CAN MED ASSOC J, V184, pE804, DOI 10.1503/cmaj.120518; Weiss JR, 2005, CANCER EPIDEM BIOMAR, V14, P20, DOI 10.1158/1055-9965.EPI-05-0414; Wernberg JA, 2009, J SURG ONCOL, V99, P16, DOI 10.1002/jso.21153	25	15	16	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0148597	10.1371/journal.pone.0148597	http://dx.doi.org/10.1371/journal.pone.0148597			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3DG	26894298	Green Published, gold, Green Submitted			2022-12-26	WOS:000371223400020
J	Hecksteden, A; Skorski, S; Schwindling, S; Hammes, D; Pfeiffer, M; Kellmann, M; Ferrauti, A; Meyer, T				Hecksteden, Anne; Skorski, Sabrina; Schwindling, Sascha; Hammes, Daniel; Pfeiffer, Mark; Kellmann, Michael; Ferrauti, Alexander; Meyer, Tim			Blood-Borne Markers of Fatigue in Competitive Athletes - Results from Simulated Training Camps	PLOS ONE			English	Article							OVERTRAINING SYNDROME; IMMUNE-SYSTEM; PERFORMANCE; CYCLISTS; REPRODUCIBILITY; DIAGNOSIS; EXERCISE; SCIENCE; SPORTS	Assessing current fatigue of athletes to fine-tune training prescriptions is a critical task in competitive sports. Blood-borne surrogate markers are widely used despite the scarcity of validation trials with representative subjects and interventions. Moreover, differences between training modes and disciplines (e.g. due to differences in eccentric force production or calorie turnover) have rarely been studied within a consistent design. Therefore, we investigated blood-borne fatigue markers during and after discipline-specific simulated training camps. A comprehensive panel of blood-born indicators was measured in 73 competitive athletes (28 cyclists, 22 team sports, 23 strength) at 3 time-points: after a run-in resting phase (d 1), after a 6-day induction of fatigue (d 8) and following a subsequent 2-day recovery period (d 11). Venous blood samples were collected between 8 and 10 a. m. Courses of blood-borne indicators are considered as fatigue dependent if a significant deviation from baseline is present at day 8 (Delta fatigue) which significantly regresses towards baseline until day 11 (Delta recovery). With cycling, a fatigue dependent course was observed for creatine kinase (CK;Delta fatigue 54 +/- 84 U/l;Delta recovery -60 +/- 83 U/l), urea (Delta fatigue 11 +/- 9 mg/dl;.recovery -10 +/- 10 mg/dl), free testosterone (Delta fatigue -1.3 +/- 2.1 pg/ml;Delta recovery 0.8 +/- 1.5 pg/ml) and insulin linke growth factor 1 (IGF-1;Delta fatigue -56 +/- 28 ng/ml;Delta recovery 53 +/- 29 ng/ml). For urea and IGF-1 95% confidence intervals for days 1 and 11 did not overlap with day 8. With strength and high-intensity interval training, respectively, fatigue-dependent courses and separated 95% confidence intervals were present for CK (strength:Delta fatigue 582 +/- 649 U/l;Delta recovery -618 +/- 419 U/l; HIIT:Delta fatigue 863 +/- 952 U/l;Delta recovery -741 +/- 842 U/l) only. These results indicate that, within a comprehensive panel of blood-borne markers, changes in fatigue are most accurately reflected by urea and IGF-1 for cycling and by CK for strength training and team sport players.	[Hecksteden, Anne; Skorski, Sabrina; Schwindling, Sascha; Hammes, Daniel; Meyer, Tim] Univ Saarland, Inst Sports & Prevent Med, D-66123 Saarbrucken, Germany; [Pfeiffer, Mark] Johannes Gutenberg Univ Mainz, Inst Sports Sci, D-55122 Mainz, Germany; [Kellmann, Michael; Ferrauti, Alexander] Ruhr Univ Bochum, Fac Sports Sci, Univ Str 150, Bochum, Germany; [Kellmann, Michael] Univ Queensland, Sch Human Movement Studies, Brisbane, Qld 4072, Australia; [Kellmann, Michael] Univ Queensland, Sch Psychol, Brisbane, Qld 4072, Australia	Saarland University; Johannes Gutenberg University of Mainz; Ruhr University Bochum; University of Queensland; University of Queensland	Hecksteden, A (corresponding author), Univ Saarland, Inst Sports & Prevent Med, D-66123 Saarbrucken, Germany.	a.hecksteden@mx.uni-saarland.de	; Kellmann, Michael/J-3508-2014	Pfeiffer, Mark/0000-0002-9287-5343; Kellmann, Michael/0000-0003-1699-9624; Hammes, Daniel/0000-0002-3304-2528; Alexander, Ferrauti/0000-0001-9807-2755	German Institute of Sport Science; project "RegMan - Management of Regeneration in Elite Sports" [IIA1-081901/12-16]	German Institute of Sport Science; project "RegMan - Management of Regeneration in Elite Sports"	The present study was funded by the German Institute of Sport Science. The research was realized within the project "RegMan - Management of Regeneration in Elite Sports" (IIA1-081901/12-16).	Areces F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138376; Buchheit M, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00073; Faria EW, 2005, SPORTS MED, V35, P285, DOI 10.2165/00007256-200535040-00002; Fernandez-Garcia B, 2002, INT J SPORTS MED, V23, P555, DOI 10.1055/s-2002-35532; Gabriel HHW, 1998, MED SCI SPORT EXER, V30, P1151, DOI 10.1097/00005768-199807000-00021; Halson SL, 2002, J APPL PHYSIOL, V93, P947, DOI 10.1152/japplphysiol.01164.2001; Hecksteden A, 1985, J APPL PHYSL; Jeukendrup A, 1996, MED SCI SPORT EXER, V28, P266, DOI 10.1097/00005768-199602000-00017; Kaikkonen P, 2008, SCAND J MED SCI SPOR, V18, P511, DOI 10.1111/j.1600-0838.2007.00728.x; Kellmann M, 2010, SCAND J MED SCI SPOR, V20, P95, DOI 10.1111/j.1600-0838.2010.01192.x; Lamberts RP, 2010, EUR J APPL PHYSIOL, V108, P183, DOI 10.1007/s00421-009-1291-3; Laursen PB, 2003, INT J SPORTS MED, V24, P481; Meeusen R, 2013, MED SCI SPORT EXER, V45, P186, DOI 10.1249/MSS.0b013e318279a10a; Meyer T, 2004, MED SCI SPORT EXER, V36, P1743, DOI 10.1249/01.MSS.0000142422.87805.74; Palmer GS, 1996, INT J SPORTS MED, V17, P293, DOI 10.1055/s-2007-972849; PARRYBILLINGS M, 1992, MED SCI SPORT EXER, V24, P1353; Paton CD, 2001, SPORTS MED, V31, P489, DOI 10.2165/00007256-200131070-00004; Sassi A, 2008, APPL PHYSIOL NUTR ME, V33, P735, DOI 10.1139/H08-046; Smith DJ, 2000, MED SCI SPORT EXER, V32, P684, DOI 10.1097/00005768-200003000-00020; Sottas PE, 2007, BIOSTATISTICS, V8, P285, DOI 10.1093/biostatistics/kxl009; Sottas PE, 2012, BIOANALYSIS, V4, P1645, DOI [10.4155/BIO.12.130, 10.4155/bio.12.130]; Steinacker JM, 2004, EUR J APPL PHYSIOL, V91, P382, DOI 10.1007/s00421-003-0960-x; Urhausen A, 2002, SPORTS MED, V32, P95, DOI 10.2165/00007256-200232020-00002; URHAUSEN A, 1995, SPORTS MED, V20, P251, DOI 10.2165/00007256-199520040-00004; Urhausen A, 1998, MED SCI SPORT EXER, V30, P407, DOI 10.1097/00005768-199803000-00011	25	39	39	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2016	11	2							e0148810	10.1371/journal.pone.0148810	http://dx.doi.org/10.1371/journal.pone.0148810			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3CO	26891051	Green Submitted, Green Published, gold			2022-12-26	WOS:000371221500014
J	Li, B; Zhang, JX; Wang, ZM; Chen, SL				Li, Bing; Zhang, Junxia; Wang, Zhimei; Chen, Shaoliang			Ivabradine Prevents Low Shear Stress Induced Endothelial Inflammation and Oxidative Stress via mTOR/eNOS Pathway	PLOS ONE			English	Article							HEART-RATE REDUCTION; STIMULATES PHOSPHORYLATION; DYSFUNCTION; ATHEROSCLEROSIS; ATHEROGENESIS; FAILURE; DISEASE; MTOR; RATS; MICE	Ivabradine not only reduces heart rate but has other cardiac and vascular protective effects including anti-inflammation and anti-oxidation. Since endothelial nitric oxide synthase (eNOS) is a crucial enzyme in maintaining endothelial activity, we aimed to investigate the impact of ivabradine in low shear stress (LSS) induced inflammation and endothelial injury and the role of eNOS played in it. Endothelial cells (ECs) were subjected to LSS at 2dyne/cm(2), with 1 hour of ivabradine (0.04 mu M) or LY294002 (10 mu M) pre-treatment. The mRNA expression of IL-6, VCAM-1 along with eNOS were measured by QPCR. Reactive oxygen species (ROS) was detected by dihydroethidium (DHE) and DCF, and protein phosphorylation was detected by western blot. It demonstrated that ivabradine decreased LSS induced inflammation and oxidative stress in endothelial cells. Western blot showed reduced rictor and Akt-Ser473 as well as increased eNOS-Thr495 phosphorylation. However, mTORC1 pathway was only increased when LSS applied within 30 minutes. These effects were reversed by ivabradine. It would appear that ivabradine diminish ROS generation by provoking mTORC2/Akt phosphorylation and repressing mTORC1 induced eNOS-Thr495 activation. These results together suggest that LSS induced endothelial inflammation and oxidative stress are suppressed by ivabradine via mTORC2/Akt activation and mTORC1/eNOS reduction.	[Li, Bing; Zhang, Junxia; Wang, Zhimei; Chen, Shaoliang] Nanjing Med Univ, Nanjing Hosp 1, Dept Cardiol, 68 Changle Rd, Nanjing 210006, Jiangsu, Peoples R China	Nanjing Medical University	Chen, SL (corresponding author), Nanjing Med Univ, Nanjing Hosp 1, Dept Cardiol, 68 Changle Rd, Nanjing 210006, Jiangsu, Peoples R China.	chmengx@126.com			National Natural Science Foundation of China [81270191]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by a grant from the National Natural Science Foundation of China (Grant No. 81270191) http://www.nsfc.gov.cn/.	Boo YC, 2002, AM J PHYSIOL-HEART C, V283, pH1819, DOI 10.1152/ajpheart.00214.2002; Castier Y, 2005, CIRC RES, V97, P533, DOI 10.1161/01.RES.0000181759.63239.21; Danchin N, 2006, ADV CARDIOL, V43, P45, DOI 10.1159/000095405; Drouin A, 2008, BRIT J PHARMACOL, V154, P749, DOI 10.1038/bjp.2008.116; Fang YH, 2012, J CARDIOVASC PHARM, V59, P260, DOI 10.1097/FJC.0b013e31823e5e01; Fox K, 2008, LANCET, V372, P807, DOI 10.1016/S0140-6736(08)61170-8; Heo KS, 2013, CIRC RES, V112, P911, DOI 10.1161/CIRCRESAHA.111.300179; Herranz B, 2012, CIRC RES, V110, P439, DOI 10.1161/CIRCRESAHA.111.253948; Huang CF, 2012, EXP CELL RES, V318, P1075, DOI 10.1016/j.yexcr.2012.03.011; Lee DY, 2010, J BIOL CHEM, V285, P30, DOI 10.1074/jbc.M109.010512; Li XH, 2014, DNA CELL BIOL, V33, P830, DOI 10.1089/dna.2014.2480; Mehta JL, 2007, CIRC RES, V100, P1634, DOI 10.1161/CIRCRESAHA.107.149724; Moore JP, 2010, ARTERIOSCL THROM VAS, V30, P561, DOI 10.1161/ATVBAHA.109.199554; Owczarek J, 2012, ARCH MED SCI, V8, P549, DOI 10.5114/aoms.2012.29411; Rajapakse AG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019237; Ramkhelawon B, 2009, CIRC RES, V105, P869, DOI 10.1161/CIRCRESAHA.109.204040; Sargento L, 2013, CLIN CARDIOL, V36, P677, DOI 10.1002/clc.22183; Sciarretta S, 2014, CIRC RES, V114, P549, DOI 10.1161/CIRCRESAHA.114.302022; Suffredini S, 2012, BRIT J PHARMACOL, V165, P1457, DOI 10.1111/j.1476-5381.2011.01627.x; Swedberg K, 2010, LANCET, V376, P875, DOI 10.1016/S0140-6736(10)61198-1; Vion AC, 2013, CIRC RES, V112, P1323, DOI 10.1161/CIRCRESAHA.112.300818; Voelkers M, 2013, CIRCULATION, V128, P2132, DOI 10.1161/CIRCULATIONAHA.113.003638; Walcher T, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/751313; Wang WY, 2010, BLOOD, V115, P2971, DOI 10.1182/blood-2009-05-224824; Zaragoza C, 2012, CURR OPIN LIPIDOL, V23, P446, DOI 10.1097/MOL.0b013e328357e837; Zhou J, 2014, ARTERIOSCL THROM VAS, V34, P2191, DOI 10.1161/ATVBAHA.114.303422; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	27	22	25	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2016	11	2							e0149694	10.1371/journal.pone.0149694	http://dx.doi.org/10.1371/journal.pone.0149694			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3CO	26890696	Green Published, Green Submitted, gold			2022-12-26	WOS:000371221500071
J	Pullinger, GD; Busquets, MG; Nomikou, K; Boyce, M; Attoui, H; Mertens, PP				Pullinger, Gillian D.; Busquets, Marc Guimera; Nomikou, Kyriaki; Boyce, Mark; Attoui, Houssam; Mertens, Peter P.			Identification of the Genome Segments of Bluetongue Virus Serotype 26 (Isolate KUW2010/02) that Restrict Replication in a Culicoides sonorensis Cell Line (KC Cells)	PLOS ONE			English	Article							COMPLETE NUCLEOTIDE-SEQUENCE; AFRICAN HORSE SICKNESS; ORBIVIRUS; PROTEINS; INFECTION; EUROPE; VECTOR; CORE; RNA; EVOLUTION	Bluetongue virus (BTV) can infect most ruminant species and is usually transmitted by adult, vector-competent biting midges (Culicoides spp.). Infection with BTV can cause severe clinical signs and can be fatal, particularly in naive sheep and some deer species. Although 24 distinct BTV serotypes were recognized for several decades, additional 'types' have recently been identified, including BTV-25 (from Switzerland), BTV-26 (from Kuwait) and BTV-27 from France (Corsica). Although BTV-25 has failed to grow in either insect or mammalian cell cultures, BTV-26 (isolate KUW2010/02), which can be transmitted horizontally between goats in the absence of vector insects, does not replicate in a Culicoides sonorensis cell line (KC cells) but can be propagated in mammalian cells (BSR cells). The BTV genome consists of ten segments of linear dsRNA. Mono-reassortant viruses were generated by reverse-genetics, each one containing a single BTV-26 genome segment in a BTV-1 genetic-background. However, attempts to recover a mono-reassortant containing genome-segment 2 (Seg-2) of BTV-26 (encoding VP2), were unsuccessful but a triple-reassortant was successfully generated containing Seg-2, Seg-6 and Seg-7 (encoding VP5 and VP7 respectively) of BTV-26. Reassortants were recovered and most replicated well in mammalian cells (BSR cells). However, mono-reassortants containing Seg-1 or Seg-3 of BTV-26 (encoding VP1, or VP3 respectively) and the triple reassortant failed to replicate, while a mono-reassortant containing Seg-7 of BTV-26 only replicated slowly in KC cells.	[Pullinger, Gillian D.; Busquets, Marc Guimera; Nomikou, Kyriaki; Boyce, Mark; Attoui, Houssam; Mertens, Peter P.] Pirbright Inst, Vector Borne Viral Dis Programme, Woking, Surrey, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute	Pullinger, GD (corresponding author), Pirbright Inst, Vector Borne Viral Dis Programme, Woking, Surrey, England.	gillian.pullinger@pirbright.ac.uk	Nomikou, Kyriaki/P-1840-2018; Nomikou, Kyriaki/Q-5555-2016	Nomikou, Kyriaki/0000-0002-7013-1853; Nomikou, Kyriaki/0000-0002-7013-1853; Attoui, Houssam/0000-0001-9639-9981; Mertens, Peter/0000-0002-3438-3738	EU EMIDA [BB/I017259/1]; BBSRC [BB/I017259/1, BBS/E/I/00001446, BBS/E/I/00001700, BBS/E/I/00001876] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/I/00001700, BB/I017259/1, BBS/E/I/00001876, BBS/E/I/00001446] Funding Source: researchfish	EU EMIDA; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by grant BB/I017259/1 from EU EMIDA (Coordination of European research on emerging and major infectious diseases of livestock) awarded to PPM.	ALEXANDER KA, 1994, AM J TROP MED HYG, V51, P568, DOI 10.4269/ajtmh.1994.51.568; Anbalagan S, 2014, J GEN VIROL, V95, P434, DOI 10.1099/vir.0.059659-0; Attoui H, 2000, J VIROL METHODS, V89, P147, DOI 10.1016/S0166-0934(00)00212-3; Attoui H, 2005, J GEN VIROL, V86, P3409, DOI 10.1099/vir.0.81258-0; Attoui H, 2009, VIROLOGY, V394, P298, DOI 10.1016/j.virol.2009.08.032; Batten CA, 2013, VET MICROBIOL, V162, P62, DOI 10.1016/j.vetmic.2012.08.014; Batten C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096049; Belhouchet M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025697; Belhouchet M, 2010, J GEN VIROL, V91, P2985, DOI 10.1099/vir.0.024760-0; Boyce M, 2008, J VIROL, V82, P8339, DOI 10.1128/JVI.00808-08; Chaignat V, 2010, SMALL RUMINANT RES, V93, P157, DOI 10.1016/j.smallrumres.2010.05.016; Chaignat V, 2009, VET MICROBIOL, V138, P11, DOI 10.1016/j.vetmic.2009.02.003; Darpel KE, 2007, VET REC, V161, P253, DOI 10.1136/vr.161.8.253; Feenstra F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092377; Firth AE, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-48; GOULD AR, 1987, VIRUS RES, V7, P169, DOI 10.1016/0168-1702(87)90078-5; Grimes JM, 1997, STRUCTURE, V5, P885, DOI 10.1016/S0969-2126(97)00243-8; Grimes JM, 1998, NATURE, V395, P470, DOI 10.1038/26694; GUMM ID, 1982, ARCH VIROL, V72, P83, DOI 10.1007/BF01314453; Hofmann MA, 2008, EMERG INFECT DIS, V14, P1855, DOI 10.3201/eid1412.080818; HOWERTH EW, 1988, AM J VET RES, V49, P1906; Huismans H, 2004, Vet Ital, V40, P417; HUISMANS H, 1981, ONDERSTEPOORT J VET, V48, P51; HUISMANS H, 1987, J VIROL, V61, P3589, DOI 10.1128/JVI.61.11.3589-3595.1987; HUISMANS H, 1979, VIROLOGY, V92, P397, DOI 10.1016/0042-6822(79)90144-2; IGARASHI A, 1978, J GEN VIROL, V40, P531, DOI 10.1099/0022-1317-40-3-531; Jenckel M, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.00016-15; Karber G, 1931, EXP PATHOL PHARM, V162, P480; King B M, 1985, Prog Clin Biol Res, V178, P289; Maan NS, 2015, J VIROL METHODS, V213, P118, DOI 10.1016/j.jviromet.2014.11.012; Maan S, 2007, J GEN VIROL, V88, P621, DOI 10.1099/vir.0.82456-0; Maan S, 2011, PLOS ONE, V6; Maan S, 2008, VIROLOGY, V377, P308, DOI 10.1016/j.virol.2008.04.028; Maan S, 2007, J VIROL METHODS, V143, P132, DOI 10.1016/j.jviromet.2007.02.016; Maan S, 2011, EMERG INFECT DIS, V17, P886, DOI 10.3201/eid1705.101742; Maan S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010323; MacLachlan NJ, 2010, VET RES, V41, DOI 10.1051/vetres/2010007; Matsuo E, 2013, J VIROL, V87, P882, DOI 10.1128/JVI.02363-12; Mertens PPC, 1996, VIROLOGY, V217, P582, DOI 10.1006/viro.1996.0153; MERTENS PPC, 1984, VIROLOGY, V135, P207, DOI 10.1016/0042-6822(84)90131-4; Mertens PPC., 2005, VIRUS TAXONOMY, P466; Meyer G, 2009, EMERG INFECT DIS, V15, P608, DOI 10.3201/eid1504.081514; Nomikou K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006437; Nunes SF, 2014, J VIROL, V88, P12222, DOI 10.1128/JVI.02183-14; PRITCHARD LI, 1995, VIRUS RES, V35, P247, DOI 10.1016/0168-1702(94)00072-K; Purse BV, 2008, REV SCI TECH OIE, V27, P427, DOI 10.20506/rst.27.2.1801; Purse BV, 2005, NAT REV MICROBIOL, V3, P171, DOI 10.1038/nrmicro1090; Quan M, 2008, J GEN VIROL, V89, P1159, DOI 10.1099/vir.0.83502-0; Ratinier M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002477; ROY P, 1992, J GEN VIROL, V73, P3051, DOI 10.1099/0022-1317-73-12-3051; ROY P, 1989, VIRUS RES, V13, P179, DOI 10.1016/0168-1702(89)90015-4; Roy P, 2008, CELL BIOCHEM BIOPHYS, V50, P143, DOI 10.1007/s12013-008-9009-4; Ruiz-Fons F, 2008, EMERG INFECT DIS, V14, P951, DOI 10.3201/eid1406.071586; SATO M, 1977, ARCH VIROL, V53, P269, DOI 10.1007/BF01314672; Shaw AE, 2013, J VIROL, V87, P543, DOI 10.1128/JVI.02266-12; Shaw AE, 2012, J VIROL, V86, P9015, DOI 10.1128/JVI.00131-12; Stewart M, 2015, J GEN VIROL, V96, P3280, DOI 10.1099/jgv.0.000267; STOTT JL, 1985, AM J VET RES, V46, P1197; Tabachnick WJ, 2010, J EXP BIOL, V213, P946, DOI 10.1242/jeb.037564; Tan BH, 2001, J VIROL, V75, P3937, DOI 10.1128/JVI.75.8.3937-3947.2001; van Gennip RGP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085788; van Gennip RGP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044619; van Gennip RGP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030540; Weaver SC, 2006, CURR TOP MICROBIOL, V299, P285; WECHSLER SJ, 1989, J INVERTEBR PATHOL, V54, P385, DOI 10.1016/0022-2011(89)90123-7; Wilson AJ, 2009, PHILOS T R SOC B, V364, P2669, DOI 10.1098/rstb.2009.0091; Zhang X, 2010, P NATL ACAD SCI USA, V107, P6292, DOI 10.1073/pnas.0913403107	67	18	18	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2016	11	2							e0149709	10.1371/journal.pone.0149709	http://dx.doi.org/10.1371/journal.pone.0149709			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3CO	26890863	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000371221500072
J	Fang, KF; Gao, S; Zhang, WW; Xing, Y; Cao, QQ; Qin, L				Fang, Kefeng; Gao, Sai; Zhang, Weiwei; Xing, Yu; Cao, Qingqin; Qin, Ling			Addition of Phenylboronic Acid to Malus domestica Pollen Tubes Alters Calcium Dynamics, Disrupts Actin Filaments and Affects Cell Wall Architecture	PLOS ONE			English	Article							RHAMNOGALACTURONAN-II; ARABINOGALACTAN PROTEINS; BORON DEFICIENCY; CROSS-LINKING; GROWTH; ROOT; CA2+; GERMINATION; ELONGATION; EXPRESSION	A key role of boron in plants is to cross-link the cell wall pectic polysaccharide rhamnogalacturonan-II (RG-II) through borate diester linkages. Phenylboronic acid (PBA) can form the same reversible ester bonds but cannot cross-link two molecules, so can be used as an antagonist to study the function of boron. This study aimed to evaluate the effect of PBA on apple (Malus domestica) pollen tube growth and the underlying regulatory mechanism. We observed that PBA caused an inhibition of pollen germination, tube growth and led to pollen tube morphological abnormalities. Fluorescent labeling, coupled with a scanning ion-selective electrode technique, revealed that PBA induced an increase in extracellular Ca2+ influx, thereby elevating the cytosolic Ca2+ concentration [Ca2+]c and disrupting the [Ca2+]c gradient, which is critical for pollen tube growth. Moreover the organization of actin filaments was severely perturbed by the PBA treatment. Immunolocalization studies and fluorescent labeling, together with Fourier-transform infrared analysis (FTIR) suggested that PBA caused an increase in the abundance of callose, de-esterified pectins and arabinogalactan proteins (AGPs) at the tip. However, it had no effect on the deposition of the wall polymers cellulose. These effects are similar to those of boron deficiency in roots and other organs, indicating that PBA can induce boron deficiency symptoms. The results provide new insights into the roles of boron in pollen tube development, which likely include regulating [Ca2+]c and the formation of the actin cytoskeleton, in addition to the synthesis and assembly of cell wall components.	[Fang, Kefeng; Gao, Sai; Zhang, Weiwei; Xing, Yu; Cao, Qingqin; Qin, Ling] Beijing Agr Univ, Coll Plant Sci & Technol, Beijing Key Lab Agr Applicat & New Tech, Beijing 102206, Peoples R China	Beijing University of Agriculture	Qin, L (corresponding author), Beijing Agr Univ, Coll Plant Sci & Technol, Beijing Key Lab Agr Applicat & New Tech, Beijing 102206, Peoples R China.	qinlingbac@126.com	cao, qingqin/W-5009-2019	Qin, Ling/0000-0002-9814-5771	National Natural Science Foundation of China [31270719, 30800874]; Importation and Development of High-Caliber Talents Project of Beijing Municipal Institutions [CITTCD201304095]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Importation and Development of High-Caliber Talents Project of Beijing Municipal Institutions	This work was supported by the National Natural Science Foundation of China (31270719, 30800874) to KFF, http://www.nsfc.gov.cn/, the Importation and Development of High-Caliber Talents Project of Beijing Municipal Institutions (CIT&TCD201304095) to KFF, http://www.bjedu.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves M.A.M., 2010, THESIS I TECNOLOGIA; Atmodjo MA, 2013, ANNU REV PLANT BIOL, V64, P747, DOI 10.1146/annurev-arplant-042811-105534; Bassil E, 2004, PLANT PHYSIOL, V136, P3383, DOI 10.1104/pp.104.040527; Braccini I, 2001, BIOMACROMOLECULES, V2, P1089, DOI 10.1021/bm010008g; Caffall KH, 2009, CARBOHYD RES, V344, P1879, DOI 10.1016/j.carres.2009.05.021; Cai G, 2011, PLANT PHYSIOL, V155, P1169, DOI 10.1104/pp.110.171371; Camacho-Cristobal JJ, 2008, J INTEGR PLANT BIOL, V50, P1247, DOI 10.1111/j.1744-7909.2008.00742.x; Cardenas L, 2008, PLANT PHYSIOL, V146, P1611, DOI 10.1104/pp.107.113035; Chebli Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058246; Chebli Y, 2012, PLANT PHYSIOL, V160, P1940, DOI 10.1104/pp.112.199729; Chen T, 2007, PLANT CELL PHYSIOL, V48, P19, DOI 10.1093/pcp/pcl036; Chen T, 2009, PLANT PHYSIOL, V149, P1111, DOI 10.1104/pp.108.127514; Dumont M, 2014, ANN BOT-LONDON, V114, P1177, DOI 10.1093/aob/mcu093; Fu Y, 2015, CURR OPIN PLANT BIOL, V28, P111, DOI 10.1016/j.pbi.2015.10.004; Gao S., 2014, J AGR, V4, P77; GLUSENKAMP KH, 1997, BORON SOILS PLANTS, P229; Gonzalez-Fontes A, 2014, PLANT SCI, V217, P135, DOI 10.1016/j.plantsci.2013.12.011; Hao HQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076660; Hepler PK, 2012, TRENDS PLANT SCI, V17, P32, DOI 10.1016/j.tplants.2011.10.007; Ishii T, 2001, PHYTOCHEMISTRY, V57, P969, DOI 10.1016/S0031-9422(01)00047-4; Iwai H, 2006, P NATL ACAD SCI USA, V103, P16592, DOI 10.1073/pnas.0605141103; Koshiba T, 2010, PLANT CELL PHYSIOL, V51, P323, DOI 10.1093/pcp/pcp179; Lamport DTA, 2014, ANN BOT-LONDON, V114, P1069, DOI 10.1093/aob/mcu161; Lamport DTA, 2013, NEW PHYTOL, V197, P58, DOI 10.1111/nph.12005; Lazzaro MD, 2003, PROTOPLASMA, V220, P201, DOI 10.1007/s00709-002-0042-7; Li YQ, 2002, PLANTA, V214, P734, DOI 10.1007/s004250100664; MARTINI F, 1993, PLANT PHYSIOL BIOCH, V31, P777; MCCANN MC, 1992, PLANT PHYSIOL, V100, P1940, DOI 10.1104/pp.100.4.1940; Miwa K, 2013, PLANT PHYSIOL, V163, P1699, DOI 10.1104/pp.113.225995; Moscatelli A, 2009, J INTEGR PLANT BIOL, V51, P727, DOI 10.1111/j.1744-7909.2009.00842.x; Nguema-Ona E, 2012, ANN BOT-LONDON, V110, P383, DOI 10.1093/aob/mcs143; Pereira AM, 2014, J EXP BOT, V65, P5459, DOI 10.1093/jxb/eru300; Qu XL, 2015, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00786; Quiles-Pando C, 2013, PLANT PHYSIOL BIOCH, V65, P55, DOI 10.1016/j.plaphy.2013.01.004; Redondo-Nieto M, 2012, NEW PHYTOL, V195, P14, DOI 10.1111/j.1469-8137.2012.04176.x; Rodriguez-Riano T, 2000, SEX PLANT REPROD, V12, P241, DOI 10.1007/s004970050008; Shi DQ, 2010, PLANT DEVELOPMENTAL BIOLOGY - BIOTECHNOLOGICAL PERSPECTIVES, VOL 1, P245, DOI 10.1007/978-3-642-02301-9_13; Springsteen G, 2002, TETRAHEDRON, V58, P5291, DOI 10.1016/S0040-4020(02)00489-1; Taylor LP, 1997, ANNU REV PLANT PHYS, V48, P461, DOI 10.1146/annurev.arplant.48.1.461; Tenhaken R, 2015, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00771; Voxeur A, 2014, PLANT J, V79, P139, DOI 10.1111/tpj.12547; Wang QL, 2003, TREE PHYSIOL, V23, P345, DOI 10.1093/treephys/23.5.345; Wolf S, 2012, PROTOPLASMA, V249, P169, DOI 10.1007/s00709-011-0371-5; Yu GH, 2014, J EXP BOT, V65, P3235, DOI 10.1093/jxb/eru171; Yu Q, 2003, PHYSIOL PLANTARUM, V117, P270, DOI 10.1034/j.1399-3054.2003.00029.x; Zhang WH, 1998, PLANT J, V15, P147, DOI 10.1046/j.1365-313X.1998.00188.x; Zhang Y, 2010, PLANT PHYSIOL, V152, P2200, DOI 10.1104/pp.109.142349	47	9	10	3	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0149232	10.1371/journal.pone.0149232	http://dx.doi.org/10.1371/journal.pone.0149232			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26886907	gold, Green Published, Green Submitted			2022-12-26	WOS:000371218400069
J	Mok, HJ; Shin, H; Lee, JW; Lee, GK; Suh, CS; Kim, KP; Lim, HJ				Mok, Hyuck Jun; Shin, Hyejin; Lee, Jae Won; Lee, Geun-Kyung; Suh, Chang Suk; Kim, Kwang Pyo; Lim, Hyunjung Jade			Age-Associated Lipidome Changes in Metaphase II Mouse Oocytes	PLOS ONE			English	Article							PROTEIN-KINASE-C; OXIDATIVE STRESS; MASS-SPECTROMETRY; CELLULAR SENESCENCE; DEVELOPMENTAL COMPETENCE; MEMBRANE-FLUIDITY; SIGNALING LIPIDS; GENE-EXPRESSION; CRYOPRESERVATION; QUANTIFICATION	The quality of mammalian oocytes declines with age, which negatively affects fertilization and developmental potential. The aging process often accompanies damages to macromolecules such as proteins, DNA, and lipids. To investigate if aged oocytes display an altered lipidome compared to young oocytes, we performed a global lipidomic analysis between oocytes from 4-week-old and 42 to 50-week-old mice. Increased oxidative stress is often considered as one of the main causes of cellular aging. Thus, we set up a group of 4-week-old oocytes treated with hydrogen peroxide (H2O2), a commonly used oxidative stressor, to compare if similar lipid species are altered between aged and oxidative-stressed oocytes. Between young and aged oocytes, we identified 26 decreased and 6 increased lipids in aged oocytes; and between young and H2O2-treated oocytes, we identified 35 decreased and 26 increased lipids in H2O2-treated oocytes. The decreased lipid species in these two comparisons were overlapped, whereas the increased lipid species were distinct. Multiple phospholipid classes, phosphatidic acid (PA), phosphatidylinositol (PI), phosphatidylserine (PS), and lysophosphatidylserine (LPS) significantly decreased both in H2O2-treated and aged oocytes, suggesting that the integrity of plasma membrane is similarly affected under these conditions. In contrast, a dramatic increase in diacylglycerol (DG) was only noted in H2O2-treated oocytes, indicating that the acute effect of H2O2-caused oxidative stress is distinct from aging-associated lipidome alteration. In H2O2-treated oocytes, the expression of lysophosphatidylcholine acyltransferase 1 increased along with increases in phosphatidylcholine. Overall, our data reveal that several classes of phospholipids are affected in aged oocytes, suggesting that the integrity of plasma membrane is associated with maintaining fertilization and developmental potential of mouse oocytes.	[Mok, Hyuck Jun; Lee, Jae Won; Kim, Kwang Pyo] Kyung Hee Univ, Inst Nat Sci, Dept Appl Chem, Yongin, Gyeonggi Do, South Korea; [Shin, Hyejin; Lee, Geun-Kyung; Lim, Hyunjung Jade] Konkuk Univ, Inst Biomed Sci & Technol, Dept Biomed Sci & Technol, Seoul, South Korea; [Suh, Chang Suk] Seoul Natl Univ, Dept Obstet & Gynecol, Bundang Hosp, Seongnam, Gyeonggi Do, South Korea; [Lim, Hyunjung Jade] Konkuk Univ, Dept Vet Med, Seoul, South Korea	Kyung Hee University; Konkuk University; Seoul National University (SNU); Konkuk University; Konkuk University Medical Center	Kim, KP (corresponding author), Kyung Hee Univ, Inst Nat Sci, Dept Appl Chem, Yongin, Gyeonggi Do, South Korea.; Lim, HJ (corresponding author), Konkuk Univ, Inst Biomed Sci & Technol, Dept Biomed Sci & Technol, Seoul, South Korea.; Lim, HJ (corresponding author), Konkuk Univ, Dept Vet Med, Seoul, South Korea.	kimkp@khu.ac.kr; hlim@konkuk.ac.kr	Lim, Hyunjung J/D-5343-2011; Kim, Kwang Pyo/AAG-1815-2020	Lim, Hyunjung J/0000-0003-2191-666X; Kim, Kwang Pyo/0000-0003-0095-3787	Korea Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [HI12C0055]	Korea Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea	This study was supported by a grant from the Korea Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (HI12C0055) (https://www.htdream.kr/).	Agarwal A, 2005, REPROD BIOL ENDOCRIN, V3, DOI 10.1186/1477-7827-3-28; Alberts B., 1995, TRENDS BIOCHEM SCI, V20, P210, DOI DOI 10.1016/S0968-0004(00)89011-8; Ambruosi B, 2009, THERIOGENOLOGY, V71, P1093, DOI 10.1016/j.theriogenology.2008.12.002; Bogliolo L, 2013, J ASSIST REPROD GEN, V30, P877, DOI 10.1007/s10815-013-0046-6; Butcher RA, 2009, P NATL ACAD SCI USA, V106, P1875, DOI 10.1073/pnas.0810338106; Dall'Armi C, 2013, CURR BIOL, V23, pR33, DOI 10.1016/j.cub.2012.10.041; de la Haba C, 2013, BBA-BIOMEMBRANES, V1828, P357, DOI 10.1016/j.bbamem.2012.08.013; Di Emidio G, 2014, HUM REPROD, V29, P2006, DOI 10.1093/humrep/deu160; Duan HM, 2005, INT J BIOCHEM CELL B, V37, P1407, DOI 10.1016/j.biocel.2005.01.010; Dunning KR, 2014, REPRODUCTION, V148, pR15, DOI 10.1530/REP-13-0251; Freikman I, 2008, BBA-BIOMEMBRANES, V1778, P2388, DOI 10.1016/j.bbamem.2008.06.008; Frippiat C, 2002, FREE RADICAL BIO MED, V33, P1334, DOI 10.1016/S0891-5849(02)01044-4; Furukawa A, 2007, CELL PHYSIOL BIOCHEM, V20, P45, DOI 10.1159/000104152; Genicot G, 2005, THERIOGENOLOGY, V63, P1181, DOI 10.1016/j.theriogenology.2004.06.006; Giraud MN, 2000, HUM REPROD, V15, P2160, DOI 10.1093/humrep/15.10.2160; Gopalacharyulu PV, 2009, MOL BIOSYST, V5, P276, DOI 10.1039/b815347g; Gray A, 2003, ANAL BIOCHEM, V313, P234, DOI 10.1016/S0003-2697(02)00607-3; Haag M, 2012, METABOLITES, V2, P57, DOI 10.3390/metabo2010057; Hagio M, 2009, J LIPID RES, V50, P173, DOI 10.1194/jlr.D800041-JLR200; Hamatani T, 2004, HUM MOL GENET, V13, P2263, DOI 10.1093/hmg/ddh241; Han XL, 2012, MASS SPECTROM REV, V31, P134, DOI 10.1002/mas.20342; Hatch GM, 2002, J LIPID RES, V43, P1380, DOI 10.1194/jlr.M200130-JLR200; Haughey NJ, 2004, ANN NEUROL, V55, P257, DOI 10.1002/ana.10828; Hawkins PT, 2015, BBA-MOL CELL BIOL L, V1851, P882, DOI 10.1016/j.bbalip.2014.12.006; Hekimi S, 2011, TRENDS CELL BIOL, V21, P569, DOI 10.1016/j.tcb.2011.06.008; Honda A, 2008, J LIPID RES, V49, P2063, DOI 10.1194/jlr.D800017-JLR200; HUANG KP, 1989, TRENDS NEUROSCI, V12, P425, DOI 10.1016/0166-2236(89)90091-X; Jiao Ze-Xu, 2012, Fertil Steril, V98, P480, DOI 10.1016/j.fertnstert.2012.04.035; Johnson KR, 2003, J BIOL CHEM, V278, P34541, DOI 10.1074/jbc.M301741200; Jung J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102620; Jungheim ES, 2011, FERTIL STERIL, V95, P1970, DOI 10.1016/j.fertnstert.2011.01.154; Lee JW, 2013, J CHROMATOGR A, V1279, P98, DOI 10.1016/j.chroma.2013.01.020; Lim J, 2011, BIOL REPROD, V84, P775, DOI 10.1095/biolreprod.110.088583; Lizaso A, 2013, AUTOPHAGY, V9, P1228, DOI 10.4161/auto.24893; Lolicato F, 2015, BIOL REPROD, V92, DOI 10.1095/biolreprod.114.120634; Masoodi M, 2006, RAPID COMMUN MASS SP, V20, P3023, DOI 10.1002/rcm.2697; Metwally M, 2007, REPROD BIOMED ONLINE, V15, P532, DOI 10.1016/S1472-6483(10)60385-9; Miao YL, 2009, HUM REPROD UPDATE, V15, P573, DOI 10.1093/humupd/dmp014; Milne S, 2006, METHODS, V39, P92, DOI 10.1016/j.ymeth.2006.05.014; OBEID LM, 1993, SCIENCE, V259, P1769, DOI 10.1126/science.8456305; Ottolenghi C, 2004, ANN NY ACAD SCI, V1034, P117, DOI 10.1196/annals.1335.015; Pan H, 2008, DEV BIOL, V316, P397, DOI 10.1016/j.ydbio.2008.01.048; Prates EG, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/692067; Prokazova NV, 2007, BIOCHEMISTRY-MOSCOW+, V72, P797, DOI 10.1134/S0006297907080019; Sasaki M, 2014, BIOCHEM BIOPH RES CO, V452, P622, DOI 10.1016/j.bbrc.2014.08.123; Seidler EA, 2015, SEMIN REPROD MED, V33, P396, DOI 10.1055/s-0035-1567822; Selesniemi K, 2011, P NATL ACAD SCI USA, V108, P12319, DOI 10.1073/pnas.1018793108; Soupene E, 2012, BMC BIOCHEM, V13, DOI 10.1186/1471-2091-13-8; Takahashi T, 2003, MOL REPROD DEV, V66, P143, DOI 10.1002/mrd.10341; Takekoshi S, 1995, BIOCHEM BIOPH RES CO, V217, P654, DOI 10.1006/bbrc.1995.2824; Tarin JJ, 1996, MOL HUM REPROD, V2, P717, DOI 10.1093/molehr/2.10.717; Tatone C, 2013, FERTIL STERIL, V99, P12, DOI 10.1016/j.fertnstert.2012.11.029; Thannickal VJ, 2000, AM J PHYSIOL-LUNG C, V279, pL1005; Vance JE, 2008, BIOCHEMISTRY OF LIPI; Yang J, 2011, MOL BIOSYST, V7, P2428, DOI 10.1039/c1mb00002k; Yang K, 2011, METABOLITES, V1, P21, DOI 10.3390/metabo1010021; Zhang W, 2012, ANIM REPROD SCI, V132, P115, DOI 10.1016/j.anireprosci.2012.05.008; Zhang X, 2006, CELL RES, V16, P841, DOI 10.1038/sj.cr.7310095; Ziegler DV, 2015, AGING CELL, V14, P1, DOI 10.1111/acel.12287	59	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0148577	10.1371/journal.pone.0148577	http://dx.doi.org/10.1371/journal.pone.0148577			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	26881843	Green Published, gold, Green Submitted			2022-12-26	WOS:000371219000018
J	Niu, YF; Ahammed, GJ; Tang, CX; Guo, LB; Yu, JQ				Niu, Yaofang; Ahammed, Golam Jalal; Tang, Caixian; Guo, Longbiao; Yu, Jingquan			Physiological and Transcriptome Responses to Combinations of Elevated CO2 and Magnesium in Arabidopsis thaliana	PLOS ONE			English	Article							ATMOSPHERIC CARBON-DIOXIDE; ENZYME-ACTIVITIES; PHOTOSYSTEM-II; BEAN-PLANTS; ROOT HAIRS; L. HEYNH; DEFICIENCY; GENE; TRANSPORTER; EXPRESSION	The unprecedented rise in atmospheric CO2 concentration and injudicious fertilization or heterogeneous distribution of Mg in the soil warrant further research to understand the synergistic and holistic mechanisms involved in the plant growth regulation. This study investigated the influence of elevated CO2 (800 mu L L-1) on physiological and transcriptomic profiles in Arabidopsis cultured in hydroponic media treated with 1 mu M (low), 1000 mu M (normal) and 10000 mu M (high) Mg2+. Following 7-d treatment, elevated CO2 increased the shoot growth and chlorophyll content under both low and normal Mg supply, whereas root growth was improved exclusively under normal Mg nutrition. Notably, the effect of elevated CO2 on mineral homeostasis in both shoots and roots was less than that ofMg supply. Irrespective of CO2 treatment, high Mg increased number of young leaf but decreased root growth and absorption of P, K, Ca, Fe andMn whereas low Mg increased the concentration of P, K, Ca and Fe in leaves. Transcriptomics results showed that elevated CO2 decreased the expression of genes related to cell redox homeostasis, cadmium response, and lipid localization, but enhanced signal transduction, protein phosphorylation, NBS-LRR disease resistance proteins and subsequently programmed cell death in low-Mg shoots. By comparison, elevated CO2 enhanced the response of lipid localization (mainly LTP transfer protein/protease inhibitor), endomembrane system, heme binding and cell wall modification in high-Mg roots. Some of these transcriptomic results are substantially in accordance with our physiological and/or biochemical analysis. The present findings broaden our current understanding on the interactive effect of elevated CO2 and Mg levels in the Arabidopsis, which may help to design the novelmetabolic engineering strategies to cope with Mg deficiency/excess in crops under elevated CO2.	[Niu, Yaofang; Guo, Longbiao] China Natl Rice Res Inst, State Key Lab Rice Biol, Hangzhou 310006, Zhejiang, Peoples R China; [Niu, Yaofang; Ahammed, Golam Jalal; Yu, Jingquan] Zhejiang Univ, Coll Agr & Biotechnol, Dept Hort, Hangzhou 310058, Zhejiang, Peoples R China; [Tang, Caixian] La Trobe Univ, Ctr AgriBiosci, Melbourne Campus, Bundoora, Vic 3086, Australia	Chinese Academy of Agricultural Sciences; China National Rice Research Institute, CAAS; Zhejiang University; La Trobe University	Guo, LB (corresponding author), China Natl Rice Res Inst, State Key Lab Rice Biol, Hangzhou 310006, Zhejiang, Peoples R China.; Yu, JQ (corresponding author), Zhejiang Univ, Coll Agr & Biotechnol, Dept Hort, Hangzhou 310058, Zhejiang, Peoples R China.	guolongb@mail.hz.zj.cn; jqyu@zju.edu.cn	Ahammed, Golam Jalal/B-7548-2012; Tang, Caixian/S-8702-2019; Yu, J.Q./C-9509-2015	Ahammed, Golam Jalal/0000-0001-9621-8431; Tang, Caixian/0000-0002-9138-8770; Yu, J.Q./0000-0002-7626-1165	China Postdoctoral Science Foundation [517000-X91403]; National Natural Science Foundation of China [31550110201]; Zhejiang Provincial priority projects in forestry sciences [KF201310, KF201311]	China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial priority projects in forestry sciences	This work was supported by grants of the China Postdoctoral Science Foundation (517000-X91403, http://jj.chinapostdoctor.org.cn/V1/Program1/Default.aspx), the National Natural Science Foundation of China (31550110201, http://www.nsfc.gov.cn/), the Zhejiang Provincial priority projects in forestry sciences (KF201310 and KF201311, http://kjc2.zafu.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank anonymous reviewers for their constructive comments on the manuscript. We thank Hangzhou Guhe Information and Technology Co., Ltd for the help with RNA-seq sequencing and bioinformatics analysis. This work was financially supported by Grants of the China Postdoctoral Science Foundation (517000-X91403, http://jj.chinapostdoctor.org.cn/V1/Program1/Default.aspx), the National Natural Science Foundation of China (31550110201, http://www.nsfc.gov.cn/) and the Zhejiang Provincial priority projects in forestry sciences (KF201310 and KF201311).	Ahuja I, 2010, TRENDS PLANT SCI, V15, P664, DOI 10.1016/j.tplants.2010.08.002; Armengaud P, 2004, PLANT PHYSIOL, V136, P2556, DOI 10.1104/pp.104.046482; Azam A, 2013, J SCI FOOD AGR, V93, P3237, DOI 10.1002/jsfa.6165; BassiriRad H, 2001, OECOLOGIA, V126, P305, DOI 10.1007/s004420000524; Berntson GM, 1997, GLOBAL CHANGE BIOL, V3, P247, DOI 10.1046/j.1365-2486.1997.00070.x; CAKMAK I, 1994, J EXP BOT, V45, P1245, DOI 10.1093/jxb/45.9.1245; CAKMAK I, 1994, J EXP BOT, V45, P1251, DOI 10.1093/jxb/45.9.1251; Cakmak I, 2008, PHYSIOL PLANTARUM, V133, P692, DOI 10.1111/j.1399-3054.2007.01042.x; CARTER DP, 1980, ARCH BIOCHEM BIOPHYS, V200, P374, DOI 10.1016/0003-9861(80)90367-7; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; David-Assael O, 2005, J EXP BOT, V56, P1039, DOI 10.1093/jxb/eri097; Rodriguez-Hernandez MD, 2014, PLANT CELL PHYSIOL, V55, P2047, DOI 10.1093/pcp/pcu130; Ding Y, 2006, ANN APPL BIOL, V149, P111, DOI 10.1111/j.1744-7348.2006.00080.x; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Gan YB, 2006, PLANT CELL, V18, P1383, DOI 10.1105/tpc.106.041533; Gardner RC, 2003, CURR OPIN PLANT BIOL, V6, P263, DOI 10.1016/S1369-5266(03)00032-3; Gebert M, 2009, PLANT CELL, V21, P4018, DOI 10.1105/tpc.109.070557; Gerendas J, 2013, PLANT SOIL, V368, P101, DOI 10.1007/s11104-012-1555-2; Hermans C, 2005, J EXP BOT, V56, P2153, DOI 10.1093/jxb/eri215; Hermans C, 2005, PLANTA, V220, P541, DOI 10.1007/s00425-004-1376-5; Hermans C, 2004, PLANTA, V220, P344, DOI 10.1007/s00425-004-1340-4; Hermans C, 2006, TRENDS PLANT SCI, V11, P610, DOI 10.1016/j.tplants.2006.10.007; Hermans C, 2010, NEW PHYTOL, V187, P132, DOI 10.1111/j.1469-8137.2010.03257.x; Hermans C, 2010, NEW PHYTOL, V187, P119, DOI 10.1111/j.1469-8137.2010.03258.x; Huber DM, 2013, PLANT SOIL, V368, P73, DOI 10.1007/s11104-012-1476-0; Iyer-Pascuzzi A, 2009, CURR OPIN PLANT BIOL, V12, P165, DOI 10.1016/j.pbi.2008.11.002; Jin CW, 2009, PLANT PHYSIOL, V150, P272, DOI 10.1104/pp.109.136721; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Karley AJ, 2009, CURR OPIN PLANT BIOL, V12, P291, DOI 10.1016/j.pbi.2009.04.013; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kogawara S, 2006, TREE PHYSIOL, V26, P25, DOI 10.1093/treephys/26.1.25; Kramer U, 2007, FEBS LETT, V581, P2263, DOI 10.1016/j.febslet.2007.04.010; Lake JA, 2009, J EXP BOT, V60, P3123, DOI 10.1093/jxb/erp147; Li LG, 2008, MOL PLANT, V1, P675, DOI 10.1093/mp/ssn031; Long SP, 2004, ANNU REV PLANT BIOL, V55, P591, DOI 10.1146/annurev.arplant.55.031903.141610; Maguire ME, 2002, BIOMETALS, V15, P203, DOI 10.1023/A:1016058229972; Maser P, 2001, PLANT PHYSIOL, V126, P1646, DOI 10.1104/pp.126.4.1646; Misson J, 2005, P NATL ACAD SCI USA, V102, P11934, DOI 10.1073/pnas.0505266102; Moller IS, 2009, PLANT CELL, V21, P2163, DOI 10.1105/tpc.108.064568; Morel M, 2009, PLANT PHYSIOL, V149, P894, DOI 10.1104/pp.108.130294; Muller AH, 2009, PLANT PHYSIOL, V150, P157, DOI 10.1104/pp.109.135277; Mundy J, 2006, TRENDS PLANT SCI, V11, P63, DOI 10.1016/j.tplants.2005.12.003; Nakata M, 2012, PLANT CELL, V24, P519, DOI 10.1105/tpc.111.092858; Neuhaus C, 2013, PLANT SOIL, V368, P41, DOI 10.1007/s11104-013-1711-3; Niu YF, 2014, PLANT SIGNAL BEHAV, V9, DOI 10.4161/psb.29720; Niu YF, 2014, PLANT CELL ENVIRON, V37, P2795, DOI 10.1111/pce.12362; Niu YF, 2013, J EXP BOT, V64, P355, DOI 10.1093/jxb/ers341; Niu YF, 2011, PLANT CELL ENVIRON, V34, P1304, DOI 10.1111/j.1365-3040.2011.02330.x; Oerke EC., 1994, CROP PRODUCTION CROP; Osuna D, 2007, PLANT J, V49, P463, DOI 10.1111/j.1365-313X.2006.02979.x; Rasmussen S, 2013, PLANT PHYSIOL, V161, P1783, DOI 10.1104/pp.112.210773; Reddy AR, 2010, CURR SCI INDIA, V99, P46; Shabala S, 2005, PLANTA, V221, P56, DOI 10.1007/s00425-004-1425-0; Shaul O, 1999, EMBO J, V18, P3973, DOI 10.1093/emboj/18.14.3973; Shaul O, 2002, BIOMETALS, V15, P309, DOI 10.1023/A:1016091118585; Shin R, 2004, P NATL ACAD SCI USA, V101, P8827, DOI 10.1073/pnas.0401707101; STITT M, 1991, PLANTA, V183, P40, DOI 10.1007/BF00197565; STULEN I, 1993, VEGETATIO, V104, P99, DOI 10.1007/BF00048147; STURN A, 2000, THESIS GRAZ U TECHNO; Taub D., 2010, NAT ED KNOWL, V3, P21; Tewari RK, 2006, SCI HORTIC-AMSTERDAM, V108, P7, DOI 10.1016/j.scienta.2005.12.006; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Usadel B, 2008, PLANT CELL ENVIRON, V31, P518, DOI 10.1111/j.1365-3040.2007.01763.x; Visscher AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012348; Wang H, 2013, PLANTA, V237, P137, DOI 10.1007/s00425-012-1763-2	67	17	17	2	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0149301	10.1371/journal.pone.0149301	http://dx.doi.org/10.1371/journal.pone.0149301			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	26881808	Green Submitted, Green Published, gold			2022-12-26	WOS:000371219000068
J	Xie, YC; Shi, CM; Tong, ML; Zhang, M; Li, TT; Xu, YQ; Guo, XR; Qin, H; Chi, X				Xie, Yachun; Shi, Chunmei; Tong, Meiling; Zhang, Min; Li, Tingting; Xu, Yaqin; Guo, Xirong; Hong, Qin; Chi, Xia			Developmental Eye Movement (DEM) Test Norms for Mandarin Chinese-Speaking Chinese Children	PLOS ONE			English	Article							READING DISABILITIES; SKILLS; POPULATION; DYSLEXIA	The Developmental Eye Movement (DEM) test is commonly used as a clinical visual-verbal ocular motor assessment tool to screen and diagnose reading problems at the onset. No established norm exists for using the DEM test with Mandarin Chinese-speaking Chinese children. This study aims to establish the normative values of the DEM test for the Mandarin Chinese-speaking population in China; it also aims to compare the values with three other published norms for English-, Spanish-, and Cantonese-speaking Chinese children. A random stratified sampling method was used to recruit children from eight kindergartens and eight primary schools in the main urban and suburban areas of Nanjing. A total of 1,425 Mandarin Chinese-speaking children aged 5 to 12 years took the DEM test in Mandarin Chinese. A digital recorder was used to record the process. All of the subjects completed a symptomatology survey, and their DEM scores were determined by a trained tester. The scores were computed using the formula in the DEM manual, except that the "vertical scores" were adjusted by taking the vertical errors into consideration. The results were compared with the three other published norms. In our subjects, a general decrease with age was observed for the four eye movement indexes: vertical score, adjusted horizontal score, ratio, and total error. For both the vertical and adjusted horizontal scores, the Mandarin Chinese-speaking children completed the tests much more quickly than the norms for English- and Spanish-speaking children. However, the same group completed the test slightly more slowly than the norms for Cantonese-speaking children. The differences in the means were significant (P<0.001) in all age groups. For several ages, the scores obtained in this study were significantly different from the reported scores of Cantonese-speaking Chinese children (P<0.005). Compared with English-speaking children, only the vertical score of the 6-year-old group, the vertical-horizontal time ratio of the 8-year-old group and the errors of 9-year-old group had no significant difference (P>0.05); compared with Spanish-speaking children, the scores were statistically significant (P<0.001) for the total error scores of the age groups, except the 6-, 9-, 10-, and 11-year-old age groups (P>0.05). DEM norms may be affected by differences in language, cultural, and educational systems among various ethnicities. The norms of the DEM test are proposed for use with Mandarin Chinese-speaking children in Nanjing and will be proposed for children throughout China.	[Xie, Yachun; Shi, Chunmei; Tong, Meiling; Zhang, Min; Li, Tingting; Xu, Yaqin; Guo, Xirong; Hong, Qin; Chi, Xia] Nanjing Med Univ, Nanjing Matern & Child Hlth Care Hosp, Dept Children Hlth Care, Nanjing, Jiangsu, Peoples R China; [Tong, Meiling; Guo, Xirong; Chi, Xia] Nanjing Med Univ, Inst Pediat, Nanjing, Jiangsu, Peoples R China; [Li, Tingting] Dachang Community Hlth Serv Ctr, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University	Chi, X (corresponding author), Nanjing Med Univ, Nanjing Matern & Child Hlth Care Hosp, Dept Children Hlth Care, Nanjing, Jiangsu, Peoples R China.; Chi, X (corresponding author), Nanjing Med Univ, Inst Pediat, Nanjing, Jiangsu, Peoples R China.	chixia2001@njmu.edu.cn			National Natural Science Foundation of China [81250008, 81270928, 81500674]; Program for Medical Talents of Jiangsu Province [RC2011022]; Nanjing Technological Development Program [201108007, WYKK12097]; Science and Technology Development Fund of Nanjing Medical University [2014NJMUZD041]; Nanjing Talent Training Program [QRX11108]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Medical Talents of Jiangsu Province; Nanjing Technological Development Program; Science and Technology Development Fund of Nanjing Medical University; Nanjing Talent Training Program	This work was supported by grants from the National Natural Science Foundation of China (81250008, 81270928, 81500674), the Program for Medical Talents of Jiangsu Province (RC2011022), the Nanjing Technological Development Program (201108007, WYKK12097), the Science and Technology Development Fund of Nanjing Medical University (2014NJMUZD041) and the Nanjing Talent Training Program (QRX11108). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen XY, 1997, DEV PSYCHOL, V33, P518, DOI 10.1037/0012-1649.33.3.518; Dandache S, 2014, DYSLEXIA, V20, P305, DOI 10.1002/dys.1482; EDEN GF, 1994, VISION RES, V34, P1345, DOI 10.1016/0042-6989(94)90209-7; FernandezVelazquez FJ, 1995, OPTOMETRY VISION SCI, V72, P902, DOI 10.1097/00006324-199512000-00009; Fluss J, 2008, ARCH PEDIATRIE, V15, P1049, DOI 10.1016/j.arcped.2008.02.012; Garzia R, 2008, OPTOMETRIC CLIN PRAC; Garzia R P, 1990, J Am Optom Assoc, V61, P124; Baptista AMG, 2011, OPTOMETRY VISION SCI, V88, P864, DOI 10.1097/OPX.0b013e3182195dae; Ho CS-H., 1999, EDUC CHILD PSYCHOL, V16, P4, DOI DOI 10.1177/0022219409345016; Jimenez R, 2003, OPHTHAL PHYSL OPT, V23, P97, DOI 10.1046/j.1475-1313.2003.00093.x; Kozeis N, 2006, INT J NEUROSCI, V116, P1347, DOI 10.1080/00207450500514011; Kulp MT, 1997, OPTOMETRY VISION SCI, V74, P37, DOI 10.1097/00006324-199701000-00018; Kulp MT, 1998, OPTOMETRY VISION SCI, V75, P284, DOI 10.1097/00006324-199804000-00026; Kunert R, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01129; Marandi RZ, 2014, BASIC CLIN NEUROSCI, V5, P55; Meng XZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108274; Palomo-Alvarez C, 2009, GRAEF ARCH CLIN EXP, V247, P1243, DOI 10.1007/s00417-009-1076-8; Pang PC, 2010, CLIN EXP OPTOM, V93, P341, DOI 10.1111/j.1444-0938.2010.00501.x; Pang PC, 2010, CLIN EXP OPTOM, V93, P213, DOI 10.1111/j.1444-0938.2010.00470.x; Powers Maureen, 2008, Optometry, V79, P228, DOI 10.1016/j.optm.2007.07.014; Richman J. E., 2009, DEV EYE MOVEMENT TES; Shaywitz SE, 1998, NEW ENGL J MED, V338, P307, DOI 10.1056/NEJM199801293380507; Solan H A, 1998, J Am Optom Assoc, V69, P455; STEVENSON HW, 1982, CHILD DEV, V53, P1164, DOI 10.2307/1129005; Tassinari J T, 2005, Optometry, V76, P387, DOI 10.1016/j.optm.2005.05.006; Webber AL, 2009, OPTOMETRY VISION SCI, V86, P760, DOI 10.1097/OPX.0b013e3181a523b7; YGGE J, 1993, ACTA OPHTHALMOL, V71, P10	27	10	11	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0148481	10.1371/journal.pone.0148481	http://dx.doi.org/10.1371/journal.pone.0148481			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	26881754	Green Submitted, Green Published, gold			2022-12-26	WOS:000371219000016
J	Xiong, WJ; Dong, HP; Wang, JJ; Zou, XM; Wen, Q; Luo, W; Liu, SD; He, JC; Cai, SX; Ma, L				Xiong, Wenjing; Dong, Haiping; Wang, Juanjuan; Zou, Xiaoming; Wen, Qian; Luo, Wei; Liu, Sudong; He, Jianchun; Cai, Shaoxi; Ma, Li			Analysis of Plasma Cytokine and Chemokine Profiles in Patients with and without Tuberculosis by Liquid Array-Based Multiplexed Immunoassays	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; MYCOBACTERIUM-TUBERCULOSIS; BIOMARKERS; INFECTION; RESPONSES; INTERLEUKIN-1-BETA; DISEASE; INFLAMMATION; ASSOCIATION; PERFORMANCE	The aim of this study was to establish plasma cytokine/chemokine profiles in patients with 3 different presentations of active tuberculosis (TB), compared to the profiles observed in bacillus Calmette-Guerin (BCG)-vaccinated healthy individuals and patients with other pulmonary diseases (non-TB patients). To this end, plasma samples were collected from 151 TB patients including 68 pulmonary TB (PTB), 43 endobronchial TB, and 40 tuberculosis pleurisy (TP) patients, as well as 107 no-TB cases including 26 non-TB patients and 81 BCG-vaccinated healthy controls. A liquid array-based multiplexed immunoassay was used to screen plasma samples for 20 distinct cytokines and chemokines. Multinomial logistic regression was used to analyze associations between cytokines/chemokines and TB/non-TB patients. Compared to our findings with the no-TB donors, the median plasma levels of the proinflammatory cytokines/chemokines TNF-alpha, IL-6, IP-10, IFN-gamma, and MIP-1 beta were significantly elevated in TB patients, suggesting their potential use as biomarkers for diagnosing TB patients. Further comparisons with healthy donors showed that only the median TNF-alpha plasma level was highly produced in the plasma of all 3 types of TB patients. Plasma IL-6 production was higher only in TP patients, while the plasma levels of IP-10, IFN-gamma, and MIP-1 beta were markedly enhanced in both PTB and TP patients. Unexpectedly, among the above cytokines/chemokines, MIP-1 beta was also highly expressed in non-TB patients, compared with healthy donors. Our results suggested that TNF-alpha may be an ideal biomarker for diagnosing the 3 forms of TB presentation, while the other factors (IL-6, IP-10, MCP-1, and IFN-gamma) can potentially facilitate differential diagnosis for the 3 TB presentation types. Further characterization of immune responses associated with different types of TB diseases will provide a basis for developing novel TB diagnostics.	[Xiong, Wenjing; Dong, Haiping; Wang, Juanjuan; Wen, Qian; Luo, Wei; Liu, Sudong; He, Jianchun; Ma, Li] Southern Med Univ, Inst Mol Immunol, Sch Biotechnol, Guangzhou 510515, Guangdong, Peoples R China; [Dong, Haiping; Cai, Shaoxi] Southern Med Univ, Nanfang Hosp, Dept Resp & Crit Care Med, Guangzhou 510515, Guangdong, Peoples R China; [Zou, Xiaoming] First Peoples Hosp Kashi, Xinjiang 844000, Peoples R China	Southern Medical University - China; Southern Medical University - China	Ma, L (corresponding author), Southern Med Univ, Inst Mol Immunol, Sch Biotechnol, Guangzhou 510515, Guangdong, Peoples R China.; Cai, SX (corresponding author), Southern Med Univ, Nanfang Hosp, Dept Resp & Crit Care Med, Guangzhou 510515, Guangdong, Peoples R China.	hxkcai@126.com; maryhmz@126.com	wang, juanjuan/GYV-5540-2022	Ma, Li/0000-0001-5847-2375	National Science and Technology Key Projects on Major Infectious Diseases [2012ZX10003002-007]; National Natural Science Foundation of China [81371764, 81171539, 81571951]; Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme; Guangdong Natural Science Foundation [2014A030313322]; Science and Technology Project of Guangdong Province [2013B010404020]; Scientific and Technological Innovation Project of Guangdong Province Discipline Construction Special Funds [2013KJCX0036]; Science and Technology Supporting Project of Xinjiang Uygur Autonomous Region [2013911122]; Institute of Molecular Immunology	National Science and Technology Key Projects on Major Infectious Diseases; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme; Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province); Science and Technology Project of Guangdong Province; Scientific and Technological Innovation Project of Guangdong Province Discipline Construction Special Funds; Science and Technology Supporting Project of Xinjiang Uygur Autonomous Region; Institute of Molecular Immunology	This work was supported by National Science and Technology Key Projects on Major Infectious Diseases (2012ZX10003002-007) http://www.most.gov.cn/index.htm; National Natural Science Foundation of China (81371764, 81171539, 81571951) http://www.nsfc.gov.cn/; Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme (2012) http://www.gdhed.edu.cn/; Guangdong Natural Science Foundation (2014A030313322) http://www.gdstc.gov.cn/; Science and Technology Project of Guangdong Province (2013B010404020) http://www.gdstc.gov.cn/; Scientific and Technological Innovation Project of Guangdong Province Discipline Construction Special Funds (2013KJCX0036) http://www.gdhed.edu.cn/; Science and Technology Supporting Project of Xinjiang Uygur Autonomous Region (2013911122) http://www.most.gov.cn/index.htm; all of these support Institute of Molecular Immunology and Li Ma is the recipient. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akarsu S, 2005, MEDIAT INFLAMM, P2, DOI 10.1155/MI.2005.2; Algood HMS, 2003, CYTOKINE GROWTH F R, V14, P467, DOI 10.1016/S1359-6101(03)00054-6; Bhat IA, 2014, META GENE, V2, P123, DOI 10.1016/j.mgene.2013.12.002; Brock L, 2004, AM J RESP CRIT CARE, V170, P65, DOI 10.1164/rccm.200402-232OC; Chegou NN, 2014, EUR RESPIR J, V43, P1472, DOI 10.1183/09031936.00151413; Clute SC, 2010, J IMMUNOL, V185, P6753, DOI 10.4049/jimmunol.1000812; Deshmane SL, 2009, J INTERF CYTOK RES, V29, P313, DOI 10.1089/jir.2008.0027; Dhanasekaran S, 2013, GENES IMMUN, V14, P356, DOI 10.1038/gene.2013.26; Dinarello CA, 2011, BLOOD, V117, P3720, DOI 10.1182/blood-2010-07-273417; Dorhoi A, 2014, SEMIN IMMUNOL, V26, P203, DOI 10.1016/j.smim.2014.04.003; Etna MP, 2014, SEMIN IMMUNOL, V26, P543, DOI 10.1016/j.smim.2014.09.011; Feng JY, 2013, DIAGN MICR INFEC DIS, V77, P46, DOI 10.1016/j.diagmicrobio.2013.05.020; Harari A, 2011, NAT MED, V17, P372, DOI 10.1038/nm.2299; Hasan Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008459; Idriss HT, 2000, MICROSC RES TECHNIQ, V50, P184, DOI 10.1002/1097-0029(20000801)50:3<184::AID-JEMT2>3.0.CO;2-H; Jo EK, 2003, CURR OPIN INFECT DIS, V16, P205, DOI 10.1097/00001432-200306000-00004; John SH, 2012, BIOMARKERS, V17, P1, DOI 10.3109/1354750X.2011.628048; Kabeer BSA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009051; Kang DD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016161; Klimiuk J, 2015, ADV EXP MED BIOL, V852, P21, DOI 10.1007/5584_2014_105; Kwan ML, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1263-4; Lalor MK, 2011, J INFECT DIS, V204, P1075, DOI 10.1093/infdis/jir515; Lin YG, 1998, INFECT IMMUN, V66, P1121, DOI 10.1128/IAI.66.3.1121-1126.1998; Liu Z, 2012, CURR MICROBIOL, V65, P313, DOI 10.1007/s00284-012-0157-9; Lou XL, 2013, CAN J MICROBIOL, V59, P620, DOI 10.1139/cjm-2013-0259; Mihret A, 2013, J INFECTION, V66, P357, DOI 10.1016/j.jinf.2012.11.005; Monin L, 2014, SEMIN IMMUNOL, V26, P552, DOI 10.1016/j.smim.2014.09.004; MUNK ME, 1995, EUR RESPIR J, V8, pS668; Murdoch C, 2000, BLOOD, V95, P3032; Nolan A, 2013, INT J TUBERC LUNG D, V17, P922, DOI 10.5588/ijtld.12.0610; Ray JCJ, 2009, J IMMUNOL, V182, P3706, DOI 10.4049/jimmunol.0802297; Sharma SK, 2004, INDIAN J MED RES, V120, P316; Shen ZT, 2013, J IMMUNOL, V191, P5139, DOI 10.4049/jimmunol.1300852; Siawaya JFD, 2009, CYTOKINE, V47, P132, DOI 10.1016/j.cyto.2009.05.016; Singh PP, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-686; Tadele A, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0585-1; Tanaka T, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016295; Toujani S, 2015, REV PNEUMOL CLIN, V71, P73, DOI 10.1016/j.pneumo.2015.02.001; Tsao TCY, 2000, CHEST, V117, P103, DOI 10.1378/chest.117.1.103; Valdes L, 1998, ARCH INTERN MED, V158, P2017, DOI 10.1001/archinte.158.18.2017; Vergne I, 2005, P NATL ACAD SCI USA, V102, P4033, DOI 10.1073/pnas.0409716102; Wang L, 2014, CANCER RES, V74, P4720, DOI 10.1158/0008-5472.CAN-14-0960; Xue Q, 2011, EUR J CLIN MICROBIOL, V30, P1039, DOI 10.1007/s10096-011-1205-2; Yamada H, 2000, LAB INVEST, V80, P759, DOI 10.1038/labinvest.3780079; Yang J, 2003, MICROB PATHOGENESIS, V34, P17, DOI 10.1016/S0882-4010(02)00190-0	45	16	17	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0148885	10.1371/journal.pone.0148885	http://dx.doi.org/10.1371/journal.pone.0148885			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	26881918	Green Submitted, Green Published, gold			2022-12-26	WOS:000371219000029
J	Diep, CS; Lemaitre, RN; Chen, TA; Baranowski, T; Lutsey, PL; Manichaikul, AW; Rich, SS; St-Jules, DE; Steffen, BT; Tsai, MY; Siscovick, DS; Frazier-Wood, AC				Diep, Cassandra S.; Lemaitre, Rozenn N.; Chen, Tzu-An; Baranowski, Tom; Lutsey, Pamela L.; Manichaikul, Ani W.; Rich, Stephen S.; St-Jules, David E.; Steffen, Brian T.; Tsai, Michael Y.; Siscovick, David S.; Frazier-Wood, Alexis C.			Acculturation and Plasma Fatty Acid Concentrations in Hispanic and Chinese-American Adults: The Multi-Ethnic Study of Atherosclerosis	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; UNITED-STATES; ASIAN-AMERICANS; HEART-DISEASE; RISK-FACTORS; HEALTH; ASSOCIATION; BEHAVIORS; DIETARY; IMMIGRANTS	Background Acculturation to the U.S. is associated with increased risk of cardiovascular disease, but the etiologic pathways are not fully understood. Plasma fatty acid levels exhibit ethnic differences and are emerging as biomarkers and predictors of cardiovascular disease risk. Thus, plasma fatty acids may represent one pathway underlying the association between acculturation and cardiovascular disease. We investigated the cross-sectional relationship between acculturation and plasma phospholipid fatty acids in a diverse sample of Hispanic- and Chinese-American adults. Methods and Findings Participants included 377 Mexican, 320 non-Mexican Hispanic, and 712 Chinese adults from the Multi-Ethnic Study of Atherosclerosis, who had full plasma phospholipid assays and acculturation information. Acculturation was determined from three proxy measures: nativity, language spoken at home, and years in the U.S., with possible scores ranging from 0 (least acculturated) to 5 (most acculturated) points. a-Linolenic acid, linoleic acid, eicosapentaenoic acid, docosahexaenoic acid, and arachidonic acid were measured in fasting plasma. Linear regression models were conducted in race/ethnicity-stratified analyses, with acculturation as the predictor and plasma phospholipid fatty acids as the outcome variables. We ran secondary analyses to examine associations between acculturation and dietary fatty acids for comparison. Covariates included age, gender, education, and income. Contrary to our hypothesis, no statistically significant associations were detected between acculturation and plasma phospholipid fatty acids for Chinese, non-Mexican Hispanic, or Mexican participants. However, acculturation was related to dietary total n-6 fatty acids and dietary n-3/n-6 ratios in expected directions for Mexican, non-Mexican Hispanic, and combined Hispanic participants. In Chinese individuals, acculturation was unexpectedly associated with lower arachidonic acid intake. Conclusion Absence of associations between acculturation and plasma phospholipid fatty acids suggests that changes in the plasma phospholipid fatty acids studied do not account for the observed associations of acculturation to the U.S. and cardiovascular disease risk. Similar findings were observed for eicosapentaenoic acid and docosahexaenoic acid, when using dietary intake. However, the observed associations between dietary n-6 fatty acids and acculturation in Hispanic individuals suggest that dietary intake may be more informative than phospholipids when investigating acculturation effects. In Chinese individuals, acculturation may have a possible protective effect through decreased arachidonic acid intake. Further research on dietary fatty acids and other cardiovascular disease biomarkers is needed to identify possible etiologic mechanisms between acculturation and cardiovascular disease.	[Diep, Cassandra S.; Chen, Tzu-An; Baranowski, Tom; Frazier-Wood, Alexis C.] Baylor Coll Med, Dept Pediat, Childrens Nutr Res Ctr, USDA ARS, Houston, TX 77030 USA; [Diep, Cassandra S.] Univ Texas MD Anderson Canc Ctr, Dept Hlth Dispar Res, Houston, TX 77030 USA; [Lemaitre, Rozenn N.] Univ Washington, Dept Med, Cardiovasc Hlth Res Unit, Seattle, WA USA; [Lutsey, Pamela L.] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN USA; [Manichaikul, Ani W.; Rich, Stephen S.] Univ Virginia, Ctr Publ Hlth Genom, Charlottesville, VA USA; [St-Jules, David E.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Steffen, Brian T.; Tsai, Michael Y.] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; [Siscovick, David S.] New York Acad Med, New York, NY USA	Baylor College of Medicine; United States Department of Agriculture (USDA); University of Texas System; UTMD Anderson Cancer Center; University of Washington; University of Washington Seattle; University of Minnesota System; University of Minnesota Twin Cities; University of Virginia; Harvard University; Harvard T.H. Chan School of Public Health; University of Minnesota System; University of Minnesota Twin Cities; New York Academy of Medicine	Diep, CS (corresponding author), Baylor Coll Med, Dept Pediat, Childrens Nutr Res Ctr, USDA ARS, Houston, TX 77030 USA.; Diep, CS (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Hlth Dispar Res, Houston, TX 77030 USA.	cassandra.diep@gmail.com	Wood, Lekki/B-8053-2010	Wood, Lekki/0000-0001-7616-2119; Steffen, Brian/0000-0001-8010-2530; Rich, Stephen/0000-0003-3872-7793; Manichaikul, Ani/0000-0002-5998-795X; Lutsey, Pamela/0000-0002-1572-1340; Tsai, Michael/0000-0001-7553-3408; Baranowski, Tom/0000-0002-0653-2222	USDA/ARS [58-6250-0-008]; National Research Service Award [T32 HP10031]; American Heart Association [14BGIA18740011]; National Heart, Lung, and Blood Institute (NHLBI); National Heart, Lung, and Blood Institute [N01-HC-95159, N01-HC-95160, N01-HC-95161, N01-HC95162, N01-HC-95163, N01-HC-95164, N01-HC95165, N01-HC-95166, N01-HC-95167, N01-HC95168, N01-HC-95169]; NCRR [UL1-TR000040, UL1-TR-001079]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001079, UL1TR000040] Funding Source: NIH RePORTER	USDA/ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work is a publication of the United States Department of Agriculture (USDA/ARS) Children's Nutrition Research Center, Department of Pediatrics, Baylor College of Medicine, Houston, Texas, and had been funded in part with federal funds from the USDA/ARS under Cooperative Agreement No. 58-6250-0-008. The contents of this publication do not necessarily reflect the views or policies of the USDA, nor does mention of trade names, commercial products, or organizations imply endorsement from the US government. CSD was supported by a Primary Care Research Training Grant from National Research Service Award (#T32 HP10031). ACF-W was supported in part by American Heart Association grant number 14BGIA18740011. MESA and the MESA SHARe project are conducted and supported by the National Heart, Lung, and Blood Institute (NHLBI) in collaboration with MESA investigators. Support for MESA is provided by contracts N01-HC-95159, N01-HC-95160, N01-HC-95161, N01-HC95162, N01-HC-95163, N01-HC-95164, N01-HC95165, N01-HC-95166, N01-HC-95167, N01-HC95168, and N01-HC-95169 from the National Heart, Lung, and Blood Institute and by grants UL1-TR000040 and UL1-TR-001079 from NCRR. A full list of participating MESA investigators and institutions can be found at http://www.mesa-nhlbi.org.	Abraido-Lanza AF, 2005, SOC SCI MED, V61, P1243, DOI 10.1016/j.socscimed.2005.01.016; Antecol H, 2006, DEMOGRAPHY, V43, P337, DOI 10.1353/dem.2006.0011; Ayala GX, 2008, J AM DIET ASSOC, V108, P1330, DOI 10.1016/j.jada.2008.05.009; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bild DE, 2002, AM J EPIDEMIOL, V156, P871, DOI 10.1093/aje/kwf113; BLOCK G, 1990, J CLIN EPIDEMIOL, V43, P1327, DOI 10.1016/0895-4356(90)90099-B; Chowdhury R, 2014, ANN INTERN MED, V160, P398, DOI 10.7326/M13-1788; Chung HJ, 2008, J NUTR, V138, P2422, DOI 10.3945/jn.108.089631; Cohen J.E., 1988, STAT POWER ANAL BEHA; Connor WE, 2000, AM J CLIN NUTR, V71, p171S, DOI 10.1093/ajcn/71.1.171S; Cordain L, 2005, AM J CLIN NUTR, V81, P341, DOI 10.1093/ajcn.81.2.341; CUSHMAN M, 1995, CLIN CHEM, V41, P264; Demory-Luce DK, 2005, NUTR RES, V25, P213, DOI 10.1016/j.nutres.2004.12.005; Diep CS, 2015, J IMMIGR MINOR HEALT, V17, P591, DOI 10.1007/s10903-013-9905-6; Fang CY, 2014, PSYCHOSOM MED, V76, P320, DOI 10.1097/PSY.0000000000000065; Gordon-Larsen P, 2003, SOC SCI MED, V57, P2023, DOI 10.1016/S0277-9536(03)00072-8; Harris WS, 2009, CIRCULATION, V119, P902, DOI 10.1161/CIRCULATIONAHA.108.191627; Hodson L, 2001, EUR J CLIN NUTR, V55, P908, DOI 10.1038/sj.ejcn.1601234; Kandula NR, 2008, DIABETES CARE, V31, P1621, DOI 10.2337/dc07-2182; Koya DL, 2007, J GEN INTERN MED, V22, P841, DOI 10.1007/s11606-007-0163-y; Lauderdale DS, 2000, INT J OBESITY, V24, P1188, DOI 10.1038/sj.ijo.0801365; Li WW, 2007, J TRANSCULT NURS, V18, P331, DOI 10.1177/1043659607305194; Lutsey PL, 2008, AM J PUBLIC HEALTH, V98, P1963, DOI 10.2105/AJPH.2007.123844; Lv N, 2004, J AM DIET ASSOC, V104, P771, DOI 10.1016/j.jada.2004.02.032; Lv N, 2010, J NUTR EDUC BEHAV, V42, P106, DOI 10.1016/j.jneb.2009.04.005; MARMOT MG, 1976, AM J EPIDEMIOL, V104, P225, DOI 10.1093/oxfordjournals.aje.a112296; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Mayer-Davis EJ, 1999, ANN EPIDEMIOL, V9, P314, DOI 10.1016/S1047-2797(98)00070-2; Molendi-Coste O, 2011, GASTROENT RES PRACT, V2011, DOI 10.1155/2011/364040; Otto MCD, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000506; Palaniappan LP, 2010, CIRCULATION, V122, P1242, DOI 10.1161/CIR.0b013e3181f22af4; Pan YL, 1999, J AM DIET ASSOC, V99, P54, DOI 10.1016/S0002-8223(99)00016-4; Patterson E, 2012, J NUTR METAB, V2012, DOI 10.1155/2012/539426; Ramsden Christopher E, 2009, Curr Treat Options Cardiovasc Med, V11, P289; Reddy KS, 2004, PUBLIC HEALTH NUTR, V7, P167, DOI 10.1079/PHN2003587; Riediger ND, 2009, J AM DIET ASSOC, V109, P668, DOI 10.1016/j.jada.2008.12.022; Satia-Abouta J, 2002, J AM DIET ASSOC, V102, P1105, DOI 10.1016/S0002-8223(02)90247-6; SCHAKEL SF, 1988, J AM DIET ASSOC, V88, P1268; Simopoulos AP, 1999, AM J CLIN NUTR, V70, p560S, DOI 10.1093/ajcn/70.3.560s; Simopoulos AP, 2002, BIOMED PHARMACOTHER, V56, P365, DOI 10.1016/S0753-3322(02)00253-6; Simopoulos AP, 2004, FOOD REV INT, V20, P77, DOI 10.1081/FRI-120028831; SIMOPOULOS AP, 1991, AM J CLIN NUTR, V54, P438, DOI 10.1093/ajcn/54.3.438; Singh GK, 2002, HUM BIOL, V74, P83, DOI 10.1353/hub.2002.0011; Song YJ, 2004, PREV MED, V39, P147, DOI 10.1016/j.ypmed.2004.01.013; Sundquist J, 1999, AM J PUBLIC HEALTH, V89, P723, DOI 10.2105/AJPH.89.5.723; Taylor VM, 2007, J COMMUN HEALTH, V32, P299, DOI 10.1007/s10900-007-9057-5; US Census Bureau, ACS DEM HOUS EST 201; WILLETT W, 1986, AM J EPIDEMIOL, V124, P17, DOI 10.1093/oxfordjournals.aje.a114366; Wong SS, 2013, J IMMIGR MINOR HEALT, V15, P560, DOI 10.1007/s10903-012-9669-4	49	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149267	10.1371/journal.pone.0149267	http://dx.doi.org/10.1371/journal.pone.0149267			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DD6SI	26872329	Green Published, Green Submitted, gold			2022-12-26	WOS:000370054100138
J	Zaloba, P; Bailey-Elkin, BA; Derksen, M; Mark, BL				Zaloba, Patryk; Bailey-Elkin, Ben A.; Derksen, Miriam; Mark, Brian L.			Structural and Biochemical Insights into the Peptidoglycan Hydrolase Domain of FlgJ from Salmonella typhimurium	PLOS ONE			English	Article							N-ACETYLGLUCOSAMINIDASE; CATALYTIC MECHANISM; CRYSTAL-STRUCTURE; GLUCOSAMINIDASE; AUTOLYSIN; VIRULENCE; PROTEIN; AUTO	FlgJ is a glycoside hydrolase (GH) enzyme belonging to the Carbohydrate Active enZyme (CAZy) family GH73. It facilitates passage of the bacterial flagellum through the peptidoglycan (PG) layer by cleaving the beta-1,4 glycosidic bond between N-acetylglucosamine and N-acetylmuramic acid sugars that comprise the glycan strands of PG. Here we describe the crystal structure of the GH domain of FlgJ from bacterial pathogen Salmonella typhimurium (StFlgJ). Interestingly, the active site of StFlgJ was blocked by the C-terminal alpha-helix of a neighbouring symmetry mate and a beta-hairpin containing the putative catalytic glutamic acid residue Glu223 was poorly resolved and could not be completely modeled into the electron density, suggesting it is flexible. Previous reports have shown that the GH73 enzyme Auto from Listeria monocytogenes is inhibited by an N-terminal a-helix that may occlude the active site in similar fashion. To investigate if the C-terminus of StFlgJ inhibits GH activity, the glycolytic activity of StFlgJ was assessed with and without the C-terminal alpha-helix. The GH activity of StFlgJ was unaffected by the presence or absence of the alpha-helix, suggesting it is not involved in regulating activity. Removal of the C-terminal alpha-helix did, however, allow a crystal structure of the domain to be obtained where the flexible beta-hairpin containing residue Glu223 was entirely resolved. The beta-hairpin was positioned such that the active site groove was fully solvent-exposed, placing Glu223 nearly 21.6 away from the putative general ac/base residue Glu184, which is too far apart for these two residues to coordinate glycosidic bond hydrolysis. The mobile nature of the StFlgJ beta-hairpin is consistent with structural studies of related GH73 enzymes, suggesting that a dynamic active site may be common to many GH73 enzymes, in which the active site opens to capture substrate and then closes to correctly orient active site residues for catalysis.	[Zaloba, Patryk; Bailey-Elkin, Ben A.; Derksen, Miriam; Mark, Brian L.] Univ Manitoba, Dept Microbiol, Winnipeg, MB R3T 2N2, Canada; [Derksen, Miriam] Univ Manitoba, Dept Biochem & Med Genet, Winnipeg, MB, Canada	University of Manitoba; University of Manitoba	Mark, BL (corresponding author), Univ Manitoba, Dept Microbiol, Winnipeg, MB R3T 2N2, Canada.	brian.mark@umanitoba.ca		Mark, Brian/0000-0002-7344-1355	Natural Sciences and Engineering Research Council (NSERC) [311775-2010, 2015-05310]; Manitoba Graduate fellowship	Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Manitoba Graduate fellowship	This research was supported by Natural Sciences and Engineering Research Council (NSERC) grants 311775-2010 and 2015-05310 (to B.L.M.). P.Z. held a Manitoba Graduate fellowship. B.B.E. holds an NSERC Postgraduate Scholarship (Doctoral). M.D. held a University of Manitoba Faculty of Science Undergraduate Student Research Award (USRA). B.L.M. holds a Manitoba Research Chair.	Abbott DW, 2009, J BIOL CHEM, V284, P11676, DOI 10.1074/jbc.M809663200; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bai XH, 2014, J BIOL CHEM, V289, P23403, DOI 10.1074/jbc.M114.579714; Bublitz M, 2009, MOL MICROBIOL, V71, P1509, DOI 10.1111/j.1365-2958.2009.06619.x; Cabanes D, 2004, MOL MICROBIOL, V51, P1601, DOI 10.1111/j.1365-2958.2003.03945.x; Camiade E, 2010, J BACTERIOL, V192, P2373, DOI 10.1128/JB.01546-09; DAVIES G, 1995, STRUCTURE, V3, P853, DOI 10.1016/S0969-2126(01)00220-9; De las Rivas B, 2002, J BACTERIOL, V184, P4988, DOI 10.1128/JB.184.18.4988-5000.2002; Dennis RJ, 2006, NAT STRUCT MOL BIOL, V13, P365, DOI 10.1038/nsmb1079; Dodson EJ, 1997, METHOD ENZYMOL, V277, P620, DOI 10.1016/S0076-6879(97)77034-4; Eckert C, 2006, J BACTERIOL, V188, P8513, DOI 10.1128/JB.01145-06; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gosink KK, 2000, INFECT IMMUN, V68, P5690, DOI 10.1128/IAI.68.10.5690-5695.2000; Hashimoto W, 2009, BIOCHEM BIOPH RES CO, V381, P16, DOI 10.1016/j.bbrc.2009.01.186; HEMSLEY A, 1989, NUCLEIC ACIDS RES, V17, P6545, DOI 10.1093/nar/17.16.6545; Herlihey FA, 2014, J BIOL CHEM, V289, P31029, DOI 10.1074/jbc.M114.603944; Hirano T, 2001, J MOL BIOL, V312, P359, DOI 10.1006/jmbi.2001.4963; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Holtje JV, 1998, MICROBIOL MOL BIOL R, V62, P181; Inagaki N, 2009, GENE, V447, P61, DOI 10.1016/j.gene.2009.08.004; KOSHLAND DE, 1953, BIOL REV, V28, P416, DOI 10.1111/j.1469-185X.1953.tb01386.x; Lipski A, 2015, GLYCOBIOLOGY, V25, P319, DOI 10.1093/glycob/cwu113; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Mark BL, 2002, CAN J CHEM, V80, P1064, DOI 10.1139/V02-130; Mark BL, 2001, J BIOL CHEM, V276, P10330, DOI 10.1074/jbc.M011067200; Markovic-Housley Z, 2000, STRUCTURE, V8, P1025, DOI 10.1016/S0969-2126(00)00511-6; Maruyama Y, 2010, J BASIC MICROB, V50, P311, DOI 10.1002/jobm.200900249; Moens S, 1996, CRIT REV MICROBIOL, V22, P67, DOI 10.3109/10408419609106456; Nambu T, 1999, J BACTERIOL, V181, P1555, DOI 10.1128/JB.181.5.1555-1561.1999; Schrodinger, 2010, PYMOL MOL GRAPHICS S; Steen A, 2005, FEBS J, V272, P2854, DOI 10.1111/j.1742-4658.2005.04706.x; Tews I, 1996, NAT STRUCT BIOL, V3, P638, DOI 10.1038/nsb0796-638; van Aalten DMF, 2001, P NATL ACAD SCI USA, V98, P8979, DOI 10.1073/pnas.151103798; Vocadlo DJ, 2008, CURR OPIN CHEM BIOL, V12, P539, DOI 10.1016/j.cbpa.2008.05.010; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P259, DOI 10.1111/j.1574-6976.2007.00099.x; Yokoi KJ, 2008, GENE, V416, P66, DOI 10.1016/j.gene.2008.03.004; Zechel DL, 2000, ACCOUNTS CHEM RES, V33, P11, DOI 10.1021/ar970172+	37	18	18	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149204	10.1371/journal.pone.0149204	http://dx.doi.org/10.1371/journal.pone.0149204			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26871950	gold, Green Published			2022-12-26	WOS:000370054100126
J	Zhang, ZY; Shi, L; Pang, WH; Liu, WW; Li, JF; Wang, HB; Shi, GG				Zhang, Zhiyu; Shi, Lei; Pang, Wenhui; Liu, Wenwen; Li, Jianfeng; Wang, Haibo; Shi, Guanggang			Dietary Fiber Intake Regulates Intestinal Microflora and Inhibits Ovalbumin-Induced Allergic Airway Inflammation in a Mouse Model	PLOS ONE			English	Article							GUT MICROBIOTA; TH2 RESPONSES; PULMONARY INFLAMMATION; HYGIENE HYPOTHESIS; HEALTH-BENEFITS; ASTHMA; RHINITIS; DISEASES; MECHANISMS; UPDATE	Background Recently, academic studies suggest that global growth of airway allergic disease has a close association with dietary changes including reduced consumption of fiber. Therefore, appropriate dietary fiber supplementation might be potential to prevent airway allergic disease (AAD). Objective We investigated whether dietary fiber intake suppressed the induction of AAD and tried to elucidate the possible underlying mechanisms. Methods The control mice and AAD model mice fed with 4% standard-fiber chow, while low-fiber group of mice fed with a 1.75% low-fiber chow. The two fiber-intervened groups including mice, apart from a standard-fiber diet, were also intragastric (i.g.) administrated daily with poorly fermentable cellulose or readily fermentable pectin (0.4% of daily body weight), respectively. All animals except normal mice were sensitized and challenged with ovalbumin (OVA) to induce airway allergic inflammation. Hallmarks of AAD were examined by histological analysis and ELISA. The variation in intestinal bacterial composition was assessed by qualitative analysis of 16S ribosomal DNA (rDNA) content in fecal samples using real-time PCR. Results Low-fiber diet aggravated inflammatory response in ovalbumin-induced allergic mice, whereas dietary fiber intake significantly suppressed the allergic responses, attenuated allergic symptoms of nasal rubbing and sneezing, decreased the pathology of eosinophil infiltration and goblet cell metaplasia in the nasal mucosa and lung, inhibited serum OVA-specific IgE levels, and lowered the levels of Th2 cytokines in NALF and BALF, but, increased Th1 (IFN-gamma) cytokines. Additionally, dietary fiber intake also increased the proportion of Bacteroidetes and Actinobacteria, and decreased Firmicutes and Proteobacteria. Levels of probiotic bacteria, such as Lactobacillus and Bifidobacterium, were upgraded significantly. Conclusion Long-term deficiency of dietary fiber intake increases the susceptibility to AAD, whereas proper fiber supplementation promotes effectively the balance of Th1/Th2 immunity and then attenuates allergic inflammatory responses significantly, as well as optimizes the structure of intestinal microbiota, which suggests potential for novel preventive and therapeutic intervention.	[Zhang, Zhiyu; Shi, Lei; Liu, Wenwen; Li, Jianfeng; Wang, Haibo; Shi, Guanggang] Shandong Univ, Shandong Prov Hosp, Dept Otolaryngol Head & Neck Surg, Jinan 250100, Peoples R China; [Zhang, Zhiyu; Liu, Wenwen; Li, Jianfeng; Wang, Haibo; Shi, Guanggang] Shandong Prov Key Lab Otol, Shandong Inst Otolaryngol, Jinan, Peoples R China; [Pang, Wenhui] Fudan Univ, Affiliated Eye Ear Nose & Throat Hosp, Dept Otolaryngol Head & Neck Surg, Shanghai 200433, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Fudan University	Shi, GG (corresponding author), Shandong Univ, Shandong Prov Hosp, Dept Otolaryngol Head & Neck Surg, Jinan 250100, Peoples R China.; Shi, GG (corresponding author), Shandong Prov Key Lab Otol, Shandong Inst Otolaryngol, Jinan, Peoples R China.	shiguangangent@hotmail.com						Akdis M, 2011, J ALLERGY CLIN IMMUN, V127, P701, DOI 10.1016/j.jaci.2010.11.050; Anderson JW, 2009, NUTR REV, V67, P188, DOI 10.1111/j.1753-4887.2009.00189.x; Bickert T, 2009, INT ARCH ALLERGY IMM, V149, P219, DOI 10.1159/000199717; Bjorksten B, 2001, J ALLERGY CLIN IMMUN, V108, P516, DOI 10.1067/mai.2001.118130; Bousquet J, 2008, ALLERGY, V63, P8, DOI 10.1111/j.1398-9995.2007.01620.x; Brooks C, 2013, CURR OPIN ALLERGY CL, V13, P70, DOI 10.1097/ACI.0b013e32835ad0d2; Brozek JL, 2010, J ALLERGY CLIN IMMUN, V126, P466, DOI 10.1016/j.jaci.2010.06.047; Cho KS, 2009, STEM CELLS, V27, P259, DOI 10.1634/stemcells.2008-0283; Ciprandi G, 2015, EXPERT REV CLIN IMMU, P1; Compalati E, 2010, EXPERT REV CLIN IMMU, V6, P413, DOI [10.1586/ECI.10.15, 10.1586/eci.10.15]; de Moura PN, 2013, IMMUN INFLAMM DIS, V1, P63, DOI 10.1002/iid3.8; Devereux G, 2006, NAT REV IMMUNOL, V6, P869, DOI 10.1038/nri1958; Faith A, 2012, ALLERGY, V67, P1007, DOI 10.1111/j.1398-9995.2012.02852.x; Frei R, 2012, ALLERGY, V67, P451, DOI 10.1111/j.1398-9995.2011.02783.x; Galli SJ, 2008, NATURE, V454, P445, DOI 10.1038/nature07204; Gophna U, 2011, SCIENCE, V334, P45, DOI 10.1126/science.1213799; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Kang JH, 2009, AM J RESP CRIT CARE, V179, P875, DOI 10.1164/rccm.200806-893OC; Kim JY, 2008, J MICROBIOL BIOTECHN, V18, P1393; Kukkonen K, 2010, PEDIAT ALLERG IMM-UK, V21, P67, DOI 10.1111/j.1399-3038.2009.00907.x; Lin IP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090293; Maslowski KM, 2011, NAT IMMUNOL, V12, P5, DOI 10.1038/ni0111-5; Meyer Diederick, 2015, Adv Food Nutr Res, V74, P47, DOI 10.1016/bs.afnr.2014.11.002; Nakaji S, 2002, EUR J NUTR, V41, P222, DOI 10.1007/s00394-002-0379-x; Nauta AJ, 2008, EUR J PHARMACOL, V585, P354, DOI 10.1016/j.ejphar.2008.02.094; Noverr MC, 2005, CLIN EXP ALLERGY, V35, P1511, DOI 10.1111/j.1365-2222.2005.02379.x; Osborn DA, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006474.pub3; Pang WH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059174; Penders J, 2007, GUT, V56, P661, DOI 10.1136/gut.2006.100164; Bernaud FSR, 2013, ARQ BRAS ENDOCRINOL, V57, P397, DOI 10.1590/S0004-27302013000600001; Saliganti V, 2015, BR J NUTR, P1; Shinmei Y, 2009, IMMUNOPHARM IMMUNOT, V31, P688, DOI 10.3109/08923970903078443; Skapenko Alla, 2007, V136, P87; Slavin J, 2013, NUTRIENTS, V5, P1417, DOI 10.3390/nu5041417; Spiess PC, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-107; Stokes JR, 2015, J ALLER CL IMM-PRACT, V3, P162, DOI 10.1016/j.jaip.2014.10.010; STRACHAN DP, 1989, BRIT MED J, V299, P1259, DOI 10.1136/bmj.299.6710.1259; Thorburn AN, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8320; Thorburn AN, 2014, IMMUNITY, V40, P833, DOI 10.1016/j.immuni.2014.05.014; Trompette A, 2014, NAT MED, V20, P159, DOI 10.1038/nm.3444; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; Velez EM, 2015, BR J NUTR, P1; Wang DY, 2000, AM J RHINOL, V14, P325, DOI 10.2500/105065800781329483; Wang T, 2009, EUR RESPIR J, V33, P1122, DOI 10.1183/09031936.00055908; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Yu WK, 2015, ANN ALLERG ASTHMA IM, V115, P63, DOI 10.1016/j.anai.2015.04.025	46	54	59	7	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0147778	10.1371/journal.pone.0147778	http://dx.doi.org/10.1371/journal.pone.0147778			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26872019	Green Published, gold, Green Submitted			2022-12-26	WOS:000370054100010
J	Lei, Y; Kansy, BA; Li, J; Cong, L; Liu, Y; Trivedi, S; Wen, H; Ting, JPY; Ouyang, H; Ferris, RL				Lei, Y.; Kansy, B. A.; Li, J.; Cong, L.; Liu, Y.; Trivedi, S.; Wen, H.; Ting, J. P-Y; Ouyang, H.; Ferris, R. L.			EGFR-targeted mAb therapy modulates autophagy in head and neck squamous cell carcinoma through NLRX1-TUFM protein complex	ONCOGENE			English	Article							NF-KAPPA-B; CANCER-CELLS; TUMOR PROGRESSION; NATURAL-KILLER; I INTERFERON; CETUXIMAB; RECEPTOR; GROWTH; P62/SQSTM1; CARFILZOMIB	Epidermal growth factor receptor (EGFR)-targeted therapy in head and neck squamous cell carcinoma (HNSCC) patients frequently results in tumor resistance to treatment. Autophagy is an emerging underlying resistance mechanism, however, the molecular autophagy machinery in HNSCC cells and potential biomarkers of patient response to EGFR-targeted therapy remain insufficiently characterized. Here we show that the EGFR blocking with cetuximab leads to varied autophagic responses, which modulate cancer cell susceptibility to EGFR inhibition. Inhibition of autophagy sensitizes HNSCC cells to EGFR blockade. Importantly, we identify a novel signaling hub centering on the NLRX1 (nucleotide-binding, lots of leucine-rich repeats-containing protein member X1)-TUFM (Tu translation elongation factor mitochondrial) protein complex, promoting autophagic flux. Defects in the expression of either NLRX1 or TUFM result in compromised autophagy when treated with EGFR inhibitors. As a previously undefined autophagy-promoting mechanism, we found that TUFM serves as a novel anchorage site, recruiting Beclin-1 to mitochondria, promoting its polyubiquitination, and interfering with its interaction with Rubicon. This protein complex is also essential for endoplasmic reticulum stress signaling induction, possibly as an additional mechanism to promote autophagy. Utilizing tumor specimens from a novel neoadjuvant clinical trial, we show that increased expression of the autophagy adaptor protein, SQSTM1/p62, is associated with poor response to cetuximab therapy. These findings expand our understanding of the components involved in HNSCC autophagy machinery that responds to EGFR inhibitors, and suggest potential combinatorial approaches to enhance its therapeutic efficacy.	[Lei, Y.; Kansy, B. A.; Li, J.; Cong, L.; Liu, Y.; Trivedi, S.; Ferris, R. L.] Univ Pittsburgh, Dept Otolaryngol, Sch Med, Inst Canc, 5117 Ctr Ave,Suite 2-26, Pittsburgh, PA 15260 USA; [Wen, H.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Sch Med, Dept Surg, Chapel Hill, NC 27599 USA; [Ting, J. P-Y] Univ N Carolina, Lineberger Comprehens Canc Ctr, Sch Med, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA; [Ouyang, H.] Univ Pittsburgh, Sch Dent Med, Dept Restorat Dent & Comprehens Care, Pittsburgh, PA USA; [Ferris, R. L.] Univ Pittsburgh, Dept Immunol, Sch Med, Pittsburgh, PA USA; [Lei, Y.] Univ Michigan, Sch Dent, Dept Periodont & Oral Med,UM Comprehens Canc Ctr, Translat Oncol Program & Distributed Hlth Technol, Ann Arbor, MI 48109 USA; [Lei, Y.] Univ Michigan, UM Comprehens Canc Ctr, Dept Otolaryngol Head & Neck Surg, Sch Med,Translat Oncol Program & Distributed Hlth, Ann Arbor, MI 48109 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Ferris, RL (corresponding author), Univ Pittsburgh, Dept Otolaryngol, Sch Med, Inst Canc, 5117 Ctr Ave,Suite 2-26, Pittsburgh, PA 15260 USA.	ferrisrl@upmc.edu	Wen, Haitao/AAJ-7621-2020	Li, Jing/0000-0002-9285-9423; Lei, Y Leo/0000-0002-9868-9824	NIH [K99 DE024173, T32 CA060397, R01 DE019727, P50 CA097190, R01 CA182418, R21 CA161150];  [P30 CA047904]; NATIONAL CANCER INSTITUTE [P30CA047904, P30CA016086, P50CA097190, R01CA182418, R21CA161150, T32CA060397] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE019727, K99DE024173, R00DE024173] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work is supported by NIH grants K99 DE024173 (YL), T32 CA060397 (RLF), R01 DE019727 (RLF), P50 CA097190 (RLF), R01 CA182418 (HO) and R21 CA161150 (HO). The UPCI core facilities are supported in part by P30 CA047904. We thank Dr Barton Branstetter for the interpretation of the radiographic findings of the enrolled patients.	Allen IC, 2011, IMMUNITY, V34, P854, DOI 10.1016/j.immuni.2011.03.026; Amaravadi RK, 2011, CLIN CANCER RES, V17, P654, DOI 10.1158/1078-0432.CCR-10-2634; Argiris A, 2008, LANCET, V371, P1695, DOI 10.1016/S0140-6736(08)60728-X; Argiris A, 2011, CLIN CANCER RES, V17, P5755, DOI 10.1158/1078-0432.CCR-11-0861; Baginska J, 2013, P NATL ACAD SCI USA, V110, P17450, DOI 10.1073/pnas.1304790110; Colosetti P, 2009, AUTOPHAGY, V5, P1092, DOI 10.4161/auto.5.8.9889; Davis BK, 2011, ANN REV IMMUNOL; Edwards BK, 2014, CANCER-AM CANCER SOC, V120, P1290, DOI 10.1002/cncr.28509; Hailey DW, 2010, CELL, V141, P656, DOI 10.1016/j.cell.2010.04.009; Jemal A, 2004, CANCER-AM CANCER SOC, V101, P3, DOI 10.1002/cncr.20288; Jie HB, 2015, CANCER RES, V75, P2200, DOI 10.1158/0008-5472.CAN-14-2788; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; Lei Y, 2013, AUTOPHAGY, V9, P432, DOI 10.4161/auto.23026; Lei Y, 2012, IMMUNITY, V36, P933, DOI 10.1016/j.immuni.2012.03.025; Li XQ, 2010, CANCER RES, V70, P5942, DOI 10.1158/0008-5472.CAN-10-0157; Liang XH, 2001, CANCER RES, V61, P3443; Liu JL, 2014, BRIT J CANCER, V111, P944, DOI 10.1038/bjc.2014.355; Liu JL, 2011, CELL, V147, P223, DOI 10.1016/j.cell.2011.08.037; Lopez-Albaitero A, 2009, CANCER IMMUNOL IMMUN, V58, P1855, DOI 10.1007/s00262-009-0697-4; Mathew R, 2009, CELL, V137, P1062, DOI 10.1016/j.cell.2009.03.048; Milani M, 2009, CANCER RES, V69, P4415, DOI 10.1158/0008-5472.CAN-08-2839; Moore CB, 2008, NATURE, V451, P573, DOI 10.1038/nature06501; Moore CB, 2010, METHODS MOL BIOL, V629, P139, DOI 10.1007/978-1-60761-657-3_10; Reeves TD, 2011, OTOLARYNG HEAD NECK, V144, P676, DOI 10.1177/0194599811399559; Rouschop KMA, 2010, J CLIN INVEST, V120, P127, DOI 10.1172/JCI40027; Rubinsztein DC, 2012, NAT REV DRUG DISCOV, V11, P709, DOI 10.1038/nrd3802; Sharafinski ME, 2010, HEAD NECK-J SCI SPEC, V32, P1412, DOI 10.1002/hed.21365; Shi CS, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000751; Srivastava RM, 2013, CLIN CANCER RES, V19, P1858, DOI 10.1158/1078-0432.CCR-12-2426; Talloczy Z, 2002, P NATL ACAD SCI USA, V99, P190, DOI 10.1073/pnas.012485299; Tan XJ, 2015, CELL, V160, P145, DOI 10.1016/j.cell.2014.12.006; Tattoli I, 2008, EMBO REP, V9, P293, DOI 10.1038/sj.embor.7401161; Ting JPY, 2008, NAT REV IMMUNOL, V8, P372, DOI 10.1038/nri2296; Ting JPY, 2010, SCIENCE, V327, P286, DOI 10.1126/science.1184004; Toepfer N, 2011, CANCER BIOL THER, V12, P691, DOI 10.4161/cbt.12.8.15978; Wei HJ, 2014, GENE DEV, V28, P1204, DOI 10.1101/gad.237354.113; Wei YJ, 2013, CELL, V154, P1269, DOI 10.1016/j.cell.2013.08.015; Wen HT, 2011, NAT IMMUNOL, V12, P408, DOI 10.1038/ni.2022; White E, 2012, NAT REV CANCER, V12, P401, DOI 10.1038/nrc3262; White E, 2009, CLIN CANCER RES, V15, P5308, DOI 10.1158/1078-0432.CCR-07-5023; Xia MH, 2014, INT J ONCOL, V45, P2341, DOI 10.3892/ijo.2014.2669; Xia XJ, 2011, IMMUNITY, V34, P843, DOI 10.1016/j.immuni.2011.02.022; Yang ZF, 2010, NAT CELL BIOL, V12, P814, DOI 10.1038/ncb0910-814; Zang Y, 2012, AUTOPHAGY, V8, P1873, DOI 10.4161/auto.22185; Zang Y, 2012, CLIN CANCER RES, V18, P5639, DOI 10.1158/1078-0432.CCR-12-1213	46	42	46	1	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 8	2016	35	36					4698	4707		10.1038/onc.2016.11	http://dx.doi.org/10.1038/onc.2016.11			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DW0IS	26876213	Green Submitted, Green Accepted			2022-12-26	WOS:000383324700003
J	Du, L; Chen, X; Cao, Y; Lu, L; Zhang, F; Bornstein, S; Li, Y; Owens, P; Malkoski, S; Said, S; Jin, F; Kulesz-Martin, M; Gross, N; Wang, XJ; Lu, SL				Du, L.; Chen, X.; Cao, Y.; Lu, L.; Zhang, F.; Bornstein, S.; Li, Y.; Owens, P.; Malkoski, S.; Said, S.; Jin, F.; Kulesz-Martin, M.; Gross, N.; Wang, X-J; Lu, S-L			Overexpression of PIK3CA in murine head and neck epithelium drives tumor invasion and metastasis through PDK1 and enhanced TGF beta signaling	ONCOGENE			English	Article							TO-MESENCHYMAL TRANSITION; SQUAMOUS-CELL-CARCINOMA; AKT ACTIVATION; CHEMICAL CARCINOGENESIS; 3-KINASE PATHWAY; PI3K PATHWAY; MOUSE MODELS; CANCER; MUTATION; GROWTH	Head and neck squamous cell carcinoma (HNSCC) patients have a poor prognosis, with invasion and metastasis as major causes of mortality. The phosphatidylinositol 3-kinase (PI3K) pathway regulates a wide range of cellular processes crucial for tumorigenesis, and PIK3CA amplification and mutation are among the most common genetic alterations in human HNSCC. Compared with the well-documented roles of the PI3K pathway in cell growth and survival, the roles of the PI3K pathway in tumor invasion and metastasis have not been well delineated. We generated a PIK3CA genetically engineered mouse model (PIK3CA-GEMM) in which wild-type PIK3CA is overexpressed in head and neck epithelium. Although PIK3CA overexpression alone was not sufficient to initiate HNSCC formation, it significantly increased tumor susceptibility in an oral carcinogenesis mouse model. PIK3CA overexpression in mouse oral epithelium increased tumor invasiveness and metastasis by increasing epithelial-mesenchymal transition and by enriching a cancer stem cell phenotype in tumor epithelial cells. In addition to these epithelial alterations, we also observed marked inflammation in tumor stroma. AKT is a central signaling mediator of the PI3K pathway. However, molecular analysis suggested that progression of PIK3CA-driven HNSCC is facilitated by 3-phosphoinositide-dependent protein kinase (PDK1) and enhanced transforming growth factor beta (TGF beta) signaling rather than by AKT. Examination of human HNSCC clinical samples revealed that both PIK3CA and PDK1 protein levels correlated with tumor progression, highlighting the significance of this pathway. In summary, our results offer significant insight into how PIK3CA overexpression drives HNSCC invasion and metastasis, providing a rationale for targeting PI3K/PDK1 and TGF beta signaling in advanced HNSCC patients with PIK3CA amplification.	[Du, L.; Chen, X.; Cao, Y.; Lu, L.; Zhang, F.; Lu, S-L] Univ Colorado, Dept Otolaryngol, Anschutz Med Campus, 12700 E 19th Ave,Mail Stop 8606, Aurora, CO 80045 USA; [Du, L.] China Med Univ, Univ Hosp 4, Dept Otolaryngol, Shenyang, Peoples R China; [Cao, Y.; Jin, F.] China Med Univ, Univ Hosp 1, Dept Surg Oncol, Shenyang, Liaoning, Peoples R China; [Bornstein, S.; Li, Y.; Owens, P.; Gross, N.] Oregon Hlth & Sci Univ, Dept Otolaryngol, Portland, OR 97201 USA; [Malkoski, S.] Univ Colorado, Dept Med, Anschutz Med Campus, Aurora, CO USA; [Said, S.; Wang, X-J; Lu, S-L] Univ Colorado, Dept Pathol, Anschutz Med Campus, Aurora, CO USA; [Kulesz-Martin, M.] Oregon Hlth & Sci Univ, Dept Dermatol, Portland, OR 97201 USA; [Lu, S-L] Univ Colorado, Dept Dermatol, Anschutz Med Campus, Aurora, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; China Medical University; China Medical University; Oregon Health & Science University; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; Oregon Health & Science University; University of Colorado System; University of Colorado Anschutz Medical Campus	Lu, SL (corresponding author), Univ Colorado, Dept Otolaryngol, Anschutz Med Campus, 12700 E 19th Ave,Mail Stop 8606, Aurora, CO 80045 USA.	shi-long.lu@ucdenver.edu			National Institutes of Health [R01DE021788, R01DE015953]; University of Colorado Academic Enrichment Fund; American Cancer Society; University of Colorado Cancer Center; Cancer League of Colorado; NATIONAL CANCER INSTITUTE [T32CA106195, P30CA046934, R21CA194662, R01CA192405, K08CA131483] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR057212] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE021788] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Colorado Academic Enrichment Fund; American Cancer Society(American Cancer Society); University of Colorado Cancer Center; Cancer League of Colorado; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work is supported by National Institutes of Health grant R01DE021788 (to S-L Lu), R01DE015953 (to X-J Wang). University of Colorado Academic Enrichment Fund (to S-L Lu), American Cancer Society (to S-L Lu), University of Colorado Cancer Center (to S-L Lu), and Cancer League of Colorado (to S-L Lu). S-L Lu is an investigator of THANC foundation. We thank the Transgenic Core of Oregon Health and Science University for generating founders of the mouse model, and the University of Colorado Skin Disease Research Center Morphology Phenotyping Core (P30 AR057212) for assisting with histological work.	Akhurst RJ, 2012, NAT REV DRUG DISCOV, V11, P790, DOI 10.1038/nrd3810; Bhola NE, 2012, MOL CANCER THER, V11, P1236, DOI 10.1158/1535-7163.MCT-11-0936; Bornstein S, 2009, J CLIN INVEST, V119, P3408, DOI 10.1172/JCI38854; Curry NL, 2013, CANCER DISCOV, V3, P908, DOI 10.1158/2159-8290.CD-12-0507; Du L, 2012, J ONCOL, V2012, DOI 10.1155/2012/450179; Du Y, 2014, PHARMACOL THERAPEUT, V142, P88, DOI 10.1016/j.pharmthera.2013.11.007; Durban VM, 2013, J CLIN INVEST, V123, P5104, DOI 10.1172/JCI69619; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Engelman JA, 2008, NAT MED, V14, P1351, DOI 10.1038/nm.1890; Eser S, 2013, CANCER CELL, V23, P406, DOI 10.1016/j.ccr.2013.01.023; Estilo CL, 2003, CLIN CANCER RES, V9, P2300; Fan QW, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000014; Feng QT, 2010, MOL CELL BIOL, V30, P3711, DOI 10.1128/MCB.00420-10; Fenic I, 2007, ONCOL REP, V18, P253; Finlay DK, 2009, J EXP MED, V206, P2441, DOI 10.1084/jem.20090219; Garcia-Carracedo D, 2013, CLIN CANCER RES, V19, P6830, DOI 10.1158/1078-0432.CCR-13-0624; Han G, 2005, J CLIN INVEST, V115, P1714, DOI 10.1172/JCI24399; Hare LM, 2014, BIOCHEM J, V458, P251, DOI 10.1042/BJ20131412; Hennessy BT, 2009, CANCER RES, V69, P4116, DOI 10.1158/0008-5472.CAN-08-3441; Iglesias-Bartolome R, 2013, CANCER DISCOV, V3, P722, DOI 10.1158/2159-8290.CD-13-0239; Iliopoulos D, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000356; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kinross KM, 2012, J CLIN INVEST, V122, P553, DOI 10.1172/JCI59309; Klarenbeek S, 2013, MOL ONCOL, V7, P146, DOI 10.1016/j.molonc.2013.02.003; Kozaki KI, 2006, CANCER SCI, V97, P1351, DOI 10.1111/j.1349-7006.2006.00343.x; Lauring J, 2010, ONCOGENE, V29, P2337, DOI 10.1038/onc.2009.516; Leemans CR, 2011, NAT REV CANCER, V11, P9, DOI 10.1038/nrc2982; Liu PX, 2011, NAT MED, V17, P1116, DOI 10.1038/nm.2402; Liu PX, 2009, NAT REV DRUG DISCOV, V8, P627, DOI 10.1038/nrd2926; Lu SL, 2006, GENE DEV, V20, P1331, DOI 10.1101/gad.1413306; Lu SL, 2004, CANCER RES, V64, P4405, DOI 10.1158/0008-5472.CAN-04-1032; Lui VWY, 2013, CANCER DISCOV, V3, P761, DOI 10.1158/2159-8290.CD-13-0103; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Marvel D, 2015, J CLIN INVEST, V125, P3356, DOI 10.1172/JCI80005; Maurer M, 2009, CANCER RES, V69, P6299, DOI 10.1158/0008-5472.CAN-09-0820; Moral M, 2009, CANCER RES, V69, P1099, DOI 10.1158/0008-5472.CAN-08-3240; Morri LGT, 2011, P NATL ACAD SCI USA, V108, P19024, DOI 10.1073/pnas.1111963108; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; Pickering CR, 2013, CANCER DISCOV, V3, P770, DOI 10.1158/2159-8290.CD-12-0537; Raimondi C, 2012, J CELL SCI, V125, P3153, DOI 10.1242/jcs.100511; Scortegagna M, 2014, ONCOGENE, V33, P4330, DOI 10.1038/onc.2013.383; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Signore M, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.188; Tan J, 2013, CANCER DISCOV, V3, P1156, DOI 10.1158/2159-8290.CD-12-0595; Vasudevan KM, 2009, CANCER CELL, V16, P21, DOI 10.1016/j.ccr.2009.04.012; Vitale-Cross L, 2009, CANCER PREV RES, V2, P419, DOI 10.1158/1940-6207.CAPR-09-0058; Vogt PK, 2009, CURR OPIN GENET DEV, V19, P12, DOI 10.1016/j.gde.2008.11.011; Wallin JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036402; Weber SM, 2011, INT J ONCOL, V39, P1193, DOI 10.3892/ijo.2011.1149; Woenckhaus J, 2002, J PATHOL, V198, P335, DOI 10.1002/path.1207; Wong KK, 2009, CANCER PREV RES, V2, P10, DOI 10.1158/1940-6207.CAPR-08-0234; Xue GD, 2012, CANCER DISCOV, V2, P248, DOI 10.1158/2159-8290.CD-11-0270; Yi JY, 2005, J BIOL CHEM, V280, P10870, DOI 10.1074/jbc.M413223200; Zhang L, 2013, TRENDS BIOCHEM SCI, V38, P612, DOI 10.1016/j.tibs.2013.10.001	54	40	41	0	7	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 1	2016	35	35					4641	4652		10.1038/onc.2016.1	http://dx.doi.org/10.1038/onc.2016.1			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DU6PE	26876212	Green Accepted			2022-12-26	WOS:000382336300010
J	Merched, AJ; Daret, D; Li, L; Franzl, N; Sauvage-Merched, M				Merched, Aksam J.; Daret, Daniele; Li, Lan; Franzl, Nathalie; Sauvage-Merched, Maria			Specific autoantigens in experimental autoimmunity-associated atherosclerosis	FASEB JOURNAL			English	Article						phagocytosis; extracellular matrix; cytoskeleton; cell junctions	VALOSIN-CONTAINING PROTEIN; MIGRATION INHIBITORY FACTOR; HEAT-SHOCK PROTEINS; SYSTEMIC-LUPUS-ERYTHEMATOSUS; MYOCARDIAL-INFARCTION; MOLECULAR CHAPERONES; INNATE IMMUNITY; AUTOPHAGY; DISEASE; DEFICIENT	Higher cardiovascular morbidity in patients with a wide range of autoimmune diseases highlights the importance of autoimmunity in promoting atherosclerosis. Our purpose was to investigate the mechanisms of accelerated atherosclerosis and identified vascular autoantigens targeted by autoimmunity. We created a mouse model of autoimmunity-associated atherosclerosis by transplanting bone marrow from FcRIIB knockout (FcRIIB(-/-)) mice into LDL receptor knockout mice. We characterized the cellular and molecular mechanisms of atherogenesis and identified specific aortic autoantigens using serologic proteomic studies. En face lesion area analysis showed more aggressive atherosclerosis in autoimmune mice compared with control mice (0.64 +/- 0.12 vs. 0.32 +/- 0.05 mm(2); P < 0.05, respectively). At the cellular level, FcRIIB(-/-) macrophages showed significant reduction (46-72%) in phagocytic capabilities. Proteomic analysis revealed circulating autoantibodies in autoimmune mice that targeted 25 atherosclerotic lesion proteins, including essential components of adhesion complex, cytoskeleton, and extracellular matrix, and proteins involved in critical functions and pathways. Microscopic examination of atherosclerotic plaques revealed essential colocalization of autoantibodies with endothelial cells, their adherence to basement membranes, the internal elastica lamina, and necrotic cores. The new vascular autoimmunosome may be a useful target for diagnostic and immunotherapeutic interventions in autoimmunity-associated diseases that have accelerated atherosclerosis.Merched, A. J., Daret, D., Li, L., Franzl, N., Sauvage-Merched, M. Specific autoantigens in experimental autoimmunity-associated atherosclerosis.	[Merched, Aksam J.] Univ Bordeaux, Dept Pharmaceut Sci, Bordeaux, France; [Merched, Aksam J.] Univ Bordeaux, INSERM, U1053, Bordeaux, France; [Merched, Aksam J.; Li, Lan] Baylor Coll Med, Dept Cell Biol, 1 Baylor Plaza, Houston, TX 77030 USA; [Daret, Daniele; Franzl, Nathalie] INSERM, U1034, Pessac, France; [Sauvage-Merched, Maria] Univ Hosp Bordeaux, Childrens Hosp, Bordeaux, France	UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Baylor College of Medicine; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; CHU Bordeaux	Merched, AJ (corresponding author), UFR Pharm, Biol Cellulaire Lab, 146 Rue Leo Saignat, F-33076 Bordeaux, France.	aksam.merched@u-bordeaux.fr		Merched, Aksam/0000-0003-4030-4538	American Heart Association [SDG 0730172N]; Marie Curie Actions (FP7 Intra-European Fellowship) [PIEF-GA-2009-237028]	American Heart Association(American Heart Association); Marie Curie Actions (FP7 Intra-European Fellowship)	This work received grant support from the American Heart Association (SDG 0730172N) and Marie Curie Actions (FP7 Intra-European Fellowship PIEF-GA-2009-237028; both to A. J. M.). The authors declare no conflicts of interest.	Amigorena S, 1999, IMMUNOL REV, V172, P279, DOI 10.1111/j.1600-065X.1999.tb01372.x; Anderton SM, 2004, CURR OPIN IMMUNOL, V16, P753, DOI 10.1016/j.coi.2004.09.001; Arur S, 2003, DEV CELL, V4, P587, DOI 10.1016/S1534-5807(03)00090-X; Bernhagen J, 2007, NAT MED, V13, P587, DOI 10.1038/nm1567; Binder CJ, 2012, ADV EXP MED BIOL, V750, P2, DOI 10.1007/978-1-4614-3461-0_1; Binder CJ, 2003, NAT MED, V9, P736, DOI 10.1038/nm876; Boldogh IR, 2001, P NATL ACAD SCI USA, V98, P3162, DOI 10.1073/pnas.051494698; Bolland S, 2000, IMMUNITY, V13, P277, DOI 10.1016/S1074-7613(00)00027-3; Bruns C, 2011, J CELL BIOL, V195, P979, DOI 10.1083/jcb.201106098; Bug M, 2012, J STRUCT BIOL, V179, P78, DOI 10.1016/j.jsb.2012.03.003; Burillo E, 2009, ATHEROSCLEROSIS, V207, P32, DOI 10.1016/j.atherosclerosis.2009.03.054; Calandra T, 2003, NAT REV IMMUNOL, V3, P791, DOI 10.1038/nri1200; Chapman SL, 2010, ARTERIOSCL THROM VAS, V30, P68, DOI 10.1161/ATVBAHA.109.196725; Chiu CC, 2011, CLIN CANCER RES, V17, P4629, DOI 10.1158/1078-0432.CCR-10-2107; Chiu KH, 2011, J PROTEOME RES, V10, P1110, DOI 10.1021/pr1008724; Chuang YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037613; Dai RM, 2001, NAT CELL BIOL, V3, P740, DOI 10.1038/35087056; Dalli J, 2008, BLOOD, V112, P2512, DOI 10.1182/blood-2008-02-140533; de la Cuesta F, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.003517; Debrand E, 2012, BIOCHEM BIOPH RES CO, V426, P190, DOI 10.1016/j.bbrc.2012.08.061; Denas G, 2015, AUTOIMMUN REV, V14, P214, DOI 10.1016/j.autrev.2014.11.003; Drenth JPH, 2005, TRENDS MOL MED, V11, P37, DOI 10.1016/j.molmed.2004.11.004; Frieri M, 2016, AUTOIMMUN REV, V15, P16, DOI 10.1016/j.autrev.2015.08.007; Gatto M, 2013, AUTOIMMUN REV, V12, P523, DOI 10.1016/j.autrev.2012.09.003; Gillon AD, 2012, BBA-MOL CELL BIOL L, V1821, P1040, DOI 10.1016/j.bbalip.2012.01.005; GOULDING NJ, 1989, ANN RHEUM DIS, V48, P843, DOI 10.1136/ard.48.10.843; Grumati P, 2010, NAT MED, V16, P1313, DOI 10.1038/nm.2247; Hahn C, 2009, NAT REV MOL CELL BIO, V10, P53, DOI 10.1038/nrm2596; Hait WN, 2006, AUTOPHAGY, V2, P294, DOI 10.4161/auto.2857; Han JH, 2011, NAT IMMUNOL, V12, P1143, DOI 10.1038/ni.2159; HANSSON GK, 1980, EXP MOL PATHOL, V33, P302, DOI 10.1016/0014-4800(80)90028-3; Hansson GK, 2011, NAT IMMUNOL, V12, P204, DOI 10.1038/ni.2001; Hollan I, 2013, AUTOIMMUN REV, V12, P1004, DOI 10.1016/j.autrev.2013.03.013; Jiang Y, 2000, IMMUNOGENETICS, V51, P429, DOI 10.1007/s002510050641; Ju JS, 2009, J CELL BIOL, V187, P875, DOI 10.1083/jcb.200908115; Kaess BM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014529; KATSUDA S, 1992, ARTERIOSCLER THROMB, V12, P494, DOI 10.1161/01.ATV.12.4.494; Kaushik S, 2012, TRENDS CELL BIOL, V22, P407, DOI 10.1016/j.tcb.2012.05.006; Koutouzis T, 2009, J PERIODONTOL, V80, P625, DOI 10.1902/jop.2009.080422; Kurosu K, 2008, J IMMUNOL, V181, P756, DOI 10.4049/jimmunol.181.1.756; Lague MN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042470; Le Clainche C, 2008, PHYSIOL REV, V88, P489, DOI 10.1152/physrev.00021.2007; Lee JJ, 2013, J BIOL CHEM, V288, P6998, DOI 10.1074/jbc.M112.417576; Lessard CJ, 2012, AM J HUM GENET, V90, P648, DOI 10.1016/j.ajhg.2012.02.023; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Li GH, 2009, CIRC RES, V104, P896, DOI 10.1161/CIRCRESAHA.108.172882; Libby P, 2012, ARTERIOSCL THROM VAS, V32, P2045, DOI 10.1161/ATVBAHA.108.179705; Lindsay EA, 1999, NATURE, V401, P379, DOI 10.1038/43900; Liu GW, 2013, J LEUKOCYTE BIOL, V93, P511, DOI 10.1189/jlb.0812389; Lovely RS, 2011, ARTERIOSCL THROM VAS, V31, P2345, DOI 10.1161/ATVBAHA.111.232710; Maday S, 2012, J CELL BIOL, V196, P407, DOI 10.1083/jcb.201106120; Mannila MN, 2007, J THROMB HAEMOST, V5, P766, DOI 10.1111/j.1538-7836.2007.02406.x; Meerang M, 2011, NAT CELL BIOL, V13, P1376, DOI 10.1038/ncb2367; Mendez-Fernandez YV, 2011, ATHEROSCLEROSIS, V214, P73, DOI 10.1016/j.atherosclerosis.2010.10.018; Menezes JS, 2007, J CLIN INVEST, V117, P2176, DOI 10.1172/JCI28277; Merched A, 2010, CARDIOVASC RES, V85, P853, DOI 10.1093/cvr/cvp347; Merched AJ, 2008, FASEB J, V22, P3595, DOI 10.1096/fj.08-112201; Merched AJ, 2011, J NUTRIGENET NUTRIGE, V4, P12, DOI 10.1159/000326890; Monastyrska I, 2008, MOL BIOL CELL, V19, P1962, DOI 10.1091/mbc.E07-09-0892; Mooren OL, 2012, ANNU REV BIOCHEM, V81, P661, DOI 10.1146/annurev-biochem-060910-094416; Nakamura T, 2002, NATURE, V415, P171, DOI 10.1038/415171a; Narshi CB, 2011, LUPUS, V20, P5, DOI 10.1177/0961203310382429; Oikonomou KG, 2011, AUTOIMMUN REV, V10, P389, DOI 10.1016/j.autrev.2010.12.009; Pan JH, 2004, CIRCULATION, V109, P3149, DOI 10.1161/01.CIR.0000134704.84454.D2; Pandey S, 2013, MOL CELL PROTEOMICS, V12, P277, DOI 10.1074/mcp.M112.017087; Pritchard NR, 2000, CURR BIOL, V10, P227, DOI 10.1016/S0960-9822(00)00344-4; PRUZANSKI W, 1994, J RHEUMATOL, V21, P252; Py BF, 2009, AUTOPHAGY, V5, P393, DOI 10.4161/auto.5.3.7762; Ramos PS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002406; Ramos PS, 2011, ARTHRITIS RHEUM-US, V63, P2049, DOI 10.1002/art.30356; Ravetch JV, 2000, SCIENCE, V290, P84, DOI 10.1126/science.290.5489.84; Rekvig OP, 2012, AUTOIMMUN REV, V11, P596, DOI 10.1016/j.autrev.2011.10.021; Rohwedder I, 2012, EMBO MOL MED, V4, P564, DOI 10.1002/emmm.201200237; Rullo OJ, 2013, ANN RHEUM DIS, V72, P56, DOI 10.1136/annrheumdis-2012-202351; Santos LL, 2009, CLIN CHIM ACTA, V399, P1, DOI 10.1016/j.cca.2008.09.014; Schmidt MR, 2009, P NATL ACAD SCI USA, V106, P15344, DOI 10.1073/pnas.0904268106; Serrander L, 2000, J IMMUNOL, V165, P2451, DOI 10.4049/jimmunol.165.5.2451; Sherer Y, 2000, APPL BIOCHEM BIOTECH, V83, P155, DOI 10.1385/ABAB:83:1-3:155; Sherer Y., 2000, APPL BIOCHEM BIOTECH, V83, P297; Silver KE, 2011, J IMMUNOL, V186, P816, DOI 10.4049/jimmunol.1002161; Skaggs BJ, 2012, NAT REV RHEUMATOL, V8, P214, DOI 10.1038/nrrheum.2012.14; Suzuki Ayako, 2010, Cancer Genomics & Proteomics, V7, P17; Symmons DPM, 2011, NAT REV RHEUMATOL, V7, P399, DOI 10.1038/nrrheum.2011.75; Tahiri F, 2008, HEPATOLOGY, V47, P937, DOI 10.1002/hep.22149; Takai T, 2002, NAT REV IMMUNOL, V2, P580, DOI 10.1038/nri856; Teixeira PC, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/868251; Wang RB, 2006, BLOOD, V107, P1636, DOI 10.1182/blood-2005-06-2559; Wehrle-Haller B, 2012, CURR OPIN CELL BIOL, V24, P116, DOI 10.1016/j.ceb.2011.11.001; Wojcik C, 2004, J CELL SCI, V117, P281, DOI 10.1242/jcs.00841; Wu MY, 2012, CELL RES, V22, P1003, DOI 10.1038/cr.2012.44; Wu TC, 2006, CELL STRESS CHAPERON, V11, P1, DOI 10.1379/CSC-155R.1; Xu QB, 2002, ARTERIOSCL THROM VAS, V22, P1547, DOI 10.1161/01.ATV.0000029720.59649.50; Xu QB, 2012, AM J PHYSIOL-HEART C, V302, pH506, DOI 10.1152/ajpheart.00646.2011; Yona S, 2006, BRIT J PHARMACOL, V148, P469, DOI 10.1038/sj.bjp.0706730; Zhang QB, 2013, J EXP MED, V210, P191, DOI 10.1084/jem.20111843; Zhao M, 2010, J IMMUNOL, V184, P2253, DOI 10.4049/jimmunol.0902654	96	12	13	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2016	30	6					2123	2134		10.1096/fj.201500131	http://dx.doi.org/10.1096/fj.201500131			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DN2FA	26891734				2022-12-26	WOS:000376878300007
J	Luo, L; Xue, J; Kwan, A; Gamsjaeger, R; Wielens, J; von Kleist, L; Cubeddu, L; Guo, Z; Stow, JL; Parker, MW; Mackay, JP; Robinson, PJ				Luo, Lin; Xue, Jing; Kwan, Ann; Gamsjaeger, Roland; Wielens, Jerome; von Kleist, Lisa; Cubeddu, Liza; Guo, Zhong; Stow, Jennifer L.; Parker, Michael W.; Mackay, Joel P.; Robinson, Phillip J.			The Binding of Syndapin SH3 Domain to Dynamin Proline-rich Domain Involves Short and Long Distance Elements	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT BULK ENDOCYTOSIS; HERPESVIRAL PROTEIN; STRUCTURAL BASIS; RECOGNITION; DOCKING; IDENTIFICATION; SPECIFICITY; P67(PHOX); CONSENSUS; HADDOCK	Dynamin is a GTPase that mediates vesicle fission during synaptic vesicle endocytosis. Its long C-terminal proline-rich domain contains 13 PXXP motifs, which orchestrate its interactions with multiple proteins. The SH3 domains of syndapin and endophilin bind the PXXP motifs called Site 2 and 3 (Pro-786-Pro-793) at the N-terminal end of the proline-rich domain, whereas the amphiphysin SH3 binds Site 9 (Pro-833-Pro-836) toward the C-terminal end. In some proteins, SH3/peptide interactions also involve short distance elements, which are 5-15 amino acid extensions flanking the central PXXP motif for high affinity binding. Here we found two previously unrecognized elements in the central and the C-terminal end of the dynamin proline-rich domain that account for a significant increase in syndapin binding affinity compared with a previously reported Site 2 and Site 3 PXXP peptide alone. The first new element (Gly-807-Gly-811) is short distance element on the C-terminal side of Site 2 PXXP, which might contact a groove identified under the RT loop of the SH3 domain. The second element (Arg-838-Pro-844) is located about 50 amino acids downstream of Site 2. These two elements provide additional specificity to the syndapin SH3 domain outside of the well described polyproline-binding groove. Thus, the dynamin/syndapin interaction is mediated via a network of multiple contacts outside the core PXXP motif over a previously unrecognized extended region of the proline-rich domain. To our knowledge this is the first example among known SH3 interactions to involve spatially separated and extended long-range elements that combine to provide a higher affinity interaction.	[Luo, Lin; Xue, Jing; Robinson, Phillip J.] Univ Sydney, Childrens Med Res Inst, Cell Signalling Unit, Locked Bag 23, Wentworthville, NSW 2145, Australia; [Luo, Lin; Guo, Zhong; Stow, Jennifer L.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Luo, Lin; Stow, Jennifer L.] Univ Queensland, IMB Ctr Inflammat & Dis Res, Brisbane, Qld 4072, Australia; [Kwan, Ann; Gamsjaeger, Roland; Cubeddu, Liza; Mackay, Joel P.] Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia; [Gamsjaeger, Roland; Cubeddu, Liza] Univ Western Sydney, Sch Sci & Hlth, Sydney, NSW 2751, Australia; [Wielens, Jerome; Parker, Michael W.] St Vincents Inst Med Res, ACRF Rat Drug Discovery Ctr, 41 Victoria Parade, Fitzroy, Vic 3065, Australia; [von Kleist, Lisa] Free Univ Berlin, Inst Chem & Biochem, Grp Cellular Biochem, Thielallee 63, D-14195 Berlin, Germany; [Parker, Michael W.] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Dept Biochem & Mol Biol, Parkville, Vic 3010, Australia	Children's Medical Research Institute - Australia; University of Sydney; University of Queensland; University of Queensland; University of Sydney; Western Sydney University; St. Vincent's Institute of Medical Research; Free University of Berlin; University of Melbourne	Robinson, PJ (corresponding author), Univ Sydney, Childrens Med Res Inst, Cell Signalling Unit, Locked Bag 23, Wentworthville, NSW 2145, Australia.; Mackay, JP (corresponding author), Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia.	joel.mackay@sydney.edu.au; probinson@cmri.org.au	Robinson, Phillip J/G-4008-2011; Mackay, Joel P/D-6834-2011; GUO, Zhong/J-8723-2014; Parker, Michael W/F-9069-2013; Luo, Lin/B-7845-2016; Stow, Jennifer/I-4723-2013	Robinson, Phillip J/0000-0002-7878-0313; Mackay, Joel P/0000-0001-7508-8033; GUO, Zhong/0000-0003-0285-5021; Parker, Michael W/0000-0002-3101-1138; Luo, Lin/0000-0001-5556-7096; Kwan, Ann/0000-0002-1506-2226; Gamsjaeger, Roland/0000-0003-1095-2569; Wielens, Jerome/0000-0003-3406-4136; Stow, Jennifer/0000-0002-5409-9101; von Kleist, Lisa/0000-0001-9938-6510	National Health and Medical Research Council Australia [GNT1047070, GNT633225, GNT1069493]; Children's Medical Research Institute (CMRI); Victorian Government Operational Infrastructure Support Scheme	National Health and Medical Research Council Australia(National Health and Medical Research Council (NHMRC) of Australia); Children's Medical Research Institute (CMRI); Victorian Government Operational Infrastructure Support Scheme	This work was supported by National Health and Medical Research Council Australia Grants GNT1047070, GNT633225, and GNT1069493 (to P. J. R.), the Children's Medical Research Institute (CMRI), and the Victorian Government Operational Infrastructure Support Scheme (to St. Vincent's Institute). The authors declare that they have no conflicts of interest with the contents of this article.	Aitio O, 2010, P NATL ACAD SCI USA, V107, P21743, DOI 10.1073/pnas.1010243107; Anggono V, 2007, J NEUROCHEM, V102, P931, DOI 10.1111/j.1471-4159.2007.04574.x; Anggono V, 2006, NAT NEUROSCI, V9, P752, DOI 10.1038/nn1695; Bauer F, 2005, PROTEIN SCI, V14, P2487, DOI 10.1110/ps.051563605; CICCHETTI P, 1992, SCIENCE, V257, P803, DOI 10.1126/science.1379745; Clayton EL, 2009, J NEUROCHEM, V111, P901, DOI 10.1111/j.1471-4159.2009.06384.x; Clayton EL, 2009, J NEUROSCI, V29, P7706, DOI 10.1523/JNEUROSCI.1976-09.2009; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; FEENEY J, 1979, J MAGN RESON, V33, P519, DOI 10.1016/0022-2364(79)90163-X; FENG SB, 1994, SCIENCE, V266, P1241, DOI 10.1126/science.7526465; Folta-Stogniew E, 1999, J Biomol Tech, V10, P51; Ghose R, 2001, NAT STRUCT BIOL, V8, P998, DOI 10.1038/nsb1101-998; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Grabs D, 1997, J BIOL CHEM, V272, P13419, DOI 10.1074/jbc.272.20.13419; Graham ME, 2007, J BIOL CHEM, V282, P14695, DOI 10.1074/jbc.M609713200; Harkiolaki M, 2003, EMBO J, V22, P2571, DOI 10.1093/emboj/cdg258; Kami K, 2002, EMBO J, V21, P4268, DOI 10.1093/emboj/cdf428; Kaneko T, 2008, FRONT BIOSCI-LANDMRK, V13, P4938, DOI 10.2741/3053; Li SSC, 2005, BIOCHEM J, V390, P641, DOI 10.1042/BJ20050411; Luo L, 2014, PROTEOMICS, V14, P19, DOI 10.1002/pmic.201300315; Marley J, 2001, J BIOMOL NMR, V20, P71, DOI 10.1023/A:1011254402785; Massenet C, 2005, J BIOL CHEM, V280, P13752, DOI 10.1074/jbc.M412897200; McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151; Mott HR, 2005, BIOCHEMISTRY-US, V44, P10977, DOI 10.1021/bi050374a; Musacchio A, 2003, ADV PROTEIN CHEM, V61, P211; Rao YJ, 2010, P NATL ACAD SCI USA, V107, P8213, DOI 10.1073/pnas.1003478107; Rasmussen RK, 1998, BIOCHEM J, V335, P119, DOI 10.1042/bj3350119; Saksela K, 2012, FEBS LETT, V586, P2609, DOI 10.1016/j.febslet.2012.04.042; Schweimer K, 2002, BIOCHEMISTRY-US, V41, P5120, DOI 10.1021/bi015986j; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Shupliakov O, 1997, SCIENCE, V276, P259, DOI 10.1126/science.276.5310.259; Solomaha E, 2005, J BIOL CHEM, V280, P23147, DOI 10.1074/jbc.M501745200; Sundborger Anna C, 2014, F1000Prime Rep, V6, P85, DOI 10.12703/P6-85; Tan TC, 2003, NAT CELL BIOL, V5, P701, DOI 10.1038/ncb1020; van Dalen J P, 1970, Histochem J, V2, P329; van Dijk ADJ, 2006, BIOINFORMATICS, V22, P2340, DOI 10.1093/bioinformatics/btl395; van Dijk M, 2006, NUCLEIC ACIDS RES, V34, P3317, DOI 10.1093/nar/gkl412	37	14	14	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2016	291	18					9411	9424		10.1074/jbc.M115.703108	http://dx.doi.org/10.1074/jbc.M115.703108			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DL4JY	26893375	hybrid, Green Published			2022-12-26	WOS:000375602300003
J	Wang, TY; Sun, YS; Muthukrishnan, N; Erazo-Oliveras, A; Najjar, K; Pellois, JP				Wang, Ting-Yi; Sun, Yusha; Muthukrishnan, Nandhini; Erazo-Oliveras, Alfredo; Najjar, Kristina; Pellois, Jean-Philippe			Membrane Oxidation Enables the Cytosolic Entry of Polyarginine Cell-penetrating Peptides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell culture; cell-penetrating peptide (CPP); oxidation-reduction (redox); peptide transport; plasma membrane	ARGININE-RICH PEPTIDES; LIPID-PEROXIDATION; CYCLIC-PEPTIDES; LIVE CELLS; DELIVERY; STRESS; INTERNALIZATION; MECHANISM; PERMEABILITY; ANTIBODIES	Arginine-rich peptides can penetrate cells and consequently be used as delivery agents in various cellular applications. The activity of these reagents is often context-dependent, and the parameters that impact cell entry are not fully understood, giving rise to variability and limiting progress toward their usage. Herein, we report that the cytosolic penetration of linear polyarginine peptides is dependent on the oxidation state of the cell. In particular, we find that hypoxia and cellular antioxidants inhibit cell penetration. In contrast, oxidants promote cytosolic cell entry with an efficiency proportional to the level of reactive oxygen species generated within membranes. Moreover, an antibody that binds to oxidized lipids inhibits cell penetration, whereas extracellularly administered pure oxidized lipids enhance peptide transport into cells. Overall, these data indicate that oxidized lipids are capable of mediating the transport of polyarginine peptides across membranes. These data may also explain variability in cell-penetrating peptide performance in different experimental conditions. These new findings therefore provide new opportunities for the rational design of future cell-permeable compounds and for the optimization of delivery protocols.	[Wang, Ting-Yi; Sun, Yusha; Muthukrishnan, Nandhini; Erazo-Oliveras, Alfredo; Najjar, Kristina; Pellois, Jean-Philippe] Texas A&M Univ, Dept Biochem & Biophys, Biochem & Biophys Bldg,Rm 430,300 Olsen Blvd, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Pellois, JP (corresponding author), Texas A&M Univ, Dept Biochem & Biophys, Biochem & Biophys Bldg,Rm 430,300 Olsen Blvd, College Stn, TX 77843 USA.	pellois@tamu.edu	Muthukrishnan, Nandhini/P-8906-2018	Pellois, Jean-Philippe/0000-0001-8528-4652; Sun, Yusha/0000-0003-4835-3000; Wang, Ting-Yi/0000-0001-5536-925X	National Institutes of Health from NIGMS [R01GM110137]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM110137] Funding Source: NIH RePORTER	National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R01GM110137 from NIGMS. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Babich H, 2009, IN VITRO CELL DEV-AN, V45, P226, DOI 10.1007/s11626-008-9168-z; Benderitter M, 2003, RADIAT RES, V159, P471, DOI 10.1667/0033-7587(2003)159[0471:TCMAAB]2.0.CO;2; Bochkov VN, 2010, ANTIOXID REDOX SIGN, V12, P1009, DOI 10.1089/ars.2009.2597; Cascales L, 2011, J BIOL CHEM, V286, P36932, DOI 10.1074/jbc.M111.264424; Chikazawa M, 2013, J BIOL CHEM, V288, P13204, DOI 10.1074/jbc.M113.452177; Chu Q, 2015, MEDCHEMCOMM, V6, P111, DOI 10.1039/c4md00131a; Davies KJA, 2000, IUBMB LIFE, V50, P279, DOI 10.1080/15216540051081010; de la Haba C, 2013, BBA-BIOMEMBRANES, V1828, P357, DOI 10.1016/j.bbamem.2012.08.013; Derossi D, 1996, J BIOL CHEM, V271, P18188, DOI 10.1074/jbc.271.30.18188; Deshayes S, 2006, BBA-BIOMEMBRANES, V1758, P1846, DOI 10.1016/j.bbamem.2006.08.010; Dietz GPH, 2004, MOL CELL NEUROSCI, V27, P85, DOI 10.1016/j.mcn.2004.03.005; Drummen GPC, 2002, FREE RADICAL BIO MED, V33, P473, DOI 10.1016/S0891-5849(02)00848-1; Duchardt F, 2007, TRAFFIC, V8, P848, DOI 10.1111/j.1600-0854.2007.00572.x; Erazo-Oliveras A, 2014, NAT METHODS, V11, P861, DOI [10.1038/NMETH.2998, 10.1038/nmeth.2998]; Erazo-Oliveras A, 2012, PHARMACEUTICALS-BASE, V5, P1177, DOI 10.3390/ph5111177; FALANGA V, 1993, J CELL PHYSIOL, V154, P506, DOI 10.1002/jcp.1041540308; Friedman P, 2002, J BIOL CHEM, V277, P7010, DOI 10.1074/jbc.M108860200; Frikke-Schmidt H, 2010, ANAL BIOCHEM, V397, P135, DOI 10.1016/j.ab.2009.09.040; Greenberg ME, 2008, J BIOL CHEM, V283, P2385, DOI 10.1074/jbc.M707348200; Halliwell B, 2003, FEBS LETT, V540, P3, DOI 10.1016/S0014-5793(03)00235-7; Halliwell Barry, 2014, Biomed J, V37, P99, DOI 10.4103/2319-4170.128725; Herce HD, 2014, J AM CHEM SOC, V136, P17459, DOI 10.1021/ja507790z; Hirose H, 2012, MOL THER, V20, P984, DOI 10.1038/mt.2011.313; Howard AC, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1594; Huotari J, 2011, EMBO J, V30, P3481, DOI 10.1038/emboj.2011.286; Ingolfsson HI, 2014, J AM CHEM SOC, V136, P14554, DOI 10.1021/ja507832e; Israel N, 1997, CELL MOL LIFE SCI, V53, P864, DOI 10.1007/s000180050106; Jiang N, 2003, J BIOL CHEM, V278, P21678, DOI 10.1074/jbc.M300286200; Jiao CY, 2009, J BIOL CHEM, V284, P33957, DOI 10.1074/jbc.M109.056309; Kawamoto S, 2012, INT J QUANTUM CHEM, V112, P178, DOI 10.1002/qua.23177; Kawamoto S, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3555531; Kim D, 2009, CELL STEM CELL, V4, P472, DOI 10.1016/j.stem.2009.05.005; Kosuge M, 2008, BIOCONJUGATE CHEM, V19, P656, DOI 10.1021/bc700289w; Kotova EA, 2011, BBA-BIOMEMBRANES, V1808, P2252, DOI 10.1016/j.bbamem.2011.05.018; Kwon YU, 2007, J AM CHEM SOC, V129, P1508, DOI 10.1021/ja0668623; Lattig-Tunnemann G, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1459; Lamaziere A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000201; Lehto T, 2012, EXPERT OPIN DRUG DEL, V9, P823, DOI 10.1517/17425247.2012.689285; Liu J, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0091606, 10.1371/journal.pone.0085755, 10.1371/journal.pone.0089315, 10.1371/journal.pone.0098300]; Long LH, 2009, BIOCHEM BIOPH RES CO, V388, P700, DOI 10.1016/j.bbrc.2009.08.069; Madani Fatemeh, 2011, J Biophys, V2011, P414729, DOI 10.1155/2011/414729; Mandal D, 2011, ANGEW CHEM INT EDIT, V50, P9633, DOI 10.1002/anie.201102572; Melikov K, 2015, BIOCHEM J, V471, P221, DOI 10.1042/BJ20150272; Milletti F, 2012, DRUG DISCOV TODAY, V17, P850, DOI 10.1016/j.drudis.2012.03.002; Muthukrishnan N, 2014, PHOTOCHEM PHOTOBIOL, V90, P1034, DOI 10.1111/php.12288; PACKER L, 1977, NATURE, V267, P423, DOI 10.1038/267423a0; Peretto I, 2003, CHEM COMMUN, P2312, DOI 10.1039/b306438g; PORTER NA, 1995, LIPIDS, V30, P277, DOI 10.1007/BF02536034; Qian ZQ, 2013, ACS CHEM BIOL, V8, P423, DOI 10.1021/cb3005275; Ramakrishna S, 2014, GENOME RES, V24, P1020, DOI 10.1101/gr.171264.113; Saito Y, 2003, J BIOL CHEM, V278, P39428, DOI 10.1074/jbc.M305542200; Sakai N, 2003, J AM CHEM SOC, V125, P14348, DOI 10.1021/ja037601l; Schroder T, 2007, BIOCONJUGATE CHEM, V18, P342, DOI 10.1021/bc0602073; Shaw PX, 2000, J CLIN INVEST, V105, P1731, DOI 10.1172/JCI8472; Swiecicki JM, 2014, CHEMBIOCHEM, V15, P884, DOI 10.1002/cbic.201300742; Takahashi M, 2001, FREE RADICAL BIO MED, V31, P164, DOI 10.1016/S0891-5849(01)00575-5; Takeuchi T, 2006, ACS CHEM BIOL, V1, P299, DOI 10.1021/cb600127m; Verdine GL, 2012, METHOD ENZYMOL, V503, P3, DOI 10.1016/B978-0-12-396962-0.00001-X; Verdurmen WPR, 2010, J CONTROL RELEASE, V147, P171, DOI 10.1016/j.jconrel.2010.06.030; Vernier PT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007966; Volinsky R, 2011, BIOPHYS J, V101, P1376, DOI 10.1016/j.bpj.2011.07.051; Wadia JS, 2004, NAT MED, V10, P310, DOI 10.1038/nm996; Wender PA, 2000, P NATL ACAD SCI USA, V97, P13003, DOI 10.1073/pnas.97.24.13003; Wender PA, 2008, ADV DRUG DELIVER REV, V60, P452, DOI 10.1016/j.addr.2007.10.016; Xiao XS, 2007, ANGEW CHEM INT EDIT, V46, P2865, DOI 10.1002/anie.200604485; Yandek LE, 2007, BIOPHYS J, V92, P2434, DOI 10.1529/biophysj.106.100198	66	21	22	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2016	291	15					7902	7914		10.1074/jbc.M115.711564	http://dx.doi.org/10.1074/jbc.M115.711564			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DJ2SZ	26888085	hybrid, Green Published			2022-12-26	WOS:000374056700013
J	Drachler, MD; Drachler, CW; Teixeira, LB; Leite, JCD				Drachler, Maria de Lourdes; Drachler, Carlos Wietzke; Teixeira, Luciana Barcellos; de Carvalho Leite, Jose Carlos			The Scale of Self-Efficacy Expectations of Adherence to Antiretroviral Treatment: A Tool for Identifying Risk for Non-Adherence to Treatment for HIV	PLOS ONE			English	Article							ADOLESCENTS; THERAPY	Background Identification of risk for non-adherence to treatment is a challenge for personalized care for people living with HIV. Standardized questionnaires of patients' expectations of their capability to overcome obstacles for treatment adherence may be used as a pre-screening for risk identification. A scale of self-efficacy expectations of adherence to antiretroviral treatment (SEA-ART scale) was previously developed. This study assesses the scale validity in predicting non-adherence to ART in adults living with HIV. Methods and Findings A prospective cohort study applied a 21-item SEA-ART scale to 275 adults in ART treatment at an outpatient public service for HIV in Southern Brazil. ART medications taken were assessed at one-month follow-up; ART adherence was devised as an intake of 95% and more of the prescribed medication. A SEA-ART score was calculated by adding up the scores of all items. Multivariable logistic regression and the Area Under the Receiver-Operating-Characteristic Curve (AUROC) were applied to examine the ability of the SEA-ART score to predict non-adherence at follow-up. The SEA-ART score varied from 21 to 105; mean 93.9; median 103.0. Non-adherence was 30.3%(n = 81/267). The odds of non-adherence was 8% lower for each unit increase of the SEA-ART score; after adjustment for age, sex, formal education and time in treatment (OR = 0.92; 95% CI 0.90-0.95; LRT for linear trend, p = 0.002). The AUROC was 0.80 (95% CI 0.73-0.87; p < 0.001). The SEA-ART optimal cut-off value was 101, providing a sensitivity of 76.5%, a specificity of 73.1%, a positive predictive value of 55.4% and a negative predictive value of 87.7%. There was no evidence of difference in sensitivity, and specificity among groups organized by age, gender, formal education and time in treatment. Conclusions The SEA-ART scale appears to have a good capacity to discriminate between adherents and non-adherents at one-month follow-up. Further studies should confirm these results in other populations.	[Drachler, Maria de Lourdes] Governo Estado Rio Grande do Sul, Secretaria Saude Estado Rio Grande do Sul, Ave Bento Goncalves 3722, BR-90650001 Porto Alegre, RS, Brazil; [Drachler, Carlos Wietzke] Univ Fed Rio Grande do Sul, Rede Governo Colaborativo Saude, Ave Joao Pessoa 155, BR-90040001 Porto Alegre, RS, Brazil; [Teixeira, Luciana Barcellos] Univ Fed Rio Grande do Sul, Escola Enfermagem, Programa Posgrad Saude Colet, Rua Sao Manoel 963, BR-90620110 Porto Alegre, RS, Brazil; [de Carvalho Leite, Jose Carlos] Ctr Univ La Salle, Saude & Desenvolvimento Humano, Ave Victor Barreto 2288, BR-92010000 Canoas, RS, Brazil	Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Centro Universitario La Salle	Leite, JCD (corresponding author), Ctr Univ La Salle, Saude & Desenvolvimento Humano, Ave Victor Barreto 2288, BR-92010000 Canoas, RS, Brazil.	jcdc.leite@gmail.com			CONSELHO NACIONAL DE DESENVOLVIMENTO CIENTIFICO E TECNOLOGICO - CNPq, Brazilian Government [478282/2010-9]; Universidade Federal do Rio Grande do Sul, Escola de Enfermagem	CONSELHO NACIONAL DE DESENVOLVIMENTO CIENTIFICO E TECNOLOGICO - CNPq, Brazilian Government(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Universidade Federal do Rio Grande do Sul, Escola de Enfermagem	This work was supported by CONSELHO NACIONAL DE DESENVOLVIMENTO CIENTIFICO E TECNOLOGICO - CNPq, Brazilian Government, Protocol no. 478282/2010-9 (http://www.cnpq.br/). Financial support for publication was provided by Universidade Federal do Rio Grande do Sul, Escola de Enfermagem. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandura A., 1997, SELF EFFICACY EXERCI, P36, DOI 10.1007/SpringerReference_223312; Chun J, 2015, CHILD YOUTH SERV REV, V50, P83, DOI 10.1016/j.childyouth.2015.01.009; Costa LS, 2008, J PEDIAT-BRAZIL, V84, P41, DOI [10.2223/JPED.1751, 10.1590/S0021-75572008000100008]; Faustino Quintino de Medeiros, 2010, Psic.: Teor. e Pesq., V26, P121, DOI 10.1590/S0102-37722010000100014; Seidl EMF, 2007, CAD SAUDE PUBLICA, V23, P2305, DOI 10.1590/S0102-311X2007001000006; Gill CJ, 2010, AIDS BEHAV, V14, P785, DOI 10.1007/s10461-009-9555-9; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Kim Youngmee, 2010, Nephrol Nurs J, V37, P271; Leite José Carlos de Carvalho, 2002, Psicol. Reflex. Crit., V15, P121, DOI 10.1590/S0102-79722002000100014; Ministerio da Saude, 2014, B EP AIDS DST; Nokes K, 2012, J NURS SCHOLARSHIP, V44, P403, DOI 10.1111/j.1547-5069.2012.01476.x; Perkins NJ, 2006, AM J EPIDEMIOL, V163, P670, DOI 10.1093/aje/kwj063; Rollnick S., 2008, MOTIVATIONAL INTERVI; Silveira Marysabel Pinto Telis, 2002, Braz J Infect Dis, V6, P164, DOI 10.1590/S1413-86702002000400003; SPSS Inc, 2013, SPSS STAT BAS 22 0 U; Thapinta D, 2012, CHIANG MAI MED J, V5, P1; Torres TDL, 2008, PSYCHOL THEORY PRACT, V10, P64; Veinot TC, 2006, J ADOLESCENT HEALTH, V38, P261, DOI 10.1016/j.jadohealth.2005.03.008; Wagner GJ, 2006, AIDS, V20, P1295, DOI 10.1097/01.aids.0000232238.28415.d2; Wang XQ, 2007, AIDS, V21, pS149, DOI 10.1097/01.aids.0000304711.87164.99; World Health Organization, 2010, UN ACC SCAL PRIOR HI; Yehia BR, 2012, AIDS, V26, P1131, DOI 10.1097/QAD.0b013e3283528afa	22	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0147443	10.1371/journal.pone.0147443	http://dx.doi.org/10.1371/journal.pone.0147443			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3DG	26895270	Green Published, Green Submitted, gold			2022-12-26	WOS:000371223400006
J	Liu, S; Guo, W; Han, X; Dai, WD; Diao, ZL; Liu, WH				Liu, Sha; Guo, Wang; Han, Xue; Dai, Wendi; Diao, Zongli; Liu, Wenhu			Role of UBIAD1 in Intracellular Cholesterol Metabolism and Vascular Cell Calcification	PLOS ONE			English	Article							CRYSTALLINE CORNEAL-DYSTROPHY; CHRONIC KIDNEY-DISEASE; SXR TARGET GENES; SMOOTH-MUSCLE-CELLS; TERE1; PHOSPHATE; PRENYLTRANSFERASE; MUTATIONS; CARCINOMA; BLADDER	Vascular calcification is an important risk factor associated with mortality among patients with chronic kidney disease. Intracellular cholesterol metabolism is involved in the process of vascular cell calcification. In this study, we investigated the role of UbiA prenyltransferase domain containing 1 (UBIAD1) in intracellular cholesterol metabolism and vascular cell calcification, and identified its subcellular location. Primary human umbilical vein smooth muscle cells (HUVSMCs) were incubated with either growth medium (1.4 mmol/L Pi) or calcification medium (CM) (3.0 mmol/L Pi). Under treatment with CM, HUVSMCs were further incubated with exogenous cholesterol, or menaquinone-4, a product of UBIAD1. The plasmid and small interfering RNA were transfected in HUVSMCs to alter the expression of UBIAD1. Matrix calcium quantitation, alkaline phosphatase activity, intracellular cholesterol level and menaquinone-4 level were measured. The expression of several genes involved in cholesterol metabolism were analyzed. Using an anti-UBIAD1 antibody, an endoplasmic reticulum marker and a Golgi marker, the subcellular location of UBIAD1 in HUVSMCs was analyzed. CM increased matrix calcium, alkaline phosphatase activity and intracellular cholesterol level, and reduced UBIAD1 expression and menaquinone-4 level. Addition of cholesterol contributed to increased matrix calcification and alkaline phosphatase activity in a dose-dependent manner. Elevated expression of UBIAD1 or menaquinone-4 in HUVSMCs treated with CM significantly reduced intracellular cholesterol level, matrix calcification and alkaline phosphatase activity, but increased menaquinone-4 level. Elevated expression of UBIAD1 or menaquinone-4 reduced the gene expression of sterol regulatory element-binding protein-2, and increased gene expression of ATP binding cassette transporters A1, which are in charge of cholesterol synthesis and efflux. UBIAD1 co-localized with the endoplasmic reticulum marker and the Golgi marker in HUVSMCs. In conclusion, high intracellular cholesterol content contributes to phosphate-induced vascular cell differentiation and calcification. UBIAD1 or menaquinone-4 could decrease vascular cell differentiation and calcification, probably via its potent role of inversely modulating cellular cholesterol.	[Liu, Sha; Guo, Wang; Han, Xue; Dai, Wendi; Diao, Zongli; Liu, Wenhu] Capital Med Univ, Fac Nephrol, Beijing Friendship Hosp, Dept Nephrol, Beijing, Peoples R China	Capital Medical University	Liu, WH (corresponding author), Capital Med Univ, Fac Nephrol, Beijing Friendship Hosp, Dept Nephrol, Beijing, Peoples R China.	liuwenhu2013@163.com			National Natural Science Foundation of China [81300607, 81570660]; Beijing Municipal Science and Technology Commission Fund [D131100004713001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Municipal Science and Technology Commission Fund	This study received financial support from the National Natural Science Foundation of China (81300607, 81570660) and Beijing Municipal Science and Technology Commission Fund (D131100004713001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedin M, 2004, ARTERIOSCL THROM VAS, V24, P1161, DOI 10.1161/01.ATV.0000133194.94939.42; Burns MP, 2010, BBA-MOL CELL BIOL L, V1801, P853, DOI 10.1016/j.bbalip.2010.03.004; Fredericks WJ, 2013, ONCOTARGET, V4, P1075, DOI 10.18632/oncotarget.1103; Fredericks WJ, 2013, J CELL BIOCHEM, V114, P2170, DOI 10.1002/jcb.24567; Fredericks WJ, 2013, INT J ONCOL, V43, P638, DOI 10.3892/ijo.2013.1985; Fredericks WJ, 2011, DNA CELL BIOL, V30, P851, DOI 10.1089/dna.2011.1315; Geng YF, 2011, J BIOL CHEM, V286, P33701, DOI 10.1074/jbc.M111.269639; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Graciolli FG, 2009, NEPHROL DIAL TRANSPL, V24, P1416, DOI 10.1093/ndt/gfn686; Huang MS, 2008, BIOCHEM BIOPH RES CO, V374, P553, DOI 10.1016/j.bbrc.2008.07.062; Johnson RC, 2006, CIRC RES, V99, P1044, DOI 10.1161/01.RES.0000249379.55535.21; Jono S, 2006, J BONE MINER METAB, V24, P176, DOI 10.1007/s00774-005-0668-6; Kapustin A, 2009, CURR OPIN PHARMACOL, V9, P84, DOI 10.1016/j.coph.2008.12.004; London GM, 2003, NEPHROL DIAL TRANSPL, V18, P1731, DOI 10.1093/ndt/gfg414; Makishima M, 2005, J PHARMACOL SCI, V97, P177, DOI 10.1254/jphs.FMJ04008X4; McGarvey TW, 2005, J CELL BIOCHEM, V95, P419, DOI 10.1002/jcb.20432; McGarvey TW, 2003, PROSTATE, V54, P144, DOI 10.1002/pros.10174; McGarvey TW, 2001, ONCOGENE, V20, P1042, DOI 10.1038/sj.onc.1204143; Mizobuchi M, 2006, NEPHROL DIAL TRANSPL, V21, P911, DOI 10.1093/ndt/gfk008; Mugoni V, 2013, CELL, V152, P504, DOI 10.1016/j.cell.2013.01.013; Nakagawa K, 2010, NATURE, V468, P117, DOI 10.1038/nature09464; Nickerson ML, 2013, HUM MUTAT, V34, P317, DOI 10.1002/humu.22230; Nickerson ML, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010760; Orr A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000685; Reynolds JL, 2004, J AM SOC NEPHROL, V15, P2857, DOI 10.1097/01.ASN.0000141960.01035.28; Schumacher MM, 2015, ELIFE, V4; Shanahan CM, 2011, CIRC RES, V109, P697, DOI 10.1161/CIRCRESAHA.110.234914; Shearer MJ, 2014, J LIPID RES, V55, P345, DOI 10.1194/jlr.R045559; Suhara Y, 2006, BIOORGAN MED CHEM, V14, P6601, DOI 10.1016/j.bmc.2006.06.004; Sun LP, 2007, P NATL ACAD SCI USA, V104, P6519, DOI 10.1073/pnas.0700907104; Tonelli M, 2006, J AM SOC NEPHROL, V17, P2034, DOI 10.1681/ASN.2005101085; Wang X. S., 2013, INT J DISTRIB SENS N, V2013, P1, DOI DOI 10.1371/J0URNAL.P0NE.0072015; Weiss JS, 2008, AM J MED GENET A, V146A, P271, DOI 10.1002/ajmg.a.32201; Weiss JS, 2007, INVEST OPHTH VIS SCI, V48, P5007, DOI 10.1167/iovs.07-0845; Weiss JS, 2010, CORNEA, V29, P777, DOI 10.1097/ICO.0b013e3181c84bcf; Yellore VS, 2007, MOL VIS, V13, P1777; Yoshida T, 2012, J BIOL CHEM, V287, P25706, DOI 10.1074/jbc.M112.361360	37	6	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2016	11	2							e0149639	10.1371/journal.pone.0149639	http://dx.doi.org/10.1371/journal.pone.0149639			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3CO	26890002	Green Published, Green Submitted, gold			2022-12-26	WOS:000371221500066
J	Tan, Y; Liu, XR; Zhou, K; He, XJ; Lu, C; He, B; Niu, XY; Xiao, C; Xu, G; Bian, ZX; Zu, XP; Zhang, G; Zhang, WD; Lu, AP				Tan, Yong; Liu, Xinru; Zhou, Ke; He, Xiaojuan; Lu, Cheng; He, Bing; Niu, Xuyan; Xiao, Cheng; Xu, Gang; Bian, Zhaoxiang; Zu, Xianpeng; Zhang, Ge; Zhang, Weidong; Lu, Aiping			The Potential Biomarkers to Identify the Development of Steatosis in Hyperuricemia	PLOS ONE			English	Article							FATTY LIVER-DISEASE; SERUM URIC-ACID; TRADITIONAL CHINESE MEDICINE; INSULIN-RESISTANCE; OXIDATIVE STRESS; METABOLIC SYNDROME; PHOSPHOLIPASE-D; ANTIOXIDANT CAPACITY; PHOSPHATIDIC-ACID; RADIX-ACONITI	Hyperuricemia (HU) often progresses to combine with non-alcoholic fatty liver disease (NAFLD) in the clinical scenario, which further exacerbates metabolic disorders; early detection of biomarkers, if obtained during the HU progression, may be beneficial for preventing its combination with NAFLD. This study aimed to decipher the biomarkers and mechanisms of the development of steatosis in HU. Four groups of subjects undergoing health screening, including healthy subjects, subjects with HU, subjects with HU combined with NAFLD (HU+NAFLD) and subjects with HU initially and then with HU+NAFLD one year later (HU -> HU+NAFLD), were recruited in this study. The metabolic profiles of all subjects' serum were analyzed by liquid chromatography quadruple time-of-flight mass spectrometry. The metabolomic data from subjects with HU and HU+NAFLD were compared, and the biomarkers for the progression from HU to HU+NAFLD were predicted. The metabolomic data from HU -> HU+NAFLD subjects were collected for further verification. The results showed that the progression was associated with disturbances of phospholipase metabolism, purine nucleotide degradation and Liver X receptor/retinoic X receptor activation as characterized by up-regulated phosphatidic acid, cholesterol ester (18:0) and down-regulated inosine. These metabolic alterations may be at least partially responsible for the development of steatosis in HU. This study provides a new paradigm for better understanding and further prevention of disease progression.	[Tan, Yong; He, Xiaojuan; Lu, Cheng; Niu, Xuyan; Lu, Aiping] China Acad Chinese Med Sci, Inst Basic Res Clin Med, Beijing, Peoples R China; [Liu, Xinru; Zu, Xianpeng; Zhang, Weidong] Second Mil Med Univ, Sch Pharm, Shanghai, Peoples R China; [Zhou, Ke] Hunan Univ Chinese Med, Affiliated Hosp 2, Changsha, Hunan, Peoples R China; [He, Bing; Xu, Gang; Bian, Zhaoxiang; Zhang, Ge; Zhang, Weidong; Lu, Aiping] Hong Kong Baptist Univ, Sch Chinese Med, Inst Adv Translat Med Bone & Joint Dis, Hong Kong, Hong Kong, Peoples R China; [Xiao, Cheng] China Japan Friendship Hosp, Beijing, Peoples R China; [Lu, Aiping] Shanghai Municipal Educ Commiss, E Inst, Shanghai, Peoples R China	China Academy of Chinese Medical Sciences; Institute of Basic Research In Clinical Medicine, CACMS; Naval Medical University; Hunan University of Chinese Medicine; Hong Kong Baptist University; China-Japan Friendship Hospital; Shanghai Municipal Education Commission (SHMEC)	Lu, AP (corresponding author), China Acad Chinese Med Sci, Inst Basic Res Clin Med, Beijing, Peoples R China.; Zhang, WD (corresponding author), Second Mil Med Univ, Sch Pharm, Shanghai, Peoples R China.; Zhang, G; Lu, AP (corresponding author), Hong Kong Baptist Univ, Sch Chinese Med, Inst Adv Translat Med Bone & Joint Dis, Hong Kong, Hong Kong, Peoples R China.; Lu, AP (corresponding author), Shanghai Municipal Educ Commiss, E Inst, Shanghai, Peoples R China.	zhangge@hkbu.edu.hk; wdzhangy@hotmail.com; aipinglu@hkbu.edu.hk	Zhang, Ge/K-9118-2019; Zu, Xian-peng/AAW-6011-2021; Xiao, Cheng/AAM-7764-2020	Zhang, Ge/0000-0002-7807-7695; Zu, Xian-peng/0000-0003-2682-0755; He, Bing/0000-0003-1719-9290	National Science Foundation of China [81230090]; Hong Kong Baptist University Strategic Development Fund [SDF13-1209-P01]; Interdisciplinary Research Matching Scheme of Hong Kong Baptist University [RC-IRMS/12-13/02]; China Postdoctoral Science Foundation [2013M541158]; E-Institutes of the Shanghai Municipal Education Commission [E03008]; Professor of Chang Jiang Scholars Program	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hong Kong Baptist University Strategic Development Fund; Interdisciplinary Research Matching Scheme of Hong Kong Baptist University; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); E-Institutes of the Shanghai Municipal Education Commission; Professor of Chang Jiang Scholars Program	This study was supported by the following sources of funding: National Science Foundation of China (no. 81230090; http://npd.nsfc.gov.cn/), the author who received the funding: WDZ; Hong Kong Baptist University Strategic Development Fund (no. SDF13-1209-P01; http://scm.hkbu.edu.hk/tc/home/index.php), the author who received the funding: APL; Interdisciplinary Research Matching Scheme of Hong Kong Baptist University (no. RC-IRMS/12-13/02; http://scm.hkbu.edu.hk/tc/home/index.php), the author who received the funding: APL; China Postdoctoral Science Foundation (no. 2013M541158; http://www.chinapostdoctor.org.cn/), the author who received the funding: KZ; E-Institutes of the Shanghai Municipal Education Commission (no. E03008; http://www.shmec.gov.cn/), the author who received the funding: WDZ; the Professor of Chang Jiang Scholars Program (http://www.moe.edu.cn/publicfiles/business/htmlfiles/moe/A04_ndgzyd/), the author who received the funding: WDZ.	Abuja PM, 1999, FEBS LETT, V446, P305, DOI 10.1016/S0014-5793(99)00231-8; Ahn SB, 2014, DIGEST DIS SCI, V59, P2975, DOI 10.1007/s10620-014-3289-x; Albano E, 2005, ALIMENT PHARM THER, V22, P71, DOI 10.1111/j.1365-2036.2005.02601.x; Athenstaedt K, 1999, EUR J BIOCHEM, V266, P1, DOI 10.1046/j.1432-1327.1999.00822.x; Bao Y, 2011, ELECTROPHORESIS, V32, P1515, DOI 10.1002/elps.201100040; Baranowski M, 2008, J PHYSIOL PHARMACOL, V59, P31; Cai W, 2013, ARQ BRAS ENDOCRINOL, V57, P617, DOI 10.1590/S0004-27302013000800006; Chalimoniuk Malgorzata, 2012, Postepy Biochem, V58, P204; Csupor D, 2011, PHARM BIOL, V49, P1097, DOI 10.3109/13880209.2011.595011; Dai HF, 2008, HEPATOB PANCREAT DIS, V7, P373; Dawson J, 2006, BRIT J CLIN PHARMACO, V62, P633, DOI 10.1111/j.1365-2125.2006.02785.x; Delon C, 2004, J BIOL CHEM, V279, P44763, DOI 10.1074/jbc.M405771200; Garcia-Ruiz I, 2006, HEPATOLOGY, V44, P581, DOI 10.1002/hep.21313; Ghaemi-Oskouie F, 2011, CURR RHEUMATOL REP, V13, P160, DOI 10.1007/s11926-011-0162-1; Hayden Melvin R, 2004, Nutr Metab (Lond), V1, P10, DOI 10.1186/1743-7075-1-10; Hediger MA, 2005, PHYSIOLOGY, V20, P125, DOI 10.1152/physiol.00039.2004; Hernaez R, 2011, HEPATOLOGY, V54, P1082, DOI 10.1002/hep.24452; Katsiki N, 2011, CURR VASC PHARMACOL, V9, P698, DOI 10.2174/157016111797484152; KENT C, 1995, ANNU REV BIOCHEM, V64, P315, DOI 10.1146/annurev.bi.64.070195.001531; Kuo CF, 2010, SCAND J RHEUMATOL, V39, P466, DOI 10.3109/03009741003742797; Kurotani K, 2012, NUTR RES, V32, P669, DOI 10.1016/j.nutres.2012.07.004; Kurtz TA, 2004, METABOLISM, V53, P138, DOI 10.1016/j.metabol.2003.09.004; Lee JW, 2010, GUT LIVER, V4, P378, DOI 10.5009/gnl.2010.4.3.378; Lee YJ, 2014, INTERN MED J, V44, P1210, DOI 10.1111/imj.12588; Llorach R, 2010, J PROTEOME RES, V9, P5859, DOI 10.1021/pr100639v; Matsuo H, 2014, SCI REP-UK, V4, DOI 10.1038/srep03755; MODAN M, 1987, DIABETOLOGIA, V30, P713, DOI 10.1007/BF00296994; Nieto FJ, 2000, ATHEROSCLEROSIS, V148, P131, DOI 10.1016/S0021-9150(99)00214-2; Pagano G, 2002, HEPATOLOGY, V35, P367, DOI 10.1053/jhep.2002.30690; Park SH, 2004, J GASTROEN HEPATOL, V19, P694, DOI 10.1111/j.1440-1746.2004.03362.x; Patterson RA, 2003, J LIPID RES, V44, P512, DOI 10.1194/jlr.M200407-JLR200; Petta S, 2011, ALIMENT PHARM THER, V34, P757, DOI 10.1111/j.1365-2036.2011.04788.x; Petta S, 2009, DIGEST LIVER DIS, V41, P615, DOI 10.1016/j.dld.2009.01.004; Rosenson RS, 2012, J LIPID RES, V53, P1767, DOI 10.1194/jlr.R024190; Shen W, 2013, J NUTR, V143, P584, DOI 10.3945/jn.112.173161; Sirota JC, 2013, METABOLISM, V62, P392, DOI 10.1016/j.metabol.2012.08.013; Sreekumar A, 2009, NATURE, V457, P910, DOI 10.1038/nature07762; SUCHARD SJ, 1994, J BIOL CHEM, V269, P8063; Sun GY, 2005, MOL NEUROBIOL, V31, P27, DOI 10.1385/MN:31:1-3:027; Tan Y, 2013, J PROTEOME RES, V12, P513, DOI 10.1021/pr300965d; Tappia PS, 2006, FREE RADICAL BIO MED, V41, P349, DOI 10.1016/j.freeradbiomed.2006.03.025; Tsutsui H, 2011, CLIN CHIM ACTA, V412, P861, DOI 10.1016/j.cca.2010.12.023; Voruganti VS, 2014, EUR J HUM GENET, V22, P938, DOI 10.1038/ejhg.2013.264; Vos MB, 2012, J PEDIATR GASTR NUTR, V54, P90, DOI 10.1097/MPG.0b013e318229da1a; VUORINENMARKKOLA H, 1994, J CLIN ENDOCR METAB, V78, P25, DOI 10.1210/jc.78.1.25; Waring WS, 2001, J CARDIOVASC PHARM, V38, P365, DOI 10.1097/00005344-200109000-00005; Xie C, 2012, BIOANALYSIS, V4, P937, DOI [10.4155/BIO.12.43, 10.4155/bio.12.43]; Xie YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067152; Zhang AH, 2010, PLANTA MED, V76, P2026, DOI 10.1055/s-0030-1250542; Zhang ZX, 2014, J PROTEOME RES, V13, P925, DOI 10.1021/pr400968c; Zhao X, 2012, RAPID COMMUN MASS SP, V26, P2443, DOI 10.1002/rcm.6360	51	9	10	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2016	11	2							e0149043	10.1371/journal.pone.0149043	http://dx.doi.org/10.1371/journal.pone.0149043			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3CO	26890003	Green Submitted, Green Published, gold			2022-12-26	WOS:000371221500021
J	Guerra-Perez, N; Aravantinou, M; Veglia, F; Goode, D; Truong, R; Derby, N; Blanchard, J; Grasperge, B; Gettie, A; Robbiani, M; Martinelli, E				Guerra-Perez, Natalia; Aravantinou, Meropi; Veglia, Filippo; Goode, Diana; Truong, Rosaline; Derby, Nina; Blanchard, James; Grasperge, Brooke; Gettie, Agegnehu; Robbiani, Melissa; Martinelli, Elena			Rectal HSV-2 Infection May Increase Rectal SIV Acquisition Even in the Context of SIV Delta nef Vaccination	PLOS ONE			English	Article							SIMIAN IMMUNODEFICIENCY VIRUS; ATTENUATED SIV; RHESUS MACAQUES; CONTROL REPLICATION; VAGINAL CHALLENGE; HIV-1 ACQUISITION; NEGATIVE MEN; LIVE; HERPES; PROTECTION	Prevalent HSV-2 infection increases the risk of HIV acquisition both in men and women even in asymptomatic subjects. Understanding the impact of HSV-2 on the mucosal micro-environment may help to identify determinants of susceptibility to HIV. Vaginal HSV-2 infection increases the frequency of cells highly susceptible to HIV in the vaginal tissue of women and macaques and this correlates with increased susceptibility to vaginal SHIV infection in macaques. However, the effect of rectal HSV-2 infection on HIV acquisition remains understudied. We developed a model of rectal HSV-2 infection in macaques in combination with rectal SIVmac239 Delta nef (SIV Delta nef) vaccination and our results suggest that rectal HSV-2 infection may increase the susceptibility of macaques to rectal SIVmac239 wild-type (wt) infection even in SIV Delta nef-infected animals. Rectal SIV Delta nef infection/vaccination protected 7 out of 7 SIV Delta nef-infected macaques from SIVmac239wt rectal infection (vs 12 out of 16 SIV Delta nef-negative macaques), while 1 out of 3 animals co-infected with SIV Delta nef and HSV-2 acquired SIVmac239wt infection. HSV-2/SIVmac239wt co-infected animals had increased concentrations of inflammatory factors in their plasma and rectal fluids and a tendency toward higher acute SIVmac239wt plasma viral load. However, they had higher blood CD4 counts and reduced depletion of CCR5+ CD4+ T cells compared to SIV-mac239wt-only infected animals. Thus, rectal HSV-2 infection generates a pro-inflammatory environment that may increase susceptibility to rectal SIV infection and may impact immunological and virological parameters during acute SIV infection. Studies with larger number of animals are needed to confirm these findings.	[Guerra-Perez, Natalia; Aravantinou, Meropi; Veglia, Filippo; Goode, Diana; Truong, Rosaline; Derby, Nina; Robbiani, Melissa; Martinelli, Elena] Populat Council, Ctr Biomed Res, 1230 York Ave, New York, NY 10021 USA; [Blanchard, James; Grasperge, Brooke] Tulane Univ, Tulane Natl Primate Res Ctr, Covington, LA USA; [Gettie, Agegnehu] Rockefeller Univ, Aaron Diamond AIDS Res Ctr, 1230 York Ave, New York, NY 10021 USA; [Veglia, Filippo] Wistar Inst Anat & Biol, 3601 Spruce St, Philadelphia, PA 19104 USA	Population Council; Tulane University; Rockefeller University; The Wistar Institute	Martinelli, E (corresponding author), Populat Council, Ctr Biomed Res, 1230 York Ave, New York, NY 10021 USA.	emartinelli@popcouncil.org	Guerra-Pérez, Natalia/I-1879-2017	Guerra-Pérez, Natalia/0000-0002-4851-3361; Martinelli, Elena/0000-0002-3416-9627; Veglia, Filippo/0000-0001-6710-1584	NIH [R37 AI040877-18, R01 AI098456-04, OD011104]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U24AI126683, R37AI040877, R01AI040877] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011104, T32OD011124] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NIH grants R37 AI040877-18, R01 AI098456-04, OD011104.	Abel K, 2004, J INFECT DIS, V190, P1697, DOI 10.1086/424600; Abu-Raddad LJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002230; Alvarez Y, 2013, J VIROL, V87, P10843, DOI 10.1128/JVI.01838-13; Arnold KB, 2016, MUCOSAL IMMUNOL, V9, P194, DOI 10.1038/mi.2015.51; Aurelian, 1992, HERPES SIMPLEX VIRUS, P473; Baba TW, 1999, NAT MED, V5, P194, DOI 10.1038/5557; BABA TW, 1995, SCIENCE, V267, P1820, DOI 10.1126/science.7892606; Barnabas RV, 2011, JAIDS-J ACQ IMM DEF, V57, P238, DOI 10.1097/QAI.0b013e31821acb5; Cline AN, 2005, J MED PRIMATOL, V34, P303; Connor RI, 1998, J VIROL, V72, P7501, DOI 10.1128/JVI.72.9.7501-7509.1998; Corey L, 2004, JAIDS-J ACQ IMM DEF, V35, P435, DOI 10.1097/00126334-200404150-00001; Cranage MP, 1997, VIROLOGY, V229, P143, DOI 10.1006/viro.1996.8419; DANIEL MD, 1992, SCIENCE, V258, P1938, DOI 10.1126/science.1470917; Freeman EE, 2006, AIDS, V20, P73, DOI 10.1097/01.aids.0000198081.09337.a7; Fukazawa Y, 2012, NAT MED, V18, P1673, DOI 10.1038/nm.2934; Goode D, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004567; Gray RH, 2004, J INFECT DIS, V189, P1209, DOI 10.1086/382750; Johnson RP, 1999, J VIROL, V73, P4952, DOI 10.1128/JVI.73.6.4952-4961.1999; Johnson RP, 1997, J VIROL, V71, P7711, DOI 10.1128/JVI.71.10.7711-7718.1997; Kaul R, 2015, CURR HIV-AIDS REP, V12, P216, DOI 10.1007/s11904-015-0269-5; Koff WC, 2006, NAT IMMUNOL, V7, P19, DOI 10.1038/ni1296; Krone MR, 1998, J INFECT DIS, V178, P978, DOI 10.1086/515666; Krone MR, 2000, CLIN INFECT DIS, V30, P261, DOI 10.1086/313647; Martinelli E, 2013, JAIDS-J ACQ IMM DEF, V64, P325, DOI 10.1097/QAI.0b013e31829f6e1a; Martinelli E, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002109; Marx PA, 1996, NAT MED, V2, P1084, DOI 10.1038/nm1096-1084; McKinnon LR, 2015, AIDS BEHAV, V19, P2204, DOI 10.1007/s10461-015-1118-7; Miller CJ, 1997, J VIROL, V71, P1911, DOI 10.1128/JVI.71.3.1911-1921.1997; Rajagopal S, 2014, OPEN FORUM INFECT DI, V1, DOI 10.1093/ofid/ofu043; Reynolds MR, 2008, J EXP MED, V205, P2537, DOI 10.1084/jem.20081524; Reynolds MR, 2010, J VIROL, V84, P9190, DOI 10.1128/JVI.00041-10; Salisch NC, 2010, J IMMUNOL, V184, P476, DOI 10.4049/jimmunol.0902781; Schacker T, 2001, Herpes, V8, P46; Shannon B, 2014, J IMMUNOL, V192, P5074, DOI 10.4049/jimmunol.1302916; Singer R, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003936; Stahl-Hennig C, 2002, J VIROL, V76, P688, DOI 10.1128/JVi.76.2.688-696.2002; Stahl-Hennig C, 2007, FRONT BIOSCI, V12, P2107, DOI 10.2741/2215; Van Kemseke C, 2009, ACTA GASTRO-ENT BELG, V72, P413; Wyand MS, 1999, J VIROL, V73, P8356, DOI 10.1128/JVI.73.10.8356-8363.1999; Wyand MS, 1996, J VIROL, V70, P3724, DOI 10.1128/JVI.70.6.3724-3733.1996; Zhu J, 2009, NAT MED, V15, P886, DOI 10.1038/nm.2006	41	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0149491	10.1371/journal.pone.0149491	http://dx.doi.org/10.1371/journal.pone.0149491			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26886938	Green Published, Green Submitted, gold			2022-12-26	WOS:000371218400091
J	Hong, M; Wang, Q; Tang, ZD; Wang, YP; Gu, YF; Lou, YL; Zheng, MQ				Hong, Meng; Wang, Qian; Tang, Zhide; Wang, Youpei; Gu, Yunfeng; Lou, Yongliang; Zheng, Meiqin			Association of Genotyping of Bacillus cereus with Clinical Features of Post-Traumatic Endophthalmitis	PLOS ONE			English	Article							POPULATION-STRUCTURE; GENE; PCR; ANTHRACIS; PATHOGEN; SURGERY	Bacillus cereus is the second most frequent cause of post-traumatic bacterial endophthalmitis. Although genotyping of B. cereus associated with gastrointestinal infections has been reported, little is known about the B. cereus clinical isolates associated with post-traumatic endophthalmitis. This is largely due to the limited number of clinical strains available isolated from infected tissues of patients with post-traumatic endophthalmitis. In this study, we report successful isolation of twenty-four B. cereus strains from individual patients with different disease severity of post-traumatic endophthalmitis. Phylogenetic analysis showed that all strains could be categorized into three genotypes (GTI, GTII and GTIII) and the clinical score showed significant differences among these groups. We then further performed genotyping using the vrrA gene, and evaluated possible correlation of genotype with the clinical features of B. cereus-caused post-traumatic endophthalmitis, and with the prognosis of infection by conducting follow-up with patients for up to 2 months. We found that the disease of onset and final vision acuity were significantly different among the three groups. These results suggested that the vrrA gene may play a significant role in the pathogenesis of endophthalmitis, and genotyping of B. cereus has the potential for predicting clinical manifestation and prognosis of endophthalmitis. To the best of our knowledge, this is the first report of isolation of large numbers of clinical isolates of B. cereus from patients with endophthalmitis. This work sets the foundation for future investigation of the pathogenesis endophthalmitis caused by B. cereus infection.	[Hong, Meng; Tang, Zhide; Wang, Youpei; Gu, Yunfeng; Zheng, Meiqin] Wenzhou Med Univ, Dept Clin Lab Med, Affiliated Eye Hosp, Wenzhou 325027, Peoples R China; [Hong, Meng; Wang, Qian; Lou, Yongliang] Wenzhou Med Univ, Zhejiang Prov Key Lab Med Genet, Minist Educ, Key Lab Lab Med, Wenzhou 325035, Zhejiang, Peoples R China	Wenzhou Medical University; Wenzhou Medical University	Zheng, MQ (corresponding author), Wenzhou Med Univ, Dept Clin Lab Med, Affiliated Eye Hosp, Wenzhou 325027, Peoples R China.; Lou, YL (corresponding author), Wenzhou Med Univ, Zhejiang Prov Key Lab Med Genet, Minist Educ, Key Lab Lab Med, Wenzhou 325035, Zhejiang, Peoples R China.	louyongliang2013@163.com; zmqlyllh@126.com			National Natural Science Foundation of China [81171611]; Zhejiang Provincial Natural Science foundation of China [Y2090468, LY13H120006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science foundation of China(Natural Science Foundation of Zhejiang Province)	This work was funded by the following: 1. National Natural Science Foundation of China (81171611),lyl,http://www.letpub.com.cn/?page=grant & 2. Zhejiang Provincial Natural Science foundation of China (Y2090468).lyl.http://www.zjnsf.gov.cn/1/xm/lx.aspx; and 3. Zhejiang Provincial Natural Science foundation of China (LY13H120006).zmq.http://www.zjnsf.gov.cn/1/xm/lx.aspx.	Alfaro DV, 1996, BRIT J OPHTHALMOL, V80, P755, DOI 10.1136/bjo.80.8.755; BEER PM, 1990, AM J OPHTHALMOL, V110, P212, DOI 10.1016/S0002-9394(14)76999-5; Bottone EJ, 2010, CLIN MICROBIOL REV, V23, P382, DOI 10.1128/CMR.00073-09; Brumlik MJ, 2001, APPL ENVIRON MICROB, V67, P3021, DOI 10.1128/AEM.67.7.3021-3028.2001; Callegan MC, 2007, PROG RETIN EYE RES, V26, P189, DOI 10.1016/j.preteyeres.2006.12.001; Chan WM, 2003, CLIN INFECT DIS, V37, pE31, DOI 10.1086/375898; Chang YH, 2003, APPL ENVIRON MICROB, V69, P4502, DOI 10.1128/AEM.69.8.4502-4510.2003; Durand ML, 2013, CLIN MICROBIOL INFEC, V19, P227, DOI 10.1111/1469-0691.12118; Hoffmaster AR, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-191; Kim JY, 2011, INVEST OPHTH VIS SCI, V52, P1742, DOI 10.1167/iovs.10-5231; Kim W, 2002, FEMS MICROBIOL LETT, V207, P21, DOI 10.1111/j.1574-6968.2002.tb11022.x; Ko KS, 2004, INFECT IMMUN, V72, P5253, DOI 10.1128/IAI.72.9.5253-5261.2004; Melo GB, 2011, J CATARACT REFR SURG, V37, P1244, DOI 10.1016/j.jcrs.2011.01.025; Priest FG, 2004, J BACTERIOL, V186, P7959, DOI 10.1128/JB.186.23.7959-7970.2004; Seal D, 2008, J CATARACT REFR SURG, V34, P1439, DOI 10.1016/j.jcrs.2008.05.043; van Belkum A, 1999, CELL MOL LIFE SCI, V56, P729, DOI 10.1007/s000180050019; Wiskur BJ, 2008, INVEST OPHTH VIS SCI, V49, P1480, DOI 10.1167/iovs.07-1303; Zahner V, 2005, APPL ENVIRON MICROB, V71, P8107, DOI 10.1128/AEM.71.12.8107-8114.2005	18	4	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0147878	10.1371/journal.pone.0147878	http://dx.doi.org/10.1371/journal.pone.0147878			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26886446	Green Published, gold			2022-12-26	WOS:000371218400010
J	Tsaousi, A; Hayes, EM; Di Gregoli, K; Bond, AR; Bevan, L; Thomas, AC; Newby, AC				Tsaousi, Aikaterini; Hayes, Elaine M.; Di Gregoli, Karina; Bond, Andrew R.; Bevan, Laura; Thomas, Anita C.; Newby, Andrew C.			Plaque Size Is Decreased but M1 Macrophage Polarization and Rupture Related Metalloproteinase Expression Are Maintained after Deleting T-Bet in ApoE Null Mice	PLOS ONE			English	Article							HUMAN ATHEROSCLEROTIC PLAQUES; E-KNOCKOUT MICE; LOW-DENSITY-LIPOPROTEIN; FOAM-CELL MACROPHAGES; APOLIPOPROTEIN-E; IFN-GAMMA; TRANSCRIPTION FACTOR; INTERFERON-GAMMA; IMMUNE-RESPONSE; DEFICIENT MICE	Background Thelper1 (Th1) lymphocytes have been previously implicated in atherosclerotic plaque growth but their role in plaque vulnerability to rupture is less clear. We investigated whether T-bet knockout that prevents Th1 lymphocyte differentiation modulates classical (M1) macrophage activation or production of matrix degrading metalloproteinases (MMPs) and their tissue inhibitors, TIMPs. Methods & Results We studied the effect of T-bet deletion in apolipoproteinE (ApoE) knockout mice fed a high fat diet (HFD) or normal chow diet (ND). Transcript levels of M1/M2 macrophage polarization markers, selected MMPs and TIMPs were measured by RT-qPCR in macrophages isolated from subcutaneous granulomas or in whole aortae. Immunohistochemistry of aortic sinus (AS) and brachiocephalic artery (BCA) plaques was conducted to quantify protein expression of the same factors. Deletion of T-bet decreased mRNA for the M1 marker NOS-2 in granuloma macrophages but levels of M2 markers (CD206, arginase-1 and Ym-1), MMPs-2, -9, -12, -13, -14 and -19 or TIMPs-1 to -3 were unchanged. No mRNA differences were observed in aortic extracts from mice fed a HFD for 12 weeks. Moreover, AS and BCA plaques were similarly sized between genotypes, and had similar areas stained for NOS-2, COX-2, MMP-12 and MMP-14 proteins. T-bet deletion increased MMP-13, MMP-14 and arginase-1 in AS plaques. After 35 weeks of ND, T-bet deletion reduced the size of AS and BCA plaques but there were no differences in the percentage areas stained for M1 or M2 markers, MMPs-12, -13, -14, or TIMP-3. Conclusions Absence of Th1 lymphocytes is associated with reduced plaque size in ApoE knockout mice fed a normal but not high fat diet. In either case, M1 macrophage polarization and expression of several MMPs related to plaque instability are either maintained or increased.	[Tsaousi, Aikaterini; Hayes, Elaine M.; Di Gregoli, Karina; Bond, Andrew R.; Bevan, Laura; Thomas, Anita C.; Newby, Andrew C.] Univ Bristol, Sch Clin Sci, Bristol, Avon, England	University of Bristol	Tsaousi, A (corresponding author), Univ Bristol, Sch Clin Sci, Bristol, Avon, England.	a.tsaousi@bristol.ac.uk	Thomas, Anita C/E-1743-2011; Bond, Andrew/AAC-5941-2020	Thomas, Anita C/0000-0002-3792-2653; Bond, Andrew/0000-0002-4255-4488	British Heart Foundation Programme [RG/09/006/27918]; British Heart Foundation [RG/09/006/27918] Funding Source: researchfish	British Heart Foundation Programme(British Heart Foundation); British Heart Foundation(British Heart Foundation)	Funding was provided by British Heart Foundation Programme Grant No. RG/09/006/27918. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Buono C, 2005, P NATL ACAD SCI USA, V102, P1596, DOI 10.1073/pnas.0409015102; Buono C, 2003, ARTERIOSCL THROM VAS, V23, P454, DOI 10.1161/01.ATV.0000059419.11002.6E; Cardilo-Reis L, 2012, EMBO MOL MED, V4, P1072, DOI 10.1002/emmm.201201374; Casagrande V, 2012, ARTERIOSCL THROM VAS, V32, P74, DOI 10.1161/ATVBAHA.111.238402; Castrillo A, 2003, J BIOL CHEM, V278, P10443, DOI 10.1074/jbc.M213071200; Chase AJ, 2002, ARTERIOSCL THROM VAS, V22, P765, DOI 10.1161/01.ATV.0000015078.09208.92; Dansky HM, 1997, P NATL ACAD SCI USA, V94, P4642, DOI 10.1073/pnas.94.9.4642; Daugherty A, 1997, J CLIN INVEST, V100, P1575, DOI 10.1172/JCI119681; Di Gregoli K, 2014, ARTERIOSCL THROM VAS, V34, P1990, DOI 10.1161/ATVBAHA.114.304088; Frostegard J, 1999, ATHEROSCLEROSIS, V145, P33, DOI 10.1016/S0021-9150(99)00011-8; Gupta S, 1997, J CLIN INVEST, V99, P2752, DOI 10.1172/JCI119465; HANSSON GK, 1991, ARTERIOSCLER THROMB, V11, P745, DOI 10.1161/01.ATV.11.3.745; HANSSON GK, 1988, CIRC RES, V63, P712, DOI 10.1161/01.RES.63.4.712; HANSSON GK, 1989, AM J PATHOL, V135, P169; Hartley CJ, 2000, AM J PHYSIOL-HEART C, V279, pH2326, DOI 10.1152/ajpheart.2000.279.5.H2326; Hayes EM, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00537; Huang WC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042507; Johnson J, 2005, CIRCULATION, V111, P1422, DOI 10.1161/01.CIR.0000158435.98035.8D; Johnson J. L., 2014, MEDIAT INFLAMM, V2014, DOI DOI 10.1155/2014/276457; Johnson JL, 2008, ARTERIOSCL THROM VAS, V28, P1647, DOI 10.1161/ATVBAHA.108.170548; Johnson JL, 2011, ARTERIOSCL THROM VAS, V31, P528, DOI 10.1161/ATVBAHA.110.219147; Johnson JL, 2005, P NATL ACAD SCI USA, V102, P15575, DOI 10.1073/pnas.0506201102; Joven J, 2007, ATHEROSCLEROSIS, V195, pE85, DOI 10.1016/j.atherosclerosis.2007.06.012; Kadl A, 2010, CIRC RES, V107, P737, DOI 10.1161/CIRCRESAHA.109.215715; Klingenberg R, 2013, J CLIN INVEST, V123, P1323, DOI 10.1172/JCI63891; Koltsova EK, 2013, CURR OPIN LIPIDOL, V24, P371, DOI 10.1097/MOL.0b013e328363d298; Libby P, 2013, J CLIN INVEST, V123, P3201, DOI 10.1172/JCI67526; Libby P, 2013, IMMUNITY, V38, P1092, DOI 10.1016/j.immuni.2013.06.009; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; Lugo-Villarino G, 2003, P NATL ACAD SCI USA, V100, P7749, DOI 10.1073/pnas.1332767100; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Lundberg AM, 2011, CURR OPIN LIPIDOL, V22, P343, DOI 10.1097/MOL.0b013e32834ada80; Lutgens E, 2010, J EXP MED, V207, P391, DOI 10.1084/jem.20091293; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954; NAKASHIMA Y, 1994, ARTERIOSCLER THROMB, V14, P133, DOI 10.1161/01.ATV.14.1.133; Naura AS, 2009, LAB INVEST, V89, P1243, DOI 10.1038/labinvest.2009.98; Newby AC, 2008, ARTERIOSCL THROM VAS, V28, P2108, DOI 10.1161/ATVBAHA.108.173898; Newby AC, 2014, CURR OPIN LIPIDOL, V25, P358, DOI 10.1097/MOL.0000000000000111; Osborn O, 2012, NAT MED, V18, P363, DOI 10.1038/nm.2627; PAIGEN B, 1990, ARTERIOSCLEROSIS, V10, P316, DOI 10.1161/01.ATV.10.2.316; Paulson KE, 2010, CIRC RES, V106, P383, DOI 10.1161/CIRCRESAHA.109.210781; Pearce EL, 2003, SCIENCE, V302, P1041, DOI 10.1126/science.1090148; Quillard T, 2014, ARTERIOSCL THROM VAS, V34, P1179, DOI 10.1161/ATVBAHA.114.303326; Quillard T, 2011, ARTERIOSCL THROM VAS, V31, P2464, DOI 10.1161/ATVBAHA.111.231563; Robbins CS, 2012, CIRCULATION, V125, P364, DOI 10.1161/CIRCULATIONAHA.111.061986; Romagnani S, 2000, ANN ALLERG ASTHMA IM, V85, P9, DOI 10.1016/S1081-1206(10)62426-X; Rong JX, 2003, P NATL ACAD SCI USA, V100, P13531, DOI 10.1073/pnas.1735526100; Rossmann A, 2008, EXP GERONTOL, V43, P229, DOI 10.1016/j.exger.2007.11.009; Schneider F, 2008, CIRCULATION, V117, P931, DOI 10.1161/CIRCULATIONAHA.107.707448; SMITH JD, 1995, P NATL ACAD SCI USA, V92, P8264, DOI 10.1073/pnas.92.18.8264; Spann NJ, 2012, CELL, V151, P138, DOI 10.1016/j.cell.2012.06.054; STEMME S, 1992, ARTERIOSCLER THROMB, V12, P206, DOI 10.1161/01.ATV.12.2.206; STEMME S, 1995, P NATL ACAD SCI USA, V92, P3893, DOI 10.1073/pnas.92.9.3893; Stohr R, 2014, ATHEROSCLEROSIS, V235, P438, DOI 10.1016/j.atherosclerosis.2014.05.946; Stolarczyk E, 2013, CELL METAB, V17, P520, DOI 10.1016/j.cmet.2013.02.019; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Szabo SJ, 2002, SCIENCE, V295, P338, DOI 10.1126/science.1065543; Tedgui A, 2006, PHYSIOL REV, V86, P515, DOI 10.1152/physrev.00024.2005; Thale C, 2005, IMMUNOBIOLOGY, V210, P673, DOI 10.1016/j.imbio.2005.07.003; Thomas AC, 2007, ARTERIOSCL THROM VAS, V27, P571, DOI 10.1161/01.ATV.0000256470.23842.94; Virmani R, 2006, J AM COLL CARDIOL, V47, pC13, DOI 10.1016/j.jacc.2005.10.065; Wang YN, 2007, CIRC RES, V101, P560, DOI 10.1161/CIRCRESAHA.107.151068; Whitman SC, 2002, J INTERF CYTOK RES, V22, P661, DOI 10.1089/10799900260100141; Wick G, 2004, ANNU REV IMMUNOL, V22, P361, DOI 10.1146/annurev.immunol.22.012703.104644; Xu W, 2007, EUR J IMMUNOL, V37, P1594, DOI 10.1002/eji.200737042; Zhou XH, 2000, CIRCULATION, V102, P2919; Zhou XH, 2003, BIOMED PHARMACOTHER, V57, P287, DOI 10.1016/S0753-3322(03)00082-9; Zhou XH, 1998, J CLIN INVEST, V101, P1717, DOI 10.1172/JCI1216; Zhou XH, 1996, AM J PATHOL, V149, P359	73	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0148873	10.1371/journal.pone.0148873	http://dx.doi.org/10.1371/journal.pone.0148873			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26886778	Green Published, Green Submitted, gold			2022-12-26	WOS:000371218400056
J	Guo, HK; Wang, GJ; Huang, LY; Hu, YX; Yuan, C; Li, R; Zhao, XH				Guo, Hengkai; Wang, Guijin; Huang, Lingyun; Hu, Yuxin; Yuan, Chun; Li, Rui; Zhao, Xihai			A Robust and Accurate Two-Step Auto-Labeling Conditional Iterative Closest Points (TACICP) Algorithm for Three-Dimensional Multi-Modal Carotid Image Registration	PLOS ONE			English	Article							NONRIGID REGISTRATION; ACTIVE CONTOURS; ULTRASOUND; SEGMENTATION; ARTERIES; PLAQUE; MRI; QUANTIFICATION; MODEL	Atherosclerosis is among the leading causes of death and disability. Combining information from multi-modal vascular images is an effective and efficient way to diagnose and monitor atherosclerosis, in which image registration is a key technique. In this paper a feature-based registration algorithm, Two-step Auto-labeling Conditional Iterative Closed Points (TACICP) algorithm, is proposed to align three-dimensional carotid image datasets from ultrasound (US) and magnetic resonance (MR). Based on 2D segmented contours, a coarse-to-fine strategy is employed with two steps: rigid initialization step and non-rigid refinement step. Conditional Iterative Closest Points (CICP) algorithm is given in rigid initialization step to obtain the robust rigid transformation and label configurations. Then the labels and CICP algorithm with non-rigid thin-plate-spline (TPS) transformation model is introduced to solve non-rigid carotid deformation between different body positions. The results demonstrate that proposed TACICP algorithm has achieved an average registration error of less than 0.2mm with no failure case, which is superior to the state-of-the-art feature-based methods.	[Guo, Hengkai; Wang, Guijin] Tsinghua Univ, Dept Elect Engn, Res Inst Image & Informat, Beijing 100084, Peoples R China; [Hu, Yuxin; Yuan, Chun; Li, Rui; Zhao, Xihai] Tsinghua Univ, Ctr Biomed Imaging Res, Dept Biomed Engn, Beijing 100084, Peoples R China; [Yuan, Chun] Univ Washington, Dept Radiol, 850 Republican St, Seattle, WA 98195 USA; [Huang, Lingyun] Philips Res China, Healthcare Dept, Shanghai, Peoples R China	Tsinghua University; Tsinghua University; University of Washington; University of Washington Seattle; Philips; Philips Research	Li, R (corresponding author), Tsinghua Univ, Ctr Biomed Imaging Res, Dept Biomed Engn, Beijing 100084, Peoples R China.	leerui@tsinghua.edu.cn	Zhao, Xihai/AAD-7181-2020					Balu N, 2011, P INT SOC MAG RESON, P113; BESL PJ, 1992, IEEE T PATTERN ANAL, V14, P239, DOI 10.1109/34.121791; Bourke P., 1988, CALCULATING AREA CEN; Carvalho DDB, 2014, MED PHYS, V41, DOI 10.1118/1.4870383; Carvalho DDB, 2012, INT J COMPUT ASS RAD, V7, P207, DOI 10.1007/s11548-011-0633-x; Chan RC, 2006, PROC SPIE, V6144, DOI 10.1117/12.651786; Chan TF, 2001, IEEE T IMAGE PROCESS, V10, P266, DOI 10.1109/83.902291; Chiu B, 2008, MED PHYS, V35, P3691, DOI 10.1118/1.2955550; Chiu B, 2012, J ULTRAS MED, V31, P1567; Chui HL, 2003, COMPUT VIS IMAGE UND, V89, P114, DOI 10.1016/S1077-3142(03)00009-2; Feldmar J, 1996, INT J COMPUT VISION, V18, P99, DOI 10.1007/BF00054998; Gupta A, 2012, BIOMED SIGNAL PROCES, V7, P560, DOI 10.1016/j.bspc.2012.05.003; He B, 2011, IEICE T INF SYST, VE94D, P2541, DOI 10.1587/transinf.E94.D.2541; Hill DLG, 2001, PHYS MED BIOL, V46, pR1, DOI 10.1088/0031-9155/46/3/201; IMPARATO AM, 1979, STROKE, V10, P238, DOI 10.1161/01.STR.10.3.238; Jian B, 2011, IEEE T PATTERN ANAL, V33, P1633, DOI 10.1109/TPAMI.2010.223; Klein S, 2010, IEEE T MED IMAGING, V29, P196, DOI 10.1109/TMI.2009.2035616; Nanayakkara ND, 2008, IEEE T MED IMAGING, V27, P1378, DOI 10.1109/TMI.2008.918326; Nanayakkara ND, 2009, MED PHYS, V36, P373, DOI 10.1118/1.3056458; Nazem F, 2014, INT J COMPUT ASS RAD, V9, P39, DOI 10.1007/s11548-013-0907-6; Pan X, 2014, SPIE MED IMAGING; Pohl KA, 2006, NEUROIMAGE, V31, P228, DOI 10.1016/j.neuroimage.2005.11.044; Rusinkiewicz S, 2001, THIRD INTERNATIONAL CONFERENCE ON 3-D DIGITAL IMAGING AND MODELING, PROCEEDINGS, P145, DOI 10.1109/IM.2001.924423; Saam T, 2005, ARTERIOSCL THROM VAS, V25, P234, DOI 10.1161/01.ATV.0000149867.61851.31; Slomka PJ, 2001, ULTRASOUND MED BIOL, V27, P945, DOI 10.1016/S0301-5629(01)00387-8; Tang H., 2011, SPIE MED IMAGING; Tang H, 2012, MED IMAGE ANAL, V16, P1202, DOI 10.1016/j.media.2012.05.014; Wahba G., 1990, SPLINE MODELS OBSERV, V59; Wang JN, 2013, MAGN RESON MED, V69, P337, DOI 10.1002/mrm.24254; Yezzi A, 2003, MED IMAGE ANAL, V7, P171, DOI 10.1016/S1361-8415(03)00004-5; Yuan C, 2006, NMR BIOMED, V19, P636, DOI 10.1002/nbm.1065	31	2	2	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0148783	10.1371/journal.pone.0148783	http://dx.doi.org/10.1371/journal.pone.0148783			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	26881433	gold, Green Published			2022-12-26	WOS:000371219000025
J	Jacobi, JL; Yang, B; Li, X; Menze, AK; Laurentz, SM; Janle, EM; Ferruzzi, MG; McCabe, GP; Chapple, C; Kirchmaier, AL				Jacobi, Jennifer L.; Yang, Bo; Li, Xu; Menze, Anna K.; Laurentz, Sara M.; Janle, Elsa M.; Ferruzzi, Mario G.; McCabe, George P.; Chapple, Clint; Kirchmaier, Ann L.			Impacts on Sirtuin Function and Bioavailability of the Dietary Bioactive Compound Dihydrocoumarin	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; HISTONE H3; SILENT CHROMATIN; CELL-CYCLE; LIFE-SPAN; TELOMERIC HETEROCHROMATIN; ADP-RIBOSYLTRANSFERASE; CANCER CHEMOPREVENTION; DEPENDENT DEACETYLASE; MULTIDRUG-RESISTANCE	The plant secondary metabolite and common food additive dihydrocoumarin (DHC) is an inhibitor of the Sirtuin family of NAD(+)-dependent deacetylases. Sirtuins are key regulators of epigenetic processes that maintain silent chromatin in yeast and have been linked to gene expression, metabolism, apoptosis, tumorogenesis and age-related processes in multiple organisms, including humans. Here we report that exposure to the polyphenol DHC led to defects in several Sirtuin-regulated processes in budding yeast including the establishment and maintenance of Sir2p-dependent silencing by causing disassembly of silent chromatin, Hst1p-dependent repression of meiotic-specific genes during the mitotic cell cycle. As both transient and prolonged exposure to environmental and dietary factors have the potential to lead to heritable alterations in epigenetic states and to modulate additional Sirtuin-dependent phenotypes, we examined the bioavailability and digestive stability of DHC using an in vivo rat model and in vitro digestive simulator. Our analyses revealed that DHC was unstable during digestion and could be converted to melilotic acid (MA), which also caused epigenetic defects, albeit less efficiently. Upon ingestion, DHC was observed primarily in intestinal tissues, but did not accumulate over time and was readily cleared from the animals. MA displayed a wider tissue distribution and, in contrast to DHC, was also detected in the blood plasma, interstitial fluid, and urine, implying that the conversion of DHC to the less bioactive compound, MA, occurred efficiently in vivo.	[Jacobi, Jennifer L.; Yang, Bo; Li, Xu; Chapple, Clint; Kirchmaier, Ann L.] Purdue Univ, Dept Biochem, W Lafayette, IN 47907 USA; [Jacobi, Jennifer L.; Yang, Bo; Kirchmaier, Ann L.] Purdue Univ, Purdue Ctr Canc Res, W Lafayette, IN 47907 USA; [Menze, Anna K.; Janle, Elsa M.] Purdue Univ, Dept Foods & Nutr, W Lafayette, IN 47907 USA; [Ferruzzi, Mario G.] Purdue Univ, Dept Food Sci, Smith Hall, W Lafayette, IN 47907 USA; [Laurentz, Sara M.; McCabe, George P.] Purdue Univ, Dept Stat, W Lafayette, IN 47907 USA; [Yang, Bo] Gene Foci Biotech Beijing Ltd Co, Room 608,Bldg 7,19 TianRong Rd, Beijing 100089, Peoples R China; [Li, Xu] N Carolina State Univ, Dept Plant & Microbial Biol, Raleigh, NC 27695 USA; [Li, Xu] N Carolina State Univ, Plants Human Hlth Inst, Kannapolis, NC USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University	Kirchmaier, AL (corresponding author), Purdue Univ, Dept Biochem, W Lafayette, IN 47907 USA.; Kirchmaier, AL (corresponding author), Purdue Univ, Purdue Ctr Canc Res, W Lafayette, IN 47907 USA.	kirchmaier@purdue.edu	Chapple, Clint CS/Q-5456-2017	Chapple, Clint CS/0000-0002-5195-562X; Kirchmaier, Ann/0000-0001-9938-9105; Ferruzzi, Mario/0000-0003-1384-2672; Li, Xu/0000-0002-4640-2529	Purdue-UAB NIH Botanicals Research Center grant NIH-NCCAM Grant [P50-AT00477]; Purdue Department of Biochemistry; NCI [CCSG CA23168]; NATIONAL CANCER INSTITUTE [P30CA023168] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001108] Funding Source: NIH RePORTER; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [P50AT000477] Funding Source: NIH RePORTER	Purdue-UAB NIH Botanicals Research Center grant NIH-NCCAM Grant; Purdue Department of Biochemistry; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine)	This work was supported by the Purdue-UAB NIH Botanicals Research Center grant NIH-NCCAM Grant P50-AT00477 (https://nccih.nih.gov) and the Purdue Department of Biochemistry (https://ag.purdue.edu/biochem/). This research was also supported by NCI CCSG CA23168 (http://www.cancer.gov) for data acquired in the Purdue University Center for Cancer Research DNA Sequencing Facility. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams A, 1997, METHODS YEAST GENETI; Adams TB, 1998, FOOD CHEM TOXICOL, V36, P249, DOI 10.1016/S0278-6915(97)00163-4; Ahn BH, 2008, P NATL ACAD SCI USA, V105, P14447, DOI 10.1073/pnas.0803790105; Ahuja N, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M705488200; Bachmeier BE, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-129; BALZI E, 1994, J BIOL CHEM, V269, P2206; Barber MF, 2012, NATURE, V487, P114, DOI 10.1038/nature11043; Bedalov A, 2001, P NATL ACAD SCI USA, V98, P15113, DOI 10.1073/pnas.261574398; Benet LZ, 2009, MOL PHARMACEUT, V6, P1631, DOI 10.1021/mp900253n; Biasutto L, 2009, CELL PHYSIOL BIOCHEM, V24, P557, DOI 10.1159/000257512; Bitterman KJ, 2002, J BIOL CHEM, V277, P45099, DOI 10.1074/jbc.M205670200; Bordone L, 2006, PLOS BIOL, V4, P210, DOI 10.1371/journal.pbio.0040031; Bordone L, 2005, NAT REV MOL CELL BIO, V6, P298, DOI 10.1038/nrm1616; Borel P, 2013, NUTR REV, V71, P319, DOI 10.1111/nure.12026; Born SL, 2000, TOXICOL SCI, V58, P23, DOI 10.1093/toxsci/58.1.23; Born SL, 2003, FOOD CHEM TOXICOL, V41, P247, DOI 10.1016/S0278-6915(02)00227-2; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Celic I, 2006, CURR BIOL, V16, P1280, DOI 10.1016/j.cub.2006.06.023; COHEN AJ, 1979, FOOD COSMET TOXICOL, V17, P277, DOI 10.1016/0015-6264(79)90289-X; Costa LG, 2003, J TOXICOL-CLIN TOXIC, V41, P37, DOI 10.1081/CLT-120018269; Crampton A, 2008, MOL CELL, V30, P156, DOI 10.1016/j.molcel.2008.02.019; Crozier A, 2009, NAT PROD REP, V26, P1001, DOI 10.1039/b802662a; Das C, 2009, NATURE, V459, P113, DOI 10.1038/nature07861; de Kok TM, 2008, EUR J NUTR, V47, P51, DOI 10.1007/s00394-008-2006-y; Del Rio D, 2010, BRIT J NUTR, V104, pS67, DOI 10.1017/S0007114510003958; Draganov DI, 2004, N-S ARCH PHARMACOL, V369, P78, DOI 10.1007/s00210-003-0833-1; Driscoll R, 2007, SCIENCE, V315, P649, DOI 10.1126/science.1135862; EHLERS D, 1995, Z LEBENSM UNTERS FOR, V201, P278, DOI 10.1007/BF01193004; Failla ML, 2014, FOOD FUNCT, V5, P1101, DOI 10.1039/c3fo60599j; Fazly A, 2012, J BIOL CHEM; Feil R, 2012, NAT REV GENET, V13, P97, DOI 10.1038/nrg3142; Ferruzzi MG, 2012, ADV NUTR, V3, P813, DOI 10.3945/an.112.003202; Ferruzzi MG, 2006, J AGR FOOD CHEM, V54, P2780, DOI 10.1021/jf0530603; Finkel T, 2009, NATURE, V460, P587, DOI 10.1038/nature08197; Firestein R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002020; Ford E, 2006, GENE DEV, V20, P1075, DOI 10.1101/gad.1399706; Furuya T, 1958, CHEM PHARM BULL, V6, P701; FURUYA T, 1958, CHEM PHARM BULL, V6, P706; Gallo CA, 2004, MOL CELL BIOL, V24, P1301, DOI 10.1128/MCB.24.3.1301-1312.2004; Gao L, 2008, MOL CELL BIOL, V28, P3979, DOI 10.1128/MCB.00019-08; Garrett DA, 1999, J AGR FOOD CHEM, V47, P4301, DOI 10.1021/jf9903298; Gerhauser C, 2013, TOP CURR CHEM, V329, P73, DOI 10.1007/128_2012_360; Gil R, 2013, NUCLEIC ACIDS RES, V41, P8537, DOI 10.1093/nar/gkt642; Grob A, 2009, J CELL SCI, V122, P489, DOI 10.1242/jcs.042382; Guo Y, 2013, MOL NUTR FOOD RES, V57, P896, DOI 10.1002/mnfr.201200619; HAGAN E. C., 1967, FOOD COSMET TOXICOL, V5, P141, DOI 10.1016/S0015-6264(67)82961-4; Haigis MC, 2006, GENE DEV, V20, P2913, DOI 10.1101/gad.1467506; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; HASSETT C, 1991, BIOCHEMISTRY-US, V30, P10141, DOI 10.1021/bi00106a010; Hirao M, 2003, J BIOL CHEM, V278, P52773, DOI 10.1074/jbc.M308966200; Hoppe GJ, 2002, MOL CELL BIOL, V22, P4167, DOI 10.1128/MCB.22.12.4167-4180.2002; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Hyland EA, 2005, MOL CELL BIOL, V25, P10060, DOI 10.1128/MCB.25.22.10060-10070.2005; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Jenner P. M., 1964, FOOD COSMET, V2, P327, DOI DOI 10.1016/S0015-6264(64)80192-9; Jiang H, 2013, NATURE, V496, P110, DOI 10.1038/nature12038; Kaidi A, 2010, SCIENCE, V329, P1348, DOI 10.1126/science.1192049; Kanfi Y, 2012, NATURE, V483, P218, DOI 10.1038/nature10815; Kawahara TLA, 2009, CELL, V136, P62, DOI 10.1016/j.cell.2008.10.052; Kemperman RA, 2010, MICROBIOL-SGM, V156, P3224, DOI 10.1099/mic.0.042127-0; Kim CY, 2011, J AGR FOOD CHEM, V59, P1012, DOI 10.1021/jf103873k; Kirchmaier AL, 2006, MOL CELL BIOL, V26, P852, DOI 10.1128/MCB.26.3.852-862.2006; Kirchmaier AL, 2001, SCIENCE, V291, P646, DOI 10.1126/science.291.5504.646; KOSUGE T, 1962, J BIOL CHEM, V237, P1653; Kugel S, 2014, TRENDS BIOCHEM SCI, V39, P72, DOI 10.1016/j.tibs.2013.12.002; Kutner M., 2004, APPL LINEAR STAT MOD; Lake BG, 2002, FOOD CHEM TOXICOL, V40, P809, DOI 10.1016/S0278-6915(02)00036-4; Leko V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066283; Li Q, 2008, CELL, V134, P244, DOI 10.1016/j.cell.2008.06.018; Link A, 2010, BIOCHEM PHARMACOL, V80, P1771, DOI 10.1016/j.bcp.2010.06.036; Liszt G, 2005, J BIOL CHEM, V280, P21313, DOI 10.1074/jbc.M413296200; Lombard DB, 2007, MOL CELL BIOL, V27, P8807, DOI 10.1128/MCB.01636-07; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Luo KH, 2002, GENE DEV, V16, P1528, DOI 10.1101/gad.988802; Maas NL, 2006, MOL CELL, V23, P109, DOI 10.1016/j.molcel.2006.06.006; MACKNESS MI, 1989, CLIN BIOCHEM, V22, P475, DOI 10.1016/S0009-9120(89)80101-8; MACKNESS MI, 1989, BIOCHEM PHARMACOL, V38, P385, DOI 10.1016/0006-2952(89)90376-6; Mao ZY, 2011, SCIENCE, V332, P1443, DOI 10.1126/science.1202723; Masumoto H, 2005, NATURE, V436, P294, DOI 10.1038/nature03714; McCord RA, 2009, AGING-US, V1, P109, DOI 10.18632/aging.100011; Michishita E, 2008, NATURE, V452, P492, DOI 10.1038/nature06736; Michishita E, 2009, CELL CYCLE, V8, P2664, DOI 10.4161/cc.8.16.9367; Miller A, 2008, GENETICS, V179, P793, DOI 10.1534/genetics.107.084525; Misaka S, 2013, CURR OPIN PHARMACOL, V13, P847, DOI 10.1016/j.coph.2013.08.010; Mochizuki H, 1998, GENE, V213, P149, DOI 10.1016/S0378-1119(98)00193-0; Mogarekar MR, 2013, INDIAN J GASTROENTER, V32, P307, DOI 10.1007/s12664-013-0334-1; Monagas M, 2010, FOOD FUNCT, V1, P233, DOI 10.1039/c0fo00132e; Mostoslavsky R, 2006, CELL, V124, P315, DOI 10.1016/J.CEL.2005.11.044; Nakagawa T, 2009, CELL, V137, P560, DOI 10.1016/j.cell.2009.02.026; National Toxicology Program, 1993, NTP TOX CARC STUD 3; Neilson AP, 2009, J AGR FOOD CHEM, V57, P9418, DOI 10.1021/jf902919k; Ng CJ, 2001, J BIOL CHEM, V276, P44444, DOI 10.1074/jbc.M105660200; North BJ, 2003, MOL CELL, V11, P437, DOI 10.1016/S1097-2765(03)00038-8; North BJ, 2007, J BIOL CHEM, V282, P19546, DOI 10.1074/jbc.M702990200; Olaharski AJ, 2005, PLOS GENET, V1, P689, DOI 10.1371/journal.pgen.0010077; Paredes S, 2014, CLIN CANCER RES, V20, P1741, DOI 10.1158/1078-0432.CCR-13-1547; Perrod S, 2001, EMBO J, V20, P197, DOI 10.1093/emboj/20.1.197; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Posakony J, 2004, J MED CHEM, V47, P2635, DOI 10.1021/jm030473r; Prasad R, 2012, ANNU REV MICROBIOL, V66, P39, DOI 10.1146/annurev-micro-092611-150111; Prozorovski T, 2008, NAT CELL BIOL, V10, P385, DOI 10.1038/ncb1700; Pruitt K, 2006, PLOS GENET, V2, P344, DOI 10.1371/journal.pgen.0020040; Rastogi SC, 1996, CONTACT DERMATITIS, V34, P423, DOI 10.1111/j.1600-0536.1996.tb02246.x; Reddy ST, 2001, ARTERIOSCL THROM VAS, V21, P542, DOI 10.1161/01.ATV.21.4.542; Rickett FL, 1974, DEER TONGUE SOME OTH, P1; RINE J, 1987, GENETICS, V116, P9; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Rusche LN, 2003, ANNU REV BIOCHEM, V72, P481, DOI 10.1146/annurev.biochem.72.121801.161547; Rusche LN, 2002, MOL BIOL CELL, V13, P2207, DOI 10.1091/mbc.E02-03-0175; SCHELINE RR, 1968, ACTA PHARMACOL TOX, V26, P325; Schlicker C, 2008, J MOL BIOL, V382, P790, DOI 10.1016/j.jmb.2008.07.048; Shin JY, 2013, CELL REP, V5, P654, DOI 10.1016/j.celrep.2013.10.007; Sinclair DA, 1997, CELL, V91, P1033, DOI 10.1016/S0092-8674(00)80493-6; Su D, 2012, NATURE, V483, P104, DOI 10.1038/nature10861; Sun C, 2007, CELL METAB, V6, P307, DOI 10.1016/j.cmet.2007.08.014; Tham WH, 2002, ONCOGENE, V21, P512, DOI 10.1038/sj.onc.1205078; Tsai YC, 2014, MOL CELL PROTEOMICS, V13, P73, DOI 10.1074/mcp.M113.031377; U. S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER), 2005, GUID IND E14 CLIN EV, P1; van der Horst A, 2004, J BIOL CHEM, V279, P28873, DOI 10.1074/jbc.M401138200; Van Leeuwen F, 2002, METHOD ENZYMOL, V350, P165, DOI 10.1016/S0076-6879(02)50962-9; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Wang DJ, 2013, FOOD CHEM, V138, P1564, DOI 10.1016/j.foodchem.2012.09.103; Wang Y, 2012, PHARMACOL THERAPEUT, V136, P305, DOI 10.1016/j.pharmthera.2012.08.009; Watanabe S, 2013, SCIENCE, V340, P195, DOI 10.1126/science.1229758; Weber JM, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-100; Wilkins BJ, 2014, SCIENCE, V343, P77, DOI 10.1126/science.1244508; Wood JG, 2004, NATURE, V430, P686, DOI 10.1038/nature02789; Xie JX, 1999, EMBO J, V18, P6448, DOI 10.1093/emboj/18.22.6448; Xu F, 2007, MOL CELL, V27, P890, DOI 10.1016/j.molcel.2007.07.021; Yang B, 2008, MOL BIOL CELL, V19, P4993, DOI 10.1091/mbc.E08-05-0524; Yang B, 2006, MOL BIOL CELL, V17, P5287, DOI 10.1091/mbc.E06-08-0669; Yang B, 2009, CELL CYCLE, V8, P2662, DOI 10.4161/cc.8.16.9329; Young TJ, 2012, BBA-GENE REGUL MECH, V1819, P303, DOI 10.1016/j.bbagrm.2011.10.006	133	4	4	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0149207	10.1371/journal.pone.0149207	http://dx.doi.org/10.1371/journal.pone.0149207			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	26882112	gold, Green Published			2022-12-26	WOS:000371219000060
J	Zhao, HY; Speir, JA; Matsui, T; Lin, ZH; Liang, LF; Lynn, AY; Varnado, B; Weiss, TM; Tang, L				Zhao, Haiyan; Speir, Jeffrey A.; Matsui, Tsutomu; Lin, Zihan; Liang, Lingfei; Lynn, Anna Y.; Varnado, Brittany; Weiss, Thomas M.; Tang, Liang			Structure of a Bacterial Virus DNA-Injection Protein Complex Reveals a Decameric Assembly with a Constricted Molecular Channel	PLOS ONE			English	Article							NEAR-ATOMIC-RESOLUTION; SCATTERING DATA-ANALYSIS; CRYO-EM STRUCTURE; BACTERIOPHAGE T7; 3-DIMENSIONAL STRUCTURE; TAILED BACTERIOPHAGES; ELECTRON-MICROSCOPY; DATA-ACQUISITION; OUTER-MEMBRANE; PORTAL PROTEIN	The multi-layered cell envelope structure of Gram-negative bacteria represents significant physical and chemical barriers for short-tailed phages to inject phage DNA into the host cytoplasm. Here we show that a DNA-injection protein of bacteriophage Sf6, gp12, forms a 465-kDa, decameric assembly in vitro. The electron microscopic structure of the gp12 assembly shows a similar to 150-angstrom, mushroom-like architecture consisting of a crown domain and a tube-like domain, which embraces a 25-angstrom-wide channel that could precisely accommodate dsDNA. The constricted channel suggests that gp12 mediates rapid, uni-directional injection of phage DNA into host cells by providing a molecular conduit for DNA translocation. The assembly exhibits a 10-fold symmetry, which may be a common feature among DNA-injection proteins of P22-like phages and may suggest a symmetry mismatch with respect to the 6-fold symmetric phage tail. The gp12 monomer is highly flexible in solution, supporting a mechanism for translocation of the protein through the conduit of the phage tail toward the host cell envelope, where it assembles into a DNA-injection device.	[Zhao, Haiyan; Lin, Zihan; Liang, Lingfei; Lynn, Anna Y.; Varnado, Brittany; Tang, Liang] Univ Kansas, Dept Mol Biosci, 1200 Sunnyside Ave, Lawrence, KS 66045 USA; [Speir, Jeffrey A.] Scripps Res Inst, Natl Resource Automated Mol Microscopy, La Jolla, CA 92037 USA; [Matsui, Tsutomu; Weiss, Thomas M.] Stanford Univ, SLAC Natl Accelerator Lab, Stanford Synchrotron Radiat Lightsource, 14 2575 Sand Hill Rd,MS69, Menlo Pk, CA USA	University of Kansas; Scripps Research Institute; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory	Tang, L (corresponding author), Univ Kansas, Dept Mol Biosci, 1200 Sunnyside Ave, Lawrence, KS 66045 USA.	tangl@ku.edu		Matsui, Tsutomu/0000-0001-7101-5259	National Institute of General Medical Sciences of the National Institutes of Health [R01GM090010]; National Institute of General Medical Sciences [P41GM103310]; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-76SF00515]; DOE Office of Biological and Environmental Research; National Institutes of Health, National Institute of General Medical Sciences [P41GM103393]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103393, R01GM090010, P41GM103310] Funding Source: NIH RePORTER	National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the grant R01GM090010 from the National Institute of General Medical Sciences of the National Institutes of Health (http://www.nigms.nih.gov) to L.T.; We thank Drs. Bridget Carragher and Clint Potter for access to the facilities at the National Resource for Automated Molecular Microscopy (NRAMM) for High-throughput electron microscopy data collection. NRAMM is supported by a grant from the National Institute of General Medical Sciences (P41GM103310). The SAXS data were collected at the beamline BL4-2 at the Stanford Synchrotron Radiation Lightsource. Use of the Stanford Synchrotron Radiation Lightsource, SLAC National Accelerator Laboratory, is supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences under Contract No. DE-AC02-76SF00515. The SSRL Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research, and by the National Institutes of Health, National Institute of General Medical Sciences (including P41GM103393). The contents of this publication are solely the responsibility of the authors and do not necessarily represent the official views of NIGMS or NIH. This work was supported by the grant R01GM090010 from the National Institute of General Medical Sciences of the National Institutes of Health to L.T.	Agirrezabala X, 2005, EMBO J, V24, P3820, DOI 10.1038/sj.emboj.7600840; Bhardwaj A, 2011, J BIOL CHEM, V286, P30867, DOI 10.1074/jbc.M111.260877; Bhardwaj A, 2009, J MOL BIOL, V391, P227, DOI 10.1016/j.jmb.2009.05.069; Bos MP, 2007, ANNU REV MICROBIOL, V61, P191, DOI 10.1146/annurev.micro.61.080706.093245; Campbell MG, 2014, J STRUCT BIOL, V188, P183, DOI 10.1016/j.jsb.2014.09.008; Casjens S, 2004, J MOL BIOL, V339, P379, DOI 10.1016/j.jmb.2004.03.068; Casjens SR, 2012, ADV EXP MED BIOL, V726, P143, DOI 10.1007/978-1-4614-0980-9_7; Casjens SR, 2011, NAT REV MICROBIOL, V9, P647, DOI 10.1038/nrmicro2632; Chang CY, 2010, VIROLOGY, V398, P176, DOI 10.1016/j.virol.2009.12.002; Chang J, 2006, STRUCTURE, V14, P1073, DOI 10.1016/j.str.2006.05.007; Chang JT, 2010, J MOL BIOL, V402, P731, DOI 10.1016/j.jmb.2010.07.058; Fokine Andrei, 2014, Bacteriophage, V4, pe28281; Gelbart WM, 2009, SCIENCE, V323, P1682, DOI 10.1126/science.1170645; Guo F, 2013, P NATL ACAD SCI USA, V110, P6811, DOI 10.1073/pnas.1215563110; HENDRIX RW, 1978, P NATL ACAD SCI USA, V75, P4779, DOI 10.1073/pnas.75.10.4779; Hu B, 2013, SCIENCE, V339, P576, DOI 10.1126/science.1231887; Hugel T, 2007, PLOS BIOL, V5, P558, DOI 10.1371/journal.pbio.0050059; ISRAEL V, 1977, J VIROL, V23, P91, DOI 10.1128/JVI.23.1.91-97.1977; Johnson JE, 2007, CURR OPIN STRUC BIOL, V17, P237, DOI 10.1016/j.sbi.2007.03.011; Kanamaru S, 2002, NATURE, V415, P553, DOI 10.1038/415553a; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kostyuchenko VA, 2005, NAT STRUCT MOL BIOL, V12, P810, DOI 10.1038/nsmb975; Lander GC, 2006, SCIENCE, V312, P1791, DOI 10.1126/science.1127981; Lander GC, 2013, NUCLEIC ACIDS RES, V41, P4518, DOI 10.1093/nar/gkt137; Lander GC, 2009, STRUCTURE, V17, P789, DOI 10.1016/j.str.2009.04.006; Lander GC, 2009, J STRUCT BIOL, V166, P95, DOI 10.1016/j.jsb.2009.01.002; Leavitt JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070936; Lebedev AA, 2007, EMBO J, V26, P1984, DOI 10.1038/sj.emboj.7601643; Leiman PG, 2004, CELL, V118, P419, DOI 10.1016/j.cell.2004.07.022; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; Liu SX, 2014, CELL, V157, P702, DOI 10.1016/j.cell.2014.02.034; Martel A, 2012, J SYNCHROTRON RADIAT, V19, P431, DOI 10.1107/S0909049512008072; Matsui T, 2014, J MOL BIOL, V426, P3773, DOI 10.1016/j.jmb.2014.09.009; McPhillips TM, 2002, J SYNCHROTRON RADIAT, V9, P401, DOI 10.1107/S0909049502015170; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Molineux IJ, 2013, NAT REV MICROBIOL, V11, P194, DOI 10.1038/nrmicro2988; Molineux IJ, 2001, MOL MICROBIOL, V40, P1, DOI 10.1046/j.1365-2958.2001.02357.x; Olia AS, 2007, NAT STRUCT MOL BIOL, V14, P1221, DOI 10.1038/nsmb1317; Olia AS, 2011, NAT STRUCT MOL BIOL, V18, P597, DOI 10.1038/nsmb.2023; Parent KN, 2012, VIROLOGY, V427, P177, DOI 10.1016/j.virol.2012.01.040; Perez GL, 2009, J BACTERIOL, V191, P135, DOI 10.1128/JB.00778-08; Petoukhov MV, 2007, J APPL CRYSTALLOGR, V40, pS223, DOI 10.1107/S0021889807002853; Qiu XY, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.028102; Ruiz N, 2006, NAT REV MICROBIOL, V4, P57, DOI 10.1038/nrmicro1322; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Serwer Philip, 2008, BMC Res Notes, V1, P36, DOI 10.1186/1756-0500-1-36; Silhavy TJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000414; Sousa D, 2007, J STRUCT BIOL, V157, P201, DOI 10.1016/j.jsb.2006.08.003; Sun L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8548; Sun L, 2014, NATURE, V505, P432, DOI 10.1038/nature12816; Sun S, 2008, CELL, V135, P1251, DOI 10.1016/j.cell.2008.11.015; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Tang JH, 2011, STRUCTURE, V19, P496, DOI 10.1016/j.str.2011.02.010; Tang L, 2005, EMBO J, V24, P2087, DOI 10.1038/sj.emboj.7600695; Voss NR, 2009, J STRUCT BIOL, V166, P205, DOI 10.1016/j.jsb.2009.01.004; Woolfson DN, 2012, CURR OPIN STRUC BIOL, V22, P432, DOI 10.1016/j.sbi.2012.03.002; Zhao HY, 2013, P NATL ACAD SCI USA, V110, P8075, DOI 10.1073/pnas.1301133110; Zhao H, 2011, VIROLOGY, V409, P319, DOI 10.1016/j.virol.2010.10.030	58	19	20	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0149337	10.1371/journal.pone.0149337	http://dx.doi.org/10.1371/journal.pone.0149337			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	26882199	Green Published, gold, Green Submitted			2022-12-26	WOS:000371219000072
J	Even, DY; Kedmi, A; Basch-Barzilay, S; Ideses, D; Tikotzki, R; Shir-Shapira, H; Shefi, O; Juven-Gershon, T				Even, Dan Y.; Kedmi, Adi; Basch-Barzilay, Shani; Ideses, Diana; Tikotzki, Ravid; Shir-Shapira, Hila; Shefi, Orit; Juven-Gershon, Tamar			Engineered Promoters for Potent Transient Overexpression	PLOS ONE			English	Article							RNA-POLYMERASE-II; CORE PROMOTER; GENE-EXPRESSION; TATA-BOX; KEY COMPONENT; TFIID BINDS; TRANSCRIPTION; ELEMENT; DOWNSTREAM; DROSOPHILA	The core promoter, which is generally defined as the region to which RNA Polymerase II is recruited to initiate transcription, plays a pivotal role in the regulation of gene expression. The core promoter consists of different combinations of several short DNA sequences, termed core promoter elements or motifs, which confer specific functional properties to each promoter. Earlier studies that examined the ability to modulate gene expression levels via the core promoter, led to the design of strong synthetic core promoters, which combine different core elements into a single core promoter. Here, we designed a new core promoter, termed super core promoter 3 (SCP3), which combines four core promoter elements (the TATA box, Inr, MTE and DPE) into a single promoter that drives prolonged and potent gene expression. We analyzed the effect of core promoter architecture on the temporal dynamics of reporter gene expression by engineering EGFP expression vectors that are driven by distinct core promoters. We used live cell imaging and flow cytometric analyses in different human cell lines to demonstrate that SCPs, particularly the novel SCP3, drive unusually strong long-term EGFP expression. Importantly, this is the first demonstration of long-term expression in transiently transfected mammalian cells, indicating that engineered core promoters can provide a novel non-viral strategy for biotechnological as well as gene-therapy-related applications that require potent expression for extended time periods.	[Even, Dan Y.; Kedmi, Adi; Basch-Barzilay, Shani; Ideses, Diana; Tikotzki, Ravid; Shir-Shapira, Hila; Juven-Gershon, Tamar] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, IL-5290002 Ramat Gan, Israel; [Shefi, Orit] Bar Ilan Univ, Fac Engn, IL-5290002 Ramat Gan, Israel; [Shefi, Orit] Bar Ilan Univ, Bar Ilan Inst Nanotechnol & Adv Mat, IL-5290002 Ramat Gan, Israel	Bar Ilan University; Bar Ilan University; Bar Ilan University	Juven-Gershon, T (corresponding author), Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, IL-5290002 Ramat Gan, Israel.	tamar.gershon@biu.ac.il	Juven-Gershon, Tamar/AAC-7799-2022	Juven-Gershon, Tamar/0000-0003-2607-5476	Legacy Heritage Biomedical Program of the Israel Science Foundation [1447/13]	Legacy Heritage Biomedical Program of the Israel Science Foundation	This research was supported in part by the Legacy Heritage Biomedical Program of the Israel Science Foundation (grant No. 1447/13) to OS and TJ-G.	Blazeck J, 2013, BIOTECHNOL J, V8, P46, DOI 10.1002/biot.201200120; Burke TW, 1997, GENE DEV, V11, P3020, DOI 10.1101/gad.11.22.3020; Burke TW, 1996, GENE DEV, V10, P711, DOI 10.1101/gad.10.6.711; Butler JEF, 2001, GENE DEV, V15, P2515, DOI 10.1101/gad.924301; Butler JEF, 2002, GENE DEV, V16, P2583, DOI 10.1101/gad.1026202; Cianfrocco MA, 2013, CELL, V152, P120, DOI 10.1016/j.cell.2012.12.005; Danino YM, 2015, BBA-GENE REGUL MECH, V1849, P1116, DOI 10.1016/j.bbagrm.2015.04.003; Deng WS, 2007, CHROMOSOMA, V116, P417, DOI 10.1007/s00412-007-0113-9; Deng WS, 2005, GENE DEV, V19, P2418, DOI 10.1101/gad.342405; Duttke SHC, 2014, J BIOL CHEM, V289, P20396, DOI 10.1074/jbc.M114.563254; EMAMI KH, 1995, MOL CELL BIOL, V15, P5906; Garraway IP, 1996, P NATL ACAD SCI USA, V93, P4336, DOI 10.1073/pnas.93.9.4336; Goldberg ML., 1979, THESIS; Heintzman ND, 2007, CELL MOL LIFE SCI, V64, P386, DOI 10.1007/s00018-006-6295-0; Juven-Gershon T, 2008, GENE DEV, V22, P2823, DOI 10.1101/gad.1698108; Juven-Gershon T, 2008, CURR OPIN CELL BIOL, V20, P253, DOI 10.1016/j.ceb.2008.03.003; Juven-Gershon T, 2006, NAT METHODS, V3, P917, DOI 10.1038/NMETH937; Juven-Gershon T, 2010, DEV BIOL, V339, P225, DOI 10.1016/j.ydbio.2009.08.009; Kadonaga JT, 2012, WIRES DEV BIOL, V1, P40, DOI 10.1002/wdev.21; Kutach AK, 2000, MOL CELL BIOL, V20, P4754, DOI 10.1128/MCB.20.13.4754-4764.2000; Lagrange T, 1998, GENE DEV, V12, P34, DOI 10.1101/gad.12.1.34; Lee DH, 2005, MOL CELL BIOL, V25, P9674, DOI 10.1128/MCB.25.21.9674-9686.2005; Lenhard B, 2012, NAT REV GENET, V13, P233, DOI 10.1038/nrg3163; Lewis BA, 2000, P NATL ACAD SCI USA, V97, P7172, DOI 10.1073/pnas.120181197; Lim CY, 2004, GENE DEV, V18, P1606, DOI 10.1101/gad.1193404; Luse DS, 2013, TRANSCRIPTION, V5; Macias MP, 1996, J VIROL, V70, P3628, DOI 10.1128/JVI.70.6.3628-3635.1996; Martinez E, 2012, TRANSCR-AUSTIN, V3, P295, DOI 10.4161/trns.21846; Muller F, 2014, BBA-GENE REGUL MECH, V1839, P118, DOI 10.1016/j.bbagrm.2013.11.003; Ohtsuki S, 1998, GENE DEV, V12, P547, DOI 10.1101/gad.12.4.547; Parry TJ, 2010, GENE DEV, V24, P2013, DOI 10.1101/gad.1951110; Pfeiffer BD, 2008, P NATL ACAD SCI USA, V105, P9715, DOI 10.1073/pnas.0803697105; SMALE ST, 1989, CELL, V57, P103, DOI 10.1016/0092-8674(89)90176-1; Smale ST, 2003, ANNU REV BIOCHEM, V72, P449, DOI 10.1146/annurev.biochem.72.121801.161520; Smale ST, 2001, GENE DEV, V15, P2503, DOI 10.1101/gad.937701; STENBERG RM, 1984, J VIROL, V49, P190, DOI 10.1128/JVI.49.1.190-199.1984; Theisen JWM, 2010, MOL CELL BIOL, V30, P3471, DOI 10.1128/MCB.00053-10; Thomas MC, 2006, CRIT REV BIOCHEM MOL, V41, P105, DOI 10.1080/10409230600648736; Yang CH, 2007, GENE, V389, P52, DOI 10.1016/j.gene.2006.09.029; Zehavi Y, 2014, J BIOL CHEM, V289, P11993, DOI 10.1074/jbc.M114.550251	40	15	16	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0148918	10.1371/journal.pone.0148918	http://dx.doi.org/10.1371/journal.pone.0148918			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26872062	gold, Green Published, Green Submitted			2022-12-26	WOS:000370054100073
J	Lenguerrand, E; Wylde, V; Gooberman-Hill, R; Sayers, A; Brunton, L; Beswick, AD; Dieppe, P; Blom, AW				Lenguerrand, Erik; Wylde, Vikki; Gooberman-Hill, Rachael; Sayers, Adrian; Brunton, Luke; Beswick, Andrew D.; Dieppe, Paul; Blom, Ashley W.			Trajectories of Pain and Function after Primary Hip and Knee Arthroplasty: The ADAPT Cohort Study	PLOS ONE			English	Article							TOTAL JOINT REPLACEMENT; QUALITY-OF-LIFE; CLINICALLY IMPORTANT DIFFERENCES; OUTCOMES; RECOVERY; OSTEOARTHRITIS; PREDICTORS; RESPONSIVENESS; EXPECTATION; SF-36	Background and Purpose Pain and function improve dramatically in the first three months after hip and knee arthroplasty but the trajectory after three months is less well described. It is also unclear how pre-operative pain and function influence short-and long-term recovery. We explored the trajectory of change in function and pain until and beyond 3-months post-operatively and the influence of pre-operative self-reported symptoms. Methods The study was a prospective cohort study of 164 patients undergoing primary hip (n = 80) or knee (n = 84) arthroplasty in the United Kingdom. Self-reported measures of pain and function using the Western Ontario and McMaster Universities Osteoarthritis index were collected pre-operatively and at 3 and 12 months post-operatively. Hip and knee arthroplasties were analysed separately, and patients were split into two groups: those with high or low symptoms pre-operatively. Multilevel regression models were used for each outcome (pain and function), and the trajectories of change were charted (0-3 months and 3-12 months). Results Hip: Most improvement occurred within the first 3 months following hip surgery and patients with worse pre-operative scores had greater changes. The mean changes observed between 3 and twelve months were statistically insignificant. One year after surgery, patients with worse pre-operative scores had post-operative outcomes similar to those observed among patients with less severe pre-operative symptoms. Knee: Most improvement occurred in the first 3 months following knee surgery with no significant change thereafter. Despite greater mean change during the first three months, patients with worse pre-operative scores had not 'caught-up' with those with less severe pre-operative symptoms 12 months after their surgery. Conclusion Most symptomatic improvement occurred within the first 3 months after surgery with no significant change between 3-12 months. Further investigations are now required to determine if patients with severe symptoms at the time of their knee arthroplasty have a different pre-surgical history than those with less severe symptoms and if they could benefit from earlier surgical intervention and tailored rehabilitation to achieve better post-operative patient-reported outcomes.	[Lenguerrand, Erik; Wylde, Vikki; Gooberman-Hill, Rachael; Sayers, Adrian; Brunton, Luke; Beswick, Andrew D.; Blom, Ashley W.] Univ Bristol, Sch Clin Sci, Musculoskeletal Res Unit, Bristol, Avon, England; [Dieppe, Paul] Univ Exeter, Sch Med, Exeter, Devon, England	University of Bristol; University of Exeter	Lenguerrand, E (corresponding author), Univ Bristol, Sch Clin Sci, Musculoskeletal Res Unit, Bristol, Avon, England.	erik.lenguerrand@bristol.ac.uk	Sayers, Adrian/AAU-8134-2020	Sayers, Adrian/0000-0001-7452-5043; Beswick, Andrew/0000-0002-7032-7514; Blom, Ashley/0000-0002-9940-1095; Gooberman-Hill, Rachael/0000-0003-3353-2882; Wylde, Vikki/0000-0002-8460-1529; Lenguerrand, Erik/0000-0002-0371-731X	National Institute for Health Research (NIHR) under Programme Grants for Applied Research programme [RP-PG-0407-10070]; NIHR, through the Comprehensive Clinical Research Network; National Institute for Health Research [RP-PG-0407-10070] Funding Source: researchfish	National Institute for Health Research (NIHR) under Programme Grants for Applied Research programme(National Institute for Health Research (NIHR)); NIHR, through the Comprehensive Clinical Research Network; National Institute for Health Research(National Institute for Health Research (NIHR))	This article presents independent research funded by the National Institute for Health Research (NIHR) under its Programme Grants for Applied Research programme (RP-PG-0407-10070). http://www.nihr.ac.uk/. All authors were funded by the above grant to perform the current work: EL VW RGH AS LB ADB PD AWB. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The research team acknowledges the support of the NIHR, through the Comprehensive Clinical Research Network. The authors would like to acknowledge and thank the participants of the ADAPT study, members of the Project Steering Committee and the following research team members: Cindy Mann, Debbie Delgado, Connie Jamera, Louise Hawkins, Sue Bowman, Leigh Morrison, Dave Rea and Jenny Tyler.	Arirachakaran Alisara, 2015, Eur J Orthop Surg Traumatol, V25, P799, DOI 10.1007/s00590-015-1610-9; Bachmeier CJM, 2001, OSTEOARTHR CARTILAGE, V9, P137, DOI 10.1053/joca.2000.0369; BELLAMY N, 1988, J RHEUMATOL, V15, P1833; Beswick AD, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000435; Browne JP, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-128; Culliford DJ, 2012, OSTEOARTHR CARTILAGE, V20, P519, DOI 10.1016/j.joca.2012.02.636; Culliford DJ, 2010, J BONE JOINT SURG BR, V92B, P130, DOI 10.1302/0301-620X.92B1.22654; Davis AM, 2011, OSTEOARTHR CARTILAGE, V19, P1413, DOI 10.1016/j.joca.2011.08.007; Dempsey KE, 2013, RHEUMATOLOGY, V52, P1802, DOI 10.1093/rheumatology/ket180; Dieppe P, 2013, RHEUMATOLOGY, V52, P1737, DOI 10.1093/rheumatology/ket242; Escobar A, 2007, OSTEOARTHR CARTILAGE, V15, P273, DOI 10.1016/j.joca.2006.09.001; Ethgen O, 2004, J BONE JOINT SURG AM, V86A, P963, DOI 10.2106/00004623-200405000-00012; Fitz Gerald JD, 2004, ARTHRIT RHEUM-ARTHR, V51, P100, DOI 10.1002/art.20090; Fortin PR, 1999, ARTHRITIS RHEUM, V42, P1722, DOI 10.1002/1529-0131(199908)42:8<1722::AID-ANR22>3.0.CO;2-R; Fortin PR, 2002, ARTHRITIS RHEUM, V46, P3327, DOI 10.1002/art.10631; Garbuz DS, 2006, CLIN ORTHOP RELAT R, P79, DOI 10.1097/01.blo.0000203477.19421.ed; Garbuz DS, 2006, J ARTHROPLASTY, V21, P998, DOI 10.1016/j.arth.2006.01.014; Hajat Shakoor, 2002, J Health Serv Res Policy, V7, P19, DOI 10.1258/1355819021927638; Halket A, 2010, J ARTHROPLASTY, V25, P254, DOI 10.1016/j.arth.2009.01.007; Hamilton D, 2012, POSTGRAD MED J, V88, P627, DOI 10.1136/postgradmedj-2011-130715; Jenny JY, 2012, ORTHOP TRAUMATOL-SUR, V98, P409, DOI 10.1016/j.otsr.2012.03.004; Johansson Henning R, 2010, J Orthop Surg (Hong Kong), V18, P6; Judge A, 2011, OSTEOARTHR CARTILAGE, V19, P659, DOI 10.1016/j.joca.2011.03.009; Judge A, 2013, BMJ OPEN, V3; Judge A, 2012, RHEUMATOLOGY, V51, P1804, DOI 10.1093/rheumatology/kes075; Judge A, 2010, ARTHRIT CARE RES, V62, P480, DOI 10.1002/acr.20038; Kennedy DM, 2008, PHYS THER, V88, P22, DOI 10.2522/ptj.20070051; Kennedy DM, 2006, BMC MUSCULOSKEL DIS, V7, DOI 10.1186/1471-2474-7-100; Kennedy DM, 2011, J ORTHOP SPORT PHYS, V41, P232, DOI 10.2519/jospt.2011.3516; Kennedy DM, 2006, J ARTHROPLASTY, V21, P559, DOI 10.1016/j.arth.2005.07.010; Larsen K, 2012, KNEE SURG SPORT TR A, V20, P1128, DOI 10.1007/s00167-012-1919-4; Lavernia C, 2009, J ARTHROPLASTY, V24, P1033, DOI 10.1016/j.arth.2008.09.010; Leckie G, 2013, J STAT SOFTW, V52, P1; Liddle AD, 2014, LANCET, V384, P1437, DOI 10.1016/S0140-6736(14)60419-0; Lingard EA, 2004, J BONE JOINT SURG AM, V86A, P2179, DOI 10.2106/00004623-200410000-00008; LITTLE RJA, 1995, J AM STAT ASSOC, V90, P1112, DOI 10.2307/2291350; Lombardi AV, 2009, CLIN ORTHOP RELAT R, V467, P1450, DOI 10.1007/s11999-009-0731-z; Losina E, 2013, ARTHRITIS RHEUM-US, V65, P1157, DOI 10.1002/art.37903; MacWilliam CH, 1996, HEALTH SERV RES, V31, P623; Mahomed NN, 2002, J RHEUMATOL, V29, P1273; Moran M, 2003, ANN ROY COLL SURG, V85, P204, DOI 10.1308/003588403321661415; Naylor JM, 2009, AUST HEALTH REV, V33, P124, DOI 10.1071/AH090124; Nilsdotter AK, 2003, ANN RHEUM DIS, V62, P923, DOI 10.1136/ard.62.10.923; Nilsdotter A, 2011, ARTHRIT CARE RES, V63, pS200, DOI 10.1002/acr.20549; Quintana JM, 2005, OSTEOARTHR CARTILAGE, V13, P1076, DOI 10.1016/j.joca.2005.06.012; Ramisetty N, 2015, J HIP PRESERVATION S, P1; Roder C, 2007, J BONE JOINT SURG AM, V89A, P11, DOI 10.2106/JBJS.E.00012; Rolfson O, 2009, J BONE JOINT SURG BR, V91B, P157, DOI 10.1302/0301-620X.91B2.20765; Roos Ewa M, 2003, Health Qual Life Outcomes, V1, P17, DOI 10.1186/1477-7525-1-17; Singh JA, 2010, OSTEOARTHR CARTILAGE, V18, P515, DOI 10.1016/j.joca.2009.12.001; Steinhoff AK, 2016, KNEE SURG SPORT TR A, V24, P2627, DOI 10.1007/s00167-014-3433-3; Troelsen A, 2012, DAN MED J, V59; Vissers MM, 2012, SEMIN ARTHRITIS RHEU, V41, P576, DOI 10.1016/j.semarthrit.2011.07.003; Wylde V, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-220	54	57	58	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149306	10.1371/journal.pone.0149306	http://dx.doi.org/10.1371/journal.pone.0149306			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26871909	Green Submitted, Green Published, gold			2022-12-26	WOS:000370054100144
J	Liew, YJ; Ryu, T; Aranda, M; Ravasi, T				Liew, Yi Jin; Ryu, Taewoo; Aranda, Manuel; Ravasi, Timothy			miRNA Repertoires of Demosponges Stylissa carteri and Xestospongia testudinaria	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; MICRORNAS; PROTEIN; EVOLUTION; INSIGHTS; RNAS; COMPLEXITY; ROLES	MicroRNAs (miRNAs) are small regulatory RNAs that are involved in many biological process in eukaryotes. They play a crucial role in modulating genetic expression of their targets, which makes them integral components of transcriptional regulatory networks. As sponges (phylum Porifera) are commonly considered the most basal metazoan, the indepth capture of miRNAs from these organisms provides additional clues to the evolution of miRNA families in metazoans. Here, we identified the core proteins involved in the biogenesis of miRNAs, and obtained evidence for bona fide miRNA sequences for two marine sponges Stylissa carteri and Xestospongia testudinaria (11 and 19 respectively). Our analysis identified several miRNAs that are conserved amongst demosponges, and revealed that all of the novel miRNAs identified in these two species are specific to the class Demospongiae.	[Liew, Yi Jin; Ryu, Taewoo; Aranda, Manuel; Ravasi, Timothy] King Abdullah Univ Sci & Technol, Div Biol & Environm Sci & Engn, Thuwal 239556900, Saudi Arabia; [Liew, Yi Jin; Aranda, Manuel] King Abdullah Univ Sci & Technol, Red Sea Res Ctr, Thuwal 239556900, Saudi Arabia; [Ryu, Taewoo; Ravasi, Timothy] King Abdullah Univ Sci & Technol, KEEP, Thuwal 239556900, Saudi Arabia	King Abdullah University of Science & Technology; King Abdullah University of Science & Technology; King Abdullah University of Science & Technology	Aranda, M; Ravasi, T (corresponding author), King Abdullah Univ Sci & Technol, Div Biol & Environm Sci & Engn, Thuwal 239556900, Saudi Arabia.; Aranda, M (corresponding author), King Abdullah Univ Sci & Technol, Red Sea Res Ctr, Thuwal 239556900, Saudi Arabia.; Ravasi, T (corresponding author), King Abdullah Univ Sci & Technol, KEEP, Thuwal 239556900, Saudi Arabia.	manuel.aranda@kaust.edu.sa; timothy.ravasi@kaust.edu.sa	Ravasi, Timothy/B-8777-2008; Liew, Yi Jin/AAI-6307-2021; Ryu, Taewoo/AAN-2634-2020; Aranda Lastra, Manuel/D-9530-2011	Liew, Yi Jin/0000-0003-2553-8870; Aranda Lastra, Manuel/0000-0001-6673-016X; Ravasi, Timothy/0000-0002-9950-465X	King Abdullah University of Science and Technology (KAUST)	King Abdullah University of Science and Technology (KAUST)(King Abdullah University of Science & Technology)	This research and all the authors are supported by the King Abdullah University of Science and Technology.; We thank Annika Haywood, Feras Lafi and Holly Bream for extracting the RNA used for sequencing, as well as two anonymous reviewers for their invaluable suggestions. This project was supported by the King Abdullah University of Science and Technology (KAUST).	Burge SW, 2013, NUCLEIC ACIDS RES, V41, pD226, DOI 10.1093/nar/gks1005; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Chapman JA, 2010, NATURE, V464, P592, DOI 10.1038/nature08830; Chen XM, 2009, ANNU REV CELL DEV BI, V25, P21, DOI 10.1146/annurev.cellbio.042308.113417; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Friedlander MR, 2012, NUCLEIC ACIDS RES, V40, P37, DOI 10.1093/nar/gkr688; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Grimson A, 2008, NATURE, V455, P1193, DOI 10.1038/nature07415; Ha M, 2014, NAT REV MOL CELL BIO, V15, P509, DOI 10.1038/nrm3838; Huang Y, 2009, NATURE, V461, P823, DOI 10.1038/nature08433; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Liew YJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091101; Lingel A, 2003, NATURE, V426, P465, DOI 10.1038/nature02123; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; Maniar JM, 2011, CURR BIOL, V21, P449, DOI 10.1016/j.cub.2011.02.019; Moran Y, 2013, MOL BIOL EVOL, V30, P2541, DOI 10.1093/molbev/mst159; Mulder Nicola, 2007, V396, P59; Nehammer C, 2015, SCI REP-UK, V5, DOI 10.1038/srep08866; Peterson KJ, 2009, BIOESSAYS, V31, P736, DOI 10.1002/bies.200900033; Prochnik SE, 2007, DEV GENES EVOL, V217, P73, DOI 10.1007/s00427-006-0116-1; Rivas FV, 2005, NAT STRUCT MOL BIOL, V12, P340, DOI 10.1038/nsmb918; Robinson JM, 2013, J EXP ZOOL PART B, V320B, P84, DOI 10.1002/jez.b.22485; Rodriguez AJ, 2005, RNA, V11, P646, DOI 10.1261/rna.7198205; Sempere LF, 2006, J EXP ZOOL PART B, V306B, P575, DOI 10.1002/jez.b.21118; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Song JJ, 2004, SCIENCE, V305, P1434, DOI 10.1126/science.1102514; Song XW, 2012, PLANT J, V71, P378, DOI 10.1111/j.1365-313X.2012.05001.x; Sperling EA, 2010, GEOBIOLOGY, V8, P24, DOI 10.1111/j.1472-4669.2009.00225.x; Suzek BE, 2007, BIOINFORMATICS, V23, P1282, DOI 10.1093/bioinformatics/btm098; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Vidigal JA, 2015, TRENDS CELL BIOL, V25, P137, DOI 10.1016/j.tcb.2014.11.004; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wheeler BM, 2009, EVOL DEV, V11, P50, DOI 10.1111/j.1525-142X.2008.00302.x; Yeom KH, 2006, NUCLEIC ACIDS RES, V34, P4622, DOI 10.1093/nar/gkl458; Zong J, 2009, GENE, V447, P29, DOI 10.1016/j.gene.2009.07.004	41	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149080	10.1371/journal.pone.0149080	http://dx.doi.org/10.1371/journal.pone.0149080			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26871907	Green Published, Green Submitted, gold			2022-12-26	WOS:000370054100099
J	Wiecki, TV; Antoniades, CA; Stevenson, A; Kennard, C; Borowsky, B; Owen, G; Leavitt, B; Roos, R; Durr, A; Tabrizi, SJ; Frank, MJ				Wiecki, Thomas V.; Antoniades, Chrystalina A.; Stevenson, Alexander; Kennard, Christopher; Borowsky, Beth; Owen, Gail; Leavitt, Blair; Roos, Raymund; Durr, Alexandra; Tabrizi, Sarah J.; Frank, Michael J.			A Computational Cognitive Biomarker for Early-Stage Huntington's Disease	PLOS ONE			English	Article							BASAL GANGLIA; PREFRONTAL CORTEX; RESPONSE-INHIBITION; FRONTAL-CORTEX; TRACK-HD; ATROPHY; MODEL; ONSET; TASK; DEFICITS	Huntington's disease (HD) is genetically determined but with variability in symptom onset, leading to uncertainty as to when pharmacological intervention should be initiated. Here we take a computational approach based on neurocognitive phenotyping, computational modeling, and classification, in an effort to provide quantitative predictors of HD before symptom onset. A large sample of subjects-consisting of both pre-manifest individuals carrying the HD mutation (pre-HD), and early symptomatic-as well as healthy controls performed the antisaccade conflict task, which requires executive control and response inhibition. While symptomatic HD subjects differed substantially from controls in behavioral measures [reaction time (RT) and error rates], there was no such clear behavioral differences in pre-HD. RT distributions and error rates were fit with an accumulator-based model which summarizes the computational processes involved and which are related to identified mechanisms in more detailed neural models of prefrontal cortex and basal ganglia. Classification based on fitted model parameters revealed a key parameter related to executive control differentiated pre-HD from controls, whereas the response inhibition parameter declined only after symptom onset. These findings demonstrate the utility of computational approaches for classification and prediction of brain disorders, and provide clues as to the underlying neural mechanisms.	[Wiecki, Thomas V.; Frank, Michael J.] Cognit Linguist & Psychol Sci, Providence, RI USA; [Antoniades, Chrystalina A.; Stevenson, Alexander; Kennard, Christopher] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Neurosci, Div Clin Neurol, Level 6 West Wing, Oxford OX3 9DU, England; [Borowsky, Beth] CHDI Fdn, CHDI Management Inc, 155 Village Blvd,Suite 200, Princeton, NJ 08540 USA; [Owen, Gail; Tabrizi, Sarah J.] UCL Inst Neurol, Huntingtons Dis Res Ctr, 2nd Floor Russell Sq House,10-12 Russell Sq, London WC1B 5EH, England; [Leavitt, Blair] Univ British Columbia, Dept Med Genet, Vancouver, BC V6T 2B5, Canada; [Roos, Raymund] Leiden Univ, Dept Neurol, Med Ctr, NL-2300 RC Leiden, Netherlands; [Durr, Alexandra] Hop La Pitie Salpetriere, AP HP, Dept Genet & Cytogenet, F-75013 Paris, France; [Durr, Alexandra] Hop La Pitie Salpetriere, AP HP, INSERM, UMR S679, F-75013 Paris, France	University of Oxford; University of London; University College London; University of British Columbia; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Frank, MJ (corresponding author), Cognit Linguist & Psychol Sci, Providence, RI USA.	michael_frank@brown.edu	Leavitt, Blair R/G-1934-2012	Tabrizi, Sarah/0000-0003-2716-2045; Antoniades, Chrystalina/0000-0002-1192-3834; Owen, Gail/0000-0001-5685-3692	CHDI/High Q Foundation; MRC [MR/J003832/1, MR/L012936/1] Funding Source: UKRI; Medical Research Council [MR/J003832/1, MR/P007015/1, MR/L012936/1] Funding Source: researchfish; Wellcome Trust [200181/Z/15/Z] Funding Source: researchfish	CHDI/High Q Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by CHDI/High Q Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Andre R, 2014, DRUG DISCOV TODAY, P2; Antoniades CA, 2007, NEUROREPORT, V18, P1133, DOI 10.1097/WNR.0b013e32821c560d; Aron AR, 2007, J NEUROSCI, V27, P3743, DOI 10.1523/JNEUROSCI.0519-07.2007; Aylward EH, 2004, NEUROLOGY, V63, P66, DOI 10.1212/01.WNL.0000132965.14653.D1; Badre D, 2008, TRENDS COGN SCI, V12, P193, DOI 10.1016/j.tics.2008.02.004; Baier B, 2010, J NEUROSCI, V30, P9788, DOI 10.1523/JNEUROSCI.1513-10.2010; Bissett PG, 2012, J EXP PSYCHOL HUMAN, V38, P746, DOI 10.1037/a0025429; Blekher T, 2009, INVEST OPHTH VIS SCI, V50, P5707, DOI 10.1167/iovs.09-3538; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Cavanagh JF, 2014, J EXPT PSYCHOL GEN; Chambers CD, 2009, NEUROSCI BIOBEHAV R, V33, P631, DOI 10.1016/j.neubiorev.2008.08.016; Chatham CH, 2014, NEURON, V81, P930, DOI 10.1016/j.neuron.2014.01.002; Collins AGE, 2014, PSYCHOL REV, V121, P337, DOI 10.1037/a0037015; Collins AGE, 2013, PSYCHOL REV, V120, P190, DOI 10.1037/a0030852; Congdon E, 2009, BIOL PSYCHOL, V81, P144, DOI 10.1016/j.biopsycho.2009.03.005; Dunovan K, 2015, ELIFE, V4, DOI 10.7554/eLife.08723; Egner T, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00154; Frank MJ, 2001, COGN AFFECT BEHAV NE, V1, P137, DOI 10.3758/CABN.1.2.137; Frank MJ, 2005, J COGNITIVE NEUROSCI, V17, P51, DOI 10.1162/0898929052880093; FRIEDMAN JH, 1991, ANN STAT, V19, P1, DOI 10.1214/aos/1176347963; FUNAHASHI S, 1993, NATURE, V365, P753, DOI 10.1038/365753a0; Golding CVP, 2006, NEUROLOGY, V67, P485, DOI 10.1212/01.wnl.0000218215.43328.88; Hicks SL, 2008, PROG BRAIN RES, V171, P555, DOI 10.1016/S0079-6123(08)00678-X; Hobbs NZ, 2009, NEUROIMAGE, V47, P1659, DOI 10.1016/j.neuroimage.2009.06.003; Isoda M, 2007, NAT NEUROSCI, V10, P240, DOI 10.1038/nn1830; Johnson KA, 2001, EXP BRAIN RES, V138, P492, DOI 10.1007/s002210100733; Johnston K, 2006, J NEUROSCI, V26, P12471, DOI 10.1523/JNEUROSCI.4101-06.2006; Kassubek J, 2005, CEREB CORTEX, V15, P846, DOI 10.1093/cercor/bhh185; Kieburtz K, 2012, LANCET NEUROL, V11, P24, DOI 10.1016/S1474-4422(11)70285-X; King JA, 2010, J NEUROSCI, V30, P12759, DOI 10.1523/JNEUROSCI.3274-10.2010; Klempir J, 2005, FUNCTIONAL NEUROLOGY, V21, P217; Kloppel S, 2008, BRAIN, V131, P196, DOI 10.1093/brain/awm275; Kravitz AV, 2012, NATURE NEUROSCIENCE; Langbehn DR, 2004, CLIN GENET, V65, P267, DOI 10.1111/j.1399-0004.2004.00241.x; MacMillan J., 1996, HUNTINGTONS DIS, P317; Maia TV, 2011, NAT NEUROSCI, V14, P154, DOI 10.1038/nn.2723; Majid DSA, 2013, J NEUROSCI, V33, P13259, DOI 10.1523/JNEUROSCI.5651-12.2013; Majid DSA, 2011, MOVEMENT DISORD, V26, P2544, DOI 10.1002/mds.23912; Majid DSA, 2011, MOVEMENT DISORD, V26, P1481, DOI 10.1002/mds.23656; Mcnab F, 2008, NAT NEUROSCI, V11, P103, DOI 10.1038/nn2024; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Milnerwood AJ, 2010, NEURON, V65, P178, DOI 10.1016/j.neuron.2010.01.008; Mink JW, 1996, PROG NEUROBIOL, V50, P381, DOI 10.1016/S0301-0082(96)00042-1; Montague PR, 2012, TRENDS COGN SCI, V16, P72, DOI 10.1016/j.tics.2011.11.018; Munoz DP, 2004, NAT REV NEUROSCI, V5, P218, DOI 10.1038/nrn1345; Noorani I, 2012, EUROPEAN J NEUROSCIE, V37, P1; Ober JK, 2003, MODEL MEAS MED, P187; Paulsen JS, 2010, BRAIN RES BULL, V82, P201, DOI 10.1016/j.brainresbull.2010.04.003; Peltsch A, 2008, EXP BRAIN RES, V186, P457, DOI 10.1007/s00221-007-1248-x; Rao JA, 2014, CORTEX, V58, P72, DOI 10.1016/j.cortex.2014.04.018; Ratcliff R, 2008, NEURAL COMPUT, V20, P873, DOI 10.1162/neco.2008.12-06-420; Ridderinkhof KR, 2011, WIRES COGN SCI, V2, P174, DOI 10.1002/wcs.99; Ridderinkhof KR, 2005, J ABNORM PSYCHOL, V114, P197, DOI 10.1037/0021-843X.114.2.197; SchlagRey M, 1997, NATURE, V390, P398, DOI 10.1038/37114; SHOULSON I, 1979, NEUROLOGY, V29, P1, DOI 10.1212/WNL.29.1.1; Tabrizi SJ, 2013, LANCET NEUROL, V12, P637, DOI 10.1016/S1474-4422(13)70088-7; Tabrizi SJ, 2009, LANCET NEUROL, V8, P791, DOI 10.1016/S1474-4422(09)70170-X; Turner BM, 2013, PSYCHONOMIC B REV; Wagenmakers EJ, 2007, PSYCHON B REV, V14, P3, DOI 10.3758/BF03194023; Wales DJ, 1997, J PHYS CHEM A, V101, P5111, DOI 10.1021/jp970984n; Watanabe M, 2011, EUR J NEUROSCI, V33, P2070, DOI 10.1111/j.1460-9568.2011.07691.x; Wegener SP, 2008, EXP BRAIN RES, V190, P463, DOI 10.1007/s00221-008-1488-4; Wiecki TV, 2015, CLIN PSYCHOL SCI, V3, P378, DOI 10.1177/2167702614565359; Wiecki TV, 2013, FRONT NEUROINFORM, V7, DOI 10.3389/fninf.2013.00014; Wiecki TV, 2013, PSYCHOL REV, V120, P329, DOI 10.1037/a0031542	67	25	25	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0148409	10.1371/journal.pone.0148409	http://dx.doi.org/10.1371/journal.pone.0148409			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26872129	Green Published, Green Submitted, gold			2022-12-26	WOS:000370054100029
J	Lee, J; Machin, M; Russell, KE; Pavlidis, S; Zhu, J; Barnes, PJ; Chung, KF; Adcock, IM; Durham, AL				Lee, Jin; Machin, Matthew; Russell, Kirsty E.; Pavlidis, Stelios; Zhu, Jie; Barnes, Peter J.; Chung, Kian F.; Adcock, Ian M.; Durham, Andrew L.			Corticosteroid modulation of immunoglobulin expression and B-cell function in COPD	FASEB JOURNAL			English	Article						DUSP1; ERK; fluticasone propionate; LABA	OBSTRUCTIVE PULMONARY-DISEASE; DUAL-SPECIFICITY PHOSPHATASES; AIRWAY GENE-EXPRESSION; MAP KINASE; INHALED FLUTICASONE; LUNG-FUNCTION; GLUCOCORTICOIDS; EXACERBATIONS; TRANSCRIPTION; INFLAMMATION	We investigated changes in gene expression that occur in chronic obstructive pulmonary disease (COPD) after corticosteroid treatment and sought to identify the mechanisms that regulate these changes. Biopsy samples were taken from patients with COPD (Global Initiative for Chronic Obstructive Lung Disease stage I to II) before and after treatment with fluticasone propionate (FP)/salmeterol (SM) (50/500, 4 wk). Gene expression was measured by microarray and was confirmed by real-time reverse transcription-quantitative PCR (RT-qPCR). The effect of FP on IgG expression and B-cell proliferation in the presence of oxidative stress was also studied. FP/SM significantly increased the expression of 180 genes while repressing 343 genes. The top 5 down-regulated genes were associated with immunoglobulin production, whereas the immunomodulatory FK506 binding protein (FK506BP) was up-regulated. Genes including IL6, IL8, and TBET-encoding TBX21 were unaffected. FP reduced IgG protein and mRNA expression and proliferation of human B cells through the dephosphorylation of ERK1/2 via increased DUSP1 (dual-specificity protein phosphatase 1) expression. Consistent with in vivo data, oxidative stress did not prevent FP-induced suppression of IgG expression in human B cells in vitro. Changes in expression were validated by RT-qPCR and by gene set enrichment analysis in distinct COPD cohorts. FP may reduce the adaptive immune response in COPD and may be more effective in patients with an increased B-cell/antibody response indicated by high autoantibody titers.-Lee, J., Machin, M., Russell, K. E., Pavlidis, S., Zhu, J., Barnes, P. J., Chung, K. F., Adcock, I. M., Durham, A. L. Corticosteroid modulation of immunoglobulin expression and B-cell function in COPD. www.fasebj.org	[Lee, Jin; Machin, Matthew; Russell, Kirsty E.; Zhu, Jie; Barnes, Peter J.; Chung, Kian F.; Adcock, Ian M.; Durham, Andrew L.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Airway Dis Sect, London, England; [Pavlidis, Stelios] Janssen Res & Dev, High Wycombe, Bucks, England	Imperial College London; Johnson & Johnson	Durham, AL (corresponding author), Natl Heart & Lung Inst, Airways Dis Sect, Dovehouse St, London SW3 6LY, England.	a.durham@imperial.ac.uk	Adcock, Ian/L-3217-2019; Chung, Kian Fan/B-1872-2012	Chung, Kian Fan/0000-0001-7101-1426; Adcock, Ian/0000-0003-2101-8843; Machin, Matthew/0000-0002-9692-4552; Durham, Andrew/0000-0003-2372-4688; Barnes, Peter/0000-0002-5122-4018	Medical Research Council [G1001367/1]; Wellcome Trust [093080/Z/10/Z]; Interuniversity Attraction Poles Program Belgian State-Belgian Science Policy Project [P7/30]; National Institute for Health Research Respiratory Disease Biomedical Research Unit; Royal Brompton National Health Service (NHS) Foundation Trust; Imperial College London; GSK; Medical Research Council [G1000758] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10148] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Interuniversity Attraction Poles Program Belgian State-Belgian Science Policy Project; National Institute for Health Research Respiratory Disease Biomedical Research Unit; Royal Brompton National Health Service (NHS) Foundation Trust; Imperial College London(General Electric); GSK(GlaxoSmithKline); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	The microarray data was carried out with the help of A. McLaren, B. P. Hayes, and C. Clayton at GlaxoSmithKline (GSK), and bronchial biopsy samples were obtained with the help of A. Torrego. I.M.A. is supported by the Medical Research Council (G1001367/1) and the Wellcome Trust (093080/Z/10/Z). I.M.A. is a member of Interuniversity Attraction Poles Program Belgian State-Belgian Science Policy Project P7/30. Research by I.M.A., P.J.B., K.F.C., and A.L.D. is supported in part by the National Institute for Health Research Respiratory Disease Biomedical Research Unit, Royal Brompton National Health Service (NHS) Foundation Trust, and Imperial College London. The views expressed in this publication are those of the authors and not necessarily those of the NHS, the National Institute for Health Research, or the Department of Health. This work was funded by the Wellcome Trust (093080/Z/10/Z) and an unrestricted research grant from GSK. The sponsors had no involvement in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; and in the decision to submit the article for publication.	Ayroldi E, 2012, FASEB J, V26, P4805, DOI 10.1096/fj.12-216382; Barnes NC, 2006, AM J RESP CRIT CARE, V173, P736, DOI 10.1164/rccm.200508-1321OC; Barnes PJ, 2013, CURR MED CHEM, V20, P1531; Barnes PJ, 2009, LANCET, V373, P1905, DOI 10.1016/S0140-6736(09)60326-3; Barnes PJ, 2003, ANN INTERN MED, V139, P359, DOI 10.7326/0003-4819-139-5_Part_1-200309020-00012; Busse PJ, 2002, J ALLERGY CLIN IMMUN, V109, P1001, DOI 10.1067/mai.2002.124999; Calverley P, 2003, LANCET, V361, P449, DOI 10.1016/S0140-6736(03)12459-2; Calverley P, 2004, EUR RESPIR J, V24, P206; Calverley PMA, 2007, NEW ENGL J MED, V356, P775, DOI 10.1056/NEJMoa063070; Christenson SA, 2015, AM J RESP CRIT CARE, V191, P758, DOI 10.1164/rccm.201408-1458OC; CUPPS TR, 1985, J CLIN INVEST, V75, P754, DOI 10.1172/JCI111757; Duncan SR, 2010, AM J RESP CRIT CARE, V181, P4, DOI 10.1164/rccm.200910-1488ED; Durham AL, 2013, FASEB J, V27, P2367, DOI 10.1096/fj.12-217083; Fokkens WJ, 1999, ALLERGY, V54, P158, DOI 10.1034/j.1398-9995.1999.00747.x; Ford PA, 2010, CHEST, V137, P1338, DOI 10.1378/chest.09-2363; Georas Steve N, 2004, Proc Am Thorac Soc, V1, P215, DOI 10.1513/pats.200402-004MS; Gold MR, 2008, IMMUNITY, V28, P488, DOI 10.1016/j.immuni.2008.03.008; Gosman MME, 2006, EUR RESPIR J, V27, P60, DOI 10.1183/09031936.06.00007005; Hanzelmann S, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-7; Hakim A, 2012, DRUGS, V72, P1299, DOI 10.2165/11634350-000000000-00000; Haque R, 2013, J ALLERGY CLIN IMMUN, V132, P1166, DOI 10.1016/j.jaci.2013.07.038; Hattotuwa KL, 2002, AM J RESP CRIT CARE, V165, P1592, DOI 10.1164/rccm.2105025; Houghton AM, 2013, NAT REV CANCER, V13, P233, DOI 10.1038/nrc3477; Hoyler T, 2012, IMMUNITY, V37, P634, DOI 10.1016/j.immuni.2012.06.020; Ito K, 2004, BIOCHEM BIOPH RES CO, V315, P240, DOI 10.1016/j.bbrc.2004.01.046; Ito K., 2001, FASEB Journal, V15, P1110; Jeffrey KL, 2007, NAT REV DRUG DISCOV, V6, P391, DOI 10.1038/nrd2289; Kassel O, 2001, EMBO J, V20, P7108, DOI 10.1093/emboj/20.24.7108; Kaur M, 2008, MOL PHARMACOL, V73, P203, DOI 10.1124/mol.107.040121; Kew KM, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010115.pub2; Kirkham PA, 2011, AM J RESP CRIT CARE, V184, P796, DOI 10.1164/rccm.201010-1605OC; Lapperre TS, 2009, ANN INTERN MED, V151, P517, DOI 10.7326/0003-4819-151-8-200910200-00004; Lee SH, 2007, NAT MED, V13, P567, DOI 10.1038/nm1583; Lim S, 1999, AM J RESP CRIT CARE, V159, P22, DOI 10.1164/ajrccm.159.1.9706006; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maas A. K., 2010, F1000 MED REP, V2, P2; Macedo P, 2009, CLIN EXP ALLERGY, V39, P1668, DOI 10.1111/j.1365-2222.2009.03319.x; Magnussen H, 2014, NEW ENGL J MED, V371, P1285, DOI 10.1056/NEJMoa1407154; Maneechotesuwan K, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000076; Mercado N, 2011, J PHARMACOL EXP THER, V337, P465, DOI 10.1124/jpet.110.175950; NICE, 2010, CHRON OBSTR PULM DIS; Nunez B, 2011, AM J RESP CRIT CARE, V183, P1025, DOI 10.1164/rccm.201001-0029OC; Pascoe S, 2015, LANCET RESP MED, V3, P435, DOI 10.1016/S2213-2600(15)00106-X; Patterson KI, 2009, BIOCHEM J, V418, P475, DOI 10.1042/BJ20082234; QUANJER PH, 1993, EUR RESPIR J, V6, P5, DOI 10.1183/09041950.005s1693; Reth M, 2014, ADV IMMUNOL, V122, P129, DOI 10.1016/B978-0-12-800267-4.00004-3; Si WZ, 2015, CANCER CELL, V27, P822, DOI 10.1016/j.ccell.2015.04.011; Statistical Solutions, POW SAMPL SIZ CALC; Steiling K, 2013, AM J RESP CRIT CARE, V187, P933, DOI 10.1164/rccm.201208-1449OC; Thornton TM, 2009, INT J BIOL SCI, V5, P44, DOI 10.7150/ijbs.5.44; van den Berge M, 2014, THORAX, V69, P14, DOI 10.1136/thoraxjnl-2012-202878; Wedzicha JA, 2012, EUR RESPIR J, V40, P1545, DOI 10.1183/09031936.00048912; Williams AS, 2007, J PHARMACOL EXP THER, V322, P351, DOI 10.1124/jpet.107.121624; ZON LI, 1991, J BIOL CHEM, V266, P22948	54	22	23	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2016	30	5					2014	2026		10.1096/fj.201500135	http://dx.doi.org/10.1096/fj.201500135			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DK4HW	26887440	Green Submitted			2022-12-26	WOS:000374879400028
J	Plecita-Hlavata, L; Engstova, H; Alan, L; Spacek, T; Dlaskova, A; Smolkova, K; Spackova, J; Tauber, J; Stradalova, V; Malinsky, J; Lessard, M; Bewersdorf, J; Jezek, P				Plecita-Hlavata, Lydie; Engstova, Hana; Alan, Lukas; Spacek, Tomas; Dlaskova, Andrea; Smolkova, Katarina; Spackova, Jitka; Tauber, Jan; Stradalova, Vendula; Malinsky, Jan; Lessard, Mark; Bewersdorf, Joerg; Jezek, Petr			Hypoxic HepG2 cell adaptation decreases ATP synthase dimers and ATP production in inflated cristae by mitofilin down-regulation concomitant to MICOS clustering	FASEB JOURNAL			English	Article						mitofilin; Mic60; OPA1; dSTORM 3D immunocytochemistry; electron microscopy; mitochondrial cristae morphology	MITOCHONDRIAL CONTACT SITE; OXIDATIVE-PHOSPHORYLATION; ORGANIZING SYSTEM; OUTER-MEMBRANE; COMPLEX-III; ELECTRON TOMOGRAPHY; MICROSCOPY REVEALS; CANCER; ARCHITECTURE; PROTEIN	The relationship of the inner mitochondrial membrane (IMM) cristae structure and intracristal space (ICS) to oxidative phosphorylation (oxphos) is not well understood. Mitofilin (subunit Mic60) of the mitochondrial contact site and cristae organizing system (MICOS) IMM complex is attached to the outer membrane (OMM) via the sorting and assembly machinery/topogenesis of mitochondrial outer membrane beta-barrel proteins (SAM/TOB) complex and controls the shape of the cristae. ATP synthase dimers determine sharp cristae edges, whereas trimeric OPA1 tightens ICS outlets. Metabolism is altered during hypoxia, and we therefore studied cristae morphology in HepG2 cells adapted to 5% oxygen for 72 h. Three dimensional (3D), super-resolution biplane fluorescence photoactivation localization microscopy with Eos-conjugated, ICS-located lactamase-beta indicated hypoxic ICS expansion with an unchanged OMM (visualized by Eos-mitochondrial fission protein-1). 3D direct stochastic optical reconstruction microscopy immunocytochemistry revealed foci of clustered mitofilin (but not MICOS subunit Mic19) in contrast to its even normoxic distribution. Mitofilin mRNA and protein decreased by similar to 20%. ATP synthase dimers vs. monomers and state-3/state-4 respiration ratios were lower during hypoxia. Electron microscopy confirmed ICS expansion (maximum in glycolytic cells), which was absent in reduced or OMM-detached cristae of OPA1- and mitofilin-silenced cells, respectively. Hypoxic adaptation is reported as rounding sharp cristae edges and expanding cristae width (ICS) by partialmitofilin/Mic60 down-regulation. Mitofilin-depleted MICOS detaches from SAM while remaining MICOS with mitofilin redistributes toward higher interdistances. This phenomenon causes partial oxphos dormancy in glycolytic cells via disruption of ATP synthase dimers.-Plecita-Hlavata, L., Engstova, H., Alan, L.,. Spacek, T., Dlaskova, A., Smolkova, K., Spackova, J., Tauber, J., Stradalova, V., Malinsky, J., Lessard, M., Bewersdorf, J., Jezek, P. Hypoxic HepG2 cell adaptation decreases ATP synthase dimers and ATP production in inflated cristae by mitofilin down-regulation concomitant to MICOS clustering. www.fasebj.org	[Plecita-Hlavata, Lydie; Engstova, Hana; Alan, Lukas; Spacek, Tomas; Dlaskova, Andrea; Smolkova, Katarina; Spackova, Jitka; Tauber, Jan; Jezek, Petr] Acad Sci Czech Republic, Inst Physiol, Dept Membrane Transport Biophys, Dept 75, Videnska 1083, CR-14220 Prague 4, Czech Republic; [Stradalova, Vendula; Malinsky, Jan] Acad Sci Czech Republic, Inst Expt Med, Microscopy Unit, Prague 14220 4, Czech Republic; [Lessard, Mark] Jackson Lab, Inst Mol Biophys, 600 Main St, Bar Harbor, ME 04609 USA; [Lessard, Mark; Bewersdorf, Joerg] Yale Univ, Dept Cell Biol, New Haven, CT USA	Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Experimental Medicine of the Czech Academy of Sciences; Jackson Laboratory; Yale University	Jezek, P (corresponding author), Acad Sci Czech Republic, Inst Physiol, Membrane Transport Biophys, Dept 75, Videnska 1083, CR-14220 Prague 4, Czech Republic.	jezek@biomed.cas.cz	Dlaskova, Andrea/AAD-5955-2020; Alán, Lukáš/H-9063-2013; Engstova, Hana/C-1015-2012; Plecita-Hlavata, Lydie/C-1028-2012; Tauber, Jan/H-9066-2013; Smolková, Katarína/C-4290-2012; Malinsky, Jan/H-2484-2014; Šantorová, Jitka/C-8303-2012; Spacek, Tomas/C-4380-2012; Dlaskova, Andrea/C-1734-2012; Engstova, Hana/AAF-6522-2020; Jezek, Petr/B-9264-2012	Dlaskova, Andrea/0000-0002-8626-3703; Alán, Lukáš/0000-0001-7417-2620; Plecita-Hlavata, Lydie/0000-0003-0759-1731; Tauber, Jan/0000-0002-4711-5716; Smolková, Katarína/0000-0002-4734-0200; Malinsky, Jan/0000-0002-1433-0989; Spacek, Tomas/0000-0002-7020-8566; Engstova, Hana/0000-0001-6341-8242; Jezek, Petr/0000-0002-2720-9395; Bewersdorf, Joerg/0000-0002-4085-7020; Lessard, Mark/0000-0002-1927-2204	Grant Agency of the Czech Republic [13-02033S, 15-02022Y];  [AV0Z50110509];  [RVO67985823]	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); ; 	The authors thank Dr. J. Zelenka for preparation of the Cy3B-conjugated secondary antibody, L. Joskova for excellent technical assistance with cell cultivation, J. Vaicova for the immunoblot analyses and blue native electrophoresis, and J. Smikova for the plasmid isolations. The project was supported by Grants 13-02033S (to P.J.) and 15-02022Y (to A.D.) from the Grant Agency of the Czech Republic, and by Research Projects AV0Z50110509 and RVO67985823. J.B. declares significant financial interest in Bruker Corp. and Hamamatsu Photonics K.K. The remaining authors declare no conflicts of interest.	Barbot M, 2015, CELL METAB, V21, P756, DOI 10.1016/j.cmet.2015.04.006; Bell EL, 2007, J CELL BIOL, V177, P1029, DOI 10.1083/jcb.200609074; Bohnert M, 2015, CELL METAB, V21, P747, DOI 10.1016/j.cmet.2015.04.007; Bohnert M, 2012, MOL BIOL CELL, V23, P3948, DOI 10.1091/mbc.E12-04-0295; Brown TA, 2011, MOL CELL BIOL, V31, P4994, DOI 10.1128/MCB.05694-11; Chen H, 2010, ANN NY ACAD SCI, V1201, P21, DOI 10.1111/j.1749-6632.2010.05615.x; Cogliati S, 2013, CELL, V155, P160, DOI 10.1016/j.cell.2013.08.032; Daum B, 2013, P NATL ACAD SCI USA, V110, P15301, DOI 10.1073/pnas.1305462110; Davies KM, 2011, P NATL ACAD SCI USA, V108, P14121, DOI 10.1073/pnas.1103621108; Fanale D, 2013, BREAST CANCER RES TR, V140, P505, DOI 10.1007/s10549-013-2649-0; Frey TG, 2002, BBA-BIOENERGETICS, V1555, P196, DOI 10.1016/S0005-2728(02)00278-5; Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025; Gomes LC, 2011, NAT CELL BIOL, V13, P589, DOI 10.1038/ncb2220; Guarani V, 2015, ELIFE, V4, DOI 10.7554/eLife.06265; Guzy RD, 2005, CELL METAB, V1, P401, DOI 10.1016/j.cmet.2005.05.001; Guzy RD, 2006, EXP PHYSIOL, V91, P807, DOI 10.1113/expphysiol.2006.033506; HACKENBROCK CR, 1966, J CELL BIOL, V30, P269, DOI 10.1083/jcb.30.2.269; Harner M, 2011, EMBO J, V30, P4356, DOI 10.1038/emboj.2011.379; Harner ME, 2014, ELIFE, V3, DOI 10.7554/eLife.01684; Hohr AIC, 2015, BBA-MOL CELL RES, V1853, P74, DOI 10.1016/j.bbamcr.2014.10.006; Jans DC, 2013, P NATL ACAD SCI USA, V110, P8936, DOI 10.1073/pnas.1301820110; Jezek P, 2010, INT J BIOCHEM CELL B, V42, P604, DOI 10.1016/j.biocel.2009.11.008; Jezek P, 2009, INT J BIOCHEM CELL B, V41, P1790, DOI 10.1016/j.biocel.2009.02.014; Jofuku A, 2005, BIOCHEM BIOPH RES CO, V333, P650, DOI 10.1016/j.bbrc.2005.05.154; Juette MF, 2008, NAT METHODS, V5, P527, DOI 10.1038/nmeth.1211; Korner C, 2012, MOL BIOL CELL, V23, P2143, DOI 10.1091/mbc.E11-10-0831; Kukat C, 2015, P NATL ACAD SCI USA, V112, P11288, DOI 10.1073/pnas.1512131112; Mannella CA, 2008, ANN NY ACAD SCI, V1147, P171, DOI 10.1196/annals.1427.020; Mlodzianoski MJ, 2011, OPT EXPRESS, V19, P15009, DOI 10.1364/OE.19.015009; Neupert W, 2012, CELL, V149, P722, DOI 10.1016/j.cell.2012.04.010; Ott C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120213; Patten DA, 2014, EMBO J, V33, P2676, DOI 10.15252/embj.201488349; Perkins GA, 2010, J NEUROSCI, V30, P1015, DOI 10.1523/JNEUROSCI.1517-09.2010; Pfanner N, 2014, J CELL BIOL, V204, P1083, DOI 10.1083/jcb.201401006; Plecita-Hlavata L, 2008, BBA-BIOENERGETICS, V1777, P834, DOI 10.1016/j.bbabio.2008.04.002; Polianskyte Z, 2009, P NATL ACAD SCI USA, V106, P18960, DOI 10.1073/pnas.0906734106; Schmidt R, 2009, NANO LETT, V9, P2508, DOI 10.1021/nl901398t; Semenza GL, 2012, TRENDS PHARMACOL SCI, V33, P207, DOI 10.1016/j.tips.2012.01.005; Smolkova K, 2011, INT J BIOCHEM CELL B, V43, P950, DOI 10.1016/j.biocel.2010.05.003; Sood A, 2014, P NATL ACAD SCI USA, V111, P16017, DOI 10.1073/pnas.1408061111; Strauss M, 2008, EMBO J, V27, P1154, DOI 10.1038/emboj.2008.35; Sun MG, 2007, NAT CELL BIOL, V9, P1057, DOI 10.1038/ncb1630; WESTERHOFF HV, 1984, FEBS LETT, V165, P1, DOI 10.1016/0014-5793(84)80002-2; Wheaton WW, 2011, AM J PHYSIOL-CELL PH, V300, pC385, DOI 10.1152/ajpcell.00485.2010; Willems PHGM, 2015, CELL METAB, V22, P207, DOI 10.1016/j.cmet.2015.06.006; Yang RF, 2015, SCI REP-UK, V5, DOI 10.1038/srep07990; Zerbes RM, 2012, J MOL BIOL, V422, P183, DOI 10.1016/j.jmb.2012.05.004	47	27	27	1	25	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2016	30	5					1941	1957		10.1096/fj.201500176	http://dx.doi.org/10.1096/fj.201500176			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DK4HW	26887443				2022-12-26	WOS:000374879400022
J	Lee, SM; Hay, DL; Pioszak, AA				Lee, Sang-Min; Hay, Debbie L.; Pioszak, Augen A.			Calcitonin and Amylin Receptor Peptide Interaction Mechanisms INSIGHTS INTO PEPTIDE-BINDING MODES AND ALLOSTERIC MODULATION OF THE CALCITONIN RECEPTOR BY RECEPTOR ACTIVITY-MODIFYING PROTEINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						allosteric regulation; cell surface receptor; G protein-coupled receptor (GPCR); glycoprotein; mutagenesis; peptide hormone; structure-function; RAMP	GENE-RELATED PEPTIDE; COUPLED-RECEPTOR; EXTRACELLULAR DOMAIN; SALMON-CALCITONIN; STRUCTURAL BASIS; DIFFERENTIALLY MODULATE; MOLECULAR RECOGNITION; CRYSTAL-STRUCTURE; ALPHA-HELIX; ADRENOMEDULLIN	Receptor activity-modifying proteins (RAMP1-3) determine the selectivity of the class B G protein-coupled calcitonin receptor (CTR) and the CTR-like receptor (CLR) for calcitonin (CT), amylin (Amy), calcitonin gene-related peptide (CGRP), and adrenomedullin (AM) peptides. RAMP1/2 alter CLR selectivity for CGRP/AM in part by RAMP1 Trp-84 or RAMP2 Glu-101 contacting the distinct CGRP/AM C-terminal residues. It is unclear whether RAMPs use a similar mechanism to modulate CTR affinity for CT and Amy, analogs of which are therapeutics for bone disorders and diabetes, respectively. Here, we reproduced the peptide selectivity of intact CTR, AMY(1) (CTRRAMP1), and AMY(2) (CTRRAMP2) receptors using purified CTR extracellular domain (ECD) and tethered RAMP1- and RAMP2-CTR ECD fusion proteins and antagonist peptides. All three proteins bound salmon calcitonin (sCT). Tethering RAMPs to CTR enhanced binding of rAmy, CGRP, and the AMY antagonist AC413. Peptide alanine-scanning mutagenesis and modeling of receptor-bound sCT and AC413 supported a shared non-helical CGRP-like conformation for their TN(T/V)G motif prior to the C terminus. After this motif, the peptides diverged; the sCT C-terminal Pro was crucial for receptor binding, whereas the AC413/rAmy C-terminal Tyr had little or no influence on binding. Accordingly, mutant RAMP1 W84A- and RAMP2 E101A-CTR ECD retained AC413/rAmy binding. ECD binding and cell-based signaling assays with antagonist sCT/AC413/rAmy variants with C-terminal residue swaps indicated that the C-terminal sCT/rAmy residue identity affects affinity more than selectivity. rAmy(8-37) Y37P exhibited enhanced antagonism of AMY(1) while retaining selectivity. These results reveal unexpected differences in how RAMPs determine CTR and CLR peptide selectivity and support the hypothesis that RAMPs allosterically modulate CTR peptide affinity.	[Lee, Sang-Min; Pioszak, Augen A.] Univ Oklahoma, Dept Biochem & Mol Biol, Hlth Sci Ctr, Oklahoma City, OK 73104 USA; [Hay, Debbie L.] Univ Auckland, Sch Biol Sci, Auckland 1142, New Zealand; [Hay, Debbie L.] Univ Auckland, Maurice Wilkins Ctr Mol Biodiscovery, Auckland 1142, New Zealand	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Auckland; University of Auckland	Pioszak, AA (corresponding author), Univ Oklahoma, Dept Biochem & Mol Biol, Hlth Sci Ctr, Oklahoma City, OK 73104 USA.	augen-pioszak@ouhsc.edu	Hay, Debbie L/D-4441-2009	Hay, Debbie L/0000-0002-9558-5122; Lee, Sangmin/0000-0002-7262-159X	National Institutes of Health [R01GM104251]; Harold Hamm Diabetes Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104251] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harold Hamm Diabetes Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R01GM104251 (to A. A. P.) and a training grant from the Harold Hamm Diabetes Center (to S. M. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Andreassen KV, 2014, AM J PHYSIOL-ENDOC M, V307, pE24, DOI 10.1152/ajpendo.00121.2014; Andreotti G, 2006, J BIOL CHEM, V281, P24193, DOI 10.1074/jbc.M603528200; Aricescu AR, 2006, ACTA CRYSTALLOGR D, V62, P1243, DOI 10.1107/S0907444906029799; Armour SL, 1999, J PHARMACOL TOXICOL, V42, P217, DOI 10.1016/S1056-8719(00)00074-5; Barwell J, 2012, BRIT J PHARMACOL, V166, P51, DOI 10.1111/j.1476-5381.2011.01525.x; Bell IM, 2014, J MED CHEM, V57, P7838, DOI 10.1021/jm500364u; Booe JM, 2015, MOL CELL, V58, P1040, DOI 10.1016/j.molcel.2015.04.018; Brain SD, 2004, PHYSIOL REV, V84, P903, DOI 10.1152/physrev.00037.2003; Chesnut CH, 2008, OSTEOPOROSIS INT, V19, P479, DOI 10.1007/s00198-007-0490-1; Christopoulos G, 1999, MOL PHARMACOL, V56, P235, DOI 10.1124/mol.56.1.235; Gingell JJ, 2010, PEPTIDES, V31, P1400, DOI 10.1016/j.peptides.2010.03.027; Guex N, 2009, ELECTROPHORESIS, V30, pS162, DOI 10.1002/elps.200900140; Hay DL, 2016, ANNU REV PHARMACOL, V56, P469, DOI 10.1146/annurev-pharmtox-010715-103120; Hay DL, 2015, PHARMACOL REV, V67, P564, DOI 10.1124/pr.115.010629; Hay DL, 2006, PHARMACOL THERAPEUT, V109, P173, DOI 10.1016/j.pharmthera.2005.06.015; Hay DL, 2005, MOL PHARMACOL, V67, P1655, DOI 10.1124/mol.104.008615; Hill HE, 2013, PROTEIN EXPRES PURIF, V88, P107, DOI 10.1016/j.pep.2012.11.019; Hilton JM, 2000, J ENDOCRINOL, V166, P213, DOI 10.1677/joe.0.1660213; Ho HH, 1999, BIOCHEMISTRY-US, V38, P1866, DOI 10.1021/bi981195e; Hoare SRJ, 2005, DRUG DISCOV TODAY, V10, P417, DOI 10.1016/S1359-6446(05)03370-2; Hong YG, 2012, BRIT J PHARMACOL, V166, P110, DOI 10.1111/j.1476-5381.2011.01530.x; Koth CM, 2010, BIOCHEMISTRY-US, V49, P1862, DOI 10.1021/bi901848m; Kusano S, 2012, PROTEIN SCI, V21, P199, DOI 10.1002/pro.2003; Lee SM, 2015, EUR J PHARMACOL, V763, P196, DOI 10.1016/j.ejphar.2015.05.013; Mack CM, 2010, INT J OBESITY, V34, P385, DOI 10.1038/ijo.2009.238; McLatchie LM, 1998, NATURE, V393, P333, DOI 10.1038/30666; Moad HE, 2013, PROTEIN SCI, V22, P1775, DOI 10.1002/pro.2377; Moore EL, 2010, BIOCHEM BIOPH RES CO, V394, P141, DOI 10.1016/j.bbrc.2010.02.131; Morfis M, 2008, ENDOCRINOLOGY, V149, P5423, DOI 10.1210/en.2007-1735; Muff R, 1999, ENDOCRINOLOGY, V140, P2924, DOI 10.1210/en.140.6.2924; Nanga RPR, 2009, J AM CHEM SOC, V131, P8252, DOI 10.1021/ja9010095; Pal K, 2010, J BIOL CHEM, V285, P40351, DOI 10.1074/jbc.M110.186072; Parthier C, 2007, P NATL ACAD SCI USA, V104, P13942, DOI 10.1073/pnas.0706404104; Patil SM, 2009, J BIOL CHEM, V284, P11982, DOI 10.1074/jbc.M809085200; Pioszak AA, 2008, J BIOL CHEM, V283, P32900, DOI 10.1074/jbc.M805749200; Pioszak AA, 2008, P NATL ACAD SCI USA, V105, P5034, DOI 10.1073/pnas.0801027105; Pioszak AA, 2009, J BIOL CHEM, V284, P28382, DOI 10.1074/jbc.M109.022905; Poyner DR, 2002, PHARMACOL REV, V54, P233, DOI 10.1124/pr.54.2.233; Purdue BW, 2002, RECEPTOR CHANNEL, V8, P243, DOI 10.1080/10606820213681; Rist B, 1998, J MED CHEM, V41, P117, DOI 10.1021/jm970533r; ROBERTS AN, 1989, P NATL ACAD SCI USA, V86, P9662, DOI 10.1073/pnas.86.24.9662; Runge S, 2008, J BIOL CHEM, V283, P11340, DOI 10.1074/jbc.M708740200; Sadry SA, 2013, NAT REV ENDOCRINOL, V9, P425, DOI 10.1038/nrendo.2013.47; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tilakaratne N, 2000, J PHARMACOL EXP THER, V294, P61; Udawela M, 2006, MOL PHARMACOL, V69, P1984, DOI 10.1124/mol.105.021915; Venkatanarayan A, 2015, NATURE, V517, P626, DOI 10.1038/nature13910; Wang YF, 2003, BIOCHEM BIOPH RES CO, V306, P582, DOI 10.1016/S0006-291X(03)01028-3; Warner ML, 2015, MOL PHARMACOL, V87, P410, DOI 10.1124/mol.114.095133; Watkins HA, 2013, BRIT J PHARMACOL, V169, P143, DOI 10.1111/bph.12118; Wong Hoi Kin, 2012, JRSM Cardiovasc Dis, V1, DOI 10.1258/cvd.2012.012003; Wookey PJ, 1996, AM J PHYSIOL-RENAL, V270, pF289, DOI 10.1152/ajprenal.1996.270.2.F289; YOUNG AA, 1994, FEBS LETT, V343, P237, DOI 10.1016/0014-5793(94)80563-6; Younk LM, 2011, EXPERT OPIN PHARMACO, V12, P1439, DOI 10.1517/14656566.2011.581663; Zumpe ET, 2000, BIOCHEM BIOPH RES CO, V267, P368, DOI 10.1006/bbrc.1999.1943	55	48	50	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2016	291	16					8686	8700		10.1074/jbc.M115.713628	http://dx.doi.org/10.1074/jbc.M115.713628			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK2VT	26895962	Green Published, hybrid			2022-12-26	WOS:000374773200031
J	Nakhaei-Rad, S; Nakhaeizadeh, H; Gotze, S; Kordes, C; Sawitza, I; Hoffmann, MJ; Franke, M; Schulz, WA; Scheller, J; Piekorz, RP; Haussinger, D; Ahmadian, MR				Nakhaei-Rad, Saeideh; Nakhaeizadeh, Hossein; Goetze, Silke; Kordes, Claus; Sawitza, Iris; Hoffmann, Michele J.; Franke, Manuel; Schulz, Wolfgang A.; Scheller, Juergen; Piekorz, Roland P.; Haeussinger, Dieter; Ahmadian, Mohammad R.			The Role of Embryonic Stem Cell-expressed RAS (ERAS) in the Maintenance of Quiescent Hepatic Stellate Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						embryonic stem cell; hepatic stellate cell (HSC); Hippo pathway; mammalian target of rapamycin (mTOR); phosphatidylinositide 3-kinase (PI 3-kinase); Raf kinase; signal transduction; embryonic stem cell-expressed RAS; embryonic stem cell-expressed RAS, ERAS; embryonic stem cell-expressed RAS, ERAS, AKT	HEPATOCYTE GROWTH-FACTOR; FAT-STORING CELLS; TYROSINE KINASE; EPIGENETIC REGULATION; MEDIATED REGULATION; SIGNALING PATHWAY; MAMMALIAN TARGET; UP-REGULATION; MAP KINASE; COMPLEX 2	Hepatic stellate cells (HSCs) were recently identified as liver-resident mesenchymal stem cells. HSCs are activated after liver injury and involved in pivotal processes, such as liver development, immunoregulation, regeneration, and also fibrogenesis. To date, several studies have reported candidate pathways that regulate the plasticity of HSCs during physiological and pathophysiological processes. Here we analyzed the expression changes and activity of the RAS family GTPases and thereby investigated the signaling networks of quiescent HSCs versus activated HSCs. For the first time, we report that embryonic stem cell-expressed RAS (ERAS) is specifically expressed in quiescent HSCs and down-regulated during HSC activation via promoter DNA methylation. Notably, in quiescent HSCs, the high level of ERAS protein correlates with the activation of AKT, STAT3, mTORC2, and HIPPO signaling pathways and inactivation of FOXO1 and YAP. Our data strongly indicate that in quiescent HSCs, ERAS targets AKT via two distinct pathways driven by PI3K alpha/delta and mTORC2, whereas in activated HSCs, RAS signaling shifts to RAF-MEK-ERK. Thus, in contrast to the reported role of ERAS in tumor cells associated with cell proliferation, our findings indicate that ERAS is important to maintain quiescence in HSCs.	[Nakhaei-Rad, Saeideh; Nakhaeizadeh, Hossein; Franke, Manuel; Scheller, Juergen; Piekorz, Roland P.; Ahmadian, Mohammad R.] Univ Dusseldorf, Fak Med, Inst Biochem & Mol Biol 2, Univ Str 1,Gebaude 22-03, D-40225 Dusseldorf, Germany; [Goetze, Silke; Kordes, Claus; Sawitza, Iris; Haeussinger, Dieter] Univ Dusseldorf, Fac Med, Clin Gastroenterol Hepatol & Infect Dis, Univ Str 1,Gebaude 22-03, D-40225 Dusseldorf, Germany; [Hoffmann, Michele J.; Schulz, Wolfgang A.] Univ Dusseldorf, Fac Med, Dept Urol, Univ Str 1,Gebaude 22-03, D-40225 Dusseldorf, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf	Ahmadian, MR (corresponding author), Univ Dusseldorf, Fak Med, Inst Biochem & Mol Biol 2, Univ Str 1,Gebaude 22-03, D-40225 Dusseldorf, Germany.	reza.ahmadian@uni-duesseldorf.de	Scheller, Jürgen/K-5290-2015; Hoffmann, Michele J./AAL-1028-2020; Nakhaeirad, Saeideh/AAV-1771-2020; Kordes, Claus/AFM-1775-2022; Schulz, Wolfgang/N-3402-2019	Nakhaeirad, Saeideh/0000-0001-8966-8960; Kordes, Claus/0000-0003-0782-1998; Schulz, Wolfgang/0000-0002-2196-463X	Deutsche Forschungsgemeinschaft through Collaborative Research Center "Communication and System Relevance during Liver Injury and Regeneration" [974, SFB 974]	Deutsche Forschungsgemeinschaft through Collaborative Research Center "Communication and System Relevance during Liver Injury and Regeneration"	This work was supported by the Deutsche Forschungsgemeinschaft through Collaborative Research Center 974 (SFB 974), "Communication and System Relevance during Liver Injury and Regeneration." The authors declare that they have no conflicts of interest with the contents of this article.	Ahmadian MR, 1997, BIOCHEMISTRY-US, V36, P4535, DOI 10.1021/bi962556y; Ahmadian MR, 1997, NAT STRUCT BIOL, V4, P686, DOI 10.1038/nsb0997-686; Aoyama M, 2010, INT J ONCOL, V37, P1011, DOI 10.3892/ijo_00000752; Avruch J, 2011, BRIT J CANCER, V104, P24, DOI 10.1038/sj.bjc.6606011; Baier R, 1999, CELL GROWTH DIFFER, V10, P447; Bitencourt S, 2014, CELL BIOCHEM BIOPHYS, V68, P387, DOI 10.1007/s12013-013-9719-0; Boccaccio C, 1998, NATURE, V391, P285, DOI 10.1038/34657; Camargo FD, 2007, CURR BIOL, V17, P2054, DOI 10.1016/j.cub.2007.10.039; Carloni V, 2002, HEPATOLOGY, V36, P582, DOI 10.1053/jhep.2002.35277; Chiang GG, 2005, J BIOL CHEM, V280, P25485, DOI 10.1074/jbc.M501707200; Chiang Jonathan, 2012, Cells, V1, P886, DOI 10.3390/cells1040886; Coll M, 2015, SCI REP-UK, V5, DOI 10.1038/srep11549; de Souza ICC, 2015, J CELL BIOCHEM, V116, P2304, DOI 10.1002/jcb.25181; De Minicis S, 2007, GASTROENTEROLOGY, V132, P1937, DOI 10.1053/j.gastro.2007.02.033; Dong S, 2015, CLIN LAB, V61, P537, DOI 10.7754/Clin.Lab.2014.141127; Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007; Fritsch R, 2013, CELL, V154, P940, DOI 10.1016/j.cell.2013.07.045; Fritsch R, 2013, CELL, V153, P1050, DOI 10.1016/j.cell.2013.04.031; Fukunaga R, 1997, EMBO J, V16, P1921, DOI 10.1093/emboj/16.8.1921; Gotze S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128745; Gremer L, 2011, HUM MUTAT, V32, P33, DOI 10.1002/humu.21377; Gu XD, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/389807; He JY, 2015, FEBS LETT, V589, P1359, DOI 10.1016/j.febslet.2015.04.010; HENDRIKS HFJ, 1985, EXP CELL RES, V160, P138, DOI 10.1016/0014-4827(85)90243-5; Hennig A, 2015, BIOL CHEM, V396, P831, DOI 10.1515/hsz-2014-0257; Huang JX, 2009, CANCER RES, V69, P6107, DOI 10.1158/0008-5472.CAN-09-0975; Huang KZ, 2014, SEMIN CELL DEV BIOL, V36, P79, DOI 10.1016/j.semcdb.2014.09.011; Hung W, 2001, J BIOL CHEM, V276, P12395, DOI 10.1074/jbc.M010715200; Iwamoto H, 2000, J LAB CLIN MED, V135, P406, DOI 10.1067/mlc.2000.105974; Jiang F, 2006, J HEPATOL, V45, P401, DOI 10.1016/j.jhep.2006.03.016; Kaizaki R, 2009, ANTICANCER RES, V29, P2189; Kang QH, 2009, ENDOCRINOLOGY, V150, P5384, DOI 10.1210/en.2009-0517; Karnoub AE, 2008, NAT REV MOL CELL BIO, V9, P517, DOI 10.1038/nrm2438; Khadem F, 2016, HEPATOLOGY, V63, P620, DOI 10.1002/hep.28130; Kim JB, 1998, P NATL ACAD SCI USA, V95, P4333, DOI 10.1073/pnas.95.8.4333; Kim JB, 1996, GENE DEV, V10, P1096, DOI 10.1101/gad.10.9.1096; Kinbara K, 2003, NAT REV MOL CELL BIO, V4, P767, DOI 10.1038/nrm1229; Kok K, 2009, TRENDS BIOCHEM SCI, V34, P115, DOI 10.1016/j.tibs.2009.01.003; Kordes C, 2008, BIOCHEM BIOPH RES CO, V367, P116, DOI 10.1016/j.bbrc.2007.12.085; Kordes C, 2007, BIOCHEM BIOPH RES CO, V352, P410, DOI 10.1016/j.bbrc.2006.11.029; Kordes C, 2014, J CLIN INVEST, V124, P5503, DOI 10.1172/JCI74119; Kordes C, 2013, J CLIN INVEST, V123, P1874, DOI 10.1172/JCI66027; Kordes C, 2013, CELL PHYSIOL BIOCHEM, V31, P290, DOI 10.1159/000343368; Kwon YW, 2015, STEM CELL RES, V15, P481, DOI 10.1016/j.scr.2015.09.004; Lakner AM, 2010, WORLD J GASTROENTERO, V16, P5047, DOI 10.3748/wjg.v16.i40.5047; Leakey TI, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn210; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Liu PD, 2014, PROTEIN CELL, V5, P171, DOI 10.1007/s13238-014-0021-8; Lu L, 2010, P NATL ACAD SCI USA, V107, P1437, DOI 10.1073/pnas.0911427107; MAHER JJ, 1993, J CLIN INVEST, V91, P2244, DOI 10.1172/JCI116451; Mannaerts I, 2015, J HEPATOL, V63, P679, DOI 10.1016/j.jhep.2015.04.011; Mason JM, 2006, TRENDS CELL BIOL, V16, P45, DOI 10.1016/j.tcb.2005.11.004; Max X, 2008, CELL, V133, P303, DOI 10.1016/j.cell.2008.02.031; Nakagawa K, 2013, BBA-MOL CELL RES, V1833, P2988, DOI 10.1016/j.bbamcr.2013.08.004; Nakamura K, 2008, ONCOGENE, V27, P2961, DOI 10.1038/sj.onc.1210956; Nakhaei-Rad S, 2015, J BIOL CHEM, V290, P15892, DOI 10.1074/jbc.M115.640607; Ni LS, 2013, STRUCTURE, V21, P1757, DOI 10.1016/j.str.2013.07.008; Oh HM, 2011, J BIOL CHEM, V286, P30888, DOI 10.1074/jbc.M111.253500; Oh WJ, 2011, CELL CYCLE, V10, P2305, DOI 10.4161/cc.10.14.16586; Paganini S, 2006, BIOCHIMIE, V88, P285, DOI 10.1016/j.biochi.2005.08.007; Parola M, 1998, J CLIN INVEST, V102, P1942, DOI 10.1172/JCI1413; Pereira A, 2013, PROG NEURO-PSYCHOPH, V40, P353, DOI 10.1016/j.pnpbp.2012.10.025; Porstmann T, 2008, CELL METAB, V8, P224, DOI 10.1016/j.cmet.2008.07.007; Prasad SB, 2015, CELL ONCOL, V38, P215, DOI 10.1007/s13402-015-0224-x; Ramos A, 2012, TRENDS CELL BIOL, V22, P339, DOI 10.1016/j.tcb.2012.04.006; Rawat SJ, 2015, TRENDS BIOCHEM SCI, V40, P149, DOI 10.1016/j.tibs.2015.01.001; Reimann T, 1997, FEBS LETT, V403, P57, DOI 10.1016/S0014-5793(97)00024-0; Rodriguez-Viciana P, 2006, MOL CELL, V22, P217, DOI 10.1016/j.molcel.2006.03.027; Rothbauer U, 2008, MOL CELL PROTEOMICS, V7, P282, DOI 10.1074/mcp.M700342-MCP200; Saile B, 2001, EUR J CELL BIOL, V80, P554, DOI 10.1078/0171-9335-00182; Sandri C, 2012, CELL RES, V22, P1479, DOI 10.1038/cr.2012.110; Saxena NK, 2004, FASEB J, V18, P1612, DOI 10.1096/fj.04-1847fje; Scheel H, 2003, CURR BIOL, V13, pR899, DOI 10.1016/j.cub.2003.11.007; SCHIRMACHER P, 1992, HEPATOLOGY, V15, P5, DOI 10.1002/hep.1840150103; Schroder WA, 2007, CELL SIGNAL, V19, P1279, DOI 10.1016/j.cellsig.2007.01.013; Soliman EM, 2009, CELL CALCIUM, V45, P284, DOI 10.1016/j.ceca.2008.11.006; Stuhlmann-Laeisz C, 2006, MOL BIOL CELL, V17, P2986, DOI 10.1091/mbc.E05-12-1129; Taha MS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091465; Takahashi K, 2003, NATURE, V423, P541, DOI 10.1038/nature01646; Tidyman WE, 2009, CURR OPIN GENET DEV, V19, P230, DOI 10.1016/j.gde.2009.04.001; Tomiya T, 2007, BIOCHEM BIOPH RES CO, V358, P176, DOI 10.1016/j.bbrc.2007.04.093; TORTI M, 1994, THROMB HAEMOSTASIS, V71, P533; Tzivion G, 2011, BBA-MOL CELL RES, V1813, P1938, DOI 10.1016/j.bbamcr.2011.06.002; van der Weyden L, 2007, BBA-REV CANCER, V1776, P58, DOI 10.1016/j.bbcan.2007.06.003; Vanhaesebroeck B, 2005, TRENDS BIOCHEM SCI, V30, P194, DOI 10.1016/j.tibs.2005.02.008; Vavvas D, 1998, J BIOL CHEM, V273, P5439, DOI 10.1074/jbc.273.10.5439; Wang RC, 2012, SCIENCE, V338, P956, DOI 10.1126/science.1225967; Wang X, 2002, MOL CELL, V9, P411, DOI 10.1016/S1097-2765(02)00439-2; Wang Y, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/925350; Wu JX, 2015, CELL SIGNAL, V27, P1198, DOI 10.1016/j.cellsig.2015.02.026; Xie GH, 2013, HEPATOLOGY, V58, P1801, DOI 10.1002/hep.26511; Yang L, 2008, STEM CELLS, V26, P2104, DOI 10.1634/stemcells.2008-0115; Yashiro M, 2009, INT J ONCOL, V35, P997, DOI 10.3892/ijo_00000414; Yasuda K, 2007, ANTICANCER RES, V27, P4071; Yimlamai D, 2014, CELL, V157, P1324, DOI 10.1016/j.cell.2014.03.060; Yin CY, 2013, J CLIN INVEST, V123, P1902, DOI 10.1172/JCI66369; Yu Y, 2014, STEM CELLS, V32, P349, DOI 10.1002/stem.1447	97	24	24	2	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2016	291	16					8399	8413		10.1074/jbc.M115.700088	http://dx.doi.org/10.1074/jbc.M115.700088			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK2VT	26884329	Green Published, hybrid			2022-12-26	WOS:000374773200008
J	Park, SE; Park, CY; Choi, JM; Chang, E; Rhee, EJ; Lee, WY; Oh, KW; Park, SW; Kang, ES; Lee, HC; Cha, BS				Park, Se Eun; Park, Cheol-Young; Choi, Jung Mook; Chang, Eugene; Rhee, Eun-Jung; Lee, Won-Young; Oh, Ki Won; Park, Sung Woo; Kang, Eun Seok; Lee, Hyun Chul; Cha, Bong Soo			Depot-Specific Changes in Fat Metabolism with Aging in a Type 2 Diabetic Animal Model	PLOS ONE			English	Article							INSULIN-RECEPTOR SUBSTRATE-1; ADIPOSE-TISSUE; BODY-COMPOSITION; GENE-EXPRESSION; GLUCOSE-UPTAKE; ELDERLY-MEN; ZUCKER RATS; ACID UPTAKE; MECHANISMS; THIAZOLIDINEDIONES	Visceral fat accretion is a hallmark of aging and is associated with aging-induced metabolic dysfunction. PPAR gamma agonist was reported to improve insulin sensitivity by redistributing fat from visceral fat to subcutaneous fat. The purpose of this study was to investigate the underlying mechanisms by which aging affects adipose tissue remodeling in a type 2 diabetic animal model and through which PPAR gamma activation modulates aging-related fat tissue distribution. At the ages of 21, 31 and 43 weeks, OLETF rats as an animal model of type 2 diabetes were evaluated for aging-related effects on adipose tissue metabolism in subcutaneous and visceral fat depots. During aging, the ratio of visceral fat weight to subcutaneous fat weight (V/S ratio) increased. Aging significantly increased the mRNA expression of genes involved in lipogenesis such as lipoprotein lipase, fatty acid binding protein aP2, lipin 1, and diacylglycerol acyltransferase 1, which were more prominent in visceral fat than subcutaneous fat. The mRNA expression of adipose triglyceride lipase, which is involved in basal lipolysis and fatty acid recycling, was also increased, more in visceral fat compared to subcutaneous fat during aging. The mRNA levels of the genes associated with lipid oxidation were increased, whereas the mRNA levels of genes associated with energy expenditure showed no significant change during aging. PPAR gamma agonist treatment in OLETF rats resulted in fat redistribution with a decreasing V/S ratio and improved glucose intolerance. The genes involved in lipogenesis decreased in visceral fat of the PPAR gamma agonist-treated rats. During aging, fat distribution was changed by stimulating lipid uptake and esterification in visceral fat rather than subcutaneous fat, and by altering the lipid oxidation.	[Park, Se Eun; Park, Cheol-Young; Rhee, Eun-Jung; Lee, Won-Young; Oh, Ki Won; Park, Sung Woo] Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Div Endocrinol & Metab,Dept Internal Med, Seoul, South Korea; [Choi, Jung Mook; Chang, Eugene] Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Diabet Res Inst, Seoul, South Korea; [Kang, Eun Seok; Lee, Hyun Chul; Cha, Bong Soo] Yonsei Univ, Coll Med, Dept Internal Med, Div Endocrinol & Metab, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Yonsei University; Yonsei University Health System	Park, CY (corresponding author), Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Div Endocrinol & Metab,Dept Internal Med, Seoul, South Korea.; Cha, BS (corresponding author), Yonsei Univ, Coll Med, Dept Internal Med, Div Endocrinol & Metab, Seoul, South Korea.	cydoctor@chol.com; bscha@yuhs.ac	Rhee, Eun-Jung/M-9294-2015; LEE, WON-YOUNG/C-7249-2018	Rhee, Eun-Jung/0000-0002-6108-7758; LEE, WON-YOUNG/0000-0002-1082-7592; Kang, Eun Seok/0000-0002-0364-4675; Cha, Bong-Soo/0000-0003-0542-2854	Samsung Biomedical Research Institute grant [SMR1130311, SMX1132381]; Medical Research Funds from Kangbuk Samsung Hospital; Korean Diabetes Association	Samsung Biomedical Research Institute grant(Samsung); Medical Research Funds from Kangbuk Samsung Hospital(Samsung); Korean Diabetes Association	This work was supported by Samsung Biomedical Research Institute grant (SMR1130311, SMX1132381, CYP), Medical Research Funds from Kangbuk Samsung Hospital, and the grant (P.S.E., 2009) from the Korean Diabetes Association.	Bays Harold E, 2008, Expert Rev Cardiovasc Ther, V6, P343, DOI 10.1586/14779072.6.3.343; Berger J, 2002, ANNU REV MED, V53, P409, DOI 10.1146/annurev.med.53.082901.104018; Boden G, 2005, DIABETES, V54, P880, DOI 10.2337/diabetes.54.3.880; Cadoudal T, 2008, DIABETES, V57, P2272, DOI 10.2337/db08-0477; Cartwright MJ, 2007, EXP GERONTOL, V42, P463, DOI 10.1016/j.exger.2007.03.003; Chen HC, 2002, DIABETES, V51, P3189, DOI 10.2337/diabetes.51.11.3189; Coort SLM, 2005, J LIPID RES, V46, P1295, DOI 10.1194/jlr.M400426-JLR200; DeNino WF, 2001, DIABETES CARE, V24, P925, DOI 10.2337/diacare.24.5.925; Festuccia WT, 2006, DIABETOLOGIA, V49, P2427, DOI 10.1007/s00125-006-0336-y; Festuccia WT, 2009, J LIPID RES, V50, P1185, DOI 10.1194/jlr.M800620-JLR200; Goodpaster BH, 2003, DIABETES CARE, V26, P372, DOI 10.2337/diacare.26.2.372; Goodpaster BH, 2005, ARCH INTERN MED, V165, P777, DOI 10.1001/archinte.165.7.777; Guo SS, 1999, AM J CLIN NUTR, V70, P405; Harris RBS, 1998, ENDOCRINOLOGY, V139, P8, DOI 10.1210/en.139.1.8; Herrero-Gonzalez S, 2009, GLIA, V57, P222, DOI 10.1002/glia.20748; Holness MJ, 2003, BIOCHEM SOC T, V31, P1143; Hughes VA, 2004, AM J CLIN NUTR, V80, P475, DOI 10.1093/ajcn/80.2.475; Kalderon B, 2003, AM J PHYSIOL-ENDOC M, V284, pE795, DOI 10.1152/ajpendo.00368.2002; Kanety H, 1996, J BIOL CHEM, V271, P9895, DOI 10.1074/jbc.271.17.9895; Lam TKT, 2003, AM J PHYSIOL-ENDOC M, V284, pE863, DOI 10.1152/ajpendo.00033.2003; Laplante M, 2003, DIABETES, V52, P291, DOI 10.2337/diabetes.52.2.291; Laplante M, 2006, DIABETES, V55, P2771, DOI 10.2337/db06-0551; Lutz W, 2008, NATURE, V451, P716, DOI 10.1038/nature06516; Lyon CJ, 2003, ENDOCRINOLOGY, V144, P2195, DOI 10.1210/en.2003-0285; Miyazaki Y, 2002, J CLIN ENDOCR METAB, V87, P2784, DOI 10.1210/jc.87.6.2784; Oakes ND, 2001, DIABETES, V50, P1158, DOI 10.2337/diabetes.50.5.1158; Ravaglia G, 1999, J GERONTOL A-BIOL, V54, pM70, DOI 10.1093/gerona/54.2.M70; Reue K, 2008, FEBS LETT, V582, P90, DOI 10.1016/j.febslet.2007.11.014; Shima K, 1999, OBESITY NIDDM LESSON, P4; Smith SR, 2005, METABOLISM, V54, P24, DOI 10.1016/j.metabol.2004.07.008; Tordjman J, 2003, J BIOL CHEM, V278, P18785, DOI 10.1074/jbc.M206999200; Wajchenberg BL, 2000, ENDOCR REV, V21, P697, DOI 10.1210/er.21.6.697; Yu CL, 2002, J BIOL CHEM, V277, P50230, DOI 10.1074/jbc.M200958200; Zamboni M, 1997, AM J CLIN NUTR, V66, P111, DOI 10.1093/ajcn/66.1.111; Zou ZG, 2001, NATURE, V414, P625, DOI 10.1038/414625a	35	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0148141	10.1371/journal.pone.0148141	http://dx.doi.org/10.1371/journal.pone.0148141			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3DG	26894429	Green Published, gold, Green Submitted			2022-12-26	WOS:000371223400010
J	Wang, TT; Li, WH; Wu, XR; Yin, B; Chu, CT; Ding, M; Cui, YF				Wang, Tingting; Li, Wenhua; Wu, Xiangru; Yin, Bing; Chu, Caiting; Ding, Ming; Cui, Yanfen			Tubo-Ovarian Abscess (with/without Pseudotumor Area) Mimicking Ovarian Malignancy: Role of Diffusion-Weighted MR Imaging with Apparent Diffusion Coefficient Values	PLOS ONE			English	Article							PELVIC-INFLAMMATORY-DISEASE; EPITHELIAL TUMORS; BENIGN	Objective To assess the added value of diffusion-weighted magnetic resonance imaging (DWI) with apparent diffusion coefficient (ADC) values compared to MRI, for characterizing the tuboovarian abscesses (TOA) mimicking ovarian malignancy. Materials and Methods Patients with TOA (or ovarian abscess alone; n = 34) or ovarian malignancy (n = 35) who underwent DWI and MRI were retrospectively reviewed. The signal intensity of cystic and solid component of TOAs and ovarian malignant tumors on DWI and the corresponding ADC values were evaluated, as well as clinical characteristics, morphological features, MRI findings were comparatively analyzed. Receiver operating characteristic (ROC) curve analysis based on logistic regression was applied to identify different imaging characteristics between the two patient groups and assess the predictive value of combination diagnosis with area under the curve (AUC) analysis. Results The mean ADC value of the cystic component in TOA was significantly lower than in malignant tumors (1.04 +/- 0.41 x 10(-3) mm(2)/s vs. 2.42 +/- 0.38 x 10(-3) mm(2)/s; p < 0.001). The mean ADC value of the enhanced solid component in 26 TOAs was 1.43 +/- 0.16x10(-3) mm(2)/s, and 46.2% (12 TOAs; pseudotumor areas) showed significantly higher signal intensity on DW-MRI than in ovarian malignancy (mean ADC value 1.44 +/- 0.20x10(-3) mm(2)/s vs. 1.18 +/- 0.36 x 10(-3) mm(2)/s; p = 0.043). The combination diagnosis of ADC value and dilated tubal structure achieved the best AUC of 0.996. Sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and accuracy of MRI vs. DWI with ADC values for predicting TOA were 47.1%, 91.4%, 84.2%, 64%, and 69.6% vs. 100%, 97.1%, 97.1%, 100%, and 98.6%, respectively. Conclusions DW-MRI is superior to MRI in the assessment of TOA mimicking ovarian malignancy, and the ADC values aid in discriminating the pseudotumor area of TOA from the solid portion of ovarian malignancy.	[Wang, Tingting; Li, Wenhua; Yin, Bing; Chu, Caiting; Ding, Ming; Cui, Yanfen] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Radiol, 1665 Kong Jiang Rd, Shanghai 200092, Peoples R China; [Wu, Xiangru] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Pathol, 1665 Kong Jiang Rd, Shanghai 200092, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Li, WH (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Radiol, 1665 Kong Jiang Rd, Shanghai 200092, Peoples R China.	wenhualimd@126.com	wang, tingting/AAK-2640-2020		 [15ZR1427500]		This work was supported by grant number: 15ZR1427500, URL: http://www.stcsm.gov.cn/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chou CP, 2012, CLIN IMAG, V36, P532, DOI 10.1016/j.clinimag.2011.11.018; Goto Y, 2015, INT J SURG CASE REP, V10, P59, DOI 10.1016/j.ijscr.2015.03.012; Harish S, 2011, SKELETAL RADIOL, V40, P285, DOI 10.1007/s00256-010-0986-1; Holzapfel K, 2007, ABDOM IMAGING, V32, P538, DOI 10.1007/s00261-007-9231-3; Kim MY, 2009, RADIOGRAPHICS, V29, P495, DOI 10.1148/rg.292085070; Koc Z, 2012, J MAGN RESON IMAGING, V35, P650, DOI 10.1002/jmri.22871; Lareau SM, 2008, INFECT DIS CLIN N AM, V22, P693, DOI 10.1016/j.idc.2008.05.008; Lee SW, 2015, GYNECOL OBSTET INVES; Li WH, 2013, ABDOM IMAGING, V38, P193, DOI 10.1007/s00261-012-9896-0; Li WH, 2012, ABDOM IMAGING, V37, P897, DOI 10.1007/s00261-011-9814-x; Luthra G, 2007, AM J NEURORADIOL, V28, P1332, DOI 10.3174/ajnr.A0548; Neubauer H, 2012, WORLD J PEDIATR, V8, P229, DOI 10.1007/s12519-012-0362-4; Orton MR, 2015, EUR RADIOL, V8; Rakheja R, 2011, NUCL MED MOLEC IMAG, V45, P223, DOI 10.1007/s13139-011-0089-5; Sepahdari Ali R, 2009, AJR Am J Roentgenol, V193, pW244, DOI 10.2214/AJR.08.1838; Sordia-Hernandez LH, 2015, INT J GYNECOLOGY OBS; Thoeny HC, 2012, RADIOLOGY, V263, P326, DOI 10.1148/radiol.12110446; Thomassin-Naggara I, 2009, EUR RADIOL, V19, P1544, DOI 10.1007/s00330-009-1299-4; Nguyen TLF, 2013, J COMPUT ASSIST TOMO, V37, P971, DOI 10.1097/RCT.0b013e31828bea16; Tukeva TA, 1999, RADIOLOGY, V210, P209, DOI 10.1148/radiology.210.1.r99ja04209; Ueda Hiroyuki, 2002, Magn Reson Med Sci, V1, P207; Umemoto M, 2006, J OBSTET GYNAECOL RE, V32, P195, DOI 10.1111/j.1447-0756.2006.00381.x; Unal O, 2011, EUR J RADIOL, V77, P490, DOI 10.1016/j.ejrad.2009.08.025; Velcani A, 2010, J RADIOL CASE REP, V4, P9, DOI 10.3941/jrcr.v4i2.133; Zhang Y, 2012, J OBSTET GYNAECOL, V32, P199, DOI 10.3109/01443615.2011.621560; Zhao SH, 2014, EUR RADIOL, V24, P2292, DOI 10.1007/s00330-014-3236-4	26	8	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0149318	10.1371/journal.pone.0149318	http://dx.doi.org/10.1371/journal.pone.0149318			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3DG	26894926	Green Published, gold, Green Submitted			2022-12-26	WOS:000371223400047
J	Koh, SJ; Choi, Y; Kim, BG; Lee, KL; Kim, DW; Kim, JH; Kim, JW; Kim, JS				Koh, Seong-Joon; Choi, Younjeong; Kim, Byeong Gwan; Lee, Kook Lae; Kim, Dae Woo; Kim, Jung Ho; Kim, Ji Won; Kim, Joo Sung			Matricellular Protein Periostin Mediates Intestinal Inflammation through the Activation of Nuclear Factor kappa B Signaling	PLOS ONE			English	Article							SONGPA-KANGDONG DISTRICT; BOWEL-DISEASE; DOSE INTENSIFICATION; MAINTENANCE THERAPY; ULCERATIVE-COLITIS; EPITHELIAL-CELLS; CROHNS-DISEASE; INFLIXIMAB; BURDEN; HEALTH	Periostin is a matricellular protein that interacts with various integrin molecules on the cell surface. Although periostin is expressed in inflamed colonic mucosa, its role in the regulation of intestinal inflammation remains unclear. We investigated the role of periostin in intestinal inflammation using Postn-deficient (Postn(-/-)) mice. Intestinal epithelial cells (IECs) were transfected by Postn small interfering RNAs. Periostin expression was determined in colon tissue samples from ulcerative colitis (UC) patients. Oral administration of dextran sulfate sodium (DSS) or rectal administration of trinitrobenzene sulfonic acid, induced severe colitis in wildtype mice, but not in Postn(-/-) mice. Administration of recombinant periostin induced colitis in Postn(-/-) mice. The periostin neutralizing-antibody ameliorated the severity of colitis in DSS-treated wild-type mice. Silencing of Postn inhibited inteleukin (IL)-8 mRNA expression and NF-kappa B DNA-binding activity in IECs. Tumor necrosis factor (TNF)-alpha upregulated mRNA expression of Postn in IECs, and recombinant periostin strongly enhanced IL-8 expression in combination with TNF-alpha, which was suppressed by an antibody against integrin a(v) (CD51). Periostin and CD51 were expressed at significantly higher levels in UC patients than in controls. Periostin mediates intestinal inflammation through the activation of NF-kappa B signaling, which suggests that periostin is a potential therapeutic target for inflammatory bowel disease.	[Koh, Seong-Joon; Choi, Younjeong; Kim, Byeong Gwan; Lee, Kook Lae; Kim, Ji Won] Seoul Natl Univ, Coll Med, Dept Internal Med, Div Gastroenterol,Boramae Hosp, Seoul 151, South Korea; [Kim, Dae Woo] Seoul Natl Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Boramae Hosp, Seoul, South Korea; [Kim, Jung Ho] Seoul Natl Univ, Coll Med, Dept Pathol, Boramae Hosp, Seoul 151, South Korea; [Kim, Joo Sung] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea; [Kim, Joo Sung] Seoul Natl Univ, Coll Med, Liver Res Inst, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU)	Kim, JW (corresponding author), Seoul Natl Univ, Coll Med, Dept Internal Med, Div Gastroenterol,Boramae Hosp, Seoul 151, South Korea.; Kim, JS (corresponding author), Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea.; Kim, JS (corresponding author), Seoul Natl Univ, Coll Med, Liver Res Inst, Seoul, South Korea.	kjwjor@snu.ac.kr; jooskim@snu.ac.kr		Kim, Jung Ho/0000-0002-6031-3629	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2014R1A1A2057695]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education [grant number NRF-2014R1A1A2057695 (S-JK)].	Adams DH, 2006, NAT REV IMMUNOL, V6, P244, DOI 10.1038/nri1784; Bader BL, 1998, CELL, V95, P507, DOI 10.1016/S0092-8674(00)81618-9; Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; Benchimol EI, 2014, GASTROENTEROLOGY, V147, P803, DOI 10.1053/j.gastro.2014.06.023; Bentley JK, 2014, J ALLERGY CLIN IMMUN, V134, P1433, DOI 10.1016/j.jaci.2014.05.029; Bernstein CN, 2015, AM J GASTROENTEROL, V110, P114, DOI 10.1038/ajg.2014.357; Billioud V, 2011, AM J GASTROENTEROL, V106, P674, DOI 10.1038/ajg.2011.60; Blumberg RS, 2008, MUCOSAL IMMUNOL, V1, P330, DOI 10.1038/mi.2008.29; Burisch J, 2013, J CROHNS COLITIS, V7, P322, DOI 10.1016/j.crohns.2013.01.010; Cheon JH, 2006, INFLAMM BOWEL DIS, V12, P1152, DOI 10.1097/01.mib.0000235830.94057.c6; Danese S, 2012, GUT, V61, P918, DOI 10.1136/gutjnl-2011-300904; Di Sabatino A, 2008, GUT, V57, P605, DOI 10.1136/gut.2007.130922; Elliott CG, 2012, J CELL SCI, V125, P121, DOI 10.1242/jcs.087841; Gisbert JP, 2009, AM J GASTROENTEROL, V104, P760, DOI 10.1038/ajg.2008.88; Hamilton DW, 2008, J CELL COMMUN SIGNAL, V2, P9, DOI 10.1007/s12079-008-0023-5; Huang Y, 2014, AM J PATHOL, V3, P786; Jobin C, 2000, AM J PHYSIOL-CELL PH, V278, pC451, DOI 10.1152/ajpcell.2000.278.3.C451; Kikuchi Y, 2008, J HISTOCHEM CYTOCHEM, V56, P753, DOI 10.1369/jhc.2008.951061; Koh SJ, 2014, J GASTROEN HEPATOL, V29, P502, DOI 10.1111/jgh.12435; Koh SJ, 2011, AM J PHYSIOL-GASTR L, V301, pG9, DOI 10.1152/ajpgi.00267.2010; Kudo A, 2011, CELL MOL LIFE SCI, V68, P3201, DOI 10.1007/s00018-011-0784-5; Lacy-Hulbert A, 2007, P NATL ACAD SCI USA, V104, P15823, DOI 10.1073/pnas.0707421104; Lee SH, 2015, INTEST RES, V13, P11, DOI 10.5217/ir.2015.13.1.11; Leiman DA, 2014, CURR OPIN GASTROEN, V30, P385, DOI 10.1097/MOG.0000000000000077; LENNARDJONES JE, 1989, SCAND J GASTROENTERO, V24, P2, DOI 10.3109/00365528909091339; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Lohr K, 2012, INFLAMM BOWEL DIS, V18, P143, DOI 10.1002/ibd.21713; Lu Y, 2014, J CLIN INVEST, V124, P3501, DOI 10.1172/JCI74438; Maloy KJ, 2011, NATURE, V474, P298, DOI 10.1038/nature10208; Masuoka M, 2012, J CLIN INVEST, V122, P2590, DOI 10.1172/JCI58978; Merle B, 2012, OSTEOPOROSIS INT, V23, P1199, DOI 10.1007/s00198-011-1892-7; Peyrin-Biroulet L, 2011, ALIMENT PHARM THER, V33, P870, DOI 10.1111/j.1365-2036.2011.04599.x; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Rios H, 2005, MOL CELL BIOL, V25, P11131, DOI 10.1128/MCB.25.24.11131-11144.2005; Ruan K, 2009, CELL MOL LIFE SCI, V66, P2219, DOI 10.1007/s00018-009-0013-7; Rutgeerts P, 2005, NEW ENGL J MED, V353, P2462, DOI 10.1056/NEJMoa050516; Sands BE, 2004, NEW ENGL J MED, V350, P876, DOI 10.1056/NEJMoa030815; Snider P, 2008, CIRC RES, V102, P752, DOI 10.1161/CIRCRESAHA.107.159517; Travis MA, 2007, NATURE, V449, P361, DOI 10.1038/nature06110; Wirtz S, 2007, NAT PROTOC, V2, P541, DOI 10.1038/nprot.2007.41; Yang SK, 2000, J GASTROEN HEPATOL, V15, P1037, DOI 10.1046/j.1440-1746.2000.02252.x; Yang SK, 2008, INFLAMM BOWEL DIS, V14, P542, DOI 10.1002/ibd.20310	42	30	33	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2016	11	2							e0149652	10.1371/journal.pone.0149652	http://dx.doi.org/10.1371/journal.pone.0149652			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3CO	26890265	gold, Green Published, Green Submitted			2022-12-26	WOS:000371221500068
J	Radford, CA; Ghazali, SM; Montgomery, JC; Jeffs, AG				Radford, Craig A.; Ghazali, Shahriman M.; Montgomery, John C.; Jeffs, Andrew G.			Vocalisation Repertoire of Female Bluefin Gurnard (Chelidonichthys kumu) in Captivity: Sound Structure, Context and Vocal Activity	PLOS ONE			English	Article							TOADFISH HALOBATRACHUS-DIDACTYLUS; ACOUSTIC COMMUNICATION; LUSITANIAN TOADFISH; POLLIMYRUS-ISIDORI; BIOLOGICAL ORIGIN; CYNOSCION-REGALIS; SPAWNING SOUNDS; HAURAKI GULF; GREY GURNARD; NEW-ZEALAND	Fish vocalisation is often a major component of underwater soundscapes. Therefore, interpretation of these soundscapes requires an understanding of the vocalisation characteristics of common soniferous fish species. This study of captive female bluefin gurnard, Chelidonichthys kumu, aims to formally characterise their vocalisation sounds and daily pattern of sound production. Four types of sound were produced and characterised, twice as many as previously reported in this species. These sounds fit two aural categories; grunt and growl, the mean peak frequencies for which ranged between 129 to 215 Hz. This species vocalized throughout the 24 hour period at an average rate of (18.5 +/- 2.0 sounds fish(-1) h(-1)) with an increase in vocalization rate at dawn and dusk. Competitive feeding did not elevate vocalisation as has been found in other gurnard species. Bluefin gurnard are common in coastal waters of New Zealand, Australia and Japan and, given their vocalization rate, are likely to be significant contributors to ambient underwater soundscape in these areas.	[Radford, Craig A.; Ghazali, Shahriman M.; Montgomery, John C.; Jeffs, Andrew G.] Univ Auckland, Leigh Marine Lab, POB 349, Warkworth 0941, New Zealand; [Ghazali, Shahriman M.] Univ Kebangsaan Malaysia, Fac Sci & Technol, Marine Ecosyst Res Ctr EKOMAR, Bangii, Malaysia; [Ghazali, Shahriman M.] Univ Kebangsaan Malaysia, Fac Sci & Technol, Sch Environm Sci & Nat Resources, Bangii, Malaysia	University of Auckland; Universiti Kebangsaan Malaysia; Universiti Kebangsaan Malaysia	Radford, CA (corresponding author), Univ Auckland, Leigh Marine Lab, POB 349, Warkworth 0941, New Zealand.	c.radford@auckland.ac.nz	Jeffs, Andrew G/D-9474-2012; Montgomery, John C/D-4310-2009	Montgomery, John C/0000-0002-7451-3541; Radford, Craig/0000-0001-7949-9497; Jeffs, Andrew/0000-0002-8504-1949	Glenn Family Foundation; Government of Malaysia; Rutherford Discovery Fellowship; UKM	Glenn Family Foundation; Government of Malaysia; Rutherford Discovery Fellowship; UKM	This work was supported by Glenn Family Foundation to AGJ, Government of Malaysia and UKM to SG, and Rutherford Discovery Fellowship to CAR.; The authors are thankful to staff and students at the University of Auckland's Leigh Marine Laboratory for technical assistance, and funding support from the Glenn Family Foundation. The study was made possible by a PhD scholarship to SMG by the Government of Malaysia and UKM. The study was conducted under University of Auckland Animal Ethics Committee approval #AEC727.	Akamatsu T, 2002, J ACOUST SOC AM, V112, P3073, DOI 10.1121/1.1515799; Amorim MCP, 2008, J MAR BIOL ASSOC UK, V88, P1069, DOI 10.1017/S0025315408001677; Amorim MCP, 2008, J FISH BIOL, V73, P1267, DOI 10.1111/j.1095-8649.2008.01974.x; Amorim MCP, 2006, J FISH BIOL, V69, P1892, DOI 10.1111/j.1095-8649.2006.01247.x; Amorim M. Clara P., 2005, Acta Zoologica Sinica, V51, P1013; Amorim MCP, 2015, ANIM SIG COMM, V4, P1, DOI 10.1007/978-3-7091-1846-7_1; Amorim Maria Clara P., 2006, P71; Amorim MCP, 2000, J FISH BIOL, V57, P895, DOI 10.1006/jfbi.2000.1356; Amorim MCP, 2005, ETHOLOGY, V111, P255, DOI 10.1111/j.1439-0310.2004.01061.x; Amorim MCP, 2004, J FISH BIOL, V65, P182, DOI 10.1111/j.0022-1112.2004.00443.x; Bass AH, 2003, PROG NEUROBIOL, V69, P1, DOI 10.1016/S0301-0082(03)00004-2; BAYOUMI A R, 1970, Marine Biology (Berlin), V5, P77, DOI 10.1007/BF00352495; CATO DH, 1980, J ACOUST SOC AM, V68, P1056, DOI 10.1121/1.384989; CLEARWATER SJ, 1994, AUST J MAR FRESH RES, V45, P131; CONNAUGHTON MA, 1995, ENVIRON BIOL FISH, V42, P233, DOI 10.1007/BF00004916; Connaughton MA, 2004, J EXP BIOL, V207, P1643, DOI 10.1242/jeb.00928; CRAWFORD JD, 1986, J COMP PHYSIOL A, V159, P297, DOI 10.1007/BF00603976; Crawford JD, 1997, BEHAVIOUR, V134, P677, DOI 10.1163/156853997X00034; Crawford JD, 1997, MAR FRESHW BEHAV PHY, V29, P65, DOI 10.1080/10236249709379001; Fay R, 2009, INTEGR ZOOL, V4, P26, DOI 10.1111/j.1749-4877.2008.00132.x; Fine ML, 2015, ANIM SIG COMM, V4, P77, DOI 10.1007/978-3-7091-1846-7_3; Hawkins AD, 2000, ENVIRON BIOL FISH, V59, P29, DOI 10.1023/A:1007615517287; Heemstra P.C., 1986, P486; Kaatz Ingrid M., 2002, Bioacoustics, V12, P230; Kasumyan A.O., 2009, J ICHTHYOL, V49, P963, DOI [10.1134/S0032945209110010, DOI 10.1134/S0032945209110010]; Kasumyan A.O., 2008, J ICHTHYOL, V48, P981, DOI [10.1134/S0032945208110039, DOI 10.1134/S0032945208110039]; Kendrick TH, 2002, NEW ZEAL J MAR FRESH, V36, P699, DOI 10.1080/00288330.2002.9517124; Kendrick TH, 2004, 200421 NZ FISH TROPH, P1; Ladich F, 2006, FISH COMMUNICATION, P121; Ladich Friedrich, 2006, P3; Locascio JV, 2008, T AM FISH SOC, V137, P606, DOI 10.1577/T06-069.1; Luczkovich JJ, 2008, T AM FISH SOC, V137, P533, DOI 10.1577/T06-258.1; Maruska KP, 2009, ENVIRON BIOL FISH, V84, P325, DOI 10.1007/s10641-009-9446-y; MOK HK, 1983, B I ZOOL ACAD SINICA, V22, P157; MOULTON JM, 1956, BIOL BULL, V111, P393, DOI 10.2307/1539146; Nordeide JT, 1999, ICES J MAR SCI, V56, P326, DOI 10.1006/jmsc.1999.0473; Olivier D, 2014, FRONTIERS ZOOLOGY, V11, P1; Parmentier E, 2013, J EXP BIOL, V216, P3189, DOI 10.1242/jeb.087205; Radford CA, 2010, MAR ECOL PROG SER, V401, P21, DOI 10.3354/meps08451; Radford CA, 2008, OECOLOGIA, V156, P921, DOI 10.1007/s00442-008-1041-y; Rice AN, 2009, J EXP BIOL, V212, P1377, DOI 10.1242/jeb.028506; Sebastianutto L, 2008, ACTA ETHOL, V11, P115, DOI 10.1007/s10211-008-0048-z; Simoes JM, 2008, J ACOUST SOC AM, V124, P1332, DOI 10.1121/1.2945712; Sirovic A, 2009, ICES J MAR SCI, V66, P981, DOI 10.1093/icesjms/fsp064; Sprague MW, 2001, COPEIA, P854, DOI 10.1643/0045-8511(2001)001[0854:DSCEOM]2.0.CO;2; Thorson RF, 2002, ENVIRON BIOL FISH, V63, P321, DOI 10.1023/A:1014334425821; Ueng JP, 2007, ZOOL STUD, V46, P103	47	5	5	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2016	11	2							e0149338	10.1371/journal.pone.0149338	http://dx.doi.org/10.1371/journal.pone.0149338			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3CO	26890124	Green Published, gold, Green Submitted			2022-12-26	WOS:000371221500037
J	Zhou, Z; Li, XD; Li, H; Guo, MZ; Liu, SG; Li, CG				Zhou, Zheng; Li, Xinde; Li, Hua; Guo, Mingzhen; Liu, Shiguo; Li, Changgui			Genetic Analysis of IL-17 Gene Polymorphisms in Gout in a Male Chinese Han Population	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; INTERLEUKIN-17; ASSOCIATION; TH17; SUSCEPTIBILITY; DISEASE; ASTHMA; SPUTUM; CELLS	Interleukin (IL)-17 is a proinflammatory cytokine mainly secreted by activated T helper 17 cells and involved in inflammatory immune responses. This study aimed to investigate the association between IL-17 variants as well as serum IL-17 levels with gout in male Chinese Han individuals. A total of 1,101 male gout patients and 1,239 ethic-matched controls were enrolled. Genetic distributions of three variants (rs2275913 in IL-17A, rs763780 in IL-17F, and rs4819554 in IL-17RA) were detected by real-time polymerase chain reaction using the Taqman probe method. The plasma concentrations of IL-17A and IL-17F were measured in 228 gout patients and 198 controls that came from above samples by an enzyme-linked immunosorbent assay. No significant differences were observed in the genetic distribution of these polymorphisms between cases and controls (rs2275913: chi(2) = 0.15, p = 0.928 by genotype, chi(2) = 0.14, p = 0.711 by allele; rs763780:. 2 = 2.24, p = 0.326 by genotype,. 2 = 0.26, p = 0.609 by allele; rs4819554:. 2 = 1.79, p = 0.409 by genotype, chi(2) = 1.46, p = 0.227 by allele). Levels of serum IL-17A and IL-17F were significantly decreased in gout patients (both p<0.001). However, no difference was observed in acute gout patients between different genotypic carriers of rs2275913 and rs763780 regarding serum IL-17A and IL-17F levels (p>0.05). Although the genetic variants in IL-17 we studied in this research do not appear to be involved in the development of gout in male Chinese Han individuals, the IL-17 cytokine family may participate in gouty inflammation in an undefined way, which requires further validation.	[Zhou, Zheng; Li, Xinde; Li, Changgui] Qingdao Univ, Affiliated Hosp, Shandong Prov Key Lab Metab Dis, Qingdao 266071, Peoples R China; [Li, Hua] Qingdao Univ, Affiliated Hosp, Dept Rheumatol, Qingdao 266071, Peoples R China; [Guo, Mingzhen; Liu, Shiguo] Qingdao Univ, Affiliated Hosp, Prenatal Diag Ctr, Qingdao 266071, Peoples R China	Qingdao University; Qingdao University; Qingdao University	Liu, SG (corresponding author), Qingdao Univ, Affiliated Hosp, Prenatal Diag Ctr, Qingdao 266071, Peoples R China.	lichanggui@medmail.com.cn			National Science Foundation of China [31371272]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Science Foundation of China (31371272), and the funder played no role in the research.	Bettelli E, 2007, CURR OPIN IMMUNOL, V19, P652, DOI 10.1016/j.coi.2007.07.020; Bullens DMA, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-135; Gaffen SL, 2008, CYTOKINE, V43, P402, DOI 10.1016/j.cyto.2008.07.017; Hayashi R, 2013, CLIN EXP MED, V13, P239, DOI 10.1007/s10238-012-0206-5; Hymowitz SG, 2001, EMBO J, V20, P5332, DOI 10.1093/emboj/20.19.5332; Kageyama Y, 2007, RHEUMATOL INT, V28, P137, DOI 10.1007/s00296-007-0388-4; Kawaguchi M, 2006, J ALLERGY CLIN IMMUN, V117, P795, DOI 10.1016/j.jaci.2005.12.1346; Kingsbury SR, 2011, J INFLAMM RES, V4, P39, DOI 10.2147/JIR.S11330; Landis R C, 2001, Curr Rheumatol Rep, V3, P36, DOI 10.1007/s11926-001-0049-7; Liu S, 2013, SCAND J RHEUMATOL, V42, P150, DOI 10.3109/03009742.2012.726372; Liu SG, 2015, MOD RHEUMATOL, V25, P449, DOI 10.3109/14397595.2014.964823; Malawista SE, 2011, FASEB J, V25, P4073, DOI 10.1096/fj.11-1201ufm; Miao ZM, 2008, J RHEUMATOL, V35, P1859; Mills KHG, 2013, J LEUKOCYTE BIOL, V93, P489, DOI 10.1189/jlb.1012543; Moseley TA, 2003, CYTOKINE GROWTH F R, V14, P155, DOI 10.1016/S1359-6101(03)00002-9; Mylona EE, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3898; Najafi S, 2014, J ASSIST REPROD GEN, V31, P1491, DOI 10.1007/s10815-014-0294-0; Nordang GBN, 2009, RHEUMATOLOGY, V48, P367, DOI 10.1093/rheumatology/ken512; Popa-Nita O, 2010, IMMUNOL CELL BIOL, V88, P32, DOI 10.1038/icb.2009.98; Shen L, 2015, GENE, V566, P18, DOI 10.1016/j.gene.2015.04.028; Shu QM, 2010, HUM IMMUNOL, V71, P988, DOI 10.1016/j.humimm.2010.06.020; Sun YC, 2005, CHINESE MED J-PEKING, V118, P953; Tesmer LA, 2008, IMMUNOL REV, V223, P87, DOI 10.1111/j.1600-065X.2008.00628.x; Toy D, 2006, J IMMUNOL, V177, P36, DOI 10.4049/jimmunol.177.1.36; Vanltallie TB, 2010, METABOLISM, V59, pS32, DOI 10.1016/j.metabol.2010.07.009; WALLACE SL, 1977, ARTHRITIS RHEUM, V20, P895, DOI 10.1002/art.1780200320; Wang SX, 2014, J NEUROL SCI, V342, P133, DOI 10.1016/j.jns.2014.05.004; Zhang W, 2006, ANN RHEUM DIS, V65, P1301, DOI 10.1136/ard.2006.055251; Zhang Y, 2015, APMIS, V123, P659, DOI 10.1111/apm.12399; Zhu YY, 2011, ARTHRITIS RHEUM-US, V63, P3136, DOI 10.1002/art.30520	30	7	7	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2016	11	2							e0148082	10.1371/journal.pone.0148082	http://dx.doi.org/10.1371/journal.pone.0148082			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3CO	26890073	gold, Green Published, Green Submitted			2022-12-26	WOS:000371221500007
J	Altemimi, A; Watson, DG; Choudhary, R; Dasari, MR; Lightfoot, DA				Altemimi, Ammar; Watson, Dennis G.; Choudhary, Ruplal; Dasari, Mallika R.; Lightfoot, David A.			Ultrasound Assisted Extraction of Phenolic Compounds from Peaches and Pumpkins	PLOS ONE			English	Article							ANTIOXIDANT ACTIVITY; OPTIMIZATION; L.; FLAVONOIDS; POLYSACCHARIDES; CAROTENOIDS; CAPACITIES; CULTIVARS	The ultrasound-assisted extraction (UAE) method was used to optimize the extraction of phenolic compounds from pumpkins and peaches. The response surface methodology (RSM) was used to study the effects of three independent variables each with three treatments. They included extraction temperatures (30, 40 and 50 degrees C), ultrasonic power levels (30, 50 and 70%) and extraction times (10, 20 and 30min). The optimal conditions for extractions of total phenolics from pumpkins were inferred to be a temperature of 41.45 degrees C, a power of 44.60% and a time of 25.67min. However, an extraction temperature of 40.99 degrees C, power of 56.01% and time of 25.71min was optimal for recovery of free radical scavenging activity (measured by 1, 1-diphenyl-2-picrylhydrazyl (DPPH) reduction). The optimal conditions for peach extracts were an extraction temperature of 41.53 degrees C, power of 43.99% and time of 27.86 min for total phenolics. However, an extraction temperature of 41.60 degrees C, power of 44.88% and time of 27.49 min was optimal for free radical scavenging activity (judged by from DPPH reduction). Further, the UAE processes were significantly better than solvent extractions without ultrasound. By electron microscopy it was concluded that ultrasonic processing caused damage in cells for all treated samples (pumpkin, peach). However, the FTIR spectra did not show any significant changes in chemical structures caused by either ultrasonic processing or solvent extraction.	[Altemimi, Ammar; Watson, Dennis G.; Choudhary, Ruplal; Lightfoot, David A.] So Illinois Univ, Dept Plant Soil & Agr Syst, Carbondale, IL 62901 USA; [Altemimi, Ammar] Univ Basrah, Coll Agr, Dept Food Sci & Biotechnol, Basrah, Basrah Province, Iraq; [Dasari, Mallika R.] So Illinois Univ, Dept Chem & Biochem, Carbondale, IL 62901 USA	Southern Illinois University System; Southern Illinois University; University of Basrah; Southern Illinois University System; Southern Illinois University	Lightfoot, DA (corresponding author), So Illinois Univ, Dept Plant Soil & Agr Syst, Carbondale, IL 62901 USA.	ga4082@siu.edu	Altemimi, B./D-7342-2017	Altemimi, B./0000-0001-7750-5988; Lightfoot, David/0000-0002-5725-4381	Government of Iraq; Higher Committee for Education Development in Iraq (HCED)	Government of Iraq; Higher Committee for Education Development in Iraq (HCED)	This work was funded by Government of Iraq to AA.; The authors like to thank the Higher Committee for Education Development in Iraq (HCED) for the financial support to achieve this work. Also, the authors are thankful to Dr. Alan Walters for providing pumpkin and peach samples. We also are grateful to Dr. Rebecca Atkinson and Dr. John Haddock for providing some of the equipment and facilities used in this study. The OECD is thanked for a 2012 Visiting Fellow Award to DAL to visit CRAG at UAB, Catalunia, Spain.	Altemimi A, 2015, MOLECULES, V20, P6611, DOI 10.3390/molecules20046611; Altemimi A, 2015, CHEM CENT J, V9, DOI 10.1186/s13065-015-0113-4; Altemimi A, 2015, ULTRASON SONOCHEM, V24, P247, DOI 10.1016/j.ultsonch.2014.10.023; Atrooz Omar M, 2009, Pak J Biol Sci, V12, P1063, DOI 10.3923/pjbs.2009.1063.1068; Ben-Amotz A, 1998, FOOD CHEM, V62, P515, DOI 10.1016/S0308-8146(97)00196-9; Braca A, 2002, J ETHNOPHARMACOL, V79, P379, DOI 10.1016/S0378-8741(01)00413-5; CHANG SS, 1977, J FOOD SCI, V42, P1102, DOI 10.1111/j.1365-2621.1977.tb12676.x; Chemat F, 2011, ULTRASON SONOCHEM, V18, P813, DOI 10.1016/j.ultsonch.2010.11.023; Dong JN, 2010, ULTRASON SONOCHEM, V17, P61, DOI 10.1016/j.ultsonch.2009.05.006; El-Shemy HA, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/801501; Escribano-Bailon MT, 2002, METHODS IN POLYPHENOL ANALYSIS, P1; Firuzi O, 2011, CURR MED CHEM, V18, P3871, DOI 10.2174/092986711803414368; Ghasemzadeh A, 2015, MOLECULES, V20, P10822, DOI 10.3390/molecules200610822; Gil MI, 2002, J AGR FOOD CHEM, V50, P4976, DOI 10.1021/jf020136b; Hossain MB, 2012, ULTRASON SONOCHEM, V19, P582, DOI 10.1016/j.ultsonch.2011.11.001; Jerman T, 2010, FOOD CHEM, V123, P175, DOI 10.1016/j.foodchem.2010.04.006; Kikuchi T., 2011, Journal of Physics: Conference Series, V279, DOI 10.1088/1742-6596/279/1/012012; Kurz C, 2008, FOOD CHEM, V106, P421, DOI 10.1016/j.foodchem.2007.05.078; Liu BG, 2013, TROP J PHARM RES, V12, P1045, DOI 10.4314/tjpr.v12i6.27; Ma YQ, 2008, J AGR FOOD CHEM, V56, P5682, DOI 10.1021/jf072474o; Muniz-Marquez DB, 2013, ULTRASON SONOCHEM, V20, P1149, DOI 10.1016/j.ultsonch.2013.02.008; Murkovic M, 2002, J FOOD COMPOS ANAL, V15, P633, DOI 10.1006/jfca.2002.1052; Nassr-Allah AA, 2009, J MED PLANTS RES, V3, P799; Ozsoy N, 2008, FOOD CHEM, V110, P571, DOI 10.1016/j.foodchem.2008.02.037; Pan GY, 2012, ULTRASON SONOCHEM, V19, P486, DOI 10.1016/j.ultsonch.2011.11.006; Prasad KN, 2011, FOOD CHEM, V128, P1121, DOI 10.1016/j.foodchem.2011.03.105; Qu CL, 2013, CHEM CENT J, V7, DOI 10.1186/1752-153X-7-160; Raso J, 1999, ULTRASON SONOCHEM, V5, P157, DOI 10.1016/S1350-4177(98)00042-X; Singleton VL., 1965, AM J ENOL VITICULT, V16, P144, DOI DOI 10.12691/IJEBB-2-1-5; Song W, 2010, J AGR FOOD CHEM, V58, P6621, DOI 10.1021/jf9035832; Toma M, 2001, ULTRASON SONOCHEM, V8, P137, DOI 10.1016/S1350-4177(00)00033-X; Versari A, 2002, FOOD CHEM, V76, P181, DOI 10.1016/S0308-8146(01)00261-8; Vilkhu K, 2008, INNOV FOOD SCI EMERG, V9, P161, DOI 10.1016/j.ifset.2007.04.014; Wu JY, 2001, ULTRASON SONOCHEM, V8, P347, DOI 10.1016/S1350-4177(01)00066-9; Xanthopoulou MN, 2009, FOOD RES INT, V42, P641, DOI 10.1016/j.foodres.2009.02.003; Yang ZD, 2010, INNOV FOOD SCI EMERG, V11, P470, DOI 10.1016/j.ifset.2010.03.003; Zahin M., 2009, INT J PHARM PHARM SC, V1, P88, DOI DOI 10.1371/J0URNAL.P0NE.0028499; Zhong K, 2010, INT J BIOL MACROMOL, V47, P356, DOI 10.1016/j.ijbiomac.2010.05.022	38	85	87	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0148758	10.1371/journal.pone.0148758	http://dx.doi.org/10.1371/journal.pone.0148758			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26885655	Green Published, Green Submitted, gold			2022-12-26	WOS:000371218400048
J	Twarog, NR; Low, JA; Currier, DG; Miller, G; Chen, TS; Shelat, AA				Twarog, Nathaniel R.; Low, Jonathan A.; Currier, Duane G.; Miller, Greg; Chen, Taosheng; Shelat, Anang A.			Robust Classification of Small-Molecule Mechanism of Action Using a Minimalist High-Content Microscopy Screen and Multidimensional Phenotypic Trajectory Analysis	PLOS ONE			English	Article							INHIBITOR; POTENT	Phenotypic screening through high-content automated microscopy is a powerful tool for evaluating the mechanism of action of candidate therapeutics. Despite more than a decade of development, however, high content assays have yielded mixed results, identifying robust phenotypes in only a small subset of compound classes. This has led to a combinatorial explosion of assay techniques, analyzing cellular phenotypes across dozens of assays with hundreds of measurements. Here, using a minimalist three-stain assay and only 23 basic cellular measurements, we developed an analytical approach that leverages informative dimensions extracted by linear discriminant analysis to evaluate similarity between the phenotypic trajectories of different compounds in response to a range of doses. This method enabled us to visualize biologically-interpretable phenotypic tracks populated by compounds of similar mechanism of action, cluster compounds according to phenotypic similarity, and classify novel compounds by comparing them to phenotypically active exemplars. Hierarchical clustering applied to 154 compounds from over a dozen different mechanistic classes demonstrated tight agreement with published compound mechanism classification. Using 11 phenotypically active mechanism classes, classification was performed on all 154 compounds: 78% were correctly identified as belonging to one of the 11 exemplar classes or to a different unspecified class, with accuracy increasing to 89% when less phenotypically active compounds were excluded. Importantly, several apparent clustering and classification failures, including rigosertib and 5-fluoro-2'-deoxycytidine, instead revealed more complex mechanisms or off-target effects verified by more recent publications. These results show that a simple, easily replicated, minimalist high-content assay can reveal subtle variations in the cellular phenotype induced by compounds and can correctly predict mechanism of action, as long as the appropriate analytical tools are used.	[Twarog, Nathaniel R.; Low, Jonathan A.; Currier, Duane G.; Miller, Greg; Chen, Taosheng; Shelat, Anang A.] St Jude Childrens Res Hosp, Dept Chem Biol & Therapeut, 332 N Lauderdale St, Memphis, TN 38105 USA	St Jude Children's Research Hospital	Shelat, AA (corresponding author), St Jude Childrens Res Hosp, Dept Chem Biol & Therapeut, 332 N Lauderdale St, Memphis, TN 38105 USA.	anang.shelat@stjude.org	Shelat, Anang/J-4995-2013; Chen, Taosheng/I-6351-2013	Shelat, Anang/0000-0002-6266-2910; Chen, Taosheng/0000-0001-6420-3809; Currier, Duane/0000-0002-0123-0233	American Lebanese Syrian Associated Charities (ALSAC)	American Lebanese Syrian Associated Charities (ALSAC)(American Lebanese Syrian Associated Charities (ALSAC))	American Lebanese Syrian Associated Charities (ALSAC, www.stjude.org) provides funds to St. Jude faculty to conduct research. There is no grant number. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham Y, 2014, J BIOMOL SCREEN, V19, P628, DOI 10.1177/1087057114524987; Beumer JH, 2006, CLIN CANCER RES, V12, P7483, DOI 10.1158/1078-0432.CCR-06-1250; Caie PD, 2010, MOL CANCER THER, V9, P1913, DOI 10.1158/1535-7163.MCT-09-1148; Cavalcante LD, 2014, EUR J PHARMACOL, V741, P8, DOI [10.1010/j.ejphar.2014.07.041, 10.1016/j.ejphar.2014.07.041]; Drexler HCA, 1997, P NATL ACAD SCI USA, V94, P855, DOI 10.1073/pnas.94.3.855; Feng Y, 2009, NAT REV DRUG DISCOV, V8, P567, DOI 10.1038/nrd2876; Freeley M, 2010, J BIOMOL SCREEN, V15, P541, DOI 10.1177/1087057110369703; Grinstein E, 2002, ONCOGENE, V21, P1485, DOI 10.1038/sj.onc.1205211; Gumireddy K, 2005, CANCER CELL, V7, P275, DOI 10.1016/j.ccr.2005.02.009; KAYSEN J, 1986, CANCER RES, V46, P4534; Loo LH, 2007, NAT METHODS, V4, P445, DOI 10.1038/NMETH1032; Lu TG, 2015, MOL PHARMACOL, V87, P18, DOI 10.1124/mol.114.093245; Newman E. M., 2002, P AN M AM SOC CLIN, V21, p108a; Perlman ZE, 2004, SCIENCE, V306, P1194, DOI 10.1126/science.1100709; RAO CR, 1948, J ROY STAT SOC B, V10, P159; Rauch A, 2014, BBA-REV CANCER, V1845, P202, DOI 10.1016/j.bbcan.2014.01.003; Reisen F, 2013, J BIOMOL SCREEN, V18, P1284, DOI 10.1177/1087057113501390; Schmidinger M, 2008, J CLIN ONCOL, V26, P5204, DOI 10.1200/JCO.2007.15.6331; Sokal RR, 1958, U KANSAS SCI B, V38, pl409; Steegmaier M, 2007, CURR BIOL, V17, P316, DOI 10.1016/j.cub.2006.12.037; Swinney DC, 2011, NAT REV DRUG DISCOV, V10, P507, DOI 10.1038/nrd3480; Tanaka M, 2005, PLOS BIOL, V3, P764, DOI 10.1371/journal.pbio.0030128; Watanabe SI, 1996, BBA-MOL CELL RES, V1312, P99, DOI 10.1016/0167-4889(96)00024-9; Wilson CJ, 2006, J BIOMOL SCREEN, V11, P21, DOI 10.1177/1087057105280726; Wolpaw AJ, 2014, METHOD ENZYMOL, V545, P265, DOI 10.1016/B978-0-12-801430-1.00011-1; Xia XF, 2010, CANCER RES, V70, P7723, DOI 10.1158/0008-5472.CAN-09-4360; Young DW, 2008, NAT CHEM BIOL, V4, P59, DOI 10.1038/nchembio.2007.53	27	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0149439	10.1371/journal.pone.0149439	http://dx.doi.org/10.1371/journal.pone.0149439			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26886014	Green Published, Green Submitted, gold			2022-12-26	WOS:000371218400083
J	Li, ZY; Huang, ZY; Sharma, DB; Xue, YB; Wang, Z; Ren, BZ				Li, Zhiyong; Huang, Zachary Y.; Sharma, Dhruv B.; Xue, Yunbo; Wang, Zhi; Ren, Bingzhong			Drone and Worker Brood Microclimates Are Regulated Differentially in Honey Bees, Apis mellifera	PLOS ONE			English	Article							COLONIAL THERMOREGULATION; PUPAL DEVELOPMENT; TEMPERATURE; NEST; ORGANIZATION; DIVERSITY; HUMIDITY	Background Honey bee (Apis mellifera) drones and workers show differences in morphology, physiology, and behavior. Because the functions of drones are more related to colony reproduction, and those of workers relate to both survival and reproduction, we hypothesize that the microclimate for worker brood is more precisely regulated than that of drone brood. Methodology/Principal Findings We assessed temperature and relative humidity (RH) inside honey bee colonies for both drone and worker brood throughout the three-stage development period, using digital HOBO (R) Data Loggers. The major findings of this study are that 1) both drone and worker castes show the highest temperature for eggs, followed by larvae and then pupae; 2) temperature in drones are maintained at higher precision (smaller variance) in drone eggs and larvae, but at a lower precision in pupae than the corresponding stages of workers; 3) RH regulation showed higher variance in drone than workers across all brood stages; and 4) RH regulation seems largely due to regulation by workers, as the contribution from empty honey combs are much smaller compared to that from adult workers. Conclusions/Significance We conclude that honey bee colonies maintain both temperature and humidity actively; that the microclimate for sealed drone brood is less precisely regulated than worker brood; and that combs with honey contribute very little to the increase of RH in honey bee colonies. These findings increase our understanding of microclimate regulation in honey bees and may have implications for beekeeping practices.	[Li, Zhiyong; Ren, Bingzhong] NE Normal Univ, Sch Life Sci, Jilin Key Lab Anim Resource Conservat & Utilizat, Changchun, Jilin Province, Peoples R China; [Li, Zhiyong; Xue, Yunbo; Wang, Zhi] Jilin Inst Apicultural Res, Jilin, Jilin Province, Peoples R China; [Huang, Zachary Y.] Michigan State Univ, Dept Entomol, E Lansing, MI 48824 USA; [Sharma, Dhruv B.] Michigan State Univ, Ctr Stat Training & Consulting, E Lansing, MI 48824 USA	Northeast Normal University - China; Michigan State University; Michigan State University	Ren, BZ (corresponding author), NE Normal Univ, Sch Life Sci, Jilin Key Lab Anim Resource Conservat & Utilizat, Changchun, Jilin Province, Peoples R China.; Huang, ZY (corresponding author), Michigan State Univ, Dept Entomol, E Lansing, MI 48824 USA.	bees@msu.edu; bzren@163.com	Huang, Zachary/D-5485-2011	Huang, Zachary/0000-0001-5354-5547	Natural Science Foundation of Jilin Province [20101574]; Special Fund for Agro-scientific Research in the Public Interest [201203080-3]	Natural Science Foundation of Jilin Province; Special Fund for Agro-scientific Research in the Public Interest	This work was supported by the Natural Science Foundation of Jilin Province (No. 20101574) and Special Fund for Agro-scientific Research in the Public Interest (201203080-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, SAS MIXED MODELS; Aronstein KA, 2010, J INVERTEBR PATHOL, V103, pS20, DOI 10.1016/j.jip.2009.06.018; Bujok B, 2002, NATURWISSENSCHAFTEN, V89, P299, DOI 10.1007/s00114-002-0338-7; Cook CN, 2013, ANIM BEHAV, V86, P323, DOI 10.1016/j.anbehav.2013.05.021; DOULL K M, 1976, Apidologie, V7, P61, DOI 10.1051/apido:19760104; Ellis MB, 2010, NATURWISSENSCHAFTEN, V97, P429, DOI 10.1007/s00114-010-0655-1; Ellis MB, 2008, J INSECT PHYSIOL, V54, P1516, DOI 10.1016/j.jinsphys.2008.08.011; ESCH H, 1991, NATURWISSENSCHAFTEN, V78, P325, DOI 10.1007/BF01221422; FREE JB, 1975, ANIM BEHAV, V23, P650, DOI 10.1016/0003-3472(75)90143-8; Graham S, 2006, INSECT SOC, V53, P226, DOI 10.1007/s00040-005-0862-5; Groh C, 2004, P NATL ACAD SCI USA, V101, P4268, DOI 10.1073/pnas.0400773101; HIMMER A., 1927, ZEITSCHR WISSENSCHAFT BIOL ABT C ZEITSCHR VERGLEICH PHYSIOL, V5, P375; Hrassnigg N, 2005, APIDOLOGIE, V36, P255, DOI 10.1051/apido:2005015; Human H, 2006, NATURWISSENSCHAFTEN, V93, P397, DOI 10.1007/s00114-006-0117-y; Jones JC, 2004, SCIENCE, V305, P402, DOI 10.1126/science.1096340; Jones JC, 2007, ADV INSECT PHYSIOL, V33, P153, DOI 10.1016/S0065-2806(06)33003-2; Kleinhenz M, 2003, J EXP BIOL, V206, P4217, DOI 10.1242/jeb.00680; KRONENBERG F, 1982, J COMP PHYSIOL, V148, P65, DOI 10.1007/BF00688889; LE CONTE Y, 1990, ENVIRON ENTOMOL, V19, P1780, DOI 10.1093/ee/19.6.1780; LEVIN CG, 1990, J APICULT RES, V29, P35, DOI 10.1080/00218839.1990.11101195; LINDAUER M., 1955, BEE WORLD, V36, P62; SEELEY TD, 1974, J INSECT PHYSIOL, V20, P2301, DOI 10.1016/0022-1910(74)90052-3; Seeley TD, 2003, INSECT SOC, V50, P134, DOI 10.1007/s00040-003-0638-8; Seeley TD, 2002, BIOL BULL-US, V202, P314, DOI 10.2307/1543484; SIMPSON J, 1961, SCIENCE, V133, P1327, DOI 10.1126/science.133.3461.1327; SOUTHWICK EE, 1987, J INSECT PHYSIOL, V33, P623, DOI 10.1016/0022-1910(87)90130-2; SOUTHWICK EE, 1991, BEHAVIOUR AND PHYSIOLOGY OF BEES, P28; Stabentheiner A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008967; Starks PT, 2000, NATURWISSENSCHAFTEN, V87, P229, DOI 10.1007/s001140050709; Starks PT, 1999, NATURWISSENSCHAFTEN, V86, P438, DOI 10.1007/s001140050648; Tautz J, 2003, P NATL ACAD SCI USA, V100, P7343, DOI 10.1073/pnas.1232346100; Weidenmuller A, 2002, ANIM BEHAV, V63, P1065, DOI 10.1006/anbe.2002.3020; Wharton KE, 2008, BEHAV ECOL, V19, P1075, DOI 10.1093/beheco/arn108; Winston Mark, 1991, BIOL HONEY BEE, P199; [No title captured]	35	9	11	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0148740	10.1371/journal.pone.0148740	http://dx.doi.org/10.1371/journal.pone.0148740			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	26882104	Green Published, gold			2022-12-26	WOS:000371219000021
J	Lui, NS; Yang, YW; van Zante, A; Buchanan, P; Jablons, DM; Lemjabbar-Alaoui, H				Lui, Natalie S.; Yang, Yi-Wei; van Zante, Annemieke; Buchanan, Petra; Jablons, David M.; Lemjabbar-Alaoui, Hassan			SULF2 Expression Is a Potential Diagnostic and Prognostic Marker in Lung Cancer	PLOS ONE			English	Article							TYROSINE KINASE INHIBITORS; HEPARAN-SULFATE; EXTRACELLULAR SULFATASES; HEPATOCELLULAR-CARCINOMA; PANCREATIC-CANCER; GROWTH; HSULF-1; GENES; CELLS; CHEMOSENSITIVITY	Aims Lung cancer is one of the most deadly cancers; median survival from diagnosis is less than one year in those with advanced disease. Novel lung cancer biomarkers are desperately needed. In this study, we evaluated SULF2 expression by immunohistochemistry and its association with overall survival in a cohort of patients with non-small cell lung cancer (NSCLC). We also looked for the presence of SULF2 protein in plasma to evaluate its potential as an early detection biomarker for NSCLC. Methods We identified patients who underwent surgical resection for pulmonary adenocarcinoma or squamous cell carcinoma at our institution. A section from each paraffin-embedded specimen was stained with a SULF2 antibody. A pathologist determined the percentage and intensity of tumor cell staining. Survival analysis was performed using a multivariate Cox proportional hazards model. Using a novel SULF2 ELISA assay, we analyzed plasma levels of SULF2 in a small cohort of healthy donors and patients with early stage NSCLC. Results SULF2 staining was present in 82% of the lung cancer samples. Squamous cell carcinomas had a higher mean percentage of staining than adenocarcinomas (100% vs. 60%; p<0.0005). After adjusting for age, sex, race, histologic type, stage, and neoadjuvant therapy, there was a non- significant (31%; p = 0.65) increase in the risk of death for patients with adenocarcinoma with SULF2 staining in tumor cells. In contrast, there was a significant decrease in the risk of death (89%; p = 0.02) for patients with squamous cell carcinoma with SULF2 staining in tumor cells. SULF2 protein was present in plasma of patients with early stage NSCLC, and soluble SULF2 levels increased with age. Finally, plasma SULF2 levels were significantly elevated in early stage NSCLC patients, compared to healthy controls. Conclusions Tumor expression of SULF2 may affect prognosis in NSCLC, while blood SULF2 levels may have a significant role in the diagnosis of this fatal disease.	[Lui, Natalie S.; Yang, Yi-Wei; Buchanan, Petra; Jablons, David M.; Lemjabbar-Alaoui, Hassan] Univ Calif San Francisco, Dept Surg, Thorac Oncol Program, San Francisco, CA USA; [van Zante, Annemieke] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Lemjabbar-Alaoui, H (corresponding author), Univ Calif San Francisco, Dept Surg, Thorac Oncol Program, San Francisco, CA USA.	hassan.lemjabbar-alaoui@ucsf.edu			National Cancer Institute (NCI), National Institutes of Health (NIH), NIH/NCI [U01CA168878]; NATIONAL CANCER INSTITUTE [U01CA168878] Funding Source: NIH RePORTER	National Cancer Institute (NCI), National Institutes of Health (NIH), NIH/NCI; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by the National Cancer Institute (NCI), which is part of the National Institutes of Health (NIH), NIH/NCI U01 grant U01CA168878 (http://www.nih.gov/about/almanac/organization/NCI.htm). The recipient of this grant is HLA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bret C, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-72; Dai YM, 2005, J BIOL CHEM, V280, P40066, DOI 10.1074/jbc.M508136200; Engelman JA, 2008, CLIN CANCER RES, V14, P2895, DOI 10.1158/1078-0432.CCR-07-2248; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Esko JD, 2001, J CLIN INVEST, V108, P169, DOI 10.1172/JCI200113530; Fossella F, 2003, J CLIN ONCOL, V21, P3016, DOI 10.1200/JCO.2003.12.046; Gallagher JT, 2001, J CLIN INVEST, V108, P357, DOI 10.1172/JCI13713; Howlader N, 2015, SEER CANC STAT REV 1; Johansson FK, 2005, ONCOGENE, V24, P3896, DOI 10.1038/sj.onc.1208553; Johansson FK, 2004, P NATL ACAD SCI USA, V101, P11334, DOI 10.1073/pnas.0402716101; Kumar V, 2005, LUNG CANC ROBBINS CO; Lai JP, 2008, HEPATOLOGY, V47, P1211, DOI 10.1002/hep.22202; Lai JP, 2010, HEPATOLOGY, V52, P1680, DOI 10.1002/hep.23848; Lai JP, 2003, J BIOL CHEM, V278, P23107, DOI 10.1074/jbc.M302203200; Lei WD, 1999, ANTICANCER RES, V19, P221; Lemjabbar-Alaoui H, 2010, ONCOGENE, V29, P635, DOI 10.1038/onc.2009.365; Li JS, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-14; Lui NS, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001624; Minna JD, 2006, HARRISONS PRINCIPLES; Morimoto-Tomita M, 2002, J BIOL CHEM, V277, P49175, DOI 10.1074/jbc.M205131200; Nawroth R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000392; Osada H, 2002, ONCOGENE, V21, P7421, DOI 10.1038/sj.onc.1205802; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Phillips JJ, 2012, J CLIN INVEST, V122, P911, DOI 10.1172/JCI58215; Proctor RN, 2001, NAT REV CANCER, V1, P82, DOI 10.1038/35094091; Rosen SD, 2010, EXPERT OPIN THER TAR, V14, P935, DOI 10.1517/14728222.2010.504718; Sato M, 2007, J THORAC ONCOL, V2, P327, DOI 10.1097/01.JTO.0000263718.69320.4c; Schiller JH, 2002, NEW ENGL J MED, V346, P92, DOI 10.1056/NEJMoa011954; Sharma SV, 2007, NAT REV CANCER, V7, P169, DOI 10.1038/nrc2088; Singer MS, 2015, CLIN CHIM ACTA, V440, P72, DOI 10.1016/j.cca.2014.10.038; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Society AC, 2015, CANC FACTS FIG 2015; Tessema M, 2011, ONCOGENE, V12, P1; Uchimura K, 2006, METHOD ENZYMOL, V416, P243, DOI 10.1016/S0076-6879(06)16015-2; Uchimura Kenji, 2006, BMC Biochemistry, V7, DOI 10.1186/1471-2091-7-2; Vicente CM, 2015, MOL CANCER RES, V13, P510, DOI 10.1158/1541-7786.MCR-14-0372; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Wang L, 2013, BMC GASTROENTEROL, V13, DOI 10.1186/1471-230X-13-173	38	14	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0148911	10.1371/journal.pone.0148911	http://dx.doi.org/10.1371/journal.pone.0148911			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	26882224	Green Published, gold			2022-12-26	WOS:000371219000032
J	Czub, B; Shah, AZ; Alfano, G; Kruczek, PM; Chakarova, CF; Bhattacharya, SS				Czub, Barbara; Shah, Amna Z.; Alfano, Giovanna; Kruczek, Przemyslaw M.; Chakarova, Christina F.; Bhattacharya, Shomi S.			TOPORS, a Dual E3 Ubiquitin and Sumo1 Ligase, Interacts with 26 S Protease Regulatory Subunit 4, Encoded by the PSMC1 Gene	PLOS ONE			English	Article							DOMINANT RETINITIS-PIGMENTOSA; PARKINSONS-DISEASE; RETINAL DEGENERATION; TOPOISOMERASE-I; MOUSE-BRAIN; SYSTEM; P53; LOCALIZATION; BINDING; NEURODEGENERATION	The significance of the ubiquitin-proteasome system (UPS) for protein degradation has been highlighted in the context of neurodegenerative diseases, including retinal dystrophies. TOPORS, a dual E3 ubiquitin and SUMO1 ligase, forms a component of the UPS and selected substrates for its enzymatic activities, such as DJ-1/PARK7 and APOBEC2, are important for neuronal as well as retinal homeostasis, respectively. TOPORS is ubiquitously expressed, yet its mutations are only known to result in autosomal dominant retinitis pigmentosa. We performed a yeast two-hybrid (Y2H) screen of a human retinal cDNA library in order to identify interacting protein partners of TOPORS from the retina, and thus begin delineating the putative disease mechanism(s) associated with the retina-specific phenotype resulting from mutations in TOPORS. The screen led to isolation of the 26 S protease regulatory subunit 4 (P26s4/PSMC1), an ATPase indispensable for correct functioning of UPS-mediated proteostasis. The interaction between endogenous TOPORS and P26s4 proteins was validated by co-immuno-precipitation from mammalian cell extracts and further characterised by immunofluorescent co-localisation studies in cell lines and retinal sections. Findings from hTERT-RPE1 and 661W cells demonstrated that TOPORS and P26s4 co-localise at the centrosome in cultured cells. Immunofluorescent staining of mouse retinae revealed a strong P26s4 reactivity at the interface between retinal pigmented epithelium (RPE) layer and the photoreceptors outer segments (OS). This finding leads us to speculate that P26s4, along with TOPORS, may have a role(s) in RPE phagocytosis, in addition to contributing to the overall photoreceptor and retinal homeostasis via the UPS.	[Czub, Barbara; Shah, Amna Z.; Alfano, Giovanna; Kruczek, Przemyslaw M.; Chakarova, Christina F.; Bhattacharya, Shomi S.] UCL, Inst Ophthalmol, London EC1V 9EL, England; [Bhattacharya, Shomi S.] Ctr Andaluz Biol Mol & Med Regenerat CABIMER, Seville 41092, Spain	University of London; University College London; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; University of Sevilla; CSIC - Centro Andaluz de Biologia Molecular y Medicina Regenerativa (CABIMER)	Czub, B; Shah, AZ (corresponding author), UCL, Inst Ophthalmol, London EC1V 9EL, England.	barbara.czub.10@ucl.ac.uk; amna.shah@ucl.ac.uk	Bhattacharya, Shom/N-2926-2016	Bhattacharya, Shom/0000-0002-1601-6344; Kramarz, Barbara/0000-0002-3898-1727	BRITISH EYE RESEARCH FOUNDATION (Fight for Sight) [1111438, 1816]; THE TERESA ROSENBAUM GOLDEN CHARITABLE TRUST (Rosetrees Trust) [298582, M233-CD1]; THE SPECIAL TRUSTEES OF MOORFIELDS EYE HOSPITAL GENERAL FUND [228064]; MOORFIELDS EYE CHARITY (Moorfields Eye Hospital NHS Foundation Trust) [1140679]; National Institute for Health Research	BRITISH EYE RESEARCH FOUNDATION (Fight for Sight); THE TERESA ROSENBAUM GOLDEN CHARITABLE TRUST (Rosetrees Trust); THE SPECIAL TRUSTEES OF MOORFIELDS EYE HOSPITAL GENERAL FUND; MOORFIELDS EYE CHARITY (Moorfields Eye Hospital NHS Foundation Trust); National Institute for Health Research(National Institute for Health Research (NIHR))	The work was funded by the following: 1. BRITISH EYE RESEARCH FOUNDATION (Fight for Sight; charity number 1111438): www.fightforsight.org.uk (PhD Studentship 1816 grant to BC and SSB); 2. THE TERESA ROSENBAUM GOLDEN CHARITABLE TRUST (Rosetrees Trust; charity number 298582): www.rosetreestrust.co.uk (Grant number M233-CD1 to BC AZS GA SSB); 3. THE SPECIAL TRUSTEES OF MOORFIELDS EYE HOSPITAL GENERAL FUND (Charity number 228064): www.moorfields.nhs.uk (Personal award to SSB for infrastructures); 4. MOORFIELDS EYE CHARITY (Moorfields Eye Hospital NHS Foundation Trust; charity number 1140679): www.moorfields.nhs.uk (Personal award to SSB for infrastructures); and 5. National Institute for Health Research: http://www.nihr.ac.uk (Personal award to SSB for infrastructures).	Anderson R.E., 2010, RETINAL DEGENERATIVE; Ardley HC, 2005, FEBS LETT, V579, P571, DOI 10.1016/j.febslet.2004.12.058; Bedford L, 2008, J NEUROSCI, V28, P8189, DOI 10.1523/JNEUROSCI.2218-08.2008; Bettencourt-Dias M, 2008, TRENDS CELL BIOL, V18, P8, DOI 10.1016/j.tcb.2007.11.002; Bowne SJ, 2008, MOL VIS, V14, P922; Campello L, 2013, MOL NEUROBIOL, V47, P790, DOI 10.1007/s12035-012-8391-5; Chakarova CF, 2007, AM J HUM GENET, V81, P1098, DOI 10.1086/521953; Chakarova CF, 2011, HUM MOL GENET, V20, P975, DOI 10.1093/hmg/ddq543; Chih B, 2012, NAT CELL BIOL, V14, P61, DOI 10.1038/ncb2410; Denuc A, 2010, BIOCHEM SOC T, V38, P34, DOI 10.1042/BST0380034; Gerdes JM, 2007, NAT GENET, V39, P1350, DOI 10.1038/ng.2007.12; Gomez-Garre P, 2012, EUR NEUROL, V68, P193, DOI 10.1159/000339003; Haluska P, 1999, NUCLEIC ACIDS RES, V27, P2538, DOI 10.1093/nar/27.12.2538; Hsiao Yi-Chun, 2012, Cilia, V1, P4, DOI 10.1186/2046-2530-1-4; Illing ME, 2002, J BIOL CHEM, V277, P34150, DOI 10.1074/jbc.M204955200; Kato I, 2013, MOL CELL BIOL, V33, P340, DOI 10.1128/MCB.01350-12; Kee H Lynn, 2013, Cilia, V2, P11, DOI 10.1186/2046-2530-2-11; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kimura A, 2012, BIOCHEMISTRY-US, V51, P8856, DOI 10.1021/bi3007862; Lee KH, 2012, PLANT SIGNAL BEHAV, V7, P973, DOI 10.4161/psb.20934; Lieberman AP, 1998, LANCET, V351, P884, DOI 10.1016/S0140-6736(05)70296-8; Lipson C, 2008, J BIOL CHEM, V283, P7166, DOI 10.1074/jbc.M705893200; Liu YP, 2014, J CLIN INVEST, V124, P2059, DOI 10.1172/JCI71898; Lobanova ES, 2013, P NATL ACAD SCI USA, V110, P9986, DOI 10.1073/pnas.1305521110; Martins-Branco D, 2012, EXP NEUROL, V238, P89, DOI 10.1016/j.expneurol.2012.08.008; Mazelova J, 2009, EMBO J, V28, P183, DOI 10.1038/emboj.2008.267; McNaught KSP, 2001, NAT REV NEUROSCI, V2, P589, DOI 10.1038/35086067; Miteva M, 2010, SUBCELL BIOCHEM, V54, P195, DOI 10.1007/978-1-4419-6676-6_16; Nozawa YI, 2013, CURR OPIN GENET DEV, V23, P429, DOI 10.1016/j.gde.2013.04.008; Paine SML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054711; Pandey UB, 2007, NATURE, V447, P859, DOI 10.1038/nature05853; Park HJ, 2008, BIOCHEMISTRY-US, V47, P13887, DOI 10.1021/bi801904q; Perry JJP, 2008, TRENDS BIOCHEM SCI, V33, P201, DOI 10.1016/j.tibs.2008.02.001; Powell C, 2014, J BIOL CHEM, V289, P28924, DOI 10.1074/jbc.M114.603043; Pungaliya P, 2007, J PROTEOME RES, V6, P3918, DOI 10.1021/pr0703674; Puram SV, 2013, CELL REP, V4, P19, DOI 10.1016/j.celrep.2013.06.006; Rachel Rivka A, 2012, Cilia, V1, P22, DOI 10.1186/2046-2530-1-22; Rajendra R, 2004, J BIOL CHEM, V279, P36440, DOI 10.1074/jbc.C400300200; Rezvani N, 2012, NEUROSCI LETT, V521, P130, DOI 10.1016/j.neulet.2012.05.070; Sampson DA, 2001, J BIOL CHEM, V276, P21664, DOI 10.1074/jbc.M100006200; Selmer KK, 2010, ACTA OPHTHALMOL, V88, P323, DOI 10.1111/j.1755-3768.2008.01465.x; Shinbo YM, 2005, INT J ONCOL, V26, P641; Simossis V., 2003, CURR PROTOC BIOINFOR; Sullivan LS, 2013, INVEST OPHTHALMOL VI; Tanahashi N, 1998, BIOCHEM BIOPH RES CO, V243, P229, DOI 10.1006/bbrc.1997.7892; Tosini G, 2014, SPR SER VIS RES, V1, P1, DOI 10.1007/978-1-4614-9613-7; Voges D, 1999, ANNU REV BIOCHEM, V68, P1015, DOI 10.1146/annurev.biochem.68.1.1015; Weger S, 2005, FEBS LETT, V579, P5007, DOI 10.1016/j.febslet.2005.07.088; Weger S, 2003, EXP CELL RES, V290, P13, DOI 10.1016/S0014-4827(03)00292-1; Welchman RL, 2005, NAT REV MOL CELL BIO, V6, P599, DOI 10.1038/nrm1700; Wigley WC, 1999, J CELL BIOL, V145, P481; Wilson VG, 2008, EXPERT REV PROTEOMIC, V5, P121, DOI 10.1586/14789450.5.1.121; Yang XM, 2009, J BIOL CHEM, V284, P18588, DOI 10.1074/jbc.C109.001560; Ying MY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023863; Zhou R, 1999, GENE, V235, P93, DOI 10.1016/S0378-1119(99)00203-6	56	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0148678	10.1371/journal.pone.0148678	http://dx.doi.org/10.1371/journal.pone.0148678			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26872363	Green Published, gold			2022-12-26	WOS:000370054100049
J	Kaasboll, OJ; Moe, IT; Ahmed, MS; Stang, E; Hagelin, EMV; Attramadal, H				Kaasboll, Ole Jorgen; Moe, Ingvild Tronstad; Ahmed, Mohammad Shakil; Stang, Espen; Hagelin, Else Marie Valbjorn; Attramadal, Havard			CTGF/CCN2 Postconditioning Increases Tolerance of Murine Hearts towards Ischemia-Reperfusion Injury	PLOS ONE			English	Article							TISSUE-GROWTH-FACTOR; PERCUTANEOUS CORONARY INTERVENTION; FIBROBLAST PROLIFERATION; CARDIAC-HYPERTROPHY; CCN FAMILY; PROTECTION; PROTEINS; DYSFUNCTION; ACTIVATION; MECHANISMS	Background and Purpose Previous studies of ischemia-reperfusion injury (IRI) in hearts from mice with cardiacrestricted overexpression of CCN2 have shown that CCN2 increases tolerance towards IRI. The objectives of this study were to investigate to what extent post-ischemic administration of recombinant human CCN2 (rhCCN2) would limit infarct size and improve functional recovery and what signaling pathways are involved. Experimental Approach Isolated mice hearts were perfused ad modum Langendorff, subjected to no-flow, global ischemia, and subsequently, exposed to mammalian cell derived, full-length (38-40kDa) rhCCN2 (250 nM) or vehicle during the first 15 min of a 60 min reperfusion period. Key Results Post-ischemic administration of rhCCN2 resulted in attenuation of infarct size from 58 +/- 4% to 34 +/- 2% (p < 0.001) which was abrogated by concomitant administration of the PI3 kinase inhibitor LY294002 (45 +/- 3% vs. 50 +/- 3%, ns). In congruence with reduction of infarct size rhCCN2 also improved recovery of left ventricular developed pressure (p < 0.05). Western blot analyses of extracts of ex vivo-perfused murine hearts also revealed that rhCCN2 evoked concentration-dependent increase of cardiac phospho-GSK3 beta (serine-9) contents. Conclusions and Implications We demonstrate that post-ischemic administration of rhCCN2 increases the tolerance of ex vivo-perfused murine hearts to IRI. Mechanistically, this postconditioning effect of rhCCN2 appeared to be mediated by activation of the reperfusion injury salvage kinase pathway as demonstrated by sensitivity to PI3 kinase inhibition and increased CCN2-induced phosphorylation of GSK3 beta (Ser - 9). Thus, the rationale for testing rhCCN2-mediated post-ischemic conditioning of the heart in more complex models is established.	[Kaasboll, Ole Jorgen; Moe, Ingvild Tronstad; Ahmed, Mohammad Shakil; Hagelin, Else Marie Valbjorn; Attramadal, Havard] Oslo Univ Hosp, Inst Surg Res, Oslo, Norway; [Kaasboll, Ole Jorgen; Moe, Ingvild Tronstad; Ahmed, Mohammad Shakil; Hagelin, Else Marie Valbjorn; Attramadal, Havard] Univ Oslo, Oslo, Norway; [Kaasboll, Ole Jorgen; Moe, Ingvild Tronstad; Ahmed, Mohammad Shakil; Hagelin, Else Marie Valbjorn; Attramadal, Havard] Univ Oslo, Ctr Heart Failure Res, Oslo, Norway; [Stang, Espen] Oslo Univ Hosp, Dept Pathol, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo	Attramadal, H (corresponding author), Oslo Univ Hosp, Inst Surg Res, Oslo, Norway.; Attramadal, H (corresponding author), Univ Oslo, Oslo, Norway.; Attramadal, H (corresponding author), Univ Oslo, Ctr Heart Failure Res, Oslo, Norway.	havard.attramadal@medisin.uio.no		Attramadal, Havard/0000-0001-9506-0687	South Eastern Norway Regional Health Authority [OUS30334_HSO2010, OUS39315_HSO2011006]; Norwegian Council on Cardiovascular Disease [2010.ST.068, 2011.DR.100]	South Eastern Norway Regional Health Authority; Norwegian Council on Cardiovascular Disease	This study was supported by grants from The South Eastern Norway Regional Health Authority (http://www.helse-sorost.no/omoss_/english_/) - grant no. OUS30334_HSO2010 (HA) and grant no. OUS39315_HSO2011006 (HA) and grants from the Norwegian Council on Cardiovascular Disease (http://www.nasjonalforeningen.no/no/Hjerte/Hjerteforskning/Forskningsprosjekter/) - grant no. 2010.ST.068 (HA; fellowship to OJK) and grant no. 2011.DR.100 (HA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu JG, 2002, NAT CELL BIOL, V4, P599, DOI 10.1038/ncb826; Accornero F, 2015, MOL CELL BIOL, V35, P2154, DOI 10.1128/MCB.00199-15; Ahmed MS, 2011, AM J PHYSIOL-HEART C, V300, pH1291, DOI 10.1152/ajpheart.00604.2010; Ahmed MS, 2004, J MOL CELL CARDIOL, V36, P393, DOI 10.1016/j.yjmcc.2003.12.004; Bohr W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0016000; Chen CC, 2007, EMBO J, V26, P1257, DOI 10.1038/sj.emboj.7601596; Crean JK, 2006, FASEB J, V20, P1712, DOI 10.1096/fj.05-5010fje; Durgan DJ, 2010, CIRC RES, V106, P546, DOI 10.1161/CIRCRESAHA.109.209346; Frangogiannis NG, 2012, PHYSIOL REV, V92, P635, DOI 10.1152/physrev.00008.2011; Gravning J, 2013, INT J CARDIOL, V168, P2049, DOI 10.1016/j.ijcard.2013.01.165; Gravning J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052120; Grotendorst GR, 2005, FASEB J, V19, P729, DOI 10.1096/fj.04-3217com; Grotendorst GR, 2004, FASEB J, V18, P469, DOI 10.1096/fj.03-0699com; Hausenloy DJ, 2013, J CLIN INVEST, V123, P92, DOI 10.1172/JCI62874; Hausenloy DJ, 2010, BASIC RES CARDIOL, V105, P677, DOI 10.1007/s00395-010-0121-4; Hausenloy DJ, 2005, AM J PHYSIOL-HEART C, V288, pH971, DOI 10.1152/ajpheart.00374.2004; Hausenloy DJ, 2004, CARDIOVASC RES, V61, P448, DOI 10.1016/j.cardiores.2003.09.024; Hausenloy DJ, 2011, NAT REV CARDIOL; Ibanez B, 2013, CIRCULATION, V128, P1495, DOI 10.1161/CIRCULATIONAHA.113.003653; Inoki I, 2001, FASEB J, V15, P219, DOI 10.1096/fj.01-0332fje; Juhaszova M, 2004, J CLIN INVEST, V113, P1535, DOI 10.1172/JCI200419906; Jun JI, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8386; Jun JI, 2011, NAT REV DRUG DISCOV, V10, P945, DOI 10.1038/nrd3599; Kim HS, 1997, P NATL ACAD SCI USA, V94, P12981, DOI 10.1073/pnas.94.24.12981; Kireeva ML, 1997, EXP CELL RES, V233, P63, DOI 10.1006/excr.1997.3548; KLONER RA, 1974, AM J PATHOL, V74, P399; Leask A, 2006, J CELL SCI, V119, P4803, DOI 10.1242/jcs.03270; LIU GS, 1991, CIRCULATION, V84, P350, DOI 10.1161/01.CIR.84.1.350; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Maeda A, 2009, J BIOCHEM, V145, P207, DOI 10.1093/jb/mvn159; Moe IT, 2013, J CELL COMMUN SIGNAL, V7, P31, DOI 10.1007/s12079-012-0183-1; Moran AE, 2014, CIRCULATION, V129, P1483, DOI 10.1161/CIRCULATIONAHA.113.004042; MURRY CE, 1986, CIRCULATION, V74, P1124, DOI 10.1161/01.CIR.74.5.1124; Nishida T, 2011, ENDOCRINOLOGY, V152, P4232, DOI 10.1210/en.2011-0234; O'Connell Timothy D, 2007, Methods Mol Biol, V357, P271; Panek AN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006743; Pizarro G, 2014, J AM COLL CARDIOL, V63, P2356, DOI 10.1016/j.jacc.2014.03.014; Pride YB, 2010, AM J CARDIOL, V106, P635, DOI 10.1016/j.amjcard.2010.04.012; Reichelt ME, 2009, EXP PHYSIOL, V94, P54, DOI 10.1113/expphysiol.2008.043554; Spoon DB, 2014, CIRCULATION, V129, P1286, DOI 10.1161/CIRCULATIONAHA.113.006518; Staat P, 2005, CIRCULATION, V112, P2143, DOI 10.1161/CIRCULATIONAHA.105.558122; Sutherland FJ, 2003, CLIN EXP PHARMACOL P, V30, P867, DOI 10.1046/j.1440-1681.2003.03925.x; Szabo Z, 2014, HYPERTENSION, V63, P1235, DOI 10.1161/HYPERTENSIONAHA.114.03279; Tsang A, 2004, CIRC RES, V95, P230, DOI 10.1161/01.RES.0000138303.76488.fe; Wang QD, 2001, ACTA PHYSIOL SCAND, V171, P123, DOI 10.1046/j.1365-201x.2001.00788.x; Wang SN, 2001, KIDNEY INT, V60, P96, DOI 10.1046/j.1523-1755.2001.00776.x; Weir RAP, 2006, AM J CARDIOL, V97, p13F, DOI 10.1016/j.amjcard.2006.03.005; Yellon D.M, 2007, NEW ENGL J MED, V357, P1121, DOI [10.1056/NEJMra071667, DOI 10.1056/NEJMRA071667]; Yoon PO, 2010, J MOL CELL CARDIOL, V49, P294, DOI 10.1016/j.yjmcc.2010.04.010	49	6	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149000	10.1371/journal.pone.0149000	http://dx.doi.org/10.1371/journal.pone.0149000			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26872261	Green Published, gold, Green Submitted			2022-12-26	WOS:000370054100084
J	Lian, JN; Choi, J; Tan, YS; Howe, A; Wen, ZY; Jarboe, LR				Lian, Jieni; Choi, Jinlyung; Tan, Yee Shiean; Howe, Adina; Wen, Zhiyou; Jarboe, Laura R.			Identification of Soil Microbes Capable of Utilizing Cellobiosan	PLOS ONE			English	Article							LEVOGLUCOSAN KINASE; ASPERGILLUS-NIGER; PYROLYSIS; FERMENTATION; PURIFICATION	Approximately 100 million tons of anhydrosugars, such as levoglucosan and cellobiosan, are produced through biomass burning every year. These sugars are also produced through fast pyrolysis, the controlled thermal depolymerization of biomass. While the microbial pathways associated with levoglucosan utilization have been characterized, there is little known about cellobiosan utilization. Here we describe the isolation and characterization of six cellobiosan-utilizing microbes from soil samples. Each of these organisms is capable of using both cellobiosan and levoglucosan as sole carbon source, though both minimal and rich media cellobiosan supported significantly higher biomass production than levoglucosan. Ribosomal sequencing was used to identify the closest reported match for these organisms: Sphingobacterium multivorum, Acinetobacter oleivorans JC3-1, Enterobacter sp SJZ-6, and Microbacterium sps FXJ8.207 and 203 and a fungal species Cryptococcus sp. The commercially-acquired Enterobacter cloacae DSM 16657 showed growth on levoglucosan and cellobiosan, supporting our isolate identification. Analysis of an existing database of 16S rRNA amplicons from Iowa soil samples confirmed the representation of our five bacterial isolates and four previously-reported levoglucosan-utilizing bacterial isolates in other soil samples and provided insight into their population distributions. Phylogenetic analysis of the 16S rRNA and 18S rRNA of strains previously reported to utilize levoglucosan and our newfound isolates showed that the organisms isolated in this study are distinct from previously described anhydrosugar-utilizing microbial species.	[Lian, Jieni] Iowa State Univ, Bioecon Inst, Ames, IA USA; [Choi, Jinlyung; Howe, Adina] Iowa State Univ, Dept Agr & Biosyst Engn, Ames, IA USA; [Tan, Yee Shiean; Jarboe, Laura R.] Iowa State Univ, Dept Chem & Biol Engn, Ames, IA USA; [Wen, Zhiyou] Iowa State Univ, Dept Food Sci & Human Nutr, Ames, IA USA	Iowa State University; Iowa State University; Iowa State University; Iowa State University	Jarboe, LR (corresponding author), Iowa State Univ, Dept Chem & Biol Engn, Ames, IA USA.	ljarboe@iastate.edu			Iowa State University Presidential Initiate; EPSCoR [1101284] Funding Source: National Science Foundation	Iowa State University Presidential Initiate; EPSCoR(National Science Foundation (NSF)NSF - Office of the Director (OD))	This work was funded by Iowa State University Presidential Initiate. The funder had no role in study design, data collection or analysis, decision to publish, or preparation of the manuscript.	Areekul Suvit, 1996, Journal of the Medical Association of Thailand, V79, P395; Bach EM, 2014, SOIL BIOL BIOCHEM, V69, P54, DOI 10.1016/j.soilbio.2013.10.033; Cole JR, 2014, NUCLEIC ACIDS RES, V42, pD633, DOI 10.1093/nar/gkt1244; Elias VO, 2001, GEOCHIM COSMOCHIM AC, V65, P267, DOI 10.1016/S0016-7037(00)00522-6; Erdogan E. E., 2012, African Journal of Biotechnology, V11, P4853; Fine PM, 2004, ENVIRON ENG SCI, V21, P705, DOI 10.1089/ees.2004.21.705; Gao S, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002324; Helle S, 2007, CARBOHYD RES, V342, P2365, DOI 10.1016/j.carres.2007.07.016; Jagannadham MV, 2000, ARCH MICROBIOL, V173, P418, DOI 10.1007/s002030000163; Jarboe LR, 2011, APPL MICROBIOL BIOT, V91, P1519, DOI 10.1007/s00253-011-3495-9; Jarchow ME, 2013, GCB BIOENERGY, V5, P281, DOI 10.1111/j.1757-1707.2012.01186.x; Kehrwald N, 2012, TELLUS B, V64, DOI 10.3402/tellusb.v64i0.18196; KITAMURA Y, 1991, AGR BIOL CHEM TOKYO, V55, P523, DOI 10.1080/00021369.1991.10870618; Knicker H, 2013, GEODERMA, V197, P43, DOI 10.1016/j.geoderma.2012.12.021; Kuzhiyil N, 2012, CHEMSUSCHEM, V5, P2228, DOI 10.1002/cssc.201200341; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Layton DS, 2011, BIORESOURCE TECHNOL, V102, P8318, DOI 10.1016/j.biortech.2011.06.011; LEVINE JS, 1995, ENVIRON SCI TECHNOL, V29, pA120; Lian JN, 2013, BIORESOURCE TECHNOL, V133, P183, DOI 10.1016/j.biortech.2013.01.031; LOMAX JA, 1991, J ANAL APPL PYROL, V19, P65, DOI 10.1016/0165-2370(91)80035-7; Malfliet S, 2013, FOOD MICROBIOL, V36, P406, DOI 10.1016/j.fm.2013.06.025; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Mullaugh KM, 2014, CHEMOSPHERE, V107, P51, DOI 10.1016/j.chemosphere.2014.03.014; NAKAHARA K, 1994, BIOSCI BIOTECH BIOCH, V58, P2193, DOI 10.1271/bbb.58.2193; Nawrocki EP, 2013, BIOINFORMATICS, V29, P2933, DOI 10.1093/bioinformatics/btt509; Ning JY, 2008, WORLD J MICROB BIOT, V24, P15, DOI 10.1007/s11274-007-9432-5; Paczia N, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-122; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Pruitt K, 2012, NCBI HDB; Radlein D, 1987, PREPR PAP AM CHEM SO, V32; RADLEIN DSG, 1987, J ANAL APPL PYROL, V12, P39, DOI 10.1016/0165-2370(87)80013-X; Rover MR, 2014, CHEMSUSCHEM; Vicente A, 2013, ATMOS ENVIRON, V71, P295, DOI 10.1016/j.atmosenv.2013.01.062; Wallner P, 2013, INT J HYG ENVIR HEAL, V216, P280, DOI 10.1016/j.ijheh.2012.05.001; Xie HJ, 2005, FEMS MICROBIOL LETT, V251, P313, DOI 10.1016/j.femsle.2005.08.024; Xie HJ, 2006, WORLD J MICROB BIOT, V22, P887, DOI 10.1007/s11274-006-9133-5; Zhuang XL, 2002, PROTEIN EXPRES PURIF, V26, P71, DOI 10.1016/S1046-5928(02)00501-6; Zhuang XL, 2001, BIORESOURCE TECHNOL, V79, P63, DOI 10.1016/S0960-8524(01)00023-2	38	11	11	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149336	10.1371/journal.pone.0149336	http://dx.doi.org/10.1371/journal.pone.0149336			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26872347	Green Published, gold, Green Submitted			2022-12-26	WOS:000370054100148
J	Sabel, BO; Buric, K; Karara, N; Thierfelder, KM; Dinkel, J; Sommer, WH; Meinel, FG				Sabel, Bastian O.; Buric, Kristijan; Karara, Nora; Thierfelder, Kolja M.; Dinkel, Julien; Sommer, Wieland H.; Meinel, Felix G.			High-Pitch CT Pulmonary Angiography in Third Generation Dual-Source CT: Image Quality in an Unselected Patient Population	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY; VASCULAR ENHANCEMENT; CONTRAST MATERIAL; DOSE REDUCTION; CHEST CT; RADIATION; EMBOLISM; PROTOCOLS; FEASIBILITY; PRINCIPLES	Objectives To investigate the feasibility of high-pitch CT pulmonary angiography (CTPA) in 3rd generation dual-source CT (DSCT) in unselected patients. Methods Forty-seven patients with suspected pulmonary embolism underwent high-pitch CTPA on a 3rd generation dual-source CT scanner. CT dose index (CTDIvol) and dose length product (DLP) were obtained. Objective image quality was analyzed by calculating signal-to-noise-ratio (SNR) and contrast-to-noise ratio (CNR). Subjective image quality on the central, lobar, segmental and subsegmental level was rated by two experienced radiologists. Results Median CTDI was 8.1 mGy and median DLP was 274 mGy*cm. Median SNR was 32.9 in the central and 31.9 in the segmental pulmonary arteries. CNR was 29.2 in the central and 28.2 in the segmental pulmonary arteries. Median image quality was "excellent" in central and lobar arteries and "good" in subsegmental arteries according to both readers. Segmental arteries varied between "excellent" and "good". Image quality was non-diagnostic in one case (2%), beginning in the lobar arteries. Thirteen patients (28%) showed minor motion artifacts. Conclusions In third-generation dual-source CT, high-pitch CTPA is feasible for unselected patients. It yields excellent image quality with minimal motion artifacts. However, compared to standard-pitch cohorts, no distinct decrease in radiation dose was observed.	[Sabel, Bastian O.; Buric, Kristijan; Karara, Nora; Thierfelder, Kolja M.; Dinkel, Julien; Sommer, Wieland H.; Meinel, Felix G.] Ludwig Maximilians Univ Hosp, Inst Clin Radiol, Munich, Germany	University of Munich	Sabel, BO (corresponding author), Ludwig Maximilians Univ Hosp, Inst Clin Radiol, Munich, Germany.	bastian.sabel@med.uni-muenchen.de		Meinel, Felix/0000-0002-3201-1033				Bae KT, 2005, EUR RADIOL, V15, pE46, DOI 10.1007/s10406-005-0165-y; Bae KT, 2007, RADIOLOGY, V242, P582, DOI 10.1148/radiol.2422052132; Bauer RW, 2012, J THORAC IMAG, V27, P376, DOI 10.1097/RTI.0b013e318250067e; Bolen MA, 2013, AM J ROENTGENOL, V201, P971, DOI 10.2214/AJR.13.10597; Boone JMSK, 2011, REPORT AM ASS PHYS M, DOI DOI 10.37206/143; Christner JA, 2012, RADIOLOGY, V265, P841, DOI 10.1148/radiol.12112365; Co SJ, 2013, EUR J RADIOL, V82, P1571, DOI 10.1016/j.ejrad.2013.04.043; De Zordo T, 2012, EUR RADIOL, V22, P279, DOI 10.1007/s00330-011-2251-y; Deak PD, 2010, RADIOLOGY, V257, P158, DOI 10.1148/radiol.10100047; Faggioni L, 2012, AM J ROENTGENOL, V199, P1220, DOI 10.2214/AJR.11.8122; Goble EW, 2014, CLIN RADIOL, V69, P36, DOI 10.1016/j.crad.2013.07.023; Heyer CM, 2007, RADIOLOGY, V245, P577, DOI 10.1148/radiol.2452061919; Holmquist F, 2009, ACTA RADIOL, V50, P181, DOI 10.1080/02841850802657269; Hou DJ, 2013, EUR J RADIOL, V82, P1793, DOI 10.1016/j.ejrad.2013.05.003; Huisman MV, 2013, J THROMB HAEMOST, V11, P412, DOI 10.1111/jth.12124; Jones SE, 2005, RADIOLOGY, V237, P329, DOI 10.1148/radiol.2371041520; Kerl JM, 2012, EUR J RADIOL, V81, P2887, DOI 10.1016/j.ejrad.2011.09.018; Krazinski AW, 2014, EUR RADIOL, V24, P2677, DOI 10.1007/s00330-014-3312-9; Laverman P, 2000, J PHARMACOL EXP THER, V293, P996; Lu GM, 2014, EUR RADIOL; McLaughlin PD, 2014, EMERG RADIOL; Meinel FG, 2014, EUR RADIOL, V24, P1643, DOI 10.1007/s00330-014-3194-x; Nyman U, 2012, ACTA RADIOL, V53, P1004, DOI 10.1258/ar.2012.120327; Pontana F, 2013, RADIOLOGY, V267, P609, DOI 10.1148/radiol.12120414; Ramadan SU, 2010, EUR RADIOL, V20, P2100, DOI 10.1007/s00330-010-1782-y; Schueller-Weidekamm C, 2006, RADIOLOGY, V241, P899, DOI 10.1148/radiol.2413040128; Sigal-Cinqualbre AB, 2004, RADIOLOGY, V231, P169, DOI 10.1148/radiol.2311030191; Sodickson A, 2012, EMERG RADIOL, V19, P437, DOI 10.1007/s10140-012-1046-z; Spearman JV, 2015, RADIOLOGY; Stein PD, 2007, RADIOLOGY, V242, P15, DOI 10.1148/radiol.2421060971; Szucs-Farkas Z, 2008, INVEST RADIOL, V43, P871, DOI 10.1097/RLI.0b013e3181875e86; Wintermark M, 2000, AM J NEURORADIOL, V21, P1881; Yu LF, 2011, RADIOGRAPHICS, V31, P835, DOI 10.1148/rg.313105079; Zamboni GA, 2012, EUR J RADIOL, V81, pE580, DOI 10.1016/j.ejrad.2011.06.051	34	25	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0146949	10.1371/journal.pone.0146949	http://dx.doi.org/10.1371/journal.pone.0146949			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26872262	Green Published, Green Submitted, gold			2022-12-26	WOS:000370054100003
J	Tuia, D; Camps-Valls, G				Tuia, Devis; Camps-Valls, Gustau			Kernel Manifold Alignment for Domain Adaptation	PLOS ONE			English	Article								The wealth of sensory data coming from different modalities has opened numerous opportunities for data analysis. The data are of increasing volume, complexity and dimensionality, thus calling for new methodological innovations towards multimodal data processing. However, multimodal architectures must rely on models able to adapt to changes in the data distribution. Differences in the density functions can be due to changes in acquisition conditions (pose, illumination), sensors characteristics (number of channels, resolution) or different views (e.g. street level vs. aerial views of a same building). We call these different acquisition modes domains, and refer to the adaptation problem as domain adaptation. In this paper, instead of adapting the trained models themselves, we alternatively focus on finding mappings of the data sources into a common, semantically meaningful, representation domain. This field of manifold alignment extends traditional techniques in statistics such as canonical correlation analysis (CCA) to deal with nonlinear adaptation and possibly non-corresponding data pairs between the domains. We introduce a kernel method for manifold alignment (KEMA) that can match an arbitrary number of data sources without needing corresponding pairs, just few labeled examples in all domains. KEMA has interesting properties: 1) it generalizes other manifold alignment methods, 2) it can align manifolds of very different complexities, performing a discriminative alignment preserving each manifold inner structure, 3) it can define a domain-specific metric to cope with multimodal specificities, 4) it can align data spaces of different dimensionality, 5) it is robust to strong nonlinear feature deformations, and 6) it is closed-form invertible, which allows transfer across-domains and data synthesis. To authors' knowledge this is the first method addressing all these important issues at once. We also present a reduced-rank version of KEMA for computational efficiency, and discuss the generalization performance of KEMA under Rademacher principles of stability. Aligning multimodal data with KEMA reports outstanding benefits when used as a data pre-conditioner step in the standard data analysis processing chain. KEMA exhibits very good performance over competing methods in synthetic controlled examples, visual object recognition and recognition of facial expressions tasks. KEMA is especially well-suited to deal with high-dimensional problems, such as images and videos, and under complicated distortions, twists and warpings of the data manifolds. A fully functional toolbox is available at https://github.com/dtuia/KEMA.git.	[Tuia, Devis] Univ Zurich, MultiModal Remote Sensing, Zurich, Switzerland; [Camps-Valls, Gustau] Univ Valencia, Image Proc Lab, Valencia, Spain	University of Zurich; University of Valencia	Tuia, D (corresponding author), Univ Zurich, MultiModal Remote Sensing, Zurich, Switzerland.	devis.tuia@geo.uzh.ch	Tuia, Devis/AAE-9339-2019; Camps-Valls, Gustavo/A-2532-2011; , Gustavo/ABC-1706-2022	Tuia, Devis/0000-0003-0374-2459; Camps-Valls, Gustavo/0000-0003-1683-2138; 	Swiss National Science Foundation [PP00P2-150593]; Spanish Ministry of Economy and Competitiveness [TIN2012-38102-C03-01]; European research council [647423]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Spanish Ministry of Economy and Competitiveness(Spanish Government); European research council(European Research Council (ERC)European Commission)	DT was supported by Swiss National Science Foundation, project PP00P2-150593 (http://www.snf.ch/en/Pages/default.aspx). GCV was supported by Spanish Ministry of Economy and Competitiveness, project TIN2012-38102-C03-01 (http://www.mineco.gob.es/portal/site/mineco?lang_choosen = en) and European research council, project 647423 (http://erc.europa.eu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakir G, 2003, P NIPS; Baktashmotlagh M, 2014, PROC CVPR IEEE, P2481, DOI 10.1109/CVPR.2014.318; Camps-Valls G, IEEE T GEOSCIENCE RE, V45, P2044; Chapelle O., 2006, SEMISUPERVISED LEARN; Courty Nicolas, 2014, Machine Learning and Knowledge Discovery in Databases. European Conference, ECML PKDD 2014. Proceedings: LNCS 8724, P274, DOI 10.1007/978-3-662-44848-9_18; Dhanjal C, 2009, IEEE T PATTERN ANAL, V31, P1347, DOI 10.1109/TPAMI.2008.171; Donahue J, 2014, PR MACH LEARN RES, V32; Donahue J, 2013, PROC CVPR IEEE, P668, DOI 10.1109/CVPR.2013.92; Duan LX, 2012, IEEE T PATTERN ANAL, V34, P465, DOI 10.1109/TPAMI.2011.114; Farhadi A, 2008, LECT NOTES COMPUT SC, V5302, P154, DOI 10.1007/978-3-540-88682-2_13; Gong BQ, 2012, PROC CVPR IEEE, P2066, DOI 10.1109/CVPR.2012.6247911; Gopalan R, 2011, IEEE I CONF COMP VIS, P999, DOI 10.1109/ICCV.2011.6126344; Gretton A, 2005, LECT NOTES ARTIF INT, V3734, P63; Ham J., 2005, P ANN C UNC ART INT, P120; Hoffman J, 2013, P ICLR SCOTTSD AZ; Hotelling H, 1936, BIOMETRIKA, V28, P321, DOI 10.2307/2333955; Jhuo IH, 2012, PROC CVPR IEEE, P2168, DOI 10.1109/CVPR.2012.6247924; Jolliffe I.T., 2002, PRINCIPAL COMPONENT, V87, P513; JONES LK, 1992, ANN STAT, V20, P608, DOI 10.1214/aos/1176348546; Kulis B, 2011, PROC CVPR IEEE, P1785, DOI 10.1109/CVPR.2011.5995702; Kwok JTY, 2004, IEEE T NEURAL NETWOR, V15, P1517, DOI 10.1109/TNN.2004.837781; Lai PL, 2000, IEEE IJCNN, P614; Long MS, 2013, IEEE I CONF COMP VIS, P2200, DOI 10.1109/ICCV.2013.274; López-Pérez Diana, 2014, Polibotánica, P1, DOI 10.1109/FIE.2014.7044379; Mackey L, 2014, ANN PROBABILITY; Maji S, 2008, 2008 IEEE COMP SOC C; Mika S, 1999, ADV NEUR IN, V11, P536; Pan SJ, 2011, IEEE T NEURAL NETWOR, V22, P199, DOI 10.1109/TNN.2010.2091281; Pan SJ, 2010, IEEE T KNOWL DATA EN, V22, P1345, DOI 10.1109/TKDE.2009.191; Patel VM, 2015, IEEE SIGNAL PROC MAG, V32, P53, DOI 10.1109/MSP.2014.2347059; Quinonero-Candela J, 2009, NEURAL INF PROCESS S, pXI; Reed M., 1981, FUNCTIONAL ANAL, V1; Riesz F., 1955, FUNCTIONAL ANAL; Saenko K, 2010, LECT NOTES COMPUT SC, V6314, P213, DOI 10.1007/978-3-642-15561-1_16; Scholkopf B, 1998, NEURAL COMPUT, V10, P1299, DOI 10.1162/089976698300017467; SHARMA A, 2012, PROC CVPR IEEE, P2160, DOI DOI 10.1109/CVPR.2012.6247923; Shawe-Taylor J, 2005, IEEE T INFORM THEORY, V51, P2510, DOI 10.1109/TIT.2005.850052; Song L., 2007, ICML, P815; Torralba A, 2011, PROC CVPR IEEE, P1521, DOI 10.1109/CVPR.2011.5995347; Tuia D, 2013, IEEE INT GEOSC REM S; Tuia D, 2014, IEEE T GEOSCI REMOTE, V52, P7708, DOI 10.1109/TGRS.2014.2317499; Tuia D, 2013, IEEE T GEOSCI REMOTE, V51, P329, DOI 10.1109/TGRS.2012.2200045; Wang C., 2011, IJCAI, P1541; Wang C., 2011, MANIFOLD LEARNING TH; Yan SC, 2007, IEEE T PATTERN ANAL, V29, P40, DOI 10.1109/TPAMI.2007.250598; Zhu F, 2014, MACHING LEARNING SIG	47	53	54	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0148655	10.1371/journal.pone.0148655	http://dx.doi.org/10.1371/journal.pone.0148655			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26872269	Green Submitted, gold, Green Published, Green Accepted			2022-12-26	WOS:000370054100048
J	Zhang, J; Guo, H; Chen, QX; Zhang, FX; Fang, Q				Zhang, Jie; Guo, Hong; Chen, Qingxiu; Zhang, Fuxian; Fang, Qin			The N-Terminal of Aquareovirus NS80 Is Required for Interacting with Viral Proteins and Viral Replication	PLOS ONE			English	Article							GRASS CARP REOVIRUS; FACTORY-LIKE INCLUSIONS; KAPPA-B ACTIVATION; MU-NS; SIGMA-NS; GENUS AQUAREOVIRUS; FAMILY REOVIRIDAE; STRANDED-RNA; VIRUS; CORE	Reovirus replication and assembly occurs within viral inclusion bodies that formed in specific intracellular compartments of cytoplasm in infected cells. Previous study indicated that aquareovirus NS80 is able to form inclusion bodies, and also can retain viral proteins within its inclusions. To better understand how NS80 performed in viral replication and assembly, the functional regions of NS80 associated with other viral proteins in aquareovirus replication were investigated in this study. Deletion mutational analysis and rotavirus NSP5-based protein association platform were used to detect association regions. Immunofluorescence images indicated that different N-terminal regions of NS80 could associate with viral proteins VP1, VP4, VP6 and NS38. Further co-immunoprecipitation analysis confirmed the interaction between VP1, VP4, VP6 or NS38 with different regions covering the N-terminal amino acid (aa, 1-471) of NS80, respectively. Moreover, removal of NS80 N-terminal sequences required for interaction with proteins VP1, VP4, VP6 or NS38 not only prevented the capacity of NS80 to support viral replication in NS80 shRNA-based replication complementation assays, but also inhibited the expression of aquareovirus proteins, suggesting that N-terminal regions of NS80 are necessary for viral replication. These results provided a foundational basis for further understanding the role of NS80 in viral replication and assembly during aquareovirus infection.	[Zhang, Jie; Guo, Hong; Chen, Qingxiu; Zhang, Fuxian; Fang, Qin] Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan 430071, Peoples R China; [Chen, Qingxiu] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Wuhan Institute of Virology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Fang, Q (corresponding author), Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan 430071, Peoples R China.	qfang@wh.iov.cn	fang, qin/GQA-8223-2022	Zhang, Fuxian/0000-0001-8486-3820	National Natural Science Foundation of China [31372565, 31172434, 31370190, 31402340]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by grants from the National Natural Science Foundation of China (31372565, 31172434, 31370190 and 31402340).	[Anonymous], 2011, VIRUS TAXONOMY; Arnold MM, 2008, VIROLOGY, V375, P412, DOI 10.1016/j.virol.2008.02.024; Arnoldi F, 2007, J VIROL, V81, P2128, DOI 10.1128/JVI.01494-06; Attoui H, 2002, J GEN VIROL, V83, P1941, DOI 10.1099/0022-1317-83-8-1941; Becker MM, 2003, J VIROL, V77, P5948, DOI 10.1128/JVI.77.10.5948-5963.2003; Berois M, 2003, J VIROL, V77, P1757, DOI 10.1128/JVI.77.3.1757-1763.2003; Brandariz-Nunez A, 2010, J VIROL, V84, P4289, DOI 10.1128/JVI.02534-09; Broering TJ, 2005, J VIROL, V79, P6194, DOI 10.1128/JVI.79.10.6194-6206.2005; Broering TJ, 2004, J VIROL, V78, P1882, DOI 10.1128/JVI.78.4.1882-1892.2004; BROOKES SM, 1993, J GEN VIROL, V74, P525, DOI 10.1099/0022-1317-74-3-525; Cheng LP, 2008, J MOL BIOL, V382, P213, DOI 10.1016/j.jmb.2008.06.075; Cheng LP, 2010, J MOL BIOL, V397, P852, DOI 10.1016/j.jmb.2009.12.027; Contin R, 2010, J GEN VIROL, V91, P1782, DOI 10.1099/vir.0.019133-0; DALES S, 1963, P NATL ACAD SCI USA, V50, P268, DOI 10.1073/pnas.50.2.268; Desmet EA, 2014, MBIO, V5, DOI 10.1128/mBio.01463-14; DOBOS P, 1976, J CLIN MICROBIOL, V3, P373; Eichwald C, 2004, J GEN VIROL, V85, P625, DOI 10.1099/vir.0.19611-0; Fabbretti E, 1999, J GEN VIROL, V80, P333, DOI 10.1099/0022-1317-80-2-333; Fan C, 2010, ARCH VIROL, V155, P1755, DOI 10.1007/s00705-010-0753-6; Fan Liming, 2014, Virologica Sinica, V29, P86, DOI 10.1007/s12250-014-3366-5; Fang Q, 2000, BIOCHEM BIOPH RES CO, V274, P762, DOI 10.1006/bbrc.2000.3215; Fang Q, 2005, SCI CHINA SER C, V48, P593, DOI 10.1360/062004-105; Fang Q, 1989, VIROL SIN, V3, P315; Fink AL, 1998, FOLD DES, V3, pR9, DOI 10.1016/S1359-0278(98)00002-9; Gillian AL, 2000, J VIROL, V74, P5939, DOI 10.1128/JVI.74.13.5939-5948.2000; Kar AK, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-4; Ke F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063737; Kobayashi T, 2006, J VIROL, V80, P9053, DOI 10.1128/JVI.00276-06; Kobayashi T, 2009, J VIROL, V83, P2892, DOI 10.1128/JVI.01495-08; Miller CL, 2010, J VIROL, V84, P867, DOI 10.1128/JVI.01571-09; Parker JSL, 2002, J VIROL, V76, P4483, DOI 10.1128/JVI.76.9.4483-4496.2002; PETRIE BL, 1984, VIRUS RES, V1, P133, DOI 10.1016/0168-1702(84)90069-8; Rangel AAC, 1999, J GEN VIROL, V80, P2399, DOI 10.1099/0022-1317-80-9-2399; Shao L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055334; Shao L, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-347; Shao Ling, 2010, Virologica Sinica, V25, P123, DOI 10.1007/s12250-010-3115-3; Silvestri LS, 2004, J VIROL, V78, P7763, DOI 10.1128/JVI.78.14.7763-7774.2004; Touris-Otero F, 2004, J MOL BIOL, V341, P361, DOI 10.1016/j.jmb.2004.06.026; Touris-Otero F, 2004, VIROLOGY, V319, P94, DOI 10.1016/j.virol.2003.10.034; Viskovska M, 2014, J VIROL, V88, P12866, DOI 10.1128/JVI.02251-14; Wei TY, 2006, J GEN VIROL, V87, P429, DOI 10.1099/vir.0.81425-0; Wen DW, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-133; Yan LM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126127; Yan LM, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-89; Zhang J, 2013, J VIROL, V87, P12935, DOI 10.1128/JVI.01952-13; Zhang J, 2013, MED MICROBIOL IMMUN, V202, P313, DOI 10.1007/s00430-013-0295-0; Zhang LL, 2010, J VIROL METHODS, V169, P28, DOI 10.1016/j.jviromet.2010.06.009	47	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0148550	10.1371/journal.pone.0148550	http://dx.doi.org/10.1371/journal.pone.0148550			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26871941	gold, Green Submitted, Green Published			2022-12-26	WOS:000370054100036
J	El Ghamrasni, S; Cardoso, R; Li, L; Guturi, KKN; Bjerregaard, VA; Liu, Y; Venkatesan, S; Hande, MP; Henderson, JT; Sanchez, O; Hickson, ID; Hakem, A; Hakem, R				El Ghamrasni, S.; Cardoso, R.; Li, L.; Guturi, K. K. N.; Bjerregaard, V. A.; Liu, Y.; Venkatesan, S.; Hande, M. P.; Henderson, J. T.; Sanchez, O.; Hickson, I. D.; Hakem, A.; Hakem, R.			Rad54 and Mus81 cooperation promotes DNA damage repair and restrains chromosome missegregation	ONCOGENE			English	Article							LARGE T-ANTIGEN; DOWN-REGULATION; RECOMBINATION; PROTEIN; INSTABILITY; DISRUPTION; INTEGRITY; CELLS; GENE	Rad54 and Mus81 mammalian proteins physically interact and are important for the homologous recombination DNA repair pathway; however, their functional interactions in vivo are poorly defined. Here, we show that combinatorial loss of Rad54 and Mus81 results in hypersensitivity to DNA-damaging agents, defects on both the homologous recombination and non-homologous DNA end joining repair pathways and reduced fertility. We also observed that while Mus81 deficiency diminished the cleavage of common fragile sites, very strikingly, Rad54 loss impaired this cleavage to even a greater extent. The inefficient repair of DNA double-strand breaks (DSBs) in Rad54(-/-) Mus81(-/-) cells was accompanied by elevated levels of chromosome missegregation and cell death. Perhaps as a consequence, tumor incidence in Rad54(-/-) Mus81(-/-) mice remained comparable to that in Mus81(-/-) mice. Our study highlights the importance of the cooperation between Rad54 and Mus81 for mediating DNA DSB repair and restraining chromosome missegregation.	[El Ghamrasni, S.; Cardoso, R.; Li, L.; Guturi, K. K. N.; Hakem, A.; Hakem, R.] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2M9, Canada; [El Ghamrasni, S.; Cardoso, R.; Li, L.; Guturi, K. K. N.; Hakem, A.; Hakem, R.] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON M5G 2M9, Canada; [Bjerregaard, V. A.; Liu, Y.; Hickson, I. D.] Univ Copenhagen, Panum Inst, Ctr Chromosome Stabil, Dept Cellular & Mol Med, Copenhagen, Denmark; [Bjerregaard, V. A.; Liu, Y.; Hickson, I. D.] Univ Copenhagen, Panum Inst, Ctr Hlth Ageing, Copenhagen, Denmark; [Venkatesan, S.; Hande, M. P.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Physiol, Singapore, Singapore; [Venkatesan, S.; Hande, M. P.] Natl Univ Singapore, Tembusu Coll, Singapore, Singapore; [Henderson, J. T.] Univ Toronto, Leslie Dan Fac Pharm, Div Biomol Sci, Dept Pharmaceut Sci, Toronto, ON, Canada; [Sanchez, O.] Univ Ontario, Inst Technol, Dept Pathol, Oshawa, ON, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Copenhagen; University of Copenhagen; National University of Singapore; National University of Singapore; University of Toronto; Ontario Tech University	Hakem, R (corresponding author), Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2M9, Canada.; Hakem, R (corresponding author), Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON M5G 2M9, Canada.	rhakem@uhnres.utoronto.ca	El Ghamrasni, Samah/AAA-1350-2022; Venkatesan, Shriram/AAY-9319-2021; Hande, M. Prakash/B-1645-2008; Hickson, Ian/AAJ-7548-2020; Venkatesan, Shriram/AFL-5405-2022	El Ghamrasni, Samah/0000-0003-4346-1360; Venkatesan, Shriram/0000-0003-0778-2474; Hande, M. Prakash/0000-0002-4511-6256; Venkatesan, Shriram/0000-0003-0778-2474; Hakem, Razqallah/0000-0001-5948-7931; Hickson, Ian/0000-0002-0583-566X	Canadian Institute of Health Research	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by the Canadian Institute of Health Research (RH). We thank P McPherson and members of the RH laboratory for helpful discussions and critical reading of the manuscript. In addition, we thank S Hakem for editing the manuscript and R Kanaar for providing Rad54<SUP>-/-</SUP> mice.	Agarwal S, 2011, J CELL BIOL, V192, P735, DOI 10.1083/jcb.201011025; Ahuja D, 2005, ONCOGENE, V24, P7729, DOI 10.1038/sj.onc.1209046; Boddy MN, 2000, MOL CELL BIOL, V20, P8758, DOI 10.1128/MCB.20.23.8758-8766.2000; Ceballos SJ, 2011, BBA-GENE REGUL MECH, V1809, P509, DOI 10.1016/j.bbagrm.2011.06.006; Chu WK, 2009, NAT REV CANCER, V9, P644, DOI 10.1038/nrc2682; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Dendouga N, 2005, MOL CELL BIOL, V25, P7569, DOI 10.1128/MCB.25.17.7569-7579.2005; Dronkert MLG, 2000, MOL CELL BIOL, V20, P3147, DOI 10.1128/MCB.20.9.3147-3156.2000; Durkin SG, 2007, ANNU REV GENET, V41, P169, DOI 10.1146/annurev.genet.41.042007.165900; El Ghamrasni S, 2015, ONCOGENE, V34, P1780, DOI 10.1038/onc.2014.121; El Ghamrasni S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001385; Essers J, 2000, EMBO J, V19, P1703, DOI 10.1093/emboj/19.7.1703; Essers J, 1997, CELL, V89, P195, DOI 10.1016/S0092-8674(00)80199-3; Garner E, 2013, CELL REP, V5, P207, DOI 10.1016/j.celrep.2013.08.041; Hakem R, 2008, EMBO J, V27, P589, DOI 10.1038/emboj.2008.15; Hanada K, 2006, EMBO J, V25, P4921, DOI 10.1038/sj.emboj.7601344; Helleday T, 2011, MOL ONCOL, V5, P387, DOI 10.1016/j.molonc.2011.07.001; Heyer WD, 2006, NUCLEIC ACIDS RES, V34, P4115, DOI 10.1093/nar/gkl481; Hiyama T, 2006, NUCLEIC ACIDS RES, V34, P880, DOI 10.1093/nar/gkj495; Hussain Syed A, 2004, Expert Rev Anticancer Ther, V4, P1179, DOI 10.1586/14737140.4.6.1179; Interthal H, 2000, MOL GEN GENET, V263, P812, DOI 10.1007/s004380000241; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Mao ZY, 2009, NEOPLASIA, V11, P683, DOI 10.1593/neo.09312; Matsuda M, 1999, ONCOGENE, V18, P3427, DOI 10.1038/sj.onc.1202692; Mazin AV, 2010, DNA REPAIR, V9, P286, DOI 10.1016/j.dnarep.2009.12.006; Mazina OM, 2008, P NATL ACAD SCI USA, V105, P18249, DOI 10.1073/pnas.0807016105; McManus KJ, 2009, P NATL ACAD SCI USA, V106, P3276, DOI 10.1073/pnas.0813414106; McPherson JP, 2004, SCIENCE, V304, P1822, DOI 10.1126/science.1094557; McPherson JP, 2004, EMBO J, V23, P3677, DOI 10.1038/sj.emboj.7600371; Munoz-Galvan S, 2012, MOL CELL BIOL, V32, P1592, DOI 10.1128/MCB.00111-12; Naim V, 2013, NAT CELL BIOL, V15, P1008, DOI 10.1038/ncb2793; Ozeri-Galai E, 2012, TRENDS GENET, V28, P295, DOI 10.1016/j.tig.2012.02.006; Pamidi A, 2007, CANCER RES, V67, P8527, DOI 10.1158/0008-5472.CAN-07-1161; Pepe A, 2014, CELL REP, V7, P1048, DOI 10.1016/j.celrep.2014.04.007; Prakash R, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016600; Sarbajna S, 2014, TRENDS BIOCHEM SCI, V39, P409, DOI 10.1016/j.tibs.2014.07.003; Tan TLR, 1999, CURR BIOL, V9, P325, DOI 10.1016/S0960-9822(99)80142-0; Wechsler T, 2011, NATURE, V471, P642, DOI 10.1038/nature09790; Wesoly J, 2006, MOL CELL BIOL, V26, P976, DOI 10.1128/MCB.26.3.976-989.2006; Wu F, 2008, CANCER-AM CANCER SOC, V112, P2002, DOI 10.1002/cncr.23396; Wu F, 2011, CANCER SCI, V102, P472, DOI 10.1111/j.1349-7006.2010.01790.x; Wu F, 2010, ANTICANCER RES, V30, P5011; Ying SM, 2013, NAT CELL BIOL, V15, P1001, DOI 10.1038/ncb2773; ZHU JY, 1991, J VIROL, V65, P6872, DOI 10.1128/JVI.65.12.6872-6880.1991	44	10	10	1	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 15	2016	35	37					4836	4845		10.1038/onc.2016.16	http://dx.doi.org/10.1038/onc.2016.16			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DW0LA	26876210				2022-12-26	WOS:000383330700002
J	Fabris, L; Berton, S; Citron, F; D'Andrea, S; Segatto, I; Nicoloso, MS; Massarut, S; Armenia, J; Zafarana, G; Rossi, S; Ivan, C; Perin, T; Vaidya, JS; Avanzo, M; Roncadin, M; Schiappacassi, M; Bristow, RG; Calin, G; Baldassarre, G; Belletti, B				Fabris, L.; Berton, S.; Citron, F.; D'Andrea, S.; Segatto, I.; Nicoloso, M. S.; Massarut, S.; Armenia, J.; Zafarana, G.; Rossi, S.; Ivan, C.; Perin, T.; Vaidya, J. S.; Avanzo, M.; Roncadin, M.; Schiappacassi, M.; Bristow, R. G.; Calin, G.; Baldassarre, G.; Belletti, B.			Radiotherapy-induced miR-223 prevents relapse of breast cancer by targeting the EGF pathway	ONCOGENE			English	Article							GROWTH-FACTOR LEVELS; INTRAOPERATIVE RADIOTHERAPY; CELL-PROLIFERATION; ERBB RECEPTORS; RADIATION; SURGERY; MORPHOGENESIS; INHIBITION; SURVIVAL; INVASION	In breast cancer (BC) patients, local recurrences often arise in proximity of the surgical scar, suggesting that response to surgery may have a causative role. Radiotherapy (RT) after lumpectomy significantly reduces the risk of recurrence. We investigated the direct effects of surgery and of RT delivered intraoperatively (IORT), by collecting irradiated and non-irradiated breast tissues from BC patients, after tumor removal. These breast tissue specimens have been profiled for their microRNA (miR) expression, in search of differentially expressed miR among patients treated or not with IORT. Our results demonstrate that IORT elicits effects that go beyond the direct killing of residual tumor cells. IORT altered the wound response, inducing the expression of miR-223 in the peritumoral breast tissue. miR-223 downregulated the local expression of epidermal growth factor (EGF), leading to decreased activation of EGF receptor (EGFR) on target cells and, eventually, dampening a positive EGF-EGFR autocrine/paracrine stimulation loop induced by the post-surgical wound-healing response. Accordingly, both RT-induced miR-223 and peri-operative inhibition of EGFR efficiently prevented BC cell growth and reduced recurrence formation in mouse models of BC. Our study uncovers unknown effects of RT delivered on a wounded tissue and prompts to the use of anti-EGFR treatments, in a peri-operative treatment schedule, aimed to timely treat BC patients and restrain recurrence formation.	[Fabris, L.; Berton, S.; Citron, F.; D'Andrea, S.; Segatto, I.; Nicoloso, M. S.; Armenia, J.; Schiappacassi, M.; Baldassarre, G.; Belletti, B.] Natl Canc Inst, CRO Aviano, Dept Translat Res, Div Expt Oncol 2, Via Gallini 2, I-33081 Aviano, Italy; [Berton, S.; Zafarana, G.; Bristow, R. G.] Univ Toronto, Dept Radiat Oncol, Princess Margaret Canc Ctr, Toronto, ON, Canada; [Berton, S.; Zafarana, G.; Bristow, R. G.] Univ Toronto, Dept Med Biophys, Princess Margaret Canc Ctr, Toronto, ON, Canada; [Nicoloso, M. S.; Rossi, S.; Ivan, C.; Calin, G.] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA; [Massarut, S.] Natl Canc Inst, CRO Aviano, Dept Oncol & Surg, Breast Surg Unit, Aviano, Italy; [Perin, T.] Natl Canc Inst, CRO Aviano, Dept Translat Res, Pathol Unit, Aviano, Italy; [Vaidya, J. S.] UCL, Div Surg & Intervent Sci, London, England; [Avanzo, M.] Natl Canc Inst, CRO Aviano, Dept Radiotherapy & Oncol, Med Phys Unit, Aviano, Italy; [Roncadin, M.] Natl Canc Inst, CRO Aviano, Dept Radiotherapy & Oncol, Radiotherapy Unit, Aviano, Italy; [Rossi, S.] Swiss Inst Bioinformat, Batiment Genopode, CH-1015 Lausanne, Switzerland	IRCCS Aviano (CRO); University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Texas System; UTMD Anderson Cancer Center; IRCCS Aviano (CRO); IRCCS Aviano (CRO); University of London; University College London; IRCCS Aviano (CRO); IRCCS Aviano (CRO); Swiss Institute of Bioinformatics	Baldassarre, G; Belletti, B (corresponding author), Natl Canc Inst, CRO Aviano, Dept Translat Res, Div Expt Oncol 2, Via Gallini 2, I-33081 Aviano, Italy.	gbaldassarre@cro.it; bbelletti@cro.it	Baldassarre, Gustavo/K-1350-2016; Nicoloso, Milena S/K-6411-2012; Vaidya, Jayant S/F-7717-2010; Schiappacassi, Monica/AAX-5505-2020; Perin, Tiziana/AAC-2403-2020; Avanzo, Michele/C-8529-2009; Belletti, Barbara/J-2028-2018; Citron, Francesca/AAC-2249-2020; Calin, George/E-9390-2011; D'Andrea, Sara/AAC-2148-2020; Massarut, Samuele/J-2995-2018; Segatto, Ilenia/AAX-5513-2020; Vaidya, Jayant S/A-7218-2008	Baldassarre, Gustavo/0000-0002-9750-8825; Nicoloso, Milena S/0000-0003-4231-9303; Vaidya, Jayant S/0000-0003-1760-1278; Schiappacassi, Monica/0000-0003-4804-4291; Perin, Tiziana/0000-0002-9823-0167; Avanzo, Michele/0000-0003-1711-4242; Belletti, Barbara/0000-0003-2249-0285; Citron, Francesca/0000-0002-5896-3008; D'Andrea, Sara/0000-0001-5736-6431; Massarut, Samuele/0000-0003-4717-0544; Segatto, Ilenia/0000-0001-5282-1028; Vaidya, Jayant S/0000-0003-1760-1278; Bristow, Robert/0000-0002-8553-9544; Ivan, Cristina/0000-0002-4848-0168; Calin, George/0000-0002-7427-0578; Calin, George/0000-0001-6704-5615	Associazione Italiana Ricerca sul Cancro (AIRC) [IG 15902, IG 12854]; CRO Intramural Research Grant; Friuli Exchange Program; AIRC-Marie Curie Outgoing International Fellowship; AIRC fellowship [16620]; NATIONAL CANCER INSTITUTE [R01CA182905] Funding Source: NIH RePORTER; National Institute for Health Research [10/104/07, 07/60/49] Funding Source: researchfish	Associazione Italiana Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); CRO Intramural Research Grant; Friuli Exchange Program; AIRC-Marie Curie Outgoing International Fellowship(Fondazione AIRC per la ricerca sul cancro); AIRC fellowship(Fondazione AIRC per la ricerca sul cancro); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute for Health Research(National Institute for Health Research (NIHR))	This work is dedicated to the memory of Dr Mauro Gaetano Trovo, who strongly supported this research. We are grateful to the patients who participated to this study. We thank Dr Debora Martinuzzo for her valuable contribution, Sara Benevol for expert technical assistance, Maria Giulia Baldassarre for her useful observations and all members of the SCICC lab for supportive scientific discussions. We thank Dr Qiao Li (University of Michigan Medical Center, USA) for providing EO771E2 cell line and Dr Roberta Maestro (CRO Aviano, Aviano, Italy) for providing HMEC hTERT cells. This work was supported by research funding from Associazione Italiana Ricerca sul Cancro (AIRC) to BB (IG 15902) and to GB (IG 12854); from CRO Intramural Research Grant to GB and SM; from Friuli Exchange Program to SB. SB was a recipient of AIRC-Marie Curie Outgoing International Fellowship. IS was a recipient of AIRC fellowship (ref. 16620).	Armenia J, 2014, ONCOTARGET, V5, P1185, DOI 10.18632/oncotarget.1803; Arteaga CL, 2014, CANCER CELL, V25, P282, DOI 10.1016/j.ccr.2014.02.025; Arwert EN, 2012, NAT REV CANCER, V12, P170, DOI 10.1038/nrc3217; Barcellos-Hoff MH, 2005, NAT REV CANCER, V5, P867, DOI 10.1038/nrc1735; Baum M, 2005, EUR J CANCER, V41, P508, DOI 10.1016/j.ejca.2004.09.031; Begg AC, 2011, NAT REV CANCER, V11, P239, DOI 10.1038/nrc3007; Belletti B, 2008, CLIN CANCER RES, V14, P1325, DOI 10.1158/1078-0432.CCR-07-4453; Christensen ME, 1996, ACTA OTO-LARYNGOL, V116, P137, DOI 10.3109/00016489609137727; de Gonzalez AB, 2013, INT J RADIAT ONCOL, V86, P224, DOI 10.1016/j.ijrobp.2012.09.001; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Demicheli R, 2008, ANN ONCOL, V19, P1821, DOI 10.1093/annonc/mdn386; Demicheli R, 2001, BRIT J CANCER, V85, P490, DOI 10.1054/bjoc.2001.1969; Demicheli R, 2007, NAT CLIN PRACT ONCOL, V4, P699, DOI 10.1038/ncponc0999; Doan PL, 2013, NAT MED, V19, P295, DOI 10.1038/nm.3070; Dumbrigue HB, 2000, ORAL SURG ORAL MED O, V89, P710, DOI 10.1067/moe.2000.106343; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; Early Breast Canc Trialists Collab, 2011, LANCET, V378, P1707, DOI 10.1016/S0140-6736(11)61629-2; Epstein JB, 2000, CANCER-AM CANCER SOC, V89, P2258, DOI 10.1002/1097-0142(20001201)89:11<2258::AID-CNCR14>3.0.CO;2-Z; Halvorsen AR, 2014, INT J CANCER, V135, P2085, DOI 10.1002/ijc.28862; Haraguchi T, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp040; Helland A, 2006, RADIOTHER ONCOL, V80, P230, DOI 10.1016/j.radonc.2006.07.007; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Inui M, 2012, CURR OPIN CELL BIOL, V24, P194, DOI 10.1016/j.ceb.2011.11.013; Iorio MV, 2012, EMBO MOL MED, V4, P143, DOI 10.1002/emmm.201100209; Johnnidis JB, 2008, NATURE, V451, P1125, DOI 10.1038/nature06607; Kuonen F, 2012, CLIN CANCER RES, V18, P5196, DOI 10.1158/1078-0432.CCR-11-1758; Liu CG, 2004, P NATL ACAD SCI USA, V101, P9740, DOI 10.1073/pnas.0403293101; Metheetrairut C, 2013, CURR OPIN GENET DEV, V23, P12, DOI 10.1016/j.gde.2013.01.002; Pinatel EM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084859; Pulikkan JA, 2010, BLOOD, V115, P1768, DOI 10.1182/blood-2009-08-240101; Redis RS, 2012, PHARMACOL THERAPEUT, V136, P169, DOI 10.1016/j.pharmthera.2012.08.003; Schmitz KH, 2012, CANCER-AM CANCER SOC, V118, P2270, DOI 10.1002/cncr.27462; Segatto I, 2014, ONCOTARGET, V5, P6267, DOI 10.18632/oncotarget.2195; Segatto I, 2014, MOL ONCOL, V8, P766, DOI 10.1016/j.molonc.2014.02.006; Segatto I, 2013, J MOL CELL BIOL, V5, P428, DOI 10.1093/jmcb/mjt027; Shao H, 2003, CANCER RES, V63, P3923; Tagliabue E, 2003, LANCET, V362, P527, DOI 10.1016/S0140-6736(03)14112-8; Vaidya JS, 2014, LANCET, V383, P603, DOI 10.1016/S0140-6736(13)61950-9; Vaidya JS, 2010, LANCET, V376, P91, DOI 10.1016/S0140-6736(10)60837-9; Wang SH, 2014, INT J BIOL SCI, V10, P25, DOI 10.7150/ijbs.6309; Yamada KM, 2007, CELL, V130, P601, DOI 10.1016/j.cell.2007.08.006	41	43	44	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 15	2016	35	37					4914	4926		10.1038/onc.2016.23	http://dx.doi.org/10.1038/onc.2016.23			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DW0LA	26876200	hybrid, Green Submitted, Green Published			2022-12-26	WOS:000383330700009
J	Li, X; Roife, D; Kang, Y; Dai, B; Pratt, M; Fleming, JB				Li, X.; Roife, D.; Kang, Y.; Dai, B.; Pratt, M.; Fleming, J. B.			Extracellular lumican augments cytotoxicity of chemotherapy in pancreatic ductal adenocarcinoma cells via autophagy inhibition	ONCOGENE			English	Article							ACTIVATED PROTEIN-KINASE; STELLATE CELLS; PHASE-III; CANCER; LOCALIZATION; GEMCITABINE; EXPRESSION; RESISTANCE; CARCINOMA; TARGET	Lumican, an extracellular matrix proteoglycan overexpressed by pancreatic stellate cells (PSCs) and pancreatic ductal adenocarcinoma cells (PDACs), drives the formation of a tumor-specific microenvironment. We recently showed that extracellular lumican inhibits pancreatic cancer cell growth and is associated with prolonged survival after surgery. Here we investigated the role of extracellular lumican in chemotherapy-mediated cancer therapy. Lumican secretion was increased by chemotherapeutic agents in PDAC, and especially in PSCs, and appeared to be linked to the extent of cells' response to chemotherapy-induced growth inhibition. In multiple PDAC models, including cell lines, patient-derived xenografts and lumican knockout mice, lumican significantly increased antitumor effect of chemotherapy. This effect was associated with DNA damage, apoptosis and inhibition of cell viability, glucose consumption, lactate production and vascular endothelial growth factor secretion. In PDAC cells, chemotherapeutic agents triggered autophagosome formation and increased LC3 expression through the reactive oxygen species-mediated AMP-activated kinase (AMPK) signaling pathway. Inhibition of gemcitabine-induced autophagy in cancer cells by treatment with AMPK inhibitor compound C, lysosomal inhibitor chloroquine or autophagy inhibitor 3MA enhanced gemcitabine-induced apoptosis, suggesting that autophagy is a protective cellular response to gemcitabine treatment. Importantly, lumican dramatically decreased AMPK activity, inhibiting chemotherapy-induced autophagy in both in vitro and in vivo PDAC models. Co-treatment of PDAC cells with lumican and gemcitabine increased mitochondrial damage, reactive oxygen species (ROS) production and cytochrome c release, indicating that lumican-induced disruption of mitochondrial function may be the mechanism of sensitization to gemcitabine. Together, our findings demonstrate that extracellular lumican augments cytotoxicity of chemotherapy in PDAC cells through inhibition of chemotherapeutic agent-induced autophagy.	[Li, X.; Roife, D.; Kang, Y.; Dai, B.; Pratt, M.; Fleming, J. B.] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, 1515 Holcombe Blvd,FCT17-5048, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Fleming, JB (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, 1515 Holcombe Blvd,FCT17-5048, Houston, TX 77030 USA.	jbflemin@mdanderson.org		Roife, David/0000-0001-9052-2248	Viragh Family Foundation; W. Smith Foundation; National Institutes of Health (NIH) [T32CA009599]	Viragh Family Foundation; W. Smith Foundation; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by grants from the Viragh Family Foundation (to JF), the W. Smith Foundation (to JF) and National Institutes of Health (NIH) grant T32CA009599 (to DR).	Apte MV, 2004, PANCREAS, V29, P179, DOI 10.1097/00006676-200410000-00002; Baba H, 2001, JPN CIRC J, V65, P445, DOI 10.1253/jcj.65.445; Berlin JD, 2002, J CLIN ONCOL, V20, P3270, DOI 10.1200/JCO.2002.11.149; Bin-Umer MA, 2014, P NATL ACAD SCI USA, V111, P11798, DOI 10.1073/pnas.1403145111; Chakravarti S, 1998, J CELL BIOL, V141, P1277, DOI 10.1083/jcb.141.5.1277; Coulson-Thomas VJ, 2013, EXP CELL RES, V319, P967, DOI 10.1016/j.yexcr.2013.01.023; Erkan M, 2007, GASTROENTEROLOGY, V132, P1447, DOI 10.1053/j.gastro.2007.01.031; Erkan M, 2012, GUT, V61, P172, DOI 10.1136/gutjnl-2011-301220; Hamada S, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00331; Hardie DG, 2015, CURR OPIN CELL BIOL, V33, P1, DOI 10.1016/j.ceb.2014.09.004; Hardie DG, 2011, GENE DEV, V25, P1895, DOI 10.1101/gad.17420111; Herrmann R, 2007, J CLIN ONCOL, V25, P2212, DOI 10.1200/JCO.2006.09.0886; Iozzo RV, 1998, ANNU REV BIOCHEM, V67, P609, DOI 10.1146/annurev.biochem.67.1.609; Ishiwata T, 2007, ONCOL REP, V18, P537; Janku F, 2011, NAT REV CLIN ONCOL, V8, P528, DOI 10.1038/nrclinonc.2011.71; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kim MP, 2012, ANN SURG ONCOL, V19, pS395, DOI 10.1245/s10434-011-1839-4; Kim MP, 2009, NAT PROTOC, V4, P1670, DOI 10.1038/nprot.2009.171; Kondo Y, 2005, NAT REV CANCER, V5, P726, DOI 10.1038/nrc1692; Kurihara Y, 2012, J BIOL CHEM, V287, P3265, DOI 10.1074/jbc.M111.280156; Li XQ, 2015, ONCOTARGET, V6, P11507, DOI 10.18632/oncotarget.3432; Li XQ, 2014, CLIN CANCER RES, V20, P6529, DOI 10.1158/1078-0432.CCR-14-0970; Masamune A, 2013, PANCREATOLOGY, V13, P102, DOI 10.1016/j.pan.2012.12.058; Masamune A, 2009, J GASTROENTEROL, V44, P249, DOI 10.1007/s00535-009-0013-2; Maycotte P, 2011, CANCER BIOL THER, V11, P127, DOI 10.4161/cbt.11.2.14627; Nikitovic D, 2008, IUBMB LIFE, V60, P818, DOI 10.1002/iub.131; Ozdemir BC, 2014, CANCER CELL, V25, P719, DOI 10.1016/j.ccr.2014.04.005; Rehman G, 2014, ARCH PHARM, V347, P457, DOI 10.1002/ardp.201300402; Shackelford DB, 2009, NAT REV CANCER, V9, P563, DOI 10.1038/nrc2676; Shaw RJ, 2009, ACTA PHYSIOL, V196, P65, DOI 10.1111/j.1748-1716.2009.01972.x; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Sui X, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.350; Vonlaufen A, 2008, CANCER RES, V68, P2085, DOI 10.1158/0008-5472.CAN-07-2477; Zhu H, 2013, J BIOL CHEM, V288, P16495, DOI 10.1074/jbc.M112.443580	34	36	36	0	22	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 15	2016	35	37					4881	4890		10.1038/onc.2016.20	http://dx.doi.org/10.1038/onc.2016.20			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DW0LA	26876211				2022-12-26	WOS:000383330700006
J	Chu, TW; MacNeil, DE; Autexier, C				Chu, Tsz Wai; MacNeil, Deanna Elise; Autexier, Chantal			Multiple Mechanisms Contribute to the Cell Growth Defects Imparted by Human Telomerase Insertion in Fingers Domain Mutations Associated with Premature Aging Diseases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell death; DNA damage response; RNA-protein interaction; telomerase; telomerase reverse transcriptase (TERT); telomere	BONE-MARROW FAILURE; RECESSIVE DYSKERATOSIS-CONGENITA; REVERSE-TRANSCRIPTASE; CAJAL BODIES; TEL-PATCH; GERMLINE MUTATION; PROTEIN TPP1; RECRUITMENT; COMPONENT; PROCESSIVITY	Normal human stem cells rely on low levels of active telomerase to sustain their high replicative requirements. Deficiency in telomere maintenance mechanisms leads to the development of premature aging diseases, such as dyskeratosis congenita and aplastic anemia. Mutations in the unique "insertion in fingers domain" (IFD) in the human telomerase reverse transcriptase catalytic subunit (hTERT) have previously been identified and shown to be associated with dyskeratosis congenita and aplastic anemia. However, little is known about the molecular mechanisms impacted by these IFD mutations. We performed comparative functional analyses of disease-associated IFD variants at the molecular and cellular levels. We report that hTERT-P721R- and hTERT-R811C-expressing cells exhibited growth defects likely due to impaired TPP1-mediated recruitment of these variant enzymes to telomeres. We showed that activity and processivity of hTERT-T726M failed to be stimulated by TPP1-POT1 overexpression and that dGTP usage by this variant was less efficient compared with the wild-type enzyme. hTERT-P785L-expressing cells did not show growth defects, and this variant likely confers cell survival through increased DNA synthesis and robust activity stimulation by TPP1-POT1. Altogether, our data suggest that multiple mechanisms contribute to cell growth defects conferred by the IFD variants.	[Chu, Tsz Wai; MacNeil, Deanna Elise; Autexier, Chantal] Jewish Gen Hosp, Bloomfield Ctr Res Aging, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada; [Chu, Tsz Wai; Autexier, Chantal] McGill Univ, Dept Med, Montreal, PQ H4A 3J1, Canada; [MacNeil, Deanna Elise; Autexier, Chantal] McGill Univ, Dept Anat & Cell Biol, Montreal, PQ H3A 0C7, Canada	Lady Davis Institute; McGill University; McGill University; McGill University	Autexier, C (corresponding author), Jewish Gen Hosp, Bloomfield Ctr Res Aging, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada.; Autexier, C (corresponding author), McGill Univ, Dept Med, Montreal, PQ H4A 3J1, Canada.; Autexier, C (corresponding author), McGill Univ, Dept Anat & Cell Biol, Montreal, PQ H3A 0C7, Canada.	chantal.autexier@mcgill.ca			Canadian Institute for Health Research Grant [MOP133449]; McGill University Faculty of Medicine internal studentship; Canadian Institute for Health Research McGill Integrated Cancer Research Training Program studentship; Fonds de la Recherche en Sante du Quebec (FRSQ) studentship; McGill Faculty of Medicine Internal Max Stern recruitment fellowship; Canada Graduate Scholarships-Master's Program; Chercheur National of the FRSQ	Canadian Institute for Health Research Grant(Canadian Institutes of Health Research (CIHR)); McGill University Faculty of Medicine internal studentship; Canadian Institute for Health Research McGill Integrated Cancer Research Training Program studentship; Fonds de la Recherche en Sante du Quebec (FRSQ) studentship; McGill Faculty of Medicine Internal Max Stern recruitment fellowship; Canada Graduate Scholarships-Master's Program; Chercheur National of the FRSQ	This work was supported in part by Canadian Institute for Health Research Grant MOP133449 (to C. A.). All authors declare no conflict of interest with the content of this article.; Supported by a McGill University Faculty of Medicine internal studentship, Canadian Institute for Health Research McGill Integrated Cancer Research Training Program studentship, and a Fonds de la Recherche en Sante du Quebec (FRSQ) studentship.; Supported by a McGill Faculty of Medicine Internal Max Stern recruitment fellowship and the Canada Graduate Scholarships-Master's Program.; Supported by Chercheur National of the FRSQ.	Abreu E, 2011, METHODS MOL BIOL, V735, P125, DOI 10.1007/978-1-61779-092-8_12; Abreu E, 2010, MOL CELL BIOL, V30, P2971, DOI 10.1128/MCB.00240-10; Alter BP, 2009, BLOOD, V113, P6549, DOI 10.1182/blood-2008-12-192880; Armanios M, 2005, P NATL ACAD SCI USA, V102, P15960, DOI 10.1073/pnas.0508124102; Armbruster BN, 2001, MOL CELL BIOL, V21, P7775, DOI 10.1128/MCB.21.22.7775-7786.2001; Artandi SE, 2000, NATURE, V406, P641, DOI 10.1038/35020592; Ballew BJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003695; Ballew BJ, 2013, HUM GENET, V132, P473, DOI 10.1007/s00439-013-1265-8; Cheung DHC, 2012, FEBS LETT, V586, P3166, DOI 10.1016/j.febslet.2012.06.028; Chu TW, 2016, MOL CELL BIOL, V36, P210, DOI 10.1128/MCB.00746-15; Collopy LC, 2015, BLOOD, V126, P176, DOI 10.1182/blood-2015-03-633388; Cristofari G, 2007, MOL CELL, V27, P882, DOI 10.1016/j.molcel.2007.07.020; D'Souza Y, 2013, MOL BIOL CELL, V24, P1469, DOI 10.1091/mbc.E12-12-0889; D'Souza Y, 2013, J CELL SCI, V126, P676, DOI 10.1242/jcs.119297; Dalby AB, 2015, J MOL BIOL, V427, P1291, DOI 10.1016/j.jmb.2015.01.008; De Lange T, 2005, COLD SH Q B, V70, P197, DOI 10.1101/sqb.2005.70.032; Deng Z, 2013, P NATL ACAD SCI USA, V110, pE3408, DOI 10.1073/pnas.1300600110; Dokal I, 2011, HEMATOL-AM SOC HEMAT, P480, DOI 10.1182/asheducation-2011.1.480; Frank AK, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005410; Guo YR, 2014, BLOOD, V124, P2767, DOI 10.1182/blood-2014-08-596445; Heiss NS, 1998, NAT GENET, V19, P32, DOI 10.1038/ng0598-32; Holohan B, 2014, J CELL BIOL, V205, P289, DOI 10.1083/jcb.201401012; Jady BE, 2006, MOL BIOL CELL, V17, P944, DOI 10.1091/mbc.E05-09-0904; Jiang JS, 2015, SCIENCE, V350, DOI 10.1126/science.aab4070; Kappei D, 2013, EMBO J, V32, P1681, DOI 10.1038/emboj.2013.105; Kaul Z, 2012, EMBO REP, V13, P52, DOI 10.1038/embor.2011.227; Keller RB, 2012, PEDIATR BLOOD CANCER, V59, P311, DOI 10.1002/pbc.24193; Kirwan M, 2009, HUM MUTAT, V30, P1567, DOI 10.1002/humu.21115; Kocak H, 2014, GENE DEV, V28, P2090, DOI 10.1101/gad.248567.114; Kong CM, 2013, FEBS J, V280, P3180, DOI 10.1111/febs.12326; Latrick CM, 2010, EMBO J, V29, P924, DOI 10.1038/emboj.2009.409; Le Guen T, 2013, HUM MOL GENET, V22, P3239, DOI 10.1093/hmg/ddt178; Li JR, 2014, NUCLEIC ACIDS RES, V42, P8527, DOI 10.1093/nar/gku541; Liang J, 2006, HAEMATOLOGICA, V91, P656; Loayza D, 2003, NATURE, V423, P1013, DOI 10.1038/nature01688; Marrone A, 2007, BLOOD, V110, P4198, DOI 10.1182/blood-2006-12-062851; Mitchell JR, 1999, NATURE, V402, P551, DOI 10.1038/990141; Moriarty TJ, 2005, RNA, V11, P1448, DOI 10.1261/rna.2910105; Nandakumar J, 2012, NATURE, V492, P285, DOI 10.1038/nature11648; Ourliac-Garnier I, 2010, J BIOL INORG CHEM, V15, P641, DOI 10.1007/s00775-010-0631-4; Robart AR, 2010, J BIOL CHEM, V285, P4375, DOI 10.1074/jbc.M109.088575; Savage SA, 2008, AM J HUM GENET, V82, P501, DOI 10.1016/j.ajhg.2007.10.004; Schmidt JC, 2014, ELIFE, V3, DOI 10.7554/eLife.03563; Shay JW, 2012, SCIENCE, V336, P1388, DOI 10.1126/science.1222394; Snow BE, 2007, MOL CELL BIOL, V27, P1017, DOI 10.1128/MCB.01866-06; Stern JL, 2012, MOL CELL BIOL, V32, P2384, DOI 10.1128/MCB.00379-12; Tomlinson RL, 2008, MOL BIOL CELL, V19, P3793, DOI 10.1091/mbc.E08-02-0184; Tomlinson RL, 2006, MOL BIOL CELL, V17, P955, DOI 10.1091/mbc.E05-09-0903; Vulliamy T, 2001, NATURE, V413, P432, DOI 10.1038/35096585; Vulliamy TJ, 2006, BLOOD, V107, P2680, DOI 10.1182/blood-2005-07-2622; Vulliamy TJ, 2005, BLOOD CELL MOL DIS, V34, P257, DOI 10.1016/j.bcmd.2004.12.008; Vulliamy T, 2008, P NATL ACAD SCI USA, V105, P8073, DOI 10.1073/pnas.0800042105; Walne AJ, 2008, BLOOD, V112, P3594, DOI 10.1182/blood-2008-05-153445; Walne AJ, 2007, HUM MOL GENET, V16, P1619, DOI 10.1093/hmg/ddm111; Walne AJ, 2013, HAEMATOLOGICA, V98, P334, DOI 10.3324/haematol.2012.071068; Wang F, 2007, NATURE, V445, P506, DOI 10.1038/nature05454; Wang F, 2011, METHODS MOL BIOL, V735, P173, DOI 10.1007/978-1-61779-092-8_17; Xi LH, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0791-1; Xin HW, 2007, NATURE, V445, P559, DOI 10.1038/nature05469; Xin ZT, 2007, BLOOD, V109, P524, DOI 10.1182/blood-2006-07-035089; Yamaguchi H, 2005, NEW ENGL J MED, V352, P1413, DOI 10.1056/NEJMoa042980; Zaug AJ, 2013, NUCLEIC ACIDS RES, V41, P8969, DOI 10.1093/nar/gkt653; Zaug AJ, 2010, GENE DEV, V24, P613, DOI 10.1101/gad.1881810; Zhang DH, 2006, NUCLEIC ACIDS RES, V34, P1393, DOI 10.1093/nar/gkl029; Zhong F, 2011, GENE DEV, V25, P11, DOI 10.1101/gad.2006411; Zhou XZ, 2001, CELL, V107, P347, DOI 10.1016/S0092-8674(01)00538-4; Zhu SS, 2014, BIOCHIMIE, V101, P93, DOI 10.1016/j.biochi.2013.12.023	67	13	14	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2016	291	16					8374	8386		10.1074/jbc.M116.714782	http://dx.doi.org/10.1074/jbc.M116.714782			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK2VT	26887940	hybrid, Green Published			2022-12-26	WOS:000374773200006
J	Crack, JC; Svistunenko, DA; Munnoch, J; Thomson, AJ; Hutchings, MI; Le Brun, NE				Crack, Jason C.; Svistunenko, Dimitri A.; Munnoch, John; Thomson, Andrew J.; Hutchings, Matthew I.; Le Brun, Nick E.			Differentiated, Promoter-specific Response of [4Fe-4S] NsrR DNA Binding to Reaction with Nitric Oxide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA-protein interaction; iron; iron-sulfur protein; nitric oxide; spectroscopy; DNA-binding protein; regulator	DINITROSYL-IRON COMPLEXES; ESCHERICHIA-COLI; S-NITROSYLATION; NO; PROTEIN; CLUSTER; REGULATORS; REPRESSOR; FNR; HMP	NsrR is an iron-sulfur cluster protein that regulates the nitric oxide (NO) stress response of many bacteria. NsrR from Streptomyces coelicolor regulates its own expression and that of only two other genes, hmpA1 and hmpA2, which encode HmpA enzymes predicted to detoxify NO. NsrR binds promoter DNA with high affinity only when coordinating a [4Fe-4S] cluster. Here we show that reaction of [4Fe-4S] NsrR with NO affects DNA binding differently depending on the gene promoter. Binding to the hmpA2 promoter was abolished at approximate to 2 NO per cluster, although for the hmpA1 and nsrR promoters, approximate to 4 and approximate to 8 NO molecules, respectively, were required to abolish DNA binding. Spectroscopic and kinetic studies of the NO reaction revealed a rapid, multi-phase, non-concerted process involving up to 8-10 NO molecules per cluster, leading to the formation of several iron-nitrosyl species. A distinct intermediate was observed at approximate to 2 NO per cluster, along with two further intermediates at approximate to 4 and approximate to 6 NO. The NsrR nitrosylation reaction was not significantly affected by DNA binding. These results show that NsrR regulates different promoters in response to different concentrations of NO. Spectroscopic evidence indicates that this is achieved by different NO-FeS complexes.	[Crack, Jason C.; Thomson, Andrew J.; Le Brun, Nick E.] Univ E Anglia, Sch Chem, Ctr Mol & Struct Biochem, Norwich Res Pk, Norwich NR4 7TJ, Norfolk, England; [Munnoch, John; Hutchings, Matthew I.] Univ E Anglia, Sch Biol Sci, Norwich Res Pk, Norwich NR4 7TJ, Norfolk, England; [Svistunenko, Dimitri A.] Univ Essex, Sch Biol Sci, Wivenhoe Pk, Colchester CO4 3SQ, Essex, England	University of East Anglia; University of East Anglia; University of Essex	Le Brun, NE (corresponding author), Univ E Anglia, Sch Chem, Ctr Mol & Struct Biochem, Norwich Res Pk, Norwich NR4 7TJ, Norfolk, England.	n.le-brun@uea.ac.uk	; Hutchings, Matthew/D-1923-2009	Crack, Jason C./0000-0002-4979-1910; Hutchings, Matthew/0000-0001-6628-5940; Svistunenko, Dimitri/0000-0001-8060-2738; Le Brun, Nick/0000-0001-9780-4061; Munnoch, John Tyson/0000-0002-9018-6026	Biotechnology and Biological Sciences Research Council [BB/J003247/1, BB/L007673/1]; Natural Environment Research Council (NERC); BBSRC [BB/L007673/1, BB/J003247/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Biotechnology and Biological Sciences Research Council Grants BB/J003247/1 (to N. L. B., M. I. H., and A. J. T.) and BB/L007673/1 (to N. L. B., J. C. C., and A. J. T.) and a Natural Environment Research Council (NERC) Ph.D. studentship (to J. M.). The authors declare that they have no conflicts of interest with the contents of this article.	Broillet MC, 1999, CELL MOL LIFE SCI, V55, P1036, DOI 10.1007/s000180050354; Bruckdorfer Richard, 2005, Molecular Aspects of Medicine, V26, P3, DOI 10.1016/j.mam.2004.09.002; Corker H, 2003, J BIOL CHEM, V278, P31584, DOI 10.1074/jbc.M303282200; Costanzo S, 2001, INORG CHIM ACTA, V318, P1, DOI 10.1016/S0020-1693(01)00402-9; Crack JC, 2015, J BIOL CHEM, V290, P12689, DOI 10.1074/jbc.M115.643072; Crack JC, 2014, ACCOUNTS CHEM RES, V47, P3196, DOI 10.1021/ar5002507; Crack JC, 2014, BIOCHEM J, V463, P83, DOI 10.1042/BJ20140169; Crack JC, 2014, METHODS MOL BIOL, V1122, P33, DOI 10.1007/978-1-62703-794-5_4; Crack JC, 2013, J BIOL CHEM, V288, P11492, DOI 10.1074/jbc.M112.439901; Crack JC, 2012, CURR OPIN CHEM BIOL, V16, P35, DOI 10.1016/j.cbpa.2012.02.009; Crack JC, 2011, J AM CHEM SOC, V133, P1112, DOI 10.1021/ja109581t; Cruz-Ramos H, 2002, EMBO J, V21, P3235, DOI 10.1093/emboj/cdf339; Drapier JC, 1997, METHODS, V11, P319, DOI 10.1006/meth.1996.0426; Heurlier K, 2008, J BACTERIOL, V190, P2488, DOI 10.1128/JB.01869-07; Isabella VM, 2009, MOL MICROBIOL, V71, P227, DOI 10.1111/j.1365-2958.2008.06522.x; Kers JA, 2004, NATURE, V429, P79, DOI 10.1038/nature02504; Kibbe WA, 2007, NUCLEIC ACIDS RES, V35, pW43, DOI 10.1093/nar/gkm234; Kommineni S, 2012, J BACTERIOL, V194, P1679, DOI 10.1128/JB.06486-11; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; Kwon YM, 2009, J BACTERIOL, V191, P5369, DOI 10.1128/JB.00586-09; Lewandowska H, 2011, DALTON T, V40, P8273, DOI 10.1039/c0dt01244k; Partridge JD, 2009, MOL MICROBIOL, V73, P680, DOI 10.1111/j.1365-2958.2009.06799.x; Rajagopalan S, 2013, NAT STRUCT MOL BIOL, V20, P740, DOI 10.1038/nsmb.2568; Schwartz CJ, 2001, P NATL ACAD SCI USA, V98, P14895, DOI 10.1073/pnas.251550898; Seth D, 2012, SCIENCE, V336, P470, DOI 10.1126/science.1215643; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Spiro S, 2007, FEMS MICROBIOL REV, V31, P193, DOI 10.1111/j.1574-6976.2006.00061.x; Stevanin TM, 2007, GENE, V398, P62, DOI 10.1016/j.gene.2007.03.021; Svistunenko DA, 2005, BBA-BIOENERGETICS, V1707, P127, DOI 10.1016/j.bbabio.2005.01.004; Svistunenko DA, 2006, BBA-BIOENERGETICS, V1757, P262, DOI 10.1016/j.bbabio.2006.03.007; Szabo C, 2007, NAT REV DRUG DISCOV, V6, P662, DOI 10.1038/nrd2222; Tinberg CE, 2010, J AM CHEM SOC, V132, P18168, DOI 10.1021/ja106290p; Tonzetich ZJ, 2010, J AM CHEM SOC, V132, P6914, DOI 10.1021/ja101002f; Tsai ML, 2015, ACCOUNTS CHEM RES, V48, P1184, DOI 10.1021/ar500459j; Tucker NP, 2010, TRENDS MICROBIOL, V18, P149, DOI 10.1016/j.tim.2009.12.009; Tucker NP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003623; VANIN AF, 1977, BIOFIZIKA+, V22, P850; Vine CE, 2011, FEMS MICROBIOL LETT, V325, P99, DOI 10.1111/j.1574-6968.2011.02425.x; Weiss B, 2006, J BACTERIOL, V188, P829, DOI 10.1128/JB.188.3.829-833.2006; Yuki ET, 2008, BIOCHEMISTRY-US, V47, P13084, DOI 10.1021/bi801342x	40	21	21	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2016	291	16					8663	8672		10.1074/jbc.M115.693192	http://dx.doi.org/10.1074/jbc.M115.693192			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK2VT	26887943	Green Accepted, Green Published, hybrid			2022-12-26	WOS:000374773200029
J	Jattani, RP; Tritapoe, JM; Pomerantz, JL				Jattani, Rakhi P.; Tritapoe, Julia M.; Pomerantz, Joel L.			Cooperative Control of Caspase Recruitment Domain-containing Protein 11 (CARD11) Signaling by an Unusual Array of Redundant Repressive Elements	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						gene regulation; lymphoma; NF-kappa B (NF-kB); oncogene; scaffold protein; signal transduction; T-cell receptor (TCR); autoinhibitory domain; CARD11; diffuse large B cell lymphoma	NF-KAPPA-B; SECONDARY STRUCTURE PREDICTION; RESPONSIVE INHIBITORY DOMAIN; CELL LYMPHOMA; STRUCTURAL BASIS; COMBINED IMMUNODEFICIENCY; KINASE-BETA; ACTIVATION; CARMA1; AUTOINHIBITION	Several classes of signaling proteins contain autoinhibitory domains that prevent unwarranted signaling and coordinate the induction of activity in response to external cues. CARD11, a scaffold protein critical for antigen receptor signaling to NF-kappa B, undergoes autoregulation by a poorly understood inhibitory domain (ID), which keeps CARD11 inactive in the absence of receptor triggering through inhibitory intramolecular interactions. This autoinhibitory strategy makes CARD11 highly susceptible to gain-of-function mutations that are frequently observed in diffuse large B cell lymphoma (DLBCL) and that disrupt ID-mediated autoinhibition, leading to constitutive NF-kappa B activity, which can promote lymphoma proliferation. Although DLBCL-associated CARD11 mutations in the caspase recruitment domain (CARD), LATCH domain, and coiled coil have been shown to disrupt intramolecular ID binding, surprisingly, no gain-of-function mutations in the ID itself have been reported and validated. In this study, we solve this paradox and report that the CARD11 ID contains an unusual array of four repressive elements that function cooperatively with redundancy to prevent spontaneous NF-kappa B activation. Our quantitative analysis suggests that potent oncogenic CARD11 mutations must perturb autoinhibition by at least three repressive elements. Our results explain the lack of ID mutations in DLBCL and reveal an unusual autoinhibitory domain structure and strategy for preventing unwarranted scaffold signaling to NF-kappa B.	[Jattani, Rakhi P.; Tritapoe, Julia M.; Pomerantz, Joel L.] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Dept Biol Chem, Miller Res Bldg,Rm 607,733 N Broadway, Baltimore, MD 21205 USA	Johns Hopkins University	Pomerantz, JL (corresponding author), Johns Hopkins Univ, Sch Med, Inst Cell Engn, Dept Biol Chem, Miller Res Bldg,Rm 607,733 N Broadway, Baltimore, MD 21205 USA.	joel.pomerantz@jhmi.edu		Pomerantz, Joel L./0000-0002-5030-1018	National Institutes of Health [RO1CA177600]; Johns Hopkins University Institute for Cell Engineering; NATIONAL CANCER INSTITUTE [R01CA177600] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007445] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Johns Hopkins University Institute for Cell Engineering; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant RO1CA177600 and funds from The Johns Hopkins University Institute for Cell Engineering. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aghazadeh B, 2000, CELL, V102, P625, DOI 10.1016/S0092-8674(00)00085-4; Blonska M, 2012, J IMMUNOL, V188, P3160, DOI 10.4049/jimmunol.1102943; Brohl AS, 2015, J CLIN IMMUNOL, V35, P32, DOI 10.1007/s10875-014-0106-4; Bu R, 2012, LEUKEMIA LYMPHOMA, V53, P1971, DOI 10.3109/10428194.2012.668286; Buchbinder D, 2015, J ALLERGY CLIN IMMUN, V136, P819, DOI 10.1016/j.jaci.2015.03.008; Bunney TD, 2012, STRUCTURE, V20, P2062, DOI 10.1016/j.str.2012.09.005; Chan WP, 2013, MOL CELL BIOL, V33, P429, DOI 10.1128/MCB.00850-12; Chen L, 2009, NATURE, V459, P1146, DOI 10.1038/nature08075; Compagno M, 2009, NATURE, V459, P717, DOI 10.1038/nature07968; Davis RE, 2001, J EXP MED, V194, P1861, DOI 10.1084/jem.194.12.1861; DeBell K, 2007, MOL CELL BIOL, V27, P854, DOI 10.1128/MCB.01400-06; Dong GH, 2011, CLIN CANCER RES, V17, P1440, DOI 10.1158/1078-0432.CCR-10-1859; Dosztanyi Z, 2005, J MOL BIOL, V347, P827, DOI 10.1016/j.jmb.2005.01.071; Duda DM, 2013, STRUCTURE, V21, P1030, DOI 10.1016/j.str.2013.04.019; Egawa T, 2003, CURR BIOL, V13, P1252, DOI 10.1016/S0960-9822(03)00491-3; Gaide O, 2002, NAT IMMUNOL, V3, P836, DOI 10.1038/ni830; Goldberg J, 1996, CELL, V84, P875, DOI 10.1016/S0092-8674(00)81066-1; Greil J, 2013, J ALLERGY CLIN IMMUN, V131, P1376, DOI 10.1016/j.jaci.2013.02.012; Hara H, 2003, IMMUNITY, V18, P763, DOI 10.1016/S1074-7613(03)00148-1; Jattani RP, 2016, J BIOL CHEM, V291, P8338, DOI 10.1074/jbc.M116.717322; Jiang CY, 2012, IMMUNOL REV, V246, P141, DOI 10.1111/j.1600-065X.2012.01110.x; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Jun JE, 2003, IMMUNITY, V18, P751, DOI 10.1016/S1074-7613(03)00141-9; Kobashigawa Y, 2011, P NATL ACAD SCI USA, V108, P20579, DOI 10.1073/pnas.1110712108; Lamason RL, 2010, MOL CELL, V40, P798, DOI 10.1016/j.molcel.2010.11.007; Lamason RL, 2010, BIOCHEMISTRY-US, V49, P8240, DOI 10.1021/bi101052d; Lenz G, 2008, SCIENCE, V319, P1676, DOI 10.1126/science.1153629; Lim KH, 2012, IMMUNOL REV, V246, P359, DOI 10.1111/j.1600-065X.2012.01105.x; Lohr JG, 2012, P NATL ACAD SCI USA, V109, P3879, DOI 10.1073/pnas.1121343109; Mari S, 2014, STRUCTURE, V22, P1639, DOI 10.1016/j.str.2014.09.006; Matsumoto R, 2005, IMMUNITY, V23, P575, DOI 10.1016/j.immuni.2005.10.007; McCully RR, 2008, MOL CELL BIOL, V28, P5668, DOI 10.1128/MCB.00418-08; Montesinos-Rongen M, 2010, ACTA NEUROPATHOL, V120, P529, DOI 10.1007/s00401-010-0709-7; Newton K, 2003, CURR BIOL, V13, P1247, DOI 10.1016/S0960-9822(03)00458-5; Ouali M, 2000, PROTEIN SCI, V9, P1162, DOI 10.1110/ps.9.6.1162; Peterson JR, 2004, J CELL BIOCHEM, V93, P68, DOI 10.1002/jcb.20184; Pomerantz JL, 2002, EMBO J, V21, P5184, DOI 10.1093/emboj/cdf505; Pufall MA, 2002, ANNU REV CELL DEV BI, V18, P421, DOI 10.1146/annurev.cellbio.18.031502.133614; Rost B, 2001, J STRUCT BIOL, V134, P204, DOI 10.1006/jsbi.2001.4336; Schulze-Luehrmann J, 2006, IMMUNITY, V25, P701, DOI 10.1016/j.immuni.2006.10.010; Shinohara H, 2007, J EXP MED, V204, P3285, DOI 10.1084/jem.20070379; Sicheri F, 1997, NATURE, V385, P602, DOI 10.1038/385602a0; Snow AL, 2012, J EXP MED, V209, P2247, DOI 10.1084/jem.20120831; Sommer K, 2005, IMMUNITY, V23, P561, DOI 10.1016/j.immuni.2005.09.014; Stepensky P, 2013, J ALLERGY CLIN IMMUN, V131, P477, DOI 10.1016/j.jaci.2012.11.050; Thome M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003004; Turvey SE, 2014, J ALLERGY CLIN IMMUN, V134, P276, DOI 10.1016/j.jaci.2014.06.015; Wang DH, 2002, NAT IMMUNOL, V3, P830, DOI 10.1038/ni824; Wegener E, 2006, MOL CELL, V23, P13, DOI 10.1016/j.molcel.2006.05.027; Xu J, 2013, NAT STRUCT MOL BIOL, V20, P1047, DOI 10.1038/nsmb.2623; Xu WQ, 1997, NATURE, V385, P595, DOI 10.1038/385595a0	52	24	25	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2016	291	16					8324	8336		10.1074/jbc.M115.683714	http://dx.doi.org/10.1074/jbc.M115.683714			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK2VT	26884335	Green Published, hybrid			2022-12-26	WOS:000374773200002
J	Hametner, S; Ferlitsch, A; Ferlitsch, M; Etschmaier, A; Schofl, R; Ziachehabi, A; Maieron, A				Hametner, Stephanie; Ferlitsch, Arnulf; Ferlitsch, Monika; Etschmaier, Alexandra; Schoefl, Rainer; Ziachehabi, Alexander; Maieron, Andreas			The VITRO Score (Von Willebrand Factor Antigen/Thrombocyte Ratio) as a New Marker for Clinically Significant Portal Hypertension in Comparison to Other Non-Invasive Parameters of Fibrosis Including ELF Test	PLOS ONE			English	Article							CHRONIC HEPATITIS-C; CHRONIC LIVER-DISEASE; ENDOTHELIAL DYSFUNCTION; STIFFNESS MEASUREMENT; GENOTYPES 1; CIRRHOSIS; PRESSURE; THERAPY; PERTURBATION; PREDICTOR	Background Clinically significant portal hypertension (CSPH), defined as hepatic venous pressure gradient (HVPG) >= 10 mmHg, causes major complications. HVPG is not always available, so a non-invasive tool to diagnose CSPH would be useful. VWF-Ag can be used to diagnose. Using the VITRO score (the VWF-Ag/platelet ratio) instead of VWF-Ag itself improves the diagnostic accuracy of detecting cirrhosis/fibrosis in HCV patients. Aim This study tested the diagnostic accuracy of VITRO score detecting CSPH compared to HVPG measurement. Methods All patients underwent HVPG testing and were categorised as CSPH or no CSPH. The following patient data were determined: CPS, D'Amico stage, VITRO score, APRI and transient elastography (TE). Results The analysis included 236 patients; 170 (72%) were male, and the median age was 57.9 (35.2-76.3; 95% CI). Disease aetiology included ALD (39.4%), HCV (23.4%), NASH (12.3%), other (8.1%) and unknown (11.9%). The CPS showed 140 patients (59.3%) with CPS A; 56 (23.7%) with CPS B; and 18 (7.6%) with CPS C. 136 patients (57.6%) had compensated and 100 (42.4%) had decompensated cirrhosis; 83.9% had HVPG >= 10 mmHg. The VWF-Ag and the VITRO score increased significantly with worsening HVPG categories (P<0.0001). ROC analysis was performed for the detection of CSPH and showed AUC values of 0.92 for TE, 0.86 for VITRO score, 0.79 for VWF-Ag, 0.68 for ELF and 0.62 for APRI. Conclusion The VITRO score is an easy way to diagnose CSPH independently of CPS in routine clinical work and may improve the management of patients with cirrhosis.	[Hametner, Stephanie; Schoefl, Rainer; Ziachehabi, Alexander; Maieron, Andreas] Elisabeth Hosp, Div Internal Med 4, Dept Gastroenterol & Hepatol, Linz, Austria; [Ferlitsch, Arnulf; Ferlitsch, Monika; Etschmaier, Alexandra] Med Univ Vienna, Div Internal Med 3, Dept Gastroenterol & Hepatol, Vienna, Austria	Ordensklinikum Linz Elisabethinen; Medical University of Vienna	Maieron, A (corresponding author), Elisabeth Hosp, Div Internal Med 4, Dept Gastroenterol & Hepatol, Linz, Austria.	andreas.maieron@elisabethinen.or.at						Afdhal N, 2008, J HEPATOL, V48, P1000, DOI 10.1016/j.jhep.2008.03.009; Ahmad W, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-44; Augustin S, 2014, J HEPATOL, V60, P561, DOI 10.1016/j.jhep.2013.10.027; Bosch J, 2006, SEMIN LIVER DIS, V26, P348, DOI 10.1055/s-2006-951603; Bosch J, 2009, NAT REV GASTRO HEPAT, V6, P573, DOI 10.1038/nrgastro.2009.149; Boursier J, 2013, HEPATOLOGY, V57, P1182, DOI 10.1002/hep.25993; Catanzaro R, 2013, HEPATOB PANCREAT DIS, V12, P500, DOI 10.1016/S1499-3872(13)60079-X; de Franchis R, 2015, J HEPATOL, V63, P743, DOI 10.1016/j.jhep.2015.05.022; de Franchis R, 2010, J HEPATOL, V53, P762, DOI 10.1016/j.jhep.2010.06.004; Ferenci P, 2010, GASTROENTEROLOGY, V138, P503, DOI 10.1053/j.gastro.2009.10.058; Ferlitsch A, 2007, AM J GASTROENTEROL, V102, P2495, DOI 10.1111/j.1572-0241.2007.01530.x; Ferlitsch M, 2012, HEPATOLOGY, V56, P1439, DOI 10.1002/hep.25806; Ferro D, 1996, HEPATOLOGY, V23, P1377, DOI 10.1053/jhep.1996.v23.pm0008675154; Homoncik M, 2005, ALIMENT PHARM THER, V21, P49, DOI 10.1111/j.1365-2036.2004.02305.x; Hubbard AR, 2004, J THROMB HAEMOST, V2, P1380, DOI 10.1111/j.1538-7836.2004.00838.x; Iannacone M, 2005, NAT MED, V11, P1167, DOI 10.1038/nm1317; Iwakiri Y, 2007, J HEPATOL, V46, P927, DOI 10.1016/j.jhep.2007.02.006; La Mura V, 2011, GUT, V60, P1133, DOI 10.1136/gut.2010.235689; Lichtinghagen R, 2013, J HEPATOL, V59, P236, DOI 10.1016/j.jhep.2013.03.016; Maieron A, 2014, ALIMENT PHARM THER, V39, P331, DOI 10.1111/apt.12564; Matei V, 2006, HEPATOLOGY, V44, P44, DOI 10.1002/hep.21228; Papatheodoridis GV, 2003, GUT, V52, P404, DOI 10.1136/gut.52.3.404; Peck-Radosavljevic M, 2013, WIEN KLIN WOCHENSCHR, V125, P200, DOI 10.1007/s00508-013-0337-z; Pramhas S, 2010, ANTIVIR THER, V15, P831, DOI 10.3851/IMP1654; Qamar AA, 2009, CLIN GASTROENTEROL H, V7, P689, DOI 10.1016/j.cgh.2009.02.021; Reiberger T, 2012, J GASTROENTEROL, V47, P561, DOI 10.1007/s00535-011-0517-4; Reiberger T, 2011, CLIN GASTROENTEROL H, V9, P602, DOI 10.1016/j.cgh.2011.03.002; Ripoll C, 2009, J HEPATOL, V50, P923, DOI 10.1016/j.jhep.2009.01.014; Schwabl P, 2015, LIVER INT, V35, P381, DOI 10.1111/liv.12623; Thabut D, 2011, HEPATOLOGY, V53, P683, DOI 10.1002/hep.24129; van Mourik JA, 1999, BLOOD, V94, P179, DOI 10.1182/blood.V94.1.179.413k18_179_185; Vizzutti F, 2007, HEPATOLOGY, V45, P1290, DOI 10.1002/hep.21665; Wahl K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051906; Wai CT, 2003, HEPATOLOGY, V38, P518, DOI 10.1053/jhep.2003.50346; Wang JH, 2014, LIVER INT, V34, P1340, DOI 10.1111/liv.12525	35	34	42	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0149230	10.1371/journal.pone.0149230	http://dx.doi.org/10.1371/journal.pone.0149230			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3DG	26895398	gold, Green Published, Green Submitted			2022-12-26	WOS:000371223400040
J	Kierdorf, U; Death, C; Hufschmid, J; Witzel, C; Kierdorf, H				Kierdorf, Uwe; Death, Clare; Hufschmid, Jasmin; Witzel, Carsten; Kierdorf, Horst			Developmental and Post-Eruptive Defects in Molar Enamel of Free-Ranging Eastern Grey Kangaroos (Macropus giganteus) Exposed to High Environmental Levels of Fluoride	PLOS ONE			English	Article							FLUOROSED DENTAL ENAMEL; HYPOPLASTIC ENAMEL; TEETH; SHEEP; MICROHARDNESS; FEATURES; LESIONS; AREAS; PERIODICITY; MECHANISMS	Dental fluorosis has recently been diagnosed in wild marsupials inhabiting a high-fluoride area in Victoria, Australia. Information on the histopathology of fluorotic marsupial enamel has thus far not been available. This study analyzed the developmental and post-eruptive defects in fluorotic molar enamel of eastern grey kangaroos (Macropus giganteus) from the same high-fluoride area using light microscopy and backscattered electron imaging in the scanning electron microscope. The fluorotic enamel exhibited a brownish to blackish discolouration due to post-eruptive infiltration of stains fromthe oral cavity and was less resistant to wear than normally mineralized enamel of kangaroos from low-fluoride areas. Developmental defects of enamel included enamel hypoplasia and a pronounced hypomineralization of the outer (sub-surface) enamel underneath a thin rim of well-mineralized surface enamel. While the hypoplastic defects denote a disturbance of ameloblast function during the secretory stage of amelogenesis, the hypomineralization is attributed to an impairment of enamelmaturation. In addition to hypoplastic defects, the fluorotic molars also exhibited numerous posteruptive enamel defects due to the flaking-off of portions of the outer, hypomineralized enamel layer during mastication. The macroscopic and histopathological lesions in fluorotic enamel of M. giganteus match those previously described for placental mammals. It is therefore concluded that there exist no principal differences in the pathogenic mechanisms of dental fluorosis between marsupial and placentalmammals. The regular occurrence of hypomineralized, opaque outer enamel in the teeth of M. giganteus and other macropodids must be considered in the differential diagnosis of dental fluorosis in these species.	[Kierdorf, Uwe; Witzel, Carsten; Kierdorf, Horst] Univ Hildesheim, Dept Biol, D-31141 Hildesheim, Germany; [Death, Clare; Hufschmid, Jasmin] Univ Melbourne, Fac Vet & Agr Sci, Werribee, Vic, Australia	University of Hildesheim; University of Melbourne	Kierdorf, U (corresponding author), Univ Hildesheim, Dept Biol, D-31141 Hildesheim, Germany.	uwe.kierdorf@uni-hildesheim.de	Hufschmid, Jasmin/Y-9079-2019; Kierdorf, Uwe/F-2539-2012; Death, Clare/ABE-2987-2020; Witzel, Carsten/AAD-9498-2022	Hufschmid, Jasmin/0000-0001-9427-7702; Kierdorf, Uwe/0000-0003-0531-2460; Death, Clare/0000-0003-4540-1214; Witzel, Carsten/0000-0002-1663-7618; Kierdorf, Horst/0000-0001-6411-9631	Australian Postgraduate Award Industry Scholarship; Alcoa Portland Aluminium Pty Ltd; Holsworth Wildlife Endowment Fund; German Academic Exchange Service (DAAD)	Australian Postgraduate Award Industry Scholarship(Australian Government); Alcoa Portland Aluminium Pty Ltd; Holsworth Wildlife Endowment Fund; German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD))	Clare Death was funded by an Australian Postgraduate Award Industry Scholarship in collaboration with Alcoa Portland Aluminium Pty Ltd, and the Holsworth Wildlife Endowment Fund. The funders are supportive of publication, but had no role in study design, data analysis, decision to publish, or preparation of the manuscript.; We gratefully acknowledge University of Melbourne travel scholarships and a grant from the German Academic Exchange Service (DAAD) to C. Death. We further thank D. Klosa for his skilful technical assistance, G. Coulson for his macropodid ecology expertise and support, and the reviewers for their helpful comments on the manuscript.	ANGMARMANSSON B, 1982, CARIES RES, V16, P334, DOI 10.1159/000260617; ANGMARMANSSON B, 1984, CARIES RES, V18, P25, DOI 10.1159/000260743; Antoine D, 2009, J ANAT, V214, P45, DOI 10.1111/j.1469-7580.2008.01010.x; Aoba T, 2002, CRIT REV ORAL BIOL M, V13, P155, DOI 10.1177/154411130201300206; Beniash E, 2009, J STRUCT BIOL, V166, P133, DOI 10.1016/j.jsb.2009.02.001; Best EC, 2013, J MAMMAL, V94, P1237, DOI 10.1644/13-MAMM-A-054.1; Boulton IC, 1997, J MORPHOL, V232, P155; BOYDE A, 1967, Z ZELLFORSCH MIK ANA, V82, P558, DOI 10.1007/BF00337122; BOYDE A, 1983, ANAT EMBRYOL, V168, P211, DOI 10.1007/BF00315817; Boyde A., 1989, HDB MICROSCOPIC ANAT, P309; Bronckers ALJJ, 2009, J DENT RES, V88, P877, DOI 10.1177/0022034509343280; Chen J, 2014, ENVIRON GEOCHEM HLTH, V36, P735, DOI 10.1007/s10653-013-9592-1; Clarke E, 2006, J ZOO WILDLIFE MED, V37, P477, DOI 10.1638/05-053.1; Coulson Graeme, 2000, P360; Cutress T W, 1990, J Dent Res, V69 Spec No, P714; Dean HT, 1936, J AMER MED ASSOC, V107, P1269, DOI 10.1001/jama.1936.02770420007002; Dean M.C., 2000, P119, DOI 10.1017/CBO9780511542626.009; Death C, 2015, SCI TOTAL ENVIRON, V533, P528, DOI 10.1016/j.scitotenv.2015.06.054; Everett ET, 2011, J DENT RES, V90, P552, DOI 10.1177/0022034510384626; FEJERSKO.O, 1974, SCAND J DENT RES, V82, P357; FEJERSKOV O, 1979, ARCH ORAL BIOL, V24, P123, DOI 10.1016/0003-9969(79)90060-8; FEJERSKOV O, 1975, CARIES RES, V9, P190, DOI 10.1159/000260157; FEJERSKOV O, 1977, SCAND J DENT RES, V85, P510; Fejerskov O., 1988, DENT FLUOROSIS HDB H; Flueck WT, 2013, J WILDLIFE DIS, V49, P355, DOI 10.7589/2012-11-272; Garrott RA, 2002, ECOSYSTEMS, V5, P659, DOI 10.1007/s10021-002-0211-8; Goldstein J., 2018, SCANNING ELECT MICRO, V4th ed.; Gustavsen F, 1972, THESIS U BERGEN NORW; Hillson S, 1997, AM J PHYS ANTHROPOL, V104, P89, DOI 10.1002/(SICI)1096-8644(199709)104:1<89::AID-AJPA6>3.0.CO;2-8; Hillson S, 2014, TOOTH DEVELOPMENT IN HUMAN EVOLUTION AND BIOARCHAEOLOGY, P1, DOI 10.1017/CBO9780511894916; Hillson S., 2005, TEETH; Hufschmid J, 2015, J COMP PATHOL, V153, P167, DOI 10.1016/j.jcpa.2015.06.002; Hufschmid J, 2011, ECOTOXICOLOGY, V20, P1378, DOI 10.1007/s10646-011-0695-0; Hume I.D., 1999, MARSUPIAL NUTR; Karstad L., 1967, B WILDLIFE DIS ASSOC, V3, P42, DOI DOI 10.7589/0090-3558-3.2.42; Kierdorf H, 2005, ANAT EMBRYOL, V209, P281, DOI 10.1007/s00429-004-0442-x; Kierdorf H, 2004, ANAT EMBRYOL, V207, P463, DOI 10.1007/s00429-003-0368-8; Kierdorf H, 2012, J ANAT, V220, P484, DOI 10.1111/j.1469-7580.2012.01482.x; Kierdorf H, 1997, CELL TISSUE RES, V289, P125, DOI 10.1007/s004410050858; Kierdorf H, 1997, ANN ANAT, V179, P405, DOI 10.1016/S0940-9602(97)80032-5; Kierdorf H, 2000, ANAT RECORD, V259, P12; Kierdorf H, 2014, ANAT REC, V297, P1935, DOI 10.1002/ar.22951; Kierdorf H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074597; Kierdorf U, 1996, J ANAT, V188, P183; KIERDORF U, 1993, ARCH ORAL BIOL, V38, P1071, DOI 10.1016/0003-9969(93)90169-M; KIERDORF U, 1989, VET PATHOL, V26, P209, DOI 10.1177/030098588902600304; Kirkpatrick TH., 1969, THESIS U QUEENSLAND; Kirkpatrick TH, 1965, QUEENSL J AGR ANIM S, V209, P169; LeGeros R Z, 1996, Adv Dent Res, V10, P225; LUCKETT WP, 1993, MAMMAL PHYLOGENY, P182; Lyaruu DM, 2014, J DENT RES, V93, P96, DOI 10.1177/0022034513510944; Lyaruu DM, 2012, CARIES RES, V46, P575, DOI 10.1159/000341802; Lyaruu DM, 2011, ARCH ORAL BIOL, V56, P238, DOI 10.1016/j.archoralbio.2010.10.006; LYARUU DM, 1989, J HISTOCHEM CYTOCHEM, V37, P581, DOI 10.1177/37.5.2703697; Nanci A., 2013, 10 CATES ORAL HISTOL, P122; O'Connor J. A., 1982, Fluoride emissions. Their monitoring and effects on vegetation and ecosystems, P77; Owen R., ODONTOGRAPHY TREATIS, VI, P1840; PALAMARA J, 1984, CELL TISSUE RES, V238, P329; PALAMARA J, 1981, CELL TISSUE RES, V221, P405, DOI 10.1007/BF00216744; PARANJPE MG, 1994, TOXICOL PATHOL, V22, P569, DOI 10.1177/019262339402200601; Pasteris JD, 2008, ELEMENTS, V4, P97, DOI 10.2113/GSELEMENTS.4.2.97; POOLE W E, 1982, Mammalian Species, P1, DOI 10.2307/3504005; PURDELLLEWIS DJ, 1987, J BIOL BUCCALE, V15, P119; Rafferty DP, 2000, J WILDLIFE DIS, V36, P636, DOI 10.7589/0090-3558-36.4.636; RICHARDS A, 1986, J DENT RES, V65, P1406, DOI 10.1177/00220345860650120501; RICHARDS A, 1992, CARIES RES, V26, P328, DOI 10.1159/000261463; Risnes S, 1998, J HUM EVOL, V35, P331, DOI 10.1006/jhev.1998.0229; Roholm K., 1937, FLUORINE INTOXICATIO; Roschger P, 1998, BONE, V23, P319, DOI 10.1016/S8756-3282(98)00112-4; Saunders S.R., 2008, BIOL ANTHR HUMAN SKE, P237; Sharma R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010895; SHEARER TR, 1978, AM J VET RES, V39, P597; SHINODA H, 1978, CALC TISS RES, V25, P75, DOI 10.1007/BF02010754; Shupe J. L., 1983, FLUORIDES EFFECTS VE, P319; SHUPE JL, 1984, J AM VET MED ASSOC, V185, P1295; Simmer JP, 2010, J DENT RES, V89, P1024, DOI 10.1177/0022034510375829; Smedley PL, 2013, ESSENTIALS MED GEOLO, P311, DOI DOI 10.1007/978-94-007-4375-5_13; Smith CE, 2005, J BONE MINER RES, V20, P240, DOI 10.1359/JBMR.041002; Smith CE, 1998, CRIT REV ORAL BIOL M, V9, P128, DOI 10.1177/10454411980090020101; Smith TM, 2008, J HUM EVOL, V54, P205, DOI 10.1016/j.jhevol.2007.09.020; Smith TM, 2006, J ANAT, V208, P99, DOI 10.1111/j.1469-7580.2006.00499.x; SUCKLING G, 1984, ARCH ORAL BIOL, V29, P165, DOI 10.1016/0003-9969(84)90050-5; SUCKLING G, 1988, ARCH ORAL BIOL, V33, P361, DOI 10.1016/0003-9969(88)90070-2; Suckling G W, 1989, Adv Dent Res, V3, P87; SUCKLING GW, 1982, CARIES RES, V16, P227, DOI 10.1159/000260602; Suga S, 1983, MECHANISMS TOOTH ENA, P167; SUNDSTROM B, 1980, CARIES RES, V14, P381, DOI 10.1159/000260480; SUTTIE JS, 1987, J WILDLIFE DIS, V23, P135, DOI 10.7589/0090-3558-23.1.135; Suzuki Masatsugu, 2003, Anatomical Science International, V78, P53, DOI 10.1046/j.0022-7722.2003.00039.x; THYLSTRUP A, 1978, ARCH ORAL BIOL, V23, P373, DOI 10.1016/0003-9969(78)90095-X; THYLSTRUP A, 1979, SCAND J DENT RES, V87, P105; Tomes J., 1849, PHILOS T R SOC LOND, V139, P403; Vikoren T, 1996, J WILDLIFE DIS, V32, P181, DOI 10.7589/0090-3558-32.2.181; von Koenigswald W., 2000, P107, DOI 10.1017/CBO9780511542626.008; WALTON KC, 1987, SCI TOTAL ENVIRON, V65, P257, DOI 10.1016/0048-9697(87)90178-1; Warshawsky H., 1988, CELL TISSUE BIOL TXB, P595; Weinstein L.H., 2004, FLUORIDES ENV; Whitford GM, 1996, MONOGR ORAL SCI, V16, P1; WHO (World Health Organization), 2002, ENV HLTH CRIT, V227; Witzel C, 2008, AM J PHYS ANTHROPOL, V136, P400, DOI 10.1002/ajpa.20822	100	13	15	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0147427	10.1371/journal.pone.0147427	http://dx.doi.org/10.1371/journal.pone.0147427			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3DG	26895178	Green Published, gold			2022-12-26	WOS:000371223400005
J	Osawa, K; Miyoshi, T; Miki, T; Koyama, Y; Sato, S; Kanazawa, S; Ito, H				Osawa, Kazuhiro; Miyoshi, Toru; Miki, Takashi; Koyama, Yasushi; Sato, Shuhei; Kanazawa, Susumu; Ito, Hiroshi			Diagnostic Performance of First-Pass Myocardial Perfusion Imaging without Stress with Computed Tomography (CT) Compared with Coronary CT Angiography Alone, with Fractional Flow Reserve as the Reference Standard	PLOS ONE			English	Article							NXT TRIAL ANALYSIS; ARTERY-DISEASE; ISCHEMIA; STENOSIS; REVASCULARIZATION; INTERVENTION; GUIDELINES; MANAGEMENT; CARDIOLOGY; SOCIETY	Coronary computed tomography angiography (CCTA) in combination with first-pass CT myocardial perfusion imaging (MPI) has a better diagnostic performance than CCTA alone, compared with invasive coronary angiography as the reference standard. The aim of this study was to investigate the additional diagnostic value of first-pass CT-MPI without stress for detecting hemodynamic significance of coronary stenosis, compared with invasive fractional flow reserve (FFR). We recruited 53 patients with suspected coronary artery disease undergoing both CCTA and first-pass CT-MPI without stress and invasive FFR, and 75 vessels were analyzed. We used the same raw data for CCTA and CT-MPI. First-pass CT-MPI was reconstructed by examining the diastolic signal densities as a bull's eye map. Invasive FFR <0.8 was considered as positive. On per-vessel analysis, the area under the receiver operating characteristic curve for CCTA plus first-pass CT-MPI and CCTA alone was 0.81 (0.73-0.90) and 0.70 (0.61-0.81), respectively (P = 0.036). CCTA plus first-pass CT-MPI without stress showed 0.73 sensitivity, 0.74 specificity, 0.53 positive predictive value, and 0.87 negative predictive value for detecting hemodynamically significant coronary stenosis. First-pass CT-MPI without stress correctly reclassified 38% of CCTA false-positive vessels as true negative. First-pass CT-MPI without stress combined with CCTA demonstrated excellent diagnostic accuracy, compared with invasive FFR as the reference standard. This technique could complement CCTA for diagnosis of coronary artery disease.	[Osawa, Kazuhiro; Miyoshi, Toru; Miki, Takashi; Ito, Hiroshi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Cardiovasc Med, Okayama, Japan; [Koyama, Yasushi] Sakurabashi Watanabe Hosp, Dept Cardiol, Osaka, Japan; [Sato, Shuhei; Kanazawa, Susumu] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Radiol, Okayama, Japan	Okayama University; Okayama University	Miyoshi, T (corresponding author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Cardiovasc Med, Okayama, Japan.	miyoshit@cc.okayama-u.ac.jp	Osawa, Kazuhiro/ABE-7537-2020		 [24591053]		This research was supported by the Grant-in-Aid for Scientific Research (C), number 24591053.	Bamberg F, 2011, RADIOLOGY, V260, P689, DOI 10.1148/radiol.11110638; Blankstein R, 2009, J AM COLL CARDIOL, V54, P1072, DOI 10.1016/j.jacc.2009.06.014; Cerqueira MD, 2002, INT J CARDIOVAS IMAG, V18, P539; Curzen N, 2014, CIRC-CARDIOVASC INTE, V7, P248, DOI 10.1161/CIRCINTERVENTIONS.113.000978; Douglas PS, 2015, EUR HEART J, V36, P3359, DOI 10.1093/eurheartj/ehv444; Gaur S, 2013, J CARDIOVASC COMPUT, V7, P279, DOI 10.1016/j.jcct.2013.09.003; George RT, 2012, CIRC-CARDIOVASC IMAG, V5, P333, DOI 10.1161/CIRCIMAGING.111.969303; Hamilos M, 2009, CIRCULATION, V120, P1505, DOI 10.1161/CIRCULATIONAHA.109.850073; Kim YH, 2013, CIRC J, V77, P1967, DOI 10.1253/circj.CJ-13-0376; Ko BS, 2012, EUR HEART J, V33, P67, DOI 10.1093/eurheartj/ehr268; Koo BK, 2011, J AM COLL CARDIOL, V58, P1989, DOI 10.1016/j.jacc.2011.06.066; Meijboom WB, 2008, J AM COLL CARDIOL, V52, P636, DOI 10.1016/j.jacc.2008.05.024; Min JK, 2015, JACC-CARDIOVASC IMAG, V8, P1209, DOI 10.1016/j.jcmg.2015.08.006; Min JK, 2012, JAMA-J AM MED ASSOC, V308, P1237, DOI 10.1001/2012.jama.11274; Miyoshi T, 2015, CIRC J, V79, P406, DOI 10.1253/circj.CJ-14-1051; Montalescot G, 2013, EUR HEART J, V34, P2949, DOI 10.1093/eurheartj/eht296; Norgaard BL, 2014, J AM COLL CARDIOL, V63, P1145, DOI 10.1016/j.jacc.2013.11.043; NOTO TJ, 1991, CATHETER CARDIO DIAG, V24, P75, DOI 10.1002/ccd.1810240202; Osawa K, 2014, HEART, V100, P1008, DOI 10.1136/heartjnl-2013-305468; Patel Manesh R, 2012, J Am Coll Cardiol, V59, P857, DOI 10.1016/j.jacc.2011.12.001; Pijls NHJ, 2007, J AM COLL CARDIOL, V49, P2105, DOI 10.1016/j.jacc.2007.01.087; Rochitte CE, 2014, EUR HEART J, V35, P1120, DOI 10.1093/eurheartj/eht488; Stuijfzand WJ, 2014, JACC-CARDIOVASC IMAG, V7, P374, DOI 10.1016/j.jcmg.2013.12.013; Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS), 2010, Eur Heart J, V31, P2501, DOI 10.1093/eurheartj/ehq277; Tonino PAL, 2009, NEW ENGL J MED, V360, P213, DOI 10.1056/NEJMoa0807611; Vavere AL, 2011, RADIOLOGY, V261, P100, DOI 10.1148/radiol.11110537; Yamada M, 2011, CIRC J, V75, P472, DOI 10.1253/circj.CJ-10-0636; Yoshioka K, 2015, INT J CARDIOVAS IMAG, V31, P51, DOI 10.1007/s10554-015-0630-1; Zoghbi GJ, 2008, J AM COLL CARDIOL, V52, P401, DOI 10.1016/j.jacc.2008.04.035	29	12	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0149170	10.1371/journal.pone.0149170	http://dx.doi.org/10.1371/journal.pone.0149170			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3DG	26894686	Green Submitted, Green Published, gold			2022-12-26	WOS:000371223400034
J	Eich, C; Lasonder, E; Cruz, LJ; Reinieren-Beeren, I; Cambi, A; Figdor, CG; Buschow, SI				Eich, Christina; Lasonder, Edwin; Cruz, Luis J.; Reinieren-Beeren, Inge; Cambi, Alessandra; Figdor, Carl G.; Buschow, Sonja I.			Proteome Based Construction of the Lymphocyte Function-Associated Antigen 1 (LFA-1) Interactome in Human Dendritic Cells	PLOS ONE			English	Article							T-CELL; INTEGRIN; RECEPTOR; ADHESION; ACTIVATION; ORGANIZATION; MIGRATION; TALIN; RECRUITMENT; REGULATOR	The beta 2-integrin lymphocyte function-associated antigen 1 (LFA-1) plays an important role in the migration, adhesion and intercellular communication of dendritic cells (DCs). During the differentiation of human DCs from monocyte precursors, LFA-1 ligand binding capacity is completely lost, even though its expression levels were remained constant. Yet LFA-1-mediated adhesive capacity on DCs can be regained by exposing DCs to the chemokine CCL21, suggesting a high degree of regulation of LFA-1 activity during the course of DC differentiation. The molecular mechanisms underlying this regulation of LFA-1 function in DCs, however, remain elusive. To get more insight we attempted to identify specific LFA-1 binding partners that may play a role in regulating LFA-1 activity in DCs. We used highly sensitive label free quantitative mass-spectrometry to identify proteins co-immunoprecipitated (co-IP) with LFA-1 from ex vivo generated DCs. Among the potential binding partners we identified not only established components of integrin signalling pathways and cytoskeletal proteins, but also several novel LFA-1 binding partners including CD13, galectin-3, thrombospondin-1 and CD44. Further comparison to the LFA-1 interaction partners in monocytes indicated that DC differentiation was accompanied by an overall increase in LFA-1 associated proteins, in particular cytoskeletal, signalling and plasma membrane (PM) proteins. The here presented LFA-1 interactome composed of 78 proteins thus represents a valuable resource of potential regulators of LFA-1 function during the DC lifecycle.	[Eich, Christina; Reinieren-Beeren, Inge; Cambi, Alessandra; Figdor, Carl G.; Buschow, Sonja I.] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, Dept Tumor Immunol, NL-6525 ED Nijmegen, Netherlands; [Lasonder, Edwin] Radboud Univ Nijmegen, Med Ctr, CMBI, Radboud Inst Mol Life Sci, NL-6525 ED Nijmegen, Netherlands; [Cruz, Luis J.] Leiden Univ, Med Ctr, Dept Radiol, Nanomed & Mol Imaging, Leiden, Netherlands; [Eich, Christina] Erasmus MC, Stem Cell Inst, Dept Cell Biol, Rotterdam, Netherlands; [Lasonder, Edwin] Univ Plymouth, Sch Biomed & Healthcare Sci, Plymouth PL4 8AA, Devon, England; [Buschow, Sonja I.] Erasmus MC Univ Med Ctr, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Erasmus University Rotterdam; Erasmus MC; University of Plymouth; Erasmus University Rotterdam; Erasmus MC	Figdor, CG (corresponding author), Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, Dept Tumor Immunol, NL-6525 ED Nijmegen, Netherlands.	carl.figdor@radboudumc.nl	Figdor, Carl G/A-4232-2010; Buschow, Sonja/AAD-3567-2020; Cambi, Alessandra/L-4242-2015	Figdor, Carl G/0000-0002-2366-9212; Lasonder, Edwin/0000-0003-2582-3444; Eich, Christina/0000-0001-7839-0932; Buschow, Sonja/0000-0002-7907-8315; Cambi, Alessandra/0000-0003-1597-1582	EU [MRTN-CT-2006-035946]; EU-Mexico grant FONCICYT; Netherlands Organization for Scientific Research grant [Meervoud 836.09.002]; Netherlands Organization for Scientific Research Spinoza Prize; ERC Adv Grant PATHFINDER [269019]; KWO award of the Dutch Cancer Society [KUN2009-4402]	EU(European Commission); EU-Mexico grant FONCICYT; Netherlands Organization for Scientific Research grant(Netherlands Organization for Scientific Research (NWO)); Netherlands Organization for Scientific Research Spinoza Prize; ERC Adv Grant PATHFINDER; KWO award of the Dutch Cancer Society	This work was financially supported by the EU grant Immunanomap, MRTN-CT-2006-035946 (to CGF, http://ec.europa.eu/research/participants/portal/desktop/en/home.html), the EU-Mexico grant FONCICYT (to CGF) and the Netherlands Organization for Scientific Research grant Meervoud 836.09.002 (to AC, www.nwo.nl). CGF is recipient of the Netherlands Organization for Scientific Research Spinoza Prize, ERC Adv Grant PATHFINDER (269019) and KWO award KUN2009-4402 of the Dutch Cancer Society (www.kwf.nl).	Abdel-Latif MMM, 2005, BRIT J PHARMACOL, V146, P1139, DOI 10.1038/sj.bjp.0706421; Alon R, 2007, IMMUNITY, V26, P17, DOI 10.1016/j.immuni.2007.01.002; Arana E, 2008, IMMUNITY, V28, P88, DOI 10.1016/j.immuni.2007.12.003; Attanasio F, 2011, EUR J CELL BIOL, V90, P115, DOI 10.1016/j.ejcb.2010.05.004; Bakker GJ, 2012, PNAS IN PRESS; Bernardini G, 2005, FASEB J, V19, P1305, DOI 10.1096/fj.04-3352fje; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Borgman KJE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099589; Buschow SI, 2010, J PROTEOME RES, V9, P1727, DOI 10.1021/pr9008546; Cambi A, 2006, MOL BIOL CELL, V17, P4270, DOI 10.1091/mbc.E05-12-1098; Cervero P, 2012, EUR J CELL BIOL, V91, P908, DOI 10.1016/j.ejcb.2012.05.005; Choi EY, 2008, BLOOD, V111, P3607, DOI 10.1182/blood-2007-07-103077; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; DUSTIN ML, 1989, NATURE, V341, P619, DOI 10.1038/341619a0; Eich C, 2011, IMMUNOL CELL BIOL, V89, P458, DOI 10.1038/icb.2010.103; Ezratty EJ, 2009, J CELL BIOL, V187, P733, DOI 10.1083/jcb.200904054; Fengos G, 2014, PROTEOME SCI, V12, DOI 10.1186/1477-5956-12-23; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Geiger T, 2012, CURR OPIN CELL BIOL, V24, P562, DOI 10.1016/j.ceb.2012.05.004; Ginsberg MH, 2005, CURR OPIN CELL BIOL, V17, P509, DOI 10.1016/j.ceb.2005.08.010; Gonzalo P, 2010, BIOFACTORS, V36, P248, DOI 10.1002/biof.99; Han JW, 2006, CURR BIOL, V16, P1796, DOI 10.1016/j.cub.2006.08.035; Hogg N, 2011, NAT REV IMMUNOL, V11, P416, DOI 10.1038/nri2986; Humphries JD, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000396; Jacquemet Guillaume, 2013, Small GTPases, V4, P199, DOI 10.4161/sgtp.27451; Johnson LA, 2008, ANN NY ACAD SCI, V1131, P119, DOI 10.1196/annals.1413.011; Katagiri K, 2002, MOL CELL BIOL, V22, P1001, DOI 10.1128/MCB.22.4.1001-1015.2002; KEIZER GD, 1985, EUR J IMMUNOL, V15, P1142, DOI 10.1002/eji.1830151114; Krauss K, 1999, J BIOL CHEM, V274, P36921, DOI 10.1074/jbc.274.52.36921; Kueh HY, 2008, J CELL BIOL, V182, P341, DOI 10.1083/jcb.200801027; Kuo JC, 2011, NAT CELL BIOL, V13, P383, DOI 10.1038/ncb2216; Lammermann T, 2008, NATURE, V453, P51, DOI 10.1038/nature06887; Lajoie P, 2009, J CELL BIOL, V185, P381, DOI 10.1083/jcb.200811059; Lakshminarayan R, 2014, NAT CELL BIOL, V16, P592, DOI 10.1038/ncb2970; Lasserre R, 2008, NAT CHEM BIOL, V4, P538, DOI 10.1038/nchembio.103; Laudanna C, 2009, WIRES SYST BIOL MED, V1, P116, DOI 10.1002/wsbm.9; Mina-Osorio P, 2008, J LEUKOCYTE BIOL, V84, P448, DOI 10.1189/jlb.1107802; MIYAMOTO S, 1995, SCIENCE, V267, P883, DOI 10.1126/science.7846531; Moser M, 2009, SCIENCE, V324, P895, DOI 10.1126/science.1163865; Ono S, 2004, J BIOL CHEM, V279, P14207, DOI 10.1074/jbc.M313418200; PETER K, 1995, J EXP MED, V181, P315, DOI 10.1084/jem.181.1.315; Pontier SM, 2008, J BIOL CHEM, V283, P24659, DOI 10.1074/jbc.M800778200; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Sampath R, 1998, J BIOL CHEM, V273, P33588, DOI 10.1074/jbc.273.50.33588; Saravanan C, 2009, J CELL SCI, V122, P3684, DOI 10.1242/jcs.045674; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Shimaoka M, 2002, ANNU REV BIOPH BIOM, V31, P485, DOI 10.1146/annurev.biophys.31.101101.140922; Tsukamoto N, 1999, J BIOL CHEM, V274, P18463, DOI 10.1074/jbc.274.26.18463; van Zanten TS, 2009, P NATL ACAD SCI USA, V106, P18557, DOI 10.1073/pnas.0905217106; Ye F, 2014, CELL, V156, DOI 10.1016/j.cell.2014.02.048; Zaidel-Bar R, 2009, J CELL BIOL, V186, P317, DOI 10.1083/jcb.200811067; Zarbock A, 2007, BLOOD, V110, P3773, DOI 10.1182/blood-2007-06-094565; Zarbock A, 2007, IMMUNITY, V26, P773, DOI 10.1016/j.immuni.2007.04.011; Zhang YB, 2012, IMMUNOLOGY, V135, P268, DOI 10.1111/j.1365-2567.2011.03549.x	55	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2016	11	2							e0149637	10.1371/journal.pone.0149637	http://dx.doi.org/10.1371/journal.pone.0149637			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3CO	26889827	gold, Green Accepted, Green Published			2022-12-26	WOS:000371221500065
J	Tobita, T; Guzman-Lepe, J; Takeishi, K; Nakao, T; Wang, Y; Meng, FY; Deng, CX; Collin de l'Hortet, A; Soto-Gutierrez, A				Tobita, Takamasa; Guzman-Lepe, Jorge; Takeishi, Kazuki; Nakao, Toshimasa; Wang, Yang; Meng, Fanying; Deng, Chu-Xia; Collin de l'Hortet, Alexandra; Soto-Gutierrez, Alejandro			SIRT1 Disruption in Human Fetal Hepatocytes Leads to Increased Accumulation of Glucose and Lipids	PLOS ONE			English	Article							FATTY LIVER-DISEASE; INSULIN-RESISTANCE; HEPATIC STEATOSIS; RESTRICTION LEADS; METABOLISM; EXPRESSION; MICE; DIET; GLUCONEOGENESIS; PROTECTS	There are unprecedented epidemics of obesity, such as type II diabetes and non-alcoholic fatty liver diseases (NAFLD) in developed countries. A concerning percentage of American children are being affected by obesity and NAFLD. Studies have suggested that the maternal environment in utero might play a role in the development of these diseases later in life. In this study, we documented that inhibiting SIRT1 signaling in human fetal hepatocytes rapidly led to an increase in intracellular glucose and lipids levels. More importantly, both de novo lipogenesis and gluconeogenesis related genes were upregulated upon SIRT1 inhibition. The AKT/FOXO1 pathway, a major negative regulator of gluconeogenesis, was decreased in the human fetal hepatocytes inhibited for SIRT1, consistent with the higher level of gluconeogenesis. These results indicate that SIRT1 is an important regulator of lipid and carbohydrate metabolisms within human fetal hepatocytes, acting as an adaptive transcriptional response to environmental changes.	[Tobita, Takamasa; Guzman-Lepe, Jorge; Takeishi, Kazuki; Nakao, Toshimasa; Wang, Yang; Meng, Fanying; Collin de l'Hortet, Alexandra; Soto-Gutierrez, Alejandro] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA USA; [Soto-Gutierrez, Alejandro] Univ Pittsburgh, Thomas E Starzl Transplant Inst, Pittsburgh, PA USA; [Soto-Gutierrez, Alejandro] McGowan Inst Regenerat Med, Pittsburgh, PA USA; [Wang, Yang] Peking Univ, Peoples Hosp, Dept Hepatobiliary Surg, Beijing 100871, Peoples R China; [Deng, Chu-Xia] Univ Macau, Fac Hlth Sci, Ave Univ, Taipa, Macau, Peoples R China	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Peking University; University of Macau	Collin de l'Hortet, A; Soto-Gutierrez, A (corresponding author), Univ Pittsburgh, Dept Pathol, Pittsburgh, PA USA.; Soto-Gutierrez, A (corresponding author), Univ Pittsburgh, Thomas E Starzl Transplant Inst, Pittsburgh, PA USA.; Soto-Gutierrez, A (corresponding author), McGowan Inst Regenerat Med, Pittsburgh, PA USA.	alexandra.collin@pitt.edu; sotogutierreza@upmc.edu	deng, chuxia/N-6713-2016; Collin de l'Hortet, Alexandra/D-6025-2016; Takeishi, Kazuki/AAC-9087-2019	Collin de l'Hortet, Alexandra/0000-0002-9437-7030; Takeishi, Kazuki/0000-0002-8448-5396	US National Institutes of Health [DK099257, UH3TR000503, ES022606]; Competitive Medical Research Fund Program from UPMC Health System; NIH from the Eunice Kennedy Shriver National Institute of Child Health AMP; Human Development [5R24HD000836]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD000836] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UH3TR000503] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK099257] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES022606] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Competitive Medical Research Fund Program from UPMC Health System; NIH from the Eunice Kennedy Shriver National Institute of Child Health AMP; Human Development; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Funding from the US National Institutes of Health (DK099257 to A.S.-G., UH3TR000503 and ES022606 subcontract to A.S.-G.), and the Competitive Medical Research Fund Program from UPMC Health System to A.S.-G. Laboratory of Developmental Biology was supported by NIH Award Number 5R24HD000836 from the Eunice Kennedy Shriver National Institute of Child Health & Human Development.	Alisi A, 2012, NAT REV GASTRO HEPAT, V9, P152, DOI 10.1038/nrgastro.2011.273; Bordone L, 2005, NAT REV MOL CELL BIO, V6, P298, DOI 10.1038/nrm1616; Borengasser SJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084209; Brenseke B, 2015, ENDOCRINOLOGY, V156, P182, DOI 10.1210/en.2014-1523; Browning JD, 2004, J CLIN INVEST, V114, P147, DOI 10.1172/JCI200422422; Chang HC, 2014, TRENDS ENDOCRIN MET, V25, P138, DOI 10.1016/j.tem.2013.12.001; Chatelain F, 1996, EUR J BIOCHEM, V235, P789, DOI 10.1111/j.1432-1033.1996.00789.x; Christopher L., 2009, NATURE REV CANC, V9; Clayton ZE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141962; Clive J., 2001, INT J EXPT DIABETES, V2, P139; Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265; Deng XQ, 2007, LIVER INT, V27, P708, DOI 10.1111/j.1478-3231.2007.01497.x; Erion DM, 2009, P NATL ACAD SCI USA, V106, P11288, DOI 10.1073/pnas.0812931106; Fernandez-Twinn DS, 2005, AM J PHYSIOL-REG I, V288, pR368, DOI 10.1152/ajpregu.00206.2004; Hales CN, 2001, BRIT MED BULL, V60, P5, DOI 10.1093/bmb/60.1.5; Herranz D, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1001; Joseph T., 2005, NATURE, V434, P113, DOI [10.1038/nature03314, DOI 10.1038/NATURE03314]; Li X, 2007, MOL CELL, V28, P91, DOI 10.1016/j.molcel.2007.07.032; Li Y, 2011, FASEB J, V25, P1664, DOI 10.1096/fj.10-173492; Liu Y, 2008, NATURE, V456, P269, DOI 10.1038/nature07349; McCurdy CE, 2009, J CLIN INVEST, V119, P323, DOI 10.1172/JCI32661; Muoio DM, 2008, NAT REV MOL CELL BIO, V9, P193, DOI 10.1038/nrm2327; Nobili V, 2015, JAMA PEDIATR, V169, P170, DOI 10.1001/jamapediatrics.2014.2702; Ozanne SE, 2003, J ENDOCRINOL, V177, P235, DOI 10.1677/joe.0.1770235; Pfluger PT, 2008, P NATL ACAD SCI USA, V105, P9793, DOI 10.1073/pnas.0802917105; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Purushotham A, 2009, CELL METAB, V9, P327, DOI 10.1016/j.cmet.2009.02.006; Rando OJ, 2015, CELL, V161, P93, DOI 10.1016/j.cell.2015.02.021; Ravelli ACJ, 1998, LANCET, V351, P173, DOI 10.1016/S0140-6736(97)07244-9; Rodgers JT, 2008, FEBS LETT, V582, P46, DOI 10.1016/j.febslet.2007.11.034; Schug TT, 2011, ANN MED, V43, P198, DOI 10.3109/07853890.2010.547211; Suter MA, 2012, FASEB J, V26, P5106, DOI 10.1096/fj.12-212878; VALDEZ R, 1994, DIABETOLOGIA, V37, P624, DOI 10.1007/s001250050157; Wang RH, 2011, J CLIN INVEST, V121, P4477, DOI 10.1172/JCI46243; Wang RH, 2010, INT J BIOL SCI, V6, P682; Yamamoto M, 2013, P NATL ACAD SCI USA, V110, P14948, DOI 10.1073/pnas.1220606110	36	36	37	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2016	11	2							e0149344	10.1371/journal.pone.0149344	http://dx.doi.org/10.1371/journal.pone.0149344			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3CO	26890260	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000371221500038
J	Eike, LM; Mauseth, B; Camilio, KA; Rekdal, O; Sveinbjornsson, B				Eike, Liv-Marie; Mauseth, Brynjar; Camilio, Ketil Andre; Rekdal, Oystein; Sveinbjornsson, Baldur			The Cytolytic Amphipathic beta(2,2)-Amino Acid LTX-401 Induces DAMP Release in Melanoma Cells and Causes Complete Regression of B16 Melanoma	PLOS ONE			English	Article							HOST-DEFENSE PEPTIDES; CYTOCHROME-C; INTRATUMORAL INJECTION; MOLECULAR-PATTERNS; ANTITUMOR-ACTIVITY; IMMUNE MODULATION; DENDRITIC CELLS; CANCER; DEATH; TUMOR	In the present study we examined the ability of the amino acid derivative LTX-401 to induce cell death in cancer cell lines, as well as the capacity to induce regression in a murine melanoma model. Mode of action studies in vitro revealed lytic cell death and release of danger-associated molecular pattern molecules, preceded by massive cytoplasmic vacuolization and compromised lysosomes in treated cells. The use of a murine melanoma model demonstrated that the majority of animals treated with intratumoural injections of LTX-401 showed complete and long-lasting remission. Taken together, these results demonstrate the potential of LTX-401 as an immunotherapeutic agent for the treatment of solid tumors.	[Eike, Liv-Marie; Mauseth, Brynjar; Camilio, Ketil Andre; Rekdal, Oystein; Sveinbjornsson, Baldur] Univ Tromso, Inst Med Biol, Fac Hlth, Dept Mol Inflammat Res, N-9037 Tromso, Norway; [Rekdal, Oystein] Lytix Biopharma, Oslo, Norway; [Sveinbjornsson, Baldur] Karolinska Inst, Dept Womens & Childrens Hlth, Childhood Canc Res Unit, Stockholm, Sweden	UiT The Arctic University of Tromso; Karolinska Institutet	Sveinbjornsson, B (corresponding author), Univ Tromso, Inst Med Biol, Fac Hlth, Dept Mol Inflammat Res, N-9037 Tromso, Norway.; Sveinbjornsson, B (corresponding author), Karolinska Inst, Dept Womens & Childrens Hlth, Childhood Canc Res Unit, Stockholm, Sweden.	baldur.sveinbjornsson@uit.no			University of Tromso; Lytix Biopharma; Northern Regional Health Authority; University Hospital of North Norway	University of Tromso; Lytix Biopharma; Northern Regional Health Authority; University Hospital of North Norway	The study was funded by grants from the University of Tromso, Lytix Biopharma and the Northern Regional Health Authority and the University Hospital of North Norway. Lytix Biopharma AS provided support in the form of salaries for the authors [B.S, O.R and K.A.C], but did not have any additional role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.; The study was funded by grants from the University of Tromso, Lytix Biopharma and the Northern Regional Health Authority, and the University Hospital of North Norway.	Adachi N, 2004, CLIN CHIM ACTA, V342, P127, DOI 10.1016/j.cccn.2003.12.011; Al-Benna S, 2011, INT J MOL SCI, V12, P8027, DOI 10.3390/ijms12118027; Ausbacher D, 2012, BBA-BIOMEMBRANES, V1818, P2917, DOI 10.1016/j.bbamem.2012.07.005; Aymeric L, 2010, CANCER RES, V70, P855, DOI 10.1158/0008-5472.CAN-09-3566; Ayna G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040069; Baird JR, 2013, J IMMUNOL, V190, P469, DOI 10.4049/jimmunol.1201209; Berge G, 2010, CANCER IMMUNOL IMMUN, V59, P1285, DOI 10.1007/s00262-010-0857-6; Bianchi ME, 2014, CELL DEATH DIFFER, V21, P1, DOI 10.1038/cdd.2013.147; Camilio KA, 2014, ONCOIMMUNOLOGY, V3, DOI 10.4161/onci.29181; Camilio KA, 2014, CANCER IMMUNOL IMMUN, V63, P601, DOI 10.1007/s00262-014-1540-0; Carta S, 2009, J LEUKOCYTE BIOL, V86, P549, DOI 10.1189/jlb.1008598; Chiang EY, 2003, J IMMUNOL, V170, P4515, DOI 10.4049/jimmunol.170.9.4515; Choi KY, 2012, J INNATE IMMUN, V4, P361, DOI 10.1159/000336630; Danielli R, 2015, CANCER IMMUNOL IMMUN, V64, P999, DOI 10.1007/s00262-015-1704-6; Eliassen LT, 2002, ANTICANCER RES, V22, P2703; Elliott MR, 2009, NATURE, V461, P282, DOI 10.1038/nature08296; Goldstein JC, 2000, NAT CELL BIOL, V2, P156, DOI 10.1038/35004029; Griffith G, 1993, FIXATION FINE STRUCT; Guerriero JL, 2011, J IMMUNOL, V186, P3517, DOI 10.4049/jimmunol.1003267; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hansen T, 2012, EUR J MED CHEM, V58, P22, DOI 10.1016/j.ejmech.2012.09.048; Hayat M. A., 1993, STAIN CYTOCHEMICAL M; Hilchie AL, 2013, NAT CHEM BIOL, V9, P761, DOI [10.1038/NCHEMBIO.1393, 10.1038/nchembio.1393]; Huang YB, 2012, INT J MOL SCI, V13, P6849, DOI 10.3390/ijms13066849; Huang YB, 2011, MOL CANCER THER, V10, P416, DOI 10.1158/1535-7163.MCT-10-0811; Inoue H, 2014, CELL DEATH DIFFER, V21, P39, DOI 10.1038/cdd.2013.84; Jemmerson R, 2002, CELL DEATH DIFFER, V9, P538, DOI 10.1038/sj.cdd.4400981; Kepp O, 2011, CANCER METAST REV, V30, P61, DOI 10.1007/s10555-011-9273-4; Kroemer G, 2013, ANNU REV IMMUNOL, V31, P51, DOI 10.1146/annurev-immunol-032712-100008; Krysko O, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.156; Ladoire S, 2014, ANTIOXID REDOX SIGN, V20, P1098, DOI 10.1089/ars.2012.5133; Lichty BD, 2014, NAT REV CANCER, V14, P559, DOI 10.1038/nrc3770; Liu YA, 2012, J IMMUNOTHER, V35, P299, DOI 10.1097/CJI.0b013e3182518e83; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; Maletzki C, 2014, ONCOTARGET, V5, P4467, DOI 10.18632/oncotarget.2039; Martins I, 2012, AUTOPHAGY, V8, P413, DOI 10.4161/auto.19009; Midura-Nowaczek K, 2014, PERSPECT MED CHEM, V6, P73, DOI 10.4137/PMC.S13215; Palombo F, 2014, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00503; Pierce RH, 2015, HUM VACC IMMUNOTHER, V11, P1901, DOI 10.1080/21645515.2015.1049779; Pokrovskaya ID, 2012, CELL MICROBIOL, V14, P656, DOI 10.1111/j.1462-5822.2012.01747.x; Prestwich RJ, 2008, CLIN CANCER RES, V14, P7358, DOI 10.1158/1078-0432.CCR-08-0831; Pullerits R, 2005, RHEUMATOLOGY, V44, P32, DOI 10.1093/rheumatology/keh406; Rozera C, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0473-5; SHIMOYAMA Y, 1989, J SURG ONCOL, V41, P12, DOI 10.1002/jso.2930410107; Singh M, 2015, CANCER IMMUNOL IMMUN, V64, P911, DOI 10.1007/s00262-015-1727-z; Strom MB, 2003, J MED CHEM, V46, P1567, DOI 10.1021/jm0340039; Szczepanski Claudia, 2014, Genes Cancer, V5, P186; Tang DL, 2010, BBA-GENE REGUL MECH, V1799, P131, DOI 10.1016/j.bbagrm.2009.11.014; Ullrich E, 2008, CELL DEATH DIFFER, V15, P21, DOI 10.1038/sj.cdd.4402266; Vacchelli E, 2014, ONCOIMMUNOLOGY, V3, DOI [10.4161/onci.27048, 10.4161/onci.27878]; Wenceslau CF, 2014, EUR HEART J, V35, P1172, DOI 10.1093/eurheartj/ehu047; Yang H, 2012, MOL MED, V18, P250, DOI 10.2119/molmed.2011.00389; Yang N, 2004, J PEPT SCI, V10, P37, DOI 10.1002/psc.470; Yang N, 2002, J PEPT RES, V60, P187, DOI 10.1034/j.1399-3011.2002.21008.x; Yang NN, 2003, J PEPT SCI, V9, P300, DOI 10.1002/psc.457; Zitvogel L, 2008, J CLIN INVEST, V118, P1991, DOI 10.1172/JCI35180	56	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0148980	10.1371/journal.pone.0148980	http://dx.doi.org/10.1371/journal.pone.0148980			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	26881822	Green Published, Green Submitted, gold			2022-12-26	WOS:000371219000038
J	Lai, XJ; Zhang, B; Jiang, YX; Li, JC; Zhao, RN; Yang, X; Zhang, XY; Zhu, SL; Wu, Q; Cai, S; Zhang, YX				Lai, Xingjian; Zhang, Bo; Jiang, Yuxin; Li, Jianchu; Zhao, Ruina; Yang, Xiao; Zhang, Xiaoyan; Zhu, Shenling; Wu, Qiong; Cai, Sheng; Zhang, Yixiu			Sonographic and Clinical Features of Papillary Thyroid Microcarcinoma Less than or Equal to Five Millimeters: A Retrospective Study	PLOS ONE			English	Article							LYMPH-NODE METASTASIS; MULTIFOCALITY	Objective To retrospectively compare the sonographic and clinical features of papillary thyroid micro-carcinoma (PTMC) <= 5 mm and PTMC >5 mm to improve the diagnostic value of ultrasonography. Methods A total of 367 cases of PTMC between January 2013 and December 2014 was included in this study. The patients were classified into group A (<= 5 mm, n = 181) or group B (>5 mm, n = 186), and the sonographic and clinical features were reviewed and compared between the two groups. Results There was no significant difference in the shape, ratio of length/width, boundary, peripheral halo ring, echogenicity, cystic change and accompanying Hashimoto's thyroiditis between these two groups. However, the calcification (61.3% vs. 72.6%) and hypervascularity (13.8% vs. 24.7%) were more frequent in group B (p = 0.026 and 0.008, respectively). The patients were younger, and more patients were aged less than 45 years (41.4% vs. 57.0%) in group B. Capsular invasion (7.2% vs. 34.4%), multifocality (21.5% vs. 48.9%), bilaterality (17.1% vs. 39.8%), central lymph node metastasis (13.8% vs. 38.2%) and lateral lymph node metastasis (1.1% vs. 5.4%) were more frequent in group B. No clinical or sonographic feature was related to cervical lymph node metastasis in group A, while less than 45 years in age (p = 0.010), male gender (p = 0.040), capsular invasion (p<0.001), multifocality (p = 0.016) and calcification (p = 0.042) were related to cervical lymph node metastasis in group B. Conclusions The sonographic features of PTMC <= 5 mm were similar to those of PTMC >5 mm, including an irregular shape, a length/width ratio of >= 1, an unclear boundary, no peripheral halo ring, hypoechogenicity, no cystic change, calcification, no hypervascularity and no accompanying Hashimoto's thyroiditis. The clinical features of PTMC <= 5 mm were less aggressive than those of PTMC >5 mm.	[Jiang, Yuxin] Chinese Acad Med Sci, Dept Ultrasound, Beijing 100730, Peoples R China; Beijing Union Med Coll Hosp, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital	Jiang, YX (corresponding author), Chinese Acad Med Sci, Dept Ultrasound, Beijing 100730, Peoples R China.	jiangyxpumch@163.com	zhao, ruina/GOH-3374-2022		National Natural Science Foundation of China [81171354]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by the National Natural Science Foundation of China (81171354). YJ received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work is supported by the National Natural Science Foundation of China (81171354).	Baloch ZW, 2006, ADV ANAT PATHOL, V13, P69, DOI 10.1097/01.pap.0000213006.10362.17; Bin-yu L, 2010, CHIN J END MET, V26, P282; Chow SM, 2003, CANCER-AM CANCER SOC, V98, P31, DOI 10.1002/cncr.11442; Gu WJ, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000841; HARACH HR, 1985, CANCER-AM CANCER SOC, V56, P531, DOI 10.1002/1097-0142(19850801)56:3<531::AID-CNCR2820560321>3.0.CO;2-3; Ito Y, 2003, THYROID, V13, P381, DOI 10.1089/105072503321669875; KASAI N, 1987, CANCER-AM CANCER SOC, V60, P1767, DOI 10.1002/1097-0142(19871015)60:8<1767::AID-CNCR2820600816>3.0.CO;2-P; Kim Joonseok, 2013, Case Rep Med, V2013, P131395, DOI 10.1155/2013/131395; Kwak JY, 2009, ANN SURG ONCOL, V16, P1348, DOI 10.1245/s10434-009-0384-x; Lee HS, 2013, EUR ARCH OTO-RHINO-L, V270, P2969, DOI 10.1007/s00405-013-2634-6; Lee SH, 2008, LARYNGOSCOPE, V118, P659, DOI 10.1097/MLG.0b013e318161f9d1; Moon HJ, 2011, ANN SURG ONCOL, V18, P1916, DOI 10.1245/s10434-011-1556-z; Moon WJ, 2008, RADIOLOGY, V247, P762, DOI 10.1148/radiol.2473070944; Page C, 2009, EUR ARCH OTO-RHINO-L, V266, P1959, DOI 10.1007/s00405-009-0952-5; SOBIN LH, 1990, HISTOPATHOLOGY, V16, P513; Wada N, 2003, ANN SURG, V237, P399, DOI 10.1097/00000658-200303000-00015; Wang Y, 2012, ULTRASOUND MED BIOL, V38, P1681, DOI 10.1016/j.ultrasmedbio.2012.05.019; Xia Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114080; Zhang L, 2012, J CLIN ENDOCR METAB, V97, P1250, DOI 10.1210/jc.2011-1546; Zhao QZ, 2013, ANN SURG ONCOL, V20, P746, DOI 10.1245/s10434-012-2654-2	20	4	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0148567	10.1371/journal.pone.0148567	http://dx.doi.org/10.1371/journal.pone.0148567			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	26881783	Green Submitted, gold, Green Published			2022-12-26	WOS:000371219000017
J	Lorenz, R; Grant, E; Muyindike, W; Maling, S; Card, C; Henry, C; Nazarali, AJ				Lorenz, Rick; Grant, Eisha; Muyindike, Winnie; Maling, Samuel; Card, Claire; Henry, Carol; Nazarali, Adil J.			Caregivers' Attitudes towards HIV Testing and Disclosure of HIV Status to At-Risk Children in Rural Uganda	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; PEDIATRIC-PATIENTS; DIAGNOSIS; ADHERENCE; CANCER; NUTRITION; FAMILIES; IMPACT	Caregivers of HIV-positive children were interviewed in the Mbarara and Isingiro districts of Uganda to identify current trends in practices related to HIV testing and the disclosure of HIV status to the child. A total of 28 caregivers of at least one HIV-positive child participated in semi-structured interviews exploring when and why they tested the child for HIV, when the child was informed of their positive status, and what the caregiver did to prepare themselves and the child for status disclosure. For a majority (96%) of respondents, the decision to test the child for HIV was due to existing illness in either the child or a relative. Other common themes identified included the existence of stigma in the caregivers' communities and doubt that the children truly understood what was being explained to them when their status was disclosed. Most (65%) children were informed of their HIV status between the ages of 5 and 9, with the mean age of disclosure occurring at the age of 7. General provision of HIV information typically began at the same age as disclosure, and as many as two thirds (64%) of the caregivers sought advice from an HIV counsellor prior to disclosure. How a caregiver chose to prepare themselves and the child did not affect the caregiver's perception of whether the disclosure experience was beneficial or not. These findings suggest that the HIV disclosure experience in Mbarara and Isingiro districts differs from current guidelines, especially with respect to age of disclosure, how caregivers prepare themselves and the child, and approaching disclosure as an ongoing process. The doubts expressed by caregivers regarding the child's level of HIV understanding following the disclosure experience suggest the children may be insufficiently prepared at the time of the initial disclosure event. The findings also suggest that examining the content of pre-disclosure counselling and HIV education, and how health care professionals are trained to facilitate the disclosure process as important avenues for further research.	[Lorenz, Rick; Grant, Eisha; Henry, Carol; Nazarali, Adil J.] Univ Saskatchewan, Coll Pharm & Nutr, Saskatoon, SK, Canada; [Card, Claire] Minist Hlth, Kampala, Uganda; [Grant, Eisha] MUST, Fac Med, Mbarara, Uganda; [Muyindike, Winnie; Maling, Samuel] Univ Saskatchewan, Western Coll Vet Med, Saskatoon, SK S7N 0W0, Canada	University of Saskatchewan; University of Saskatchewan	Nazarali, AJ (corresponding author), Univ Saskatchewan, Coll Pharm & Nutr, Saskatoon, SK, Canada.	aj.nazarali@usask.ca	Muyindike, Winnie/W-2892-2019		University of Saskatchewan President's Social Sciences and Humanities Research Council (Canada) Research Fund; International Development Research Centre (IDRC)/University of Saskatchewan Global Partners Fund; Veterinarians Without Borders-Veterinaires sans Frontieres	University of Saskatchewan President's Social Sciences and Humanities Research Council (Canada) Research Fund; International Development Research Centre (IDRC)/University of Saskatchewan Global Partners Fund; Veterinarians Without Borders-Veterinaires sans Frontieres	Funding for this study was provided by the University of Saskatchewan President's Social Sciences and Humanities Research Council (Canada) Research Fund (AN), International Development Research Centre (IDRC)/University of Saskatchewan Global Partners Fund (AN), and Veterinarians Without Borders-Veterinaires sans Frontieres (CC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to all the caregivers' for their participation in this study. We thank the nursing staff and physicians at the ISS clinic and the staff at FAOC. Funding for this study was provided by the University of Saskatchewan President's Social Sciences and Humanities Research Council (Canada) Research Fund, the International Development Research Centre (IDRC)/University of Saskatchewan Global Partners Fund, and Veterinarians Without Borders-Veterinaires sans Frontieres. We thank Andrea Silver for reviewing the manuscript.	Beale EA, 2005, J CLIN ONCOL, V23, P3629, DOI 10.1200/JCO.2005.11.015; BIBACE R, 1980, PEDIATRICS, V66, P912; Bikaako-Kajura W, 2006, AIDS BEHAV, V10, pS85, DOI 10.1007/s10461-006-9141-3; Blasini I, 2004, J DEV BEHAV PEDIATR, V25, P181, DOI 10.1097/00004703-200406000-00007; Bolton-Moore C, 2007, JAMA-J AM MED ASSOC, V298, P1888, DOI 10.1001/jama.298.16.1888; Brady MT, 2010, JAIDS-J ACQ IMM DEF, V53, P86, DOI 10.1097/QAI.0b013e3181b9869f; Cantrell K, 2013, AIDS EDUC PREV, V25, P302, DOI 10.1521/aeap.2013.25.4.302; Dewey KG, 2011, MATERN CHILD NUTR, V7, P5, DOI 10.1111/j.1740-8709.2011.00349.x; Flanagan-Klygis E, 2001, J CLIN ETHIC, V12, P150; FREEMAN HE, 1980, AM J PUBLIC HEALTH, V70, P1277, DOI 10.2105/AJPH.70.12.1277; Government of Uganda, 2013, 2013 UG HIV AIDS COU; Haberer JE, 2014, AIDS CARE, P1; KATZ ER, 1984, CLIN PSYCHOL REV, V4, P525, DOI 10.1016/0272-7358(84)90042-4; Kiwanuka J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093276; Kouyoumdjian FG, 2005, J TROP PEDIATRICS, V51, P285, DOI 10.1093/tropej/fmi014; Kuhanen Jan, 2008, HIST AFR, V35, P301, DOI [DOI 10.1353/HIA.0.0009, 10.1353/hia.0.0009]; LIPSON M, 1993, HASTINGS CENT REP, V23, P6, DOI 10.2307/3562811; Mellins CA., 2002, CLIN CHILD PSYCHOL P, V7, P101, DOI [10.1177/1359104502007001008, DOI 10.1177/1359104502007001008]; Miller L G, 2000, HIV Clin Trials, V1, P36; Ministry of Health (MoH) Uganda, 2003, UG NAT POL GUID HIV; New York State Department of Health AIDS Institute, 2009, DISCL HIV PER INF CH; Rwemisisi J, 2008, HEALTH POLICY PLANN, V23, P36, DOI 10.1093/heapol/czm040; SIGMAN M, 1991, J CHILD PSYCHOL PSYC, V32, P307, DOI 10.1111/j.1469-7610.1991.tb00309.x; SLAVIN LA, 1982, AM J PSYCHIAT, V139, P179; Thorne C, 2000, CHILD CARE HLTH DEV, V26, P29, DOI 10.1046/j.1365-2214.2000.00128.x; UNAIDS, 2010, UNAIDS EX SUMM REP G; Vaz L, 2008, AIDS CARE, V20, P842, DOI 10.1080/09540120701742276; Vaz LME, 2010, AIDS PATIENT CARE ST, V24, P247, DOI 10.1089/apc.2009.0217; Vreeman RC, 2010, AIDS PATIENT CARE ST, V24, P639, DOI 10.1089/apc.2010.0079; Wagner GJ, 2000, AIDS CARE, V12, P405, DOI 10.1080/09540120050123800; Waugh S, 2003, AIDS CARE, V15, P169, DOI 10.1080/0954012031000068317; WHO, 2013, GLOB UPD HIV TREATM; WIENER L, 1994, AM J ORTHOPSYCHIAT, V64, P485, DOI 10.1037/h0079539; Wiener LS, 1998, CHILD WELFARE, V77, P115; World Health Organization, 2010, UN ACC SCAL PRIOR HI	35	16	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0148950	10.1371/journal.pone.0148950	http://dx.doi.org/10.1371/journal.pone.0148950			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF3BP	26881773	Green Submitted, Green Published, gold			2022-12-26	WOS:000371219000037
J	Romer, M; Eichner, J; Drager, A; Wrzodek, C; Wrzodek, F; Zell, A				Roemer, Michael; Eichner, Johannes; Draeger, Andreas; Wrzodek, Clemens; Wrzodek, Finja; Zell, Andreas			ZBIT Bioinformatics Toolbox: A Web-Platform for Systems Biology and Expression Data Analysis	PLOS ONE			English	Article							GENE-EXPRESSION; PATHWAY DATA; ARRAY DATA; SBML; MODELS; MICROARRAY; IDENTIFICATION; TOXICITY; CLASSIFICATION; REPRESENTATION	Bioinformatics analysis has become an integral part of research in biology. However, installation and use of scientific software can be difficult and often requires technical expert knowledge. Reasons are dependencies on certain operating systems or required third-party libraries, missing graphical user interfaces and documentation, or nonstandard input and output formats. In order to make bioinformatics software easily accessible to researchers, we here present a web-based platform. The Center for Bioinformatics Tuebingen (ZBIT) Bioinformatics Toolbox provides web-based access to a collection of bioinformatics tools developed for systems biology, protein sequence annotation, and expression data analysis. Currently, the collection encompasses software for conversion and processing of community standards SBML and BioPAX, transcription factor analysis, and analysis of microarray data from transcriptomics and proteomics studies. All tools are hosted on a customized Galaxy instance and run on a dedicated computation cluster. Users only need a web browser and an active internet connection in order to benefit from this service. The web platform is designed to facilitate the usage of the bioinformatics tools for researchers without advanced technical background. Users can combine tools for complex analyses or use predefined, customizable workflows. All results are stored persistently and reproducible. For each tool, we provide documentation, tutorials, and example data to maximize usability. The ZBIT Bioinformatics Toolbox is freely available at https://webservices.cs.uni-tuebingen.de/.	[Roemer, Michael; Eichner, Johannes; Draeger, Andreas; Wrzodek, Clemens; Wrzodek, Finja; Zell, Andreas] Univ Tubingen, Dept Comp Sci, Tubingen, Germany; [Draeger, Andreas] Univ Calif San Diego, Dept Bioengn, San Diego, CA 92103 USA	Eberhard Karls University of Tubingen; University of California System; University of California San Diego	Romer, M (corresponding author), Univ Tubingen, Dept Comp Sci, Tubingen, Germany.	michael.roemer@uni-tuebingen.de	Dräger, Andreas/F-5620-2015	Dräger, Andreas/0000-0002-1240-5553; Wrzodek, Clemens/0000-0003-4995-780X; Wrzodek, Finja/0000-0001-5031-1016	Innovative Medicine Initiative Joint Undertaking (IMI JU) [115001]; Marie Curie International Outgoing Fellowship within the EU 7th Framework Program for Research and Technological Development (project AMBiCon) [332020]; German Research Foundation (DFG); University of Tuebingen	Innovative Medicine Initiative Joint Undertaking (IMI JU); Marie Curie International Outgoing Fellowship within the EU 7th Framework Program for Research and Technological Development (project AMBiCon); German Research Foundation (DFG)(German Research Foundation (DFG)); University of Tuebingen	The research leading to this work was funded by the Innovative Medicine Initiative Joint Undertaking (IMI JU) under grant agreement nr. 115001 (MARCAR project) and a Marie Curie International Outgoing Fellowship within the EU 7th Framework Program for Research and Technological Development (project AMBiCon, 332020). The authors acknowledge support by the German Research Foundation (DFG) and the Open Access Publishing Fund of the University of Tuebingen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMES BN, 1975, MUTAT RES, V31, P347, DOI 10.1016/0165-1161(75)90046-1; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brazma A, 2000, FEBS LETT, V480, P17, DOI 10.1016/S0014-5793(00)01772-5; Buchel F, 2013, BMC SYSTEMS BIOL, V7; Buchel F, 2012, BIOINFORMATICS, V28, P2648, DOI 10.1093/bioinformatics/bts508; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Chaouiya C, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-135; Chelliah V, 2015, NUCLEIC ACIDS RES, V43, pD542, DOI 10.1093/nar/gku1181; Courtot M, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.77; Demir E, 2010, NAT BIOTECHNOL, V28, P935, DOI 10.1038/nbt.1666; Dogrusoz U, 2006, BIOINFORMATICS, V22, P374, DOI 10.1093/bioinformatics/bti776; Drager A, 2009, BIOINFORMATICS, V25, P1455, DOI 10.1093/bioinformatics/btp170; Drager A, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-39; Drager Andreas, 2014, Front Bioeng Biotechnol, V2, P61, DOI 10.3389/fbioe.2014.00061; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Eichner J, 2014, BIOSYSTEMS, V122, P19, DOI 10.1016/j.biosystems.2014.06.009; Eichner J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082238; Gallagher RI, 2014, MOL DIAGN THER, V18, P619, DOI 10.1007/s40291-014-0122-3; Ganter B, 2005, J BIOTECHNOL, V119, P219, DOI 10.1016/j.jbiotec.2005.03.022; Ganter M, 2013, BIOINFORMATICS, V29, P815, DOI 10.1093/bioinformatics/btt036; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Gupta MK, 2013, NETW MODEL ANAL HLTH, V2, P45, DOI 10.1007/s13721-013-0023-0; Haimovitz-Friedman A, 1997, BRIT MED BULL, V53, P539; Hildebrandt AK, 2015, BIOINFORMATICS, V31, P121, DOI 10.1093/bioinformatics/btu574; Hucka M, 2003, BIOINFORMATICS, V19, P524, DOI 10.1093/bioinformatics/btg015; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; King ZA, 2015, NUCLEIC ACIDS RES; King ZA, 2015, BIGG MODELS ID SPECI; Kitano H, 2002, NATURE, V420, P206, DOI 10.1038/nature01254; Konig M, 2012, BIOINFORMATICS, V28, P2402, DOI 10.1093/bioinformatics/bts432; Krause F, 2010, BIOINFORMATICS, V26, P421, DOI 10.1093/bioinformatics/btp642; Li C, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-92; Lima BS, 2000, REGUL TOXICOL PHARM, V32, P135; List M, 2014, BIOINFORMATICS, V30, pI631, DOI 10.1093/bioinformatics/btu473; Liu B, 2015, NUCLEIC ACIDS RES, V43, pW65, DOI 10.1093/nar/gkv458; Liu B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106691; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; Narang P, 2014, BMC SYST BIOL, V8, DOI 10.1186/s12918-014-0130-2; Nystrom-Persson J, 2013, BIOINFORMATICS, V29, P3080, DOI 10.1093/bioinformatics/btt531; OBEID LM, 1993, SCIENCE, V259, P1769, DOI 10.1126/science.8456305; Pan JB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080747; Pan JB, 2012, BIOINFORMATICS, V28, P1544, DOI 10.1093/bioinformatics/bts169; Pathak RK, 2013, BIOINFORMATION, V9, P443, DOI 10.6026/97320630009443; R Core Team, 2013, R LANG ENV STAT COMP; Romer M, 2014, INT J MOL SCI, V15, P19037, DOI 10.3390/ijms151019037; Romer M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097640; Schaefer CF, 2009, NUCLEIC ACIDS RES, V37, pD674, DOI 10.1093/nar/gkn653; Schroder A, 2011, BIOINFORMATICS, V27, P2473, DOI 10.1093/bioinformatics/btr416; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Song L, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-298; Uehara T, 2010, MOL NUTR FOOD RES, V54, P218, DOI 10.1002/mnfr.200900169; Unterberger EB, 2014, INT J CANCER, V135, P1574, DOI 10.1002/ijc.28798; Wachter Astrid, 2015, Microarrays (Basel), V4, P520, DOI 10.3390/microarrays4040520; Wan FY, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000067; Wasserman WW, 2004, NAT REV GENET, V5, P276, DOI 10.1038/nrg1315; Waters MD, 2010, MUTAT RES-REV MUTAT, V705, P184, DOI 10.1016/j.mrrev.2010.04.005; Wittig U, 2012, NUCLEIC ACIDS RES, V40, pD790, DOI 10.1093/nar/gkr1046; Wrzodek C, 2013, BIOINFORMATICS, V29, P506, DOI 10.1093/bioinformatics/bts709; Xing L, 2014, J APPL TOXICOL, V34, P805, DOI 10.1002/jat.2923; Zou Q, 2014, BRIEF BIOINFORM, V15, P637, DOI 10.1093/bib/bbs088	62	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0149263	10.1371/journal.pone.0149263	http://dx.doi.org/10.1371/journal.pone.0149263			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	26882475	Green Published, gold			2022-12-26	WOS:000371219000063
J	Belle, A; Ansari, S; Spadafore, M; Convertino, VA; Ward, KR; Derksen, H; Najarian, K				Belle, Ashwin; Ansari, Sardar; Spadafore, Maxwell; Convertino, Victor A.; Ward, Kevin R.; Derksen, Harm; Najarian, Kayvan			A Signal Processing Approach for Detection of Hemodynamic Instability before Decompensation	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; COMPLEX WAVELETS; BLOOD-PRESSURE; MORTALITY	Advanced hemodynamic monitoring is a critical component of treatment in clinical situations where aggressive yet guided hemodynamic interventions are required in order to stabilize the patient and optimize outcomes. While there are many tools at a physician's disposal to monitor patients in a hospital setting, the reality is that none of these tools allow hi-fidelity assessment or continuous monitoring towards early detection of hemodynamic instability. We present an advanced automated analytical system which would act as a continuous monitoring and early warning mechanism that can indicate pending decompensation before traditional metrics can identify any clinical abnormality. This system computes novel features or bio-markers from both heart rate variability (HRV) as well as the morphology of the electrocardiogram (ECG). To compare their effectiveness, these features are compared with the standard HRV based bio-markers which are commonly used for hemodynamic assessment. This study utilized a unique database containing ECG waveforms from healthy volunteer subjects who underwent simulated hypovolemia under controlled experimental settings. A support vector machine was utilized to develop a model which predicts the stability or instability of the subjects. Results showed that the proposed novel set of features outperforms the traditional HRV features in predicting hemodynamic instability.	[Belle, Ashwin; Ansari, Sardar; Ward, Kevin R.; Najarian, Kayvan] Univ Michigan, Dept Emergency Med, Ann Arbor, MI 48109 USA; [Belle, Ashwin; Ansari, Sardar; Ward, Kevin R.; Derksen, Harm; Najarian, Kayvan] Univ Michigan, Michigan Ctr Integrat Res Crit Care, Ann Arbor, MI 48109 USA; [Derksen, Harm] Univ Michigan, Dept Math, Ann Arbor, MI 48109 USA; [Najarian, Kayvan] Univ Michigan, Dept Computat Med & Bioinformat, Ann Arbor, MI 48109 USA; [Spadafore, Maxwell] Univ Michigan, Coll Literature Sci & Arts, Ann Arbor, MI 48109 USA; [Convertino, Victor A.] US Army Inst Surg Res, Combat Casualty Care Res Program, San Antonio, TX USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; United States Department of Defense; United States Army	Belle, A (corresponding author), Univ Michigan, Dept Emergency Med, Ann Arbor, MI 48109 USA.; Belle, A (corresponding author), Univ Michigan, Michigan Ctr Integrat Res Crit Care, Ann Arbor, MI 48109 USA.	bellea@med.umich.edu		Spadafore, Maxwell/0000-0001-5927-1428; Convertino, Victor/0000-0001-9246-0554	U.S. Army Medical Research and Material Command Combat Casualty Care Research Program [05-0033-02]	U.S. Army Medical Research and Material Command Combat Casualty Care Research Program	Initial work of this project was funded by: U.S. Army Medical Research and Material Command Combat Casualty Care Research Program, Grant: 05-0033-02: KN KW. The authors had no role in the design of experimental setup and data collection for the LBNP study. The LBNP study was designed and data was collected by USASR which partially funded the project in the early stages.	Bradley AP, 2004, CLIN NEUROPHYSIOL, V115, P1114, DOI 10.1016/j.clinph.2003.11.016; Brunk HD., 1972, STAT INFERENCE ORDER; Buchman Timothy G, 2002, Curr Opin Crit Care, V8, P311, DOI 10.1097/00075198-200208000-00007; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Choi H, 2000, INT CONF ACOUST SPEE, P133, DOI 10.1109/ICASSP.2000.861889; Chouhan V, 2007, TOTAL REMOVAL BASELI, P512; Convertino VA, 2012, AVIAT SPACE ENVIR MD, V83, P614, DOI 10.3357/ASEM.3204.2012; Convertino VA, 2011, J TRAUMA, V71, pS25, DOI 10.1097/TA.0b013e3182211601; Cooke WH, 2004, J APPL PHYSIOL, V96, P1249, DOI 10.1152/japplphysiol.01155.2003; Daubechies I., 1992, SOC IND APPL MATH, DOI [DOI 10.1137/1.9781611970104, 10.1137/1.9781611970104]; Davies PL, 2001, ANN STAT, V29, P1, DOI 10.1214/aos/996986501; Engelse W. A. H., 1979, Computers in Cardiology, P37; FARRAR DE, 1967, REV ECON STAT, V49, P92, DOI 10.2307/1937887; Guelen I, 2003, BLOOD PRESS MONIT, V8, P27, DOI 10.1097/00126097-200302000-00006; HOCKING RR, 1976, BIOMETRICS, V32, P1, DOI 10.2307/2529336; Ji SY, 2013, J CLIN MONIT COMPUT, V27, P289, DOI 10.1007/s10877-013-9434-9; Katz MH, 2006, MULTIVARIABLE ANALYSIS: A PRACTICAL GUIDE FOR CLINICIANS, 2ND EDITION, P1, DOI 10.1017/CBO9780511811692; Kingsbury N, 2003, IEEE IMAGE PROC, P1013; Kingsbury N, 2001, APPL COMPUT HARMON A, V10, P234, DOI 10.1006/acha.2000.0343; Kingsbury NG, 1998, P 8 IEEE DSP WORKSH, P120; MALLAT SG, 1989, IEEE T PATTERN ANAL, V11, P674, DOI 10.1109/34.192463; McQuillan P, 1998, BMJ-BRIT MED J, V316, P1853; Meyer Y., 1995, WAVELETS OPERATORS, V1; Miller AJ, 2002, SUBSET SELECTION REG, DOI DOI 10.1201/9781420035933; Moody G. B., 1985, Computers in Cardiology (Cat. No.85CH2217-8), P113; Najarian K., 2005, BIOMEDICAL SIGNAL IM; Nolan J, 1998, CIRCULATION, V98, P1510, DOI 10.1161/01.CIR.98.15.1510; Oppenheim A.V., 1989, OTHERS DISCRETE TIME, V2; Rabiner L. R., 1978, DIGITAL PROCESSING S; Romberg J, 2000, 2000 INTERNATIONAL CONFERENCE ON IMAGE PROCESSING, VOL II, PROCEEDINGS, P371, DOI 10.1109/ICIP.2000.899396; Ryan ML, 2011, J TRAUMA, V70, P1371, DOI 10.1097/TA.0b013e31821858e6; Saritha C., 2008, Bulgarian Journal of Physics, V35, P68; Schafer RW, 2011, IEEE SIGNAL PROC MAG, V28, P111, DOI 10.1109/MSP.2011.941097; Selesnick IW, 2005, IEEE SIGNAL PROC MAG, V22, P123, DOI 10.1109/MSP.2005.1550194; Stoica P., 1997, INTRO SPECTRAL ANAL, V1; Tarvainen MP, 2008, KUBIOS HRV VERSION 2; Tavakolian K, 2014, SHOCK, V41, P91, DOI 10.1097/SHK.0000000000000077; Winters BD, 2006, JAMA-J AM MED ASSOC, V296, P1645, DOI 10.1001/jama.296.13.1645; WO CCJ, 1993, CRIT CARE MED, V21, P218, DOI 10.1097/00003246-199302000-00012	39	16	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0148544	10.1371/journal.pone.0148544	http://dx.doi.org/10.1371/journal.pone.0148544			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26871715	Green Submitted, gold, Green Published			2022-12-26	WOS:000370054100035
J	Miller, AC; Nelson, AK; Livchits, V; Greenfield, SF; Yanova, G; Yanov, S; Connery, HS; Atwood, S; Lastimoso, CS; Shin, SS				Miller, Ann C.; Nelson, A. Katrina; Livchits, Viktoria; Greenfield, Shelly F.; Yanova, Galina; Yanov, Sergei; Connery, Hilary S.; Atwood, Sidney; Lastimoso, Charmaine S.; Shin, Sonya S.		Tomsk Tuberculosis Alcohol Working	Understanding HIV Risk Behavior among Tuberculosis Patients with Alcohol Use Disorders in Tomsk, Russian Federation	PLOS ONE			English	Article							MULTICENTER AIDS COHORT; GENDER-DIFFERENCES; ST-PETERSBURG; CONSUMPTION; MORTALITY; INFECTION; HEALTH; IDENTIFICATION; MANAGEMENT; DRINKING	Russian Federation's (RF) HIV epidemic is the fastest growing of any country. This study explores factors associated with high HIV risk behavior in tuberculosis (TB) patients with alcohol use disorders in Tomsk, RF. This analysis was nested within the Integrated Management of Physician-delivered Alcohol Care for TB Patients (IMPACT, trial number NCT00675961) randomized controlled study of integrating alcohol treatment into TB treatment in Tomsk. Demographics, HIV risk behavior (defined as participant report of high-risk intravenous drug use and/or multiple sexual partners with inconsistent condom use in the last six months), clinical data, alcohol use, depression and psychosocial factors were collected from 196 participants (161 male and 35 female) at baseline. Forty-six participants (23.5%) endorsed HIV risk behavior at baseline. Incarceration history(Odds Ratio (OR) 3.93, 95% confidence interval (CI) 1.95, 7.95), age under 41 (OR: 2.97, CI: 1.46, 6.04), drug addiction(OR: 3.60 CI: 1.10, 11.77), history of a sexually transmitted disease(STD)(OR 2.00 CI: 1.02, 3.90), low social capital (OR: 2.81 CI: 0.99, 8.03) and heavier alcohol use (OR: 2.56 CI: 1.02, 6.46) were significantly more likely to be associated with HIV risk behavior at baseline. In adjusted analysis, age under 41(OR: 4.93, CI: 2.10, 11.58), incarceration history (OR: 3.56 CI: 1.55, 8.17) and STD history (OR: 3.48, CI: 1.5, 8.10) continued to be significantly associated with HIV risk behavior. Understanding HIV transmission dynamics in Russia remains an urgent priority to inform strategies to address the epidemic. Larger studies addressing sex differences in risks and barriers to protective behavior are needed.	[Miller, Ann C.; Shin, Sonya S.] Harvard Univ, Sch Med, Dept Global Hlth & Social Med, Boston, MA USA; [Nelson, A. Katrina; Atwood, Sidney; Lastimoso, Charmaine S.; Shin, Sonya S.] Brigham & Womens Hosp, Div Global Hlth Equ, 75 Francis St, Boston, MA 02115 USA; [Livchits, Viktoria] Partners Hlth Representat Off Russian Federat, Moscow, Russia; [Greenfield, Shelly F.; Connery, Hilary S.] McLean Hosp, Alcohol & Drug Abuse Treatment Program, 115 Mill St, Belmont, MA 02178 USA; [Greenfield, Shelly F.; Connery, Hilary S.] Harvard Univ, Sch Med, Dept Psychiat, Boston, MA 02115 USA; [Greenfield, Shelly F.] McLean Hosp, Div Womens Mental Hlth, 115 Mill St, Belmont, MA 02178 USA; [Yanova, Galina; Yanov, Sergei] Tomsk Oblast TB Hosp, Tomsk, Russia	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; McLean Hospital; Harvard University; Harvard Medical School; Harvard University; McLean Hospital	Miller, AC (corresponding author), Harvard Univ, Sch Med, Dept Global Hlth & Social Med, Boston, MA USA.	Ann_miller@hms.harvard.edu	Yanova, Galina/S-5085-2016	Yanova, Galina/0000-0003-2222-6281	US National Institutes of Health [R01AA016318]; US National Institute on Drug Abuse [U10DA15831, K24 DA 019855]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA016318] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [U10DA015831, K24DA019855] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported in part by the US National Institutes of Health (www.nih.gov) (grant R01AA016318, S.S.) and the US National Institute on Drug Abuse (www.drugabuse.gov) (grant U10DA15831, H.S.C) (grant K24 DA 019855, S.F.G.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, GLOB HIV AIDS RESP E; Blume SB, 1991, ALCOHOL HEALTH RES W, V15, P136; Brooks A, 2010, SUBST USE MISUSE, V45, P2444, DOI 10.3109/10826084.2010.490928; Chander G, 2006, JAIDS-J ACQ IMM DEF, V43, P411, DOI 10.1097/01.qai.0000243121.44659.a4; Cooper ML, 2002, J STUD ALCOHOL, P101, DOI 10.15288/jsas.2002.s14.101; Crooks D, 2015, AIDS BEHAV, V19, P405, DOI 10.1007/s10461-014-0754-7; Ehrenstein V, 2004, DRUG ALCOHOL DEPEN, V73, P159, DOI 10.1016/j.drugalcdep.2003.10.011; Fleming MF, 2006, INT J TUBERC LUNG D, V10, P565; Hessol NA, 2007, CLIN INFECT DIS, V44, P287, DOI 10.1086/510488; Kalichman SC, 2007, PREV SCI, V8, P141, DOI 10.1007/s11121-006-0061-2; [Кладов С.Ю. Kladov S.Yu.], 2010, [Бюллетень сибирской медицины, Byulleten' sibirskoi meditsiny], V9, P126; Krupitsky EM, 2006, EUR ADDICT RES, V12, P12, DOI 10.1159/000088578; Krupitsky EM, 2005, DRUG ALCOHOL DEPEN, V79, P251, DOI 10.1016/j.drugalcdep.2005.01.015; Laatikainen T, 2002, ALCOHOL ALCOHOLISM, V37, P282, DOI 10.1093/alcalc/37.3.282; Leon DA, 1997, LANCET, V350, P383, DOI 10.1016/S0140-6736(97)03360-6; Mathew TA, 2009, EUR J PUBLIC HEALTH, V19, P16, DOI 10.1093/eurpub/ckn093; MCLELLAN AT, 1992, J SUBST ABUSE TREAT, V9, P199, DOI 10.1016/0740-5472(92)90062-S; METZGER DS, 1993, J ACQ IMMUN DEF SYND, V6, P1049; Miller AC, 2012, INT J TUBERC LUNG D, V16, P891, DOI 10.5588/ijtld.11.0795; NAVALINE HA, 1994, AIDS RES HUM RETROV, V10, pS281; Organization WH, 2013, KEY FACTS HIV EP RUS; PENKOWER L, 1991, AM J PUBLIC HEALTH, V81, P194, DOI 10.2105/AJPH.81.2.194; Ruchkina EV, 1996, TERAPEVT ARKH, V68, P51; Samet JH, 2008, ADDICTION, V103, P1474, DOI 10.1111/j.1360-0443.2008.02251.x; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Shin S, 2013, ADDICTION, V108, P1387, DOI 10.1111/add.12148; Shin Sonya S., 2010, Central European Journal of Public Health, V18, P132; Shuter J, 1999, J URBAN HEALTH, V76, P237, DOI 10.1007/BF02344679; Sobell L. C., 1992, MEASURING ALCOHOL CO, P41, DOI [10.1007/978-1-4612-0357-5_3, 10.1007/978-1-4612-0357-5, DOI 10.1007/978-1-4612-0357-5_3]; Stickley A, 2013, DRUG ALCOHOL DEPEN, V133, P838, DOI 10.1016/j.drugalcdep.2013.08.028; Stimson GV, 2005, INT J DRUG POLICY, V16, pS7, DOI 10.1016/j.drugpo.2005.02.007; Vasquez C, 2013, AIDS PATIENT CARE ST, V27, P304, DOI 10.1089/apc.2013.0019; Weinhardt L S, 2000, Annu Rev Sex Res, V11, P125; WEISSMAN MM, 1977, AM J EPIDEMIOL, V106, P203, DOI 10.1093/oxfordjournals.aje.a112455; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; Wilsnack RW, 2000, ADDICTION, V95, P251, DOI 10.1046/j.1360-0443.2000.95225112.x; Wirtz AL, 2016, AIDS BEHAV, V20, P523, DOI 10.1007/s10461-015-1066-2; Zaridze D, 2014, LANCET, V383, P1465, DOI 10.1016/S0140-6736(13)62247-3	38	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0148910	10.1371/journal.pone.0148910	http://dx.doi.org/10.1371/journal.pone.0148910			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DD6SI	26871943	Green Submitted, Green Published, gold			2022-12-26	WOS:000370054100072
J	Pinto, SM; Almendinger, J; Cabello, J; Hengartner, MO				Pinto, Sergio M.; Almendinger, Johann; Cabello, Juan; Hengartner, Michael O.			Loss of Acetylcholine Signaling Reduces Cell Clearance Deficiencies in Caenorhabditis elegans	PLOS ONE			English	Article							APOPTOTIC CELLS; C-ELEGANS; MEDIATES RECOGNITION; CORPSE CLEARANCE; ALPHA-7 SUBUNIT; PHOSPHATIDYLSERINE; ENGULFMENT; PHAGOCYTOSIS; NEMATODE; PROMOTES	The ability to eliminate undesired cells by apoptosis is a key mechanism to maintain organismal health and homeostasis. Failure to clear apoptotic cells efficiently can cause autoimmune diseases in mammals. Genetic studies in Caenorhabditis elegans have greatly helped to decipher the regulation of apoptotic cell clearance. In this study, we show that the loss of levamisole-sensitive acetylcholine receptor, but not of a typical neuronal acetylcholine receptor causes a reduction in the number of persistent cell corpses in worms suffering from an engulfment deficiency. This reduction is not caused by impaired or delayed cell death but rather by a partial restoration of the cell clearance capacity. Mutants in acetylcholine turn-over elicit a similar phenotype, implying that acetylcholine signaling is the process responsible for these observations. Surprisingly, tissue specific RNAi suggests that UNC-38, a major component of the levamisole-sensitive receptor, functions in the dying germ cell to influence engulfment efficiency. Animals with loss of acetylcholine receptor exhibit a higher fraction of cell corpses positive for the "eat-me" signal phosphatidylserine. Our results suggest that modulation by ion channels of ion flow across plasma membrane in dying cells can influence the dynamics of phosphatidylserine exposure and thus clearance efficiency.	[Pinto, Sergio M.; Almendinger, Johann; Hengartner, Michael O.] Univ Zurich, Inst Mol Life Sci, Zurich, Switzerland; [Pinto, Sergio M.] Univ Porto, Grad Program Areas Basic & Appl Biol, Rua Campo Alegre 823, P-4100 Porto, Portugal; [Cabello, Juan] Ctr Biomed Res La Rioja CIBIR, Logrono, La Rioja, Spain	University of Zurich; Universidade do Porto	Hengartner, MO (corresponding author), Univ Zurich, Inst Mol Life Sci, Zurich, Switzerland.	michael.hengartner@imls.uzh.ch	Cabello, Juan/AAM-1683-2020	Cabello, Juan/0000-0002-3835-0116; Hengartner, Michael/0000-0002-7584-596X	Swiss National Science Foundation [31003A-143932]; Portuguese Foundation for Science and Technology; NIH Office of Research Infrastructure Programs [P40 OD010440]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); NIH Office of Research Infrastructure Programs(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the Swiss National Science Foundation (grant no. 31003A-143932 to MOH) (http://www.snf.ch/ and by a doctoral fellowship from the Portuguese Foundation for Science and Technology (SMP) (http://www.fct.pt/). Some C. elegans strains were provided by the Caenorhabditis Genetics Center (CGC; https://www.cbs.umn.edu/research/resources/cgc), which is funded by NIH Office of Research Infrastructure Programs (P40 OD010440). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akakura S, 2005, J CELL PHYSIOL, V204, P344, DOI 10.1002/jcp.20288; BARNARD EA, 1992, TRENDS BIOCHEM SCI, V17, P368, DOI 10.1016/0968-0004(92)90002-Q; Boulin T, 2008, P NATL ACAD SCI USA, V105, P18590, DOI 10.1073/pnas.0806933105; BRENNER S, 1974, GENETICS, V77, P71; Chen YZ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3726; Combes D, 2000, J MOL BIOL, V300, P727, DOI 10.1006/jmbi.2000.3917; Cuttell L, 2008, CELL, V135, P524, DOI 10.1016/j.cell.2008.08.033; DeBakker CD, 2004, CURR BIOL, V14, P2208, DOI 10.1016/j.cub.2004.12.029; Drisdel RC, 2000, J NEUROSCI, V20, P133, DOI 10.1523/JNEUROSCI.20-01-00133.2000; FADOK VA, 1992, J IMMUNOL, V148, P2207; GALZI JL, 1995, NEUROPHARMACOLOGY, V34, P563, DOI 10.1016/0028-3908(95)00034-4; Gottschalk A, 2005, EMBO J, V24, P2566, DOI 10.1038/sj.emboj.7600741; Gronski MA, 2009, CELL DEATH DIFFER, V16, P1323, DOI 10.1038/cdd.2009.55; Gumienny TL, 2001, CELL, V107, P27, DOI 10.1016/S0092-8674(01)00520-7; Gumienny TL, 1999, DEVELOPMENT, V126, P1011; HENGARTNER MO, 1992, NATURE, V356, P494, DOI 10.1038/356494a0; Hurwitz ME, 2009, PLOS BIOL, V7, P876, DOI 10.1371/journal.pbio.1000099; Jones AK, 2004, BIOESSAYS, V26, P39, DOI 10.1002/bies.10377; Jones Andrew K., 2007, Invertebrate Neuroscience, V7, P129, DOI 10.1007/s10158-007-0049-z; Jospin M, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000265; Kamath RS, 2003, METHODS, V30, P313, DOI 10.1016/S1046-2023(03)00050-1; Ketting RF, 1999, CELL, V99, P133, DOI 10.1016/S0092-8674(00)81645-1; Kinchen JM, 2005, NATURE, V434, P93, DOI 10.1038/nature03263; Levin M, 2012, DEV CELL, V22, P1101, DOI 10.1016/j.devcel.2012.04.004; LEWIS JA, 1980, GENETICS, V95, P905; Li Z, 2015, PLOS GENET, V11, DOI [10.1371/journal.pgen.1005285, 10.1371/journal.pgen.1005418]; Liu QA, 1998, CELL, V93, P961, DOI 10.1016/S0092-8674(00)81202-7; Mapes J, 2012, CURR BIOL, V22, P1267, DOI 10.1016/j.cub.2012.05.052; Maus ADJ, 1998, MOL PHARMACOL, V54, P779, DOI 10.1124/mol.54.5.779; Nagata S, 2010, CELL, V140, P619, DOI 10.1016/j.cell.2010.02.014; Pinto SM, 2012, CURR OPIN CELL BIOL, V24, P881, DOI 10.1016/j.ceb.2012.11.002; Savill J, 2000, NATURE, V407, P784, DOI 10.1038/35037722; Schnabel R, 1997, DEV BIOL, V184, P234, DOI 10.1006/dbio.1997.8509; Schwartz HT, 2007, NAT PROTOC, V2, P705, DOI 10.1038/nprot.2007.93; Sijen T, 2001, CELL, V107, P465, DOI 10.1016/S0092-8674(01)00576-1; Stanfield GM, 2000, MOL CELL, V5, P423, DOI 10.1016/S1097-2765(00)80437-2; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; Suzuki J, 2013, SCIENCE, V341, P403, DOI 10.1126/science.1236758; Suzuki J, 2010, NATURE, V468, P834, DOI 10.1038/nature09583; Venegas V, 2007, MOL BIOL CELL, V18, P3180, DOI 10.1091/mbc.E07-02-0138; VERNINO S, 1992, NEURON, V8, P127, DOI 10.1016/0896-6273(92)90114-S; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; Wang XC, 2007, NAT CELL BIOL, V9, P541, DOI 10.1038/ncb1574; Wang XC, 2010, NAT CELL BIOL, V12, P655, DOI 10.1038/ncb2068; Wu YC, 1998, NATURE, V392, P501, DOI 10.1038/33163; Yang HW, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6717; Yu XM, 2006, DEV CELL, V10, P743, DOI 10.1016/j.devcel.2006.04.007	47	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149274	10.1371/journal.pone.0149274	http://dx.doi.org/10.1371/journal.pone.0149274			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26872385	Green Submitted, Green Published, gold			2022-12-26	WOS:000370054100139
J	Sood, RF; Arbabi, S; Honari, S; Gibran, NS				Sood, Ravi F.; Arbabi, Saman; Honari, Shari; Gibran, Nicole S.			Missense Variant in MAPK Inactivator PTPN5 Is Associated with Decreased Severity of Post-Burn Hypertrophic Scarring	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; ACTIVATED PROTEIN-KINASES; BURN WOUNDS; NEUROPSYCHIATRIC DISORDERS; TYROSINE PHOSPHATASES; RISK-FACTORS; PATHWAYS; CSMD1; EPIDEMIOLOGY; INFLAMMATION	Background Hypertrophic scarring (HTS) is hypothesized to have a genetic mechanism, yet its genetic determinants are largely unknown. The mitogen-activated protein kinase (MAPK) pathways are important mediators of inflammatory signaling, and experimental evidence implicates MAPKs in HTS formation. We hypothesized that single-nucleotide polymorphisms (SNPs) in MAPK-pathway genes would be associated with severity of post-burn HTS. Methods We analyzed data from a prospective-cohort genome-wide association study of post-burn HTS. We included subjects with deep-partial-thickness burns admitted to our center who provided blood for genotyping and had at least one Vancouver Scar Scale (VSS) assessment. After adjusting for HTS risk factors and population stratification, we tested MAPK-pathway gene SNPs for association with the four VSS variables in a joint regression model. In addition to individual-SNP analysis, we performed gene-based association testing. Results Our study population consisted of 538 adults (median age 40 years) who were predominantly White (76%) males (71%) admitted to our center from 2007-2014 with small-to-moderate- sized burns (median burn size 6% total body surface area). Of 2,146 SNPs tested, a rare missense variant in the PTPN5 gene (rs56234898; minor allele frequency 1.5%) was significantly associated with decreased severity of post-burn HTS (P = 1.3x10(-6)). In gene-based analysis, PTPN5 (P = 1.2x10(-5)) showed a significant association and BDNF (P = 9.5x10(-4)) a borderline-significant association with HTS severity. Conclusions We report PTPN5 as a novel genetic locus associated with HTS severity. PTPN5 is a MAPK inhibitor expressed in neurons, suggesting a potential role for neurotrophic factors and neuroinflammatory signaling in HTS pathophysiology.	[Sood, Ravi F.; Arbabi, Saman; Honari, Shari; Gibran, Nicole S.] Univ Washington, Harborview Med Ctr, Dept Surg, UW Med Reg Burn Ctr, Seattle, WA 98104 USA	Harborview Medical Center; University of Washington; University of Washington Seattle	Sood, RF (corresponding author), Univ Washington, Harborview Med Ctr, Dept Surg, UW Med Reg Burn Ctr, Seattle, WA 98104 USA.	rfsood@uw.edu		Gibran, Nicole/0000-0003-4697-0988	NIH [R01 GM089704, T32 GM007037]; David & Nancy Auth-Washington Research Foundation Endowed Chair for Restorative Burn Surgery; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089704, T32GM007037] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); David & Nancy Auth-Washington Research Foundation Endowed Chair for Restorative Burn Surgery; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by NIH R01 GM089704, NIH T32 GM007037, and the David & Nancy Auth-Washington Research Foundation Endowed Chair for Restorative Burn Surgery.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Arbabi S, 2002, CRIT CARE MED, V30, pS74, DOI 10.1097/00003246-200201001-00010; Autry AE, 2012, PHARMACOL REV, V64, P238, DOI 10.1124/pr.111.005108; Baryza Mary Jo, 1995, Journal of Burn Care and Rehabilitation, V16, P535, DOI 10.1097/00004630-199509000-00013; Branski LK, 2012, TOTAL BURN CARE, P1; CASTAGNOLI C, 1990, HUM IMMUNOL, V29, P229, DOI 10.1016/0198-8859(90)90117-8; DEITCH EA, 1983, J TRAUMA, V23, P895, DOI 10.1097/00005373-198310000-00009; Du QC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075635; Escudero-Esparza A, 2013, FASEB J, V27, P5083, DOI 10.1096/fj.13-230706; Eswaran J, 2006, BIOCHEM J, V395, P483, DOI 10.1042/BJ20051931; Fitzpatrick CJ, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00047; Friedstat JS, 2014, ANN PLAS SURG, V72, pS198, DOI 10.1097/SAP.0000000000000103; Galesloot TE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095923; Gangemi EN, 2008, ARCH FACIAL PLAST S, V10, P93, DOI 10.1001/archfaci.10.2.93; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Han S, 2014, SPINAL CORD, V52, P867, DOI 10.1038/sc.2014.173; Harvey A. R., 2014, BRAIN RES; Hinz B, 2007, J INVEST DERMATOL, V127, P526, DOI 10.1038/sj.jid.5700613; Hirano S, 2002, J SURG RES, V102, P77, DOI 10.1006/jsre.2001.6315; Ipaktchi K, 2006, SHOCK, V26, P201, DOI 10.1097/01.shk.0000225739.13796.f2; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Karasawa T, 2014, NEUROSCI RES, V89, P1, DOI 10.1016/j.neures.2014.08.018; Kraus DM, 2006, J IMMUNOL, V176, P4419, DOI 10.4049/jimmunol.176.7.4419; Lamel SA, 2013, CUTAN OCUL TOXICOL, V32, P67, DOI 10.3109/15569527.2012.684419; Lawrence JW, 2012, J BURN CARE RES, V33, P136, DOI 10.1097/BCR.0b013e3182374452; Li MX, 2011, AM J HUM GENET, V88, P283, DOI 10.1016/j.ajhg.2011.01.019; Liang Z, 2004, BURNS, V30, P57, DOI 10.1016/j.burns.2003.09.004; LOMBROSO PJ, 1991, P NATL ACAD SCI USA, V88, P7242, DOI 10.1073/pnas.88.16.7242; Lotan A, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00331; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; Munoz JJ, 2003, BIOCHEM J, V372, P193, DOI 10.1042/BJ20021941; O'Reilly PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034861; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qi MS, 2005, J CELL SCI, V118, P3569, DOI 10.1242/jcs.02470; R Core Team, R LANG ENV STAT COMP; Scott JR, 2007, WOUND REPAIR REGEN, V15, pS27, DOI 10.1111/j.1524-475X.2007.00222.x; Scott JR, 2005, PLAST RECONSTR SURG, V115, P1095, DOI 10.1097/01.PRS.0000156151.54042.DA; Sood R. F., 2015, J BURN CARE RES S1, V36, pS279; Sood RF, 2015, ANN SURG, V262, P563, DOI 10.1097/SLA.0000000000001439; Sood RF, 2015, J INVEST DERMATOL, V135, P2394, DOI 10.1038/jid.2015.197; Szade A, 2015, IUBMB LIFE, V67, P145, DOI 10.1002/iub.1358; Tang MR, 2012, APOPTOSIS, V17, P927, DOI 10.1007/s10495-012-0727-0; Thompson CM, 2013, J BURN CARE RES, V34, P477, DOI 10.1097/BCR.0b013e3182a2aa41; van der Veer WM, 2009, BURNS, V35, P15, DOI 10.1016/j.burns.2008.06.020; Warsen A., WOUND REPAIR R UNPUB; Yoshii A, 2010, DEV NEUROBIOL, V70, P304, DOI 10.1002/dneu.20765; Zhang W, 2002, CELL RES, V12, P9, DOI 10.1038/sj.cr.7290105; Zhu KQ, 2007, WOUND REPAIR REGEN, V15, pS32, DOI 10.1111/j.1524-475X.2007.00223.x; Zhu ZS, 2013, J CELL COMMUN SIGNAL, V7, P239, DOI 10.1007/s12079-013-0195-5	50	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149206	10.1371/journal.pone.0149206	http://dx.doi.org/10.1371/journal.pone.0149206			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26872063	gold, Green Published, Green Submitted			2022-12-26	WOS:000370054100127
J	Shimonaka, S; Nonaka, T; Suzuki, G; Hisanaga, S; Hasegawa, M				Shimonaka, Shotaro; Nonaka, Takashi; Suzuki, Genjiro; Hisanaga, Shin-ichi; Hasegawa, Masato			Templated Aggregation of TAR DNA-binding Protein of 43 kDa (TDP-43) by Seeding with TDP-43 Peptide Fibrils	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; FRONTOTEMPORAL LOBAR DEGENERATION; ALPHA-SYNUCLEIN; IN-VITRO; FTLD-TDP; MUTATIONS; INCLUSIONS; ALS; CLASSIFICATION; FILAMENTS	TAR DNA-binding protein of 43 kDa (TDP-43) has been identified as the major component of ubiquitin-positive neuronal and glial inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Aggregation of TDP-43 to amyloid-like fibrils and spreading of the aggregates are suggested to account for the pathogenesis and progression of these diseases. To investigate the molecular mechanisms of TDP-43 aggregation, we attempted to identify the amino acid sequence required for the aggregation. By expressing a series of deletion mutants lacking 20 amino acid residues in the C-terminal region in SH-SY5Y cells, we established that residues 274-313 in the glycine-rich region are essential for aggregation. In vitro aggregation experiments using synthetic peptides of 40 amino acids from this sequence and adjacent regions showed that peptides 274-313 and 314-353 formed amyloid-like fibrils. Transduction of these fibrils induced seed-dependent aggregation of TDP-43 in cells expressing wild-type TDP-43 or TDP-43 lacking nuclear localization signal. These cells showed different phosphorylated C-terminal fragments of TDP-43 and different trypsin-resistant bands. These results suggest that residues 274-353 are responsible for the conversion of TDP-43 to amyloid-like fibrils and that templated aggregation of TDP-43 by seeding with different peptides induces various types of TDP-43 pathologies, i.e. the peptides appear to act like prion strains.	[Shimonaka, Shotaro; Nonaka, Takashi; Suzuki, Genjiro; Hasegawa, Masato] Tokyo Metropolitan Inst Med Sci, Dept Dementia & Higher Brain Funct, Tokyo 1568506, Japan; [Shimonaka, Shotaro; Hisanaga, Shin-ichi] Tokyo Metropolitan Univ, Dept Biol Sci, Tokyo 1920397, Japan	Tokyo Metropolitan Institute of Medical Science; Tokyo Metropolitan University	Hasegawa, M (corresponding author), Tokyo Metropolitan Inst Med Sci, Dept Dementia & Higher Brain Funct, Setagaya Ku, Tokyo 1568506, Japan.	hasegawa-ms@igakuken.or.jp	Nonaka, Takashi/L-8572-2017	Nonaka, Takashi/0000-0002-0830-9403	Ministry of Education, Culture, Sports, Science and Technology KAKENHI [26117005, 26111730]; Japan Society for the Promotion of Science KAKENHI [23228004]; Ministry of Health, Labor, and Welfare of Japan [12946221]; Research Committee on Establishment of Novel Treatments for Amyotrophic Lateral Sclerosis; Brain Mapping by Integrated Neurotechnologies for Disease Studies (Brain/MINDS) from Japan Agency for Medical Research and Development, AMED; Grants-in-Aid for Scientific Research [15H02356] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Research Committee on Establishment of Novel Treatments for Amyotrophic Lateral Sclerosis; Brain Mapping by Integrated Neurotechnologies for Disease Studies (Brain/MINDS) from Japan Agency for Medical Research and Development, AMED(Japan Agency for Medical Research and Development (AMED)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Ministry of Education, Culture, Sports, Science and Technology KAKENHI Grants 26117005 (to M. H.) and 26111730 (to T. N.), Japan Society for the Promotion of Science KAKENHI Grant 23228004 (to M. H.), Health and Labor Sciences Research Grant 12946221 from Ministry of Health, Labor, and Welfare of Japan (to M. H.), grant-in-aid for research on rare and intractable diseases, the Research Committee on Establishment of Novel Treatments for Amyotrophic Lateral Sclerosis, and the Brain Mapping by Integrated Neurotechnologies for Disease Studies (Brain/MINDS) from Japan Agency for Medical Research and Development, AMED (to M. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Berriman J, 2003, P NATL ACAD SCI USA, V100, P9034, DOI 10.1073/pnas.1530287100; Bigio EH, 2013, ACTA NEUROPATHOL, V125, P463, DOI 10.1007/s00401-013-1089-6; Buratti E, 2001, EMBO J, V20, P1774, DOI 10.1093/emboj/20.7.1774; Chen AKH, 2010, J AM CHEM SOC, V132, P1186, DOI 10.1021/ja9066207; Daoud H, 2009, J MED GENET, V46, P112, DOI 10.1136/jmg.2008.062463; Furukawa Y, 2011, J BIOL CHEM, V286, P18664, DOI 10.1074/jbc.M111.231209; Gitcho MA, 2008, ANN NEUROL, V63, P535, DOI 10.1002/ana.21344; Goedert M, 2015, SCIENCE, V349, DOI 10.1126/science.1255555; Guo WR, 2011, NAT STRUCT MOL BIOL, V18, P822, DOI 10.1038/nsmb.2053; Hasegawa M, 2008, ANN NEUROL, V64, P60, DOI 10.1002/ana.21425; IGNATIUS SH, 1995, J VIROL, V69, P3584, DOI 10.1128/JVI.69.6.3584-3596.1995; Inukai Y, 2008, FEBS LETT, V582, P2899, DOI 10.1016/j.febslet.2008.07.027; Jiang LL, 2013, J BIOL CHEM, V288, P19614, DOI 10.1074/jbc.M113.463828; Kabashi E, 2008, NAT GENET, V40, P572, DOI 10.1038/ng.132; Kuehnlein P, 2008, ARCH NEUROL-CHICAGO, V65, P1185, DOI 10.1001/archneur.65.9.1185; Mackenzie IRA, 2011, ACTA NEUROPATHOL, V122, P87, DOI 10.1007/s00401-011-0838-7; Masuda-Suzukake M, 2013, BRAIN, V136, P1128, DOI 10.1093/brain/awt037; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Nonaka T, 2013, CELL REP, V4, P124, DOI 10.1016/j.celrep.2013.06.007; Nonaka T, 2010, J BIOL CHEM, V285, P34885, DOI 10.1074/jbc.M110.148460; Nonaka T, 2009, HUM MOL GENET, V18, P3353, DOI 10.1093/hmg/ddp275; Nonaka T, 2009, FEBS LETT, V583, P394, DOI 10.1016/j.febslet.2008.12.031; Rutherford NJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000193; Saini A, 2011, CHEMBIOCHEM, V12, P2495, DOI 10.1002/cbic.201100427; Serpell LC, 2000, P NATL ACAD SCI USA, V97, P4897, DOI 10.1073/pnas.97.9.4897; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Sun CS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103644; Tsuji H, 2012, BRAIN, V135, P3380, DOI 10.1093/brain/aws230; Van Deerlin VM, 2008, LANCET NEUROL, V7, P409, DOI 10.1016/S1474-4422(08)70071-1; Wang YT, 2013, J BIOL CHEM, V288, P9049, DOI 10.1074/jbc.M112.438564; Yokoseki A, 2008, ANN NEUROL, V63, P538, DOI 10.1002/ana.21392	32	61	61	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2016	291	17					8896	8907		10.1074/jbc.M115.713552	http://dx.doi.org/10.1074/jbc.M115.713552			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK3WV	26887947	Green Published, hybrid			2022-12-26	WOS:000374849000004
J	Sultana, R; Tanneeru, K; Kumar, ABR; Guruprasad, L				Sultana, Rafiya; Tanneeru, Karunakar; Kumar, Ashwin B. R.; Guruprasad, Lalitha			Prediction of Certain Well-Characterized Domains of Known Functions within the PE and PPE Proteins of Mycobacteria	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; NONRIBOSOMAL PEPTIDE SYNTHETASE; CELLULOSE-BINDING DOMAIN; PE/PPE MULTIGENE FAMILY; CELL-SURFACE; 3-DIMENSIONAL STRUCTURE; TUBERCULOSIS GENES; CRYSTAL-STRUCTURE; CLASSIFICATION; VIRULENCE	The PE and PPE protein family are unique to mycobacteria. Though the complete genome sequences for over 500 M. tuberculosis strains and mycobacterial species are available, few PE and PPE proteins have been structurally and functionally characterized. We have therefore used bioinformatics tools to characterize the structure and function of these proteins. We selected representative members of the PE and PPE protein family by phylogeny analysis and using structure-based sequence annotation identified ten well-characterized protein domains of known function. Some of these domains were observed to be common to all mycobacterial species and some were species specific.	[Sultana, Rafiya; Tanneeru, Karunakar; Kumar, Ashwin B. R.; Guruprasad, Lalitha] Univ Hyderabad, Sch Chem, Hyderabad 500046, Andhra Pradesh, India	University of Hyderabad	Guruprasad, L (corresponding author), Univ Hyderabad, Sch Chem, Hyderabad 500046, Andhra Pradesh, India.	lalitha.guruprasad@uohyd.ac.in	Tanneeru, Karunakar/C-8200-2019	Tanneeru, PhD, FICS, Dr. Karunakar/0000-0002-9250-6476	DBT; Council of Scientific and Industrial Research; DSK Kothari, UGC	DBT(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); DSK Kothari, UGC	LGP thanks DBT for the Fast Track Fellowship and University with Potential for Excellence-2, University of Hyderabad for research facilities. RS thanks the Council of Scientific and Industrial Research for the Senior Research Fellowship. KT thanks DSK Kothari, UGC for the post-doctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; LGP thanks DBT for Fast Track fellowship and University with Potential for Excellence-2, University of Hyderabad for research facilities. RS thanks Council of Scientific and Industrial Research for Senior Research Fellowship. KT thanks DSK Kothari, UGC for post-doctoral fellowship. The authors also thank the anonymous reviewers and the Academic Editor for very useful comments to improve the manuscript.	Abdallah AM, 2009, MOL MICROBIOL, V73, P329, DOI 10.1111/j.1365-2958.2009.06783.x; Adindla S, 2003, J BIOSCIENCES, V28, P169, DOI 10.1007/BF02706216; Adindla S, 2013, BIOINFORMATICS P AND, P125; Adindla S, 2007, INT J BIOL MACROMOL, V41, P454, DOI 10.1016/j.ijbiomac.2007.06.004; Akhter Y, 2012, BIOCHIMIE, V94, P110, DOI 10.1016/j.biochi.2011.09.026; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anand P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027044; Barathy DV, 2013, FEBS OPEN BIO, V3, P256, DOI 10.1016/j.fob.2013.05.004; Bentley SD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001552; Brohawn SG, 2009, NAT STRUCT MOL BIOL, V16, P1173, DOI 10.1038/nsmb.1713; Brown K, 2000, NAT STRUCT BIOL, V7, P191; Brown K, 2000, J BIOL CHEM, V275, P41133, DOI 10.1074/jbc.M008617200; Cascioferro A, 2007, MOL MICROBIOL, V66, P1536, DOI 10.1111/j.1365-2958.2007.06023.x; Cascioferro A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027713; Chen CKM, 2011, TRENDS BIOCHEM SCI, V36, P553, DOI 10.1016/j.tibs.2011.07.004; COLE ST, 1995, EUR RESPIR J, V8, pS701; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; COLMAN PM, 1994, PROTEIN SCI, V3, P1687, DOI 10.1002/pro.5560031007; Cooper JB, 2002, CURR DRUG TARGETS, V3, P155, DOI 10.2174/1389450024605382; Cryle MJ, 2011, METALLOMICS, V3, P323, DOI 10.1039/c0mt00081g; Daleke MH, 2011, J BIOL CHEM, V286, P19024, DOI 10.1074/jbc.M110.204966; Danielson PB, 2002, CURR DRUG METAB, V3, P561, DOI 10.2174/1389200023337054; DAVIES G, 1995, STRUCTURE, V3, P853, DOI 10.1016/S0969-2126(01)00220-9; Davies G, 1997, COMPREHENSIVE BBIOLO, P119; Deng WY, 2014, CELL PHYSIOL BIOCHEM, V33, P273, DOI 10.1159/000356668; DIN N, 1994, P NATL ACAD SCI USA, V91, P11383, DOI 10.1073/pnas.91.24.11383; DIN N, 1991, BIO-TECHNOL, V9, P1096, DOI 10.1038/nbt1191-1096; Doxey AC, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-23; Dubnau E, 2002, INFECT IMMUN, V70, P2787, DOI 10.1128/IAI.70.6.2787-2795.2002; Dunn B, 1989, PROTEOLITIC ENZYMES; Ehebauer MT, 2011, PROTEOMICS, V11, P3128, DOI 10.1002/pmic.201000787; Fishbein S, 2015, MOL MICROBIOL, V96, P901, DOI 10.1111/mmi.12981; Garnier T, 2003, P NATL ACAD SCI USA, V100, P7877, DOI 10.1073/pnas.1130426100; Garrett CK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135447; Gey van Pittius NC, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-95; Gordon EHJ, 2003, J BIOL CHEM, V278, P11773, DOI 10.1074/jbc.M211886200; Harries AD, 2010, LANCET, V375, P1906, DOI 10.1016/S0140-6736(10)60409-6; Henrissat B, 1997, CURR OPIN STRUC BIOL, V7, P637, DOI 10.1016/S0959-440X(97)80072-3; Henrissat B, 1996, BIOCHEM J, V316, P695, DOI 10.1042/bj3160695; HENRISSAT B, 1991, BIOCHEM J, V280, P309, DOI 10.1042/bj2800309; HENRISSAT B, 1995, P NATL ACAD SCI USA, V92, P7090, DOI 10.1073/pnas.92.15.7090; Hotelier T, 2004, NUCLEIC ACIDS RES, V32, pD145, DOI 10.1093/nar/gkh141; Hur GH, 2012, NAT PROD REP, V29, P1074, DOI 10.1039/c2np20025b; Iantomasi R, 2012, CELL MICROBIOL, V14, P356, DOI 10.1111/j.1462-5822.2011.01721.x; Ishikawa J, 2004, P NATL ACAD SCI USA, V101, P14925, DOI 10.1073/pnas.0406410101; Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7; Johnson PE, 1996, BIOCHEMISTRY-US, V35, P14381, DOI 10.1021/bi961612s; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kim BS, 2012, J BACTERIOL, V194, P4441, DOI 10.1128/JB.00848-12; Kohli S, 2012, NUCLEIC ACIDS RES, V40, P7113, DOI 10.1093/nar/gks465; KOSHLAND DE, 1953, BIOL REV, V28, P416, DOI 10.1111/j.1469-185X.1953.tb01386.x; Li LL, 2005, P NATL ACAD SCI USA, V102, P12344, DOI 10.1073/pnas.0505662102; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; LIETZKE SE, 1994, PLANT PHYSIOL, V106, P849, DOI 10.1104/pp.106.3.849; Lin DYW, 2012, P NATL ACAD SCI USA, V109, P1925, DOI 10.1073/pnas.1115025109; Lin DYW, 2011, J BIOL CHEM, V286, P441, DOI 10.1074/jbc.M110.167643; Mackenzie N, 2009, J CLIN MICROBIOL, V47, P1002, DOI 10.1128/JCM.01313-08; McEvoy CRE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030593; Mitraki A, 2002, J STRUCT BIOL, V137, P236, DOI 10.1006/jsbi.2002.4447; Nair Shiny, 2014, Proceedings of the Indian National Science Academy, V80, P1055; Narita M, 1998, AM J RESP CRIT CARE, V158, P157, DOI 10.1164/ajrccm.158.1.9712001; Pearson WR, 2013, INTRO SEQUENCE SIMIL; Pieper U, 2011, NUCLEIC ACIDS RES, V39, pD465, DOI 10.1093/nar/gkq1091; Pohle S, 2011, J AM CHEM SOC, V133, P6194, DOI 10.1021/ja108971p; POULSEN K, 1976, BIOCHIM BIOPHYS ACTA, V452, P533, DOI 10.1016/0005-2744(76)90205-9; Sampson SL, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/497203; Singh S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115020; SINNOTT ML, 1990, CHEM REV, V90, P1171, DOI 10.1021/cr00105a006; SNIDER DE, 1994, J INFECT DIS, V169, P1189, DOI 10.1093/infdis/169.6.1189; SONG WC, 1993, P NATL ACAD SCI USA, V90, P8519, DOI 10.1073/pnas.90.18.8519; Srivastava V, 2007, MICROBIOL-SGM, V153, P659, DOI 10.1099/mic.0.2006/000547-0; Stinear TP, 2008, GENOME RES, V18, P729, DOI 10.1101/gr.075069.107; Sultana R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055320; Sultana R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016745; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Taylor NR, 1998, J MED CHEM, V41, P798, DOI 10.1021/jm9703754; Tormo J, 1996, EMBO J, V15, P5739, DOI 10.1002/j.1460-2075.1996.tb00960.x; TORRONEN A, 1994, EMBO J, V13, P2493, DOI 10.1002/j.1460-2075.1994.tb06536.x; Tundup S, 2006, FEBS LETT, V580, P1285, DOI 10.1016/j.febslet.2006.01.042; Tundup S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003586; Uhlmann S, 2013, ACS CHEM BIOL, V8, P2586, DOI 10.1021/cb400555e; van Helden P., 2008, HDB TUBERCULOSIS CLI; Vissa V. D., 2001, Genome Biology, V2, P1023, DOI 10.1186/gb-2001-2-8-reviews1023; World Health Organization, 2006, GUID PROGR MAN DRUG; Wu HM, 2009, J BIOL CHEM, V284, P26708, DOI 10.1074/jbc.M109.010983; Zaman K, 2010, J HEALTH POPUL NUTR, V28, P111; Zheng QQ, 2014, J BIOL CHEM, V289, P21242, DOI 10.1074/jbc.M114.569913; Zumbo A, 2013, PATHOG DIS, V69, P232, DOI 10.1111/2049-632X.12096	88	4	4	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2016	11	2							e0146786	10.1371/journal.pone.0146786	http://dx.doi.org/10.1371/journal.pone.0146786			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3CO	26891364	Green Published, Green Submitted, gold			2022-12-26	WOS:000371221500002
J	Wilkie, H; Gossner, A; Bishop, S; Hopkins, J				Wilkie, Hazel; Gossner, Anton; Bishop, Stephen; Hopkins, John			Variations in T Cell Transcription Factor Sequence and Expression Associated with Resistance to the Sheep Nematode Teladorsagia circumcincta	PLOS ONE			English	Article							RECEPTOR ROR-ALPHA; GENE-EXPRESSION; GENOMIC STRUCTURE; DNA-BINDING; INFECTION; GATA3; LAMBS; BET; DIFFERENTIATION; ISOFORM	This study used selected lambs that varied in their resistance to the gastrointestinal parasite Teladorsagia circumcincta. Infection over 12 weeks identified susceptible (high adult worm count, AWC; high fecal egg count, FEC; low body weight, BW; low IgA) and resistant sheep (no/low AWC and FEC, high BW and high IgA). Resistance is mediated largely by a Th2 response and IgA and IgE antibodies, and is a heritable characteristic. The polarization of T cells and the development of appropriate immune responses is controlled by the master regulators, T-bet (TBX21), GATA-3 (GATA3), ROR gamma t (RORC2) and ROR alpha (RORA); and several inflammatory diseases of humans and mice are associated with allelic or transcript variants of these transcription factors. This study tested the hypothesis that resistance of sheep to T. circumcincta is associated with variations in the structure, sequence or expression levels of individual master regulator transcripts. We have identified and sequenced one variant of sheep TBX21, two variants of GATA3 and RORC2 and five variants of RORA from lymph node mRNA. Relative RT-qPCR analysis showed that TBX21, GATA3 and RORC2 were not significantly differentially-expressed between the nine most resistant (AWC, 0; FEC, 0) and the nine most susceptible sheep (AWC, mean 6078; FEC, mean 350). Absolute RT-qPCR on all 45 animals identified RORVv5 as being significantly differentially-expressed (p = 0.038) between resistant, intermediate and susceptible groups; RORCv2 was not differentially-expressed (p = 0.77). Spearman's rank analysis showed that RORAv5 transcript copy number was significantly negatively correlated with parameters of susceptibility, AWC and FEC; and was positively correlated with BW. RORCv2 was not correlated with AWC, FEC or BW but was significantly negatively correlated with IgA antibody levels. This study identifies the full length RORA variant (RORAv5) as important in controlling the protective immune response to T. circumcincta infection in sheep.	[Hopkins, John] Univ Edinburgh, Roslin Inst, Easter Bush EH25 9RG, Midlothian, Scotland; Univ Edinburgh, RDSVS, Easter Bush EH25 9RG, Midlothian, Scotland	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh	Hopkins, J (corresponding author), Univ Edinburgh, Roslin Inst, Easter Bush EH25 9RG, Midlothian, Scotland.	john.hopkins@ed.ac.uk	Hopkins, John/C-7756-2013	Hopkins, John/0000-0002-9530-8037; Wilkie, Hazel/0000-0002-6586-4518	Biotechnology and Biological Sciences Research Council (BBSRC) Institute Strategic Programme Grant; BBSRC Industrial CASE scholarship; Sheep Improved Genetics Ltd; AHDB Beef and Lamb [BB/J012653/1]; Natural Environment Research Council (NERC) [NE/D000645/1]; Sheep Improved Genetics Ltd (SIG); BBSRC CASE Scholarship; BBSRC; AHDN Animal Health Beef and Lamb (Eblex); BBSRC [BBS/E/D/20231760, BBS/E/D/20231759] Funding Source: UKRI; NERC [NE/D000645/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/D/20231759, 1232400, BBS/E/D/20231760] Funding Source: researchfish; Natural Environment Research Council [NE/D000645/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC) Institute Strategic Programme Grant(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC Industrial CASE scholarship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Sheep Improved Genetics Ltd; AHDB Beef and Lamb; Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Sheep Improved Genetics Ltd (SIG); BBSRC CASE Scholarship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); AHDN Animal Health Beef and Lamb (Eblex); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This project was funded by the Biotechnology and Biological Sciences Research Council (BBSRC) Institute Strategic Programme Grant to The Roslin Institute and by a BBSRC Industrial CASE scholarship to JH and SB, for HW, sponsored by Sheep Improved Genetics Ltd and AHDB Beef and Lamb (Grant BB/J012653/1). The initial work was funded by the Natural Environment Research Council (NERC) through its 'PostGenomics and Proteomics' programme (grant NE/D000645/1). No funding was obtained from Sheep Improved Genetics Ltd (SIG). Their support was essential to obtain the BBSRC CASE Scholarship, but all the funds came from either BBSRC or AHDN Animal Health Beef and Lamb (originally called Eblex). SIG had no influence on the design of the experiments and have no rights to the data.	Anthony RM, 2007, NAT REV IMMUNOL, V7, P975, DOI 10.1038/nri2199; Aschrafi A, 2006, BBA-MOL CELL RES, V1763, P805, DOI 10.1016/j.bbamcr.2006.05.006; Beraldi D, 2008, INT J PARASITOL, V38, P1567, DOI 10.1016/j.ijpara.2008.04.011; Besnard S, 2002, FEBS LETT, V511, P36, DOI 10.1016/S0014-5793(01)03275-6; Brunsdon RV, 1988, EC IMPORTANCE PARASI, V1, P4; Davies G, 2006, HEREDITY, V96, P252, DOI 10.1038/sj.hdy.6800788; Delerive P, 2001, EMBO REP, V2, P42, DOI 10.1093/embo-reports/kve007; Diez-Tascon C, 2005, PHYSIOL GENOMICS, V21, P59, DOI 10.1152/physiolgenomics.00257.2004; GIGUERE V, 1994, GENE DEV, V8, P538, DOI 10.1101/gad.8.5.538; Gossner A, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-68; Gossner AG, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-26; Halliday AM, 2010, PARASITE IMMUNOL, V32, P81, DOI 10.1111/j.1365-3024.2009.01173.x; Huebner M, 2008, J ALLERGY CLIN IMMUN, V121, P408, DOI 10.1016/j.jaci.2007.09.020; Hwang ES, 2005, SCIENCE, V307, P430, DOI 10.1126/science.1103336; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Kanai T, 2012, MUCOSAL IMMUNOL, V5, P240, DOI 10.1038/mi.2012.6; Knight PA, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-78; Lazarevic V, 2013, NAT REV IMMUNOL, V13, P777, DOI 10.1038/nri3536; Lazarevic V, 2011, NAT IMMUNOL, V12, P597, DOI 10.1038/ni.2059; LEE CH, 1995, GENOMICS, V30, P46, DOI 10.1006/geno.1995.0007; Maizels RM, 2009, J EXP MED, V206, P2059, DOI 10.1084/jem.20091903; Maizels RM, 2003, NAT REV IMMUNOL, V3, P733, DOI 10.1038/nri1183; Matsuoka K, 2004, GUT, V53, P1303, DOI 10.1136/gut.2003.024190; Medvedev A, 1997, GENOMICS, V46, P93, DOI 10.1006/geno.1997.4980; Migita H, 2004, FEBS LETT, V557, P269, DOI 10.1016/S0014-5793(03)01502-3; Murphy L, 2010, PARASITOLOGY, V137, P1249, DOI 10.1017/S0031182010000028; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Nisbet AJ, 2009, PARASITE IMMUNOL, V31, P32, DOI 10.1111/j.1365-3024.2008.01070.x; Ohtani K, 2010, PEDIATR INT, V52, P584, DOI 10.1111/j.1442-200X.2009.03019.x; Pemberton JM, 2011, MOL ECOL, V20, P910, DOI 10.1111/j.1365-294X.2010.04992.x; Pykalainen M, 2005, J ALLERGY CLIN IMMUN, V115, P80, DOI 10.1016/j.jaci.2004.10.006; Rauen T, 2012, GENES IMMUN, V13, P346, DOI 10.1038/gene.2011.85; Rowe A, 2008, VET PARASITOL, V154, P71, DOI 10.1016/j.vetpar.2008.02.014; Sayers G., 2005, Animal Health Research Reviews, V6, P159, DOI 10.1079/AHR2005108; Shaw RJ, 2012, VET PARASITOL, V186, P109, DOI 10.1016/j.vetpar.2011.11.051; Shinnakasu R, 2006, J IMMUNOL, V177, P5801, DOI 10.4049/jimmunol.177.9.5801; SMITH WD, 1986, RES VET SCI, V41, P300, DOI 10.1016/S0034-5288(18)30620-9; Stear MJ, 1999, INT J PARASITOL, V29, P51, DOI 10.1016/S0020-7519(98)00179-9; Stear MJ, 1999, VET IMMUNOL IMMUNOP, V72, P213, DOI 10.1016/S0165-2427(99)00134-8; Steinmayr M, 1998, P NATL ACAD SCI USA, V95, P3960, DOI 10.1073/pnas.95.7.3960; Urquhart GM, 1987, VET PARASITOLOGY AVO; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Weaver CT, 2007, ANNU REV IMMUNOL, V25, P821, DOI 10.1146/annurev.immunol.25.022106.141557; Wojno EDT, 2012, CELL HOST MICROBE, V12, P445, DOI 10.1016/j.chom.2012.10.003; Wong SH, 2012, NAT IMMUNOL, V13, P229, DOI 10.1038/ni.2208; Yagi RJ, 2014, IMMUNITY, V40, P378, DOI 10.1016/j.immuni.2014.01.012; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8; Zhu JF, 2006, CELL RES, V16, P3, DOI 10.1038/sj.cr.7310002; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	50	7	8	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2016	11	2							e0149644	10.1371/journal.pone.0149644	http://dx.doi.org/10.1371/journal.pone.0149644			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3CO	26890074	Green Published, Green Submitted, gold			2022-12-26	WOS:000371221500067
J	Ibanez, M; Carbonell-Caballero, J; Garcia-Alonso, L; Such, E; Jimenez-Almazan, J; Vidal, E; Barragan, E; Lopez-Pavia, M; LLop, M; Martin, I; Gomez-Segui, I; Montesinos, P; Sanz, MA; Dopazo, J; Cervera, J				Ibanez, Mariam; Carbonell-Caballero, Jose; Garcia-Alonso, Luz; Such, Esperanza; Jimenez-Almazan, Jorge; Vidal, Enrique; Barragan, Eva; Lopez-Pavia, Maria; LLop, Marta; Martin, Ivan; Gomez-Segui, Ines; Montesinos, Pau; Sanz, Miguel A.; Dopazo, Joaquin; Cervera, Jose			The Mutational Landscape of Acute Promyelocytic Leukemia Reveals an Interacting Network of Co-Occurrences and Recurrent Mutations	PLOS ONE			English	Article							PROTEIN-INTERACTION NETWORKS; ACUTE MYELOID-LEUKEMIA; SOMATIC MUTATIONS; TOOL	Preliminary Acute Promyelocytic Leukemia (APL) whole exome sequencing (WES) studies have identified a huge number of somatic mutations affecting more than a hundred different genes mainly in a non-recurrent manner, suggesting that APL is a heterogeneous disease with secondary relevant changes not yet defined. To extend our knowledge of subtle genetic alterations involved in APL that might cooperate with PML/RARA in the leukemogenic process, we performed a comprehensive analysis of somatic mutations in APL combining WES with sequencing of a custom panel of targeted genes by next-generation sequencing. To select a reduced subset of high confidence candidate driver genes, further in silico analysis were carried out. After prioritization and network analysis we found recurrent deleterious mutations in 8 individual genes (STAG2, U2AF1, SMC1A, USP9X, IKZF1, LYN, MYCBP2 and PTPN11) with a strong potential of being involved in APL pathogenesis. Our network analysis of multiple mutations provides a reliable approach to prioritize genes for additional analysis, improving our knowledge of the leukemogenesis interactome. Additionally, we have defined a functional module in the interactome of APL. The hypothesis is that the number, or the specific combinations, of mutations harbored in each patient might not be as important as the disturbance caused in biological key functions, triggered by several not necessarily recurrent mutations.	[Ibanez, Mariam; Such, Esperanza; Lopez-Pavia, Maria; Martin, Ivan; Gomez-Segui, Ines; Montesinos, Pau; Sanz, Miguel A.; Cervera, Jose] Hosp Univ & Politecn La Fe, Hematol Serv, Valencia, Spain; [Carbonell-Caballero, Jose; Garcia-Alonso, Luz; Jimenez-Almazan, Jorge; Vidal, Enrique; Dopazo, Joaquin] Ctr Invest Principe Felipe, Computat Genom Dept, Valencia, Spain; [Barragan, Eva; LLop, Marta] Hosp Univ La Fe, Dept Clin Chem, Mol Biol Lab, Valencia, Spain; [Dopazo, Joaquin] CIPF, Spanish Natl Inst Bioinformat, Funct Genom Node, Valencia 46012, Spain; [Dopazo, Joaquin] CIBER Enfermedades Raras CIBERER, Bioinformat Rare Dis BIER, Valencia, Spain; [Cervera, Jose] Hosp Univ & Politecn La Fe, Genet Unit, Valencia, Spain	Hospital Universitari i Politecnic La Fe; Prince Felipe Research Center; Hospital Universitari i Politecnic La Fe; Prince Felipe Research Center; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Hospital Universitari i Politecnic La Fe	Cervera, J (corresponding author), Hosp Univ & Politecn La Fe, Hematol Serv, Valencia, Spain.; Dopazo, J (corresponding author), Ctr Invest Principe Felipe, Computat Genom Dept, Valencia, Spain.; Dopazo, J (corresponding author), CIPF, Spanish Natl Inst Bioinformat, Funct Genom Node, Valencia 46012, Spain.; Dopazo, J (corresponding author), CIBER Enfermedades Raras CIBERER, Bioinformat Rare Dis BIER, Valencia, Spain.; Cervera, J (corresponding author), Hosp Univ & Politecn La Fe, Genet Unit, Valencia, Spain.	jdopazo@cipf.es; cervera_jos@gva.es	Martin, Ivan/K-9286-2016; Cervera, Jose/ABF-2143-2020; Sanz, Miguel A./F-7485-2018; Martín, Iván/AAL-7783-2021; IBAÑEZ COMPANY, MARIAM/AAW-9082-2021; Dopazo, Joaquin/A-9270-2014; Seguí, Inés Gómez/ABH-5290-2020	Cervera, Jose/0000-0001-8252-1106; Sanz, Miguel A./0000-0003-1489-1177; IBAÑEZ COMPANY, MARIAM/0000-0002-7486-4659; Dopazo, Joaquin/0000-0003-3318-120X; Carbonell Caballero, Jose/0000-0002-9170-0533; Montesinos, Pau/0000-0002-3275-5593; Llop, Marta/0000-0002-0106-7296; Lopez Pavia, Maria/0000-0002-8529-4372; Such, Esperanza/0000-0001-6892-403X; Garcia-Alonso, Luz/0000-0002-7863-9619	Fundacion Espanola de Hematologia (FEHH); Red Tematica de Investigacion Cooperativa en Cancer [RD12/0036/0014]; Instituto de Salud Carlos III [PI12/01047, PI13/01640, PT13/0010/0026, PIE13/00046]; "Conselleria de Educacion, Cultura y Deporte" of the Valencian Community [PROMETEOII/2014/025, PROMETEOII/2015/008]; Spanish Ministry of Economy and Competitiveness [BIO2014-57291-R]	Fundacion Espanola de Hematologia (FEHH); Red Tematica de Investigacion Cooperativa en Cancer; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); "Conselleria de Educacion, Cultura y Deporte" of the Valencian Community; Spanish Ministry of Economy and Competitiveness(Spanish Government)	This study was supported in part by research funding from "Fundacion Espanola de Hematologia (FEHH)"; "Red Tematica de Investigacion Cooperativa en Cancer" grant (RD12/0036/0014); "Instituto de Salud Carlos III" grants PI12/01047, PI13/01640, PT13/0010/0026 and PIE13/00046; from the "Conselleria de Educacion, Cultura y Deporte" of the Valencian Community (PROMETEOII/2014/025 and PROMETEOII/2015/008) and from the Spanish Ministry of Economy and Competitiveness (BIO2014-57291-R).	Akagi T, 2009, BLOOD, V113, P1741, DOI 10.1182/blood-2007-12-130260; Al-Shahrour F, 2004, BIOINFORMATICS, V20, P578, DOI 10.1093/bioinformatics/btg455; Alonso R, 2015, NUCLEIC ACIDS RES, V43, pW117, DOI 10.1093/nar/gkv384; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Chuang HY, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100180; Dolnik A, 2012, BLOOD, V120, pE83, DOI 10.1182/blood-2011-12-401471; Garcia-Alonso L, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145222; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Gomez-Segui I, 2012, ANN HEMATOL, V91, P19, DOI 10.1007/s00277-011-1331-z; Gonzalez-Perez A, 2013, NAT METHODS, V10, P1081, DOI [10.1038/NMETH.2642, 10.1038/nmeth.2642]; Greif PA, 2011, LEUKEMIA, V25, P1519, DOI 10.1038/leu.2011.114; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Minguez P, 2009, NUCLEIC ACIDS RES, V37, pW109, DOI 10.1093/nar/gkp402; Mitra K, 2013, NAT REV GENET, V14, P719, DOI 10.1038/nrg3552; Oti M, 2007, CLIN GENET, V71, P1, DOI 10.1111/j.1399-0004.2006.00708.x; Patel VN, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003237; Porta-Pardo E, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004518; Riva L, 2013, BLOOD CANCER J, V3, DOI 10.1038/bcj.2013.46; Stoll G, 2013, NUCLEIC ACIDS RES, V41, P8853, DOI 10.1093/nar/gkt678; Taylor IW, 2009, NAT BIOTECHNOL, V27, P199, DOI 10.1038/nbt.1522; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Welch JS, 2011, JAMA-J AM MED ASSOC, V305, P1577, DOI 10.1001/jama.2011.497; Zimonjic DB, 2000, P NATL ACAD SCI USA, V97, P13306, DOI 10.1073/pnas.97.24.13306	23	20	21	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0148346	10.1371/journal.pone.0148346	http://dx.doi.org/10.1371/journal.pone.0148346			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26886259	gold, Green Submitted, Green Published			2022-12-26	WOS:000371218400031
J	de Almeida, LFR; Portella, RD; Bufalo, J; Marques, MOM; Facanali, R; Frei, F				Rolim de Almeida, Luiz Fernando; Portella, Roberto de Oliveira; Bufalo, Jennifer; Mayo Marques, Marcia Ortiz; Facanali, Roselaine; Frei, Fernando			Non-Oxygenated Sesquiterpenes in the Essential Oil of Copaifera langsdorffii Desf. Increase during the Day in the Dry Season	PLOS ONE			English	Article							CHEMICAL-COMPOSITION; ANTIMICROBIAL ACTIVITY; BIOLOGICAL-ACTIVITIES; L.; TEMPERATURE; EMISSIONS; LEAVES; CONSTITUENTS; OLEORESINS; COMPONENTS	The present study aimed to evaluate the effect of seasonal and diurnal events on the chemical profile of the essential oil obtained from the leaves of Copaifera langsdorffii Desf. This study was performed in a Brazilian savanna named Cerrado. We identified the best harvesting period for obtaining the highest amount of compounds used for commercial and industrial purposes. The chemical profile of the essential oils was evaluated by GC-FID and GC-MS, and the results were assessed through multivariate analyses. The data showed that the time of day and seasonal variations affect the quality of the essential oil obtained. Leaves harvested at the end of the day (5: 00 pm) in the dry season resulted in richer essential oils with higher amounts of non-oxygenated sesquiterpenes. To the best of our knowledge, environmental conditions induce metabolic responses in the leaves of C. langsdorffii, which changes the patterns of sesquiterpene production. Therefore, these factors need to be considered to obtain better concentrations of bioactive compounds for pharmacological studies.	[Rolim de Almeida, Luiz Fernando; Portella, Roberto de Oliveira; Bufalo, Jennifer] Univ Estadual Paulista UNESP, Dept Bot, Inst Biosci Botucatu, POB 510, BR-18618970 Sao Paulo, Brazil; [Mayo Marques, Marcia Ortiz; Facanali, Roselaine] IAC, Inst Agron, POB 28, BR-13001970 Sao Paulo, Brazil; [Frei, Fernando] Univ Estadual Paulista UNESP, Dept Biol Sci, BR-19800000 Sao Paulo, Brazil	Universidade Estadual Paulista; Instituto Agronomico de Campinas (IAC); Universidade Estadual Paulista	Bufalo, J (corresponding author), Univ Estadual Paulista UNESP, Dept Bot, Inst Biosci Botucatu, POB 510, BR-18618970 Sao Paulo, Brazil.	jenniferbufalo@yahoo.com.br	Portella, Roberto O/O-8392-2015; Marques, Marcia O.M./E-1283-2019; de Oliveira Portella, Roberto/AAT-7276-2020	Portella, Roberto O/0000-0002-8668-3425; Marques, Marcia O.M./0000-0001-8270-4308; ROLIM ALMEIDA, LUIZ FERNANDO/0000-0002-2961-2794	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Roberto Oliveira Portela [2013/07629-1];  [2010/15585-6]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Roberto Oliveira Portela; 	This research was funded by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP). Luiz Fernando Rolim de Almeida received financial support process no 2010/15585-6 and Roberto Oliveira Portela scholarship process no 2013/07629-1 (http://www.fapesp.br/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams R.P., 2007, IDENTIFICATION ESSEN, V4th; Angelopoulou D, 2002, BIOCHEM SYST ECOL, V30, P189, DOI 10.1016/S0305-1978(01)00074-6; Asghari G, 2014, JUNDISHAPUR J NAT PH, V9, P35, DOI 10.17795/jjnpp-12229; Bakkali F, 2008, FOOD CHEM TOXICOL, V46, P446, DOI 10.1016/j.fct.2007.09.106; Cascon V, 2000, PHYTOCHEMISTRY, V55, P773, DOI 10.1016/S0031-9422(00)00284-3; Chen F, 2009, PLANT PHYSIOL BIOCH, V47, P1017, DOI 10.1016/j.plaphy.2009.07.005; Christensen CS, 2000, ATMOS ENVIRON, V34, P3057, DOI 10.1016/S1352-2310(99)00502-6; Coutinho Leopoldo Magno, 2006, Acta Bot. Bras., V20, P13, DOI 10.1590/S0102-33062006000100002; Del-Vechio-Vieira G, 2009, REC NAT PROD, V3, P52; Duhl TR, 2008, BIOGEOSCIENCES, V5, P761, DOI 10.5194/bg-5-761-2008; Figueiredo AC, 2008, FLAVOUR FRAG J, V23, P213, DOI 10.1002/ffj.1875; FREITAS CRISTIANE V., 2002, Braz. J. Bot., V25, P311, DOI 10.1590/S0100-84042002000300007; Fuentes JD, 1996, J ATMOS CHEM, V25, P67, DOI 10.1007/BF00053286; Gawronska K, 2013, J PLANT PHYSIOL, V170, P129, DOI 10.1016/j.jplph.2012.09.019; Gelmini F, 2013, INT J PHARMACEUT, V440, P170, DOI 10.1016/j.ijpharm.2012.08.021; Gramosa MV, 2005, J ESSENT OIL RES, V17, P130; Helmig D, 2006, ATMOS ENVIRON, V40, P4150, DOI 10.1016/j.atmosenv.2006.02.035; Hussain AI, 2008, FOOD CHEM, V108, P986, DOI 10.1016/j.foodchem.2007.12.010; Klink CA, 2005, CONSERV BIOL, V19, P707, DOI 10.1111/j.1523-1739.2005.00702.x; Kobaisy M, 2002, PHYTOCHEMISTRY, V61, P37, DOI 10.1016/S0031-9422(02)00207-8; Kucukbay FZ, 2012, NAT PROD RES, V26, P1668, DOI 10.1080/14786419.2011.599808; Kumar R, 2013, SCI HORTIC-AMSTERDAM, V154, P102, DOI 10.1016/j.scienta.2013.02.002; Leandro LM, 2012, MOLECULES, V17, P3866, DOI 10.3390/molecules17043866; LINCOLN DE, 1978, BIOCHEM SYST ECOL, V6, P21, DOI 10.1016/0305-1978(78)90021-2; McGimpsey Jennifer A., 1994, Flavour and Fragrance Journal, V9, P347, DOI 10.1002/ffj.2730090613; McLafferty F.W., 1989, WILEY NBS REGISTRY M, V1; Michel CG, 2011, J ETHNOPHARMACOL, V133, P53, DOI 10.1016/j.jep.2010.09.001; Nagappan T, 2011, MOLECULES, V16, P9651, DOI 10.3390/molecules16119651; Nascimento ME, 2012, BIOCH SYST ECOL, V43, P1; Oliveira PS, 2002, CERRADOS BRAZIL ECOL, P289; Paolini J, 2010, BIOCHEM SYST ECOL, V38, P865, DOI 10.1016/j.bse.2010.07.009; Ribeiro AF, 2014, BIOCHEM SYST ECOL, V55, P249, DOI 10.1016/j.bse.2014.03.014; Ribeiro DA, 2014, J ETHNOPHARMACOL, V155, P1522, DOI 10.1016/j.jep.2014.07.042; Ribeiro JF., 1998, CERRADO AMBIENTE FLO, P89; Rigano D, 2011, NAT PROD RES, V25, P614, DOI 10.1080/14786419.2010.488623; Rodilla JM, 2008, BIOCHEM SYST ECOL, V36, P167, DOI 10.1016/j.bse.2007.09.001; Rodrigues TM, 2014, TREES-STRUCT FUNCT, V28, P613, DOI 10.1007/s00468-013-0976-8; de Almeida LFR, 2014, J ESSENT OIL RES, V26, P292, DOI 10.1080/10412905.2014.889050; Sangwan NS, 2001, PLANT GROWTH REGUL, V34, P3, DOI 10.1023/A:1013386921596; Sartor T, 2013, IND CROP PROD, V51, P355, DOI 10.1016/j.indcrop.2013.09.018; SILVA EF, 2007, R BRAS BIOCI, V5, P948; Telci I, 2011, IND CROP PROD, V34, P1193, DOI 10.1016/j.indcrop.2011.04.010; Toncer O, 2009, NOT BOT HORTI AGROBO, V37, P177; Vallat A, 2005, PHYTOCHEMISTRY, V66, P1540, DOI 10.1016/j.phytochem.2005.04.038; VANDENDOOL H, 1963, J CHROMATOGR, V11, P463, DOI 10.1016/S0021-9673(01)80947-X; Veiga VF, 2006, J ESSENT OIL RES, V18, P430, DOI 10.1080/10412905.2006.9699132; Veiga VF, 2002, QUIM NOVA, V25, P273, DOI 10.1590/S0100-40422002000200016; Vidovic M, 2015, PLANT PHYSIOL BIOCH, V93, P44, DOI 10.1016/j.plaphy.2015.01.008; VOIRIN B, 1990, PHYTOCHEMISTRY, V29, P749, DOI 10.1016/0031-9422(90)80012-6; VON RUDLOFF E., 1965, PHYTOCHEMISTRY, V4, P11, DOI 10.1016/S0031-9422(00)86141-5; Wang HW, 2012, IND CROP PROD, V36, P229, DOI 10.1016/j.indcrop.2011.09.011; Zoghbi MDB, 2009, J ESSENT OIL RES, V21, P403	52	22	22	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0149332	10.1371/journal.pone.0149332	http://dx.doi.org/10.1371/journal.pone.0149332			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26886431	gold, Green Submitted, Green Published			2022-12-26	WOS:000371218400076
J	Acosta, AL; Giannini, TC; Imperatriz-Fonseca, VL; Saraiva, AM				Acosta, Andre L.; Giannini, Tereza C.; Imperatriz-Fonseca, Vera L.; Saraiva, Antonio M.			Worldwide Alien Invasion: A Methodological Approach to Forecast the Potential Spread of a Highly Invasive Pollinator	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; BOMBUS-TERRESTRIS L.; BUMBLE BEE HYMENOPTERA; PSEUDO-ABSENCES; BIOLOGICAL INVASIONS; INTRODUCED BEES; DISTRIBUTIONS; NICHE; APIDAE; PERFORMANCE	The ecological impacts of alien species invasion are a major threat to global biodiversity. The increasing number of invasion events by alien species and the high cost and difficulty of eradicating invasive species once established require the development of new methods and tools for predicting the most susceptible areas to invasion. Invasive pollinators pose serious threats to biodiversity and human activity due to their close relationship with many plants (including crop species) and high potential competitiveness for resources with native pollinators. Although at an early stage of expansion, the bumblebee species Bombus terrestris is becoming a representative case of pollinator invasion at a global scale, particularly given its high velocity of invasive spread and the increasing number of reports of its impacts on native bees and crops in many countries. We present here a methodological framework of habitat suitability modeling that integrates new approaches for detecting habitats that are susceptible to Bombus terrestris invasion at a global scale. Our approach did not include reported invaded locations in the modeling procedure; instead, those locations were used exclusively to evaluate the accuracy of the models in predicting suitability over regions already invaded. Moreover, a new and more intuitive approach was developed to select the models and evaluate different algorithms based on their performance and predictive convergence. Finally, we present a comprehensive global map of susceptibility to Bombus terrestris invasion that highlights priority areas for monitoring.	[Acosta, Andre L.; Giannini, Tereza C.; Imperatriz-Fonseca, Vera L.] Univ Sao Paulo, Biosci Inst, Dept Ecol, Rua Matao,Travessa 14,321, BR-05508090 Sao Paulo, SP, Brazil; [Giannini, Tereza C.; Imperatriz-Fonseca, Vera L.] Vale Inst Technol Sustainable Dev, Rua Boaventura da Silva 955, BR-66055090 Belem, Para, Brazil; [Saraiva, Antonio M.] Univ Sao Paulo, Dept Comp & Digital Syst Engn, Polytech Sch, Ave Prof Luciano Gualberto 380, BR-05508970 Sao Paulo, SP, Brazil; [Acosta, Andre L.; Giannini, Tereza C.; Imperatriz-Fonseca, Vera L.; Saraiva, Antonio M.] Res Ctr Biodivers & Comp BioComp, Ave Prof Luciano Gualberto,Travessa 3,158, BR-05508900 Sao Paulo Capital, SP, Brazil	Universidade de Sao Paulo; Instituto Tecnologico Vale Desenvolvimento Sustentavel; Universidade de Sao Paulo	Acosta, AL (corresponding author), Univ Sao Paulo, Biosci Inst, Dept Ecol, Rua Matao,Travessa 14,321, BR-05508090 Sao Paulo, SP, Brazil.; Acosta, AL (corresponding author), Res Ctr Biodivers & Comp BioComp, Ave Prof Luciano Gualberto,Travessa 3,158, BR-05508900 Sao Paulo Capital, SP, Brazil.	andreluisacosta@usp.br	Imperatriz-Fonseca, Vera Lucia/AAU-7633-2021; Acosta, Andre Luis/H-2036-2012; Giannini, Tereza C/F-2676-2012; Saraiva, Antonio M/B-6350-2011; Imperatriz-Fonseca, Vera Lucia/H-5582-2012; Giannini, Tereza Cristina/AAA-2958-2019	Imperatriz-Fonseca, Vera Lucia/0000-0002-1079-2158; Acosta, Andre Luis/0000-0002-4244-9637; Saraiva, Antonio M/0000-0003-2283-1123; Imperatriz-Fonseca, Vera Lucia/0000-0002-1079-2158; Giannini, Tereza Cristina/0000-0001-9830-1204	Sao Paulo State Research Foundation [2011/12779-7]; National Counsel of Technological and Scientific Development [472702/2013-0]; Sao Paulo State Research Foundation (FAPESP) [2011/12779-7]; National Counsel of Technological and Scientific Development (CNPq) [472702/2013-0]	Sao Paulo State Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Counsel of Technological and Scientific Development(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Sao Paulo State Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Counsel of Technological and Scientific Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Sao Paulo State Research Foundation (2011/12779-7) to ALA (http://www.fapesp.br/) and National Counsel of Technological and Scientific Development (472702/2013-0) to TCG (http://www.cnpq.br/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to Luisa Carvalheiro, Jean Paul Metzger and Jesus Aguirre-Gutierrez for their suggestions on earlier versions of this manuscript. We thank the Sao Paulo State Research Foundation (FAPESP) for the scholarship of Andre L. Acosta (2011/12779-7) and the National Counsel of Technological and Scientific Development (CNPq) for granting Tereza C. Giannini (472702/2013-0). We also thank the Research Center on Biodiversity and Computing (NAP-Biocomp, Universidade de Sao Paulo) for providing computing infrastructure.	Aguirre-Gutierrez J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063708; AHGA-Australian Hydroponics and Greenhouse Association, 2005, EX SUMM PROP IMP BOM; Aizen MA, 2014, NEW PHYTOL, V204, P322, DOI 10.1111/nph.12924; Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; Alpert Peter, 2000, Perspectives in Plant Ecology Evolution and Systematics, V3, P52, DOI 10.1078/1433-8319-00004; [Anonymous], 2001, CBD TECHNICAL SERI N, V1; [Anonymous], 2010, ESRI ARCGIS DESKT 10, pR10; Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; Arbetman MP, 2013, BIOL INVASIONS, V15, P489, DOI 10.1007/s10530-012-0311-0; Aslan MM, 2008, J ENVIRON BIOL, V29, P151; Bahn V, 2013, OIKOS, V122, P321, DOI 10.1111/j.1600-0706.2012.00299.x; Barbet-Massin M, 2012, METHODS ECOL EVOL, V3, P327, DOI 10.1111/j.2041-210X.2011.00172.x; Bontemps S, 2009, GLOBCOVER PRODUCT DE; Broennimann O, 2007, ECOL LETT, V10, P701, DOI 10.1111/j.1461-0248.2007.01060.x; Broennimann O, 2008, BIOL LETTERS, V4, P585, DOI 10.1098/rsbl.2008.0254; CDB-Convention on Biological Diversity, 2009, INVASIVE ALIEN SPECI; Chefaoui RM, 2008, ECOL MODEL, V210, P478, DOI 10.1016/j.ecolmodel.2007.08.010; Dafni A., 1996, CONSERVATION BEES; Dafni A, 2010, APPL ENTOMOL ZOOL, V45, P101, DOI 10.1303/aez.2010.101; Domisch S, 2013, ECOL MODEL, V257, P1, DOI 10.1016/j.ecolmodel.2013.02.019; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Engler R, 2011, GLOBAL CHANGE BIOL, V17, P2330, DOI 10.1111/j.1365-2486.2010.02393.x; Evangelista PH, 2008, DIVERS DISTRIB, V14, P808, DOI 10.1111/j.1472-4642.2008.00486.x; Ficetola GF, 2007, DIVERS DISTRIB, V13, P476, DOI 10.1111/j.1472-4642.2007.00377.x; Franklin J, 2009, MAPPING SPECIES DIST; Furst MA, 2014, NATURE, V506, P364, DOI 10.1038/nature12977; GADM, 2012, GLOB ADM AR YEAR 201, V20; Gallien L, 2012, GLOBAL ECOL BIOGEOGR, V21, P1126, DOI 10.1111/j.1466-8238.2012.00768.x; Giannini TC, 2013, ECOGRAPHY, V36, P649, DOI 10.1111/j.1600-0587.2012.07191.x; Giovanelli JGR, 2008, BIOL INVASIONS, V10, P585, DOI 10.1007/s10530-007-9154-5; Goshtasby AA, 2012, ADV COMPUTER VISION, P7, DOI DOI 10.1007/978-1-4471-2458-02; Goulson D, 2004, NEW ZEAL J ECOL, V28, P225; Goulson D, 2003, ANNU REV ECOL EVOL S, V34, P1, DOI 10.1146/annurev.ecolsys.34.011802.132355; Goulson D, 2001, APIDOLOGIE, V32, P105, DOI 10.1051/apido:2001115; Goulson D, 2010, BUMBLEBEES BEHAV ECO, V2; Griffiths D., 2004, PRACTICAL HYDROPONIC, V77, P42; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hijmans RJ., 2012, RASTER GEOGRAPHIC AN; Hingston AB, 2002, AUSTRAL ECOL, V27, P162, DOI 10.1046/j.1442-9993.2002.01179.x; Hingston AB, 1998, AUSTR J ECOLOGY, V23, P39; Hopkins I., 1914, NZ DEP AGR IND COMME, V46, P1; Howlett BG, 2010, NZ ENTOMOL, V33, P92, DOI 10.1080/00779962.2010.9722196; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; Inari N, 2005, POPUL ECOL, V47, P77, DOI 10.1007/s10144-004-0205-9; Inoue MN, 2008, J INSECT CONSERV, V12, P135, DOI 10.1007/s10841-007-9071-z; Jimenez-Valverde A, 2011, BIOL INVASIONS, V13, P2785, DOI 10.1007/s10530-011-9963-4; Jimenez-Valverde A, 2007, ACTA OECOL, V31, P361, DOI 10.1016/j.actao.2007.02.001; Jones CC, 2010, ECOL APPL, V20, P311, DOI 10.1890/08-2261.1; Kadoya T, 2010, BIOL CONSERV, V143, P1228, DOI 10.1016/j.biocon.2010.02.030; Kadoya T, 2009, BIOL CONSERV, V142, P1011, DOI 10.1016/j.biocon.2009.01.012; Kearney M, 2009, ECOL LETT, V12, P334, DOI 10.1111/j.1461-0248.2008.01277.x; Kenis M, 2009, BIOL INVASIONS, V11, P21, DOI 10.1007/s10530-008-9318-y; Kondo NI, 2009, NATURWISSENSCHAFTEN, V96, P467, DOI 10.1007/s00114-008-0495-4; Lavergne S, 2010, ANNU REV ECOL EVOL S, V41, P321, DOI 10.1146/annurev-ecolsys-102209-144628; Le Maitre DC, 2008, GLOBAL ECOL BIOGEOGR, V17, P569, DOI 10.1111/j.1466-8238.2008.00407.x; Levine JM, 2003, CONSERV BIOL, V17, P322, DOI 10.1046/j.1523-1739.2003.02038.x; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Loo SE, 2007, ECOL APPL, V17, P181, DOI 10.1890/1051-0761(2007)017[0181:FNZMIR]2.0.CO;2; Mack Richard N., 2011, NeoBiota, V9, P13, DOI 10.3897/neobiota.9.1156; Mateo RG, 2010, DIVERS DISTRIB, V16, P84, DOI 10.1111/j.1472-4642.2009.00617.x; Matsumura Chizuru, 2004, Global Environmental Research, V8, P51; McClay A, 2005, CLIMEX MODELS PREDIC; McGregor S. E., 1976, INSECT POLLINATION C; Medley KA, 2010, GLOBAL ECOL BIOGEOGR, V19, P122, DOI 10.1111/j.1466-8238.2009.00497.x; Merckx B, 2011, ECOL MODEL, V222, P588, DOI 10.1016/j.ecolmodel.2010.11.016; Milbau A, 2009, BIOL INVASIONS, V11, P941, DOI 10.1007/s10530-008-9306-2; Morales CL, 2013, FRONT ECOL ENVIRON, V11, P529, DOI 10.1890/120321; Morandin LA, 2001, J ECON ENTOMOL, V94, P172, DOI 10.1603/0022-0493-94.1.172; Morandin LA, 2001, J ECON ENTOMOL, V94, P462, DOI 10.1603/0022-0493-94.2.462; Mouton AM, 2010, ECOL MODEL, V221, P1995, DOI 10.1016/j.ecolmodel.2010.04.017; Nenzen HK, 2011, ECOL MODEL, V222, P3346, DOI 10.1016/j.ecolmodel.2011.07.011; NSW-New South Wales Government, 2004, AUSTR INTR LARG EART; Ozbek H., 1993, Melissa, P7; Parolo G, 2008, J APPL ECOL, V45, P1410, DOI 10.1111/j.1365-2664.2008.01516.x; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; Perkins LB, 2011, ECOL EVOL, V1, DOI 10.1002/ece3.47; Peterson AT, 2007, ENTOMOL EXP APPL, V125, P39, DOI 10.1111/j.1570-7458.2007.00603.x; Peterson AT, 2003, WEED SCI, V51, P863, DOI 10.1614/P2002-081; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1; Potts SG, 2001, OIKOS, V92, P71, DOI 10.1034/j.1600-0706.2001.920109.x; Pulliam HR, 2000, ECOL LETT, V3, P349, DOI 10.1046/j.1461-0248.2000.00143.x; R Development Core Team, 2011, R A LANGUAGE AND ENV; Richardson David M., 2000, Diversity and Distributions, V6, P93, DOI 10.1046/j.1472-4642.2000.00083.x; Roques A., 2009, HDB ALIEN SPECIES EU; Ruz L, 2001, ACTA HORTIC, P165, DOI 10.17660/ActaHortic.2001.561.24; Ruz L, 2002, POLLINATING BEES CON, P155; Schmid-Hempel P, 2007, HEREDITY, V99, P414, DOI 10.1038/sj.hdy.6801017; Schmid-Hempel R, 2014, J ANIM ECOL, V83, P823, DOI 10.1111/1365-2656.12185; SEMMENS TD, 1993, J AUST ENTOMOL SOC, V32, P346; Shi JA, 2010, BIODIVERS CONSERV, V19, P2485, DOI 10.1007/s10531-010-9855-4; Sladen FWL, 1912, HUMBLE BEE ITS ITS L; Soberon Jorge, 2005, Biodiversity Informatics, V2, P1; Stout JC, 2000, BEE WORLD, V81, P80, DOI 10.1080/0005772X.2000.11099475; Thuiller W, 2005, GLOBAL CHANGE BIOL, V11, P2234, DOI 10.1111/j.1365-2486.2005.001018.x; Thuiller W, 2013, ENSEMBLE PLATFORM SP; Thuiller W, 2009, ECOGRAPHY, V32, P369, DOI 10.1111/j.1600-0587.2008.05742.x; Torretta JP, 2006, T AM ENTOMOL SOC, V132, P285; Velthuis H.H.W., 2002, POLLINATING BEES CON, P177; Velthuis HHW, 2006, APIDOLOGIE, V37, P421, DOI 10.1051/apido:2006019; Walther-Hellwig K, 2000, J APPL ENTOMOL, V124, P299, DOI 10.1046/j.1439-0418.2000.00484.x; Ward DF, 2007, BIOL INVASIONS, V9, P723, DOI 10.1007/s10530-006-9072-y; Williamson M, 1999, ECOGRAPHY, V22, P5, DOI 10.1111/j.1600-0587.1999.tb00449.x; Winter K., 2006, IMPORTATION NONNATIV, P1; Wisz MS, 2008, DIVERS DISTRIB, V14, P763, DOI 10.1111/j.1472-4642.2008.00482.x; Wolf S, 2008, APIDOLOGIE, V39, P419, DOI 10.1051/apido:2008020	106	26	27	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0148295	10.1371/journal.pone.0148295	http://dx.doi.org/10.1371/journal.pone.0148295			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	26882479	gold, Green Submitted, Green Published			2022-12-26	WOS:000371219000014
J	Forbes, S; Latimer, J; Sreenivasan, PK; McBain, AJ				Forbes, Sarah; Latimer, Joe; Sreenivasan, Prem K.; McBain, Andrew J.			Simultaneous Assessment of Acidogenesis-Mitigation and Specific Bacterial Growth-Inhibition by Dentifrices	PLOS ONE			English	Article							DENTAL PLAQUE; STREPTOCOCCUS-MUTANS; CARIES; TRICLOSAN; GLYCOLYSIS; GINGIVITIS; BIOCIDES; SPECTRUM; AGENT; SUGAR	Dentifrices can augment oral hygiene by inactivating bacteria and at sub-lethal concentrations may affect bacterial metabolism, potentially inhibiting acidogenesis, the main cause of caries. Reported herein is the development of a rapid method to simultaneously measure group-specific bactericidal and acidogenesis-mitigation effects of dentifrices on oral bacteria. Saliva was incubated aerobically and anaerobically in Tryptone Soya Broth, Wilkins-Chalgren Broth with mucin, or artificial saliva and was exposed to dentifrices containing triclosan/ copolymer (TD); sodium fluoride (FD); stannous fluoride and zinc lactate (SFD1); or stannous fluoride, zinc lactate and stannous chloride (SFD2). Minimum inhibitory concentrations (MIC) were determined turbidometrically whilst group-specific minimum bactericidal concentrations (MBC) were assessed using growth media and conditions selective for total aerobes, total anaerobes, streptococci and Gram-negative anaerobes. Minimum acid neutralization concentration (MNC) was defined as the lowest concentration of dentifrice at which acidification was inhibited. Differences between MIC and MNC were calculated and normalized with respect to MIC to derive the combined inhibitory and neutralizing capacity (CINC), a cumulative measure of acidogenesis-mitigation and growth inhibition. The overall rank order for growth inhibition potency (MIC) under aerobic and anaerobic conditions was: TD>SFD2>SFD1>FD. Acidogenesis-mitigation (MNC) was ordered; TD>FD>SFD2>SFD1. CINC was ordered TD>FD>SFD2>SFD1 aerobically and TD>FD>SFD1>SFD2 anaerobically. With respect to group-specific bactericidal activity, TD generally exhibited the greatest potency, particularly against total aerobes, total anaerobes and streptococci. This approach enables the rapid simultaneous evaluation of acidity mitigation, growth inhibition and specific antimicrobial activity by dentifrices.	[Forbes, Sarah; Latimer, Joe; McBain, Andrew J.] Univ Manchester, Manchester Pharm Sch, Manchester, Lancs, England; [Sreenivasan, Prem K.] Colgate Palmol Technol Ctr, Piscataway, NJ USA	University of Manchester	McBain, AJ (corresponding author), Univ Manchester, Manchester Pharm Sch, Manchester, Lancs, England.	andrew.mcbain@manchester.ac.uk		McBain, Andrew/0000-0002-5255-5425; Sreenivasan, Prem/0000-0003-3902-1135	Colgate Palmolive Company	Colgate Palmolive Company	This research was supported by an unrestricted grant from Colgate Palmolive Company. The authors SF, JL, AJM discussed study design with PKS. The funders had no role in study design, data collection and analysis or decision to publish. However, PKS provided constructive comments on drafts of the manuscript.	Aas JA, 2005, J CLIN MICROBIOL, V43, P5721, DOI 10.1128/JCM.43.11.5721-5732.2005; Axelsson P, 2004, J CLIN PERIODONTOL, V31, P749, DOI 10.1111/j.1600-051X.2004.00563.x; BIBBY BG, 1986, J DENT RES, V65, P686, DOI 10.1177/00220345860650051101; Chandrabhan D, 2012, OPEN J MED MICROBIOL, V2; Dong YM, 1999, CARIES RES, V33, P428, DOI 10.1159/000016547; Filoche SK, 2008, FEMS IMMUNOL MED MIC, V54, P27, DOI 10.1111/j.1574-695X.2008.00443.x; Giacaman RA, 2010, ARCH ORAL BIOL, V55, P550, DOI 10.1016/j.archoralbio.2010.05.010; He G, 2002, ARCH ORAL BIOL, V47, P117, DOI 10.1016/S0003-9969(01)00093-0; Heath RJ, 1998, J BIOL CHEM, V273, P30316, DOI 10.1074/jbc.273.46.30316; HELDERMAN WHV, 1983, ARCH ORAL BIOL, V28, P599; KORNMAN KS, 1986, J PERIODONTAL RES, V21, P5, DOI 10.1111/j.1600-0765.1986.tb01511.x; Leonardo MR, 1999, J ENDODONT, V25, P167, DOI 10.1016/S0099-2399(99)80135-6; Mankodi S, 2005, J CLIN PERIODONTOL, V32, P75, DOI 10.1111/j.1600-051X.2004.00639.x; Marczuk-Kolada Grazyna, 2006, Postepy Hig Med Dosw (Online), V60, P416; Marsh P D, 1994, Adv Dent Res, V8, P263; MAZZA JE, 1981, J CLIN PERIODONTOL, V8, P203, DOI 10.1111/j.1600-051X.1981.tb02031.x; McBain AJ, 2003, J APPL MICROBIOL, V94, P655, DOI 10.1046/j.1365-2672.2003.01876.x; McMurry LM, 1998, NATURE, V394, P531, DOI 10.1038/28970; Moore LE, 2008, APPL ENVIRON MICROB, V74, P4825, DOI 10.1128/AEM.00573-08; NEWBRUN E, 1982, SCIENCE, V217, P418, DOI 10.1126/science.7046052; Panagakos Fotinos S, 2005, J Clin Dent, V16 Suppl, pS1; Phan TN, 2006, CAN J MICROBIOL, V52, P977, DOI 10.1139/W06-055; REGOS J, 1979, DERMATOLOGICA, V158, P72, DOI 10.1159/000250746; Touger-Decker R, 2003, AM J CLIN NUTR, V78, p881S, DOI 10.1093/ajcn/78.4.881S; Triratana T, 2002, J AM DENT ASSOC, V133, P219, DOI 10.14219/jada.archive.2002.0147; Van Loveren C, 1990, J Dent Res, V69 Spec No, P676; VANHOUTE J, 1991, J DENT RES, V70, P1503, DOI 10.1177/00220345910700120601; VANHOUTE J, 1991, J DENT RES, V70, P1497, DOI 10.1177/00220345910700120501; Villalain J, 2001, ARCH BIOCHEM BIOPHYS, V390, P128, DOI 10.1006/abbi.2001.2356; Wiegand A, 2007, DENT MATER, V23, P343, DOI 10.1016/j.dental.2006.01.022; WOODWARD M, 1994, BRIT DENT J, V176, P297, DOI 10.1038/sj.bdj.4808437	31	5	5	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0149390	10.1371/journal.pone.0149390	http://dx.doi.org/10.1371/journal.pone.0149390			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	26882309	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000371219000073
J	Mohan, I; Gupta, R; Misra, A; Sharma, KK; Agrawal, A; Vikram, NK; Sharma, V; Shrivastava, U; Pandey, RM				Mohan, Indu; Gupta, Rajeev; Misra, Anoop; Sharma, Krishna Kumar; Agrawal, Aachu; Vikram, Naval K.; Sharma, Vinita; Shrivastava, Usha; Pandey, Ravindra M.			Disparities in Prevalence of Cardiometablic Risk Factors in Rural, Urban-Poor, and Urban-Middle Class Women in India	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; MYOCARDIAL-INFARCTION; CARDIOVASCULAR-DISEASE; GLOBAL BURDEN; TRANSITION; HEALTH; EPIDEMIOLOGY; POPULATION; COUNTRIES; MORTALITY	Objective Urbanization is an important determinant of cardiovascular disease (CVD) risk. To determine location-based differences in CVD risk factors in India we performed studies among women in rural, urban-poor and urban middle-class locations. Methods Population-based cross-sectional studies in rural, urban-poor, and urban-middle class women (35-70y) were performed at multiple sites. We evaluated 6853 women (rural 2616, 5 sites; urban-poor 2008, 4 sites; urban middle-class 2229, 11 sites) for socioeconomic, lifestyle, anthropometric and biochemical risk factors. Descriptive statistics are reported. Results Mean levels of body mass index (BMI), waist circumference, waist-hip ratio (WHR), systolic BP, fasting glucose and cholesterol in rural, urban-poor and urban-middle class women showed significantly increasing trends (ANOVA(trend), p < 0.001). Age-adjusted prevalence of diabetes and risk factors among rural, urban-poor and urban-middle class women, respectively was, diabetes (2.2, 9.3, 17.7%), overweight BMI >= 25 kg/m(2) (22.5, 45.6, 57.4%), waist >80 cm (28.3, 63.4, 61.9%), waist >90 cm (8.4, 31.4, 38.2%), waist hip ratio (WHR) >0.8 (60.4, 90.7, 88.5), WHR>0.9 (13.0, 44.3, 56.1%), hypertension (31.6, 48.2, 59.0%) and hypercholesterolemia (13.5, 27.7, 37.4%) (Mantel Haenszel X-2 p(trend) < 0.01). Inverse trend was observed for tobacco use (41.6, 19.6, 9.4%). There was significant association of hypertension, hypercholesterolemia and diabetes with overweight and obesity (adjusted R-2 0.89-0.99). Conclusions There are significant location based differences in cardiometabolic risk factors in India. The urban-middle class women have the highest risk compared to urban-poor and rural.	[Mohan, Indu] RUHS Coll Med Sci, Dept Prevent & Social Med, Jaipur, Rajasthan, India; [Gupta, Rajeev] Fortis Escorts Hosp, Dept Med, Jaipur, Rajasthan, India; [Misra, Anoop; Shrivastava, Usha] Fortis C DOC Ctr Excellence, Dept Diabet & Metab Dis, Chiragh Enclave, New Delhi, India; [Sharma, Krishna Kumar] Rajasthan Univ Hlth Sci, Dept Pharmacol, Jaipur, Rajasthan, India; [Agrawal, Aachu] Univ Rajasthan, Dept Home Sci, Jaipur 302004, Rajasthan, India; [Vikram, Naval K.] All India Inst Med Sci, Dept Med, New Delhi 110029, India; [Sharma, Vinita] Govt India, Dept Sci & Technol, Sci & Soc Div, New Delhi, India; [Pandey, Ravindra M.] All India Inst Med Sci, Dept Biostat, New Delhi, India	Fortis Escorts Hospital; University of Rajasthan; All India Institute of Medical Sciences (AIIMS) New Delhi; Department of Science & Technology (India); All India Institute of Medical Sciences (AIIMS) New Delhi	Gupta, R (corresponding author), Fortis Escorts Hosp, Dept Med, Jaipur, Rajasthan, India.	rajeevgg@gmail.com			Science and Society Division, Department of Science and Technology, Government of India, New Delhi, India; South Asian Society for Atherosclerosis and Thrombosis, Bangalore, India	Science and Society Division, Department of Science and Technology, Government of India, New Delhi, India(Department of Science & Technology (India)); South Asian Society for Atherosclerosis and Thrombosis, Bangalore, India	The studies were funded by Science and Society Division, Department of Science and Technology, Government of India, New Delhi, India; and South Asian Society for Atherosclerosis and Thrombosis, Bangalore, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r The studies are financially supported by Science and Society Division, Department of Science and Technology, Government of India, New Delhi; and South Asian Society for Atherosclerosis and Thrombosis, Bangalore, India.	Ahuja R, 1999, SOC INDIA CONCEPTS T; Allender S, 2011, J URBAN HEALTH, V88, P906, DOI 10.1007/s11524-011-9586-1; Allender S, 2010, B WORLD HEALTH ORGAN, V88, P297, DOI 10.2471/BLT.09.065847; Anand SS, 2008, EUR HEART J, V29, P932, DOI 10.1093/eurheartj/ehn018; [Anonymous], 2009, REP CAUS DEATH IND 2; BarrettConnor E, 1997, CIRCULATION, V95, P252, DOI 10.1161/01.CIR.95.1.252; Bhan N, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001348; Bharathi AV, 2000, INDIAN J MED RES, V111, P95; Cockerham WC, 2007, SOCIAL CAUSES HLTH D, p[25, 102]; Defo BK, 2014, GLOB HLTH ACTION, V7; Ezzati M, 2005, PLOS MED, V2, P404, DOI 10.1371/journal.pmed.0020133; FerroLuzzi A, 1995, WHO TECH REP SER, V854, P1; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Gupta R, 2008, HEART, V94, P16, DOI 10.1136/hrt.2007.132951; GUPTA R, 1994, BRIT MED J, V309, P1332, DOI 10.1136/bmj.309.6965.1332; Gupta R, 1997, NATL MED J INDIA, V10, P139; Gupta R, 1995, Indian Heart J, V47, P331; Gupta R, 2012, PLOS ONE, V7; Gupta R, 2015, J GLOB HEALTH, V5, P150, DOI 10.7189/jogh.05.010411; Gupta R, 2012, WORLD J CARDIOL, V4, P112, DOI 10.4330/wjc.v4.i4.112; Gupta Rajeev, 2009, Indian Heart J, V61, P358; Joshi P, 2007, JAMA-J AM MED ASSOC, V297, P286, DOI 10.1001/jama.297.3.286; KAPLAN GA, 1993, CIRCULATION, V88, P1973, DOI 10.1161/01.CIR.88.4.1973; Krishna A., 2010, ONE ILLNESS AWAY WHY; Liu YL, 1998, HEALTH POLICY, V44, P103, DOI 10.1016/S0168-8510(98)00010-4; Luepkar RV, 2002, CARDIOVASCULAR SURVE; Marmot M, 2002, STRESS AND THE HEART: PSYCHOSOCIAL PATHWAYS TO CORONARY HEART DISEASE, P5; McKinsey Global Institute, 2010, INDIAS URBAN AWAKENI; Misra A, 2001, INT J OBESITY, V25, P1722, DOI 10.1038/sj.ijo.0801748; Murray CJL, 2015, LANCET, V386, P2145, DOI 10.1016/S0140-6736(15)61340-X; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Pandey RM, 2013, INT J CARDIOL, V163, P157, DOI 10.1016/j.ijcard.2011.06.008; Prabhakaran D, 2013, INT J EPIDEMIOL, V42, P1431, DOI 10.1093/ije/dyt119; Rydin Y, 2012, LANCET, V379, P2079, DOI 10.1016/S0140-6736(12)60435-8; Satija A, 2015, PUBLIC HEALTH NUTR, V18; Sullivan R, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-13; Task Force on Noncommunicable Diseases, 2014, EM CRIS NONC DIS; Vaz M, 2009, ASIA PAC J CLIN NUTR, V18, P71; Yusuf S, 2001, CIRCULATION, V104, P2746, DOI 10.1161/hc4601.099487; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	40	20	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0149437	10.1371/journal.pone.0149437	http://dx.doi.org/10.1371/journal.pone.0149437			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	26881429	Green Submitted, gold, Green Published			2022-12-26	WOS:000371219000075
J	Seoane, IV; Ortiz, AM; Piris, L; Lamana, A; Juarranz, Y; Garcia-Vicuna, R; Gonzalez-Alvaro, I; Gomariz, RP; Martinez, C				Seoane, Iria V.; Ortiz, Ana M.; Piris, Lorena; Lamana, Amalia; Juarranz, Yasmina; Garcia-Vicuna, Rosario; Gonzalez-Alvaro, Isidoro; Gomariz, Rosa P.; Martinez, Carmen			Clinical Relevance of VPAC1 Receptor Expression in Early Arthritis: Association with IL-6 and Disease Activity	PLOS ONE			English	Article							VASOACTIVE-INTESTINAL-PEPTIDE; EARLY RHEUMATOID-ARTHRITIS; RHEUMATOLOGY/EUROPEAN LEAGUE; SYNOVIAL FIBROBLASTS; AUTOIMMUNE-DISEASES; ALTERED EXPRESSION; AMERICAN-COLLEGE; IMMUNE CELLS; TASK-FORCE; MICE	Background The vasoactive intestinal peptide (VIP) receptors VPAC1 and VPAC2 mediate anti-inflammatory and immunoregulatory responses in rheumatoid arthritis (RA). Data on the expression of these receptors could complement clinical assessment in the management of RA. Our goal was to investigate the correlation between expression of both receptors and the 28-Joint Disease Activity Score (DAS28) in peripheral blood mononuclear cells (PBMCs) from patients with early arthritis (EA). We also measured expression of IL-6 to evaluate the association between VIP receptors and systemic inflammation. Methods We analyzed 250 blood samples collected at any of the 5 scheduled follow-up visits from 125 patients enrolled in the Princesa Early Arthritis Register Longitudinal study. Samples from 22 healthy donors were also analyzed. Sociodemographic, clinical, and therapeutic data were systematically recorded. mRNA expression levels were determined using real-time PCR. Then, longitudinal multivariate analyses were performed. Results PBMCs from EA patients showed significantly higher expression of VPAC2 receptors at baseline compared to healthy donors (p<0.001). With time, however, VPAC2 expression tended to be significantly lower while VPAC1 receptor expression increased in correlation with a reduction in DAS28 index. Our results reveal that more severe inflammation, based on high levels of IL-6, is associated with lower expression of VPAC1 (p<0.001) and conversely with increased expression of VPAC2 (p<0.001). A major finding of this study is that expression of VPAC1 is lower in patients with increased disease activity (p = 0.001), thus making it possible to differentiate between patients with various degrees of clinical disease activity. Conclusion Patients with more severe inflammation and higher disease activity show lower levels of VPAC1 expression, which is associated with patient-reported impairment. Therefore, VPAC1 is a biological marker in EA.	[Seoane, Iria V.; Juarranz, Yasmina; Gomariz, Rosa P.] Univ Complutense Madrid, Fac Biol, Dept Biol Celular, E-28040 Madrid, Spain; [Ortiz, Ana M.; Lamana, Amalia; Garcia-Vicuna, Rosario; Gonzalez-Alvaro, Isidoro] Hosp Univ Princesa, Inst Invest Sanitaria Princesa, Serv Reumatol, Madrid, Spain; [Piris, Lorena] Hosp Univ Princesa, Inst Invest Sanitaria Princesa, Unidad Apoyo Metodol, Madrid, Spain; [Martinez, Carmen] Univ Complutense Madrid, Dept Biol Celular, Fac Med, Madrid, Spain	Complutense University of Madrid; Complutense University of Madrid	Martinez, C (corresponding author), Univ Complutense Madrid, Dept Biol Celular, Fac Med, Madrid, Spain.	cmmora@bio.ucm.es	Juarranz, Yasmina/H-5545-2019; LAMANA, AMALIA/I-6971-2017; de VicuÃa, Rosario Garcia/ABD-7892-2020; Juarranz, Yasmina/H-7942-2016; Martínez, Carmen/AAC-2077-2020	Juarranz, Yasmina/0000-0001-5886-8273; LAMANA, AMALIA/0000-0001-8779-5034; de VicuÃa, Rosario Garcia/0000-0001-9096-3780; Juarranz, Yasmina/0000-0001-5886-8273; 	Fondo de Investigacion Sanitaria, Instituto de Salud Carlos III - Fondo Europeo de Desarrollo Regional (FEDER) [PI14/00477, PI14/001236, PI11/00195, PI11/00505, PI12/0758, RD12/0009]; FEDER funds from EU; Comunidad de Madrid [S2010/BMD-2350]	Fondo de Investigacion Sanitaria, Instituto de Salud Carlos III - Fondo Europeo de Desarrollo Regional (FEDER); FEDER funds from EU; Comunidad de Madrid(Comunidad de Madrid)	This work was supported by the Fondo de Investigacion Sanitaria, Instituto de Salud Carlos III (Grant No PI14/00477, PI14/001236, PI11/00195, PI11/00505, PI12/0758, RD12/0009) cofinanced by Fondo Europeo de Desarrollo Regional (FEDER), and by FEDER funds from EU, S2010/BMD-2350 from Comunidad de Madrid. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aletaha D, 2009, ARTHRIT RHEUM-ARTHR, V61, P313, DOI 10.1002/art.24282; Aletaha D, 2010, ARTHRITIS RHEUM-US, V62, P2569, DOI 10.1002/art.27584; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Carrion M, 2011, ARTHRITIS RHEUM-US, V63, P1626, DOI 10.1002/art.30294; Castrejon I, 2008, CLIN EXP RHEUMATOL, V26, P769; Centola M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060635; Choy E, 2012, CURR MED RES OPIN, V28, P1733, DOI 10.1185/03007995.2012.731388; Combe B, 2007, ANN RHEUM DIS, V66, P34, DOI 10.1136/ard.2005.044354; Couvineau A, 2012, BRIT J PHARMACOL, V166, P42, DOI 10.1111/j.1476-5381.2011.01676.x; Delgado M, 2002, J MOL MED, V80, P16, DOI 10.1007/s00109-001-0291-5; Delgado M, 2008, BRAIN BEHAV IMMUN, V22, P1146, DOI 10.1016/j.bbi.2008.06.001; Delgado M, 2008, ARTHRITIS RHEUM-US, V58, P1010, DOI 10.1002/art.23482; Dorsam Glenn Paul, 2011, World J Biol Chem, V2, P146, DOI 10.4331/wjbc.v2.i6.146; Eriksson C, 2013, SCAND J RHEUMATOL, V42, P260, DOI 10.3109/03009742.2012.754937; Felson DT, 2011, ARTHRITIS RHEUM-US, V63, P573, DOI 10.1002/art.30129; Ganea D, 2015, ACTA PHYSIOL, V213, P442, DOI 10.1111/apha.12427; Goetzl EJ, 2001, P NATL ACAD SCI USA, V98, P13854, DOI 10.1073/pnas.241503798; Gomariz RP, 2001, CURR PHARM DESIGN, V7, P89, DOI 10.2174/1381612013398374; Gonzalez-Alvaro I, 2015, CURR PHARM DESIGN, V21, P170; Gonzalez-Rey E, 2007, ANN RHEUM DIS, V66, P70, DOI 10.1136/ard.2007.078519; Gutierrez-Canas I, 2008, BRAIN BEHAV IMMUN, V22, P312, DOI 10.1016/j.bbi.2007.09.007; Hauk V, 2014, CLIN EXP IMMUNOL, V177, P662, DOI 10.1111/cei.12378; Heiberg T, 2008, ANN RHEUM DIS, V67, P967, DOI 10.1136/ard.2007.077503; Jimeno R, 2015, J LEUKOCYTE BIOL, V98, P257, DOI 10.1189/jlb.3A0714-327R; Jimeno R, 2015, J MOL MED, V93, P457, DOI 10.1007/s00109-014-1232-4; Juarranz MG, 2004, RHEUMATOLOGY, V43, P416, DOI 10.1093/rheumatology/keh061; Juarranz Y, 2005, ARTHRITIS RES THER, V7, pR1034, DOI 10.1186/ar1779; Juarranz Y, 2008, ARTHRITIS RHEUM, V58, P1086, DOI 10.1002/art.23403; Keystone EC, 2012, RHEUMATOLOGY, V51, pV48, DOI 10.1093/rheumatology/kes122; Kirwan John R, 2005, J Rheumatol, V32, P2250; Lara-Marquez ML, 2001, J IMMUNOL, V166, P2522, DOI 10.4049/jimmunol.166.4.2522; Martinez C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085248; Nishimoto N, 2006, NAT CLIN PRACT RHEUM, V2, P619, DOI 10.1038/ncprheum0338; PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107; Shimamoto K, 2013, J RHEUMATOL, V40, P1074, DOI 10.3899/jrheum.121389; Smolen JS, 2010, ANN RHEUM DIS, V69, P631, DOI 10.1136/ard.2009.123919; Sun W, 2006, INT IMMUNOL, V18, P1691, DOI 10.1093/intimm/dxl103; Tan YV, 2015, BRAIN BEHAV IMMUN, V44, P167, DOI 10.1016/j.bbi.2014.09.020; VANLEEUWEN MA, 1993, BRIT J RHEUMATOL, V32, P9; Voice JK, 2003, J IMMUNOL, V170, P308, DOI 10.4049/jimmunol.170.1.308; Zhao PW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095346	41	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0149141	10.1371/journal.pone.0149141	http://dx.doi.org/10.1371/journal.pone.0149141			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	26881970	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000371219000050
J	Zou, Q; Wu, MJ; Zhong, LW; Fan, ZX; Zhang, B; Chen, Q; Ma, F				Zou, Qing; Wu, Mingjun; Zhong, Liwu; Fan, Zhaoxin; Zhang, Bo; Chen, Qiang; Ma, Feng			Development of a Xeno-Free Feeder-Layer System from Human Umbilical Cord Mesenchymal Stem Cells for Prolonged Expansion of Human Induced Pluripotent Stem Cells in Culture	PLOS ONE			English	Article							AMNIOTIC-FLUID; UNDIFFERENTIATED PROPAGATION; SELF-RENEWAL; SUPPORT; GROWTH; DIFFERENTIATION; DISEASE; MAINTENANCE; FIBROBLASTS; DERIVATION	Various feeder layers have been extensively applied to support the prolonged growth of human pluripotent stem cells (hPSCs) for in vitro cultures. Among them, mouse embryonic fibroblast (MEF) and mouse fibroblast cell line (SNL) are most commonly used feeder cells for hPSCs culture. However, these feeder layers from animal usually cause immunogenic contaminations, which compromises the potential of hPSCs in clinical applications. In the present study, we tested human umbilical cord mesenchymal stem cells (hUC-MSCs) as a potent xeno-free feeder system for maintaining human induced pluripotent stem cells (hiPSCs). The hUC-MSCs showed characteristics of MSCs in xeno-free culture condition. On the mitomycin-treated hUC-MSCs feeder, hiPSCs maintained the features of undifferentiated human embryonic stem cells (hESCs), such as low efficiency of spontaneous differentiation, stable expression of stemness markers, maintenance of normal karyotypes, in vitro pluripotency and in vivo ability to form teratomas, even after a prolonged culture of more than 30 passages. Our study indicates that the xeno-free culture system may be a good candidate for growth and expansion of hiPSCs as the stepping stone for stem cell research to further develop better and safer stem cells.	[Zou, Qing; Wu, Mingjun; Zhong, Liwu; Fan, Zhaoxin; Zhang, Bo; Chen, Qiang; Ma, Feng] Sichuan Neolife Stem Cell Biotech INC, Res Ctr Stem Cell & Regenerat Med, Chengdu, Sichuan, Peoples R China; [Zou, Qing; Chen, Qiang; Ma, Feng] Chinese Acad Med Sci, Inst Blood Transfus, Ctr Stem Cell Res & Applicat, Chengdu, Sichuan, Peoples R China; [Zou, Qing; Chen, Qiang; Ma, Feng] Peking Union Med Coll, Chengdu, Sichuan, Peoples R China; [Ma, Feng] Chinese Acad Med Sci, State Key Lab Expt Hematol, Tianjin, Peoples R China; [Ma, Feng] Peking Union Med Coll, Tianjin, Peoples R China; [Ma, Feng] Sichuan Univ, West China Hosp, Collaborat Innovat Ctr Biotherapy, State Key Lab Biotherapy, Chengdu 610064, Sichuan, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Blood Transfusion - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Sichuan University	Chen, Q; Ma, F (corresponding author), Sichuan Neolife Stem Cell Biotech INC, Res Ctr Stem Cell & Regenerat Med, Chengdu, Sichuan, Peoples R China.; Chen, Q; Ma, F (corresponding author), Chinese Acad Med Sci, Inst Blood Transfus, Ctr Stem Cell Res & Applicat, Chengdu, Sichuan, Peoples R China.; Chen, Q; Ma, F (corresponding author), Peking Union Med Coll, Chengdu, Sichuan, Peoples R China.; Ma, F (corresponding author), Chinese Acad Med Sci, State Key Lab Expt Hematol, Tianjin, Peoples R China.; Ma, F (corresponding author), Peking Union Med Coll, Tianjin, Peoples R China.; Ma, F (corresponding author), Sichuan Univ, West China Hosp, Collaborat Innovat Ctr Biotherapy, State Key Lab Biotherapy, Chengdu 610064, Sichuan, Peoples R China.	qchen0810@126.com; mafeng@hotmail.co.jp		Chen, Qiang/0000-0003-2759-987X	National Basic Research Program of China (973 Program) [2015CB964902]; Sichuan Provincial Science and Technology Planning [2014SZ0122]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Sichuan Provincial Science and Technology Planning	This study was funded from the National Basic Research Program of China (973 Program); No. 2015CB964902 (website: http://www.most.gov.cn/eng/) and the Sichuan Provincial Science and Technology Planning Project Grants; No. 2014SZ0122 (website: http://www.scst.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amit M, 2003, BIOL REPROD, V68, P2150, DOI 10.1095/biolreprod.102.012583; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Batsali AK, 2013, CURR STEM CELL RES T, V8, P144; Cartwright P, 2005, DEVELOPMENT, V132, P885, DOI 10.1242/dev.01670; Carvalho MM, 2011, CURR STEM CELL RES T, V6, P221; Cheng HC, 2011, MOL BIOL REP, V38, P5161, DOI 10.1007/s11033-010-0665-2; Cheng LZ, 2003, STEM CELLS, V21, P131, DOI 10.1634/stemcells.21-2-131; Cho M, 2010, FERTIL STERIL, V93, P2525, DOI 10.1016/j.fertnstert.2010.03.027; Cyranoski D, 2014, NATURE; Deans RJ, 2000, EXP HEMATOL, V28, P875, DOI 10.1016/S0301-472X(00)00482-3; Deuse T, 2011, CELL TRANSPLANT, V20, P655, DOI 10.3727/096368910X536473; Ding DC, 2012, CELL TRANSPLANT, V21, P1515, DOI 10.3727/096368912X647199; Draper JS, 2004, NAT BIOTECHNOL, V22, P53, DOI 10.1038/nbt922; Drawnel FM, 2014, CELL REP, V9, P810, DOI 10.1016/j.celrep.2014.09.055; Esposito M, 2013, IN VIVO, V27, P495; Fukusumi H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055226; Guo J, 2011, EUR J HAEMATOL, V87, P235, DOI 10.1111/j.1600-0609.2011.01635.x; Harris DT, 2013, CURR STEM CELL RES T, V8, P394; Havasi P, 2013, MOL BIOL REP, V40, P3023, DOI 10.1007/s11033-012-2376-3; Holm F, 2010, HUM REPROD, V25, P1271, DOI 10.1093/humrep/deq040; Hovatta O, 2003, HUM REPROD, V18, P1404, DOI 10.1093/humrep/deg290; Kalmar T, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000149; Kao SY, 2015, STEM CELLS INT, V2015, DOI 10.1155/2015/306158; Kim N, 2013, ANN HEMATOL, V92, P1295, DOI 10.1007/s00277-013-1796-z; Klein C, 2013, TISSUE ENG PT A, V19, P2577, DOI 10.1089/ten.tea.2013.0073; Lei T, 2007, CELL RES, V17, P682, DOI 10.1038/cr.2007.61; Leite C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111059; Li HL, 2015, STEM CELL REP, V4, P143, DOI 10.1016/j.stemcr.2014.10.013; Lu LL, 2006, HAEMATOLOGICA, V91, P1017; Ma F, 2008, P NATL ACAD SCI USA, V105, P13087, DOI 10.1073/pnas.0802220105; Ma F, 2008, STEM CELLS, V26, P706, DOI 10.1634/stemcells.2007-0348; Ma F, 2007, INT J HEMATOL, V85, P371, DOI 10.1532/IJH97.06203; Ma XR, 2014, INT J CLIN EXP PATHO, V7, P4661; Mallon BS, 2006, INT J BIOCHEM CELL B, V38, P1063, DOI 10.1016/j.biocel.2005.12.014; Mannello F, 2007, STEM CELLS, V25, P1603, DOI 10.1634/stemcells.2007-0127; Mobarra Naser, 2014, Int J Hematol Oncol Stem Cell Res, V8, P20; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Park Y, 2010, STEM CELLS DEV, V19, P1713, DOI 10.1089/scd.2010.0014; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Richards M, 2002, NAT BIOTECHNOL, V20, P933, DOI 10.1038/nbt726; Robinton DA, 2012, NATURE, V481, P295, DOI 10.1038/nature10761; Roubelakis MG, 2007, STEM CELLS DEV, V16, P931, DOI 10.1089/scd.2007.0036; Sampsell-Barron Tori, 2013, Methods Mol Biol, V1001, P81, DOI 10.1007/978-1-62703-363-3_8; Sanchez L, 2012, TISSUE ENG PART C-ME, V18, P387, DOI [10.1089/ten.TEC.2011.0546, 10.1089/ten.tec.2011.0546]; Sharma RR, 2014, TRANSFUSION, V54, P1418, DOI 10.1111/trf.12421; Shinoda G, 2007, BLOOD, V109, P2406, DOI 10.1182/blood-2006-06-031039; Son MY, 2015, PROTEOMICS, V15, P2220, DOI 10.1002/pmic.201400510; Soong YK, 2015, J TISSUE ENG REGEN M, V9, pE302, DOI 10.1002/term.1702; Stenderup K, 2003, BONE, V33, P919, DOI 10.1016/j.bone.2003.07.005; Suh JH, 2014, BIOCHEM BIOPH RES CO, V444, P311, DOI 10.1016/j.bbrc.2014.01.038; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Umeda K, 2006, STEM CELLS, V24, P2627, DOI 10.1634/stemcells.2006-0199; Unger C, 2009, HUM REPROD, V24, P2567, DOI 10.1093/humrep/dep232; Varlakhanova NV, 2010, DIFFERENTIATION, V80, P9, DOI 10.1016/j.diff.2010.05.001; Watson N, 2015, CYTOTHERAPY, V17, P18, DOI 10.1016/j.jcyt.2014.08.009; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang LF, 2013, CELL REPROGRAM, V15, P216, DOI 10.1089/cell.2012.0064; Zheng G, 2015, BIO-MED MATER ENG, V25, pS145, DOI 10.3233/BME-141249	59	9	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0149023	10.1371/journal.pone.0149023	http://dx.doi.org/10.1371/journal.pone.0149023			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	26882313	Green Published, Green Submitted, gold			2022-12-26	WOS:000371219000043
J	Forero-Castro, M; Robledo, C; Benito, R; Abaigar, M; Martin, AA; Arefi, M; Fuster, JL; de las Heras, N; Rodriguez, JN; Quintero, J; Riesco, S; Hermosin, L; de la Fuente, I; Recio, I; Ribera, J; Labrador, J; Alonso, JM; Olivier, C; Sierra, M; Megido, M; Corchete-Sanchez, LA; Pizarro, JC; Garcia, JL; Ribera, JM; Hernandez-Rivas, JM				Forero-Castro, Maribel; Robledo, Cristina; Benito, Rocio; Abaigar, Maria; Africa Martin, Ana; Arefi, Maryam; Luis Fuster, Jose; de las Heras, Natalia; Rodriguez, Juan N.; Quintero, Jonathan; Riesco, Susana; Hermosin, Lourdes; de la Fuente, Ignacio; Recio, Isabel; Ribera, Jordi; Labrador, Jorge; Alonso, Jose M.; Olivier, Carmen; Sierra, Magdalena; Megido, Marta; Corchete-Sanchez, Luis A.; Ciudad Pizarro, Juana; Luis Garcia, Juan; Ribera, Jose M.; Hernandez-Rivas, Jesus M.			Genome-Wide DNA Copy Number Analysis of Acute Lymphoblastic Leukemia Identifies New Genetic Markers Associated with Clinical Outcome	PLOS ONE			English	Article							CHEMOTHERAPY INCLUDING RITUXIMAB; MINIMAL RESIDUAL DISEASE; CONCERTED ACTION REPORT; CHROMOSOMAL REARRANGEMENTS; GLUCOCORTICOID RESISTANCE; PEDIATRIC DISEASE; CANCER GENOMES; CHROMOTHRIPSIS; HYBRIDIZATION; CHILDHOOD	Identifying additional genetic alterations associated with poor prognosis in acute lymphoblastic leukemia (ALL) is still a challenge. Aims: To characterize the presence of additional DNA copy number alterations (CNAs) in children and adults with ALL by whole-genome oligonucleotide array (aCGH) analysis, and to identify their associations with clinical features and outcome. Array-CGH was carried out in 265 newly diagnosed ALLs (142 children and 123 adults). The NimbleGen CGH 12x135K array (Roche) was used to analyze genetic gains and losses. CNAs were analyzed with GISTIC and aCGHweb software. Clinical and biological variables were analyzed. Three of the patients showed chromothripsis (cth6, cth14q and cth15q). CNAs were associated with age, phenotype, genetic subtype and overall survival (OS). In the whole cohort of children, the losses on 14q32.33 (p = 0.019) and 15q13.2 (p = 0.04) were related to shorter OS. In the group of children without good-or poor-risk cytogenetics, the gain on 1p36.11 was a prognostic marker independently associated with shorter OS. In adults, the gains on 19q13.2 (p = 0.001) and Xp21.1 (p = 0.029), and the loss of 17p (p = 0.014) were independent markers of poor prognosis with respect to OS. In summary, CNAs are frequent in ALL and are associated with clinical parameters and survival. Genome-wide DNA copy number analysis allows the identification of genetic markers that predict clinical outcome, suggesting that detection of these genetic lesions will be useful in the management of patients newly diagnosed with ALL.	[Forero-Castro, Maribel; Robledo, Cristina; Benito, Rocio; Abaigar, Maria; Africa Martin, Ana; Hernandez-Rivas, Jesus M.] Univ Salamanca, CSIC, IBMCC, IBSAL,Canc Res Ctr, E-37008 Salamanca, Spain; [Forero-Castro, Maribel] Pedag & Technol Univ Colombia UPTC, Sch Biol Sci GEBIMOL, Tunja, Colombia; [Africa Martin, Ana; Corchete-Sanchez, Luis A.; Hernandez-Rivas, Jesus M.] Univ Hosp Salamanca, Dept Hematol, Salamanca, Spain; [Arefi, Maryam] Clin Univ Hosp Valladolid, Dept Hematol, Valladolid, Spain; [Luis Fuster, Jose] Clin Univ Hosp Virgen Arrixaca, Dept Pediat Oncohematol, Murcia, Spain; [de las Heras, Natalia] Virgen Blanca Hosp, Dept Hematol, Leon, Spain; [Rodriguez, Juan N.] Juan Raman Jimenez Hosp, Dept Hematol, Huelva, Spain; [Quintero, Jonathan] Miguel Servet Hosp, Dept Hematol, Zaragoza, Spain; [Riesco, Susana] Univ Hosp Salamanca, Dept Pediat Oncohematol, Salamanca, Spain; [Hermosin, Lourdes] Jerez Hosp, Jerez Frontera, Dept Hematol, Cadiz, Spain; [de la Fuente, Ignacio] Rio Hortega Hosp, Dept Hematol, Valladolid, Spain; [Recio, Isabel] Nuestra Senora Sonsoles Hosp, Dept Hematol, Avila, Spain; [Ribera, Jordi] Josep Carreras Res Inst, ICO Hosp Germans Trias & Pujol, Dept Hematol, Badalona, Spain; [Labrador, Jorge; Ribera, Jose M.] Univ Hosp Burgos, Dept Hematol, Burgos, Spain; [Alonso, Jose M.] Rio Carrion Hosp, Dept Hematol, Palencia, Spain; [Olivier, Carmen] Gen Hosp Segovia, Dept Hematol, Segovia, Spain; [Sierra, Magdalena] Virgen Concha Hosp, Dept Hematol, Zamora, Spain; [Megido, Marta] Bierzo Hosp, Dept Hematol, Leon Ponferrada, Spain; [Ciudad Pizarro, Juana] USAL, Cytometry Serv NUCLEUS Res Support Platform, Salamanca, Spain; [Luis Garcia, Juan] Inst Hlth Sci Studies Castile & Leon IESCYL, Salamanca, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca; Universidad Pedagogica y Tecnologica de Colombia (UPTC); University of Salamanca; Hospital Clinico Universitario Virgen de la Arrixaca; Miguel Servet University Hospital; Hospital del Rio Hortega; Catalan Institute of Oncology; Institut de Recerca Contra la Leucemia Josep Carreras (IJC); University of Salamanca	Hernandez-Rivas, JM (corresponding author), Univ Salamanca, CSIC, IBMCC, IBSAL,Canc Res Ctr, E-37008 Salamanca, Spain.; Hernandez-Rivas, JM (corresponding author), Univ Hosp Salamanca, Dept Hematol, Salamanca, Spain.	jmhr@usal.es	Sánchez, Luis Antonio Corchete/D-1336-2018; Forero-Castro, Maribel/O-6035-2019; Alvarado, María Abáigar/V-9309-2017; Ribera, Jordi/K-6597-2014; Robledo Montero, Cristina/B-4495-2017; Ribera, JM/B-8181-2009; Hernández, Jesus M/B-5459-2017; BENITO, ROCIO/B-4271-2017; garcia, Juan/B-4617-2017; Riesco, Susana/AAF-7159-2021	Sánchez, Luis Antonio Corchete/0000-0003-4577-8599; Alvarado, María Abáigar/0000-0002-5716-6242; Ribera, Jordi/0000-0003-4796-6470; Robledo Montero, Cristina/0000-0003-0445-3210; Ribera, JM/0000-0003-1042-6024; Hernández, Jesus M/0000-0002-9661-9371; BENITO, ROCIO/0000-0001-9781-4198; garcia, Juan/0000-0002-2146-5726; DE LA FUENTE GRACIANI, IGNACIO/0000-0001-5381-820X; Forero-Castro, Maribel/0000-0002-5205-8891	European Union [306242-NGS-PTL]; Fundacion Castellano Leonesa de Hematologia y Hemoterapia (FUCALHH); Consejeria de Educacion, Junta de Castilla y Leon [HUS272U13]; Proyectos de Investigacion del SACYL, Spain [GRS 994/A/14, BIO/SA10/14, BIO/SA31/13]; Spanish Fondo de Investigaciones Sanitarias [FIS 09/01543, PI12/00281]; COST Action EuGESMA [BM0801]; Fundacion Espanola de Hematologia y Hemoterapia (FEHH); Red Tematica de Investigacion Cooperativa en Cancer (RTICC), Instituto de Salud Carlos III (ISCIII) [RD12/0036/0069]; Spanish Ministry of Economy and Competitiveness; European Regional Development Fund (ERDF) "Una manera de hacer Europa" (Innocampus) [CEI-2010-1-0010]; Universidad Pedagogica y Tecnologica de Colombia, Colombia [223-2011]	European Union(European Commission); Fundacion Castellano Leonesa de Hematologia y Hemoterapia (FUCALHH); Consejeria de Educacion, Junta de Castilla y Leon(Junta de Castilla y Leon); Proyectos de Investigacion del SACYL, Spain; Spanish Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); COST Action EuGESMA(European Cooperation in Science and Technology (COST)); Fundacion Espanola de Hematologia y Hemoterapia (FEHH); Red Tematica de Investigacion Cooperativa en Cancer (RTICC), Instituto de Salud Carlos III (ISCIII); Spanish Ministry of Economy and Competitiveness(Spanish Government); European Regional Development Fund (ERDF) "Una manera de hacer Europa" (Innocampus); Universidad Pedagogica y Tecnologica de Colombia, Colombia	The research leading to these results has received funding from the European Union's Seventh Framework Programme (FP7/2007-2013) under grant agreement no306242-NGS-PTL, the Fundacion Castellano Leonesa de Hematologia y Hemoterapia (FUCALHH 2013), the Consejeria de Educacion, Junta de Castilla y Leon (HUS272U13), Proyectos de Investigacion del SACYL, Spain: GRS 994/A/14, BIO/SA10/14, BIO/SA31/13. The work was partially supported by grants from the Spanish Fondo de Investigaciones Sanitarias FIS 09/01543, PI12/00281, COST Action EuGESMA (BM0801), Fundacion Espanola de Hematologia y Hemoterapia (FEHH), and by grants (RD12/0036/0069) from the Red Tematica de Investigacion Cooperativa en Cancer (RTICC), Instituto de Salud Carlos III (ISCIII), the Spanish Ministry of Economy and Competitiveness and the European Regional Development Fund (ERDF) "Una manera de hacer Europa" (Innocampus; CEI-2010-1-0010). MFC was supported by study commission (no. 223-2011) granted by the Universidad Pedagogica y Tecnologica de Colombia, Colombia.	Agueli C, 2010, AM J HEMATOL, V85, P575, DOI 10.1002/ajh.21758; Bacher U, 2009, CANCER GENET CYTOGEN, V188, P108, DOI 10.1016/j.cancergencyto.2008.09.004; Baughn LB, 2015, CANCER GENET-NY, V208, P1, DOI 10.1016/j.cancergen.2014.11.003; Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; Bhojwani D, 2015, PEDIATR CLIN N AM, V62, P47, DOI 10.1016/j.pcl.2014.09.004; Bokemeyer A, 2014, HAEMATOLOGICA, V99, P706, DOI 10.3324/haematol.2012.072470; Bungaro S, 2009, GENE CHROMOSOME CANC, V48, P22, DOI 10.1002/gcc.20616; Cai H, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-82; Chiaretti S, 2013, HAEMATOLOGICA, V98, pE59, DOI 10.3324/haematol.2012.076786; Dawson AJ, 2011, CURR ONCOL, V18, pE210; DICCIANNI MB, 1994, BLOOD, V84, P3105; Forment JV, 2012, NAT REV CANCER, V12, P663, DOI 10.1038/nrc3352; Garcia JL, 2003, LEUKEMIA, V17, P2016, DOI 10.1038/sj.leu.2403080; Harrison CJ, 2015, BLOOD, V125, P1383, DOI 10.1182/blood-2014-08-569228; Hatch EM, 2015, CURR BIOL, V25, pR397, DOI 10.1016/j.cub.2015.02.033; Hof J, 2011, J CLIN ONCOL, V29, P3185, DOI 10.1200/JCO.2011.34.8144; Iacobucci I, 2012, CURR HEMATOL MALIG R, V7, P133, DOI 10.1007/s11899-012-0122-5; Jones CL, 2014, J BIOL CHEM, V289, P20502, DOI 10.1074/jbc.M114.569889; Jones MJK, 2012, DEV CELL, V23, P908, DOI 10.1016/j.devcel.2012.10.010; Kawamata N, 2008, BLOOD, V111, P776, DOI 10.1182/blood-2007-05-088310; Kinsella M, 2014, NUCLEIC ACIDS RES, V42, P8231, DOI 10.1093/nar/gku525; Kloosterman WP, 2014, CURR OPIN ONCOL, V26, P64, DOI 10.1097/CCO.0000000000000038; Korbel JO, 2013, CELL, V152, P1226, DOI 10.1016/j.cell.2013.02.023; Kowalczyk JR, 2010, CANCER GENET CYTOGEN, V200, P161, DOI 10.1016/j.cancergencyto.2010.04.016; Krijgsman O, 2012, GENE CHROMOSOME CANC, V51, P344, DOI 10.1002/gcc.21920; Kuchinskaya E, 2008, BRIT J HAEMATOL, V140, P572, DOI 10.1111/j.1365-2141.2007.06917.x; Kuiper RP, 2007, LEUKEMIA, V21, P1258, DOI 10.1038/sj.leu.2404691; Lai W, 2008, BIOINFORMATICS, V24, P1014, DOI 10.1093/bioinformatics/btn067; Li YL, 2014, NATURE, V508, P98, DOI 10.1038/nature13115; Lucio P, 2001, LEUKEMIA, V15, P1185, DOI 10.1038/sj.leu.2402150; Michels E, 2007, GENET MED, V9, P574, DOI 10.1097/GIM.0b013e318145b25b; Moorman AV, 2012, J CLIN ONCOL, V30, P3100, DOI 10.1200/JCO.2011.40.3907; Muhlbacher V, 2016, LEUKEMIA, V30, P318, DOI 10.1038/leu.2015.276; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; Mullighan CG, 2012, HEMATOL-AM SOC HEMAT, P389, DOI 10.1182/asheducation-2012.1.389; Mullighan CG, 2009, NEW ENGL J MED, V360, P470, DOI 10.1056/NEJMoa0808253; Mullighan CG, 2009, SEMIN HEMATOL, V46, P3, DOI 10.1053/j.seminhematol.2008.09.005; Neale GAM, 2004, LEUKEMIA, V18, P934, DOI 10.1038/sj.leu.2403348; O'Reilly J, 2013, PATHOLOGY, V45, P609, DOI 10.1097/PAT.0b013e3283653bd1; Okamoto R, 2010, HAEMATOL-HEMATOL J, V95, P1481, DOI 10.3324/haematol.2009.011114; Olsson L, 2014, LEUKEMIA, V28, P302, DOI 10.1038/leu.2013.206; Othman Moneeb A K, 2014, Leuk Res Treatment, V2014, P357123, DOI 10.1155/2014/357123; Paulsson K, 2008, P NATL ACAD SCI USA, V105, P6708, DOI 10.1073/pnas.0800408105; Paulsson K, 2015, NAT GENET, V47, P672, DOI 10.1038/ng.3301; Pellestor F, 2014, M S-MED SCI, V30, P266, DOI 10.1051/medsci/20143003014; Ploner C, 2005, J STEROID BIOCHEM, V93, P153, DOI 10.1016/j.jsbmb.2004.12.017; Porwit-MacDonald A, 2000, LEUKEMIA, V14, P816, DOI 10.1038/sj.leu.2401741; Pui CH, 1998, NEW ENGL J MED, V339, P605, DOI 10.1056/NEJM199808273390907; Pui CH, 2008, LANCET, V371, P1030, DOI 10.1016/S0140-6736(08)60457-2; Rabin KR, 2008, PEDIATR BLOOD CANCER, V51, P171, DOI 10.1002/pbc.21488; Ribera JM, 2013, CANCER-AM CANCER SOC, V119, P1660, DOI 10.1002/cncr.27918; Roberts KG, 2015, NAT REV CLIN ONCOL, V12, P344, DOI 10.1038/nrclinonc.2015.38; Safavi S, 2015, HAEMATOLOGICA, V100, P55, DOI 10.3324/haematol.2014.112912; Sorzano COS, 2013, CELL CYCLE, V12, P2016, DOI 10.4161/cc.25266; Simons A, 2011, GENE CHROMOSOME CANC, V50, P969, DOI 10.1002/gcc.20919; Steinemann D, 2008, GENE CHROMOSOME CANC, V47, P471, DOI 10.1002/gcc.20557; Strefford JC, 2007, ONCOGENE, V26, P4306, DOI 10.1038/sj.onc.1210190; Strefford Jon C., 2009, V538, P151, DOI 10.1007/978-1-59745-418-6_8; Usvasalo A, 2010, LEUKEMIA RES, V34, P1476, DOI 10.1016/j.leukres.2010.02.031; Usvasalo A, 2009, CANCER GENET CYTOGEN, V192, P10, DOI 10.1016/j.cancergencyto.2009.02.015; van Dongen JJM, 2012, LEUKEMIA, V26, P1908, DOI 10.1038/leu.2012.120; Wang Chang, 2008, Zhonghua Nei Ke Za Zhi, V47, P111; Woo JS, 2014, EXP HEMATOL ONCOL, V3, DOI 10.1186/2162-3619-3-16; Wyatt AW, 2013, J PATHOL, V231, P1, DOI 10.1002/path.4220; Xicoy B, 2014, LEUKEMIA LYMPHOMA, V55, P2341, DOI 10.3109/10428194.2013.878933; Yasar D, 2010, CANCER GENET CYTOGEN, V197, P122, DOI 10.1016/j.cancergencyto.2009.11.018; Zakaria Z, 2012, MOL CYTOGENET, V5, DOI 10.1186/1755-8166-5-41; Zhang CZ, 2013, GENE DEV, V27, P2513, DOI 10.1101/gad.229559.113; Zhang JH, 2012, NATURE, V481, P157, DOI 10.1038/nature10725; Zhang R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087637	70	30	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0148972	10.1371/journal.pone.0148972	http://dx.doi.org/10.1371/journal.pone.0148972			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26872047	Green Published, Green Submitted, gold			2022-12-26	WOS:000370054100082
J	Tallam, A; Perumal, TM; Antony, PM; Jager, C; Fritz, JV; Vallar, L; Balling, R; del Sol, A; Michelucci, A				Tallam, Aravind; Perumal, Thaneer M.; Antony, Paul M.; Jaeger, Christian; Fritz, Joelle V.; Vallar, Laurent; Balling, Rudi; del Sol, Antonio; Michelucci, Alessandro			Gene Regulatory Network Inference of Immunoresponsive Gene 1 (IRG1) Identifies Interferon Regulatory Factor 1 (IRF1) as Its Transcriptional Regulator in Mammalian Macrophages	PLOS ONE			English	Article							NITRIC-OXIDE PRODUCTION; IMMUNE-RESPONSIVE GENE-1; FACTOR-I; IFN-BETA; MYCOBACTERIUM-TUBERCULOSIS; NO SYNTHASE; EXPRESSION; BINDING; PROTEIN; INDUCTION	Immunoresponsive gene 1 (IRG1) is one of the highest induced genes in macrophages under pro-inflammatory conditions. Its function has been recently described: it codes for immune-responsive gene 1 protein/cis-aconitic acid decarboxylase (IRG1/CAD), an enzyme catalysing the production of itaconic acid from cis-aconitic acid, a tricarboxylic acid (TCA) cycle intermediate. Itaconic acid possesses specific antimicrobial properties inhibiting isocitrate lyase, the first enzyme of the glyoxylate shunt, an anaplerotic pathway that bypasses the TCA cycle and enables bacteria to survive on limited carbon conditions. To elucidate the mechanisms underlying itaconic acid production through IRG1 induction in macrophages, we examined the transcriptional regulation of IRG1. To this end, we studied IRG1 expression in human immune cells under different inflammatory stimuli, such as TNF alpha and IFN gamma, in addition to lipopolysaccharides. Under these conditions, as previously shown in mouse macrophages, IRG1/CAD accumulates in mitochondria. Furthermore, using literature information and transcription factor prediction models, we re-constructed raw gene regulatory networks (GRNs) for IRG1 in mouse and human macrophages. We further implemented a contextualization algorithm that relies on genome-wide gene expression data to infer putative cell type-specific gene regulatory interactions in mouse and human macrophages, which allowed us to predict potential transcriptional regulators of IRG1. Among the computationally identified regulators, siRNA-mediated gene silencing of interferon regulatory factor 1 (IRF1) in macrophages significantly decreased the expression of IRG1/CAD at the gene and protein level, which correlated with a reduced production of itaconic acid. Using a synergistic approach of both computational and experimental methods, we here shed more light on the transcriptional machinery of IRG1 expression and could pave the way to therapeutic approaches targeting itaconic acid levels.	[Tallam, Aravind; Perumal, Thaneer M.; Antony, Paul M.; Jaeger, Christian; Fritz, Joelle V.; Balling, Rudi; del Sol, Antonio; Michelucci, Alessandro] Univ Luxembourg, Luxembourg Ctr Syst Biomed, Esch Sur Alzette, Luxembourg; [Vallar, Laurent] Luxembourg Inst Hlth, Genom Res Lab, Luxembourg, Luxembourg; [Michelucci, Alessandro] Luxembourg Inst Hlth, NORLUX Neurooncol Lab, Luxembourg, Luxembourg; [Tallam, Aravind] Zentrum Expt & Klin Infekt Forsch, TWINCORE, Hannover, Germany; [Perumal, Thaneer M.] Sage Bionetworks, Seattle, WA USA	University of Luxembourg; Luxembourg Institute of Health; Luxembourg Institute of Health	del Sol, A; Michelucci, A (corresponding author), Univ Luxembourg, Luxembourg Ctr Syst Biomed, Esch Sur Alzette, Luxembourg.; Michelucci, A (corresponding author), Luxembourg Inst Hlth, NORLUX Neurooncol Lab, Luxembourg, Luxembourg.	antonio.delsol@uni.lu; alessandro.michelucci@lih.lu	del Sol, Antonio/M-7431-2017; Antony, Paul/C-8152-2016	del Sol, Antonio/0000-0002-9926-617X; Perumal, Thanneer Malai/0000-0003-1168-8982; Michelucci, Alessandro/0000-0003-1230-061X; Fritz, Joelle/0000-0002-4694-3923; Balling, Rudi/0000-0003-2902-5650; Antony, Paul/0000-0002-0450-9301; Vallar, Laurent/0000-0002-4404-1010	Fondation du Pelican de Mie et Pierre Hippert-Faber under the aegis of Fondation de Luxembourg	Fondation du Pelican de Mie et Pierre Hippert-Faber under the aegis of Fondation de Luxembourg	AT was supported by Fondation du Pelican de Mie et Pierre Hippert-Faber under the aegis of Fondation de Luxembourg.	Akira S, 2003, J BIOL CHEM, V278, P38105, DOI 10.1074/jbc.R300028200; Aly S, 2009, J CELL MOL MED, V13, P2069, DOI 10.1111/j.1582-4934.2008.00470.x; Basler T, 2006, J LEUKOCYTE BIOL, V79, P628, DOI 10.1189/jlb.0905520; Bertholet S, 1999, J LEUKOCYTE BIOL, V65, P50, DOI 10.1002/jlb.65.1.50; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Chen B, 2003, MOL ENDOCRINOL, V17, P2340, DOI 10.1210/me.2003-0207; Cheon YP, 2003, ENDOCRINOLOGY, V144, P5623, DOI 10.1210/en.2003-0585; Chiang JH, 2003, BIOINFORMATICS, V19, P1417, DOI 10.1093/bioinformatics/btg160; Cho H, 2013, NAT MED, V19, P458, DOI 10.1038/nm.3108; Crespo I, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-140; Crespo I, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks785; De Smet R, 2010, NAT REV MICROBIOL, V8, P717, DOI 10.1038/nrmicro2419; Degrandi D, 2009, J INTERF CYTOK RES, V29, P55, DOI 10.1089/jir.2008.0013; DING AH, 1988, J IMMUNOL, V141, P2407; Dorsett Y, 2004, NAT REV DRUG DISCOV, V3, P318, DOI 10.1038/nrd1345; Farlik M, 2010, IMMUNITY, V33, P25, DOI 10.1016/j.immuni.2010.07.001; Hall CJ, 2013, CELL METAB, V18, P265, DOI 10.1016/j.cmet.2013.06.018; Hattori Y, 1996, BIOCHEM MOL BIOL INT, V40, P889; Haury AC, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-145; He F, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.56; Hiller K, 2009, ANAL CHEM, V81, P3429, DOI 10.1021/ac802689c; Hirotani T, 2005, BIOCHEM BIOPH RES CO, V328, P383, DOI 10.1016/j.bbrc.2004.12.184; Iglesias MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032306; Judge AD, 2005, NAT BIOTECHNOL, V23, P457, DOI 10.1038/nbt1081; KAMIJO R, 1994, SCIENCE, V263, P1612, DOI 10.1126/science.7510419; Kawai T, 2001, J IMMUNOL, V167, P5887, DOI 10.4049/jimmunol.167.10.5887; Kel AE, 2003, NUCLEIC ACIDS RES, V31, P3576, DOI 10.1093/nar/gkg585; KIMURA T, 1994, SCIENCE, V264, P1921, DOI 10.1126/science.8009222; LEE CGL, 1995, IMMUNOGENETICS, V41, P263, DOI 10.1007/BF00172150; Li YL, 2013, EURASIP J IMAGE VIDE, DOI 10.1186/1687-5281-2013-11; Liang K-C, 2013, GENE; LIN RT, 1994, J BIOL CHEM, V269, P17542; Lin RT, 1999, MOL CELL BIOCHEM, V191, P169, DOI 10.1023/A:1006850009017; Marbach D, 2012, NAT METHODS, V9, P796, DOI [10.1038/nmeth.2016, 10.1038/NMETH.2016]; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; Maruyama S, 2003, J IMMUNOL, V170, P997, DOI 10.4049/jimmunol.170.2.997; Matsuno F, 1996, J BIOCHEM-TOKYO, V119, P524; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; Michelucci A, 2013, P NATL ACAD SCI USA, V110, P7820, DOI 10.1073/pnas.1218599110; MORRIS SM, 1994, AM J PHYSIOL, V266, pE829, DOI 10.1152/ajpendo.1994.266.6.E829; Munoz-Elias EJ, 2005, NAT MED, V11, P638, DOI 10.1038/nm1252; Negishi H, 2006, P NATL ACAD SCI USA, V103, P15136, DOI 10.1073/pnas.0607181103; Nikitin A, 2003, BIOINFORMATICS, V19, P2155, DOI 10.1093/bioinformatics/btg290; Panaro M. A., 2003, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V3, P210, DOI 10.2174/1568008033340216; Preusse M, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-293; RASCHKE WC, 1978, CELL, V15, P261, DOI 10.1016/0092-8674(78)90101-0; Rodriguez A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127216; Rodriguez N, 2007, PHYSIOL GENOMICS, V30, P134, DOI 10.1152/physiolgenomics.00011.2007; Russell DG, 2001, NAT REV MOL CELL BIO, V2, P569, DOI 10.1038/35085034; Schneemann M, 2002, NAT IMMUNOL, V3, P102, DOI 10.1038/ni0202-102a; Schneemann M, 2007, J LEUKOCYTE BIOL, V81, P579, DOI 10.1189/jlb.1106702; Shi SP, 2005, J IMMUNOL, V175, P3318, DOI 10.4049/jimmunol.175.5.3318; Spink J, 1997, J BIOL CHEM, V272, P24417, DOI 10.1074/jbc.272.39.24417; Sugiyama T, 2004, MICROBIOL IMMUNOL, V48, P957, DOI 10.1111/j.1348-0421.2004.tb03625.x; Takahashi K, 2013, BIOMED RES-TOKYO, V34, P205; Tan RSP, 1999, INFECT IMMUN, V67, P2277, DOI 10.1128/IAI.67.5.2277-2283.1999; Taniguchi T, 1997, BBA-REV CANCER, V1333, pM9, DOI 10.1016/S0304-419X(97)00014-0; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; Upreti M, 2005, MOL BIOL REP, V32, P103, DOI 10.1007/s11033-004-6940-3; WATANABE N, 1991, NUCLEIC ACIDS RES, V19, P4421, DOI 10.1093/nar/19.16.4421; WEINBERG JB, 1995, BLOOD, V86, P1184; Weinberg JB, 1998, MOL MED, V4, P557, DOI 10.1007/BF03401758; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Yang E, 2007, ANN BIOMED ENG, V35, P1053, DOI 10.1007/s10439-007-9268-z; Zhang LM, 2012, MOL MED, V18, P201, DOI 10.2119/molmed.2011.00282	66	47	49	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149050	10.1371/journal.pone.0149050	http://dx.doi.org/10.1371/journal.pone.0149050			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26872335	gold, Green Published, Green Submitted			2022-12-26	WOS:000370054100093
J	Jiang, YY; Shang, L; Shi, ZZ; Zhang, TT; Ma, S; Lu, CC; Zhang, Y; Hao, JJ; Shi, C; Shi, F; Xu, X; Cai, Y; Jia, XM; Zhan, QM; Wang, MR				Jiang, Y-Y; Shang, L.; Shi, Z-Z; Zhang, T-T; Ma, S.; Lu, C-C; Zhang, Y.; Hao, J-J; Shi, C.; Shi, F.; Xu, X.; Cai, Y.; Jia, X-M; Zhan, Q-M; Wang, M-R			Microtubule-associated protein 4 is an important regulator of cell invasion/migration and a potential therapeutic target in esophageal squamous cell carcinoma	ONCOGENE			English	Article							ENDOTHELIAL GROWTH-FACTOR; CANCER CELLS; BREAST-CANCER; TUMOR-GROWTH; FACTOR VEGF; P38 MAPK; ANGIOGENESIS; INVASION; PATHWAY; METASTASIS	Cell invasion and migration significantly contribute to tumor metastasis. Microtubule-associated protein 4 (MAP4) protein is one member of microtubule-associate proteins family. It is responsible for stabilization of microtubules by modulation of microtubule dynamics. However, there is little information about the involvement of MAP4 in human cancer. Here we show that MAP4 serves as a regulator of invasion and migration in esophageal squamous cancer cells. By activating the ERK-c-Jun-vascular endothelial growth factor A signaling pathway, MAP4 promotes cell invasion and migration in vitro, tumor growth and metastasis in mouse models. Immunohistochemical staining of operative tissues indicated that MAP4 expression was associated with tumor stage, lymph node metastasis and shorter survival of the patients with esophageal squamous cell carcinoma (ESCC). Multivariate Cox regression analysis showed that MAP4 is an independent prognostic indicator. In the serial sections of ESCC tissues, there was a positive correlation between MAP4 and vascular endothelial growth factor A expression. Notably, an intratumoral injection of MAP4-small interfering RNA (siRNA) remarkably inhibited the growth of the tumors that formed by the MAP4-expressing ESCC cells in nude mice, and a combination of MAP4-siRNA and Bevacizumab significantly enhanced the inhibition effect. Our data suggest that MAP4 is probably a useful prognostic biomarker and a potential therapeutic target for the disease.	[Jiang, Y-Y; Shang, L.; Shi, Z-Z; Zhang, T-T; Ma, S.; Zhang, Y.; Hao, J-J; Shi, C.; Shi, F.; Xu, X.; Cai, Y.; Zhan, Q-M; Wang, M-R] Peking Union Med Coll, Canc Inst Hosp, State Key Lab Mol Oncol, Panjiayuan South 17, Beijing 100021, Peoples R China; [Jiang, Y-Y; Shang, L.; Shi, Z-Z; Zhang, T-T; Ma, S.; Zhang, Y.; Hao, J-J; Shi, C.; Shi, F.; Xu, X.; Cai, Y.; Zhan, Q-M; Wang, M-R] Chinese Acad Med Sci, Panjiayuan South 17, Beijing 100021, Peoples R China; [Lu, C-C; Jia, X-M] Anhui Med Univ, Dept Histol & Embryol, Hefei, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Anhui Medical University	Wang, MR (corresponding author), Peking Union Med Coll, Canc Inst Hosp, State Key Lab Mol Oncol, Panjiayuan South 17, Beijing 100021, Peoples R China.; Wang, MR (corresponding author), Chinese Acad Med Sci, Panjiayuan South 17, Beijing 100021, Peoples R China.	wangmr2015@126.com		WANG, Ming-Rong/0000-0002-8767-9356	National Natural Science Foundation of China [81330052, 81321091]; National High-Tech R&D Program of China [2012AA02A503, 2012AA020206]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High-Tech R&D Program of China(National High Technology Research and Development Program of China)	This work was supported by National Natural Science Foundation of China (81330052 and 81321091) and National High-Tech R&D Program of China (2012AA02A503 and 2012AA020206).	Brock A, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007048; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Chang W, 2001, J CELL SCI, V114, P2879; Chen HX, 2001, ONCOLOGY-NY, V15, P1017; Darrington E, 2012, ASIAN J ANDROL, V14, P745, DOI 10.1038/aja.2011.197; Deng ZY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036739; Enzinger PC, 2003, NEW ENGL J MED, V349, P2241, DOI 10.1056/NEJMra035010; Feng YB, 2009, INT J CANCER, V124, P578, DOI 10.1002/ijc.23990; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Fruchon S, 2012, LEUKEMIA, V26, P795, DOI 10.1038/leu.2011.248; Galliher AJ, 2007, CANCER RES, V67, P3752, DOI 10.1158/0008-5472.CAN-06-3851; Gerber HP, 1998, J BIOL CHEM, V273, P13313, DOI 10.1074/jbc.273.21.13313; Gerber HP, 1998, J BIOL CHEM, V273, P30336, DOI 10.1074/jbc.273.46.30336; GITAYGOREN H, 1992, J BIOL CHEM, V267, P6093; He Yu-Tong, 2005, Asian Pac J Cancer Prev, V6, P510; Honma N, 2006, LAB INVEST, V86, P687, DOI 10.1038/labinvest.3700427; Hu JY, 2010, CELL MOL LIFE SCI, V67, P321, DOI 10.1007/s00018-009-0187-z; Huang S, 2000, CANCER RES, V60, P5334; Jiang GZ, 2010, GUT, V59, P1535, DOI 10.1136/gut.2009.200105; Kappas NC, 2008, J CELL BIOL, V181, P847, DOI 10.1083/jcb.200709114; Kremer BE, 2005, MOL BIOL CELL, V16, P4648, DOI 10.1091/mbc.E05-03-0267; Lee TH, 2007, PLOS MED, V4, P1101, DOI 10.1371/journal.pmed.0040186; Lee WJ, 2008, TOXICOL APPL PHARM, V226, P178, DOI 10.1016/j.taap.2007.09.013; Luo ML, 2006, CANCER RES, V66, P11690, DOI 10.1158/0008-5472.CAN-06-1484; Monami G, 2006, CANCER RES, V66, P7103, DOI 10.1158/0008-5472.CAN-06-0633; Murphy M, 1996, GENE DEV, V10, P2971, DOI 10.1101/gad.10.23.2971; Nagy JA, 2002, J EXP MED, V196, P1497, DOI 10.1084/jem.20021244; Neufeld G, 1999, FASEB J, V13, P9, DOI 10.1096/fasebj.13.1.9; OOKATA K, 1995, J CELL BIOL, V128, P849, DOI 10.1083/jcb.128.5.849; Ou Y, 2014, UROL ONCOL, V32, pe21, DOI DOI 10.1016/J.UR0L0NC.2013.06.017; PARK JE, 1993, MOL BIOL CELL, V4, P1317, DOI 10.1091/mbc.4.12.1317; PARYSEK LM, 1984, J CELL BIOL, V99, P1309, DOI 10.1083/jcb.99.4.1309; Patel V, 2011, CANCER RES, V71, P7103, DOI 10.1158/0008-5472.CAN-10-3192; Permana S, 2005, CELL STRUCT FUNCT, V29, P147, DOI 10.1247/csf.29.147; Shibuya M, 2006, J BIOCHEM MOL BIOL, V39, P469; Tekedereli I, 2013, MOL THER-NUCL ACIDS, V2, DOI 10.1038/mtna.2013.45; Weigand Melanie, 2005, Angiogenesis, V8, P197, DOI 10.1007/s10456-005-9010-0; Xu YB, 2013, EUR REV MED PHARMACO, V17, P2486; Zhang Y, 2008, INT J CANCER, V122, P260, DOI 10.1002/ijc.23104; Zhu B, 2012, HEPATO-GASTROENTEROL, V59, P785, DOI 10.5754/hge11427	40	24	25	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 15	2016	35	37					4846	4856		10.1038/onc.2016.17	http://dx.doi.org/10.1038/onc.2016.17			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DW0LA	26876215				2022-12-26	WOS:000383330700003
J	Zhang, ZM; Wu, JF; Luo, QC; Liu, QF; Wu, QW; Ye, GD; She, HQ; Li, BA				Zhang, Z-M; Wu, J-F; Luo, Q-C; Liu, Q-F; Wu, Q-W; Ye, G-D; She, H-Q; Li, B-A			Pygo2 activates MDR1 expression and mediates chemoresistance in breast cancer via the Wnt/beta-catenin pathway	ONCOGENE			English	Article							WNT SIGNALING PATHWAY; BETA-CATENIN; GENE-EXPRESSION; CELLS; NEUROBLASTOMA; COMPLEX; TRANSACTIVATION; TRANSCRIPTION; METHYLATION; MECHANISMS	The Wnt/beta-catenin pathway has important roles in chemoresistance and multidrug resistance 1 (MDR1) expression in some cancers, but its involvement in breast cancer and the underlying molecular mechanism are undefined. In this study, we demonstrated that the Wnt/beta-catenin pathway is activated in chemoresistant breast cancer cells. Using a Wnt pathway-specific PCR array screening assay, we detected that Pygo2, a newly identified Wnt/beta-catenin pathway component, was the most upregulated gene in the resistant cells. Additional experiments indicated that Pygo2 activated MDR1 expression in the resistant cells via the Wnt/beta-catenin pathway. Moreover, the inhibition of Pygo2 expression restored the chemotherapeutic drug sensitivity of the resistant cells and reduced the breast cancer stem cell population in these cells in response to chemotherapy. Importantly, these activities induced by Pygo2 were mediated by MDR1. We also determined the effect of Pygo2 on the sensitivity of breast tumors resistant to doxorubicin in a mouse model. Finally, RNA samples from 64 paired patient tumors (before and after chemotherapy) highly and significantly overexpressed Pygo2 and/or MDR1 after treatment, thus underlining a pivotal role for the Pygo2-mediated Wnt/beta-catenin pathway in the clinical chemoresistance of breast cancer. Our data represent the first implication of the Wnt/beta-catenin pathway in breast cancer chemoresistance and identify potential new targets to treat the recurrence of breast cancer.	[Zhang, Z-M; Luo, Q-C; Wu, Q-W; She, H-Q] Xiamen Univ, Affiliated Hosp 1, Dept Breast Surg, 55 Zhenhai Rd, Xiamen 361003, Fujian, Peoples R China; [Zhang, Z-M; Wu, J-F; Liu, Q-F; Ye, G-D; Li, B-A] Xiamen Univ, Sch Life Sci, Innovat Ctr Cell Signaling Network, State Key Lab Cellular Stress Biol, Xiamen, Fujian, Peoples R China; [Wu, J-F] Henan Univ Sci & Technol, Dept Bioengn, Coll Food & Bioengn, Luoyang, Peoples R China; [Liu, Q-F; Ye, G-D; Li, B-A] Xiamen Univ, Sch Life Sci, Engn Res Ctr Mol Diagnost, Minist Educ, Xiamen, Fujian, Peoples R China	Xiamen University; Xiamen University; Henan University of Science & Technology; Xiamen University	She, HQ (corresponding author), Xiamen Univ, Affiliated Hosp 1, Dept Breast Surg, 55 Zhenhai Rd, Xiamen 361003, Fujian, Peoples R China.; Li, BA (corresponding author), Xiamen Univ, Dept Biomed Sci, Sch Life Sci, D212 Huang Chaoyang Hall,Xiangan Campus, Xiamen 361100, Fujian, Peoples R China.	hongqiangshe68@163.com; bali@xmu.edu.cn	LUO, QI/GQH-7209-2022		'973' Project of the Ministry of Science and Technology [2013CB530600]; National Natural Science Foundation of China [U1205023, 81472457, 81201616, 81201617, 81272384]; Health-Education Joint Research Project of Fujian Province [WKJ-FJ-23]; Major Project of Science and Technology from the Department of Education [313051]; Natural Science Foundation of Fujian Province [2011D017]; Science and Technology Program of Xiamen [3502Z20114003]; 'Project 111' - State Bureau of Foreign Experts and Ministry of Education [B06016]	'973' Project of the Ministry of Science and Technology(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Health-Education Joint Research Project of Fujian Province; Major Project of Science and Technology from the Department of Education; Natural Science Foundation of Fujian Province(Natural Science Foundation of Fujian Province); Science and Technology Program of Xiamen; 'Project 111' - State Bureau of Foreign Experts and Ministry of Education	This work was supported by grants from the '973' Project of the Ministry of Science and Technology (grant numbers 2013CB530600 to B-AL); the National Natural Science Foundation of China (grant numbers U1205023, 81472457, 81201616, 81201617 and 81272384 to B-AL, Q-CL and Q-FL); the Health-Education Joint Research Project of Fujian Province (grant numbers WKJ-FJ-23 to B-AL and Z-MZ); the Major Project of Science and Technology from the Department of Education (grant number 313051 to B-AL); the Natural Science Foundation of Fujian Province (grant numbers 2011D017 to Z-MZ); the Science and Technology Program of Xiamen (grant numbers 3502Z20114003 to H-QS) and 'Project 111' sponsored by the State Bureau of Foreign Experts and Ministry of Education (grant number B06016).	Abdullah LN, 2013, CLIN TRANSL MED, V2, DOI 10.1186/2001-1326-2-3; Andrews PGP, 2007, INT J ONCOL, V30, P357; Andrews PGP, 2009, BIOCHEM J, V422, P493, DOI 10.1042/BJ20090134; Bafico A, 2004, CANCER CELL, V6, P497, DOI 10.1016/j.ccr.2004.09.032; Blanc E, 2003, AM J PATHOL, V163, P321, DOI 10.1016/S0002-9440(10)63656-5; Cai WY, 2013, J CELL SCI, V126, P2877, DOI 10.1242/jcs.123810; Cantu C, 2013, DEVELOPMENT, V140, P2377, DOI 10.1242/dev.093591; Carrera I, 2008, P NATL ACAD SCI USA, V105, P6644, DOI 10.1073/pnas.0709749105; Chen JK, 2010, MOL CELL BIOL, V30, P5621, DOI 10.1128/MCB.00465-10; Flahaut M, 2009, ONCOGENE, V28, P2245, DOI 10.1038/onc.2009.80; Gu BN, 2013, CELL STEM CELL, V13, P48, DOI 10.1016/j.stem.2013.04.012; Gu BN, 2009, J CELL BIOL, V185, P811, DOI 10.1083/jcb.200810133; Haber M, 1997, EUR J CANCER, V33, P2031, DOI 10.1016/S0959-8049(97)00229-3; Han CY, 2008, CARCINOGENESIS, V29, P1837, DOI 10.1093/carcin/bgn092; Huang Chenghui, 2009, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V34, P369; Kramps T, 2002, CELL, V109, P47, DOI 10.1016/S0092-8674(02)00679-7; Krieghoff E, 2006, J CELL SCI, V119, P1453, DOI 10.1242/jcs.02864; Li B, 2007, GENESIS, V45, P318, DOI 10.1002/dvg.20299; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Liu Y, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-346; Lustig B, 2003, J CANCER RES CLIN, V129, P199, DOI 10.1007/s00432-003-0431-0; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Milovanovic T, 2004, INT J ONCOL, V25, P1337; Moghbeli M, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0516-9; Munoz M, 2007, IUBMB LIFE, V59, P752, DOI 10.1080/15216540701736285; Nagahata T, 2003, CANCER SCI, V94, P515, DOI 10.1111/j.1349-7006.2003.tb01475.x; Polakis P, 2000, GENE DEV, V14, P1837; Popadiuk CM, 2006, CLIN CANCER RES, V12, P2216, DOI 10.1158/1078-0432.CCR-05-2433; Sun P, 2014, P NATL ACAD SCI USA, V111, P10215, DOI 10.1073/pnas.1311395111; Thompson B, 2002, NAT CELL BIOL, V4, P367, DOI 10.1038/ncb786; Townsley FM, 2004, NAT CELL BIOL, V6, P626, DOI 10.1038/ncb1141; Veeck J, 2006, ONCOGENE, V25, P3479, DOI 10.1038/sj.onc.1209386; Wang ZX, 2010, J NEURO-ONCOL, V100, P31, DOI 10.1007/s11060-010-0144-6; Watanabe K, 2014, ONCOGENE, V33, P632, DOI 10.1038/onc.2012.620; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Wright KJ, 2009, P NATL ACAD SCI USA, V106, P55, DOI 10.1073/pnas.0811914106; Yamada T, 2000, CANCER RES, V60, P4761; Zardawi SJ, 2009, HISTOL HISTOPATHOL, V24, P385, DOI 10.14670/HH-24.385	38	55	60	3	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 8	2016	35	36					4787	4797		10.1038/onc.2016.10	http://dx.doi.org/10.1038/onc.2016.10			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DW0IS	26876203				2022-12-26	WOS:000383324700011
J	Wei, YJ; Zhang, JF; Li, ZG; Gow, A; Chung, KF; Hu, M; Sun, ZS; Zeng, LM; Zhu, T; Jia, G; Li, XQ; Duarte, M; Tang, XY				Wei, Yongjie; Zhang, Junfeng (Jim); Li, Zhigang; Gow, Andrew; Chung, Kian Fan; Hu, Min; Sun, Zhongsheng; Zeng, Limin; Zhu, Tong; Jia, Guang; Li, Xiaoqian; Duarte, Marlyn; Tang, Xiaoyan			Chronic exposure to air pollution particles increases the risk of obesity and metabolic syndrome: findings from a natural experiment in Beijing	FASEB JOURNAL			English	Article						chronic inflammation; metabolic dysfunction; particulate matter	TUMOR-NECROSIS-FACTOR; INSULIN-RESISTANCE; ADIPOSE-TISSUE; MACROPHAGE INFILTRATION; MOUSE MODEL; INFLAMMATION; ASSOCIATION; INTERLEUKIN-10; PROTEIN; UPDATE	Epidemiologic evidence suggests that air pollution is a risk factor for childhood obesity. Limited experimental data have shown that early-life exposure to ambient particles either increases susceptibility to diet-induced weight gain in adulthood or increases insulin resistance, adiposity, and inflammation. However, no data have directly supported a link between air pollution and non-diet-induced weight increases. In a rodent model, we found that breathing Beijing's highly polluted air resulted in weight gain and cardiorespiratory and metabolic dysfunction. Compared to those exposed to filtered air, pregnant rats exposed to unfiltered Beijing air were significantly heavier at the end of pregnancy. At 8 wk old, the offspring prenatally and postnatally exposed to unfiltered air were significantly heavier than those exposed to filtered air. In both rat dams and their offspring, after continuous exposure to unfiltered air we observed pronounced histologic evidence for both perivascular and peribronchial inflammation in the lungs, increased tissue and systemic oxidative stress, dyslipidemia, and an enhanced proinflammatory status of epididymal fat. Results suggest that TLR2/4-dependent inflammatory activation and lipid oxidation in the lung can spill over systemically, leading to metabolic dysfunction and weight gain.Wei, Y., Zhang, J., Li, Z., Gow, A., Chung, K. F., Hu, M., Sun, Z., Zeng, L., Zhu, T., Jia, G., Li, X., Duarte, M., Tang, X. Chronic exposure to air pollution particles increases the risk of obesity and metabolic syndrome: findings from a natural experiment in Beijing.	[Wei, Yongjie; Hu, Min; Zeng, Limin; Zhu, Tong; Tang, Xiaoyan] Peking Univ, Coll Environm Sci & Engn, State Key Joint Lab Environm Simulat & Pollut Con, Beijing 100871, Peoples R China; [Wei, Yongjie; Li, Zhigang; Li, Xiaoqian] Chinese Res Inst Environm Sci, State Key Lab Environm Criteria, Beijing, Peoples R China; [Wei, Yongjie; Li, Zhigang; Li, Xiaoqian] Chinese Res Inst Environm Sci, Risk Assessment & Environm Stand Inst, Beijing, Peoples R China; [Zhang, Junfeng (Jim); Duarte, Marlyn] Duke Univ, Nicholas Sch Environm, Box 90328,308 Res Dr, Durham, NC 27708 USA; [Zhang, Junfeng (Jim); Duarte, Marlyn] Duke Univ, Duke Global Hlth Inst, Durham, NC 27708 USA; [Zhang, Junfeng (Jim)] Duke Kunshan Univ, Kunshan, Peoples R China; [Gow, Andrew] Rutgers State Univ, Dept Pharmacol & Toxicol, Piscataway, NJ 08854 USA; [Chung, Kian Fan] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England; [Sun, Zhongsheng] Chinese Acad Sci, Beijing Inst Life Sci, Beijing, Peoples R China; [Jia, Guang] Peking Univ, Dept Occupat & Environm Hlth Sci, Sch Publ Hlth, Beijing 100871, Peoples R China	Peking University; Chinese Research Academy of Environmental Sciences; Chinese Research Academy of Environmental Sciences; Duke University; Duke University; Duke Kunshan University; Rutgers State University New Brunswick; Imperial College London; Chinese Academy of Sciences; Peking University	Tang, XY (corresponding author), Peking Univ, Coll Environm Sci & Engn, State Key Joint Lab Environm Simulat & Pollut Con, Beijing 100871, Peoples R China.; Zhang, JF (corresponding author), Duke Univ, Nicholas Sch Environm, Box 90328,308 Res Dr, Durham, NC 27708 USA.; Zhang, JF (corresponding author), Duke Univ, Duke Global Hlth Inst, Durham, NC 27708 USA.	junfeng.zhang@duke.edu; xytang@pku.edu.cn	Zeng, Limin/D-3948-2013; HU, Min/D-1037-2011; Wei, Yongjie/G-1007-2010; Gow, Andrew/AAR-2309-2020; Zhang, Junfeng/AAJ-9183-2020; Chung, Kian Fan/B-1872-2012; ZHU, TONG/H-6501-2011; Sun, Zhongsheng/AAS-4883-2020	HU, Min/0000-0003-4816-9123; Gow, Andrew/0000-0003-0876-5158; Zhang, Junfeng/0000-0003-3759-6672; Chung, Kian Fan/0000-0001-7101-1426; ZHU, TONG/0000-0002-2752-7924; Sun, Zhongsheng/0000-0002-7640-5026	National Natural Science Foundation of China [21190051, 21477119]; State Key Joint Laboratory of Environment Simulation and Pollution Control [13K03ESPCP]; China Postdoctoral Science Foundation [201003010]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086621] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Joint Laboratory of Environment Simulation and Pollution Control; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by grants from the National Natural Science Foundation of China ( 21190051, 21477119), the Open Fund of the State Key Joint Laboratory of Environment Simulation and Pollution Control ( 13K03ESPCP), and the China Postdoctoral Science Foundation ( 201003010).	Bluher M, 2005, EXP CLIN ENDOCR DIAB, V113, P534, DOI 10.1055/s-2005-872851; Bolton JL, 2012, FASEB J, V26, P4743, DOI 10.1096/fj.12-210989; Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1; Charles BA, 2011, J CLIN ENDOCR METAB, V96, pE2018, DOI 10.1210/jc.2011-1497; Chavey C, 2009, AGING-US, V1, P674, DOI 10.18632/aging.100064; Chavey C, 2009, CELL METAB, V9, P339, DOI 10.1016/j.cmet.2009.03.002; Ferrante AW, 2007, J INTERN MED, V262, P408, DOI 10.1111/j.1365-2796.2007.01852.x; FRANKEL EN, 1983, BIOCHIM BIOPHYS ACTA, V754, P264, DOI 10.1016/0005-2760(83)90141-8; GRUNFELD C, 1991, BIOTHERAPY, V3, P143, DOI 10.1007/BF02172087; HOTAMISLIGIL GS, 1994, P NATL ACAD SCI USA, V91, P4854, DOI 10.1073/pnas.91.11.4854; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jerrett M, 2010, PREV MED, V50, pS50, DOI 10.1016/j.ypmed.2009.09.026; Juge-Aubry CE, 2005, CYTOKINE, V29, P270, DOI 10.1016/j.cyto.2004.10.017; Lee YS, 2012, DIABETOLOGIA, V55, P2456, DOI 10.1007/s00125-012-2592-3; Mendez R, 2013, AM J TRANSL RES, V5, P224; Rajagopalan S, 2012, DIABETES, V61, P3037, DOI 10.2337/db12-0190; Rundle A, 2012, AM J EPIDEMIOL, V175, P1163, DOI 10.1093/aje/kwr455; Shoelson SE, 2007, GASTROENTEROLOGY, V132, P2169, DOI 10.1053/j.gastro.2007.03.059; Sun QH, 2009, CIRCULATION, V119, P538, DOI 10.1161/CIRCULATIONAHA.108.799015; Thiering E, 2013, DIABETOLOGIA, V56, P1696, DOI 10.1007/s00125-013-2925-x; Weldy CS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088582; Xu XH, 2010, ARTERIOSCL THROM VAS, V30, P2518, DOI 10.1161/ATVBAHA.110.215350; Zuberi K, 2013, NUCLEIC ACIDS RES, V41, pW115, DOI 10.1093/nar/gkt533	23	138	143	6	63	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2016	30	6					2115	2122		10.1096/fj.201500142	http://dx.doi.org/10.1096/fj.201500142			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DN2FA	26891735	Green Published			2022-12-26	WOS:000376878300006
J	Noble, CG; Lim, SP; Arora, R; Yokokawa, F; Nilar, S; Seh, CC; Wright, SK; Benson, TE; Smith, PW; Shi, PY				Noble, Christian G.; Lim, Siew Pheng; Arora, Rishi; Yokokawa, Fumiaki; Nilar, Shahul; Seh, Cheah Chen; Wright, S. Kirk; Benson, Timothy E.; Smith, Paul W.; Shi, Pei-Yong			A Conserved Pocket in the Dengue Virus Polymerase Identified through Fragment-based Screening	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						crystallography; dengue virus (DENV); enzyme inhibitor; flavivirus; inhibitor; RNA polymerase; viral polymerase	DEPENDENT RNA-POLYMERASE; HEPATITIS-C VIRUS; CRYSTAL-STRUCTURE; INHIBITORS; INITIATION; PROTEIN; DESIGN; DOMAIN	We performed a fragment screen on the dengue virus serotype 3 RNA-dependent RNA polymerase using x-ray crystallography. A screen of 1,400 fragments in pools of eight identified a single hit that bound in a novel pocket in the protein. This pocket is located in the polymerase palm subdomain and conserved across the four serotypes of dengue virus. The compound binds to the polymerase in solution as evidenced by surface plasmon resonance and isothermal titration calorimetry analyses. Related compounds where a phenyl is replaced by a thiophene show higher affinity binding, indicating the potential for rational design. Importantly, inhibition of enzyme activity correlated with the binding affinity, showing that the pocket is functionally important for polymerase activity. This fragment is an excellent starting point for optimization through rational structure-based design.	[Noble, Christian G.; Lim, Siew Pheng; Yokokawa, Fumiaki; Nilar, Shahul; Seh, Cheah Chen; Smith, Paul W.; Shi, Pei-Yong] Novartis Inst Trop Dis, 10 Biopolis Rd,05-01 Chromos, Singapore 138670, Singapore; [Arora, Rishi; Wright, S. Kirk; Benson, Timothy E.] Novartis Inst BioMed Res Inc, Cambridge, MA 02139 USA; [Shi, Pei-Yong] Univ Texas Med Branch, Dept Biochem & Mol Biol, Sealy Ctr Struct Biol & Mol Biophys, Galveston, TX 77555 USA	Novartis; Novartis; University of Texas System; University of Texas Medical Branch Galveston	Noble, CG (corresponding author), Novartis Inst Trop Dis, 10 Biopolis Rd,05-01 Chromos, Singapore 138670, Singapore.; Shi, PY (corresponding author), Univ Texas Med Branch, 5-138 Med Res Bldg, Galveston, TX 77555 USA.	christian.noble@novartis.com; peshi@utmb.edu	Pheng, Lim Siew/AAG-4368-2021; Lim, Siew Pheng/P-8528-2016; /AAJ-1244-2020	Pheng, Lim Siew/0000-0002-7377-5662; Benson, Timothy/0000-0001-8633-2142				Appleby TC, 2015, SCIENCE, V347, P771, DOI 10.1126/science.1259210; Beckett D, 1999, PROTEIN SCI, V8, P921, DOI 10.1110/ps.8.4.921; Beno BR, 2015, J MED CHEM, V58, P4383, DOI 10.1021/jm501853m; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Caillet-Saguy C, 2014, ANTIVIR RES, V105, P8, DOI 10.1016/j.antiviral.2014.02.006; Dong HP, 2014, J GEN VIROL, V95, P763, DOI 10.1099/vir.0.062208-0; Lim SP, 2015, ANTIVIR RES, V119, P57, DOI 10.1016/j.antiviral.2015.04.010; Lim SP, 2013, J BIOL CHEM, V288, P31105, DOI 10.1074/jbc.M113.508606; Malet H, 2007, J BIOL CHEM, V282, P10678, DOI 10.1074/jbc.M607273200; Niyomrattanakit P, 2011, J BIOMOL SCREEN, V16, P201, DOI 10.1177/1087057110389323; Niyomrattanakit P, 2010, J VIROL, V84, P5678, DOI 10.1128/JVI.02451-09; Noble CG, 2013, J VIROL, V87, P5291, DOI 10.1128/JVI.00045-13; Nyanguile O, 2010, J VIROL, V84, P2923, DOI 10.1128/JVI.01980-09; Simmons CP, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001752; Smith TM, 2015, J BIOMOL SCREEN, V20, P153, DOI 10.1177/1087057114551141; Surana P, 2014, NUCLEIC ACIDS RES, V42, P2758, DOI 10.1093/nar/gkt1106; Whitehorn J, 2011, VACCINE, V29, P7221, DOI 10.1016/j.vaccine.2011.07.022; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yap TL, 2007, J VIROL, V81, P4753, DOI 10.1128/JVI.02283-06; Zhao YQ, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004682	20	43	43	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2016	291	16					8541	8548		10.1074/jbc.M115.710731	http://dx.doi.org/10.1074/jbc.M115.710731			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK2VT	26872970	Green Published, hybrid			2022-12-26	WOS:000374773200019
J	Algasaier, SI; Exell, JC; Bennet, IA; Thompson, MJ; Gotham, VJB; Shaw, SJ; Craggs, TD; Finger, LD; Grasby, JA				Algasaier, Sana I.; Exell, Jack C.; Bennet, Ian A.; Thompson, Mark J.; Gotham, Victoria J. B.; Shaw, Steven J.; Craggs, Timothy D.; Finger, L. David; Grasby, Jane A.			DNA and Protein Requirements for Substrate Conformational Changes Necessary for Human Flap Endonuclease-1-catalyzed Reaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						circular dichroism (CD); DNA endonuclease; DNA repair; DNA replication; DNA-protein interaction; fluorescence resonance energy transfer (FRET); nucleic acid enzymology	METAL-IONS; MECHANISM; ENDONUCLEASES; SPECIFICITY; FEN1; REPLICATION; RECOGNITION; SUPERFAMILY; CATALYSIS; NUCLEASE	Human flap endonuclease-1 (hFEN1) catalyzes the essential removal of single-stranded flaps arising at DNA junctions during replication and repair processes. hFEN1 biological function must be precisely controlled, and consequently, the protein relies on a combination of protein and substrate conformational changes as a prerequisite for reaction. These include substrate bending at the duplex-duplex junction and transfer of unpaired reacting duplex end into the active site. When present, 5-flaps are thought to thread under the helical cap, limiting reaction to flaps with free 5-termini in vivo. Here we monitored DNA bending by FRET and DNA unpairing using 2-aminopurine exciton pair CD to determine the DNA and protein requirements for these substrate conformational changes. Binding of DNA to hFEN1 in a bent conformation occurred independently of 5-flap accommodation and did not require active site metal ions or the presence of conserved active site residues. More stringent requirements exist for transfer of the substrate to the active site. Placement of the scissile phosphate diester in the active site required the presence of divalent metal ions, a free 5-flap (if present), a Watson-Crick base pair at the terminus of the reacting duplex, and the intact secondary structure of the enzyme helical cap. Optimal positioning of the scissile phosphate additionally required active site conserved residues Tyr(40), Asp(181), and Arg(100) and a reacting duplex 5-phosphate. These studies suggest a FEN1 reaction mechanism where junctions are bound and 5-flaps are threaded (when present), and finally the substrate is transferred onto active site metals initiating cleavage.	[Algasaier, Sana I.; Exell, Jack C.; Bennet, Ian A.; Thompson, Mark J.; Gotham, Victoria J. B.; Shaw, Steven J.; Finger, L. David; Grasby, Jane A.] Univ Sheffield, Ctr Chem Biol, Krebs Inst, Dept Chem, Sheffield S3 7HF, S Yorkshire, England; [Craggs, Timothy D.] Univ Bristol, Sch Biochem, DNA Prot Interact Unit, Bristol BS8 1TD, Avon, England; [Exell, Jack C.] Univ Calif Davis, Dept Microbiol & Mol Genet, Briggs Hall,One Shields Ave, Davis, CA 95616 USA	University of Sheffield; University of Bristol; University of California System; University of California Davis	Grasby, JA (corresponding author), Univ Sheffield, Ctr Chem Biol, Krebs Inst, Dept Chem, Sheffield S3 7HF, S Yorkshire, England.	j.a.grasby@sheffield.ac.uk		Craggs, Timothy/0000-0002-7121-0609; Finger, L. David/0000-0002-2342-9569; Bennet, Ian/0000-0002-2543-2032; Shaw, Steven/0000-0002-1236-1810	Biotechnology and Biological Sciences Research Council [BB/K009079/1, BB/M00404X/1]; Ministry of Higher Education Libya; EPSRC; Astra Zeneca; Biotechnology and Biological Sciences Research Council White Rose Studentship [DTP BB/J014443/1]; BBSRC [BB/K009079/1, BB/M00404X/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [1477884] Funding Source: researchfish; Engineering and Physical Sciences Research Council [1623361] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Ministry of Higher Education Libya; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Astra Zeneca(AstraZeneca); Biotechnology and Biological Sciences Research Council White Rose Studentship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by Biotechnology and Biological Sciences Research Council Grants BB/K009079/1 and BB/M00404X/1. This work was also supported by a studentship from the Ministry of Higher Education Libya (to S. I. A.), studentships from the EPSRC and Astra Zeneca (to J. C. E.), and Biotechnology and Biological Sciences Research Council White Rose Studentship DTP BB/J014443/1 (to I. A. B.). The authors declare that they have no conflicts of interest with the contents of this article.	Allawi HT, 2003, J MOL BIOL, V328, P537, DOI 10.1016/S0022-2836(03)00351-6; Balakrishnan L, 2013, ANNU REV BIOCHEM, V82, P119, DOI 10.1146/annurev-biochem-072511-122603; Beddows A, 2012, CHEM COMMUN, V48, P8895, DOI 10.1039/c2cc33400c; Chapados BR, 2004, CELL, V116, P39, DOI 10.1016/S0092-8674(03)01036-5; CLEGG RM, 1992, BIOCHEMISTRY-US, V31, P4846, DOI 10.1021/bi00135a016; Craggs TD, 2014, NUCLEIC ACIDS RES, V42, P1857, DOI 10.1093/nar/gkt1116; Finger LD, 2013, NUCLEIC ACIDS RES, V41, P9839, DOI 10.1093/nar/gkt737; Finger L David, 2012, Subcell Biochem, V62, P301, DOI 10.1007/978-94-007-4572-8_16; Finger LD, 2009, J BIOL CHEM, V284, P22184, DOI 10.1074/jbc.M109.015065; Gloor JW, 2010, J BIOL CHEM, V285, P34922, DOI 10.1074/jbc.M110.165902; Grasby JA, 2012, TRENDS BIOCHEM SCI, V37, P74, DOI 10.1016/j.tibs.2011.10.003; Johnson NP, 2004, P NATL ACAD SCI USA, V101, P3426, DOI 10.1073/pnas.0400591101; Jose D, 2009, P NATL ACAD SCI USA, V106, P4231, DOI 10.1073/pnas.0900803106; Kaiser MW, 1999, J BIOL CHEM, V274, P21387, DOI 10.1074/jbc.274.30.21387; Kalinin S, 2012, NAT METHODS, V9, P1218, DOI [10.1038/nmeth.2222, 10.1038/NMETH.2222]; Orans J, 2011, CELL, V145, P212, DOI 10.1016/j.cell.2011.03.005; Patel N, 2013, J BIOL CHEM, V288, P34239, DOI 10.1074/jbc.M113.509489; Patel N, 2012, NUCLEIC ACIDS RES, V40, P4507, DOI 10.1093/nar/gks051; Sengerova B, 2010, BIOCHEMISTRY-US, V49, P8085, DOI 10.1021/bi100895j; Sobhy MA, 2013, CELL REP, V3, P1785, DOI 10.1016/j.celrep.2013.05.001; Syson K, 2008, J BIOL CHEM, V283, P28741, DOI 10.1074/jbc.M801264200; Tomlinson CG, 2011, J BIOL CHEM, V286, P30878, DOI 10.1074/jbc.M111.230391; Tomlinson CG, 2010, BIOCHEM SOC T, V38, P433, DOI 10.1042/BST0380433; Tsutakawa SE, 2011, CELL, V145, P198, DOI 10.1016/j.cell.2011.03.004; Zheng L, 2011, NUCLEIC ACIDS RES, V39, P781, DOI 10.1093/nar/gkq884	25	13	13	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2016	291	15					8258	8268		10.1074/jbc.M115.698993	http://dx.doi.org/10.1074/jbc.M115.698993			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DJ2SZ	26884332	hybrid, Green Accepted, Green Published			2022-12-26	WOS:000374056700041
J	Kume, A; Kawase, K; Komenoi, S; Usuki, T; Takeshita, E; Sakai, H; Sakane, F				Kume, Aiko; Kawase, Koki; Komenoi, Suguru; Usuki, Takako; Takeshita, Ena; Sakai, Hiromichi; Sakane, Fumio			The Pleckstrin Homology Domain of Diacylglycerol Kinase Strongly and Selectively Binds to Phosphatidylinositol 4,5-Bisphosphate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cancer; diacylglycerol; extracellular signal-regulated kinase (ERK); inositol phospholipid; lipid-binding protein; phosphatidylinositol signaling; phosphatidylinositol 4; 5-bisphosphate; pleckstrin homology domain; diacylglycerol kinase	PHOSPHOLIPASE-C; PHOSPHATIDIC-ACID; ISOZYMES DELTA; SAM DOMAIN; ETA; MEMBRANE; LOCALIZATION; EXPRESSION; IDENTIFICATION; INOSITOL	Type II diacylglycerol kinase (DGK) isozymes (, , and ) have a pleckstrin homology domain (PH) at their N termini. Here, we investigated the lipid binding properties of the PHs of type II DGK isozymes using protein-lipid overlay and liposome binding assays. The PH of DGK showed the most pronounced binding activity to phosphatidylinositol (PI) 4,5-bisphosphate (PI(4,5)P-2) among the various glycero- and sphingolipids including PI 3,4,5-trisphosphate, PI 3,4-bisphosphate, PI 3-phosphate, PI 4-phosphate, and PI 5-phosphate. Moreover, the PI(4,5)P-2 binding activity of the DGK-PH was significantly stronger than that of other type II DGK isozymes. Notably, compared with the PH of phospholipase C (PLC) 1, which is generally utilized as a cellular PI(4,5)P-2- probe, the DGK-PH is equal to or superior than the PLC1-PH in terms of affinity and selectivity for PI(4,5)P-2. Furthermore, in COS-7 cells, GFP-fused wild-type DGK1 and its PH partly translocated from the cytoplasm to the plasma membrane where the PLC1-PH was co-localized in response to hyperosmotic stress in an inositol 5-phosphatase-sensitive manner, whereas a PH deletion mutant did not. Moreover, K74A and R85A mutants of DGK-PH, which lack the conserved basic amino acids thought to ligate PI(4,5)P-2, were indeed unable to bind to PI(4,5)P-2 and co-localize with the PLC1-PH even in osmotically shocked cells. Overexpression of wild-type DGK1 enhanced EGF-dependent phosphorylation of ERK, whereas either K74A or R85A mutant did not. Taken together, these results indicate that the DGK-PH preferentially interacts with PI(4,5)P-2 and has crucial roles in regulating the subcellular localization and physiological function of DGK. Moreover, the DGK-PH could serve as an excellent cellular sensor for PI(4,5)P-2.	[Kume, Aiko; Kawase, Koki; Komenoi, Suguru; Usuki, Takako; Takeshita, Ena; Sakai, Hiromichi; Sakane, Fumio] Chiba Univ, Grad Sch Sci, Dept Chem, Inage Ku, 1-33 Yayoi Cho, Chiba 2638522, Japan	Chiba University	Sakane, F (corresponding author), Chiba Univ, Grad Sch Sci, Dept Chem, Inage Ku, 1-33 Yayoi Cho, Chiba 2638522, Japan.	sakane@faculty.chiba-u.jp	Sakai, Hiromichi/K-8457-2019; Sakane, Fumio/H-2693-2017	Sakane, Fumio/0000-0003-0857-0377	Ministry of Education, Culture, Sports, Science and Technology of Japan [22370047, 23116505, 25116704, 26291017]; Japan Science and Technology Agency [AS221Z00794F, AS231Z00139G, AS251Z01788Q]; Naito Foundation; Hamaguchi Foundation for the Advancement of Biochemistry; Daiichi-Sankyo Foundation of Life Science; Terumo Life Science Foundation; Futaba Electronic Memorial Foundation; Daiwa Securities Health Foundation; Ono Medical Research Foundation; Japan Foundation for Applied Enzymology; Food Science Institute Foundation; Skylark Food Science Institute; Asahi Group Foundation; Grants-in-Aid for Scientific Research [26291017, 16J06865] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Naito Foundation(Naito Memorial Foundation); Hamaguchi Foundation for the Advancement of Biochemistry(Hamaguchi Foundation for the Advancement of Biochemistry); Daiichi-Sankyo Foundation of Life Science; Terumo Life Science Foundation(Terumo Life Science Foundation); Futaba Electronic Memorial Foundation; Daiwa Securities Health Foundation; Ono Medical Research Foundation; Japan Foundation for Applied Enzymology; Food Science Institute Foundation; Skylark Food Science Institute; Asahi Group Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Ministry of Education, Culture, Sports, Science and Technology of Japan Grants 22370047, 23116505, 25116704, and 26291017; Japan Science and Technology Agency Grants AS221Z00794F, AS231Z00139G, and AS251Z01788Q; the Naito Foundation, the Hamaguchi Foundation for the Advancement of Biochemistry, the Daiichi-Sankyo Foundation of Life Science, the Terumo Life Science Foundation, the Futaba Electronic Memorial Foundation, the Daiwa Securities Health Foundation, the Ono Medical Research Foundation, the Japan Foundation for Applied Enzymology, the Food Science Institute Foundation, the Skylark Food Science Institute; the Food Science Institute Foundation, and the Asahi Group Foundation. The authors declare that they have no conflicts of interest with the contents of this article.	Baum AE, 2008, MOL PSYCHIATR, V13, P197, DOI 10.1038/sj.mp.4002012; Belmaker RH, 1998, NEUROPSYCHOPHARMACOL, V19, P220, DOI 10.1016/S0893-133X(98)00017-7; Chibalin AV, 2008, CELL, V132, P375, DOI 10.1016/j.cell.2007.12.035; Crotty T, 2006, P NATL ACAD SCI USA, V103, P15485, DOI 10.1073/pnas.0604104103; English D, 1996, CELL SIGNAL, V8, P341, DOI 10.1016/0898-6568(95)00076-3; EXTON JH, 1994, BBA-LIPID LIPID MET, V1212, P26, DOI 10.1016/0005-2760(94)90186-4; FERGUSON KM, 1995, CELL, V83, P1037, DOI 10.1016/0092-8674(95)90219-8; Goto K, 2006, BBA-MOL CELL BIOL L, V1761, P535, DOI 10.1016/j.bbalip.2006.04.001; Guo YJ, 2003, J BIOL CHEM, V278, P29995, DOI 10.1074/jbc.M301438200; Hagihara H, 2013, NEURAL PLAST, V2013, DOI 10.1155/2013/318596; Harada BT, 2008, STRUCTURE, V16, P380, DOI 10.1016/j.str.2007.12.017; Hayes MJ, 2004, J BIOL CHEM, V279, P14157, DOI 10.1074/jbc.M313025200; Hurley JH, 1997, PROTEIN SCI, V6, P477; Imai S, 2005, J BIOL CHEM, V280, P39870, DOI 10.1074/jbc.M500669200; Imai S, 2004, BIOCHEM J, V382, P957, DOI 10.1042/BJ20040681; Imai S, 2002, J BIOL CHEM, V277, P35323, DOI 10.1074/jbc.M202035200; Isakoff SJ, 1998, EMBO J, V17, P5374, DOI 10.1093/emboj/17.18.5374; Kavran JM, 1998, J BIOL CHEM, V273, P30497, DOI 10.1074/jbc.273.46.30497; Klauck TM, 1996, J BIOL CHEM, V271, P19781, DOI 10.1074/jbc.271.33.19781; Knight MJ, 2010, BIOCHEMISTRY-US, V49, P9667, DOI 10.1021/bi101261x; Leach NT, 2007, AM J HUM GENET, V80, P792, DOI 10.1086/513019; LEMMON MA, 1995, P NATL ACAD SCI USA, V92, P10472, DOI 10.1073/pnas.92.23.10472; Lemmon MA, 2000, BIOCHEM J, V350, P1, DOI 10.1042/0264-6021:3500001; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Maffucci T, 2001, FEBS LETT, V506, P173, DOI 10.1016/S0014-5793(01)02909-X; Maloku E, 2010, P NATL ACAD SCI USA, V107, P4407, DOI 10.1073/pnas.0914483107; Matsutomo D, 2013, J BIOCHEM, V153, P179, DOI 10.1093/jb/mvs130; McPherson PS, 1996, NATURE, V379, P353, DOI 10.1038/379353a0; Merida I, 2008, BIOCHEM J, V409, P1, DOI 10.1042/BJ20071040; Miele C, 2007, J BIOL CHEM, V282, P31835, DOI 10.1074/jbc.M702481200; Moya PR, 2010, INT J NEUROPSYCHOPH, V13, P1127, DOI 10.1017/S1461145710000593; Murakami T, 2003, J BIOL CHEM, V278, P34364, DOI 10.1074/jbc.M301542200; Nakano T, 2014, CLIN TRANSL ONCOL, V16, P29, DOI 10.1007/s12094-013-1036-y; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; NOH DY, 1995, BBA-REV CANCER, V1242, P99, DOI 10.1016/0304-419X(95)00006-0; Ron D, 1999, FASEB J, V13, P1658, DOI 10.1096/fasebj.13.13.1658; Sakai H, 2012, J BIOCHEM, V152, P397, DOI 10.1093/jb/mvs104; Sakane F, 2002, J BIOL CHEM, V277, P43519, DOI 10.1074/jbc.M206895200; Sakane F, 1996, J BIOL CHEM, V271, P8394, DOI 10.1074/jbc.271.14.8394; Sakane F, 2007, BBA-MOL CELL BIOL L, V1771, P793, DOI 10.1016/j.bbalip.2007.04.006; Shionoya T, 2015, BMC DEV BIOL, V15, DOI 10.1186/s12861-015-0055-z; Shulga YV, 2011, CHEM REV, V111, P6186, DOI 10.1021/cr1004106; Tsushima S, 2004, J BIOL CHEM, V279, P28603, DOI 10.1074/jbc.M314031200; Usuki T, 2015, J HISTOCHEM CYTOCHEM, V63, P57, DOI 10.1369/0022155414559130; van Blitterswijk WJ, 2000, CELL SIGNAL, V12, P595, DOI 10.1016/S0898-6568(00)00113-3; van der Zanden LFM, 2011, NAT GENET, V43, P48, DOI 10.1038/ng.721; Walton NM, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.56; Watt SA, 2002, BIOCHEM J, V363, P657, DOI 10.1042/0264-6021:3630657; Weber H, 2011, NEUROPSYCHOPHARMACOL, V36, P2076, DOI 10.1038/npp.2011.98; Yamamoto M, 2006, J BIOL CHEM, V281, P32630, DOI 10.1074/jbc.M605928200; Yasuda S, 2009, J BIOL CHEM, V284, P29559, DOI 10.1074/jbc.M109.043604	51	14	16	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2016	291	15					8150	8161		10.1074/jbc.M115.648717	http://dx.doi.org/10.1074/jbc.M115.648717			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DJ2SZ	26887948	hybrid, Green Published			2022-12-26	WOS:000374056700032
J	Zhang, XL; Sullivan, E; Scimeca, M; Wu, XZ; Li, YM; Sisodia, SS				Zhang, Xulun; Sullivan, Eric; Scimeca, Maggie; Wu, Xianzhong; Li, Yue-ming; Sisodia, Sangram S.			Evidence That the "Lid" Domain of Nicastrin Is Not Essential for Regulating -Secretase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alzheimer disease; amyloid precursor protein (APP); gamma-secretase; mutagenesis; Notch protein; nicastrin; lid; substrate binding	GAMMA-SECRETASE; PRESENILIN-1; TRAFFICKING; MUTATIONS; RECEPTOR; PROTEIN	Understanding of the structure of the -secretase complex consisting of presenilin (PS), anterior pharynx-defective 1 (APH-1), nicastrin (NCT), and presenilin enhancer 2 (PEN-2) is of significant therapeutic interest for the design of -secretase modulators for Alzheimer disease. The structure of -secretase revealed by cryo-EM approaches suggested a substrate binding mechanism for NCT, a bilobar structure that involved rotation of the two lobes around a central pivot and opening of a lid region that facilitates substrate recruitment. To validate this proposal, we expressed NCT that lacks the lid entirely, or a variety of NCT variants that harbor mutations at highly conserved residues in the lid region in NCT-deficient cells, and then assessed their impact on -secretase assembly, activity, and stability. In addition, we assessed the impact of mutating a critical residue proposed to be a pivot around which the two lobes of NCT rotate. Our results show that neither the mutations on the lid tested here nor the entire lid deletion has any significant impact on -secretase assembly, activity, and stability, and that NCT with the mutation of the proposed pivot rescues -secretase activity in NCT-deficient cells in a manner indistinguishable from WT NCT. These findings indicate that the NCT lid is not an essential element necessary for -secretase assembly, activity, and stability, and that rotation of the two lobes appears not to be a prerequisite for substrate binding and -secretase function.	[Zhang, Xulun; Sullivan, Eric; Scimeca, Maggie; Sisodia, Sangram S.] Univ Chicago, Dept Neurobiol, Chicago, IL 60637 USA; [Wu, Xianzhong; Li, Yue-ming] Mem Sloan Kettering Canc Ctr, Mol Pharmacol & Chem Program, New York, NY 10065 USA	University of Chicago; Memorial Sloan Kettering Cancer Center	Sisodia, SS (corresponding author), Univ Chicago, Dept Neurobiol, Chicago, IL 60637 USA.	ssisodia@bsd.uchicago.edu	LI, Yue/GRS-8071-2022		Adler Foundation; Edward H. Levy Fund; Cure Alzheimer's Fund; National Institutes of Health [R01AG026660, 5P30CA008748]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG026660] Funding Source: NIH RePORTER	Adler Foundation; Edward H. Levy Fund; Cure Alzheimer's Fund; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by The Adler Foundation, Edward H. Levy Fund, and Cure Alzheimer's Fund (to S. S. S.) and National Institutes of Health Grants R01AG026660 (to Y. L.) and 5P30CA008748 (to C. B. Thompson). The corresponding author (S. S. S.) discloses that he is a paid consultant of Eisai Research Labs Inc., AZ Therapies Inc., and Jannsen Pharmaceutica NV, but is not a shareholder in any company that is a maker or owner of a FDA-regulated drug or device. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahn K, 2010, P NATL ACAD SCI USA, V107, P21435, DOI 10.1073/pnas.1013246107; Bai XC, 2015, NATURE, V525, P212, DOI 10.1038/nature14892; Chau DM, 2012, J BIOL CHEM, V287, P17288, DOI 10.1074/jbc.M111.300483; De Strooper B, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006304; Dries DR, 2009, J BIOL CHEM, V284, P29714, DOI 10.1074/jbc.M109.038737; Goutte C, 2002, P NATL ACAD SCI USA, V99, P775, DOI 10.1073/pnas.022523499; Hu Y, 2002, DEV CELL, V2, P69, DOI 10.1016/S1534-5807(01)00105-8; Li T, 2003, J NEUROSCI, V23, P3272; Lu PL, 2014, NATURE, V512, P166, DOI 10.1038/nature13567; Rand MD, 2000, MOL CELL BIOL, V20, P1825, DOI 10.1128/MCB.20.5.1825-1835.2000; Shah S, 2005, CELL, V122, P435, DOI 10.1016/j.cell.2005.05.022; Takasugi N, 2003, NATURE, V422, P438, DOI 10.1038/nature01506; Xie T, 2014, P NATL ACAD SCI USA, V111, P13349, DOI 10.1073/pnas.1414837111; Zhang XL, 2015, J INVEST DERMATOL, V135, P618, DOI 10.1038/jid.2014.399; Zhang XL, 2014, J BIOL CHEM, V289, P34851, DOI 10.1074/jbc.M114.609636; Zhang XL, 2012, P NATL ACAD SCI USA, V109, P8534, DOI 10.1073/pnas.1202691109	16	5	5	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2016	291	13					6748	6753		10.1074/jbc.C115.701649	http://dx.doi.org/10.1074/jbc.C115.701649			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DI2BC	26887941	Green Published, hybrid			2022-12-26	WOS:000373299700014
J	Prado, CHBD; de Camargo-Bortolin, LHG; Castro, E; Martinez, CA				Britto de Assis Prado, Carlos Henrique; Guedes de Camargo-Bortolin, Livia Haik; Castro, Erique; Martinez, Carlos Alberto			Leaf Dynamics of Panicum maximum under Future Climatic Changes	PLOS ONE			English	Article							ATMOSPHERIC CARBON-DIOXIDE; CO2 ENRICHMENT FACE; TEMPERATURE-ACCLIMATION; C-4 GRASSES; PHOTOSYNTHESIS; RESPONSES; PLANTS; CLASSIFICATION; GROWTH; STATE	Panicum maximum Jacq. 'Mombaca' (C4) was grown in field conditions with sufficient water and nutrients to examine the effects of warming and elevated CO2 concentrations during the winter. Plants were exposed to either the ambient temperature and regular atmospheric CO2 (Control); elevated CO2 (600 ppm, eC); canopy warming (+2 degrees C above regular canopy temperature, eT); or elevated CO2 and canopy warming (eC+eT). The temperatures and CO2 in the field were controlled by temperature free-air controlled enhancement (T-FACE) and mini free-air CO2 enrichment (miniFACE) facilities. The most green, expanding, and expanded leaves and the highest leaf appearance rate (LAR, leaves day(-1)) and leaf elongation rate (LER, cm day(-1)) were observed under eT. Leaf area and leaf biomass were higher in the eT and eC+ eT treatments. The higher LER and LAR without significant differences in the number of senescent leaves could explain why tillers had higher foliage area and leaf biomass in the eT treatment. The eC treatment had the lowest LER and the fewest expanded and green leaves, similar to Control. The inhibitory effect of eC on foliage development in winter was indicated by the fewer green, expanded, and expanding leaves under eC+ eT than eT. The stimulatory and inhibitory effects of the eT and eC treatments, respectively, on foliage raised and lowered, respectively, the foliar nitrogen concentration. The inhibition of foliage by eC was confirmed by the eC treatment having the lowest leaf/stem biomass ratio and by the change in leaf biomass-area relationships from linear or exponential growth to rectangular hyperbolic growth under eC. Besides, eC+ eT had a synergist effect, speeding up leaf maturation. Therefore, with sufficient water and nutrients in winter, the inhibitory effect of elevated CO2 on foliage could be partially offset by elevated temperatures and relatively high P. maximum foliage production could be achieved under future climatic change.	[Britto de Assis Prado, Carlos Henrique; Guedes de Camargo-Bortolin, Livia Haik; Castro, Erique] Univ Fed Sao Paulo, Dept Bot, BR-13565905 Sao Paulo, Brazil; [Martinez, Carlos Alberto] Univ Sao Paulo, FFCLRP, Dept Biol, BR-14040901 Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo	de Camargo-Bortolin, LHG (corresponding author), Univ Fed Sao Paulo, Dept Bot, BR-13565905 Sao Paulo, Brazil.	li.bortolin@gmail.com	Castro, Erique/U-7369-2019; Martinez, Carlos/B-8222-2011; Camargo-Bortolin, Lívia H. G./D-3888-2016; de Assis Prado, Carlos Henrique Britto/ABB-6028-2020	Castro, Erique/0000-0002-0931-2575; Martinez, Carlos/0000-0002-0246-9481; Camargo-Bortolin, Lívia H. G./0000-0002-2764-2009; Prado, Carlos/0000-0002-1652-2642	Sao Paulo Research Foundation, FAPESP [08/58075-8]; LHGCB [2012/20847-5]; CNPq	Sao Paulo Research Foundation, FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); LHGCB; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by the Sao Paulo Research Foundation, FAPESP (http://www.fapesp.br) to CAM (Thematic Project Grant 08/58075-8) and LHGCB (PhD scholarship 2012/20847-5). CAM and CHBAP are fellow researchers from CNPq. CNPq provided a graduate scholarship to EC.	Ainsworth EA, 2005, NEW PHYTOL, V165, P351, DOI 10.1111/j.1469-8137.2004.01224.x; [Anonymous], 1999, SOIL TAX BAS SYST SO; [Anonymous], 2010, GLOBAL CLIMATE CHANG; Barros VR, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT B: REGIONAL ASPECTS, P1133; Batistoti C, 2012, ANIM FEED SCI TECH, V171, P173, DOI 10.1016/j.anifeedsci.2011.11.008; BAZZAZ FA, 1990, ANNU REV ECOL SYST, V21, P167, DOI 10.1146/annurev.es.21.110190.001123; Bhatt RK, 2007, PHOTOSYNTHETICA, V45, P296, DOI 10.1007/s11099-007-0048-7; Dwyer SA, 2007, PLANT CELL ENVIRON, V30, P53, DOI 10.1111/j.1365-3040.2006.01605.x; Geiger R., 1928, KLIMATE DER ERDE; Kim SH, 2007, ENVIRON EXP BOT, V61, P224, DOI 10.1016/j.envexpbot.2007.06.005; Kimball BA, 2008, GLOBAL CHANGE BIOL, V14, P309, DOI 10.1111/j.1365-2486.2007.01486.x; Leakey ADB, 2012, CURR OPIN PLANT BIOL, V15, P228, DOI 10.1016/j.pbi.2012.01.009; Leakey ADB, 2009, P ROY SOC B-BIOL SCI, V276, P2333, DOI 10.1098/rspb.2008.1517; Li PH, 2007, TRENDS PLANT SCI, V12, P87, DOI 10.1016/j.tplants.2007.01.003; Long SP, 2004, ANNU REV PLANT BIOL, V55, P591, DOI 10.1146/annurev.arplant.55.031903.141610; Long SP, 2006, SCIENCE, V312, P1918, DOI 10.1126/science.1114722; MacAdam JW, 2003, AGRON J, V95, P414, DOI 10.2134/agronj2003.0414; Malavolta E., 1989, AVALIACAO ESTADO NUT; Miglietta F, 2001, NEW PHYTOL, V150, P465, DOI 10.1046/j.1469-8137.2001.00115.x; Pinto H, 2014, J EXP BOT, V65, P3669, DOI 10.1093/jxb/eru155; Rolim GD, 2016, INT J CLIMATOL, V36, P636, DOI 10.1002/joc.4372; Rolim Glauco de Souza, 2007, Bragantia, V66, P711, DOI 10.1590/S0006-87052007000400022; Rudmann SG, 2001, ANN BOT-LONDON, V88, P571, DOI 10.1006/anbo.2001.1503; Santos P. M., 2011, REV BRASILEIRA GEOGR, V4, P1176; Santos RM, 2014, REV BRAS ZOOTECN, V43, P404, DOI 10.1590/S1516-35982014000800002; Streck Nereu Augusto, 2005, Cienc. Rural, V35, P730, DOI 10.1590/S0103-84782005000300041; Thornthwaite CW, 1948, GEOGR REV, V38, P55, DOI 10.2307/210739; Wand SJE, 1999, GLOB CHANGE BIOL, V5, P723, DOI 10.1046/j.1365-2486.1999.00265.x; Watling JR, 2000, PLANT PHYSIOL, V123, P1143, DOI 10.1104/pp.123.3.1143; Yamori W, 2014, PHOTOSYNTH RES, V119, P101, DOI 10.1007/s11120-013-9874-6; Yamori W, 2012, PLANT J, V71, P871, DOI 10.1111/j.1365-313X.2012.05041.x	31	21	21	4	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0149620	10.1371/journal.pone.0149620	http://dx.doi.org/10.1371/journal.pone.0149620			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3DG	26894932	Green Published, gold, Green Submitted			2022-12-26	WOS:000371223400069
J	Li, XM; Zhang, SF; Xu, HW; Tang, XF; Zhou, HX; Yuan, JQ; Wang, XH; Qu, ZY; Wang, FG; Zhu, H; Guo, S; Tian, DH; Zhang, WJ				Li, Xuemei; Zhang, Shengfa; Xu, Huiwen; Tang, Xinfeng; Zhou, Huixuan; Yuan, Jiaqi; Wang, Xiaohua; Qu, Zhiyong; Wang, Fugang; Zhu, He; Guo, Shuai; Tian, Donghua; Zhang, Weijun			Type D Personality Predicts Poor Medication Adherence in Chinese Patients with Type 2 Diabetes Mellitus: A Six-Month Follow-Up Study	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; SELF-CARE; DEPRESSIVE SYMPTOMS; HEALTH LITERACY; MORTALITY; FAILURE; NONADHERENCE; OUTCOMES; THERAPY; IMPACT	Background Type D personality and medication nonadherence have been shown to be associated with poor health outcomes. Type D personality is associated with poor medication adherence in patients with coronary artery disease, myocardial infarction, and heart failure. However, the relationship between type D personality and medication adherence in patients with Type 2 Diabetes Mellitus (T2DM) remains unknown. This study aims to examine whether type D personality was associated with medication adherence in patients with T2DM. Design and Settings A follow-up study was conducted in general hospital of the People's Liberation Army in Beijing. Methods 412 T2DM patients (205 females), who were recruited by circular systematic random sampling, provided demographic and baseline data about medical information and completed measures of Type D personality. Then, 330 patients went on to complete a self-report measure of medication adherence at the sixth month after baseline data collection. Chi-square test, t tests, and hierarchical multiple regression analyses were conducted, as needed. Results Patients with type D personality were significantly more likely to have poor medication adherence (p < 0.001). Type D personality predicts poor medication adherence before and after controlling for covariates when it was analyzed as a categorical variable. However, the dimensional construct of type D personality was not associated with medication adherence when analyzed as a continuous variable. Conclusion Although, as a dimensional construct, type D personality may not reflect the components of the personality associated with poor medication adherence in patients with T2DM, screening for type D personality may help to identify those who are at higher risk of poor medication adherence. Interventions, aiming to improve medication adherence, should be launched for these high-risk patients.	[Zhang, Shengfa; Tang, Xinfeng; Zhou, Huixuan; Yuan, Jiaqi; Wang, Xiaohua; Qu, Zhiyong; Wang, Fugang; Guo, Shuai; Tian, Donghua; Zhang, Weijun] Beijing Normal Univ, China Inst Hlth, Sch Social Dev & Publ Policy, Beijing 100875, Peoples R China; [Li, Xuemei] Peoples Liberat Army, Hosp 301, Gen Hosp, Clin Cadre,Dept Outpatient, Beijing, Peoples R China; [Xu, Huiwen] Univ Rochester, Sch Med & Dent, Dept Publ Hlth Sci, Rochester, NY USA; [Zhu, He] Duke Univ, Med Ctr, Sch Med, Dept Psychiat & Behav Sci, Durham, NC 27710 USA	Beijing Normal University; Chinese People's Liberation Army General Hospital; University of Rochester; Duke University	Tian, DH; Zhang, WJ (corresponding author), Beijing Normal Univ, China Inst Hlth, Sch Social Dev & Publ Policy, Beijing 100875, Peoples R China.	tian65216@hotmail.com; zwj@bnu.edu.cn	Zhou, Huixuan/GRY-5023-2022; zhang, weijun/AFU-6997-2022; Xu, Huiwen/HHN-2986-2022; Xu, Huiwen/AAP-8744-2020	zhang, weijun/0000-0003-3436-3371; Xu, Huiwen/0000-0002-4033-0659; Guo, Shuai/0000-0001-7279-2412; Tang, Xinfeng/0000-0001-5017-1295	Fundamental Research Funds for the Central Universities [SKZZX2013053]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This study was supported by the Fundamental Research Funds for the Central Universities (No. SKZZX2013053 in Beijing Normal University).	Al-Qazaz HK, 2010, DIABETES RES CLIN PR, V90, P216, DOI 10.1016/j.diabres.2010.08.012; Aquarius AE, 2009, ARCH SURG-CHICAGO, V144, P728, DOI 10.1001/archsurg.2009.75; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Bauer AM, 2013, J GEN INTERN MED, V28, P1181, DOI 10.1007/s11606-013-2402-8; Bezie Y, 2006, DIABETES METAB, V32, P611, DOI 10.1016/S1262-3636(07)70316-6; Brostrom A, 2007, J SLEEP RES, V16, P439, DOI 10.1111/j.1365-2869.2007.00620.x; Buse J.B., 2011, WILLIAMS TXB ENDOCRI, P1371; Buysman EK, 2015, ADV THER, V32, P341, DOI 10.1007/s12325-015-0199-z; Cani CG, 2015, CLINICS, V70, P102, DOI 10.6061/clinics/2015(02)06; Clifford S, 2014, CURR MED RES OPIN, V30, P1071, DOI 10.1185/03007995.2014.884491; Cohen HW, 2010, DIABETIC MED, V27, P210, DOI 10.1111/j.1464-5491.2009.02898.x; Conden E, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-11; Corsonello Andrea, 2009, Ther Clin Risk Manag, V5, P209; Coyne JC, 2011, PSYCHOSOM MED, V73, P557, DOI 10.1097/PSY.0b013e318227ac75; Curkendall SM, 2013, CURR MED RES OPIN, V29, P1275, DOI 10.1185/03007995.2013.821056; Dailey G, 2001, CLIN THER, V23, P1311, DOI 10.1016/S0149-2918(01)80110-7; de Oliveira AD, 2014, RES SOC ADMIN PHARM, V10, P554, DOI 10.1016/j.sapharm.2013.10.006; de Voogd JN, 2009, ANN BEHAV MED, V38, P86, DOI 10.1007/s12160-009-9105-8; Denollet J, 2000, CIRCULATION, V102, P630, DOI 10.1161/01.CIR.102.6.630; Denollet J, 2006, AM J CARDIOL, V97, P970, DOI 10.1016/j.amjcard.2005.10.035; Denollet J, 2005, PSYCHOSOM MED, V67, P89, DOI 10.1097/01.psy.0000149256.81953.49; Denollet J, 2003, BRAIN BEHAV IMMUN, V17, P304, DOI 10.1016/S0889-1591(03)00060-6; Denollet J, 1996, LANCET, V347, P417, DOI 10.1016/S0140-6736(96)90007-0; Denollet J, 2008, BRAIN BEHAV IMMUN, V22, P736, DOI 10.1016/j.bbi.2007.10.015; Dieltjens M, 2013, SLEEP BREATH, V17, P985, DOI 10.1007/s11325-012-0788-x; Elliott DJ, 2013, POPUL HEALTH MANAG, V16, P99, DOI 10.1089/pop.2012.0031; Ferguson E, 2009, PSYCHOSOM MED, V71, P981, DOI 10.1097/PSY.0b013e3181bd888b; Geisel-Marbaise S, 2010, J PUBLIC HEALTH-HEID, V18, P219, DOI 10.1007/s10389-009-0305-2; Gilmour J, 2012, J HEALTH PSYCHOL, V17, P471, DOI 10.1177/1359105311423117; Grande G, 2011, PSYCHOSOM MED, V73, P548, DOI 10.1097/PSY.0b013e318227a9bc; Grant RW, 2003, DIABETES CARE, V26, P1408, DOI 10.2337/diacare.26.5.1408; Ho PM, 2006, ARCH INTERN MED, V166, P1836, DOI 10.1001/archinte.166.17.1836; International Diabetes Federation, 2015, IDF DIAB ATL, V7; Jackson IL, 2015, DIABETES TECHNOL THE, V17, P398, DOI 10.1089/dia.2014.0279; Kupper N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058370; Kupper N, 2009, PSYCHOSOM MED, V71, P973, DOI 10.1097/PSY.0b013e3181bee6dc; Lane JD, 2000, DIABETES CARE, V23, P1321, DOI 10.2337/diacare.23.9.1321; Lee GKY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062775; Lin EHB, 2004, DIABETES CARE, V27, P2154, DOI 10.2337/diacare.27.9.2154; Mahler C, 2012, J EVAL CLIN PRACT, V18, P409, DOI 10.1111/j.1365-2753.2010.01589.x; Marzec LN, 2013, CURR CARDIOL REP, V15, DOI 10.1007/s11886-013-0418-7; MAXWELL SE, 1993, PSYCHOL BULL, V113, P181, DOI 10.1037/0033-2909.113.1.181; Meece Jerry, 2014, J Pharm Pract, V27, P187, DOI 10.1177/0897190013513803; Molloy GJ, 2008, PSYCHOSOM MED, V70, P863, DOI 10.1097/PSY.0b013e3181842e0c; Molloy GJ, 2012, PSYCHOSOM MED, V74, P100, DOI 10.1097/PSY.0b013e31823a5b2f; Morisky DE, 2008, J CLIN HYPERTENS, V10, P348, DOI 10.1111/j.1751-7176.2008.07572.x; Odegard PS, 2008, DIABETES EDUCATOR, V34, P692, DOI 10.1177/0145721708320558; Odegard PS, 2007, DIABETES EDUCATOR, V33, P1014, DOI 10.1177/0145721707308407; Osborn CY, 2012, GEN HOSP PSYCHIAT, V34, P249, DOI 10.1016/j.genhosppsych.2012.01.015; Osborn CY, 2011, J HEALTH COMMUN, V16, P268, DOI 10.1080/10810730.2011.604388; Paes AHP, 1997, DIABETES CARE, V20, P1512, DOI 10.2337/diacare.20.10.1512; Pedersini R, 2014, VALUE HEALTH, V17, pA183, DOI 10.1016/j.jval.2014.03.1066; Pelle AJ, 2010, INT J CARDIOL, V142, P65, DOI 10.1016/j.ijcard.2008.12.086; Pelle AJ, 2010, CIRC-HEART FAIL, V3, P261, DOI 10.1161/CIRCHEARTFAILURE.109.871483; Rivellese AA, 2010, NUTR METAB CARDIOVAS, V20, P474, DOI 10.1016/j.numecd.2010.01.008; Sakthong P, 2009, ANN PHARMACOTHER, V43, P950, DOI 10.1345/aph.1L453; Saleh F, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-431; Schiffer AA, 2007, HEART, V93, P814, DOI 10.1136/hrt.2006.102822; Schiffer AA, 2010, INT J CARDIOL, V142, P230, DOI 10.1016/j.ijcard.2008.12.090; Shamsi A, 2014, J DIABETES METAB DIS, V13, DOI 10.1186/s40200-014-0096-z; Siyu Z, 2010, CHINESE J ANTITUBERC, V32, P55; Smith TW, 2011, PSYCHOSOM MED, V73, P528, DOI 10.1097/PSY.0b013e31822e095e; Tzeng JI, 2008, J PAIN SYMPTOM MANAG, V36, P157, DOI 10.1016/j.jpainsymman.2007.10.015; Volz A, 2011, J BEHAV MED, V34, P13, DOI 10.1007/s10865-010-9282-8; Voorham J, 2011, CLIN THER, V33, P121, DOI 10.1016/j.clinthera.2011.01.024; Walker RJ, 2012, GEN HOSP PSYCHIAT, V34, P598, DOI 10.1016/j.genhosppsych.2012.07.005; Wallach-Kildemoes H, 2013, EUR J CLIN PHARMACOL, V69, P1553, DOI 10.1007/s00228-013-1488-6; [王洁 Wang Jie], 2013, [中国糖尿病杂志, Chinese Journal of Diabetes], V21, P1101; Williams L, 2008, J PSYCHOSOM RES, V64, P63, DOI 10.1016/j.jpsychores.2007.06.008; Williams L, 2012, J PSYCHOSOM RES, V72, P422, DOI 10.1016/j.jpsychores.2012.02.007; Williams L, 2011, PSYCHOL HEALTH, V26, P703, DOI 10.1080/08870446.2010.488265; Williams L, 2009, PSYCHOL HEALTH, V24, P489, DOI 10.1080/08870440701885616; Wong MCS, 2015, J CLIN PHARMACOL, V55, P279, DOI 10.1002/jcph.408; Wu JR, 2014, INT J BEHAV MED, V21, P833, DOI 10.1007/s12529-013-9366-2; Xu Y, 2013, JAMA-J AM MED ASSOC, V310, P948, DOI 10.1001/jama.2013.168118; Yu XN, 2008, J PSYCHOSOM RES, V65, P595, DOI 10.1016/j.jpsychores.2008.06.009; Zhang WJ, 2015, DIABETOL METAB SYNDR, V7, DOI 10.1186/s13098-015-0053-0; Zhang Yong, 2011, Depress Res Treat, V2011, P143045, DOI 10.1155/2011/143045	78	20	22	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0146892	10.1371/journal.pone.0146892	http://dx.doi.org/10.1371/journal.pone.0146892			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF3DG	26894925	Green Published, gold, Green Submitted			2022-12-26	WOS:000371223400003
J	Braschler, B; Baur, B				Braschler, Brigitte; Baur, Bruno			Diverse Effects of a Seven-Year Experimental Grassland Fragmentation on Major Invertebrate Groups	PLOS ONE			English	Article							EXPERIMENTAL HABITAT FRAGMENTATION; CALCAREOUS GRASSLANDS; SPECIES LOSS; PLANTS; EXTINCTION; DYNAMICS; COLONIZATION; CONSERVATION; LANDSCAPES; MOVEMENT	Habitat fragmentation is a major driver of biodiversity loss, but observed effects vary and may depend on the group examined. Time since fragmentation may explain some differences between taxonomical groups, as some species and thus species composition respond with a delay to changes in their environment. Impacts of drivers of global change may thus be underestimated in short-term studies. In our study we experimentally fragmented nutrient-poor dry calcareous grasslands and studied the response of species richness, individual density and species composition of various groups of invertebrates (gastropods, ants, ground beetles, rove beetles, orthoptera, spiders, woodlice) in 12 small (1.5 m * 1.5 m) and 12 large (4.5 m * 4.5 m) fragments and their corresponding control plots after 7 years. We further examined responses to fragmentation in relation to body size and habitat preferences. Responses to fragmentation varied between taxonomical groups. While spider species richness and individual density were lower in fragments, the opposite was true for an orthopteran species and woodlice. Species composition and beta-diversity differed between fragments and control plots for some groups. However, the interaction treatment*plot size was rarely significant. Species with high occupancy rates in undisturbed control plots responded more negatively to the fragmentation, while species with large body size were relatively more abundant in fragments in some groups. No effect of the fragmentation was found for ants, which may have the longest lag times because of long-lived colonies. However, relationships between abundance and the species' preferences for environmental factors affected by edge effects indicate that ant diversity too may be affected in the longer-term. Our results show the importance of considering different groups in conservation management in times of widespread fragmentation of landscapes. While species richness may respond slowly, changes in abundance related to habitat preferences or morphology may allow insights into likely long-term changes.	[Braschler, Brigitte; Baur, Bruno] Univ Basel, Dept Environm Sci, Sect Conservat Biol, Basel, Switzerland	University of Basel	Braschler, B (corresponding author), Univ Basel, Dept Environm Sci, Sect Conservat Biol, Basel, Switzerland.	brigitte.braschler@unibas.ch	Braschler, Brigitte/N-6953-2017	Braschler, Brigitte/0000-0003-0088-3651	Swiss National Science Foundation [5001-44620]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	The study was funded by the Swiss National Science Foundation (www.snf.ch; grant 5001-44620 to BBaur). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar R, 2006, ECOL LETT, V9, P968, DOI 10.1111/j.1461-0248.2006.00927.x; ANDREN H, 1994, OIKOS, V71, P355, DOI 10.2307/3545823; [Anonymous], 1995, GAIA ECOL PERSP SCI, DOI [10.14512/gaia.4.4.5, DOI 10.14512/GAIA.4.4.5]; BAUR A, 1990, CAN J ZOOL, V68, P613, DOI 10.1139/z90-091; Baur B, 1996, REV SUISSE ZOOL, V103, P801, DOI 10.5962/bhl.part.79977; Bhattacharya M, 2003, BIOL CONSERV, V109, P37, DOI 10.1016/S0006-3207(02)00130-1; Bommarco R, 2014, DIVERS DISTRIB, V20, P591, DOI 10.1111/ddi.12187; Braschler B, 2003, ECOL ENTOMOL, V28, P651, DOI 10.1111/j.1365-2311.2003.00549.x; Braschler B, 2005, OECOLOGIA, V143, P291, DOI 10.1007/s00442-004-1778-x; Braschler B, 2003, OIKOS, V100, P581, DOI 10.1034/j.1600-0706.2003.12220.x; Braschler B, 2009, ECOL ENTOMOL, V34, P321, DOI 10.1111/j.1365-2311.2008.01080.x; Braschler Brigitte, 2002, Mitteilungen der Entomologischen Gesellschaft Basel, V52, P139; Collinge SK, 2000, ECOLOGY, V81, P2211, DOI 10.1890/0012-9658(2000)081[2211:EOGFOI]2.0.CO;2; Debinski DM, 2000, CONSERV BIOL, V14, P342, DOI 10.1046/j.1523-1739.2000.98081.x; Dolt C, 2005, ACTA OECOL, V27, P49, DOI 10.1016/j.actao.2004.09.002; Ellenberg H., 1996, VEGETATION MITTELEUR, V5th ed; Essl F, 2015, TRENDS ECOL EVOL, V30, P375, DOI 10.1016/j.tree.2015.05.002; Falkner G., 2001, SHELLED GASTROPODA W; Gonzalez A, 2002, J ANIM ECOL, V71, P594, DOI 10.1046/j.1365-2656.2002.00625.x; Goverde M, 2002, BIOL CONSERV, V104, P293, DOI 10.1016/S0006-3207(01)00194-X; Groppe K, 2001, J ECOL, V89, P247, DOI 10.1046/j.1365-2745.2001.00538.x; HANSKI I, 1994, TRENDS ECOL EVOL, V9, P131, DOI 10.1016/0169-5347(94)90177-5; HARRISON S, 1991, BIOL J LINN SOC, V42, P73, DOI 10.1111/j.1095-8312.1991.tb00552.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Holsinger KE, 2000, CONSERV BIOL SER, V4, P55; Joshi J, 2006, OECOLOGIA, V148, P144, DOI 10.1007/s00442-005-0341-8; KAREIVA P, 1987, NATURE, V326, P388, DOI 10.1038/326388a0; Koleff P, 2003, J ANIM ECOL, V72, P367, DOI 10.1046/j.1365-2656.2003.00710.x; Krauss J, 2004, MOL ECOL, V13, P311, DOI 10.1046/j.1365-294X.2003.02072.x; KRUESS A, 1994, SCIENCE, V264, P1581, DOI 10.1126/science.264.5165.1581; Kuussaari M, 2009, TRENDS ECOL EVOL, V24, P564, DOI 10.1016/j.tree.2009.04.011; Niemela J, 1998, BIODIVERS CONSERV, V7, P1407, DOI 10.1023/A:1008835529764; Oggier Peter, 1998, Malakologische Abhandlungen (Dresden), V19, P89; Oksanen J., 2020, VEGAN COMMUNITY ECOL; PICKETT S T A, 1989, P110; Pinheiro J, 2020, R PACKAGE VERSION 31; R Core Team, 2012, LANG ENV STAT COMP; Radford JQ, 2005, BIOL CONSERV, V124, P317, DOI 10.1016/j.biocon.2005.01.039; Rossetti MR, 2014, ARTHROPOD-PLANT INTE, V8, P593, DOI 10.1007/s11829-014-9342-z; Rusterholz HP, 2010, OECOLOGIA, V163, P141, DOI 10.1007/s00442-010-1567-7; SAUNDERS DA, 1991, CONSERV BIOL, V5, P18, DOI 10.1111/j.1523-1739.1991.tb00384.x; Schlapfer M, 1998, BOT HELV, V108, P57; SEIFERT B, 2007, AMEISEN MITTEL NORDE; STAMPS JA, 1987, AM NAT, V129, P533, DOI 10.1086/284656; Stangler ES, 2015, BIODIVERS CONSERV, V24, P563, DOI 10.1007/s10531-014-0836-x; Stoll P, 2009, J ANIM ECOL, V78, P236, DOI 10.1111/j.1365-2656.2008.01478.x; Stoll P, 2006, BASIC APPL ECOL, V7, P307, DOI 10.1016/j.baae.2005.09.001; WallisDeVries MF, 2002, BIOL CONSERV, V104, P265, DOI 10.1016/S0006-3207(01)00191-4; Wiens JA, 1994, IBIS, V137, P97, DOI DOI 10.1111/J.1474-919X.1995.TB08464.X; Wirth Thierry, 1999, Zeitschrift fuer Oekologie und Naturschutz, V8, P23; Zoller H., 1947, BER GEOBOT INST RUBEL ZURICH, V1946, P51; Zschokke S, 2000, OECOLOGIA, V125, P559, DOI 10.1007/s004420000483	52	10	12	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2016	11	2							e0149567	10.1371/journal.pone.0149567	http://dx.doi.org/10.1371/journal.pone.0149567			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3CO	26891049	gold, Green Published, Green Submitted			2022-12-26	WOS:000371221500060
J	Castano, J; Morera, C; Sese, B; Boue, S; Bonet-Costa, C; Marti, M; Roque, A; Jordan, A; Barrero, MJ				Castano, Julio; Morera, Cristina; Sese, Borja; Boue, Stephanie; Bonet-Costa, Carles; Marti, Merce; Roque, Alicia; Jordan, Albert; Barrero, Maria J.			SETD7 Regulates the Differentiation of Human Embryonic Stem Cells	PLOS ONE			English	Article							LYSINE METHYLATION; SECONDARY STRUCTURE; HISTONE H1; TRANSCRIPTIONAL ACTIVATION; SET9-MEDIATED METHYLATION; INFRARED-SPECTROSCOPY; SELF-RENEWAL; P53 ACTIVITY; HUMAN ESCS; METHYLTRANSFERASE	The successful use of specialized cells in regenerative medicine requires an optimization in the differentiation protocols that are currently used. Understanding the molecular events that take place during the differentiation of human pluripotent cells is essential for the improvement of these protocols and the generation of high quality differentiated cells. In an effort to understand the molecular mechanisms that govern differentiation we identify the methyltransferase SETD7 as highly induced during the differentiation of human embryonic stem cells and differentially expressed between induced pluripotent cells and somatic cells. Knock-down of SETD7 causes differentiation defects in human embryonic stem cell including delay in both the silencing of pluripotency-related genes and the induction of differentiation genes. We show that SETD7 methylates linker histone H1 in vitro causing conformational changes in H1. These effects correlate with a decrease in the recruitment of H1 to the pluripotency genes OCT4 and NANOG during differentiation in the SETD7 knock down that might affect the proper silencing of these genes during differentiation.	[Castano, Julio; Morera, Cristina; Sese, Borja; Boue, Stephanie; Marti, Merce; Barrero, Maria J.] Ctr Regenerat Med Barcelona CMRB, Barcelona 08003, Spain; [Boue, Stephanie] Biomed Res Networking Ctr Bioengn, Biomat & Nanomed CIBER BBN, Madrid 28029, Spain; [Bonet-Costa, Carles; Roque, Alicia; Jordan, Albert] Inst Biol Mol Barcelona IBMB CSIC, Barcelona 08028, Spain; [Roque, Alicia] Univ Autonoma Barcelona, Dept Bioquim & Biol Mol, Fac Biociencias, Barcelona 08193, Spain; [Barrero, Maria J.] Spanish Natl Canc Res Ctr CNIO, Madrid 28029, Spain; [Castano, Julio] Univ Barcelona, Fac Med, Josep Carreras Leukaemia Res Inst, Barcelona 08036, Spain; [Sese, Borja] BWH Regenerat Med Ctr, Boston, MA 02139 USA	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Centro de Medicina Regenerativa de Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB); Autonomous University of Barcelona; Centro Nacional de Investigaciones Oncologicas (CNIO); Institut de Recerca Contra la Leucemia Josep Carreras (IJC); University of Barcelona	Barrero, MJ (corresponding author), Ctr Regenerat Med Barcelona CMRB, Barcelona 08003, Spain.; Barrero, MJ (corresponding author), Spanish Natl Canc Res Ctr CNIO, Madrid 28029, Spain.	mjbarrero@cnio.es	Córdova, Alicia Roque/W-5229-2019; Barrero, Maria J./Q-1785-2017; jordan, albert/K-4678-2014; jordan, albert/ABC-8229-2020; Roque, Alicia/H-7756-2015; Cardoso, Julio Castaño/AAB-5820-2019	Córdova, Alicia Roque/0000-0002-6206-6481; Barrero, Maria J./0000-0002-5990-7040; jordan, albert/0000-0002-3970-8693; jordan, albert/0000-0002-3970-8693; Roque, Alicia/0000-0002-6206-6481; Sese, Borja/0000-0001-8554-897X; Castano Cardoso, Julio/0000-0002-0712-5856; Bonet-Costa, Carles/0000-0003-4720-8928; Boue, Stephanie/0000-0003-0680-4168	Ramon y Cajal program of MEC [RYC-2007-01510]; MEC [BES-2008-009567]; PRB2-ISCIII-SGEFI-FEDER-PE I+D+i [PT13/0001/0041]; Fundacion CELLEX; TERCEL-RETICS-ISCIII-MINECO-FEDER [RD12/0019/0034]; MICINN [SAF2009-08588];  [BFU2014-52237]	Ramon y Cajal program of MEC(German Research Foundation (DFG)); MEC(European Commission); PRB2-ISCIII-SGEFI-FEDER-PE I+D+i; Fundacion CELLEX(Foundation CELLEX); TERCEL-RETICS-ISCIII-MINECO-FEDER; MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); 	M.J.B. was partially supported by the Ramon y Cajal program of MEC (RYC-2007-01510). B.S. was a recipient of a predoctoral fellowship from MEC (BES-2008-009567). C.M. was supported by PT13/0001/0041 PRB2-ISCIII-SGEFI-FEDER-PE I+D+i 2013-2016. J.C. was partially supported by Fundacion CELLEX. This work was partially supported by grant RD12/0019/0034 TERCEL-RETICS-ISCIII-MINECO-FEDER, grant SAF2009-08588 from MICINN to M.J.B and grant BFU2014-52237 to A.J. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aasen T, 2008, NAT BIOTECHNOL, V26, P1276, DOI 10.1038/nbt.1503; Arrondo JLR, 1999, PROG BIOPHYS MOL BIO, V72, P367, DOI 10.1016/S0079-6107(99)00007-3; Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Balasubramaniyan N, 2012, AM J PHYSIOL-GASTR L, V302, pG937, DOI 10.1152/ajpgi.00441.2011; Barrero MJ, 2006, MOL CELL, V24, P233, DOI 10.1016/j.molcel.2006.09.020; Barrero MJ, 2013, J BIOL CHEM, V288, P16110, DOI 10.1074/jbc.M113.466144; Barrero MJ, 2013, CELL REP, V3, P1005, DOI 10.1016/j.celrep.2013.02.029; Barrero MJ, 2013, CELL REP; Barsyte-Lovejoy D, 2014, P NATL ACAD SCI USA, V111, P12853, DOI 10.1073/pnas.1407358111; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Boue S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012664; Boulard M, 2015, NAT GENET, V47, P479, DOI 10.1038/ng.3272; Chuikov S, 2004, NATURE, V432, P353, DOI 10.1038/nature03117; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Eisert RJ, 2015, BIOCHEMISTRY-US, V54, P2314, DOI 10.1021/acs.biochem.5b00024; Esteve PO, 2009, P NATL ACAD SCI USA, V106, P5076, DOI 10.1073/pnas.0810362106; Fang L, 2014, MOL CELL, V55, P537, DOI 10.1016/j.molcel.2014.06.018; Gaughan L, 2011, NUCLEIC ACIDS RES, V39, P1266, DOI 10.1093/nar/gkq861; Herberts CA, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-29; Hughes RM, 2007, P NATL ACAD SCI USA, V104, P11184, DOI 10.1073/pnas.0610850104; Kamieniarz K, 2012, GENE DEV, V26, P797, DOI 10.1101/gad.182014.111; Kassner I, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.120173; Kassner I, 2013, EPIGENET CHROMATIN, V6, DOI 10.1186/1756-8935-6-1; Kim SK, 2014, CELL STEM CELL, V15, P735, DOI 10.1016/j.stem.2014.10.016; Kontaki H, 2010, MOL CELL, V39, P152, DOI 10.1016/j.molcel.2010.06.006; Kouskouti A, 2004, MOL CELL, V14, P175, DOI 10.1016/S1097-2765(04)00182-0; Laurent LC, 2011, CELL STEM CELL, V8, P106, DOI 10.1016/j.stem.2010.12.003; Lee MR, 2013, STEM CELLS, V31, P666, DOI 10.1002/stem.1302; Lehnertz B, 2011, MOL CELL, V43, P673, DOI 10.1016/j.molcel.2011.08.006; Lian I, 2010, GENE DEV, V24, P1106, DOI 10.1101/gad.1903310; Liu XY, 2011, P NATL ACAD SCI USA, V108, P1925, DOI 10.1073/pnas.1019619108; Lopez R, 2015, NUCLEIC ACIDS RES, V43, P4463, DOI 10.1093/nar/gkv304; Loyola A, 2004, METHOD ENZYMOL, V377, P474; Masatsugu T, 2009, BIOCHEM BIOPH RES CO, V381, P22, DOI 10.1016/j.bbrc.2009.01.185; Meshorer E, 2006, DEV CELL, V10, P105, DOI 10.1016/j.devcel.2005.10.017; Millan-Arino L, 2014, NUCLEIC ACIDS RES, V42, P4474, DOI 10.1093/nar/gku079; Munro S, 2010, ONCOGENE, V29, P2357, DOI 10.1038/onc.2009.511; Nishioka K, 2002, GENE DEV, V16, P479, DOI 10.1101/gad.967202; Oudhoff MJ, 2013, DEV CELL, V26, P188, DOI 10.1016/j.devcel.2013.05.025; Raya A, 2008, COLD SH Q B, V73, P127, DOI 10.1101/sqb.2008.73.038; Roque A, 2008, NUCLEIC ACIDS RES, V36, P4719, DOI 10.1093/nar/gkn440; Sampath P, 2008, CELL STEM CELL, V2, P448, DOI 10.1016/j.stem.2008.03.013; STEWART C, 1987, CELL, V51, P383, DOI 10.1016/0092-8674(87)90634-9; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Subramanian K, 2008, MOL CELL, V30, P336, DOI 10.1016/j.molcel.2008.03.022; Tabar V, 2014, NAT REV GENET, V15, P82, DOI 10.1038/nrg3563; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Terme JM, 2011, J BIOL CHEM; Trievel RC, 2002, CELL, V111, P91, DOI 10.1016/S0092-8674(02)01000-0; Vila R, 2001, J BIOL CHEM, V276, P30898, DOI 10.1074/jbc.M104189200; Virtaneva K, 2001, P NATL ACAD SCI USA, V98, P1124, DOI 10.1073/pnas.98.3.1124; Voigt P, 2013, GENE DEV, V27, P1318, DOI 10.1101/gad.219626.113; Wang DL, 2013, P NATL ACAD SCI USA, V110, P5516, DOI 10.1073/pnas.1216596110; Wang HB, 2001, MOL CELL, V8, P1207, DOI 10.1016/S1097-2765(01)00405-1; Wisniewski JR, 2007, MOL CELL PROTEOMICS, V6, P72, DOI 10.1074/mcp.M600255-MCP200; Wiznerowicz M, 2003, J VIROL, V77, P8957, DOI 10.1128/JVI.77.16.8957-8951.2003; Wu XD, 2013, MOL CELL, V49, P1134, DOI 10.1016/j.molcel.2013.01.016; Xie Q, 2012, EMBO REP, V13, P371, DOI 10.1038/embor.2012.25; Xie RY, 2013, CELL STEM CELL, V12, P224, DOI 10.1016/j.stem.2012.11.023; Yang JB, 2010, P NATL ACAD SCI USA, V107, P21499, DOI 10.1073/pnas.1016147107	61	12	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2016	11	2							e0149502	10.1371/journal.pone.0149502	http://dx.doi.org/10.1371/journal.pone.0149502			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3CO	26890252	Green Submitted, Green Published, gold			2022-12-26	WOS:000371221500053
J	Shaik, SS; Obata, T; Hebelstrup, KH; Schwahn, K; Fernie, AR; Mateiu, RV; Blennow, A				Shaik, Shahnoor S.; Obata, Toshihiro; Hebelstrup, Kim H.; Schwahn, Kevin; Fernie, Alisdair R.; Mateiu, Ramona V.; Blennow, Andreas			Starch Granule Re-Structuring by Starch Branching Enzyme and Glucan Water Dikinase Modulation Affects Caryopsis Physiology and Metabolism	PLOS ONE			English	Article							ADP-GLUCOSE PYROPHOSPHORYLASE; MUTATOR INSERTIONAL MUTANTS; ARABIDOPSIS LEAVES; SEED DEVELOPMENT; GENE-EXPRESSION; SOLUBLE SUGARS; SPRING WHEAT; BARLEY; PROTEIN; REVEAL	Starch is of fundamental importance for plant development and reproduction and its optimized molecular assembly is potentially necessary for correct starch metabolism. Re-structuring of starch granules in-planta can therefore potentially affect plant metabolism. Modulation of granule micro-structure was achieved by decreasing starch branching and increasing starch-bound phosphate content in the barley caryopsis starch by RNAi suppression of all three Starch Branching Enzyme (SBE) isoforms or overexpression of potato Glucan Water Dikinase (GWD). The resulting lines displayed Amylose-Only (AO) and Hyper-Phosphorylated (HP) starch chemotypes, respectively. We studied the influence of these alterations on primary metabolism, grain composition, starch structural features and starch granule morphology over caryopsis development at 10, 20 and 30 days after pollination (DAP) and at grain maturity. While HP showed relatively little effect, AO showed significant reduction in starch accumulation with re-direction to protein and beta-glucan (BG) accumulation. Metabolite profiling indicated significantly higher sugar accumulation in AO, with re-partitioning of carbon to accumulate amino acids, and interestingly it also had high levels of some important stress-related metabolites and potentially protective metabolites, possibly to elude deleterious effects. Investigations on starch molecular structure revealed significant increase in starch phosphate and amylose content in HP and AO respectively with obvious differences in starch granule morphology at maturity. The results demonstrate that decreasing the storage starch branching resulted in metabolic adjustments and re-directions, tuning to evade deleterious effects on caryopsis physiology and plant performance while only little effect was evident by increasing starch-bound phosphate as a result of over-expressing GWD.	[Shaik, Shahnoor S.; Blennow, Andreas] Univ Copenhagen, Dept Plant & Environm Sci, Thorvaldsensvej 40, DK-1871 Frederiksberg C, Denmark; [Obata, Toshihiro; Schwahn, Kevin; Fernie, Alisdair R.] Max Planck Inst Mol Pflanzenphysiol, Muhlenberg 1, D-14476 Potsdam, Germany; [Hebelstrup, Kim H.] Aarhus Univ, Dept Mol Biol & Genet, Forsogsvej 1, DK-4200 Slagelse, Denmark; [Mateiu, Ramona V.] Tech Univ Denmark, Dept Micro & Nanotechnol, DK-2800 Lyngby, Denmark	University of Copenhagen; Max Planck Society; Aarhus University; Technical University of Denmark	Blennow, A (corresponding author), Univ Copenhagen, Dept Plant & Environm Sci, Thorvaldsensvej 40, DK-1871 Frederiksberg C, Denmark.	abl@plen.ku.dk	Mateiu, Ramona/K-9106-2015; Obata, Toshihiro/AAX-4353-2020	Mateiu, Ramona/0000-0003-2968-5704; Obata, Toshihiro/0000-0001-8931-7722	Danish Council for Independent Research Technology and Production Sciences [274-08-0220]; Graduate School of Agriculture, Food and Environment (SAFE), Aarhus University	Danish Council for Independent Research Technology and Production Sciences(Det Frie Forskningsrad (DFF)); Graduate School of Agriculture, Food and Environment (SAFE), Aarhus University	This work was supported by The Danish Council for Independent Research Technology and Production Sciences (Andreas Blennow) 274-08-0220, and Graduate School of Agriculture, Food and Environment (SAFE), Aarhus University (Kim Hebelstrup).; We thank Massimiliano Carciofi for his help with plant growth and Lene Hornum Rasmussen, KMC, Denmark, for her technical assistance with starch granule distribution analysis. This work was funded by The Danish Council for Independent Research Technology and Production Sciences and by Graduate School of Agriculture, Food and Environment (SAFE), Aarhus University. We acknowledge Center for Advanced Bioimaging (CAB), Faculty of Science, University of Copenhagen for microscopy facilities.	Alexander RD, 2006, PROTEOMICS, V6, P1886, DOI 10.1002/pmic.200500548; Baud S, 2002, PLANT PHYSIOL BIOCH, V40, P151, DOI 10.1016/S0981-9428(01)01350-X; Baunsgaard L, 2005, PLANT J, V41, P595, DOI 10.1111/j.1365-313X.2004.02322.x; Blauth SL, 2002, PLANT MOL BIOL, V48, P287, DOI 10.1023/A:1013335217744; Blauth SL, 2001, PLANT PHYSIOL, V125, P1396, DOI 10.1104/pp.125.3.1396; Blennow A, 1998, J CHROMATOGR A, V829, P385, DOI 10.1016/S0021-9673(98)00855-3; Blennow A, 1998, CARBOHYD RES, V307, P45, DOI 10.1016/S0008-6215(98)00015-9; Blennow A, 2003, J STRUCT BIOL, V143, P229, DOI 10.1016/j.jsb.2003.08.009; Blennow A, 2000, CARBOHYD POLYM, V41, P163, DOI 10.1016/S0144-8617(99)00082-X; Blennow A, 2013, CEREAL CHEM, V90, P274, DOI 10.1094/CCHEM-01-13-0010-FI; Blennow A, 2010, TRENDS PLANT SCI, V15, P236, DOI 10.1016/j.tplants.2010.01.009; BOYER CD, 1981, PLANT PHYSIOL, V67, P1141, DOI 10.1104/pp.67.6.1141; Brancourt-Hulmel M, 2003, CROP SCI, V43, P37, DOI 10.2135/cropsci2003.0037; Carciofi M, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-223; Carciofi M, 2011, J CEREAL SCI, V54, P339, DOI 10.1016/j.jcs.2011.06.013; Casey R, 1998, J PLANT PHYSIOL, V152, P636, DOI 10.1016/S0176-1617(98)80023-0; DELZER BW, 1995, CROP SCI, V35, P730, DOI 10.2135/cropsci1995.0011183X003500030014x; Edner C, 2007, PLANT PHYSIOL, V145, P17, DOI 10.1104/pp.107.104224; ElSayed AI, 2014, PLANT BIOLOGY, V16, P1, DOI 10.1111/plb.12053; ENGLYST H, 1982, ANALYST, V107, P307, DOI 10.1039/an9820700307; Faix B, 2012, PLANT J, V69, P1077, DOI 10.1111/j.1365-313X.2011.04857.x; FANNON JE, 1993, CEREAL CHEM, V70, P611; FANNON JE, 1992, CEREAL CHEM, V69, P284; Fernie AR, 2011, PLANT CELL, V23, P2477, DOI 10.1105/tpc.111.086272; Fincher G., 2011, BARLEY PRODUCTION IM, P449; Furtado A, 2009, PLANT BIOTECHNOL J, V7, P240, DOI 10.1111/j.1467-7652.2008.00394.x; GARWOOD DL, 1976, CEREAL CHEM, V53, P355; Geigenberger P, 2011, PLANT PHYSIOL, V155, P1566, DOI 10.1104/pp.110.170399; Gibon Y, 2002, PLANT J, V30, P221, DOI 10.1046/j.1365-313X.2001.01278.x; Gubatz S., 2011, BARLEY PRODUCTION IM, P391; Han XZ, 2005, CEREAL CHEM, V82, P351, DOI 10.1094/CC-82-0351; Hejazi M, 2009, PLANT PHYSIOL, V150, P962, DOI 10.1104/pp.109.138750; Heyer AG, 1999, CURR OPIN BIOTECH, V10, P169, DOI 10.1016/S0958-1669(99)80030-5; Hofvander P, 2004, PLANT BIOTECHNOL J, V2, P311, DOI 10.1111/j.1467-7652.2004.00073.x; Izumo A, 2011, PLANT SCI, V180, P238, DOI 10.1016/j.plantsci.2010.08.014; Jobling S, 2004, CURR OPIN PLANT BIOL, V7, P210, DOI 10.1016/j.pbi.2003.12.001; Kopka J, 2005, BIOINFORMATICS, V21, P1635, DOI 10.1093/bioinformatics/bti236; Kotting O, 2005, PLANT PHYSIOL, V137, P242, DOI 10.1104/pp.104.055954; LI XM, 1993, ANN BOT-LONDON, V71, P303, DOI 10.1006/anbo.1993.1039; Lisec J, 2006, NAT PROTOC, V1, P387, DOI 10.1038/nprot.2006.59; Liu FS, 2009, J EXP BOT, V60, P4423, DOI 10.1093/jxb/erp297; Luedemann Alexander, 2012, Methods Mol Biol, V860, P255, DOI 10.1007/978-1-61779-594-7_16; Mangelsen E, 2010, PLANT PHYSIOL, V153, P14, DOI 10.1104/pp.110.154856; Munck L, 2004, J CEREAL SCI, V40, P213, DOI 10.1016/j.jcs.2004.07.006; Obata T, 2012, CELL MOL LIFE SCI, V69, P3225, DOI 10.1007/s00018-012-1091-5; Patrick JW, 2001, J EXP BOT, V52, P551, DOI 10.1093/jexbot/52.356.551; Patron NJ, 2004, PLANT PHYSIOL, V135, P2088, DOI 10.1104/pp.104.045203; Perez M. D., 1993, Seed Science Research, V3, P187, DOI 10.1017/S096025850000177X; Radchuk VV, 2009, PLANT PHYSIOL, V150, P190, DOI 10.1104/pp.108.133520; Ral JP, 2012, PLANT BIOTECHNOL J, V10, P871, DOI 10.1111/j.1467-7652.2012.00711.x; Regina A, 2006, P NATL ACAD SCI USA, V103, P3546, DOI 10.1073/pnas.0510737103; Ritte G, 2006, FEBS LETT, V580, P4872, DOI 10.1016/j.febslet.2006.07.085; Rolletschek H, 2002, PLANTA, V214, P954, DOI 10.1007/s00425-001-0710-4; SARAVITZ DM, 1987, PLANT PHYSIOL, V83, P185, DOI 10.1104/pp.83.1.185; Schwall GP, 2000, NAT BIOTECHNOL, V18, P551, DOI 10.1038/75427; Schwender J, 2008, CURR OPIN BIOTECH, V19, P131, DOI 10.1016/j.copbio.2008.02.006; Shaik SS, 2014, J EXP BOT, V65, P2257, DOI 10.1093/jxb/eru107; Skeffington AW, 2014, PLANT PHYSIOL, V165, P866, DOI 10.1104/pp.114.237016; SMITH AM, 1988, PLANTA, V175, P270, DOI 10.1007/BF00392437; Sreenivasulu N, 2004, PLANT J, V37, P539, DOI 10.1046/j.1365-313X.2003.01981.x; Sreenivasulu N, 2008, PLANT PHYSIOL, V146, P1738, DOI 10.1104/pp.107.111781; Sreenivasulu N, 2006, PLANT J, V47, P310, DOI 10.1111/j.1365-313X.2006.02789.x; STEWART DW, 1990, CAN J PLANT SCI, V70, P33, DOI 10.4141/cjps90-004; TAKEDA Y, 1987, CARBOHYD RES, V165, P139, DOI 10.1016/0008-6215(87)80089-7; Tetlow IJ, 2011, SEED SCI RES, V21, P5, DOI 10.1017/S0960258510000292; Tetlow IJ, 2004, J EXP BOT, V55, P2131, DOI 10.1093/jxb/erh248; Topping DL, 2001, PHYSIOL REV, V81, P1031, DOI 10.1152/physrev.2001.81.3.1031; Wang T. L., 1991, Seed Science Research, V1, P3, DOI 10.1017/S096025850000057X; Weigelt K, 2009, PLANT PHYSIOL, V149, P395, DOI 10.1104/pp.108.129940; Weschke W, 2000, PLANT J, V21, P455, DOI 10.1046/j.1365-313x.2000.00695.x; Wickramasinghe HAM, 2009, CARBOHYD POLYM, V77, P118, DOI 10.1016/j.carbpol.2008.12.013; WISE RR, 1995, PHOTOSYNTH RES, V45, P79, DOI 10.1007/BF00032579; Yu TS, 2001, PLANT CELL, V13, P1907, DOI 10.1105/tpc.13.8.1907; Zeeman SC, 2010, ANNU REV PLANT BIOL, V61, P209, DOI 10.1146/annurev-arplant-042809-112301	74	22	24	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2016	11	2							e0149613	10.1371/journal.pone.0149613	http://dx.doi.org/10.1371/journal.pone.0149613			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3CO	26891365	Green Published, gold, Green Submitted			2022-12-26	WOS:000371221500063
J	Wang, T; Chen, XY; Long, XH; Liu, ZP; Yan, SH				Wang, Tao; Chen, Xiaoyan; Long, Xiaohua; Liu, Zhaopu; Yan, Shaohua			Copper Nanoparticles and Copper Sulphate Induced Cytotoxicity in Hepatocyte Primary Cultures of Epinephelus coioides	PLOS ONE			English	Article							ORANGE-SPOTTED GROUPER; OXIDATIVE STRESS; INDUCED APOPTOSIS; IMMUNE-RESPONSES; RAINBOW-TROUT; ANTIOXIDANT DEFENSE; CUO NANOPARTICLES; DOWN-REGULATION; DNA-DAMAGE; IN-VITRO	Copper nanoparticles (Cu-NPs) were widely used in various industrial and commercial applications. The aim of this study was to analyze the cytotoxicity of Cu-NPs on primary hepatocytes of E. coioides compared with copper sulphate (CuSO4). Cultured cells were exposed to 0 or 2.4 mg Cu L-1 as CuSO4 or Cu-NPs for 24-h. Results showed either form of Cu caused a dramatic loss in cell viability, more so in the CuSO4 than Cu-NPs treatment. Compared to control, either CuSO4 or Cu-NPs significantly increased reactive oxygen species (ROS) and malondialdehyde(MDA) concentration in hepatocytes by overwhelming total superoxide dismutase (T-SOD) activity, catalase(CAT) activity and glutathione(GSH) concentration. In addition, the antioxidative-related genes [SOD (Cu/Zn), SOD (Mn), CAT, GPx(4)] were also down-regulated. The apoptosis and necrosis percentage was significantly higher after the CuSO4 or Cu-NPs treatment than the control. The apoptosis was induced by the increased cytochrome c concentration in the cytosol and elevated caspase-3, caspase-8 and caspase-9 activities. Additionally, the apoptosis-related genes (p53, p38 beta and TNF-alpha) and protein (p53 protein) were up-regulated after the CuSO4 or Cu-NPs treatment, with CuSO4 exposure having a greater effect than Cu-NPs. In conclusion, Cu-NPs had similar types of toxic effects as CuSO4 on primary hepatocytes of E. coioides, but toxicity of CuSO4 was more severe than that of Cu-NPs.	[Wang, Tao; Chen, Xiaoyan; Long, Xiaohua; Liu, Zhaopu; Yan, Shaohua] Nanjing Agr Univ, Jiangsu Prov Key Lab Marine Biol, Coll Resources & Environm Sci, Nanjing 210095, Jiangsu, Peoples R China	Nanjing Agricultural University	Long, XH (corresponding author), Nanjing Agr Univ, Jiangsu Prov Key Lab Marine Biol, Coll Resources & Environm Sci, Nanjing 210095, Jiangsu, Peoples R China.	longxiaohua@njau.edu.cn	chen, xi/GXH-3653-2022; chen, xia/GYR-3948-2022; chen, xia/GXM-5435-2022		National Key Projects of Scientific and Technical Support Programs - Ministry of Science and Technology of China [2011BAD13B09]	National Key Projects of Scientific and Technical Support Programs - Ministry of Science and Technology of China	The authors are grateful for the financial support of the National Key Projects of Scientific and Technical Support Programs funded by the Ministry of Science and Technology of China (No. 2011BAD13B09).	Ahamed M, 2010, BIOCHEM BIOPH RES CO, V396, P578, DOI 10.1016/j.bbrc.2010.04.156; Al-Bairuty GA, 2013, AQUAT TOXICOL, V126, P104, DOI 10.1016/j.aquatox.2012.10.005; Aruoja V, 2009, SCI TOTAL ENVIRON, V407, P1461, DOI 10.1016/j.scitotenv.2008.10.053; Barillet S, 2010, TOXICOL LETT, V198, P324, DOI 10.1016/j.toxlet.2010.07.009; Bondarenko O, 2013, ARCH TOXICOL, V87, P1181, DOI 10.1007/s00204-013-1079-4; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cai J, 2011, FISH SHELLFISH IMMUN, V31, P1129, DOI 10.1016/j.fsi.2011.10.004; Chang CC, 2006, FISH SHELLFISH IMMUN, V20, P574, DOI 10.1016/j.fsi.2005.06.012; Choi YJ, 2004, FASEB J, V18, pA906; Cruz-Lacierda ER, 2001, AQUACULTURE, V201, P211, DOI 10.1016/S0044-8486(01)00668-8; Cui YT, 2014, FISH SHELLFISH IMMUN, V38, P74, DOI 10.1016/j.fsi.2014.02.018; DaMata JP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141196; Dan XM, 2013, FISH SHELLFISH IMMUN, V34, P885, DOI 10.1016/j.fsi.2012.12.011; Gomes T, 2011, ENVIRON SCI TECHNOL, V45, P9356, DOI 10.1021/es200955s; Guicciardi ME, 2005, GUT, V54, P1024, DOI 10.1136/gut.2004.053850; Handy RD, 2011, J FISH BIOL, V79, P821, DOI 10.1111/j.1095-8649.2011.03080.x; Ivanov VN, 2000, ONCOGENE, V19, P3003, DOI 10.1038/sj.onc.1203602; Jia R, 2014, AQUAT TOXICOL, V152, P11, DOI 10.1016/j.aquatox.2014.02.014; Ju-Nam Y, 2008, SCI TOTAL ENVIRON, V400, P396, DOI 10.1016/j.scitotenv.2008.06.042; Kong XH, 2013, CHEMOSPHERE, V92, P1458, DOI 10.1016/j.chemosphere.2013.04.004; Kumar S, 2007, CELL DEATH DIFFER, V14, P32, DOI 10.1038/sj.cdd.4402060; Larsen BD, 2010, P NATL ACAD SCI USA, V107, P4230, DOI 10.1073/pnas.0913089107; Li J, 1998, AQUAT TOXICOL, V43, P1, DOI 10.1016/S0166-445X(98)00047-2; Lin YH, 2008, AQUACULTURE, V274, P161, DOI 10.1016/j.aquaculture.2007.11.006; Liu XJ, 2010, ECOTOX ENVIRON SAFE, V73, P1286, DOI 10.1016/j.ecoenv.2010.06.019; McConkey DJ, 1998, TOXICOL LETT, V99, P157, DOI 10.1016/S0378-4274(98)00155-6; Niska K, 2015, TOXICOL IN VITRO, V29, P663, DOI 10.1016/j.tiv.2015.02.004; Nowack B, 2012, ENVIRON TOXICOL CHEM, V31, P50, DOI 10.1002/etc.726; Pan CY, 2012, FISH SHELLFISH IMMUN, V32, P947, DOI 10.1016/j.fsi.2012.01.023; Paz-Elizur T, 2008, CANCER LETT, V266, P60, DOI 10.1016/j.canlet.2008.02.032; Qi ZH, 2013, FISH SHELLFISH IMMUN, V35, P1466, DOI 10.1016/j.fsi.2013.08.011; Rocchetta I, 2006, ENVIRON POLLUT, V141, P353, DOI 10.1016/j.envpol.2005.08.035; Saquib Q, 2012, TOXICOL IN VITRO, V26, P351, DOI 10.1016/j.tiv.2011.12.011; Selvaraj V, 2013, CHEMOSPHERE, V90, P1201, DOI 10.1016/j.chemosphere.2012.09.039; Shaw BJ, 2012, AQUAT TOXICOL, V116, P90, DOI 10.1016/j.aquatox.2012.02.032; Shaw BJ, 2011, ENVIRON INT, V37, P1083, DOI 10.1016/j.envint.2011.03.009; Singh S, 2007, TOXICOL APPL PHARM, V222, P141, DOI 10.1016/j.taap.2007.05.001; Sovova T, 2014, AQUAT TOXICOL, V152, P195, DOI 10.1016/j.aquatox.2014.04.003; Suska F, 2003, BIOMATERIALS, V24, P461, DOI 10.1016/S0142-9612(02)00359-9; TELFORD WG, 1991, CELL PROLIFERAT, V24, P447, DOI 10.1111/j.1365-2184.1991.tb01173.x; Thit A, 2015, TOXICOL IN VITRO, V29, P1053, DOI 10.1016/j.tiv.2015.03.020; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Vera LM, 2009, AQUACULTURE, V296, P150, DOI 10.1016/j.aquaculture.2009.08.010; von Moos N, 2015, AQUAT TOXICOL, V161, P267, DOI 10.1016/j.aquatox.2015.02.010; Wang T, 2015, FISH SHELLFISH IMMUN, V44, P674, DOI 10.1016/j.fsi.2015.03.030; Wang T, 2014, AQUAT TOXICOL, V152, P96, DOI 10.1016/j.aquatox.2014.03.023; Xu WN, 2009, CHEMOSPHERE, V77, P895, DOI 10.1016/j.chemosphere.2009.08.043; Zhang YM, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-13; Zhao J, 2011, J HAZARD MATER, V197, P304, DOI 10.1016/j.jhazmat.2011.09.094	49	30	30	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2016	11	2							e0149484	10.1371/journal.pone.0149484	http://dx.doi.org/10.1371/journal.pone.0149484			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3CO	26890000	Green Submitted, Green Published, gold			2022-12-26	WOS:000371221500051
J	Bartholomew, AJ; Lad, EM; Cao, DC; Bach, M; Cirulli, ET				Bartholomew, Alex J.; Lad, Eleonora M.; Cao, Dingcai; Bach, Michael; Cirulli, Elizabeth T.			Individual Differences in Scotopic Visual Acuity and Contrast Sensitivity: Genetic and Non-Genetic Influences	PLOS ONE			English	Article							STATIONARY NIGHT BLINDNESS; LOSS-OF-FUNCTION; IRIS COLOR; VISION; MUTATIONS; PERFORMANCE; ASSOCIATION; ABERRATIONS; QUALITY; RODS	Despite the large amount of variation found in the night (scotopic) vision capabilities of healthy volunteers, little effort has been made to characterize this variation and factors, genetic and non-genetic, that influence it. In the largest population of healthy observers measured for scotopic visual acuity (VA) and contrast sensitivity (CS) to date, we quantified the effect of a range of variables on visual performance. We found that young volunteers with excellent photopic vision exhibit great variation in their scotopic VA and CS, and this variation is reliable from one testing session to the next. We additionally identified that factors such as Circadian preference, iris color, astigmatism, depression, sex and education have no significant impact on scotopic visual function. We confirmed previous work showing that the amount of time spent on the vision test influences performance and that laser eye surgery results in worse scotopic vision. We also showed a significant effect of intelligence and photopic visual performance on scotopic VA and CS, but all of these variables collectively explain <30% of the variation in scotopic vision. The wide variation seen in young healthy volunteers with excellent photopic vision, the high test-retest agreement, and the vast majority of the variation in scotopic vision remaining unexplained by obvious non-genetic factors suggests a strong genetic component. Our preliminary genome-wide association study (GWAS) of 106 participants ruled out any common genetic variants of very large effect and paves the way for future, larger genetic studies of scotopic vision.	[Bartholomew, Alex J.; Cirulli, Elizabeth T.] Duke Univ, Sch Med, Ctr Appl Genom & Precis Med, Durham, NC 27708 USA; [Lad, Eleonora M.] Duke Univ, Dept Ophthalmol, Durham, NC 27710 USA; [Cao, Dingcai] Univ Illinois, Dept Ophthalmol & Visual Sci, Chicago, IL 60612 USA; [Bach, Michael] Univ Freiburg, Sect Visual Funct, Ctr Eye, Hugstetter Str 55, D-79106 Freiburg, Germany	Duke University; Duke University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Freiburg	Cirulli, ET (corresponding author), Duke Univ, Sch Med, Ctr Appl Genom & Precis Med, Durham, NC 27708 USA.	etc3@duke.edu	Bach, Michael/A-6637-2010	Bach, Michael/0000-0003-2028-535X; Cirulli Rogers, Liz/0000-0001-7808-2809	National Institute of Mental Health of the National Institutes of Health [K01MH098126]; NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH098126] Funding Source: NIH RePORTER	National Institute of Mental Health of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Research reported in this publication was supported by the National Institute of Mental Health of the National Institutes of Health under award number K01MH098126. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bach M, 1996, OPTOMETRY VISION SCI, V73, P49, DOI 10.1097/00006324-199601000-00008; Bach M, 2007, GRAEF ARCH CLIN EXP, V245, P965, DOI 10.1007/s00417-006-0474-4; Barbur J, 2010, PHOTOPIC MESOPIC SCO; Bartholomew AJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091773; BASSI CJ, 1986, PHYSIOL BEHAV, V38, P871, DOI 10.1016/0031-9384(86)90056-9; Bech-Hansen NT, 1998, NAT GENET, V19, P264, DOI 10.1038/947; Beck A.T., 1996, PSYCHOL ASSESS, V10, DOI [10.1037/t00742-000, DOI 10.1037/T00742-000]; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bradley JC, 2010, J OCUL PHARMACOL TH, V26, P335, DOI 10.1089/jop.2010.0061; Christian P, 1998, AM J CLIN NUTR, V68, p435S, DOI 10.1093/ajcn/68.2.435S; Cirulli E. T., 2015, SCIENCE; Cirulli ET, 2011, CLIN NEUROPSYCHOL, V25, P778, DOI 10.1080/13854046.2011.578587; Cirulli ET, 2010, EUR J HUM GENET, V18, P815, DOI 10.1038/ejhg.2010.2; Cremers FPM, 1998, HUM MOL GENET, V7, P355, DOI 10.1093/hmg/7.3.355; CURCIO CA, 1993, INVEST OPHTH VIS SCI, V34, P3278; Dirani M, 2006, TWIN RES HUM GENET, V9, P566, DOI 10.1375/twin.9.4.566; Feng S, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-12; FERRIS FL, 1982, AM J OPHTHALMOL, V94, P91, DOI 10.1016/0002-9394(82)90197-0; Flanagan SE, 2010, GENET TEST MOL BIOMA, V14, P533, DOI 10.1089/gtmb.2010.0036; Hammond BR, 2000, OPHTHAL PHYSL OPT, V20, P381, DOI 10.1016/S0275-5408(99)00098-8; Hecht S, 1939, J GEN PHYSIOL, V22, P593, DOI 10.1085/jgp.22.5.593; Heinrich SP, 2010, GRAEF ARCH CLIN EXP, V248, P389, DOI 10.1007/s00417-009-1268-2; Hertenstein H, 2015, GRAEFES ARCH CLIN EX, P1; Hohberger B, 2007, GRAEF ARCH CLIN EXP, V245, P1805, DOI 10.1007/s00417-007-0662-x; Jackson GR, 2000, VISION RES, V40, P2467, DOI 10.1016/S0042-6989(00)00108-5; Jagle H, 2006, GRAEF ARCH CLIN EXP, V244, P447, DOI 10.1007/s00417-005-0086-4; Kabanarou SA, 2004, BRIT J OPHTHALMOL, V88, P1018, DOI 10.1136/bjo.2003.033555; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Kasper T, 2006, J CATARACT REFR SURG, V32, P2022, DOI 10.1016/j.jcrs.2006.07.029; Kniestedt Christoph, 2003, Ophthalmol Clin North Am, V16, P155, DOI 10.1016/S0896-1549(03)00013-0; Koh S, 2002, AM J OPHTHALMOL, V134, P115, DOI 10.1016/S0002-9394(02)01430-7; Kohnen T, 2005, ESSENT OPHTHALMOL, P303; Lee YC, 2003, J CATARACT REFR SURG, V29, P769, DOI 10.1016/S0886-3350(02)01844-8; MIYAKE Y, 1986, ARCH OPHTHALMOL-CHIC, V104, P1013, DOI 10.1001/archopht.1986.01050190071042; Muth E R, 2000, Altern Med Rev, V5, P164; Ottoni GL, 2011, CHRONOBIOL INT, V28, P229, DOI 10.3109/07420528.2011.553696; Owsley C, 2010, VISION RES, V50, P2348, DOI 10.1016/j.visres.2010.05.021; Pierce EA, 1999, NAT GENET, V22, P248, DOI 10.1038/10305; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pulvermuller A, 1997, BIOCHEMISTRY-US, V36, P9253, DOI 10.1021/bi970772g; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Puts MJH, 2005, J NEUROSCI METH, V142, P77, DOI 10.1016/j.jneumeth.2004.07.013; Ribelayga C, 2008, NEURON, V59, P790, DOI 10.1016/j.neuron.2008.07.017; Roosing S, 2013, AM J HUM GENET, V93, P110, DOI 10.1016/j.ajhg.2013.05.005; ROSENFELD PJ, 1992, NAT GENET, V1, P209, DOI 10.1038/ng0692-209; Schefrin BE, 1999, VISION RES, V39, P3728, DOI 10.1016/S0042-6989(99)00072-3; Seiler T, 2000, ARCH OPHTHALMOL-CHIC, V118, P17, DOI 10.1001/archopht.118.1.17; Sherwin JC, 2012, T ROY SOC TROP MED H, V106, P205, DOI 10.1016/j.trstmh.2012.01.004; SMITH VC, 1975, VISION RES, V15, P161, DOI 10.1016/0042-6989(75)90203-5; StataCorp, 2013, STAT STAT SOFTW STAT; Sullivan LS, 1999, NAT GENET, V22, P255, DOI 10.1038/10314; SUNG CH, 1991, P NATL ACAD SCI USA, V88, P8840, DOI 10.1073/pnas.88.19.8840; TEIKARI JM, 1992, SCAND J SOC MED, V20, P73; Terman JS, 1999, BIOL PSYCHIAT, V46, P1642, DOI 10.1016/S0006-3223(99)00221-8; Verhulst S, 1998, VISION RES, V38, P3387, DOI 10.1016/S0042-6989(97)00339-8; Villa C, 2007, BRIT J OPHTHALMOL, V91, P1031, DOI 10.1136/bjo.2006.110874; WIKLER KC, 1990, J COMP NEUROL, V297, P499, DOI 10.1002/cne.902970404; Zele AJ, 2014, FRONT PSYCHOL, P5	60	12	12	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0148192	10.1371/journal.pone.0148192	http://dx.doi.org/10.1371/journal.pone.0148192			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26886100	Green Published, Green Submitted, gold			2022-12-26	WOS:000371218400018
J	Detree, C; Chabenat, A; Lallier, FH; Satoh, N; Shoguchi, E; Tanguy, A; Mary, J				Detree, Camille; Chabenat, Apolline; Lallier, Francois H.; Satoh, Nori; Shoguchi, Eiichi; Tanguy, Arnaud; Mary, Jean			Multiple I-Type Lysozymes in the Hydrothermal Vent Mussel Bathymodiolus azoricus and Their Role in Symbiotic Plasticity	PLOS ONE			English	Article							GOOSE-TYPE LYSOZYME; MID-ATLANTIC RIDGE; OYSTER CRASSOSTREA-VIRGINICA; INVERTEBRATE-TYPE LYSOZYMES; EASTERN OYSTER; CDNA CLONING; DE-NOVO; ANTIMICROBIAL ACTIVITY; RECOMBINANT PROTEIN; ADAPTIVE EVOLUTION	The aim of this study was first to identify lysozymes paralogs in the deep sea mussel Bathymodiolus azoricus then to measure their relative expression or activity in different tissue or conditions. B. azoricus is a bivalve that lives close to hydrothermal chimney in the Mid-Atlantic Ridge (MAR). They harbour in specialized gill cells two types of endosymbiont (grambacteria): sulphide oxidizing bacteria (SOX) and methanotrophic bacteria (MOX). This association is thought to be ruled by specific mechanism or actors of regulation to deal with the presence of symbiont but these mechanisms are still poorly understood. Here, we focused on the implication of lysozyme, a bactericidal enzyme, in this endosymbiosis. The relative expression of Ba-lysozymes paralogs and the global anti-microbial activity, were measured in natural population (Lucky Strike - 1700m, Mid-Atlantic Ridge), and in in situ experimental conditions. B. azoricus individuals were moved away from the hydrothermal fluid to induce a loss of symbiont. Then after 6 days some mussels were brought back to the mussel bed to induce a re-acquisition of symbiotic bacteria. Results show the presence of 6 paralogs in B. azoricus. In absence of symbionts, 3 paralogs are up-regulated while others are not differentially expressed. Moreover the global activity of lysozyme is increasing with the loss of symbiont. All together these results suggest that lysozyme may play a crucial role in symbiont regulation.	[Detree, Camille; Chabenat, Apolline; Lallier, Francois H.; Tanguy, Arnaud; Mary, Jean] Univ Paris 06, Sorbonne Univ, CNRS,Stn Biol Roscoff, UMR 7144,Adaptat & Divers Milieu Marin,Equipe ABI, F-29680 Roscoff, France; [Satoh, Nori; Shoguchi, Eiichi] Okinawa Inst Sci & Technol, Marine Genom Unit, Onna, Japan	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite; Okinawa Institute of Science & Technology Graduate University	Mary, J (corresponding author), Univ Paris 06, Sorbonne Univ, CNRS,Stn Biol Roscoff, UMR 7144,Adaptat & Divers Milieu Marin,Equipe ABI, F-29680 Roscoff, France.	jmary@sb-roscoff.fr	Satoh, Nori/C-4123-2009; Mary, Jean/H-2344-2011; Detree, Camille/P-7073-2019	Satoh, Nori/0000-0002-4480-3572; Mary, Jean/0000-0002-2438-8383; Detree, Camille/0000-0001-5518-2380	Region Bretagne; JST/CNRS program	Region Bretagne(Region Bretagne); JST/CNRS program	This study was supported by the Region Bretagne (C.D.) and the JST/CNRS program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r We would like to thank the crew and pilot of the N/O Pourquoi pas? and the ROV Victor 6000 for their assistance and technical support as well as the chief scientist of the Momarsat 2013 cruise, Jerome Blandin. We also want to thank Celine Wichlacz and Aurelie Tasiemski from the Universite de Lille for their help on lysozyme activity measurements and Didier Jollivet for his help on phylogeny. We are very grateful to the Region Bretagne and to JST/CNRS program for funding.	Allam B, 2000, J INVERTEBR PATHOL, V76, P63, DOI 10.1006/jipa.2000.4940; Anselme C, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-43; Bachali S, 2002, J MOL EVOL, V54, P652, DOI 10.1007/s00239-001-0061-6; Bathige SDNK, 2013, FISH SHELLFISH IMMUN, V35, P1369, DOI 10.1016/j.fsi.2013.07.048; Boutet I, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-530; Broderick NA, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00072; Callewaert L, 2010, J BIOSCIENCES, V35, P127, DOI 10.1007/s12038-010-0015-5; CAVANAUGH CM, 1992, APPL ENVIRON MICROB, V58, P3799, DOI 10.1128/AEM.58.12.3799-3803.1992; CAVANAUGH CM, 1987, NATURE, V325, P346, DOI 10.1038/325346a0; CHENG TC, 1983, AM ZOOL, V23, P129; CHIPMAN DM, 1969, SCIENCE, V165, P454, DOI 10.1126/science.165.3892.454; Chu HT, 2013, NAT IMMUNOL, V14, P668, DOI 10.1038/ni.2635; Colaco A, 2002, DEEP-SEA RES PT I, V49, P395, DOI 10.1016/S0967-0637(01)00060-7; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cong LN, 2009, J BIOSCI BIOENG, V107, P583, DOI 10.1016/j.jbiosc.2009.01.016; De Busserolles F, 2009, DEEP-SEA RES PT II, V56, P1649, DOI 10.1016/j.dsr2.2009.05.011; Ding JF, 2011, FISH SHELLFISH IMMUN, V30, P163, DOI 10.1016/j.fsi.2010.10.008; Duperron S, 2009, CR BIOL, V332, P298, DOI 10.1016/j.crvi.2008.08.003; Fiala-Medioni A, 2002, MAR BIOL, V141, P1035, DOI 10.1007/s00227-002-0903-9; FIALAMEDIONI A, 1994, CR ACAD SCI III-VIE, V317, P239; FISHER CR, 1987, MAR BIOL, V96, P59, DOI 10.1007/BF00394838; Futahashi R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064557; Goto T, 2007, J BIOL CHEM, V282, P27459, DOI 10.1074/jbc.M704555200; Guezi H, 2014, SYMBIOSIS, V63, P19, DOI 10.1007/s13199-014-0284-0; Hanson RS, 1996, MICROBIOL REV, V60, P439, DOI 10.1128/MMBR.60.2.439-471.1996; He CB, 2012, COMP BIOCHEM PHYS B, V162, P34, DOI 10.1016/j.cbpb.2012.02.002; Itoh N, 2007, FISH SHELLFISH IMMUN, V23, P957, DOI 10.1016/j.fsi.2007.03.006; Itoh N, 2007, COMP BIOCHEM PHYS B, V148, P160, DOI 10.1016/j.cbpb.2007.05.005; JOLLES J, 1989, J MOL EVOL, V28, P528, DOI 10.1007/BF02602933; Jolles J, 1996, J MOL EVOL, V43, P523, DOI 10.1007/BF02337523; Kadar E, 2005, J EXP MAR BIOL ECOL, V318, P99, DOI 10.1016/j.jembe.2004.12.025; Kim JK, 2014, DEV COMP IMMUNOL, V43, P10, DOI 10.1016/j.dci.2013.10.010; Kleiner M, 2012, CURR OPIN MICROBIOL, V15, P621, DOI 10.1016/j.mib.2012.09.003; Konig S, 2015, MICROSC RES TECHNIQ, V78, P173, DOI 10.1002/jemt.22458; Kuwano Y, 2013, BIOSCI BIOTECH BIOCH, V77, P2269, DOI 10.1271/bbb.130534; LEPENNEC M, 1995, COMP BIOCHEM PHYS A, V111, P183, DOI 10.1016/0300-9629(94)00211-B; Mallo GV, 2002, CURR BIOL, V12, P1209, DOI 10.1016/S0960-9822(02)00928-4; Matsumoto T, 2006, COMP BIOCHEM PHYS B, V145, P325, DOI 10.1016/j.cbpb.2006.08.003; MCHENERY JG, 1979, COMP BIOCHEM PHYS B, V63, P25, DOI 10.1016/0305-0491(79)90228-1; Nakabachi A, 2005, P NATL ACAD SCI USA, V102, P5477, DOI 10.1073/pnas.0409034102; Nilsen IW, 2003, CELL MOL LIFE SCI, V60, P2210, DOI 10.1007/s00018-003-3252-z; Nishikori K, 2009, J INSECT PHYSIOL, V55, P351, DOI 10.1016/j.jinsphys.2009.01.001; PAGE HM, 1990, MAR BIOL, V104, P251, DOI 10.1007/BF01313266; Pan BP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123296; Paskewitz SM, 2008, INSECT MOL BIOL, V17, P217, DOI 10.1111/j.1365-2583.2008.00797.x; Petersen JM, 2011, NATURE, V476, P176, DOI 10.1038/nature10325; Raulfs EC, 2004, J MAR BIOL ASSOC UK, V84, P229, DOI 10.1017/S0025315404009087h; Ren Q, 2012, FISH SHELLFISH IMMUN, V33, P909, DOI 10.1016/j.fsi.2012.07.019; Riou V, 2008, BIOGEOSCIENCES, V5, P1681, DOI 10.5194/bg-5-1681-2008; Royet J, 2011, NAT REV IMMUNOL, V11, P837, DOI 10.1038/nri3089; SALTON MRJ, 1957, BACTERIOL REV, V21, P82, DOI 10.1128/MMBR.21.2.82-100.1957; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; SHUGAR D, 1952, BIOCHIM BIOPHYS ACTA, V8, P302, DOI 10.1016/0006-3002(52)90045-0; STEWART CB, 1987, NATURE, V330, P401, DOI 10.1038/330401a0; Von Cosel R, 1999, VELIGER, V42, P218; Wang Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067469; Wang Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045148; Wendeberg A, 2012, ISME J, V6, P104, DOI 10.1038/ismej.2011.81; Xue QG, 2007, CELL MOL LIFE SCI, V64, P82, DOI 10.1007/s00018-006-6386-y; Xue QG, 2004, COMP BIOCHEM PHYS B, V139, P11, DOI 10.1016/j.cbpc.2004.05.011; Xue QG, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-213; Zavalova LL, 2004, BIOCHEMISTRY-MOSCOW+, V69, P776, DOI 10.1023/B:BIRY.0000040203.37624.ef; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhao J, 2007, MOL IMMUNOL, V44, P1198, DOI 10.1016/j.molimm.2006.06.008	65	10	11	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0148988	10.1371/journal.pone.0148988	http://dx.doi.org/10.1371/journal.pone.0148988			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	26882089	Green Published, gold			2022-12-26	WOS:000371219000041
J	Fotschki, B; Juskiewicz, J; Jurgonski, A; Kolodziejczyk, K; Milala, J; Kosmala, M; Zdunczyk, Z				Fotschki, Bartosz; Juskiewicz, Jerzy; Jurgonski, Adam; Kolodziejczyk, Krzysztof; Milala, Joanna; Kosmala, Monika; Zdunczyk, Zenon			Anthocyanins in Strawberry Polyphenolic Extract Enhance the Beneficial Effects of Diets with Fructooligosaccharides in the Rat Cecal Environment	PLOS ONE			English	Article							CHAIN FATTY-ACIDS; ELLAGIC ACID; PHENOLIC-COMPOUNDS; HUMAN HEALTH; ELLAGITANNINS; PROANTHOCYANIDINS; BIOAVAILABILITY; METABOLITES; CONSUMPTION; COMPONENTS	The administration of fructooligosaccharides (FOS) beneficially modulates gastrointestinal functions and may enhance the metabolism of polyphenols. However, different polyphenolic components in the diet may have different influences on the activities of the digestive enzymes and microbiota in the gastrointestinal tract. Therefore, a 4-week study of fortyeight male Wistar rats was conducted to investigate the physiological response of the rat cecal environment to diets without and with FOS that contained two different strawberry polyphenolic extracts, specifically EP (polyphenolic profile 60, 35, 5, and 0% ellagitannins, proanthocyanidins, flavonols, anthocyanins, respectively) and EPA (polyphenolic profile: 50, 35, 6, and 9%, respectively). When combined with FOS, both extracts beneficially enhanced the acidification of the cecal digesta (P <= 0.05 vs the groups without extracts), but the dietary combination of EPA and FOS elicited the greatest reduction in putrefactive short-chain fatty acid production and the lowest fecal beta-glucuronidase activity in the cecum (P <= 0.05 vs group EP). Moreover, the addition of dietary FOS elevated the metabolism of the examined strawberry extracts in the cecum and thereby increased the concentrations of the metabolites in the cecal digesta and urine (P <= 0.05 vs the group with cellulose). Overall, both strawberry extracts modulated the effects of FOS in the gastrointestinal tract; however, the combination with EPA extract that contained anthocyanins exhibited greater beneficial effects in the lower gut environment than the EP extract.	[Fotschki, Bartosz; Juskiewicz, Jerzy; Jurgonski, Adam; Zdunczyk, Zenon] Polish Acad Sci, Inst Anim Reprod & Food Res, Div Food Sci, Olsztyn, Poland; [Kolodziejczyk, Krzysztof; Milala, Joanna; Kosmala, Monika] Lodz Univ Technol, Inst Food Technol & Anal, Lodz, Poland	Polish Academy of Sciences; Institute of Animal Reproduction & Food Research of the Polish Academy of Sciences; Lodz University of Technology	Fotschki, B (corresponding author), Polish Acad Sci, Inst Anim Reprod & Food Res, Div Food Sci, Olsztyn, Poland.	b.fotschki@pan.olsztyn.pl	Kołodziejczyk, Krzysztof/M-2951-2018; Kosmala, Monika/AAB-3395-2019; FOTSCHKI, Bartosz/Q-4275-2019; Zduńczyk, Zenon/H-7272-2017; Milala, Joanna/AAZ-6460-2021; Fotschki, Bartosz/H-7172-2017; Jurgonski, Adam/A-5864-2009; Juśkiewicz, Jerzy/H-7193-2017	Kołodziejczyk, Krzysztof/0000-0003-3817-5140; Kosmala, Monika/0000-0002-9018-3028; Zduńczyk, Zenon/0000-0002-0640-7552; Milala, Joanna/0000-0002-4732-1907; Fotschki, Bartosz/0000-0002-9727-7481; Jurgonski, Adam/0000-0003-3524-3259; Juśkiewicz, Jerzy/0000-0003-0068-5970	National Science Centre of Poland [DEC-2012/05/B/NZ9/03402]	National Science Centre of Poland(National Science Centre, Poland)	This study was financially supported by the National Science Centre of Poland (Grant DEC-2012/05/B/NZ9/03402), https://www.ncn.gov.pl/?language=en. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaby K, 2012, FOOD CHEM, V132, P86, DOI 10.1016/j.foodchem.2011.10.037; AOAC, 2005, OFFICIAL METHODS ANA; Asgar MA, 2013, INT J FOOD PROP, V16, P91, DOI 10.1080/10942912.2011.595864; Aviram M, 2004, CLIN NUTR, V23, P423, DOI 10.1016/j.clnu.2003.10.002; Beecher GR, 2004, PHARM BIOL, V42, P2, DOI 10.3109/13880200490893474; Blade C, 2010, MOL NUTR FOOD RES, V54, P37, DOI 10.1002/mnfr.200900476; DANIEL EM, 1991, J NAT PROD, V54, P946, DOI 10.1021/np50076a004; Duda-Chodak A, 2015, EUR J NUTR, V54, P325, DOI 10.1007/s00394-015-0852-y; Duncan SH, 2002, APPL ENVIRON MICROB, V68, P5186, DOI 10.1128/AEM.68.10.5186-5190.2002; Espin J. C., 2013, EVID-BASED COMPL ALT, V2013, P1; Fernandes I, 2014, J FUNCT FOODS, V7, P54, DOI 10.1016/j.jff.2013.05.010; Fotschki B, 2014, POL J FOOD NUTR SCI, V64, P193, DOI 10.2478/pjfns-2013-0001; Fotschki B, 2014, J AGR FOOD CHEM, V62, P5871, DOI 10.1021/jf405612a; Gimenez-Bastida JA, 2012, MOL NUTR FOOD RES, V56, P784, DOI 10.1002/mnfr.201100677; Jakobsdottir G, 2013, J NUTR METAB, V2013, DOI 10.1155/2013/202534; Jurgonski A, 2008, J ANIM FEED SCI, V17, P88, DOI 10.22358/jafs/66473/2008; Jurgonski A, 2013, NUTRITION, V29, P898, DOI 10.1016/j.nut.2012.11.006; Juskiewicz J, 2011, BRIT J NUTR, V105, P710, DOI 10.1017/S0007114510004344; Juskiewicz J, 2011, NUTRITION, V27, P351, DOI 10.1016/j.nut.2010.02.002; Kennedy JA, 2001, J AGR FOOD CHEM, V49, P1740, DOI 10.1021/jf001030o; Klewicka E, 2009, EUR FOOD RES TECHNOL, V229, P153, DOI 10.1007/s00217-009-1036-x; Kosmala M, 2015, J AGR FOOD CHEM, V63, P2989, DOI 10.1021/acs.jafc.5b00648; Kosmala M, 2014, EUR J NUTR, V53, P521, DOI 10.1007/s00394-013-0557-z; Landete JM, 2011, FOOD RES INT, V44, P1150, DOI 10.1016/j.foodres.2011.04.027; Larrosa M, 2006, J NUTR BIOCHEM, V17, P611, DOI 10.1016/j.jnutbio.2005.09.004; Lhoste EF, 2001, J SCI FOOD AGR, V81, P1397, DOI 10.1002/jsfa.957; McDougall GJ, 2005, J AGR FOOD CHEM, V53, P2760, DOI 10.1021/jf0489926; Nile SH, 2014, NUTRITION, V30, P134, DOI 10.1016/j.nut.2013.04.007; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Reeves PG, 1997, J NUTR, V127, pS838; Roberfroid MB, 2005, BRIT J NUTR, V93, pS13, DOI 10.1079/BJN20041350; Seeram NP, 2004, CLIN CHIM ACTA, V348, P63, DOI 10.1016/j.cccn.2004.04.029; Sojka M, 2013, EUR FOOD RES TECHNOL, V237, P995, DOI 10.1007/s00217-013-2070-2; Topping DL, 2001, PHYSIOL REV, V81, P1031, DOI 10.1152/physrev.2001.81.3.1031; VISEK WJ, 1978, AM J CLIN NUTR, V31, pS216, DOI 10.1093/ajcn/31.10.S216; Zdunczyk Z, 2006, NUTRITION, V22, P898, DOI 10.1016/j.nut.2006.05.010	37	37	37	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0149081	10.1371/journal.pone.0149081	http://dx.doi.org/10.1371/journal.pone.0149081			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	26882456	Green Submitted, gold, Green Published			2022-12-26	WOS:000371219000044
J	Hornschemeyer, P; Liss, V; Heermann, R; Jung, K; Hunke, S				Hoernschemeyer, Patrick; Liss, Viktoria; Heermann, Ralf; Jung, Kirsten; Hunke, Sabine			Interaction Analysis of a Two-Component System Using Nanodiscs	PLOS ONE			English	Article							ENVELOPE STRESS-RESPONSE; ESCHERICHIA-COLI; SIGNAL-TRANSDUCTION; HISTIDINE KINASE; MICROSCALE THERMOPHORESIS; PROTEIN; REGULATOR; PHOSPHORYLATION; SPECIFICITY; INTEGRATION	Two-component systems are the major means by which bacteria couple adaptation to environmental changes. All utilize a phosphorylation cascade from a histidine kinase to a response regulator, and some also employ an accessory protein. The system-wide signaling fidelity of two-component systems is based on preferential binding between the signaling proteins. However, information on the interaction kinetics between membrane embedded histidine kinase and its partner proteins is lacking. Here, we report the first analysis of the interactions between the full-length membrane-bound histidine kinase CpxA, which was reconstituted in nanodiscs, and its cognate response regulator CpxR and accessory protein CpxP. Using surface plasmon resonance spectroscopy in combination with interaction map analysis, the affinity of membrane-embedded CpxA for CpxR was quantified, and found to increase by tenfold in the presence of ATP, suggesting that a considerable portion of phosphorylated CpxR might be stably associated with CpxA in vivo. Using microscale thermophoresis, the affinity between CpxA in nanodiscs and CpxP was determined to be substantially lower than that between CpxA and CpxR. Taken together, the quantitative interaction data extend our understanding of the signal transduction mechanism used by two-component systems.	[Hoernschemeyer, Patrick; Liss, Viktoria; Hunke, Sabine] Univ Osnabruck, Fachbereich Biol Chem, Mikrobiol, Barbarastr 11, D-49076 Osnabruck, Germany; [Heermann, Ralf; Jung, Kirsten] Univ Munich, Dept Microbiol, Munich Ctr Integrated Prot Sci CiPSM, D-82152 Martinsried, Germany	University Osnabruck; University of Munich	Hunke, S (corresponding author), Univ Osnabruck, Fachbereich Biol Chem, Mikrobiol, Barbarastr 11, D-49076 Osnabruck, Germany.	sabine.hunke@uos.de	Heermann, Ralf/E-1793-2013; Heermann, Ralf/CAF-8609-2022	Heermann, Ralf/0000-0003-0631-6156; Liss, Viktoria/0000-0002-1304-2512	DFG [Hu1011/2-1, SFB944];  [Exc114/2]	DFG(German Research Foundation (DFG)); 	This work was supported by DFG grants Hu1011/2-1 and SFB944 to S.H. as well as Exc114/2 to K.J.; We thank K.-H. Altendorf and Daniel Kummel for continuous support, Michael Hensel, Jacob Piehler and Karl Andersson for fruitful discussions, and E. Limpinsel for technical support. SPR spectroscopy was performed in the Bioanalytics Core Facility at the Ludwig-Maximilians-Universitat Munchen Biocenter. This work was supported by DFG grants Hu1011/2-1 and SFB944 to S.H. as well as Exc114/2 to K.J.	Altschuh D, 2012, BIOCHEM BIOPH RES CO, V428, P74, DOI 10.1016/j.bbrc.2012.10.008; Barbieri CM, 2008, ANAL BIOCHEM, V376, P73, DOI 10.1016/j.ab.2008.02.004; Bauer J, 2013, MOL PLANT, V6, P959, DOI 10.1093/mp/sss126; Bayburt TH, 2010, FEBS LETT, V584, P1721, DOI 10.1016/j.febslet.2009.10.024; Bernal-Cabas M, 2015, J BACTERIOL, V197, P603, DOI 10.1128/JB.02449-14; Bhattacharya M, 2010, BIOCHIMIE, V92, P263, DOI 10.1016/j.biochi.2009.11.009; Buelow DR, 2010, MOL MICROBIOL, V75, P547, DOI 10.1111/j.1365-2958.2009.06982.x; Bury-Mone S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000651; Casino P, 2009, CELL, V139, P325, DOI 10.1016/j.cell.2009.08.032; Danese PN, 1998, J BACTERIOL, V180, P831, DOI 10.1128/JB.180.4.831-839.1998; DeGrip WJ, 1998, BIOCHEM J, V330, P667; Denisov IG, 2004, J AM CHEM SOC, V126, P3477, DOI 10.1021/ja0393574; Dorel C, 2006, RES MICROBIOL, V157, P306, DOI 10.1016/j.resmic.2005.12.003; Fleischer R, 2007, J BIOL CHEM, V282, P8583, DOI 10.1074/jbc.M605785200; Gobin AS, 2006, INT J NANOMED, V1, P81, DOI 10.2147/nano.2006.1.1.81; Heermann R, 2010, FEMS MICROBIOL LETT, V304, P97, DOI 10.1111/j.1574-6968.2010.01906.x; Hung DL, 2001, EMBO J, V20, P1508, DOI 10.1093/emboj/20.7.1508; Hunke S, 2012, FEMS MICROBIOL LETT, V326, P12, DOI 10.1111/j.1574-6968.2011.02436.x; Isaac DD, 2005, P NATL ACAD SCI USA, V102, P17775, DOI 10.1073/pnas.0508936102; IUCHI S, 1993, J BIOL CHEM, V268, P23972; Jerabek-Willemsen M, 2011, ASSAY DRUG DEV TECHN, V9, P342, DOI 10.1089/adt.2011.0380; Jung K, 2012, CURR OPIN MICROBIOL, V15, P118, DOI 10.1016/j.mib.2011.11.009; Kinoshita E, 2011, PROTEOMICS, V11, P319, DOI 10.1002/pmic.201000472; Krell T, 2010, ANNU REV MICROBIOL, V64, P539, DOI 10.1146/annurev.micro.112408.134054; Kwon E, 2012, PROTEIN SCI, V21, P1334, DOI 10.1002/pro.2120; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Laub MT, 2007, ANNU REV GENET, V41, P121, DOI 10.1146/annurev.genet.41.042007.170548; MacRitchie DM, 2008, ADV EXP MED BIOL, V631, P80, DOI 10.1007/978-0-387-78885-2_6; Marman HE, 2014, INFECT IMMUN, V82, P3612, DOI 10.1128/IAI.01532-13; Martin J, 1997, P NATL ACAD SCI USA, V94, P1107, DOI 10.1073/pnas.94.4.1107; Mattison K, 2002, J BIOL CHEM, V277, P11143, DOI 10.1074/jbc.M111128200; MCCLEARY WR, 1994, J BIOL CHEM, V269, P31567; Mechaly AE, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001776; Minton AP, 2001, J BIOL CHEM, V276, P10577, DOI 10.1074/jbc.R100005200; Mullineaux CW, 2006, J BACTERIOL, V188, P3442, DOI 10.1128/JB.188.10.3442-3448.2006; Nakayama SI, 1998, J BACTERIOL, V180, P3522, DOI 10.1128/JB.180.14.3522-3528.1998; Podgornaia AI, 2013, CURR OPIN MICROBIOL, V16, P156, DOI 10.1016/j.mib.2013.01.004; Raivio TL, 2005, MOL MICROBIOL, V56, P1119, DOI 10.1111/j.1365-2958.2005.04625.x; Raivio TL, 1999, J BACTERIOL, V181, P5263, DOI 10.1128/JB.181.17.5263-5272.1999; Raivio TL, 2014, BBA-MOL CELL RES, V1843, P1529, DOI 10.1016/j.bbamcr.2013.10.018; Rowley G, 2006, NAT REV MICROBIOL, V4, P383, DOI 10.1038/nrmicro1394; Schrecke K, 2013, MOL MICROBIOL, V87, P769, DOI 10.1111/mmi.12130; Shi L, 2012, SCIENCE, V335, P1355, DOI 10.1126/science.1214984; Silhavy TJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000414; Sochacki KA, 2011, BIOPHYS J, V100, P22, DOI 10.1016/j.bpj.2010.11.044; Srivastava SK, 2014, J BACTERIOL, V196, P2876, DOI 10.1128/JB.01530-14; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; STOCK JB, 1977, J BIOL CHEM, V252, P7850; Szurmant H, 2010, CURR OPIN MICROBIOL, V13, P190, DOI 10.1016/j.mib.2010.01.007; Tschauner K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107383; Vogt SL, 2014, J BACTERIOL, V196, P4229, DOI 10.1128/JB.02138-14; Wienken CJ, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1093; Willett JW, 2013, MBIO, V4, DOI 10.1128/mBio.00420-13; Wolfe AJ, 2008, J BACTERIOL, V190, P2314, DOI 10.1128/JB.01906-07; Yoshida T, 2002, MOL MICROBIOL, V46, P1283, DOI 10.1046/j.1365-2958.2002.03240.x; Zhou XH, 2011, J BIOL CHEM, V286, P9805, DOI 10.1074/jbc.M110.194092	56	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0149187	10.1371/journal.pone.0149187	http://dx.doi.org/10.1371/journal.pone.0149187			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	26882435	Green Published, gold, Green Submitted			2022-12-26	WOS:000371219000054
J	Naud, MJ; Sauer, WHH; McKeown, NJ; Shaw, PW				Naud, Marie-Jose; Sauer, Warwick H. H.; McKeown, Niall J.; Shaw, Paul W.			Multiple Mating, Paternity and Complex Fertilisation Patterns in the Chokka Squid Loligo reynaudii	PLOS ONE			English	Article							CRYPTIC FEMALE CHOICE; REPRODUCTIVE SUCCESS; PARENTAL GENOTYPES; GIANT CUTTLEFISH; SPERM PRECEDENCE; EGG CAPSULES; DYNAMICS; MOLLUSCA; DNA; CEPHALOPODA	Polyandry is widespread and influences patterns of sexual selection, with implications for sexual conflict over mating. Assessing sperm precedence patterns is a first step towards understanding sperm competition within a female and elucidating the roles of male- and female-controlled factors. In this study behavioural field data and genetic data were combined to investigate polyandry in the chokka squid Loligo reynaudii. Microsatellite DNA-based paternity analysis revealed multiple paternity to be the norm, with 79% of broods sired by at least two males. Genetic data also determined that the male who was guarding the female at the moment of sampling was a sire in 81% of the families tested, highlighting mate guarding as a successful male tactic with postcopulatory benefits linked to sperm deposition site giving privileged access to extruded egg strings. As females lay multiple eggs in capsules (egg strings) wherein their position is not altered during maturation it is possible to describe the spatial / temporal sequence of fertilisation / sperm precedence There were four different patterns of fertilisation found among the tested egg strings: 1) unique sire; 2) dominant sire, with one or more rare sires; 3) randomly mixed paternity (two or more sires); and 4) a distinct switch in paternity occurring along the egg string. The latter pattern cannot be explained by a random use of stored sperm, and suggests postcopulatory female sperm choice. Collectively the data indicate multiple levels of male- and female-controlled influences on sperm precedence, and highlights squid as interesting models to study the interplay between sexual and natural selection.	[Naud, Marie-Jose] Royal Holloway Univ London, Sch Biol Sci, Egham, Surrey, England; [Sauer, Warwick H. H.; Shaw, Paul W.] Rhodes Univ, Dept Ichthyol & Fisheries Sci, ZA-6140 Grahamstown, South Africa; [McKeown, Niall J.; Shaw, Paul W.] Aberystwyth Univ, Inst Biol Environm & Rural Sci, Aberystwyth SY23 3FG, Dyfed, Wales	University of London; Royal Holloway University London; Rhodes University; Aberystwyth University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Institute of Biological, Environmental, Rural & Sciences (IBERS)	Shaw, PW (corresponding author), Rhodes Univ, Dept Ichthyol & Fisheries Sci, ZA-6140 Grahamstown, South Africa.; Shaw, PW (corresponding author), Aberystwyth Univ, Inst Biol Environm & Rural Sci, Aberystwyth SY23 3FG, Dyfed, Wales.	pws3@aber.ac.uk	McKeown, Niall/AAK-5989-2020; Sauer, Warwick/GJI-2267-2022	McKeown, Niall/0000-0002-7351-5553; Sauer, Warwick/0000-0002-9756-1757; Shaw, Paul/0000-0003-2637-6332	EU Marie Curie Fellowship; National Research Foundation (NRF, South Africa); South African Squid Management Industrial Association (SASMIA, South Africa)	EU Marie Curie Fellowship(European Commission); National Research Foundation (NRF, South Africa)(National Research Foundation - South Africa); South African Squid Management Industrial Association (SASMIA, South Africa)	M-JN was supported through this study by an EU Marie Curie Fellowship. This study was supported financially by the National Research Foundation (NRF, South Africa) and the South African Squid Management Industrial Association (SASMIA, South Africa).	Arbuthnott D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090207; Barbosa F, 2009, BEHAV ECOL, V20, P957, DOI 10.1093/beheco/arp083; Birkhead T.R., 1998, P579, DOI 10.1016/B978-012100543-6/50039-8; Birkhead TR, 1998, EVOLUTION, V52, P1212, DOI [10.1111/j.1558-5646.1998.tb01848.x, 10.2307/2411251]; BOLETZKY SV, 1986, AM MALACOL BULL, V4, P217; Boyle P. R., 2005, CEPHALOPODS ECOLOGY; Buresch KC, 2009, MAR ECOL PROG SER, V387, P197, DOI 10.3354/meps08052; Buresch KM, 2001, MAR ECOL PROG SER, V210, P161, DOI 10.3354/meps210161; den Boer SPA, 2010, SCIENCE, V327, P1506, DOI 10.1126/science.1184709; DeWoody JA, 2000, GENETICS, V154, P1907; Dottorini T, 2012, PATHOG GLOB HEALTH, V106, P405, DOI 10.1179/2047773212Y.0000000058; Eberhard W. G., 1996, FEMALE CONTROL SEXUA; Emery AM, 2001, MOL ECOL, V10, P1265, DOI 10.1046/j.1365-294X.2001.01258.x; Hanlon RT, 1997, BIOL BULL, V193, P212, DOI 10.1086/BBLv193n2p212; Hanlon RT, 2004, MAR BIOL, V145, P923, DOI 10.1007/s00227-004-1383-x; Hanlon RT, 2002, B MAR SCI, V71, P331; Hanlon RT, 1996, CEPHALOPOD BEHAV; Harvey IF, 2000, P ROY SOC B-BIOL SCI, V267, P2537, DOI 10.1098/rspb.2000.1317; Iwata Y, 2005, MAR ECOL PROG SER, V298, P219, DOI 10.3354/meps298219; Iwata Y, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-236; Jantzen TM, 2003, BIOL BULL-US, V204, P305, DOI 10.2307/1543601; Jones AG, 2005, MOL ECOL NOTES, V5, P708, DOI 10.1111/j.1471-8286.2005.01029.x; Liu JX, 2011, MAR BIOL, V158, P893, DOI 10.1007/s00227-010-1616-0; Maynard Smith J., 1982, pi; Naud MJ, 2008, MOL ECOL RESOUR, V8, P943, DOI 10.1111/j.1755-0998.2008.02125.x; Naud MJ, 2006, MAR BIOL, V148, P559, DOI 10.1007/s00227-005-0109-z; Naud MJ, 2004, ANIM BEHAV, V67, P1043, DOI 10.1016/j.anbehav.2003.10.005; Neff BD, 2002, J FISH BIOL, V61, P739, DOI 10.1111/j.1095-8649.2002.tb00908.x; ONO T, 1989, PHYSIOL ENTOMOL, V14, P195, DOI 10.1111/j.1365-3032.1989.tb00952.x; Pizzari T, 2000, NATURE, V405, P787, DOI 10.1038/35015558; Pizzari T, 2013, PHILOS T R SOC B, P368; Ribou AC, 2012, P ROY SOC B-BIOL SCI, V279, P2196, DOI 10.1098/rspb.2011.2422; Roderick GK, 2003, ANN ENTOMOL SOC AM, V96, P631, DOI 10.1603/0013-8746(2003)096[0631:SPICPB]2.0.CO;2; Rosengrave P, 2008, BEHAV ECOL, V19, P1179, DOI 10.1093/beheco/arn089; Sauer WHH, 1995, S AFR J MARINE SCI, V16, P185; Sauer WHH, 1997, BIOL BULL, V192, P203, DOI 10.2307/1542714; Schlechter-Helas J, 2011, NATURWISSENSCHAFTEN, V98, P855, DOI 10.1007/s00114-011-0836-6; Shashar N, 2013, J EXP MAR BIOL ECOL, V447, P65, DOI 10.1016/j.jembe.2013.02.011; Shaw PW, 2010, MAR ECOL PROG SER, V408, P117, DOI 10.3354/meps08593; Shaw PW, 2004, MAR ECOL PROG SER, V270, P173, DOI 10.3354/meps270173; Shaw PW, 1997, MAR ECOL PROG SER, V160, P279, DOI 10.3354/meps160279; Simmons L. W., 2001, MG BEH ECOL; Simmons LW, 2005, ANNU REV ECOL EVOL S, V36, P125, DOI 10.1146/annurev.ecolsys.36.102403.112501; Sugg DW, 1996, TRENDS ECOL EVOL, V11, P338, DOI 10.1016/0169-5347(96)20050-3; van Camp LM, 2005, MAR FRESHWATER RES, V56, P933, DOI 10.1071/MF04287; WAAGE JK, 1979, SCIENCE, V203, P916, DOI 10.1126/science.203.4383.916; Walker D, 2007, MAR BIOL, V151, P53, DOI 10.1007/s00227-006-0463-5; WINNEPENNINCKX B, 1993, TRENDS GENET, V9, P407; Wolfner MF, 2009, J HERED, V100, P399, DOI 10.1093/jhered/esp013	49	21	22	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0146995	10.1371/journal.pone.0146995	http://dx.doi.org/10.1371/journal.pone.0146995			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26872354	Green Submitted, gold, Green Published			2022-12-26	WOS:000370054100004
J	Villahermosa, D; Corzo, A; Garcia-Robledo, E; Gonzalez, JM; Papaspyrou, S				Villahermosa, Desiree; Corzo, Alfonso; Garcia-Robledo, Emilio; Gonzalez, Juan M.; Papaspyrou, Sokratis			Kinetics of Indigenous Nitrate Reducing Sulfide Oxidizing Activity in Microaerophilic Wastewater Biofilms	PLOS ONE			English	Article							BACTERIAL SULFATE REDUCTION; HYDROGEN-SULFIDE; OXYGEN-UPTAKE; AUTOTROPHIC DENITRIFICATION; NITROGEN TRANSFORMATIONS; OXIDATION; INHIBITION; DIFFUSION; REMOVAL; WASTEWATERS	Nitrate decreases sulfide release in wastewater treatment plants (WWTP), but little is known on how it affects the microzonation and kinetics of related microbial processes within the biofilm. The effect of nitrate addition on these properties for sulfate reduction, sulfide oxidation, and oxygen respiration were studied with the use of microelectrodes in microaerophilic wastewater biofilms. Mass balance calaculations and community composition analysis were also performed. At basal WWTP conditions, the biofilm presented a double-layer system. The upper microaerophilic layer (similar to 300 mu m) showed low sulfide production (0.31 mu mol cm(-3) h(-1)) and oxygen consumption rates (0.01 mu mol cm(-3) h(-1)). The anoxic lower layer showed high sulfide production (2.7 mu mol cm(-3) h(-1)). Nitrate addition decreased net sulfide production rates, caused by an increase in sulfide oxidation rates (SOR) in the upper layer, rather than an inhibition of sulfate reducing bacteria (SRB). This suggests that the indigenous nitrate reducing-sulfide oxidizing bacteria (NR-SOB) were immediately activated by nitrate. The functional vertical structure of the biofilm changed to a triple-layer system, where the previously upper sulfide-producing layer in the absence of nitrate split into two new layers: 1) an upper sulfide-consuming layer, whose thickness is probably determined by the nitrate penetration depth within the biofilm, and 2) a middle layer producing sulfide at an even higher rate than in the absence of nitrate in some cases. Below these layers, the lower net sulfide-producing layer remained unaffected. Net SOR varied from 0.05 to 0.72 mu mol cm(-3) h(-1) depending on nitrate and sulfate availability. Addition of low nitrate concentrations likely increased sulfate availability within the biofilm and resulted in an increase of both net sulfate reduction and net sulfide oxidation by overcoming sulfate diffusional limitation from the water phase and the strong coupling between SRB and NR-SOB syntrophic relationship.	[Villahermosa, Desiree; Corzo, Alfonso; Garcia-Robledo, Emilio; Papaspyrou, Sokratis] Univ Cadiz, Dept Biol, Fac Ciencias Mar & Ambientales, Pol Rio San Pedro S-N, Cadiz 11510, Spain; [Gonzalez, Juan M.] IRNAS CSIC, Inst Recursos Nat & Agrobiol, Avda Reina Mercedes 10, Seville 41012, Spain; [Garcia-Robledo, Emilio] Aarhus Univ, Dept Biosci, Microbiol Sect, DK-8000 Aarhus, Denmark; [Papaspyrou, Sokratis] Univ Cadiz, Dept Biomed Biotecnol & Salud Publ, Pol Rio San Pedro S-N, Puerto Real 11510, Spain	Universidad de Cadiz; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Recursos Naturales y Agrobiologia de Sevilla (IRNAS); Aarhus University; Universidad de Cadiz	Corzo, A (corresponding author), Univ Cadiz, Dept Biol, Fac Ciencias Mar & Ambientales, Pol Rio San Pedro S-N, Cadiz 11510, Spain.	alfonso.corzo@uca.es	Corzo, Alfonso/L-9669-2015; Papaspyrou, Sokratis/H-5022-2011; Garcia-Robledo, Emilio/B-3781-2017; Villahermosa Caballero, Desiree/F-3745-2017	Corzo, Alfonso/0000-0003-3718-941X; Papaspyrou, Sokratis/0000-0003-4406-0702; Garcia-Robledo, Emilio/0000-0002-4337-6433; Villahermosa Caballero, Desiree/0000-0003-4072-6159; Gonzalez, Juan Miguel/0000-0003-4746-6775	Consejeria de Innovacion, Ciencia y Empresa, Junta de Andalucia [RNM-214, BIO-288]; Spanish Ministry of Economy and Competitiveness [CTM2013-43857-R];  [P06-RNM-01787];  [P11-RNM-7199]	Consejeria de Innovacion, Ciencia y Empresa, Junta de Andalucia(Junta de Andalucia); Spanish Ministry of Economy and Competitiveness(Spanish Government); ; 	AC was funded by projects P06-RNM-01787, P11-RNM-7199, the PAI group RNM-214 from Consejeria de Innovacion, Ciencia y Empresa, Junta de Andalucia and CTM2013-43857-R from the Spanish Ministry of Economy and Competitiveness. JMG was funded by the PAI group BIO-288 from Consejeria de Innovacion, Ciencia y Empresa, Junta de Andalucia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The study was funded by projects P06-RNM-01787, P11-RNM-7199, the PAI groups RNM-214 and BIO-288 from Consejeria de Innovacion, Ciencia y Empresa, Junta de Andalucia and CTM2013-43857-R from the Spanish Ministry of Economy and Competitiveness. We also want to acknowledge the personnel from Guadalete WWTP and AJEMSA for the technical help during the biofilm growth in situ and collection for experiments.	ABDOLLAHI H, 1979, MICROB ECOL, V5, P73, DOI 10.1007/BF02010581; American Society of Civil Engineers, 1989, SULF WAST COLL TREAT; Andrussow L., 1969, LANDOLTBORNSTEIN ZAH, VII, P513; [Anonymous], 2005, STANDARD METHODS EXA; BAK F, 1991, FEMS MICROBIOL ECOL, V85, P43; Barton LL, 2007, SULPHATE-REDUCING BACTERIA: ENVIRONMENTAL AND ENGINEERED SYSTEMS, P1, DOI 10.1017/CBO9780511541490; Berg P, 1998, LIMNOL OCEANOGR, V43, P1500, DOI 10.4319/lo.1998.43.7.1500; Cardoso RB, 2006, BIOTECHNOL BIOENG, V95, P1148, DOI 10.1002/bit.21084; Bodtker G, 2008, J IND MICROBIOL BIOT, V35, P1625, DOI 10.1007/s10295-008-0406-x; Boeije G, 1999, CHEMOSPHERE, V38, P699, DOI 10.1016/S0045-6535(98)00311-7; BOWER CE, 1980, CAN J FISH AQUAT SCI, V37, P794, DOI 10.1139/f80-106; Can-Dogan E, 2010, WATER SCI TECHNOL, V62, P2286, DOI 10.2166/wst.2010.545; Chen Y, 2008, BIORESOURCE TECHNOL, V99, P4044, DOI 10.1016/j.biortech.2007.01.057; Cirne Dores G., 2008, Reviews in Environmental Science and Bio/Technology, V7, P93, DOI 10.1007/s11157-008-9128-9; CLAUS G, 1985, APPL MICROBIOL BIOT, V22, P283; De Gusseme B, 2009, FEMS MICROBIOL ECOL, V67, P151, DOI 10.1111/j.1574-6941.2008.00598.x; de Lomas JG, 2006, BIOTECHNOL BIOENG, V93, P801, DOI 10.1002/bit.20768; Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002; Eary LE, 1990, ACS S SERIES; Gadekar S, 2006, WATER RES, V40, P2436, DOI 10.1016/j.watres.2006.04.007; Garcia de Lomas J, 2007, WATER RES, V41, P3121, DOI DOI 10.1016/J.WATRES.2007.04.004; Garcia-Robledo E, 2014, MAR CHEM, V162, P30, DOI 10.1016/j.marchem.2014.03.002; Gevertz D, 2000, APPL ENVIRON MICROB, V66, P2491, DOI 10.1128/AEM.66.6.2491-2501.2000; Gonzalez JM, 2003, J MICROBIOL METH, V55, P459, DOI 10.1016/S0167-7012(03)00171-4; Greene EA, 2003, ENVIRON MICROBIOL, V5, P607, DOI 10.1046/j.1462-2920.2003.00446.x; HALL POJ, 1989, LIMNOL OCEANOGR, V34, P734, DOI 10.4319/lo.1989.34.4.0734; Haveman SA, 2004, J BACTERIOL, V186, P7944, DOI 10.1128/JB.186.23.7944-7950.2004; Hoor A.T.-T., 1975, NOV NETH J SEA RES, V9, P344, DOI DOI 10.1016/0077-7579(75)90008-3; INGVORSEN K, 1984, APPL ENVIRON MICROB, V47, P403, DOI 10.1128/AEM.47.2.403-408.1984; INGVORSEN K, 1981, APPL ENVIRON MICROB, V42, P1029, DOI 10.1128/AEM.42.6.1029-1036.1981; Isaksen MF, 1996, APPL ENVIRON MICROB, V62, P408, DOI 10.1128/AEM.62.2.408-414.1996; Ito T, 2002, APPL ENVIRON MICROB, V68, P1392, DOI 10.1128/AEM.68.3.1392-1402.2002; JAENCHEN R, 1984, ARCH MICROBIOL, V137, P362, DOI 10.1007/BF00410735; Jiang GM, 2013, WATER RES, V47, P1783, DOI 10.1016/j.watres.2012.12.036; Jiang GM, 2009, WATER RES, V43, P4430, DOI 10.1016/j.watres.2009.07.001; JORGENSEN BB, 1985, LIMNOL OCEANOGR, V30, P111, DOI 10.4319/lo.1985.30.1.0111; KUHL M, 1992, APPL ENVIRON MICROB, V58, P1164; LENS PN, 1995, WATER RES, V29, P871, DOI 10.1016/0043-1354(94)00195-D; LI YH, 1974, GEOCHIM COSMOCHIM AC, V38, P703; MCCARTNEY DM, 1991, WATER RES, V25, P203, DOI 10.1016/0043-1354(91)90030-T; MILLERO FJ, 1986, MAR CHEM, V18, P121, DOI 10.1016/0304-4203(86)90003-4; Mohanakrishnan J, 2011, APPL MICROBIOL BIOT, V91, P1647, DOI 10.1007/s00253-011-3330-3; Mora M, 2015, APPL MICROBIOL BIOT, V99, P77, DOI 10.1007/s00253-014-5688-5; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Nemati M, 2001, BIOTECHNOL PROGR, V17, P852, DOI 10.1021/bp010084v; NIELSEN PH, 1987, APPL ENVIRON MICROB, V53, P27, DOI 10.1128/AEM.53.1.27-32.1987; Okabe S, 1999, APPL ENVIRON MICROB, V65, P5107; Okabe S, 1999, APPL ENVIRON MICROB, V65, P3182; Okabe S, 2005, APPL ENVIRON MICROB, V71, P2520, DOI 10.1128/AEM.71.5.2520-2529.2005; Okabe S, 2003, WATER SCI TECHNOL, V47, P281, DOI 10.2166/wst.2003.0616; Okabe S, 2003, APPL MICROBIOL BIOT, V63, P322, DOI 10.1007/s00253-003-1395-3; Okabe S, 1998, WATER SCI TECHNOL, V37, P131, DOI 10.1016/S0273-1223(98)00095-X; ONUMA M, 1985, BIOTECHNOL BIOENG, V27, P1533, DOI 10.1002/bit.260271103; Paredes D, 2007, ENG LIFE SCI, V7, P13, DOI 10.1002/elsc.200620170; Portillo MC, 2008, ANTON LEEUW INT J G, V94, P157, DOI 10.1007/s10482-008-9221-7; Portillo MC, 2011, APPL ENVIRON MICROB, V77, P351, DOI 10.1128/AEM.01316-10; Portillo MC, 2009, ANTON LEEUW INT J G, V96, P559, DOI 10.1007/s10482-009-9371-2; Raju HP, 2009, J SCI IND RES INDIA, V68, P406; RAMSING NB, 1993, APPL ENVIRON MICROB, V59, P3840, DOI 10.1128/AEM.59.11.3840-3849.1993; RASMUSSEN H, 1992, MAR ECOL PROG SER, V81, P289, DOI 10.3354/meps081289; REIS MAM, 1992, BIOTECHNOL BIOENG, V40, P593, DOI 10.1002/bit.260400506; Revsbech NP, 2006, ANTON LEEUW INT J G, V90, P361, DOI 10.1007/s10482-006-9087-5; REVSBECH NP, 1989, LIMNOL OCEANOGR, V34, P474, DOI 10.4319/lo.1989.34.2.0474; REVSBECH NP, 1986, ADV MICROB ECOL, V9, P293; Santegoeds CM, 1998, APPL ENVIRON MICROB, V64, P3731; SIEGRIST H, 1985, WATER RES, V19, P1369, DOI 10.1016/0043-1354(85)90303-3; Soreanu G, 2008, WATER SCI TECHNOL, V57, P201, DOI 10.2166/wst.2008.023; Soreanu G, 2008, J ENVIRON ENG SCI, V7, P543, DOI 10.1139/S08-023; Stewart PS, 2003, J BACTERIOL, V185, P1485, DOI 10.1128/JB.185.5.1485-1491.2003; Stewart PS, 1998, BIOTECHNOL BIOENG, V59, P261, DOI 10.1002/(SICI)1097-0290(19980805)59:3<261::AID-BIT1>3.0.CO;2-9; Villahermosa D, 2013, WATER AIR SOIL POLL, V224, DOI 10.1007/s11270-013-1738-3; Watnick P, 2000, J BACTERIOL, V182, P2675, DOI 10.1128/JB.182.10.2675-2679.2000; Zeng H, 2005, WATER RES, V39, P4941, DOI 10.1016/j.watres.2005.09.034	73	4	4	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149096	10.1371/journal.pone.0149096	http://dx.doi.org/10.1371/journal.pone.0149096			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26872267	Green Submitted, Green Published, gold			2022-12-26	WOS:000370054100102
J	Mikolajczyk, TP; Nosalski, R; Szczepaniak, P; Budzyn, K; Osmenda, G; Skiba, D; Sagan, A; Wu, J; Vinh, A; Marvar, PJ; Guzik, B; Podolec, J; Drummond, G; Lob, HE; Harrison, DG; Guzik, TJ				Mikolajczyk, Tomasz P.; Nosalski, Ryszard; Szczepaniak, Piotr; Budzyn, Klaudia; Osmenda, Grzegorz; Skiba, Dominik; Sagan, Agnieszka; Wu, Jing; Vinh, Antony; Marvar, Paul J.; Guzik, Bartlomiej; Podolec, Jakub; Drummond, Grant; Lob, Heinrich E.; Harrison, David G.; Guzik, Tomasz J.			Role of chemokine RANTES in the regulation of perivascular inflammation, T-cell accumulation, and vascular dysfunction in hypertension	FASEB JOURNAL			English	Article						blood pressure; endothelial function; vascular inflammation; immune activation; superoxide	II-DEPENDENT HYPERTENSION; GAMMA-DELTA-T; ADIPOSE-TISSUE; INTERFERON-GAMMA; BLOOD-PRESSURE; MICE; OBESITY; KIDNEY; INJURY; ATHEROSCLEROSIS	Recent studies have emphasized the role of perivascular inflammation in cardiovascular disease. We studied mechanisms of perivascular leukocyte infiltration in angiotensin II (Ang II)-induced hypertension and their links to vascular dysfunction. Chronic Ang II infusion in mice increased immune cell content of T cells (255 +/- 130 to 1664 +/- 349 cells/mg; P < 0.01), M1 and M2 macrophages, and dendritic cells in perivascular adipose tissue. In particular, the content of T lymphocytes bearing CC chemokine receptor (CCR) 1, CCR3, and CCR5 receptors for RANTES chemokine was increased by Ang II (CCR1, 15.6 +/- 1.5% vs. 31 +/- 5%; P < 0.01). Hypertension was associated with an increase in perivascular adipose tissue expression of the chemokine RANTES (relative quantification, 1.2 +/- 0.2 vs. 3.5 +/- 1.1; P < 0.05), which induced T-cell chemotaxis and vascular accumulation of T cells expressing the chemokine receptors CCR1, CCR3, and CCR5. Mechanistically, RANTES(-/-) knockout protected against vascular leukocyte, and in particular T lymphocyte infiltration (26 +/- 5% in wild type Ang II vs. 15 +/- 4% in RANTES(-/-)), which was associated with protection from endothelial dysfunction induced by Ang II. This effect was linked with diminished infiltration of IFN-gamma-producing CD8(+) and double-negative CD3(+)CD4(-)CD8(-) T cells in perivascular space and reduced vascular oxidative stress while FoxP3(+) T-regulatory cells were unaltered. IFN-gamma ex vivo caused significant endothelial dysfunction, which was reduced by superoxide anion scavenging. In a human cohort, a significant inverse correlation was observed between circulating RANTES levels as a biomarker and vascular function measured as flow-mediated dilatation (R = -0.3, P < 0.01) or endothelial injury marker von Willebrand factor (R = +0.3; P < 0.01). Thus, chemokine RANTES is important in the regulation of vascular dysfunction through modulation of perivascular inflammation.-Mikolajczyk, T. P., Nosalski, R., Szczepaniak, P., Budzyn, K., Osmenda, G., Skiba, D., Sagan, A., Wu, J., Vinh, A., Marvar, P. J., Guzik, B., Podolec, J., Drummond, G., Lob, H. E., Harrison, D. G., Guzik, T. J. Role of chemokine RANTES in the regulation of perivascular inflammation, T-cell accumulation, and vascular dysfunction in hypertension. www.fasebj.org	[Mikolajczyk, Tomasz P.; Nosalski, Ryszard; Szczepaniak, Piotr; Osmenda, Grzegorz; Skiba, Dominik; Sagan, Agnieszka; Guzik, Bartlomiej; Podolec, Jakub; Guzik, Tomasz J.] Jagiellonian Univ, Dept Internal Med, Krakow, Poland; [Mikolajczyk, Tomasz P.; Nosalski, Ryszard; Szczepaniak, Piotr; Skiba, Dominik; Sagan, Agnieszka; Guzik, Tomasz J.] Univ Glasgow, British Heart Fdn Ctr Excellence, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland; [Budzyn, Klaudia; Vinh, Antony; Drummond, Grant] Monash Univ, Dept Pharmacol, Melbourne, Vic 3004, Australia; [Wu, Jing; Harrison, David G.] Vanderbilt Univ, Dept Med, Sch Med, Div Clin Pharmacol, Nashville, TN USA; [Marvar, Paul J.] George Washington Univ, Dept Physiol & Pharmacol, Washington, DC USA; [Lob, Heinrich E.] Cornell Univ, Dept Biomed Sci, Ithaca, NY USA	Jagiellonian University; University of Glasgow; Monash University; Vanderbilt University; George Washington University; Cornell University	Guzik, TJ (corresponding author), Univ Glasgow, British Heart Fdn Ctr Excellence, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland.	tomasz.guzik@glasgow.ac.uk	Wu, Jing/AAH-2288-2022; Skiba, Dominik S/X-6617-2019; Guzik, BartÅomiej/AAP-4826-2020; Nosalski, Ryszard/AAG-2611-2019; Wu, Jing/ADF-5420-2022; Guzik, Tomasz Jan/AAM-5007-2020; Mikolajczyk, Tomasz/AFQ-2278-2022; Skiba, Dominik S/X-1190-2019; Skiba, Dominik S/S-3510-2016; Vinh, Antony/I-1563-2014	Wu, Jing/0000-0003-2013-2863; Skiba, Dominik S/0000-0002-5910-2955; Guzik, BartÅomiej/0000-0002-0630-8394; Nosalski, Ryszard/0000-0003-4661-8773; Wu, Jing/0000-0003-2013-2863; Mikolajczyk, Tomasz/0000-0002-7990-2896; Skiba, Dominik S/0000-0002-5910-2955; Skiba, Dominik S/0000-0002-5910-2955; Drummond, Grant/0000-0001-8556-9738; Vinh, Antony/0000-0001-8367-6134; Podolec, Jakub/0000-0001-9169-3428; Guzik, Tomasz/0000-0002-5039-7849; Szczepaniak, Piotr/0000-0003-2622-7337	Polish National Science Centre [2011/03/B/NZ4/02454]; Foundation for Polish Science Welcome [FNP/2009/Welcome02]; Wellcome Trust; Mobility Plus; British Heart Foundation Centre for Excellence	Polish National Science Centre; Foundation for Polish Science Welcome; Wellcome Trust(Wellcome TrustEuropean Commission); Mobility Plus; British Heart Foundation Centre for Excellence	This work was supported in part by the Polish National Science Centre (Agreement 2011/03/B/NZ4/02454); the Foundation for Polish Science Welcome (FNP/2009/Welcome02; to G.O., T.M., and T.G.); an International Senior Research Fellowship from the Wellcome Trust (to T.J.G.); Mobility Plus (to A.S., T.M., and D.S.); and the British Heart Foundation Centre for Excellence.	Agrewala JN, 2007, J BIOL CHEM, V282, P6106, DOI 10.1074/jbc.M608266200; Barhoumi T, 2011, HYPERTENSION, V57, P469, DOI 10.1161/HYPERTENSIONAHA.110.162941; Crowley SD, 2010, HYPERTENSION, V55, P99, DOI 10.1161/HYPERTENSIONAHA.109.144964; De Miguel C, 2015, CURR HYPERTENS REP, V17, DOI 10.1007/s11906-014-0507-z; Frontini A, 2010, CELL METAB, V11, P253, DOI 10.1016/j.cmet.2010.03.004; Galkina E, 2006, J EXP MED, V203, P1273, DOI 10.1084/jem.20052205; Gao YJ, 2007, CURR PHARM DESIGN, V13, P2185; Guzik TJ, 2007, J EXP MED, V204, P2449, DOI 10.1084/jem.20070657; Ji H, 2014, HYPERTENSION, V64, P573, DOI 10.1161/HYPERTENSIONAHA.114.03663; Kirabo A, 2014, J CLIN INVEST, V124, P4642, DOI 10.1172/JCI74084; Koenen RR, 2009, NAT MED, V15, P97, DOI 10.1038/nm.1898; Kossmann S, 2013, ARTERIOSCL THROM VAS, V33, P1313, DOI 10.1161/ATVBAHA.113.301437; Kraus BJ, 2015, FASEB J, V29, P3133, DOI 10.1096/fj.14-266064; Lee DL, 2006, AM J PHYSIOL-HEART C, V290, pH935, DOI 10.1152/ajpheart.00708.2005; Levy JA, 2009, J IMMUNOL, V182, P3945, DOI 10.4049/jimmunol.0990015; Li YL, 2014, HYPERTENSION, V64, P305, DOI 10.1161/HYPERTENSIONAHA.113.02604; Lu C, 2011, EUR J PHARMACOL, V656, P68, DOI 10.1016/j.ejphar.2011.01.023; Madhur MS, 2010, HYPERTENSION, V55, P500, DOI 10.1161/HYPERTENSIONAHA.109.145094; Manea SA, 2014, J CELL MOL MED, V18, P1467, DOI 10.1111/jcmm.12289; Margaritis M, 2013, CIRCULATION, V127, P2209, DOI 10.1161/CIRCULATIONAHA.112.001133; Marko L, 2012, HYPERTENSION, V60, P1430, DOI 10.1161/HYPERTENSIONAHA.112.199265; Marques RE, 2013, EXPERT OPIN THER TAR, V17, P1439, DOI 10.1517/14728222.2013.837886; Mateo T, 2006, J IMMUNOL, V176, P5577, DOI 10.4049/jimmunol.176.9.5577; Mattson DL, 2013, AM J PHYSIOL-REG I, V304, pR407, DOI 10.1152/ajpregu.00304.2012; Omar A, 2014, ARTERIOSCL THROM VAS, V34, P1631, DOI 10.1161/ATVBAHA.114.303030; Peng XG, 2015, J PATHOL, V235, P79, DOI 10.1002/path.4430; Pons H, 2013, AM J PHYSIOL-RENAL, V304, pF289, DOI 10.1152/ajprenal.00517.2012; Rocha VZ, 2008, CIRC RES, V103, P467, DOI 10.1161/CIRCRESAHA.108.177105; Rudemiller N, 2014, HYPERTENSION, V63, P559, DOI 10.1161/HYPERTENSIONAHA.113.02191; Saleh MA, 2015, J CLIN INVEST, V125, P1189, DOI 10.1172/JCI76327; SCHALL TJ, 1988, J IMMUNOL, V141, P1018; Schiffrin EL, 2014, CLIN SCI, V126, P267, DOI 10.1042/CS20130407; Takemori K, 2007, HYPERTENSION, V49, P365, DOI 10.1161/01.HYP.0000255576.16089.b9; Uemura Y, 2015, FASEB J, V29, P141, DOI 10.1096/fj.14-258129; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Veillard NR, 2004, CIRC RES, V94, P253, DOI 10.1161/01.RES.0000109793.17591.4E; Wenzel P, 2011, CIRCULATION, V124, P1370, DOI 10.1161/CIRCULATIONAHA.111.034470; WIRSEN C, 1964, NATURE, V202, P913, DOI 10.1038/202913a0; Wolf G, 1997, J CLIN INVEST, V100, P1047, DOI 10.1172/JCI119615; Wolkow PP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108587; Wu HZ, 2007, CIRCULATION, V115, P1029, DOI 10.1161/CIRCULATIONAHA.106.638379; Zhang JD, 2014, HYPERTENSION, V64, P1275, DOI 10.1161/HYPERTENSIONAHA.114.03863	42	148	158	0	30	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2016	30	5					1987	1999		10.1096/fj.201500088R	http://dx.doi.org/10.1096/fj.201500088R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DK4HW	26873938	Green Published, hybrid, Green Accepted			2022-12-26	WOS:000374879400026
J	Baek, JI; Kwon, SH; Zuo, XF; Choi, SY; Kim, SH; Lipschutz, JH				Baek, Jeong-In; Kwon, Sang-Ho; Zuo, Xiaofeng; Choi, Soo Young; Kim, Seok-Hyung; Lipschutz, Joshua H.			Dynamin Binding Protein (Tuba) Deficiency Inhibits Ciliogenesis and Nephrogenesis in Vitro and in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						CDC42; cilia; guanine nucleotide exchange factor (GEF); kidney; membrane trafficking	NUCLEOTIDE EXCHANGE FACTORS; CDC42 GEF; PRIMARY CILIUM; ZEBRAFISH PRONEPHROS; EXTRACELLULAR-MATRIX; EPITHELIAL POLARITY; SPINDLE ORIENTATION; KUPFFERS VESICLE; LINKS DYNAMIN; WILD-TYPE	Dysfunction of renal primary cilia leads to polycystic kidney disease. We previously showed that the exocyst, a protein trafficking complex, is essential for ciliogenesis and regulated by multiple Rho and Rab family GTPases, such as Cdc42. Cdc42 deficiency resulted in a disruption of renal ciliogenesis and a polycystic kidney disease phenotype in zebrafish and mice. Here we investigate the role of Dynamin binding protein (also known as Tuba), a Cdc42-specific guanine nucleotide exchange factor, in ciliogenesis and nephrogenesis using Tuba knockdown Madin-Darby canine kidney cells and tuba knockdown in zebrafish. Tuba depletion resulted in an absence of cilia, with impaired apical polarization and inhibition of hepatocyte growth factor-induced tubulogenesis in Tuba knockdown Madin-Darby canine kidney cell cysts cultured in a collagen gel. In zebrafish, tuba was expressed in multiple ciliated organs, and, accordingly, tuba start and splice site morphants showed various ciliary mutant phenotypes in these organs. Co-injection of tuba and cdc42 morpholinos at low doses, which alone had no effect, resulted in genetic synergy and led to abnormal kidney development with highly disorganized pronephric duct cilia. Morpholinos targeting two other guanine nucleotide exchange factors not known to be in the Cdc42/ciliogenesis pathway and a scrambled control morpholino showed no phenotypic effect. Given the molecular nature of Cdc42 and Tuba, our data strongly suggest that tuba and cdc42 act in the same ciliogenesis pathway. Our study demonstrates that Tuba deficiency causes an abnormal renal ciliary and morphogenetic phenotype. Tuba most likely plays a critical role in ciliogenesis and nephrogenesis by regulating Cdc42 activity.	[Baek, Jeong-In; Kwon, Sang-Ho; Zuo, Xiaofeng; Choi, Soo Young; Kim, Seok-Hyung; Lipschutz, Joshua H.] Med Univ S Carolina, Dept Med, Clin Sci Bldg 829,96 Jonathan Lucas St, Charleston, SC 29425 USA; [Lipschutz, Joshua H.] Ralph H Johnson Vet Affairs Med Ctr, Dept Med, Charleston, SC 29401 USA	Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center	Lipschutz, JH (corresponding author), Med Univ S Carolina, Dept Med, Clin Sci Bldg 829,96 Jonathan Lucas St, Charleston, SC 29425 USA.	Lipschut@musc.edu		Kwon, Sang-Ho/0000-0001-9074-4641	Department of Veterans Affairs Merit Award [2I01BX000820]; National Institutes of Health [2P30DK074038]; PKD Foundation fellowship award; NATIONAL CANCER INSTITUTE [P30CA138313] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK074038] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000820] Funding Source: NIH RePORTER	Department of Veterans Affairs Merit Award(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PKD Foundation fellowship award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported in part by Department of Veterans Affairs Merit Award 2I01BX000820 (to J. H. L.), National Institutes of Health Grant 2P30DK074038 (to J. H. L.), and a PKD Foundation fellowship award (to J. I. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Badano JL, 2006, ANNU REV GENOM HUM G, V7, P125, DOI 10.1146/annurev.genom.7.080505.115610; Bao Q, 1999, GLYCOBIOLOGY, V9, P489, DOI 10.1093/glycob/9.5.489; BAO Q, 1995, J CELL SCI, V108, P2791; Baschieri F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5839; Bryant DM, 2010, NAT CELL BIOL, V12, P1035, DOI 10.1038/ncb2106; Cestra G, 2005, METHOD ENZYMOL, V404, P537, DOI 10.1016/S0076-6879(05)04047-4; Cheng HY, 2005, J AM SOC NEPHROL, V16, P1612, DOI 10.1681/ASN.2004121145; Choi SY, 2013, J AM SOC NEPHROL, V24, P1435, DOI 10.1681/ASN.2012121236; Clement A, 2011, DEVELOPMENT, V138, P291, DOI 10.1242/dev.055038; Dixon-Salazar TJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003544; Essner JJ, 2005, DEVELOPMENT, V132, P1247, DOI 10.1242/dev.01663; Essner JJ, 2002, NATURE, V418, P37, DOI 10.1038/418037a; Etienne-Manneville S, 2004, J CELL SCI, V117, P1291, DOI 10.1242/jcs.01115; Fan SL, 2004, CURR BIOL, V14, P1451, DOI 10.1016/j.cub.2004.08.025; Fogelgren B, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001361; Genot E, 2012, J CELL SCI, V125, P3265, DOI 10.1242/jcs.093419; Gerdes JM, 2007, NAT GENET, V39, P1350, DOI 10.1038/ng.2007.12; Gerdes JM, 2009, CELL, V137, P32, DOI 10.1016/j.cell.2009.03.023; Gherman A, 2006, NAT GENET, V38, P961, DOI 10.1038/ng0906-961; Gudjonsson T, 2002, J CELL SCI, V115, P39; Guo W, 1999, J BIOL CHEM, V274, P23558, DOI 10.1074/jbc.274.33.23558; Guo W, 1999, EMBO J, V18, P1071, DOI 10.1093/emboj/18.4.1071; Hao Y, 2010, CURR BIOL, V20, P1809, DOI 10.1016/j.cub.2010.09.032; Hauptmann G, 2000, METH MOL B, V137, P139; Hou P, 2003, HUM MOL GENET, V12, P1981, DOI 10.1093/hmg/ddg209; Jaffe KM, 2010, METHOD CELL BIOL, V97, P415, DOI 10.1016/S0091-679X(10)97022-2; Jurisch-Yaksi N, 2013, J CELL BIOL, V200, P709, DOI 10.1083/jcb.201208175; Kim J, 2010, NATURE, V464, P1048, DOI 10.1038/nature08895; Kovacs EM, 2006, J CELL SCI, V119, P2715, DOI 10.1242/jcs.03005; Kovacs EM, 2011, CELL ADHES MIGR, V5, P344, DOI 10.4161/cam.5.4.16717; Kramer-Zucker AG, 2005, DEVELOPMENT, V132, P1907, DOI 10.1242/dev.01772; LINDSTEDT R, 1993, J BIOL CHEM, V268, P11750; Lipschutz JH, 2002, CURR BIOL, V12, pR212, DOI 10.1016/S0960-9822(02)00753-4; Lipschutz JH, 2000, MOL BIOL CELL, V11, P4259, DOI 10.1091/mbc.11.12.4259; Liu JL, 2012, PROTOPLASMA, V249, P587, DOI 10.1007/s00709-011-0330-1; Lu Q, 2015, NAT CELL BIOL, V17, P228, DOI 10.1038/ncb3109; Mao ZG, 2011, AM J PHYSIOL-RENAL, V300, pF1375, DOI 10.1152/ajprenal.00482.2010; Marszalek JR, 1999, P NATL ACAD SCI USA, V96, P5043, DOI 10.1073/pnas.96.9.5043; McGavin MKH, 2001, J EXP MED, V194, P1777, DOI 10.1084/jem.194.12.1777; Meder D, 2005, J CELL BIOL, V168, P303, DOI 10.1083/jcb.200407072; Nakanishi H, 2008, J CELL MOL MED, V12, P1169, DOI 10.1111/j.1582-4934.2008.00345.x; O'Brien LE, 2004, DEV CELL, V7, P21, DOI 10.1016/j.devcel.2004.06.001; O'Brien LE, 2002, NAT REV MOL CELL BIO, V3, P531, DOI 10.1038/nrm859; O'Brien LE, 2001, NAT CELL BIOL, V3, P831, DOI 10.1038/ncb0901-831; Oishi I, 2006, NAT GENET, V38, P1316, DOI 10.1038/ng1892; Otani T, 2006, J CELL BIOL, V175, P135, DOI 10.1083/jcb.200605012; Otto EA, 2003, NAT GENET, V34, P413, DOI 10.1038/ng1217; Pennekamp Petra, 2015, Cilia, V4, P1, DOI 10.1186/s13630-014-0010-9; Pollack AL, 1998, DEV BIOL, V204, P64, DOI 10.1006/dbio.1998.9091; Pruliere G, 2011, MOL BIOL CELL, V22, P2042, DOI 10.1091/mbc.E10-10-0844; Qin Y, 2010, J CELL BIOL, V189, P661, DOI 10.1083/jcb.201002097; Raeker MO, 2010, DEV BIOL, V337, P432, DOI 10.1016/j.ydbio.2009.11.018; Rodriguez-Boulan E, 2014, NAT REV MOL CELL BIO, V15, P225, DOI 10.1038/nrm3775; Rodriguez-Fraticelli AE, 2010, J CELL BIOL, V189, P725, DOI 10.1083/jcb.201002047; Rogers KK, 2003, KIDNEY INT, V63, P1632, DOI 10.1046/j.1523-1755.2003.00902.x; Sakurai H, 1998, KIDNEY INT, V54, P14, DOI 10.1046/j.1523-1755.1998.00969.x; Salazar MA, 2003, J BIOL CHEM, V278, P49031, DOI 10.1074/jbc.M308104200; SANTOS OFP, 1993, DEV BIOL, V160, P293, DOI 10.1006/dbio.1993.1308; SATO S, 1993, EXP CELL RES, V207, P8, DOI 10.1006/excr.1993.1157; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Sfakianos J, 2007, J CELL BIOL, V179, P1133, DOI 10.1083/jcb.200709111; Sun ZX, 2004, DEVELOPMENT, V131, P4085, DOI 10.1242/dev.01240; THISSE C, 1993, DEVELOPMENT, V119, P1203; Tobin JL, 2008, PEDIATR NEPHROL, V23, P2095, DOI 10.1007/s00467-008-0898-7; Wakayama Y, 2015, DEV CELL, V32, P109, DOI 10.1016/j.devcel.2014.11.024; Wessely O, 2008, FRONT BIOSCI-LANDMRK, V13, P1866, DOI 10.2741/2806; Wingert RA, 2008, KIDNEY INT, V73, P1120, DOI 10.1038/ki.2008.37; Wingert RA, 2007, PLOS GENET, V3, P1922, DOI 10.1371/journal.pgen.0030189; Yu W, 2005, MOL BIOL CELL, V16, P433, DOI 10.1091/mbc.e04-05-0435; Yu W, 2008, EMBO REP, V9, P923, DOI 10.1038/embor.2008.135; Zhang XY, 2001, J BIOL CHEM, V276, P46745, DOI 10.1074/jbc.M107464200; Zhao CT, 2012, P NATL ACAD SCI USA, V109, P2388, DOI 10.1073/pnas.1116035109; Zuo XF, 2011, J BIOL CHEM, V286, P22469, DOI 10.1074/jbc.M111.238469; Zuo XF, 2009, MOL BIOL CELL, V20, P2522, DOI 10.1091/mbc.E08-07-0772	74	12	14	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2016	291	16					8632	8643		10.1074/jbc.M115.688663	http://dx.doi.org/10.1074/jbc.M115.688663			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK2VT	26895965	Green Published, hybrid			2022-12-26	WOS:000374773200026
J	Badu-Nkansah, A; Mason, AC; Eichman, BF; Cortez, D				Badu-Nkansah, Akosua; Mason, Aaron C.; Eichman, Brandt F.; Cortez, David			Identification of a Substrate Recognition Domain in the Replication Stress Response Protein Zinc Finger Ran-binding Domain-containing Protein 3 (ZRANB3)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA; DNA-binding protein; DNA damage response; DNA repair; DNA replication; endonuclease; protein domain	SCHIMKE IMMUNOOSSEOUS DYSPLASIA; ANNEALING HELICASE; FORK REVERSAL; HUMAN HLTF; DNA; REPAIR; TRANSLOCASE; MUTATION; RESTART; CANCER	DNA damage and other forms of replication stress can cause replication forks to stall. Replication stress response proteins stabilize and resolve stalled forks by mechanisms that include fork remodeling to facilitate repair or bypass of damaged templates. Several enzymes including SMARCAL1, HLTF, and ZRANB3 catalyze these reactions. SMARCAL1 and HLTF utilize structurally distinct accessory domains attached to an ATPase motor domain to facilitate DNA binding and catalysis of fork remodeling reactions. Here we describe a substrate recognition domain within ZRANB3 that is needed for it to recognize forked DNA structures, hydrolyze ATP, catalyze fork remodeling, and act as a structure-specific endonuclease. Thus, substrate recognition domains are a common feature of fork remodeling, SNF2-family, DNA-dependent ATPases, and our study provides further mechanistic understanding of how these enzymes maintain genome integrity during DNA replication.	[Badu-Nkansah, Akosua; Eichman, Brandt F.; Cortez, David] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA; [Mason, Aaron C.; Eichman, Brandt F.] Vanderbilt Univ, Coll Arts & Sci, Dept Biol Sci, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	Cortez, D (corresponding author), Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA.	david.cortez@vanderbilt.edu	Classen, Scott/AAY-8176-2020		National Institutes of Health [R01CA102729-11A1S1, R01CA160432, P01CA092584];  [3R01CA102729]; NATIONAL CANCER INSTITUTE [R01CA160432, T32CA009582, R01CA102729, P01CA092584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM116616, R01GM117299] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01CA102729-11A1S1, R01CA160432, and P01CA092584 (to D. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by a diversity supplement grant 3R01CA102729.	Achar YJ, 2015, NUCLEIC ACIDS RES, V43, P10277, DOI 10.1093/nar/gkv896; Bansbach CE, 2009, GENE DEV, V23, P2405, DOI 10.1101/gad.1839909; Baradaran-Heravi A, 2012, AM J MED GENET A, V158A, P2204, DOI 10.1002/ajmg.a.35532; Betous R, 2013, CELL REP, V3, P1958, DOI 10.1016/j.celrep.2013.05.002; Betous R, 2012, GENE DEV, V26, P151, DOI 10.1101/gad.178459.111; Bhat KP, 2015, J BIOL CHEM, V290, P4110, DOI 10.1074/jbc.M114.627083; Blastyak A, 2010, MOL CELL BIOL, V30, P684, DOI 10.1128/MCB.00863-09; Boerkoel CF, 2002, NAT GENET, V30, P215, DOI 10.1038/ng821; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; Carroll C, 2015, AM J MED GENET A, V167, P2260, DOI 10.1002/ajmg.a.37146; Carroll C, 2013, PEDIATR BLOOD CANCER, V60, pE88, DOI 10.1002/pbc.24542; Chen XY, 2013, ADV DRUG DELIVER REV, V65, P1357, DOI 10.1016/j.addr.2012.09.039; Ciccia A, 2012, MOL CELL, V47, P396, DOI 10.1016/j.molcel.2012.05.024; Ciccia A, 2009, GENE DEV, V23, P2415, DOI 10.1101/gad.1832309; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Flaus A, 2006, NUCLEIC ACIDS RES, V34, P2887, DOI 10.1093/nar/gkl295; Hishiki A, 2015, J BIOL CHEM, V290, P13215, DOI 10.1074/jbc.M115.643643; Kile AC, 2015, MOL CELL, V58, P1090, DOI 10.1016/j.molcel.2015.05.013; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Mason AC, 2014, P NATL ACAD SCI USA, V111, P7618, DOI 10.1073/pnas.1324143111; Moinova HR, 2002, P NATL ACAD SCI USA, V99, P4562, DOI 10.1073/pnas.062459899; Neelsen KJ, 2015, NAT REV MOL CELL BIO, V16, P207, DOI 10.1038/nrm3935; Petermann E, 2010, NAT REV MOL CELL BIO, V11, P683, DOI 10.1038/nrm2974; Porollo AA, 2004, BIOINFORMATICS, V20, P2460, DOI 10.1093/bioinformatics/bth248; Postow L, 2009, J BIOL CHEM, V284, P35951, DOI 10.1074/jbc.M109.048330; Weston R, 2012, GENE DEV, V26, P1558, DOI 10.1101/gad.193516.112; Yuan JS, 2012, MOL CELL, V47, P410, DOI 10.1016/j.molcel.2012.05.025; Yuan JS, 2009, GENE DEV, V23, P2394, DOI 10.1101/gad.1836409; Yusufzai T, 2008, SCIENCE, V322, P748, DOI 10.1126/science.1161233; Yusufzai T, 2010, P NATL ACAD SCI USA, V107, P20970, DOI 10.1073/pnas.1011196107; Zeman MK, 2014, NAT CELL BIOL, V16, P2, DOI 10.1038/ncb2897	31	16	16	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2016	291	15					8251	8257		10.1074/jbc.M115.709733	http://dx.doi.org/10.1074/jbc.M115.709733			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DJ2SZ	26884333	hybrid, Green Published			2022-12-26	WOS:000374056700040
J	Chang, Y; Li, B; Xu, XL; Shen, L; Bai, HX; Gao, F; Zhang, ZB; Jonas, JB				Chang, Ying; Li, Bin; Xu, Xiaolin; Shen, Ling; Bai, Haixia; Gao, Fei; Zhang, Zhibao; Jonas, Jost B.			Lentivirus-Mediated Knockdown of Astrocyte Elevated Gene-1 Inhibits Growth and Induces Apoptosis through MAPK Pathways in Human Retinoblastoma Cells	PLOS ONE			English	Article							RAPID SUBTRACTION HYBRIDIZATION; PROTEIN-KINASES; CYTOCHROME-C; CANCER-CELLS; EXPRESSION; PROGRESSION; ACTIVATION; SURVIVAL; DEATH; JNK	Purpose To explore expression and function of astrocyte elevated gene-1 (AEG-1) in human retinoblastoma (RB). Methods The expression of AEG-1 in histological sections of human RBs and in RB cell lines was examined using immunohistochemical staining and RT-PCR and Western blotting respectively. We knocked down AEG-1 gene levels by AEG-1-siRNA lentivirus transfection of human RB cell lines SO-RB50 and Y79, and using an MTT assay, we assessed the role of AEG-1 on RB cell proliferation. The biological significance of lentivirus transfection induced AEG-1 down-regulation was examined by assessing the apoptosis rate in the transfected RB cells by Annexin V-APC staining and flow cytometry. We additionally measured the expression of Bcl-2, Bax, cleaved-caspase-3 and caspase-3, and the phosphorylation and non-phosphorylation alternation of MAPKs. Results AEG-1 expression was detected to be strongly positive in the histological slides of 35 out of 54 (65%) patients with RB. AEG-1 expression increased significantly (P<0.05) with tumor stage. In the RB cell lines SO-RB50, Y79 and WERI-RB1 as compared with retinal pigment epithelium cells, expression of AEG-1 mRNA and AEG-1 protein was significantly higher. In AEG-1-siRNA lentivirus transfected cell cultures as compared with negative control lentivirus transfected cell cultures, levels of AEG-1 mRNA and of AEG-1 protein (P<0.05) and cell growth rates (P<0.01) were significantly lower, and apoptosis rate (P<0.001), Bax/Bcl-2 ratio and cleaved-caspase-3 protein level were significantly increased. The P-ERK/ERK ratio was significantly decreased in the AEG-1-siRNA lentivirus transfected cell lines. Conclusions Expression of AEG-1 was associated with RB, in histological slides of patients and in cell culture experiments. Lentivirus transfection induced knockdown of AEG-1 had a tumor suppressive effect, potentially by tumor cell apoptosis induction through inhibition of ERK.	[Chang, Ying; Li, Bin; Xu, Xiaolin; Shen, Ling; Bai, Haixia; Gao, Fei; Zhang, Zhibao] Capital Med Univ, Beijing TongRen Hosp, Beijing Ophthalmol & Visual Sci Key Lab, Beijing Inst Ophthalmol,Beijing TongRen Eye Ctr, Beijing, Peoples R China; [Jonas, Jost B.] Heidelberg Univ, Med Fac Mannheim, Dept Ophthalmol, Mannheim, Germany	Capital Medical University; Ruprecht Karls University Heidelberg	Li, B (corresponding author), Capital Med Univ, Beijing TongRen Hosp, Beijing Ophthalmol & Visual Sci Key Lab, Beijing Inst Ophthalmol,Beijing TongRen Eye Ctr, Beijing, Peoples R China.	libin43_99@163.com	Shen, Ling/AAF-9067-2020; fei, Gao/GQQ-8024-2022; Bai, Haixia/HDO-0641-2022		National Natural Science Foundation of China [81172393]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (grant No. 81172393, 2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allaman-Pillet N, 2013, OPHTHALMIC GENET, V34, P1, DOI 10.3109/13816810.2011.615077; Cai BB, 2006, J BIOL CHEM, V281, P25215, DOI 10.1074/jbc.M512627200; Chevez-Barrios P, 2000, AM J PATHOL, V157, P1405, DOI 10.1016/S0002-9440(10)64653-6; Corson TW, 2007, GENE CHROMOSOME CANC, V46, P617, DOI 10.1002/gcc.20457; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; de Jong MC, 2014, LANCET ONCOL, V15, P1157, DOI 10.1016/S1470-2045(14)70336-5; Dimaras H, 2012, LANCET, V379, P1436, DOI 10.1016/S0140-6736(11)61137-9; Emdad L, 2007, PHARMACOL THERAPEUT, V114, P155, DOI 10.1016/j.pharmthera.2007.01.010; Emdad L, 2013, ADV CANCER RES, V120, P75, DOI 10.1016/B978-0-12-401676-7.00003-6; Emdad L, 2010, MOL CANCER THER, V9, P79, DOI 10.1158/1535-7163.MCT-09-0752; Fan MY, 2001, DRUG RESIST UPDATE, V4, P253, DOI 10.1054/drup.2001.0214; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Kivela T, 2003, OPHTHALMOLOGY, V110, P1983, DOI 10.1016/S0161-6420(03)00484-6; Knudson AG, 2001, NAT REV CANCER, V1, P157, DOI 10.1038/35101031; Kong XL, 2012, CANCER BIOL THER, V13, P43, DOI 10.4161/cbt.13.1.18868; Lee SG, 2009, ONCOGENE, V28, P2476, DOI 10.1038/onc.2009.93; Li J, 2008, CLIN CANCER RES, V14, P3319, DOI 10.1158/1078-0432.CCR-07-4054; Li L, 2011, INVEST OPHTH VIS SCI, V52, P8393, DOI 10.1167/iovs.11-8139; Li SP, 2003, CANCER RES, V63, P3473; Liu LP, 2010, CANCER RES, V70, P3750, DOI 10.1158/0008-5472.CAN-09-3838; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MCFALL RC, 1977, CANCER RES, V37, P1003; Min HB, 2012, MOL CARCINOGEN, V51, P576, DOI 10.1002/mc.20825; Muthusamy V, 2010, ARCH DERMATOL RES, V302, P5, DOI 10.1007/s00403-009-0994-y; Ow YLP, 2008, NAT REV MOL CELL BIO, V9, P532, DOI 10.1038/nrm2434; Park KJ, 2015, J NEURO-ONCOL, V121, P31, DOI 10.1007/s11060-014-1603-2; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; REID TW, 1974, J NATL CANCER I, V53, P347, DOI 10.1093/jnci/53.2.347; Rodriguez-Galindo C, 2008, PEDIATRICS, V122, pE763, DOI 10.1542/peds.2008-0518; Seregard S, 2004, OPHTHALMOLOGY, V111, P1228, DOI 10.1016/j.ophtha.2003.10.023; Singh L, 2015, CLIN EXP OPHTHALMOL, V43, P259, DOI 10.1111/ceo.12397; Su ZZ, 2003, GENE, V306, P67, DOI 10.1016/S0378-1119(03)00404-9; Su ZZ, 2002, ONCOGENE, V21, P3592, DOI 10.1038/sj.onc.1205445; Temming P, 2012, FUTURE ONCOL, V8, P525, DOI [10.2217/fon.12.41, 10.2217/FON.12.41]; Tournier C, 2000, SCIENCE, V288, P870, DOI 10.1126/science.288.5467.870; Wagner N, 2003, EXP EYE RES, V77, P1, DOI 10.1016/s0014-4835(03)00108-8; Wang JW, 2014, FEBS J, V281, P1355, DOI 10.1111/febs.12659; Wang JW, 2022, FEBS LETT, DOI 10.1016/j.febslet.2013.04.029; Xia ZB, 2010, CLIN NEUROL NEUROSUR, V112, P413, DOI 10.1016/j.clineuro.2010.02.007; Xu YF, 2009, CANCER LETT, V284, P229, DOI 10.1016/j.canlet.2009.04.028; Yoo BK, 2011, PHARMACOL THERAPEUT, V130, P1, DOI 10.1016/j.pharmthera.2011.01.008; Yoo BK, 2009, J CLIN INVEST, V119, P465, DOI 10.1172/JCI36460; Yunoki T, 2015, GRAEF ARCH CLIN EXP, V253, P399, DOI 10.1007/s00417-014-2874-1	44	15	16	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0148763	10.1371/journal.pone.0148763	http://dx.doi.org/10.1371/journal.pone.0148763			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3DG	26894431	Green Submitted, Green Published, gold			2022-12-26	WOS:000371223400021
J	Mastrantonio, R; Cervelli, M; Pietropaoli, S; Mariottini, P; Colasanti, M; Persichini, T				Mastrantonio, Roberta; Cervelli, Manuela; Pietropaoli, Stefano; Mariottini, Paolo; Colasanti, Marco; Persichini, Tiziana			HIV-Tat Induces the Nrf2/ARE Pathway through NMDA Receptor-Elicited Spermine Oxidase Activation in Human Neuroblastoma Cells	PLOS ONE			English	Article							OXIDATIVE STRESS; POLYAMINE CATABOLISM; PROTEIN; NEUROTOXICITY; LOCALIZATION; EXPRESSION; DAMAGE; GP120; MODEL; ACID	Previously, we reported that HIV-Tat elicits spermine oxidase (SMO) activity upregulation through NMDA receptor (NMDAR) stimulation in human SH-SY5Y neuroblastoma cells, thus increasing ROS generation, which in turn leads to GSH depletion, oxidative stress, and reduced cell viability. In several cell types, ROS can trigger an antioxidant cell response through the transcriptional induction of oxidative stress-responsive genes regulated by the nuclear factor erythroid 2-related factor 2 (Nrf2). Here, we demonstrate that Tat induces both antioxidant gene expression and Nrf2 activation in SH-SY5Y cells, mediated by SMO activity. Furthermore, NMDAR is involved in Tat-induced Nrf2 activation. These findings suggest that the NMDAR/SMO/Nrf2 pathway is an important target for protection against HIV-associated neurocognitive disorders.	[Mastrantonio, Roberta; Cervelli, Manuela; Pietropaoli, Stefano; Mariottini, Paolo; Colasanti, Marco; Persichini, Tiziana] Univ ROMA TRE, Dept Sci, Rome, Italy	Italfarmaco; Roma Tre University	Persichini, T (corresponding author), Univ ROMA TRE, Dept Sci, Rome, Italy.	tiziana.persichini@uniroma3.it	COLASANTI, MARCO/A-5616-2010; Cervelli, Manuela/ABC-6913-2020	COLASANTI, MARCO/0000-0002-5752-4943; Cervelli, Manuela/0000-0001-8535-8279; PERSICHINI, TIZIANA/0000-0001-8291-6706; mastrantonio, roberta/0000-0002-1764-457X; Pietropaoli, Stefano/0000-0002-8423-9187	University "ROMA TRE"	University "ROMA TRE"	This work was supported by University "ROMA TRE" contribution for the laboratory (CAL) to M. Cervelli, M. Colasanti, PM, TP, and for the PhD school (Department of Science) to RM and SP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akay C, 2014, J NEUROVIROL, V20, P39, DOI 10.1007/s13365-013-0227-1; Banerjee A, 2010, FREE RADICAL BIO MED, V48, P1388, DOI 10.1016/j.freeradbiomed.2010.02.023; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Capone C, 2013, FREE RADICAL BIO MED, V63, P99, DOI 10.1016/j.freeradbiomed.2013.05.007; Casero RA, 2009, BIOCHEM J, V421, P323, DOI 10.1042/BJ20090598; Cervelli M, 2004, EUR J BIOCHEM, V271, P760, DOI 10.1111/j.1432-1033.2004.03979.x; Cervelli M, 2003, J BIOL CHEM, V278, P5271, DOI 10.1074/jbc.M207888200; Cervelli M, 2014, AMINO ACIDS, V46, P521, DOI 10.1007/s00726-013-1572-3; Cervelli M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064810; Cervelli M, 2013, J ENZYM INHIB MED CH, V28, P463, DOI 10.3109/14756366.2011.650691; Cervelli M, 2012, AMINO ACIDS, V42, P441, DOI 10.1007/s00726-011-1014-z; Chang HC, 1997, AIDS, V11, P1421, DOI 10.1097/00002030-199712000-00006; Davinelli S, 2014, BIOGERONTOLOGY, V15, P449, DOI 10.1007/s10522-014-9511-6; de Vera N, 2008, J NEUROSCI RES, V86, P861, DOI 10.1002/jnr.21538; Facecchia K, 2011, J TOXICOL-US, V2011, DOI 10.1155/2011/683728; Ghafouri M, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-28; Gill AJ, 2013, CRIT REV IMMUNOL, V33, P307, DOI 10.1615/critrevimmunol.2013007247; Isaguliants M, 2013, HUM VACC IMMUNOTHER, V9, P2111, DOI 10.4161/hv.25813; Jing X, 2015, NEUROSCIENCE, V286, P131, DOI 10.1016/j.neuroscience.2014.11.047; Johnson DA, 2015, FREE RADIC IN PRESS; Kanninen KM, 2015, FREE RADIC IN PRESS; Kolson DL, 2002, CLIN LAB MED, V22, P703, DOI 10.1016/S0272-2712(02)00009-4; Kwak MK, 2003, BIOCHEM BIOPH RES CO, V305, P662, DOI 10.1016/S0006-291X(03)00834-9; LEFF JA, 1992, FREE RADICAL BIO MED, V13, P143, DOI 10.1016/0891-5849(92)90076-S; Mann GE, 2015, FREE RADIC BIOL MED; MATES JM, 1992, AGENTS ACTIONS, V36, P17, DOI 10.1007/BF01991222; Niture SK, 2014, FREE RADICAL BIO MED, V66, P36, DOI 10.1016/j.freeradbiomed.2013.02.008; PACE GW, 1995, FREE RADICAL BIO MED, V19, P523, DOI 10.1016/0891-5849(95)00047-2; Park MH, 2013, BIOMOL THER, V21, P1, DOI 10.4062/biomolther.2012.097; Persichini T, 2014, FREE RADICAL BIO MED, V74, P14, DOI 10.1016/j.freeradbiomed.2014.06.009; Reddy PVB, 2012, NEUROCHEM INT, V61, P807, DOI 10.1016/j.neuint.2011.06.011; Reynolds A, 2007, INT REV NEUROBIOL, V82, P297, DOI 10.1016/S0074-7742(07)82016-2; Suzuki T, 2015, FREE RADIC IN PRESS; Takahashi K, 1996, ANN NEUROL, V39, P705, DOI 10.1002/ana.410390606; Toborek M, 2003, J NEUROCHEM, V84, P169, DOI 10.1046/j.1471-4159.2003.01543.x; Wang Q, 2005, MOL NEUROBIOL, V31, P3, DOI 10.1385/MN:31:1-3:003; Wood PL, 2006, BRAIN RES, V1095, P190, DOI 10.1016/j.brainres.2006.04.038; Zahedi K, 2010, J NEUROTRAUM, V27, P515, DOI 10.1089/neu.2009.1097; Zhang HS, 2009, FREE RADICAL BIO MED, V47, P261, DOI 10.1016/j.freeradbiomed.2009.04.028	39	34	37	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0149802	10.1371/journal.pone.0149802	http://dx.doi.org/10.1371/journal.pone.0149802			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3DG	26895301	Green Submitted, Green Published, gold			2022-12-26	WOS:000371223400083
J	Odajima, T; Takanashi, M; Sugimori, H; Tanba, T; Yoshinaga, K; Motoji, T; Munakata, M; Nakajima, K; Minami, M				Odajima, Takeshi; Takanashi, Minoko; Sugimori, Hiroki; Tanba, Taiko; Yoshinaga, Kentaro; Motoji, Toshiko; Munakata, Masaya; Nakajima, Kazunori; Minami, Mutsuhiko			Impact of Elevated Hemoglobin and Serum Protein on Vasovagal Reaction from Blood Donation	PLOS ONE			English	Article							ADVERSE-REACTIONS; DONORS; SEX	We conducted a cross-sectional study to elucidate factors contributing to vasovagal reaction (VVR), the most frequent side effect following whole blood and apheresis donations. Complications recorded at the collection sites after voluntary donations by the Japanese Red Cross Tokyo Blood Center (JRC), in the 2006 and 2007 fiscal years, were analyzed by both univariate analysis and the multivariate conditional logistic regression model. Of 1,119,716 blood donations over the full two years, complications were recorded for 13,320 donations (1.18%), among which 67% were VVR. There were 4,303 VVR cases which had sufficient information and could be used for this study. For each VVR case, two sex- and age-matched controls (n = 8,606) were randomly selected from the donors without complications. Age, sex, body mass index (BMI), predonation blood pressure, pulse and blood test results, including total protein, albumin, and hemoglobin, were compared between the VVR group and the control group. In univariate analysis, the VVR group was significantly younger, with a lower BMI, higher blood pressure and higher blood protein and hemoglobin levels than the control group (p<0.001). Furthermore, blood protein and hemoglobin levels showed dose-dependent relationships with VVR incidences by the Cochran-Armitage trend test (p<0.01). For both sexes, after adjusting for confounders with the multivariate conditional logistic regression model, the higher than median groups for total protein (male: OR 1.97; 95% CI 1.76,-2.21; female: OR 2.29; 95% CI 2.05-2.56), albumin (male: 1.75; 1.55-1.96; female: 1.76; 1.57-1.97) and hemoglobin (male: 1.98; 1.76-2.22; female: 1.62; 1.45-1.81) had statistically significant higher risk of VVR compared to the lower than median groups. These elevated serum protein and hemoglobin levels might offer new indicators to help understand VVR occurrence.	[Odajima, Takeshi; Nakajima, Kazunori; Minami, Mutsuhiko] Japanese Red Cross Kanto Koshinetsu Block Blood C, Koto Ku, Tokyo, Japan; [Takanashi, Minoko] Japanese Red Cross Soc, Minato Ku, Tokyo, Japan; [Sugimori, Hiroki; Tanba, Taiko; Munakata, Masaya] Daito Bunka Univ, Dept Sports & Hlth Sci, Saitama, Japan; [Yoshinaga, Kentaro; Motoji, Toshiko] Tokyo Womens Med Univ, Dept Haematol, Shinjuku Ku, Tokyo, Japan	Tokyo Women's Medical University	Sugimori, H (corresponding author), Daito Bunka Univ, Dept Sports & Hlth Sci, Saitama, Japan.	hsugimor@ic.daito.ac.jp		SUGIMORI, HIROKI/0000-0003-1234-417X				Ando S, 2009, TRANSFUSION, V49, P1630, DOI 10.1111/j.1537-2995.2009.02189.x; Bravo M, 2011, VOX SANG, V101, P303, DOI 10.1111/j.1423-0410.2011.01494.x; Eder AF, 2008, TRANSFUSION, V48, P1809, DOI 10.1111/j.1537-2995.2008.01811.x; Eder AF, 2008, JAMA-J AM MED ASSOC, V299, P2279, DOI 10.1001/jama.299.19.2279; Goncalez TT, 2012, TRANSFUSION, V52, P1070, DOI 10.1111/j.1537-2995.2011.03432.x; Hanson SA, 2004, TRANSFUSION, V44, P924, DOI 10.1111/j.1537-2995.2004.03426.x; Kaga Y, 2006, J JPN B, V29, P439; Kamel H, 2010, TRANSFUSION, V50, P556, DOI 10.1111/j.1537-2995.2009.02397.x; Ministry of Health Labour and Welfare, 2009, ANN REP BLOOD PROGR; Ministry of Health Labour and Welfare, 2011, ANN REP BLOOD PROGR; Ministry of Health Labour and Welfare, 2010, ANN REP BLOOD PROGR; Newman BH, 2005, TRANSFUSION, V45, P1715, DOI 10.1111/j.1537-2995.2005.00595.x; Newman BH, 2002, TRANSFUSION, V42, P1557, DOI 10.1046/j.1537-2995.2002.00238.x; Newman B, 2007, TRANSFUSION, V47, P1524, DOI 10.1111/j.1537-2995.2007.01293.x; OGATA H, 1980, TRANSFUSION, V20, P679, DOI 10.1046/j.1537-2995.1980.20681057157.x; OGAWA R, 1970, Respiration and Circulation, V18, P833; Philip Joseph, 2014, Asian J Transfus Sci, V8, P43, DOI 10.4103/0973-6247.126690; Rios JA, 2010, TRANSFUSION, V50, P1265, DOI 10.1111/j.1537-2995.2009.02578.x; Saito F, 2013, TRANSFUSION, V53, P2744, DOI 10.1111/trf.12120; SAS Institute Inc, 1993, SAS US GUID STAT VER; Takanashi M, 2012, TRANSFUS APHER SCI, V47, P319, DOI 10.1016/j.transci.2012.04.002; Tomita T, 2002, TRANSFUSION, V42, P1561, DOI 10.1046/j.1537-2995.2002.00241.x; Trouern-Trend JJ, 1999, TRANSFUSION, V39, P316, DOI 10.1046/j.1537-2995.1999.39399219291.x; Vandenbroucke JP, 2007, EPIDEMIOLOGY, V18, P805, DOI 10.1097/EDE.0b013e3181577511; Wiltbank TB, 2008, TRANSFUSION, V48, P1799, DOI 10.1111/j.1537-2995.2008.01745.x	25	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0148854	10.1371/journal.pone.0148854	http://dx.doi.org/10.1371/journal.pone.0148854			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3DG	26894814	Green Published, Green Submitted, gold			2022-12-26	WOS:000371223400024
J	Lee, CS; Taib, NAM; Ashrafzadeh, A; Fadzli, F; Harun, F; Rahmat, K; Hoong, SM; Abdul-Rahman, PS; Hashim, OH				Lee, Cheng-Siang; Taib, Nur Aishah Mohd; Ashrafzadeh, Ali; Fadzli, Farhana; Harun, Faizah; Rahmat, Kartini; Hoong, See Mee; Abdul-Rahman, Puteri Shafinaz; Hashim, Onn Haji			Unmasking Heavily O-Glycosylated Serum Proteins Using Perchloric Acid: Identification of Serum Proteoglycan 4 and Protease C1 Inhibitor as Molecular Indicators for Screening of Breast Cancer	PLOS ONE			English	Article							BOVINE SYNOVIAL-FLUID; LINKED GLYCOSYLATION; BIOMARKER DISCOVERY; ARTOCARPUS-INTEGER; MASS-SPECTROMETRY; BINDING LECTINS; MUCIN; LUBRICIN; GLYCOPROTEOME; DISEASES	Heavily glycosylated mucin glycopeptides such as CA 27.29 and CA 15-3 are currently being used as biomarkers for detection and monitoring of breast cancer. However, they are not well detected at the early stages of the cancer. In the present study, perchloric acid (PCA) was used to enhance detection of mucin-type O-glycosylated proteins in the serum in an attempt to identify new biomarkers for early stage breast cancer. Sensitivity and specificity of an earlier developed sandwich enzyme-linked lectin assay were significantly improved with the use of serum PCA isolates. When a pilot case-control study was performed using the serum PCA isolates of normal participants (n = 105) and patients with stage 0 (n = 31) and stage I (n = 48) breast cancer, higher levels of total O-glycosylated proteins in sera of both groups of early stage breast cancer patients compared to the normal control women were demonstrated. Further analysis by gel-based proteomics detected significant inverse altered abundance of proteoglycan 4 and plasma protease C1 inhibitor in both the early stages of breast cancer patients compared to the controls. Our data suggests that the ratio of serum proteoglycan 4 to protease C1 inhibitor may be used for screening of early breast cancer although this requires further validation in clinically representative populations.	[Lee, Cheng-Siang; Abdul-Rahman, Puteri Shafinaz; Hashim, Onn Haji] Univ Malaya, Fac Med, Dept Mol Med, Kuala Lumpur, Malaysia; [Taib, Nur Aishah Mohd; Fadzli, Farhana; Harun, Faizah; Hoong, See Mee] Univ Malaya, Fac Med, Dept Surg, Kuala Lumpur, Malaysia; [Ashrafzadeh, Ali] Univ Malaya, Med Biotechnol Lab, Fac Med, Kuala Lumpur, Malaysia; [Rahmat, Kartini] Univ Malaya, Fac Med, Dept Biomed Imaging, Kuala Lumpur, Malaysia; [Abdul-Rahman, Puteri Shafinaz; Hashim, Onn Haji] Univ Malaya, Univ Malaya Ctr Prote Res, Fac Med, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya; Universiti Malaya; Universiti Malaya; Universiti Malaya	Hashim, OH (corresponding author), Univ Malaya, Fac Med, Dept Mol Med, Kuala Lumpur, Malaysia.; Hashim, OH (corresponding author), Univ Malaya, Univ Malaya Ctr Prote Res, Fac Med, Kuala Lumpur, Malaysia.	onnhashim@um.edu.my	Taib, Nur Aishah Mohd/B-2370-2010; See, Mee Hoong/AAO-9275-2021; See, Mee-Hoong/P-8440-2014; FADZLI, FARHANA/B-8487-2010; Fadzli, Farhana/AAB-5625-2022; Hashim, Onn H/B-9459-2010; See, Mee-Hoong/GRN-9904-2022; Lee, Cheng-Siang/N-7704-2018; Rahman, Puteri Shafinaz Akmar Binti Abdul/B-9511-2010; Rahmat, Kartini/A-2218-2013	Taib, Nur Aishah Mohd/0000-0001-8419-0478; See, Mee Hoong/0000-0002-3966-3368; See, Mee-Hoong/0000-0002-7197-5759; FADZLI, FARHANA/0000-0001-8276-5813; Hashim, Onn H/0000-0002-0196-6793; See, Mee-Hoong/0000-0002-3966-3368; Rahman, Puteri Shafinaz Akmar Binti Abdul/0000-0002-1818-4552; Rahmat, Kartini/0000-0001-8513-9076	HIR-MOHE research grant from the University of Malaya [H-20001-00-E000009]	HIR-MOHE research grant from the University of Malaya	This work was funded by the HIR-MOHE H-20001-00-E000009 research grant from the University of Malaya. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was funded by the HIR-MOHE H-20001-00-E000009 research grant from the University of Malaya. The authors declare no potential conflicts of interest with respect to the authorship and/or publication of this article. All authors have read the journal's authorship agreement and policy on disclosure of potential conflicts of interest.	Adamczyk B, 2012, BBA-GEN SUBJECTS, V1820, P1347, DOI 10.1016/j.bbagen.2011.12.001; Ali L, 2014, MOL CELL PROTEOMICS, V13, P3396, DOI 10.1074/mcp.M114.040865; ANDERSON AJ, 1965, NATURE, V208, P491, DOI 10.1038/208491a0; Bennett EP, 2012, GLYCOBIOLOGY, V22, P736, DOI 10.1093/glycob/cwr182; BOCK SC, 1986, BIOCHEMISTRY-US, V25, P4292, DOI 10.1021/bi00363a018; Bringans S, 2008, PROTEOMICS, V8, P1081, DOI 10.1002/pmic.200700948; Brockhausen I, 2001, BIOL CHEM, V382, P219; Brockhausen I., 2009, ESSENTIALS GLYCOBIOL; Bunkenborg J, 2004, PROTEOMICS, V4, P454, DOI 10.1002/pmic.200300556; BURSTON D, 1963, BRIT J CANCER, V17, P162, DOI 10.1038/bjc.1963.24; Caliezi C, 2000, PHARMACOL REV, V52, P91; Campos D, 2015, EXPERT REV PROTEOMIC, V12, P337, DOI 10.1586/14789450.2015.1059758; Campos D, 2015, MOL CELL PROTEOMICS, V14, P1616, DOI 10.1074/mcp.M114.046862; Cheriyan T, 2012, J BIOMED MATER RES B, V100B, P1961, DOI 10.1002/jbm.b.32763; Cicardi M, 2005, SPRINGER SEMIN IMMUN, V27, P286, DOI 10.1007/s00281-005-0001-4; Clausen H, 1996, GLYCOBIOLOGY, V6, P635, DOI 10.1093/glycob/6.6.635; Duffy MJ, 2010, CLIN CHIM ACTA, V411, P1869, DOI 10.1016/j.cca.2010.08.039; Gomes C, 2013, J PROTEOME RES, V12, P1454, DOI 10.1021/pr301112x; Halim A, 2013, J PROTEOME RES, V12, P573, DOI 10.1021/pr300963h; Halim A, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.013649; HASHIM OH, 1991, MOL IMMUNOL, V28, P393, DOI 10.1016/0161-5890(91)90152-A; HASHIM OH, 1993, BIOCHEM MOL BIOL INT, V29, P69; Ikegawa S, 2000, CYTOGENET CELL GENET, V90, P291, DOI 10.1159/000056791; JAY GD, 1992, CONNECT TISSUE RES, V28, P71, DOI 10.3109/03008209209014228; Jayapalan JJ, 2012, ELECTROPHORESIS, V33, P1855, DOI 10.1002/elps.201100608; Jin CS, 2012, J BIOL CHEM, V287, P35922, DOI 10.1074/jbc.M112.363119; Lee CS, 2013, ANALYST, V138, P3522, DOI 10.1039/c3an36258b; Liu DX, 2005, INFECT IMMUN, V73, P4478, DOI 10.1128/IAI.73.8.4478-4487.2005; Liu T, 2005, J PROTEOME RES, V4, P2070, DOI 10.1021/pr0502065; Mohamed E, 2013, BIOMARK RES, V1, DOI 10.1186/2050-7771-1-19; Mukhopadhyay P, 2011, BBA-REV CANCER, V1815, P224, DOI 10.1016/j.bbcan.2011.01.001; Nakano M, 2004, GLYCOBIOLOGY, V14, P431, DOI 10.1093/glycob/cwh034; Nilsson J, 2009, NAT METHODS, V6, P809, DOI [10.1038/NMETH.1392, 10.1038/nmeth.1392]; Pichon MF, 2009, CLIN CHEM LAB MED, V47, P985, DOI 10.1515/CCLM.2009.213; Pinho SS, 2015, NAT REV CANCER, V15, P540, DOI 10.1038/nrc3982; Rahman MA, 2002, BIOCHEM BIOPH RES CO, V295, P1007, DOI 10.1016/S0006-291X(02)00795-7; Reis CA, 2010, J CLIN PATHOL, V63, P322, DOI 10.1136/jcp.2009.071035; Schmidt TA, 2013, JAMA OPHTHALMOL, V131, P766, DOI 10.1001/jamaophthalmol.2013.2385; STARCEVIC D, 1991, ANN CLIN BIOCHEM, V28, P595, DOI 10.1177/000456329102800609; Steentoft C, 2011, NAT METHODS, V8, P977, DOI [10.1038/nmeth.1731, 10.1038/NMETH.1731]; SWANN DA, 1985, BIOCHEM J, V225, P195, DOI 10.1042/bj2250195; SWANN DA, 1977, BIOCHEM J, V161, P473, DOI 10.1042/bj1610473; TREUHEIT MJ, 1992, BIOCHEM J, V283, P105, DOI 10.1042/bj2830105; Triggianese P, 2015, AUTOIMMUN REV; VARIYAM EP, 1981, GASTROENTEROLOGY, V81, P751; Velaiutham S, 2008, ASIAN PAC J CANCER P, V9, P445; WINZLER RJ, 1948, J CLIN INVEST, V27, P609, DOI 10.1172/JCI102006	47	17	18	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2016	11	2							e0149551	10.1371/journal.pone.0149551	http://dx.doi.org/10.1371/journal.pone.0149551			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3CO	26890881	Green Published, gold, Green Submitted			2022-12-26	WOS:000371221500058
J	Xu, XY; Chai, JJ; Chen, YP; Rui, HL; Wang, YY; Dong, HR; Man, YL; Cheng, H				Xu, Xiao-yi; Chai, Jing-jing; Chen, Yi-pu; Rui, Hong-liang; Wang, Yan-yan; Dong, Hong-rui; Man, Yu-lin; Cheng, Hong			Hirsutella sinensis Attenuates Aristolochic Acid-Induced Renal Tubular Epithelial-Mesenchymal Transition by Inhibiting TGF-beta 1 and Snail Expression	PLOS ONE			English	Article							INTERSTITIAL FIBROSIS; KIDNEY FIBROSIS; MYOFIBROBLASTS; ORIGIN; EVENTS; CELLS; RDNA	Objective To investigate the inhibitory effect of Hirsutella sinensis (HS) on epithelial-mesenchymal transition (EMT) of renal tubular epithelial cells induced by aristolochic acid (AA) and its possible mechanism. Methods 18 male Sprague-Dawley rats were randomly and equally divided into the following 3 groups: AA group, AA+HS group and control group. Urinary protein excretion and creatinine clearance (CCr) were measured. All rats were sacrificed at the end of 12th week. The pathological examination of renal tissue was performed and the mRNA and protein expression of transforming growth factor-beta 1 (TGF-beta 1), alpha-smooth muscle actin (alpha-SMA), cytokeratin-18 and Snail in renal cortex were determined by real time quantitative PCR and immunohistochemical staining respectively. In addition, human renal proximal tubule epithelial cells line (HKC) was divided into the following 4 groups: AA group, AA+HS group, HS control group and control group. The above mRNA and protein expression in HKC was determined by real time quantitative PCR and Western blot respectively. Results (1) CCr was significantly decreased, and the urinary protein excretion and relative area of renal interstitial fibrosis were significantly increased in the rats of AA and AA+HS group compared to those in control group (P<0.05 or P<0.01); all the above abnormalities significantly lightened in the rats of AA+HS group compared to those in AA group (P<0.05). (2) The mRNA and protein expression of TGF-beta 1, alpha-SMA and Snail was significantly up-regulated and the expression of cytokeratin-18 was significantly down-regulated in the rat renal cortex as well as in the cultured HKC cells in AA and AA+HS groups compared to those in control group (P<0.05 or P<0.01); all the above abnormalities significantly alleviated in AA+HS group compared to those in AA group (P<0.05 or P<0.01). (3) Knockdown endogenous Snail expression by siRNA could ameliorate AA-induced EMT of HKC cells, while overexpression of Snail by plasmid transfection diminished the antagonistic effect of HS on AA-induced EMT. These results suggest Snail might be a potential target of HS effect. Conclusion HS is able to antagonize, to some extent, tubular EMT and renal interstitial fibrosis caused by AA, which might be related to its inhibitory effects on the TGF-beta 1 and Snail expression.	[Xu, Xiao-yi; Chen, Yi-pu; Rui, Hong-liang; Wang, Yan-yan; Dong, Hong-rui; Man, Yu-lin; Cheng, Hong] Capital Med Univ, Beijing Anzhen Hosp, Div Nephrol, Beijing 100029, Peoples R China; [Chai, Jing-jing] Beijing Union Med Coll Hosp, Emergency Dept, Beijing 100730, Peoples R China	Capital Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital	Chen, YP (corresponding author), Capital Med Univ, Beijing Anzhen Hosp, Div Nephrol, Beijing 100029, Peoples R China.	chen_yipu@medmail.com.cn	Rui, Hongliang/GNM-9930-2022; wang, yan/GSE-6489-2022; Wang, Yanbo/HFZ-8018-2022	Rui, Hongliang/0000-0002-7584-9610; Chen, Yi-pu/0000-0002-5079-4334; Cheng, Hong/0000-0002-7908-3333	National Natural Science Foundation of China [81001516, 8144134]; Beijing Municipal Natural Science Foundation [7132090]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Municipal Natural Science Foundation(Beijing Natural Science Foundation)	Our work was supported by National Natural Science Foundation of China (81001516 and 8144134) and Beijing Municipal Natural Science Foundation (7132090). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Nieto MA, 2009, INT J DEV BIOL, V53, P1541, DOI 10.1387/ijdb.072410mn; Ballhause TM, 2014, INT UROL NEPHROL, V46, P659, DOI 10.1007/s11255-013-0626-5; Barnes JL, 2011, CONTRIB NEPHROL, V169, P73, DOI 10.1159/000313946; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Carver EA, 2001, MOL CELL BIOL, V21, P8184, DOI 10.1128/MCB.21.23.8184-8188.2001; Chen YP, 2009, CHIN J INTAGR TRADIT, V10, P847; Chen YQ, 2001, BIOCHEM SYST ECOL, V29, P597, DOI 10.1016/S0305-1978(00)00100-9; Chen YQ, 2002, PLANTA MED, V68, P635, DOI 10.1055/s-2002-32892; Falke LL, 2015, NAT REV NEPHROL, V11, P233, DOI 10.1038/nrneph.2014.246; Fan JM, 1999, KIDNEY INT, V56, P1455, DOI 10.1046/j.1523-1755.1999.00656.x; [方静 Fang Jing], 2004, [中华肾脏病杂志, Chinese Journal of Nephrology], V20, P321; [高艳丽 Gao Yanli], 2005, [中华肾脏病杂志, Chinese Journal of Nephrology], V21, P31; Gao YL, 2003, CHIN J INTEGR TRAD S, V23, P109; [胡征 Hu Zheng], 2003, [氨基酸和生物资源, Amino acids & biotic resources], V25, P20; Iwano M, 2002, J CLIN INVEST, V110, P341, DOI 10.1172/JCI200215518; Jiang Yi, 2003, Mycosystema, V22, P161; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kim YS, 2014, EXP MOL MED, V46, DOI 10.1038/emm.2014.44; LeBleu VS, 2013, NAT MED, V19, P1047, DOI 10.1038/nm.3218; Lin RQ, 2009, CHIN J INTAGR TRADIT, V10, P921; Lin RQ, 2009, CHIN J INTAGR TRADIT, V10, P1011; Liu XJ, 1989, MYCOSYSTEMA, V8, P35; Liu YH, 2004, J AM SOC NEPHROL, V15, P1, DOI 10.1097/01.ASN.0000106015.29070.E7; Mack M, 2015, KIDNEY INT, V87, P297, DOI 10.1038/ki.2014.287; Mo MH, 2001, MYCOSYSTEMA, V20, P482; National Committee of Pharmacopoeia, 2012, PHARM PEOPL REP CHIN, P681; Nieto MA, 2002, NAT REV MOL CELL BIO, V3, P155, DOI 10.1038/nrm757; Ohkubo T, 2004, J CELL SCI, V117, P1675, DOI 10.1242/jcs.01004; Sato M, 2003, J CLIN INVEST, V112, P1486, DOI 10.1172/JCI200319270; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; [魏鑫丽 Wei Xinli], 2006, [菌物学报, Mygosystema], V25, P192; Xiong J, 2014, MOL BIOL REP, V41, P241, DOI 10.1007/s11033-013-2857-z; Yang JW, 2001, AM J PATHOL, V159, P1465, DOI 10.1016/S0002-9440(10)62533-3; Yang YL, 2011, J CELL BIOCHEM, V112, P2558, DOI 10.1002/jcb.23180; Yoshino J, 2007, BIOCHEM BIOPH RES CO, V362, P63, DOI 10.1016/j.bbrc.2007.07.146; Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183; [张聪 ZHANG Cong], 2006, [中华肾脏病杂志, Chinese Journal of Nephrology], V22, P49; [张媺 Zhang Mei], 2006, [中华肾脏病杂志, Chinese Journal of Nephrology], V22, P472; Zhu Yun-feng, 2007, Zhonghua Yi Xue Za Zhi, V87, P2667; 唐功耀, 2002, [中华肾脏病杂志, Chinese Journal of Nephrology], V18, P266	40	5	9	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2016	11	2							e0149242	10.1371/journal.pone.0149242	http://dx.doi.org/10.1371/journal.pone.0149242			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3CO	26890569	gold, Green Published, Green Submitted			2022-12-26	WOS:000371221500026
J	Chisholm, SA; McHugh, E; Lundie, R; Dixon, MWA; Ghosh, S; O'Keefe, M; Tilley, L; Kalanon, M; de Koning-Ward, TF				Chisholm, Scott A.; McHugh, Emma; Lundie, Rachel; Dixon, Matthew W. A.; Ghosh, Sreejoyee; O'Keefe, Meredith; Tilley, Leann; Kalanon, Ming; de Koning-Ward, Tania F.			Contrasting Inducible Knockdown of the Auxiliary PTEX Component PTEX88 in P-falciparum and P-berghei Unmasks a Role in Parasite Virulence	PLOS ONE			English	Article							RED-BLOOD-CELLS; EXPORTED PROTEINS PTEX; MALARIA PARASITES; INFECTED ERYTHROCYTES; HOST ERYTHROCYTE; MAURERS CLEFTS; IN-VIVO; TRANSLOCON; LOCALIZATION; PATHOGENESIS	Pathogenesis of malaria infections is linked to remodeling of erythrocytes, a process dependent on the trafficking of hundreds of parasite-derived proteins into the host erythrocyte. Recent studies have demonstrated that the Plasmodium translocon of exported proteins (PTEX) serves as the central gateway for trafficking of these proteins, as inducible knockdown of the core PTEX constituents blocked the trafficking of all classes of cargo into the erythrocyte. However, the role of the auxiliary component PTEX88 in protein export remains less clear. Here we have used inducible knockdown technologies in P. falciparum and P. berghei to assess the role of PTEX88 in parasite development and protein export, which reveal that the in vivo growth of PTEX88-deficient parasites is hindered. Interestingly, we were unable to link this observation to a general defect in export of a variety of known parasite proteins, suggesting that PTEX88 functions in a different fashion to the core PTEX components. Strikingly, PTEX88-deficient P. berghei were incapable of causing cerebral malaria despite a robust pro-inflammatory response from the host. These parasites also exhibited a reduced ability to sequester in peripheral tissues and were removed more readily from the circulation by the spleen. In keeping with these findings, PTEX88-deficient P. falciparum-infected erythrocytes displayed reduced binding to the endothelial cell receptor, CD36. This suggests that PTEX88 likely plays a specific direct or indirect role in mediating parasite sequestration rather than making a universal contribution to the trafficking of all exported proteins.	[Chisholm, Scott A.; Ghosh, Sreejoyee; Kalanon, Ming; de Koning-Ward, Tania F.] Deakin Univ, Sch Med, Waurn Ponds, Vic, Australia; [McHugh, Emma; Dixon, Matthew W. A.; Tilley, Leann] Bio21 Inst, Dept Biochem & Mol Biol, Melbourne, Vic, Australia; [Lundie, Rachel; O'Keefe, Meredith] Burnet Inst, Melbourne, Vic, Australia	Deakin University; Burnet Institute	de Koning-Ward, TF (corresponding author), Deakin Univ, Sch Med, Waurn Ponds, Vic, Australia.	taniad@deakin.edu.au	Ghosh, Sreejoyee/AAQ-8421-2020; Dixon, Matthew/N-4503-2019; Chisholm, Scott/K-2661-2019; de Koning-Ward, Tania F/N-3572-2017; Tilley, Leann/AAU-5281-2020; O'Keeffe, Meredith/U-9347-2017	Dixon, Matthew/0000-0001-9732-9686; Chisholm, Scott/0000-0002-3833-8854; de Koning-Ward, Tania F/0000-0001-5810-8063; O'Keeffe, Meredith/0000-0002-0779-4654; Tilley, Leann/0000-0001-9910-0199; McHugh, Emma/0000-0003-0278-4171	National Health and Medical Research Council [APP1021560, APP1006091]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was funded by the National Health and Medical Research Council, APP1021560, APP1006091 (https://www.nhmrc.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Bachmann A, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0784-2; BARUCH DI, 1995, CELL, V82, P77, DOI 10.1016/0092-8674(95)90054-3; Beck JR, 2014, NATURE, V511, P592, DOI 10.1038/nature13574; Blisnick T, 2000, MOL BIOCHEM PARASIT, V111, P107, DOI 10.1016/S0166-6851(00)00301-7; Boddey JA, 2013, ANNU REV MICROBIOL, V67, P243, DOI 10.1146/annurev-micro-092412-155730; Bullen HE, 2012, J BIOL CHEM, V287, P7871, DOI 10.1074/jbc.M111.328591; de Koning-Ward TF, 2009, NATURE, V459, P945, DOI 10.1038/nature08104; Decherf G, 2004, BLOOD CELL MOL DIS, V32, P366, DOI 10.1016/j.bcmd.2004.01.008; Deitsch KW, 1996, MOL BIOCHEM PARASIT, V76, P1, DOI 10.1016/0166-6851(95)02575-8; Denks K, 2014, MOL MEMBR BIOL, V31, P58, DOI 10.3109/09687688.2014.907455; Dixon MWA, 2008, TRAFFIC, V9, P1316, DOI 10.1111/j.1600-0854.2008.00768.x; Dondorp AM, 2002, T ROY SOC TROP MED H, V96, P282, DOI 10.1016/S0035-9203(02)90100-8; Elsworth B, 2014, NATURE, V511, P587, DOI 10.1038/nature13555; Fidock DA, 1997, P NATL ACAD SCI USA, V94, P10931, DOI 10.1073/pnas.94.20.10931; Fischer K, 1998, MOL BIOCHEM PARASIT, V92, P47, DOI 10.1016/S0166-6851(97)00224-7; Frenal K, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005069; Goel S, 2015, NAT MED, V21, P314, DOI 10.1038/nm.3812; Gold DA, 2015, CELL HOST MICROBE, V17, P642, DOI 10.1016/j.chom.2015.04.003; Haase S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061482; Haase S, 2013, MALARIA PARASITES: COMPARATIVE GENOMICS , EVOLUTION AND MOLECULAR BIOLOGY, P199; Haase S, 2010, CELL MICROBIOL, V12, P580, DOI 10.1111/j.1462-5822.2010.01455.x; Haque A, 2011, EUR J IMMUNOL, V41, P2688, DOI 10.1002/eji.201141539; Heiber A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003546; Hiller NL, 2004, SCIENCE, V306, P1934, DOI 10.1126/science.1102737; Ingmundson A, 2012, MOL MICROBIOL, V83, P1229, DOI 10.1111/j.1365-2958.2012.08004.x; Janse CJ, 2006, NAT PROTOC, V1, P614, DOI 10.1038/nprot.2006.88; Johnson D, 1994, PARASITOLOGY, V109; Kalanon M, 2015, CELL MICROB IN PRESS; Maier AG, 2008, CELL, V134, P48, DOI 10.1016/j.cell.2008.04.051; Maier AG, 2009, NAT REV MICROBIOL, V7, P341, DOI 10.1038/nrmicro2110; MAKLER MT, 1993, AM J TROP MED HYG, V48, P205, DOI 10.4269/ajtmh.1993.48.205; Marti M, 2004, SCIENCE, V306, P1930, DOI 10.1126/science.1102452; Matthews K, 2013, MOL MICROBIOL, V89, P1167, DOI 10.1111/mmi.12334; Matz JM, 2015, EUKARYOT CELL, V14, P528, DOI 10.1128/EC.00276-14; Matz JM, 2013, MOL BIOCHEM PARASIT, V191, P44, DOI 10.1016/j.molbiopara.2013.09.003; McHugh E, 2015, MOL MICROBIOL; Miller LH, 2002, NATURE, V415, P673, DOI 10.1038/415673a; Niang M, 2014, CELL HOST MICROBE, V16, P81, DOI 10.1016/j.chom.2014.06.004; Paschen SA, 2000, EMBO J, V19, P6392, DOI 10.1093/emboj/19.23.6392; Pasini EM, 2013, MOL CELL PROTEOMICS, V12, P426, DOI 10.1074/mcp.M112.021238; Pick C, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-167; Pino P, 2012, CELL HOST MICROBE, V12, P824, DOI 10.1016/j.chom.2012.10.016; Spycher C, 2003, J BIOL CHEM, V278, P35373, DOI 10.1074/jbc.M305851200; Stanley WA, 2007, FEBS LETT, V581, P4795, DOI 10.1016/j.febslet.2007.09.001; SU XZ, 1995, CELL, V82, P89, DOI 10.1016/0092-8674(95)90055-1; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Vremec D, 2000, J IMMUNOL, V164, P2978, DOI 10.4049/jimmunol.164.6.2978; WHO, 2013, WORLD MALARIA REPORT 2013, P1; Yanez DM, 1996, J IMMUNOL, V157, P1620; Zhang Y, 2015, P NATL ACAD SCI USA, V112, P6068, DOI 10.1073/pnas.1505584112	50	22	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0149296	10.1371/journal.pone.0149296	http://dx.doi.org/10.1371/journal.pone.0149296			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26886275	Green Published, gold			2022-12-26	WOS:000371218400075
J	Hsia, J; Holtz, WJ; Maharbiz, MM; Arcak, M; Keasling, JD				Hsia, Justin; Holtz, William J.; Maharbiz, Michel M.; Arcak, Murat; Keasling, Jay D.			Modular Synthetic Inverters from Zinc Finger Proteins and Small RNAs	PLOS ONE			English	Article							ESCHERICHIA-COLI; GENE-EXPRESSION; REGULATORS; ROBUST; SWITCH	Synthetic zinc finger proteins (ZFPs) can be created to target promoter DNA sequences, repressing transcription. The binding of small RNA (sRNA) to ZFP mRNA creates an ultra-sensitive response to generate higher effective Hill coefficients. Here we combined three "off the shelf" ZFPs and three sRNAs to create new modular inverters in E. coli and quantify their behavior using induction fold. We found a general ordering of the effects of the ZFPs and sRNAs on induction fold that mostly held true when combining these parts. We then attempted to construct a ring oscillator using our new inverters. Our chosen parts performed insufficiently to create oscillations, but we include future directions for improvement upon our work presented here.	[Hsia, Justin; Holtz, William J.; Maharbiz, Michel M.; Arcak, Murat] Univ Calif Berkeley, Dept Elect Engn & Comp Sci, Berkeley, CA 94720 USA; [Holtz, William J.; Keasling, Jay D.] Joint BioEnergy Inst, Emeryville, CA USA; [Keasling, Jay D.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA; [Keasling, Jay D.] Univ Calif Berkeley, Dept Chem & Biomol Engn, Berkeley, CA 94720 USA; [Keasling, Jay D.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Biol Syst & Engn, Berkeley, CA 94720 USA; [Holtz, William J.] Lygos Inc, Emeryville, CA USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Hsia, J (corresponding author), Univ Calif Berkeley, Dept Elect Engn & Comp Sci, Berkeley, CA 94720 USA.	jhsia@eecs.berkeley.edu	Keasling, Jay D/J-9162-2012	Keasling, Jay D/0000-0003-4170-6088; Arcak, Murat/0000-0001-9060-4032; Holtz, William/0000-0001-5281-1794	Joint BioEnergy Institute - US Department of Energy, Office of Science, Office of Biological and Environmental Research [DE-AC02-05CH11231]; Synthetic Biology Engineering Research Center (SynBERC) through National Science Foundation [NSF EEC 0540879]; National Institute of Health National Institute of General Medical Sciences [1R01GM109460-01]; Air Force Office of Scientific Research [FA9550-14-1-0089]; Berkeley Sensor & Actuator Center; Lawrence Berkeley National Laboratory; US Department of Energy; NIH National Institute of General Medical Sciences [1R01GM109460-01]; AFOSR [FA9550-14-1-0089]; Berkeley Sensor & Actuator Center (BSAC); Novo Nordisk Fonden [NNF10CC1016517] Funding Source: researchfish; NNF Center for Biosustainability [Synthetic Biology Tools for Yeast] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM109460] Funding Source: NIH RePORTER	Joint BioEnergy Institute - US Department of Energy, Office of Science, Office of Biological and Environmental Research; Synthetic Biology Engineering Research Center (SynBERC) through National Science Foundation; National Institute of Health National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Berkeley Sensor & Actuator Center; Lawrence Berkeley National Laboratory(United States Department of Energy (DOE)); US Department of Energy(United States Department of Energy (DOE)); NIH National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); AFOSR(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Berkeley Sensor & Actuator Center (BSAC); Novo Nordisk Fonden(Novo Nordisk Foundation); NNF Center for Biosustainability; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by the Joint BioEnergy Institute (http://www.jbei.org), which is supported by the US Department of Energy, Office of Science, Office of Biological and Environmental Research, through contract DE-AC02-05CH11231 between Lawrence Berkeley National Laboratory and the US Department of Energy and by the Synthetic Biology Engineering Research Center (SynBERC) through National Science Foundation grant NSF EEC 0540879. This work was also funded by the National Institute of Health (http://www.nih.gov) National Institute of General Medical Sciences grant 1R01GM109460-01, Air Force Office of Scientific Research (http://www.afosr.af.mil) grant FA9550-14-1-0089, and the Berkeley Sensor & Actuator Center (http://bsac.eecs.berkeley.edu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was funded by the Joint BioEnergy Institute (http://www.jbei.org), which is supported by the US Department of Energy, Office of Science, Office of Biological and Environmental Research, through contract DE-AC02-05CH11231 between Lawrence Berkeley National Laboratory and the US Department of Energy and by the Synthetic Biology Engineering Research Center (SynBERC) through National Science Foundation grant NSF EEC 0540879. Authors would like to acknowledge funding from NIH National Institute of General Medical Sciences 1R01GM109460-01, AFOSR FA9550-14-1-0089, and the Berkeley Sensor & Actuator Center (BSAC).	Anderson JC, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100173; [Anonymous], 2009, REGISTRY STANDARD BI; Boch J, 2011, NAT BIOTECHNOL, V29, P135, DOI 10.1038/nbt.1767; Buchler NE, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.30; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Gersbach CA, 2014, ACCOUNTS CHEM RES, V47, P2309, DOI 10.1021/ar500039w; HEMSLEY A, 1989, NUCLEIC ACIDS RES, V17, P6545, DOI 10.1093/nar/17.16.6545; Hillson NJ, 2012, ACS SYNTH BIOL, V1, P14, DOI 10.1021/sb2000116; Holtz WJ, 2011, ENG SCALABLE COMBINA; Hsia J, 2012, IEEE DECIS CONTR P, P1633, DOI 10.1109/CDC.2012.6426642; Hsia J, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002331; Huang D, 2012, J BIOL ENG, V6, DOI 10.1186/1754-1611-6-9; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Khlebnikov A, 2002, J IND MICROBIOL BIOT, V29, P34, DOI 10.1038/sj.jim.7000259; Kizer L, 2008, APPL ENVIRON MICROB, V74, P3229, DOI 10.1128/AEM.02750-07; Lee TS, 2011, J BIOL ENG, V5, DOI 10.1186/1754-1611-5-12; Lucks JB, 2011, P NATL ACAD SCI USA, V108, P8617, DOI 10.1073/pnas.1015741108; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; Mutalik VK, 2013, NAT METHODS, V10, P354, DOI [10.1038/NMETH.2404, 10.1038/nmeth.2404]; Mutalik VK, 2012, NAT CHEM BIOL, V8, P447, DOI [10.1038/NCHEMBIO.919, 10.1038/nchembio.919]; Na D, 2013, NAT BIOTECHNOL, V31, P170, DOI 10.1038/nbt.2461; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Quan JY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006441; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Stricker J, 2008, NATURE, V456, P516, DOI 10.1038/nature07389; Tamsir A, 2011, NATURE, V469, P212, DOI 10.1038/nature09565; Wang BJ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1516	28	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0149483	10.1371/journal.pone.0149483	http://dx.doi.org/10.1371/journal.pone.0149483			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26886888	gold, Green Published, Green Submitted			2022-12-26	WOS:000371218400090
J	Miyamoto, T; Kato, Y; Sekiguchi, Y; Tsuneda, S; Noda, N				Miyamoto, Tatsuki; Kato, Yuka; Sekiguchi, Yuji; Tsuneda, Satoshi; Noda, Naohiro			Characterization of MazF-Mediated Sequence-Specific RNA Cleavage in Pseudomonas putida Using Massive Parallel Sequencing	PLOS ONE			English	Article							TOXIN-ANTITOXIN SYSTEMS; PROGRAMMED CELL-DEATH; MESSENGER-RNA; ESCHERICHIA-COLI; BACTERIAL PERSISTENCE; STOCHASTIC INDUCTION; RIBOSOMAL-RNA; TRANSLATION; INTERFERASES; GROWTH	Under environmental stress, microbes are known to alter their translation patterns using sequence-specific endoribonucleases that we call RNA interferases. However, there has been limited insight regarding which RNAs are specifically cleaved by these RNA interferases, hence their physiological functions remain unknown. In the current study, we developed a novel method to effectively identify cleavage specificities with massive parallel sequencing. This approach uses artificially designed RNAs composed of diverse sequences, which do not form extensive secondary structures, and it correctly identified the cleavage sequence of a well-characterized Escherichia coli RNA interferase, MazF, as ACA. In addition, we also determined that an uncharacterized MazF homologue isolated from Pseudomonas putida specifically recognizes the unique triplet, UAC. Using a real-time fluorescence resonance energy transfer assay, the UAC triplet was further proved to be essential for cleavage in P. putida MazF. These results highlight an effective method to determine cleavage specificity of RNA interferases.	[Miyamoto, Tatsuki; Tsuneda, Satoshi; Noda, Naohiro] Waseda Univ, Dept Life Sci & Med Biosci, Shinjuku Ku, 2-2 Wakamatsu Cho, Tokyo 1628480, Japan; [Miyamoto, Tatsuki; Kato, Yuka; Sekiguchi, Yuji; Noda, Naohiro] Natl Inst Adv Ind Sci & Technol, Biomed Res Inst, 1-1-1 Higashi, Tsukuba, Ibaraki 3058566, Japan	Waseda University; National Institute of Advanced Industrial Science & Technology (AIST)	Tsuneda, S; Noda, N (corresponding author), Waseda Univ, Dept Life Sci & Med Biosci, Shinjuku Ku, 2-2 Wakamatsu Cho, Tokyo 1628480, Japan.; Noda, N (corresponding author), Natl Inst Adv Ind Sci & Technol, Biomed Res Inst, 1-1-1 Higashi, Tsukuba, Ibaraki 3058566, Japan.	stsuneda@waseda.jp; noda-naohiro@aist.go.jp	NODA, Naohiro/M-2383-2018	NODA, Naohiro/0000-0001-7592-5495				Aizenman E, 1996, P NATL ACAD SCI USA, V93, P6059, DOI 10.1073/pnas.93.12.6059; Akiyama H, 2015, ANAL BIOCHEM, V472, P75, DOI 10.1016/j.ab.2014.11.012; Amitai S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000390; Buermans HPJ, 2014, BBA-MOL BASIS DIS, V1842, P1932, DOI 10.1016/j.bbadis.2014.06.015; Chopra N, 2013, GENOME BIOL EVOL, V5, P2268, DOI 10.1093/gbe/evt175; Christensen SK, 2003, MOL MICROBIOL, V48, P1389, DOI 10.1046/j.1365-2958.2003.03512.x; Christensen-Dalsgaard M, 2006, MOL MICROBIOL, V62, P397, DOI 10.1111/j.1365-2958.2006.05385.x; Christensen-Dalsgaard M, 2010, MOL MICROBIOL, V75, P333, DOI 10.1111/j.1365-2958.2009.06969.x; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Cruz JW, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8480; Germain E, 2015, P NATL ACAD SCI USA, V112, P5171, DOI 10.1073/pnas.1423536112; Hazan R, 2004, J BACTERIOL, V186, P3663, DOI 10.1128/JB.186.11.3663-3669.2004; Jorgensen MG, 2009, J BACTERIOL, V191, P1191, DOI 10.1128/JB.01013-08; KIRPEKAR F, 1994, NUCLEIC ACIDS RES, V22, P3866, DOI 10.1093/nar/22.19.3866; Koga M, 2011, GENETICS, V187, P123, DOI 10.1534/genetics.110.121798; Maisonneuve E, 2013, CELL, V154, P1140, DOI 10.1016/j.cell.2013.07.048; Maisonneuve E, 2011, P NATL ACAD SCI USA, V108, P13206, DOI 10.1073/pnas.1100186108; Makarova KS, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-19; McKenzie JL, 2012, RNA, V18, P1267, DOI 10.1261/rna.031229.111; Nariya H, 2008, CELL, V132, P55, DOI 10.1016/j.cell.2007.11.044; Otsuka Y, 2007, GENES GENET SYST, V82, P291, DOI 10.1266/ggs.82.291; Pandey DP, 2005, NUCLEIC ACIDS RES, V33, P966, DOI 10.1093/nar/gki201; Park JH, 2011, FEBS LETT, V585, P2526, DOI 10.1016/j.febslet.2011.07.008; Poblete-Castro I, 2012, APPL MICROBIOL BIOT, V93, P2279, DOI 10.1007/s00253-012-3928-0; Prysak MH, 2009, MOL MICROBIOL, V71, P1071, DOI 10.1111/j.1365-2958.2008.06572.x; Rothenbacher FP, 2012, J BACTERIOL, V194, P3464, DOI 10.1128/JB.00217-12; Sat B, 2001, J BACTERIOL, V183, P2041, DOI 10.1128/JB.183.6.2041-2045.2001; Schifano JM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4538; Schifano JM, 2013, P NATL ACAD SCI USA, V110, P8501, DOI 10.1073/pnas.1222031110; Schuster CF, 2013, FEMS MICROBIOL LETT, V340, P73, DOI 10.1111/1574-6968.12074; Schuster CF, 2013, J BACTERIOL, V195, P115, DOI 10.1128/JB.00400-12; Shao YC, 2011, NUCLEIC ACIDS RES, V39, pD606, DOI 10.1093/nar/gkq908; Sharp JD, 2012, J BIOL CHEM, V287, P12835, DOI 10.1074/jbc.M112.340109; Tamman H, 2014, J BACTERIOL, V196, P157, DOI 10.1128/JB.00851-13; Tiwari P, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7059; Verma S, 2014, BIOCHEM BIOPH RES CO, V450, P998, DOI 10.1016/j.bbrc.2014.06.092; Vesper O, 2011, CELL, V147, P147, DOI 10.1016/j.cell.2011.07.047; Wang NR, 2007, ANAL BIOCHEM, V371, P173, DOI 10.1016/j.ab.2007.07.017; Yamaguchi Y, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1621; Yamaguchi Y, 2011, NAT REV MICROBIOL, V9, P779, DOI 10.1038/nrmicro2651; Yamaguchi Y, 2009, J BIOL CHEM, V284, P28746, DOI 10.1074/jbc.M109.032904; Zhang JJ, 2004, J BIOL CHEM, V279, P20678, DOI 10.1074/jbc.M314284200; Zhang YL, 2005, J BIOL CHEM, V280, P26080, DOI 10.1074/jbc.M502050200; Zhang YL, 2003, MOL CELL, V12, P913, DOI 10.1016/S1097-2765(03)00402-7; Zhang YL, 2005, J BIOL CHEM, V280, P3143, DOI 10.1074/jbc.M411811200; Zhang YL, 2009, J BIOL CHEM, V284, P25522, DOI 10.1074/jbc.M109.036624; Zhang Y, 2009, J BIOL CHEM, V284, P6627, DOI 10.1074/jbc.M808779200; Zhu L, 2008, MOL MICROBIOL, V69, P559, DOI 10.1111/j.1365-2958.2008.06284.x; Zhu L, 2006, J BIOL CHEM, V281, P18638, DOI 10.1074/jbc.M512693200; Zhu L, 2009, J BACTERIOL, V191, P3248, DOI 10.1128/JB.01815-08	50	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0149494	10.1371/journal.pone.0149494	http://dx.doi.org/10.1371/journal.pone.0149494			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26885644	Green Published, Green Submitted, gold			2022-12-26	WOS:000371218400092
J	Uranbileg, B; Ikeda, H; Kurano, M; Enooku, K; Sato, M; Saigusa, D; Aoki, J; Ishizawa, T; Hasegawa, K; Kokudo, N; Yatomi, Y				Uranbileg, Baasanjav; Ikeda, Hitoshi; Kurano, Makoto; Enooku, Kenichiro; Sato, Masaya; Saigusa, Daisuke; Aoki, Junken; Ishizawa, Takeaki; Hasegawa, Kiyoshi; Kokudo, Norihiro; Yatomi, Yutaka			Increased mRNA Levels of Sphingosine Kinases and S1P Lyase and Reduced Levels of S1P Were Observed in Hepatocellular Carcinoma in Association with Poorer Differentiation and Earlier Recurrence	PLOS ONE			English	Article							1-PHOSPHATE RECEPTOR 2; IN-VIVO; LYSOPHOSPHOLIPID RECEPTORS; BIOLOGICAL SAMPLES; G-PROTEIN; SPHINGOSINE-1-PHOSPHATE; ACTIVATION; EXPRESSION; CANCER; CELLS	Although sphingosine 1-phosphate (S1P) has been reported to play an important role in cancer pathophysiology, little is known about S1P and hepatocellular carcinoma (HCC). To clarify the relationship between S1P and HCC, 77 patients with HCC who underwent surgical treatment were consecutively enrolled in this study. In addition, S1P and its metabolites were quantitated by LC-MS/MS. The mRNA levels of sphingosine kinases (SKs), which phosphorylate sphingosine to generate S1P, were increased in HCC tissues compared with adjacent non-HCC tissues. Higher mRNA levels of SKs in HCC were associated with poorer differentiation and microvascular invasion, whereas a higher level of SK2 mRNA was a risk factor for intra-and extra-hepatic recurrence. S1P levels, however, were unexpectedly reduced in HCC compared with non-HCC tissues, and increased mRNA levels of S1P lyase (SPL), which degrades S1P, were observed in HCC compared with non-HCC tissues. Higher SPL mRNA levels in HCC were associated with poorer differentiation. Finally, in HCC cell lines, inhibition of the expression of SKs or SPL by siRNA led to reduced proliferation, invasion and migration, whereas overexpression of SKs or SPL enhanced proliferation. In conclusion, increased SK and SPL mRNA expression along with reduced S1P levels were more commonly observed in HCC tissues compared with adjacent non-HCC tissues and were associated with poor differentiation and early recurrence. SPL as well as SKs may be therapeutic targets for HCC treatment.	[Uranbileg, Baasanjav; Ikeda, Hitoshi; Kurano, Makoto; Enooku, Kenichiro; Sato, Masaya; Yatomi, Yutaka] Univ Tokyo, Dept Clin Lab Med, Tokyo, Japan; [Ishizawa, Takeaki; Hasegawa, Kiyoshi; Kokudo, Norihiro] Univ Tokyo, Dept Surg, Hepatobiliary Pancreat Surg Div, Tokyo, Japan; [Saigusa, Daisuke] Tohoku Med Megabank Org, Dept Integrat Genom, Sendai, Miyagi, Japan; [Aoki, Junken] Tohoku Univ, Grad Sch Pharmaceut Sci, Sendai, Miyagi 980, Japan; [Ikeda, Hitoshi; Kurano, Makoto; Saigusa, Daisuke; Aoki, Junken; Yatomi, Yutaka] JST, CREST, Tokyo, Japan	University of Tokyo; University of Tokyo; Tohoku University; Japan Science & Technology Agency (JST)	Ikeda, H (corresponding author), Univ Tokyo, Dept Clin Lab Med, Tokyo, Japan.; Ikeda, H (corresponding author), JST, CREST, Tokyo, Japan.	ikeda-1im@h.u-tokyo.ac.jp		Aoki, Junken/0000-0001-9435-1896; Saigusa, Daisuke/0000-0001-9484-9870; xing zhi, shi zhi/0000-0003-3289-5681; Yatomi, Yutaka/0000-0003-1719-4297	JSPS [25253040, 15H05906]; AMED-CREST; Grants-in-Aid for Scientific Research [16K09343, 15H05897] Funding Source: KAKEN	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); AMED-CREST; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Number 25253040 and 15H05906 (YY) and by AMED-CREST.	Abuhusain HJ, 2013, J BIOL CHEM, V288, P37355, DOI 10.1074/jbc.M113.494740; Bao MY, 2012, LIVER INT, V32, P331, DOI 10.1111/j.1478-3231.2011.02666.x; Bayerl MG, 2008, LEUKEMIA LYMPHOMA, V49, P948, DOI 10.1080/10428190801911654; Beljanski V, 2011, CANCER BIOL THER, V11, P524, DOI 10.4161/cbt.11.5.14677; Brizuela L, 2012, MOL CANCER THER, V11, P1841, DOI 10.1158/1535-7163.MCT-12-0227; Chae SS, 2004, J CLIN INVEST, V114, P1082, DOI 10.1172/JCI200422716; Cuvillier O, 1996, NATURE, V381, P800, DOI 10.1038/381800a0; Degagne E, 2014, CLIN EXP GASTROENTER, V7, P205, DOI 10.2147/CEG.S43453; Don AS, 2014, BIOMOLECULES, V4, P315, DOI 10.3390/biom4010315; Edsall LC, 1997, J NEUROSCI, V17, P6952; El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683; French KJ, 2003, CANCER RES, V63, P5962; Gardell SE, 2006, TRENDS MOL MED, V12, P65, DOI 10.1016/j.molmed.2005.12.001; GOODEMOTE KA, 1995, J BIOL CHEM, V270, P10272, DOI 10.1074/jbc.270.17.10272; Herr DR, 2007, J NEUROSCI, V27, P1474, DOI 10.1523/JNEUROSCI.4245-06.2007; Hibbs K, 2004, AM J PATHOL, V165, P397, DOI 10.1016/S0002-9440(10)63306-8; Ikeda H, 2000, AM J PHYSIOL-GASTR L, V279, pG304, DOI 10.1152/ajpgi.2000.279.2.G304; Ikeda H, 2004, BIOCHEM BIOPH RES CO, V320, P754, DOI 10.1016/j.bbrc.2004.04.207; Ikeda H, 2003, GASTROENTEROLOGY, V124, P459, DOI 10.1053/gast.2003.50049; Ikeda H, 2009, J LIPID RES, V50, P556, DOI 10.1194/jlr.M800496-JLR200; Ishii I, 2004, ANNU REV BIOCHEM, V73, P321, DOI 10.1146/annurev.biochem.73.011303.073731; Jiang YX, 2013, BIOMOLECULES, V3, P435, DOI 10.3390/biom3030435; Kageyama Y, 2012, HEPATOLOGY, V56, P1427, DOI 10.1002/hep.25780; Kariya Y, 2005, GENES CELLS, V10, P605, DOI 10.1111/j.1365-2443.2005.00862.x; Kharel Y, 2011, BIOCHEM J, V440, P345, DOI 10.1042/BJ20110817; Kihara A, 2014, BBA-MOL CELL BIOL L, V1841, P766, DOI 10.1016/j.bbalip.2013.08.014; Lafaro KJ, 2015, SURG ONCOL CLIN N AM, V24, P1, DOI 10.1016/j.soc.2014.09.001; Li CY, 2011, J HEPATOL, V54, P1205, DOI 10.1016/j.jhep.2010.08.028; Li CY, 2009, AM J PATHOL, V175, P1464, DOI 10.2353/ajpath.2009.090037; Li CY, 2009, J HEPATOL, V50, P1174, DOI 10.1016/j.jhep.2009.01.028; Liang J, 2013, CANCER CELL, V23, P107, DOI 10.1016/j.ccr.2012.11.013; Liu YJ, 2000, J CLIN INVEST, V106, P951, DOI 10.1172/JCI10905; Nagahashi M, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/651727; Okudaira M, 2014, J LIPID RES, V55, P2178, DOI 10.1194/jlr.D048439; OLIVERA A, 1993, NATURE, V365, P557, DOI 10.1038/365557a0; Oskouian B, 2006, P NATL ACAD SCI USA, V103, P17384, DOI 10.1073/pnas.0600050103; Pappu R, 2007, SCIENCE, V316, P295, DOI 10.1126/science.1139221; Pyne NJ, 2010, NAT REV CANCER, V10, P489, DOI 10.1038/nrc2875; Rex K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068328; Schnute ME, 2012, BIOCHEM J, V444, P79, DOI 10.1042/BJ20111929; Serriere-Lanneau V, 2007, FASEB J, V21, P2005, DOI 10.1096/fj.06-6889com; Tosaka M, 2001, STROKE, V32, P2913, DOI 10.1161/hs1201.099525; Uranbileg B, 2014, INT J CANCER, V134, P2189, DOI 10.1002/ijc.28547; Van Brocklyn JR, 2005, J NEUROPATH EXP NEUR, V64, P695, DOI 10.1097/01.jnen.0000175329.59092.2c; Yang AH, 2002, BBA-MOL CELL BIOL L, V1582, P197, DOI 10.1016/S1388-1981(02)00172-5; YATOMI Y, 1995, ANAL BIOCHEM, V230, P315, DOI 10.1006/abio.1995.1480	46	40	40	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0149462	10.1371/journal.pone.0149462	http://dx.doi.org/10.1371/journal.pone.0149462			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26886371	Green Submitted, Green Published, gold			2022-12-26	WOS:000371218400086
J	Willener, AST; Handrich, Y; Halsey, LG; Strike, S				Willener, Astrid S. T.; Handrich, Yves; Halsey, Lewis G.; Strike, Siobhan			Fat King Penguins Are Less Steady on Their Feet	PLOS ONE			English	Article							METABOLIC-RATE; STEP WIDTH; GAIT; WALKING; ACCELERATION; BIOMECHANICS; VARIABILITY; LOCOMOTION; ENERGETICS; ADULTS	Returning to the shore after a feeding sojourn at sea, king penguins often undertake a relatively long terrestrial journey to the breeding colony carrying a heavy, mostly frontal, accumulation of fat along with food in the stomach for chick-provisioning. There they must survive a fasting period of up to a month in duration, during which their complete reliance on endogenous energy stores results in a dramatic loss in body mass. Our aim was to determine if the king penguin's walking gait changes with variations in body mass. We investigated this by walking king penguins on a treadmill while instrumented with an acceleration data logger. The stride frequency, dynamic body acceleration (DBA) and posture of fat (pre-fasting; 13.2 kg) and slim (post fasting; 11 kg) king penguins were assessed while they walked at the same speed (1.4km/h) on a treadmill. Paired statistical tests indicated no evidence for a difference in dynamic body acceleration or stride frequency between the two body masses however there was substantially less variability in both leaning angle and the leaning amplitude of the body when the birds were slimmer. Furthermore, there was some evidence that the slimmer birds exhibited a decrease in waddling amplitude. We suggest the increase in variability of both leaning angle and amplitude, as well as a possibly greater variability in the waddling amplitude, is likely to result from the frontal fat accumulation when the birds are heavier, which may move the centre of mass anteriorly, resulting in a less stable upright posture. This study is the first to use accelerometry to better understand the gait of a species within a specific ecological context: the considerable body mass change exhibited by king penguins.	[Willener, Astrid S. T.; Halsey, Lewis G.; Strike, Siobhan] Univ Roehampton, Dept Life Sci, London, England; [Willener, Astrid S. T.; Handrich, Yves] Univ Strasbourg, Inst Pluridisciplinaire Hubert CURIEN, Strasbourg, France; [Willener, Astrid S. T.; Handrich, Yves] CNRS, Unite Mixte Rech 7178, Strasbourg, France	Roehampton University; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Willener, AST (corresponding author), Univ Roehampton, Dept Life Sci, London, England.; Willener, AST (corresponding author), Univ Strasbourg, Inst Pluridisciplinaire Hubert CURIEN, Strasbourg, France.; Willener, AST (corresponding author), CNRS, Unite Mixte Rech 7178, Strasbourg, France.	astrid.willener@gmail.com	Handrich, Yves/AAD-6472-2022; Halsey, Lewis/B-8498-2011	Halsey, Lewis/0000-0002-0786-7585; Strike, Siobhan/0000-0001-8195-6888	French Polar Institut (Institut Polaire Paul Emile Victor); Experimental Biology	French Polar Institut (Institut Polaire Paul Emile Victor); Experimental Biology	French Polar Institut (Institut Polaire Paul Emile Victor): financial and logistical support for the field part; The Swiss Fund for Women at University (Association Suisse des femmes diplomees des universites): founded part of the material; Company of Biologists and the Society: founded part of the travel cost for the field work; Experimental Biology provided funding for travel costs.	Barrat A, 1976, COM NAT FR RECH ANTA, V40, P9, DOI DOI 10.1016/J.ATHEROSCLEROSIS.2014.12.010; CHEREL Y, 1994, J ZOOL, V234, P1, DOI 10.1111/j.1469-7998.1994.tb06052.x; CHEREL Y, 1993, PHYSIOL ZOOL, V66, P750, DOI 10.1086/physzool.66.5.30163822; DEWASMES G, 1980, J APPL PHYSIOL, V49, P888, DOI 10.1152/jappl.1980.49.5.888; FISHER RA, 1959, STAT METHODS SCI INF; Fourati H, 2011, BIOMED SIGNAL PROCES, V6, P94, DOI 10.1016/j.bspc.2010.06.004; Gilleard WL, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-71; Griffin TM, 2000, NATURE, V408, P929, DOI 10.1038/35050167; Halsey LG, 2007, COMP BIOCHEM PHYS A, V147, P1009, DOI 10.1016/j.cbpa.2007.03.009; Halsey LG, 2015, NAT METHODS, V12, P179, DOI 10.1038/nmeth.3288; Hausdorff JM, 2001, ARCH PHYS MED REHAB, V82, P1050, DOI 10.1053/apmr.2001.24893; Helbostad JL, 2003, GAIT POSTURE, V18, P27, DOI 10.1016/S0966-6362(02)00197-2; Kirtley C, 2006, CLIN GAIT ANAL THEOR; Kurz MJ, 2008, J THEOR BIOL, V252, P272, DOI 10.1016/j.jtbi.2008.01.012; Lai PPK, 2008, CLIN BIOMECH, V23, pS2, DOI 10.1016/j.clinbiomech.2008.02.004; LaRoche DP, 2011, J ELECTROMYOGR KINES, V21, P754, DOI 10.1016/j.jelekin.2011.07.006; Lew MJ, 2012, BRIT J PHARMACOL, V166, P1559, DOI 10.1111/j.1476-5381.2012.01931.x; Moe-Nilssen R, 2005, GAIT POSTURE, V21, P164, DOI 10.1016/j.gaitpost.2004.01.013; PINSHOW B, 1977, SCIENCE, V195, P592, DOI 10.1126/science.835018; PINSHOW B, 1976, AM J PHYSIOL, V231, P903, DOI 10.1152/ajplegacy.1976.231.3.903; R Core Team, 2012, R LANG ENV STAT COMP; Ranavolo A, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/142323; Runhaar J, 2011, OBES REV, V12, P1071, DOI 10.1111/j.1467-789X.2011.00916.x; Willener AST, 2015, J THEOR BIOL, V387, P166, DOI 10.1016/j.jtbi.2015.09.019; Wilson RP, 2006, J ANIM ECOL, V75, P1081, DOI 10.1111/j.1365-2656.2006.01127.x	25	3	4	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0147784	10.1371/journal.pone.0147784	http://dx.doi.org/10.1371/journal.pone.0147784			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26886216	Green Submitted, gold, Green Published			2022-12-26	WOS:000371218400008
J	Wu, WH; Tran, W; Taatjes, CA; Alonso-Gutierrez, J; Lee, TS; Gladden, JM				Wu, Weihua; Tran, William; Taatjes, Craig A.; Alonso-Gutierrez, Jorge; Lee, Taek Soon; Gladden, John M.			Rapid Discovery and Functional Characterization of Terpene Synthases from Four Endophytic Xylariaceae	PLOS ONE			English	Article							FIR ABIES-GRANDIS; TRANS-CARYOPHYLLENE; BETA-CARYOPHYLLENE; ESCHERICHIA-COLI; CDNA ISOLATION; (E)-BETA-CARYOPHYLLENE SYNTHASE; (-)-LIMONENE SYNTHASE; DIPHOSPHATE SYNTHASE; PINENE SYNTHASE; ALPHA-PINENE	Endophytic fungi are ubiquitous plant endosymbionts that establish complex and poorly understood relationships with their host organisms. Many endophytic fungi are known to produce a wide spectrum of volatile organic compounds (VOCs) with potential energy applications, which have been described as "mycodiesel". Many of these mycodiesel hydrocarbons are terpenes, a chemically diverse class of compounds produced by many plants, fungi, and bacteria. Due to their high energy densities, terpenes, such as pinene and bisabolene, are actively being investigated as potential "drop-in" biofuels for replacing diesel and aviation fuel. In this study, we rapidly discovered and characterized 26 terpene synthases (TPSs) derived from four endophytic fungi known to produce mycodiesel hydrocarbons. The TPS genes were expressed in an E. coli strain harboring a heterologous mevalonate pathway designed to enhance terpene production, and their product profiles were determined using Solid Phase Micro-Extraction (SPME) and GC-MS. Out of the 26 TPS's profiled, 12 TPS's were functional, with the majority of them exhibiting both monoterpene and sesquiterpene synthase activity.	[Wu, Weihua; Tran, William; Gladden, John M.] Sandia Natl Labs, Biomass Sci & Convers Technol, Livermore, CA USA; [Taatjes, Craig A.] Sandia Natl Labs, Combust Chem Dept, Livermore, CA USA; [Alonso-Gutierrez, Jorge; Lee, Taek Soon] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Alonso-Gutierrez, Jorge; Lee, Taek Soon; Gladden, John M.] Joint BioEnergy Inst, Emeryville, CA USA	United States Department of Energy (DOE); Sandia National Laboratories; United States Department of Energy (DOE); Sandia National Laboratories; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI	Gladden, JM (corresponding author), Sandia Natl Labs, Biomass Sci & Convers Technol, Livermore, CA USA.; Gladden, JM (corresponding author), Joint BioEnergy Inst, Emeryville, CA USA.	jmgladden@lbl.gov		Taatjes, Craig/0000-0002-9271-0282	Laboratory Directed Research and Development program at Sandia National Laboratories [DE-AC04-94AL85000]; U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research [DE-AC02-05CH1123]	Laboratory Directed Research and Development program at Sandia National Laboratories; U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research(United States Department of Energy (DOE))	This work was supported by the Laboratory Directed Research and Development program at Sandia National Laboratories, which is a multiprogram laboratory operated by Sandia Corporation, a Lockheed Martin Company, for the United States Department of Energy's National Nuclear Security Agency under contract DE-AC04-94AL85000. The funders provided financial support in the form of all authors' salaries and/or research materials, but had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Also this work was partially performed at Joint BioEnergy Institute (http://www.jbei.org) supported by the U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research, through contract DE-AC02-05CH11231 between Lawrence Berkeley National Laboratory and the U.S. Department of Energy.	Al Mansouri S, 2014, PHARMACOL BIOCHEM BE, V124, P260, DOI 10.1016/j.pbb.2014.06.025; Alonso-Gutierrez J, 2013, METAB ENG, V19, P33, DOI 10.1016/j.ymben.2013.05.004; Banerjee D, 2014, INDIAN J MICROBIOL, V54, P27, DOI 10.1007/s12088-013-0400-5; Benjamin G, 2010, ENERG FUEL, V24, P264; Bogorad IW, 2014, P NATL ACAD SCI USA, V111, P15928, DOI 10.1073/pnas.1413470111; Bohlmann J, 1997, J BIOL CHEM, V272, P21784, DOI 10.1074/jbc.272.35.21784; Bombarda I, 2001, ANAL CHIM ACTA, V447, P113, DOI 10.1016/S0003-2670(01)01307-1; Burke C, 2002, ARCH BIOCHEM BIOPHYS, V405, P130, DOI 10.1016/S0003-9861(02)00335-1; Carothers JM, 2010, NUCLEIC ACIDS RES, V38, P2736, DOI 10.1093/nar/gkq082; Chang MCY, 2006, NAT CHEM BIOL, V2, P674, DOI 10.1038/nchembio836; Chappell J, 2008, IN VITRO CELL DEV-AN, V44, pS27; Chen WQ, 2015, J PHARMACOL SCI, V127, P332, DOI 10.1016/j.jphs.2015.01.008; Cheng AX, 2007, PHYTOCHEMISTRY, V68, P1632, DOI 10.1016/j.phytochem.2007.04.008; Croteau R Ga H, 1984, J BIOL CHEM, V259, P740; Davis EM, 2000, TOP CURR CHEM, V209, P53; Degenhardt J, 2009, PHYTOCHEMISTRY, V70, P1621, DOI 10.1016/j.phytochem.2009.07.030; Dewick PM, 2002, NAT PROD REP, V19, P181, DOI 10.1039/b002685i; Fischbach RJ, 2000, PHYTOCHEMISTRY, V54, P257, DOI 10.1016/S0031-9422(00)00119-9; FUJISAKI S, 1990, J BIOCHEM-TOKYO, V108, P995, DOI 10.1093/oxfordjournals.jbchem.a123327; Gladden CAT, 2013, 2013201310094 SAND; Gong CMS, 2004, ABSTR PAP AM CHEM S, V227, pU84; Griffin MA, 2010, MICROBIOL-SGM, V156, P3814, DOI 10.1099/mic.0.041327-0; Gunnewich N, 2007, NAT PROD COMMUN, V2, P223; Haehnel-Taguchi M, 2014, J NEUROPHYSIOL, V112, P1329, DOI 10.1152/jn.00274.2014; Han LH, 2014, EUR FOOD RES TECHNOL, V239, P1061, DOI 10.1007/s00217-014-2302-0; Harvey BG, 2015, ENERG FUEL, V29, P2431, DOI 10.1021/ef5027746; He ZL, 2010, APPL ENVIRON MICROB, V76, P1574, DOI 10.1128/AEM.02141-09; Huang XZ, 2013, PLANT PHYSIOL BIOCH, V73, P302, DOI 10.1016/j.plaphy.2013.10.017; Hyatt DC, 2005, ARCH BIOCHEM BIOPHYS, V439, P222, DOI 10.1016/j.abb.2005.05.017; Katoh S, 2004, ARCH BIOCHEM BIOPHYS, V425, P65, DOI 10.1016/j.abb.2004.02.015; Khodayari A, 2014, METAB ENG, V25, P50, DOI 10.1016/j.ymben.2014.05.014; Klauke AL, 2014, EUR NEUROPSYCHOPHARM, V24, P608, DOI 10.1016/j.euroneuro.2013.10.008; Koksal M, 2011, NATURE, V469, P116, DOI 10.1038/nature09628; Kollner TG, 2008, PLANT CELL, V20, P482, DOI 10.1105/tpc.107.051672; Kudalkar P, 2012, MYCOSCIENCE, V53, P319, DOI 10.1007/s10267-011-0165-9; Kumar S, 2012, BIOINFORMATICS, V28, P2685, DOI 10.1093/bioinformatics/bts507; Kumeta Y, 2010, PLANT PHYSIOL, V154, P1998, DOI 10.1104/pp.110.161828; Guzman-Gutierrez SL, 2015, LIFE SCI, V128, P24, DOI 10.1016/j.lfs.2015.02.021; Lee JB, 2014, NAT PROD COMMUN, V9, P1231; Liu H, 2015, NEUROCHEM RES, V40, P118, DOI 10.1007/s11064-014-1474-0; Lu S, 2002, PLANT PHYSIOL, V130, P477, DOI 10.1104/pp.006544; Myburg AA, 2014, NATURE, V510, P356, DOI 10.1038/nature13308; Nagegowda DA, 2008, PLANT J, V55, P224, DOI 10.1111/j.1365-313X.2008.03496.x; Nakano C, 2011, CHEMBIOCHEM, V12, P1988, DOI 10.1002/cbic.201100330; Oldfield E, 2012, ANGEW CHEM INT EDIT, V51, P1124, DOI 10.1002/anie.201103110; Ouyang Z, 2012, REV BRAS FARMACOGN, V22, P957, DOI 10.1590/S0102-695X2012005000051; Pant A, 2014, EXP GERONTOL, V57, P81, DOI 10.1016/j.exger.2014.05.007; Paula-Freire LIG, 2014, PHYTOMEDICINE, V21, P356, DOI 10.1016/j.phymed.2013.08.006; Peralta-Yahya PP, 2011, NAT COMMUN, P2; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Phillips MA, 2003, ARCH BIOCHEM BIOPHYS, V411, P267, DOI 10.1016/S0003-9861(02)00746-4; Rabe P, 2013, CHEMBIOCHEM, V14, P2345, DOI 10.1002/cbic.201300329; Riyaz-Ul-Hassan S, 2013, J MICROBIOL BIOTECHN, V23, P29, DOI 10.4014/jmb.1208.04062; Rufino AT, 2015, EUR J PHARMACOL, V750, P141, DOI 10.1016/j.ejphar.2015.01.018; Saranya J, 2012, J ESSENT OIL BEAR PL, V15, P283, DOI 10.1080/0972060X.2012.10644048; Schmidt CO, 1999, ARCH BIOCHEM BIOPHYS, V364, P167, DOI 10.1006/abbi.1999.1122; Schwab W, 2001, ARCH BIOCHEM BIOPHYS, V392, P123, DOI 10.1006/abbi.2001.2442; Shaw JJ, 2015, J BIOL CHEM, V290, P8511, DOI 10.1074/jbc.M114.636159; Shen Hai-Yan, 2007, Sheng Wu Gong Cheng Xue Bao, V23, P976, DOI 10.1016/S1872-2075(07)60059-4; Singh SK, 2011, MICROB ECOL, V61, P729, DOI 10.1007/s00248-011-9818-7; Sosa ME, 2012, BIOCHEM SYST ECOL, V43, P132, DOI 10.1016/j.bse.2012.03.007; Steele CL, 1998, J BIOL CHEM, V273, P2078, DOI 10.1074/jbc.273.4.2078; Stolle A, 2009, HELV CHIM ACTA, V92, P1673, DOI 10.1002/hlca.200900041; Strobel G, 2004, J NAT PROD, V67, P257, DOI 10.1021/np030397v; Strobel GA, 1996, J IND MICROBIOL BIOT, V17, P417, DOI 10.1007/BF01574772; Strobel GA, 1998, ASM NEWS, V64, P263; Strobel G, 2014, CURR OPIN MICROBIOL, V19, P52, DOI 10.1016/j.mib.2014.06.003; Strobel G, 2011, FEMS MICROBIOL LETT, V320, P87, DOI 10.1111/j.1574-6968.2011.02297.x; Strobel GA, 2008, MICROBIOL-SGM, V154, P3319, DOI 10.1099/mic.0.2008/022186-0; Tang YJJ, 2009, J BACTERIOL, V191, P5224, DOI 10.1128/JB.00085-09; Tholl D, 2005, PLANT J, V42, P757, DOI 10.1111/j.1365-313X.2005.02417.x; Tim Edwards CM, 2010, 46 AIAA ASME SAE ASE; Tomsheck AR, 2010, MICROB ECOL, V60, P903, DOI 10.1007/s00248-010-9759-6; Ul-Hassan SR, 2012, MICROBIOL-SGM, V158, P465, DOI 10.1099/mic.0.054643-0; VanDien SJ, 1997, APPL ENVIRON MICROB, V63, P1689, DOI 10.1128/AEM.63.5.1689-1695.1997; Wang SJ, 2014, BIOCHEM BIOPH RES CO, V444, P451, DOI 10.1016/j.bbrc.2013.11.136; Wu SQ, 2005, PLANT PHYSIOL, V138, P1322, DOI 10.1104/pp.105.059386; Yukie Kumeta MI, 2011, J NATURAL MED, V65, P508, DOI [10.1007/s11418-011-0529-7, DOI 10.1007/S11418-011-0529-7]; Zhang Z, 2015, DRUG RES, V65, P214, DOI 10.1055/s-0034-1377025	79	22	26	3	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0146983	10.1371/journal.pone.0146983	http://dx.doi.org/10.1371/journal.pone.0146983			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26885833	Green Published, gold, Green Submitted			2022-12-26	WOS:000371218400005
J	Chun, Y; Kim, R; Lee, S				Chun, Younghwa; Kim, Raehyung; Lee, Soojin			Centromere Protein (CENP)-W Interacts with Heterogeneous Nuclear Ribonucleoprotein (hnRNP) U and May Contribute to Kinetochore-Microtubule Attachment in Mitotic Cells	PLOS ONE			English	Article							CENP-T; CHROMOSOME CONGRESSION; OUTER KINETOCHORE; MATRIX PROTEIN; HELA-CELLS; SAF-A; RNA; CHECKPOINT; TUBULIN; CANCER	Background Recent studies have shown that heterogeneous nuclear ribonucleoprotein U (hnRNP U), a component of the hnRNP complex, contributes to stabilize the kinetochore-microtubule interaction during mitosis. CENP-W was identified as an inner centromere component that plays crucial roles in the formation of a functional kinetochore complex. Results We report that hnRNP U interacts with CENP-W, and the interaction between hnRNP U and CENP-W mutually increased each other's protein stability by inhibiting the proteasome-mediated degradation. Further, their co-localization was observed chiefly in the nuclear matrix region and at the microtubule-kinetochore interface during interphase and mitosis, respectively. Both microtubule-stabilizing and microtubule-destabilizing agents significantly decreased the protein stability of CENP-W. Furthermore, loss of microtubules and defects in microtubule organization were observed in CENP-W-depleted cells. Conclusion Our data imply that CENP-W plays an important role in the attachment and interaction between microtubules and kinetochore during mitosis.	[Chun, Younghwa; Kim, Raehyung; Lee, Soojin] Chungnam Natl Univ, Dept Microbiol & Mol Biol, Coll Biosci & Biotechnol, Daejeon, South Korea	Chungnam National University	Lee, S (corresponding author), Chungnam Natl Univ, Dept Microbiol & Mol Biol, Coll Biosci & Biotechnol, Daejeon, South Korea.	leesoojin@cnu.ac.kr		Lee, Soojin/0000-0002-0383-5025	Basic Science Research Program by the Ministry of Education, Science and Technology of Korea [2013R1A1A3A04005274]; Chungnam National University	Basic Science Research Program by the Ministry of Education, Science and Technology of Korea; Chungnam National University	This research was supported by the Basic Science Research Program by the Ministry of Education, Science and Technology of Korea (2013R1A1A3A04005274) and the research fund of Chungnam National University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by Basic Science Research Program by the Ministry of Education, Science and Technology of Korea (2013R1A1A3A04005274) and research fund of Chungnam National University.	Akoumianaki T, 2009, J CELL SCI, V122, P1111, DOI 10.1242/jcs.043034; Ameyar-Zazoua M, 2009, J BIOL CHEM, V284, P27974, DOI 10.1074/jbc.M109.037929; Amin MA, 2008, FEBS LETT, V582, P3839, DOI 10.1016/j.febslet.2008.10.023; Cheeseman IM, 2008, NAT REV MOL CELL BIO, V9, P33, DOI 10.1038/nrm2310; Chun Y, 2013, J BIOL CHEM, V288, P27208, DOI 10.1074/jbc.M113.469221; Chun Y, 2011, J BIOL CHEM, V286, P42758, DOI 10.1074/jbc.M111.228411; Hasegawa Y, 2010, DEV CELL, V19, P469, DOI 10.1016/j.devcel.2010.08.006; Higa LAA, 2003, NAT CELL BIOL, V5, P1008, DOI 10.1038/ncb1061; Hori T, 2008, CELL, V135, P1039, DOI 10.1016/j.cell.2008.10.019; Kaczmarczyk A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106464; KILEDJIAN M, 1992, EMBO J, V11, P2655, DOI 10.1002/j.1460-2075.1992.tb05331.x; Kim H, 2009, MOL CELLS, V27, P697, DOI 10.1007/s10059-009-0083-2; Kops GJPL, 2005, NAT REV CANCER, V5, P773, DOI 10.1038/nrc1714; Lee S, 2007, BIOCHEM BIOPH RES CO, V360, P633, DOI 10.1016/j.bbrc.2007.06.102; Lyapina S, 2001, SCIENCE, V292, P1382, DOI 10.1126/science.1059780; Ma N, 2007, J CELL SCI, V120, P2091, DOI 10.1242/jcs.008771; Ma N, 2011, J CELL SCI, V124, P394, DOI 10.1242/jcs.063347; Maiato H, 2004, J CELL SCI, V117, P5461, DOI 10.1242/jcs.01536; Mellone B, 2006, NAT CELL BIOL, V8, P427, DOI 10.1038/ncb0506-427; MITHIEUX G, 1984, J BIOL CHEM, V259, P5523; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Nishino T, 2013, EMBO J, V32, P424, DOI 10.1038/emboj.2012.348; Nishino T, 2012, CELL, V148, P487, DOI 10.1016/j.cell.2011.11.061; Quenet D, 2012, CHROMOSOME RES, V20, P465, DOI 10.1007/s10577-012-9301-4; ROMIG H, 1992, EMBO J, V11, P3431, DOI 10.1002/j.1460-2075.1992.tb05422.x; Rosic S, 2014, J CELL BIOL, V207, P335, DOI 10.1083/jcb.201404097; Screpanti E, 2011, CURR BIOL, V21, P391, DOI 10.1016/j.cub.2010.12.039; Tanenbaum ME, 2010, CHROMOSOMA, V119, P415, DOI 10.1007/s00412-010-0267-8; Yeh IT, 2004, CELL MOTIL CYTOSKEL, V57, P96, DOI 10.1002/cm.10157	29	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0149127	10.1371/journal.pone.0149127	http://dx.doi.org/10.1371/journal.pone.0149127			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	26881882	gold, Green Published, Green Submitted			2022-12-26	WOS:000371219000049
J	Mateus, CS; Almeida, PR; Mesquita, N; Quintella, BR; Alves, MJ				Mateus, Catarina Sofia; Almeida, Pedro Raposo; Mesquita, Natacha; Quintella, Bernardo Ruivo; Alves, Maria Judite			European Lampreys: New Insights on Postglacial Colonization, Gene Flow and Speciation	PLOS ONE			English	Article							LAMPETRA-FLUVIATILIS L.; MICROSATELLITE LOCI; PETROMYZONTIFORMES PETROMYZONTIDAE; ICHTHYOMYZON-UNICUSPIS; POPULATION-GENETICS; MIGRATION RATES; PLANERI BLOCH; I. FOSSOR; BROOK; RIVER	Ice ages are known to be the most dominant palaeoclimatic feature occurring on Earth, producing severe climatic oscillations and consequently shaping the distribution and the population structure of several species. Lampreys constitute excellent models to study the colonization of freshwater systems, as they commonly appear in pairs of closely related species of anadromous versus freshwater resident adults, thus having the ability to colonize new habitats, through the anadromous species, and establish freshwater resident derivates. We used 10 microsatellite loci to investigate the spatial structure, patterns of gene flow and migration routes of Lampetra populations in Europe. We sampled 11 populations including the migratory L. fluviatilis and four resident species, L. planeri, L. alavariensis, L. auremensis and L. lusitanica, the last three endemic to the Iberian Peninsula. In this southern glacial refugium almost all sampled populations represent a distinct genetic cluster, showing high levels of allopatric differentiation, reflecting long periods of isolation. As result of their more recent common ancestor, populations from northern Europe are less divergent among them, they are represented by fewer genetic clusters, and there is evidence of strong recent gene flow among populations. These previously glaciated areas from northern Europe may have been colonized from lampreys expanding out of the Iberian refugia. The pair L. fluviatilis/L. planeri is apparently at different stages of speciation in different locations, showing evidences of high reproductive isolation in the southern refugium, and low differentiation in the north.	[Mateus, Catarina Sofia; Almeida, Pedro Raposo; Quintella, Bernardo Ruivo] Univ Evora, MARE Ctr Ciencias Mar & Ambiente, Evora, Portugal; [Mateus, Catarina Sofia; Mesquita, Natacha; Alves, Maria Judite] Univ Lisbon, Museu Nacl Hist Nat & Ciencia, P-1699 Lisbon, Portugal; [Mateus, Catarina Sofia; Mesquita, Natacha; Alves, Maria Judite] Univ Lisbon, Ctr Ecol Evolucao & Alteracoes Ambientais, P-1699 Lisbon, Portugal; [Almeida, Pedro Raposo] Univ Evora, Escola Ciencias & Tecnol, Dept Biol, Evora, Portugal; [Quintella, Bernardo Ruivo] Univ Lisbon, Fac Ciencias, Dept Biol Anim, Lisbon, Portugal	University of Evora; Universidade de Lisboa; Universidade de Lisboa; University of Evora; Universidade de Lisboa	Mateus, CS (corresponding author), Univ Evora, MARE Ctr Ciencias Mar & Ambiente, Evora, Portugal.; Mateus, CS (corresponding author), Univ Lisbon, Museu Nacl Hist Nat & Ciencia, P-1699 Lisbon, Portugal.; Mateus, CS (corresponding author), Univ Lisbon, Ctr Ecol Evolucao & Alteracoes Ambientais, P-1699 Lisbon, Portugal.	csmateus@fc.ul.pt	Almeida, Pedro R./B-1895-2012; Quintella, Bernardo/B-4028-2012; Alves, Maria Judite/K-9315-2014	Almeida, Pedro R./0000-0002-2776-5420; Quintella, Bernardo/0000-0002-0509-4515; Alves, Maria Judite/0000-0002-0550-4190; Mateus, Catarina/0000-0002-8067-4536	Fundacao para a Ciencia e a Tecnologia (FCT); FEDER; COMPETE; QREN [PTDC/BIA-BDE/71826/2006, PEst-OE/MAR/UI0199/2011]; FCT-Foundation for Science and Technology [UID/MAR/04292/2013]; FCT [SFRH/BD/44029/2008, SFRH/BPD/14557/2003]	Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); FEDER(European Commission); COMPETE; QREN; FCT-Foundation for Science and Technology(Portuguese Foundation for Science and Technology); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	Financial support was provided by Fundacao para a Ciencia e a Tecnologia (FCT), FEDER, COMPETE, and QREN through project funding (PTDC/BIA-BDE/71826/2006), the pluriannual funding program to the Center of Oceanography (PEst-OE/MAR/UI0199/2011) and by National Funds through FCT-Foundation for Science and Technology under the Project UID/MAR/04292/2013. CSM and NM were supported by FCT grants SFRH/BD/44029/2008 and SFRH/BPD/14557/2003, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors especially thank Alpo Huhmarniemi and Jaakko Erkinaro (Finnish Game and Fisheries Research Institute, Finland), Michael Ovidio (University of Liege, Belgium) and Martin Krappe (Society for Nature Conservation and Landscape Ecology, Kratzeburg, Germany) for the donation of samples. We are also grateful to Hugo Gante and Vitor Sousa for valuable suggestions on data analysis, to Maria Drago for assistance in early phases of the labwork and to Carlos Alexandre and Tadeu Pereira for assistance in the fieldwork. We thank the collecting permits provided by Instituto da Conservacao da Natureza e das Florestas (ICNF), and Fluviario de Mora for logistic support. Financial support was provided by Fundacao para a Ciencia e a Tecnologia (FCT), FEDER, COMPETE, and QREN through project funding (PTDC/BIABDE/71826/2006) and), through the pluriannual funding program to the Center of Oceanography (PEst-OE/MAR/UI0199/2011).) and by National Funds through FCT - Foundation for Science and Technology under the Project UID/MAR/04292/2013. C.S. Mateus and N. Mesquita were supported by FCT grants SFRH/BD/44029/2008 and SFRH/BPD/14557/2003, respectively.	Aboim MA, 2013, BIOL J LINN SOC, V109, P656, DOI 10.1111/bij.12059; ABOUSEEDO FS, 1979, J ZOOL, V188, P5; Anderson EC, 2002, GENETICS, V160, P1217; [Anonymous], 1996, 5000 CNRS UMR; Beerli P, 2004, MOL ECOL, V13, P827, DOI 10.1111/j.1365-294X.2004.02101.x; Bell M.A., 1997, EXS, V82, P323; Blank M, 2008, CAN J FISH AQUAT SCI, V65, P2780, DOI 10.1139/F08-178; Boguski DA, 2012, J FISH BIOL, V81, P1891, DOI 10.1111/j.1095-8649.2012.03417.x; Bracken FSA, 2015, MOL ECOL, V24, P1188, DOI 10.1111/mec.13112; Bryan MB, 2003, CONSERV GENET, V4, P113, DOI 10.1023/A:1021808909811; Consuegra S, 2002, MOL ECOL, V11, P2037, DOI 10.1046/j.1365-294X.2002.01592.x; Cornuet JM, 1999, GENETICS, V153, P1989; Docker MF, 2012, CONSERV GENET, V13, P823, DOI 10.1007/s10592-012-0332-3; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Espanhol R, 2007, MOL ECOL, V16, P1909, DOI 10.1111/j.1365-294X.2007.03279.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Filcek KB, 2005, N AM J FISH MANAGE, V25, P502, DOI 10.1577/M03-206.1; Fu YX, 1997, GENETICS, V147, P915; Gante HF, 2009, MOL ECOL, V18, P3240, DOI 10.1111/j.1365-294X.2009.04264.x; Garza JC, 2001, MOL ECOL, V10, P305, DOI 10.1046/j.1365-294x.2001.01190.x; Goodman DH, 2008, J FISH BIOL, V72, P400, DOI 10.1111/j.1095-8649.2007.01731.x; Hardisty M.W., 1971, P85; Hardisty M. W., 1986, FRESHWATER FISHES 1, V1, P19; Hewitt GM, 1999, BIOL J LINN SOC, V68, P87, DOI 10.1111/j.1095-8312.1999.tb01160.x; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; Hubbs CL, 1940, AM NAT, V74, P198, DOI 10.1086/280888; Hubbz C. L., 1925, Papers from the Michigan Academy of Science, V4, P587; Kemp PS, 2011, RIVER RES APPL, V27, P488, DOI 10.1002/rra.1364; Lorenzini R, 2006, BIOL J LINN SOC, V88, P85, DOI 10.1111/j.1095-8312.2006.00606.x; Luikart G, 1998, J HERED, V89, P238, DOI 10.1093/jhered/89.3.238; Luzier CW, 2010, CONSERV GENET RESOUR, V2, P71, DOI 10.1007/s12686-009-9155-z; Mateus CS, 2011, CONSERV GENET, V12, P1061, DOI 10.1007/s10592-011-0209-x; Mateus CS, 2013, CURR BIOL, V23, pR649, DOI 10.1016/j.cub.2013.06.026; Mateus CS, 2013, CONTRIB ZOOL, V82, P37, DOI 10.1163/18759866-08201003; Mateus Catarina S., 2012, Endangered Species Research, V16, P183, DOI 10.3354/esr00405; McFarlane CT, 2009, CONSERV GENET RESOUR, V1, P377, DOI 10.1007/s12686-009-9087-7; Mesquita N, 2005, MOL ECOL, V14, P1939, DOI 10.1111/j.1365-294X.2005.02569.x; Paetkau D, 2004, MOL ECOL, V13, P55, DOI 10.1046/j.1365-294X.2004.02008.x; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Pritchard JK, 2000, GENETICS, V155, P945; Rambaut A., 2014, TRACER V1 6; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rougemont Q, 2015, J EVOLUTION BIOL, V28, P2248, DOI 10.1111/jeb.12750; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Schreiber A, 1998, J ZOOL SYST EVOL RES, V36, P85, DOI 10.1111/j.1439-0469.1998.tb00781.x; Spice EK, 2012, MOL ECOL, V21, P2916, DOI 10.1111/j.1365-294X.2012.05585.x; Stewart JR, 2001, TRENDS ECOL EVOL, V16, P608, DOI 10.1016/S0169-5347(01)02338-2; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Taberlet P, 1998, MOL ECOL, V7, P453, DOI 10.1046/j.1365-294x.1998.00289.x; TAJIMA F, 1989, GENETICS, V123, P585; Takeshima H, 2005, MOL ECOL NOTES, V5, P812, DOI 10.1111/j.1471-8286.2005.01072.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; VLADYKOV VD, 1979, CAN J ZOOL, V57, P860, DOI 10.1139/z79-106; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wilson GA, 2003, GENETICS, V163, P1177; ZANANDREA G, 1959, NATURE, V184, P380	63	22	23	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0148107	10.1371/journal.pone.0148107	http://dx.doi.org/10.1371/journal.pone.0148107			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26871930	gold, Green Published			2022-12-26	WOS:000370054100018
J	Yang, LP; Sun, GX; Guo, Y; Hou, ZF; Chen, S				Yang, Lanping; Sun, Guoxiang; Guo, Yong; Hou, Zhifei; Chen, Shuai			Holistic Evaluation of Quality Consistency of Ixeris sonchifolia (Bunge) Hance Injectables by Quantitative Fingerprinting in Combination with Antioxidant Activity and Chemometric Methods	PLOS ONE			English	Article							CHROMATOGRAPHIC FINGERPRINTS; PILL; IDENTIFICATION; ASSAY; TOOL	A widely used herbal medicine, Ixeris sonchifolia (Bge.) Hance Injectable (ISHI) was investigated for quality consistency. Characteristic fingerprints of 23 batches of the ISHI samples were generated at five wavelengths and evaluated by the systematic quantitative fingerprint method (SQFM) as well as simultaneous analysis of the content of seven marker compounds. Chemometric methods, i.e., support vector machine (SVM) and principal component analysis (PCA) were performed to assist in fingerprint evaluation of the ISHI samples. Qualitative classification of the ISHI samples by SVM was consistent with PCA, and in agreement with the quantitative evaluation by SQFM. In addition, the antioxidant activities of the ISHI samples were determined by both the off-line and on-line DPPH (2, 2-diphenyl-1- picryldrazyl) radical scavenging assays. A fingerprint-efficacy relationship linking the chemical components and in vitro antioxidant activity was established and validated using the partial least squares (PLS) and orthogonal projection to latent structures (OPLS) models; and the online DPPH assay further revealed those components that had position contribution to the total antioxidant activity. Therefore, the combined use of the chemometric methods, quantitative fingerprint evaluation by SQFM, and multiple marker compound analysis in conjunction with the assay of antioxidant activity provides a powerful and holistic approach to evaluate quality consistency of herbal medicines and their preparations.	[Yang, Lanping; Sun, Guoxiang; Hou, Zhifei; Chen, Shuai] Shenyang Pharmaceut Univ, Sch Pharm, Shenyang 110016, Peoples R China; [Guo, Yong] Fairleigh Dickinson Univ, Sch Pharm, Florham Pk, NJ 07932 USA	Shenyang Pharmaceutical University; Fairleigh Dickinson University	Sun, GX (corresponding author), Shenyang Pharmaceut Univ, Sch Pharm, Shenyang 110016, Peoples R China.	gxswmwys@163.com		Guo, Yong/0000-0003-0488-3093				Alaerts G, 2014, J PHARMACEUT BIOMED, V95, P34, DOI 10.1016/j.jpba.2014.02.006; Babbar N, 2014, J FOOD SCI TECH MYS, V51, P2568, DOI 10.1007/s13197-012-0754-4; Benzi G, 1997, PHARMACOL RES, V35, P355, DOI 10.1006/phrs.1997.0132; Bhandari P, 2010, INDIAN J EXP BIOL, V48, P323; Chang YX, 2008, J CHROMATOGR A, V1208, P76, DOI 10.1016/j.chroma.2008.08.054; [陈春光 Chen Chunguang], 2012, [中国临床药理学杂志, The Chinese Journal of Clinical Pharmacology], V28, P196; China Drug Administration Bureau of, 2000, CHIN TRAD PAT MED, V22, P671; Custers D, 2014, TALANTA, V123, P78, DOI 10.1016/j.talanta.2014.01.020; Ding XP, 2009, J CHROMATOGR A, V1216, P2204, DOI 10.1016/j.chroma.2008.08.115; European Medicines Agency, 2010, GUID DECL HERB SUBST; Food and Drug Administration, 2004, GUID IND BOT DRUG PR; Ghandi M, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003711; Ibrahim FA, 2014, ACTA CHIM SLOV, V61, P11; Information Office of the State Council of the People's Republic of China, 2008, STAT QUO DRUG SUP CH; Li ZJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067451; Liang J, 2013, J CHROMATOGR A, V1294, P58, DOI 10.1016/j.chroma.2013.04.016; [刘睿 Liu Rui], 2013, [中草药, Chinese Traditional and Herbal Drugs], V44, P2542; Liu Ying, 2013, Zhongguo Zhong Yao Za Zhi, V38, P2675; Pomerantsev AL, 2014, J CHEMOMETR, V28, P429, DOI 10.1002/cem.2506; Prevc T, 2013, TALANTA, V109, P13, DOI 10.1016/j.talanta.2013.03.046; Sharma OP, 2009, FOOD CHEM, V113, P1202, DOI 10.1016/j.foodchem.2008.08.008; Shi PY, 2011, PHYTOCHEM ANALYSIS, V22, P66, DOI 10.1002/pca.1253; Sun Guo-xiang, 2009, Yaoxue Xuebao, V44, P401; Sun GX, 2013, ANN TRANSL MED, V1, DOI 10.3978/j.issn.2305-5839.2013.03.03; Sun GX, 2014, ANAL METHODS-UK, V6, P838, DOI 10.1039/c3ay41670d; Sun GX, 2009, CHIN J CHROMATOGR, V27, P318; Tistaert C, 2011, ANAL CHIM ACTA, V690, P148, DOI 10.1016/j.aca.2011.02.023; Trygg J, 2002, J CHEMOMETR, V16, P119, DOI 10.1002/cem.695; WHO, 1991, GUIDELINES ASSESSMEN; Wu JH, 2008, J AGR FOOD CHEM, V56, P328, DOI 10.1021/jf072314c; Yin L, 2013, J CHROMATOGR B, V931, P12, DOI 10.1016/j.jchromb.2013.04.039; Zhang J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057928; Zhang WZ, 2008, J ASIAN NAT PROD RES, V10, P1087, DOI 10.1080/10286020802361180; Zhang YC, 2013, FOOD CHEM TOXICOL, V59, P272, DOI 10.1016/j.fct.2013.05.058; Zhang YC, 2013, CHEM BIODIVERS, V10, P1373, DOI 10.1002/cbdv.201100234; Zhu JQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087462	36	17	17	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0148878	10.1371/journal.pone.0148878	http://dx.doi.org/10.1371/journal.pone.0148878			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26872364	Green Published, gold, Green Submitted			2022-12-26	WOS:000370054100067
J	Bachiller, E; Skaret, G; Nottestad, L; Slotte, A				Bachiller, Eneko; Skaret, Georg; Nottestad, Leif; Slotte, Aril			Feeding Ecology of Northeast Atlantic Mackerel, Norwegian Spring-Spawning Herring and Blue Whiting in the Norwegian Sea	PLOS ONE			English	Article							CAPELIN MALLOTUS-VILLOSUS; SMALL PELAGIC FISH; CLUPEA-HARENGUS L; CALANUS-FINMARCHICUS; PLANKTIVOROUS FISH; SCOMBER-SCOMBRUS; BARENTS SEA; OVERLAP; SUMMER; MIGRATION	The Norwegian spring-spawning (NSS) herring (Clupea harengus), blue whiting (Micromesistius poutassou) and Northeast Atlantic (NEA) mackerel (Scomber scombrus) are extremely abundant pelagic planktivores that feed in the Norwegian Sea (NS) during spring and summer. This study investigated the feeding ecology and diet composition of these commercially important fish stocks on the basis of biological data, including an extensive set of stomach samples in combination with hydrographical data, zooplankton samples and acoustic abundance data from 12 stock monitoring surveys carried out in 2005-2010. Mackerel were absent during the spring, but had generally high feeding overlap with herring in the summer, with a diet mainly based on calanoid copepods, especially Calanus finmarchicus, as well as a similar diet width. Stomach fullness in herring diminished from spring to summer and feeding incidence was lower than that of mackerel in summer. However, stomach fullness did not differ between the two species, indicating that herring maintain an equally efficient pattern of feeding as mackerel in summer, but on a diet that is less dominated by copepods and is more reliant on larger prey. Blue whiting tended to have a low dietary overlap with mackerel and herring, with larger prey such as euphausiids and amphipods dominating, and stomach fullness and feeding incidence increasing with length. For all the species, feeding incidence increased with decreasing temperature, and for mackerel so did stomach fullness, indicating that feeding activity is highest in areas associated with colder water masses. Significant annual effects on diet composition and feeding-related variables suggested that the three species are able to adapt to different food and environmental conditions. These annual effects are likely to have an important impact on the predation pressure on different plankton groups and the carrying capacity of individual systems, and emphasise the importance of regular monitoring of pelagic fish diets.	[Bachiller, Eneko; Skaret, Georg; Nottestad, Leif; Slotte, Aril] Inst Marine Res, Pelag Fish Res Grp, POB 1870, NO-5817 Bergen, Norway; [Bachiller, Eneko] AZTI Fdn, Marine Ecosyst Functioning Area, Gipuzkoa 20110, Basque Country, Spain	Institute of Marine Research - Norway; AZTI	Bachiller, E (corresponding author), Inst Marine Res, Pelag Fish Res Grp, POB 1870, NO-5817 Bergen, Norway.; Bachiller, E (corresponding author), AZTI Fdn, Marine Ecosyst Functioning Area, Gipuzkoa 20110, Basque Country, Spain.	eneko.bachiller@imr.no	Bachiller, Eneko/H-3528-2019	Bachiller, Eneko/0000-0002-6189-6176	Department of Education, Language policy and Culture of the Basque Country Government	Department of Education, Language policy and Culture of the Basque Country Government	This work was supported by a postdoctoral fellowship to EB from the Department of Education, Language policy and Culture of the Basque Country Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, R LANG ENV STAT COMP; Bachiller E, 2015, MAR ECOL PROG SER, V534, P179, DOI 10.3354/meps11375; Bachiller E, 2013, ICES J MAR SCI, V70, P232, DOI 10.1093/icesjms/fss171; Berge J, 2015, ARCTIC, V68, P54, DOI 10.14430/arctic4455; Blindheim J., 1989, P366; Broms C, 2012, MAR BIOL RES, V8, P461, DOI 10.1080/17451000.2011.640689; Dalpadado P, 1998, SARSIA, V83, P103; Dalpadado P, 2000, ICES J MAR SCI, V57, P843, DOI 10.1006/jmsc.2000.0573; Dragesund O, 1997, SARSIA, V82, P97, DOI 10.1080/00364827.1997.10413643; Entsminger GL, 2014, ECOSIM PROFESSIONAL; FAO, 2005, REVIEW OF THE STATE; Ferno A, 1998, SARSIA, V83, P149; GIBSON RN, 1992, J FISH BIOL, V40, P577, DOI 10.1111/j.1095-8649.1992.tb02607.x; Gislason A, 2002, FOOD NORWEGIAN SPRIN, P236; Hamre J., 1980, Rapports et Proces-Verbaux des Reunions Conseil International pour l'Exploration de la Mer, V177, P212; Harris R., 2000, ICES ZOOPLANKTON MET; HASSEL A, 1991, POLAR RES, V10, P371, DOI 10.1111/j.1751-8369.1991.tb00660.x; Huse G, 1996, SARSIA, V81, P143, DOI 10.1080/00364827.1996.10413618; Huse G, 2012, MAR BIOL RES, V8, P488, DOI 10.1080/17451000.2011.639779; Huse G, 2012, MAR BIOL RES, V8, P415, DOI 10.1080/17451000.2011.653372; HYSLOP EJ, 1980, J FISH BIOL, V17, P411, DOI 10.1111/j.1095-8649.1980.tb02775.x; ICES (International Council for the Exploration of the Sea), 2014, REP WORK GROUP WID D; Iversen S.A., 2002, ICES J MAR SCI, V215, P382, DOI [10.17895/ices.pub.8877, DOI 10.17895/ICES.PUB.8877]; Johannessen O.M., 1986, BRIEF OVERVIEW PHYS, P103; Kaartvedt S, 2000, ICES J MAR SCI, V57, P1819, DOI 10.1006/jmsc.2000.0964; Langoy H, 2012, MAR BIOL RES, V8, P442, DOI 10.1080/17451000.2011.642803; LAWLOR LR, 1980, AM NAT, V116, P394, DOI 10.1086/283634; Melle W, 2004, ZOOPLANKTON LINK HIG, P137; Misund OA, 1998, SARSIA, V83, P117; Mjanger H, 2007, BERGEN I MAR RES, V3, P45; Nottestad L, 1999, CAN J FISH AQUAT SCI, V56, P26, DOI 10.1139/cjfas-56-S1-26; Nottestad L, 1996, SARSIA, V80, P277, DOI 10.1080/00364827.1996.10413601; Nottestad L, ICES J MAR SCI; Olaso T, 2005, J MAR BIOL ASSOC UK, V85, P415, DOI 10.1017/S0025315405011343h; PIANKA ER, 1974, P NATL ACAD SCI USA, V71, P2141, DOI 10.1073/pnas.71.5.2141; Prokopchuk I, 2006, ICES J MAR SCI, V63, P117, DOI 10.1016/j.icesjms.2005.08.005; Skaret G, 2015, ICES J MAR SCI, V72, P2313, DOI 10.1093/icesjms/fsv087; Skjoldal H.R., 2004, NORWEGIAN SEA ECOSYS; Toresen R, 2000, FISH FISH, V1, P231, DOI 10.1111/j.1467-2979.2000.00022.x; Utne KR, 2012, MAR BIOL RES, V8, P548, DOI 10.1080/17451000.2011.639781; Utne KR, 2012, MAR BIOL RES, V8, P527, DOI 10.1080/17451000.2011.642804; Utne KR, 2012, MAR BIOL RES, V8, P420, DOI 10.1080/17451000.2011.640937; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; ZILANOV VK, 1964, MATERIALY RYBOKHOZUS, V4, P45; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x	45	59	59	1	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0149238	10.1371/journal.pone.0149238	http://dx.doi.org/10.1371/journal.pone.0149238			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3DG	26895485	Green Published, Green Submitted, gold			2022-12-26	WOS:000371223400041
J	Chen, X; Zou, XB; He, JM; Zheng, J; Chiarella, J; Kozal, MJ				Chen, Xi; Zou, Xiaobai; He, Jianmei; Zheng, Jun; Chiarella, Jennifer; Kozal, Michael J.			HIV Drug Resistance Mutations (DRMs) Detected by Deep Sequencing in Virologic Failure Subjects on Therapy from Hunan Province, China	PLOS ONE			English	Article							TREATMENT-EXPERIENCED PATIENTS; REVERSE-TRANSCRIPTASE; ANTIRETROVIRAL TREATMENT; MINORITY POPULATIONS; IMPACT; VARIANTS; GENOTYPE; RISK	Objective Determine HIV drug resistance mutations (DRMs) prevalence at low and high levels in ART-experienced patients experiencing virologic failure (VF). Methods 29 subjects from 18 counties in Hunan Province that experienced VF were evaluated for the prevalence of DRMs (Stanford DRMs with an algorithm value >= 15, include low-, intermediate and high-level resistance) by both Sanger sequencing (SS) and deep sequencing (DS) to 1% frequency levels. Results DS was performed on samples from 29 ART-experienced subjects; the median viral load 4.95x10(4) c/ml; 82.76% subtype CRF01_AE. 58 DRMs were detected by DS. 18 DRMs were detected by SS. Of the 58 mutations detected by DS, 40 were at levels <20% frequency (26 NNRTI, 12 NRTI and 2 PI) and the majority of these 95.00% (38/40) were not detected by standard genotyping. Of these 40 low-level DRMs, 16 (40%) were detected at frequency levels of 1-4% and 24 (60%) at levels of 5-19%. SS detected 15 of 17 (88.24%) DRMs at levels >= 20% that were detected by DS. The only variable associated with the detection of DRMs by DS was ART adherence (missed doses in the prior 7 days); all patients that reported missing a dose in the last 7 days had DRMs detected by DS. Conclusions DS of VF samples from treatment experienced subjects infected with primarily AE subtype frequently identified Stanford HIVdb NRTI and NNRTI resistance mutations with an algorithm value 15. Low frequency level resistant variants detected by DS were frequently missed by standard genotyping in VF specimens from antiretroviral-experienced subjects.	[Chen, Xi; Zou, Xiaobai; He, Jianmei; Zheng, Jun] Hunan Prov Ctr Dis Control & Prevent, Changsha, Hunan, Peoples R China; [Chiarella, Jennifer; Kozal, Michael J.] Yale Univ, Sch Med, New Haven, CT USA	Yale University	Chen, X (corresponding author), Hunan Prov Ctr Dis Control & Prevent, Changsha, Hunan, Peoples R China.	Chenxi161@sohu.com		, Michael/0000-0002-7719-7396; Kozal, Michael/0000-0002-3100-8254	National Science and Technology Major Project of China [2012ZX1001001]	National Science and Technology Major Project of China	This work was funded by National Science and Technology Major Project of China (No. 2012ZX1001001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avidor B, 2013, J CLIN MICROBIOL, V51, P880, DOI 10.1128/JCM.02652-12; Barzon L, 2011, INT J MOL SCI, V12, P7861, DOI 10.3390/ijms12117861; Bennett DE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004724; Chabria SB, 2014, ANNU REV GENOM HUM G, V15, P295, DOI 10.1146/annurev-genom-091212-153406; Chen X, 2005, PRACTICAL PREVENTIVE, V12, P483; Chen Xi, 2008, Zhonghua Liu Xing Bing Xue Za Zhi, V29, P787; Chinese center for disease control and prevention, 2012, NAT FREE AIDS ARV GU; Codoner FM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019461; Cozzi-Lepri A, 2014, J ANTIMICROB CHEMOTH; Dunn DT, 2011, CURR OPIN HIV AIDS, V6, P251, DOI 10.1097/COH.0b013e32834732e8; Fisher R, 2012, J VIROL, V86, P6231, DOI 10.1128/JVI.06541-11; Geretti AM, 2015, CURR OPIN INFECT DIS, V28, P23, DOI 10.1097/QCO.0000000000000136; Gianella S, 2011, J VIROL, V85, P8359, DOI 10.1128/JVI.02582-10; Halvas EK, 2010, J INFECT DIS, V201, P672, DOI 10.1086/650542; He JM, 2007, PRACT PREV MED, V14, P1260; Hedskog C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011345; Johnson JA, 2008, PLOS MED, V5, P1112, DOI 10.1371/journal.pmed.0050158; Johnson Victoria A, 2011, Top Antivir Med, V19, P156; Kozal MJ, 2007, HIV CLIN TRIALS, V8, P357, DOI 10.1310/hct0806-357; Lataillade M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030118; Lataillade M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010952; Le T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006079; Lecossier D, 2005, JAIDS-J ACQ IMM DEF, V38, P37, DOI 10.1097/00126334-200501010-00007; Li JZ, 2013, J INFECT DIS, V207, P893, DOI 10.1093/infdis/jis925; Li JZ, 2012, AIDS, V26, P185, DOI 10.1097/QAD.0b013e32834e9d7d; Li JZ, 2011, JAMA-J AM MED ASSOC, V305, P1327, DOI 10.1001/jama.2011.375; Metzner KJ, 2011, J CLIN VIROL, V50, P156, DOI 10.1016/j.jcv.2010.10.001; Metzner KJ, 2009, CLIN INFECT DIS, V48, P239, DOI 10.1086/595703; Mitsuya Y, 2008, J VIROL, V82, P10747, DOI 10.1128/JVI.01827-07; Palmer S, 2006, AIDS, V20, P701, DOI 10.1097/01.aids.0000216370.69066.7f; Palmer S, 2005, J CLIN MICROBIOL, V43, P406, DOI 10.1128/JCM.43.1.406-413.2005; Pou C, 2014, CLIN INFECT DIS, V59, P578, DOI 10.1093/cid/ciu287; Roquebert B, 2006, AIDS, V20, P287, DOI 10.1097/01.aids.0000202650.03279.69; Santos AF, 2009, J ANTIMICROB CHEMOTH, V63, P593, DOI 10.1093/jac/dkn526; Shao YM, 2001, AIDS PATIENT CARE ST, V15, P431, DOI 10.1089/108729101316914449; Simen BB, 2014, J VIROL METHODS, V204, P31, DOI 10.1016/j.jviromet.2014.04.007; Simen BB, 2009, J INFECT DIS, V199, P693, DOI 10.1086/596736; Svarovskaia ES, 2007, JAIDS-J ACQ IMM DEF, V46, P174, DOI 10.1097/QAI.0b013e31814258c0; Thompson MA, 2012, JAMA-J AM MED ASSOC, V308, P387, DOI 10.1001/jama.2012.7961; Vandenbroucke I, 2011, BIOTECHNIQUES, V51, P167, DOI 10.2144/000113733; Vandenhende MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086771; Zou XB, 2010, CHIN J INFECT CONTRO, V9, P305; Zou XB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098740	43	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0149215	10.1371/journal.pone.0149215	http://dx.doi.org/10.1371/journal.pone.0149215			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3DG	26895182	Green Published, Green Submitted, gold			2022-12-26	WOS:000371223400038
J	Ho, MH; Huang, L; Goodwin, JS; Dong, XH; Chen, CH; Xie, H				Ho, Meng-Hsuan; Huang, Li; Goodwin, J. Shawn; Dong, Xinhong; Chen, Chin-Ho; Xie, Hua			Two Small Molecules Block Oral Epithelial Cell Invasion by Porphyromons gingivalis	PLOS ONE			English	Article							MEMBRANE VESICLE PRODUCTION; IN-VITRO; BACTERIAL INVASION; IDENTIFICATION; MECHANISMS; MICROBIOTA; INTEGRINS; VIRULENCE; ALOPERINE; DYNASORE	Porphyromonas gingivalis is a keystone pathogen of periodontitis. One of its bacterial characteristics is the ability to invade various host cells, including nonphagocytic epithelial cells and fibroblasts, which is known to facilitate P. gingivalis adaptation and survival in the gingival environment. In this study, we investigated two small compounds, Alop1 and dynasore, for their role in inhibition of P. gingivalis invasion. Using confocal microscopy, we showed that these two compounds significantly reduced invasion of P. gingivalis and its outer membrane vesicles into human oral keratinocytes in a dose-dependent manner. The inhibitory effects of dynasore, a dynamin inhibitor, on the bacterial entry is consistent with the notion that P. gingivalis invasion is mediated by a clathrin-mediated endocytic machinery. We also observed that microtubule arrangement, but not actin, was altered in the host cells treated with Alop1 or dynasore, suggesting an involvement of microtubule in this inhibitory activity. This work provides an opportunity to develop compounds against P. gingivalis infection.	[Ho, Meng-Hsuan; Xie, Hua] Meharry Med Coll, Sch Dent, Nashville, TN 37208 USA; [Huang, Li; Chen, Chin-Ho] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA; [Goodwin, J. Shawn] Meharry Med Coll, Dept Biochem & Canc Biol, Nashville, TN 37208 USA; [Dong, Xinhong] Meharry Med Coll, Dept Microbiol, Nashville, TN 37208 USA	Meharry Medical College; Duke University; Meharry Medical College; Meharry Medical College	Xie, H (corresponding author), Meharry Med Coll, Sch Dent, Nashville, TN 37208 USA.; Chen, CH (corresponding author), Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA.	chc@duke.edu; hxie@mmc.edu			NIDCR [DE022428, 025332]; NIMHD [MD007593, MD007586]; NCRR [UL1 RR024975]; NCATS [UL1 TR000445]; NIH [MD007593, MD007586, CA163069, DA036420, RR0254970]; NATIONAL CANCER INSTITUTE [U54CA163069] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000445] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024975, S10RR025497] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R21DE022428] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R24DA036420] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007586, U54MD007593, U54MD007586] Funding Source: NIH RePORTER	NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIMHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCATS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by NIDCR grants DE022428 and 025332 (HX) and by NIMHD grants MD007593 and MD007586. The project described was also supported by NCRR grant UL1 RR024975 (currently NCATS grant UL1 TR000445). Microscopy was conducted in the MMC Morphology Core, which is supported by NIH grants MD007593, MD007586, CA163069, DA036420, and RR0254970.	Abazeed ME, 2005, J BIOL CHEM, V280, P4442, DOI 10.1074/jbc.M412553200; Amar S, 2009, J IMMUNOL, V182, P1584, DOI 10.4049/jimmunol.182.3.1584; Belton CM, 1999, CELL MICROBIOL, V1, P215, DOI 10.1046/j.1462-5822.1999.00022.x; Boisvert H, 2008, CELL MICROBIOL, V10, P2538, DOI 10.1111/j.1462-5822.2008.01228.x; Chaudhuri S, 2014, INFECT IMMUN, V82, P2728, DOI 10.1128/IAI.00084-14; Chu VC, 2004, P NATL ACAD SCI USA, V101, P18153, DOI 10.1073/pnas.0405172102; Dang Z, 2014, ACS MED CHEM LETT, V5, P942, DOI 10.1021/ml500236n; Danino D, 2004, J STRUCT BIOL, V147, P259, DOI 10.1016/j.jsb.2004.04.005; Deshpande RG, 1998, INFECT IMMUN, V66, P5337, DOI 10.1128/IAI.66.11.5337-5343.1998; Dorn BR, 2002, INT ENDOD J, V35, P366, DOI 10.1046/j.0143-2885.2001.00489.x; Foster TJ, 2014, NAT REV MICROBIOL, V12, P49, DOI 10.1038/nrmicro3161; Furuta N, 2009, INFECT IMMUN, V77, P4187, DOI 10.1128/IAI.00009-09; Hajishengallis G, 2012, NAT REV MICROBIOL, V10, P717, DOI 10.1038/nrmicro2873; Hajishengallis G, 2011, CELL HOST MICROBE, V10, P497, DOI 10.1016/j.chom.2011.10.006; Ho MH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123448; Hunstad DA, 2010, ANNU REV MICROBIOL, V64, P203, DOI 10.1146/annurev.micro.112408.134258; Killoy WJ, 2002, J CLIN PERIODONTOL, V29, P22; Kolenbrander PE, 2000, ANNU REV MICROBIOL, V54, P413, DOI 10.1146/annurev.micro.54.1.413; Kulp A, 2010, ANNU REV MICROBIOL, V64, P163, DOI 10.1146/annurev.micro.091208.073413; Lamont RJ, 2000, ORAL MICROBIOL IMMUN, V15, P341, DOI 10.1034/j.1399-302x.2000.150601.x; LAMONT RJ, 1995, INFECT IMMUN, V63, P3878, DOI 10.1128/IAI.63.10.3878-3885.1995; Lamont RJ, 2002, PERIODONTOL 2000, V30, P61, DOI 10.1034/j.1600-0757.2002.03006.x; Lamont RJ, 1998, MICROBIOL MOL BIOL R, V62, P1244, DOI 10.1128/MMBR.62.4.1244-1263.1998; Li L, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-26; Lin WC, 2011, J AGR FOOD CHEM, V59, P184, DOI 10.1021/jf103581r; MacDonald IA, 2013, J BACTERIOL, V195, P2971, DOI 10.1128/JB.02267-12; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Madianos PN, 1996, INFECT IMMUN, V64, P660, DOI 10.1128/IAI.64.2.660-664.1996; Mantri CK, 2015, MICROBIOLOGYOPEN, V4, P53, DOI 10.1002/mbo3.221; Moffatt CE, 2012, CELL MICROBIOL, V14, P577, DOI 10.1111/j.1462-5822.2011.01743.x; Mues MB, 2015, J VIROL, V89, P6673, DOI 10.1128/JVI.00636-15; Nakagawa I, 2005, MICROBES INFECT, V7, P157, DOI 10.1016/j.micinf.2004.10.007; Radhakrishnan Girish K, 2012, Biomol Concepts, V3, P571; Robinson MS, 2015, TRAFFIC, V16, P1210, DOI 10.1111/tra.12335; Takeuchi Hiroki, 2011, Commun Integr Biol, V4, P587, DOI 10.4161/cib.4.5.16549; Takeuchi H, 2011, CELL MICROBIOL, V13, P677, DOI 10.1111/j.1462-5822.2010.01564.x; Thompson HM, 2004, NAT CELL BIOL, V6, P335, DOI 10.1038/ncb1112; Tribble GD, 2006, P NATL ACAD SCI USA, V103, P11027, DOI 10.1073/pnas.0509813103; Tribble GD, 2010, PERIODONTOL 2000, V52, P68, DOI 10.1111/j.1600-0757.2009.00323.x; Wang H, 2015, J HEMATOL ONCOL, V8, DOI 10.1186/s13045-015-0120-x; Ximenez-Fyvie LA, 2000, J CLIN PERIODONTOL, V27, P648, DOI 10.1034/j.1600-051x.2000.027009648.x; Yilmaz O, 2003, MICROBIOL-SGM, V149, P2417, DOI 10.1099/mic.0.26483-0; Yilmaz O, 2002, CELL MICROBIOL, V4, P305, DOI 10.1046/j.1462-5822.2002.00192.x; Yoshida S, 2003, TRENDS MICROBIOL, V11, P139, DOI 10.1016/S0966-842X(03)00023-4; Zenobia C, 2015, VIRULENCE, V6, P236, DOI 10.1080/21505594.2014.999567; ZHOU CC, 1989, ACTA PHARM SINIC, V10, P360	46	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0149618	10.1371/journal.pone.0149618	http://dx.doi.org/10.1371/journal.pone.0149618			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3DG	26894834	Green Published, gold			2022-12-26	WOS:000371223400068
J	Hu, Y; Xie, SY; Yao, JH				Hu, Yu; Xie, Shuying; Yao, Jihua			Identification of Novel Reference Genes Suitable for qRT-PCR Normalization with Respect to the Zebrafish Developmental Stage	PLOS ONE			English	Article							RNA-SEQ DATA; EXPRESSION ANALYSIS; HOUSEKEEPING GENES; RT-QPCR; EMBRYONIC-DEVELOPMENT; PROSTATE-CANCER; SELECTION; TISSUE; TOOL; VALIDATION	Reference genes used in normalizing qRT-PCR data are critical for the accuracy of gene expression analysis. However, many traditional reference genes used in zebrafish early development are not appropriate because of their variable expression levels during embryogenesis. In the present study, we used our previous RNA-Seq dataset to identify novel reference genes suitable for gene expression analysis during zebrafish early developmental stages. We first selected 197 most stably expressed genes from an RNA-Seq dataset (29,291 genes in total), according to the ratio of their maximum to minimum RPKM values. Among the 197 genes, 4 genes with moderate expression levels and the least variation throughout 9 developmental stages were identified as candidate reference genes. Using four independent statistical algorithms (delta-CT, geNorm, BestKeeper and NormFinder), the stability of qRT-PCR expression of these candidates was then evaluated and compared to that of actb1 and actb2, two commonly used zebrafish reference genes. Stability rankings showed that two genes, namely mobk13 (mob4) and lsm12b, were more stable than actb1 and actb2 in most cases. To further test the suitability of mobk13 and lsm12b as novel reference genes, they were used to normalize three well-studied target genes. The results showed that mobk13 and lsm12b were more suitable than actb1 and actb2 with respect to zebrafish early development. We recommend mobk13 and lsm12b as new optimal reference genes for zebrafish qRT-PCR analysis during embryogenesis and early larval stages.	[Hu, Yu; Xie, Shuying; Yao, Jihua] Fudan Univ, Sch Life Sci, Inst Genet, State Key Lab Genet Engn, Shanghai 200433, Peoples R China	Fudan University	Yao, JH (corresponding author), Fudan Univ, Sch Life Sci, Inst Genet, State Key Lab Genet Engn, Shanghai 200433, Peoples R China.	yaojh@fudan.edu.cn	Hu, Yu/AAI-1837-2020	Hu, Yu/0000-0003-3178-0874	National Basic Research Program of China [2012CB944603, 2011CB943804]; State Key Laboratory of Genetic Engineering, Fudan University [SKLGE-1408]	National Basic Research Program of China(National Basic Research Program of China); State Key Laboratory of Genetic Engineering, Fudan University	This work was funded by the National Basic Research Program of China (2012CB944603 and 2011CB943804) and the Open Research Funds of the State Key Laboratory of Genetic Engineering, Fudan University (SKLGE-1408). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht M, 2004, FEBS LETT, V569, P18, DOI 10.1016/j.febslet.2004.03.126; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Brudal Espen, 2013, BMC Res Notes, V6, P76, DOI 10.1186/1756-0500-6-76; Carvalho DM, 2014, ANTON LEEUW INT J G, V106, P605, DOI 10.1007/s10482-014-0231-3; Casadei R, 2011, GENE EXPR PATTERNS, V11, P271, DOI 10.1016/j.gep.2011.01.003; Chang EM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033278; Coulson DTR, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-46; Souza AFD, 2013, MOL BIOL REP, V40, P2955, DOI 10.1007/s11033-012-2366-5; Danielsson F, 2013, J PROTEOME RES, V12, P299, DOI 10.1021/pr3009308; De Santis C, 2011, MAR BIOTECHNOL, V13, P170, DOI 10.1007/s10126-010-9277-z; Elsalini OA, 2003, DEV GENES EVOL, V212, P593, DOI 10.1007/s00427-002-0279-3; Flanagan-Steet HR, 2013, GLYCOCONJUGATE J, V30, P33, DOI 10.1007/s10719-012-9390-5; Galeano Esteban, 2014, BMC Res Notes, V7, P464, DOI 10.1186/1756-0500-7-464; Gonzalez-Aguero M, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-878; Guo CM, 2013, CLIN TRANSL ONCOL, V15, P167, DOI 10.1007/s12094-012-0924-x; Haas BJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-734; Huang Y, 2013, J COMPUT BIOL, V20, P167, DOI 10.1089/cmb.2012.0230; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Liu JJ, 2013, J BIOSCI BIOENG, V116, P460, DOI 10.1016/j.jbiosc.2013.04.011; Ma LM, 2013, MAR GENOM, V11, P67, DOI 10.1016/j.margen.2013.08.002; Martin JA, 2011, NAT REV GENET, V12, P671, DOI 10.1038/nrg3068; Martyn U, 2003, DEV BIOL, V260, P58, DOI 10.1016/S0012-1606(03)00221-5; McCurley AT, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-102; McGowan I, 2015, CYTOKINE, V71, P81, DOI 10.1016/j.cyto.2014.08.010; Merrick BA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061768; Mori R, 2008, PROSTATE, V68, P1555, DOI 10.1002/pros.20815; Nikaido M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054833; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pollier J, 2014, PLANT PHYSIOL BIOCH, V83, P20, DOI 10.1016/j.plaphy.2014.07.004; Schulte J, 2010, J NEUROSCI, V30, P5189, DOI 10.1523/JNEUROSCI.5823-09.2010; Silver N, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-33; Sinha DK, 2014, SCI REP-UK, V4, DOI 10.1038/srep05059; Sun Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041659; Swisher KD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010006; Tang RY, 2007, ACTA BIOCH BIOPH SIN, V39, P384, DOI 10.1111/j.1745-7270.2007.00283.x; Tobia C, 2013, BBA-MOL BASIS DIS, V1832, P1371, DOI 10.1016/j.bbadis.2013.01.016; Trammell MA, 2008, J CELL SCI, V121, P1284, DOI 10.1242/jcs.017210; van Delft J, 2012, TOXICOL SCI, V130, P427, DOI 10.1093/toxsci/kfs250; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vanhauwaert S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109091; Wang M, 2013, GENE, V530, P44, DOI 10.1016/j.gene.2013.07.084; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Westerfield M, 1994, ZEBRAFISH BOOK; Xiong J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030630; Yang CG, 2013, GENE, V527, P183, DOI 10.1016/j.gene.2013.06.013; Yang HL, 2014, GENE, V538, P113, DOI 10.1016/j.gene.2013.12.057; Yang HX, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0064799, 10.1371/journal.pone.0064058]; Zemp N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092893; Zhan C, 2014, ACTA BIOCH BIOPH SIN, V46, P330, DOI 10.1093/abbs/gmt153; Zhang C, 2005, DEV BIOL, V278, P526, DOI 10.1016/j.ydbio.2004.11.008	51	19	20	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2016	11	2							e0149277	10.1371/journal.pone.0149277	http://dx.doi.org/10.1371/journal.pone.0149277			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3CO	26891128	Green Published, Green Submitted, gold			2022-12-26	WOS:000371221500031
J	Sanford, EL; Choy, KW; Donahoe, PK; Tracy, AA; Hila, R; Loscertales, M; Longoni, M				Sanford, Ethan L.; Choy, Kwong W.; Donahoe, Patricia K.; Tracy, Adam A.; Hila, Regis; Loscertales, Maria; Longoni, Mauro			MiR-449a Affects Epithelial Proliferation during the Pseudoglandular and Canalicular Phases of Avian and Mammal Lung Development	PLOS ONE			English	Article							CONGENITAL DIAPHRAGMATIC-HERNIA; REPLICATION-COMPETENT RETROVIRUSES; N-MYC ONCOGENE; PROGENITOR CELLS; GENE-EXPRESSION; DIFFERENTIATION; MORPHOGENESIS; MICRORNAS; AIRWAY; PATHOGENESIS	Congenital diaphragmatic hernia is associated with pulmonary hypoplasia and respiratory distress, which result in high mortality and morbidity. Although several transgenic mouse models of lung hypoplasia exist, the role of miRNAs in this phenotype is incompletely characterized. In this study, we assessed microRNA expression levels during the pseudoglandular to canalicular phase transition of normal human fetal lung development. At this critical time, when the distal respiratory portion of the airways begins to form, microarray analysis showed that the most significantly differentially expressed miRNA was miR-449a. Prediction algorithms determined that N-myc is a target of miR-449a and identified the likely miR-449a: N-myc binding sites, confirmed by luciferase assays and targeted mutagenesis. Functional ex vivo knock-down in organ cultures of murine embryonic lungs, as well as in ovo overexpression in avian embryonic lungs, suggested a role for miR-449a in distal epithelial proliferation. Finally, miR-449a expression was found to be abnormal in rare pulmonary specimens of human fetuses with Congenital Diaphragmatic Hernia in the pseudoglandular or canalicular phase. This study confirms the conserved role of miR-449a for proper pulmonary organogenesis, supporting the delicate balance between expansion of progenitor cells and their terminal differentiation, and proposes the potential involvement of this miRNA in human pulmonary hypoplasia.	[Sanford, Ethan L.; Hila, Regis; Loscertales, Maria; Longoni, Mauro] Massachusetts Gen Hosp, Pediat Surg Res Labs, Boston, MA 02114 USA; [Sanford, Ethan L.] Harvard Univ, Sch Med, Hlth Sci & Technol Med Program, Boston, MA USA; [Sanford, Ethan L.] Boston Childrens Hosp, Dept Med, Boston, MA USA; [Choy, Kwong W.] Chinese Univ Hong Kong, Dept Obstet & Gynaecol, Hong Kong, Hong Kong, Peoples R China; [Donahoe, Patricia K.; Tracy, Adam A.; Loscertales, Maria; Longoni, Mauro] Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA; [Donahoe, Patricia K.; Tracy, Adam A.] Broad Inst & Harvard, Cambridge, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Chinese University of Hong Kong; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Loscertales, M; Longoni, M (corresponding author), Massachusetts Gen Hosp, Pediat Surg Res Labs, Boston, MA 02114 USA.; Loscertales, M; Longoni, M (corresponding author), Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA.	mloscertales@mgh.harvard.edu; mlongoni@mgh.harvard.edu	Choy, Richard/AAW-8230-2020	Choy, Richard/0000-0002-3616-6200; Sanford, Ethan/0000-0002-7423-6521	National Institute of Child Health and Human Development [P01 HD068250-03]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD068250] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Funding was provided by National Institute of Child Health and Human Development P01 HD068250-03 to P.K.D. (www.nichd.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AREECHON W, 1963, BRIT MED J, P230, DOI 10.1136/bmj.1.5325.230; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Beltran H, 2014, MOL CANCER RES, V12, P815, DOI 10.1158/1541-7786.MCR-13-0536; Bhaskaran M, 2009, PHYSIOL GENOMICS, V37, P268, DOI 10.1152/physiolgenomics.90268.2008; Cardoso WV, 2006, DEVELOPMENT, V133, P1611, DOI 10.1242/dev.02310; Cognet M, 2011, EUR J HUM GENET, V19, P602, DOI 10.1038/ejhg.2010.225; Dong J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010854; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Greer JJ, 2013, RESP PHYSIOL NEUROBI, V189, P232, DOI 10.1016/j.resp.2013.04.015; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Harris KS, 2006, P NATL ACAD SCI USA, V103, P2208, DOI 10.1073/pnas.0510839103; Khoshgoo N, 2013, PEDIATR PULM, V48, P317, DOI 10.1002/ppul.22739; Kim YH, 2006, ONCOGENE, V25, P130, DOI 10.1038/sj.onc.1208997; Kimura J, 2007, PEDIATR DEVEL PATHOL, V10, P335, DOI 10.2350/07-06-0290.1; Kinane TB, 2007, AM J MED GENET C, V145C, P117, DOI 10.1002/ajmg.c.30124; KITAGAWA M, 1971, BRIT J SURG, V58, P342, DOI 10.1002/bjs.1800580507; Lize M, 2010, CELL DEATH DIFFER, V17, P452, DOI 10.1038/cdd.2009.188; Lize M, 2010, CELL CYCLE, V9, P4579, DOI 10.4161/cc.9.22.13870; Logan M, 1998, METHODS, V14, P407, DOI 10.1006/meth.1998.0595; Longoni M, 2014, P NATL ACAD SCI USA, V111, P12450, DOI 10.1073/pnas.1412509111; Loscertales M, 2008, DEVELOPMENT, V135, P1365, DOI 10.1242/dev.010504; Lu Y, 2007, DEV BIOL, V310, P442, DOI 10.1016/j.ydbio.2007.08.007; Lu Yun, 2008, Proc Am Thorac Soc, V5, P300, DOI 10.1513/pats.200710-162DR; Lytle JR, 2007, P NATL ACAD SCI USA, V104, P9667, DOI 10.1073/pnas.0703820104; Marcet B, 2011, NAT CELL BIOL, V13, P693, DOI 10.1038/ncb2241; Matsushita S, 1999, DEV GROWTH DIFFER, V41, P313; Morgan BA, 1996, METHOD CELL BIOL, V51, P185, DOI 10.1016/S0091-679X(08)60629-9; Okubo T, 2005, DEVELOPMENT, V132, P1363, DOI 10.1242/dev.01678; Pacheco BA, 1997, SURG FORUM, P652; Perl AKT, 2002, P NATL ACAD SCI USA, V99, P10482, DOI 10.1073/pnas.152238499; Pober BR, 1993, SOURCE GENEREVIEWSTM; Rhodes J, 2015, AM J PHYSIOL-LUNG C, V309, pL168, DOI 10.1152/ajplung.00299.2014; Russell MK, 2012, P NATL ACAD SCI USA, V109, P2978, DOI 10.1073/pnas.1121621109; Schmitz R, 2014, COLD SPRING HARB PER, V4; SEEGER RC, 1985, NEW ENGL J MED, V313, P1111, DOI 10.1056/NEJM198510313131802; Sluiter I, 2013, EXP MOL PATHOL, V94, P195, DOI 10.1016/j.yexmp.2012.09.010; STANTON BR, 1992, GENE DEV, V6, P2235, DOI 10.1101/gad.6.12a.2235; Theiler K., 1989, HOUSE MOUSE, P1; Tsao PN, 2008, J BIOL CHEM, V283, P29532, DOI 10.1074/jbc.M801565200; Ventura A, 2008, CELL, V132, P875, DOI 10.1016/j.cell.2008.02.019; Warburton D, 2000, MECH DEVELOP, V92, P55, DOI 10.1016/S0925-4773(99)00325-1; Warburton D, 2010, CURR TOP DEV BIOL, V90, P73, DOI 10.1016/S0070-2153(10)90003-3; Yang XJ, 2009, GENE DEV, V23, P2388, DOI 10.1101/gad.1819009	43	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2016	11	2							e0149425	10.1371/journal.pone.0149425	http://dx.doi.org/10.1371/journal.pone.0149425			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3CO	26891231	gold, Green Published, Green Submitted			2022-12-26	WOS:000371221500046
J	Gross, K; Sun, M; Schiestl, FP				Gross, Karin; Sun, Mimi; Schiestl, Florian P.			Why Do Floral Perfumes Become Different? Region-Specific Selection on Floral Scent in a Terrestrial Orchid	PLOS ONE			English	Article							POLLINATOR-MEDIATED SELECTION; FLOWER COLOR; PHENOTYPIC SELECTION; SPUR LENGTH; GEOGRAPHIC STRUCTURE; SPATIAL VARIATION; EVOLUTION; TRAITS; PLANT; ADAPTATION	Geographically structured phenotypic selection can lead to adaptive divergence. However, in flowering plants, such divergent selection has rarely been shown, and selection on floral signals is generally little understood. In this study, we measured phenotypic selection on display size, floral color, and floral scent in four lowland and four mountain populations of the nectar-rewarding terrestrial orchid Gymnadenia odoratissima in two years. We also quantified population differences in these traits and pollinator community composition. Our results show positive selection on display size and positive, negative, or absence of selection on different scent compounds and floral color. Selection on the main scent compounds was consistently stronger in the lowlands than in the mountains, and lowland plants emitted higher amounts of most of these compounds. Pollinator community composition also differed between regions, suggesting different pollinators select for differences in floral volatiles. Overall, our study is the first to document consistent regional differences in selection on floral scent, suggesting this pattern of selection is one of the evolutionary forces contributing to regional divergence in floral chemical signaling.	[Gross, Karin; Sun, Mimi; Schiestl, Florian P.] Univ Zurich, Inst Systemat Bot, Zollikerstr 107, CH-8008 Zurich, Switzerland	University of Zurich	Schiestl, FP (corresponding author), Univ Zurich, Inst Systemat Bot, Zollikerstr 107, CH-8008 Zurich, Switzerland.	florian.schiestl@systbot.uzh.ch		Gross, Karin/0000-0002-2363-452X; Schiestl, Florian/0000-0001-7637-6918	Swiss National Science Foundation [31003A-125340]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This study was funded by the Swiss National Science Foundation grant 31003A-125340 to FPS.	Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bischoff M, 2013, NEW ZEAL J BOT, V51, P181, DOI 10.1080/0028825X.2013.806933; Boberg E, 2014, ANN BOT-LONDON, V113, P267, DOI 10.1093/aob/mct217; BRAY J. ROGER, 1957, ECOL MONOGR, V27, P325, DOI 10.2307/1942268; Brown M, 2011, PLANT SYST EVOL, V294, P199, DOI 10.1007/s00606-011-0443-1; Brunet J, 2009, ANN BOT-LONDON, V103, P1567, DOI 10.1093/aob/mcp096; Bustamante E, 2010, AM J BOT, V97, P2020, DOI 10.3732/ajb.1000071; Campbell DR, 2012, J EVOLUTION BIOL, V25, P352, DOI 10.1111/j.1420-9101.2011.02430.x; Campbell DR, 1997, AM NAT, V149, P295, DOI 10.1086/285991; Caruso CM, 2010, INT J PLANT SCI, V171, P1020, DOI 10.1086/656511; Chittka L, 2006, CURR OPIN PLANT BIOL, V9, P428, DOI 10.1016/j.pbi.2006.05.002; Dotterl S, 2005, PHYTOCHEMISTRY, V66, P203, DOI 10.1016/j.phytochem.2004.12.002; Dudash MR, 2011, AM J BOT, V98, P275, DOI 10.3732/ajb.1000350; Ehrlen J, 2012, BASIC APPL ECOL, V13, P509, DOI 10.1016/j.baae.2012.08.001; Fenster CB, 2004, ANNU REV ECOL EVOL S, V35, P375, DOI 10.1146/annurev.ecolsys.34.011802.132347; GALEN C, 1985, ECOLOGY, V66, P792, DOI 10.2307/1940540; Gomez JM, 2008, P ROY SOC B-BIOL SCI, V275, P2241, DOI 10.1098/rspb.2008.0512; Goslee SC, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i07; GRANT V, 1949, EVOLUTION, V3, P82, DOI 10.2307/2405454; Gustafsson S, 2002, CONSERV GENET, V3, P225, DOI 10.1023/A:1019969014333; Hall MC, 2006, EVOLUTION, V60, P2466, DOI 10.1554/05-688.1; Harder LD, 2009, NEW PHYTOL, V183, P530, DOI 10.1111/j.1469-8137.2009.02914.x; Herrera C.M., 2006, ECOLOGY EVOLUTION FL, P278; Hess HE, 1976, FLORA DER SCHWEIZ UN; Hirota SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085601; Hopkins R, 2012, EVOLUTION, V66, P469, DOI 10.1111/j.1558-5646.2011.01452.x; Huber FK, 2005, OECOLOGIA, V142, P564, DOI 10.1007/s00442-004-1750-9; Hulten E., 1986, ATLAS N EUROPEAN VAS; Johnson SD, 1997, EVOLUTION, V51, P45, DOI 10.1111/j.1558-5646.1997.tb02387.x; Junker RR, 2010, ANN BOT-LONDON, V105, P777, DOI 10.1093/aob/mcq045; LANDE R, 1983, EVOLUTION, V37, P1210, DOI 10.1111/j.1558-5646.1983.tb00236.x; Maad J, 2000, EVOLUTION, V54, P112, DOI 10.1111/j.0014-3820.2000.tb00012.x; Majetic CJ, 2008, ANN BOT-LONDON, V102, P911, DOI 10.1093/aob/mcn181; Malo JE, 2002, DIVERS DISTRIB, V8, P365, DOI 10.1046/j.1472-4642.2002.00161.x; Mant J, 2005, EVOLUTION, V59, P1449, DOI 10.1111/j.0014-3820.2005.tb01795.x; Gomez JM, 2010, INT J PLANT SCI, V171, P987, DOI 10.1086/656475; Moeller DA, 2006, ECOLOGY, V87, P1510, DOI 10.1890/0012-9658(2006)87[1510:GSOPCR]2.0.CO;2; Newman E, 2012, P ROY SOC B-BIOL SCI, V279, P2309, DOI 10.1098/rspb.2011.2375; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Parachnowitsch AL, 2012, NEW PHYTOL, V195, P667, DOI 10.1111/j.1469-8137.2012.04188.x; PELLMYR O, 1986, OECOLOGIA, V68, P304, DOI 10.1007/BF00384804; Price MV, 2005, ECOLOGY, V86, P2106, DOI 10.1890/04-1274; Raguso RA, 2008, ENTOMOL EXP APPL, V128, P196, DOI 10.1111/j.1570-7458.2008.00683.x; RCoreTeam, 2013, LANG ENV STAT COMP; Renoult JP, 2013, J EVOLUTION BIOL, V26, P2415, DOI 10.1111/jeb.12234; Reynolds RJ, 2010, EVOLUTION, V64, P358, DOI 10.1111/j.1558-5646.2009.00805.x; Salzmann CC, 2007, PLANT BIOLOGY, V9, P720, DOI 10.1055/s-2007-965614; Sandring S, 2009, EVOLUTION, V63, P1292, DOI 10.1111/j.1558-5646.2009.00624.x; Schemske DW, 1999, P NATL ACAD SCI USA, V96, P11910, DOI 10.1073/pnas.96.21.11910; Schiestl FP, 2015, NEW PHYTOL, V206, P571, DOI 10.1111/nph.13243; Schiestl FP, 2013, TRENDS ECOL EVOL, V28, P307, DOI 10.1016/j.tree.2013.01.019; Schiestl FP, 2011, EVOL ECOL, V25, P237, DOI 10.1007/s10682-010-9409-y; Siepielski AM, 2013, ECOL LETT, V16, P1382, DOI 10.1111/ele.12174; Sletvold N, 2010, INT J PLANT SCI, V171, P999, DOI 10.1086/656597; Sletvold N, 2010, NEW PHYTOL, V188, P385, DOI 10.1111/j.1469-8137.2010.03296.x; Soler C, 2011, PHYTOCHEMISTRY, V72, P74, DOI 10.1016/j.phytochem.2010.10.012; Strauss S.Y., 2006, ECOLOGY EVOLUTION FL, P120; Suinyuy TN, 2012, BIOL J LINN SOC, V106, P514, DOI 10.1111/j.1095-8312.2012.01905.x; Sun M, 2014, ANN BOT-LONDON, V113, P289, DOI 10.1093/aob/mct219; Thompson JN, 2006, ECOLOGY, V87, P103, DOI 10.1890/05-0123; Thompson JN, 2002, NATURE, V417, P735, DOI 10.1038/nature00810; Thompson John N., 2005, pi; van der Niet T, 2012, TRENDS ECOL EVOL, V27, P353, DOI 10.1016/j.tree.2012.02.002; van dersCingel N. A., 1995, ATLAS ORCHID POLLINA; Vereecken NJ, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-103; Zu PJ, 2016, NEW PHYTOL, V209, P1208, DOI 10.1111/nph.13652	66	68	69	2	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0147975	10.1371/journal.pone.0147975	http://dx.doi.org/10.1371/journal.pone.0147975			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26886766	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000371218400012
J	Velankar, AD; Kumara, HN; Pal, A; Mishra, PS; Singh, M				Velankar, Avadhoot D.; Kumara, Honnavalli N.; Pal, Arijit; Mishra, Partha Sarathi; Singh, Mewa			Population Recovery of Nicobar Long-Tailed Macaque Macaca fascicularis umbrosus following a Tsunami in the Nicobar Islands, India	PLOS ONE			English	Article							DECEMBER; DROUGHT; GROWTH; IMPACT	Natural disasters pose a threat to isolated populations of species with restricted distributions, especially those inhabiting islands. The Nicobar long tailed macaque. Macaca fascicularis umbrosus, is one such species found in the three southernmost islands (viz. Great Nicobar, Little Nicobar and Katchal) of the Andaman and Nicobar archipelago, India. These islands were hit by a massive tsunami (Indian Ocean tsunami, 26 December 2004) after a 9.2 magnitude earthquake. Earlier studies [Umapathy et al. 2003; Sivakumar, 2004] reported a sharp decline in the population of M. f. umbrosus after thetsunami. We studied the distribution and population status of M. f. umbrosus on thethree Nicobar Islands and compared our results with those of the previous studies. We carried out trail surveys on existing paths and trails on three islands to get encounter rate as measure of abundance. We also checked the degree of inundation due to tsunami by using Normalized Difference Water Index (NDWI) on landsat imageries of the study area before and after tsunami. Theencounter rate of groups per kilometre of M. f. umbrosus in Great Nicobar, Little Nicobar and Katchal was 0.30, 0.35 and 0.48 respectively with the mean group size of 39 in Great Nicobar and 43 in Katchal following the tsunami. This was higher than that reported in the two earlier studies conducted before and after the tsunami. Post tsunami, there was a significant change in the proportion of adult males, adult females and immatures, but mean group size did not differ as compared to pre tsunami. The results show that population has recovered from a drastic decline caused by tsunami, but it cannot be ascertained whether it has reached stability because of the altered group structure. This study demonstrates the effect of natural disasters on island occurring species.	[Velankar, Avadhoot D.; Kumara, Honnavalli N.; Pal, Arijit; Mishra, Partha Sarathi] Salim Ali Ctr Ornithol & Nat Hist, Coimbatore, Tamil Nadu, India; [Velankar, Avadhoot D.; Pal, Arijit] Manipal Univ, Manipal, Karnataka, India; [Singh, Mewa] Univ Mysore, Biopsychol Lab, Mysore, Karnataka, India; [Singh, Mewa] Univ Mysore, Inst Excellence, Mysore, Karnataka, India; [Singh, Mewa] Indian Inst Sci, Jawaharlal Nehru Ctr Adv Sci Res, Organismal Biol Unit, Bangalore 560012, Karnataka, India; [Singh, Mewa] Natl Inst Adv Studies, Bangalore, Karnataka, India	Salim Ali Center for Ornithology & Natural History (SACON); Manipal Academy of Higher Education (MAHE); University of Mysore; University of Mysore; Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR); Indian Institute of Science (IISC) - Bangalore	Kumara, HN (corresponding author), Salim Ali Ctr Ornithol & Nat Hist, Coimbatore, Tamil Nadu, India.	honnavallik@gmail.com		PAL, ARIJIT/0000-0002-1472-2878; Kumara, Honnavalli/0000-0002-7958-6395	Department of Science and Technology, Government of India [SR/SO/AS-49/2011]	Department of Science and Technology, Government of India(Department of Science & Technology (India))	This work was conducted with the financial support from the Department of Science and Technology, Government of India to HNK (Grant No. SR/SO/AS-49/2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews HV, 2006, INDIAN OCEAN TURTLE, V4, P3; Berec L, 2007, TRENDS ECOL EVOL, V22, P185, DOI 10.1016/j.tree.2006.12.002; BERENSTAIN L, 1986, BIOTROPICA, V18, P257, DOI 10.2307/2388494; BIRCH LC, 1948, J ANIM ECOL, V17, P15, DOI 10.2307/1605; Chevin LM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000357; Crawford RJM, 2006, AFR J MAR SCI, V28, P99, DOI 10.2989/18142320609504137; DITTUS WPJ, 1979, BEHAVIOUR, V69, P265, DOI 10.1163/156853979X00511; Eudey Ardith A., 2008, Primate Conservation, V23, P129, DOI 10.1896/052.023.0115; Ewens W.J., 1987, P59, DOI 10.1017/CBO9780511623400.005; Fedigan LM, 1998, INT J PRIMATOL, V19, P405, DOI 10.1023/A:1020304304558; Fittinghoff N.A. Jr, 1980, P182; FOODEN J, 1982, Primates, V23, P574, DOI 10.1007/BF02373969; Fooden J., 1995, FIELDIANA ZOOLOGY, V81, P1, DOI DOI 10.5962/BHL.TITLE.3456; Gerber LR, 2001, MAMMAL REV, V31, P131, DOI 10.1046/j.1365-2907.2001.00081.x; GOLDSTEIN SJ, 1989, INT J PRIMATOL, V10, P531, DOI 10.1007/BF02739364; Gould L, 1999, INT J PRIMATOL, V20, P69, DOI 10.1023/A:1020584200807; Gumert Michael D., 2011, P3; Hahn I, 2015, POPUL ECOL, V57, P143, DOI 10.1007/s10144-014-0457-y; Hajra PK, 1999, FLORA GREAT NICOBAR; Karr J.R., 1985, P153; LEWIS J, 1990, DISASTERS, V14, P240, DOI 10.1111/j.1467-7717.1990.tb01066.x; MARTIN JL, 1995, OIKOS, V72, P115, DOI 10.2307/3546045; McConkey KR, 2004, ORYX, V38, P439, DOI 10.1017/S0030605304000821; McFeeters SK, 1996, INT J REMOTE SENS, V17, P1425, DOI 10.1080/01431169608948714; Milton K, 1982, DIETARY QUALITY POPU, P273; Ong P., 2008, IUCN RED LIST THREAT; Porwal MC, 2012, BIODIVERS CONSERV, V21, P1267, DOI 10.1007/s10531-011-0214-x; Ramachandran S, 2005, CURR SCI INDIA, V89, P195; SALTER R E, 1985, Primates, V26, P436, DOI 10.1007/BF02382458; Sekhsaria Pankaj, 2009, Journal of the Bombay Natural History Society, V106, P256; Shaffer M., 1987, P69, DOI 10.1017/CBO9780511623400.006; Shilova SA, 2005, RUSS J ECOL+, V36, P27, DOI 10.1007/s11184-005-0005-2; Sivakumar K, 2010, ORYX, V44, P71, DOI 10.1017/S0030605309990810; Sivakumar K, 2010, HYSTRIX, V21, P35; Stephens PA, 1999, OIKOS, V87, P185, DOI 10.2307/3547011; Thieler RE, 2009, DIGITAL SHORELINE AN; Umapathy G, 2003, INT J PRIMATOL, V24, P281, DOI 10.1023/A:1023045132009; Van Schaik C. P., 1996, P160; Viera VM, 2006, POLAR BIOL, V29, P713, DOI 10.1007/s00300-006-0128-3	39	8	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0148205	10.1371/journal.pone.0148205	http://dx.doi.org/10.1371/journal.pone.0148205			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26886197	Green Submitted, Green Published, gold			2022-12-26	WOS:000371218400019
J	Werner, A; Sturzl, W; Zanker, J				Werner, Annette; Stuerzl, Wolfgang; Zanker, Johannes			Object Recognition in Flight: How Do Bees Distinguish between 3D Shapes?	PLOS ONE			English	Article							PATTERN-RECOGNITION; COLOR CONSTANCY; MOTION PARALLAX; PERCEPTION; HONEYBEE; DISCRIMINATION; INFORMATION; NAVIGATION	Honeybees (Apis mellifera) discriminate multiple object features such as colour, pattern and 2D shape, but it remains unknown whether and how bees recover three-dimensional shape. Here we show that bees can recognize objects by their three-dimensional form, whereby they employ an active strategy to uncover the depth profiles. We trained individual, free flying honeybees to collect sugar water from small three-dimensional objects made of styrofoam (sphere, cylinder, cuboids) or folded paper (convex, concave, planar) and found that bees can easily discriminate between these stimuli. We also tested possible strategies employed by the bees to uncover the depth profiles. For the card stimuli, we excluded overall shape and pictorial features (shading, texture gradients) as cues for discrimination. Lacking sufficient stereo vision, bees are known to use speed gradients in optic flow to detect edges; could the bees apply this strategy also to recover the fine details of a surface depth profile? Analysing the bees' flight tracks in front of the stimuli revealed specific combinations of flight maneuvers (lateral translations in combination with yaw rotations), which are particularly suitable to extract depth cues from motion parallax. We modelled the generated optic flow and found characteristic patterns of angular displacement corresponding to the depth profiles of our stimuli: optic flow patterns from pure translations successfully recovered depth relations from the magnitude of angular displacements, additional rotation provided robust depth information based on the direction of the displacements; thus, the bees flight maneuvers may reflect an optimized visuo-motor strategy to extract depth structure from motion signals. The robustness and simplicity of this strategy offers an efficient solution for 3D-object-recognition without stereo vision, and could be employed by other flying insects, or mobile robots.	[Werner, Annette] Univ Tubingen, Ctr Ophthalmol, Inst Ophthalm Res, Tubingen, Germany; [Stuerzl, Wolfgang] German Aerosp Ctr DLR, Inst Robot & Mechatron, Wessling, Germany; [Zanker, Johannes] Royal Holloway Univ London, Dept Psychol, Egham, Surrey, England	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Aerospace Centre (DLR); University of London; Royal Holloway University London	Werner, A (corresponding author), Univ Tubingen, Ctr Ophthalmol, Inst Ophthalm Res, Tubingen, Germany.	annette.werner@uni-tuebingen.de			Bundesministerium fur Bildung und Forschung (BMBF)-Bernsteinzentrum fur Computational Neuroscience Tubingen [BMBF FKZ 01GQ1002]; Werner Reichardt Centre for Integrative Neuroscience Tubingen; DFG; Open Access Publishing Fund of University of Tubingen	Bundesministerium fur Bildung und Forschung (BMBF)-Bernsteinzentrum fur Computational Neuroscience Tubingen(Federal Ministry of Education & Research (BMBF)); Werner Reichardt Centre for Integrative Neuroscience Tubingen; DFG(German Research Foundation (DFG)); Open Access Publishing Fund of University of Tubingen	This work was supported by Bundesministerium fur Bildung und Forschung (BMBF)-Bernsteinzentrum fur Computational Neuroscience Tubingen BMBF FKZ 01GQ1002 and Werner Reichardt Centre for Integrative Neuroscience Tubingen. This work was also supported by DFG and Open Access Publishing Fund of University of Tubingen.	ANDERSON AM, 1977, ANIM BEHAV, V25, P67, DOI 10.1016/0003-3472(77)90068-9; Autrum H, 1957, STUD GEN, V10, P211; Avargues-Weber A, 2011, ANNU REV ENTOMOL, V56, P423, DOI 10.1146/annurev-ento-120709-144855; Baird E, 2013, P NATL ACAD SCI USA, V110, P18686, DOI 10.1073/pnas.1314311110; Campan R, 2002, J EXP BIOL, V205, P559; Chen L, 2003, P NATL ACAD SCI USA, V100, P6884, DOI 10.1073/pnas.0732090100; Chittka L, 2014, J COMP PHYSIOL A, V200, P435, DOI 10.1007/s00359-014-0897-z; Collett TS, 1996, CURR DIR PSYCHOL SCI, V5, P149, DOI 10.1111/1467-8721.ep11512352; Dittmar L, 2010, J EXP BIOL, V213, P2913, DOI 10.1242/jeb.043737; Efler D, 2000, VISION RES, V40, P3391, DOI 10.1016/S0042-6989(00)00189-9; Evangelista C, 2010, J EXP BIOL, V213, P262, DOI 10.1242/jeb.037465; GIBSON EJ, 1959, J EXP PSYCHOL, V58, P40, DOI 10.1037/h0043883; Giurfa M, 1996, NATURE, V382, P458, DOI 10.1038/382458a0; GOULD JL, 1986, ANIM BEHAV, V34, P990, DOI 10.1016/S0003-3472(86)80157-9; HERTZ MATHILDE, 1929, ZEITSCHR VERGL PHYSIOL, V8, P693, DOI 10.1007/BF00340937; Kapustjansky A, 2010, NATURWISSENSCHAFTEN, V97, P229, DOI 10.1007/s00114-009-0627-5; Lehrer M, 2005, J EXP BIOL, V208, P3233, DOI 10.1242/jeb.01790; LEHRER M, 1991, BEHAVIOUR AND PHYSIOLOGY OF BEES, P185; LEHRER M, 1993, J COMP PHYSIOL A, V172, P549, DOI 10.1007/BF00213678; LEHRER M, 1988, NATURE, V332, P356, DOI 10.1038/332356a0; Lehrer M, 1996, J EXP BIOL, V199, P253; Lent DD, 2013, CURR BIOL, V23, P684, DOI 10.1016/j.cub.2013.03.016; MAZOKHIN-PORSHNYAKOV G A, 1969, Zoologicheskii Zhurnal, V48, P1125; Menzel R, 2001, TRENDS COGN SCI, V5, P62, DOI 10.1016/S1364-6613(00)01601-6; Riesenhuber M, 2000, NAT NEUROSCI, V3, P1199, DOI 10.1038/81479; RONACHER B, 1992, ETHOLOGY, V92, P205, DOI 10.1111/j.1439-0310.1992.tb00960.x; SCHNETTER B, 1968, Z VERGL PHYSIOL, V59, P90, DOI 10.1007/BF00298814; Serres JR, 2008, NATURWISSENSCHAFTEN, V95, P1181, DOI 10.1007/s00114-008-0440-6; Srinivasan MV, 2011, PHYSIOL REV, V91, P413, DOI 10.1152/physrev.00005.2010; Srinivasan MV, 2010, ANNU REV ENTOMOL, V55, P267, DOI 10.1146/annurev.ento.010908.164537; Srinivasan MV, 2006, CURR BIOL, V16, pR58, DOI 10.1016/j.cub.2006.01.002; Srinivasan MV, 2004, ANNU REV NEUROSCI, V27, P679, DOI 10.1146/annurev.neuro.27.070203.144343; SRINIVASAN MV, 1990, PROC R SOC SER B-BIO, V238, P331, DOI 10.1098/rspb.1990.0003; Srinivasan MV, 1998, ECOL PSYCHOL, V10, P251, DOI 10.1207/s15326969eco103&4_5; Stach S, 2004, NATURE, V429, P758, DOI 10.1038/nature02594; Tarr MJ, 1998, COGNITION, V67, P1, DOI 10.1016/S0010-0277(98)00026-2; von Frisch, 1915, ZOOL JB ABT ALLG ZOO, V35, P1; Voss R, 1998, J COMP PHYSIOL A, V182, P377, DOI 10.1007/s003590050187; WEHNER R, 1967, NATURE, V215, P1244, DOI 10.1038/2151244a0; WERNER A, 1988, J NEUROSCI, V8, P156; Zanker JM, 2014, PERCEPTION, V43, P162; Zeil J, 1996, J EXP BIOL, V199, P245; ZEIL J, 1993, J COMP PHYSIOL A, V172, P189, DOI 10.1007/BF00189396; ZHANG SW, 1995, P NATL ACAD SCI USA, V92, P3029, DOI 10.1073/pnas.92.7.3029	44	8	8	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0147106	10.1371/journal.pone.0147106	http://dx.doi.org/10.1371/journal.pone.0147106			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26886006	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000371218400006
J	Kim, NS; Mbongue, JC; Nicholas, DA; Esebanmen, GE; Unternaehrer, JJ; Firek, AF; Langridge, WHR				Kim, Nan-Sun; Mbongue, Jacques C.; Nicholas, Dequina A.; Esebanmen, Grace E.; Unternaehrer, Juli J.; Firek, Anthony F.; Langridge, William H. R.			Chimeric Vaccine Stimulation of Human Dendritic Cell Indoleamine 2, 3-Dioxygenase Occurs via the Non-Canonical NF-kappa B Pathway	PLOS ONE			English	Article							T-CELLS; NF-KAPPA-B2 P100; NOD MICE; CD40-TRAF6; INDUCTION; KINASE; CD40; IDO; 2,3-DIOXYGENASE; ACTIVATION	A chimeric protein vaccine composed of the cholera toxin B subunit fused to proinsulin (CTB-INS) was shown to suppress type 1 diabetes onset in NOD mice and upregulate biosynthesis of the tryptophan catabolic enzyme indoleamine 2, 3-dioxygenase (IDO1) in human dendritic cells (DCs). Here we demonstrate siRNA inhibition of the NF-kappa B-inducing kinase (NIK) suppresses vaccine-induced IDO1 biosynthesis as well as IKKa phosphorylation. Chromatin immunoprecipitation (ChIP) analysis of CTB-INS inoculated DCs showed that RelB bound to NF-kappa B consensus sequences in the IDO1 promoter, suggesting vaccine stimulation of the non-canonical NF-kappa B pathway activates IDO1 expression in vivo. The addition of Tumor Necrosis Factor Associated Factors (TRAF) TRAF 2, 3 and TRAF6 blocking peptides to vaccine inoculated DCs was shown to inhibit IDO1 biosynthesis. This experimental outcome suggests vaccine activation of the TNFR super-family receptor pathway leads to upregulation of IDO1 biosynthesis in CTB-INS inoculated dendritic cells. Together, our experimental data suggest the CTB-INS vaccine uses a TNFR-dependent signaling pathway of the non-canonical NF-kappa B signaling pathway resulting in suppression of dendritic cell mediated type 1 diabetes autoimmunity.	[Kim, Nan-Sun; Mbongue, Jacques C.; Nicholas, Dequina A.; Esebanmen, Grace E.; Langridge, William H. R.] Loma Linda Univ, Sch Med, Dept Basic Sci, Ctr Hlth Dispar & Mol Med, Loma Linda, CA USA; [Kim, Nan-Sun] Chonbuk Natl Univ, Dept Mol Biol, Jeonju 561756, South Korea; [Mbongue, Jacques C.] Loma Linda Univ, Sch Med, Dept Basic Sci, Div Physiol, Loma Linda, CA USA; [Esebanmen, Grace E.] Loma Linda Univ, Sch Med, Dept Earth & Biol Sci, Loma Linda, CA USA; [Nicholas, Dequina A.; Unternaehrer, Juli J.; Langridge, William H. R.] Loma Linda Univ, Sch Med, Dept Basic Sci, Div Biochem, Loma Linda, CA USA; [Firek, Anthony F.] JL Pettis Mem VA Med Ctr, Endocrinol Sect, Loma Linda, CA USA	Loma Linda University; Jeonbuk National University; Loma Linda University; Loma Linda University; Loma Linda University	Langridge, WHR (corresponding author), Loma Linda Univ, Sch Med, Dept Basic Sci, Ctr Hlth Dispar & Mol Med, Loma Linda, CA USA.; Langridge, WHR (corresponding author), Loma Linda Univ, Sch Med, Dept Basic Sci, Div Biochem, Loma Linda, CA USA.	blangridge@llu.edu	Nicholas, Dequina/AAF-1412-2019	Mbongue, Jacques/0000-0002-7123-3480; Nicholas, Dequina/0000-0003-4996-2190; Unternaehrer-Hamm, Julia/0000-0001-5864-4704	NIH [DK-99-013, NRF-20151A1A3A04001542]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded in part by NIH award DK-99-013 to WHRL, by the NRF-20151A1A3A04001542 to NSK, to the Loma Linda University Center for Health Disparities and Molecular Medicine and to the Loma Linda University Research Fund to AFF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JS, 2009, DIABETES, V58, P138, DOI 10.2337/db08-0964; Aspord C, 2002, CLIN EXP IMMUNOL, V130, P204, DOI 10.1046/j.1365-2249.2002.01988.x; Bergerot I, 1997, P NATL ACAD SCI USA, V94, P4610, DOI 10.1073/pnas.94.9.4610; Bishop GA, 2003, CYTOKINE GROWTH F R, V14, P297, DOI 10.1016/S1359-6101(03)00024-8; Bishop GA, 2007, ADV EXP MED BIOL, V597, P131; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Chatzigeorgiou A, 2014, P NATL ACAD SCI USA, V111, P4644, DOI 10.1073/pnas.1403231111; Chatzigeorgioua A, 2014, P NATL ACAD SCI USA, V111, P2686, DOI 10.1073/pnas.1400419111; Claudio E, 2002, NAT IMMUNOL, V3, P958, DOI 10.1038/ni842; Coope HJ, 2002, EMBO J, V21, P5375, DOI 10.1093/emboj/cdf542; Denes B, 2005, J IMMUNOTHER, V28, P438, DOI 10.1097/01.cji.0000171315.82997.9a; EISENBARTH GS, 1986, NEW ENGL J MED, V314, P1360; Elgueta R, 2009, IMMUNOL REV, V229, P152, DOI 10.1111/j.1600-065X.2009.00782.x; Forbes JM, 2013, PHYSIOL REV, V93, P137, DOI 10.1152/physrev.00045.2011; Ganguly D, 2013, NAT REV IMMUNOL, V13, P566, DOI 10.1038/nri3477; Grohmann U, 2007, NAT MED, V13, P579, DOI 10.1038/nm1563; Harnett Margaret M, 2004, Sci STKE, V2004, ppe25, DOI 10.1126/stke.2372004pe25; Hostager BS, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00376; Hsu HL, 1997, J BIOL CHEM, V272, P13471, DOI 10.1074/jbc.272.21.13471; Karin M, 2004, NAT REV DRUG DISCOV, V3, P17, DOI 10.1038/nrd1279; Lutgens E, 2012, VASC PHARMACOL, V56, P337, DOI 10.1016/j.vph.2011.08.092; Ma DY, 2009, SEMIN IMMUNOL, V21, P265, DOI 10.1016/j.smim.2009.05.010; Malinin NL, 1997, NATURE, V385, P540, DOI 10.1038/385540a0; Manches O, 2012, P NATL ACAD SCI USA, V109, P14122, DOI 10.1073/pnas.1204032109; Mbongue J, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/857143; Mbongue JC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118562; Melendez-Ramirez LY, 2010, ENDOCRIN METAB CLIN, V39, P625, DOI 10.1016/j.ecl.2010.05.009; Montgomery RI, 1996, CELL, V87, P427, DOI 10.1016/S0092-8674(00)81363-X; Morrison MD, 2005, J BIOL CHEM, V280, P10018, DOI 10.1074/jbc.M413634200; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Novack DV, 2003, J EXP MED, V198, P771, DOI 10.1084/jem.20030116; Odumosu O, 2010, TOXINS, V2, P1612, DOI 10.3390/toxins2071612; Pallotta MT, 2011, NAT IMMUNOL, V12, P870, DOI 10.1038/ni.2077; Ploix C, 1999, DIABETES, V48, P2150, DOI 10.2337/diabetes.48.11.2150; Portillo JAC, 2014, INVEST OPHTH VIS SCI, V55, P8590, DOI 10.1167/iovs.14-15340; Portillo JAC, 2015, IMMUNOLOGY, V144, P21, DOI 10.1111/imm.12361; Puccetti P, 2007, NAT REV IMMUNOL, V7, P817, DOI 10.1038/nri2163; Solan NJ, 2002, J BIOL CHEM, V277, P1405, DOI 10.1074/jbc.M109619200; Song YJ, 2010, VIRUS GENES, V41, P174, DOI 10.1007/s11262-010-0505-4; Sun SC, 2008, TRENDS IMMUNOL, V29, P469, DOI 10.1016/j.it.2008.07.003; Sun SC, 2011, CELL RES, V21, P71, DOI 10.1038/cr.2010.177; Sun SC, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3123pe18; Tas SW, 2007, BLOOD, V110, P1540, DOI 10.1182/blood-2006-11-056010; Theill LE, 2002, ANNU REV IMMUNOL, V20, P795, DOI 10.1146/annurev.immunol.20.100301.064753; Tisch R, 1996, CELL, V85, P291, DOI 10.1016/S0092-8674(00)81106-X; Vallabhapurapu S, 2008, NAT IMMUNOL, V9, P1364, DOI 10.1038/ni.1678; Volpi C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2874; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Xiao GT, 2004, J BIOL CHEM, V279, P30099, DOI 10.1074/jbc.M401428200; Xiao GT, 2001, MOL CELL, V7, P401, DOI 10.1016/S1097-2765(01)00187-3	50	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0147509	10.1371/journal.pone.0147509	http://dx.doi.org/10.1371/journal.pone.0147509			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	26881431	Green Submitted, Green Published, gold			2022-12-26	WOS:000371219000005
J	Liu, LJ; Tong, Q; Liu, S; Cui, JL; Zhang, QS; Sun, W; Yang, S				Liu, Lingjia; Tong, Qi; Liu, Shuo; Cui, Jianlin; Zhang, Quansheng; Sun, Wei; Yang, Shuang			ZEB1 Upregulates VEGF Expression and Stimulates Angiogenesis in Breast Cancer	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; TO-MESENCHYMAL TRANSITION; E-CADHERIN EXPRESSION; TRANSCRIPTIONAL REPRESSOR; ZINC-FINGER; CELLS; DELTA-EF1; DIFFERENTIATION; ACTIVATION; MUSCLE	Although zinc finger E-box binding homeobox 1 (ZEB1) has been identified as a key factor in the regulation of breast cancer differentiation and metastasis, its potential role in modulating tumor angiogenesis has not been fully examined. Here, we present the novel finding that conditioned medium derived from ZEB1-expressing MDA-MB-231 cells significantly increased the capillary tube formation of human umbilical vein endothelial cells (HUVECs), whereas ZEB1 knockdown by RNA interference had the opposite effect. ZEB1 caused marked upregulation of the expression of vascular endothelial growth factor A (VEGFA) at both mRNA and protein levels. Pre-incubation of HUVECs with anti-VEGFA neutralized antibody attenuated ZEB1-mediated tube formation of HUVECs. In breast cancer tissues, expression of ZEB1 was positively correlated with those of VEGFA and CD31. At the molecular level, ZEB1 activated VEGFA transcription by increasing SP1 recruitment to its promoter, which was mediated via the activation of PI3K and p38 pathways. Using a nude mouse xenograft model, we demonstrated that elevated expression of ZEB1 promotes in vivo tumorigenesis and angiogenesis in breast cancer. Collectively, we found that ZEB1-expressing breast cancer cells increase VEGFA production and thus stimulate tumor growth and angiogenesis via a paracrine mechanism.	[Liu, Lingjia; Tong, Qi; Liu, Shuo; Cui, Jianlin; Sun, Wei; Yang, Shuang] Nankai Univ, Coll Med, Tianjin Key Lab Tumor Microenvironm & Neurovasc R, Tianjin 300071, Peoples R China; [Zhang, Quansheng] Tianjin First Ctr Hosp, Tianjin Key Lab Organ Transplantat, Tianjin 300192, Peoples R China	Nankai University	Sun, W; Yang, S (corresponding author), Nankai Univ, Coll Med, Tianjin Key Lab Tumor Microenvironm & Neurovasc R, Tianjin 300071, Peoples R China.	sunweibio@nankai.edu.cn; yangshuang@nankai.edu.cn			International S&T Cooperation Program of China [2015DFA30420]; National Natural Science Foundation of China [81272184, 81472545, 81170443, 81372386]; Natural Science Foundation of Tianjin [13JCZDJC30200]	International S&T Cooperation Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Tianjin(Natural Science Foundation of Tianjin)	This work is supported by grants from the International S&T Cooperation Program of China (No. 2015DFA30420), the National Natural Science Foundation of China (No. 81272184; No. 81472545; No. 81170443), the Natural Science Foundation of Tianjin (No. 13JCZDJC30200). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work is supported by grants from the International S&T Cooperation Program of China (No. 2015DFA30420), the National Natural Science Foundation of China (No. 81272184; No. 81372386; No. 81472545), the Natural Science Foundation of Tianjin (No. 13JCZDJC30200).	Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183; Ahn YH, 2012, J CLIN INVEST, V122, P3170, DOI 10.1172/JCI63608; Blancher C, 2000, CANCER RES, V60, P7106; Brabletz T, 1999, INT IMMUNOL, V11, P1701, DOI 10.1093/intimm/11.10.1701; Bracken CP, 2008, CANCER RES, V68, P7846, DOI 10.1158/0008-5472.CAN-08-1942; Bruick RK, 2001, GENE DEV, V15, P2497, DOI 10.1101/gad.931601; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Chaffer CL, 2013, CELL, V154, P61, DOI 10.1016/j.cell.2013.06.005; Chua HL, 2007, ONCOGENE, V26, P711, DOI 10.1038/sj.onc.1209808; Chuang CW, 2013, J CELL PHYSIOL, V228, P341, DOI 10.1002/jcp.24136; Clarhaut J, 2009, NEOPLASIA, V11, P157, DOI 10.1593/neo.81074; Dai JL, 2005, CANCER RES, V65, P8274, DOI 10.1158/0008-5472.CAN-05-1891; Ebrahem Q, 2010, AM J PATHOL, V176, P496, DOI 10.2353/ajpath.2010.080642; Eger A, 2005, ONCOGENE, V24, P2375, DOI 10.1038/sj.onc.1208429; Finkenzeller Gunter, 2004, Angiogenesis, V7, P59, DOI 10.1023/B:AGEN.0000037332.66411.f0; Fitzpatrick TE, 2003, EXP CELL RES, V283, P247, DOI 10.1016/S0014-4827(02)00044-7; Folkman J, 2007, NAT REV DRUG DISCOV, V6, P273, DOI 10.1038/nrd2115; Fox SB, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1796; FUNAHASHI J, 1993, DEVELOPMENT, V119, P433; Graham TR, 2008, CANCER RES, V68, P2479, DOI 10.1158/0008-5472.CAN-07-2559; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Guo SC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052380; Hu F, 2011, BBA-GENE REGUL MECH, V1809, P200, DOI 10.1016/j.bbagrm.2011.01.003; Hurt EM, 2008, MOL CELL BIOCHEM, V318, P89, DOI 10.1007/s11010-008-9860-z; Jia D, 2013, BLOOD, V121, P707, DOI 10.1182/blood-2012-05-433045; Joseph JV, 2015, CANCER LETT, V359, P107, DOI 10.1016/j.canlet.2015.01.010; Karihtala P, 2013, BREAST CANCER RES TR, V138, P81, DOI 10.1007/s10549-013-2442-0; Krishnamachary B, 2006, CANCER RES, V66, P2725, DOI 10.1158/0008-5472.CAN-05-3719; Kumar S. R. S., 2012, International Journal of Advanced Life Sciences (IJALS), V1, P1; Loureiro RMB, 2005, CYTOKINE GROWTH F R, V16, P77, DOI 10.1016/j.cytogfr.2005.01.005; Luo ZL, 2013, STEM CELLS, V31, P1749, DOI 10.1002/stem.1448; Maae E, 2012, BREAST CANCER RES TR, V133, P257, DOI 10.1007/s10549-012-1957-0; Mironchik Y, 2005, CANCER RES, V65, P10801, DOI 10.1158/0008-5472.CAN-05-0712; Morel AP, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002723; Ponticos M, 2004, MOL CELL BIOL, V24, P6151, DOI 10.1128/MCB.24.14.6151-6161.2004; Pore N, 2004, MOL BIOL CELL, V15, P4841, DOI 10.1091/mbc.E04-05-0374; Postigo AA, 1999, MOL CELL BIOL, V19, P7961; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; Roy R, 2006, EXP CELL RES, V312, P608, DOI 10.1016/j.yexcr.2005.11.022; Roy R, 2009, J CLIN ONCOL, V27, P5287, DOI 10.1200/JCO.2009.23.5556; Sanchez-Tillo E, 2011, P NATL ACAD SCI USA, V108, P19204, DOI 10.1073/pnas.1108977108; Schmalhofer O, 2009, CANCER METAST REV, V28, P151, DOI 10.1007/s10555-008-9179-y; Shenoy SK, 2012, ONCOGENE, V31, P282, DOI 10.1038/onc.2011.238; Siles L, 2013, MOL CELL BIOL, V33, P1368, DOI 10.1128/MCB.01259-12; Song YD, 2009, CLIN CANCER RES, V15, P492, DOI 10.1158/1078-0432.CCR-08-1945; Takagi T, 1998, DEVELOPMENT, V125, P21; Wang J, 2009, INT IMMUNOL, V21, P227, DOI 10.1093/intimm/dxn143; Wang YS, 2014, CANCER RES, V74, P520, DOI 10.1158/0008-5472.CAN-13-2182; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; Wong LL, 2010, EXP CELL RES, V316, P3387, DOI 10.1016/j.yexcr.2010.06.007; Xu KM, 2007, CANCER RES, V67, P6121, DOI 10.1158/0008-5472.CAN-07-0141; Yang S, 2007, J BIOMED SCI, V14, P663, DOI 10.1007/s11373-007-9155-5; Yang S, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-211; Yang YA, 2014, J CLIN INVEST, V124, P2696, DOI 10.1172/JCI72171; Yao YS, 2015, J CELL MOL MED, V19, P760, DOI 10.1111/jcmm.12432; Yen G, 2001, MOL BRAIN RES, V96, P59, DOI 10.1016/S0169-328X(01)00267-4; Yen L, 2000, ONCOGENE, V19, P3460, DOI 10.1038/sj.onc.1203685	57	29	31	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0148774	10.1371/journal.pone.0148774	http://dx.doi.org/10.1371/journal.pone.0148774			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	26882471	Green Published, Green Submitted, gold			2022-12-26	WOS:000371219000024
J	Wada, M; Yano, S; Hamano, T; Nabika, T; Kumakura, S				Wada, Masayuki; Yano, Shozo; Hamano, Tsuyoshi; Nabika, Toru; Kumakura, Shunichi			Effect of Serum Cholesterol on Insulin Secretory Capacity: Shimane CoHRE Study	PLOS ONE			English	Article							BETA-CELL DYSFUNCTION; WOMEN; MEN	Objectives Previous studies indicate that, in addition to the blood glucose level, the lipid level in the blood may affect functions of pancreatic beta cells. In this study, we aimed to examine whether there was a relationship between the serum level of total cholesterol (TC) and the insulin secretory capacity in healthy subjects. Subjects and Methods In participants of health examinations conducted from 2006 to 2010, we analyzed data from a total of 2,499 subjects (1,057 men and 1,442 women) after exclusion of individuals with dyslipidemia, thyroid dysfunction, diabetes, HbA1c >= 6.5%, or fasting blood glucose >= 126 mg/dL. Homeostasis model assessment for beta cell function (HOMA-beta) was utilized as a model representing the pancreatic beta cell function. Results Although the serum TC level had a positive correlation with HOMA-beta in a univariate correlation analysis, after adjustment by confounding factors in a multiple regression analysis, HOMA-beta had a negative correlation with TC. This was further confirmed in a multiple logistic regression analysis, showing that higher TC was an independent risk factor for decreased insulin secretory capacity (defined as HOMA-beta >= 30%) together with higher age, lower BMI, lower TG, male sex and regular alcohol intake. After the participants were stratified by BMI into three groups, the effect of TC on HOMA-beta increased along with the increase in BMI, and it was highly significant in the highest tertile. Conclusion This cross-sectional study indicated that increased serum TC level might be related to the decrease of insulin secretory capacity in aged healthy population and that reduction of TC is more necessary in obese subjects to prevent diabetes.	[Wada, Masayuki] Okuizumo Municipal Hosp, Dept Internal Med, Hamada, Shimane, Japan; [Yano, Shozo] Shimane Univ, Fac Med, Dept Lab Med, Hamada, Shimane, Japan; [Yano, Shozo; Hamano, Tsuyoshi; Nabika, Toru] Ctr Community Based Hlth Res & Educ CoHRE, Hamada, Shimane, Japan; [Nabika, Toru] Shimane Univ, Fac Med, Dept Funct Pathol, Hamada, Shimane, Japan; [Wada, Masayuki; Kumakura, Shunichi] Shimane Univ, Fac Med, Dept Med Educ & Res, Hamada, Shimane, Japan	Shimane University; Shimane University; Shimane University	Yano, S (corresponding author), Shimane Univ, Fac Med, Dept Lab Med, Hamada, Shimane, Japan.; Yano, S (corresponding author), Ctr Community Based Hlth Res & Educ CoHRE, Hamada, Shimane, Japan.	syano@med.shimane-u.ac.jp		Hamano, Tsuyoshi/0000-0002-6755-9138				Brunham LR, 2007, NAT MED, V13, P340, DOI 10.1038/nm1546; Freeman DJ, 2001, CIRCULATION, V103, P357; Garg M K, 2011, Indian J Endocrinol Metab, V15, pS44, DOI 10.4103/2230-8210.83059; Hamano T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049122; Hao M, 2007, DIABETES, V56, P2328, DOI 10.2337/db07-0056; Iwao T, 2014, INTERNAL MED, V53, P383, DOI 10.2169/internalmedicine.53.0337; Johns BR, 2011, CLIN CHEM, V57, P627, DOI 10.1373/clinchem.2010.152744; Kashiwagi A, 2012, J DIABETES INVEST, V3, P39, DOI 10.1111/j.2040-1124.2012.00207.x; Khan HA, 2007, CLIN EXP MED, V7, P24, DOI 10.1007/s10238-007-0121-3; Kruit JK, 2011, DIABETES, V60, P3186, DOI 10.2337/db11-0081; Lu XL, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-123; Lu XL, 2011, CELL STRESS CHAPERON, V16, P539, DOI 10.1007/s12192-011-0265-7; Mahalle Namita, 2014, Indian J Endocrinol Metab, V18, P48, DOI 10.4103/2230-8210.126532; Ministry of Health Labour and Welfare, 2012, OUTL RES NAT HLTH NU; Oda E, 2009, INTERNAL MED, V48, P1607, DOI 10.2169/internalmedicine.48.2398; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Sakurai M, 2009, DIABETIC MED, V26, P753, DOI 10.1111/j.1464-5491.2009.02773.x; Vergeer M, 2010, DIABETES CARE, V33, P869, DOI 10.2337/dc09-1562; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; Yano S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141035; Zheng TP, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-634	21	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0149452	10.1371/journal.pone.0149452	http://dx.doi.org/10.1371/journal.pone.0149452			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	26881755	gold, Green Published, Green Submitted			2022-12-26	WOS:000371219000076
J	Aggarwal, V; Dickinson, RB; Lele, TP				Aggarwal, Varun; Dickinson, Richard B.; Lele, Tanmay P.			Concentration Sensing by the Moving Nucleus in Cell Fate Determination: A Computational Analysis	PLOS ONE			English	Article							NEURAL-TUBE; ASYMMETRIC INHERITANCE; MIGRATION; NEUROGENESIS; DIFFERENTIATION; NEUROEPITHELIA; PROLIFERATION; EPITHELIUM; NEURONS; RETINA	During development of the vertebrate neuroepithelium, the nucleus in neural progenitor cells (NPCs) moves from the apex toward the base and returns to the apex (called interkinetic nuclear migration) at which point the cell divides. The fate of the resulting daughter cells is thought to depend on the sampling by the moving nucleus of a spatial concentration profile of the cytoplasmic Notch intracellular domain (NICD). However, the nucleus executes complex stochastic motions including random waiting and back and forth motions, which can expose the nucleus to randomly varying levels of cytoplasmic NICD. How nuclear position can determine daughter cell fate despite the stochastic nature of nuclear migration is not clear. Here we derived a mathematical model for reaction, diffusion, and nuclear accumulation of NICD in NPCs during interkinetic nuclear migration (INM). Using experimentally measured trajectory-dependent probabilities of nuclear turning, nuclear waiting times and average nuclear speeds in NPCs in the developing zebrafish retina, we performed stochastic simulations to compute the nuclear trajectory-dependent probabilities of NPC differentiation. Comparison with experimentally measured nuclear NICD concentrations and trajectory-dependent probabilities of differentiation allowed estimation of the NICD cytoplasmic gradient. Spatially polarized production of NICD, rapid NICD cytoplasmic consumption and the time-averaging effect of nuclear import/export kinetics are sufficient to explain the experimentally observed differentiation probabilities. Our computational studies lend quantitative support to the feasibility of the nuclear concentration-sensing mechanism for NPC fate determination in zebrafish retina.	[Aggarwal, Varun; Dickinson, Richard B.; Lele, Tanmay P.] Univ Florida, Dept Chem Engn, Gainesville, FL 32611 USA	State University System of Florida; University of Florida	Lele, TP (corresponding author), Univ Florida, Dept Chem Engn, Gainesville, FL 32611 USA.	tlele@che.ufl.edu	Dickinson, Richard B/A-4435-2012	Dickinson, Richard B/0000-0002-7415-2889; Aggarwal, Varun/0000-0002-8406-0961	National Science Foundation [CMMI 0954302]; National Institutes of Health [R01GM102486, R01EB014869]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB014869] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102486] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Science Foundation (www.nsf.org) under award CMMI 0954302 (T.P.L.) and by the National Institutes of Health (www.nih.org) under awards R01GM102486 (T.P.L. and R.B.D.) and R01EB014869 (T.P.L.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000390; Baye LM, 2007, J NEUROSCI, V27, P10143, DOI 10.1523/JNEUROSCI.2754-07.2007; Bort R, 2006, DEV BIOL, V290, P44, DOI 10.1016/j.ydbio.2005.11.006; Cardarelli F, 2012, J BIOL CHEM, V287, P5554, DOI 10.1074/jbc.M111.304899; CHENN A, 1995, CELL, V82, P631, DOI 10.1016/0092-8674(95)90035-7; Clark BS, 2012, DEVELOPMENT, V139, P1599, DOI 10.1242/dev.078097; Davis RL, 2001, ONCOGENE, V20, P8342, DOI 10.1038/sj.onc.1205094; Del Bene F, 2008, CELL, V134, P1055, DOI 10.1016/j.cell.2008.07.017; DORSKY RI, 1995, NEURON, V14, P487, DOI 10.1016/0896-6273(95)90305-4; FUJITA S, 1962, EXP CELL RES, V28, P52, DOI 10.1016/0014-4827(62)90311-7; Grosse AS, 2011, DEVELOPMENT, V138, P4423, DOI 10.1242/dev.065789; Kosodo Y, 2011, EMBO J, V30, P1690, DOI 10.1038/emboj.2011.81; Leung L, 2011, DEVELOPMENT, V138, P5003, DOI 10.1242/dev.071522; Meyer EJ, 2011, CURR BIOL, V21, P485, DOI 10.1016/j.cub.2011.02.002; Miyata T, 2001, NEURON, V31, P727, DOI 10.1016/S0896-6273(01)00420-2; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; Norden C, 2009, CELL, V138, P1195, DOI 10.1016/j.cell.2009.06.032; Perumalsamy LR, 2009, CELL DEATH DIFFER, V16, P879, DOI 10.1038/cdd.2009.20; Sauer FC, 1935, J COMP NEUROL, V62, P377, DOI 10.1002/cne.900620207; SAUER ME, 1959, EXP CELL RES, V16, P1, DOI 10.1016/0014-4827(59)90189-2; SAUER ME, 1959, P SOC EXP BIOL MED, V101, P557; Schenk J, 2009, P NATL ACAD SCI USA, V106, P16487, DOI 10.1073/pnas.0908928106; SIDMAN RL, 1959, EXP NEUROL, V1, P322, DOI 10.1016/0014-4886(59)90024-X; Tsai JW, 2010, NAT NEUROSCI, V13, P1463, DOI 10.1038/nn.2665; Tsujikawa M, 2007, P NATL ACAD SCI USA, V104, P14819, DOI 10.1073/pnas.0700178104	25	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149213	10.1371/journal.pone.0149213	http://dx.doi.org/10.1371/journal.pone.0149213			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26872214	Green Published, Green Submitted, gold			2022-12-26	WOS:000370054100128
J	Daniels-Treffandier, H; de Nie, K; Marsay, L; Dold, C; Sadarangani, M; Reyes-Sandoval, A; Langford, PR; Wyllie, D; Hill, F; Pollard, AJ; Rollier, CS				Daniels-Treffandier, Helene; de Nie, Karlijn; Marsay, Leanne; Dold, Christina; Sadarangani, Manish; Reyes-Sandoval, Arturo; Langford, Paul R.; Wyllie, David; Hill, Fergal; Pollard, Andrew J.; Rollier, Christine S.			Impact of Reducing Complement Inhibitor Binding on the Immunogenicity of Native Neisseria meningitidis Outer Membrane Vesicles	PLOS ONE			English	Article							MENINGOCOCCAL SEROGROUP-B; FACTOR-H FH; BACTERICIDAL ACTIVITY; ANTIBODY-RESPONSES; VACCINE CANDIDATE; SERUM RESISTANCE; PROTEIN COMPLEX; DISEASE; MICE; ADJUVANTS	Neisseria meningitidis recruits host human complement inhibitors to its surface to down-regulate complement activation and enhance survival in blood. We have investigated whether such complement inhibitor binding occurs after vaccination with native outer membrane vesicles (nOMVs), and limits immunogenicity of such vaccines. To this end, nOMVs reactogenic lipopolysaccharide was detoxified by deletion of the lpxl1 gene (nOMV(lpxl1)). nOMVs unable to bind human complement factor H (hfH) were generated by additional deletions of the genes encoding factor H binding protein (fHbp) and neisserial surface protein A (NspA) (nOMV(dis)). Antibody responses elicited in mice with nOMVdis were compared to those elicited with nOMVlpxl1 in the presence of hfH. Results demonstrate that the administration of human fH to mice immunized with fHbp containing OMVlpxl1 decreased immunogenicity against fHbp (but not against the OMV as a whole). The majority of the OMV-induced bactericidal immune response (OMVlpxl1 or OMVdis) was versus PorA. Despite a considerable reduction of hfH binding to nOMV(dis), and the absence of the vaccine antigen fHbp, immunogenicity in mice was not different from nOMV(lpxl1), in the absence or presence of hfH (serum bactericidal titers of 1:64 vs 1:128 after one dose in the nOMV(dis) and nOMV(lpxl1)-immunized groups respectively). Therefore, partial inhibition of fH binding did not enhance immunity in this model.	[Daniels-Treffandier, Helene; de Nie, Karlijn; Marsay, Leanne; Dold, Christina; Sadarangani, Manish; Pollard, Andrew J.; Rollier, Christine S.] Univ Oxford, Dept Paediat, Oxford Vaccine Grp, Oxford OX3 7LE, England; [Daniels-Treffandier, Helene; de Nie, Karlijn; Marsay, Leanne; Dold, Christina; Sadarangani, Manish; Pollard, Andrew J.; Rollier, Christine S.] Churchill Hosp, Ctr Clin Vaccinol & Trop Med, NIHR Oxford Biomed Res Ctr, Oxford OX3 7LE, England; [Reyes-Sandoval, Arturo; Wyllie, David] Univ Oxford, Jenner Inst, Ctr Cellular & Mol Physiol, Henry Wellcome Bldg Mol Physiol,Roosevelt Dr, Oxford OX3 7BN, England; [Langford, Paul R.] Univ London Imperial Coll Sci Technol & Med, Paediat Sect, St Marys Campus, London W2 1PG, England; [Hill, Fergal] Imaxio, 99 Rue Gerland, F-69007 Lyon, France	University of Oxford; University of Oxford; University of Oxford; Jenner Institute; Imperial College London	Rollier, CS (corresponding author), Univ Oxford, Dept Paediat, Oxford Vaccine Grp, Oxford OX3 7LE, England.; Rollier, CS (corresponding author), Churchill Hosp, Ctr Clin Vaccinol & Trop Med, NIHR Oxford Biomed Res Ctr, Oxford OX3 7LE, England.	christine.rollier@paediatrics.ox.ac.uk	Daniels-Treffandier, Hélène Sophie/Y-7461-2019; DANIELS-TREFFANDIER, Hélène/AAN-8475-2021; Dold, Christina/ABA-4237-2021; Sadarangani, Manish/V-5609-2019; Hill, Fergal/AAI-1329-2021	Reyes-Sandoval, Arturo/0000-0002-2648-1696; Sadarangani, Manish/0000-0002-9985-6452; dold, christina/0000-0003-2314-507X; Daniels, Helene/0000-0001-7426-2423	Sparks for Children's Health [10OXF01]; Meningitis UK; Action Medical Research; NIHR Oxford Biomedical Research Centre (Vaccine theme); Sparks Charity [10OXF01] Funding Source: researchfish	Sparks for Children's Health; Meningitis UK; Action Medical Research; NIHR Oxford Biomedical Research Centre (Vaccine theme); Sparks Charity	This work was supported by a project grant from Sparks for Children's Health (grant number 10OXF01). CR was also supported by research grants from Meningitis UK and Action Medical Research. She is a Jenner Institute Investigator and an Oxford Martin fellow. AJP and CR are supported by the NIHR Oxford Biomedical Research Centre (Vaccine theme). AJP is a Jenner Investigator and James Martin Senior Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Imaxio provided support in the form of salaries for author [FH], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author (FH) are articulated in the 'author contributions' section.	Beernink PT, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002688; Beernink PT, 2011, J IMMUNOL, V186, P3606, DOI 10.4049/jimmunol.1003470; Borrow R, 2005, CLIN DIAGN LAB IMMUN, V12, P970, DOI 10.1128/CDLI.12.8.970-976.2005; Bosse JT, 2009, APPL ENVIRON MICROB, V75, P6124, DOI 10.1128/AEM.00809-09; Dunkelberger JR, 2010, CELL RES, V20, P34, DOI 10.1038/cr.2009.139; Fakhouri F, 2010, KIDNEY INT, V78, P279, DOI 10.1038/ki.2010.132; FINNE J, 1983, LANCET, V2, P355; Frandoloso R, 2015, INFECT IMMUN, V83, P1030, DOI 10.1128/IAI.02572-14; Giuntini S, 2015, INFECT IMMUN, V83, P1536, DOI 10.1128/IAI.02984-14; Granoff DM, 2015, J INFECT DIS, V212, P784, DOI 10.1093/infdis/jiv081; Granoff DM, 2013, CLIN VACCINE IMMUNOL, V20, P1099, DOI 10.1128/CVI.00260-13; Granoff DM, 2009, INFECT IMMUN, V77, P764, DOI 10.1128/IAI.01191-08; Griffiths NJ, 2011, MOL MICROBIOL, V82, P1129, DOI 10.1111/j.1365-2958.2011.07876.x; Halperin SA, 2012, VACCINE, V30, pB26, DOI 10.1016/j.vaccine.2011.12.032; Jarva H, 2005, J IMMUNOL, V174, P6299, DOI 10.4049/jimmunol.174.10.6299; Lai ZZ, 2011, CLIN VACCINE IMMUNOL, V18, P724, DOI 10.1128/CVI.00053-11; Lewis LA, 2013, MBIO, V4, DOI 10.1128/mBio.00339-13; Lewis LA, 2012, J IMMUNOL, V188, P5063, DOI 10.4049/jimmunol.1103748; Lewis LA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001027; Madico G, 2006, J IMMUNOL, V177, P501, DOI 10.4049/jimmunol.177.1.501; Masignani V, 2003, J EXP MED, V197, P789, DOI 10.1084/jem.20021911; McNeil LK, 2013, MICROBIOL MOL BIOL R, V77, P234, DOI 10.1128/MMBR.00056-12; Nadel S, 2012, ARCH DIS CHILD, V97, P993, DOI 10.1136/archdischild-2012-302036; Nagaputra JC, 2014, CLIN VACCINE IMMUNOL, V21, P234, DOI 10.1128/CVI.00561-13; Pajon R, 2010, VACCINE, V28, P2122, DOI 10.1016/j.vaccine.2009.12.027; Rollier CS, 2015, EXPERT OPIN BIOL TH, V15, P131, DOI 10.1517/14712598.2015.983897; Sadarangani M, 2010, LANCET INFECT DIS, V10, P112, DOI 10.1016/S1473-3099(09)70324-X; Sambrook J., 2001, MOL CLONING LAB MANU; Sanders H, 2011, EXPERT REV VACCINES, V10, P323, DOI [10.1586/erv.11.10, 10.1586/ERV.11.10]; Schneider MC, 2009, NATURE, V458, P890, DOI 10.1038/nature07769; Tappero JW, 1999, JAMA-J AM MED ASSOC, V281, P1520, DOI 10.1001/jama.281.16.1520; Ufret-Vincenty RL, 2010, INVEST OPHTH VIS SCI, V51, P5878, DOI 10.1167/iovs.09-4457; van Dam V, 2012, METHODS MOL BIOL, V799, P55, DOI 10.1007/978-1-61779-346-2_4; van de Waterbeemd B, 2012, VACCINE, V30, P3683, DOI 10.1016/j.vaccine.2012.03.028; van der Ley P, 2011, HUM VACCINES, V7, P886, DOI 10.4161/hv.7.8.16086; van der Veen S, 2014, INFECT IMMUN, V82, P1157, DOI 10.1128/IAI.01183-13; VANDERLEY P, 1992, INFECT IMMUN, V60, P3156, DOI 10.1128/IAI.60.8.3156-3161.1992; VanDerVoort ER, 1996, INFECT IMMUN, V64, P2745, DOI 10.1128/IAI.64.7.2745-2751.1996; Wu YM, 2006, P NATL ACAD SCI USA, V103, P18243, DOI 10.1073/pnas.0608545103; Zariri A, 2013, VACCINE, V31, P5585, DOI 10.1016/j.vaccine.2013.07.069	40	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0148840	10.1371/journal.pone.0148840	http://dx.doi.org/10.1371/journal.pone.0148840			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26871712	gold, Green Published, Green Submitted			2022-12-26	WOS:000370054100062
J	Singhal, G; Fisher, FM; Chee, MJ; Tan, TG; El Ouaamari, A; Adams, AC; Najarian, R; Kulkarni, RN; Benoist, C; Flier, JS; Maratos-Flier, E				Singhal, Garima; Fisher, Ffolliott Martin; Chee, Melissa J.; Tan, Tze Guan; El Ouaamari, Abdelfattah; Adams, Andrew C.; Najarian, Robert; Kulkarni, Rohit N.; Benoist, Christophe; Flier, Jeffrey S.; Maratos-Flier, Eleftheria			Fibroblast Growth Factor 21 (FGF21) Protects against High Fat Diet Induced Inflammation and Islet Hyperplasia in Pancreas	PLOS ONE			English	Article							IMPROVES INSULIN SENSITIVITY; ADIPOSE-TISSUE; PPAR-ALPHA; METABOLIC REGULATOR; RESISTANT STATES; MICE; RECEPTOR; LIVER; FIBROBLAST-GROWTH-FACTOR-21; ACTIVATION	Fibroblast growth factor 21 (FGF21) is an important endocrine metabolic regulator expressed in multiple tissues including liver and adipose tissue. Although highest levels of expression are in pancreas, little is known about the function of FGF21 in this tissue. In order to understand the physiology of FGF21 in the pancreas, we analyzed its expression and regulation in both acinar and islet tissues. We found that acinar tissue express 20-fold higher levels than that observed in islets. We also observed that pancreatic FGF21 is nutritionally regulated; a marked reduction in FGF21 expression was noted with fasting while obesity is associated with 3-4 fold higher expression. Acinar and islet cells are targets of FGF21, which when systemically administered, leads to phosphorylation of the downstream target ERK 1/2 in about half of acinar cells and a small subset of islet cells. Chronic, systemic FGF21 infusion down-regulates its own expression in the pancreas. Mice lacking FGF21 develop significant islet hyperplasia and periductal lymphocytic inflammation when fed with a high fat obesogenic diet. Inflammatory infiltrates consist of TCRb+Thy1+T lymphocytes with increased levels of Foxp3+ regulatory T cells. Increased levels of inflammatory cells were coupled with elevated expression of cytokines such as TNF alpha, IFN gamma and IL1 beta. We conclude that FGF21 acts to limit islet hyperplasia and may also prevent pancreatic inflammation.	[Singhal, Garima; Fisher, Ffolliott Martin; Chee, Melissa J.; Flier, Jeffrey S.; Maratos-Flier, Eleftheria] Beth Israel Deaconess Med Ctr, Div Endocrinol, Boston, MA 02215 USA; [Tan, Tze Guan; Benoist, Christophe] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02215 USA; [El Ouaamari, Abdelfattah; Kulkarni, Rohit N.] Joslin Diabet Ctr, Sect Islet Cell Biol & Regenerat Med, Boston, MA 02215 USA; [Adams, Andrew C.] Lilly Res Labs, Diabet Res, Indianapolis, IN 46225 USA; [Najarian, Robert] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Pathol, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Harvard University; Joslin Diabetes Center, Inc.; Eli Lilly; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Maratos-Flier, E (corresponding author), Beth Israel Deaconess Med Ctr, Div Endocrinol, Boston, MA 02215 USA.	emaratos@bidmc.harvard.edu	Flier, jeffrey/AAG-6223-2019; Chee, Melissa/G-4150-2014	Chee, Melissa/0000-0003-3815-9095	NIH [DK28082]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK028082, R01DK067536, R37DK028082, R01DK103215] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The research work presented here is is funded by different sources as given below: NIH DK28082 (EMF) for study design, data collection, data analysis, writing manuscript. NIH RO1 DK67536 (RNK) and RO1 DK103215 (RNK) for data collection. Lilly research laboratories provided recombinant FGF21 and FGF21 Knock out mice on the basis of a Material transfer agreement. One of the co-authors, ACA, is employed and therefore paid by the company. Lilly research laboratories did not provide funding for the present manuscript. They do not have any role in study design, data collection, data analysis or writing manuscript. The authors have added the following statement to the amended funding statement. The funder provided support in the form of salaries for authors [ACA], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of ACA is articulated in the 'author contributions' section.	Adams AC, 2012, CURR DIABETES REV, V8, P285, DOI 10.2174/157339912800840505; Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002; Badman MK, 2009, ENDOCRINOLOGY, V150, P4931, DOI 10.1210/en.2009-0532; Bonner-Weir S., 1993, P759; CAMPBELL IL, 1994, AM J PATHOL, V145, P157; Camporez JPG, 2013, ENDOCRINOLOGY, V154, P3099, DOI 10.1210/en.2013-1191; Chartoumpekis DV, 2011, MOL MED, V17, P736, DOI 10.2119/molmed.2011.00075; Dawson DW, 2013, CANCER PREV RES, V6, P1064, DOI 10.1158/1940-6207.CAPR-13-0065; Dirice E, 2014, DIABETES, V63, P188, DOI 10.2337/db13-0204; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; El Ouaamari A, 2013, CELL REP, V3, P401, DOI 10.1016/j.celrep.2013.01.007; Fisher FM, 2014, GASTROENTEROLOGY, V147, P1073, DOI 10.1053/j.gastro.2014.07.044; Fisher FM, 2012, GENE DEV, V26, P271, DOI 10.1101/gad.177857.111; Fisher FM, 2010, DIABETES, V59, P2781, DOI 10.2337/db10-0193; Flier SN, 2001, P NATL ACAD SCI USA, V98, P7475, DOI 10.1073/pnas.131192998; Galman C, 2008, CELL METAB, V8, P169, DOI 10.1016/j.cmet.2008.06.014; Gimeno RE, 2014, TRENDS ENDOCRIN MET, V25, P303, DOI 10.1016/j.tem.2014.03.001; Hondares E, 2011, J BIOL CHEM, V286, P12983, DOI 10.1074/jbc.M110.215889; Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003; Johnson CL, 2014, AM J PHYSIOL-ENDOC M, V306, pE916, DOI 10.1152/ajpendo.00559.2013; Johnson CL, 2009, GASTROENTEROLOGY, V137, P1795, DOI 10.1053/j.gastro.2009.07.064; Junnila RK, 2013, NAT REV ENDOCRINOL, V9, P366, DOI 10.1038/nrendo.2013.67; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Kim A, 2009, ISLETS, V1, P129, DOI 10.4161/isl.1.2.9480; Kim KH, 2013, NAT MED, V19, P83, DOI 10.1038/nm.3014; Kulkarni RN, 1999, CELL, V96, P329, DOI 10.1016/S0092-8674(00)80546-2; Kulkarni RN, 1999, J CLIN INVEST, V104, pR69, DOI 10.1172/JCI8339; Markan KR, 2014, DIABETES, V63, P4057, DOI 10.2337/db14-0595; Omar BA, 2014, DIABETES, V63, P101, DOI 10.2337/db13-0710; Pfluger PT, 2008, P NATL ACAD SCI USA, V105, P9793, DOI 10.1073/pnas.0802917105; Planavila A, 2015, CARDIOVASC RES, V106, P19, DOI 10.1093/cvr/cvu263; So WY, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.80; So WY, 2013, DIABETES, V62, P3751, DOI 10.2337/db13-0645; Tanaka N, 2015, BBA-MOL BASIS DIS, V1852, P1242, DOI 10.1016/j.bbadis.2015.02.012; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Uonaga T, 2010, ISLETS, V2, P247, DOI 10.4161/isl.2.4.12402; Wellen KE, 2003, J CLIN INVEST, V112, P1785, DOI 10.1172/JCI20514; Wente W, 2006, DIABETES, V55, P2470, DOI 10.2337/db05-1435; Xu J, 2009, DIABETES, V58, P250, DOI 10.2337/db08-0392; Xu J, 2009, AM J PHYSIOL-ENDOC M, V297, pE1105, DOI 10.1152/ajpendo.00348.2009; Yakar S, 2004, J CLIN INVEST, V113, P96, DOI 10.1172/JCI200417763; Yan XQ, 2015, J CELL MOL MED, V19, P1557, DOI 10.1111/jcmm.12530	42	78	82	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0148252	10.1371/journal.pone.0148252	http://dx.doi.org/10.1371/journal.pone.0148252			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26872145	Green Published, gold, Green Submitted			2022-12-26	WOS:000370054100020
J	Cui, J; Xia, T; Xie, D; Gao, Y; Jia, Z; Wei, D; Wang, L; Huang, S; Quan, M; Xie, K				Cui, J.; Xia, T.; Xie, D.; Gao, Y.; Jia, Z.; Wei, D.; Wang, L.; Huang, S.; Quan, M.; Xie, K.			HGF/Met and FOXM1 form a positive feedback loop and render pancreatic cancer cells resistance to Met inhibition and aggressive phenotypes	ONCOGENE			English	Article							C-MET; TRANSCRIPTION FACTOR; GENE-EXPRESSION; PROMOTES; GROWTH; PROGRESSION; RECEPTOR; TARGET; INDUCTION; HGF/SF	Hepatocyte growth factor (HGF)/Met signaling has critical roles in pancreatic ductal adenocarcinoma (PDA) development and progression and is considered a potential therapeutic target for this disease. However, the mechanism of aberrant activation of HGF/Met signaling and resistance to Met inhibition in PDA remains unclear. The mechanistic role of cross talk between Forkhead box M1 (FOXM1) and HGF/Met signaling in promotion of PDA growth and resistance to Met inhibition was examined using cell culture, molecular biology and mouse models; and the relevance of our experimental and mechanistic findings were validated using human PDA tissues. Met was markedly overexpressed in both PDA cell lines and pancreatic tumor specimens, and the expression of Met correlated directly with that of FOXM1 in human tumor specimens. Mechanistically, FOXM1 bound to the promoter region of the Met gene and transcriptionally increased the expression of Met. Increased expression of FOXM1 enhanced the activation of HGF/Met signaling and its downstream pathways, including retrovirus-associated DNA sequences/extracellular signal-regulated kinase 1/2, phosphoinositide 3-kinase/AKT and signal transducer and activator of transcription 3. Furthermore, activation of HGF/Met signaling increased the expression and transcriptional activity of FOXM1, and the cross talk between FOXM1 and HGF/Met signaling promoted PDA growth and resistance to Met inhibition. Collectively, our findings identified a positive feedback loop formed by FOXM1 and HGF/Met and revealed that this loop is a potentially effective therapeutic target for PDA.	[Cui, J.; Jia, Z.; Wei, D.; Wang, L.; Quan, M.; Xie, K.] Univ Texas MD Anderson Canc Ctr, Dept Gastroenterol Hepatol & Nutr, Houston, TX 77030 USA; [Xia, T.] Second Mil Med Univ, Shanghai Changhai Hosp, Dept Gastroenterol, Shanghai, Peoples R China; [Xie, D.; Gao, Y.; Quan, M.] Shanghai Tongji Univ, Dept Oncol, Affiliated East Hosp, Shanghai, Peoples R China; [Huang, S.] Univ Texas MD Anderson Canc Ctr, Dept Neurosurg, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; Naval Medical University; Tongji University; University of Texas System; UTMD Anderson Cancer Center	Quan, M (corresponding author), Shanghai Tongji Univ, Dept Oncol, Affiliated East Hosp, Shanghai, Peoples R China.; Xie, K (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Gastroenterol Hepatol & Nutr, Unit 1466, 1515 Holcombe Blvd, Houston, TX 77030 USA.	quanming2013@gmail.com; kepxie@mdanderson.org		Wang, Liang/0000-0001-5038-694X	National Cancer Institute, National Institutes of Health [R01-CA129956, R01-CA148954, R01CA152309, R01CA172233]; NATIONAL CANCER INSTITUTE [R01CA148954, R01CA198090, R01CA172233, R01CA195651, R01CA152309, R01CA129956] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Don Norwood for editorial assistance and Xuemei Wang, Associate Director of Quantitative Research at The University of Texas MD Anderson Cancer Center, for assistance with statistical analyses. This work was supported by grants R01-CA129956, R01-CA148954, R01CA152309, and R01CA172233 from the National Cancer Institute, National Institutes of Health (to K Xie).	Altomare DA, 2010, CLIN CANCER RES, V16, P486, DOI 10.1158/1078-0432.CCR-09-1026; Avan A, 2014, CURR MED CHEM, V21, P975, DOI 10.2174/09298673113209990231; Bao B, 2011, J CELL BIOCHEM, V112, P2296, DOI 10.1002/jcb.23150; Birchmeier C, 1998, TRENDS CELL BIOL, V8, P404, DOI 10.1016/S0962-8924(98)01359-2; Chiu WT, 2015, ONCOTARGET, V6, P2349, DOI 10.18632/oncotarget.2957; Christensen JG, 2003, CANCER RES, V63, P7345; CLARK KL, 1993, NATURE, V364, P412, DOI 10.1038/364412a0; Cui JJ, 2014, J MED CHEM, V57, P4427, DOI 10.1021/jm401427c; Cui JJ, 2014, CLIN CANCER RES, V20, P2595, DOI 10.1158/1078-0432.CCR-13-2407; Dai B, 2007, ONCOGENE, V26, P6212, DOI 10.1038/sj.onc.1210443; De Bacco F, 2011, J NATL CANCER I, V103, P645, DOI 10.1093/jnci/djr093; Hidalgo M, 2010, NEW ENGL J MED, V362, P1605, DOI 10.1056/NEJMra0901557; Hu B, 2007, ONCOGENE, V26, P5577, DOI 10.1038/sj.onc.1210348; Huang C, 2014, BBA-REV CANCER, V1845, P104, DOI 10.1016/j.bbcan.2014.01.002; Huang C, 2012, CANCER RES, V72, P655, DOI 10.1158/0008-5472.CAN-11-3102; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Ketterer K, 2009, CANCER LETT, V277, P72, DOI 10.1016/j.canlet.2008.11.028; Kitajima Y, 2008, CANCER SCI, V99, P1341, DOI 10.1111/j.1349-7006.2008.00828.x; Lam AKY, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00011; Li L, 2014, GASTROENTEROLOGY, V147, P485, DOI 10.1053/j.gastro.2014.04.048; Liu MG, 2006, CANCER RES, V66, P3593, DOI 10.1158/0008-5472.CAN-05-2912; Logan-Collins J, 2010, CANCER RES, V70, P1130, DOI 10.1158/0008-5472.CAN-09-0761; Mencalha AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048160; Neesse A, 2011, GUT, V60, P861, DOI 10.1136/gut.2010.226092; Otte JM, 2000, SCAND J GASTROENTERO, V35, P90; Qi J, 2011, CANCER RES, V71, P1081, DOI 10.1158/0008-5472.CAN-10-1623; Sanders DA, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0696-z; Sen N, 2012, P NATL ACAD SCI USA, V109, P600, DOI 10.1073/pnas.1114232109; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Sunaga N, 2013, ONCOGENE, V32, P4034, DOI 10.1038/onc.2012.402; Wang HX, 2010, CARCINOGENESIS, V31, P1132, DOI 10.1093/carcin/bgq058; Wang ZW, 2010, CANCER TREAT REV, V36, P151, DOI 10.1016/j.ctrv.2009.11.006; Wierstra I, 2007, BIOL CHEM, V388, P1257, DOI 10.1515/BC.2007.159; Wierstra I, 2006, BIOL CHEM, V387, P963, DOI 10.1515/BC.2006.120; Xue JF, 2014, J CLIN INVEST, V124, P564, DOI 10.1172/JCI71104; Yeh CY, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-139; Zhang N, 2011, CANCER CELL, V20, P427, DOI 10.1016/j.ccr.2011.08.016; Zhang YJ, 2008, CANCER RES, V68, P8733, DOI 10.1158/0008-5472.CAN-08-1968; Zhang YW, 2003, J CELL BIOCHEM, V88, P408, DOI 10.1002/jcb.10358; Zhao S, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.36; Zhu GH, 2011, DIGEST DIS SCI, V56, P1090, DOI 10.1007/s10620-010-1416-x	41	29	30	0	11	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 8	2016	35	36					4708	4718		10.1038/onc.2016.14	http://dx.doi.org/10.1038/onc.2016.14			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DW0IS	26876216	Green Accepted			2022-12-26	WOS:000383324700004
J	Singh, G; Zhang, JW; Ma, YL; Cerione, RA; Antonyak, MA				Singh, Garima; Zhang, Jingwen; Ma, Yilun; Cerione, Richard A.; Antonyak, Marc A.			The Different Conformational States of Tissue Transglutaminase Have Opposing Affects on Cell Viability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-ANGLE SCATTERING; DOXORUBICIN-INDUCED APOPTOSIS; HUNTINGTONS-DISEASE BRAIN; GROWTH-FACTOR RECEPTOR; BREAST-CANCER CELLS; PHOSPHATIDYLINOSITOL 3-KINASE; BIOLOGICAL MACROMOLECULES; TRANSAMIDATION ACTIVITY; ALZHEIMERS-DISEASE; CROSS-LINKING	Tissue transglutaminase (tTG) is an acyltransferase/GTP-binding protein that contributes to the development of various diseases. In human cancer cells, tTG activates signaling pathways that promote cell growth and survival, whereas in other disorders (i.e. neurodegeneration), overexpression of tTG enhances cell death. Therefore, it is important to understand how tTG is differentially regulated and functioning to promote diametrically distinct cellular outcomes. Previous structural studies revealed that tTG adopts either a nucleotide-bound closed conformation or a transamidation-competent open conformation. Here we provide evidence showing that these different conformational states determine whether tTG promotes, or is detrimental to, cell survival, with the open conformation of the protein being responsible for inducing cell death. First, we demonstrate that a nucleotide binding-defective form of tTG, which has previously been shown to induce cell death, assumes an open conformation in solution as assessed by an enhanced sensitivity to trypsin digestion and by small angle x-ray scattering (SAXS) analysis. We next identify two pairs of intramolecular hydrogen bonds that, based on existing x-ray structures, are predicted to form between the most C-terminal beta-barrel domain and the catalytic core domain of tTG. By disrupting these hydrogen bonds, we are able to generate forms of tTG that constitutively assume an open conformation and induce apoptosis. These findings provide important insights into how tTG participates in the pathogenesis of neurodegenerative diseases, particularly with regard to the actions of a C-terminal truncated form of tTG (TG-Short) that has been linked to such disorders and induces apoptosis by assuming an open-like conformation.	[Singh, Garima; Zhang, Jingwen; Ma, Yilun; Cerione, Richard A.; Antonyak, Marc A.] Cornell Univ, Dept Mol Med, Ithaca, NY 14853 USA; [Cerione, Richard A.] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA	Cornell University; Cornell University	Cerione, RA (corresponding author), Cornell Univ, Coll Vet Med, Dept Mol Med, Ithaca, NY 14853 USA.	rac1@cornell.edu	Zhang, Jing/GWZ-7332-2022	Ma, Yilun/0000-0002-2297-9980	National Institutes of Health [P41 GM103485]; NATIONAL CANCER INSTITUTE [R01CA201402] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103485, R01GM040654] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. Richard Gillilan and MacCHESS (National Institutes of Health Grant P41 GM103485) for SAXS data collection and help with the analyses and Cindy Westmiller for expert secretarial assistance.	AESCHLIMANN D, 1993, J CELL BIOL, V120, P1461, DOI 10.1083/jcb.120.6.1461; Antonyak MA, 2004, J BIOL CHEM, V279, P41461, DOI 10.1074/jbc.M404976200; Antonyak MA, 2006, P NATL ACAD SCI USA, V103, P18609, DOI 10.1073/pnas.0604844103; Antonyak MA, 2011, P NATL ACAD SCI USA, V108, P4852, DOI 10.1073/pnas.1017667108; Antonyak MA, 2009, J BIOL CHEM, V284, P17914, DOI 10.1074/jbc.M109.013037; AUGER KR, 1992, J BIOL CHEM, V267, P5408; Bernardi P., 2007, V45, P481; Boroughs LK, 2014, J BIOL CHEM, V289, P10115, DOI 10.1074/jbc.M113.464693; Caccamo D, 2010, EXPERT OPIN THER TAR, V14, P989, DOI 10.1517/14728222.2010.510134; Chen QC, 2015, ONCOL LETT, V10, P17, DOI 10.3892/ol.2015.3184; Citron BA, 2002, NEUROCHEM INT, V40, P69, DOI 10.1016/S0197-0186(01)00062-6; Citron BA, 2001, J BIOL CHEM, V276, P3295, DOI 10.1074/jbc.M004776200; Datta S, 2007, BIOCHEMISTRY-US, V46, P14819, DOI 10.1021/bi701422h; Datta S, 2006, BIOCHEMISTRY-US, V45, P13163, DOI 10.1021/bi0606795; Dias SMG, 2009, NAT STRUCT MOL BIOL, V16, P930, DOI 10.1038/nsmb.1649; Eckert RL, 2015, MOL CARCINOGEN, V54, P947, DOI 10.1002/mc.22375; Festoff BW, 2002, J NEUROCHEM, V81, P708, DOI 10.1046/j.1471-4159.2002.00850.x; FOLK JE, 1980, ANNU REV BIOCHEM, V49, P517, DOI 10.1146/annurev.bi.49.070180.002505; Gundemir S, 2013, BBA-MOL CELL RES, V1833, P1, DOI 10.1016/j.bbamcr.2012.10.011; Gundemir S, 2012, BBA-MOL CELL RES, V1823, P406, DOI 10.1016/j.bbamcr.2011.09.012; Jeitner TM, 2009, FUTUR NEUROL, V4, P449, DOI 10.2217/FNL.09.17; Karpuj MV, 1999, P NATL ACAD SCI USA, V96, P7388, DOI 10.1073/pnas.96.13.7388; Katt WP, 2015, MOL PHARMACEUT, V12, P46, DOI 10.1021/mp500405h; Kim DS, 2006, CANCER RES, V66, P10936, DOI 10.1158/0008-5472.CAN-06-1521; Kim SY, 1999, J BIOL CHEM, V274, P30715, DOI 10.1074/jbc.274.43.30715; Lai TS, 2013, FRONT BIOSCI-LANDMRK, V18, P504, DOI 10.2741/4117; LEE KN, 1993, BIOCHIM BIOPHYS ACTA, V1202, P1, DOI 10.1016/0167-4838(93)90055-V; Lesort M, 1999, J NEUROCHEM, V73, P2018; Levkowitz G, 1998, GENE DEV, V12, P3663, DOI 10.1101/gad.12.23.3663; Li B, 2010, P NATL ACAD SCI USA, V107, P1408, DOI 10.1073/pnas.0907907107; Liu SP, 2002, P NATL ACAD SCI USA, V99, P2743, DOI 10.1073/pnas.042454899; LIU XQ, 1993, MOL CELL BIOL, V13, P5225, DOI 10.1128/MCB.13.9.5225; MEHTA K, 1986, CANCER RES, V46, P1388; NAKAOKA H, 1994, SCIENCE, V264, P1593, DOI 10.1126/science.7911253; Nielsen SS, 2009, J APPL CRYSTALLOGR, V42, P959, DOI 10.1107/S0021889809023863; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Pinkas DM, 2007, PLOS BIOL, V5, P2788, DOI 10.1371/journal.pbio.0050327; Polivka J, 2014, PHARMACOL THERAPEUT, V142, P164, DOI 10.1016/j.pharmthera.2013.12.004; Siegel M, 2007, PHARMACOL THERAPEUT, V115, P232, DOI 10.1016/j.pharmthera.2007.05.003; Singer CF, 2006, CLIN EXP METASTAS, V23, P33, DOI 10.1007/s10585-006-9015-0; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1991, J APPL CRYSTALLOGR, V24, P485, DOI 10.1107/S0021889891001280; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Telci D, 2006, FRONT BIOSCI-LANDMRK, V11, P867, DOI 10.2741/1843; Verderio EAM, 2004, AMINO ACIDS, V26, P387, DOI 10.1007/s00726-004-0094-4; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wang Z, 2011, EXP CELL RES, V317, P367, DOI 10.1016/j.yexcr.2010.10.015; Waterman H, 1999, J BIOL CHEM, V274, P22151, DOI 10.1074/jbc.274.32.22151; Yuan L, 2007, ONCOGENE, V26, P2563, DOI 10.1038/sj.onc.1210048; Zhang JW, 2013, CELL REP, V3, P2008, DOI 10.1016/j.celrep.2013.05.021	51	19	19	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2016	291	17					9119	9132		10.1074/jbc.M115.699108	http://dx.doi.org/10.1074/jbc.M115.699108			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK3WV	26893378	Green Published, hybrid			2022-12-26	WOS:000374849000024
J	Chuang, TW; Lee, KM; Lou, YC; Lu, CC; Tarn, WY				Chuang, Tzu-Wei; Lee, Kuo-Ming; Lou, Yuan-Chao; Lu, Chia-Chen; Tarn, Woan-Yuh			A Point Mutation in the Exon Junction Complex Factor Y14 Disrupts Its Function in mRNA Cap Binding and Translation Enhancement	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mRNA; mRNA decay; translation; translation control; translation regulation; decapping; exon-junction complex; mRNA cap; mRNA stability	DECAPPING PROTEIN; MAMMALIAN-CELLS; YEAST-CELLS; DECAY; INTERACTS; EXPORT; RECOGNITION; CYTOPLASM; CORE; DCP1	Eukaryotic mRNA biogenesis involves a series of interconnected steps mediated by RNA-binding proteins. The exon junction complex core protein Y14 is required for nonsense-mediated mRNA decay (NMD) and promotes translation. Moreover, Y14 binds the cap structure of mRNAs and inhibits the activity of the decapping enzyme Dcp2. In this report, we show that an evolutionarily conserved tryptophan residue (Trp-73) of Y14 is critical for its binding to the mRNA cap structure. A Trp-73 mutant (W73V) bound weakly to mRNAs and failed to protect them from degradation. However, this mutant could still interact with the NMD and mRNA degradation factors and retained partial NMD activity. In addition, we found that the W73V mutant could not interact with translation initiation factors. Overexpression of W73V suppressed reporter mRNA translation in vitro and in vivo and reduced the level of a set of nascent proteins. These results reveal a residue of Y14 that confers cap-binding activity and is essential for Y14-mediated enhancement of translation. Finally, we demonstrated that Y14 may selectively and differentially modulate protein biosynthesis.	[Chuang, Tzu-Wei; Lee, Kuo-Ming; Lou, Yuan-Chao; Lu, Chia-Chen; Tarn, Woan-Yuh] Acad Sinica, Inst Biomed Sci, Taipei 11529, Taiwan	Academia Sinica - Taiwan	Tarn, WY (corresponding author), 128 Acad Rd,Sect 2, Taipei 11529, Taiwan.	wtarn@ibms.sinica.edu.tw	Tarn, Woan-Yuh/N-8464-2018	Lee, Kuo-Ming/0000-0002-3215-8342	Ministry of Science and Technology, Taiwan [MOST 102-2311-B-001-025-MY3]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by Grant MOST 102-2311-B-001-025-MY3 from the Ministry of Science and Technology, Taiwan. The authors declare that they have no conflicts of interest with the contents of this article.	Bono F, 2004, EMBO REP, V5, P304, DOI 10.1038/sj.embor.7400091; Chang WL, 2009, NUCLEIC ACIDS RES, V37, P6600, DOI 10.1093/nar/gkp717; Chuang TW, 2013, MOL BIOL CELL, V24, P1, DOI 10.1091/mbc.E12-03-0217; Chuang TW, 2011, J BIOL CHEM, V286, P8722, DOI 10.1074/jbc.M110.190587; Diem MD, 2007, NAT STRUCT MOL BIOL, V14, P1173, DOI 10.1038/nsmb1321; Dostie J, 2002, CURR BIOL, V12, P1060, DOI 10.1016/S0960-9822(02)00902-8; Fenger-Gron M, 2005, MOL CELL, V20, P905, DOI 10.1016/j.molcel.2005.10.031; Fischer N, 2002, EMBO J, V21, P2788, DOI 10.1093/emboj/21.11.2788; Fribourg S, 2003, NAT STRUCT BIOL, V10, P433, DOI 10.1038/nsb926; Gatfield D, 2002, J CELL BIOL, V159, P579, DOI 10.1083/jcb.200207128; Gehring NH, 2005, MOL CELL, V20, P65, DOI 10.1016/j.molcel.2005.08.012; Gong PC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084842; Hachet O, 2001, CURR BIOL, V11, P1666, DOI 10.1016/S0960-9822(01)00508-5; HSU CL, 1993, MOL CELL BIOL, V13, P4826, DOI 10.1128/MCB.13.8.4826; Hsu IW, 2005, J BIOL CHEM, V280, P34507, DOI 10.1074/jbc.M507658200; Kashima I, 2006, GENE DEV, V20, P355, DOI 10.1101/gad.1389006; Khanna R, 2004, EMBO J, V23, P1968, DOI 10.1038/sj.emboj.7600213; Kshirsagar M, 2004, GENETICS, V166, P729, DOI 10.1534/genetics.166.2.729; Lai MC, 2000, J BIOL CHEM, V275, P7950, DOI 10.1074/jbc.275.11.7950; Lai MC, 2008, MOL BIOL CELL, V19, P3847, DOI 10.1091/mbc.E07-12-1264; LARIMER FW, 1992, GENE, V120, P51, DOI 10.1016/0378-1119(92)90008-D; Le Hir H, 2001, EMBO J, V20, P4987, DOI 10.1093/emboj/20.17.4987; Lee HC, 2009, BIOCHEM BIOPH RES CO, V384, P334, DOI 10.1016/j.bbrc.2009.04.123; Lee KM, 2010, NUCLEIC ACIDS RES, V38, P3340, DOI 10.1093/nar/gkq017; Lejeune F, 2002, EMBO J, V21, P3536, DOI 10.1093/emboj/cdf345; Li Y, 2008, MOL CELL BIOL, V28, P939, DOI 10.1128/MCB.01727-07; Lin JC, 2007, P NATL ACAD SCI USA, V104, P2235, DOI 10.1073/pnas.0611015104; Marcotrigiano J, 1997, CELL, V89, P951, DOI 10.1016/S0092-8674(00)80280-9; Mazza C, 2002, EMBO J, V21, P5548, DOI 10.1093/emboj/cdf538; Mazza C, 2001, MOL CELL, V8, P383, DOI 10.1016/S1097-2765(01)00299-4; Mohr SE, 2001, GENE DEV, V15, P2886; Nott A, 2004, GENE DEV, V18, P210, DOI 10.1101/gad.1163204; Schwartz DC, 2000, MOL CELL BIOL, V20, P7933, DOI 10.1128/MCB.20.21.7933-7942.2000; Singh G, 2007, MOL CELL, V27, P780, DOI 10.1016/j.molcel.2007.06.030; Tange TO, 2005, RNA, V11, P1869, DOI 10.1261/rna.2155905; Vilela C, 2000, EMBO J, V19, P4372, DOI 10.1093/emboj/19.16.4372	36	9	10	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2016	291	16					8565	8574		10.1074/jbc.M115.704544	http://dx.doi.org/10.1074/jbc.M115.704544			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK2VT	26887951	hybrid, Green Published			2022-12-26	WOS:000374773200021
J	Turner, KB; Naciri, J; Liu, JL; Anderson, GP; Goldman, ER; Zabetakis, D				Turner, Kendrick B.; Naciri, Jennifer; Liu, Jinny L.; Anderson, George P.; Goldman, Ellen R.; Zabetakis, Dan			Next-Generation Sequencing of a Single Domain Antibody Repertoire Reveals Quality of Phage Display Selected Candidates	PLOS ONE			English	Article							FRAGMENTS; TOXIN; LIBRARY; SEQ	Next-Generation Sequencing and bioinformatics are powerful tools for analyzing the large number of DNA sequences present in an immune library. In this work, we constructed a cDNA library of single domain antibodies from a llama immunized with staphylococcal enterotoxin B. The resulting library was sequenced, resulting in approximately 8.5 million sequences with 5.4 million representing intact, useful sequences. The sequenced library was interrogated using sequences of known SEB-binding single domain antibodies from the library obtained through phage display panning methods in a previous study. New antibodies were identified, produced, and characterized, and were shown to have affinities and melting temperatures comparable to those obtained by traditional panning methods. This demonstrates the utility of using NGS as a complementary tool to phage-displayed biopanning as a means for rapidly obtaining additional antibodies from an immune library. It also shows that phage display, using a library of high diversity, is able to select high quality antibodies even when they are low in frequency.	[Turner, Kendrick B.; Naciri, Jennifer] US Naval Res Lab, Washington, DC USA; [Liu, Jinny L.; Anderson, George P.; Goldman, Ellen R.; Zabetakis, Dan] US Naval Res Lab, Ctr Bio Mol Sci & Engn, Washington, DC USA	United States Department of Defense; United States Navy; Naval Research Laboratory; United States Department of Defense; United States Navy; Naval Research Laboratory	Zabetakis, D (corresponding author), US Naval Res Lab, Ctr Bio Mol Sci & Engn, Washington, DC USA.	daniel.zabetakis@nrl.navy.mil	Turner, Kendrick/A-5063-2018; Anderson, George P/D-2461-2011	Turner, Kendrick/0000-0002-4966-3396; Anderson, George P/0000-0001-7545-9893	 [DTRA: CBCALL12-LS6-2-0036]		This study was supported by DTRA: CBCALL12-LS6-2-0036 (www.dtra.mil). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson GP, 2012, ANAL CHEM, V84, P5198, DOI 10.1021/ac300864j; Anderson GP, 2008, ANAL CHEM, V80, P9604, DOI 10.1021/ac8019398; Baum PD, 2012, EUR J IMMUNOL, V42, P2834, DOI 10.1002/eji.201242999; Benichou J, 2012, IMMUNOLOGY, V135, P183, DOI 10.1111/j.1365-2567.2011.03527.x; Bolotin D, 2012, TISSUE ANTIGENS, V79, P545; de Marco A, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-44; Eyer L, 2012, VET MED-CZECH, V57, P439, DOI 10.17221/6336-VETMED; Fischer N, 2011, MABS-AUSTIN, V3, P17, DOI 10.4161/mabs.3.1.14169; Fridy PC, 2014, NAT METHODS, V11, P1253, DOI [10.1038/NMETH.3170, 10.1038/nmeth.3170]; Gasper WC, 2014, SCI REP-UK, V4, DOI 10.1038/srep05152; Ghahroudi MA, 1997, FEBS LETT, V414, P521, DOI 10.1016/S0014-5793(97)01062-4; HAMERSCASTERMAN C, 1993, NATURE, V363, P446, DOI 10.1038/363446a0; Harmsen MM, 2007, APPL MICROBIOL BIOT, V77, P13, DOI 10.1007/s00253-007-1142-2; He LL, 2014, SCI REP-UK, V4, DOI 10.1038/srep06778; Heyduk E, 2014, ANAL BIOCHEM, V464, P73, DOI 10.1016/j.ab.2014.07.014; Jirimutu, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2192; Liu JL, 2007, MOL IMMUNOL, V44, P1775, DOI 10.1016/j.molimm.2006.07.299; MacRae T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072884; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Murigneux V, 2013, METHODS, V63, P32, DOI 10.1016/j.ymeth.2013.03.022; Turner Kendrick B, 2015, Biotechnol Rep (Amst), V6, P27, DOI 10.1016/j.btre.2015.01.001; Turner KB, 2014, SENSORS-BASEL, V14, P10846, DOI 10.3390/s140610846; Turner KB, 2014, PROTEIN ENG DES SEL, V27, P89, DOI 10.1093/protein/gzu001; Wang CL, 2010, P NATL ACAD SCI USA, V107, P1518, DOI 10.1073/pnas.0913939107; Warren RL, 2011, GENOME RES, V21, P790, DOI 10.1101/gr.115428.110; Weinstein JA, 2009, SCIENCE, V324, P807, DOI 10.1126/science.1170020	26	22	23	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0149393	10.1371/journal.pone.0149393	http://dx.doi.org/10.1371/journal.pone.0149393			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3DG	26895405	Green Published, gold, Green Submitted			2022-12-26	WOS:000371223400051
J	Han, YC; Huang, HM; Sun, L; Tan, CM; Gao, M; Liu, H; Tang, RN; Wang, YL; Wang, B; Ma, KL; Liu, BC				Han, Yu-Chen; Huang, Han-Ming; Sun, Ling; Tan, Chao-Ming; Gao, Min; Liu, Hong; Tang, Ri-Ning; Wang, Yan-Li; Wang, Bei; Ma, Kun-Ling; Liu, Bi-Cheng			Epidemiological Study of RRT-Treated ESRD in Nanjing - A Ten-Year Experience in Nearly Three Million Insurance Covered Population	PLOS ONE			English	Article							KIDNEY-DISEASE; CHINA; HEMODIALYSIS; SURVIVAL; ACCESS; CARE	Background The growing burden of end-stage renal disease (ESRD) has been a great challenge to the health care system of China. However, the exact epidemiological data for ESRD in China remain unclear. We aimed to investigate the epidemiology of ESRD treated by renal replacement therapy (RRT) in Nanjing based on analysing ten-year data of Nanjing three million insurance covered population. Methods Using the electronic registry system of Urban Employee Basic Medical Insurance (UEBMI), we included all subjects insured by UEBMI in Nanjing from 2005 to 2014 and identified subjects who developed ESRD and started RRT in this cohort. Results The UEBMI population in Nanjing increased from 1,301,882 in 2005 to 2,921,065 in 2014, among which a total of 5,840 subjects developed ESRD and received RRT. Over the 10-year period, the adjusted incidence rates of RRT in the UEBMI cohort gradually decreased from 289.3pmp in 2005 to 218.8pmp in 2014. However, the adjusted prevalence rate increased steadily from 891.7pmp in 2005 to 1,228.6pmp in 2014. The adjusted annual mortality rate decreased from 138.4 per 1000 patient-years in 2005 to 97.8 per 1000 patient-years in 2014. The long-term survival rate fluctuated over the past decade, with the 1-year survival rate ranging from 85.1% to 91.7%, the 3-year survival rate from 69.9% to 78.3% and the 5-year survival rate from 58% to 65.4%. Conclusion Nanjing is facing an increasing burden of ESRD with its improvement of medical reform. The ten-year complete registry data on RRT in urban employees in Nanjing provided a unique opportunity to understand the real threat of ESRD confronting China during its process of health care transition.	[Han, Yu-Chen; Sun, Ling; Gao, Min; Liu, Hong; Tang, Ri-Ning; Wang, Yan-Li; Ma, Kun-Ling; Liu, Bi-Cheng] Southeast Univ, Sch Med, Zhongda Hosp, Inst Nephrol, Nanjing, Jiangsu, Peoples R China; [Huang, Han-Ming; Tan, Chao-Ming] Nanjing Municipal Human Resources & Social Secur, Social Insurance Management Ctr, Nanjing, Jiangsu, Peoples R China; [Wang, Bei] Southeast Univ, Sch Publ Hlth, Nanjing, Jiangsu, Peoples R China	Southeast University - China; Southeast University - China	Liu, BC (corresponding author), Southeast Univ, Sch Med, Zhongda Hosp, Inst Nephrol, Nanjing, Jiangsu, Peoples R China.	liubc64@163.com			National Natural Science Foundation of China [81130010, 81470997]; National Key Basic Research Project ("973"); Clinic Research Center program of Jiangsu Province [BL2014080]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Project ("973")(National Basic Research Program of China); Clinic Research Center program of Jiangsu Province	This study was supported by grants to Bi-Cheng Liu from the National Natural Science Foundation of China (81130010, 81470997), National Key Basic Research Project ("973") and Clinic Research Center program of Jiangsu Province (BL2014080). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, LANCET, V378, P457, DOI DOI 10.1016/S0140-6736(11)61232-4; Gan L, 2015, CLIN NEPHROL, V83; Kimmel PL, 2013, J AM SOC NEPHROL, V24, P293, DOI 10.1681/ASN.2012070659; Kurella-Tamura M, 2014, J AM SOC NEPHROL, V25, P1321, DOI 10.1681/ASN.2013060658; Liyanage T, 2015, LANCET, V385, P1975, DOI 10.1016/S0140-6736(14)61601-9; Nakai S, 2014, THER APHER DIAL, V18, P535, DOI 10.1111/1744-9987.12281; Nanjing Municipal Human Resources and Social Security Bureau, 2010, COMP DOC URB EMPL BA; Steenkamp R, 2015, NEPHRON, V129, P99, DOI 10.1159/000370275; U.S. Renal Data System USRDS, 2013, USDRS 2013 ANN DAT R; Wu M-S, 2012, ACTA NEPHROLOGICA, V26, P104; Yang GH, 2008, LANCET, V372, P1697, DOI 10.1016/S0140-6736(08)61366-5; Yang GH, 2013, LANCET, V381, P1987, DOI 10.1016/S0140-6736(13)61097-1; Yao Q, 2009, ETHN DIS S1, V19; Yip WCM, 2012, LANCET, V379, P833, DOI 10.1016/S0140-6736(11)61880-1; Zhang LX, 2012, LANCET, V379, P815, DOI 10.1016/S0140-6736(12)60033-6; ZHANG W, 2012, CHIN J BLOOD PURIF, V11, P233; Zuo L, 2010, CLIN NEPHROL, V74, pS20; Zuo L, 2006, ETHN DIS S2, V16; Zuo L, 2013, KIDNEY INT SUPPL, V3, P167, DOI 10.1038/kisup.2013.6; 2001, CHIN J NEPHROL, V17, P77	20	7	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2016	11	2							e0149038	10.1371/journal.pone.0149038	http://dx.doi.org/10.1371/journal.pone.0149038			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3CO	26889828	Green Submitted, Green Published, gold			2022-12-26	WOS:000371221500020
J	Thompson, B; Varticovski, L; Baek, S; Hager, GL				Thompson, Bethtrice; Varticovski, Lyuba; Baek, Songjoon; Hager, Gordon L.			Genome-Wide Chromatin Landscape Transitions Identify Novel Pathways in Early Commitment to Osteoblast Differentiation	PLOS ONE			English	Article							GLUCOCORTICOID-RECEPTOR; TRANSCRIPTION FACTORS; STEM-CELLS; EXPRESSION; RUNX2; INTERLEUKIN-11; ANTAGONISTS; MUTATIONS; MECHANISM; LINEAGE	Bone continuously undergoes remodeling by a tightly regulated process that involves osteoblast differentiation from Mesenchymal Stem Cells ( MSC). However, commitment of MSC to osteoblastic lineage is a poorly understood process. Chromatin organization functions as a molecular gatekeeper of DNA functions. Detection of sites that are hypersensitive to Dnase I has been used for detailed examination of changes in response to hormones and differentiation cues. To investigate the early steps in commitment of MSC to osteoblasts, we used a model human temperature-sensitive cell line, hFOB. When shifted to non-permissive temperature, these cells undergo "spontaneous" differentiation that takes several weeks, a process that is greatly accelerated by osteogenic induction media. We performed Dnase I hypersensitivity assays combined with deep sequencing to identify genome-wide potential regulatory events in cells undergoing early steps of commitment to osteoblasts. Massive reorganization of chromatin occurred within hours of differentiation. Whereas similar to 30% of unique DHS sites were located in the promoters, the majority was outside of the promoters, designated as enhancers. Many of them were at novel genomic sites and need to be confirmed experimentally. We developed a novel method for identification of cellular networks based solely on DHS enhancers signature correlated to gene expression. The analysis of enhancers that were unique to differentiating cells led to identification of bone developmental program encompassing 147 genes that directly or indirectly participate in osteogenesis. Identification of these pathways provided an unprecedented view of genomic regulation during early steps of differentiation and changes related to WNT, AP-1 and other pathways may have therapeutic implications.	[Thompson, Bethtrice; Varticovski, Lyuba; Baek, Songjoon; Hager, Gordon L.] NCI, Lab Receptor Biol & Gene Express, NIH, Bethesda, MD 20892 USA; [Thompson, Bethtrice] Clark Atlanta Univ, Ctr Canc Res & Therapeut Dev, Atlanta, GA 30314 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Clark Atlanta University	Varticovski, L (corresponding author), NCI, Lab Receptor Biol & Gene Express, NIH, Bethesda, MD 20892 USA.	varticol@mail.nih.gov		Varticovski, Lyuba/0000-0002-5105-9008	Intramural NIH program; NATIONAL CANCER INSTITUTE [ZIABC005450] Funding Source: NIH RePORTER	Intramural NIH program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Government funding was provided: Intramural NIH program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah BM, 2015, BONE, V70, P28, DOI 10.1016/j.bone.2014.07.028; Astuti D, 2012, NAT GENET, V44, P277, DOI 10.1038/ng.1071; Aubin J E, 2001, Rev Endocr Metab Disord, V2, P81, DOI 10.1023/A:1010011209064; Baek S, 2012, METHODS MOL BIOL, V833, P433, DOI 10.1007/978-1-61779-477-3_26; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Benisch P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045142; Biddie SC, 2010, TRENDS ENDOCRIN MET, V21, P3, DOI 10.1016/j.tem.2009.08.006; Chen Y, 2012, STEM CELLS DEV, V21, P143, DOI 10.1089/scd.2010.0585; Cohnheim J, 2015, PATH ANAT PHYSL KLIN, V40, P1; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Gifre L, 2013, BONE, V57, P272, DOI 10.1016/j.bone.2013.08.016; Hakelien AM, 2014, STEM CELLS, V32, P2780, DOI 10.1002/stem.1759; HARRIS SA, 1995, J BONE MINER RES, V10, P178; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Inoue K, 2014, J BONE MINER RES, V29, P1823, DOI 10.1002/jbmr.2229; John S, 2013, CURR PROTOC MOL BIOL, P1; John S, 2008, MOL CELL, V29, P611, DOI 10.1016/j.molcel.2008.02.010; John S, 2011, NAT GENET, V43, P264, DOI 10.1038/ng.759; Kawano Y, 2003, J CELL SCI, V116, P2627, DOI 10.1242/jcs.00623; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Keogh MB, 2011, BIOTECHNOL BIOENG, V108, P1203, DOI 10.1002/bit.23032; Kim DS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083363; Kim EK, 2012, J CELL PHYSIOL, V227, P1680, DOI 10.1002/jcp.22892; Komori T, 2010, CELL TISSUE RES, V339, P189, DOI 10.1007/s00441-009-0832-8; Kuriwaka-Kido R, 2013, ENDOCRINOLOGY, V154, P1156, DOI 10.1210/en.2013-1915; Li J, 2006, BONE, V39, P754, DOI 10.1016/j.bone.2006.03.017; Maes C, 2013, CALCIFIED TISSUE INT, V92, P307, DOI 10.1007/s00223-012-9689-z; Matsumoto T, 2012, ENDOCR J, V59, P91, DOI 10.1507/endocrj.EJ11-0219; Meyer MB, 2014, J BIOL CHEM, V289, P16016, DOI 10.1074/jbc.M114.552216; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Ohnaka K, 2004, BIOCHEM BIOPH RES CO, V318, P259, DOI 10.1016/j.bbrc.2004.04.025; Pregizer S, 2008, J CELL BIOCHEM, V105, P965, DOI 10.1002/jcb.21900; Przekora A, 2015, BIOMED MATER, V10, DOI 10.1088/1748-6041/10/1/015009; Puc J, 2015, CELL, V160, P367, DOI 10.1016/j.cell.2014.12.023; Rawadi G, 2005, EXPERT OPIN THER TAR, V9, P1063, DOI 10.1517/14728222.9.5.1063; Siersbaek R, 2011, COLD SPRING HARB PER, V3, P1; Siersbaek R, 2011, EMBO J, V30, P1459, DOI 10.1038/emboj.2011.65; Tassabehji M, 2008, HUM MUTAT, V29, P1017, DOI 10.1002/humu.20741; van der Deen M, 2012, J BIOL CHEM, V287, P4503, DOI 10.1074/jbc.M111.287771; Wu H, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r52; Yen ML, 2007, STEM CELLS, V25, P125, DOI 10.1634/stemcells.2006-0295; Yu SH, 2013, BIOCHEM BIOPH RES CO, V430, P173, DOI 10.1016/j.bbrc.2012.11.033	43	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2016	11	2							e0148619	10.1371/journal.pone.0148619	http://dx.doi.org/10.1371/journal.pone.0148619			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3CO	26890492	gold, Green Published, Green Submitted			2022-12-26	WOS:000371221500010
J	Guo, YC; Sun, NY; Duan, XB; Xu, X; Zheng, LW; Seriwatanachai, D; Wang, YY; Yuan, Q				Guo, Yuchen; Sun, Ningyuan; Duan, Xiaobo; Xu, Xin; Zheng, Liwei; Seriwatanachai, Dutmanee; Wang, Yongyue; Yuan, Quan			Estrogen Deficiency Leads to Further Bone Loss in the Mandible of CKD Mice	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; STAGE RENAL-DISEASE; OF-THE-LITERATURE; HEMODIALYSIS-PATIENTS; TITANIUM IMPLANTS; JAW ENLARGEMENT; MOUSE MODEL; OSTEOPOROSIS; RATS; HISTOMORPHOMETRY	Background Chronic kidney disease (CKD) has been regarded as a grave public health problem. Estrogen is a critical factor for both renal protection and bone remodeling. Our previous study demonstrated that CKD impairs the healing of titanium implants. The aim of this study was to investigate the effects of estrogen deficiency on the mandibular bone in CKD mice. Methods Forty eleven-week-old female C57BL mice were used in this study. Uremia and estrogen deficiency were induced by 5/6 nephrectomy and ovariectomy (OVX), respectively. After 8 weeks, the mice were sacrificed, and their mandibles were collected for micro-CT analysis and histological examination. Results All the mice survived the experimental period. Serum measurements confirmed a significant increase in BUN in the CKD group that was further increased by OVX. OVX led to significant decreases in both the BV/TV and cortical thickness of the mandibular bone in CKD mice. Conclusion In summary, our findings indicate that estrogen deficiency leads to further mandibular bone loss in CKD mice.	[Guo, Yuchen; Sun, Ningyuan; Duan, Xiaobo; Xu, Xin; Zheng, Liwei; Wang, Yongyue; Yuan, Quan] Sichuan Univ, West China Hosp Stomatol, State Key Lab Oral Dis, Chengdu 610064, Peoples R China; [Seriwatanachai, Dutmanee] Mahidol Univ, Fac Dent, Dept Oral Biol, Bangkok 10700, Thailand	Sichuan University; Mahidol University	Wang, YY; Yuan, Q (corresponding author), Sichuan Univ, West China Hosp Stomatol, State Key Lab Oral Dis, Chengdu 610064, Peoples R China.	westchinawangyy@163.com; yuanquan@scu.edu.cn	yuan, quan/GZM-5597-2022; Seriwatanachai, Dutmanee/K-3423-2019	Seriwatanachai, Dutmanee/0000-0001-8955-1324; Xu, Xin/0000-0003-4608-4556; Yuan, Quan/0000-0002-2836-1081	National Natural Science Foundation of China (NSFC) [81371173, 81321002]; 111 project of Ministry of Education of China; Sichuan Province Youth Fund [2013JQ0017]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); 111 project of Ministry of Education of China(Ministry of Education, China - 111 Project); Sichuan Province Youth Fund	This work was supported by grants from the National Natural Science Foundation of China (NSFC 81371173, 81321002) (http://www.nsfc.gov.cn/), 111 project of Ministry of Education of China, and Sichuan Province Youth Fund (2013JQ0017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen MR, 2013, AM J NEPHROL, V38, P458, DOI 10.1159/000356335; Barreto FC, 2006, KIDNEY INT, V69, P1852, DOI 10.1038/sj.ki.5000311; Bayraktar G, 2007, ORAL DIS, V13, P393, DOI 10.1111/j.1601-0825.2006.01297.x; Carrillo-Lopez N, 2009, J AM SOC NEPHROL, V20, P2009, DOI 10.1681/ASN.2008121258; Cauley JA, 2015, STEROIDS A, V99, P11, DOI [10.1016/j.steroids.2014.12.010, DOI 10.1016/J.STEROIDS.2014.12.010]; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Diaz MN, 2007, BONE, V41, P614, DOI 10.1016/j.bone.2007.06.026; GAGNON RF, 1988, UROL RES, V16, P119, DOI 10.1007/BF00261969; Gal-Moscovici A, 2007, ADV CHRONIC KIDNEY D, V14, P27, DOI 10.1053/j.ackd.2006.10.010; Giro G, 2008, ORAL SURG ORAL MED O, V105, P162, DOI 10.1016/j.tripleo.2007.06.010; Golde WT, 2005, LAB ANIMAL, V34, P39, DOI 10.1038/laban1005-39; Gross ML, 2004, J AM SOC NEPHROL, V15, P348, DOI 10.1097/01.ASN.0000105993.63023.D8; Holley JL, 2001, SEMIN DIALYSIS, V14, P146, DOI 10.1046/j.1525-139X.2001.00040.x; Hutchens MP, 2012, AM J PHYSIOL-RENAL, V303, pF377, DOI 10.1152/ajprenal.00354.2011; Imai Yuuki, 2014, Clin Calcium, V24, P815, DOI CliCa1406815819; Cervero AJ, 2008, MED ORAL PATOL ORAL, V13, pE419; Kalyvas D, 2004, ORAL SURG ORAL MED O, V97, P68, DOI 10.1016/S1079-2104(03)00381-0; Kimura Genjiro, 2007, Clin Exp Nephrol, V11, P188, DOI 10.1007/s10157-007-0474-7; Kummer S, 2012, PEDIATR NEPHROL, V27, P1213, DOI 10.1007/s00467-011-1963-1; Lasota A, 2004, Rocz Akad Med Bialymst, V49 Suppl 1, P129; Lee MM, 2010, J PERIODONTOL, V81, P300, DOI 10.1902/jop.2009.090379; Lerman MA, 2012, OR SURG OR MED OR PA, V113, P384, DOI 10.1016/j.tripleo.2011.04.039; Maeda SS, 2014, ARQ BRAS ENDOCRINOL, V58, P162, DOI 10.1590/0004-2730000003039; Manolagas SC, 2000, ENDOCR REV, V21, P115, DOI 10.1210/er.21.2.115; Manolagas SC, 2010, ENDOCR REV, V31, P266, DOI 10.1210/er.2009-0024; Moe S, 2006, KIDNEY INT, V69, P1945, DOI 10.1038/sj.ki.5000414; Neugarten J, 2002, J AM SOC NEPHROL, V13, P2807, DOI 10.1097/01.ASN.0000035846.89753.D4; Nociti FH, 2002, J DENT RES, V81, P817, DOI 10.1177/154405910208101204; RICHELSON LS, 1984, NEW ENGL J MED, V311, P1273, DOI 10.1056/NEJM198411153112002; Riggs BL, 2002, NOVART FDN SYMP, V242, P247; Schober HC, 1998, J AM SOC NEPHROL, V9, P1225; Tarrass F, 2008, HEMODIAL INT, V12, P316, DOI 10.1111/j.1542-4758.2008.00273.x; Tateishi H, 2013, INT J ORAL MAX IMPL, V28, pE252, DOI 10.11607/jomi.te05; Thorman R, 2009, SCAND J UROL NEPHROL, V43, P154, DOI 10.1080/00365590802464817; Weisinger JR, 2000, KIDNEY INT, V58, P331, DOI 10.1046/j.1523-1755.2000.00170.x; Yang J, 2005, J DENT, V33, P123, DOI 10.1016/j.jdent.2004.09.001; Yang J, 2003, DENTOMAXILLOFAC RAD, V32, P247, DOI 10.1259/dmfr/12560890; Zhang LX, 2012, LANCET, V379, P815, DOI 10.1016/S0140-6736(12)60033-6; Zhang S, 2015, OSTEOPOROSIS INT, V26, P1073, DOI 10.1007/s00198-014-2952-6; Zhao D, 2014, J PERIODONTOL, V85, P1515, DOI 10.1902/jop.2014.140119; Zou HW, 2013, BONE, V56, P410, DOI 10.1016/j.bone.2013.07.014	41	9	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0148804	10.1371/journal.pone.0148804	http://dx.doi.org/10.1371/journal.pone.0148804			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26886008	Green Submitted, Green Published, gold			2022-12-26	WOS:000371218400050
J	Kornfeld, SF; Lynch-Godrei, A; Bonin, SR; Gibeault, S; De Repentigny, Y; Kothary, R				Kornfeld, Samantha F.; Lynch-Godrei, Anisha; Bonin, Sawyer R.; Gibeault, Sabrina; De Repentigny, Yves; Kothary, Rashmi			Cytoskeletal Linker Protein Dystonin Is Not Critical to Terminal Oligodendrocyte Differentiation or CNS Myelination	PLOS ONE			English	Article							SCHWANN-CELLS; PROCESS OUTGROWTH; NERVOUS-SYSTEM; BPAG1 LOCUS; ACTIN; NEURONS; KINASE; MACF; REGENERATION; EXPRESSION	Oligodendrocyte differentiation and central nervous system myelination require massive reorganization of the oligodendrocyte cytoskeleton. Loss of specific actin-and tubulin-organizing factors can lead to impaired morphological and/or molecular differentiation of oligodendrocytes, resulting in a subsequent loss of myelination. Dystonin is a cytoskeletal linker protein with both actin-and tubulin-binding domains. Loss of function of this protein results in a sensory neuropathy called Hereditary Sensory Autonomic Neuropathy VI in humans and dystonia musculorum in mice. This disease presents with severe ataxia, dystonic muscle and is ultimately fatal early in life. While loss of the neuronal isoforms of dystonin primarily leads to sensory neuron degeneration, it has also been shown that peripheral myelination is compromised due to intrinsic Schwann cell differentiation abnormalities. The role of this cytoskeletal linker in oligodendrocytes, however, remains unclear. We sought to determine the effects of the loss of neuronal dystonin on oligodendrocyte differentiation and central myelination. To address this, primary oligodendrocytes were isolated from a severe model of dystonia musculorum, Dst(dt-27J), and assessed for morphological and molecular differentiation capacity. No defects could be discerned in the differentiation of Dst(dt-27J) oligodendrocytes relative to oligodendrocytes from wild-type littermates. Survival was also compared between Dst(dt-27J) and wild-type oligodendrocytes, revealing no significant difference. Using a recently developed migration assay, we further analysed the ability of primary oligodendrocyte progenitor cell motility, and found that Dst(dt-27J) oligodendrocyte progenitor cells were able to migrate normally. Finally, in vivo analysis of oligodendrocyte myelination was done in phenotype-stage optic nerve, cerebral cortex and spinal cord. The density of myelinated axons and g-ratios of Dst(dt-27J) optic nerves was normal, as was myelin basic protein expression in both cerebral cortex and spinal cord. Together these data suggest that, unlike Schwann cells, oligodendrocytes do not have an intrinsic requirement for neuronal dystonin for differentiation and myelination.	[Kornfeld, Samantha F.; Lynch-Godrei, Anisha; Bonin, Sawyer R.; Gibeault, Sabrina; De Repentigny, Yves; Kothary, Rashmi] Ottawa Hosp, Res Inst, Regenerat Med Program, Ottawa, ON K1H 8L6, Canada; [Kornfeld, Samantha F.; Lynch-Godrei, Anisha; Kothary, Rashmi] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON K1H 8M5, Canada; [Kothary, Rashmi] Univ Ottawa, Dept Med, Ottawa, ON K1H 8M5, Canada; [Kothary, Rashmi] Univ Ottawa, Ctr Neuromuscular Dis, Ottawa, ON K1H 8M5, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa; University of Ottawa	Kothary, R (corresponding author), Ottawa Hosp, Res Inst, Regenerat Med Program, Ottawa, ON K1H 8L6, Canada.; Kothary, R (corresponding author), Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON K1H 8M5, Canada.; Kothary, R (corresponding author), Univ Ottawa, Dept Med, Ottawa, ON K1H 8M5, Canada.; Kothary, R (corresponding author), Univ Ottawa, Ctr Neuromuscular Dis, Ottawa, ON K1H 8M5, Canada.	rkothary@ohri.ca		Kothary, Rashmi/0000-0002-9239-7310; Kornfeld, Samantha F./0000-0002-2372-2626; Lynch-Godrei, Anisha/0000-0001-5195-3264	Canadian Institutes of Health Research [MOP-126085]; Frederick Banting and Charles Best Canadian Institutes of Health Research Doctoral Studentship [CGSD-291473, CGSM-136195]; Natural Sciences and Engineering Research Council [USRA-472230]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Frederick Banting and Charles Best Canadian Institutes of Health Research Doctoral Studentship(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	This project was funded by a grant from the Canadian Institutes of Health Research (MOP-126085) to RK. SFK was supported by a Frederick Banting and Charles Best Canadian Institutes of Health Research Doctoral Studentship (CGSD-291473), ALG was supported by a Frederick Banting and Charles Best Canadian Institutes of Health Research Master's Studentship (CGSM-136195), and SRB was a recipient of a Natural Sciences and Engineering Research Council Undergraduate Student Research Award (USRA-472230).	Bacon C, 2007, GLIA, V55, P844, DOI 10.1002/glia.20505; Bauer NG, 2009, GLIA, V57, P1691, DOI 10.1002/glia.20885; Baumann N, 2001, PHYSIOL REV, V81, P871, DOI 10.1152/physrev.2001.81.2.871; Bernier G, 1995, MOL CELL NEUROSCI, V6, P509, DOI 10.1006/mcne.1995.0003; Bernier G, 1998, DEVELOPMENT, V125, P2135; Bernier G, 1996, GENOMICS, V38, P19, DOI 10.1006/geno.1996.0587; Bernier G, 2000, DEV DYNAM, V219, P216, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1041>3.0.CO;2-O; BROWN A, 1995, GENOMICS, V29, P777, DOI 10.1006/geno.1995.9936; BROWN A, 1995, NAT GENET, V10, P301, DOI 10.1038/ng0795-301; BUNGE RP, 1989, J CELL BIOL, V109, P273, DOI 10.1083/jcb.109.1.273; Chen Y, 2007, NAT PROTOC, V2, P1044, DOI 10.1038/nprot.2007.149; Dalpe G, 1998, MOL CELL NEUROSCI, V10, P243, DOI 10.1006/mcne.1997.0660; De Repentigny Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021093; Edvardson S, 2012, ANN NEUROL, V71, P569, DOI 10.1002/ana.23524; Fancy SPJ, 2011, ANNU REV NEUROSCI, V34, P21, DOI 10.1146/annurev-neuro-061010-113629; Ferrier A, 2013, INT REV CEL MOL BIO, V300, P85, DOI 10.1016/B978-0-12-405210-9.00003-5; Forrest AD, 2009, J NEUROSCI RES, V87, P3456, DOI 10.1002/jnr.22022; Franklin RJM, 1999, J NEUROSCI RES, V58, P207, DOI 10.1002/(SICI)1097-4547(19991015)58:2<207::AID-JNR1>3.0.CO;2-1; Karakesisoglou I, 2000, J CELL BIOL, V149, P195, DOI 10.1083/jcb.149.1.195; Kim HJ, 2006, J NEUROSCI, V26, P5849, DOI 10.1523/JNEUROSCI.4921-05.2006; Klein C, 2002, J NEUROSCI, V22, P698, DOI 10.1523/JNEUROSCI.22-03-00698.2002; Lee J, 2005, J CELL BIOL, V170, P661, DOI 10.1083/jcb.200411047; Lee YJ, 2012, NATURE, V487, P443, DOI 10.1038/nature11314; Lehotzky A, 2010, GLIA, V58, P157, DOI 10.1002/glia.20909; Leung CL, 1999, J CELL BIOL, V147, P1275, DOI 10.1083/jcb.147.6.1275; Leung CL, 1999, J CELL BIOL, V144, P435, DOI 10.1083/jcb.144.3.435; Leung CL, 2001, J CELL BIOL, V154, P691, DOI 10.1083/jcb.200012098; Monteiro de Castro G, 2015, AM J PATHOL AM SOC I, V185, P1; Nave KA, 2010, NAT REV NEUROSCI, V11, P275, DOI 10.1038/nrn2797; O'Meara RW, 2016, BMC NEUROSCI, V17, DOI 10.1186/s12868-016-0242-2; O'Meara RW, 2013, J NEUROSCI, V33, P9781, DOI 10.1523/JNEUROSCI.5582-12.2013; O'Meara RW, 2011, JOVE-J VIS EXP, DOI 10.3791/3324; O'Meara Ryan W, 2011, J Signal Transduct, V2011, P354091, DOI 10.1155/2011/354091; Okumura M, 2002, J BIOL CHEM, V277, P6682, DOI 10.1074/jbc.M109209200; Pellegatta M, 2013, J NEUROSCI, V33, P17995, DOI 10.1523/JNEUROSCI.3179-13.2013; Pfeiffer Steve E., 1993, Trends in Cell Biology, V3, P191, DOI 10.1016/0962-8924(93)90213-K; Poliak S, 2003, NAT REV NEUROSCI, V4, P968, DOI 10.1038/nrn1253; Poliakova K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107535; Pool M, 2005, MAMM GENOME, V16, P909, DOI 10.1007/s00335-005-0073-4; Ryan SD, 2012, J CELL BIOL, V196, P727, DOI 10.1083/jcb.201107096; Saulnier R, 2002, J NEUROSCI RES, V69, P233, DOI 10.1002/jnr.10289; SAWAMURA D, 1991, J BIOL CHEM, V266, P17784; Simons M, 2014, J CELL BIOL, V206, P335, DOI 10.1083/jcb.201404154; Triolo D, 2012, DEVELOPMENT, V139, P1359, DOI 10.1242/dev.072371; Tsiper MV, 2002, J CELL SCI, V115, P1005; Zawadzka M, 2010, CELL STEM CELL, V6, P578, DOI 10.1016/j.stem.2010.04.002	46	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0149201	10.1371/journal.pone.0149201	http://dx.doi.org/10.1371/journal.pone.0149201			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26886550	gold, Green Published, Green Submitted			2022-12-26	WOS:000371218400066
J	Teixidor, P; Arraez, MA; Villalba, G; Garcia, R; Tardaguila, M; Gonzalez, JJ; Rimbau, J; Vidal, X; Montane, E				Teixidor, Pilar; Angel Arraez, Miguel; Villalba, Gloria; Garcia, Roser; Tardaguila, Manel; Jose Gonzalez, Juan; Rimbau, Jordi; Vidal, Xavier; Montane, Eva			Safety and Efficacy of 5-Aminolevulinic Acid for High Grade Glioma in Usual Clinical Practice: A Prospective Cohort Study	PLOS ONE			English	Article							ADJUVANT TEMOZOLOMIDE; PHASE-III; RESECTION; GLIOBLASTOMA; SURVIVAL; FLUORESCENCE; EPIDEMIOLOGY; RADIOTHERAPY; CONCOMITANT; EXTENT	Background During the last decade, the use of 5-aminolevulinic acid (5-ALA) has been steadily increasing in neurosurgery. The study's main objectives were to prospectively evaluate the effectiveness and safety of 5-ALA when used in clinical practice setting on high-grade gliomas' patients. Methods National, multicenter and prospective observational study. Inclusion criteria: authorized conditions of use of 5-ALA. Exclusion criteria: contraindication to 5-ALA, inoperable or partial resected tumors, pregnancy and children. Epidemiological, clinical, laboratory, radiological, and safety data were collected. Effectiveness was assessed using complete resection of the tumor, and progression-free and overall survival probabilities. Results Between May 2010 and September 2014, 85 patients treated with 5-ALA were included, and 77 were suitable for the effectiveness analysis. Complete resection was achieved in 41 patients (54%). Surgeons considered suboptimal the fluorescence of 5-ALA in 40% of the patients assessed. The median duration of follow-up was 12.3 months. The progression-free survival probability at 6 months was 58%. The median duration overall survival was 14.2 months. Progression tumor risk factors were grade of glioma, age and resection degree; and death risk factors were grade of glioma and gender. No severe adverse effects were reported. At one month after surgery, new or increased neurological morbidity was 6.5%. Hepatic enzymes were frequently increased within the first month after surgery; however, they subsequently normalized, and this was found to have no clinical significance. Conclusion In clinical practice, the 5-ALA showed a good safety profile, but the benefits related to 5-ALA have not been yet clearly shown. The improved differentiation expected by fluorescence between normal and tumor cerebral tissue was suboptimal in a relevant number of patients; in addition, the expected higher degree of resection was lower than in clinical trials as well as incomplete resection was not identified as a prognostic factor risk for death. Because optimal fluorescence was correlated to higher complete resection rate, further research is needed to identify patients (or tumors) with more surgery benefits when using the 5-ALA.	[Teixidor, Pilar; Garcia, Roser; Tardaguila, Manel; Rimbau, Jordi] Hosp Badalona Germans Trias & Pujol, Dept Neurosurg, Barcelona, Spain; [Angel Arraez, Miguel] Hosp Carlos Haya, Dept Neurosurg, Malaga, Spain; [Villalba, Gloria] Hosp del Mar, Dept Neurosurg, Barcelona, Spain; [Jose Gonzalez, Juan] Hosp Clin I Prov Barcelona, Dept Neurosurg, Barcelona, Spain; [Vidal, Xavier] Hosp Univ Vall dHebron, Fundacio Inst Catala Farmacol, Barcelona, Spain; [Vidal, Xavier; Montane, Eva] Univ Autonoma Barcelona, Dept Pharmacol Therapeut & Toxicol, E-08193 Barcelona, Spain; [Montane, Eva] Hosp Badalona Germans Trias & Pujol, Dept Clin Pharmacol, Barcelona, Spain	Hospital Germans Trias i Pujol; Hospital Carlos Haya; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Hospital Universitari Vall d'Hebron; Autonomous University of Barcelona; Hospital Germans Trias i Pujol	Montane, E (corresponding author), Univ Autonoma Barcelona, Dept Pharmacol Therapeut & Toxicol, E-08193 Barcelona, Spain.; Montane, E (corresponding author), Hosp Badalona Germans Trias & Pujol, Dept Clin Pharmacol, Barcelona, Spain.	emontane.germanstrias@gencat.cat	Vidal, Xavier/I-5958-2019; Eva, Montané/O-5164-2019	Vidal, Xavier/0000-0001-6705-4298; Eva, Montané/0000-0002-1691-7652; Garcia-Armengol, Roser/0000-0002-9315-0985	Spanish Ministry of Health [TRA-085, SAS 2481/2009, EC11-040, SPI 2885/2011]	Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government)	Funding for this work was provided by the Spanish Ministry of Health (through two research projects which codes were: TRA-085 [convocatoria de ayudas para el fomento de la traslacion de la aplicacion de terapeutica de medicamentos de uso humano, huerfanos y terapias avanzadas de la Orden Ministerial SAS 2481/2009] and EC11-040 [convocatoria de ayudas para la investigacion clinica independiente de la Orden Ministerial SPI 2885/2011]). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chaichana KL, 2014, NEURO-ONCOLOGY, V16, P113, DOI 10.1093/neuonc/not137; Chung IWH, 2013, PHOTODIAGN PHOTODYN, V10, P362, DOI 10.1016/j.pdpdt.2013.03.007; Crocetti E, 2012, EUR J CANCER, V48, P1532, DOI 10.1016/j.ejca.2011.12.013; Della Puppa A, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/232561; Valle RD, 2014, NEUROLOGIA, V29, P131, DOI 10.1016/j.nrl.2013.05.004; Valle RD, 2011, J NEURO-ONCOL, V102, P105, DOI 10.1007/s11060-010-0296-4; Eljamel S, 2015, INT J MOL SCI, V16, P10443, DOI 10.3390/ijms160510443; Henegar MM, 1996, J NEUROSURG, V84, P174, DOI 10.3171/jns.1996.84.2.0174; Honorato-Cia C, 2015, J NEUROSURG ANESTH, V27, P304, DOI 10.1097/ANA.0000000000000172; MacLehose R R, 2000, Health Technol Assess, V4, P1; Orringer D, 2012, J NEUROSURG, V117, P851, DOI 10.3171/2012.8.JNS12234; Sanai N, 2011, REV NEUROL-FRANCE, V167, P648, DOI 10.1016/j.neurol.2011.07.004; Schucht P, 2015, SWISS MED WKLY, V145, DOI 10.4414/smw.2015.14082; Song JW, 2010, PLAST RECONSTR SURG, V126, P2234, DOI 10.1097/PRS.0b013e3181f44abc; Stark AM, 2012, CLIN NEUROL NEUROSUR, V114, P840, DOI 10.1016/j.clineuro.2012.01.026; Stummer W, 2006, LANCET ONCOL, V7, P392, DOI 10.1016/S1470-2045(06)70665-9; Stummer W, 1998, J PHOTOCH PHOTOBIO B, V45, P160, DOI 10.1016/S1011-1344(98)00176-6; Stummer W, 2011, J NEUROSURG, V114, P613, DOI 10.3171/2010.3.JNS097; Stummer W, 2009, CURR OPIN NEUROL, V22, P645, DOI 10.1097/WCO.0b013e3283320165; Stupp R, 2014, ANN ONCOL, V25, P93, DOI 10.1093/annonc/mdu050; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Valdes PA, 2011, J NEUROSURG, V115, P11, DOI 10.3171/2011.2.JNS101451; Vandenbroucke JP, 2007, PLOS MED, V4, P1628, DOI 10.1371/journal.pmed.0040297; Zhao SG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063682	25	53	55	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0149244	10.1371/journal.pone.0149244	http://dx.doi.org/10.1371/journal.pone.0149244			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26885645	Green Published, gold, Green Submitted			2022-12-26	WOS:000371218400070
J	Vega, JF; Vicente-Alique, E; Nunez-Ramirez, R; Wang, Y; Martinez-Salazar, J				Vega, Juan F.; Vicente-Alique, Ernesto; Nunez-Ramirez, Rafael; Wang, Yang; Martinez-Salazar, Javier			Evidences of Changes in Surface Electrostatic Charge Distribution during Stabilization of HPV16 Virus-Like Particles	PLOS ONE			English	Article							PAPILLOMAVIRUS TYPE-16 L1; DYNAMIC LIGHT-SCATTERING; BOVINE SERUM-ALBUMIN; ELECTROPHORETIC MOBILITY; MONOCLONAL-ANTIBODIES; IONIC-STRENGTH; PROTEIN; CAPSIDS; BACTERIOPHAGE-MS2; RECONSTRUCTION	The stabilization of human papillomavirus type 16 virus-like particles has been examined by means of different techniques including dynamic and static light scattering, transmission electron microscopy and electrophoretic mobility. All these techniques provide different and often complementary perspectives about the aggregation process and generation of stabilized virus-like particles after a period of time of 48 hours at a temperature of 298 K. Interestingly, static light scattering results point towards a clear colloidal instability in the initial systems, as suggested by a negative value of the second virial coefficient. This is likely related to small repulsive electrostatic interactions among the particles, and in agreement with relatively small absolute values of the electrophoretic mobility and, hence, of the net surface charges. At this initial stage the small repulsive interactions are not able to compensate binding interactions, which tend to aggregate the particles. As time proceeds, an increase of the size of the particles is accompanied by strong increases, in absolute values, of the electrophoretic mobility and net surface charge, suggesting enhanced repulsive electrostatic interactions and, consequently, a stabilized colloidal system. These results show that electrophoretic mobility is a useful methodology that can be applied to screen the stabilization factors for virus-like particles during vaccine development.	[Vega, Juan F.; Vicente-Alique, Ernesto; Nunez-Ramirez, Rafael; Martinez-Salazar, Javier] CSIC, IEM, Biophym, Dept Fis Macromol, Madrid, Spain; [Wang, Yang] Sino Biol Inc, Beijing, Peoples R China	Autonomous University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Estructura de la Materia (IEM)	Vega, JF (corresponding author), CSIC, IEM, Biophym, Dept Fis Macromol, Madrid, Spain.	jf.vega@csic.es	martinez-salazar, javier/H-9763-2015; Vega, Juan F/C-2087-2011	martinez-salazar, javier/0000-0003-0755-0155; Vega, Juan F/0000-0002-0377-4410; Nunez, Rafael/0000-0002-2949-8709	Spanish Ministry of Economy and Competitiveness (MINECO) [MAT2012-36341]; CSIC [PIE201360E097]; Sino Biological, Inc.	Spanish Ministry of Economy and Competitiveness (MINECO); CSIC; Sino Biological, Inc.	This research work was supported by Spanish Ministry of Economy and Competitiveness (MINECO), Project MAT2012-36341, and by the CSIC, Project PIE201360E097. Sino Biological, Inc., provided support in the form of salaries for author YW, but did not have any additional role, such as in the study design or data collection.	BAKER TS, 1991, BIOPHYS J, V60, P1445, DOI 10.1016/S0006-3495(91)82181-6; Belnap DM, 1996, J MOL BIOL, V259, P249, DOI 10.1006/jmbi.1996.0317; Berne B. J., 2000, DYNAMIC LIGHT SCATTE; Bozic AL, 2013, J CHEM PHYS, V138, DOI 10.1063/1.4790576; Buck CB, 2005, J VIROL, V79, P2839, DOI 10.1128/JVI.79.5.2839-2846.2005; Buck CB, 2008, J VIROL, V82, P5190, DOI 10.1128/JVI.02726-07; CANN PL, 1994, FEMS MICROBIOL LETT, V117, P269, DOI DOI 10.1111/J.1574-6968.1994.TB06778.X; Cardone G, 2014, MBIO, V5, DOI 10.1128/mBio.01104-14; Carpentier GS, 2005, J MED VIROL, V77, P558, DOI 10.1002/jmv.20492; Casini GL, 2004, VIROLOGY, V325, P320, DOI 10.1016/j.virol.2004.04.034; Chen XJS, 2000, MOL CELL, V5, P557, DOI 10.1016/S1097-2765(00)80449-9; Christensen ND, 1996, VIROLOGY, V223, P174, DOI 10.1006/viro.1996.0466; Cook JC, 1999, PROTEIN EXPRES PURIF, V17, P477, DOI 10.1006/prep.1999.1155; Dika C, 2011, APPL ENVIRON MICROB, V77, P4939, DOI 10.1128/AEM.00407-11; Duval JFL, 2006, LANGMUIR, V22, P3533, DOI 10.1021/la0528293; Finnen RL, 2003, J VIROL, V77, P4818, DOI 10.1128/JVI.77.8.4818-4826.2003; Frisken BJ, 2001, APPL OPTICS, V40, P4087, DOI 10.1364/AO.40.004087; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hanslip SJ, 2008, BIOCHEM BIOPH RES CO, V375, P351, DOI 10.1016/j.bbrc.2008.08.019; Hassan PA, 2006, J COLLOID INTERF SCI, V300, P744, DOI 10.1016/j.jcis.2006.04.013; Itakura M, 2006, J APPL POLYM SCI, V99, P1953, DOI 10.1002/app.22695; JOHNSON MW, 1973, J GEN VIROL, V19, P263, DOI 10.1099/0022-1317-19-2-263; KIRNBAUER R, 1993, J VIROL, V67, P6929, DOI 10.1128/JVI.67.12.6929-6936.1993; KIRNBAUER R, 1992, P NATL ACAD SCI USA, V89, P12180, DOI 10.1073/pnas.89.24.12180; Kulski JK, 1998, VIROLOGY, V243, P275, DOI 10.1006/viro.1997.9011; Kuznetsov YG, 2011, MICROBIOL MOL BIOL R, V75, P268, DOI 10.1128/MMBR.00041-10; Langlet J, 2008, BIOPHYS J, V94, P3293, DOI 10.1529/biophysj.107.115477; Leckband D, 2000, ANNU REV BIOPH BIOM, V29, P1, DOI 10.1146/annurev.biophys.29.1.1; Lua LHL, 2014, BIOTECHNOL BIOENG, V111, P425, DOI 10.1002/bit.25159; Ma YF, 2015, J BIOL PHYS, V41, P85, DOI 10.1007/s10867-014-9367-7; Mach H, 2006, J PHARM SCI-US, V95, P2195, DOI 10.1002/jps.20696; MCMILLAN WG, 1945, J CHEM PHYS, V13, P276, DOI 10.1063/1.1724036; Mertens BS, 2015, SOFT MATTER, V11, P8621, DOI 10.1039/c5sm01778e; Michen B, 2010, J APPL MICROBIOL, V109, P388, DOI 10.1111/j.1365-2672.2010.04663.x; Modis Y, 2002, EMBO J, V21, P4754, DOI 10.1093/emboj/cdf494; Neal BL, 1998, BIOPHYS J, V75, P2469, DOI 10.1016/S0006-3495(98)77691-X; Nguyen TH, 2011, SOFT MATTER, V7, P10449, DOI 10.1039/c1sm06092a; PENROD SL, 1995, J COLLOID INTERF SCI, V173, P521, DOI 10.1006/jcis.1995.1354; PROVENCHER SW, 1982, COMPUT PHYS COMMUN, V27, P213, DOI 10.1016/0010-4655(82)90173-4; Siber A, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.061906; STIGTER D, 1959, J PHYS CHEM-US, V63, P551, DOI 10.1021/j150574a025; TAYLOR DH, 1981, J COLLOID INTERF SCI, V83, P153, DOI 10.1016/0021-9797(81)90020-5; THOMAS JC, 1987, J COLLOID INTERF SCI, V117, P187, DOI 10.1016/0021-9797(87)90182-2; Trus BL, 1997, NAT STRUCT BIOL, V4, P413, DOI 10.1038/nsb0597-413; van der Schoot P, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.061928; VANREGEN.MH, 1967, VIROLOGY, V31, P391, DOI 10.1016/0042-6822(67)90217-6; Vega-Acosta JR, 2014, J PHYS CHEM B, V118, P1984, DOI 10.1021/jp407379t; von Smoluchowski, 1903, B INT ACAD SCI CRACO, V8, P182; White WI, 1999, J VIROL, V73, P4882, DOI 10.1128/JVI.73.6.4882-4889.1999; Wolf M, 2010, P NATL ACAD SCI USA, V107, P6298, DOI 10.1073/pnas.0914604107; Wu JZ, 1999, FLUID PHASE EQUILIBR, V155, P139, DOI 10.1016/S0378-3812(98)00435-X; Zandi R, 2006, BIOPHYS J, V90, P1939, DOI 10.1529/biophysj.105.072975; Zhao QJ, 2012, NANOMED-NANOTECHNOL, V8, P1182, DOI 10.1016/j.nano.2012.01.007; Zhao QJ, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-52; ZIMM BH, 1948, J CHEM PHYS, V16, P1093, DOI 10.1063/1.1746738	55	5	5	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0149009	10.1371/journal.pone.0149009	http://dx.doi.org/10.1371/journal.pone.0149009			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26885635	gold, Green Published			2022-12-26	WOS:000371218400059
J	De Luca, D; Catanese, G; Procaccini, G; Fiorito, G				De Luca, Daniele; Catanese, Gaetano; Procaccini, Gabriele; Fiorito, Graziano			Octopus vulgaris (Cuvier, 1797) in the Mediterranean Sea: Genetic Diversity and Population Structure	PLOS ONE			English	Article							DNA MARKERS; PHYLOGENETIC-RELATIONSHIPS; MOLLUSCA CEPHALOPODA; IBERIAN PENINSULA; RE-IMPLEMENTATION; COMPUTER-PROGRAM; N-E; SQUID; DIFFERENTIATION; OCTOPODIDAE	The common octopus, Octopus vulgaris Cuvier 1797, is a largely exploited cephalopod species in the Mediterranean Sea and the Atlantic Ocean, as well as along the coasts of Africa, Brazil and Japan, where its taxonomic identity is still debated. The assessment of its genetic structure is a pressing need to correctly manage the resource and to avoid over-fishing and collapsing of local stocks. Here we analysed genetic variation and population structure of O. vulgaris using thirteen microsatellite loci in seven sampling localities from the Mediterranean Sea and one from the Atlantic Ocean. We also used a DNA barcoding approach by COI gene fragment to understand the phylogenetic relationships among the specimens here investigated and the ones whose sequences are available in literature. Our results reveal high levels of allelic richness and moderate heterozygosity in all samples investigated, and a pronounced differentiation of the Atlantic and Sicilian specimens. This latter aspect seems to support the isolation of the biota within the Strait of Messina. A certain degree of differentiation was detected among the other geographic samples within the Mediterranean Sea, which is more compatible with an island model than isolation by distance. The occurrence of null alleles affected more genetic diversity indices than population structure estimations. This study provides new insights about the genetic diversity and structure of O. vulgaris in the area of interest, which can be used as guidelines for a fisheries management perspective.	[De Luca, Daniele; Catanese, Gaetano; Procaccini, Gabriele; Fiorito, Graziano] Stn Zool Anton Dohrn, I-80121 Naples, Italy	Stazione Zoologica Anton Dohrn di Napoli	De Luca, D (corresponding author), Stn Zool Anton Dohrn, I-80121 Naples, Italy.	daniele.deluca088@gmail.com	Procaccini, Gabriele/A-6618-2010; De Luca, Daniele/AAG-8715-2020; Procaccini, Gabriele/AAA-7040-2019; CATANESE, GAETANO/A-7510-2009	Procaccini, Gabriele/0000-0002-6179-468X; De Luca, Daniele/0000-0002-1639-9138; Procaccini, Gabriele/0000-0002-6179-468X; CATANESE, GAETANO/0000-0001-6219-4494	Ritmare Italian Flagship Project [SP2_WP4AZ2UO03]; Stazione Zoologica Anton Dohrn di Napoli	Ritmare Italian Flagship Project; Stazione Zoologica Anton Dohrn di Napoli	Funding provided by SP2_WP4AZ2UO03, www.ritmare.it, Ritmare Italian Flagship Project, GP GF and www.szn.it, Stazione Zoologica Anton Dohrn di Napoli, GP GF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addison JA, 2005, BIOL LETTERS, V1, P450, DOI 10.1098/rsbl.2005.0353; Addison JA, 2008, MOL ECOL, V17, P4222, DOI 10.1111/j.1365-294X.2008.03905.x; Alberto F., 2006, STANDARICH V1 00 R P; Allendorf F, 2013, CONSERV GENET, V2nd; Antao T, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-323; Arnaud-Haond S, 2007, MOL ECOL NOTES, V7, P15, DOI 10.1111/j.1471-8286.2006.01522.x; Bahri-Sfar L, 2000, P ROY SOC B-BIOL SCI, V267, P929, DOI 10.1098/rspb.2000.1092; Belkhir K, 1996, GENETIX 4 05 LOGICIE; BIGNAMI F, 1990, NATO ADV SCI I C-MAT, V318, P95; Boyle PR, 1996, PHILOS T R SOC B, V351, P985, DOI 10.1098/rstb.1996.0089; Buresch KC, 2006, MAR ECOL PROG SER, V310, P263, DOI 10.3354/meps310263; Cabranes C, 2008, ICES J MAR SCI, V65, P12, DOI 10.1093/icesjms/fsm178; Caddy JF, 1983, ADV ASSESSMENT WORLD, V231, P416; Casu M, 2002, ITAL J ZOOL, V69, P295, DOI 10.1080/11250000209356472; Dai LN, 2012, MOL ECOL RESOUR, V12, P437, DOI 10.1111/j.1755-0998.2012.03118.x; De Luca D, 2015, CONSERV GENET RESOUR, V7, P299, DOI 10.1007/s12686-014-0365-7; De Luca D, 2014, FRONT ECOL EVOL, V2, DOI 10.3389/fevo.2014.00055; Sales JBD, 2013, J SHELLFISH RES, V32, P325, DOI 10.2983/035.032.0211; Do C, 2014, MOL ECOL RESOUR, V14, P209, DOI 10.1111/1755-0998.12157; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fadhlaoui-Zid K, 2012, CR BIOL, V335, P625, DOI 10.1016/j.crvi.2012.10.004; Faure V, 2000, FISH OCEANOGR, V9, P343, DOI 10.1046/j.1365-2419.2000.00149.x; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Forsythe J.W., 1987, P135; Forsythe John W., 1993, P133; Forsythe JW, 2004, MAR FRESHWATER RES, V55, P331, DOI 10.1071/MF03146; Garoia F, 2004, HEREDITY, V93, P166, DOI 10.1038/sj.hdy.6800489; Gerlach G, 2010, MOL ECOL, V19, P3845, DOI 10.1111/j.1365-294X.2010.04784.x; Giantsis IA, 2014, J MAR BIOL ASSOC UK, V94, P797, DOI 10.1017/S0025315414000174; Greatorex EC, 2000, MOL ECOL, V9, P641, DOI 10.1046/j.1365-294x.2000.00882-7.x; Guerra A, 2010, ICES J MAR SCI, V67, P1401, DOI 10.1093/icesjms/fsq040; Hale ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045170; Hauser L, 2002, P NATL ACAD SCI USA, V99, P11742, DOI 10.1073/pnas.172242899; Haye PA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088613; Hellberg ME, 2009, ANNU REV ECOL EVOL S, V40, P291, DOI 10.1146/annurev.ecolsys.110308.120223; Herke SW, 2002, MAR BIOL, V140, P103, DOI 10.1007/s002270100680; Hernandez-Lopez JL, 2001, FISH B-NOAA, V99, P679; Higgins KL, 2013, MAR ECOL PROG SER, V486, P203, DOI 10.3354/meps10330; Hoffman JI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063954; Hoffman JI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032415; Ibanez CM, 2012, J MAR BIOL ASSOC UK, V92, P197, DOI 10.1017/S0025315411000440; Ibanez CM, 2011, MAR ECOL PROG SER, V431, P163, DOI 10.3354/meps09133; Jereb P, 2013, CEPHALOPODS WORLD AN, V3; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Kalinowski ST, 2006, MOL ECOL NOTES, V6, P576, DOI 10.1111/j.1471-8286.2006.01256.x; Kaneko N, 2011, MALACOLOGIA, V54, P97, DOI 10.4002/040.054.0102; Kenchington EL, 2006, MOL ECOL, V15, P1781, DOI 10.1111/j.1365-294X.2006.02915.x; Keskin E, 2013, MITOCHONDR DNA, V24, P440, DOI 10.3109/19401736.2012.762576; Keskin E, 2011, BIOCHEM SYST ECOL, V39, P277, DOI 10.1016/j.bse.2011.08.015; Li JJ, 2014, BIOCHEM SYST ECOL, V56, P8, DOI 10.1016/j.bse.2014.04.011; Lo Bianco Salvatore, 1909, Mitteilungen aus der Zoologischen Station zu Neapel Berlin, V19; Lu ZM, 2013, GENET MOL RES, V12, P3755, DOI 10.4238/2013.September.19.7; Maltagliati F, 2002, B MAR SCI, V71, P473; Mangold K., 1983, P335; MATHER JA, 1994, J ZOOL, V233, P359, DOI 10.1111/j.1469-7998.1994.tb05270.x; Meriam T, 2015, MOL BIOL REP, V42, P77, DOI 10.1007/s11033-014-3743-z; Moreira AA, 2011, J EXP MAR BIOL ECOL, V407, P34, DOI 10.1016/j.jembe.2011.06.029; Moreno A, 2009, J PLANKTON RES, V31, P73, DOI 10.1093/plankt/fbn103; Murphy JM, 2002, B MAR SCI, V71, P545; Nomura T, 2008, EVOL APPL, V1, P462, DOI 10.1111/j.1752-4571.2008.00015.x; Paetkau D, 2004, MOL ECOL, V13, P55, DOI 10.1046/j.1365-294X.2004.02008.x; PAETKAU D, 1995, MOL ECOL, V4, P347, DOI 10.1111/j.1365-294X.1995.tb00227.x; Patarnello T, 2007, MOL ECOL, V16, P4426, DOI 10.1111/j.1365-294X.2007.03477.x; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Perez-Losada M, 2002, HEREDITY, V89, P417, DOI 10.1038/sj.hdy.6800160; Perez-Ruzafa A, 2006, BIOL CONSERV, V129, P244, DOI 10.1016/j.biocon.2005.10.040; Pierce GJ, 2008, HYDROBIOLOGIA, V612, P49, DOI 10.1007/s10750-008-9489-7; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; R Core Team, 2021, R LANGUAGE ENV STAT; Ranzi S., 1930, ATT 9 C GEOGR IT, V2, P1; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Reichow D, 2001, MOL ECOL, V10, P1101, DOI 10.1046/j.1365-294X.2001.01257.x; Robinson A.R., 2001, OCEAN CURRENTS MEDIT, DOI [10.1006/rwos.2001.0376, DOI 10.1006/RWOS.2001.0376]; Rose CG, 2006, J HERED, V97, P158, DOI 10.1093/jhered/esj019; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Serra IA, 2010, MOL ECOL, V19, P557, DOI 10.1111/j.1365-294X.2009.04462.x; Shaw PW, 2004, MAR BIOL, V144, P961, DOI 10.1007/s00227-003-1260-z; Shaw PW, 2000, MOL ECOL, V9, P237, DOI 10.1046/j.1365-294x.2000.00804.x; SMALE MJ, 1981, MAR BIOL, V65, P1, DOI 10.1007/BF00397061; Strugnell JM, 2014, HYDROBIOLOGIA, V725, P215, DOI 10.1007/s10750-013-1517-6; Takumiya M, 2005, ZOOL SCI, V22, P147, DOI 10.2108/zsj.22.147; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Teske PR, 2007, MAR BIOL, V151, P2119, DOI 10.1007/s00227-007-0644-x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Villamor A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101135; Villanueva R, 1997, J EXP MAR BIOL ECOL, V208, P169, DOI 10.1016/S0022-0981(96)02670-6; Villanueva R, 2014, CEPHALOPOD CULTURE, P479, DOI DOI 10.1007/978-94-017-8648-5_26; Wang CL, 2012, GENETICS, V192, P651, DOI 10.1534/genetics.112.139519; Waples RS, 2010, EVOL APPL, V3, P244, DOI 10.1111/j.1752-4571.2009.00104.x; Waples RS, 1998, J HERED, V89, P438, DOI 10.1093/jhered/89.5.438; Weersing K, 2009, MAR ECOL PROG SER, V393, P1, DOI 10.3354/meps08287; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Whitlock MC, 2011, MOL ECOL, V20, P1083, DOI 10.1111/j.1365-294X.2010.04996.x; Williams RC, 2015, MOL ECOL, V24, P3316, DOI 10.1111/mec.13255; Xavier JC, 2015, J MAR BIOL ASSOC UK, V95, P999, DOI 10.1017/S0025315414000782	98	21	21	2	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0149496	10.1371/journal.pone.0149496	http://dx.doi.org/10.1371/journal.pone.0149496			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	26881847	Green Submitted, gold, Green Published			2022-12-26	WOS:000371219000078
J	Oba, J; Nakahara, T; Hashimoto-Hachiya, A; Liu, M; Abe, T; Hagihara, A; Yokomizo, T; Furue, M				Oba, Junna; Nakahara, Takeshi; Hashimoto-Hachiya, Akiko; Liu, Min; Abe, Takeru; Hagihara, Akihito; Yokomizo, Takehiko; Furue, Masutaka			CD10-Equipped Melanoma Cells Acquire Highly Potent Tumorigenic Activity: A Plausible Explanation of Their Significance for a Poor Prognosis	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; CARCINOMA IN-VITRO; NEUTRAL ENDOPEPTIDASE; MALIGNANT-MELANOMA; TUMOR PROGRESSION; BREAST-CANCER; STROMAL CELLS; CUTANEOUS MELANOMA; CD10 EXPRESSION; GENE-EXPRESSION	CD10 has been widely used in cancer diagnosis. We previously demonstrated that its expression in melanoma increased with tumor progression and predicted poor patient survival. However, the mechanism by which CD10 promotes melanoma progression remains unclear. In order to elucidate the role of CD10 in melanoma, we established CD10-overexpressing A375 melanoma cells and performed DNA microarray and qRT-PCR analyses to identify changes in the gene expression profile. The microarray analysis revealed that upregulated genes in CD10-A375 were mostly involved in cell proliferation, angiogenesis, and resistance to apoptosis; down-regulated genes mostly belonged to the categories associated with cell adhesion and migration. Accordingly, in functional experiments, CD10-A375 showed significantly greater cell proliferation in vitro and higher tumorigenicity in vivo; CD10 enzymatic inhibitors, thiorphan and phosphoramidon, significantly blocked the tumor growth of CD10-A375 in mice. In migration and invasion assays, CD10-A375 displayed lower migratory and invasive capacity than mock-A375. CD10 augmented melanoma cell resistance to apoptosis mediated by etoposide and gemcitabine. These findings indicate that CD10 may promote tumor progression by regulating the expression profiles of genes related to cell proliferation, angiogenesis, and resistance to apoptosis.	[Oba, Junna; Nakahara, Takeshi; Hashimoto-Hachiya, Akiko; Furue, Masutaka] Kyushu Univ, Dept Dermatol, Grad Sch Med Sci, Fukuoka 812, Japan; [Liu, Min; Yokomizo, Takehiko] Juntendo Univ, Sch Med, Dept Biochem, Tokyo 113, Japan; [Abe, Takeru; Hagihara, Akihito] Kyushu Univ, Dept Hlth Serv Management & Policy, Grad Sch Med Sci, Fukuoka 812, Japan; [Nakahara, Takeshi] Kyushu Univ, Grad Sch Med Sci, Dept Dermatol, Div Skin Surface Sensing, Fukuoka 812, Japan; [Liu, Min] Shanghai Jiao Tong Univ, Sch Med, Dept Endocrinol, Shanghai Peoples Hosp 9, Shanghai 200030, Peoples R China; [Abe, Takeru] Yokohama City Univ, Med Ctr, Adv Crit Care & Emergency Ctr, Yokohama, Kanagawa 232, Japan	Kyushu University; Juntendo University; Kyushu University; Kyushu University; Shanghai Jiao Tong University; Yokohama City University	Nakahara, T (corresponding author), Kyushu Univ, Dept Dermatol, Grad Sch Med Sci, Fukuoka 812, Japan.	nakahara@dermatol.med.kyushu-u.ac.jp	Abe, Takeru/J-9512-2014; Oba, Junna/AAV-7048-2020; Yokomizo, Takehiko/P-5673-2016	Abe, Takeru/0000-0003-3496-1953; Yokomizo, Takehiko/0000-0002-5219-1553; Oba, Junna/0000-0002-2899-3919	Ministry of Education, Culture, Sports, Science and Technology; Ministry of Health, Labor and Welfare; World Fusion Co., Ltd.; Government to the National Cancer Center, Japan [21S-7[6]]; Grants-in-Aid for Scientific Research [15H05897] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan); World Fusion Co., Ltd.; Government to the National Cancer Center, Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was partly supported by grants from the Ministry of Education, Culture, Sports, Science and Technology, the Ministry of Health, Labor and Welfare, and the Government to the National Cancer Center (21S-7[6]), Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We appreciate the technical support from the Research Support Center, Kyushu University. The microarray analysis was supported by World Fusion Co., Ltd.	Abdou AG, 2007, APMIS, V115, P1206, DOI 10.1111/j.1600-0643.2007.00645.x; Balch CM, 2009, J CLIN ONCOL, V27, P6199, DOI 10.1200/JCO.2009.23.4799; Bilalovic N, 2004, MODERN PATHOL, V17, P1251, DOI 10.1038/modpathol.3800174; Celia-Terrassa T, 2012, J CLIN INVEST, V122, P1849, DOI 10.1172/JCI59218; Chu PG, 2000, AM J CLIN PATHOL, V113, P374, DOI 10.1309/8VAV-J2FU-8CU9-EK18; Dai HY, 2005, CANCER RES, V65, P4059, DOI 10.1158/0008-5472.CAN-04-3953; Dall'Era Marc A, 2007, BMC Urol, V7, P3, DOI 10.1186/1471-2490-7-3; David C, 1999, J MED CHEM, V42, P5197, DOI 10.1021/jm9903040; Desmedt C, 2012, CLIN CANCER RES, V18, P1004, DOI 10.1158/1078-0432.CCR-11-0383; Fleischmann A, 2011, VIRCHOWS ARCH, V458, P741, DOI 10.1007/s00428-011-1084-z; Fleischmann A, 2008, CLIN CANCER RES, V14, P7838, DOI 10.1158/1078-0432.CCR-08-1432; Ganju RK, 1996, BLOOD, V88, P4159; Garber ME, 2001, P NATL ACAD SCI USA, V98, P13784, DOI 10.1073/pnas.241500798; Giese A, 1996, INT J CANCER, V67, P275, DOI 10.1002/(SICI)1097-0215(19960717)67:2<275::AID-IJC20>3.0.CO;2-9; Giese A, 2003, J CLIN ONCOL, V21, P1624, DOI 10.1200/JCO.2003.05.063; Godard S, 2003, CANCER RES, V63, P6613; Godlewski J, 2010, MOL CELL, V37, P620, DOI 10.1016/j.molcel.2010.02.018; Hoek KS, 2008, CANCER RES, V68, P650, DOI 10.1158/0008-5472.CAN-07-2491; Huang WB, 2005, JPN J CLIN ONCOL, V35, P245, DOI 10.1093/jjco/hyi076; Ikenaga N, 2010, GASTROENTEROLOGY, V139, P1041, DOI 10.1053/j.gastro.2010.05.084; Jerby L, 2012, CANCER RES, V72, P5712, DOI 10.1158/0008-5472.CAN-12-2215; Kajiyama H, 2005, CLIN CANCER RES, V11, P1798, DOI 10.1158/1078-0432.CCR-04-2395; Kuniyasu H, 2010, GUT, V59, P348, DOI 10.1136/gut.2009.178376; Lee KW, 2015, INT J CANCER, V136, P310, DOI 10.1002/ijc.29006; Lee KW, 2012, ANN SURG ONCOL, V19, P326, DOI 10.1245/s10434-011-1867-0; Maguer-Satta V, 2011, STEM CELLS, V29, P389, DOI 10.1002/stem.592; Mandala M, 2014, VIRCHOWS ARCH, V464, P265, DOI 10.1007/s00428-013-1526-x; Markert EK, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.140; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Oba J, 2011, BRIT J DERMATOL, V165, P506, DOI 10.1111/j.1365-2133.2011.10409.x; Oba J, 2014, J AM ACAD DERMATOL, V70, P954, DOI 10.1016/j.jaad.2014.01.880; Oba J, 2011, J AM ACAD DERMATOL, V65, P1152, DOI 10.1016/j.jaad.2010.10.019; Oefner C, 2000, J MOL BIOL, V296, P341, DOI 10.1006/jmbi.1999.3492; Omran OM, 2012, J ENVIRON PATHOL TOX, V31, P203, DOI 10.1615/JEnvironPatholToxicolOncol.v31.i3.20; Rothberg BEG, 2009, JNCI-J NATL CANCER I, V101, P452, DOI 10.1093/jnci/djp038; SHIPP MA, 1993, BLOOD, V82, P1052, DOI 10.1182/blood.V82.4.1052.bloodjournal8241052; Sumitomo M, 2005, BBA-PROTEINS PROTEOM, V1751, P52, DOI 10.1016/j.bbapap.2004.11.001; Terauchi M, 2005, ONCOLOGY-BASEL, V69, P52, DOI 10.1159/000087476; Tsuji T, 2008, CANCER RES, V68, P10377, DOI 10.1158/0008-5472.CAN-08-1444; Velazquez EF, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-2; Voutsadakis IA, 2012, UROL INT, V88, P158, DOI 10.1159/000335299; Waldman YY, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003806; Xie LN, 2010, CANCER SCI, V101, P2570, DOI 10.1111/j.1349-7006.2010.01735.x	43	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0149285	10.1371/journal.pone.0149285	http://dx.doi.org/10.1371/journal.pone.0149285			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	26881775	Green Submitted, gold, Green Published			2022-12-26	WOS:000371219000067
J	Baur, B; Bozdag, S				Baur, Brittany; Bozdag, Serdar			A Feature Selection Algorithm to Compute Gene Centric Methylation from Probe Level Methylation Data	PLOS ONE			English	Article							DNA METHYLATION; EXPRESSION; EPIGENOMICS; TOOL	DNA methylation is an important epigenetic event that effects gene expression during development and various diseases such as cancer. Understanding the mechanism of action of DNA methylation is important for downstream analysis. In the Illumina Infinium HumanMethylation 450K array, there are tens of probes associated with each gene. Given methylation intensities of all these probes, it is necessary to compute which of these probes are most representative of the gene centric methylation level. In this study, we developed a feature selection algorithm based on sequential forward selection that utilized different classification methods to compute gene centric DNA methylation using probe level DNA methylation data. We compared our algorithm to other feature selection algorithms such as support vector machines with recursive feature elimination, genetic algorithms and ReliefF. We evaluated all methods based on the predictive power of selected probes on their mRNA expression levels and found that a K-Nearest Neighbors classification using the sequential forward selection algorithm performed better than other algorithms based on all metrics. We also observed that transcriptional activities of certain genes were more sensitive to DNA methylation changes than transcriptional activities of other genes. Our algorithm was able to predict the expression of those genes with high accuracy using only DNA methylation data. Our results also showed that those DNA methylation-sensitive genes were enriched in Gene Ontology terms related to the regulation of various biological processes.	[Baur, Brittany; Bozdag, Serdar] Marquette Univ, Dept Math Stat & Comp Sci, Milwaukee, WI 53233 USA	Marquette University	Bozdag, S (corresponding author), Marquette Univ, Dept Math Stat & Comp Sci, Milwaukee, WI 53233 USA.	Serdar.bozdag@marquette.edu			Marquette University	Marquette University	This work is supported by the startup funding to SB from Marquette University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], MATLAB STAT TOOLB RE; Baur B, 2015, J COMPUT BIOL, V22, P289, DOI 10.1089/cmb.2014.0296; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Brenet F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014524; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; de la Rica L, 2013, J AUTOIMMUN, V41, P6, DOI 10.1016/j.jaut.2012.12.005; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Farre P, 2015, EPIGENET CHROMATIN, V8, DOI 10.1186/s13072-015-0011-y; Friedman J. H., 1977, ACM Transactions on Mathematical Software, V3, P209, DOI 10.1145/355744.355745; Huang DW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r183; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; John GH, 1995, P 11 C UNC ART INT S; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Li HL, 2014, ONCOTARGET, V5, P587, DOI 10.18632/oncotarget.1782; Li J, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/1471-2105-16-S5-S10; Maeda O, 2014, ONCOL REP, V31, P1883, DOI 10.3892/or.2014.3014; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Oluleye B., 2014, INT J ELECT COMMUN C, V5, P899; Quinlan JR, 1999, INT J HUM-COMPUT ST, V51, P497, DOI 10.1006/ijhc.1987.0321; Rhee JK, 2013, NUCLEIC ACIDS RES, V41, P8464, DOI 10.1093/nar/gkt643; Schuebel KE, 2007, PLOS GENET, V3, P1709, DOI 10.1371/journal.pgen.0030157; Selamat SA, 2012, GENOME RES, V22, P1197, DOI 10.1101/gr.132662.111; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Varley KE, 2013, GENOME RES, V23, P555, DOI 10.1101/gr.147942.112; Weisenberger DJ, ILLUMINA EPIGENETIC; Yan K, 2015, SENSOR ACTUAT B-CHEM, V212, P353, DOI 10.1016/j.snb.2015.02.025	29	16	16	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0148977	10.1371/journal.pone.0148977	http://dx.doi.org/10.1371/journal.pone.0148977			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26872146	Green Published, Green Submitted, gold			2022-12-26	WOS:000370054100083
J	Bruinsma, SM; van der Heide, A; van der Lee, ML; Vergouwe, Y; Rietjens, JAC				Bruinsma, S. M.; van der Heide, A.; van der Lee, M. L.; Vergouwe, Y.; Rietjens, J. A. C.			No Negative Impact of Palliative Sedation on Relatives' Experience of the Dying Phase and Their Wellbeing after the Patient's Death: An Observational Study	PLOS ONE			English	Article							CONTINUOUS DEEP SEDATION; OF-LIFE CARE; RANDOMIZED CONTROLLED-TRIAL; FAMILY-MEMBERS; BEREAVED RELATIVES; CANCER-PATIENTS; EUROPEAN COUNTRIES; MEDICAL-CARE; UNTIL DEATH; EUTHANASIA	Background Palliative sedation is the widely-used intervention of administering sedating agents to induce a state of unconsciousness to take away a dying patient's perception of otherwise irrelievable symptoms. However, it remains questionable whether this ethically complex intervention is beneficial for patients and whether the associated lack of communication in the last phase of life has a negative impact on relatives' wellbeing. Methods An observational questionnaire study was conducted among relatives of a consecutive sample of patients who died a non-sudden death in the Erasmus MC Cancer Institute or in the hospice 'Laurens Cadenza' (both in Rotterdam) between 2010 and 2013. Results Relatives filled in questionnaires regarding 151 patients who had been sedated and 90 patients who had not been sedated. The median time since all patients had passed away was 21 (IQR 14-32) months. No significant differences were found in relatives 'assessments of the quality of end-of-life care, patients 'quality of life in the last week before death and their quality of dying, between patients who did and did not receive sedation, or in relatives' satisfaction with their own life, their general health and their mental wellbeing after the patient's death. Conclusions The use of sedation in these patients appears to have no negative effect on bereaved relatives' evaluation of the patient's dying phase, or on their own wellbeing after the patient's death.	[Bruinsma, S. M.; van der Heide, A.; Vergouwe, Y.; Rietjens, J. A. C.] Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands; [van der Lee, M. L.] Helen Dowling Inst, Bilthoven, Netherlands	Erasmus University Rotterdam; Erasmus MC	Bruinsma, SM (corresponding author), Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands.	s.m.bruinsma@erasmusmc.nl		van der Lee, Marije/0000-0002-1316-7008	Economic and Social Research Council (UK); Research Foundation Flanders (BE); Flemish Cancer Association (BE); Research Council of Ghent University (BE); Netherlands Organisation for Scientific Research (NL); Netherlands Organisation for Health Research and Development (NL) [11510006]; Innovational Research Incentives Scheme Veni of the Netherlands Organisation for Scientific Research (NWO); UNESCO; L'Oreal	Economic and Social Research Council (UK)(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Research Foundation Flanders (BE)(FWO); Flemish Cancer Association (BE); Research Council of Ghent University (BE); Netherlands Organisation for Scientific Research (NL)(Netherlands Organization for Scientific Research (NWO)); Netherlands Organisation for Health Research and Development (NL)(Netherlands Organization for Health Research and Development); Innovational Research Incentives Scheme Veni of the Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); UNESCO; L'Oreal(L'Oreal Group)	The research on which this paper is based is linked to a larger project, the 'UNBIASED' study (UK - Netherlands - Belgium InternAtional SEDation study) is a collaboration between research teams in the UK, Belgium and the Netherlands with funding from the Economic and Social Research Council (UK), the Research Foundation Flanders (BE), the Flemish Cancer Association (BE), the Research Council of Ghent University (BE), the Netherlands Organisation for Scientific Research (NL) and the Netherlands Organisation for Health Research and Development (NL) (grant number: 11510006). Dr. Rietjens was supported by the Innovational Research Incentives Scheme Veni of the Netherlands Organisation for Scientific Research (NWO) and the 'For Women in Science' fellowship of UNESCO and L'Oreal. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank the senior clinical staff members of the participating settings for recruitment of the bereaved participants, as well as the bereaved persons who participated in this study. Dr Rietjens was supported by the Innovational Research Incentives Scheme Veni of the Netherlands Organisation for Scientific Research (NWO) and the 'For Women in Science' fellowship of UNESCO and L'Oreal.	Addington-Hall J, 1998, J EPIDEMIOL COMMUN H, V52, P802, DOI 10.1136/jech.52.12.802; Addington-Hall JM, 2009, PALLIATIVE MED, V23, P190, DOI 10.1177/0269216309102525; Aktas A, 2015, SUPPORT CARE CANCER, V23, P2189, DOI 10.1007/s00520-015-2732-7; Andershed B, 1999, NURS SCI QUART, V12, P45, DOI 10.1177/08943189922106404; Andershed B, 2006, J CLIN NURS, V15, P1158, DOI 10.1111/j.1365-2702.2006.01473.x; Anquinet L, 2012, J PAIN SYMPTOM MANAG, V44, P33, DOI 10.1016/j.jpainsymman.2011.07.007; AstedtKurki P, 1997, J ADV NURS, V25, P908, DOI 10.1046/j.1365-2648.1997.1997025908.x; Billings JA, 1996, J PALLIAT CARE, V12, P21, DOI 10.1177/082585979601200404; Bilsen J, 2007, SOC SCI MED, V65, P803, DOI 10.1016/j.socscimed.2007.04.016; Bruera E, 1991, J Palliat Care, V7, P6; Bruinsma SM, 2014, SUPPORT CARE CANCER, V22, P3243, DOI 10.1007/s00520-014-2344-7; Bruinsma S, 2013, J PALLIAT MED, V16, P349, DOI 10.1089/jpm.2012.0410; Bruinsma SM, 2012, J PAIN SYMPTOM MANAG, V44, P431, DOI 10.1016/j.jpainsymman.2011.09.006; Cantril H., 1965, PATTERN HUMAN CONCER; Carpenter J S, 1996, J Nurs Meas, V4, P171; Chambaere K, 2010, ARCH INTERN MED, V170, P490, DOI 10.1001/archinternmed.2009.542; Cherny NI, 2009, PALLIATIVE MED, V23, P581, DOI 10.1177/0269216309107024; Claessen S, 2009, WEG NAAR EEN CQ INDE; Curtis JR, 2002, J PAIN SYMPTOM MANAG, V24, P17, DOI 10.1016/S0885-3924(02)00419-0; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Gallagher R, 2013, BMC PALLIAT CARE, V12, DOI 10.1186/1472-684X-12-25; GREER DS, 1986, J CHRON DIS, V39, P9, DOI 10.1016/0021-9681(86)90103-7; Hudson P, 2014, BMJ SUPPORT PALLIAT, V4, P231, DOI 10.1136/bmjspcare-2013-000500; KANE RL, 1984, LANCET, V1, P890; Lautrette A, 2007, NEW ENGL J MED, V356, P469, DOI 10.1056/NEJMoa063446; Mercadante S, 2009, J PAIN SYMPTOM MANAG, V37, P771, DOI 10.1016/j.jpainsymman.2008.04.020; Miccinesi G, 2006, J PAIN SYMPTOM MANAG, V31, P122, DOI 10.1016/j.jpainsymman.2005.07.004; Morita T, 2004, J PAIN SYMPTOM MANAG, V28, P557, DOI 10.1016/j.jpainsymman.2004.03.004; Morita T, 2004, SUPPORT CARE CANCER, V12, P885, DOI 10.1007/s00520-004-0678-2; Onwuteaka-Philipsen BD, 2012, LANCET, V380, P908, DOI 10.1016/S0140-6736(12)61034-4; Pierson CM, 2002, AIDS CARE, V14, P587, DOI 10.1080/0954012021000005416; Rietjens J, 2008, BRIT MED J, V336, P810, DOI 10.1136/bmj.39504.531505.25; Rietjens JAC, 2006, PALLIATIVE MED, V20, P685, DOI 10.1177/0269216306070241; Royal Dutch Medical Association (KNMG), 2009, GUID PALL SED; Seale C, 2009, PALLIATIVE MED, V23, P198, DOI 10.1177/0269216308102042; Seale C RK, 2014, HEALTH IN PRESS; Seale C, 2010, J PAIN SYMPTOM MANAG, V39, P44, DOI 10.1016/j.jpainsymman.2009.06.007; Steinhauser AE, 2000, JAMA-J AM MED ASSOC, V284, P2476, DOI 10.1001/jama.284.19.2476; Steinhauser KE, 2014, PALLIAT SUPPORT CARE, V8, P1, DOI DOI 10.1097/SPC.0000000000000035; STROEBE MS, 1989, OMEGA-J DEATH DYING, V20, P1, DOI 10.2190/C3JE-C9L1-5R91-DWDU; Swarte NB, 2003, BMJ-BRIT MED J, V327, P189, DOI 10.1136/bmj.327.7408.189; Teno JM, 2001, J PAIN SYMPTOM MANAG, V22, P738, DOI 10.1016/S0885-3924(01)00335-9; van Delden JJM, 2011, KNOWLEDGE OPINIONS G; van Dooren S, 2009, J PAIN SYMPTOM MANAG, V38, P452, DOI 10.1016/j.jpainsymman.2008.11.011; Veerbeek L, 2008, AM J HOSP PALLIAT ME, V25, P207, DOI 10.1177/1049909108315515; Ware J., 1993, SF 36 HLTH SURVEY MA; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Wilson KG, 2004, CAN J PSYCHIAT, V49, P350, DOI 10.1177/070674370404900603; World Health Organization, 2008, DEF PALL CAR; Wright AA, 2008, JAMA-J AM MED ASSOC, V300, P1665, DOI 10.1001/jama.300.14.1665	50	10	10	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149250	10.1371/journal.pone.0149250	http://dx.doi.org/10.1371/journal.pone.0149250			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DD6SI	26871717	Green Published, Green Submitted, gold			2022-12-26	WOS:000370054100134
J	van der Maten, E; van Selm, S; Langereis, JD; Bootsma, HJ; van Opzeeland, FJH; de Groot, R; de Jonge, MI; van der Flier, M				van der Maten, Erika; van Selm, Saskia; Langereis, Jeroen D.; Bootsma, Hester J.; van Opzeeland, Fred J. H.; de Groot, Ronald; de Jonge, Marien I.; van der Flier, Michiel			Alternative Pathway Inhibition by Exogenous Factor H Fails to Attenuate Inflammation and Vascular Leakage in Experimental Pneumococcal Sepsis in Mice	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE; COMPLEMENT PATHWAY; CLASSICAL PATHWAY; C5A; DISEASE; AMPLIFICATION; DEFICIENCIES; ACTIVATION; EXPRESSION; PROTECTION	Streptococcus pneumoniae is a common cause of sepsis. Effective complement activation is an important component of host defence against invading pathogens, whilst excessive complement activation has been associated with endothelial dysfunction and organ damage. The alternative pathway amplification loop is important for the enhancement of complement activation. Factor H is a key negative regulator of the alternative pathway amplification loop and contributes to tight control of complement activation. We assessed the effect of inhibition of the alternative pathway on sepsis associated inflammation and disease severity using human factor H treatment in a clinically relevant mice model of pneumococcal sepsis. Mice were infected intravenously with live Streptococcus pneumoniae. At the first clinical signs of infection, 17 hours post-infection, mice were treated with ceftriaxone antibiotic. At the same time purified human factor H or in controls PBS was administered. Treatment with human factor H did not attenuate disease scores, serum pro-inflammatory cytokines, or vascular permeability and did not significantly affect C3 and C3a production at 26 h post-infection. Therefore, we conclude that inhibition of the alternative complement pathway by exogenous human factor H fails to attenuate inflammation and vascular leakage at a clinically relevant intervention time point in pneumococcal sepsis in mice.	[van der Maten, Erika; van Selm, Saskia; Langereis, Jeroen D.; Bootsma, Hester J.; van Opzeeland, Fred J. H.; de Groot, Ronald; de Jonge, Marien I.; van der Flier, Michiel] Radboudumc, Radboud Inst Mol Life Sci, Dept Pediat, Lab Pediat Infect Dis, Nijmegen, Netherlands; [van der Flier, Michiel] Radboudumc, Dept Pediat, Pediat Infect Dis & Immunol, Nijmegen, Netherlands; [Bootsma, Hester J.] RIVM, Ctr Infect Dis Control, Lab Infect Dis & Screening, Bilthoven, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Netherlands National Institute for Public Health & the Environment	van der Flier, M (corresponding author), Radboudumc, Radboud Inst Mol Life Sci, Dept Pediat, Lab Pediat Infect Dis, Nijmegen, Netherlands.; van der Flier, M (corresponding author), Radboudumc, Dept Pediat, Pediat Infect Dis & Immunol, Nijmegen, Netherlands.	Michiel.vanderFlier@radboudumc.nl	Langereis, Jeroen/H-1042-2013; van der Flier, M./L-4307-2015; de Jonge, Marien I./P-5869-2015; van der Maten, Erika/G-4497-2016	Langereis, Jeroen/0000-0001-5317-3202; van der Flier, M./0000-0003-1296-0159; de Jonge, Marien I./0000-0003-2812-5895; 	European Union's seventh Framework program [EC-GA] [279185]; European childhood life-threatening infectious diseases study (EUCLIDS) (RdG)	European Union's seventh Framework program [EC-GA]; European childhood life-threatening infectious diseases study (EUCLIDS) (RdG)	This work was supported by the European Union's seventh Framework program [EC-GA#279185], European childhood life-threatening infectious diseases study (EUCLIDS) (RdG received the grant and salary of EvdM was paid by this grant). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali YM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002793; Ali YM, 2014, P NATL ACAD SCI USA, V111, P5301, DOI 10.1073/pnas.1401011111; Angus DC, 2013, NEW ENGL J MED, V369, P2063, DOI 10.1056/NEJMc1312359; Baig K, 2007, ANN THORAC SURG, V83, P1477, DOI 10.1016/j.athoracsur.2006.10.049; Brandtzaeg P, 1996, J INFECT DIS, V173, P647, DOI 10.1093/infdis/173.3.647; Brown JS, 2002, P NATL ACAD SCI USA, V99, P16969, DOI 10.1073/pnas.012669199; Czermak BJ, 1999, NAT MED, V5, P788, DOI 10.1038/10512; Dahlke K, 2011, J IMMUNOL, V186, P3066, DOI 10.4049/jimmunol.1002741; Davis AE, 2007, IMMUNOBIOLOGY, V212, P313, DOI 10.1016/j.imbio.2006.10.003; Ding JD, 2015, AM J PATHOL, V185, P29, DOI 10.1016/j.ajpath.2014.08.026; Fakhouri F, 2010, KIDNEY INT, V78, P279, DOI 10.1038/ki.2010.132; Flierl MA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002560; Guo RF, 2005, ANNU REV IMMUNOL, V23, P821, DOI 10.1146/annurev.immunol.23.021704.115835; Hajishengallis G, 2010, TRENDS IMMUNOL, V31, P154, DOI 10.1016/j.it.2010.01.002; Harboe M, 2004, CLIN EXP IMMUNOL, V138, P439, DOI 10.1111/j.1365-2249.2004.02627.x; Harboe M, 2008, J CELL MOL MED, V12, P1074, DOI 10.1111/j.1582-4934.2008.00350.x; Huber-Lang MS, 2001, FASEB J, V15, P568; Hyams C, 2013, INFECT IMMUN, V81, P354, DOI 10.1128/IAI.00862-12; Igonin AA, 2012, CRIT CARE MED, V40, P770, DOI 10.1097/CCM.0b013e318236edb8; Jansen AGSC, 2009, CLIN INFECT DIS, V49, pE23, DOI 10.1086/600045; Jansen PM, 1998, J IMMUNOL, V160, P475; Lappegard KT, 2009, P NATL ACAD SCI USA, V106, P15861, DOI 10.1073/pnas.0903613106; Liu D, 2007, J IMMUNOL, V179, P3966; Liu ZM, 2010, MOL IMMUNOL, V47, P1325, DOI 10.1016/j.molimm.2009.11.001; Lu L, 2008, J IMMUNOL, V181, P7138, DOI 10.4049/jimmunol.181.10.7138; Makou E, 2013, BIOCHEMISTRY-US, V52, P3949, DOI 10.1021/bi4003452; Muhammad Riyadh D, 2013, Clin Infect Dis, V56, pe59, DOI 10.1093/cid/cis971; Niederbichler AD, 2006, J EXP MED, V203, P53, DOI 10.1084/jem.20051207; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; PANGBURN MK, 1977, J EXP MED, V146, P257, DOI 10.1084/jem.146.1.257; Pettigrew HD, 2009, ANN NY ACAD SCI, V1173, P108, DOI 10.1111/j.1749-6632.2009.04633.x; Ram S, 2010, CLIN MICROBIOL REV, V23, P740, DOI 10.1128/CMR.00048-09; Riedemann NC, 2002, J CLIN INVEST, V110, P101, DOI 10.1172/JCI200215409; Rittirsch D, 2008, NAT MED, V14, P551, DOI 10.1038/nm1753; Rowinska-Zyrek M, 2013, NEW J CHEM, V37, P58, DOI 10.1039/c2nj40558j; Silasi-Mansat R, 2010, BLOOD, V116, P1002, DOI 10.1182/blood-2010-02-269746; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; von Drygalski A, 2012, THROMB HAEMOSTASIS, V108, P981, DOI 10.1160/TH12-03-0196; WEILER JM, 1976, P NATL ACAD SCI USA, V73, P3268, DOI 10.1073/pnas.73.9.3268; WHALEY K, 1976, J EXP MED, V144, P1147, DOI 10.1084/jem.144.5.1147; Woehrl B, 2011, J CLIN INVEST, V121, P3943, DOI 10.1172/JCI57522; Younger JG, 2010, ACAD EMERG MED, V17, P353, DOI 10.1111/j.1553-2712.2010.00713.x; Zhang XH, 2007, BLOOD, V110, P228, DOI 10.1182/blood-2006-12-063636; Zimmer J, 2015, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00689	44	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149307	10.1371/journal.pone.0149307	http://dx.doi.org/10.1371/journal.pone.0149307			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26872035	Green Published, Green Submitted, gold			2022-12-26	WOS:000370054100145
J	Franciosa, G; Diluvio, G; Del Gaudio, F; Giuli, MV; Palermo, R; Grazioli, P; Campese, AF; Talora, C; Bellavia, D; D'Amati, G; Besharat, ZM; Nicoletti, C; Siebel, CW; Choy, L; Rustighi, A; Del Sal, G; Screpanti, I; Checquolo, S				Franciosa, G.; Diluvio, G.; Del Gaudio, F.; Giuli, M. V.; Palermo, R.; Grazioli, P.; Campese, A. F.; Talora, C.; Bellavia, D.; D'Amati, G.; Besharat, Z. M.; Nicoletti, C.; Siebel, C. W.; Choy, L.; Rustighi, A.; Del Sal, G.; Screpanti, I.; Checquolo, S.			Prolyl-isomerase Pin1 controls Notch3 protein expression and regulates T-ALL progression	ONCOGENE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; ACUTE PROMYELOCYTIC LEUKEMIA; TRANS-RETINOIC ACID; FACTOR-KAPPA-B; CELL LEUKEMIA; BREAST-CANCER; DOWN-REGULATION; PRE-TCR; DRUG-SENSITIVITY; INVASION	Deregulated Notch signaling is associated with T-cell Acute Lymphoblastic Leukemia (T-ALL) development and progression. Increasing evidence reveals that Notch pathway has an important role in the invasion ability of tumor cells, including leukemia, although the underlying molecular mechanisms remain mostly unclear. Here, we show that Notch3 is a novel target protein of the prolyl-isomerase Pin1, which is able to regulate Notch3 protein processing and to stabilize the cleaved product, leading to the increased expression of the intracellular domain (N3(IC)), finally enhancing Notch3-dependent invasiveness properties. We demonstrate that the combined inhibition of Notch3 and Pin1 in the Notch3-overexpressing human leukemic TALL-1 cells reduces their high invasive potential, by decreasing the expression of the matrix metalloprotease MMP9. Consistently, Pin1 depletion in a mouse model of Notch3-induced T-ALL, by reducing N3(IC) expression and signaling, impairs the expansion/invasiveness of CD4(+)CD8(+) DP cells in peripheral lymphoid and non-lymphoid organs. Notably, in in silico gene expression analysis of human T-ALL samples we observed a significant correlation between Pin1 and Notch3 expression levels, which may further suggest a key role of the newly identified Notch3-Pin1 axis in T-ALL aggressiveness and progression. Thus, combined suppression of Pin1 and Notch3 proteins may be exploited as an additional target therapy for T-ALL.	[Franciosa, G.; Diluvio, G.; Del Gaudio, F.; Giuli, M. V.; Grazioli, P.; Campese, A. F.; Talora, C.; Bellavia, D.; Besharat, Z. M.; Screpanti, I.] Sapienza Univ, Dept Mol Med, Lab Mol Pathol, Rome, Italy; [Palermo, R.; Screpanti, I.] Ist Italiano Tecnol, Ctr Life Nano Sci Sapienza, Rome, Italy; [D'Amati, G.] Sapienza Univ, Dept Radiol Oncol & Pathol Sci, Rome, Italy; [Nicoletti, C.] Sapienza Univ, Dept Anat Histol Forens Med & Orthopaed, Unit Histol & Med Embryol, Rome, Italy; [Siebel, C. W.; Choy, L.] Genentech Inc, Dept Discovery Oncol, San Francisco, CA USA; [Rustighi, A.; Del Sal, G.] Univ Trieste, Lab Nazl CIB Area Sci Pk Trieste, Trieste, Italy; [Rustighi, A.; Del Sal, G.] Univ Trieste, Dept Life Sci, Trieste, Italy; [Screpanti, I.] Sapienza Univ, Inst Pasteur, Fdn Cenci Bolognetti, Rome, Italy; [Checquolo, S.] Sapienza Univ, Dept Med Surg Sci & Biotechnol, Corso Repubbl 69, I-04100 Latina, Italy	Sapienza University Rome; Istituto Italiano di Tecnologia - IIT; Sapienza University Rome; Sapienza University Rome; Roche Holding; Genentech; University of Trieste; University of Trieste; Fondazione Cenci Bolognetti; Sapienza University Rome; Sapienza University Rome	Checquolo, S (corresponding author), Sapienza Univ, Dept Med Surg Sci & Biotechnol, Corso Repubbl 69, I-04100 Latina, Italy.; Screpanti, I (corresponding author), Sapienza Univ, Dept Mol Med, Viale Regina Elena 291, I-00161 Rome, Italy.	isabella.screpanti@uniroma1.it; saula.checquolo@uniroma1.it	Talora, Claduio/AIC-4932-2022; Del Gaudio, Francesca/AAD-3685-2022; Bellavia, Diana/AAO-6348-2021; Besharat, Zein Mersini/G-5413-2013; Franciosa, Giulia/AAV-1211-2021; d'Amati, Giulia/F-1251-2011; Palermo, Rocco/I-5140-2016	Talora, Claduio/0000-0002-6973-2184; Del Gaudio, Francesca/0000-0001-8342-1377; Besharat, Zein Mersini/0000-0003-0317-9854; Franciosa, Giulia/0000-0001-5309-5558; d'Amati, Giulia/0000-0002-6959-691X; Palermo, Rocco/0000-0003-0134-9370; CHECQUOLO, Saula/0000-0001-5109-8392; CAMPESE, Antonio Francesco/0000-0002-8535-6609; NICOLETTI, Carmine/0000-0001-5896-2040; DILUVIO, GIULIA/0000-0002-9541-848X	Italian Association for Cancer Research (AIRC) [13214]; Italian Ministry of University and Research (MIUR); FIRB Program [RBAP11WCRZ]; PRIN (MCLPLB) Program; AIRC Special Program Molecular Clinical Oncology '5 per mille'; Italian Ministry of Health Ricerca-Finalizzata	Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); Italian Ministry of University and Research (MIUR)(Ministry of Education, Universities and Research (MIUR)); FIRB Program(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); PRIN (MCLPLB) Program(Ministry of Education, Universities and Research (MIUR)); AIRC Special Program Molecular Clinical Oncology '5 per mille'(Fondazione AIRC per la ricerca sul cancro); Italian Ministry of Health Ricerca-Finalizzata(Ministry of Health, Italy)	This work was supported by the Italian Association for Cancer Research (AIRC) IG 13214, the Italian Ministry of University and Research (MIUR), FIRB (RBAP11WCRZ) and PRIN (2010 MCLPLB) Programs to IS, AIRC Special Program Molecular Clinical Oncology '5 per mille', and Italian Ministry of Health Ricerca-Finalizzata 2011 to GDS.	Agnusdei V, 2014, LEUKEMIA, V28, P278, DOI 10.1038/leu.2013.183; Aifantis L, 1998, IMMUNITY, V9, P649, DOI 10.1016/S1074-7613(00)80662-7; Arasada RR, 2014, CANCER RES, V74, P5572, DOI 10.1158/0008-5472.CAN-13-3724; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Aster JC, 2000, MOL CELL BIOL, V20, P7505, DOI 10.1128/MCB.20.20.7505-7515.2000; Atchison FW, 2003, DEVELOPMENT, V130, P3579, DOI 10.1242/dev.00584; Baik SH, 2015, ANN NEUROL, V77, P504, DOI 10.1002/ana.24347; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bellavia D, 2000, EMBO J, V19, P3337, DOI 10.1093/emboj/19.13.3337; Bellavia D, 2002, P NATL ACAD SCI USA, V99, P3788, DOI 10.1073/pnas.062050599; Beverly LJ, 2005, CANCER RES, V65, P7159, DOI 10.1158/0008-5472.CAN-05-1664; Buonamici S, 2009, NATURE, V459, P1000, DOI 10.1038/nature08020; Campese AF, 2009, INT IMMUNOL, V21, P727, DOI 10.1093/intimm/dxp042; Checquolo S, 2010, ONCOGENE, V29, P1463, DOI 10.1038/onc.2009.446; Cialfi S, 2013, LEUKEMIA, V27, P485, DOI 10.1038/leu.2012.192; Demarest RM, 2011, BLOOD, V117, P2901, DOI 10.1182/blood-2010-05-286351; Fan G, 2009, CANCER RES, V69, P4589, DOI 10.1158/0008-5472.CAN-08-4117; Fortini ME, 2009, DEV CELL, V16, P633, DOI 10.1016/j.devcel.2009.03.010; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Ghisi M, 2011, BLOOD, V117, P7053, DOI 10.1182/blood-2010-12-326629; Grabher C, 2006, NAT REV CANCER, V6, P347, DOI 10.1038/nrc1880; HIRAKI S, 1978, GANN, V69, P115; Homminga I, 2011, CANCER CELL, V19, P484, DOI 10.1016/j.ccr.2011.02.008; HUANG ME, 1988, BLOOD, V72, P567, DOI 10.1182/blood.V72.2.567.567; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Joutel A, 2000, J CLIN INVEST, V105, P597, DOI 10.1172/JCI8047; Kumar V, 2014, LEUKEMIA, V28, P2324, DOI 10.1038/leu.2014.133; Lee SY, 2005, LEUKEMIA, V19, P1841, DOI 10.1038/sj.leu.2403896; Lin LI, 2002, BRIT J HAEMATOL, V117, P835, DOI 10.1046/j.1365-2141.2002.03510.x; Liou YC, 2011, TRENDS BIOCHEM SCI, V36, P501, DOI 10.1016/j.tibs.2011.07.001; Lopez-Guerra M, 2015, LEUKEMIA, V29, P96, DOI 10.1038/leu.2014.143; Louvi A, 2012, SEMIN CELL DEV BIOL, V23, P473, DOI 10.1016/j.semcdb.2012.02.005; Lu KP, 2007, NAT REV MOL CELL BIO, V8, P904, DOI 10.1038/nrm2261; Mansour MR, 2006, LEUKEMIA, V20, P537, DOI 10.1038/sj.leu.2404101; Martin-Blanco NM, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.438; Min SH, 2012, MOL CELL, V46, P771, DOI 10.1016/j.molcel.2012.04.012; O'Neil J, 2007, J EXP MED, V204, P1813, DOI 10.1084/jem.20070876; Palermo R, 2014, CURR MOL MED, V14, P34, DOI 10.2174/1566524013666131118105216; Palermo R, 2012, ONCOGENE, V31, P3807, DOI 10.1038/onc.2011.533; Palomero T, 2007, NAT MED, V13, P1203, DOI 10.1038/nm1636; Pear WS, 1996, J EXP MED, V183, P2283, DOI 10.1084/jem.183.5.2283; Pelullo M, 2014, NEOPLASIA, V16, P1007, DOI 10.1016/j.neo.2014.10.004; Ranganathan R, 1997, CELL, V89, P875, DOI 10.1016/S0092-8674(00)80273-1; Redondo-Munoz J, 2010, CANCER CELL, V17, P160, DOI 10.1016/j.ccr.2009.12.044; Rustighi A, 2014, EMBO MOL MED, V6, P99, DOI 10.1002/emmm.201302909; Rustighi A, 2009, NAT CELL BIOL, V11, P133, DOI 10.1038/ncb1822; Santarpia L, 2012, BREAST CANCER RES TR, V134, P333, DOI 10.1007/s10549-012-2035-3; Screpanti I, 2003, TRENDS MOL MED, V9, P30, DOI 10.1016/S1471-4914(02)00003-5; Sorrentino G, 2014, MITOCHONDRION, V19, P88, DOI 10.1016/j.mito.2014.08.003; Talora C, 2003, EMBO REP, V4, P1067, DOI 10.1038/sj.embor.7400013; Vacca A, 2006, EMBO J, V25, P1000, DOI 10.1038/sj.emboj.7600996; Vacca A, 2000, Dev Immunol, V7, P77, DOI 10.1155/2000/74372; Wang J, 2011, ONCOL REP, V26, P1295, DOI 10.3892/or.2011.1399; Wang XW, 2015, ONCOL REP, V33, P1402, DOI 10.3892/or.2015.3731; Wang ZW, 2006, CANCER RES, V66, P2778, DOI 10.1158/0008-5472.CAN-05-4281; Wei S, 2015, NAT MED, V21, P457, DOI 10.1038/nm.3839; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Wulf G, 2005, NAT CELL BIOL, V7, P435, DOI 10.1038/ncb0505-435; Wulf GM, 2001, EMBO J, V20, P3459, DOI 10.1093/emboj/20.13.3459; Yaffe MB, 1997, SCIENCE, V278, P1957, DOI 10.1126/science.278.5345.1957; Yin CC, 2015, EXP CELL RES, V332, P39, DOI 10.1016/j.yexcr.2015.01.008; Zampieri M, 2014, BBA-GENE REGUL MECH, V1839, P813, DOI 10.1016/j.bbagrm.2014.06.017; Zhang ZY, 2010, AM J PATHOL, V177, P1459, DOI 10.2353/ajpath.2010.090476; Zhou L, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0057382, 10.1371/journal.pone.0073724]; Zou J, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-3	65	41	43	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 8	2016	35	36					4741	4751		10.1038/onc.2016.5	http://dx.doi.org/10.1038/onc.2016.5			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DW0IS	26876201	hybrid, Green Published			2022-12-26	WOS:000383324700007
J	Kim, DY; Helfman, DM				Kim, D. Y.; Helfman, D. M.			Loss of MLCK leads to dleisruption of cell-cell adhesion and invasive behavior of breast epithelial cells via increased expression of EGFR and ERK/JNK signaling	ONCOGENE			English	Article							LIGHT-CHAIN KINASE; E-CADHERIN; CANCER-CELLS; SPHEROID FORMATION; DISTINCT ROLES; MIGRATION; PHOSPHORYLATION; PAXILLIN; RECEPTOR; GROWTH	Myosin light chain kinase (MLCK) expression is downregulated in breast cancer, including invasive ductal carcinoma compared with ductal breast carcinoma in situ and metastatic breast tumors. However, little is known about how loss of MLCK expression contributes to tumor progression. MLCK is a component of the actin cytoskeleton and its known role is the phosphorylation of the regulatory light chain of myosin II. To gain insights into the role of MLCK in breast cancer, we perturbed its function using small interfering RNA (siRNA) or pharmacological inhibition in untransformed breast epithelial cells (MCF10A). Loss of MLCK by siRNAs led to increased cell migration and invasion, disruption of cell-cell adhesions and enhanced formation of focal adhesions at the leading edge of migratory cells. In addition, downregulation of MLCK cooperated with HER2 in MCF10A cells to promote cell migration and invasion and low levels of MLCK is associated with a poor prognosis in HER2-positive breast cancer patients. Associated with these altered migratory behaviors were increased expression of epidermal growth factor receptor and activation of extracellular signal-regulated kinase and c-Jun N-terminal kinase signaling pathways in MLCK downregulated MCF10A cells. By contrast, inhibition of the kinase function of MLCK using pharmacological agents inhibited cell migration and invasion, and did not affect cellular adhesions. Our results show that loss of MLCK contributes to the migratory properties of epithelial cells resulting from changes in cell-cell and cell-matrix adhesions, and increased epidermal growth factor receptor signaling. These findings suggest that decreased expression of MLCK may have a critical role during tumor progression by facilitating the metastatic potential of tumor cells.	[Kim, D. Y.; Helfman, D. M.] Korea Adv Inst Sci & Technol, Dept Biol Sci, 291 Daehak Ro, Daejeon 34141, South Korea	Korea Advanced Institute of Science & Technology (KAIST)	Helfman, DM (corresponding author), Korea Adv Inst Sci & Technol, Dept Biol Sci, 291 Daehak Ro, Daejeon 34141, South Korea.	dhelfman@kaist.ac.kr			National Research Foundation of Korea - Ministry of Education Science and Technology [R1A2A2A01003372]	National Research Foundation of Korea - Ministry of Education Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of Korea)	DMH is supported by the National Research Foundation of Korea funded by the Ministry of Education Science and Technology (#R1A2A2A01003372).	Bill HM, 2004, MOL CELL BIOL, V24, P8586, DOI 10.1128/MCB.24.19.8586-8599.2004; Birukov KG, 2001, J BIOL CHEM, V276, P8567, DOI 10.1074/jbc.M005270200; Cabodi S, 2004, BIOCHEM SOC T, V32, P438, DOI 10.1042/BST0320438; Chen C, 2014, J BIOL CHEM, V289, P28478, DOI 10.1074/jbc.M114.567446; Chen J, 2012, CANCER RES, V72, P4130, DOI 10.1158/0008-5472.CAN-12-0655; Choi C, 2014, ONCOGENE, V33, P3668, DOI 10.1038/onc.2013.341; Connell LE, 2006, J CELL SCI, V119, P2269, DOI 10.1242/jcs.02926; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Duan L, 2011, J BIOL CHEM, V286, P620, DOI 10.1074/jbc.M110.188086; Dudek SM, 2002, BIOCHEM BIOPH RES CO, V298, P511, DOI 10.1016/S0006-291X(02)02492-0; Dudek SM, 2010, MOL BIOL CELL, V21, P4042, DOI 10.1091/mbc.E09-10-0876; Dulyaninova NG, 2004, J CELL SCI, V117, P1481, DOI 10.1242/jcs.00993; Fazal F, 2005, MOL CELL BIOL, V25, P6259, DOI 10.1128/MCB.25.14.6259-6266.2005; Garcia JGN, 1999, AM J PHYSIOL-LUNG C, V276, pL989, DOI 10.1152/ajplung.1999.276.6.L989; Giampieri S, 2009, NAT CELL BIOL, V11, P1287, DOI 10.1038/ncb1973; Glinsky VV, 2003, CANCER RES, V63, P3805; Gu LZ, 2006, EUR J CANCER, V42, P948, DOI 10.1016/j.ejca.2005.12.017; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Hazan RB, 1998, J BIOL CHEM, V273, P9078, DOI 10.1074/jbc.273.15.9078; Hidalgo-Carcedo C, 2011, NAT CELL BIOL, V13, P49, DOI 10.1038/ncb2133; Huang C, 2004, CELL CYCLE, V3, P4, DOI 10.4161/cc.3.1.601; Huang C, 2003, NATURE, V424, P219, DOI 10.1038/nature01745; Ivascu A, 2007, INT J ONCOL, V31, P1403; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kimura K, 2008, INVEST OPHTH VIS SCI, V49, P125, DOI 10.1167/iovs.07-0725; Laprise P, 2004, J CELL PHYSIOL, V199, P32, DOI 10.1002/jcp.10432; Li QW, 2008, NEOPLASIA, V10, P1444, DOI 10.1593/neo.08968; Lin RZ, 2006, CELL TISSUE RES, V324, P411, DOI 10.1007/s00441-005-0148-2; Mukherjee M, 2012, EMBO J, V31, P1308, DOI 10.1038/emboj.2011.496; Olson MF, 2009, CLIN EXP METASTAS, V26, P273, DOI 10.1007/s10585-008-9174-2; Ren G, 2009, J BIOL CHEM, V284, P18913, DOI 10.1074/jbc.M109.000307; Rhodes DR, 2007, NEOPLASIA, V9, P166, DOI 10.1593/neo.07112; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Simpson KJ, 2008, NAT CELL BIOL, V10, P1027, DOI 10.1038/ncb1762; Sodek KL, 2009, INT J CANCER, V124, P2060, DOI 10.1002/ijc.24188; Streuli CH, 2009, BIOCHEM J, V418, P491, DOI 10.1042/BJ20081948; Totsukawa G, 2004, J CELL BIOL, V164, P427, DOI 10.1083/jcb.200306172; Totsukawa G, 2000, J CELL BIOL, V150, P797, DOI 10.1083/jcb.150.4.797; Usatyuk PV, 2012, J BIOL CHEM, V287, P9360, DOI 10.1074/jbc.M111.294546; Verin AD, 1998, AM J RESP CELL MOL, V19, P767, DOI 10.1165/ajrcmb.19.5.3126; Wadgaonkar R, 2003, J CELL BIOCHEM, V88, P623, DOI 10.1002/jcb.10370; Wang HH, 2009, AM J PHYSIOL-HEART C, V296, pH1683, DOI 10.1152/ajpheart.00965.2008; WATTERSON DM, 1995, FEBS LETT, V373, P217; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Wu Q, 2010, ONCOGENE, V29, P4183, DOI 10.1038/onc.2010.165; Yilmaz M, 2010, MOL CANCER RES, V8, P629, DOI 10.1158/1541-7786.MCR-10-0139; Yilmaz M, 2009, CANCER METAST REV, V28, P15, DOI 10.1007/s10555-008-9169-0; Yu HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079776; Zhao HJ, 2004, MOL BIOL CELL, V15, P2523, DOI 10.1091/mbc.E03-11-0786	49	15	15	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG	2016	35	34					4495	4508		10.1038/onc.2015.508	http://dx.doi.org/10.1038/onc.2015.508			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DU4AC	26876209				2022-12-26	WOS:000382153100007
J	Elagabani, MN; Brisevac, D; Kintscher, M; Pohle, J; Kohr, G; Schmitz, D; Kornau, HC				Elagabani, Mohammad Nael; Brisevac, Dusica; Kintscher, Michael; Pohle, Joerg; Koehr, Georg; Schmitz, Dietmar; Kornau, Hans-Christian			Subunit-selective N-Methyl-D-aspartate (NMDA) Receptor Signaling through Brefeldin A-resistant Arf Guanine Nucleotide Exchange Factors BRAG1 and BRAG2 during Synapse Maturation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SILENT SYNAPSES; POSTSYNAPTIC DENSITY; AMPA RECEPTORS; EXPRESSION; MECHANISM; PLASTICITY; ROLES; BRAIN; NR2B; ACTIVATION	The maturation of glutamatergic synapses in the CNS is regulated by NMDA receptors (NMDARs) that gradually change from a GluN2B- to a GluN2A-dominated subunit composition during postnatal development. Here we show that NMDARs control the activity of the small GTPase ADP-ribosylation factor 6 (Arf6) by consecutively recruiting two related brefeldin A-resistant Arf guanine nucleotide exchange factors, BRAG1 and BRAG2, in a GluN2 subunit-dependent manner. In young cortical cultures, GluN2B and BRAG1 tonically activated Arf6. In mature cultures, Arf6 was activated through GluN2A and BRAG2 upon NMDA treatment, whereas the tonic Arf6 activation was not detectable any longer. This shift in Arf6 regulation and the associated drop in Arf6 activity were reversed by a knockdown of BRAG2. Given their sequential recruitment during development, we examined whether BRAG1 and BRAG2 influence synaptic currents in hippocampal CA1 pyramidal neurons using patch clamp recordings in acute slices from mice at different ages. The number of AMPA receptor (AMPAR) miniature events was reduced by depletion of BRAG1 but not by depletion of BRAG2 during the first 2 weeks after birth. In contrast, depletion of BRAG2 during postnatal weeks 4 and 5 reduced the number of AMPAR miniature events and compromised the quantal sizes of both AMPAR and NMDAR currents evoked at Schaffer collateral synapses. We conclude that both Arf6 activation through GluN2B-BRAG1 during early development and the transition from BRAG1- to BRAG2-dependent Arf6 signaling induced by the GluN2 subunit switch are critical for the development of mature glutamatergic synapses.	[Elagabani, Mohammad Nael; Brisevac, Dusica; Kintscher, Michael; Schmitz, Dietmar; Kornau, Hans-Christian] Charite, Neurosci Res Ctr NWFZ, Charite Pl 1, D-10117 Berlin, Germany; [Elagabani, Mohammad Nael; Brisevac, Dusica; Kornau, Hans-Christian] Charite, Inst Biochem, Charite Pl 1, D-10117 Berlin, Germany; [Pohle, Joerg; Koehr, Georg] Heidelberg Univ, Med Fac Mannheim, Cent Inst Mental Hlth, D-68159 Mannheim, Germany; [Kintscher, Michael] Ecole Polytech Fed Lausanne, Sch Life Sci, Brain Mind Inst, Lab Synapt Mech, CH-1015 Lausanne, Switzerland	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Central Institute of Mental Health; Ruprecht Karls University Heidelberg; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Kornau, HC (corresponding author), Charite, Neurosci Res Ctr NWFZ, Charite Pl 1, D-10117 Berlin, Germany.	hckornau@charite.de		Schmitz, Dietmar/0000-0003-2741-5241; Kintscher, Michael/0000-0003-2355-1369; Brisevac, Dusica/0000-0003-1439-5333; Elagabani, Mohammad Nael/0000-0002-8611-3975	Deutsche Forschungsgemeinschaft [KO 2290/2-1, EXC 257 NeuroCure, KO 2290/1-1]; CHS Stiftung	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); CHS Stiftung	This work was supported by the Deutsche Forschungsgemeinschaft (KO 2290/2-1 and EXC 257 NeuroCure). The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of a Chica and Heinz Schaller (CHS) short term fellowship from the CHS Stiftung and a Heisenberg fellowship (KO 2290/1-1) from the Deutsche Forschungsgemeinschaft.	Adesnik H, 2008, P NATL ACAD SCI USA, V105, P5597, DOI 10.1073/pnas.0800946105; Bellone C, 2007, NEURON, V55, P779, DOI 10.1016/j.neuron.2007.07.035; CARMIGNOTO G, 1992, SCIENCE, V258, P1007, DOI 10.1126/science.1279803; Choi S, 2006, J NEUROSCI, V26, P4811, DOI 10.1523/JNEUROSCI.4182-05.2006; Choi YB, 1999, NEURON, V23, P171, DOI 10.1016/S0896-6273(00)80763-1; Dittgen T, 2004, P NATL ACAD SCI USA, V101, P18206, DOI 10.1073/pnas.0407976101; Donaldson JG, 2003, J BIOL CHEM, V278, P41573, DOI 10.1074/jbc.R300026200; Donaldson JG, 2011, NAT REV MOL CELL BIO, V12, P362, DOI 10.1038/nrm3117; Gray JA, 2011, NEURON, V71, P1085, DOI 10.1016/j.neuron.2011.08.007; Hall BJ, 2007, J NEUROSCI, V27, P13446, DOI 10.1523/JNEUROSCI.3793-07.2007; Hanse E, 2013, NAT REV NEUROSCI, V14, P839, DOI 10.1038/nrn3642; Humphreys D, 2013, P NATL ACAD SCI USA, V110, P16880, DOI 10.1073/pnas.1311680110; Ippolito Dominic M, 2010, J Vis Exp, DOI 10.3791/2270; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; Kerchner GA, 2008, NAT REV NEUROSCI, V9, P813, DOI 10.1038/nrn2501; Kim Y, 2015, J BIOL CHEM, V290, P7323, DOI 10.1074/jbc.M114.634527; Kiraly DD, 2011, J NEUROSCI, V31, P12554, DOI 10.1523/JNEUROSCI.3143-11.2011; Kirkwood A, 1996, NATURE, V381, P526, DOI 10.1038/381526a0; Krapivinsky G, 2003, NEURON, V40, P775, DOI 10.1016/S0896-6273(03)00645-7; Lee MC, 2010, NEURON, V66, P859, DOI 10.1016/j.neuron.2010.05.015; Li SM, 2006, J NEUROSCI, V26, P1721, DOI 10.1523/JNEUROSCI.3990-05.2006; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; Lock M, 2010, HUM GENE THER, V21, P1259, DOI 10.1089/hum.2010.055; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Lowenthal MS, 2015, J PROTEOME RES, V14, P2528, DOI 10.1021/acs.jproteome.5b00109; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; Murphy JA, 2006, BRAIN RES, V1120, P35, DOI 10.1016/j.brainres.2006.08.096; Myers KR, 2012, J NEUROSCI, V32, P11716, DOI 10.1523/JNEUROSCI.1942-12.2012; Oku Y, 2013, J NEUROSCI, V33, P12586, DOI 10.1523/JNEUROSCI.0341-13.2013; Palmer I., 2004, CURRENT PROTOCOLS PR, DOI DOI 10.1002/0471140864.PS0603S38.UNIT6.3; Paoletti P, 2000, NEURON, V28, P911, DOI 10.1016/S0896-6273(00)00163-X; Paoletti P, 1997, J NEUROSCI, V17, P5711; Paoletti P, 2013, NAT REV NEUROSCI, V14, P383, DOI 10.1038/nrn3504; Rauner C, 2011, J BIOL CHEM, V286, P7558, DOI 10.1074/jbc.M110.182600; Ryan TJ, 2013, NAT NEUROSCI, V16, P25, DOI 10.1038/nn.3277; Sakagami H, 2008, NEUROSCI RES, V60, P199, DOI 10.1016/j.neures.2007.10.013; Santy LC, 2001, J CELL BIOL, V154, P599, DOI 10.1083/jcb.200104019; SCHALL TJ, 1990, CELL, V61, P361, DOI 10.1016/0092-8674(90)90816-W; Scholz R, 2010, NEURON, V66, P768, DOI 10.1016/j.neuron.2010.05.003; Schwechter B, 2013, P NATL ACAD SCI USA, V110, P14462, DOI 10.1073/pnas.1304340110; SHENG M, 1994, NATURE, V368, P144, DOI 10.1038/368144a0; Sheng M, 2007, ANNU REV BIOCHEM, V76, P823, DOI 10.1146/annurev.biochem.76.060805.160029; Shoubridge C, 2010, NAT GENET, V42, P486, DOI 10.1038/ng.588; Takumi Y, 1999, NAT NEUROSCI, V2, P618, DOI 10.1038/10172; Um K, 2014, DEV CELL, V29, P701, DOI 10.1016/j.devcel.2014.05.011; Xu XM, 2009, NAT PROTOC, V4, P1338, DOI 10.1038/nprot.2009.145; Yashiro K, 2008, NEUROPHARMACOLOGY, V55, P1081, DOI 10.1016/j.neuropharm.2008.07.046; Zheng N, 2015, ELIFE, V4, DOI 10.7554/eLife.06878	48	20	20	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2016	291	17					9105	9118		10.1074/jbc.M115.691717	http://dx.doi.org/10.1074/jbc.M115.691717			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK3WV	26884337	hybrid, Green Published, Green Accepted			2022-12-26	WOS:000374849000023
J	Sivanesan, D; Beauchamp, C; Quinou, C; Lee, J; Lesage, S; Chemtob, S; Rioux, JD; Michnick, SW				Sivanesan, Durga; Beauchamp, Claudine; Quinou, Christiane; Lee, Jonathan; Lesage, Sylvie; Chemtob, Sylvain; Rioux, John D.; Michnick, Stephen W.			IL23R (Interleukin 23 Receptor) Variants Protective against Inflammatory Bowel Diseases (IBD) Display Loss of Function due to Impaired Protein Stability and Intracellular Trafficking	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						genetic polymorphism; glycosylation; inflammatory bowel disease (IBD); protein trafficking (Golgi); receptor; interleukin 23 receptor	GENOME-WIDE ASSOCIATION; AMYLOID PRECURSOR PROTEIN; MEMBRANE-PROXIMAL REGION; CROHNS-DISEASE; ERYTHROPOIETIN RECEPTOR; AUTOIMMUNE INFLAMMATION; PROPROTEIN CONVERTASES; ENDOPLASMIC-RETICULUM; SUSCEPTIBILITY LOCI; FLUORESCENT PROTEIN	Genome-wide association studies as well as murine models have shown that the interleukin 23 receptor (IL23R) pathway plays a pivotal role in chronic inflammatory diseases such as Crohn disease (CD), ulcerative colitis, psoriasis, and type 1 diabetes. Genome-wide association studies and targeted re-sequencing studies have revealed the presence of multiple potentially causal variants of the IL23R. Specifically the G149R, V362I, and R381Q IL23R chain variants are linked to protection against the development of Crohn disease and ulcerative colitis in humans. Moreover, the exact mechanism of action of these receptor variants has not been elucidated. We show that all three of these IL23R variants cause a reduction in IL23 receptor activation-mediated phosphorylation of the signal-transducing activator of transcription 3 (STAT3) and phosphorylation of signal transducing activator of transcription 4 (STAT4). The reduction in signaling is due to lower levels of cell surface receptor expression. For G149R, the receptor retention in the endoplasmic reticulum is due to an impairment of receptor maturation, whereas the R381Q and V362I variants have reduced protein stability. Finally, we demonstrate that the endogenous expression of IL23R protein from V362I and R381Q variants in human lymphoblastoid cell lines exhibited lower expression levels relative to susceptibility alleles. Our results suggest a convergent cause of IL23R variant protection against chronic inflammatory disease.	[Sivanesan, Durga; Michnick, Stephen W.] Univ Montreal, Dept Biochem, Montreal, PQ H3C 3J7, Canada; [Beauchamp, Claudine; Rioux, John D.] Univ Montreal, Montreal, PQ H1T 1C8, Canada; [Beauchamp, Claudine; Rioux, John D.] Res Ctr, Montreal Heart Inst, Montreal, PQ H1T 1C8, Canada; [Lesage, Sylvie] Univ Montreal, Ctr Rech, Hosp Maisonneuve Rosemont, Montreal, PQ H1T 2M4, Canada; [Lesage, Sylvie] Univ Montreal, Dept Microbiol Infect & Immunol, Montreal, PQ H1T 2M4, Canada; [Quinou, Christiane; Chemtob, Sylvain] CHU Sainte Justine, Res Ctr, Montreal, PQ H3T 1C5, Canada; [Sivanesan, Durga; Lee, Jonathan] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON K1H 8M5, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal; University of Ottawa	Michnick, SW (corresponding author), Univ Montreal, Dept Biochem, Montreal, PQ H3C 3J7, Canada.	stephen.michnick@umontreal.ca	Rioux, John D/A-9599-2015	Rioux, John D/0000-0001-7560-8326; Lesage, Sylvie/0000-0002-0968-2795	NIDDK, National Institutes of Health	NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Debasmita Talapatra for assisting with experiments. We also thank the laboratory of Dr. Gerardo Ferberye for the pLpC binary vector and Monique Vasseur for help with microscopy. We extend our appreciation to Veronique Bourdeau, Emmanuelle Quierdo, Jacqueline Kowarzyk Moreno, Vincent Messier, and Jean-Francois Paradis for discussions. We also thank Dr. Nabil G. Sediah for identifying the possibility of G149R as a substrate for convertase in Golgi. We thank Katherine Harding for help with editing of the manuscript and discussion. The NIDDK Inflammatory Bowel Disease Genetics Consortium (IBDGC) study was conducted by the IBDGC Investigators and supported by the NIDDK, National Institutes of Health. The lymphoblastoid cell lines and related data from the Inflammatory Bowel Disease Genetics Consortium reported here were supplied by the NIDDK Central Repositories.	Abraham C, 2009, INFLAMM BOWEL DIS, V15, P1090, DOI 10.1002/ibd.20894; Ali BR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026206; Amre DK, 2008, AM J GASTROENTEROL, V103, P615, DOI 10.1111/j.1572-0241.2007.01661.x; Arkin MR, 2004, NAT REV DRUG DISCOV, V3, P301, DOI 10.1038/nrd1343; Awasthi A, 2009, J IMMUNOL, V182, P5904, DOI 10.4049/jimmunol.0900732; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Beaudoin M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003723; Bonaventure J, 2007, FEBS J, V274, P3078, DOI 10.1111/j.1742-4658.2007.05835.x; Budarf ML, 2009, TRENDS GENET, V25, P137, DOI 10.1016/j.tig.2009.01.001; Capon F, 2007, HUM GENET, V122, P201, DOI 10.1007/s00439-007-0397-0; CAPORASO GL, 1992, P NATL ACAD SCI USA, V89, P2252, DOI 10.1073/pnas.89.6.2252; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; Cho JH, 2008, NAT REV IMMUNOL, V8, P458, DOI 10.1038/nri2340; Chognard G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089092; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Di Meglio P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017160; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Eken A, 2014, MUCOSAL IMMUNOL, V7, P143, DOI 10.1038/mi.2013.33; Eugene E, 2007, J NEUROSCI, V27, P14108, DOI 10.1523/JNEUROSCI.2618-07.2007; Floss DM, 2013, J BIOL CHEM, V288, P19386, DOI 10.1074/jbc.M112.432153; Franke A, 2010, NAT GENET, V42, P292, DOI 10.1038/ng.553; Glosson-Byers Nicole L, 2014, JAKSTAT, V3, pe955393, DOI 10.4161/21623988.2014.955393; Guo W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045625; Hebert DN, 2005, TRENDS CELL BIOL, V15, P364, DOI 10.1016/j.tcb.2005.05.007; Heim EN, 2015, P NATL ACAD SCI USA, V112, pE4717, DOI 10.1073/pnas.1514230112; Hue S, 2006, J EXP MED, V203, P2473, DOI 10.1084/jem.20061099; Kizhakkedath P, 2014, BBA-MOL CELL RES, V1843, P2871, DOI 10.1016/j.bbamcr.2014.08.013; Lamon S, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00176; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Livnah O, 1999, SCIENCE, V283, P987, DOI 10.1126/science.283.5404.987; Loening AM, 2007, J MOL BIOL, V374, P1017, DOI 10.1016/j.jmb.2007.09.078; McGeachy MJ, 2009, NAT IMMUNOL, V10, P314, DOI 10.1038/ni.1698; McKenzie BS, 2006, TRENDS IMMUNOL, V27, P17, DOI 10.1016/j.it.2005.10.003; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Niederreiter L, 2013, CURR DRUG TARGETS, V14, P1379, DOI 10.2174/13894501113146660229; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Ouyang W, 2008, MUCOSAL IMMUNOL, V1, P335, DOI 10.1038/mi.2008.26; Parham C, 2002, J IMMUNOL, V168, P5699, DOI 10.4049/jimmunol.168.11.5699; Pidasheva S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025038; Quiniou C, 2014, AM J PHYSIOL-REG I, V307, pR1216, DOI 10.1152/ajpregu.00540.2013; Remy I, 1999, SCIENCE, V283, P990, DOI 10.1126/science.283.5404.990; Reshetnyak AV, 2013, P NATL ACAD SCI USA, V110, P17832, DOI 10.1073/pnas.1317118110; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Roy S, 2007, MOL ENDOCRINOL, V21, P1656, DOI 10.1210/me.2007-0041; Roy S, 2010, ENDOCRINOLOGY, V151, P660, DOI 10.1210/en.2009-0826; Sarin R, 2011, P NATL ACAD SCI USA, V108, P9560, DOI 10.1073/pnas.1017854108; Seidah NG, 2013, J BIOL CHEM, V288, P21473, DOI 10.1074/jbc.R113.481549; Seidah NG, 2011, METHODS MOL BIOL, V768, P23, DOI 10.1007/978-1-61779-204-5_3; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Silverberg MS, 2009, NAT GENET, V41, P216, DOI 10.1038/ng.275; Spoerri L, 2012, J BIOL CHEM, V287, P26840, DOI 10.1074/jbc.M112.355743; Stefan E, 2007, P NATL ACAD SCI USA, V104, P16916, DOI 10.1073/pnas.0704257104; Stefan E, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1605; Tchekanda E, 2014, NAT METHODS, V11, P641, DOI [10.1038/nmeth.2934, 10.1038/NMETH.2934]; Tong W, 2006, J BIOL CHEM, V281, P38930, DOI 10.1074/jbc.M607524200; van Geest M, 2000, MICROBIOL MOL BIOL R, V64, P13, DOI 10.1128/MMBR.64.1.13-33.2000; Vogt G, 2008, J EXP MED, V205, P1729, DOI 10.1084/jem.20071987; VONHEIJNE G, 1992, J MOL BIOL, V225, P487, DOI 10.1016/0022-2836(92)90934-C; Wells JA, 2007, NATURE, V450, P1001, DOI 10.1038/nature06526; Wheatley M, 1999, HUM REPROD UPDATE, V5, P356, DOI 10.1093/humupd/5.4.356; Yen D, 2006, J CLIN INVEST, V116, P1310, DOI 10.1172/JCI21404; Zhao XQ, 2011, J MATER CHEM, V21, P7240, DOI 10.1039/c1jm10277j; Zwiers A, 2012, J IMMUNOL, V188, P1573, DOI 10.4049/jimmunol.1101494	64	46	48	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2016	291	16					8673	8685		10.1074/jbc.M116.715870	http://dx.doi.org/10.1074/jbc.M116.715870			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK2VT	26887945	hybrid, Green Published			2022-12-26	WOS:000374773200030
J	Han, WGH; Hodemaekers, HM; Nagarajah, B; Poelen, MMC; Helm, K; Janssen, R; van Els, CACM				Han, Wanda G. H.; Hodemaekers, Hennie M.; Nagarajah, Bhawani; Poelen, Martien M. C.; Helm, Kina; Janssen, Riny; van Els, Cecile A. C. M.			Association of Vitamin D Receptor Polymorphism with Susceptibility to Symptomatic Pertussis	PLOS ONE			English	Article							SYNCYTIAL VIRUS BRONCHIOLITIS; BINDING LECTIN DEFICIENCY; BORDETELLA-PERTUSSIS; GENETIC SUSCEPTIBILITY; INFECTIOUS-DISEASES; RSV BRONCHIOLITIS; IMMUNE-SYSTEM; T-CELLS; PATHOGENESIS; EPIDEMIOLOGY	Pertussis, caused by infection with the gram negative B. pertussis bacterium, is a serious respiratory illness that can last for months. While B. pertussis infection rates are estimated between 1-10% in the general population, notifications of symptomatic pertussis only comprise 0.01-0.1% indicating that most individuals clear B. pertussis infections without developing (severe) clinical symptoms. In this study we investigated whether genetic risk factors are involved in the development of symptomatic pertussis upon B. pertussis infection. Single-nucleotide polymorphisms (SNPs) in candidate genes, MBL2, IL17A, TNF alpha, VDR, and IL10 were genotyped in a unique Dutch cohort of symptomatic clinically confirmed (ex-)pertussis patients and in a Dutch population cohort. Of the seven investigated SNPs in five genes, a polymorphism in the Vitamin D receptor (VDR) gene (rs10735810) was associated with pertussis. The VDR major allele and its homozygous genotype were more present in the symptomatic pertussis patient cohort compared to the control population cohort. Interestingly, the VDR major allele correlated also with the duration of reported pertussis symptoms. Vitamin D-3 (VD3) and VDR are important regulators of immune activation. Altogether, these findings suggest that polymorphisms in the VDR gene may affect immune activation and the clinical outcome of B. pertussis infection.	[Han, Wanda G. H.; Poelen, Martien M. C.; Helm, Kina; van Els, Cecile A. C. M.] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, NL-3720 BA Bilthoven, Netherlands; [Hodemaekers, Hennie M.; Nagarajah, Bhawani; Janssen, Riny] Natl Inst Publ Hlth & Environm, Ctr Hlth Protect, NL-3720 BA Bilthoven, Netherlands	Netherlands National Institute for Public Health & the Environment; Netherlands National Institute for Public Health & the Environment	Han, WGH (corresponding author), Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, NL-3720 BA Bilthoven, Netherlands.	wanda.han@rivm.nl			Dutch government	Dutch government	This study was financially supported by the Dutch government.	Asner SA, 2014, CLIN MICROBIOL INFEC, V20, P1246, DOI 10.1111/1469-0691.12806; Barrat FJ, 2002, J EXP MED, V195, P603, DOI 10.1084/jem.20011629; Brock KE, 2013, J STEROID BIOCHEM, V136, P214, DOI 10.1016/j.jsbmb.2012.12.005; Caballero MT, 2015, J CLIN INVEST, V125, P571, DOI 10.1172/JCI75183; Chen JH, 2010, J CLIN IMMUNOL, V30, P539, DOI 10.1007/s10875-010-9391-8; Cherry JD, 2012, NEW ENGL J MED, V367, P785, DOI 10.1056/NEJMp1209051; Chun RF, 2014, J STEROID BIOCHEM, V144, P132, DOI 10.1016/j.jsbmb.2013.09.012; Clark TA, 2014, J INFECT DIS, V209, P978, DOI 10.1093/infdis/jiu001; Dickie LJ, 2010, RHEUMATOLOGY, V49, P1466, DOI 10.1093/rheumatology/keq124; Eisen DP, 2003, CLIN INFECT DIS, V37, P1496, DOI 10.1086/379324; Gao L, 2010, INT J TUBERC LUNG D, V14, P15; Geurtsen J, 2007, CLIN VACCINE IMMUNOL, V14, P821, DOI 10.1128/CVI.00074-07; Grondahl-Yli-Hannuksela K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088919; Grondahl-Yli-Hannuksela K, 2013, APMIS, V121, P311, DOI 10.1111/apm.12000; Heitzeneder S, 2012, CLIN IMMUNOL, V143, P22, DOI 10.1016/j.clim.2011.11.002; Hewlett EL, 2014, J INFECT DIS, V209, P982, DOI 10.1093/infdis/jit639; Higgins SC, 2006, J IMMUNOL, V177, P7980, DOI 10.4049/jimmunol.177.11.7980; Hoebee B, 2004, J INFECT DIS, V189, P239, DOI 10.1086/380908; Hoebee B, 2003, J INFECT DIS, V187, P2, DOI 10.1086/345859; Janssen R, 2007, J INFECT DIS, V196, P826, DOI 10.1086/520886; Jeffery LE, 2012, J IMMUNOL, V189, P5155, DOI 10.4049/jimmunol.1200786; Jurutka PW, 2000, MOL ENDOCRINOL, V14, P401, DOI 10.1210/me.14.3.401; Khoo AL, 2012, CRIT REV MICROBIOL, V38, P122, DOI 10.3109/1040841X.2011.622716; Kresfelder TL, 2011, J MED VIROL, V83, P1834, DOI 10.1002/jmv.22179; Louis E, 1998, CLIN EXP IMMUNOL, V113, P401; Lucas RM, 2013, J STEROID BIOCHEM, V136, P300, DOI 10.1016/j.jsbmb.2013.01.011; Mattoo S, 2005, CLIN MICROBIOL REV, V18, P326, DOI 10.1128/CMR.18.2.326-382.2005; Melvin JA, 2014, NAT REV MICROBIOL, V12, P274, DOI 10.1038/nrmicro3235; Mora JR, 2008, NAT REV IMMUNOL, V8, P685, DOI 10.1038/nri2378; Paddock CD, 2008, CLIN INFECT DIS, V47, P328, DOI 10.1086/589753; Randolph AG, 2014, CLIN EXP ALLERGY, V44, P231, DOI 10.1111/cea.12247; Ross PJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003264; Roth DE, 2008, J INFECT DIS, V197, P676, DOI 10.1086/527488; Sadeghi K, 2006, EUR J IMMUNOL, V36, P361, DOI 10.1002/eji.200425995; Temple SEL, 2003, IMMUNOGENETICS, V55, P629, DOI 10.1007/s00251-003-0621-6; Unger WWJ, 2009, EUR J IMMUNOL, V39, P3147, DOI 10.1002/eji.200839103; van der Ark AAJ, 2012, EXPERT REV VACCINES, V11, P1121, DOI [10.1586/ERV.12.83, 10.1586/erv.12.83]; van der Maas NAT, 2013, VACCINE, V31, P4541, DOI 10.1016/j.vaccine.2013.07.060; van Etten E, 2007, EUR J IMMUNOL, V37, P395, DOI 10.1002/eji.200636043; van Lier EA, 2014, 150202003 RIVM; Viet AL vGH, 1998, RISK FACTORS HLTH NE; Wang T, 2004, J NEURAL ENG, V1, DOI 10.1088/1741-2560/1/1/001; Warfel JM, 2014, P NATL ACAD SCI USA, V111, P787, DOI 10.1073/pnas.1314688110; Whitfield GK, 2001, MOL CELL ENDOCRINOL, V177, P145; Wilkinson RJ, 2000, LANCET, V355, P618, DOI 10.1016/S0140-6736(99)02301-6; Yu W, 2008, NAT GENET, V40, P124, DOI 10.1038/ng0208-124; YU XP, 1995, P NATL ACAD SCI USA, V92, P10990, DOI 10.1073/pnas.92.24.10990; Yucesoy B, 2009, VACCINE, V27, P6991, DOI 10.1016/j.vaccine.2009.09.076	48	14	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0149576	10.1371/journal.pone.0149576	http://dx.doi.org/10.1371/journal.pone.0149576			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3DG	26894582	gold, Green Published			2022-12-26	WOS:000371223400066
J	Munang'andu, HM; Santi, N; Fredriksen, BN; Lokling, KE; Evensen, O				Munang'andu, Hetron Mweemba; Santi, Nina; Fredriksen, Borge Nilsen; Lokling, Knut-Egil; Evensen, Oystein			A Systematic Approach towards Optimizing a Cohabitation Challenge Model for Infectious Pancreatic Necrosis Virus in Atlantic Salmon (Salmo salar L.)	PLOS ONE			English	Article							PARAFFIN-EMBEDDED SPECIMENS; TROUT ONCORHYNCHUS-MYKISS; SAMPLE-SIZE; VACCINATION; VIRULENCE; EFFICACY; IPNV	A cohabitation challenge model was developed for use in evaluating the efficacy of vaccines developed against infectious pancreatic necrosis virus (IPNV) in Atlantic salmon (Salmo salar L) using a stepwise approach. The study involved identifying a set of input variables that were optimized before inclusion in the model. Input variables identified included the highly virulent Norwegian Sp strain NVI015-TA encoding the T(217)A(221) motif having the ability to cause >90% mortality and a hazard risk ratio of 490.18 (p<0.000) for use as challenge virus. The challenge dose was estimated at 1x10(7) TCID50/mL per fish while the proportion of virus shedders was estimated at 12.5% of the total number of fish per tank. The model was designed based on a three parallel tank system in which the Cox hazard proportional regression model was used to estimate the minimum number of fish required to show significant differences between the vaccinated and control fish in each tank. All input variables were optimized to generate mortality >75% in the unvaccinated fish in order to attain a high discriminatory capacity (DC) between the vaccinated and control fish as a measure of vaccine efficacy. The model shows the importance of using highly susceptible fish to IPNV in the optimization of challenge models by showing that highly susceptible fish had a better DC of differentiating vaccine protected fish from the unvaccinated control fish than the less susceptible fish. Once all input variables were optimized, the model was tested for its reproducibility by generating similar results from three independent cohabitation challenge trials using the same input variables. Overall, data presented here show that the cohabitation challenge model developed in this study is reproducible and that it can reliably be used to evaluate the efficacy of vaccines developed against IPNV in Atlantic salmon. We envision that the approach used here will open new avenues for developing optimal challenge models for use in evaluating the efficacy of different vaccines used in aquaculture.	[Munang'andu, Hetron Mweemba; Evensen, Oystein] Norwegian Univ Life Sci, Fac Vet Med & Biosci, Dept Basic Sci & Aquat Med, Sect Aquat Med & Nutr, Ullevalsveien 72, Oslo, Norway; [Santi, Nina] AquaGen, Trondheim, Norway; [Fredriksen, Borge Nilsen; Lokling, Knut-Egil] PHARMAQ AS, Harbitzalleen 2A, N-0275 Oslo, Norway	Norwegian University of Life Sciences	Evensen, O (corresponding author), Norwegian Univ Life Sci, Fac Vet Med & Biosci, Dept Basic Sci & Aquat Med, Sect Aquat Med & Nutr, Ullevalsveien 72, Oslo, Norway.	oystein.evensen@nmbu.no	Munang'andu, Hetron Mweemba/C-5926-2014	Munang'andu, Hetron Mweemba/0000-0002-1021-6396				Amend D.F., 1981, FISH BIOL SERODIAGNO, V49, P447; BLACKWELDER WC, 1993, STAT MED, V12, P691, DOI 10.1002/sim.4780120708; Bowden TJ, 2003, J FISH DIS, V26, P309, DOI 10.1046/j.1365-2761.2003.00456.x; Bowden TJ, 2002, J FISH DIS, V25, P555, DOI 10.1046/j.1365-2761.2002.00402.x; Carpenter TE, 2001, AM J VET RES, V62, P1582, DOI 10.2460/ajvr.2001.62.1582; COX DR, 1972, J R STAT SOC B, V34, P187; DOBOS P, 1976, NUCLEIC ACIDS RES, V3, P1903, DOI 10.1093/nar/3.8.1903; EMEA, 1998, EUR AG EV MED PROD C; Evensen O, 1997, VET PATHOL, V34, P253, DOI 10.1177/030098589703400316; Evensen O, 1997, DIS AQUAT ORGAN, V29, P227, DOI 10.3354/dao029227; Gomez-Casado E, 2011, VACCINE, V29, P2657, DOI 10.1016/j.vaccine.2011.01.097; JARP J, 1995, J FISH DIS, V18, P67, DOI 10.1111/j.1365-2761.1995.tb01267.x; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Munang'andu HM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054263; Munang'andu HM, 2012, VACCINE, V30, P4007, DOI 10.1016/j.vaccine.2012.04.039; Munang'andu HM, 2014, DEV COMP IMMUNOL, V43, P184, DOI 10.1016/j.dci.2013.08.008; Munang'andu HM, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-7; Munang'andu HM, 2013, VACCINE, V31, P1956, DOI 10.1016/j.vaccine.2013.02.008; Munang'andu HM, 2013, THESIS NORWEGIAN SCH; Mutoloki S, 2013, FISH SHELLFISH IMMUN, V34, P1667, DOI 10.1016/j.fsi.2013.03.103; Ramstad A, 2008, J FISH DIS, V31, P567, DOI 10.1111/j.1365-2761.2008.00929.x; Ramstad A, 2007, J FISH DIS, V30, P723, DOI 10.1111/j.1365-2761.2007.00858.x; Rao MR, 2002, VACCINE, V20, P3364, DOI 10.1016/S0264-410X(02)00317-1; Rusche B, 2003, ALTEX-ALTERN TIEREXP, V20, P63; Santi N, 2004, VIROLOGY, V322, P31, DOI 10.1016/j.virol.2003.12.016	25	14	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0148467	10.1371/journal.pone.0148467	http://dx.doi.org/10.1371/journal.pone.0148467			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3DG	26895162	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000371223400016
J	Singh, UB; Pandey, P; Mehta, G; Bhatnagar, AK; Mohan, A; Goyal, V; Ahuja, V; Ramachandran, R; Sachdeva, KS; Samantaray, JC				Singh, Urvashi B.; Pandey, Pooja; Mehta, Girija; Bhatnagar, Anuj K.; Mohan, Anant; Goyal, Vinay; Ahuja, Vineet; Ramachandran, Ranjani; Sachdeva, Kuldeep S.; Samantaray, Jyotish C.			Genotypic, Phenotypic and Clinical Validation of GeneXpert in Extra-Pulmonary and Pulmonary Tuberculosis in India	PLOS ONE			English	Article							XPERT MTB/RIF ASSAY; MYCOBACTERIUM-TUBERCULOSIS; RIFAMPIN RESISTANCE; DRUG-RESISTANCE; RAPID DIAGNOSIS; RPOB GENE; PERFORMANCE; COMPLEX; HETERORESISTANCE; EPIDEMIOLOGY	Background Newer molecular diagnostics have brought paradigm shift in early diagnosis of tuberculosis [TB]. WHO recommended use of GeneXpert MTB/RIF [Xpert] for Extra-pulmonary [EP] TB; critics have since questioned its efficiency. Methods The present study was designed to assess the performance of GeneXpert in 761 extra-pulmonary and 384 pulmonary specimens from patients clinically suspected of TB and compare with Phenotypic, Genotypic and Composite reference standards [CRS]. Results Comparison of GeneXpert results to CRS, demonstrated sensitivity of 100% and 90.68%, specificity of 100% and 99.62% for pulmonary and extra-pulmonary samples. On comparison with culture, sensitivity for Rifampicin [Rif] resistance detection was 87.5% and 81.82% respectively, while specificity was 100% for both pulmonary and extra-pulmonary TB. On comparison to sequencing of rpoB gene [Rif resistance determining region, RRDR], sensitivity was respectively 93.33% and 90% while specificity was 100% in both pulmonary and extra-pulmonary TB. GeneXpert assay missed 533CCG mutation in one sputum and dual mutation [517 & 519] in one pus sample, detected by sequencing. Sequencing picked dual mutation [529, 530] in a sputum sample sensitive to Rif, demonstrating, not all RRDR mutations lead to resistance. Conclusions Current study reports observations in a patient care setting in a high burden region, from a large collection of pulmonary and extra-pulmonary samples and puts to rest questions regarding sensitivity, specificity, detection of infrequent mutations and mutations responsible for low-level Rif resistance by GeneXpert. Improvements in the assay could offer further improvement in sensitivity of detection in different patient samples; nevertheless it may be difficult to improve sensitivity of Rif resistance detection if only one gene is targeted. Assay specificity was high both for TB detection and Rif resistance detection. Despite a few misses, the assay offers major boost to early diagnosis of TB and MDR-TB, in difficult to diagnose pauci-bacillary TB.	[Singh, Urvashi B.; Pandey, Pooja; Mehta, Girija; Samantaray, Jyotish C.] All India Inst Med Sci, Dept Microbiol, New Delhi 110029, India; [Bhatnagar, Anuj K.] Rajan Babu Inst Pulm Med & TB, Delhi, India; [Mohan, Anant] All India Inst Med Sci, Dept Pulm Med & Sleep Disorders, New Delhi, India; [Goyal, Vinay] All India Inst Med Sci, Dept Neurol, New Delhi, India; [Ahuja, Vineet] All India Inst Med Sci, Dept Gastroenterol & Human Nutr, New Delhi, India; [Ramachandran, Ranjani] WHO, Country Off India, New Delhi, India; [Sachdeva, Kuldeep S.] Govt India, Cent TB Div, New Delhi, India	All India Institute of Medical Sciences (AIIMS) New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi; World Health Organization	Singh, UB (corresponding author), All India Inst Med Sci, Dept Microbiol, New Delhi 110029, India.	drurvashi@gmail.com	Ahuja, Vineet/N-1705-2019; Kedia, Saurabh/AAD-7227-2020	Ahuja, Vineet/0000-0002-5474-9709; 	Indian Council of Medical Research [5/8/5/27/2011-ECD-1]; Indian Council of Medical Research [ICMR]	Indian Council of Medical Research(Indian Council of Medical Research (ICMR)); Indian Council of Medical Research [ICMR](Indian Council of Medical Research (ICMR))	This work was supported by Indian Council of Medical Research 5/8/5/27/2011-ECD-1, http://www.icmr.nic.in/ (UBS). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank all our patients that made this study possible. We also thank the technical staff of TB division, Department of Microbiology, AIIMS, New Delhi, India for their support. The authors acknowledge the funding received from Indian Council of Medical Research [ICMR].	Al-Mutairi NM, 2011, INT J TUBERC LUNG D, V15, P110; Blakemore R, 2010, J CLIN MICROBIOL, V48, P2495, DOI 10.1128/JCM.00128-10; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Central TB Division Ministry of Health and Family Welfare, 2010, TRAIN MOD MED PRACT; Central TB Division Ministry of Health and Family Welfare, 2009, TRAIN MAN MYC TUB CU; Central TB Division Ministry of Health and Family Welfare New Delhi India Revised National TB Control Programme, 2012, GUIDELINES PROGRAMMA; Chakravorty S, 2012, J CLIN MICROBIOL, V50, P2194, DOI 10.1128/JCM.00143-12; Denkinger CM, 2014, EUR RESPIR J, V44, P435, DOI 10.1183/09031936.00007814; El-Hajj HH, 2001, J CLIN MICROBIOL, V39, P4131, DOI 10.1128/JCM.39.11.4131-4137.2001; Friedrich SO, 2011, J CLIN MICROBIOL, V49, P4341, DOI 10.1128/JCM.05454-11; Gandhi NR, 2010, AM J RESP CRIT CARE, V181, P80, DOI 10.1164/rccm.200907-0989OC; Helb D, 2010, J CLIN MICROBIOL, V48, P229, DOI 10.1128/JCM.01463-09; Huang WL, 2009, J CLIN MICROBIOL, V47, P2520, DOI 10.1128/JCM.02499-08; Jamieson FB, 2014, J CLIN MICROBIOL, V52, P2157, DOI 10.1128/JCM.00691-14; Jou R, 2005, J CLIN MICROBIOL, V43, P1390, DOI 10.1128/JCM.43.3.1390-1394.2005; Kim S., 2012, J NANOMATER, V2012, P1, DOI DOI 10.1080/19443994.2012.664382; KUBICA GP, 1963, AM REV RESPIR DIS, V87, P775; Ligthelm LJ, 2011, J CLIN MICROBIOL, V49, P3967, DOI 10.1128/JCM.01310-11; Mathema B, 2006, CLIN MICROBIOL REV, V19, P658, DOI 10.1128/CMR.00061-05; Rigouts L, 2013, J CLIN MICROBIOL, V51, P2641, DOI 10.1128/JCM.02741-12; Sharma SK, 2004, INDIAN J MED RES, V120, P354; Siddiqi SH, 2006, MGIT PROCEDURE MANUA; Somoskovi A, 2014, J CLIN MICROBIOL, V52, P705, DOI 10.1128/JCM.02682-13; Somoskovi A, 2006, J CLIN MICROBIOL, V44, P4459, DOI 10.1128/JCM.01506-06; SUO J, 1988, AM REV RESPIR DIS, V138, P999, DOI 10.1164/ajrccm/138.4.999; Suresh N, 2006, INFECT GENET EVOL, V6, P474, DOI 10.1016/j.meegid.2006.03.001; Taniguchi H, 1996, FEMS MICROBIOL LETT, V144, P103, DOI 10.1016/0378-1097(96)00346-1; Thomsen Todd W, 2006, N Engl J Med, V355, pe16, DOI 10.1056/NEJMvcm053812; Tortoli E, 2012, EUR RESPIR J, V40, P442, DOI 10.1183/09031936.00176311; Vadwai V, 2011, J CLIN MICROBIOL, V49, P2540, DOI 10.1128/JCM.02319-10; Van Deun A, 2011, INT J TUBERC LUNG D, V15, P116; Van Deun A, 2009, J CLIN MICROBIOL, V47, P3501, DOI 10.1128/JCM.01209-09; Van Deun A, 2013, J CLIN MICROBIOL, V51, P2633, DOI 10.1128/JCM.00553-13; van Rie A, 2005, AM J RESP CRIT CARE, V172, P636, DOI 10.1164/rccm.200503-449OC; VANSOOLINGEN D, 1991, J CLIN MICROBIOL, V29, P2578, DOI 10.1128/JCM.29.11.2578-2586.1991; Varma-Basil M, 2004, J CLIN MICROBIOL, V42, P5512, DOI 10.1128/JCM.42.12.5512-5516.2004; Victor TC, 2002, IUBMB LIFE, V53, P231, DOI 10.1080/15216540212642; WHO, STANDARD OPERATING P; World Health Organization, 2008, MOL LIN PROB ASS RAP; World Health Organization, 2011, RAP IMPL XPERT MTB R; World Health Organization, 2013, DEFINITIONS REPORTIN; World Health Organization, 2007, US LIQ TB CULT DRUG; Zeka AN, 2011, J CLIN MICROBIOL, V49, P4138, DOI 10.1128/JCM.05434-11; Zetola NM, 2014, J CLIN MICROBIOL, V52, P2422, DOI 10.1128/JCM.02489-13; Zhang ZJ, 2014, ANTIMICROB AGENTS CH, V58, P5632, DOI 10.1128/AAC.02778-14	46	35	37	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0149258	10.1371/journal.pone.0149258	http://dx.doi.org/10.1371/journal.pone.0149258			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3DG	26894283	Green Submitted, Green Published, gold			2022-12-26	WOS:000371223400042
J	Soldanova, M; Selbach, C; Sures, B				Soldanova, Miroslava; Selbach, Christian; Sures, Bernd			The Early Worm Catches the Bird? Productivity and Patterns of Trichobilharzia szidati Cercarial Emission from Lymnaea stagnalis	PLOS ONE			English	Article							DIPLOSTOMUM-SPATHACEUM; BIOMPHALARIA-GLABRATA; SCHISTOSOMA-MANSONI; TREMATODE COMMUNITIES; LARVAL POPULATIONS; PARASITES; HOST; TRANSMISSION; DIVERSITY; EMERGENCE	Digenean trematodes are common and abundant in aquatic habitats and their free-living larvae, the cercariae, have recently been recognized as important components of ecosystems in terms of comprising a significant proportion of biomass and in having a potentially strong influence on food web dynamics. One strategy to enhance their transmission success is to produce high numbers of cercariae which are available during the activity peak of the next host. In laboratory experiments with 13 Lymnaea stagnalis snails infected with Trichobilharzia szidati the average daily emergence rate per snail was determined as 2,621 cercariae, with a maximum of 29,560. During a snail's lifetime this summed up to a mass equivalent of or even exceeding the snail's own body mass. Extrapolated for the eutrophic pond where the snails were collected, annual T. szidati biomass may reach 4.65 tons, a value equivalent to a large Asian elephant. Emission peaks were observed after the onset of illumination, indicating emission synchronizing with the high morning activities of the definitive hosts, ducks. However, high cercarial emission is possible throughout the day under favorable lightning conditions. Therefore, although bird schistosomes, such as T. szidati constitute only a fraction of the diverse trematode communities in the studied aquatic ecosystem, their cercariae can still pose a considerable risk for humans of getting cercarial dermatitis (swimmer's itch) due to the high number of cercariae emitted from infected snails.	[Soldanova, Miroslava] Acad Sci Czech Republ, Inst Parasitol, Ctr Biol, Branisovska 31, CR-37005 Ceske Budejovice, Czech Republic; [Selbach, Christian; Sures, Bernd] Univ Duisburg Essen, Dept Aquat Ecol, Essen, Germany; [Selbach, Christian; Sures, Bernd] Univ Duisburg Essen, Ctr Water & Environm Res ZWU, Essen, Germany; [Sures, Bernd] Univ Johannesburg, Dept Zool, Johannesburg, South Africa	Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; University of Duisburg Essen; University of Duisburg Essen; University of Johannesburg	Soldanova, M (corresponding author), Acad Sci Czech Republ, Inst Parasitol, Ctr Biol, Branisovska 31, CR-37005 Ceske Budejovice, Czech Republic.	soldanova@paru.cas.cz	Sures, Bernd/B-6652-2013; Soldanova, Miroslava/G-7215-2014	Soldanova, Miroslava/0000-0002-5277-3799; Selbach, Christian/0000-0002-7777-6515; Sures, Bernd/0000-0001-6865-6186	Czech Science Foundation [15-14198S]; Institute of Parasitology, Biology Centre of the Czech Academy of Sciences [RVO:60077344]; Bundesministerium fur Bildung und Forschung (BMBF) [02WRS1283]; Deutsche Bundesstiftung Umwelt (DBU); Faculty of Biology of the University of Duisburg-Essen	Czech Science Foundation(Grant Agency of the Czech Republic); Institute of Parasitology, Biology Centre of the Czech Academy of Sciences; Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF)); Deutsche Bundesstiftung Umwelt (DBU); Faculty of Biology of the University of Duisburg-Essen	This study was partially funded by the Czech Science Foundation (Proj. No. 15-14198S to MS), Institute of Parasitology, Biology Centre of the Czech Academy of Sciences (RVO:60077344) and the 'Sichere Ruhr' project as part of the Bundesministerium fur Bildung und Forschung (BMBF) program 'Sustainable Water Management' (grant 02WRS1283 to MS and BS). CS benefited from a Deutsche Bundesstiftung Umwelt (DBU) PhD fellowship and a research grant by the Faculty of Biology of the University of Duisburg-Essen.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Amundsen PA, 2009, J ANIM ECOL, V78, P563, DOI 10.1111/j.1365-2656.2008.01518.x; ANDERSON PA, 1976, CAN J ZOOL, V54, P1481, DOI 10.1139/z76-171; Brant SV, 2013, TRENDS PARASITOL, V29, P449, DOI 10.1016/j.pt.2013.06.004; BRASSARD P, 1982, CAN J ZOOL, V60, P2258, DOI 10.1139/z82-291; Brown R, 2011, PARASITOL RES, V108, P137, DOI 10.1007/s00436-010-2047-z; COMBES C, 1994, PARASITOLOGY, V109, pS3, DOI 10.1017/S0031182000085048; ESCH GW, 1994, AM MIDL NAT, V131, P209, DOI 10.2307/2426248; Finch Caleb E., 1999, P613; Galaktionov K.V., 2003, BIOL EVOLUTION TREMA; Gloer P., 2002, DIE SU BETA WASSERGA; Haas W, 2003, ZOOLOGY, V106, P349, DOI 10.1078/0944-2006-00125; Hechinger RF, 2005, P ROY SOC B-BIOL SCI, V272, P1059, DOI 10.1098/rspb.2005.3070; Hechinger RF, 2009, EVOL ECOL, V23, P651, DOI 10.1007/s10682-008-9262-4; Hechinger RF, 2007, OECOLOGIA, V151, P82, DOI 10.1007/s00442-006-0568-z; Hechinger RF, 2013, AM NAT, V182, P234, DOI 10.1086/670820; Horak P, 2005, PARASITE IMMUNOL, V27, P247, DOI 10.1111/j.1365-3024.2005.00776.x; Horak P, 2002, ADV PARASIT, V52, P155, DOI 10.1016/S0065-308X(02)52012-1; Horak P, 2001, TRENDS PARASITOL, V17, P66, DOI 10.1016/S1471-4922(00)01770-0; Horak P, 2015, CLIN MICROBIOL REV, V28, P165, DOI 10.1128/CMR.00043-14; Horak P, 2014, ADV EXP MED BIOL, V766, P331, DOI 10.1007/978-1-4939-0915-5_10; Horak P, 2011, FRESHWATER BIOL, V56, P779, DOI 10.1111/j.1365-2427.2010.02545.x; Horsak M, 2013, MEKKYSI CESKE SLOVEN; Hudson P, 2005, PARASITISM AND ECOSYSTEMS, P1; Johnson PTJ, 2010, TRENDS ECOL EVOL, V25, P362, DOI 10.1016/j.tree.2010.01.005; Jurkiewicz-Karnkowska E, 2008, POL J ECOL, V56, P99; Karvonen A, 2004, PARASITOLOGY, V129, P87, DOI 10.1017/S0031182004005281; Koehler AV, 2012, EVOL ECOL, V26, P1497, DOI 10.1007/s10682-012-9558-2; KURIS A, 1990, PARASITE COMMUNITIES : PATTERNS AND PROCESSES, P69, DOI 10.1007/978-94-009-0837-6_4; Kuris AM, 2008, NATURE, V454, P515, DOI 10.1038/nature06970; Lafferty KD, 2008, ECOL LETT, V11, P533, DOI 10.1111/j.1461-0248.2008.01174.x; Lafferty KD, 2006, P NATL ACAD SCI USA, V103, P11211, DOI 10.1073/pnas.0604755103; Lindblade KA, 1998, J PARASITOL, V84, P19, DOI 10.2307/3284521; Loy C, 2001, PARASITOL RES, V87, P878, DOI 10.1007/s004360100462; Lyholt HCK, 1996, DIS AQUAT ORGAN, V25, P169, DOI 10.3354/dao025169; Morley NJ, 2013, PARASITOLOGY, V140, P1211, DOI 10.1017/S0031182012001783; Morley NJ, 2012, HYDROBIOLOGIA, V691, P7, DOI 10.1007/s10750-012-1029-9; Neuhaus W., 1952, Zeitschrift fuer Parasitenkunde, V15, P203; NGoran E, 1997, ACTA TROP, V66, P35, DOI 10.1016/S0001-706X(97)00676-1; PAGES JR, 1990, INT J PARASITOL, V20, P193, DOI 10.1016/0020-7519(90)90100-2; Pietrock M, 2003, TRENDS PARASITOL, V19, P293, DOI 10.1016/S1471-4922(03)00117-X; Poulin R, 2006, PARASITOLOGY, V132, P143, DOI 10.1017/S0031182005008693; Poulin R, 2007, INT J PARASITOL, V37, P359, DOI 10.1016/j.ijpara.2006.11.009; Preston DL, 2013, J ANIM ECOL, V82, P509, DOI 10.1111/1365-2656.12030; Preston Daniel L., 2012, Ecology (Washington D C), V93, P1760; Rudolfova J, 2005, PARASITOL RES, V95, P79, DOI 10.1007/s00436-004-1262-x; Sauter A, 2012, J ORNITHOL, V153, P713, DOI 10.1007/s10336-011-0788-9; Selbach C, 2015, INT J HYG E IN PRESS; SLUITERS JF, 1980, Z PARASITENKD, V63, P13, DOI 10.1007/BF00927722; Soldanova M, 2011, PARASITOLOGY, V138, P789, DOI 10.1017/S0031182011000291; Soldanova M, 2013, TRENDS PARASITOL, V29, P65, DOI 10.1016/j.pt.2012.12.002; Soldanova M, 2012, J PARASITOL, V98, P460, DOI 10.1645/GE-2964.1; Soldanova M, 2011, INT J PARASITOL, V41, P981, DOI 10.1016/j.ijpara.2011.05.005; Soldanova M, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-56; Studer A, 2013, MAR BIOL, V160, P2763, DOI 10.1007/s00227-013-2269-6; Taskinen J, 1998, J PARASITOL, V84, P345, DOI 10.2307/3284493; Theron A, 1997, PARASITOL RES, V83, P356, DOI 10.1007/s004360050261; THERON A, 1981, ANN TROP MED PARASIT, V75, P547, DOI 10.1080/00034983.1981.11687479; THERON A, 1981, ANN TROP MED PARASIT, V75, P71, DOI 10.1080/00034983.1981.11720796; Thieltges DW, 2008, PARASITOLOGY, V135, P407, DOI 10.1017/S0031182007000248; Thieltges DW, 2013, OIKOS, V122, P1473, DOI 10.1111/j.1600-0706.2013.00243.x; Thieltges DW, 2008, MAR ECOL PROG SER, V372, P147, DOI 10.3354/meps07703; Toledo R, 1999, J PARASITOL, V85, P263, DOI 10.2307/3285630; Verbrugge LM, 2004, J PARASITOL, V90, P697, DOI 10.1645/GE-237R; Welsh JE, 2014, J MAR BIOL ASSOC UK, V94, P697, DOI 10.1017/S0025315414000034; Zbikowska E, 2001, Wiad Parazytol, V47, P427; Zbikowska E, 2006, PARASITOL RES, V99, P434, DOI 10.1007/s00436-006-0178-z; Zikmundova J, 2014, SYST PARASITOL, V88, P37, DOI 10.1007/s11230-014-9481-8	68	46	46	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0149678	10.1371/journal.pone.0149678	http://dx.doi.org/10.1371/journal.pone.0149678			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3DG	26895541	Green Published, gold, Green Submitted			2022-12-26	WOS:000371223400074
J	Vea, IM; Tanaka, S; Shiotsuki, T; Jouraku, A; Tanaka, T; Minakuchi, C				Vea, Isabelle Mifom; Tanaka, Sayumi; Shiotsuki, Takahiro; Jouraku, Akiya; Tanaka, Toshiharu; Minakuchi, Chieka			Differential Juvenile Hormone Variations in Scale Insect Extreme Sexual Dimorphism	PLOS ONE			English	Article							BEETLE TRIBOLIUM-CASTANEUM; RED FLOUR BEETLE; KRUPPEL HOMOLOG 1; METHOPRENE-TOLERANT; BROAD-COMPLEX; DROSOPHILA-MELANOGASTER; METAMORPHOSIS; GENE; EVOLUTION; EXPRESSION	Scale insects have evolved extreme sexual dimorphism, as demonstrated by sedentary juvenile-like females and ephemeral winged males. This dimorphism is established during the post-embryonic development; however, the underlying regulatory mechanisms have not yet been examined. We herein assessed the role of juvenile hormone (JH) on the diverging developmental pathways occurring in the male and female Japanese mealybug Planococcus kraunhiae (Kuwana). We provide, for the first time, detailed gene expression profiles related to JH signaling in scale insects. Prior to adult emergence, the transcript levels of JH acid O-methyltransferase, encoding a rate-limiting enzyme in JH biosynthesis, were higher in males than in females, suggesting that JH levels are higher in males. Furthermore, male quiescent pupal-like stages were associated with higher transcript levels of the JH receptor gene, Methoprene-tolerant and its co-activator taiman, as well as the JH early-response genes, Kruppel homolog 1 and broad. The exposure of male juveniles to an ectopic JH mimic prolonged the expression of Kruppel homolog 1 and broad, and delayed adult emergence by producing a supernumeral pupal stage. We propose that male wing development is first induced by up-regulated JH signaling compared to female expression pattern, but a decrease at the end of the prepupal stage is necessary for adult emergence, as evidenced by the JH mimic treatments. Furthermore, wing development seems linked to JH titers as JHM treatments on the pupal stage led to wing deformation. The female pedomorphic appearance was not reflected by the maintenance of high levels of JH. The results in this study suggest that differential variations in JH signaling may be responsible for sex-specific and radically different modes of metamorphosis.	[Vea, Isabelle Mifom; Tanaka, Sayumi; Tanaka, Toshiharu; Minakuchi, Chieka] Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan; [Shiotsuki, Takahiro; Jouraku, Akiya] Natl Inst Agrobiol Sci, Tsukuba, Ibaraki, Japan; [Vea, Isabelle Mifom; Minakuchi, Chieka] Nagoya Univ, Grad Sch Bioagr Sci, Appl Entomol Lab, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648601, Japan	Nagoya University; National Institute of Agrobiological Sciences - Japan; Nagoya University	Vea, IM (corresponding author), Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan.; Vea, IM (corresponding author), Nagoya Univ, Grad Sch Bioagr Sci, Appl Entomol Lab, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648601, Japan.	isabelle.vea@gmail.com	; Vea, Isabelle/K-1618-2015	Shiotsuki, Takahiro/0000-0001-5077-7270; Vea, Isabelle/0000-0001-9351-7970; Jouraku, Akiya/0000-0003-3264-8293	Japanese Society for the Promotion of Science; Japan Society for the Promotion of Science [15K07791]; Grants-in-Aid for Scientific Research [14F04402, 15K07791] Funding Source: KAKEN	Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	IMV was funded by a Japanese Society for the Promotion of Science Postdoctoral Fellowship for North American and European and a Postdoctoral Fellowship for Overseas Researchers and this work was supported by a Grant-in-aid for Scientific Research (15K07791) to CM from the Japan Society for the Promotion of Science.	Bachtrog D, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001899; Beck Y, 2004, DEV BIOL, V268, P64, DOI 10.1016/j.ydbio.2003.12.017; Belles X., 2011, ORIGIN AND EVOLUTION; Belles X, 2014, INSECT BIOCHEM MOLEC, V52, P60, DOI 10.1016/j.ibmb.2014.06.009; Bongiorni S, 2001, DEVELOPMENT, V128, P3809; Charles JP, 2011, P NATL ACAD SCI USA, V108, P21128, DOI 10.1073/pnas.1116123109; Erezyilmaz DF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093614; Erezyilmaz DF, 2006, P NATL ACAD SCI USA, V103, P6925, DOI 10.1073/pnas.0509983103; Grimaldi D, 2005, EVOLUTION OF THE INS; Gullan PJ, 1997, ANNU REV ENTOMOL, V42, P23, DOI 10.1146/annurev.ento.42.1.23; Hodin J, 2000, DEV GENES EVOL, V210, P358, DOI 10.1007/s004270000079; Huang JH, 2013, BBA-GEN SUBJECTS, V1830, P2178, DOI 10.1016/j.bbagen.2012.09.025; Jindra M, 2015, CURR OPIN INSECT SCI, V11, P39, DOI 10.1016/j.cois.2015.08.004; Jindra M, 2013, ANNU REV ENTOMOL, V58, P181, DOI 10.1146/annurev-ento-120811-153700; Karlson P, 1996, INT J DEV BIOL, V40, P93; Kayukawa T, 2012, P NATL ACAD SCI USA, V109, P11729, DOI 10.1073/pnas.1204951109; KISS I, 1988, GENETICS, V118, P247; KISS I, 1976, NATURE, V262, P136, DOI 10.1038/262136a0; Konopova B, 2008, DEVELOPMENT, V135, P559, DOI 10.1242/dev.016097; Konopova B, 2007, P NATL ACAD SCI USA, V104, P10488, DOI 10.1073/pnas.0703719104; Konopova B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028728; Li M, 2011, P NATL ACAD SCI USA, V108, P638, DOI 10.1073/pnas.1013914108; Li WF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068544; Lozano J, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004769; Lozano J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103614; Lozano J, 2011, SCI REP-UK, V1, DOI 10.1038/srep00163; Marchal E, 2011, INSECT BIOCHEM MOLEC, V41, P219, DOI 10.1016/j.ibmb.2010.12.007; Matsuda R, 1976, MORPHOLOGY AND EVOLU; Matsuda R., 1987, ANIMAL EVOLUTION IN; Minakuchi C, 2009, DEV BIOL, V325, P341, DOI 10.1016/j.ydbio.2008.10.016; Minakuchi C, 2008, FEBS J, V275, P2919, DOI 10.1111/j.1742-4658.2008.06428.x; Minakuchi C, 2008, MECH DEVELOP, V125, P91, DOI 10.1016/j.mod.2007.10.002; Minakuchi C, 2011, INSECT BIOCHEM MOLEC, V41, P125, DOI 10.1016/j.ibmb.2010.11.004; Misof B, 2014, SCIENCE, V346, P763, DOI 10.1126/science.1257570; Miura K, 2005, FEBS J, V272, P1169, DOI 10.1111/j.1742-4658.2005.04552.x; Nijhout H.F., 1998, INSECT HORMONES, P280; NUR U, 1980, INSECT CYTOGENETICS, P97; Parthasarathy R, 2008, MECH DEVELOP, V125, P299, DOI 10.1016/j.mod.2007.11.001; Pecasse F, 2000, DEV BIOL, V221, P53, DOI 10.1006/dbio.2000.9687; Pflugfelder O., 1936, Zoologischer Anzeiger Leipzig, V114, P49; Piulachs MD, 2010, INSECT BIOCHEM MOLEC, V40, P468, DOI 10.1016/j.ibmb.2010.04.006; RIDDIFORD LM, 1994, ADV INSECT PHYSIOL, V24, P213, DOI 10.1016/S0065-2806(08)60084-3; Ross L, 2010, EVOL ECOL RES, V12, P89; Schrader F, 1921, BIOL BULL-US, V40, P259, DOI 10.2307/1536736; SCHUH R, 1986, CELL, V47, P1025, DOI 10.1016/0092-8674(86)90817-2; Sehnal Frantisek, 1996, P3, DOI 10.1016/B978-012283245-1/50003-8; Shinoda T, 2003, P NATL ACAD SCI USA, V100, P11986, DOI 10.1073/pnas.2134232100; Suzuki Y, 2008, DEVELOPMENT, V135, P569, DOI 10.1242/dev.015263; Truman JW, 1999, NATURE, V401, P447, DOI 10.1038/46737; Truman JW, 2002, ANNU REV ENTOMOL, V47, P467, DOI 10.1146/annurev.ento.47.091201.145230; Vea IM, 2015, AM MUS NOVIT, P1, DOI 10.1206/3823.1; Wigglesworth VB, 1934, Q J MICROSC SCI, V77, P191; Yang P, 2015, SCI REP-UK, V5, DOI 10.1038/srep08141; Zhang ZL, 2011, J BIOL CHEM, V286, P8437, DOI 10.1074/jbc.M110.191684; Zhou BH, 2001, DEV BIOL, V231, P125, DOI 10.1006/dbio.2000.0143; Zhou XF, 2002, DEVELOPMENT, V129, P2259	56	21	21	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0149459	10.1371/journal.pone.0149459	http://dx.doi.org/10.1371/journal.pone.0149459			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3DG	26894583	Green Published, gold, Green Submitted			2022-12-26	WOS:000371223400055
J	Mi, F; Zhang, Y; Yang, D; Tang, XZ; Wang, PF; He, XX; Zhang, YR; Dong, JY; Cao, Y; Liu, CL; Zhang, KQ; Xu, JP				Mi, Fei; Zhang, Ying; Yang, Dan; Tang, Xiaozhao; Wang, Pengfei; He, Xiaoxia; Zhang, Yunrun; Dong, Jianyong; Cao, Yang; Liu, Chunli; Zhang, Ke-Qin; Xu, Jianping			Evidence for Inbreeding and Genetic Differentiation among Geographic Populations of the Saprophytic Mushroom Trogia venenata from Southwestern China	PLOS ONE			English	Article							NATURAL-POPULATIONS; EVOLUTION; RECOMBINATION; HYBRIDIZATION; DIVERGENCE; DIVERSITY; SOFTWARE; YUNNAN	During the past 40 years, more than 400 Sudden Unexplained Deaths (SUDs) have occurred in Yunnan, southwestern China. Epidemiological and toxicological analyses suggested that a newly discovered mushroom called Trogia venenata was the leading culprit for SUDs. At present, relatively little is known about the genetics and natural history of this mushroom. In this study, we analyzed the sequence variation at four DNA fragments among 232 fruiting bodies of T. venenata collected from seven locations. Our ITS sequence analyses confirmed that all the isolates belonged to the same species. The widespread presence of sequence heterozygosity within many strains at each of three protein-coding genes suggested that the fruiting bodies were diploid, dikaryotic or heterokaryotic. Within individual geographic populations, we found significant deviations of genotype frequencies from Hardy-Weinberg expectations, with the overall observed heterozygosity lower than that expected under random mating, consistent with prevalent inbreeding within local populations. The geographic populations were overall genetically differentiated. Interestingly, while a positive correlation was found between population genetic distance and geographic distance, there was little correlation between genetic distance and barium concentration difference for the geographic populations. Our results suggest frequent inbreeding, geographic structuring, and limited gene flow among geographic populations of T. venenata from southwestern China.	[Mi, Fei; Zhang, Ying; Yang, Dan; Tang, Xiaozhao; Wang, Pengfei; He, Xiaoxia; Zhang, Yunrun; Dong, Jianyong; Zhang, Ke-Qin; Xu, Jianping] Yunnan Univ, Minist Educ, Lab Conservat & Utilizat Bio Resources, Kunming, Yunnan, Peoples R China; [Mi, Fei; Zhang, Ying; Yang, Dan; Tang, Xiaozhao; Wang, Pengfei; He, Xiaoxia; Zhang, Yunrun; Dong, Jianyong; Zhang, Ke-Qin; Xu, Jianping] Yunnan Univ, Minist Educ, Key Lab Microbial Resources, Kunming, Yunnan, Peoples R China; [Mi, Fei] Guizhou Prov Ctr Dis Control & Prevent, Inst Communicable Dis Control & Prevent, Guiyang, Guizhou, Peoples R China; [Cao, Yang] Yunnan Inst Trop Crop Res, Jinghong, Yunnan, Peoples R China; [Liu, Chunli] All China Federat Supply & Mkt Cooperat, Kunming Edible Fungi Inst, Kunming, Yunnan, Peoples R China; [Xu, Jianping] McMaster Univ, Dept Biol, Hamilton, ON, Canada	Yunnan University; Yunnan University; McMaster University	Xu, JP (corresponding author), Yunnan Univ, Minist Educ, Lab Conservat & Utilizat Bio Resources, Kunming, Yunnan, Peoples R China.; Xu, JP (corresponding author), Yunnan Univ, Minist Educ, Key Lab Microbial Resources, Kunming, Yunnan, Peoples R China.; Xu, JP (corresponding author), McMaster Univ, Dept Biol, Hamilton, ON, Canada.	jpxu@mcmaster.ca	zhang, ke/AAH-8217-2019		Yunnan Provincial Department of Science and Technology [2010CI106]; National Natural Science Foundation Program of the People's Republic of China [31100018, 31470147]; Education Department of Yunnan Province [2014Z005]	Yunnan Provincial Department of Science and Technology; National Natural Science Foundation Program of the People's Republic of China(National Natural Science Foundation of China (NSFC)); Education Department of Yunnan Province	This study was jointly supported by grants from the Yunnan Provincial Department of Science and Technology (2010CI106), National Natural Science Foundation Program of the People's Republic of China (31100018 and 31470147), and Education Department of Yunnan Province (2014Z005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agapow PM, 2001, MOL ECOL NOTES, V1, P101, DOI 10.1046/j.1471-8278.2000.00014.x; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arabatzis M, 2012, MYCOLOGIA, P11; Arora D, 1986, MUSHROOMS DEMYSTIFIE; Cao Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073174; Chen W, 2011, J ZOOL, V284, P215, DOI 10.1111/j.1469-7998.2011.00797.x; Chen ZH, 2014, FUNGAL DIVERS, V64, P123, DOI 10.1007/s13225-013-0260-7; Chowdhary A, 2011, ENVIRON MICROBIOL, V13, P1875, DOI 10.1111/j.1462-2920.2011.02510.x; Daniel F, 2003, GENETICS, V164, P574; DIETZ EJ, 1983, SYST ZOOL, V32, P21, DOI 10.2307/2413216; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Iii EJB, 2010, PLOS PATHOG, V6, P1257; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kidd SE, 2005, EUKARYOT CELL, V4, P1629, DOI 10.1128/EC.4.10.1629-1638.2005; Kopelman NM, 2015, MOL ECOL RESOUR, V15, P1179, DOI 10.1111/1755-0998.12387; Lecis R, 2006, MOL ECOL, V15, P119, DOI 10.1111/j.1365-294X.2005.02812.x; Levy D, 2008, MOL BIOL EVOL, V23; Li MC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010684; Liang J, 2009, FUNGAL DIVERS, V38, pe124; Liang Y, 2004, MYCORRHIZA, V14, P235, DOI 10.1007/s00572-003-0260-7; Liao DQ, 2000, J MOL EVOL, V51, P305, DOI 10.1007/s002390010093; Lu BL, 2010, CHIN J DIS CONTROL P, V14, P305; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; [卯晓岚 MAO XiaoLan], 2006, [菌物学报, Mygosystema], V25, P345; Matheny PB, 2007, MOL PHYLOGENET EVOL, V43, P430, DOI 10.1016/j.ympev.2006.08.024; Meirmans PG, 2006, EVOLUTION, V60, P2399, DOI 10.1111/j.0014-3820.2006.tb01874.x; Nagy LG, 2011, SYST BIOL, V60, P303, DOI 10.1093/sysbio/syr005; Ostrowski MF, 2006, MOL ECOL, V15, P1507, DOI 10.1111/j.1365-294X.2006.02865.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pritchard JK, 2000, GENETICS, V155, P945; Sha T, 2008, MICROBIOL-SGM, V154, P3460, DOI 10.1099/mic.0.2008/020495-0; Shi GQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038712; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stone R, 2010, SCIENCE, V329, P132, DOI 10.1126/science.329.5988.132; Swindell S R, 1997, Methods Mol Biol, V70, P75, DOI 10.1385/0-89603-358-9:75; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Urbanelli S, 2003, HEREDITY, V90, P253, DOI 10.1038/sj.hdy.6800239; Wang HM, 2007, FUNGAL GENET BIOL, V44, P991, DOI 10.1016/j.fgb.2007.03.005; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Wright S, 1931, GENETICS, V16, P0097; Xu J, 1997, J HERED, V88, P482, DOI 10.1093/oxfordjournals.jhered.a023141; Xu J, 2010, INT J FOOD MICROBIOL, V143, P254; Xu JP, 2008, MOL ECOL, V17, P1238, DOI 10.1111/j.1365-294X.2007.03665.x; Xu J, 2006, CURR ISSUES MOL BIOL, V8, P75; Xu JP, 2009, MOL ECOL, V18, P2628, DOI 10.1111/j.1365-294X.2009.04227.x; Xu JP, 2000, MOL ECOL, V9, P1471, DOI 10.1046/j.1365-294x.2000.01021.x; XU JP, 1994, TRENDS GENET, V10, P226, DOI 10.1016/0168-9525(94)90158-9; XU JP, 1995, GENETICS, V141, P137; Yang L, 2008, J PREVENTIVE MED INF, V21, P110; Yang ZL, 2012, MYCOL PROG, V11, P937, DOI 10.1007/s11557-012-0809-y; Zeisset I, 2001, P ROY SOC B-BIOL SCI, V268, P933, DOI 10.1098/rspb.2001.1600; Zhang Y, 2012, APPL ENVIRON MICROB, V78, P8834, DOI 10.1128/AEM.01798-12; Zhao MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083253; Zhou ZY, 2012, ANGEW CHEM INT EDIT, V51, P2368, DOI 10.1002/anie.201106502	57	8	8	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2016	11	2							e0149507	10.1371/journal.pone.0149507	http://dx.doi.org/10.1371/journal.pone.0149507			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3CO	26890380	Green Published, gold			2022-12-26	WOS:000371221500054
J	Dale, R; Ohmuro-Matsuyama, Y; Ueda, H; Kato, N				Dale, Renee; Ohmuro-Matsuyama, Yuki; Ueda, Hiroshi; Kato, Naohiro			Mathematical Model of the Firefly Luciferase Complementation Assay Reveals a Non-Linear Relationship between the Detected Luminescence and the Affinity of the Protein Pair Being Analyzed	PLOS ONE			English	Article								The firefly luciferase complementation assay is widely used as a bioluminescent reporter technology to detect protein-protein interactions in vitro, in cellulo, and in vivo. Upon the interaction of a protein pair, complemented firefly luciferase emits light through the adenylation and oxidation of its substrate, luciferin. Although it has been suggested that kinetics of light production in the firefly luciferase complementation assay is different from that in full length luciferase, the mechanism behind this is still not understood. To quantitatively understand the different kinetics and how changes in affinity of a protein pair affect the light emission in the assay, a mathematical model of the in vitro firefly luciferase complementation assay was constructed. Analysis of the model finds that the change in kinetics is caused by rapid dissociation of the protein pair, low adenylation rate of luciferin, and increased affinity of adenylated luciferin to the enzyme. The model suggests that the affinity of the protein pair has an exponential relationship with the light detected in the assay. This relationship causes the change of affinity in a protein pair to be underestimated. This study underlines the importance of understanding the molecular mechanism of the firefly luciferase complementation assay in order to analyze protein pair affinities quantitatively.	[Dale, Renee; Kato, Naohiro] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA; [Ohmuro-Matsuyama, Yuki; Ueda, Hiroshi] Tokyo Inst Technol, Chem Resources Lab, Nagatsuta Cho, Yokohama, Kanagawa 227, Japan	Louisiana State University System; Louisiana State University; Tokyo Institute of Technology	Kato, N (corresponding author), Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA.	kato@lsu.edu	Dale, Renee/AAG-8754-2021; Ueda, Hiroshi/A-3515-2011; Kato, Naohiro/B-2353-2008	Dale, Renee/0000-0002-1674-1247; Ueda, Hiroshi/0000-0001-8849-4217; Kato, Naohiro/0000-0002-4571-3456	Grants-in-Aid for Scientific Research [15H04191] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Aelvoet SA, NONINVASIVE BIOLUMIN, V34, P16518; Aouida M, SACCHAROMYCES CEREVI, V8; Arkin MR, SMALL MOL INHIBITORS, V3, P301; Ayabe K, ROLE FIREFLY LUCIFER, V579, P4389; Azad T, OSCILLATION APOPTOSO, V760, P64; Banaszynski LA, CHARACTERIZATION FKB, V127, P4715; Beyleveld G, NEW GENERATION SCREE, V100, P120; Branchini BR, 2000, BIOCHEMISTRY-US, V39, P5433, DOI 10.1021/bi9928804; Branchini BR, MUTAGENESIS STUDY PU, V42, P10429; Branchini BR, MUTAGENESIS EVIDENCE, V44, P1385; Cer RZ, 2000, IC50 TO KI WEB BASED, V37, pW441; Chen H, FIREFLY LUCIFERASE C, V146, P368; Choi Jida, IDENTIFICATION SUMO, V56, P176; Close DM, IN VIVO BIOLUMINESCE, V11, P180; Conti E, CRYSTAL STRUCTURE FI, V4, P287; Coppola JM, NONINVASIVE IMAGING, V14, P2492; Dai M, 2000, PP6 TYPE PHOSPHATASE, V24, P2497; Deng K, LECTIN RECEPTOR KINA, V8; Endo M, TISSUE SPECIFIC CLOC, V515, P419; Endoh T, CONSTRUCTION INTRAMO, V18, P956; Esteves da Silva JCG, KINETICS INHIBITION, V10, P1039; Fujikawa Y, TECHNICAL ADV SPLIT, V52, P185; Gaud G, EVER2 PROTEIN BINDS, V4, pe499; Hashimoto T, CHARACTERIZATION OLI, V286, P27081; Hsu WC, IDENTIFYING KINASE N, V10; Huang D, GIBBERELLIN MEDIATED; Hubbard BP, CARBOXAMIDE SIRT1 IN, V12, P2233; Huwaldt JA, PLOT DIGITIZER; Ignowski JM, KINETIC ANAL MODELIN, V86, P827; Jiang J, 2001, ARABIDOPSIS RNA BIND, V9; Kato N., LUCIFERASE BIOLUMINE, V02; Kim HK, 2008, FUNCTIONAL ROLES FGL, V8; Kim HK, SPLIT LUCIFERASE COM, V58, P179; Kimura M, FUNCTIONAL MOL IMAGI, V123, P747; Krycer JR, CROSS TALK ANDROGEN, V286, P20637; Lake MC, LUCIFERASE FRAGMENT, V1, P310; Lang Z, METHYL CPG BINDING P, V57, P971; Li JF, LARGE SCALE PROTEIN, V6; Li L, FLS2 ASS KINASE BIK1, V15, P329; Li W, PSEUDOMONAS SYRINGAE, V161, P2062; Luker KE, 2007, CONSTITUTIVE CHEMOKI, V29, P4599; Luker KE, CONSTITUTIVE CHEMOKI, V29, P4599; Luker KE, KINETICS REGULATED P, V101, P12288; Marques SM, FIREFLY BIOLUMINESCE, V61, P6; Moisy D, 2001, HMGB1 PROTEIN BINDS, V86, P9122; Morsy M, CHARTING PLANT INTER, V13, P183; Nyati S, NOVEL MOL IMAGING PL, V10, P23; Ohmuro-Matsuyama Y, DEMONSTRATION PROTEI, V13, P31; Paulmurugan R, NONINVASIVE IMAGING, V99, P15608; Pollard TD, GUIDE SIMPLE INFORM, V21, P4061; Ramiere C, 2000, ACTIVITY HEXOKINASE, V88, P3246; Ramkumar KM, REPORTER PROTEIN COM, V85, P7542; Ray P, 2007, CARBOXY TERMINUS CXC, V44, P669; Ray P, SECRETED CXCL 12 SDF, V442, P433; Schon O, MOL MECH INTERACTION, V323, P491; Sebaugh JL., 2000, GUIDELINES ACCURATE, V10, P128; Shavkunov AS, FIBROBLAST GROWTH FA, V288, P19370; Shrestha B, INVOLVEMENT COREPRES, V14, P54; Thorne N, ILLUMINATING INSIGHT, V17, P646; Velten J, LUCIFERASE REPORTER, V2, P1; Wang M, BOLOST1 ORTHOLOG OPE, V442, P214; Willmann JK, 2007, MOL IMAGING DRUG DEV, V7, P591; Xie CG, ROLES SCABP8 SALT ST, V4, P956; Xiong Y, RAPAMYCIN GLUCOSE TA, V287, P2836; Zako T, LUMINESCENT SUBSTRAT, V1649, P183; Zhang L, MOL IMAGING C MET TY, V412, P1; Zhu Y, 2002, ANAL INTERACTIONS CL, V61, P223; Zhu Y, ANAL INTERACTIONS CL, V61, P223	68	4	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0148256	10.1371/journal.pone.0148256	http://dx.doi.org/10.1371/journal.pone.0148256			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26886551	Green Submitted, Green Published, gold			2022-12-26	WOS:000371218400022
J	Hampel, D; Shahab-Ferdows, S; Adair, LS; Bentley, ME; Flax, VL; Jamieson, DJ; Ellington, SR; Tegha, G; Chasela, CS; Kamwendo, D; Allen, LH				Hampel, Daniela; Shahab-Ferdows, Setareh; Adair, Linda S.; Bentley, Margaret E.; Flax, Valerie L.; Jamieson, Denise J.; Ellington, Sascha R.; Tegha, Gerald; Chasela, Charles S.; Kamwendo, Debbie; Allen, Lindsay H.			Thiamin and Riboflavin in Human Milk: Effects of Lipid-Based Nutrient Supplementation and Stage of Lactation on Vitamer Secretion and Contributions to Total Vitamin Content	PLOS ONE			English	Article							CANCER RESISTANCE PROTEIN; BREAST-MILK; RANDOMIZED-TRIAL; MATERNAL STATUS; B VITAMINS; WOMEN; TRANSPORTER; DEFICIENCY; TRANSMISSION; POSTPARTUM	While thiamin and riboflavin in breast milk have been analyzed for over 50 years, less attention has been given to the different forms of each vitamin. Thiamin-monophosphate (TMP) and free thiamin contribute to total thiamin content; flavin adenine-dinucleotide (FAD) and free riboflavin are the main contributors to total riboflavin. We analyzed milk collected at 2 (n = 258) or 6 (n = 104), and 24 weeks (n = 362) from HIV-infected Malawian mothers within the Breastfeeding, Antiretrovirals and Nutrition (BAN) study, randomly assigned at delivery to lipid-based nutrient supplements (LNS) or a control group, to investigate each vitamer's contribution to total milk vitamin content and the effects of supplementation on the different thiamin and riboflavin vitamers at early and later stages of lactation, and obtain insight into the transport and distribution of these vitamers in human milk. Thiamin vitamers were derivatized into thiochrome-esters and analyzed by high-performance liquid-chromatography-fluorescence-detection (HPLC-FLD). Riboflavin and FAD were analyzed by ultra-performance liquid-chromatography-tandem-mass-spectrometry (ULPC-MS/MS). Thiamin-pyrophosphate (TPP), identified here for the first time in breast milk, contributed 1.9-4.5% to total thiamin. Free thiamin increased significantly from 2/6 to 24 weeks regardless of treatment indicating an active transport of this vitamer in milk. LNS significantly increased TMP and free thiamin only at 2 weeks compared to the control: median 170 versus 151 mu g/L (TMP), 13.3 versus 10.5 mu g/L (free thiamin, p<0.05 for both, suggesting an up-regulated active mechanism for TMP and free thiamin accumulation at early stages of lactation. Free riboflavin was consistently and significantly increased with LNS (range: 14.8-19.6 mu g/L (LNS) versus 5.0-7.4 mu g/L (control), p<0.001), shifting FAD: riboflavin relative amounts from 92-94:6-8% to 85:15%, indicating a preferred secretion of the free form into breast milk. The continuous presence of FAD in breast milk suggests an active transport and secretion system for this vitamer or possibly formation of this co-enymatic form in the mammary gland.	[Hampel, Daniela; Shahab-Ferdows, Setareh; Allen, Lindsay H.] ARS, USDA, Western Human Nutr Res Ctr, Davis, CA USA; [Hampel, Daniela; Allen, Lindsay H.] Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA; [Adair, Linda S.; Bentley, Margaret E.; Flax, Valerie L.] Univ N Carolina, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA; [Jamieson, Denise J.; Ellington, Sascha R.] Ctr Dis Control & Prevent, Atlanta, GA USA; [Tegha, Gerald; Chasela, Charles S.; Kamwendo, Debbie] UNC Project, Lilongwe, Malawi; [Chasela, Charles S.] Univ Witwatersrand, Sch Publ Hlth, Div Epidemiol & Biostat, Johannesburg, South Africa	United States Department of Agriculture (USDA); University of California System; University of California Davis; University of North Carolina; University of North Carolina Chapel Hill; Centers for Disease Control & Prevention - USA; University of Witwatersrand	Hampel, D (corresponding author), ARS, USDA, Western Human Nutr Res Ctr, Davis, CA USA.; Hampel, D (corresponding author), Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA.	dhampel@ucdavis.edu		Jamieson, Denise/0000-0003-2597-1201; Flax, Valerie/0000-0003-0200-3355	Prevention Research Centers Special Interest Project of the Centers for Disease Control and Prevention [SIP 13-01 U48-CCU409660-09, SIP 26-04 U48-DP000059-01, SIP 22-09 U48-DP001944-01]; Bill & Melinda Gates Foundation [OPP53107, OPP1061055]; National Institute of Allergy and Infectious Diseases; University of North Carolina Center for AIDS Research [P30-AI50410]; Carolina Population Center [R24 HD050924]; NIH Fogarty AIDS International Training and Research Program [DHHS/NIH/FIC 2-D43 Tw01039-06, R24 Tw00798]; NIH Fogarty AIDS International Training and Research Program (American Recovery and Reinvestment Act); intramural USDA-ARS Project [5306-51000-003-00D]; Elizabeth Glaser Pediatric AIDS Foundation; United Nations Children's Fund; World Food Program; Malawi Ministry of Health and Population; Johnson Johnson; U.S. Agency for International Development; ARS [ARS-0426640] Funding Source: Federal RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD050924, P2CHD050924] Funding Source: NIH RePORTER; FOGARTY INTERNATIONAL CENTER [D43TW001039] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050410] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056350] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126] Funding Source: NIH RePORTER	Prevention Research Centers Special Interest Project of the Centers for Disease Control and Prevention; Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); University of North Carolina Center for AIDS Research; Carolina Population Center; NIH Fogarty AIDS International Training and Research Program; NIH Fogarty AIDS International Training and Research Program (American Recovery and Reinvestment Act); intramural USDA-ARS Project; Elizabeth Glaser Pediatric AIDS Foundation; United Nations Children's Fund; World Food Program; Malawi Ministry of Health and Population; Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); U.S. Agency for International Development(United States Agency for International Development (USAID)); ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The Breastfeeding, Antiretrovirals, and Nutrition Study was supported by grants from the Prevention Research Centers Special Interest Project of the Centers for Disease Control and Prevention (SIP 13-01 U48-CCU409660-09, SIP 26-04 U48-DP000059-01, and SIP 22-09 U48-DP001944-01), Bill & Melinda Gates Foundation (OPP53107 and OPP1061055), the National Institute of Allergy and Infectious Diseases, the University of North Carolina Center for AIDS Research (P30-AI50410), the Carolina Population Center (R24 HD050924), the NIH Fogarty AIDS International Training and Research Program (DHHS/NIH/FIC 2-D43 Tw01039-06 and R24 Tw00798; the American Recovery and Reinvestment Act), and intramural USDA-ARS Project (5306-51000-003-00D). The antiretrovirals used in the BAN study were donated by Abbott Laboratories, GlaxoSmithKline, Boehringer Ingelheim, Roche Pharmaceuticals, and Bristol-Myers Squibb. The Call to Action PMTCT program was supported by the Elizabeth Glaser Pediatric AIDS Foundation, the United Nations Children's Fund, the World Food Program, the Malawi Ministry of Health and Population, Johnson & Johnson, and the U.S. Agency for International Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen L H, 1994, SCN News, P21; Allen LH, 2015, AM J CLIN NUTR, V102, P1468, DOI 10.3945/ajcn.114.105106; Allen LH, 2012, ADV NUTR, V3, P362, DOI 10.3945/an.111.001172; BATES CJ, 1982, AM J CLIN NUTR, V35, P701, DOI 10.1093/ajcn/35.4.701; Bernshaw N J, 1991, J Hum Lact, V7, P73, DOI 10.1177/089033449100700227; BETTENDORFF L, 2013, OA BIOCH, V1, P1; Bohm V, 1997, Z ERNAHRUNGSWISS, V36, P214, DOI 10.1007/BF01623366; Buehler BA, 2011, J EVID-BASED INTEGR, V16, P88, DOI 10.1177/1533210110392943; Chasela CS, 2010, NEW ENGL J MED, V362, P2271, DOI 10.1056/NEJMoa0911486; Coats D, 2013, AM J CLIN NUTR, V98, P839, DOI 10.3945/ajcn.113.062737; Dedina L., 2012, THESIS U TORONTO; Dutta B, 1999, J BIOL CHEM, V274, P31925, DOI 10.1074/jbc.274.45.31925; EITENMILLER RR, 1999, VITAMIN ANAL HLTH FO; Eudy JD, 2000, MOL GENET METAB, V71, P581, DOI 10.1006/mgme.2000.3112; Ferguson YO, 2009, AIDS EDUC PREV, V21, P141, DOI 10.1521/aeap.2009.21.2.141; Gibson RS, 1990, Q REV BIOL; Hampel D, 2012, J CHROMATOGR B, V903, P7, DOI 10.1016/j.jchromb.2012.06.024; Institute of Medicine, 1998, DIET REF INT THIAM R; Kauffman G, 2011, AM J CLIN NUTR, V94, P616, DOI 10.3945/ajcn.111.018457; Kayira D, 2012, AM J CLIN NUTR, V95, P759, DOI 10.3945/ajcn.111.018812; Khounnorath S, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000969; Liu SQ, 2003, MOL CANCER RES, V1, P665; LONNERDAL B, 1986, J NUTR, V116, P499; Luxemburger C, 2003, T ROY SOC TROP MED H, V97, P251, DOI 10.1016/S0035-9203(03)90134-9; McGready R, 2001, AM J CLIN NUTR, V74, P808; Montalbetti N, 2014, J MAMMARY GLAND BIOL, V19, P73, DOI 10.1007/s10911-014-9317-9; NAIL PA, 1980, AM J CLIN NUTR, V33, P198, DOI 10.1093/ajcn/33.2.198; Ortega RM, 2004, BRIT J NUTR, V92, P129, DOI 10.1079/BJN20041153; Ortega RM, 1999, J AM COLL NUTR, V18, P324, DOI 10.1080/07315724.1999.10718871; Picciano MF, 2003, J NUTR, V133, p1997S, DOI 10.1093/jn/133.6.1997S; Powers HJ, 2003, AM J CLIN NUTR, V77, P1352; RINDI G, 1982, Acta Vitaminologica et Enzymologica, V4, P59; Rindi G, 2000, P SOC EXP BIOL MED, V224, P246, DOI 10.1046/j.1525-1373.2000.22428.x; ROUGHEAD ZK, 1990, AM J CLIN NUTR, V52, P854, DOI 10.1093/ajcn/52.5.854; Said HM, 2004, AM J PHYSIOL-GASTR L, V286, pG491, DOI 10.1152/ajpgi.00361.2003; Sakurai T, 2005, J NUTR SCI VITAMINOL, V51, P239, DOI 10.3177/jnsv.51.239; Stuetz W., 2011, EUROPEAN J CLIN NUTR, V51, P425, DOI DOI 10.1007/S00394-011-0226-Z; Stuetz W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036280; THOMAS MR, 1980, AM J CLIN NUTR, V33, P2151, DOI 10.1093/ajcn/33.10.2151; van der Horst C, 2009, CONTEMP CLIN TRIALS, V30, P24, DOI 10.1016/j.cct.2008.09.001; van Herwaarden AE, 2006, TRENDS PHARMACOL SCI, V27, P10, DOI 10.1016/j.tips.2005.11.007; van Herwaarden AE, 2007, MOL CELL BIOL, V27, P1247, DOI 10.1128/MCB.01621-06; World Health Organization, 2001, OPT DUR EXCL BREASTF; World Health Organization, 2010, GUID HIV INF FEED 20; Zastre JA, 2013, J NUTR BIOCHEM, V24, P1616, DOI 10.1016/j.jnutbio.2013.02.002	45	23	23	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0149479	10.1371/journal.pone.0149479	http://dx.doi.org/10.1371/journal.pone.0149479			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26886782	Green Published, gold			2022-12-26	WOS:000371218400089
J	Kazior, Z; Willis, SJ; Moberg, M; Apro, W; Calbet, JAL; Holmberg, HC; Blomstrand, E				Kazior, Zuzanna; Willis, Sarah J.; Moberg, Marcus; Apro, William; Calbet, Jose A. L.; Holmberg, Hans-Christer; Blomstrand, Eva			Endurance Exercise Enhances the Effect of Strength Training on Muscle Fiber Size and Protein Expression of Akt and mTOR	PLOS ONE			English	Article							HUMAN SKELETAL-MUSCLE; RESISTANCE EXERCISE; MESSENGER-RNA; ADENOSINE TRIPHOSPHATASE; CONTRACTILE ACTIVITY; CONCURRENT EXERCISE; MOLECULAR-BASES; KINASE-ACTIVITY; TIME-COURSE; HYPERTROPHY	Reports concerning the effect of endurance exercise on the anabolic response to strength training have been contradictory. This study re-investigated this issue, focusing on training effects on indicators of protein synthesis and degradation. Two groups of male subjects performed 7 weeks of resistance exercise alone (R; n = 7) or in combination with preceding endurance exercise, including both continuous and interval cycling (ER; n = 9). Muscle biopsies were taken before and after the training period. Similar increases in leg-press 1 repetition maximum (30%; P< 0.05) were observed in both groups, whereas maximal oxygen uptake was elevated (8%; P< 0.05) only in the ER group. The ER training enlarged the areas of both type I and type II fibers, whereas the R protocol increased only the type II fibers. The mean fiber area increased by 28% (P< 0.05) in the ER group, whereas no significant increase was observed in the R group. Moreover, expression of Akt and mTOR protein was enhanced in the ER group, whereas only the level of mTOR was elevated following R training. Training-induced alterations in the levels of both Akt and mTOR protein were correlated to changes in type I fiber area (r = 0.55-0.61, P< 0.05), as well as mean fiber area (r = 0.55-0.61, P< 0.05), reflecting the important role played by these proteins in connection with muscle hypertrophy. Both training regimes reduced the level of MAFbx protein (P< 0.05) and tended to elevate that of MuRF-1. The present findings indicate that the larger hypertrophy observed in the ER group is due more to pronounced stimulation of anabolic rather than inhibition of catabolic processes.	[Kazior, Zuzanna; Willis, Sarah J.; Holmberg, Hans-Christer] Mid Sweden Univ, Dept Hlth Sci, Swedish Winter Sports Res Ctr, Ostersund, Sweden; [Moberg, Marcus; Apro, William; Blomstrand, Eva] Swedish Sch Sport & Hlth Sci, Stockholm, Sweden; [Calbet, Jose A. L.] Univ Las Palmas Gran Canaria, Dept Phys Educ, Las Palmas Gran Canaria, Spain; [Calbet, Jose A. L.] Univ Las Palmas Gran Canaria, Res Inst Biomed & Hlth Sci IUIBS, Campus Univ Tafira S-N, Las Palmas Gran Canaria, Canary Island, Spain	Mid-Sweden University; Swedish School of Sport & Health Sciences; Universidad de Las Palmas de Gran Canaria; Universidad de Las Palmas de Gran Canaria	Blomstrand, E (corresponding author), Swedish Sch Sport & Hlth Sci, Stockholm, Sweden.	eva.blomstrand@gih.se	Apro, William/AAZ-4717-2020; Calbet, Jose A L/H-6693-2015; Moberg, Marcus/AAU-5487-2021	Calbet, Jose A L/0000-0002-9215-6234; Moberg, Marcus/0000-0003-3747-0148; Holmberg, Hans-Christer/0000-0002-3814-6246; antunez, Ariel/0000-0002-2548-7885; Apro, William/0000-0003-1942-2919; Willis, Sarah/0000-0002-0150-3182	Swedish National Centre for Research in Sports [55-351/10]	Swedish National Centre for Research in Sports	This study was supported by funding from the Swedish National Centre for Research in Sports to HCH (55-351/10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALP PR, 1976, BIOCHEM J, V154, P689, DOI 10.1042/bj1540689; ANDERSEN P, 1975, ACTA PHYSIOL SCAND, V95, P203, DOI 10.1111/j.1748-1716.1975.tb10043.x; ANDERSEN P, 1977, J PHYSIOL-LONDON, V270, P677, DOI 10.1113/jphysiol.1977.sp011975; Apro W, 2015, AM J PHYSIOL-ENDOC M, V308, pE470, DOI 10.1152/ajpendo.00486.2014; Apro W, 2013, AM J PHYSIOL-ENDOC M, V305, pE22, DOI 10.1152/ajpendo.00091.2013; Baechle TR, 2008, ESSENTIALS STRENGTH; Benziane B, 2008, AM J PHYSIOL-ENDOC M, V295, pE1427, DOI 10.1152/ajpendo.90428.2008; Bergstrom J, 1962, SCAND J CLIN LAB INV; BLOMSTRAND E, 1982, ACTA PHYSIOL SCAND, V116, P437, DOI 10.1111/j.1748-1716.1982.tb07163.x; BLOMSTRAND E, 1984, ACTA PHYSIOL SCAND, V122, P545, DOI 10.1111/j.1748-1716.1984.tb07543.x; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Bodine SC, 2014, AM J PHYSIOL-ENDOC M, V307, pE469, DOI 10.1152/ajpendo.00204.2014; Bolster DR, 2002, J BIOL CHEM, V277, P23977, DOI 10.1074/jbc.C200171200; Borgenvik M, 2012, AM J PHYSIOL-ENDOC M, V302, pE510, DOI 10.1152/ajpendo.00353.2011; Borsheim E, 2004, J APPL PHYSIOL, V96, P674, DOI 10.1152/japplphysiol.00333.2003; BROOKE MH, 1970, J HISTOCHEM CYTOCHEM, V18, P670, DOI 10.1177/18.9.670; BROOKE MH, 1969, J HISTOCHEM CYTOCHEM, V17, P431, DOI 10.1177/17.6.431; Camera DM, 2015, MED SCI SPORT EXER, V47, P82, DOI 10.1249/MSS.0000000000000390; Camera DM, 2010, MED SCI SPORT EXER, V42, P1843, DOI 10.1249/MSS.0b013e3181d964e4; Carrithers JA, 2007, AVIAT SPACE ENVIR MD, V78, P457; Chen ZP, 2003, DIABETES, V52, P2205, DOI 10.2337/diabetes.52.9.2205; Churchley EG, 2007, J APPL PHYSIOL, V102, P1604, DOI 10.1152/japplphysiol.01260.2006; Coffey VG, 2007, SPORTS MED, V37, P737, DOI 10.2165/00007256-200737090-00001; Coffey VG, 2009, AM J PHYSIOL-REG I, V297, pR1441, DOI 10.1152/ajpregu.00351.2009; Coffey VG, 2009, J APPL PHYSIOL, V106, P1187, DOI 10.1152/japplphysiol.91221.2008; Coffey VG, 2006, AM J PHYSIOL-ENDOC M, V290, pE849, DOI 10.1152/ajpendo.00299.2005; COSTILL DL, 1979, J APPL PHYSIOL, V46, P96, DOI 10.1152/jappl.1979.46.1.96; Deldicque L, 2008, EUR J APPL PHYSIOL, V104, P57, DOI 10.1007/s00421-008-0786-7; Drummond MJ, 2009, J APPL PHYSIOL, V106, P1403, DOI 10.1152/japplphysiol.90842.2008; Egerman MA, 2014, CRIT REV BIOCHEM MOL, V49, P59, DOI 10.3109/10409238.2013.857291; ESSEN B, 1975, ACTA PHYSIOL SCAND, V95, P153, DOI 10.1111/j.1748-1716.1975.tb10038.x; Fry AC, 2004, SPORTS MED, V34, P663, DOI 10.2165/00007256-200434100-00004; Fyfe JJ, 2014, SPORTS MED, V44, P743, DOI 10.1007/s40279-014-0162-1; Green H, 1999, AM J PHYSIOL-REG I, V276, pR591, DOI 10.1152/ajpregu.1999.276.2.R591; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; Hennessey JV, 1997, J APPL PHYSIOL, V82, P1739, DOI 10.1152/jappl.1997.82.6.1739; HICKSON RC, 1980, EUR J APPL PHYSIOL O, V45, P255, DOI 10.1007/BF00421333; JANSSON E, 1990, ACTA PHYSIOL SCAND, V140, P359, DOI 10.1111/j.1748-1716.1990.tb09010.x; Krook A, 1998, DIABETES, V47, P1281, DOI 10.2337/diabetes.47.8.1281; Lamas L, 2010, SCAND J MED SCI SPOR, V20, P216, DOI 10.1111/j.1600-0838.2009.00905.x; Lecker SH, 2006, J AM SOC NEPHROL, V17, P1807, DOI 10.1681/ASN.2006010083; Leveritt M, 1999, SPORTS MED, V28, P413, DOI 10.2165/00007256-199928060-00004; Louis E, 2007, J APPL PHYSIOL, V103, P1744, DOI 10.1152/japplphysiol.00679.2007; Lundberg TR, 2014, J APPL PHYSIOL, V116, P611, DOI 10.1152/japplphysiol.01082.2013; Lundberg TR, 2013, J APPL PHYSIOL, V114, P81, DOI 10.1152/japplphysiol.01013.2012; MacNeil LG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109189; Mascher H, 2008, AM J PHYSIOL-ENDOC M, V294, pE43, DOI 10.1152/ajpendo.00504.2007; Perez-Gomez J, 2008, APPL PHYSIOL NUTR ME, V33, P501, DOI 10.1139/H08-026; Phillips SM, 2002, CAN J PHYSIOL PHARM, V80, P1045, DOI [10.1139/y02-134, 10.1139/Y02-134]; Phillips SM, 2014, SPORTS MED, V44, P71, DOI 10.1007/s40279-014-0152-3; Rahbek SK, 2014, AMINO ACIDS, V46, P2377, DOI 10.1007/s00726-014-1792-1; Rommel C, 2001, NAT CELL BIOL, V3, P1009, DOI 10.1038/ncb1101-1009; Saltin B, 2010, COMPR PHYSIOL, P555; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; SCHANTZ P, 1983, CLIN PHYSIOL, V3, P141, DOI 10.1111/j.1475-097X.1983.tb00685.x; Schiaffino S, 1996, PHYSIOL REV, V76, P371, DOI 10.1152/physrev.1996.76.2.371; Tang JE, 2006, APPL PHYSIOL NUTR ME, V31, P495, DOI 10.1139/H06-026; Thorell A, 1999, AM J PHYSIOL-ENDOC M, V277, pE733, DOI 10.1152/ajpendo.1999.277.4.E733; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Wang L, 2011, J APPL PHYSIOL, V111, P1335, DOI 10.1152/japplphysiol.00086.2011; Wojtaszewski JFP, 2000, J PHYSIOL-LONDON, V528, P221, DOI 10.1111/j.1469-7793.2000.t01-1-00221.x; Wong ML, 2005, BIOTECHNIQUES, V39, P75, DOI 10.2144/05391RV01; Yu M, 2001, J APPL PHYSIOL, V90, P29, DOI 10.1152/jappl.2001.90.1.29	63	41	42	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0149082	10.1371/journal.pone.0149082	http://dx.doi.org/10.1371/journal.pone.0149082			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26885978	Green Submitted, Green Published, gold			2022-12-26	WOS:000371218400061
J	Nakajima, M; Yoshida, R; Miyanaga, A; Abe, K; Takahashi, Y; Sugimoto, N; Toyoizumi, H; Nakai, H; Kitaoka, M; Taguchi, H				Nakajima, Masahiro; Yoshida, Ryuta; Miyanaga, Akimasa; Abe, Koichi; Takahashi, Yuta; Sugimoto, Naohisa; Toyoizumi, Hiroyuki; Nakai, Hiroyuki; Kitaoka, Motomitsu; Taguchi, Hayao			Functional and Structural Analysis of a beta-Glucosidase Involved in beta-1,2-Glucan Metabolism in Listeria innocua	PLOS ONE			English	Article							FLAVOBACTERIUM-MENINGOSEPTICUM; 3-DIMENSIONAL STRUCTURE; CYCLIC BETA-1,2-GLUCAN; SUBSTRATE-SPECIFICITY; PERIPLASMIC GLUCANS; CRYSTAL-STRUCTURES; IDENTIFICATION; PURIFICATION; ADAPTATION; VIRULENCE	Despite the presence of beta-1,2-glucan in nature, few beta-1,2-glucan degrading enzymes have been reported to date. Recently, the Lin1839 protein from Listeria innocua was identified as a 1,2-beta-oligoglucan phosphorylase. Since the adjacent lin1840 gene in the gene cluster encodes a putative glycoside hydrolase family 3 beta-glucosidase, we hypothesized that Lin1840 is also involved in beta-1,2-glucan dissimilation. Here we report the functional and structural analysis of Lin1840. A recombinant Lin1840 protein (Lin1840r) showed the highest hydrolytic activity toward sophorose (Glc-beta-1,2-Glc) among beta-1,2-glucooligosaccharides, suggesting that Lin1840 is a beta-glucosidase involved in sophorose degradation. The enzyme also rapidly hydrolyzed laminaribiose (beta-1,3), but not cellobiose (beta-1,4) or gentiobiose (beta-1,6) among beta-linked gluco-disaccharides. We determined the crystal structures of Lin1840r in complexes with sophorose and laminaribiose as productive binding forms. In these structures, Arg572 forms many hydrogen bonds with sophorose and laminaribiose at subsite + 1, which seems to be a key factor for substrate selectivity. The opposite side of subsite + 1 from Arg572 is connected to a large empty space appearing to be subsite + 2 for the binding of sophorotriose (Glc-beta-1,2-Glc-beta-1,2-Glc) in spite of the higher Km value for sophorotriose than that for sophorose. The conformations of sophorose and laminaribiose are almost the same on the Arg572 side but differ on the subsite + 2 side that provides no interaction with a substrate. Therefore, Lin1840r is unable to distinguish between sophorose and laminaribiose as substrates. These results provide the first mechanistic insights into beta-1,2-glucooligosaccharide recognition by beta-glucosidase.	[Nakajima, Masahiro; Yoshida, Ryuta; Abe, Koichi; Toyoizumi, Hiroyuki; Taguchi, Hayao] Tokyo Univ Sci, Fac Sci & Technol, Dept Appl Biol Sci, Noda, Chiba 278, Japan; [Miyanaga, Akimasa] Tokyo Inst Technol, Dept Chem, Meguro Ku, Tokyo 152, Japan; [Takahashi, Yuta; Sugimoto, Naohisa; Nakai, Hiroyuki] Niigata Univ, Grad Sch Sci & Technol, Nishi Ku, Niigata 9518510, Japan; [Kitaoka, Motomitsu] Natl Agr & Food Res Org, Natl Food Res Inst, Tsukuba, Ibaraki, Japan	Tokyo University of Science; Tokyo Institute of Technology; Niigata University; National Agriculture & Food Research Organization - Japan; National Food Research Institute - Japan	Nakajima, M (corresponding author), Tokyo Univ Sci, Fac Sci & Technol, Dept Appl Biol Sci, Noda, Chiba 278, Japan.	m-nakajima@rs.tus.ac.jp	Nakajima, Masahiro/J-3566-2019; Kitaoka, Motomitsu/R-1536-2019; Miyanaga, Akimasa/C-1472-2015	Nakajima, Masahiro/0000-0002-3182-0859; Kitaoka, Motomitsu/0000-0002-0083-1838; Miyanaga, Akimasa/0000-0003-2219-6051; Taguchi, Hayao/0000-0001-5270-581X				Abe K., 2015, J APPL GLYCOSCI, V62, P47, DOI [DOI 10.5458/JAG.JAG, 10.5458/jag.jag.JAG-2014_011, DOI 10.5458/JAG.JAG.JAG-2014_011]; Arellano-Reynoso B, 2005, NAT IMMUNOL, V6, P618, DOI 10.1038/ni1202; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Baba Y, 2015, AMB EXPRESS, V5, DOI 10.1186/s13568-014-0090-3; Bacik JP, 2012, CHEM BIOL, V19, P1471, DOI 10.1016/j.chembiol.2012.09.016; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Bohin JP, 2000, FEMS MICROBIOL LETT, V186, P11, DOI 10.1016/S0378-1097(00)00110-5; BREEDVELD MW, 1994, MICROBIOL REV, V58, P145, DOI 10.1128/MMBR.58.2.145-161.1994; Briones G, 2001, INFECT IMMUN, V69, P4528, DOI 10.1128/IAI.69.7.4528-4535.2001; Buchrieser C, 2003, FEMS IMMUNOL MED MIC, V35, P207, DOI 10.1016/S0928-8244(02)00448-0; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Chir J, 2002, BIOCHEM J, V365, P857, DOI 10.1042/BJ20020186; CREMER D, 1975, J AM CHEM SOC, V97, P1354, DOI 10.1021/ja00839a011; Davies GJ, 1998, BIOCHEMISTRY-US, V37, P11707, DOI 10.1021/bi981315i; Di Tommaso P, 2007, NUCLEIC ACIDS RES, V39, pW13; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gay-Fraret J, 2012, FEMS MICROBIOL LETT, V333, P28, DOI 10.1111/j.1574-6968.2012.02595.x; HISAMATSU M, 1982, J GEN MICROBIOL, V128, P1873; HISAMATSU M, 1992, CARBOHYD RES, V231, P137, DOI 10.1016/0008-6215(92)84014-J; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hovel K, 2003, EMBO J, V22, P4922, DOI 10.1093/emboj/cdg494; Hrmova M, 2004, J BIOL CHEM, V279, P4970, DOI 10.1074/jbc.M307188200; Hrmova M, 2002, PLANT CELL, V14, P1033, DOI 10.1105/tpc.010442; Hrmova M, 2001, STRUCTURE, V9, P1005, DOI 10.1016/S0969-2126(01)00673-6; Karkehabadi S, 2014, J BIOL CHEM, V289, P31624, DOI 10.1074/jbc.M114.587766; KITAHATA S, 1987, AGR BIOL CHEM TOKYO, V51, P2701; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Li YK, 2002, BIOCHEMISTRY-US, V41, P2751, DOI 10.1021/bi016049e; Li YK, 1998, J CHIN CHEM SOC-TAIP, V45, P603, DOI 10.1002/jccs.199800091; McAndrew RP, 2013, J BIOL CHEM, V288, P14985, DOI 10.1074/jbc.M113.458356; MENDOZA NS, 1983, J FERMENT TECHNOL, V61, P473; MILLER KJ, 1986, SCIENCE, V231, P48, DOI 10.1126/science.3941890; Morris RJ, 2002, ACTA CRYSTALLOGR D, V58, P968, DOI 10.1107/S0907444902005462; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakajima M, 2014, ACTA CRYSTALLOGR F, V70, P1398, DOI 10.1107/S2053230X14018597; Nakajima M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092353; Nakajima M, 2012, APPL MICROBIOL BIOT, V93, P1989, DOI 10.1007/s00253-011-3538-2; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pozzo T, 2010, J MOL BIOL, V397, P724, DOI 10.1016/j.jmb.2010.01.072; Rigano LA, 2007, PLANT CELL, V19, P2077, DOI 10.1105/tpc.106.047944; Schmidt S, 2010, RAPID COMMUN MASS SP, V24, P2009, DOI 10.1002/rcm.4605; Stortz CA, 2003, CARBOHYD RES, V338, P1679, DOI 10.1016/S0008-6215(03)00265-9; Suzuki K, 2013, BIOCHEM J, V452, P211, DOI 10.1042/BJ20130054; TALAGA P, 1994, J BACTERIOL, V176, P6538, DOI 10.1128/JB.176.21.6538-6544.1994; Varghese JN, 1999, STRUCTURE, V7, P179, DOI 10.1016/S0969-2126(99)80024-0; Vasella A, 2002, CURR OPIN CHEM BIOL, V6, P619, DOI 10.1016/S1367-5931(02)00380-0; Yoshida E, 2010, BIOCHEM J, V431, P39, DOI 10.1042/BJ20100351; Zheng HP, 2014, NAT PROTOC, V9, P156, DOI 10.1038/nprot.2013.172	51	27	28	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0148870	10.1371/journal.pone.0148870	http://dx.doi.org/10.1371/journal.pone.0148870			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26886583	Green Published, gold, Green Submitted			2022-12-26	WOS:000371218400055
J	Reijne, AC; Ciapaite, J; van Dijk, TH; Havinga, R; van der Zee, EA; Groen, AK; Reijngoud, DJ; Bakker, BM; van Dijk, G				Reijne, Aaffien C.; Ciapaite, Jolita; van Dijk, Theo H.; Havinga, Rick; van der Zee, Eddy A.; Groen, Albert K.; Reijngoud, Dirk-Jan; Bakker, Barbara M.; van Dijk, Gertjan			Whole-Body Vibration Partially Reverses Aging-Induced Increases in Visceral Adiposity and Hepatic Lipid Storage in Mice	PLOS ONE			English	Article							RAT SKELETAL-MUSCLE; BONE-MINERAL DENSITY; UNCOUPLING PROTEIN-2; POSTMENOPAUSAL WOMEN; METABOLIC-RATE; OBESE WOMEN; EXERCISE; STRENGTH; MITOCHONDRIA; STIMULATION	At old age, humans generally have declining muscle mass and increased fat deposition, which can increase the risk of developing cardiometabolic diseases. While regular physical activity postpones these age-related derangements, this is not always possible in the elderly because of disabilities or risk of injury. Whole-body vibration (WBV) training may be considered as an alternative to physical activity particularly in the frail population. To explore this possibility, we characterized whole-body and organ-specific metabolic processes in 6-month and 25-month old mice, over a period of 14 weeks of WBV versus sham training. WBV training tended to increase blood glucose turnover rates and stimulated hepatic glycogen utilization during fasting irrespective of age. WBV was effective in reducing white fat mass and hepatic triglyceride content only in old but not in young mice and these reductions were related to upregulation of hepatic mitochondrial uncoupling of metabolism (assessed by high-resolution respirometry) and increased expression of uncoupling protein 2. Because these changes occurred independent of changes in food intake and whole-body metabolic rate (assessed by indirect calorimetry), the liver-specific effects of WBV may be a primary mechanism to improve metabolic health during aging, rather than that it is a consequence of alterations in energy balance.	[Reijne, Aaffien C.; van Dijk, Gertjan] Univ Groningen, Unit Behav Neurosci, Neurobiol, Groningen Inst Evolutionary Life Sci, Nijenborgh 7, NL-9747 AG Groningen, Netherlands; [Reijne, Aaffien C.; Ciapaite, Jolita; Havinga, Rick; Groen, Albert K.; Reijngoud, Dirk-Jan; Bakker, Barbara M.] Univ Groningen, Univ Med Ctr Groningen, Ctr Liver Digest & Metab Dis, Dept Pediat, Hanzepl 1, NL-9713 GZ Groningen, Netherlands; [Reijne, Aaffien C.; Ciapaite, Jolita; Groen, Albert K.; Reijngoud, Dirk-Jan; Bakker, Barbara M.] Univ Groningen, Univ Med Ctr Groningen, Syst Biol Ctr Energy Metab & Ageing, Antonius Deusinglaan 1, NL-9713 AV Groningen, Netherlands; [van Dijk, Theo H.] Univ Groningen, Univ Med Ctr Groningen, Dept Lab Med, Hanzepl 1, NL-9700 RB Groningen, Netherlands; [van der Zee, Eddy A.] Univ Groningen, Mol Neurobiol Unit, Groningen Inst Evolutionary Life Sci, Neurobiol, Nijenborgh 7, NL-9747 AG Groningen, Netherlands; [van Dijk, Gertjan] Univ Groningen, ESRIG Ctr Isotope Res, Nijenborgh 4, NL-9747 AG Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen; University of Groningen; University of Groningen; University of Groningen	van Dijk, G (corresponding author), Univ Groningen, Unit Behav Neurosci, Neurobiol, Groningen Inst Evolutionary Life Sci, Nijenborgh 7, NL-9747 AG Groningen, Netherlands.; van Dijk, G (corresponding author), Univ Groningen, ESRIG Ctr Isotope Res, Nijenborgh 4, NL-9747 AG Groningen, Netherlands.	Gertjan.van.dijk@rug.nl	van Dijk, Theo/H-6436-2013; van der Zee, Eddy/AAZ-2120-2020	Bakker, Barbara/0000-0001-6274-3633; Ciapaite, Jolita/0000-0001-8761-9233; Reijngoud, Dirk-Jan/0000-0003-1157-4491	Netherlands Organization for Scientific Research (NWO) [853.00.110]; Rosalind Franklin Fellowship for the University of Groningen	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Rosalind Franklin Fellowship for the University of Groningen	This work was supported by a grant from the Netherlands Organization for Scientific Research (NWO, grant no. 853.00.110); http://www.nwo.nl/onderzoek-en-resultaten/onderzoeksprojecten/94/2300159494.html. Barbara M. Bakker was supported by a Rosalind Franklin Fellowship for the University of Groningen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando H, 2003, SCAND J WORK ENV HEA, V29, P216, DOI 10.5271/sjweh.724; Andrews ZB, 2009, AM J PHYSIOL-ENDOC M, V296, pE621, DOI 10.1152/ajpendo.90903.2008; Badin PM, 2013, TRENDS ENDOCRIN MET, V24, P607, DOI 10.1016/j.tem.2013.08.001; Bann D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116058; Barazzoni R, 2000, J BIOL CHEM, V275, P3343, DOI 10.1074/jbc.275.5.3343; Barazzoni R, 2001, AM J PHYSIOL-ENDOC M, V280, pE413, DOI 10.1152/ajpendo.2001.280.3.E413; Baum Klaus, 2007, Int J Med Sci, V4, P159; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bosco C, 2000, EUR J APPL PHYSIOL, V81, P449, DOI 10.1007/s004210050067; Bosco C, 1999, CLIN PHYSIOL, V19, P183; BURKE D, 1976, J NEUROL NEUROSUR PS, V39, P729, DOI 10.1136/jnnp.39.8.729; Cochrane DJ, 2012, SCAND J MED SCI SPOR, V22, P705, DOI 10.1111/j.1600-0838.2011.01411.x; Conn VS, 2014, J PRIM CARE COMMUNIT, V5, P211, DOI 10.1177/2150131913520328; Divakaruni AS, 2011, PHYSIOLOGY, V26, P192, DOI 10.1152/physiol.00046.2010; Echtay KS, 2002, NATURE, V415, P96, DOI 10.1038/415096a; FERRANNINI E, 1988, METABOLISM, V37, P287, DOI 10.1016/0026-0495(88)90110-2; Fielding RA, 2011, J AM MED DIR ASSOC, V12, P249, DOI 10.1016/j.jamda.2011.01.003; Hazell TJ, 2012, EUR J APPL PHYSIOL, V112, P413, DOI 10.1007/s00421-011-1984-2; Houtkooper RH, 2011, SCI REP-UK, V1, DOI 10.1038/srep00134; Huang CC, 2014, INT J MED SCI, V11, P1218, DOI 10.7150/ijms.9975; Issurin VB, 1999, J SPORT SCI, V17, P177, DOI 10.1080/026404199366073; Kang CH, 2013, EXP GERONTOL, V48, P1343, DOI 10.1016/j.exger.2013.08.004; Kim TN, 2015, J CELL BIOCHEM, V116, P1171, DOI 10.1002/jcb.25077; Kvorning T, 2006, EUR J APPL PHYSIOL, V96, P615, DOI 10.1007/s00421-006-0139-3; Lameloise N, 2001, DIABETES, V50, P803, DOI 10.2337/diabetes.50.4.803; Lau RWK, 2011, CLIN REHABIL, V25, P975, DOI 10.1177/0269215511405078; LAVOINNE A, 1987, BIOCHEM J, V248, P429, DOI 10.1042/bj2480429; Lin CI, 2015, METABOLISM, V64, P1146, DOI 10.1016/j.metabol.2015.05.007; Liu CJ, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002759.pub2; LUSK G, 1976, ELEMENTS SCI NUTR; Maddalozzo GF, 2008, INT J OBESITY, V32, P1348, DOI 10.1038/ijo.2008.111; Mildaziene V, 2002, TOXICOL SCI, V65, P220, DOI 10.1093/toxsci/65.2.220; Nagase I, 2001, FEBS LETT, V494, P175, DOI 10.1016/S0014-5793(01)02341-9; Naghii MR, 2011, ACTA PHYSIOL HUNG, V98, P442, DOI 10.1556/APhysiol.98.2011.4.7; Oklejewicz M, 1997, J BIOL RHYTHM, V12, P413, DOI 10.1177/074873049701200503; Papa S, 1997, MOL CELL BIOCHEM, V174, P305, DOI 10.1023/A:1006873518427; Prisby RD, 2008, AGEING RES REV, V7, P319, DOI 10.1016/j.arr.2008.07.004; Rees SS, 2008, PHYS THER, V88, P462, DOI 10.2522/ptj.20070027; Regterschot GRH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100506; Riedel G, 2010, FEMS FOR, P5; Rittweger J, 2002, INT J SPORTS MED, V23, P428, DOI 10.1055/s-2002-33739; Rizzo MR, 2005, J CLIN ENDOCR METAB, V90, P409, DOI 10.1210/jc.2004-0390; Roelants M, 2004, INT J SPORTS MED, V25, P1, DOI 10.1055/s-2003-45238; Samec S, 1999, POSTSTARVATION GENE, V17, P1339; Srere PA, 1963, ACTA CHEM SCAND; Stuermer EK, 2010, CALCIFIED TISSUE INT, V87, P168, DOI 10.1007/s00223-010-9381-0; Tapp LR, 2014, CLIN INTERV AGING, V9, P63, DOI 10.2147/CIA.S30048; Timmer M, 2006, FENS FOR, P3; van den Broek NMA, 2010, FASEB J, V24, P1354, DOI 10.1096/fj.09-143842; van Dijk TH, 2003, ANAL BIOCHEM, V322, P1, DOI 10.1016/j.ab.2003.07.008; van Dijk TH, 2001, J BIOL CHEM, V276, P25727, DOI 10.1074/jbc.M101223200; Verschueren SMP, 2004, J BONE MINER RES, V19, P352, DOI 10.1359/JBMR.0301245; VidalPuig A, 1997, BIOCHEM BIOPH RES CO, V235, P79, DOI 10.1006/bbrc.1997.6740; Vissers D, 2009, PHYSICIAN SPORTSMED, V37, P88, DOI 10.3810/psm.2009.10.1733; Vissers D, 2010, OBESITY FACTS, V3, P93, DOI 10.1159/000301785; von Stengel S, 2011, OSTEOPOROSIS INT, V22, P317, DOI 10.1007/s00198-010-1215-4; Vozza A, 2014, P NATL ACAD SCI USA, V111, P960, DOI 10.1073/pnas.1317400111; Wilms B, 2012, INT J SPORTS MED, V33, P740, DOI 10.1055/s-0032-1306284; WINKLER E, 1994, J BIOL CHEM, V269, P2508; Zhao L, 2014, EXP GERONTOL, V56, P3, DOI 10.1016/j.exger.2014.02.001	60	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0149419	10.1371/journal.pone.0149419	http://dx.doi.org/10.1371/journal.pone.0149419			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26886917	gold, Green Published, Green Submitted			2022-12-26	WOS:000371218400080
J	Wu, W; Sun, X; Gao, Y; Jiang, J; Cui, ZL; Ge, BX; Wu, H; Zhang, L; Li, Y				Wu, Wei; Sun, Xian; Gao, Yun; Jiang, Jun; Cui, Zhenling; Ge, Baoxue; Wu, Hai; Zhang, Lu; Li, Yao			Genome-Wide De Novo Prediction of Cis-Regulatory Binding Sites in Mycobacterium tuberculosis H37Rv	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; REPRESSOR; DATABASE; REGULON; NUCLEOTIDE; COMPLEXITY	The transcription regulatory system of Mycobacterium tuberculosis (M. tb) remains incompletely understood. In this study, we have applied the eGLECLUBS algorithm to a group of related prokaryotic genomes for de novo genome-wide prediction of cis-regulatory binding sites (CRBSs) inM. tb H37Rv. The top 250 clusters from our prediction recovered 83.3% (50/60) of all known CRBSs in extracted inter-operonic sequences of this strain. We further demonstrated that the integration of our prediction results with the ChIP-Seq datasets is very effective in identifying true binding sites of TFs. Using electrophoretic mobility shift assays and real-time RT-PCR, we experimentally verified our prediction of CRBSs for Rv0081, an important transcription factor thought to be involved in regulation ofM. tb under hypoxia.	[Wu, Wei; Sun, Xian; Gao, Yun; Jiang, Jun; Wu, Hai; Zhang, Lu; Li, Yao] Fudan Univ, Coll Life Sci, Shanghai Engn Res Ctr Ind Microorganisms, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Cui, Zhenling; Ge, Baoxue] Tongji Univ, Sch Med, Shanghai Pulm Hosp, Shanghai Key Lab TB, Shanghai 200092, Peoples R China	Fudan University; Tongji University	Zhang, L; Li, Y (corresponding author), Fudan Univ, Coll Life Sci, Shanghai Engn Res Ctr Ind Microorganisms, State Key Lab Genet Engn, Shanghai 200433, Peoples R China.	zhanglu407@fudan.edu.cn; yaoli@fudan.edu.cn	Li, Yao/AAE-3550-2019	Zhang, Lu/0000-0002-4858-0361	National Key Technologies R & D Program of China [2013ZX10003007-003]; National Natural Science Foundation of China [31171246]; Shanghai Science and Technology Commission [13DZ2252000]	National Key Technologies R & D Program of China(National Key Technology R&D Program); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Commission(Shanghai Science & Technology CommitteeScience & Technology Commission of Shanghai Municipality (STCSM))	This work was supported by a grant from the National Key Technologies R & D Program of China during the Twelfth Five-Year Plan Period (No. 2013ZX10003007-003, http://www.most.gov.cn/), a grant from the National Natural Science Foundation of China (No. 31171246, http://www.nsfc.gov.cn/), and a grant from Shanghai Science and Technology Commission (No. 13DZ2252000, http://www.stcsm.gov.cn/). YL received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand S, 2012, FEBS J, V279, P3214, DOI 10.1111/j.1742-4658.2012.08707.x; Badis G, 2009, SCIENCE, V324, P1720, DOI 10.1126/science.1162327; Bolla JR, 2012, NUCLEIC ACIDS RES, V40, P9340, DOI 10.1093/nar/gks677; Brosch R, 2002, P NATL ACAD SCI USA, V99, P3684, DOI 10.1073/pnas.052548299; Cavet JS, 2003, J BIOL CHEM, V278, P44560, DOI 10.1074/jbc.M307877200; Engohang-Ndong J, 2004, MOL MICROBIOL, V51, P175, DOI 10.1046/j.1365-2958.2003.03809.x; Galagan J, 2013, CURR TOP MICROBIOL, V363, P43, DOI 10.1007/82_2012_257; Galagan JE, 2013, NATURE, V499, P178, DOI 10.1038/nature12337; Haydel SE, 2006, J BACTERIOL, V188, P150, DOI 10.1128/JB.188.1.150-159.2006; Kendall SL, 2007, MOL MICROBIOL, V65, P684, DOI 10.1111/j.1365-2958.2007.05827.x; Kummerfeld SK, 2006, NUCLEIC ACIDS RES, V34, pD74, DOI 10.1093/nar/gkj131; Liu T, 2007, NAT CHEM BIOL, V3, P60, DOI 10.1038/nchembio844; Maciag A, 2007, J BACTERIOL, V189, P730, DOI 10.1128/JB.01190-06; Mao FL, 2009, NUCLEIC ACIDS RES, V37, pD459, DOI 10.1093/nar/gkn757; Micklinghoff JC, 2009, J BACTERIOL, V191, P7260, DOI 10.1128/JB.01009-09; Midha M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036094; Park HD, 2003, MOL MICROBIOL, V48, P833, DOI 10.1046/j.1365-2958.2003.03474.x; Reddy TBK, 2009, NUCLEIC ACIDS RES, V37, pD499, DOI 10.1093/nar/gkn652; Rhee HS, 2011, CELL, V147, P1408, DOI 10.1016/j.cell.2011.11.013; Sala C, 2009, MOL MICROBIOL, V71, P1102, DOI 10.1111/j.1365-2958.2008.06583.x; TAGLE DA, 1988, J MOL BIOL, V203, P439, DOI 10.1016/0022-2836(88)90011-3; Zhang SQ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-397; Zhang SQ, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp248	23	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0148965	10.1371/journal.pone.0148965	http://dx.doi.org/10.1371/journal.pone.0148965			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26886880	Green Published, gold, Green Submitted			2022-12-26	WOS:000371218400057
J	Feinauer, C; Szurmant, H; Weigt, M; Pagnani, A				Feinauer, Christoph; Szurmant, Hendrik; Weigt, Martin; Pagnani, Andrea			Inter-Protein Sequence Co-Evolution Predicts Known Physical Interactions in Bacterial Ribosomes and the Trp Operon	PLOS ONE			English	Article							STRUCTURAL BASIS; IDENTIFICATION; CONSERVATION; COMPLEXES; CONTACTS; SYNTHASE; ORDER	Interaction between proteins is a fundamental mechanism that underlies virtually all biological processes. Many important interactions are conserved across a large variety of species. The need to maintain interaction leads to a high degree of co-evolution between residues in the interface between partner proteins. The inference of protein-protein interaction networks from the rapidly growing sequence databases is one of the most formidable tasks in systems biology today. We propose here a novel approach based on the Direct-Coupling Analysis of the co-evolution between inter-protein residue pairs. We use ribosomal and trp operon proteins as test cases: For the small resp. large ribosomal subunit our approach predicts protein-interaction partners at a true-positive rate of 70% resp. 90% within the first 10 predictions, with areas of 0.69 resp. 0.81 under the ROC curves for all predictions. In the trp operon, it assigns the two largest interaction scores to the only two interactions experimentally known. On the level of residue interactions we show that for both the small and the large ribosomal subunit our approach predicts interacting residues in the system with a true positive rate of 60% and 85% in the first 20 predictions. We use artificial data to show that the performance of our approach depends crucially on the size of the joint multiple sequence alignments and analyze how many sequences would be necessary for a perfect prediction if the sequences were sampled from the same model that we use for prediction. Given the performance of our approach on the test data we speculate that it can be used to detect new interactions, especially in the light of the rapid growth of available sequence data.	[Feinauer, Christoph; Pagnani, Andrea] Politecn Torino, Dept Appl Sci & Technol, Turin, Italy; [Feinauer, Christoph; Pagnani, Andrea] Politecn Torino, Ctr Computat Sci, Turin, Italy; [Szurmant, Hendrik] Scripps Res Inst, Dept Mol & Expt Med, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA; [Weigt, Martin] Univ Paris 04, UPMC, UMR 7238, Computat & Quantitat Biol, Paris, France; [Weigt, Martin] CNRS, UMR 7238, Computat & Quantitat Biol, Paris, France; [Pagnani, Andrea] Human Genet Fdn, Ctr Mol Biotechnol, Turin, Italy	Polytechnic University of Turin; Polytechnic University of Turin; Scripps Research Institute; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Pagnani, A (corresponding author), Politecn Torino, Dept Appl Sci & Technol, Turin, Italy.; Pagnani, A (corresponding author), Politecn Torino, Ctr Computat Sci, Turin, Italy.; Weigt, M (corresponding author), Univ Paris 04, UPMC, UMR 7238, Computat & Quantitat Biol, Paris, France.; Weigt, M (corresponding author), CNRS, UMR 7238, Computat & Quantitat Biol, Paris, France.; Pagnani, A (corresponding author), Human Genet Fdn, Ctr Mol Biotechnol, Turin, Italy.	martin.weigt@upmc.fr; andrea.pagnani@polito.it	Feinauer, Christoph/AAU-3423-2021; Weigt, Martin/L-8851-2016; Pagnani, Andrea/J-2363-2015	Weigt, Martin/0000-0002-0492-3684; Pagnani, Andrea/0000-0002-6509-0807	EU Marie Curie Training Network NETADIS, (FP7 Grant) [290038]; US National Institute of General Medical Sciences, National Institutes of Health [GM106085, GM019416]; Agence Nationale de la Recherche project COEVSTAT [ANR-13-BS04-0012-01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM106085, R37GM019416, R01GM019416] Funding Source: NIH RePORTER	EU Marie Curie Training Network NETADIS, (FP7 Grant); US National Institute of General Medical Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Agence Nationale de la Recherche project COEVSTAT(French National Research Agency (ANR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Christoph Feinauer and Andrea Pagnani received financial support from EU Marie Curie Training Network NETADIS, (FP7 Grant 290038, http://cordis.europa.eu/fp7/home_en.html). Hendrik Szurmant received financial support from the US National Institute of General Medical Sciences, National Institutes of Health, grants GM106085 and GM019416 (http://www.nigms.nih.gov/Research/Pages/default.aspx). Martin Weigt received financial support from Agence Nationale de la Recherche project COEVSTAT (ANR-13-BS04-0012-01, http://www.agence-nationale-recherche.fr/en/anr-funded-project/?tx_lwmsuivibilan_pi2%5BCODE%5D=ANR-13-BS04-0012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; CF and AP are supported from the EU Marie Curie Training Network NETADIS, (FP7 Grant 290038). HS was supported by grants GM106085 and GM019416 from the US National Institute of General Medical Sciences, National Institutes of Health. MW was supported by the Agence Nationale de la Recherche project COEVSTAT (ANR-13-BS04-0012-01). CF and AP acknowledge Riccardo Zecchina and Carlo Baldassi for many interesting discussions.	Altenhoff AM, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002514; Balakrishnan S, 2011, PROTEINS, V79, P1061, DOI 10.1002/prot.22934; Baldassi C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092721; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Borovinskaya MA, 2007, NAT STRUCT MOL BIOL, V14, P727, DOI 10.1038/nsmb1271; Braun P, 2009, NAT METHODS, V6, P91, DOI [10.1038/NMETH.1281, 10.1038/nmeth.1281]; Burger L, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb4100203; Cheng RR, 2014, P NATL ACAD SCI USA, V111, pE563, DOI 10.1073/pnas.1323734111; Dago AE, 2012, P NATL ACAD SCI USA, V109, pE1733, DOI 10.1073/pnas.1201301109; Dandekar T, 1998, TRENDS BIOCHEM SCI, V23, P324, DOI 10.1016/S0968-0004(98)01274-2; de Juan D, 2013, NAT REV GENET, V14, P249, DOI 10.1038/nrg3414; Ekeberg M, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.012707; Feinauer C, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003847; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Galperin MY, 2000, NAT BIOTECHNOL, V18, P609, DOI 10.1038/76443; Harrington ED, 2008, FEBS LETT, V582, P1251, DOI 10.1016/j.febslet.2008.02.033; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Hopf TA, 2014, ELIFE, V3, DOI 10.7554/eLife.03430; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Juan D, 2008, P NATL ACAD SCI USA, V105, P934, DOI 10.1073/pnas.0709671105; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Knochel T, 1999, P NATL ACAD SCI USA, V96, P9479, DOI 10.1073/pnas.96.17.9479; Lathe WC, 2000, TRENDS BIOCHEM SCI, V25, P474, DOI 10.1016/S0968-0004(00)01663-7; Marcotte Cynthia J Verjovsky, 2002, Appl Bioinformatics, V1, P93; Morcos F, 2011, P NATL ACAD SCI USA, V108, pE1293, DOI 10.1073/pnas.1111471108; Nehrt NL, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002073; Ovchinnikov S, 2014, ELIFE, V3, DOI 10.7554/eLife.02030; Overbeek R, 1999, P NATL ACAD SCI USA, V96, P2896, DOI 10.1073/pnas.96.6.2896; Pazos F, 2002, PROTEINS, V47, P219, DOI 10.1002/prot.10074; Pellegrini M, 1999, P NATL ACAD SCI USA, V96, P4285, DOI 10.1073/pnas.96.8.4285; Procaccini A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019729; Rogozin IB, 2004, BRIEF BIOINFORM, V5, P131, DOI 10.1093/bib/5.2.131; Schug A, 2009, P NATL ACAD SCI USA, V106, P22124, DOI 10.1073/pnas.0912100106; Valencia A, 2002, CURR OPIN STRUC BIOL, V12, P368, DOI 10.1016/S0959-440X(02)00333-0; Weigt M, 2009, P NATL ACAD SCI USA, V106, P67, DOI 10.1073/pnas.0805923106; Weyand M, 2002, J BIOL CHEM, V277, P10647, DOI 10.1074/jbc.M111285200; WILMANNS M, 1992, J MOL BIOL, V223, P477, DOI 10.1016/0022-2836(92)90665-7; WLODAWER A, 1984, J MOL BIOL, V180, P301, DOI 10.1016/S0022-2836(84)80006-6; Yeang CH, 2007, PLOS COMPUT BIOL, V3, P2122, DOI 10.1371/journal.pcbi.0030211	40	28	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0149166	10.1371/journal.pone.0149166	http://dx.doi.org/10.1371/journal.pone.0149166			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	26882169	Green Published, Green Submitted, gold			2022-12-26	WOS:000371219000052
J	Saloojee, S; Burns, JK; Motala, AA				Saloojee, Shamima; Burns, Jonathan K.; Motala, Ayesha A.			Metabolic Syndrome in South African Patients with Severe Mental Illness: Prevalence and Associated Risk Factors	PLOS ONE			English	Article							CARDIOVASCULAR RISK; BODY-MASS; SCHIZOPHRENIA; ANTIPSYCHOTICS; DISORDERS; PATTERNS; DISEASE; OBESITY; POLYPHARMACY; MORTALITY	Background There is a surge of cardiovascular disease (CVD) in Africa. CVD is the leading cause of mortality among patients with severe mental illness (SMI) in developed countries, with little evidence from the African context. Objective To determine the prevalence and risk factors for MetS among South African patients with SMI. Method In a cross sectional study, individuals with SMI treated with antipsychotics and a control group without a mental illness, matched for age, gender and ethnicity were evaluated for MetS using the 2009 Joint Interim statement (JIS) criteria. Results Of the 276 study group subjects, 65.9% were male, 84.1% black African, 9.1% white, 5.4% of Indian descent and 1.5% coloured (mixed race) with a mean age of 34.7 years (+/- 12.5). Schizophrenia was the most common diagnosis (73.2%) and 40% were taking first generation antipsychotics. The prevalence of MetS was 23.2% (M: 15.4%, F: 38.3%) in the study group and 19.9%(M: 11.9%, F: 36.3%) in the control group (p = 0.4). MetS prevalence was significantly higher in study subjects over 55 years compared to controls (p = 0.03). Increased waist circumference (p<0.001) and low high density lipoprotein (HDL) cholesterol (p = 0.003) were significantly more prevalent in study subjects compared to controls. In study subjects, risk factors associated with MetS included age (OR: 1.09, 95% CI 1.06-1.12, p < 0.001), female gender (OR: 2.19, 95% CI 1.06-4.55, p = 0.035) and Indian descent (OR: 5.84, 95% CI 1.66-20.52, p = 0.006) but not class of antipsychotic (p = 0.26). Conclusion The overall MetS prevalence was not increased in patients with SMI compared to controls; however, the higher prevalence of the individual components (HDL cholesterol and waist circumference) suggests an increased risk for CVD, especially in patients over 55 years.	[Saloojee, Shamima; Burns, Jonathan K.] Univ KwaZulu Natal, Nelson R Mandela Sch Med, Dept Psychiat, Durban, South Africa; [Motala, Ayesha A.] Univ KwaZulu Natal, Nelson R Mandela Sch Med, Dept Endocrinol & Diabet, Durban, South Africa	University of Kwazulu Natal; University of Kwazulu Natal	Saloojee, S (corresponding author), Univ KwaZulu Natal, Nelson R Mandela Sch Med, Dept Psychiat, Durban, South Africa.	saloojees1@ukzn.ac.za		Motala, Ayesha/0000-0003-0517-1784	Office of the U.S. Global AIDS Coordinator [R24TW008863]; FOGARTY INTERNATIONAL CENTER [R24TW008863] Funding Source: NIH RePORTER	Office of the U.S. Global AIDS Coordinator; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This publication was made possible by grant number: R24TW008863 from the Office of the U.S. Global AIDS Coordinator and the U. S. Department of Health and Human Services, National Institutes of Health (NIH OAR and NIH ORWH). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the government."	Ader M, 2008, J PSYCHIATR RES, V42, P1076, DOI 10.1016/j.jpsychires.2008.01.004; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Diaz-Dominguez DA, 2013, INT J MENT HEALTH, V42, P95, DOI 10.2753/IMH0020-7411420405; Aly HAA, 2015, WHO TECH REP SER, V994, P1; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; [Anonymous], FAT CHANCE SLIM NONE; Arango C, 2008, SCHIZOPHR RES, V104, P1, DOI 10.1016/j.schres.2008.05.009; Baptista T, 2011, SCHIZOPHR RES, V126, P93, DOI 10.1016/j.schres.2010.10.014; Bressington DT, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-87; Carliner H, 2014, COMPR PSYCHIAT, V55, P233, DOI 10.1016/j.comppsych.2013.09.009; Chang HH, 2010, J AFFECT DISORDERS, V124, P319, DOI 10.1016/j.jad.2009.12.011; Chiliza B, 2015, EUR PSYCHIAT, V30, DOI 10.1016/j.eurpsy.2014.11.013; Coccurello R, 2010, PHARMACOL THERAPEUT, V127, P210, DOI 10.1016/j.pharmthera.2010.04.008; Correll CU, 2007, SCHIZOPHR RES, V89, P91, DOI 10.1016/j.schres.2006.08.017; De Hert M, 2009, EUR PSYCHIAT, V24, P412, DOI 10.1016/j.eurpsy.2009.01.005; Hert M, 2012, NAT REV ENDOCRINOL, V8, P114, DOI 10.1038/nrendo.2011.156; Dold M, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009831.pub2; Draper CE, 2016, PUBLIC HEALTH NUTR, V19, P548, DOI 10.1017/S1368980015001688; Faasen N, 2014, SAJP-S AFR J PSYCHI, V20, P54, DOI 10.7196/SAJP.528; Falissard B, 2011, INT CLIN PSYCHOPHARM, V26, P291, DOI 10.1097/YIC.0b013e32834a5bf6; FerroLuzzi A, 1995, WHO TECH REP SER, V854, P1; Fisher MD, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/s12888-014-0341-5; Foley DL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082606; Gale EAM, 2005, DIABETOLOGIA, V48, P1679, DOI 10.1007/s00125-005-1873-5; Gallego JA, 2012, SCHIZOPHR RES, V138, P18, DOI 10.1016/j.schres.2012.03.018; Gardner-Sood P, 2015, PSYCHOL MED, V45, P2619, DOI 10.1017/S0033291715000562; Hagg S, 2006, INT CLIN PSYCHOPHARM, V21, P93; Hennekens CH, 2005, AM HEART J, V150, P1115, DOI 10.1016/j.ahj.2005.02.007; Holt RIG, 2015, NAT REV ENDOCRINOL, V11, P79, DOI 10.1038/nrendo.2014.203; Horowitz E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092573; Kahn R, 2008, LANCET, V371, P1892, DOI 10.1016/S0140-6736(08)60731-X; Keenan TE, 2013, SCHIZOPHR RES, V150, P211, DOI 10.1016/j.schres.2013.07.022; Lasich A J, 2007, Afr J Psychiatry (Johannesbg), V10, P143; Laursen TM, 2012, CURR OPIN PSYCHIATR, V25, P83, DOI 10.1097/YCO.0b013e32835035ca; Lee NY, 2011, PROG NEURO-PSYCHOPH, V35, P1273, DOI 10.1016/j.pnpbp.2011.03.022; Leucht S, 2013, LANCET, V382, P951, DOI 10.1016/S0140-6736(13)60733-3; Leucht S, 2009, LANCET, V373, P31, DOI 10.1016/S0140-6736(08)61764-X; Maaroganye K, 2013, AFR J PSYCHIATRY, V16, P414, DOI [http://dx.doi.org/10.4314/ajpsy.v16i6.53, 10.4314/ajpsy.v16i6.53]; Marthoenis M, 2015, ASIAN J PSYCHIATR, V15, P10, DOI 10.1016/j.ajp.2015.04.004; McEvoy JP, 2005, SCHIZOPHR RES, V80, P19, DOI 10.1016/j.schres.2005.07.014; Mensah GA, 2015, CARDIOVASC J AFR, V26, pS6, DOI 10.5830/CVJA-2015-036; Mitchell AJ, 2013, SCHIZOPHRENIA BULL, V39, P306, DOI 10.1093/schbul/sbr148; Motala AA, 2011, DIABETES CARE, V34, P1032, DOI 10.2337/dc10-1921; Palaniappan LP, 2011, INT J OBESITY, V35, P393, DOI 10.1038/ijo.2010.152; Papanastasiou E, 2013, THER ADV PSYCHOPHARM, V3, P33, DOI 10.1177/2045125312464385; Peer N, 2014, SAMJ S AFR MED J, V104, P691, DOI [10.7196/SAMJ.8125, 10.7196/samj.8125]; Peer N, 2015, EUR J PREV CARDIOL, V22, P1036, DOI 10.1177/2047487314549744; Purgato M, 2012, INT J MENT HEALTH SY, V6, DOI 10.1186/1752-4458-6-9; Ritchie SA, 2007, NUTR METAB CARDIOVAS, V17, P319, DOI 10.1016/j.numecd.2006.07.005; Rukat A, 2014, J CLIN PSYCHOPHARM, V34, P571, DOI 10.1097/JCP.0000000000000166; Rummel-Kluge C, 2010, SCHIZOPHR RES, V123, P225, DOI 10.1016/j.schres.2010.07.012; Seeman MV, 2009, SCHIZOPHRENIA BULL, V35, P937, DOI 10.1093/schbul/sbn023; Srisurapanont M, 2007, BMC PSYCHIATRY, V7, DOI 10.1186/1471-244X-7-14; Sugawara N, 2010, SCHIZOPHR RES, V123, P244, DOI 10.1016/j.schres.2010.08.030; Tirupati S, 2007, AUST NZ J PSYCHIAT, V41, P606, DOI 10.1080/00048670701392841	55	23	24	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0149209	10.1371/journal.pone.0149209	http://dx.doi.org/10.1371/journal.pone.0149209			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF3BP	26882230	Green Published, Green Submitted, gold			2022-12-26	WOS:000371219000061
J	Andersen, MM; Thisted, DLA; Amer-Wahlin, I; Krebs, L				Andersen, Malene M.; Thisted, Dorthe L. A.; Amer-Wahlin, Isis; Krebs, Lone		Danish CTG Monitoring VBAC Study	Can Intrapartum Cardiotocography Predict Uterine Rupture among Women with Prior Caesarean Delivery?: A Population Based Case-Control Study	PLOS ONE			English	Article							FETAL HEART-RATE; RATE TRACINGS; LABOR; PATTERNS; TRIAL; FORM	Objective To compare cardiotocographic abnormalities recorded during labour in women with prior caesarean delivery (CD) and complete uterine rupture with those recorded in controls with prior CD without uterine rupture. Study Design Women with complete uterine rupture during labour between 1997 and 2008 were identified in the Danish Medical Birth Registry (n = 181). Cases were validated by review of medical records and 53 cases with prior CD, trial of labour, available cardiotocogram (CTG) and complete uterine rupture were included and compared with 43 controls with prior CD, trial of labour and available CTG. The CTG tracings were assessed by 19 independent experts divided into groups of three different experts for each tracing. The assessors were blinded to group, outcome and clinical data. They analyzed occurrence of defined abnormalities and classified the traces as normal, suspicious, pathological or pre-terminal according to international guidelines (FIGO). Results A pathological CTG during the first stage of labour was present in 77% of cases and in 53% of the controls (OR 2.58 [CI: 0.96-6.94] P = 0.066). Fetal tachycardia was more frequent in cases with uterine rupture (OR 2.50 [CI: 1.0-6.26] P = 0.053). Significantly more cases showed more than 10 severe variable decelerations compared with controls (OR 22 [ CI: 1.54-314.2] P = 0.022). Uterine tachysystole was not correlated with the presence of uterine rupture. Conclusion A pathological cardiotocogram should lead to particular attention on threatening uterine rupture but cannot be considered a strong predictor as it is common in all women with trial of labour after caesarean delivery.	[Andersen, Malene M.; Thisted, Dorthe L. A.; Krebs, Lone] Univ Copenhagen, Holbaek Hosp, Dept Obstet & Gynaecol, Holbaek, Denmark; [Thisted, Dorthe L. A.] Univ Copenhagen, Hvidovre Hosp, Dept Obstet & Gynecol, DK-2650 Hvidovre, Denmark; [Amer-Wahlin, Isis] Karolinska Inst, Dept Women & Child Hlth, Stockholm, Sweden	Holbaek Hospital; University of Copenhagen; University of Copenhagen; Karolinska Institutet	Andersen, MM (corresponding author), Univ Copenhagen, Holbaek Hosp, Dept Obstet & Gynaecol, Holbaek, Denmark.	malenemie@yahoo.com	Krebs, Lone/AAD-8273-2021	Krebs, Lone/0000-0001-5433-4776	Regional Research Unit in Holbaek Sygehus	Regional Research Unit in Holbaek Sygehus	MA received a 3 month scholarship from the Regional Research Unit in Holbaek Sygehus. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfirevic Z, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006066; Amer-Wahlin I, 2011, ACTA OBSTET GYN SCAN, V90, P990, DOI 10.1111/j.1600-0412.2011.01203.x; American College of Obstetricians and Gynecologists, 2010, OBSTET GYNECOL 1, V116, P450; Ayres AW, 2001, INT J GYNECOL OBSTET, V74, P235, DOI 10.1016/S0020-7292(01)00445-3; Ayres-de-Campos D, 2011, BJOG-INT J OBSTET GY, V118, P978, DOI 10.1111/j.1471-0528.2011.03003.x; Pryor EC, 2007, AM J PERINAT, V24, P317, DOI 10.1055/s-2007-981433; Doria V, 2007, BJOG-INT J OBSTET GY, V114, P1202, DOI 10.1111/j.1471-0528.2007.01480.x; Guiliano M, 2014, EUR J OBSTET GYN R B, V179, P130, DOI 10.1016/j.ejogrb.2014.05.004; Lydon-Rochelle M, 2001, NEW ENGL J MED, V345, P3, DOI 10.1056/NEJM200107053450101; Patel RM, 2010, SEMIN PERINATOL, V34, P272, DOI 10.1053/j.semperi.2010.03.007; Phelan JP, 1998, OBSTET GYNECOL, V92, P394, DOI 10.1016/S0029-7844(98)00232-4; Ridgeway JJ, 2004, OBSTET GYNECOL, V103, P506, DOI 10.1097/01.AOG.0000113619.67704.99; Santo S, 2012, CURR OPIN OBSTET GYN, V24, P84, DOI 10.1097/GCO.0b013e3283505b3c; Schiermeier S, 2008, BJOG-INT J OBSTET GY, V115, P1557, DOI 10.1111/j.1471-0528.2008.01857.x; Scott JR, 2014, BJOG-INT J OBSTET GY, V121, P157, DOI 10.1111/1471-0528.12449; Sheiner E, 2004, J REPROD MED, V49, P373; Thisted DLA, 2014, EUR J OBSTET GYN R B, V173, P23, DOI 10.1016/j.ejogrb.2013.10.033	17	4	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0146347	10.1371/journal.pone.0146347	http://dx.doi.org/10.1371/journal.pone.0146347			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26872018	Green Published, gold, Green Submitted			2022-12-26	WOS:000370054100001
J	Chan, KF; Wong, PY; Yu, P; Hardick, J; Wong, KY; Wilson, SA; Wu, T; Hui, Z; Gaydos, C; Wong, SS				Chan, Kamfai; Wong, Pui-Yan; Yu, Peter; Hardick, Justin; Wong, Kah-Yat; Wilson, Scott A.; Wu, Tiffany; Hui, Zoe; Gaydos, Charlotte; Wong, Season S.			A Rapid and Low-Cost PCR Thermal Cycler for Infectious Disease Diagnostics	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; REAL-TIME PCR; REACTION AMPLIFICATION; MICROFLUIDIC DEVICES; SAMPLE PREPARATION; DNA AMPLIFICATION; ESCHERICHIA-COLI; RT-PCR; CHIP; FUTURE	The ability to make rapid diagnosis of infectious diseases broadly available in a portable, low-cost format would mark a great step forward in global health. Many molecular diagnostic assays are developed based on using thermal cyclers to carry out polymerase chain reaction (PCR) and reverse-transcription PCR for DNA and RNA amplification and detection, respectively. Unfortunately, most commercial thermal cyclers are expensive and need continuous electrical power supply, so they are not suitable for uses in low-resource settings. We have previously reported a low-cost and simple approach to amplify DNA using vacuum insulated stainless steel thermoses food cans, which we have named it thermos thermal cycler or TTC. Here, we describe the use of an improved set up to enable the detection of viral RNA targets by reverse-transcription PCR (RT-PCR), thus expanding the TTC's ability to identify highly infectious, RNA virus-based diseases in low resource settings. The TTC was successful in demonstrating high-speed and sensitive detection of DNA or RNA targets of sexually transmitted diseases, HIV/AIDS, Ebola hemorrhagic fever, and dengue fever. Our innovative TTC costs less than $200 to build and has a capacity of at least eight tubes. In terms of speed, the TTC's performance exceeded that of commercial thermal cyclers tested. When coupled with low-cost endpoint detection technologies such as nucleic acid lateral-flow assay or a cell-phone-based fluorescence detector, the TTC will increase the availability of on-site molecular diagnostics in low-resource settings.	[Chan, Kamfai; Wong, Pui-Yan; Yu, Peter; Wong, Kah-Yat; Wilson, Scott A.; Wu, Tiffany; Hui, Zoe; Wong, Season S.] AI Biosci Inc, College Stn, TX USA; [Hardick, Justin; Gaydos, Charlotte] Johns Hopkins Univ, Dept Med, Baltimore, MD USA	Johns Hopkins University	Wong, SS (corresponding author), AI Biosci Inc, College Stn, TX USA.	season.wong@aibiosciences.com	Gaydos, Charlotte A./E-9937-2010		Small Business Innovative Research (SBIR) from US National Institutes of Health [1R43AI106239, 1R43AI107984]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R43AI106239, R43AI107984] Funding Source: NIH RePORTER	Small Business Innovative Research (SBIR) from US National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work is supported by Small Business Innovative Research (SBIR) grants from the US National Institutes of Health, Grant #s 1R43AI106239 and 1R43AI107984. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Belgrader P, 2003, ANAL CHEM, V75, P3446, DOI 10.1021/ac034062u; Brooks HA, 2005, J VIROL METHODS, V127, P109, DOI 10.1016/j.jviromet.2005.03.017; Butler D, 2006, NATURE, V440, P6, DOI 10.1038/440006a; Chen ZY, 2004, ANAL CHEM, V76, P3707, DOI 10.1021/ac049914k; Cheng JY, 2005, ANALYST, V130, P931, DOI 10.1039/b501061f; Chin CD, 2007, LAB CHIP, V7, P41, DOI 10.1039/b611455e; Chiou J, 2001, ANAL CHEM, V73, P2018, DOI 10.1021/ac001227f; Elenitoba-Johnson O, 2008, BIOTECHNIQUES, V44, P487, DOI 10.2144/000112722; Farrar JS, 2015, CLIN CHEM, V61, P145, DOI 10.1373/clinchem.2014.228304; Frey O, 2007, BIOMED MICRODEVICES, V9, P711, DOI 10.1007/s10544-007-9080-4; Hennig M, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2051787; Johnson BW, 2005, J CLIN MICROBIOL, V43, P4977, DOI 10.1128/JCM.43.10.4977-4983.2005; Khandurina J, 2000, ANAL CHEM, V72, P2995, DOI 10.1021/ac991471a; King DA, 2006, SCIENCE, V313, P1392, DOI 10.1126/science.1129134; Kopp MU, 1998, SCIENCE, V280, P1046, DOI 10.1126/science.280.5366.1046; Lin MH, 2001, CLIN BIOCHEM, V34, P661, DOI 10.1016/S0009-9120(01)00281-8; Liu P, 2007, ANAL CHEM, V79, P1881, DOI 10.1021/ac061961k; Liu RH, 2004, ANAL CHEM, V76, P1824, DOI 10.1021/ac0353029; Logan J., 2009, REAL TIME PCR CURREN; Lu XY, 2014, J CLIN MICROBIOL, V52, P67, DOI 10.1128/JCM.02533-13; MANNUCCI A, 1994, INT J LEGAL MED, V106, P190, DOI 10.1007/BF01371335; Nachamkin I, 1997, CLIN INFECT DIS, V24, P894, DOI 10.1093/clinids/24.5.894; Noble RT, 2010, APPL ENVIRON MICROB, V76, P7437, DOI 10.1128/AEM.00651-10; Obeid PJ, 2003, ANAL CHEM, V75, P288, DOI 10.1021/ac0260239; Oda RP, 1998, ANAL CHEM, V70, P4361, DOI 10.1021/ac980452i; Oh MH, 2009, J FOOD PROTECT, V72, P1262, DOI 10.4315/0362-028X-72.6.1262; Pipper J, 2008, ANGEW CHEM INT EDIT, V47, P3900, DOI 10.1002/anie.200705016; Santiago GA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002311; Sauer S, 2005, NAT REV GENET, V6, P465, DOI 10.1038/nrg1618; Syvanen AC, 2005, NAT GENET, V37, pS5, DOI 10.1038/ng1558; Walker FM, 2014, ANAL CHEM, V86, P9236, DOI 10.1021/ac5022419; Wang H, 2006, ANAL CHEM, V78, P6223, DOI 10.1021/ac060568b; WEISSENSTEINER T, 2004, PCR TECHNOLOGY CURRE; Wheeler EK, 2004, ANAL CHEM, V76, P4011, DOI 10.1021/ac034941g; WITTWER CT, 1989, NUCLEIC ACIDS RES, V17, P4353, DOI 10.1093/nar/17.11.4353; Wong G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131701; Xiang Q, 2005, BIOMED MICRODEVICES, V7, P273, DOI 10.1007/s10544-005-6069-8; Yager P, 2006, NATURE, V442, P412, DOI 10.1038/nature05064; Yang S, 2004, LANCET INFECT DIS, V4, P337, DOI 10.1016/S1473-3099(04)01044-8; Yu CY, 2007, J CHIN INST CHEM ENG, V38, P333, DOI 10.1016/j.jcice.2007.05.001; Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721; Zhang CS, 2006, BIOTECHNOL ADV, V24, P243, DOI 10.1016/j.biotechadv.2005.10.002; [No title captured]	43	16	17	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149150	10.1371/journal.pone.0149150	http://dx.doi.org/10.1371/journal.pone.0149150			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26872358	Green Published, Green Submitted, gold			2022-12-26	WOS:000370054100112
J	Feng, YF; Hodiamont, CJ; van Hest, RM; Brul, S; Schultsz, C; ter Kuile, BH				Feng, Yanfang; Hodiamont, Caspar J.; van Hest, Reinier M.; Brul, Stanley; Schultsz, Constance; ter Kuile, Benno H.			Development of Antibiotic Resistance during Simulated Treatment of Pseudomonas aeruginosa in Chemostats	PLOS ONE			English	Article							CRITICALLY-ILL PATIENTS; INTENSIVE-CARE-UNIT; ANTIMICROBIAL RESISTANCE; THERAPY; CEFTAZIDIME; MUTATIONS; MEROPENEM; SURVIVAL; IMPACT; COSTS	During treatment of infections with antibiotics in critically ill patients in the intensive care resistance often develops. This study aims to establish whether under those conditions this resistance can develop de novo or that genetic exchange between bacteria is by necessity involved. Chemostat cultures of Pseudomonas aeruginosa were exposed to treatment regimes with ceftazidime and meropenem that simulated conditions expected in patient plasma. Development of antibiotic resistance was monitored and mutations in resistance genes were searched for by sequencing PCR products. Even at the highest concentrations that can be expected in patients, sufficient bacteria survived in clumps of filamentous cells to recover and grow out after 3 to 5 days. At the end of a 7 days simulated treatment, the minimal inhibitory concentration (MIC) had increased by a factor between 10 and 10,000 depending on the antibiotic and the treatment protocol. The fitness costs of resistance were minimal. In the resistant strains, only three mutations were observed in genes associated with beta-lactam resistance. The development of resistance often observed during patient treatment can be explained by de novo acquisition of resistance and genetic exchange of resistance genes is not by necessity involved. As far as conclusions based on an in vitro study using P. aeruginosa and only two antibiotics can be generalized, it seems that development of resistance can be minimized by treating with antibiotics in the highest concentration the patient can endure for the shortest time needed to eliminate the infection.	[Feng, Yanfang; Brul, Stanley; ter Kuile, Benno H.] Univ Amsterdam, Swammerdam Inst Life Sci, Dept Mol Biol & Microbial Food Safety, Amsterdam, Netherlands; [Hodiamont, Caspar J.; Schultsz, Constance] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, NL-1105 AZ Amsterdam, Netherlands; [van Hest, Reinier M.] Univ Amsterdam, Acad Med Ctr, Dept Hosp Pharm & Clin Pharmacol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [Schultsz, Constance] Univ Amsterdam, Acad Med Ctr, Amsterdam Inst Global Hlth & Dev, Dept Global Hlth, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [ter Kuile, Benno H.] Netherlands Food & Consumer Prod Safety Author, Off Risk Assessment & Res Coordinat, Utrecht, Netherlands	University of Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	ter Kuile, BH (corresponding author), Univ Amsterdam, Swammerdam Inst Life Sci, Dept Mol Biol & Microbial Food Safety, Amsterdam, Netherlands.; ter Kuile, BH (corresponding author), Netherlands Food & Consumer Prod Safety Author, Off Risk Assessment & Res Coordinat, Utrecht, Netherlands.	B.H.terKuile@uva.nl	Kuile, Benno Ter/AAD-1699-2021	van Hest, Reinier/0000-0002-2506-8795	Netherlands Food and Consumer Product Safety Authority; Chinese Research Council	Netherlands Food and Consumer Product Safety Authority; Chinese Research Council	This project was funded by The Netherlands Food and Consumer Product Safety Authority. Yanfang Feng received a scholarship from the Chinese Research Council.	Andersson DI, 2006, CURR OPIN MICROBIOL, V9, P461, DOI 10.1016/j.mib.2006.07.002; Sanchez-Romero MA, 2014, P NATL ACAD SCI USA, V111, P355, DOI 10.1073/pnas.1316084111; Benko AS, 1996, ANTIMICROB AGENTS CH, V40, P691, DOI 10.1128/AAC.40.3.691; Berthoin K, 2010, J ANTIMICROB CHEMOTH, V65, P1073, DOI 10.1093/jac/dkq044; Blot S, 2003, J HOSP INFECT, V53, P18, DOI 10.1053/jhin.2002.1329; Bos J, 2015, P NATL ACAD SCI USA, V112, P178, DOI 10.1073/pnas.1420702111; Brusselaers N, 2011, ANN INTENSIVE CARE, V1, DOI 10.1186/2110-5820-1-47; Coward C, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004359; Delattre IK, 2012, CLIN BIOCHEM, V45, P780, DOI 10.1016/j.clinbiochem.2012.03.030; Drlica K, 2007, CLIN INFECT DIS, V44, P681, DOI 10.1086/511642; Feng YF, 2014, ANTIBIOTICS-BASEL, V3, P49, DOI 10.3390/antibiotics3010049; Fernandez L, 2011, DRUG RESIST UPDATE, V14, P1, DOI 10.1016/j.drup.2011.01.001; Fish DN, 2006, CRIT CARE CLIN, V22, P291, DOI 10.1016/j.ccc.2006.02.006; Gaieski DF, 2010, CRIT CARE MED, V38, P1045, DOI 10.1097/CCM.0b013e3181cc4824; Garnacho-Montero J, 2003, CRIT CARE MED, V31, P2742, DOI 10.1097/01.CCM.0000098031.24329.10; Handel N, 2014, ANTIMICROB AGENTS CH, V58, P4371, DOI 10.1128/AAC.02892-14; Handel N, 2013, ANTIMICROB AGENTS CH, V57, P3752, DOI 10.1128/AAC.02096-12; Henrichfreise B, 2007, ANTIMICROB AGENTS CH, V51, P3642, DOI 10.1128/AAC.00160-07; Hoiby N, 2001, MICROBES INFECT, V3, P23, DOI 10.1016/S1286-4579(00)01349-6; Jin L, 2012, ANTIMICROB AGENTS CH, V56, P5240, DOI 10.1128/AAC.00713-12; Justice SS, 2008, NAT REV MICROBIOL, V6, P162, DOI 10.1038/nrmicro1820; Kollef MH, 2001, CRIT CARE, V5, P189, DOI 10.1186/cc1022; Kumar A, 2006, CRIT CARE MED, V34, P1589, DOI 10.1097/01.CCM.0000217961.75225.E9; Lee HH, 2010, NATURE, V467, P82, DOI 10.1038/nature09354; Martinez JL, 2000, ANTIMICROB AGENTS CH, V44, P1771, DOI 10.1128/AAC.44.7.1771-1777.2000; Melnyk AH, 2015, EVOL APPL, V8, P273, DOI 10.1111/eva.12196; Mogre A, 2014, DNA RES, V21, P711, DOI 10.1093/dnares/dsu032; Oz T, 2014, MOL BIOL EVOL, V31, P2387, DOI 10.1093/molbev/msu191; Roberts JA, 2008, CRIT CARE MED, V36, P2433, DOI 10.1097/CCM.0b013e318180fe62; Schuurmans JM, 2009, J MICROBIOL METH, V79, P44, DOI 10.1016/j.mimet.2009.07.017; Singh R, 2012, ANTIMICROB AGENTS CH, V56, P1680, DOI 10.1128/AAC.05693-11; Smith Susan V, 2004, Expert Rev Anti Infect Ther, V2, P227, DOI 10.1586/14787210.2.2.227; Toprak E, 2012, NAT GENET, V44, P101, DOI 10.1038/ng.1034; van der Horst MA, 2011, MICROB DRUG RESIST, V17, P141, DOI 10.1089/mdr.2010.0101; Vega NM, 2014, CURR OPIN MICROBIOL, V21, P28, DOI 10.1016/j.mib.2014.09.003	35	13	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149310	10.1371/journal.pone.0149310	http://dx.doi.org/10.1371/journal.pone.0149310			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26872140	Green Published, Green Submitted, gold			2022-12-26	WOS:000370054100146
J	Huson, MAM; Scicluna, BP; van Vught, LA; Wiewel, MA; Hoogendijk, AJ; Cremer, OL; Bonten, MJM; Schultz, MJ; Franitza, M; Toliat, MR; Nurnberg, P; Grobusch, MP; van der Poll, T				Huson, Michaela A. M.; Scicluna, Brendon P.; van Vught, Lonneke A.; Wiewel, Maryse A.; Hoogendijk, Arie J.; Cremer, Olaf L.; Bonten, Marc J. M.; Schultz, Marcus J.; Franitza, Marek; Toliat, Mohammad R.; Nuernberg, Peter; Grobusch, Martin P.; van der Poll, Tom			The Impact of HIV Co-Infection on the Genomic Response to Sepsis	PLOS ONE			English	Article							GENE-EXPRESSION; HOST RESPONSE; SEPTIC SHOCK; INFECTIONS; CARE; DEFINITIONS; BIOMARKER	HIV patients have an increased risk to develop sepsis and HIV infection affects several components of the immune system involved in sepsis pathogenesis. We hypothesized that HIV infection might aggrevate the aberrant immune response during sepsis, so we aimed to determine the impact of HIV infection on the genomic host response to sepsis. We compared whole blood leukocyte gene expression profiles among sepsis patients with or without HIV co-infection in the intensive care unit (ICU) and validated our findings in a cohort of patients admitted to the same ICUs in a different time frame. To examine the influence of HIV infection per se, we also determined the expression of genes of interest in a cohort of asymptomatic HIV patients. We identified a predominantly common host response in sepsis patients with or without HIV co-infection. HIV positive sepsis patients in both ICU cohorts showed overexpression of genes involved in granzyme signaling (GZMA, GZMB), cytotoxic T-cell signaling (CD8A, CD8B) and T-cell inhibitory signaling (LAG3), compared to HIV negative patients. Enhanced expression of CD8A, CD8B and LAG3 was also unmasked in asymptomatic HIV patients. Plasma levels of granzymes in sepsis patients were largely below detection limit, without differences according to HIV status. These results demonstrate that sepsis is characterized by a massive common response with few differences between HIV positive and HIV negative sepsis patients. Observed differences in granzyme signaling, cytotoxic T-cell signaling and T-cell inhibitory signaling appear to be changes commonly observed in asymptomatic HIV patients which persist during sepsis.	[Huson, Michaela A. M.; Scicluna, Brendon P.; van Vught, Lonneke A.; Wiewel, Maryse A.; Hoogendijk, Arie J.; van der Poll, Tom] Univ Amsterdam, Acad Med Ctr, Ctr Expt & Mol Med, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [Huson, Michaela A. M.; Grobusch, Martin P.] Ctr Rech Med Lambarene, Lambarene, Gabon; [Cremer, Olaf L.] Univ Med Ctr Utrecht, Dept Intens Care Med, Utrecht, Netherlands; [Bonten, Marc J. M.] Univ Med Ctr Utrecht, Dept Med Microbiol, Utrecht, Netherlands; [Bonten, Marc J. M.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Schultz, Marcus J.] Univ Amsterdam, Acad Med Ctr, Dept Intens Care, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [Franitza, Marek; Toliat, Mohammad R.; Nuernberg, Peter] Univ Cologne, CCG, D-50931 Cologne, Germany; [Franitza, Marek; Nuernberg, Peter] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50931 Cologne, Germany; [Nuernberg, Peter] Univ Cologne, Ctr Mol Med Cologne, D-50931 Cologne, Germany; [Grobusch, Martin P.] Univ Amsterdam, Acad Med Ctr, Ctr Trop Med & Travel Med, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [Grobusch, Martin P.; van der Poll, Tom] Univ Amsterdam, Acad Med Ctr, Div Infect Dis, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Amsterdam; University of Cologne; University of Cologne; University of Cologne; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Huson, MAM (corresponding author), Univ Amsterdam, Acad Med Ctr, Ctr Expt & Mol Med, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.; Huson, MAM (corresponding author), Ctr Rech Med Lambarene, Lambarene, Gabon.	m.a.huson@amc.uva.nl	Cremer, Olaf L/G-3855-2016; Schultz, Marcus/AAB-6379-2021; Scicluna, Brendon/T-8112-2018	Cremer, Olaf L/0000-0003-4264-1108; Schultz, Marcus/0000-0003-3969-7792; Scicluna, Brendon/0000-0003-2826-0341	CTMM, the Center for Translational Molecular Medicine, project MARS [04I-201]	CTMM, the Center for Translational Molecular Medicine, project MARS	This research was performed within the framework of CTMM, the Center for Translational Molecular Medicine (www.ctmm.nl), project MARS (grant 04I-201).	Amancio RT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068730; Angus DC, 2013, NEW ENGL J MED, V369, P840, DOI [10.1056/NEJMc1312359, 10.1056/NEJMra1208623]; Bourgon R, 2010, P NATL ACAD SCI USA, V107, P9546, DOI 10.1073/pnas.0914005107; Calandra T, 2005, CRIT CARE MED, V33, P1538, DOI 10.1097/01.CCM.0000168253.91200.83; Chiang HH, 2011, CRIT CARE, V15, DOI 10.1186/cc10419; Ewen CL, 2012, CELL DEATH DIFFER, V19, P28, DOI 10.1038/cdd.2011.153; GARNER JS, 1988, AM J INFECT CONTROL, V16, P128, DOI 10.1016/0196-6553(88)90053-3; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gekonge B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041153; Hotchkiss RS, 2013, LANCET INFECT DIS, V13, P260, DOI 10.1016/S1473-3099(13)70001-X; Huson MAM, 2015, J INFECT DIS, V212, P474, DOI 10.1093/infdis/jiv074; Huson MAM, 2015, LANCET INFECT DIS, V15, P95, DOI 10.1016/S1473-3099(14)70917-X; Huson MAM, 2014, CLIN INFECT DIS, V58, P79, DOI 10.1093/cid/cit596; Jenner RG, 2005, NAT REV MICROBIOL, V3, P281, DOI 10.1038/nrmicro1126; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kaukonen KM, 2014, JAMA-J AM MED ASSOC, V311, P1308, DOI 10.1001/jama.2014.2637; Khaitan Alka, 2011, Curr HIV/AIDS Rep, V8, P4, DOI 10.1007/s11904-010-0066-0; Klouwenberg PMCK, 2013, CRIT CARE MED, V41, P2373, DOI 10.1097/CCM.0b013e3182923712; Larsson M, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-31; Leek JT, 2007, PLOS GENET, V3, P1724, DOI 10.1371/journal.pgen.0030161; Levy MM, 2001, INTENS CARE MED, V29, P530, DOI DOI 10.1007/S00134-003-1662-X; Lieberman J, 2003, NAT REV IMMUNOL, V3, P361, DOI 10.1038/nri1083; Mankhambo LA, 2010, CRIT CARE, V14, DOI 10.1186/cc9025; Parlato M, 2015, METHODS MOL BIOL, V1237, P149, DOI 10.1007/978-1-4939-1776-1_15; Rosenberg AL, 2001, CRIT CARE MED, V29, P548, DOI 10.1097/00003246-200103000-00013; Ruijter JM, 2013, METHODS, V59, P32, DOI 10.1016/j.ymeth.2012.08.011; Scicluna BP, 2015, AM J RESP CRIT CARE, V192, P826, DOI 10.1164/rccm.201502-0355OC; Silva JM, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.17344; Smith PR, 2000, J CLIN PATHOL, V53, P177, DOI 10.1136/jcp.53.3.177; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Spaeny-Dekking EHA, 1998, J IMMUNOL, V160, P3610; Tang BM, 2010, CRIT CARE, V14, DOI 10.1186/cc9392; Tang BMP, 2008, CRIT CARE MED, V36, P1125, DOI 10.1097/CCM.0b013e3181692c0b; van Lieshout MH, 2014, AM J RESP CELL MOL, V50, P699, DOI 10.1165/rcmb.2013-0015OC; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Wong HR, 2012, CRIT CARE, V16, DOI [10.1186/cc10537, 10.1186/cc10811]; Xiao WZ, 2011, J EXP MED, V208, P2581, DOI 10.1084/jem.20111354; Zeerleder S, 2005, CLIN IMMUNOL, V116, P158, DOI 10.1016/j.clim.2005.03.006	38	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0148955	10.1371/journal.pone.0148955	http://dx.doi.org/10.1371/journal.pone.0148955			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26871709	Green Submitted, Green Published, gold			2022-12-26	WOS:000370054100080
J	Smits, FM; Porcaro, C; Cottone, C; Cancelli, A; Rossini, PM; Tecchio, F				Smits, Fenne Margreeth; Porcaro, Camillo; Cottone, Carlo; Cancelli, Andrea; Rossini, Paolo Maria; Tecchio, Franca			Electroencephalographic Fractal Dimension in Healthy Ageing and Alzheimer's Disease	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; FUNCTIONAL SOURCE SEPARATION; CORTICAL RHYTHMS; FREE COPPER; EEG; BRAIN; COMPLEXITY; STATE; ADULTS; SCALE	Brain activity is complex; a reflection of its structural and functional organization. Among other measures of complexity, the fractal dimension is emerging as being sensitive to neuronal damage secondary to neurological and psychiatric diseases. Here, we calculated Higuchi's fractal dimension (HFD) in resting-state eyes-closed electroencephalography (EEG) recordings from 41 healthy controls (age: 20-89 years) and 67 Alzheimer's Disease (AD) patients (age: 50-88 years), to investigate whether HFD is sensitive to brain activity changes typical in healthy aging and in AD. Additionally, we considered whether AD-accelerating effects of the copper fraction not bound to ceruloplasmin (also called "free" copper) are reflected in HFD fluctuations. The HFD measure showed an inverted U-shaped relationship with age in healthy people (R-2 = .575, p < .001). Onset of HFD decline appeared around the age of 60, and was most evident in central-parietal regions. In this region, HFD decreased with aging stronger in the right than in the left hemisphere (p = .006). AD patients demonstrated reduced HFD compared to age-and education-matched healthy controls, especially in temporal-occipital regions. This was associated with decreasing cognitive status as assessed by mini-mental state examination, and with higher levels of non-ceruloplasmin copper. Taken together, our findings show that resting-state EEG complexity increases from youth to maturity and declines in healthy, aging individuals. In AD, brain activity complexity is further reduced in correlation with cognitive impairment. In addition, elevated levels of non-ceruloplasmin copper appear to accelerate the reduction of neural activity complexity. Overall, HDF appears to be a proper indicator for monitoring EEG-derived brain activity complexity in healthy and pathological aging.	[Smits, Fenne Margreeth; Porcaro, Camillo; Cottone, Carlo; Cancelli, Andrea; Tecchio, Franca] Osped Fatebenefratelli, LETS, ISTC, CNR, Rome, Italy; [Smits, Fenne Margreeth] Univ Amsterdam, Amsterdam, Netherlands; [Porcaro, Camillo] Newcastle Univ, Sch Med, Inst Neurosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Cancelli, Andrea; Rossini, Paolo Maria] Univ Cattolica Sacro Cuore, Inst Neurol, Rome, Italy; [Rossini, Paolo Maria; Tecchio, Franca] IRCCS San Raffaele Pisana, Unit Neuroimaging, Rome, Italy; [Porcaro, Camillo] Univ Politecn Marche, Dept Informat Engn, Ancona, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze e Tecnologie della Cognizione (ISTC-CNR); University of Amsterdam; Newcastle University - UK; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; IRCCS San Raffaele Pisana; Marche Polytechnic University	Tecchio, F (corresponding author), Osped Fatebenefratelli, LETS, ISTC, CNR, Rome, Italy.; Tecchio, F (corresponding author), IRCCS San Raffaele Pisana, Unit Neuroimaging, Rome, Italy.	franca.tecchio@cnr.it	Cancelli, Andrea/K-7824-2016; Porcaro, Camillo/K-7864-2016; tecchio, franca/AAX-2770-2020; Rossini, Paolo Maria/D-4994-2013	Cancelli, Andrea/0000-0002-3654-323X; Porcaro, Camillo/0000-0003-4847-163X; tecchio, franca/0000-0002-1325-5059; Rossini, Paolo Maria/0000-0003-2665-534X; Smits, Fenne/0000-0001-9697-1028	FISM - Fondazione Italiana Sclerosi Multipla [2014/R]; MIUR [2010SH7H3F]; PNR-CNR Aging Program	FISM - Fondazione Italiana Sclerosi Multipla(Fondazione Italiana Sclerosi Multipla (FISM)); MIUR(Ministry of Education, Universities and Research (MIUR)); PNR-CNR Aging Program	This work was supported by FISM - Fondazione Italiana Sclerosi Multipla-Cod.2014/R [FaReMuS CuNeH], MIUR Prot. 2010SH7H3F 'Functional connectivity and neuroplasticity in physiological and pathological aging [ConnAge]' and PNR-CNR Aging Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadi K, 2013, NEUROSCI LETT, V535, P7, DOI 10.1016/j.neulet.2012.12.043; Ahmadlou M, 2011, ALZ DIS ASSOC DIS, V25, P85, DOI 10.1097/WAD.0b013e3181ed1160; Allen EA, 2014, CEREB CORTEX, V24, P663, DOI 10.1093/cercor/bhs352; Babiloni C, 2006, CLIN NEUROPHYSIOL, V117, P252, DOI 10.1016/j.clinph.2005.09.019; Babiloni C, 2006, HUM BRAIN MAPP, V27, P162, DOI 10.1002/hbm.20175; Babiloni C, 2007, CLIN NEUROPHYSIOL, V118, P1244, DOI 10.1016/j.clinph.2007.03.016; Barbati G, 2004, CLIN NEUROPHYSIOL, V115, P1220, DOI 10.1016/j.clinph.2003.12.015; Bo J, 2014, BRAIN CONNECT, V4, P166, DOI 10.1089/brain.2013.0155; Buzsaki G, 2014, NAT REV NEUROSCI, V15, P264, DOI 10.1038/nrn3687; Cottone C, 2013, BRAIN TOPOGR, V26, P186, DOI 10.1007/s10548-012-0240-3; Dauwels J, 2010, NEUROIMAGE, V49, P668, DOI 10.1016/j.neuroimage.2009.06.056; Dolcos F, 2002, NEUROSCI BIOBEHAV R, V26, P819, DOI 10.1016/S0149-7634(02)00068-4; Filippo Z, 2015, PLOS ONE IN PRESS; Fjell AM, 2013, J NEUROSCI, V33, P8237, DOI 10.1523/JNEUROSCI.5506-12.2013; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gaal ZA, 2010, NEUROSCI LETT, V479, P79, DOI 10.1016/j.neulet.2010.05.037; Goldberger AL, 2002, NEUROBIOL AGING, V23, P23, DOI 10.1016/S0197-4580(01)00266-4; Graziadio S, 2010, J NEUROSCI, V30, P3663, DOI 10.1523/JNEUROSCI.5621-09.2010; Handwerker DA, 2012, NEUROIMAGE, V63, P1712, DOI 10.1016/j.neuroimage.2012.06.078; He BYJ, 2011, J NEUROSCI, V31, P13786, DOI 10.1523/JNEUROSCI.2111-11.2011; Helmberger M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087515; HIGUCHI T, 1988, PHYSICA D, V31, P277, DOI 10.1016/0167-2789(88)90081-4; Jeong JS, 2004, CLIN NEUROPHYSIOL, V115, P1490, DOI 10.1016/j.clinph.2004.01.001; Liddell Belinda J., 2007, Journal of Integrative Neuroscience, V6, P141, DOI 10.1142/S0219635207001374; Long XJ, 2013, HUM BRAIN MAPP, V34, P3400, DOI 10.1002/hbm.22157; McBridea JC, 2014, COMPUT METH PROG BIO, V114, P153, DOI 10.1016/j.cmpb.2014.01.019; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Medaglia MT, 2009, CONTRADICTION UNIVER, V4197, P4187; Meerwijk EL, 2015, BIOL PSYCHOL, V105, P106, DOI 10.1016/j.biopsycho.2015.01.003; Mizuno T, 2010, CLIN NEUROPHYSIOL, V121, P1438, DOI 10.1016/j.clinph.2010.03.025; Moledina S, 2011, HEART, V97, P1245, DOI 10.1136/hrt.2010.214130; Narayanan B, 2013, J STUD ALCOHOL DRUGS, V74, P245, DOI 10.15288/jsad.2013.74.245; Niedermeyer E., 2004, ELECTROENCEPHALOGRAP; Pal A, 2015, J ALZHEIMERS DIS, V44, P343, DOI 10.3233/JAD-141194; Pascual-Leone A, 2011, BRAIN TOPOGR, V24, P302, DOI 10.1007/s10548-011-0196-8; Pereda E, 1999, NEUROSCI LETT, V263, P37, DOI 10.1016/S0304-3940(99)00104-4; Porcaro C, 2009, HAND SOMATOSENSORY S, V674, P660; Porcaro C, 2015, NEUROIMAGE, V105, P171, DOI 10.1016/j.neuroimage.2014.10.049; Porcaro C, 2014, SIGNALS COMMUN TECHN, P521, DOI 10.1007/978-3-642-55016-4_19; Ramon C, 2015, CURR OPIN NEUROBIOL, V31, P127, DOI 10.1016/j.conb.2014.10.001; Roberts JA, 2014, J NEUROSCI, V34, P6557, DOI 10.1523/JNEUROSCI.4701-13.2014; Sala-Llonch R, 2012, FRONTIERS HUMAN NEUR; Salustri C, 2010, CLIN NEUROPHYSIOL, V121, P502, DOI 10.1016/j.clinph.2009.11.090; Smith SM, 2012, P NATL ACAD SCI USA, V109, P3131, DOI 10.1073/pnas.1121329109; Stam CJ, 2007, CEREB CORTEX, V17, P92, DOI 10.1093/cercor/bhj127; Stam CJ, 2005, CLIN NEUROPHYSIOL, V116, P2266, DOI 10.1016/j.clinph.2005.06.011; Staudinger T, 2011, IEEE ENG MED BIO, P2033, DOI 10.1109/IEMBS.2011.6090374; Sun JF, 2012, AGING DIS, V3, P181; Tecchio F, 2007, J PHYSIOL-LONDON, V580, P703, DOI 10.1113/jphysiol.2007.129163; Tononi G, 1998, TRENDS COGN SCI, V2, P474, DOI 10.1016/S1364-6613(98)01259-5; Walshe JM, 2003, ANN CLIN BIOCHEM, V40, P115, DOI 10.1258/000456303763046021; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4; Zappasodi F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100199	53	68	69	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149587	10.1371/journal.pone.0149587	http://dx.doi.org/10.1371/journal.pone.0149587			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26872349	gold, Green Published, Green Submitted			2022-12-26	WOS:000370054100166
J	Kim, SS; Rawat, R; Mwangi, EM; Tesfaye, R; Abebe, Y; Baker, J; Frongillo, EA; Ruel, MT; Menon, P				Kim, Sunny S.; Rawat, Rahul; Mwangi, Edina M.; Tesfaye, Roman; Abebe, Yewelsew; Baker, Jean; Frongillo, Edward A.; Ruel, Marie T.; Menon, Purnima			Exposure to Large-Scale Social and Behavior Change Communication Interventions Is Associated with Improvements in Infant and Young Child Feeding Practices in Ethiopia	PLOS ONE			English	Article							HEALTH EXTENSION PROGRAM; EVALUATION DESIGNS; NUTRITION; IMPACT; PROVISION; COUNTRIES; EDUCATION; GROWTH	Optimal breastfeeding (BF) practices in Ethiopia are far below the government's targets, and complementary feeding practices are poor. The Alive & Thrive initiative aimed to improve infant and young child feeding (IYCF) practices through large-scale implementation of social and behavior change communication interventions in four regions of Ethiopia. The study assessed the effects of the interventions on IYCF practices and anthropometry over time in two regions-Southern Nations, Nationalities and Peoples Region and Tigray. A pre- and post-intervention adequacy evaluation design was used; repeated cross-sectional surveys of households with children aged 0-23.9 mo (n = 1481 and n = 1494) and with children aged 24-59.9 mo (n = 1481 and n = 1475) were conducted at baseline (2010) and endline (2014), respectively. Differences in outcomes over time were estimated using regression models, accounting for clustering and covariates. Plausibility analyses included tracing recall of key messages and promoted foods and dose-response analyses. We observed improvements in most WHO-recommended IYCF indicators. Early BF initiation and exclusive BF increased by 13.7 and 9.4 percentage points (pp), respectively. Differences for timely introduction of complementary foods, minimum dietary diversity (MDD), minimum meal frequency (MMF), minimum acceptable diet (MAD), and consumption of iron-rich foods were 22.2, 3.3, 26.2, 3.5, and 2.7 pp, respectively. Timely introduction and intake of foods promoted by the interventions improved significantly, but anthropometric outcomes did not. We also observed a dose-response association between health post visits and early initiation of BF (OR: 1.8); higher numbers of home visits by community volunteers and key messages recalled were associated with 1.8-4.4 times greater odds of achieving MDD, MMF, and MAD, and higher numbers of radio spots heard were associated with 3 times greater odds of achieving MDD and MAD. The interventions were associated with plausible improvements in IYCF practices, but large gaps in improving children's diets in Ethiopia remain, particularly during complementary feeding.	[Kim, Sunny S.; Mwangi, Edina M.; Ruel, Marie T.] Int Food Policy Res Inst, Poverty Hlth & Nutr Div, Washington, DC 20036 USA; [Rawat, Rahul] Int Food Policy Res Inst, Poverty Hlth & Nutr Div, Dakar, Senegal; [Tesfaye, Roman] Int Food Policy Res Inst, Poverty Hlth & Nutr Div, Addis Ababa, Ethiopia; [Abebe, Yewelsew] Alive & Thrive, FHI 360, Addis Ababa, Ethiopia; [Baker, Jean] Alive & Thrive, FHI 360, Washington, DC USA; [Frongillo, Edward A.] Univ South Carolina, Dept Hlth Promot Educ & Behav, Columbia, SC USA; [Menon, Purnima] Int Food Policy Res Inst, Poverty Hlth & Nutr Div, New Delhi, India	CGIAR; International Food Policy Research Institute (IFPRI); CGIAR; International Food Policy Research Institute (IFPRI); CGIAR; International Food Policy Research Institute (IFPRI); University of South Carolina System; University of South Carolina Columbia; CGIAR; International Food Policy Research Institute (IFPRI)	Kim, SS (corresponding author), Int Food Policy Res Inst, Poverty Hlth & Nutr Div, Washington, DC 20036 USA.	sunny.kim@cgiar.org		Ruel, Marie/0000-0002-9506-348X	Regional Health Bureaus of Tigray; SNNPR; A&T implementing partners; Bill & Melinda Gates Foundation, through Alive Thrive; CGIAR Research Program on Agriculture for Nutrition and Health [A4NH]	Regional Health Bureaus of Tigray; SNNPR; A&T implementing partners; Bill & Melinda Gates Foundation, through Alive Thrive(CGIAR); CGIAR Research Program on Agriculture for Nutrition and Health(CGIAR)	Funding for this evaluation and the implementation of the interventions was provided by the Bill & Melinda Gates Foundation, through Alive & Thrive, managed by FHI360; additional financial support to the evaluation study was provided by the CGIAR Research Program on Agriculture for Nutrition and Health (A4NH), led by the International Food Policy Research Institute (IFPRI).; The support from the Regional Health Bureaus of Tigray and SNNPR, woreda health officials, health extension workers, community health volunteers, and the A&T implementing partners, particularly Integrated Family Health Program (IFHP) and Relief Society of Tigray (REST), were critical for data collection. We gratefully acknowledge data collection by Addis Continental Institute of Public Health (ACIPH), Addis Ababa. We thank all the study participants for sharing their time and information. We also gratefully acknowledge comments on this manuscript from Ellen Piwoz (Bill & Melinda Gates Foundation), Silvia Alayon (A&T and Save the Children), and Kim Winnard (FHI 360).	Abebe Bekele, 2008, Ethiopian Journal of Health Development, V22, P302; Ali D, J NUTR; Alive & Thrive, 2014, IMPROVING CHILD FEED; Baker J, 2013, FOOD NUTR BULL, V34, pS146, DOI 10.1177/15648265130343S202; Banteyerga H, 2011, MEDICC REV, V13, P46, DOI 10.37757/MR2011V13.N3.11; Bhutta ZA, 2013, LANCET, V382, P452, DOI 10.1016/S0140-6736(13)60996-4; Bhutta ZA, 2011, LANCET, V378, P378, DOI 10.1016/S0140-6736(11)60897-0; Caulfield Laura E., 1999, Food and Nutrition Bulletin, V20, P183; Central Statistical Agency,, 2012, ETH DEM HLTH SURV 20; Central Statistical Agency, 2014, 2014 ETH MIN HLTH SU; Central statistics agency ORC, 2006, ETH DEM HLTH SURV 20; Cogill B, 2003, ANTHROPOMETRIC INDIC; Daelmans B, 2009, FOOD NUTR BULL, V30, pS256, DOI 10.1177/15648265090302S210; Devereux S., 2000, FOOD INSECURITY ETHI; Dewey KG, 2008, REV ARTICLE SYSTEMAT, P24; Ethiopian Public Health Institute, 2015, ETH NAT NUTR PROGR E; Ethiopian Public Health Institute, 2013, ETH NAT FOOD CONS SU; Federal Democratic Republic of Ethiopia Ministry of Health, 2010, HLTH SECT DEV PROGR; Gillespie S, 2015, ADV NUTR, V6, P440, DOI 10.3945/an.115.008276; Habicht JP, 1999, INT J EPIDEMIOL, V28, P10, DOI 10.1093/ije/28.1.10; Haroon S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-S3-S20; Hoddinott J., 2002, DIETARY DIVERSITY FO; Imdad A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S24; Imdad A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S25; Kim SS, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1650-4; Lassi ZS, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-S3-S13; Menon P, COMBINING INTE UNPUB; Menon P, 2013, FOOD NUTR BULL, V34, pS195, DOI 10.1177/15648265130343S206; Perez-Escamilla R, 2012, ADV NUTR, V3, P790, DOI 10.3945/an.112.002873; Rawat R, INCORPORATI IN PRESS; REYNOLDS WM, 1982, J CLIN PSYCHOL, V38, P119, DOI 10.1002/1097-4679(198201)38:1<119::AID-JCLP2270380118>3.0.CO;2-I; Sanghvi T, 2013, FOOD NUTR BULL, V34, pS169, DOI 10.1177/15648265130343S204; Sima, 2013, EVALUATION ETHIOPIAS; Sinha B, 2015, ACTA PAEDIATR, V104, P114, DOI 10.1111/apa.13127; Teklehaimanot HD, 2013, HUM RESOUR HEALTH, V11, DOI 10.1186/1478-4491-11-39; White J., 2012, ASSESSING IMPACT CHI; WHO Multicentre Growth Reference Study Group, 2006, PAEDIATRIA CROATIC S; WHO; UNICEF USAID AED UCDAVIS IFPRI, 2008, IND ASS INF YOUNG 2; World Bank, 2014, WORLD DEV IND 2014	39	178	186	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2016	11	10							e0164800	10.1371/journal.pone.0164800	http://dx.doi.org/10.1371/journal.pone.0164800			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NV	26881746	Green Published, gold, Green Submitted			2022-12-26	WOS:000386203800035
J	Kim, SB; Kang, OH; Lee, YS; Han, SH; Ahn, YS; Cha, SW; Seo, YS; Kong, R; Kwon, DY				Kim, Sung-Bae; Kang, Ok-Hwa; Lee, Young-Seob; Han, Sin-Hee; Ahn, Young-Sup; Cha, Seon-Woo; Seo, Yun-Soo; Kong, Ryong; Kwon, Dong-Yeul			Hepatoprotective Effect and Synergism of Bisdemethoycurcumin against MCD Diet-Induced Nonalcoholic Fatty Liver Disease in Mice	PLOS ONE			English	Article							CURCUMA-LONGA; HEPATIC STEATOSIS; 3T3-L1 ADIPOCYTES; PPAR-GAMMA; STEATOHEPATITIS; ACID; POPULATION; OBESITY; ALPHA; BISDEMETHOXYCURCUMIN	Nonalcoholic fatty liver disease (NAFLD), the hepatic manifestation of the metabolic syndrome, has become one of the most common causes of chronic liver disease over the last decade in developed countries. NAFLD includes a spectrum of pathological hepatic changes, such as steatosis, steatohepatitis, advanced fibrosis, and cirrhosis. Bisdemethoxycurcumin (BDMC) is polyphenolic compounds with a diarylheptanoid skeleton, curcumin close analogues, which is derived from the Curcumae Longae Rhizoma. While the rich bioavailability research of curcumin, BDMC is the poor studies. We investigated whether BDMC has the hepatoprotective effect and combinatory preventive effect with silymarin on methionine choline deficient (MCD)-diet-induced NAFLD in C57BL/6J mice. C57BL/6J mice were divided into five groups of normal (normal diet without any treatment), MCD diet (MCD diet only), MCD + silymarin (SIL) 100 mg/kg group, MCD + BDMC 100 mg/kg group, MCD + SIL 50 mg/kg + BDMC 50 mg/kg group. Body weight, liver weight, liver function tests, histological changes were assessed and quantitative real-time polymerase chain reaction and Western blot analyses were conducted after 4 weeks. Mice lost body weight on the MCD-diet, but BDMC did not lose less than the MCD-diet group. Liver weights decreased from BDMC, but they increased significantly in the MCD-diet groups. All liver function test values decreased from the MCD-diet, whereas those from the BDMC increased significantly. The MCD-diet induced severe hepatic fatty accumulation, but the fatty change was reduced in the BDMC. The BDMC showed an inhibitory effect on liver lipogenesis by reducing associated gene expression caused by the MCD-diet. In all experiments, the combinations of BDMC with SIL had a synergistic effect against MCD-diet models. In conclusion, our findings indicate that BDMC has a potential suppressive effect on NAFLD. Therefore, our data suggest that BDMC may act as a novel and potent therapeutic agent against NAFLD.	[Kim, Sung-Bae; Kang, Ok-Hwa; Seo, Yun-Soo; Kwon, Dong-Yeul] Wonkwang Univ, Wonkwang Oriental Med Res Inst, Dept Oriental Pharm, Coll Pharm, Iksan 570749, Jeonbuk, South Korea; [Lee, Young-Seob; Kong, Ryong] Wonkwang Univ, Profess Grad Sch Oriental Med, Plus Team BK21, Iksan 570749, Jeonbuk, South Korea; [Han, Sin-Hee; Ahn, Young-Sup; Cha, Seon-Woo] RDA, Dept Herbal Crop Res, Natl Inst Hort & Herbal Sci, 92 Bisanro, Eumsung 369873, Chungbuk, South Korea	Wonkwang University; Wonkwang University; National Institute of Horticultural & Herbal Science (NIHHS), Republic of Korea; Rural Development Administration (RDA), Republic of Korea	Kwon, DY (corresponding author), Wonkwang Univ, Wonkwang Oriental Med Res Inst, Dept Oriental Pharm, Coll Pharm, Iksan 570749, Jeonbuk, South Korea.	sssimi@wku.ac.kr		Ruel, Marie/0000-0002-9506-348X	Basic Science Research Program through the National Research Foundation (NRF) of Korea - Ministry of Education [NRF-2013R1A1A2064673, 2013060380]; Korea government (MSIP) [20080062484]; Cooperative Research Program for Agriculture Science & Technology Development, Rural Development Administration, Republic of Korea [PJ00962201]	Basic Science Research Program through the National Research Foundation (NRF) of Korea - Ministry of Education; Korea government (MSIP); Cooperative Research Program for Agriculture Science & Technology Development, Rural Development Administration, Republic of Korea(Rural Development Administration (RDA), Republic of Korea)	This study was supported by the Basic Science Research Program through the National Research Foundation (NRF) of Korea funded by the Ministry of Education (NRF-2013R1A1A2064673), 2013060380, the Korea government (MSIP) (20080062484), and Cooperative Research Program for Agriculture Science & Technology Development (Project No. PJ00962201), Rural Development Administration, Republic of Korea.	Abdelmegeed MA, 2011, J NUTR, V141, P603, DOI 10.3945/jn.110.135210; Adams LA, 2005, GASTROENTEROLOGY, V129, P113, DOI 10.1053/j.gastro.2005.04.014; Ahsan H, 1999, CHEM-BIOL INTERACT, V121, P161, DOI 10.1016/S0009-2797(99)00096-4; Alappat L, 2010, NUTR REV, V68, P729, DOI 10.1111/j.1753-4887.2010.00341.x; AMMON HPT, 1991, PLANTA MED, V57, P1, DOI 10.1055/s-2006-960004; Anstee QM, 2006, INT J EXP PATHOL, V87, P1, DOI 10.1111/j.0959-9673.2006.00465.x; Aoyama T, 1998, J BIOL CHEM, V273, P5678, DOI 10.1074/jbc.273.10.5678; Begriche K, 2006, MITOCHONDRION, V6, P1, DOI 10.1016/j.mito.2005.10.004; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; Chowdhry S, 2010, FREE RADICAL BIO MED, V48, P357, DOI 10.1016/j.freeradbiomed.2009.11.007; Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265; de Melo CL, 2010, CHEM-BIOL INTERACT, V185, P59, DOI 10.1016/j.cbi.2010.02.028; Ejaz A, 2009, J NUTR, V139, P919, DOI 10.3945/jn.108.100966; Hamaguchi M, 2005, ANN INTERN MED, V143, P722, DOI 10.7326/0003-4819-143-10-200511150-00009; Heikkinen S, 2007, BBA-MOL CELL BIOL L, V1771, P999, DOI 10.1016/j.bbalip.2007.03.006; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Hu YC, 2014, J SEP SCI, V37, P404, DOI 10.1002/jssc.201301102; Ip E, 2003, HEPATOLOGY, V38, P123, DOI 10.1053/jhep.2003.50307; Jang HH, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-27; Jayaprakasha GK, 2002, J AGR FOOD CHEM, V50, P3668, DOI 10.1021/jf025506a; Kim DSHL, 2001, NEUROSCI LETT, V303, P57, DOI 10.1016/S0304-3940(01)01677-9; Klover PJ, 2003, DIABETES, V52, P2784, DOI 10.2337/diabetes.52.11.2784; Koteish A, 2002, BEST PRACT RES CL GA, V16, P679, DOI 10.1053/bega.2002.0332; Leclercq IA, 2000, J CLIN INVEST, V105, P1067, DOI 10.1172/JCI8814; Lee YK, 2009, J AGR FOOD CHEM, V57, P305, DOI 10.1021/jf802737z; Li YY, 2013, BIOCHEM PHARMACOL, V86, P1517, DOI 10.1016/j.bcp.2013.08.015; Mesa M. D., 2000, ARS PHARM, V41, P307; Nan YM, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-124; Neuschwander-Tetri BA, 2010, HEPATOLOGY, V52, P774, DOI 10.1002/hep.23719; Oguz A, 2013, EUR REV MED PHARMACO, V17, P457; OSAWA T, 1995, BIOSCI BIOTECH BIOCH, V59, P1609, DOI 10.1271/bbb.59.1609; Ramadori G, 1999, SEMIN LIVER DIS, V19, P141, DOI 10.1055/s-2007-1007106; Rizki G, 2006, J LIPID RES, V47, P2280, DOI 10.1194/jlr.M600198-JLR200; Salamone F, 2012, DIGEST LIVER DIS, V44, P334, DOI 10.1016/j.dld.2011.11.010; Semenkovich CF, 1997, PROG LIPID RES, V36, P43, DOI 10.1016/S0163-7827(97)00003-9; Semwal AD, 1997, J FOOD SCI TECH MYS, V34, P67; Simon A, 1998, CANCER LETT, V129, P111, DOI 10.1016/S0304-3835(98)00092-5; Starley BQ, 2010, HEPATOLOGY, V51, P1820, DOI 10.1002/hep.23594; Suzuki A, 2005, HEPATOLOGY, V41, P64, DOI 10.1002/hep.20543; TODA S, 1985, CHEM PHARM BULL, V33, P1725; Viollet B, 2006, J PHYSIOL-LONDON, V574, P41, DOI 10.1113/jphysiol.2006.108506; YAO Z, 1990, BIOCHEM CELL BIOL, V68, P552, DOI 10.1139/o90-079; You Y, 2010, FOOD CHEM TOXICOL, V48, P1632, DOI 10.1016/j.fct.2010.03.037; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	44	178	186	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0147745	10.1371/journal.pone.0147745	http://dx.doi.org/10.1371/journal.pone.0147745			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	26881746	Green Submitted, Green Published, gold			2022-12-26	WOS:000371219000006
